id|nct_id|result_group_id|ctgov_group_code|period|reason|count|drop_withdraw_comment|reason_comment|count_units
27835739|NCT03305848|54320605|FG000|Overall Study|Symptom resolution after consent, but before study drug administration|1|||
27835740|NCT03305848|54320605|FG000|Overall Study|Physician Decision|2|||
27835741|NCT01563029|54320614|FG000|Overall Study|Adverse Event|1|||
27835742|NCT01563029|54320615|FG001|Overall Study|Adverse Event|0|||
27835743|NCT01563029|54320616|FG002|Overall Study|Adverse Event|1|||
27835744|NCT01563029|54320617|FG003|Overall Study|Adverse Event|2|||
27835745|NCT01563029|54320618|FG004|Overall Study|Adverse Event|1|||
27835746|NCT01563029|54320614|FG000|Overall Study|Lack of Efficacy|42|||
27835747|NCT01563029|54320615|FG001|Overall Study|Lack of Efficacy|16|||
27835748|NCT01563029|54320616|FG002|Overall Study|Lack of Efficacy|23|||
27835749|NCT01563029|54320617|FG003|Overall Study|Lack of Efficacy|21|||
27835750|NCT01563029|54320618|FG004|Overall Study|Lack of Efficacy|19|||
27835751|NCT01563029|54320614|FG000|Overall Study|Protocol Violation|1|||
28103832|NCT03366194|54760568|FG000|Overall Study|Lost to Follow-up|2|||
28103833|NCT02839798|54760573|FG000|Overall Study|Withdrawal by Subject|2|||
28103834|NCT03345836|54760580|FG000|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|5|||
28103835|NCT03345836|54760581|FG001|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|17|||
28103836|NCT03345836|54760582|FG002|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|2|||
28103837|NCT03345836|54760583|FG003|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
27746811|NCT02117050|54196457|FG000|Overall Study|Subject Enrolled but not Dosed|1|||
27746812|NCT02728895|54196464|FG000|Overall Study|Other|1|||
27746813|NCT02728895|54196465|FG001|Overall Study|Other|2|||
27746814|NCT02728895|54196464|FG000|Overall Study|Withdrawal by Subject|0|||
27746815|NCT02728895|54196465|FG001|Overall Study|Withdrawal by Subject|3|||
27746816|NCT02606877|54196473|FG000|Overall Study|Adverse Event|3|||
27746817|NCT02606877|54196474|FG001|Overall Study|Adverse Event|0|||
27835752|NCT01563029|54320615|FG001|Overall Study|Protocol Violation|2|||
27835753|NCT01563029|54320616|FG002|Overall Study|Protocol Violation|3|||
27835754|NCT01563029|54320617|FG003|Overall Study|Protocol Violation|1|||
27835755|NCT01563029|54320618|FG004|Overall Study|Protocol Violation|3|||
27835756|NCT01563029|54320614|FG000|Overall Study|Protocol defined stopping criteria|1|||
27835757|NCT01563029|54320615|FG001|Overall Study|Protocol defined stopping criteria|0|||
27835758|NCT01563029|54320616|FG002|Overall Study|Protocol defined stopping criteria|0|||
27835759|NCT01563029|54320617|FG003|Overall Study|Protocol defined stopping criteria|0|||
27835760|NCT01563029|54320618|FG004|Overall Study|Protocol defined stopping criteria|0|||
27835761|NCT01563029|54320614|FG000|Overall Study|Lost to Follow-up|1|||
27835762|NCT01563029|54320615|FG001|Overall Study|Lost to Follow-up|0|||
27835763|NCT01563029|54320616|FG002|Overall Study|Lost to Follow-up|1|||
27835764|NCT01563029|54320617|FG003|Overall Study|Lost to Follow-up|1|||
27835765|NCT01563029|54320618|FG004|Overall Study|Lost to Follow-up|1|||
27835766|NCT01563029|54320614|FG000|Overall Study|Physician Decision|3|||
27835767|NCT01563029|54320615|FG001|Overall Study|Physician Decision|5|||
28103838|NCT03345836|54760584|FG004|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
28103839|NCT03345836|54760585|FG005|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
28103840|NCT03345836|54760580|FG000|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
28103841|NCT03345836|54760581|FG001|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
27746818|NCT02606877|54196473|FG000|Overall Study|Non-compliance with protocol|0|||
27835768|NCT01563029|54320616|FG002|Overall Study|Physician Decision|2|||
27835769|NCT01563029|54320617|FG003|Overall Study|Physician Decision|4|||
27835770|NCT01563029|54320618|FG004|Overall Study|Physician Decision|2|||
27835771|NCT01563029|54320614|FG000|Overall Study|Withdrawal by Subject|4|||
27835772|NCT01563029|54320615|FG001|Overall Study|Withdrawal by Subject|1|||
27835773|NCT01563029|54320616|FG002|Overall Study|Withdrawal by Subject|3|||
27835774|NCT01563029|54320617|FG003|Overall Study|Withdrawal by Subject|4|||
27835775|NCT01563029|54320618|FG004|Overall Study|Withdrawal by Subject|3|||
27835776|NCT01562873|54320631|FG000|Overall Study|Disease Progression per RECIST|10|||
27835777|NCT01562873|54320632|FG001|Overall Study|Disease Progression per RECIST|0|||
27835778|NCT01562873|54320631|FG000|Overall Study|Adverse Event|1|||
27835779|NCT01562873|54320632|FG001|Overall Study|Adverse Event|0|||
27835780|NCT01562873|54320631|FG000|Overall Study|Clinical Disease Progression|9|||
27835781|NCT01562873|54320632|FG001|Overall Study|Clinical Disease Progression|0|||
27835782|NCT01562873|54320631|FG000|Overall Study|Clinical PD and adverse event|1|||
27835783|NCT01562873|54320632|FG001|Overall Study|Clinical PD and adverse event|0|||
27835784|NCT03273712|54320636|FG000|Overall Study|Death|5|||
27835785|NCT03273712|54320636|FG000|Overall Study|Adverse Event|1|||
27835786|NCT03273712|54320636|FG000|Overall Study|Disease Progression|1|||
27835787|NCT01562327|54320641|FG000|Overall Study|Adverse Event|2|||
27746819|NCT02606877|54196474|FG001|Overall Study|Non-compliance with protocol|1|||
27835788|NCT01562327|54320641|FG000|Overall Study|Lack of Efficacy|1|||
27835789|NCT01562327|54320641|FG000|Overall Study|Participant drop-out|1|||
27835790|NCT01562327|54320641|FG000|Overall Study|Infusion not received at 6 month window|4|||
27835791|NCT01561313|54320648|FG000|Overall Study|Withdrawal by Subject|1|||
28103842|NCT03345836|54760582|FG002|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|3|||
28103843|NCT03345836|54760583|FG003|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
27746820|NCT02606877|54196473|FG000|Overall Study|Other than listed above|1|||
28103844|NCT03345836|54760584|FG004|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
28103845|NCT03345836|54760585|FG005|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
28103846|NCT03345836|54760580|FG000|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
28103847|NCT03345836|54760581|FG001|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|1|||
28103848|NCT03345836|54760582|FG002|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
28103849|NCT03345836|54760583|FG003|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
28103850|NCT03345836|54760584|FG004|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
28103851|NCT03345836|54760585|FG005|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
28103852|NCT03345836|54760580|FG000|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|8|||
28103853|NCT03345836|54760581|FG001|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|4|||
28103854|NCT03345836|54760582|FG002|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
28103855|NCT03345836|54760583|FG003|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
28103856|NCT03345836|54760584|FG004|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
28103857|NCT03345836|54760585|FG005|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
28103858|NCT03345836|54760580|FG000|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
28103859|NCT03345836|54760581|FG001|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|3|||
28103860|NCT03345836|54760582|FG002|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
28103861|NCT03345836|54760583|FG003|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
28103862|NCT03345836|54760584|FG004|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
28103863|NCT03345836|54760585|FG005|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
28103864|NCT03345836|54760580|FG000|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
28103865|NCT03345836|54760581|FG001|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
28103866|NCT03345836|54760582|FG002|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
28103867|NCT03345836|54760583|FG003|Period 2: 12-Week Extended Treatment|Adverse Event|8|||
28103868|NCT03345836|54760584|FG004|Period 2: 12-Week Extended Treatment|Adverse Event|5|||
28103869|NCT03345836|54760585|FG005|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
28103870|NCT03345836|54760580|FG000|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
28103871|NCT03345836|54760581|FG001|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
28103872|NCT03345836|54760582|FG002|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
28103873|NCT03345836|54760583|FG003|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
28103874|NCT03345836|54760584|FG004|Period 2: 12-Week Extended Treatment|Withdrew Consent|5|||
28103875|NCT03345836|54760585|FG005|Period 2: 12-Week Extended Treatment|Withdrew Consent|1|||
28103876|NCT03345836|54760580|FG000|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
28103877|NCT03345836|54760581|FG001|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
28103878|NCT03345836|54760582|FG002|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
28103879|NCT03345836|54760583|FG003|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
28103880|NCT03345836|54760584|FG004|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
28103881|NCT03345836|54760585|FG005|Period 2: 12-Week Extended Treatment|Lost to Follow-up|1|||
28103882|NCT03345836|54760580|FG000|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
28103883|NCT03345836|54760581|FG001|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
28103884|NCT03345836|54760582|FG002|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
28103885|NCT03345836|54760583|FG003|Period 2: 12-Week Extended Treatment|Lack of Efficacy|2|||
28103886|NCT03345836|54760584|FG004|Period 2: 12-Week Extended Treatment|Lack of Efficacy|6|||
28103887|NCT03345836|54760585|FG005|Period 2: 12-Week Extended Treatment|Lack of Efficacy|3|||
28103888|NCT03345836|54760580|FG000|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
28103889|NCT03345836|54760581|FG001|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
28103890|NCT03345836|54760582|FG002|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
28103891|NCT03345836|54760583|FG003|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
28103892|NCT03345836|54760584|FG004|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|1|||
27746821|NCT02606877|54196474|FG001|Overall Study|Other than listed above|0|||
27746822|NCT02606643|54196484|FG000|Overall Study|did not meet inclusion criteria|1|||
27746823|NCT02606643|54196485|FG001|Overall Study|did not meet inclusion criteria|3|||
27746824|NCT02609607|54196516|FG000|Overall Study|Lost to Follow-up|0|||
27746825|NCT02609607|54196517|FG001|Overall Study|Lost to Follow-up|1|||
27746826|NCT02606253|54196526|FG000|Overall Study|Adverse Event|2|||
27746827|NCT02606253|54196527|FG001|Overall Study|Adverse Event|0|||
27746828|NCT02606253|54196528|FG002|Overall Study|Adverse Event|0|||
27746829|NCT02606253|54196526|FG000|Overall Study|Protocol Violation|2|||
27746830|NCT02606253|54196527|FG001|Overall Study|Protocol Violation|1|||
27746831|NCT02606253|54196528|FG002|Overall Study|Protocol Violation|0|||
27746832|NCT02606253|54196526|FG000|Overall Study|Physician Decision|1|||
27746833|NCT02606253|54196527|FG001|Overall Study|Physician Decision|1|||
27746834|NCT02606253|54196528|FG002|Overall Study|Physician Decision|0|||
27746835|NCT02607735|54196538|FG000|Primary Study|Randomized but Never Treated|1|||
27746836|NCT02607735|54196539|FG001|Primary Study|Randomized but Never Treated|0|||
28103893|NCT03345836|54760585|FG005|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
28103894|NCT03345836|54760580|FG000|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
28103895|NCT03345836|54760581|FG001|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
28103896|NCT03345836|54760582|FG002|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
28103897|NCT03345836|54760583|FG003|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
28103898|NCT03345836|54760584|FG004|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
28103899|NCT03345836|54760585|FG005|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
28103900|NCT02839330|54760605|FG000|Overall Study|Adverse Event|0|||
28103901|NCT02839330|54760606|FG001|Overall Study|Adverse Event|1|||
28103902|NCT02839330|54760607|FG002|Overall Study|Adverse Event|2|||
28103903|NCT02839330|54760608|FG003|Overall Study|Adverse Event|2|||
28103904|NCT02839330|54760605|FG000|Overall Study|Death|4|||
28103905|NCT02839330|54760606|FG001|Overall Study|Death|6|||
28103906|NCT02839330|54760607|FG002|Overall Study|Death|1|||
28103907|NCT02839330|54760608|FG003|Overall Study|Death|1|||
28103908|NCT02839330|54760605|FG000|Overall Study|Withdrawal by Subject|27|||
28103909|NCT02839330|54760606|FG001|Overall Study|Withdrawal by Subject|19|||
28103910|NCT02839330|54760607|FG002|Overall Study|Withdrawal by Subject|11|||
28103911|NCT02839330|54760608|FG003|Overall Study|Withdrawal by Subject|13|||
28103912|NCT02839330|54760605|FG000|Overall Study|Lost to Follow-up|22|||
28103913|NCT02839330|54760606|FG001|Overall Study|Lost to Follow-up|27|||
28103914|NCT02839330|54760607|FG002|Overall Study|Lost to Follow-up|29|||
28103915|NCT02839330|54760608|FG003|Overall Study|Lost to Follow-up|25|||
28103916|NCT02839330|54760605|FG000|Overall Study|Administrative Reason|0|||
28103917|NCT02839330|54760606|FG001|Overall Study|Administrative Reason|0|||
28103918|NCT02839330|54760607|FG002|Overall Study|Administrative Reason|0|||
28103919|NCT02839330|54760608|FG003|Overall Study|Administrative Reason|1|||
28103920|NCT02839330|54760605|FG000|Overall Study|Protocol Violation|1|||
28103921|NCT02839330|54760606|FG001|Overall Study|Protocol Violation|2|||
28103922|NCT02839330|54760607|FG002|Overall Study|Protocol Violation|2|||
28103923|NCT02839330|54760608|FG003|Overall Study|Protocol Violation|3|||
28103924|NCT02839330|54760605|FG000|Overall Study|Other reason, not specified|4|||
28103925|NCT02839330|54760606|FG001|Overall Study|Other reason, not specified|3|||
28103926|NCT02839330|54760607|FG002|Overall Study|Other reason, not specified|3|||
28103927|NCT02839330|54760608|FG003|Overall Study|Other reason, not specified|6|||
28103928|NCT03363776|54760622|FG000|Overall Study|Progressive disease|2|||
28103929|NCT03363776|54760623|FG001|Overall Study|Progressive disease|3|||
28103930|NCT03363776|54760624|FG002|Overall Study|Progressive disease|1|||
28103931|NCT03363776|54760622|FG000|Overall Study|Study drug toxicity|0|||
28103932|NCT03363776|54760623|FG001|Overall Study|Study drug toxicity|0|||
28103933|NCT03363776|54760624|FG002|Overall Study|Study drug toxicity|1|||
28103934|NCT03363776|54760622|FG000|Overall Study|Death|1|||
28103935|NCT03363776|54760623|FG001|Overall Study|Death|0|||
28103936|NCT03363776|54760624|FG002|Overall Study|Death|0|||
28103937|NCT03360344|54760635|FG000|Overall Study|Withdrawal by Subject|0|||
28103938|NCT03360344|54760636|FG001|Overall Study|Withdrawal by Subject|1|||
28103939|NCT03360344|54760637|FG002|Overall Study|Withdrawal by Subject|1|||
28103940|NCT02838628|54760647|FG000|Recurrence Follow-up Period|AK Recurrence|18|||
28103941|NCT02838628|54760648|FG001|Recurrence Follow-up Period|AK Recurrence|13|||
28103942|NCT02838628|54760647|FG000|Recurrence Follow-up Period|Adverse Event|1|||
28103943|NCT02838628|54760648|FG001|Recurrence Follow-up Period|Adverse Event|0|||
28103944|NCT02838628|54760647|FG000|Recurrence Follow-up Period|Non-compliance|0|||
28103945|NCT02838628|54760648|FG001|Recurrence Follow-up Period|Non-compliance|1|||
28103946|NCT02838628|54760647|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
27746837|NCT02607735|54196540|FG002|Primary Study|Randomized but Never Treated|0|||
27746838|NCT02607735|54196538|FG000|Primary Study|Lost to Follow-up|4|||
27746839|NCT02607735|54196539|FG001|Primary Study|Lost to Follow-up|0|||
27746840|NCT02607735|54196540|FG002|Primary Study|Lost to Follow-up|0|||
27746841|NCT02607735|54196538|FG000|Primary Study|Withdrew Consent|2|||
27746842|NCT02607735|54196539|FG001|Primary Study|Withdrew Consent|0|||
27746843|NCT02607735|54196540|FG002|Primary Study|Withdrew Consent|0|||
27746844|NCT02607735|54196538|FG000|Deferred Treatment Substudy|Lost to Follow-up|0|||
27746845|NCT02607735|54196539|FG001|Deferred Treatment Substudy|Lost to Follow-up|0|||
27746846|NCT02607735|54196540|FG002|Deferred Treatment Substudy|Lost to Follow-up|4|||
27746847|NCT02607735|54196538|FG000|Deferred Treatment Substudy|Withdrew Consent|0|||
27746848|NCT02607735|54196539|FG001|Deferred Treatment Substudy|Withdrew Consent|0|||
28103947|NCT02838628|54760648|FG001|Recurrence Follow-up Period|Withdrawal by Subject|2|||
28103948|NCT02838628|54760647|FG000|Recurrence Follow-up Period|Other un-specified|1|||
28103949|NCT02838628|54760648|FG001|Recurrence Follow-up Period|Other un-specified|1|||
28103950|NCT02835820|54760657|FG000|Overall Study|Baseline Screen Failure|0|||
28103951|NCT02835820|54760658|FG001|Overall Study|Baseline Screen Failure|3|||
28103952|NCT03359174|54760664|FG000|Overall Study|Adverse Event|1|||
28103953|NCT02832622|54760668|FG000|Overall Study|MPP not programmed|1259|||
27746849|NCT02607735|54196540|FG002|Deferred Treatment Substudy|Withdrew Consent|1|||
27746850|NCT01668537|54196550|FG000|Overall Study|Request to Discontinue Prematurely|1|||
27746851|NCT01668537|54196551|FG001|Overall Study|Request to Discontinue Prematurely|1|||
28103954|NCT02832622|54760668|FG000|Overall Study|Withdrawal by Subject|123|||
28103955|NCT02832622|54760668|FG000|Overall Study|Death|119|||
28103956|NCT02832622|54760668|FG000|Overall Study|Unsuccessful CRT implant|93|||
28103957|NCT02832622|54760668|FG000|Overall Study|Lost to Follow-up|45|||
28103958|NCT02832622|54760668|FG000|Overall Study|Patient non-compliance|42|||
28103959|NCT02832622|54760668|FG000|Overall Study|Withdrawal by other reasons|25|||
28103960|NCT02832622|54760668|FG000|Overall Study|System explant|24|||
28103961|NCT02832622|54760668|FG000|Overall Study|Physician Decision|6|||
28103962|NCT00093015|54760675|FG000|Overall Study|Withdrawal by Subject|194|||
28103963|NCT00093015|54760676|FG001|Overall Study|Withdrawal by Subject|171|||
28103964|NCT00093015|54760675|FG000|Overall Study|Lost to Follow-up|96|||
28103965|NCT00093015|54760676|FG001|Overall Study|Lost to Follow-up|108|||
28103966|NCT00093015|54760675|FG000|Overall Study|Death|375|||
28103967|NCT00093015|54760676|FG001|Overall Study|Death|385|||
28103968|NCT03358472|54760685|FG000|Overall Study|Death|6|||
28103969|NCT03358472|54760686|FG001|Overall Study|Death|3|||
28103970|NCT03358472|54760687|FG002|Overall Study|Death|10|||
28103971|NCT03358472|54760685|FG000|Overall Study|Physician Decision|0|||
28103972|NCT03358472|54760686|FG001|Overall Study|Physician Decision|1|||
28103973|NCT03358472|54760687|FG002|Overall Study|Physician Decision|0|||
28103974|NCT03358472|54760685|FG000|Overall Study|Withdrawal by Subject|0|||
28103975|NCT03358472|54760686|FG001|Overall Study|Withdrawal by Subject|0|||
28103976|NCT03358472|54760687|FG002|Overall Study|Withdrawal by Subject|1|||
28103977|NCT03358472|54760685|FG000|Overall Study|On-going at clinical cut off date|9|||
28103978|NCT03358472|54760686|FG001|Overall Study|On-going at clinical cut off date|6|||
28103979|NCT03358472|54760687|FG002|Overall Study|On-going at clinical cut off date|5|||
28103980|NCT03358238|54760697|FG000|Overall Study|Withdrawal by Subject|0|||
28103981|NCT03358238|54760698|FG001|Overall Study|Withdrawal by Subject|1|||
28103982|NCT03342638|54760710|FG000|Overall Study|Withdrawal by Subject|1|||
28103983|NCT03342638|54760711|FG001|Overall Study|Withdrawal by Subject|0|||
28103984|NCT03342638|54760710|FG000|Overall Study|Physician Decision|0|||
28103985|NCT03342638|54760711|FG001|Overall Study|Physician Decision|1|||
28103986|NCT03342560|54760717|FG000|Overall Study|Lost to Follow-up|2|||
28103987|NCT03355742|54760734|FG000|Overall Study|Lost to Follow-up|4|||
28103988|NCT03355742|54760734|FG000|Overall Study|Withdrawal by Subject|29|||
28103989|NCT03355742|54760734|FG000|Overall Study|Physician Decision|6|||
28103990|NCT03355742|54760734|FG000|Overall Study|Death|55|||
28103991|NCT03355742|54760734|FG000|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5|||
28103992|NCT03341312|54760738|FG000|Period 1|Withdrawal by Subject|0|||
28103993|NCT03341312|54760739|FG001|Period 1|Withdrawal by Subject|1|||
28103994|NCT03341312|54760740|FG002|Period 1|Withdrawal by Subject|0|||
28103995|NCT03341312|54760741|FG003|Period 1|Withdrawal by Subject|0|||
28103996|NCT02949908|54760753|FG000|Overall Study|Study termination|2|||
28103997|NCT01358734|54760760|FG000|Overall Study|Adverse Event|4|||
28103998|NCT01358734|54760761|FG001|Overall Study|Adverse Event|7|||
28103999|NCT01358734|54760762|FG002|Overall Study|Adverse Event|3|||
28104000|NCT01358734|54760760|FG000|Overall Study|Lack of Efficacy|0|||
28104001|NCT01358734|54760761|FG001|Overall Study|Lack of Efficacy|1|||
28104002|NCT01358734|54760762|FG002|Overall Study|Lack of Efficacy|3|||
28104003|NCT01358734|54760760|FG000|Overall Study|Withdrawal by Subject|1|||
28104004|NCT01358734|54760761|FG001|Overall Study|Withdrawal by Subject|6|||
28104005|NCT01358734|54760762|FG002|Overall Study|Withdrawal by Subject|3|||
28104006|NCT01358734|54760760|FG000|Overall Study|Death|3|||
28104007|NCT01358734|54760761|FG001|Overall Study|Death|7|||
28104008|NCT01358734|54760762|FG002|Overall Study|Death|2|||
28104009|NCT01358734|54760760|FG000|Overall Study|Progressive Disease|5|||
28104010|NCT01358734|54760761|FG001|Overall Study|Progressive Disease|13|||
28104011|NCT01358734|54760762|FG002|Overall Study|Progressive Disease|16|||
28104012|NCT01358734|54760760|FG000|Overall Study|Non-compliance with study drug|0|||
28104013|NCT01358734|54760761|FG001|Overall Study|Non-compliance with study drug|0|||
28104014|NCT01358734|54760762|FG002|Overall Study|Non-compliance with study drug|1|||
28104015|NCT01358734|54760760|FG000|Overall Study|Other|2|||
28104016|NCT01358734|54760761|FG001|Overall Study|Other|5|||
28104017|NCT01358734|54760762|FG002|Overall Study|Other|4|||
28104018|NCT01358734|54760760|FG000|Overall Study|Protocol Violation|0|||
28104019|NCT01358734|54760761|FG001|Overall Study|Protocol Violation|0|||
28104020|NCT01358734|54760762|FG002|Overall Study|Protocol Violation|2|||
28104021|NCT01341652|54760772|FG000|Overall Study|Incorrect Random Assignment|0|||
28104022|NCT01341652|54760773|FG001|Overall Study|Incorrect Random Assignment|1|||
28104023|NCT01341652|54760772|FG000|Overall Study|ineligible; presence metastatic disease|0|||
28104024|NCT01341652|54760773|FG001|Overall Study|ineligible; presence metastatic disease|1|||
28104025|NCT02828644|54760781|FG000|Overall Study|Lost to Follow-up|23|||
28104026|NCT02828644|54760782|FG001|Overall Study|Lost to Follow-up|22|||
28104027|NCT02949362|54760791|FG000|Retrospective Period|Inform consent not signed by participant|4|||
28104028|NCT02949362|54760792|FG001|Retrospective Period|Inform consent not signed by participant|1|||
28104029|NCT02949362|54760793|FG002|Retrospective Period|Inform consent not signed by participant|0|||
28104030|NCT02949362|54760794|FG003|Retrospective Period|Inform consent not signed by participant|0|||
28104031|NCT02949362|54760791|FG000|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
28104032|NCT02949362|54760792|FG001|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
28104033|NCT02949362|54760793|FG002|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|1|||
28104034|NCT02949362|54760794|FG003|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
28104035|NCT02949362|54760791|FG000|Prospective Period|Other|0|||
28104036|NCT02949362|54760792|FG001|Prospective Period|Other|0|||
27746852|NCT01668537|54196550|FG000|Overall Study|Subject unwilling/unable to comply|5|||
27746853|NCT01668537|54196551|FG001|Overall Study|Subject unwilling/unable to comply|0|||
27746854|NCT01668537|54196550|FG000|Overall Study|Reason Precludes Participation|1|||
27746855|NCT01668537|54196551|FG001|Overall Study|Reason Precludes Participation|0|||
27746856|NCT01668537|54196550|FG000|Overall Study|Lost to Follow-up|13|||
27746857|NCT01668537|54196551|FG001|Overall Study|Lost to Follow-up|6|||
27746858|NCT01668537|54196550|FG000|Overall Study|Other|2|||
27746859|NCT01668537|54196551|FG001|Overall Study|Other|3|||
27746860|NCT01668147|54196557|FG000|Overall Study|Withdrawal by Subject|6|||
27746861|NCT02600559|54196574|FG000|Overall Study|Withdrawal by Subject|3|||
27746862|NCT02600559|54196574|FG000|Overall Study|Lost to Follow-up|20|||
27746863|NCT02601573|54196583|FG000|Overall Study|Lost to Follow-up|0|||
27746864|NCT02601573|54196584|FG001|Overall Study|Lost to Follow-up|3|||
27746865|NCT02601573|54196585|FG002|Overall Study|Lost to Follow-up|1|||
27746866|NCT02601573|54196586|FG003|Overall Study|Lost to Follow-up|0|||
27746867|NCT02601573|54196587|FG004|Overall Study|Lost to Follow-up|2|||
28104037|NCT02949362|54760793|FG002|Prospective Period|Other|0|||
28104038|NCT02949362|54760794|FG003|Prospective Period|Other|4|||
28104039|NCT02947022|54760806|FG000|Overall Study|Study Stopped|1|||
28104040|NCT03338972|54760817|FG000|Overall Study|Death|1|||
28104041|NCT03338972|54760818|FG001|Overall Study|Death|1|||
28104042|NCT03338972|54760819|FG002|Overall Study|Death|0|||
28104043|NCT03338972|54760820|FG003|Overall Study|Death|0|||
28104044|NCT03338972|54760817|FG000|Overall Study|Withdrawal by Subject|1|||
28104045|NCT03338972|54760818|FG001|Overall Study|Withdrawal by Subject|0|||
28104046|NCT03338972|54760819|FG002|Overall Study|Withdrawal by Subject|0|||
27746868|NCT02601573|54196583|FG000|Overall Study|Withdrawal by Subject|0|||
27746869|NCT02601573|54196584|FG001|Overall Study|Withdrawal by Subject|1|||
27746870|NCT02601573|54196585|FG002|Overall Study|Withdrawal by Subject|0|||
27746871|NCT02601573|54196586|FG003|Overall Study|Withdrawal by Subject|1|||
27746872|NCT02601573|54196587|FG004|Overall Study|Withdrawal by Subject|0|||
27746873|NCT02601027|54196601|FG000|Registration to Surgery|Withdrawal by Subject|20|||
27746874|NCT02601027|54196602|FG001|Registration to Surgery|Withdrawal by Subject|10|||
27746875|NCT02600871|54196610|FG000|Overall Study|Lost to Follow-up|13|||
27746876|NCT02600871|54196611|FG001|Overall Study|Lost to Follow-up|10|||
27746877|NCT02598297|54196620|FG000|Overall Study|Study terminated by Sponsor|21|||
27746878|NCT02598297|54196621|FG001|Overall Study|Study terminated by Sponsor|23|||
27746879|NCT02598297|54196620|FG000|Overall Study|Adverse Event|1|||
27746880|NCT02598297|54196621|FG001|Overall Study|Adverse Event|1|||
27746881|NCT02598297|54196620|FG000|Overall Study|Physician Decision|1|||
27746882|NCT02598297|54196621|FG001|Overall Study|Physician Decision|0|||
28104047|NCT03338972|54760820|FG003|Overall Study|Withdrawal by Subject|0|||
28104048|NCT03338894|54760830|FG000|Overall Study|not able able to attend 9 or more classes|10|||
28104049|NCT03338816|54760836|FG000|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
28104050|NCT03338816|54760837|FG001|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
28104051|NCT03338816|54760838|FG002|6-Month DB + Open-Label Extension Period|Adverse Event|2|||
28104052|NCT03338816|54760839|FG003|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
28104053|NCT03338816|54760836|FG000|6-Month DB + Open-Label Extension Period|Death|0|||
28104054|NCT03338816|54760837|FG001|6-Month DB + Open-Label Extension Period|Death|0|||
28104055|NCT03338816|54760838|FG002|6-Month DB + Open-Label Extension Period|Death|0|||
28104056|NCT03338816|54760839|FG003|6-Month DB + Open-Label Extension Period|Death|1|||
27746883|NCT02598297|54196620|FG000|Overall Study|Subject/guardian decision|1|||
27746884|NCT02598297|54196621|FG001|Overall Study|Subject/guardian decision|0|||
27746885|NCT02598297|54196620|FG000|Overall Study|Followed for survival|1|||
27746886|NCT02598297|54196621|FG001|Overall Study|Followed for survival|0|||
27746887|NCT02596893|54196631|FG000|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61|||
27746888|NCT02596893|54196632|FG001|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56|||
27746889|NCT02596893|54196633|FG002|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48|||
27746890|NCT02596893|54196634|FG003|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58|||
28104057|NCT03338816|54760836|FG000|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
28104058|NCT03338816|54760837|FG001|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
28104059|NCT03338816|54760838|FG002|6-Month DB + Open-Label Extension Period|Lost to Follow-up|1|||
28104060|NCT03338816|54760839|FG003|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
28104061|NCT03338816|54760836|FG000|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
28104062|NCT03338816|54760837|FG001|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
28104063|NCT03338816|54760838|FG002|6-Month DB + Open-Label Extension Period|Physician Decision|1|||
27746891|NCT02596893|54196631|FG000|Overall Double-Blind Period Weeks 0-52|Adverse Event|11|||
27835792|NCT01561313|54320649|FG001|Overall Study|Withdrawal by Subject|0|||
27835793|NCT01561313|54320648|FG000|Overall Study|Adverse event and withdrawal by subject|1|||
27835794|NCT01561313|54320649|FG001|Overall Study|Adverse event and withdrawal by subject|0|||
27835795|NCT01561079|54320655|FG000|Overall Study|Physician Decision|17|||
27835796|NCT01561079|54320655|FG000|Overall Study|Withdrawal by Subject|59|||
27835797|NCT01561079|54320655|FG000|Overall Study|Protocol Violation|2|||
27835798|NCT01559675|54320700|FG000|Overall Study|Protocol Violation|1|||
27835799|NCT01559675|54320701|FG001|Overall Study|Protocol Violation|2|||
27835800|NCT01559675|54320700|FG000|Overall Study|2nd operation on same patient excluded|14|||
27835801|NCT01559675|54320701|FG001|Overall Study|2nd operation on same patient excluded|12|||
27835802|NCT01374906|54320709|FG000|Overall Study|Abnormal laboratory value(s)|0|||
27835803|NCT01374906|54320710|FG001|Overall Study|Abnormal laboratory value(s)|3|||
27835804|NCT01374906|54320709|FG000|Overall Study|Administrative problems|2|||
27835805|NCT01374906|54320710|FG001|Overall Study|Administrative problems|2|||
27835806|NCT01374906|54320709|FG000|Overall Study|Adverse Event|10|||
27835807|NCT01374906|54320710|FG001|Overall Study|Adverse Event|11|||
27835808|NCT01374906|54320709|FG000|Overall Study|Death|0|||
27835809|NCT01374906|54320710|FG001|Overall Study|Death|2|||
27835810|NCT01374906|54320709|FG000|Overall Study|Protocol Violation|2|||
27835811|NCT01374906|54320710|FG001|Overall Study|Protocol Violation|2|||
27835812|NCT01374906|54320709|FG000|Overall Study|Withdrawal by Subject|15|||
27835813|NCT01374906|54320710|FG001|Overall Study|Withdrawal by Subject|9|||
27835814|NCT01374906|54320709|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
27835815|NCT01374906|54320710|FG001|Overall Study|Unsatisfactory therapeutic effect|19|||
27835816|NCT02683746|54320740|FG000|Overall Study|Adverse Event|3|||
27835817|NCT02683746|54320741|FG001|Overall Study|Adverse Event|2|||
27835818|NCT02683746|54320740|FG000|Overall Study|Lost to Follow-up|5|||
27835819|NCT02683746|54320741|FG001|Overall Study|Lost to Follow-up|6|||
27835820|NCT02683746|54320740|FG000|Overall Study|Withdrawal by Subject|6|||
27835821|NCT02683746|54320741|FG001|Overall Study|Withdrawal by Subject|5|||
27835822|NCT02683746|54320740|FG000|Overall Study|Physician Decision|2|||
27835823|NCT02683746|54320741|FG001|Overall Study|Physician Decision|1|||
27835824|NCT01559129|54320749|FG000|Treatment Phase|Adverse Event|0|||
27835825|NCT01559129|54320750|FG001|Treatment Phase|Adverse Event|2|||
27835826|NCT01559129|54320749|FG000|Treatment Phase|Progressive Disease|1|||
27835827|NCT01559129|54320750|FG001|Treatment Phase|Progressive Disease|1|||
27835828|NCT01559129|54320749|FG000|Treatment Phase|Lack of Efficacy|0|||
27835829|NCT01559129|54320750|FG001|Treatment Phase|Lack of Efficacy|1|||
27835830|NCT01559129|54320749|FG000|Treatment Phase|Study Terminated by Sponsor|3|||
27835831|NCT01559129|54320750|FG001|Treatment Phase|Study Terminated by Sponsor|2|||
27835832|NCT01559129|54320749|FG000|Treatment Phase|Protocol Exclusion Criteria|1|||
27835833|NCT01559129|54320750|FG001|Treatment Phase|Protocol Exclusion Criteria|0|||
27835834|NCT01559129|54320749|FG000|Treatment Phase|Did Not Receive Study Drug|0|||
27835835|NCT01559129|54320750|FG001|Treatment Phase|Did Not Receive Study Drug|1|||
27835836|NCT01559129|54320749|FG000|Open-label Extension Period|Adverse Event|1|||
27835837|NCT01559129|54320750|FG001|Open-label Extension Period|Adverse Event|0|||
27835838|NCT01559129|54320749|FG000|Open-label Extension Period|Study Terminated by Sponsor|5|||
27835839|NCT01559129|54320750|FG001|Open-label Extension Period|Study Terminated by Sponsor|2|||
27835840|NCT02691468|54320764|FG000|Overall Study|Bronchial blocker use|2|||
27835841|NCT02691468|54320765|FG001|Overall Study|Bronchial blocker use|1|||
27835842|NCT02691468|54320764|FG000|Overall Study|Lost to Follow-up|2|||
27835843|NCT02691468|54320765|FG001|Overall Study|Lost to Follow-up|1|||
27835844|NCT02691468|54320764|FG000|Overall Study|Failure to advance FOB|2|||
27835845|NCT02691468|54320765|FG001|Overall Study|Failure to advance FOB|0|||
27835846|NCT02678676|54320773|FG000|Overall Study|Death|619|||
27746892|NCT02596893|54196632|FG001|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
27746893|NCT02596893|54196633|FG002|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
27746894|NCT02596893|54196634|FG003|Overall Double-Blind Period Weeks 0-52|Adverse Event|12|||
27746895|NCT02596893|54196631|FG000|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
27746896|NCT02596893|54196632|FG001|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
27746897|NCT02596893|54196633|FG002|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
27746898|NCT02596893|54196634|FG003|Overall Double-Blind Period Weeks 0-52|Pregnancy|1|||
27746899|NCT02596893|54196631|FG000|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15|||
27746900|NCT02596893|54196632|FG001|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
27835847|NCT02678676|54320774|FG001|Overall Study|Death|649|||
27835848|NCT02678676|54320773|FG000|Overall Study|Withdrawal by Subject|13|||
27835849|NCT02678676|54320774|FG001|Overall Study|Withdrawal by Subject|5|||
27835850|NCT02678676|54320773|FG000|Overall Study|Lost to Follow-up|171|||
27835851|NCT02678676|54320774|FG001|Overall Study|Lost to Follow-up|151|||
27835852|NCT02678676|54320773|FG000|Overall Study|Unconfirmed for lost to follow-up|85|||
27835853|NCT02678676|54320774|FG001|Overall Study|Unconfirmed for lost to follow-up|67|||
27835854|NCT01558739|54320780|FG000|Overall Study|Adverse Event|7|||
27835855|NCT01558739|54320780|FG000|Overall Study|Withdrawal by Subject|2|||
27835856|NCT01558739|54320780|FG000|Overall Study|Death|3|||
27835857|NCT01558739|54320780|FG000|Overall Study|Disease Progression|4|||
27835858|NCT01558739|54320780|FG000|Overall Study|Protocol Violation|1|||
27835859|NCT02683668|54320784|FG000|Period 2|Withdrawal by Subject|0|||
27835860|NCT02683668|54320785|FG001|Period 2|Withdrawal by Subject|1|||
27835861|NCT02683668|54320786|FG002|Period 2|Withdrawal by Subject|0|||
27835862|NCT02678286|54320794|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2|||
27835863|NCT02678286|54320795|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1|||
27835864|NCT02678286|54320794|FG000|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0|||
27835865|NCT02678286|54320795|FG001|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1|||
27835866|NCT02678286|54320794|FG000|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1|||
27835867|NCT02678286|54320795|FG001|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0|||
27835868|NCT02678286|54320794|FG000|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3|||
27835869|NCT02678286|54320795|FG001|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2|||
27835870|NCT02678286|54320794|FG000|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
27835871|NCT02678286|54320795|FG001|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
27835872|NCT02682264|54320803|FG000|Overall Study|Withdrawal by Subject|56|||
27835873|NCT02682264|54320804|FG001|Overall Study|Withdrawal by Subject|45|||
27835874|NCT02682264|54320803|FG000|Overall Study|Lost to Follow-up|49|||
27835875|NCT02682264|54320804|FG001|Overall Study|Lost to Follow-up|41|||
27835876|NCT02682264|54320803|FG000|Overall Study|Lack of Efficacy|14|||
27835877|NCT02682264|54320804|FG001|Overall Study|Lack of Efficacy|16|||
27835878|NCT02682264|54320803|FG000|Overall Study|Withdrawal by Parent|6|||
27835879|NCT02682264|54320804|FG001|Overall Study|Withdrawal by Parent|7|||
27835880|NCT02682264|54320803|FG000|Overall Study|Adverse Event|9|||
27835881|NCT02682264|54320804|FG001|Overall Study|Adverse Event|0|||
27835882|NCT02682264|54320803|FG000|Overall Study|Noncompliance with study drug|1|||
27835883|NCT02682264|54320804|FG001|Overall Study|Noncompliance with study drug|4|||
27835884|NCT02682264|54320803|FG000|Overall Study|Pregnancy|1|||
27835885|NCT02682264|54320804|FG001|Overall Study|Pregnancy|2|||
27835886|NCT02682264|54320803|FG000|Overall Study|Recovery|1|||
27835887|NCT02682264|54320804|FG001|Overall Study|Recovery|2|||
27835888|NCT02682264|54320803|FG000|Overall Study|Progressive Disease|1|||
27835889|NCT02682264|54320804|FG001|Overall Study|Progressive Disease|0|||
27835890|NCT02682264|54320803|FG000|Overall Study|Technical Problems|0|||
27835891|NCT02682264|54320804|FG001|Overall Study|Technical Problems|1|||
27835892|NCT02682264|54320803|FG000|Overall Study|Moved abroad and unable to continue|0|||
27835893|NCT02682264|54320804|FG001|Overall Study|Moved abroad and unable to continue|3|||
27835894|NCT02682264|54320803|FG000|Overall Study|Stopped test article application|0|||
27835895|NCT02682264|54320804|FG001|Overall Study|Stopped test article application|1|||
27835896|NCT01566721|54320812|FG000|Treatment Period|Withdrawal by Subject|35|||
27835897|NCT01566721|54320813|FG001|Treatment Period|Withdrawal by Subject|9|||
27835898|NCT01566721|54320812|FG000|Treatment Period|Disease Progression/Recurrence|37|||
27835899|NCT01566721|54320813|FG001|Treatment Period|Disease Progression/Recurrence|13|||
27835900|NCT01566721|54320812|FG000|Treatment Period|Investigator/Sponsor Decision|6|||
27835901|NCT01566721|54320813|FG001|Treatment Period|Investigator/Sponsor Decision|3|||
27835902|NCT01566721|54320812|FG000|Treatment Period|Other|13|||
27835903|NCT01566721|54320813|FG001|Treatment Period|Other|2|||
27835904|NCT01566721|54320812|FG000|Treatment Period|Lack of Compliance|5|||
27835905|NCT01566721|54320813|FG001|Treatment Period|Lack of Compliance|1|||
27835906|NCT01566721|54320812|FG000|Treatment Period|Adverse Event|100|||
27835907|NCT01566721|54320813|FG001|Treatment Period|Adverse Event|30|||
27835908|NCT01566721|54320812|FG000|Treatment Period|Pregnancy|1|||
27835909|NCT01566721|54320813|FG001|Treatment Period|Pregnancy|0|||
27835910|NCT01566721|54320812|FG000|Safety Follow-up|Physician Decision|6|||
27835911|NCT01566721|54320813|FG001|Safety Follow-up|Physician Decision|4|||
28014905|NCT00547300|54673843|FG000|Overall Study|Study was Administratively Terminated|25|||
28104064|NCT03338816|54760839|FG003|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
28104065|NCT03338816|54760836|FG000|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
28104066|NCT03338816|54760837|FG001|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
28104067|NCT03338816|54760838|FG002|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
28104068|NCT03338816|54760839|FG003|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
28104069|NCT03338816|54760836|FG000|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
28104070|NCT03338816|54760837|FG001|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
28104071|NCT03338816|54760838|FG002|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
28104072|NCT03338816|54760839|FG003|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
27835912|NCT01566721|54320812|FG000|Safety Follow-up|Lost to Follow-up|101|||
27835913|NCT01566721|54320813|FG001|Safety Follow-up|Lost to Follow-up|48|||
27835914|NCT01566721|54320812|FG000|Safety Follow-up|Withdrawal by Subject|155|||
27835915|NCT01566721|54320813|FG001|Safety Follow-up|Withdrawal by Subject|49|||
27835916|NCT01566721|54320812|FG000|Safety Follow-up|Death|28|||
27835917|NCT01566721|54320813|FG001|Safety Follow-up|Death|4|||
28104073|NCT03338816|54760836|FG000|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
28104074|NCT03338816|54760837|FG001|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
27835918|NCT01566721|54320812|FG000|Safety Follow-up|Non-compliance|7|||
27835919|NCT01566721|54320813|FG001|Safety Follow-up|Non-compliance|3|||
27835920|NCT01566721|54320812|FG000|Safety Follow-up|Protocol Violation|7|||
27835921|NCT01566721|54320813|FG001|Safety Follow-up|Protocol Violation|0|||
27835922|NCT01566721|54320812|FG000|Safety Follow-up|Site closure|2|||
27835923|NCT01566721|54320813|FG001|Safety Follow-up|Site closure|3|||
27835924|NCT01566721|54320812|FG000|Safety Follow-up|Erroneous reporting or late reporting|2|||
27835925|NCT01566721|54320813|FG001|Safety Follow-up|Erroneous reporting or late reporting|0|||
27835926|NCT01566721|54320812|FG000|Safety Follow-up|Missing|7|||
27835927|NCT01566721|54320813|FG001|Safety Follow-up|Missing|2|||
27835928|NCT01566721|54320812|FG000|Safety Follow-up|Disease progression /disease recurrence|223|||
27835929|NCT01566721|54320813|FG001|Safety Follow-up|Disease progression /disease recurrence|90|||
27835930|NCT01566721|54320812|FG000|Safety Follow-up|Sponsor decision|1|||
27835931|NCT01566721|54320813|FG001|Safety Follow-up|Sponsor decision|0|||
27835932|NCT01566721|54320812|FG000|Safety Follow-up|Adverse Event|8|||
27835933|NCT01566721|54320813|FG001|Safety Follow-up|Adverse Event|4|||
27835934|NCT01541215|54320828|FG000|Treatment Period (52 Weeks)|Withdrawal criteria|6|||
27835935|NCT01541215|54320829|FG001|Treatment Period (52 Weeks)|Withdrawal criteria|8|||
27835936|NCT01541215|54320828|FG000|Treatment Period (52 Weeks)|Non-compliance|4|||
27835937|NCT01541215|54320829|FG001|Treatment Period (52 Weeks)|Non-compliance|4|||
27835938|NCT01541215|54320828|FG000|Treatment Period (52 Weeks)|Adverse Event|0|||
27835939|NCT01541215|54320829|FG001|Treatment Period (52 Weeks)|Adverse Event|1|||
27835940|NCT01541215|54320828|FG000|Treatment Period (52 Weeks)|Unclassified|0|||
27835941|NCT01541215|54320829|FG001|Treatment Period (52 Weeks)|Unclassified|3|||
27835942|NCT01541215|54320828|FG000|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1|||
27835943|NCT01541215|54320829|FG001|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0|||
27835944|NCT01541215|54320828|FG000|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1|||
27835945|NCT01541215|54320829|FG001|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0|||
27835946|NCT01540981|54320841|FG000|Overall Study|Withdrawal by Subject|1|||
27835947|NCT01540981|54320842|FG001|Overall Study|Withdrawal by Subject|0|||
27835948|NCT01585987|54320850|FG000|Randomized|Withdrawal by Subject|0|||
27835949|NCT01585987|54320851|FG001|Randomized|Withdrawal by Subject|4|||
27835950|NCT01585987|54320850|FG000|Randomized|No longer met criteria|0|||
27835951|NCT01585987|54320851|FG001|Randomized|No longer met criteria|2|||
27835952|NCT01585987|54320850|FG000|Treated|Disease Progression|39|||
27835953|NCT01585987|54320851|FG001|Treated|Disease Progression|36|||
27835954|NCT01585987|54320850|FG000|Treated|Study Drug Toxicity|9|||
27835955|NCT01585987|54320851|FG001|Treated|Study Drug Toxicity|5|||
27835956|NCT01585987|54320850|FG000|Treated|Adverse Event|3|||
27835957|NCT01585987|54320851|FG001|Treated|Adverse Event|0|||
27835958|NCT01585987|54320850|FG000|Treated|Withdrawal by Subject|1|||
27835959|NCT01585987|54320851|FG001|Treated|Withdrawal by Subject|2|||
27835960|NCT01585987|54320850|FG000|Treated|Death|1|||
27835961|NCT01585987|54320851|FG001|Treated|Death|0|||
27835962|NCT01585987|54320850|FG000|Treated|Lost to Follow-up|0|||
27835963|NCT01585987|54320851|FG001|Treated|Lost to Follow-up|1|||
27835964|NCT01585987|54320850|FG000|Treated|Maximum Clinical Benefit|0|||
27835965|NCT01585987|54320851|FG001|Treated|Maximum Clinical Benefit|1|||
27835966|NCT01585987|54320850|FG000|Treated|Non-Specified|1|||
27835967|NCT01585987|54320851|FG001|Treated|Non-Specified|2|||
27835968|NCT01585987|54320850|FG000|Treated|Subject Request|0|||
27835969|NCT01585987|54320851|FG001|Treated|Subject Request|1|||
27835970|NCT01585987|54320850|FG000|Treated|Poor/Non-Compliance|0|||
27835971|NCT01585987|54320851|FG001|Treated|Poor/Non-Compliance|1|||
27835972|NCT01585831|54320860|FG000|Overall Study|Physician Decision|0|||
27835973|NCT01585831|54320861|FG001|Overall Study|Physician Decision|1|||
27835974|NCT01585831|54320860|FG000|Overall Study|Withdrawal by Subject|2|||
27835975|NCT01585831|54320861|FG001|Overall Study|Withdrawal by Subject|1|||
27835976|NCT01565941|54320869|FG000|Overall Study|Withdrawn by parent/guardian|3|||
27835977|NCT01565941|54320870|FG001|Overall Study|Withdrawn by parent/guardian|2|||
27835978|NCT01565941|54320869|FG000|Overall Study|Randomized; did not receive intevention|8|||
28104075|NCT03338816|54760838|FG002|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
28159925|NCT02737475|54830027|FG005|Overall Study|Other reasons|1|||
27835979|NCT01565941|54320870|FG001|Overall Study|Randomized; did not receive intevention|2|||
27835980|NCT01558271|54320881|FG000|Overall Study|Adverse Event|6|||
27835981|NCT01558271|54320882|FG001|Overall Study|Adverse Event|3|||
27835982|NCT01558271|54320883|FG002|Overall Study|Adverse Event|4|||
27835983|NCT01558271|54320881|FG000|Overall Study|Lost to Follow-up|1|||
27835984|NCT01558271|54320882|FG001|Overall Study|Lost to Follow-up|0|||
27835985|NCT01558271|54320883|FG002|Overall Study|Lost to Follow-up|0|||
27835986|NCT01558271|54320881|FG000|Overall Study|Protocol Violation|1|||
27835987|NCT01558271|54320882|FG001|Overall Study|Protocol Violation|0|||
27835988|NCT01558271|54320883|FG002|Overall Study|Protocol Violation|0|||
27835989|NCT01558271|54320881|FG000|Overall Study|Withdrawal by Subject|10|||
27835990|NCT01558271|54320882|FG001|Overall Study|Withdrawal by Subject|6|||
27835991|NCT01558271|54320883|FG002|Overall Study|Withdrawal by Subject|12|||
27835992|NCT01558271|54320881|FG000|Overall Study|Physician Decision|0|||
27835993|NCT01558271|54320882|FG001|Overall Study|Physician Decision|2|||
27835994|NCT01558271|54320883|FG002|Overall Study|Physician Decision|1|||
27835995|NCT01565707|54320899|FG000|Overall Study|Adverse Event|1|||
27835996|NCT01565707|54320900|FG001|Overall Study|Adverse Event|6|||
27835997|NCT01565707|54320901|FG002|Overall Study|Adverse Event|2|||
27835998|NCT01565707|54320902|FG003|Overall Study|Adverse Event|1|||
27835999|NCT01565707|54320899|FG000|Overall Study|Lost to Follow-up|1|||
27836000|NCT01565707|54320900|FG001|Overall Study|Lost to Follow-up|0|||
27836001|NCT01565707|54320901|FG002|Overall Study|Lost to Follow-up|0|||
27836002|NCT01565707|54320902|FG003|Overall Study|Lost to Follow-up|0|||
27836003|NCT01565707|54320899|FG000|Overall Study|Protocol Violation|1|||
27836004|NCT01565707|54320900|FG001|Overall Study|Protocol Violation|0|||
27836005|NCT01565707|54320901|FG002|Overall Study|Protocol Violation|0|||
27836006|NCT01565707|54320902|FG003|Overall Study|Protocol Violation|1|||
27836007|NCT01565707|54320899|FG000|Overall Study|Withdrawal by Subject|3|||
27836008|NCT01565707|54320900|FG001|Overall Study|Withdrawal by Subject|1|||
27836009|NCT01565707|54320901|FG002|Overall Study|Withdrawal by Subject|1|||
27836010|NCT01565707|54320902|FG003|Overall Study|Withdrawal by Subject|1|||
27836011|NCT01565707|54320899|FG000|Overall Study|Randomized but not evaluable|2|||
27836012|NCT01565707|54320900|FG001|Overall Study|Randomized but not evaluable|0|||
27836013|NCT01565707|54320901|FG002|Overall Study|Randomized but not evaluable|0|||
27836014|NCT01565707|54320902|FG003|Overall Study|Randomized but not evaluable|0|||
27836015|NCT01565707|54320899|FG000|Overall Study|Miscellaneous|1|||
27836016|NCT01565707|54320900|FG001|Overall Study|Miscellaneous|1|||
27836017|NCT01565707|54320901|FG002|Overall Study|Miscellaneous|0|||
27836018|NCT01565707|54320902|FG003|Overall Study|Miscellaneous|2|||
27836019|NCT01557569|54320921|FG000|Overall Study|Adverse Event|2|||
27836020|NCT01557569|54320922|FG001|Overall Study|Adverse Event|0|||
27836021|NCT01557569|54320921|FG000|Overall Study|high blood pressure|0|||
27836022|NCT01557569|54320922|FG001|Overall Study|high blood pressure|1|||
27836023|NCT01557569|54320921|FG000|Overall Study|Withdrawal by Subject|3|||
27836024|NCT01557569|54320922|FG001|Overall Study|Withdrawal by Subject|5|||
27836025|NCT01557569|54320921|FG000|Overall Study|noncompliance with rules of residential|0|||
27836026|NCT01557569|54320922|FG001|Overall Study|noncompliance with rules of residential|1|||
27836027|NCT01538719|54320930|FG000|Overall Study|Lost to Follow-up|2|||
27836028|NCT01538719|54320931|FG001|Overall Study|Lost to Follow-up|0|||
27836029|NCT01537783|54320939|FG000|Overall Study|Lost to Follow-up|11|||
27836030|NCT01537783|54320940|FG001|Overall Study|Lost to Follow-up|2|||
27836031|NCT01556165|54320948|FG000|Overall Study|Adverse Event|5|||
27836032|NCT01556165|54320949|FG001|Overall Study|Adverse Event|3|||
27836033|NCT01556165|54320948|FG000|Overall Study|Protocol Violation|0|||
27836034|NCT01556165|54320949|FG001|Overall Study|Protocol Violation|3|||
27836035|NCT01556165|54320948|FG000|Overall Study|Withdrawal of Consent|7|||
27836036|NCT01556165|54320949|FG001|Overall Study|Withdrawal of Consent|1|||
27836037|NCT01537549|54320955|FG000|Overall Study|Lost to Follow-up|1|||
27836038|NCT01537549|54320955|FG000|Overall Study|Withdrawal by Subject|2|||
27836039|NCT01555931|54320963|FG000|Overall Study|Lost to Follow-up|2|||
27836040|NCT01555931|54320964|FG001|Overall Study|Lost to Follow-up|5|||
27836041|NCT01583179|54320972|FG000|Overall Study|Screen failure|1|||
27836042|NCT01583179|54320973|FG001|Overall Study|Screen failure|2|||
27836043|NCT01582945|54320979|FG000|Overall Study|Intolerable side-effects|1|||
27836044|NCT01582945|54320979|FG000|Overall Study|Scheduling conflicts|1|||
27836045|NCT01565083|54320985|FG000|Overall Study|Withdrawal by Subject|6|||
27836046|NCT01565083|54320986|FG001|Overall Study|Withdrawal by Subject|4|||
27836047|NCT01565083|54320985|FG000|Overall Study|Lost to Follow-up|2|||
27836048|NCT01565083|54320986|FG001|Overall Study|Lost to Follow-up|7|||
27836049|NCT01565083|54320985|FG000|Overall Study|Death|22|||
27836050|NCT01565083|54320986|FG001|Overall Study|Death|23|||
27836051|NCT01565083|54320985|FG000|Overall Study|Other|3|||
27836052|NCT01565083|54320986|FG001|Overall Study|Other|5|||
27836053|NCT01582789|54320992|FG000|Second Intervention (14 Days)|Withdrawal by Subject|1|||
27836054|NCT01582789|54320993|FG001|Second Intervention (14 Days)|Withdrawal by Subject|0|||
27836055|NCT01537393|54321003|FG000|Overall Study|Exclude prior to study|32|||
27925917|NCT01296932|54582476|FG000|Overall Study|Dose limiting toxicity|0|||
27925918|NCT01296932|54582477|FG001|Overall Study|Dose limiting toxicity|0|||
27925919|NCT01296932|54582478|FG002|Overall Study|Dose limiting toxicity|0|||
27836056|NCT01537393|54321004|FG001|Overall Study|Exclude prior to study|44|||
27836057|NCT01537393|54321003|FG000|Overall Study|Death|20|||
27836058|NCT01537393|54321004|FG001|Overall Study|Death|32|||
27836059|NCT01537393|54321003|FG000|Overall Study|Withdrawal by Subject|18|||
27836060|NCT01537393|54321004|FG001|Overall Study|Withdrawal by Subject|17|||
27836061|NCT01537393|54321003|FG000|Overall Study|Lost to Follow-up|53|||
27836062|NCT01537393|54321004|FG001|Overall Study|Lost to Follow-up|48|||
27836063|NCT01537393|54321003|FG000|Overall Study|Failure - Regrafted|28|||
27836064|NCT01537393|54321004|FG001|Overall Study|Failure - Regrafted|43|||
27836065|NCT01537393|54321003|FG000|Overall Study|Failure - Not regrafted|2|||
27836066|NCT01537393|54321004|FG001|Overall Study|Failure - Not regrafted|6|||
27836067|NCT01537393|54321003|FG000|Overall Study|Censored (severe event unrelated to PT)|1|||
27836068|NCT01537393|54321004|FG001|Overall Study|Censored (severe event unrelated to PT)|1|||
27836069|NCT01555151|54321014|FG000|Overall Study|Withdrawal by Subject|6|||
27836070|NCT01555151|54321015|FG001|Overall Study|Withdrawal by Subject|2|||
27836071|NCT01555151|54321016|FG002|Overall Study|Withdrawal by Subject|0|||
27836072|NCT01555151|54321017|FG003|Overall Study|Withdrawal by Subject|2|||
27836073|NCT01555151|54321014|FG000|Overall Study|Administrative|3|||
27836074|NCT01555151|54321015|FG001|Overall Study|Administrative|1|||
27836075|NCT01555151|54321016|FG002|Overall Study|Administrative|2|||
27836076|NCT01555151|54321017|FG003|Overall Study|Administrative|0|||
27836077|NCT01555151|54321014|FG000|Overall Study|Protocol Violation|3|||
27836078|NCT01555151|54321015|FG001|Overall Study|Protocol Violation|3|||
27836079|NCT01555151|54321016|FG002|Overall Study|Protocol Violation|3|||
27836080|NCT01555151|54321017|FG003|Overall Study|Protocol Violation|5|||
27836081|NCT01555151|54321014|FG000|Overall Study|Adverse Event|1|||
27836082|NCT01555151|54321015|FG001|Overall Study|Adverse Event|2|||
27836083|NCT01555151|54321016|FG002|Overall Study|Adverse Event|1|||
27836084|NCT01555151|54321017|FG003|Overall Study|Adverse Event|2|||
27836085|NCT01555151|54321014|FG000|Overall Study|Lost to Follow-up|0|||
27836086|NCT01555151|54321015|FG001|Overall Study|Lost to Follow-up|0|||
27836087|NCT01555151|54321016|FG002|Overall Study|Lost to Follow-up|0|||
27836088|NCT01555151|54321017|FG003|Overall Study|Lost to Follow-up|1|||
27836089|NCT01537081|54321031|FG000|Overall Study|Adverse Event|5|||
27836090|NCT01537081|54321032|FG001|Overall Study|Adverse Event|2|||
27836091|NCT01537081|54321033|FG002|Overall Study|Adverse Event|2|||
27836092|NCT01537081|54321031|FG000|Overall Study|Lack of Efficacy|2|||
27836093|NCT01537081|54321032|FG001|Overall Study|Lack of Efficacy|1|||
27836094|NCT01537081|54321033|FG002|Overall Study|Lack of Efficacy|0|||
27836095|NCT01537081|54321031|FG000|Overall Study|Lost to Follow-up|17|||
27836096|NCT01537081|54321032|FG001|Overall Study|Lost to Follow-up|15|||
27836097|NCT01537081|54321033|FG002|Overall Study|Lost to Follow-up|9|||
27836098|NCT01537081|54321031|FG000|Overall Study|Protocol Violation|3|||
27836099|NCT01537081|54321032|FG001|Overall Study|Protocol Violation|2|||
27836100|NCT01537081|54321033|FG002|Overall Study|Protocol Violation|2|||
27836101|NCT01537081|54321031|FG000|Overall Study|Withdrawal by Subject|6|||
27836102|NCT01537081|54321032|FG001|Overall Study|Withdrawal by Subject|11|||
27836103|NCT01537081|54321033|FG002|Overall Study|Withdrawal by Subject|3|||
27836104|NCT01537081|54321031|FG000|Overall Study|Physician Decision|5|||
27836105|NCT01537081|54321032|FG001|Overall Study|Physician Decision|6|||
27836106|NCT01537081|54321033|FG002|Overall Study|Physician Decision|0|||
27836107|NCT01537081|54321031|FG000|Overall Study|Sponsor decision|0|||
27836108|NCT01537081|54321032|FG001|Overall Study|Sponsor decision|1|||
27836109|NCT01537081|54321033|FG002|Overall Study|Sponsor decision|0|||
27836110|NCT01537081|54321031|FG000|Overall Study|Assigned but never dosed|1|||
27836111|NCT01537081|54321032|FG001|Overall Study|Assigned but never dosed|0|||
27836112|NCT01537081|54321033|FG002|Overall Study|Assigned but never dosed|0|||
27836113|NCT01564459|54321045|FG000|Run-In|Adverse Event|7|||
27836114|NCT01564459|54321046|FG001|Run-In|Adverse Event|0|||
27836115|NCT01564459|54321047|FG002|Run-In|Adverse Event|0|||
27836116|NCT01564459|54321045|FG000|Run-In|Lost to Follow-up|1|||
27836117|NCT01564459|54321046|FG001|Run-In|Lost to Follow-up|0|||
27836118|NCT01564459|54321047|FG002|Run-In|Lost to Follow-up|0|||
27836119|NCT01564459|54321045|FG000|Run-In|Non-compliance with study drug|2|||
27836120|NCT01564459|54321046|FG001|Run-In|Non-compliance with study drug|0|||
27836121|NCT01564459|54321047|FG002|Run-In|Non-compliance with study drug|0|||
27836122|NCT01564459|54321045|FG000|Run-In|Protocol Violation|1|||
27836123|NCT01564459|54321046|FG001|Run-In|Protocol Violation|0|||
27925920|NCT01296932|54582479|FG003|Overall Study|Dose limiting toxicity|0|||
27925921|NCT01296932|54582480|FG004|Overall Study|Dose limiting toxicity|0|||
27925922|NCT01296932|54582481|FG005|Overall Study|Dose limiting toxicity|0|||
27925923|NCT01296932|54582482|FG006|Overall Study|Dose limiting toxicity|1|||
27925924|NCT01296932|54582483|FG007|Overall Study|Dose limiting toxicity|0|||
27925925|NCT01296932|54582484|FG008|Overall Study|Dose limiting toxicity|1|||
27925926|NCT01296932|54582476|FG000|Overall Study|Progressive disease|2|||
27925927|NCT01296932|54582477|FG001|Overall Study|Progressive disease|0|||
28014906|NCT00547300|54673844|FG001|Overall Study|Study was Administratively Terminated|24|||
27925928|NCT01296932|54582478|FG002|Overall Study|Progressive disease|1|||
27836124|NCT01564459|54321047|FG002|Run-In|Protocol Violation|0|||
27836125|NCT01564459|54321045|FG000|Run-In|Withdrawal by Subject|1|||
27836126|NCT01564459|54321046|FG001|Run-In|Withdrawal by Subject|0|||
27836127|NCT01564459|54321047|FG002|Run-In|Withdrawal by Subject|0|||
27836128|NCT01564459|54321045|FG000|Double-blind Treatment|Adverse Event|0|||
27836129|NCT01564459|54321046|FG001|Double-blind Treatment|Adverse Event|0|||
27836130|NCT01564459|54321047|FG002|Double-blind Treatment|Adverse Event|1|||
27836131|NCT01555073|54321062|FG000|Overall Study|Lost to Follow-up|1|||
27836132|NCT01555073|54321063|FG001|Overall Study|Lost to Follow-up|2|||
27836133|NCT01555073|54321064|FG002|Overall Study|Lost to Follow-up|0|||
27836134|NCT01555073|54321065|FG003|Overall Study|Lost to Follow-up|5|||
27836135|NCT01582243|54321075|FG000|Overall Study|Withdrawal by Subject|1|||
27836136|NCT01582243|54321075|FG000|Overall Study|Adverse Event|1|||
27836137|NCT01582243|54321075|FG000|Overall Study|Lost to Follow-up|1|||
27836138|NCT01536535|54321081|FG000|Overall Study|Withdrawal by Subject|10|||
27925929|NCT01296932|54582479|FG003|Overall Study|Progressive disease|1|||
27925930|NCT01296932|54582480|FG004|Overall Study|Progressive disease|2|||
27925931|NCT01296932|54582481|FG005|Overall Study|Progressive disease|3|||
27925932|NCT01296932|54582482|FG006|Overall Study|Progressive disease|1|||
27925933|NCT01296932|54582483|FG007|Overall Study|Progressive disease|0|||
27925934|NCT01296932|54582484|FG008|Overall Study|Progressive disease|0|||
27925935|NCT01296932|54582476|FG000|Overall Study|Withdrawal by Subject|0|||
27925936|NCT01296932|54582477|FG001|Overall Study|Withdrawal by Subject|0|||
27925937|NCT01296932|54582478|FG002|Overall Study|Withdrawal by Subject|1|||
27925938|NCT01296932|54582479|FG003|Overall Study|Withdrawal by Subject|1|||
27925939|NCT01296932|54582480|FG004|Overall Study|Withdrawal by Subject|0|||
27925940|NCT01296932|54582481|FG005|Overall Study|Withdrawal by Subject|0|||
27925941|NCT01296932|54582482|FG006|Overall Study|Withdrawal by Subject|3|||
27925942|NCT01296932|54582483|FG007|Overall Study|Withdrawal by Subject|0|||
27925943|NCT01296932|54582484|FG008|Overall Study|Withdrawal by Subject|0|||
27925944|NCT01296932|54582476|FG000|Overall Study|Adverse Event|1|||
27925945|NCT01296932|54582477|FG001|Overall Study|Adverse Event|1|||
27925946|NCT01296932|54582478|FG002|Overall Study|Adverse Event|1|||
27925947|NCT01296932|54582479|FG003|Overall Study|Adverse Event|2|||
27925948|NCT01296932|54582480|FG004|Overall Study|Adverse Event|1|||
27925949|NCT01296932|54582481|FG005|Overall Study|Adverse Event|0|||
27925950|NCT01296932|54582482|FG006|Overall Study|Adverse Event|0|||
27925951|NCT01296932|54582483|FG007|Overall Study|Adverse Event|0|||
27925952|NCT01296932|54582484|FG008|Overall Study|Adverse Event|1|||
27925953|NCT01296932|54582476|FG000|Overall Study|Investigator decision|0|||
27925954|NCT01296932|54582477|FG001|Overall Study|Investigator decision|1|||
27925955|NCT01296932|54582478|FG002|Overall Study|Investigator decision|0|||
27925956|NCT01296932|54582479|FG003|Overall Study|Investigator decision|1|||
27925957|NCT01296932|54582480|FG004|Overall Study|Investigator decision|0|||
27925958|NCT01296932|54582481|FG005|Overall Study|Investigator decision|0|||
27925959|NCT01296932|54582482|FG006|Overall Study|Investigator decision|1|||
27925960|NCT01296932|54582483|FG007|Overall Study|Investigator decision|0|||
27925961|NCT01296932|54582484|FG008|Overall Study|Investigator decision|1|||
27925962|NCT01296932|54582476|FG000|Overall Study|No clinical benefit anymore|0|||
27925963|NCT01296932|54582477|FG001|Overall Study|No clinical benefit anymore|1|||
27925964|NCT01296932|54582478|FG002|Overall Study|No clinical benefit anymore|0|||
27925965|NCT01296932|54582479|FG003|Overall Study|No clinical benefit anymore|0|||
27925966|NCT01296932|54582480|FG004|Overall Study|No clinical benefit anymore|0|||
27925967|NCT01296932|54582481|FG005|Overall Study|No clinical benefit anymore|0|||
27925968|NCT01296932|54582482|FG006|Overall Study|No clinical benefit anymore|0|||
27925969|NCT01296932|54582483|FG007|Overall Study|No clinical benefit anymore|0|||
27925970|NCT01296932|54582484|FG008|Overall Study|No clinical benefit anymore|0|||
27925971|NCT01296932|54582476|FG000|Overall Study|Physician Decision|0|||
27925972|NCT01296932|54582477|FG001|Overall Study|Physician Decision|0|||
27925973|NCT01296932|54582478|FG002|Overall Study|Physician Decision|1|||
27925974|NCT01296932|54582479|FG003|Overall Study|Physician Decision|0|||
27925975|NCT01296932|54582480|FG004|Overall Study|Physician Decision|0|||
27925976|NCT01296932|54582481|FG005|Overall Study|Physician Decision|0|||
27925977|NCT01296932|54582482|FG006|Overall Study|Physician Decision|0|||
27925978|NCT01296932|54582483|FG007|Overall Study|Physician Decision|0|||
27925979|NCT01296932|54582484|FG008|Overall Study|Physician Decision|0|||
27925980|NCT01296932|54582476|FG000|Overall Study|IV problems, administration not possible|0|||
27925981|NCT01296932|54582477|FG001|Overall Study|IV problems, administration not possible|0|||
27925982|NCT01296932|54582478|FG002|Overall Study|IV problems, administration not possible|1|||
27925983|NCT01296932|54582479|FG003|Overall Study|IV problems, administration not possible|0|||
27925984|NCT01296932|54582480|FG004|Overall Study|IV problems, administration not possible|0|||
27925985|NCT01296932|54582481|FG005|Overall Study|IV problems, administration not possible|0|||
27925986|NCT01296932|54582482|FG006|Overall Study|IV problems, administration not possible|0|||
27925987|NCT01296932|54582483|FG007|Overall Study|IV problems, administration not possible|0|||
27925988|NCT01296932|54582484|FG008|Overall Study|IV problems, administration not possible|0|||
27925989|NCT01296932|54582476|FG000|Overall Study|per protocol|0|||
27925990|NCT01296932|54582477|FG001|Overall Study|per protocol|0|||
27925991|NCT01296932|54582478|FG002|Overall Study|per protocol|1|||
28104076|NCT03338816|54760839|FG003|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|1|||
27836139|NCT01536535|54321082|FG001|Overall Study|Withdrawal by Subject|5|||
27925992|NCT01296932|54582479|FG003|Overall Study|per protocol|1|||
27925993|NCT01296932|54582480|FG004|Overall Study|per protocol|0|||
27836140|NCT01536535|54321081|FG000|Overall Study|Lost to Follow-up|4|||
27836141|NCT01536535|54321082|FG001|Overall Study|Lost to Follow-up|6|||
27836142|NCT01536535|54321081|FG000|Overall Study|Physician Decision|1|||
27836143|NCT01536535|54321082|FG001|Overall Study|Physician Decision|1|||
27836144|NCT01536535|54321081|FG000|Overall Study|Participant moved|0|||
27925994|NCT01296932|54582481|FG005|Overall Study|per protocol|0|||
27836145|NCT01536535|54321082|FG001|Overall Study|Participant moved|1|||
27925995|NCT01296932|54582482|FG006|Overall Study|per protocol|0|||
27925996|NCT01296932|54582483|FG007|Overall Study|per protocol|0|||
27925997|NCT01296932|54582484|FG008|Overall Study|per protocol|0|||
27925998|NCT01296932|54582476|FG000|Overall Study|Low benefit and too many side effects|0|||
27925999|NCT01296932|54582477|FG001|Overall Study|Low benefit and too many side effects|0|||
27926000|NCT01296932|54582478|FG002|Overall Study|Low benefit and too many side effects|0|||
27926001|NCT01296932|54582479|FG003|Overall Study|Low benefit and too many side effects|0|||
27926002|NCT01296932|54582480|FG004|Overall Study|Low benefit and too many side effects|0|||
27926003|NCT01296932|54582481|FG005|Overall Study|Low benefit and too many side effects|0|||
27926004|NCT01296932|54582482|FG006|Overall Study|Low benefit and too many side effects|0|||
27926005|NCT01296932|54582483|FG007|Overall Study|Low benefit and too many side effects|1|||
27926006|NCT01296932|54582484|FG008|Overall Study|Low benefit and too many side effects|0|||
27926007|NCT01296932|54582476|FG000|Overall Study|No adequate treatment response|0|||
27926008|NCT01296932|54582477|FG001|Overall Study|No adequate treatment response|0|||
27926009|NCT01296932|54582478|FG002|Overall Study|No adequate treatment response|0|||
27926010|NCT01296932|54582479|FG003|Overall Study|No adequate treatment response|0|||
27926011|NCT01296932|54582480|FG004|Overall Study|No adequate treatment response|0|||
27926012|NCT01296932|54582481|FG005|Overall Study|No adequate treatment response|0|||
27926013|NCT01296932|54582482|FG006|Overall Study|No adequate treatment response|0|||
27926014|NCT01296932|54582483|FG007|Overall Study|No adequate treatment response|1|||
27926015|NCT01296932|54582484|FG008|Overall Study|No adequate treatment response|0|||
27926016|NCT01296932|54582476|FG000|Overall Study|Dosage already reduced, AE still present|0|||
27926017|NCT01296932|54582477|FG001|Overall Study|Dosage already reduced, AE still present|0|||
27926018|NCT01296932|54582478|FG002|Overall Study|Dosage already reduced, AE still present|0|||
27926019|NCT01296932|54582479|FG003|Overall Study|Dosage already reduced, AE still present|0|||
27926020|NCT01296932|54582480|FG004|Overall Study|Dosage already reduced, AE still present|0|||
27926021|NCT01296932|54582481|FG005|Overall Study|Dosage already reduced, AE still present|0|||
27926022|NCT01296932|54582482|FG006|Overall Study|Dosage already reduced, AE still present|0|||
27926023|NCT01296932|54582483|FG007|Overall Study|Dosage already reduced, AE still present|0|||
27926024|NCT01296932|54582484|FG008|Overall Study|Dosage already reduced, AE still present|1|||
27926025|NCT01296698|54582507|FG000|Overall Study|Adverse Event|1|||
27926026|NCT01296698|54582508|FG001|Overall Study|Adverse Event|0|||
27926027|NCT01296698|54582507|FG000|Overall Study|Death|1|||
27926028|NCT01296698|54582508|FG001|Overall Study|Death|0|||
27926029|NCT01296698|54582507|FG000|Overall Study|Lost to Follow-up|19|||
27926030|NCT01296698|54582508|FG001|Overall Study|Lost to Follow-up|1|||
27926031|NCT01296698|54582507|FG000|Overall Study|Withdrawal by Subject|12|||
27926032|NCT01296698|54582508|FG001|Overall Study|Withdrawal by Subject|0|||
27926033|NCT01296698|54582507|FG000|Overall Study|Difficulty Contacting Subject|2|||
27926034|NCT01296698|54582508|FG001|Overall Study|Difficulty Contacting Subject|0|||
27926035|NCT01296698|54582507|FG000|Overall Study|Study Terminated by Sponsor|209|||
27926036|NCT01296698|54582508|FG001|Overall Study|Study Terminated by Sponsor|12|||
27926037|NCT01001221|54582518|FG000|Overall Study|Adverse Event|1|||
27926038|NCT01001221|54582519|FG001|Overall Study|Adverse Event|2|||
27926039|NCT01001221|54582520|FG002|Overall Study|Adverse Event|0|||
27926040|NCT01001221|54582521|FG003|Overall Study|Adverse Event|2|||
27926041|NCT01001221|54582522|FG004|Overall Study|Adverse Event|0|||
27926042|NCT01001221|54582518|FG000|Overall Study|Disease progression|3|||
27926043|NCT01001221|54582519|FG001|Overall Study|Disease progression|2|||
27926044|NCT01001221|54582520|FG002|Overall Study|Disease progression|2|||
27926045|NCT01001221|54582521|FG003|Overall Study|Disease progression|4|||
27926046|NCT01001221|54582522|FG004|Overall Study|Disease progression|0|||
27926047|NCT01001221|54582518|FG000|Overall Study|Other|1|||
27926048|NCT01001221|54582519|FG001|Overall Study|Other|1|||
27926049|NCT01001221|54582520|FG002|Overall Study|Other|0|||
27926050|NCT01001221|54582521|FG003|Overall Study|Other|0|||
27926051|NCT01001221|54582522|FG004|Overall Study|Other|0|||
27926052|NCT01001221|54582518|FG000|Overall Study|Not treated; protocol exclusion|0|||
27926053|NCT01001221|54582519|FG001|Overall Study|Not treated; protocol exclusion|0|||
27926054|NCT01001221|54582520|FG002|Overall Study|Not treated; protocol exclusion|1|||
27926055|NCT01001221|54582521|FG003|Overall Study|Not treated; protocol exclusion|0|||
27926056|NCT01001221|54582522|FG004|Overall Study|Not treated; protocol exclusion|0|||
27926057|NCT01296152|54582533|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
27926058|NCT01002547|54582540|FG000|Overall Study|Withdrawal by Subject|4|||
27926059|NCT01002547|54582541|FG001|Overall Study|Withdrawal by Subject|0|||
27926060|NCT01002547|54582542|FG002|Overall Study|Withdrawal by Subject|5|||
27926061|NCT01002547|54582540|FG000|Overall Study|Lost to Follow-up|2|||
27926062|NCT01002547|54582541|FG001|Overall Study|Lost to Follow-up|1|||
27926063|NCT01002547|54582542|FG002|Overall Study|Lost to Follow-up|1|||
27926064|NCT01002547|54582540|FG000|Overall Study|Physician Decision|1|||
27926065|NCT01002547|54582541|FG001|Overall Study|Physician Decision|0|||
27926066|NCT01002547|54582542|FG002|Overall Study|Physician Decision|0|||
27926067|NCT01002547|54582540|FG000|Overall Study|Death|0|||
27926068|NCT01002547|54582541|FG001|Overall Study|Death|2|||
27926069|NCT01002547|54582542|FG002|Overall Study|Death|2|||
28014907|NCT00547300|54673843|FG000|Overall Study|Did not Meet Entry Criteria|0|||
27926070|NCT01002547|54582540|FG000|Overall Study|Adverse Event|1|||
27926071|NCT01002547|54582541|FG001|Overall Study|Adverse Event|0|||
27926072|NCT01002547|54582542|FG002|Overall Study|Adverse Event|0|||
27926073|NCT01225731|54582555|FG000|Part 1|Did not meet eligibility criteria|1|||
27926074|NCT01225731|54582556|FG001|Part 1|Did not meet eligibility criteria|0|||
27926075|NCT01225731|54582557|FG002|Part 1|Did not meet eligibility criteria|0|||
27926076|NCT01225731|54582558|FG003|Part 1|Did not meet eligibility criteria|0|||
27926077|NCT01225731|54582559|FG004|Part 1|Did not meet eligibility criteria|1|||
27926078|NCT01225731|54582560|FG005|Part 1|Did not meet eligibility criteria|0|||
27926079|NCT01225731|54582561|FG006|Part 1|Did not meet eligibility criteria|0|||
27926080|NCT01225731|54582562|FG007|Part 1|Did not meet eligibility criteria|0|||
27926081|NCT01225731|54582563|FG008|Part 1|Did not meet eligibility criteria|0|||
27926082|NCT01225731|54582564|FG009|Part 1|Did not meet eligibility criteria|0|||
27926083|NCT01225731|54582565|FG010|Part 1|Did not meet eligibility criteria|0|||
27926084|NCT01225731|54582566|FG011|Part 1|Did not meet eligibility criteria|0|||
27926085|NCT01225731|54582567|FG012|Part 1|Did not meet eligibility criteria|0|||
27926086|NCT01225731|54582555|FG000|Part 1|Adverse Event|1|||
27926087|NCT01225731|54582556|FG001|Part 1|Adverse Event|2|||
27926088|NCT01225731|54582557|FG002|Part 1|Adverse Event|1|||
27926089|NCT01225731|54582558|FG003|Part 1|Adverse Event|1|||
27926090|NCT01225731|54582559|FG004|Part 1|Adverse Event|1|||
27926091|NCT01225731|54582560|FG005|Part 1|Adverse Event|0|||
27926092|NCT01225731|54582561|FG006|Part 1|Adverse Event|0|||
27926093|NCT01225731|54582562|FG007|Part 1|Adverse Event|0|||
27926094|NCT01225731|54582563|FG008|Part 1|Adverse Event|0|||
27926095|NCT01225731|54582564|FG009|Part 1|Adverse Event|0|||
27926096|NCT01225731|54582565|FG010|Part 1|Adverse Event|0|||
27926097|NCT01225731|54582566|FG011|Part 1|Adverse Event|0|||
27926098|NCT01225731|54582567|FG012|Part 1|Adverse Event|0|||
27926099|NCT01225731|54582555|FG000|Part 1|Withdrawal by Subject|0|||
27926100|NCT01225731|54582556|FG001|Part 1|Withdrawal by Subject|3|||
27926101|NCT01225731|54582557|FG002|Part 1|Withdrawal by Subject|0|||
27926102|NCT01225731|54582558|FG003|Part 1|Withdrawal by Subject|0|||
27926103|NCT01225731|54582559|FG004|Part 1|Withdrawal by Subject|4|||
27926104|NCT01225731|54582560|FG005|Part 1|Withdrawal by Subject|0|||
27926105|NCT01225731|54582561|FG006|Part 1|Withdrawal by Subject|0|||
27926106|NCT01225731|54582562|FG007|Part 1|Withdrawal by Subject|0|||
27926107|NCT01225731|54582563|FG008|Part 1|Withdrawal by Subject|0|||
27926108|NCT01225731|54582564|FG009|Part 1|Withdrawal by Subject|0|||
27926109|NCT01225731|54582565|FG010|Part 1|Withdrawal by Subject|0|||
27926110|NCT01225731|54582566|FG011|Part 1|Withdrawal by Subject|0|||
27926111|NCT01225731|54582567|FG012|Part 1|Withdrawal by Subject|0|||
27926112|NCT01225731|54582555|FG000|Part 1|Protocol Violation|0|||
27926113|NCT01225731|54582556|FG001|Part 1|Protocol Violation|0|||
27926114|NCT01225731|54582557|FG002|Part 1|Protocol Violation|0|||
27926115|NCT01225731|54582558|FG003|Part 1|Protocol Violation|1|||
27926116|NCT01225731|54582559|FG004|Part 1|Protocol Violation|0|||
27926117|NCT01225731|54582560|FG005|Part 1|Protocol Violation|0|||
27926118|NCT01225731|54582561|FG006|Part 1|Protocol Violation|0|||
27926119|NCT01225731|54582562|FG007|Part 1|Protocol Violation|0|||
27926120|NCT01225731|54582563|FG008|Part 1|Protocol Violation|0|||
27926121|NCT01225731|54582564|FG009|Part 1|Protocol Violation|0|||
28104077|NCT03337490|54760851|FG000|Overall Study|Withdrawal by Subject|1|||
28104078|NCT03337490|54760852|FG001|Overall Study|Withdrawal by Subject|0|||
28104079|NCT03337490|54760853|FG002|Overall Study|Withdrawal by Subject|0|||
28104080|NCT03337490|54760851|FG000|Overall Study|Lack of Efficacy|10|||
27926122|NCT01225731|54582565|FG010|Part 1|Protocol Violation|0|||
27926123|NCT01225731|54582566|FG011|Part 1|Protocol Violation|0|||
27926124|NCT01225731|54582567|FG012|Part 1|Protocol Violation|0|||
27926125|NCT01225731|54582555|FG000|Part 2|Protocol Violation|0|||
27926126|NCT01225731|54582556|FG001|Part 2|Protocol Violation|0|||
27926127|NCT01225731|54582557|FG002|Part 2|Protocol Violation|0|||
27926128|NCT01225731|54582558|FG003|Part 2|Protocol Violation|0|||
27926129|NCT01225731|54582559|FG004|Part 2|Protocol Violation|0|||
27926130|NCT01225731|54582560|FG005|Part 2|Protocol Violation|1|||
27926131|NCT01225731|54582561|FG006|Part 2|Protocol Violation|0|||
27926132|NCT01225731|54582562|FG007|Part 2|Protocol Violation|0|||
27926133|NCT01225731|54582563|FG008|Part 2|Protocol Violation|1|||
27926134|NCT01225731|54582564|FG009|Part 2|Protocol Violation|0|||
27926135|NCT01225731|54582565|FG010|Part 2|Protocol Violation|0|||
27926136|NCT01225731|54582566|FG011|Part 2|Protocol Violation|0|||
27926137|NCT01225731|54582567|FG012|Part 2|Protocol Violation|0|||
27926138|NCT01225731|54582555|FG000|Part 2|Adverse Event|0|||
27926139|NCT01225731|54582556|FG001|Part 2|Adverse Event|0|||
27926140|NCT01225731|54582557|FG002|Part 2|Adverse Event|0|||
27926141|NCT01225731|54582558|FG003|Part 2|Adverse Event|0|||
27926142|NCT01225731|54582559|FG004|Part 2|Adverse Event|0|||
27926143|NCT01225731|54582560|FG005|Part 2|Adverse Event|0|||
27926144|NCT01225731|54582561|FG006|Part 2|Adverse Event|4|||
27926145|NCT01225731|54582562|FG007|Part 2|Adverse Event|4|||
27926146|NCT01225731|54582563|FG008|Part 2|Adverse Event|2|||
27926147|NCT01225731|54582564|FG009|Part 2|Adverse Event|0|||
28104081|NCT03337490|54760852|FG001|Overall Study|Lack of Efficacy|12|||
28104082|NCT03337490|54760853|FG002|Overall Study|Lack of Efficacy|35|||
27926148|NCT01225731|54582565|FG010|Part 2|Adverse Event|0|||
27926149|NCT01225731|54582566|FG011|Part 2|Adverse Event|0|||
27926150|NCT01225731|54582567|FG012|Part 2|Adverse Event|0|||
27926151|NCT01225731|54582555|FG000|Part 2|Lack of Efficacy|0|||
27926152|NCT01225731|54582556|FG001|Part 2|Lack of Efficacy|0|||
27926153|NCT01225731|54582557|FG002|Part 2|Lack of Efficacy|0|||
27926154|NCT01225731|54582558|FG003|Part 2|Lack of Efficacy|0|||
27926155|NCT01225731|54582559|FG004|Part 2|Lack of Efficacy|0|||
27926156|NCT01225731|54582560|FG005|Part 2|Lack of Efficacy|1|||
27926157|NCT01225731|54582561|FG006|Part 2|Lack of Efficacy|0|||
27926158|NCT01225731|54582562|FG007|Part 2|Lack of Efficacy|12|||
27926159|NCT01225731|54582563|FG008|Part 2|Lack of Efficacy|3|||
27926160|NCT01225731|54582564|FG009|Part 2|Lack of Efficacy|0|||
27926161|NCT01225731|54582565|FG010|Part 2|Lack of Efficacy|0|||
27926162|NCT01225731|54582566|FG011|Part 2|Lack of Efficacy|0|||
27926163|NCT01225731|54582567|FG012|Part 2|Lack of Efficacy|0|||
27926164|NCT01225731|54582555|FG000|Part 2|Pregnancy|0|||
27926165|NCT01225731|54582556|FG001|Part 2|Pregnancy|0|||
27926166|NCT01225731|54582557|FG002|Part 2|Pregnancy|0|||
27926167|NCT01225731|54582558|FG003|Part 2|Pregnancy|0|||
27926168|NCT01225731|54582559|FG004|Part 2|Pregnancy|0|||
27926169|NCT01225731|54582560|FG005|Part 2|Pregnancy|0|||
27926170|NCT01225731|54582561|FG006|Part 2|Pregnancy|1|||
27926171|NCT01225731|54582562|FG007|Part 2|Pregnancy|0|||
27926172|NCT01225731|54582563|FG008|Part 2|Pregnancy|1|||
27926173|NCT01225731|54582564|FG009|Part 2|Pregnancy|0|||
27926174|NCT01225731|54582565|FG010|Part 2|Pregnancy|0|||
27926175|NCT01225731|54582566|FG011|Part 2|Pregnancy|0|||
27926176|NCT01225731|54582567|FG012|Part 2|Pregnancy|0|||
27926177|NCT01225731|54582555|FG000|Part 2|Lost to Follow-up|0|||
27926178|NCT01225731|54582556|FG001|Part 2|Lost to Follow-up|0|||
27926179|NCT01225731|54582557|FG002|Part 2|Lost to Follow-up|0|||
27926180|NCT01225731|54582558|FG003|Part 2|Lost to Follow-up|0|||
27926181|NCT01225731|54582559|FG004|Part 2|Lost to Follow-up|0|||
27926182|NCT01225731|54582560|FG005|Part 2|Lost to Follow-up|0|||
27926183|NCT01225731|54582561|FG006|Part 2|Lost to Follow-up|0|||
27926184|NCT01225731|54582562|FG007|Part 2|Lost to Follow-up|3|||
27926185|NCT01225731|54582563|FG008|Part 2|Lost to Follow-up|1|||
27926186|NCT01225731|54582564|FG009|Part 2|Lost to Follow-up|0|||
27926187|NCT01225731|54582565|FG010|Part 2|Lost to Follow-up|0|||
27926188|NCT01225731|54582566|FG011|Part 2|Lost to Follow-up|0|||
27836146|NCT01554527|54321092|FG000|Overall Study|Withdrawal by Subject|1|||
27836147|NCT01554527|54321093|FG001|Overall Study|Withdrawal by Subject|0|||
27836148|NCT01554527|54321094|FG002|Overall Study|Withdrawal by Subject|3|||
27836149|NCT01554527|54321092|FG000|Overall Study|Lost to Follow-up|0|||
27836150|NCT01554527|54321093|FG001|Overall Study|Lost to Follow-up|0|||
27836151|NCT01554527|54321094|FG002|Overall Study|Lost to Follow-up|4|||
27836152|NCT01554527|54321092|FG000|Overall Study|Physician Decision|0|||
27836153|NCT01554527|54321093|FG001|Overall Study|Physician Decision|0|||
27836154|NCT01554527|54321094|FG002|Overall Study|Physician Decision|1|||
27926189|NCT01225731|54582567|FG012|Part 2|Lost to Follow-up|0|||
27926190|NCT01225731|54582555|FG000|Part 2|Physician Decision|0|||
27926191|NCT01225731|54582556|FG001|Part 2|Physician Decision|0|||
27926192|NCT01225731|54582557|FG002|Part 2|Physician Decision|0|||
27926193|NCT01225731|54582558|FG003|Part 2|Physician Decision|0|||
27926194|NCT01225731|54582559|FG004|Part 2|Physician Decision|0|||
27926195|NCT01225731|54582560|FG005|Part 2|Physician Decision|0|||
27926196|NCT01225731|54582561|FG006|Part 2|Physician Decision|0|||
27926197|NCT01225731|54582562|FG007|Part 2|Physician Decision|2|||
27926198|NCT01225731|54582563|FG008|Part 2|Physician Decision|2|||
27926199|NCT01225731|54582564|FG009|Part 2|Physician Decision|0|||
27926200|NCT01225731|54582565|FG010|Part 2|Physician Decision|0|||
27926201|NCT01225731|54582566|FG011|Part 2|Physician Decision|0|||
27926202|NCT01225731|54582567|FG012|Part 2|Physician Decision|0|||
27926203|NCT01225731|54582555|FG000|Part 2|Withdrawal by Subject|0|||
27926204|NCT01225731|54582556|FG001|Part 2|Withdrawal by Subject|0|||
27926205|NCT01225731|54582557|FG002|Part 2|Withdrawal by Subject|0|||
27926206|NCT01225731|54582558|FG003|Part 2|Withdrawal by Subject|0|||
27926207|NCT01225731|54582559|FG004|Part 2|Withdrawal by Subject|0|||
27926208|NCT01225731|54582560|FG005|Part 2|Withdrawal by Subject|1|||
27926209|NCT01225731|54582561|FG006|Part 2|Withdrawal by Subject|3|||
27926210|NCT01225731|54582562|FG007|Part 2|Withdrawal by Subject|4|||
27926211|NCT01225731|54582563|FG008|Part 2|Withdrawal by Subject|1|||
27926212|NCT01225731|54582564|FG009|Part 2|Withdrawal by Subject|0|||
27926213|NCT01225731|54582565|FG010|Part 2|Withdrawal by Subject|0|||
27836155|NCT01563913|54321105|FG000|Overall Study|Physician Decision|1|||
27926214|NCT01225731|54582566|FG011|Part 2|Withdrawal by Subject|0|||
27926215|NCT01225731|54582567|FG012|Part 2|Withdrawal by Subject|0|||
27926216|NCT01225731|54582555|FG000|Part 3|Adverse Event|0|||
27926217|NCT01225731|54582556|FG001|Part 3|Adverse Event|0|||
27926218|NCT01225731|54582557|FG002|Part 3|Adverse Event|0|||
27926219|NCT01225731|54582558|FG003|Part 3|Adverse Event|0|||
27926220|NCT01225731|54582559|FG004|Part 3|Adverse Event|0|||
27926221|NCT01225731|54582560|FG005|Part 3|Adverse Event|0|||
27926222|NCT01225731|54582561|FG006|Part 3|Adverse Event|0|||
27926223|NCT01225731|54582562|FG007|Part 3|Adverse Event|0|||
27926224|NCT01225731|54582563|FG008|Part 3|Adverse Event|0|||
27926225|NCT01225731|54582564|FG009|Part 3|Adverse Event|0|||
27926226|NCT01225731|54582565|FG010|Part 3|Adverse Event|1|||
27926227|NCT01225731|54582566|FG011|Part 3|Adverse Event|1|||
27926228|NCT01225731|54582567|FG012|Part 3|Adverse Event|0|||
27926229|NCT01225731|54582555|FG000|Part 3|Lost to Follow-up|0|||
27926230|NCT01225731|54582556|FG001|Part 3|Lost to Follow-up|0|||
27926231|NCT01225731|54582557|FG002|Part 3|Lost to Follow-up|0|||
27926232|NCT01225731|54582558|FG003|Part 3|Lost to Follow-up|0|||
27926233|NCT01225731|54582559|FG004|Part 3|Lost to Follow-up|0|||
27926234|NCT01225731|54582560|FG005|Part 3|Lost to Follow-up|0|||
27926235|NCT01225731|54582561|FG006|Part 3|Lost to Follow-up|0|||
27926236|NCT01225731|54582562|FG007|Part 3|Lost to Follow-up|0|||
27926237|NCT01225731|54582563|FG008|Part 3|Lost to Follow-up|0|||
27926238|NCT01225731|54582564|FG009|Part 3|Lost to Follow-up|0|||
27926239|NCT01225731|54582565|FG010|Part 3|Lost to Follow-up|1|||
27926240|NCT01225731|54582566|FG011|Part 3|Lost to Follow-up|2|||
27926241|NCT01225731|54582567|FG012|Part 3|Lost to Follow-up|1|||
27926242|NCT01225731|54582555|FG000|Part 3|Physician Decision|0|||
27926243|NCT01225731|54582556|FG001|Part 3|Physician Decision|0|||
27926244|NCT01225731|54582557|FG002|Part 3|Physician Decision|0|||
27926245|NCT01225731|54582558|FG003|Part 3|Physician Decision|0|||
27926246|NCT01225731|54582559|FG004|Part 3|Physician Decision|0|||
27926247|NCT01225731|54582560|FG005|Part 3|Physician Decision|0|||
27926248|NCT01225731|54582561|FG006|Part 3|Physician Decision|0|||
27926249|NCT01225731|54582562|FG007|Part 3|Physician Decision|0|||
27926250|NCT01225731|54582563|FG008|Part 3|Physician Decision|0|||
27926251|NCT01225731|54582564|FG009|Part 3|Physician Decision|0|||
27926252|NCT01225731|54582565|FG010|Part 3|Physician Decision|0|||
27926253|NCT01225731|54582566|FG011|Part 3|Physician Decision|1|||
27926254|NCT01225731|54582567|FG012|Part 3|Physician Decision|2|||
27926255|NCT01225731|54582555|FG000|Part 3|Withdrawal by Subject|0|||
27926256|NCT01225731|54582556|FG001|Part 3|Withdrawal by Subject|0|||
27926257|NCT01225731|54582557|FG002|Part 3|Withdrawal by Subject|0|||
27926258|NCT01225731|54582558|FG003|Part 3|Withdrawal by Subject|0|||
27926259|NCT01225731|54582559|FG004|Part 3|Withdrawal by Subject|0|||
27926260|NCT01225731|54582560|FG005|Part 3|Withdrawal by Subject|0|||
27926261|NCT01225731|54582561|FG006|Part 3|Withdrawal by Subject|0|||
27926262|NCT01225731|54582562|FG007|Part 3|Withdrawal by Subject|0|||
27926263|NCT01225731|54582563|FG008|Part 3|Withdrawal by Subject|0|||
27926264|NCT01225731|54582564|FG009|Part 3|Withdrawal by Subject|0|||
27926265|NCT01225731|54582565|FG010|Part 3|Withdrawal by Subject|4|||
27926266|NCT01225731|54582566|FG011|Part 3|Withdrawal by Subject|6|||
27926267|NCT01225731|54582567|FG012|Part 3|Withdrawal by Subject|4|||
27926268|NCT01007149|54582598|FG000|Overall Study|Administrative problems|0|||
27926269|NCT01007149|54582599|FG001|Overall Study|Administrative problems|1|||
27926270|NCT00998335|54582607|FG000|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0|||
27926271|NCT00998335|54582608|FG001|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2|||
27926272|NCT01294670|54582625|FG000|Overall Study|Not treated|1|||
27926273|NCT01294670|54582626|FG001|Overall Study|Not treated|0|||
27926274|NCT01294670|54582627|FG002|Overall Study|Not treated|0|||
27926275|NCT01294670|54582628|FG003|Overall Study|Not treated|0|||
27926276|NCT01294670|54582629|FG004|Overall Study|Not treated|0|||
27926277|NCT01006603|54582643|FG000|Overall Study|Withdrawal by Subject|17|||
27926278|NCT01006603|54582644|FG001|Overall Study|Withdrawal by Subject|19|||
27926279|NCT01006603|54582643|FG000|Overall Study|Lost to Follow-up|0|||
27926280|NCT01006603|54582644|FG001|Overall Study|Lost to Follow-up|1|||
27926281|NCT01006603|54582643|FG000|Overall Study|Safety reason|1|||
27926282|NCT01006603|54582644|FG001|Overall Study|Safety reason|1|||
27926283|NCT01006603|54582643|FG000|Overall Study|Protocol Violation|1|||
27926284|NCT01006603|54582644|FG001|Overall Study|Protocol Violation|3|||
27926285|NCT01006603|54582643|FG000|Overall Study|Incorrect enrolment|0|||
27926286|NCT01006603|54582644|FG001|Overall Study|Incorrect enrolment|2|||
27926287|NCT01006603|54582643|FG000|Overall Study|Adverse Event|15|||
27926288|NCT01006603|54582644|FG001|Overall Study|Adverse Event|7|||
27926289|NCT01006603|54582643|FG000|Overall Study|Death|1|||
27926290|NCT01006603|54582644|FG001|Overall Study|Death|1|||
27926291|NCT01006603|54582643|FG000|Overall Study|Study specific discontinuation criteria|33|||
27926292|NCT01006603|54582644|FG001|Overall Study|Study specific discontinuation criteria|34|||
27926293|NCT01006603|54582643|FG000|Overall Study|Other|3|||
27926294|NCT01006603|54582644|FG001|Overall Study|Other|7|||
27836156|NCT01563913|54321106|FG001|Overall Study|Physician Decision|0|||
27926295|NCT00997321|54582652|FG000|Overall Study|did not undergo sedation after enrollmen|0|||
27926296|NCT00997321|54582653|FG001|Overall Study|did not undergo sedation after enrollmen|3|||
27926297|NCT01294592|54582667|FG000|Overall Study|Adverse Event|28|||
27926298|NCT01294592|54582668|FG001|Overall Study|Adverse Event|13|||
27926299|NCT01294592|54582667|FG000|Overall Study|Lack of Efficacy|7|||
28104083|NCT03337490|54760851|FG000|Overall Study|Physician Decision|0|||
27926300|NCT01294592|54582668|FG001|Overall Study|Lack of Efficacy|5|||
27926301|NCT01294592|54582667|FG000|Overall Study|Protocol Violation|1|||
27926302|NCT01294592|54582668|FG001|Overall Study|Protocol Violation|7|||
27926303|NCT01294592|54582667|FG000|Overall Study|Lost to Follow-up|7|||
27926304|NCT01294592|54582668|FG001|Overall Study|Lost to Follow-up|9|||
27926305|NCT01294592|54582667|FG000|Overall Study|Physician Decision|6|||
27926306|NCT01294592|54582668|FG001|Overall Study|Physician Decision|11|||
27926307|NCT01294592|54582667|FG000|Overall Study|Withdrawal by Subject|28|||
27926308|NCT01294592|54582668|FG001|Overall Study|Withdrawal by Subject|28|||
27926309|NCT00997243|54582677|FG000|Overall Study|Early termination of study by sponsor|7|||
27926310|NCT01294514|54582681|FG000|Overall Study|Excluded due to Arrhythmia|1|||
27926311|NCT00999661|54582689|FG000|Overall Study|Lost to Follow-up|59|||
27926312|NCT00999661|54582689|FG000|Overall Study|Adverse Event|1|||
27836157|NCT01563913|54321105|FG000|Overall Study|Spouse Passed Away|1|||
27836158|NCT01563913|54321106|FG001|Overall Study|Spouse Passed Away|0|||
27836159|NCT01553747|54321115|FG000|Overall Study|Protocol Violation|0|||
27836160|NCT01553747|54321116|FG001|Overall Study|Protocol Violation|2|||
27836161|NCT01553747|54321117|FG002|Overall Study|Protocol Violation|0|||
27836162|NCT01553747|54321115|FG000|Overall Study|Voluntarily withdrew|70|||
27836163|NCT01553747|54321116|FG001|Overall Study|Voluntarily withdrew|66|||
27836164|NCT01553747|54321117|FG002|Overall Study|Voluntarily withdrew|74|||
27836165|NCT01553747|54321115|FG000|Overall Study|Adverse event or SAE|32|||
27836166|NCT01553747|54321116|FG001|Overall Study|Adverse event or SAE|28|||
27836167|NCT01553747|54321117|FG002|Overall Study|Adverse event or SAE|19|||
27836168|NCT01553747|54321115|FG000|Overall Study|Physician decision: other|10|||
27836169|NCT01553747|54321116|FG001|Overall Study|Physician decision: other|8|||
27836170|NCT01553747|54321117|FG002|Overall Study|Physician decision: other|7|||
27836171|NCT01553747|54321115|FG000|Overall Study|Lost to Follow-up|11|||
27836172|NCT01553747|54321116|FG001|Overall Study|Lost to Follow-up|5|||
27836173|NCT01553747|54321117|FG002|Overall Study|Lost to Follow-up|6|||
27836174|NCT01553747|54321115|FG000|Overall Study|Sponsor decision, specify|7|||
27836175|NCT01553747|54321116|FG001|Overall Study|Sponsor decision, specify|5|||
27836176|NCT01553747|54321117|FG002|Overall Study|Sponsor decision, specify|0|||
27836177|NCT01553747|54321115|FG000|Overall Study|Physician decision: lack of efficacy|1|||
27836178|NCT01553747|54321116|FG001|Overall Study|Physician decision: lack of efficacy|5|||
27836179|NCT01553747|54321117|FG002|Overall Study|Physician decision: lack of efficacy|3|||
27836180|NCT01536379|54321130|FG000|Overall Study|Adverse Event|1|||
27836181|NCT01536379|54321131|FG001|Overall Study|Adverse Event|2|||
27836182|NCT01536379|54321130|FG000|Overall Study|Withdrawal by Subject|1|||
27836183|NCT01536379|54321131|FG001|Overall Study|Withdrawal by Subject|1|||
27836184|NCT01536145|54321137|FG000|Overall Study|Progressive disease|3|||
27836185|NCT01536145|54321138|FG001|Overall Study|Progressive disease|4|||
27836186|NCT01536145|54321139|FG002|Overall Study|Progressive disease|1|||
27836187|NCT01536145|54321140|FG003|Overall Study|Progressive disease|2|||
27836188|NCT01536145|54321141|FG004|Overall Study|Progressive disease|1|||
27836189|NCT01536145|54321142|FG005|Overall Study|Progressive disease|2|||
27836190|NCT01536145|54321143|FG006|Overall Study|Progressive disease|1|||
27836191|NCT01536145|54321144|FG007|Overall Study|Progressive disease|2|||
27836192|NCT01536145|54321145|FG008|Overall Study|Progressive disease|1|||
27836193|NCT01536145|54321146|FG009|Overall Study|Progressive disease|3|||
27836194|NCT01536145|54321147|FG010|Overall Study|Progressive disease|3|||
27836195|NCT01536145|54321137|FG000|Overall Study|Withdrawal by Subject|0|||
27836196|NCT01536145|54321138|FG001|Overall Study|Withdrawal by Subject|0|||
27836197|NCT01536145|54321139|FG002|Overall Study|Withdrawal by Subject|1|||
27836198|NCT01536145|54321140|FG003|Overall Study|Withdrawal by Subject|0|||
27836199|NCT01536145|54321141|FG004|Overall Study|Withdrawal by Subject|0|||
27836200|NCT01536145|54321142|FG005|Overall Study|Withdrawal by Subject|1|||
27836201|NCT01536145|54321143|FG006|Overall Study|Withdrawal by Subject|0|||
27836202|NCT01536145|54321144|FG007|Overall Study|Withdrawal by Subject|0|||
27836203|NCT01536145|54321145|FG008|Overall Study|Withdrawal by Subject|2|||
27836204|NCT01536145|54321146|FG009|Overall Study|Withdrawal by Subject|0|||
27836205|NCT01536145|54321147|FG010|Overall Study|Withdrawal by Subject|2|||
27746901|NCT02596893|54196633|FG002|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
27746902|NCT02596893|54196634|FG003|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13|||
27746903|NCT02596893|54196631|FG000|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10|||
27746904|NCT02596893|54196632|FG001|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4|||
27746905|NCT02596893|54196633|FG002|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13|||
27746906|NCT02596893|54196634|FG003|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5|||
27746907|NCT02596893|54196631|FG000|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1|||
27746908|NCT02596893|54196632|FG001|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
27746909|NCT02596893|54196633|FG002|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0|||
27746910|NCT02596893|54196634|FG003|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
27746911|NCT02596893|54196631|FG000|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0|||
27926313|NCT00999661|54582689|FG000|Overall Study|Withdrawal by Subject|1|||
27746912|NCT02596893|54196632|FG001|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
27746913|NCT02596893|54196633|FG002|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
27746914|NCT02596893|54196634|FG003|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
27746915|NCT02596893|54196631|FG000|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
27831152|NCT00708552|54307299|FG002|Overall Study|Protocol Violation|2|||
27926314|NCT00999661|54582689|FG000|Overall Study|Not meeting eligibility criteria|9|||
27831153|NCT00708552|54307300|FG003|Overall Study|Protocol Violation|4|||
27836206|NCT01536145|54321137|FG000|Overall Study|Other|0|||
27836207|NCT01536145|54321138|FG001|Overall Study|Other|0|||
27836208|NCT01536145|54321139|FG002|Overall Study|Other|0|||
27836209|NCT01536145|54321140|FG003|Overall Study|Other|0|||
27836210|NCT01536145|54321141|FG004|Overall Study|Other|1|||
27836211|NCT01536145|54321142|FG005|Overall Study|Other|0|||
27836212|NCT01536145|54321143|FG006|Overall Study|Other|0|||
27836213|NCT01536145|54321144|FG007|Overall Study|Other|0|||
27836214|NCT01536145|54321145|FG008|Overall Study|Other|0|||
27836215|NCT01536145|54321146|FG009|Overall Study|Other|3|||
27836216|NCT01536145|54321147|FG010|Overall Study|Other|2|||
27836217|NCT01536145|54321137|FG000|Overall Study|Death|0|||
27836218|NCT01536145|54321138|FG001|Overall Study|Death|0|||
27836219|NCT01536145|54321139|FG002|Overall Study|Death|0|||
27836220|NCT01536145|54321140|FG003|Overall Study|Death|0|||
27836221|NCT01536145|54321141|FG004|Overall Study|Death|0|||
27836222|NCT01536145|54321142|FG005|Overall Study|Death|0|||
27836223|NCT01536145|54321143|FG006|Overall Study|Death|1|||
27836224|NCT01536145|54321144|FG007|Overall Study|Death|0|||
27836225|NCT01536145|54321145|FG008|Overall Study|Death|0|||
27836226|NCT01536145|54321146|FG009|Overall Study|Death|0|||
27836227|NCT01536145|54321147|FG010|Overall Study|Death|0|||
27836228|NCT01536145|54321137|FG000|Overall Study|Adverse Event|0|||
27836229|NCT01536145|54321138|FG001|Overall Study|Adverse Event|0|||
27836230|NCT01536145|54321139|FG002|Overall Study|Adverse Event|0|||
27836231|NCT01536145|54321140|FG003|Overall Study|Adverse Event|0|||
27836232|NCT01536145|54321141|FG004|Overall Study|Adverse Event|0|||
27836233|NCT01536145|54321142|FG005|Overall Study|Adverse Event|0|||
27836234|NCT01536145|54321143|FG006|Overall Study|Adverse Event|0|||
27836235|NCT01536145|54321144|FG007|Overall Study|Adverse Event|2|||
27836236|NCT01536145|54321145|FG008|Overall Study|Adverse Event|0|||
27836237|NCT01536145|54321146|FG009|Overall Study|Adverse Event|0|||
27836238|NCT01536145|54321147|FG010|Overall Study|Adverse Event|3|||
27836239|NCT01536067|54321178|FG000|Overall Study|Disease Progression|1|||
27836240|NCT01582009|54321182|FG000|Overall Study|Withdrawal by Subject|1|||
27836241|NCT01582009|54321182|FG000|Overall Study|Physician Decision|1|||
27836242|NCT01553591|54321189|FG000|Overall Study|Voluntarily withdrew|94|||
27836243|NCT01553591|54321190|FG001|Overall Study|Voluntarily withdrew|79|||
27836244|NCT01553591|54321191|FG002|Overall Study|Voluntarily withdrew|96|||
27836245|NCT01553591|54321189|FG000|Overall Study|Adverse Event|36|||
27836246|NCT01553591|54321190|FG001|Overall Study|Adverse Event|45|||
27836247|NCT01553591|54321191|FG002|Overall Study|Adverse Event|16|||
27836248|NCT01553591|54321189|FG000|Overall Study|Lost to Follow-up|25|||
27836249|NCT01553591|54321190|FG001|Overall Study|Lost to Follow-up|23|||
27836250|NCT01553591|54321191|FG002|Overall Study|Lost to Follow-up|16|||
27836251|NCT01553591|54321189|FG000|Overall Study|Physician decision: other|11|||
27836252|NCT01553591|54321190|FG001|Overall Study|Physician decision: other|14|||
27836253|NCT01553591|54321191|FG002|Overall Study|Physician decision: other|16|||
27836254|NCT01553591|54321189|FG000|Overall Study|Physician decision: lack of efficacy|2|||
27836255|NCT01553591|54321190|FG001|Overall Study|Physician decision: lack of efficacy|3|||
27836256|NCT01553591|54321191|FG002|Overall Study|Physician decision: lack of efficacy|7|||
27836257|NCT01553591|54321189|FG000|Overall Study|Protocol Violation|3|||
27836258|NCT01553591|54321190|FG001|Overall Study|Protocol Violation|4|||
27836259|NCT01553591|54321191|FG002|Overall Study|Protocol Violation|4|||
27836260|NCT01553591|54321189|FG000|Overall Study|Sponsor decision|1|||
27836261|NCT01553591|54321190|FG001|Overall Study|Sponsor decision|0|||
27836262|NCT01553591|54321191|FG002|Overall Study|Sponsor decision|3|||
27836263|NCT01553591|54321189|FG000|Overall Study|Randomized and never dispensed drug|0|||
27836264|NCT01553591|54321190|FG001|Overall Study|Randomized and never dispensed drug|1|||
27836265|NCT01553591|54321191|FG002|Overall Study|Randomized and never dispensed drug|0|||
27836266|NCT01581931|54321199|FG000|Washout|Adverse Event|0|||
27836267|NCT01581931|54321200|FG001|Washout|Adverse Event|1|||
27836268|NCT01581619|54321206|FG000|Overall Study|Withdrawal by Subject|1|||
27836269|NCT01581619|54321206|FG000|Overall Study|Lost to Follow-up|1|||
27836270|NCT01581307|54321212|FG000|Overall Study|Withdrawal by Subject|1|||
27836271|NCT01580995|54321218|FG000|Overall Study|Lost to Follow-up|2|||
27836272|NCT01580995|54321219|FG001|Overall Study|Lost to Follow-up|2|||
27836273|NCT01535599|54321227|FG000|Overall Study|Adverse Event|6|||
27836274|NCT01535599|54321228|FG001|Overall Study|Adverse Event|15|||
27836275|NCT01535599|54321227|FG000|Overall Study|Lost to Follow-up|3|||
27836276|NCT01535599|54321228|FG001|Overall Study|Lost to Follow-up|4|||
27836277|NCT01535599|54321227|FG000|Overall Study|Subj Decision Unrelated to Adverse Event|4|||
27836278|NCT01535599|54321228|FG001|Overall Study|Subj Decision Unrelated to Adverse Event|3|||
27836279|NCT01535599|54321227|FG000|Overall Study|Treatment Failure|33|||
27836280|NCT01535599|54321228|FG001|Overall Study|Treatment Failure|66|||
27836281|NCT01535599|54321227|FG000|Overall Study|BL Culture + for Group A Strep|0|||
27836282|NCT01535599|54321228|FG001|Overall Study|BL Culture + for Group A Strep|1|||
27836283|NCT01535599|54321227|FG000|Overall Study|BL Culture + for Yeast//Fungi|0|||
27836284|NCT01535599|54321228|FG001|Overall Study|BL Culture + for Yeast//Fungi|1|||
27836285|NCT01535599|54321227|FG000|Overall Study|Randomized in Error|2|||
27836286|NCT01535599|54321228|FG001|Overall Study|Randomized in Error|4|||
27836287|NCT01535599|54321227|FG000|Overall Study|Did not use product|1|||
27836288|NCT01535599|54321228|FG001|Overall Study|Did not use product|0|||
27836289|NCT01535599|54321227|FG000|Overall Study|Other|1|||
27836290|NCT01535599|54321228|FG001|Overall Study|Other|0|||
27836291|NCT01535599|54321227|FG000|Overall Study|Stopped medication|0|||
27836292|NCT01535599|54321228|FG001|Overall Study|Stopped medication|1|||
27836293|NCT01535599|54321227|FG000|Overall Study|Noncompliance|0|||
27836294|NCT01535599|54321228|FG001|Overall Study|Noncompliance|1|||
27836295|NCT01553279|54321236|FG000|Part 1 (Infant Vaccinations)|Lost to Follow-up|1|||
27836296|NCT01553279|54321237|FG001|Part 1 (Infant Vaccinations)|Lost to Follow-up|0|||
27836297|NCT01553279|54321236|FG000|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
27836298|NCT01553279|54321237|FG001|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
27836299|NCT01553279|54321236|FG000|Interim Period|Withdrawal by Subject|2|||
27836300|NCT01553279|54321237|FG001|Interim Period|Withdrawal by Subject|2|||
27836301|NCT01553279|54321236|FG000|Interim Period|Lost to Follow-up|1|||
27836302|NCT01553279|54321237|FG001|Interim Period|Lost to Follow-up|0|||
27836303|NCT01553279|54321236|FG000|Period 2: Toddler Vaccinations|Withdrawal by Subject|0|||
27836304|NCT01553279|54321237|FG001|Period 2: Toddler Vaccinations|Withdrawal by Subject|5|||
27836305|NCT01553279|54321236|FG000|Period 2: Toddler Vaccinations|Lost to Follow-up|3|||
27836306|NCT01553279|54321237|FG001|Period 2: Toddler Vaccinations|Lost to Follow-up|2|||
27836307|NCT01562743|54321244|FG000|Overall Study|Adverse Event|29|||
27836308|NCT01562743|54321244|FG000|Overall Study|Lack of Efficacy|3|||
27836309|NCT01562743|54321244|FG000|Overall Study|Withdrawal by Subject|13|||
27836310|NCT01562743|54321244|FG000|Overall Study|Protocol Violation|1|||
27836311|NCT01562743|54321244|FG000|Overall Study|Discontinuation criteria|2|||
27836312|NCT01562743|54321244|FG000|Overall Study|Lost to Follow-up|2|||
27836313|NCT01562743|54321244|FG000|Overall Study|Physician Decision|2|||
27836314|NCT01535443|54321248|FG000|Overall Study|Physician Decision|3|||
27836315|NCT01535287|54321255|FG000|Overall Study|drug not prepared in time|5|||
27836316|NCT01535287|54321256|FG001|Overall Study|drug not prepared in time|6|||
27836317|NCT01551173|54321264|FG000|Overall Study|Withdrawal by Subject|11|||
27836318|NCT01551173|54321265|FG001|Overall Study|Withdrawal by Subject|16|||
27926315|NCT01294436|54582695|FG000|Overall Study|Adverse Event|10|||
27926316|NCT01294436|54582696|FG001|Overall Study|Adverse Event|17|||
27926317|NCT01294436|54582695|FG000|Overall Study|Withdrawal by Subject|11|||
27926318|NCT01294436|54582696|FG001|Overall Study|Withdrawal by Subject|28|||
27926319|NCT01294436|54582695|FG000|Overall Study|subject no longer meets study criteria|5|||
27926320|NCT01294436|54582696|FG001|Overall Study|subject no longer meets study criteria|20|||
27926321|NCT01294436|54582695|FG000|Overall Study|poor/non-compliance|2|||
27926322|NCT01294436|54582696|FG001|Overall Study|poor/non-compliance|5|||
27926323|NCT00995371|54582704|FG000|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
27926324|NCT00995371|54582705|FG001|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
27926325|NCT01294358|54582713|FG000|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
27926326|NCT01294358|54582714|FG001|Cohort 2: 6/9/11-9/17/12|Disease progression|2|||
27926327|NCT01294358|54582715|FG002|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
27926328|NCT01294358|54582716|FG003|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
27926329|NCT01294358|54582717|FG004|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
27926330|NCT01294358|54582713|FG000|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
27926331|NCT01294358|54582714|FG001|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
27926332|NCT01294358|54582715|FG002|Cohort 3: 12/1/11-10/6/12|Disease progression|2|||
27926333|NCT01294358|54582716|FG003|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
27926334|NCT01294358|54582717|FG004|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
27926335|NCT01294358|54582713|FG000|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
27926336|NCT01294358|54582714|FG001|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
27926337|NCT01294358|54582715|FG002|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
27926338|NCT01294358|54582716|FG003|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1|||
27926339|NCT01294358|54582717|FG004|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
27926340|NCT01294358|54582713|FG000|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
27926341|NCT01294358|54582714|FG001|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
27926342|NCT01294358|54582715|FG002|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
27926343|NCT01294358|54582716|FG003|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
27926344|NCT01294358|54582717|FG004|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1|||
27926345|NCT00994279|54582736|FG000|Overall Study|Withdrawal by Subject|2|||
27926346|NCT00994279|54582737|FG001|Overall Study|Withdrawal by Subject|2|||
27926347|NCT00994279|54582736|FG000|Overall Study|Toxicity|1|||
27926348|NCT00994279|54582737|FG001|Overall Study|Toxicity|0|||
27926349|NCT00994279|54582736|FG000|Overall Study|Multiple reasons|1|||
27926350|NCT00994279|54582737|FG001|Overall Study|Multiple reasons|3|||
27926351|NCT01294046|54582743|FG000|Overall Study|Infection and surgical explant|1|||
27926352|NCT01294046|54582743|FG000|Overall Study|Eligibility criteria expanded|1|||
27926353|NCT01294046|54582743|FG000|Overall Study|Stimulation response inadqequate|1|||
27926354|NCT01224639|54582758|FG000|Overall Study|Withdrawal by Subject|0|||
27926355|NCT01224639|54582759|FG001|Overall Study|Withdrawal by Subject|0|||
27926356|NCT01224639|54582760|FG002|Overall Study|Withdrawal by Subject|0|||
27926357|NCT01224639|54582761|FG003|Overall Study|Withdrawal by Subject|0|||
27926358|NCT01224639|54582762|FG004|Overall Study|Withdrawal by Subject|2|||
27926359|NCT01224639|54582763|FG005|Overall Study|Withdrawal by Subject|0|||
27926360|NCT01224639|54582764|FG006|Overall Study|Withdrawal by Subject|1|||
27926361|NCT01224639|54582765|FG007|Overall Study|Withdrawal by Subject|1|||
27926362|NCT01224639|54582758|FG000|Overall Study|Adverse Event|0|||
27926363|NCT01224639|54582759|FG001|Overall Study|Adverse Event|0|||
27926364|NCT01224639|54582760|FG002|Overall Study|Adverse Event|0|||
27926365|NCT01224639|54582761|FG003|Overall Study|Adverse Event|0|||
27926366|NCT01224639|54582762|FG004|Overall Study|Adverse Event|0|||
27926367|NCT01224639|54582763|FG005|Overall Study|Adverse Event|0|||
27926368|NCT01224639|54582764|FG006|Overall Study|Adverse Event|0|||
27926369|NCT01224639|54582765|FG007|Overall Study|Adverse Event|1|||
27926370|NCT01293968|54582785|FG000|Overall Study|non-cooperation|3|||
27926371|NCT01293968|54582786|FG001|Overall Study|non-cooperation|3|||
27926372|NCT01293032|54582796|FG000|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
27926373|NCT01293032|54582797|FG001|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
27926374|NCT01293032|54582798|FG002|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5|||
27926375|NCT01293032|54582799|FG003|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
27926376|NCT01293032|54582796|FG000|Treatment|Adverse Event|0|||
27926377|NCT01293032|54582797|FG001|Treatment|Adverse Event|0|||
27926378|NCT01293032|54582798|FG002|Treatment|Adverse Event|1|||
27926379|NCT01293032|54582799|FG003|Treatment|Adverse Event|1|||
27926380|NCT01293032|54582796|FG000|Treatment|Withdrawal by Subject|2|||
27926381|NCT01293032|54582797|FG001|Treatment|Withdrawal by Subject|4|||
27926382|NCT01293032|54582798|FG002|Treatment|Withdrawal by Subject|0|||
27926383|NCT01293032|54582799|FG003|Treatment|Withdrawal by Subject|0|||
27926384|NCT01293032|54582796|FG000|Treatment|Disease Progression, relapse|0|||
27926385|NCT01293032|54582797|FG001|Treatment|Disease Progression, relapse|1|||
27926386|NCT01293032|54582798|FG002|Treatment|Disease Progression, relapse|0|||
27926387|NCT01293032|54582799|FG003|Treatment|Disease Progression, relapse|0|||
27926388|NCT01292876|54582806|FG000|Overall Study|Physician Decision|4|||
27926389|NCT01224171|54582814|FG000|Overall Study|Adverse Event|8|||
27926390|NCT01224171|54582815|FG001|Overall Study|Adverse Event|4|||
27926391|NCT01224171|54582814|FG000|Overall Study|Protocol Violation|0|||
27926392|NCT01224171|54582815|FG001|Overall Study|Protocol Violation|1|||
27926393|NCT01224171|54582814|FG000|Overall Study|Lack of Efficacy|5|||
27926394|NCT01224171|54582815|FG001|Overall Study|Lack of Efficacy|1|||
27926395|NCT01224171|54582814|FG000|Overall Study|Withdrawal of Consent|2|||
27926396|NCT01224171|54582815|FG001|Overall Study|Withdrawal of Consent|4|||
27926397|NCT01224171|54582814|FG000|Overall Study|Lost to Follow-up|0|||
27926398|NCT01224171|54582815|FG001|Overall Study|Lost to Follow-up|3|||
27926399|NCT01292486|54582821|FG000|Overall Study|Protocol Violation|2|||
27926400|NCT01292486|54582821|FG000|Overall Study|Did not meet screening criteria|2|||
27926401|NCT01292486|54582821|FG000|Overall Study|Adverse Event|1|||
27926402|NCT01292486|54582821|FG000|Overall Study|Physician Decision|1|||
27926403|NCT01223937|54582828|FG000|Overall Study|Withdrawal by Subject|3|||
27926404|NCT01223937|54582829|FG001|Overall Study|Withdrawal by Subject|2|||
27926405|NCT01223937|54582828|FG000|Overall Study|Lost to Follow-up|1|||
27926406|NCT01223937|54582829|FG001|Overall Study|Lost to Follow-up|4|||
27926407|NCT01223937|54582828|FG000|Overall Study|Adverse Event|1|||
27926408|NCT01223937|54582829|FG001|Overall Study|Adverse Event|4|||
27926409|NCT01223937|54582828|FG000|Overall Study|Protocol Violation|8|||
27926410|NCT01223937|54582829|FG001|Overall Study|Protocol Violation|7|||
27926411|NCT01223937|54582828|FG000|Overall Study|Other|4|||
27926412|NCT01223937|54582829|FG001|Overall Study|Other|1|||
27926413|NCT01290224|54582835|FG000|Overall Study|Adverse Event|1|||
27926414|NCT01290224|54582835|FG000|Overall Study|Refused Further Treatment|4|||
27926415|NCT01223235|54582841|FG000|Overall Study|Withdrawal by Subject|1|||
27926416|NCT01290068|54582847|FG000|Overall Study|Adverse Event|1|||
27926417|NCT01290068|54582848|FG001|Overall Study|Adverse Event|3|||
27926418|NCT01290068|54582847|FG000|Overall Study|Lost to Follow-up|3|||
27926419|NCT01290068|54582848|FG001|Overall Study|Lost to Follow-up|0|||
27926420|NCT01290068|54582847|FG000|Overall Study|Withdrawal by subject prior to implant|0|||
27926421|NCT01290068|54582848|FG001|Overall Study|Withdrawal by subject prior to implant|2|||
27926422|NCT01290068|54582847|FG000|Overall Study|Other|3|||
27926423|NCT01290068|54582848|FG001|Overall Study|Other|1|||
27926424|NCT00998881|54582856|FG000|Overall Study|Adverse Event|2|||
27926425|NCT00998881|54582857|FG001|Overall Study|Adverse Event|2|||
27926426|NCT00998881|54582856|FG000|Overall Study|Lack of Efficacy|1|||
27926427|NCT00998881|54582857|FG001|Overall Study|Lack of Efficacy|0|||
27926428|NCT00998881|54582856|FG000|Overall Study|Physician Decision|3|||
27926429|NCT00998881|54582857|FG001|Overall Study|Physician Decision|0|||
27926430|NCT00998881|54582856|FG000|Overall Study|Withdrawal by Subject|1|||
27926431|NCT00998881|54582857|FG001|Overall Study|Withdrawal by Subject|0|||
27926432|NCT00998881|54582856|FG000|Overall Study|Personal matter|1|||
27926433|NCT00998881|54582857|FG001|Overall Study|Personal matter|0|||
27926434|NCT01222767|54582863|FG000|Overall Study|Progressive disease|13|||
27926435|NCT01222767|54582863|FG000|Overall Study|Adverse Event|2|||
27926436|NCT01222767|54582863|FG000|Overall Study|Surgical resection|1|||
27926437|NCT01222767|54582863|FG000|Overall Study|Never treated|1|||
27926438|NCT00993967|54582867|FG000|Overall Study|Adverse Event|8|||
27926439|NCT00993967|54582867|FG000|Overall Study|Death|1|||
27926440|NCT00993967|54582867|FG000|Overall Study|Lost to Follow-up|14|||
27926441|NCT00993967|54582867|FG000|Overall Study|Withdrawal by Subject|36|||
27926442|NCT00993967|54582867|FG000|Overall Study|Protocol Violation|2|||
27926443|NCT01222533|54582871|FG000|Overall Study|Adverse Event|5|||
27926444|NCT01222533|54582871|FG000|Overall Study|Withdrawal by Subject|5|||
27926445|NCT01222533|54582871|FG000|Overall Study|Other|4|||
27926446|NCT01221753|54582883|FG000|Overall Study|Adverse Event|1|||
27926447|NCT01221597|54582889|FG000|Overall Study|Adverse Event|4|||
27926448|NCT01221597|54582890|FG001|Overall Study|Adverse Event|1|||
27926449|NCT01221597|54582889|FG000|Overall Study|Withdrawal by Subject|20|||
27926450|NCT01221597|54582890|FG001|Overall Study|Withdrawal by Subject|6|||
27926451|NCT01221597|54582889|FG000|Overall Study|Lost to Follow-up|6|||
27926452|NCT01221597|54582890|FG001|Overall Study|Lost to Follow-up|5|||
27926453|NCT01221597|54582889|FG000|Overall Study|Protocol Violation|1|||
27926454|NCT01221597|54582890|FG001|Overall Study|Protocol Violation|0|||
27926455|NCT01221597|54582889|FG000|Overall Study|Other|3|||
27926456|NCT01221597|54582890|FG001|Overall Study|Other|4|||
27926457|NCT01221597|54582889|FG000|Overall Study|Death|2|||
27926458|NCT01221597|54582890|FG001|Overall Study|Death|0|||
27926459|NCT01221363|54582899|FG000|Overall Study|Pregnancy|1|||
27926460|NCT01221363|54582900|FG001|Overall Study|Pregnancy|0|||
27926461|NCT01221363|54582899|FG000|Overall Study|Withdrawal by Subject|11|||
27926462|NCT01221363|54582900|FG001|Overall Study|Withdrawal by Subject|5|||
27926463|NCT01221285|54582906|FG000|Overall Study|Withdrawal by Subject|1|||
27926464|NCT01014988|54582916|FG000|Overall Study|Adverse Event|20|||
27926465|NCT01014988|54582917|FG001|Overall Study|Adverse Event|0|||
27926466|NCT01014988|54582918|FG002|Overall Study|Adverse Event|1|||
27926467|NCT01014988|54582919|FG003|Overall Study|Adverse Event|0|||
27926468|NCT01014988|54582920|FG004|Overall Study|Adverse Event|1|||
27926469|NCT01014988|54582921|FG005|Overall Study|Adverse Event|3|||
27926470|NCT01014988|54582916|FG000|Overall Study|Lost to Follow-up|1|||
27926471|NCT01014988|54582917|FG001|Overall Study|Lost to Follow-up|0|||
27926472|NCT01014988|54582918|FG002|Overall Study|Lost to Follow-up|1|||
27926473|NCT01014988|54582919|FG003|Overall Study|Lost to Follow-up|0|||
27926474|NCT01014988|54582920|FG004|Overall Study|Lost to Follow-up|0|||
27926475|NCT01014988|54582921|FG005|Overall Study|Lost to Follow-up|0|||
27926476|NCT01014988|54582916|FG000|Overall Study|Physician Decision|1|||
27926477|NCT01014988|54582917|FG001|Overall Study|Physician Decision|0|||
27926478|NCT01014988|54582918|FG002|Overall Study|Physician Decision|0|||
27926479|NCT01014988|54582919|FG003|Overall Study|Physician Decision|0|||
27926480|NCT01014988|54582920|FG004|Overall Study|Physician Decision|0|||
27926481|NCT01014988|54582921|FG005|Overall Study|Physician Decision|0|||
27926482|NCT01014988|54582916|FG000|Overall Study|Withdrawal by Subject|1|||
27926483|NCT01014988|54582917|FG001|Overall Study|Withdrawal by Subject|0|||
27926484|NCT01014988|54582918|FG002|Overall Study|Withdrawal by Subject|0|||
27926485|NCT01014988|54582919|FG003|Overall Study|Withdrawal by Subject|0|||
27926486|NCT01014988|54582920|FG004|Overall Study|Withdrawal by Subject|0|||
27926487|NCT01014988|54582921|FG005|Overall Study|Withdrawal by Subject|0|||
27926488|NCT01014910|54582945|FG000|Overall Study|Withdrawal by Subject|0|||
27926489|NCT01014910|54582946|FG001|Overall Study|Withdrawal by Subject|2|||
27926490|NCT01019980|54582954|FG000|Overall Study|Drug not available.|2|||
27926491|NCT01019980|54582955|FG001|Overall Study|Drug not available.|0|||
27926492|NCT00993499|54582967|FG000|Run-in Period (8 Days)|Adverse Event|0|||
27926493|NCT00993499|54582968|FG001|Run-in Period (8 Days)|Adverse Event|1|||
27926494|NCT00993499|54582969|FG002|Run-in Period (8 Days)|Adverse Event|0|||
27926495|NCT00993499|54582970|FG003|Run-in Period (8 Days)|Adverse Event|0|||
27926496|NCT00993499|54582971|FG004|Run-in Period (8 Days)|Adverse Event|0|||
27926497|NCT00993499|54582972|FG005|Run-in Period (8 Days)|Adverse Event|0|||
27926498|NCT00993499|54582967|FG000|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1|||
27926499|NCT00993499|54582968|FG001|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
27926500|NCT00993499|54582969|FG002|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
27926501|NCT00993499|54582970|FG003|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
27926502|NCT00993499|54582971|FG004|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
27926503|NCT00993499|54582972|FG005|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
27926504|NCT00993499|54582967|FG000|Run-in Period (8 Days)|Consent withdrawn|0|||
27926505|NCT00993499|54582968|FG001|Run-in Period (8 Days)|Consent withdrawn|1|||
27926506|NCT00993499|54582969|FG002|Run-in Period (8 Days)|Consent withdrawn|0|||
27926507|NCT00993499|54582970|FG003|Run-in Period (8 Days)|Consent withdrawn|0|||
27926508|NCT00993499|54582971|FG004|Run-in Period (8 Days)|Consent withdrawn|0|||
27926509|NCT00993499|54582972|FG005|Run-in Period (8 Days)|Consent withdrawn|0|||
27926510|NCT00993499|54582967|FG000|Run-in Period (8 Days)|Progressive disease|0|||
27926511|NCT00993499|54582968|FG001|Run-in Period (8 Days)|Progressive disease|1|||
27926512|NCT00993499|54582969|FG002|Run-in Period (8 Days)|Progressive disease|1|||
27926513|NCT00993499|54582970|FG003|Run-in Period (8 Days)|Progressive disease|0|||
27926514|NCT00993499|54582971|FG004|Run-in Period (8 Days)|Progressive disease|0|||
27926515|NCT00993499|54582972|FG005|Run-in Period (8 Days)|Progressive disease|0|||
27926516|NCT00993499|54582967|FG000|Discontinued Before Starting Course 3|Progressive Disease|2|||
27926517|NCT00993499|54582968|FG001|Discontinued Before Starting Course 3|Progressive Disease|2|||
27926518|NCT00993499|54582969|FG002|Discontinued Before Starting Course 3|Progressive Disease|0|||
27926519|NCT00993499|54582970|FG003|Discontinued Before Starting Course 3|Progressive Disease|0|||
27926520|NCT00993499|54582971|FG004|Discontinued Before Starting Course 3|Progressive Disease|0|||
27926521|NCT00993499|54582972|FG005|Discontinued Before Starting Course 3|Progressive Disease|0|||
27926522|NCT00993499|54582967|FG000|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
27926523|NCT00993499|54582968|FG001|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
27926524|NCT00993499|54582969|FG002|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
27926525|NCT00993499|54582970|FG003|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
27926526|NCT00993499|54582971|FG004|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
27926527|NCT00993499|54582972|FG005|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
27926528|NCT00993499|54582967|FG000|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
27926529|NCT00993499|54582968|FG001|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
27926530|NCT00993499|54582969|FG002|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
27926531|NCT00993499|54582970|FG003|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
27926532|NCT00993499|54582971|FG004|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
27926533|NCT00993499|54582972|FG005|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
27926534|NCT00993499|54582967|FG000|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
27926535|NCT00993499|54582968|FG001|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
27926536|NCT00993499|54582969|FG002|Discontinued Before Starting Course 3|Non compliance with the protocol|2|||
27926537|NCT00993499|54582970|FG003|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
27926538|NCT00993499|54582971|FG004|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
27926539|NCT00993499|54582972|FG005|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
27926540|NCT00993499|54582967|FG000|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
27926541|NCT00993499|54582968|FG001|Discontinued After Starting Course 3|Withdrawal by Subject|1|||
27926542|NCT00993499|54582969|FG002|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
27926543|NCT00993499|54582970|FG003|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
27926544|NCT00993499|54582971|FG004|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
27926545|NCT00993499|54582972|FG005|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
27926546|NCT00993499|54582967|FG000|Discontinued After Starting Course 3|Progressive Disease|6|||
27926547|NCT00993499|54582968|FG001|Discontinued After Starting Course 3|Progressive Disease|4|||
27926548|NCT00993499|54582969|FG002|Discontinued After Starting Course 3|Progressive Disease|3|||
27926549|NCT00993499|54582970|FG003|Discontinued After Starting Course 3|Progressive Disease|1|||
27926550|NCT00993499|54582971|FG004|Discontinued After Starting Course 3|Progressive Disease|3|||
27926551|NCT00993499|54582972|FG005|Discontinued After Starting Course 3|Progressive Disease|3|||
27926552|NCT00993499|54582967|FG000|Discontinued After Starting Course 3|DLT|1|||
27926553|NCT00993499|54582968|FG001|Discontinued After Starting Course 3|DLT|0|||
27926554|NCT00993499|54582969|FG002|Discontinued After Starting Course 3|DLT|2|||
27926555|NCT00993499|54582970|FG003|Discontinued After Starting Course 3|DLT|1|||
27926556|NCT00993499|54582971|FG004|Discontinued After Starting Course 3|DLT|0|||
27926557|NCT00993499|54582972|FG005|Discontinued After Starting Course 3|DLT|0|||
27926558|NCT00993499|54582967|FG000|Discontinued After Starting Course 3|Other adverse event|1|||
27926559|NCT00993499|54582968|FG001|Discontinued After Starting Course 3|Other adverse event|0|||
27926560|NCT00993499|54582969|FG002|Discontinued After Starting Course 3|Other adverse event|1|||
27926561|NCT00993499|54582970|FG003|Discontinued After Starting Course 3|Other adverse event|0|||
27926562|NCT00993499|54582971|FG004|Discontinued After Starting Course 3|Other adverse event|0|||
27926563|NCT00993499|54582972|FG005|Discontinued After Starting Course 3|Other adverse event|0|||
27926564|NCT01014442|54582988|FG000|Overall Study|Adverse Event|0|||
27926565|NCT01014442|54582989|FG001|Overall Study|Adverse Event|8|||
27926566|NCT01014442|54582988|FG000|Overall Study|Withdrawal by Subject|4|||
28104084|NCT03337490|54760852|FG001|Overall Study|Physician Decision|1|||
28104085|NCT03337490|54760853|FG002|Overall Study|Physician Decision|0|||
28104086|NCT03337490|54760851|FG000|Overall Study|Lost to Follow-up|0|||
28104087|NCT03337490|54760852|FG001|Overall Study|Lost to Follow-up|1|||
27926567|NCT01014442|54582989|FG001|Overall Study|Withdrawal by Subject|4|||
27926568|NCT01014442|54582988|FG000|Overall Study|Protocol Violation|2|||
28104088|NCT03337490|54760853|FG002|Overall Study|Lost to Follow-up|0|||
28104089|NCT02944448|54760863|FG000|Overall Study|Adverse Event|37|||
28104090|NCT02944448|54760864|FG001|Overall Study|Adverse Event|6|||
28104091|NCT02944448|54760863|FG000|Overall Study|Lack of Efficacy|8|||
28104092|NCT02944448|54760864|FG001|Overall Study|Lack of Efficacy|5|||
28104093|NCT02944448|54760863|FG000|Overall Study|Lost to Follow-up|3|||
28104094|NCT02944448|54760864|FG001|Overall Study|Lost to Follow-up|1|||
28104095|NCT02944448|54760863|FG000|Overall Study|Protocol Violation|25|||
28104096|NCT02944448|54760864|FG001|Overall Study|Protocol Violation|7|||
28104097|NCT02944448|54760863|FG000|Overall Study|Withdrawal by Subject|14|||
28104098|NCT02944448|54760864|FG001|Overall Study|Withdrawal by Subject|4|||
28104099|NCT02944448|54760863|FG000|Overall Study|Sponsor did not supply drug in time|0|||
28104100|NCT02944448|54760864|FG001|Overall Study|Sponsor did not supply drug in time|1|||
28104101|NCT02944448|54760863|FG000|Overall Study|Noncompliant with dosing|1|||
28104102|NCT02944448|54760864|FG001|Overall Study|Noncompliant with dosing|0|||
27926569|NCT01014442|54582989|FG001|Overall Study|Protocol Violation|5|||
27926570|NCT01014442|54582988|FG000|Overall Study|Lack of Compliance|0|||
27926571|NCT01014442|54582989|FG001|Overall Study|Lack of Compliance|1|||
27926572|NCT01014442|54582988|FG000|Overall Study|Unspecified Reason|1|||
27926573|NCT01014442|54582989|FG001|Overall Study|Unspecified Reason|1|||
27926574|NCT00996307|54583003|FG000|Overall Study|Adverse Event|0|||
27926575|NCT00996307|54583004|FG001|Overall Study|Adverse Event|1|||
27926576|NCT00996307|54583005|FG002|Overall Study|Adverse Event|0|||
27926577|NCT00996307|54583006|FG003|Overall Study|Adverse Event|0|||
27926578|NCT00996307|54583003|FG000|Overall Study|Withdrawal by Subject|3|||
27926579|NCT00996307|54583004|FG001|Overall Study|Withdrawal by Subject|2|||
27926580|NCT00996307|54583005|FG002|Overall Study|Withdrawal by Subject|5|||
27926581|NCT00996307|54583006|FG003|Overall Study|Withdrawal by Subject|5|||
27926582|NCT00996307|54583003|FG000|Overall Study|Lost to Follow-up|13|||
27926583|NCT00996307|54583004|FG001|Overall Study|Lost to Follow-up|13|||
27926584|NCT00996307|54583005|FG002|Overall Study|Lost to Follow-up|7|||
27926585|NCT00996307|54583006|FG003|Overall Study|Lost to Follow-up|15|||
27926586|NCT00996307|54583003|FG000|Overall Study|Administrative reason|0|||
27926587|NCT00996307|54583004|FG001|Overall Study|Administrative reason|1|||
27926588|NCT00996307|54583005|FG002|Overall Study|Administrative reason|0|||
27926589|NCT00996307|54583006|FG003|Overall Study|Administrative reason|0|||
27926590|NCT00996307|54583003|FG000|Overall Study|Unable to classify|4|||
27926591|NCT00996307|54583004|FG001|Overall Study|Unable to classify|0|||
27926592|NCT00996307|54583005|FG002|Overall Study|Unable to classify|2|||
27926593|NCT00996307|54583006|FG003|Overall Study|Unable to classify|1|||
27926594|NCT01219959|54583036|FG000|Overall Study|Adverse Event|6|||
27926595|NCT01219959|54583037|FG001|Overall Study|Adverse Event|14|||
27926596|NCT01219959|54583036|FG000|Overall Study|Physician Decision|0|||
27926597|NCT01219959|54583037|FG001|Overall Study|Physician Decision|4|||
27926598|NCT01219959|54583036|FG000|Overall Study|Withdrawal by Subject|0|||
27926599|NCT01219959|54583037|FG001|Overall Study|Withdrawal by Subject|2|||
27926600|NCT01219959|54583036|FG000|Overall Study|Renal Transplantation|0|||
27926601|NCT01219959|54583037|FG001|Overall Study|Renal Transplantation|3|||
27926602|NCT01219959|54583036|FG000|Overall Study|Other|1|||
27926603|NCT01219959|54583037|FG001|Overall Study|Other|0|||
27926604|NCT00993421|54583050|FG000|Overall Study|Adverse Event|2|||
27926605|NCT00993421|54583051|FG001|Overall Study|Adverse Event|7|||
27926606|NCT00993421|54583052|FG002|Overall Study|Adverse Event|6|||
27926607|NCT00993421|54583053|FG003|Overall Study|Adverse Event|9|||
27926608|NCT00993421|54583054|FG004|Overall Study|Adverse Event|5|||
27926609|NCT00993421|54583055|FG005|Overall Study|Adverse Event|7|||
27926610|NCT00993421|54583056|FG006|Overall Study|Adverse Event|1|||
27926611|NCT00993421|54583050|FG000|Overall Study|Sponsor Decision|36|||
27926612|NCT00993421|54583051|FG001|Overall Study|Sponsor Decision|31|||
27926613|NCT00993421|54583052|FG002|Overall Study|Sponsor Decision|28|||
27926614|NCT00993421|54583053|FG003|Overall Study|Sponsor Decision|30|||
27926615|NCT00993421|54583054|FG004|Overall Study|Sponsor Decision|38|||
27926616|NCT00993421|54583055|FG005|Overall Study|Sponsor Decision|30|||
27926617|NCT00993421|54583056|FG006|Overall Study|Sponsor Decision|29|||
27926618|NCT00993421|54583050|FG000|Overall Study|Lost to Follow-up|3|||
27926619|NCT00993421|54583051|FG001|Overall Study|Lost to Follow-up|5|||
27926620|NCT00993421|54583052|FG002|Overall Study|Lost to Follow-up|5|||
27926621|NCT00993421|54583053|FG003|Overall Study|Lost to Follow-up|0|||
27926622|NCT00993421|54583054|FG004|Overall Study|Lost to Follow-up|0|||
27926623|NCT00993421|54583055|FG005|Overall Study|Lost to Follow-up|0|||
27926624|NCT00993421|54583056|FG006|Overall Study|Lost to Follow-up|6|||
27926625|NCT00993421|54583050|FG000|Overall Study|Withdrawal by Subject|3|||
27926626|NCT00993421|54583051|FG001|Overall Study|Withdrawal by Subject|2|||
27926627|NCT00993421|54583052|FG002|Overall Study|Withdrawal by Subject|3|||
27926628|NCT00993421|54583053|FG003|Overall Study|Withdrawal by Subject|3|||
27926629|NCT00993421|54583054|FG004|Overall Study|Withdrawal by Subject|3|||
27926630|NCT00993421|54583055|FG005|Overall Study|Withdrawal by Subject|5|||
28104103|NCT02944448|54760863|FG000|Overall Study|Abnormal laboratory values|1|||
28104104|NCT02944448|54760864|FG001|Overall Study|Abnormal laboratory values|0|||
28104105|NCT02943668|54760871|FG000|Overall Study|Disease Progression|1|||
28104106|NCT02891408|54760906|FG000|Overall Study|Lost to Follow-up|0|||
28104107|NCT02891408|54760907|FG001|Overall Study|Lost to Follow-up|0|||
28104108|NCT02891408|54760908|FG002|Overall Study|Lost to Follow-up|1|||
27926631|NCT00993421|54583056|FG006|Overall Study|Withdrawal by Subject|3|||
27926632|NCT00993421|54583050|FG000|Overall Study|Death|0|||
27926633|NCT00993421|54583051|FG001|Overall Study|Death|0|||
27926634|NCT00993421|54583052|FG002|Overall Study|Death|0|||
27926635|NCT00993421|54583053|FG003|Overall Study|Death|0|||
27926636|NCT00993421|54583054|FG004|Overall Study|Death|0|||
27926637|NCT00993421|54583055|FG005|Overall Study|Death|0|||
27926638|NCT00993421|54583056|FG006|Overall Study|Death|1|||
27926639|NCT00993421|54583050|FG000|Overall Study|Entry Criteria Exclusion|0|||
27926640|NCT00993421|54583051|FG001|Overall Study|Entry Criteria Exclusion|0|||
27926641|NCT00993421|54583052|FG002|Overall Study|Entry Criteria Exclusion|1|||
27926642|NCT00993421|54583053|FG003|Overall Study|Entry Criteria Exclusion|3|||
27926643|NCT00993421|54583054|FG004|Overall Study|Entry Criteria Exclusion|0|||
27926644|NCT00993421|54583055|FG005|Overall Study|Entry Criteria Exclusion|1|||
27926645|NCT00993421|54583056|FG006|Overall Study|Entry Criteria Exclusion|0|||
27926646|NCT00993421|54583050|FG000|Overall Study|Physician Decision|0|||
27926647|NCT00993421|54583051|FG001|Overall Study|Physician Decision|0|||
27926648|NCT00993421|54583052|FG002|Overall Study|Physician Decision|0|||
27926649|NCT00993421|54583053|FG003|Overall Study|Physician Decision|0|||
27926650|NCT00993421|54583054|FG004|Overall Study|Physician Decision|0|||
27926651|NCT00993421|54583055|FG005|Overall Study|Physician Decision|1|||
27926652|NCT00993421|54583056|FG006|Overall Study|Physician Decision|1|||
27926653|NCT00993421|54583050|FG000|Overall Study|Protocol Violation|0|||
27926654|NCT00993421|54583051|FG001|Overall Study|Protocol Violation|0|||
27926655|NCT00993421|54583052|FG002|Overall Study|Protocol Violation|0|||
27926656|NCT00993421|54583053|FG003|Overall Study|Protocol Violation|0|||
27926657|NCT00993421|54583054|FG004|Overall Study|Protocol Violation|0|||
27926658|NCT00993421|54583055|FG005|Overall Study|Protocol Violation|2|||
27926659|NCT00993421|54583056|FG006|Overall Study|Protocol Violation|1|||
27926660|NCT01014208|54583074|FG000|Overall Study|Lost to Follow-up|2|||
27926661|NCT01014208|54583075|FG001|Overall Study|Lost to Follow-up|5|||
27926662|NCT01014208|54583074|FG000|Overall Study|Participant Withdrew Consent|12|||
27926663|NCT01014208|54583075|FG001|Overall Study|Participant Withdrew Consent|12|||
27926664|NCT01014208|54583074|FG000|Overall Study|Did Not Receive Study Drug|2|||
27926665|NCT01014208|54583075|FG001|Overall Study|Did Not Receive Study Drug|0|||
27926666|NCT01014208|54583074|FG000|Overall Study|Study Closed/terminated|78|||
27926667|NCT01014208|54583075|FG001|Overall Study|Study Closed/terminated|83|||
27926668|NCT00991939|54583083|FG000|Overall Study|Lost to Follow-up|0|||
27926669|NCT00991939|54583084|FG001|Overall Study|Lost to Follow-up|1|||
27926670|NCT00991939|54583083|FG000|Overall Study|Withdrawal by Subject|1|||
27926671|NCT00991939|54583084|FG001|Overall Study|Withdrawal by Subject|0|||
27926672|NCT00991939|54583083|FG000|Overall Study|Entire study terminated|4|||
27926673|NCT00991939|54583084|FG001|Overall Study|Entire study terminated|1|||
27926674|NCT00993265|54583094|FG000|Overall Study|Adverse Event|1|||
27926675|NCT00993265|54583095|FG001|Overall Study|Adverse Event|0|||
27926676|NCT00993265|54583094|FG000|Overall Study|Changed dose of concomitant drug|2|||
27926677|NCT00993265|54583095|FG001|Overall Study|Changed dose of concomitant drug|0|||
27926678|NCT00993265|54583094|FG000|Overall Study|Non-compliant with study medication|1|||
27926679|NCT00993265|54583095|FG001|Overall Study|Non-compliant with study medication|0|||
27926680|NCT04211389|54583103|FG000|Overall Study|Adverse Event|1|||
27926681|NCT04211389|54583104|FG001|Overall Study|Adverse Event|2|||
27926682|NCT04211389|54583103|FG000|Overall Study|Lost to Follow-up|15|||
27926683|NCT04211389|54583104|FG001|Overall Study|Lost to Follow-up|7|||
27926684|NCT04211389|54583103|FG000|Overall Study|Protocol Violation|0|||
27926685|NCT04211389|54583104|FG001|Overall Study|Protocol Violation|1|||
27926686|NCT04211389|54583103|FG000|Overall Study|Withdrawal by Subject|10|||
27926687|NCT04211389|54583104|FG001|Overall Study|Withdrawal by Subject|11|||
27926688|NCT00993031|54583112|FG000|Overall Study|Death|0|||
27926689|NCT00993031|54583113|FG001|Overall Study|Death|1|||
27926690|NCT00993031|54583112|FG000|Overall Study|Physician Decision|0|||
27926691|NCT00993031|54583113|FG001|Overall Study|Physician Decision|2|||
27926692|NCT00993031|54583112|FG000|Overall Study|Withdrawal by Subject|3|||
27926693|NCT00993031|54583113|FG001|Overall Study|Withdrawal by Subject|3|||
27926694|NCT00993031|54583112|FG000|Overall Study|Lost to Follow-up|19|||
28014908|NCT00547300|54673844|FG001|Overall Study|Did not Meet Entry Criteria|2|||
28014909|NCT00612807|54673852|FG000|Overall Study|Withdrawal by Subject|2|||
27926695|NCT00993031|54583113|FG001|Overall Study|Lost to Follow-up|13|||
27926696|NCT01010776|54583123|FG000|Main Phase|Withdrawal by Subject|14|||
27926697|NCT01010776|54583123|FG000|Main Phase|Lack of Efficacy|8|||
27926698|NCT01010776|54583123|FG000|Main Phase|Adverse Event|7|||
27926699|NCT01010776|54583123|FG000|Main Phase|Lost to Follow-up|6|||
27926700|NCT01010776|54583123|FG000|Main Phase|Non-compliance to study medication|5|||
27926701|NCT01010776|54583123|FG000|Main Phase|Selection failure|2|||
27926702|NCT01010776|54583123|FG000|Main Phase|Inform consent withdrawal|1|||
27926703|NCT01010776|54583123|FG000|Main Phase|Other|1|||
27926704|NCT01010776|54583123|FG000|Main Phase|Did not received study medication|5|||
27926705|NCT01010776|54583123|FG000|In-Between Main Phase & Extension Phase|Extension phase was optional|15|||
27926706|NCT01010776|54583123|FG000|Extension Phase|Other|3|||
27926707|NCT01018810|54583143|FG000|Overall Study|Withdrawal by Subject|0|||
27926708|NCT01018810|54583144|FG001|Overall Study|Withdrawal by Subject|1|||
27926709|NCT01018810|54583145|FG002|Overall Study|Withdrawal by Subject|0|||
27926710|NCT01018810|54583146|FG003|Overall Study|Withdrawal by Subject|0|||
27926711|NCT01018810|54583147|FG004|Overall Study|Withdrawal by Subject|0|||
27926712|NCT01018810|54583143|FG000|Overall Study|Sponsor Decision|2|||
27926713|NCT01018810|54583144|FG001|Overall Study|Sponsor Decision|0|||
27926714|NCT01018810|54583145|FG002|Overall Study|Sponsor Decision|1|||
27926715|NCT01018810|54583146|FG003|Overall Study|Sponsor Decision|1|||
27926716|NCT01018810|54583147|FG004|Overall Study|Sponsor Decision|1|||
27926717|NCT01018732|54583162|FG000|Overall Study|Lost to Follow-up|0|||
27926718|NCT01018732|54583163|FG001|Overall Study|Lost to Follow-up|0|||
27926719|NCT01018732|54583164|FG002|Overall Study|Lost to Follow-up|3|||
27926720|NCT01018732|54583162|FG000|Overall Study|Protocol Violation|1|||
27926721|NCT01018732|54583163|FG001|Overall Study|Protocol Violation|1|||
27926722|NCT01018732|54583164|FG002|Overall Study|Protocol Violation|0|||
27926723|NCT01018732|54583162|FG000|Overall Study|Inappropriate Enrollment|0|||
27926724|NCT01018732|54583163|FG001|Overall Study|Inappropriate Enrollment|1|||
27926725|NCT01018732|54583164|FG002|Overall Study|Inappropriate Enrollment|0|||
27926726|NCT01018732|54583162|FG000|Overall Study|Unable to Classify|0|||
27926727|NCT01018732|54583163|FG001|Overall Study|Unable to Classify|0|||
27926728|NCT01018732|54583164|FG002|Overall Study|Unable to Classify|1|||
27926729|NCT01218867|54583183|FG000|Overall Study|Death during treatment|0|||
27926730|NCT01218867|54583184|FG001|Overall Study|Death during treatment|0|||
27926731|NCT01218867|54583185|FG002|Overall Study|Death during treatment|0|||
27926732|NCT01218867|54583186|FG003|Overall Study|Death during treatment|0|||
27926733|NCT01218867|54583187|FG004|Overall Study|Death during treatment|0|||
27926734|NCT01218867|54583188|FG005|Overall Study|Death during treatment|0|||
27926735|NCT01218867|54583189|FG006|Overall Study|Death during treatment|1|||
27926736|NCT01218867|54583190|FG007|Overall Study|Death during treatment|0|||
27926737|NCT01218867|54583191|FG008|Overall Study|Death during treatment|0|||
27926738|NCT01218867|54583192|FG009|Overall Study|Death during treatment|0|||
27926739|NCT01218867|54583193|FG010|Overall Study|Death during treatment|0|||
27926740|NCT01018264|54583230|FG000|Overall Study|Withdrawal by Subject|1|||
27926741|NCT01018264|54583231|FG001|Overall Study|Withdrawal by Subject|0|||
27926742|NCT01018264|54583230|FG000|Overall Study|Lost to Follow-up|0|||
27926743|NCT01018264|54583231|FG001|Overall Study|Lost to Follow-up|1|||
27926744|NCT01018186|54583240|FG000|2-week Run-in Period|Protocol Violation|1|||
27926745|NCT01018186|54583241|FG001|2-week Run-in Period|Protocol Violation|0|||
27926746|NCT01018186|54583242|FG002|2-week Run-in Period|Protocol Violation|0|||
27926747|NCT01018186|54583243|FG003|2-week Run-in Period|Protocol Violation|0|||
27926748|NCT01018186|54583240|FG000|2-week Run-in Period|Lost to Follow-up|2|||
27926749|NCT01018186|54583241|FG001|2-week Run-in Period|Lost to Follow-up|0|||
27926750|NCT01018186|54583242|FG002|2-week Run-in Period|Lost to Follow-up|0|||
27926751|NCT01018186|54583243|FG003|2-week Run-in Period|Lost to Follow-up|0|||
27926752|NCT01018186|54583240|FG000|2-week Run-in Period|Physician Decision|3|||
27926753|NCT01018186|54583241|FG001|2-week Run-in Period|Physician Decision|0|||
27926754|NCT01018186|54583242|FG002|2-week Run-in Period|Physician Decision|0|||
27926755|NCT01018186|54583243|FG003|2-week Run-in Period|Physician Decision|0|||
27926756|NCT01018186|54583240|FG000|2-week Run-in Period|Withdrawal by Subject|11|||
27926757|NCT01018186|54583241|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
27926758|NCT01018186|54583242|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
27926759|NCT01018186|54583243|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
27926760|NCT01018186|54583240|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|97|||
27926761|NCT01018186|54583241|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
27926762|NCT01018186|54583242|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
27926763|NCT01018186|54583243|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
27926764|NCT01018186|54583240|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
27926765|NCT01018186|54583241|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
27926766|NCT01018186|54583242|FG002|52-week Double-blind Treatment Period|Adverse Event|3|||
27926767|NCT01018186|54583243|FG003|52-week Double-blind Treatment Period|Adverse Event|6|||
27926768|NCT01018186|54583240|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
27926769|NCT01018186|54583241|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
27926770|NCT01018186|54583242|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|4|||
27926771|NCT01018186|54583243|FG003|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
27926772|NCT01018186|54583240|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
27926773|NCT01018186|54583241|FG001|52-week Double-blind Treatment Period|Protocol Violation|8|||
27926774|NCT01018186|54583242|FG002|52-week Double-blind Treatment Period|Protocol Violation|8|||
27926775|NCT01018186|54583243|FG003|52-week Double-blind Treatment Period|Protocol Violation|2|||
27926776|NCT01018186|54583240|FG000|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
27926777|NCT01018186|54583241|FG001|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14|||
27926778|NCT01018186|54583242|FG002|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16|||
27926779|NCT01018186|54583243|FG003|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
28104109|NCT02891408|54760909|FG003|Overall Study|Lost to Follow-up|0|||
27926780|NCT01018186|54583240|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
27926781|NCT01018186|54583241|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|1|||
27926782|NCT01018186|54583242|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|3|||
27926783|NCT01018186|54583243|FG003|52-week Double-blind Treatment Period|Lost to Follow-up|4|||
27926784|NCT01018186|54583240|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
27926785|NCT01018186|54583241|FG001|52-week Double-blind Treatment Period|Physician Decision|1|||
27926786|NCT01018186|54583242|FG002|52-week Double-blind Treatment Period|Physician Decision|0|||
27926787|NCT01018186|54583243|FG003|52-week Double-blind Treatment Period|Physician Decision|3|||
27926788|NCT01018186|54583240|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
27926789|NCT01018186|54583241|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|10|||
27926790|NCT01018186|54583242|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|7|||
27926791|NCT01018186|54583243|FG003|52-week Double-blind Treatment Period|Withdrawal by Subject|9|||
27926792|NCT00987337|54583258|FG000|Overall Study|Adverse Event|10|||
27926793|NCT00987337|54583259|FG001|Overall Study|Adverse Event|9|||
27926794|NCT00987337|54583260|FG002|Overall Study|Adverse Event|8|||
27926795|NCT00987337|54583258|FG000|Overall Study|Insufficient Virologic Response|10|||
27926796|NCT00987337|54583259|FG001|Overall Study|Insufficient Virologic Response|7|||
27926797|NCT00987337|54583260|FG002|Overall Study|Insufficient Virologic Response|12|||
27926798|NCT00987337|54583258|FG000|Overall Study|Virologic Breakthrough|2|||
27926799|NCT00987337|54583259|FG001|Overall Study|Virologic Breakthrough|2|||
27926800|NCT00987337|54583260|FG002|Overall Study|Virologic Breakthrough|8|||
27926801|NCT00987337|54583258|FG000|Overall Study|Lost to Follow-up|10|||
27926802|NCT00987337|54583259|FG001|Overall Study|Lost to Follow-up|6|||
27926803|NCT00987337|54583260|FG002|Overall Study|Lost to Follow-up|2|||
27926804|NCT00987337|54583258|FG000|Overall Study|Withdrawal by Subject|6|||
27926805|NCT00987337|54583259|FG001|Overall Study|Withdrawal by Subject|9|||
27926806|NCT00987337|54583260|FG002|Overall Study|Withdrawal by Subject|9|||
27926807|NCT00987337|54583258|FG000|Overall Study|Other|0|||
27926808|NCT00987337|54583259|FG001|Overall Study|Other|2|||
27926809|NCT00987337|54583260|FG002|Overall Study|Other|5|||
27926810|NCT00987337|54583258|FG000|Overall Study|Protocol Violation|1|||
27926811|NCT00987337|54583259|FG001|Overall Study|Protocol Violation|0|||
27926812|NCT00987337|54583260|FG002|Overall Study|Protocol Violation|2|||
27926813|NCT00987337|54583258|FG000|Overall Study|Participant Relapsed|18|||
27926814|NCT00987337|54583259|FG001|Overall Study|Participant Relapsed|20|||
27926815|NCT00987337|54583260|FG002|Overall Study|Participant Relapsed|5|||
27926816|NCT00992407|54583272|FG000|Overall Study|Protocol Violation|2|||
27926817|NCT00992407|54583273|FG001|Overall Study|Protocol Violation|1|||
27926818|NCT00992407|54583272|FG000|Overall Study|Lost to Follow-up|3|||
27926819|NCT00992407|54583273|FG001|Overall Study|Lost to Follow-up|3|||
27926820|NCT00992407|54583272|FG000|Overall Study|Adverse Event|3|||
27926821|NCT00992407|54583273|FG001|Overall Study|Adverse Event|2|||
27926822|NCT00992407|54583272|FG000|Overall Study|protocol Violation & Adverse events|2|||
27926823|NCT00992407|54583273|FG001|Overall Study|protocol Violation & Adverse events|4|||
27926824|NCT00992407|54583272|FG000|Overall Study|Other|2|||
27926825|NCT00992407|54583273|FG001|Overall Study|Other|0|||
27926826|NCT00992407|54583272|FG000|Overall Study|Loss of follow-up & Adverse events|2|||
27926827|NCT00992407|54583273|FG001|Overall Study|Loss of follow-up & Adverse events|1|||
27926828|NCT00992407|54583272|FG000|Overall Study|Study medication not administered|17|||
27926829|NCT00992407|54583273|FG001|Overall Study|Study medication not administered|13|||
27926830|NCT00986479|54583284|FG000|Period 1|Improved mood|1|||
27926831|NCT00986479|54583285|FG001|Period 1|Improved mood|0|||
27926832|NCT00986479|54583284|FG000|Period 1|Administrative reasons|1|||
27926833|NCT00986479|54583285|FG001|Period 1|Administrative reasons|0|||
27926834|NCT00986245|54583291|FG000|First Intervention|Poor compliance|8|||
27926835|NCT00986245|54583292|FG001|First Intervention|Poor compliance|4|||
27926836|NCT00986245|54583291|FG000|First Intervention|Lack of Efficacy|1|||
27926837|NCT00986245|54583292|FG001|First Intervention|Lack of Efficacy|2|||
27926838|NCT00986245|54583291|FG000|First Intervention|Withdrawal by Subject|0|||
27926839|NCT00986245|54583292|FG001|First Intervention|Withdrawal by Subject|1|||
27926840|NCT00986245|54583291|FG000|First Intervention|Protocol Violation|0|||
27926841|NCT00986245|54583292|FG001|First Intervention|Protocol Violation|1|||
27926842|NCT00986245|54583291|FG000|First Intervention|Out of indication|1|||
27926843|NCT00986245|54583292|FG001|First Intervention|Out of indication|0|||
28014910|NCT00612807|54673853|FG001|Overall Study|Withdrawal by Subject|0|||
27926844|NCT00986245|54583291|FG000|Second Intervention|Poor compliance|1|||
27926845|NCT00986245|54583292|FG001|Second Intervention|Poor compliance|0|||
27926846|NCT00986245|54583291|FG000|Second Intervention|Lost to Follow-up|1|||
27926847|NCT00986245|54583292|FG001|Second Intervention|Lost to Follow-up|0|||
27926848|NCT00986245|54583291|FG000|Second Intervention|Protocol Violation|0|||
27926849|NCT00986245|54583292|FG001|Second Intervention|Protocol Violation|1|||
27926850|NCT00989833|54583306|FG000|Overall Study|Lost to Follow-up|0|||
27926851|NCT00989833|54583307|FG001|Overall Study|Lost to Follow-up|1|||
27926852|NCT00989833|54583308|FG002|Overall Study|Lost to Follow-up|0|||
27926853|NCT00989833|54583306|FG000|Overall Study|Protocol Violation|1|||
27926854|NCT00989833|54583307|FG001|Overall Study|Protocol Violation|2|||
27926855|NCT00989833|54583308|FG002|Overall Study|Protocol Violation|1|||
27926856|NCT00989833|54583306|FG000|Overall Study|Withdrawal by Subject|0|||
27926857|NCT00989833|54583307|FG001|Overall Study|Withdrawal by Subject|0|||
27926858|NCT00989833|54583308|FG002|Overall Study|Withdrawal by Subject|1|||
27926859|NCT00989833|54583306|FG000|Overall Study|Incorrectly randomized|1|||
27926860|NCT00989833|54583307|FG001|Overall Study|Incorrectly randomized|0|||
27926861|NCT00989833|54583308|FG002|Overall Study|Incorrectly randomized|0|||
27926862|NCT01218477|54583320|FG000|Overall Study|Disease progression|2|||
27926863|NCT01218477|54583321|FG001|Overall Study|Disease progression|3|||
27926864|NCT01218477|54583322|FG002|Overall Study|Disease progression|6|||
27926865|NCT01218477|54583323|FG003|Overall Study|Disease progression|2|||
27926866|NCT01218477|54583320|FG000|Overall Study|Study drug toxicity|0|||
27926867|NCT01218477|54583321|FG001|Overall Study|Study drug toxicity|2|||
27926868|NCT01218477|54583322|FG002|Overall Study|Study drug toxicity|5|||
27926869|NCT01218477|54583323|FG003|Overall Study|Study drug toxicity|0|||
27926870|NCT01218477|54583320|FG000|Overall Study|No longer meets study criteria|1|||
28014911|NCT00678210|54673863|FG000|Overall Study|Adverse Event|1|||
28014912|NCT00678210|54673864|FG001|Overall Study|Adverse Event|2|||
28014913|NCT00678210|54673865|FG002|Overall Study|Adverse Event|3|||
28014914|NCT00678210|54673866|FG003|Overall Study|Adverse Event|3|||
28014915|NCT00678210|54673863|FG000|Overall Study|Lack of Efficacy|2|||
28014916|NCT00678210|54673864|FG001|Overall Study|Lack of Efficacy|3|||
28014917|NCT00678210|54673865|FG002|Overall Study|Lack of Efficacy|1|||
28014918|NCT00678210|54673866|FG003|Overall Study|Lack of Efficacy|9|||
28014919|NCT00678210|54673863|FG000|Overall Study|Lost to Follow-up|4|||
28014920|NCT00678210|54673864|FG001|Overall Study|Lost to Follow-up|2|||
28014921|NCT00678210|54673865|FG002|Overall Study|Lost to Follow-up|0|||
28014922|NCT00678210|54673866|FG003|Overall Study|Lost to Follow-up|1|||
28014923|NCT00678210|54673863|FG000|Overall Study|Withdrawal by Subject|3|||
28014924|NCT00678210|54673864|FG001|Overall Study|Withdrawal by Subject|4|||
28014925|NCT00678210|54673865|FG002|Overall Study|Withdrawal by Subject|1|||
28014926|NCT00678210|54673866|FG003|Overall Study|Withdrawal by Subject|7|||
28014927|NCT00678210|54673863|FG000|Overall Study|Other|1|||
28014928|NCT00678210|54673864|FG001|Overall Study|Other|0|||
28014929|NCT00678210|54673865|FG002|Overall Study|Other|1|||
28014930|NCT00678210|54673866|FG003|Overall Study|Other|0|||
28014931|NCT00611715|54673878|FG000|Overall Study|Disease Progression|24|||
28014932|NCT00611715|54673879|FG001|Overall Study|Disease Progression|4|||
28014933|NCT00611715|54673878|FG000|Overall Study|Withdrawal by Subject|5|||
28014934|NCT00611715|54673879|FG001|Overall Study|Withdrawal by Subject|1|||
28014935|NCT00611715|54673878|FG000|Overall Study|Adverse Event|9|||
28014936|NCT00611715|54673879|FG001|Overall Study|Adverse Event|1|||
28014937|NCT00611715|54673878|FG000|Overall Study|Death|1|||
28014938|NCT00611715|54673879|FG001|Overall Study|Death|0|||
28014939|NCT00611715|54673878|FG000|Overall Study|two patients are still on treatment|2|||
28014940|NCT00611715|54673879|FG001|Overall Study|two patients are still on treatment|0|||
28014941|NCT00677820|54673893|FG000|Overall Study|Lost to Follow-up|1|||
28014942|NCT00677820|54673894|FG001|Overall Study|Lost to Follow-up|0|||
28014943|NCT00611559|54673903|FG000|Overall Study|Lost to Follow-up|0|||
28014944|NCT00611559|54673904|FG001|Overall Study|Lost to Follow-up|1|||
28014945|NCT00611559|54673905|FG002|Overall Study|Lost to Follow-up|0|||
28014946|NCT00611559|54673903|FG000|Overall Study|Protocol Violation|1|||
28014947|NCT00611559|54673904|FG001|Overall Study|Protocol Violation|0|||
28014948|NCT00611559|54673905|FG002|Overall Study|Protocol Violation|1|||
28014949|NCT00611247|54673915|FG000|Overall Study|Death|1|||
28014950|NCT00611247|54673916|FG001|Overall Study|Death|5|||
28014951|NCT00611247|54673915|FG000|Overall Study|Lack of Efficacy|1|||
28014952|NCT00611247|54673916|FG001|Overall Study|Lack of Efficacy|16|||
28014953|NCT00675948|54673925|FG000|Overall Study|Adverse Event|23|||
28014954|NCT00675948|54673926|FG001|Overall Study|Adverse Event|1|||
28014955|NCT00675948|54673925|FG000|Overall Study|Lack of Efficacy|3|||
28014956|NCT00675948|54673926|FG001|Overall Study|Lack of Efficacy|0|||
28014957|NCT00675948|54673925|FG000|Overall Study|Withdrawal by Subject|7|||
28014958|NCT00675948|54673926|FG001|Overall Study|Withdrawal by Subject|0|||
28014959|NCT00675948|54673925|FG000|Overall Study|Lost to Follow-up|2|||
28014960|NCT00675948|54673926|FG001|Overall Study|Lost to Follow-up|0|||
28014961|NCT00675948|54673925|FG000|Overall Study|Protocol Violation|1|||
28014962|NCT00675948|54673926|FG001|Overall Study|Protocol Violation|0|||
28014963|NCT00675948|54673925|FG000|Overall Study|Pain under control|1|||
27926871|NCT01218477|54583321|FG001|Overall Study|No longer meets study criteria|0|||
27926872|NCT01218477|54583322|FG002|Overall Study|No longer meets study criteria|0|||
28014964|NCT00675948|54673926|FG001|Overall Study|Pain under control|0|||
28014965|NCT00675948|54673925|FG000|Overall Study|Sponsor decision|0|||
28014966|NCT00675948|54673926|FG001|Overall Study|Sponsor decision|1|||
28014967|NCT00675948|54673925|FG000|Overall Study|Patient died|1|||
28014968|NCT00675948|54673926|FG001|Overall Study|Patient died|0|||
28014969|NCT00675948|54673925|FG000|Overall Study|Patient unable to comply with diaries|1|||
28014970|NCT00675948|54673926|FG001|Overall Study|Patient unable to comply with diaries|0|||
28014971|NCT00675948|54673925|FG000|Overall Study|Patient feels unable to take medication|0|||
28014972|NCT00675948|54673926|FG001|Overall Study|Patient feels unable to take medication|1|||
28014973|NCT00610935|54673935|FG000|Overall Study|Lost to Follow-up|0|||
28014974|NCT00610935|54673936|FG001|Overall Study|Lost to Follow-up|1|||
28014975|NCT00610935|54673935|FG000|Overall Study|Withdrawal by Subject|0|||
28014976|NCT00610935|54673936|FG001|Overall Study|Withdrawal by Subject|2|||
28014977|NCT00610935|54673935|FG000|Overall Study|Sponsor Discontinuation|1|||
28014978|NCT00610935|54673936|FG001|Overall Study|Sponsor Discontinuation|0|||
28014979|NCT00610857|54673951|FG000|Overall Study|Not evaluable for response|2|||
28014980|NCT00672984|54673958|FG000|First Intervention|Adverse Event|5|||
28014981|NCT00672984|54673959|FG001|First Intervention|Adverse Event|0|||
28014982|NCT00672984|54673960|FG002|First Intervention|Adverse Event|0|||
28014983|NCT00672984|54673958|FG000|First Intervention|Withdrawal by Subject|1|||
28014984|NCT00672984|54673959|FG001|First Intervention|Withdrawal by Subject|2|||
28014985|NCT00672984|54673960|FG002|First Intervention|Withdrawal by Subject|2|||
28014986|NCT00672984|54673958|FG000|First Intervention|Sponsor decision|3|||
28014987|NCT00672984|54673959|FG001|First Intervention|Sponsor decision|0|||
28014988|NCT00672984|54673960|FG002|First Intervention|Sponsor decision|0|||
28014989|NCT00672984|54673958|FG000|Second Intervention|Non-compliance with facility policies|0|||
28014990|NCT00672984|54673959|FG001|Second Intervention|Non-compliance with facility policies|2|||
28014991|NCT00672984|54673960|FG002|Second Intervention|Non-compliance with facility policies|0|||
28014992|NCT00672984|54673958|FG000|Second Intervention|Withdrawal by Subject|0|||
28014993|NCT00672984|54673959|FG001|Second Intervention|Withdrawal by Subject|3|||
28014994|NCT00672984|54673960|FG002|Second Intervention|Withdrawal by Subject|0|||
28014995|NCT00672984|54673958|FG000|Second Intervention|Protocol Violation|0|||
28014996|NCT00672984|54673959|FG001|Second Intervention|Protocol Violation|1|||
28014997|NCT00672984|54673960|FG002|Second Intervention|Protocol Violation|1|||
28014998|NCT00672984|54673958|FG000|Third Intervention|Adverse Event|1|||
28014999|NCT00672984|54673959|FG001|Third Intervention|Adverse Event|0|||
28015000|NCT00672984|54673960|FG002|Third Intervention|Adverse Event|1|||
28015001|NCT00546364|54673973|FG000|Overall Study|Disease progression|5|||
28015002|NCT00546364|54673974|FG001|Overall Study|Disease progression|11|||
28015003|NCT00546364|54673975|FG002|Overall Study|Disease progression|8|||
28015004|NCT00546364|54673973|FG000|Overall Study|Completed and off treatment|1|||
28015005|NCT00546364|54673974|FG001|Overall Study|Completed and off treatment|0|||
28015006|NCT00546364|54673975|FG002|Overall Study|Completed and off treatment|2|||
28015007|NCT00546364|54673973|FG000|Overall Study|Administrative reason by sponsor|1|||
28015008|NCT00546364|54673974|FG001|Overall Study|Administrative reason by sponsor|0|||
28015009|NCT00546364|54673975|FG002|Overall Study|Administrative reason by sponsor|0|||
28015010|NCT00546364|54673973|FG000|Overall Study|Poor compliance/noncompliance|0|||
28015011|NCT00546364|54673974|FG001|Overall Study|Poor compliance/noncompliance|0|||
28015012|NCT00546364|54673975|FG002|Overall Study|Poor compliance/noncompliance|1|||
28015013|NCT00546364|54673973|FG000|Overall Study|No longer meets study criteria|1|||
28015014|NCT00546364|54673974|FG001|Overall Study|No longer meets study criteria|1|||
28015015|NCT00546364|54673975|FG002|Overall Study|No longer meets study criteria|0|||
28015016|NCT00546364|54673973|FG000|Overall Study|Withdrawal by Subject|5|||
28015017|NCT00546364|54673974|FG001|Overall Study|Withdrawal by Subject|6|||
28015018|NCT00546364|54673975|FG002|Overall Study|Withdrawal by Subject|3|||
28015019|NCT00546364|54673973|FG000|Overall Study|Prior taxotere|1|||
28015020|NCT00546364|54673974|FG001|Overall Study|Prior taxotere|0|||
28015021|NCT00546364|54673975|FG002|Overall Study|Prior taxotere|0|||
28015022|NCT00546364|54673973|FG000|Overall Study|Mixed response|1|||
28015023|NCT00546364|54673974|FG001|Overall Study|Mixed response|0|||
28015024|NCT00546364|54673975|FG002|Overall Study|Mixed response|0|||
28015025|NCT00546364|54673973|FG000|Overall Study|Palliative treatment|1|||
28015026|NCT00546364|54673974|FG001|Overall Study|Palliative treatment|0|||
28015027|NCT00546364|54673975|FG002|Overall Study|Palliative treatment|1|||
28015028|NCT00546364|54673973|FG000|Overall Study|Target lesions resected|1|||
28015029|NCT00546364|54673974|FG001|Overall Study|Target lesions resected|0|||
28015030|NCT00546364|54673975|FG002|Overall Study|Target lesions resected|0|||
28015031|NCT00546364|54673973|FG000|Overall Study|Physician Decision|0|||
28015032|NCT00546364|54673974|FG001|Overall Study|Physician Decision|0|||
28015033|NCT00546364|54673975|FG002|Overall Study|Physician Decision|1|||
28015034|NCT00546364|54673973|FG000|Overall Study|Sponsor decision|0|||
28015035|NCT00546364|54673974|FG001|Overall Study|Sponsor decision|0|||
28015036|NCT00546364|54673975|FG002|Overall Study|Sponsor decision|1|||
28015037|NCT05020327|54674005|FG000|Overall Study|Physician Decision|3|||
28015038|NCT05020327|54674006|FG001|Overall Study|Physician Decision|0|||
28015039|NCT05020327|54674007|FG002|Overall Study|Physician Decision|0|||
28015040|NCT05020327|54674005|FG000|Overall Study|Withdrawal by Subject|1|||
28015041|NCT05020327|54674006|FG001|Overall Study|Withdrawal by Subject|1|||
28015042|NCT05020327|54674007|FG002|Overall Study|Withdrawal by Subject|0|||
28015043|NCT05020327|54674005|FG000|Overall Study|personal/cultural, ineligible|12|||
28015044|NCT05020327|54674006|FG001|Overall Study|personal/cultural, ineligible|0|||
28015045|NCT05020327|54674007|FG002|Overall Study|personal/cultural, ineligible|0|||
28104110|NCT02891408|54760910|FG004|Overall Study|Lost to Follow-up|0|||
28015046|NCT04907032|54674021|FG000|Overall Study|Withdrawal by Subject|7|||
28015047|NCT04907032|54674022|FG001|Overall Study|Withdrawal by Subject|1|||
28015048|NCT04739709|54674043|FG000|Overall Study|Physician Decision|1|||
28015049|NCT04739709|54674044|FG001|Overall Study|Physician Decision|0|||
28015050|NCT04710927|54674061|FG000|Overall Study|Lost to Follow-up|7|||
28015051|NCT04710927|54674062|FG001|Overall Study|Lost to Follow-up|6|||
28015052|NCT04710927|54674063|FG002|Overall Study|Lost to Follow-up|5|||
28015053|NCT04657666|54674074|FG000|Period 1|Withdrawal of participant consent|2|||
28015054|NCT04657666|54674075|FG001|Period 1|Withdrawal of participant consent|1|||
28015055|NCT04657666|54674074|FG000|Period 1|Withdrawn/discontinued due to AE|1|||
28015056|NCT04657666|54674075|FG001|Period 1|Withdrawn/discontinued due to AE|0|||
28015057|NCT04657666|54674074|FG000|Period 1|Administrative decision by investigator, GW, or a regulatory authority|0|||
28015058|NCT04657666|54674075|FG001|Period 1|Administrative decision by investigator, GW, or a regulatory authority|1|||
28015059|NCT04657666|54674074|FG000|Period 2|Other|2|||
28015060|NCT04657666|54674075|FG001|Period 2|Other|0|||
28015061|NCT04657666|54674074|FG000|Period 2|Withdrawn/discontinued due to AE|0|||
28015062|NCT04657666|54674075|FG001|Period 2|Withdrawn/discontinued due to AE|3|||
28015063|NCT04495829|54674094|FG000|Overall Study|Lost to Follow-up|2|||
28015064|NCT04495829|54674094|FG000|Overall Study|Inclusion criterion not met|3|||
28015065|NCT04101721|54674109|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
28015066|NCT04101721|54674110|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
28015067|NCT04101721|54674109|FG000|Overall Study|Death|0|||
28015068|NCT04101721|54674110|FG001|Overall Study|Death|1|||
28015069|NCT04101721|54674109|FG000|Overall Study|Lost to Follow-up|0|||
28015070|NCT04101721|54674110|FG001|Overall Study|Lost to Follow-up|3|||
28015071|NCT03864926|54674118|FG000|Overall Study|Death|0|||
28015072|NCT03864926|54674119|FG001|Overall Study|Death|2|||
28015073|NCT03654274|54674137|FG000|Overall Study|Adverse Event|19|||
28015074|NCT03654274|54674138|FG001|Overall Study|Adverse Event|23|||
28015075|NCT03654274|54674139|FG002|Overall Study|Adverse Event|24|||
28015076|NCT03654274|54674137|FG000|Overall Study|Protocol Deviation|0|||
28015077|NCT03654274|54674138|FG001|Overall Study|Protocol Deviation|2|||
28015078|NCT03654274|54674139|FG002|Overall Study|Protocol Deviation|0|||
28015079|NCT03654274|54674137|FG000|Overall Study|Lost to Follow-up|8|||
28015080|NCT03654274|54674138|FG001|Overall Study|Lost to Follow-up|6|||
28015081|NCT03654274|54674139|FG002|Overall Study|Lost to Follow-up|5|||
28015082|NCT03654274|54674137|FG000|Overall Study|Withdrawal by Subject|46|||
28015083|NCT03654274|54674138|FG001|Overall Study|Withdrawal by Subject|25|||
28015084|NCT03654274|54674139|FG002|Overall Study|Withdrawal by Subject|33|||
28015085|NCT03654274|54674137|FG000|Overall Study|Lack of Efficacy|4|||
28015086|NCT03654274|54674138|FG001|Overall Study|Lack of Efficacy|5|||
28015087|NCT03654274|54674139|FG002|Overall Study|Lack of Efficacy|7|||
28015088|NCT03654274|54674137|FG000|Overall Study|Pregnancy|2|||
28015089|NCT03654274|54674138|FG001|Overall Study|Pregnancy|2|||
28015090|NCT03654274|54674139|FG002|Overall Study|Pregnancy|1|||
28015091|NCT03654274|54674137|FG000|Overall Study|Other|27|||
28015092|NCT03654274|54674138|FG001|Overall Study|Other|29|||
28015093|NCT03654274|54674139|FG002|Overall Study|Other|32|||
28015094|NCT03654274|54674137|FG000|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
28015095|NCT03654274|54674138|FG001|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
28015096|NCT03654274|54674139|FG002|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|1|||
28015097|NCT03623243|54674151|FG000|Overall Study|Adverse Event|15|||
28015098|NCT03623243|54674151|FG000|Overall Study|Guardian Decision|1|||
28015099|NCT03623243|54674151|FG000|Overall Study|New Therapy for Study Indication|1|||
28015100|NCT03623243|54674151|FG000|Overall Study|Protocol Deviation|3|||
28015101|NCT03623243|54674151|FG000|Overall Study|Physician Decision|4|||
28015102|NCT03623243|54674151|FG000|Overall Study|Patient Decision|15|||
28015103|NCT03258853|54674157|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
28015104|NCT03258853|54674158|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
28015105|NCT03089606|54674199|FG000|Overall Study|Progression after Cycle 1|1|||
28015106|NCT03006848|54674231|FG000|Overall Study|Adverse Event|1|||
28015107|NCT03006848|54674231|FG000|Overall Study|Physician Decision|1|||
28015108|NCT03006848|54674231|FG000|Overall Study|Lack of Efficacy|16|||
28015109|NCT02828358|54674271|FG000|Overall Study|Physician Decision|7|||
28015110|NCT02828358|54674272|FG001|Overall Study|Physician Decision|1|||
28015111|NCT02828358|54674271|FG000|Overall Study|Treatment Failure|6|||
28015112|NCT02828358|54674272|FG001|Overall Study|Treatment Failure|0|||
28015113|NCT02828358|54674271|FG000|Overall Study|Patients without KMT2A rearrangement|0|||
28015114|NCT02828358|54674272|FG001|Overall Study|Patients without KMT2A rearrangement|21|||
28015115|NCT02828358|54674271|FG000|Overall Study|Refusal of further protocol therapy|2|||
28015116|NCT02828358|54674272|FG001|Overall Study|Refusal of further protocol therapy|0|||
28015117|NCT02828358|54674271|FG000|Overall Study|Relapse|25|||
28015118|NCT02828358|54674272|FG001|Overall Study|Relapse|0|||
28015119|NCT02828358|54674271|FG000|Overall Study|Still on therapy|5|||
28015120|NCT02828358|54674272|FG001|Overall Study|Still on therapy|0|||
28015121|NCT02810444|54674277|FG000|Overall Study|Screen Failures|14|||
28015122|NCT02810444|54674277|FG000|Overall Study|Withdrawal by Subject|4|||
28015123|NCT02810444|54674277|FG000|Overall Study|Adverse Event|3|||
28015124|NCT02501096|54674313|FG000|Overall Study|Lost to Follow-up|0|||
28015125|NCT02501096|54674314|FG001|Overall Study|Lost to Follow-up|0|||
28015126|NCT02501096|54674315|FG002|Overall Study|Lost to Follow-up|0|||
28015127|NCT02501096|54674316|FG003|Overall Study|Lost to Follow-up|0|||
28015128|NCT02501096|54674317|FG004|Overall Study|Lost to Follow-up|1|||
28015129|NCT02501096|54674318|FG005|Overall Study|Lost to Follow-up|1|||
28015130|NCT02501096|54674319|FG006|Overall Study|Lost to Follow-up|3|||
28015131|NCT02501096|54674320|FG007|Overall Study|Lost to Follow-up|0|||
28015132|NCT02501096|54674321|FG008|Overall Study|Lost to Follow-up|0|||
28015133|NCT02501096|54674313|FG000|Overall Study|Withdrawal by Subject|1|||
28015134|NCT02501096|54674314|FG001|Overall Study|Withdrawal by Subject|0|||
28015135|NCT02501096|54674315|FG002|Overall Study|Withdrawal by Subject|7|||
28015136|NCT02501096|54674316|FG003|Overall Study|Withdrawal by Subject|13|||
28015137|NCT02501096|54674317|FG004|Overall Study|Withdrawal by Subject|2|||
28015138|NCT02501096|54674318|FG005|Overall Study|Withdrawal by Subject|2|||
28015139|NCT02501096|54674319|FG006|Overall Study|Withdrawal by Subject|2|||
28015140|NCT02501096|54674320|FG007|Overall Study|Withdrawal by Subject|3|||
28015141|NCT02501096|54674321|FG008|Overall Study|Withdrawal by Subject|0|||
28015142|NCT02501096|54674313|FG000|Overall Study|Survival follow-up discontinued by sponsor|0|||
28015143|NCT02501096|54674314|FG001|Overall Study|Survival follow-up discontinued by sponsor|0|||
28015144|NCT02501096|54674315|FG002|Overall Study|Survival follow-up discontinued by sponsor|29|||
28015145|NCT02501096|54674316|FG003|Overall Study|Survival follow-up discontinued by sponsor|58|||
28015146|NCT02501096|54674317|FG004|Overall Study|Survival follow-up discontinued by sponsor|3|||
28015147|NCT02501096|54674318|FG005|Overall Study|Survival follow-up discontinued by sponsor|2|||
28015148|NCT02501096|54674319|FG006|Overall Study|Survival follow-up discontinued by sponsor|2|||
28015149|NCT02501096|54674320|FG007|Overall Study|Survival follow-up discontinued by sponsor|1|||
28015150|NCT02501096|54674321|FG008|Overall Study|Survival follow-up discontinued by sponsor|0|||
28015151|NCT02501096|54674313|FG000|Overall Study|Death|1|||
28015152|NCT02501096|54674314|FG001|Overall Study|Death|1|||
28015153|NCT02501096|54674315|FG002|Overall Study|Death|88|||
28015154|NCT02501096|54674316|FG003|Overall Study|Death|74|||
28015155|NCT02501096|54674317|FG004|Overall Study|Death|15|||
28015156|NCT02501096|54674318|FG005|Overall Study|Death|16|||
28015157|NCT02501096|54674319|FG006|Overall Study|Death|15|||
28015158|NCT02501096|54674320|FG007|Overall Study|Death|16|||
28015159|NCT02501096|54674321|FG008|Overall Study|Death|1|||
28015160|NCT01991977|54674353|FG000|Overall Study|Withdrew prior to receiving treatment|7|||
28015161|NCT01991977|54674353|FG000|Overall Study|Withdrew after start of treatment|5|||
28015162|NCT01633541|54674359|FG000|Overall Study|Death|1|||
28015163|NCT01633541|54674360|FG001|Overall Study|Death|0|||
28015164|NCT01466036|54674370|FG000|Overall Study|Death|1|||
28015165|NCT01466036|54674371|FG001|Overall Study|Death|1|||
28015166|NCT01466036|54674370|FG000|Overall Study|Physician Decision|0|||
28015167|NCT01466036|54674371|FG001|Overall Study|Physician Decision|4|||
28015168|NCT01466036|54674370|FG000|Overall Study|Adverse Event|2|||
28015169|NCT01466036|54674371|FG001|Overall Study|Adverse Event|6|||
28015170|NCT01466036|54674370|FG000|Overall Study|Withdrawal by Subject|2|||
28015171|NCT01466036|54674371|FG001|Overall Study|Withdrawal by Subject|8|||
28015172|NCT01466036|54674370|FG000|Overall Study|progression/relapse|14|||
28015173|NCT01466036|54674371|FG001|Overall Study|progression/relapse|21|||
28015174|NCT01466036|54674370|FG000|Overall Study|prolonged treatment delay|1|||
28015175|NCT01466036|54674371|FG001|Overall Study|prolonged treatment delay|1|||
28015176|NCT01399372|54674380|FG000|Overall Study|Protocol Violation|3|||
28015177|NCT01399372|54674381|FG001|Overall Study|Protocol Violation|1|||
28015178|NCT01063517|54674389|FG000|Overall Study|Consent withdrawal|1|||
28015179|NCT01063517|54674390|FG001|Overall Study|Consent withdrawal|0|||
28015180|NCT01063517|54674389|FG000|Overall Study|Study reached data cut-off|19|||
28015181|NCT01063517|54674390|FG001|Overall Study|Study reached data cut-off|7|||
28015182|NCT01063517|54674389|FG000|Overall Study|Lost to Follow-up|4|||
28015183|NCT01063517|54674390|FG001|Overall Study|Lost to Follow-up|3|||
28015184|NCT01063517|54674389|FG000|Overall Study|Withdrawal by Subject|1|||
28015185|NCT01063517|54674390|FG001|Overall Study|Withdrawal by Subject|2|||
28015186|NCT01063517|54674389|FG000|Overall Study|Death|33|||
28015187|NCT01063517|54674390|FG001|Overall Study|Death|48|||
28015188|NCT00920621|54674400|FG000|Overall Study|Lost to Follow-up|16|||
28015189|NCT00920621|54674401|FG001|Overall Study|Lost to Follow-up|17|||
28015190|NCT00920621|54674402|FG002|Overall Study|Lost to Follow-up|19|||
28015191|NCT00920621|54674403|FG003|Overall Study|Lost to Follow-up|21|||
28015192|NCT00920621|54674400|FG000|Overall Study|Fetal/neonatal deaths|16|||
28015193|NCT00920621|54674401|FG001|Overall Study|Fetal/neonatal deaths|14|||
28015194|NCT00920621|54674402|FG002|Overall Study|Fetal/neonatal deaths|16|||
28015195|NCT00920621|54674403|FG003|Overall Study|Fetal/neonatal deaths|14|||
28015196|NCT00920621|54674400|FG000|Overall Study|Blood sample not collected|22|||
28015197|NCT00920621|54674401|FG001|Overall Study|Blood sample not collected|14|||
28015198|NCT00920621|54674402|FG002|Overall Study|Blood sample not collected|0|||
28015199|NCT00920621|54674403|FG003|Overall Study|Blood sample not collected|0|||
28015200|NCT00612105|54674416|FG000|Period Title 1: 6-Week Titration Phase|Adverse Event|18|||
28015201|NCT00612105|54674417|FG001|Period Title 1: 6-Week Titration Phase|Adverse Event|1|||
28015202|NCT00612105|54674416|FG000|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6|||
28015203|NCT00612105|54674417|FG001|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1|||
28015204|NCT00612105|54674416|FG000|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2|||
28015205|NCT00612105|54674417|FG001|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0|||
28015206|NCT00612105|54674416|FG000|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
28015207|NCT00612105|54674417|FG001|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
28015208|NCT00612105|54674416|FG000|Period Title 1: 6-Week Titration Phase|Protocol Violation|1|||
28015209|NCT00612105|54674417|FG001|Period Title 1: 6-Week Titration Phase|Protocol Violation|0|||
28015210|NCT00612105|54674416|FG000|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3|||
28015211|NCT00612105|54674417|FG001|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1|||
28015212|NCT00612105|54674416|FG000|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5|||
28015213|NCT00612105|54674417|FG001|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0|||
28015214|NCT00612105|54674416|FG000|Period Title 1: 6-Week Titration Phase|Other|0|||
28015215|NCT00612105|54674417|FG001|Period Title 1: 6-Week Titration Phase|Other|1|||
28015216|NCT00612105|54674416|FG000|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9|||
28015217|NCT00612105|54674417|FG001|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1|||
28015218|NCT00612105|54674416|FG000|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
28015219|NCT00612105|54674417|FG001|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
28015220|NCT00612105|54674416|FG000|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1|||
28015221|NCT00612105|54674417|FG001|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0|||
28015222|NCT00612105|54674416|FG000|Period Title 3: 3-Week Taper Phase|Other|1|||
28015223|NCT00612105|54674417|FG001|Period Title 3: 3-Week Taper Phase|Other|0|||
28015224|NCT00546052|54674423|FG000|Overall Study|Adverse Event|47|||
28015225|NCT00546052|54674423|FG000|Overall Study|Lost to Follow-up|144|||
28015226|NCT00546052|54674423|FG000|Overall Study|Protocol Violation|9|||
28015227|NCT00546052|54674423|FG000|Overall Study|Withdrawal by Subject|20|||
28015228|NCT00546052|54674423|FG000|Overall Study|Non Compliance|7|||
28015229|NCT00673920|54674438|FG000|Baseline up to Week 48|Withdrew consent|1|||
28015230|NCT00673920|54674439|FG001|Baseline up to Week 48|Withdrew consent|0|||
28015231|NCT00673920|54674440|FG002|Baseline up to Week 48|Withdrew consent|2|||
28015232|NCT00673920|54674441|FG003|Baseline up to Week 48|Withdrew consent|0|||
28015233|NCT00673920|54674442|FG004|Baseline up to Week 48|Withdrew consent|0|||
28015234|NCT00673920|54674443|FG005|Baseline up to Week 48|Withdrew consent|0|||
28015235|NCT00673920|54674444|FG006|Baseline up to Week 48|Withdrew consent|0|||
28015236|NCT00673920|54674445|FG007|Baseline up to Week 48|Withdrew consent|0|||
28015237|NCT00673920|54674438|FG000|Baseline up to Week 48|Refused treatment|1|||
28015238|NCT00673920|54674439|FG001|Baseline up to Week 48|Refused treatment|0|||
28015239|NCT00673920|54674440|FG002|Baseline up to Week 48|Refused treatment|0|||
28015240|NCT00673920|54674441|FG003|Baseline up to Week 48|Refused treatment|0|||
28015241|NCT00673920|54674442|FG004|Baseline up to Week 48|Refused treatment|0|||
28015242|NCT00673920|54674443|FG005|Baseline up to Week 48|Refused treatment|0|||
28015243|NCT00673920|54674444|FG006|Baseline up to Week 48|Refused treatment|0|||
28015244|NCT00673920|54674445|FG007|Baseline up to Week 48|Refused treatment|0|||
28015245|NCT00673920|54674438|FG000|Baseline up to Week 48|Insufficient therapeutic response|2|||
28015246|NCT00673920|54674439|FG001|Baseline up to Week 48|Insufficient therapeutic response|1|||
28015247|NCT00673920|54674440|FG002|Baseline up to Week 48|Insufficient therapeutic response|0|||
28015248|NCT00673920|54674441|FG003|Baseline up to Week 48|Insufficient therapeutic response|0|||
28015249|NCT00673920|54674442|FG004|Baseline up to Week 48|Insufficient therapeutic response|0|||
28015250|NCT00673920|54674443|FG005|Baseline up to Week 48|Insufficient therapeutic response|0|||
28015251|NCT00673920|54674444|FG006|Baseline up to Week 48|Insufficient therapeutic response|0|||
28015252|NCT00673920|54674445|FG007|Baseline up to Week 48|Insufficient therapeutic response|0|||
28015253|NCT00673920|54674438|FG000|Baseline up to Week 48|Protocol Violation|0|||
28015254|NCT00673920|54674439|FG001|Baseline up to Week 48|Protocol Violation|0|||
28015255|NCT00673920|54674440|FG002|Baseline up to Week 48|Protocol Violation|1|||
28015256|NCT00673920|54674441|FG003|Baseline up to Week 48|Protocol Violation|0|||
28015257|NCT00673920|54674442|FG004|Baseline up to Week 48|Protocol Violation|0|||
28015258|NCT00673920|54674443|FG005|Baseline up to Week 48|Protocol Violation|0|||
28015259|NCT00673920|54674444|FG006|Baseline up to Week 48|Protocol Violation|0|||
28015260|NCT00673920|54674445|FG007|Baseline up to Week 48|Protocol Violation|0|||
28015261|NCT00673920|54674438|FG000|Baseline up to Week 48|Violation of selection criteria at entry|0|||
28015262|NCT00673920|54674439|FG001|Baseline up to Week 48|Violation of selection criteria at entry|0|||
28015263|NCT00673920|54674440|FG002|Baseline up to Week 48|Violation of selection criteria at entry|1|||
28015264|NCT00673920|54674441|FG003|Baseline up to Week 48|Violation of selection criteria at entry|0|||
28015265|NCT00673920|54674442|FG004|Baseline up to Week 48|Violation of selection criteria at entry|0|||
28015266|NCT00673920|54674443|FG005|Baseline up to Week 48|Violation of selection criteria at entry|0|||
28015267|NCT00673920|54674444|FG006|Baseline up to Week 48|Violation of selection criteria at entry|0|||
28015268|NCT00673920|54674445|FG007|Baseline up to Week 48|Violation of selection criteria at entry|0|||
28015269|NCT00673920|54674438|FG000|Baseline up to Week 48|Administrative/Other|0|||
28015270|NCT00673920|54674439|FG001|Baseline up to Week 48|Administrative/Other|1|||
28015271|NCT00673920|54674440|FG002|Baseline up to Week 48|Administrative/Other|2|||
28015272|NCT00673920|54674441|FG003|Baseline up to Week 48|Administrative/Other|0|||
28015273|NCT00673920|54674442|FG004|Baseline up to Week 48|Administrative/Other|0|||
28015274|NCT00673920|54674443|FG005|Baseline up to Week 48|Administrative/Other|0|||
28015275|NCT00673920|54674444|FG006|Baseline up to Week 48|Administrative/Other|0|||
28015276|NCT00673920|54674445|FG007|Baseline up to Week 48|Administrative/Other|0|||
28015277|NCT00673920|54674438|FG000|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
28015278|NCT00673920|54674439|FG001|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
28015279|NCT00673920|54674440|FG002|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
28015280|NCT00673920|54674441|FG003|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
28015281|NCT00673920|54674442|FG004|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
28015282|NCT00673920|54674443|FG005|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
28015283|NCT00673920|54674444|FG006|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
28015284|NCT00673920|54674445|FG007|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
28015285|NCT00673920|54674438|FG000|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
28015286|NCT00673920|54674439|FG001|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
28015287|NCT00673920|54674440|FG002|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
28015288|NCT00673920|54674441|FG003|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
28015289|NCT00673920|54674442|FG004|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
28015290|NCT00673920|54674443|FG005|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
28015291|NCT00673920|54674444|FG006|Week 24 to Week 48|Adverse event/intercurrent illness|1|||
28015292|NCT00673920|54674445|FG007|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
28015293|NCT00673920|54674438|FG000|Week 24 to Week 48|Failure to return|0|||
28015294|NCT00673920|54674439|FG001|Week 24 to Week 48|Failure to return|0|||
28015295|NCT00673920|54674440|FG002|Week 24 to Week 48|Failure to return|0|||
28015296|NCT00673920|54674441|FG003|Week 24 to Week 48|Failure to return|0|||
28015297|NCT00673920|54674442|FG004|Week 24 to Week 48|Failure to return|0|||
28015298|NCT00673920|54674443|FG005|Week 24 to Week 48|Failure to return|1|||
28015299|NCT00673920|54674444|FG006|Week 24 to Week 48|Failure to return|0|||
28015300|NCT00673920|54674445|FG007|Week 24 to Week 48|Failure to return|0|||
28015301|NCT00673920|54674438|FG000|Week 24 to Week 48|Insufficient therapeutic response|0|||
28015302|NCT00673920|54674439|FG001|Week 24 to Week 48|Insufficient therapeutic response|0|||
28015303|NCT00673920|54674440|FG002|Week 24 to Week 48|Insufficient therapeutic response|0|||
28015304|NCT00673920|54674441|FG003|Week 24 to Week 48|Insufficient therapeutic response|0|||
28015305|NCT00673920|54674442|FG004|Week 24 to Week 48|Insufficient therapeutic response|0|||
28015306|NCT00673920|54674443|FG005|Week 24 to Week 48|Insufficient therapeutic response|1|||
28015307|NCT00673920|54674444|FG006|Week 24 to Week 48|Insufficient therapeutic response|0|||
28015308|NCT00673920|54674445|FG007|Week 24 to Week 48|Insufficient therapeutic response|0|||
28015309|NCT00673920|54674438|FG000|Week 24 to Week 48|Death|0|||
28015310|NCT00673920|54674439|FG001|Week 24 to Week 48|Death|0|||
28015311|NCT00673920|54674440|FG002|Week 24 to Week 48|Death|0|||
28015312|NCT00673920|54674441|FG003|Week 24 to Week 48|Death|0|||
28015313|NCT00673920|54674442|FG004|Week 24 to Week 48|Death|0|||
28015314|NCT00673920|54674443|FG005|Week 24 to Week 48|Death|1|||
28015315|NCT00673920|54674444|FG006|Week 24 to Week 48|Death|0|||
28015316|NCT00673920|54674445|FG007|Week 24 to Week 48|Death|0|||
28015317|NCT00673920|54674438|FG000|Week 24 to Week 48|Adminstrative/Other|0|||
28015318|NCT00673920|54674439|FG001|Week 24 to Week 48|Adminstrative/Other|0|||
28015319|NCT00673920|54674440|FG002|Week 24 to Week 48|Adminstrative/Other|0|||
28015320|NCT00673920|54674441|FG003|Week 24 to Week 48|Adminstrative/Other|1|||
28015321|NCT00673920|54674442|FG004|Week 24 to Week 48|Adminstrative/Other|0|||
28015322|NCT00673920|54674443|FG005|Week 24 to Week 48|Adminstrative/Other|0|||
28015323|NCT00673920|54674444|FG006|Week 24 to Week 48|Adminstrative/Other|0|||
28015324|NCT00673920|54674445|FG007|Week 24 to Week 48|Adminstrative/Other|0|||
28015325|NCT00379795|54674472|FG000|Overall Study|Death|31|||
28015326|NCT00379795|54674473|FG001|Overall Study|Death|8|||
28015327|NCT00379795|54674474|FG002|Overall Study|Death|6|||
28015328|NCT00379795|54674475|FG003|Overall Study|Death|4|||
28015329|NCT00379795|54674476|FG004|Overall Study|Death|7|||
28015330|NCT00379795|54674472|FG000|Overall Study|Adverse Event|17|||
28015331|NCT00379795|54674473|FG001|Overall Study|Adverse Event|3|||
28015332|NCT00379795|54674474|FG002|Overall Study|Adverse Event|3|||
28015333|NCT00379795|54674475|FG003|Overall Study|Adverse Event|1|||
28015334|NCT00379795|54674476|FG004|Overall Study|Adverse Event|4|||
28015335|NCT00379795|54674472|FG000|Overall Study|Lost to Follow-up|8|||
28015336|NCT00379795|54674473|FG001|Overall Study|Lost to Follow-up|1|||
28015337|NCT00379795|54674474|FG002|Overall Study|Lost to Follow-up|2|||
28015338|NCT00379795|54674475|FG003|Overall Study|Lost to Follow-up|1|||
28015339|NCT00379795|54674476|FG004|Overall Study|Lost to Follow-up|4|||
28015340|NCT00379795|54674472|FG000|Overall Study|Physician Decision|25|||
28015341|NCT00379795|54674473|FG001|Overall Study|Physician Decision|0|||
28015342|NCT00379795|54674474|FG002|Overall Study|Physician Decision|2|||
28015343|NCT00379795|54674475|FG003|Overall Study|Physician Decision|2|||
28015344|NCT00379795|54674476|FG004|Overall Study|Physician Decision|2|||
28015345|NCT00379795|54674472|FG000|Overall Study|Withdrawal by Subject|94|||
28015346|NCT00379795|54674473|FG001|Overall Study|Withdrawal by Subject|11|||
28015347|NCT00379795|54674474|FG002|Overall Study|Withdrawal by Subject|19|||
28015348|NCT00379795|54674475|FG003|Overall Study|Withdrawal by Subject|7|||
28015349|NCT00379795|54674476|FG004|Overall Study|Withdrawal by Subject|14|||
28015350|NCT00379795|54674472|FG000|Overall Study|Subject non-compliance|7|||
28015351|NCT00379795|54674473|FG001|Overall Study|Subject non-compliance|2|||
28015352|NCT00379795|54674474|FG002|Overall Study|Subject non-compliance|0|||
28015353|NCT00379795|54674475|FG003|Overall Study|Subject non-compliance|0|||
28015354|NCT00379795|54674476|FG004|Overall Study|Subject non-compliance|1|||
28015355|NCT00379795|54674472|FG000|Overall Study|Verteporfin photodynamic therapy in eye|3|||
28015356|NCT00379795|54674473|FG001|Overall Study|Verteporfin photodynamic therapy in eye|0|||
28015357|NCT00379795|54674474|FG002|Overall Study|Verteporfin photodynamic therapy in eye|0|||
28015358|NCT00379795|54674475|FG003|Overall Study|Verteporfin photodynamic therapy in eye|1|||
28015359|NCT00379795|54674476|FG004|Overall Study|Verteporfin photodynamic therapy in eye|0|||
28015360|NCT00379795|54674472|FG000|Overall Study|Subjects condition mandated intervention|34|||
28015361|NCT00379795|54674473|FG001|Overall Study|Subjects condition mandated intervention|9|||
28015362|NCT00379795|54674474|FG002|Overall Study|Subjects condition mandated intervention|7|||
28015363|NCT00379795|54674475|FG003|Overall Study|Subjects condition mandated intervention|5|||
28015364|NCT00379795|54674476|FG004|Overall Study|Subjects condition mandated intervention|7|||
28015365|NCT00379795|54674472|FG000|Overall Study|Sponsor's decision|257|||
28015366|NCT00379795|54674473|FG001|Overall Study|Sponsor's decision|17|||
28015367|NCT00379795|54674474|FG002|Overall Study|Sponsor's decision|54|||
28015368|NCT00379795|54674475|FG003|Overall Study|Sponsor's decision|47|||
28015369|NCT00379795|54674476|FG004|Overall Study|Sponsor's decision|10|||
28015370|NCT00610155|54674491|FG000|Period 1|Withdrawal by Subject|0|||
28015371|NCT00610155|54674492|FG001|Period 1|Withdrawal by Subject|0|||
28015372|NCT00610155|54674493|FG002|Period 1|Withdrawal by Subject|1|||
28015373|NCT00610155|54674494|FG003|Period 1|Withdrawal by Subject|0|||
28015374|NCT00610155|54674495|FG004|Period 1|Withdrawal by Subject|0|||
28015375|NCT00610155|54674496|FG005|Period 1|Withdrawal by Subject|0|||
28015376|NCT00610155|54674491|FG000|Period 3|Adverse Event|1|||
28015377|NCT00610155|54674492|FG001|Period 3|Adverse Event|0|||
28015378|NCT00610155|54674493|FG002|Period 3|Adverse Event|0|||
28015379|NCT00610155|54674494|FG003|Period 3|Adverse Event|0|||
28015380|NCT00610155|54674495|FG004|Period 3|Adverse Event|0|||
28015381|NCT00610155|54674496|FG005|Period 3|Adverse Event|0|||
28015382|NCT00674700|54674507|FG000|Year 1|Adverse Event|17|||
28015383|NCT00674700|54674508|FG001|Year 1|Adverse Event|20|||
28015384|NCT00674700|54674509|FG002|Year 1|Adverse Event|5|||
28015385|NCT00674700|54674507|FG000|Year 1|Withdrawal by Subject|7|||
28015386|NCT00674700|54674508|FG001|Year 1|Withdrawal by Subject|7|||
28015387|NCT00674700|54674509|FG002|Year 1|Withdrawal by Subject|6|||
28015388|NCT00674700|54674507|FG000|Year 1|Any other reason not above-mentioned|7|||
28015389|NCT00674700|54674508|FG001|Year 1|Any other reason not above-mentioned|7|||
28015390|NCT00674700|54674509|FG002|Year 1|Any other reason not above-mentioned|6|||
28015391|NCT00674700|54674507|FG000|Year 2 Follow-up Without Treatment|Adverse Event|0|||
28015392|NCT00674700|54674508|FG001|Year 2 Follow-up Without Treatment|Adverse Event|1|||
28015393|NCT00674700|54674509|FG002|Year 2 Follow-up Without Treatment|Adverse Event|1|||
28015394|NCT00674700|54674507|FG000|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
28015395|NCT00674700|54674508|FG001|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
28015396|NCT00674700|54674509|FG002|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4|||
28015397|NCT00674700|54674507|FG000|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5|||
28015398|NCT00674700|54674508|FG001|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10|||
28015399|NCT00674700|54674509|FG002|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7|||
28015400|NCT00546910|54674519|FG000|Overall Study|Adverse Event|2|||
28015401|NCT00546910|54674520|FG001|Overall Study|Adverse Event|3|||
28015402|NCT00546910|54674519|FG000|Overall Study|Lack of Efficacy|5|||
28015403|NCT00546910|54674520|FG001|Overall Study|Lack of Efficacy|7|||
28015404|NCT00546910|54674519|FG000|Overall Study|Physician Decision|0|||
28015405|NCT00546910|54674520|FG001|Overall Study|Physician Decision|1|||
28015406|NCT00546910|54674519|FG000|Overall Study|Withdrawal by Subject|2|||
28015407|NCT00546910|54674520|FG001|Overall Study|Withdrawal by Subject|0|||
28015408|NCT00379639|54674531|FG000|Overall Study|Disease Progression|3|||
28015409|NCT00379639|54674532|FG001|Overall Study|Disease Progression|3|||
28015410|NCT00379639|54674533|FG002|Overall Study|Disease Progression|3|||
28015411|NCT00379639|54674534|FG003|Overall Study|Disease Progression|4|||
28015412|NCT00379639|54674535|FG004|Overall Study|Disease Progression|4|||
28015413|NCT00379639|54674531|FG000|Overall Study|Physician Decision|0|||
28015414|NCT00379639|54674532|FG001|Overall Study|Physician Decision|2|||
28015415|NCT00379639|54674533|FG002|Overall Study|Physician Decision|1|||
28015416|NCT00379639|54674534|FG003|Overall Study|Physician Decision|1|||
28104111|NCT02891408|54760911|FG005|Overall Study|Lost to Follow-up|0|||
28104112|NCT02891408|54760912|FG006|Overall Study|Lost to Follow-up|0|||
28015417|NCT00379639|54674535|FG004|Overall Study|Physician Decision|0|||
28015418|NCT00379639|54674531|FG000|Overall Study|Symptomatic Deterioration|0|||
28015419|NCT00379639|54674532|FG001|Overall Study|Symptomatic Deterioration|0|||
28015420|NCT00379639|54674533|FG002|Overall Study|Symptomatic Deterioration|1|||
28015421|NCT00379639|54674534|FG003|Overall Study|Symptomatic Deterioration|0|||
28015422|NCT00379639|54674535|FG004|Overall Study|Symptomatic Deterioration|1|||
28015423|NCT00379639|54674531|FG000|Overall Study|Adverse Event|0|||
28015424|NCT00379639|54674532|FG001|Overall Study|Adverse Event|0|||
28015425|NCT00379639|54674533|FG002|Overall Study|Adverse Event|1|||
28015426|NCT00379639|54674534|FG003|Overall Study|Adverse Event|0|||
28015427|NCT00379639|54674535|FG004|Overall Study|Adverse Event|1|||
28015428|NCT00379639|54674531|FG000|Overall Study|Lost to Follow-up|0|||
28015429|NCT00379639|54674532|FG001|Overall Study|Lost to Follow-up|0|||
28015430|NCT00379639|54674533|FG002|Overall Study|Lost to Follow-up|0|||
28015431|NCT00379639|54674534|FG003|Overall Study|Lost to Follow-up|1|||
28015432|NCT00379639|54674535|FG004|Overall Study|Lost to Follow-up|0|||
28015433|NCT00379639|54674531|FG000|Overall Study|Other|0|||
28015434|NCT00379639|54674532|FG001|Overall Study|Other|0|||
28015435|NCT00379639|54674533|FG002|Overall Study|Other|3|||
28015436|NCT00379639|54674534|FG003|Overall Study|Other|0|||
28015437|NCT00379639|54674535|FG004|Overall Study|Other|0|||
28015438|NCT03948334|54674549|FG000|Overall Study|Adverse Event|1|||
28015439|NCT03948334|54674550|FG001|Overall Study|Adverse Event|4|||
28015440|NCT03948334|54674549|FG000|Overall Study|Lack of Efficacy|2|||
28015441|NCT03948334|54674550|FG001|Overall Study|Lack of Efficacy|0|||
28015442|NCT03948334|54674549|FG000|Overall Study|Lost to Follow-up|1|||
28015443|NCT03948334|54674550|FG001|Overall Study|Lost to Follow-up|0|||
28015444|NCT03948334|54674549|FG000|Overall Study|Physician Decision|1|||
28015445|NCT03948334|54674550|FG001|Overall Study|Physician Decision|0|||
28015446|NCT03948334|54674549|FG000|Overall Study|Pregnancy|0|||
28015447|NCT03948334|54674550|FG001|Overall Study|Pregnancy|1|||
28015448|NCT03948334|54674549|FG000|Overall Study|Protocol Deviation|1|||
28015449|NCT03948334|54674550|FG001|Overall Study|Protocol Deviation|0|||
28015450|NCT03948334|54674549|FG000|Overall Study|Study terminated by Sponsor|50|||
28015451|NCT03948334|54674550|FG001|Overall Study|Study terminated by Sponsor|51|||
28015452|NCT03948334|54674549|FG000|Overall Study|Subject Decision /Guardian Decision|4|||
28015453|NCT03948334|54674550|FG001|Overall Study|Subject Decision /Guardian Decision|7|||
28015454|NCT00609765|54674564|FG000|Overall Study|Study ended prior to 12 months|1|||
28015455|NCT00608829|54674568|FG000|Overall Study|Death|6|||
28015456|NCT00608829|54674568|FG000|Overall Study|Withdrawal by Subject|4|||
28015457|NCT00608829|54674568|FG000|Overall Study|Subject refuses to follow up or return.|5|||
28015458|NCT00545818|54674574|FG000|Overall Study|Protocol Violation|1|||
28015459|NCT00545818|54674575|FG001|Overall Study|Protocol Violation|0|||
28015460|NCT00545818|54674574|FG000|Overall Study|Adverse Event|1|||
28015461|NCT00545818|54674575|FG001|Overall Study|Adverse Event|1|||
28015462|NCT00545818|54674574|FG000|Overall Study|Lost to Follow-up|1|||
28015463|NCT00545818|54674575|FG001|Overall Study|Lost to Follow-up|6|||
28015464|NCT00674154|54674583|FG000|Overall Study|Withdrawal by Subject|3|||
28015465|NCT00674154|54674584|FG001|Overall Study|Withdrawal by Subject|1|||
28015466|NCT00674154|54674583|FG000|Overall Study|Did not want parathyroidectomy|0|||
28015467|NCT00674154|54674584|FG001|Overall Study|Did not want parathyroidectomy|2|||
28015468|NCT00608517|54674593|FG000|Overall Study|Death|1|||
28015469|NCT00608517|54674594|FG001|Overall Study|Death|0|||
28015470|NCT00608517|54674595|FG002|Overall Study|Death|0|||
28015471|NCT00608205|54674606|FG000|Overall Study|Adverse Event|3|||
28015472|NCT00608205|54674607|FG001|Overall Study|Adverse Event|2|||
28015473|NCT00608205|54674606|FG000|Overall Study|Patient non-compliant|0|||
28015474|NCT00608205|54674607|FG001|Overall Study|Patient non-compliant|1|||
28015475|NCT00670800|54674617|FG000|Overall Study|2 controls were insulin resistant|0|||
28015476|NCT00670800|54674618|FG001|Overall Study|2 controls were insulin resistant|2|||
28015477|NCT00607893|54674628|FG000|Overall Study|Lost to Follow-up|4|||
28015478|NCT00607893|54674629|FG001|Overall Study|Lost to Follow-up|0|||
28015479|NCT00607893|54674628|FG000|Overall Study|withdrew due to loss of interest|0|||
28015480|NCT00607893|54674629|FG001|Overall Study|withdrew due to loss of interest|1|||
28015481|NCT00607893|54674628|FG000|Overall Study|Withdrew due to osteomyelitis surgery|0|||
28015482|NCT00607893|54674629|FG001|Overall Study|Withdrew due to osteomyelitis surgery|1|||
28015483|NCT00607893|54674628|FG000|Overall Study|withdrew could not tolerate CPAP|0|||
28015484|NCT00607893|54674629|FG001|Overall Study|withdrew could not tolerate CPAP|1|||
28015485|NCT00607893|54674628|FG000|Overall Study|Declined to be treated|1|||
28015486|NCT00607893|54674629|FG001|Overall Study|Declined to be treated|0|||
28015487|NCT00607893|54674628|FG000|Overall Study|Withdrew due to hypertensive urgency|1|||
28015488|NCT00607893|54674629|FG001|Overall Study|Withdrew due to hypertensive urgency|1|||
28015489|NCT00571038|54674639|FG000|Overall Study|Lost to Follow-up|1|||
28015490|NCT00571038|54674640|FG001|Overall Study|Lost to Follow-up|4|||
28015491|NCT00571038|54674639|FG000|Overall Study|Death|7|||
28015492|NCT00571038|54674640|FG001|Overall Study|Death|5|||
28015493|NCT00571038|54674639|FG000|Overall Study|Withdrawal by Subject|1|||
28015494|NCT00571038|54674640|FG001|Overall Study|Withdrawal by Subject|3|||
28015495|NCT00571038|54674639|FG000|Overall Study|Moved out of state|2|||
28015496|NCT00571038|54674640|FG001|Overall Study|Moved out of state|2|||
28015497|NCT00545740|54674650|FG000|Overall Study|Lack of Efficacy|34|||
28015498|NCT00545740|54674651|FG001|Overall Study|Lack of Efficacy|35|||
28015499|NCT00545740|54674652|FG002|Overall Study|Lack of Efficacy|47|||
28015500|NCT00545740|54674653|FG003|Overall Study|Lack of Efficacy|36|||
28015501|NCT00545740|54674650|FG000|Overall Study|Withdrawal by Subject|17|||
28015502|NCT00545740|54674651|FG001|Overall Study|Withdrawal by Subject|15|||
28015503|NCT00545740|54674652|FG002|Overall Study|Withdrawal by Subject|16|||
28015504|NCT00545740|54674653|FG003|Overall Study|Withdrawal by Subject|18|||
28015505|NCT00545740|54674650|FG000|Overall Study|Adverse Event|10|||
28015506|NCT00545740|54674651|FG001|Overall Study|Adverse Event|18|||
28015507|NCT00545740|54674652|FG002|Overall Study|Adverse Event|19|||
28015508|NCT00545740|54674653|FG003|Overall Study|Adverse Event|9|||
28015509|NCT00545740|54674650|FG000|Overall Study|Lost to Follow-up|7|||
28015510|NCT00545740|54674651|FG001|Overall Study|Lost to Follow-up|5|||
28015511|NCT00545740|54674652|FG002|Overall Study|Lost to Follow-up|5|||
28015512|NCT00545740|54674653|FG003|Overall Study|Lost to Follow-up|6|||
28015513|NCT00545740|54674650|FG000|Overall Study|Protocol Violation|1|||
28015514|NCT00545740|54674651|FG001|Overall Study|Protocol Violation|3|||
28015515|NCT00545740|54674652|FG002|Overall Study|Protocol Violation|1|||
28015516|NCT00545740|54674653|FG003|Overall Study|Protocol Violation|0|||
28015517|NCT00545740|54674650|FG000|Overall Study|Non-compliance|0|||
28015518|NCT00545740|54674651|FG001|Overall Study|Non-compliance|2|||
28015519|NCT00545740|54674652|FG002|Overall Study|Non-compliance|1|||
28015520|NCT00545740|54674653|FG003|Overall Study|Non-compliance|0|||
28015521|NCT00545740|54674650|FG000|Overall Study|Moved|2|||
28015522|NCT00545740|54674651|FG001|Overall Study|Moved|0|||
28015523|NCT00545740|54674652|FG002|Overall Study|Moved|1|||
28015524|NCT00545740|54674653|FG003|Overall Study|Moved|0|||
28015525|NCT00545740|54674650|FG000|Overall Study|Diverticulitis attack|0|||
28015526|NCT00545740|54674651|FG001|Overall Study|Diverticulitis attack|0|||
28015527|NCT00545740|54674652|FG002|Overall Study|Diverticulitis attack|1|||
28015528|NCT00545740|54674653|FG003|Overall Study|Diverticulitis attack|1|||
28015529|NCT00545740|54674650|FG000|Overall Study|Suspected Diverticulitis Recurrence|1|||
28015530|NCT00545740|54674651|FG001|Overall Study|Suspected Diverticulitis Recurrence|1|||
28015531|NCT00545740|54674652|FG002|Overall Study|Suspected Diverticulitis Recurrence|1|||
28015532|NCT00545740|54674653|FG003|Overall Study|Suspected Diverticulitis Recurrence|1|||
28015533|NCT00545740|54674650|FG000|Overall Study|Site closure|1|||
28015534|NCT00545740|54674651|FG001|Overall Study|Site closure|0|||
28015535|NCT00545740|54674652|FG002|Overall Study|Site closure|0|||
28015536|NCT00545740|54674653|FG003|Overall Study|Site closure|0|||
28015537|NCT00545740|54674650|FG000|Overall Study|Missed visit|1|||
28015538|NCT00545740|54674651|FG001|Overall Study|Missed visit|0|||
28015539|NCT00545740|54674652|FG002|Overall Study|Missed visit|0|||
28015540|NCT00545740|54674653|FG003|Overall Study|Missed visit|0|||
28015541|NCT00545740|54674650|FG000|Overall Study|Physician Decision|0|||
28015542|NCT00545740|54674651|FG001|Overall Study|Physician Decision|0|||
28015543|NCT00545740|54674652|FG002|Overall Study|Physician Decision|3|||
28015544|NCT00545740|54674653|FG003|Overall Study|Physician Decision|0|||
28015545|NCT00545740|54674650|FG000|Overall Study|Accepted only monthly telephone calls|1|||
28015546|NCT00545740|54674651|FG001|Overall Study|Accepted only monthly telephone calls|0|||
28015547|NCT00545740|54674652|FG002|Overall Study|Accepted only monthly telephone calls|0|||
28015548|NCT00545740|54674653|FG003|Overall Study|Accepted only monthly telephone calls|0|||
28015549|NCT00545740|54674650|FG000|Overall Study|Sponsor decision|0|||
28015550|NCT00545740|54674651|FG001|Overall Study|Sponsor decision|1|||
28015551|NCT00545740|54674652|FG002|Overall Study|Sponsor decision|0|||
28015552|NCT00545740|54674653|FG003|Overall Study|Sponsor decision|0|||
28015553|NCT00545740|54674650|FG000|Overall Study|Lack of time|0|||
28015554|NCT00545740|54674651|FG001|Overall Study|Lack of time|1|||
28015555|NCT00545740|54674652|FG002|Overall Study|Lack of time|0|||
28015556|NCT00545740|54674653|FG003|Overall Study|Lack of time|0|||
28015557|NCT00545740|54674650|FG000|Overall Study|Non-adherence to visits|0|||
28015558|NCT00545740|54674651|FG001|Overall Study|Non-adherence to visits|1|||
28015559|NCT00545740|54674652|FG002|Overall Study|Non-adherence to visits|0|||
28015560|NCT00545740|54674653|FG003|Overall Study|Non-adherence to visits|0|||
28015561|NCT00545740|54674650|FG000|Overall Study|Patient difficulties|0|||
28015562|NCT00545740|54674651|FG001|Overall Study|Patient difficulties|1|||
28015563|NCT00545740|54674652|FG002|Overall Study|Patient difficulties|0|||
28015564|NCT00545740|54674653|FG003|Overall Study|Patient difficulties|0|||
28015565|NCT00545740|54674650|FG000|Overall Study|Husband against study|0|||
28015566|NCT00545740|54674651|FG001|Overall Study|Husband against study|0|||
28015567|NCT00545740|54674652|FG002|Overall Study|Husband against study|1|||
28015568|NCT00545740|54674653|FG003|Overall Study|Husband against study|0|||
28015569|NCT00609609|54674665|FG000|Overall Study|Withdrawal by Subject|2|||
28015570|NCT00609609|54674666|FG001|Overall Study|Withdrawal by Subject|0|||
28015571|NCT00609609|54674665|FG000|Overall Study|Progression|4|||
28015572|NCT00609609|54674666|FG001|Overall Study|Progression|2|||
28015573|NCT00673452|54674674|FG000|Acute Double-Blind Phase|Adverse Event|41|||
28015574|NCT00673452|54674675|FG001|Acute Double-Blind Phase|Adverse Event|24|||
28015575|NCT00673452|54674674|FG000|Acute Double-Blind Phase|Lack of Efficacy|9|||
28015576|NCT00673452|54674675|FG001|Acute Double-Blind Phase|Lack of Efficacy|14|||
28015577|NCT00673452|54674674|FG000|Acute Double-Blind Phase|Lost to Follow-up|16|||
28015578|NCT00673452|54674675|FG001|Acute Double-Blind Phase|Lost to Follow-up|19|||
28015579|NCT00673452|54674674|FG000|Acute Double-Blind Phase|Physician Decision|0|||
28015580|NCT00673452|54674675|FG001|Acute Double-Blind Phase|Physician Decision|6|||
28015581|NCT00673452|54674674|FG000|Acute Double-Blind Phase|Protocol Violation|5|||
28015582|NCT00673452|54674675|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
28015583|NCT00673452|54674674|FG000|Acute Double-Blind Phase|Sponsor Decision|0|||
28015584|NCT00673452|54674675|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
28015585|NCT00673452|54674674|FG000|Acute Double-Blind Phase|Withdrawal by Subject|16|||
28015586|NCT00673452|54674675|FG001|Acute Double-Blind Phase|Withdrawal by Subject|13|||
28015587|NCT00673452|54674674|FG000|Continuation Double-Blind Phase|Adverse Event|5|||
28015588|NCT00673452|54674675|FG001|Continuation Double-Blind Phase|Adverse Event|13|||
28015589|NCT00673452|54674674|FG000|Continuation Double-Blind Phase|Withdrawal by Subject|9|||
28015590|NCT00673452|54674675|FG001|Continuation Double-Blind Phase|Withdrawal by Subject|5|||
28015591|NCT00673452|54674674|FG000|Continuation Double-Blind Phase|Lost to Follow-up|4|||
28015592|NCT00673452|54674675|FG001|Continuation Double-Blind Phase|Lost to Follow-up|5|||
28015593|NCT00673452|54674674|FG000|Continuation Double-Blind Phase|Lack of Efficacy|2|||
28015594|NCT00673452|54674675|FG001|Continuation Double-Blind Phase|Lack of Efficacy|5|||
28015595|NCT00673452|54674674|FG000|Continuation Double-Blind Phase|Protocol Violation|2|||
28015596|NCT00673452|54674675|FG001|Continuation Double-Blind Phase|Protocol Violation|3|||
28015597|NCT00673452|54674674|FG000|Continuation Double-Blind Phase|Sponsor Decision|0|||
28015598|NCT00673452|54674675|FG001|Continuation Double-Blind Phase|Sponsor Decision|3|||
28015599|NCT00673452|54674674|FG000|Continuation Double-Blind Phase|Physician Decision|2|||
28015600|NCT00673452|54674675|FG001|Continuation Double-Blind Phase|Physician Decision|0|||
28015601|NCT00673452|54674674|FG000|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1|||
28015602|NCT00673452|54674675|FG001|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0|||
28015603|NCT00545584|54674684|FG000|Overall Study|Only one reason for discontinuation|62|||
28015604|NCT00545584|54674685|FG001|Overall Study|Only one reason for discontinuation|61|||
28015605|NCT00545584|54674686|FG002|Overall Study|Only one reason for discontinuation|48|||
28015606|NCT00545584|54674684|FG000|Overall Study|Two or more reasons for discontinuation|17|||
28015607|NCT00545584|54674685|FG001|Overall Study|Two or more reasons for discontinuation|19|||
28015608|NCT00545584|54674686|FG002|Overall Study|Two or more reasons for discontinuation|8|||
28015609|NCT00378703|54674698|FG000|Overall Study|Disease progression|59|||
28015610|NCT00378703|54674699|FG001|Overall Study|Disease progression|43|||
28015611|NCT00378703|54674700|FG002|Overall Study|Disease progression|48|||
28015612|NCT00378703|54674701|FG003|Overall Study|Disease progression|49|||
28015613|NCT00378703|54674698|FG000|Overall Study|Adverse Event|11|||
28015614|NCT00378703|54674699|FG001|Overall Study|Adverse Event|17|||
28015615|NCT00378703|54674700|FG002|Overall Study|Adverse Event|20|||
28015616|NCT00378703|54674701|FG003|Overall Study|Adverse Event|18|||
28015617|NCT00378703|54674698|FG000|Overall Study|Death|2|||
28015618|NCT00378703|54674699|FG001|Overall Study|Death|2|||
28015619|NCT00378703|54674700|FG002|Overall Study|Death|4|||
28015620|NCT00378703|54674701|FG003|Overall Study|Death|3|||
28015621|NCT00378703|54674698|FG000|Overall Study|Withdrawal by Subject|4|||
28015622|NCT00378703|54674699|FG001|Overall Study|Withdrawal by Subject|8|||
28015623|NCT00378703|54674700|FG002|Overall Study|Withdrawal by Subject|5|||
28015624|NCT00378703|54674701|FG003|Overall Study|Withdrawal by Subject|7|||
28015625|NCT00378703|54674698|FG000|Overall Study|Physician Decision|1|||
28015626|NCT00378703|54674699|FG001|Overall Study|Physician Decision|4|||
28015627|NCT00378703|54674700|FG002|Overall Study|Physician Decision|1|||
28015628|NCT00378703|54674701|FG003|Overall Study|Physician Decision|0|||
28015629|NCT00378703|54674698|FG000|Overall Study|Alternative therapy|4|||
28015630|NCT00378703|54674699|FG001|Overall Study|Alternative therapy|2|||
28015631|NCT00378703|54674700|FG002|Overall Study|Alternative therapy|0|||
28015632|NCT00378703|54674701|FG003|Overall Study|Alternative therapy|0|||
28015633|NCT00378703|54674698|FG000|Overall Study|Other complicated disease|0|||
28015634|NCT00378703|54674699|FG001|Overall Study|Other complicated disease|2|||
28015635|NCT00378703|54674700|FG002|Overall Study|Other complicated disease|2|||
28015636|NCT00378703|54674701|FG003|Overall Study|Other complicated disease|0|||
28015637|NCT00378703|54674698|FG000|Overall Study|Symptomatic deterioration|0|||
28015638|NCT00378703|54674699|FG001|Overall Study|Symptomatic deterioration|1|||
28015639|NCT00378703|54674700|FG002|Overall Study|Symptomatic deterioration|0|||
28015640|NCT00378703|54674701|FG003|Overall Study|Symptomatic deterioration|2|||
28015641|NCT00378703|54674698|FG000|Overall Study|Surgery|1|||
28015642|NCT00378703|54674699|FG001|Overall Study|Surgery|0|||
28015643|NCT00378703|54674700|FG002|Overall Study|Surgery|0|||
28015644|NCT00378703|54674701|FG003|Overall Study|Surgery|1|||
28015645|NCT00378703|54674698|FG000|Overall Study|Joint decision of physician and patient|1|||
28015646|NCT00378703|54674699|FG001|Overall Study|Joint decision of physician and patient|0|||
28015647|NCT00378703|54674700|FG002|Overall Study|Joint decision of physician and patient|0|||
28015648|NCT00378703|54674701|FG003|Overall Study|Joint decision of physician and patient|0|||
28015649|NCT00378703|54674698|FG000|Overall Study|Adverse events and progressive disease|0|||
28015650|NCT00378703|54674699|FG001|Overall Study|Adverse events and progressive disease|0|||
28015651|NCT00378703|54674700|FG002|Overall Study|Adverse events and progressive disease|0|||
28015652|NCT00378703|54674701|FG003|Overall Study|Adverse events and progressive disease|1|||
28015653|NCT00378703|54674698|FG000|Overall Study|Relocation|0|||
28015654|NCT00378703|54674699|FG001|Overall Study|Relocation|0|||
28015655|NCT00378703|54674700|FG002|Overall Study|Relocation|1|||
28015656|NCT00378703|54674701|FG003|Overall Study|Relocation|0|||
28015657|NCT00378703|54674698|FG000|Overall Study|Ineligible|4|||
28015658|NCT00378703|54674699|FG001|Overall Study|Ineligible|7|||
28015659|NCT00378703|54674700|FG002|Overall Study|Ineligible|7|||
28015660|NCT00378703|54674701|FG003|Overall Study|Ineligible|7|||
28015661|NCT00378703|54674698|FG000|Overall Study|Never started treatment|1|||
28015662|NCT00378703|54674699|FG001|Overall Study|Never started treatment|4|||
28015663|NCT00378703|54674700|FG002|Overall Study|Never started treatment|0|||
28015664|NCT00378703|54674701|FG003|Overall Study|Never started treatment|0|||
28015665|NCT00378703|54674698|FG000|Overall Study|Other|1|||
28015666|NCT00378703|54674699|FG001|Overall Study|Other|1|||
28015667|NCT00378703|54674700|FG002|Overall Study|Other|2|||
28015668|NCT00378703|54674701|FG003|Overall Study|Other|3|||
28015669|NCT00368641|54674717|FG000|Overall Study|Adverse Event|2|||
28015670|NCT00368641|54674718|FG001|Overall Study|Adverse Event|1|||
28015671|NCT00368641|54674717|FG000|Overall Study|Death|1|||
28015672|NCT00368641|54674718|FG001|Overall Study|Death|0|||
28015673|NCT00368641|54674717|FG000|Overall Study|Withdrawal by Subject|1|||
28015674|NCT00368641|54674718|FG001|Overall Study|Withdrawal by Subject|0|||
28015675|NCT00368641|54674717|FG000|Overall Study|Sponsor decision to terminate study|2|||
28015676|NCT00368641|54674718|FG001|Overall Study|Sponsor decision to terminate study|5|||
28015677|NCT00608985|54674728|FG000|Overall Study|Adverse Event|2|||
28015678|NCT00608985|54674729|FG001|Overall Study|Adverse Event|7|||
28015679|NCT00608985|54674730|FG002|Overall Study|Adverse Event|4|||
28015680|NCT00608985|54674731|FG003|Overall Study|Adverse Event|6|||
28015681|NCT00608985|54674728|FG000|Overall Study|Administrative/Other|7|||
28015682|NCT00608985|54674729|FG001|Overall Study|Administrative/Other|4|||
28015683|NCT00608985|54674730|FG002|Overall Study|Administrative/Other|1|||
28015684|NCT00608985|54674731|FG003|Overall Study|Administrative/Other|2|||
28015685|NCT00608985|54674728|FG000|Overall Study|Withdrawal of Consent|5|||
28015686|NCT00608985|54674729|FG001|Overall Study|Withdrawal of Consent|1|||
28015687|NCT00608985|54674730|FG002|Overall Study|Withdrawal of Consent|1|||
28015688|NCT00608985|54674731|FG003|Overall Study|Withdrawal of Consent|1|||
28015689|NCT00608985|54674728|FG000|Overall Study|Lost to Follow-up|2|||
28015690|NCT00608985|54674729|FG001|Overall Study|Lost to Follow-up|1|||
28015691|NCT00608985|54674730|FG002|Overall Study|Lost to Follow-up|0|||
28015692|NCT00608985|54674731|FG003|Overall Study|Lost to Follow-up|0|||
28015693|NCT00368251|54674744|FG000|Overall Study|SAE, non-fatal|1|||
28015694|NCT00368251|54674745|FG001|Overall Study|SAE, non-fatal|0|||
28015695|NCT00368251|54674746|FG002|Overall Study|SAE, non-fatal|0|||
28015696|NCT00368251|54674744|FG000|Overall Study|AE, non-serious non-fatal|0|||
28015697|NCT00368251|54674745|FG001|Overall Study|AE, non-serious non-fatal|0|||
28015698|NCT00368251|54674746|FG002|Overall Study|AE, non-serious non-fatal|1|||
28015699|NCT00378079|54674757|FG000|Overall Study|Lost to Follow-up|6|||
28015700|NCT00378079|54674758|FG001|Overall Study|Lost to Follow-up|1|||
28015701|NCT00378079|54674759|FG002|Overall Study|Lost to Follow-up|0|||
28015702|NCT03936244|54674769|FG000|Overall Study|Lost to Follow-up|5|||
28015703|NCT03936244|54674770|FG001|Overall Study|Lost to Follow-up|1|||
28015704|NCT03936244|54674769|FG000|Overall Study|Physician Decision|7|||
28015705|NCT03936244|54674770|FG001|Overall Study|Physician Decision|3|||
28015706|NCT03923530|54674777|FG000|Overall Study|Withdrawal by Subject|1|||
28015707|NCT03923530|54674777|FG000|Overall Study|screen failure|3|||
28015708|NCT00608907|54674784|FG000|Overall Study|Adverse Event|6|||
28015709|NCT00608907|54674785|FG001|Overall Study|Adverse Event|0|||
28015710|NCT00608907|54674786|FG002|Overall Study|Adverse Event|1|||
28015711|NCT00608907|54674784|FG000|Overall Study|Death|1|||
28015712|NCT00608907|54674785|FG001|Overall Study|Death|0|||
28015713|NCT00608907|54674786|FG002|Overall Study|Death|0|||
28015714|NCT00608907|54674784|FG000|Overall Study|Withdrawal by Subject|4|||
28015715|NCT00608907|54674785|FG001|Overall Study|Withdrawal by Subject|0|||
28015716|NCT00608907|54674786|FG002|Overall Study|Withdrawal by Subject|0|||
28015717|NCT00608907|54674784|FG000|Overall Study|Progressive Disease|1|||
28015718|NCT00608907|54674785|FG001|Overall Study|Progressive Disease|0|||
28015719|NCT00608907|54674786|FG002|Overall Study|Progressive Disease|0|||
28015720|NCT00377611|54674796|FG000|Overall Study|Adverse Event|2|||
28015721|NCT00377611|54674797|FG001|Overall Study|Adverse Event|9|||
28015722|NCT00377611|54674796|FG000|Overall Study|Protocol Violation|2|||
28015723|NCT00377611|54674797|FG001|Overall Study|Protocol Violation|0|||
28015724|NCT00377611|54674796|FG000|Overall Study|Withdrawal by Subject|0|||
28015725|NCT00377611|54674797|FG001|Overall Study|Withdrawal by Subject|5|||
28015726|NCT00377611|54674796|FG000|Overall Study|Lost to Follow-up|18|||
28015727|NCT00377611|54674797|FG001|Overall Study|Lost to Follow-up|16|||
28015728|NCT00377611|54674796|FG000|Overall Study|Other|0|||
28015729|NCT00377611|54674797|FG001|Overall Study|Other|3|||
28015730|NCT00545272|54674810|FG000|Overall Study|Protocol deviation|0|||
28015731|NCT00545272|54674811|FG001|Overall Study|Protocol deviation|1|||
28015732|NCT00545272|54674812|FG002|Overall Study|Protocol deviation|0|||
28015733|NCT00545272|54674813|FG003|Overall Study|Protocol deviation|1|||
28015734|NCT00545272|54674814|FG004|Overall Study|Protocol deviation|0|||
28015735|NCT00545272|54674815|FG005|Overall Study|Protocol deviation|1|||
28015736|NCT00545272|54674810|FG000|Overall Study|Adverse Event|0|||
28015737|NCT00545272|54674811|FG001|Overall Study|Adverse Event|0|||
28015738|NCT00545272|54674812|FG002|Overall Study|Adverse Event|1|||
28015739|NCT00545272|54674813|FG003|Overall Study|Adverse Event|0|||
28015740|NCT00545272|54674814|FG004|Overall Study|Adverse Event|0|||
28015741|NCT00545272|54674815|FG005|Overall Study|Adverse Event|1|||
28015742|NCT00545272|54674810|FG000|Overall Study|Abnormal laboratory value(s)|0|||
28015743|NCT00545272|54674811|FG001|Overall Study|Abnormal laboratory value(s)|0|||
28015744|NCT00545272|54674812|FG002|Overall Study|Abnormal laboratory value(s)|0|||
28015745|NCT00545272|54674813|FG003|Overall Study|Abnormal laboratory value(s)|0|||
28015746|NCT00545272|54674814|FG004|Overall Study|Abnormal laboratory value(s)|0|||
28015747|NCT00545272|54674815|FG005|Overall Study|Abnormal laboratory value(s)|1|||
28015748|NCT00545272|54674810|FG000|Overall Study|Abnormal test procedure result(s)|0|||
28015749|NCT00545272|54674811|FG001|Overall Study|Abnormal test procedure result(s)|0|||
28015750|NCT00545272|54674812|FG002|Overall Study|Abnormal test procedure result(s)|0|||
28015751|NCT00545272|54674813|FG003|Overall Study|Abnormal test procedure result(s)|0|||
28015752|NCT00545272|54674814|FG004|Overall Study|Abnormal test procedure result(s)|1|||
28015753|NCT00545272|54674815|FG005|Overall Study|Abnormal test procedure result(s)|0|||
28015754|NCT00545272|54674810|FG000|Overall Study|Lost to Follow-up|0|||
28015755|NCT00545272|54674811|FG001|Overall Study|Lost to Follow-up|0|||
28015756|NCT00545272|54674812|FG002|Overall Study|Lost to Follow-up|0|||
28015757|NCT00545272|54674813|FG003|Overall Study|Lost to Follow-up|0|||
28015758|NCT00545272|54674814|FG004|Overall Study|Lost to Follow-up|1|||
28015759|NCT00545272|54674815|FG005|Overall Study|Lost to Follow-up|0|||
28015760|NCT00377455|54674829|FG000|Overall Study|Withdrawal by Subject|1|||
28015761|NCT00377299|54674835|FG000|Overall Study|Lost to Follow-up|14|||
28015762|NCT00377299|54674836|FG001|Overall Study|Lost to Follow-up|19|||
28015763|NCT00377299|54674835|FG000|Overall Study|Adverse Event|0|||
28015764|NCT00377299|54674836|FG001|Overall Study|Adverse Event|1|||
28015765|NCT00377299|54674835|FG000|Overall Study|Withdrawal by Subject|5|||
28015766|NCT00377299|54674836|FG001|Overall Study|Withdrawal by Subject|4|||
28015767|NCT00376675|54674845|FG000|Overall Study|Withdrawal by Subject|9|||
28015768|NCT00376675|54674846|FG001|Overall Study|Withdrawal by Subject|2|||
28015769|NCT00376675|54674845|FG000|Overall Study|Adverse Event|10|||
28015770|NCT00376675|54674846|FG001|Overall Study|Adverse Event|5|||
28015771|NCT00376675|54674845|FG000|Overall Study|Other Reason|1|||
28015772|NCT00376675|54674846|FG001|Overall Study|Other Reason|7|||
28015773|NCT03931330|54674852|FG000|Overall Study|Physician Decision|1|||
28015774|NCT00367237|54674859|FG000|Overall Study|Adverse Event|7|||
28015775|NCT00367237|54674860|FG001|Overall Study|Adverse Event|2|||
28015776|NCT00367237|54674859|FG000|Overall Study|Lost to Follow-up|1|||
28015777|NCT00367237|54674860|FG001|Overall Study|Lost to Follow-up|0|||
28015778|NCT00367237|54674859|FG000|Overall Study|Withdrawal by Subject|0|||
28015779|NCT00367237|54674860|FG001|Overall Study|Withdrawal by Subject|4|||
28015780|NCT00367237|54674859|FG000|Overall Study|Protocol Violation|2|||
28015781|NCT00367237|54674860|FG001|Overall Study|Protocol Violation|5|||
28015782|NCT00544882|54674868|FG000|Cycle 1: Run-in Cycle|Withdrawal by Subject|2|||
28015783|NCT00544882|54674869|FG001|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
28015784|NCT00544882|54674870|FG002|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
28015785|NCT00544882|54674868|FG000|Cycle 1: Run-in Cycle|Adverse Event|1|||
28015786|NCT00544882|54674869|FG001|Cycle 1: Run-in Cycle|Adverse Event|0|||
28015787|NCT00544882|54674870|FG002|Cycle 1: Run-in Cycle|Adverse Event|0|||
28015788|NCT00544882|54674868|FG000|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
28015789|NCT00544882|54674869|FG001|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1|||
28015790|NCT00544882|54674870|FG002|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
28015791|NCT00544882|54674868|FG000|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
28015792|NCT00544882|54674869|FG001|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
28015793|NCT00544882|54674870|FG002|Cycle 2: Randomized Treatment Cycle|Noncompliance|1|||
28015794|NCT00544882|54674868|FG000|Cycle 3: Follow-up|Noncompliance|0|||
28015795|NCT00544882|54674869|FG001|Cycle 3: Follow-up|Noncompliance|1|||
28015796|NCT00544882|54674870|FG002|Cycle 3: Follow-up|Noncompliance|0|||
28015797|NCT00544882|54674868|FG000|Cycle 3: Follow-up|Pregnancy|0|||
28015798|NCT00544882|54674869|FG001|Cycle 3: Follow-up|Pregnancy|1|||
28015799|NCT00544882|54674870|FG002|Cycle 3: Follow-up|Pregnancy|0|||
28015800|NCT00606801|54674878|FG000|Intervention|Protocol Violation|3|||
28015801|NCT00606801|54674879|FG001|Intervention|Protocol Violation|3|||
28015802|NCT00606177|54674891|FG000|Overall Study|Adverse Event|9|||
28015803|NCT00606177|54674892|FG001|Overall Study|Adverse Event|5|||
28015804|NCT00606177|54674891|FG000|Overall Study|Lack of Efficacy|3|||
28015805|NCT00606177|54674892|FG001|Overall Study|Lack of Efficacy|7|||
28015806|NCT00606177|54674891|FG000|Overall Study|Physician Decision|1|||
28015807|NCT00606177|54674892|FG001|Overall Study|Physician Decision|0|||
28015808|NCT00606177|54674891|FG000|Overall Study|Protocol Violation|1|||
28015809|NCT00606177|54674892|FG001|Overall Study|Protocol Violation|4|||
28015810|NCT00606177|54674891|FG000|Overall Study|Withdrawal by Subject|5|||
28015811|NCT00606177|54674892|FG001|Overall Study|Withdrawal by Subject|6|||
28015812|NCT00606177|54674891|FG000|Overall Study|Progression to depressive phase|6|||
28015813|NCT00606177|54674892|FG001|Overall Study|Progression to depressive phase|1|||
28015814|NCT00606177|54674891|FG000|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
28015815|NCT00606177|54674892|FG001|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
28015816|NCT00606177|54674891|FG000|Overall Study|Change of residence or other commitments|1|||
28015817|NCT00606177|54674892|FG001|Overall Study|Change of residence or other commitments|1|||
28015818|NCT00359281|54674907|FG000|Overall Study|Adverse Event|1|||
28015819|NCT00359281|54674908|FG001|Overall Study|Adverse Event|0|||
28015820|NCT00359281|54674909|FG002|Overall Study|Adverse Event|0|||
28015821|NCT00359281|54674910|FG003|Overall Study|Adverse Event|0|||
28015822|NCT00359281|54674911|FG004|Overall Study|Adverse Event|0|||
28015823|NCT00359281|54674912|FG005|Overall Study|Adverse Event|0|||
28015824|NCT00359281|54674913|FG006|Overall Study|Adverse Event|1|||
28015825|NCT00359281|54674914|FG007|Overall Study|Adverse Event|0|||
28015826|NCT00359281|54674915|FG008|Overall Study|Adverse Event|0|||
28015827|NCT00359281|54674907|FG000|Overall Study|Withdrawal by Subject|0|||
28015828|NCT00359281|54674908|FG001|Overall Study|Withdrawal by Subject|0|||
28015829|NCT00359281|54674909|FG002|Overall Study|Withdrawal by Subject|0|||
28015830|NCT00359281|54674910|FG003|Overall Study|Withdrawal by Subject|0|||
28015831|NCT00359281|54674911|FG004|Overall Study|Withdrawal by Subject|0|||
28015832|NCT00359281|54674912|FG005|Overall Study|Withdrawal by Subject|0|||
28015833|NCT00359281|54674913|FG006|Overall Study|Withdrawal by Subject|1|||
28015834|NCT00359281|54674914|FG007|Overall Study|Withdrawal by Subject|0|||
28015835|NCT00359281|54674915|FG008|Overall Study|Withdrawal by Subject|0|||
28015836|NCT00366535|54674944|FG000|First Phase: 12 Weeks|Adverse Event|1|||
28015837|NCT00366535|54674945|FG001|First Phase: 12 Weeks|Adverse Event|3|||
28015838|NCT00366535|54674944|FG000|First Phase: 12 Weeks|Withdrawal by Subject|2|||
28015839|NCT00366535|54674945|FG001|First Phase: 12 Weeks|Withdrawal by Subject|5|||
28015840|NCT00366535|54674944|FG000|Second Phase: 12 Weeks|Adverse Event|1|||
28015841|NCT00366535|54674945|FG001|Second Phase: 12 Weeks|Adverse Event|1|||
28015842|NCT00366535|54674944|FG000|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
28015843|NCT00366535|54674945|FG001|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
28015844|NCT00350545|54674959|FG000|Overall Study|Withdrawal by Subject|2|||
28015845|NCT00349921|54674967|FG000|First Spinal Injection|Physician Decision|1|||
28015846|NCT00349921|54674968|FG001|First Spinal Injection|Physician Decision|0|||
28015847|NCT00349921|54674969|FG002|First Spinal Injection|Physician Decision|0|||
28015848|NCT00349921|54674970|FG003|First Spinal Injection|Physician Decision|0|||
28015849|NCT00349921|54674967|FG000|First Spinal Injection|Adverse Event|0|||
28015850|NCT00349921|54674968|FG001|First Spinal Injection|Adverse Event|0|||
28015851|NCT00349921|54674969|FG002|First Spinal Injection|Adverse Event|1|||
28015852|NCT00349921|54674970|FG003|First Spinal Injection|Adverse Event|0|||
28015853|NCT00606021|54674981|FG000|Induction Phase|Death|73|||
28015854|NCT00606021|54674982|FG001|Induction Phase|Death|0|||
28015855|NCT00606021|54674983|FG002|Induction Phase|Death|0|||
28015856|NCT00606021|54674981|FG000|Induction Phase|Physician Decision|2|||
28015857|NCT00606021|54674982|FG001|Induction Phase|Physician Decision|0|||
28015858|NCT00606021|54674983|FG002|Induction Phase|Physician Decision|0|||
28015859|NCT00606021|54674981|FG000|Induction Phase|Withdrawal by Subject|2|||
28015860|NCT00606021|54674982|FG001|Induction Phase|Withdrawal by Subject|0|||
28015861|NCT00606021|54674983|FG002|Induction Phase|Withdrawal by Subject|0|||
28015862|NCT00606021|54674981|FG000|Induction Phase|Lost to Follow-up|10|||
28015863|NCT00606021|54674982|FG001|Induction Phase|Lost to Follow-up|0|||
28015864|NCT00606021|54674983|FG002|Induction Phase|Lost to Follow-up|0|||
28015865|NCT00606021|54674981|FG000|Maintenance Phase|Death|0|||
28015866|NCT00606021|54674982|FG001|Maintenance Phase|Death|17|||
28015867|NCT00606021|54674983|FG002|Maintenance Phase|Death|15|||
28015868|NCT00606021|54674981|FG000|Maintenance Phase|Physician Decision|0|||
28015869|NCT00606021|54674982|FG001|Maintenance Phase|Physician Decision|1|||
28015870|NCT00606021|54674983|FG002|Maintenance Phase|Physician Decision|0|||
28015871|NCT00606021|54674981|FG000|Maintenance Phase|Lost to Follow-up|0|||
28015872|NCT00606021|54674982|FG001|Maintenance Phase|Lost to Follow-up|5|||
28015873|NCT00606021|54674983|FG002|Maintenance Phase|Lost to Follow-up|2|||
28015874|NCT00337675|54674994|FG000|Overall Study|Adverse Event|10|||
28015875|NCT00337675|54674995|FG001|Overall Study|Adverse Event|9|||
28015876|NCT00337675|54674996|FG002|Overall Study|Adverse Event|19|||
28015877|NCT00337675|54674994|FG000|Overall Study|Lack of Efficacy|10|||
28015878|NCT00337675|54674995|FG001|Overall Study|Lack of Efficacy|7|||
28104113|NCT03283670|54760938|FG000|Placebo Gas|Withdrawal by Subject|2|||
28015879|NCT00337675|54674996|FG002|Overall Study|Lack of Efficacy|9|||
28015880|NCT00337675|54674994|FG000|Overall Study|Lost to Follow-up|22|||
28015881|NCT00337675|54674995|FG001|Overall Study|Lost to Follow-up|19|||
28015882|NCT00337675|54674996|FG002|Overall Study|Lost to Follow-up|17|||
28015883|NCT00337675|54674994|FG000|Overall Study|Physician Decision|9|||
28015884|NCT00337675|54674995|FG001|Overall Study|Physician Decision|17|||
28015885|NCT00337675|54674996|FG002|Overall Study|Physician Decision|14|||
28015886|NCT00337675|54674994|FG000|Overall Study|Protocol Violation|21|||
28015887|NCT00337675|54674995|FG001|Overall Study|Protocol Violation|24|||
28015888|NCT00337675|54674996|FG002|Overall Study|Protocol Violation|19|||
28015889|NCT00337675|54674994|FG000|Overall Study|Withdrawal by Subject|25|||
28015890|NCT00337675|54674995|FG001|Overall Study|Withdrawal by Subject|25|||
28015891|NCT00337675|54674996|FG002|Overall Study|Withdrawal by Subject|19|||
28015892|NCT00337675|54674994|FG000|Overall Study|Progressive Disease|0|||
28015893|NCT00337675|54674995|FG001|Overall Study|Progressive Disease|2|||
28015894|NCT00337675|54674996|FG002|Overall Study|Progressive Disease|0|||
28015895|NCT00337675|54674994|FG000|Overall Study|Trial Terminated|0|||
28015896|NCT00337675|54674995|FG001|Overall Study|Trial Terminated|0|||
28015897|NCT00337675|54674996|FG002|Overall Study|Trial Terminated|2|||
28015898|NCT00337285|54675004|FG000|Overall Study|Withdrawal by Subject|42|||
28015899|NCT00337285|54675004|FG000|Overall Study|Lost to Follow-up|41|||
28015900|NCT00337285|54675004|FG000|Overall Study|Adverse Event|28|||
28015901|NCT00337285|54675004|FG000|Overall Study|Protocol Violation|27|||
28015902|NCT00337285|54675004|FG000|Overall Study|Lack of Efficacy|11|||
28015903|NCT00337285|54675004|FG000|Overall Study|Death|1|||
28015904|NCT00337285|54675004|FG000|Overall Study|Physician Decision|1|||
28015905|NCT00337285|54675004|FG000|Overall Study|Lack of protocol compliance|7|||
28015906|NCT00605865|54675008|FG000|Overall Study|Protocol Violation|115|||
28015907|NCT00348673|54675048|FG000|Stage 1|Randomized but not Treated|0|||
28015908|NCT00348673|54675049|FG001|Stage 1|Randomized but not Treated|0|||
28015909|NCT00348673|54675050|FG002|Stage 1|Randomized but not Treated|1|||
28015910|NCT00348673|54675051|FG003|Stage 1|Randomized but not Treated|0|||
28015911|NCT00348673|54675052|FG004|Stage 1|Randomized but not Treated|0|||
28015912|NCT00348673|54675053|FG005|Stage 1|Randomized but not Treated|0|||
28015913|NCT00348673|54675054|FG006|Stage 1|Randomized but not Treated|0|||
28015914|NCT00348673|54675055|FG007|Stage 1|Randomized but not Treated|0|||
28015915|NCT00348673|54675056|FG008|Stage 1|Randomized but not Treated|0|||
28015916|NCT00337207|54675074|FG000|Overall Study|Withdrawal by Subject|3|||
28015917|NCT00604695|54675081|FG000|Overall Study|Did not receive first bolus.|0|||
28015918|NCT00604695|54675082|FG001|Overall Study|Did not receive first bolus.|4|||
28015919|NCT00348595|54675090|FG000|Overall Study|Adverse Event|5|||
28015920|NCT00348595|54675091|FG001|Overall Study|Adverse Event|8|||
28015921|NCT00337129|54675097|FG000|Overall Study|Adverse Event|4|||
28015922|NCT00337129|54675097|FG000|Overall Study|Withdrawal by Subject|1|||
28015923|NCT00337129|54675097|FG000|Overall Study|Lack of Efficacy|32|||
28015924|NCT00337129|54675097|FG000|Overall Study|Death|2|||
28015925|NCT00337129|54675097|FG000|Overall Study|not protocol specified|1|||
28015926|NCT00605085|54675103|FG000|Overall Study|Withdrawal by Subject|8|||
28015927|NCT00605085|54675104|FG001|Overall Study|Withdrawal by Subject|5|||
28015928|NCT00605085|54675103|FG000|Overall Study|Adverse Event|9|||
28015929|NCT00605085|54675104|FG001|Overall Study|Adverse Event|5|||
28015930|NCT00605085|54675103|FG000|Overall Study|Pregnancy|2|||
28015931|NCT00605085|54675104|FG001|Overall Study|Pregnancy|0|||
28015932|NCT00605085|54675103|FG000|Overall Study|Protocol Violation|3|||
28015933|NCT00605085|54675104|FG001|Overall Study|Protocol Violation|2|||
28015934|NCT00605085|54675103|FG000|Overall Study|Lost to Follow-up|10|||
28015935|NCT00605085|54675104|FG001|Overall Study|Lost to Follow-up|5|||
28015936|NCT00605085|54675103|FG000|Overall Study|administrative reasons|18|||
28015937|NCT00605085|54675104|FG001|Overall Study|administrative reasons|8|||
28015938|NCT00348283|54675112|FG000|Induction|Adverse Event|0|||
28015939|NCT00348283|54675113|FG001|Induction|Adverse Event|2|||
28015940|NCT00348283|54675112|FG000|Induction|Protocol Violation|0|||
28015941|NCT00348283|54675113|FG001|Induction|Protocol Violation|4|||
28015942|NCT00348283|54675112|FG000|Double Blind|Adverse Event|2|||
28015943|NCT00348283|54675113|FG001|Double Blind|Adverse Event|5|||
28015944|NCT00348283|54675112|FG000|Double Blind|Withdrawal by Subject|1|||
28015945|NCT00348283|54675113|FG001|Double Blind|Withdrawal by Subject|1|||
28015946|NCT00348283|54675112|FG000|Double Blind|Protocol Violation|0|||
28015947|NCT00348283|54675113|FG001|Double Blind|Protocol Violation|1|||
28015948|NCT00348283|54675112|FG000|Double Blind|Lack of Efficacy|2|||
28015949|NCT00348283|54675113|FG001|Double Blind|Lack of Efficacy|2|||
28015950|NCT00348283|54675112|FG000|Double Blind|Pregnancy|0|||
28015951|NCT00348283|54675113|FG001|Double Blind|Pregnancy|1|||
28015952|NCT00348283|54675112|FG000|Open Label|Adverse Event|0|||
28015953|NCT00348283|54675113|FG001|Open Label|Adverse Event|8|||
28015954|NCT00348283|54675112|FG000|Open Label|Withdrawal by Subject|0|||
28015955|NCT00348283|54675113|FG001|Open Label|Withdrawal by Subject|4|||
28015956|NCT00348283|54675112|FG000|Open Label|Lost to Follow-up|0|||
28015957|NCT00348283|54675113|FG001|Open Label|Lost to Follow-up|1|||
28015958|NCT00348283|54675112|FG000|Open Label|Lack of Efficacy|0|||
28015959|NCT00348283|54675113|FG001|Open Label|Lack of Efficacy|13|||
28104114|NCT03283670|54760938|FG000|25% Nitrous Oxide|Withdrawal by Subject|4|||
28104115|NCT03283670|54760938|FG000|50% Nitrous Oxide|Withdrawal by Subject|1|||
28104116|NCT01358578|54760959|FG000|Induction Period|Adverse Event|2|||
28104117|NCT01358578|54760960|FG001|Induction Period|Adverse Event|4|||
28104118|NCT01358578|54760961|FG002|Induction Period|Adverse Event|2|||
28104119|NCT01358578|54760962|FG003|Induction Period|Adverse Event|6|||
28104120|NCT01358578|54760963|FG004|Induction Period|Adverse Event|0|||
28104121|NCT01358578|54760964|FG005|Induction Period|Adverse Event|0|||
28104122|NCT01358578|54760959|FG000|Induction Period|Lack of Efficacy|0|||
28104123|NCT01358578|54760960|FG001|Induction Period|Lack of Efficacy|0|||
28104124|NCT01358578|54760961|FG002|Induction Period|Lack of Efficacy|9|||
28104125|NCT01358578|54760962|FG003|Induction Period|Lack of Efficacy|1|||
28104126|NCT01358578|54760963|FG004|Induction Period|Lack of Efficacy|0|||
28104127|NCT01358578|54760964|FG005|Induction Period|Lack of Efficacy|0|||
28104128|NCT01358578|54760959|FG000|Induction Period|Lost to Follow-up|0|||
28104129|NCT01358578|54760960|FG001|Induction Period|Lost to Follow-up|0|||
28104130|NCT01358578|54760961|FG002|Induction Period|Lost to Follow-up|1|||
28104131|NCT01358578|54760962|FG003|Induction Period|Lost to Follow-up|4|||
28104132|NCT01358578|54760963|FG004|Induction Period|Lost to Follow-up|0|||
28104133|NCT01358578|54760964|FG005|Induction Period|Lost to Follow-up|0|||
28104134|NCT01358578|54760959|FG000|Induction Period|Physician Decision|2|||
28104135|NCT01358578|54760960|FG001|Induction Period|Physician Decision|1|||
28104136|NCT01358578|54760961|FG002|Induction Period|Physician Decision|2|||
28104137|NCT01358578|54760962|FG003|Induction Period|Physician Decision|0|||
28104138|NCT01358578|54760963|FG004|Induction Period|Physician Decision|0|||
28104139|NCT01358578|54760964|FG005|Induction Period|Physician Decision|0|||
28104140|NCT01358578|54760959|FG000|Induction Period|Protocol Deviation|3|||
28104141|NCT01358578|54760960|FG001|Induction Period|Protocol Deviation|5|||
28104142|NCT01358578|54760961|FG002|Induction Period|Protocol Deviation|0|||
28104143|NCT01358578|54760962|FG003|Induction Period|Protocol Deviation|3|||
28104144|NCT01358578|54760963|FG004|Induction Period|Protocol Deviation|0|||
28104145|NCT01358578|54760964|FG005|Induction Period|Protocol Deviation|0|||
28104146|NCT01358578|54760959|FG000|Induction Period|technical problems|0|||
28104147|NCT01358578|54760960|FG001|Induction Period|technical problems|0|||
28104148|NCT01358578|54760961|FG002|Induction Period|technical problems|1|||
28104149|NCT01358578|54760962|FG003|Induction Period|technical problems|1|||
28104150|NCT01358578|54760963|FG004|Induction Period|technical problems|0|||
28104151|NCT01358578|54760964|FG005|Induction Period|technical problems|0|||
28104152|NCT01358578|54760959|FG000|Induction Period|Withdrawal by Subject|5|||
28104153|NCT01358578|54760960|FG001|Induction Period|Withdrawal by Subject|5|||
28104154|NCT01358578|54760961|FG002|Induction Period|Withdrawal by Subject|10|||
28104155|NCT01358578|54760962|FG003|Induction Period|Withdrawal by Subject|6|||
28104156|NCT01358578|54760963|FG004|Induction Period|Withdrawal by Subject|0|||
28104157|NCT01358578|54760964|FG005|Induction Period|Withdrawal by Subject|0|||
28104158|NCT01358578|54760959|FG000|Maintenance Period|Adverse Event|2|||
28104159|NCT01358578|54760960|FG001|Maintenance Period|Adverse Event|7|||
28104160|NCT01358578|54760961|FG002|Maintenance Period|Adverse Event|0|||
28104161|NCT01358578|54760962|FG003|Maintenance Period|Adverse Event|6|||
28104162|NCT01358578|54760963|FG004|Maintenance Period|Adverse Event|4|||
28104163|NCT01358578|54760964|FG005|Maintenance Period|Adverse Event|3|||
28104164|NCT01358578|54760959|FG000|Maintenance Period|Lack of Efficacy|10|||
28015960|NCT00348283|54675112|FG000|Open Label|Administrative reasons|0|||
28015961|NCT00348283|54675113|FG001|Open Label|Administrative reasons|5|||
28015962|NCT00348283|54675112|FG000|Open Label|Subject moved to the United States|0|||
28015963|NCT00348283|54675113|FG001|Open Label|Subject moved to the United States|1|||
28015964|NCT00348283|54675112|FG000|Open Label|Pregnancy|0|||
28015965|NCT00348283|54675113|FG001|Open Label|Pregnancy|1|||
28015966|NCT00348283|54675112|FG000|Open Label|Sponsor decision|0|||
28015967|NCT00348283|54675113|FG001|Open Label|Sponsor decision|1|||
28015968|NCT00336895|54675119|FG000|Overall Study|diarrhea|1|||
28015969|NCT00336895|54675119|FG000|Overall Study|nausea and upset stomach|1|||
28015970|NCT00336895|54675119|FG000|Overall Study|Physician Decision|1|||
28015971|NCT00336895|54675119|FG000|Overall Study|screen failed|1|||
28015972|NCT00336583|54675123|FG000|Overall Study|Lost to Follow-up|1|||
28015973|NCT00336583|54675123|FG000|Overall Study|Death|1|||
28015974|NCT00336505|54675129|FG000|Overall Study|Adverse Event|10|||
28015975|NCT00336505|54675130|FG001|Overall Study|Adverse Event|9|||
28015976|NCT00336505|54675129|FG000|Overall Study|Lack of Efficacy|8|||
28015977|NCT00336505|54675130|FG001|Overall Study|Lack of Efficacy|4|||
28015978|NCT00336505|54675129|FG000|Overall Study|Lost to Follow-up|7|||
28015979|NCT00336505|54675130|FG001|Overall Study|Lost to Follow-up|4|||
28015980|NCT00336505|54675129|FG000|Overall Study|Withdrawal by Subject|5|||
28015981|NCT00336505|54675130|FG001|Overall Study|Withdrawal by Subject|3|||
28015982|NCT00336505|54675129|FG000|Overall Study|Other|7|||
28015983|NCT00336505|54675130|FG001|Overall Study|Other|7|||
28015984|NCT00357877|54675138|FG000|Overall Study|Death|2|||
28015985|NCT00357877|54675139|FG001|Overall Study|Death|1|||
28104165|NCT01358578|54760960|FG001|Maintenance Period|Lack of Efficacy|2|||
28104166|NCT01358578|54760961|FG002|Maintenance Period|Lack of Efficacy|0|||
28104167|NCT01358578|54760962|FG003|Maintenance Period|Lack of Efficacy|11|||
28104168|NCT01358578|54760963|FG004|Maintenance Period|Lack of Efficacy|3|||
28104169|NCT01358578|54760964|FG005|Maintenance Period|Lack of Efficacy|0|||
28104170|NCT01358578|54760959|FG000|Maintenance Period|Lost to Follow-up|4|||
28104171|NCT01358578|54760960|FG001|Maintenance Period|Lost to Follow-up|0|||
28104172|NCT01358578|54760961|FG002|Maintenance Period|Lost to Follow-up|0|||
28104173|NCT01358578|54760962|FG003|Maintenance Period|Lost to Follow-up|5|||
28104174|NCT01358578|54760963|FG004|Maintenance Period|Lost to Follow-up|1|||
28104175|NCT01358578|54760964|FG005|Maintenance Period|Lost to Follow-up|1|||
28104176|NCT01358578|54760959|FG000|Maintenance Period|Non-compliance with study treatment|3|||
28104177|NCT01358578|54760960|FG001|Maintenance Period|Non-compliance with study treatment|1|||
28104178|NCT01358578|54760961|FG002|Maintenance Period|Non-compliance with study treatment|0|||
28104179|NCT01358578|54760962|FG003|Maintenance Period|Non-compliance with study treatment|2|||
28104180|NCT01358578|54760963|FG004|Maintenance Period|Non-compliance with study treatment|1|||
28104181|NCT01358578|54760964|FG005|Maintenance Period|Non-compliance with study treatment|2|||
28104182|NCT01358578|54760959|FG000|Maintenance Period|Physician Decision|0|||
28104183|NCT01358578|54760960|FG001|Maintenance Period|Physician Decision|1|||
28104184|NCT01358578|54760961|FG002|Maintenance Period|Physician Decision|0|||
28104185|NCT01358578|54760962|FG003|Maintenance Period|Physician Decision|1|||
28104186|NCT01358578|54760963|FG004|Maintenance Period|Physician Decision|0|||
28104187|NCT01358578|54760964|FG005|Maintenance Period|Physician Decision|0|||
28104188|NCT01358578|54760959|FG000|Maintenance Period|Pregnancy|1|||
28104189|NCT01358578|54760960|FG001|Maintenance Period|Pregnancy|0|||
28104190|NCT01358578|54760961|FG002|Maintenance Period|Pregnancy|0|||
28104191|NCT01358578|54760962|FG003|Maintenance Period|Pregnancy|0|||
28104192|NCT01358578|54760963|FG004|Maintenance Period|Pregnancy|0|||
28104193|NCT01358578|54760964|FG005|Maintenance Period|Pregnancy|0|||
28104194|NCT01358578|54760959|FG000|Maintenance Period|Protocol deviation|7|||
28104195|NCT01358578|54760960|FG001|Maintenance Period|Protocol deviation|4|||
28104196|NCT01358578|54760961|FG002|Maintenance Period|Protocol deviation|0|||
28104197|NCT01358578|54760962|FG003|Maintenance Period|Protocol deviation|2|||
28104198|NCT01358578|54760963|FG004|Maintenance Period|Protocol deviation|2|||
28104199|NCT01358578|54760964|FG005|Maintenance Period|Protocol deviation|2|||
28104200|NCT01358578|54760959|FG000|Maintenance Period|Withdrawal by Subject|12|||
28104201|NCT01358578|54760960|FG001|Maintenance Period|Withdrawal by Subject|7|||
28104202|NCT01358578|54760961|FG002|Maintenance Period|Withdrawal by Subject|2|||
28104203|NCT01358578|54760962|FG003|Maintenance Period|Withdrawal by Subject|15|||
28104204|NCT01358578|54760963|FG004|Maintenance Period|Withdrawal by Subject|6|||
28104205|NCT01358578|54760964|FG005|Maintenance Period|Withdrawal by Subject|3|||
28104206|NCT01358578|54760959|FG000|Follow-up Period|Adverse Event|1|||
28104207|NCT01358578|54760960|FG001|Follow-up Period|Adverse Event|1|||
28104208|NCT01358578|54760961|FG002|Follow-up Period|Adverse Event|0|||
28104209|NCT01358578|54760962|FG003|Follow-up Period|Adverse Event|0|||
28104210|NCT01358578|54760963|FG004|Follow-up Period|Adverse Event|0|||
28104211|NCT01358578|54760964|FG005|Follow-up Period|Adverse Event|0|||
28104212|NCT01358578|54760959|FG000|Follow-up Period|Lack of Efficacy|3|||
28104213|NCT01358578|54760960|FG001|Follow-up Period|Lack of Efficacy|0|||
28104214|NCT01358578|54760961|FG002|Follow-up Period|Lack of Efficacy|4|||
28104215|NCT01358578|54760962|FG003|Follow-up Period|Lack of Efficacy|1|||
28104216|NCT01358578|54760963|FG004|Follow-up Period|Lack of Efficacy|0|||
28104217|NCT01358578|54760964|FG005|Follow-up Period|Lack of Efficacy|0|||
28104218|NCT01358578|54760959|FG000|Follow-up Period|Lost to Follow-up|0|||
28104219|NCT01358578|54760960|FG001|Follow-up Period|Lost to Follow-up|1|||
28104220|NCT01358578|54760961|FG002|Follow-up Period|Lost to Follow-up|0|||
28104221|NCT01358578|54760962|FG003|Follow-up Period|Lost to Follow-up|4|||
28104222|NCT01358578|54760963|FG004|Follow-up Period|Lost to Follow-up|0|||
28104223|NCT01358578|54760964|FG005|Follow-up Period|Lost to Follow-up|0|||
28104224|NCT01358578|54760959|FG000|Follow-up Period|non- compliance with study treatment|1|||
28104225|NCT01358578|54760960|FG001|Follow-up Period|non- compliance with study treatment|0|||
28104226|NCT01358578|54760961|FG002|Follow-up Period|non- compliance with study treatment|0|||
28104227|NCT01358578|54760962|FG003|Follow-up Period|non- compliance with study treatment|0|||
28104228|NCT01358578|54760963|FG004|Follow-up Period|non- compliance with study treatment|0|||
28104229|NCT01358578|54760964|FG005|Follow-up Period|non- compliance with study treatment|0|||
28104230|NCT01358578|54760959|FG000|Follow-up Period|Pregnancy|1|||
28104231|NCT01358578|54760960|FG001|Follow-up Period|Pregnancy|0|||
28104232|NCT01358578|54760961|FG002|Follow-up Period|Pregnancy|0|||
28104233|NCT01358578|54760962|FG003|Follow-up Period|Pregnancy|0|||
28104234|NCT01358578|54760963|FG004|Follow-up Period|Pregnancy|0|||
28104235|NCT01358578|54760964|FG005|Follow-up Period|Pregnancy|0|||
28104236|NCT01358578|54760959|FG000|Follow-up Period|Withdrawal by Subject|3|||
28104237|NCT01358578|54760960|FG001|Follow-up Period|Withdrawal by Subject|3|||
28104238|NCT01358578|54760961|FG002|Follow-up Period|Withdrawal by Subject|1|||
28104239|NCT01358578|54760962|FG003|Follow-up Period|Withdrawal by Subject|12|||
28104240|NCT01358578|54760963|FG004|Follow-up Period|Withdrawal by Subject|0|||
28104241|NCT01358578|54760964|FG005|Follow-up Period|Withdrawal by Subject|0|||
28104242|NCT01358578|54760959|FG000|Follow-up Period|Physician Decision|1|||
28104243|NCT01358578|54760960|FG001|Follow-up Period|Physician Decision|1|||
28104244|NCT01358578|54760961|FG002|Follow-up Period|Physician Decision|0|||
28104245|NCT01358578|54760962|FG003|Follow-up Period|Physician Decision|2|||
28104246|NCT01358578|54760963|FG004|Follow-up Period|Physician Decision|0|||
28104247|NCT01358578|54760964|FG005|Follow-up Period|Physician Decision|0|||
28104248|NCT02833948|54760994|FG000|Overall Study|Death|2|||
28104249|NCT02833948|54760995|FG001|Overall Study|Death|3|||
28104250|NCT02833948|54760994|FG000|Overall Study|were not scanned|8|||
28104251|NCT02833948|54760995|FG001|Overall Study|were not scanned|13|||
28104252|NCT02833948|54760994|FG000|Overall Study|scans could not be evaluated|5|||
28104253|NCT02833948|54760995|FG001|Overall Study|scans could not be evaluated|2|||
28104254|NCT02828020|54761008|FG000|Treatment Period|Adverse Event|3|||
28104255|NCT02828020|54761009|FG001|Treatment Period|Adverse Event|1|||
28104256|NCT02828020|54761010|FG002|Treatment Period|Adverse Event|1|||
28104257|NCT02828020|54761008|FG000|Treatment Period|Withdrawal of Consent|10|||
28104258|NCT02828020|54761009|FG001|Treatment Period|Withdrawal of Consent|14|||
28104259|NCT02828020|54761010|FG002|Treatment Period|Withdrawal of Consent|9|||
28104260|NCT02828020|54761008|FG000|Treatment Period|Lost to Follow-up|21|||
28104261|NCT02828020|54761009|FG001|Treatment Period|Lost to Follow-up|24|||
28104262|NCT02828020|54761010|FG002|Treatment Period|Lost to Follow-up|18|||
28104263|NCT02828020|54761008|FG000|Treatment Period|Lack of Qualifying Event|44|||
28104264|NCT02828020|54761009|FG001|Treatment Period|Lack of Qualifying Event|53|||
28104265|NCT02828020|54761010|FG002|Treatment Period|Lack of Qualifying Event|43|||
28104266|NCT02828020|54761008|FG000|Treatment Period|Pregnancy|0|||
28104267|NCT02828020|54761009|FG001|Treatment Period|Pregnancy|2|||
28104268|NCT02828020|54761010|FG002|Treatment Period|Pregnancy|0|||
28104269|NCT02828020|54761008|FG000|Treatment Period|Protocol Violation|2|||
28104270|NCT02828020|54761009|FG001|Treatment Period|Protocol Violation|4|||
28104271|NCT02828020|54761010|FG002|Treatment Period|Protocol Violation|7|||
28104272|NCT02828020|54761008|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
28104273|NCT02828020|54761009|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
28104274|NCT02828020|54761010|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
28104275|NCT02828020|54761008|FG000|Safety Follow-up Period|Withdrawal of Consent|10|||
28104276|NCT02828020|54761009|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
28104277|NCT02828020|54761010|FG002|Safety Follow-up Period|Withdrawal of Consent|7|||
28104278|NCT02828020|54761008|FG000|Safety Follow-up Period|Lost to Follow-up|9|||
28104279|NCT02828020|54761009|FG001|Safety Follow-up Period|Lost to Follow-up|8|||
28104280|NCT02828020|54761010|FG002|Safety Follow-up Period|Lost to Follow-up|11|||
28104281|NCT02828020|54761008|FG000|Safety Follow-up Period|Protocol Violation|0|||
28104282|NCT02828020|54761009|FG001|Safety Follow-up Period|Protocol Violation|2|||
28104283|NCT02828020|54761010|FG002|Safety Follow-up Period|Protocol Violation|1|||
28104284|NCT02828020|54761008|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|1|||
28104285|NCT02828020|54761009|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
28104286|NCT02828020|54761010|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
28104287|NCT02827708|54761029|FG000|Overall Study|Lost to Follow-up|3|||
28104288|NCT02827708|54761030|FG001|Overall Study|Lost to Follow-up|1|||
28104289|NCT02827708|54761029|FG000|Overall Study|Withdrawal by Subject|1|||
28104290|NCT02827708|54761030|FG001|Overall Study|Withdrawal by Subject|2|||
28104291|NCT02827708|54761029|FG000|Overall Study|Death|1|||
28104292|NCT02827708|54761030|FG001|Overall Study|Death|2|||
28104293|NCT03760185|54761036|FG000|Overall Study|Lost to Follow-up|1|||
28104294|NCT03760185|54761037|FG001|Overall Study|Lost to Follow-up|1|||
28104295|NCT02891174|54761047|FG000|First Intervention (24 Hours)|Declined any study medication|1|||
28104296|NCT02891174|54761048|FG001|First Intervention (24 Hours)|Declined any study medication|5|||
28104297|NCT02891174|54761047|FG000|First Intervention (24 Hours)|Discharged prior to cross-over|0|||
28104298|NCT02891174|54761048|FG001|First Intervention (24 Hours)|Discharged prior to cross-over|2|||
28104299|NCT02891174|54761047|FG000|First Intervention (24 Hours)|Withdrew after receiving study drug|2|||
28104300|NCT02891174|54761048|FG001|First Intervention (24 Hours)|Withdrew after receiving study drug|6|||
28104301|NCT02891174|54761047|FG000|Second Intervention (24 Hours)|No blood pressure after cross-over|1|||
28104302|NCT02891174|54761048|FG001|Second Intervention (24 Hours)|No blood pressure after cross-over|0|||
28104303|NCT02891174|54761047|FG000|Second Intervention (24 Hours)|Discharged during second intervention|3|||
28104304|NCT02891174|54761048|FG001|Second Intervention (24 Hours)|Discharged during second intervention|5|||
28104305|NCT02891174|54761047|FG000|Second Intervention (24 Hours)|Withdrew after receiving study drug|2|||
28104306|NCT02891174|54761048|FG001|Second Intervention (24 Hours)|Withdrew after receiving study drug|1|||
28104307|NCT02891174|54761047|FG000|Second Intervention (24 Hours)|Protocol Violation|0|||
28104308|NCT02891174|54761048|FG001|Second Intervention (24 Hours)|Protocol Violation|1|||
28104309|NCT01751984|54761069|FG000|Overall Study|Adverse Event|5|||
28104310|NCT01751984|54761070|FG001|Overall Study|Adverse Event|3|||
28104311|NCT01751984|54761069|FG000|Overall Study|Withdrawal by Subject|0|||
28104312|NCT01751984|54761070|FG001|Overall Study|Withdrawal by Subject|1|||
28104313|NCT01751984|54761069|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
28104314|NCT01751984|54761070|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
28104315|NCT03330236|54761078|FG000|Overall Study|Death|2|||
28104316|NCT03330236|54761079|FG001|Overall Study|Death|1|||
28104317|NCT03330236|54761078|FG000|Overall Study|Withdrawal by Subject|2|||
28104318|NCT03330236|54761079|FG001|Overall Study|Withdrawal by Subject|4|||
28104319|NCT03330236|54761078|FG000|Overall Study|Lost to Follow-up|0|||
28104320|NCT03330236|54761079|FG001|Overall Study|Lost to Follow-up|2|||
28104321|NCT03330236|54761078|FG000|Overall Study|Physician Decision|2|||
28104322|NCT03330236|54761079|FG001|Overall Study|Physician Decision|0|||
28104323|NCT03330236|54761078|FG000|Overall Study|Protocol Violation|4|||
28104324|NCT03330236|54761079|FG001|Overall Study|Protocol Violation|3|||
28104325|NCT03330236|54761078|FG000|Overall Study|SedLine malfunction/blinding|19|||
28104326|NCT03330236|54761079|FG001|Overall Study|SedLine malfunction/blinding|14|||
28104327|NCT03330236|54761078|FG000|Overall Study|Volatile anesthetics used|11|||
28104328|NCT03330236|54761079|FG001|Overall Study|Volatile anesthetics used|8|||
28104329|NCT03330236|54761078|FG000|Overall Study|Surgery aborted/converted to open|60|||
28104330|NCT03330236|54761079|FG001|Overall Study|Surgery aborted/converted to open|52|||
28104331|NCT02831764|54761087|FG000|Overall Study|Protocol specific withdrawal criteria|0|||
28104332|NCT02831764|54761088|FG001|Overall Study|Protocol specific withdrawal criteria|2|||
28104333|NCT02831764|54761087|FG000|Overall Study|Withdrawal by Subject|7|||
28104334|NCT02831764|54761088|FG001|Overall Study|Withdrawal by Subject|6|||
28104335|NCT02831764|54761087|FG000|Overall Study|Physician Decision|2|||
28104336|NCT02831764|54761088|FG001|Overall Study|Physician Decision|2|||
28104337|NCT02831764|54761087|FG000|Overall Study|Lost to Follow-up|6|||
28104338|NCT02831764|54761088|FG001|Overall Study|Lost to Follow-up|5|||
28104339|NCT02831764|54761087|FG000|Overall Study|Adverse Event|8|||
28104340|NCT02831764|54761088|FG001|Overall Study|Adverse Event|5|||
28104341|NCT02831764|54761087|FG000|Overall Study|Lack of Efficacy|2|||
28104342|NCT02831764|54761088|FG001|Overall Study|Lack of Efficacy|2|||
28104343|NCT02831764|54761087|FG000|Overall Study|Protocol Violation|5|||
28104344|NCT02831764|54761088|FG001|Overall Study|Protocol Violation|2|||
28104345|NCT02831764|54761087|FG000|Overall Study|Ongoing at the time of the analysis|330|||
28104346|NCT02831764|54761088|FG001|Overall Study|Ongoing at the time of the analysis|335|||
28104347|NCT03330002|54761094|FG000|Overall Study|Lost to Follow-up|15|||
28104348|NCT03330002|54761094|FG000|Overall Study|Death|7|||
28104349|NCT02948582|54761098|FG000|Washout Period 1|Adverse Event|0|||
28104350|NCT02948582|54761099|FG001|Washout Period 1|Adverse Event|2|||
28104351|NCT02948582|54761100|FG002|Washout Period 1|Adverse Event|0|||
28104352|NCT02948582|54761101|FG003|Washout Period 1|Adverse Event|0|||
28104353|NCT02948582|54761102|FG004|Washout Period 1|Adverse Event|0|||
28104354|NCT02948582|54761103|FG005|Washout Period 1|Adverse Event|0|||
28104355|NCT02948582|54761098|FG000|Washout Period 1|Protocol Violation|0|||
28104356|NCT02948582|54761099|FG001|Washout Period 1|Protocol Violation|0|||
28104357|NCT02948582|54761100|FG002|Washout Period 1|Protocol Violation|0|||
28104358|NCT02948582|54761101|FG003|Washout Period 1|Protocol Violation|0|||
28104359|NCT02948582|54761102|FG004|Washout Period 1|Protocol Violation|0|||
28104360|NCT02948582|54761103|FG005|Washout Period 1|Protocol Violation|1|||
28104361|NCT02948582|54761098|FG000|Washout Period 2|Adverse Event|0|||
28104362|NCT02948582|54761099|FG001|Washout Period 2|Adverse Event|1|||
28104363|NCT02948582|54761100|FG002|Washout Period 2|Adverse Event|0|||
28104364|NCT02948582|54761101|FG003|Washout Period 2|Adverse Event|0|||
28104365|NCT02948582|54761102|FG004|Washout Period 2|Adverse Event|0|||
28104366|NCT02948582|54761103|FG005|Washout Period 2|Adverse Event|0|||
28104367|NCT02948582|54761098|FG000|Washout Period 2|personal reasons|0|||
28104368|NCT02948582|54761099|FG001|Washout Period 2|personal reasons|0|||
28104369|NCT02948582|54761100|FG002|Washout Period 2|personal reasons|0|||
28104370|NCT02948582|54761101|FG003|Washout Period 2|personal reasons|1|||
28104371|NCT02948582|54761102|FG004|Washout Period 2|personal reasons|0|||
28104372|NCT02948582|54761103|FG005|Washout Period 2|personal reasons|0|||
28104373|NCT02948582|54761098|FG000|Washout Period 4|Adverse Event|1|||
28104374|NCT02948582|54761099|FG001|Washout Period 4|Adverse Event|0|||
28104375|NCT02948582|54761100|FG002|Washout Period 4|Adverse Event|1|||
28104376|NCT02948582|54761101|FG003|Washout Period 4|Adverse Event|0|||
28104377|NCT02948582|54761102|FG004|Washout Period 4|Adverse Event|0|||
28104378|NCT02948582|54761103|FG005|Washout Period 4|Adverse Event|0|||
28104379|NCT03756285|54761119|FG000|Overall Study|Lost to Follow-up|0|||
28104380|NCT03756285|54761120|FG001|Overall Study|Lost to Follow-up|1|||
28104381|NCT03756285|54761119|FG000|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|0|||
28104382|NCT03756285|54761120|FG001|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|1|||
28104383|NCT03756285|54761119|FG000|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
28104384|NCT03756285|54761120|FG001|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
28104385|NCT02825992|54761146|FG000|Overall Study|Withdrawal by Subject|4|||
28104386|NCT02825992|54761146|FG000|Overall Study|Lost to Follow-up|2|||
28104387|NCT02825992|54761146|FG000|Overall Study|Procedure terminated|2|||
28104388|NCT01339000|54761158|FG000|Overall Study|study closed due to lack of drug supply|1|||
28104389|NCT01339000|54761159|FG001|Overall Study|study closed due to lack of drug supply|0|||
28104390|NCT03755661|54761170|FG000|Overall Study|Lost to Follow-up|1|||
28104391|NCT03755661|54761171|FG001|Overall Study|Lost to Follow-up|0|||
28104392|NCT03752151|54761177|FG000|Overall Study|Withdrawal by Subject|1|||
28104393|NCT03752151|54761177|FG000|Overall Study|Protocol Violation|1|||
28104394|NCT01336634|54761185|FG000|Overall Study|Study closed/terminated|5|||
28104395|NCT01336634|54761186|FG001|Overall Study|Study closed/terminated|6|||
28104396|NCT01336634|54761187|FG002|Overall Study|Study closed/terminated|6|||
28104397|NCT01336634|54761185|FG000|Overall Study|Lost to Follow-up|2|||
28104398|NCT01336634|54761186|FG001|Overall Study|Lost to Follow-up|1|||
28104399|NCT01336634|54761187|FG002|Overall Study|Lost to Follow-up|1|||
28104400|NCT01336634|54761185|FG000|Overall Study|Physician Decision|1|||
28104401|NCT01336634|54761186|FG001|Overall Study|Physician Decision|1|||
28104402|NCT01336634|54761187|FG002|Overall Study|Physician Decision|0|||
28104403|NCT01336634|54761185|FG000|Overall Study|Withdrawal by Subject|6|||
28104404|NCT01336634|54761186|FG001|Overall Study|Withdrawal by Subject|0|||
28104405|NCT01336634|54761187|FG002|Overall Study|Withdrawal by Subject|2|||
28104406|NCT02947100|54761202|FG000|Overall Study|study terminated early|3|||
28104407|NCT02947100|54761202|FG000|Overall Study|did not meet inclusion criteria|1|||
28104408|NCT03329846|54761208|FG000|Overall Study|Disease progression|4|||
28104409|NCT03329846|54761209|FG001|Overall Study|Disease progression|6|||
28104410|NCT03329846|54761208|FG000|Overall Study|Study drug toxicity|1|||
28104411|NCT03329846|54761209|FG001|Overall Study|Study drug toxicity|0|||
28104412|NCT03329846|54761208|FG000|Overall Study|Participant request to discontinue treatment|0|||
28104413|NCT03329846|54761209|FG001|Overall Study|Participant request to discontinue treatment|1|||
28104414|NCT03329846|54761208|FG000|Overall Study|Participant withdrew consent|1|||
28104415|NCT03329846|54761209|FG001|Overall Study|Participant withdrew consent|0|||
28104416|NCT03329846|54761208|FG000|Overall Study|Other reasons|2|||
28104417|NCT03329846|54761209|FG001|Overall Study|Other reasons|2|||
28104418|NCT03325010|54761217|FG000|Overall Study|Adverse Event|3|||
28104419|NCT03325010|54761218|FG001|Overall Study|Adverse Event|8|||
28104420|NCT03325010|54761217|FG000|Overall Study|Protocol Violation|1|||
28104421|NCT03325010|54761218|FG001|Overall Study|Protocol Violation|8|||
28104422|NCT03325010|54761217|FG000|Overall Study|Withdrawal by Subject|1|||
28104423|NCT03325010|54761218|FG001|Overall Study|Withdrawal by Subject|3|||
28104424|NCT03325010|54761217|FG000|Overall Study|Lost to Follow-up|1|||
28104425|NCT03325010|54761218|FG001|Overall Study|Lost to Follow-up|0|||
28104426|NCT03325010|54761217|FG000|Overall Study|Physician Decision|1|||
28104427|NCT03325010|54761218|FG001|Overall Study|Physician Decision|1|||
28104428|NCT03325010|54761217|FG000|Overall Study|Lack of Efficacy|2|||
28104429|NCT03325010|54761218|FG001|Overall Study|Lack of Efficacy|0|||
28104430|NCT02824432|54761226|FG000|Overall Study|Major Protocol Deviation|1|||
28104431|NCT02824432|54761227|FG001|Overall Study|Major Protocol Deviation|0|||
27746916|NCT02596893|54196632|FG001|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
27746917|NCT02596893|54196633|FG002|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1|||
27746918|NCT02596893|54196634|FG003|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2|||
28104432|NCT02823964|54761233|FG000|Overall Study|Adverse Event|2|||
28104433|NCT02823964|54761233|FG000|Overall Study|Physician Decision|1|||
28104434|NCT02823964|54761233|FG000|Overall Study|Lack of Efficacy|1|||
28104435|NCT02823964|54761233|FG000|Overall Study|Withdrawal by Subject|1|||
28104436|NCT01338610|54761240|FG000|Overall Study|Patient Decision Unrelated to Advs Event|1|||
28104437|NCT01338610|54761241|FG001|Overall Study|Patient Decision Unrelated to Advs Event|1|||
28104438|NCT01338610|54761242|FG002|Overall Study|Patient Decision Unrelated to Advs Event|0|||
28104439|NCT01338610|54761240|FG000|Overall Study|Protocol Violation|1|||
28104440|NCT01338610|54761241|FG001|Overall Study|Protocol Violation|0|||
28104441|NCT01338610|54761242|FG002|Overall Study|Protocol Violation|1|||
28104442|NCT01338610|54761240|FG000|Overall Study|Adverse Event|3|||
28104443|NCT01338610|54761241|FG001|Overall Study|Adverse Event|0|||
28104444|NCT01338610|54761242|FG002|Overall Study|Adverse Event|0|||
28104445|NCT01355302|54761249|FG000|Phase 1b|Death|4|||
28104446|NCT01355302|54761250|FG001|Phase 1b|Death|0|||
28104447|NCT01355302|54761251|FG002|Phase 1b|Death|0|||
28104448|NCT01355302|54761249|FG000|Phase 1b|Study terminated by sponsor|2|||
28104449|NCT01355302|54761250|FG001|Phase 1b|Study terminated by sponsor|0|||
28104450|NCT01355302|54761251|FG002|Phase 1b|Study terminated by sponsor|0|||
28104451|NCT01355068|54761259|FG000|First Intervention Period|Adverse Event|0|||
28104452|NCT01355068|54761260|FG001|First Intervention Period|Adverse Event|1|||
28104453|NCT01355068|54761259|FG000|First Intervention Period|Withdrawal by Subject|0|||
28104454|NCT01355068|54761260|FG001|First Intervention Period|Withdrawal by Subject|1|||
28104455|NCT03756129|54761272|FG000|Overall Study|Adverse Event|1|||
28104456|NCT03756129|54761273|FG001|Overall Study|Adverse Event|1|||
28104457|NCT03756129|54761274|FG002|Overall Study|Adverse Event|0|||
28104458|NCT03756129|54761275|FG003|Overall Study|Adverse Event|2|||
28104459|NCT03756129|54761276|FG004|Overall Study|Adverse Event|0|||
28104460|NCT03756129|54761277|FG005|Overall Study|Adverse Event|0|||
28104461|NCT03756129|54761272|FG000|Overall Study|Withdrawal by Subject|2|||
28104462|NCT03756129|54761273|FG001|Overall Study|Withdrawal by Subject|1|||
28104463|NCT03756129|54761274|FG002|Overall Study|Withdrawal by Subject|3|||
28104464|NCT03756129|54761275|FG003|Overall Study|Withdrawal by Subject|1|||
28104465|NCT03756129|54761276|FG004|Overall Study|Withdrawal by Subject|1|||
28104466|NCT03756129|54761277|FG005|Overall Study|Withdrawal by Subject|3|||
28104467|NCT03756129|54761272|FG000|Overall Study|Lost to Follow-up|0|||
28104468|NCT03756129|54761273|FG001|Overall Study|Lost to Follow-up|0|||
28104469|NCT03756129|54761274|FG002|Overall Study|Lost to Follow-up|0|||
28104470|NCT03756129|54761275|FG003|Overall Study|Lost to Follow-up|0|||
28104471|NCT03756129|54761276|FG004|Overall Study|Lost to Follow-up|0|||
28104472|NCT03756129|54761277|FG005|Overall Study|Lost to Follow-up|1|||
28104473|NCT03756129|54761272|FG000|Overall Study|Physician Decision|0|||
28104474|NCT03756129|54761273|FG001|Overall Study|Physician Decision|0|||
28104475|NCT03756129|54761274|FG002|Overall Study|Physician Decision|0|||
28104476|NCT03756129|54761275|FG003|Overall Study|Physician Decision|0|||
28104477|NCT03756129|54761276|FG004|Overall Study|Physician Decision|0|||
28104478|NCT03756129|54761277|FG005|Overall Study|Physician Decision|1|||
28104479|NCT02822794|54761303|FG000|Overall Study|Withdrew Consent|1|||
28104480|NCT02822794|54761304|FG001|Overall Study|Withdrew Consent|0|||
28104481|NCT01338298|54761319|FG000|Overall Study|Withdrawal by Subject|1|||
28104482|NCT01338298|54761320|FG001|Overall Study|Withdrawal by Subject|1|||
28104483|NCT01338298|54761319|FG000|Overall Study|Abdominal Pain and scheduled surgery|0|||
28104484|NCT01338298|54761320|FG001|Overall Study|Abdominal Pain and scheduled surgery|1|||
28104485|NCT01338298|54761319|FG000|Overall Study|Administrative error|0|||
28104486|NCT01338298|54761320|FG001|Overall Study|Administrative error|1|||
28104487|NCT01338298|54761319|FG000|Overall Study|Positive symptom worsening|1|||
28104488|NCT01338298|54761320|FG001|Overall Study|Positive symptom worsening|0|||
28104489|NCT01338298|54761319|FG000|Overall Study|Depressive symptoms and nausea|1|||
28104490|NCT01338298|54761320|FG001|Overall Study|Depressive symptoms and nausea|0|||
28104491|NCT01338298|54761319|FG000|Overall Study|Non-adherence|1|||
28104492|NCT01338298|54761320|FG001|Overall Study|Non-adherence|0|||
28104493|NCT01354132|54761328|FG000|Randomization|Physician Decision|1|||
28104494|NCT01354132|54761329|FG001|Randomization|Physician Decision|0|||
28104495|NCT01354132|54761328|FG000|Randomization|Withdrawal by Subject|0|||
28104496|NCT01354132|54761329|FG001|Randomization|Withdrawal by Subject|1|||
28104497|NCT01354132|54761328|FG000|Double Blind (Visits 1-7)|Adverse Event|1|||
28104498|NCT01354132|54761329|FG001|Double Blind (Visits 1-7)|Adverse Event|0|||
28104499|NCT01354132|54761328|FG000|Double Blind (Visits 1-7)|Withdrawal by Subject|8|||
28104500|NCT01354132|54761329|FG001|Double Blind (Visits 1-7)|Withdrawal by Subject|11|||
28104501|NCT01354132|54761328|FG000|1 Month Post Study Medication|Withdrawal by Subject|1|||
28104502|NCT01354132|54761329|FG001|1 Month Post Study Medication|Withdrawal by Subject|3|||
28104503|NCT01353898|54761344|FG000|Overall Study|Study site terminated|0|||
28104504|NCT01353898|54761345|FG001|Overall Study|Study site terminated|0|||
28104505|NCT01353898|54761346|FG002|Overall Study|Study site terminated|0|||
28104506|NCT01353898|54761347|FG003|Overall Study|Study site terminated|0|||
28104507|NCT01353898|54761348|FG004|Overall Study|Study site terminated|0|||
28104508|NCT01353898|54761349|FG005|Overall Study|Study site terminated|1|||
28104509|NCT01372150|54761366|FG000|Overall Study|Lack of Efficacy|3|||
28104510|NCT01372150|54761367|FG001|Overall Study|Lack of Efficacy|0|||
28104511|NCT01372150|54761368|FG002|Overall Study|Lack of Efficacy|1|||
28104512|NCT01372150|54761366|FG000|Overall Study|Lost to Follow-up|4|||
28104513|NCT01372150|54761367|FG001|Overall Study|Lost to Follow-up|5|||
28104514|NCT01372150|54761368|FG002|Overall Study|Lost to Follow-up|6|||
28104515|NCT01372150|54761366|FG000|Overall Study|Protocol Violation|1|||
28104516|NCT01372150|54761367|FG001|Overall Study|Protocol Violation|0|||
28104517|NCT01372150|54761368|FG002|Overall Study|Protocol Violation|3|||
28104518|NCT01372150|54761366|FG000|Overall Study|Withdrawal by Subject|2|||
28104519|NCT01372150|54761367|FG001|Overall Study|Withdrawal by Subject|7|||
28104520|NCT01372150|54761368|FG002|Overall Study|Withdrawal by Subject|2|||
28104521|NCT01372150|54761366|FG000|Overall Study|Other|1|||
28104522|NCT01372150|54761367|FG001|Overall Study|Other|0|||
28104523|NCT01372150|54761368|FG002|Overall Study|Other|2|||
28104524|NCT01372150|54761366|FG000|Overall Study|Adverse Event|2|||
28104525|NCT01372150|54761367|FG001|Overall Study|Adverse Event|1|||
28104526|NCT01372150|54761368|FG002|Overall Study|Adverse Event|2|||
28104527|NCT01372150|54761366|FG000|Overall Study|Randomized but not treated|0|||
28104528|NCT01372150|54761367|FG001|Overall Study|Randomized but not treated|1|||
28104529|NCT01372150|54761368|FG002|Overall Study|Randomized but not treated|0|||
28104530|NCT03749109|54761378|FG000|Overall Study|Adverse Event|2|||
28104531|NCT03749109|54761379|FG001|Overall Study|Adverse Event|0|||
28104532|NCT03329690|54761391|FG000|Overall Study|Progressive disease per RECIST|85|||
28104533|NCT03329690|54761392|FG001|Overall Study|Progressive disease per RECIST|44|||
28104534|NCT03329690|54761393|FG002|Overall Study|Progressive disease per RECIST|6|||
28104535|NCT03329690|54761394|FG003|Overall Study|Progressive disease per RECIST|16|||
28104536|NCT03329690|54761395|FG004|Overall Study|Progressive disease per RECIST|20|||
28104537|NCT03329690|54761391|FG000|Overall Study|Clinical progression|7|||
28104538|NCT03329690|54761392|FG001|Overall Study|Clinical progression|4|||
28104539|NCT03329690|54761393|FG002|Overall Study|Clinical progression|1|||
28104540|NCT03329690|54761394|FG003|Overall Study|Clinical progression|1|||
28104541|NCT03329690|54761395|FG004|Overall Study|Clinical progression|1|||
28104542|NCT03329690|54761391|FG000|Overall Study|Adverse Event|22|||
28104543|NCT03329690|54761392|FG001|Overall Study|Adverse Event|4|||
28104544|NCT03329690|54761393|FG002|Overall Study|Adverse Event|0|||
28104545|NCT03329690|54761394|FG003|Overall Study|Adverse Event|1|||
28104546|NCT03329690|54761395|FG004|Overall Study|Adverse Event|2|||
28104547|NCT03329690|54761391|FG000|Overall Study|Death|2|||
28104548|NCT03329690|54761392|FG001|Overall Study|Death|0|||
28104549|NCT03329690|54761393|FG002|Overall Study|Death|0|||
28104550|NCT03329690|54761394|FG003|Overall Study|Death|1|||
28104551|NCT03329690|54761395|FG004|Overall Study|Death|0|||
28104552|NCT03329690|54761391|FG000|Overall Study|Withdrawal by Subject|2|||
28104553|NCT03329690|54761392|FG001|Overall Study|Withdrawal by Subject|3|||
28104554|NCT03329690|54761393|FG002|Overall Study|Withdrawal by Subject|0|||
28104555|NCT03329690|54761394|FG003|Overall Study|Withdrawal by Subject|1|||
28104556|NCT03329690|54761395|FG004|Overall Study|Withdrawal by Subject|0|||
28104557|NCT03329690|54761391|FG000|Overall Study|Physician Decision|1|||
28104558|NCT03329690|54761392|FG001|Overall Study|Physician Decision|0|||
28104559|NCT03329690|54761393|FG002|Overall Study|Physician Decision|0|||
28104560|NCT03329690|54761394|FG003|Overall Study|Physician Decision|0|||
28104561|NCT03329690|54761395|FG004|Overall Study|Physician Decision|1|||
28104562|NCT03329690|54761391|FG000|Overall Study|Miscellaneous|6|||
28104563|NCT03329690|54761392|FG001|Overall Study|Miscellaneous|0|||
28104564|NCT03329690|54761393|FG002|Overall Study|Miscellaneous|0|||
28104565|NCT03329690|54761394|FG003|Overall Study|Miscellaneous|0|||
28104566|NCT03329690|54761395|FG004|Overall Study|Miscellaneous|0|||
28104567|NCT03329690|54761391|FG000|Overall Study|Did not receive treatment|1|||
28104568|NCT03329690|54761392|FG001|Overall Study|Did not receive treatment|0|||
28104569|NCT03329690|54761393|FG002|Overall Study|Did not receive treatment|0|||
28104570|NCT03329690|54761394|FG003|Overall Study|Did not receive treatment|1|||
28104571|NCT03329690|54761395|FG004|Overall Study|Did not receive treatment|0|||
28104572|NCT03328832|54761415|FG000|Overall Study|Lost to Follow-up|0|||
28104573|NCT03328832|54761416|FG001|Overall Study|Lost to Follow-up|1|||
28104574|NCT02820844|54761424|FG000|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1|||
28104575|NCT02820844|54761425|FG001|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3|||
28104576|NCT02820844|54761426|FG002|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
28104577|NCT02820844|54761427|FG003|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
28104578|NCT02820844|54761428|FG004|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
28104579|NCT02820844|54761429|FG005|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
28104580|NCT02820844|54761424|FG000|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1|||
28104581|NCT02820844|54761425|FG001|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2|||
28104582|NCT02820844|54761426|FG002|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
28104583|NCT02820844|54761427|FG003|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
28104584|NCT02820844|54761428|FG004|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
28104585|NCT02820844|54761429|FG005|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
28104586|NCT02820844|54761424|FG000|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
28104587|NCT02820844|54761425|FG001|Double-blinded (Up to 48 Weeks)|Protocol Violation|3|||
28104588|NCT02820844|54761426|FG002|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
28104589|NCT02820844|54761427|FG003|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
28104590|NCT02820844|54761428|FG004|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
28104591|NCT02820844|54761429|FG005|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
28104592|NCT02820844|54761424|FG000|Double-blinded (Up to 48 Weeks)|Adverse Event|2|||
28104593|NCT02820844|54761425|FG001|Double-blinded (Up to 48 Weeks)|Adverse Event|1|||
28104594|NCT02820844|54761426|FG002|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
28104595|NCT02820844|54761427|FG003|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
28104596|NCT02820844|54761428|FG004|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
28104597|NCT02820844|54761429|FG005|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
28104598|NCT02820844|54761424|FG000|Double-blinded (Up to 48 Weeks)|Investigator discretion|1|||
28104599|NCT02820844|54761425|FG001|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
28104600|NCT02820844|54761426|FG002|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
28104601|NCT02820844|54761427|FG003|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
28104602|NCT02820844|54761428|FG004|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
28104603|NCT02820844|54761429|FG005|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
28104604|NCT02820844|54761424|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
28104605|NCT02820844|54761425|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
28104606|NCT02820844|54761426|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1|||
28104607|NCT02820844|54761427|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2|||
28104608|NCT02820844|54761428|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
28104609|NCT02820844|54761429|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
28104610|NCT02820844|54761424|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
28104611|NCT02820844|54761425|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
28104612|NCT02820844|54761426|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1|||
28104613|NCT02820844|54761427|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
28104614|NCT02820844|54761428|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
28104615|NCT02820844|54761429|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
28104616|NCT02820844|54761424|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
28104617|NCT02820844|54761425|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
28104618|NCT02820844|54761426|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7|||
28104619|NCT02820844|54761427|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2|||
28104620|NCT02820844|54761428|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
28104621|NCT02820844|54761429|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
28104622|NCT02820844|54761424|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
28104623|NCT02820844|54761425|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
28104624|NCT02820844|54761426|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
28104625|NCT02820844|54761427|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
28104626|NCT02820844|54761428|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2|||
28104627|NCT02820844|54761429|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
28104628|NCT02820844|54761424|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
28104629|NCT02820844|54761425|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
28104630|NCT02820844|54761426|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
28104631|NCT02820844|54761427|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
28104632|NCT02820844|54761428|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
28104633|NCT02820844|54761429|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1|||
28104634|NCT02942576|54761448|FG000|Overall Study|Adverse Event|28|||
28104635|NCT02942576|54761449|FG001|Overall Study|Adverse Event|6|||
28104636|NCT02942576|54761448|FG000|Overall Study|Withdrawal by Subject|7|||
28104637|NCT02942576|54761449|FG001|Overall Study|Withdrawal by Subject|5|||
28104638|NCT02942576|54761448|FG000|Overall Study|Physician Decision|1|||
28104639|NCT02942576|54761449|FG001|Overall Study|Physician Decision|4|||
28104640|NCT02942576|54761448|FG000|Overall Study|Other|10|||
28104641|NCT02942576|54761449|FG001|Overall Study|Other|8|||
28104642|NCT02820298|54761457|FG000|Overall Study|Withdrawal by Subject|0|||
28104643|NCT02820298|54761458|FG001|Overall Study|Withdrawal by Subject|1|||
28104644|NCT02820298|54761457|FG000|Overall Study|Physician Decision|1|||
28104645|NCT02820298|54761458|FG001|Overall Study|Physician Decision|0|||
28104646|NCT02820298|54761457|FG000|Overall Study|Protocol Violation|0|||
28104647|NCT02820298|54761458|FG001|Overall Study|Protocol Violation|1|||
28104648|NCT02819440|54761472|FG000|Overall Study|Adverse Event|3|||
28104649|NCT02819440|54761473|FG001|Overall Study|Adverse Event|1|||
28104650|NCT02819440|54761472|FG000|Overall Study|Lost to Follow-up|1|||
28104651|NCT02819440|54761473|FG001|Overall Study|Lost to Follow-up|3|||
28104652|NCT02819440|54761472|FG000|Overall Study|Withdrawal by Subject|9|||
28104653|NCT02819440|54761473|FG001|Overall Study|Withdrawal by Subject|8|||
28104654|NCT03814720|54761484|FG000|Overall Study|Lost to Follow-up|0|||
28104655|NCT03814720|54761485|FG001|Overall Study|Lost to Follow-up|1|||
28104656|NCT03814720|54761486|FG002|Overall Study|Lost to Follow-up|0|||
28104657|NCT03814720|54761487|FG003|Overall Study|Lost to Follow-up|0|||
28104658|NCT03814720|54761488|FG004|Overall Study|Lost to Follow-up|0|||
28104659|NCT02818036|54761504|FG000|Overall Study|head did not fit in fMRI scanner headres|1|||
28104660|NCT02818036|54761505|FG001|Overall Study|head did not fit in fMRI scanner headres|0|||
28104661|NCT02818036|54761504|FG000|Overall Study|Withdrawal by Subject|1|||
28104662|NCT02818036|54761505|FG001|Overall Study|Withdrawal by Subject|0|||
28104663|NCT01287741|54761513|FG000|Overall Study|Withdrawal by Subject|35|||
28104664|NCT01287741|54761514|FG001|Overall Study|Withdrawal by Subject|38|||
28104665|NCT01287741|54761513|FG000|Overall Study|Protocol Violation|2|||
28104666|NCT01287741|54761514|FG001|Overall Study|Protocol Violation|0|||
28104667|NCT01287741|54761513|FG000|Overall Study|Physician Decision|15|||
28104668|NCT01287741|54761514|FG001|Overall Study|Physician Decision|23|||
28104669|NCT01287741|54761513|FG000|Overall Study|Non-compliance|8|||
28104670|NCT01287741|54761514|FG001|Overall Study|Non-compliance|6|||
28104671|NCT01287741|54761513|FG000|Overall Study|Lost to Follow-up|10|||
28104672|NCT01287741|54761514|FG001|Overall Study|Lost to Follow-up|8|||
28104673|NCT01287741|54761513|FG000|Overall Study|Death|32|||
28104674|NCT01287741|54761514|FG001|Overall Study|Death|44|||
28104675|NCT01287741|54761513|FG000|Overall Study|Adverse Event|4|||
28104676|NCT01287741|54761514|FG001|Overall Study|Adverse Event|6|||
28104677|NCT01287741|54761513|FG000|Overall Study|Study terminated by Sponsor|307|||
28104678|NCT01287741|54761514|FG001|Overall Study|Study terminated by Sponsor|315|||
28104679|NCT01287741|54761513|FG000|Overall Study|Progressive disease|190|||
28104680|NCT01287741|54761514|FG001|Overall Study|Progressive disease|166|||
28104681|NCT01287741|54761513|FG000|Overall Study|Reason not specified|23|||
28104682|NCT01287741|54761514|FG001|Overall Study|Reason not specified|9|||
28104683|NCT03739203|54761528|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
28104684|NCT03739203|54761529|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|9|||
28104685|NCT03739203|54761530|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|13|||
28104686|NCT03739203|54761528|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
28104687|NCT03739203|54761529|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
28104688|NCT03739203|54761530|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
28104689|NCT03739203|54761528|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
28104690|NCT03739203|54761529|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
28104691|NCT03739203|54761530|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
28104692|NCT03739203|54761528|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
28104693|NCT03739203|54761529|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
28104694|NCT03739203|54761530|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|6|||
28104695|NCT03739203|54761528|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
28104696|NCT03739203|54761529|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
28104697|NCT03739203|54761530|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
28104698|NCT03739203|54761528|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
28104699|NCT03739203|54761529|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|3|||
28104700|NCT03739203|54761530|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
28104701|NCT03739203|54761528|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
28104702|NCT03739203|54761529|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
28104703|NCT03739203|54761530|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
28104704|NCT03739203|54761528|FG000|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|1|||
28104705|NCT03739203|54761529|FG001|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|2|||
28104706|NCT03739203|54761530|FG002|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|0|||
28104707|NCT03739203|54761528|FG000|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
28104708|NCT03739203|54761529|FG001|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
28104709|NCT03739203|54761530|FG002|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|2|||
28104710|NCT03739203|54761528|FG000|Safety Follow-Up Period (4 Weeks)|Death|1|||
28104711|NCT03739203|54761529|FG001|Safety Follow-Up Period (4 Weeks)|Death|0|||
28104712|NCT03739203|54761530|FG002|Safety Follow-Up Period (4 Weeks)|Death|0|||
28104713|NCT03739203|54761528|FG000|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
28104714|NCT03739203|54761529|FG001|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
28104715|NCT03739203|54761530|FG002|Safety Follow-Up Period (4 Weeks)|Reason not Specified|2|||
28104716|NCT02942264|54761547|FG000|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
28104717|NCT02942264|54761548|FG001|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
28104718|NCT02942264|54761549|FG002|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
28104719|NCT02942264|54761550|FG003|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
28104720|NCT02942264|54761551|FG004|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
28104721|NCT02942264|54761552|FG005|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
28104722|NCT02942264|54761553|FG006|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
28104723|NCT02942264|54761554|FG007|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
28104724|NCT02942264|54761555|FG008|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
28104725|NCT02942264|54761547|FG000|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
28104726|NCT02942264|54761548|FG001|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
28104727|NCT02942264|54761549|FG002|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
28104728|NCT02942264|54761550|FG003|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
28104729|NCT02942264|54761551|FG004|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
28104730|NCT02942264|54761552|FG005|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
28104731|NCT02942264|54761553|FG006|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
28104732|NCT02942264|54761554|FG007|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
28104733|NCT02942264|54761555|FG008|Phase 1 Cohort Expansion Stage|Withdrawal of consent|1|||
28104734|NCT03322514|54761582|FG000|Overall Study|Withdrawal by Subject|1|||
28104735|NCT03322514|54761583|FG001|Overall Study|Withdrawal by Subject|1|||
28104736|NCT03325712|54761597|FG000|Overall Study|Protocol Violation|0|||
28104737|NCT03325712|54761598|FG001|Overall Study|Protocol Violation|0|||
28104738|NCT03325712|54761599|FG002|Overall Study|Protocol Violation|0|||
28104739|NCT03325712|54761600|FG003|Overall Study|Protocol Violation|0|||
28104740|NCT03325712|54761601|FG004|Overall Study|Protocol Violation|1|||
28104741|NCT03325712|54761602|FG005|Overall Study|Protocol Violation|0|||
28104742|NCT03325712|54761603|FG006|Overall Study|Protocol Violation|0|||
28104743|NCT03325712|54761604|FG007|Overall Study|Protocol Violation|0|||
28104744|NCT03325712|54761597|FG000|Overall Study|Adverse Event|0|||
28104745|NCT03325712|54761598|FG001|Overall Study|Adverse Event|0|||
28104746|NCT03325712|54761599|FG002|Overall Study|Adverse Event|0|||
28104747|NCT03325712|54761600|FG003|Overall Study|Adverse Event|0|||
28104748|NCT03325712|54761601|FG004|Overall Study|Adverse Event|1|||
28104749|NCT03325712|54761602|FG005|Overall Study|Adverse Event|0|||
28104750|NCT03325712|54761603|FG006|Overall Study|Adverse Event|0|||
28104751|NCT03325712|54761604|FG007|Overall Study|Adverse Event|0|||
28104752|NCT03734679|54761632|FG000|Overall Study|Missed Visit|1|||
28104753|NCT03325556|54761636|FG000|Open-label Period|Lack of Response in OL period|70|||
28104754|NCT03325556|54761637|FG001|Open-label Period|Lack of Response in OL period|0|||
28104755|NCT03325556|54761638|FG002|Open-label Period|Lack of Response in OL period|0|||
28104756|NCT03325556|54761636|FG000|Open-label Period|Adverse Event|27|||
28104757|NCT03325556|54761637|FG001|Open-label Period|Adverse Event|0|||
28104758|NCT03325556|54761638|FG002|Open-label Period|Adverse Event|0|||
28104759|NCT03325556|54761636|FG000|Open-label Period|Death|1|||
28104760|NCT03325556|54761637|FG001|Open-label Period|Death|0|||
28104761|NCT03325556|54761638|FG002|Open-label Period|Death|0|||
28104762|NCT03325556|54761636|FG000|Open-label Period|Lost to Follow-up|1|||
28104763|NCT03325556|54761637|FG001|Open-label Period|Lost to Follow-up|0|||
28104764|NCT03325556|54761638|FG002|Open-label Period|Lost to Follow-up|0|||
28104765|NCT03325556|54761636|FG000|Open-label Period|Non-compliance with study drug|5|||
28104766|NCT03325556|54761637|FG001|Open-label Period|Non-compliance with study drug|0|||
28104767|NCT03325556|54761638|FG002|Open-label Period|Non-compliance with study drug|0|||
28104768|NCT03325556|54761636|FG000|Open-label Period|Use of prohibited medication|1|||
28104769|NCT03325556|54761637|FG001|Open-label Period|Use of prohibited medication|0|||
28104770|NCT03325556|54761638|FG002|Open-label Period|Use of prohibited medication|0|||
28104771|NCT03325556|54761636|FG000|Open-label Period|Protocol Violation|4|||
28104772|NCT03325556|54761637|FG001|Open-label Period|Protocol Violation|0|||
28104773|NCT03325556|54761638|FG002|Open-label Period|Protocol Violation|0|||
28104774|NCT03325556|54761636|FG000|Open-label Period|Withdrawal by Subject|17|||
28104775|NCT03325556|54761637|FG001|Open-label Period|Withdrawal by Subject|0|||
28104776|NCT03325556|54761638|FG002|Open-label Period|Withdrawal by Subject|0|||
28104777|NCT03325556|54761636|FG000|Open-label Period|Not otherwise specified|8|||
28104778|NCT03325556|54761637|FG001|Open-label Period|Not otherwise specified|0|||
28104779|NCT03325556|54761638|FG002|Open-label Period|Not otherwise specified|0|||
28104780|NCT03325556|54761636|FG000|Open-label Period|Administrative discont. at study termination|41|||
28104781|NCT03325556|54761637|FG001|Open-label Period|Administrative discont. at study termination|0|||
28104782|NCT03325556|54761638|FG002|Open-label Period|Administrative discont. at study termination|0|||
28104783|NCT03325556|54761636|FG000|Double-blind Period|Relapse|0|||
28104784|NCT03325556|54761637|FG001|Double-blind Period|Relapse|15|||
28104785|NCT03325556|54761638|FG002|Double-blind Period|Relapse|34|||
28104786|NCT03325556|54761636|FG000|Double-blind Period|Adverse Event|0|||
28104787|NCT03325556|54761637|FG001|Double-blind Period|Adverse Event|3|||
28104788|NCT03325556|54761638|FG002|Double-blind Period|Adverse Event|1|||
28104789|NCT03325556|54761636|FG000|Double-blind Period|Noncompliance with study drug|0|||
28104790|NCT03325556|54761637|FG001|Double-blind Period|Noncompliance with study drug|0|||
28104791|NCT03325556|54761638|FG002|Double-blind Period|Noncompliance with study drug|1|||
28104792|NCT03325556|54761636|FG000|Double-blind Period|Use of prohibited medication|0|||
28104793|NCT03325556|54761637|FG001|Double-blind Period|Use of prohibited medication|1|||
28104794|NCT03325556|54761638|FG002|Double-blind Period|Use of prohibited medication|0|||
28104795|NCT03325556|54761636|FG000|Double-blind Period|Physician Decision|0|||
28104796|NCT03325556|54761637|FG001|Double-blind Period|Physician Decision|0|||
28104797|NCT03325556|54761638|FG002|Double-blind Period|Physician Decision|1|||
28104798|NCT03325556|54761636|FG000|Double-blind Period|Withdrawal by Subject|0|||
28104799|NCT03325556|54761637|FG001|Double-blind Period|Withdrawal by Subject|6|||
28104800|NCT03325556|54761638|FG002|Double-blind Period|Withdrawal by Subject|4|||
28104801|NCT03325556|54761636|FG000|Double-blind Period|Not otherwise specified|0|||
28104802|NCT03325556|54761637|FG001|Double-blind Period|Not otherwise specified|1|||
28104803|NCT03325556|54761638|FG002|Double-blind Period|Not otherwise specified|5|||
28104804|NCT03325556|54761636|FG000|Double-blind Period|Administrative discont. at study termination|0|||
28104805|NCT03325556|54761637|FG001|Double-blind Period|Administrative discont. at study termination|35|||
28104806|NCT03325556|54761638|FG002|Double-blind Period|Administrative discont. at study termination|31|||
28104807|NCT03320564|54761645|FG000|Overall Study|Protocol Violation|1|||
28104808|NCT03325166|54761649|FG000|Overall Study|Adverse Event|1|||
28104809|NCT02888756|54761656|FG000|Analytical Treatment Interruption|Physician Decision|10|||
28104810|NCT02888756|54761657|FG001|Analytical Treatment Interruption|Physician Decision|6|||
28104811|NCT02888756|54761658|FG002|Analytical Treatment Interruption|Physician Decision|5|||
28104812|NCT03305666|54761668|FG000|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|2|||
28104813|NCT03305666|54761669|FG001|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|0|||
28104814|NCT03304184|54761677|FG000|Overall Study|Withdrawal by Subject|1|||
28104815|NCT03304184|54761678|FG001|Overall Study|Withdrawal by Subject|2|||
28104816|NCT03736785|54761688|FG000|Overall Study|Adverse Event|1|||
28104817|NCT03736785|54761689|FG001|Overall Study|Adverse Event|1|||
28104818|NCT03736785|54761690|FG002|Overall Study|Adverse Event|1|||
28104819|NCT03736785|54761688|FG000|Overall Study|Death|1|||
28104820|NCT03736785|54761689|FG001|Overall Study|Death|0|||
28104821|NCT03736785|54761690|FG002|Overall Study|Death|1|||
28104822|NCT03736785|54761688|FG000|Overall Study|Lost to Follow-up|0|||
28104823|NCT03736785|54761689|FG001|Overall Study|Lost to Follow-up|2|||
28104824|NCT03736785|54761690|FG002|Overall Study|Lost to Follow-up|3|||
28104825|NCT03736785|54761688|FG000|Overall Study|Non compliance with study drug|1|||
28104826|NCT03736785|54761689|FG001|Overall Study|Non compliance with study drug|1|||
28104827|NCT03736785|54761690|FG002|Overall Study|Non compliance with study drug|0|||
28104828|NCT03736785|54761688|FG000|Overall Study|Physician Decision|0|||
28104829|NCT03736785|54761689|FG001|Overall Study|Physician Decision|1|||
28104830|NCT03736785|54761690|FG002|Overall Study|Physician Decision|1|||
28104831|NCT03736785|54761688|FG000|Overall Study|Protocol Violation|1|||
28104832|NCT03736785|54761689|FG001|Overall Study|Protocol Violation|4|||
28104833|NCT03736785|54761690|FG002|Overall Study|Protocol Violation|3|||
28104834|NCT03736785|54761688|FG000|Overall Study|Sponsor Decision|1|||
28104835|NCT03736785|54761689|FG001|Overall Study|Sponsor Decision|0|||
28104836|NCT03736785|54761690|FG002|Overall Study|Sponsor Decision|0|||
28104837|NCT03736785|54761688|FG000|Overall Study|Unknown/Missing data|3|||
28104838|NCT03736785|54761689|FG001|Overall Study|Unknown/Missing data|2|||
28104839|NCT03736785|54761690|FG002|Overall Study|Unknown/Missing data|1|||
28104840|NCT03736785|54761688|FG000|Overall Study|Withdrawal by Subject|9|||
28104841|NCT03736785|54761689|FG001|Overall Study|Withdrawal by Subject|6|||
28104842|NCT03736785|54761690|FG002|Overall Study|Withdrawal by Subject|4|||
28104843|NCT03734991|54761701|FG000|Overall Study|Adverse Event|4|||
28104844|NCT03734991|54761702|FG001|Overall Study|Adverse Event|0|||
28104845|NCT03734991|54761701|FG000|Overall Study|Lost to Follow-up|4|||
28104846|NCT03734991|54761702|FG001|Overall Study|Lost to Follow-up|0|||
28104847|NCT03734991|54761701|FG000|Overall Study|Physician Decision|0|||
28104848|NCT03734991|54761702|FG001|Overall Study|Physician Decision|1|||
28104849|NCT03734991|54761701|FG000|Overall Study|Pregnancy|1|||
28104850|NCT03734991|54761702|FG001|Overall Study|Pregnancy|0|||
28104851|NCT03734991|54761701|FG000|Overall Study|Withdrawal by Subject|6|||
28104852|NCT03734991|54761702|FG001|Overall Study|Withdrawal by Subject|3|||
28104853|NCT03734991|54761701|FG000|Overall Study|Lack of efficacy and or/use of antifungal therapy|49|||
28104854|NCT03734991|54761702|FG001|Overall Study|Lack of efficacy and or/use of antifungal therapy|41|||
28104855|NCT03734991|54761701|FG000|Overall Study|Other|2|||
28104856|NCT03734991|54761702|FG001|Overall Study|Other|2|||
28104857|NCT03303092|54761711|FG000|Overall Study|Adverse Event|1|||
28104858|NCT03303092|54761712|FG001|Overall Study|Adverse Event|0|||
28104859|NCT03303092|54761713|FG002|Overall Study|Adverse Event|1|||
28104860|NCT03303092|54761711|FG000|Overall Study|Protocol Violation|1|||
28104861|NCT03303092|54761712|FG001|Overall Study|Protocol Violation|5|||
28104862|NCT03303092|54761713|FG002|Overall Study|Protocol Violation|1|||
28104863|NCT03303092|54761711|FG000|Overall Study|Withdrawal by Subject|1|||
28104864|NCT03303092|54761712|FG001|Overall Study|Withdrawal by Subject|1|||
28104865|NCT03303092|54761713|FG002|Overall Study|Withdrawal by Subject|3|||
28104866|NCT03302936|54761723|FG000|Overall Study|Protocol Violation|3|||
28104867|NCT03302936|54761724|FG001|Overall Study|Protocol Violation|4|||
28104868|NCT03733899|54761734|FG000|Period 1|Protocol Violation|0|||
28104869|NCT03733899|54761735|FG001|Period 1|Protocol Violation|0|||
28104870|NCT03733899|54761736|FG002|Period 1|Protocol Violation|0|||
28104871|NCT03733899|54761737|FG003|Period 1|Protocol Violation|0|||
28104872|NCT03733899|54761738|FG004|Period 1|Protocol Violation|0|||
28104873|NCT03733899|54761739|FG005|Period 1|Protocol Violation|1|||
28104874|NCT03733899|54761734|FG000|Period 2|Unscuccessful Treatment|0|||
28104875|NCT03733899|54761735|FG001|Period 2|Unscuccessful Treatment|1|||
28104876|NCT03733899|54761736|FG002|Period 2|Unscuccessful Treatment|0|||
28104877|NCT03733899|54761737|FG003|Period 2|Unscuccessful Treatment|0|||
28104878|NCT03733899|54761738|FG004|Period 2|Unscuccessful Treatment|0|||
28104879|NCT03733899|54761739|FG005|Period 2|Unscuccessful Treatment|0|||
28104880|NCT03733899|54761734|FG000|Period 3|Withdrawal by Subject|1|||
28104881|NCT03733899|54761735|FG001|Period 3|Withdrawal by Subject|0|||
28104882|NCT03733899|54761736|FG002|Period 3|Withdrawal by Subject|0|||
28104883|NCT03733899|54761737|FG003|Period 3|Withdrawal by Subject|0|||
28104884|NCT03733899|54761738|FG004|Period 3|Withdrawal by Subject|0|||
28104885|NCT03733899|54761739|FG005|Period 3|Withdrawal by Subject|0|||
28104886|NCT03727347|54761752|FG000|Overall Study|Withdrawal by Subject|2|||
28104887|NCT03727347|54761752|FG000|Overall Study|Lost to Follow-up|1|||
28104888|NCT03302234|54761767|FG000|Overall Study|Death|137|||
28104889|NCT03302234|54761768|FG001|Overall Study|Death|135|||
28104890|NCT03302234|54761767|FG000|Overall Study|Withdrawal by Subject|1|||
28104891|NCT03302234|54761768|FG001|Overall Study|Withdrawal by Subject|1|||
28104892|NCT03302234|54761767|FG000|Overall Study|Laryngeal carcinoma|0|||
28104893|NCT03302234|54761768|FG001|Overall Study|Laryngeal carcinoma|1|||
28104894|NCT03915626|54761775|FG000|Overall Study|study was halted due to COVID-19; once started again volunteer could no longer participate|1|||
28104895|NCT03301844|54761787|FG000|Overall Study|suspected colon cancer|1|||
28104896|NCT03301844|54761788|FG001|Overall Study|suspected colon cancer|1|||
28104897|NCT03313310|54761796|FG000|Phase 2|Lost to Follow-up|4|||
28104898|NCT03313310|54761797|FG001|Phase 2|Lost to Follow-up|0|||
28104899|NCT03313310|54761796|FG000|Phase 3|Lost to Follow-up|0|||
28104900|NCT03313310|54761797|FG001|Phase 3|Lost to Follow-up|1|||
28104901|NCT03313076|54761807|FG000|Overall Study|Withdrawal by Subject|2|||
28104902|NCT03313076|54761808|FG001|Overall Study|Withdrawal by Subject|0|||
28104903|NCT03313076|54761809|FG002|Overall Study|Withdrawal by Subject|0|||
28104904|NCT03313076|54761810|FG003|Overall Study|Withdrawal by Subject|0|||
28104905|NCT03313076|54761807|FG000|Overall Study|Lost to Follow-up|0|||
28104906|NCT03313076|54761808|FG001|Overall Study|Lost to Follow-up|2|||
28104907|NCT03313076|54761809|FG002|Overall Study|Lost to Follow-up|2|||
28104908|NCT03313076|54761810|FG003|Overall Study|Lost to Follow-up|2|||
28104909|NCT02940626|54761828|FG000|Overall Study|Death|40|||
28104910|NCT02940626|54761829|FG001|Overall Study|Death|32|||
28104911|NCT02940626|54761828|FG000|Overall Study|Lost to Follow-up|5|||
28104912|NCT02940626|54761829|FG001|Overall Study|Lost to Follow-up|2|||
28104913|NCT02940626|54761828|FG000|Overall Study|Withdrawal by Subject|1|||
28104914|NCT02940626|54761829|FG001|Overall Study|Withdrawal by Subject|0|||
28104915|NCT02940626|54761828|FG000|Overall Study|Transfer to Hospice Care|1|||
28104916|NCT02940626|54761829|FG001|Overall Study|Transfer to Hospice Care|0|||
28104917|NCT02940626|54761828|FG000|Overall Study|Prohibited Concomitant Medication|0|||
28104918|NCT02940626|54761829|FG001|Overall Study|Prohibited Concomitant Medication|1|||
28104919|NCT03300050|54761842|FG000|Overall Study|Lost to Follow-up|2|||
28104920|NCT03300050|54761843|FG001|Overall Study|Lost to Follow-up|1|||
28104921|NCT03300050|54761844|FG002|Overall Study|Lost to Follow-up|0|||
28104922|NCT03300050|54761845|FG003|Overall Study|Lost to Follow-up|0|||
28104923|NCT03300050|54761846|FG004|Overall Study|Lost to Follow-up|1|||
28104924|NCT03300050|54761842|FG000|Overall Study|Withdrawal by Subject|1|||
28104925|NCT03300050|54761843|FG001|Overall Study|Withdrawal by Subject|1|||
28104926|NCT03300050|54761844|FG002|Overall Study|Withdrawal by Subject|1|||
28104927|NCT03300050|54761845|FG003|Overall Study|Withdrawal by Subject|0|||
28104928|NCT03300050|54761846|FG004|Overall Study|Withdrawal by Subject|0|||
28104929|NCT03300050|54761842|FG000|Overall Study|Death|0|||
28104930|NCT03300050|54761843|FG001|Overall Study|Death|0|||
28104931|NCT03300050|54761844|FG002|Overall Study|Death|1|||
28104932|NCT03300050|54761845|FG003|Overall Study|Death|0|||
28104933|NCT03300050|54761846|FG004|Overall Study|Death|0|||
28104934|NCT03300050|54761842|FG000|Overall Study|Not Eligible at Randomization|0|||
28104935|NCT03300050|54761843|FG001|Overall Study|Not Eligible at Randomization|0|||
28104936|NCT03300050|54761844|FG002|Overall Study|Not Eligible at Randomization|1|||
28104937|NCT03300050|54761845|FG003|Overall Study|Not Eligible at Randomization|1|||
28104938|NCT03300050|54761846|FG004|Overall Study|Not Eligible at Randomization|0|||
28104939|NCT03725085|54761858|FG000|Overall Study|Lost to Follow-up|2|||
28104940|NCT02940392|54761863|FG000|Overall Study|Lost to Follow-up|3|||
28104941|NCT02940392|54761863|FG000|Overall Study|Retreatment|3|||
28104942|NCT02940392|54761863|FG000|Overall Study|Death|2|||
28104943|NCT03298412|54761876|FG000|Run-in Period|Other, Not Specified|1|||
28104944|NCT03298412|54761876|FG000|Run-in Period|Disease Progression|1|||
28104945|NCT03298412|54761876|FG000|Run-in Period|Ineligibility Determined|1|||
28104946|NCT03298412|54761876|FG000|Run-in Period|Decision by Sponsor|6|||
28104947|NCT03297398|54761883|FG000|Overall Study|Sponsor's decision|6|||
28104948|NCT03297398|54761884|FG001|Overall Study|Sponsor's decision|9|||
28104949|NCT03297398|54761885|FG002|Overall Study|Sponsor's decision|7|||
28104950|NCT03297398|54761883|FG000|Overall Study|Adverse Event|1|||
28104951|NCT03297398|54761884|FG001|Overall Study|Adverse Event|4|||
28104952|NCT03297398|54761885|FG002|Overall Study|Adverse Event|4|||
28104953|NCT03297398|54761883|FG000|Overall Study|Withdrawal by Subject|1|||
28104954|NCT03297398|54761884|FG001|Overall Study|Withdrawal by Subject|2|||
28104955|NCT03297398|54761885|FG002|Overall Study|Withdrawal by Subject|2|||
28104956|NCT03297398|54761883|FG000|Overall Study|Protocol Violation|0|||
28104957|NCT03297398|54761884|FG001|Overall Study|Protocol Violation|2|||
28104958|NCT03297398|54761885|FG002|Overall Study|Protocol Violation|0|||
28104959|NCT03297398|54761883|FG000|Overall Study|Physician Decision|0|||
28104960|NCT03297398|54761884|FG001|Overall Study|Physician Decision|0|||
28104961|NCT03297398|54761885|FG002|Overall Study|Physician Decision|1|||
28104962|NCT03297398|54761883|FG000|Overall Study|Lost to Follow-up|0|||
28104963|NCT03297398|54761884|FG001|Overall Study|Lost to Follow-up|0|||
28104964|NCT03297398|54761885|FG002|Overall Study|Lost to Follow-up|1|||
28104965|NCT03293654|54761896|FG000|Overall Study|Lost to Follow-up|0|||
28104966|NCT03293654|54761897|FG001|Overall Study|Lost to Follow-up|1|||
28104967|NCT03293654|54761898|FG002|Overall Study|Lost to Follow-up|0|||
28104968|NCT03312218|54761908|FG000|Overall Study|Never signed in to access the app|54|||
28104969|NCT03312218|54761909|FG001|Overall Study|Never signed in to access the app|58|||
28104970|NCT03930615|54761917|FG000|Overall Study|Death|9|||
28104971|NCT03930615|54761918|FG001|Overall Study|Death|3|||
28104972|NCT03930615|54761917|FG000|Overall Study|Lost to Follow-up|1|||
28104973|NCT03930615|54761918|FG001|Overall Study|Lost to Follow-up|2|||
28104974|NCT03930615|54761917|FG000|Overall Study|Physician Decision|3|||
28104975|NCT03930615|54761918|FG001|Overall Study|Physician Decision|4|||
28104976|NCT03930615|54761917|FG000|Overall Study|Withdrawal by Subject|13|||
28104977|NCT03930615|54761918|FG001|Overall Study|Withdrawal by Subject|2|||
28104978|NCT03930615|54761917|FG000|Overall Study|Not treated|1|||
28104979|NCT03930615|54761918|FG001|Overall Study|Not treated|1|||
28104980|NCT03292640|54761926|FG000|Overall Study|Withdrawal by Subject|17|||
28104981|NCT03292640|54761927|FG001|Overall Study|Withdrawal by Subject|16|||
28104982|NCT03292640|54761926|FG000|Overall Study|Adverse Event|20|||
28104983|NCT03292640|54761927|FG001|Overall Study|Adverse Event|2|||
28104984|NCT03292640|54761926|FG000|Overall Study|Lost to Follow-up|24|||
28104985|NCT03292640|54761927|FG001|Overall Study|Lost to Follow-up|24|||
28104986|NCT03292406|54761940|FG000|Overall Study|Progressive Disease|6|||
28104987|NCT03292406|54761941|FG001|Overall Study|Progressive Disease|3|||
28104988|NCT03292406|54761942|FG002|Overall Study|Progressive Disease|4|||
28104989|NCT03292406|54761940|FG000|Overall Study|Adverse Event|7|||
28104990|NCT03292406|54761941|FG001|Overall Study|Adverse Event|1|||
28104991|NCT03292406|54761942|FG002|Overall Study|Adverse Event|4|||
28104992|NCT03292406|54761940|FG000|Overall Study|Withdrawal by Subject|0|||
28104993|NCT03292406|54761941|FG001|Overall Study|Withdrawal by Subject|7|||
28104994|NCT03292406|54761942|FG002|Overall Study|Withdrawal by Subject|2|||
28104995|NCT03292406|54761940|FG000|Overall Study|Protocol Violation|0|||
28104996|NCT03292406|54761941|FG001|Overall Study|Protocol Violation|1|||
28104997|NCT03292406|54761942|FG002|Overall Study|Protocol Violation|1|||
28104998|NCT03292406|54761940|FG000|Overall Study|Other|0|||
28104999|NCT03292406|54761941|FG001|Overall Study|Other|1|||
28105000|NCT03292406|54761942|FG002|Overall Study|Other|2|||
28105001|NCT03292016|54761979|FG000|Second Washout|Adverse Event|0|||
28105002|NCT03292016|54761980|FG001|Second Washout|Adverse Event|1|||
28105003|NCT03292016|54761981|FG002|Second Washout|Adverse Event|0|||
28105004|NCT03292016|54761982|FG003|Second Washout|Adverse Event|0|||
28105005|NCT03292016|54761983|FG004|Second Washout|Adverse Event|0|||
28105006|NCT03292016|54761984|FG005|Second Washout|Adverse Event|0|||
28105007|NCT03290300|54761992|FG000|Overall Study|Lost to Follow-up|3|||
28105008|NCT03289676|54762005|FG000|Overall Study|Withdrawal by Subject|2|||
28105009|NCT03289676|54762006|FG001|Overall Study|Withdrawal by Subject|0|||
28105010|NCT03289676|54762005|FG000|Overall Study|Protocol Violation|2|||
28105011|NCT03289676|54762006|FG001|Overall Study|Protocol Violation|0|||
28105012|NCT03289676|54762005|FG000|Overall Study|Lost to Follow-up|0|||
28105013|NCT03289676|54762006|FG001|Overall Study|Lost to Follow-up|1|||
28105014|NCT03287804|54762022|FG000|Overall Study|Death|1|||
28105015|NCT03287804|54762022|FG000|Overall Study|Physician Decision|2|||
28105016|NCT03287804|54762022|FG000|Overall Study|Progressive disease|8|||
28105017|NCT03286400|54762027|FG000|Overall Study|Death|10|||
28105018|NCT03286400|54762027|FG000|Overall Study|Lost to Follow-up|10|||
28105019|NCT03286400|54762027|FG000|Overall Study|Physician Decision|1|||
28105020|NCT03286400|54762027|FG000|Overall Study|Scheduling difficulty|4|||
28105021|NCT03310970|54762031|FG000|Overall Study|Withdrawal by Subject|0|||
28105022|NCT03310970|54762032|FG001|Overall Study|Withdrawal by Subject|1|||
28105023|NCT03285308|54762041|FG000|Overall Study|Adverse Event|3|||
28105024|NCT03285308|54762042|FG001|Overall Study|Adverse Event|7|||
28105025|NCT03285308|54762041|FG000|Overall Study|Withdrawal by Subject|8|||
28105026|NCT03285308|54762042|FG001|Overall Study|Withdrawal by Subject|9|||
28105027|NCT03285308|54762041|FG000|Overall Study|Lost to Follow-up|3|||
28105028|NCT03285308|54762042|FG001|Overall Study|Lost to Follow-up|1|||
28105029|NCT03285308|54762041|FG000|Overall Study|Protocol Deviation|6|||
28105030|NCT03285308|54762042|FG001|Overall Study|Protocol Deviation|5|||
28105031|NCT03285308|54762041|FG000|Overall Study|Reason not Specified|0|||
28105032|NCT03285308|54762042|FG001|Overall Study|Reason not Specified|1|||
28105033|NCT03537651|54762049|FG000|Overall Study|Adverse Event|2|||
28105034|NCT03537651|54762049|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
28105035|NCT03537651|54762049|FG000|Overall Study|Commercial Drug is Available for Participant|56|||
28105036|NCT03537651|54762049|FG000|Overall Study|Other|1|||
28105037|NCT03723915|54762065|FG000|Screening|Failed to meet screening requirements.|2|||
28105038|NCT03723915|54762065|FG000|On Treatment|Failed to meet treatment requirements|2|||
28105039|NCT03281876|54762071|FG000|Overall Study|Adverse Event|4|||
28105040|NCT03281876|54762072|FG001|Overall Study|Adverse Event|15|||
28105041|NCT03281876|54762071|FG000|Overall Study|Lost to Follow-up|1|||
28105042|NCT03281876|54762072|FG001|Overall Study|Lost to Follow-up|4|||
28105043|NCT03281876|54762071|FG000|Overall Study|Withdrawal by Subject|11|||
28105044|NCT03281876|54762072|FG001|Overall Study|Withdrawal by Subject|15|||
28105045|NCT03281876|54762071|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
28105046|NCT03281876|54762072|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
28105047|NCT03281876|54762071|FG000|Overall Study|OTHER|5|||
28105048|NCT03281876|54762072|FG001|Overall Study|OTHER|5|||
28105049|NCT02819518|54762083|FG000|Overall Study|Death|9|||
28105050|NCT02819518|54762084|FG001|Overall Study|Death|11|||
28105051|NCT02819518|54762085|FG002|Overall Study|Death|9|||
28105052|NCT02819518|54762086|FG003|Overall Study|Death|447|||
28105053|NCT02819518|54762087|FG004|Overall Study|Death|233|||
28105054|NCT02819518|54762083|FG000|Overall Study|Withdrawal by Subject|0|||
28105055|NCT02819518|54762084|FG001|Overall Study|Withdrawal by Subject|0|||
28105056|NCT02819518|54762085|FG002|Overall Study|Withdrawal by Subject|0|||
28105057|NCT02819518|54762086|FG003|Overall Study|Withdrawal by Subject|21|||
28105058|NCT02819518|54762087|FG004|Overall Study|Withdrawal by Subject|6|||
28105059|NCT02819518|54762083|FG000|Overall Study|Ongoing in Study|2|||
28105060|NCT02819518|54762084|FG001|Overall Study|Ongoing in Study|3|||
28105061|NCT02819518|54762085|FG002|Overall Study|Ongoing in Study|1|||
28105062|NCT02819518|54762086|FG003|Overall Study|Ongoing in Study|98|||
28105063|NCT02819518|54762087|FG004|Overall Study|Ongoing in Study|42|||
28105064|NCT03310580|54762104|FG000|Overall Study|Adverse Event|0|||
28105065|NCT03310580|54762105|FG001|Overall Study|Adverse Event|1|||
28105066|NCT03310580|54762106|FG002|Overall Study|Adverse Event|0|||
28105067|NCT03415022|54762129|FG000|Overall Study|Withdrawal by Subject|1|||
28105068|NCT03415022|54762130|FG001|Overall Study|Withdrawal by Subject|2|||
28105069|NCT03415022|54762129|FG000|Overall Study|COVID-19 Suspension|2|||
28105070|NCT03415022|54762130|FG001|Overall Study|COVID-19 Suspension|3|||
28105071|NCT03415022|54762129|FG000|Overall Study|Lost to Follow-up|2|||
28105072|NCT03415022|54762130|FG001|Overall Study|Lost to Follow-up|0|||
28105073|NCT02816398|54762136|FG000|Overall Study|Death|5|||
28105074|NCT02816398|54762136|FG000|Overall Study|Lack of Efficacy|8|||
28105075|NCT02816398|54762136|FG000|Overall Study|Lost to Follow-up|1|||
28105076|NCT02812186|54762142|FG000|Period 1|Post randomization screen failure|5|||
28105077|NCT02812186|54762143|FG001|Period 1|Post randomization screen failure|9|||
28105078|NCT02812186|54762142|FG000|Period 1|nonevaluable data sets|6|||
28105079|NCT02812186|54762143|FG001|Period 1|nonevaluable data sets|6|||
28105080|NCT02811640|54762152|FG000|Overall Study|Technology malfunction|2|||
28105081|NCT03310268|54762159|FG000|Overall Study|(Not specified)|1|||
28105082|NCT03310268|54762160|FG001|Overall Study|(Not specified)|5|||
28105083|NCT03310268|54762161|FG002|Overall Study|(Not specified)|0|||
28105084|NCT02810392|54762171|FG000|Overall Study|Subject too ill to continue|1|||
28105085|NCT02810392|54762172|FG001|Overall Study|Subject too ill to continue|0|||
28105086|NCT02810392|54762171|FG000|Overall Study|COVID 19 research restrictions|0|||
28105087|NCT02810392|54762172|FG001|Overall Study|COVID 19 research restrictions|1|||
28105088|NCT02815540|54762178|FG000|Overall Study|Physician left institution and study was discontinued. No other PI was available.|2|||
28105089|NCT03280550|54762184|FG000|Overall Study|Withdrawal by Subject|2|||
28105090|NCT03280550|54762185|FG001|Overall Study|Withdrawal by Subject|2|||
28105091|NCT03280550|54762184|FG000|Overall Study|Physician Decision|0|||
28105092|NCT03280550|54762185|FG001|Overall Study|Physician Decision|1|||
28105093|NCT03276026|54762193|FG000|Overall Study|Protocol Violation|1|||
28105094|NCT03276026|54762194|FG001|Overall Study|Protocol Violation|0|||
28105095|NCT01589523|54762200|FG000|Overall Study|Withdrawal by Subject|1|||
28105096|NCT03277352|54762206|FG000|Overall Study|Study Terminated By Sponsor|2|||
28105097|NCT03277352|54762206|FG000|Overall Study|Withdrawal by Subject|4|||
28105098|NCT03277352|54762206|FG000|Overall Study|Death|4|||
28105099|NCT02814838|54762213|FG000|Overall Study|3 agreed dates for the final visit missed|1|||
28105100|NCT02814838|54762214|FG001|Overall Study|3 agreed dates for the final visit missed|0|||
28105101|NCT02814838|54762213|FG000|Overall Study|Consent withdrawal|1|||
28105102|NCT02814838|54762214|FG001|Overall Study|Consent withdrawal|1|||
28105103|NCT03276728|54762228|FG000|Overall Study|Lost to Follow-up|0|||
28105104|NCT03276728|54762229|FG001|Overall Study|Lost to Follow-up|0|||
28105105|NCT03276728|54762230|FG002|Overall Study|Lost to Follow-up|2|||
28105106|NCT03276728|54762231|FG003|Overall Study|Lost to Follow-up|2|||
28105107|NCT03276728|54762232|FG004|Overall Study|Lost to Follow-up|0|||
28105108|NCT03276728|54762233|FG005|Overall Study|Lost to Follow-up|0|||
28105109|NCT03276728|54762234|FG006|Overall Study|Lost to Follow-up|0|||
28105110|NCT03276728|54762235|FG007|Overall Study|Lost to Follow-up|0|||
28105111|NCT03276728|54762228|FG000|Overall Study|Withdrawal by Subject|0|||
28105112|NCT03276728|54762229|FG001|Overall Study|Withdrawal by Subject|0|||
28105113|NCT03276728|54762230|FG002|Overall Study|Withdrawal by Subject|0|||
28105114|NCT03276728|54762231|FG003|Overall Study|Withdrawal by Subject|3|||
28105115|NCT03276728|54762232|FG004|Overall Study|Withdrawal by Subject|0|||
28105116|NCT03276728|54762233|FG005|Overall Study|Withdrawal by Subject|0|||
28105117|NCT03276728|54762234|FG006|Overall Study|Withdrawal by Subject|0|||
28105118|NCT03276728|54762235|FG007|Overall Study|Withdrawal by Subject|0|||
28105119|NCT03276728|54762228|FG000|Overall Study|Decision by sponsor|0|||
28105120|NCT03276728|54762229|FG001|Overall Study|Decision by sponsor|0|||
28105121|NCT03276728|54762230|FG002|Overall Study|Decision by sponsor|0|||
28105122|NCT03276728|54762231|FG003|Overall Study|Decision by sponsor|0|||
28105123|NCT03276728|54762232|FG004|Overall Study|Decision by sponsor|1|||
28105124|NCT03276728|54762233|FG005|Overall Study|Decision by sponsor|0|||
28105125|NCT03276728|54762234|FG006|Overall Study|Decision by sponsor|2|||
28105126|NCT03276728|54762235|FG007|Overall Study|Decision by sponsor|1|||
28105127|NCT03275246|54762255|FG000|Overall Study|Protocol Violation|5|||
28105128|NCT03275246|54762255|FG000|Overall Study|The study was stopped before the patient reached the final 1 year follow-up|1|||
28105129|NCT02940860|54762261|FG000|Overall Study|Non-serious AE|1|||
28105130|NCT02940860|54762262|FG001|Overall Study|Non-serious AE|2|||
28105131|NCT02940860|54762261|FG000|Overall Study|Serious AE|7|||
28105132|NCT02940860|54762262|FG001|Overall Study|Serious AE|3|||
28105133|NCT02940860|54762261|FG000|Overall Study|Withdrawal by Subject|19|||
28105134|NCT02940860|54762262|FG001|Overall Study|Withdrawal by Subject|9|||
28105135|NCT02940860|54762261|FG000|Overall Study|Lost to Follow-up|13|||
28105136|NCT02940860|54762262|FG001|Overall Study|Lost to Follow-up|7|||
28105137|NCT02940860|54762261|FG000|Overall Study|Physician Decision|5|||
28105138|NCT02940860|54762262|FG001|Overall Study|Physician Decision|3|||
28105139|NCT02940860|54762261|FG000|Overall Study|Sponsor Decision|0|||
28105140|NCT02940860|54762262|FG001|Overall Study|Sponsor Decision|1|||
28105141|NCT02940860|54762261|FG000|Overall Study|Protocol Violation|0|||
28105142|NCT02940860|54762262|FG001|Overall Study|Protocol Violation|2|||
28105143|NCT02940860|54762261|FG000|Overall Study|Death|3|||
28105144|NCT02940860|54762262|FG001|Overall Study|Death|2|||
28105145|NCT02940860|54762261|FG000|Overall Study|Moved, poor venous access, transport|6|||
28105146|NCT02940860|54762262|FG001|Overall Study|Moved, poor venous access, transport|4|||
28105147|NCT02940860|54762261|FG000|Overall Study|Not treated|2|||
28105148|NCT02940860|54762262|FG001|Overall Study|Not treated|2|||
28105149|NCT03309020|54762272|FG000|Overall Study|Death|1|||
28105150|NCT03309020|54762273|FG001|Overall Study|Death|0|||
28105151|NCT03309020|54762272|FG000|Overall Study|Did not undergo surgery|2|||
28105152|NCT03309020|54762273|FG001|Overall Study|Did not undergo surgery|1|||
28105153|NCT02806960|54762281|FG000|Period 1|Study Terminated (withdrawn by sponsor)|3|||
28105154|NCT02806960|54762282|FG001|Period 1|Study Terminated (withdrawn by sponsor)|3|||
28105155|NCT02806960|54762283|FG002|Period 1|Study Terminated (withdrawn by sponsor)|3|||
28105156|NCT02806960|54762284|FG003|Period 1|Study Terminated (withdrawn by sponsor)|3|||
28105157|NCT03718143|54762294|FG000|Overall Study|Death|1|||
28105158|NCT03718143|54762295|FG001|Overall Study|Death|0|||
28105159|NCT03718143|54762296|FG002|Overall Study|Death|0|||
28105160|NCT03718143|54762294|FG000|Overall Study|Progression of Disease|1|||
28105161|NCT03718143|54762295|FG001|Overall Study|Progression of Disease|0|||
28105162|NCT03718143|54762296|FG002|Overall Study|Progression of Disease|0|||
28105163|NCT03718143|54762294|FG000|Overall Study|Withdrawal of Informed Consent|1|||
28105164|NCT03718143|54762295|FG001|Overall Study|Withdrawal of Informed Consent|2|||
28105165|NCT03718143|54762296|FG002|Overall Study|Withdrawal of Informed Consent|1|||
28105166|NCT03274466|54762306|FG000|Overall Study|Withdrawal by Subject|7|||
28105167|NCT03274466|54762307|FG001|Overall Study|Withdrawal by Subject|3|||
28105168|NCT03274466|54762306|FG000|Overall Study|Protocol Specified Withdrawal|5|||
28105169|NCT03274466|54762307|FG001|Overall Study|Protocol Specified Withdrawal|11|||
28105170|NCT03274466|54762306|FG000|Overall Study|Lost to Follow-up|5|||
28105171|NCT03274466|54762307|FG001|Overall Study|Lost to Follow-up|7|||
28105172|NCT03274466|54762306|FG000|Overall Study|Subject Non-compliance|0|||
28105173|NCT03274466|54762307|FG001|Overall Study|Subject Non-compliance|1|||
28105174|NCT03274466|54762306|FG000|Overall Study|Adverse Event|3|||
28105175|NCT03274466|54762307|FG001|Overall Study|Adverse Event|3|||
28105176|NCT03274466|54762306|FG000|Overall Study|Physician Decision|0|||
28105177|NCT03274466|54762307|FG001|Overall Study|Physician Decision|1|||
28105178|NCT03274466|54762306|FG000|Overall Study|Protocol Violation|3|||
28105179|NCT03274466|54762307|FG001|Overall Study|Protocol Violation|3|||
28105180|NCT02806726|54762313|FG000|Overall Study|Lost to Follow-up|1|||
28105181|NCT02806414|54762318|FG000|Overall Study|Lost to Follow-up|2|||
28105182|NCT02806024|54762324|FG000|Overall Study|Night Delivery|1|||
28105183|NCT02806024|54762325|FG001|Overall Study|Night Delivery|1|||
28105184|NCT02806024|54762324|FG000|Overall Study|DVT during antepartum admission|0|||
28105185|NCT02806024|54762325|FG001|Overall Study|DVT during antepartum admission|1|||
28105186|NCT02805790|54762333|FG000|Second Intervention (4 Weeks)|Physician Decision|0|||
28105187|NCT02805790|54762334|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
28105188|NCT02802592|54762340|FG000|Overall Study|Study terminated due to loss of funding|4|||
28105189|NCT02803138|54762345|FG000|Overall Study|Failure to return|38|||
28105190|NCT02803138|54762345|FG000|Overall Study|Insufficient virological response|2|||
28105191|NCT02803138|54762345|FG000|Overall Study|Withdrawn consent|1|||
28105192|NCT02803138|54762345|FG000|Overall Study|Death|1|||
28105193|NCT02803138|54762345|FG000|Overall Study|Other, not specified|28|||
28105194|NCT02801578|54762351|FG000|Overall Study|Adverse Event|2|||
28105195|NCT02799472|54762357|FG000|Overall Study|Withdrawal by Subject|2|||
28105196|NCT02799472|54762358|FG001|Overall Study|Withdrawal by Subject|4|||
28105197|NCT02799472|54762357|FG000|Overall Study|Lack of Efficacy|2|||
28105198|NCT02799472|54762358|FG001|Overall Study|Lack of Efficacy|0|||
28105199|NCT02799472|54762357|FG000|Overall Study|Lost to Follow-up|0|||
28105200|NCT02799472|54762358|FG001|Overall Study|Lost to Follow-up|1|||
28105201|NCT03245450|54762371|FG000|Overall Study|Radiological disease progression|3|||
28105202|NCT03245450|54762372|FG001|Overall Study|Radiological disease progression|3|||
28105203|NCT03245450|54762373|FG002|Overall Study|Radiological disease progression|2|||
28105204|NCT03245450|54762374|FG003|Overall Study|Radiological disease progression|2|||
28105205|NCT03245450|54762375|FG004|Overall Study|Radiological disease progression|7|||
28105206|NCT03245450|54762376|FG005|Overall Study|Radiological disease progression|6|||
28105207|NCT03245450|54762377|FG006|Overall Study|Radiological disease progression|6|||
28105208|NCT03245450|54762371|FG000|Overall Study|Clinical disease progression|0|||
28105209|NCT03245450|54762372|FG001|Overall Study|Clinical disease progression|0|||
28105210|NCT03245450|54762373|FG002|Overall Study|Clinical disease progression|1|||
28105211|NCT03245450|54762374|FG003|Overall Study|Clinical disease progression|0|||
28105212|NCT03245450|54762375|FG004|Overall Study|Clinical disease progression|0|||
28105213|NCT03245450|54762376|FG005|Overall Study|Clinical disease progression|2|||
28105214|NCT03245450|54762377|FG006|Overall Study|Clinical disease progression|0|||
28105215|NCT03245450|54762371|FG000|Overall Study|Other|0|||
28105216|NCT03245450|54762372|FG001|Overall Study|Other|0|||
28105217|NCT03245450|54762373|FG002|Overall Study|Other|0|||
28105218|NCT03245450|54762374|FG003|Overall Study|Other|1|||
28105219|NCT03245450|54762375|FG004|Overall Study|Other|1|||
28105220|NCT03245450|54762376|FG005|Overall Study|Other|1|||
28105221|NCT03245450|54762377|FG006|Overall Study|Other|1|||
28105222|NCT03245450|54762371|FG000|Overall Study|Withdrawal by Subject|0|||
28105223|NCT03245450|54762372|FG001|Overall Study|Withdrawal by Subject|1|||
28105224|NCT03245450|54762373|FG002|Overall Study|Withdrawal by Subject|0|||
28105225|NCT03245450|54762374|FG003|Overall Study|Withdrawal by Subject|0|||
28105226|NCT03245450|54762375|FG004|Overall Study|Withdrawal by Subject|0|||
28105227|NCT03245450|54762376|FG005|Overall Study|Withdrawal by Subject|0|||
28105228|NCT03245450|54762377|FG006|Overall Study|Withdrawal by Subject|0|||
28105229|NCT03245450|54762371|FG000|Overall Study|Adverse Event|0|||
28105230|NCT03245450|54762372|FG001|Overall Study|Adverse Event|0|||
28105231|NCT03245450|54762373|FG002|Overall Study|Adverse Event|0|||
28105232|NCT03245450|54762374|FG003|Overall Study|Adverse Event|0|||
28105233|NCT03245450|54762375|FG004|Overall Study|Adverse Event|1|||
28105234|NCT03245450|54762376|FG005|Overall Study|Adverse Event|0|||
28105235|NCT03245450|54762377|FG006|Overall Study|Adverse Event|2|||
28105236|NCT03712917|54762402|FG000|Overall Study|Pregnancy|0|||
28105237|NCT03712917|54762403|FG001|Overall Study|Pregnancy|0|||
28105238|NCT03712917|54762404|FG002|Overall Study|Pregnancy|1|||
28105239|NCT03712917|54762402|FG000|Overall Study|Adverse Event|0|||
28105240|NCT03712917|54762403|FG001|Overall Study|Adverse Event|4|||
28105241|NCT03712917|54762404|FG002|Overall Study|Adverse Event|3|||
28105242|NCT03712917|54762402|FG000|Overall Study|Lost to Follow-up|9|||
28105243|NCT03712917|54762403|FG001|Overall Study|Lost to Follow-up|4|||
28105244|NCT03712917|54762404|FG002|Overall Study|Lost to Follow-up|5|||
28105245|NCT02748694|54762427|FG000|Overall Study|Voluntary Withdrawal|0|||
28105246|NCT02748694|54762428|FG001|Overall Study|Voluntary Withdrawal|0|||
28105247|NCT02748694|54762429|FG002|Overall Study|Voluntary Withdrawal|0|||
28105248|NCT02748694|54762430|FG003|Overall Study|Voluntary Withdrawal|0|||
28105249|NCT02748694|54762431|FG004|Overall Study|Voluntary Withdrawal|0|||
28105250|NCT02748694|54762432|FG005|Overall Study|Voluntary Withdrawal|0|||
28105251|NCT02748694|54762433|FG006|Overall Study|Voluntary Withdrawal|0|||
28105252|NCT02748694|54762434|FG007|Overall Study|Voluntary Withdrawal|0|||
28105253|NCT02748694|54762435|FG008|Overall Study|Voluntary Withdrawal|0|||
28105254|NCT02748694|54762436|FG009|Overall Study|Voluntary Withdrawal|0|||
28105255|NCT02748694|54762437|FG010|Overall Study|Voluntary Withdrawal|0|||
28105256|NCT02748694|54762438|FG011|Overall Study|Voluntary Withdrawal|0|||
28105257|NCT02748694|54762439|FG012|Overall Study|Voluntary Withdrawal|0|||
28105258|NCT02748694|54762440|FG013|Overall Study|Voluntary Withdrawal|0|||
28105259|NCT02748694|54762441|FG014|Overall Study|Voluntary Withdrawal|2|||
28105260|NCT02800642|54762497|FG000|Overall Study|Death|3|||
28105261|NCT02800642|54762497|FG000|Overall Study|Other|10|||
28105262|NCT02800642|54762497|FG000|Overall Study|Physician Decision|2|||
28105263|NCT02800642|54762497|FG000|Overall Study|Adverse Event|6|||
28105264|NCT02800642|54762497|FG000|Overall Study|Withdrawal by Subject|3|||
28105265|NCT02800642|54762497|FG000|Overall Study|Lost to Follow-up|1|||
28105266|NCT02799784|54762501|FG000|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
28105267|NCT02799784|54762502|FG001|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
28105268|NCT02799784|54762501|FG000|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5|||
28105269|NCT02799784|54762502|FG001|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0|||
28105270|NCT02799784|54762501|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0|||
28105271|NCT02799784|54762502|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1|||
28105272|NCT02799784|54762501|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1|||
27926873|NCT01218477|54583323|FG003|Overall Study|No longer meets study criteria|0|||
27926874|NCT01218477|54583320|FG000|Overall Study|Withdrawal by Subject|0|||
27926875|NCT01218477|54583321|FG001|Overall Study|Withdrawal by Subject|0|||
27926876|NCT01218477|54583322|FG002|Overall Study|Withdrawal by Subject|1|||
28105273|NCT02799784|54762502|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0|||
28105274|NCT02799784|54762501|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0|||
28105275|NCT02799784|54762502|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1|||
28105276|NCT02799784|54762501|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0|||
28105277|NCT02799784|54762502|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1|||
28105278|NCT01333072|54762510|FG000|Overall Study|Lost to Follow-up|3|||
28105279|NCT01333072|54762511|FG001|Overall Study|Lost to Follow-up|0|||
28105280|NCT01333072|54762510|FG000|Overall Study|Adverse Event|2|||
28105281|NCT01333072|54762511|FG001|Overall Study|Adverse Event|4|||
28105282|NCT01333072|54762510|FG000|Overall Study|Physician Decision|1|||
28105283|NCT01333072|54762511|FG001|Overall Study|Physician Decision|0|||
28105284|NCT01315353|54762520|FG000|Overall Study|Death|2|||
28105285|NCT01315353|54762521|FG001|Overall Study|Death|1|||
28105286|NCT01315353|54762522|FG002|Overall Study|Death|0|||
28105287|NCT01315353|54762520|FG000|Overall Study|Withdrawal by Subject|2|||
28105288|NCT01315353|54762521|FG001|Overall Study|Withdrawal by Subject|6|||
28105289|NCT01315353|54762522|FG002|Overall Study|Withdrawal by Subject|1|||
28105290|NCT01315353|54762520|FG000|Overall Study|Lost to Follow-up|13|||
28105291|NCT01315353|54762521|FG001|Overall Study|Lost to Follow-up|6|||
28105292|NCT01315353|54762522|FG002|Overall Study|Lost to Follow-up|6|||
28105293|NCT01315353|54762520|FG000|Overall Study|Unwilling to adhere to requirements|5|||
28105294|NCT01315353|54762521|FG001|Overall Study|Unwilling to adhere to requirements|5|||
28105295|NCT01315353|54762522|FG002|Overall Study|Unwilling to adhere to requirements|4|||
28105296|NCT01315353|54762520|FG000|Overall Study|Site closing|7|||
28105297|NCT01315353|54762521|FG001|Overall Study|Site closing|4|||
28105298|NCT01315353|54762522|FG002|Overall Study|Site closing|0|||
28105299|NCT01315353|54762520|FG000|Overall Study|Taken off study by site in error|0|||
28105300|NCT01315353|54762521|FG001|Overall Study|Taken off study by site in error|1|||
28105301|NCT01315353|54762522|FG002|Overall Study|Taken off study by site in error|0|||
28105302|NCT01315353|54762520|FG000|Overall Study|Inadvertent randomization/assignment|0|||
28105303|NCT01315353|54762521|FG001|Overall Study|Inadvertent randomization/assignment|0|||
28105304|NCT01315353|54762522|FG002|Overall Study|Inadvertent randomization/assignment|2|||
28105305|NCT03712449|54762532|FG000|Overall Study|Withdraw Consent|0|||
28105306|NCT03712449|54762533|FG001|Overall Study|Withdraw Consent|1|||
28105307|NCT03517540|54762543|FG000|Overall Study|Protocol Violation|2|||
28105308|NCT03517540|54762544|FG001|Overall Study|Protocol Violation|0|||
28105309|NCT03517540|54762545|FG002|Overall Study|Protocol Violation|0|||
28105310|NCT03517540|54762546|FG003|Overall Study|Protocol Violation|1|||
28105311|NCT03517540|54762543|FG000|Overall Study|Adverse Event|9|||
28105312|NCT03517540|54762544|FG001|Overall Study|Adverse Event|3|||
28105313|NCT03517540|54762545|FG002|Overall Study|Adverse Event|8|||
28105314|NCT03517540|54762546|FG003|Overall Study|Adverse Event|1|||
28105315|NCT03517540|54762543|FG000|Overall Study|Withdrawal by Subject|3|||
28105316|NCT03517540|54762544|FG001|Overall Study|Withdrawal by Subject|4|||
28105317|NCT03517540|54762545|FG002|Overall Study|Withdrawal by Subject|1|||
28105318|NCT03517540|54762546|FG003|Overall Study|Withdrawal by Subject|3|||
28105319|NCT02799082|54762558|FG000|Overall Study|Refused second PDT or withdraw consent|4|||
28105320|NCT02799082|54762559|FG001|Overall Study|Refused second PDT or withdraw consent|3|||
28105321|NCT02799082|54762558|FG000|Overall Study|Protocol Violation|0|||
28105322|NCT02799082|54762559|FG001|Overall Study|Protocol Violation|1|||
28105323|NCT03710889|54762565|FG000|Overall Study|Adverse Event|2|||
28105324|NCT03710889|54762565|FG000|Overall Study|Protocol Deviation|1|||
28105325|NCT02797678|54762569|FG000|Screening Phase|Meeting Inclusion/Exclusion criteria|25|||
28105326|NCT02797678|54762570|FG001|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
28105327|NCT02797678|54762571|FG002|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
28105328|NCT02797678|54762572|FG003|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
28105329|NCT02797678|54762569|FG000|First Intervention (5 Nights)|study/device use non-compliance|0|||
28105330|NCT02797678|54762570|FG001|First Intervention (5 Nights)|study/device use non-compliance|1|||
28105331|NCT02797678|54762571|FG002|First Intervention (5 Nights)|study/device use non-compliance|0|||
28105332|NCT02797678|54762572|FG003|First Intervention (5 Nights)|study/device use non-compliance|0|||
28105333|NCT02797678|54762569|FG000|Second Intervention (5 Nights)|study/device use non-compliance|0|||
28105334|NCT02797678|54762570|FG001|Second Intervention (5 Nights)|study/device use non-compliance|0|||
28105335|NCT02797678|54762571|FG002|Second Intervention (5 Nights)|study/device use non-compliance|1|||
28105336|NCT02797678|54762572|FG003|Second Intervention (5 Nights)|study/device use non-compliance|0|||
28105337|NCT03308942|54762590|FG000|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
28105338|NCT03308942|54762591|FG001|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
28105339|NCT03308942|54762592|FG002|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|2|||
28105340|NCT03308942|54762593|FG003|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
28105341|NCT03308942|54762594|FG004|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
28105342|NCT03308942|54762590|FG000|Stage 1 (Up to a Maximum of 45 Months)|Death|11|||
28105343|NCT03308942|54762591|FG001|Stage 1 (Up to a Maximum of 45 Months)|Death|16|||
28105344|NCT03308942|54762592|FG002|Stage 1 (Up to a Maximum of 45 Months)|Death|1|||
28105345|NCT03308942|54762593|FG003|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
28105346|NCT03308942|54762594|FG004|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
28105347|NCT03308942|54762590|FG000|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
28105348|NCT03308942|54762591|FG001|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|1|||
28105349|NCT03308942|54762592|FG002|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
28105350|NCT03308942|54762593|FG003|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
28105351|NCT03308942|54762594|FG004|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
28105352|NCT03308942|54762590|FG000|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|3|||
28105353|NCT03308942|54762591|FG001|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|1|||
28105354|NCT03308942|54762592|FG002|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
28105355|NCT03308942|54762593|FG003|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
28105356|NCT03308942|54762594|FG004|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
28105357|NCT03308942|54762590|FG000|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
28105358|NCT03308942|54762591|FG001|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
28105359|NCT03308942|54762592|FG002|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
28105360|NCT03308942|54762593|FG003|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|3|||
28105361|NCT03308942|54762594|FG004|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
28105362|NCT03308942|54762590|FG000|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
28105363|NCT03308942|54762591|FG001|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
28105364|NCT03308942|54762592|FG002|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
28105365|NCT03308942|54762593|FG003|Stage 2 (Up to a Maximum of 29 Months)|Death|6|||
28105366|NCT03308942|54762594|FG004|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
28105367|NCT03308942|54762590|FG000|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
28105368|NCT03308942|54762591|FG001|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
28105369|NCT03308942|54762592|FG002|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
28105370|NCT03308942|54762593|FG003|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|3|||
28105371|NCT03308942|54762594|FG004|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
28105372|NCT03308786|54762607|FG000|Overall Study|study terminated after discussion with Safety Monitoring Committee|9|||
28105373|NCT03274076|54762614|FG000|24 Weeks Double Blind|Withdrawal by Subject|0|||
28105374|NCT03274076|54762615|FG001|24 Weeks Double Blind|Withdrawal by Subject|1|||
28105375|NCT03274076|54762616|FG002|24 Weeks Double Blind|Withdrawal by Subject|0|||
28105376|NCT03274076|54762617|FG003|24 Weeks Double Blind|Withdrawal by Subject|0|||
28105377|NCT03274076|54762614|FG000|24 Weeks Open Label|Adverse Event|0|||
28105378|NCT03274076|54762615|FG001|24 Weeks Open Label|Adverse Event|0|||
28105379|NCT03274076|54762616|FG002|24 Weeks Open Label|Adverse Event|2|||
28105380|NCT03274076|54762617|FG003|24 Weeks Open Label|Adverse Event|0|||
28105381|NCT03274076|54762614|FG000|24 Weeks Open Label|Withdrawal by Subject|0|||
28105382|NCT03274076|54762615|FG001|24 Weeks Open Label|Withdrawal by Subject|0|||
28105383|NCT03274076|54762616|FG002|24 Weeks Open Label|Withdrawal by Subject|0|||
28105384|NCT03274076|54762617|FG003|24 Weeks Open Label|Withdrawal by Subject|1|||
28105385|NCT02797522|54762647|FG000|Overall Study|Study Terminated by Sponsor|0|||
28105386|NCT02797522|54762648|FG001|Overall Study|Study Terminated by Sponsor|0|||
28105387|NCT02797522|54762649|FG002|Overall Study|Study Terminated by Sponsor|0|||
28105388|NCT02797522|54762650|FG003|Overall Study|Study Terminated by Sponsor|0|||
28105389|NCT02797522|54762651|FG004|Overall Study|Study Terminated by Sponsor|0|||
28105390|NCT02797522|54762652|FG005|Overall Study|Study Terminated by Sponsor|0|||
28105391|NCT02797522|54762653|FG006|Overall Study|Study Terminated by Sponsor|0|||
28105392|NCT02797522|54762654|FG007|Overall Study|Study Terminated by Sponsor|4|||
28105393|NCT02797522|54762655|FG008|Overall Study|Study Terminated by Sponsor|2|||
28105394|NCT02797522|54762656|FG009|Overall Study|Study Terminated by Sponsor|4|||
28105395|NCT02797522|54762657|FG010|Overall Study|Study Terminated by Sponsor|1|||
28105396|NCT02659514|54762696|FG000|Overall Study|Adverse Event|3|||
28105397|NCT02659514|54762697|FG001|Overall Study|Adverse Event|12|||
28105398|NCT02659514|54762696|FG000|Overall Study|Disease Progression|23|||
28105399|NCT02659514|54762697|FG001|Overall Study|Disease Progression|13|||
28105400|NCT02659514|54762696|FG000|Overall Study|Withdrawal by Subject|0|||
28105401|NCT02659514|54762697|FG001|Overall Study|Withdrawal by Subject|4|||
28105402|NCT02659514|54762696|FG000|Overall Study|Lost to Follow-up|0|||
28105403|NCT02659514|54762697|FG001|Overall Study|Lost to Follow-up|1|||
28105404|NCT02659514|54762696|FG000|Overall Study|Death|6|||
28105405|NCT02659514|54762697|FG001|Overall Study|Death|1|||
28105406|NCT02659514|54762696|FG000|Overall Study|Reason Unspecified|0|||
28105407|NCT02659514|54762697|FG001|Overall Study|Reason Unspecified|3|||
28105408|NCT04570670|54762705|FG000|Overall Study|Withdrawal by Subject|1|||
28105409|NCT04570670|54762706|FG001|Overall Study|Withdrawal by Subject|0|||
28105410|NCT02797132|54762712|FG000|Part A (15 Days)|Adverse Event|1|||
28105411|NCT02797132|54762712|FG000|Part B (24 Weeks)|Adverse Event|3|||
28105412|NCT03270644|54762725|FG000|Day 1 Lasmiditan Reference|Physician Decision|1|||
28105413|NCT03270644|54762725|FG000|Day 4 - 10 Propranolol Reference|Adverse Event|1|||
28105414|NCT03269552|54762736|FG000|Overall Study|Adverse Event|2|||
28105415|NCT02796664|54762743|FG000|Overall Study|Withdrawal by Subject|0|||
28105416|NCT02796664|54762744|FG001|Overall Study|Withdrawal by Subject|3|||
28105417|NCT02796664|54762743|FG000|Overall Study|Noncompliance|1|||
28105418|NCT02796664|54762744|FG001|Overall Study|Noncompliance|1|||
28105419|NCT02796664|54762743|FG000|Overall Study|Death|0|||
28105420|NCT02796664|54762744|FG001|Overall Study|Death|1|||
28105421|NCT01370356|54762754|FG000|Overall Study|Death|1|||
28105422|NCT01370356|54762755|FG001|Overall Study|Death|0|||
28105423|NCT01370356|54762754|FG000|Overall Study|Lack of Efficacy|6|||
28105424|NCT01370356|54762755|FG001|Overall Study|Lack of Efficacy|28|||
28105425|NCT01370356|54762754|FG000|Overall Study|Lost to Follow-up|76|||
28105426|NCT01370356|54762755|FG001|Overall Study|Lost to Follow-up|81|||
28105427|NCT01370356|54762754|FG000|Overall Study|Withdrawal by Subject|54|||
28105428|NCT01370356|54762755|FG001|Overall Study|Withdrawal by Subject|59|||
28105429|NCT01370356|54762754|FG000|Overall Study|Reason not specified|39|||
28105430|NCT01370356|54762755|FG001|Overall Study|Reason not specified|43|||
28105431|NCT01370356|54762754|FG000|Overall Study|Protocol Violation|3|||
27831154|NCT00708552|54307297|FG000|Overall Study|Lost to Follow-up|4|||
28105432|NCT01370356|54762755|FG001|Overall Study|Protocol Violation|3|||
28105433|NCT01370356|54762754|FG000|Overall Study|Adverse event (AE) Related to Study Drug|12|||
28105434|NCT01370356|54762755|FG001|Overall Study|Adverse event (AE) Related to Study Drug|9|||
28105435|NCT01370356|54762754|FG000|Overall Study|AE Not Related to Study Drug|1|||
28105436|NCT01370356|54762755|FG001|Overall Study|AE Not Related to Study Drug|4|||
28105437|NCT02794870|54762763|FG000|Overall Study|Withdrawal by Subject|2|||
28105438|NCT02794870|54762764|FG001|Overall Study|Withdrawal by Subject|0|||
28105439|NCT01370590|54762772|FG000|Period 1|Adverse Event|8|||
28105440|NCT01370590|54762773|FG001|Period 1|Adverse Event|4|||
28105441|NCT01370590|54762772|FG000|Period 1|Lost to Follow-up|2|||
28105442|NCT01370590|54762773|FG001|Period 1|Lost to Follow-up|2|||
28105443|NCT01370590|54762772|FG000|Period 1|Protocol Violation|2|||
28105444|NCT01370590|54762773|FG001|Period 1|Protocol Violation|2|||
28105445|NCT01370590|54762772|FG000|Period 1|Withdrawal by Subject|4|||
28105446|NCT01370590|54762773|FG001|Period 1|Withdrawal by Subject|2|||
28105447|NCT01370590|54762772|FG000|Period 1|Could not access randomization system|0|||
28105448|NCT01370590|54762773|FG001|Period 1|Could not access randomization system|1|||
28105449|NCT01370590|54762772|FG000|Crossover Washout Period|Adverse Event|1|||
28105450|NCT01370590|54762773|FG001|Crossover Washout Period|Adverse Event|4|||
28105451|NCT01370590|54762772|FG000|Crossover Washout Period|Lost to Follow-up|2|||
28105452|NCT01370590|54762773|FG001|Crossover Washout Period|Lost to Follow-up|0|||
28105453|NCT01370590|54762772|FG000|Crossover Washout Period|Non-compliance with Study Drug|1|||
28105454|NCT01370590|54762773|FG001|Crossover Washout Period|Non-compliance with Study Drug|0|||
28105455|NCT01370590|54762772|FG000|Crossover Washout Period|Withdrawal by Subject|2|||
28105456|NCT01370590|54762773|FG001|Crossover Washout Period|Withdrawal by Subject|2|||
28105457|NCT01370590|54762772|FG000|Period 2|Adverse Event|0|||
28105458|NCT01370590|54762773|FG001|Period 2|Adverse Event|1|||
28105459|NCT01370590|54762772|FG000|Period 2|Withdrawal by Subject|1|||
28105460|NCT01370590|54762773|FG001|Period 2|Withdrawal by Subject|1|||
28105461|NCT05200455|54762784|FG000|Overall Study|These patients were not implanted with intracranial electrodes for clinical reasons .|4|||
28105462|NCT04646109|54762791|FG000|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0|||
28105463|NCT04646109|54762792|FG001|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6|||
28105464|NCT04502979|54762801|FG000|Overall Study|Lost to Follow-up|1|||
28105465|NCT04502979|54762802|FG001|Overall Study|Lost to Follow-up|3|||
27831155|NCT00708552|54307298|FG001|Overall Study|Lost to Follow-up|2|||
27746919|NCT02596893|54196631|FG000|Overall Double-Blind Period Weeks 0-52|Death|0|||
27746920|NCT02596893|54196632|FG001|Overall Double-Blind Period Weeks 0-52|Death|0|||
27746921|NCT02596893|54196633|FG002|Overall Double-Blind Period Weeks 0-52|Death|1|||
27746922|NCT02596893|54196634|FG003|Overall Double-Blind Period Weeks 0-52|Death|0|||
27746923|NCT02596893|54196631|FG000|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
27746924|NCT02596893|54196632|FG001|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
27746925|NCT02596893|54196633|FG002|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
27746926|NCT02596893|54196634|FG003|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2|||
27746927|NCT02596893|54196631|FG000|Overall Double-Blind Period Weeks 0-52|Early Escape|66|||
27746928|NCT02596893|54196632|FG001|Overall Double-Blind Period Weeks 0-52|Early Escape|76|||
27746929|NCT02596893|54196633|FG002|Overall Double-Blind Period Weeks 0-52|Early Escape|69|||
27746930|NCT02596893|54196634|FG003|Overall Double-Blind Period Weeks 0-52|Early Escape|70|||
27746931|NCT02592447|54196650|FG000|Overall Study|Lost to Follow-up|1|||
27746932|NCT02592447|54196651|FG001|Overall Study|Lost to Follow-up|0|||
27746933|NCT02592447|54196650|FG000|Overall Study|Ineligible after randomization|1|||
27746934|NCT02592447|54196651|FG001|Overall Study|Ineligible after randomization|0|||
27746935|NCT02592447|54196650|FG000|Overall Study|Withdrawal by Subject|0|||
27746936|NCT02592447|54196651|FG001|Overall Study|Withdrawal by Subject|1|||
27746937|NCT02595723|54196660|FG000|First Washout (21 Days)|Withdrawal by Subject|1|||
27746938|NCT02595723|54196661|FG001|First Washout (21 Days)|Withdrawal by Subject|0|||
27746939|NCT02595723|54196662|FG002|First Washout (21 Days)|Withdrawal by Subject|0|||
27746940|NCT02595723|54196660|FG000|First Washout (21 Days)|Lost to Follow-up|1|||
27746941|NCT02595723|54196661|FG001|First Washout (21 Days)|Lost to Follow-up|0|||
27746942|NCT02595723|54196662|FG002|First Washout (21 Days)|Lost to Follow-up|0|||
27746943|NCT01667679|54196672|FG000|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2|||
27746944|NCT01667679|54196673|FG001|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6|||
27746945|NCT01667679|54196672|FG000|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2|||
27746946|NCT01667679|54196673|FG001|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0|||
27746947|NCT01667679|54196672|FG000|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2|||
27746948|NCT01667679|54196673|FG001|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0|||
27746949|NCT01667679|54196672|FG000|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1|||
27746950|NCT01667679|54196673|FG001|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0|||
27746951|NCT01667679|54196672|FG000|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6|||
27746952|NCT01667679|54196673|FG001|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13|||
27746953|NCT01667679|54196672|FG000|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
27746954|NCT01667679|54196673|FG001|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
27746955|NCT01667679|54196672|FG000|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0|||
27746956|NCT01667679|54196673|FG001|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2|||
27746957|NCT01667679|54196672|FG000|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0|||
27746958|NCT01667679|54196673|FG001|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2|||
27746959|NCT01667679|54196672|FG000|Treatment Period 1 (<=12 Weeks)|Non-compliance|0|||
27746960|NCT01667679|54196673|FG001|Treatment Period 1 (<=12 Weeks)|Non-compliance|3|||
27746961|NCT01667679|54196672|FG000|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0|||
27746962|NCT01667679|54196673|FG001|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1|||
27746963|NCT01667679|54196672|FG000|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6|||
27746964|NCT01667679|54196673|FG001|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4|||
27746965|NCT01667679|54196672|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2|||
27746966|NCT01667679|54196673|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0|||
27746967|NCT01667679|54196672|FG000|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8|||
27746968|NCT01667679|54196673|FG001|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10|||
27746969|NCT01667679|54196672|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance|3|||
27746970|NCT01667679|54196673|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance|4|||
27746971|NCT01667679|54196672|FG000|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1|||
27746972|NCT01667679|54196673|FG001|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0|||
27746973|NCT01667679|54196672|FG000|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1|||
27746974|NCT01667679|54196673|FG001|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0|||
27746975|NCT01667679|54196672|FG000|Treatment Period 2 (<=12 Weeks)|Adverse Event|1|||
27746976|NCT01667679|54196673|FG001|Treatment Period 2 (<=12 Weeks)|Adverse Event|0|||
27746977|NCT01667679|54196672|FG000|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0|||
27746978|NCT01667679|54196673|FG001|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1|||
27746979|NCT01667679|54196672|FG000|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0|||
27746980|NCT01667679|54196673|FG001|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1|||
27746981|NCT01667679|54196672|FG000|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0|||
27746982|NCT01667679|54196673|FG001|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1|||
27746983|NCT01667679|54196672|FG000|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0|||
27746984|NCT01667679|54196673|FG001|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1|||
27746985|NCT02597049|54196684|FG000|Overall Study|Lost to Follow-up|0|||
27746986|NCT02597049|54196685|FG001|Overall Study|Lost to Follow-up|3|||
27746987|NCT02597049|54196686|FG002|Overall Study|Lost to Follow-up|2|||
27746988|NCT02597049|54196684|FG000|Overall Study|Withdrawal by Subject|2|||
27746989|NCT02597049|54196685|FG001|Overall Study|Withdrawal by Subject|2|||
27746990|NCT02597049|54196686|FG002|Overall Study|Withdrawal by Subject|1|||
27746991|NCT02597049|54196684|FG000|Overall Study|Adverse Event|2|||
27746992|NCT02597049|54196685|FG001|Overall Study|Adverse Event|0|||
27746993|NCT02597049|54196686|FG002|Overall Study|Adverse Event|0|||
27746994|NCT02597049|54196684|FG000|Overall Study|Death|2|||
27746995|NCT02597049|54196685|FG001|Overall Study|Death|0|||
27746996|NCT02597049|54196686|FG002|Overall Study|Death|0|||
27746997|NCT02597049|54196684|FG000|Overall Study|Noncompliant with Study Visits|1|||
27746998|NCT02597049|54196685|FG001|Overall Study|Noncompliant with Study Visits|0|||
27746999|NCT02597049|54196686|FG002|Overall Study|Noncompliant with Study Visits|0|||
27747000|NCT02594163|54196696|FG000|Treatment Period|Progressive disease|2|||
27747001|NCT02594163|54196697|FG001|Treatment Period|Progressive disease|3|||
27747002|NCT02594163|54196696|FG000|Treatment Period|Adverse Event|1|||
27747003|NCT02594163|54196697|FG001|Treatment Period|Adverse Event|5|||
27747004|NCT02594163|54196696|FG000|Treatment Period|Physician Decision|1|||
27747005|NCT02594163|54196697|FG001|Treatment Period|Physician Decision|3|||
27747006|NCT02594163|54196696|FG000|Treatment Period|Study termination by sponsor|2|||
27747007|NCT02594163|54196697|FG001|Treatment Period|Study termination by sponsor|1|||
27747008|NCT02594163|54196696|FG000|Treatment Period|Other, Non-AE|1|||
27747009|NCT02594163|54196697|FG001|Treatment Period|Other, Non-AE|0|||
27747010|NCT02594163|54196696|FG000|Follow-up Period|Withdrawal by Subject|0|||
27747011|NCT02594163|54196697|FG001|Follow-up Period|Withdrawal by Subject|1|||
27747012|NCT02594163|54196696|FG000|Follow-up Period|Study Termination by Sponsor|6|||
27747013|NCT02594163|54196697|FG001|Follow-up Period|Study Termination by Sponsor|4|||
27747014|NCT02594163|54196696|FG000|Follow-up Period|Lost to Follow-up|1|||
27747015|NCT02594163|54196697|FG001|Follow-up Period|Lost to Follow-up|0|||
27747016|NCT02594163|54196696|FG000|Follow-up Period|Death|2|||
27747017|NCT02594163|54196697|FG001|Follow-up Period|Death|5|||
27747018|NCT02594163|54196696|FG000|Follow-up Period|Adverse Event|0|||
27747019|NCT02594163|54196697|FG001|Follow-up Period|Adverse Event|1|||
27747020|NCT02594163|54196696|FG000|Follow-up Period|Progressive Disease|2|||
27747021|NCT02594163|54196697|FG001|Follow-up Period|Progressive Disease|0|||
27747022|NCT02594163|54196696|FG000|Follow-up Period|Physician Decision|0|||
27747023|NCT02594163|54196697|FG001|Follow-up Period|Physician Decision|1|||
27747024|NCT02712983|54196712|FG000|Treatment Phase|Adverse Event|3|||
27747025|NCT02712983|54196713|FG001|Treatment Phase|Adverse Event|1|||
27747026|NCT02712983|54196714|FG002|Treatment Phase|Adverse Event|1|||
27747027|NCT02712983|54196715|FG003|Treatment Phase|Adverse Event|4|||
27747028|NCT02712983|54196716|FG004|Treatment Phase|Adverse Event|3|||
27747029|NCT02712983|54196717|FG005|Treatment Phase|Adverse Event|0|||
27747030|NCT02712983|54196718|FG006|Treatment Phase|Adverse Event|6|||
27747031|NCT02712983|54196719|FG007|Treatment Phase|Adverse Event|6|||
27747032|NCT02712983|54196720|FG008|Treatment Phase|Adverse Event|1|||
27747033|NCT02712983|54196712|FG000|Treatment Phase|Protocol Deviation|0|||
27747034|NCT02712983|54196713|FG001|Treatment Phase|Protocol Deviation|0|||
27747035|NCT02712983|54196714|FG002|Treatment Phase|Protocol Deviation|0|||
27747036|NCT02712983|54196715|FG003|Treatment Phase|Protocol Deviation|2|||
27747037|NCT02712983|54196716|FG004|Treatment Phase|Protocol Deviation|0|||
27747038|NCT02712983|54196717|FG005|Treatment Phase|Protocol Deviation|0|||
27747039|NCT02712983|54196718|FG006|Treatment Phase|Protocol Deviation|1|||
27747040|NCT02712983|54196719|FG007|Treatment Phase|Protocol Deviation|0|||
27747041|NCT02712983|54196720|FG008|Treatment Phase|Protocol Deviation|0|||
27747042|NCT02712983|54196712|FG000|Treatment Phase|Technical Problems|0|||
27747043|NCT02712983|54196713|FG001|Treatment Phase|Technical Problems|0|||
27747044|NCT02712983|54196714|FG002|Treatment Phase|Technical Problems|0|||
27747045|NCT02712983|54196715|FG003|Treatment Phase|Technical Problems|0|||
27747046|NCT02712983|54196716|FG004|Treatment Phase|Technical Problems|0|||
27747047|NCT02712983|54196717|FG005|Treatment Phase|Technical Problems|0|||
27747048|NCT02712983|54196718|FG006|Treatment Phase|Technical Problems|1|||
27747049|NCT02712983|54196719|FG007|Treatment Phase|Technical Problems|0|||
27747050|NCT02712983|54196720|FG008|Treatment Phase|Technical Problems|0|||
27747051|NCT02712983|54196712|FG000|Treatment Phase|Physician Decision|0|||
27747052|NCT02712983|54196713|FG001|Treatment Phase|Physician Decision|0|||
27747053|NCT02712983|54196714|FG002|Treatment Phase|Physician Decision|0|||
27747054|NCT02712983|54196715|FG003|Treatment Phase|Physician Decision|0|||
27747055|NCT02712983|54196716|FG004|Treatment Phase|Physician Decision|0|||
27747056|NCT02712983|54196717|FG005|Treatment Phase|Physician Decision|0|||
27747057|NCT02712983|54196718|FG006|Treatment Phase|Physician Decision|0|||
27747058|NCT02712983|54196719|FG007|Treatment Phase|Physician Decision|1|||
27747059|NCT02712983|54196720|FG008|Treatment Phase|Physician Decision|1|||
27747060|NCT02712983|54196712|FG000|Treatment Phase|Subject Decision|2|||
27747061|NCT02712983|54196713|FG001|Treatment Phase|Subject Decision|0|||
27747062|NCT02712983|54196714|FG002|Treatment Phase|Subject Decision|0|||
27747063|NCT02712983|54196715|FG003|Treatment Phase|Subject Decision|2|||
27747064|NCT02712983|54196716|FG004|Treatment Phase|Subject Decision|1|||
27747065|NCT02712983|54196717|FG005|Treatment Phase|Subject Decision|0|||
27747066|NCT02712983|54196718|FG006|Treatment Phase|Subject Decision|1|||
27747067|NCT02712983|54196719|FG007|Treatment Phase|Subject Decision|2|||
27747068|NCT02712983|54196720|FG008|Treatment Phase|Subject Decision|0|||
27747069|NCT02712983|54196712|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
27747070|NCT02712983|54196713|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
27747071|NCT02712983|54196714|FG002|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
27747072|NCT02712983|54196715|FG003|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
27747073|NCT02712983|54196716|FG004|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
27747074|NCT02712983|54196717|FG005|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
27747075|NCT02712983|54196718|FG006|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
27747076|NCT02712983|54196719|FG007|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
27747077|NCT02712983|54196720|FG008|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
27747078|NCT02712983|54196712|FG000|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
27747079|NCT02712983|54196713|FG001|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
27747080|NCT02712983|54196714|FG002|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
27747081|NCT02712983|54196715|FG003|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1|||
27747082|NCT02712983|54196716|FG004|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
27747083|NCT02712983|54196717|FG005|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
27747084|NCT02712983|54196718|FG006|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
27747085|NCT02712983|54196719|FG007|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
27747086|NCT02712983|54196720|FG008|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
27747087|NCT02712983|54196712|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
27747088|NCT02712983|54196713|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
27747089|NCT02712983|54196714|FG002|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
27747090|NCT02712983|54196715|FG003|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
27747091|NCT02712983|54196716|FG004|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
27747092|NCT02712983|54196717|FG005|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
27747093|NCT02712983|54196718|FG006|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
27747094|NCT02712983|54196719|FG007|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
27747095|NCT02712983|54196720|FG008|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
27747096|NCT02596971|54196743|FG000|Overall Study|Death|5|||
27747097|NCT02596971|54196744|FG001|Overall Study|Death|1|||
27747098|NCT02596971|54196745|FG002|Overall Study|Death|5|||
27747099|NCT02596971|54196743|FG000|Overall Study|Withdrawal by Subject|5|||
27747100|NCT02596971|54196744|FG001|Overall Study|Withdrawal by Subject|1|||
27747101|NCT02596971|54196745|FG002|Overall Study|Withdrawal by Subject|4|||
27747102|NCT02593773|54196756|FG000|Overall Study|Voluntary Withdrawal|3|||
27747103|NCT02593773|54196756|FG000|Overall Study|Study Terminated by Sponsor|31|||
27747104|NCT02593773|54196756|FG000|Overall Study|Death|1|||
27747105|NCT02593539|54196760|FG000|Overall Study|Adverse Event|1|||
27747106|NCT00919763|54196769|FG000|Overall Study|Adverse Event|7|||
27747107|NCT00919763|54196770|FG001|Overall Study|Adverse Event|1|||
27747108|NCT00919763|54196769|FG000|Overall Study|Lost to Follow-up|1|||
27747109|NCT00919763|54196770|FG001|Overall Study|Lost to Follow-up|0|||
27747110|NCT00919763|54196769|FG000|Overall Study|Protocol Violation|1|||
27747111|NCT00919763|54196770|FG001|Overall Study|Protocol Violation|1|||
27747112|NCT00919763|54196769|FG000|Overall Study|Withdrawal by Subject|3|||
27747113|NCT00919763|54196770|FG001|Overall Study|Withdrawal by Subject|1|||
27747114|NCT00919763|54196769|FG000|Overall Study|Non-compliance|0|||
27747115|NCT00919763|54196770|FG001|Overall Study|Non-compliance|1|||
27747116|NCT02593305|54196788|FG000|Post 1|Comparison only group. No intervention.|0|||
27747117|NCT02593305|54196789|FG001|Post 1|Comparison only group. No intervention.|0|||
27747118|NCT02593305|54196790|FG002|Post 1|Comparison only group. No intervention.|10|||
27747119|NCT02593149|54196801|FG000|Run-In|Didn't use CVC for at least 21 days|36|||
27747120|NCT02593149|54196802|FG001|Run-In|Didn't use CVC for at least 21 days|38|||
27747121|NCT02593149|54196801|FG000|Intervention|Didn't use CVC for at least 21 day|116|||
27747122|NCT02593149|54196802|FG001|Intervention|Didn't use CVC for at least 21 day|115|||
27747123|NCT02177812|54196817|FG000|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
27747124|NCT02177812|54196818|FG001|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
27747125|NCT02177812|54196819|FG002|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
27747126|NCT02177812|54196820|FG003|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
27747127|NCT02177812|54196821|FG004|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
27747128|NCT02177812|54196822|FG005|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
27747129|NCT02177812|54196823|FG006|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2|||
27747130|NCT02177812|54196824|FG007|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
27747131|NCT02177812|54196825|FG008|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
27747132|NCT02177812|54196817|FG000|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
27747133|NCT02177812|54196818|FG001|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
27831156|NCT00708552|54307299|FG002|Overall Study|Lost to Follow-up|0|||
27747134|NCT02177812|54196819|FG002|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
27747135|NCT02177812|54196820|FG003|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
27747136|NCT02177812|54196821|FG004|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
27747137|NCT02177812|54196822|FG005|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
27747138|NCT02177812|54196823|FG006|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
27747139|NCT02177812|54196824|FG007|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
27747140|NCT02177812|54196825|FG008|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
27747141|NCT02177812|54196817|FG000|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
27747142|NCT02177812|54196818|FG001|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
27747143|NCT02177812|54196819|FG002|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
27747144|NCT02177812|54196820|FG003|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
27747145|NCT02177812|54196821|FG004|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
27747146|NCT02177812|54196822|FG005|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
27747147|NCT02177812|54196823|FG006|Part 1 (Median of 4 Weeks)|Adverse Event|6|||
27747148|NCT02177812|54196824|FG007|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
27747149|NCT02177812|54196825|FG008|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
27747150|NCT01626352|54196869|FG000|Overall Study|Disease Progression|3|||
27747151|NCT01626352|54196869|FG000|Overall Study|Intercurrent Illness|2|||
27747152|NCT01626352|54196869|FG000|Overall Study|Death|2|||
27747153|NCT01626352|54196869|FG000|Overall Study|Withdrawal by Subject|1|||
27747154|NCT01626352|54196869|FG000|Overall Study|Non-Compliance|1|||
27747155|NCT01626352|54196869|FG000|Overall Study|Never Treated|1|||
27747156|NCT01626118|54196880|FG000|Overall Study|Lack of Efficacy|1|||
27747157|NCT01626118|54196881|FG001|Overall Study|Lack of Efficacy|0|||
27747158|NCT01626118|54196882|FG002|Overall Study|Lack of Efficacy|1|||
27747159|NCT01626118|54196883|FG003|Overall Study|Lack of Efficacy|3|||
27747160|NCT01626118|54196880|FG000|Overall Study|Lost to Follow-up|1|||
27747161|NCT01626118|54196881|FG001|Overall Study|Lost to Follow-up|0|||
27747162|NCT01626118|54196882|FG002|Overall Study|Lost to Follow-up|0|||
27747163|NCT01626118|54196883|FG003|Overall Study|Lost to Follow-up|0|||
27747164|NCT01626118|54196880|FG000|Overall Study|Adverse Event|0|||
27747165|NCT01626118|54196881|FG001|Overall Study|Adverse Event|1|||
27747166|NCT01626118|54196882|FG002|Overall Study|Adverse Event|1|||
27747167|NCT01626118|54196883|FG003|Overall Study|Adverse Event|0|||
27747168|NCT01626118|54196880|FG000|Overall Study|Investigator Decision|0|||
27747169|NCT01626118|54196881|FG001|Overall Study|Investigator Decision|1|||
27747170|NCT01626118|54196882|FG002|Overall Study|Investigator Decision|0|||
27747171|NCT01626118|54196883|FG003|Overall Study|Investigator Decision|0|||
27747172|NCT02152384|54196893|FG000|Period 1|Withdrawal by Subject|0|||
27747173|NCT02152384|54196894|FG001|Period 1|Withdrawal by Subject|1|||
27747174|NCT02152384|54196893|FG000|Period 1|Adverse Event|1|||
27747175|NCT02152384|54196894|FG001|Period 1|Adverse Event|1|||
27747176|NCT02177266|54196906|FG000|Overall Study|Adverse Event|0|||
27747177|NCT02177266|54196907|FG001|Overall Study|Adverse Event|1|||
27747178|NCT02177266|54196906|FG000|Overall Study|Withdrawal by Subject|1|||
27747179|NCT02177266|54196907|FG001|Overall Study|Withdrawal by Subject|0|||
27747180|NCT02177032|54196917|FG000|Overall Study|ADMINISTRATIVE REASON|2|||
27747181|NCT02177032|54196918|FG001|Overall Study|ADMINISTRATIVE REASON|0|||
27747182|NCT02177032|54196919|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
27747183|NCT02177032|54196920|FG003|Overall Study|ADMINISTRATIVE REASON|0|||
27747184|NCT02177032|54196917|FG000|Overall Study|Lost to Follow-up|0|||
27747185|NCT02177032|54196918|FG001|Overall Study|Lost to Follow-up|2|||
27747186|NCT02177032|54196919|FG002|Overall Study|Lost to Follow-up|0|||
27747187|NCT02177032|54196920|FG003|Overall Study|Lost to Follow-up|0|||
27747188|NCT02177032|54196917|FG000|Overall Study|OTHER|2|||
27747189|NCT02177032|54196918|FG001|Overall Study|OTHER|0|||
27747190|NCT02177032|54196919|FG002|Overall Study|OTHER|1|||
27747191|NCT02177032|54196920|FG003|Overall Study|OTHER|0|||
27747192|NCT02177032|54196917|FG000|Overall Study|Withdrawal by Subject|1|||
27747193|NCT02177032|54196918|FG001|Overall Study|Withdrawal by Subject|0|||
27747194|NCT02177032|54196919|FG002|Overall Study|Withdrawal by Subject|1|||
27747195|NCT02177032|54196920|FG003|Overall Study|Withdrawal by Subject|0|||
27747196|NCT02116972|54196944|FG000|Overall Study|Adverse Event|4|||
27747197|NCT02116972|54196945|FG001|Overall Study|Adverse Event|4|||
27747198|NCT02116972|54196946|FG002|Overall Study|Adverse Event|1|||
27747199|NCT02116972|54196944|FG000|Overall Study|Withdrawal by Subject|1|||
27747200|NCT02116972|54196945|FG001|Overall Study|Withdrawal by Subject|1|||
27747201|NCT02116972|54196946|FG002|Overall Study|Withdrawal by Subject|5|||
27747202|NCT02116972|54196944|FG000|Overall Study|Protocol Violation|1|||
27747203|NCT02116972|54196945|FG001|Overall Study|Protocol Violation|0|||
27747204|NCT02116972|54196946|FG002|Overall Study|Protocol Violation|1|||
27747205|NCT02116972|54196944|FG000|Overall Study|Lost to Follow-up|4|||
27747206|NCT02116972|54196945|FG001|Overall Study|Lost to Follow-up|3|||
27747207|NCT02116972|54196946|FG002|Overall Study|Lost to Follow-up|1|||
27747208|NCT02116972|54196944|FG000|Overall Study|Lack of Efficacy|6|||
27747209|NCT02116972|54196945|FG001|Overall Study|Lack of Efficacy|6|||
27747210|NCT02116972|54196946|FG002|Overall Study|Lack of Efficacy|5|||
27747211|NCT02116972|54196944|FG000|Overall Study|scheduling conflicts and relocation|3|||
27747212|NCT02116972|54196945|FG001|Overall Study|scheduling conflicts and relocation|3|||
27747213|NCT02116972|54196946|FG002|Overall Study|scheduling conflicts and relocation|6|||
27747214|NCT02176642|54196958|FG000|Overall Study|Withdrawal by Subject|0|||
27747215|NCT02176642|54196959|FG001|Overall Study|Withdrawal by Subject|1|||
27747216|NCT02116660|54196967|FG000|Overall Study|Deteriorating renal function|0|||
27747217|NCT02116660|54196968|FG001|Overall Study|Deteriorating renal function|1|||
27747218|NCT02116660|54196967|FG000|Overall Study|Adverse Event|1|||
27747219|NCT02116660|54196968|FG001|Overall Study|Adverse Event|1|||
27747220|NCT02116660|54196967|FG000|Overall Study|Withdrawal by Subject|0|||
27747221|NCT02116660|54196968|FG001|Overall Study|Withdrawal by Subject|2|||
27747222|NCT02116660|54196967|FG000|Overall Study|Organization reason|1|||
27747223|NCT02116660|54196968|FG001|Overall Study|Organization reason|0|||
27747224|NCT02589405|54196976|FG000|Overall Study|Adverse Event|3|||
27747225|NCT02589405|54196976|FG000|Overall Study|Withdrawal by Subject|1|||
27747226|NCT02176018|54196982|FG000|Overall Study|Adverse Event|0|||
27747227|NCT02176018|54196983|FG001|Overall Study|Adverse Event|2|||
27747228|NCT02176018|54196982|FG000|Overall Study|Lost to Follow-up|3|||
27747229|NCT02176018|54196983|FG001|Overall Study|Lost to Follow-up|1|||
27747230|NCT02176018|54196982|FG000|Overall Study|Protocol Violation|1|||
27747231|NCT02176018|54196983|FG001|Overall Study|Protocol Violation|1|||
27747232|NCT02176018|54196982|FG000|Overall Study|Withdrawal by Subject|1|||
27747233|NCT02176018|54196983|FG001|Overall Study|Withdrawal by Subject|2|||
27747234|NCT02116582|54196989|FG000|Overall Study|Enrolled but Never Received Study Drug|1|||
27747235|NCT02116582|54196989|FG000|Overall Study|Adverse Event|22|||
27747236|NCT02116582|54196989|FG000|Overall Study|Death|9|||
27747237|NCT02116582|54196989|FG000|Overall Study|Progressive Disease|148|||
27747238|NCT02116582|54196989|FG000|Overall Study|Protocol Violation|3|||
27747239|NCT02116582|54196989|FG000|Overall Study|Withdrawal by Subject|8|||
27747240|NCT02116582|54196989|FG000|Overall Study|Other: Miscellaneous|11|||
27747241|NCT02116582|54196989|FG000|Overall Study|Lost to Follow-up|1|||
27747242|NCT02116582|54196989|FG000|Overall Study|Other: Transitioned to 9785-CL-0123|12|||
27747243|NCT02589639|54196996|FG000|Overall Study|Lost to Follow-up|1|||
27747244|NCT02589639|54196997|FG001|Overall Study|Lost to Follow-up|0|||
27747245|NCT02589639|54196998|FG002|Overall Study|Lost to Follow-up|0|||
27747246|NCT02589639|54196996|FG000|Overall Study|Protocol Violation|1|||
27747247|NCT02589639|54196997|FG001|Overall Study|Protocol Violation|0|||
27747248|NCT02589639|54196998|FG002|Overall Study|Protocol Violation|0|||
27747249|NCT02589639|54196996|FG000|Overall Study|Patient withdrawal, not due to AE|3|||
27747250|NCT02589639|54196997|FG001|Overall Study|Patient withdrawal, not due to AE|0|||
27747251|NCT02589639|54196998|FG002|Overall Study|Patient withdrawal, not due to AE|0|||
27747252|NCT02589639|54196996|FG000|Overall Study|Adverse Event|4|||
27747253|NCT02589639|54196997|FG001|Overall Study|Adverse Event|5|||
27747254|NCT02589639|54196998|FG002|Overall Study|Adverse Event|3|||
27747255|NCT02589639|54196996|FG000|Overall Study|Other reason than specified above|1|||
27747256|NCT02589639|54196997|FG001|Overall Study|Other reason than specified above|2|||
27747257|NCT02589639|54196998|FG002|Overall Study|Other reason than specified above|1|||
27747258|NCT02589639|54196996|FG000|Overall Study|Not Treated|0|||
27747259|NCT02589639|54196997|FG001|Overall Study|Not Treated|3|||
27747260|NCT02589639|54196998|FG002|Overall Study|Not Treated|0|||
27747261|NCT02151682|54197008|FG000|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
27747262|NCT02151682|54197009|FG001|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2|||
27747263|NCT02151682|54197010|FG002|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
27747264|NCT02151682|54197011|FG003|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
27747265|NCT02151682|54197012|FG004|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
27747266|NCT02151682|54197013|FG005|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
27747267|NCT02151682|54197008|FG000|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
27747268|NCT02151682|54197009|FG001|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1|||
27747269|NCT02151682|54197010|FG002|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
27747270|NCT02151682|54197011|FG003|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
27747271|NCT02151682|54197012|FG004|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
27747272|NCT02151682|54197013|FG005|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
27747273|NCT02151682|54197008|FG000|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
27747274|NCT02151682|54197009|FG001|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1|||
27747275|NCT02151682|54197010|FG002|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
27747276|NCT02151682|54197011|FG003|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
27747277|NCT02151682|54197012|FG004|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
27747278|NCT02151682|54197013|FG005|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
27747279|NCT02151682|54197008|FG000|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
27747280|NCT02151682|54197009|FG001|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
27747281|NCT02151682|54197010|FG002|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
27747282|NCT02151682|54197011|FG003|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
27747283|NCT02151682|54197012|FG004|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
27747284|NCT02151682|54197013|FG005|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
27747285|NCT02151682|54197008|FG000|Part 1: 14 Days Morphine or Tapentadol|Missing|1|||
27747286|NCT02151682|54197009|FG001|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
27747287|NCT02151682|54197010|FG002|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
27747288|NCT02151682|54197011|FG003|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
27747289|NCT02151682|54197012|FG004|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
27747290|NCT02151682|54197013|FG005|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
27747291|NCT02151682|54197008|FG000|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
27747292|NCT02151682|54197009|FG001|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
27747293|NCT02151682|54197010|FG002|Part 2: Tapent. Extension or Observation|Adverse Event|3|||
27747294|NCT02151682|54197011|FG003|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
27747295|NCT02151682|54197012|FG004|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
27747296|NCT02151682|54197013|FG005|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
27747297|NCT02151682|54197008|FG000|Part 2: Tapent. Extension or Observation|Death|0|||
27747298|NCT02151682|54197009|FG001|Part 2: Tapent. Extension or Observation|Death|0|||
27747299|NCT02151682|54197010|FG002|Part 2: Tapent. Extension or Observation|Death|0|||
27747300|NCT02151682|54197011|FG003|Part 2: Tapent. Extension or Observation|Death|2|||
27747301|NCT02151682|54197012|FG004|Part 2: Tapent. Extension or Observation|Death|0|||
27747302|NCT02151682|54197013|FG005|Part 2: Tapent. Extension or Observation|Death|0|||
27747303|NCT02151682|54197008|FG000|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
27747304|NCT02151682|54197009|FG001|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
27747305|NCT02151682|54197010|FG002|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
27747306|NCT02151682|54197011|FG003|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
27747307|NCT02151682|54197012|FG004|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
27747308|NCT02151682|54197013|FG005|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
27747309|NCT02151682|54197008|FG000|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
27747310|NCT02151682|54197009|FG001|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
27747311|NCT02151682|54197010|FG002|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3|||
27747312|NCT02151682|54197011|FG003|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
27747313|NCT02151682|54197012|FG004|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
27747314|NCT02151682|54197013|FG005|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
27747315|NCT02151682|54197008|FG000|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
27747316|NCT02151682|54197009|FG001|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
27747317|NCT02151682|54197010|FG002|Part 2: Tapent. Extension or Observation|Protocol Violation|1|||
27747318|NCT02151682|54197011|FG003|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
27747319|NCT02151682|54197012|FG004|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
27747320|NCT02151682|54197013|FG005|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
27747321|NCT02151682|54197008|FG000|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
27747322|NCT02151682|54197009|FG001|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
27747323|NCT02151682|54197010|FG002|Part 2: Tapent. Extension or Observation|No need for opioid|13|||
27747324|NCT02151682|54197011|FG003|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
27747325|NCT02151682|54197012|FG004|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
27747326|NCT02151682|54197013|FG005|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
27747327|NCT02151682|54197008|FG000|Part 2: Tapent. Extension or Observation|Missing|0|||
27747328|NCT02151682|54197009|FG001|Part 2: Tapent. Extension or Observation|Missing|0|||
27747329|NCT02151682|54197010|FG002|Part 2: Tapent. Extension or Observation|Missing|0|||
27747330|NCT02151682|54197011|FG003|Part 2: Tapent. Extension or Observation|Missing|1|||
27747331|NCT02151682|54197012|FG004|Part 2: Tapent. Extension or Observation|Missing|0|||
27747332|NCT02151682|54197013|FG005|Part 2: Tapent. Extension or Observation|Missing|0|||
27747333|NCT02151682|54197008|FG000|Part 2: Tapent. Extension or Observation|Various other|0|||
27747334|NCT02151682|54197009|FG001|Part 2: Tapent. Extension or Observation|Various other|0|||
27747335|NCT02151682|54197010|FG002|Part 2: Tapent. Extension or Observation|Various other|6|||
27747336|NCT02151682|54197011|FG003|Part 2: Tapent. Extension or Observation|Various other|0|||
27747337|NCT02151682|54197012|FG004|Part 2: Tapent. Extension or Observation|Various other|0|||
27747338|NCT02151682|54197013|FG005|Part 2: Tapent. Extension or Observation|Various other|0|||
27747339|NCT02151682|54197008|FG000|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
27747340|NCT02151682|54197009|FG001|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
27747341|NCT02151682|54197010|FG002|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1|||
27747342|NCT02151682|54197011|FG003|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
27747343|NCT02151682|54197012|FG004|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
27747344|NCT02151682|54197013|FG005|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
27747345|NCT02151682|54197008|FG000|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
27747346|NCT02151682|54197009|FG001|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
27747347|NCT02151682|54197010|FG002|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
27747348|NCT02151682|54197011|FG003|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
27747349|NCT02151682|54197012|FG004|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
27747350|NCT02151682|54197013|FG005|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1|||
27747351|NCT02151682|54197008|FG000|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
27747352|NCT02151682|54197009|FG001|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
27747353|NCT02151682|54197010|FG002|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
27747354|NCT02151682|54197011|FG003|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
27747355|NCT02151682|54197012|FG004|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
27747356|NCT02151682|54197013|FG005|Part 2: Observ. Aft. Tapent. Extension|Death|1|||
27747357|NCT02151682|54197008|FG000|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
27747358|NCT02151682|54197009|FG001|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
27747359|NCT02151682|54197010|FG002|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
27747360|NCT02151682|54197011|FG003|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
27747361|NCT02151682|54197012|FG004|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
27747362|NCT02151682|54197013|FG005|Part 2: Observ. Aft. Tapent. Extension|Missing|3|||
27747363|NCT02151682|54197008|FG000|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
27747364|NCT02151682|54197009|FG001|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
27747365|NCT02151682|54197010|FG002|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
27747366|NCT02151682|54197011|FG003|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
27747367|NCT02151682|54197012|FG004|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
27747368|NCT02151682|54197013|FG005|Part 2: Observ. Aft. Tapent. Extension|Various other|2|||
27747369|NCT02174848|54197033|FG000|Overall Study|Adverse Event|2|||
27747370|NCT02174848|54197034|FG001|Overall Study|Adverse Event|1|||
27747371|NCT02174848|54197033|FG000|Overall Study|Withdrawal by Subject|3|||
27747372|NCT02174848|54197034|FG001|Overall Study|Withdrawal by Subject|3|||
27747373|NCT02174848|54197033|FG000|Overall Study|Lost to Follow-up|0|||
27747374|NCT02174848|54197034|FG001|Overall Study|Lost to Follow-up|1|||
27747375|NCT02174848|54197033|FG000|Overall Study|Worsening of disease|1|||
27747376|NCT02174848|54197034|FG001|Overall Study|Worsening of disease|1|||
27747377|NCT02174848|54197033|FG000|Overall Study|Unable to comply with study requirements|1|||
27747378|NCT02174848|54197034|FG001|Overall Study|Unable to comply with study requirements|0|||
27747379|NCT02151058|54197048|FG000|Overall Study|Withdrawal by Subject|1|||
27747380|NCT02151058|54197049|FG001|Overall Study|Withdrawal by Subject|1|||
27747381|NCT02151058|54197050|FG002|Overall Study|Withdrawal by Subject|3|||
27747382|NCT02151058|54197048|FG000|Overall Study|Lost to Follow-up|1|||
27747383|NCT02151058|54197049|FG001|Overall Study|Lost to Follow-up|0|||
27747384|NCT02151058|54197050|FG002|Overall Study|Lost to Follow-up|2|||
27747385|NCT02149810|54197060|FG000|Overall Study|Physician Decision|1|||
27747386|NCT02149810|54197061|FG001|Overall Study|Physician Decision|2|||
27747387|NCT02149810|54197060|FG000|Overall Study|Lost to Follow-up|2|||
27747388|NCT02149810|54197061|FG001|Overall Study|Lost to Follow-up|1|||
27747389|NCT02149810|54197060|FG000|Overall Study|Withdrawal by Subject|5|||
27747390|NCT02149810|54197061|FG001|Overall Study|Withdrawal by Subject|1|||
27747391|NCT02149420|54197070|FG000|Core Study|Administrative problems|0|||
27747392|NCT02149420|54197071|FG001|Core Study|Administrative problems|1|||
27747393|NCT02149420|54197072|FG002|Core Study|Administrative problems|2|||
27747394|NCT02149420|54197070|FG000|Open Label VAY736 10 mg/kg Extension|Administrative problems|1|||
27747395|NCT02149420|54197071|FG001|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
27747396|NCT02149420|54197072|FG002|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
27747397|NCT02149264|54197085|FG000|Overall Study|Withdrawal by Subject|9|||
27747398|NCT02149264|54197085|FG000|Overall Study|Adverse Event|7|||
27747399|NCT02149264|54197085|FG000|Overall Study|Physician Decision|3|||
27747400|NCT02149264|54197085|FG000|Overall Study|Protocol Violation|1|||
27747401|NCT02115256|54197091|FG000|Overall Study|Withdrawal by Subject|0|||
27747402|NCT02115256|54197092|FG001|Overall Study|Withdrawal by Subject|1|||
27747403|NCT02173054|54197101|FG000|Overall Study|lack of compliance|1|||
27747404|NCT02173054|54197102|FG001|Overall Study|lack of compliance|0|||
27747405|NCT02173054|54197103|FG002|Overall Study|lack of compliance|0|||
27747406|NCT02173054|54197101|FG000|Overall Study|Withdrawal by Subject|0|||
27747407|NCT02173054|54197102|FG001|Overall Study|Withdrawal by Subject|0|||
27747408|NCT02173054|54197103|FG002|Overall Study|Withdrawal by Subject|1|||
27747409|NCT02149108|54197132|FG000|Overall Study|Not treated|1|||
27747410|NCT02149108|54197133|FG001|Overall Study|Not treated|2|||
27747411|NCT02149108|54197132|FG000|Overall Study|Progressive Disease (PD)|324|||
27747412|NCT02149108|54197133|FG001|Overall Study|Progressive Disease (PD)|318|||
27747413|NCT02149108|54197132|FG000|Overall Study|Worsening/adverse event cancer disease|31|||
27747414|NCT02149108|54197133|FG001|Overall Study|Worsening/adverse event cancer disease|32|||
27747415|NCT02149108|54197132|FG000|Overall Study|Other Adverse Event (AE)|8|||
27747416|NCT02149108|54197133|FG001|Overall Study|Other Adverse Event (AE)|18|||
27747417|NCT02149108|54197132|FG000|Overall Study|Other not defined above|0|||
27747418|NCT02149108|54197133|FG001|Overall Study|Other not defined above|2|||
27747419|NCT02149108|54197132|FG000|Overall Study|Refusal to continue trial medication|15|||
27747420|NCT02149108|54197133|FG001|Overall Study|Refusal to continue trial medication|11|||
27747421|NCT02149108|54197132|FG000|Overall Study|Lost to Follow-up|1|||
27747422|NCT02149108|54197133|FG001|Overall Study|Lost to Follow-up|0|||
27747423|NCT02148952|54197141|FG000|Assessing Eligibility and Consent|Were not eligible for inclusion|1241|||
27747424|NCT02148952|54197142|FG001|Assessing Eligibility and Consent|Were not eligible for inclusion|1591|||
27747425|NCT02148952|54197141|FG000|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862|||
27747426|NCT02148952|54197142|FG001|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556|||
27747427|NCT02148952|54197141|FG000|Follow-Up|Lost to Follow-up|219|||
27747428|NCT02148952|54197142|FG001|Follow-Up|Lost to Follow-up|231|||
27747429|NCT02148952|54197141|FG000|Follow-Up|Withdrawal by Subject|46|||
27747430|NCT02148952|54197142|FG001|Follow-Up|Withdrawal by Subject|48|||
27747431|NCT02148718|54197166|FG000|Overall Study|Protocol Violation|26|||
27747432|NCT02148718|54197166|FG000|Overall Study|Discontinued Study Prematurely|5|||
27747433|NCT02148250|54197170|FG000|Screening|Withdrawal by Subject|5|||
27747434|NCT02148250|54197171|FG001|Screening|Withdrawal by Subject|0|||
27747435|NCT02147626|54197180|FG000|Overall Study|Lost to Follow-up|4|||
27747436|NCT02147626|54197181|FG001|Overall Study|Lost to Follow-up|4|||
27747437|NCT02147626|54197180|FG000|Overall Study|Pregnancy|1|||
27747438|NCT02147626|54197181|FG001|Overall Study|Pregnancy|2|||
27747439|NCT02147626|54197180|FG000|Overall Study|Withdrawal by Subject|0|||
27747440|NCT02147626|54197181|FG001|Overall Study|Withdrawal by Subject|1|||
27747441|NCT02172664|54197187|FG000|Overall Study|Lost to Follow-up|4|||
27747442|NCT02172664|54197188|FG001|Overall Study|Lost to Follow-up|4|||
27747443|NCT02172664|54197187|FG000|Overall Study|Death|1|||
27747444|NCT02172664|54197188|FG001|Overall Study|Death|1|||
27747445|NCT02172664|54197187|FG000|Overall Study|Moved out of area|1|||
27747446|NCT02172664|54197188|FG001|Overall Study|Moved out of area|1|||
27747447|NCT02172040|54197197|FG000|Overall Study|Adverse Event|0|||
27747448|NCT02172040|54197198|FG001|Overall Study|Adverse Event|2|||
27747449|NCT02172040|54197199|FG002|Overall Study|Adverse Event|0|||
27747450|NCT02172040|54197200|FG003|Overall Study|Adverse Event|0|||
27747451|NCT02172040|54197197|FG000|Overall Study|Protocol Violation|0|||
27747452|NCT02172040|54197198|FG001|Overall Study|Protocol Violation|1|||
27747453|NCT02172040|54197199|FG002|Overall Study|Protocol Violation|0|||
27747454|NCT02172040|54197200|FG003|Overall Study|Protocol Violation|0|||
27747455|NCT02172040|54197197|FG000|Overall Study|Withdrawal by Subject|0|||
27747456|NCT02172040|54197198|FG001|Overall Study|Withdrawal by Subject|0|||
27747457|NCT02172040|54197199|FG002|Overall Study|Withdrawal by Subject|1|||
27747458|NCT02172040|54197200|FG003|Overall Study|Withdrawal by Subject|0|||
27747459|NCT02172040|54197197|FG000|Overall Study|Not available for Day 13 & 14 visits|0|||
27747460|NCT02172040|54197198|FG001|Overall Study|Not available for Day 13 & 14 visits|0|||
27747461|NCT02172040|54197199|FG002|Overall Study|Not available for Day 13 & 14 visits|1|||
27747462|NCT02172040|54197200|FG003|Overall Study|Not available for Day 13 & 14 visits|0|||
27747463|NCT02172040|54197197|FG000|Overall Study|Family emergency abroad|0|||
27747464|NCT02172040|54197198|FG001|Overall Study|Family emergency abroad|0|||
27747465|NCT02172040|54197199|FG002|Overall Study|Family emergency abroad|0|||
27747466|NCT02172040|54197200|FG003|Overall Study|Family emergency abroad|1|||
27747467|NCT02112994|54197240|FG000|Overall Study|Progressive Disease|0|||
27747468|NCT02112994|54197241|FG001|Overall Study|Progressive Disease|0|||
27747469|NCT02112994|54197242|FG002|Overall Study|Progressive Disease|1|||
27747470|NCT02112994|54197240|FG000|Overall Study|Pregnancy|0|||
27747471|NCT02112994|54197241|FG001|Overall Study|Pregnancy|1|||
27747472|NCT02112994|54197242|FG002|Overall Study|Pregnancy|1|||
27747473|NCT02112994|54197240|FG000|Overall Study|Liver Transplant|0|||
27747474|NCT02112994|54197241|FG001|Overall Study|Liver Transplant|1|||
27747475|NCT02112994|54197242|FG002|Overall Study|Liver Transplant|0|||
27747476|NCT02112994|54197240|FG000|Overall Study|Withdrawal by Subject|0|||
27747477|NCT02112994|54197241|FG001|Overall Study|Withdrawal by Subject|0|||
27747478|NCT02112994|54197242|FG002|Overall Study|Withdrawal by Subject|1|||
27747479|NCT02147158|54197260|FG000|Treatment Course 1|Adverse Event|1|||
27747480|NCT02147158|54197261|FG001|Treatment Course 1|Adverse Event|4|||
27747481|NCT02147158|54197262|FG002|Treatment Course 1|Adverse Event|3|||
27747482|NCT02147158|54197263|FG003|Treatment Course 1|Adverse Event|4|||
27747483|NCT02147158|54197264|FG004|Treatment Course 1|Adverse Event|1|||
27747484|NCT02147158|54197265|FG005|Treatment Course 1|Adverse Event|2|||
27747485|NCT02147158|54197260|FG000|Treatment Course 1|Lost to Follow-up|2|||
27747486|NCT02147158|54197261|FG001|Treatment Course 1|Lost to Follow-up|4|||
27747487|NCT02147158|54197262|FG002|Treatment Course 1|Lost to Follow-up|3|||
27747488|NCT02147158|54197263|FG003|Treatment Course 1|Lost to Follow-up|3|||
27747489|NCT02147158|54197264|FG004|Treatment Course 1|Lost to Follow-up|2|||
27747490|NCT02147158|54197265|FG005|Treatment Course 1|Lost to Follow-up|4|||
27747491|NCT02147158|54197260|FG000|Treatment Course 1|Protocol Violation|0|||
27747492|NCT02147158|54197261|FG001|Treatment Course 1|Protocol Violation|0|||
27747493|NCT02147158|54197262|FG002|Treatment Course 1|Protocol Violation|1|||
27747494|NCT02147158|54197263|FG003|Treatment Course 1|Protocol Violation|1|||
27747495|NCT02147158|54197264|FG004|Treatment Course 1|Protocol Violation|0|||
27747496|NCT02147158|54197265|FG005|Treatment Course 1|Protocol Violation|0|||
27747497|NCT02147158|54197260|FG000|Treatment Course 1|Withdrawal of Consent|1|||
27747498|NCT02147158|54197261|FG001|Treatment Course 1|Withdrawal of Consent|1|||
27747499|NCT02147158|54197262|FG002|Treatment Course 1|Withdrawal of Consent|1|||
27747500|NCT02147158|54197263|FG003|Treatment Course 1|Withdrawal of Consent|5|||
27747501|NCT02147158|54197264|FG004|Treatment Course 1|Withdrawal of Consent|3|||
27747502|NCT02147158|54197265|FG005|Treatment Course 1|Withdrawal of Consent|2|||
27747503|NCT02147158|54197260|FG000|Off-Treatment Interval 1|Adverse Event|1|||
27747504|NCT02147158|54197261|FG001|Off-Treatment Interval 1|Adverse Event|0|||
27747505|NCT02147158|54197262|FG002|Off-Treatment Interval 1|Adverse Event|0|||
27747506|NCT02147158|54197263|FG003|Off-Treatment Interval 1|Adverse Event|1|||
27747507|NCT02147158|54197264|FG004|Off-Treatment Interval 1|Adverse Event|0|||
27747508|NCT02147158|54197265|FG005|Off-Treatment Interval 1|Adverse Event|0|||
27747509|NCT02147158|54197260|FG000|Off-Treatment Interval 1|Lost to Follow-up|2|||
27747510|NCT02147158|54197261|FG001|Off-Treatment Interval 1|Lost to Follow-up|1|||
27747511|NCT02147158|54197262|FG002|Off-Treatment Interval 1|Lost to Follow-up|3|||
27747512|NCT02147158|54197263|FG003|Off-Treatment Interval 1|Lost to Follow-up|2|||
27747513|NCT02147158|54197264|FG004|Off-Treatment Interval 1|Lost to Follow-up|4|||
27747514|NCT02147158|54197265|FG005|Off-Treatment Interval 1|Lost to Follow-up|2|||
27747515|NCT02147158|54197260|FG000|Off-Treatment Interval 1|Protocol Violation|1|||
27747516|NCT02147158|54197261|FG001|Off-Treatment Interval 1|Protocol Violation|0|||
27747517|NCT02147158|54197262|FG002|Off-Treatment Interval 1|Protocol Violation|2|||
27747518|NCT02147158|54197263|FG003|Off-Treatment Interval 1|Protocol Violation|0|||
27747519|NCT02147158|54197264|FG004|Off-Treatment Interval 1|Protocol Violation|1|||
27747520|NCT02147158|54197265|FG005|Off-Treatment Interval 1|Protocol Violation|0|||
27747521|NCT02147158|54197260|FG000|Off-Treatment Interval 1|Withdrawal of Consent|4|||
27747522|NCT02147158|54197261|FG001|Off-Treatment Interval 1|Withdrawal of Consent|3|||
27747523|NCT02147158|54197262|FG002|Off-Treatment Interval 1|Withdrawal of Consent|5|||
27747524|NCT02147158|54197263|FG003|Off-Treatment Interval 1|Withdrawal of Consent|10|||
27747525|NCT02147158|54197264|FG004|Off-Treatment Interval 1|Withdrawal of Consent|2|||
27747526|NCT02147158|54197265|FG005|Off-Treatment Interval 1|Withdrawal of Consent|3|||
27747527|NCT02147158|54197260|FG000|Off-Treatment Interval 1|Lack of Efficacy|0|||
27747528|NCT02147158|54197261|FG001|Off-Treatment Interval 1|Lack of Efficacy|0|||
27747529|NCT02147158|54197262|FG002|Off-Treatment Interval 1|Lack of Efficacy|2|||
27747530|NCT02147158|54197263|FG003|Off-Treatment Interval 1|Lack of Efficacy|0|||
27747531|NCT02147158|54197264|FG004|Off-Treatment Interval 1|Lack of Efficacy|1|||
27747532|NCT02147158|54197265|FG005|Off-Treatment Interval 1|Lack of Efficacy|0|||
27747533|NCT02147158|54197260|FG000|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
27747534|NCT02147158|54197261|FG001|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
27747535|NCT02147158|54197262|FG002|Off-Treatment Interval 1|Other Miscellaneous Reasons|3|||
27747536|NCT02147158|54197263|FG003|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
27747537|NCT02147158|54197264|FG004|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
27747538|NCT02147158|54197265|FG005|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
27747539|NCT02147158|54197260|FG000|Treatment Course 2|Adverse Event|0|||
27747540|NCT02147158|54197261|FG001|Treatment Course 2|Adverse Event|4|||
27747541|NCT02147158|54197262|FG002|Treatment Course 2|Adverse Event|2|||
27747542|NCT02147158|54197263|FG003|Treatment Course 2|Adverse Event|1|||
27747543|NCT02147158|54197264|FG004|Treatment Course 2|Adverse Event|0|||
27747544|NCT02147158|54197265|FG005|Treatment Course 2|Adverse Event|1|||
27747545|NCT02147158|54197260|FG000|Treatment Course 2|Withdrawal of Consent|0|||
27747546|NCT02147158|54197261|FG001|Treatment Course 2|Withdrawal of Consent|1|||
27747547|NCT02147158|54197262|FG002|Treatment Course 2|Withdrawal of Consent|2|||
27747548|NCT02147158|54197263|FG003|Treatment Course 2|Withdrawal of Consent|3|||
27747549|NCT02147158|54197264|FG004|Treatment Course 2|Withdrawal of Consent|0|||
27747550|NCT02147158|54197265|FG005|Treatment Course 2|Withdrawal of Consent|0|||
27747551|NCT02147158|54197260|FG000|Treatment Course 2|Lost to Follow-up|1|||
27747552|NCT02147158|54197261|FG001|Treatment Course 2|Lost to Follow-up|0|||
27747553|NCT02147158|54197262|FG002|Treatment Course 2|Lost to Follow-up|1|||
27747554|NCT02147158|54197263|FG003|Treatment Course 2|Lost to Follow-up|1|||
27747555|NCT02147158|54197264|FG004|Treatment Course 2|Lost to Follow-up|0|||
27747556|NCT02147158|54197265|FG005|Treatment Course 2|Lost to Follow-up|1|||
27747557|NCT02147158|54197260|FG000|Off-Treatment Interval 2|Lack of Efficacy|0|||
27747558|NCT02147158|54197261|FG001|Off-Treatment Interval 2|Lack of Efficacy|1|||
27747559|NCT02147158|54197262|FG002|Off-Treatment Interval 2|Lack of Efficacy|1|||
27747560|NCT02147158|54197263|FG003|Off-Treatment Interval 2|Lack of Efficacy|0|||
27747561|NCT02147158|54197264|FG004|Off-Treatment Interval 2|Lack of Efficacy|0|||
27747562|NCT02147158|54197265|FG005|Off-Treatment Interval 2|Lack of Efficacy|0|||
27747563|NCT02147158|54197260|FG000|Off-Treatment Interval 2|Withdrawal of Consent|4|||
27747564|NCT02147158|54197261|FG001|Off-Treatment Interval 2|Withdrawal of Consent|0|||
27747565|NCT02147158|54197262|FG002|Off-Treatment Interval 2|Withdrawal of Consent|5|||
27747566|NCT02147158|54197263|FG003|Off-Treatment Interval 2|Withdrawal of Consent|4|||
27747567|NCT02147158|54197264|FG004|Off-Treatment Interval 2|Withdrawal of Consent|0|||
27747568|NCT02147158|54197265|FG005|Off-Treatment Interval 2|Withdrawal of Consent|1|||
27747569|NCT02147158|54197260|FG000|Off-Treatment Interval 2|Lost to Follow-up|0|||
27747570|NCT02147158|54197261|FG001|Off-Treatment Interval 2|Lost to Follow-up|0|||
27747571|NCT02147158|54197262|FG002|Off-Treatment Interval 2|Lost to Follow-up|3|||
27747572|NCT02147158|54197263|FG003|Off-Treatment Interval 2|Lost to Follow-up|2|||
27747573|NCT02147158|54197264|FG004|Off-Treatment Interval 2|Lost to Follow-up|2|||
27747574|NCT02147158|54197265|FG005|Off-Treatment Interval 2|Lost to Follow-up|2|||
27747575|NCT02147158|54197260|FG000|Off-Treatment Interval 2|Protocol Violation|0|||
27747576|NCT02147158|54197261|FG001|Off-Treatment Interval 2|Protocol Violation|0|||
27747577|NCT02147158|54197262|FG002|Off-Treatment Interval 2|Protocol Violation|0|||
27747578|NCT02147158|54197263|FG003|Off-Treatment Interval 2|Protocol Violation|1|||
27747579|NCT02147158|54197264|FG004|Off-Treatment Interval 2|Protocol Violation|0|||
27747580|NCT02147158|54197265|FG005|Off-Treatment Interval 2|Protocol Violation|0|||
27747581|NCT02147158|54197260|FG000|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
27747582|NCT02147158|54197261|FG001|Off-Treatment Interval 2|Other Miscellaneous Reasons|3|||
27747583|NCT02147158|54197262|FG002|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
27747584|NCT02147158|54197263|FG003|Off-Treatment Interval 2|Other Miscellaneous Reasons|4|||
27747585|NCT02147158|54197264|FG004|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
27747586|NCT02147158|54197265|FG005|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
27747587|NCT02112448|54197284|FG000|Overall Study|lab values precluding use of ketorolac|2|||
27747588|NCT02112448|54197285|FG001|Overall Study|lab values precluding use of ketorolac|2|||
27747589|NCT02112448|54197284|FG000|Overall Study|Protocol Violation|1|||
27747590|NCT02112448|54197285|FG001|Overall Study|Protocol Violation|2|||
27747591|NCT02112448|54197284|FG000|Overall Study|Physician Decision|4|||
27747592|NCT02112448|54197285|FG001|Overall Study|Physician Decision|6|||
27747593|NCT02112448|54197284|FG000|Overall Study|required heparin so could not use ketoro|1|||
27747594|NCT02112448|54197285|FG001|Overall Study|required heparin so could not use ketoro|0|||
27747595|NCT02171260|54197297|FG000|Overall Study|Death|0|||
27747596|NCT02171260|54197298|FG001|Overall Study|Death|0|||
27747597|NCT02171260|54197299|FG002|Overall Study|Death|0|||
27747598|NCT02171260|54197300|FG003|Overall Study|Death|1|||
27747599|NCT02171260|54197297|FG000|Overall Study|Physician Decision|1|||
27747600|NCT02171260|54197298|FG001|Overall Study|Physician Decision|0|||
27747601|NCT02171260|54197299|FG002|Overall Study|Physician Decision|1|||
27747602|NCT02171260|54197300|FG003|Overall Study|Physician Decision|0|||
27747603|NCT02171260|54197297|FG000|Overall Study|Withdrawal by Subject|1|||
27747604|NCT02171260|54197298|FG001|Overall Study|Withdrawal by Subject|0|||
27747605|NCT02171260|54197299|FG002|Overall Study|Withdrawal by Subject|0|||
27747606|NCT02171260|54197300|FG003|Overall Study|Withdrawal by Subject|0|||
27747607|NCT02171260|54197297|FG000|Overall Study|Evidence of progressive disease|4|||
27747608|NCT02171260|54197298|FG001|Overall Study|Evidence of progressive disease|6|||
27747609|NCT02171260|54197299|FG002|Overall Study|Evidence of progressive disease|4|||
27747610|NCT02171260|54197300|FG003|Overall Study|Evidence of progressive disease|4|||
27747611|NCT02110732|54197318|FG000|Overall Study|Physician Decision|5|||
27747612|NCT02110732|54197319|FG001|Overall Study|Physician Decision|2|||
27747613|NCT02110732|54197318|FG000|Overall Study|Lost to Follow-up|1|||
27747614|NCT02110732|54197319|FG001|Overall Study|Lost to Follow-up|1|||
27747615|NCT02109562|54197328|FG000|Overall Study|Insufficient clinical response|2|||
27747616|NCT02109562|54197329|FG001|Overall Study|Insufficient clinical response|0|||
27747617|NCT02109562|54197330|FG002|Overall Study|Insufficient clinical response|4|||
27747618|NCT02109562|54197328|FG000|Overall Study|Adverse Event|0|||
27747619|NCT02109562|54197329|FG001|Overall Study|Adverse Event|2|||
27747620|NCT02109562|54197330|FG002|Overall Study|Adverse Event|3|||
27747621|NCT02109562|54197328|FG000|Overall Study|Lost to Follow-up|1|||
27747622|NCT02109562|54197329|FG001|Overall Study|Lost to Follow-up|0|||
27747623|NCT02109562|54197330|FG002|Overall Study|Lost to Follow-up|1|||
27747624|NCT02109562|54197328|FG000|Overall Study|Protocol Violation|0|||
27747625|NCT02109562|54197329|FG001|Overall Study|Protocol Violation|3|||
27747626|NCT02109562|54197330|FG002|Overall Study|Protocol Violation|1|||
27747627|NCT02109562|54197328|FG000|Overall Study|Withdrawal by Subject|20|||
27747628|NCT02109562|54197329|FG001|Overall Study|Withdrawal by Subject|25|||
27747629|NCT02109562|54197330|FG002|Overall Study|Withdrawal by Subject|21|||
27926877|NCT01218477|54583323|FG003|Overall Study|Withdrawal by Subject|0|||
27926878|NCT01218477|54583320|FG000|Overall Study|Prepared for cell transplantation|0|||
27926879|NCT01218477|54583321|FG001|Overall Study|Prepared for cell transplantation|1|||
27926880|NCT01218477|54583322|FG002|Overall Study|Prepared for cell transplantation|1|||
28105466|NCT04502979|54762801|FG000|Overall Study|Withdrawal by Subject|2|||
27747630|NCT02109562|54197328|FG000|Overall Study|Physician Decision|3|||
27747631|NCT02109562|54197329|FG001|Overall Study|Physician Decision|4|||
27747632|NCT02109562|54197330|FG002|Overall Study|Physician Decision|5|||
27747633|NCT02109484|54197346|FG000|Overall Study|Lost to Follow-up|0|||
27747634|NCT02109484|54197347|FG001|Overall Study|Lost to Follow-up|0|||
27747635|NCT02109484|54197348|FG002|Overall Study|Lost to Follow-up|0|||
27747636|NCT02109484|54197349|FG003|Overall Study|Lost to Follow-up|1|||
27747637|NCT02109484|54197350|FG004|Overall Study|Lost to Follow-up|1|||
27747638|NCT02109484|54197351|FG005|Overall Study|Lost to Follow-up|0|||
27747639|NCT02109484|54197352|FG006|Overall Study|Lost to Follow-up|1|||
27747640|NCT02109484|54197353|FG007|Overall Study|Lost to Follow-up|0|||
27747641|NCT02109484|54197346|FG000|Overall Study|Withdrawal by Subject|0|||
27747642|NCT02109484|54197347|FG001|Overall Study|Withdrawal by Subject|0|||
27747643|NCT02109484|54197348|FG002|Overall Study|Withdrawal by Subject|0|||
27747644|NCT02109484|54197349|FG003|Overall Study|Withdrawal by Subject|0|||
27747645|NCT02109484|54197350|FG004|Overall Study|Withdrawal by Subject|1|||
27747646|NCT02109484|54197351|FG005|Overall Study|Withdrawal by Subject|1|||
27747647|NCT02109484|54197352|FG006|Overall Study|Withdrawal by Subject|1|||
27747648|NCT02109484|54197353|FG007|Overall Study|Withdrawal by Subject|0|||
27747649|NCT02109484|54197346|FG000|Overall Study|Physician Decision|0|||
27747650|NCT02109484|54197347|FG001|Overall Study|Physician Decision|0|||
27747651|NCT02109484|54197348|FG002|Overall Study|Physician Decision|0|||
27747652|NCT02109484|54197349|FG003|Overall Study|Physician Decision|0|||
27747653|NCT02109484|54197350|FG004|Overall Study|Physician Decision|2|||
27747654|NCT02109484|54197351|FG005|Overall Study|Physician Decision|0|||
27747655|NCT02109484|54197352|FG006|Overall Study|Physician Decision|0|||
27747656|NCT02109484|54197353|FG007|Overall Study|Physician Decision|0|||
27747657|NCT02109484|54197346|FG000|Overall Study|Death|0|||
27747658|NCT02109484|54197347|FG001|Overall Study|Death|0|||
27747659|NCT02109484|54197348|FG002|Overall Study|Death|0|||
27747660|NCT02109484|54197349|FG003|Overall Study|Death|0|||
27747661|NCT02109484|54197350|FG004|Overall Study|Death|0|||
27747662|NCT02109484|54197351|FG005|Overall Study|Death|0|||
27747663|NCT02109484|54197352|FG006|Overall Study|Death|0|||
27747664|NCT02109484|54197353|FG007|Overall Study|Death|2|||
27747665|NCT02109484|54197346|FG000|Overall Study|Moved away from study area|0|||
27747666|NCT02109484|54197347|FG001|Overall Study|Moved away from study area|0|||
27747667|NCT02109484|54197348|FG002|Overall Study|Moved away from study area|0|||
27747668|NCT02109484|54197349|FG003|Overall Study|Moved away from study area|0|||
27747669|NCT02109484|54197350|FG004|Overall Study|Moved away from study area|0|||
27747670|NCT02109484|54197351|FG005|Overall Study|Moved away from study area|0|||
27747671|NCT02109484|54197352|FG006|Overall Study|Moved away from study area|1|||
27747672|NCT02109484|54197353|FG007|Overall Study|Moved away from study area|1|||
27747673|NCT02105974|54197390|FG000|2 Week Run-in Period|Withdrew during pre-screen period|158|||
27747674|NCT02105974|54197391|FG001|2 Week Run-in Period|Withdrew during pre-screen period|0|||
27747675|NCT02105974|54197392|FG002|2 Week Run-in Period|Withdrew during pre-screen period|0|||
27747676|NCT02105974|54197390|FG000|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603|||
27747677|NCT02105974|54197391|FG001|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
27747678|NCT02105974|54197392|FG002|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
27747679|NCT02105974|54197390|FG000|2 Week Run-in Period|Adverse Event|6|||
27747680|NCT02105974|54197391|FG001|2 Week Run-in Period|Adverse Event|0|||
27747681|NCT02105974|54197392|FG002|2 Week Run-in Period|Adverse Event|0|||
27747682|NCT02105974|54197390|FG000|2 Week Run-in Period|Study closed/terminated|1|||
27747683|NCT02105974|54197391|FG001|2 Week Run-in Period|Study closed/terminated|0|||
27747684|NCT02105974|54197392|FG002|2 Week Run-in Period|Study closed/terminated|0|||
27747685|NCT02105974|54197390|FG000|2 Week Run-in Period|Lost to Follow-up|2|||
28105467|NCT04502979|54762802|FG001|Overall Study|Withdrawal by Subject|1|||
28105468|NCT04590027|54762810|FG000|Overall Study|Lost to Follow-up|17|||
28105469|NCT04590027|54762811|FG001|Overall Study|Lost to Follow-up|14|||
28105470|NCT04590027|54762810|FG000|Overall Study|Protocol Violation|0|||
28105471|NCT04590027|54762811|FG001|Overall Study|Protocol Violation|3|||
28105472|NCT04587453|54762823|FG000|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|0|||
28105473|NCT04587453|54762824|FG001|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|1|||
28105474|NCT02793232|54762841|FG000|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
28105475|NCT02793232|54762842|FG001|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
27747686|NCT02105974|54197391|FG001|2 Week Run-in Period|Lost to Follow-up|0|||
27747687|NCT02105974|54197392|FG002|2 Week Run-in Period|Lost to Follow-up|0|||
27747688|NCT02105974|54197390|FG000|2 Week Run-in Period|Withdrew consent|23|||
27747689|NCT02105974|54197391|FG001|2 Week Run-in Period|Withdrew consent|0|||
27747690|NCT02105974|54197392|FG002|2 Week Run-in Period|Withdrew consent|0|||
27747691|NCT02105974|54197390|FG000|2 Week Run-in Period|Investigator discretion|8|||
27747692|NCT02105974|54197391|FG001|2 Week Run-in Period|Investigator discretion|0|||
27747693|NCT02105974|54197392|FG002|2 Week Run-in Period|Investigator discretion|0|||
28159926|NCT02737475|54830028|FG006|Overall Study|Other reasons|0|||
27747694|NCT02105974|54197390|FG000|12 Week (Wk) Treatment Period (TP)|Adverse Event|0|||
27747695|NCT02105974|54197391|FG001|12 Week (Wk) Treatment Period (TP)|Adverse Event|14|||
27747696|NCT02105974|54197392|FG002|12 Week (Wk) Treatment Period (TP)|Adverse Event|18|||
27747697|NCT02105974|54197390|FG000|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0|||
27747698|NCT02105974|54197391|FG001|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6|||
27747699|NCT02105974|54197392|FG002|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9|||
27747700|NCT02105974|54197390|FG000|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0|||
27747701|NCT02105974|54197391|FG001|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2|||
27831157|NCT00708552|54307300|FG003|Overall Study|Lost to Follow-up|1|||
27747702|NCT02105974|54197392|FG002|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6|||
27747703|NCT02105974|54197390|FG000|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0|||
27747704|NCT02105974|54197391|FG001|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1|||
27747705|NCT02105974|54197392|FG002|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2|||
27747706|NCT02105974|54197390|FG000|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
27747707|NCT02105974|54197391|FG001|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
27747708|NCT02105974|54197392|FG002|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1|||
27747709|NCT02105974|54197390|FG000|12 Week (Wk) Treatment Period (TP)|Physician Decision|0|||
27747710|NCT02105974|54197391|FG001|12 Week (Wk) Treatment Period (TP)|Physician Decision|7|||
27747711|NCT02105974|54197392|FG002|12 Week (Wk) Treatment Period (TP)|Physician Decision|4|||
27747712|NCT02105974|54197390|FG000|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0|||
27747713|NCT02105974|54197391|FG001|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12|||
27747714|NCT02105974|54197392|FG002|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18|||
27747715|NCT02105662|54197398|FG000|Overall Study|Lost to Follow-up|5|||
27747716|NCT02105662|54197398|FG000|Overall Study|Withdrawal by Subject|1|||
27747717|NCT02143102|54197404|FG000|Overall Study|Lost to Follow-up|11|||
27747718|NCT02143102|54197405|FG001|Overall Study|Lost to Follow-up|0|||
27747719|NCT02143024|54197413|FG000|Overall Study|Lost to Follow-up|1|||
27747720|NCT02143024|54197414|FG001|Overall Study|Lost to Follow-up|1|||
27747721|NCT02143024|54197413|FG000|Overall Study|Withdrawal by Subject|1|||
27747722|NCT02143024|54197414|FG001|Overall Study|Withdrawal by Subject|0|||
27747723|NCT02142712|54197423|FG000|Overall Study|Lost to Follow-up|1|||
27747724|NCT02142712|54197424|FG001|Overall Study|Lost to Follow-up|1|||
27747725|NCT02142712|54197425|FG002|Overall Study|Lost to Follow-up|1|||
27747726|NCT02142712|54197426|FG003|Overall Study|Lost to Follow-up|0|||
27747727|NCT02105272|54197437|FG000|Overall Study|Adverse Event|1|||
27747728|NCT02105272|54197438|FG001|Overall Study|Adverse Event|2|||
27747729|NCT02105272|54197437|FG000|Overall Study|Physician Decision|0|||
27747730|NCT02105272|54197438|FG001|Overall Study|Physician Decision|1|||
27747731|NCT02105272|54197437|FG000|Overall Study|Protocol Violation|2|||
27747732|NCT02105272|54197438|FG001|Overall Study|Protocol Violation|0|||
27747733|NCT02105272|54197437|FG000|Overall Study|Withdrawal by Subject|2|||
27747734|NCT02105272|54197438|FG001|Overall Study|Withdrawal by Subject|0|||
27747735|NCT02141854|54197449|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|25|||
27747736|NCT02141854|54197450|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
27747737|NCT02141854|54197451|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
27747738|NCT02141854|54197452|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
27747739|NCT02141854|54197453|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
27747740|NCT02141854|54197454|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
27747741|NCT02141854|54197449|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|76|||
27747742|NCT02141854|54197450|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
27747743|NCT02141854|54197451|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
27747744|NCT02141854|54197452|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
27747745|NCT02141854|54197453|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
27747746|NCT02141854|54197454|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
27747747|NCT02141854|54197449|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|14|||
27747748|NCT02141854|54197450|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
27747749|NCT02141854|54197451|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
27747750|NCT02141854|54197452|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
27747751|NCT02141854|54197453|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
27747752|NCT02141854|54197454|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
27747753|NCT02141854|54197449|FG000|Run-In Period (Pre-assignment)|Other|14|||
27747754|NCT02141854|54197450|FG001|Run-In Period (Pre-assignment)|Other|0|||
27747755|NCT02141854|54197451|FG002|Run-In Period (Pre-assignment)|Other|0|||
27747756|NCT02141854|54197452|FG003|Run-In Period (Pre-assignment)|Other|0|||
27747757|NCT02141854|54197453|FG004|Run-In Period (Pre-assignment)|Other|0|||
27747758|NCT02141854|54197454|FG005|Run-In Period (Pre-assignment)|Other|0|||
27747759|NCT02141854|54197449|FG000|Run-In Period (Pre-assignment)|Adverse Event|10|||
27747760|NCT02141854|54197450|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
27747761|NCT02141854|54197451|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
27747762|NCT02141854|54197452|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
27747763|NCT02141854|54197453|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
27747764|NCT02141854|54197454|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
27747765|NCT02141854|54197449|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|9|||
27747766|NCT02141854|54197450|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
27747767|NCT02141854|54197451|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
27747768|NCT02141854|54197452|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
27747769|NCT02141854|54197453|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
27747770|NCT02141854|54197454|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
27747771|NCT02141854|54197449|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
27747772|NCT02141854|54197450|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
27747773|NCT02141854|54197451|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
27747774|NCT02141854|54197452|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
27747775|NCT02141854|54197453|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
27747776|NCT02141854|54197454|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
27747777|NCT02141854|54197449|FG000|Treatment Period|Protocol Violation|0|||
27747778|NCT02141854|54197450|FG001|Treatment Period|Protocol Violation|1|||
27747779|NCT02141854|54197451|FG002|Treatment Period|Protocol Violation|0|||
27747780|NCT02141854|54197452|FG003|Treatment Period|Protocol Violation|2|||
27747781|NCT02141854|54197453|FG004|Treatment Period|Protocol Violation|2|||
27747782|NCT02141854|54197454|FG005|Treatment Period|Protocol Violation|1|||
27747783|NCT02141854|54197449|FG000|Treatment Period|Noncompliance|0|||
27747784|NCT02141854|54197450|FG001|Treatment Period|Noncompliance|0|||
27836319|NCT01551173|54321264|FG000|Overall Study|Adverse Event|7|||
27836320|NCT01551173|54321265|FG001|Overall Study|Adverse Event|6|||
27836321|NCT01551173|54321264|FG000|Overall Study|Lost to Follow-up|5|||
27747785|NCT02141854|54197451|FG002|Treatment Period|Noncompliance|0|||
27747786|NCT02141854|54197452|FG003|Treatment Period|Noncompliance|1|||
27747787|NCT02141854|54197453|FG004|Treatment Period|Noncompliance|0|||
27747788|NCT02141854|54197454|FG005|Treatment Period|Noncompliance|0|||
27747789|NCT02141854|54197449|FG000|Treatment Period|Lack of Efficacy|0|||
27747790|NCT02141854|54197450|FG001|Treatment Period|Lack of Efficacy|0|||
27747791|NCT02141854|54197451|FG002|Treatment Period|Lack of Efficacy|0|||
27747792|NCT02141854|54197452|FG003|Treatment Period|Lack of Efficacy|1|||
27747793|NCT02141854|54197453|FG004|Treatment Period|Lack of Efficacy|1|||
27747794|NCT02141854|54197454|FG005|Treatment Period|Lack of Efficacy|7|||
27747795|NCT02141854|54197449|FG000|Treatment Period|Pregnancy|0|||
27747796|NCT02141854|54197450|FG001|Treatment Period|Pregnancy|1|||
27747797|NCT02141854|54197451|FG002|Treatment Period|Pregnancy|0|||
27747798|NCT02141854|54197452|FG003|Treatment Period|Pregnancy|0|||
27747799|NCT02141854|54197453|FG004|Treatment Period|Pregnancy|0|||
27747800|NCT02141854|54197454|FG005|Treatment Period|Pregnancy|0|||
27747801|NCT02141854|54197449|FG000|Treatment Period|Other|0|||
27747802|NCT02141854|54197450|FG001|Treatment Period|Other|1|||
27747803|NCT02141854|54197451|FG002|Treatment Period|Other|2|||
27747804|NCT02141854|54197452|FG003|Treatment Period|Other|0|||
27747805|NCT02141854|54197453|FG004|Treatment Period|Other|1|||
27747806|NCT02141854|54197454|FG005|Treatment Period|Other|2|||
27747807|NCT02141854|54197449|FG000|Treatment Period|Adverse Event|0|||
27747808|NCT02141854|54197450|FG001|Treatment Period|Adverse Event|2|||
27747809|NCT02141854|54197451|FG002|Treatment Period|Adverse Event|2|||
27747810|NCT02141854|54197452|FG003|Treatment Period|Adverse Event|0|||
27747811|NCT02141854|54197453|FG004|Treatment Period|Adverse Event|2|||
27747812|NCT02141854|54197454|FG005|Treatment Period|Adverse Event|2|||
27747813|NCT02141854|54197449|FG000|Treatment Period|Withdrawal by Subject|0|||
27747814|NCT02141854|54197450|FG001|Treatment Period|Withdrawal by Subject|2|||
27747815|NCT02141854|54197451|FG002|Treatment Period|Withdrawal by Subject|3|||
27747816|NCT02141854|54197452|FG003|Treatment Period|Withdrawal by Subject|3|||
27747817|NCT02141854|54197453|FG004|Treatment Period|Withdrawal by Subject|4|||
27747818|NCT02141854|54197454|FG005|Treatment Period|Withdrawal by Subject|7|||
27747819|NCT02141854|54197449|FG000|Treatment Period|Disease progression|0|||
27747820|NCT02141854|54197450|FG001|Treatment Period|Disease progression|2|||
27747821|NCT02141854|54197451|FG002|Treatment Period|Disease progression|1|||
27747822|NCT02141854|54197452|FG003|Treatment Period|Disease progression|3|||
27747823|NCT02141854|54197453|FG004|Treatment Period|Disease progression|0|||
27747824|NCT02141854|54197454|FG005|Treatment Period|Disease progression|18|||
27747825|NCT02141854|54197449|FG000|Treatment Period|Lost to Follow-up|0|||
27747826|NCT02141854|54197450|FG001|Treatment Period|Lost to Follow-up|1|||
27747827|NCT02141854|54197451|FG002|Treatment Period|Lost to Follow-up|1|||
27747828|NCT02141854|54197452|FG003|Treatment Period|Lost to Follow-up|1|||
27747829|NCT02141854|54197453|FG004|Treatment Period|Lost to Follow-up|0|||
27747830|NCT02141854|54197454|FG005|Treatment Period|Lost to Follow-up|1|||
27747831|NCT02587221|54197468|FG000|Overall Study|Adverse Event|3|||
27747832|NCT02587221|54197469|FG001|Overall Study|Adverse Event|3|||
27747833|NCT02587221|54197468|FG000|Overall Study|Death|33|||
27747834|NCT02587221|54197469|FG001|Overall Study|Death|34|||
27747835|NCT02587221|54197468|FG000|Overall Study|Withdrawal by Subject|66|||
27747836|NCT02587221|54197469|FG001|Overall Study|Withdrawal by Subject|61|||
27747837|NCT02587221|54197468|FG000|Overall Study|Lost to Follow-up|21|||
27747838|NCT02587221|54197469|FG001|Overall Study|Lost to Follow-up|19|||
27747839|NCT02587221|54197468|FG000|Overall Study|Protocol Violation|6|||
27747840|NCT02587221|54197469|FG001|Overall Study|Protocol Violation|5|||
27747841|NCT02587221|54197468|FG000|Overall Study|Other Reason or Unspecified|2|||
27747842|NCT02587221|54197469|FG001|Overall Study|Other Reason or Unspecified|1|||
27747843|NCT02141620|54197475|FG000|Treatment Condition 1 (7 Days)|Adverse Event|1|||
27747844|NCT02141620|54197476|FG001|Treatment Condition 1 (7 Days)|Adverse Event|0|||
27747845|NCT02106910|54197484|FG000|Overall Study|Lost to Follow-up|1|||
27747846|NCT02106910|54197485|FG001|Overall Study|Lost to Follow-up|1|||
27747847|NCT01664949|54197494|FG000|Overall Study|Adverse Event|11|||
27747848|NCT01664949|54197495|FG001|Overall Study|Adverse Event|12|||
27747849|NCT01664949|54197494|FG000|Overall Study|Lack of Efficacy|1|||
27747850|NCT01664949|54197495|FG001|Overall Study|Lack of Efficacy|1|||
27747851|NCT01664949|54197494|FG000|Overall Study|Lost to Follow-up|1|||
27747852|NCT01664949|54197495|FG001|Overall Study|Lost to Follow-up|2|||
27747853|NCT01664949|54197494|FG000|Overall Study|Personal Reasons|3|||
27747854|NCT01664949|54197495|FG001|Overall Study|Personal Reasons|4|||
27747855|NCT01664949|54197494|FG000|Overall Study|Protocol Violation|5|||
27747856|NCT01664949|54197495|FG001|Overall Study|Protocol Violation|5|||
27747857|NCT01664949|54197494|FG000|Overall Study|Other Miscellaneous Reasons|3|||
27747858|NCT01664949|54197495|FG001|Overall Study|Other Miscellaneous Reasons|1|||
27747859|NCT02587143|54197503|FG000|Overall Study|Adverse Event|1|||
27747860|NCT02587143|54197504|FG001|Overall Study|Adverse Event|0|||
27747861|NCT02587065|54197510|FG000|Overall Study|Adverse Event|14|||
27747862|NCT02587065|54197510|FG000|Overall Study|Withdrawal of Informed Consent (IC)|5|||
27747863|NCT02587065|54197510|FG000|Overall Study|Non-adherence to the Protocol|3|||
27747864|NCT02587065|54197510|FG000|Overall Study|Discontinuation of Study Medication|2|||
27747865|NCT02587065|54197510|FG000|Overall Study|Reason not Specified|3|||
27747866|NCT02106832|54197518|FG000|Overall Study|Adverse Event|1|||
27747867|NCT02106832|54197519|FG001|Overall Study|Adverse Event|2|||
27747868|NCT02106832|54197520|FG002|Overall Study|Adverse Event|3|||
27747869|NCT02106832|54197521|FG003|Overall Study|Adverse Event|0|||
27747870|NCT02106832|54197518|FG000|Overall Study|Death|4|||
27747871|NCT02106832|54197519|FG001|Overall Study|Death|4|||
27747872|NCT02106832|54197520|FG002|Overall Study|Death|1|||
27747873|NCT02106832|54197521|FG003|Overall Study|Death|4|||
27747874|NCT02106832|54197518|FG000|Overall Study|Deterioration of general conditions|0|||
27747875|NCT02106832|54197519|FG001|Overall Study|Deterioration of general conditions|0|||
27747876|NCT02106832|54197520|FG002|Overall Study|Deterioration of general conditions|1|||
27747877|NCT02106832|54197521|FG003|Overall Study|Deterioration of general conditions|0|||
27747878|NCT02106832|54197518|FG000|Overall Study|Lost to Follow-up|0|||
27747879|NCT02106832|54197519|FG001|Overall Study|Lost to Follow-up|1|||
27747880|NCT02106832|54197520|FG002|Overall Study|Lost to Follow-up|1|||
27747881|NCT02106832|54197521|FG003|Overall Study|Lost to Follow-up|3|||
27747882|NCT02106832|54197518|FG000|Overall Study|Physician Decision|1|||
27747883|NCT02106832|54197519|FG001|Overall Study|Physician Decision|0|||
27747884|NCT02106832|54197520|FG002|Overall Study|Physician Decision|0|||
27747885|NCT02106832|54197521|FG003|Overall Study|Physician Decision|0|||
27747886|NCT02106832|54197518|FG000|Overall Study|Protocol Violation|0|||
27747887|NCT02106832|54197519|FG001|Overall Study|Protocol Violation|0|||
27747888|NCT02106832|54197520|FG002|Overall Study|Protocol Violation|0|||
27747889|NCT02106832|54197521|FG003|Overall Study|Protocol Violation|1|||
27747890|NCT02106832|54197518|FG000|Overall Study|Withdrawal by Subject|17|||
27747891|NCT02106832|54197519|FG001|Overall Study|Withdrawal by Subject|17|||
27747892|NCT02106832|54197520|FG002|Overall Study|Withdrawal by Subject|10|||
27747893|NCT02106832|54197521|FG003|Overall Study|Withdrawal by Subject|7|||
27747894|NCT02106832|54197518|FG000|Overall Study|Technical problems|0|||
27747895|NCT02106832|54197519|FG001|Overall Study|Technical problems|1|||
27747896|NCT02106832|54197520|FG002|Overall Study|Technical problems|0|||
27747897|NCT02106832|54197521|FG003|Overall Study|Technical problems|0|||
27747898|NCT02106442|54197533|FG000|Overall Study|Case Report Forms Uncollected|7|||
27747899|NCT02106442|54197533|FG000|Overall Study|Protocol Deviation|30|||
27747900|NCT02105116|54197537|FG000|Overall Study|not eligible for step 2 of trial|5|||
27747901|NCT02105116|54197537|FG000|Overall Study|Death|1|||
27747902|NCT02104804|54197543|FG000|Overall Study|Did not take study medication|0|||
27747903|NCT02104804|54197544|FG001|Overall Study|Did not take study medication|1|||
27747904|NCT02104804|54197543|FG000|Overall Study|Study specific discontinuation criteria|6|||
27747905|NCT02104804|54197544|FG001|Overall Study|Study specific discontinuation criteria|1|||
27747906|NCT02104804|54197543|FG000|Overall Study|Other listed|2|||
27747907|NCT02104804|54197544|FG001|Overall Study|Other listed|1|||
27747908|NCT02104804|54197543|FG000|Overall Study|Protocol Violation|0|||
27747909|NCT02104804|54197544|FG001|Overall Study|Protocol Violation|1|||
27747910|NCT02104804|54197543|FG000|Overall Study|Adverse Event|4|||
27747911|NCT02104804|54197544|FG001|Overall Study|Adverse Event|3|||
27747912|NCT02104804|54197543|FG000|Overall Study|Withdrawal by Subject|4|||
27747913|NCT02104804|54197544|FG001|Overall Study|Withdrawal by Subject|12|||
27747914|NCT02075008|54197550|FG000|Overall Study|Technical problems|1|||
27747915|NCT02075008|54197550|FG000|Overall Study|Pregnancy|1|||
27747916|NCT02075008|54197550|FG000|Overall Study|Physician Decision|1|||
27747917|NCT02075008|54197550|FG000|Overall Study|Lost to Follow-up|1|||
27747918|NCT02075008|54197550|FG000|Overall Study|Lack of Efficacy|1|||
27747919|NCT02075008|54197550|FG000|Overall Study|Death|1|||
27747920|NCT02075008|54197550|FG000|Overall Study|Adverse Event|5|||
27747921|NCT02075008|54197550|FG000|Overall Study|Withdrawal by Subject|6|||
27747922|NCT02075008|54197550|FG000|Overall Study|Study terminated by Sponsor|159|||
27747923|NCT01666119|54197581|FG000|Overall Study|Adverse Event|6|||
27747924|NCT01666119|54197581|FG000|Overall Study|Withdrawal by Subject|16|||
27747925|NCT01666119|54197581|FG000|Overall Study|Lost to Follow-up|7|||
27747926|NCT01666119|54197581|FG000|Overall Study|non compliance with study medication, pa|18|||
27747927|NCT01666119|54197581|FG000|Overall Study|Subject experiencing withdrawal symptoms|5|||
27747928|NCT05128773|54197585|FG000|Overall Study|Sponsor decision to terminate study|3|||
27747929|NCT01665807|54197593|FG000|Overall Study|Withdrawal by Subject|2|||
27747930|NCT01665807|54197594|FG001|Overall Study|Withdrawal by Subject|0|||
27747931|NCT01665807|54197595|FG002|Overall Study|Withdrawal by Subject|1|||
27747932|NCT02584959|54197606|FG000|Period 1|Withdrawn from study|3|||
27747933|NCT02584959|54197607|FG001|Period 1|Withdrawn from study|4|||
27747934|NCT02584959|54197608|FG002|Period 1|Withdrawn from study|0|||
27747935|NCT02584959|54197606|FG000|Period 2|Withdrawn from study|6|||
27747936|NCT02584959|54197607|FG001|Period 2|Withdrawn from study|1|||
27747937|NCT02584959|54197608|FG002|Period 2|Withdrawn from study|2|||
27747938|NCT02584257|54197625|FG000|Period 1|Withdrawal by Subject|0|||
27747939|NCT02584257|54197626|FG001|Period 1|Withdrawal by Subject|0|||
27747940|NCT02584257|54197627|FG002|Period 1|Withdrawal by Subject|0|||
27747941|NCT02584257|54197628|FG003|Period 1|Withdrawal by Subject|0|||
27747942|NCT02584257|54197629|FG004|Period 1|Withdrawal by Subject|0|||
27747943|NCT02584257|54197630|FG005|Period 1|Withdrawal by Subject|0|||
27747944|NCT02584257|54197631|FG006|Period 1|Withdrawal by Subject|1|||
27747945|NCT02584257|54197632|FG007|Period 1|Withdrawal by Subject|0|||
27747946|NCT02584257|54197633|FG008|Period 1|Withdrawal by Subject|0|||
27747947|NCT02584257|54197625|FG000|Period 2|Physician Decision|1|||
27747948|NCT02584257|54197626|FG001|Period 2|Physician Decision|0|||
27747949|NCT02584257|54197627|FG002|Period 2|Physician Decision|0|||
27747950|NCT02584257|54197628|FG003|Period 2|Physician Decision|0|||
27747951|NCT02584257|54197629|FG004|Period 2|Physician Decision|0|||
27747952|NCT02584257|54197630|FG005|Period 2|Physician Decision|0|||
27747953|NCT02584257|54197631|FG006|Period 2|Physician Decision|0|||
27747954|NCT02584257|54197632|FG007|Period 2|Physician Decision|0|||
27747955|NCT02584257|54197633|FG008|Period 2|Physician Decision|0|||
27747956|NCT02584257|54197625|FG000|Period 2|Adverse Event|0|||
27747957|NCT02584257|54197626|FG001|Period 2|Adverse Event|1|||
27747958|NCT02584257|54197627|FG002|Period 2|Adverse Event|0|||
27747959|NCT02584257|54197628|FG003|Period 2|Adverse Event|0|||
27747960|NCT02584257|54197629|FG004|Period 2|Adverse Event|0|||
27747961|NCT02584257|54197630|FG005|Period 2|Adverse Event|0|||
27747962|NCT02584257|54197631|FG006|Period 2|Adverse Event|0|||
27747963|NCT02584257|54197632|FG007|Period 2|Adverse Event|0|||
27747964|NCT02584257|54197633|FG008|Period 2|Adverse Event|0|||
27747965|NCT02583711|54197648|FG000|Overall Study|Withdrawal by Subject|0|||
27747966|NCT02583711|54197649|FG001|Overall Study|Withdrawal by Subject|10|||
27747967|NCT02583711|54197650|FG002|Overall Study|Withdrawal by Subject|0|||
27747968|NCT02583477|54197662|FG000|Overall Study|Adverse Event|0|||
27747969|NCT02583477|54197663|FG001|Overall Study|Adverse Event|2|||
27747970|NCT02583477|54197662|FG000|Overall Study|Death|1|||
27747971|NCT02583477|54197663|FG001|Overall Study|Death|16|||
27747972|NCT02583477|54197662|FG000|Overall Study|Study terminated|2|||
27747973|NCT02583477|54197663|FG001|Overall Study|Study terminated|2|||
27747974|NCT02583399|54197670|FG000|Overall Study|Able to be discharged|3|||
27747975|NCT02583399|54197670|FG000|Overall Study|Wanted to use a restricted medication|3|||
27747976|NCT02580591|54197678|FG000|Overall Study|Adverse Event|0|||
27747977|NCT02580591|54197679|FG001|Overall Study|Adverse Event|1|||
27747978|NCT02580591|54197680|FG002|Overall Study|Adverse Event|2|||
27747979|NCT02580591|54197681|FG003|Overall Study|Adverse Event|5|||
27747980|NCT02580591|54197678|FG000|Overall Study|Protocol Violation|3|||
27747981|NCT02580591|54197679|FG001|Overall Study|Protocol Violation|2|||
27747982|NCT02580591|54197680|FG002|Overall Study|Protocol Violation|1|||
27747983|NCT02580591|54197681|FG003|Overall Study|Protocol Violation|1|||
27747984|NCT02580591|54197678|FG000|Overall Study|Lost to Follow-up|5|||
27747985|NCT02580591|54197679|FG001|Overall Study|Lost to Follow-up|3|||
27747986|NCT02580591|54197680|FG002|Overall Study|Lost to Follow-up|3|||
27747987|NCT02580591|54197681|FG003|Overall Study|Lost to Follow-up|1|||
27747988|NCT02580591|54197678|FG000|Overall Study|Withdrawal by Subject|6|||
27747989|NCT02580591|54197679|FG001|Overall Study|Withdrawal by Subject|1|||
27747990|NCT02580591|54197680|FG002|Overall Study|Withdrawal by Subject|2|||
27747991|NCT02580591|54197681|FG003|Overall Study|Withdrawal by Subject|3|||
27747992|NCT02580591|54197678|FG000|Overall Study|Not treated|1|||
27747993|NCT02580591|54197679|FG001|Overall Study|Not treated|1|||
27747994|NCT02580591|54197680|FG002|Overall Study|Not treated|0|||
27747995|NCT02580591|54197681|FG003|Overall Study|Not treated|0|||
27747996|NCT02580591|54197678|FG000|Overall Study|Other than specified|3|||
27747997|NCT02580591|54197679|FG001|Overall Study|Other than specified|2|||
27747998|NCT02580591|54197680|FG002|Overall Study|Other than specified|5|||
27747999|NCT02580591|54197681|FG003|Overall Study|Other than specified|2|||
27748000|NCT02580357|54197694|FG000|Overall Study|Lost to Follow-up|2|||
27748001|NCT02580357|54197695|FG001|Overall Study|Lost to Follow-up|0|||
27748002|NCT02580357|54197696|FG002|Overall Study|Lost to Follow-up|0|||
27748003|NCT02580357|54197694|FG000|Overall Study|Protocol Violation|1|||
27748004|NCT02580357|54197695|FG001|Overall Study|Protocol Violation|0|||
27748005|NCT02580357|54197696|FG002|Overall Study|Protocol Violation|0|||
27748006|NCT01664091|54197704|FG000|Overall Study|Death|1|||
27748007|NCT01664091|54197704|FG000|Overall Study|Disease Progression|2|||
27748008|NCT01664091|54197704|FG000|Overall Study|Lost to Follow-up|2|||
27748009|NCT01664091|54197704|FG000|Overall Study|Withdrawal by Subject|1|||
27748010|NCT02577315|54197711|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
27748011|NCT02577315|54197712|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
27748012|NCT02711345|54197728|FG000|Overall Study|Adverse Event|0|||
27748013|NCT02711345|54197729|FG001|Overall Study|Adverse Event|0|||
27748014|NCT02711345|54197730|FG002|Overall Study|Adverse Event|0|||
27748015|NCT02711345|54197731|FG003|Overall Study|Adverse Event|1|||
27748016|NCT02711345|54197732|FG004|Overall Study|Adverse Event|1|||
27748017|NCT02711345|54197733|FG005|Overall Study|Adverse Event|2|||
27748018|NCT02711345|54197734|FG006|Overall Study|Adverse Event|1|||
27748019|NCT02711345|54197735|FG007|Overall Study|Adverse Event|0|||
27748020|NCT02711345|54197736|FG008|Overall Study|Adverse Event|0|||
27748021|NCT02711345|54197737|FG009|Overall Study|Adverse Event|2|||
27748022|NCT02711345|54197728|FG000|Overall Study|Physician Decision|0|||
27748023|NCT02711345|54197729|FG001|Overall Study|Physician Decision|0|||
27748024|NCT02711345|54197730|FG002|Overall Study|Physician Decision|1|||
27748025|NCT02711345|54197731|FG003|Overall Study|Physician Decision|0|||
27748026|NCT02711345|54197732|FG004|Overall Study|Physician Decision|0|||
27748027|NCT02711345|54197733|FG005|Overall Study|Physician Decision|0|||
27748028|NCT02711345|54197734|FG006|Overall Study|Physician Decision|0|||
27748029|NCT02711345|54197735|FG007|Overall Study|Physician Decision|0|||
27748030|NCT02711345|54197736|FG008|Overall Study|Physician Decision|1|||
27748031|NCT02711345|54197737|FG009|Overall Study|Physician Decision|0|||
27748032|NCT02711345|54197728|FG000|Overall Study|Progressive disease|1|||
27748033|NCT02711345|54197729|FG001|Overall Study|Progressive disease|3|||
27748034|NCT02711345|54197730|FG002|Overall Study|Progressive disease|5|||
27748035|NCT02711345|54197731|FG003|Overall Study|Progressive disease|3|||
27748036|NCT02711345|54197732|FG004|Overall Study|Progressive disease|7|||
27748037|NCT02711345|54197733|FG005|Overall Study|Progressive disease|2|||
27748038|NCT02711345|54197734|FG006|Overall Study|Progressive disease|8|||
27748039|NCT02711345|54197735|FG007|Overall Study|Progressive disease|4|||
27748040|NCT02711345|54197736|FG008|Overall Study|Progressive disease|5|||
27748041|NCT02711345|54197737|FG009|Overall Study|Progressive disease|6|||
27748042|NCT02711345|54197728|FG000|Overall Study|Subject/guardian decision|0|||
27748043|NCT02711345|54197729|FG001|Overall Study|Subject/guardian decision|0|||
27748044|NCT02711345|54197730|FG002|Overall Study|Subject/guardian decision|0|||
27748045|NCT02711345|54197731|FG003|Overall Study|Subject/guardian decision|0|||
27748046|NCT02711345|54197732|FG004|Overall Study|Subject/guardian decision|0|||
27748047|NCT02711345|54197733|FG005|Overall Study|Subject/guardian decision|2|||
27748048|NCT02711345|54197734|FG006|Overall Study|Subject/guardian decision|3|||
27748049|NCT02711345|54197735|FG007|Overall Study|Subject/guardian decision|1|||
27748050|NCT02711345|54197736|FG008|Overall Study|Subject/guardian decision|0|||
27748051|NCT02711345|54197737|FG009|Overall Study|Subject/guardian decision|4|||
27748052|NCT02711345|54197728|FG000|Overall Study|Death|1|||
27748053|NCT02711345|54197729|FG001|Overall Study|Death|0|||
27748054|NCT02711345|54197730|FG002|Overall Study|Death|0|||
27748055|NCT02711345|54197731|FG003|Overall Study|Death|0|||
27748056|NCT02711345|54197732|FG004|Overall Study|Death|0|||
27748057|NCT02711345|54197733|FG005|Overall Study|Death|0|||
27748058|NCT02711345|54197734|FG006|Overall Study|Death|0|||
27748059|NCT02711345|54197735|FG007|Overall Study|Death|1|||
27748060|NCT02711345|54197736|FG008|Overall Study|Death|0|||
27748061|NCT02711345|54197737|FG009|Overall Study|Death|0|||
27748062|NCT02581995|54197774|FG000|Overall Study|Unspecified other|3|||
27748063|NCT02581995|54197774|FG000|Overall Study|Adverse Event|6|||
27748064|NCT02581995|54197774|FG000|Overall Study|Lost to Follow-up|5|||
27748065|NCT02581995|54197774|FG000|Overall Study|Withdrawal by participant|12|||
27748066|NCT02581995|54197774|FG000|Overall Study|Physician Decision|1|||
27748067|NCT02581995|54197774|FG000|Overall Study|Death|4|||
27748068|NCT02577003|54197780|FG000|Overall Study|Adverse Event|2|||
27748069|NCT02577003|54197781|FG001|Overall Study|Adverse Event|4|||
27748070|NCT02577003|54197780|FG000|Overall Study|Withdrawal by Subject|0|||
27748071|NCT02577003|54197781|FG001|Overall Study|Withdrawal by Subject|1|||
27748072|NCT02446899|54197789|FG000|Overall Study|Adverse Event|4|||
27748073|NCT02446899|54197790|FG001|Overall Study|Adverse Event|7|||
27748074|NCT02446899|54197789|FG000|Overall Study|Condition Under Investigation Worsened|1|||
27748075|NCT02446899|54197790|FG001|Overall Study|Condition Under Investigation Worsened|4|||
27748076|NCT02446899|54197789|FG000|Overall Study|Study Specific Withdrawal Criteria|1|||
27748077|NCT02446899|54197790|FG001|Overall Study|Study Specific Withdrawal Criteria|0|||
27748078|NCT02446899|54197789|FG000|Overall Study|Lack of Efficacy|2|||
27748079|NCT02446899|54197790|FG001|Overall Study|Lack of Efficacy|8|||
27748080|NCT02446899|54197789|FG000|Overall Study|Lost to Follow-up|1|||
27748081|NCT02446899|54197790|FG001|Overall Study|Lost to Follow-up|3|||
27748082|NCT02446899|54197789|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
27748083|NCT02446899|54197790|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
27748084|NCT02446899|54197789|FG000|Overall Study|Withdrawal by Subject|11|||
27748085|NCT02446899|54197790|FG001|Overall Study|Withdrawal by Subject|19|||
27748086|NCT02446899|54197789|FG000|Overall Study|Miscellaneous|5|||
27748087|NCT02446899|54197790|FG001|Overall Study|Miscellaneous|4|||
27748088|NCT02446899|54197789|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
27748089|NCT02446899|54197790|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
27748090|NCT02709785|54197799|FG000|Overall Study|Withdrawal by Subject|1|||
27748091|NCT02709785|54197800|FG001|Overall Study|Withdrawal by Subject|2|||
27748092|NCT02709785|54197801|FG002|Overall Study|Withdrawal by Subject|1|||
27748093|NCT02356887|54197809|FG000|Overall Study|poor compliance|2|||
27748094|NCT01604265|54197821|FG000|Overall Study|Adverse Event|1|||
27748095|NCT01604265|54197822|FG001|Overall Study|Adverse Event|0|||
27748096|NCT01604265|54197821|FG000|Overall Study|Withdrawal by Subject|1|||
27748097|NCT01604265|54197822|FG001|Overall Study|Withdrawal by Subject|0|||
27748098|NCT01664247|54197830|FG000|Overall Study|Adverse Event|5|||
27748099|NCT01664247|54197831|FG001|Overall Study|Adverse Event|3|||
27748100|NCT01664247|54197830|FG000|Overall Study|Protocol Violation|3|||
27748101|NCT01664247|54197831|FG001|Overall Study|Protocol Violation|5|||
27748102|NCT01664247|54197830|FG000|Overall Study|Withdrawal Criteria|1|||
27748103|NCT01664247|54197831|FG001|Overall Study|Withdrawal Criteria|4|||
27748104|NCT01664247|54197830|FG000|Overall Study|Unclassified|5|||
27748105|NCT01664247|54197831|FG001|Overall Study|Unclassified|29|||
27748106|NCT03191903|54197855|FG000|Overall Study|Withdrawal by Subject|6|||
27748107|NCT03191903|54197856|FG001|Overall Study|Withdrawal by Subject|5|||
27748108|NCT03191903|54197857|FG002|Overall Study|Withdrawal by Subject|4|||
27748109|NCT03191903|54197855|FG000|Overall Study|Adverse Event|1|||
27748110|NCT03191903|54197856|FG001|Overall Study|Adverse Event|0|||
27748111|NCT03191903|54197857|FG002|Overall Study|Adverse Event|0|||
27748112|NCT02576535|54197870|FG000|Overall Study|Withdrawal by Subject|2|||
27748113|NCT02576145|54197876|FG000|Overall Study|Adverse Event|1|||
27748114|NCT02576145|54197877|FG001|Overall Study|Adverse Event|0|||
27748115|NCT02576145|54197876|FG000|Overall Study|Withdrawal by Subject|1|||
27748116|NCT02576145|54197877|FG001|Overall Study|Withdrawal by Subject|0|||
27748117|NCT02576145|54197876|FG000|Overall Study|Acute rejection|1|||
27748118|NCT02576145|54197877|FG001|Overall Study|Acute rejection|0|||
27748119|NCT02576145|54197876|FG000|Overall Study|Tetanus Titers Decreased|0|||
27748120|NCT02576145|54197877|FG001|Overall Study|Tetanus Titers Decreased|1|||
27748121|NCT02576067|54197922|FG000|Overall Study|Death|0|||
27748122|NCT02576067|54197923|FG001|Overall Study|Death|1|||
27748123|NCT02576067|54197922|FG000|Overall Study|Lack of Efficacy|1|||
27748124|NCT02576067|54197923|FG001|Overall Study|Lack of Efficacy|0|||
27748125|NCT02576067|54197922|FG000|Overall Study|Lost to Follow-up|11|||
27748126|NCT02576067|54197923|FG001|Overall Study|Lost to Follow-up|0|||
27748127|NCT02576067|54197922|FG000|Overall Study|Withdrawal by Subject|11|||
27748128|NCT02576067|54197923|FG001|Overall Study|Withdrawal by Subject|2|||
27748129|NCT02576067|54197922|FG000|Overall Study|study closure of main CIRT trial)|0|||
27748130|NCT02576067|54197923|FG001|Overall Study|study closure of main CIRT trial)|8|||
27748131|NCT02576067|54197922|FG000|Overall Study|not randomized, failed run-in|7|||
27748132|NCT02576067|54197923|FG001|Overall Study|not randomized, failed run-in|0|||
27748133|NCT02576067|54197922|FG000|Overall Study|screen failure/ re-enrolled|0|||
27748134|NCT02576067|54197923|FG001|Overall Study|screen failure/ re-enrolled|25|||
27748135|NCT02576067|54197922|FG000|Overall Study|Physician Decision|4|||
27748136|NCT02576067|54197923|FG001|Overall Study|Physician Decision|0|||
27748137|NCT02575911|54197929|FG000|Overall Study|Lost to Follow-up|1|||
27748138|NCT02575833|54197943|FG000|Overall Study|Withdrawal by Subject|0|||
27748139|NCT02575833|54197944|FG001|Overall Study|Withdrawal by Subject|1|||
27748140|NCT02575833|54197943|FG000|Overall Study|Lost to Follow-up|1|||
27748141|NCT02575833|54197944|FG001|Overall Study|Lost to Follow-up|0|||
27748142|NCT02709083|54197950|FG000|Overall Study|Original PI left institution|7|||
27748143|NCT02709005|54197956|FG000|Overall Study|Lost to Follow-up|1|||
27748144|NCT02709005|54197957|FG001|Overall Study|Lost to Follow-up|1|||
27748145|NCT02709005|54197956|FG000|Overall Study|Withdrawal by Subject|3|||
27748146|NCT02709005|54197957|FG001|Overall Study|Withdrawal by Subject|0|||
27748147|NCT02573883|54197965|FG000|Six Month Follow Up|Lost to Follow-up|1|||
27748148|NCT02573883|54197966|FG001|Six Month Follow Up|Lost to Follow-up|0|||
27748149|NCT02573883|54197967|FG002|Six Month Follow Up|Lost to Follow-up|0|||
27748150|NCT02573883|54197968|FG003|Six Month Follow Up|Lost to Follow-up|0|||
27748151|NCT02573883|54197965|FG000|One Year Follow Up|Lost to Follow-up|2|||
27748152|NCT02573883|54197966|FG001|One Year Follow Up|Lost to Follow-up|1|||
27748153|NCT02573883|54197967|FG002|One Year Follow Up|Lost to Follow-up|0|||
27748154|NCT02573883|54197968|FG003|One Year Follow Up|Lost to Follow-up|0|||
27748155|NCT02575365|54197983|FG000|Overall Study|Lost to Follow-up|4|||
27748156|NCT02707991|54197989|FG000|Overall Study|Protocol Violation|1|||
27748157|NCT02707991|54197990|FG001|Overall Study|Protocol Violation|0|||
27748158|NCT02707991|54197989|FG000|Overall Study|Became ineligible|0|||
27748159|NCT02707991|54197990|FG001|Overall Study|Became ineligible|1|||
27748160|NCT02707757|54197998|FG000|Overall Study|Protocol Violation|3|||
27748161|NCT02707757|54197999|FG001|Overall Study|Protocol Violation|2|||
27748162|NCT02707757|54197998|FG000|Overall Study|Withdrawal by Subject|2|||
27748163|NCT02707757|54197999|FG001|Overall Study|Withdrawal by Subject|0|||
27748164|NCT02707757|54197998|FG000|Overall Study|Death|0|||
27748165|NCT02707757|54197999|FG001|Overall Study|Death|1|||
27748166|NCT02707757|54197998|FG000|Overall Study|Adverse Event|6|||
27748167|NCT02707757|54197999|FG001|Overall Study|Adverse Event|4|||
27748168|NCT02707757|54197998|FG000|Overall Study|Renal transplant/elective operation|1|||
27748169|NCT02707757|54197999|FG001|Overall Study|Renal transplant/elective operation|5|||
27748170|NCT02572401|54198009|FG000|Overall Study|Lost to Follow-up|5|||
27748171|NCT02572401|54198010|FG001|Overall Study|Lost to Follow-up|8|||
27748172|NCT02572401|54198011|FG002|Overall Study|Lost to Follow-up|9|||
27748173|NCT02572401|54198012|FG003|Overall Study|Lost to Follow-up|9|||
27748174|NCT02572401|54198009|FG000|Overall Study|Death|0|||
27748175|NCT02572401|54198010|FG001|Overall Study|Death|0|||
27748176|NCT02572401|54198011|FG002|Overall Study|Death|0|||
27748177|NCT02572401|54198012|FG003|Overall Study|Death|1|||
27748178|NCT02431325|54198024|FG000|Overall Study|Adverse Event|3|||
27748179|NCT02431325|54198025|FG001|Overall Study|Adverse Event|0|||
27748180|NCT02431325|54198024|FG000|Overall Study|Lost to Follow-up|0|||
27748181|NCT02431325|54198025|FG001|Overall Study|Lost to Follow-up|1|||
27748182|NCT02431325|54198024|FG000|Overall Study|Withdrawal by Subject|1|||
27748183|NCT02431325|54198025|FG001|Overall Study|Withdrawal by Subject|2|||
27748184|NCT02431325|54198024|FG000|Overall Study|Declined to take study medication|1|||
27748185|NCT02431325|54198025|FG001|Overall Study|Declined to take study medication|0|||
27748186|NCT02431325|54198024|FG000|Overall Study|Withdrew before starting study medication|1|||
27748187|NCT02431325|54198025|FG001|Overall Study|Withdrew before starting study medication|0|||
27748188|NCT02431325|54198024|FG000|Overall Study|Placebo shortage|2|||
27748189|NCT02431325|54198025|FG001|Overall Study|Placebo shortage|0|||
27748190|NCT02103478|54198038|FG000|Overall Study|Adverse Event|0|||
27748191|NCT02103478|54198039|FG001|Overall Study|Adverse Event|0|||
27748192|NCT02103478|54198040|FG002|Overall Study|Adverse Event|1|||
27748193|NCT02103478|54198041|FG003|Overall Study|Adverse Event|1|||
27748194|NCT02103478|54198042|FG004|Overall Study|Adverse Event|2|||
27748195|NCT02103478|54198043|FG005|Overall Study|Adverse Event|1|||
27748196|NCT02103478|54198044|FG006|Overall Study|Adverse Event|0|||
27748197|NCT02103478|54198045|FG007|Overall Study|Adverse Event|0|||
27748198|NCT02103478|54198046|FG008|Overall Study|Adverse Event|0|||
27748199|NCT02103478|54198038|FG000|Overall Study|Death|2|||
27748200|NCT02103478|54198039|FG001|Overall Study|Death|2|||
27748201|NCT02103478|54198040|FG002|Overall Study|Death|1|||
27748202|NCT02103478|54198041|FG003|Overall Study|Death|1|||
27748203|NCT02103478|54198042|FG004|Overall Study|Death|5|||
27748204|NCT02103478|54198043|FG005|Overall Study|Death|15|||
27748205|NCT02103478|54198044|FG006|Overall Study|Death|14|||
27748206|NCT02103478|54198045|FG007|Overall Study|Death|10|||
27748207|NCT02103478|54198046|FG008|Overall Study|Death|11|||
27748208|NCT02103478|54198038|FG000|Overall Study|Progressive Disease|2|||
27748209|NCT02103478|54198039|FG001|Overall Study|Progressive Disease|1|||
27748210|NCT02103478|54198040|FG002|Overall Study|Progressive Disease|2|||
27748211|NCT02103478|54198041|FG003|Overall Study|Progressive Disease|0|||
27748212|NCT02103478|54198042|FG004|Overall Study|Progressive Disease|9|||
27748213|NCT02103478|54198043|FG005|Overall Study|Progressive Disease|1|||
27748214|NCT02103478|54198044|FG006|Overall Study|Progressive Disease|2|||
27748215|NCT02103478|54198045|FG007|Overall Study|Progressive Disease|0|||
27748216|NCT02103478|54198046|FG008|Overall Study|Progressive Disease|1|||
27748217|NCT02103478|54198038|FG000|Overall Study|Withdrawal by Subject|2|||
27748218|NCT02103478|54198039|FG001|Overall Study|Withdrawal by Subject|0|||
27748219|NCT02103478|54198040|FG002|Overall Study|Withdrawal by Subject|0|||
27748220|NCT02103478|54198041|FG003|Overall Study|Withdrawal by Subject|4|||
27748221|NCT02103478|54198042|FG004|Overall Study|Withdrawal by Subject|0|||
27748222|NCT02103478|54198043|FG005|Overall Study|Withdrawal by Subject|0|||
27748223|NCT02103478|54198044|FG006|Overall Study|Withdrawal by Subject|1|||
27748224|NCT02103478|54198045|FG007|Overall Study|Withdrawal by Subject|1|||
27748225|NCT02103478|54198046|FG008|Overall Study|Withdrawal by Subject|0|||
27748226|NCT02103478|54198038|FG000|Overall Study|Lost to Follow-up|0|||
27748227|NCT02103478|54198039|FG001|Overall Study|Lost to Follow-up|0|||
27748228|NCT02103478|54198040|FG002|Overall Study|Lost to Follow-up|0|||
27748229|NCT02103478|54198041|FG003|Overall Study|Lost to Follow-up|0|||
27748230|NCT02103478|54198042|FG004|Overall Study|Lost to Follow-up|0|||
27748231|NCT02103478|54198043|FG005|Overall Study|Lost to Follow-up|0|||
27748232|NCT02103478|54198044|FG006|Overall Study|Lost to Follow-up|0|||
27748233|NCT02103478|54198045|FG007|Overall Study|Lost to Follow-up|1|||
27748234|NCT02103478|54198046|FG008|Overall Study|Lost to Follow-up|0|||
27748235|NCT02103478|54198038|FG000|Overall Study|Other|1|||
27748236|NCT02103478|54198039|FG001|Overall Study|Other|3|||
27748237|NCT02103478|54198040|FG002|Overall Study|Other|2|||
27748238|NCT02103478|54198041|FG003|Overall Study|Other|0|||
27748239|NCT02103478|54198042|FG004|Overall Study|Other|3|||
27748240|NCT02103478|54198043|FG005|Overall Study|Other|8|||
27748241|NCT02103478|54198044|FG006|Overall Study|Other|8|||
27748242|NCT02103478|54198045|FG007|Overall Study|Other|4|||
27748243|NCT02103478|54198046|FG008|Overall Study|Other|2|||
27748244|NCT02102464|54198078|FG000|Randomized Study|Withdrawal by Subject|0|||
27748245|NCT02102464|54198079|FG001|Randomized Study|Withdrawal by Subject|1|||
27748246|NCT02102464|54198080|FG002|Randomized Study|Withdrawal by Subject|0|||
27748247|NCT02707601|54198091|FG000|Overall Study|Death|0|||
27748248|NCT02707601|54198092|FG001|Overall Study|Death|1|||
27748249|NCT02707601|54198091|FG000|Overall Study|Lack of Efficacy|0|||
27748250|NCT02707601|54198092|FG001|Overall Study|Lack of Efficacy|1|||
27748251|NCT02707601|54198091|FG000|Overall Study|Investigator's Discretion|1|||
27748252|NCT02707601|54198092|FG001|Overall Study|Investigator's Discretion|0|||
27748253|NCT02707601|54198091|FG000|Overall Study|Withdrew Consent|0|||
27748254|NCT02707601|54198092|FG001|Overall Study|Withdrew Consent|1|||
27748255|NCT02707601|54198091|FG000|Overall Study|Lost to Follow-up|1|||
27748256|NCT02707601|54198092|FG001|Overall Study|Lost to Follow-up|1|||
27748257|NCT02707601|54198091|FG000|Overall Study|Participants Randomized but Not Treated|2|||
27748258|NCT02707601|54198092|FG001|Overall Study|Participants Randomized but Not Treated|0|||
27748259|NCT02707055|54198104|FG000|Phase 1|Withdrawal by Subject|1|||
27748260|NCT02707055|54198105|FG001|Phase 1|Withdrawal by Subject|2|||
27748261|NCT02707055|54198104|FG000|Phase 1|Physician Decision|0|||
27748262|NCT02707055|54198105|FG001|Phase 1|Physician Decision|1|||
27748263|NCT02707055|54198104|FG000|Phase 2|Adverse Event|1|||
27748264|NCT02707055|54198105|FG001|Phase 2|Adverse Event|2|||
27748265|NCT02073682|54198113|FG000|Overall Study|Low Creatinine Clearance|1|||
27748266|NCT02073682|54198114|FG001|Overall Study|Low Creatinine Clearance|2|||
27748267|NCT02073682|54198113|FG000|Overall Study|Death|86|||
27748268|NCT02073682|54198114|FG001|Overall Study|Death|100|||
27748269|NCT02073682|54198113|FG000|Overall Study|Cancer Cured|10|||
27748270|NCT02073682|54198114|FG001|Overall Study|Cancer Cured|15|||
27748271|NCT02073682|54198113|FG000|Overall Study|ID: Patient Noncompliance|1|||
27748272|NCT02073682|54198114|FG001|Overall Study|ID: Patient Noncompliance|2|||
27748273|NCT02073682|54198113|FG000|Overall Study|ID: Palliative Treatment Only|10|||
27748274|NCT02073682|54198114|FG001|Overall Study|ID: Palliative Treatment Only|7|||
27748275|NCT02073682|54198113|FG000|Overall Study|Prohibited Concomitant Medication Use|0|||
27748276|NCT02073682|54198114|FG001|Overall Study|Prohibited Concomitant Medication Use|1|||
27748277|NCT02073682|54198113|FG000|Overall Study|Platelet Count <50,000/mL|1|||
27748278|NCT02073682|54198114|FG001|Overall Study|Platelet Count <50,000/mL|2|||
27748279|NCT02073682|54198113|FG000|Overall Study|Surgery/Medical Procedure|3|||
27748280|NCT02073682|54198114|FG001|Overall Study|Surgery/Medical Procedure|1|||
27748281|NCT02073682|54198113|FG000|Overall Study|Withdrawal by Subject|6|||
27748282|NCT02073682|54198114|FG001|Overall Study|Withdrawal by Subject|8|||
27748283|NCT02073682|54198113|FG000|Overall Study|Start of New Chemotherapy Regimen|6|||
27748284|NCT02073682|54198114|FG001|Overall Study|Start of New Chemotherapy Regimen|3|||
27748285|NCT02073682|54198113|FG000|Overall Study|Cancer Progression|53|||
27748286|NCT02073682|54198114|FG001|Overall Study|Cancer Progression|33|||
27748287|NCT02073682|54198113|FG000|Overall Study|Protocol Violation|1|||
27748288|NCT02073682|54198114|FG001|Overall Study|Protocol Violation|0|||
27748289|NCT02073682|54198113|FG000|Overall Study|Adverse Event|79|||
27748290|NCT02073682|54198114|FG001|Overall Study|Adverse Event|62|||
27748291|NCT02073682|54198113|FG000|Overall Study|No reason provided|11|||
27748292|NCT02073682|54198114|FG001|Overall Study|No reason provided|9|||
27748293|NCT02073682|54198113|FG000|Overall Study|PD: Inconvenience of Dosing|21|||
27748294|NCT02073682|54198114|FG001|Overall Study|PD: Inconvenience of Dosing|78|||
27748295|NCT02073682|54198113|FG000|Overall Study|Lost to Follow-up|1|||
27748296|NCT02073682|54198114|FG001|Overall Study|Lost to Follow-up|1|||
27748297|NCT02073682|54198113|FG000|Overall Study|ID: Benefit/Risk Judgment|32|||
27748298|NCT02073682|54198114|FG001|Overall Study|ID: Benefit/Risk Judgment|46|||
27748299|NCT02072980|54198120|FG000|Period 2, Second Wear|Adverse Event|0|||
27748300|NCT02072980|54198121|FG001|Period 2, Second Wear|Adverse Event|1|||
27748301|NCT02706899|54198129|FG000|Overall Study|Withdrawal by Subject|1|||
27748302|NCT02706899|54198130|FG001|Overall Study|Withdrawal by Subject|0|||
27748303|NCT02706899|54198129|FG000|Overall Study|Death|8|||
27748304|NCT02706899|54198130|FG001|Overall Study|Death|0|||
27748305|NCT02706899|54198129|FG000|Overall Study|Study Termination by Sponsor|4|||
27748306|NCT02706899|54198130|FG001|Overall Study|Study Termination by Sponsor|6|||
27748307|NCT02072824|54198139|FG000|Overall Study|Insufficient clinical response|1|||
27748308|NCT02072824|54198140|FG001|Overall Study|Insufficient clinical response|0|||
27748309|NCT02072824|54198141|FG002|Overall Study|Insufficient clinical response|1|||
27748310|NCT02072824|54198139|FG000|Overall Study|No longer willing to participate|1|||
27748311|NCT02072824|54198140|FG001|Overall Study|No longer willing to participate|0|||
27748312|NCT02072824|54198141|FG002|Overall Study|No longer willing to participate|1|||
27748313|NCT02072824|54198139|FG000|Overall Study|Medication error|0|||
27748314|NCT02072824|54198140|FG001|Overall Study|Medication error|1|||
27748315|NCT02072824|54198141|FG002|Overall Study|Medication error|0|||
27748316|NCT02072824|54198139|FG000|Overall Study|Adverse Event|0|||
27748317|NCT02072824|54198140|FG001|Overall Study|Adverse Event|0|||
27748318|NCT02072824|54198141|FG002|Overall Study|Adverse Event|1|||
27748319|NCT02072668|54198149|FG000|Second Intervention|Lost to Follow-up|1|||
27748320|NCT02072668|54198150|FG001|Second Intervention|Lost to Follow-up|0|||
27748321|NCT02140762|54198160|FG000|Overall Study|Adverse Event|1|||
27748322|NCT02140762|54198161|FG001|Overall Study|Adverse Event|1|||
27748323|NCT02140762|54198160|FG000|Overall Study|Lost to Follow-up|9|||
27748324|NCT02140762|54198161|FG001|Overall Study|Lost to Follow-up|5|||
27748325|NCT02140762|54198160|FG000|Overall Study|Protocol Violation|1|||
27748326|NCT02140762|54198161|FG001|Overall Study|Protocol Violation|1|||
27748327|NCT02140762|54198160|FG000|Overall Study|Withdrawal by Subject|6|||
27748328|NCT02140762|54198161|FG001|Overall Study|Withdrawal by Subject|4|||
27748329|NCT02140762|54198160|FG000|Overall Study|Other|0|||
27748330|NCT02140762|54198161|FG001|Overall Study|Other|1|||
27748331|NCT02101294|54198172|FG000|Overall Study|Withdrawal by Subject|5|||
27748332|NCT02101294|54198172|FG000|Overall Study|Lost to Follow-up|6|||
27748333|NCT01598506|54198179|FG000|Overall Study|Withdrawal by Subject|2|||
27748334|NCT02140060|54198190|FG000|Overall Study|Adverse Event|0|||
27748335|NCT02140060|54198191|FG001|Overall Study|Adverse Event|0|||
27748336|NCT02140060|54198192|FG002|Overall Study|Adverse Event|0|||
27748337|NCT02140060|54198193|FG003|Overall Study|Adverse Event|1|||
27748338|NCT02140060|54198194|FG004|Overall Study|Adverse Event|1|||
27748339|NCT02140060|54198195|FG005|Overall Study|Adverse Event|1|||
27748340|NCT02140060|54198190|FG000|Overall Study|Lack of Efficacy|0|||
27748341|NCT02140060|54198191|FG001|Overall Study|Lack of Efficacy|0|||
27748342|NCT02140060|54198192|FG002|Overall Study|Lack of Efficacy|0|||
27748343|NCT02140060|54198193|FG003|Overall Study|Lack of Efficacy|1|||
27748344|NCT02140060|54198194|FG004|Overall Study|Lack of Efficacy|0|||
27748345|NCT02140060|54198195|FG005|Overall Study|Lack of Efficacy|0|||
27748346|NCT02139982|54198220|FG000|Overall Study|Lack of Efficacy|0|||
27748347|NCT02139982|54198221|FG001|Overall Study|Lack of Efficacy|1|||
27748348|NCT02139982|54198222|FG002|Overall Study|Lack of Efficacy|0|||
27748349|NCT02139982|54198223|FG003|Overall Study|Lack of Efficacy|1|||
27748350|NCT02139982|54198224|FG004|Overall Study|Lack of Efficacy|0|||
27748351|NCT02139982|54198225|FG005|Overall Study|Lack of Efficacy|0|||
27748352|NCT02139982|54198226|FG006|Overall Study|Lack of Efficacy|0|||
27748353|NCT02139982|54198227|FG007|Overall Study|Lack of Efficacy|0|||
27748354|NCT02139982|54198228|FG008|Overall Study|Lack of Efficacy|0|||
27748355|NCT02139982|54198229|FG009|Overall Study|Lack of Efficacy|0|||
27748356|NCT02139826|54198251|FG000|Overall Study|Adverse Event|1|||
27748357|NCT02139592|54198261|FG000|Overall Study|Case Report Forms Uncollected|8|||
27748358|NCT02139280|54198267|FG000|Overall Study|No longer eligible|2|||
27748359|NCT02139280|54198268|FG001|Overall Study|No longer eligible|0|||
27748360|NCT02072434|54198276|FG000|Overall Study|Protocol Violation|10|||
27748361|NCT02072434|54198277|FG001|Overall Study|Protocol Violation|9|||
27748362|NCT02072434|54198276|FG000|Overall Study|Physician Decision|5|||
27748363|NCT02072434|54198277|FG001|Overall Study|Physician Decision|10|||
27748364|NCT02072434|54198276|FG000|Overall Study|Adverse event, serious fatal|1|||
27748365|NCT02072434|54198277|FG001|Overall Study|Adverse event, serious fatal|6|||
27748366|NCT02072434|54198276|FG000|Overall Study|Adverse Event|7|||
27748367|NCT02072434|54198277|FG001|Overall Study|Adverse Event|6|||
27748368|NCT02072434|54198276|FG000|Overall Study|Withdrawal by Subject|17|||
27748369|NCT02072434|54198277|FG001|Overall Study|Withdrawal by Subject|29|||
27748370|NCT02072434|54198276|FG000|Overall Study|Other|14|||
27748371|NCT02072434|54198277|FG001|Overall Study|Other|29|||
27748372|NCT02072434|54198276|FG000|Overall Study|Lost to Follow-up|0|||
27748373|NCT02072434|54198277|FG001|Overall Study|Lost to Follow-up|1|||
27748374|NCT02101060|54198285|FG000|Overall Study|Adverse Event|1|||
27748375|NCT02101060|54198286|FG001|Overall Study|Adverse Event|0|||
27748376|NCT02101060|54198285|FG000|Overall Study|Withdrawal by Subject|1|||
27748377|NCT02101060|54198286|FG001|Overall Study|Withdrawal by Subject|1|||
27748378|NCT02101060|54198285|FG000|Overall Study|Lost to Follow-up|3|||
27748379|NCT02101060|54198286|FG001|Overall Study|Lost to Follow-up|3|||
27748380|NCT02139124|54198297|FG000|Overall Study|Adverse Event|2|||
27748381|NCT02139124|54198298|FG001|Overall Study|Adverse Event|0|||
27748382|NCT02139124|54198299|FG002|Overall Study|Adverse Event|1|||
27748383|NCT02139124|54198300|FG003|Overall Study|Adverse Event|2|||
27748384|NCT02139124|54198301|FG004|Overall Study|Adverse Event|5|||
27748385|NCT02139124|54198297|FG000|Overall Study|Withdrawal by Subject|2|||
27748386|NCT02139124|54198298|FG001|Overall Study|Withdrawal by Subject|2|||
27748387|NCT02139124|54198299|FG002|Overall Study|Withdrawal by Subject|2|||
27748388|NCT02139124|54198300|FG003|Overall Study|Withdrawal by Subject|2|||
27748389|NCT02139124|54198301|FG004|Overall Study|Withdrawal by Subject|3|||
27748390|NCT02139124|54198297|FG000|Overall Study|Protocol Violation|0|||
27748391|NCT02139124|54198298|FG001|Overall Study|Protocol Violation|0|||
27748392|NCT02139124|54198299|FG002|Overall Study|Protocol Violation|0|||
27748393|NCT02139124|54198300|FG003|Overall Study|Protocol Violation|1|||
27748394|NCT02139124|54198301|FG004|Overall Study|Protocol Violation|1|||
27748395|NCT02139124|54198297|FG000|Overall Study|non-compliant|1|||
27748396|NCT02139124|54198298|FG001|Overall Study|non-compliant|0|||
27748397|NCT02139124|54198299|FG002|Overall Study|non-compliant|0|||
27748398|NCT02139124|54198300|FG003|Overall Study|non-compliant|2|||
27748399|NCT02139124|54198301|FG004|Overall Study|non-compliant|0|||
27748400|NCT02139124|54198297|FG000|Overall Study|incarceration|0|||
27748401|NCT02139124|54198298|FG001|Overall Study|incarceration|0|||
27748402|NCT02139124|54198299|FG002|Overall Study|incarceration|1|||
27748403|NCT02139124|54198300|FG003|Overall Study|incarceration|0|||
27748404|NCT02139124|54198301|FG004|Overall Study|incarceration|0|||
27748405|NCT02139124|54198297|FG000|Overall Study|subject moved|1|||
27748406|NCT02139124|54198298|FG001|Overall Study|subject moved|0|||
27748407|NCT02139124|54198299|FG002|Overall Study|subject moved|0|||
27748408|NCT02139124|54198300|FG003|Overall Study|subject moved|0|||
27748409|NCT02139124|54198301|FG004|Overall Study|subject moved|0|||
27748410|NCT02139124|54198297|FG000|Overall Study|Lost to Follow-up|3|||
27748411|NCT02139124|54198298|FG001|Overall Study|Lost to Follow-up|2|||
27748412|NCT02139124|54198299|FG002|Overall Study|Lost to Follow-up|0|||
27748413|NCT02139124|54198300|FG003|Overall Study|Lost to Follow-up|5|||
27748414|NCT02139124|54198301|FG004|Overall Study|Lost to Follow-up|4|||
27748415|NCT02139046|54198318|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
27748416|NCT02139046|54198319|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
27748417|NCT02139046|54198320|FG002|Overall Study|Pretreatment Event/Adverse Event|10|||
27748418|NCT02139046|54198321|FG003|Overall Study|Pretreatment Event/Adverse Event|13|||
27748419|NCT02139046|54198322|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
27748420|NCT02139046|54198318|FG000|Overall Study|Major Protocol Deviation|9|||
27748421|NCT02139046|54198319|FG001|Overall Study|Major Protocol Deviation|10|||
27748422|NCT02139046|54198320|FG002|Overall Study|Major Protocol Deviation|16|||
27748423|NCT02139046|54198321|FG003|Overall Study|Major Protocol Deviation|12|||
27748424|NCT02139046|54198322|FG004|Overall Study|Major Protocol Deviation|6|||
27748425|NCT02139046|54198318|FG000|Overall Study|Lost to Follow-up|13|||
27748426|NCT02139046|54198319|FG001|Overall Study|Lost to Follow-up|16|||
27748427|NCT02139046|54198320|FG002|Overall Study|Lost to Follow-up|16|||
27748428|NCT02139046|54198321|FG003|Overall Study|Lost to Follow-up|18|||
27748429|NCT02139046|54198322|FG004|Overall Study|Lost to Follow-up|13|||
27748430|NCT02139046|54198318|FG000|Overall Study|Voluntary Withdrawal|20|||
27748431|NCT02139046|54198319|FG001|Overall Study|Voluntary Withdrawal|8|||
27748432|NCT02139046|54198320|FG002|Overall Study|Voluntary Withdrawal|10|||
27748433|NCT02139046|54198321|FG003|Overall Study|Voluntary Withdrawal|15|||
27748434|NCT02139046|54198322|FG004|Overall Study|Voluntary Withdrawal|16|||
27748435|NCT02139046|54198318|FG000|Overall Study|Lack of Efficacy|0|||
27748436|NCT02139046|54198319|FG001|Overall Study|Lack of Efficacy|1|||
27748437|NCT02139046|54198320|FG002|Overall Study|Lack of Efficacy|2|||
27748438|NCT02139046|54198321|FG003|Overall Study|Lack of Efficacy|1|||
27748439|NCT02139046|54198322|FG004|Overall Study|Lack of Efficacy|2|||
27748440|NCT02139046|54198318|FG000|Overall Study|Withdrawal due to a Gout Flare|1|||
27748441|NCT02139046|54198319|FG001|Overall Study|Withdrawal due to a Gout Flare|1|||
27748442|NCT02139046|54198320|FG002|Overall Study|Withdrawal due to a Gout Flare|1|||
27748443|NCT02139046|54198321|FG003|Overall Study|Withdrawal due to a Gout Flare|0|||
27748444|NCT02139046|54198322|FG004|Overall Study|Withdrawal due to a Gout Flare|1|||
27748445|NCT02139046|54198318|FG000|Overall Study|Other Miscellaneous Reasons|10|||
27748446|NCT02139046|54198319|FG001|Overall Study|Other Miscellaneous Reasons|9|||
27748447|NCT02139046|54198320|FG002|Overall Study|Other Miscellaneous Reasons|4|||
27748448|NCT02139046|54198321|FG003|Overall Study|Other Miscellaneous Reasons|9|||
27748449|NCT02139046|54198322|FG004|Overall Study|Other Miscellaneous Reasons|12|||
27748450|NCT02138890|54198336|FG000|Overall Study|Adverse Event|1|||
27748451|NCT02138890|54198337|FG001|Overall Study|Adverse Event|0|||
27748452|NCT02100670|54198348|FG000|Overall Study|Adverse Event|10|||
27748453|NCT02100670|54198349|FG001|Overall Study|Adverse Event|3|||
27748454|NCT02100670|54198350|FG002|Overall Study|Adverse Event|3|||
27748455|NCT02100670|54198351|FG003|Overall Study|Adverse Event|0|||
27748456|NCT02100670|54198348|FG000|Overall Study|Lost to Follow-up|1|||
27748457|NCT02100670|54198349|FG001|Overall Study|Lost to Follow-up|0|||
27748458|NCT02100670|54198350|FG002|Overall Study|Lost to Follow-up|0|||
27748459|NCT02100670|54198351|FG003|Overall Study|Lost to Follow-up|0|||
27748460|NCT02100670|54198348|FG000|Overall Study|Protocol Violation|0|||
27748461|NCT02100670|54198349|FG001|Overall Study|Protocol Violation|1|||
27748462|NCT02100670|54198350|FG002|Overall Study|Protocol Violation|0|||
27748463|NCT02100670|54198351|FG003|Overall Study|Protocol Violation|1|||
27748464|NCT02100670|54198348|FG000|Overall Study|Withdrawal of Consent|0|||
27748465|NCT02100670|54198349|FG001|Overall Study|Withdrawal of Consent|1|||
27748466|NCT02100670|54198350|FG002|Overall Study|Withdrawal of Consent|1|||
27748467|NCT02100670|54198351|FG003|Overall Study|Withdrawal of Consent|0|||
27748468|NCT02100670|54198348|FG000|Overall Study|No swelling no pain|1|||
27748469|NCT02100670|54198349|FG001|Overall Study|No swelling no pain|0|||
27748470|NCT02100670|54198350|FG002|Overall Study|No swelling no pain|0|||
27748471|NCT02100670|54198351|FG003|Overall Study|No swelling no pain|0|||
27748472|NCT02100670|54198348|FG000|Overall Study|Poor Efficacy|0|||
27748473|NCT02100670|54198349|FG001|Overall Study|Poor Efficacy|1|||
27748474|NCT02100670|54198350|FG002|Overall Study|Poor Efficacy|0|||
27748475|NCT02100670|54198351|FG003|Overall Study|Poor Efficacy|0|||
27748476|NCT02100670|54198348|FG000|Overall Study|Physician Decision|0|||
27748477|NCT02100670|54198349|FG001|Overall Study|Physician Decision|1|||
27748478|NCT02100670|54198350|FG002|Overall Study|Physician Decision|0|||
27748479|NCT02100670|54198351|FG003|Overall Study|Physician Decision|0|||
27748480|NCT02100670|54198348|FG000|Overall Study|Withdrawal by Subject|1|||
27748481|NCT02100670|54198349|FG001|Overall Study|Withdrawal by Subject|0|||
27748482|NCT02100670|54198350|FG002|Overall Study|Withdrawal by Subject|0|||
27748483|NCT02100670|54198351|FG003|Overall Study|Withdrawal by Subject|0|||
27748484|NCT02070484|54198370|FG000|Overall Study|Withdrawal by Subject|1|||
27748485|NCT02070484|54198371|FG001|Overall Study|Withdrawal by Subject|0|||
27748486|NCT02100514|54198379|FG000|Treatment Period|Adverse Event|0|||
27748487|NCT02100514|54198380|FG001|Treatment Period|Adverse Event|5|||
27748488|NCT02100514|54198381|FG002|Treatment Period|Adverse Event|0|||
27748489|NCT02100514|54198382|FG003|Treatment Period|Adverse Event|0|||
27748490|NCT02100514|54198383|FG004|Treatment Period|Adverse Event|0|||
27748491|NCT02100514|54198379|FG000|Treatment Period|Death|2|||
27748492|NCT02100514|54198380|FG001|Treatment Period|Death|2|||
27748493|NCT02100514|54198381|FG002|Treatment Period|Death|0|||
27748494|NCT02100514|54198382|FG003|Treatment Period|Death|0|||
27748495|NCT02100514|54198383|FG004|Treatment Period|Death|0|||
27748496|NCT02100514|54198379|FG000|Treatment Period|Lost to Follow-up|5|||
27748497|NCT02100514|54198380|FG001|Treatment Period|Lost to Follow-up|17|||
27748498|NCT02100514|54198381|FG002|Treatment Period|Lost to Follow-up|0|||
27748499|NCT02100514|54198382|FG003|Treatment Period|Lost to Follow-up|0|||
27748500|NCT02100514|54198383|FG004|Treatment Period|Lost to Follow-up|0|||
27748501|NCT02100514|54198379|FG000|Treatment Period|Did Not Meet Entrance Criteria|0|||
27748502|NCT02100514|54198380|FG001|Treatment Period|Did Not Meet Entrance Criteria|1|||
27748503|NCT02100514|54198381|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
27748504|NCT02100514|54198382|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
27748505|NCT02100514|54198383|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
27748506|NCT02100514|54198379|FG000|Treatment Period|Protocol Violation|1|||
27748507|NCT02100514|54198380|FG001|Treatment Period|Protocol Violation|1|||
27748508|NCT02100514|54198381|FG002|Treatment Period|Protocol Violation|0|||
27748509|NCT02100514|54198382|FG003|Treatment Period|Protocol Violation|0|||
27748510|NCT02100514|54198383|FG004|Treatment Period|Protocol Violation|0|||
27748511|NCT02100514|54198379|FG000|Treatment Period|Withdrawal by Subject|12|||
27748512|NCT02100514|54198380|FG001|Treatment Period|Withdrawal by Subject|37|||
27748513|NCT02100514|54198381|FG002|Treatment Period|Withdrawal by Subject|0|||
27748514|NCT02100514|54198382|FG003|Treatment Period|Withdrawal by Subject|0|||
27748515|NCT02100514|54198383|FG004|Treatment Period|Withdrawal by Subject|0|||
27748516|NCT02100514|54198379|FG000|Treatment Period|Other|9|||
27748517|NCT02100514|54198380|FG001|Treatment Period|Other|11|||
27748518|NCT02100514|54198381|FG002|Treatment Period|Other|0|||
27748519|NCT02100514|54198382|FG003|Treatment Period|Other|0|||
27748520|NCT02100514|54198383|FG004|Treatment Period|Other|0|||
27748521|NCT02100514|54198379|FG000|Extension Period|Withdrew consent|0|||
27748522|NCT02100514|54198380|FG001|Extension Period|Withdrew consent|0|||
27748523|NCT02100514|54198381|FG002|Extension Period|Withdrew consent|2|||
27748524|NCT02100514|54198382|FG003|Extension Period|Withdrew consent|0|||
27748525|NCT02100514|54198383|FG004|Extension Period|Withdrew consent|0|||
27748526|NCT02069392|54198399|FG000|Overall Study|Withdrawal by Subject|4|||
27748527|NCT02069392|54198400|FG001|Overall Study|Withdrawal by Subject|2|||
27748528|NCT02047318|54198408|FG000|Core Study Period|Did not consent to 52-week follow- up|8|||
27748529|NCT02047318|54198408|FG000|Core Study Period|Adverse Event|1|||
27748530|NCT02047318|54198408|FG000|Core Study Period|Withdrawal by caregiver|3|||
27748531|NCT02047318|54198408|FG000|Long-term Follow-up Treatment Period|consent withdrawn by subject|1|||
27748532|NCT02100124|54198426|FG000|Overall Study|Lost to Follow-up|5|||
27748533|NCT02100124|54198427|FG001|Overall Study|Lost to Follow-up|11|||
27748534|NCT02100124|54198428|FG002|Overall Study|Lost to Follow-up|3|||
27748535|NCT02100124|54198426|FG000|Overall Study|Withdrawal by Subject|1|||
27748536|NCT02100124|54198427|FG001|Overall Study|Withdrawal by Subject|0|||
27748537|NCT02100124|54198428|FG002|Overall Study|Withdrawal by Subject|0|||
27748538|NCT02068768|54198436|FG000|Overall Study|Lost to Follow-up|5|||
27748539|NCT02068768|54198436|FG000|Overall Study|Early Termination by Sponsor|2|||
27748540|NCT02046616|54198440|FG000|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1|||
27748541|NCT02046616|54198440|FG000|24-Week Treatment Period|Any Other Adverse Event|13|||
27748542|NCT02046616|54198440|FG000|24-Week Treatment Period|Insufficient Therapeutic Response|1|||
27748543|NCT02046616|54198440|FG000|24-Week Treatment Period|Physician Decision|3|||
27748544|NCT02046616|54198440|FG000|24-Week Treatment Period|Other|1|||
27748545|NCT02046616|54198440|FG000|8-Week FU Period|Lost to Follow-up|1|||
27748546|NCT02099344|54198446|FG000|Overall Study|Physician Decision|1|||
27748547|NCT02099344|54198447|FG001|Overall Study|Physician Decision|0|||
27748548|NCT02068222|54198455|FG000|Overall Study|Lost to Follow-up|1|||
27748549|NCT02099110|54198464|FG000|Overall Study|Protocol Violation|2|||
27748550|NCT02099110|54198465|FG001|Overall Study|Protocol Violation|1|||
27748551|NCT02099110|54198466|FG002|Overall Study|Protocol Violation|0|||
27748552|NCT02099110|54198467|FG003|Overall Study|Protocol Violation|3|||
27748553|NCT02099110|54198468|FG004|Overall Study|Protocol Violation|1|||
27748554|NCT02099110|54198464|FG000|Overall Study|Participant moved|1|||
27748555|NCT02099110|54198465|FG001|Overall Study|Participant moved|1|||
27748556|NCT02099110|54198466|FG002|Overall Study|Participant moved|1|||
27748557|NCT02099110|54198467|FG003|Overall Study|Participant moved|0|||
27748558|NCT02099110|54198468|FG004|Overall Study|Participant moved|2|||
27748559|NCT02099110|54198464|FG000|Overall Study|Withdrawal by Subject|7|||
27748560|NCT02099110|54198465|FG001|Overall Study|Withdrawal by Subject|11|||
27748561|NCT02099110|54198466|FG002|Overall Study|Withdrawal by Subject|13|||
27748562|NCT02099110|54198467|FG003|Overall Study|Withdrawal by Subject|9|||
27748563|NCT02099110|54198468|FG004|Overall Study|Withdrawal by Subject|13|||
27748564|NCT02099110|54198464|FG000|Overall Study|Adverse Event|3|||
27748565|NCT02099110|54198465|FG001|Overall Study|Adverse Event|5|||
27748566|NCT02099110|54198466|FG002|Overall Study|Adverse Event|2|||
27748567|NCT02099110|54198467|FG003|Overall Study|Adverse Event|3|||
27748568|NCT02099110|54198468|FG004|Overall Study|Adverse Event|2|||
27748569|NCT02099110|54198464|FG000|Overall Study|Lost to Follow-up|6|||
27748570|NCT02099110|54198465|FG001|Overall Study|Lost to Follow-up|12|||
27748571|NCT02099110|54198466|FG002|Overall Study|Lost to Follow-up|11|||
27748572|NCT02099110|54198467|FG003|Overall Study|Lost to Follow-up|5|||
27748573|NCT02099110|54198468|FG004|Overall Study|Lost to Follow-up|6|||
27748574|NCT02099110|54198464|FG000|Overall Study|Death|0|||
27748575|NCT02099110|54198465|FG001|Overall Study|Death|1|||
27748576|NCT02099110|54198466|FG002|Overall Study|Death|0|||
27748577|NCT02099110|54198467|FG003|Overall Study|Death|0|||
27748578|NCT02099110|54198468|FG004|Overall Study|Death|0|||
27748579|NCT02099110|54198464|FG000|Overall Study|Screen failure|0|||
27748580|NCT02099110|54198465|FG001|Overall Study|Screen failure|0|||
27748581|NCT02099110|54198466|FG002|Overall Study|Screen failure|0|||
27748582|NCT02099110|54198467|FG003|Overall Study|Screen failure|0|||
27748583|NCT02099110|54198468|FG004|Overall Study|Screen failure|1|||
27748584|NCT02099110|54198464|FG000|Overall Study|Non-compliance with study drug|2|||
27748585|NCT02099110|54198465|FG001|Overall Study|Non-compliance with study drug|0|||
27748586|NCT02099110|54198466|FG002|Overall Study|Non-compliance with study drug|0|||
27748587|NCT02099110|54198467|FG003|Overall Study|Non-compliance with study drug|0|||
27748588|NCT02099110|54198468|FG004|Overall Study|Non-compliance with study drug|1|||
27748589|NCT02099110|54198464|FG000|Overall Study|Physician Decision|3|||
27748590|NCT02099110|54198465|FG001|Overall Study|Physician Decision|0|||
27748591|NCT02099110|54198466|FG002|Overall Study|Physician Decision|1|||
27748592|NCT02099110|54198467|FG003|Overall Study|Physician Decision|2|||
27748593|NCT02099110|54198468|FG004|Overall Study|Physician Decision|1|||
27748594|NCT02098876|54198482|FG000|Overall Study|Withdrawal by Subject|5|||
27748595|NCT02098876|54198483|FG001|Overall Study|Withdrawal by Subject|5|||
27748596|NCT01624090|54198493|FG000|Overall Study|DLT, taken off therapy|0|||
27748597|NCT01624090|54198494|FG001|Overall Study|DLT, taken off therapy|1|||
27748598|NCT01624090|54198495|FG002|Overall Study|DLT, taken off therapy|0|||
27748599|NCT01624090|54198496|FG003|Overall Study|DLT, taken off therapy|0|||
27748600|NCT01624090|54198493|FG000|Overall Study|Withdrew prior to treatment|0|||
27748601|NCT01624090|54198494|FG001|Overall Study|Withdrew prior to treatment|1|||
27748602|NCT01624090|54198495|FG002|Overall Study|Withdrew prior to treatment|0|||
27748603|NCT01624090|54198496|FG003|Overall Study|Withdrew prior to treatment|0|||
27748604|NCT01624090|54198493|FG000|Overall Study|Died on study|0|||
27748605|NCT01624090|54198494|FG001|Overall Study|Died on study|0|||
27748606|NCT01624090|54198495|FG002|Overall Study|Died on study|2|||
27748607|NCT01624090|54198496|FG003|Overall Study|Died on study|0|||
27748608|NCT01624090|54198493|FG000|Overall Study|Did not complete 1 crse of therapy|0|||
27748609|NCT01624090|54198494|FG001|Overall Study|Did not complete 1 crse of therapy|0|||
27748610|NCT01624090|54198495|FG002|Overall Study|Did not complete 1 crse of therapy|2|||
27748611|NCT01624090|54198496|FG003|Overall Study|Did not complete 1 crse of therapy|0|||
27748612|NCT01624090|54198493|FG000|Overall Study|Dose escalated|0|||
27748613|NCT01624090|54198494|FG001|Overall Study|Dose escalated|0|||
27748614|NCT01624090|54198495|FG002|Overall Study|Dose escalated|3|||
27748615|NCT01624090|54198496|FG003|Overall Study|Dose escalated|0|||
27748616|NCT02571777|54198511|FG000|Overall Study|Subject/guardian decision|34|||
27748617|NCT02571777|54198512|FG001|Overall Study|Subject/guardian decision|26|||
27748618|NCT02571777|54198513|FG002|Overall Study|Subject/guardian decision|26|||
27748619|NCT02571777|54198514|FG003|Overall Study|Subject/guardian decision|25|||
27748620|NCT02571777|54198515|FG004|Overall Study|Subject/guardian decision|27|||
27748621|NCT02571777|54198511|FG000|Overall Study|Protocol Deviation|2|||
27748622|NCT02571777|54198512|FG001|Overall Study|Protocol Deviation|3|||
27748623|NCT02571777|54198513|FG002|Overall Study|Protocol Deviation|4|||
27748624|NCT02571777|54198514|FG003|Overall Study|Protocol Deviation|8|||
27748625|NCT02571777|54198515|FG004|Overall Study|Protocol Deviation|4|||
27748626|NCT02571777|54198511|FG000|Overall Study|Death|1|||
27748627|NCT02571777|54198512|FG001|Overall Study|Death|1|||
27748628|NCT02571777|54198513|FG002|Overall Study|Death|4|||
27748629|NCT02571777|54198514|FG003|Overall Study|Death|0|||
27748630|NCT02571777|54198515|FG004|Overall Study|Death|0|||
27748631|NCT02571777|54198511|FG000|Overall Study|Lost to Follow-up|1|||
27748632|NCT02571777|54198512|FG001|Overall Study|Lost to Follow-up|1|||
27748633|NCT02571777|54198513|FG002|Overall Study|Lost to Follow-up|2|||
27748634|NCT02571777|54198514|FG003|Overall Study|Lost to Follow-up|0|||
27748635|NCT02571777|54198515|FG004|Overall Study|Lost to Follow-up|1|||
27748636|NCT02571777|54198511|FG000|Overall Study|Physician Decision|1|||
27748637|NCT02571777|54198512|FG001|Overall Study|Physician Decision|7|||
27748638|NCT02571777|54198513|FG002|Overall Study|Physician Decision|5|||
27748639|NCT02571777|54198514|FG003|Overall Study|Physician Decision|2|||
27748640|NCT02571777|54198515|FG004|Overall Study|Physician Decision|4|||
27748641|NCT02571777|54198511|FG000|Overall Study|Pregnancy|0|||
27748642|NCT02571777|54198512|FG001|Overall Study|Pregnancy|0|||
27748643|NCT02571777|54198513|FG002|Overall Study|Pregnancy|0|||
27748644|NCT02571777|54198514|FG003|Overall Study|Pregnancy|2|||
27748645|NCT02571777|54198515|FG004|Overall Study|Pregnancy|0|||
27748646|NCT02571075|54198529|FG000|Overall Study|Lost to Follow-up|20|||
27748647|NCT02571075|54198530|FG001|Overall Study|Lost to Follow-up|24|||
27748648|NCT02705105|54198544|FG000|Treatment|Objective Disease Progression|1|||
27748649|NCT02705105|54198545|FG001|Treatment|Objective Disease Progression|50|||
27748650|NCT02705105|54198544|FG000|Treatment|Withdrawal by Subject|3|||
27748651|NCT02705105|54198545|FG001|Treatment|Withdrawal by Subject|5|||
27748652|NCT02705105|54198544|FG000|Treatment|Adverse Event|0|||
27748653|NCT02705105|54198545|FG001|Treatment|Adverse Event|17|||
27748654|NCT02705105|54198544|FG000|Treatment|Clinical Disease Progression|0|||
27748655|NCT02705105|54198545|FG001|Treatment|Clinical Disease Progression|32|||
27748656|NCT02705105|54198544|FG000|Treatment|Physician Decision|0|||
27748657|NCT02705105|54198545|FG001|Treatment|Physician Decision|3|||
27748658|NCT02705105|54198544|FG000|Treatment|Ongoing w/ Treatment at time of data cut|0|||
27748659|NCT02705105|54198545|FG001|Treatment|Ongoing w/ Treatment at time of data cut|2|||
27748660|NCT02705105|54198544|FG000|Follow-Up|Death|3|||
27748661|NCT02705105|54198545|FG001|Follow-Up|Death|68|||
27748662|NCT02705105|54198544|FG000|Follow-Up|Withdrawal by Subject|1|||
27748663|NCT02705105|54198545|FG001|Follow-Up|Withdrawal by Subject|14|||
27748664|NCT02705105|54198544|FG000|Follow-Up|Study Terminated|0|||
27748665|NCT02705105|54198545|FG001|Follow-Up|Study Terminated|26|||
27748666|NCT02705105|54198544|FG000|Follow-Up|Discontinued per Amendment 3|0|||
27748667|NCT02705105|54198545|FG001|Follow-Up|Discontinued per Amendment 3|2|||
27748668|NCT02097472|54198571|FG000|Received Vaccination 2|Adverse Event|0|||
27748669|NCT02097472|54198572|FG001|Received Vaccination 2|Adverse Event|0|||
27748670|NCT02097472|54198573|FG002|Received Vaccination 2|Adverse Event|0|||
27748671|NCT02097472|54198574|FG003|Received Vaccination 2|Adverse Event|0|||
27748672|NCT02097472|54198575|FG004|Received Vaccination 2|Adverse Event|0|||
27748673|NCT02097472|54198576|FG005|Received Vaccination 2|Adverse Event|0|||
27748674|NCT02097472|54198577|FG006|Received Vaccination 2|Adverse Event|1|||
27748675|NCT02097472|54198578|FG007|Received Vaccination 2|Adverse Event|0|||
27748676|NCT01623310|54198662|FG000|Overall Study|Adverse Event|21|||
27748677|NCT01623310|54198662|FG000|Overall Study|Lost to Follow-up|18|||
27748678|NCT01623310|54198662|FG000|Overall Study|Lack of Efficacy|6|||
27748679|NCT01623310|54198662|FG000|Overall Study|Protocol Violation|6|||
27748680|NCT01623310|54198662|FG000|Overall Study|Withdrawal by Subject|25|||
27748681|NCT01623310|54198662|FG000|Overall Study|Became potentially child-bearing|1|||
27748682|NCT01623310|54198662|FG000|Overall Study|Diagnoses of bilateral cateracts|1|||
27748683|NCT01623310|54198662|FG000|Overall Study|Investigators Discretion-Noncompliant|1|||
27748684|NCT02046226|54198666|FG000|Overall Study|Lost to Follow-up|7|||
27748685|NCT02046148|54198673|FG000|Overall Study|Lost to Follow-up|1|||
27748686|NCT02046148|54198674|FG001|Overall Study|Lost to Follow-up|1|||
27748687|NCT02046148|54198673|FG000|Overall Study|Withdrawal by Subject|0|||
27748688|NCT02046148|54198674|FG001|Overall Study|Withdrawal by Subject|2|||
27748689|NCT02097238|54198680|FG000|Overall Study|Death|1|||
27748690|NCT02097238|54198680|FG000|Overall Study|Physician Decision|1|||
27748691|NCT02097238|54198680|FG000|Overall Study|Progressive Disease|17|||
27748692|NCT02704091|54198687|FG000|Overall Study|Adverse Event|4|||
27748693|NCT02704091|54198688|FG001|Overall Study|Adverse Event|3|||
27748694|NCT02704091|54198687|FG000|Overall Study|Protocol Violation|5|||
27748695|NCT02704091|54198688|FG001|Overall Study|Protocol Violation|3|||
27748696|NCT02704091|54198687|FG000|Overall Study|Consent withdrawn|4|||
27748697|NCT02704091|54198688|FG001|Overall Study|Consent withdrawn|4|||
27748698|NCT02704091|54198687|FG000|Overall Study|Lost to Follow-up|13|||
27748699|NCT02704091|54198688|FG001|Overall Study|Lost to Follow-up|5|||
27748700|NCT02704091|54198687|FG000|Overall Study|Other|2|||
27748701|NCT02704091|54198688|FG001|Overall Study|Other|8|||
27748702|NCT02702609|54198696|FG000|Overall Study|Lost to Follow-up|8|||
27748703|NCT02702609|54198697|FG001|Overall Study|Lost to Follow-up|4|||
27748704|NCT02702609|54198696|FG000|Overall Study|Physician Decision|1|||
27748705|NCT02702609|54198697|FG001|Overall Study|Physician Decision|0|||
27748706|NCT02046070|54198706|FG000|Overall Study|Progressive Disease|18|||
27748707|NCT02046070|54198707|FG001|Overall Study|Progressive Disease|11|||
27748708|NCT02046070|54198708|FG002|Overall Study|Progressive Disease|40|||
27748709|NCT02046070|54198706|FG000|Overall Study|Adverse Event|8|||
27748710|NCT02046070|54198707|FG001|Overall Study|Adverse Event|10|||
27748711|NCT02046070|54198708|FG002|Overall Study|Adverse Event|17|||
27748712|NCT02046070|54198706|FG000|Overall Study|Withdrawal by Subject|1|||
27748713|NCT02046070|54198707|FG001|Overall Study|Withdrawal by Subject|2|||
27748714|NCT02046070|54198708|FG002|Overall Study|Withdrawal by Subject|6|||
27748715|NCT02046070|54198706|FG000|Overall Study|Study Terminated by Sponsor|1|||
27748716|NCT02046070|54198707|FG001|Overall Study|Study Terminated by Sponsor|1|||
27748717|NCT02046070|54198708|FG002|Overall Study|Study Terminated by Sponsor|1|||
27748718|NCT02046070|54198706|FG000|Overall Study|Reason not Specified|4|||
27748719|NCT02046070|54198707|FG001|Overall Study|Reason not Specified|4|||
27748720|NCT02046070|54198708|FG002|Overall Study|Reason not Specified|6|||
27748721|NCT01663857|54198720|FG000|Overall Study|Withdrew Consent to Study Participation|0|||
27748722|NCT01663857|54198721|FG001|Overall Study|Withdrew Consent to Study Participation|1|||
27748723|NCT01663857|54198722|FG002|Overall Study|Withdrew Consent to Study Participation|7|||
27748724|NCT01663857|54198723|FG003|Overall Study|Withdrew Consent to Study Participation|3|||
27748725|NCT01663857|54198720|FG000|Overall Study|Lost to Follow-up|0|||
27748726|NCT01663857|54198721|FG001|Overall Study|Lost to Follow-up|0|||
27748727|NCT01663857|54198722|FG002|Overall Study|Lost to Follow-up|3|||
27748728|NCT01663857|54198723|FG003|Overall Study|Lost to Follow-up|1|||
27748729|NCT02094898|54198739|FG000|Overall Study|Clinical Worsening|2|||
27748730|NCT02094898|54198739|FG000|Overall Study|Adverse Event|2|||
27748731|NCT02094898|54198739|FG000|Overall Study|Lack of Efficacy|1|||
27748732|NCT02045836|54198747|FG000|Overall Study|Adverse Event|4|||
27748733|NCT02045836|54198748|FG001|Overall Study|Adverse Event|4|||
27748734|NCT02045836|54198747|FG000|Overall Study|Withdrawal by Subject|1|||
27748735|NCT02045836|54198748|FG001|Overall Study|Withdrawal by Subject|1|||
27748736|NCT02045836|54198747|FG000|Overall Study|Lost to Follow-up|4|||
27748737|NCT02045836|54198748|FG001|Overall Study|Lost to Follow-up|7|||
27748738|NCT02045836|54198747|FG000|Overall Study|Migrated from study area|0|||
27748739|NCT02045836|54198748|FG001|Overall Study|Migrated from study area|2|||
27748740|NCT02569437|54198757|FG000|Overall Study|Lost to Follow-up|12|||
27748741|NCT02569437|54198758|FG001|Overall Study|Lost to Follow-up|14|||
27748742|NCT02045212|54198766|FG000|Overall Study|Adverse Event|0|||
27748743|NCT02045212|54198767|FG001|Overall Study|Adverse Event|1|||
27748744|NCT02045212|54198766|FG000|Overall Study|Withdrawal by Subject|1|||
27748745|NCT02045212|54198767|FG001|Overall Study|Withdrawal by Subject|0|||
27748746|NCT02045212|54198766|FG000|Overall Study|Finished 13 weeks, chose not to extend|1|||
27748747|NCT02045212|54198767|FG001|Overall Study|Finished 13 weeks, chose not to extend|0|||
27748748|NCT02044822|54198777|FG000|Overall Study|Study Terminated by Sponsor|77|||
27748749|NCT02044822|54198777|FG000|Overall Study|Investigator's Discretion|10|||
27748750|NCT02044822|54198777|FG000|Overall Study|Withdrew Consent|3|||
27748751|NCT02044822|54198777|FG000|Overall Study|Initiation of Anti-Neoplastic Therapy|2|||
27748752|NCT02044822|54198777|FG000|Overall Study|Lost to Follow-up|1|||
27748753|NCT02044510|54198783|FG000|Overall Study|Adverse Event|1|||
27748754|NCT02044510|54198784|FG001|Overall Study|Adverse Event|2|||
27748755|NCT02067676|54198796|FG000|Overall Study|Withdrawal by Subject|1|||
27748756|NCT02067676|54198797|FG001|Overall Study|Withdrawal by Subject|0|||
27748757|NCT02067676|54198798|FG002|Overall Study|Withdrawal by Subject|0|||
27748758|NCT02067676|54198799|FG003|Overall Study|Withdrawal by Subject|0|||
27748759|NCT02067676|54198800|FG004|Overall Study|Withdrawal by Subject|0|||
27748760|NCT02067676|54198801|FG005|Overall Study|Withdrawal by Subject|0|||
27748761|NCT01623154|54198820|FG000|Overall Study|Did not drink Pranactin Citric|4|||
27748762|NCT00702689|54198826|FG000|Overall Study|Withdrawal by Subject|4|||
27748763|NCT00702689|54198826|FG000|Overall Study|Recurrent malignancy|1|||
27748764|NCT00702689|54198826|FG000|Overall Study|Adverse Event|1|||
27748765|NCT02065570|54198832|FG000|Induction Study|Adverse Event|5|||
27748766|NCT02065570|54198833|FG001|Induction Study|Adverse Event|12|||
27748767|NCT02065570|54198834|FG002|Induction Study|Adverse Event|0|||
27748768|NCT02065570|54198835|FG003|Induction Study|Adverse Event|0|||
27748769|NCT02065570|54198832|FG000|Induction Study|Withdrawal by Subject|2|||
27748770|NCT02065570|54198833|FG001|Induction Study|Withdrawal by Subject|3|||
27748771|NCT02065570|54198834|FG002|Induction Study|Withdrawal by Subject|0|||
27748772|NCT02065570|54198835|FG003|Induction Study|Withdrawal by Subject|0|||
27748773|NCT02065570|54198832|FG000|Induction Study|Lost to Follow-up|1|||
27748774|NCT02065570|54198833|FG001|Induction Study|Lost to Follow-up|1|||
27748775|NCT02065570|54198834|FG002|Induction Study|Lost to Follow-up|0|||
27748776|NCT02065570|54198835|FG003|Induction Study|Lost to Follow-up|0|||
27748777|NCT02065570|54198832|FG000|Induction Study|Other, Not Specified|6|||
27748778|NCT02065570|54198833|FG001|Induction Study|Other, Not Specified|5|||
27748779|NCT02065570|54198834|FG002|Induction Study|Other, Not Specified|0|||
27748780|NCT02065570|54198835|FG003|Induction Study|Other, Not Specified|0|||
27748781|NCT02065570|54198832|FG000|Maintenance Study|Adverse Event|0|||
27748782|NCT02065570|54198833|FG001|Maintenance Study|Adverse Event|0|||
27748783|NCT02065570|54198834|FG002|Maintenance Study|Adverse Event|8|||
27748784|NCT02065570|54198835|FG003|Maintenance Study|Adverse Event|8|||
27748785|NCT02065570|54198832|FG000|Maintenance Study|Withdrawal by Subject|0|||
27748786|NCT02065570|54198833|FG001|Maintenance Study|Withdrawal by Subject|0|||
27748787|NCT02065570|54198834|FG002|Maintenance Study|Withdrawal by Subject|1|||
27748788|NCT02065570|54198835|FG003|Maintenance Study|Withdrawal by Subject|4|||
27748789|NCT02065570|54198832|FG000|Maintenance Study|Lost to Follow-up|0|||
27748790|NCT02065570|54198833|FG001|Maintenance Study|Lost to Follow-up|0|||
27748791|NCT02065570|54198834|FG002|Maintenance Study|Lost to Follow-up|2|||
27748792|NCT02065570|54198835|FG003|Maintenance Study|Lost to Follow-up|2|||
27748793|NCT02065570|54198832|FG000|Maintenance Study|Other, Not Specified|0|||
27748794|NCT02065570|54198833|FG001|Maintenance Study|Other, Not Specified|0|||
27748795|NCT02065570|54198834|FG002|Maintenance Study|Other, Not Specified|11|||
27748796|NCT02065570|54198835|FG003|Maintenance Study|Other, Not Specified|5|||
27748797|NCT02566005|54198848|FG000|Overall Study|vaginal bleeding|0|||
27748798|NCT02566005|54198849|FG001|Overall Study|vaginal bleeding|1|||
27748799|NCT02566005|54198848|FG000|Overall Study|received foley|8|||
27748800|NCT02566005|54198849|FG001|Overall Study|received foley|0|||
27748801|NCT02566005|54198848|FG000|Overall Study|did not receive foley|0|||
27748802|NCT02566005|54198849|FG001|Overall Study|did not receive foley|1|||
27748803|NCT02566005|54198848|FG000|Overall Study|labor after randomization|0|||
27748804|NCT02566005|54198849|FG001|Overall Study|labor after randomization|4|||
27836322|NCT01551173|54321265|FG001|Overall Study|Lost to Follow-up|7|||
27748805|NCT02065336|54198867|FG000|Extension Phase|Study Terminated by Sponsor|0|||
27748806|NCT02065336|54198868|FG001|Extension Phase|Study Terminated by Sponsor|0|||
27748807|NCT02065336|54198869|FG002|Extension Phase|Study Terminated by Sponsor|0|||
27748808|NCT02065336|54198870|FG003|Extension Phase|Study Terminated by Sponsor|0|||
27748809|NCT02065336|54198871|FG004|Extension Phase|Study Terminated by Sponsor|0|||
27748810|NCT02065336|54198872|FG005|Extension Phase|Study Terminated by Sponsor|0|||
27748811|NCT02065336|54198873|FG006|Extension Phase|Study Terminated by Sponsor|0|||
27748812|NCT02065336|54198874|FG007|Extension Phase|Study Terminated by Sponsor|0|||
27748813|NCT02065336|54198875|FG008|Extension Phase|Study Terminated by Sponsor|2|||
27748814|NCT02065336|54198876|FG009|Extension Phase|Study Terminated by Sponsor|8|||
27748815|NCT02701985|54198909|FG000|Overall Study|Withdrawal by Subject|1|||
27748816|NCT02701985|54198910|FG001|Overall Study|Withdrawal by Subject|1|||
27748817|NCT02701985|54198909|FG000|Overall Study|Lost to Follow-up|1|||
27748818|NCT02701985|54198910|FG001|Overall Study|Lost to Follow-up|0|||
27748819|NCT02701985|54198909|FG000|Overall Study|Death|1|||
27748820|NCT02701985|54198910|FG001|Overall Study|Death|0|||
27748821|NCT02701985|54198909|FG000|Overall Study|Adverse Event|0|||
27748822|NCT02701985|54198910|FG001|Overall Study|Adverse Event|5|||
27748823|NCT02064868|54198919|FG000|Overall Study|Lost to Follow-up|14|||
27748824|NCT02064868|54198920|FG001|Overall Study|Lost to Follow-up|8|||
27748825|NCT02064868|54198919|FG000|Overall Study|Physician Decision|1|||
27748826|NCT02064868|54198920|FG001|Overall Study|Physician Decision|0|||
27748827|NCT02064868|54198919|FG000|Overall Study|Withdrawal by Subject|14|||
27748828|NCT02064868|54198920|FG001|Overall Study|Withdrawal by Subject|3|||
27748829|NCT02064868|54198919|FG000|Overall Study|Technical Problems or Missing|5|||
27748830|NCT02064868|54198920|FG001|Overall Study|Technical Problems or Missing|2|||
27748831|NCT02064166|54198928|FG000|Overall Study|Adverse Event|1|||
27748832|NCT02064166|54198929|FG001|Overall Study|Adverse Event|0|||
27748833|NCT02565615|54198962|FG000|Overall Study|Death|0|||
27748834|NCT02565615|54198963|FG001|Overall Study|Death|1|||
27748835|NCT02565615|54198964|FG002|Overall Study|Death|0|||
27748836|NCT02565615|54198965|FG003|Overall Study|Death|0|||
27748837|NCT02565615|54198966|FG004|Overall Study|Death|4|||
27748838|NCT02565615|54198962|FG000|Overall Study|Not willing to participate in study|2|||
27748839|NCT02565615|54198963|FG001|Overall Study|Not willing to participate in study|21|||
27748840|NCT02565615|54198964|FG002|Overall Study|Not willing to participate in study|0|||
27748841|NCT02565615|54198965|FG003|Overall Study|Not willing to participate in study|1|||
27748842|NCT02565615|54198966|FG004|Overall Study|Not willing to participate in study|169|||
27748843|NCT02565615|54198962|FG000|Overall Study|Lost to Follow-up|0|||
27748844|NCT02565615|54198963|FG001|Overall Study|Lost to Follow-up|4|||
27748845|NCT02565615|54198964|FG002|Overall Study|Lost to Follow-up|0|||
27748846|NCT02565615|54198965|FG003|Overall Study|Lost to Follow-up|1|||
27748847|NCT02565615|54198966|FG004|Overall Study|Lost to Follow-up|765|||
27748848|NCT02565615|54198962|FG000|Overall Study|Not meeting eligibility criteria|0|||
27748849|NCT02565615|54198963|FG001|Overall Study|Not meeting eligibility criteria|7|||
27748850|NCT02565615|54198964|FG002|Overall Study|Not meeting eligibility criteria|0|||
27748851|NCT02565615|54198965|FG003|Overall Study|Not meeting eligibility criteria|0|||
27748852|NCT02565615|54198966|FG004|Overall Study|Not meeting eligibility criteria|25|||
27748853|NCT02565615|54198962|FG000|Overall Study|Reason not defined|0|||
27748854|NCT02565615|54198963|FG001|Overall Study|Reason not defined|2|||
27748855|NCT02565615|54198964|FG002|Overall Study|Reason not defined|0|||
27748856|NCT02565615|54198965|FG003|Overall Study|Reason not defined|1|||
27748857|NCT02565615|54198966|FG004|Overall Study|Reason not defined|62|||
27748858|NCT02565615|54198962|FG000|Overall Study|Adverse Event|1|||
27748859|NCT02565615|54198963|FG001|Overall Study|Adverse Event|1|||
27748860|NCT02565615|54198964|FG002|Overall Study|Adverse Event|0|||
27748861|NCT02565615|54198965|FG003|Overall Study|Adverse Event|0|||
27748862|NCT02565615|54198966|FG004|Overall Study|Adverse Event|9|||
27748863|NCT02565615|54198962|FG000|Overall Study|Untreated|0|||
27748864|NCT02565615|54198963|FG001|Overall Study|Untreated|0|||
27748865|NCT02565615|54198964|FG002|Overall Study|Untreated|0|||
27748866|NCT02565615|54198965|FG003|Overall Study|Untreated|0|||
27748867|NCT02565615|54198966|FG004|Overall Study|Untreated|567|||
27748868|NCT02701361|54198981|FG000|Overall Study|Lost to Follow-up|5|||
27748869|NCT02701361|54198982|FG001|Overall Study|Lost to Follow-up|2|||
27748870|NCT02701361|54198983|FG002|Overall Study|Lost to Follow-up|1|||
27748871|NCT02701361|54198981|FG000|Overall Study|Withdrawal by Subject|4|||
27748872|NCT02701361|54198982|FG001|Overall Study|Withdrawal by Subject|0|||
27748873|NCT02701361|54198983|FG002|Overall Study|Withdrawal by Subject|0|||
27748874|NCT02701361|54198981|FG000|Overall Study|timed out in rehab center|0|||
27748875|NCT02701361|54198982|FG001|Overall Study|timed out in rehab center|1|||
27748876|NCT02701361|54198983|FG002|Overall Study|timed out in rehab center|0|||
27748877|NCT02701361|54198981|FG000|Overall Study|incarceration|0|||
27748878|NCT02701361|54198982|FG001|Overall Study|incarceration|0|||
27748879|NCT02701361|54198983|FG002|Overall Study|incarceration|1|||
27748880|NCT02566785|54199004|FG000|Overall Study|Lost to Follow-up|0|||
27748881|NCT02566785|54199005|FG001|Overall Study|Lost to Follow-up|2|||
27748882|NCT02566785|54199004|FG000|Overall Study|Worsening condition|1|||
27748883|NCT02566785|54199005|FG001|Overall Study|Worsening condition|1|||
27748884|NCT01662999|54199017|FG000|Period 3|Withdrawal by Subject|0|||
27748885|NCT01662999|54199018|FG001|Period 3|Withdrawal by Subject|1|||
27748886|NCT01662999|54199019|FG002|Period 3|Withdrawal by Subject|0|||
27748887|NCT01662999|54199020|FG003|Period 3|Withdrawal by Subject|0|||
27748888|NCT01662999|54199021|FG004|Period 3|Withdrawal by Subject|0|||
27748889|NCT01662999|54199022|FG005|Period 3|Withdrawal by Subject|0|||
27748890|NCT02565381|54199055|FG000|Overall Study|Lost to Follow-up|1|||
27748891|NCT02565381|54199056|FG001|Overall Study|Lost to Follow-up|0|||
27748892|NCT02565381|54199057|FG002|Overall Study|Lost to Follow-up|1|||
27748893|NCT02063854|54199072|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
27748894|NCT02063854|54199073|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
27748895|NCT02063854|54199074|FG002|Overall Study|Pretreatment Event/Adverse Event|13|||
27748896|NCT02063854|54199075|FG003|Overall Study|Pretreatment Event/Adverse Event|8|||
27748897|NCT02063854|54199076|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
27748898|NCT02063854|54199077|FG005|Overall Study|Pretreatment Event/Adverse Event|18|||
27748899|NCT02063854|54199078|FG006|Overall Study|Pretreatment Event/Adverse Event|4|||
27748900|NCT02063854|54199072|FG000|Overall Study|Major Protocol Deviation|0|||
27748901|NCT02063854|54199073|FG001|Overall Study|Major Protocol Deviation|0|||
27748902|NCT02063854|54199074|FG002|Overall Study|Major Protocol Deviation|3|||
27748903|NCT02063854|54199075|FG003|Overall Study|Major Protocol Deviation|0|||
27748904|NCT02063854|54199076|FG004|Overall Study|Major Protocol Deviation|0|||
27748905|NCT02063854|54199077|FG005|Overall Study|Major Protocol Deviation|0|||
27748906|NCT02063854|54199078|FG006|Overall Study|Major Protocol Deviation|0|||
27748907|NCT02063854|54199072|FG000|Overall Study|Voluntary Withdrawal|2|||
27748908|NCT02063854|54199073|FG001|Overall Study|Voluntary Withdrawal|0|||
27748909|NCT02063854|54199074|FG002|Overall Study|Voluntary Withdrawal|8|||
27748910|NCT02063854|54199075|FG003|Overall Study|Voluntary Withdrawal|1|||
27748911|NCT02063854|54199076|FG004|Overall Study|Voluntary Withdrawal|3|||
27748912|NCT02063854|54199077|FG005|Overall Study|Voluntary Withdrawal|6|||
27748913|NCT02063854|54199078|FG006|Overall Study|Voluntary Withdrawal|1|||
27748914|NCT02063854|54199072|FG000|Overall Study|Surgical Dental Work Performed/Planned|5|||
27748915|NCT02063854|54199073|FG001|Overall Study|Surgical Dental Work Performed/Planned|2|||
27748916|NCT02063854|54199074|FG002|Overall Study|Surgical Dental Work Performed/Planned|6|||
27748917|NCT02063854|54199075|FG003|Overall Study|Surgical Dental Work Performed/Planned|1|||
27748918|NCT02063854|54199076|FG004|Overall Study|Surgical Dental Work Performed/Planned|1|||
27748919|NCT02063854|54199077|FG005|Overall Study|Surgical Dental Work Performed/Planned|6|||
27748920|NCT02063854|54199078|FG006|Overall Study|Surgical Dental Work Performed/Planned|1|||
27748921|NCT02063854|54199072|FG000|Overall Study|Reason Not Specified|1|||
27748922|NCT02063854|54199073|FG001|Overall Study|Reason Not Specified|0|||
27748923|NCT02063854|54199074|FG002|Overall Study|Reason Not Specified|0|||
27748924|NCT02063854|54199075|FG003|Overall Study|Reason Not Specified|0|||
27748925|NCT02063854|54199076|FG004|Overall Study|Reason Not Specified|0|||
27748926|NCT02063854|54199077|FG005|Overall Study|Reason Not Specified|0|||
27748927|NCT02063854|54199078|FG006|Overall Study|Reason Not Specified|0|||
27748928|NCT02063854|54199072|FG000|Overall Study|Did Not Receive Study Drug|0|||
27748929|NCT02063854|54199073|FG001|Overall Study|Did Not Receive Study Drug|0|||
27748930|NCT02063854|54199074|FG002|Overall Study|Did Not Receive Study Drug|0|||
27748931|NCT02063854|54199075|FG003|Overall Study|Did Not Receive Study Drug|0|||
27748932|NCT02063854|54199076|FG004|Overall Study|Did Not Receive Study Drug|0|||
27748933|NCT02063854|54199077|FG005|Overall Study|Did Not Receive Study Drug|1|||
27748934|NCT02063854|54199078|FG006|Overall Study|Did Not Receive Study Drug|0|||
27748935|NCT02063698|54199098|FG000|Overall Study|did not complete booklet for days 2-8|1|||
27748936|NCT02063698|54199099|FG001|Overall Study|did not complete booklet for days 2-8|2|||
27748937|NCT04701333|54199107|FG000|Overall Study|Lost to Follow-up|3|||
27748938|NCT04701333|54199108|FG001|Overall Study|Lost to Follow-up|7|||
27748939|NCT04701333|54199107|FG000|Overall Study|Withdrawal by Subject|0|||
27748940|NCT04701333|54199108|FG001|Overall Study|Withdrawal by Subject|1|||
27748941|NCT02062450|54199116|FG000|Overall Study|No follow-up visit|124|||
27748942|NCT02561247|54199124|FG000|Overall Study|Protocol Violation|1|||
27748943|NCT02561247|54199124|FG000|Overall Study|Withdrawal by Subject|1|||
27748944|NCT02561247|54199124|FG000|Overall Study|Two filter changes required within the first 24 hours.|4|||
27748945|NCT02061592|54199130|FG000|Period 1|Withdrawal by Subject|1|||
27748946|NCT02061592|54199131|FG001|Period 1|Withdrawal by Subject|0|||
27748947|NCT02061592|54199130|FG000|Period 1|Protocol Violation|1|||
27748948|NCT02061592|54199131|FG001|Period 1|Protocol Violation|0|||
27748949|NCT02061592|54199130|FG000|Period 2|Lost to Follow-up|0|||
27748950|NCT02061592|54199131|FG001|Period 2|Lost to Follow-up|1|||
27748951|NCT01663623|54199141|FG000|Overall Study|Adverse Event|3|||
27748952|NCT01663623|54199142|FG001|Overall Study|Adverse Event|7|||
27748953|NCT01663623|54199141|FG000|Overall Study|Lack of Efficacy|5|||
27748954|NCT01663623|54199142|FG001|Overall Study|Lack of Efficacy|6|||
27748955|NCT01663623|54199141|FG000|Overall Study|Protocol Violation|0|||
27748956|NCT01663623|54199142|FG001|Overall Study|Protocol Violation|1|||
27748957|NCT01663623|54199141|FG000|Overall Study|Other-Study closed/terminated|1|||
27748958|NCT01663623|54199142|FG001|Overall Study|Other-Study closed/terminated|1|||
27748959|NCT01663623|54199141|FG000|Overall Study|Physician Decision|1|||
27748960|NCT01663623|54199142|FG001|Overall Study|Physician Decision|4|||
27748961|NCT01663623|54199141|FG000|Overall Study|Withdrawal by Subject|2|||
27748962|NCT01663623|54199142|FG001|Overall Study|Withdrawal by Subject|1|||
27748963|NCT02042950|54199148|FG000|Overall Study|Progressive Disease|4|||
27748964|NCT02042404|54199152|FG000|Overall Study|Death|1|||
27748965|NCT02042404|54199153|FG001|Overall Study|Death|0|||
27748966|NCT02042404|54199152|FG000|Overall Study|Unrelated Adverse Event|3|||
27748967|NCT02042404|54199153|FG001|Overall Study|Unrelated Adverse Event|0|||
27748968|NCT02042404|54199152|FG000|Overall Study|Inability to meet time requirements|1|||
27748969|NCT02042404|54199153|FG001|Overall Study|Inability to meet time requirements|0|||
27748970|NCT02042014|54199160|FG000|Overall Study|Adverse Event|1|||
27748971|NCT02042014|54199160|FG000|Overall Study|Physician Decision|7|||
27748972|NCT02041702|54199166|FG000|Overall Study|Lost to Follow-up|1|||
27748973|NCT02041702|54199167|FG001|Overall Study|Lost to Follow-up|6|||
27748974|NCT02041702|54199166|FG000|Overall Study|Death|4|||
27748975|NCT02041702|54199167|FG001|Overall Study|Death|0|||
27748976|NCT02041702|54199166|FG000|Overall Study|Withdrawal by Subject|4|||
27748977|NCT02041702|54199167|FG001|Overall Study|Withdrawal by Subject|3|||
27748978|NCT02041702|54199166|FG000|Overall Study|Patient not confirmed as MRI compatible|1|||
27748979|NCT02041702|54199167|FG001|Overall Study|Patient not confirmed as MRI compatible|0|||
27748980|NCT02041702|54199166|FG000|Overall Study|Cardiac Resynchronization Therapy|1|||
27748981|NCT02041702|54199167|FG001|Overall Study|Cardiac Resynchronization Therapy|0|||
27748982|NCT02565147|54199175|FG000|Overall Study|Withdrawal by Subject|5|||
27748983|NCT02565147|54199176|FG001|Overall Study|Withdrawal by Subject|1|||
27748984|NCT02565147|54199175|FG000|Overall Study|Lost to Follow-up|0|||
27748985|NCT02565147|54199176|FG001|Overall Study|Lost to Follow-up|1|||
27748986|NCT02565147|54199175|FG000|Overall Study|Death|1|||
27748987|NCT02565147|54199176|FG001|Overall Study|Death|1|||
27748988|NCT02061280|54199184|FG000|Overall Study|Protocol Violation|12|||
27748989|NCT02061280|54199185|FG001|Overall Study|Protocol Violation|8|||
27748990|NCT02061280|54199184|FG000|Overall Study|moved out of state|0|||
27748991|NCT02061280|54199185|FG001|Overall Study|moved out of state|1|||
27748992|NCT02061280|54199184|FG000|Overall Study|Withdrawal by Subject|1|||
27748993|NCT02061280|54199185|FG001|Overall Study|Withdrawal by Subject|2|||
27748994|NCT02061280|54199184|FG000|Overall Study|Lost to Follow-up|5|||
27748995|NCT02061280|54199185|FG001|Overall Study|Lost to Follow-up|1|||
27748996|NCT02061202|54199196|FG000|Overall Study|Lost to Follow-up|1|||
27748997|NCT02061202|54199197|FG001|Overall Study|Lost to Follow-up|1|||
27748998|NCT02059408|54199206|FG000|Overall Study|Did not get tested|0|||
27748999|NCT02059408|54199207|FG001|Overall Study|Did not get tested|330|||
27749000|NCT02059408|54199208|FG002|Overall Study|Did not get tested|358|||
27749001|NCT01625338|54199221|FG000|Overall Study|Enrolled but not Treated|0|||
27749002|NCT01625338|54199222|FG001|Overall Study|Enrolled but not Treated|0|||
27749003|NCT01625338|54199223|FG002|Overall Study|Enrolled but not Treated|1|||
27749004|NCT01625338|54199221|FG000|Overall Study|Efficacy Failure|27|||
27749005|NCT01625338|54199222|FG001|Overall Study|Efficacy Failure|39|||
27749006|NCT01625338|54199223|FG002|Overall Study|Efficacy Failure|31|||
27749007|NCT01625338|54199221|FG000|Overall Study|Lost to Follow-up|3|||
27749008|NCT01625338|54199222|FG001|Overall Study|Lost to Follow-up|3|||
27749009|NCT01625338|54199223|FG002|Overall Study|Lost to Follow-up|2|||
27749010|NCT01625338|54199221|FG000|Overall Study|Investigator Decision|0|||
27749011|NCT01625338|54199222|FG001|Overall Study|Investigator Decision|2|||
27749012|NCT01625338|54199223|FG002|Overall Study|Investigator Decision|1|||
27749013|NCT01625338|54199221|FG000|Overall Study|Subject Withdrew Consent|1|||
27749014|NCT01625338|54199222|FG001|Overall Study|Subject Withdrew Consent|0|||
27749015|NCT01625338|54199223|FG002|Overall Study|Subject Withdrew Consent|2|||
27749016|NCT01625338|54199221|FG000|Overall Study|Adverse Event|1|||
27749017|NCT01625338|54199222|FG001|Overall Study|Adverse Event|0|||
27749018|NCT01625338|54199223|FG002|Overall Study|Adverse Event|1|||
27749019|NCT01625338|54199221|FG000|Overall Study|Study Discontinued by Sponsor|0|||
27749020|NCT01625338|54199222|FG001|Overall Study|Study Discontinued by Sponsor|0|||
27749021|NCT01625338|54199223|FG002|Overall Study|Study Discontinued by Sponsor|1|||
27749022|NCT02560623|54199235|FG000|Overall Study|Unable to swallow sponge|0|||
27749023|NCT02560623|54199236|FG001|Overall Study|Unable to swallow sponge|1|||
27749024|NCT02560623|54199237|FG002|Overall Study|Unable to swallow sponge|0|||
27749025|NCT02560623|54199238|FG003|Overall Study|Unable to swallow sponge|0|||
27749026|NCT02560623|54199235|FG000|Overall Study|Intervention prior to sponge administration|0|||
27749027|NCT02560623|54199236|FG001|Overall Study|Intervention prior to sponge administration|1|||
27749028|NCT02560623|54199237|FG002|Overall Study|Intervention prior to sponge administration|0|||
27749029|NCT02560623|54199238|FG003|Overall Study|Intervention prior to sponge administration|0|||
27749030|NCT02560389|54199251|FG000|Overall Study|Lost to Follow-up|1|||
27749031|NCT02560389|54199252|FG001|Overall Study|Lost to Follow-up|2|||
27749032|NCT02560389|54199253|FG002|Overall Study|Lost to Follow-up|2|||
27749033|NCT02560389|54199251|FG000|Overall Study|Tested positive for illicit substance|0|||
27749034|NCT02560389|54199252|FG001|Overall Study|Tested positive for illicit substance|1|||
27749035|NCT02560389|54199253|FG002|Overall Study|Tested positive for illicit substance|0|||
27749036|NCT02564211|54199261|FG000|Overall Study|Adverse Event|4|||
27749037|NCT02093026|54199265|FG000|Overall Study|Adverse Event|26|||
27749038|NCT02093026|54199265|FG000|Overall Study|Death|10|||
27749039|NCT02093026|54199265|FG000|Overall Study|Other|157|||
27749040|NCT02040844|54199273|FG000|Overall Study|Adverse Event|0|||
27749041|NCT02040844|54199274|FG001|Overall Study|Adverse Event|0|||
27749042|NCT02040844|54199275|FG002|Overall Study|Adverse Event|1|||
27749043|NCT02040844|54199273|FG000|Overall Study|Withdrawal by Subject|16|||
27749044|NCT02040844|54199274|FG001|Overall Study|Withdrawal by Subject|22|||
27749045|NCT02040844|54199275|FG002|Overall Study|Withdrawal by Subject|25|||
27749046|NCT02040844|54199273|FG000|Overall Study|Lost to Follow-up|12|||
27749047|NCT02040844|54199274|FG001|Overall Study|Lost to Follow-up|9|||
27749048|NCT02040844|54199275|FG002|Overall Study|Lost to Follow-up|13|||
27749049|NCT02040844|54199273|FG000|Overall Study|Missing|13|||
27749050|NCT02040844|54199274|FG001|Overall Study|Missing|3|||
27749051|NCT02040844|54199275|FG002|Overall Study|Missing|2|||
27749052|NCT02040844|54199273|FG000|Overall Study|Non-specified|8|||
27749053|NCT02040844|54199274|FG001|Overall Study|Non-specified|2|||
27749054|NCT02040844|54199275|FG002|Overall Study|Non-specified|5|||
27749055|NCT02040844|54199273|FG000|Overall Study|Concomitant medication|1|||
27749056|NCT02040844|54199274|FG001|Overall Study|Concomitant medication|3|||
27749057|NCT02040844|54199275|FG002|Overall Study|Concomitant medication|1|||
27749058|NCT02059174|54199283|FG000|Period 1|Withdrawal by Subject|0|||
27749059|NCT02059174|54199284|FG001|Period 1|Withdrawal by Subject|2|||
27749060|NCT02059174|54199283|FG000|Period 2|Withdrawal by Subject|0|||
27749061|NCT02059174|54199284|FG001|Period 2|Withdrawal by Subject|2|||
27749062|NCT02059174|54199283|FG000|Period 2|Protocol Violation|1|||
27749063|NCT02059174|54199284|FG001|Period 2|Protocol Violation|0|||
27749064|NCT02059174|54199283|FG000|Period 3|Physician Decision|1|||
27749065|NCT02059174|54199284|FG001|Period 3|Physician Decision|0|||
27749066|NCT02092324|54199292|FG000|Overall Study|Adverse Event|1|||
27749067|NCT02092324|54199292|FG000|Overall Study|Lack of Efficacy|6|||
27749068|NCT02092324|54199292|FG000|Overall Study|Proceed to Transplant|3|||
27749069|NCT02092324|54199292|FG000|Overall Study|Physician Decision|7|||
27749070|NCT02092324|54199292|FG000|Overall Study|Misdiagnosis|2|||
27749071|NCT02040766|54199304|FG000|Overall Study|Adverse Event|1|||
27749072|NCT02040766|54199305|FG001|Overall Study|Adverse Event|1|||
27749073|NCT02040766|54199306|FG002|Overall Study|Adverse Event|1|||
27749074|NCT02040766|54199307|FG003|Overall Study|Adverse Event|0|||
27749075|NCT02040766|54199308|FG004|Overall Study|Adverse Event|2|||
27749076|NCT02040766|54199304|FG000|Overall Study|Withdrawal by Subject|4|||
27749077|NCT02040766|54199305|FG001|Overall Study|Withdrawal by Subject|3|||
27749078|NCT02040766|54199306|FG002|Overall Study|Withdrawal by Subject|2|||
27749079|NCT02040766|54199307|FG003|Overall Study|Withdrawal by Subject|3|||
27749080|NCT02040766|54199308|FG004|Overall Study|Withdrawal by Subject|2|||
27749081|NCT02040766|54199304|FG000|Overall Study|Non-compliance|0|||
27749082|NCT02040766|54199305|FG001|Overall Study|Non-compliance|1|||
27749083|NCT02040766|54199306|FG002|Overall Study|Non-compliance|0|||
27749084|NCT02040766|54199307|FG003|Overall Study|Non-compliance|0|||
27749085|NCT02040766|54199308|FG004|Overall Study|Non-compliance|0|||
27749086|NCT02040766|54199304|FG000|Overall Study|Protocol Violation|2|||
27749087|NCT02040766|54199305|FG001|Overall Study|Protocol Violation|1|||
27749088|NCT02040766|54199306|FG002|Overall Study|Protocol Violation|2|||
27749089|NCT02040766|54199307|FG003|Overall Study|Protocol Violation|3|||
27749090|NCT02040766|54199308|FG004|Overall Study|Protocol Violation|0|||
27749091|NCT02040766|54199304|FG000|Overall Study|Lost to Follow-up|4|||
27749092|NCT02040766|54199305|FG001|Overall Study|Lost to Follow-up|1|||
27749093|NCT02040766|54199306|FG002|Overall Study|Lost to Follow-up|3|||
27749094|NCT02040766|54199307|FG003|Overall Study|Lost to Follow-up|1|||
27749095|NCT02040766|54199308|FG004|Overall Study|Lost to Follow-up|4|||
27749096|NCT02040766|54199304|FG000|Overall Study|Not reported|1|||
27749097|NCT02040766|54199305|FG001|Overall Study|Not reported|0|||
27749098|NCT02040766|54199306|FG002|Overall Study|Not reported|0|||
27749099|NCT02040766|54199307|FG003|Overall Study|Not reported|0|||
27749100|NCT02040766|54199308|FG004|Overall Study|Not reported|0|||
27749101|NCT02040766|54199304|FG000|Overall Study|Lack of Efficacy|6|||
27749102|NCT02040766|54199305|FG001|Overall Study|Lack of Efficacy|3|||
27749103|NCT02040766|54199306|FG002|Overall Study|Lack of Efficacy|4|||
27749104|NCT02040766|54199307|FG003|Overall Study|Lack of Efficacy|6|||
27749105|NCT02040766|54199308|FG004|Overall Study|Lack of Efficacy|5|||
27749106|NCT02040532|54199321|FG000|Overall Study|Lost to Follow-up|1|||
27749107|NCT02040532|54199321|FG000|Overall Study|Physician Decision|4|||
27749108|NCT02040532|54199321|FG000|Overall Study|Adverse Event|4|||
27749109|NCT02040532|54199321|FG000|Overall Study|Withdrawal by Subject|3|||
27749110|NCT02039908|54199325|FG000|Phase 1-Summer|Withdrawal by Subject|7|||
27749111|NCT02039908|54199326|FG001|Phase 1-Summer|Withdrawal by Subject|6|||
27749112|NCT02039908|54199327|FG002|Phase 1-Summer|Withdrawal by Subject|0|||
27749113|NCT02039908|54199328|FG003|Phase 1-Summer|Withdrawal by Subject|0|||
27749114|NCT02039908|54199325|FG000|Phase 1-Summer|Protocol Violation|6|||
27749115|NCT02039908|54199326|FG001|Phase 1-Summer|Protocol Violation|0|||
27749116|NCT02039908|54199327|FG002|Phase 1-Summer|Protocol Violation|0|||
27749117|NCT02039908|54199328|FG003|Phase 1-Summer|Protocol Violation|0|||
27749118|NCT02039908|54199325|FG000|Phase 2-School Year|Lost to Follow-up|0|||
27749119|NCT02039908|54199326|FG001|Phase 2-School Year|Lost to Follow-up|0|||
27749120|NCT02039908|54199327|FG002|Phase 2-School Year|Lost to Follow-up|1|||
27749121|NCT02039908|54199328|FG003|Phase 2-School Year|Lost to Follow-up|3|||
27749122|NCT02039908|54199325|FG000|Phase 2-School Year|Protocol Violation|0|||
27749123|NCT02039908|54199326|FG001|Phase 2-School Year|Protocol Violation|0|||
27749124|NCT02039908|54199327|FG002|Phase 2-School Year|Protocol Violation|3|||
27749125|NCT02039908|54199328|FG003|Phase 2-School Year|Protocol Violation|0|||
27749126|NCT02039908|54199325|FG000|Phase 2-School Year|Withdrawal by Subject|0|||
27749127|NCT02039908|54199326|FG001|Phase 2-School Year|Withdrawal by Subject|0|||
27749128|NCT02039908|54199327|FG002|Phase 2-School Year|Withdrawal by Subject|8|||
27749129|NCT02039908|54199328|FG003|Phase 2-School Year|Withdrawal by Subject|5|||
27749130|NCT02058940|54199336|FG000|Overall Study|Discharged from Critical Care Unit|1|||
27749131|NCT02058628|54199342|FG000|Overall Study|Adverse Event|1|||
27749132|NCT02058628|54199343|FG001|Overall Study|Adverse Event|0|||
27749133|NCT02058628|54199342|FG000|Overall Study|Withdrawal by Subject|2|||
27749134|NCT02058628|54199343|FG001|Overall Study|Withdrawal by Subject|2|||
27749135|NCT02058628|54199342|FG000|Overall Study|Lost to Follow-up|2|||
27749136|NCT02058628|54199343|FG001|Overall Study|Lost to Follow-up|4|||
27749137|NCT02058628|54199342|FG000|Overall Study|Not in time schedule|0|||
27749138|NCT02058628|54199343|FG001|Overall Study|Not in time schedule|1|||
27749139|NCT02058628|54199342|FG000|Overall Study|The visit date was not in timeline|0|||
27749140|NCT02058628|54199343|FG001|Overall Study|The visit date was not in timeline|1|||
27749141|NCT02058628|54199342|FG000|Overall Study|A lot of time for study for participant|1|||
27749142|NCT02058628|54199343|FG001|Overall Study|A lot of time for study for participant|0|||
27749143|NCT02058628|54199342|FG000|Overall Study|Non compliance|1|||
27749144|NCT02058628|54199343|FG001|Overall Study|Non compliance|0|||
27749145|NCT02058160|54199354|FG000|Overall Study|Randomized but not treated|2|||
27749146|NCT02058160|54199355|FG001|Overall Study|Randomized but not treated|4|||
27749147|NCT02058160|54199354|FG000|Overall Study|Poor compliance to protocol|4|||
27749148|NCT02058160|54199355|FG001|Overall Study|Poor compliance to protocol|1|||
27749149|NCT02058160|54199354|FG000|Overall Study|Adverse Event|12|||
27749150|NCT02058160|54199355|FG001|Overall Study|Adverse Event|3|||
27749151|NCT02058160|54199354|FG000|Overall Study|Lost to Follow-up|1|||
27749152|NCT02058160|54199355|FG001|Overall Study|Lost to Follow-up|0|||
27749153|NCT02058160|54199354|FG000|Overall Study|Other than specified above|12|||
27749154|NCT02058160|54199355|FG001|Overall Study|Other than specified above|6|||
27749155|NCT02090764|54199363|FG000|Overall Study|Adverse Event|1|||
27749156|NCT02090764|54199364|FG001|Overall Study|Adverse Event|3|||
27749157|NCT02090764|54199363|FG000|Overall Study|Lack of Efficacy|0|||
27749158|NCT02090764|54199364|FG001|Overall Study|Lack of Efficacy|13|||
27749159|NCT02090764|54199363|FG000|Overall Study|Withdrawal by Subject|2|||
27749160|NCT02090764|54199364|FG001|Overall Study|Withdrawal by Subject|1|||
27749161|NCT02090764|54199363|FG000|Overall Study|Intercurrent illness and other|1|||
27749162|NCT02090764|54199364|FG001|Overall Study|Intercurrent illness and other|1|||
27749163|NCT02090764|54199363|FG000|Overall Study|Lost to Follow-up|2|||
27749164|NCT02090764|54199364|FG001|Overall Study|Lost to Follow-up|2|||
27749165|NCT02057692|54199374|FG000|Overall Study|Adverse Event|1|||
27749166|NCT02057692|54199375|FG001|Overall Study|Adverse Event|0|||
27749167|NCT02057692|54199376|FG002|Overall Study|Adverse Event|0|||
27749168|NCT02057692|54199377|FG003|Overall Study|Adverse Event|0|||
27749169|NCT02057692|54199374|FG000|Overall Study|Lost to Follow-up|0|||
27749170|NCT02057692|54199375|FG001|Overall Study|Lost to Follow-up|0|||
27749171|NCT02057692|54199376|FG002|Overall Study|Lost to Follow-up|0|||
27749172|NCT02057692|54199377|FG003|Overall Study|Lost to Follow-up|1|||
27749173|NCT02038036|54199395|FG000|Core Study|Adverse Event|7|||
27749174|NCT02038036|54199396|FG001|Core Study|Adverse Event|7|||
27749175|NCT02038036|54199395|FG000|Core Study|Death|1|||
27749176|NCT02038036|54199396|FG001|Core Study|Death|1|||
27749177|NCT02038036|54199395|FG000|Core Study|Disease progression|2|||
27749178|NCT02038036|54199396|FG001|Core Study|Disease progression|2|||
27749179|NCT02038036|54199395|FG000|Core Study|Lost to Follow-up|0|||
27749180|NCT02038036|54199396|FG001|Core Study|Lost to Follow-up|1|||
27749181|NCT02038036|54199395|FG000|Core Study|Physician Decision|2|||
27749182|NCT02038036|54199396|FG001|Core Study|Physician Decision|1|||
27749183|NCT02038036|54199395|FG000|Core Study|Subject/guardian decision|0|||
27749184|NCT02038036|54199396|FG001|Core Study|Subject/guardian decision|1|||
27749185|NCT02038036|54199395|FG000|Core Study|Withdrawal by Subject|3|||
27749186|NCT02038036|54199396|FG001|Core Study|Withdrawal by Subject|1|||
27749187|NCT02038036|54199395|FG000|Crossover Period|Withdrawal by Subject|0|||
27749188|NCT02038036|54199396|FG001|Crossover Period|Withdrawal by Subject|3|||
27749189|NCT02038036|54199395|FG000|Crossover Period|Adverse Event|0|||
27749190|NCT02038036|54199396|FG001|Crossover Period|Adverse Event|9|||
27749191|NCT02038036|54199395|FG000|Crossover Period|Death|0|||
27749192|NCT02038036|54199396|FG001|Crossover Period|Death|2|||
27749193|NCT02038036|54199395|FG000|Crossover Period|Disease progression|0|||
27749194|NCT02038036|54199396|FG001|Crossover Period|Disease progression|3|||
27749195|NCT02038036|54199395|FG000|Crossover Period|Lost to Follow-up|0|||
27749196|NCT02038036|54199396|FG001|Crossover Period|Lost to Follow-up|1|||
27749197|NCT02038036|54199395|FG000|Crossover Period|Physician Decision|0|||
27749198|NCT02038036|54199396|FG001|Crossover Period|Physician Decision|2|||
27749199|NCT02037568|54199407|FG000|Overall Study|Withdrawal by Subject|17|||
27749200|NCT02037568|54199408|FG001|Overall Study|Withdrawal by Subject|24|||
27749201|NCT02037568|54199407|FG000|Overall Study|Lost to Follow-up|16|||
27749202|NCT02037568|54199408|FG001|Overall Study|Lost to Follow-up|13|||
27749203|NCT02037568|54199407|FG000|Overall Study|Screen Failure|3|||
27749204|NCT02037568|54199408|FG001|Overall Study|Screen Failure|1|||
27749205|NCT02037568|54199407|FG000|Overall Study|Patient did not receive transplant|0|||
27749206|NCT02037568|54199408|FG001|Overall Study|Patient did not receive transplant|1|||
27749207|NCT02088034|54199417|FG000|Overall Study|Lost to Follow-up|1|||
27749208|NCT02088034|54199418|FG001|Overall Study|Lost to Follow-up|1|||
27749209|NCT02088034|54199419|FG002|Overall Study|Lost to Follow-up|0|||
27749210|NCT02088034|54199417|FG000|Overall Study|Pregnancy|2|||
27749211|NCT02088034|54199418|FG001|Overall Study|Pregnancy|1|||
27749212|NCT02088034|54199419|FG002|Overall Study|Pregnancy|2|||
27749213|NCT02037256|54199429|FG000|Overall Study|Protocol Violation|0|||
27749214|NCT02037256|54199430|FG001|Overall Study|Protocol Violation|1|||
27749215|NCT02037256|54199429|FG000|Overall Study|Withdrawn prior to Velcade|0|||
27749216|NCT02037256|54199430|FG001|Overall Study|Withdrawn prior to Velcade|2|||
27749217|NCT02035696|54199442|FG000|Overall Study|Lost to Follow-up|0|||
27749218|NCT02035696|54199443|FG001|Overall Study|Lost to Follow-up|3|||
27749219|NCT02035696|54199444|FG002|Overall Study|Lost to Follow-up|1|||
27749220|NCT02035696|54199445|FG003|Overall Study|Lost to Follow-up|2|||
27749221|NCT02035696|54199442|FG000|Overall Study|Withdrawal by Subject|3|||
27749222|NCT02035696|54199443|FG001|Overall Study|Withdrawal by Subject|0|||
27749223|NCT02035696|54199444|FG002|Overall Study|Withdrawal by Subject|2|||
27749224|NCT02035696|54199445|FG003|Overall Study|Withdrawal by Subject|1|||
27749225|NCT02057458|54199459|FG000|Met Inclusion Criteria|Prior history of migraine headaches|0|||
27749226|NCT02057458|54199460|FG001|Met Inclusion Criteria|Prior history of migraine headaches|1|||
27749227|NCT02057458|54199461|FG002|Met Inclusion Criteria|Prior history of migraine headaches|0|||
27749228|NCT02057458|54199459|FG000|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2|||
27749229|NCT02057458|54199460|FG001|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
27749230|NCT02057458|54199461|FG002|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
27749231|NCT02057458|54199459|FG000|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1|||
27749232|NCT02057458|54199460|FG001|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
27749233|NCT02057458|54199461|FG002|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
27749234|NCT02057068|54199493|FG000|Overall Study|Withdrawal by Subject|2|||
27749235|NCT02057068|54199494|FG001|Overall Study|Withdrawal by Subject|2|||
27749236|NCT02057068|54199493|FG000|Overall Study|Caregiver (CG) Health|0|||
27749237|NCT02057068|54199494|FG001|Overall Study|Caregiver (CG) Health|2|||
27749238|NCT02057068|54199493|FG000|Overall Study|Carepartner (CP) Health|4|||
27749239|NCT02057068|54199494|FG001|Overall Study|Carepartner (CP) Health|2|||
27749240|NCT02057068|54199493|FG000|Overall Study|Lost to Follow-up|2|||
27749241|NCT02057068|54199494|FG001|Overall Study|Lost to Follow-up|2|||
27749242|NCT02056834|54199502|FG000|Overall Study|Lost to Follow-up|7|||
27749243|NCT02087176|54199507|FG000|Overall Study|Withdrawal by Subject|1|||
27749244|NCT02087176|54199507|FG000|Overall Study|Death|10|||
27749245|NCT02087176|54199507|FG000|Overall Study|Censored|19|||
27831158|NCT00708552|54307297|FG000|Overall Study|Physician Decision|1|||
27749246|NCT02087176|54199507|FG000|Overall Study|Study Terminated by Sponsor|2|||
27749247|NCT02056288|54199513|FG000|In-Hospital Data|Surgery cancelled|1|||
27749248|NCT02056288|54199514|FG001|In-Hospital Data|Surgery cancelled|0|||
27749249|NCT02056288|54199513|FG000|In-Hospital Data|Protocol Violation|3|||
27749250|NCT02056288|54199514|FG001|In-Hospital Data|Protocol Violation|0|||
27749251|NCT02056288|54199513|FG000|In-Hospital Data|Physician Decision|1|||
27749252|NCT02056288|54199514|FG001|In-Hospital Data|Physician Decision|0|||
27749253|NCT02056288|54199513|FG000|48-Hour Post-Discharge Data|Did not return diary|14|||
27749254|NCT02056288|54199514|FG001|48-Hour Post-Discharge Data|Did not return diary|20|||
27749255|NCT02086162|54199522|FG000|Overall Study|Withdrawal by Subject|4|||
27749256|NCT02086162|54199523|FG001|Overall Study|Withdrawal by Subject|4|||
27749257|NCT02086162|54199522|FG000|Overall Study|moved|1|||
27749258|NCT02086162|54199523|FG001|Overall Study|moved|1|||
27749259|NCT02086162|54199522|FG000|Overall Study|Lost to Follow-up|4|||
27749260|NCT02086162|54199523|FG001|Overall Study|Lost to Follow-up|2|||
27749261|NCT02086162|54199522|FG000|Overall Study|Death|1|||
27749262|NCT02086162|54199523|FG001|Overall Study|Death|0|||
27749263|NCT02700815|54199537|FG000|Overall Study|Adverse Event|0|||
27749264|NCT02700815|54199538|FG001|Overall Study|Adverse Event|6|||
27749265|NCT02700815|54199539|FG002|Overall Study|Adverse Event|2|||
27749266|NCT02700815|54199540|FG003|Overall Study|Adverse Event|3|||
27749267|NCT02700815|54199537|FG000|Overall Study|Lack of Efficacy|0|||
27749268|NCT02700815|54199538|FG001|Overall Study|Lack of Efficacy|0|||
27749269|NCT02700815|54199539|FG002|Overall Study|Lack of Efficacy|1|||
27749270|NCT02700815|54199540|FG003|Overall Study|Lack of Efficacy|2|||
27749271|NCT02700815|54199537|FG000|Overall Study|Lost to Follow-up|1|||
27749272|NCT02700815|54199538|FG001|Overall Study|Lost to Follow-up|0|||
27749273|NCT02700815|54199539|FG002|Overall Study|Lost to Follow-up|0|||
27749274|NCT02700815|54199540|FG003|Overall Study|Lost to Follow-up|1|||
27749275|NCT02700815|54199537|FG000|Overall Study|Refusal to continue medication|0|||
27749276|NCT02700815|54199538|FG001|Overall Study|Refusal to continue medication|1|||
27749277|NCT02700815|54199539|FG002|Overall Study|Refusal to continue medication|0|||
27749278|NCT02700815|54199540|FG003|Overall Study|Refusal to continue medication|1|||
27749279|NCT02700815|54199537|FG000|Overall Study|Withdrawal by Subject|0|||
27749280|NCT02700815|54199538|FG001|Overall Study|Withdrawal by Subject|0|||
27749281|NCT02700815|54199539|FG002|Overall Study|Withdrawal by Subject|1|||
27749282|NCT02700815|54199540|FG003|Overall Study|Withdrawal by Subject|0|||
27749283|NCT00708305|54199550|FG000|Period 1|Protocol Violation|1|||
27749284|NCT00708305|54199551|FG001|Period 1|Protocol Violation|0|||
27749285|NCT00708305|54199552|FG002|Period 1|Protocol Violation|1|||
27749286|NCT00708305|54199553|FG003|Period 1|Protocol Violation|0|||
27749287|NCT00708305|54199550|FG000|Period 1|Other Reason|0|||
27749288|NCT00708305|54199551|FG001|Period 1|Other Reason|0|||
27749289|NCT00708305|54199552|FG002|Period 1|Other Reason|0|||
27749290|NCT00708305|54199553|FG003|Period 1|Other Reason|2|||
27749291|NCT00708305|54199550|FG000|Period 2|Lost to Follow-up|0|||
27749292|NCT00708305|54199551|FG001|Period 2|Lost to Follow-up|1|||
27749293|NCT00708305|54199552|FG002|Period 2|Lost to Follow-up|0|||
27749294|NCT00708305|54199553|FG003|Period 2|Lost to Follow-up|0|||
27749295|NCT00708305|54199550|FG000|Period 2|Protocol Violation|0|||
27749296|NCT00708305|54199551|FG001|Period 2|Protocol Violation|1|||
27749297|NCT00708305|54199552|FG002|Period 2|Protocol Violation|0|||
27749298|NCT00708305|54199553|FG003|Period 2|Protocol Violation|0|||
27749299|NCT00708305|54199550|FG000|Period 2|Other Reason|1|||
27749300|NCT00708305|54199551|FG001|Period 2|Other Reason|0|||
27749301|NCT00708305|54199552|FG002|Period 2|Other Reason|0|||
27749302|NCT00708305|54199553|FG003|Period 2|Other Reason|1|||
27749303|NCT00708305|54199550|FG000|Period 3|Protocol Violation|0|||
27749304|NCT00708305|54199551|FG001|Period 3|Protocol Violation|2|||
27749305|NCT00708305|54199552|FG002|Period 3|Protocol Violation|0|||
27749306|NCT00708305|54199553|FG003|Period 3|Protocol Violation|0|||
27749307|NCT00708305|54199550|FG000|Period 3|Other Reason|1|||
27749308|NCT00708305|54199551|FG001|Period 3|Other Reason|0|||
27749309|NCT00708305|54199552|FG002|Period 3|Other Reason|0|||
27749310|NCT00708305|54199553|FG003|Period 3|Other Reason|0|||
27749311|NCT02055976|54199575|FG000|Overall Study|Other|0|||
27749312|NCT02055976|54199576|FG001|Overall Study|Other|0|||
27749313|NCT02055976|54199577|FG002|Overall Study|Other|1|||
27749314|NCT02055976|54199578|FG003|Overall Study|Other|0|||
27749315|NCT02055976|54199579|FG004|Overall Study|Other|0|||
27749316|NCT02055976|54199580|FG005|Overall Study|Other|0|||
27749317|NCT02055976|54199581|FG006|Overall Study|Other|0|||
27749318|NCT02055976|54199582|FG007|Overall Study|Other|0|||
27749319|NCT02055976|54199583|FG008|Overall Study|Other|0|||
27749320|NCT02055976|54199575|FG000|Overall Study|Adverse Event|0|||
27749321|NCT02055976|54199576|FG001|Overall Study|Adverse Event|0|||
27749322|NCT02055976|54199577|FG002|Overall Study|Adverse Event|0|||
27749323|NCT02055976|54199578|FG003|Overall Study|Adverse Event|0|||
27749324|NCT02055976|54199579|FG004|Overall Study|Adverse Event|0|||
27749325|NCT02055976|54199580|FG005|Overall Study|Adverse Event|1|||
27749326|NCT02055976|54199581|FG006|Overall Study|Adverse Event|1|||
27749327|NCT02055976|54199582|FG007|Overall Study|Adverse Event|0|||
27749328|NCT02055976|54199583|FG008|Overall Study|Adverse Event|0|||
27749329|NCT02055976|54199575|FG000|Overall Study|Does not meet entrance criteria|0|||
27749330|NCT02055976|54199576|FG001|Overall Study|Does not meet entrance criteria|0|||
27749331|NCT02055976|54199577|FG002|Overall Study|Does not meet entrance criteria|0|||
27749332|NCT02055976|54199578|FG003|Overall Study|Does not meet entrance criteria|0|||
27749333|NCT02055976|54199579|FG004|Overall Study|Does not meet entrance criteria|0|||
27749334|NCT02055976|54199580|FG005|Overall Study|Does not meet entrance criteria|0|||
27749335|NCT02055976|54199581|FG006|Overall Study|Does not meet entrance criteria|1|||
27749336|NCT02055976|54199582|FG007|Overall Study|Does not meet entrance criteria|0|||
27749337|NCT02055976|54199583|FG008|Overall Study|Does not meet entrance criteria|0|||
27749338|NCT02055976|54199575|FG000|Overall Study|Lost to Follow-up|0|||
27749339|NCT02055976|54199576|FG001|Overall Study|Lost to Follow-up|0|||
27749340|NCT02055976|54199577|FG002|Overall Study|Lost to Follow-up|0|||
27749341|NCT02055976|54199578|FG003|Overall Study|Lost to Follow-up|1|||
27749342|NCT02055976|54199579|FG004|Overall Study|Lost to Follow-up|0|||
27749343|NCT02055976|54199580|FG005|Overall Study|Lost to Follow-up|0|||
27749344|NCT02055976|54199581|FG006|Overall Study|Lost to Follow-up|0|||
27749345|NCT02055976|54199582|FG007|Overall Study|Lost to Follow-up|0|||
27749346|NCT02055976|54199583|FG008|Overall Study|Lost to Follow-up|0|||
27749347|NCT02055898|54199612|FG000|First Intervention (5 Days)|Physician Decision|2|||
27749348|NCT02055898|54199613|FG001|First Intervention (5 Days)|Physician Decision|0|||
27749349|NCT02055898|54199612|FG000|First Intervention (5 Days)|Withdrawal by Subject|0|||
27749350|NCT02055898|54199613|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
27749351|NCT02564055|54199625|FG000|Overall Study|Adverse Event|1|||
27749352|NCT02564055|54199626|FG001|Overall Study|Adverse Event|0|||
27749353|NCT02564055|54199627|FG002|Overall Study|Adverse Event|4|||
27749354|NCT02564055|54199628|FG003|Overall Study|Adverse Event|1|||
27749355|NCT02564055|54199629|FG004|Overall Study|Adverse Event|4|||
27749356|NCT02564055|54199630|FG005|Overall Study|Adverse Event|1|||
27749357|NCT02564055|54199625|FG000|Overall Study|Protocol Violation|1|||
27749358|NCT02564055|54199626|FG001|Overall Study|Protocol Violation|0|||
27749359|NCT02564055|54199627|FG002|Overall Study|Protocol Violation|0|||
27749360|NCT02564055|54199628|FG003|Overall Study|Protocol Violation|0|||
27749361|NCT02564055|54199629|FG004|Overall Study|Protocol Violation|0|||
27749362|NCT02564055|54199630|FG005|Overall Study|Protocol Violation|0|||
27749363|NCT02564055|54199625|FG000|Overall Study|Reached stopping criteria|0|||
27749364|NCT02564055|54199626|FG001|Overall Study|Reached stopping criteria|0|||
27749365|NCT02564055|54199627|FG002|Overall Study|Reached stopping criteria|0|||
27749366|NCT02564055|54199628|FG003|Overall Study|Reached stopping criteria|0|||
27749367|NCT02564055|54199629|FG004|Overall Study|Reached stopping criteria|0|||
27749368|NCT02564055|54199630|FG005|Overall Study|Reached stopping criteria|1|||
27749369|NCT02564055|54199625|FG000|Overall Study|Lost to Follow-up|0|||
27749370|NCT02564055|54199626|FG001|Overall Study|Lost to Follow-up|1|||
27749371|NCT02564055|54199627|FG002|Overall Study|Lost to Follow-up|4|||
27749372|NCT02564055|54199628|FG003|Overall Study|Lost to Follow-up|2|||
27749373|NCT02564055|54199629|FG004|Overall Study|Lost to Follow-up|1|||
27749374|NCT02564055|54199630|FG005|Overall Study|Lost to Follow-up|0|||
27749375|NCT02564055|54199625|FG000|Overall Study|Physician Decision|0|||
27749376|NCT02564055|54199626|FG001|Overall Study|Physician Decision|0|||
27749377|NCT02564055|54199627|FG002|Overall Study|Physician Decision|1|||
27749378|NCT02564055|54199628|FG003|Overall Study|Physician Decision|0|||
27749379|NCT02564055|54199629|FG004|Overall Study|Physician Decision|0|||
27749380|NCT02564055|54199630|FG005|Overall Study|Physician Decision|0|||
27749381|NCT02564055|54199625|FG000|Overall Study|Withdrawal by Subject|4|||
27749382|NCT02564055|54199626|FG001|Overall Study|Withdrawal by Subject|4|||
27749383|NCT02564055|54199627|FG002|Overall Study|Withdrawal by Subject|3|||
27749384|NCT02564055|54199628|FG003|Overall Study|Withdrawal by Subject|3|||
27749385|NCT02564055|54199629|FG004|Overall Study|Withdrawal by Subject|10|||
27749386|NCT02564055|54199630|FG005|Overall Study|Withdrawal by Subject|10|||
27749387|NCT02563899|54199648|FG000|Overall Study|Protocol Violation|1|||
27749388|NCT02563899|54199649|FG001|Overall Study|Protocol Violation|0|||
27749389|NCT02563899|54199650|FG002|Overall Study|Protocol Violation|0|||
27749390|NCT02563899|54199651|FG003|Overall Study|Protocol Violation|0|||
27749391|NCT02563899|54199648|FG000|Overall Study|Withdrawal by Subject|0|||
27749392|NCT02563899|54199649|FG001|Overall Study|Withdrawal by Subject|0|||
27749393|NCT02563899|54199650|FG002|Overall Study|Withdrawal by Subject|1|||
27749394|NCT02563899|54199651|FG003|Overall Study|Withdrawal by Subject|0|||
27749395|NCT02699099|54199665|FG000|Overall Study|Adverse Event|1|||
27749396|NCT02699099|54199666|FG001|Overall Study|Adverse Event|0|||
27749397|NCT02699099|54199667|FG002|Overall Study|Adverse Event|2|||
27749398|NCT02699099|54199665|FG000|Overall Study|Lost to Follow-up|0|||
27749399|NCT02699099|54199666|FG001|Overall Study|Lost to Follow-up|1|||
27749400|NCT02699099|54199667|FG002|Overall Study|Lost to Follow-up|0|||
27749401|NCT02699099|54199665|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|7|||
27749402|NCT02699099|54199666|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
27749403|NCT02699099|54199667|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|4|||
27749404|NCT04399551|54199677|FG000|Overall Study|Adverse Event|12|||
27749405|NCT04399551|54199677|FG000|Overall Study|Withdrawal by Subject|6|||
27749406|NCT04399551|54199677|FG000|Overall Study|Physician Decision|3|||
27749407|NCT04399551|54199677|FG000|Overall Study|Lost to Follow-up|1|||
27749408|NCT04399551|54199677|FG000|Overall Study|Protocol Deviation|2|||
27749409|NCT04399551|54199677|FG000|Overall Study|Ongoing|100|||
27749410|NCT02698865|54199691|FG000|Overall Study|Other|11|||
27749411|NCT02698865|54199692|FG001|Overall Study|Other|11|||
27749412|NCT02698865|54199691|FG000|Overall Study|Withdrawal by Subject|20|||
27749413|NCT02698865|54199692|FG001|Overall Study|Withdrawal by Subject|16|||
27749414|NCT02698865|54199691|FG000|Overall Study|Physician Decision|0|||
27749415|NCT02698865|54199692|FG001|Overall Study|Physician Decision|4|||
27749416|NCT02698865|54199691|FG000|Overall Study|Lost to Follow-up|4|||
27749417|NCT02698865|54199692|FG001|Overall Study|Lost to Follow-up|2|||
27749418|NCT02698787|54199700|FG000|Second Intervention (3 Months)|Withdrawal by Subject|0|||
27749419|NCT02698787|54199701|FG001|Second Intervention (3 Months)|Withdrawal by Subject|1|||
27749420|NCT02698475|54199708|FG000|Main Study Period|Lack of Efficacy|1|||
27749421|NCT02698475|54199708|FG000|Main Study Period|Protocol Violation|2|||
27749422|NCT02698475|54199708|FG000|Long-Term Extension Period|Lost to Follow-up|1|||
27749423|NCT02698475|54199708|FG000|Long-Term Extension Period|Trial Site Terminated by Sponsor|1|||
27749424|NCT02698475|54199708|FG000|Long-Term Extension Period|Withdrawal by Subject|3|||
27749425|NCT02698475|54199708|FG000|Long-Term Extension Period|Due to Long Term Extension Protocol-Specified Criteria|22|||
27749426|NCT02698475|54199708|FG000|Long-Term Extension Period|Other|1|||
27749427|NCT02559687|54199715|FG000|Overall Study|Death|112|||
27749428|NCT02559687|54199715|FG000|Overall Study|Sponsor Decision|5|||
27749429|NCT02559687|54199715|FG000|Overall Study|Withdrawal by Subject|4|||
27749430|NCT04294719|54199729|FG000|Overall Study|Withdrawal by Subject|1|||
27749431|NCT02703311|54199737|FG000|Overall Study|Death|5|||
27749432|NCT02703311|54199737|FG000|Overall Study|Withdrawal by Subject|3|||
27749433|NCT02697617|54199741|FG000|Overall Study|Withdrawal by Subject|0|||
27749434|NCT02697617|54199742|FG001|Overall Study|Withdrawal by Subject|2|||
27749435|NCT02697617|54199741|FG000|Overall Study|Pregnancy|1|||
27749436|NCT02697617|54199742|FG001|Overall Study|Pregnancy|0|||
27749437|NCT02698241|54199752|FG000|Overall Study|Inclusion/exclusion criteria not met|4|||
27749438|NCT02698241|54199752|FG000|Overall Study|Screening not met|7|||
27749439|NCT02698241|54199752|FG000|Overall Study|Withdrawal by Subject|7|||
27749440|NCT02698241|54199752|FG000|Overall Study|Physician Decision|2|||
27749441|NCT02698241|54199752|FG000|Overall Study|Subject underwent system modification|2|||
27749442|NCT02698241|54199752|FG000|Overall Study|Lost to Follow-up|3|||
27749443|NCT02698241|54199752|FG000|Overall Study|Subject on inodrip not safe to continue|6|||
27749444|NCT02698241|54199752|FG000|Overall Study|geographic and licensing issue|1|||
27749445|NCT02698241|54199752|FG000|Overall Study|Death|2|||
27749446|NCT01663233|54199758|FG000|Overall Study|Withdrawal by Subject|3|||
27749447|NCT01663233|54199759|FG001|Overall Study|Withdrawal by Subject|2|||
27749448|NCT01663233|54199758|FG000|Overall Study|Protocol Deviation|1|||
27749449|NCT01663233|54199759|FG001|Overall Study|Protocol Deviation|4|||
27749450|NCT01663233|54199758|FG000|Overall Study|Lost to Follow-up|0|||
27749451|NCT01663233|54199759|FG001|Overall Study|Lost to Follow-up|1|||
27749452|NCT02556255|54199778|FG000|Overall Study|Lost to Follow-up|4|||
27749453|NCT02556801|54199786|FG000|Overall Study|Lost to Follow-up|1|||
27749454|NCT02556801|54199787|FG001|Overall Study|Lost to Follow-up|0|||
27749455|NCT02556801|54199788|FG002|Overall Study|Lost to Follow-up|2|||
27749456|NCT02556801|54199789|FG003|Overall Study|Lost to Follow-up|0|||
27749457|NCT02556801|54199786|FG000|Overall Study|Withdrawal by Subject|1|||
27749458|NCT02556801|54199787|FG001|Overall Study|Withdrawal by Subject|1|||
27749459|NCT02556801|54199788|FG002|Overall Study|Withdrawal by Subject|1|||
27749460|NCT02556801|54199789|FG003|Overall Study|Withdrawal by Subject|0|||
27749461|NCT02556801|54199786|FG000|Overall Study|Protocol Violation|0|||
27749462|NCT02556801|54199787|FG001|Overall Study|Protocol Violation|3|||
27749463|NCT02556801|54199788|FG002|Overall Study|Protocol Violation|1|||
27749464|NCT02556801|54199789|FG003|Overall Study|Protocol Violation|1|||
27749465|NCT02556801|54199786|FG000|Overall Study|Adverse Event|0|||
27749466|NCT02556801|54199787|FG001|Overall Study|Adverse Event|2|||
27749467|NCT02556801|54199788|FG002|Overall Study|Adverse Event|0|||
27749468|NCT02556801|54199789|FG003|Overall Study|Adverse Event|3|||
27749469|NCT02556801|54199786|FG000|Overall Study|Pregnancy|0|||
27749470|NCT02556801|54199787|FG001|Overall Study|Pregnancy|1|||
27749471|NCT02556801|54199788|FG002|Overall Study|Pregnancy|0|||
27749472|NCT02556801|54199789|FG003|Overall Study|Pregnancy|0|||
27749473|NCT02556801|54199786|FG000|Overall Study|Personal reasons patient|0|||
27749474|NCT02556801|54199787|FG001|Overall Study|Personal reasons patient|0|||
27749475|NCT02556801|54199788|FG002|Overall Study|Personal reasons patient|0|||
27749476|NCT02556801|54199789|FG003|Overall Study|Personal reasons patient|1|||
27749477|NCT02556177|54199801|FG000|Overall Study|Subjects did not complete all 4 visits|283|||
27749478|NCT02556177|54199802|FG001|Overall Study|Subjects did not complete all 4 visits|61|||
27749479|NCT02554929|54199810|FG000|Overall Study|Lost to Follow-up|4|||
27749480|NCT02554929|54199811|FG001|Overall Study|Lost to Follow-up|4|||
27749481|NCT02554929|54199810|FG000|Overall Study|Withdrawal by Subject|2|||
27749482|NCT02554929|54199811|FG001|Overall Study|Withdrawal by Subject|8|||
27926881|NCT01218477|54583323|FG003|Overall Study|Prepared for cell transplantation|0|||
27926882|NCT01218477|54583320|FG000|Overall Study|Administrative reason by sponsor|0|||
27926883|NCT01218477|54583321|FG001|Overall Study|Administrative reason by sponsor|0|||
27926884|NCT01218477|54583322|FG002|Overall Study|Administrative reason by sponsor|1|||
27926885|NCT01218477|54583323|FG003|Overall Study|Administrative reason by sponsor|0|||
27926886|NCT01218477|54583320|FG000|Overall Study|Maximum clinical benefit|0|||
27926887|NCT01218477|54583321|FG001|Overall Study|Maximum clinical benefit|2|||
27926888|NCT01218477|54583322|FG002|Overall Study|Maximum clinical benefit|0|||
27926889|NCT01218477|54583323|FG003|Overall Study|Maximum clinical benefit|0|||
27926890|NCT01218243|54583339|FG000|Overall Study|Lack of Efficacy|1|||
27926891|NCT01218243|54583340|FG001|Overall Study|Lack of Efficacy|1|||
27749495|NCT02697773|54199842|FG000|Overall Study|Adverse Event|2|||
27749496|NCT02697773|54199843|FG001|Overall Study|Adverse Event|1|||
27749497|NCT02697773|54199844|FG002|Overall Study|Adverse Event|2|||
27749498|NCT02697773|54199842|FG000|Overall Study|Death|0|||
27749499|NCT02697773|54199843|FG001|Overall Study|Death|0|||
27749500|NCT02697773|54199844|FG002|Overall Study|Death|2|||
27749501|NCT02697773|54199842|FG000|Overall Study|Lack of Efficacy|4|||
27749502|NCT02697773|54199843|FG001|Overall Study|Lack of Efficacy|6|||
27749503|NCT02697773|54199844|FG002|Overall Study|Lack of Efficacy|6|||
27749504|NCT02697773|54199842|FG000|Overall Study|Lost to Follow-up|5|||
27749505|NCT02697773|54199843|FG001|Overall Study|Lost to Follow-up|5|||
27749506|NCT02697773|54199844|FG002|Overall Study|Lost to Follow-up|7|||
27749507|NCT02697773|54199842|FG000|Overall Study|Other|15|||
27749508|NCT02697773|54199843|FG001|Overall Study|Other|11|||
27749509|NCT02697773|54199844|FG002|Overall Study|Other|10|||
27749510|NCT02697773|54199842|FG000|Overall Study|Protocol Violation|1|||
27749511|NCT02697773|54199843|FG001|Overall Study|Protocol Violation|1|||
27749512|NCT02697773|54199844|FG002|Overall Study|Protocol Violation|0|||
27749513|NCT02697773|54199842|FG000|Overall Study|Withdrawal by Subject|10|||
27749514|NCT02697773|54199843|FG001|Overall Study|Withdrawal by Subject|13|||
27749515|NCT02697773|54199844|FG002|Overall Study|Withdrawal by Subject|13|||
27749516|NCT02697773|54199842|FG000|Overall Study|Randomized but not treated|1|||
27749517|NCT02697773|54199843|FG001|Overall Study|Randomized but not treated|1|||
27749518|NCT02697773|54199844|FG002|Overall Study|Randomized but not treated|0|||
27749519|NCT02693171|54199852|FG000|Overall Study|Adverse Event|1|||
27749520|NCT02693171|54199852|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
27749521|NCT02692703|54199856|FG000|Overall Study|Lost to Follow-up|1|||
27749522|NCT02692703|54199856|FG000|Overall Study|Other|1|||
27749523|NCT02692235|54199862|FG000|Overall Study|Withdrawal by Subject|2|||
27749524|NCT02692235|54199863|FG001|Overall Study|Withdrawal by Subject|1|||
27749525|NCT02692235|54199862|FG000|Overall Study|Adverse Event|1|||
27749526|NCT02692235|54199863|FG001|Overall Study|Adverse Event|2|||
27749527|NCT02552121|54199877|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2|||
27749528|NCT02552121|54199878|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
27749529|NCT02552121|54199879|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
27749530|NCT02552121|54199880|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
27749531|NCT02552121|54199881|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
27749532|NCT02552121|54199882|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
27749533|NCT02552121|54199883|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
27749534|NCT02552121|54199884|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
27749535|NCT02552121|54199877|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1|||
27749536|NCT02552121|54199878|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
27749537|NCT02552121|54199879|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
27749538|NCT02552121|54199880|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
27749539|NCT02552121|54199881|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
27749540|NCT02552121|54199882|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
27749541|NCT02552121|54199883|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
27749542|NCT02552121|54199884|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
27749543|NCT02552121|54199877|FG000|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
27749544|NCT02552121|54199878|FG001|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1|||
27749545|NCT02552121|54199879|FG002|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
27749546|NCT02552121|54199880|FG003|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
27749547|NCT02552121|54199881|FG004|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
27749548|NCT02552121|54199882|FG005|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
27749549|NCT02552121|54199883|FG006|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
27749550|NCT02552121|54199884|FG007|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
27749551|NCT02552121|54199877|FG000|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
27749552|NCT02552121|54199878|FG001|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2|||
27749553|NCT02552121|54199879|FG002|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
27749554|NCT02552121|54199880|FG003|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
27749555|NCT02552121|54199881|FG004|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
27749556|NCT02552121|54199882|FG005|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
27749557|NCT02552121|54199883|FG006|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
27749558|NCT02552121|54199884|FG007|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
27749559|NCT02552121|54199877|FG000|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
27749560|NCT02552121|54199878|FG001|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2|||
27749561|NCT02552121|54199879|FG002|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
27749562|NCT02552121|54199880|FG003|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
27749563|NCT02552121|54199881|FG004|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
27749564|NCT02552121|54199882|FG005|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
27749565|NCT02552121|54199883|FG006|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
27749566|NCT02552121|54199884|FG007|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
27749567|NCT02552121|54199877|FG000|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
27749568|NCT02552121|54199878|FG001|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1|||
27749569|NCT02552121|54199879|FG002|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
27749570|NCT02552121|54199880|FG003|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
27749571|NCT02552121|54199881|FG004|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
27749572|NCT02552121|54199882|FG005|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
27749573|NCT02552121|54199883|FG006|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
27749574|NCT02552121|54199884|FG007|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
27749575|NCT02552121|54199877|FG000|Part 2: Cohort Expansion|Patient Choice|0|||
27749576|NCT02552121|54199878|FG001|Part 2: Cohort Expansion|Patient Choice|0|||
27749577|NCT02552121|54199879|FG002|Part 2: Cohort Expansion|Patient Choice|1|||
27749578|NCT02552121|54199880|FG003|Part 2: Cohort Expansion|Patient Choice|0|||
27749579|NCT02552121|54199881|FG004|Part 2: Cohort Expansion|Patient Choice|0|||
27749580|NCT02552121|54199882|FG005|Part 2: Cohort Expansion|Patient Choice|0|||
27749581|NCT02552121|54199883|FG006|Part 2: Cohort Expansion|Patient Choice|1|||
27749582|NCT02552121|54199884|FG007|Part 2: Cohort Expansion|Patient Choice|0|||
27749583|NCT02552121|54199877|FG000|Part 2: Cohort Expansion|Disease Progression|0|||
27749584|NCT02552121|54199878|FG001|Part 2: Cohort Expansion|Disease Progression|0|||
27749585|NCT02552121|54199879|FG002|Part 2: Cohort Expansion|Disease Progression|3|||
27749586|NCT02552121|54199880|FG003|Part 2: Cohort Expansion|Disease Progression|2|||
27749587|NCT02552121|54199881|FG004|Part 2: Cohort Expansion|Disease Progression|1|||
27749588|NCT02552121|54199882|FG005|Part 2: Cohort Expansion|Disease Progression|4|||
27749589|NCT02552121|54199883|FG006|Part 2: Cohort Expansion|Disease Progression|0|||
27749590|NCT02552121|54199884|FG007|Part 2: Cohort Expansion|Disease Progression|3|||
27749591|NCT02552121|54199877|FG000|Part 2: Cohort Expansion|Adverse Event|0|||
27749592|NCT02552121|54199878|FG001|Part 2: Cohort Expansion|Adverse Event|0|||
27749593|NCT02552121|54199879|FG002|Part 2: Cohort Expansion|Adverse Event|6|||
27749594|NCT02552121|54199880|FG003|Part 2: Cohort Expansion|Adverse Event|1|||
27749595|NCT02552121|54199881|FG004|Part 2: Cohort Expansion|Adverse Event|0|||
27749596|NCT02552121|54199882|FG005|Part 2: Cohort Expansion|Adverse Event|0|||
27749597|NCT02552121|54199883|FG006|Part 2: Cohort Expansion|Adverse Event|0|||
27749598|NCT02552121|54199884|FG007|Part 2: Cohort Expansion|Adverse Event|0|||
27749599|NCT02552121|54199877|FG000|Part 2: Cohort Expansion|Death|0|||
27749600|NCT02552121|54199878|FG001|Part 2: Cohort Expansion|Death|0|||
27749601|NCT02552121|54199879|FG002|Part 2: Cohort Expansion|Death|1|||
27749602|NCT02552121|54199880|FG003|Part 2: Cohort Expansion|Death|0|||
27749603|NCT02552121|54199881|FG004|Part 2: Cohort Expansion|Death|0|||
27749604|NCT02552121|54199882|FG005|Part 2: Cohort Expansion|Death|0|||
27749605|NCT02552121|54199883|FG006|Part 2: Cohort Expansion|Death|0|||
27749606|NCT02552121|54199884|FG007|Part 2: Cohort Expansion|Death|0|||
27749607|NCT02552355|54199929|FG000|Overall Study|Adverse Event|0|||
27749608|NCT02552355|54199930|FG001|Overall Study|Adverse Event|2|||
27749609|NCT02552355|54199931|FG002|Overall Study|Adverse Event|2|||
27749610|NCT02552355|54199932|FG003|Overall Study|Adverse Event|0|||
27749611|NCT02552355|54199929|FG000|Overall Study|Withdrawal by Subject|0|||
27749612|NCT02552355|54199930|FG001|Overall Study|Withdrawal by Subject|0|||
27749613|NCT02552355|54199931|FG002|Overall Study|Withdrawal by Subject|0|||
27749614|NCT02552355|54199932|FG003|Overall Study|Withdrawal by Subject|1|||
27749615|NCT02551731|54199942|FG000|Overall Study|Withdrawal by Subject|2|||
27749616|NCT02542605|54199946|FG000|Part B: Challenge Phase|Sponsor decision|1|||
27749617|NCT02542605|54199947|FG001|Part B: Challenge Phase|Sponsor decision|0|||
27749618|NCT02542605|54199948|FG002|Part B: Challenge Phase|Sponsor decision|0|||
27749619|NCT02542605|54199946|FG000|Part B: Randomization Phase|Withdrawal by Subject|0|||
27749620|NCT02542605|54199947|FG001|Part B: Randomization Phase|Withdrawal by Subject|0|||
27749621|NCT02542605|54199948|FG002|Part B: Randomization Phase|Withdrawal by Subject|1|||
27749622|NCT02550873|54199959|FG000|Randomized Double Blind|Adverse Event|3|||
27749623|NCT02550873|54199960|FG001|Randomized Double Blind|Adverse Event|1|||
27749624|NCT02550873|54199961|FG002|Randomized Double Blind|Adverse Event|0|||
27749625|NCT02550873|54199959|FG000|Randomized Double Blind|Disease progression|1|||
27749626|NCT02550873|54199960|FG001|Randomized Double Blind|Disease progression|1|||
27749627|NCT02550873|54199961|FG002|Randomized Double Blind|Disease progression|0|||
27749628|NCT02550873|54199959|FG000|Open Label Extension|Study ongoing|0|||
27749629|NCT02550873|54199960|FG001|Open Label Extension|Study ongoing|0|||
27749630|NCT02550873|54199961|FG002|Open Label Extension|Study ongoing|111|||
27749631|NCT02535741|54199983|FG000|Overall Study|Adverse Event|3|||
27749632|NCT02535741|54199983|FG000|Overall Study|Withdrawal by Subject|9|||
27749633|NCT02535741|54199983|FG000|Overall Study|Lost to Follow-up|10|||
27749634|NCT02535741|54199983|FG000|Overall Study|Exclusion criteria: Bilateral implant|4|||
27749635|NCT02535741|54199983|FG000|Overall Study|Missing data|6|||
27749636|NCT03299049|54200003|FG000|Overall Study|On-going|486|||
27749637|NCT03299049|54200004|FG001|Overall Study|On-going|481|||
27749638|NCT03299049|54200003|FG000|Overall Study|Withdrawal by Subject|6|||
27749639|NCT03299049|54200004|FG001|Overall Study|Withdrawal by Subject|21|||
27749640|NCT03299049|54200003|FG000|Overall Study|Physician Decision|5|||
27749641|NCT03299049|54200004|FG001|Overall Study|Physician Decision|1|||
27749642|NCT03299049|54200003|FG000|Overall Study|Lost to Follow-up|2|||
27749643|NCT03299049|54200004|FG001|Overall Study|Lost to Follow-up|0|||
27749644|NCT03299049|54200003|FG000|Overall Study|Pregnancy|1|||
27749645|NCT03299049|54200004|FG001|Overall Study|Pregnancy|3|||
27749646|NCT03299049|54200003|FG000|Overall Study|Protocol Violation|1|||
27749647|NCT03299049|54200004|FG001|Overall Study|Protocol Violation|1|||
27749648|NCT03299049|54200003|FG000|Overall Study|Lack of Efficacy|9|||
27749649|NCT03299049|54200004|FG001|Overall Study|Lack of Efficacy|3|||
27749650|NCT03299049|54200003|FG000|Overall Study|Adverse Event|12|||
27749651|NCT03299049|54200004|FG001|Overall Study|Adverse Event|13|||
27749652|NCT02550795|54200020|FG000|Overall Study|Physician Decision|0|||
27749653|NCT02550795|54200021|FG001|Overall Study|Physician Decision|1|||
27749654|NCT02550795|54200022|FG002|Overall Study|Physician Decision|0|||
27749655|NCT02541903|54200030|FG000|Overall Study|Death|1|||
27749656|NCT02541669|54200039|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
27749657|NCT02541669|54200040|FG001|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
27749658|NCT02541669|54200041|FG002|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
27749659|NCT02541669|54200042|FG003|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
27749660|NCT02541669|54200043|FG004|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
27749661|NCT02549859|54200054|FG000|Long-term 60 Hz DBS|Study Closed|1|||
27749662|NCT02688647|54200064|FG000|Initial Treatment Period (24 Weeks)|Death|0|||
27749663|NCT02688647|54200065|FG001|Initial Treatment Period (24 Weeks)|Death|1|||
27749664|NCT02688647|54200064|FG000|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|0|||
27749665|NCT02688647|54200065|FG001|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|5|||
27749666|NCT02688647|54200064|FG000|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|1|||
27749667|NCT02688647|54200065|FG001|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|0|||
27749668|NCT02688647|54200064|FG000|Post Switch Treatment Period (72 Weeks)|Death|7|||
27749669|NCT02688647|54200065|FG001|Post Switch Treatment Period (72 Weeks)|Death|2|||
27749670|NCT02688647|54200064|FG000|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|1|||
27749671|NCT02688647|54200065|FG001|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|0|||
27749672|NCT02688647|54200064|FG000|Post Switch Treatment Period (72 Weeks)|Other|10|||
27749673|NCT02688647|54200065|FG001|Post Switch Treatment Period (72 Weeks)|Other|6|||
27749674|NCT02688647|54200064|FG000|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|10|||
27749675|NCT02688647|54200065|FG001|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|6|||
27749676|NCT02687711|54200083|FG000|Overall Study|Adverse Event|89|||
27749677|NCT02687711|54200083|FG000|Overall Study|Lack of Efficacy|70|||
27749678|NCT02687711|54200083|FG000|Overall Study|Lost to Follow-up|20|||
27749679|NCT02687711|54200083|FG000|Overall Study|Consent withdrawn|15|||
27749680|NCT02687711|54200083|FG000|Overall Study|Participant moved to another country and continued treatment for epilepsy in that country|1|||
27749681|NCT02687711|54200083|FG000|Overall Study|Too expensive|4|||
27749682|NCT02687711|54200083|FG000|Overall Study|Participant moved abroad|1|||
27749683|NCT02687711|54200083|FG000|Overall Study|Progression of other medical condition (dementia, pneumonia)|1|||
27749684|NCT02687711|54200083|FG000|Overall Study|Perceived increase in seizures but diary records show no increase compared to pre-study|1|||
27749685|NCT02687711|54200083|FG000|Overall Study|Disliked taste|1|||
27749686|NCT02687711|54200083|FG000|Overall Study|Low mood|1|||
27749687|NCT02687711|54200083|FG000|Overall Study|Side effects|1|||
27749688|NCT02687711|54200083|FG000|Overall Study|Change of Hospital|1|||
27749689|NCT02687711|54200083|FG000|Overall Study|Liver Encephalopathy|1|||
27749690|NCT02687711|54200083|FG000|Overall Study|Participant experience side effects, fatigue. Most likely not related to investigational product|1|||
27749691|NCT02687711|54200083|FG000|Overall Study|Withdrawn due to intake interruption|1|||
27749692|NCT02687711|54200083|FG000|Overall Study|Stopped in preparation for epilepsy surgery|1|||
27749693|NCT02687711|54200083|FG000|Overall Study|Diagnosis epilepsy revised to psychogenic seizures|1|||
27749694|NCT02687711|54200083|FG000|Overall Study|Participant was not able to come in our clinic because participant could not find a car driver|1|||
27749695|NCT01662063|54200089|FG000|Overall Study|Adverse Event or Intercurrent Illness|1|||
27749696|NCT01662063|54200090|FG001|Overall Study|Adverse Event or Intercurrent Illness|12|||
27749697|NCT01662063|54200091|FG002|Overall Study|Adverse Event or Intercurrent Illness|0|||
27749698|NCT01662063|54200089|FG000|Overall Study|Lack of Efficacy|1|||
27749699|NCT01662063|54200090|FG001|Overall Study|Lack of Efficacy|6|||
27749700|NCT01662063|54200091|FG002|Overall Study|Lack of Efficacy|0|||
27749701|NCT01662063|54200089|FG000|Overall Study|Lost to Follow-up|0|||
27749702|NCT01662063|54200090|FG001|Overall Study|Lost to Follow-up|4|||
27749703|NCT01662063|54200091|FG002|Overall Study|Lost to Follow-up|0|||
27749704|NCT01662063|54200089|FG000|Overall Study|Protocol Violation|1|||
27749705|NCT01662063|54200090|FG001|Overall Study|Protocol Violation|0|||
27749706|NCT01662063|54200091|FG002|Overall Study|Protocol Violation|0|||
27749707|NCT01662063|54200089|FG000|Overall Study|Withdrawal by Subject|2|||
27749708|NCT01662063|54200090|FG001|Overall Study|Withdrawal by Subject|4|||
27749709|NCT01662063|54200091|FG002|Overall Study|Withdrawal by Subject|1|||
27749710|NCT01662063|54200089|FG000|Overall Study|Physician Decision|0|||
27749711|NCT01662063|54200090|FG001|Overall Study|Physician Decision|2|||
27749712|NCT01662063|54200091|FG002|Overall Study|Physician Decision|0|||
27749713|NCT01662063|54200089|FG000|Overall Study|Other|0|||
27749714|NCT01662063|54200090|FG001|Overall Study|Other|1|||
27749715|NCT01662063|54200091|FG002|Overall Study|Other|0|||
27749716|NCT02548455|54200099|FG000|Overall Study|Withdrawal by Subject|27|||
27749717|NCT02548455|54200099|FG000|Overall Study|Death|26|||
27749718|NCT02548455|54200099|FG000|Overall Study|Lost to Follow-up|14|||
27749719|NCT02548455|54200099|FG000|Overall Study|Visit not completed|173|||
27749720|NCT02691455|54200105|FG000|Overall Study|Withdrawal by Subject|1|||
27749721|NCT02691455|54200106|FG001|Overall Study|Withdrawal by Subject|2|||
27749722|NCT02691455|54200105|FG000|Overall Study|Lost to Follow-up|15|||
27749723|NCT02691455|54200106|FG001|Overall Study|Lost to Follow-up|15|||
27749724|NCT02534883|54200114|FG000|Overall Study|Early Termination|8|||
27749725|NCT02534883|54200115|FG001|Overall Study|Early Termination|3|||
27749726|NCT02685995|54200123|FG000|Overall Study|Insertion of immediately puncturable graft.|1|||
27749727|NCT02685995|54200124|FG001|Overall Study|Insertion of immediately puncturable graft.|1|||
27749728|NCT02548143|54200132|FG000|Overall Study|Adverse Event|1|||
27749729|NCT02548143|54200133|FG001|Overall Study|Adverse Event|0|||
27749730|NCT02548143|54200132|FG000|Overall Study|Withdrawal by Subject|0|||
27749731|NCT02548143|54200133|FG001|Overall Study|Withdrawal by Subject|1|||
27749732|NCT02547441|54200141|FG000|Double-Blind Study Period|Adverse Event|4|||
27749733|NCT02547441|54200142|FG001|Double-Blind Study Period|Adverse Event|9|||
27749734|NCT02547441|54200141|FG000|Double-Blind Study Period|Lost to Follow-up|2|||
27749735|NCT02547441|54200142|FG001|Double-Blind Study Period|Lost to Follow-up|4|||
27749736|NCT02547441|54200141|FG000|Double-Blind Study Period|Physician Decision|1|||
27749737|NCT02547441|54200142|FG001|Double-Blind Study Period|Physician Decision|0|||
27749738|NCT02547441|54200141|FG000|Double-Blind Study Period|Protocol Violation|1|||
27749739|NCT02547441|54200142|FG001|Double-Blind Study Period|Protocol Violation|2|||
27749740|NCT02547441|54200141|FG000|Double-Blind Study Period|Withdrawal by Subject|15|||
27749741|NCT02547441|54200142|FG001|Double-Blind Study Period|Withdrawal by Subject|17|||
27749742|NCT02547441|54200141|FG000|Double-Blind Study Period|Sponsor Decision|1|||
27749743|NCT02547441|54200142|FG001|Double-Blind Study Period|Sponsor Decision|0|||
27749744|NCT02547441|54200141|FG000|Open-Label Study Period|Adverse Event|10|||
27749745|NCT02547441|54200142|FG001|Open-Label Study Period|Adverse Event|11|||
27749746|NCT02547441|54200141|FG000|Open-Label Study Period|Lack of Efficacy|3|||
27749747|NCT02547441|54200142|FG001|Open-Label Study Period|Lack of Efficacy|2|||
27749748|NCT02547441|54200141|FG000|Open-Label Study Period|Lost to Follow-up|7|||
27749749|NCT02547441|54200142|FG001|Open-Label Study Period|Lost to Follow-up|8|||
27749750|NCT02547441|54200141|FG000|Open-Label Study Period|Physician Decision|1|||
27749751|NCT02547441|54200142|FG001|Open-Label Study Period|Physician Decision|0|||
27749752|NCT02547441|54200141|FG000|Open-Label Study Period|Protocol Violation|2|||
27749753|NCT02547441|54200142|FG001|Open-Label Study Period|Protocol Violation|0|||
27749754|NCT02547441|54200141|FG000|Open-Label Study Period|Withdrawal by Subject|33|||
27749755|NCT02547441|54200142|FG001|Open-Label Study Period|Withdrawal by Subject|37|||
27749756|NCT02547441|54200141|FG000|Open-Label Study Period|Terminated by Sponsor|66|||
27749757|NCT02547441|54200142|FG001|Open-Label Study Period|Terminated by Sponsor|69|||
27749758|NCT02540265|54200152|FG000|Overall Study|Lost to Follow-up|0|||
27749759|NCT02540265|54200153|FG001|Overall Study|Lost to Follow-up|0|||
27749760|NCT02540265|54200154|FG002|Overall Study|Lost to Follow-up|1|||
27749761|NCT02547363|54200164|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
27749762|NCT02547363|54200165|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
27749763|NCT02547363|54200164|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
27749764|NCT02547363|54200165|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8|||
27749765|NCT02547363|54200164|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
27749766|NCT02547363|54200165|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
27749767|NCT02547363|54200164|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
27749768|NCT02547363|54200165|FG001|3-day Treatment and 8-week Follow-up|Other|1|||
27749769|NCT02547363|54200164|FG000|12-month Follow-up|Withdrawal by Subject|4|||
27749770|NCT02547363|54200165|FG001|12-month Follow-up|Withdrawal by Subject|3|||
27749771|NCT02547363|54200164|FG000|12-month Follow-up|Lost to Follow-up|4|||
27749772|NCT02547363|54200165|FG001|12-month Follow-up|Lost to Follow-up|1|||
27749773|NCT02547363|54200164|FG000|12-month Follow-up|Lack of Efficacy|1|||
27749774|NCT02547363|54200165|FG001|12-month Follow-up|Lack of Efficacy|1|||
27749775|NCT02547363|54200164|FG000|12-month Follow-up|Other|1|||
27749776|NCT02547363|54200165|FG001|12-month Follow-up|Other|0|||
27749777|NCT02539797|54200173|FG000|Overall Study|Lost to Follow-up|0|||
27749778|NCT02539797|54200174|FG001|Overall Study|Lost to Follow-up|1|||
27749779|NCT02539797|54200175|FG002|Overall Study|Lost to Follow-up|0|||
27749780|NCT02684357|54200186|FG000|Part A|Adverse Event (Worsening of Disease)|1|||
27749781|NCT02684357|54200187|FG001|Part A|Adverse Event (Worsening of Disease)|0|||
27749782|NCT02684357|54200188|FG002|Part A|Adverse Event (Worsening of Disease)|0|||
27749783|NCT02684357|54200189|FG003|Part A|Adverse Event (Worsening of Disease)|0|||
27749784|NCT02684357|54200190|FG004|Part A|Adverse Event (Worsening of Disease)|0|||
27749785|NCT02684357|54200191|FG005|Part A|Adverse Event (Worsening of Disease)|0|||
27749786|NCT02684357|54200186|FG000|Part A|Lost to Follow-up|0|||
27749787|NCT02684357|54200187|FG001|Part A|Lost to Follow-up|2|||
27749788|NCT02684357|54200188|FG002|Part A|Lost to Follow-up|2|||
27749789|NCT02684357|54200189|FG003|Part A|Lost to Follow-up|0|||
27749790|NCT02684357|54200190|FG004|Part A|Lost to Follow-up|0|||
27749791|NCT02684357|54200191|FG005|Part A|Lost to Follow-up|0|||
27749792|NCT02684357|54200186|FG000|Part A|Withdrawal by Subject|3|||
27749793|NCT02684357|54200187|FG001|Part A|Withdrawal by Subject|0|||
27749794|NCT02684357|54200188|FG002|Part A|Withdrawal by Subject|0|||
27749795|NCT02684357|54200189|FG003|Part A|Withdrawal by Subject|0|||
27749796|NCT02684357|54200190|FG004|Part A|Withdrawal by Subject|0|||
27749797|NCT02684357|54200191|FG005|Part A|Withdrawal by Subject|0|||
27749798|NCT02684357|54200186|FG000|Part A|Other|0|||
27749799|NCT02684357|54200187|FG001|Part A|Other|1|||
27749800|NCT02684357|54200188|FG002|Part A|Other|0|||
27749801|NCT02684357|54200189|FG003|Part A|Other|0|||
27749802|NCT02684357|54200190|FG004|Part A|Other|0|||
27749803|NCT02684357|54200191|FG005|Part A|Other|0|||
27749804|NCT02684357|54200186|FG000|Part B|Adverse Event (Other)|0|||
27749805|NCT02684357|54200187|FG001|Part B|Adverse Event (Other)|0|||
27749806|NCT02684357|54200188|FG002|Part B|Adverse Event (Other)|0|||
27749807|NCT02684357|54200189|FG003|Part B|Adverse Event (Other)|1|||
27749808|NCT02684357|54200190|FG004|Part B|Adverse Event (Other)|1|||
27749809|NCT02684357|54200191|FG005|Part B|Adverse Event (Other)|1|||
27749810|NCT02684357|54200186|FG000|Part B|Lost to Follow-up|0|||
27749811|NCT02684357|54200187|FG001|Part B|Lost to Follow-up|0|||
27749812|NCT02684357|54200188|FG002|Part B|Lost to Follow-up|0|||
27749813|NCT02684357|54200189|FG003|Part B|Lost to Follow-up|1|||
27749814|NCT02684357|54200190|FG004|Part B|Lost to Follow-up|1|||
27749815|NCT02684357|54200191|FG005|Part B|Lost to Follow-up|7|||
27749816|NCT02684357|54200186|FG000|Part B|Withdrawal by Subject|0|||
27749817|NCT02684357|54200187|FG001|Part B|Withdrawal by Subject|0|||
27749818|NCT02684357|54200188|FG002|Part B|Withdrawal by Subject|0|||
27749819|NCT02684357|54200189|FG003|Part B|Withdrawal by Subject|0|||
27749820|NCT02684357|54200190|FG004|Part B|Withdrawal by Subject|2|||
27749821|NCT02684357|54200191|FG005|Part B|Withdrawal by Subject|4|||
27749822|NCT02684357|54200186|FG000|Part B|Other|0|||
27749823|NCT02684357|54200187|FG001|Part B|Other|0|||
27749824|NCT02684357|54200188|FG002|Part B|Other|0|||
27749825|NCT02684357|54200189|FG003|Part B|Other|1|||
27749826|NCT02684357|54200190|FG004|Part B|Other|0|||
27749827|NCT02684357|54200191|FG005|Part B|Other|1|||
27749828|NCT02684279|54200204|FG000|Overall Study|Adverse Event|87|||
27749829|NCT02684279|54200204|FG000|Overall Study|Lack of Efficacy|4|||
27749830|NCT02684279|54200204|FG000|Overall Study|Lost to Follow-up|61|||
27749831|NCT02684279|54200204|FG000|Overall Study|Protocol Violation|6|||
27749832|NCT02684279|54200204|FG000|Overall Study|Pregnancy|8|||
27749833|NCT02684279|54200204|FG000|Overall Study|Withdrawal by Subject|92|||
27749834|NCT02684279|54200204|FG000|Overall Study|non-compliance with study drug|9|||
27749835|NCT02684279|54200204|FG000|Overall Study|non compliance with study visits|2|||
27749836|NCT02684279|54200204|FG000|Overall Study|subject to have surgery|1|||
27749837|NCT02684279|54200204|FG000|Overall Study|family emergency|1|||
27749838|NCT02684279|54200204|FG000|Overall Study|Site closures|7|||
27749839|NCT02684279|54200204|FG000|Overall Study|Physician Decision|1|||
27749840|NCT03206073|54200212|FG000|Overall Study|Participant Noncompliance|0|||
27749841|NCT03206073|54200213|FG001|Overall Study|Participant Noncompliance|1|||
27749842|NCT03206073|54200214|FG002|Overall Study|Participant Noncompliance|0|||
27749843|NCT03206073|54200215|FG003|Overall Study|Participant Noncompliance|0|||
27749844|NCT03206073|54200212|FG000|Overall Study|Unable to complete the dose limiting toxicity period|1|||
27749845|NCT03206073|54200213|FG001|Overall Study|Unable to complete the dose limiting toxicity period|0|||
27749846|NCT03206073|54200214|FG002|Overall Study|Unable to complete the dose limiting toxicity period|0|||
27749847|NCT03206073|54200215|FG003|Overall Study|Unable to complete the dose limiting toxicity period|0|||
27749848|NCT03206073|54200212|FG000|Overall Study|Death|0|||
27749849|NCT03206073|54200213|FG001|Overall Study|Death|0|||
27749850|NCT03206073|54200214|FG002|Overall Study|Death|1|||
27749851|NCT03206073|54200215|FG003|Overall Study|Death|0|||
27749852|NCT03206073|54200212|FG000|Overall Study|Taken off active treatment|0|||
27749853|NCT03206073|54200213|FG001|Overall Study|Taken off active treatment|0|||
27749854|NCT03206073|54200214|FG002|Overall Study|Taken off active treatment|3|||
27749855|NCT03206073|54200215|FG003|Overall Study|Taken off active treatment|0|||
27749856|NCT02534493|54200225|FG000|Overall Study|Lost to Follow-up|1|||
27749857|NCT02534493|54200225|FG000|Overall Study|Withdrawal by Subject|1|||
27749858|NCT02547129|54200233|FG000|Overall Study|Difficulty with ongoing infection|1|||
27749859|NCT02547129|54200234|FG001|Overall Study|Difficulty with ongoing infection|0|||
27749860|NCT02546193|54200242|FG000|Overall Study|Withdrawal by Subject|2|||
27749861|NCT02546193|54200243|FG001|Overall Study|Withdrawal by Subject|0|||
27749862|NCT02546193|54200244|FG002|Overall Study|Withdrawal by Subject|1|||
27749863|NCT02546193|54200245|FG003|Overall Study|Withdrawal by Subject|0|||
27749864|NCT02546193|54200242|FG000|Overall Study|Not eligible at time of induction|4|||
27749865|NCT02546193|54200243|FG001|Overall Study|Not eligible at time of induction|6|||
27749866|NCT02546193|54200244|FG002|Overall Study|Not eligible at time of induction|1|||
27749867|NCT02546193|54200245|FG003|Overall Study|Not eligible at time of induction|0|||
27749868|NCT02538471|54200251|FG000|Overall Study|Progression of disease|2|||
27749869|NCT01661595|54200259|FG000|Phase 1: Week 0-4|Adverse Event|1|||
27749870|NCT01661595|54200260|FG001|Phase 1: Week 0-4|Adverse Event|0|||
27749871|NCT01661595|54200261|FG002|Phase 1: Week 0-4|Adverse Event|0|||
27749872|NCT01661595|54200262|FG003|Phase 1: Week 0-4|Adverse Event|0|||
27749873|NCT01661595|54200259|FG000|Phase 2: Week 5-8.|Protocol Violation|0|||
27749874|NCT01661595|54200260|FG001|Phase 2: Week 5-8.|Protocol Violation|0|||
27749875|NCT01661595|54200261|FG002|Phase 2: Week 5-8.|Protocol Violation|1|||
27749876|NCT01661595|54200262|FG003|Phase 2: Week 5-8.|Protocol Violation|0|||
27749877|NCT02213133|54200282|FG000|Overall Study|Participant discontinued study therapy|2|||
27749878|NCT02213133|54200283|FG001|Overall Study|Participant discontinued study therapy|0|||
27749879|NCT02213133|54200284|FG002|Overall Study|Participant discontinued study therapy|0|||
27749880|NCT02213133|54200282|FG000|Overall Study|Participant withdrew informed consent|2|||
27749881|NCT02213133|54200283|FG001|Overall Study|Participant withdrew informed consent|1|||
27749882|NCT02213133|54200284|FG002|Overall Study|Participant withdrew informed consent|2|||
27749883|NCT02213133|54200282|FG000|Overall Study|Disease progression|11|||
27749884|NCT02213133|54200283|FG001|Overall Study|Disease progression|2|||
27749885|NCT02213133|54200284|FG002|Overall Study|Disease progression|0|||
27749886|NCT02213133|54200282|FG000|Overall Study|Adverse Event (AE)|1|||
27749887|NCT02213133|54200283|FG001|Overall Study|Adverse Event (AE)|0|||
27749888|NCT02213133|54200284|FG002|Overall Study|Adverse Event (AE)|0|||
27749889|NCT02213133|54200282|FG000|Overall Study|Death|16|||
27749890|NCT02213133|54200283|FG001|Overall Study|Death|2|||
27749891|NCT02213133|54200284|FG002|Overall Study|Death|1|||
27749892|NCT02213133|54200282|FG000|Overall Study|Other|5|||
27749893|NCT02213133|54200283|FG001|Overall Study|Other|0|||
27749894|NCT02213133|54200284|FG002|Overall Study|Other|0|||
27749895|NCT02684981|54200296|FG000|Overall Study|Permanently discontinued the treatment|157|||
27749896|NCT02684981|54200297|FG001|Overall Study|Permanently discontinued the treatment|161|||
27749897|NCT02684981|54200298|FG002|Overall Study|Permanently discontinued the treatment|110|||
27749898|NCT02684981|54200296|FG000|Overall Study|Other|83|||
27749899|NCT02684981|54200297|FG001|Overall Study|Other|49|||
27749900|NCT02684981|54200298|FG002|Overall Study|Other|17|||
27749901|NCT02146833|54200312|FG000|Overall Study|Death|10|||
27749902|NCT02146833|54200312|FG000|Overall Study|No longer consented to study treatment|1|||
27749903|NCT02690207|54200316|FG000|Overall Study|Lost to Follow-up|48|||
27749904|NCT02690207|54200316|FG000|Overall Study|Withdrawal by Subject|46|||
27749905|NCT02690207|54200316|FG000|Overall Study|Protocol Violation|2|||
27749906|NCT02690207|54200316|FG000|Overall Study|Serious adverse event|110|||
27749907|NCT02690207|54200316|FG000|Overall Study|Non-serious Adverse Event|18|||
27749908|NCT02690207|54200316|FG000|Overall Study|Migrated/moved from study area|5|||
27749909|NCT02690207|54200316|FG000|Overall Study|Suspected HZ Episode|1|||
27749910|NCT02690207|54200316|FG000|Overall Study|Other reasons for withdrawal|23|||
27749911|NCT02689349|54200322|FG000|Overall Study|Not implanted|4|||
27749912|NCT02689349|54200323|FG001|Overall Study|Not implanted|0|||
27749913|NCT02689349|54200322|FG000|Overall Study|Withdrawal by Subject|9|||
27749914|NCT02689349|54200323|FG001|Overall Study|Withdrawal by Subject|0|||
27749915|NCT02679287|54200334|FG000|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2|||
27749916|NCT02679287|54200335|FG001|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1|||
27749917|NCT02679287|54200334|FG000|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2|||
27749918|NCT02679287|54200335|FG001|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3|||
27749919|NCT02679287|54200334|FG000|Period 1: Randomization-Study Session 1|Disliked mobile system|0|||
27749920|NCT02679287|54200335|FG001|Period 1: Randomization-Study Session 1|Disliked mobile system|1|||
27749921|NCT02679287|54200334|FG000|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0|||
27749922|NCT02679287|54200335|FG001|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1|||
27749923|NCT02679287|54200334|FG000|Period 2|Work/Scheduling Conflict|1|||
27749924|NCT02679287|54200335|FG001|Period 2|Work/Scheduling Conflict|0|||
27749925|NCT02679287|54200334|FG000|Period 2|Disliked Mobile System|2|||
27749926|NCT02679287|54200335|FG001|Period 2|Disliked Mobile System|0|||
27749927|NCT02679287|54200334|FG000|Period 3|Work/Scheduling Conflict|0|||
27749928|NCT02679287|54200335|FG001|Period 3|Work/Scheduling Conflict|1|||
27749929|NCT02544633|54200351|FG000|Treatment Period|Patient Still on Treatment/Study|0|||
27749930|NCT02544633|54200352|FG001|Treatment Period|Patient Still on Treatment/Study|1|||
27749931|NCT02544633|54200353|FG002|Treatment Period|Patient Still on Treatment/Study|1|||
27749932|NCT02544633|54200354|FG003|Treatment Period|Patient Still on Treatment/Study|0|||
27749933|NCT02544633|54200351|FG000|Treatment Period|Adverse Event|7|||
27749934|NCT02544633|54200352|FG001|Treatment Period|Adverse Event|4|||
27749935|NCT02544633|54200353|FG002|Treatment Period|Adverse Event|0|||
27749936|NCT02544633|54200354|FG003|Treatment Period|Adverse Event|5|||
27749937|NCT02544633|54200351|FG000|Treatment Period|Lack of Efficacy|17|||
27749938|NCT02544633|54200352|FG001|Treatment Period|Lack of Efficacy|11|||
27749939|NCT02544633|54200353|FG002|Treatment Period|Lack of Efficacy|5|||
27749940|NCT02544633|54200354|FG003|Treatment Period|Lack of Efficacy|5|||
27749941|NCT02544633|54200351|FG000|Treatment Period|Global Deterioration of Health|3|||
27749942|NCT02544633|54200352|FG001|Treatment Period|Global Deterioration of Health|3|||
27749943|NCT02544633|54200353|FG002|Treatment Period|Global Deterioration of Health|0|||
27749944|NCT02544633|54200354|FG003|Treatment Period|Global Deterioration of Health|1|||
27749945|NCT02544633|54200351|FG000|Treatment Period|Withdrawal by Subject|1|||
27749946|NCT02544633|54200352|FG001|Treatment Period|Withdrawal by Subject|0|||
27749947|NCT02544633|54200353|FG002|Treatment Period|Withdrawal by Subject|0|||
27749948|NCT02544633|54200354|FG003|Treatment Period|Withdrawal by Subject|0|||
27749949|NCT02544633|54200351|FG000|Treatment Period|Lost to Follow-up|0|||
27749950|NCT02544633|54200352|FG001|Treatment Period|Lost to Follow-up|1|||
27749951|NCT02544633|54200353|FG002|Treatment Period|Lost to Follow-up|0|||
27749952|NCT02544633|54200354|FG003|Treatment Period|Lost to Follow-up|0|||
27749953|NCT02544633|54200351|FG000|Treatment Period|Death|0|||
27749954|NCT02544633|54200352|FG001|Treatment Period|Death|0|||
27749955|NCT02544633|54200353|FG002|Treatment Period|Death|1|||
27749956|NCT02544633|54200354|FG003|Treatment Period|Death|0|||
27749957|NCT02544633|54200351|FG000|Treatment Period|Non-compliance|0|||
27749958|NCT02544633|54200352|FG001|Treatment Period|Non-compliance|0|||
27749959|NCT02544633|54200353|FG002|Treatment Period|Non-compliance|1|||
27749960|NCT02544633|54200354|FG003|Treatment Period|Non-compliance|0|||
27749961|NCT02544633|54200351|FG000|Treatment Period|Clinical Disease Progression|0|||
27749962|NCT02544633|54200352|FG001|Treatment Period|Clinical Disease Progression|0|||
27749963|NCT02544633|54200353|FG002|Treatment Period|Clinical Disease Progression|0|||
27749964|NCT02544633|54200354|FG003|Treatment Period|Clinical Disease Progression|1|||
27749965|NCT02544633|54200351|FG000|Survival Follow-up Period|Death|12|||
27749966|NCT02544633|54200352|FG001|Survival Follow-up Period|Death|14|||
27749967|NCT02544633|54200353|FG002|Survival Follow-up Period|Death|3|||
27749968|NCT02544633|54200354|FG003|Survival Follow-up Period|Death|9|||
27749969|NCT02544633|54200351|FG000|Survival Follow-up Period|Lost to Follow-up|0|||
27749970|NCT02544633|54200352|FG001|Survival Follow-up Period|Lost to Follow-up|1|||
27749971|NCT02544633|54200353|FG002|Survival Follow-up Period|Lost to Follow-up|1|||
27749972|NCT02544633|54200354|FG003|Survival Follow-up Period|Lost to Follow-up|0|||
27926892|NCT01218243|54583339|FG000|Overall Study|Lost to Follow-up|3|||
27749973|NCT02544633|54200351|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
27749974|NCT02544633|54200352|FG001|Survival Follow-up Period|Withdrawal by Subject|0|||
27749975|NCT02544633|54200353|FG002|Survival Follow-up Period|Withdrawal by Subject|1|||
27749976|NCT02544633|54200354|FG003|Survival Follow-up Period|Withdrawal by Subject|0|||
27749977|NCT02544633|54200351|FG000|Survival Follow-up Period|Study Terminated by Sponsor|12|||
27749978|NCT02544633|54200352|FG001|Survival Follow-up Period|Study Terminated by Sponsor|4|||
27749979|NCT02544633|54200353|FG002|Survival Follow-up Period|Study Terminated by Sponsor|2|||
27749980|NCT02544633|54200354|FG003|Survival Follow-up Period|Study Terminated by Sponsor|3|||
27749981|NCT02678351|54200376|FG000|Overall Study|Withdrawal by Subject|1|||
27749982|NCT02683187|54200380|FG000|Overall Study|Failed IV access|3|||
27749983|NCT02683187|54200380|FG000|Overall Study|Withdrawal by Subject|5|||
27749984|NCT02683109|54200390|FG000|Overall Study|Adverse Event|1|||
27749985|NCT02683109|54200391|FG001|Overall Study|Adverse Event|0|||
27749986|NCT02544321|54200400|FG000|Overall Study|Withdrawal by Subject|1|||
27749987|NCT02544321|54200401|FG001|Overall Study|Withdrawal by Subject|2|||
27749988|NCT02544321|54200400|FG000|Overall Study|Adverse Event|1|||
27749989|NCT02544321|54200401|FG001|Overall Study|Adverse Event|1|||
27749990|NCT02544321|54200400|FG000|Overall Study|Protocol Violation|0|||
27749991|NCT02544321|54200401|FG001|Overall Study|Protocol Violation|1|||
27749992|NCT02533401|54200416|FG000|Overall Study|Adverse Event/Intercurrent Disease|3|||
27749993|NCT02533401|54200416|FG000|Overall Study|Death|5|||
27749994|NCT02533401|54200416|FG000|Overall Study|Insufficient Response/Progressed Disease|1|||
27749995|NCT02533401|54200416|FG000|Overall Study|Lost to Follow-up|1|||
27749996|NCT02533401|54200416|FG000|Overall Study|Violation of Selection Criteria|1|||
27749997|NCT02536833|54200424|FG000|Overall Study|Discontinued Before Treatment|0|||
27749998|NCT02536833|54200425|FG001|Overall Study|Discontinued Before Treatment|0|||
27749999|NCT02536833|54200426|FG002|Overall Study|Discontinued Before Treatment|1|||
27750000|NCT02536833|54200427|FG003|Overall Study|Discontinued Before Treatment|2|||
27750001|NCT02536833|54200424|FG000|Overall Study|Adverse Event|1|||
27750002|NCT02536833|54200425|FG001|Overall Study|Adverse Event|3|||
27750003|NCT02536833|54200426|FG002|Overall Study|Adverse Event|4|||
27750004|NCT02536833|54200427|FG003|Overall Study|Adverse Event|1|||
27750005|NCT02536833|54200424|FG000|Overall Study|Lost to Follow-up|2|||
27750006|NCT02536833|54200425|FG001|Overall Study|Lost to Follow-up|1|||
27750007|NCT02536833|54200426|FG002|Overall Study|Lost to Follow-up|2|||
27750008|NCT02536833|54200427|FG003|Overall Study|Lost to Follow-up|2|||
27750009|NCT02536833|54200424|FG000|Overall Study|Physician Decision|0|||
27750010|NCT02536833|54200425|FG001|Overall Study|Physician Decision|0|||
27750011|NCT02536833|54200426|FG002|Overall Study|Physician Decision|0|||
27750012|NCT02536833|54200427|FG003|Overall Study|Physician Decision|1|||
27750013|NCT02536833|54200424|FG000|Overall Study|Site Terminated by Sponsor|2|||
27750014|NCT02536833|54200425|FG001|Overall Study|Site Terminated by Sponsor|2|||
27750015|NCT02536833|54200426|FG002|Overall Study|Site Terminated by Sponsor|2|||
27750016|NCT02536833|54200427|FG003|Overall Study|Site Terminated by Sponsor|2|||
27750017|NCT02536833|54200424|FG000|Overall Study|Subject Non-Compliance|0|||
27750018|NCT02536833|54200425|FG001|Overall Study|Subject Non-Compliance|1|||
27750019|NCT02536833|54200426|FG002|Overall Study|Subject Non-Compliance|1|||
27750020|NCT02536833|54200427|FG003|Overall Study|Subject Non-Compliance|0|||
27750021|NCT02536833|54200424|FG000|Overall Study|Withdrawal by Subject|4|||
27750022|NCT02536833|54200425|FG001|Overall Study|Withdrawal by Subject|3|||
27750023|NCT02536833|54200426|FG002|Overall Study|Withdrawal by Subject|5|||
27750024|NCT02536833|54200427|FG003|Overall Study|Withdrawal by Subject|11|||
27750025|NCT02680847|54200441|FG000|Overall Study|Other|2|||
27750026|NCT02680847|54200442|FG001|Overall Study|Other|0|||
27750027|NCT02680847|54200443|FG002|Overall Study|Other|0|||
27750028|NCT02680847|54200441|FG000|Overall Study|No longer met eligibility criteria|2|||
27750029|NCT02680847|54200442|FG001|Overall Study|No longer met eligibility criteria|2|||
27750030|NCT02680847|54200443|FG002|Overall Study|No longer met eligibility criteria|0|||
27750031|NCT02680847|54200441|FG000|Overall Study|Unwilling to participate in study|1|||
27750032|NCT02680847|54200442|FG001|Overall Study|Unwilling to participate in study|1|||
27750033|NCT02680847|54200443|FG002|Overall Study|Unwilling to participate in study|0|||
27750034|NCT02680847|54200441|FG000|Overall Study|Lack of Efficacy|0|||
27750035|NCT02680847|54200442|FG001|Overall Study|Lack of Efficacy|0|||
27750036|NCT02680847|54200443|FG002|Overall Study|Lack of Efficacy|2|||
27750037|NCT02680847|54200441|FG000|Overall Study|Adverse Event|0|||
27750038|NCT02680847|54200442|FG001|Overall Study|Adverse Event|0|||
27750039|NCT02680847|54200443|FG002|Overall Study|Adverse Event|1|||
27750040|NCT02532855|54200453|FG000|Overall Study|Lost to Follow-up|4|||
27750041|NCT02532855|54200454|FG001|Overall Study|Lost to Follow-up|3|||
27750042|NCT02532855|54200453|FG000|Overall Study|Withdrawal by Subject|4|||
27750043|NCT02532855|54200454|FG001|Overall Study|Withdrawal by Subject|8|||
27750044|NCT02530125|54200460|FG000|Completed Treatment|Early termination of study|1|||
27750045|NCT02530125|54200460|FG000|Followed for Survival for 2 Years|Early termination of study|3|||
27750046|NCT01661205|54200464|FG000|Overall Study|Physician Decision|2|||
27750047|NCT02055820|54200478|FG000|Phase I: Dose-Finding|Death|1|||
27750048|NCT02055820|54200479|FG001|Phase I: Dose-Finding|Death|0|||
27750049|NCT02055820|54200480|FG002|Phase I: Dose-Finding|Death|1|||
27750050|NCT02055820|54200481|FG003|Phase I: Dose-Finding|Death|2|||
27750051|NCT02055820|54200482|FG004|Phase I: Dose-Finding|Death|0|||
27750052|NCT02055820|54200483|FG005|Phase I: Dose-Finding|Death|1|||
27750053|NCT02055820|54200484|FG006|Phase I: Dose-Finding|Death|1|||
27750054|NCT02055820|54200485|FG007|Phase I: Dose-Finding|Death|0|||
27750055|NCT02055820|54200486|FG008|Phase I: Dose-Finding|Death|0|||
27750056|NCT02055820|54200487|FG009|Phase I: Dose-Finding|Death|0|||
27750057|NCT02055820|54200478|FG000|Phase I: Dose-Finding|Withdrawal by Subject|0|||
27750058|NCT02055820|54200479|FG001|Phase I: Dose-Finding|Withdrawal by Subject|0|||
27750059|NCT02055820|54200480|FG002|Phase I: Dose-Finding|Withdrawal by Subject|0|||
27750060|NCT02055820|54200481|FG003|Phase I: Dose-Finding|Withdrawal by Subject|0|||
27750061|NCT02055820|54200482|FG004|Phase I: Dose-Finding|Withdrawal by Subject|0|||
27750062|NCT02055820|54200483|FG005|Phase I: Dose-Finding|Withdrawal by Subject|1|||
27750063|NCT02055820|54200484|FG006|Phase I: Dose-Finding|Withdrawal by Subject|0|||
27750064|NCT02055820|54200485|FG007|Phase I: Dose-Finding|Withdrawal by Subject|0|||
27750065|NCT02055820|54200486|FG008|Phase I: Dose-Finding|Withdrawal by Subject|0|||
27750066|NCT02055820|54200487|FG009|Phase I: Dose-Finding|Withdrawal by Subject|0|||
27750067|NCT02055820|54200478|FG000|Phase I: Dose-Finding|Lost to Follow-up|0|||
27750068|NCT02055820|54200479|FG001|Phase I: Dose-Finding|Lost to Follow-up|0|||
27750069|NCT02055820|54200480|FG002|Phase I: Dose-Finding|Lost to Follow-up|0|||
27750070|NCT02055820|54200481|FG003|Phase I: Dose-Finding|Lost to Follow-up|1|||
27750071|NCT02055820|54200482|FG004|Phase I: Dose-Finding|Lost to Follow-up|0|||
27750072|NCT02055820|54200483|FG005|Phase I: Dose-Finding|Lost to Follow-up|0|||
27750073|NCT02055820|54200484|FG006|Phase I: Dose-Finding|Lost to Follow-up|1|||
27750074|NCT02055820|54200485|FG007|Phase I: Dose-Finding|Lost to Follow-up|0|||
27750075|NCT02055820|54200486|FG008|Phase I: Dose-Finding|Lost to Follow-up|0|||
27750076|NCT02055820|54200487|FG009|Phase I: Dose-Finding|Lost to Follow-up|0|||
27750077|NCT02055820|54200478|FG000|Phase II: Expansion|Death|0|||
27750078|NCT02055820|54200479|FG001|Phase II: Expansion|Death|0|||
27750079|NCT02055820|54200480|FG002|Phase II: Expansion|Death|0|||
27750080|NCT02055820|54200481|FG003|Phase II: Expansion|Death|0|||
27750081|NCT02055820|54200482|FG004|Phase II: Expansion|Death|33|||
27750082|NCT02055820|54200483|FG005|Phase II: Expansion|Death|0|||
27750083|NCT02055820|54200484|FG006|Phase II: Expansion|Death|0|||
27750084|NCT02055820|54200485|FG007|Phase II: Expansion|Death|0|||
27750085|NCT02055820|54200486|FG008|Phase II: Expansion|Death|0|||
27750086|NCT02055820|54200487|FG009|Phase II: Expansion|Death|0|||
27750087|NCT02055820|54200478|FG000|Phase II: Expansion|Lost to Follow-up|0|||
27750088|NCT02055820|54200479|FG001|Phase II: Expansion|Lost to Follow-up|0|||
27750089|NCT02055820|54200480|FG002|Phase II: Expansion|Lost to Follow-up|0|||
27750090|NCT02055820|54200481|FG003|Phase II: Expansion|Lost to Follow-up|0|||
27750091|NCT02055820|54200482|FG004|Phase II: Expansion|Lost to Follow-up|4|||
27750092|NCT02055820|54200483|FG005|Phase II: Expansion|Lost to Follow-up|0|||
27750093|NCT02055820|54200484|FG006|Phase II: Expansion|Lost to Follow-up|0|||
27750094|NCT02055820|54200485|FG007|Phase II: Expansion|Lost to Follow-up|0|||
27750095|NCT02055820|54200486|FG008|Phase II: Expansion|Lost to Follow-up|0|||
27750096|NCT02055820|54200487|FG009|Phase II: Expansion|Lost to Follow-up|0|||
27750097|NCT02055820|54200478|FG000|Phase II: Expansion|Withdrawal by Subject|0|||
27750098|NCT02055820|54200479|FG001|Phase II: Expansion|Withdrawal by Subject|0|||
27750099|NCT02055820|54200480|FG002|Phase II: Expansion|Withdrawal by Subject|0|||
27750100|NCT02055820|54200481|FG003|Phase II: Expansion|Withdrawal by Subject|0|||
27750101|NCT02055820|54200482|FG004|Phase II: Expansion|Withdrawal by Subject|12|||
27750102|NCT02055820|54200483|FG005|Phase II: Expansion|Withdrawal by Subject|0|||
27750103|NCT02055820|54200484|FG006|Phase II: Expansion|Withdrawal by Subject|0|||
27750104|NCT02055820|54200485|FG007|Phase II: Expansion|Withdrawal by Subject|0|||
27750105|NCT02055820|54200486|FG008|Phase II: Expansion|Withdrawal by Subject|0|||
27750106|NCT02055820|54200487|FG009|Phase II: Expansion|Withdrawal by Subject|0|||
27750107|NCT02055352|54200531|FG000|Overall Study|Adverse Event|0|||
27750108|NCT02055352|54200532|FG001|Overall Study|Adverse Event|1|||
27750109|NCT02055352|54200531|FG000|Overall Study|Non-eligible|0|||
27750110|NCT02055352|54200532|FG001|Overall Study|Non-eligible|1|||
27750111|NCT02055352|54200531|FG000|Overall Study|Poor compliance|1|||
27750112|NCT02055352|54200532|FG001|Overall Study|Poor compliance|1|||
27750113|NCT02055352|54200531|FG000|Overall Study|Death|1|||
27750114|NCT02055352|54200532|FG001|Overall Study|Death|2|||
27750115|NCT02055352|54200531|FG000|Overall Study|Patient decision|1|||
27750116|NCT02055352|54200532|FG001|Overall Study|Patient decision|1|||
27750117|NCT02055352|54200531|FG000|Overall Study|Use of prohibited treatment|0|||
27750118|NCT02055352|54200532|FG001|Overall Study|Use of prohibited treatment|3|||
27750119|NCT02055352|54200531|FG000|Overall Study|AE, study drug would be detrimental|1|||
27750120|NCT02055352|54200532|FG001|Overall Study|AE, study drug would be detrimental|3|||
27750121|NCT02055352|54200531|FG000|Overall Study|Withdrawal of informed consent|1|||
27750122|NCT02055352|54200532|FG001|Overall Study|Withdrawal of informed consent|0|||
27750123|NCT02055352|54200531|FG000|Overall Study|Reason unknown|1|||
27750124|NCT02055352|54200532|FG001|Overall Study|Reason unknown|5|||
27750125|NCT02034916|54200540|FG000|Overall Study|Death|39|||
27750126|NCT02034916|54200541|FG001|Overall Study|Death|28|||
27831159|NCT00708552|54307298|FG001|Overall Study|Physician Decision|2|||
27750127|NCT02034916|54200540|FG000|Overall Study|Withdrawal by Subject|2|||
27750128|NCT02034916|54200541|FG001|Overall Study|Withdrawal by Subject|1|||
27750129|NCT02034916|54200540|FG000|Overall Study|Lost to Follow-up|4|||
27750130|NCT02034916|54200541|FG001|Overall Study|Lost to Follow-up|1|||
27750131|NCT02034916|54200540|FG000|Overall Study|Study terminated by sponsor|4|||
27750132|NCT02034916|54200541|FG001|Overall Study|Study terminated by sponsor|5|||
27750133|NCT01374425|54200550|FG000|Overall Study|Radiographic Disease Progression|86|||
27750134|NCT01374425|54200551|FG001|Overall Study|Radiographic Disease Progression|81|||
27750135|NCT01374425|54200550|FG000|Overall Study|Clinical Disease Progression|9|||
27750136|NCT01374425|54200551|FG001|Overall Study|Clinical Disease Progression|6|||
27750137|NCT01374425|54200550|FG000|Overall Study|Adverse Event|29|||
27750138|NCT01374425|54200551|FG001|Overall Study|Adverse Event|18|||
27750139|NCT01374425|54200550|FG000|Overall Study|Death (Progression of Disease)|1|||
27750140|NCT01374425|54200551|FG001|Overall Study|Death (Progression of Disease)|0|||
27750141|NCT01374425|54200550|FG000|Overall Study|Death (Adverse Event)|2|||
27750142|NCT01374425|54200551|FG001|Overall Study|Death (Adverse Event)|4|||
27750143|NCT01374425|54200550|FG000|Overall Study|Withdrawal by Subject|6|||
27750144|NCT01374425|54200551|FG001|Overall Study|Withdrawal by Subject|7|||
27750145|NCT01374425|54200550|FG000|Overall Study|Refused Treatment|10|||
27750146|NCT01374425|54200551|FG001|Overall Study|Refused Treatment|24|||
27750147|NCT01374425|54200550|FG000|Overall Study|Protocol Violation|2|||
27750148|NCT01374425|54200551|FG001|Overall Study|Protocol Violation|3|||
27750149|NCT01374425|54200550|FG000|Overall Study|Sponsor Decision|0|||
27750150|NCT01374425|54200551|FG001|Overall Study|Sponsor Decision|1|||
27750151|NCT01374425|54200550|FG000|Overall Study|Lost to Follow-up|2|||
27750152|NCT01374425|54200551|FG001|Overall Study|Lost to Follow-up|1|||
27750153|NCT01374425|54200550|FG000|Overall Study|Other|41|||
27750154|NCT01374425|54200551|FG001|Overall Study|Other|43|||
27750155|NCT02085460|54200581|FG000|Overall Study|Adverse Event|2|||
27750156|NCT02085460|54200582|FG001|Overall Study|Adverse Event|2|||
27750157|NCT02085460|54200583|FG002|Overall Study|Adverse Event|1|||
27750158|NCT02085460|54200581|FG000|Overall Study|Physician Decision|1|||
27750159|NCT02085460|54200582|FG001|Overall Study|Physician Decision|1|||
27750160|NCT02085460|54200583|FG002|Overall Study|Physician Decision|2|||
27750161|NCT02085460|54200581|FG000|Overall Study|Withdrawal by Subject|11|||
27750162|NCT02085460|54200582|FG001|Overall Study|Withdrawal by Subject|5|||
27750163|NCT02085460|54200583|FG002|Overall Study|Withdrawal by Subject|7|||
27750164|NCT02084134|54200593|FG000|Overall Study|Protocol Violation|4|||
27750165|NCT02084134|54200594|FG001|Overall Study|Protocol Violation|2|||
27750166|NCT02084134|54200593|FG000|Overall Study|Death|0|||
27750167|NCT02084134|54200594|FG001|Overall Study|Death|1|||
27750168|NCT02034058|54200600|FG000|Overall Study|Death|3|||
27750169|NCT01374269|54200606|FG000|Overall Study|Withdrawal by Subject|4|||
27750170|NCT01374269|54200607|FG001|Overall Study|Withdrawal by Subject|0|||
27750171|NCT01374269|54200606|FG000|Overall Study|Lost to Follow-up|1|||
27750172|NCT01374269|54200607|FG001|Overall Study|Lost to Follow-up|3|||
27750173|NCT01374269|54200606|FG000|Overall Study|closed research|1|||
27750174|NCT01374269|54200607|FG001|Overall Study|closed research|2|||
27750175|NCT02679755|54200615|FG000|Overall Study|Death|0|||
27750176|NCT02679755|54200616|FG001|Overall Study|Death|3|||
27750177|NCT02679755|54200615|FG000|Overall Study|Global deterioration of health status|1|||
27750178|NCT02679755|54200616|FG001|Overall Study|Global deterioration of health status|8|||
27750179|NCT02679755|54200615|FG000|Overall Study|Lost to Follow-up|1|||
27750180|NCT02679755|54200616|FG001|Overall Study|Lost to Follow-up|0|||
27750181|NCT02679755|54200615|FG000|Overall Study|Objective progression or relapse|24|||
27750182|NCT02679755|54200616|FG001|Overall Study|Objective progression or relapse|83|||
27750183|NCT02679755|54200615|FG000|Overall Study|Not defined|0|||
27750184|NCT02679755|54200616|FG001|Overall Study|Not defined|2|||
27750185|NCT02679755|54200615|FG000|Overall Study|Withdrawal by participant|6|||
27750186|NCT02679755|54200616|FG001|Overall Study|Withdrawal by participant|3|||
27750187|NCT02679755|54200615|FG000|Overall Study|Adverse Event|1|||
27750188|NCT02679755|54200616|FG001|Overall Study|Adverse Event|4|||
27750189|NCT02679755|54200615|FG000|Overall Study|Adverse events not related to study drug|1|||
27750190|NCT02679755|54200616|FG001|Overall Study|Adverse events not related to study drug|2|||
27750191|NCT02675231|54200628|FG000|Overall Study|Withdrawal by Subject|1|||
27750192|NCT02675231|54200629|FG001|Overall Study|Withdrawal by Subject|3|||
27750193|NCT02675231|54200630|FG002|Overall Study|Withdrawal by Subject|1|||
27750194|NCT02675231|54200628|FG000|Overall Study|Lost to Follow-up|2|||
27750195|NCT02675231|54200629|FG001|Overall Study|Lost to Follow-up|2|||
27750196|NCT02675231|54200630|FG002|Overall Study|Lost to Follow-up|2|||
27750197|NCT02675231|54200628|FG000|Overall Study|On study treatment/follow up|23|||
27750198|NCT02675231|54200629|FG001|Overall Study|On study treatment/follow up|31|||
27750199|NCT02675231|54200630|FG002|Overall Study|On study treatment/follow up|23|||
27750200|NCT02675075|54200641|FG000|Overall Study|Lost to Follow-up|3|||
27750201|NCT02675075|54200642|FG001|Overall Study|Lost to Follow-up|0|||
27750202|NCT02673515|54200652|FG000|Overall Study|Lack of motivation|2|||
27750203|NCT02673515|54200653|FG001|Overall Study|Lack of motivation|1|||
27750204|NCT02667275|54200661|FG000|Overall Study|Protocol Violation|11|||
27750205|NCT02667275|54200662|FG001|Overall Study|Protocol Violation|7|||
27750206|NCT02667275|54200661|FG000|Overall Study|Lost to Follow-up|0|||
27750207|NCT02667275|54200662|FG001|Overall Study|Lost to Follow-up|2|||
27750208|NCT02667275|54200661|FG000|Overall Study|Withdrawal by Subject|0|||
27750209|NCT02667275|54200662|FG001|Overall Study|Withdrawal by Subject|5|||
27750210|NCT02667275|54200661|FG000|Overall Study|Discontinued early without completing|0|||
27750211|NCT02667275|54200662|FG001|Overall Study|Discontinued early without completing|1|||
27750212|NCT02672423|54200671|FG000|Period 1|Adverse Event|0|||
27750213|NCT02672423|54200672|FG001|Period 1|Adverse Event|0|||
27750214|NCT02672423|54200673|FG002|Period 1|Adverse Event|0|||
27750215|NCT02672423|54200674|FG003|Period 1|Adverse Event|0|||
27750216|NCT02672423|54200675|FG004|Period 1|Adverse Event|1|||
27750217|NCT02672423|54200676|FG005|Period 1|Adverse Event|0|||
27750218|NCT02672423|54200677|FG006|Period 1|Adverse Event|0|||
27750219|NCT02672423|54200678|FG007|Period 1|Adverse Event|0|||
27750220|NCT02672423|54200679|FG008|Period 1|Adverse Event|0|||
27750221|NCT02672423|54200680|FG009|Period 1|Adverse Event|0|||
27750222|NCT02672423|54200671|FG000|Period 2|Withdrawal by Subject|0|||
27750223|NCT02672423|54200672|FG001|Period 2|Withdrawal by Subject|0|||
27750224|NCT02672423|54200673|FG002|Period 2|Withdrawal by Subject|1|||
27750225|NCT02672423|54200674|FG003|Period 2|Withdrawal by Subject|0|||
27750226|NCT02672423|54200675|FG004|Period 2|Withdrawal by Subject|0|||
27750227|NCT02672423|54200676|FG005|Period 2|Withdrawal by Subject|0|||
27750228|NCT02672423|54200677|FG006|Period 2|Withdrawal by Subject|0|||
27750229|NCT02672423|54200678|FG007|Period 2|Withdrawal by Subject|0|||
27750230|NCT02672423|54200679|FG008|Period 2|Withdrawal by Subject|0|||
27750231|NCT02672423|54200680|FG009|Period 2|Withdrawal by Subject|0|||
27750232|NCT02672423|54200671|FG000|Period 3|Withdrawal by Subject|0|||
27750233|NCT02672423|54200672|FG001|Period 3|Withdrawal by Subject|0|||
27750234|NCT02672423|54200673|FG002|Period 3|Withdrawal by Subject|0|||
27750235|NCT02672423|54200674|FG003|Period 3|Withdrawal by Subject|0|||
27750236|NCT02672423|54200675|FG004|Period 3|Withdrawal by Subject|0|||
27750237|NCT02672423|54200676|FG005|Period 3|Withdrawal by Subject|0|||
27750238|NCT02672423|54200677|FG006|Period 3|Withdrawal by Subject|0|||
27750239|NCT02672423|54200678|FG007|Period 3|Withdrawal by Subject|1|||
27750240|NCT02672423|54200679|FG008|Period 3|Withdrawal by Subject|0|||
27750241|NCT02672423|54200680|FG009|Period 3|Withdrawal by Subject|0|||
27750242|NCT02672423|54200671|FG000|Period 3|Physician Decision|0|||
27750243|NCT02672423|54200672|FG001|Period 3|Physician Decision|0|||
27750244|NCT02672423|54200673|FG002|Period 3|Physician Decision|0|||
27750245|NCT02672423|54200674|FG003|Period 3|Physician Decision|0|||
27750246|NCT02672423|54200675|FG004|Period 3|Physician Decision|0|||
27750247|NCT02672423|54200676|FG005|Period 3|Physician Decision|1|||
27750248|NCT02672423|54200677|FG006|Period 3|Physician Decision|0|||
27750249|NCT02672423|54200678|FG007|Period 3|Physician Decision|0|||
27750250|NCT02672423|54200679|FG008|Period 3|Physician Decision|0|||
27750251|NCT02672423|54200680|FG009|Period 3|Physician Decision|0|||
27750252|NCT02670551|54200704|FG000|Overall Study|Adverse Event|4|||
27750253|NCT02670551|54200705|FG001|Overall Study|Adverse Event|7|||
27750254|NCT02670551|54200706|FG002|Overall Study|Adverse Event|9|||
27750255|NCT02670551|54200704|FG000|Overall Study|Lack of Efficacy|2|||
27750256|NCT02670551|54200705|FG001|Overall Study|Lack of Efficacy|0|||
27750257|NCT02670551|54200706|FG002|Overall Study|Lack of Efficacy|3|||
27750258|NCT02670551|54200704|FG000|Overall Study|Withdrawal of Consent|6|||
27750259|NCT02670551|54200705|FG001|Overall Study|Withdrawal of Consent|3|||
27750260|NCT02670551|54200706|FG002|Overall Study|Withdrawal of Consent|8|||
27750261|NCT02670551|54200704|FG000|Overall Study|Lost to Follow-up|5|||
27750262|NCT02670551|54200705|FG001|Overall Study|Lost to Follow-up|7|||
27750263|NCT02670551|54200706|FG002|Overall Study|Lost to Follow-up|6|||
27750264|NCT02670551|54200704|FG000|Overall Study|Protocol Violation|1|||
27750265|NCT02670551|54200705|FG001|Overall Study|Protocol Violation|0|||
27750266|NCT02670551|54200706|FG002|Overall Study|Protocol Violation|0|||
27750267|NCT02670551|54200704|FG000|Overall Study|Noncompliance with study drug|3|||
27750268|NCT02670551|54200705|FG001|Overall Study|Noncompliance with study drug|3|||
27750269|NCT02670551|54200706|FG002|Overall Study|Noncompliance with study drug|2|||
27750270|NCT02670551|54200704|FG000|Overall Study|Other Miscellaneous Reasons|2|||
27750271|NCT02670551|54200705|FG001|Overall Study|Other Miscellaneous Reasons|3|||
27750272|NCT02670551|54200706|FG002|Overall Study|Other Miscellaneous Reasons|3|||
27750273|NCT02670551|54200704|FG000|Overall Study|Did Not Receive Treatment|5|||
27750274|NCT02670551|54200705|FG001|Overall Study|Did Not Receive Treatment|3|||
27750275|NCT02670551|54200706|FG002|Overall Study|Did Not Receive Treatment|0|||
27750276|NCT02670473|54200714|FG000|Overall Study|Withdrawal by Subject|1|||
27750277|NCT02667119|54200729|FG000|Overall Study|Lost to Follow-up|3|||
27750278|NCT02667119|54200730|FG001|Overall Study|Lost to Follow-up|0|||
27750279|NCT02670083|54200738|FG000|Overall Study|Adverse Event|16|||
27750280|NCT02670083|54200739|FG001|Overall Study|Adverse Event|13|||
27750281|NCT02670083|54200738|FG000|Overall Study|Death|4|||
27750282|NCT02670083|54200739|FG001|Overall Study|Death|6|||
27750283|NCT02670083|54200738|FG000|Overall Study|Lost to Follow-up|2|||
27750284|NCT02670083|54200739|FG001|Overall Study|Lost to Follow-up|2|||
27750285|NCT02670083|54200738|FG000|Overall Study|Multiple Reasons|9|||
27750286|NCT02670083|54200739|FG001|Overall Study|Multiple Reasons|9|||
27750287|NCT02670083|54200738|FG000|Overall Study|Physician Decision|0|||
27750288|NCT02670083|54200739|FG001|Overall Study|Physician Decision|2|||
27750289|NCT02670083|54200738|FG000|Overall Study|Study Terminated By Sponsor|257|||
27750290|NCT02670083|54200739|FG001|Overall Study|Study Terminated By Sponsor|254|||
27750291|NCT02670083|54200738|FG000|Overall Study|Symptomatic Deterioration|0|||
27750292|NCT02670083|54200739|FG001|Overall Study|Symptomatic Deterioration|2|||
27750293|NCT02670083|54200738|FG000|Overall Study|Withdrawal by Subject|32|||
27750294|NCT02670083|54200739|FG001|Overall Study|Withdrawal by Subject|31|||
27750295|NCT02670083|54200738|FG000|Overall Study|Non-Compliance With Study Drug|1|||
27750296|NCT02670083|54200739|FG001|Overall Study|Non-Compliance With Study Drug|0|||
27750297|NCT02669849|54200749|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
27750298|NCT02669849|54200750|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
27750299|NCT02669849|54200751|FG002|Overall Study|Withdrawal of Consent (not due to AE)|3|||
27750300|NCT02669849|54200749|FG000|Overall Study|Lost to Follow-up|1|||
27750301|NCT02669849|54200750|FG001|Overall Study|Lost to Follow-up|0|||
27750302|NCT02669849|54200751|FG002|Overall Study|Lost to Follow-up|3|||
27750303|NCT02669849|54200749|FG000|Overall Study|Death|1|||
27750304|NCT02669849|54200750|FG001|Overall Study|Death|1|||
27750305|NCT02669849|54200751|FG002|Overall Study|Death|2|||
27750306|NCT02669849|54200749|FG000|Overall Study|Study terminated by sponsor|16|||
27750307|NCT02669849|54200750|FG001|Overall Study|Study terminated by sponsor|1|||
27750308|NCT02669849|54200751|FG002|Overall Study|Study terminated by sponsor|14|||
27750309|NCT02669849|54200749|FG000|Overall Study|Other|0|||
27750310|NCT02669849|54200750|FG001|Overall Study|Other|0|||
27750311|NCT02669849|54200751|FG002|Overall Study|Other|2|||
27750312|NCT03625895|54200759|FG000|Overall Study|Protocol Violation|585|||
27750313|NCT02663687|54200768|FG000|Overall Study|Adverse Event|1|||
27750314|NCT02663687|54200769|FG001|Overall Study|Adverse Event|0|||
27750315|NCT02663687|54200770|FG002|Overall Study|Adverse Event|0|||
27750316|NCT02663687|54200771|FG003|Overall Study|Adverse Event|0|||
27750317|NCT02663687|54200772|FG004|Overall Study|Adverse Event|0|||
27750318|NCT02663687|54200768|FG000|Overall Study|Other|1|||
27750319|NCT02663687|54200769|FG001|Overall Study|Other|0|||
27750320|NCT02663687|54200770|FG002|Overall Study|Other|1|||
27750321|NCT02663687|54200771|FG003|Overall Study|Other|0|||
27750322|NCT02663687|54200772|FG004|Overall Study|Other|0|||
27831160|NCT00708552|54307299|FG002|Overall Study|Physician Decision|0|||
27831161|NCT00708552|54307300|FG003|Overall Study|Physician Decision|0|||
27831162|NCT00708552|54307297|FG000|Overall Study|Withdrawal by Subject|12|||
27831163|NCT00708552|54307298|FG001|Overall Study|Withdrawal by Subject|7|||
27831164|NCT00708552|54307299|FG002|Overall Study|Withdrawal by Subject|8|||
27831165|NCT00708552|54307300|FG003|Overall Study|Withdrawal by Subject|10|||
27831166|NCT01816295|54307430|FG000|Double Blind Phase|Adverse Event|11|||
27831167|NCT01816295|54307431|FG001|Double Blind Phase|Adverse Event|8|||
27831168|NCT01816295|54307430|FG000|Double Blind Phase|Entry Criteria Not Met|0|||
27831169|NCT01816295|54307431|FG001|Double Blind Phase|Entry Criteria Not Met|2|||
27831170|NCT01816295|54307430|FG000|Double Blind Phase|Lost to Follow-up|3|||
27831171|NCT01816295|54307431|FG001|Double Blind Phase|Lost to Follow-up|5|||
27831172|NCT01816295|54307430|FG000|Double Blind Phase|Physician Decision|2|||
27831173|NCT01816295|54307431|FG001|Double Blind Phase|Physician Decision|2|||
27831174|NCT01816295|54307430|FG000|Double Blind Phase|Protocol Violation|17|||
27831175|NCT01816295|54307431|FG001|Double Blind Phase|Protocol Violation|11|||
27831176|NCT01816295|54307430|FG000|Double Blind Phase|Sponsor Decision|8|||
27831177|NCT01816295|54307431|FG001|Double Blind Phase|Sponsor Decision|8|||
27831178|NCT01816295|54307430|FG000|Double Blind Phase|Withdrawal by Subject|22|||
27831179|NCT01816295|54307431|FG001|Double Blind Phase|Withdrawal by Subject|20|||
27831180|NCT01816295|54307430|FG000|OLE Phase|Adverse Event|17|||
27831181|NCT01816295|54307431|FG001|OLE Phase|Adverse Event|15|||
27831182|NCT01816295|54307430|FG000|OLE Phase|Death|1|||
27831183|NCT01816295|54307431|FG001|OLE Phase|Death|0|||
27831184|NCT01816295|54307430|FG000|OLE Phase|Entry Criteria Not Met|3|||
27831185|NCT01816295|54307431|FG001|OLE Phase|Entry Criteria Not Met|5|||
27831186|NCT01816295|54307430|FG000|OLE Phase|Lost to Follow-up|5|||
27831187|NCT01816295|54307431|FG001|OLE Phase|Lost to Follow-up|5|||
27831188|NCT01816295|54307430|FG000|OLE Phase|Physician Decision|3|||
27831189|NCT01816295|54307431|FG001|OLE Phase|Physician Decision|1|||
27831190|NCT01816295|54307430|FG000|OLE Phase|Protocol Violation|4|||
27831191|NCT01816295|54307431|FG001|OLE Phase|Protocol Violation|4|||
27831192|NCT01816295|54307430|FG000|OLE Phase|Sponsor Decision|7|||
27831193|NCT01816295|54307431|FG001|OLE Phase|Sponsor Decision|9|||
27831194|NCT01816295|54307430|FG000|OLE Phase|Withdrawal by Subject|10|||
27831195|NCT01816295|54307431|FG001|OLE Phase|Withdrawal by Subject|10|||
27831196|NCT01816295|54307430|FG000|OLE Phase|Lack of Efficacy|3|||
27831197|NCT01816295|54307431|FG001|OLE Phase|Lack of Efficacy|7|||
27831198|NCT01610297|54307456|FG000|Overall Study|Lost to Follow-up|1|||
27831199|NCT01793051|54307467|FG000|Overall Study|Withdrawal by Subject|6|||
27831200|NCT01793051|54307468|FG001|Overall Study|Withdrawal by Subject|4|||
27750323|NCT02663453|54200803|FG000|Overall Study|Death|4|||
27750324|NCT02663453|54200804|FG001|Overall Study|Death|4|||
27750325|NCT02663453|54200803|FG000|Overall Study|Withdrawal by Subject|1|||
27750326|NCT02663453|54200804|FG001|Overall Study|Withdrawal by Subject|0|||
27750327|NCT02055118|54200813|FG000|Overall Study|Withdrawal by Subject|0|||
27750328|NCT02055118|54200814|FG001|Overall Study|Withdrawal by Subject|2|||
27750329|NCT02055118|54200815|FG002|Overall Study|Withdrawal by Subject|0|||
27750330|NCT02084056|54200826|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
27750331|NCT02084056|54200827|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
27750332|NCT02084056|54200828|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
27750333|NCT02084056|54200829|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
27750334|NCT02084056|54200826|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
27750335|NCT02084056|54200827|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
27750336|NCT02084056|54200828|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
27750337|NCT02084056|54200829|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
27750338|NCT01625182|54200841|FG000|Overall Study|Administrative problems|1|||
27750339|NCT01625182|54200842|FG001|Overall Study|Administrative problems|0|||
27750340|NCT01625182|54200841|FG000|Overall Study|Protocol deviation|0|||
27750341|NCT01625182|54200842|FG001|Overall Study|Protocol deviation|2|||
27750342|NCT01625182|54200841|FG000|Overall Study|Adverse Event|2|||
27750343|NCT01625182|54200842|FG001|Overall Study|Adverse Event|0|||
27750344|NCT01625182|54200841|FG000|Overall Study|Withdrawal by Subject|5|||
27750345|NCT01625182|54200842|FG001|Overall Study|Withdrawal by Subject|1|||
27750346|NCT01625182|54200841|FG000|Overall Study|Lack of Efficacy|12|||
27750347|NCT01625182|54200842|FG001|Overall Study|Lack of Efficacy|8|||
27750348|NCT02661815|54200853|FG000|Overall Study|Withdrawal by Subject|1|||
27750349|NCT02661815|54200854|FG001|Overall Study|Withdrawal by Subject|0|||
27750350|NCT02661815|54200855|FG002|Overall Study|Withdrawal by Subject|0|||
27750351|NCT02661815|54200856|FG003|Overall Study|Withdrawal by Subject|0|||
27750352|NCT02053792|54200872|FG000|Overall Study|Physician Decision|0|||
27750353|NCT02053792|54200873|FG001|Overall Study|Physician Decision|1|||
27750354|NCT02053792|54200872|FG000|Overall Study|Development of High titer FIX inhibitor|0|||
27750355|NCT02053792|54200873|FG001|Overall Study|Development of High titer FIX inhibitor|1|||
27750356|NCT02053792|54200872|FG000|Overall Study|Lack of Efficacy|1|||
27750357|NCT02053792|54200873|FG001|Overall Study|Lack of Efficacy|0|||
27750358|NCT02053792|54200872|FG000|Overall Study|Adverse Event|1|||
27750359|NCT02053792|54200873|FG001|Overall Study|Adverse Event|0|||
27750360|NCT02053792|54200872|FG000|Overall Study|Withdrawal by Subject|2|||
27750361|NCT02053792|54200873|FG001|Overall Study|Withdrawal by Subject|2|||
27750362|NCT02053792|54200872|FG000|Overall Study|The patient was not compliant to the study procedure|1|||
27750363|NCT02053792|54200873|FG001|Overall Study|The patient was not compliant to the study procedure|0|||
27750364|NCT02053792|54200872|FG000|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|1|||
27750365|NCT02053792|54200873|FG001|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|0|||
27750366|NCT02082340|54200881|FG000|Overall Study|Lost to Follow-up|1|||
27750367|NCT02082340|54200882|FG001|Overall Study|Lost to Follow-up|1|||
27750368|NCT02053246|54200888|FG000|Overall Study|Withdrawal by Subject|3|||
27750369|NCT02053246|54200888|FG000|Overall Study|Physician Decision|1|||
27750370|NCT02053168|54200892|FG000|Overall Study|Withdrawal by Subject|1|||
27750371|NCT02053168|54200892|FG000|Overall Study|Physician Decision|1|||
27750372|NCT02053168|54200892|FG000|Overall Study|Lost to Follow-up|1|||
27750373|NCT02052466|54200896|FG000|Overall Study|Withdrawal by Subject|1|||
27750374|NCT02052466|54200896|FG000|Overall Study|Acromial fracture|1|||
27750375|NCT02032888|54200903|FG000|Treatment Period|Poor compliance/noncompliance|1|||
27750376|NCT02032888|54200904|FG001|Treatment Period|Poor compliance/noncompliance|1|||
27750377|NCT02032888|54200905|FG002|Treatment Period|Poor compliance/noncompliance|0|||
27750378|NCT02032888|54200903|FG000|Treatment Period|Other|1|||
27750379|NCT02032888|54200904|FG001|Treatment Period|Other|1|||
27750380|NCT02032888|54200905|FG002|Treatment Period|Other|0|||
27750381|NCT02032888|54200903|FG000|Follow-up Period|Lost to Follow-up|1|||
27750382|NCT02032888|54200904|FG001|Follow-up Period|Lost to Follow-up|1|||
27750383|NCT02032888|54200905|FG002|Follow-up Period|Lost to Follow-up|0|||
27750384|NCT02032888|54200903|FG000|Follow-up Period|Death|1|||
27750385|NCT02032888|54200904|FG001|Follow-up Period|Death|1|||
27750386|NCT02032888|54200905|FG002|Follow-up Period|Death|0|||
27750387|NCT02032888|54200903|FG000|Follow-up Period|Other|1|||
27750388|NCT02032888|54200904|FG001|Follow-up Period|Other|0|||
27750389|NCT02032888|54200905|FG002|Follow-up Period|Other|0|||
27750390|NCT02082262|54200922|FG000|Overall Study|Withdrawal by Subject|3|||
27750391|NCT02082262|54200922|FG000|Overall Study|Adverse Event|48|||
27750392|NCT04697069|54200928|FG000|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|0|||
27750393|NCT04697069|54200929|FG001|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|1|||
27750394|NCT04697069|54200928|FG000|Overall Study|Study termination|2|||
27750395|NCT04697069|54200929|FG001|Overall Study|Study termination|1|||
27750396|NCT02082184|54200937|FG000|Overall Study|Adverse Event|1|||
27750397|NCT02082184|54200938|FG001|Overall Study|Adverse Event|0|||
27750398|NCT02082184|54200937|FG000|Overall Study|Medical diagnosis|1|||
27750399|NCT02082184|54200938|FG001|Overall Study|Medical diagnosis|2|||
27750400|NCT02082184|54200937|FG000|Overall Study|Device associated symptoms|5|||
27750401|NCT02082184|54200938|FG001|Overall Study|Device associated symptoms|0|||
27750402|NCT02082184|54200937|FG000|Overall Study|Withdrawal by Subject|3|||
27750403|NCT02082184|54200938|FG001|Overall Study|Withdrawal by Subject|2|||
27750404|NCT02082184|54200937|FG000|Overall Study|Protocol Violation|0|||
27750405|NCT02082184|54200938|FG001|Overall Study|Protocol Violation|6|||
27750406|NCT02082184|54200937|FG000|Overall Study|Lost to Follow-up|0|||
27750407|NCT02082184|54200938|FG001|Overall Study|Lost to Follow-up|2|||
27750408|NCT02082184|54200937|FG000|Overall Study|Subject non-compliance|0|||
27750409|NCT02082184|54200938|FG001|Overall Study|Subject non-compliance|1|||
27750410|NCT01624870|54200944|FG000|Overall Study|Death|19|||
27750411|NCT01624870|54200944|FG000|Overall Study|Withdrawal by Subject|1|||
27750412|NCT01624870|54200944|FG000|Overall Study|CoreValve not implanted|6|||
27750413|NCT01624870|54200944|FG000|Overall Study|Lost to follow up|1|||
27750414|NCT02031640|54200955|FG000|Screening Period|Adverse Event|1|||
27750415|NCT02031640|54200956|FG001|Screening Period|Adverse Event|0|||
27750416|NCT02031640|54200957|FG002|Screening Period|Adverse Event|0|||
27750417|NCT02031640|54200958|FG003|Screening Period|Adverse Event|0|||
27750418|NCT02031640|54200959|FG004|Screening Period|Adverse Event|0|||
27750419|NCT02031640|54200960|FG005|Screening Period|Adverse Event|0|||
27750420|NCT02031640|54200955|FG000|Screening Period|Withdrawal by Subject|29|||
27750421|NCT02031640|54200956|FG001|Screening Period|Withdrawal by Subject|0|||
27750422|NCT02031640|54200957|FG002|Screening Period|Withdrawal by Subject|0|||
27750423|NCT02031640|54200958|FG003|Screening Period|Withdrawal by Subject|0|||
27750424|NCT02031640|54200959|FG004|Screening Period|Withdrawal by Subject|0|||
27750425|NCT02031640|54200960|FG005|Screening Period|Withdrawal by Subject|0|||
27750426|NCT02031640|54200955|FG000|Screening Period|Inclusion criteria not met|312|||
27750427|NCT02031640|54200956|FG001|Screening Period|Inclusion criteria not met|0|||
27750428|NCT02031640|54200957|FG002|Screening Period|Inclusion criteria not met|0|||
27750429|NCT02031640|54200958|FG003|Screening Period|Inclusion criteria not met|0|||
27750430|NCT02031640|54200959|FG004|Screening Period|Inclusion criteria not met|0|||
27750431|NCT02031640|54200960|FG005|Screening Period|Inclusion criteria not met|0|||
27750432|NCT02031640|54200955|FG000|Screening Period|Exclusion criteria met|30|||
27750433|NCT02031640|54200956|FG001|Screening Period|Exclusion criteria met|0|||
27750434|NCT02031640|54200957|FG002|Screening Period|Exclusion criteria met|0|||
27750435|NCT02031640|54200958|FG003|Screening Period|Exclusion criteria met|0|||
27750436|NCT02031640|54200959|FG004|Screening Period|Exclusion criteria met|0|||
27750437|NCT02031640|54200960|FG005|Screening Period|Exclusion criteria met|0|||
27750438|NCT02031640|54200955|FG000|Screening Period|Lost to Follow-up|14|||
27750439|NCT02031640|54200956|FG001|Screening Period|Lost to Follow-up|0|||
27750440|NCT02031640|54200957|FG002|Screening Period|Lost to Follow-up|0|||
27750441|NCT02031640|54200958|FG003|Screening Period|Lost to Follow-up|0|||
27750442|NCT02031640|54200959|FG004|Screening Period|Lost to Follow-up|0|||
27750443|NCT02031640|54200960|FG005|Screening Period|Lost to Follow-up|0|||
27750444|NCT02031640|54200955|FG000|Screening Period|Enrollment closed|26|||
27750445|NCT02031640|54200956|FG001|Screening Period|Enrollment closed|0|||
27750446|NCT02031640|54200957|FG002|Screening Period|Enrollment closed|0|||
27750447|NCT02031640|54200958|FG003|Screening Period|Enrollment closed|0|||
27750448|NCT02031640|54200959|FG004|Screening Period|Enrollment closed|0|||
27750449|NCT02031640|54200960|FG005|Screening Period|Enrollment closed|0|||
27750450|NCT02031640|54200955|FG000|Run-In Period|Adverse Event|4|||
27750451|NCT02031640|54200956|FG001|Run-In Period|Adverse Event|0|||
27750452|NCT02031640|54200957|FG002|Run-In Period|Adverse Event|0|||
27750453|NCT02031640|54200958|FG003|Run-In Period|Adverse Event|0|||
27750454|NCT02031640|54200959|FG004|Run-In Period|Adverse Event|0|||
27750455|NCT02031640|54200960|FG005|Run-In Period|Adverse Event|0|||
27750456|NCT02031640|54200955|FG000|Run-In Period|Withdrawal by Subject|17|||
27750457|NCT02031640|54200956|FG001|Run-In Period|Withdrawal by Subject|0|||
27750458|NCT02031640|54200957|FG002|Run-In Period|Withdrawal by Subject|0|||
27750459|NCT02031640|54200958|FG003|Run-In Period|Withdrawal by Subject|0|||
27750460|NCT02031640|54200959|FG004|Run-In Period|Withdrawal by Subject|0|||
27750461|NCT02031640|54200960|FG005|Run-In Period|Withdrawal by Subject|0|||
27750462|NCT02031640|54200955|FG000|Run-In Period|Inclusion criteria not met|38|||
27750463|NCT02031640|54200956|FG001|Run-In Period|Inclusion criteria not met|0|||
27750464|NCT02031640|54200957|FG002|Run-In Period|Inclusion criteria not met|0|||
27750465|NCT02031640|54200958|FG003|Run-In Period|Inclusion criteria not met|0|||
27750466|NCT02031640|54200959|FG004|Run-In Period|Inclusion criteria not met|0|||
27750467|NCT02031640|54200960|FG005|Run-In Period|Inclusion criteria not met|0|||
27750468|NCT02031640|54200955|FG000|Run-In Period|Exclusion criteria met|8|||
27750469|NCT02031640|54200956|FG001|Run-In Period|Exclusion criteria met|0|||
27750470|NCT02031640|54200957|FG002|Run-In Period|Exclusion criteria met|0|||
27750471|NCT02031640|54200958|FG003|Run-In Period|Exclusion criteria met|0|||
27750472|NCT02031640|54200959|FG004|Run-In Period|Exclusion criteria met|0|||
27750473|NCT02031640|54200960|FG005|Run-In Period|Exclusion criteria met|0|||
27750474|NCT02031640|54200955|FG000|Run-In Period|Randomization criteria not met|85|||
27750475|NCT02031640|54200956|FG001|Run-In Period|Randomization criteria not met|0|||
27750476|NCT02031640|54200957|FG002|Run-In Period|Randomization criteria not met|0|||
27750477|NCT02031640|54200958|FG003|Run-In Period|Randomization criteria not met|0|||
27750478|NCT02031640|54200959|FG004|Run-In Period|Randomization criteria not met|0|||
27750479|NCT02031640|54200960|FG005|Run-In Period|Randomization criteria not met|0|||
27750480|NCT02031640|54200955|FG000|Run-In Period|Various administrative reasons|17|||
27750481|NCT02031640|54200956|FG001|Run-In Period|Various administrative reasons|0|||
27750482|NCT02031640|54200957|FG002|Run-In Period|Various administrative reasons|0|||
27750483|NCT02031640|54200958|FG003|Run-In Period|Various administrative reasons|0|||
27750484|NCT02031640|54200959|FG004|Run-In Period|Various administrative reasons|0|||
27750485|NCT02031640|54200960|FG005|Run-In Period|Various administrative reasons|0|||
27750486|NCT02031640|54200955|FG000|Double-blind Treatment Period|Protocol deviation|0|||
27750487|NCT02031640|54200956|FG001|Double-blind Treatment Period|Protocol deviation|2|||
27750488|NCT02031640|54200957|FG002|Double-blind Treatment Period|Protocol deviation|0|||
27750489|NCT02031640|54200958|FG003|Double-blind Treatment Period|Protocol deviation|1|||
27750490|NCT02031640|54200959|FG004|Double-blind Treatment Period|Protocol deviation|3|||
27750491|NCT02031640|54200960|FG005|Double-blind Treatment Period|Protocol deviation|1|||
27750492|NCT02031640|54200955|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
27750493|NCT02031640|54200956|FG001|Double-blind Treatment Period|Lack of Efficacy|14|||
27750494|NCT02031640|54200957|FG002|Double-blind Treatment Period|Lack of Efficacy|3|||
27750495|NCT02031640|54200958|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
27750496|NCT02031640|54200959|FG004|Double-blind Treatment Period|Lack of Efficacy|5|||
27750497|NCT02031640|54200960|FG005|Double-blind Treatment Period|Lack of Efficacy|1|||
27750498|NCT02031640|54200955|FG000|Double-blind Treatment Period|Non-compliance|0|||
27750499|NCT02031640|54200956|FG001|Double-blind Treatment Period|Non-compliance|1|||
27750500|NCT02031640|54200957|FG002|Double-blind Treatment Period|Non-compliance|0|||
27750501|NCT02031640|54200958|FG003|Double-blind Treatment Period|Non-compliance|1|||
27750502|NCT02031640|54200959|FG004|Double-blind Treatment Period|Non-compliance|1|||
27750503|NCT02031640|54200960|FG005|Double-blind Treatment Period|Non-compliance|0|||
27750504|NCT02031640|54200955|FG000|Double-blind Treatment Period|Adverse Event|0|||
27750505|NCT02031640|54200956|FG001|Double-blind Treatment Period|Adverse Event|0|||
27750506|NCT02031640|54200957|FG002|Double-blind Treatment Period|Adverse Event|0|||
27750507|NCT02031640|54200958|FG003|Double-blind Treatment Period|Adverse Event|2|||
27750508|NCT02031640|54200959|FG004|Double-blind Treatment Period|Adverse Event|0|||
27750509|NCT02031640|54200960|FG005|Double-blind Treatment Period|Adverse Event|0|||
27750510|NCT02031640|54200955|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
27750511|NCT02031640|54200956|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
27750512|NCT02031640|54200957|FG002|Double-blind Treatment Period|Withdrawal by Subject|3|||
27750513|NCT02031640|54200958|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
27750514|NCT02031640|54200959|FG004|Double-blind Treatment Period|Withdrawal by Subject|1|||
27750515|NCT02031640|54200960|FG005|Double-blind Treatment Period|Withdrawal by Subject|1|||
27750516|NCT02031640|54200955|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
27750517|NCT02031640|54200956|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
27750518|NCT02031640|54200957|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
27750519|NCT02031640|54200958|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
27750520|NCT02031640|54200959|FG004|Double-blind Treatment Period|Lost to Follow-up|1|||
27750521|NCT02031640|54200960|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
27750522|NCT02370173|54200986|FG000|Overall Study|Protocol Violation|1|||
27750523|NCT02370173|54200987|FG001|Overall Study|Protocol Violation|1|||
27750524|NCT02370173|54200986|FG000|Overall Study|Withdrawal by Subject|2|||
27750525|NCT02370173|54200987|FG001|Overall Study|Withdrawal by Subject|2|||
27750526|NCT02660489|54200997|FG000|Overall Study|Lost to Follow-up|1|||
27750527|NCT02660489|54200998|FG001|Overall Study|Lost to Follow-up|1|||
27750528|NCT02660489|54200997|FG000|Overall Study|Adverse Event|1|||
27750529|NCT02660489|54200998|FG001|Overall Study|Adverse Event|3|||
27750530|NCT02660489|54200997|FG000|Overall Study|no rhinovirus infection|4|||
27750531|NCT02660489|54200998|FG001|Overall Study|no rhinovirus infection|4|||
27750532|NCT02052310|54201006|FG000|Overall Study|Death|64|||
27750533|NCT02052310|54201007|FG001|Overall Study|Death|54|||
27750534|NCT02052310|54201006|FG000|Overall Study|Withdrawal by Subject|37|||
27750535|NCT02052310|54201007|FG001|Overall Study|Withdrawal by Subject|49|||
27750536|NCT02052310|54201006|FG000|Overall Study|Other than specified|32|||
27750537|NCT02052310|54201007|FG001|Overall Study|Other than specified|29|||
27750538|NCT02052310|54201006|FG000|Overall Study|Adverse Event|29|||
27750539|NCT02052310|54201007|FG001|Overall Study|Adverse Event|22|||
27750540|NCT02052310|54201006|FG000|Overall Study|Kidney Transplant|23|||
27750541|NCT02052310|54201007|FG001|Overall Study|Kidney Transplant|29|||
27750542|NCT02052310|54201006|FG000|Overall Study|Physician Decision|14|||
27750543|NCT02052310|54201007|FG001|Overall Study|Physician Decision|7|||
27750544|NCT02052310|54201006|FG000|Overall Study|Lack of Efficacy|6|||
27750545|NCT02052310|54201007|FG001|Overall Study|Lack of Efficacy|1|||
27831201|NCT01793051|54307467|FG000|Overall Study|Adverse Event|0|||
27750546|NCT02052310|54201006|FG000|Overall Study|Site Terminated by Sponsor|5|||
27750547|NCT02052310|54201007|FG001|Overall Study|Site Terminated by Sponsor|13|||
27750548|NCT02052310|54201006|FG000|Overall Study|Lost to Follow-up|4|||
27750549|NCT02052310|54201007|FG001|Overall Study|Lost to Follow-up|2|||
27750550|NCT02052310|54201006|FG000|Overall Study|Protocol Violation|1|||
27750551|NCT02052310|54201007|FG001|Overall Study|Protocol Violation|6|||
27750552|NCT02051764|54201015|FG000|Overall Study|Study terminated by sponsor|0|||
27750553|NCT02051764|54201016|FG001|Overall Study|Study terminated by sponsor|7|||
27750554|NCT02051296|54201024|FG000|Overall Study|Lost to Follow-up|1|||
27750555|NCT02051296|54201025|FG001|Overall Study|Lost to Follow-up|2|||
27750556|NCT02051296|54201024|FG000|Overall Study|withdraw prior to treatment|7|||
27750557|NCT02051296|54201025|FG001|Overall Study|withdraw prior to treatment|7|||
27750558|NCT02050048|54201033|FG000|Overall Study|Lost to Follow-up|0|||
27750559|NCT02050048|54201034|FG001|Overall Study|Lost to Follow-up|1|||
27750560|NCT02050048|54201033|FG000|Overall Study|Death|1|||
27750561|NCT02050048|54201034|FG001|Overall Study|Death|0|||
27750562|NCT02050048|54201033|FG000|Overall Study|Ineligible after ERCP|4|||
27750563|NCT02050048|54201034|FG001|Overall Study|Ineligible after ERCP|1|||
27750564|NCT02049814|54201042|FG000|Overall Study|Reason not Specified|4|||
27750565|NCT02049814|54201043|FG001|Overall Study|Reason not Specified|3|||
27750566|NCT02049814|54201042|FG000|Overall Study|Pregnancy|1|||
27750567|NCT02049814|54201043|FG001|Overall Study|Pregnancy|0|||
27750568|NCT02049814|54201042|FG000|Overall Study|Lost to Follow-up|2|||
27750569|NCT02049814|54201043|FG001|Overall Study|Lost to Follow-up|3|||
27750570|NCT02049814|54201042|FG000|Overall Study|Serious Protocol Violation|5|||
27750571|NCT02049814|54201043|FG001|Overall Study|Serious Protocol Violation|7|||
27750572|NCT02049814|54201042|FG000|Overall Study|Study Termination|0|||
27750573|NCT02049814|54201043|FG001|Overall Study|Study Termination|1|||
27750574|NCT02049814|54201042|FG000|Overall Study|Pretreatment event/Adverse Event (AE)|8|||
27750575|NCT02049814|54201043|FG001|Overall Study|Pretreatment event/Adverse Event (AE)|5|||
27750576|NCT02049814|54201042|FG000|Overall Study|Voluntary withdrawal|9|||
27750577|NCT02049814|54201043|FG001|Overall Study|Voluntary withdrawal|8|||
27750578|NCT02079844|54201061|FG000|Treatment Period 1|Voluntary Withdrawal|0|||
27750579|NCT02079844|54201062|FG001|Treatment Period 1|Voluntary Withdrawal|0|||
27750580|NCT02079844|54201063|FG002|Treatment Period 1|Voluntary Withdrawal|2|||
27750581|NCT02079844|54201061|FG000|Treatment Period 2|Voluntary Withdrawal|0|||
27750582|NCT02079844|54201062|FG001|Treatment Period 2|Voluntary Withdrawal|1|||
27750583|NCT02079844|54201063|FG002|Treatment Period 2|Voluntary Withdrawal|0|||
27750584|NCT02048722|54201083|FG000|2 Cycles of Treatment|Adverse Event|2|||
27750585|NCT02048722|54201083|FG000|2 Cycles of Treatment|Withdrawal by Subject|4|||
27750586|NCT02048722|54201083|FG000|2 Cycles of Treatment|Progressive Disease|2|||
27750587|NCT02048722|54201083|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|10|||
27750588|NCT02048722|54201083|FG000|Follow up 5 Years or Cut of Timepoint|Death|24|||
27750589|NCT02048722|54201083|FG000|Follow up 5 Years or Cut of Timepoint|Withdrawal by Subject|3|||
27750590|NCT02030002|54201087|FG000|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1|||
27750591|NCT02030002|54201087|FG000|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4|||
27750592|NCT02030002|54201087|FG000|Follow-up|Lost to Follow-up|2|||
27750593|NCT02079610|54201095|FG000|Overall Study|Withdrawal by Subject|1|||
27750594|NCT02079610|54201096|FG001|Overall Study|Withdrawal by Subject|1|||
27750595|NCT02079532|54201102|FG000|Overall Study|Adverse Event|7|||
27750596|NCT02079532|54201102|FG000|Overall Study|Additional or changed therapy|2|||
27750597|NCT02079532|54201102|FG000|Overall Study|Lack of Efficacy|9|||
27750598|NCT02079532|54201102|FG000|Overall Study|Protocol Violation|3|||
27750599|NCT02079532|54201102|FG000|Overall Study|Withdrawal by Subject|1|||
27750600|NCT02079532|54201102|FG000|Overall Study|Administrative problems|1|||
27750601|NCT02079532|54201102|FG000|Overall Study|Inclusion into ReFIRST|3|||
27750602|NCT02079532|54201102|FG000|Overall Study|Other|3|||
27750603|NCT02709889|54201155|FG000|Overall Study|Withdrawal by Subject|11|||
27750604|NCT02709889|54201156|FG001|Overall Study|Withdrawal by Subject|10|||
27750605|NCT02709889|54201157|FG002|Overall Study|Withdrawal by Subject|2|||
27750606|NCT02709889|54201158|FG003|Overall Study|Withdrawal by Subject|12|||
27750607|NCT02709889|54201155|FG000|Overall Study|Death|25|||
27750608|NCT02709889|54201156|FG001|Overall Study|Death|38|||
27750609|NCT02709889|54201157|FG002|Overall Study|Death|4|||
27750610|NCT02709889|54201158|FG003|Overall Study|Death|44|||
27750611|NCT02709889|54201155|FG000|Overall Study|Physician Decision|1|||
27750612|NCT02709889|54201156|FG001|Overall Study|Physician Decision|2|||
27750613|NCT02709889|54201157|FG002|Overall Study|Physician Decision|3|||
27750614|NCT02709889|54201158|FG003|Overall Study|Physician Decision|5|||
27750615|NCT02709889|54201155|FG000|Overall Study|Lost to Follow-up|2|||
27750616|NCT02709889|54201156|FG001|Overall Study|Lost to Follow-up|0|||
27750617|NCT02709889|54201157|FG002|Overall Study|Lost to Follow-up|0|||
27750618|NCT02709889|54201158|FG003|Overall Study|Lost to Follow-up|4|||
27750619|NCT02709889|54201155|FG000|Overall Study|Study Terminated by Sponsor|4|||
27750620|NCT02709889|54201156|FG001|Overall Study|Study Terminated by Sponsor|6|||
27750621|NCT02709889|54201157|FG002|Overall Study|Study Terminated by Sponsor|2|||
27750622|NCT02709889|54201158|FG003|Overall Study|Study Terminated by Sponsor|17|||
27750623|NCT02709889|54201155|FG000|Overall Study|Other, Not Specified|0|||
27750624|NCT02709889|54201156|FG001|Overall Study|Other, Not Specified|1|||
27750625|NCT02709889|54201157|FG002|Overall Study|Other, Not Specified|1|||
27750626|NCT02709889|54201158|FG003|Overall Study|Other, Not Specified|6|||
27750627|NCT02711995|54201203|FG000|Washout (90 Days)|Conflicting medication|1|||
27750628|NCT02514239|54201241|FG000|Overall Study|Refused to continue trial medication|0|||
27750629|NCT02514239|54201242|FG001|Overall Study|Refused to continue trial medication|0|||
27750630|NCT02514239|54201243|FG002|Overall Study|Refused to continue trial medication|0|||
27750631|NCT02514239|54201244|FG003|Overall Study|Refused to continue trial medication|0|||
27750632|NCT02514239|54201245|FG004|Overall Study|Refused to continue trial medication|0|||
27750633|NCT02514239|54201246|FG005|Overall Study|Refused to continue trial medication|0|||
27750634|NCT02514239|54201247|FG006|Overall Study|Refused to continue trial medication|0|||
27750635|NCT02514239|54201248|FG007|Overall Study|Refused to continue trial medication|0|||
27750636|NCT02514239|54201249|FG008|Overall Study|Refused to continue trial medication|0|||
27750637|NCT02514239|54201250|FG009|Overall Study|Refused to continue trial medication|1|||
27750638|NCT02514239|54201241|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
27750639|NCT02514239|54201242|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
27750640|NCT02514239|54201243|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
27750641|NCT02514239|54201244|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
27750642|NCT02514239|54201245|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
27750643|NCT02514239|54201246|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
27750644|NCT02514239|54201247|FG006|Overall Study|Dose-limiting toxicity (DLT)|0|||
27750645|NCT02514239|54201248|FG007|Overall Study|Dose-limiting toxicity (DLT)|0|||
27750646|NCT02514239|54201249|FG008|Overall Study|Dose-limiting toxicity (DLT)|1|||
27750647|NCT02514239|54201250|FG009|Overall Study|Dose-limiting toxicity (DLT)|2|||
27750648|NCT02514239|54201241|FG000|Overall Study|Not treated|0|||
27750649|NCT02514239|54201242|FG001|Overall Study|Not treated|1|||
27750650|NCT02514239|54201243|FG002|Overall Study|Not treated|0|||
27750651|NCT02514239|54201244|FG003|Overall Study|Not treated|0|||
27750652|NCT02514239|54201245|FG004|Overall Study|Not treated|0|||
27750653|NCT02514239|54201246|FG005|Overall Study|Not treated|0|||
27750654|NCT02514239|54201247|FG006|Overall Study|Not treated|0|||
27750655|NCT02514239|54201248|FG007|Overall Study|Not treated|0|||
27750656|NCT02514239|54201249|FG008|Overall Study|Not treated|0|||
27750657|NCT02514239|54201250|FG009|Overall Study|Not treated|0|||
27750658|NCT02514239|54201241|FG000|Overall Study|Other Adverse Events|2|||
27750659|NCT02514239|54201242|FG001|Overall Study|Other Adverse Events|0|||
27750660|NCT02514239|54201243|FG002|Overall Study|Other Adverse Events|0|||
27750661|NCT02514239|54201244|FG003|Overall Study|Other Adverse Events|1|||
27750662|NCT02514239|54201245|FG004|Overall Study|Other Adverse Events|0|||
27750663|NCT02514239|54201246|FG005|Overall Study|Other Adverse Events|1|||
27750664|NCT02514239|54201247|FG006|Overall Study|Other Adverse Events|0|||
27750665|NCT02514239|54201248|FG007|Overall Study|Other Adverse Events|1|||
27750666|NCT02514239|54201249|FG008|Overall Study|Other Adverse Events|2|||
27750667|NCT02514239|54201250|FG009|Overall Study|Other Adverse Events|0|||
27750668|NCT02514239|54201241|FG000|Overall Study|Progressive disease|3|||
27750669|NCT02514239|54201242|FG001|Overall Study|Progressive disease|3|||
27750670|NCT02514239|54201243|FG002|Overall Study|Progressive disease|2|||
27750671|NCT02514239|54201244|FG003|Overall Study|Progressive disease|2|||
27750672|NCT02514239|54201245|FG004|Overall Study|Progressive disease|3|||
27750673|NCT02514239|54201246|FG005|Overall Study|Progressive disease|3|||
27750674|NCT02514239|54201247|FG006|Overall Study|Progressive disease|4|||
27750675|NCT02514239|54201248|FG007|Overall Study|Progressive disease|2|||
27750676|NCT02514239|54201249|FG008|Overall Study|Progressive disease|5|||
27750677|NCT02514239|54201250|FG009|Overall Study|Progressive disease|0|||
27750678|NCT02709109|54201294|FG000|Treatment Period 1 (28 Days)|Adverse Event|3|||
27750679|NCT02709109|54201295|FG001|Treatment Period 1 (28 Days)|Adverse Event|3|||
27750680|NCT02709109|54201296|FG002|Treatment Period 1 (28 Days)|Adverse Event|1|||
27750681|NCT02709109|54201297|FG003|Treatment Period 1 (28 Days)|Adverse Event|0|||
27750682|NCT02709109|54201294|FG000|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
27750683|NCT02709109|54201295|FG001|Treatment Period 1 (28 Days)|Participant refused further dosing|2|||
27750684|NCT02709109|54201296|FG002|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
27750685|NCT02709109|54201297|FG003|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
27750686|NCT02709109|54201294|FG000|Treatment Period 1 (28 Days)|Non-compliance with study drug|1|||
27750687|NCT02709109|54201295|FG001|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
27750688|NCT02709109|54201296|FG002|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
27750689|NCT02709109|54201297|FG003|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
27750690|NCT02709109|54201294|FG000|Washout Period (28 Days)|Other|2|||
27750691|NCT02709109|54201295|FG001|Washout Period (28 Days)|Other|2|||
27750692|NCT02709109|54201296|FG002|Washout Period (28 Days)|Other|3|||
27750693|NCT02709109|54201297|FG003|Washout Period (28 Days)|Other|0|||
27750694|NCT02709109|54201294|FG000|Treatment Period 2 (28 Days)|Adverse Event|2|||
27750695|NCT02709109|54201295|FG001|Treatment Period 2 (28 Days)|Adverse Event|3|||
27750696|NCT02709109|54201296|FG002|Treatment Period 2 (28 Days)|Adverse Event|0|||
27750697|NCT02709109|54201297|FG003|Treatment Period 2 (28 Days)|Adverse Event|0|||
27750698|NCT02709109|54201294|FG000|Treatment Period 2 (28 Days)|Other non-compliance|0|||
27750699|NCT02709109|54201295|FG001|Treatment Period 2 (28 Days)|Other non-compliance|1|||
27750700|NCT02709109|54201296|FG002|Treatment Period 2 (28 Days)|Other non-compliance|1|||
27750701|NCT02709109|54201297|FG003|Treatment Period 2 (28 Days)|Other non-compliance|0|||
27750702|NCT02709109|54201294|FG000|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
27750703|NCT02709109|54201295|FG001|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
27750704|NCT02709109|54201296|FG002|Treatment Period 2 (28 Days)|Requires prohibited medication|1|||
27750705|NCT02709109|54201297|FG003|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
27750706|NCT02709109|54201294|FG000|Treatment Period 2 (28 Days)|Other|0|||
27750707|NCT02709109|54201295|FG001|Treatment Period 2 (28 Days)|Other|0|||
27750708|NCT02709109|54201296|FG002|Treatment Period 2 (28 Days)|Other|1|||
27750709|NCT02709109|54201297|FG003|Treatment Period 2 (28 Days)|Other|0|||
27750710|NCT04289051|54201312|FG000|Overall Study|Lost to Follow-up|0|||
27750711|NCT04289051|54201313|FG001|Overall Study|Lost to Follow-up|0|||
27750712|NCT04289051|54201314|FG002|Overall Study|Lost to Follow-up|2|||
27750713|NCT02709655|54201322|FG000|Single-Blind Phase (4 Weeks)|Adverse Event|2|||
27750714|NCT02709655|54201323|FG001|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
27750715|NCT02709655|54201324|FG002|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
27750716|NCT02709655|54201325|FG003|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
27750717|NCT02709655|54201326|FG004|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
27750718|NCT02709655|54201322|FG000|Single-Blind Phase (4 Weeks)|Lack of Efficacy|8|||
27750719|NCT02709655|54201323|FG001|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
27750720|NCT02709655|54201324|FG002|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
27750721|NCT02709655|54201325|FG003|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
27750722|NCT02709655|54201326|FG004|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
27750723|NCT02709655|54201322|FG000|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|3|||
27750724|NCT02709655|54201323|FG001|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
27750725|NCT02709655|54201324|FG002|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
27750726|NCT02709655|54201325|FG003|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
27750727|NCT02709655|54201326|FG004|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
27750728|NCT02709655|54201322|FG000|Single-Blind Phase (4 Weeks)|Protocol Violation|3|||
27750729|NCT02709655|54201323|FG001|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
27750730|NCT02709655|54201324|FG002|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
27750731|NCT02709655|54201325|FG003|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
27750732|NCT02709655|54201326|FG004|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
27750733|NCT02709655|54201322|FG000|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|15|||
27750734|NCT02709655|54201323|FG001|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
27750735|NCT02709655|54201324|FG002|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
27750736|NCT02709655|54201325|FG003|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
27750737|NCT02709655|54201326|FG004|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
27750738|NCT02709655|54201322|FG000|Single-Blind Phase (4 Weeks)|Lost to Follow-up|1|||
27750739|NCT02709655|54201323|FG001|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
27750740|NCT02709655|54201324|FG002|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
27750741|NCT02709655|54201325|FG003|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
27750742|NCT02709655|54201326|FG004|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
27750743|NCT02709655|54201322|FG000|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|85|||
27750744|NCT02709655|54201323|FG001|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
27750745|NCT02709655|54201324|FG002|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
27750746|NCT02709655|54201325|FG003|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
27750747|NCT02709655|54201326|FG004|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
27750748|NCT02709655|54201322|FG000|Single-Blind Phase (4 Weeks)|Other than specified|20|||
27750749|NCT02709655|54201323|FG001|Single-Blind Phase (4 Weeks)|Other than specified|0|||
27750750|NCT02709655|54201324|FG002|Single-Blind Phase (4 Weeks)|Other than specified|0|||
27750751|NCT02709655|54201325|FG003|Single-Blind Phase (4 Weeks)|Other than specified|0|||
27750752|NCT02709655|54201326|FG004|Single-Blind Phase (4 Weeks)|Other than specified|0|||
27750753|NCT02709655|54201322|FG000|Single-Blind Phase (4 Weeks)|Enrolled but not treated|6|||
27750754|NCT02709655|54201323|FG001|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
27750755|NCT02709655|54201324|FG002|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
27750756|NCT02709655|54201325|FG003|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
27750757|NCT02709655|54201326|FG004|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
27750758|NCT02709655|54201322|FG000|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
27750759|NCT02709655|54201323|FG001|Double-Blind Phase (8 Weeks)|Adverse Event|1|||
27750760|NCT02709655|54201324|FG002|Double-Blind Phase (8 Weeks)|Adverse Event|2|||
27750761|NCT02709655|54201325|FG003|Double-Blind Phase (8 Weeks)|Adverse Event|3|||
27836323|NCT01551173|54321264|FG000|Overall Study|Other|5|||
27750762|NCT02709655|54201326|FG004|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
27750763|NCT02709655|54201322|FG000|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
27750764|NCT02709655|54201323|FG001|Double-Blind Phase (8 Weeks)|Lack of Efficacy|2|||
27750765|NCT02709655|54201324|FG002|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
27750766|NCT02709655|54201325|FG003|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
27750767|NCT02709655|54201326|FG004|Double-Blind Phase (8 Weeks)|Lack of Efficacy|1|||
27750768|NCT02709655|54201322|FG000|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|0|||
27750769|NCT02709655|54201323|FG001|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
27750770|NCT02709655|54201324|FG002|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|3|||
27750771|NCT02709655|54201325|FG003|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|6|||
27750772|NCT02709655|54201326|FG004|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
27750773|NCT02709655|54201322|FG000|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
27750774|NCT02709655|54201323|FG001|Double-Blind Phase (8 Weeks)|Protocol Violation|1|||
27750775|NCT02709655|54201324|FG002|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
27750776|NCT02709655|54201325|FG003|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
27750777|NCT02709655|54201326|FG004|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
27750778|NCT02709655|54201322|FG000|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|0|||
27750779|NCT02709655|54201323|FG001|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
27750780|NCT02709655|54201324|FG002|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
27750781|NCT02709655|54201325|FG003|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
27750782|NCT02709655|54201326|FG004|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|1|||
27750783|NCT02709655|54201322|FG000|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
27750784|NCT02709655|54201323|FG001|Double-Blind Phase (8 Weeks)|Lost to Follow-up|1|||
27750785|NCT02709655|54201324|FG002|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
27750786|NCT02709655|54201325|FG003|Double-Blind Phase (8 Weeks)|Lost to Follow-up|2|||
27750787|NCT02709655|54201326|FG004|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
27750788|NCT02709655|54201322|FG000|Double-Blind Phase (8 Weeks)|Other than specified|0|||
27750789|NCT02709655|54201323|FG001|Double-Blind Phase (8 Weeks)|Other than specified|5|||
27750790|NCT02709655|54201324|FG002|Double-Blind Phase (8 Weeks)|Other than specified|7|||
27750791|NCT02709655|54201325|FG003|Double-Blind Phase (8 Weeks)|Other than specified|5|||
27750792|NCT02709655|54201326|FG004|Double-Blind Phase (8 Weeks)|Other than specified|2|||
27750793|NCT02708485|54201340|FG000|Overall Study|Withdrawal by Subject|3|||
27750794|NCT02708485|54201341|FG001|Overall Study|Withdrawal by Subject|2|||
27750795|NCT02709577|54201353|FG000|Overall Study|non-accommodating anatomy|0|||
27750796|NCT02709577|54201354|FG001|Overall Study|non-accommodating anatomy|1|||
27750797|NCT02709577|54201355|FG002|Overall Study|non-accommodating anatomy|0|||
27750798|NCT02709577|54201356|FG003|Overall Study|non-accommodating anatomy|0|||
27750799|NCT02709577|54201353|FG000|Overall Study|procedural complication|0|||
27750800|NCT02709577|54201354|FG001|Overall Study|procedural complication|1|||
27750801|NCT02709577|54201355|FG002|Overall Study|procedural complication|0|||
27750802|NCT02709577|54201356|FG003|Overall Study|procedural complication|0|||
27750803|NCT02709577|54201353|FG000|Overall Study|Withdrawal by Subject|2|||
27750804|NCT02709577|54201354|FG001|Overall Study|Withdrawal by Subject|3|||
27750805|NCT02709577|54201355|FG002|Overall Study|Withdrawal by Subject|2|||
27750806|NCT02709577|54201356|FG003|Overall Study|Withdrawal by Subject|0|||
27750807|NCT02078752|54201377|FG000|Overall Study|Death|0|||
27750808|NCT02078752|54201378|FG001|Overall Study|Death|3|||
27750809|NCT02078752|54201379|FG002|Overall Study|Death|0|||
27750810|NCT02078752|54201380|FG003|Overall Study|Death|0|||
27750811|NCT02078752|54201381|FG004|Overall Study|Death|0|||
27750812|NCT02078752|54201382|FG005|Overall Study|Death|1|||
27750813|NCT02078752|54201383|FG006|Overall Study|Death|0|||
27750814|NCT02078752|54201384|FG007|Overall Study|Death|1|||
27750815|NCT02078752|54201385|FG008|Overall Study|Death|0|||
27750816|NCT02078752|54201386|FG009|Overall Study|Death|4|||
27750817|NCT02078752|54201377|FG000|Overall Study|Lost to Follow-up|1|||
27750818|NCT02078752|54201378|FG001|Overall Study|Lost to Follow-up|0|||
27750819|NCT02078752|54201379|FG002|Overall Study|Lost to Follow-up|0|||
27750820|NCT02078752|54201380|FG003|Overall Study|Lost to Follow-up|1|||
27750821|NCT02078752|54201381|FG004|Overall Study|Lost to Follow-up|0|||
27750822|NCT02078752|54201382|FG005|Overall Study|Lost to Follow-up|0|||
27750823|NCT02078752|54201383|FG006|Overall Study|Lost to Follow-up|0|||
27750824|NCT02078752|54201384|FG007|Overall Study|Lost to Follow-up|0|||
27750825|NCT02078752|54201385|FG008|Overall Study|Lost to Follow-up|0|||
27750826|NCT02078752|54201386|FG009|Overall Study|Lost to Follow-up|0|||
27750827|NCT02078752|54201377|FG000|Overall Study|Withdrawal by Subject|1|||
27750828|NCT02078752|54201378|FG001|Overall Study|Withdrawal by Subject|1|||
27750829|NCT02078752|54201379|FG002|Overall Study|Withdrawal by Subject|1|||
27750830|NCT02078752|54201380|FG003|Overall Study|Withdrawal by Subject|1|||
27750831|NCT02078752|54201381|FG004|Overall Study|Withdrawal by Subject|0|||
27750832|NCT02078752|54201382|FG005|Overall Study|Withdrawal by Subject|3|||
27750833|NCT02078752|54201383|FG006|Overall Study|Withdrawal by Subject|2|||
27750834|NCT02078752|54201384|FG007|Overall Study|Withdrawal by Subject|1|||
27750835|NCT02078752|54201385|FG008|Overall Study|Withdrawal by Subject|0|||
27750836|NCT02078752|54201386|FG009|Overall Study|Withdrawal by Subject|1|||
27750837|NCT02078752|54201377|FG000|Overall Study|Other|0|||
27750838|NCT02078752|54201378|FG001|Overall Study|Other|3|||
27750839|NCT02078752|54201379|FG002|Overall Study|Other|0|||
27750840|NCT02078752|54201380|FG003|Overall Study|Other|0|||
27750841|NCT02078752|54201381|FG004|Overall Study|Other|1|||
27750842|NCT02078752|54201382|FG005|Overall Study|Other|0|||
27750843|NCT02078752|54201383|FG006|Overall Study|Other|0|||
27750844|NCT02078752|54201384|FG007|Overall Study|Other|1|||
27750845|NCT02078752|54201385|FG008|Overall Study|Other|0|||
27750846|NCT02078752|54201386|FG009|Overall Study|Other|0|||
27750847|NCT02078752|54201377|FG000|Overall Study|Study terminated by sponsor|0|||
27750848|NCT02078752|54201378|FG001|Overall Study|Study terminated by sponsor|0|||
27750849|NCT02078752|54201379|FG002|Overall Study|Study terminated by sponsor|0|||
27750850|NCT02078752|54201380|FG003|Overall Study|Study terminated by sponsor|0|||
27750851|NCT02078752|54201381|FG004|Overall Study|Study terminated by sponsor|0|||
27750852|NCT02078752|54201382|FG005|Overall Study|Study terminated by sponsor|0|||
27750853|NCT02078752|54201383|FG006|Overall Study|Study terminated by sponsor|0|||
27750854|NCT02078752|54201384|FG007|Overall Study|Study terminated by sponsor|0|||
27750855|NCT02078752|54201385|FG008|Overall Study|Study terminated by sponsor|0|||
27750856|NCT02078752|54201386|FG009|Overall Study|Study terminated by sponsor|5|||
27750857|NCT02022748|54201419|FG000|Overall Study|Adverse Event|1|||
27750858|NCT02022748|54201420|FG001|Overall Study|Adverse Event|1|||
27750859|NCT02022748|54201421|FG002|Overall Study|Adverse Event|0|||
27750860|NCT02022748|54201419|FG000|Overall Study|Withdrawal by Subject|0|||
27750861|NCT02022748|54201420|FG001|Overall Study|Withdrawal by Subject|1|||
27750862|NCT02022748|54201421|FG002|Overall Study|Withdrawal by Subject|0|||
27750863|NCT02022670|54201432|FG000|Overall Study|Adverse Event|1|||
27750864|NCT02022670|54201433|FG001|Overall Study|Adverse Event|0|||
27750865|NCT02022670|54201434|FG002|Overall Study|Adverse Event|1|||
27750866|NCT02076334|54201447|FG000|Overall Study|Protocol Violation|1|||
27750867|NCT02076334|54201448|FG001|Overall Study|Protocol Violation|0|||
27750868|NCT02076334|54201449|FG002|Overall Study|Protocol Violation|0|||
27750869|NCT02076334|54201450|FG003|Overall Study|Protocol Violation|0|||
27750870|NCT02076334|54201447|FG000|Overall Study|Lost to Follow-up|0|||
27750871|NCT02076334|54201448|FG001|Overall Study|Lost to Follow-up|1|||
27750872|NCT02076334|54201449|FG002|Overall Study|Lost to Follow-up|1|||
27750873|NCT02076334|54201450|FG003|Overall Study|Lost to Follow-up|0|||
27750874|NCT02076334|54201447|FG000|Overall Study|muscle soreness|0|||
27750875|NCT02076334|54201448|FG001|Overall Study|muscle soreness|0|||
27750876|NCT02076334|54201449|FG002|Overall Study|muscle soreness|0|||
27750877|NCT02076334|54201450|FG003|Overall Study|muscle soreness|1|||
27750878|NCT02021812|54201460|FG000|Overall Study|Death|8|||
27750879|NCT02021812|54201460|FG000|Overall Study|Withdrawal by Subject|3|||
27750880|NCT02021812|54201460|FG000|Overall Study|Lost to Follow-up|2|||
27750881|NCT02021812|54201460|FG000|Overall Study|Refuse to return, COVD 19|2|||
27750882|NCT02021656|54201464|FG000|Overall Study|Adverse Event|1|||
27750883|NCT02021656|54201464|FG000|Overall Study|Lack of Efficacy|2|||
27750884|NCT02021656|54201464|FG000|Overall Study|Lost to Follow-up|1|||
27750885|NCT02021656|54201464|FG000|Overall Study|Withdrew Consent|2|||
27750886|NCT02076022|54201474|FG000|Overall Study|Withdrawal by Subject|2|||
27750887|NCT02076022|54201475|FG001|Overall Study|Withdrawal by Subject|0|||
27750888|NCT02075632|54201483|FG000|Overall Study|Adverse Event|1|||
27750889|NCT02075632|54201484|FG001|Overall Study|Adverse Event|1|||
27750890|NCT02075632|54201483|FG000|Overall Study|Lost to Follow-up|0|||
27750891|NCT02075632|54201484|FG001|Overall Study|Lost to Follow-up|3|||
27750892|NCT02075632|54201483|FG000|Overall Study|Withdrawal by Subject|0|||
27750893|NCT02075632|54201484|FG001|Overall Study|Withdrawal by Subject|1|||
27750894|NCT02075554|54201490|FG000|Overall Study|Lost to Follow-up|7|||
27750895|NCT02075554|54201490|FG000|Overall Study|Withdrawal by Subject|5|||
27750896|NCT02075554|54201490|FG000|Overall Study|Physician Decision|3|||
27750897|NCT02075476|54201496|FG000|Overall Study|Death|2|||
27750898|NCT02075476|54201497|FG001|Overall Study|Death|2|||
27750899|NCT02075476|54201496|FG000|Overall Study|Lost to Follow-up|1|||
27750900|NCT02075476|54201497|FG001|Overall Study|Lost to Follow-up|3|||
27750901|NCT02075320|54201503|FG000|Overall Study|Withdrawal by Subject|2|||
27750902|NCT02708095|54201510|FG000|Overall Study|Adverse Event|4|||
27750903|NCT02708095|54201511|FG001|Overall Study|Adverse Event|10|||
27750904|NCT02708095|54201512|FG002|Overall Study|Adverse Event|11|||
27750905|NCT02708095|54201510|FG000|Overall Study|Lack of Efficacy|9|||
27750906|NCT02708095|54201511|FG001|Overall Study|Lack of Efficacy|3|||
27750907|NCT02708095|54201512|FG002|Overall Study|Lack of Efficacy|0|||
27750908|NCT02708095|54201510|FG000|Overall Study|Lost to Follow-up|2|||
27750909|NCT02708095|54201511|FG001|Overall Study|Lost to Follow-up|0|||
27750910|NCT02708095|54201512|FG002|Overall Study|Lost to Follow-up|0|||
27750911|NCT02708095|54201510|FG000|Overall Study|Physician Decision|2|||
27750912|NCT02708095|54201511|FG001|Overall Study|Physician Decision|3|||
27750913|NCT02708095|54201512|FG002|Overall Study|Physician Decision|2|||
27750914|NCT02708095|54201510|FG000|Overall Study|Protocol Violation|0|||
27750915|NCT02708095|54201511|FG001|Overall Study|Protocol Violation|0|||
27750916|NCT02708095|54201512|FG002|Overall Study|Protocol Violation|1|||
27750917|NCT02708095|54201510|FG000|Overall Study|Withdrawal by Subject|5|||
27750918|NCT02708095|54201511|FG001|Overall Study|Withdrawal by Subject|3|||
27750919|NCT02708095|54201512|FG002|Overall Study|Withdrawal by Subject|4|||
27750920|NCT02707861|54201524|FG000|Overall Study|Went onto commercial drug|30|||
27750921|NCT02707861|54201525|FG001|Overall Study|Went onto commercial drug|23|||
27750922|NCT02707861|54201524|FG000|Overall Study|Adverse Event|2|||
27750923|NCT02707861|54201525|FG001|Overall Study|Adverse Event|3|||
27750924|NCT02707861|54201524|FG000|Overall Study|Death|5|||
27750925|NCT02707861|54201525|FG001|Overall Study|Death|2|||
27750926|NCT02707861|54201524|FG000|Overall Study|Lack of Efficacy|0|||
27750927|NCT02707861|54201525|FG001|Overall Study|Lack of Efficacy|2|||
27750928|NCT02707861|54201524|FG000|Overall Study|Physician Decision|1|||
27750929|NCT02707861|54201525|FG001|Overall Study|Physician Decision|4|||
27750930|NCT02707861|54201524|FG000|Overall Study|Withdrawal by Subject|2|||
27750931|NCT02707861|54201525|FG001|Overall Study|Withdrawal by Subject|1|||
27750932|NCT02707861|54201524|FG000|Overall Study|Lost to Follow-up|1|||
27750933|NCT02707861|54201525|FG001|Overall Study|Lost to Follow-up|3|||
27750934|NCT02027428|54201533|FG000|Induction|Never treated|7|||
27750935|NCT02027428|54201534|FG001|Induction|Never treated|0|||
27750936|NCT02027428|54201535|FG002|Induction|Never treated|0|||
27750937|NCT02027428|54201533|FG000|Induction|Progressive disease|77|||
27750938|NCT02027428|54201534|FG001|Induction|Progressive disease|0|||
27750939|NCT02027428|54201535|FG002|Induction|Progressive disease|0|||
27750940|NCT02027428|54201533|FG000|Induction|Adverse Event|51|||
27750941|NCT02027428|54201534|FG001|Induction|Adverse Event|0|||
27750942|NCT02027428|54201535|FG002|Induction|Adverse Event|0|||
27750943|NCT02027428|54201533|FG000|Induction|Withdrawal by Subject|22|||
27750944|NCT02027428|54201534|FG001|Induction|Withdrawal by Subject|0|||
27750945|NCT02027428|54201535|FG002|Induction|Withdrawal by Subject|0|||
27750946|NCT02027428|54201533|FG000|Induction|Death|21|||
27750947|NCT02027428|54201534|FG001|Induction|Death|0|||
27750948|NCT02027428|54201535|FG002|Induction|Death|0|||
27750949|NCT02027428|54201533|FG000|Induction|Symptomatic deterioration|16|||
27750950|NCT02027428|54201534|FG001|Induction|Symptomatic deterioration|0|||
27750951|NCT02027428|54201535|FG002|Induction|Symptomatic deterioration|0|||
27750952|NCT02027428|54201533|FG000|Induction|Study terminated by sponsor|12|||
27750953|NCT02027428|54201534|FG001|Induction|Study terminated by sponsor|0|||
27750954|NCT02027428|54201535|FG002|Induction|Study terminated by sponsor|0|||
27750955|NCT02027428|54201533|FG000|Induction|Protocol Violation|1|||
27750956|NCT02027428|54201534|FG001|Induction|Protocol Violation|0|||
27750957|NCT02027428|54201535|FG002|Induction|Protocol Violation|0|||
27750958|NCT02027428|54201533|FG000|Induction|Miscellaneous|14|||
27750959|NCT02027428|54201534|FG001|Induction|Miscellaneous|0|||
27750960|NCT02027428|54201535|FG002|Induction|Miscellaneous|0|||
27750961|NCT02027428|54201533|FG000|Induction|Induction Treatment Ongoing|4|||
27750962|NCT02027428|54201534|FG001|Induction|Induction Treatment Ongoing|0|||
27750963|NCT02027428|54201535|FG002|Induction|Induction Treatment Ongoing|0|||
27750964|NCT02027428|54201533|FG000|Maintenance|Death|0|||
27750965|NCT02027428|54201534|FG001|Maintenance|Death|3|||
27750966|NCT02027428|54201535|FG002|Maintenance|Death|2|||
27750967|NCT02027428|54201533|FG000|Maintenance|Adverse Event|0|||
27750968|NCT02027428|54201534|FG001|Maintenance|Adverse Event|21|||
27750969|NCT02027428|54201535|FG002|Maintenance|Adverse Event|1|||
27750970|NCT02027428|54201533|FG000|Maintenance|Progressive disease|0|||
27750971|NCT02027428|54201534|FG001|Maintenance|Progressive disease|84|||
27750972|NCT02027428|54201535|FG002|Maintenance|Progressive disease|47|||
27750973|NCT02027428|54201533|FG000|Maintenance|Symptomatic deterioration|0|||
27750974|NCT02027428|54201534|FG001|Maintenance|Symptomatic deterioration|4|||
27750975|NCT02027428|54201535|FG002|Maintenance|Symptomatic deterioration|1|||
27750976|NCT02027428|54201533|FG000|Maintenance|Withdrawal by Subject|0|||
27750977|NCT02027428|54201534|FG001|Maintenance|Withdrawal by Subject|6|||
27750978|NCT02027428|54201535|FG002|Maintenance|Withdrawal by Subject|5|||
27750979|NCT02027428|54201533|FG000|Maintenance|Protocol Violation|0|||
27750980|NCT02027428|54201534|FG001|Maintenance|Protocol Violation|0|||
27750981|NCT02027428|54201535|FG002|Maintenance|Protocol Violation|1|||
27750982|NCT02027428|54201533|FG000|Maintenance|Other|0|||
27750983|NCT02027428|54201534|FG001|Maintenance|Other|6|||
27750984|NCT02027428|54201535|FG002|Maintenance|Other|3|||
27750985|NCT02027428|54201533|FG000|Survival Follow-up|Death|0|||
27750986|NCT02027428|54201534|FG001|Survival Follow-up|Death|78|||
27750987|NCT02027428|54201535|FG002|Survival Follow-up|Death|45|||
27750988|NCT02027428|54201533|FG000|Survival Follow-up|Lost to Follow-up|0|||
27750989|NCT02027428|54201534|FG001|Survival Follow-up|Lost to Follow-up|1|||
27750990|NCT02027428|54201535|FG002|Survival Follow-up|Lost to Follow-up|1|||
27750991|NCT01995136|54201558|FG000|Overall Study|Change in residence|1|||
27750992|NCT01994902|54201562|FG000|Test Period 1|Withdrawal by Subject|3|||
27750993|NCT01994902|54201563|FG001|Test Period 1|Withdrawal by Subject|0|||
27750994|NCT01994902|54201562|FG000|Test Period 1|device deficiency with adverse event|0|||
27750995|NCT01994902|54201563|FG001|Test Period 1|device deficiency with adverse event|1|||
27750996|NCT01994902|54201562|FG000|Test Period 1|Adverse Event|2|||
27750997|NCT01994902|54201563|FG001|Test Period 1|Adverse Event|1|||
27750998|NCT01994902|54201562|FG000|Test Period 1|Lack of Efficacy|0|||
27750999|NCT01994902|54201563|FG001|Test Period 1|Lack of Efficacy|1|||
27751000|NCT01994902|54201562|FG000|Test Period 1|bag too small|1|||
27751001|NCT01994902|54201563|FG001|Test Period 1|bag too small|0|||
27751002|NCT01994902|54201562|FG000|Test Period 2|Withdrawal by Subject|0|||
27751003|NCT01994902|54201563|FG001|Test Period 2|Withdrawal by Subject|2|||
27751004|NCT01994902|54201562|FG000|Test Period 2|Lack of Efficacy|0|||
27751005|NCT01994902|54201563|FG001|Test Period 2|Lack of Efficacy|1|||
27751006|NCT01994902|54201562|FG000|Test Period 2|Other|0|||
27751007|NCT01994902|54201563|FG001|Test Period 2|Other|3|||
27751008|NCT02026258|54201571|FG000|Randomized|Did not start treatment|2|||
27751009|NCT02026258|54201572|FG001|Randomized|Did not start treatment|1|||
27751010|NCT02026258|54201571|FG000|Randomized|Change in treatment plan|1|||
27751011|NCT02026258|54201572|FG001|Randomized|Change in treatment plan|0|||
27751012|NCT02026258|54201571|FG000|Randomized|Presence of periodontal disease|1|||
27751013|NCT02026258|54201572|FG001|Randomized|Presence of periodontal disease|1|||
27751014|NCT02026258|54201571|FG000|Recieved Allocated Intervention|Withdrawal by Subject|1|||
27751015|NCT02026258|54201572|FG001|Recieved Allocated Intervention|Withdrawal by Subject|1|||
27751016|NCT02026258|54201571|FG000|Recieved Allocated Intervention|Lost to Follow-up|0|||
27751017|NCT02026258|54201572|FG001|Recieved Allocated Intervention|Lost to Follow-up|1|||
27751018|NCT01994590|54201579|FG000|Overall Study|Adverse Event|1|||
27751019|NCT01994590|54201579|FG000|Overall Study|Trial Terminated|1|||
27751020|NCT02019550|54201585|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
27751021|NCT02019550|54201586|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
27751022|NCT02019472|54201597|FG000|Overall Study|Adverse Event|14|||
27751023|NCT02019472|54201598|FG001|Overall Study|Adverse Event|23|||
27751024|NCT02019472|54201599|FG002|Overall Study|Adverse Event|17|||
27751025|NCT02019472|54201597|FG000|Overall Study|Death|0|||
27751026|NCT02019472|54201598|FG001|Overall Study|Death|1|||
27751027|NCT02019472|54201599|FG002|Overall Study|Death|1|||
27751028|NCT02019472|54201597|FG000|Overall Study|Lack of Efficacy|7|||
27751029|NCT02019472|54201598|FG001|Overall Study|Lack of Efficacy|4|||
27751030|NCT02019472|54201599|FG002|Overall Study|Lack of Efficacy|4|||
27751031|NCT02019472|54201597|FG000|Overall Study|Lost to Follow-up|0|||
27751032|NCT02019472|54201598|FG001|Overall Study|Lost to Follow-up|2|||
27751033|NCT02019472|54201599|FG002|Overall Study|Lost to Follow-up|1|||
27751034|NCT02019472|54201597|FG000|Overall Study|Physician Decision|1|||
27751035|NCT02019472|54201598|FG001|Overall Study|Physician Decision|2|||
27751036|NCT02019472|54201599|FG002|Overall Study|Physician Decision|0|||
27751037|NCT02019472|54201597|FG000|Overall Study|Pregnancy|1|||
27751038|NCT02019472|54201598|FG001|Overall Study|Pregnancy|2|||
27751039|NCT02019472|54201599|FG002|Overall Study|Pregnancy|2|||
27751040|NCT02019472|54201597|FG000|Overall Study|Withdrawal by Subject|11|||
27751041|NCT02019472|54201598|FG001|Overall Study|Withdrawal by Subject|10|||
27751042|NCT02019472|54201599|FG002|Overall Study|Withdrawal by Subject|11|||
27751043|NCT02019472|54201597|FG000|Overall Study|Other|3|||
27751044|NCT02019472|54201598|FG001|Overall Study|Other|8|||
27751045|NCT02019472|54201599|FG002|Overall Study|Other|6|||
27751046|NCT02705755|54201611|FG000|Part A (6 Days)|Adverse Event|1|||
27751047|NCT02705755|54201612|FG001|Part A (6 Days)|Adverse Event|0|||
27751048|NCT02705755|54201613|FG002|Part A (6 Days)|Adverse Event|0|||
27751049|NCT02705755|54201614|FG003|Part A (6 Days)|Adverse Event|0|||
27751050|NCT02705755|54201611|FG000|Part A (6 Days)|Physician Decision|3|||
27751051|NCT02705755|54201612|FG001|Part A (6 Days)|Physician Decision|0|||
27751052|NCT02705755|54201613|FG002|Part A (6 Days)|Physician Decision|0|||
27751053|NCT02705755|54201614|FG003|Part A (6 Days)|Physician Decision|0|||
27751054|NCT02705755|54201611|FG000|Part A (6 Days)|Withdrawal by Subject|1|||
27751055|NCT02705755|54201612|FG001|Part A (6 Days)|Withdrawal by Subject|0|||
27751056|NCT02705755|54201613|FG002|Part A (6 Days)|Withdrawal by Subject|0|||
27751057|NCT02705755|54201614|FG003|Part A (6 Days)|Withdrawal by Subject|0|||
27751058|NCT02705755|54201611|FG000|Part C (20 Weeks)|Physician Decision|0|||
27751059|NCT02705755|54201612|FG001|Part C (20 Weeks)|Physician Decision|0|||
27751060|NCT02705755|54201613|FG002|Part C (20 Weeks)|Physician Decision|0|||
27751061|NCT02705755|54201614|FG003|Part C (20 Weeks)|Physician Decision|2|||
27751062|NCT02705755|54201611|FG000|Part C (20 Weeks)|Adverse Event|0|||
27751063|NCT02705755|54201612|FG001|Part C (20 Weeks)|Adverse Event|0|||
27751064|NCT02705755|54201613|FG002|Part C (20 Weeks)|Adverse Event|0|||
27751065|NCT02705755|54201614|FG003|Part C (20 Weeks)|Adverse Event|6|||
27751066|NCT02705755|54201611|FG000|Part C (20 Weeks)|Withdrawal by Subject|0|||
27751067|NCT02705755|54201612|FG001|Part C (20 Weeks)|Withdrawal by Subject|0|||
27751068|NCT02705755|54201613|FG002|Part C (20 Weeks)|Withdrawal by Subject|0|||
27751069|NCT02705755|54201614|FG003|Part C (20 Weeks)|Withdrawal by Subject|2|||
27751070|NCT02024932|54201647|FG000|Overall Study|Adverse Event|2|||
27751071|NCT02024932|54201648|FG001|Overall Study|Adverse Event|3|||
27751072|NCT02024932|54201649|FG002|Overall Study|Adverse Event|0|||
27751073|NCT02024932|54201650|FG003|Overall Study|Adverse Event|0|||
27751074|NCT02024932|54201651|FG004|Overall Study|Adverse Event|2|||
27751075|NCT02024932|54201652|FG005|Overall Study|Adverse Event|0|||
27751076|NCT02024932|54201647|FG000|Overall Study|Abnormal laboratory value|0|||
27751077|NCT02024932|54201648|FG001|Overall Study|Abnormal laboratory value|0|||
27751078|NCT02024932|54201649|FG002|Overall Study|Abnormal laboratory value|0|||
27751079|NCT02024932|54201650|FG003|Overall Study|Abnormal laboratory value|2|||
27751080|NCT02024932|54201651|FG004|Overall Study|Abnormal laboratory value|0|||
27751081|NCT02024932|54201652|FG005|Overall Study|Abnormal laboratory value|0|||
27751082|NCT01993888|54201683|FG000|Overall Study|Death|1|||
27751083|NCT01993888|54201684|FG001|Overall Study|Death|1|||
27751084|NCT01993888|54201683|FG000|Overall Study|Lost to Follow-up|1|||
27751085|NCT01993888|54201684|FG001|Overall Study|Lost to Follow-up|1|||
27751086|NCT01993888|54201683|FG000|Overall Study|Withdrawal by Subject|0|||
27751087|NCT01993888|54201684|FG001|Overall Study|Withdrawal by Subject|1|||
27751088|NCT02024698|54201690|FG000|First Intervention (7 Days)|Withdrawal by Subject|0|||
27751089|NCT02024698|54201691|FG001|First Intervention (7 Days)|Withdrawal by Subject|1|||
27751090|NCT02018458|54201697|FG000|Overall Study|Death|4|||
27751091|NCT02017522|54201701|FG000|Overall Study|Withdrawal by Subject|1|||
27751092|NCT02017444|54201708|FG000|Overall Study|Physician Decision|1|||
27751093|NCT02017444|54201709|FG001|Overall Study|Physician Decision|0|||
27751094|NCT02017444|54201708|FG000|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|1|||
27751095|NCT02017444|54201709|FG001|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|0|||
27751096|NCT01993186|54201717|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|1|||
27751097|NCT01993186|54201718|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
27751098|NCT01993186|54201717|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1|||
27751099|NCT01993186|54201718|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
27751100|NCT01993186|54201717|FG000|Open-Label Extension Period|Other, Not Specified|0|||
27751101|NCT01993186|54201718|FG001|Open-Label Extension Period|Other, Not Specified|1|||
27751102|NCT01993186|54201717|FG000|Open-Label Extension Period|Adverse Event|1|||
27751103|NCT01993186|54201718|FG001|Open-Label Extension Period|Adverse Event|0|||
27751104|NCT01993186|54201717|FG000|Open-Label Extension Period|Principal Investigator Decision|1|||
27751105|NCT01993186|54201718|FG001|Open-Label Extension Period|Principal Investigator Decision|0|||
27751106|NCT01993186|54201717|FG000|Open-Label Extension Period|Withdrawal by Subject|4|||
27751107|NCT01993186|54201718|FG001|Open-Label Extension Period|Withdrawal by Subject|5|||
27751108|NCT01993186|54201717|FG000|Open-Label Extension Period|Subject Non-Compliance|1|||
27751109|NCT01993186|54201718|FG001|Open-Label Extension Period|Subject Non-Compliance|0|||
27751110|NCT02016898|54201727|FG000|Overall Study|Death|1|||
27751111|NCT02016898|54201728|FG001|Overall Study|Death|1|||
27751112|NCT02016898|54201727|FG000|Overall Study|Lost to Follow-up|4|||
27751113|NCT02016898|54201728|FG001|Overall Study|Lost to Follow-up|4|||
27751114|NCT01993030|54201736|FG000|Overall Study|Adverse Event|0|||
27751115|NCT01993030|54201737|FG001|Overall Study|Adverse Event|4|||
27751116|NCT01992094|54201746|FG000|Overall Study|ADMINISTRATIVE REASON|6|||
27751117|NCT01992094|54201747|FG001|Overall Study|ADMINISTRATIVE REASON|7|||
27751118|NCT01992094|54201748|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
27751119|NCT01992094|54201746|FG000|Overall Study|Adverse Event|1|||
27751120|NCT01992094|54201747|FG001|Overall Study|Adverse Event|0|||
27751121|NCT01992094|54201748|FG002|Overall Study|Adverse Event|0|||
27751122|NCT01992094|54201746|FG000|Overall Study|Death|5|||
27751123|NCT01992094|54201747|FG001|Overall Study|Death|5|||
27751124|NCT01992094|54201748|FG002|Overall Study|Death|2|||
27751125|NCT01992094|54201746|FG000|Overall Study|Lost to Follow-up|26|||
27751126|NCT01992094|54201747|FG001|Overall Study|Lost to Follow-up|9|||
27751127|NCT01992094|54201748|FG002|Overall Study|Lost to Follow-up|13|||
27751128|NCT01992094|54201746|FG000|Overall Study|OTHER|4|||
27751129|NCT01992094|54201747|FG001|Overall Study|OTHER|0|||
27751130|NCT01992094|54201748|FG002|Overall Study|OTHER|0|||
27751131|NCT01992094|54201746|FG000|Overall Study|Protocol Violation|1|||
27751132|NCT01992094|54201747|FG001|Overall Study|Protocol Violation|0|||
27751133|NCT01992094|54201748|FG002|Overall Study|Protocol Violation|1|||
27751134|NCT01992094|54201746|FG000|Overall Study|Withdrawal by Subject|7|||
27751135|NCT01992094|54201747|FG001|Overall Study|Withdrawal by Subject|3|||
27751136|NCT01992094|54201748|FG002|Overall Study|Withdrawal by Subject|4|||
27751137|NCT02706691|54201772|FG000|Overall Study|Adverse Event|1|||
27751138|NCT01991470|54201777|FG000|Enlite 1 Period|Withdrawal by Subject|18|||
27751139|NCT01991470|54201777|FG000|Enlite 1 Period|Adverse Event|1|||
27751140|NCT01991470|54201777|FG000|Enlite 1 Period|Inclusion/Exclusion not met|1|||
27751141|NCT01991470|54201777|FG000|Enlite 3 Period|Lost to Follow-up|1|||
27751142|NCT01991470|54201777|FG000|Enlite 3 Period|Physician Decision|2|||
27751143|NCT01991470|54201777|FG000|Enlite 3 Period|Physician Decision|8|||
27751144|NCT01991470|54201777|FG000|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1|||
27751145|NCT01991314|54201791|FG000|Overall Study|Adverse Event|5|||
27751146|NCT01991314|54201792|FG001|Overall Study|Adverse Event|1|||
27751147|NCT01991314|54201791|FG000|Overall Study|Lost to Follow-up|6|||
27751148|NCT01991314|54201792|FG001|Overall Study|Lost to Follow-up|10|||
27751149|NCT01990768|54201801|FG000|Intervention Started|Found to be ineligible|14|||
27751150|NCT01990768|54201802|FG001|Intervention Started|Found to be ineligible|13|||
27751151|NCT01990768|54201803|FG002|Intervention Started|Found to be ineligible|11|||
27751152|NCT01990768|54201801|FG000|Intervention Started|Study drug issue or kit malfunction|9|||
27751153|NCT01990768|54201802|FG001|Intervention Started|Study drug issue or kit malfunction|6|||
27751154|NCT01990768|54201803|FG002|Intervention Started|Study drug issue or kit malfunction|7|||
27751155|NCT01990768|54201801|FG000|Intervention Started|Patient became ineligible due to vitals|5|||
27751156|NCT01990768|54201802|FG001|Intervention Started|Patient became ineligible due to vitals|5|||
27751157|NCT01990768|54201803|FG002|Intervention Started|Patient became ineligible due to vitals|2|||
27751158|NCT01990768|54201801|FG000|Intervention Started|Not enough time for EMS to enroll|4|||
27751159|NCT01990768|54201802|FG001|Intervention Started|Not enough time for EMS to enroll|3|||
27751160|NCT01990768|54201803|FG002|Intervention Started|Not enough time for EMS to enroll|0|||
27751161|NCT01990768|54201801|FG000|Intervention Started|Patient care priority|1|||
27751162|NCT01990768|54201802|FG001|Intervention Started|Patient care priority|2|||
27751163|NCT01990768|54201803|FG002|Intervention Started|Patient care priority|3|||
27751164|NCT01990768|54201801|FG000|Intervention Started|IV lost|2|||
27751165|NCT01990768|54201802|FG001|Intervention Started|IV lost|2|||
27751166|NCT01990768|54201803|FG002|Intervention Started|IV lost|2|||
27751167|NCT01990768|54201801|FG000|Intervention Started|Required CPR|1|||
27751168|NCT01990768|54201802|FG001|Intervention Started|Required CPR|1|||
27751169|NCT01990768|54201803|FG002|Intervention Started|Required CPR|0|||
27751170|NCT01990768|54201801|FG000|Intervention Started|Seizure or hx of seizure|0|||
27751171|NCT01990768|54201802|FG001|Intervention Started|Seizure or hx of seizure|0|||
27751172|NCT01990768|54201803|FG002|Intervention Started|Seizure or hx of seizure|2|||
27751173|NCT01990768|54201801|FG000|Intervention Started|Discovered to be pregnant|0|||
27751174|NCT01990768|54201802|FG001|Intervention Started|Discovered to be pregnant|1|||
27751175|NCT01990768|54201803|FG002|Intervention Started|Discovered to be pregnant|0|||
27751176|NCT01990768|54201801|FG000|Prehospital Study Drug Infusion|Protocol non-compliance|4|||
27751177|NCT01990768|54201802|FG001|Prehospital Study Drug Infusion|Protocol non-compliance|11|||
27751178|NCT01990768|54201803|FG002|Prehospital Study Drug Infusion|Protocol non-compliance|10|||
27751179|NCT01990768|54201801|FG000|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
27751180|NCT01990768|54201802|FG001|Prehospital Study Drug Infusion|Seizure or concern for seizure|3|||
27751181|NCT01990768|54201803|FG002|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
27751182|NCT01990768|54201801|FG000|Prehospital Study Drug Infusion|Required CPR|2|||
27751183|NCT01990768|54201802|FG001|Prehospital Study Drug Infusion|Required CPR|6|||
27751184|NCT01990768|54201803|FG002|Prehospital Study Drug Infusion|Required CPR|0|||
27751185|NCT01990768|54201801|FG000|Prehospital Study Drug Infusion|Other safety concern|2|||
27751186|NCT01990768|54201802|FG001|Prehospital Study Drug Infusion|Other safety concern|1|||
27751187|NCT01990768|54201803|FG002|Prehospital Study Drug Infusion|Other safety concern|1|||
27751188|NCT01990768|54201801|FG000|Prehospital Study Drug Infusion|Death|3|||
27751189|NCT01990768|54201802|FG001|Prehospital Study Drug Infusion|Death|1|||
27751190|NCT01990768|54201803|FG002|Prehospital Study Drug Infusion|Death|1|||
27751191|NCT01990768|54201801|FG000|Prehospital Study Drug Infusion|Discharged|2|||
27751192|NCT01990768|54201802|FG001|Prehospital Study Drug Infusion|Discharged|1|||
27751193|NCT01990768|54201803|FG002|Prehospital Study Drug Infusion|Discharged|0|||
27751194|NCT01990768|54201801|FG000|Prehospital Study Drug Infusion|Withdrawal by Subject|1|||
27751195|NCT01990768|54201802|FG001|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
27751196|NCT01990768|54201803|FG002|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
27751197|NCT01990768|54201801|FG000|Prehospital Study Drug Infusion|Emergency unblinding|0|||
27751198|NCT01990768|54201802|FG001|Prehospital Study Drug Infusion|Emergency unblinding|0|||
27751199|NCT01990768|54201803|FG002|Prehospital Study Drug Infusion|Emergency unblinding|1|||
27751200|NCT01990768|54201801|FG000|Prehospital Study Drug Infusion|Unknown if completed|1|||
27751201|NCT01990768|54201802|FG001|Prehospital Study Drug Infusion|Unknown if completed|4|||
27751202|NCT01990768|54201803|FG002|Prehospital Study Drug Infusion|Unknown if completed|2|||
27751203|NCT01990768|54201801|FG000|In-Hospital Study Drug Infusion|Discharged|19|||
27751204|NCT01990768|54201802|FG001|In-Hospital Study Drug Infusion|Discharged|18|||
27751205|NCT01990768|54201803|FG002|In-Hospital Study Drug Infusion|Discharged|13|||
27751206|NCT01990768|54201801|FG000|In-Hospital Study Drug Infusion|Protocol non-compliance|14|||
27751207|NCT01990768|54201802|FG001|In-Hospital Study Drug Infusion|Protocol non-compliance|17|||
27751208|NCT01990768|54201803|FG002|In-Hospital Study Drug Infusion|Protocol non-compliance|10|||
27751209|NCT01990768|54201801|FG000|In-Hospital Study Drug Infusion|Withdrawal by Subject|13|||
27751210|NCT01990768|54201802|FG001|In-Hospital Study Drug Infusion|Withdrawal by Subject|7|||
27751211|NCT01990768|54201803|FG002|In-Hospital Study Drug Infusion|Withdrawal by Subject|12|||
27751212|NCT01990768|54201801|FG000|In-Hospital Study Drug Infusion|Death or comfort care|12|||
27751213|NCT01990768|54201802|FG001|In-Hospital Study Drug Infusion|Death or comfort care|11|||
27751214|NCT01990768|54201803|FG002|In-Hospital Study Drug Infusion|Death or comfort care|6|||
27751215|NCT01990768|54201801|FG000|In-Hospital Study Drug Infusion|Emergency unblinding|11|||
27751216|NCT01990768|54201802|FG001|In-Hospital Study Drug Infusion|Emergency unblinding|4|||
27751217|NCT01990768|54201803|FG002|In-Hospital Study Drug Infusion|Emergency unblinding|7|||
27751218|NCT01990768|54201801|FG000|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8|||
27751219|NCT01990768|54201802|FG001|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9|||
27751220|NCT01990768|54201803|FG002|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17|||
27751221|NCT01990768|54201801|FG000|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
27751222|NCT01990768|54201802|FG001|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
27751223|NCT01990768|54201803|FG002|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4|||
27751224|NCT01990768|54201801|FG000|In-Hospital Study Drug Infusion|Required CPR|3|||
27751225|NCT01990768|54201802|FG001|In-Hospital Study Drug Infusion|Required CPR|7|||
27751226|NCT01990768|54201803|FG002|In-Hospital Study Drug Infusion|Required CPR|1|||
27751227|NCT01990768|54201801|FG000|In-Hospital Study Drug Infusion|Other safety concern|4|||
27751228|NCT01990768|54201802|FG001|In-Hospital Study Drug Infusion|Other safety concern|2|||
27751229|NCT01990768|54201803|FG002|In-Hospital Study Drug Infusion|Other safety concern|3|||
27751230|NCT01990768|54201801|FG000|In-Hospital Study Drug Infusion|Taken into police custody|4|||
27751231|NCT01990768|54201802|FG001|In-Hospital Study Drug Infusion|Taken into police custody|0|||
27751232|NCT01990768|54201803|FG002|In-Hospital Study Drug Infusion|Taken into police custody|3|||
27751233|NCT01990768|54201801|FG000|In-Hospital Study Drug Infusion|Found not to be injured|1|||
27751234|NCT01990768|54201802|FG001|In-Hospital Study Drug Infusion|Found not to be injured|1|||
27751235|NCT01990768|54201803|FG002|In-Hospital Study Drug Infusion|Found not to be injured|1|||
27751236|NCT01990768|54201801|FG000|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
27751237|NCT01990768|54201802|FG001|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
27751238|NCT01990768|54201803|FG002|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0|||
27751239|NCT01990768|54201801|FG000|In-Hospital Study Drug Infusion|Other procoagulant administered|0|||
27751240|NCT01990768|54201802|FG001|In-Hospital Study Drug Infusion|Other procoagulant administered|1|||
27751241|NCT01990768|54201803|FG002|In-Hospital Study Drug Infusion|Other procoagulant administered|2|||
27751242|NCT01990768|54201801|FG000|In-Hospital Study Drug Infusion|Unknown if completed|0|||
27751243|NCT01990768|54201802|FG001|In-Hospital Study Drug Infusion|Unknown if completed|0|||
27751244|NCT01990768|54201803|FG002|In-Hospital Study Drug Infusion|Unknown if completed|1|||
27751245|NCT01990768|54201801|FG000|6-Month Follow-up|Withdrawal by Subject|25|||
27751246|NCT01990768|54201802|FG001|6-Month Follow-up|Withdrawal by Subject|25|||
27751247|NCT01990768|54201803|FG002|6-Month Follow-up|Withdrawal by Subject|26|||
27751248|NCT01990768|54201801|FG000|6-Month Follow-up|Calls unreturned or refused contact|4|||
27751249|NCT01990768|54201802|FG001|6-Month Follow-up|Calls unreturned or refused contact|15|||
27751250|NCT01990768|54201803|FG002|6-Month Follow-up|Calls unreturned or refused contact|20|||
27751251|NCT01990768|54201801|FG000|6-Month Follow-up|No contact information|5|||
27751252|NCT01990768|54201802|FG001|6-Month Follow-up|No contact information|6|||
27751253|NCT01990768|54201803|FG002|6-Month Follow-up|No contact information|5|||
27751254|NCT01990768|54201801|FG000|6-Month Follow-up|Homeless|4|||
27751255|NCT01990768|54201802|FG001|6-Month Follow-up|Homeless|3|||
27751256|NCT01990768|54201803|FG002|6-Month Follow-up|Homeless|6|||
27751257|NCT01990768|54201801|FG000|6-Month Follow-up|Prisoner at time of enrollment|0|||
27751258|NCT01990768|54201802|FG001|6-Month Follow-up|Prisoner at time of enrollment|0|||
27751259|NCT01990768|54201803|FG002|6-Month Follow-up|Prisoner at time of enrollment|1|||
27751260|NCT01990768|54201801|FG000|6-Month Follow-up|Prisoner at time of follow-up|0|||
27751261|NCT01990768|54201802|FG001|6-Month Follow-up|Prisoner at time of follow-up|2|||
27751262|NCT01990768|54201803|FG002|6-Month Follow-up|Prisoner at time of follow-up|0|||
27751263|NCT01990768|54201801|FG000|6-Month Follow-up|Patient at psychiatric hospital|1|||
27751264|NCT01990768|54201802|FG001|6-Month Follow-up|Patient at psychiatric hospital|0|||
27751265|NCT01990768|54201803|FG002|6-Month Follow-up|Patient at psychiatric hospital|0|||
27751266|NCT01990612|54201814|FG000|Overall Study|Lost to Follow-up|2|||
27751267|NCT01990612|54201815|FG001|Overall Study|Lost to Follow-up|1|||
27751268|NCT01990612|54201814|FG000|Overall Study|Withdrawal by Subject|5|||
27751269|NCT01990612|54201815|FG001|Overall Study|Withdrawal by Subject|2|||
27751270|NCT01990534|54201821|FG000|Overall Study|Death|22|||
27751271|NCT01990534|54201821|FG000|Overall Study|Progressive disease|3|||
27751272|NCT01990534|54201821|FG000|Overall Study|Protocol Violation|1|||
27751273|NCT01990534|54201821|FG000|Overall Study|Withdrawal of Informed Consent|2|||
27751274|NCT01990534|54201821|FG000|Overall Study|Symptomatic Deterioration|1|||
27751275|NCT01990534|54201821|FG000|Overall Study|Withdrawal by Subject|3|||
27751276|NCT01990534|54201821|FG000|Overall Study|Reason not Specified|2|||
27751277|NCT01990534|54201821|FG000|Overall Study|Lost to Follow-up|1|||
27751278|NCT01967134|54201828|FG000|Overall Study|Lost to Follow-up|0|||
27751279|NCT01967134|54201829|FG001|Overall Study|Lost to Follow-up|1|||
27751280|NCT01967134|54201830|FG002|Overall Study|Lost to Follow-up|0|||
27751281|NCT01990300|54201838|FG000|Overall Study|Case Report Forms Uncollected|89|||
27751282|NCT01990300|54201838|FG000|Overall Study|Protocol Deviation|53|||
27751283|NCT01966432|54201845|FG000|Overall Study|Lost to Follow-up|3|||
27751284|NCT01966432|54201846|FG001|Overall Study|Lost to Follow-up|2|||
27751285|NCT01966432|54201847|FG002|Overall Study|Lost to Follow-up|5|||
27751286|NCT01966432|54201845|FG000|Overall Study|Withdrawal by Subject|1|||
27751287|NCT01966432|54201846|FG001|Overall Study|Withdrawal by Subject|3|||
27751288|NCT01966432|54201847|FG002|Overall Study|Withdrawal by Subject|0|||
27751289|NCT01966432|54201845|FG000|Overall Study|Subject Incarcerated|0|||
27831202|NCT01793051|54307468|FG001|Overall Study|Adverse Event|2|||
27751290|NCT01966432|54201846|FG001|Overall Study|Subject Incarcerated|0|||
27751291|NCT01966432|54201847|FG002|Overall Study|Subject Incarcerated|1|||
27751292|NCT01966432|54201845|FG000|Overall Study|SBIRT program ended|1|||
27751293|NCT01966432|54201846|FG001|Overall Study|SBIRT program ended|8|||
27751294|NCT01966432|54201847|FG002|Overall Study|SBIRT program ended|20|||
27751295|NCT01966120|54201859|FG000|Overall Study|Withdrawal by Subject|0|||
27751296|NCT01966120|54201860|FG001|Overall Study|Withdrawal by Subject|5|||
27751297|NCT01966120|54201859|FG000|Overall Study|Lost to Follow-up|1|||
27751298|NCT01966120|54201860|FG001|Overall Study|Lost to Follow-up|1|||
27751299|NCT02702401|54201868|FG000|Overall Study|Death|242|||
27751300|NCT02702401|54201869|FG001|Overall Study|Death|125|||
27751301|NCT02702401|54201868|FG000|Overall Study|Withdrawal by Subject|15|||
27751302|NCT02702401|54201869|FG001|Overall Study|Withdrawal by Subject|5|||
27751303|NCT02702401|54201868|FG000|Overall Study|Sponsor Decision|19|||
27751304|NCT02702401|54201869|FG001|Overall Study|Sponsor Decision|3|||
27751305|NCT02702401|54201868|FG000|Overall Study|Physician Decision|1|||
27751306|NCT02702401|54201869|FG001|Overall Study|Physician Decision|2|||
27751307|NCT02702401|54201868|FG000|Overall Study|Lost to Follow-up|1|||
27751308|NCT02702401|54201869|FG001|Overall Study|Lost to Follow-up|0|||
27751309|NCT02703337|54201876|FG000|Period One (Part A)|Withdrawal by Subject|0|||
27751310|NCT02703337|54201877|FG001|Period One (Part A)|Withdrawal by Subject|0|||
27751311|NCT02703337|54201878|FG002|Period One (Part A)|Withdrawal by Subject|0|||
27751312|NCT02703337|54201879|FG003|Period One (Part A)|Withdrawal by Subject|0|||
27751313|NCT02703337|54201880|FG004|Period One (Part A)|Withdrawal by Subject|1|||
27751314|NCT02703337|54201881|FG005|Period One (Part A)|Withdrawal by Subject|0|||
27751315|NCT02703337|54201882|FG006|Period One (Part A)|Withdrawal by Subject|0|||
27751316|NCT02703337|54201883|FG007|Period One (Part A)|Withdrawal by Subject|0|||
27751317|NCT01680497|54201901|FG000|Overall Study|Lost to Follow-up|2|||
27751318|NCT01680341|54201907|FG000|Overall Study|Adverse Event|3|||
27751319|NCT01680341|54201908|FG001|Overall Study|Adverse Event|2|||
27751320|NCT01680341|54201907|FG000|Overall Study|Unclassified|18|||
27751321|NCT01680341|54201908|FG001|Overall Study|Unclassified|15|||
27751322|NCT01679405|54201916|FG000|Overall Study|Death|2|||
27751323|NCT01679405|54201917|FG001|Overall Study|Death|5|||
27751324|NCT01603355|54201923|FG000|Overall Study|Lack of Efficacy|2|||
27751325|NCT02703259|54201929|FG000|24 Hours Postoperative Assessment|Lost to Follow-up|1|||
27751326|NCT02703259|54201930|FG001|24 Hours Postoperative Assessment|Lost to Follow-up|4|||
27751327|NCT02703259|54201929|FG000|24 Hours Postoperative Assessment|excluded from analysis per protocol|1|||
27751328|NCT02703259|54201930|FG001|24 Hours Postoperative Assessment|excluded from analysis per protocol|2|||
27751329|NCT02703259|54201929|FG000|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
27751330|NCT02703259|54201930|FG001|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
27751331|NCT00701701|54201938|FG000|Overall Study|Withdrawal by Subject|0|||
27751332|NCT00701701|54201939|FG001|Overall Study|Withdrawal by Subject|1|||
27751333|NCT00701701|54201938|FG000|Overall Study|Adverse Event|0|||
27751334|NCT00701701|54201939|FG001|Overall Study|Adverse Event|1|||
27751335|NCT01989754|54201948|FG000|Overall Study|Withdrawal by Subject|10|||
27751336|NCT01989754|54201949|FG001|Overall Study|Withdrawal by Subject|14|||
27751337|NCT01989754|54201948|FG000|Overall Study|Lost to Follow-up|28|||
27751338|NCT01989754|54201949|FG001|Overall Study|Lost to Follow-up|20|||
27751339|NCT01989754|54201948|FG000|Overall Study|Closed Site|1|||
27751340|NCT01989754|54201949|FG001|Overall Study|Closed Site|1|||
27751341|NCT01619878|54201955|FG000|6 Week Follow-up Phase|Adverse Event|1|||
27751342|NCT01619878|54201955|FG000|Follow-up at 12 Months of Age|Lost to Follow-up|1|||
27751343|NCT01619878|54201955|FG000|Follow-up at 12 Months of Age|Death|2|||
27751344|NCT02015104|54201961|FG000|Overall Study|Withdrew consent after first dose drug|1|||
27751345|NCT02015104|54201962|FG001|Overall Study|Withdrew consent after first dose drug|0|||
27751346|NCT02015104|54201961|FG000|Overall Study|Withdrew consent prior to treatment|0|||
27751347|NCT02015104|54201962|FG001|Overall Study|Withdrew consent prior to treatment|1|||
27751348|NCT01619800|54201973|FG000|Overall Study|study terminated|2|||
27751349|NCT01619800|54201974|FG001|Overall Study|study terminated|0|||
27751350|NCT01989208|54201982|FG000|200 mg (7 Days)|Protocol Violation|0|||
27751351|NCT01989208|54201983|FG001|200 mg (7 Days)|Protocol Violation|1|||
27751352|NCT01619410|54202003|FG000|Overall Study|Lost to Follow-up|7|||
27751353|NCT01619410|54202004|FG001|Overall Study|Lost to Follow-up|4|||
27751354|NCT01966042|54202010|FG000|Overall Study|Death|2|||
27751355|NCT02014480|54202014|FG000|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
27751356|NCT02014480|54202015|FG001|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
27751357|NCT02014480|54202016|FG002|Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
27751358|NCT02014480|54202017|FG003|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
27751359|NCT02014480|54202018|FG004|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
27751360|NCT02014480|54202019|FG005|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
27751361|NCT02014480|54202014|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
27751362|NCT02014480|54202015|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
27751363|NCT02014480|54202016|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
27751364|NCT02014480|54202017|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
27751365|NCT02014480|54202018|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
27751366|NCT02014480|54202019|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
27751367|NCT02014480|54202014|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
27751368|NCT02014480|54202015|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
27751369|NCT02014480|54202016|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
27751370|NCT02014480|54202017|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
27751371|NCT02014480|54202018|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
27751372|NCT02014480|54202019|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
27751373|NCT02014480|54202014|FG000|Treatment Period 2 (14 Days)|Protocol Violation|1|||
27751374|NCT02014480|54202015|FG001|Treatment Period 2 (14 Days)|Protocol Violation|1|||
27751375|NCT02014480|54202016|FG002|Treatment Period 2 (14 Days)|Protocol Violation|2|||
27751376|NCT02014480|54202017|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
27751377|NCT02014480|54202018|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
27751378|NCT02014480|54202019|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
27751379|NCT02014480|54202014|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
27751380|NCT02014480|54202015|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
27751381|NCT02014480|54202016|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
27751382|NCT02014480|54202017|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
27751383|NCT02014480|54202018|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
27751384|NCT02014480|54202019|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
27751385|NCT02014480|54202014|FG000|Treatment Period 3 (14 Days)|Adverse Event|0|||
27751386|NCT02014480|54202015|FG001|Treatment Period 3 (14 Days)|Adverse Event|0|||
27751387|NCT02014480|54202016|FG002|Treatment Period 3 (14 Days)|Adverse Event|1|||
27751388|NCT02014480|54202017|FG003|Treatment Period 3 (14 Days)|Adverse Event|0|||
27751389|NCT02014480|54202018|FG004|Treatment Period 3 (14 Days)|Adverse Event|0|||
27751390|NCT02014480|54202019|FG005|Treatment Period 3 (14 Days)|Adverse Event|1|||
27751391|NCT02014480|54202014|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
27751392|NCT02014480|54202015|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
27751393|NCT02014480|54202016|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
27751394|NCT02014480|54202017|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
27751395|NCT02014480|54202018|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
27751396|NCT02014480|54202019|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
27751397|NCT01261247|54202027|FG000|Overall Study|Ineligible|2|||
27751398|NCT01677767|54202031|FG000|Overall Study|Adverse Event|1|||
27751399|NCT01677767|54202031|FG000|Overall Study|Death|4|||
27751400|NCT01677767|54202031|FG000|Overall Study|Protocol Violation|4|||
27751401|NCT01677767|54202031|FG000|Overall Study|Withdrawal by Subject|10|||
27751402|NCT01677767|54202031|FG000|Overall Study|Non-compliance by the participants|3|||
27751403|NCT01603277|54202052|FG000|Overall Study|Adverse Event|1|||
27751404|NCT01603277|54202053|FG001|Overall Study|Adverse Event|2|||
27751405|NCT01603277|54202052|FG000|Overall Study|Physician Decision|0|||
27751406|NCT01603277|54202053|FG001|Overall Study|Physician Decision|1|||
27751407|NCT01603277|54202052|FG000|Overall Study|Protocol Violation|6|||
27751408|NCT01603277|54202053|FG001|Overall Study|Protocol Violation|10|||
27751409|NCT01603277|54202052|FG000|Overall Study|Withdrawal by Subject|5|||
27751410|NCT01603277|54202053|FG001|Overall Study|Withdrawal by Subject|4|||
27751411|NCT01603277|54202052|FG000|Overall Study|Non-Compliance|2|||
27751412|NCT01603277|54202053|FG001|Overall Study|Non-Compliance|1|||
27751413|NCT01678313|54202061|FG000|Completed the 3-month Therapy|Lost to Follow-up|3|||
27751414|NCT01678313|54202062|FG001|Completed the 3-month Therapy|Lost to Follow-up|8|||
27751415|NCT01678313|54202061|FG000|Completed the 3-month Therapy|Physician Decision|3|||
27751416|NCT01678313|54202062|FG001|Completed the 3-month Therapy|Physician Decision|4|||
27751417|NCT01678313|54202061|FG000|PSA >4 ng/dL at 3 Months|PSA≦4|8|||
27751418|NCT01678313|54202062|FG001|PSA >4 ng/dL at 3 Months|PSA≦4|9|||
27751419|NCT01678313|54202061|FG000|Prostate Biopsy at 3 Months|Not received prostate biopsy|11|||
27751420|NCT01678313|54202062|FG001|Prostate Biopsy at 3 Months|Not received prostate biopsy|12|||
27751421|NCT01603121|54202068|FG000|Second Intervention, 10 Hours|Adverse Event|1|||
27751422|NCT01603121|54202069|FG001|Second Intervention, 10 Hours|Adverse Event|0|||
27751423|NCT01603043|54202077|FG000|Overall Study|Study Futility|7|||
27751424|NCT01603043|54202078|FG001|Overall Study|Study Futility|3|||
27751425|NCT02014402|54202088|FG000|Overall Study|Adverse Event|1|||
27751426|NCT02014402|54202089|FG001|Overall Study|Adverse Event|0|||
27751427|NCT02014402|54202090|FG002|Overall Study|Adverse Event|0|||
27751428|NCT02014402|54202091|FG003|Overall Study|Adverse Event|0|||
27751429|NCT02014402|54202088|FG000|Overall Study|Withdrawal by Subject|1|||
27751430|NCT02014402|54202089|FG001|Overall Study|Withdrawal by Subject|2|||
27751431|NCT02014402|54202090|FG002|Overall Study|Withdrawal by Subject|2|||
27751432|NCT02014402|54202091|FG003|Overall Study|Withdrawal by Subject|1|||
27751433|NCT02014402|54202088|FG000|Overall Study|Subject did not have transportation|0|||
27751434|NCT02014402|54202089|FG001|Overall Study|Subject did not have transportation|1|||
27751435|NCT02014402|54202090|FG002|Overall Study|Subject did not have transportation|0|||
27751436|NCT02014402|54202091|FG003|Overall Study|Subject did not have transportation|0|||
27751437|NCT02014402|54202088|FG000|Overall Study|Lost to Follow-up|0|||
27751438|NCT02014402|54202089|FG001|Overall Study|Lost to Follow-up|0|||
27751439|NCT02014402|54202090|FG002|Overall Study|Lost to Follow-up|1|||
27751440|NCT02014402|54202091|FG003|Overall Study|Lost to Follow-up|2|||
27751441|NCT01988662|54202110|FG000|Overall Study|Subject/guardian decision|1|||
27751442|NCT01988662|54202111|FG001|Overall Study|Subject/guardian decision|1|||
27751443|NCT01988662|54202110|FG000|Overall Study|Adverse Event|3|||
27751444|NCT01988662|54202111|FG001|Overall Study|Adverse Event|1|||
27751445|NCT02839343|54202120|FG000|Overall Study|Withdrawal by Subject|3|||
27751446|NCT02839343|54202121|FG001|Overall Study|Withdrawal by Subject|1|||
27751447|NCT02839343|54202120|FG000|Overall Study|Disease Progression Prior to Treatment|1|||
27751448|NCT02839343|54202121|FG001|Overall Study|Disease Progression Prior to Treatment|0|||
27751449|NCT02839343|54202120|FG000|Overall Study|Adverse Event|1|||
27751450|NCT02839343|54202121|FG001|Overall Study|Adverse Event|0|||
27751451|NCT01965652|54202150|FG000|Overall Study|Adverse Event|40|||
27751452|NCT01965652|54202151|FG001|Overall Study|Adverse Event|37|||
27751453|NCT01965652|54202150|FG000|Overall Study|Withdrawal by Subject|62|||
27751454|NCT01965652|54202151|FG001|Overall Study|Withdrawal by Subject|69|||
27751455|NCT01965652|54202150|FG000|Overall Study|Lost to Follow-up|53|||
27751456|NCT01965652|54202151|FG001|Overall Study|Lost to Follow-up|40|||
27751457|NCT01965652|54202150|FG000|Overall Study|Protocol Violation|34|||
27751458|NCT01965652|54202151|FG001|Overall Study|Protocol Violation|38|||
27751459|NCT01965652|54202150|FG000|Overall Study|Death|3|||
27751460|NCT01965652|54202151|FG001|Overall Study|Death|4|||
27751461|NCT01965652|54202150|FG000|Overall Study|Other - Miscellaneous|18|||
27751462|NCT01965652|54202151|FG001|Overall Study|Other - Miscellaneous|21|||
27751463|NCT01965652|54202150|FG000|Overall Study|Pregnancy|0|||
27751464|NCT01965652|54202151|FG001|Overall Study|Pregnancy|1|||
27751465|NCT01602965|54202159|FG000|Overall Study|Lost to Follow-up|4|||
27751466|NCT01602965|54202160|FG001|Overall Study|Lost to Follow-up|2|||
27751467|NCT01987960|54202168|FG000|Period 1|Adverse Event|24|||
27751468|NCT01987960|54202169|FG001|Period 1|Adverse Event|0|||
27751469|NCT01987960|54202170|FG002|Period 1|Adverse Event|0|||
27751470|NCT01987960|54202171|FG003|Period 1|Adverse Event|0|||
27751471|NCT01987960|54202168|FG000|Period 1|Lack of Efficacy|4|||
27751472|NCT01987960|54202169|FG001|Period 1|Lack of Efficacy|0|||
27751473|NCT01987960|54202170|FG002|Period 1|Lack of Efficacy|0|||
27751474|NCT01987960|54202171|FG003|Period 1|Lack of Efficacy|0|||
27751475|NCT01987960|54202168|FG000|Period 1|Non-compliance with IMP|6|||
27751476|NCT01987960|54202169|FG001|Period 1|Non-compliance with IMP|0|||
27751477|NCT01987960|54202170|FG002|Period 1|Non-compliance with IMP|0|||
27751478|NCT01987960|54202171|FG003|Period 1|Non-compliance with IMP|0|||
27751479|NCT01987960|54202168|FG000|Period 1|Protocol Violation|12|||
27751480|NCT01987960|54202169|FG001|Period 1|Protocol Violation|0|||
27751481|NCT01987960|54202170|FG002|Period 1|Protocol Violation|0|||
27751482|NCT01987960|54202171|FG003|Period 1|Protocol Violation|0|||
27751483|NCT01987960|54202168|FG000|Period 1|Withdrawal by Subject|21|||
27751484|NCT01987960|54202169|FG001|Period 1|Withdrawal by Subject|0|||
27751485|NCT01987960|54202170|FG002|Period 1|Withdrawal by Subject|0|||
27751486|NCT01987960|54202171|FG003|Period 1|Withdrawal by Subject|0|||
27751487|NCT01987960|54202168|FG000|Period 1|Lost to Follow-up|40|||
27751488|NCT01987960|54202169|FG001|Period 1|Lost to Follow-up|0|||
27751489|NCT01987960|54202170|FG002|Period 1|Lost to Follow-up|0|||
27751490|NCT01987960|54202171|FG003|Period 1|Lost to Follow-up|0|||
27751491|NCT01987960|54202168|FG000|Period 1|administrative or other reason|75|||
27751492|NCT01987960|54202169|FG001|Period 1|administrative or other reason|0|||
27751493|NCT01987960|54202170|FG002|Period 1|administrative or other reason|0|||
27751494|NCT01987960|54202171|FG003|Period 1|administrative or other reason|0|||
27751495|NCT01987960|54202168|FG000|Period 1|Withdrawal of consent before treatment|4|||
27751496|NCT01987960|54202169|FG001|Period 1|Withdrawal of consent before treatment|0|||
27751497|NCT01987960|54202170|FG002|Period 1|Withdrawal of consent before treatment|0|||
27751498|NCT01987960|54202171|FG003|Period 1|Withdrawal of consent before treatment|0|||
27751499|NCT01987960|54202168|FG000|Period 2|Adverse Event|0|||
27751500|NCT01987960|54202169|FG001|Period 2|Adverse Event|0|||
27751501|NCT01987960|54202170|FG002|Period 2|Adverse Event|1|||
27751502|NCT01987960|54202171|FG003|Period 2|Adverse Event|0|||
27751503|NCT01987960|54202168|FG000|Period 2|Withdrawal by Subject|0|||
27751504|NCT01987960|54202169|FG001|Period 2|Withdrawal by Subject|0|||
27751505|NCT01987960|54202170|FG002|Period 2|Withdrawal by Subject|1|||
27751506|NCT01987960|54202171|FG003|Period 2|Withdrawal by Subject|0|||
27751507|NCT01987960|54202168|FG000|Period 2|Administrative or other reason|0|||
27751508|NCT01987960|54202169|FG001|Period 2|Administrative or other reason|5|||
27751509|NCT01987960|54202170|FG002|Period 2|Administrative or other reason|7|||
27751510|NCT01987960|54202171|FG003|Period 2|Administrative or other reason|0|||
27751511|NCT01987960|54202168|FG000|Period 3|Adverse Event|0|||
27751512|NCT01987960|54202169|FG001|Period 3|Adverse Event|0|||
27751513|NCT01987960|54202170|FG002|Period 3|Adverse Event|0|||
27751514|NCT01987960|54202171|FG003|Period 3|Adverse Event|7|||
27751515|NCT01987960|54202168|FG000|Period 3|Non-compliance with IMP|0|||
27751516|NCT01987960|54202169|FG001|Period 3|Non-compliance with IMP|0|||
27751517|NCT01987960|54202170|FG002|Period 3|Non-compliance with IMP|0|||
27751518|NCT01987960|54202171|FG003|Period 3|Non-compliance with IMP|1|||
27751519|NCT01987960|54202168|FG000|Period 3|Protocol Violation|0|||
27751520|NCT01987960|54202169|FG001|Period 3|Protocol Violation|0|||
27751521|NCT01987960|54202170|FG002|Period 3|Protocol Violation|0|||
27751522|NCT01987960|54202171|FG003|Period 3|Protocol Violation|6|||
27751523|NCT01987960|54202168|FG000|Period 3|Withdrawal by Subject|0|||
27751524|NCT01987960|54202169|FG001|Period 3|Withdrawal by Subject|0|||
27751525|NCT01987960|54202170|FG002|Period 3|Withdrawal by Subject|0|||
27751526|NCT01987960|54202171|FG003|Period 3|Withdrawal by Subject|9|||
27751527|NCT01987960|54202168|FG000|Period 3|Lost to Follow-up|0|||
27751528|NCT01987960|54202169|FG001|Period 3|Lost to Follow-up|0|||
27751529|NCT01987960|54202170|FG002|Period 3|Lost to Follow-up|0|||
27751530|NCT01987960|54202171|FG003|Period 3|Lost to Follow-up|5|||
27751531|NCT01987960|54202168|FG000|Period 3|Administrative or other reason|0|||
27751532|NCT01987960|54202169|FG001|Period 3|Administrative or other reason|0|||
27751533|NCT01987960|54202170|FG002|Period 3|Administrative or other reason|0|||
27751534|NCT01987960|54202171|FG003|Period 3|Administrative or other reason|43|||
27751535|NCT02013778|54202181|FG000|Overall Study|Death|4|||
27751536|NCT02013778|54202181|FG000|Overall Study|Withdrawal by Subject|1|||
27751537|NCT02013778|54202181|FG000|Overall Study|Physician Decision|1|||
27751538|NCT02013778|54202181|FG000|Overall Study|Adverse Event|1|||
27751539|NCT02013622|54202185|FG000|Overall Study|Lost to Follow-up|10|||
27751540|NCT02013622|54202185|FG000|Overall Study|Adverse Event|3|||
27751541|NCT02013622|54202185|FG000|Overall Study|Met Withdrawal Criteria|3|||
27751542|NCT02013622|54202185|FG000|Overall Study|Withdrawal by Subject|6|||
27751543|NCT02013622|54202185|FG000|Overall Study|Protocol Deviation|1|||
27751544|NCT02013622|54202185|FG000|Overall Study|Lack of Efficacy|1|||
27751545|NCT01987102|54202191|FG000|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
27751546|NCT01987102|54202192|FG001|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
27751547|NCT01987102|54202191|FG000|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1|||
27751548|NCT01987102|54202192|FG001|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2|||
27751549|NCT01987102|54202191|FG000|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1|||
27751550|NCT01987102|54202192|FG001|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0|||
27751551|NCT01987102|54202191|FG000|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0|||
27751552|NCT01987102|54202192|FG001|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1|||
27751553|NCT01987102|54202191|FG000|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0|||
27751554|NCT01987102|54202192|FG001|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1|||
27751555|NCT01987102|54202191|FG000|2 Courses of HDMTX With MOD Rescue|Adverse Event|0|||
27751556|NCT01987102|54202192|FG001|2 Courses of HDMTX With MOD Rescue|Adverse Event|1|||
27751557|NCT02013544|54202201|FG000|Overall Study|Adverse Event|5|||
27751558|NCT02013544|54202202|FG001|Overall Study|Adverse Event|5|||
27751559|NCT02013544|54202201|FG000|Overall Study|Lost to Follow-up|2|||
27751560|NCT02013544|54202202|FG001|Overall Study|Lost to Follow-up|3|||
27751561|NCT02013544|54202201|FG000|Overall Study|Withdrawal by Subject|2|||
27751562|NCT02013544|54202202|FG001|Overall Study|Withdrawal by Subject|8|||
27751563|NCT02013544|54202201|FG000|Overall Study|Physician Decision|0|||
27751564|NCT02013544|54202202|FG001|Overall Study|Physician Decision|1|||
27751565|NCT02013544|54202201|FG000|Overall Study|Entry criteria not met/non-compliance|2|||
27751566|NCT02013544|54202202|FG001|Overall Study|Entry criteria not met/non-compliance|3|||
27751567|NCT02013388|54202216|FG000|Overall Study|work emergency|1|||
27751568|NCT02013388|54202217|FG001|Overall Study|work emergency|0|||
27751569|NCT02013388|54202218|FG002|Overall Study|work emergency|0|||
27751570|NCT02013388|54202219|FG003|Overall Study|work emergency|0|||
27751571|NCT02013388|54202220|FG004|Overall Study|work emergency|1|||
27751572|NCT02013388|54202221|FG005|Overall Study|work emergency|0|||
27751573|NCT02013388|54202222|FG006|Overall Study|work emergency|0|||
27751574|NCT02013388|54202223|FG007|Overall Study|work emergency|0|||
27751575|NCT02012686|54202247|FG000|Overall Study|muscle contraction|0|||
27751576|NCT02012686|54202248|FG001|Overall Study|muscle contraction|1|||
27751577|NCT02012686|54202247|FG000|Overall Study|electrocardiography monitoring noise|0|||
27751578|NCT02012686|54202248|FG001|Overall Study|electrocardiography monitoring noise|1|||
27751579|NCT02012452|54202256|FG000|Overall Study|Lost to Follow-up|2|||
27751580|NCT02012452|54202257|FG001|Overall Study|Lost to Follow-up|1|||
27751581|NCT02012452|54202256|FG000|Overall Study|Withdrawal by Subject|4|||
27751582|NCT02012452|54202257|FG001|Overall Study|Withdrawal by Subject|0|||
27926893|NCT01218243|54583340|FG001|Overall Study|Lost to Follow-up|3|||
27751583|NCT01676909|54202265|FG000|Overall Study|Withdrawal by Subject|3|||
27751584|NCT01676909|54202266|FG001|Overall Study|Withdrawal by Subject|5|||
27751585|NCT01676909|54202265|FG000|Overall Study|Lost to Follow-up|15|||
27751586|NCT01676909|54202266|FG001|Overall Study|Lost to Follow-up|9|||
27751587|NCT02012296|54202277|FG000|Overall Study|Lack of Efficacy|0|||
27751588|NCT02012296|54202278|FG001|Overall Study|Lack of Efficacy|0|||
27751589|NCT02012296|54202279|FG002|Overall Study|Lack of Efficacy|15|||
27751590|NCT02012296|54202277|FG000|Overall Study|Adverse Event|0|||
27751591|NCT02012296|54202278|FG001|Overall Study|Adverse Event|0|||
27751592|NCT02012296|54202279|FG002|Overall Study|Adverse Event|2|||
27926894|NCT01218243|54583339|FG000|Overall Study|Protocol Violation|5|||
27751593|NCT02012296|54202277|FG000|Overall Study|Early study closure|0|||
27751594|NCT02012296|54202278|FG001|Overall Study|Early study closure|0|||
27751595|NCT02012296|54202279|FG002|Overall Study|Early study closure|5|||
27751596|NCT02012296|54202277|FG000|Overall Study|Protocol Violation|0|||
27751597|NCT02012296|54202278|FG001|Overall Study|Protocol Violation|1|||
27751598|NCT02012296|54202279|FG002|Overall Study|Protocol Violation|0|||
27751599|NCT02012218|54202296|FG000|Overall Study|Withdrawal by Subject|1|||
27751600|NCT02012218|54202297|FG001|Overall Study|Withdrawal by Subject|0|||
27751601|NCT02012218|54202298|FG002|Overall Study|Withdrawal by Subject|1|||
27751602|NCT02012218|54202299|FG003|Overall Study|Withdrawal by Subject|1|||
27751603|NCT02012218|54202300|FG004|Overall Study|Withdrawal by Subject|1|||
27751604|NCT02012218|54202296|FG000|Overall Study|Adverse Event|1|||
27751605|NCT02012218|54202297|FG001|Overall Study|Adverse Event|0|||
27751606|NCT02012218|54202298|FG002|Overall Study|Adverse Event|0|||
27751607|NCT02012218|54202299|FG003|Overall Study|Adverse Event|1|||
27751608|NCT02012218|54202300|FG004|Overall Study|Adverse Event|0|||
27751609|NCT02012218|54202296|FG000|Overall Study|Lost to Follow-up|0|||
27751610|NCT02012218|54202297|FG001|Overall Study|Lost to Follow-up|1|||
27751611|NCT02012218|54202298|FG002|Overall Study|Lost to Follow-up|1|||
27751612|NCT02012218|54202299|FG003|Overall Study|Lost to Follow-up|0|||
27751613|NCT02012218|54202300|FG004|Overall Study|Lost to Follow-up|0|||
27751614|NCT02012218|54202296|FG000|Overall Study|Protocol Specified|1|||
27751615|NCT02012218|54202297|FG001|Overall Study|Protocol Specified|0|||
27751616|NCT02012218|54202298|FG002|Overall Study|Protocol Specified|0|||
27751617|NCT02012218|54202299|FG003|Overall Study|Protocol Specified|0|||
27751618|NCT02012218|54202300|FG004|Overall Study|Protocol Specified|0|||
27751619|NCT02012218|54202296|FG000|Overall Study|Protocol Deviation|1|||
27751620|NCT02012218|54202297|FG001|Overall Study|Protocol Deviation|0|||
27751621|NCT02012218|54202298|FG002|Overall Study|Protocol Deviation|0|||
27751622|NCT02012218|54202299|FG003|Overall Study|Protocol Deviation|0|||
27751623|NCT02012218|54202300|FG004|Overall Study|Protocol Deviation|0|||
27751624|NCT01965262|54202312|FG000|Second Intervention (7 Days)|Discontinued|0|||
27751625|NCT01965262|54202313|FG001|Second Intervention (7 Days)|Discontinued|1|||
27751626|NCT01965262|54202312|FG000|Second Intervention (7 Days)|Poor lens fit|0|||
27751627|NCT01965262|54202313|FG001|Second Intervention (7 Days)|Poor lens fit|9|||
27751628|NCT01965262|54202312|FG000|Second Intervention (7 Days)|Poor visual acuity|1|||
27751629|NCT01965262|54202313|FG001|Second Intervention (7 Days)|Poor visual acuity|0|||
27751630|NCT01677377|54202322|FG000|Overall Study|Protocol Violation|1|||
27751631|NCT01677377|54202323|FG001|Overall Study|Protocol Violation|0|||
27751632|NCT01677377|54202324|FG002|Overall Study|Protocol Violation|0|||
27751633|NCT01677377|54202322|FG000|Overall Study|Lost to Follow-up|0|||
27751634|NCT01677377|54202323|FG001|Overall Study|Lost to Follow-up|1|||
27751635|NCT01677377|54202324|FG002|Overall Study|Lost to Follow-up|1|||
27751636|NCT01677377|54202322|FG000|Overall Study|Withdrawal by Subject|0|||
27751637|NCT01677377|54202323|FG001|Overall Study|Withdrawal by Subject|0|||
27751638|NCT01677377|54202324|FG002|Overall Study|Withdrawal by Subject|3|||
27751639|NCT01677377|54202322|FG000|Overall Study|Lack of Efficacy|0|||
27751640|NCT01677377|54202323|FG001|Overall Study|Lack of Efficacy|0|||
27751641|NCT01677377|54202324|FG002|Overall Study|Lack of Efficacy|1|||
27751642|NCT01677377|54202322|FG000|Overall Study|Pregnancy|0|||
27751643|NCT01677377|54202323|FG001|Overall Study|Pregnancy|0|||
27751644|NCT01677377|54202324|FG002|Overall Study|Pregnancy|1|||
27751645|NCT01964950|54202334|FG000|Overall Study|Protocol Violation|25|||
27751646|NCT01964716|54202343|FG000|Overall Study|Withdrawal by Subject|2|||
27751647|NCT01964716|54202344|FG001|Overall Study|Withdrawal by Subject|3|||
27751648|NCT01964716|54202343|FG000|Overall Study|Lost to Follow-up|1|||
27751649|NCT01964716|54202344|FG001|Overall Study|Lost to Follow-up|2|||
27926895|NCT01218243|54583340|FG001|Overall Study|Protocol Violation|10|||
27926896|NCT00989287|54583348|FG000|Overall Study|Adverse Event|1|||
27926897|NCT00989287|54583349|FG001|Overall Study|Adverse Event|0|||
27926898|NCT00989287|54583348|FG000|Overall Study|Lost to Follow-up|0|||
27926899|NCT00989287|54583349|FG001|Overall Study|Lost to Follow-up|1|||
27926900|NCT01218087|54583370|FG000|Overall Study|Death|2|||
27926901|NCT01218087|54583371|FG001|Overall Study|Death|1|||
27926902|NCT01218087|54583370|FG000|Overall Study|Withdrawal by Subject|5|||
27926903|NCT01218087|54583371|FG001|Overall Study|Withdrawal by Subject|0|||
27751650|NCT01964716|54202343|FG000|Overall Study|No longer met eligibility criteria|1|||
27751651|NCT01964716|54202344|FG001|Overall Study|No longer met eligibility criteria|1|||
27751652|NCT01964716|54202343|FG000|Overall Study|Death|1|||
27751653|NCT01964716|54202344|FG001|Overall Study|Death|0|||
27751654|NCT01964560|54202358|FG000|Overall Study|Adverse Event|23|||
27751655|NCT01964560|54202358|FG000|Overall Study|Lack of Efficacy|46|||
27751656|NCT01964560|54202358|FG000|Overall Study|Protocol deviation|2|||
27751657|NCT01964560|54202358|FG000|Overall Study|Lost to Follow-up|4|||
27751658|NCT01964560|54202358|FG000|Overall Study|Withdrawal by Subject|64|||
27751659|NCT01964560|54202358|FG000|Overall Study|Surgery-hemispherotomy|1|||
27926904|NCT01218087|54583370|FG000|Overall Study|Transferred|8|||
27926905|NCT01218087|54583371|FG001|Overall Study|Transferred|5|||
27751660|NCT01964560|54202358|FG000|Overall Study|Surgery|1|||
27751661|NCT01964560|54202358|FG000|Overall Study|Seizures appeared resolved with epilepsy surgery|1|||
27751662|NCT01964560|54202358|FG000|Overall Study|Patient and Investigator choice|1|||
27751663|NCT01964560|54202358|FG000|Overall Study|Patient was prescribed CBD|1|||
27751664|NCT01964560|54202358|FG000|Overall Study|Participant moved to another country|1|||
27751665|NCT02659943|54202369|FG000|Overall Study|Switched to alternative treatment|1|||
27751666|NCT02659943|54202370|FG001|Overall Study|Switched to alternative treatment|1|||
27751667|NCT02659943|54202371|FG002|Overall Study|Switched to alternative treatment|0|||
27751668|NCT02659943|54202372|FG003|Overall Study|Switched to alternative treatment|2|||
27751669|NCT02659943|54202373|FG004|Overall Study|Switched to alternative treatment|1|||
27751670|NCT02659943|54202374|FG005|Overall Study|Switched to alternative treatment|0|||
27751671|NCT02659943|54202375|FG006|Overall Study|Switched to alternative treatment|1|||
27751672|NCT02659943|54202369|FG000|Overall Study|Disease progression on study|0|||
27751673|NCT02659943|54202370|FG001|Overall Study|Disease progression on study|1|||
27751674|NCT02659943|54202371|FG002|Overall Study|Disease progression on study|1|||
27751675|NCT02659943|54202372|FG003|Overall Study|Disease progression on study|1|||
27751676|NCT02659943|54202373|FG004|Overall Study|Disease progression on study|1|||
27751677|NCT02659943|54202374|FG005|Overall Study|Disease progression on study|4|||
27751678|NCT02659943|54202375|FG006|Overall Study|Disease progression on study|0|||
27751679|NCT02659943|54202369|FG000|Overall Study|Patient's condition per principal investigator|0|||
27751680|NCT02659943|54202370|FG001|Overall Study|Patient's condition per principal investigator|0|||
27751681|NCT02659943|54202371|FG002|Overall Study|Patient's condition per principal investigator|0|||
27751682|NCT02659943|54202372|FG003|Overall Study|Patient's condition per principal investigator|0|||
27751683|NCT02659943|54202373|FG004|Overall Study|Patient's condition per principal investigator|0|||
27751684|NCT02659943|54202374|FG005|Overall Study|Patient's condition per principal investigator|1|||
27751685|NCT02659943|54202375|FG006|Overall Study|Patient's condition per principal investigator|0|||
27751686|NCT02659943|54202369|FG000|Overall Study|Ineligible|0|||
27751687|NCT02659943|54202370|FG001|Overall Study|Ineligible|0|||
27751688|NCT02659943|54202371|FG002|Overall Study|Ineligible|0|||
27751689|NCT02659943|54202372|FG003|Overall Study|Ineligible|0|||
27751690|NCT02659943|54202373|FG004|Overall Study|Ineligible|0|||
27751691|NCT02659943|54202374|FG005|Overall Study|Ineligible|0|||
27751692|NCT02659943|54202375|FG006|Overall Study|Ineligible|1|||
27751693|NCT02659943|54202369|FG000|Overall Study|No longer meets eligibility|0|||
27751694|NCT02659943|54202370|FG001|Overall Study|No longer meets eligibility|0|||
27751695|NCT02659943|54202371|FG002|Overall Study|No longer meets eligibility|0|||
27751696|NCT02659943|54202372|FG003|Overall Study|No longer meets eligibility|0|||
27751697|NCT02659943|54202373|FG004|Overall Study|No longer meets eligibility|0|||
27751698|NCT02659943|54202374|FG005|Overall Study|No longer meets eligibility|0|||
27751699|NCT02659943|54202375|FG006|Overall Study|No longer meets eligibility|1|||
27751700|NCT02659943|54202369|FG000|Overall Study|No treatment, per protocol|0|||
27751701|NCT02659943|54202370|FG001|Overall Study|No treatment, per protocol|0|||
27751702|NCT02659943|54202371|FG002|Overall Study|No treatment, per protocol|0|||
27751703|NCT02659943|54202372|FG003|Overall Study|No treatment, per protocol|0|||
27751704|NCT02659943|54202373|FG004|Overall Study|No treatment, per protocol|0|||
27751705|NCT02659943|54202374|FG005|Overall Study|No treatment, per protocol|0|||
27751706|NCT02659943|54202375|FG006|Overall Study|No treatment, per protocol|3|||
27751707|NCT01677299|54202400|FG000|Overall Study|Adverse Event|0|||
27751708|NCT01677299|54202401|FG001|Overall Study|Adverse Event|2|||
27751709|NCT01677299|54202402|FG002|Overall Study|Adverse Event|1|||
27751710|NCT01677299|54202403|FG003|Overall Study|Adverse Event|0|||
27751711|NCT01677299|54202400|FG000|Overall Study|Withdrawal by Subject|0|||
27751712|NCT01677299|54202401|FG001|Overall Study|Withdrawal by Subject|1|||
27751713|NCT01677299|54202402|FG002|Overall Study|Withdrawal by Subject|0|||
27751714|NCT01677299|54202403|FG003|Overall Study|Withdrawal by Subject|1|||
27751715|NCT01964326|54202417|FG000|Overall Study|Adverse Event|48|||
27751716|NCT01964326|54202417|FG000|Overall Study|Death|2|||
27751717|NCT01964326|54202417|FG000|Overall Study|Protocol Violation|4|||
27751718|NCT01964326|54202417|FG000|Overall Study|Lost to Follow-up|88|||
27751719|NCT01964326|54202417|FG000|Overall Study|Withdrawal by Subject|87|||
27751720|NCT01964326|54202417|FG000|Overall Study|Pregnancy|1|||
27751721|NCT01964326|54202417|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
27751722|NCT01964326|54202417|FG000|Overall Study|Physician Decision|55|||
27751723|NCT01964326|54202417|FG000|Overall Study|Investigator Discretion|1|||
27751724|NCT01964326|54202417|FG000|Overall Study|Other|9|||
27751725|NCT01964326|54202417|FG000|Overall Study|Did not meet eligibility criteria|1|||
27751726|NCT02699749|54202435|FG000|Overall Study|Other|0|||
27751727|NCT02699749|54202436|FG001|Overall Study|Other|0|||
27751728|NCT02699749|54202437|FG002|Overall Study|Other|2|||
27751729|NCT02699749|54202438|FG003|Overall Study|Other|0|||
27751730|NCT02699749|54202439|FG004|Overall Study|Other|0|||
27751731|NCT02699749|54202440|FG005|Overall Study|Other|1|||
27751732|NCT02699749|54202441|FG006|Overall Study|Other|1|||
27751733|NCT02699749|54202442|FG007|Overall Study|Other|0|||
27751734|NCT02699749|54202443|FG008|Overall Study|Other|0|||
27751735|NCT02699749|54202444|FG009|Overall Study|Other|0|||
27751736|NCT02699749|54202445|FG010|Overall Study|Other|1|||
27751737|NCT02699749|54202446|FG011|Overall Study|Other|0|||
27751738|NCT02699749|54202447|FG012|Overall Study|Other|0|||
27751739|NCT02699749|54202448|FG013|Overall Study|Other|0|||
27751740|NCT02699749|54202435|FG000|Overall Study|Progressive Disease|3|||
27751741|NCT02699749|54202436|FG001|Overall Study|Progressive Disease|3|||
27751742|NCT02699749|54202437|FG002|Overall Study|Progressive Disease|14|||
27751743|NCT02699749|54202438|FG003|Overall Study|Progressive Disease|3|||
27751744|NCT02699749|54202439|FG004|Overall Study|Progressive Disease|3|||
27751745|NCT02699749|54202440|FG005|Overall Study|Progressive Disease|7|||
27751746|NCT02699749|54202441|FG006|Overall Study|Progressive Disease|5|||
27751747|NCT02699749|54202442|FG007|Overall Study|Progressive Disease|5|||
27751748|NCT02699749|54202443|FG008|Overall Study|Progressive Disease|6|||
27751749|NCT02699749|54202444|FG009|Overall Study|Progressive Disease|6|||
27751750|NCT02699749|54202445|FG010|Overall Study|Progressive Disease|5|||
27751751|NCT02699749|54202446|FG011|Overall Study|Progressive Disease|4|||
27751752|NCT02699749|54202447|FG012|Overall Study|Progressive Disease|3|||
27751753|NCT02699749|54202448|FG013|Overall Study|Progressive Disease|5|||
27751754|NCT02699749|54202435|FG000|Overall Study|Death|0|||
27751755|NCT02699749|54202436|FG001|Overall Study|Death|0|||
27751756|NCT02699749|54202437|FG002|Overall Study|Death|0|||
27751757|NCT02699749|54202438|FG003|Overall Study|Death|0|||
27751758|NCT02699749|54202439|FG004|Overall Study|Death|0|||
27751759|NCT02699749|54202440|FG005|Overall Study|Death|0|||
27751760|NCT02699749|54202441|FG006|Overall Study|Death|0|||
27751761|NCT02699749|54202442|FG007|Overall Study|Death|0|||
27751762|NCT02699749|54202443|FG008|Overall Study|Death|0|||
27751763|NCT02699749|54202444|FG009|Overall Study|Death|0|||
27751764|NCT02699749|54202445|FG010|Overall Study|Death|0|||
27751765|NCT02699749|54202446|FG011|Overall Study|Death|0|||
27751766|NCT02699749|54202447|FG012|Overall Study|Death|0|||
27751767|NCT02699749|54202448|FG013|Overall Study|Death|1|||
27751768|NCT02699749|54202435|FG000|Overall Study|Lost to Follow-up|0|||
27751769|NCT02699749|54202436|FG001|Overall Study|Lost to Follow-up|0|||
27751770|NCT02699749|54202437|FG002|Overall Study|Lost to Follow-up|0|||
27751771|NCT02699749|54202438|FG003|Overall Study|Lost to Follow-up|0|||
27751772|NCT02699749|54202439|FG004|Overall Study|Lost to Follow-up|0|||
27751773|NCT02699749|54202440|FG005|Overall Study|Lost to Follow-up|1|||
27751774|NCT02699749|54202441|FG006|Overall Study|Lost to Follow-up|0|||
27751775|NCT02699749|54202442|FG007|Overall Study|Lost to Follow-up|1|||
27751776|NCT02699749|54202443|FG008|Overall Study|Lost to Follow-up|0|||
27751777|NCT02699749|54202444|FG009|Overall Study|Lost to Follow-up|0|||
27751778|NCT02699749|54202445|FG010|Overall Study|Lost to Follow-up|0|||
27751779|NCT02699749|54202446|FG011|Overall Study|Lost to Follow-up|0|||
27751780|NCT02699749|54202447|FG012|Overall Study|Lost to Follow-up|0|||
27751781|NCT02699749|54202448|FG013|Overall Study|Lost to Follow-up|0|||
27751782|NCT02699593|54202478|FG000|Period 1|Unsatisfactory Visual Response|0|||
27751783|NCT02699593|54202479|FG001|Period 1|Unsatisfactory Visual Response|1|||
27751784|NCT02699593|54202478|FG000|Period 1|Torn Contact Len|4|||
27751785|NCT02699593|54202479|FG001|Period 1|Torn Contact Len|3|||
27751786|NCT02699593|54202478|FG000|Period 1|Protocol Violation|0|||
27751787|NCT02699593|54202479|FG001|Period 1|Protocol Violation|1|||
27751788|NCT02699593|54202478|FG000|Period 1|Withdrawal by Subject|0|||
27751789|NCT02699593|54202479|FG001|Period 1|Withdrawal by Subject|1|||
27751790|NCT02699593|54202478|FG000|Period 1|Adverse Event|1|||
27751791|NCT02699593|54202479|FG001|Period 1|Adverse Event|1|||
27751792|NCT02699593|54202478|FG000|Period 2|Adverse Event|1|||
27751793|NCT02699593|54202479|FG001|Period 2|Adverse Event|1|||
27751794|NCT02699593|54202478|FG000|Period 2|Lost Contact Lens|0|||
27751795|NCT02699593|54202479|FG001|Period 2|Lost Contact Lens|1|||
27751796|NCT02699593|54202478|FG000|Period 2|Torn Contact Lens|1|||
27751797|NCT02699593|54202479|FG001|Period 2|Torn Contact Lens|0|||
27751798|NCT00708097|54202485|FG000|Period 1|Protocol Violation|0|||
27751799|NCT00708097|54202486|FG001|Period 1|Protocol Violation|1|||
27751800|NCT00708097|54202487|FG002|Period 1|Protocol Violation|0|||
27751801|NCT00708097|54202488|FG003|Period 1|Protocol Violation|2|||
27751802|NCT00708097|54202489|FG004|Period 1|Protocol Violation|0|||
27751803|NCT00708097|54202485|FG000|Period 1|Other Reason|0|||
27751804|NCT00708097|54202486|FG001|Period 1|Other Reason|0|||
27751805|NCT00708097|54202487|FG002|Period 1|Other Reason|0|||
27751806|NCT00708097|54202488|FG003|Period 1|Other Reason|0|||
27751807|NCT00708097|54202489|FG004|Period 1|Other Reason|1|||
27751808|NCT00708097|54202485|FG000|Period 2|Protocol Violation|0|||
27751809|NCT00708097|54202486|FG001|Period 2|Protocol Violation|1|||
27751810|NCT00708097|54202487|FG002|Period 2|Protocol Violation|1|||
27751811|NCT00708097|54202488|FG003|Period 2|Protocol Violation|1|||
27751812|NCT00708097|54202489|FG004|Period 2|Protocol Violation|0|||
27751813|NCT02659631|54202516|FG000|Overall Study|Lost to Follow-up|0|||
27751814|NCT02659631|54202517|FG001|Overall Study|Lost to Follow-up|0|||
27751815|NCT02659631|54202518|FG002|Overall Study|Lost to Follow-up|2|||
27751816|NCT02659631|54202519|FG003|Overall Study|Lost to Follow-up|0|||
27751817|NCT02659631|54202520|FG004|Overall Study|Lost to Follow-up|0|||
27751818|NCT02659631|54202521|FG005|Overall Study|Lost to Follow-up|1|||
27751819|NCT02659631|54202522|FG006|Overall Study|Lost to Follow-up|0|||
27751820|NCT02659631|54202523|FG007|Overall Study|Lost to Follow-up|0|||
27751821|NCT02659631|54202524|FG008|Overall Study|Lost to Follow-up|0|||
27751822|NCT02659631|54202525|FG009|Overall Study|Lost to Follow-up|0|||
27751823|NCT02659631|54202516|FG000|Overall Study|Withdrawal prior to treatment|0|||
27751824|NCT02659631|54202517|FG001|Overall Study|Withdrawal prior to treatment|0|||
27751825|NCT02659631|54202518|FG002|Overall Study|Withdrawal prior to treatment|0|||
27751826|NCT02659631|54202519|FG003|Overall Study|Withdrawal prior to treatment|0|||
27751827|NCT02659631|54202520|FG004|Overall Study|Withdrawal prior to treatment|1|||
27751828|NCT02659631|54202521|FG005|Overall Study|Withdrawal prior to treatment|0|||
27751829|NCT02659631|54202522|FG006|Overall Study|Withdrawal prior to treatment|0|||
27751830|NCT02659631|54202523|FG007|Overall Study|Withdrawal prior to treatment|0|||
27751831|NCT02659631|54202524|FG008|Overall Study|Withdrawal prior to treatment|0|||
27751832|NCT02659631|54202525|FG009|Overall Study|Withdrawal prior to treatment|0|||
27751833|NCT02659631|54202516|FG000|Overall Study|Participant refused further follow-up|0|||
27751834|NCT02659631|54202517|FG001|Overall Study|Participant refused further follow-up|0|||
27751835|NCT02659631|54202518|FG002|Overall Study|Participant refused further follow-up|0|||
27751836|NCT02659631|54202519|FG003|Overall Study|Participant refused further follow-up|1|||
27751837|NCT02659631|54202520|FG004|Overall Study|Participant refused further follow-up|0|||
27751838|NCT02659631|54202521|FG005|Overall Study|Participant refused further follow-up|0|||
27751839|NCT02659631|54202522|FG006|Overall Study|Participant refused further follow-up|0|||
27751840|NCT02659631|54202523|FG007|Overall Study|Participant refused further follow-up|0|||
27751841|NCT02659631|54202524|FG008|Overall Study|Participant refused further follow-up|1|||
27751842|NCT02659631|54202525|FG009|Overall Study|Participant refused further follow-up|0|||
27751843|NCT02659631|54202516|FG000|Overall Study|Death (follow-up phase)|1|||
27751844|NCT02659631|54202517|FG001|Overall Study|Death (follow-up phase)|2|||
27751845|NCT02659631|54202518|FG002|Overall Study|Death (follow-up phase)|1|||
27751846|NCT02659631|54202519|FG003|Overall Study|Death (follow-up phase)|1|||
27751847|NCT02659631|54202520|FG004|Overall Study|Death (follow-up phase)|3|||
27751848|NCT02659631|54202521|FG005|Overall Study|Death (follow-up phase)|2|||
27751849|NCT02659631|54202522|FG006|Overall Study|Death (follow-up phase)|0|||
27751850|NCT02659631|54202523|FG007|Overall Study|Death (follow-up phase)|3|||
27751851|NCT02659631|54202524|FG008|Overall Study|Death (follow-up phase)|1|||
27751852|NCT02659631|54202525|FG009|Overall Study|Death (follow-up phase)|0|||
27751853|NCT02659631|54202516|FG000|Overall Study|Death (treatment phase)|0|||
27751854|NCT02659631|54202517|FG001|Overall Study|Death (treatment phase)|0|||
27751855|NCT02659631|54202518|FG002|Overall Study|Death (treatment phase)|0|||
27751856|NCT02659631|54202519|FG003|Overall Study|Death (treatment phase)|0|||
27751857|NCT02659631|54202520|FG004|Overall Study|Death (treatment phase)|1|||
27751858|NCT02659631|54202521|FG005|Overall Study|Death (treatment phase)|0|||
27751859|NCT02659631|54202522|FG006|Overall Study|Death (treatment phase)|1|||
27751860|NCT02659631|54202523|FG007|Overall Study|Death (treatment phase)|0|||
27751861|NCT02659631|54202524|FG008|Overall Study|Death (treatment phase)|0|||
27751862|NCT02659631|54202525|FG009|Overall Study|Death (treatment phase)|0|||
27751863|NCT02699125|54202549|FG000|Placebo|Lost to Follow-up|2|||
27751864|NCT02699125|54202550|FG001|Placebo|Lost to Follow-up|0|||
27751865|NCT02699125|54202549|FG000|Placebo|Protocol Violation|1|||
27751866|NCT02699125|54202550|FG001|Placebo|Protocol Violation|0|||
27751867|NCT02699125|54202549|FG000|Placebo|Withdrawal by Subject|0|||
27751868|NCT02699125|54202550|FG001|Placebo|Withdrawal by Subject|4|||
27751869|NCT02699125|54202549|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|7|||
27751870|NCT02699125|54202550|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
27751871|NCT02698891|54202560|FG000|Overall Study|Withdrawal by Subject|2|||
27751872|NCT02698891|54202560|FG000|Overall Study|deemed ineligible|1|||
27751873|NCT02698891|54202560|FG000|Overall Study|Adverse Event|9|||
27751874|NCT02698423|54202566|FG000|Overall Study|Lost to Follow-up|19|||
27751875|NCT02698423|54202567|FG001|Overall Study|Lost to Follow-up|24|||
27751876|NCT02700997|54202575|FG000|Overall Study|Did not undergo CT imaging|1|||
27751877|NCT02700997|54202575|FG000|Overall Study|No CT measurement - pelvic calcification|1|||
27751878|NCT02658149|54202581|FG000|Overall Study|Physician Decision|1|||
27751879|NCT02658149|54202582|FG001|Overall Study|Physician Decision|0|||
27751880|NCT02698189|54202590|FG000|Overall Study|Physician Decision|3|||
27751881|NCT02698189|54202591|FG001|Overall Study|Physician Decision|0|||
27751882|NCT02698189|54202590|FG000|Overall Study|Progressive disease|0|||
27751883|NCT02698189|54202591|FG001|Overall Study|Progressive disease|5|||
27751884|NCT02698189|54202590|FG000|Overall Study|Study terminated by sponsor|0|||
27751885|NCT02698189|54202591|FG001|Overall Study|Study terminated by sponsor|1|||
27751886|NCT02702011|54202603|FG000|Overall Study|Withdrawal by Subject|0|||
27926906|NCT01218009|54583379|FG000|Overall Study|Protocol Violation|2|||
27751887|NCT02702011|54202604|FG001|Overall Study|Withdrawal by Subject|1|||
27751888|NCT02702011|54202605|FG002|Overall Study|Withdrawal by Subject|0|||
27751889|NCT02702011|54202606|FG003|Overall Study|Withdrawal by Subject|0|||
27751890|NCT02657369|54202616|FG000|Overall Study|Death|27|||
27751891|NCT02657369|54202616|FG000|Overall Study|Study terminated by sponsor|7|||
27751892|NCT02701777|54202624|FG000|Overall Study|Some subjects did not like the stimulation.|4|||
27751893|NCT02701777|54202625|FG001|Overall Study|Some subjects did not like the stimulation.|0|||
27751894|NCT02701777|54202626|FG002|Overall Study|Some subjects did not like the stimulation.|0|||
27751895|NCT02701777|54202627|FG003|Overall Study|Some subjects did not like the stimulation.|2|||
27751896|NCT02701777|54202624|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
27751897|NCT02701777|54202625|FG001|Overall Study|Some subjects were unable to commit to the training study.|3|||
27751898|NCT02701777|54202626|FG002|Overall Study|Some subjects were unable to commit to the training study.|4|||
27751899|NCT02701777|54202627|FG003|Overall Study|Some subjects were unable to commit to the training study.|0|||
27751900|NCT01675661|54202643|FG000|Overall Study|Lost to Follow-up|22|||
27751901|NCT01675661|54202644|FG001|Overall Study|Lost to Follow-up|23|||
27751902|NCT01675661|54202643|FG000|Overall Study|Practical problems|9|||
27751903|NCT01675661|54202644|FG001|Overall Study|Practical problems|5|||
27751904|NCT01675661|54202643|FG000|Overall Study|Moved away|5|||
27751905|NCT01675661|54202644|FG001|Overall Study|Moved away|6|||
27751906|NCT01675661|54202643|FG000|Overall Study|Withdrawal by Subject|3|||
27751907|NCT01675661|54202644|FG001|Overall Study|Withdrawal by Subject|7|||
27751908|NCT01675661|54202643|FG000|Overall Study|Physician Decision|0|||
27751909|NCT01675661|54202644|FG001|Overall Study|Physician Decision|2|||
27751910|NCT01675661|54202643|FG000|Overall Study|Death|0|||
27751911|NCT01675661|54202644|FG001|Overall Study|Death|1|||
27751912|NCT01675661|54202643|FG000|Overall Study|Other reason|1|||
27751913|NCT01675661|54202644|FG001|Overall Study|Other reason|2|||
27751914|NCT01602341|54202652|FG000|Overall Study|Adverse Event|0|||
27751915|NCT01602341|54202653|FG001|Overall Study|Adverse Event|1|||
27751916|NCT02700919|54202666|FG000|Overall Study|Physician Decision|1|||
27751917|NCT02700919|54202667|FG001|Overall Study|Physician Decision|0|||
27751918|NCT02700919|54202668|FG002|Overall Study|Physician Decision|0|||
27751919|NCT02700919|54202666|FG000|Overall Study|Protocol Violation|1|||
27751920|NCT02700919|54202667|FG001|Overall Study|Protocol Violation|0|||
27751921|NCT02700919|54202668|FG002|Overall Study|Protocol Violation|0|||
27751922|NCT02700919|54202666|FG000|Overall Study|Adverse Event|1|||
27751923|NCT02700919|54202667|FG001|Overall Study|Adverse Event|3|||
27751924|NCT02700919|54202668|FG002|Overall Study|Adverse Event|1|||
27751925|NCT02700919|54202666|FG000|Overall Study|Withdrawal by Subject|5|||
27751926|NCT02700919|54202667|FG001|Overall Study|Withdrawal by Subject|8|||
27751927|NCT02700919|54202668|FG002|Overall Study|Withdrawal by Subject|2|||
27751928|NCT02700919|54202666|FG000|Overall Study|Lost to Follow-up|2|||
27751929|NCT02700919|54202667|FG001|Overall Study|Lost to Follow-up|0|||
27751930|NCT02700919|54202668|FG002|Overall Study|Lost to Follow-up|0|||
27751931|NCT02700919|54202666|FG000|Overall Study|Other|2|||
27751932|NCT02700919|54202667|FG001|Overall Study|Other|1|||
27751933|NCT02700919|54202668|FG002|Overall Study|Other|1|||
27751934|NCT01986010|54202693|FG000|Overall Study|Adverse Event|0|||
27751935|NCT01986010|54202694|FG001|Overall Study|Adverse Event|1|||
27751936|NCT01986010|54202695|FG002|Overall Study|Adverse Event|0|||
27751937|NCT01986010|54202696|FG003|Overall Study|Adverse Event|0|||
27751938|NCT01986010|54202697|FG004|Overall Study|Adverse Event|0|||
27751939|NCT01986010|54202698|FG005|Overall Study|Adverse Event|0|||
27751940|NCT01986010|54202699|FG006|Overall Study|Adverse Event|0|||
27751941|NCT01986010|54202700|FG007|Overall Study|Adverse Event|0|||
27751942|NCT01986010|54202701|FG008|Overall Study|Adverse Event|0|||
27751943|NCT01986010|54202702|FG009|Overall Study|Adverse Event|0|||
27751944|NCT01986010|54202703|FG010|Overall Study|Adverse Event|0|||
27751945|NCT01986010|54202704|FG011|Overall Study|Adverse Event|0|||
27751946|NCT01986010|54202705|FG012|Overall Study|Adverse Event|0|||
27751947|NCT01986010|54202706|FG013|Overall Study|Adverse Event|0|||
27751948|NCT01986010|54202707|FG014|Overall Study|Adverse Event|0|||
27751949|NCT01986010|54202708|FG015|Overall Study|Adverse Event|1|||
27751950|NCT01986010|54202709|FG016|Overall Study|Adverse Event|0|||
27751951|NCT01986010|54202693|FG000|Overall Study|Lost to Follow-up|2|||
27751952|NCT01986010|54202694|FG001|Overall Study|Lost to Follow-up|1|||
27751953|NCT01986010|54202695|FG002|Overall Study|Lost to Follow-up|2|||
27751954|NCT01986010|54202696|FG003|Overall Study|Lost to Follow-up|2|||
27751955|NCT01986010|54202697|FG004|Overall Study|Lost to Follow-up|2|||
27751956|NCT01986010|54202698|FG005|Overall Study|Lost to Follow-up|2|||
27751957|NCT01986010|54202699|FG006|Overall Study|Lost to Follow-up|0|||
27751958|NCT01986010|54202700|FG007|Overall Study|Lost to Follow-up|0|||
27751959|NCT01986010|54202701|FG008|Overall Study|Lost to Follow-up|4|||
27751960|NCT01986010|54202702|FG009|Overall Study|Lost to Follow-up|2|||
27751961|NCT01986010|54202703|FG010|Overall Study|Lost to Follow-up|0|||
27751962|NCT01986010|54202704|FG011|Overall Study|Lost to Follow-up|1|||
27751963|NCT01986010|54202705|FG012|Overall Study|Lost to Follow-up|1|||
27751964|NCT01986010|54202706|FG013|Overall Study|Lost to Follow-up|1|||
27751965|NCT01986010|54202707|FG014|Overall Study|Lost to Follow-up|2|||
27751966|NCT01986010|54202708|FG015|Overall Study|Lost to Follow-up|0|||
27751967|NCT01986010|54202709|FG016|Overall Study|Lost to Follow-up|0|||
27751968|NCT01986010|54202693|FG000|Overall Study|Physician Decision|0|||
27751969|NCT01986010|54202694|FG001|Overall Study|Physician Decision|0|||
27751970|NCT01986010|54202695|FG002|Overall Study|Physician Decision|0|||
27751971|NCT01986010|54202696|FG003|Overall Study|Physician Decision|0|||
27751972|NCT01986010|54202697|FG004|Overall Study|Physician Decision|0|||
27751973|NCT01986010|54202698|FG005|Overall Study|Physician Decision|0|||
27751974|NCT01986010|54202699|FG006|Overall Study|Physician Decision|0|||
27751975|NCT01986010|54202700|FG007|Overall Study|Physician Decision|0|||
27751976|NCT01986010|54202701|FG008|Overall Study|Physician Decision|0|||
27751977|NCT01986010|54202702|FG009|Overall Study|Physician Decision|0|||
27751978|NCT01986010|54202703|FG010|Overall Study|Physician Decision|0|||
27751979|NCT01986010|54202704|FG011|Overall Study|Physician Decision|0|||
27751980|NCT01986010|54202705|FG012|Overall Study|Physician Decision|0|||
27751981|NCT01986010|54202706|FG013|Overall Study|Physician Decision|0|||
27751982|NCT01986010|54202707|FG014|Overall Study|Physician Decision|1|||
27751983|NCT01986010|54202708|FG015|Overall Study|Physician Decision|0|||
27751984|NCT01986010|54202709|FG016|Overall Study|Physician Decision|0|||
27751985|NCT01986010|54202693|FG000|Overall Study|Withdrawal by Subject|2|||
27751986|NCT01986010|54202694|FG001|Overall Study|Withdrawal by Subject|2|||
27751987|NCT01986010|54202695|FG002|Overall Study|Withdrawal by Subject|3|||
27751988|NCT01986010|54202696|FG003|Overall Study|Withdrawal by Subject|0|||
27751989|NCT01986010|54202697|FG004|Overall Study|Withdrawal by Subject|2|||
27751990|NCT01986010|54202698|FG005|Overall Study|Withdrawal by Subject|4|||
27751991|NCT01986010|54202699|FG006|Overall Study|Withdrawal by Subject|0|||
27751992|NCT01986010|54202700|FG007|Overall Study|Withdrawal by Subject|0|||
27751993|NCT01986010|54202701|FG008|Overall Study|Withdrawal by Subject|0|||
27751994|NCT01986010|54202702|FG009|Overall Study|Withdrawal by Subject|0|||
27751995|NCT01986010|54202703|FG010|Overall Study|Withdrawal by Subject|0|||
27751996|NCT01986010|54202704|FG011|Overall Study|Withdrawal by Subject|2|||
27751997|NCT01986010|54202705|FG012|Overall Study|Withdrawal by Subject|0|||
27751998|NCT01986010|54202706|FG013|Overall Study|Withdrawal by Subject|1|||
27751999|NCT01986010|54202707|FG014|Overall Study|Withdrawal by Subject|2|||
27752000|NCT01986010|54202708|FG015|Overall Study|Withdrawal by Subject|0|||
27752001|NCT01986010|54202709|FG016|Overall Study|Withdrawal by Subject|0|||
27752002|NCT01986010|54202693|FG000|Overall Study|Status Not Recorded|2|||
27752003|NCT01986010|54202694|FG001|Overall Study|Status Not Recorded|4|||
27752004|NCT01986010|54202695|FG002|Overall Study|Status Not Recorded|2|||
27752005|NCT01986010|54202696|FG003|Overall Study|Status Not Recorded|0|||
27752006|NCT01986010|54202697|FG004|Overall Study|Status Not Recorded|1|||
27752007|NCT01986010|54202698|FG005|Overall Study|Status Not Recorded|2|||
27752008|NCT01986010|54202699|FG006|Overall Study|Status Not Recorded|0|||
27752009|NCT01986010|54202700|FG007|Overall Study|Status Not Recorded|0|||
27752010|NCT01986010|54202701|FG008|Overall Study|Status Not Recorded|2|||
27752011|NCT01986010|54202702|FG009|Overall Study|Status Not Recorded|1|||
27752012|NCT01986010|54202703|FG010|Overall Study|Status Not Recorded|7|||
27752013|NCT01986010|54202704|FG011|Overall Study|Status Not Recorded|7|||
27752014|NCT01986010|54202705|FG012|Overall Study|Status Not Recorded|9|||
27752015|NCT01986010|54202706|FG013|Overall Study|Status Not Recorded|9|||
27752016|NCT01986010|54202707|FG014|Overall Study|Status Not Recorded|5|||
27752017|NCT01986010|54202708|FG015|Overall Study|Status Not Recorded|10|||
27752018|NCT01986010|54202709|FG016|Overall Study|Status Not Recorded|4|||
27752019|NCT01963780|54202755|FG000|Overall Study|Death|7|||
27752020|NCT02009878|54202762|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
27752021|NCT02009878|54202763|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
27752022|NCT02009878|54202764|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
27752023|NCT02009722|54202774|FG000|Overall Study|Protocol Violation|1|||
27752024|NCT02009722|54202775|FG001|Overall Study|Protocol Violation|2|||
27752025|NCT02009722|54202774|FG000|Overall Study|Did not receive intervention|0|||
27752026|NCT02009722|54202775|FG001|Overall Study|Did not receive intervention|1|||
27752027|NCT02655419|54202783|FG000|Overall Study|Enrolled but not treated|1|||
27752028|NCT02655419|54202784|FG001|Overall Study|Enrolled but not treated|5|||
27752029|NCT02655419|54202783|FG000|Overall Study|Withdrawal by Subject|4|||
27752030|NCT02655419|54202784|FG001|Overall Study|Withdrawal by Subject|1|||
27752031|NCT02655419|54202783|FG000|Overall Study|Other|0|||
27752032|NCT02655419|54202784|FG001|Overall Study|Other|1|||
27752033|NCT01962922|54202796|FG000|PK Portion Day 7|Withdrawal by Subject|3|||
27752034|NCT01962922|54202797|FG001|PK Portion Day 7|Withdrawal by Subject|0|||
27752035|NCT01962922|54202796|FG000|PK Portion Day 7|non-compliance|1|||
27752036|NCT01962922|54202797|FG001|PK Portion Day 7|non-compliance|0|||
27752037|NCT01962922|54202796|FG000|Extendion Portion (up to Month 6)|no longer wished to participate in study|4|||
27752038|NCT01962922|54202797|FG001|Extendion Portion (up to Month 6)|no longer wished to participate in study|3|||
27752039|NCT01962922|54202796|FG000|Extendion Portion (up to Month 6)|Physician Decision|1|||
27752040|NCT01962922|54202797|FG001|Extendion Portion (up to Month 6)|Physician Decision|0|||
27752041|NCT01984684|54202805|FG000|Overall Study|Lost to Follow-up|25|||
27752042|NCT01984684|54202806|FG001|Overall Study|Lost to Follow-up|24|||
27752043|NCT01984684|54202805|FG000|Overall Study|Adverse Event|8|||
27752044|NCT01984684|54202806|FG001|Overall Study|Adverse Event|12|||
27752045|NCT01984684|54202805|FG000|Overall Study|Withdrawal by Subject|9|||
27752046|NCT01984684|54202806|FG001|Overall Study|Withdrawal by Subject|9|||
27752047|NCT01984684|54202805|FG000|Overall Study|Lack of Efficacy|3|||
27752048|NCT01984684|54202806|FG001|Overall Study|Lack of Efficacy|6|||
27752049|NCT01984684|54202805|FG000|Overall Study|Physician Decision|4|||
27752050|NCT01984684|54202806|FG001|Overall Study|Physician Decision|2|||
27752051|NCT01984684|54202805|FG000|Overall Study|Protocol Violation|4|||
27752052|NCT01984684|54202806|FG001|Overall Study|Protocol Violation|2|||
27752053|NCT01984684|54202805|FG000|Overall Study|Death|0|||
27752054|NCT01984684|54202806|FG001|Overall Study|Death|1|||
27752055|NCT01984684|54202805|FG000|Overall Study|Noncompliance with study drug|2|||
27752056|NCT01984684|54202806|FG001|Overall Study|Noncompliance with study drug|1|||
27752057|NCT01984684|54202805|FG000|Overall Study|Subject incarcerated|1|||
27752058|NCT01984684|54202806|FG001|Overall Study|Subject incarcerated|0|||
27752059|NCT01984684|54202805|FG000|Overall Study|Study drug not available at site|1|||
27752060|NCT01984684|54202806|FG001|Overall Study|Study drug not available at site|1|||
27752061|NCT01984684|54202805|FG000|Overall Study|Subject had inadequate IV access|0|||
27752062|NCT01984684|54202806|FG001|Overall Study|Subject had inadequate IV access|1|||
27752063|NCT02694523|54202814|FG000|Part A|Adverse Event|7|||
27752064|NCT02694523|54202815|FG001|Part A|Adverse Event|3|||
27752065|NCT02694523|54202816|FG002|Part A|Adverse Event|0|||
27752066|NCT02694523|54202817|FG003|Part A|Adverse Event|0|||
27752067|NCT02694523|54202818|FG004|Part A|Adverse Event|0|||
27752068|NCT02694523|54202819|FG005|Part A|Adverse Event|0|||
27752069|NCT02694523|54202820|FG006|Part A|Adverse Event|0|||
27752070|NCT02694523|54202814|FG000|Part A|Protocol Violation|1|||
27752071|NCT02694523|54202815|FG001|Part A|Protocol Violation|0|||
27752072|NCT02694523|54202816|FG002|Part A|Protocol Violation|0|||
27752073|NCT02694523|54202817|FG003|Part A|Protocol Violation|0|||
27752074|NCT02694523|54202818|FG004|Part A|Protocol Violation|0|||
27752075|NCT02694523|54202819|FG005|Part A|Protocol Violation|0|||
27752076|NCT02694523|54202820|FG006|Part A|Protocol Violation|0|||
27752077|NCT02694523|54202814|FG000|Part A|Lost to Follow-up|1|||
27752078|NCT02694523|54202815|FG001|Part A|Lost to Follow-up|2|||
27752079|NCT02694523|54202816|FG002|Part A|Lost to Follow-up|0|||
27752080|NCT02694523|54202817|FG003|Part A|Lost to Follow-up|0|||
27752081|NCT02694523|54202818|FG004|Part A|Lost to Follow-up|0|||
27752082|NCT02694523|54202819|FG005|Part A|Lost to Follow-up|0|||
27752083|NCT02694523|54202820|FG006|Part A|Lost to Follow-up|0|||
27752084|NCT02694523|54202814|FG000|Part A|Withdrawal by Subject|3|||
27752085|NCT02694523|54202815|FG001|Part A|Withdrawal by Subject|1|||
27752086|NCT02694523|54202816|FG002|Part A|Withdrawal by Subject|0|||
27752087|NCT02694523|54202817|FG003|Part A|Withdrawal by Subject|0|||
27752088|NCT02694523|54202818|FG004|Part A|Withdrawal by Subject|0|||
27752089|NCT02694523|54202819|FG005|Part A|Withdrawal by Subject|0|||
27752090|NCT02694523|54202820|FG006|Part A|Withdrawal by Subject|0|||
27752091|NCT02694523|54202814|FG000|Part A|Other|1|||
27752092|NCT02694523|54202815|FG001|Part A|Other|1|||
27752093|NCT02694523|54202816|FG002|Part A|Other|0|||
27752094|NCT02694523|54202817|FG003|Part A|Other|0|||
27752095|NCT02694523|54202818|FG004|Part A|Other|0|||
27752096|NCT02694523|54202819|FG005|Part A|Other|0|||
27752097|NCT02694523|54202820|FG006|Part A|Other|0|||
27752098|NCT02694523|54202814|FG000|Part B|Adverse Event|0|||
27752099|NCT02694523|54202815|FG001|Part B|Adverse Event|0|||
27752100|NCT02694523|54202816|FG002|Part B|Adverse Event|7|||
27752101|NCT02694523|54202817|FG003|Part B|Adverse Event|1|||
27752102|NCT02694523|54202818|FG004|Part B|Adverse Event|1|||
27752103|NCT02694523|54202819|FG005|Part B|Adverse Event|2|||
27752104|NCT02694523|54202820|FG006|Part B|Adverse Event|0|||
27752105|NCT02694523|54202814|FG000|Part B|Protocol Violation|0|||
27752106|NCT02694523|54202815|FG001|Part B|Protocol Violation|0|||
27752107|NCT02694523|54202816|FG002|Part B|Protocol Violation|1|||
27752108|NCT02694523|54202817|FG003|Part B|Protocol Violation|0|||
27752109|NCT02694523|54202818|FG004|Part B|Protocol Violation|0|||
27752110|NCT02694523|54202819|FG005|Part B|Protocol Violation|0|||
27752111|NCT02694523|54202820|FG006|Part B|Protocol Violation|0|||
27752112|NCT02694523|54202814|FG000|Part B|Lost to Follow-up|0|||
27752113|NCT02694523|54202815|FG001|Part B|Lost to Follow-up|0|||
27752114|NCT02694523|54202816|FG002|Part B|Lost to Follow-up|2|||
27752115|NCT02694523|54202817|FG003|Part B|Lost to Follow-up|3|||
27752116|NCT02694523|54202818|FG004|Part B|Lost to Follow-up|2|||
27752117|NCT02694523|54202819|FG005|Part B|Lost to Follow-up|0|||
27752118|NCT02694523|54202820|FG006|Part B|Lost to Follow-up|1|||
27752119|NCT02694523|54202814|FG000|Part B|Withdrawal by Subject|0|||
27752120|NCT02694523|54202815|FG001|Part B|Withdrawal by Subject|0|||
27752121|NCT02694523|54202816|FG002|Part B|Withdrawal by Subject|9|||
27752122|NCT02694523|54202817|FG003|Part B|Withdrawal by Subject|0|||
27752123|NCT02694523|54202818|FG004|Part B|Withdrawal by Subject|1|||
27752124|NCT02694523|54202819|FG005|Part B|Withdrawal by Subject|3|||
27752125|NCT02694523|54202820|FG006|Part B|Withdrawal by Subject|0|||
27752126|NCT02694523|54202814|FG000|Part B|Other|0|||
27752127|NCT02694523|54202815|FG001|Part B|Other|0|||
27752128|NCT02694523|54202816|FG002|Part B|Other|1|||
27752129|NCT02694523|54202817|FG003|Part B|Other|0|||
27752130|NCT02694523|54202818|FG004|Part B|Other|0|||
27752131|NCT02694523|54202819|FG005|Part B|Other|0|||
27752132|NCT02694523|54202820|FG006|Part B|Other|1|||
27752133|NCT01353703|54202834|FG000|Overall Study|Migrated/moved from study area|1|||
27752134|NCT01353703|54202835|FG001|Overall Study|Migrated/moved from study area|0|||
27752135|NCT02009332|54202849|FG000|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
27752136|NCT02009332|54202850|FG001|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|1|||
27752137|NCT02009332|54202851|FG002|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
27752138|NCT02009332|54202852|FG003|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
27752139|NCT02009332|54202853|FG004|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
27752140|NCT02009332|54202854|FG005|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
27752141|NCT02009332|54202849|FG000|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
27752142|NCT02009332|54202850|FG001|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
27752143|NCT02009332|54202851|FG002|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
27752144|NCT02009332|54202852|FG003|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
27752145|NCT02009332|54202853|FG004|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|1|||
27752146|NCT02009332|54202854|FG005|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
27752147|NCT02009332|54202849|FG000|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
27752148|NCT02009332|54202850|FG001|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
27752149|NCT02009332|54202851|FG002|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
27752150|NCT02009332|54202852|FG003|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
27752151|NCT02009332|54202853|FG004|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
27752152|NCT02009332|54202854|FG005|Phase 2 (Weeks 206-252)|Withdrawal by Subject|1|||
27752153|NCT01984294|54202871|FG000|Overall Study|Randomized but Never Treated|0|||
27752154|NCT01984294|54202872|FG001|Overall Study|Randomized but Never Treated|0|||
27752155|NCT01984294|54202873|FG002|Overall Study|Randomized but Never Treated|1|||
27752156|NCT01984294|54202871|FG000|Overall Study|Lack of Efficacy|4|||
27752157|NCT01984294|54202872|FG001|Overall Study|Lack of Efficacy|2|||
27752158|NCT01984294|54202873|FG002|Overall Study|Lack of Efficacy|6|||
27752159|NCT01984294|54202871|FG000|Overall Study|Adverse Event|0|||
27752160|NCT01984294|54202872|FG001|Overall Study|Adverse Event|1|||
27752161|NCT01984294|54202873|FG002|Overall Study|Adverse Event|0|||
27752162|NCT01962298|54202886|FG000|Overall Study|Protocol Violation|1|||
27752163|NCT01962298|54202887|FG001|Overall Study|Protocol Violation|0|||
27752164|NCT01962298|54202888|FG002|Overall Study|Protocol Violation|1|||
27752165|NCT01962298|54202889|FG003|Overall Study|Protocol Violation|1|||
27752166|NCT01962298|54202890|FG004|Overall Study|Protocol Violation|0|||
27752167|NCT01962298|54202886|FG000|Overall Study|Data quality insufficient|2|||
27752168|NCT01962298|54202887|FG001|Overall Study|Data quality insufficient|0|||
27752169|NCT01962298|54202888|FG002|Overall Study|Data quality insufficient|3|||
27752170|NCT01962298|54202889|FG003|Overall Study|Data quality insufficient|1|||
27752171|NCT01962298|54202890|FG004|Overall Study|Data quality insufficient|4|||
27752172|NCT01962298|54202886|FG000|Overall Study|Insufficient data|0|||
27752173|NCT01962298|54202887|FG001|Overall Study|Insufficient data|2|||
27752174|NCT01962298|54202888|FG002|Overall Study|Insufficient data|1|||
27752175|NCT01962298|54202889|FG003|Overall Study|Insufficient data|0|||
27752176|NCT01962298|54202890|FG004|Overall Study|Insufficient data|1|||
27752177|NCT01962298|54202886|FG000|Overall Study|Incorrect data recorded|0|||
27752178|NCT01962298|54202887|FG001|Overall Study|Incorrect data recorded|1|||
27752179|NCT01962298|54202888|FG002|Overall Study|Incorrect data recorded|0|||
27752180|NCT01962298|54202889|FG003|Overall Study|Incorrect data recorded|0|||
27752181|NCT01962298|54202890|FG004|Overall Study|Incorrect data recorded|0|||
27752182|NCT01962298|54202886|FG000|Overall Study|Physician Decision|0|||
27752183|NCT01962298|54202887|FG001|Overall Study|Physician Decision|1|||
27752184|NCT01962298|54202888|FG002|Overall Study|Physician Decision|0|||
27752185|NCT01962298|54202889|FG003|Overall Study|Physician Decision|0|||
27752186|NCT01962298|54202890|FG004|Overall Study|Physician Decision|1|||
27752187|NCT02693743|54202904|FG000|Overall Study|Physician Decision|1|||
27752188|NCT02693743|54202905|FG001|Overall Study|Physician Decision|0|||
27752189|NCT02655887|54202911|FG000|Overall Study|Lost to Follow-up|3|||
27752190|NCT02655887|54202911|FG000|Overall Study|Death|4|||
27752191|NCT02655887|54202911|FG000|Overall Study|Withdrawal by Subject|3|||
27752192|NCT02655887|54202911|FG000|Overall Study|Missed 12-month follow-up visit|4|||
27752193|NCT02008318|54202917|FG000|Overall Study|Adverse Event|4|||
27752194|NCT02008318|54202918|FG001|Overall Study|Adverse Event|0|||
27752195|NCT02008318|54202917|FG000|Overall Study|Physician Decision|2|||
27752196|NCT02008318|54202918|FG001|Overall Study|Physician Decision|0|||
27752197|NCT02008318|54202917|FG000|Overall Study|Progressive Disease|2|||
27752198|NCT02008318|54202918|FG001|Overall Study|Progressive Disease|0|||
27752199|NCT02008318|54202917|FG000|Overall Study|Protocol Violation|1|||
27752200|NCT02008318|54202918|FG001|Overall Study|Protocol Violation|1|||
27752201|NCT02008318|54202917|FG000|Overall Study|Withdrawal by Subject|3|||
27752202|NCT02008318|54202918|FG001|Overall Study|Withdrawal by Subject|0|||
27752203|NCT01982812|54202929|FG000|Overall Study|Death|1|||
27752204|NCT01982812|54202930|FG001|Overall Study|Death|5|||
27752205|NCT01982812|54202929|FG000|Overall Study|Adverse Event|0|||
27752206|NCT01982812|54202930|FG001|Overall Study|Adverse Event|5|||
27752207|NCT02007070|54202936|FG000|Overall Study|Adverse Event|4|||
27752208|NCT02007070|54202936|FG000|Overall Study|Clinical Progression|4|||
27752209|NCT02007070|54202936|FG000|Overall Study|Death|1|||
27752210|NCT02007070|54202936|FG000|Overall Study|Protocol Violation|2|||
27752211|NCT02007070|54202936|FG000|Overall Study|Physician Decision|1|||
27752212|NCT02007070|54202936|FG000|Overall Study|Progressive Disease|21|||
27752213|NCT02006758|54202940|FG000|Overall Study|Protocol Violation|1|||
27752214|NCT02006758|54202940|FG000|Overall Study|Death|1|||
27752215|NCT02006758|54202940|FG000|Overall Study|Lost to Follow-up|4|||
27752216|NCT02006758|54202940|FG000|Overall Study|Withdrawal by Subject|4|||
27752217|NCT02006758|54202940|FG000|Overall Study|Procedurally excluded|1|||
27752218|NCT02006758|54202940|FG000|Overall Study|Other|2|||
27752219|NCT01960816|54202945|FG000|Overall Study|Lost to Follow-up|1|||
27752220|NCT01602419|54202949|FG000|Overall Study|Not treated with Wilate|9|||
27752221|NCT01602419|54202949|FG000|Overall Study|Adverse Drug Reaction|4|||
27752222|NCT01602419|54202949|FG000|Overall Study|Insurance issues|3|||
27752223|NCT01602419|54202949|FG000|Overall Study|Changed treatment centre|1|||
27752224|NCT01602419|54202949|FG000|Overall Study|Treatment centre closed|1|||
27752225|NCT01602419|54202949|FG000|Overall Study|Withdrawal by Subject|5|||
27752226|NCT01602419|54202949|FG000|Overall Study|Lost to Follow-up|6|||
27752227|NCT01981954|54202994|FG000|Titration Period|Protocol Deviation|1|||
27752228|NCT01981954|54202994|FG000|Fixed-Dose Assessment Period|Lack of Efficacy|1|||
27752229|NCT02693119|54203000|FG000|Open-Label Period|Withdrawal by Subject|0|||
27752230|NCT02693119|54203001|FG001|Open-Label Period|Withdrawal by Subject|1|||
27752231|NCT01960348|54203039|FG000|Overall Study|Adverse event, not serious|2|||
27752232|NCT01960348|54203040|FG001|Overall Study|Adverse event, not serious|2|||
27752233|NCT01960348|54203039|FG000|Overall Study|Adverse event, serious fatal|6|||
27752234|NCT01960348|54203040|FG001|Overall Study|Adverse event, serious fatal|5|||
27752235|NCT01960348|54203039|FG000|Overall Study|Adverse event, serious non-fatal|0|||
27752236|NCT01960348|54203040|FG001|Overall Study|Adverse event, serious non-fatal|3|||
27752237|NCT01960348|54203039|FG000|Overall Study|Withdrawal by Subject|1|||
27752238|NCT01960348|54203040|FG001|Overall Study|Withdrawal by Subject|11|||
27752239|NCT01960348|54203039|FG000|Overall Study|Physician Decision|0|||
27752240|NCT01960348|54203040|FG001|Overall Study|Physician Decision|1|||
27752241|NCT01960348|54203039|FG000|Overall Study|Protocol Violation|1|||
27752242|NCT01960348|54203040|FG001|Overall Study|Protocol Violation|0|||
27752243|NCT02653625|54203046|FG000|Overall Study|Adverse Event|1|||
27752244|NCT02653625|54203046|FG000|Overall Study|Non-compliance with Study Drug|1|||
27752245|NCT02653625|54203046|FG000|Overall Study|Protocol Violation|1|||
27752246|NCT02653625|54203046|FG000|Overall Study|Suspected Drug Induced Liver Injury|1|||
27752247|NCT01981096|54203052|FG000|Overall Study|Parent illness|1|||
27752248|NCT01981096|54203053|FG001|Overall Study|Parent illness|0|||
27752249|NCT01981096|54203052|FG000|Overall Study|Withdrawal by Subject|0|||
27752250|NCT01981096|54203053|FG001|Overall Study|Withdrawal by Subject|1|||
27752251|NCT01981096|54203052|FG000|Overall Study|Lost to Follow-up|2|||
27752252|NCT01981096|54203053|FG001|Overall Study|Lost to Follow-up|0|||
27752253|NCT02652767|54203059|FG000|Overall Study|Death|2|||
27752254|NCT02652767|54203059|FG000|Overall Study|Lost to Follow-up|1|||
27752255|NCT02652767|54203059|FG000|Overall Study|Withdrawal by Subject|1|||
27752256|NCT01980940|54203073|FG000|Overall Study|Protocol Violation|0|||
27752257|NCT01980940|54203074|FG001|Overall Study|Protocol Violation|0|||
27752258|NCT01980940|54203075|FG002|Overall Study|Protocol Violation|0|||
27752259|NCT01980940|54203076|FG003|Overall Study|Protocol Violation|0|||
27752260|NCT01980940|54203077|FG004|Overall Study|Protocol Violation|0|||
27752261|NCT01980940|54203078|FG005|Overall Study|Protocol Violation|2|||
27752262|NCT01980940|54203079|FG006|Overall Study|Protocol Violation|0|||
27752263|NCT01980940|54203080|FG007|Overall Study|Protocol Violation|0|||
27752264|NCT02699983|54203106|FG000|Overall Study|Withdrawal by Subject|1|||
27752265|NCT02699983|54203107|FG001|Overall Study|Withdrawal by Subject|0|||
27752266|NCT01960114|54203119|FG000|Overall Study|Adverse Event|1|||
27752267|NCT01960114|54203120|FG001|Overall Study|Adverse Event|0|||
27752268|NCT01960114|54203119|FG000|Overall Study|Could not swallow study medication|0|||
27752269|NCT01960114|54203120|FG001|Overall Study|Could not swallow study medication|1|||
27752270|NCT02005276|54203130|FG000|Overall Study|No longer interested|5|||
27752271|NCT02005276|54203131|FG001|Overall Study|No longer interested|2|||
27752272|NCT02005276|54203132|FG002|Overall Study|No longer interested|3|||
27752273|NCT02005276|54203133|FG003|Overall Study|No longer interested|3|||
27752274|NCT01980706|54203148|FG000|Overall Study|Withdrawal by Subject|9|||
27752275|NCT01980706|54203149|FG001|Overall Study|Withdrawal by Subject|6|||
27752276|NCT01980706|54203150|FG002|Overall Study|Withdrawal by Subject|2|||
27752277|NCT01980706|54203148|FG000|Overall Study|Adverse Event|1|||
27752278|NCT01980706|54203149|FG001|Overall Study|Adverse Event|2|||
27752279|NCT01980706|54203150|FG002|Overall Study|Adverse Event|5|||
27752280|NCT01980706|54203148|FG000|Overall Study|Lost to Follow-up|3|||
27752281|NCT01980706|54203149|FG001|Overall Study|Lost to Follow-up|4|||
27752282|NCT01980706|54203150|FG002|Overall Study|Lost to Follow-up|3|||
27752283|NCT01980706|54203148|FG000|Overall Study|miscellaneous|4|||
27752284|NCT01980706|54203149|FG001|Overall Study|miscellaneous|5|||
27752285|NCT01980706|54203150|FG002|Overall Study|miscellaneous|3|||
27752286|NCT02692417|54203160|FG000|Overall Study|Withdrawal by Subject|5|||
27752287|NCT02692417|54203161|FG001|Overall Study|Withdrawal by Subject|1|||
27752288|NCT02692417|54203160|FG000|Overall Study|Adverse Event|1|||
27752289|NCT02692417|54203161|FG001|Overall Study|Adverse Event|0|||
27752290|NCT02004886|54203171|FG000|Overall Study|Adverse Event|0|||
27752291|NCT02004886|54203172|FG001|Overall Study|Adverse Event|1|||
27752292|NCT02004886|54203173|FG002|Overall Study|Adverse Event|0|||
27752293|NCT02004886|54203174|FG003|Overall Study|Adverse Event|0|||
27752294|NCT02004886|54203171|FG000|Overall Study|Unable to attend future visits|1|||
27752295|NCT02004886|54203172|FG001|Overall Study|Unable to attend future visits|0|||
27752296|NCT02004886|54203173|FG002|Overall Study|Unable to attend future visits|0|||
27752297|NCT02004886|54203174|FG003|Overall Study|Unable to attend future visits|0|||
27752298|NCT01959880|54203188|FG000|Overall Study|Withdrawal by Subject|11|||
27752299|NCT01959880|54203189|FG001|Overall Study|Withdrawal by Subject|13|||
27752300|NCT01959880|54203190|FG002|Overall Study|Withdrawal by Subject|8|||
27752301|NCT01959880|54203191|FG003|Overall Study|Withdrawal by Subject|7|||
27752302|NCT01959880|54203188|FG000|Overall Study|Death|1|||
27752303|NCT01959880|54203189|FG001|Overall Study|Death|10|||
27752304|NCT01959880|54203190|FG002|Overall Study|Death|1|||
27752305|NCT01959880|54203191|FG003|Overall Study|Death|2|||
27752306|NCT01959880|54203188|FG000|Overall Study|Lost to Follow-up|95|||
27752307|NCT01959880|54203189|FG001|Overall Study|Lost to Follow-up|18|||
27752308|NCT01959880|54203190|FG002|Overall Study|Lost to Follow-up|15|||
27752309|NCT01959880|54203191|FG003|Overall Study|Lost to Follow-up|8|||
27752310|NCT01959880|54203188|FG000|Overall Study|Explantation w/o study device reimplant.|22|||
27752311|NCT01959880|54203189|FG001|Overall Study|Explantation w/o study device reimplant.|17|||
27752312|NCT01959880|54203190|FG002|Overall Study|Explantation w/o study device reimplant.|5|||
27752313|NCT01959880|54203191|FG003|Overall Study|Explantation w/o study device reimplant.|12|||
27752314|NCT01959880|54203188|FG000|Overall Study|Study completed early-FDA approved|1003|||
27752315|NCT01959880|54203189|FG001|Overall Study|Study completed early-FDA approved|311|||
27752316|NCT01959880|54203190|FG002|Overall Study|Study completed early-FDA approved|179|||
27752317|NCT01959880|54203191|FG003|Overall Study|Study completed early-FDA approved|152|||
27752318|NCT01980628|54203201|FG000|Overall Study|Adverse Event|12|||
27752319|NCT01980628|54203201|FG000|Overall Study|Physician Decision|5|||
27752320|NCT01980628|54203201|FG000|Overall Study|Withdrawal by Subject|4|||
27752321|NCT01980628|54203201|FG000|Overall Study|PD, Subj non-Compliant,Study Terminated|42|||
27752322|NCT01979614|54203208|FG000|Overall Study|Adverse Event|1|||
27752323|NCT01979614|54203209|FG001|Overall Study|Adverse Event|1|||
27752324|NCT02654717|54203217|FG000|Overall Study|Adverse Event|2|||
27752325|NCT02654717|54203218|FG001|Overall Study|Adverse Event|2|||
27752326|NCT02654717|54203217|FG000|Overall Study|Protocol Violation|1|||
27752327|NCT02654717|54203218|FG001|Overall Study|Protocol Violation|2|||
27752328|NCT02654717|54203217|FG000|Overall Study|Withdrawal by Subject|0|||
27752329|NCT02654717|54203218|FG001|Overall Study|Withdrawal by Subject|1|||
27752330|NCT02654717|54203217|FG000|Overall Study|Non-permitted medication|3|||
27752331|NCT02654717|54203218|FG001|Overall Study|Non-permitted medication|0|||
27752332|NCT03343301|54203226|FG000|Overall Study|Withdrawal by Subject|1|||
27752333|NCT03343301|54203227|FG001|Overall Study|Withdrawal by Subject|1|||
27752334|NCT03343301|54203226|FG000|Overall Study|Death|0|||
27752335|NCT03343301|54203227|FG001|Overall Study|Death|2|||
27752336|NCT03343301|54203226|FG000|Overall Study|Other|0|||
27752337|NCT03343301|54203227|FG001|Overall Study|Other|6|||
27752338|NCT03343301|54203226|FG000|Overall Study|Missing|2|||
27752339|NCT03343301|54203227|FG001|Overall Study|Missing|0|||
27752340|NCT02696785|54203237|FG000|Blinded Treatment Period|Adverse Event|0|||
27752341|NCT02696785|54203238|FG001|Blinded Treatment Period|Adverse Event|1|||
27752342|NCT02696785|54203239|FG002|Blinded Treatment Period|Adverse Event|3|||
27752343|NCT02696785|54203240|FG003|Blinded Treatment Period|Adverse Event|0|||
27752344|NCT02696785|54203237|FG000|Blinded Treatment Period|Withdrawal by Subject|0|||
27752345|NCT02696785|54203238|FG001|Blinded Treatment Period|Withdrawal by Subject|1|||
27752346|NCT02696785|54203239|FG002|Blinded Treatment Period|Withdrawal by Subject|1|||
27752347|NCT02696785|54203240|FG003|Blinded Treatment Period|Withdrawal by Subject|2|||
27752348|NCT02696785|54203237|FG000|Blinded Treatment Period|Lack of Efficacy|0|||
27752349|NCT02696785|54203238|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
27752350|NCT02696785|54203239|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
27752351|NCT02696785|54203240|FG003|Blinded Treatment Period|Lack of Efficacy|1|||
27752352|NCT02696785|54203237|FG000|Blinded Treatment Period|Screen Failure|1|||
27752353|NCT02696785|54203238|FG001|Blinded Treatment Period|Screen Failure|0|||
27752354|NCT02696785|54203239|FG002|Blinded Treatment Period|Screen Failure|0|||
27752355|NCT02696785|54203240|FG003|Blinded Treatment Period|Screen Failure|0|||
27752356|NCT02696785|54203237|FG000|Washout Period|Withdrawal by Subject|0|||
27752357|NCT02696785|54203238|FG001|Washout Period|Withdrawal by Subject|1|||
27752358|NCT02696785|54203239|FG002|Washout Period|Withdrawal by Subject|0|||
27752359|NCT02696785|54203240|FG003|Washout Period|Withdrawal by Subject|0|||
27752360|NCT02696785|54203237|FG000|Washout Period|Lack of Efficacy|0|||
27752361|NCT02696785|54203238|FG001|Washout Period|Lack of Efficacy|1|||
27752362|NCT02696785|54203239|FG002|Washout Period|Lack of Efficacy|0|||
27752363|NCT02696785|54203240|FG003|Washout Period|Lack of Efficacy|0|||
27752364|NCT02696785|54203237|FG000|Extended Treatment Period|Adverse Event|2|||
27752365|NCT02696785|54203238|FG001|Extended Treatment Period|Adverse Event|3|||
27752366|NCT02696785|54203239|FG002|Extended Treatment Period|Adverse Event|2|||
27752367|NCT02696785|54203240|FG003|Extended Treatment Period|Adverse Event|1|||
27752368|NCT02696785|54203237|FG000|Extended Treatment Period|Lack of Efficacy|0|||
27752369|NCT02696785|54203238|FG001|Extended Treatment Period|Lack of Efficacy|1|||
27752370|NCT02696785|54203239|FG002|Extended Treatment Period|Lack of Efficacy|0|||
27752371|NCT02696785|54203240|FG003|Extended Treatment Period|Lack of Efficacy|0|||
27752372|NCT02696785|54203237|FG000|Extended Treatment Period|Withdrawal by Subject|1|||
27752373|NCT02696785|54203238|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
27752374|NCT02696785|54203239|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
27752375|NCT02696785|54203240|FG003|Extended Treatment Period|Withdrawal by Subject|5|||
27752376|NCT02696785|54203237|FG000|Follow-up Period|Adverse Event|0|||
27752377|NCT02696785|54203238|FG001|Follow-up Period|Adverse Event|0|||
27752378|NCT02696785|54203239|FG002|Follow-up Period|Adverse Event|8|||
27752379|NCT02696785|54203240|FG003|Follow-up Period|Adverse Event|2|||
27752380|NCT02696785|54203237|FG000|Follow-up Period|Lost to Follow-up|0|||
27752381|NCT02696785|54203238|FG001|Follow-up Period|Lost to Follow-up|0|||
27752382|NCT02696785|54203239|FG002|Follow-up Period|Lost to Follow-up|0|||
27752383|NCT02696785|54203240|FG003|Follow-up Period|Lost to Follow-up|1|||
27752384|NCT02696785|54203237|FG000|Follow-up Period|Lack of Efficacy|0|||
27752385|NCT02696785|54203238|FG001|Follow-up Period|Lack of Efficacy|0|||
27752386|NCT02696785|54203239|FG002|Follow-up Period|Lack of Efficacy|0|||
27752387|NCT02696785|54203240|FG003|Follow-up Period|Lack of Efficacy|1|||
27752388|NCT02696785|54203237|FG000|Follow-up Period|Withdrawal by Subject|1|||
27752389|NCT02696785|54203238|FG001|Follow-up Period|Withdrawal by Subject|0|||
27752390|NCT02696785|54203239|FG002|Follow-up Period|Withdrawal by Subject|5|||
27752391|NCT02696785|54203240|FG003|Follow-up Period|Withdrawal by Subject|4|||
27752392|NCT02004262|54203274|FG000|Overall Study|Death|67|||
27752393|NCT02004262|54203275|FG001|Overall Study|Death|64|||
27752394|NCT02004262|54203276|FG002|Overall Study|Death|66|||
27752395|NCT02004262|54203277|FG003|Overall Study|Death|28|||
27752396|NCT02004262|54203278|FG004|Overall Study|Death|29|||
27752397|NCT02004262|54203279|FG005|Overall Study|Death|22|||
27752398|NCT02004262|54203274|FG000|Overall Study|Withdrawal by Subject|1|||
27752399|NCT02004262|54203275|FG001|Overall Study|Withdrawal by Subject|0|||
27752400|NCT02004262|54203276|FG002|Overall Study|Withdrawal by Subject|4|||
27752401|NCT02004262|54203277|FG003|Overall Study|Withdrawal by Subject|0|||
27752402|NCT02004262|54203278|FG004|Overall Study|Withdrawal by Subject|1|||
27752403|NCT02004262|54203279|FG005|Overall Study|Withdrawal by Subject|3|||
27752404|NCT02004262|54203274|FG000|Overall Study|Lost to Follow-up|1|||
27752405|NCT02004262|54203275|FG001|Overall Study|Lost to Follow-up|1|||
27752406|NCT02004262|54203276|FG002|Overall Study|Lost to Follow-up|0|||
27752407|NCT02004262|54203277|FG003|Overall Study|Lost to Follow-up|0|||
27752408|NCT02004262|54203278|FG004|Overall Study|Lost to Follow-up|0|||
27752409|NCT02004262|54203279|FG005|Overall Study|Lost to Follow-up|0|||
27752410|NCT02004262|54203274|FG000|Overall Study|Study Terminated by Sponsor|4|||
27752411|NCT02004262|54203275|FG001|Overall Study|Study Terminated by Sponsor|3|||
27752412|NCT02004262|54203276|FG002|Overall Study|Study Terminated by Sponsor|2|||
27752413|NCT02004262|54203277|FG003|Overall Study|Study Terminated by Sponsor|1|||
27752414|NCT02004262|54203278|FG004|Overall Study|Study Terminated by Sponsor|1|||
27752415|NCT02004262|54203279|FG005|Overall Study|Study Terminated by Sponsor|5|||
27752416|NCT01675427|54203293|FG000|Overall Study|Withdrawal by Subject|7|||
27752417|NCT01675427|54203293|FG000|Overall Study|Participant Refused Sample Collection|18|||
27752418|NCT01675427|54203293|FG000|Overall Study|Sample not Collected by Mistake|2|||
27752419|NCT01675427|54203293|FG000|Overall Study|Lost to Follow-up|5|||
27752420|NCT01675427|54203293|FG000|Overall Study|Other|2|||
27752421|NCT01978912|54203331|FG000|Overall Study|Adverse Event|0|||
27752422|NCT01978912|54203332|FG001|Overall Study|Adverse Event|1|||
27752423|NCT01978912|54203333|FG002|Overall Study|Adverse Event|0|||
27752424|NCT01978912|54203334|FG003|Overall Study|Adverse Event|0|||
27752425|NCT01978912|54203331|FG000|Overall Study|Lost to Follow-up|1|||
27752426|NCT01978912|54203332|FG001|Overall Study|Lost to Follow-up|1|||
27752427|NCT01978912|54203333|FG002|Overall Study|Lost to Follow-up|0|||
27752428|NCT01978912|54203334|FG003|Overall Study|Lost to Follow-up|1|||
27752429|NCT01978912|54203331|FG000|Overall Study|Withdrawal by Subject|1|||
27752430|NCT01978912|54203332|FG001|Overall Study|Withdrawal by Subject|0|||
27752431|NCT01978912|54203333|FG002|Overall Study|Withdrawal by Subject|2|||
27752432|NCT01978912|54203334|FG003|Overall Study|Withdrawal by Subject|2|||
27752433|NCT01978912|54203331|FG000|Overall Study|Lumbar Surgery|1|||
27752434|NCT01978912|54203332|FG001|Overall Study|Lumbar Surgery|0|||
27752435|NCT01978912|54203333|FG002|Overall Study|Lumbar Surgery|1|||
27752436|NCT01978912|54203334|FG003|Overall Study|Lumbar Surgery|0|||
27752437|NCT01978912|54203331|FG000|Overall Study|Intradiscal Steroid Injection|0|||
27752438|NCT01978912|54203332|FG001|Overall Study|Intradiscal Steroid Injection|1|||
27752439|NCT01978912|54203333|FG002|Overall Study|Intradiscal Steroid Injection|0|||
27752440|NCT01978912|54203334|FG003|Overall Study|Intradiscal Steroid Injection|0|||
27752441|NCT01977898|54203346|FG000|Overall Study|Non functioning catheter|1|||
27752442|NCT01977898|54203347|FG001|Overall Study|Non functioning catheter|1|||
27752443|NCT02003638|54203355|FG000|Overall Study|Withdrawal by Subject|1|||
27752444|NCT02003638|54203356|FG001|Overall Study|Withdrawal by Subject|0|||
27752445|NCT02696317|54203362|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|2|||
27752446|NCT02696317|54203363|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|4|||
27752447|NCT02696317|54203362|FG000|Period 2, 10 Days of Wear|Withdrawal by Subject|1|||
27752448|NCT02696317|54203363|FG001|Period 2, 10 Days of Wear|Withdrawal by Subject|0|||
27752449|NCT01959412|54203371|FG000|Overall Study|Protocol deviation|1|||
27752450|NCT01959412|54203372|FG001|Overall Study|Protocol deviation|1|||
27752451|NCT01959412|54203373|FG002|Overall Study|Protocol deviation|0|||
27752452|NCT01959412|54203374|FG003|Overall Study|Protocol deviation|1|||
27752453|NCT01959412|54203375|FG004|Overall Study|Protocol deviation|3|||
27752454|NCT01959412|54203376|FG005|Overall Study|Protocol deviation|0|||
27752455|NCT01959412|54203371|FG000|Overall Study|Adverse Event|0|||
27752456|NCT01959412|54203372|FG001|Overall Study|Adverse Event|0|||
27752457|NCT01959412|54203373|FG002|Overall Study|Adverse Event|0|||
27752458|NCT01959412|54203374|FG003|Overall Study|Adverse Event|1|||
27752459|NCT01959412|54203375|FG004|Overall Study|Adverse Event|0|||
27752460|NCT01959412|54203376|FG005|Overall Study|Adverse Event|0|||
27752461|NCT01977820|54203392|FG000|Overall Study|Sponsor terminated the study|1|||
27752462|NCT01977820|54203393|FG001|Overall Study|Sponsor terminated the study|1|||
27752463|NCT02003014|54203399|FG000|Overall Study|Case report forms uncollected|9|||
27752464|NCT02003014|54203399|FG000|Overall Study|Treatment started after contract period|1|||
27752465|NCT02003014|54203399|FG000|Overall Study|Patient did not visit the study site|5|||
27752466|NCT02003014|54203399|FG000|Overall Study|Investigator's transfer|4|||
27752467|NCT01977352|54203405|FG000|Overall Study|Lost to Follow-up|1|||
27752468|NCT01977352|54203406|FG001|Overall Study|Lost to Follow-up|2|||
27752469|NCT02001688|54203415|FG000|Overall Study|Withdrawal by Subject|0|||
27752470|NCT02001688|54203416|FG001|Overall Study|Withdrawal by Subject|0|||
27752471|NCT02001688|54203417|FG002|Overall Study|Withdrawal by Subject|1|||
27752472|NCT02001688|54203415|FG000|Overall Study|Adverse Event|0|||
27752473|NCT02001688|54203416|FG001|Overall Study|Adverse Event|1|||
27752474|NCT02001688|54203417|FG002|Overall Study|Adverse Event|0|||
27752475|NCT02001064|54203428|FG000|Overall Study|Withdrawal by Subject|2|||
27752476|NCT02001064|54203429|FG001|Overall Study|Withdrawal by Subject|1|||
27752477|NCT02000752|54203437|FG000|Overall Study|Dystocic delivery|19|||
27752478|NCT02000752|54203438|FG001|Overall Study|Dystocic delivery|8|||
27752479|NCT02000752|54203437|FG000|Overall Study|Shift Changes|12|||
27752480|NCT02000752|54203438|FG001|Overall Study|Shift Changes|5|||
27752481|NCT02000440|54203444|FG000|Overall Study|Adverse Event|3|||
27752482|NCT02000440|54203444|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
27752483|NCT02687815|54203450|FG000|Overall Study|Lost to Follow-up|2|||
27752484|NCT02687815|54203451|FG001|Overall Study|Lost to Follow-up|4|||
27752485|NCT02687815|54203450|FG000|Overall Study|Withdrawal by Subject|2|||
27752486|NCT02687815|54203451|FG001|Overall Study|Withdrawal by Subject|4|||
27752487|NCT01959334|54203459|FG000|Second Dose|Adverse Event|1|||
27752488|NCT01959334|54203460|FG001|Second Dose|Adverse Event|0|||
27752489|NCT01959334|54203459|FG000|Third Dose|Adverse Event|0|||
27752490|NCT01959334|54203460|FG001|Third Dose|Adverse Event|1|||
27752491|NCT02687581|54203470|FG000|Overall Study|Withdrawal by Subject|1|||
27752492|NCT02687581|54203471|FG001|Overall Study|Withdrawal by Subject|0|||
27752493|NCT02687581|54203472|FG002|Overall Study|Withdrawal by Subject|0|||
27752494|NCT02687581|54203473|FG003|Overall Study|Withdrawal by Subject|1|||
27752495|NCT02687581|54203470|FG000|Overall Study|Lost to Follow-up|2|||
27752496|NCT02687581|54203471|FG001|Overall Study|Lost to Follow-up|2|||
27752497|NCT02687581|54203472|FG002|Overall Study|Lost to Follow-up|0|||
27752498|NCT02687581|54203473|FG003|Overall Study|Lost to Follow-up|0|||
27752499|NCT02687581|54203470|FG000|Overall Study|the device is too small for the patient.|1|||
27752500|NCT02687581|54203471|FG001|Overall Study|the device is too small for the patient.|0|||
27752501|NCT02687581|54203472|FG002|Overall Study|the device is too small for the patient.|0|||
27752502|NCT02687581|54203473|FG003|Overall Study|the device is too small for the patient.|0|||
27752503|NCT01977040|54203483|FG000|Overall Study|Vasa previa not confirmed|2|||
27752504|NCT01958476|54203493|FG000|Overall Study|Parent requested exclusion from analysis|1|||
27752505|NCT01958476|54203494|FG001|Overall Study|Parent requested exclusion from analysis|0|||
27752506|NCT02695537|54203530|FG000|Overall Study|Adverse Event|3|||
27752507|NCT02695537|54203530|FG000|Overall Study|Lack of Efficacy|28|||
27752508|NCT02695537|54203530|FG000|Overall Study|Withdrawal by Subject|4|||
27752509|NCT02695537|54203530|FG000|Overall Study|Protocol Violation|3|||
27752510|NCT01353313|54203536|FG000|Overall Study|Lost to Follow-up|22|||
27752511|NCT01353313|54203537|FG001|Overall Study|Lost to Follow-up|23|||
27752512|NCT01353313|54203536|FG000|Overall Study|Incomplete Follow-up or No Study Data|12|||
27752513|NCT01353313|54203537|FG001|Overall Study|Incomplete Follow-up or No Study Data|15|||
27752514|NCT02691247|54203546|FG000|Overall Study|Withdrawal by Subject|1|||
27752515|NCT02691247|54203547|FG001|Overall Study|Withdrawal by Subject|2|||
27752516|NCT02691247|54203548|FG002|Overall Study|Withdrawal by Subject|2|||
27752517|NCT02691247|54203546|FG000|Overall Study|Lost to Follow-up|2|||
27752518|NCT02691247|54203547|FG001|Overall Study|Lost to Follow-up|0|||
27752519|NCT02691247|54203548|FG002|Overall Study|Lost to Follow-up|1|||
27752520|NCT01362491|54203559|FG000|Overall Study|Ineligible|1|||
27752521|NCT01362491|54203560|FG001|Overall Study|Ineligible|0|||
27752522|NCT01362491|54203561|FG002|Overall Study|Ineligible|0|||
27752523|NCT02687191|54203576|FG000|Overall Study|Death|0|||
27752524|NCT02687191|54203577|FG001|Overall Study|Death|1|||
27752525|NCT02687191|54203578|FG002|Overall Study|Death|1|||
27752526|NCT02687191|54203579|FG003|Overall Study|Death|0|||
27752527|NCT02687191|54203580|FG004|Overall Study|Death|1|||
27752528|NCT02687191|54203581|FG005|Overall Study|Death|1|||
27752529|NCT02687191|54203576|FG000|Overall Study|Withdrawal by Subject|0|||
27752530|NCT02687191|54203577|FG001|Overall Study|Withdrawal by Subject|0|||
27752531|NCT02687191|54203578|FG002|Overall Study|Withdrawal by Subject|0|||
27752532|NCT02687191|54203579|FG003|Overall Study|Withdrawal by Subject|1|||
27752533|NCT02687191|54203580|FG004|Overall Study|Withdrawal by Subject|0|||
27752534|NCT02687191|54203581|FG005|Overall Study|Withdrawal by Subject|0|||
27752535|NCT02687035|54203595|FG000|Overall Study|Withdrawal by Subject|1|||
27752536|NCT02687035|54203595|FG000|Overall Study|Death|87|||
27752537|NCT02687035|54203595|FG000|Overall Study|Lost to Follow-up|1|||
27752538|NCT02687035|54203595|FG000|Overall Study|Missed Visit|87|||
27752539|NCT02687035|54203595|FG000|Overall Study|Did not receive Study Device|8|||
27752540|NCT02691013|54203601|FG000|Overall Study|Withdrawal by Subject|3|||
27752541|NCT02691013|54203602|FG001|Overall Study|Withdrawal by Subject|0|||
27752542|NCT02690701|54203612|FG000|Treatment Period 1|Adverse Event|2|||
27752543|NCT02690701|54203613|FG001|Treatment Period 1|Adverse Event|2|||
27752544|NCT02690701|54203612|FG000|Treatment Period 1|Withdrawal by Subject|0|||
27752545|NCT02690701|54203613|FG001|Treatment Period 1|Withdrawal by Subject|1|||
27752546|NCT02690701|54203612|FG000|Treatment Period 2|Adverse Event|2|||
27752547|NCT02690701|54203613|FG001|Treatment Period 2|Adverse Event|0|||
27752548|NCT02690701|54203612|FG000|Treatment Period 2|Lack of Efficacy|1|||
27752549|NCT02690701|54203613|FG001|Treatment Period 2|Lack of Efficacy|0|||
27752550|NCT02690701|54203612|FG000|Treatment Period 2|Lost to Follow-up|0|||
27752551|NCT02690701|54203613|FG001|Treatment Period 2|Lost to Follow-up|2|||
27752552|NCT02690701|54203612|FG000|Treatment Period 2|Withdrawal by Subject|0|||
27752553|NCT02690701|54203613|FG001|Treatment Period 2|Withdrawal by Subject|2|||
27752554|NCT02690701|54203612|FG000|Treatment Period 2|Protocol Violation|0|||
27752555|NCT02690701|54203613|FG001|Treatment Period 2|Protocol Violation|1|||
27752556|NCT02694757|54203620|FG000|Overall Study|Lack of Efficacy|3|||
27752557|NCT03805841|54203627|FG000|Overall Study|Clinical Progression|2|||
27752558|NCT03805841|54203628|FG001|Overall Study|Clinical Progression|0|||
27752559|NCT03805841|54203629|FG002|Overall Study|Clinical Progression|0|||
27752560|NCT03805841|54203627|FG000|Overall Study|Death|0|||
27752561|NCT03805841|54203628|FG001|Overall Study|Death|3|||
27752562|NCT03805841|54203629|FG002|Overall Study|Death|1|||
27752563|NCT03805841|54203627|FG000|Overall Study|Lost to Follow-up|0|||
27752564|NCT03805841|54203628|FG001|Overall Study|Lost to Follow-up|0|||
27752565|NCT03805841|54203629|FG002|Overall Study|Lost to Follow-up|1|||
27752566|NCT03805841|54203627|FG000|Overall Study|Withdrawal by Subject|2|||
27752567|NCT03805841|54203628|FG001|Overall Study|Withdrawal by Subject|3|||
27752568|NCT03805841|54203629|FG002|Overall Study|Withdrawal by Subject|0|||
27752569|NCT03805841|54203627|FG000|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
27752570|NCT03805841|54203628|FG001|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|4|||
27752571|NCT03805841|54203629|FG002|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
27752572|NCT02684617|54203640|FG000|Overall Study|Adverse Event|1|||
27752573|NCT02684617|54203641|FG001|Overall Study|Adverse Event|0|||
27752574|NCT02684617|54203642|FG002|Overall Study|Adverse Event|1|||
27752575|NCT02684617|54203640|FG000|Overall Study|Death|8|||
27752576|NCT02684617|54203641|FG001|Overall Study|Death|16|||
27752577|NCT02684617|54203642|FG002|Overall Study|Death|28|||
27752578|NCT02684617|54203640|FG000|Overall Study|Withdrawal by Subject|2|||
27752579|NCT02684617|54203641|FG001|Overall Study|Withdrawal by Subject|0|||
27752580|NCT02684617|54203642|FG002|Overall Study|Withdrawal by Subject|4|||
27752581|NCT02684617|54203640|FG000|Overall Study|Screen Failure|1|||
27752582|NCT02684617|54203641|FG001|Overall Study|Screen Failure|0|||
27752583|NCT02684617|54203642|FG002|Overall Study|Screen Failure|2|||
27752584|NCT02684617|54203640|FG000|Overall Study|Study Terminated by Sponsor|6|||
27752585|NCT02684617|54203641|FG001|Overall Study|Study Terminated by Sponsor|1|||
27752586|NCT02684617|54203642|FG002|Overall Study|Study Terminated by Sponsor|5|||
27752587|NCT01999972|54203656|FG000|Dose Escalation Part|Participant refused further follow-up|1|||
27752588|NCT01999972|54203657|FG001|Dose Escalation Part|Participant refused further follow-up|0|||
27752589|NCT01999972|54203658|FG002|Dose Escalation Part|Participant refused further follow-up|1|||
27752590|NCT01999972|54203659|FG003|Dose Escalation Part|Participant refused further follow-up|1|||
27752591|NCT01999972|54203660|FG004|Dose Escalation Part|Participant refused further follow-up|0|||
27752592|NCT01999972|54203661|FG005|Dose Escalation Part|Participant refused further follow-up|0|||
27752593|NCT01999972|54203656|FG000|Dose Escalation Part|Death|0|||
27752594|NCT01999972|54203657|FG001|Dose Escalation Part|Death|1|||
27752595|NCT01999972|54203658|FG002|Dose Escalation Part|Death|0|||
27752596|NCT01999972|54203659|FG003|Dose Escalation Part|Death|0|||
27752597|NCT01999972|54203660|FG004|Dose Escalation Part|Death|0|||
27752598|NCT01999972|54203661|FG005|Dose Escalation Part|Death|0|||
27752599|NCT01999972|54203656|FG000|Dose Escalation Part|Enrolled but not treated|0|||
27752600|NCT01999972|54203657|FG001|Dose Escalation Part|Enrolled but not treated|0|||
27752601|NCT01999972|54203658|FG002|Dose Escalation Part|Enrolled but not treated|1|||
27752602|NCT01999972|54203659|FG003|Dose Escalation Part|Enrolled but not treated|1|||
27752603|NCT01999972|54203660|FG004|Dose Escalation Part|Enrolled but not treated|0|||
27752604|NCT01999972|54203661|FG005|Dose Escalation Part|Enrolled but not treated|0|||
27752605|NCT01999972|54203656|FG000|Dose Escalation Part|Disease progression|3|||
27752606|NCT01999972|54203657|FG001|Dose Escalation Part|Disease progression|2|||
27752607|NCT01999972|54203658|FG002|Dose Escalation Part|Disease progression|3|||
27752608|NCT01999972|54203659|FG003|Dose Escalation Part|Disease progression|6|||
27752609|NCT01999972|54203660|FG004|Dose Escalation Part|Disease progression|0|||
27752610|NCT01999972|54203661|FG005|Dose Escalation Part|Disease progression|0|||
27752611|NCT01999972|54203656|FG000|Dose Escalation Part|Adverse Event|0|||
27752612|NCT01999972|54203657|FG001|Dose Escalation Part|Adverse Event|0|||
27752613|NCT01999972|54203658|FG002|Dose Escalation Part|Adverse Event|0|||
27752614|NCT01999972|54203659|FG003|Dose Escalation Part|Adverse Event|2|||
27752615|NCT01999972|54203660|FG004|Dose Escalation Part|Adverse Event|0|||
27752616|NCT01999972|54203661|FG005|Dose Escalation Part|Adverse Event|0|||
27752617|NCT01999972|54203656|FG000|Dose Escalation Part|Global deterioration of health status|1|||
27752618|NCT01999972|54203657|FG001|Dose Escalation Part|Global deterioration of health status|0|||
27752619|NCT01999972|54203658|FG002|Dose Escalation Part|Global deterioration of health status|0|||
27752620|NCT01999972|54203659|FG003|Dose Escalation Part|Global deterioration of health status|1|||
27752621|NCT01999972|54203660|FG004|Dose Escalation Part|Global deterioration of health status|0|||
27752622|NCT01999972|54203661|FG005|Dose Escalation Part|Global deterioration of health status|0|||
27752623|NCT01999972|54203656|FG000|Dose Expansion Part|Death|0|||
27752624|NCT01999972|54203657|FG001|Dose Expansion Part|Death|0|||
27752625|NCT01999972|54203658|FG002|Dose Expansion Part|Death|0|||
27752626|NCT01999972|54203659|FG003|Dose Expansion Part|Death|0|||
27752627|NCT01999972|54203660|FG004|Dose Expansion Part|Death|2|||
27752628|NCT01999972|54203661|FG005|Dose Expansion Part|Death|1|||
27752629|NCT01999972|54203656|FG000|Dose Expansion Part|Disease progression|0|||
27752630|NCT01999972|54203657|FG001|Dose Expansion Part|Disease progression|0|||
27752631|NCT01999972|54203658|FG002|Dose Expansion Part|Disease progression|0|||
27752632|NCT01999972|54203659|FG003|Dose Expansion Part|Disease progression|0|||
27752633|NCT01999972|54203660|FG004|Dose Expansion Part|Disease progression|9|||
27752634|NCT01999972|54203661|FG005|Dose Expansion Part|Disease progression|3|||
27752635|NCT01999972|54203656|FG000|Dose Expansion Part|Sponsor decision|0|||
27752636|NCT01999972|54203657|FG001|Dose Expansion Part|Sponsor decision|0|||
27752637|NCT01999972|54203658|FG002|Dose Expansion Part|Sponsor decision|0|||
27752638|NCT01999972|54203659|FG003|Dose Expansion Part|Sponsor decision|0|||
27752639|NCT01999972|54203660|FG004|Dose Expansion Part|Sponsor decision|1|||
27752640|NCT01999972|54203661|FG005|Dose Expansion Part|Sponsor decision|0|||
27752641|NCT01999972|54203656|FG000|Dose Expansion Part|Adverse Event|0|||
27752642|NCT01999972|54203657|FG001|Dose Expansion Part|Adverse Event|0|||
27752643|NCT01999972|54203658|FG002|Dose Expansion Part|Adverse Event|0|||
27752644|NCT01999972|54203659|FG003|Dose Expansion Part|Adverse Event|0|||
27752645|NCT01999972|54203660|FG004|Dose Expansion Part|Adverse Event|4|||
27752646|NCT01999972|54203661|FG005|Dose Expansion Part|Adverse Event|2|||
27752647|NCT01999972|54203656|FG000|Dose Expansion Part|Participant's non-compliance|0|||
27752648|NCT01999972|54203657|FG001|Dose Expansion Part|Participant's non-compliance|0|||
27752649|NCT01999972|54203658|FG002|Dose Expansion Part|Participant's non-compliance|0|||
27752650|NCT01999972|54203659|FG003|Dose Expansion Part|Participant's non-compliance|0|||
27752651|NCT01999972|54203660|FG004|Dose Expansion Part|Participant's non-compliance|0|||
27752652|NCT01999972|54203661|FG005|Dose Expansion Part|Participant's non-compliance|1|||
27752653|NCT01999972|54203656|FG000|Dose Expansion Part|Participant refused further follow-up|0|||
27752654|NCT01999972|54203657|FG001|Dose Expansion Part|Participant refused further follow-up|0|||
27752655|NCT01999972|54203658|FG002|Dose Expansion Part|Participant refused further follow-up|0|||
27752656|NCT01999972|54203659|FG003|Dose Expansion Part|Participant refused further follow-up|0|||
27752657|NCT01999972|54203660|FG004|Dose Expansion Part|Participant refused further follow-up|4|||
27752658|NCT01999972|54203661|FG005|Dose Expansion Part|Participant refused further follow-up|0|||
27752659|NCT01999972|54203656|FG000|Dose Expansion Part|Changed to standard of care|0|||
27752660|NCT01999972|54203657|FG001|Dose Expansion Part|Changed to standard of care|0|||
27752661|NCT01999972|54203658|FG002|Dose Expansion Part|Changed to standard of care|0|||
27752662|NCT01999972|54203659|FG003|Dose Expansion Part|Changed to standard of care|0|||
27752663|NCT01999972|54203660|FG004|Dose Expansion Part|Changed to standard of care|1|||
27752664|NCT01999972|54203661|FG005|Dose Expansion Part|Changed to standard of care|0|||
27752665|NCT01999894|54203677|FG000|Overall Study|Adverse Event|9|||
27752666|NCT01999894|54203677|FG000|Overall Study|Lack of Efficacy|5|||
27752667|NCT01999894|54203677|FG000|Overall Study|Protocol Violation|1|||
27752668|NCT01999894|54203677|FG000|Overall Study|Withdrawal by Subject|7|||
27752669|NCT01999894|54203677|FG000|Overall Study|Lost to Follow-up|10|||
27752670|NCT01999894|54203677|FG000|Overall Study|Other Reason|3|||
27752671|NCT01999894|54203677|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
27752672|NCT02679235|54203682|FG000|Overall Study|Withdrawal by Subject|3|||
27752673|NCT02679235|54203682|FG000|Overall Study|Adverse Event|1|||
27752674|NCT01976806|54203688|FG000|Overall Study|Lost to Follow-up|1|||
27752675|NCT01976806|54203689|FG001|Overall Study|Lost to Follow-up|4|||
27752676|NCT01976806|54203688|FG000|Overall Study|Adverse Event|1|||
27752677|NCT01976806|54203689|FG001|Overall Study|Adverse Event|1|||
27752678|NCT01976806|54203688|FG000|Overall Study|Withdrawal by Subject|1|||
27752679|NCT01976806|54203689|FG001|Overall Study|Withdrawal by Subject|1|||
27752680|NCT02679079|54203698|FG000|Overall Study|Adverse Event|2|||
27752681|NCT02679079|54203699|FG001|Overall Study|Adverse Event|0|||
27752682|NCT02679079|54203700|FG002|Overall Study|Adverse Event|2|||
27752683|NCT02679079|54203698|FG000|Overall Study|Protocol Violation|0|||
27752684|NCT02679079|54203699|FG001|Overall Study|Protocol Violation|1|||
27752685|NCT02679079|54203700|FG002|Overall Study|Protocol Violation|0|||
27752686|NCT02679079|54203698|FG000|Overall Study|Withdrawal by Subject|2|||
27752687|NCT02679079|54203699|FG001|Overall Study|Withdrawal by Subject|1|||
27752688|NCT02679079|54203700|FG002|Overall Study|Withdrawal by Subject|0|||
27752689|NCT02678923|54203710|FG000|Overall Study|Protocol Deviation (Not Dosed)|1|||
27752690|NCT02678923|54203711|FG001|Overall Study|Protocol Deviation (Not Dosed)|3|||
27752691|NCT02678923|54203710|FG000|Overall Study|Withdrawal by Subject|3|||
27752692|NCT02678923|54203711|FG001|Overall Study|Withdrawal by Subject|2|||
27752693|NCT02678923|54203710|FG000|Overall Study|Lost to Follow-up|1|||
27752694|NCT02678923|54203711|FG001|Overall Study|Lost to Follow-up|0|||
27752695|NCT02678923|54203710|FG000|Overall Study|Did Not Return for Study Visits|1|||
27752696|NCT02678923|54203711|FG001|Overall Study|Did Not Return for Study Visits|0|||
27752697|NCT01976728|54203721|FG000|Overall Study|Subject missed multiple doses of IMP|1|||
27752698|NCT01976728|54203722|FG001|Overall Study|Subject missed multiple doses of IMP|0|||
27752699|NCT01976728|54203723|FG002|Overall Study|Subject missed multiple doses of IMP|0|||
27752700|NCT01976728|54203724|FG003|Overall Study|Subject missed multiple doses of IMP|0|||
27752701|NCT02689219|54203752|FG000|Overall Study|Death|1|||
27752702|NCT02689219|54203753|FG001|Overall Study|Death|1|||
27752703|NCT02689219|54203752|FG000|Overall Study|Disease Progression|10|||
27752704|NCT02689219|54203753|FG001|Overall Study|Disease Progression|6|||
27752705|NCT02683525|54203759|FG000|Overall Study|Lost to Follow-up|1|||
27752706|NCT02683525|54203759|FG000|Overall Study|Physician Decision|1|||
27752707|NCT02683525|54203759|FG000|Overall Study|Disease Progression|6|||
27752708|NCT01976338|54203765|FG000|Overall Study|Physician Decision|0|||
27752709|NCT01976338|54203766|FG001|Overall Study|Physician Decision|1|||
27752710|NCT01976338|54203765|FG000|Overall Study|Lost to Follow-up|3|||
27752711|NCT01976338|54203766|FG001|Overall Study|Lost to Follow-up|0|||
27752712|NCT01976338|54203765|FG000|Overall Study|Withdrawal by Subject|5|||
27752713|NCT01976338|54203766|FG001|Overall Study|Withdrawal by Subject|2|||
27752714|NCT01976338|54203765|FG000|Overall Study|Adverse Event|5|||
27752715|NCT01976338|54203766|FG001|Overall Study|Adverse Event|1|||
27752716|NCT02674633|54203775|FG000|Overall Study|Lost to Follow-up|3|||
27752717|NCT02674633|54203776|FG001|Overall Study|Lost to Follow-up|2|||
27752718|NCT02674633|54203775|FG000|Overall Study|Physician Decision|1|||
27752719|NCT02674633|54203776|FG001|Overall Study|Physician Decision|0|||
27752720|NCT02674633|54203775|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
27752721|NCT02674633|54203776|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
27752722|NCT02651987|54203784|FG000|Overall Study|Adverse Event|2|||
27752723|NCT02651987|54203785|FG001|Overall Study|Adverse Event|2|||
27752724|NCT02651987|54203784|FG000|Overall Study|Consent Withdrawn|2|||
27752725|NCT02651987|54203785|FG001|Overall Study|Consent Withdrawn|0|||
27752726|NCT02651987|54203784|FG000|Overall Study|Local PD|0|||
27752727|NCT02651987|54203785|FG001|Overall Study|Local PD|2|||
27752728|NCT02651987|54203784|FG000|Overall Study|Investigator Decision|1|||
27752729|NCT02651987|54203785|FG001|Overall Study|Investigator Decision|1|||
27752730|NCT02677987|54203796|FG000|Overall Study|Withdrawal by Subject|3|||
27752731|NCT02677987|54203797|FG001|Overall Study|Withdrawal by Subject|0|||
27752732|NCT02677987|54203796|FG000|Overall Study|Lost to Follow-up|1|||
27752733|NCT02677987|54203797|FG001|Overall Study|Lost to Follow-up|0|||
27752734|NCT01999114|54203816|FG000|Overall Study|Adverse Event|8|||
27752735|NCT01999114|54203817|FG001|Overall Study|Adverse Event|7|||
27752736|NCT01999114|54203818|FG002|Overall Study|Adverse Event|2|||
27752737|NCT01999114|54203819|FG003|Overall Study|Adverse Event|2|||
27752738|NCT01999114|54203820|FG004|Overall Study|Adverse Event|1|||
27752739|NCT01999114|54203816|FG000|Overall Study|Withdrawal by Subject|0|||
27752740|NCT01999114|54203817|FG001|Overall Study|Withdrawal by Subject|0|||
27752741|NCT01999114|54203818|FG002|Overall Study|Withdrawal by Subject|1|||
27752742|NCT01999114|54203819|FG003|Overall Study|Withdrawal by Subject|0|||
27752743|NCT01999114|54203820|FG004|Overall Study|Withdrawal by Subject|1|||
27752744|NCT01999114|54203816|FG000|Overall Study|Lost to Follow-up|0|||
27752745|NCT01999114|54203817|FG001|Overall Study|Lost to Follow-up|0|||
27752746|NCT01999114|54203818|FG002|Overall Study|Lost to Follow-up|1|||
27752747|NCT01999114|54203819|FG003|Overall Study|Lost to Follow-up|0|||
27752748|NCT01999114|54203820|FG004|Overall Study|Lost to Follow-up|0|||
27752749|NCT01999114|54203816|FG000|Overall Study|Administrative|0|||
27752750|NCT01999114|54203817|FG001|Overall Study|Administrative|0|||
27752751|NCT01999114|54203818|FG002|Overall Study|Administrative|1|||
27752752|NCT01999114|54203819|FG003|Overall Study|Administrative|1|||
27752753|NCT01999114|54203820|FG004|Overall Study|Administrative|2|||
27752754|NCT02682823|54203851|FG000|Overall Study|Withdrawal by Subject|0|||
27752755|NCT02682823|54203852|FG001|Overall Study|Withdrawal by Subject|0|||
27752756|NCT02682823|54203853|FG002|Overall Study|Withdrawal by Subject|1|||
27752757|NCT02682823|54203854|FG003|Overall Study|Withdrawal by Subject|0|||
27752758|NCT02682823|54203855|FG004|Overall Study|Withdrawal by Subject|1|||
27752759|NCT02682823|54203851|FG000|Overall Study|Protocol Deviation|0|||
27752760|NCT02682823|54203852|FG001|Overall Study|Protocol Deviation|1|||
27752761|NCT02682823|54203853|FG002|Overall Study|Protocol Deviation|0|||
27752762|NCT02682823|54203854|FG003|Overall Study|Protocol Deviation|0|||
27752763|NCT02682823|54203855|FG004|Overall Study|Protocol Deviation|0|||
27752764|NCT02682823|54203851|FG000|Overall Study|Adverse Event|0|||
27752765|NCT02682823|54203852|FG001|Overall Study|Adverse Event|0|||
27752766|NCT02682823|54203853|FG002|Overall Study|Adverse Event|0|||
27752767|NCT02682823|54203854|FG003|Overall Study|Adverse Event|1|||
27752768|NCT02682823|54203855|FG004|Overall Study|Adverse Event|0|||
27752769|NCT01374451|54203869|FG000|Overall Study|Administrative problems|1|||
27752770|NCT01374451|54203870|FG001|Overall Study|Administrative problems|0|||
27752771|NCT02674477|54203878|FG000|Overall Study|Protocol Violation|8|||
27752772|NCT02674477|54203879|FG001|Overall Study|Protocol Violation|2|||
27752773|NCT01352845|54203887|FG000|Overall Study|Lost to Follow-up|313|||
27752774|NCT01352845|54203888|FG001|Overall Study|Lost to Follow-up|92|||
27752775|NCT01352845|54203887|FG000|Overall Study|No Longer Willing to Participate|205|||
27752776|NCT01352845|54203888|FG001|Overall Study|No Longer Willing to Participate|58|||
27752777|NCT01352845|54203887|FG000|Overall Study|Withdrawal by Subject|48|||
27752778|NCT01352845|54203888|FG001|Overall Study|Withdrawal by Subject|16|||
27752779|NCT01352845|54203887|FG000|Overall Study|No Longer Meets Eligibility Criteria|24|||
27752780|NCT01352845|54203888|FG001|Overall Study|No Longer Meets Eligibility Criteria|11|||
27752781|NCT01352845|54203887|FG000|Overall Study|Pregnancy|27|||
27752782|NCT01352845|54203888|FG001|Overall Study|Pregnancy|7|||
27752783|NCT01352845|54203887|FG000|Overall Study|Adverse Event|22|||
27752784|NCT01352845|54203888|FG001|Overall Study|Adverse Event|6|||
27752785|NCT01352845|54203887|FG000|Overall Study|Other|17|||
27752786|NCT01352845|54203888|FG001|Overall Study|Other|7|||
27752787|NCT01352845|54203887|FG000|Overall Study|Protocol Violation|12|||
27752788|NCT01352845|54203888|FG001|Overall Study|Protocol Violation|6|||
27752789|NCT01352845|54203887|FG000|Overall Study|Death|3|||
27752790|NCT01352845|54203888|FG001|Overall Study|Death|0|||
27752791|NCT02674399|54203896|FG000|Overall Study|Lost to Follow-up|2|||
27752792|NCT02674399|54203897|FG001|Overall Study|Lost to Follow-up|0|||
27752793|NCT02676895|54203906|FG000|Overall Study|Administrative reason|1|||
27752794|NCT02676895|54203907|FG001|Overall Study|Administrative reason|0|||
27752795|NCT02676895|54203908|FG002|Overall Study|Administrative reason|0|||
27752796|NCT02676895|54203906|FG000|Overall Study|Protocol Violation|1|||
27752797|NCT02676895|54203907|FG001|Overall Study|Protocol Violation|0|||
27752798|NCT02676895|54203908|FG002|Overall Study|Protocol Violation|0|||
27752799|NCT02676895|54203906|FG000|Overall Study|Adverse Event|0|||
27752800|NCT02676895|54203907|FG001|Overall Study|Adverse Event|3|||
27752801|NCT02676895|54203908|FG002|Overall Study|Adverse Event|1|||
27752802|NCT02676895|54203906|FG000|Overall Study|Lost to Follow-up|0|||
27752803|NCT02676895|54203907|FG001|Overall Study|Lost to Follow-up|0|||
27752804|NCT02676895|54203908|FG002|Overall Study|Lost to Follow-up|1|||
27752805|NCT02676895|54203906|FG000|Overall Study|Withdrawal by Subject|0|||
27752806|NCT02676895|54203907|FG001|Overall Study|Withdrawal by Subject|0|||
27752807|NCT02676895|54203908|FG002|Overall Study|Withdrawal by Subject|1|||
27752808|NCT02673697|54203919|FG000|Overall Study|Adverse Event|2|||
27752809|NCT02673697|54203920|FG001|Overall Study|Adverse Event|0|||
27752810|NCT02673697|54203919|FG000|Overall Study|Death|32|||
27752811|NCT02673697|54203920|FG001|Overall Study|Death|24|||
27752812|NCT02673697|54203919|FG000|Overall Study|Lost to Follow-up|5|||
27752813|NCT02673697|54203920|FG001|Overall Study|Lost to Follow-up|2|||
27752814|NCT02673697|54203919|FG000|Overall Study|Physician Decision|2|||
27752815|NCT02673697|54203920|FG001|Overall Study|Physician Decision|1|||
27752816|NCT02673697|54203919|FG000|Overall Study|Withdrawal by Subject|10|||
27752817|NCT02673697|54203920|FG001|Overall Study|Withdrawal by Subject|7|||
27831203|NCT01793051|54307467|FG000|Overall Study|Too ill to continue|1|||
27752818|NCT02673697|54203919|FG000|Overall Study|Change subj medical status|1|||
27752819|NCT02673697|54203920|FG001|Overall Study|Change subj medical status|2|||
27752820|NCT02673697|54203919|FG000|Overall Study|Explant|10|||
27752821|NCT02673697|54203920|FG001|Overall Study|Explant|5|||
27752822|NCT02673697|54203919|FG000|Overall Study|Sponsor Decision to stop follow up|391|||
27752823|NCT02673697|54203920|FG001|Overall Study|Sponsor Decision to stop follow up|416|||
27752824|NCT05168579|54203928|FG000|Overall Study|Lack of Consent|1|||
27752825|NCT05168579|54203929|FG001|Overall Study|Lack of Consent|0|||
27752826|NCT05168579|54203928|FG000|Overall Study|Conflicts with time|2|||
27752827|NCT05168579|54203929|FG001|Overall Study|Conflicts with time|0|||
27752828|NCT05168579|54203928|FG000|Overall Study|Time slots were full|3|||
27752829|NCT05168579|54203929|FG001|Overall Study|Time slots were full|0|||
27752830|NCT05168579|54203928|FG000|Overall Study|Lost to Follow-up|0|||
27752831|NCT05168579|54203929|FG001|Overall Study|Lost to Follow-up|15|||
27752832|NCT02673619|54203942|FG000|Overall Study|Lost to Follow-up|1|||
27752833|NCT02673619|54203943|FG001|Overall Study|Lost to Follow-up|0|||
27752834|NCT02673619|54203944|FG002|Overall Study|Lost to Follow-up|0|||
27752835|NCT02673619|54203945|FG003|Overall Study|Lost to Follow-up|0|||
27752836|NCT02673619|54203942|FG000|Overall Study|Withdrawal by Subject|1|||
27752837|NCT02673619|54203943|FG001|Overall Study|Withdrawal by Subject|1|||
27752838|NCT02673619|54203944|FG002|Overall Study|Withdrawal by Subject|1|||
27752839|NCT02673619|54203945|FG003|Overall Study|Withdrawal by Subject|0|||
27752840|NCT02673619|54203942|FG000|Overall Study|Adverse Event|0|||
27752841|NCT02673619|54203943|FG001|Overall Study|Adverse Event|0|||
27752842|NCT02673619|54203944|FG002|Overall Study|Adverse Event|1|||
27752843|NCT02673619|54203945|FG003|Overall Study|Adverse Event|0|||
27752844|NCT02673619|54203942|FG000|Overall Study|Lack of Efficacy|0|||
27752845|NCT02673619|54203943|FG001|Overall Study|Lack of Efficacy|0|||
27752846|NCT02673619|54203944|FG002|Overall Study|Lack of Efficacy|1|||
27752847|NCT02673619|54203945|FG003|Overall Study|Lack of Efficacy|0|||
27752848|NCT02680639|54203967|FG000|Screening Period|Screen Failure|7|||
27752849|NCT02680639|54203968|FG001|Screening Period|Screen Failure|0|||
27752850|NCT02680639|54203969|FG002|Screening Period|Screen Failure|0|||
27752851|NCT01674725|54203981|FG000|Overall Study|Adverse Event|1|||
27752852|NCT01674725|54203982|FG001|Overall Study|Adverse Event|0|||
27752853|NCT01674725|54203981|FG000|Overall Study|Did not receive study drug|1|||
27752854|NCT01674725|54203982|FG001|Overall Study|Did not receive study drug|0|||
27752855|NCT01674725|54203981|FG000|Overall Study|Withdrawal by Subject|1|||
27752856|NCT01674725|54203982|FG001|Overall Study|Withdrawal by Subject|0|||
27752857|NCT01674725|54203981|FG000|Overall Study|Lost to Follow-up|0|||
27752858|NCT01674725|54203982|FG001|Overall Study|Lost to Follow-up|1|||
27752859|NCT01674569|54203988|FG000|Overall Study|Adverse Event|0|||
27752860|NCT01674569|54203989|FG001|Overall Study|Adverse Event|2|||
27752861|NCT01674569|54203990|FG002|Overall Study|Adverse Event|0|||
27752862|NCT01674569|54203991|FG003|Overall Study|Adverse Event|1|||
27752863|NCT01674569|54203992|FG004|Overall Study|Adverse Event|2|||
27752864|NCT01674569|54203993|FG005|Overall Study|Adverse Event|2|||
27752865|NCT01674569|54203988|FG000|Overall Study|Protocol Violation|0|||
27752866|NCT01674569|54203989|FG001|Overall Study|Protocol Violation|1|||
27752867|NCT01674569|54203990|FG002|Overall Study|Protocol Violation|1|||
27752868|NCT01674569|54203991|FG003|Overall Study|Protocol Violation|0|||
27752869|NCT01674569|54203992|FG004|Overall Study|Protocol Violation|0|||
27752870|NCT01674569|54203993|FG005|Overall Study|Protocol Violation|0|||
27752871|NCT01674569|54203988|FG000|Overall Study|Withdrawal by Subject|0|||
27752872|NCT01674569|54203989|FG001|Overall Study|Withdrawal by Subject|0|||
27752873|NCT01674569|54203990|FG002|Overall Study|Withdrawal by Subject|1|||
27752874|NCT01674569|54203991|FG003|Overall Study|Withdrawal by Subject|0|||
27752875|NCT01674569|54203992|FG004|Overall Study|Withdrawal by Subject|0|||
27752876|NCT01674569|54203993|FG005|Overall Study|Withdrawal by Subject|0|||
27752877|NCT01374217|54203997|FG000|Overall Study|Lack of Efficacy|13|||
27752878|NCT01674647|54204003|FG000|Treatment Period|Death|4|||
27752879|NCT01674647|54204004|FG001|Treatment Period|Death|1|||
27752880|NCT01674647|54204003|FG000|Treatment Period|Efficacy outcome reached|0|||
27752881|NCT01674647|54204004|FG001|Treatment Period|Efficacy outcome reached|1|||
27752882|NCT01674647|54204003|FG000|Treatment Period|Physician Decision|3|||
27752883|NCT01674647|54204004|FG001|Treatment Period|Physician Decision|1|||
27752884|NCT01674647|54204003|FG000|Treatment Period|Adverse Event|60|||
27752885|NCT01674647|54204004|FG001|Treatment Period|Adverse Event|22|||
27752886|NCT01674647|54204003|FG000|Treatment Period|Non-compliance with study drug|3|||
27752887|NCT01674647|54204004|FG001|Treatment Period|Non-compliance with study drug|0|||
27752888|NCT01674647|54204003|FG000|Treatment Period|Lost to Follow-up|1|||
27752889|NCT01674647|54204004|FG001|Treatment Period|Lost to Follow-up|1|||
27752890|NCT01674647|54204003|FG000|Treatment Period|Withdrawal by Subject|19|||
27752891|NCT01674647|54204004|FG001|Treatment Period|Withdrawal by Subject|16|||
27752892|NCT01674647|54204003|FG000|Treatment Period|Switching to other therapy|5|||
27752893|NCT01674647|54204004|FG001|Treatment Period|Switching to other therapy|2|||
27752894|NCT01674647|54204003|FG000|Treatment Period|Logistical difficulties|5|||
27752895|NCT01674647|54204004|FG001|Treatment Period|Logistical difficulties|8|||
27752896|NCT01674647|54204003|FG000|Treatment Period|Treatment failure|0|||
27752897|NCT01674647|54204004|FG001|Treatment Period|Treatment failure|14|||
27752898|NCT01674647|54204003|FG000|Treatment Period|Protocol Violation|56|||
27752899|NCT01674647|54204004|FG001|Treatment Period|Protocol Violation|36|||
27752900|NCT01674647|54204003|FG000|30-day Safety Follow-up Period|Death|3|||
27752901|NCT01674647|54204004|FG001|30-day Safety Follow-up Period|Death|2|||
27752902|NCT01674647|54204003|FG000|30-day Safety Follow-up Period|Non-compliance with study drug|0|||
27752903|NCT01674647|54204004|FG001|30-day Safety Follow-up Period|Non-compliance with study drug|1|||
27752904|NCT01674647|54204003|FG000|30-day Safety Follow-up Period|Protocol Violation|39|||
27752905|NCT01674647|54204004|FG001|30-day Safety Follow-up Period|Protocol Violation|22|||
27752906|NCT01674647|54204003|FG000|30-day Safety Follow-up Period|Logistical difficulties|1|||
27752907|NCT01674647|54204004|FG001|30-day Safety Follow-up Period|Logistical difficulties|3|||
27752908|NCT01674647|54204003|FG000|30-day Safety Follow-up Period|Withdrawal by Subject|7|||
27752909|NCT01674647|54204004|FG001|30-day Safety Follow-up Period|Withdrawal by Subject|8|||
27752910|NCT01674647|54204003|FG000|30-day Safety Follow-up Period|Lost to Follow-up|8|||
27752911|NCT01674647|54204004|FG001|30-day Safety Follow-up Period|Lost to Follow-up|5|||
27752912|NCT02669407|54204010|FG000|Overall Study|Physician Decision|3|||
27752913|NCT02667457|54204016|FG000|Overall Study|Withdrawal by Subject|1|||
27752914|NCT02667457|54204017|FG001|Overall Study|Withdrawal by Subject|0|||
27752915|NCT02667457|54204016|FG000|Overall Study|Other Reason|0|||
27752916|NCT02667457|54204017|FG001|Overall Study|Other Reason|2|||
27752917|NCT02669095|54204026|FG000|Overall Study|Adverse Event|1|||
27752918|NCT02669095|54204027|FG001|Overall Study|Adverse Event|0|||
27752919|NCT02669095|54204026|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
27752920|NCT02669095|54204027|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
27752921|NCT02669095|54204026|FG000|Overall Study|Torn Lens|0|||
27752922|NCT02669095|54204027|FG001|Overall Study|Torn Lens|1|||
27752923|NCT02669095|54204026|FG000|Overall Study|Visit 5 assessments not completed|0|||
27752924|NCT02669095|54204027|FG001|Overall Study|Visit 5 assessments not completed|1|||
27752925|NCT02667301|54204033|FG000|Overall Study|Adverse Event|1|||
27752926|NCT02667301|54204033|FG000|Overall Study|Lack of Efficacy|1|||
27752927|NCT05274165|54204041|FG000|Overall Study|Withdrawal by Subject|3|||
27752928|NCT05274165|54204042|FG001|Overall Study|Withdrawal by Subject|3|||
27752929|NCT04510090|54204084|FG000|FE-HS|Withdrawal by Subject|0|||
27752930|NCT04510090|54204085|FG001|FE-HS|Withdrawal by Subject|0|||
27752931|NCT04510090|54204086|FG002|FE-HS|Withdrawal by Subject|0|||
27752932|NCT04510090|54204087|FG003|FE-HS|Withdrawal by Subject|0|||
27752933|NCT04510090|54204088|FG004|FE-HS|Withdrawal by Subject|1|||
27752934|NCT04510090|54204089|FG005|FE-HS|Withdrawal by Subject|0|||
27752935|NCT04510090|54204090|FG006|FE-HS|Withdrawal by Subject|0|||
27752936|NCT04510090|54204091|FG007|FE-HS|Withdrawal by Subject|0|||
27752937|NCT04491006|54204121|FG000|Overall Study|Adverse Event|0|||
27752938|NCT04491006|54204122|FG001|Overall Study|Adverse Event|3|||
27752939|NCT04491006|54204123|FG002|Overall Study|Adverse Event|5|||
27752940|NCT04491006|54204121|FG000|Overall Study|Withdrawal by Subject|1|||
27752941|NCT04491006|54204122|FG001|Overall Study|Withdrawal by Subject|0|||
27752942|NCT04491006|54204123|FG002|Overall Study|Withdrawal by Subject|2|||
27752943|NCT04162470|54204166|FG000|Overall Study|Withdrawn due to sponsor's decision|24|||
27752944|NCT04122625|54204176|FG000|Part A (up to 2.92 Years)|Death|2|||
27752945|NCT04122625|54204177|FG001|Part A (up to 2.92 Years)|Death|4|||
27752946|NCT04122625|54204178|FG002|Part A (up to 2.92 Years)|Death|0|||
27752947|NCT04122625|54204179|FG003|Part A (up to 2.92 Years)|Death|0|||
27752948|NCT04122625|54204180|FG004|Part A (up to 2.92 Years)|Death|0|||
27752949|NCT04122625|54204181|FG005|Part A (up to 2.92 Years)|Death|0|||
27752950|NCT04122625|54204176|FG000|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
27752951|NCT04122625|54204177|FG001|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
27752952|NCT04122625|54204178|FG002|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
27752953|NCT04122625|54204179|FG003|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
27752954|NCT04122625|54204180|FG004|Part B (up to 2.33 Years)|Patient lost to follow-up|2|||
27752955|NCT04122625|54204181|FG005|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
27752956|NCT04122625|54204176|FG000|Part B (up to 2.33 Years)|Death|0|||
27752957|NCT04122625|54204177|FG001|Part B (up to 2.33 Years)|Death|0|||
27752958|NCT04122625|54204178|FG002|Part B (up to 2.33 Years)|Death|5|||
27752959|NCT04122625|54204179|FG003|Part B (up to 2.33 Years)|Death|7|||
27752960|NCT04122625|54204180|FG004|Part B (up to 2.33 Years)|Death|6|||
27752961|NCT04122625|54204181|FG005|Part B (up to 2.33 Years)|Death|7|||
27752962|NCT03824704|54204199|FG000|Overall Study|Study Terminated by Sponsor|1|||
27836324|NCT01551173|54321265|FG001|Overall Study|Other|3|||
27752963|NCT03766581|54204215|FG000|Randomization|Other reasons|2|||
27752964|NCT03766581|54204216|FG001|Randomization|Other reasons|1|||
27752965|NCT03766581|54204217|FG002|Randomization|Other reasons|0|||
27752966|NCT03766581|54204218|FG003|Randomization|Other reasons|1|||
27752967|NCT03766581|54204219|FG004|Randomization|Other reasons|0|||
27752968|NCT03766581|54204220|FG005|Randomization|Other reasons|0|||
27752969|NCT03766581|54204221|FG006|Randomization|Other reasons|0|||
27752970|NCT03766581|54204222|FG007|Randomization|Other reasons|0|||
27752971|NCT03766581|54204215|FG000|Randomization|Participant no longer meets study criteria|5|||
27752972|NCT03766581|54204216|FG001|Randomization|Participant no longer meets study criteria|3|||
27752973|NCT03766581|54204217|FG002|Randomization|Participant no longer meets study criteria|4|||
27752974|NCT03766581|54204218|FG003|Randomization|Participant no longer meets study criteria|0|||
27752975|NCT03766581|54204219|FG004|Randomization|Participant no longer meets study criteria|2|||
27752976|NCT03766581|54204220|FG005|Randomization|Participant no longer meets study criteria|3|||
27752977|NCT03766581|54204221|FG006|Randomization|Participant no longer meets study criteria|0|||
27752978|NCT03766581|54204222|FG007|Randomization|Participant no longer meets study criteria|1|||
27752979|NCT03766581|54204215|FG000|Randomization|Participant request to discontinue study treatment|1|||
27752980|NCT03766581|54204216|FG001|Randomization|Participant request to discontinue study treatment|0|||
27752981|NCT03766581|54204217|FG002|Randomization|Participant request to discontinue study treatment|0|||
27752982|NCT03766581|54204218|FG003|Randomization|Participant request to discontinue study treatment|0|||
27752983|NCT03766581|54204219|FG004|Randomization|Participant request to discontinue study treatment|1|||
27752984|NCT03766581|54204220|FG005|Randomization|Participant request to discontinue study treatment|2|||
27752985|NCT03766581|54204221|FG006|Randomization|Participant request to discontinue study treatment|0|||
27752986|NCT03766581|54204222|FG007|Randomization|Participant request to discontinue study treatment|0|||
27752987|NCT03766581|54204215|FG000|Randomization|Participant withdrew consent|1|||
27752988|NCT03766581|54204216|FG001|Randomization|Participant withdrew consent|0|||
27752989|NCT03766581|54204217|FG002|Randomization|Participant withdrew consent|1|||
27752990|NCT03766581|54204218|FG003|Randomization|Participant withdrew consent|2|||
27752991|NCT03766581|54204219|FG004|Randomization|Participant withdrew consent|1|||
27752992|NCT03766581|54204220|FG005|Randomization|Participant withdrew consent|1|||
27752993|NCT03766581|54204221|FG006|Randomization|Participant withdrew consent|0|||
27752994|NCT03766581|54204222|FG007|Randomization|Participant withdrew consent|0|||
27752995|NCT03766581|54204215|FG000|Treatment|Adverse Event|82|||
27752996|NCT03766581|54204216|FG001|Treatment|Adverse Event|44|||
27752997|NCT03766581|54204217|FG002|Treatment|Adverse Event|47|||
27752998|NCT03766581|54204218|FG003|Treatment|Adverse Event|46|||
27752999|NCT03766581|54204219|FG004|Treatment|Adverse Event|50|||
27753000|NCT03766581|54204220|FG005|Treatment|Adverse Event|77|||
27753001|NCT03766581|54204221|FG006|Treatment|Adverse Event|5|||
27753002|NCT03766581|54204222|FG007|Treatment|Adverse Event|2|||
27753003|NCT03766581|54204215|FG000|Treatment|Participant request to discontinue treatment|34|||
27753004|NCT03766581|54204216|FG001|Treatment|Participant request to discontinue treatment|6|||
27753005|NCT03766581|54204217|FG002|Treatment|Participant request to discontinue treatment|10|||
27753006|NCT03766581|54204218|FG003|Treatment|Participant request to discontinue treatment|10|||
27753007|NCT03766581|54204219|FG004|Treatment|Participant request to discontinue treatment|14|||
27753008|NCT03766581|54204220|FG005|Treatment|Participant request to discontinue treatment|15|||
27753009|NCT03766581|54204221|FG006|Treatment|Participant request to discontinue treatment|0|||
27753010|NCT03766581|54204222|FG007|Treatment|Participant request to discontinue treatment|1|||
27753011|NCT03766581|54204215|FG000|Treatment|Participant withdrew consent|11|||
27753012|NCT03766581|54204216|FG001|Treatment|Participant withdrew consent|4|||
27753013|NCT03766581|54204217|FG002|Treatment|Participant withdrew consent|5|||
27753014|NCT03766581|54204218|FG003|Treatment|Participant withdrew consent|5|||
27753015|NCT03766581|54204219|FG004|Treatment|Participant withdrew consent|4|||
27753016|NCT03766581|54204220|FG005|Treatment|Participant withdrew consent|4|||
27753017|NCT03766581|54204221|FG006|Treatment|Participant withdrew consent|0|||
27753018|NCT03766581|54204222|FG007|Treatment|Participant withdrew consent|0|||
27753019|NCT03766581|54204215|FG000|Treatment|Death|1|||
27753020|NCT03766581|54204216|FG001|Treatment|Death|0|||
27753021|NCT03766581|54204217|FG002|Treatment|Death|0|||
27753022|NCT03766581|54204218|FG003|Treatment|Death|0|||
27753023|NCT03766581|54204219|FG004|Treatment|Death|0|||
27753024|NCT03766581|54204220|FG005|Treatment|Death|0|||
27753025|NCT03766581|54204221|FG006|Treatment|Death|0|||
27753026|NCT03766581|54204222|FG007|Treatment|Death|0|||
27753027|NCT03766581|54204215|FG000|Treatment|Lost to Follow-up|1|||
27753028|NCT03766581|54204216|FG001|Treatment|Lost to Follow-up|0|||
27753029|NCT03766581|54204217|FG002|Treatment|Lost to Follow-up|0|||
27753030|NCT03766581|54204218|FG003|Treatment|Lost to Follow-up|1|||
27753031|NCT03766581|54204219|FG004|Treatment|Lost to Follow-up|0|||
27753032|NCT03766581|54204220|FG005|Treatment|Lost to Follow-up|0|||
27753033|NCT03766581|54204221|FG006|Treatment|Lost to Follow-up|0|||
27753034|NCT03766581|54204222|FG007|Treatment|Lost to Follow-up|0|||
27753035|NCT03766581|54204215|FG000|Treatment|Poor/Non compliance|2|||
27753036|NCT03766581|54204216|FG001|Treatment|Poor/Non compliance|2|||
27753037|NCT03766581|54204217|FG002|Treatment|Poor/Non compliance|1|||
27753038|NCT03766581|54204218|FG003|Treatment|Poor/Non compliance|1|||
27753039|NCT03766581|54204219|FG004|Treatment|Poor/Non compliance|1|||
27753040|NCT03766581|54204220|FG005|Treatment|Poor/Non compliance|1|||
27753041|NCT03766581|54204221|FG006|Treatment|Poor/Non compliance|0|||
27753042|NCT03766581|54204222|FG007|Treatment|Poor/Non compliance|0|||
27753043|NCT03766581|54204215|FG000|Treatment|Participant no longer meets study criteria|9|||
27831204|NCT01793051|54307468|FG001|Overall Study|Too ill to continue|0|||
27753044|NCT03766581|54204216|FG001|Treatment|Participant no longer meets study criteria|1|||
27753045|NCT03766581|54204217|FG002|Treatment|Participant no longer meets study criteria|5|||
27753046|NCT03766581|54204218|FG003|Treatment|Participant no longer meets study criteria|4|||
27753047|NCT03766581|54204219|FG004|Treatment|Participant no longer meets study criteria|4|||
27753048|NCT03766581|54204220|FG005|Treatment|Participant no longer meets study criteria|4|||
27753049|NCT03766581|54204221|FG006|Treatment|Participant no longer meets study criteria|2|||
27753050|NCT03766581|54204222|FG007|Treatment|Participant no longer meets study criteria|0|||
27753051|NCT03766581|54204215|FG000|Treatment|Other reasons|13|||
27753052|NCT03766581|54204216|FG001|Treatment|Other reasons|8|||
27753053|NCT03766581|54204217|FG002|Treatment|Other reasons|3|||
27753054|NCT03766581|54204218|FG003|Treatment|Other reasons|7|||
27753055|NCT03766581|54204219|FG004|Treatment|Other reasons|3|||
27753056|NCT03766581|54204220|FG005|Treatment|Other reasons|3|||
27753057|NCT03766581|54204221|FG006|Treatment|Other reasons|0|||
27753058|NCT03766581|54204222|FG007|Treatment|Other reasons|0|||
27753059|NCT03675321|54204247|FG000|Overall Study|Lack of Efficacy|2|||
27753060|NCT03675321|54204248|FG001|Overall Study|Lack of Efficacy|2|||
27753061|NCT03675321|54204247|FG000|Overall Study|Withdrawal by Subject|1|||
27753062|NCT03675321|54204248|FG001|Overall Study|Withdrawal by Subject|3|||
27753063|NCT03635983|54204256|FG000|Pre-Treatment Period|Not yet treated at the time of database lock|1|||
27753064|NCT03635983|54204257|FG001|Pre-Treatment Period|Not yet treated at the time of database lock|0|||
27753065|NCT03635983|54204256|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
27753066|NCT03635983|54204257|FG001|Pre-Treatment Period|Withdrawal by Subject|7|||
27753067|NCT03635983|54204256|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
27753068|NCT03635983|54204257|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
27753069|NCT03635983|54204256|FG000|Pre-Treatment Period|Other reasons|1|||
27753070|NCT03635983|54204257|FG001|Pre-Treatment Period|Other reasons|2|||
27753071|NCT03635983|54204256|FG000|Pre-Treatment Period|Disease Progression|0|||
27753072|NCT03635983|54204257|FG001|Pre-Treatment Period|Disease Progression|1|||
27753073|NCT03635983|54204256|FG000|Pre-Treatment Period|Adverse Event unrelated to Study drug|1|||
27753074|NCT03635983|54204257|FG001|Pre-Treatment Period|Adverse Event unrelated to Study drug|0|||
27753075|NCT03635983|54204256|FG000|Treatment Period|Completed treatment period|13|||
27753076|NCT03635983|54204257|FG001|Treatment Period|Completed treatment period|20|||
27753077|NCT03635983|54204256|FG000|Treatment Period|Participant request to discontinue Study treatment|5|||
27753078|NCT03635983|54204257|FG001|Treatment Period|Participant request to discontinue Study treatment|5|||
27753079|NCT03635983|54204256|FG000|Treatment Period|Withdrawal by Subject|2|||
27753080|NCT03635983|54204257|FG001|Treatment Period|Withdrawal by Subject|4|||
27753081|NCT03635983|54204256|FG000|Treatment Period|Death|3|||
27753082|NCT03635983|54204257|FG001|Treatment Period|Death|4|||
27753083|NCT03635983|54204256|FG000|Treatment Period|Poor/Non-compliance|1|||
27753084|NCT03635983|54204257|FG001|Treatment Period|Poor/Non-compliance|0|||
27753085|NCT03635983|54204256|FG000|Treatment Period|Participant no longer meets Study criteria|0|||
27753086|NCT03635983|54204257|FG001|Treatment Period|Participant no longer meets Study criteria|2|||
27753087|NCT03635983|54204256|FG000|Treatment Period|Other reasons|5|||
27753088|NCT03635983|54204257|FG001|Treatment Period|Other reasons|2|||
27753089|NCT03635983|54204256|FG000|Treatment Period|Disease progression|184|||
27753090|NCT03635983|54204257|FG001|Treatment Period|Disease progression|168|||
27753091|NCT03635983|54204256|FG000|Treatment Period|Study drug toxicity|26|||
27753092|NCT03635983|54204257|FG001|Treatment Period|Study drug toxicity|29|||
27753093|NCT03635983|54204256|FG000|Treatment Period|Adverse event unrelated to Study drug|10|||
27753094|NCT03635983|54204257|FG001|Treatment Period|Adverse event unrelated to Study drug|11|||
27753095|NCT03635983|54204256|FG000|Treatment Period|Maximum clinical benefit|3|||
27753096|NCT03635983|54204257|FG001|Treatment Period|Maximum clinical benefit|2|||
27753097|NCT03527745|54204303|FG000|Overall Study|Lost to Follow-up|3|||
27753098|NCT03527745|54204304|FG001|Overall Study|Lost to Follow-up|6|||
27753099|NCT03527745|54204305|FG002|Overall Study|Lost to Follow-up|7|||
27753100|NCT03527745|54204306|FG003|Overall Study|Lost to Follow-up|9|||
27753101|NCT03527745|54204307|FG004|Overall Study|Lost to Follow-up|0|||
27753102|NCT03527745|54204308|FG005|Overall Study|Lost to Follow-up|2|||
27753103|NCT03527745|54204309|FG006|Overall Study|Lost to Follow-up|3|||
27753104|NCT03527745|54204310|FG007|Overall Study|Lost to Follow-up|2|||
27753105|NCT03527745|54204311|FG008|Overall Study|Lost to Follow-up|3|||
27753106|NCT03527745|54204312|FG009|Overall Study|Lost to Follow-up|2|||
27753107|NCT03527745|54204313|FG010|Overall Study|Lost to Follow-up|1|||
27753108|NCT03527745|54204314|FG011|Overall Study|Lost to Follow-up|1|||
27753109|NCT03527745|54204315|FG012|Overall Study|Lost to Follow-up|0|||
27753110|NCT03527745|54204316|FG013|Overall Study|Lost to Follow-up|0|||
27753111|NCT03527745|54204317|FG014|Overall Study|Lost to Follow-up|0|||
27753112|NCT03527745|54204318|FG015|Overall Study|Lost to Follow-up|0|||
27753113|NCT03527745|54204319|FG016|Overall Study|Lost to Follow-up|1|||
27753114|NCT03527745|54204320|FG017|Overall Study|Lost to Follow-up|0|||
27753115|NCT03527745|54204321|FG018|Overall Study|Lost to Follow-up|0|||
27753116|NCT03527745|54204322|FG019|Overall Study|Lost to Follow-up|1|||
27753117|NCT03527745|54204323|FG020|Overall Study|Lost to Follow-up|1|||
27753118|NCT03527745|54204324|FG021|Overall Study|Lost to Follow-up|5|||
27753119|NCT03527745|54204325|FG022|Overall Study|Lost to Follow-up|6|||
27753120|NCT03527745|54204326|FG023|Overall Study|Lost to Follow-up|8|||
27753121|NCT03527745|54204327|FG024|Overall Study|Lost to Follow-up|1|||
27753122|NCT03527745|54204328|FG025|Overall Study|Lost to Follow-up|3|||
27753123|NCT03330405|54204419|FG000|Overall Study|Other|0|||
27753124|NCT03330405|54204420|FG001|Overall Study|Other|1|||
27753125|NCT03330405|54204421|FG002|Overall Study|Other|0|||
27753126|NCT03330405|54204422|FG003|Overall Study|Other|0|||
27753127|NCT03330405|54204423|FG004|Overall Study|Other|0|||
27753128|NCT03330405|54204424|FG005|Overall Study|Other|0|||
27753129|NCT03330405|54204425|FG006|Overall Study|Other|1|||
27753130|NCT03330405|54204426|FG007|Overall Study|Other|0|||
27753131|NCT03330405|54204427|FG008|Overall Study|Other|0|||
27753132|NCT03330405|54204428|FG009|Overall Study|Other|0|||
27753133|NCT03330405|54204429|FG010|Overall Study|Other|0|||
27753134|NCT03330405|54204419|FG000|Overall Study|Ongoing|1|||
27753135|NCT03330405|54204420|FG001|Overall Study|Ongoing|4|||
27753136|NCT03330405|54204421|FG002|Overall Study|Ongoing|1|||
27753137|NCT03330405|54204422|FG003|Overall Study|Ongoing|0|||
27753138|NCT03330405|54204423|FG004|Overall Study|Ongoing|2|||
27753139|NCT03330405|54204424|FG005|Overall Study|Ongoing|0|||
27753140|NCT03330405|54204425|FG006|Overall Study|Ongoing|0|||
27753141|NCT03330405|54204426|FG007|Overall Study|Ongoing|2|||
27753142|NCT03330405|54204427|FG008|Overall Study|Ongoing|0|||
27753143|NCT03330405|54204428|FG009|Overall Study|Ongoing|0|||
27753144|NCT03330405|54204429|FG010|Overall Study|Ongoing|0|||
27753145|NCT03330405|54204419|FG000|Overall Study|Progressive disease|8|||
27753146|NCT03330405|54204420|FG001|Overall Study|Progressive disease|26|||
27753147|NCT03330405|54204421|FG002|Overall Study|Progressive disease|4|||
27753148|NCT03330405|54204422|FG003|Overall Study|Progressive disease|18|||
27753149|NCT03330405|54204423|FG004|Overall Study|Progressive disease|16|||
27753150|NCT03330405|54204424|FG005|Overall Study|Progressive disease|14|||
27753151|NCT03330405|54204425|FG006|Overall Study|Progressive disease|7|||
27753152|NCT03330405|54204426|FG007|Overall Study|Progressive disease|29|||
27753153|NCT03330405|54204427|FG008|Overall Study|Progressive disease|9|||
27753154|NCT03330405|54204428|FG009|Overall Study|Progressive disease|11|||
27753155|NCT03330405|54204429|FG010|Overall Study|Progressive disease|5|||
27753156|NCT03330405|54204419|FG000|Overall Study|Withdrawal by Subject|1|||
27753157|NCT03330405|54204420|FG001|Overall Study|Withdrawal by Subject|4|||
27753158|NCT03330405|54204421|FG002|Overall Study|Withdrawal by Subject|0|||
27753159|NCT03330405|54204422|FG003|Overall Study|Withdrawal by Subject|1|||
27753160|NCT03330405|54204423|FG004|Overall Study|Withdrawal by Subject|1|||
27753161|NCT03330405|54204424|FG005|Overall Study|Withdrawal by Subject|1|||
27753162|NCT03330405|54204425|FG006|Overall Study|Withdrawal by Subject|0|||
27753163|NCT03330405|54204426|FG007|Overall Study|Withdrawal by Subject|1|||
27753164|NCT03330405|54204427|FG008|Overall Study|Withdrawal by Subject|2|||
27753165|NCT03330405|54204428|FG009|Overall Study|Withdrawal by Subject|1|||
27753166|NCT03330405|54204429|FG010|Overall Study|Withdrawal by Subject|1|||
27753167|NCT03330405|54204419|FG000|Overall Study|Global deterioration of health status|2|||
27753168|NCT03330405|54204420|FG001|Overall Study|Global deterioration of health status|3|||
27753169|NCT03330405|54204421|FG002|Overall Study|Global deterioration of health status|0|||
27753170|NCT03330405|54204422|FG003|Overall Study|Global deterioration of health status|2|||
27753171|NCT03330405|54204423|FG004|Overall Study|Global deterioration of health status|3|||
27753172|NCT03330405|54204424|FG005|Overall Study|Global deterioration of health status|3|||
27753173|NCT03330405|54204425|FG006|Overall Study|Global deterioration of health status|0|||
27753174|NCT03330405|54204426|FG007|Overall Study|Global deterioration of health status|2|||
27753175|NCT03330405|54204427|FG008|Overall Study|Global deterioration of health status|8|||
27753176|NCT03330405|54204428|FG009|Overall Study|Global deterioration of health status|4|||
27753177|NCT03330405|54204429|FG010|Overall Study|Global deterioration of health status|1|||
27753178|NCT03330405|54204419|FG000|Overall Study|Adverse Event|0|||
27753179|NCT03330405|54204420|FG001|Overall Study|Adverse Event|0|||
27753180|NCT03330405|54204421|FG002|Overall Study|Adverse Event|0|||
27753181|NCT03330405|54204422|FG003|Overall Study|Adverse Event|1|||
27753182|NCT03330405|54204423|FG004|Overall Study|Adverse Event|1|||
27753183|NCT03330405|54204424|FG005|Overall Study|Adverse Event|1|||
27753184|NCT03330405|54204425|FG006|Overall Study|Adverse Event|3|||
27753185|NCT03330405|54204426|FG007|Overall Study|Adverse Event|3|||
27753186|NCT03330405|54204427|FG008|Overall Study|Adverse Event|2|||
27753187|NCT03330405|54204428|FG009|Overall Study|Adverse Event|2|||
27753188|NCT03330405|54204429|FG010|Overall Study|Adverse Event|2|||
27753189|NCT03330405|54204419|FG000|Overall Study|Death|0|||
27753190|NCT03330405|54204420|FG001|Overall Study|Death|4|||
27753191|NCT03330405|54204421|FG002|Overall Study|Death|0|||
27753192|NCT03330405|54204422|FG003|Overall Study|Death|0|||
27753193|NCT03330405|54204423|FG004|Overall Study|Death|0|||
27753194|NCT03330405|54204424|FG005|Overall Study|Death|1|||
27753195|NCT03330405|54204425|FG006|Overall Study|Death|0|||
27753196|NCT03330405|54204426|FG007|Overall Study|Death|2|||
27753197|NCT03330405|54204427|FG008|Overall Study|Death|0|||
27753198|NCT03330405|54204428|FG009|Overall Study|Death|0|||
27753199|NCT03330405|54204429|FG010|Overall Study|Death|0|||
27753200|NCT03330405|54204419|FG000|Overall Study|Physician Decision|0|||
27753201|NCT03330405|54204420|FG001|Overall Study|Physician Decision|0|||
27753202|NCT03330405|54204421|FG002|Overall Study|Physician Decision|0|||
27753203|NCT03330405|54204422|FG003|Overall Study|Physician Decision|0|||
27753204|NCT03330405|54204423|FG004|Overall Study|Physician Decision|0|||
27753205|NCT03330405|54204424|FG005|Overall Study|Physician Decision|0|||
27753206|NCT03330405|54204425|FG006|Overall Study|Physician Decision|0|||
27753207|NCT03330405|54204426|FG007|Overall Study|Physician Decision|1|||
27753208|NCT03330405|54204427|FG008|Overall Study|Physician Decision|0|||
27753209|NCT03330405|54204428|FG009|Overall Study|Physician Decision|0|||
27753210|NCT03330405|54204429|FG010|Overall Study|Physician Decision|0|||
27753211|NCT03174782|54204474|FG000|Overall Study|Protocol Violation|1|||
27753212|NCT03174782|54204475|FG001|Overall Study|Protocol Violation|0|||
27753213|NCT03174782|54204474|FG000|Overall Study|Unable to perform procedure by medical staff|0|||
27753214|NCT03174782|54204475|FG001|Overall Study|Unable to perform procedure by medical staff|1|||
27753215|NCT02919969|54204481|FG000|Overall Study|Lack of Efficacy|22|||
27753216|NCT02919969|54204481|FG000|Overall Study|Death|4|||
27753217|NCT02919969|54204481|FG000|Overall Study|Physician Decision|3|||
27753218|NCT02919969|54204481|FG000|Overall Study|Withdrawal by Subject|2|||
27753219|NCT02003209|54204501|FG000|Overall Study|Patient not at risk for primary endpoint|5|||
27753220|NCT02003209|54204502|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
27753221|NCT01891344|54204512|FG000|Overall Study|Ongoing|6|||
27753222|NCT01891344|54204513|FG001|Overall Study|Ongoing|2|||
27753223|NCT01891344|54204514|FG002|Overall Study|Ongoing|0|||
27753224|NCT01891344|54204515|FG003|Overall Study|Ongoing|1|||
27753225|NCT01891344|54204516|FG004|Overall Study|Ongoing|4|||
27753226|NCT01891344|54204517|FG005|Overall Study|Ongoing|1|||
27753227|NCT01891344|54204518|FG006|Overall Study|Ongoing|0|||
27753228|NCT01891344|54204519|FG007|Overall Study|Ongoing|0|||
27753229|NCT01828099|54204539|FG000|Overall Study|Adverse Event|15|||
27753230|NCT01828099|54204540|FG001|Overall Study|Adverse Event|18|||
27753231|NCT01828099|54204539|FG000|Overall Study|Death|9|||
27753232|NCT01828099|54204540|FG001|Overall Study|Death|11|||
27753233|NCT01828099|54204539|FG000|Overall Study|Lost to Follow-up|2|||
27753234|NCT01828099|54204540|FG001|Overall Study|Lost to Follow-up|0|||
27753235|NCT01828099|54204539|FG000|Overall Study|Non-compliance with study treatment|2|||
27753236|NCT01828099|54204540|FG001|Overall Study|Non-compliance with study treatment|0|||
27753237|NCT01828099|54204539|FG000|Overall Study|Physician Decision|7|||
27753238|NCT01828099|54204540|FG001|Overall Study|Physician Decision|11|||
27753239|NCT01828099|54204539|FG000|Overall Study|Progressive disease|51|||
27753240|NCT01828099|54204540|FG001|Overall Study|Progressive disease|94|||
27753241|NCT01828099|54204539|FG000|Overall Study|Protocol Violation|1|||
27753242|NCT01828099|54204540|FG001|Overall Study|Protocol Violation|0|||
27753243|NCT01828099|54204539|FG000|Overall Study|Subject/guardian decision|7|||
27753244|NCT01828099|54204540|FG001|Overall Study|Subject/guardian decision|23|||
27753245|NCT01188096|54204546|FG000|Overall Study|progression of disease|4|||
27753246|NCT01188096|54204546|FG000|Overall Study|Withdrawal by Subject|2|||
27753247|NCT00579826|54204566|FG000|Overall Study|Withdrawal by Subject|5|||
27753248|NCT00579826|54204567|FG001|Overall Study|Withdrawal by Subject|3|||
27753249|NCT00106691|54204575|FG000|Overall Study|Adverse Event|60|||
27753250|NCT00106691|54204576|FG001|Overall Study|Adverse Event|64|||
27753251|NCT00106691|54204575|FG000|Overall Study|Lost to Follow-up|23|||
27753252|NCT00106691|54204576|FG001|Overall Study|Lost to Follow-up|18|||
27753253|NCT00106691|54204575|FG000|Overall Study|Physician Decision|18|||
27753254|NCT00106691|54204576|FG001|Overall Study|Physician Decision|21|||
27753255|NCT00106691|54204575|FG000|Overall Study|Protocol Violation|13|||
27753256|NCT00106691|54204576|FG001|Overall Study|Protocol Violation|18|||
27753257|NCT00106691|54204575|FG000|Overall Study|Withdrawal by Subject|75|||
27753258|NCT00106691|54204576|FG001|Overall Study|Withdrawal by Subject|70|||
27753259|NCT00106691|54204575|FG000|Overall Study|Failure to comply w/dosing regimen|6|||
27753260|NCT00106691|54204576|FG001|Overall Study|Failure to comply w/dosing regimen|4|||
27753261|NCT00106691|54204575|FG000|Overall Study|QTc>480|3|||
27753262|NCT00106691|54204576|FG001|Overall Study|QTc>480|1|||
27753263|NCT00106691|54204575|FG000|Overall Study|mililtary deployment|2|||
27753264|NCT00106691|54204576|FG001|Overall Study|mililtary deployment|0|||
27753265|NCT00106691|54204575|FG000|Overall Study|Study Site Closing/PI Moved|1|||
27753266|NCT00106691|54204576|FG001|Overall Study|Study Site Closing/PI Moved|2|||
27753267|NCT00106691|54204575|FG000|Overall Study|Cardiologist recommendation|1|||
27753268|NCT00106691|54204576|FG001|Overall Study|Cardiologist recommendation|0|||
27753269|NCT00106691|54204575|FG000|Overall Study|Pt. moved to another state|1|||
27753270|NCT00106691|54204576|FG001|Overall Study|Pt. moved to another state|0|||
27753271|NCT00106691|54204575|FG000|Overall Study|Taking exclusionary avodart|1|||
27753272|NCT00106691|54204576|FG001|Overall Study|Taking exclusionary avodart|0|||
27753273|NCT00106691|54204575|FG000|Overall Study|Not able to discontinue plavix|0|||
27753274|NCT00106691|54204576|FG001|Overall Study|Not able to discontinue plavix|1|||
27753275|NCT04209725|54204584|FG000|Overall Study|Adverse Event|1|||
27753276|NCT02644967|54204677|FG000|Overall Study|Death|26|||
27753277|NCT02644967|54204677|FG000|Overall Study|Physician Decision|1|||
27753278|NCT02644967|54204677|FG000|Overall Study|Withdrawal by Subject|2|||
27753279|NCT02644967|54204677|FG000|Overall Study|Protocol Violation|1|||
27753280|NCT02644967|54204677|FG000|Overall Study|Progressive Disease|1|||
27753281|NCT02644967|54204677|FG000|Overall Study|Study Terminated by Sponsor|4|||
27753282|NCT02644343|54204681|FG000|Overall Study|Withdrawal by Subject|1|||
27753283|NCT02644109|54204687|FG000|Overall Study|Adverse Event|0|||
27753284|NCT02644109|54204688|FG001|Overall Study|Adverse Event|4|||
27753285|NCT02642159|54204696|FG000|Overall Study|Randomized but not treated|1|||
27753286|NCT02642159|54204697|FG001|Overall Study|Randomized but not treated|0|||
27753287|NCT02642159|54204696|FG000|Overall Study|Adverse Event|10|||
27753288|NCT02642159|54204697|FG001|Overall Study|Adverse Event|4|||
27753289|NCT02642159|54204696|FG000|Overall Study|Withdrawal by Subject|9|||
27753290|NCT02642159|54204697|FG001|Overall Study|Withdrawal by Subject|1|||
27753291|NCT02642159|54204696|FG000|Overall Study|Poor compliance to study protocol|1|||
27753292|NCT02642159|54204697|FG001|Overall Study|Poor compliance to study protocol|0|||
27753293|NCT02642159|54204696|FG000|Overall Study|Other than specified above|10|||
27753294|NCT02642159|54204697|FG001|Overall Study|Other than specified above|3|||
27753295|NCT02669017|54204713|FG000|Overall Study|Death|1|||
27753296|NCT02669017|54204714|FG001|Overall Study|Death|2|||
27753297|NCT02669017|54204715|FG002|Overall Study|Death|2|||
27753298|NCT02669017|54204716|FG003|Overall Study|Death|3|||
27753299|NCT02669017|54204717|FG004|Overall Study|Death|8|||
27753300|NCT02669017|54204718|FG005|Overall Study|Death|18|||
27753301|NCT02669017|54204719|FG006|Overall Study|Death|10|||
27753302|NCT02669017|54204720|FG007|Overall Study|Death|47|||
27753303|NCT02669017|54204721|FG008|Overall Study|Death|20|||
27753304|NCT02669017|54204713|FG000|Overall Study|Withdrawal by Subject|0|||
27753305|NCT02669017|54204714|FG001|Overall Study|Withdrawal by Subject|0|||
27753306|NCT02669017|54204715|FG002|Overall Study|Withdrawal by Subject|0|||
27753307|NCT02669017|54204716|FG003|Overall Study|Withdrawal by Subject|1|||
27753308|NCT02669017|54204717|FG004|Overall Study|Withdrawal by Subject|2|||
27753309|NCT02669017|54204718|FG005|Overall Study|Withdrawal by Subject|0|||
27753310|NCT02669017|54204719|FG006|Overall Study|Withdrawal by Subject|0|||
27753311|NCT02669017|54204720|FG007|Overall Study|Withdrawal by Subject|2|||
27753312|NCT02669017|54204721|FG008|Overall Study|Withdrawal by Subject|2|||
27753313|NCT02669017|54204713|FG000|Overall Study|Lost to Follow-up|0|||
27753314|NCT02669017|54204714|FG001|Overall Study|Lost to Follow-up|0|||
27753315|NCT02669017|54204715|FG002|Overall Study|Lost to Follow-up|0|||
27753316|NCT02669017|54204716|FG003|Overall Study|Lost to Follow-up|0|||
27753317|NCT02669017|54204717|FG004|Overall Study|Lost to Follow-up|0|||
27753318|NCT02669017|54204718|FG005|Overall Study|Lost to Follow-up|0|||
27753319|NCT02669017|54204719|FG006|Overall Study|Lost to Follow-up|0|||
27753320|NCT02669017|54204720|FG007|Overall Study|Lost to Follow-up|0|||
27753321|NCT02669017|54204721|FG008|Overall Study|Lost to Follow-up|1|||
27753322|NCT02669017|54204713|FG000|Overall Study|Miscellaneous|0|||
27753323|NCT02669017|54204714|FG001|Overall Study|Miscellaneous|0|||
27753324|NCT02669017|54204715|FG002|Overall Study|Miscellaneous|0|||
27753325|NCT02669017|54204716|FG003|Overall Study|Miscellaneous|0|||
27753326|NCT02669017|54204717|FG004|Overall Study|Miscellaneous|2|||
27753327|NCT02669017|54204718|FG005|Overall Study|Miscellaneous|1|||
27753328|NCT02669017|54204719|FG006|Overall Study|Miscellaneous|1|||
27753329|NCT02669017|54204720|FG007|Overall Study|Miscellaneous|13|||
27753330|NCT02669017|54204721|FG008|Overall Study|Miscellaneous|2|||
27753331|NCT02668393|54204751|FG000|Overall Study|Progressive disease|6|||
27753332|NCT02668393|54204752|FG001|Overall Study|Progressive disease|3|||
27753333|NCT02668393|54204751|FG000|Overall Study|Adverse Event|0|||
27753334|NCT02668393|54204752|FG001|Overall Study|Adverse Event|2|||
27753335|NCT02668393|54204751|FG000|Overall Study|Withdrawal from the trial|0|||
27753336|NCT02668393|54204752|FG001|Overall Study|Withdrawal from the trial|1|||
27753337|NCT02668393|54204751|FG000|Overall Study|Lack of benefit and side effects|1|||
27753338|NCT02668393|54204752|FG001|Overall Study|Lack of benefit and side effects|0|||
27753339|NCT01998958|54204766|FG000|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
27753340|NCT01998958|54204767|FG001|Period 1 (Panel A and B)|Withdrawal by Subject|1|||
27753341|NCT01998958|54204768|FG002|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
27753342|NCT01998958|54204769|FG003|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
27753343|NCT01998958|54204770|FG004|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
27753344|NCT01998958|54204771|FG005|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
27753345|NCT01998958|54204772|FG006|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
27753346|NCT01998958|54204773|FG007|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
27753347|NCT01998958|54204774|FG008|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
27753348|NCT01998958|54204775|FG009|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
27753349|NCT01998958|54204776|FG010|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
27753350|NCT01998958|54204777|FG011|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
27753351|NCT01998958|54204778|FG012|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
27753352|NCT01998958|54204779|FG013|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
27753353|NCT01998958|54204780|FG014|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
27753354|NCT01998958|54204781|FG015|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
27753355|NCT01998958|54204782|FG016|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
27753356|NCT01998958|54204783|FG017|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
27753357|NCT01998958|54204784|FG018|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
27753358|NCT01998958|54204785|FG019|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
27753359|NCT01998958|54204786|FG020|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
27753360|NCT01998958|54204787|FG021|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
27753361|NCT01998958|54204788|FG022|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
27753362|NCT01998958|54204789|FG023|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
27753363|NCT01998958|54204790|FG024|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
27753364|NCT01998958|54204791|FG025|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
27753365|NCT01998958|54204792|FG026|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
27753366|NCT01998958|54204793|FG027|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
27753367|NCT01998958|54204794|FG028|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
27753368|NCT01998958|54204795|FG029|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
27753369|NCT01998958|54204796|FG030|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
27753370|NCT01998958|54204797|FG031|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
27753371|NCT01998958|54204766|FG000|Period 1 (Panel A and B)|Lack of Efficacy|0|||
27753372|NCT01998958|54204767|FG001|Period 1 (Panel A and B)|Lack of Efficacy|1|||
27753373|NCT01998958|54204768|FG002|Period 1 (Panel A and B)|Lack of Efficacy|0|||
27753374|NCT01998958|54204769|FG003|Period 1 (Panel A and B)|Lack of Efficacy|0|||
27753375|NCT01998958|54204770|FG004|Period 1 (Panel A and B)|Lack of Efficacy|0|||
27753376|NCT01998958|54204771|FG005|Period 1 (Panel A and B)|Lack of Efficacy|0|||
27753377|NCT01998958|54204772|FG006|Period 1 (Panel A and B)|Lack of Efficacy|0|||
27753378|NCT01998958|54204773|FG007|Period 1 (Panel A and B)|Lack of Efficacy|0|||
27753379|NCT01998958|54204774|FG008|Period 1 (Panel A and B)|Lack of Efficacy|0|||
27753380|NCT01998958|54204775|FG009|Period 1 (Panel A and B)|Lack of Efficacy|0|||
27753381|NCT01998958|54204776|FG010|Period 1 (Panel A and B)|Lack of Efficacy|0|||
27753382|NCT01998958|54204777|FG011|Period 1 (Panel A and B)|Lack of Efficacy|0|||
27753383|NCT01998958|54204778|FG012|Period 1 (Panel A and B)|Lack of Efficacy|0|||
27753384|NCT01998958|54204779|FG013|Period 1 (Panel A and B)|Lack of Efficacy|0|||
27753385|NCT01998958|54204780|FG014|Period 1 (Panel A and B)|Lack of Efficacy|0|||
27753386|NCT01998958|54204781|FG015|Period 1 (Panel A and B)|Lack of Efficacy|0|||
27753387|NCT01998958|54204782|FG016|Period 1 (Panel A and B)|Lack of Efficacy|0|||
27753388|NCT01998958|54204783|FG017|Period 1 (Panel A and B)|Lack of Efficacy|0|||
27753389|NCT01998958|54204784|FG018|Period 1 (Panel A and B)|Lack of Efficacy|0|||
27753390|NCT01998958|54204785|FG019|Period 1 (Panel A and B)|Lack of Efficacy|0|||
27753391|NCT01998958|54204786|FG020|Period 1 (Panel A and B)|Lack of Efficacy|0|||
27753392|NCT01998958|54204787|FG021|Period 1 (Panel A and B)|Lack of Efficacy|0|||
27753393|NCT01998958|54204788|FG022|Period 1 (Panel A and B)|Lack of Efficacy|0|||
27753394|NCT01998958|54204789|FG023|Period 1 (Panel A and B)|Lack of Efficacy|0|||
27753395|NCT01998958|54204790|FG024|Period 1 (Panel A and B)|Lack of Efficacy|0|||
27753396|NCT01998958|54204791|FG025|Period 1 (Panel A and B)|Lack of Efficacy|0|||
27753397|NCT01998958|54204792|FG026|Period 1 (Panel A and B)|Lack of Efficacy|0|||
27753398|NCT01998958|54204793|FG027|Period 1 (Panel A and B)|Lack of Efficacy|0|||
27753399|NCT01998958|54204794|FG028|Period 1 (Panel A and B)|Lack of Efficacy|0|||
27753400|NCT01998958|54204795|FG029|Period 1 (Panel A and B)|Lack of Efficacy|0|||
27753401|NCT01998958|54204796|FG030|Period 1 (Panel A and B)|Lack of Efficacy|0|||
27753402|NCT01998958|54204797|FG031|Period 1 (Panel A and B)|Lack of Efficacy|0|||
27753403|NCT01998958|54204766|FG000|Period 1 (Panel A and B)|Adverse Event|0|||
27753404|NCT01998958|54204767|FG001|Period 1 (Panel A and B)|Adverse Event|1|||
27753405|NCT01998958|54204768|FG002|Period 1 (Panel A and B)|Adverse Event|0|||
27836325|NCT01549613|54321274|FG000|Overall Study|Lost to Follow-up|11|||
27836326|NCT01549613|54321275|FG001|Overall Study|Lost to Follow-up|11|||
27836327|NCT01548599|54321283|FG000|Overall Study|Lost to Follow-up|0|||
27836328|NCT01548599|54321284|FG001|Overall Study|Lost to Follow-up|1|||
27836329|NCT01548599|54321283|FG000|Overall Study|Withdrawal by Subject|4|||
27836330|NCT01548599|54321284|FG001|Overall Study|Withdrawal by Subject|0|||
27836331|NCT01548599|54321283|FG000|Overall Study|Death|2|||
27836332|NCT01548599|54321284|FG001|Overall Study|Death|1|||
27836333|NCT01548287|54321297|FG000|Screening|No reason provided|0|||
27753406|NCT01998958|54204769|FG003|Period 1 (Panel A and B)|Adverse Event|0|||
27753407|NCT01998958|54204770|FG004|Period 1 (Panel A and B)|Adverse Event|0|||
27753408|NCT01998958|54204771|FG005|Period 1 (Panel A and B)|Adverse Event|0|||
27753409|NCT01998958|54204772|FG006|Period 1 (Panel A and B)|Adverse Event|0|||
27753410|NCT01998958|54204773|FG007|Period 1 (Panel A and B)|Adverse Event|0|||
27753411|NCT01998958|54204774|FG008|Period 1 (Panel A and B)|Adverse Event|0|||
27753412|NCT01998958|54204775|FG009|Period 1 (Panel A and B)|Adverse Event|0|||
27836334|NCT01548287|54321298|FG001|Screening|No reason provided|0|||
27836335|NCT01548287|54321299|FG002|Screening|No reason provided|0|||
27836336|NCT01548287|54321300|FG003|Screening|No reason provided|0|||
27836337|NCT01548287|54321301|FG004|Screening|No reason provided|9|||
27836338|NCT01548287|54321297|FG000|Screening|Did not meet eligibility criteria|0|||
27836339|NCT01548287|54321298|FG001|Screening|Did not meet eligibility criteria|0|||
27836340|NCT01548287|54321299|FG002|Screening|Did not meet eligibility criteria|0|||
27836341|NCT01548287|54321300|FG003|Screening|Did not meet eligibility criteria|0|||
27836342|NCT01548287|54321301|FG004|Screening|Did not meet eligibility criteria|74|||
27836343|NCT01548287|54321297|FG000|Randomized Period|Did not meet inclusion criteria|0|||
27836344|NCT01548287|54321298|FG001|Randomized Period|Did not meet inclusion criteria|0|||
27836345|NCT01548287|54321299|FG002|Randomized Period|Did not meet inclusion criteria|2|||
27836346|NCT01548287|54321300|FG003|Randomized Period|Did not meet inclusion criteria|0|||
27836347|NCT01548287|54321301|FG004|Randomized Period|Did not meet inclusion criteria|0|||
27836348|NCT01548287|54321297|FG000|Randomized Period|Adverse Event|0|||
27836349|NCT01548287|54321298|FG001|Randomized Period|Adverse Event|2|||
27836350|NCT01548287|54321299|FG002|Randomized Period|Adverse Event|5|||
27836351|NCT01548287|54321300|FG003|Randomized Period|Adverse Event|0|||
27836352|NCT01548287|54321301|FG004|Randomized Period|Adverse Event|0|||
27836353|NCT01546883|54321311|FG000|Overall Study|Withdrawal by Subject|3|||
27836354|NCT01546883|54321311|FG000|Overall Study|Adverse Event|4|||
27836355|NCT01546883|54321311|FG000|Overall Study|Lost to Follow-up|2|||
27836356|NCT01546883|54321311|FG000|Overall Study|early closure of study|2|||
27836357|NCT01546883|54321311|FG000|Overall Study|other unrelated illness|1|||
27836358|NCT01580293|54321322|FG000|Part A_Main Trial|Adverse Event|0|||
27836359|NCT01580293|54321323|FG001|Part A_Main Trial|Adverse Event|2|||
27836360|NCT01580293|54321324|FG002|Part A_Main Trial|Adverse Event|0|||
27836361|NCT01580293|54321322|FG000|Part A_Main Trial|Withdrawal by Subject|1|||
27836362|NCT01580293|54321323|FG001|Part A_Main Trial|Withdrawal by Subject|4|||
27836363|NCT01580293|54321324|FG002|Part A_Main Trial|Withdrawal by Subject|0|||
27836364|NCT01580293|54321322|FG000|Part A_Main Trial|Non-adherence to the protocol|1|||
27836365|NCT01580293|54321323|FG001|Part A_Main Trial|Non-adherence to the protocol|0|||
27836366|NCT01580293|54321324|FG002|Part A_Main Trial|Non-adherence to the protocol|0|||
27836367|NCT01580293|54321322|FG000|Part A_Extension|Adverse Event|0|||
27836368|NCT01580293|54321323|FG001|Part A_Extension|Adverse Event|2|||
27836369|NCT01580293|54321324|FG002|Part A_Extension|Adverse Event|0|||
27836370|NCT01580293|54321322|FG000|Part A_Extension|Withdrawal by Subject|0|||
27836371|NCT01580293|54321323|FG001|Part A_Extension|Withdrawal by Subject|3|||
27836372|NCT01580293|54321324|FG002|Part A_Extension|Withdrawal by Subject|0|||
27836373|NCT01580293|54321322|FG000|Part A_Extension|Lost to Follow-up|0|||
27836374|NCT01580293|54321323|FG001|Part A_Extension|Lost to Follow-up|1|||
27836375|NCT01580293|54321324|FG002|Part A_Extension|Lost to Follow-up|0|||
27836376|NCT01580293|54321322|FG000|Part A_Extension|Other Reason|0|||
27836377|NCT01580293|54321323|FG001|Part A_Extension|Other Reason|1|||
27836378|NCT01580293|54321324|FG002|Part A_Extension|Other Reason|0|||
27836379|NCT01580293|54321322|FG000|Part A_Extension|Completed Japan only|0|||
27836380|NCT01580293|54321323|FG001|Part A_Extension|Completed Japan only|5|||
27836381|NCT01580293|54321324|FG002|Part A_Extension|Completed Japan only|0|||
27836382|NCT01580293|54321322|FG000|Part B|Withdrawal by Subject|0|||
27836383|NCT01580293|54321323|FG001|Part B|Withdrawal by Subject|0|||
27836384|NCT01580293|54321324|FG002|Part B|Withdrawal by Subject|1|||
27836385|NCT01580293|54321322|FG000|Part B|Other reason|0|||
27836386|NCT01580293|54321323|FG001|Part B|Other reason|0|||
27836387|NCT01580293|54321324|FG002|Part B|Other reason|1|||
27836388|NCT01546649|54321353|FG000|Overall Study|Adverse Event|4|||
27836389|NCT01546649|54321354|FG001|Overall Study|Adverse Event|5|||
27836390|NCT01546649|54321353|FG000|Overall Study|Protocol Violation|1|||
27836391|NCT01546649|54321354|FG001|Overall Study|Protocol Violation|0|||
27836392|NCT01546649|54321353|FG000|Overall Study|Lack of Efficacy|1|||
27836393|NCT01546649|54321354|FG001|Overall Study|Lack of Efficacy|0|||
27836394|NCT01546649|54321353|FG000|Overall Study|Recurrence|1|||
27836395|NCT01546649|54321354|FG001|Overall Study|Recurrence|1|||
27836396|NCT01546649|54321353|FG000|Overall Study|Discovery of secondary cancer|0|||
27836397|NCT01546649|54321354|FG001|Overall Study|Discovery of secondary cancer|1|||
27836398|NCT01546649|54321353|FG000|Overall Study|Withdrawal by Subject|1|||
27836399|NCT01546649|54321354|FG001|Overall Study|Withdrawal by Subject|2|||
27753413|NCT01998958|54204776|FG010|Period 1 (Panel A and B)|Adverse Event|0|||
27753414|NCT01998958|54204777|FG011|Period 1 (Panel A and B)|Adverse Event|0|||
27753415|NCT01998958|54204778|FG012|Period 1 (Panel A and B)|Adverse Event|0|||
27753416|NCT01998958|54204779|FG013|Period 1 (Panel A and B)|Adverse Event|0|||
27753417|NCT01998958|54204780|FG014|Period 1 (Panel A and B)|Adverse Event|0|||
27753418|NCT01998958|54204781|FG015|Period 1 (Panel A and B)|Adverse Event|0|||
27753419|NCT01998958|54204782|FG016|Period 1 (Panel A and B)|Adverse Event|0|||
27753420|NCT01998958|54204783|FG017|Period 1 (Panel A and B)|Adverse Event|0|||
27753421|NCT01998958|54204784|FG018|Period 1 (Panel A and B)|Adverse Event|0|||
27836400|NCT01544309|54321362|FG000|Overall Study|Withdrawal by Subject|12|||
27836401|NCT01544309|54321363|FG001|Overall Study|Withdrawal by Subject|7|||
27836402|NCT01544309|54321362|FG000|Overall Study|Protocol Violation|2|||
27836403|NCT01544309|54321363|FG001|Overall Study|Protocol Violation|1|||
27836404|NCT01544309|54321362|FG000|Overall Study|Physician Decision|4|||
27836405|NCT01544309|54321363|FG001|Overall Study|Physician Decision|1|||
27836406|NCT01544309|54321362|FG000|Overall Study|Not performed pre-dose examination|1|||
27836407|NCT01544309|54321363|FG001|Overall Study|Not performed pre-dose examination|2|||
27836408|NCT01544309|54321362|FG000|Overall Study|Administered prohibit prior medication|1|||
27836409|NCT01544309|54321363|FG001|Overall Study|Administered prohibit prior medication|0|||
27836410|NCT01544153|54321375|FG000|Overall Study|Under 18|0|||
27836411|NCT01544153|54321376|FG001|Overall Study|Under 18|1|||
27836412|NCT01544153|54321377|FG002|Overall Study|Under 18|0|||
27836413|NCT01544153|54321378|FG003|Overall Study|Under 18|0|||
27836414|NCT01544153|54321375|FG000|Overall Study|Non-smoker|0|||
27836415|NCT01544153|54321376|FG001|Overall Study|Non-smoker|0|||
27836416|NCT01544153|54321377|FG002|Overall Study|Non-smoker|1|||
27836417|NCT01544153|54321378|FG003|Overall Study|Non-smoker|0|||
27836418|NCT01543685|54321393|FG000|Overall Study|Lack of Efficacy|1|||
27836419|NCT01543685|54321394|FG001|Overall Study|Lack of Efficacy|2|||
27836420|NCT01543685|54321395|FG002|Overall Study|Lack of Efficacy|2|||
27836421|NCT01543685|54321396|FG003|Overall Study|Lack of Efficacy|0|||
27836422|NCT01543685|54321397|FG004|Overall Study|Lack of Efficacy|2|||
27836423|NCT01543685|54321393|FG000|Overall Study|Adverse Event|2|||
27836424|NCT01543685|54321394|FG001|Overall Study|Adverse Event|1|||
27836425|NCT01543685|54321395|FG002|Overall Study|Adverse Event|0|||
27836426|NCT01543685|54321396|FG003|Overall Study|Adverse Event|0|||
27836427|NCT01543685|54321397|FG004|Overall Study|Adverse Event|2|||
27836428|NCT01541969|54321411|FG000|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0|||
27836429|NCT01541969|54321412|FG001|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1|||
27836430|NCT01541969|54321411|FG000|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
27836431|NCT01541969|54321412|FG001|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
27836432|NCT01541969|54321411|FG000|Double-blind (0-12 Weeks)|Withdrawal by Subject|2|||
27836433|NCT01541969|54321412|FG001|Double-blind (0-12 Weeks)|Withdrawal by Subject|0|||
27836434|NCT01541969|54321411|FG000|Double-blind (0-12 Weeks)|Lost to Follow-up|1|||
27836435|NCT01541969|54321412|FG001|Double-blind (0-12 Weeks)|Lost to Follow-up|0|||
27836436|NCT01541969|54321411|FG000|Double-blind (0-12 Weeks)|Adverse Event|2|||
27836437|NCT01541969|54321412|FG001|Double-blind (0-12 Weeks)|Adverse Event|0|||
27836438|NCT01541969|54321411|FG000|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
27836439|NCT01541969|54321412|FG001|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
27836440|NCT01541969|54321411|FG000|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1|||
27836441|NCT01541969|54321412|FG001|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0|||
27836442|NCT01541969|54321411|FG000|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
27836443|NCT01541969|54321412|FG001|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
27836444|NCT01541969|54321411|FG000|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6|||
27836445|NCT01541969|54321412|FG001|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8|||
27836446|NCT01541969|54321411|FG000|Open Label Extension (12-36 Weeks)|Adverse Event|2|||
27836447|NCT01541969|54321412|FG001|Open Label Extension (12-36 Weeks)|Adverse Event|3|||
27836448|NCT01540565|54321421|FG000|Overall Study|Ineligible|2|||
27836449|NCT01540487|54321427|FG000|Overall Study|Protocol Violation|1|||
27836450|NCT01540487|54321428|FG001|Overall Study|Protocol Violation|0|||
27836451|NCT01539863|54321440|FG000|Overall Study|Lost to Follow-up|5|||
27836452|NCT01539863|54321441|FG001|Overall Study|Lost to Follow-up|4|||
27836453|NCT01539317|54321449|FG000|Overall Study|Screening Error. Deleted from analysis.|1|||
27836454|NCT01539317|54321450|FG001|Overall Study|Screening Error. Deleted from analysis.|0|||
27836455|NCT01539239|54321461|FG000|Overall Study|Death|5|||
27836456|NCT01539239|54321462|FG001|Overall Study|Death|5|||
27836457|NCT01539239|54321461|FG000|Overall Study|Lost to Follow-up|7|||
27836458|NCT01539239|54321462|FG001|Overall Study|Lost to Follow-up|12|||
27836459|NCT01539083|54321468|FG000|Before Randomization (VCD Induction)|Withdrawal by Subject|4|||
27836460|NCT01539083|54321469|FG001|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
27753422|NCT01998958|54204785|FG019|Period 1 (Panel A and B)|Adverse Event|0|||
27753423|NCT01998958|54204786|FG020|Period 1 (Panel A and B)|Adverse Event|0|||
27753424|NCT01998958|54204787|FG021|Period 1 (Panel A and B)|Adverse Event|0|||
27753425|NCT01998958|54204788|FG022|Period 1 (Panel A and B)|Adverse Event|0|||
27753426|NCT01998958|54204789|FG023|Period 1 (Panel A and B)|Adverse Event|0|||
27753427|NCT01998958|54204790|FG024|Period 1 (Panel A and B)|Adverse Event|0|||
27753428|NCT01998958|54204791|FG025|Period 1 (Panel A and B)|Adverse Event|0|||
27753429|NCT01998958|54204792|FG026|Period 1 (Panel A and B)|Adverse Event|0|||
27753430|NCT01998958|54204793|FG027|Period 1 (Panel A and B)|Adverse Event|0|||
27753431|NCT01998958|54204794|FG028|Period 1 (Panel A and B)|Adverse Event|0|||
27753432|NCT01998958|54204795|FG029|Period 1 (Panel A and B)|Adverse Event|0|||
27753433|NCT01998958|54204796|FG030|Period 1 (Panel A and B)|Adverse Event|0|||
27753434|NCT01998958|54204797|FG031|Period 1 (Panel A and B)|Adverse Event|0|||
27753435|NCT01998958|54204766|FG000|Period 1 (Panel A and B)|Other|1|||
27753436|NCT01998958|54204767|FG001|Period 1 (Panel A and B)|Other|0|||
27753437|NCT01998958|54204768|FG002|Period 1 (Panel A and B)|Other|0|||
27753438|NCT01998958|54204769|FG003|Period 1 (Panel A and B)|Other|0|||
27836461|NCT01539083|54321470|FG002|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
27836462|NCT01539083|54321468|FG000|Before Randomization (VCD Induction)|Adverse Event|14|||
27836463|NCT01539083|54321469|FG001|Before Randomization (VCD Induction)|Adverse Event|0|||
27836464|NCT01539083|54321470|FG002|Before Randomization (VCD Induction)|Adverse Event|0|||
27836465|NCT01539083|54321468|FG000|Before Randomization (VCD Induction)|Death|6|||
27836466|NCT01539083|54321469|FG001|Before Randomization (VCD Induction)|Death|0|||
27836467|NCT01539083|54321470|FG002|Before Randomization (VCD Induction)|Death|0|||
27836468|NCT01539083|54321468|FG000|Before Randomization (VCD Induction)|Protocol Violation|2|||
27836469|NCT01539083|54321469|FG001|Before Randomization (VCD Induction)|Protocol Violation|0|||
27836470|NCT01539083|54321470|FG002|Before Randomization (VCD Induction)|Protocol Violation|0|||
27836471|NCT01539083|54321468|FG000|Before Randomization (VCD Induction)|Physician Decision|14|||
27836472|NCT01539083|54321469|FG001|Before Randomization (VCD Induction)|Physician Decision|0|||
27836473|NCT01539083|54321470|FG002|Before Randomization (VCD Induction)|Physician Decision|0|||
27836474|NCT01539083|54321468|FG000|Before Randomization (VCD Induction)|Progressive Disease|8|||
27836475|NCT01539083|54321469|FG001|Before Randomization (VCD Induction)|Progressive Disease|0|||
27836476|NCT01539083|54321470|FG002|Before Randomization (VCD Induction)|Progressive Disease|0|||
27836477|NCT01539083|54321468|FG000|Before Randomization (VCD Induction)|Other|5|||
27836478|NCT01539083|54321469|FG001|Before Randomization (VCD Induction)|Other|0|||
27836479|NCT01539083|54321470|FG002|Before Randomization (VCD Induction)|Other|0|||
27836480|NCT01539083|54321468|FG000|After Randomization (TP and VTP)|Physician Decision|0|||
27836481|NCT01539083|54321469|FG001|After Randomization (TP and VTP)|Physician Decision|0|||
27836482|NCT01539083|54321470|FG002|After Randomization (TP and VTP)|Physician Decision|1|||
27836483|NCT01539083|54321468|FG000|After Randomization (TP and VTP)|Other|0|||
27836484|NCT01539083|54321469|FG001|After Randomization (TP and VTP)|Other|1|||
27836485|NCT01539083|54321470|FG002|After Randomization (TP and VTP)|Other|1|||
27836486|NCT01539083|54321468|FG000|After Randomization (TP and VTP)|Adverse Event|0|||
27836487|NCT01539083|54321469|FG001|After Randomization (TP and VTP)|Adverse Event|1|||
27836488|NCT01539083|54321470|FG002|After Randomization (TP and VTP)|Adverse Event|1|||
27836489|NCT01539083|54321468|FG000|After Randomization (TP and VTP)|Lost to Follow-up|0|||
27836490|NCT01539083|54321469|FG001|After Randomization (TP and VTP)|Lost to Follow-up|2|||
27836491|NCT01539083|54321470|FG002|After Randomization (TP and VTP)|Lost to Follow-up|2|||
27836492|NCT01539083|54321468|FG000|After Randomization (TP and VTP)|Withdrawal by Subject|0|||
27836493|NCT01539083|54321469|FG001|After Randomization (TP and VTP)|Withdrawal by Subject|5|||
27836494|NCT01539083|54321470|FG002|After Randomization (TP and VTP)|Withdrawal by Subject|4|||
27836495|NCT01539083|54321468|FG000|After Randomization (TP and VTP)|Progressive Disease|0|||
27836496|NCT01539083|54321469|FG001|After Randomization (TP and VTP)|Progressive Disease|6|||
27836497|NCT01539083|54321470|FG002|After Randomization (TP and VTP)|Progressive Disease|3|||
27836498|NCT01539083|54321468|FG000|After Randomization (TP and VTP)|Death|0|||
27836499|NCT01539083|54321469|FG001|After Randomization (TP and VTP)|Death|6|||
27836500|NCT01539083|54321470|FG002|After Randomization (TP and VTP)|Death|11|||
27836501|NCT01537211|54321479|FG000|Overall Study|Lost to Follow-up|0|||
27836502|NCT01537211|54321480|FG001|Overall Study|Lost to Follow-up|1|||
27836503|NCT01537133|54321494|FG000|Overall Study|Withdrawal by Subject|2|||
27836504|NCT01537133|54321495|FG001|Overall Study|Withdrawal by Subject|0|||
27836505|NCT01537133|54321496|FG002|Overall Study|Withdrawal by Subject|0|||
27836506|NCT01537133|54321497|FG003|Overall Study|Withdrawal by Subject|0|||
27836507|NCT01537133|54321494|FG000|Overall Study|Lost to Follow-up|1|||
27836508|NCT01537133|54321495|FG001|Overall Study|Lost to Follow-up|0|||
27836509|NCT01537133|54321496|FG002|Overall Study|Lost to Follow-up|0|||
27836510|NCT01537133|54321497|FG003|Overall Study|Lost to Follow-up|0|||
27836511|NCT01536587|54321505|FG000|Overall Study|Adverse Event|2|||
27836512|NCT01536119|54321511|FG000|Overall Study|Lost to Follow-up|17|||
27836513|NCT01536119|54321512|FG001|Overall Study|Lost to Follow-up|14|||
27836514|NCT01535729|54321518|FG000|Overall Study|Withdrawal by Subject|2|||
27836515|NCT01535729|54321518|FG000|Overall Study|Disease progression|230|||
27836516|NCT01535729|54321518|FG000|Overall Study|Discontinued treatment|25|||
27836517|NCT01535729|54321518|FG000|Overall Study|Lost to Follow-up|8|||
27836518|NCT01535729|54321518|FG000|Overall Study|Death|52|||
27836519|NCT01535729|54321518|FG000|Overall Study|Other|19|||
27836520|NCT01535729|54321518|FG000|Overall Study|Did not sign informed consent|1|||
27836521|NCT01535729|54321518|FG000|Overall Study|No previous chemotherapy|33|||
27836522|NCT01535729|54321518|FG000|Overall Study|NSCLC grade IV histology not confirmed|20|||
27836523|NCT01535729|54321518|FG000|Overall Study|Protocol Violation|11|||
27836524|NCT01535729|54321518|FG000|Overall Study|Screening failure|1|||
27836525|NCT01535729|54321518|FG000|Overall Study|Not treated|9|||
27836526|NCT01535729|54321518|FG000|Overall Study|No participant record available|5|||
27836527|NCT01535261|54321522|FG000|Overall Study|Physician Decision|8|||
27836528|NCT01535261|54321522|FG000|Overall Study|Protocol Violation|3|||
27836529|NCT01535261|54321522|FG000|Overall Study|Death|5|||
27836530|NCT01535261|54321522|FG000|Overall Study|Lost to Follow-up|8|||
27836531|NCT01535261|54321522|FG000|Overall Study|Withdrawal by Subject|14|||
27836532|NCT01535261|54321522|FG000|Overall Study|Adverse Event|12|||
27836533|NCT01534637|54321526|FG000|Overall Study|Physician Decision|3|||
27836534|NCT01534637|54321526|FG000|Overall Study|Lack of Efficacy|3|||
27836535|NCT01534637|54321526|FG000|Overall Study|Withdrawal by Subject|1|||
27836536|NCT01534637|54321526|FG000|Overall Study|Adverse Event|1|||
27836537|NCT01534637|54321526|FG000|Overall Study|Liver Mets before treatment|1|||
27836538|NCT02655016|54321532|FG000|Overall Study|Disease progression|6|||
27836539|NCT02655016|54321533|FG001|Overall Study|Disease progression|4|||
27836540|NCT02655016|54321532|FG000|Overall Study|Site closed|0|||
27836541|NCT02655016|54321533|FG001|Overall Study|Site closed|1|||
27836542|NCT02655016|54321532|FG000|Overall Study|Death|30|||
27836543|NCT02655016|54321533|FG001|Overall Study|Death|48|||
27836544|NCT02655016|54321532|FG000|Overall Study|Lost to Follow-up|1|||
27836545|NCT02655016|54321533|FG001|Overall Study|Lost to Follow-up|1|||
27836546|NCT02655016|54321532|FG000|Overall Study|Withdrawal by Subject|18|||
27836547|NCT02655016|54321533|FG001|Overall Study|Withdrawal by Subject|36|||
27836548|NCT01533935|54321540|FG000|Overall Study|Adverse Event|5|||
27836549|NCT01533935|54321541|FG001|Overall Study|Adverse Event|7|||
27836550|NCT01533935|54321542|FG002|Overall Study|Adverse Event|1|||
27836551|NCT01533935|54321543|FG003|Overall Study|Adverse Event|5|||
27836552|NCT01533935|54321544|FG004|Overall Study|Adverse Event|3|||
27836553|NCT01533935|54321540|FG000|Overall Study|Protocol Violation|0|||
27836554|NCT01533935|54321541|FG001|Overall Study|Protocol Violation|2|||
27836555|NCT01533935|54321542|FG002|Overall Study|Protocol Violation|0|||
27836556|NCT01533935|54321543|FG003|Overall Study|Protocol Violation|0|||
27836557|NCT01533935|54321544|FG004|Overall Study|Protocol Violation|0|||
27836558|NCT01533935|54321540|FG000|Overall Study|Lost to Follow-up|0|||
27836559|NCT01533935|54321541|FG001|Overall Study|Lost to Follow-up|0|||
27836560|NCT01533935|54321542|FG002|Overall Study|Lost to Follow-up|1|||
27836561|NCT01533935|54321543|FG003|Overall Study|Lost to Follow-up|0|||
27836562|NCT01533935|54321544|FG004|Overall Study|Lost to Follow-up|0|||
27836563|NCT01533935|54321540|FG000|Overall Study|Withdrawal by Subject|0|||
27836564|NCT01533935|54321541|FG001|Overall Study|Withdrawal by Subject|4|||
27836565|NCT01533935|54321542|FG002|Overall Study|Withdrawal by Subject|5|||
27836566|NCT01533935|54321543|FG003|Overall Study|Withdrawal by Subject|2|||
27836567|NCT01533935|54321544|FG004|Overall Study|Withdrawal by Subject|4|||
27836568|NCT01533935|54321540|FG000|Overall Study|Other reason not defined above|1|||
27836569|NCT01533935|54321541|FG001|Overall Study|Other reason not defined above|0|||
27836570|NCT01533935|54321542|FG002|Overall Study|Other reason not defined above|1|||
27836571|NCT01533935|54321543|FG003|Overall Study|Other reason not defined above|0|||
27836572|NCT01533935|54321544|FG004|Overall Study|Other reason not defined above|1|||
27836573|NCT01532999|54321558|FG000|Overall Study|Lost to Follow-up|14|||
27836574|NCT01532999|54321559|FG001|Overall Study|Lost to Follow-up|8|||
27836575|NCT01532999|54321558|FG000|Overall Study|Physician Decision|1|||
27836576|NCT01532999|54321559|FG001|Overall Study|Physician Decision|2|||
27836577|NCT01532999|54321558|FG000|Overall Study|Withdrawal by Subject|5|||
27836578|NCT01532999|54321559|FG001|Overall Study|Withdrawal by Subject|0|||
27836579|NCT01532999|54321558|FG000|Overall Study|Relocated|2|||
27836580|NCT01532999|54321559|FG001|Overall Study|Relocated|0|||
27836581|NCT01532999|54321558|FG000|Overall Study|should not have been randomized|1|||
27836582|NCT01532999|54321559|FG001|Overall Study|should not have been randomized|0|||
27836583|NCT01532999|54321558|FG000|Overall Study|substantial noncompliance|2|||
27836584|NCT01532999|54321559|FG001|Overall Study|substantial noncompliance|0|||
27836585|NCT01532999|54321558|FG000|Overall Study|no show for week 9 assessments|6|||
27836586|NCT01532999|54321559|FG001|Overall Study|no show for week 9 assessments|4|||
27836587|NCT01532999|54321558|FG000|Overall Study|Adverse Event|0|||
27836588|NCT01532999|54321559|FG001|Overall Study|Adverse Event|1|||
27836589|NCT01532999|54321558|FG000|Overall Study|incarcerated|0|||
27836590|NCT01532999|54321559|FG001|Overall Study|incarcerated|1|||
27836591|NCT01532999|54321558|FG000|Overall Study|New job|0|||
27836592|NCT01532999|54321559|FG001|Overall Study|New job|2|||
27836593|NCT01532921|54321565|FG000|Overall Study|Death|3|||
27836594|NCT01532921|54321565|FG000|Overall Study|Withdrawal by Subject|2|||
27836595|NCT01532921|54321565|FG000|Overall Study|Lost to Follow-up|3|||
27836596|NCT01532921|54321565|FG000|Overall Study|Physician Decision|7|||
27836597|NCT01532921|54321565|FG000|Overall Study|Device was explanted during procedure|1|||
27836598|NCT01532687|54321575|FG000|Overall Study|Death|2|||
27836599|NCT01532687|54321576|FG001|Overall Study|Death|0|||
27836600|NCT01532687|54321575|FG000|Overall Study|Adverse Event|6|||
27836601|NCT01532687|54321576|FG001|Overall Study|Adverse Event|1|||
27836602|NCT01532687|54321575|FG000|Overall Study|Withdrawal by Subject|1|||
27836603|NCT01532687|54321576|FG001|Overall Study|Withdrawal by Subject|0|||
27836604|NCT01532687|54321575|FG000|Overall Study|Physician Decision|2|||
27836605|NCT01532687|54321576|FG001|Overall Study|Physician Decision|1|||
27836606|NCT01532687|54321575|FG000|Overall Study|Protocol-defined delay > 3 weeks|3|||
27836607|NCT01532687|54321576|FG001|Overall Study|Protocol-defined delay > 3 weeks|0|||
27836608|NCT02677116|54321593|FG000|Overall Study|Adverse Event|0|||
27836609|NCT02677116|54321594|FG001|Overall Study|Adverse Event|1|||
27836610|NCT02677116|54321595|FG002|Overall Study|Adverse Event|0|||
27836611|NCT02677116|54321596|FG003|Overall Study|Adverse Event|0|||
27836612|NCT02677116|54321597|FG004|Overall Study|Adverse Event|0|||
27836613|NCT02677116|54321598|FG005|Overall Study|Adverse Event|1|||
27836614|NCT02677116|54321599|FG006|Overall Study|Adverse Event|1|||
27836615|NCT02677116|54321600|FG007|Overall Study|Adverse Event|0|||
27836616|NCT02677116|54321601|FG008|Overall Study|Adverse Event|0|||
27836617|NCT02677116|54321593|FG000|Overall Study|Physician Decision|0|||
27836618|NCT02677116|54321594|FG001|Overall Study|Physician Decision|2|||
27836619|NCT02677116|54321595|FG002|Overall Study|Physician Decision|3|||
27836620|NCT02677116|54321596|FG003|Overall Study|Physician Decision|2|||
27836621|NCT02677116|54321597|FG004|Overall Study|Physician Decision|1|||
27836622|NCT02677116|54321598|FG005|Overall Study|Physician Decision|3|||
27836623|NCT02677116|54321599|FG006|Overall Study|Physician Decision|1|||
27836624|NCT02677116|54321600|FG007|Overall Study|Physician Decision|1|||
27836625|NCT02677116|54321601|FG008|Overall Study|Physician Decision|2|||
27836626|NCT02677116|54321593|FG000|Overall Study|Withdrawal by parent or guardian|2|||
27836627|NCT02677116|54321594|FG001|Overall Study|Withdrawal by parent or guardian|1|||
27836628|NCT02677116|54321595|FG002|Overall Study|Withdrawal by parent or guardian|0|||
27836629|NCT02677116|54321596|FG003|Overall Study|Withdrawal by parent or guardian|1|||
27836630|NCT02677116|54321597|FG004|Overall Study|Withdrawal by parent or guardian|0|||
27836631|NCT02677116|54321598|FG005|Overall Study|Withdrawal by parent or guardian|0|||
27836632|NCT02677116|54321599|FG006|Overall Study|Withdrawal by parent or guardian|2|||
27836633|NCT02677116|54321600|FG007|Overall Study|Withdrawal by parent or guardian|1|||
27836634|NCT02677116|54321601|FG008|Overall Study|Withdrawal by parent or guardian|0|||
27836635|NCT02677116|54321593|FG000|Overall Study|Withdrawal by Subject|1|||
27836636|NCT02677116|54321594|FG001|Overall Study|Withdrawal by Subject|0|||
27836637|NCT02677116|54321595|FG002|Overall Study|Withdrawal by Subject|0|||
27753439|NCT01998958|54204770|FG004|Period 1 (Panel A and B)|Other|0|||
27753440|NCT01998958|54204771|FG005|Period 1 (Panel A and B)|Other|0|||
27753441|NCT01998958|54204772|FG006|Period 1 (Panel A and B)|Other|0|||
27753442|NCT01998958|54204773|FG007|Period 1 (Panel A and B)|Other|0|||
27753443|NCT01998958|54204774|FG008|Period 1 (Panel A and B)|Other|0|||
27753444|NCT01998958|54204775|FG009|Period 1 (Panel A and B)|Other|0|||
27753445|NCT01998958|54204776|FG010|Period 1 (Panel A and B)|Other|0|||
27753446|NCT01998958|54204777|FG011|Period 1 (Panel A and B)|Other|0|||
27753447|NCT01998958|54204778|FG012|Period 1 (Panel A and B)|Other|0|||
27753448|NCT01998958|54204779|FG013|Period 1 (Panel A and B)|Other|0|||
27836638|NCT02677116|54321596|FG003|Overall Study|Withdrawal by Subject|0|||
27836639|NCT02677116|54321597|FG004|Overall Study|Withdrawal by Subject|0|||
27836640|NCT02677116|54321598|FG005|Overall Study|Withdrawal by Subject|0|||
27836641|NCT02677116|54321599|FG006|Overall Study|Withdrawal by Subject|0|||
27836642|NCT02677116|54321600|FG007|Overall Study|Withdrawal by Subject|0|||
27836643|NCT02677116|54321601|FG008|Overall Study|Withdrawal by Subject|0|||
27836644|NCT02689518|54321644|FG000|Overall Study|Withdrawal by Subject|3|||
27836645|NCT02681094|54321651|FG000|1 -Modified Enrolled Participants Set|Participant decision|7|||
27836646|NCT02681094|54321652|FG001|1 -Modified Enrolled Participants Set|Participant decision|10|||
27836647|NCT02681094|54321653|FG002|1 -Modified Enrolled Participants Set|Participant decision|9|||
27836648|NCT02681094|54321651|FG000|1 -Modified Enrolled Participants Set|Adverse Event|10|||
27836649|NCT02681094|54321652|FG001|1 -Modified Enrolled Participants Set|Adverse Event|4|||
27836650|NCT02681094|54321653|FG002|1 -Modified Enrolled Participants Set|Adverse Event|1|||
27836651|NCT02681094|54321651|FG000|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2|||
27836652|NCT02681094|54321652|FG001|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0|||
27836653|NCT02681094|54321653|FG002|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1|||
27836654|NCT02681094|54321651|FG000|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1|||
27836655|NCT02681094|54321652|FG001|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5|||
27836656|NCT02681094|54321653|FG002|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14|||
27836657|NCT02681094|54321651|FG000|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11|||
27836658|NCT02681094|54321652|FG001|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13|||
27836659|NCT02681094|54321653|FG002|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20|||
27836660|NCT02681094|54321651|FG000|1 -Modified Enrolled Participants Set|Other|6|||
27753449|NCT01998958|54204780|FG014|Period 1 (Panel A and B)|Other|0|||
27753450|NCT01998958|54204781|FG015|Period 1 (Panel A and B)|Other|0|||
27753451|NCT01998958|54204782|FG016|Period 1 (Panel A and B)|Other|0|||
27836661|NCT02681094|54321652|FG001|1 -Modified Enrolled Participants Set|Other|6|||
27836662|NCT02681094|54321653|FG002|1 -Modified Enrolled Participants Set|Other|7|||
27836663|NCT02681094|54321651|FG000|1 -Modified Enrolled Participants Set|No treatment given|0|||
27836664|NCT02681094|54321652|FG001|1 -Modified Enrolled Participants Set|No treatment given|1|||
27836665|NCT02681094|54321653|FG002|1 -Modified Enrolled Participants Set|No treatment given|1|||
27836666|NCT02681094|54321651|FG000|2 - Enrolled Participants Set|Participant decision|7|||
27753452|NCT01998958|54204783|FG017|Period 1 (Panel A and B)|Other|0|||
27836667|NCT02681094|54321652|FG001|2 - Enrolled Participants Set|Participant decision|10|||
27836668|NCT02681094|54321653|FG002|2 - Enrolled Participants Set|Participant decision|9|||
27836669|NCT02681094|54321651|FG000|2 - Enrolled Participants Set|Adverse Event|10|||
27836670|NCT02681094|54321652|FG001|2 - Enrolled Participants Set|Adverse Event|4|||
27836671|NCT02681094|54321653|FG002|2 - Enrolled Participants Set|Adverse Event|1|||
27836672|NCT02681094|54321651|FG000|2 - Enrolled Participants Set|Severe non-compliance to protocol|2|||
27836673|NCT02681094|54321652|FG001|2 - Enrolled Participants Set|Severe non-compliance to protocol|0|||
27836674|NCT02681094|54321653|FG002|2 - Enrolled Participants Set|Severe non-compliance to protocol|1|||
27753453|NCT01998958|54204784|FG018|Period 1 (Panel A and B)|Other|0|||
27753454|NCT01998958|54204785|FG019|Period 1 (Panel A and B)|Other|0|||
27753455|NCT01998958|54204786|FG020|Period 1 (Panel A and B)|Other|0|||
27753456|NCT01998958|54204787|FG021|Period 1 (Panel A and B)|Other|0|||
27836675|NCT02681094|54321651|FG000|2 - Enrolled Participants Set|Lack of therapeutic response|1|||
27836676|NCT02681094|54321652|FG001|2 - Enrolled Participants Set|Lack of therapeutic response|5|||
27836677|NCT02681094|54321653|FG002|2 - Enrolled Participants Set|Lack of therapeutic response|14|||
27836678|NCT02681094|54321651|FG000|2 - Enrolled Participants Set|Study specific discontinuation criteria|14|||
27836679|NCT02681094|54321652|FG001|2 - Enrolled Participants Set|Study specific discontinuation criteria|15|||
27836680|NCT02681094|54321653|FG002|2 - Enrolled Participants Set|Study specific discontinuation criteria|21|||
27836681|NCT02681094|54321651|FG000|2 - Enrolled Participants Set|Other|6|||
27836682|NCT02681094|54321652|FG001|2 - Enrolled Participants Set|Other|6|||
27836683|NCT02681094|54321653|FG002|2 - Enrolled Participants Set|Other|7|||
27753457|NCT01998958|54204788|FG022|Period 1 (Panel A and B)|Other|0|||
27836684|NCT02681094|54321651|FG000|2 - Enrolled Participants Set|No treatment given|0|||
27836685|NCT02681094|54321652|FG001|2 - Enrolled Participants Set|No treatment given|1|||
27836686|NCT02681094|54321653|FG002|2 - Enrolled Participants Set|No treatment given|1|||
27836687|NCT02689284|54321664|FG000|Overall Study|Adverse Event|1|||
27836688|NCT02689284|54321665|FG001|Overall Study|Adverse Event|8|||
27836689|NCT02689284|54321664|FG000|Overall Study|Death|0|||
27836690|NCT02689284|54321665|FG001|Overall Study|Death|1|||
27836691|NCT02689284|54321664|FG000|Overall Study|Physician Decision|1|||
27836692|NCT02689284|54321665|FG001|Overall Study|Physician Decision|2|||
27836693|NCT02689284|54321664|FG000|Overall Study|Withdrawal by Subject|0|||
27836694|NCT02689284|54321665|FG001|Overall Study|Withdrawal by Subject|1|||
27836695|NCT02689284|54321664|FG000|Overall Study|progression of cancer|1|||
27836696|NCT02689284|54321665|FG001|Overall Study|progression of cancer|72|||
27836697|NCT02689284|54321664|FG000|Overall Study|decreased heart function|0|||
27836698|NCT02689284|54321665|FG001|Overall Study|decreased heart function|1|||
27836699|NCT02689284|54321664|FG000|Overall Study|concern for anemia|0|||
27836700|NCT02689284|54321665|FG001|Overall Study|concern for anemia|1|||
27836701|NCT02689284|54321664|FG000|Overall Study|no measurable cancer for evaluation|0|||
27836702|NCT02689284|54321665|FG001|Overall Study|no measurable cancer for evaluation|1|||
27836703|NCT02676882|54321674|FG000|Overall Study|Adverse Event|1|||
27836704|NCT02676882|54321675|FG001|Overall Study|Adverse Event|0|||
27836705|NCT02676882|54321674|FG000|Overall Study|Lost to Follow-up|1|||
27836706|NCT02676882|54321675|FG001|Overall Study|Lost to Follow-up|0|||
27836707|NCT02676882|54321674|FG000|Overall Study|Withdrawal by Subject|1|||
27836708|NCT02676882|54321675|FG001|Overall Study|Withdrawal by Subject|2|||
27836709|NCT02674386|54321684|FG000|Overall Study|Lost to Follow-up|0|||
27836710|NCT02674386|54321685|FG001|Overall Study|Lost to Follow-up|1|||
27836711|NCT02674386|54321686|FG002|Overall Study|Lost to Follow-up|1|||
27836712|NCT02674386|54321684|FG000|Overall Study|Withdrawal by Subject|0|||
27836713|NCT02674386|54321685|FG001|Overall Study|Withdrawal by Subject|4|||
27836714|NCT02674386|54321686|FG002|Overall Study|Withdrawal by Subject|0|||
27836715|NCT02674386|54321684|FG000|Overall Study|Other|0|||
27836716|NCT02674386|54321685|FG001|Overall Study|Other|1|||
27836717|NCT02674386|54321686|FG002|Overall Study|Other|0|||
27836718|NCT02674386|54321684|FG000|Overall Study|Enrolled but not evaluated|0|||
27836719|NCT02674386|54321685|FG001|Overall Study|Enrolled but not evaluated|4|||
27836720|NCT02674386|54321686|FG002|Overall Study|Enrolled but not evaluated|0|||
27836721|NCT02680002|54321705|FG000|Overall Study|Lost to Follow-up|5|||
27836722|NCT02680002|54321706|FG001|Overall Study|Lost to Follow-up|1|||
27836723|NCT02680002|54321707|FG002|Overall Study|Lost to Follow-up|4|||
27836724|NCT02680002|54321708|FG003|Overall Study|Lost to Follow-up|2|||
27836725|NCT02680002|54321709|FG004|Overall Study|Lost to Follow-up|0|||
27836726|NCT02680002|54321710|FG005|Overall Study|Lost to Follow-up|2|||
27836727|NCT02680002|54321705|FG000|Overall Study|Physician Decision|5|||
27836728|NCT02680002|54321706|FG001|Overall Study|Physician Decision|1|||
27753458|NCT01998958|54204789|FG023|Period 1 (Panel A and B)|Other|0|||
27753459|NCT01998958|54204790|FG024|Period 1 (Panel A and B)|Other|0|||
27753460|NCT01998958|54204791|FG025|Period 1 (Panel A and B)|Other|0|||
27753461|NCT01998958|54204792|FG026|Period 1 (Panel A and B)|Other|0|||
27836729|NCT02680002|54321707|FG002|Overall Study|Physician Decision|1|||
27836730|NCT02680002|54321708|FG003|Overall Study|Physician Decision|1|||
27753462|NCT01998958|54204793|FG027|Period 1 (Panel A and B)|Other|0|||
27753463|NCT01998958|54204794|FG028|Period 1 (Panel A and B)|Other|0|||
27753464|NCT01998958|54204795|FG029|Period 1 (Panel A and B)|Other|0|||
27753465|NCT01998958|54204796|FG030|Period 1 (Panel A and B)|Other|0|||
27836731|NCT02680002|54321709|FG004|Overall Study|Physician Decision|1|||
27836732|NCT02680002|54321710|FG005|Overall Study|Physician Decision|1|||
27836733|NCT02680002|54321705|FG000|Overall Study|Protocol Violation|1|||
27753466|NCT01998958|54204797|FG031|Period 1 (Panel A and B)|Other|0|||
27753467|NCT01998958|54204766|FG000|Period 2 (Panel A and B)|Adverse Event|0|||
27753468|NCT01998958|54204767|FG001|Period 2 (Panel A and B)|Adverse Event|0|||
27753469|NCT01998958|54204768|FG002|Period 2 (Panel A and B)|Adverse Event|0|||
27753470|NCT01998958|54204769|FG003|Period 2 (Panel A and B)|Adverse Event|0|||
27753471|NCT01998958|54204770|FG004|Period 2 (Panel A and B)|Adverse Event|0|||
27753472|NCT01998958|54204771|FG005|Period 2 (Panel A and B)|Adverse Event|0|||
27836734|NCT02680002|54321706|FG001|Overall Study|Protocol Violation|0|||
27836735|NCT02680002|54321707|FG002|Overall Study|Protocol Violation|1|||
27836736|NCT02680002|54321708|FG003|Overall Study|Protocol Violation|0|||
27836737|NCT02680002|54321709|FG004|Overall Study|Protocol Violation|1|||
27836738|NCT02680002|54321710|FG005|Overall Study|Protocol Violation|2|||
27836739|NCT02680002|54321705|FG000|Overall Study|Withdrawal by Subject|0|||
27836740|NCT02680002|54321706|FG001|Overall Study|Withdrawal by Subject|0|||
27836741|NCT02680002|54321707|FG002|Overall Study|Withdrawal by Subject|1|||
27836742|NCT02680002|54321708|FG003|Overall Study|Withdrawal by Subject|0|||
27836743|NCT02680002|54321709|FG004|Overall Study|Withdrawal by Subject|2|||
27753473|NCT01998958|54204772|FG006|Period 2 (Panel A and B)|Adverse Event|0|||
27753474|NCT01998958|54204773|FG007|Period 2 (Panel A and B)|Adverse Event|0|||
27753475|NCT01998958|54204774|FG008|Period 2 (Panel A and B)|Adverse Event|0|||
27753476|NCT01998958|54204775|FG009|Period 2 (Panel A and B)|Adverse Event|0|||
27836744|NCT02680002|54321710|FG005|Overall Study|Withdrawal by Subject|2|||
27836745|NCT02680002|54321705|FG000|Overall Study|Missed Visit 8 (Day 201)|2|||
27836746|NCT02680002|54321706|FG001|Overall Study|Missed Visit 8 (Day 201)|1|||
27836747|NCT02680002|54321707|FG002|Overall Study|Missed Visit 8 (Day 201)|3|||
27836748|NCT02680002|54321708|FG003|Overall Study|Missed Visit 8 (Day 201)|1|||
27836749|NCT02680002|54321709|FG004|Overall Study|Missed Visit 8 (Day 201)|5|||
27836750|NCT02680002|54321710|FG005|Overall Study|Missed Visit 8 (Day 201)|0|||
27836751|NCT02680002|54321705|FG000|Overall Study|Other|0|||
27836752|NCT02680002|54321706|FG001|Overall Study|Other|1|||
27836753|NCT02680002|54321707|FG002|Overall Study|Other|0|||
27836754|NCT02680002|54321708|FG003|Overall Study|Other|0|||
27836755|NCT02680002|54321709|FG004|Overall Study|Other|1|||
27836756|NCT02680002|54321710|FG005|Overall Study|Other|0|||
27836757|NCT02680002|54321705|FG000|Overall Study|Adverse Event|0|||
27836758|NCT02680002|54321706|FG001|Overall Study|Adverse Event|0|||
27836759|NCT02680002|54321707|FG002|Overall Study|Adverse Event|0|||
27836760|NCT02680002|54321708|FG003|Overall Study|Adverse Event|0|||
27836761|NCT02680002|54321709|FG004|Overall Study|Adverse Event|1|||
27836762|NCT02680002|54321710|FG005|Overall Study|Adverse Event|2|||
27836763|NCT04557384|54321727|FG000|Overall Study|Study Terminated by Sponsor|1|||
27836764|NCT04557384|54321727|FG000|Overall Study|Death|1|||
27836765|NCT02673684|54321733|FG000|Overall Study|Study not completed d/t loss of funding|9|||
27836766|NCT02673684|54321734|FG001|Overall Study|Study not completed d/t loss of funding|8|||
27836767|NCT02675634|54321742|FG000|Test Period 1|Adverse Event|0|||
27836768|NCT02675634|54321743|FG001|Test Period 1|Adverse Event|1|||
27836769|NCT02675634|54321744|FG002|Test Period 1|Adverse Event|0|||
27836770|NCT02675634|54321745|FG003|Test Period 1|Adverse Event|1|||
27836771|NCT02675634|54321746|FG004|Test Period 1|Adverse Event|0|||
27836772|NCT02675634|54321747|FG005|Test Period 1|Adverse Event|0|||
27836773|NCT02675634|54321742|FG000|Test Period 1|Device deficiency that did not lead to A|0|||
27836774|NCT02675634|54321743|FG001|Test Period 1|Device deficiency that did not lead to A|0|||
27836775|NCT02675634|54321744|FG002|Test Period 1|Device deficiency that did not lead to A|1|||
27836776|NCT02675634|54321745|FG003|Test Period 1|Device deficiency that did not lead to A|0|||
27836777|NCT02675634|54321746|FG004|Test Period 1|Device deficiency that did not lead to A|0|||
27836778|NCT02675634|54321747|FG005|Test Period 1|Device deficiency that did not lead to A|0|||
27836779|NCT02675634|54321742|FG000|Test Period 2|Lack of Efficacy|1|||
27836780|NCT02675634|54321743|FG001|Test Period 2|Lack of Efficacy|0|||
27836781|NCT02675634|54321744|FG002|Test Period 2|Lack of Efficacy|0|||
27836782|NCT02675634|54321745|FG003|Test Period 2|Lack of Efficacy|0|||
27836783|NCT02675634|54321746|FG004|Test Period 2|Lack of Efficacy|0|||
27836784|NCT02675634|54321747|FG005|Test Period 2|Lack of Efficacy|0|||
27836785|NCT02675634|54321742|FG000|Test Period 2|Adverse Event|0|||
27836786|NCT02675634|54321743|FG001|Test Period 2|Adverse Event|0|||
27836787|NCT02675634|54321744|FG002|Test Period 2|Adverse Event|0|||
27836788|NCT02675634|54321745|FG003|Test Period 2|Adverse Event|0|||
27753477|NCT01998958|54204776|FG010|Period 2 (Panel A and B)|Adverse Event|1|||
27753478|NCT01998958|54204777|FG011|Period 2 (Panel A and B)|Adverse Event|0|||
27753479|NCT01998958|54204778|FG012|Period 2 (Panel A and B)|Adverse Event|0|||
27836789|NCT02675634|54321746|FG004|Test Period 2|Adverse Event|0|||
27753480|NCT01998958|54204779|FG013|Period 2 (Panel A and B)|Adverse Event|0|||
27753481|NCT01998958|54204780|FG014|Period 2 (Panel A and B)|Adverse Event|1|||
27836790|NCT02675634|54321747|FG005|Test Period 2|Adverse Event|1|||
27836791|NCT02671500|54321755|FG000|Overall Study|Lack of Efficacy|12|||
27836792|NCT02671500|54321755|FG000|Overall Study|Lost to Follow-up|2|||
27836793|NCT02671422|54321763|FG000|Overall Study|Lost to Follow-up|1|||
27836794|NCT02671422|54321763|FG000|Overall Study|Adverse Event|68|||
27836795|NCT02671422|54321763|FG000|Overall Study|Lack of Efficacy|1|||
27836796|NCT02671422|54321763|FG000|Overall Study|Lost to Follow-up|4|||
27836797|NCT02671422|54321763|FG000|Overall Study|Withdrawal by Subject|7|||
27836798|NCT02671422|54321763|FG000|Overall Study|Progressive Disease|156|||
27836799|NCT02671422|54321763|FG000|Overall Study|Worsening of Disease|4|||
27836800|NCT02671422|54321763|FG000|Overall Study|Sponsor decision|5|||
27836801|NCT02671422|54321763|FG000|Overall Study|Adverse Event unrelated to Vargatef®|8|||
27836802|NCT02671422|54321763|FG000|Overall Study|Not treated with Vargatef®|3|||
27836803|NCT02671422|54321763|FG000|Overall Study|Other not defined above|3|||
27836804|NCT02671266|54321769|FG000|Overall Study|Withdrawal by Subject|1|||
27836805|NCT02671266|54321770|FG001|Overall Study|Withdrawal by Subject|1|||
27836806|NCT03320070|54321778|FG000|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
27753482|NCT01998958|54204781|FG015|Period 2 (Panel A and B)|Adverse Event|0|||
27753483|NCT01998958|54204782|FG016|Period 2 (Panel A and B)|Adverse Event|0|||
27753484|NCT01998958|54204783|FG017|Period 2 (Panel A and B)|Adverse Event|0|||
27753485|NCT01998958|54204784|FG018|Period 2 (Panel A and B)|Adverse Event|0|||
27753486|NCT01998958|54204785|FG019|Period 2 (Panel A and B)|Adverse Event|0|||
27753487|NCT01998958|54204786|FG020|Period 2 (Panel A and B)|Adverse Event|0|||
27753488|NCT01998958|54204787|FG021|Period 2 (Panel A and B)|Adverse Event|0|||
27753489|NCT01998958|54204788|FG022|Period 2 (Panel A and B)|Adverse Event|0|||
27753490|NCT01998958|54204789|FG023|Period 2 (Panel A and B)|Adverse Event|0|||
27753491|NCT01998958|54204790|FG024|Period 2 (Panel A and B)|Adverse Event|0|||
27753492|NCT01998958|54204791|FG025|Period 2 (Panel A and B)|Adverse Event|0|||
27753493|NCT01998958|54204792|FG026|Period 2 (Panel A and B)|Adverse Event|0|||
27753494|NCT01998958|54204793|FG027|Period 2 (Panel A and B)|Adverse Event|0|||
27753495|NCT01998958|54204794|FG028|Period 2 (Panel A and B)|Adverse Event|0|||
27753496|NCT01998958|54204795|FG029|Period 2 (Panel A and B)|Adverse Event|0|||
27753497|NCT01998958|54204796|FG030|Period 2 (Panel A and B)|Adverse Event|0|||
27753498|NCT01998958|54204797|FG031|Period 2 (Panel A and B)|Adverse Event|0|||
27753499|NCT01998958|54204766|FG000|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
27753500|NCT01998958|54204767|FG001|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
27753501|NCT01998958|54204768|FG002|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
27836807|NCT03320070|54321779|FG001|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
27836808|NCT03320070|54321778|FG000|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
27836809|NCT03320070|54321779|FG001|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
27836810|NCT03320070|54321778|FG000|OLE Phase (Week 25 to Week 48)|Adverse Event|3|||
27836811|NCT03320070|54321779|FG001|OLE Phase (Week 25 to Week 48)|Adverse Event|0|||
27836812|NCT03320070|54321778|FG000|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|0|||
27836813|NCT03320070|54321779|FG001|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|1|||
27836814|NCT03320070|54321778|FG000|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|1|||
27753502|NCT01998958|54204769|FG003|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
27753503|NCT01998958|54204770|FG004|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
27753504|NCT01998958|54204771|FG005|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
27753505|NCT01998958|54204772|FG006|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
27836815|NCT03320070|54321779|FG001|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|0|||
27836816|NCT03320070|54321778|FG000|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
27836817|NCT03320070|54321779|FG001|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
27836818|NCT02667912|54321790|FG000|Overall Study|Death|3|||
27836819|NCT02667912|54321791|FG001|Overall Study|Death|1|||
27836820|NCT02667912|54321790|FG000|Overall Study|Withdrawal by Subject|1|||
27836821|NCT02667912|54321791|FG001|Overall Study|Withdrawal by Subject|2|||
27836822|NCT02667912|54321790|FG000|Overall Study|Withdrawal by Subject|1|||
27836823|NCT02667912|54321791|FG001|Overall Study|Withdrawal by Subject|0|||
27836824|NCT01373346|54321797|FG000|Overall Study|Death|1|||
27753506|NCT01998958|54204773|FG007|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
27753507|NCT01998958|54204774|FG008|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
27753508|NCT01998958|54204775|FG009|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
27753509|NCT01998958|54204776|FG010|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
27753510|NCT01998958|54204777|FG011|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
27753511|NCT01998958|54204778|FG012|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
27753512|NCT01998958|54204779|FG013|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
27836825|NCT03284424|54321808|FG000|Overall Study|Death|56|||
27836826|NCT03284424|54321809|FG001|Overall Study|Death|13|||
27836827|NCT03284424|54321808|FG000|Overall Study|Lost to Follow-up|1|||
27836828|NCT03284424|54321809|FG001|Overall Study|Lost to Follow-up|0|||
27836829|NCT03284424|54321808|FG000|Overall Study|Physician Decision|1|||
27753513|NCT01998958|54204780|FG014|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
27753514|NCT01998958|54204781|FG015|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
27753515|NCT01998958|54204782|FG016|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
27753516|NCT01998958|54204783|FG017|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
27753517|NCT01998958|54204784|FG018|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
27753518|NCT01998958|54204785|FG019|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
27753519|NCT01998958|54204786|FG020|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
27753520|NCT01998958|54204787|FG021|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
27753521|NCT01998958|54204788|FG022|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
27753522|NCT01998958|54204789|FG023|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
27753523|NCT01998958|54204790|FG024|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
27753524|NCT01998958|54204791|FG025|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
27753525|NCT01998958|54204792|FG026|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
27753526|NCT01998958|54204793|FG027|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
27753527|NCT01998958|54204794|FG028|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
27753528|NCT01998958|54204795|FG029|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
27753529|NCT01998958|54204796|FG030|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
27753530|NCT01998958|54204797|FG031|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
27753531|NCT01998958|54204766|FG000|Open Label Phase (Optional)|Adverse Event|0|||
27753532|NCT01998958|54204767|FG001|Open Label Phase (Optional)|Adverse Event|0|||
27753533|NCT01998958|54204768|FG002|Open Label Phase (Optional)|Adverse Event|0|||
27753534|NCT01998958|54204769|FG003|Open Label Phase (Optional)|Adverse Event|0|||
27753535|NCT01998958|54204770|FG004|Open Label Phase (Optional)|Adverse Event|0|||
27753536|NCT01998958|54204771|FG005|Open Label Phase (Optional)|Adverse Event|0|||
27753537|NCT01998958|54204772|FG006|Open Label Phase (Optional)|Adverse Event|0|||
27753538|NCT01998958|54204773|FG007|Open Label Phase (Optional)|Adverse Event|0|||
27753539|NCT01998958|54204774|FG008|Open Label Phase (Optional)|Adverse Event|0|||
27753540|NCT01998958|54204775|FG009|Open Label Phase (Optional)|Adverse Event|0|||
27753541|NCT01998958|54204776|FG010|Open Label Phase (Optional)|Adverse Event|0|||
27753542|NCT01998958|54204777|FG011|Open Label Phase (Optional)|Adverse Event|0|||
27753543|NCT01998958|54204778|FG012|Open Label Phase (Optional)|Adverse Event|0|||
27753544|NCT01998958|54204779|FG013|Open Label Phase (Optional)|Adverse Event|0|||
27753545|NCT01998958|54204780|FG014|Open Label Phase (Optional)|Adverse Event|0|||
27753546|NCT01998958|54204781|FG015|Open Label Phase (Optional)|Adverse Event|0|||
27753547|NCT01998958|54204782|FG016|Open Label Phase (Optional)|Adverse Event|0|||
27753548|NCT01998958|54204783|FG017|Open Label Phase (Optional)|Adverse Event|0|||
27753549|NCT01998958|54204784|FG018|Open Label Phase (Optional)|Adverse Event|0|||
27753550|NCT01998958|54204785|FG019|Open Label Phase (Optional)|Adverse Event|0|||
27753551|NCT01998958|54204786|FG020|Open Label Phase (Optional)|Adverse Event|0|||
27753552|NCT01998958|54204787|FG021|Open Label Phase (Optional)|Adverse Event|0|||
27753553|NCT01998958|54204788|FG022|Open Label Phase (Optional)|Adverse Event|0|||
27753554|NCT01998958|54204789|FG023|Open Label Phase (Optional)|Adverse Event|1|||
27753555|NCT01998958|54204790|FG024|Open Label Phase (Optional)|Adverse Event|0|||
27753556|NCT01998958|54204791|FG025|Open Label Phase (Optional)|Adverse Event|0|||
27753557|NCT01998958|54204792|FG026|Open Label Phase (Optional)|Adverse Event|0|||
27753558|NCT01998958|54204793|FG027|Open Label Phase (Optional)|Adverse Event|0|||
27753559|NCT01998958|54204794|FG028|Open Label Phase (Optional)|Adverse Event|0|||
27753560|NCT01998958|54204795|FG029|Open Label Phase (Optional)|Adverse Event|0|||
27753561|NCT01998958|54204796|FG030|Open Label Phase (Optional)|Adverse Event|0|||
27753562|NCT01998958|54204797|FG031|Open Label Phase (Optional)|Adverse Event|0|||
27753563|NCT01998958|54204766|FG000|Open Label Phase (Optional)|Other|0|||
27753564|NCT01998958|54204767|FG001|Open Label Phase (Optional)|Other|0|||
27753565|NCT01998958|54204768|FG002|Open Label Phase (Optional)|Other|0|||
27753566|NCT01998958|54204769|FG003|Open Label Phase (Optional)|Other|0|||
27753567|NCT01998958|54204770|FG004|Open Label Phase (Optional)|Other|0|||
27836830|NCT03284424|54321809|FG001|Overall Study|Physician Decision|0|||
27836831|NCT03284424|54321808|FG000|Overall Study|Withdrawal by Subject|3|||
27836832|NCT03284424|54321809|FG001|Overall Study|Withdrawal by Subject|2|||
27836833|NCT03284424|54321808|FG000|Overall Study|Ongoing in study|44|||
27836834|NCT03284424|54321809|FG001|Overall Study|Ongoing in study|39|||
27836835|NCT02674854|54321817|FG000|Overall Study|Adverse Event|17|||
27836836|NCT02674854|54321818|FG001|Overall Study|Adverse Event|15|||
27836837|NCT02674854|54321819|FG002|Overall Study|Adverse Event|5|||
27836838|NCT02674854|54321817|FG000|Overall Study|Withdrawal by Subject|1|||
27836839|NCT02674854|54321818|FG001|Overall Study|Withdrawal by Subject|5|||
27836840|NCT02674854|54321819|FG002|Overall Study|Withdrawal by Subject|4|||
27836841|NCT02674854|54321817|FG000|Overall Study|No-compliant subject|1|||
27836842|NCT02674854|54321818|FG001|Overall Study|No-compliant subject|0|||
27836843|NCT02674854|54321819|FG002|Overall Study|No-compliant subject|1|||
27836844|NCT02674854|54321817|FG000|Overall Study|Lost to Follow-up|1|||
27836845|NCT02674854|54321818|FG001|Overall Study|Lost to Follow-up|0|||
27836846|NCT02674854|54321819|FG002|Overall Study|Lost to Follow-up|2|||
27836847|NCT02674854|54321817|FG000|Overall Study|Lack of Efficacy|0|||
27836848|NCT02674854|54321818|FG001|Overall Study|Lack of Efficacy|3|||
27836849|NCT02674854|54321819|FG002|Overall Study|Lack of Efficacy|0|||
27836850|NCT02674854|54321817|FG000|Overall Study|Disallowed Concurrent Medication|2|||
27836851|NCT02674854|54321818|FG001|Overall Study|Disallowed Concurrent Medication|2|||
27836852|NCT02674854|54321819|FG002|Overall Study|Disallowed Concurrent Medication|0|||
27836853|NCT02674854|54321817|FG000|Overall Study|Protocol Violation|1|||
27836854|NCT02674854|54321818|FG001|Overall Study|Protocol Violation|1|||
27836855|NCT02674854|54321819|FG002|Overall Study|Protocol Violation|2|||
27836856|NCT02674854|54321817|FG000|Overall Study|Death|0|||
27836857|NCT02674854|54321818|FG001|Overall Study|Death|1|||
27836858|NCT02674854|54321819|FG002|Overall Study|Death|0|||
27836859|NCT02674854|54321817|FG000|Overall Study|Subject missed V6.2|1|||
27836860|NCT02674854|54321818|FG001|Overall Study|Subject missed V6.2|0|||
27836861|NCT02674854|54321819|FG002|Overall Study|Subject missed V6.2|0|||
27836862|NCT02667288|54321827|FG000|Overall Study|Protocol Violation|5|||
27836863|NCT02667288|54321827|FG000|Overall Study|Lost to Follow-up|3|||
27836864|NCT02667288|54321827|FG000|Overall Study|Withdrawal by Subject|5|||
27836865|NCT02670330|54321833|FG000|Overall Study|Protocol Deviation|1|||
27836866|NCT02670330|54321834|FG001|Overall Study|Protocol Deviation|0|||
27836867|NCT02670330|54321833|FG000|Overall Study|Study Terminated By Sponsor|36|||
27836868|NCT02670330|54321834|FG001|Overall Study|Study Terminated By Sponsor|43|||
27836869|NCT02670330|54321833|FG000|Overall Study|Adverse Event|1|||
27836870|NCT02670330|54321834|FG001|Overall Study|Adverse Event|3|||
27836871|NCT02670330|54321833|FG000|Overall Study|Withdrawal by Subject|34|||
27836872|NCT02670330|54321834|FG001|Overall Study|Withdrawal by Subject|29|||
27836873|NCT02670330|54321833|FG000|Overall Study|Lost to Follow-up|3|||
27836874|NCT02670330|54321834|FG001|Overall Study|Lost to Follow-up|2|||
27836875|NCT02669940|54321842|FG000|Overall Study|Failure to return|0|||
27836876|NCT02669940|54321843|FG001|Overall Study|Failure to return|3|||
27836877|NCT02669940|54321842|FG000|Overall Study|Insufficient follow-up data|1|||
27836878|NCT02669940|54321843|FG001|Overall Study|Insufficient follow-up data|0|||
27836879|NCT02669862|54321859|FG000|Overall Study|Lost to Follow-up|0|||
27836880|NCT02669862|54321860|FG001|Overall Study|Lost to Follow-up|2|||
27836881|NCT02669862|54321861|FG002|Overall Study|Lost to Follow-up|1|||
27836882|NCT02669862|54321859|FG000|Overall Study|Withdrawal by Subject|2|||
27836883|NCT02669862|54321860|FG001|Overall Study|Withdrawal by Subject|2|||
27836884|NCT02669862|54321861|FG002|Overall Study|Withdrawal by Subject|3|||
27836885|NCT02669862|54321859|FG000|Overall Study|moved|0|||
27836886|NCT02669862|54321860|FG001|Overall Study|moved|1|||
27836887|NCT02669862|54321861|FG002|Overall Study|moved|0|||
27836888|NCT02669862|54321859|FG000|Overall Study|Protocol Violation|0|||
27836889|NCT02669862|54321860|FG001|Overall Study|Protocol Violation|0|||
27836890|NCT02669862|54321861|FG002|Overall Study|Protocol Violation|1|||
27836891|NCT01531673|54321885|FG000|Overall Study|Non-Compliance|0|||
27836892|NCT01531673|54321886|FG001|Overall Study|Non-Compliance|0|||
27836893|NCT01531673|54321887|FG002|Overall Study|Non-Compliance|0|||
27836894|NCT01531673|54321888|FG003|Overall Study|Non-Compliance|0|||
27836895|NCT01531673|54321889|FG004|Overall Study|Non-Compliance|0|||
27836896|NCT01531673|54321890|FG005|Overall Study|Non-Compliance|1|||
27836897|NCT01531673|54321891|FG006|Overall Study|Non-Compliance|0|||
27836898|NCT01531673|54321892|FG007|Overall Study|Non-Compliance|0|||
27836899|NCT01531673|54321893|FG008|Overall Study|Non-Compliance|0|||
27836900|NCT01531673|54321894|FG009|Overall Study|Non-Compliance|0|||
27836901|NCT01531673|54321895|FG010|Overall Study|Non-Compliance|0|||
27836902|NCT01531673|54321896|FG011|Overall Study|Non-Compliance|0|||
27836903|NCT01531673|54321897|FG012|Overall Study|Non-Compliance|0|||
27836904|NCT01531673|54321885|FG000|Overall Study|Adverse Event|0|||
27836905|NCT01531673|54321886|FG001|Overall Study|Adverse Event|1|||
27836906|NCT01531673|54321887|FG002|Overall Study|Adverse Event|0|||
27836907|NCT01531673|54321888|FG003|Overall Study|Adverse Event|0|||
27836908|NCT01531673|54321889|FG004|Overall Study|Adverse Event|0|||
27836909|NCT01531673|54321890|FG005|Overall Study|Adverse Event|0|||
27753568|NCT01998958|54204771|FG005|Open Label Phase (Optional)|Other|0|||
27753569|NCT01998958|54204772|FG006|Open Label Phase (Optional)|Other|0|||
27753570|NCT01998958|54204773|FG007|Open Label Phase (Optional)|Other|0|||
27753571|NCT01998958|54204774|FG008|Open Label Phase (Optional)|Other|0|||
27753572|NCT01998958|54204775|FG009|Open Label Phase (Optional)|Other|0|||
27753573|NCT01998958|54204776|FG010|Open Label Phase (Optional)|Other|0|||
27753574|NCT01998958|54204777|FG011|Open Label Phase (Optional)|Other|0|||
27753575|NCT01998958|54204778|FG012|Open Label Phase (Optional)|Other|0|||
27753576|NCT01998958|54204779|FG013|Open Label Phase (Optional)|Other|0|||
27753577|NCT01998958|54204780|FG014|Open Label Phase (Optional)|Other|0|||
27753578|NCT01998958|54204781|FG015|Open Label Phase (Optional)|Other|0|||
27753579|NCT01998958|54204782|FG016|Open Label Phase (Optional)|Other|0|||
27753580|NCT01998958|54204783|FG017|Open Label Phase (Optional)|Other|0|||
27753581|NCT01998958|54204784|FG018|Open Label Phase (Optional)|Other|0|||
27753582|NCT01998958|54204785|FG019|Open Label Phase (Optional)|Other|0|||
27753583|NCT01998958|54204786|FG020|Open Label Phase (Optional)|Other|0|||
27753584|NCT01998958|54204787|FG021|Open Label Phase (Optional)|Other|0|||
27753585|NCT01998958|54204788|FG022|Open Label Phase (Optional)|Other|5|||
27753586|NCT01998958|54204789|FG023|Open Label Phase (Optional)|Other|1|||
27753587|NCT01998958|54204790|FG024|Open Label Phase (Optional)|Other|0|||
27753588|NCT01998958|54204791|FG025|Open Label Phase (Optional)|Other|0|||
27753589|NCT01998958|54204792|FG026|Open Label Phase (Optional)|Other|0|||
27753590|NCT01998958|54204793|FG027|Open Label Phase (Optional)|Other|0|||
27753591|NCT01998958|54204794|FG028|Open Label Phase (Optional)|Other|0|||
27753592|NCT01998958|54204795|FG029|Open Label Phase (Optional)|Other|0|||
27753593|NCT01998958|54204796|FG030|Open Label Phase (Optional)|Other|0|||
27753594|NCT01998958|54204797|FG031|Open Label Phase (Optional)|Other|0|||
27753595|NCT01998958|54204766|FG000|Open Label Phase (Optional)|Lost to Follow-up|0|||
27753596|NCT01998958|54204767|FG001|Open Label Phase (Optional)|Lost to Follow-up|0|||
27753597|NCT01998958|54204768|FG002|Open Label Phase (Optional)|Lost to Follow-up|0|||
27753598|NCT01998958|54204769|FG003|Open Label Phase (Optional)|Lost to Follow-up|0|||
27753599|NCT01998958|54204770|FG004|Open Label Phase (Optional)|Lost to Follow-up|0|||
27753600|NCT01998958|54204771|FG005|Open Label Phase (Optional)|Lost to Follow-up|0|||
27753601|NCT01998958|54204772|FG006|Open Label Phase (Optional)|Lost to Follow-up|0|||
27753602|NCT01998958|54204773|FG007|Open Label Phase (Optional)|Lost to Follow-up|0|||
27753603|NCT01998958|54204774|FG008|Open Label Phase (Optional)|Lost to Follow-up|0|||
27753604|NCT01998958|54204775|FG009|Open Label Phase (Optional)|Lost to Follow-up|0|||
27753605|NCT01998958|54204776|FG010|Open Label Phase (Optional)|Lost to Follow-up|0|||
27753606|NCT01998958|54204777|FG011|Open Label Phase (Optional)|Lost to Follow-up|0|||
27753607|NCT01998958|54204778|FG012|Open Label Phase (Optional)|Lost to Follow-up|0|||
27753608|NCT01998958|54204779|FG013|Open Label Phase (Optional)|Lost to Follow-up|0|||
27753609|NCT01998958|54204780|FG014|Open Label Phase (Optional)|Lost to Follow-up|0|||
27753610|NCT01998958|54204781|FG015|Open Label Phase (Optional)|Lost to Follow-up|0|||
27753611|NCT01998958|54204782|FG016|Open Label Phase (Optional)|Lost to Follow-up|0|||
27753612|NCT01998958|54204783|FG017|Open Label Phase (Optional)|Lost to Follow-up|0|||
27753613|NCT01998958|54204784|FG018|Open Label Phase (Optional)|Lost to Follow-up|0|||
27753614|NCT01998958|54204785|FG019|Open Label Phase (Optional)|Lost to Follow-up|0|||
27753615|NCT01998958|54204786|FG020|Open Label Phase (Optional)|Lost to Follow-up|0|||
27753616|NCT01998958|54204787|FG021|Open Label Phase (Optional)|Lost to Follow-up|0|||
27753617|NCT01998958|54204788|FG022|Open Label Phase (Optional)|Lost to Follow-up|1|||
27753618|NCT01998958|54204789|FG023|Open Label Phase (Optional)|Lost to Follow-up|0|||
27753619|NCT01998958|54204790|FG024|Open Label Phase (Optional)|Lost to Follow-up|0|||
27753620|NCT01998958|54204791|FG025|Open Label Phase (Optional)|Lost to Follow-up|0|||
27753621|NCT01998958|54204792|FG026|Open Label Phase (Optional)|Lost to Follow-up|0|||
27753622|NCT01998958|54204793|FG027|Open Label Phase (Optional)|Lost to Follow-up|0|||
27753623|NCT01998958|54204794|FG028|Open Label Phase (Optional)|Lost to Follow-up|0|||
27753624|NCT01998958|54204795|FG029|Open Label Phase (Optional)|Lost to Follow-up|0|||
27753625|NCT01998958|54204796|FG030|Open Label Phase (Optional)|Lost to Follow-up|0|||
27753626|NCT01998958|54204797|FG031|Open Label Phase (Optional)|Lost to Follow-up|0|||
27753627|NCT01998958|54204766|FG000|Open Label Phase (Optional)|Lack of Efficacy|0|||
27753628|NCT01998958|54204767|FG001|Open Label Phase (Optional)|Lack of Efficacy|0|||
27753629|NCT01998958|54204768|FG002|Open Label Phase (Optional)|Lack of Efficacy|0|||
27753630|NCT01998958|54204769|FG003|Open Label Phase (Optional)|Lack of Efficacy|0|||
27753631|NCT01998958|54204770|FG004|Open Label Phase (Optional)|Lack of Efficacy|0|||
27753632|NCT01998958|54204771|FG005|Open Label Phase (Optional)|Lack of Efficacy|0|||
27753633|NCT01998958|54204772|FG006|Open Label Phase (Optional)|Lack of Efficacy|0|||
27753634|NCT01998958|54204773|FG007|Open Label Phase (Optional)|Lack of Efficacy|0|||
27753635|NCT01998958|54204774|FG008|Open Label Phase (Optional)|Lack of Efficacy|0|||
27753636|NCT01998958|54204775|FG009|Open Label Phase (Optional)|Lack of Efficacy|0|||
27831205|NCT01793051|54307467|FG000|Overall Study|Switched chemo|1|||
27831206|NCT01793051|54307468|FG001|Overall Study|Switched chemo|1|||
27831207|NCT01793051|54307467|FG000|Overall Study|Lack of compliance|1|||
27831208|NCT01793051|54307468|FG001|Overall Study|Lack of compliance|0|||
27831209|NCT01793051|54307467|FG000|Overall Study|Requested to be removed from the study|1|||
27836910|NCT01531673|54321891|FG006|Overall Study|Adverse Event|0|||
27836911|NCT01531673|54321892|FG007|Overall Study|Adverse Event|0|||
27836912|NCT01531673|54321893|FG008|Overall Study|Adverse Event|0|||
27836913|NCT01531673|54321894|FG009|Overall Study|Adverse Event|0|||
27836914|NCT01531673|54321895|FG010|Overall Study|Adverse Event|0|||
27836915|NCT01531673|54321896|FG011|Overall Study|Adverse Event|0|||
27836916|NCT01531673|54321897|FG012|Overall Study|Adverse Event|0|||
27836917|NCT01531673|54321885|FG000|Overall Study|Lost to Follow-up|0|||
27836918|NCT01531673|54321886|FG001|Overall Study|Lost to Follow-up|0|||
27753637|NCT01998958|54204776|FG010|Open Label Phase (Optional)|Lack of Efficacy|0|||
27753638|NCT01998958|54204777|FG011|Open Label Phase (Optional)|Lack of Efficacy|0|||
27753639|NCT01998958|54204778|FG012|Open Label Phase (Optional)|Lack of Efficacy|0|||
27753640|NCT01998958|54204779|FG013|Open Label Phase (Optional)|Lack of Efficacy|0|||
27753641|NCT01998958|54204780|FG014|Open Label Phase (Optional)|Lack of Efficacy|0|||
27753642|NCT01998958|54204781|FG015|Open Label Phase (Optional)|Lack of Efficacy|0|||
27753643|NCT01998958|54204782|FG016|Open Label Phase (Optional)|Lack of Efficacy|0|||
27753644|NCT01998958|54204783|FG017|Open Label Phase (Optional)|Lack of Efficacy|0|||
27753645|NCT01998958|54204784|FG018|Open Label Phase (Optional)|Lack of Efficacy|0|||
27753646|NCT01998958|54204785|FG019|Open Label Phase (Optional)|Lack of Efficacy|0|||
27753647|NCT01998958|54204786|FG020|Open Label Phase (Optional)|Lack of Efficacy|0|||
27753648|NCT01998958|54204787|FG021|Open Label Phase (Optional)|Lack of Efficacy|1|||
27753649|NCT01998958|54204788|FG022|Open Label Phase (Optional)|Lack of Efficacy|2|||
27753650|NCT01998958|54204789|FG023|Open Label Phase (Optional)|Lack of Efficacy|0|||
27753651|NCT01998958|54204790|FG024|Open Label Phase (Optional)|Lack of Efficacy|0|||
27753652|NCT01998958|54204791|FG025|Open Label Phase (Optional)|Lack of Efficacy|0|||
27753653|NCT01998958|54204792|FG026|Open Label Phase (Optional)|Lack of Efficacy|0|||
27753654|NCT01998958|54204793|FG027|Open Label Phase (Optional)|Lack of Efficacy|0|||
27753655|NCT01998958|54204794|FG028|Open Label Phase (Optional)|Lack of Efficacy|0|||
27753656|NCT01998958|54204795|FG029|Open Label Phase (Optional)|Lack of Efficacy|0|||
27753657|NCT01998958|54204796|FG030|Open Label Phase (Optional)|Lack of Efficacy|0|||
27753658|NCT01998958|54204797|FG031|Open Label Phase (Optional)|Lack of Efficacy|0|||
27753659|NCT01998958|54204766|FG000|Open Label Phase (Optional)|Withdrawal by Subject|0|||
27753660|NCT01998958|54204767|FG001|Open Label Phase (Optional)|Withdrawal by Subject|0|||
27753661|NCT01998958|54204768|FG002|Open Label Phase (Optional)|Withdrawal by Subject|0|||
27753662|NCT01998958|54204769|FG003|Open Label Phase (Optional)|Withdrawal by Subject|0|||
27753663|NCT01998958|54204770|FG004|Open Label Phase (Optional)|Withdrawal by Subject|0|||
27753664|NCT01998958|54204771|FG005|Open Label Phase (Optional)|Withdrawal by Subject|0|||
27753665|NCT01998958|54204772|FG006|Open Label Phase (Optional)|Withdrawal by Subject|0|||
27753666|NCT01998958|54204773|FG007|Open Label Phase (Optional)|Withdrawal by Subject|0|||
27753667|NCT01998958|54204774|FG008|Open Label Phase (Optional)|Withdrawal by Subject|0|||
27753668|NCT01998958|54204775|FG009|Open Label Phase (Optional)|Withdrawal by Subject|0|||
27753669|NCT01998958|54204776|FG010|Open Label Phase (Optional)|Withdrawal by Subject|0|||
27753670|NCT01998958|54204777|FG011|Open Label Phase (Optional)|Withdrawal by Subject|0|||
27753671|NCT01998958|54204778|FG012|Open Label Phase (Optional)|Withdrawal by Subject|0|||
27753672|NCT01998958|54204779|FG013|Open Label Phase (Optional)|Withdrawal by Subject|0|||
27753673|NCT01998958|54204780|FG014|Open Label Phase (Optional)|Withdrawal by Subject|0|||
27753674|NCT01998958|54204781|FG015|Open Label Phase (Optional)|Withdrawal by Subject|0|||
27753675|NCT01998958|54204782|FG016|Open Label Phase (Optional)|Withdrawal by Subject|0|||
27753676|NCT01998958|54204783|FG017|Open Label Phase (Optional)|Withdrawal by Subject|0|||
27753677|NCT01998958|54204784|FG018|Open Label Phase (Optional)|Withdrawal by Subject|0|||
27753678|NCT01998958|54204785|FG019|Open Label Phase (Optional)|Withdrawal by Subject|0|||
27753679|NCT01998958|54204786|FG020|Open Label Phase (Optional)|Withdrawal by Subject|0|||
27753680|NCT01998958|54204787|FG021|Open Label Phase (Optional)|Withdrawal by Subject|2|||
27753681|NCT01998958|54204788|FG022|Open Label Phase (Optional)|Withdrawal by Subject|1|||
27753682|NCT01998958|54204789|FG023|Open Label Phase (Optional)|Withdrawal by Subject|2|||
27753683|NCT01998958|54204790|FG024|Open Label Phase (Optional)|Withdrawal by Subject|0|||
27753684|NCT01998958|54204791|FG025|Open Label Phase (Optional)|Withdrawal by Subject|0|||
27753685|NCT01998958|54204792|FG026|Open Label Phase (Optional)|Withdrawal by Subject|0|||
27753686|NCT01998958|54204793|FG027|Open Label Phase (Optional)|Withdrawal by Subject|0|||
27753687|NCT01998958|54204794|FG028|Open Label Phase (Optional)|Withdrawal by Subject|0|||
27753688|NCT01998958|54204795|FG029|Open Label Phase (Optional)|Withdrawal by Subject|0|||
27753689|NCT01998958|54204796|FG030|Open Label Phase (Optional)|Withdrawal by Subject|0|||
27753690|NCT01998958|54204797|FG031|Open Label Phase (Optional)|Withdrawal by Subject|0|||
27753691|NCT01958164|54204849|FG000|Overall Study|Adverse Event|0|||
27753692|NCT01958164|54204850|FG001|Overall Study|Adverse Event|2|||
27753693|NCT01958164|54204849|FG000|Overall Study|Lost to Follow-up|2|||
27753694|NCT01958164|54204850|FG001|Overall Study|Lost to Follow-up|3|||
27753695|NCT01976104|54204860|FG000|Overall Study|Adverse Event|0|||
27836919|NCT01531673|54321887|FG002|Overall Study|Lost to Follow-up|0|||
27836920|NCT01531673|54321888|FG003|Overall Study|Lost to Follow-up|0|||
27836921|NCT01531673|54321889|FG004|Overall Study|Lost to Follow-up|1|||
27836922|NCT01531673|54321890|FG005|Overall Study|Lost to Follow-up|0|||
27836923|NCT01531673|54321891|FG006|Overall Study|Lost to Follow-up|0|||
27753696|NCT01976104|54204861|FG001|Overall Study|Adverse Event|0|||
27753697|NCT01976104|54204862|FG002|Overall Study|Adverse Event|1|||
27753698|NCT01976104|54204863|FG003|Overall Study|Adverse Event|0|||
27753699|NCT01976104|54204860|FG000|Overall Study|Lost to Follow-up|3|||
27753700|NCT01976104|54204861|FG001|Overall Study|Lost to Follow-up|0|||
27753701|NCT01976104|54204862|FG002|Overall Study|Lost to Follow-up|1|||
27753702|NCT01976104|54204863|FG003|Overall Study|Lost to Follow-up|1|||
27753703|NCT01976104|54204860|FG000|Overall Study|Subject Choice|0|||
27753704|NCT01976104|54204861|FG001|Overall Study|Subject Choice|1|||
27753705|NCT01976104|54204862|FG002|Overall Study|Subject Choice|0|||
27753706|NCT01976104|54204863|FG003|Overall Study|Subject Choice|1|||
27753707|NCT01976104|54204860|FG000|Overall Study|Withdrawal by Subject|3|||
27753708|NCT01976104|54204861|FG001|Overall Study|Withdrawal by Subject|0|||
27753709|NCT01976104|54204862|FG002|Overall Study|Withdrawal by Subject|0|||
27753710|NCT01976104|54204863|FG003|Overall Study|Withdrawal by Subject|1|||
27753711|NCT01976104|54204860|FG000|Overall Study|Other|0|||
27753712|NCT01976104|54204861|FG001|Overall Study|Other|1|||
27753713|NCT01976104|54204862|FG002|Overall Study|Other|0|||
27753714|NCT01976104|54204863|FG003|Overall Study|Other|0|||
27753715|NCT01372501|54204874|FG000|Overall Study|Adverse Event|4|||
27753716|NCT01372501|54204874|FG000|Overall Study|Device migration|1|||
27753717|NCT01958008|54204883|FG000|Overall Study|Worsening of disease under study|0|||
27753718|NCT01958008|54204884|FG001|Overall Study|Worsening of disease under study|0|||
27753719|NCT01958008|54204885|FG002|Overall Study|Worsening of disease under study|1|||
27753720|NCT01958008|54204886|FG003|Overall Study|Worsening of disease under study|0|||
27753721|NCT01958008|54204883|FG000|Overall Study|Other adverse event|1|||
27753722|NCT01958008|54204884|FG001|Overall Study|Other adverse event|0|||
27753723|NCT01958008|54204885|FG002|Overall Study|Other adverse event|0|||
27753724|NCT01958008|54204886|FG003|Overall Study|Other adverse event|0|||
27836924|NCT01531673|54321892|FG007|Overall Study|Lost to Follow-up|0|||
27836925|NCT01531673|54321893|FG008|Overall Study|Lost to Follow-up|0|||
27836926|NCT01531673|54321894|FG009|Overall Study|Lost to Follow-up|0|||
27836927|NCT01531673|54321895|FG010|Overall Study|Lost to Follow-up|0|||
27836928|NCT01531673|54321896|FG011|Overall Study|Lost to Follow-up|0|||
27836929|NCT01531673|54321897|FG012|Overall Study|Lost to Follow-up|0|||
27836930|NCT01531673|54321885|FG000|Overall Study|Other|0|||
27836931|NCT01531673|54321886|FG001|Overall Study|Other|0|||
27836932|NCT01531673|54321887|FG002|Overall Study|Other|0|||
27836933|NCT01531673|54321888|FG003|Overall Study|Other|1|||
27836934|NCT01531673|54321889|FG004|Overall Study|Other|0|||
27836935|NCT01531673|54321890|FG005|Overall Study|Other|0|||
27836936|NCT01531673|54321891|FG006|Overall Study|Other|0|||
27836937|NCT01531673|54321892|FG007|Overall Study|Other|0|||
27836938|NCT01531673|54321893|FG008|Overall Study|Other|0|||
27836939|NCT01531673|54321894|FG009|Overall Study|Other|1|||
27836940|NCT01531673|54321895|FG010|Overall Study|Other|0|||
27836941|NCT01531673|54321896|FG011|Overall Study|Other|0|||
27836942|NCT01531673|54321897|FG012|Overall Study|Other|0|||
27836943|NCT01531205|54321949|FG000|Overall Study|Did not proceed to surgery|1|||
27836944|NCT01529645|54321965|FG000|Overall Study|Lost to Follow-up|0|||
27836945|NCT01529645|54321966|FG001|Overall Study|Lost to Follow-up|1|||
27836946|NCT01529645|54321967|FG002|Overall Study|Lost to Follow-up|1|||
27836947|NCT01529645|54321968|FG003|Overall Study|Lost to Follow-up|1|||
27836948|NCT01529645|54321969|FG004|Overall Study|Lost to Follow-up|1|||
27836949|NCT01529645|54321970|FG005|Overall Study|Lost to Follow-up|0|||
27836950|NCT01529645|54321971|FG006|Overall Study|Lost to Follow-up|2|||
27836951|NCT01529645|54321972|FG007|Overall Study|Lost to Follow-up|0|||
27836952|NCT01529645|54321973|FG008|Overall Study|Lost to Follow-up|1|||
27836953|NCT01529645|54321974|FG009|Overall Study|Lost to Follow-up|0|||
27836954|NCT01529645|54321965|FG000|Overall Study|SAE - Premature contractions|0|||
27836955|NCT01529645|54321966|FG001|Overall Study|SAE - Premature contractions|0|||
27836956|NCT01529645|54321967|FG002|Overall Study|SAE - Premature contractions|1|||
27836957|NCT01529645|54321968|FG003|Overall Study|SAE - Premature contractions|0|||
27836958|NCT01529645|54321969|FG004|Overall Study|SAE - Premature contractions|0|||
27753725|NCT01998880|54204914|FG000|Overall Study|Adverse Events or Intercurrent Illness|16|||
27753726|NCT01998880|54204915|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
27753727|NCT01998880|54204914|FG000|Overall Study|Disease Progression|1|||
27753728|NCT01998880|54204915|FG001|Overall Study|Disease Progression|8|||
27753729|NCT01998880|54204914|FG000|Overall Study|Withdrew Consent|2|||
27753730|NCT01998880|54204915|FG001|Overall Study|Withdrew Consent|1|||
27836959|NCT01529645|54321970|FG005|Overall Study|SAE - Premature contractions|0|||
27836960|NCT01529645|54321971|FG006|Overall Study|SAE - Premature contractions|0|||
27836961|NCT01529645|54321972|FG007|Overall Study|SAE - Premature contractions|0|||
27836962|NCT01529645|54321973|FG008|Overall Study|SAE - Premature contractions|0|||
27753731|NCT01998880|54204914|FG000|Overall Study|Death|3|||
27836963|NCT01529645|54321974|FG009|Overall Study|SAE - Premature contractions|0|||
27753732|NCT01998880|54204915|FG001|Overall Study|Death|6|||
27836964|NCT01529645|54321965|FG000|Overall Study|Withdrawal by Subject|2|||
27836965|NCT01529645|54321966|FG001|Overall Study|Withdrawal by Subject|0|||
27836966|NCT01529645|54321967|FG002|Overall Study|Withdrawal by Subject|0|||
27836967|NCT01529645|54321968|FG003|Overall Study|Withdrawal by Subject|1|||
27836968|NCT01529645|54321969|FG004|Overall Study|Withdrawal by Subject|1|||
27836969|NCT01529645|54321970|FG005|Overall Study|Withdrawal by Subject|1|||
27836970|NCT01529645|54321971|FG006|Overall Study|Withdrawal by Subject|0|||
27836971|NCT01529645|54321972|FG007|Overall Study|Withdrawal by Subject|0|||
27836972|NCT01529645|54321973|FG008|Overall Study|Withdrawal by Subject|0|||
27836973|NCT01529645|54321974|FG009|Overall Study|Withdrawal by Subject|0|||
27836974|NCT01528787|54322008|FG000|Overall Study|Withdrawal by Subject|0|||
27836975|NCT01528787|54322009|FG001|Overall Study|Withdrawal by Subject|0|||
27836976|NCT01528787|54322010|FG002|Overall Study|Withdrawal by Subject|0|||
27836977|NCT01528787|54322011|FG003|Overall Study|Withdrawal by Subject|1|||
27836978|NCT01528787|54322008|FG000|Overall Study|Family Emergency|0|||
27836979|NCT01528787|54322009|FG001|Overall Study|Family Emergency|0|||
27836980|NCT01528787|54322010|FG002|Overall Study|Family Emergency|1|||
27836981|NCT01528787|54322011|FG003|Overall Study|Family Emergency|0|||
27836982|NCT01528709|54322023|FG000|Overall Study|Death|2|||
27836983|NCT01528709|54322024|FG001|Overall Study|Death|0|||
27836984|NCT01528709|54322023|FG000|Overall Study|Withdrawal by Subject|10|||
27836985|NCT01528709|54322024|FG001|Overall Study|Withdrawal by Subject|15|||
27836986|NCT01528709|54322023|FG000|Overall Study|allergy|1|||
27836987|NCT01528709|54322024|FG001|Overall Study|allergy|0|||
27836988|NCT01527383|54322032|FG000|Overall Study|Adverse Event|5|||
27836989|NCT01527383|54322033|FG001|Overall Study|Adverse Event|0|||
27836990|NCT01527383|54322032|FG000|Overall Study|Lost to Follow-up|3|||
27836991|NCT01527383|54322033|FG001|Overall Study|Lost to Follow-up|0|||
27836992|NCT01527383|54322032|FG000|Overall Study|Physician Decision|2|||
27836993|NCT01527383|54322033|FG001|Overall Study|Physician Decision|0|||
27836994|NCT01527383|54322032|FG000|Overall Study|Pregnancy|1|||
27836995|NCT01527383|54322033|FG001|Overall Study|Pregnancy|0|||
27836996|NCT01527383|54322032|FG000|Overall Study|Protocol Violation|1|||
27836997|NCT01527383|54322033|FG001|Overall Study|Protocol Violation|0|||
27836998|NCT01527383|54322032|FG000|Overall Study|Screen failure|1|||
27836999|NCT01527383|54322033|FG001|Overall Study|Screen failure|0|||
27837000|NCT01527383|54322032|FG000|Overall Study|Participant moved|0|||
27837001|NCT01527383|54322033|FG001|Overall Study|Participant moved|1|||
27837002|NCT01527383|54322032|FG000|Overall Study|Withdrawal by Subject|2|||
27837003|NCT01527383|54322033|FG001|Overall Study|Withdrawal by Subject|3|||
27837004|NCT01526057|54322042|FG000|Overall Study|Withdrawal by Subject|3|||
27837005|NCT01526057|54322043|FG001|Overall Study|Withdrawal by Subject|2|||
27837006|NCT01526057|54322044|FG002|Overall Study|Withdrawal by Subject|2|||
27837007|NCT01526057|54322042|FG000|Overall Study|Adverse Event|3|||
27837008|NCT01526057|54322043|FG001|Overall Study|Adverse Event|1|||
27837009|NCT01526057|54322044|FG002|Overall Study|Adverse Event|1|||
27837010|NCT01526057|54322042|FG000|Overall Study|Death|1|||
27753733|NCT01998880|54204914|FG000|Overall Study|Insufficient Therapeutic Response|1|||
27753734|NCT01998880|54204915|FG001|Overall Study|Insufficient Therapeutic Response|5|||
27753735|NCT01998880|54204914|FG000|Overall Study|Administrative/Other|1|||
27753736|NCT01998880|54204915|FG001|Overall Study|Administrative/Other|1|||
27753737|NCT01998880|54204914|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
27753738|NCT01998880|54204915|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
27753739|NCT01998880|54204914|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
27753740|NCT01998880|54204915|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
27753741|NCT01998880|54204914|FG000|Overall Study|Did Not Receive Treatment|3|||
27753742|NCT01998880|54204915|FG001|Overall Study|Did Not Receive Treatment|2|||
27753743|NCT01975948|54204925|FG000|Overall Study|Withdrawal by Subject|17|||
27753744|NCT01975948|54204926|FG001|Overall Study|Withdrawal by Subject|21|||
27753745|NCT01975948|54204927|FG002|Overall Study|Withdrawal by Subject|7|||
27753746|NCT01975948|54204928|FG003|Overall Study|Withdrawal by Subject|6|||
27753747|NCT01975246|54204940|FG000|Overall Study|Adverse Event|2|||
27753748|NCT01975246|54204941|FG001|Overall Study|Adverse Event|1|||
27753749|NCT01975246|54204940|FG000|Overall Study|Lack of Efficacy|1|||
27753750|NCT01975246|54204941|FG001|Overall Study|Lack of Efficacy|0|||
27837011|NCT01526057|54322043|FG001|Overall Study|Death|0|||
27837012|NCT01526057|54322044|FG002|Overall Study|Death|0|||
27837013|NCT01526057|54322042|FG000|Overall Study|Lost to Follow-up|1|||
27837014|NCT01526057|54322043|FG001|Overall Study|Lost to Follow-up|0|||
27837015|NCT01526057|54322044|FG002|Overall Study|Lost to Follow-up|1|||
27837016|NCT01526057|54322042|FG000|Overall Study|Other|1|||
27837017|NCT01526057|54322043|FG001|Overall Study|Other|0|||
27837018|NCT01526057|54322044|FG002|Overall Study|Other|1|||
27837019|NCT01526057|54322042|FG000|Overall Study|Protocol Violation|0|||
27837020|NCT01526057|54322043|FG001|Overall Study|Protocol Violation|0|||
27753751|NCT01975246|54204940|FG000|Overall Study|Protocol Violation|1|||
27837021|NCT01526057|54322044|FG002|Overall Study|Protocol Violation|1|||
27837022|NCT01525901|54322056|FG000|Period 2: 12 Weeks|Adverse Event|0|||
27837023|NCT01525901|54322057|FG001|Period 2: 12 Weeks|Adverse Event|1|||
27837024|NCT01525901|54322058|FG002|Period 2: 12 Weeks|Adverse Event|0|||
27837025|NCT01525901|54322059|FG003|Period 2: 12 Weeks|Adverse Event|0|||
27753752|NCT01975246|54204941|FG001|Overall Study|Protocol Violation|0|||
27753753|NCT01975246|54204940|FG000|Overall Study|Other than stated|0|||
27753754|NCT01975246|54204941|FG001|Overall Study|Other than stated|1|||
27753755|NCT01621126|54204947|FG000|Overall Study|Physician Decision|6|||
27753756|NCT01973998|54204953|FG000|Overall Study|Death|2|||
27753757|NCT01973998|54204954|FG001|Overall Study|Death|2|||
27753758|NCT02664415|54204962|FG000|Overall Study|Adverse Event|1|||
27753759|NCT02664415|54204963|FG001|Overall Study|Adverse Event|0|||
27753760|NCT02661061|54204971|FG000|Overall Study|Lack of Efficacy|1|||
27753761|NCT02661061|54204972|FG001|Overall Study|Lack of Efficacy|1|||
27753762|NCT02661061|54204971|FG000|Overall Study|Withdrawal by Subject|1|||
27753763|NCT02661061|54204972|FG001|Overall Study|Withdrawal by Subject|1|||
27753764|NCT01995838|54204985|FG000|Overall Study|Lost to Follow-up|0|||
27753765|NCT01995838|54204986|FG001|Overall Study|Lost to Follow-up|1|||
27753766|NCT01995838|54204987|FG002|Overall Study|Lost to Follow-up|0|||
27753767|NCT01995838|54204988|FG003|Overall Study|Lost to Follow-up|0|||
27837026|NCT01525589|54322172|FG000|Overall Study|Non-treatment-related AE|1|||
27837027|NCT01525589|54322173|FG001|Overall Study|Non-treatment-related AE|0|||
27837028|NCT01525589|54322174|FG002|Overall Study|Non-treatment-related AE|0|||
27837029|NCT01525589|54322172|FG000|Overall Study|Progressive disease|48|||
27837030|NCT01525589|54322173|FG001|Overall Study|Progressive disease|15|||
27837031|NCT01525589|54322174|FG002|Overall Study|Progressive disease|29|||
27837032|NCT01525589|54322172|FG000|Overall Study|Never treated|2|||
27837033|NCT01525589|54322173|FG001|Overall Study|Never treated|0|||
27837034|NCT01525589|54322174|FG002|Overall Study|Never treated|0|||
27837035|NCT01525589|54322172|FG000|Overall Study|Physician Decision|4|||
27837036|NCT01525589|54322173|FG001|Overall Study|Physician Decision|2|||
27837037|NCT01525589|54322174|FG002|Overall Study|Physician Decision|2|||
27837038|NCT01525589|54322172|FG000|Overall Study|Death|0|||
27837039|NCT01525589|54322173|FG001|Overall Study|Death|0|||
27837040|NCT01525589|54322174|FG002|Overall Study|Death|2|||
27837041|NCT01525589|54322172|FG000|Overall Study|Treatment-related AE|1|||
27837042|NCT01525589|54322173|FG001|Overall Study|Treatment-related AE|1|||
27837043|NCT01525589|54322174|FG002|Overall Study|Treatment-related AE|2|||
27837044|NCT01525589|54322172|FG000|Overall Study|Other reasons|0|||
27837045|NCT01525589|54322173|FG001|Overall Study|Other reasons|1|||
27837046|NCT01525589|54322174|FG002|Overall Study|Other reasons|0|||
27837047|NCT01525589|54322172|FG000|Overall Study|Withdrawal by Subject|0|||
27837048|NCT01525589|54322173|FG001|Overall Study|Withdrawal by Subject|1|||
27837049|NCT01525589|54322174|FG002|Overall Study|Withdrawal by Subject|0|||
27837050|NCT01524887|54322185|FG000|Overall Study|Withdrawal by Subject|6|||
27837051|NCT01524887|54322186|FG001|Overall Study|Withdrawal by Subject|2|||
27837052|NCT01524887|54322187|FG002|Overall Study|Withdrawal by Subject|3|||
27837053|NCT01524887|54322185|FG000|Overall Study|Adverse Event|5|||
27837054|NCT01524887|54322186|FG001|Overall Study|Adverse Event|1|||
27837055|NCT01524887|54322187|FG002|Overall Study|Adverse Event|1|||
27837056|NCT01524887|54322185|FG000|Overall Study|Protocol Violation|0|||
27837057|NCT01524887|54322186|FG001|Overall Study|Protocol Violation|0|||
27837058|NCT01524887|54322187|FG002|Overall Study|Protocol Violation|1|||
27837059|NCT01524887|54322185|FG000|Overall Study|Study termination|73|||
27837060|NCT01524887|54322186|FG001|Overall Study|Study termination|87|||
27837061|NCT01524887|54322187|FG002|Overall Study|Study termination|79|||
27837062|NCT01524887|54322185|FG000|Overall Study|Withdrawal by Caregiver|0|||
27926907|NCT01218009|54583380|FG001|Overall Study|Protocol Violation|1|||
27753768|NCT01995838|54204989|FG004|Overall Study|Lost to Follow-up|0|||
27753769|NCT01995838|54204990|FG005|Overall Study|Lost to Follow-up|0|||
27753770|NCT01995838|54204991|FG006|Overall Study|Lost to Follow-up|1|||
27837063|NCT01524887|54322186|FG001|Overall Study|Withdrawal by Caregiver|0|||
27837064|NCT01524887|54322187|FG002|Overall Study|Withdrawal by Caregiver|2|||
27837065|NCT01524887|54322185|FG000|Overall Study|Use of prohibited medication|1|||
27837066|NCT01524887|54322186|FG001|Overall Study|Use of prohibited medication|0|||
27837067|NCT01524887|54322187|FG002|Overall Study|Use of prohibited medication|0|||
27837068|NCT01523873|54322213|FG000|Overall Study|Protocol Violation|422|||
27837069|NCT01522235|54322238|FG000|Overall Study|Physician Decision|1|||
27837070|NCT01522235|54322239|FG001|Overall Study|Physician Decision|1|||
27837071|NCT01521923|54322276|FG000|Overall Study|AE, serious fatal|1|||
27837072|NCT01521923|54322277|FG001|Overall Study|AE, serious fatal|0|||
27837073|NCT01521923|54322278|FG002|Overall Study|AE, serious fatal|0|||
27837074|NCT01521923|54322279|FG003|Overall Study|AE, serious fatal|0|||
27837075|NCT01521923|54322276|FG000|Overall Study|SAE, non-fatal|0|||
27837076|NCT01521923|54322277|FG001|Overall Study|SAE, non-fatal|2|||
27837077|NCT01521923|54322278|FG002|Overall Study|SAE, non-fatal|2|||
27837078|NCT01521923|54322279|FG003|Overall Study|SAE, non-fatal|0|||
27837079|NCT01521923|54322276|FG000|Overall Study|AE, non-serious, non-fatal|1|||
27753771|NCT01995838|54204985|FG000|Overall Study|Participant choice|2|||
27753772|NCT01995838|54204986|FG001|Overall Study|Participant choice|0|||
27837080|NCT01521923|54322277|FG001|Overall Study|AE, non-serious, non-fatal|3|||
27837081|NCT01521923|54322278|FG002|Overall Study|AE, non-serious, non-fatal|6|||
27837082|NCT01521923|54322279|FG003|Overall Study|AE, non-serious, non-fatal|2|||
27837083|NCT01521923|54322276|FG000|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
27837084|NCT01521923|54322277|FG001|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
27837085|NCT01521923|54322278|FG002|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
27837086|NCT01521923|54322279|FG003|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1|||
27837087|NCT01521923|54322276|FG000|Overall Study|Lack of Efficacy|1|||
27837088|NCT01521923|54322277|FG001|Overall Study|Lack of Efficacy|1|||
27837089|NCT01521923|54322278|FG002|Overall Study|Lack of Efficacy|0|||
27837090|NCT01521923|54322279|FG003|Overall Study|Lack of Efficacy|0|||
27837091|NCT01521923|54322276|FG000|Overall Study|Protocol Violation|0|||
27837092|NCT01521923|54322277|FG001|Overall Study|Protocol Violation|0|||
27837093|NCT01521923|54322278|FG002|Overall Study|Protocol Violation|1|||
27837094|NCT01521923|54322279|FG003|Overall Study|Protocol Violation|0|||
27837095|NCT01521923|54322276|FG000|Overall Study|Lost to Follow-up|1|||
27837096|NCT01521923|54322277|FG001|Overall Study|Lost to Follow-up|0|||
27837097|NCT01521923|54322278|FG002|Overall Study|Lost to Follow-up|2|||
27837098|NCT01521923|54322279|FG003|Overall Study|Lost to Follow-up|1|||
27753773|NCT01995838|54204987|FG002|Overall Study|Participant choice|0|||
27753774|NCT01995838|54204988|FG003|Overall Study|Participant choice|0|||
27753775|NCT01995838|54204989|FG004|Overall Study|Participant choice|0|||
27753776|NCT01995838|54204990|FG005|Overall Study|Participant choice|1|||
27753777|NCT01995838|54204991|FG006|Overall Study|Participant choice|1|||
27753778|NCT01995838|54204985|FG000|Overall Study|Adverse Event|0|||
27753779|NCT01995838|54204986|FG001|Overall Study|Adverse Event|0|||
27753780|NCT01995838|54204987|FG002|Overall Study|Adverse Event|0|||
27753781|NCT01995838|54204988|FG003|Overall Study|Adverse Event|0|||
27753782|NCT01995838|54204989|FG004|Overall Study|Adverse Event|0|||
27753783|NCT01995838|54204990|FG005|Overall Study|Adverse Event|0|||
27753784|NCT01995838|54204991|FG006|Overall Study|Adverse Event|1|||
27753785|NCT01995838|54204985|FG000|Overall Study|Withdrawal by Subject|0|||
27753786|NCT01995838|54204986|FG001|Overall Study|Withdrawal by Subject|0|||
27753787|NCT01995838|54204987|FG002|Overall Study|Withdrawal by Subject|0|||
27753788|NCT01995838|54204988|FG003|Overall Study|Withdrawal by Subject|0|||
27753789|NCT01995838|54204989|FG004|Overall Study|Withdrawal by Subject|1|||
27753790|NCT01995838|54204990|FG005|Overall Study|Withdrawal by Subject|0|||
27753791|NCT01995838|54204991|FG006|Overall Study|Withdrawal by Subject|0|||
27753792|NCT01995838|54204985|FG000|Overall Study|Other|3|||
27753793|NCT01995838|54204986|FG001|Overall Study|Other|1|||
27837099|NCT01521923|54322276|FG000|Overall Study|Withdrawal by Subject|1|||
27837100|NCT01521923|54322277|FG001|Overall Study|Withdrawal by Subject|1|||
27837101|NCT01521923|54322278|FG002|Overall Study|Withdrawal by Subject|1|||
27837102|NCT01521923|54322279|FG003|Overall Study|Withdrawal by Subject|2|||
27837103|NCT01521923|54322276|FG000|Overall Study|Other|2|||
27837104|NCT01521923|54322277|FG001|Overall Study|Other|1|||
27837105|NCT01521923|54322278|FG002|Overall Study|Other|3|||
27837106|NCT01521923|54322279|FG003|Overall Study|Other|6|||
27837107|NCT01521923|54322276|FG000|Overall Study|AE, captured in Period 1|0|||
27837108|NCT01521923|54322277|FG001|Overall Study|AE, captured in Period 1|1|||
27837109|NCT01521923|54322278|FG002|Overall Study|AE, captured in Period 1|0|||
27837110|NCT01521923|54322279|FG003|Overall Study|AE, captured in Period 1|1|||
27837111|NCT01520987|54322403|FG000|Overall Study|Withdrawal by Subject|1|||
27837112|NCT01520987|54322404|FG001|Overall Study|Withdrawal by Subject|0|||
27837113|NCT01520987|54322405|FG002|Overall Study|Withdrawal by Subject|0|||
27837114|NCT01520987|54322406|FG003|Overall Study|Withdrawal by Subject|0|||
27837115|NCT01520987|54322407|FG004|Overall Study|Withdrawal by Subject|0|||
27837116|NCT01520987|54322408|FG005|Overall Study|Withdrawal by Subject|1|||
27753794|NCT01995838|54204987|FG002|Overall Study|Other|0|||
27753795|NCT01995838|54204988|FG003|Overall Study|Other|2|||
27753796|NCT01995838|54204989|FG004|Overall Study|Other|1|||
27753797|NCT01995838|54204990|FG005|Overall Study|Other|1|||
27753798|NCT01995838|54204991|FG006|Overall Study|Other|2|||
27837117|NCT01520987|54322409|FG006|Overall Study|Withdrawal by Subject|0|||
27837118|NCT01520987|54322410|FG007|Overall Study|Withdrawal by Subject|0|||
27837119|NCT01562275|54322484|FG000|Stage 1|Adverse Event|0|||
27837120|NCT01562275|54322485|FG001|Stage 1|Adverse Event|0|||
27837121|NCT01562275|54322486|FG002|Stage 1|Adverse Event|0|||
27837122|NCT01562275|54322487|FG003|Stage 1|Adverse Event|1|||
27837123|NCT01562275|54322488|FG004|Stage 1|Adverse Event|1|||
27837124|NCT01562275|54322489|FG005|Stage 1|Adverse Event|0|||
27837125|NCT01562275|54322490|FG006|Stage 1|Adverse Event|0|||
27837126|NCT01562275|54322491|FG007|Stage 1|Adverse Event|0|||
27837127|NCT01562275|54322492|FG008|Stage 1|Adverse Event|0|||
27837128|NCT01562275|54322493|FG009|Stage 1|Adverse Event|1|||
27837129|NCT01562275|54322494|FG010|Stage 1|Adverse Event|0|||
27753799|NCT01957462|54205012|FG000|Test Period 1|Withdrawal by Subject|1|||
27753800|NCT01957462|54205013|FG001|Test Period 1|Withdrawal by Subject|0|||
27837130|NCT01562275|54322495|FG011|Stage 1|Adverse Event|0|||
27837131|NCT01562275|54322496|FG012|Stage 1|Adverse Event|0|||
27837132|NCT01562275|54322484|FG000|Stage 1|Death|1|||
27837133|NCT01562275|54322485|FG001|Stage 1|Death|0|||
27837134|NCT01562275|54322486|FG002|Stage 1|Death|0|||
27837135|NCT01562275|54322487|FG003|Stage 1|Death|0|||
27753801|NCT01957462|54205012|FG000|Test Period 1|Adverse Event|1|||
27753802|NCT01957462|54205013|FG001|Test Period 1|Adverse Event|0|||
27753803|NCT01957150|54205021|FG000|Overall Study|Adverse Event|23|||
27753804|NCT01957150|54205022|FG001|Overall Study|Adverse Event|20|||
27753805|NCT01957150|54205021|FG000|Overall Study|Withdrawal by Subject|13|||
27753806|NCT01957150|54205022|FG001|Overall Study|Withdrawal by Subject|17|||
27753807|NCT01957150|54205021|FG000|Overall Study|Physician Decision|3|||
27753808|NCT01957150|54205022|FG001|Overall Study|Physician Decision|6|||
27753809|NCT01957150|54205021|FG000|Overall Study|Lost to Follow-up|4|||
27753810|NCT01957150|54205022|FG001|Overall Study|Lost to Follow-up|4|||
27753811|NCT01957150|54205021|FG000|Overall Study|Protocol Violation|1|||
27753812|NCT01957150|54205022|FG001|Overall Study|Protocol Violation|0|||
27753813|NCT01957150|54205021|FG000|Overall Study|Lack of Efficacy|11|||
27753814|NCT01957150|54205022|FG001|Overall Study|Lack of Efficacy|11|||
27753815|NCT01955122|54205030|FG000|Overall Study|Physician Decision|5|||
27753816|NCT01955122|54205031|FG001|Overall Study|Physician Decision|5|||
27753817|NCT01995526|54205043|FG000|Overall Study|Physician Decision|1|||
27753818|NCT01955044|54205050|FG000|Overall Study|Death|1|||
27753819|NCT01955044|54205051|FG001|Overall Study|Death|1|||
27753820|NCT01955044|54205052|FG002|Overall Study|Death|0|||
27753821|NCT01973218|54205062|FG000|Overall Study|Adverse Event|1|||
27753822|NCT01973218|54205063|FG001|Overall Study|Adverse Event|0|||
27753823|NCT01973218|54205062|FG000|Overall Study|Withdrawal by Subject|1|||
27753824|NCT01973218|54205063|FG001|Overall Study|Withdrawal by Subject|0|||
27753825|NCT01954342|54205075|FG000|Overall Study|Missing data from 13-16week study visit|0|||
27753826|NCT01954342|54205076|FG001|Overall Study|Missing data from 13-16week study visit|0|||
27753827|NCT01954342|54205077|FG002|Overall Study|Missing data from 13-16week study visit|0|||
27753828|NCT01954342|54205078|FG003|Overall Study|Missing data from 13-16week study visit|1|||
27753829|NCT01954342|54205075|FG000|Overall Study|Miscarriage|0|||
27753830|NCT01954342|54205076|FG001|Overall Study|Miscarriage|0|||
27753831|NCT01954342|54205077|FG002|Overall Study|Miscarriage|0|||
27753832|NCT01954342|54205078|FG003|Overall Study|Miscarriage|3|||
27753833|NCT01954342|54205075|FG000|Overall Study|Lost to Follow-up|0|||
27753834|NCT01954342|54205076|FG001|Overall Study|Lost to Follow-up|0|||
27753835|NCT01954342|54205077|FG002|Overall Study|Lost to Follow-up|0|||
27753836|NCT01954342|54205078|FG003|Overall Study|Lost to Follow-up|5|||
27753837|NCT01954342|54205075|FG000|Overall Study|Preterm delivery|0|||
27753838|NCT01954342|54205076|FG001|Overall Study|Preterm delivery|0|||
27753839|NCT01954342|54205077|FG002|Overall Study|Preterm delivery|0|||
27753840|NCT01954342|54205078|FG003|Overall Study|Preterm delivery|3|||
27753841|NCT01954342|54205075|FG000|Overall Study|Pre-eclampsia|0|||
27753842|NCT01954342|54205076|FG001|Overall Study|Pre-eclampsia|0|||
27753843|NCT01954342|54205077|FG002|Overall Study|Pre-eclampsia|0|||
27753844|NCT01954342|54205078|FG003|Overall Study|Pre-eclampsia|4|||
27753845|NCT01954342|54205075|FG000|Overall Study|Unreliable Data|0|||
27753846|NCT01954342|54205076|FG001|Overall Study|Unreliable Data|0|||
27753847|NCT01954342|54205077|FG002|Overall Study|Unreliable Data|0|||
27753848|NCT01954342|54205078|FG003|Overall Study|Unreliable Data|2|||
27753849|NCT01972438|54205090|FG000|Baseline-Month 3 Crossover Period|Death|1|||
27753850|NCT01972438|54205091|FG001|Baseline-Month 3 Crossover Period|Death|0|||
27753851|NCT01972438|54205090|FG000|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1|||
27753852|NCT01972438|54205091|FG001|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0|||
27753853|NCT01972438|54205090|FG000|Baseline-Month 3 Crossover Period|Unable to donate blood|0|||
27753854|NCT01972438|54205091|FG001|Baseline-Month 3 Crossover Period|Unable to donate blood|1|||
27753855|NCT01972438|54205090|FG000|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1|||
27753856|NCT01972438|54205091|FG001|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2|||
27753857|NCT01972438|54205090|FG000|Months 3-6 Crossover Period|Early Study Closure|0|||
27753858|NCT01972438|54205091|FG001|Months 3-6 Crossover Period|Early Study Closure|1|||
27753859|NCT01972438|54205090|FG000|Months 6-12 Study Period|Death|1|||
27753860|NCT01972438|54205091|FG001|Months 6-12 Study Period|Death|0|||
27753861|NCT01972438|54205090|FG000|Months 6-12 Study Period|Early Study Closure|2|||
27753862|NCT01972438|54205091|FG001|Months 6-12 Study Period|Early Study Closure|2|||
27753863|NCT01972438|54205090|FG000|Post Month 12 Study Period|Early Study Closure|3|||
27753864|NCT01972438|54205091|FG001|Post Month 12 Study Period|Early Study Closure|4|||
27753865|NCT01946152|54205103|FG000|Overall Study|Adverse Event|1|||
27753866|NCT01946152|54205104|FG001|Overall Study|Adverse Event|0|||
27753867|NCT01946152|54205105|FG002|Overall Study|Adverse Event|0|||
27753868|NCT01946152|54205106|FG003|Overall Study|Adverse Event|0|||
27753869|NCT01946152|54205103|FG000|Overall Study|Withdrawal by Subject|0|||
27753870|NCT01946152|54205104|FG001|Overall Study|Withdrawal by Subject|2|||
27753871|NCT01946152|54205105|FG002|Overall Study|Withdrawal by Subject|0|||
27753872|NCT01946152|54205106|FG003|Overall Study|Withdrawal by Subject|0|||
27753873|NCT01946152|54205103|FG000|Overall Study|Progression|0|||
27837136|NCT01562275|54322488|FG004|Stage 1|Death|0|||
27753874|NCT01946152|54205104|FG001|Overall Study|Progression|1|||
27753875|NCT01946152|54205105|FG002|Overall Study|Progression|4|||
27753876|NCT01946152|54205106|FG003|Overall Study|Progression|7|||
27837137|NCT01562275|54322489|FG005|Stage 1|Death|0|||
27837138|NCT01562275|54322490|FG006|Stage 1|Death|0|||
27837139|NCT01562275|54322491|FG007|Stage 1|Death|0|||
27837140|NCT01562275|54322492|FG008|Stage 1|Death|0|||
27837141|NCT01562275|54322493|FG009|Stage 1|Death|0|||
27837142|NCT01562275|54322494|FG010|Stage 1|Death|0|||
27837143|NCT01562275|54322495|FG011|Stage 1|Death|0|||
27837144|NCT01562275|54322496|FG012|Stage 1|Death|0|||
27837145|NCT01562275|54322484|FG000|Stage 1|Non Compliance|0|||
27837146|NCT01562275|54322485|FG001|Stage 1|Non Compliance|0|||
27837147|NCT01562275|54322486|FG002|Stage 1|Non Compliance|1|||
27837148|NCT01562275|54322487|FG003|Stage 1|Non Compliance|0|||
27837149|NCT01562275|54322488|FG004|Stage 1|Non Compliance|0|||
27837150|NCT01562275|54322489|FG005|Stage 1|Non Compliance|0|||
27837151|NCT01562275|54322490|FG006|Stage 1|Non Compliance|0|||
27837152|NCT01562275|54322491|FG007|Stage 1|Non Compliance|0|||
27837153|NCT01562275|54322492|FG008|Stage 1|Non Compliance|0|||
27837154|NCT01562275|54322493|FG009|Stage 1|Non Compliance|0|||
27837155|NCT01562275|54322494|FG010|Stage 1|Non Compliance|0|||
27837156|NCT01562275|54322495|FG011|Stage 1|Non Compliance|0|||
27837157|NCT01562275|54322496|FG012|Stage 1|Non Compliance|0|||
27837158|NCT01562275|54322484|FG000|Stage 1|Physician Decision|0|||
27837159|NCT01562275|54322485|FG001|Stage 1|Physician Decision|0|||
27837160|NCT01562275|54322486|FG002|Stage 1|Physician Decision|0|||
27837161|NCT01562275|54322487|FG003|Stage 1|Physician Decision|0|||
27837162|NCT01562275|54322488|FG004|Stage 1|Physician Decision|1|||
27837163|NCT01562275|54322489|FG005|Stage 1|Physician Decision|0|||
27837164|NCT01562275|54322490|FG006|Stage 1|Physician Decision|1|||
27837165|NCT01562275|54322491|FG007|Stage 1|Physician Decision|0|||
27837166|NCT01562275|54322492|FG008|Stage 1|Physician Decision|1|||
27837167|NCT01562275|54322493|FG009|Stage 1|Physician Decision|0|||
27837168|NCT01562275|54322494|FG010|Stage 1|Physician Decision|0|||
27837169|NCT01562275|54322495|FG011|Stage 1|Physician Decision|0|||
27837170|NCT01562275|54322496|FG012|Stage 1|Physician Decision|0|||
27837171|NCT01562275|54322484|FG000|Stage 1|Progression of Disease|2|||
27837172|NCT01562275|54322485|FG001|Stage 1|Progression of Disease|6|||
27837173|NCT01562275|54322486|FG002|Stage 1|Progression of Disease|2|||
27837174|NCT01562275|54322487|FG003|Stage 1|Progression of Disease|1|||
27837175|NCT01562275|54322488|FG004|Stage 1|Progression of Disease|2|||
27837176|NCT01562275|54322489|FG005|Stage 1|Progression of Disease|4|||
27837177|NCT01562275|54322490|FG006|Stage 1|Progression of Disease|1|||
27837178|NCT01562275|54322491|FG007|Stage 1|Progression of Disease|7|||
27837179|NCT01562275|54322492|FG008|Stage 1|Progression of Disease|2|||
27837180|NCT01562275|54322493|FG009|Stage 1|Progression of Disease|5|||
27837181|NCT01562275|54322494|FG010|Stage 1|Progression of Disease|3|||
27837182|NCT01562275|54322495|FG011|Stage 1|Progression of Disease|0|||
27837183|NCT01562275|54322496|FG012|Stage 1|Progression of Disease|0|||
27837184|NCT01562275|54322484|FG000|Stage 1|Withdrawal by Subject|0|||
27837185|NCT01562275|54322485|FG001|Stage 1|Withdrawal by Subject|1|||
27837186|NCT01562275|54322486|FG002|Stage 1|Withdrawal by Subject|0|||
27837187|NCT01562275|54322487|FG003|Stage 1|Withdrawal by Subject|2|||
27837188|NCT01562275|54322488|FG004|Stage 1|Withdrawal by Subject|0|||
27837189|NCT01562275|54322489|FG005|Stage 1|Withdrawal by Subject|0|||
27837190|NCT01562275|54322490|FG006|Stage 1|Withdrawal by Subject|1|||
27837191|NCT01562275|54322491|FG007|Stage 1|Withdrawal by Subject|0|||
27837192|NCT01562275|54322492|FG008|Stage 1|Withdrawal by Subject|0|||
27837193|NCT01562275|54322493|FG009|Stage 1|Withdrawal by Subject|1|||
27837194|NCT01562275|54322494|FG010|Stage 1|Withdrawal by Subject|0|||
27837195|NCT01562275|54322495|FG011|Stage 1|Withdrawal by Subject|0|||
27837196|NCT01562275|54322496|FG012|Stage 1|Withdrawal by Subject|0|||
27837197|NCT01562275|54322484|FG000|Stage 2|Death|0|||
27837198|NCT01562275|54322485|FG001|Stage 2|Death|0|||
27837199|NCT01562275|54322486|FG002|Stage 2|Death|0|||
27837200|NCT01562275|54322487|FG003|Stage 2|Death|0|||
27837201|NCT01562275|54322488|FG004|Stage 2|Death|0|||
27837202|NCT01562275|54322489|FG005|Stage 2|Death|0|||
27837203|NCT01562275|54322490|FG006|Stage 2|Death|0|||
27837204|NCT01562275|54322491|FG007|Stage 2|Death|0|||
27837205|NCT01562275|54322492|FG008|Stage 2|Death|0|||
27837206|NCT01562275|54322493|FG009|Stage 2|Death|0|||
27837207|NCT01562275|54322494|FG010|Stage 2|Death|0|||
27837208|NCT01562275|54322495|FG011|Stage 2|Death|2|||
27837209|NCT01562275|54322496|FG012|Stage 2|Death|1|||
27837210|NCT01562275|54322484|FG000|Stage 2|Progression of Disease|0|||
27837211|NCT01562275|54322485|FG001|Stage 2|Progression of Disease|0|||
27837212|NCT01562275|54322486|FG002|Stage 2|Progression of Disease|0|||
27837213|NCT01562275|54322487|FG003|Stage 2|Progression of Disease|0|||
27837214|NCT01562275|54322488|FG004|Stage 2|Progression of Disease|0|||
27837215|NCT01562275|54322489|FG005|Stage 2|Progression of Disease|0|||
27837216|NCT01562275|54322490|FG006|Stage 2|Progression of Disease|0|||
27837217|NCT01562275|54322491|FG007|Stage 2|Progression of Disease|0|||
27837218|NCT01562275|54322492|FG008|Stage 2|Progression of Disease|0|||
27837219|NCT01562275|54322493|FG009|Stage 2|Progression of Disease|0|||
27837220|NCT01562275|54322494|FG010|Stage 2|Progression of Disease|0|||
27837221|NCT01562275|54322495|FG011|Stage 2|Progression of Disease|12|||
27837222|NCT01562275|54322496|FG012|Stage 2|Progression of Disease|4|||
27837223|NCT01535053|54322528|FG000|Overall Study|Ineligible|1|||
27837224|NCT01535053|54322529|FG001|Overall Study|Ineligible|2|||
27837225|NCT01534663|54322537|FG000|Overall Study|Lost to Follow-up|0|||
27837226|NCT01534663|54322538|FG001|Overall Study|Lost to Follow-up|2|||
27837227|NCT01534663|54322537|FG000|Overall Study|Adverse Event|2|||
27837228|NCT01534663|54322538|FG001|Overall Study|Adverse Event|1|||
27837229|NCT01520909|54322546|FG000|Part 1 (Randomized Period)|Adverse Event|1|||
27837230|NCT01520909|54322547|FG001|Part 1 (Randomized Period)|Adverse Event|2|||
27837231|NCT01520909|54322548|FG002|Part 1 (Randomized Period)|Adverse Event|0|||
27837232|NCT01520909|54322546|FG000|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
27837233|NCT01520909|54322547|FG001|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
27837234|NCT01520909|54322548|FG002|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4|||
27837235|NCT01520909|54322546|FG000|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
27837236|NCT01520909|54322547|FG001|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
27837237|NCT01520909|54322548|FG002|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2|||
27837238|NCT01520909|54322546|FG000|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
27837239|NCT01520909|54322547|FG001|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
27753877|NCT01946152|54205103|FG000|Overall Study|Physician Decision|0|||
27753878|NCT01946152|54205104|FG001|Overall Study|Physician Decision|0|||
27837240|NCT01520909|54322548|FG002|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1|||
27837241|NCT01520363|54322570|FG000|Overall Study|Withdrawal by Subject|2|||
27837242|NCT01520363|54322571|FG001|Overall Study|Withdrawal by Subject|0|||
27753879|NCT01946152|54205105|FG002|Overall Study|Physician Decision|1|||
27753880|NCT01946152|54205106|FG003|Overall Study|Physician Decision|0|||
27753881|NCT01946152|54205103|FG000|Overall Study|Second malignancy|0|||
27753882|NCT01946152|54205104|FG001|Overall Study|Second malignancy|0|||
27753883|NCT01946152|54205105|FG002|Overall Study|Second malignancy|1|||
27753884|NCT01946152|54205106|FG003|Overall Study|Second malignancy|0|||
27753885|NCT01946152|54205103|FG000|Overall Study|Adverse Event|0|||
27753886|NCT01946152|54205104|FG001|Overall Study|Adverse Event|0|||
27753887|NCT01946152|54205105|FG002|Overall Study|Adverse Event|0|||
27753888|NCT01946152|54205106|FG003|Overall Study|Adverse Event|1|||
27753889|NCT01945996|54205120|FG000|Overall Study|Lost to Follow-up|3|||
27753890|NCT01945996|54205121|FG001|Overall Study|Lost to Follow-up|5|||
27753891|NCT01971346|54205129|FG000|Overall Study|Protocol Violation|3|||
27753892|NCT01971346|54205129|FG000|Overall Study|Lost to Follow-up|2|||
27753893|NCT01971346|54205129|FG000|Overall Study|Withdrawal by Subject|2|||
27753894|NCT01971346|54205129|FG000|Overall Study|Physician Decision|1|||
27837243|NCT01578499|54322603|FG000|Overall Study|Reason not Specified|0|||
27837244|NCT01578499|54322604|FG001|Overall Study|Reason not Specified|1|||
27837245|NCT01578499|54322603|FG000|Overall Study|Lost to Follow-up|2|||
27837246|NCT01578499|54322604|FG001|Overall Study|Lost to Follow-up|1|||
27837247|NCT01578499|54322603|FG000|Overall Study|Withdrawal by Subject|10|||
27837248|NCT01578499|54322604|FG001|Overall Study|Withdrawal by Subject|16|||
27837249|NCT01578499|54322603|FG000|Overall Study|Death|20|||
27837250|NCT01578499|54322604|FG001|Overall Study|Death|25|||
27837251|NCT01578499|54322603|FG000|Overall Study|Died and End of Study Page not Completed|2|||
27837252|NCT01578499|54322604|FG001|Overall Study|Died and End of Study Page not Completed|0|||
27837253|NCT01578187|54322614|FG000|Usability Phase|Withdrawal by Subject|1|||
27837254|NCT01561963|54322620|FG000|Overall Study|Adverse Event|1|||
27837255|NCT01576783|54322631|FG000|Overall Study|Change in Medical Care|1|||
27837256|NCT01576783|54322632|FG001|Overall Study|Change in Medical Care|0|||
27837257|NCT01576783|54322631|FG000|Overall Study|Lost to Follow-up|14|||
27837258|NCT01576783|54322632|FG001|Overall Study|Lost to Follow-up|16|||
27837259|NCT01576783|54322631|FG000|Overall Study|Withdrawal by Subject|5|||
27837260|NCT01576783|54322632|FG001|Overall Study|Withdrawal by Subject|1|||
27753895|NCT01945216|54205144|FG000|Overall Study|Case report forms (CRF) uncollected|52|||
27753896|NCT01945216|54205144|FG000|Overall Study|Protocol Violation|42|||
27753897|NCT01945216|54205144|FG000|Overall Study|CRF not assured by investigators|5|||
27753898|NCT02641379|54205163|FG000|Overall Study|Exclusion criterion during screening|1|||
27753899|NCT02641379|54205164|FG001|Overall Study|Exclusion criterion during screening|0|||
27753900|NCT02641379|54205165|FG002|Overall Study|Exclusion criterion during screening|0|||
27753901|NCT02641379|54205166|FG003|Overall Study|Exclusion criterion during screening|1|||
27837261|NCT01534351|54322641|FG000|Overall Study|Study Terminated Early|1|||
27837262|NCT01534351|54322642|FG001|Overall Study|Study Terminated Early|0|||
27837263|NCT01534351|54322643|FG002|Overall Study|Study Terminated Early|0|||
27837264|NCT01534273|54322655|FG000|Period 1|Physician Decision|0|||
27837265|NCT01534273|54322656|FG001|Period 1|Physician Decision|0|||
27837266|NCT01534273|54322657|FG002|Period 1|Physician Decision|0|||
27837267|NCT01534273|54322658|FG003|Period 1|Physician Decision|1|||
27837268|NCT01534273|54322659|FG004|Period 1|Physician Decision|0|||
27837269|NCT01534273|54322660|FG005|Period 1|Physician Decision|0|||
27837270|NCT01534273|54322661|FG006|Period 1|Physician Decision|0|||
27837271|NCT01534195|54322684|FG000|Overall Study|Withdrawal by Subject|1|||
27837272|NCT01534195|54322685|FG001|Overall Study|Withdrawal by Subject|1|||
27837273|NCT01560949|54322691|FG000|Systemic Phase: mFOLFIRINOX|Adverse Event|6|||
27837274|NCT01560949|54322691|FG000|Surgery Phase|Physician Decision|3|||
27837275|NCT01372878|54322699|FG000|Overall Study|Withdrawal by Subject|63|||
27837276|NCT01372878|54322699|FG000|Overall Study|Protocol Violation|17|||
27837277|NCT01372878|54322699|FG000|Overall Study|incomplete study procedure|104|||
27837278|NCT01533493|54322705|FG000|Overall Study|Adverse Event|2|||
27837279|NCT01533493|54322706|FG001|Overall Study|Adverse Event|1|||
27837280|NCT01533493|54322705|FG000|Overall Study|Withdrawal by Subject|1|||
27837281|NCT01533493|54322706|FG001|Overall Study|Withdrawal by Subject|2|||
27837282|NCT01533493|54322705|FG000|Overall Study|Lost to Follow-up|2|||
27837283|NCT01533493|54322706|FG001|Overall Study|Lost to Follow-up|0|||
27837284|NCT01533181|54322782|FG000|Overall Study|Disease progression pre-active treatment|0|||
27837285|NCT01533181|54322783|FG001|Overall Study|Disease progression pre-active treatment|1|||
27837286|NCT01533181|54322782|FG000|Overall Study|Patient withdrawal pre-active treatment|1|||
27837287|NCT01533181|54322783|FG001|Overall Study|Patient withdrawal pre-active treatment|0|||
27837288|NCT02669082|54322789|FG000|Overall Study|Adverse Event|1|||
27837289|NCT02668692|54322853|FG000|Overall Study|Adverse Event|1|||
27837290|NCT02668692|54322854|FG001|Overall Study|Adverse Event|0|||
27837291|NCT02662764|54322868|FG000|Overall Study|Adverse Event|6|||
27837292|NCT02662764|54322868|FG000|Overall Study|Lack of Efficacy|8|||
27837293|NCT02662764|54322868|FG000|Overall Study|Protocol Violation|1|||
27837294|NCT02662764|54322868|FG000|Overall Study|Withdrawal by Subject|5|||
27837295|NCT02662764|54322868|FG000|Overall Study|Device failure|4|||
27837296|NCT02662764|54322868|FG000|Overall Study|Patient changed treatment|1|||
27837297|NCT02662764|54322868|FG000|Overall Study|Patient discharged prior to 24 hrs|5|||
27837298|NCT01519817|54322877|FG000|Overall Study|Withdrawal by Subject|1|||
27837299|NCT01519817|54322878|FG001|Overall Study|Withdrawal by Subject|0|||
27837300|NCT01519817|54322879|FG002|Overall Study|Withdrawal by Subject|0|||
27837301|NCT01519817|54322880|FG003|Overall Study|Withdrawal by Subject|0|||
27837302|NCT01519817|54322877|FG000|Overall Study|Off study due to infection|0|||
27837303|NCT01519817|54322878|FG001|Overall Study|Off study due to infection|0|||
27837304|NCT01519817|54322879|FG002|Overall Study|Off study due to infection|0|||
27837305|NCT01519817|54322880|FG003|Overall Study|Off study due to infection|1|||
27837306|NCT03478956|54322892|FG000|Overall Study|Adverse Event|1|||
27837307|NCT03478956|54322893|FG001|Overall Study|Adverse Event|0|||
27837308|NCT03478956|54322892|FG000|Overall Study|Withdrawal by Subject|0|||
27837309|NCT03478956|54322893|FG001|Overall Study|Withdrawal by Subject|1|||
27837310|NCT03478956|54322892|FG000|Overall Study|Ongoing in the Study|11|||
27837311|NCT03478956|54322893|FG001|Overall Study|Ongoing in the Study|11|||
27837312|NCT01519661|54322899|FG000|Overall Study|Protocol deviation|6|||
27837313|NCT01519661|54322899|FG000|Overall Study|Lost to Follow-up|3|||
27837314|NCT01519661|54322899|FG000|Overall Study|Withdrawal by Subject|17|||
27837315|NCT01519661|54322899|FG000|Overall Study|Lack of Efficacy|6|||
27753902|NCT02641379|54205167|FG004|Overall Study|Exclusion criterion during screening|2|||
27753903|NCT02641379|54205168|FG005|Overall Study|Exclusion criterion during screening|0|||
27753904|NCT02641379|54205169|FG006|Overall Study|Exclusion criterion during screening|0|||
27753905|NCT02641379|54205170|FG007|Overall Study|Exclusion criterion during screening|0|||
27753906|NCT02641379|54205171|FG008|Overall Study|Exclusion criterion during screening|0|||
27753907|NCT02641379|54205172|FG009|Overall Study|Exclusion criterion during screening|0|||
27753908|NCT02641379|54205173|FG010|Overall Study|Exclusion criterion during screening|0|||
27753909|NCT02641379|54205163|FG000|Overall Study|Withdrawal of informed consent|0|||
27753910|NCT02641379|54205164|FG001|Overall Study|Withdrawal of informed consent|1|||
27753911|NCT02641379|54205165|FG002|Overall Study|Withdrawal of informed consent|0|||
27753912|NCT02641379|54205166|FG003|Overall Study|Withdrawal of informed consent|0|||
27753913|NCT02641379|54205167|FG004|Overall Study|Withdrawal of informed consent|0|||
27753914|NCT02641379|54205168|FG005|Overall Study|Withdrawal of informed consent|0|||
27753915|NCT02641379|54205169|FG006|Overall Study|Withdrawal of informed consent|0|||
27753916|NCT02641379|54205170|FG007|Overall Study|Withdrawal of informed consent|1|||
27753917|NCT02641379|54205171|FG008|Overall Study|Withdrawal of informed consent|0|||
27837316|NCT01519661|54322899|FG000|Overall Study|Adverse Event|29|||
27837317|NCT01519427|54322904|FG000|Overall Study|disease progression|2|||
27837318|NCT01518257|54322910|FG000|Overall Study|Lost to Follow-up|1|||
27837319|NCT01518257|54322911|FG001|Overall Study|Lost to Follow-up|0|||
27837320|NCT01518257|54322910|FG000|Overall Study|Other Miscellaneous Reason|1|||
27837321|NCT01518257|54322911|FG001|Overall Study|Other Miscellaneous Reason|0|||
27837322|NCT02668302|54322919|FG000|Overall Study|Withdrawal by Subject|1|||
27837323|NCT02668302|54322920|FG001|Overall Study|Withdrawal by Subject|0|||
27837324|NCT01517867|54322928|FG000|Overall Study|never started treatment|29|||
27837325|NCT01517867|54322929|FG001|Overall Study|never started treatment|32|||
27837326|NCT01517867|54322928|FG000|Overall Study|Withdrawal by Subject|34|||
27837327|NCT01517867|54322929|FG001|Overall Study|Withdrawal by Subject|30|||
27837328|NCT01517867|54322928|FG000|Overall Study|Still in treatment at study end|0|||
27837329|NCT01517867|54322929|FG001|Overall Study|Still in treatment at study end|3|||
27837330|NCT01514357|54322937|FG000|Overall Study|Screen failure|2|||
27837331|NCT01514357|54322938|FG001|Overall Study|Screen failure|0|||
27753918|NCT02641379|54205172|FG009|Overall Study|Withdrawal of informed consent|0|||
27753919|NCT02641379|54205173|FG010|Overall Study|Withdrawal of informed consent|0|||
27753920|NCT02641379|54205163|FG000|Overall Study|Adverse Event|7|||
27753921|NCT02641379|54205164|FG001|Overall Study|Adverse Event|8|||
27753922|NCT02641379|54205165|FG002|Overall Study|Adverse Event|2|||
27753923|NCT02641379|54205166|FG003|Overall Study|Adverse Event|2|||
27753924|NCT02641379|54205167|FG004|Overall Study|Adverse Event|5|||
27753925|NCT02641379|54205168|FG005|Overall Study|Adverse Event|1|||
27753926|NCT02641379|54205169|FG006|Overall Study|Adverse Event|5|||
27753927|NCT02641379|54205170|FG007|Overall Study|Adverse Event|0|||
27753928|NCT02641379|54205171|FG008|Overall Study|Adverse Event|1|||
27753929|NCT02641379|54205172|FG009|Overall Study|Adverse Event|1|||
27753930|NCT02641379|54205173|FG010|Overall Study|Adverse Event|5|||
27753931|NCT02641379|54205163|FG000|Overall Study|Lack of Efficacy|0|||
27753932|NCT02641379|54205164|FG001|Overall Study|Lack of Efficacy|0|||
27753933|NCT02641379|54205165|FG002|Overall Study|Lack of Efficacy|2|||
27753934|NCT02641379|54205166|FG003|Overall Study|Lack of Efficacy|0|||
27753935|NCT02641379|54205167|FG004|Overall Study|Lack of Efficacy|0|||
27753936|NCT02641379|54205168|FG005|Overall Study|Lack of Efficacy|2|||
27753937|NCT02641379|54205169|FG006|Overall Study|Lack of Efficacy|0|||
27753938|NCT02641379|54205170|FG007|Overall Study|Lack of Efficacy|5|||
27753939|NCT02641379|54205171|FG008|Overall Study|Lack of Efficacy|0|||
27753940|NCT02641379|54205172|FG009|Overall Study|Lack of Efficacy|0|||
27753941|NCT02641379|54205173|FG010|Overall Study|Lack of Efficacy|0|||
27753942|NCT02641379|54205163|FG000|Overall Study|Participant unable to attend study visit|4|||
27753943|NCT02641379|54205164|FG001|Overall Study|Participant unable to attend study visit|10|||
27753944|NCT02641379|54205165|FG002|Overall Study|Participant unable to attend study visit|1|||
27753945|NCT02641379|54205166|FG003|Overall Study|Participant unable to attend study visit|2|||
27753946|NCT02641379|54205167|FG004|Overall Study|Participant unable to attend study visit|5|||
27753947|NCT02641379|54205168|FG005|Overall Study|Participant unable to attend study visit|1|||
27753948|NCT02641379|54205169|FG006|Overall Study|Participant unable to attend study visit|1|||
27753949|NCT02641379|54205170|FG007|Overall Study|Participant unable to attend study visit|1|||
27753950|NCT02641379|54205171|FG008|Overall Study|Participant unable to attend study visit|0|||
27753951|NCT02641379|54205172|FG009|Overall Study|Participant unable to attend study visit|2|||
27753952|NCT02641379|54205173|FG010|Overall Study|Participant unable to attend study visit|0|||
27753953|NCT02641379|54205163|FG000|Overall Study|Participant's compliance|0|||
27753954|NCT02641379|54205164|FG001|Overall Study|Participant's compliance|1|||
27753955|NCT02641379|54205165|FG002|Overall Study|Participant's compliance|0|||
27753956|NCT02641379|54205166|FG003|Overall Study|Participant's compliance|1|||
27753957|NCT02641379|54205167|FG004|Overall Study|Participant's compliance|0|||
27753958|NCT02641379|54205168|FG005|Overall Study|Participant's compliance|2|||
27753959|NCT02641379|54205169|FG006|Overall Study|Participant's compliance|0|||
27753960|NCT02641379|54205170|FG007|Overall Study|Participant's compliance|0|||
27753961|NCT02641379|54205171|FG008|Overall Study|Participant's compliance|1|||
27753962|NCT02641379|54205172|FG009|Overall Study|Participant's compliance|1|||
27753963|NCT02641379|54205173|FG010|Overall Study|Participant's compliance|1|||
27753964|NCT02641379|54205163|FG000|Overall Study|Participant cannot be reached|4|||
27753965|NCT02641379|54205164|FG001|Overall Study|Participant cannot be reached|4|||
27753966|NCT02641379|54205165|FG002|Overall Study|Participant cannot be reached|0|||
27753967|NCT02641379|54205166|FG003|Overall Study|Participant cannot be reached|8|||
27753968|NCT02641379|54205167|FG004|Overall Study|Participant cannot be reached|2|||
27753969|NCT02641379|54205168|FG005|Overall Study|Participant cannot be reached|1|||
27753970|NCT02641379|54205169|FG006|Overall Study|Participant cannot be reached|0|||
27753971|NCT02641379|54205170|FG007|Overall Study|Participant cannot be reached|1|||
27753972|NCT02641379|54205171|FG008|Overall Study|Participant cannot be reached|0|||
27753973|NCT02641379|54205172|FG009|Overall Study|Participant cannot be reached|2|||
27753974|NCT02641379|54205173|FG010|Overall Study|Participant cannot be reached|1|||
27753975|NCT02641379|54205163|FG000|Overall Study|PCR positive at Week 24|15|||
27753976|NCT02641379|54205164|FG001|Overall Study|PCR positive at Week 24|21|||
27753977|NCT02641379|54205165|FG002|Overall Study|PCR positive at Week 24|62|||
27753978|NCT02641379|54205166|FG003|Overall Study|PCR positive at Week 24|0|||
27753979|NCT02641379|54205167|FG004|Overall Study|PCR positive at Week 24|0|||
27753980|NCT02641379|54205168|FG005|Overall Study|PCR positive at Week 24|6|||
27753981|NCT02641379|54205169|FG006|Overall Study|PCR positive at Week 24|3|||
27753982|NCT02641379|54205170|FG007|Overall Study|PCR positive at Week 24|8|||
27753983|NCT02641379|54205171|FG008|Overall Study|PCR positive at Week 24|0|||
27753984|NCT02641379|54205172|FG009|Overall Study|PCR positive at Week 24|1|||
27753985|NCT02641379|54205173|FG010|Overall Study|PCR positive at Week 24|0|||
27753986|NCT02641379|54205163|FG000|Overall Study|PCR positive at follow up 2|1|||
27753987|NCT02641379|54205164|FG001|Overall Study|PCR positive at follow up 2|0|||
27753988|NCT02641379|54205165|FG002|Overall Study|PCR positive at follow up 2|0|||
27753989|NCT02641379|54205166|FG003|Overall Study|PCR positive at follow up 2|0|||
27753990|NCT02641379|54205167|FG004|Overall Study|PCR positive at follow up 2|0|||
27753991|NCT02641379|54205168|FG005|Overall Study|PCR positive at follow up 2|0|||
27837332|NCT01514357|54322937|FG000|Overall Study|Withdrawal by Subject|2|||
27837333|NCT01514357|54322938|FG001|Overall Study|Withdrawal by Subject|0|||
27837334|NCT01532869|54322946|FG000|Blinded-Treatment Period (Up to Week 24)|Death|0|||
27837335|NCT01532869|54322947|FG001|Blinded-Treatment Period (Up to Week 24)|Death|1|||
27837336|NCT01532869|54322946|FG000|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2|||
27837337|NCT01532869|54322947|FG001|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3|||
27837338|NCT01532869|54322946|FG000|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0|||
27837339|NCT01532869|54322947|FG001|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1|||
27837340|NCT01532869|54322946|FG000|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1|||
27837341|NCT01532869|54322947|FG001|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0|||
27837342|NCT01532869|54322946|FG000|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
27837343|NCT01532869|54322947|FG001|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
27837344|NCT01532869|54322946|FG000|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4|||
27837345|NCT01532869|54322947|FG001|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2|||
27837346|NCT01532869|54322946|FG000|Blinded-Treatment Period (Up to Week 48)|Death|0|||
27837347|NCT01532869|54322947|FG001|Blinded-Treatment Period (Up to Week 48)|Death|3|||
27837348|NCT01532869|54322946|FG000|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4|||
27837349|NCT01532869|54322947|FG001|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5|||
27837350|NCT01532869|54322946|FG000|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0|||
27837351|NCT01532869|54322947|FG001|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1|||
27837352|NCT01532869|54322946|FG000|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1|||
27837353|NCT01532869|54322947|FG001|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0|||
27837354|NCT01532869|54322946|FG000|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0|||
27837355|NCT01532869|54322947|FG001|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1|||
27837356|NCT01532869|54322946|FG000|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5|||
27837357|NCT01532869|54322947|FG001|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3|||
27837358|NCT01532869|54322946|FG000|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1|||
27837359|NCT01532869|54322947|FG001|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0|||
27837360|NCT01532869|54322946|FG000|Open-label Period (Week 48 to Week 96)|Adverse Event|4|||
27837361|NCT01532869|54322947|FG001|Open-label Period (Week 48 to Week 96)|Adverse Event|1|||
27837362|NCT01532869|54322946|FG000|Open-label Period (Week 48 to Week 96)|Non-compliance|1|||
27837363|NCT01532869|54322947|FG001|Open-label Period (Week 48 to Week 96)|Non-compliance|0|||
27837364|NCT01532869|54322946|FG000|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
27837365|NCT01532869|54322947|FG001|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
27837366|NCT01532869|54322946|FG000|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
27837367|NCT01532869|54322947|FG001|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
27837368|NCT01531387|54322960|FG000|Overall Study|Early termination of study|11|||
27837369|NCT01531387|54322961|FG001|Overall Study|Early termination of study|11|||
27837370|NCT01531153|54322970|FG000|Overall Study|Withdrawal by Subject|10|||
27837371|NCT01531153|54322971|FG001|Overall Study|Withdrawal by Subject|9|||
27837372|NCT01531153|54322972|FG002|Overall Study|Withdrawal by Subject|15|||
27837373|NCT01529749|54322987|FG000|Overall Study|Lost to Follow-up|0|||
27837374|NCT01529749|54322988|FG001|Overall Study|Lost to Follow-up|1|||
27837375|NCT01529749|54322989|FG002|Overall Study|Lost to Follow-up|1|||
27837376|NCT01529749|54322990|FG003|Overall Study|Lost to Follow-up|0|||
27837377|NCT01529749|54322987|FG000|Overall Study|Physician Decision|0|||
27837378|NCT01529749|54322988|FG001|Overall Study|Physician Decision|0|||
27837379|NCT01529749|54322989|FG002|Overall Study|Physician Decision|0|||
27837380|NCT01529749|54322990|FG003|Overall Study|Physician Decision|1|||
27837381|NCT01529749|54322987|FG000|Overall Study|Withdrawal by Subject|0|||
27837382|NCT01529749|54322988|FG001|Overall Study|Withdrawal by Subject|1|||
27837383|NCT01529749|54322989|FG002|Overall Study|Withdrawal by Subject|1|||
27837384|NCT01529749|54322990|FG003|Overall Study|Withdrawal by Subject|0|||
27837385|NCT01529749|54322987|FG000|Overall Study|Protocol Violation|0|||
27837386|NCT01529749|54322988|FG001|Overall Study|Protocol Violation|0|||
27837387|NCT01529749|54322989|FG002|Overall Study|Protocol Violation|0|||
27837388|NCT01529749|54322990|FG003|Overall Study|Protocol Violation|1|||
27837389|NCT01529515|54323002|FG000|TRANSITION PHASE|Adverse Event|16|||
27837390|NCT01529515|54323003|FG001|TRANSITION PHASE|Adverse Event|0|||
27837391|NCT01529515|54323004|FG002|TRANSITION PHASE|Adverse Event|0|||
27837392|NCT01529515|54323005|FG003|TRANSITION PHASE|Adverse Event|0|||
27837393|NCT01529515|54323002|FG000|TRANSITION PHASE|Death|1|||
27837394|NCT01529515|54323003|FG001|TRANSITION PHASE|Death|0|||
27837395|NCT01529515|54323004|FG002|TRANSITION PHASE|Death|0|||
27837396|NCT01529515|54323005|FG003|TRANSITION PHASE|Death|0|||
27837397|NCT01529515|54323002|FG000|TRANSITION PHASE|Lack of Efficacy|19|||
27837398|NCT01529515|54323003|FG001|TRANSITION PHASE|Lack of Efficacy|0|||
27837399|NCT01529515|54323004|FG002|TRANSITION PHASE|Lack of Efficacy|0|||
27837400|NCT01529515|54323005|FG003|TRANSITION PHASE|Lack of Efficacy|0|||
27837401|NCT01529515|54323002|FG000|TRANSITION PHASE|Lost to Follow-up|19|||
27837402|NCT01529515|54323003|FG001|TRANSITION PHASE|Lost to Follow-up|0|||
27837403|NCT01529515|54323004|FG002|TRANSITION PHASE|Lost to Follow-up|0|||
27837404|NCT01529515|54323005|FG003|TRANSITION PHASE|Lost to Follow-up|0|||
27837405|NCT01529515|54323002|FG000|TRANSITION PHASE|Protocol Violation|4|||
27837406|NCT01529515|54323003|FG001|TRANSITION PHASE|Protocol Violation|0|||
27837407|NCT01529515|54323004|FG002|TRANSITION PHASE|Protocol Violation|0|||
27837408|NCT01529515|54323005|FG003|TRANSITION PHASE|Protocol Violation|0|||
27837409|NCT01529515|54323002|FG000|TRANSITION PHASE|Withdrawal by Subject|51|||
27837410|NCT01529515|54323003|FG001|TRANSITION PHASE|Withdrawal by Subject|0|||
27837411|NCT01529515|54323004|FG002|TRANSITION PHASE|Withdrawal by Subject|0|||
27837412|NCT01529515|54323005|FG003|TRANSITION PHASE|Withdrawal by Subject|0|||
27837413|NCT01529515|54323002|FG000|TRANSITION PHASE|Failed Maintenance Phase Criteria|8|||
27837414|NCT01529515|54323003|FG001|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
27837415|NCT01529515|54323004|FG002|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
27837416|NCT01529515|54323005|FG003|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
27837417|NCT01529515|54323002|FG000|TRANSITION PHASE|Other|9|||
27837418|NCT01529515|54323003|FG001|TRANSITION PHASE|Other|0|||
27837419|NCT01529515|54323004|FG002|TRANSITION PHASE|Other|0|||
27837420|NCT01529515|54323005|FG003|TRANSITION PHASE|Other|0|||
27837421|NCT01529515|54323002|FG000|MAINTENANCE PHASE|Adverse Event|0|||
27837422|NCT01529515|54323003|FG001|MAINTENANCE PHASE|Adverse Event|10|||
27837423|NCT01529515|54323004|FG002|MAINTENANCE PHASE|Adverse Event|0|||
27837424|NCT01529515|54323005|FG003|MAINTENANCE PHASE|Adverse Event|0|||
27837425|NCT01529515|54323002|FG000|MAINTENANCE PHASE|Lack of Efficacy|0|||
27837426|NCT01529515|54323003|FG001|MAINTENANCE PHASE|Lack of Efficacy|9|||
27837427|NCT01529515|54323004|FG002|MAINTENANCE PHASE|Lack of Efficacy|0|||
27837428|NCT01529515|54323005|FG003|MAINTENANCE PHASE|Lack of Efficacy|0|||
27837429|NCT01529515|54323002|FG000|MAINTENANCE PHASE|Lost to Follow-up|0|||
27837430|NCT01529515|54323003|FG001|MAINTENANCE PHASE|Lost to Follow-up|5|||
27837431|NCT01529515|54323004|FG002|MAINTENANCE PHASE|Lost to Follow-up|0|||
27837432|NCT01529515|54323005|FG003|MAINTENANCE PHASE|Lost to Follow-up|0|||
27837433|NCT01529515|54323002|FG000|MAINTENANCE PHASE|Protocol Violation|0|||
27837434|NCT01529515|54323003|FG001|MAINTENANCE PHASE|Protocol Violation|12|||
27837435|NCT01529515|54323004|FG002|MAINTENANCE PHASE|Protocol Violation|0|||
27837436|NCT01529515|54323005|FG003|MAINTENANCE PHASE|Protocol Violation|0|||
27837437|NCT01529515|54323002|FG000|MAINTENANCE PHASE|Withdrawal by Subject|0|||
27837438|NCT01529515|54323003|FG001|MAINTENANCE PHASE|Withdrawal by Subject|15|||
27837439|NCT01529515|54323004|FG002|MAINTENANCE PHASE|Withdrawal by Subject|0|||
27837440|NCT01529515|54323005|FG003|MAINTENANCE PHASE|Withdrawal by Subject|0|||
27837441|NCT01529515|54323002|FG000|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
27837442|NCT01529515|54323003|FG001|MAINTENANCE PHASE|Failed Randomization Criteria|13|||
27837443|NCT01529515|54323004|FG002|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
27837444|NCT01529515|54323005|FG003|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
27837445|NCT01529515|54323002|FG000|MAINTENANCE PHASE|Other|0|||
27837446|NCT01529515|54323003|FG001|MAINTENANCE PHASE|Other|10|||
27837447|NCT01529515|54323004|FG002|MAINTENANCE PHASE|Other|0|||
27837448|NCT01529515|54323005|FG003|MAINTENANCE PHASE|Other|0|||
27837449|NCT01529515|54323002|FG000|DOUBLE BLIND PHASE|Adverse Event|0|||
27837450|NCT01529515|54323003|FG001|DOUBLE BLIND PHASE|Adverse Event|0|||
27837451|NCT01529515|54323004|FG002|DOUBLE BLIND PHASE|Adverse Event|1|||
27837452|NCT01529515|54323005|FG003|DOUBLE BLIND PHASE|Adverse Event|0|||
27837453|NCT01529515|54323002|FG000|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
27837454|NCT01529515|54323003|FG001|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
27837455|NCT01529515|54323004|FG002|DOUBLE BLIND PHASE|Lost to Follow-up|1|||
27837456|NCT01529515|54323005|FG003|DOUBLE BLIND PHASE|Lost to Follow-up|3|||
27837457|NCT01529515|54323002|FG000|DOUBLE BLIND PHASE|Pregnancy|0|||
27837458|NCT01529515|54323003|FG001|DOUBLE BLIND PHASE|Pregnancy|0|||
27837459|NCT01529515|54323004|FG002|DOUBLE BLIND PHASE|Pregnancy|1|||
27837460|NCT01529515|54323005|FG003|DOUBLE BLIND PHASE|Pregnancy|0|||
27837461|NCT01529515|54323002|FG000|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
27837462|NCT01529515|54323003|FG001|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
27837463|NCT01529515|54323004|FG002|DOUBLE BLIND PHASE|Withdrawal by Subject|10|||
27837464|NCT01529515|54323005|FG003|DOUBLE BLIND PHASE|Withdrawal by Subject|7|||
27837465|NCT01529515|54323002|FG000|DOUBLE BLIND PHASE|Protocol Violation|0|||
27837466|NCT01529515|54323003|FG001|DOUBLE BLIND PHASE|Protocol Violation|0|||
27837467|NCT01529515|54323004|FG002|DOUBLE BLIND PHASE|Protocol Violation|1|||
27837468|NCT01529515|54323005|FG003|DOUBLE BLIND PHASE|Protocol Violation|0|||
27837469|NCT01529515|54323002|FG000|DOUBLE BLIND PHASE|Other|0|||
27837470|NCT01529515|54323003|FG001|DOUBLE BLIND PHASE|Other|0|||
27837471|NCT01529515|54323004|FG002|DOUBLE BLIND PHASE|Other|9|||
27837472|NCT01529515|54323005|FG003|DOUBLE BLIND PHASE|Other|2|||
27837473|NCT01528969|54323014|FG000|Overall Study|absent from the school at baseline|2|||
27837474|NCT01528969|54323015|FG001|Overall Study|absent from the school at baseline|0|||
27837475|NCT01514201|54323025|FG000|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1|||
27837476|NCT01514201|54323026|FG001|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
27837477|NCT01514201|54323027|FG002|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
27837478|NCT01514201|54323028|FG003|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
27837479|NCT01514201|54323025|FG000|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
27837480|NCT01514201|54323026|FG001|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
27837481|NCT01514201|54323027|FG002|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
27837482|NCT01514201|54323028|FG003|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
27837483|NCT01514201|54323025|FG000|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
27837484|NCT01514201|54323026|FG001|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
27837485|NCT01514201|54323027|FG002|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5|||
27837486|NCT01514201|54323028|FG003|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
27837487|NCT01514201|54323025|FG000|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
27837488|NCT01514201|54323026|FG001|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
27837489|NCT01514201|54323027|FG002|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
27837490|NCT01514201|54323028|FG003|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
27837491|NCT01514201|54323025|FG000|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
27837492|NCT01514201|54323026|FG001|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
27837493|NCT01514201|54323027|FG002|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
27837494|NCT01514201|54323028|FG003|PHASE II: Veliparib + Radiation Therapy|Ineligible|1|||
27837495|NCT01514201|54323025|FG000|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
27837496|NCT01514201|54323026|FG001|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
27837497|NCT01514201|54323027|FG002|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
27837498|NCT01514201|54323028|FG003|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2|||
27837499|NCT01514201|54323025|FG000|PHASE II: Veliparib + Radiation Therapy|Death|0|||
27837500|NCT01514201|54323026|FG001|PHASE II: Veliparib + Radiation Therapy|Death|0|||
27837501|NCT01514201|54323027|FG002|PHASE II: Veliparib + Radiation Therapy|Death|0|||
27837502|NCT01514201|54323028|FG003|PHASE II: Veliparib + Radiation Therapy|Death|1|||
27837503|NCT01514201|54323025|FG000|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
27837504|NCT01514201|54323026|FG001|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
27837505|NCT01514201|54323027|FG002|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
27837506|NCT01514201|54323028|FG003|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2|||
27837507|NCT01514201|54323025|FG000|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
27837508|NCT01514201|54323026|FG001|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
27837509|NCT01514201|54323027|FG002|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
27837510|NCT01514201|54323028|FG003|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6|||
27837511|NCT01514201|54323025|FG000|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
27837512|NCT01514201|54323026|FG001|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
27837513|NCT01514201|54323027|FG002|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
27837514|NCT01514201|54323028|FG003|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4|||
27837515|NCT01514201|54323025|FG000|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
27837516|NCT01514201|54323026|FG001|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
27837517|NCT01514201|54323027|FG002|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
27837518|NCT01514201|54323028|FG003|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7|||
27837519|NCT01514201|54323025|FG000|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
27837520|NCT01514201|54323026|FG001|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
27837521|NCT01514201|54323027|FG002|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
27837522|NCT01514201|54323028|FG003|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22|||
27837523|NCT02666664|54323050|FG000|Overall Study|Physician Decision|0|||
27837524|NCT02666664|54323051|FG001|Overall Study|Physician Decision|1|||
27837525|NCT02666664|54323050|FG000|Overall Study|Protocol Violation|0|||
27837526|NCT02666664|54323051|FG001|Overall Study|Protocol Violation|2|||
27837527|NCT02666664|54323050|FG000|Overall Study|Other|0|||
27837528|NCT02666664|54323051|FG001|Overall Study|Other|1|||
27837529|NCT02666664|54323050|FG000|Overall Study|Adverse Event|12|||
27837530|NCT02666664|54323051|FG001|Overall Study|Adverse Event|37|||
27837531|NCT02666664|54323050|FG000|Overall Study|Withdrawal by participant|23|||
27837532|NCT02666664|54323051|FG001|Overall Study|Withdrawal by participant|40|||
27837533|NCT02666664|54323050|FG000|Overall Study|Sponsor decision|0|||
27837534|NCT02666664|54323051|FG001|Overall Study|Sponsor decision|1|||
27837535|NCT02666664|54323050|FG000|Overall Study|Lost to Follow-up|1|||
27837536|NCT02666664|54323051|FG001|Overall Study|Lost to Follow-up|2|||
27837537|NCT01528735|54323059|FG000|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
27837538|NCT01528735|54323060|FG001|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
27837539|NCT01528735|54323059|FG000|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1|||
27837540|NCT01528735|54323060|FG001|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0|||
27837541|NCT02661594|54323072|FG000|Overall Study|Protocol Violation|1|||
27837542|NCT02661594|54323073|FG001|Overall Study|Protocol Violation|0|||
27837543|NCT02661594|54323074|FG002|Overall Study|Protocol Violation|1|||
27837544|NCT02661594|54323075|FG003|Overall Study|Protocol Violation|0|||
27837545|NCT01528345|54323087|FG000|Overall Study|Adverse Event|10|||
27753992|NCT02641379|54205169|FG006|Overall Study|PCR positive at follow up 2|0|||
27753993|NCT02641379|54205170|FG007|Overall Study|PCR positive at follow up 2|0|||
27753994|NCT02641379|54205171|FG008|Overall Study|PCR positive at follow up 2|0|||
27753995|NCT02641379|54205172|FG009|Overall Study|PCR positive at follow up 2|0|||
27753996|NCT02641379|54205173|FG010|Overall Study|PCR positive at follow up 2|0|||
27753997|NCT02641379|54205163|FG000|Overall Study|Participant showed relapse|1|||
27753998|NCT02641379|54205164|FG001|Overall Study|Participant showed relapse|0|||
27753999|NCT02641379|54205165|FG002|Overall Study|Participant showed relapse|0|||
27754000|NCT02641379|54205166|FG003|Overall Study|Participant showed relapse|0|||
27754001|NCT02641379|54205167|FG004|Overall Study|Participant showed relapse|0|||
27754002|NCT02641379|54205168|FG005|Overall Study|Participant showed relapse|0|||
27754003|NCT02641379|54205169|FG006|Overall Study|Participant showed relapse|1|||
27754004|NCT02641379|54205170|FG007|Overall Study|Participant showed relapse|0|||
27754005|NCT02641379|54205171|FG008|Overall Study|Participant showed relapse|0|||
27754006|NCT02641379|54205172|FG009|Overall Study|Participant showed relapse|0|||
27754007|NCT02641379|54205173|FG010|Overall Study|Participant showed relapse|0|||
27754008|NCT02641379|54205163|FG000|Overall Study|Participant stopped study/treatment|1|||
27754009|NCT02641379|54205164|FG001|Overall Study|Participant stopped study/treatment|3|||
27754010|NCT02641379|54205165|FG002|Overall Study|Participant stopped study/treatment|1|||
27754011|NCT02641379|54205166|FG003|Overall Study|Participant stopped study/treatment|0|||
27754012|NCT02641379|54205167|FG004|Overall Study|Participant stopped study/treatment|0|||
27754013|NCT02641379|54205168|FG005|Overall Study|Participant stopped study/treatment|1|||
27754014|NCT02641379|54205169|FG006|Overall Study|Participant stopped study/treatment|2|||
27754015|NCT02641379|54205170|FG007|Overall Study|Participant stopped study/treatment|0|||
27754016|NCT02641379|54205171|FG008|Overall Study|Participant stopped study/treatment|1|||
27754017|NCT02641379|54205172|FG009|Overall Study|Participant stopped study/treatment|0|||
27754018|NCT02641379|54205173|FG010|Overall Study|Participant stopped study/treatment|0|||
27754019|NCT02641379|54205163|FG000|Overall Study|Therapy stopped due to misunderstanding|1|||
27754020|NCT02641379|54205164|FG001|Overall Study|Therapy stopped due to misunderstanding|0|||
27754021|NCT02641379|54205165|FG002|Overall Study|Therapy stopped due to misunderstanding|0|||
27754022|NCT02641379|54205166|FG003|Overall Study|Therapy stopped due to misunderstanding|0|||
27754023|NCT02641379|54205167|FG004|Overall Study|Therapy stopped due to misunderstanding|0|||
27754024|NCT02641379|54205168|FG005|Overall Study|Therapy stopped due to misunderstanding|0|||
27754025|NCT02641379|54205169|FG006|Overall Study|Therapy stopped due to misunderstanding|0|||
27754026|NCT02641379|54205170|FG007|Overall Study|Therapy stopped due to misunderstanding|0|||
27754027|NCT02641379|54205171|FG008|Overall Study|Therapy stopped due to misunderstanding|0|||
27754028|NCT02641379|54205172|FG009|Overall Study|Therapy stopped due to misunderstanding|0|||
27754029|NCT02641379|54205173|FG010|Overall Study|Therapy stopped due to misunderstanding|0|||
27754030|NCT02641379|54205163|FG000|Overall Study|Financial problems|0|||
27754031|NCT02641379|54205164|FG001|Overall Study|Financial problems|1|||
27754032|NCT02641379|54205165|FG002|Overall Study|Financial problems|0|||
27754033|NCT02641379|54205166|FG003|Overall Study|Financial problems|0|||
27754034|NCT02641379|54205167|FG004|Overall Study|Financial problems|0|||
27754035|NCT02641379|54205168|FG005|Overall Study|Financial problems|0|||
27754036|NCT02641379|54205169|FG006|Overall Study|Financial problems|0|||
27754037|NCT02641379|54205170|FG007|Overall Study|Financial problems|0|||
27754038|NCT02641379|54205171|FG008|Overall Study|Financial problems|0|||
27754039|NCT02641379|54205172|FG009|Overall Study|Financial problems|0|||
27754040|NCT02641379|54205173|FG010|Overall Study|Financial problems|0|||
27754041|NCT02641379|54205163|FG000|Overall Study|PCR positive at Week 68|0|||
27754042|NCT02641379|54205164|FG001|Overall Study|PCR positive at Week 68|1|||
27754043|NCT02641379|54205165|FG002|Overall Study|PCR positive at Week 68|0|||
27754044|NCT02641379|54205166|FG003|Overall Study|PCR positive at Week 68|0|||
27754045|NCT02641379|54205167|FG004|Overall Study|PCR positive at Week 68|0|||
27754046|NCT02641379|54205168|FG005|Overall Study|PCR positive at Week 68|0|||
27754047|NCT02641379|54205169|FG006|Overall Study|PCR positive at Week 68|0|||
27754048|NCT02641379|54205170|FG007|Overall Study|PCR positive at Week 68|0|||
27754049|NCT02641379|54205171|FG008|Overall Study|PCR positive at Week 68|0|||
27754050|NCT02641379|54205172|FG009|Overall Study|PCR positive at Week 68|0|||
27754051|NCT02641379|54205173|FG010|Overall Study|PCR positive at Week 68|0|||
27754052|NCT02641379|54205163|FG000|Overall Study|PCR positive at Week 48|0|||
27754053|NCT02641379|54205164|FG001|Overall Study|PCR positive at Week 48|1|||
27754054|NCT02641379|54205165|FG002|Overall Study|PCR positive at Week 48|0|||
27754055|NCT02641379|54205166|FG003|Overall Study|PCR positive at Week 48|0|||
27754056|NCT02641379|54205167|FG004|Overall Study|PCR positive at Week 48|0|||
27754057|NCT02641379|54205168|FG005|Overall Study|PCR positive at Week 48|0|||
27754058|NCT02641379|54205169|FG006|Overall Study|PCR positive at Week 48|0|||
27754059|NCT02641379|54205170|FG007|Overall Study|PCR positive at Week 48|0|||
27754060|NCT02641379|54205171|FG008|Overall Study|PCR positive at Week 48|0|||
27754061|NCT02641379|54205172|FG009|Overall Study|PCR positive at Week 48|0|||
27754062|NCT02641379|54205173|FG010|Overall Study|PCR positive at Week 48|0|||
27754063|NCT02641379|54205163|FG000|Overall Study|PCR not performed at Week 12|0|||
27754064|NCT02641379|54205164|FG001|Overall Study|PCR not performed at Week 12|0|||
27837546|NCT01528345|54323088|FG001|Overall Study|Adverse Event|1|||
27837547|NCT01528345|54323087|FG000|Overall Study|Death|1|||
27837548|NCT01528345|54323088|FG001|Overall Study|Death|1|||
27837549|NCT01528345|54323087|FG000|Overall Study|Non-compliance with study treatment|1|||
27837550|NCT01528345|54323088|FG001|Overall Study|Non-compliance with study treatment|0|||
27837551|NCT01528345|54323087|FG000|Overall Study|Progressive Disease|26|||
27837552|NCT01528345|54323088|FG001|Overall Study|Progressive Disease|40|||
27837553|NCT01528345|54323087|FG000|Overall Study|Study Terminated by Sponsor|4|||
27837554|NCT01528345|54323088|FG001|Overall Study|Study Terminated by Sponsor|8|||
27837555|NCT01528345|54323087|FG000|Overall Study|Subject/Guardian Decision|5|||
27837556|NCT01528345|54323088|FG001|Overall Study|Subject/Guardian Decision|0|||
27837557|NCT01513967|54323102|FG000|Overall Study|Pregnancy|0|||
27837558|NCT01513967|54323103|FG001|Overall Study|Pregnancy|0|||
27837559|NCT01513967|54323104|FG002|Overall Study|Pregnancy|0|||
27837560|NCT01513967|54323105|FG003|Overall Study|Pregnancy|0|||
27837561|NCT01513967|54323106|FG004|Overall Study|Pregnancy|0|||
27837562|NCT01513967|54323107|FG005|Overall Study|Pregnancy|0|||
27837563|NCT01513967|54323108|FG006|Overall Study|Pregnancy|1|||
27837564|NCT01513967|54323109|FG007|Overall Study|Pregnancy|0|||
27837565|NCT01513967|54323102|FG000|Overall Study|missed a study visit|0|||
27837566|NCT01513967|54323103|FG001|Overall Study|missed a study visit|0|||
27837567|NCT01513967|54323104|FG002|Overall Study|missed a study visit|0|||
27837568|NCT01513967|54323105|FG003|Overall Study|missed a study visit|0|||
27837569|NCT01513967|54323106|FG004|Overall Study|missed a study visit|0|||
27837570|NCT01513967|54323107|FG005|Overall Study|missed a study visit|0|||
27837571|NCT01513967|54323108|FG006|Overall Study|missed a study visit|1|||
27754065|NCT02641379|54205165|FG002|Overall Study|PCR not performed at Week 12|1|||
27754066|NCT02641379|54205166|FG003|Overall Study|PCR not performed at Week 12|0|||
27754067|NCT02641379|54205167|FG004|Overall Study|PCR not performed at Week 12|0|||
27754068|NCT02641379|54205168|FG005|Overall Study|PCR not performed at Week 12|0|||
27754069|NCT02641379|54205169|FG006|Overall Study|PCR not performed at Week 12|0|||
27754070|NCT02641379|54205170|FG007|Overall Study|PCR not performed at Week 12|0|||
27754071|NCT02641379|54205171|FG008|Overall Study|PCR not performed at Week 12|0|||
27754072|NCT02641379|54205172|FG009|Overall Study|PCR not performed at Week 12|0|||
27754073|NCT02641379|54205173|FG010|Overall Study|PCR not performed at Week 12|0|||
27754074|NCT02641379|54205163|FG000|Overall Study|No PCR at baseline|0|||
27754075|NCT02641379|54205164|FG001|Overall Study|No PCR at baseline|0|||
27754076|NCT02641379|54205165|FG002|Overall Study|No PCR at baseline|1|||
27754077|NCT02641379|54205166|FG003|Overall Study|No PCR at baseline|0|||
27754078|NCT02641379|54205167|FG004|Overall Study|No PCR at baseline|0|||
27754079|NCT02641379|54205168|FG005|Overall Study|No PCR at baseline|0|||
27754080|NCT02641379|54205169|FG006|Overall Study|No PCR at baseline|0|||
27754081|NCT02641379|54205170|FG007|Overall Study|No PCR at baseline|0|||
27754082|NCT02641379|54205171|FG008|Overall Study|No PCR at baseline|0|||
27754083|NCT02641379|54205172|FG009|Overall Study|No PCR at baseline|0|||
27754084|NCT02641379|54205173|FG010|Overall Study|No PCR at baseline|0|||
27754085|NCT02641379|54205163|FG000|Overall Study|PCR positive at Week 28|0|||
27754086|NCT02641379|54205164|FG001|Overall Study|PCR positive at Week 28|0|||
27754087|NCT02641379|54205165|FG002|Overall Study|PCR positive at Week 28|1|||
27754088|NCT02641379|54205166|FG003|Overall Study|PCR positive at Week 28|0|||
27754089|NCT02641379|54205167|FG004|Overall Study|PCR positive at Week 28|0|||
27754090|NCT02641379|54205168|FG005|Overall Study|PCR positive at Week 28|0|||
27754091|NCT02641379|54205169|FG006|Overall Study|PCR positive at Week 28|0|||
27754092|NCT02641379|54205170|FG007|Overall Study|PCR positive at Week 28|0|||
27754093|NCT02641379|54205171|FG008|Overall Study|PCR positive at Week 28|0|||
27754094|NCT02641379|54205172|FG009|Overall Study|PCR positive at Week 28|0|||
27754095|NCT02641379|54205173|FG010|Overall Study|PCR positive at Week 28|0|||
27754096|NCT02641379|54205163|FG000|Overall Study|PCR sample for Week 4 not drawn|0|||
27754097|NCT02641379|54205164|FG001|Overall Study|PCR sample for Week 4 not drawn|0|||
27754098|NCT02641379|54205165|FG002|Overall Study|PCR sample for Week 4 not drawn|0|||
27754099|NCT02641379|54205166|FG003|Overall Study|PCR sample for Week 4 not drawn|1|||
27754100|NCT02641379|54205167|FG004|Overall Study|PCR sample for Week 4 not drawn|0|||
27837572|NCT01513967|54323109|FG007|Overall Study|missed a study visit|0|||
27837573|NCT01513967|54323102|FG000|Overall Study|excluded due to positive drug screen|0|||
27837574|NCT01513967|54323103|FG001|Overall Study|excluded due to positive drug screen|0|||
27837575|NCT01513967|54323104|FG002|Overall Study|excluded due to positive drug screen|0|||
27837576|NCT01513967|54323105|FG003|Overall Study|excluded due to positive drug screen|0|||
27754101|NCT02641379|54205168|FG005|Overall Study|PCR sample for Week 4 not drawn|0|||
27754102|NCT02641379|54205169|FG006|Overall Study|PCR sample for Week 4 not drawn|0|||
27754103|NCT02641379|54205170|FG007|Overall Study|PCR sample for Week 4 not drawn|0|||
27754104|NCT02641379|54205171|FG008|Overall Study|PCR sample for Week 4 not drawn|0|||
27754105|NCT02641379|54205172|FG009|Overall Study|PCR sample for Week 4 not drawn|0|||
27754106|NCT02641379|54205173|FG010|Overall Study|PCR sample for Week 4 not drawn|0|||
27754107|NCT02641379|54205163|FG000|Overall Study|Inclusion criteria not fulfilled|0|||
27837577|NCT01513967|54323106|FG004|Overall Study|excluded due to positive drug screen|0|||
27837578|NCT01513967|54323107|FG005|Overall Study|excluded due to positive drug screen|0|||
27837579|NCT01513967|54323108|FG006|Overall Study|excluded due to positive drug screen|0|||
27837580|NCT01513967|54323109|FG007|Overall Study|excluded due to positive drug screen|2|||
27837581|NCT01513967|54323102|FG000|Overall Study|Physician Decision|0|||
27837582|NCT01513967|54323103|FG001|Overall Study|Physician Decision|0|||
27837583|NCT01513967|54323104|FG002|Overall Study|Physician Decision|0|||
27837584|NCT01513967|54323105|FG003|Overall Study|Physician Decision|0|||
27837585|NCT01513967|54323106|FG004|Overall Study|Physician Decision|0|||
27837586|NCT01513967|54323107|FG005|Overall Study|Physician Decision|1|||
27837587|NCT01513967|54323108|FG006|Overall Study|Physician Decision|0|||
27837588|NCT01513967|54323109|FG007|Overall Study|Physician Decision|0|||
27837589|NCT01511939|54323153|FG000|Overall Study|Withdrawal by Subject|2|||
27837590|NCT01511939|54323154|FG001|Overall Study|Withdrawal by Subject|1|||
27837591|NCT01511939|54323155|FG002|Overall Study|Withdrawal by Subject|0|||
27837592|NCT01576705|54323167|FG000|Overall Study|TSH > 7 mIU/L at baseline|3|||
27837593|NCT01576705|54323168|FG001|Overall Study|TSH > 7 mIU/L at baseline|7|||
27837594|NCT01576705|54323169|FG002|Overall Study|TSH > 7 mIU/L at baseline|5|||
27837595|NCT01576705|54323170|FG003|Overall Study|TSH > 7 mIU/L at baseline|3|||
27837596|NCT01576705|54323167|FG000|Overall Study|invalid ICF|0|||
27837597|NCT01576705|54323168|FG001|Overall Study|invalid ICF|1|||
27837598|NCT01576705|54323169|FG002|Overall Study|invalid ICF|0|||
27837599|NCT01576705|54323170|FG003|Overall Study|invalid ICF|0|||
27837600|NCT02666430|54323182|FG000|Period 1|Lost to Follow-up|1|||
27837601|NCT02666430|54323183|FG001|Period 1|Lost to Follow-up|0|||
27837602|NCT02666430|54323182|FG000|Period 1|Adverse Event|0|||
27837603|NCT02666430|54323183|FG001|Period 1|Adverse Event|1|||
27837604|NCT02666430|54323182|FG000|Period 2|Withdrawal by Subject|1|||
27837605|NCT02666430|54323183|FG001|Period 2|Withdrawal by Subject|4|||
27837606|NCT02666430|54323182|FG000|Period 3|Lost to Follow-up|1|||
27837607|NCT02666430|54323183|FG001|Period 3|Lost to Follow-up|0|||
27837608|NCT01576549|54323189|FG000|Overall Study|Sponsor Decision|2|||
27837609|NCT01576159|54323202|FG000|Overall Study|Withdrawal by Subject|0|||
27837610|NCT01576159|54323203|FG001|Overall Study|Withdrawal by Subject|1|||
27837611|NCT01576159|54323204|FG002|Overall Study|Withdrawal by Subject|0|||
27837612|NCT01576159|54323205|FG003|Overall Study|Withdrawal by Subject|0|||
27837613|NCT01576159|54323202|FG000|Overall Study|Physician Decision|0|||
27837614|NCT01576159|54323203|FG001|Overall Study|Physician Decision|0|||
27837615|NCT01576159|54323204|FG002|Overall Study|Physician Decision|1|||
27837616|NCT01576159|54323205|FG003|Overall Study|Physician Decision|0|||
27837617|NCT01576159|54323202|FG000|Overall Study|Lost to Follow-up|0|||
27837618|NCT01576159|54323203|FG001|Overall Study|Lost to Follow-up|0|||
27837619|NCT01576159|54323204|FG002|Overall Study|Lost to Follow-up|0|||
27837620|NCT01576159|54323205|FG003|Overall Study|Lost to Follow-up|1|||
27837621|NCT01576159|54323202|FG000|Overall Study|Protocol Violation|1|||
27754108|NCT02641379|54205164|FG001|Overall Study|Inclusion criteria not fulfilled|0|||
27754109|NCT02641379|54205165|FG002|Overall Study|Inclusion criteria not fulfilled|0|||
27754110|NCT02641379|54205166|FG003|Overall Study|Inclusion criteria not fulfilled|1|||
27754111|NCT02641379|54205167|FG004|Overall Study|Inclusion criteria not fulfilled|0|||
27754112|NCT02641379|54205168|FG005|Overall Study|Inclusion criteria not fulfilled|0|||
27754113|NCT02641379|54205169|FG006|Overall Study|Inclusion criteria not fulfilled|0|||
27754114|NCT02641379|54205170|FG007|Overall Study|Inclusion criteria not fulfilled|0|||
27754115|NCT02641379|54205171|FG008|Overall Study|Inclusion criteria not fulfilled|0|||
27754116|NCT02641379|54205172|FG009|Overall Study|Inclusion criteria not fulfilled|0|||
27754117|NCT02641379|54205173|FG010|Overall Study|Inclusion criteria not fulfilled|0|||
27754118|NCT02641379|54205163|FG000|Overall Study|Baseline viral load unavailable|0|||
27837622|NCT01576159|54323203|FG001|Overall Study|Protocol Violation|0|||
27837623|NCT01576159|54323204|FG002|Overall Study|Protocol Violation|0|||
27837624|NCT01576159|54323205|FG003|Overall Study|Protocol Violation|0|||
27837625|NCT01510769|54323236|FG000|Overall Study|Adverse Event|7|||
27837626|NCT01510769|54323237|FG001|Overall Study|Adverse Event|6|||
27837627|NCT01510769|54323238|FG002|Overall Study|Adverse Event|4|||
27837628|NCT01510769|54323236|FG000|Overall Study|Gout Flare|0|||
27837629|NCT01510769|54323237|FG001|Overall Study|Gout Flare|3|||
27837630|NCT01510769|54323238|FG002|Overall Study|Gout Flare|1|||
27754119|NCT02641379|54205164|FG001|Overall Study|Baseline viral load unavailable|0|||
27837631|NCT01510769|54323236|FG000|Overall Study|Protocol Violation|11|||
27837632|NCT01510769|54323237|FG001|Overall Study|Protocol Violation|10|||
27837633|NCT01510769|54323238|FG002|Overall Study|Protocol Violation|9|||
27754120|NCT02641379|54205165|FG002|Overall Study|Baseline viral load unavailable|0|||
27754121|NCT02641379|54205166|FG003|Overall Study|Baseline viral load unavailable|1|||
27837634|NCT01510769|54323236|FG000|Overall Study|Lost to Follow-up|5|||
27837635|NCT01510769|54323237|FG001|Overall Study|Lost to Follow-up|1|||
27837636|NCT01510769|54323238|FG002|Overall Study|Lost to Follow-up|5|||
27837637|NCT01510769|54323236|FG000|Overall Study|Withdrawal by Subject|3|||
27837638|NCT01510769|54323237|FG001|Overall Study|Withdrawal by Subject|4|||
27837639|NCT01510769|54323238|FG002|Overall Study|Withdrawal by Subject|3|||
27837640|NCT01510769|54323236|FG000|Overall Study|Death|1|||
27837641|NCT01510769|54323237|FG001|Overall Study|Death|1|||
27837642|NCT01510769|54323238|FG002|Overall Study|Death|0|||
27837643|NCT01575769|54323246|FG000|Overall Study|Adverse Event|1|||
27837644|NCT01575769|54323246|FG000|Overall Study|Study terminated by sponsor|40|||
27837645|NCT01510145|54323252|FG000|Overall Study|Adverse Event|6|||
27837646|NCT01510145|54323252|FG000|Overall Study|Lost to Follow-up|5|||
27837647|NCT01510145|54323252|FG000|Overall Study|Withdrawal by Subject|6|||
27837648|NCT01510145|54323252|FG000|Overall Study|Relative reported subject withdrew|1|||
27837649|NCT01528033|54323258|FG000|Primary Endpoint Assessment ITT|Withdrawal by Subject|8|||
27837650|NCT01528033|54323259|FG001|Primary Endpoint Assessment ITT|Withdrawal by Subject|7|||
27837651|NCT01528033|54323258|FG000|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
27837652|NCT01528033|54323259|FG001|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
27837653|NCT01528033|54323258|FG000|Primary Endpoint Assessment ITT|Death|2|||
27837654|NCT01528033|54323259|FG001|Primary Endpoint Assessment ITT|Death|2|||
27837655|NCT01528033|54323258|FG000|Primary Endpoint Assessment ITT|Physician Decision|2|||
27837656|NCT01528033|54323259|FG001|Primary Endpoint Assessment ITT|Physician Decision|1|||
27837657|NCT01528033|54323258|FG000|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
27837658|NCT01528033|54323259|FG001|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
27837659|NCT01528033|54323258|FG000|Follow Up|No data available|46|||
27837660|NCT01528033|54323259|FG001|Follow Up|No data available|44|||
27837661|NCT01560871|54323276|FG000|Overall Study|transportation issues|2|||
27837662|NCT01560871|54323277|FG001|Overall Study|transportation issues|1|||
27837663|NCT01560871|54323276|FG000|Overall Study|relocation|1|||
27837664|NCT01560871|54323277|FG001|Overall Study|relocation|0|||
27837665|NCT01560871|54323276|FG000|Overall Study|readmission to a hospital|2|||
27837666|NCT01560871|54323277|FG001|Overall Study|readmission to a hospital|1|||
27837667|NCT01560871|54323276|FG000|Overall Study|Lost to Follow-up|1|||
27837668|NCT01560871|54323277|FG001|Overall Study|Lost to Follow-up|0|||
27837669|NCT01509053|54323284|FG000|Oral Aripirazole (Phase A)|Sponsor discontinued study|11|||
27837670|NCT01509053|54323284|FG000|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1|||
27837671|NCT01509053|54323284|FG000|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13|||
27837672|NCT01509053|54323284|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1|||
27837673|NCT01509053|54323284|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1|||
27837674|NCT01509053|54323284|FG000|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3|||
27837675|NCT01560403|54323298|FG000|Overall Study|Lost to Follow-up|0|||
27837676|NCT01560403|54323299|FG001|Overall Study|Lost to Follow-up|1|||
27837677|NCT01527487|54323346|FG000|Overall Study|MD Discretion/Lack of Efficacy|3|||
27837678|NCT01527487|54323347|FG001|Overall Study|MD Discretion/Lack of Efficacy|4|||
27837679|NCT01527487|54323346|FG000|Overall Study|Disease Progression|4|||
27837680|NCT01527487|54323347|FG001|Overall Study|Disease Progression|1|||
27837681|NCT01527487|54323346|FG000|Overall Study|Adverse Event|1|||
27837682|NCT01527487|54323347|FG001|Overall Study|Adverse Event|1|||
27837683|NCT01527487|54323346|FG000|Overall Study|Death|0|||
27837684|NCT01527487|54323347|FG001|Overall Study|Death|1|||
27837685|NCT01506947|54323358|FG000|Overall Study|Lost to Follow-up|7|||
27837686|NCT01506947|54323358|FG000|Overall Study|Adverse Event|5|||
27837687|NCT01506947|54323358|FG000|Overall Study|Death|1|||
27754122|NCT02641379|54205167|FG004|Overall Study|Baseline viral load unavailable|0|||
27754123|NCT02641379|54205168|FG005|Overall Study|Baseline viral load unavailable|0|||
27754124|NCT02641379|54205169|FG006|Overall Study|Baseline viral load unavailable|0|||
27754125|NCT02641379|54205170|FG007|Overall Study|Baseline viral load unavailable|0|||
27754126|NCT02641379|54205171|FG008|Overall Study|Baseline viral load unavailable|0|||
27754127|NCT02641379|54205172|FG009|Overall Study|Baseline viral load unavailable|0|||
27754128|NCT02641379|54205173|FG010|Overall Study|Baseline viral load unavailable|0|||
27754129|NCT02641379|54205163|FG000|Overall Study|Blood could not be drawn|0|||
27754130|NCT02641379|54205164|FG001|Overall Study|Blood could not be drawn|0|||
27754131|NCT02641379|54205165|FG002|Overall Study|Blood could not be drawn|0|||
27754132|NCT02641379|54205166|FG003|Overall Study|Blood could not be drawn|0|||
27754133|NCT02641379|54205167|FG004|Overall Study|Blood could not be drawn|1|||
27754134|NCT02641379|54205168|FG005|Overall Study|Blood could not be drawn|0|||
27754135|NCT02641379|54205169|FG006|Overall Study|Blood could not be drawn|0|||
27754136|NCT02641379|54205170|FG007|Overall Study|Blood could not be drawn|0|||
27754137|NCT02641379|54205171|FG008|Overall Study|Blood could not be drawn|0|||
27754138|NCT02641379|54205172|FG009|Overall Study|Blood could not be drawn|0|||
27754139|NCT02641379|54205173|FG010|Overall Study|Blood could not be drawn|0|||
27754140|NCT02641379|54205163|FG000|Overall Study|Protocol Violation|0|||
27754141|NCT02641379|54205164|FG001|Overall Study|Protocol Violation|0|||
27754142|NCT02641379|54205165|FG002|Overall Study|Protocol Violation|0|||
27754143|NCT02641379|54205166|FG003|Overall Study|Protocol Violation|0|||
27754144|NCT02641379|54205167|FG004|Overall Study|Protocol Violation|2|||
27754145|NCT02641379|54205168|FG005|Overall Study|Protocol Violation|0|||
27754146|NCT02641379|54205169|FG006|Overall Study|Protocol Violation|0|||
27837688|NCT01506947|54323358|FG000|Overall Study|Did Not Meet Eligibility Criteria|3|||
27837689|NCT02665338|54323375|FG000|Overall Study|Withdrawal by Subject|0|||
27837690|NCT02665338|54323376|FG001|Overall Study|Withdrawal by Subject|1|||
27837691|NCT01506479|54323385|FG000|Overall Study|Lost to Follow-up|1|||
27837692|NCT01506479|54323386|FG001|Overall Study|Lost to Follow-up|2|||
27837693|NCT01506479|54323387|FG002|Overall Study|Lost to Follow-up|2|||
27837694|NCT01506479|54323385|FG000|Overall Study|Withdrawal by Subject|1|||
27837695|NCT01506479|54323386|FG001|Overall Study|Withdrawal by Subject|2|||
27837696|NCT01506479|54323387|FG002|Overall Study|Withdrawal by Subject|1|||
27754147|NCT02641379|54205170|FG007|Overall Study|Protocol Violation|0|||
27837697|NCT01506479|54323385|FG000|Overall Study|Missing assessment|1|||
27837698|NCT01506479|54323386|FG001|Overall Study|Missing assessment|0|||
27837699|NCT01506479|54323387|FG002|Overall Study|Missing assessment|0|||
27837700|NCT01506479|54323385|FG000|Overall Study|Adverse Event|0|||
27837701|NCT01506479|54323386|FG001|Overall Study|Adverse Event|1|||
27837702|NCT01506479|54323387|FG002|Overall Study|Adverse Event|0|||
27837703|NCT01506323|54323411|FG000|Overall Study|Lost to Follow-up|5|||
27837704|NCT01506323|54323412|FG001|Overall Study|Lost to Follow-up|4|||
27837705|NCT01506323|54323411|FG000|Overall Study|Withdrawal by Subject|4|||
27837706|NCT01506323|54323412|FG001|Overall Study|Withdrawal by Subject|4|||
27837707|NCT01506323|54323411|FG000|Overall Study|Lack of Efficacy|1|||
27837708|NCT01506323|54323412|FG001|Overall Study|Lack of Efficacy|3|||
27837709|NCT01506323|54323411|FG000|Overall Study|Moved out of area|5|||
27837710|NCT01506323|54323412|FG001|Overall Study|Moved out of area|2|||
27837711|NCT01506323|54323411|FG000|Overall Study|Schedule or Transportation conflict|8|||
27837712|NCT01506323|54323412|FG001|Overall Study|Schedule or Transportation conflict|0|||
27837713|NCT01506323|54323411|FG000|Overall Study|Started another treatment|1|||
27837714|NCT01506323|54323412|FG001|Overall Study|Started another treatment|0|||
27837715|NCT01505387|54323425|FG000|Overall Study|Protocol Violation|1|||
27837716|NCT01505387|54323426|FG001|Overall Study|Protocol Violation|0|||
27837717|NCT01505387|54323425|FG000|Overall Study|Withdrawal by Subject|1|||
27837718|NCT01505387|54323426|FG001|Overall Study|Withdrawal by Subject|1|||
27837719|NCT01504841|54323514|FG000|Overall Study|Withdrawal by Subject|1|||
27837720|NCT01504841|54323515|FG001|Overall Study|Withdrawal by Subject|1|||
27837721|NCT01504841|54323516|FG002|Overall Study|Withdrawal by Subject|0|||
27837722|NCT01502423|54323529|FG000|Overall Study|Withdrawal by Subject|0|||
27837723|NCT01502423|54323530|FG001|Overall Study|Withdrawal by Subject|1|||
27837724|NCT01502033|54323536|FG000|Overall Study|1 participant had scalp discomfort|1|||
27837725|NCT01502033|54323536|FG000|Overall Study|1 participant had worsening depression|1|||
27837726|NCT01502033|54323536|FG000|Overall Study|1 participant went back to school|1|||
27837727|NCT01500629|54323544|FG000|Washout Period of 14 to 30 Days|Pregnancy|1|||
27837728|NCT01500629|54323545|FG001|Washout Period of 14 to 30 Days|Pregnancy|0|||
27837729|NCT01500317|54323561|FG000|Overall Study|Withdrawal by Subject|3|||
27837730|NCT01500317|54323562|FG001|Overall Study|Withdrawal by Subject|2|||
27837731|NCT01500317|54323563|FG002|Overall Study|Withdrawal by Subject|0|||
27837732|NCT01500083|54323618|FG000|Overall Study|Adverse Event|4|||
27837733|NCT01500083|54323619|FG001|Overall Study|Adverse Event|17|||
27837734|NCT01500083|54323618|FG000|Overall Study|Death|0|||
27837735|NCT01500083|54323619|FG001|Overall Study|Death|2|||
27837736|NCT01500083|54323618|FG000|Overall Study|Lost to Follow-up|1|||
27837737|NCT01500083|54323619|FG001|Overall Study|Lost to Follow-up|0|||
27837738|NCT01500083|54323618|FG000|Overall Study|Withdrawal of Consent|0|||
27837739|NCT01500083|54323619|FG001|Overall Study|Withdrawal of Consent|1|||
27837740|NCT01500083|54323618|FG000|Overall Study|Disease Progression|2|||
27837741|NCT01500083|54323619|FG001|Overall Study|Disease Progression|10|||
27837742|NCT01500083|54323618|FG000|Overall Study|Investigator Discretion|3|||
27837743|NCT01500083|54323619|FG001|Overall Study|Investigator Discretion|8|||
27754148|NCT02641379|54205171|FG008|Overall Study|Protocol Violation|1|||
27754149|NCT02641379|54205172|FG009|Overall Study|Protocol Violation|0|||
27754150|NCT02641379|54205173|FG010|Overall Study|Protocol Violation|0|||
27754151|NCT02641379|54205163|FG000|Overall Study|Participation in sili rescue study|0|||
27754152|NCT02641379|54205164|FG001|Overall Study|Participation in sili rescue study|0|||
27754153|NCT02641379|54205165|FG002|Overall Study|Participation in sili rescue study|0|||
27754154|NCT02641379|54205166|FG003|Overall Study|Participation in sili rescue study|0|||
27754155|NCT02641379|54205167|FG004|Overall Study|Participation in sili rescue study|0|||
27754156|NCT02641379|54205168|FG005|Overall Study|Participation in sili rescue study|1|||
27754157|NCT02641379|54205169|FG006|Overall Study|Participation in sili rescue study|0|||
27754158|NCT02641379|54205170|FG007|Overall Study|Participation in sili rescue study|0|||
27754159|NCT02641379|54205171|FG008|Overall Study|Participation in sili rescue study|0|||
27837744|NCT01500083|54323618|FG000|Overall Study|Other Reasons|2|||
27837745|NCT01500083|54323619|FG001|Overall Study|Other Reasons|5|||
27837746|NCT01499849|54323649|FG000|Overall Study|Adverse Event|28|||
27837747|NCT01499849|54323650|FG001|Overall Study|Adverse Event|32|||
27837748|NCT01499849|54323649|FG000|Overall Study|Chemo completed or Change in Therapy|70|||
27837749|NCT01499849|54323650|FG001|Overall Study|Chemo completed or Change in Therapy|67|||
27837750|NCT01499849|54323649|FG000|Overall Study|Withdrawal by Subject|43|||
27837751|NCT01499849|54323650|FG001|Overall Study|Withdrawal by Subject|43|||
27837752|NCT01499849|54323649|FG000|Overall Study|Death|5|||
27837753|NCT01499849|54323650|FG001|Overall Study|Death|7|||
27837754|NCT01499849|54323649|FG000|Overall Study|Disease Progression|11|||
27837755|NCT01499849|54323650|FG001|Overall Study|Disease Progression|10|||
27837756|NCT01499849|54323649|FG000|Overall Study|Protocol Violation|11|||
27837757|NCT01499849|54323650|FG001|Overall Study|Protocol Violation|11|||
27837758|NCT01499849|54323649|FG000|Overall Study|Physician Decision|20|||
27837759|NCT01499849|54323650|FG001|Overall Study|Physician Decision|19|||
27837760|NCT01499849|54323649|FG000|Overall Study|Lack of Efficacy|3|||
27837761|NCT01499849|54323650|FG001|Overall Study|Lack of Efficacy|4|||
27837762|NCT01499849|54323649|FG000|Overall Study|Lost to Follow-up|6|||
27837763|NCT01499849|54323650|FG001|Overall Study|Lost to Follow-up|3|||
27837764|NCT01499849|54323649|FG000|Overall Study|Other Reasons|27|||
27837765|NCT01499849|54323650|FG001|Overall Study|Other Reasons|30|||
27754160|NCT02641379|54205172|FG009|Overall Study|Participation in sili rescue study|0|||
27754161|NCT02641379|54205173|FG010|Overall Study|Participation in sili rescue study|0|||
27754162|NCT02641379|54205163|FG000|Overall Study|Lost to Follow-up|0|||
27754163|NCT02641379|54205164|FG001|Overall Study|Lost to Follow-up|0|||
27754164|NCT02641379|54205165|FG002|Overall Study|Lost to Follow-up|0|||
27754165|NCT02641379|54205166|FG003|Overall Study|Lost to Follow-up|0|||
27754166|NCT02641379|54205167|FG004|Overall Study|Lost to Follow-up|0|||
27837766|NCT01499303|54323669|FG000|Overall Study|Ongoing|2|||
27837767|NCT01499303|54323670|FG001|Overall Study|Ongoing|1|||
27837768|NCT01499303|54323669|FG000|Overall Study|Withdrawal by Subject|0|||
27837769|NCT01499303|54323670|FG001|Overall Study|Withdrawal by Subject|1|||
27837770|NCT01499303|54323669|FG000|Overall Study|Adverse Event|1|||
27837771|NCT01499303|54323670|FG001|Overall Study|Adverse Event|4|||
27837772|NCT01499303|54323669|FG000|Overall Study|Other|0|||
27837773|NCT01499303|54323670|FG001|Overall Study|Other|1|||
27837774|NCT01498679|54323691|FG000|Overall Study|Adverse Event|1|||
27837775|NCT01498679|54323692|FG001|Overall Study|Adverse Event|4|||
27837776|NCT01498679|54323691|FG000|Overall Study|Lack of Efficacy|72|||
27837777|NCT01498679|54323692|FG001|Overall Study|Lack of Efficacy|12|||
27837778|NCT01498679|54323691|FG000|Overall Study|Protocol Violation|4|||
27837779|NCT01498679|54323692|FG001|Overall Study|Protocol Violation|0|||
27837780|NCT01498679|54323691|FG000|Overall Study|Physician Decision|0|||
27837781|NCT01498679|54323692|FG001|Overall Study|Physician Decision|2|||
27837782|NCT01498679|54323691|FG000|Overall Study|Withdrawal by Subject|12|||
27837783|NCT01498679|54323692|FG001|Overall Study|Withdrawal by Subject|4|||
27837784|NCT01526785|54323715|FG000|Overall Study|Study Terminated by Sponsor|8|||
27837785|NCT01526785|54323715|FG000|Overall Study|Death|2|||
27837786|NCT01526785|54323715|FG000|Overall Study|Physician Decision|1|||
27837787|NCT01526785|54323715|FG000|Overall Study|Withdrawal by Subject|2|||
27837788|NCT01559389|54323721|FG000|Overall Study|Withdrawal by Subject|20|||
27837789|NCT01559389|54323722|FG001|Overall Study|Withdrawal by Subject|20|||
27837790|NCT01526551|54323732|FG000|Overall Study|Lack of returned parental consent form|424|||
27837791|NCT01559311|54323810|FG000|Overall Study|Protocol Violation|0|||
27837792|NCT01559311|54323811|FG001|Overall Study|Protocol Violation|0|||
27837793|NCT01559311|54323812|FG002|Overall Study|Protocol Violation|2|||
27837794|NCT01559311|54323810|FG000|Overall Study|Difficulty in cannulating the lateral ve|1|||
27837795|NCT01559311|54323811|FG001|Overall Study|Difficulty in cannulating the lateral ve|0|||
27837796|NCT01559311|54323812|FG002|Overall Study|Difficulty in cannulating the lateral ve|0|||
27837797|NCT01559311|54323810|FG000|Overall Study|Withdrawal by Subject|2|||
27837798|NCT01559311|54323811|FG001|Overall Study|Withdrawal by Subject|1|||
27837799|NCT01559311|54323812|FG002|Overall Study|Withdrawal by Subject|0|||
27837800|NCT01559311|54323810|FG000|Overall Study|Death|0|||
27754167|NCT02641379|54205168|FG005|Overall Study|Lost to Follow-up|0|||
27837801|NCT01559311|54323811|FG001|Overall Study|Death|2|||
27837802|NCT01559311|54323812|FG002|Overall Study|Death|3|||
27837803|NCT01559311|54323810|FG000|Overall Study|Lost to Follow-up|0|||
27837804|NCT01559311|54323811|FG001|Overall Study|Lost to Follow-up|3|||
27837805|NCT01559311|54323812|FG002|Overall Study|Lost to Follow-up|2|||
27837806|NCT01559311|54323810|FG000|Overall Study|Adverse Event|0|||
27837807|NCT01559311|54323811|FG001|Overall Study|Adverse Event|0|||
27837808|NCT01559311|54323812|FG002|Overall Study|Adverse Event|1|||
27837809|NCT01498445|54323835|FG000|Overall Study|Lack of Efficacy|0|||
27754168|NCT02641379|54205169|FG006|Overall Study|Lost to Follow-up|0|||
27837810|NCT01498445|54323836|FG001|Overall Study|Lack of Efficacy|0|||
27837811|NCT01498445|54323837|FG002|Overall Study|Lack of Efficacy|1|||
27837812|NCT01498445|54323838|FG003|Overall Study|Lack of Efficacy|2|||
27837813|NCT01498445|54323839|FG004|Overall Study|Lack of Efficacy|0|||
27837814|NCT01498445|54323840|FG005|Overall Study|Lack of Efficacy|0|||
27837815|NCT01498445|54323835|FG000|Overall Study|Screen Failure|0|||
27754169|NCT02641379|54205170|FG007|Overall Study|Lost to Follow-up|0|||
27754170|NCT02641379|54205171|FG008|Overall Study|Lost to Follow-up|1|||
27837816|NCT01498445|54323836|FG001|Overall Study|Screen Failure|0|||
27837817|NCT01498445|54323837|FG002|Overall Study|Screen Failure|0|||
27837818|NCT01498445|54323838|FG003|Overall Study|Screen Failure|0|||
27837819|NCT01498445|54323839|FG004|Overall Study|Screen Failure|1|||
27837820|NCT01498445|54323840|FG005|Overall Study|Screen Failure|1|||
27837821|NCT01558297|54323857|FG000|Overall Study|Withdrawal by Subject|2|||
27837822|NCT01558297|54323858|FG001|Overall Study|Withdrawal by Subject|2|||
27837823|NCT01558297|54323859|FG002|Overall Study|Withdrawal by Subject|1|||
27837824|NCT01525849|54323869|FG000|Overall Study|Lost to Follow-up|3|||
27837825|NCT01525849|54323870|FG001|Overall Study|Lost to Follow-up|2|||
27837826|NCT01525849|54323869|FG000|Overall Study|Withdrawal by Subject|1|||
27837827|NCT01525849|54323870|FG001|Overall Study|Withdrawal by Subject|9|||
27837828|NCT01525849|54323869|FG000|Overall Study|Unrelated medical issue (not treated)|1|||
27837829|NCT01525849|54323870|FG001|Overall Study|Unrelated medical issue (not treated)|2|||
27837830|NCT01525849|54323869|FG000|Overall Study|Anatomic exclusion criteria identified|0|||
27837831|NCT01525849|54323870|FG001|Overall Study|Anatomic exclusion criteria identified|3|||
27837832|NCT01525615|54323889|FG000|Overall Study|Adverse Event|11|||
27837833|NCT01525615|54323890|FG001|Overall Study|Adverse Event|7|||
27837834|NCT01525615|54323891|FG002|Overall Study|Adverse Event|5|||
27837835|NCT01525615|54323889|FG000|Overall Study|Lost to Follow-up|1|||
27837836|NCT01525615|54323890|FG001|Overall Study|Lost to Follow-up|0|||
27837837|NCT01525615|54323891|FG002|Overall Study|Lost to Follow-up|0|||
27837838|NCT01525615|54323889|FG000|Overall Study|Withdrawal by Subject|1|||
27837839|NCT01525615|54323890|FG001|Overall Study|Withdrawal by Subject|0|||
27837840|NCT01525615|54323891|FG002|Overall Study|Withdrawal by Subject|0|||
27837841|NCT01525615|54323889|FG000|Overall Study|Other reason not described above|1|||
27837842|NCT01525615|54323890|FG001|Overall Study|Other reason not described above|0|||
27837843|NCT01525615|54323891|FG002|Overall Study|Other reason not described above|1|||
27837844|NCT01525225|54323933|FG000|Enrollment|No longer met study criteria|1|||
27837845|NCT01525225|54323933|FG000|Enrollment|Other|1|||
27837846|NCT02660580|54323952|FG000|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
27837847|NCT02660580|54323953|FG001|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
27837848|NCT02660580|54323954|FG002|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
27837849|NCT02660580|54323955|FG003|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
27837850|NCT02660580|54323956|FG004|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
27837851|NCT02660580|54323952|FG000|Core Treatment Period (Week 1 to 16)|Protocol Violation|3|||
27837852|NCT02660580|54323953|FG001|Core Treatment Period (Week 1 to 16)|Protocol Violation|1|||
27837853|NCT02660580|54323954|FG002|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
27837854|NCT02660580|54323955|FG003|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
27837855|NCT02660580|54323956|FG004|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
27837856|NCT02660580|54323952|FG000|Core Treatment Period (Week 1 to 16)|Other un-specified|1|||
27837857|NCT02660580|54323953|FG001|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
27837858|NCT02660580|54323954|FG002|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
27837859|NCT02660580|54323955|FG003|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
27837860|NCT02660580|54323956|FG004|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
27837861|NCT02660580|54323952|FG000|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
27837862|NCT02660580|54323953|FG001|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2|||
27837863|NCT02660580|54323954|FG002|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
27837864|NCT02660580|54323955|FG003|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
27837865|NCT02660580|54323956|FG004|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
27837866|NCT02660580|54323952|FG000|Core Treatment Period (Week 1 to 16)|Adverse Event|2|||
27837867|NCT02660580|54323953|FG001|Core Treatment Period (Week 1 to 16)|Adverse Event|9|||
27837868|NCT02660580|54323954|FG002|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
27837869|NCT02660580|54323955|FG003|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
27837870|NCT02660580|54323956|FG004|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
27837871|NCT02660580|54323952|FG000|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1|||
27837872|NCT02660580|54323953|FG001|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4|||
27837873|NCT02660580|54323954|FG002|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
27837874|NCT02660580|54323955|FG003|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
27837875|NCT02660580|54323956|FG004|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
27837876|NCT02660580|54323952|FG000|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1|||
27754171|NCT02641379|54205172|FG009|Overall Study|Lost to Follow-up|0|||
27754172|NCT02641379|54205173|FG010|Overall Study|Lost to Follow-up|0|||
27754173|NCT02641379|54205163|FG000|Overall Study|Source data not found|0|||
27754174|NCT02641379|54205164|FG001|Overall Study|Source data not found|0|||
27754175|NCT02641379|54205165|FG002|Overall Study|Source data not found|0|||
27754176|NCT02641379|54205166|FG003|Overall Study|Source data not found|0|||
27754177|NCT02641379|54205167|FG004|Overall Study|Source data not found|0|||
27754178|NCT02641379|54205168|FG005|Overall Study|Source data not found|1|||
27754179|NCT02641379|54205169|FG006|Overall Study|Source data not found|0|||
27754180|NCT02641379|54205170|FG007|Overall Study|Source data not found|0|||
27754181|NCT02641379|54205171|FG008|Overall Study|Source data not found|0|||
27837877|NCT02660580|54323953|FG001|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2|||
27754182|NCT02641379|54205172|FG009|Overall Study|Source data not found|0|||
27837878|NCT02660580|54323954|FG002|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
27837879|NCT02660580|54323955|FG003|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
27837880|NCT02660580|54323956|FG004|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
27837881|NCT02660580|54323952|FG000|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
27837882|NCT02660580|54323953|FG001|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
27837883|NCT02660580|54323954|FG002|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2|||
27837884|NCT02660580|54323955|FG003|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
27837885|NCT02660580|54323956|FG004|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1|||
27837886|NCT02660580|54323952|FG000|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
27837887|NCT02660580|54323953|FG001|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
27837888|NCT02660580|54323954|FG002|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
27837889|NCT02660580|54323955|FG003|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
27837890|NCT02660580|54323956|FG004|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
27837891|NCT02660580|54323952|FG000|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
27837892|NCT02660580|54323953|FG001|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
27837893|NCT02660580|54323954|FG002|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4|||
27837894|NCT02660580|54323955|FG003|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
27837895|NCT02660580|54323956|FG004|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
27837896|NCT02660580|54323952|FG000|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
27837897|NCT02660580|54323953|FG001|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
27837898|NCT02660580|54323954|FG002|Extended Treatment Period(Week 16 to 52)|Adverse Event|8|||
27837899|NCT02660580|54323955|FG003|Extended Treatment Period(Week 16 to 52)|Adverse Event|6|||
27837900|NCT02660580|54323956|FG004|Extended Treatment Period(Week 16 to 52)|Adverse Event|4|||
27837901|NCT02660580|54323952|FG000|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
27837902|NCT02660580|54323953|FG001|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
27837903|NCT02660580|54323954|FG002|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3|||
27837904|NCT02660580|54323955|FG003|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
27837905|NCT02660580|54323956|FG004|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
27837906|NCT02660580|54323952|FG000|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
27837907|NCT02660580|54323953|FG001|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
27837908|NCT02660580|54323954|FG002|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
27837909|NCT02660580|54323955|FG003|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
27837910|NCT02660580|54323956|FG004|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
27837911|NCT01524991|54323975|FG000|Overall Study|Adverse Event|12|||
27837912|NCT01524991|54323975|FG000|Overall Study|Death|1|||
27837913|NCT01524991|54323975|FG000|Overall Study|Disease ProgressionDu|17|||
27837914|NCT01524991|54323975|FG000|Overall Study|Other complicating disease|1|||
27837915|NCT01524991|54323975|FG000|Overall Study|Withdrawal by Subject|2|||
27837916|NCT01524991|54323975|FG000|Overall Study|Symptomatic Deterioration|1|||
27837917|NCT01524913|54323982|FG000|Overall Study|Lost to Follow-up|4|||
27837918|NCT01524913|54323983|FG001|Overall Study|Lost to Follow-up|0|||
27837919|NCT01524913|54323984|FG002|Overall Study|Lost to Follow-up|0|||
27837920|NCT01524679|54323994|FG000|Overall Study|Lost to Follow-up|1|||
27837921|NCT01524679|54323995|FG001|Overall Study|Lost to Follow-up|4|||
27837922|NCT01524679|54323994|FG000|Overall Study|Withdrawal by Subject|4|||
27837923|NCT01524679|54323995|FG001|Overall Study|Withdrawal by Subject|4|||
27837924|NCT01524679|54323994|FG000|Overall Study|Adverse Event|9|||
27837925|NCT01524679|54323995|FG001|Overall Study|Adverse Event|0|||
27837926|NCT01524679|54323994|FG000|Overall Study|Protocol Violation|1|||
27837927|NCT01524679|54323995|FG001|Overall Study|Protocol Violation|0|||
27837928|NCT01524679|54323994|FG000|Overall Study|Lack of Efficacy|2|||
27837929|NCT01524679|54323995|FG001|Overall Study|Lack of Efficacy|0|||
27837930|NCT01524679|54323994|FG000|Overall Study|e.g.wish for children, relocation|6|||
27837931|NCT01524679|54323995|FG001|Overall Study|e.g.wish for children, relocation|1|||
27837932|NCT01524289|54324012|FG000|Overall Study|Lost to Follow-up|0|||
27837933|NCT01524289|54324013|FG001|Overall Study|Lost to Follow-up|1|||
27837934|NCT01524289|54324012|FG000|Overall Study|Physician Decision|1|||
27837935|NCT01524289|54324013|FG001|Overall Study|Physician Decision|0|||
27837936|NCT01524289|54324012|FG000|Overall Study|Protocol Violation|5|||
27837937|NCT01524289|54324013|FG001|Overall Study|Protocol Violation|1|||
27837938|NCT01524289|54324012|FG000|Overall Study|Withdrawal by Subject|11|||
27837939|NCT01524289|54324013|FG001|Overall Study|Withdrawal by Subject|7|||
27837940|NCT01524289|54324012|FG000|Overall Study|Adverse Event|12|||
27837941|NCT01524289|54324013|FG001|Overall Study|Adverse Event|5|||
27837942|NCT01524289|54324012|FG000|Overall Study|Did not take study medication|1|||
27837943|NCT01524289|54324013|FG001|Overall Study|Did not take study medication|0|||
27837944|NCT01498289|54324023|FG000|Overall Study|Adverse Event|16|||
27837945|NCT01498289|54324024|FG001|Overall Study|Adverse Event|18|||
27837946|NCT01498289|54324023|FG000|Overall Study|Death|6|||
27837947|NCT01498289|54324024|FG001|Overall Study|Death|8|||
27837948|NCT01498289|54324023|FG000|Overall Study|Withdrawal unrelated to AE|16|||
27837949|NCT01498289|54324024|FG001|Overall Study|Withdrawal unrelated to AE|16|||
27837950|NCT01498289|54324023|FG000|Overall Study|Progression/relapse|53|||
27837951|NCT01498289|54324024|FG001|Overall Study|Progression/relapse|59|||
27837952|NCT01498289|54324023|FG000|Overall Study|Not protocol specified|7|||
27837953|NCT01498289|54324024|FG001|Overall Study|Not protocol specified|2|||
27837954|NCT01498289|54324023|FG000|Overall Study|Reason under review|0|||
27837955|NCT01498289|54324024|FG001|Overall Study|Reason under review|1|||
27837956|NCT01524133|54324037|FG000|Treatment Phase|Withdrawal by Subject|13|||
27837957|NCT01524133|54324038|FG001|Treatment Phase|Withdrawal by Subject|28|||
27837958|NCT01524133|54324039|FG002|Treatment Phase|Withdrawal by Subject|31|||
27837959|NCT01524133|54324037|FG000|Treatment Phase|Physician Decision|6|||
27837960|NCT01524133|54324038|FG001|Treatment Phase|Physician Decision|3|||
27837961|NCT01524133|54324039|FG002|Treatment Phase|Physician Decision|3|||
27837962|NCT01524133|54324037|FG000|Treatment Phase|Lost to Follow-up|0|||
27837963|NCT01524133|54324038|FG001|Treatment Phase|Lost to Follow-up|1|||
27837964|NCT01524133|54324039|FG002|Treatment Phase|Lost to Follow-up|2|||
27837965|NCT01524133|54324037|FG000|Overall Study 52 Weeks|Withdrawal by Subject|4|||
27837966|NCT01524133|54324038|FG001|Overall Study 52 Weeks|Withdrawal by Subject|5|||
27837967|NCT01524133|54324039|FG002|Overall Study 52 Weeks|Withdrawal by Subject|10|||
27837968|NCT01524133|54324037|FG000|Overall Study 52 Weeks|Physician Decision|1|||
27837969|NCT01524133|54324038|FG001|Overall Study 52 Weeks|Physician Decision|0|||
27837970|NCT01524133|54324039|FG002|Overall Study 52 Weeks|Physician Decision|2|||
27837971|NCT01524133|54324037|FG000|Overall Study 52 Weeks|Lost to Follow-up|16|||
27837972|NCT01524133|54324038|FG001|Overall Study 52 Weeks|Lost to Follow-up|15|||
27837973|NCT01524133|54324039|FG002|Overall Study 52 Weeks|Lost to Follow-up|15|||
27837974|NCT04304534|54324073|FG000|Overall Study|Subject decision COVID-19 pandemic related|1|||
27837975|NCT04304534|54324074|FG001|Overall Study|Subject decision COVID-19 pandemic related|0|||
27837976|NCT04304534|54324075|FG002|Overall Study|Subject decision COVID-19 pandemic related|1|||
27837977|NCT04304534|54324076|FG003|Overall Study|Subject decision COVID-19 pandemic related|0|||
27837978|NCT04304534|54324073|FG000|Overall Study|Non-Compliance with study drug|0|||
27837979|NCT04304534|54324074|FG001|Overall Study|Non-Compliance with study drug|1|||
27837980|NCT04304534|54324075|FG002|Overall Study|Non-Compliance with study drug|1|||
27837981|NCT04304534|54324076|FG003|Overall Study|Non-Compliance with study drug|1|||
27837982|NCT04304534|54324073|FG000|Overall Study|Lost to Follow-up|0|||
27837983|NCT04304534|54324074|FG001|Overall Study|Lost to Follow-up|1|||
27837984|NCT04304534|54324075|FG002|Overall Study|Lost to Follow-up|2|||
27837985|NCT04304534|54324076|FG003|Overall Study|Lost to Follow-up|3|||
27837986|NCT04304534|54324073|FG000|Overall Study|Unspecific|4|||
27837987|NCT04304534|54324074|FG001|Overall Study|Unspecific|2|||
27837988|NCT04304534|54324075|FG002|Overall Study|Unspecific|2|||
27837989|NCT04304534|54324076|FG003|Overall Study|Unspecific|2|||
27837990|NCT04304534|54324073|FG000|Overall Study|Technical Problems|2|||
27837991|NCT04304534|54324074|FG001|Overall Study|Technical Problems|2|||
27837992|NCT04304534|54324075|FG002|Overall Study|Technical Problems|3|||
27837993|NCT04304534|54324076|FG003|Overall Study|Technical Problems|4|||
27837994|NCT04304534|54324073|FG000|Overall Study|Death|7|||
27837995|NCT04304534|54324074|FG001|Overall Study|Death|2|||
27837996|NCT04304534|54324075|FG002|Overall Study|Death|4|||
27837997|NCT04304534|54324076|FG003|Overall Study|Death|3|||
27837998|NCT04304534|54324073|FG000|Overall Study|Withdrawal by Subject|7|||
27837999|NCT04304534|54324074|FG001|Overall Study|Withdrawal by Subject|2|||
27838000|NCT04304534|54324075|FG002|Overall Study|Withdrawal by Subject|7|||
27838001|NCT04304534|54324076|FG003|Overall Study|Withdrawal by Subject|4|||
27838002|NCT04304534|54324073|FG000|Overall Study|Physician Decision|4|||
27838003|NCT04304534|54324074|FG001|Overall Study|Physician Decision|9|||
27838004|NCT04304534|54324075|FG002|Overall Study|Physician Decision|9|||
27838005|NCT04304534|54324076|FG003|Overall Study|Physician Decision|5|||
27838006|NCT04304534|54324073|FG000|Overall Study|Subject Decision|34|||
27838007|NCT04304534|54324074|FG001|Overall Study|Subject Decision|25|||
27838008|NCT04304534|54324075|FG002|Overall Study|Subject Decision|25|||
27838009|NCT04304534|54324076|FG003|Overall Study|Subject Decision|26|||
27838010|NCT04304534|54324073|FG000|Overall Study|Adverse Event|35|||
27838011|NCT04304534|54324074|FG001|Overall Study|Adverse Event|40|||
27838012|NCT04304534|54324075|FG002|Overall Study|Adverse Event|39|||
27838013|NCT04304534|54324076|FG003|Overall Study|Adverse Event|44|||
27838014|NCT04223609|54324089|FG000|Overall Study|Adverse Event|0|||
27838015|NCT04223609|54324090|FG001|Overall Study|Adverse Event|1|||
27838016|NCT04223609|54324089|FG000|Overall Study|Missed last visit|0|||
27838017|NCT04223609|54324090|FG001|Overall Study|Missed last visit|1|||
27838018|NCT04176458|54324096|FG000|Overall Study|Covid 19|4|||
27838019|NCT03941548|54324102|FG000|Overall Study|Adverse Event|0|||
27838020|NCT03941548|54324103|FG001|Overall Study|Adverse Event|1|||
27838021|NCT03941548|54324102|FG000|Overall Study|Lost to Follow-up|0|||
27838022|NCT03941548|54324103|FG001|Overall Study|Lost to Follow-up|1|||
27838023|NCT03941548|54324102|FG000|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|1|||
27838024|NCT03941548|54324103|FG001|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|0|||
27838025|NCT03925727|54324112|FG000|Overall Study|Adverse Event|4|||
27838026|NCT03925727|54324113|FG001|Overall Study|Adverse Event|0|||
27838027|NCT03925727|54324114|FG002|Overall Study|Adverse Event|3|||
27838028|NCT03925727|54324112|FG000|Overall Study|Protocol Violation|1|||
27838029|NCT03925727|54324113|FG001|Overall Study|Protocol Violation|2|||
27838030|NCT03925727|54324114|FG002|Overall Study|Protocol Violation|2|||
27838031|NCT03925727|54324112|FG000|Overall Study|Withdrawal by Subject|3|||
27838032|NCT03925727|54324113|FG001|Overall Study|Withdrawal by Subject|2|||
27838033|NCT03925727|54324114|FG002|Overall Study|Withdrawal by Subject|4|||
27838034|NCT03925727|54324112|FG000|Overall Study|Administrative Reasons|3|||
27838035|NCT03925727|54324113|FG001|Overall Study|Administrative Reasons|1|||
27838036|NCT03925727|54324114|FG002|Overall Study|Administrative Reasons|2|||
27838037|NCT03925727|54324112|FG000|Overall Study|Randomized in error or Disqualified|8|||
27838038|NCT03925727|54324113|FG001|Overall Study|Randomized in error or Disqualified|1|||
27838039|NCT03925727|54324114|FG002|Overall Study|Randomized in error or Disqualified|7|||
27838040|NCT03387150|54324131|FG000|Overall Study|Withdrawal by Subject|3|||
27838041|NCT03387150|54324132|FG001|Overall Study|Withdrawal by Subject|0|||
27838042|NCT03387150|54324133|FG002|Overall Study|Withdrawal by Subject|3|||
27838043|NCT03387150|54324134|FG003|Overall Study|Withdrawal by Subject|4|||
27838044|NCT03387150|54324135|FG004|Overall Study|Withdrawal by Subject|1|||
27838045|NCT03387150|54324136|FG005|Overall Study|Withdrawal by Subject|2|||
27838046|NCT03387150|54324137|FG006|Overall Study|Withdrawal by Subject|0|||
27838047|NCT03387150|54324131|FG000|Overall Study|Lost to Follow-up|3|||
27838048|NCT03387150|54324132|FG001|Overall Study|Lost to Follow-up|2|||
27838049|NCT03387150|54324133|FG002|Overall Study|Lost to Follow-up|2|||
27838050|NCT03387150|54324134|FG003|Overall Study|Lost to Follow-up|3|||
27838051|NCT03387150|54324135|FG004|Overall Study|Lost to Follow-up|3|||
27838052|NCT03387150|54324136|FG005|Overall Study|Lost to Follow-up|3|||
27838053|NCT03387150|54324137|FG006|Overall Study|Lost to Follow-up|0|||
27838054|NCT03387150|54324131|FG000|Overall Study|Participant unable to adhere to visit|0|||
27838055|NCT03387150|54324132|FG001|Overall Study|Participant unable to adhere to visit|1|||
27838056|NCT03387150|54324133|FG002|Overall Study|Participant unable to adhere to visit|0|||
27838057|NCT03387150|54324134|FG003|Overall Study|Participant unable to adhere to visit|0|||
27838058|NCT03387150|54324135|FG004|Overall Study|Participant unable to adhere to visit|2|||
27838059|NCT03387150|54324136|FG005|Overall Study|Participant unable to adhere to visit|2|||
27838060|NCT03387150|54324137|FG006|Overall Study|Participant unable to adhere to visit|0|||
27838061|NCT03289208|54324169|FG000|Overall Study|Adverse Event|1|||
27838062|NCT03289208|54324170|FG001|Overall Study|Adverse Event|0|||
27838063|NCT03289208|54324171|FG002|Overall Study|Adverse Event|0|||
27838064|NCT03244059|54324181|FG000|Specific Aim 1|Physician Decision|1|||
27838065|NCT03244059|54324182|FG001|Specific Aim 1|Physician Decision|0|||
27838066|NCT03244059|54324181|FG000|Specific Aim 2|Physician Decision|1|||
27838067|NCT03244059|54324182|FG001|Specific Aim 2|Physician Decision|0|||
27838068|NCT03036566|54324201|FG000|Overall Study|Lost to Follow-up|3|||
27838069|NCT02754141|54324232|FG000|Overall Study|Disease progression|11|||
27838070|NCT02754141|54324233|FG001|Overall Study|Disease progression|7|||
27838071|NCT02754141|54324234|FG002|Overall Study|Disease progression|8|||
27838072|NCT02754141|54324235|FG003|Overall Study|Disease progression|5|||
27838073|NCT02754141|54324236|FG004|Overall Study|Disease progression|7|||
27838074|NCT02754141|54324237|FG005|Overall Study|Disease progression|7|||
27838075|NCT02754141|54324238|FG006|Overall Study|Disease progression|7|||
27838076|NCT02754141|54324239|FG007|Overall Study|Disease progression|6|||
27838077|NCT02754141|54324240|FG008|Overall Study|Disease progression|11|||
27838078|NCT02754141|54324241|FG009|Overall Study|Disease progression|16|||
27838079|NCT02754141|54324242|FG010|Overall Study|Disease progression|18|||
27838080|NCT02754141|54324243|FG011|Overall Study|Disease progression|13|||
27838081|NCT02754141|54324244|FG012|Overall Study|Disease progression|10|||
27838082|NCT02754141|54324245|FG013|Overall Study|Disease progression|12|||
27838083|NCT02754141|54324246|FG014|Overall Study|Disease progression|12|||
27838084|NCT02754141|54324247|FG015|Overall Study|Disease progression|14|||
27838085|NCT02754141|54324248|FG016|Overall Study|Disease progression|0|||
27838086|NCT02754141|54324249|FG017|Overall Study|Disease progression|1|||
27838087|NCT02754141|54324232|FG000|Overall Study|Study drug toxicity|1|||
27838088|NCT02754141|54324233|FG001|Overall Study|Study drug toxicity|1|||
27838089|NCT02754141|54324234|FG002|Overall Study|Study drug toxicity|0|||
27838090|NCT02754141|54324235|FG003|Overall Study|Study drug toxicity|0|||
27838091|NCT02754141|54324236|FG004|Overall Study|Study drug toxicity|0|||
27838092|NCT02754141|54324237|FG005|Overall Study|Study drug toxicity|0|||
27838093|NCT02754141|54324238|FG006|Overall Study|Study drug toxicity|0|||
27838094|NCT02754141|54324239|FG007|Overall Study|Study drug toxicity|0|||
27838095|NCT02754141|54324240|FG008|Overall Study|Study drug toxicity|0|||
27838096|NCT02754141|54324241|FG009|Overall Study|Study drug toxicity|0|||
27838097|NCT02754141|54324242|FG010|Overall Study|Study drug toxicity|2|||
27838098|NCT02754141|54324243|FG011|Overall Study|Study drug toxicity|1|||
27838099|NCT02754141|54324244|FG012|Overall Study|Study drug toxicity|1|||
27838100|NCT02754141|54324245|FG013|Overall Study|Study drug toxicity|0|||
27838101|NCT02754141|54324246|FG014|Overall Study|Study drug toxicity|0|||
27838102|NCT02754141|54324247|FG015|Overall Study|Study drug toxicity|0|||
27838103|NCT02754141|54324248|FG016|Overall Study|Study drug toxicity|0|||
27838104|NCT02754141|54324249|FG017|Overall Study|Study drug toxicity|0|||
27838105|NCT02754141|54324232|FG000|Overall Study|AE unrelated to study drug|1|||
27838106|NCT02754141|54324233|FG001|Overall Study|AE unrelated to study drug|1|||
27838107|NCT02754141|54324234|FG002|Overall Study|AE unrelated to study drug|0|||
27838108|NCT02754141|54324235|FG003|Overall Study|AE unrelated to study drug|1|||
27838109|NCT02754141|54324236|FG004|Overall Study|AE unrelated to study drug|3|||
27838110|NCT02754141|54324237|FG005|Overall Study|AE unrelated to study drug|2|||
27838111|NCT02754141|54324238|FG006|Overall Study|AE unrelated to study drug|1|||
27838112|NCT02754141|54324239|FG007|Overall Study|AE unrelated to study drug|0|||
27838113|NCT02754141|54324240|FG008|Overall Study|AE unrelated to study drug|0|||
27838114|NCT02754141|54324241|FG009|Overall Study|AE unrelated to study drug|0|||
27838115|NCT02754141|54324242|FG010|Overall Study|AE unrelated to study drug|0|||
27838116|NCT02754141|54324243|FG011|Overall Study|AE unrelated to study drug|0|||
27838117|NCT02754141|54324244|FG012|Overall Study|AE unrelated to study drug|0|||
27838118|NCT02754141|54324245|FG013|Overall Study|AE unrelated to study drug|0|||
27838119|NCT02754141|54324246|FG014|Overall Study|AE unrelated to study drug|0|||
27838120|NCT02754141|54324247|FG015|Overall Study|AE unrelated to study drug|0|||
27838121|NCT02754141|54324248|FG016|Overall Study|AE unrelated to study drug|0|||
27838122|NCT02754141|54324249|FG017|Overall Study|AE unrelated to study drug|0|||
27838123|NCT02754141|54324232|FG000|Overall Study|Request to discontinue|0|||
27838124|NCT02754141|54324233|FG001|Overall Study|Request to discontinue|0|||
27838125|NCT02754141|54324234|FG002|Overall Study|Request to discontinue|0|||
27838126|NCT02754141|54324235|FG003|Overall Study|Request to discontinue|0|||
27838127|NCT02754141|54324236|FG004|Overall Study|Request to discontinue|0|||
27838128|NCT02754141|54324237|FG005|Overall Study|Request to discontinue|0|||
27838129|NCT02754141|54324238|FG006|Overall Study|Request to discontinue|0|||
27838130|NCT02754141|54324239|FG007|Overall Study|Request to discontinue|0|||
27838131|NCT02754141|54324240|FG008|Overall Study|Request to discontinue|1|||
27838132|NCT02754141|54324241|FG009|Overall Study|Request to discontinue|0|||
27838133|NCT02754141|54324242|FG010|Overall Study|Request to discontinue|0|||
27838134|NCT02754141|54324243|FG011|Overall Study|Request to discontinue|0|||
27838135|NCT02754141|54324244|FG012|Overall Study|Request to discontinue|0|||
27838136|NCT02754141|54324245|FG013|Overall Study|Request to discontinue|1|||
27838137|NCT02754141|54324246|FG014|Overall Study|Request to discontinue|1|||
27838138|NCT02754141|54324247|FG015|Overall Study|Request to discontinue|0|||
27838139|NCT02754141|54324248|FG016|Overall Study|Request to discontinue|0|||
27838140|NCT02754141|54324249|FG017|Overall Study|Request to discontinue|0|||
27838141|NCT02754141|54324232|FG000|Overall Study|Withdrew consent|0|||
27838142|NCT02754141|54324233|FG001|Overall Study|Withdrew consent|0|||
27838143|NCT02754141|54324234|FG002|Overall Study|Withdrew consent|0|||
27838144|NCT02754141|54324235|FG003|Overall Study|Withdrew consent|0|||
27838145|NCT02754141|54324236|FG004|Overall Study|Withdrew consent|0|||
27838146|NCT02754141|54324237|FG005|Overall Study|Withdrew consent|0|||
27838147|NCT02754141|54324238|FG006|Overall Study|Withdrew consent|0|||
27838148|NCT02754141|54324239|FG007|Overall Study|Withdrew consent|0|||
27838149|NCT02754141|54324240|FG008|Overall Study|Withdrew consent|0|||
27838150|NCT02754141|54324241|FG009|Overall Study|Withdrew consent|1|||
27838151|NCT02754141|54324242|FG010|Overall Study|Withdrew consent|0|||
27838152|NCT02754141|54324243|FG011|Overall Study|Withdrew consent|0|||
27838153|NCT02754141|54324244|FG012|Overall Study|Withdrew consent|0|||
27838154|NCT02754141|54324245|FG013|Overall Study|Withdrew consent|0|||
27838155|NCT02754141|54324246|FG014|Overall Study|Withdrew consent|0|||
27838156|NCT02754141|54324247|FG015|Overall Study|Withdrew consent|0|||
27838157|NCT02754141|54324248|FG016|Overall Study|Withdrew consent|0|||
27838158|NCT02754141|54324249|FG017|Overall Study|Withdrew consent|0|||
27838159|NCT02754141|54324232|FG000|Overall Study|Maximum clinical benefit|0|||
27838160|NCT02754141|54324233|FG001|Overall Study|Maximum clinical benefit|0|||
27838161|NCT02754141|54324234|FG002|Overall Study|Maximum clinical benefit|0|||
27838162|NCT02754141|54324235|FG003|Overall Study|Maximum clinical benefit|1|||
27838163|NCT02754141|54324236|FG004|Overall Study|Maximum clinical benefit|0|||
27838164|NCT02754141|54324237|FG005|Overall Study|Maximum clinical benefit|0|||
27838165|NCT02754141|54324238|FG006|Overall Study|Maximum clinical benefit|0|||
27838166|NCT02754141|54324239|FG007|Overall Study|Maximum clinical benefit|0|||
27838167|NCT02754141|54324240|FG008|Overall Study|Maximum clinical benefit|0|||
27838168|NCT02754141|54324241|FG009|Overall Study|Maximum clinical benefit|0|||
27838169|NCT02754141|54324242|FG010|Overall Study|Maximum clinical benefit|0|||
27838170|NCT02754141|54324243|FG011|Overall Study|Maximum clinical benefit|0|||
27838171|NCT02754141|54324244|FG012|Overall Study|Maximum clinical benefit|0|||
27838172|NCT02754141|54324245|FG013|Overall Study|Maximum clinical benefit|0|||
27838173|NCT02754141|54324246|FG014|Overall Study|Maximum clinical benefit|0|||
27838174|NCT02754141|54324247|FG015|Overall Study|Maximum clinical benefit|0|||
27838175|NCT02754141|54324248|FG016|Overall Study|Maximum clinical benefit|0|||
27838176|NCT02754141|54324249|FG017|Overall Study|Maximum clinical benefit|0|||
27838177|NCT02754141|54324232|FG000|Overall Study|No longer meets study criteria|0|||
27838178|NCT02754141|54324233|FG001|Overall Study|No longer meets study criteria|0|||
27838179|NCT02754141|54324234|FG002|Overall Study|No longer meets study criteria|0|||
27838180|NCT02754141|54324235|FG003|Overall Study|No longer meets study criteria|1|||
27838181|NCT02754141|54324236|FG004|Overall Study|No longer meets study criteria|0|||
27838182|NCT02754141|54324237|FG005|Overall Study|No longer meets study criteria|0|||
27838183|NCT02754141|54324238|FG006|Overall Study|No longer meets study criteria|0|||
27838184|NCT02754141|54324239|FG007|Overall Study|No longer meets study criteria|0|||
27838185|NCT02754141|54324240|FG008|Overall Study|No longer meets study criteria|0|||
27838186|NCT02754141|54324241|FG009|Overall Study|No longer meets study criteria|0|||
27838187|NCT02754141|54324242|FG010|Overall Study|No longer meets study criteria|0|||
27838188|NCT02754141|54324243|FG011|Overall Study|No longer meets study criteria|0|||
27838189|NCT02754141|54324244|FG012|Overall Study|No longer meets study criteria|0|||
27838190|NCT02754141|54324245|FG013|Overall Study|No longer meets study criteria|0|||
27838191|NCT02754141|54324246|FG014|Overall Study|No longer meets study criteria|0|||
27838192|NCT02754141|54324247|FG015|Overall Study|No longer meets study criteria|0|||
27838193|NCT02754141|54324248|FG016|Overall Study|No longer meets study criteria|0|||
27838194|NCT02754141|54324249|FG017|Overall Study|No longer meets study criteria|0|||
27838195|NCT02754141|54324232|FG000|Overall Study|Other reasons|0|||
27838196|NCT02754141|54324233|FG001|Overall Study|Other reasons|0|||
27754183|NCT02641379|54205173|FG010|Overall Study|Source data not found|0|||
27754184|NCT02641379|54205163|FG000|Overall Study|Participant showed weight reduction|0|||
27754185|NCT02641379|54205164|FG001|Overall Study|Participant showed weight reduction|0|||
27754186|NCT02641379|54205165|FG002|Overall Study|Participant showed weight reduction|0|||
27754187|NCT02641379|54205166|FG003|Overall Study|Participant showed weight reduction|0|||
27754188|NCT02641379|54205167|FG004|Overall Study|Participant showed weight reduction|0|||
27754189|NCT02641379|54205168|FG005|Overall Study|Participant showed weight reduction|0|||
27754190|NCT02641379|54205169|FG006|Overall Study|Participant showed weight reduction|0|||
27754191|NCT02641379|54205170|FG007|Overall Study|Participant showed weight reduction|1|||
27754192|NCT02641379|54205171|FG008|Overall Study|Participant showed weight reduction|0|||
27754193|NCT02641379|54205172|FG009|Overall Study|Participant showed weight reduction|0|||
27754194|NCT02641379|54205173|FG010|Overall Study|Participant showed weight reduction|0|||
27754195|NCT02641379|54205163|FG000|Overall Study|Non-response Week 12|0|||
27754196|NCT02641379|54205164|FG001|Overall Study|Non-response Week 12|0|||
27754197|NCT02641379|54205165|FG002|Overall Study|Non-response Week 12|0|||
27754198|NCT02641379|54205166|FG003|Overall Study|Non-response Week 12|0|||
27754199|NCT02641379|54205167|FG004|Overall Study|Non-response Week 12|0|||
27754200|NCT02641379|54205168|FG005|Overall Study|Non-response Week 12|0|||
27754201|NCT02641379|54205169|FG006|Overall Study|Non-response Week 12|0|||
27754202|NCT02641379|54205170|FG007|Overall Study|Non-response Week 12|1|||
27754203|NCT02641379|54205171|FG008|Overall Study|Non-response Week 12|0|||
27754204|NCT02641379|54205172|FG009|Overall Study|Non-response Week 12|0|||
27754205|NCT02641379|54205173|FG010|Overall Study|Non-response Week 12|0|||
27754206|NCT02641379|54205163|FG000|Overall Study|No 2 Log drop at Week 12|0|||
27754207|NCT02641379|54205164|FG001|Overall Study|No 2 Log drop at Week 12|0|||
27838197|NCT02754141|54324234|FG002|Overall Study|Other reasons|0|||
27838198|NCT02754141|54324235|FG003|Overall Study|Other reasons|0|||
27838199|NCT02754141|54324236|FG004|Overall Study|Other reasons|0|||
27838200|NCT02754141|54324237|FG005|Overall Study|Other reasons|0|||
27838201|NCT02754141|54324238|FG006|Overall Study|Other reasons|0|||
27838202|NCT02754141|54324239|FG007|Overall Study|Other reasons|1|||
27838203|NCT02754141|54324240|FG008|Overall Study|Other reasons|0|||
27838204|NCT02754141|54324241|FG009|Overall Study|Other reasons|0|||
27838205|NCT02754141|54324242|FG010|Overall Study|Other reasons|0|||
27838206|NCT02754141|54324243|FG011|Overall Study|Other reasons|0|||
27838207|NCT02754141|54324244|FG012|Overall Study|Other reasons|2|||
27838208|NCT02754141|54324245|FG013|Overall Study|Other reasons|0|||
27838209|NCT02754141|54324246|FG014|Overall Study|Other reasons|0|||
27838210|NCT02754141|54324247|FG015|Overall Study|Other reasons|0|||
27838211|NCT02754141|54324248|FG016|Overall Study|Other reasons|0|||
27838212|NCT02754141|54324249|FG017|Overall Study|Other reasons|0|||
27838213|NCT02754141|54324232|FG000|Overall Study|Completed treatment as per protocol|0|||
27754208|NCT02641379|54205165|FG002|Overall Study|No 2 Log drop at Week 12|0|||
27838214|NCT02754141|54324233|FG001|Overall Study|Completed treatment as per protocol|1|||
27838215|NCT02754141|54324234|FG002|Overall Study|Completed treatment as per protocol|0|||
27838216|NCT02754141|54324235|FG003|Overall Study|Completed treatment as per protocol|0|||
27838217|NCT02754141|54324236|FG004|Overall Study|Completed treatment as per protocol|0|||
27838218|NCT02754141|54324237|FG005|Overall Study|Completed treatment as per protocol|0|||
27838219|NCT02754141|54324238|FG006|Overall Study|Completed treatment as per protocol|0|||
27838220|NCT02754141|54324239|FG007|Overall Study|Completed treatment as per protocol|0|||
27838221|NCT02754141|54324240|FG008|Overall Study|Completed treatment as per protocol|0|||
27838222|NCT02754141|54324241|FG009|Overall Study|Completed treatment as per protocol|0|||
27838223|NCT02754141|54324242|FG010|Overall Study|Completed treatment as per protocol|0|||
27838224|NCT02754141|54324243|FG011|Overall Study|Completed treatment as per protocol|0|||
27838225|NCT02754141|54324244|FG012|Overall Study|Completed treatment as per protocol|1|||
27838226|NCT02754141|54324245|FG013|Overall Study|Completed treatment as per protocol|0|||
27838227|NCT02754141|54324246|FG014|Overall Study|Completed treatment as per protocol|0|||
27838228|NCT02754141|54324247|FG015|Overall Study|Completed treatment as per protocol|0|||
27838229|NCT02754141|54324248|FG016|Overall Study|Completed treatment as per protocol|0|||
27838230|NCT02754141|54324249|FG017|Overall Study|Completed treatment as per protocol|0|||
27838231|NCT02754141|54324232|FG000|Overall Study|Not completing monotherapy|0|||
27838232|NCT02754141|54324233|FG001|Overall Study|Not completing monotherapy|0|||
27838233|NCT02754141|54324234|FG002|Overall Study|Not completing monotherapy|0|||
27838234|NCT02754141|54324235|FG003|Overall Study|Not completing monotherapy|0|||
27838235|NCT02754141|54324236|FG004|Overall Study|Not completing monotherapy|0|||
27838236|NCT02754141|54324237|FG005|Overall Study|Not completing monotherapy|0|||
27838237|NCT02754141|54324238|FG006|Overall Study|Not completing monotherapy|0|||
27838238|NCT02754141|54324239|FG007|Overall Study|Not completing monotherapy|0|||
27838239|NCT02754141|54324240|FG008|Overall Study|Not completing monotherapy|0|||
27838240|NCT02754141|54324241|FG009|Overall Study|Not completing monotherapy|0|||
27838241|NCT02754141|54324242|FG010|Overall Study|Not completing monotherapy|0|||
27838242|NCT02754141|54324243|FG011|Overall Study|Not completing monotherapy|0|||
27838243|NCT02754141|54324244|FG012|Overall Study|Not completing monotherapy|0|||
27838244|NCT02754141|54324245|FG013|Overall Study|Not completing monotherapy|1|||
27838245|NCT02754141|54324246|FG014|Overall Study|Not completing monotherapy|0|||
27838246|NCT02754141|54324247|FG015|Overall Study|Not completing monotherapy|0|||
27838247|NCT02754141|54324248|FG016|Overall Study|Not completing monotherapy|0|||
27838248|NCT02754141|54324249|FG017|Overall Study|Not completing monotherapy|0|||
27838249|NCT02659059|54324328|FG000|Overall Study|Other reasons|6|||
27838250|NCT02659059|54324329|FG001|Overall Study|Other reasons|1|||
27838251|NCT02659059|54324328|FG000|Overall Study|Disease Progression|143|||
27838252|NCT02659059|54324329|FG001|Overall Study|Disease Progression|16|||
27838253|NCT02659059|54324328|FG000|Overall Study|Study Drug toxicity|56|||
27838254|NCT02659059|54324329|FG001|Overall Study|Study Drug toxicity|9|||
27838255|NCT02659059|54324328|FG000|Overall Study|Death|3|||
27838256|NCT02659059|54324329|FG001|Overall Study|Death|1|||
27838257|NCT02659059|54324328|FG000|Overall Study|Adverse Event unrelated to Study drug|32|||
27838258|NCT02659059|54324329|FG001|Overall Study|Adverse Event unrelated to Study drug|4|||
27838259|NCT02659059|54324328|FG000|Overall Study|Participant request to discontinue study treatment|5|||
27838260|NCT02659059|54324329|FG001|Overall Study|Participant request to discontinue study treatment|0|||
27838261|NCT02659059|54324328|FG000|Overall Study|Participant withdrew consent|6|||
27838262|NCT02659059|54324329|FG001|Overall Study|Participant withdrew consent|1|||
27838263|NCT01164891|54324344|FG000|Overall Study|Disease Progression|5|||
27838264|NCT01164891|54324344|FG000|Overall Study|Adverse Event|1|||
27838265|NCT01497899|54324353|FG000|Double-Blind Phase|Randomized but not Treated|1|||
27838266|NCT01497899|54324354|FG001|Double-Blind Phase|Randomized but not Treated|0|||
27838267|NCT01497899|54324355|FG002|Double-Blind Phase|Randomized but not Treated|0|||
27838268|NCT01497899|54324356|FG003|Double-Blind Phase|Randomized but not Treated|0|||
27838269|NCT01497899|54324353|FG000|Double-Blind Phase|Adverse Event|1|||
27838270|NCT01497899|54324354|FG001|Double-Blind Phase|Adverse Event|0|||
27838271|NCT01497899|54324355|FG002|Double-Blind Phase|Adverse Event|0|||
27838272|NCT01497899|54324356|FG003|Double-Blind Phase|Adverse Event|0|||
27838273|NCT01497899|54324353|FG000|Double-Blind Phase|Lack of Efficacy|0|||
27838274|NCT01497899|54324354|FG001|Double-Blind Phase|Lack of Efficacy|1|||
27838275|NCT01497899|54324355|FG002|Double-Blind Phase|Lack of Efficacy|0|||
27838276|NCT01497899|54324356|FG003|Double-Blind Phase|Lack of Efficacy|0|||
27838277|NCT01497899|54324353|FG000|Double-Blind Phase|Investigator's Discretion|1|||
27838278|NCT01497899|54324354|FG001|Double-Blind Phase|Investigator's Discretion|0|||
27838279|NCT01497899|54324355|FG002|Double-Blind Phase|Investigator's Discretion|0|||
27838280|NCT01497899|54324356|FG003|Double-Blind Phase|Investigator's Discretion|0|||
27838281|NCT01497899|54324353|FG000|Double-Blind Phase|Withdrew Consent|0|||
27838282|NCT01497899|54324354|FG001|Double-Blind Phase|Withdrew Consent|1|||
27838283|NCT01497899|54324355|FG002|Double-Blind Phase|Withdrew Consent|0|||
27838284|NCT01497899|54324356|FG003|Double-Blind Phase|Withdrew Consent|0|||
27838285|NCT01497899|54324353|FG000|Double-Blind Phase|Lost to Follow-up|3|||
27838286|NCT01497899|54324354|FG001|Double-Blind Phase|Lost to Follow-up|2|||
27838287|NCT01497899|54324355|FG002|Double-Blind Phase|Lost to Follow-up|0|||
27838288|NCT01497899|54324356|FG003|Double-Blind Phase|Lost to Follow-up|0|||
27838289|NCT01497899|54324353|FG000|Double-Blind Phase|Subject Non-Compliance|0|||
27838290|NCT01497899|54324354|FG001|Double-Blind Phase|Subject Non-Compliance|1|||
27838291|NCT01497899|54324355|FG002|Double-Blind Phase|Subject Non-Compliance|0|||
27838292|NCT01497899|54324356|FG003|Double-Blind Phase|Subject Non-Compliance|0|||
27838293|NCT01497899|54324353|FG000|Open-Label Extension Phase|Adverse Event|1|||
27838294|NCT01497899|54324354|FG001|Open-Label Extension Phase|Adverse Event|0|||
27838295|NCT01497899|54324355|FG002|Open-Label Extension Phase|Adverse Event|0|||
27838296|NCT01497899|54324356|FG003|Open-Label Extension Phase|Adverse Event|0|||
27838297|NCT01497899|54324353|FG000|Open-Label Extension Phase|Death|1|||
27838298|NCT01497899|54324354|FG001|Open-Label Extension Phase|Death|0|||
27838299|NCT01497899|54324355|FG002|Open-Label Extension Phase|Death|0|||
27838300|NCT01497899|54324356|FG003|Open-Label Extension Phase|Death|0|||
27838301|NCT01497899|54324353|FG000|Open-Label Extension Phase|Withdrew Consent|8|||
27838302|NCT01497899|54324354|FG001|Open-Label Extension Phase|Withdrew Consent|3|||
27838303|NCT01497899|54324355|FG002|Open-Label Extension Phase|Withdrew Consent|2|||
27838304|NCT01497899|54324356|FG003|Open-Label Extension Phase|Withdrew Consent|0|||
27838305|NCT01497899|54324353|FG000|Open-Label Extension Phase|Pregnancy|0|||
27838306|NCT01497899|54324354|FG001|Open-Label Extension Phase|Pregnancy|1|||
27838307|NCT01497899|54324355|FG002|Open-Label Extension Phase|Pregnancy|1|||
27838308|NCT01497899|54324356|FG003|Open-Label Extension Phase|Pregnancy|0|||
27838309|NCT01497899|54324353|FG000|Open-Label Extension Phase|Protocol Violation|0|||
27838310|NCT01497899|54324354|FG001|Open-Label Extension Phase|Protocol Violation|0|||
27838311|NCT01497899|54324355|FG002|Open-Label Extension Phase|Protocol Violation|1|||
27838312|NCT01497899|54324356|FG003|Open-Label Extension Phase|Protocol Violation|0|||
27838313|NCT01497899|54324353|FG000|Open-Label Extension Phase|Lost to Follow-up|9|||
27838314|NCT01497899|54324354|FG001|Open-Label Extension Phase|Lost to Follow-up|3|||
27838315|NCT01497899|54324355|FG002|Open-Label Extension Phase|Lost to Follow-up|5|||
27838316|NCT01497899|54324356|FG003|Open-Label Extension Phase|Lost to Follow-up|5|||
27838317|NCT01497275|54324363|FG000|Overall Study|Death|1|||
27838318|NCT01497275|54324363|FG000|Overall Study|Adverse Event|1|||
27838319|NCT01557517|54324369|FG000|Overall Study|Death|1|||
27838320|NCT01557517|54324370|FG001|Overall Study|Death|0|||
27838321|NCT01557517|54324369|FG000|Overall Study|Refused further treatment|0|||
27838322|NCT01557517|54324370|FG001|Overall Study|Refused further treatment|2|||
27838323|NCT01557517|54324369|FG000|Overall Study|Adverse Event|0|||
27838324|NCT01557517|54324370|FG001|Overall Study|Adverse Event|2|||
27838325|NCT01557517|54324369|FG000|Overall Study|Pt declined before treatment started|1|||
27838326|NCT01557517|54324370|FG001|Overall Study|Pt declined before treatment started|0|||
27838327|NCT01497197|54324385|FG000|Overall Study|Lost to Follow-up|1|||
27838328|NCT01497197|54324386|FG001|Overall Study|Lost to Follow-up|0|||
27838329|NCT01497197|54324385|FG000|Overall Study|Protocol Violation|0|||
27838330|NCT01497197|54324386|FG001|Overall Study|Protocol Violation|2|||
27838331|NCT01497197|54324385|FG000|Overall Study|Withdrawal by Subject|2|||
27838332|NCT01497197|54324386|FG001|Overall Study|Withdrawal by Subject|1|||
27838333|NCT01497197|54324385|FG000|Overall Study|Excessive/lack of response to treatment|1|||
27838334|NCT01497197|54324386|FG001|Overall Study|Excessive/lack of response to treatment|0|||
27838335|NCT01497197|54324385|FG000|Overall Study|Risk of OHSS|1|||
27838336|NCT01497197|54324386|FG001|Overall Study|Risk of OHSS|0|||
27838337|NCT01497197|54324385|FG000|Overall Study|No oocytes retrieved|3|||
27838338|NCT01497197|54324386|FG001|Overall Study|No oocytes retrieved|2|||
27838339|NCT01497197|54324385|FG000|Overall Study|No fertilisation|6|||
27838340|NCT01497197|54324386|FG001|Overall Study|No fertilisation|5|||
27838341|NCT01497197|54324385|FG000|Overall Study|Intention to freeze all embryos|0|||
27838342|NCT01497197|54324386|FG001|Overall Study|Intention to freeze all embryos|1|||
27838343|NCT01497197|54324385|FG000|Overall Study|All embryos discarded|0|||
27838344|NCT01497197|54324386|FG001|Overall Study|All embryos discarded|3|||
27838345|NCT01497197|54324385|FG000|Overall Study|Other|3|||
27838346|NCT01497197|54324386|FG001|Overall Study|Other|1|||
27838347|NCT01496885|54324392|FG000|Overall Study|Lost to Follow-up|13|||
27838348|NCT01496885|54324392|FG000|Overall Study|Withdrawal by Subject|7|||
27838349|NCT01496885|54324392|FG000|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2|||
27838350|NCT01496885|54324392|FG000|Overall Study|Death|1|||
27838351|NCT01557283|54324396|FG000|Overall Study|Lost to Follow-up|7|||
27838352|NCT01557283|54324396|FG000|Overall Study|Non-responder|19|||
27838353|NCT01557283|54324396|FG000|Overall Study|Adverse Event|7|||
27838354|NCT01557283|54324396|FG000|Overall Study|Lack of Efficacy|1|||
27838355|NCT01557283|54324396|FG000|Overall Study|Non-compliance|1|||
27838356|NCT01557283|54324396|FG000|Overall Study|Withdrawal by Subject|1|||
27838357|NCT01557283|54324396|FG000|Overall Study|Participant's weight too high for dose|1|||
27838358|NCT01557283|54324396|FG000|Overall Study|Worsening of psoriasis|1|||
27838359|NCT01557283|54324396|FG000|Overall Study|Other|6|||
27838360|NCT01523743|54324413|FG000|Period 1|Adverse Event|1|||
27838361|NCT01523743|54324414|FG001|Period 1|Adverse Event|0|||
27838362|NCT01523743|54324413|FG000|Period 1|Withdrawal by Subject|6|||
27838363|NCT01523743|54324414|FG001|Period 1|Withdrawal by Subject|2|||
27838364|NCT01523743|54324413|FG000|Period 1|Lost to Follow-up|1|||
27838365|NCT01523743|54324414|FG001|Period 1|Lost to Follow-up|0|||
27838366|NCT01523743|54324413|FG000|Period 1|Lack of Efficacy|1|||
27838367|NCT01523743|54324414|FG001|Period 1|Lack of Efficacy|0|||
27838368|NCT01523743|54324413|FG000|Period 1|Felt unable to empty bladder|1|||
27838369|NCT01523743|54324414|FG001|Period 1|Felt unable to empty bladder|0|||
27838370|NCT01523743|54324413|FG000|Period 2|Withdrawal by Subject|0|||
27838371|NCT01523743|54324414|FG001|Period 2|Withdrawal by Subject|2|||
27838372|NCT01523743|54324413|FG000|Period 2|Adverse Event|1|||
27838373|NCT01523743|54324414|FG001|Period 2|Adverse Event|0|||
27838374|NCT01496807|54324429|FG000|Overall Study|Progressive Disease|21|||
27838375|NCT01496807|54324429|FG000|Overall Study|Participant preference/toxicity|8|||
27838376|NCT01496807|54324429|FG000|Overall Study|Change in diagnosis|1|||
27838377|NCT01496183|54324435|FG000|Overall Study|Physician Decision|3|||
27838378|NCT01496183|54324436|FG001|Overall Study|Physician Decision|1|||
27838379|NCT01496183|54324435|FG000|Overall Study|Withdrawal by Subject|0|||
27838380|NCT01496183|54324436|FG001|Overall Study|Withdrawal by Subject|1|||
27838381|NCT01495793|54324443|FG000|Overall Study|Lost to Follow-up|1|||
27838382|NCT01495793|54324443|FG000|Overall Study|Violation of inclusion criteria|1|||
27838383|NCT01494467|54324449|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|1|||
27838384|NCT01494467|54324450|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
27838385|NCT01494467|54324449|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|6|||
27838386|NCT01494467|54324450|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
27838387|NCT01494467|54324449|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9|||
27838388|NCT01494467|54324450|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8|||
27838389|NCT01494467|54324449|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|4|||
27838390|NCT01494467|54324450|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|0|||
27838391|NCT01494467|54324449|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
27838392|NCT01494467|54324450|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
27838393|NCT01494467|54324449|FG000|Part A Vehicle Control (12 Weeks)|Other|1|||
27838394|NCT01494467|54324450|FG001|Part A Vehicle Control (12 Weeks)|Other|1|||
27838395|NCT01494467|54324449|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
27838396|NCT01494467|54324450|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
27838397|NCT01494467|54324449|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|2|||
27838398|NCT01494467|54324450|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|0|||
27838399|NCT01494467|54324449|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1|||
27838400|NCT01494467|54324450|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
27838401|NCT01494467|54324449|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|3|||
27838402|NCT01494467|54324450|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
27838403|NCT01494467|54324449|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32|||
27838404|NCT01494467|54324450|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24|||
27838405|NCT01494467|54324449|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|3|||
27838406|NCT01494467|54324450|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|5|||
27838407|NCT01494467|54324449|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26|||
27838408|NCT01494467|54324450|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
27838409|NCT01494467|54324449|FG000|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8|||
27838410|NCT01494467|54324450|FG001|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2|||
27838411|NCT01493687|54324464|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|2|||
27838412|NCT01493687|54324465|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
27838413|NCT01493687|54324464|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
27838414|NCT01493687|54324465|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
27838415|NCT01493687|54324464|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|7|||
27838416|NCT01493687|54324465|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
27838417|NCT01493687|54324464|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18|||
27754209|NCT02641379|54205166|FG003|Overall Study|No 2 Log drop at Week 12|0|||
27754210|NCT02641379|54205167|FG004|Overall Study|No 2 Log drop at Week 12|0|||
27754211|NCT02641379|54205168|FG005|Overall Study|No 2 Log drop at Week 12|0|||
27754212|NCT02641379|54205169|FG006|Overall Study|No 2 Log drop at Week 12|0|||
27754213|NCT02641379|54205170|FG007|Overall Study|No 2 Log drop at Week 12|0|||
27754214|NCT02641379|54205171|FG008|Overall Study|No 2 Log drop at Week 12|0|||
27754215|NCT02641379|54205172|FG009|Overall Study|No 2 Log drop at Week 12|0|||
27754216|NCT02641379|54205173|FG010|Overall Study|No 2 Log drop at Week 12|1|||
27838418|NCT01493687|54324465|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7|||
27838419|NCT01493687|54324464|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|2|||
27838420|NCT01493687|54324465|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|1|||
27838421|NCT01493687|54324464|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7|||
27838422|NCT01493687|54324465|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
27838423|NCT01493687|54324464|FG000|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
27838424|NCT01493687|54324465|FG001|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
27838425|NCT01493687|54324464|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|5|||
27838426|NCT01493687|54324465|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|1|||
27838427|NCT01493687|54324464|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2|||
27838428|NCT01493687|54324465|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
27838429|NCT01493687|54324464|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
27838430|NCT01493687|54324465|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|4|||
27838431|NCT01493687|54324464|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27|||
27838432|NCT01493687|54324465|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16|||
27838433|NCT01493687|54324464|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|1|||
27838434|NCT01493687|54324465|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|0|||
27754217|NCT02641379|54205163|FG000|Overall Study|Negative PCR result|0|||
27838435|NCT01493687|54324464|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16|||
27838436|NCT01493687|54324465|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
27838437|NCT01493687|54324464|FG000|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5|||
27838438|NCT01493687|54324465|FG001|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1|||
27838439|NCT01493687|54324464|FG000|Part C Safety Follow up (4 Weeks)|Adverse Event|0|||
27838440|NCT01493687|54324465|FG001|Part C Safety Follow up (4 Weeks)|Adverse Event|1|||
27838441|NCT01523587|54324497|FG000|Overall Study|Other than listed|5|||
27838442|NCT01523587|54324498|FG001|Overall Study|Other than listed|5|||
27838443|NCT01523587|54324497|FG000|Overall Study|Worsening of underlying cancer disease|19|||
27838444|NCT01523587|54324498|FG001|Overall Study|Worsening of underlying cancer disease|34|||
27838445|NCT01523587|54324497|FG000|Overall Study|Adverse Event|68|||
27838446|NCT01523587|54324498|FG001|Overall Study|Adverse Event|52|||
27838447|NCT01523587|54324497|FG000|Overall Study|Protocol Violation|5|||
27838448|NCT01523587|54324498|FG001|Overall Study|Protocol Violation|3|||
27838449|NCT01523587|54324497|FG000|Overall Study|Lost to Follow-up|2|||
27838450|NCT01523587|54324498|FG001|Overall Study|Lost to Follow-up|2|||
27838451|NCT01523587|54324497|FG000|Overall Study|Withdrawal by Subject|28|||
27838452|NCT01523587|54324498|FG001|Overall Study|Withdrawal by Subject|20|||
27838453|NCT01523587|54324497|FG000|Overall Study|Withdrew due to Progressive disease|265|||
27838454|NCT01523587|54324498|FG001|Overall Study|Withdrew due to Progressive disease|279|||
27838455|NCT01523587|54324497|FG000|Overall Study|Randomised but bot treated|6|||
27838456|NCT01523587|54324498|FG001|Overall Study|Randomised but bot treated|2|||
27838457|NCT01493531|54324527|FG000|Overall Study|Adverse Event|4|||
27838458|NCT01493531|54324528|FG001|Overall Study|Adverse Event|12|||
27754218|NCT02641379|54205164|FG001|Overall Study|Negative PCR result|0|||
27754219|NCT02641379|54205165|FG002|Overall Study|Negative PCR result|0|||
27754220|NCT02641379|54205166|FG003|Overall Study|Negative PCR result|0|||
27754221|NCT02641379|54205167|FG004|Overall Study|Negative PCR result|0|||
27754222|NCT02641379|54205168|FG005|Overall Study|Negative PCR result|0|||
27754223|NCT02641379|54205169|FG006|Overall Study|Negative PCR result|0|||
27754224|NCT02641379|54205170|FG007|Overall Study|Negative PCR result|0|||
27754225|NCT02641379|54205171|FG008|Overall Study|Negative PCR result|0|||
27754226|NCT02641379|54205172|FG009|Overall Study|Negative PCR result|1|||
27754227|NCT02641379|54205173|FG010|Overall Study|Negative PCR result|0|||
27754228|NCT02641379|54205163|FG000|Overall Study|Participant's PCR high|0|||
27754229|NCT02641379|54205164|FG001|Overall Study|Participant's PCR high|0|||
27754230|NCT02641379|54205165|FG002|Overall Study|Participant's PCR high|0|||
27838459|NCT01493531|54324529|FG002|Overall Study|Adverse Event|9|||
27838460|NCT01493531|54324527|FG000|Overall Study|Gout flare|3|||
27754231|NCT02641379|54205166|FG003|Overall Study|Participant's PCR high|0|||
27754232|NCT02641379|54205167|FG004|Overall Study|Participant's PCR high|0|||
27838461|NCT01493531|54324528|FG001|Overall Study|Gout flare|0|||
27754233|NCT02641379|54205168|FG005|Overall Study|Participant's PCR high|0|||
27838462|NCT01493531|54324529|FG002|Overall Study|Gout flare|2|||
27838463|NCT01493531|54324527|FG000|Overall Study|Protocol Violation|8|||
27838464|NCT01493531|54324528|FG001|Overall Study|Protocol Violation|15|||
27838465|NCT01493531|54324529|FG002|Overall Study|Protocol Violation|12|||
27838466|NCT01493531|54324527|FG000|Overall Study|Sponsor terminated study|5|||
27838467|NCT01493531|54324528|FG001|Overall Study|Sponsor terminated study|2|||
27838468|NCT01493531|54324529|FG002|Overall Study|Sponsor terminated study|3|||
27838469|NCT01493531|54324527|FG000|Overall Study|Lost to Follow-up|5|||
27838470|NCT01493531|54324528|FG001|Overall Study|Lost to Follow-up|7|||
27838471|NCT01493531|54324529|FG002|Overall Study|Lost to Follow-up|11|||
27838472|NCT01493531|54324527|FG000|Overall Study|Withdrawal by Subject|16|||
27838473|NCT01493531|54324528|FG001|Overall Study|Withdrawal by Subject|13|||
27838474|NCT01493531|54324529|FG002|Overall Study|Withdrawal by Subject|11|||
27838475|NCT01493531|54324527|FG000|Overall Study|Death|0|||
27838476|NCT01493531|54324528|FG001|Overall Study|Death|1|||
27838477|NCT01493531|54324529|FG002|Overall Study|Death|0|||
27838478|NCT01523275|54324553|FG000|Overall Study|Lost to Follow-up|1|||
27838479|NCT01523275|54324554|FG001|Overall Study|Lost to Follow-up|2|||
27838480|NCT01523275|54324553|FG000|Overall Study|Withdrawal by Subject|1|||
27838481|NCT01523275|54324554|FG001|Overall Study|Withdrawal by Subject|0|||
27838482|NCT01492439|54324571|FG000|Overall Study|Withdrew from RTE|4|||
27838483|NCT01492439|54324572|FG001|Overall Study|Withdrew from RTE|9|||
27754234|NCT02641379|54205169|FG006|Overall Study|Participant's PCR high|0|||
27754235|NCT02641379|54205170|FG007|Overall Study|Participant's PCR high|1|||
27754236|NCT02641379|54205171|FG008|Overall Study|Participant's PCR high|0|||
27754237|NCT02641379|54205172|FG009|Overall Study|Participant's PCR high|0|||
27754238|NCT02641379|54205173|FG010|Overall Study|Participant's PCR high|0|||
27754239|NCT02641379|54205163|FG000|Overall Study|Participant treated after Week 24|0|||
27754240|NCT02641379|54205164|FG001|Overall Study|Participant treated after Week 24|0|||
27754241|NCT02641379|54205165|FG002|Overall Study|Participant treated after Week 24|0|||
27754242|NCT02641379|54205166|FG003|Overall Study|Participant treated after Week 24|0|||
27754243|NCT02641379|54205167|FG004|Overall Study|Participant treated after Week 24|0|||
27754244|NCT02641379|54205168|FG005|Overall Study|Participant treated after Week 24|0|||
27754245|NCT02641379|54205169|FG006|Overall Study|Participant treated after Week 24|0|||
27754246|NCT02641379|54205170|FG007|Overall Study|Participant treated after Week 24|0|||
27838484|NCT01572727|54324607|FG000|Overall Study|Adverse Event|43|||
27838485|NCT01572727|54324608|FG001|Overall Study|Adverse Event|15|||
27838486|NCT01572727|54324607|FG000|Overall Study|Lost to Follow-up|1|||
27838487|NCT01572727|54324608|FG001|Overall Study|Lost to Follow-up|1|||
27754247|NCT02641379|54205171|FG008|Overall Study|Participant treated after Week 24|1|||
27838488|NCT01572727|54324607|FG000|Overall Study|Physician Decision|23|||
27754248|NCT02641379|54205172|FG009|Overall Study|Participant treated after Week 24|0|||
27754249|NCT02641379|54205173|FG010|Overall Study|Participant treated after Week 24|0|||
27754250|NCT02641379|54205163|FG000|Overall Study|Missing PCR result at Week 8|0|||
27754251|NCT02641379|54205164|FG001|Overall Study|Missing PCR result at Week 8|0|||
27754252|NCT02641379|54205165|FG002|Overall Study|Missing PCR result at Week 8|0|||
27754253|NCT02641379|54205166|FG003|Overall Study|Missing PCR result at Week 8|0|||
27754254|NCT02641379|54205167|FG004|Overall Study|Missing PCR result at Week 8|0|||
27754255|NCT02641379|54205168|FG005|Overall Study|Missing PCR result at Week 8|0|||
27754256|NCT02641379|54205169|FG006|Overall Study|Missing PCR result at Week 8|0|||
27754257|NCT02641379|54205170|FG007|Overall Study|Missing PCR result at Week 8|0|||
27754258|NCT02641379|54205171|FG008|Overall Study|Missing PCR result at Week 8|0|||
27754259|NCT02641379|54205172|FG009|Overall Study|Missing PCR result at Week 8|1|||
27754260|NCT02641379|54205173|FG010|Overall Study|Missing PCR result at Week 8|0|||
27754261|NCT02641379|54205163|FG000|Overall Study|PCR positive|0|||
27754262|NCT02641379|54205164|FG001|Overall Study|PCR positive|0|||
27754263|NCT02641379|54205165|FG002|Overall Study|PCR positive|0|||
27754264|NCT02641379|54205166|FG003|Overall Study|PCR positive|0|||
27754265|NCT02641379|54205167|FG004|Overall Study|PCR positive|0|||
27754266|NCT02641379|54205168|FG005|Overall Study|PCR positive|0|||
27754267|NCT02641379|54205169|FG006|Overall Study|PCR positive|1|||
27754268|NCT02641379|54205170|FG007|Overall Study|PCR positive|0|||
27754269|NCT02641379|54205171|FG008|Overall Study|PCR positive|0|||
27754270|NCT02641379|54205172|FG009|Overall Study|PCR positive|0|||
27754271|NCT02641379|54205173|FG010|Overall Study|PCR positive|0|||
27754272|NCT02660983|54205204|FG000|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1|||
27754273|NCT02660983|54205205|FG001|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5|||
27754274|NCT02660983|54205204|FG000|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15|||
27754275|NCT02660983|54205205|FG001|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12|||
27754276|NCT02660983|54205204|FG000|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8|||
27754277|NCT02660983|54205205|FG001|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9|||
27754278|NCT02660983|54205204|FG000|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
27754279|NCT02660983|54205205|FG001|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
27754280|NCT02660983|54205204|FG000|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1|||
27754281|NCT02660983|54205205|FG001|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4|||
27754282|NCT02660983|54205204|FG000|Open Label Extension Phase (24 Weeks)|Adverse Event|1|||
27754283|NCT02660983|54205205|FG001|Open Label Extension Phase (24 Weeks)|Adverse Event|3|||
27754284|NCT02660983|54205204|FG000|Open Label Extension Phase (24 Weeks)|Other|0|||
27754285|NCT02660983|54205205|FG001|Open Label Extension Phase (24 Weeks)|Other|1|||
27754286|NCT01953328|54205220|FG000|Overall Study|Withdrawal by Subject|0|||
27754287|NCT01953328|54205221|FG001|Overall Study|Withdrawal by Subject|0|||
27754288|NCT01953328|54205222|FG002|Overall Study|Withdrawal by Subject|0|||
27754289|NCT01953328|54205223|FG003|Overall Study|Withdrawal by Subject|0|||
27754290|NCT01953328|54205224|FG004|Overall Study|Withdrawal by Subject|1|||
27754291|NCT01953328|54205225|FG005|Overall Study|Withdrawal by Subject|0|||
27754292|NCT01953328|54205226|FG006|Overall Study|Withdrawal by Subject|0|||
27754293|NCT01953328|54205227|FG007|Overall Study|Withdrawal by Subject|0|||
27754294|NCT01953328|54205220|FG000|Overall Study|Lost to Follow-up|0|||
27754295|NCT01953328|54205221|FG001|Overall Study|Lost to Follow-up|0|||
27754296|NCT01953328|54205222|FG002|Overall Study|Lost to Follow-up|0|||
27754297|NCT01953328|54205223|FG003|Overall Study|Lost to Follow-up|0|||
27754298|NCT01953328|54205224|FG004|Overall Study|Lost to Follow-up|1|||
27754299|NCT01953328|54205225|FG005|Overall Study|Lost to Follow-up|0|||
27754300|NCT01953328|54205226|FG006|Overall Study|Lost to Follow-up|0|||
27754301|NCT01953328|54205227|FG007|Overall Study|Lost to Follow-up|0|||
27838489|NCT01572727|54324608|FG001|Overall Study|Physician Decision|9|||
27754302|NCT02640755|54205247|FG000|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0|||
27754303|NCT02640755|54205248|FG001|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1|||
27754304|NCT02640755|54205247|FG000|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1|||
27838490|NCT01572727|54324607|FG000|Overall Study|Progressive disease|59|||
27754305|NCT02640755|54205248|FG001|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0|||
27754306|NCT02640755|54205247|FG000|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1|||
27754307|NCT02640755|54205248|FG001|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0|||
27754308|NCT02640677|54205255|FG000|Overall Study|Lost to Follow-up|1|||
27754309|NCT02640677|54205255|FG000|Overall Study|Withdrawal by Subject|1|||
27754310|NCT02643251|54205272|FG000|Overall Study|Adverse Event|3|||
27754311|NCT02643251|54205273|FG001|Overall Study|Adverse Event|1|||
27754312|NCT02643251|54205272|FG000|Overall Study|Withdrawal by Subject|2|||
27754313|NCT02643251|54205273|FG001|Overall Study|Withdrawal by Subject|0|||
27754314|NCT02643251|54205272|FG000|Overall Study|Lost to Follow-up|4|||
27754315|NCT02643251|54205273|FG001|Overall Study|Lost to Follow-up|1|||
27754316|NCT02643251|54205272|FG000|Overall Study|Protocol Violation|1|||
27754317|NCT02643251|54205273|FG001|Overall Study|Protocol Violation|0|||
27754318|NCT02643251|54205272|FG000|Overall Study|PI Decision to terminate patient|1|||
27754319|NCT02643251|54205273|FG001|Overall Study|PI Decision to terminate patient|0|||
27754320|NCT01970878|54205283|FG000|Overall Study|Withdrawal by Subject|11|||
27754321|NCT01970878|54205284|FG001|Overall Study|Withdrawal by Subject|10|||
27754322|NCT01970878|54205285|FG002|Overall Study|Withdrawal by Subject|14|||
27754323|NCT01970878|54205286|FG003|Overall Study|Withdrawal by Subject|7|||
27754324|NCT01970878|54205283|FG000|Overall Study|Lost to Follow-up|1|||
27754325|NCT01970878|54205284|FG001|Overall Study|Lost to Follow-up|3|||
27754326|NCT01970878|54205285|FG002|Overall Study|Lost to Follow-up|2|||
27754327|NCT01970878|54205286|FG003|Overall Study|Lost to Follow-up|4|||
27754328|NCT01970878|54205283|FG000|Overall Study|Administrative Reasons|1|||
27754329|NCT01970878|54205284|FG001|Overall Study|Administrative Reasons|0|||
27754330|NCT01970878|54205285|FG002|Overall Study|Administrative Reasons|0|||
27754331|NCT01970878|54205286|FG003|Overall Study|Administrative Reasons|4|||
27754332|NCT01970878|54205283|FG000|Overall Study|Lack of Efficacy|2|||
27838491|NCT01572727|54324608|FG001|Overall Study|Progressive disease|82|||
27838492|NCT01572727|54324607|FG000|Overall Study|Protocol Violation|0|||
27754333|NCT01970878|54205284|FG001|Overall Study|Lack of Efficacy|1|||
27754334|NCT01970878|54205285|FG002|Overall Study|Lack of Efficacy|2|||
27754335|NCT01970878|54205286|FG003|Overall Study|Lack of Efficacy|0|||
27754336|NCT01970878|54205283|FG000|Overall Study|Adverse Event|12|||
27754337|NCT01970878|54205284|FG001|Overall Study|Adverse Event|7|||
27838493|NCT01572727|54324608|FG001|Overall Study|Protocol Violation|1|||
27754338|NCT01970878|54205285|FG002|Overall Study|Adverse Event|4|||
27838494|NCT01572727|54324607|FG000|Overall Study|Study terminated by sponsor|61|||
27838495|NCT01572727|54324608|FG001|Overall Study|Study terminated by sponsor|83|||
27838496|NCT01572727|54324607|FG000|Overall Study|Parent/guardian decision|14|||
27754339|NCT01970878|54205286|FG003|Overall Study|Adverse Event|3|||
27838497|NCT01572727|54324608|FG001|Overall Study|Parent/guardian decision|9|||
27838498|NCT01572727|54324607|FG000|Overall Study|Death|2|||
27838499|NCT01572727|54324608|FG001|Overall Study|Death|2|||
27838500|NCT01572727|54324607|FG000|Overall Study|Untreated|4|||
27838501|NCT01572727|54324608|FG001|Overall Study|Untreated|7|||
27838502|NCT01522651|54324655|FG000|Overall Study|Adverse Event|3|||
27838503|NCT01522651|54324656|FG001|Overall Study|Adverse Event|4|||
27838504|NCT01522651|54324657|FG002|Overall Study|Adverse Event|4|||
27838505|NCT01522651|54324658|FG003|Overall Study|Adverse Event|5|||
27838506|NCT01522651|54324659|FG004|Overall Study|Adverse Event|4|||
27838507|NCT01522651|54324655|FG000|Overall Study|Cardioversion|1|||
27838508|NCT01522651|54324656|FG001|Overall Study|Cardioversion|0|||
27838509|NCT01522651|54324657|FG002|Overall Study|Cardioversion|0|||
27838510|NCT01522651|54324658|FG003|Overall Study|Cardioversion|0|||
27838511|NCT01522651|54324659|FG004|Overall Study|Cardioversion|0|||
27838512|NCT01522651|54324655|FG000|Overall Study|Device Malfunction|0|||
27838513|NCT01522651|54324656|FG001|Overall Study|Device Malfunction|1|||
27838514|NCT01522651|54324657|FG002|Overall Study|Device Malfunction|0|||
27838515|NCT01522651|54324658|FG003|Overall Study|Device Malfunction|0|||
27838516|NCT01522651|54324659|FG004|Overall Study|Device Malfunction|0|||
27838517|NCT01522651|54324655|FG000|Overall Study|Investigator's Discretion|0|||
27838518|NCT01522651|54324656|FG001|Overall Study|Investigator's Discretion|1|||
27838519|NCT01522651|54324657|FG002|Overall Study|Investigator's Discretion|0|||
27838520|NCT01522651|54324658|FG003|Overall Study|Investigator's Discretion|0|||
27838521|NCT01522651|54324659|FG004|Overall Study|Investigator's Discretion|0|||
27838522|NCT01522651|54324655|FG000|Overall Study|Protocol Violation|3|||
27838523|NCT01522651|54324656|FG001|Overall Study|Protocol Violation|0|||
27838524|NCT01522651|54324657|FG002|Overall Study|Protocol Violation|0|||
27838525|NCT01522651|54324658|FG003|Overall Study|Protocol Violation|0|||
27838526|NCT01522651|54324659|FG004|Overall Study|Protocol Violation|0|||
27838527|NCT01522651|54324655|FG000|Overall Study|Reason Not Specified|0|||
27838528|NCT01522651|54324656|FG001|Overall Study|Reason Not Specified|0|||
27838529|NCT01522651|54324657|FG002|Overall Study|Reason Not Specified|0|||
27838530|NCT01522651|54324658|FG003|Overall Study|Reason Not Specified|1|||
27838531|NCT01522651|54324659|FG004|Overall Study|Reason Not Specified|0|||
27838532|NCT01522651|54324655|FG000|Overall Study|Participant Non-Compliance|1|||
27838533|NCT01522651|54324656|FG001|Overall Study|Participant Non-Compliance|0|||
27838534|NCT01522651|54324657|FG002|Overall Study|Participant Non-Compliance|0|||
27838535|NCT01522651|54324658|FG003|Overall Study|Participant Non-Compliance|0|||
27838536|NCT01522651|54324659|FG004|Overall Study|Participant Non-Compliance|0|||
27838537|NCT01522651|54324655|FG000|Overall Study|Withdrew Consent|1|||
27838538|NCT01522651|54324656|FG001|Overall Study|Withdrew Consent|1|||
27838539|NCT01522651|54324657|FG002|Overall Study|Withdrew Consent|0|||
27838540|NCT01522651|54324658|FG003|Overall Study|Withdrew Consent|1|||
27838541|NCT01522651|54324659|FG004|Overall Study|Withdrew Consent|1|||
28015986|NCT00357877|54675138|FG000|Overall Study|Lost to Follow-up|20|||
27838542|NCT01522651|54324655|FG000|Overall Study|Randomized but Never Treated|0|||
27838543|NCT01522651|54324656|FG001|Overall Study|Randomized but Never Treated|1|||
27838544|NCT01522651|54324657|FG002|Overall Study|Randomized but Never Treated|0|||
27838545|NCT01522651|54324658|FG003|Overall Study|Randomized but Never Treated|1|||
27838546|NCT01522651|54324659|FG004|Overall Study|Randomized but Never Treated|1|||
27838547|NCT01554241|54324686|FG000|Overall Study|Death|3|||
27838548|NCT01554241|54324687|FG001|Overall Study|Death|1|||
27838549|NCT01554241|54324688|FG002|Overall Study|Death|1|||
27838550|NCT01554241|54324689|FG003|Overall Study|Death|0|||
27754340|NCT01970878|54205283|FG000|Overall Study|Protocol Specified Criteria|10|||
27754341|NCT01970878|54205284|FG001|Overall Study|Protocol Specified Criteria|4|||
27754342|NCT01970878|54205285|FG002|Overall Study|Protocol Specified Criteria|3|||
27754343|NCT01970878|54205286|FG003|Overall Study|Protocol Specified Criteria|6|||
27754344|NCT01970878|54205283|FG000|Overall Study|Physician Decision|0|||
27754345|NCT01970878|54205284|FG001|Overall Study|Physician Decision|1|||
27754346|NCT01970878|54205285|FG002|Overall Study|Physician Decision|1|||
27754347|NCT01970878|54205286|FG003|Overall Study|Physician Decision|0|||
27754348|NCT01970878|54205283|FG000|Overall Study|No Completion Status|0|||
27754349|NCT01970878|54205284|FG001|Overall Study|No Completion Status|1|||
27754350|NCT01970878|54205285|FG002|Overall Study|No Completion Status|0|||
27754351|NCT01970878|54205286|FG003|Overall Study|No Completion Status|0|||
27754352|NCT01970488|54205298|FG000|Part 1: Through Week 16|Protocol-specified Criteria|1|||
27754353|NCT01970488|54205299|FG001|Part 1: Through Week 16|Protocol-specified Criteria|2|||
27754354|NCT01970488|54205300|FG002|Part 1: Through Week 16|Protocol-specified Criteria|0|||
27754355|NCT01970488|54205301|FG003|Part 1: Through Week 16|Protocol-specified Criteria|0|||
27754356|NCT01970488|54205302|FG004|Part 1: Through Week 16|Protocol-specified Criteria|0|||
27754357|NCT01970488|54205298|FG000|Part 1: Through Week 16|Protocol Violation|1|||
27754358|NCT01970488|54205299|FG001|Part 1: Through Week 16|Protocol Violation|2|||
27838551|NCT01554241|54324686|FG000|Overall Study|protocol specified renal stone|0|||
27838552|NCT01554241|54324687|FG001|Overall Study|protocol specified renal stone|0|||
27754359|NCT01970488|54205300|FG002|Part 1: Through Week 16|Protocol Violation|0|||
27754360|NCT01970488|54205301|FG003|Part 1: Through Week 16|Protocol Violation|0|||
27754361|NCT01970488|54205302|FG004|Part 1: Through Week 16|Protocol Violation|0|||
27838553|NCT01554241|54324688|FG002|Overall Study|protocol specified renal stone|0|||
27838554|NCT01554241|54324689|FG003|Overall Study|protocol specified renal stone|1|||
27754362|NCT01970488|54205298|FG000|Part 1: Through Week 16|Adverse Event|6|||
27838555|NCT01554241|54324686|FG000|Overall Study|protocol specified change in eGFR|0|||
28015987|NCT00357877|54675139|FG001|Overall Study|Lost to Follow-up|23|||
27754363|NCT01970488|54205299|FG001|Part 1: Through Week 16|Adverse Event|5|||
27754364|NCT01970488|54205300|FG002|Part 1: Through Week 16|Adverse Event|0|||
27754365|NCT01970488|54205301|FG003|Part 1: Through Week 16|Adverse Event|0|||
27754366|NCT01970488|54205302|FG004|Part 1: Through Week 16|Adverse Event|0|||
27754367|NCT01970488|54205298|FG000|Part 1: Through Week 16|Withdrawal by Subject|3|||
27754368|NCT01970488|54205299|FG001|Part 1: Through Week 16|Withdrawal by Subject|2|||
27754369|NCT01970488|54205300|FG002|Part 1: Through Week 16|Withdrawal by Subject|0|||
28159927|NCT02737475|54830029|FG007|Overall Study|Other reasons|0|||
28159928|NCT02737475|54830030|FG008|Overall Study|Other reasons|1|||
28159929|NCT02737475|54830031|FG009|Overall Study|Other reasons|0|||
28159930|NCT02737475|54830032|FG010|Overall Study|Other reasons|1|||
28159931|NCT02737475|54830033|FG011|Overall Study|Other reasons|0|||
28159932|NCT02737475|54830034|FG012|Overall Study|Other reasons|0|||
28159933|NCT02737475|54830035|FG013|Overall Study|Other reasons|0|||
28159934|NCT02737475|54830036|FG014|Overall Study|Other reasons|0|||
28159935|NCT02737475|54830037|FG015|Overall Study|Other reasons|0|||
28159936|NCT02737475|54830038|FG016|Overall Study|Other reasons|0|||
28159937|NCT02737475|54830039|FG017|Overall Study|Other reasons|0|||
28159938|NCT02737475|54830040|FG018|Overall Study|Other reasons|0|||
27838556|NCT01554241|54324687|FG001|Overall Study|protocol specified change in eGFR|0|||
27838557|NCT01554241|54324688|FG002|Overall Study|protocol specified change in eGFR|1|||
27754370|NCT01970488|54205301|FG003|Part 1: Through Week 16|Withdrawal by Subject|0|||
27754371|NCT01970488|54205302|FG004|Part 1: Through Week 16|Withdrawal by Subject|0|||
27838558|NCT01554241|54324689|FG003|Overall Study|protocol specified change in eGFR|0|||
27754372|NCT01970488|54205298|FG000|Part 1: Through Week 16|Lost to Follow-up|0|||
27754373|NCT01970488|54205299|FG001|Part 1: Through Week 16|Lost to Follow-up|2|||
27754374|NCT01970488|54205300|FG002|Part 1: Through Week 16|Lost to Follow-up|0|||
27754375|NCT01970488|54205301|FG003|Part 1: Through Week 16|Lost to Follow-up|0|||
27838559|NCT01554241|54324686|FG000|Overall Study|Withdrawal by Subject|0|||
27838560|NCT01554241|54324687|FG001|Overall Study|Withdrawal by Subject|0|||
27838561|NCT01554241|54324688|FG002|Overall Study|Withdrawal by Subject|2|||
27838562|NCT01554241|54324689|FG003|Overall Study|Withdrawal by Subject|0|||
27838563|NCT01521559|54324701|FG000|Overall Study|Adverse Event|0|||
27838564|NCT01521559|54324702|FG001|Overall Study|Adverse Event|4|||
27838565|NCT01521559|54324701|FG000|Overall Study|Death|1|||
27838566|NCT01521559|54324702|FG001|Overall Study|Death|0|||
27838567|NCT01521559|54324701|FG000|Overall Study|Withdrawal by Subject|9|||
27838568|NCT01521559|54324702|FG001|Overall Study|Withdrawal by Subject|11|||
27838569|NCT01521559|54324701|FG000|Overall Study|Lost to Follow-up|3|||
27838570|NCT01521559|54324702|FG001|Overall Study|Lost to Follow-up|1|||
27838571|NCT01521559|54324701|FG000|Overall Study|Protocol Violation|1|||
27838572|NCT01521559|54324702|FG001|Overall Study|Protocol Violation|0|||
27838573|NCT01521559|54324701|FG000|Overall Study|Other|1|||
27838574|NCT01521559|54324702|FG001|Overall Study|Other|2|||
27754376|NCT01970488|54205302|FG004|Part 1: Through Week 16|Lost to Follow-up|0|||
27754377|NCT01970488|54205298|FG000|Part 2: Post Week 16|Physician Decision|0|||
27754378|NCT01970488|54205299|FG001|Part 2: Post Week 16|Physician Decision|0|||
27754379|NCT01970488|54205300|FG002|Part 2: Post Week 16|Physician Decision|0|||
27754380|NCT01970488|54205301|FG003|Part 2: Post Week 16|Physician Decision|0|||
27754381|NCT01970488|54205302|FG004|Part 2: Post Week 16|Physician Decision|1|||
27754382|NCT01970488|54205298|FG000|Part 2: Post Week 16|Non-compliance|0|||
27754383|NCT01970488|54205299|FG001|Part 2: Post Week 16|Non-compliance|0|||
27754384|NCT01970488|54205300|FG002|Part 2: Post Week 16|Non-compliance|1|||
27754385|NCT01970488|54205301|FG003|Part 2: Post Week 16|Non-compliance|0|||
27754386|NCT01970488|54205302|FG004|Part 2: Post Week 16|Non-compliance|0|||
27754387|NCT01970488|54205298|FG000|Part 2: Post Week 16|Lack of Efficacy|0|||
27754388|NCT01970488|54205299|FG001|Part 2: Post Week 16|Lack of Efficacy|0|||
27754389|NCT01970488|54205300|FG002|Part 2: Post Week 16|Lack of Efficacy|2|||
27754390|NCT01970488|54205301|FG003|Part 2: Post Week 16|Lack of Efficacy|3|||
27838575|NCT01554163|54324711|FG000|Overall Study|Adverse Event|3|||
27754391|NCT01970488|54205302|FG004|Part 2: Post Week 16|Lack of Efficacy|1|||
27754392|NCT01970488|54205298|FG000|Part 2: Post Week 16|Adverse Event|0|||
27838576|NCT01554163|54324712|FG001|Overall Study|Adverse Event|0|||
27754393|NCT01970488|54205299|FG001|Part 2: Post Week 16|Adverse Event|0|||
27754394|NCT01970488|54205300|FG002|Part 2: Post Week 16|Adverse Event|5|||
27754395|NCT01970488|54205301|FG003|Part 2: Post Week 16|Adverse Event|1|||
27838577|NCT01554163|54324711|FG000|Overall Study|Lack of Efficacy|1|||
27754396|NCT01970488|54205302|FG004|Part 2: Post Week 16|Adverse Event|1|||
27838578|NCT01554163|54324712|FG001|Overall Study|Lack of Efficacy|0|||
27754397|NCT01970488|54205298|FG000|Part 2: Post Week 16|Withdrawal by Subject|0|||
27754398|NCT01970488|54205299|FG001|Part 2: Post Week 16|Withdrawal by Subject|0|||
27838579|NCT01554163|54324711|FG000|Overall Study|Lost to Follow-up|1|||
27838580|NCT01554163|54324712|FG001|Overall Study|Lost to Follow-up|0|||
27754399|NCT01970488|54205300|FG002|Part 2: Post Week 16|Withdrawal by Subject|8|||
27754400|NCT01970488|54205301|FG003|Part 2: Post Week 16|Withdrawal by Subject|3|||
27838581|NCT01554163|54324711|FG000|Overall Study|Non-Compliance With Study Drug|1|||
27838582|NCT01554163|54324712|FG001|Overall Study|Non-Compliance With Study Drug|1|||
27838583|NCT01554163|54324711|FG000|Overall Study|Protocol Violation|0|||
27838584|NCT01554163|54324712|FG001|Overall Study|Protocol Violation|4|||
27838585|NCT01554163|54324711|FG000|Overall Study|Withdrawal by Subject|1|||
27838586|NCT01554163|54324712|FG001|Overall Study|Withdrawal by Subject|5|||
27838587|NCT01554163|54324711|FG000|Overall Study|Not Treated|1|||
27838588|NCT01554163|54324712|FG001|Overall Study|Not Treated|0|||
27838589|NCT01553851|54324718|FG000|Overall Study|Adverse Event|2|||
27838590|NCT01553851|54324718|FG000|Overall Study|constipation|1|||
27838591|NCT01552915|54324738|FG000|Overall Study|Adverse Event|3|||
27838592|NCT01552915|54324739|FG001|Overall Study|Adverse Event|14|||
27838593|NCT01552915|54324740|FG002|Overall Study|Adverse Event|3|||
27754401|NCT01970488|54205302|FG004|Part 2: Post Week 16|Withdrawal by Subject|3|||
27754402|NCT01970488|54205298|FG000|Part 2: Post Week 16|Lost to Follow-up|0|||
27754403|NCT01970488|54205299|FG001|Part 2: Post Week 16|Lost to Follow-up|0|||
27754404|NCT01970488|54205300|FG002|Part 2: Post Week 16|Lost to Follow-up|1|||
27754405|NCT01970488|54205301|FG003|Part 2: Post Week 16|Lost to Follow-up|1|||
27754406|NCT01970488|54205302|FG004|Part 2: Post Week 16|Lost to Follow-up|2|||
27754407|NCT02661217|54205319|FG000|Overall Study|Physician Decision|12|||
27754408|NCT02661217|54205320|FG001|Overall Study|Physician Decision|15|||
27754409|NCT02661217|54205319|FG000|Overall Study|Lost to Follow-up|1|||
27754410|NCT02661217|54205320|FG001|Overall Study|Lost to Follow-up|4|||
27754411|NCT02661217|54205319|FG000|Overall Study|Protocol Deviation|0|||
27754412|NCT02661217|54205320|FG001|Overall Study|Protocol Deviation|4|||
27754413|NCT02661217|54205319|FG000|Overall Study|Non-compliance with study treatment|5|||
27754414|NCT02661217|54205320|FG001|Overall Study|Non-compliance with study treatment|5|||
27754415|NCT02661217|54205319|FG000|Overall Study|Death|21|||
27754416|NCT02661217|54205320|FG001|Overall Study|Death|15|||
27754417|NCT02661217|54205319|FG000|Overall Study|Adverse Event|10|||
27754418|NCT02661217|54205320|FG001|Overall Study|Adverse Event|8|||
27754419|NCT02661217|54205319|FG000|Overall Study|Withdrawal by Subject|15|||
27838594|NCT01552915|54324738|FG000|Overall Study|Lost to Follow-up|4|||
27838595|NCT01552915|54324739|FG001|Overall Study|Lost to Follow-up|6|||
27838596|NCT01552915|54324740|FG002|Overall Study|Lost to Follow-up|5|||
27838597|NCT01552915|54324738|FG000|Overall Study|Withdrawal by Subject|6|||
27838598|NCT01552915|54324739|FG001|Overall Study|Withdrawal by Subject|4|||
27838599|NCT01552915|54324740|FG002|Overall Study|Withdrawal by Subject|5|||
27838600|NCT01552915|54324738|FG000|Overall Study|Protocol Violation|0|||
27838601|NCT01552915|54324739|FG001|Overall Study|Protocol Violation|4|||
27838602|NCT01552915|54324740|FG002|Overall Study|Protocol Violation|4|||
27838603|NCT01552915|54324738|FG000|Overall Study|Lack of Efficacy|8|||
27838604|NCT01552915|54324739|FG001|Overall Study|Lack of Efficacy|1|||
27838605|NCT01552915|54324740|FG002|Overall Study|Lack of Efficacy|4|||
27838606|NCT01552915|54324738|FG000|Overall Study|Other|2|||
27838607|NCT01552915|54324739|FG001|Overall Study|Other|0|||
27838608|NCT01552915|54324740|FG002|Overall Study|Other|6|||
27838609|NCT01552681|54324769|FG000|Overall Study|Withdrawal by Subject|4|||
27838610|NCT01552681|54324770|FG001|Overall Study|Withdrawal by Subject|0|||
27838611|NCT01552681|54324769|FG000|Overall Study|Physician Decision|1|||
27838612|NCT01552681|54324770|FG001|Overall Study|Physician Decision|0|||
27838613|NCT01552681|54324769|FG000|Overall Study|Subject moved away|0|||
27838614|NCT01552681|54324770|FG001|Overall Study|Subject moved away|1|||
27838615|NCT01570387|54324802|FG000|Overall Study|Adverse Event|1|||
27838616|NCT01570387|54324803|FG001|Overall Study|Adverse Event|0|||
27838617|NCT01570387|54324804|FG002|Overall Study|Adverse Event|0|||
27838618|NCT01570387|54324805|FG003|Overall Study|Adverse Event|0|||
27838619|NCT01570387|54324802|FG000|Overall Study|Death|0|||
27838620|NCT01570387|54324803|FG001|Overall Study|Death|0|||
27838621|NCT01570387|54324804|FG002|Overall Study|Death|0|||
27838622|NCT01570387|54324805|FG003|Overall Study|Death|1|||
27838623|NCT01570387|54324802|FG000|Overall Study|Withdrawal by Subject|0|||
27838624|NCT01570387|54324803|FG001|Overall Study|Withdrawal by Subject|0|||
27838625|NCT01570387|54324804|FG002|Overall Study|Withdrawal by Subject|0|||
27838626|NCT01570387|54324805|FG003|Overall Study|Withdrawal by Subject|1|||
27838627|NCT01570309|54324814|FG000|Overall Study|Withdrawal by Subject|3|||
27838628|NCT01570309|54324815|FG001|Overall Study|Withdrawal by Subject|3|||
27838629|NCT01519921|54324827|FG000|Overall Study|Adverse Event|10|||
27838630|NCT01519921|54324828|FG001|Overall Study|Adverse Event|9|||
27838631|NCT01519921|54324827|FG000|Overall Study|Lack of Efficacy|4|||
27838632|NCT01519921|54324828|FG001|Overall Study|Lack of Efficacy|3|||
27838633|NCT01519921|54324827|FG000|Overall Study|Withdrawal by Subject|3|||
27838634|NCT01519921|54324828|FG001|Overall Study|Withdrawal by Subject|0|||
27838635|NCT01519921|54324827|FG000|Overall Study|Lost to Follow-up|2|||
27838636|NCT01519921|54324828|FG001|Overall Study|Lost to Follow-up|1|||
27838637|NCT01519921|54324827|FG000|Overall Study|Treatment refusal|2|||
27838638|NCT01519921|54324828|FG001|Overall Study|Treatment refusal|1|||
27838639|NCT01519921|54324827|FG000|Overall Study|High alanine aminotransferase (ALT)|0|||
27838640|NCT01519921|54324828|FG001|Overall Study|High alanine aminotransferase (ALT)|1|||
27838641|NCT01519765|54324836|FG000|Overall Study|Adverse Event|0|||
27838642|NCT01519765|54324837|FG001|Overall Study|Adverse Event|1|||
27838643|NCT01519765|54324836|FG000|Overall Study|Lack of Efficacy|2|||
27838644|NCT01519765|54324837|FG001|Overall Study|Lack of Efficacy|0|||
27838645|NCT01519765|54324836|FG000|Overall Study|Protocol Violation|1|||
27838646|NCT01519765|54324837|FG001|Overall Study|Protocol Violation|0|||
27838647|NCT01519765|54324836|FG000|Overall Study|Withdrawal by Subject|0|||
27838648|NCT01519765|54324837|FG001|Overall Study|Withdrawal by Subject|1|||
27838649|NCT01552603|54324844|FG000|Overall Study|Physician Decision|1|||
27838650|NCT01552369|54324850|FG000|Overall Study|Did not consent to extended follow up|8|||
27838651|NCT01552369|54324851|FG001|Overall Study|Did not consent to extended follow up|9|||
27838652|NCT01552057|54324861|FG000|Overall Study|Adverse Event|14|||
27838653|NCT01552057|54324862|FG001|Overall Study|Adverse Event|15|||
27838654|NCT01552057|54324861|FG000|Overall Study|Lack of Efficacy|8|||
27838655|NCT01552057|54324862|FG001|Overall Study|Lack of Efficacy|23|||
27838656|NCT01552057|54324861|FG000|Overall Study|Withdrawal by Subject|5|||
27838657|NCT01552057|54324862|FG001|Overall Study|Withdrawal by Subject|8|||
27838658|NCT01552057|54324861|FG000|Overall Study|Entry Criteria Not Met|2|||
27838659|NCT01552057|54324862|FG001|Overall Study|Entry Criteria Not Met|2|||
27838660|NCT01552057|54324861|FG000|Overall Study|Physician Decision|1|||
27838661|NCT01552057|54324862|FG001|Overall Study|Physician Decision|0|||
27838662|NCT01551745|54324868|FG000|Overall Study|Withdrawal by Subject|1|||
27838663|NCT01551745|54324868|FG000|Overall Study|Disease Progression|2|||
27838664|NCT01551355|54324878|FG000|Overall Study|Lost to Follow-up|51|||
27838665|NCT01551355|54324879|FG001|Overall Study|Lost to Follow-up|49|||
27754420|NCT02661217|54205320|FG001|Overall Study|Withdrawal by Subject|19|||
27754421|NCT02661217|54205319|FG000|Overall Study|Did not enter follow-up epoch|7|||
27754422|NCT02661217|54205320|FG001|Overall Study|Did not enter follow-up epoch|10|||
27838666|NCT01551355|54324880|FG002|Overall Study|Lost to Follow-up|34|||
27838667|NCT01551355|54324881|FG003|Overall Study|Lost to Follow-up|24|||
27838668|NCT01551355|54324882|FG004|Overall Study|Lost to Follow-up|9|||
27838669|NCT01551355|54324883|FG005|Overall Study|Lost to Follow-up|6|||
27838670|NCT01569841|54324891|FG000|Period A (6 Weeks)|Withdrawal by Subject|0|||
27838671|NCT01569841|54324892|FG001|Period A (6 Weeks)|Withdrawal by Subject|1|||
27838672|NCT01569763|54324902|FG000|Overall Study|Lack of Efficacy|2|||
27838673|NCT01569763|54324903|FG001|Overall Study|Lack of Efficacy|7|||
27838674|NCT01569763|54324902|FG000|Overall Study|Adverse Event|1|||
27838675|NCT01569763|54324903|FG001|Overall Study|Adverse Event|0|||
27838676|NCT01550965|54324909|FG000|Overall Study|Adverse Event|26|||
27838677|NCT01550965|54324909|FG000|Overall Study|Withdrawal by Subject|10|||
27838678|NCT01550965|54324909|FG000|Overall Study|Lost to Follow-up|2|||
27754423|NCT02661217|54205319|FG000|Overall Study|Death - no study drug received|1|||
27754424|NCT02661217|54205320|FG001|Overall Study|Death - no study drug received|2|||
27754425|NCT02661217|54205319|FG000|Overall Study|Mis-randomized (not in treatment epoch)|3|||
27754426|NCT02661217|54205320|FG001|Overall Study|Mis-randomized (not in treatment epoch)|1|||
27754427|NCT01952080|54205331|FG000|Overall Study|Withdrawal by Subject|0|||
27754428|NCT01952080|54205332|FG001|Overall Study|Withdrawal by Subject|0|||
27754429|NCT01952080|54205333|FG002|Overall Study|Withdrawal by Subject|0|||
27838679|NCT01550965|54324909|FG000|Overall Study|Lack of Efficacy|59|||
27754430|NCT01952080|54205334|FG003|Overall Study|Withdrawal by Subject|1|||
27754431|NCT01952080|54205331|FG000|Overall Study|Protocol Non-compliance|0|||
27754432|NCT01952080|54205332|FG001|Overall Study|Protocol Non-compliance|1|||
27754433|NCT01952080|54205333|FG002|Overall Study|Protocol Non-compliance|0|||
27754434|NCT01952080|54205334|FG003|Overall Study|Protocol Non-compliance|0|||
27838680|NCT01550965|54324909|FG000|Overall Study|Other|13|||
27838681|NCT01569295|54325030|FG000|Overall Study|Progressive Disease|75|||
27838682|NCT01569295|54325031|FG001|Overall Study|Progressive Disease|139|||
27838683|NCT01569295|54325030|FG000|Overall Study|Adverse Event|39|||
27838684|NCT01569295|54325031|FG001|Overall Study|Adverse Event|14|||
27838685|NCT01569295|54325030|FG000|Overall Study|Withdrawal by Subject|25|||
27838686|NCT01569295|54325031|FG001|Overall Study|Withdrawal by Subject|12|||
27838687|NCT01569295|54325030|FG000|Overall Study|Death|19|||
27838688|NCT01569295|54325031|FG001|Overall Study|Death|15|||
27838689|NCT01569295|54325030|FG000|Overall Study|Physician Decision|13|||
27838690|NCT01569295|54325031|FG001|Overall Study|Physician Decision|18|||
27926908|NCT01218009|54583379|FG000|Overall Study|Withdrawal by Subject|3|||
27926909|NCT01218009|54583380|FG001|Overall Study|Withdrawal by Subject|1|||
27926910|NCT01218009|54583379|FG000|Overall Study|Sponsor terminated study|161|||
27838691|NCT01569295|54325030|FG000|Overall Study|Study Terminated by Sponsor|24|||
27754435|NCT01951378|54205346|FG000|Overall Study|Study Terminated-Not completed|23|||
28159939|NCT02737475|54830041|FG019|Overall Study|Other reasons|0|||
28159940|NCT02737475|54830042|FG020|Overall Study|Other reasons|0|||
28159941|NCT02737475|54830043|FG021|Overall Study|Other reasons|1|||
28159942|NCT02737475|54830044|FG022|Overall Study|Other reasons|0|||
28159943|NCT02737475|54830045|FG023|Overall Study|Other reasons|1|||
28159944|NCT02737475|54830046|FG024|Overall Study|Other reasons|1|||
28159945|NCT02737475|54830047|FG025|Overall Study|Other reasons|1|||
28159946|NCT02737475|54830048|FG026|Overall Study|Other reasons|0|||
28159947|NCT02737475|54830022|FG000|Overall Study|Death|1|||
28159948|NCT02737475|54830023|FG001|Overall Study|Death|0|||
28159949|NCT02737475|54830024|FG002|Overall Study|Death|0|||
28159950|NCT02737475|54830025|FG003|Overall Study|Death|1|||
27754436|NCT01951378|54205347|FG001|Overall Study|Study Terminated-Not completed|17|||
27754437|NCT01944670|54205353|FG000|Overall Study|Lost to Follow-up|2|||
27754438|NCT01361009|54205357|FG000|Overall Study|Protocol Violation|116|||
27754439|NCT01944046|54205363|FG000|Randomized to DB|Adverse Event|5|||
27754440|NCT01944046|54205364|FG001|Randomized to DB|Adverse Event|2|||
27754441|NCT01944046|54205363|FG000|Randomized to DB|Clinical Worsening|3|||
27754442|NCT01944046|54205364|FG001|Randomized to DB|Clinical Worsening|2|||
27754443|NCT01944046|54205363|FG000|Randomized to DB|Lost to Follow-up|3|||
27754444|NCT01944046|54205364|FG001|Randomized to DB|Lost to Follow-up|3|||
27754445|NCT01944046|54205363|FG000|Randomized to DB|Withdrawal by Subject|2|||
27754446|NCT01944046|54205364|FG001|Randomized to DB|Withdrawal by Subject|4|||
27754447|NCT01944046|54205363|FG000|Randomized to DB|Physician Decision|1|||
27754448|NCT01944046|54205364|FG001|Randomized to DB|Physician Decision|2|||
27754449|NCT01944046|54205363|FG000|Randomized to DB|Did not have baseline ABC-SW|2|||
27754450|NCT01944046|54205364|FG001|Randomized to DB|Did not have baseline ABC-SW|0|||
27754451|NCT01944046|54205363|FG000|Randomized to DB|Did not have a postbaseline ABC SW|5|||
27754452|NCT01944046|54205364|FG001|Randomized to DB|Did not have a postbaseline ABC SW|6|||
27754453|NCT01944046|54205363|FG000|Open Label Eligible and Consented|Lost to Follow-up|3|||
27754454|NCT01944046|54205364|FG001|Open Label Eligible and Consented|Lost to Follow-up|5|||
27754455|NCT01944046|54205363|FG000|Open Label Eligible and Consented|Adverse Event|6|||
27754456|NCT01944046|54205364|FG001|Open Label Eligible and Consented|Adverse Event|1|||
27754457|NCT01944046|54205363|FG000|Open Label Eligible and Consented|Clinical Worsening|4|||
27754458|NCT01944046|54205364|FG001|Open Label Eligible and Consented|Clinical Worsening|2|||
27754459|NCT01944046|54205363|FG000|Open Label Eligible and Consented|Withdrawal by Subject|1|||
27754460|NCT01944046|54205364|FG001|Open Label Eligible and Consented|Withdrawal by Subject|0|||
27754461|NCT01969084|54205376|FG000|Overall Study|Adverse Event|0|||
27754462|NCT01969084|54205377|FG001|Overall Study|Adverse Event|1|||
27754463|NCT01942486|54205387|FG000|Overall Study|Lost to Follow-up|27|||
27754464|NCT01941940|54205391|FG000|Overall Study|Adverse Event|11|||
27754465|NCT01941940|54205391|FG000|Overall Study|Lost to Follow-up|2|||
27754466|NCT01941940|54205391|FG000|Overall Study|Physician Decision|2|||
27754467|NCT01941940|54205391|FG000|Overall Study|Withdrawal by Subject|15|||
27754468|NCT01941940|54205391|FG000|Overall Study|Death|1|||
27754469|NCT01941940|54205391|FG000|Overall Study|Other|1|||
27754470|NCT01941940|54205391|FG000|Overall Study|Other|1|||
27754471|NCT01968694|54205397|FG000|Washout (1 Month)|Lost to Follow-up|0|||
27754472|NCT01968694|54205398|FG001|Washout (1 Month)|Lost to Follow-up|1|||
27754473|NCT01968226|54205406|FG000|Overall Study|[F-18] RDG-K5 was not available|2|||
27754474|NCT02640053|54205412|FG000|Overall Study|Withdrawal by Subject|2|||
27754475|NCT02640053|54205413|FG001|Overall Study|Withdrawal by Subject|1|||
27754476|NCT02640053|54205412|FG000|Overall Study|Adverse Event|1|||
27754477|NCT02640053|54205413|FG001|Overall Study|Adverse Event|1|||
27754478|NCT02640053|54205412|FG000|Overall Study|Alternative Therapy|1|||
27754479|NCT02640053|54205413|FG001|Overall Study|Alternative Therapy|1|||
27754480|NCT02640053|54205412|FG000|Overall Study|Chemo regimen changed after 1st Rx|0|||
27754481|NCT02640053|54205413|FG001|Overall Study|Chemo regimen changed after 1st Rx|1|||
27754482|NCT01950364|54205421|FG000|Overall Study|Adverse Event|3|||
27754483|NCT01950364|54205422|FG001|Overall Study|Adverse Event|0|||
27754484|NCT01950364|54205421|FG000|Overall Study|Stem Cell Transplant|2|||
27754485|NCT01950364|54205422|FG001|Overall Study|Stem Cell Transplant|6|||
27754486|NCT01950364|54205421|FG000|Overall Study|Disease Progression|5|||
27754487|NCT01950364|54205422|FG001|Overall Study|Disease Progression|2|||
27754488|NCT01950364|54205421|FG000|Overall Study|Withdrawal by Subject|0|||
27754489|NCT01950364|54205422|FG001|Overall Study|Withdrawal by Subject|1|||
27754490|NCT01950364|54205421|FG000|Overall Study|Protocol Violation|0|||
27754491|NCT01950364|54205422|FG001|Overall Study|Protocol Violation|1|||
27754492|NCT01968070|54205446|FG000|Period 1|Withdrawal by Subject|0|||
27754493|NCT01968070|54205447|FG001|Period 1|Withdrawal by Subject|1|||
27754494|NCT01968070|54205448|FG002|Period 1|Withdrawal by Subject|0|||
27754495|NCT01968070|54205449|FG003|Period 1|Withdrawal by Subject|0|||
27754496|NCT01968070|54205450|FG004|Period 1|Withdrawal by Subject|0|||
27754497|NCT01968070|54205451|FG005|Period 1|Withdrawal by Subject|0|||
27754498|NCT01968070|54205452|FG006|Period 1|Withdrawal by Subject|1|||
27754499|NCT01968070|54205453|FG007|Period 1|Withdrawal by Subject|0|||
27754500|NCT01968070|54205454|FG008|Period 1|Withdrawal by Subject|0|||
27754501|NCT01968070|54205455|FG009|Period 1|Withdrawal by Subject|0|||
27754502|NCT01968070|54205456|FG010|Period 1|Withdrawal by Subject|0|||
27754503|NCT01968070|54205457|FG011|Period 1|Withdrawal by Subject|0|||
27754504|NCT01968070|54205458|FG012|Period 1|Withdrawal by Subject|0|||
27754505|NCT01968070|54205459|FG013|Period 1|Withdrawal by Subject|0|||
27754506|NCT01968070|54205460|FG014|Period 1|Withdrawal by Subject|0|||
27754507|NCT01968070|54205461|FG015|Period 1|Withdrawal by Subject|1|||
27754508|NCT01968070|54205462|FG016|Period 1|Withdrawal by Subject|0|||
27926911|NCT01218009|54583380|FG001|Overall Study|Sponsor terminated study|163|||
27926912|NCT00992017|54583386|FG000|Overall Study|Lost to Follow-up|2|||
27926913|NCT00992017|54583386|FG000|Overall Study|Withdrawal by Subject|2|||
27926914|NCT00992017|54583386|FG000|Overall Study|Unable to get to clinic|5|||
27838692|NCT01569295|54325031|FG001|Overall Study|Study Terminated by Sponsor|2|||
27926915|NCT00992017|54583386|FG000|Overall Study|Not adhere to study requirements|1|||
27754509|NCT01968070|54205463|FG017|Period 1|Withdrawal by Subject|0|||
27754510|NCT01968070|54205446|FG000|Period 1|Protocol Violation|0|||
27754511|NCT01968070|54205447|FG001|Period 1|Protocol Violation|0|||
27754512|NCT01968070|54205448|FG002|Period 1|Protocol Violation|0|||
27754513|NCT01968070|54205449|FG003|Period 1|Protocol Violation|1|||
27754514|NCT01968070|54205450|FG004|Period 1|Protocol Violation|1|||
27754515|NCT01968070|54205451|FG005|Period 1|Protocol Violation|0|||
27754516|NCT01968070|54205452|FG006|Period 1|Protocol Violation|0|||
27754517|NCT01968070|54205453|FG007|Period 1|Protocol Violation|0|||
27754518|NCT01968070|54205454|FG008|Period 1|Protocol Violation|0|||
27754519|NCT01968070|54205455|FG009|Period 1|Protocol Violation|0|||
27754520|NCT01968070|54205456|FG010|Period 1|Protocol Violation|0|||
27754521|NCT01968070|54205457|FG011|Period 1|Protocol Violation|0|||
27838693|NCT01569295|54325030|FG000|Overall Study|Other Reason not Specified|3|||
27838694|NCT01569295|54325031|FG001|Overall Study|Other Reason not Specified|5|||
27838695|NCT01569295|54325030|FG000|Overall Study|Non-Compliance with Study Drug|6|||
27838696|NCT01569295|54325031|FG001|Overall Study|Non-Compliance with Study Drug|1|||
27838697|NCT01569295|54325030|FG000|Overall Study|Other Anticancer/Experimental Therapy|2|||
27838698|NCT01569295|54325031|FG001|Overall Study|Other Anticancer/Experimental Therapy|2|||
27838699|NCT01569295|54325030|FG000|Overall Study|Lost to Follow-up|1|||
27838700|NCT01569295|54325031|FG001|Overall Study|Lost to Follow-up|1|||
27838701|NCT01549951|54325088|FG000|Overall Study|Adverse Event|15|||
27838702|NCT01549951|54325088|FG000|Overall Study|Withdrawal by Subject|2|||
27838703|NCT01549951|54325088|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
27838704|NCT01549951|54325088|FG000|Overall Study|Progressive disease|29|||
27838705|NCT01549951|54325088|FG000|Overall Study|Symptomatic deterioration|1|||
27838706|NCT01549951|54325088|FG000|Overall Study|Other|2|||
27838707|NCT01517893|54325094|FG000|Overall Study|Withdrawal by Subject|3|||
27838708|NCT01517893|54325095|FG001|Overall Study|Withdrawal by Subject|0|||
27838709|NCT01489891|54325103|FG000|Overall Study|Endoscopy failure|1|||
27838710|NCT01489891|54325104|FG001|Overall Study|Endoscopy failure|0|||
27838711|NCT04062240|54325186|FG000|Overall Study|equipment malfunction|1|||
27838712|NCT02790138|54325192|FG000|Overall Study|Adverse Event|5|||
27838713|NCT02790138|54325193|FG001|Overall Study|Adverse Event|2|||
27838714|NCT02790138|54325192|FG000|Overall Study|Significant Protocol Deviation|0|||
27838715|NCT02790138|54325193|FG001|Overall Study|Significant Protocol Deviation|1|||
27838716|NCT02790138|54325192|FG000|Overall Study|Lost to Follow-up|1|||
27838717|NCT02790138|54325193|FG001|Overall Study|Lost to Follow-up|0|||
27838718|NCT02790138|54325192|FG000|Overall Study|Voluntary Withdrawal|8|||
27838719|NCT02790138|54325193|FG001|Overall Study|Voluntary Withdrawal|9|||
27838720|NCT02790138|54325192|FG000|Overall Study|Lack of Efficacy|6|||
27838721|NCT02790138|54325193|FG001|Overall Study|Lack of Efficacy|7|||
27838722|NCT02790138|54325192|FG000|Overall Study|Reason not Specified|1|||
27838723|NCT02790138|54325193|FG001|Overall Study|Reason not Specified|0|||
27838724|NCT01489189|54325348|FG000|Overall Study|Withdrawal by Subject|20|||
27838725|NCT01489189|54325349|FG001|Overall Study|Withdrawal by Subject|23|||
27838726|NCT01489189|54325348|FG000|Overall Study|Death|10|||
27838727|NCT01489189|54325349|FG001|Overall Study|Death|8|||
27838728|NCT01489189|54325348|FG000|Overall Study|Missed Visit|1|||
27838729|NCT01489189|54325349|FG001|Overall Study|Missed Visit|4|||
27838730|NCT01549873|54325358|FG000|Overall Study|Physician Decision|0|||
27838731|NCT01549873|54325359|FG001|Overall Study|Physician Decision|1|||
27838732|NCT01489111|54325365|FG000|Overall Study|Withdrawal criterion|1|||
27838733|NCT01488487|54325369|FG000|Overall Study|Adverse Event|6|||
27838734|NCT01488487|54325369|FG000|Overall Study|Death|1|||
27838735|NCT01488487|54325369|FG000|Overall Study|Withdrawal by Subject|2|||
27838736|NCT01488097|54325373|FG000|Overall Study|Lost to Follow-up|1|||
27838737|NCT01516879|54325379|FG000|Overall Study|Withdrawal by Subject|9|||
27838738|NCT01516879|54325380|FG001|Overall Study|Withdrawal by Subject|11|||
27838739|NCT01516879|54325379|FG000|Overall Study|Death|0|||
27754522|NCT01968070|54205458|FG012|Period 1|Protocol Violation|0|||
27754523|NCT01968070|54205459|FG013|Period 1|Protocol Violation|0|||
27754524|NCT01968070|54205460|FG014|Period 1|Protocol Violation|0|||
27754525|NCT01968070|54205461|FG015|Period 1|Protocol Violation|0|||
27754526|NCT01968070|54205462|FG016|Period 1|Protocol Violation|0|||
27754527|NCT01968070|54205463|FG017|Period 1|Protocol Violation|0|||
27754528|NCT01968070|54205446|FG000|Period 1|Lost to Follow-up|0|||
27838740|NCT01516879|54325380|FG001|Overall Study|Death|2|||
27838741|NCT01516879|54325379|FG000|Overall Study|Lost to Follow-up|2|||
27838742|NCT01516879|54325380|FG001|Overall Study|Lost to Follow-up|11|||
27838743|NCT01516879|54325379|FG000|Overall Study|Other|5|||
27838744|NCT01516879|54325380|FG001|Overall Study|Other|10|||
27838745|NCT01515865|54325386|FG000|Part A (Open-label)|Other|3|||
27838746|NCT01515865|54325387|FG001|Part A (Open-label)|Other|0|||
27838747|NCT01515865|54325388|FG002|Part A (Open-label)|Other|0|||
27754529|NCT01968070|54205447|FG001|Period 1|Lost to Follow-up|0|||
27754530|NCT01968070|54205448|FG002|Period 1|Lost to Follow-up|0|||
27838748|NCT01515865|54325386|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
27754531|NCT01968070|54205449|FG003|Period 1|Lost to Follow-up|1|||
27754532|NCT01968070|54205450|FG004|Period 1|Lost to Follow-up|0|||
27754533|NCT01968070|54205451|FG005|Period 1|Lost to Follow-up|0|||
27838749|NCT01515865|54325387|FG001|Part B (Open-label)|Withdrawal by Subject|0|||
27838750|NCT01515865|54325388|FG002|Part B (Open-label)|Withdrawal by Subject|0|||
27838751|NCT01515865|54325386|FG000|Part B (Open-label)|Other|1|||
27838752|NCT01515865|54325387|FG001|Part B (Open-label)|Other|0|||
27838753|NCT01515865|54325388|FG002|Part B (Open-label)|Other|0|||
27838754|NCT01547299|54325398|FG000|Overall Study|Withdrawal by Subject|2|||
27838755|NCT01547299|54325399|FG001|Overall Study|Withdrawal by Subject|2|||
27838756|NCT01515475|54325409|FG000|Overall Study|Lost to Follow-up|20|||
27838757|NCT01515475|54325410|FG001|Overall Study|Lost to Follow-up|15|||
27838758|NCT01515475|54325411|FG002|Overall Study|Lost to Follow-up|12|||
27838759|NCT01515475|54325412|FG003|Overall Study|Lost to Follow-up|12|||
27838760|NCT01515319|54325498|FG000|Overall Study|Withdrawal by Subject|0|||
27838761|NCT01515319|54325499|FG001|Overall Study|Withdrawal by Subject|0|||
27838762|NCT01515319|54325500|FG002|Overall Study|Withdrawal by Subject|0|||
27838763|NCT01515319|54325501|FG003|Overall Study|Withdrawal by Subject|0|||
27754534|NCT01968070|54205452|FG006|Period 1|Lost to Follow-up|0|||
27838764|NCT01515319|54325502|FG004|Overall Study|Withdrawal by Subject|0|||
27838765|NCT01515319|54325503|FG005|Overall Study|Withdrawal by Subject|0|||
27754535|NCT01968070|54205453|FG007|Period 1|Lost to Follow-up|0|||
27754536|NCT01968070|54205454|FG008|Period 1|Lost to Follow-up|0|||
27754537|NCT01968070|54205455|FG009|Period 1|Lost to Follow-up|0|||
27754538|NCT01968070|54205456|FG010|Period 1|Lost to Follow-up|0|||
27754539|NCT01968070|54205457|FG011|Period 1|Lost to Follow-up|0|||
27754540|NCT01968070|54205458|FG012|Period 1|Lost to Follow-up|0|||
27754541|NCT01968070|54205459|FG013|Period 1|Lost to Follow-up|0|||
27754542|NCT01968070|54205460|FG014|Period 1|Lost to Follow-up|0|||
27838766|NCT01515319|54325504|FG006|Overall Study|Withdrawal by Subject|1|||
27838767|NCT01515319|54325505|FG007|Overall Study|Withdrawal by Subject|0|||
27838768|NCT01515319|54325506|FG008|Overall Study|Withdrawal by Subject|0|||
27838769|NCT01515319|54325507|FG009|Overall Study|Withdrawal by Subject|0|||
27838770|NCT01515319|54325498|FG000|Overall Study|Adverse Event|0|||
27838771|NCT01515319|54325499|FG001|Overall Study|Adverse Event|0|||
27838772|NCT01515319|54325500|FG002|Overall Study|Adverse Event|0|||
27754543|NCT01968070|54205461|FG015|Period 1|Lost to Follow-up|0|||
27754544|NCT01968070|54205462|FG016|Period 1|Lost to Follow-up|0|||
27754545|NCT01968070|54205463|FG017|Period 1|Lost to Follow-up|0|||
27754546|NCT01968070|54205446|FG000|Period 1|Adverse Event|0|||
27754547|NCT01968070|54205447|FG001|Period 1|Adverse Event|0|||
27754548|NCT01968070|54205448|FG002|Period 1|Adverse Event|0|||
27754549|NCT01968070|54205449|FG003|Period 1|Adverse Event|0|||
27754550|NCT01968070|54205450|FG004|Period 1|Adverse Event|0|||
27754551|NCT01968070|54205451|FG005|Period 1|Adverse Event|0|||
27838773|NCT01515319|54325501|FG003|Overall Study|Adverse Event|0|||
27838774|NCT01515319|54325502|FG004|Overall Study|Adverse Event|0|||
27838775|NCT01515319|54325503|FG005|Overall Study|Adverse Event|0|||
27838776|NCT01515319|54325504|FG006|Overall Study|Adverse Event|0|||
27838777|NCT01515319|54325505|FG007|Overall Study|Adverse Event|0|||
27838778|NCT01515319|54325506|FG008|Overall Study|Adverse Event|3|||
27838779|NCT01515319|54325507|FG009|Overall Study|Adverse Event|0|||
27838780|NCT01515319|54325498|FG000|Overall Study|Protocol Violation|0|||
27838781|NCT01515319|54325499|FG001|Overall Study|Protocol Violation|0|||
27838782|NCT01515319|54325500|FG002|Overall Study|Protocol Violation|0|||
27838783|NCT01515319|54325501|FG003|Overall Study|Protocol Violation|0|||
27838784|NCT01515319|54325502|FG004|Overall Study|Protocol Violation|0|||
27838785|NCT01515319|54325503|FG005|Overall Study|Protocol Violation|0|||
27838786|NCT01515319|54325504|FG006|Overall Study|Protocol Violation|0|||
27838787|NCT01515319|54325505|FG007|Overall Study|Protocol Violation|0|||
27838788|NCT01515319|54325506|FG008|Overall Study|Protocol Violation|2|||
27838789|NCT01515319|54325507|FG009|Overall Study|Protocol Violation|0|||
27838790|NCT01492361|54325544|FG000|Overall Study|Withdrawal by Subject|281|||
27838791|NCT01492361|54325545|FG001|Overall Study|Withdrawal by Subject|297|||
27838792|NCT01492361|54325544|FG000|Overall Study|Physician Decision|12|||
27838793|NCT01492361|54325545|FG001|Overall Study|Physician Decision|12|||
27754552|NCT01968070|54205452|FG006|Period 1|Adverse Event|1|||
27754553|NCT01968070|54205453|FG007|Period 1|Adverse Event|0|||
27754554|NCT01968070|54205454|FG008|Period 1|Adverse Event|0|||
27754555|NCT01968070|54205455|FG009|Period 1|Adverse Event|0|||
27754556|NCT01968070|54205456|FG010|Period 1|Adverse Event|0|||
27754557|NCT01968070|54205457|FG011|Period 1|Adverse Event|0|||
27754558|NCT01968070|54205458|FG012|Period 1|Adverse Event|0|||
27838794|NCT01492361|54325544|FG000|Overall Study|Lost to Follow-up|6|||
27838795|NCT01492361|54325545|FG001|Overall Study|Lost to Follow-up|13|||
27838796|NCT01492361|54325544|FG000|Overall Study|Other than specified above|106|||
27838797|NCT01492361|54325545|FG001|Overall Study|Other than specified above|138|||
27838798|NCT01514461|54325624|FG000|Overall Study|Adverse Event|2|||
27838799|NCT01514461|54325625|FG001|Overall Study|Adverse Event|1|||
27838800|NCT01514461|54325626|FG002|Overall Study|Adverse Event|3|||
27838801|NCT01514461|54325624|FG000|Overall Study|Physician Decision|1|||
27838802|NCT01514461|54325625|FG001|Overall Study|Physician Decision|1|||
27838803|NCT01514461|54325626|FG002|Overall Study|Physician Decision|0|||
27838804|NCT01514461|54325624|FG000|Overall Study|Patient/guardian decision|1|||
27838805|NCT01514461|54325625|FG001|Overall Study|Patient/guardian decision|1|||
27838806|NCT01514461|54325626|FG002|Overall Study|Patient/guardian decision|1|||
27838807|NCT01514461|54325624|FG000|Overall Study|Death|1|||
27838808|NCT01514461|54325625|FG001|Overall Study|Death|0|||
27838809|NCT01514461|54325626|FG002|Overall Study|Death|0|||
27838810|NCT01491737|54325672|FG000|Overall Study|Withdrawal by Subject|20|||
27838811|NCT01491737|54325673|FG001|Overall Study|Withdrawal by Subject|17|||
27838812|NCT01491737|54325672|FG000|Overall Study|Lost to Follow-up|2|||
27838813|NCT01491737|54325673|FG001|Overall Study|Lost to Follow-up|10|||
27838814|NCT01491737|54325672|FG000|Overall Study|Death|63|||
27838815|NCT01491737|54325673|FG001|Overall Study|Death|57|||
27838816|NCT01491737|54325672|FG000|Overall Study|Study Termination by Sponsor|36|||
27838817|NCT01491737|54325673|FG001|Overall Study|Study Termination by Sponsor|36|||
27838818|NCT01491737|54325672|FG000|Overall Study|Reason Not Specified|8|||
27838819|NCT01491737|54325673|FG001|Overall Study|Reason Not Specified|9|||
27838820|NCT01487863|54325685|FG000|Overall Study|Death|19|||
27838821|NCT01487863|54325686|FG001|Overall Study|Death|19|||
27838822|NCT01487161|54325705|FG000|Overall Study|Adverse Event|1|||
27838823|NCT01487161|54325706|FG001|Overall Study|Adverse Event|0|||
27838824|NCT01487161|54325707|FG002|Overall Study|Adverse Event|0|||
27838825|NCT01487161|54325708|FG003|Overall Study|Adverse Event|0|||
27838826|NCT01487161|54325705|FG000|Overall Study|Withdrawal by Subject|1|||
27838827|NCT01487161|54325706|FG001|Overall Study|Withdrawal by Subject|1|||
27838828|NCT01487161|54325707|FG002|Overall Study|Withdrawal by Subject|1|||
27838829|NCT01487161|54325708|FG003|Overall Study|Withdrawal by Subject|2|||
27838830|NCT01487161|54325705|FG000|Overall Study|missing data|0|||
27838831|NCT01487161|54325706|FG001|Overall Study|missing data|1|||
27838832|NCT01487161|54325707|FG002|Overall Study|missing data|0|||
27838833|NCT01487161|54325708|FG003|Overall Study|missing data|0|||
27838834|NCT01491035|54325763|FG000|Overall Study|Lost to Follow-up|0|||
27838835|NCT01491035|54325764|FG001|Overall Study|Lost to Follow-up|0|||
27838836|NCT01491035|54325765|FG002|Overall Study|Lost to Follow-up|0|||
27838837|NCT01491035|54325766|FG003|Overall Study|Lost to Follow-up|0|||
27838838|NCT01491035|54325767|FG004|Overall Study|Lost to Follow-up|1|||
27838839|NCT01491035|54325768|FG005|Overall Study|Lost to Follow-up|0|||
27838840|NCT01491035|54325769|FG006|Overall Study|Lost to Follow-up|0|||
27754559|NCT01968070|54205459|FG013|Period 1|Adverse Event|0|||
27754560|NCT01968070|54205460|FG014|Period 1|Adverse Event|0|||
27838841|NCT01491035|54325770|FG007|Overall Study|Lost to Follow-up|0|||
27754561|NCT01968070|54205461|FG015|Period 1|Adverse Event|0|||
27754562|NCT01968070|54205462|FG016|Period 1|Adverse Event|0|||
27754563|NCT01968070|54205463|FG017|Period 1|Adverse Event|0|||
27838842|NCT01488071|54325794|FG000|Overall Study|Adverse Event|15|||
27838843|NCT01488071|54325795|FG001|Overall Study|Adverse Event|23|||
27838844|NCT01488071|54325794|FG000|Overall Study|Lack of Efficacy|11|||
27838845|NCT01488071|54325795|FG001|Overall Study|Lack of Efficacy|17|||
27838846|NCT01488071|54325794|FG000|Overall Study|Non-compliance with study drug|2|||
27838847|NCT01488071|54325795|FG001|Overall Study|Non-compliance with study drug|0|||
27838848|NCT01488071|54325794|FG000|Overall Study|Protocol Violation|5|||
27838849|NCT01488071|54325795|FG001|Overall Study|Protocol Violation|7|||
27838850|NCT01488071|54325794|FG000|Overall Study|Withdrawal of Consent|14|||
27838851|NCT01488071|54325795|FG001|Overall Study|Withdrawal of Consent|12|||
27838852|NCT01488071|54325794|FG000|Overall Study|Lost to Follow-up|1|||
27838853|NCT01488071|54325795|FG001|Overall Study|Lost to Follow-up|0|||
27838854|NCT01488071|54325794|FG000|Overall Study|Administrative or Other Reason(s)|5|||
27838855|NCT01488071|54325795|FG001|Overall Study|Administrative or Other Reason(s)|4|||
27838856|NCT01487525|54325803|FG000|Overall Study|Withdrawal by Subject|0|||
27838857|NCT01487525|54325804|FG001|Overall Study|Withdrawal by Subject|1|||
27838858|NCT01486199|54325812|FG000|Two Year Period Between Study Days|Physician Decision|1|||
27838859|NCT01486199|54325813|FG001|Two Year Period Between Study Days|Physician Decision|0|||
27838860|NCT01485887|54325819|FG000|Overall Study|Withdrawal by Subject|2|||
27838861|NCT01485887|54325819|FG000|Overall Study|Adverse Event|8|||
27838862|NCT01485887|54325819|FG000|Overall Study|Deterioration of primary disease|1|||
27838863|NCT01485887|54325819|FG000|Overall Study|Primary disease markedly improved|1|||
27838864|NCT01546519|54325827|FG000|Overall Study|Adverse Event|0|||
27838865|NCT01546519|54325828|FG001|Overall Study|Adverse Event|0|||
27838866|NCT01546519|54325829|FG002|Overall Study|Adverse Event|1|||
27838867|NCT01546519|54325830|FG003|Overall Study|Adverse Event|1|||
27838868|NCT01546519|54325827|FG000|Overall Study|Death|0|||
27838869|NCT01546519|54325828|FG001|Overall Study|Death|1|||
27838870|NCT01546519|54325829|FG002|Overall Study|Death|3|||
27838871|NCT01546519|54325830|FG003|Overall Study|Death|1|||
27838872|NCT01546519|54325827|FG000|Overall Study|related to disease progression|2|||
27838873|NCT01546519|54325828|FG001|Overall Study|related to disease progression|2|||
27838874|NCT01546519|54325829|FG002|Overall Study|related to disease progression|2|||
27838875|NCT01546519|54325830|FG003|Overall Study|related to disease progression|1|||
27838876|NCT01546519|54325827|FG000|Overall Study|Physician Decision|6|||
27838877|NCT01546519|54325828|FG001|Overall Study|Physician Decision|5|||
27838878|NCT01546519|54325829|FG002|Overall Study|Physician Decision|2|||
27838879|NCT01546519|54325830|FG003|Overall Study|Physician Decision|3|||
27838880|NCT01546519|54325827|FG000|Overall Study|Withdrawal by Subject|1|||
27838881|NCT01546519|54325828|FG001|Overall Study|Withdrawal by Subject|0|||
27838882|NCT01546519|54325829|FG002|Overall Study|Withdrawal by Subject|0|||
27838883|NCT01546519|54325830|FG003|Overall Study|Withdrawal by Subject|0|||
27838884|NCT01484951|54325844|FG000|Overall Study|Adverse Event|3|||
27838885|NCT01484951|54325844|FG000|Overall Study|Personal Reasons|1|||
27838886|NCT01484951|54325844|FG000|Overall Study|Non-Compliance|1|||
27838887|NCT01484873|54325848|FG000|Overall Study|Withdrawal by Subject|2|||
27838888|NCT01486927|54325853|FG000|Overall Study|Knee surgery (prior to surgery substudy)|1|||
27838889|NCT01486927|54325853|FG000|Overall Study|Physician Decision|1|||
27838890|NCT01486927|54325853|FG000|Overall Study|50 Exposure days not reached|2|||
27838891|NCT01486927|54325853|FG000|Overall Study|Withdrawal by Subject|8|||
27838892|NCT01486927|54325853|FG000|Overall Study|Subject did not reach 6 mo of treatment|1|||
27838893|NCT01513759|54325886|FG000|Overall Study|Protocol Violation|4|||
27838894|NCT01513759|54325886|FG000|Overall Study|Death during catheter placement|1|||
27838895|NCT01484561|54325892|FG000|Overall Study|Lack of Efficacy|3|||
27838896|NCT01484561|54325893|FG001|Overall Study|Lack of Efficacy|1|||
27838897|NCT01484561|54325892|FG000|Overall Study|Lost to Follow-up|1|||
27838898|NCT01484561|54325893|FG001|Overall Study|Lost to Follow-up|0|||
27838899|NCT01484561|54325892|FG000|Overall Study|Withdrawal by Subject|3|||
27838900|NCT01484561|54325893|FG001|Overall Study|Withdrawal by Subject|0|||
27838901|NCT01484561|54325892|FG000|Overall Study|Other|1|||
27838902|NCT01484561|54325893|FG001|Overall Study|Other|1|||
27838903|NCT01484561|54325892|FG000|Overall Study|Adverse Event|1|||
27838904|NCT01484561|54325893|FG001|Overall Study|Adverse Event|4|||
27838905|NCT01546207|54325899|FG000|Overall Study|Death|1|||
27838906|NCT01513291|54325905|FG000|Treatment Period|Adverse Event|8|||
27838907|NCT01513291|54325906|FG001|Treatment Period|Adverse Event|4|||
27838908|NCT01513291|54325907|FG002|Treatment Period|Adverse Event|0|||
27838909|NCT01513291|54325908|FG003|Treatment Period|Adverse Event|0|||
27838910|NCT01513291|54325909|FG004|Treatment Period|Adverse Event|0|||
27838911|NCT01513291|54325905|FG000|Treatment Period|Lack of Efficacy|3|||
27838912|NCT01513291|54325906|FG001|Treatment Period|Lack of Efficacy|0|||
27838913|NCT01513291|54325907|FG002|Treatment Period|Lack of Efficacy|0|||
27838914|NCT01513291|54325908|FG003|Treatment Period|Lack of Efficacy|0|||
27838915|NCT01513291|54325909|FG004|Treatment Period|Lack of Efficacy|0|||
27838916|NCT01513291|54325905|FG000|Treatment Period|Lost to Follow-up|2|||
27838917|NCT01513291|54325906|FG001|Treatment Period|Lost to Follow-up|3|||
27838918|NCT01513291|54325907|FG002|Treatment Period|Lost to Follow-up|0|||
27838919|NCT01513291|54325908|FG003|Treatment Period|Lost to Follow-up|0|||
27838920|NCT01513291|54325909|FG004|Treatment Period|Lost to Follow-up|0|||
27838921|NCT01513291|54325905|FG000|Treatment Period|Physician Decision|1|||
27838922|NCT01513291|54325906|FG001|Treatment Period|Physician Decision|0|||
27838923|NCT01513291|54325907|FG002|Treatment Period|Physician Decision|0|||
27838924|NCT01513291|54325908|FG003|Treatment Period|Physician Decision|0|||
27838925|NCT01513291|54325909|FG004|Treatment Period|Physician Decision|0|||
27838926|NCT01513291|54325905|FG000|Treatment Period|Protocol Violation|1|||
27838927|NCT01513291|54325906|FG001|Treatment Period|Protocol Violation|2|||
27754564|NCT01968070|54205446|FG000|Period 1|Physician Decision|0|||
27838928|NCT01513291|54325907|FG002|Treatment Period|Protocol Violation|0|||
27838929|NCT01513291|54325908|FG003|Treatment Period|Protocol Violation|0|||
27754565|NCT01968070|54205447|FG001|Period 1|Physician Decision|0|||
27754566|NCT01968070|54205448|FG002|Period 1|Physician Decision|0|||
27754567|NCT01968070|54205449|FG003|Period 1|Physician Decision|0|||
27838930|NCT01513291|54325909|FG004|Treatment Period|Protocol Violation|0|||
27754568|NCT01968070|54205450|FG004|Period 1|Physician Decision|0|||
27838931|NCT01513291|54325905|FG000|Treatment Period|Withdrawal by Subject|8|||
27838932|NCT01513291|54325906|FG001|Treatment Period|Withdrawal by Subject|5|||
27754569|NCT01968070|54205451|FG005|Period 1|Physician Decision|0|||
27754570|NCT01968070|54205452|FG006|Period 1|Physician Decision|0|||
27754571|NCT01968070|54205453|FG007|Period 1|Physician Decision|0|||
27754572|NCT01968070|54205454|FG008|Period 1|Physician Decision|0|||
27754573|NCT01968070|54205455|FG009|Period 1|Physician Decision|0|||
27754574|NCT01968070|54205456|FG010|Period 1|Physician Decision|0|||
27754575|NCT01968070|54205457|FG011|Period 1|Physician Decision|1|||
27754576|NCT01968070|54205458|FG012|Period 1|Physician Decision|0|||
27754577|NCT01968070|54205459|FG013|Period 1|Physician Decision|0|||
27838933|NCT01513291|54325907|FG002|Treatment Period|Withdrawal by Subject|0|||
27754578|NCT01968070|54205460|FG014|Period 1|Physician Decision|0|||
27754579|NCT01968070|54205461|FG015|Period 1|Physician Decision|0|||
27838934|NCT01513291|54325908|FG003|Treatment Period|Withdrawal by Subject|0|||
27838935|NCT01513291|54325909|FG004|Treatment Period|Withdrawal by Subject|0|||
27838936|NCT01513291|54325905|FG000|Treatment Period|Randomized not treated|0|||
27838937|NCT01513291|54325906|FG001|Treatment Period|Randomized not treated|2|||
27838938|NCT01513291|54325907|FG002|Treatment Period|Randomized not treated|0|||
27838939|NCT01513291|54325908|FG003|Treatment Period|Randomized not treated|0|||
27838940|NCT01513291|54325909|FG004|Treatment Period|Randomized not treated|0|||
27838941|NCT01513291|54325905|FG000|Run-out Period|Lost to Follow-up|0|||
27838942|NCT01513291|54325906|FG001|Run-out Period|Lost to Follow-up|0|||
27838943|NCT01513291|54325907|FG002|Run-out Period|Lost to Follow-up|0|||
27838944|NCT01513291|54325908|FG003|Run-out Period|Lost to Follow-up|1|||
27838945|NCT01513291|54325909|FG004|Run-out Period|Lost to Follow-up|0|||
27838946|NCT01513291|54325905|FG000|Run-out Period|Withdrawal by Subject|0|||
27838947|NCT01513291|54325906|FG001|Run-out Period|Withdrawal by Subject|0|||
27838948|NCT01513291|54325907|FG002|Run-out Period|Withdrawal by Subject|0|||
27838949|NCT01513291|54325908|FG003|Run-out Period|Withdrawal by Subject|1|||
27838950|NCT01513291|54325909|FG004|Run-out Period|Withdrawal by Subject|0|||
27838951|NCT01483937|54325923|FG000|Overall Study|Withdrawal by Subject|4|||
27754580|NCT01968070|54205462|FG016|Period 1|Physician Decision|0|||
27838952|NCT01483937|54325924|FG001|Overall Study|Withdrawal by Subject|3|||
27838953|NCT01483625|54325935|FG000|Overall Study|Adverse Event|1|||
27838954|NCT01483625|54325936|FG001|Overall Study|Adverse Event|1|||
27838955|NCT01483625|54325935|FG000|Overall Study|Refused to continue medication|2|||
27838956|NCT01483625|54325936|FG001|Overall Study|Refused to continue medication|1|||
27838957|NCT01483625|54325935|FG000|Overall Study|Due to other reason|1|||
27838958|NCT01483625|54325936|FG001|Overall Study|Due to other reason|0|||
27838959|NCT01485991|54325944|FG000|Overall Study|Adverse Event|0|||
27838960|NCT01485991|54325945|FG001|Overall Study|Adverse Event|4|||
27838961|NCT01485991|54325944|FG000|Overall Study|Lost to Follow-up|13|||
27838962|NCT01485991|54325945|FG001|Overall Study|Lost to Follow-up|10|||
27838963|NCT01485991|54325944|FG000|Overall Study|Withdrawal by Subject|13|||
27838964|NCT01485991|54325945|FG001|Overall Study|Withdrawal by Subject|20|||
27838965|NCT01485991|54325944|FG000|Overall Study|randomized but not treated|6|||
27838966|NCT01485991|54325945|FG001|Overall Study|randomized but not treated|2|||
27838967|NCT01482767|54325977|FG000|Overall Study|Death|1|||
27838968|NCT01482767|54325978|FG001|Overall Study|Death|1|||
27838969|NCT01482767|54325977|FG000|Overall Study|Withdrawal by Subject|7|||
27838970|NCT01482767|54325978|FG001|Overall Study|Withdrawal by Subject|5|||
27838971|NCT01482767|54325977|FG000|Overall Study|Lost to Follow-up|12|||
27838972|NCT01482767|54325978|FG001|Overall Study|Lost to Follow-up|6|||
27838973|NCT01482767|54325977|FG000|Overall Study|Adverse Event|0|||
27838974|NCT01482767|54325978|FG001|Overall Study|Adverse Event|3|||
27838975|NCT01482767|54325977|FG000|Overall Study|Site closure|22|||
27838976|NCT01482767|54325978|FG001|Overall Study|Site closure|14|||
27838977|NCT01482767|54325977|FG000|Overall Study|Non-adherence to study requirements|4|||
27838978|NCT01482767|54325978|FG001|Overall Study|Non-adherence to study requirements|7|||
27838979|NCT01482767|54325977|FG000|Overall Study|Alternate HCV treatment|7|||
27838980|NCT01482767|54325978|FG001|Overall Study|Alternate HCV treatment|8|||
27838981|NCT01482767|54325977|FG000|Overall Study|Ineligible|0|||
27838982|NCT01482767|54325978|FG001|Overall Study|Ineligible|5|||
27838983|NCT01482767|54325977|FG000|Overall Study|Nurse error|1|||
27838984|NCT01482767|54325978|FG001|Overall Study|Nurse error|0|||
27838985|NCT01482221|54326007|FG000|Overall Study|Lack of Efficacy|1|||
27838986|NCT01482221|54326008|FG001|Overall Study|Lack of Efficacy|0|||
27838987|NCT01482221|54326009|FG002|Overall Study|Lack of Efficacy|1|||
27838988|NCT01482221|54326007|FG000|Overall Study|Lost to Follow-up|3|||
27838989|NCT01482221|54326008|FG001|Overall Study|Lost to Follow-up|2|||
27838990|NCT01482221|54326009|FG002|Overall Study|Lost to Follow-up|1|||
27838991|NCT01482221|54326007|FG000|Overall Study|Study-Specific Withdrawal Criteria|2|||
27838992|NCT01482221|54326008|FG001|Overall Study|Study-Specific Withdrawal Criteria|0|||
27838993|NCT01482221|54326009|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
27838994|NCT01482221|54326007|FG000|Overall Study|Condition under Investigation Worsened|3|||
27838995|NCT01482221|54326008|FG001|Overall Study|Condition under Investigation Worsened|2|||
27838996|NCT01482221|54326009|FG002|Overall Study|Condition under Investigation Worsened|4|||
27838997|NCT01482221|54326007|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
27838998|NCT01482221|54326008|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
27838999|NCT01482221|54326009|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
27839000|NCT01482221|54326007|FG000|Overall Study|Adverse Event|1|||
27754581|NCT01968070|54205463|FG017|Period 1|Physician Decision|0|||
27839001|NCT01482221|54326008|FG001|Overall Study|Adverse Event|7|||
27926916|NCT01217463|54583397|FG000|Overall Study|Adverse Event|8|||
27926917|NCT01217463|54583398|FG001|Overall Study|Adverse Event|5|||
27926918|NCT01217463|54583397|FG000|Overall Study|Physician Decision|0|||
27926919|NCT01217463|54583398|FG001|Overall Study|Physician Decision|1|||
27839002|NCT01482221|54326009|FG002|Overall Study|Adverse Event|3|||
27839003|NCT01482221|54326007|FG000|Overall Study|Withdrawal by Subject|10|||
27839004|NCT01482221|54326008|FG001|Overall Study|Withdrawal by Subject|7|||
27839005|NCT01482221|54326009|FG002|Overall Study|Withdrawal by Subject|12|||
27839006|NCT01482221|54326007|FG000|Overall Study|Incorrect randomization|0|||
27839007|NCT01482221|54326008|FG001|Overall Study|Incorrect randomization|1|||
27839008|NCT01482221|54326009|FG002|Overall Study|Incorrect randomization|0|||
27839009|NCT01482221|54326007|FG000|Overall Study|Physician Decision|0|||
27839010|NCT01482221|54326008|FG001|Overall Study|Physician Decision|1|||
27839011|NCT01482221|54326009|FG002|Overall Study|Physician Decision|0|||
27839012|NCT01482065|54326019|FG000|Overall Study|Withdrawal by Subject|0|||
27839013|NCT01482065|54326020|FG001|Overall Study|Withdrawal by Subject|1|||
27839014|NCT01545817|54326035|FG000|Pazopanib|Disease progression|51|||
27839015|NCT01545817|54326036|FG001|Pazopanib|Disease progression|0|||
27839016|NCT01545817|54326035|FG000|Pazopanib|Adverse Event|19|||
27839017|NCT01545817|54326036|FG001|Pazopanib|Adverse Event|0|||
27839018|NCT01545817|54326035|FG000|Pazopanib|Other reason|4|||
27839019|NCT01545817|54326036|FG001|Pazopanib|Other reason|0|||
27839020|NCT01545817|54326035|FG000|Everolimus|Other reason|0|||
27839021|NCT01545817|54326036|FG001|Everolimus|Other reason|7|||
27839022|NCT01545817|54326035|FG000|Everolimus|Disease progression|0|||
27839023|NCT01545817|54326036|FG001|Everolimus|Disease progression|25|||
27839024|NCT01545817|54326035|FG000|Everolimus|Adverse Event|0|||
27839025|NCT01545817|54326036|FG001|Everolimus|Adverse Event|6|||
27839026|NCT01512979|54326055|FG000|Overall Study|Adverse Event|2|||
27839027|NCT01512979|54326056|FG001|Overall Study|Adverse Event|2|||
27839028|NCT01512979|54326055|FG000|Overall Study|Protocol Violation|1|||
27839029|NCT01512979|54326056|FG001|Overall Study|Protocol Violation|4|||
27839030|NCT01512979|54326055|FG000|Overall Study|Lost to Follow-up|2|||
27839031|NCT01512979|54326056|FG001|Overall Study|Lost to Follow-up|5|||
27839032|NCT01512979|54326055|FG000|Overall Study|Withdrawal by Subject|1|||
27754582|NCT01968070|54205446|FG000|Period 2|Withdrawal by Subject|0|||
27754583|NCT01968070|54205447|FG001|Period 2|Withdrawal by Subject|0|||
27754584|NCT01968070|54205448|FG002|Period 2|Withdrawal by Subject|0|||
27754585|NCT01968070|54205449|FG003|Period 2|Withdrawal by Subject|0|||
27754586|NCT01968070|54205450|FG004|Period 2|Withdrawal by Subject|1|||
27754587|NCT01968070|54205451|FG005|Period 2|Withdrawal by Subject|0|||
27754588|NCT01968070|54205452|FG006|Period 2|Withdrawal by Subject|0|||
28159951|NCT02737475|54830026|FG004|Overall Study|Death|0|||
28159952|NCT02737475|54830027|FG005|Overall Study|Death|0|||
28159953|NCT02737475|54830028|FG006|Overall Study|Death|0|||
27754589|NCT01968070|54205453|FG007|Period 2|Withdrawal by Subject|0|||
27754590|NCT01968070|54205454|FG008|Period 2|Withdrawal by Subject|0|||
27754591|NCT01968070|54205455|FG009|Period 2|Withdrawal by Subject|0|||
28159954|NCT02737475|54830029|FG007|Overall Study|Death|2|||
28159955|NCT02737475|54830030|FG008|Overall Study|Death|0|||
28159956|NCT02737475|54830031|FG009|Overall Study|Death|0|||
28159957|NCT02737475|54830032|FG010|Overall Study|Death|0|||
28159958|NCT02737475|54830033|FG011|Overall Study|Death|4|||
28159959|NCT02737475|54830034|FG012|Overall Study|Death|2|||
28159960|NCT02737475|54830035|FG013|Overall Study|Death|2|||
27754592|NCT01968070|54205456|FG010|Period 2|Withdrawal by Subject|0|||
27754593|NCT01968070|54205457|FG011|Period 2|Withdrawal by Subject|0|||
27839033|NCT01512979|54326056|FG001|Overall Study|Withdrawal by Subject|2|||
27839034|NCT01512979|54326055|FG000|Overall Study|Reason other than stated above|13|||
27839035|NCT01512979|54326056|FG001|Overall Study|Reason other than stated above|9|||
27839036|NCT01512745|54326068|FG000|Overall Study|Adverse Event|22|||
27839037|NCT01512745|54326069|FG001|Overall Study|Adverse Event|3|||
27839038|NCT01512745|54326068|FG000|Overall Study|Death|9|||
27839039|NCT01512745|54326069|FG001|Overall Study|Death|13|||
27754594|NCT01968070|54205458|FG012|Period 2|Withdrawal by Subject|0|||
27839040|NCT01512745|54326068|FG000|Overall Study|Withdrawal by Subject|2|||
27839041|NCT01512745|54326069|FG001|Overall Study|Withdrawal by Subject|2|||
27839042|NCT01512745|54326068|FG000|Overall Study|Lost to Follow-up|4|||
27754595|NCT01968070|54205459|FG013|Period 2|Withdrawal by Subject|0|||
27754596|NCT01968070|54205460|FG014|Period 2|Withdrawal by Subject|0|||
27839043|NCT01512745|54326069|FG001|Overall Study|Lost to Follow-up|0|||
27839044|NCT01512745|54326068|FG000|Overall Study|Lack of Efficacy|2|||
27839045|NCT01512745|54326069|FG001|Overall Study|Lack of Efficacy|2|||
27839046|NCT01512745|54326068|FG000|Overall Study|Protocol Violation|1|||
27839047|NCT01512745|54326069|FG001|Overall Study|Protocol Violation|0|||
27754597|NCT01968070|54205461|FG015|Period 2|Withdrawal by Subject|0|||
27754598|NCT01968070|54205462|FG016|Period 2|Withdrawal by Subject|0|||
27754599|NCT01968070|54205463|FG017|Period 2|Withdrawal by Subject|0|||
27754600|NCT01949662|54205503|FG000|Overall Study|Death|9|||
27839048|NCT01478321|54326075|FG000|Concurrent Therapy (5 Weeks)|Adverse Event|4|||
27839049|NCT01478321|54326075|FG000|Concurrent Therapy (5 Weeks)|Death|2|||
27839050|NCT01478321|54326075|FG000|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5|||
27839051|NCT01478321|54326075|FG000|Concurrent Therapy (5 Weeks)|Progressive Disease|5|||
27839052|NCT01478321|54326075|FG000|Started Adjuvant Therapy|Withdrawal by Subject|1|||
27754601|NCT01949662|54205504|FG001|Overall Study|Death|7|||
27754602|NCT01949662|54205503|FG000|Overall Study|Discharged before an agitation event|8|||
27839053|NCT01478321|54326075|FG000|Adjuvant Therapy Until PD or Toxicity|Death|1|||
27839054|NCT01478321|54326075|FG000|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1|||
27839055|NCT01478321|54326075|FG000|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8|||
27839056|NCT01544491|54326081|FG000|Overall Study|Withdrawal by Subject|3|||
27839057|NCT01544491|54326082|FG001|Overall Study|Withdrawal by Subject|2|||
27839058|NCT01544491|54326081|FG000|Overall Study|Lost to Follow-up|0|||
27839059|NCT01544491|54326082|FG001|Overall Study|Lost to Follow-up|1|||
27839060|NCT01544491|54326081|FG000|Overall Study|administrative problems|2|||
27754603|NCT01949662|54205504|FG001|Overall Study|Discharged before an agitation event|3|||
27754604|NCT01949662|54205503|FG000|Overall Study|Dropped out|1|||
27754605|NCT01949662|54205504|FG001|Overall Study|Dropped out|3|||
27754606|NCT01949662|54205503|FG000|Overall Study|Ineligible|0|||
27754607|NCT01949662|54205504|FG001|Overall Study|Ineligible|1|||
27754608|NCT01918774|54205510|FG000|Overall Study|Lost prior to first CBTw session|4|||
27754609|NCT01918774|54205510|FG000|Overall Study|Lost to Follow-up|1|||
27754610|NCT01949116|54205516|FG000|Overall Study|Death|2|||
27754611|NCT01949116|54205517|FG001|Overall Study|Death|0|||
27754612|NCT01949116|54205516|FG000|Overall Study|Lost to Follow-up|1|||
27754613|NCT01949116|54205517|FG001|Overall Study|Lost to Follow-up|3|||
27754614|NCT01949116|54205516|FG000|Overall Study|Withdrawal by Subject|5|||
27754615|NCT01949116|54205517|FG001|Overall Study|Withdrawal by Subject|3|||
27754616|NCT01673009|54205527|FG000|Overall Study|Physician Decision|5|||
27754617|NCT01673009|54205527|FG000|Overall Study|Withdrawal by Subject|8|||
27754618|NCT01939366|54205536|FG000|Overall Study|Adverse Event|8|||
27754619|NCT01939366|54205537|FG001|Overall Study|Adverse Event|17|||
27754620|NCT01939366|54205538|FG002|Overall Study|Adverse Event|30|||
27754621|NCT01939366|54205539|FG003|Overall Study|Adverse Event|8|||
27754622|NCT01939366|54205540|FG004|Overall Study|Adverse Event|5|||
27754623|NCT01939366|54205536|FG000|Overall Study|Lack of Efficacy|2|||
27754624|NCT01939366|54205537|FG001|Overall Study|Lack of Efficacy|1|||
27754625|NCT01939366|54205538|FG002|Overall Study|Lack of Efficacy|1|||
27754626|NCT01939366|54205539|FG003|Overall Study|Lack of Efficacy|1|||
27754627|NCT01939366|54205540|FG004|Overall Study|Lack of Efficacy|3|||
27754628|NCT01939366|54205536|FG000|Overall Study|Lost to Follow-up|1|||
27754629|NCT01939366|54205537|FG001|Overall Study|Lost to Follow-up|1|||
27754630|NCT01939366|54205538|FG002|Overall Study|Lost to Follow-up|0|||
27754631|NCT01939366|54205539|FG003|Overall Study|Lost to Follow-up|0|||
27754632|NCT01939366|54205540|FG004|Overall Study|Lost to Follow-up|0|||
27754633|NCT01939366|54205536|FG000|Overall Study|Withdrawal by Subject|1|||
27754634|NCT01939366|54205537|FG001|Overall Study|Withdrawal by Subject|0|||
27754635|NCT01939366|54205538|FG002|Overall Study|Withdrawal by Subject|2|||
28159961|NCT02737475|54830036|FG014|Overall Study|Death|0|||
27754636|NCT01939366|54205539|FG003|Overall Study|Withdrawal by Subject|2|||
27754637|NCT01939366|54205540|FG004|Overall Study|Withdrawal by Subject|3|||
27754638|NCT01939366|54205536|FG000|Overall Study|Inclusion criteria not met|0|||
27754639|NCT01939366|54205537|FG001|Overall Study|Inclusion criteria not met|1|||
27754640|NCT01939366|54205538|FG002|Overall Study|Inclusion criteria not met|1|||
27754641|NCT01939366|54205539|FG003|Overall Study|Inclusion criteria not met|0|||
27754642|NCT01939366|54205540|FG004|Overall Study|Inclusion criteria not met|1|||
27839061|NCT01544491|54326082|FG001|Overall Study|administrative problems|0|||
28159962|NCT02737475|54830037|FG015|Overall Study|Death|2|||
27754643|NCT01939366|54205536|FG000|Overall Study|Other|0|||
27754644|NCT01939366|54205537|FG001|Overall Study|Other|0|||
27754645|NCT01939366|54205538|FG002|Overall Study|Other|2|||
27754646|NCT01939366|54205539|FG003|Overall Study|Other|2|||
27754647|NCT01939366|54205540|FG004|Overall Study|Other|1|||
27754648|NCT01939366|54205536|FG000|Overall Study|Protocol Violation|0|||
27754649|NCT01939366|54205537|FG001|Overall Study|Protocol Violation|0|||
27754650|NCT01939366|54205538|FG002|Overall Study|Protocol Violation|0|||
27754651|NCT01939366|54205539|FG003|Overall Study|Protocol Violation|1|||
27754652|NCT01939366|54205540|FG004|Overall Study|Protocol Violation|0|||
27754653|NCT01939366|54205536|FG000|Overall Study|Sponsor decision|0|||
27754654|NCT01939366|54205537|FG001|Overall Study|Sponsor decision|0|||
27839062|NCT01478087|54326101|FG000|Overall Study|due to sponsor closing study|1|||
27754655|NCT01939366|54205538|FG002|Overall Study|Sponsor decision|0|||
27839063|NCT01477853|54326119|FG000|Phase A|Adverse Event|1|||
27839064|NCT01477853|54326120|FG001|Phase A|Adverse Event|2|||
27839065|NCT01477853|54326121|FG002|Phase A|Adverse Event|2|||
27839066|NCT01477853|54326119|FG000|Phase A|Lost to Follow-up|4|||
27839067|NCT01477853|54326120|FG001|Phase A|Lost to Follow-up|3|||
27754656|NCT01939366|54205539|FG003|Overall Study|Sponsor decision|0|||
27754657|NCT01939366|54205540|FG004|Overall Study|Sponsor decision|2|||
27839068|NCT01477853|54326121|FG002|Phase A|Lost to Follow-up|2|||
27754658|NCT01939366|54205536|FG000|Overall Study|GCP non-compliance at site|2|||
27754659|NCT01939366|54205537|FG001|Overall Study|GCP non-compliance at site|3|||
27754660|NCT01939366|54205538|FG002|Overall Study|GCP non-compliance at site|2|||
27754661|NCT01939366|54205539|FG003|Overall Study|GCP non-compliance at site|3|||
27754662|NCT01939366|54205540|FG004|Overall Study|GCP non-compliance at site|3|||
27754663|NCT01918306|54205554|FG000|Overall Study|progresive disease|4|||
27754664|NCT01918306|54205555|FG001|Overall Study|progresive disease|0|||
27754665|NCT01918306|54205556|FG002|Overall Study|progresive disease|1|||
27754666|NCT01918306|54205557|FG003|Overall Study|progresive disease|1|||
27754667|NCT01918306|54205554|FG000|Overall Study|Withdrawal by Subject|0|||
27754668|NCT01918306|54205555|FG001|Overall Study|Withdrawal by Subject|0|||
27754669|NCT01918306|54205556|FG002|Overall Study|Withdrawal by Subject|0|||
27754670|NCT01918306|54205557|FG003|Overall Study|Withdrawal by Subject|2|||
27754671|NCT01918306|54205554|FG000|Overall Study|neutropenia|1|||
27754672|NCT01918306|54205555|FG001|Overall Study|neutropenia|0|||
27754673|NCT01918306|54205556|FG002|Overall Study|neutropenia|0|||
27754674|NCT01918306|54205557|FG003|Overall Study|neutropenia|0|||
27754675|NCT01918306|54205554|FG000|Overall Study|Lack of Efficacy|1|||
27754676|NCT01918306|54205555|FG001|Overall Study|Lack of Efficacy|0|||
27754677|NCT01918306|54205556|FG002|Overall Study|Lack of Efficacy|0|||
27754678|NCT01918306|54205557|FG003|Overall Study|Lack of Efficacy|0|||
27754679|NCT01918306|54205554|FG000|Overall Study|progress disease, crossover|0|||
27754680|NCT01918306|54205555|FG001|Overall Study|progress disease, crossover|0|||
27754681|NCT01918306|54205556|FG002|Overall Study|progress disease, crossover|1|||
27754682|NCT01918306|54205557|FG003|Overall Study|progress disease, crossover|0|||
27754683|NCT01917526|54205579|FG000|Overall Study|Protocol Violation|1|||
27754684|NCT01917526|54205580|FG001|Overall Study|Protocol Violation|1|||
27754685|NCT01948258|54205586|FG000|Overall Study|Pregnancy|41|||
27754686|NCT01948258|54205586|FG000|Overall Study|Did not complete by cut-off date|35|||
27754687|NCT01948258|54205586|FG000|Overall Study|Lost to Follow-up|27|||
27754688|NCT01948258|54205586|FG000|Overall Study|Withdrawal by SPD|8|||
27754689|NCT01948258|54205586|FG000|Overall Study|Withdrawal by Subject|6|||
27754690|NCT01948258|54205586|FG000|Overall Study|Health Care Professional|43|||
27754691|NCT01948258|54205586|FG000|Overall Study|Removed from statistical analysis|2|||
27754692|NCT01916980|54205592|FG000|Overall Study|Adverse Event|4|||
27754693|NCT01916980|54205593|FG001|Overall Study|Adverse Event|2|||
27754694|NCT01916980|54205592|FG000|Overall Study|Lack of Efficacy|2|||
27754695|NCT01916980|54205593|FG001|Overall Study|Lack of Efficacy|2|||
27754696|NCT01916980|54205592|FG000|Overall Study|Withdrawal by Subject|1|||
27754697|NCT01916980|54205593|FG001|Overall Study|Withdrawal by Subject|0|||
27754698|NCT05062759|54205605|FG000|Overall Study|Death|0|||
27754699|NCT05062759|54205606|FG001|Overall Study|Death|1|||
27754700|NCT05062759|54205605|FG000|Overall Study|Lost to Follow-up|1|||
27754701|NCT05062759|54205606|FG001|Overall Study|Lost to Follow-up|0|||
27754702|NCT05033262|54205625|FG000|Overall Study|Lost to Follow-up|1|||
27754703|NCT05033262|54205626|FG001|Overall Study|Lost to Follow-up|0|||
27754704|NCT05033262|54205627|FG002|Overall Study|Lost to Follow-up|0|||
27754705|NCT05033262|54205628|FG003|Overall Study|Lost to Follow-up|1|||
27754706|NCT04963062|54205642|FG000|Overall Study|withdrew by the study team|4|||
27754707|NCT04963062|54205643|FG001|Overall Study|withdrew by the study team|2|||
27754708|NCT04900220|54205655|FG000|Overall Study|Lost to Follow-up|1|||
27754709|NCT04900220|54205656|FG001|Overall Study|Lost to Follow-up|1|||
27754710|NCT04599062|54205668|FG000|Overall Study|Physician Decision|1|||
27754711|NCT04599062|54205669|FG001|Overall Study|Physician Decision|0|||
27754712|NCT04585815|54205677|FG000|Sub-study A- Treatment Phase|Adverse Event|0|||
27754713|NCT04585815|54205678|FG001|Sub-study A- Treatment Phase|Adverse Event|1|||
27754714|NCT04585815|54205677|FG000|Sub-study A- Treatment Phase|Death|0|||
27754715|NCT04585815|54205678|FG001|Sub-study A- Treatment Phase|Death|1|||
27754716|NCT04585815|54205677|FG000|Sub-study A- Treatment Phase|Withdrawal by Subject|1|||
27754717|NCT04585815|54205678|FG001|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
27754718|NCT04585815|54205677|FG000|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
27754719|NCT04585815|54205678|FG001|Sub-study A- Treatment Phase|Global deterioration of health status|1|||
27754720|NCT04585815|54205677|FG000|Sub-study A- Treatment Phase|Other|1|||
27754721|NCT04585815|54205678|FG001|Sub-study A- Treatment Phase|Other|0|||
27754722|NCT04585815|54205677|FG000|Sub-study A- Treatment Phase|Ongoing treatment|2|||
27754723|NCT04585815|54205678|FG001|Sub-study A- Treatment Phase|Ongoing treatment|6|||
27754724|NCT04585815|54205677|FG000|Sub-study A- Follow-up Phase|Ongoing in study|0|||
27754725|NCT04585815|54205678|FG001|Sub-study A- Follow-up Phase|Ongoing in study|1|||
27754726|NCT04537208|54205697|FG000|Overall Study|Adverse Event|0|||
27754727|NCT04537208|54205698|FG001|Overall Study|Adverse Event|0|||
27754728|NCT04537208|54205699|FG002|Overall Study|Adverse Event|0|||
27754729|NCT04537208|54205700|FG003|Overall Study|Adverse Event|0|||
27754730|NCT04537208|54205701|FG004|Overall Study|Adverse Event|0|||
27754731|NCT04537208|54205702|FG005|Overall Study|Adverse Event|0|||
27754732|NCT04537208|54205703|FG006|Overall Study|Adverse Event|0|||
27754733|NCT04537208|54205704|FG007|Overall Study|Adverse Event|0|||
27754734|NCT04537208|54205705|FG008|Overall Study|Adverse Event|1|||
27754735|NCT04537208|54205706|FG009|Overall Study|Adverse Event|0|||
27754736|NCT04537208|54205707|FG010|Overall Study|Adverse Event|0|||
27754737|NCT04537208|54205697|FG000|Overall Study|Protocol deviation|0|||
27754738|NCT04537208|54205698|FG001|Overall Study|Protocol deviation|0|||
27754739|NCT04537208|54205699|FG002|Overall Study|Protocol deviation|2|||
27754740|NCT04537208|54205700|FG003|Overall Study|Protocol deviation|0|||
27754741|NCT04537208|54205701|FG004|Overall Study|Protocol deviation|0|||
27754742|NCT04537208|54205702|FG005|Overall Study|Protocol deviation|2|||
27754743|NCT04537208|54205703|FG006|Overall Study|Protocol deviation|4|||
27754744|NCT04537208|54205704|FG007|Overall Study|Protocol deviation|0|||
27754745|NCT04537208|54205705|FG008|Overall Study|Protocol deviation|1|||
27754746|NCT04537208|54205706|FG009|Overall Study|Protocol deviation|0|||
27754747|NCT04537208|54205707|FG010|Overall Study|Protocol deviation|2|||
27754748|NCT04537208|54205697|FG000|Overall Study|Withdrawal by Subject|4|||
27754749|NCT04537208|54205698|FG001|Overall Study|Withdrawal by Subject|2|||
27754750|NCT04537208|54205699|FG002|Overall Study|Withdrawal by Subject|1|||
27754751|NCT04537208|54205700|FG003|Overall Study|Withdrawal by Subject|3|||
27754752|NCT04537208|54205701|FG004|Overall Study|Withdrawal by Subject|5|||
27754753|NCT04537208|54205702|FG005|Overall Study|Withdrawal by Subject|1|||
27754754|NCT04537208|54205703|FG006|Overall Study|Withdrawal by Subject|6|||
27754755|NCT04537208|54205704|FG007|Overall Study|Withdrawal by Subject|1|||
27754756|NCT04537208|54205705|FG008|Overall Study|Withdrawal by Subject|7|||
27754757|NCT04537208|54205706|FG009|Overall Study|Withdrawal by Subject|2|||
27754758|NCT04537208|54205707|FG010|Overall Study|Withdrawal by Subject|4|||
27754759|NCT04537208|54205697|FG000|Overall Study|Lost to Follow-up|4|||
27754760|NCT04537208|54205698|FG001|Overall Study|Lost to Follow-up|1|||
27754761|NCT04537208|54205699|FG002|Overall Study|Lost to Follow-up|3|||
27754762|NCT04537208|54205700|FG003|Overall Study|Lost to Follow-up|4|||
27754763|NCT04537208|54205701|FG004|Overall Study|Lost to Follow-up|3|||
27754764|NCT04537208|54205702|FG005|Overall Study|Lost to Follow-up|2|||
27754765|NCT04537208|54205703|FG006|Overall Study|Lost to Follow-up|3|||
27754766|NCT04537208|54205704|FG007|Overall Study|Lost to Follow-up|2|||
27754767|NCT04537208|54205705|FG008|Overall Study|Lost to Follow-up|7|||
27754768|NCT04537208|54205706|FG009|Overall Study|Lost to Follow-up|2|||
27754769|NCT04537208|54205707|FG010|Overall Study|Lost to Follow-up|2|||
27754770|NCT04502433|54205736|FG000|Overall Study|Death|2|||
27754771|NCT04502433|54205737|FG001|Overall Study|Death|4|||
27754772|NCT04502433|54205736|FG000|Overall Study|Lost to Follow-up|1|||
27754773|NCT04502433|54205737|FG001|Overall Study|Lost to Follow-up|0|||
27754774|NCT04502433|54205736|FG000|Overall Study|Physician Decision|0|||
27754775|NCT04502433|54205737|FG001|Overall Study|Physician Decision|1|||
27754776|NCT04442503|54205745|FG000|Overall Study|Adverse Event|1|||
27754777|NCT04442503|54205746|FG001|Overall Study|Adverse Event|1|||
27754778|NCT04442503|54205745|FG000|Overall Study|Lost to Follow-up|8|||
27754779|NCT04442503|54205746|FG001|Overall Study|Lost to Follow-up|6|||
27754780|NCT04442503|54205745|FG000|Overall Study|Physician Decision|0|||
27754781|NCT04442503|54205746|FG001|Overall Study|Physician Decision|2|||
27754782|NCT04442503|54205745|FG000|Overall Study|Withdrawal by Subject|3|||
27754783|NCT04442503|54205746|FG001|Overall Study|Withdrawal by Subject|4|||
27754784|NCT04442503|54205745|FG000|Overall Study|Reason not Specified|0|||
27754785|NCT04442503|54205746|FG001|Overall Study|Reason not Specified|1|||
27754786|NCT04442503|54205745|FG000|Overall Study|Randomized but not Treated|3|||
27754787|NCT04442503|54205746|FG001|Overall Study|Randomized but not Treated|1|||
27754788|NCT04411914|54205754|FG000|CLAV 500mg/Day for Days 1-3|Adverse Event|1|||
27754789|NCT04411914|54205755|FG001|CLAV 500mg/Day for Days 1-3|Adverse Event|0|||
27754790|NCT04389671|54205774|FG000|Overall Study|Death|7|||
27754791|NCT04381494|54205778|FG000|Overall Study|Early termination of trial|19|||
27754792|NCT04381494|54205778|FG000|Overall Study|Investigator's discretion|1|||
27754793|NCT04381494|54205778|FG000|Overall Study|Withdrawal by Subject|9|||
27754794|NCT04381494|54205778|FG000|Overall Study|NSCLC disease progression|4|||
27754795|NCT04381494|54205778|FG000|Overall Study|Device-Related Adverse Event|2|||
27754796|NCT04094584|54205833|FG000|Overall Study|No interest in study|88|||
27754797|NCT04094584|54205833|FG000|Overall Study|Unwilling to undergo screening tests|36|||
27754798|NCT04094584|54205833|FG000|Overall Study|Liver disease (enzymes >5 times upper limit of cirrhosis)|8|||
27754799|NCT04094584|54205833|FG000|Overall Study|Opioid use|7|||
27754800|NCT04094584|54205833|FG000|Overall Study|Need for major surgery in study period|4|||
27754801|NCT04094584|54205833|FG000|Overall Study|eligible but declined enrollment|4|||
27754802|NCT04094584|54205833|FG000|Overall Study|Chose to stop injections after week 4 but continued case management and provided complete data|2|||
27754803|NCT04094584|54205833|FG000|Overall Study|Missed study visits resulting. in incomplete data but sufficient for a pre-post comparison|2|||
27754804|NCT04094584|54205833|FG000|Overall Study|Lost to Follow-up|3|||
27754805|NCT04094584|54205833|FG000|Overall Study|Withdrawal by Subject|2|||
27754806|NCT04021290|54205848|FG000|Randomized Phase (Day1 to Week 52)|Adverse Event|4|||
27754807|NCT04021290|54205849|FG001|Randomized Phase (Day1 to Week 52)|Adverse Event|3|||
27754808|NCT04021290|54205850|FG002|Randomized Phase (Day1 to Week 52)|Adverse Event|0|||
27754809|NCT04021290|54205848|FG000|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
27754810|NCT04021290|54205849|FG001|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|3|||
27754811|NCT04021290|54205850|FG002|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
27754812|NCT04021290|54205848|FG000|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|2|||
27754813|NCT04021290|54205849|FG001|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|1|||
27754814|NCT04021290|54205850|FG002|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|0|||
27754815|NCT04021290|54205848|FG000|Randomized Phase (Day1 to Week 52)|Death|1|||
27754816|NCT04021290|54205849|FG001|Randomized Phase (Day1 to Week 52)|Death|0|||
27754817|NCT04021290|54205850|FG002|Randomized Phase (Day1 to Week 52)|Death|0|||
27754818|NCT04021290|54205848|FG000|Randomized Phase (Day1 to Week 52)|Physician Decision|1|||
27754819|NCT04021290|54205849|FG001|Randomized Phase (Day1 to Week 52)|Physician Decision|2|||
27754820|NCT04021290|54205850|FG002|Randomized Phase (Day1 to Week 52)|Physician Decision|0|||
27754821|NCT04021290|54205848|FG000|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|1|||
27754822|NCT04021290|54205849|FG001|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|5|||
27754823|NCT04021290|54205850|FG002|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|0|||
27754824|NCT04021290|54205848|FG000|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|96|||
27754825|NCT04021290|54205849|FG001|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
27754826|NCT04021290|54205850|FG002|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
27754827|NCT04021290|54205848|FG000|Randomized Phase (Day1 to Week 52)|Protocol Deviation|5|||
27754828|NCT04021290|54205849|FG001|Randomized Phase (Day1 to Week 52)|Protocol Deviation|4|||
27754829|NCT04021290|54205850|FG002|Randomized Phase (Day1 to Week 52)|Protocol Deviation|0|||
27754830|NCT04021290|54205848|FG000|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
27754831|NCT04021290|54205849|FG001|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
27754832|NCT04021290|54205850|FG002|Continuation Phase (Week 52 to Week 132)|Physician Decision|1|||
27754833|NCT04021290|54205848|FG000|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
27754834|NCT04021290|54205849|FG001|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
27839069|NCT01477853|54326119|FG000|Phase A|Physician Decision|1|||
27839070|NCT01477853|54326120|FG001|Phase A|Physician Decision|0|||
27839071|NCT01477853|54326121|FG002|Phase A|Physician Decision|1|||
27754835|NCT04021290|54205850|FG002|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|1|||
27754836|NCT04021290|54205848|FG000|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
27754837|NCT04021290|54205849|FG001|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
27754838|NCT04021290|54205850|FG002|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|1|||
27754839|NCT04021290|54205848|FG000|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
27839072|NCT01477853|54326119|FG000|Phase A|Study terminated by sponsor|37|||
27754840|NCT04021290|54205849|FG001|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
27754841|NCT04021290|54205850|FG002|Continuation Phase (Week 52 to Week 132)|Adverse Event|2|||
27754842|NCT04020341|54205860|FG000|Overall Study|Adverse Event|8|||
27754843|NCT04020341|54205861|FG001|Overall Study|Adverse Event|6|||
27754844|NCT04020341|54205860|FG000|Overall Study|Lost to Follow-up|8|||
27754845|NCT04020341|54205861|FG001|Overall Study|Lost to Follow-up|2|||
27754846|NCT04020341|54205860|FG000|Overall Study|Withdrawal by Subject|16|||
27754847|NCT04020341|54205861|FG001|Overall Study|Withdrawal by Subject|16|||
27754848|NCT04020341|54205860|FG000|Overall Study|Participant not able to swallow the tablet|1|||
27754849|NCT04020341|54205861|FG001|Overall Study|Participant not able to swallow the tablet|0|||
27754850|NCT04020341|54205860|FG000|Overall Study|Physician Decision|0|||
27754851|NCT04020341|54205861|FG001|Overall Study|Physician Decision|2|||
27754852|NCT04020341|54205860|FG000|Overall Study|Protocol Deviation|0|||
27754853|NCT04020341|54205861|FG001|Overall Study|Protocol Deviation|2|||
27754854|NCT03868891|54205883|FG000|Overall Study|Adverse Event|1|||
27754855|NCT03868891|54205884|FG001|Overall Study|Adverse Event|0|||
27754856|NCT03868891|54205883|FG000|Overall Study|Lost to Follow-up|2|||
27754857|NCT03868891|54205884|FG001|Overall Study|Lost to Follow-up|1|||
27754858|NCT03868891|54205883|FG000|Overall Study|COVID-19 Restrictions|1|||
27754859|NCT03868891|54205884|FG001|Overall Study|COVID-19 Restrictions|2|||
27754860|NCT03827655|54205929|FG000|Overall Study|Death|0|||
27754861|NCT03827655|54205930|FG001|Overall Study|Death|0|||
27754862|NCT03827655|54205931|FG002|Overall Study|Death|0|||
27754863|NCT03827655|54205932|FG003|Overall Study|Death|0|||
27754864|NCT03827655|54205933|FG004|Overall Study|Death|1|||
27754865|NCT03827655|54205929|FG000|Overall Study|Protocol Deviation|1|||
27754866|NCT03827655|54205930|FG001|Overall Study|Protocol Deviation|0|||
27754867|NCT03827655|54205931|FG002|Overall Study|Protocol Deviation|1|||
27754868|NCT03827655|54205932|FG003|Overall Study|Protocol Deviation|1|||
27754869|NCT03827655|54205933|FG004|Overall Study|Protocol Deviation|0|||
27754870|NCT03827655|54205929|FG000|Overall Study|Withdrawal by Subject|3|||
27754871|NCT03827655|54205930|FG001|Overall Study|Withdrawal by Subject|2|||
27754872|NCT03827655|54205931|FG002|Overall Study|Withdrawal by Subject|2|||
27754873|NCT03827655|54205932|FG003|Overall Study|Withdrawal by Subject|0|||
27754874|NCT03827655|54205933|FG004|Overall Study|Withdrawal by Subject|1|||
27754875|NCT03827655|54205929|FG000|Overall Study|Reason not Specified|3|||
27754876|NCT03827655|54205930|FG001|Overall Study|Reason not Specified|1|||
27754877|NCT03827655|54205931|FG002|Overall Study|Reason not Specified|1|||
27754878|NCT03827655|54205932|FG003|Overall Study|Reason not Specified|1|||
27754879|NCT03827655|54205933|FG004|Overall Study|Reason not Specified|1|||
27754880|NCT03782064|54205968|FG000|Overall Study|Lack of Efficacy|2|||
27754881|NCT03782064|54205968|FG000|Overall Study|Progression Prior to Starting Treatment|3|||
27754882|NCT03772522|54205974|FG000|Pre-intervention|Withdrawal by Subject|3|||
27754883|NCT03772522|54205975|FG001|Pre-intervention|Withdrawal by Subject|4|||
27754884|NCT03772522|54205974|FG000|Intervention|Withdrawal by Subject|1|||
27754885|NCT03772522|54205975|FG001|Intervention|Withdrawal by Subject|0|||
27754886|NCT03772522|54205974|FG000|Post-intervention Follow-up|Lost to Follow-up|1|||
27754887|NCT03772522|54205975|FG001|Post-intervention Follow-up|Lost to Follow-up|0|||
27754888|NCT03759379|54205988|FG000|Treatment Period|Remained in this Period at Time of Data Cut|119|||
27754889|NCT03759379|54205989|FG001|Treatment Period|Remained in this Period at Time of Data Cut|38|||
27754890|NCT03759379|54205988|FG000|Treatment Period|Death|2|||
27754891|NCT03759379|54205989|FG001|Treatment Period|Death|3|||
27754892|NCT03759379|54205988|FG000|Treatment Period|Lost to Follow-up|1|||
27754893|NCT03759379|54205989|FG001|Treatment Period|Lost to Follow-up|0|||
27754894|NCT03759379|54205988|FG000|Treatment Period|Physician Decision|0|||
27754895|NCT03759379|54205989|FG001|Treatment Period|Physician Decision|1|||
27754896|NCT03755518|54205995|FG000|Overall Study|Adverse Event|6|||
27754897|NCT03755518|54205995|FG000|Overall Study|Lack of Efficacy|6|||
27754898|NCT03755518|54205995|FG000|Overall Study|Bone Marrow Transplant|4|||
27754899|NCT03755518|54205995|FG000|Overall Study|Withdrawal by participant|4|||
27754900|NCT03755518|54205995|FG000|Overall Study|Progressive Disease|2|||
27754901|NCT03755518|54205995|FG000|Overall Study|Death|1|||
27754902|NCT03755518|54205995|FG000|Overall Study|Physician Decision|1|||
27754903|NCT03755518|54205995|FG000|Overall Study|Withdrawal by investigator for non compliance|1|||
27754904|NCT03739112|54206001|FG000|Overall Study|Adverse Event|2|||
27754905|NCT03739112|54206002|FG001|Overall Study|Adverse Event|2|||
27754906|NCT03739112|54206001|FG000|Overall Study|Withdrawal by Subject|38|||
27754907|NCT03739112|54206002|FG001|Overall Study|Withdrawal by Subject|19|||
27754908|NCT03739112|54206001|FG000|Overall Study|Lost to Follow-up|31|||
27754909|NCT03739112|54206002|FG001|Overall Study|Lost to Follow-up|33|||
27754910|NCT03739112|54206001|FG000|Overall Study|Protocol Deviation|12|||
27754911|NCT03739112|54206002|FG001|Overall Study|Protocol Deviation|9|||
27754912|NCT03739112|54206001|FG000|Overall Study|Physician Decision|1|||
27754913|NCT03739112|54206002|FG001|Overall Study|Physician Decision|0|||
27754914|NCT03739112|54206001|FG000|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|12|||
27839073|NCT01477853|54326120|FG001|Phase A|Study terminated by sponsor|40|||
27754915|NCT03739112|54206002|FG001|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|16|||
27754916|NCT03739112|54206001|FG000|Overall Study|Site went on hold|65|||
27754917|NCT03739112|54206002|FG001|Overall Study|Site went on hold|67|||
27754918|NCT03739112|54206001|FG000|Overall Study|Other than specified|8|||
27754919|NCT03739112|54206002|FG001|Overall Study|Other than specified|5|||
27754920|NCT03739112|54206001|FG000|Overall Study|Randomized but not vaccinated|31|||
27754921|NCT03739112|54206002|FG001|Overall Study|Randomized but not vaccinated|25|||
27754922|NCT03622593|54206022|FG000|Overall Study|Withdrawal by Subject|11|||
27754923|NCT03622593|54206023|FG001|Overall Study|Withdrawal by Subject|9|||
27754924|NCT03622593|54206024|FG002|Overall Study|Withdrawal by Subject|13|||
27754925|NCT03622593|54206022|FG000|Overall Study|Death|12|||
27754926|NCT03622593|54206023|FG001|Overall Study|Death|9|||
27754927|NCT03622593|54206024|FG002|Overall Study|Death|10|||
27754928|NCT03622593|54206022|FG000|Overall Study|Lost to Follow-up|11|||
27754929|NCT03622593|54206023|FG001|Overall Study|Lost to Follow-up|5|||
27754930|NCT03622593|54206024|FG002|Overall Study|Lost to Follow-up|8|||
27754931|NCT03622593|54206022|FG000|Overall Study|Adverse Event|4|||
27754932|NCT03622593|54206023|FG001|Overall Study|Adverse Event|5|||
27754933|NCT03622593|54206024|FG002|Overall Study|Adverse Event|6|||
27754934|NCT03622593|54206022|FG000|Overall Study|Physician Decision|2|||
27754935|NCT03622593|54206023|FG001|Overall Study|Physician Decision|1|||
27754936|NCT03622593|54206024|FG002|Overall Study|Physician Decision|6|||
27754937|NCT03622593|54206022|FG000|Overall Study|Other|2|||
27754938|NCT03622593|54206023|FG001|Overall Study|Other|2|||
27754939|NCT03622593|54206024|FG002|Overall Study|Other|3|||
27754940|NCT03622593|54206022|FG000|Overall Study|Protocol Violation|0|||
27754941|NCT03622593|54206023|FG001|Overall Study|Protocol Violation|0|||
27754942|NCT03622593|54206024|FG002|Overall Study|Protocol Violation|1|||
27754943|NCT03622593|54206022|FG000|Overall Study|Pregnancy|0|||
27754944|NCT03622593|54206023|FG001|Overall Study|Pregnancy|0|||
27754945|NCT03622593|54206024|FG002|Overall Study|Pregnancy|1|||
27754946|NCT03593655|54206035|FG000|First Product Use Period|Withdrawal by Subject|1|||
27754947|NCT03593655|54206036|FG001|First Product Use Period|Withdrawal by Subject|1|||
27754948|NCT03593655|54206035|FG000|First Product Use Period|Lost to Follow-up|1|||
27754949|NCT03593655|54206036|FG001|First Product Use Period|Lost to Follow-up|3|||
27754950|NCT03593655|54206035|FG000|Second Product Use Period|Withdrawal by Subject|1|||
27754951|NCT03593655|54206036|FG001|Second Product Use Period|Withdrawal by Subject|1|||
27754952|NCT03593655|54206035|FG000|Second Product Use Period|Lost to Follow-up|1|||
27754953|NCT03593655|54206036|FG001|Second Product Use Period|Lost to Follow-up|0|||
27754954|NCT03593655|54206035|FG000|Third Product Use Period|Lost to Follow-up|1|||
27754955|NCT03593655|54206036|FG001|Third Product Use Period|Lost to Follow-up|2|||
27754956|NCT03593655|54206035|FG000|Third Product Use Period|Physician Decision|0|||
27754957|NCT03593655|54206036|FG001|Third Product Use Period|Physician Decision|1|||
27754958|NCT03593655|54206035|FG000|Third Product Use Period|Withdrawal by Subject|0|||
27754959|NCT03593655|54206036|FG001|Third Product Use Period|Withdrawal by Subject|1|||
27754960|NCT03577106|54206045|FG000|Overall Study|Withdrawal by Subject|3|||
27754961|NCT03534180|54206049|FG000|Overall Study|Withdrawal by Subject|1|||
27754962|NCT03382561|54206059|FG000|Overall Study|Disease progression|47|||
27754963|NCT03382561|54206060|FG001|Overall Study|Disease progression|6|||
27754964|NCT03382561|54206059|FG000|Overall Study|Adverse Event|10|||
27754965|NCT03382561|54206060|FG001|Overall Study|Adverse Event|2|||
27754966|NCT03382561|54206059|FG000|Overall Study|Death|8|||
27754967|NCT03382561|54206060|FG001|Overall Study|Death|3|||
27754968|NCT03382561|54206059|FG000|Overall Study|Withdrawal by Subject|6|||
27754969|NCT03382561|54206060|FG001|Overall Study|Withdrawal by Subject|5|||
27754970|NCT03382561|54206059|FG000|Overall Study|Alternative therapy|2|||
27754971|NCT03382561|54206060|FG001|Overall Study|Alternative therapy|8|||
27754972|NCT03382561|54206059|FG000|Overall Study|Never started treatment|3|||
27754973|NCT03382561|54206060|FG001|Overall Study|Never started treatment|6|||
27754974|NCT03382561|54206059|FG000|Overall Study|Lack of Efficacy|0|||
27754975|NCT03382561|54206060|FG001|Overall Study|Lack of Efficacy|1|||
27754976|NCT03382561|54206059|FG000|Overall Study|Physician Decision|0|||
27754977|NCT03382561|54206060|FG001|Overall Study|Physician Decision|1|||
27839074|NCT01477853|54326121|FG002|Phase A|Study terminated by sponsor|39|||
27839075|NCT01477853|54326119|FG000|Phase B|Lost to Follow-up|0|||
27839076|NCT01477853|54326120|FG001|Phase B|Lost to Follow-up|1|||
27839077|NCT01477853|54326121|FG002|Phase B|Lost to Follow-up|0|||
27754978|NCT03382561|54206059|FG000|Overall Study|Other complicating disease|0|||
27754979|NCT03382561|54206060|FG001|Overall Study|Other complicating disease|1|||
27754980|NCT03364231|54206068|FG000|Overall Study|Adverse Event|1|||
27754981|NCT03364231|54206069|FG001|Overall Study|Adverse Event|4|||
27754982|NCT03364231|54206068|FG000|Overall Study|Death|1|||
27754983|NCT03364231|54206069|FG001|Overall Study|Death|0|||
27754984|NCT03364231|54206068|FG000|Overall Study|Investigator Decision|2|||
27754985|NCT03364231|54206069|FG001|Overall Study|Investigator Decision|2|||
27754986|NCT03364231|54206068|FG000|Overall Study|Sponsor Discontinuation of the Study|2|||
27754987|NCT03364231|54206069|FG001|Overall Study|Sponsor Discontinuation of the Study|1|||
27754988|NCT03364231|54206068|FG000|Overall Study|Withdrawal of Subject Consent|1|||
27754989|NCT03364231|54206069|FG001|Overall Study|Withdrawal of Subject Consent|0|||
27754990|NCT03364231|54206068|FG000|Overall Study|Reason Not Specified|1|||
27754991|NCT03364231|54206069|FG001|Overall Study|Reason Not Specified|0|||
27754992|NCT03364231|54206068|FG000|Overall Study|Disease Progression|0|||
27754993|NCT03364231|54206069|FG001|Overall Study|Disease Progression|6|||
27754994|NCT03303625|54206080|FG000|Overall Study|Withdrawal by Subject|2|||
27754995|NCT03303625|54206081|FG001|Overall Study|Withdrawal by Subject|0|||
27754996|NCT03303625|54206082|FG002|Overall Study|Withdrawal by Subject|0|||
27754997|NCT03303625|54206083|FG003|Overall Study|Withdrawal by Subject|0|||
27754998|NCT03299816|54206095|FG000|Phase 1: 4-month Intervention Period|Withdrawal by Subject|1|||
27754999|NCT03299816|54206096|FG001|Phase 1: 4-month Intervention Period|Withdrawal by Subject|0|||
27755000|NCT03299816|54206095|FG000|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|1|||
27755001|NCT03299816|54206096|FG001|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|0|||
27755002|NCT03299816|54206095|FG000|Phase 2: 12-month Follow-up Period|Lost to Follow-up|2|||
27755003|NCT03299816|54206096|FG001|Phase 2: 12-month Follow-up Period|Lost to Follow-up|3|||
27755004|NCT03291431|54206104|FG000|Overall Study|Protocol Violation|2|||
27755005|NCT03291431|54206105|FG001|Overall Study|Protocol Violation|1|||
27755006|NCT03291431|54206104|FG000|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|1|||
27755007|NCT03291431|54206105|FG001|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|0|||
27755008|NCT03291431|54206104|FG000|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|0|||
27755009|NCT03291431|54206105|FG001|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|1|||
27755010|NCT03288493|54206118|FG000|Overall Study|Withdrawal by Subject|4|||
27755011|NCT03288493|54206119|FG001|Overall Study|Withdrawal by Subject|0|||
27755012|NCT03288493|54206120|FG002|Overall Study|Withdrawal by Subject|0|||
27755013|NCT03288493|54206121|FG003|Overall Study|Withdrawal by Subject|0|||
27755014|NCT03288493|54206122|FG004|Overall Study|Withdrawal by Subject|0|||
27755015|NCT03288493|54206123|FG005|Overall Study|Withdrawal by Subject|2|||
27755016|NCT03288493|54206124|FG006|Overall Study|Withdrawal by Subject|0|||
27755017|NCT03288493|54206118|FG000|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|52|||
27755018|NCT03288493|54206119|FG001|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
27755019|NCT03288493|54206120|FG002|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|1|||
27755020|NCT03288493|54206121|FG003|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|6|||
27755021|NCT03288493|54206122|FG004|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|5|||
27755022|NCT03288493|54206123|FG005|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|10|||
27755023|NCT03288493|54206124|FG006|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
27755024|NCT03288493|54206118|FG000|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|6|||
27755025|NCT03288493|54206119|FG001|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
27755026|NCT03288493|54206120|FG002|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
27755027|NCT03288493|54206121|FG003|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|2|||
27755028|NCT03288493|54206122|FG004|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
27755029|NCT03288493|54206123|FG005|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|4|||
27755030|NCT03288493|54206124|FG006|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
27755031|NCT03288493|54206118|FG000|Overall Study|Death|2|||
27755032|NCT03288493|54206119|FG001|Overall Study|Death|0|||
27755033|NCT03288493|54206120|FG002|Overall Study|Death|0|||
27755034|NCT03288493|54206121|FG003|Overall Study|Death|0|||
27755035|NCT03288493|54206122|FG004|Overall Study|Death|0|||
27755036|NCT03288493|54206123|FG005|Overall Study|Death|0|||
27755037|NCT03288493|54206124|FG006|Overall Study|Death|0|||
27755038|NCT03288493|54206118|FG000|Overall Study|other reason not listed above|2|||
27755039|NCT03288493|54206119|FG001|Overall Study|other reason not listed above|0|||
27755040|NCT03288493|54206120|FG002|Overall Study|other reason not listed above|0|||
27755041|NCT03288493|54206121|FG003|Overall Study|other reason not listed above|0|||
27755042|NCT03288493|54206122|FG004|Overall Study|other reason not listed above|0|||
27755043|NCT03288493|54206123|FG005|Overall Study|other reason not listed above|0|||
27755044|NCT03288493|54206124|FG006|Overall Study|other reason not listed above|0|||
27755045|NCT03238300|54206144|FG000|Baseline (Before Intervention)|Physician Decision|0|||
27755046|NCT03238300|54206145|FG001|Baseline (Before Intervention)|Physician Decision|1|||
27755047|NCT03238300|54206144|FG000|Washout Period (11-Days)|Withdrawal by Subject|1|||
27755048|NCT03238300|54206145|FG001|Washout Period (11-Days)|Withdrawal by Subject|0|||
27755049|NCT03238300|54206144|FG000|Second Intervention (10-Days)|Lost to Follow-up|1|||
27755050|NCT03238300|54206145|FG001|Second Intervention (10-Days)|Lost to Follow-up|0|||
27755051|NCT03238300|54206144|FG000|Second Intervention (10-Days)|Withdrawal by Subject|1|||
27755052|NCT03238300|54206145|FG001|Second Intervention (10-Days)|Withdrawal by Subject|0|||
27755053|NCT03235544|54206159|FG000|Overall Study|Participants Still Ongoing in the Study|1|||
27755054|NCT03235544|54206160|FG001|Overall Study|Participants Still Ongoing in the Study|13|||
27755055|NCT03235544|54206161|FG002|Overall Study|Participants Still Ongoing in the Study|19|||
27755056|NCT03235544|54206162|FG003|Overall Study|Participants Still Ongoing in the Study|55|||
27755057|NCT03235544|54206159|FG000|Overall Study|Death|11|||
27755058|NCT03235544|54206160|FG001|Overall Study|Death|23|||
27755059|NCT03235544|54206161|FG002|Overall Study|Death|11|||
27755060|NCT03235544|54206162|FG003|Overall Study|Death|20|||
27755061|NCT03235544|54206159|FG000|Overall Study|Lost to Follow-up|0|||
27755062|NCT03235544|54206160|FG001|Overall Study|Lost to Follow-up|1|||
27755063|NCT03235544|54206161|FG002|Overall Study|Lost to Follow-up|0|||
27755064|NCT03235544|54206162|FG003|Overall Study|Lost to Follow-up|1|||
27755065|NCT03235544|54206159|FG000|Overall Study|Withdrawal by Participant|0|||
27755066|NCT03235544|54206160|FG001|Overall Study|Withdrawal by Participant|0|||
27755067|NCT03235544|54206161|FG002|Overall Study|Withdrawal by Participant|1|||
27755068|NCT03235544|54206162|FG003|Overall Study|Withdrawal by Participant|0|||
27755069|NCT03235544|54206159|FG000|Overall Study|Reason not Specified|0|||
27755070|NCT03235544|54206160|FG001|Overall Study|Reason not Specified|4|||
27755071|NCT03235544|54206161|FG002|Overall Study|Reason not Specified|0|||
27755072|NCT03235544|54206162|FG003|Overall Study|Reason not Specified|1|||
27755073|NCT03178045|54206175|FG000|Overall Study|Withdrawal by Subject|5|||
27755074|NCT03178045|54206176|FG001|Overall Study|Withdrawal by Subject|7|||
27755075|NCT03178045|54206175|FG000|Overall Study|Surgery Cancelled/Relocated|34|||
27755076|NCT03178045|54206176|FG001|Overall Study|Surgery Cancelled/Relocated|30|||
27755077|NCT03178045|54206175|FG000|Overall Study|Procedure Ineligible Post-Operatively/Pr|47|||
27755078|NCT03178045|54206176|FG001|Overall Study|Procedure Ineligible Post-Operatively/Pr|46|||
27755079|NCT03113500|54206200|FG000|Overall Study|Withdrawal by Subject|1|||
27755080|NCT02927301|54206219|FG000|Overall Study|Adverse Event|7|||
27755081|NCT02927301|54206219|FG000|Overall Study|Withdrawal by Subject|1|||
27755082|NCT02927301|54206219|FG000|Overall Study|Physician Decision|2|||
27755083|NCT02924727|54206225|FG000|Overall Study|Withdrawal by Subject|2|||
27755084|NCT02924727|54206226|FG001|Overall Study|Withdrawal by Subject|4|||
27755085|NCT02924727|54206225|FG000|Overall Study|Lost to Follow-up|2|||
27755086|NCT02924727|54206226|FG001|Overall Study|Lost to Follow-up|5|||
27755087|NCT02924727|54206225|FG000|Overall Study|Death|221|||
27755088|NCT02924727|54206226|FG001|Overall Study|Death|247|||
27755089|NCT02924727|54206225|FG000|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|4|||
27755090|NCT02924727|54206226|FG001|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|3|||
27755091|NCT02901626|54206236|FG000|Overall Study|Lost to Follow-up|1|||
27755092|NCT02901626|54206237|FG001|Overall Study|Lost to Follow-up|1|||
27755093|NCT02720692|54206288|FG000|Overall Study|Withdrawal by Subject|3|||
27755094|NCT02720692|54206289|FG001|Overall Study|Withdrawal by Subject|0|||
27755095|NCT02720692|54206288|FG000|Overall Study|Physician Decision|1|||
27755096|NCT02720692|54206289|FG001|Overall Study|Physician Decision|0|||
27755097|NCT02720692|54206288|FG000|Overall Study|Lost to Follow-up|8|||
27755098|NCT02720692|54206289|FG001|Overall Study|Lost to Follow-up|3|||
27755099|NCT02720692|54206288|FG000|Overall Study|Subject unable to return for visit|1|||
27755100|NCT02720692|54206289|FG001|Overall Study|Subject unable to return for visit|0|||
27755101|NCT02656303|54206298|FG000|Overall Study|Adverse Event|3|||
27755102|NCT02656303|54206299|FG001|Overall Study|Adverse Event|2|||
27755103|NCT02656303|54206300|FG002|Overall Study|Adverse Event|0|||
27755104|NCT02656303|54206298|FG000|Overall Study|Death|12|||
27755105|NCT02656303|54206299|FG001|Overall Study|Death|4|||
27755106|NCT02656303|54206300|FG002|Overall Study|Death|1|||
27755107|NCT02656303|54206298|FG000|Overall Study|Lack of Efficacy|1|||
27755108|NCT02656303|54206299|FG001|Overall Study|Lack of Efficacy|0|||
27755109|NCT02656303|54206300|FG002|Overall Study|Lack of Efficacy|0|||
27755110|NCT02656303|54206298|FG000|Overall Study|Non-Compliance with Study|1|||
27755111|NCT02656303|54206299|FG001|Overall Study|Non-Compliance with Study|1|||
27755112|NCT02656303|54206300|FG002|Overall Study|Non-Compliance with Study|0|||
27839078|NCT01477853|54326119|FG000|Phase B|Study terminated by sponsor|12|||
27839079|NCT01477853|54326120|FG001|Phase B|Study terminated by sponsor|10|||
27755113|NCT02656303|54206298|FG000|Overall Study|Investigator Decision|2|||
27755114|NCT02656303|54206299|FG001|Overall Study|Investigator Decision|1|||
27755115|NCT02656303|54206300|FG002|Overall Study|Investigator Decision|0|||
27755116|NCT02656303|54206298|FG000|Overall Study|Progressive Disease|25|||
27755117|NCT02656303|54206299|FG001|Overall Study|Progressive Disease|14|||
27755118|NCT02656303|54206300|FG002|Overall Study|Progressive Disease|10|||
27755119|NCT02656303|54206298|FG000|Overall Study|Study Terminated by Sponsor|20|||
27755120|NCT02656303|54206299|FG001|Overall Study|Study Terminated by Sponsor|7|||
27755121|NCT02656303|54206300|FG002|Overall Study|Study Terminated by Sponsor|5|||
27755122|NCT02656303|54206298|FG000|Overall Study|Withdrawal of Consent by Participants|1|||
27755123|NCT02656303|54206299|FG001|Overall Study|Withdrawal of Consent by Participants|1|||
27755124|NCT02656303|54206300|FG002|Overall Study|Withdrawal of Consent by Participants|0|||
27755125|NCT02656303|54206298|FG000|Overall Study|Initiation of Non-protocol Intervention|1|||
27755126|NCT02656303|54206299|FG001|Overall Study|Initiation of Non-protocol Intervention|0|||
27755127|NCT02656303|54206300|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
27755128|NCT02656303|54206298|FG000|Overall Study|Reason not Specified|1|||
27755129|NCT02656303|54206299|FG001|Overall Study|Reason not Specified|1|||
27755130|NCT02656303|54206300|FG002|Overall Study|Reason not Specified|2|||
27755131|NCT02628626|54206310|FG000|Overall Study|Withdrawal by Subject|2|||
27755132|NCT02628626|54206311|FG001|Overall Study|Withdrawal by Subject|2|||
27755133|NCT02527707|54206343|FG000|Overall Study|Adverse Event|1|||
27755134|NCT02527707|54206343|FG000|Overall Study|Adverse Event|1|||
27755135|NCT02453191|54206354|FG000|Overall Study|Withdrawal by Subject|1|||
27755136|NCT02352090|54206362|FG000|Overall Study|general malaise|1|||
27755137|NCT02352090|54206363|FG001|Overall Study|general malaise|0|||
27755138|NCT02352090|54206364|FG002|Overall Study|general malaise|0|||
27755139|NCT02352090|54206362|FG000|Overall Study|non-specified mild side-effects|0|||
27755140|NCT02352090|54206363|FG001|Overall Study|non-specified mild side-effects|0|||
27755141|NCT02352090|54206364|FG002|Overall Study|non-specified mild side-effects|2|||
27755142|NCT02294461|54206374|FG000|Double-blind Period (up to 29.4 Months)|Death|6|||
27755143|NCT02294461|54206375|FG001|Double-blind Period (up to 29.4 Months)|Death|4|||
27755144|NCT02294461|54206374|FG000|Double-blind Period (up to 29.4 Months)|Miscellaneous|30|||
27755145|NCT02294461|54206375|FG001|Double-blind Period (up to 29.4 Months)|Miscellaneous|66|||
27755146|NCT02294461|54206374|FG000|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|27|||
27755147|NCT02294461|54206375|FG001|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|54|||
27755148|NCT02294461|54206374|FG000|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
27755149|NCT02294461|54206375|FG001|Double-blind Period (up to 29.4 Months)|Protocol Deviation|2|||
27755150|NCT02294461|54206374|FG000|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|1|||
27755151|NCT02294461|54206375|FG001|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
27755152|NCT02294461|54206374|FG000|Double-blind Period (up to 29.4 Months)|Progressive Disease|38|||
27755153|NCT02294461|54206375|FG001|Double-blind Period (up to 29.4 Months)|Progressive Disease|51|||
27755154|NCT02294461|54206374|FG000|Double-blind Period (up to 29.4 Months)|Adverse Event|16|||
27755155|NCT02294461|54206375|FG001|Double-blind Period (up to 29.4 Months)|Adverse Event|15|||
27755156|NCT02294461|54206374|FG000|Open-label Period (up to 54.3 Months)|Ongoing|19|||
27755157|NCT02294461|54206375|FG001|Open-label Period (up to 54.3 Months)|Ongoing|9|||
27755158|NCT02294461|54206374|FG000|Open-label Period (up to 54.3 Months)|Miscellaneous|16|||
27755159|NCT02294461|54206375|FG001|Open-label Period (up to 54.3 Months)|Miscellaneous|12|||
27755160|NCT02294461|54206374|FG000|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|18|||
27755161|NCT02294461|54206375|FG001|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|9|||
27755162|NCT02294461|54206374|FG000|Open-label Period (up to 54.3 Months)|Protocol Deviation|2|||
27755163|NCT02294461|54206375|FG001|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
27755164|NCT02294461|54206374|FG000|Open-label Period (up to 54.3 Months)|Lost to Follow-up|3|||
27755165|NCT02294461|54206375|FG001|Open-label Period (up to 54.3 Months)|Lost to Follow-up|1|||
27755166|NCT02294461|54206374|FG000|Open-label Period (up to 54.3 Months)|Progressive Disease|15|||
27755167|NCT02294461|54206375|FG001|Open-label Period (up to 54.3 Months)|Progressive Disease|9|||
27755168|NCT02294461|54206374|FG000|Open-label Period (up to 54.3 Months)|Death|6|||
27755169|NCT02294461|54206375|FG001|Open-label Period (up to 54.3 Months)|Death|5|||
27755170|NCT02294461|54206374|FG000|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
27755171|NCT02294461|54206375|FG001|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
27755172|NCT02135107|54206395|FG000|Treatment Period|Withdrawal by Subject|11|||
27755173|NCT02135107|54206396|FG001|Treatment Period|Withdrawal by Subject|0|||
27755174|NCT02135107|54206397|FG002|Treatment Period|Withdrawal by Subject|0|||
27755175|NCT02135107|54206398|FG003|Treatment Period|Withdrawal by Subject|0|||
27755176|NCT02135107|54206395|FG000|Treatment Period|Adverse Event|5|||
27755177|NCT02135107|54206396|FG001|Treatment Period|Adverse Event|2|||
27839080|NCT01477853|54326121|FG002|Phase B|Study terminated by sponsor|11|||
27755178|NCT02135107|54206397|FG002|Treatment Period|Adverse Event|0|||
27755179|NCT02135107|54206398|FG003|Treatment Period|Adverse Event|0|||
27839081|NCT01511419|54326153|FG000|Dose 2|Physician Decision|1|||
27839082|NCT01511419|54326154|FG001|Dose 2|Physician Decision|0|||
27839083|NCT01511107|54326216|FG000|Overall Study|Ineligible|3|||
27839084|NCT01511107|54326217|FG001|Overall Study|Ineligible|2|||
27755180|NCT02135107|54206395|FG000|Treatment Period|Pregnancy|1|||
27755181|NCT02135107|54206396|FG001|Treatment Period|Pregnancy|0|||
27755182|NCT02135107|54206397|FG002|Treatment Period|Pregnancy|0|||
27755183|NCT02135107|54206398|FG003|Treatment Period|Pregnancy|0|||
27755184|NCT02135107|54206395|FG000|Treatment Period|Other|115|||
27755185|NCT02135107|54206396|FG001|Treatment Period|Other|24|||
27755186|NCT02135107|54206397|FG002|Treatment Period|Other|0|||
27755187|NCT02135107|54206398|FG003|Treatment Period|Other|0|||
27755188|NCT02135107|54206395|FG000|Maintenance Therapy Period|Adverse Event|0|||
27755189|NCT02135107|54206396|FG001|Maintenance Therapy Period|Adverse Event|0|||
27755190|NCT02135107|54206397|FG002|Maintenance Therapy Period|Adverse Event|3|||
27755191|NCT02135107|54206398|FG003|Maintenance Therapy Period|Adverse Event|7|||
27755192|NCT02135107|54206395|FG000|Maintenance Therapy Period|Withdrawal by Subject|0|||
27755193|NCT02135107|54206396|FG001|Maintenance Therapy Period|Withdrawal by Subject|0|||
27755194|NCT02135107|54206397|FG002|Maintenance Therapy Period|Withdrawal by Subject|5|||
27755195|NCT02135107|54206398|FG003|Maintenance Therapy Period|Withdrawal by Subject|4|||
27755196|NCT02135107|54206395|FG000|Maintenance Therapy Period|Pregnancy|0|||
27755197|NCT02135107|54206396|FG001|Maintenance Therapy Period|Pregnancy|0|||
27755198|NCT02135107|54206397|FG002|Maintenance Therapy Period|Pregnancy|0|||
27755199|NCT02135107|54206398|FG003|Maintenance Therapy Period|Pregnancy|1|||
27755200|NCT02135107|54206395|FG000|Maintenance Therapy Period|Other|0|||
27755201|NCT02135107|54206396|FG001|Maintenance Therapy Period|Other|0|||
27755202|NCT02135107|54206397|FG002|Maintenance Therapy Period|Other|7|||
27755203|NCT02135107|54206398|FG003|Maintenance Therapy Period|Other|8|||
27755204|NCT02030847|54206410|FG000|Overall Study|Death|10|||
27755205|NCT02030847|54206410|FG000|Overall Study|Disease Progression|15|||
27755206|NCT02030847|54206410|FG000|Overall Study|New Cancer Therapy|8|||
27755207|NCT02030847|54206410|FG000|Overall Study|Physician Decision|3|||
27755208|NCT02030847|54206410|FG000|Overall Study|Withdrawal by Subject|1|||
27755209|NCT02030834|54206418|FG000|Overall Study|Death|4|||
27755210|NCT02030834|54206419|FG001|Overall Study|Death|0|||
27755211|NCT02030834|54206420|FG002|Overall Study|Death|0|||
27755212|NCT02030834|54206418|FG000|Overall Study|Manufacturing failure|2|||
27755213|NCT02030834|54206419|FG001|Overall Study|Manufacturing failure|0|||
27755214|NCT02030834|54206420|FG002|Overall Study|Manufacturing failure|1|||
27755215|NCT02030834|54206418|FG000|Overall Study|Disease progression|2|||
27755216|NCT02030834|54206419|FG001|Overall Study|Disease progression|0|||
27755217|NCT02030834|54206420|FG002|Overall Study|Disease progression|2|||
27755218|NCT02030834|54206418|FG000|Overall Study|Lost to Follow-up|1|||
27755219|NCT02030834|54206419|FG001|Overall Study|Lost to Follow-up|0|||
27755220|NCT02030834|54206420|FG002|Overall Study|Lost to Follow-up|0|||
27755221|NCT02030834|54206418|FG000|Overall Study|Withdrawal by Subject|1|||
27755222|NCT02030834|54206419|FG001|Overall Study|Withdrawal by Subject|0|||
27755223|NCT02030834|54206420|FG002|Overall Study|Withdrawal by Subject|0|||
27755224|NCT02030834|54206418|FG000|Overall Study|Lack of funding|1|||
27755225|NCT02030834|54206419|FG001|Overall Study|Lack of funding|0|||
27755226|NCT02030834|54206420|FG002|Overall Study|Lack of funding|0|||
27755227|NCT02025010|54206428|FG000|Overall Study|Symptomatic or radiographic progression|36|||
27755228|NCT02025010|54206428|FG000|Overall Study|Adverse Event|6|||
27755229|NCT02025010|54206428|FG000|Overall Study|Physician Decision|7|||
27755230|NCT02025010|54206428|FG000|Overall Study|Withdrawal by Subject|3|||
27755231|NCT02025010|54206428|FG000|Overall Study|Intercurrent illness|3|||
27755232|NCT02025010|54206428|FG000|Overall Study|Patients still on treatment|3|||
27755233|NCT02025010|54206428|FG000|Overall Study|Never initiate the treatment|2|||
27755234|NCT01982448|54206436|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
27755235|NCT01982448|54206437|FG001|Preoperative Chemotherapy|Withdrawal by Subject|2|||
27755236|NCT01982448|54206436|FG000|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|1|||
27755237|NCT01982448|54206437|FG001|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|0|||
27755238|NCT01982448|54206436|FG000|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|0|||
27755239|NCT01982448|54206437|FG001|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|2|||
27839085|NCT01511107|54326216|FG000|Overall Study|Lost to Follow-up|10|||
27755240|NCT01982448|54206436|FG000|Preoperative Chemotherapy|Lost to Follow-up|0|||
27755241|NCT01982448|54206437|FG001|Preoperative Chemotherapy|Lost to Follow-up|1|||
27755242|NCT01844986|54206449|FG000|Overall Study (Global Cohort)|Severe non-compliance to protocol|1|||
27755243|NCT01844986|54206450|FG001|Overall Study (Global Cohort)|Severe non-compliance to protocol|0|||
27755244|NCT01844986|54206449|FG000|Overall Study (Global Cohort)|Withdrawal by Subject|21|||
27755245|NCT01844986|54206450|FG001|Overall Study (Global Cohort)|Withdrawal by Subject|14|||
27755246|NCT01844986|54206449|FG000|Overall Study (Global Cohort)|Death|55|||
27755247|NCT01844986|54206450|FG001|Overall Study (Global Cohort)|Death|26|||
27755248|NCT01844986|54206449|FG000|Overall Study (China Cohort)|Withdrawal by Subject|1|||
27755249|NCT01844986|54206450|FG001|Overall Study (China Cohort)|Withdrawal by Subject|0|||
27755250|NCT01844986|54206449|FG000|Overall Study (China Cohort)|Death|10|||
27755251|NCT01844986|54206450|FG001|Overall Study (China Cohort)|Death|6|||
27755252|NCT01773421|54206464|FG000|Treatment Phase|Other|0|||
27755253|NCT01773421|54206465|FG001|Treatment Phase|Other|0|||
27755254|NCT01773421|54206466|FG002|Treatment Phase|Other|2|||
27755255|NCT01773421|54206467|FG003|Treatment Phase|Other|0|||
27755256|NCT01773421|54206468|FG004|Treatment Phase|Other|0|||
27755257|NCT01773421|54206469|FG005|Treatment Phase|Other|0|||
27755258|NCT01773421|54206470|FG006|Treatment Phase|Other|0|||
27755259|NCT01773421|54206464|FG000|Treatment Phase|Adverse Event|0|||
27755260|NCT01773421|54206465|FG001|Treatment Phase|Adverse Event|0|||
27755261|NCT01773421|54206466|FG002|Treatment Phase|Adverse Event|3|||
27755262|NCT01773421|54206467|FG003|Treatment Phase|Adverse Event|1|||
27755263|NCT01773421|54206468|FG004|Treatment Phase|Adverse Event|0|||
27755264|NCT01773421|54206469|FG005|Treatment Phase|Adverse Event|0|||
27755265|NCT01773421|54206470|FG006|Treatment Phase|Adverse Event|0|||
27755266|NCT01773421|54206464|FG000|Treatment Phase|Withdrawal by Subject|0|||
27755267|NCT01773421|54206465|FG001|Treatment Phase|Withdrawal by Subject|0|||
27755268|NCT01773421|54206466|FG002|Treatment Phase|Withdrawal by Subject|1|||
27755269|NCT01773421|54206467|FG003|Treatment Phase|Withdrawal by Subject|1|||
27755270|NCT01773421|54206468|FG004|Treatment Phase|Withdrawal by Subject|0|||
27755271|NCT01773421|54206469|FG005|Treatment Phase|Withdrawal by Subject|0|||
27755272|NCT01773421|54206470|FG006|Treatment Phase|Withdrawal by Subject|0|||
27755273|NCT01773421|54206464|FG000|Extension Phase|Other|0|||
27755274|NCT01773421|54206465|FG001|Extension Phase|Other|0|||
27755275|NCT01773421|54206466|FG002|Extension Phase|Other|0|||
27755276|NCT01773421|54206467|FG003|Extension Phase|Other|0|||
27755277|NCT01773421|54206468|FG004|Extension Phase|Other|1|||
27755278|NCT01773421|54206469|FG005|Extension Phase|Other|2|||
27755279|NCT01773421|54206470|FG006|Extension Phase|Other|0|||
27755280|NCT01773421|54206464|FG000|Extension Phase|Adverse Event|0|||
27755281|NCT01773421|54206465|FG001|Extension Phase|Adverse Event|0|||
27755282|NCT01773421|54206466|FG002|Extension Phase|Adverse Event|0|||
27755283|NCT01773421|54206467|FG003|Extension Phase|Adverse Event|0|||
27755284|NCT01773421|54206468|FG004|Extension Phase|Adverse Event|2|||
27755285|NCT01773421|54206469|FG005|Extension Phase|Adverse Event|0|||
27755286|NCT01773421|54206470|FG006|Extension Phase|Adverse Event|0|||
27926920|NCT01217463|54583397|FG000|Overall Study|Withdrawal by Subject|3|||
27926921|NCT01217463|54583398|FG001|Overall Study|Withdrawal by Subject|0|||
27926922|NCT01217463|54583397|FG000|Overall Study|Surgery on the Target Limb|0|||
27926923|NCT01217463|54583398|FG001|Overall Study|Surgery on the Target Limb|1|||
27926924|NCT01217463|54583397|FG000|Overall Study|Patient Non-compliant|1|||
27926925|NCT01217463|54583398|FG001|Overall Study|Patient Non-compliant|0|||
27926926|NCT01217463|54583397|FG000|Overall Study|Other|1|||
27926927|NCT01217463|54583398|FG001|Overall Study|Other|1|||
27839086|NCT01511107|54326217|FG001|Overall Study|Lost to Follow-up|19|||
27839087|NCT01511107|54326216|FG000|Overall Study|Withdrawal by Subject|9|||
27839088|NCT01511107|54326217|FG001|Overall Study|Withdrawal by Subject|20|||
27839089|NCT01484977|54326252|FG000|Overall Study|Adverse Event|8|||
27839090|NCT01484977|54326252|FG000|Overall Study|Lack of Efficacy|4|||
27839091|NCT01484977|54326252|FG000|Overall Study|Protocol Violation|6|||
27839092|NCT01484977|54326252|FG000|Overall Study|Lost to Follow-up|1|||
27839093|NCT01484977|54326252|FG000|Overall Study|Withdrawal by Subject|4|||
27839094|NCT01484977|54326252|FG000|Overall Study|Subject Protocol Non-compliant|1|||
27839095|NCT01484977|54326252|FG000|Overall Study|Moving Overseas|1|||
27839096|NCT01484977|54326252|FG000|Overall Study|Low White Blood Cell Count|1|||
27839097|NCT01484977|54326252|FG000|Overall Study|Lack of Compliance|1|||
27839098|NCT01475825|54326332|FG000|Overall Study|Adverse Event|41|||
27839099|NCT01475825|54326333|FG001|Overall Study|Adverse Event|15|||
27839100|NCT01475825|54326334|FG002|Overall Study|Adverse Event|27|||
27839101|NCT01475825|54326335|FG003|Overall Study|Adverse Event|11|||
27839102|NCT01475825|54326332|FG000|Overall Study|Death|1|||
27839103|NCT01475825|54326333|FG001|Overall Study|Death|0|||
27926928|NCT01217307|54583408|FG000|Overall Study|Withdrawal by Subject|0|||
27926929|NCT01217307|54583409|FG001|Overall Study|Withdrawal by Subject|1|||
27926930|NCT01217229|54583415|FG000|Overall Study|Adverse Event|1|||
27755299|NCT01747486|54206497|FG000|Stage 1|Physician Decision|3|||
27755300|NCT01747486|54206498|FG001|Stage 1|Physician Decision|0|||
27839104|NCT01475825|54326334|FG002|Overall Study|Death|1|||
27839105|NCT01475825|54326335|FG003|Overall Study|Death|0|||
27839106|NCT01475825|54326332|FG000|Overall Study|Lack of Efficacy|0|||
27839107|NCT01475825|54326333|FG001|Overall Study|Lack of Efficacy|0|||
27755301|NCT01747486|54206497|FG000|Stage 1|Withdrawal by Subject|4|||
27755302|NCT01747486|54206498|FG001|Stage 1|Withdrawal by Subject|3|||
27755303|NCT01747486|54206497|FG000|Stage 1|Disease progression|4|||
27755304|NCT01747486|54206498|FG001|Stage 1|Disease progression|9|||
27755305|NCT01747486|54206497|FG000|Stage 1|Death|1|||
27755306|NCT01747486|54206498|FG001|Stage 1|Death|1|||
27755307|NCT01747486|54206497|FG000|Stage 2|Physician Decision|2|||
27755308|NCT01747486|54206498|FG001|Stage 2|Physician Decision|0|||
27755309|NCT01747486|54206497|FG000|Stage 2|Withdrawal by Subject|1|||
27755310|NCT01747486|54206498|FG001|Stage 2|Withdrawal by Subject|0|||
27755311|NCT01747486|54206497|FG000|Stage 2|New Cancer Therapy|3|||
27755312|NCT01747486|54206498|FG001|Stage 2|New Cancer Therapy|0|||
27755313|NCT01747486|54206497|FG000|Stage 2|Disease Progression|3|||
27755314|NCT01747486|54206498|FG001|Stage 2|Disease Progression|0|||
27755315|NCT01659151|54206508|FG000|Overall Study|Inadequate TIL growth|1|||
27755316|NCT01593254|54206514|FG000|Overall Study|Disease progression|2|||
27755317|NCT01593254|54206515|FG001|Overall Study|Disease progression|7|||
27755318|NCT01593254|54206514|FG000|Overall Study|Study drug toxicity|6|||
27755319|NCT01593254|54206515|FG001|Overall Study|Study drug toxicity|20|||
27755320|NCT01593254|54206514|FG000|Overall Study|Death|3|||
27755321|NCT01593254|54206515|FG001|Overall Study|Death|3|||
27755322|NCT01593254|54206514|FG000|Overall Study|AE unrelated to study drug|0|||
27755323|NCT01593254|54206515|FG001|Overall Study|AE unrelated to study drug|1|||
27755324|NCT01593254|54206514|FG000|Overall Study|participant request to discontinue study treatment|1|||
27755325|NCT01593254|54206515|FG001|Overall Study|participant request to discontinue study treatment|3|||
27755326|NCT01593254|54206514|FG000|Overall Study|participant withdrew consent|0|||
27755327|NCT01593254|54206515|FG001|Overall Study|participant withdrew consent|9|||
27755328|NCT01593254|54206514|FG000|Overall Study|lost to follow up|1|||
27755329|NCT01593254|54206515|FG001|Overall Study|lost to follow up|6|||
27755330|NCT01593254|54206514|FG000|Overall Study|maximum clinical benefit|1|||
27755331|NCT01593254|54206515|FG001|Overall Study|maximum clinical benefit|2|||
27755332|NCT01593254|54206514|FG000|Overall Study|Poor/non compliance|1|||
27755333|NCT01593254|54206515|FG001|Overall Study|Poor/non compliance|1|||
27755334|NCT01593254|54206514|FG000|Overall Study|Pregnancy|0|||
27755335|NCT01593254|54206515|FG001|Overall Study|Pregnancy|3|||
27755336|NCT01593254|54206514|FG000|Overall Study|participant no longer meets study criteria|1|||
27755337|NCT01593254|54206515|FG001|Overall Study|participant no longer meets study criteria|1|||
27755338|NCT01593254|54206514|FG000|Overall Study|Admin reason by sponsor|7|||
27755339|NCT01593254|54206515|FG001|Overall Study|Admin reason by sponsor|3|||
27755340|NCT01593254|54206514|FG000|Overall Study|Imatinib treatment failure|2|||
27755341|NCT01593254|54206515|FG001|Overall Study|Imatinib treatment failure|0|||
27755342|NCT01593254|54206514|FG000|Overall Study|Other Reasons|61|||
27755343|NCT01593254|54206515|FG001|Overall Study|Other Reasons|115|||
27755344|NCT01559818|54206522|FG000|Overall Study|Physician Decision|1|||
27755345|NCT01559818|54206522|FG000|Overall Study|Pregnancy|1|||
27755346|NCT01559818|54206522|FG000|Overall Study|Study terminated by Sponsor|4|||
27755347|NCT01559818|54206522|FG000|Overall Study|Withdrawal by Subject|1|||
27755348|NCT01454934|54206529|FG000|Overall Study|Clinical progression|28|||
27755349|NCT01454934|54206530|FG001|Overall Study|Clinical progression|25|||
27755350|NCT01454934|54206529|FG000|Overall Study|Other|6|||
27755351|NCT01454934|54206530|FG001|Overall Study|Other|17|||
27755352|NCT01454934|54206529|FG000|Overall Study|Adverse Event|28|||
27755353|NCT01454934|54206530|FG001|Overall Study|Adverse Event|24|||
27755354|NCT01454934|54206529|FG000|Overall Study|Withdrawn consent|2|||
27755355|NCT01454934|54206530|FG001|Overall Study|Withdrawn consent|5|||
27755356|NCT01454934|54206529|FG000|Overall Study|Withdrawal by Subject|11|||
27755357|NCT01454934|54206530|FG001|Overall Study|Withdrawal by Subject|15|||
27755358|NCT01454934|54206529|FG000|Overall Study|Disease progression|194|||
27755359|NCT01454934|54206530|FG001|Overall Study|Disease progression|181|||
27755360|NCT01454934|54206529|FG000|Overall Study|Lost to Follow-up|0|||
27755361|NCT01454934|54206530|FG001|Overall Study|Lost to Follow-up|1|||
27755362|NCT01454934|54206529|FG000|Overall Study|Not treated|1|||
27755363|NCT01454934|54206530|FG001|Overall Study|Not treated|2|||
27755364|NCT01439282|54206538|FG000|Overall Study|Adverse Event|5|||
27755365|NCT01439282|54206539|FG001|Overall Study|Adverse Event|0|||
27755366|NCT01439282|54206538|FG000|Overall Study|Withdrawal by Subject|2|||
27755367|NCT01439282|54206539|FG001|Overall Study|Withdrawal by Subject|0|||
27755368|NCT01439282|54206538|FG000|Overall Study|Other|1|||
27755369|NCT01439282|54206539|FG001|Overall Study|Other|1|||
27755370|NCT01326312|54206549|FG000|Overall Study|Adverse Event|11|||
27755371|NCT01326312|54206550|FG001|Overall Study|Adverse Event|11|||
27755372|NCT01326312|54206551|FG002|Overall Study|Adverse Event|1|||
27755373|NCT01326312|54206549|FG000|Overall Study|Withdrawal by Subject|1|||
27755374|NCT01326312|54206550|FG001|Overall Study|Withdrawal by Subject|2|||
27755375|NCT01326312|54206551|FG002|Overall Study|Withdrawal by Subject|1|||
27755376|NCT01326312|54206549|FG000|Overall Study|Protocol Violation|0|||
27755377|NCT01326312|54206550|FG001|Overall Study|Protocol Violation|1|||
27755378|NCT01326312|54206551|FG002|Overall Study|Protocol Violation|0|||
27755379|NCT01326312|54206549|FG000|Overall Study|Lack of Efficacy|13|||
27755380|NCT01326312|54206550|FG001|Overall Study|Lack of Efficacy|7|||
27755381|NCT01326312|54206551|FG002|Overall Study|Lack of Efficacy|1|||
27755382|NCT01326312|54206549|FG000|Overall Study|Death|1|||
27755383|NCT01326312|54206550|FG001|Overall Study|Death|0|||
27755384|NCT01326312|54206551|FG002|Overall Study|Death|1|||
27755385|NCT01326312|54206549|FG000|Overall Study|progressive disease|0|||
27755386|NCT01326312|54206550|FG001|Overall Study|progressive disease|1|||
27755387|NCT01326312|54206551|FG002|Overall Study|progressive disease|1|||
27755388|NCT01326312|54206549|FG000|Overall Study|Study terminated by Sponsor|8|||
27755389|NCT01326312|54206550|FG001|Overall Study|Study terminated by Sponsor|32|||
27755390|NCT01326312|54206551|FG002|Overall Study|Study terminated by Sponsor|46|||
27755391|NCT01326312|54206549|FG000|Overall Study|Treatment arm terminated|19|||
27755392|NCT01326312|54206550|FG001|Overall Study|Treatment arm terminated|0|||
27755393|NCT01326312|54206551|FG002|Overall Study|Treatment arm terminated|0|||
27755394|NCT01326312|54206549|FG000|Overall Study|QTc > 500|0|||
27755395|NCT01326312|54206550|FG001|Overall Study|QTc > 500|1|||
27755396|NCT01326312|54206551|FG002|Overall Study|QTc > 500|0|||
27755397|NCT01269346|54206573|FG000|Treatment Phase|Disease progression|3|||
27755398|NCT01269346|54206573|FG000|Treatment Phase|Adverse Event|3|||
27755399|NCT01269346|54206573|FG000|Treatment Phase|Withdrawal by Subject|1|||
27755400|NCT01269346|54206573|FG000|Treatment Phase|Other|2|||
27755401|NCT01269346|54206573|FG000|Extension Phase|Adverse Event|6|||
27755402|NCT01269346|54206573|FG000|Extension Phase|Withdrawal by Subject|4|||
27755403|NCT01269346|54206573|FG000|Extension Phase|Disease progression|22|||
27755404|NCT01269346|54206573|FG000|Extension Phase|Physician decision or participant choice|9|||
27755405|NCT01269346|54206573|FG000|Extension Phase|Clinical progression|1|||
27755406|NCT01269346|54206573|FG000|Extension Phase|Started a prohibited con med|1|||
27755407|NCT01268293|54206578|FG000|Overall Study|Disease progression|7|||
27755408|NCT01268293|54206578|FG000|Overall Study|Adverse Event|1|||
27755409|NCT01268293|54206578|FG000|Overall Study|Subject choice|1|||
27755410|NCT01268150|54206582|FG000|Treatment Phase|Progression of disease|18|||
27755411|NCT01268150|54206582|FG000|Treatment Phase|Adverse Event|3|||
27755412|NCT01268150|54206582|FG000|Treatment Phase|Withdrawal by Subject|3|||
27755413|NCT01268150|54206582|FG000|Treatment Phase|Other|4|||
27755414|NCT01268150|54206582|FG000|Extension Phase|Adverse Event|3|||
27755415|NCT01268150|54206582|FG000|Extension Phase|Disease progression|18|||
27755416|NCT01268150|54206582|FG000|Extension Phase|Other|6|||
27755417|NCT01267175|54206586|FG000|Overall Study|Withdrawal by Subject|1|||
27755418|NCT01267175|54206586|FG000|Overall Study|Lost to Follow-up|1|||
27755419|NCT01133756|54206597|FG000|Overall Study|Adverse Event|1|||
27755420|NCT01133756|54206598|FG001|Overall Study|Adverse Event|2|||
27755421|NCT01133756|54206599|FG002|Overall Study|Adverse Event|1|||
27755422|NCT01133756|54206597|FG000|Overall Study|Investigator Decision|1|||
27755423|NCT01133756|54206598|FG001|Overall Study|Investigator Decision|0|||
27839108|NCT01475825|54326334|FG002|Overall Study|Lack of Efficacy|1|||
27839109|NCT01475825|54326335|FG003|Overall Study|Lack of Efficacy|0|||
27755424|NCT01133756|54206599|FG002|Overall Study|Investigator Decision|0|||
27755425|NCT01133756|54206597|FG000|Overall Study|Withdrawal by Subject|0|||
27755426|NCT01133756|54206598|FG001|Overall Study|Withdrawal by Subject|1|||
27755427|NCT01133756|54206599|FG002|Overall Study|Withdrawal by Subject|0|||
27755428|NCT01133756|54206597|FG000|Overall Study|Progression of Disease|0|||
27755429|NCT01133756|54206598|FG001|Overall Study|Progression of Disease|0|||
27755430|NCT01133756|54206599|FG002|Overall Study|Progression of Disease|1|||
27755431|NCT01126736|54206612|FG000|Overall Study|Death|2|||
27755432|NCT01126736|54206613|FG001|Overall Study|Death|2|||
27755433|NCT01126736|54206614|FG002|Overall Study|Death|1|||
27839110|NCT01475825|54326332|FG000|Overall Study|Lost to Follow-up|0|||
27839111|NCT01475825|54326333|FG001|Overall Study|Lost to Follow-up|0|||
27839112|NCT01475825|54326334|FG002|Overall Study|Lost to Follow-up|3|||
27839113|NCT01475825|54326335|FG003|Overall Study|Lost to Follow-up|1|||
27839114|NCT01475825|54326332|FG000|Overall Study|Non-compliance with Study Drug|1|||
27839115|NCT01475825|54326333|FG001|Overall Study|Non-compliance with Study Drug|2|||
27839116|NCT01475825|54326334|FG002|Overall Study|Non-compliance with Study Drug|4|||
27839117|NCT01475825|54326335|FG003|Overall Study|Non-compliance with Study Drug|0|||
27839118|NCT01475825|54326332|FG000|Overall Study|Other: Not available|0|||
27839119|NCT01475825|54326333|FG001|Overall Study|Other: Not available|0|||
27839120|NCT01475825|54326334|FG002|Overall Study|Other: Not available|2|||
27839121|NCT01475825|54326335|FG003|Overall Study|Other: Not available|0|||
27839122|NCT01475825|54326332|FG000|Overall Study|Protocol Violation|1|||
27839123|NCT01475825|54326333|FG001|Overall Study|Protocol Violation|0|||
27839124|NCT01475825|54326334|FG002|Overall Study|Protocol Violation|0|||
27839125|NCT01475825|54326335|FG003|Overall Study|Protocol Violation|0|||
27839126|NCT01475825|54326332|FG000|Overall Study|Physician Decision|0|||
27839127|NCT01475825|54326333|FG001|Overall Study|Physician Decision|1|||
27839128|NCT01475825|54326334|FG002|Overall Study|Physician Decision|0|||
27839129|NCT01475825|54326335|FG003|Overall Study|Physician Decision|0|||
27839130|NCT01475825|54326332|FG000|Overall Study|Withdrawal by Subject|8|||
27839131|NCT01475825|54326333|FG001|Overall Study|Withdrawal by Subject|3|||
27839132|NCT01475825|54326334|FG002|Overall Study|Withdrawal by Subject|11|||
27839133|NCT01475825|54326335|FG003|Overall Study|Withdrawal by Subject|7|||
27839134|NCT01475825|54326332|FG000|Overall Study|Did not enter OLC|15|||
27839135|NCT01475825|54326333|FG001|Overall Study|Did not enter OLC|11|||
27755434|NCT01126736|54206615|FG003|Overall Study|Death|19|||
27755435|NCT01126736|54206616|FG004|Overall Study|Death|19|||
27755436|NCT01126736|54206612|FG000|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
27755437|NCT01126736|54206613|FG001|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
27755438|NCT01126736|54206614|FG002|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
27755439|NCT01126736|54206615|FG003|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
27755440|NCT01126736|54206616|FG004|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
27755441|NCT01126736|54206612|FG000|Overall Study|Lost to Follow-up|0|||
27755442|NCT01126736|54206613|FG001|Overall Study|Lost to Follow-up|0|||
27755443|NCT01126736|54206614|FG002|Overall Study|Lost to Follow-up|0|||
27755444|NCT01126736|54206615|FG003|Overall Study|Lost to Follow-up|1|||
27755445|NCT01126736|54206616|FG004|Overall Study|Lost to Follow-up|1|||
27755446|NCT01126736|54206612|FG000|Overall Study|Administrative reasons|0|||
27755447|NCT01126736|54206613|FG001|Overall Study|Administrative reasons|0|||
27755448|NCT01126736|54206614|FG002|Overall Study|Administrative reasons|0|||
27755449|NCT01126736|54206615|FG003|Overall Study|Administrative reasons|0|||
27755450|NCT01126736|54206616|FG004|Overall Study|Administrative reasons|1|||
27755451|NCT01126736|54206612|FG000|Overall Study|Progressive disease|0|||
27755452|NCT01126736|54206613|FG001|Overall Study|Progressive disease|0|||
27755453|NCT01126736|54206614|FG002|Overall Study|Progressive disease|0|||
27755454|NCT01126736|54206615|FG003|Overall Study|Progressive disease|2|||
27755455|NCT01126736|54206616|FG004|Overall Study|Progressive disease|1|||
27755456|NCT01126736|54206612|FG000|Overall Study|Withdrawal by Subject|0|||
27755457|NCT01126736|54206613|FG001|Overall Study|Withdrawal by Subject|0|||
27755458|NCT01126736|54206614|FG002|Overall Study|Withdrawal by Subject|0|||
27755459|NCT01126736|54206615|FG003|Overall Study|Withdrawal by Subject|1|||
27755460|NCT01126736|54206616|FG004|Overall Study|Withdrawal by Subject|1|||
27755461|NCT01126736|54206612|FG000|Overall Study|Other|2|||
27755462|NCT01126736|54206613|FG001|Overall Study|Other|4|||
27755463|NCT01126736|54206614|FG002|Overall Study|Other|4|||
27755464|NCT01126736|54206615|FG003|Overall Study|Other|16|||
27755465|NCT01126736|54206616|FG004|Overall Study|Other|15|||
27755466|NCT01111461|54206628|FG000|Overall Study|Adverse Event|32|||
27755467|NCT01111461|54206628|FG000|Overall Study|Participant choice|11|||
27755468|NCT01111461|54206628|FG000|Overall Study|Lost to Follow-up|1|||
27755469|NCT01111461|54206628|FG000|Overall Study|Withdrawal by Subject|1|||
27755470|NCT01111461|54206628|FG000|Overall Study|Other|6|||
27755471|NCT01104155|54206634|FG000|Overall Study|Adverse Event|15|||
27755472|NCT01104155|54206635|FG001|Overall Study|Adverse Event|8|||
27839136|NCT01475825|54326334|FG002|Overall Study|Did not enter OLC|15|||
27839137|NCT01475825|54326335|FG003|Overall Study|Did not enter OLC|11|||
27755473|NCT01104155|54206634|FG000|Overall Study|Participant choice|6|||
27755474|NCT01104155|54206635|FG001|Overall Study|Participant choice|5|||
27755475|NCT01104155|54206634|FG000|Overall Study|Withdrawal of consent|1|||
27755476|NCT01104155|54206635|FG001|Overall Study|Withdrawal of consent|1|||
27755477|NCT01104155|54206634|FG000|Overall Study|Other|3|||
27755478|NCT01104155|54206635|FG001|Overall Study|Other|4|||
27755479|NCT01065597|54206641|FG000|Overall Study|Adverse Event|1|||
27755480|NCT01051856|54206647|FG000|Overall Study|Withdrawal by Subject|1|||
27755481|NCT01051856|54206648|FG001|Overall Study|Withdrawal by Subject|0|||
27755482|NCT01029366|54206656|FG000|Overall Study|Withdrawal by Subject|1|||
27839138|NCT01484431|54326357|FG000|Period 1: High Dose|Physician Decision|0|||
27839139|NCT01484431|54326358|FG001|Period 1: High Dose|Physician Decision|1|||
27755483|NCT01029366|54206657|FG001|Overall Study|Withdrawal by Subject|0|||
27755484|NCT01029366|54206656|FG000|Overall Study|Death|1|||
27755485|NCT01029366|54206657|FG001|Overall Study|Death|1|||
27755486|NCT01029366|54206656|FG000|Overall Study|disease progression|2|||
27755487|NCT01029366|54206657|FG001|Overall Study|disease progression|0|||
27755488|NCT01029366|54206656|FG000|Overall Study|manufacturing failure|0|||
27755489|NCT01029366|54206657|FG001|Overall Study|manufacturing failure|1|||
27755490|NCT01005745|54206664|FG000|Overall Study|No TIL growth|1|||
27755491|NCT01005745|54206664|FG000|Overall Study|Disease progressed during TIL growth|3|||
27755492|NCT01005745|54206664|FG000|Overall Study|Death prior to treatment|1|||
27755493|NCT01005745|54206664|FG000|Overall Study|Inappropriate antidiuretic hormone|1|||
27755494|NCT00879086|54206670|FG000|Overall Study|Adverse Event|3|||
27755495|NCT00879086|54206671|FG001|Overall Study|Adverse Event|15|||
27755496|NCT00879086|54206670|FG000|Overall Study|Participant choice|2|||
27755497|NCT00879086|54206671|FG001|Overall Study|Participant choice|2|||
27755498|NCT00879086|54206670|FG000|Overall Study|Progression of disease|40|||
27755499|NCT00879086|54206671|FG001|Overall Study|Progression of disease|26|||
27755500|NCT00879086|54206670|FG000|Overall Study|Withdrawal of consent|2|||
27755501|NCT00879086|54206671|FG001|Overall Study|Withdrawal of consent|1|||
27755502|NCT00879086|54206670|FG000|Overall Study|Other|4|||
27755503|NCT00879086|54206671|FG001|Overall Study|Other|6|||
27755504|NCT00879086|54206670|FG000|Overall Study|Death|1|||
27755505|NCT00879086|54206671|FG001|Overall Study|Death|2|||
27755506|NCT00244933|54206687|FG000|Overall Study|Not response evaluable|2|||
27755507|NCT02637557|54206768|FG000|Overall Study|Adverse Event|3|||
27755508|NCT02637557|54206769|FG001|Overall Study|Adverse Event|1|||
27755509|NCT02637557|54206770|FG002|Overall Study|Adverse Event|3|||
27755510|NCT02637557|54206771|FG003|Overall Study|Adverse Event|3|||
27755511|NCT02637557|54206768|FG000|Overall Study|Lost to Follow-up|1|||
27755512|NCT02637557|54206769|FG001|Overall Study|Lost to Follow-up|1|||
27755513|NCT02637557|54206770|FG002|Overall Study|Lost to Follow-up|0|||
27755514|NCT02637557|54206771|FG003|Overall Study|Lost to Follow-up|1|||
27755515|NCT02637557|54206768|FG000|Overall Study|Physician Decision|1|||
27755516|NCT02637557|54206769|FG001|Overall Study|Physician Decision|0|||
27755517|NCT02637557|54206770|FG002|Overall Study|Physician Decision|0|||
27755518|NCT02637557|54206771|FG003|Overall Study|Physician Decision|0|||
27755519|NCT02637557|54206768|FG000|Overall Study|Protocol Violation|2|||
27755520|NCT02637557|54206769|FG001|Overall Study|Protocol Violation|0|||
27755521|NCT02637557|54206770|FG002|Overall Study|Protocol Violation|2|||
27755522|NCT02637557|54206771|FG003|Overall Study|Protocol Violation|1|||
27755523|NCT02637557|54206768|FG000|Overall Study|Withdrawal by Subject|1|||
27755524|NCT02637557|54206769|FG001|Overall Study|Withdrawal by Subject|3|||
27755525|NCT02637557|54206770|FG002|Overall Study|Withdrawal by Subject|4|||
27755526|NCT02637557|54206771|FG003|Overall Study|Withdrawal by Subject|2|||
27755527|NCT02638493|54206784|FG000|Overall Study|Inability to provide semen samples|2|||
27755528|NCT02638493|54206785|FG001|Overall Study|Inability to provide semen samples|0|||
27755529|NCT02638493|54206786|FG002|Overall Study|Inability to provide semen samples|0|||
27755530|NCT02638337|54206796|FG000|Overall Study|Adverse Event|6|||
27755531|NCT02638337|54206797|FG001|Overall Study|Adverse Event|10|||
27755532|NCT02638337|54206796|FG000|Overall Study|Protocol Violation|3|||
27755533|NCT02638337|54206797|FG001|Overall Study|Protocol Violation|0|||
27755534|NCT02638337|54206796|FG000|Overall Study|Withdrawal by Subject|13|||
27755535|NCT02638337|54206797|FG001|Overall Study|Withdrawal by Subject|16|||
27755536|NCT02638337|54206796|FG000|Overall Study|Lost to Follow-up|7|||
27755537|NCT02638337|54206797|FG001|Overall Study|Lost to Follow-up|7|||
27755538|NCT02638337|54206796|FG000|Overall Study|Other - Miscellaneous|4|||
27755539|NCT02638337|54206797|FG001|Overall Study|Other - Miscellaneous|3|||
27755540|NCT02638259|54206805|FG000|Treatment Period 1|Adverse Event|1|||
27755541|NCT02638259|54206806|FG001|Treatment Period 1|Adverse Event|5|||
27755542|NCT02638259|54206805|FG000|Treatment Period 1|Death|0|||
27755543|NCT02638259|54206806|FG001|Treatment Period 1|Death|1|||
27839140|NCT01484431|54326359|FG002|Period 1: High Dose|Physician Decision|0|||
27755544|NCT02638259|54206805|FG000|Treatment Period 1|Lack of Efficacy|0|||
27755545|NCT02638259|54206806|FG001|Treatment Period 1|Lack of Efficacy|1|||
27755546|NCT02638259|54206805|FG000|Treatment Period 1|Protocol Violation|0|||
27755547|NCT02638259|54206806|FG001|Treatment Period 1|Protocol Violation|3|||
27839141|NCT01484431|54326357|FG000|Period 2|Death|0|||
27755548|NCT02638259|54206805|FG000|Treatment Period 1|Withdrawal by Subject|4|||
27755549|NCT02638259|54206806|FG001|Treatment Period 1|Withdrawal by Subject|6|||
27755550|NCT02638259|54206805|FG000|Treatment Period 1|Withdrawn per sponsor decision|0|||
27755551|NCT02638259|54206806|FG001|Treatment Period 1|Withdrawn per sponsor decision|2|||
27755552|NCT02638259|54206805|FG000|Treatment Period 2|Adverse Event|5|||
27755553|NCT02638259|54206806|FG001|Treatment Period 2|Adverse Event|4|||
27755554|NCT02638259|54206805|FG000|Treatment Period 2|Withdrawal by Subject|1|||
27755555|NCT02638259|54206806|FG001|Treatment Period 2|Withdrawal by Subject|7|||
27755556|NCT02637323|54206818|FG000|Overall Study|Lost to Follow-up|2|||
27755557|NCT02637323|54206819|FG001|Overall Study|Lost to Follow-up|0|||
27755558|NCT02637323|54206818|FG000|Overall Study|Protocol Violation|0|||
27839142|NCT01484431|54326358|FG001|Period 2|Death|1|||
27755559|NCT02637323|54206819|FG001|Overall Study|Protocol Violation|1|||
27755560|NCT03573817|54206828|FG000|Overall Study|Adverse Event|0|||
27755561|NCT03573817|54206829|FG001|Overall Study|Adverse Event|2|||
27755562|NCT03573817|54206828|FG000|Overall Study|Protocol Violation|0|||
27755563|NCT03573817|54206829|FG001|Overall Study|Protocol Violation|1|||
27755564|NCT03573817|54206828|FG000|Overall Study|Withdrawal by Subject|1|||
27755565|NCT03573817|54206829|FG001|Overall Study|Withdrawal by Subject|1|||
27755566|NCT02638103|54206844|FG000|Overall Study|Adverse Event|13|||
27755567|NCT02638103|54206845|FG001|Overall Study|Adverse Event|12|||
27755568|NCT02638103|54206846|FG002|Overall Study|Adverse Event|19|||
27755569|NCT02638103|54206847|FG003|Overall Study|Adverse Event|12|||
27755570|NCT02638103|54206844|FG000|Overall Study|Withdrawal by Subject|43|||
27755571|NCT02638103|54206845|FG001|Overall Study|Withdrawal by Subject|53|||
27755572|NCT02638103|54206846|FG002|Overall Study|Withdrawal by Subject|30|||
27755573|NCT02638103|54206847|FG003|Overall Study|Withdrawal by Subject|61|||
27755574|NCT02638103|54206844|FG000|Overall Study|Protocol Violation|1|||
27755575|NCT02638103|54206845|FG001|Overall Study|Protocol Violation|2|||
27755576|NCT02638103|54206846|FG002|Overall Study|Protocol Violation|1|||
27755577|NCT02638103|54206847|FG003|Overall Study|Protocol Violation|4|||
27755578|NCT02638103|54206844|FG000|Overall Study|Pregnancy|2|||
27755579|NCT02638103|54206845|FG001|Overall Study|Pregnancy|3|||
27755580|NCT02638103|54206846|FG002|Overall Study|Pregnancy|0|||
27755581|NCT02638103|54206847|FG003|Overall Study|Pregnancy|1|||
27755582|NCT02638103|54206844|FG000|Overall Study|Non-compliance to Study Procedures|2|||
27755583|NCT02638103|54206845|FG001|Overall Study|Non-compliance to Study Procedures|1|||
27755584|NCT02638103|54206846|FG002|Overall Study|Non-compliance to Study Procedures|1|||
27755585|NCT02638103|54206847|FG003|Overall Study|Non-compliance to Study Procedures|1|||
27755586|NCT02638103|54206844|FG000|Overall Study|Lost to Follow-up|26|||
27755587|NCT02638103|54206845|FG001|Overall Study|Lost to Follow-up|33|||
27755588|NCT02638103|54206846|FG002|Overall Study|Lost to Follow-up|20|||
27755589|NCT02638103|54206847|FG003|Overall Study|Lost to Follow-up|37|||
27755590|NCT02638103|54206844|FG000|Overall Study|Lack of Efficacy|14|||
27755591|NCT02638103|54206845|FG001|Overall Study|Lack of Efficacy|10|||
27755592|NCT02638103|54206846|FG002|Overall Study|Lack of Efficacy|12|||
27755593|NCT02638103|54206847|FG003|Overall Study|Lack of Efficacy|22|||
27755594|NCT02638103|54206844|FG000|Overall Study|Other than specified|5|||
27755595|NCT02638103|54206845|FG001|Overall Study|Other than specified|4|||
27755596|NCT02638103|54206846|FG002|Overall Study|Other than specified|2|||
27755597|NCT02638103|54206847|FG003|Overall Study|Other than specified|4|||
27755598|NCT03551743|54206869|FG000|Overall Study|Adverse Event|1|||
27755599|NCT03551743|54206870|FG001|Overall Study|Adverse Event|0|||
27755600|NCT03551743|54206871|FG002|Overall Study|Adverse Event|0|||
27755601|NCT03551743|54206872|FG003|Overall Study|Adverse Event|0|||
27755602|NCT03551743|54206869|FG000|Overall Study|Withdrawal by Subject|1|||
27755603|NCT03551743|54206870|FG001|Overall Study|Withdrawal by Subject|0|||
27755604|NCT03551743|54206871|FG002|Overall Study|Withdrawal by Subject|0|||
27755605|NCT03551743|54206872|FG003|Overall Study|Withdrawal by Subject|0|||
27755606|NCT02636699|54206884|FG000|Overall Study|Adverse Event|4|||
27755607|NCT02636699|54206885|FG001|Overall Study|Adverse Event|0|||
27755608|NCT02636699|54206884|FG000|Overall Study|Lost to Follow-up|3|||
27755609|NCT02636699|54206885|FG001|Overall Study|Lost to Follow-up|3|||
27755610|NCT02636699|54206884|FG000|Overall Study|Non-compliance with the investigational product (IP)|2|||
27755611|NCT02636699|54206885|FG001|Overall Study|Non-compliance with the investigational product (IP)|0|||
27755612|NCT02636699|54206884|FG000|Overall Study|Physician Decision|0|||
27755613|NCT02636699|54206885|FG001|Overall Study|Physician Decision|1|||
27755614|NCT02636699|54206884|FG000|Overall Study|Withdrawal by Subject|13|||
27755615|NCT02636699|54206885|FG001|Overall Study|Withdrawal by Subject|6|||
27755616|NCT02636699|54206884|FG000|Overall Study|Other|3|||
27755617|NCT02636699|54206885|FG001|Overall Study|Other|1|||
27755618|NCT02634983|54206891|FG000|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2|||
27755619|NCT02634983|54206892|FG001|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0|||
27839143|NCT01484431|54326359|FG002|Period 2|Death|1|||
27755620|NCT02633501|54206904|FG000|Overall Study|Adverse Event|0|||
27755621|NCT02633501|54206905|FG001|Overall Study|Adverse Event|0|||
27839144|NCT01484431|54326357|FG000|Period 2|Physician Decision|0|||
27755622|NCT02633501|54206906|FG002|Overall Study|Adverse Event|1|||
27755623|NCT02633501|54206907|FG003|Overall Study|Adverse Event|0|||
27755624|NCT02633501|54206908|FG004|Overall Study|Adverse Event|1|||
27755625|NCT02633501|54206909|FG005|Overall Study|Adverse Event|1|||
27755626|NCT02633501|54206904|FG000|Overall Study|Withdrawal by Subject|2|||
27755627|NCT02633501|54206905|FG001|Overall Study|Withdrawal by Subject|1|||
27755628|NCT02633501|54206906|FG002|Overall Study|Withdrawal by Subject|2|||
27755629|NCT02633501|54206907|FG003|Overall Study|Withdrawal by Subject|2|||
27755630|NCT02633501|54206908|FG004|Overall Study|Withdrawal by Subject|1|||
27755631|NCT02633501|54206909|FG005|Overall Study|Withdrawal by Subject|3|||
27755632|NCT02633501|54206904|FG000|Overall Study|Various other reasons|0|||
27755633|NCT02633501|54206905|FG001|Overall Study|Various other reasons|2|||
27755634|NCT02633501|54206906|FG002|Overall Study|Various other reasons|4|||
27755635|NCT02633501|54206907|FG003|Overall Study|Various other reasons|1|||
27755636|NCT02633501|54206908|FG004|Overall Study|Various other reasons|7|||
27755637|NCT02633501|54206909|FG005|Overall Study|Various other reasons|11|||
27755638|NCT02633501|54206904|FG000|Overall Study|Lost to Follow-up|0|||
27755639|NCT02633501|54206905|FG001|Overall Study|Lost to Follow-up|0|||
27755640|NCT02633501|54206906|FG002|Overall Study|Lost to Follow-up|0|||
27755641|NCT02633501|54206907|FG003|Overall Study|Lost to Follow-up|1|||
27755642|NCT02633501|54206908|FG004|Overall Study|Lost to Follow-up|2|||
27755643|NCT02633501|54206909|FG005|Overall Study|Lost to Follow-up|0|||
27755644|NCT03138499|54206930|FG000|Overall Study|Lost to Follow-up|1|||
27755645|NCT03138499|54206931|FG001|Overall Study|Lost to Follow-up|0|||
27755646|NCT03138499|54206930|FG000|Overall Study|Participants withdrew consent|1|||
27755647|NCT03138499|54206931|FG001|Overall Study|Participants withdrew consent|0|||
27755648|NCT03138499|54206930|FG000|Overall Study|Participant discontinued study before treatment|0|||
27755649|NCT03138499|54206931|FG001|Overall Study|Participant discontinued study before treatment|1|||
27755650|NCT03138499|54206930|FG000|Overall Study|Disease Progression|2|||
27755651|NCT03138499|54206931|FG001|Overall Study|Disease Progression|6|||
27839145|NCT01484431|54326358|FG001|Period 2|Physician Decision|0|||
27839146|NCT01484431|54326359|FG002|Period 2|Physician Decision|1|||
27839147|NCT01484431|54326357|FG000|Period 2|Non-Compliance with Study Drug|1|||
27839148|NCT01484431|54326358|FG001|Period 2|Non-Compliance with Study Drug|0|||
27839149|NCT01484431|54326359|FG002|Period 2|Non-Compliance with Study Drug|0|||
27839150|NCT01473953|54326407|FG000|Overall Study|Other|1|||
27839151|NCT01473953|54326408|FG001|Overall Study|Other|0|||
27755652|NCT03138499|54206930|FG000|Overall Study|Study drug toxicity|2|||
27755653|NCT03138499|54206931|FG001|Overall Study|Study drug toxicity|2|||
27755654|NCT03138499|54206930|FG000|Overall Study|Participant request to discontinue study treatment|1|||
27755655|NCT03138499|54206931|FG001|Overall Study|Participant request to discontinue study treatment|1|||
27755656|NCT03138499|54206930|FG000|Overall Study|Other reasons|2|||
27755657|NCT03138499|54206931|FG001|Overall Study|Other reasons|0|||
27755658|NCT04508621|54206940|FG000|Overall Study|Adverse Event|39|||
27755659|NCT04508621|54206941|FG001|Overall Study|Adverse Event|16|||
27755660|NCT04508621|54206940|FG000|Overall Study|Lack of Efficacy|2|||
27755661|NCT04508621|54206941|FG001|Overall Study|Lack of Efficacy|8|||
27755662|NCT04508621|54206940|FG000|Overall Study|Physician Decision|0|||
27755663|NCT04508621|54206941|FG001|Overall Study|Physician Decision|1|||
27755664|NCT04508621|54206940|FG000|Overall Study|Withdrawal by Subject|10|||
27755665|NCT04508621|54206941|FG001|Overall Study|Withdrawal by Subject|14|||
27755666|NCT04508621|54206940|FG000|Overall Study|Lost to Follow-up|12|||
27755667|NCT04508621|54206941|FG001|Overall Study|Lost to Follow-up|9|||
27755668|NCT04508621|54206940|FG000|Overall Study|COVID-19 related crisis|3|||
27755669|NCT04508621|54206941|FG001|Overall Study|COVID-19 related crisis|0|||
27755670|NCT04508621|54206940|FG000|Overall Study|Subject non-compliance|1|||
27755671|NCT04508621|54206941|FG001|Overall Study|Subject non-compliance|0|||
27755672|NCT03591107|54206949|FG000|Overall Study|Same patient in both arms|1|||
27755673|NCT03591107|54206950|FG001|Overall Study|Same patient in both arms|1|||
27755674|NCT03591107|54206949|FG000|Overall Study|Sought care at other clinics|0|||
27755675|NCT03591107|54206950|FG001|Overall Study|Sought care at other clinics|2|||
27755676|NCT03591107|54206949|FG000|Overall Study|Discharged from clinic|0|||
27755677|NCT03591107|54206950|FG001|Overall Study|Discharged from clinic|1|||
27755678|NCT03591107|54206949|FG000|Overall Study|Withdrawal by Subject|0|||
27755679|NCT03591107|54206950|FG001|Overall Study|Withdrawal by Subject|1|||
27755680|NCT02922023|54206963|FG000|Overall Study|Lost to Follow-up|2|||
27755681|NCT02922023|54206964|FG001|Overall Study|Lost to Follow-up|0|||
27755682|NCT01672853|54206973|FG000|Overall Study|Protocol Specified Criteria for Withdraw|0|||
27755683|NCT01672853|54206974|FG001|Overall Study|Protocol Specified Criteria for Withdraw|4|||
27755684|NCT01672853|54206975|FG002|Overall Study|Protocol Specified Criteria for Withdraw|0|||
27755685|NCT01672853|54206973|FG000|Overall Study|Pregnancy|0|||
27755686|NCT01672853|54206974|FG001|Overall Study|Pregnancy|1|||
27755687|NCT01672853|54206975|FG002|Overall Study|Pregnancy|0|||
27755688|NCT01672853|54206973|FG000|Overall Study|Investigator's Discretion|1|||
27755689|NCT01672853|54206974|FG001|Overall Study|Investigator's Discretion|0|||
27755690|NCT01672853|54206975|FG002|Overall Study|Investigator's Discretion|0|||
27755691|NCT01672853|54206973|FG000|Overall Study|Withdrew Consent|5|||
27839152|NCT01473953|54326409|FG002|Overall Study|Other|0|||
27839153|NCT01473953|54326410|FG003|Overall Study|Other|0|||
27755692|NCT01672853|54206974|FG001|Overall Study|Withdrew Consent|5|||
27755693|NCT01672853|54206975|FG002|Overall Study|Withdrew Consent|5|||
27755694|NCT01672853|54206973|FG000|Overall Study|Adverse Event|4|||
27755695|NCT01672853|54206974|FG001|Overall Study|Adverse Event|6|||
27755696|NCT01672853|54206975|FG002|Overall Study|Adverse Event|8|||
27839154|NCT01473953|54326411|FG004|Overall Study|Other|0|||
27755697|NCT01672853|54206973|FG000|Overall Study|Lost to Follow-up|0|||
27755698|NCT01672853|54206974|FG001|Overall Study|Lost to Follow-up|1|||
27755699|NCT01672853|54206975|FG002|Overall Study|Lost to Follow-up|0|||
27755700|NCT01672853|54206973|FG000|Overall Study|Randomized but Never Treated|0|||
27755701|NCT01672853|54206974|FG001|Overall Study|Randomized but Never Treated|0|||
27755702|NCT01672853|54206975|FG002|Overall Study|Randomized but Never Treated|1|||
27755703|NCT01603459|54206983|FG000|Overall Study|Adverse Event|5|||
27755704|NCT01603459|54206983|FG000|Overall Study|Withdrawal by Subject|5|||
27755705|NCT01603459|54206983|FG000|Overall Study|Lost to Follow-up|3|||
27755706|NCT01603459|54206983|FG000|Overall Study|Predefined discontinuation criteria|3|||
27755707|NCT01603459|54206983|FG000|Overall Study|Non-compliance|1|||
27755708|NCT01603459|54206983|FG000|Overall Study|Administrative reason|1|||
27755709|NCT01678807|54207022|FG000|Overall Study|Adverse Event|4|||
27755710|NCT01678807|54207023|FG001|Overall Study|Adverse Event|4|||
27755711|NCT01678807|54207024|FG002|Overall Study|Adverse Event|0|||
27755712|NCT01678807|54207022|FG000|Overall Study|Withdrawn by Parent/Guardian|0|||
27755713|NCT01678807|54207023|FG001|Overall Study|Withdrawn by Parent/Guardian|1|||
27755714|NCT01678807|54207024|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
27755715|NCT03073525|54207035|FG000|Overall Study|Withdrawal by Subject|0|||
27755716|NCT03073525|54207036|FG001|Overall Study|Withdrawal by Subject|0|||
27755717|NCT03073525|54207037|FG002|Overall Study|Withdrawal by Subject|3|||
27755718|NCT02631551|54207058|FG000|Overall Study|Adverse Event|1|||
27755719|NCT02631551|54207059|FG001|Overall Study|Adverse Event|2|||
27755720|NCT02631551|54207060|FG002|Overall Study|Adverse Event|4|||
27755721|NCT02631551|54207061|FG003|Overall Study|Adverse Event|0|||
27755722|NCT02631551|54207058|FG000|Overall Study|Lack of Efficacy|0|||
27755723|NCT02631551|54207059|FG001|Overall Study|Lack of Efficacy|0|||
27755724|NCT02631551|54207060|FG002|Overall Study|Lack of Efficacy|1|||
27755725|NCT02631551|54207061|FG003|Overall Study|Lack of Efficacy|0|||
27755726|NCT02631551|54207058|FG000|Overall Study|Lost to Follow-up|1|||
27755727|NCT02631551|54207059|FG001|Overall Study|Lost to Follow-up|2|||
27755728|NCT02631551|54207060|FG002|Overall Study|Lost to Follow-up|0|||
27755729|NCT02631551|54207061|FG003|Overall Study|Lost to Follow-up|3|||
27755730|NCT02631551|54207058|FG000|Overall Study|Withdrawal by Subject|2|||
27755731|NCT02631551|54207059|FG001|Overall Study|Withdrawal by Subject|2|||
27755732|NCT02631551|54207060|FG002|Overall Study|Withdrawal by Subject|0|||
27755733|NCT02631551|54207061|FG003|Overall Study|Withdrawal by Subject|5|||
27755734|NCT02631551|54207058|FG000|Overall Study|Protocol deviation|3|||
27755735|NCT02631551|54207059|FG001|Overall Study|Protocol deviation|6|||
27755736|NCT02631551|54207060|FG002|Overall Study|Protocol deviation|3|||
27755737|NCT02631551|54207061|FG003|Overall Study|Protocol deviation|0|||
27755738|NCT02631551|54207058|FG000|Overall Study|Non-compliance with study procedures|0|||
27755739|NCT02631551|54207059|FG001|Overall Study|Non-compliance with study procedures|0|||
27755740|NCT02631551|54207060|FG002|Overall Study|Non-compliance with study procedures|1|||
27755741|NCT02631551|54207061|FG003|Overall Study|Non-compliance with study procedures|1|||
27755742|NCT02631551|54207058|FG000|Overall Study|Non-compliance with study drug|1|||
27755743|NCT02631551|54207059|FG001|Overall Study|Non-compliance with study drug|0|||
27755744|NCT02631551|54207060|FG002|Overall Study|Non-compliance with study drug|0|||
27755745|NCT02631551|54207061|FG003|Overall Study|Non-compliance with study drug|0|||
27755746|NCT02631551|54207058|FG000|Overall Study|Other, specific reasons not collected|5|||
27755747|NCT02631551|54207059|FG001|Overall Study|Other, specific reasons not collected|7|||
27755748|NCT02631551|54207060|FG002|Overall Study|Other, specific reasons not collected|2|||
27755749|NCT02631551|54207061|FG003|Overall Study|Other, specific reasons not collected|2|||
27755750|NCT01680991|54207074|FG000|Overall Study|Adverse Event|1|||
27755751|NCT01680991|54207075|FG001|Overall Study|Adverse Event|0|||
27755752|NCT01680991|54207076|FG002|Overall Study|Adverse Event|0|||
27755753|NCT01680991|54207074|FG000|Overall Study|Death|1|||
27755754|NCT01680991|54207075|FG001|Overall Study|Death|0|||
27755755|NCT01680991|54207076|FG002|Overall Study|Death|1|||
27755756|NCT01680991|54207074|FG000|Overall Study|Protocol Violation|0|||
27755757|NCT01680991|54207075|FG001|Overall Study|Protocol Violation|1|||
27755758|NCT01680991|54207076|FG002|Overall Study|Protocol Violation|0|||
27755759|NCT01680991|54207074|FG000|Overall Study|Withdrawal by Subject|5|||
27755760|NCT01680991|54207075|FG001|Overall Study|Withdrawal by Subject|1|||
27755761|NCT01680991|54207076|FG002|Overall Study|Withdrawal by Subject|0|||
27839155|NCT01510717|54326425|FG000|Overall Study|Adverse Event|1|||
27755762|NCT01680991|54207074|FG000|Overall Study|Progressive disease (PD)|0|||
27755763|NCT01680991|54207075|FG001|Overall Study|Progressive disease (PD)|10|||
27755764|NCT01680991|54207076|FG002|Overall Study|Progressive disease (PD)|0|||
27755765|NCT01680991|54207074|FG000|Overall Study|Physician Decision|0|||
27755766|NCT01680991|54207075|FG001|Overall Study|Physician Decision|7|||
27755767|NCT01680991|54207076|FG002|Overall Study|Physician Decision|2|||
27755768|NCT01680991|54207074|FG000|Overall Study|Bad physical condition|0|||
27755769|NCT01680991|54207075|FG001|Overall Study|Bad physical condition|0|||
27755770|NCT01680991|54207076|FG002|Overall Study|Bad physical condition|1|||
27755771|NCT01680991|54207074|FG000|Overall Study|PD confirmed in other hospital|1|||
27755772|NCT01680991|54207075|FG001|Overall Study|PD confirmed in other hospital|0|||
27755773|NCT01680991|54207076|FG002|Overall Study|PD confirmed in other hospital|0|||
27755774|NCT02819479|54207086|FG000|Overall Study|Adverse Event|2|||
27755775|NCT04064411|54207093|FG000|Overall Study|Adverse Event|29|||
27755776|NCT04064411|54207094|FG001|Overall Study|Adverse Event|19|||
27755777|NCT04064411|54207093|FG000|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|0|||
27755778|NCT04064411|54207094|FG001|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|2|||
27755779|NCT04064411|54207093|FG000|Overall Study|Protocol Deviation|0|||
27755780|NCT04064411|54207094|FG001|Overall Study|Protocol Deviation|2|||
27755781|NCT04064411|54207093|FG000|Overall Study|Withdrawal by Subject|25|||
27755782|NCT04064411|54207094|FG001|Overall Study|Withdrawal by Subject|29|||
27755783|NCT04064411|54207093|FG000|Overall Study|Lost to Follow-up|5|||
27755784|NCT04064411|54207094|FG001|Overall Study|Lost to Follow-up|2|||
27755785|NCT04064411|54207093|FG000|Overall Study|Other than Specified|4|||
27755786|NCT04064411|54207094|FG001|Overall Study|Other than Specified|1|||
27755787|NCT04064411|54207093|FG000|Overall Study|Death|1|||
27755788|NCT04064411|54207094|FG001|Overall Study|Death|0|||
27755789|NCT02004691|54207102|FG000|PAP: Up to 52 Weeks|Poor compliance|1|||
27755790|NCT02004691|54207103|FG001|PAP: Up to 52 Weeks|Poor compliance|0|||
27755791|NCT02004691|54207102|FG000|ETP: Ongoing From Week 52|Related to Coronavirus Disease (COVID-19)|1|||
27755792|NCT02004691|54207103|FG001|ETP: Ongoing From Week 52|Related to Coronavirus Disease (COVID-19)|0|||
27755793|NCT02004691|54207102|FG000|ETP: Ongoing From Week 52|Withdrawal by Subject|0|||
27755794|NCT02004691|54207103|FG001|ETP: Ongoing From Week 52|Withdrawal by Subject|1|||
27755795|NCT02004691|54207102|FG000|ETP: Ongoing From Week 52|Other|0|||
27755796|NCT02004691|54207103|FG001|ETP: Ongoing From Week 52|Other|1|||
27755797|NCT02004691|54207102|FG000|ETP: Ongoing From Week 52|Ongoing|16|||
27755798|NCT02004691|54207103|FG001|ETP: Ongoing From Week 52|Ongoing|16|||
27755799|NCT02629133|54207111|FG000|Overall Study|Lost to Follow-up|3|||
27755800|NCT02629133|54207112|FG001|Overall Study|Lost to Follow-up|1|||
27755801|NCT02629133|54207111|FG000|Overall Study|Withdrawal by Subject|1|||
27755802|NCT02629133|54207112|FG001|Overall Study|Withdrawal by Subject|1|||
27755803|NCT02660359|54207121|FG000|Overall Study|Protocol Deviation|0|||
27755804|NCT02660359|54207122|FG001|Overall Study|Protocol Deviation|0|||
27755805|NCT02660359|54207123|FG002|Overall Study|Protocol Deviation|1|||
27755806|NCT02660359|54207121|FG000|Overall Study|Sponsor Decision to Terminate Study|73|||
27755807|NCT02660359|54207122|FG001|Overall Study|Sponsor Decision to Terminate Study|75|||
27755808|NCT02660359|54207123|FG002|Overall Study|Sponsor Decision to Terminate Study|71|||
27755809|NCT02660359|54207121|FG000|Overall Study|Lack of Efficacy|1|||
27755810|NCT02660359|54207122|FG001|Overall Study|Lack of Efficacy|1|||
27755811|NCT02660359|54207123|FG002|Overall Study|Lack of Efficacy|1|||
27755812|NCT02660359|54207121|FG000|Overall Study|Adverse Event|0|||
27755813|NCT02660359|54207122|FG001|Overall Study|Adverse Event|1|||
27755814|NCT02660359|54207123|FG002|Overall Study|Adverse Event|0|||
27755815|NCT02660359|54207121|FG000|Overall Study|Other|2|||
27755816|NCT02660359|54207122|FG001|Overall Study|Other|1|||
27755817|NCT02660359|54207123|FG002|Overall Study|Other|3|||
27755818|NCT02660359|54207121|FG000|Overall Study|Withdrawal by Subject|7|||
27755819|NCT02660359|54207122|FG001|Overall Study|Withdrawal by Subject|5|||
27755820|NCT02660359|54207123|FG002|Overall Study|Withdrawal by Subject|8|||
27755821|NCT02660359|54207121|FG000|Overall Study|Lost to Follow-up|3|||
27755822|NCT02660359|54207122|FG001|Overall Study|Lost to Follow-up|3|||
27755823|NCT02660359|54207123|FG002|Overall Study|Lost to Follow-up|0|||
27839156|NCT01510717|54326426|FG001|Overall Study|Adverse Event|2|||
27839157|NCT01510717|54326425|FG000|Overall Study|Death|1|||
27755824|NCT02628743|54207131|FG000|Overall Study|Other|3|||
27755825|NCT02628743|54207131|FG000|Overall Study|Withdrawal by Subject|50|||
27755826|NCT02628743|54207131|FG000|Overall Study|Study Terminated by Sponsor|76|||
27755827|NCT02628743|54207131|FG000|Overall Study|Physician Decision|2|||
27755828|NCT03839459|54207135|FG000|Overall Study|Withdrawal by Subject|2|||
27755829|NCT03839459|54207135|FG000|Overall Study|progression of disease|3|||
27755830|NCT02630693|54207141|FG000|Overall Study|No receive treatment|0|||
27755831|NCT02630693|54207142|FG001|Overall Study|No receive treatment|1|||
27755832|NCT05059301|54207151|FG000|Overall Study|Adverse Event|0|||
27755833|NCT05059301|54207152|FG001|Overall Study|Adverse Event|2|||
27755834|NCT05059301|54207153|FG002|Overall Study|Adverse Event|2|||
27755835|NCT05059301|54207151|FG000|Overall Study|Lost to Follow-up|2|||
27755836|NCT05059301|54207152|FG001|Overall Study|Lost to Follow-up|3|||
27755837|NCT05059301|54207153|FG002|Overall Study|Lost to Follow-up|3|||
27755838|NCT01938430|54207179|FG000|Overall Study|Randomized but Not Treated|0|||
27755839|NCT01938430|54207180|FG001|Overall Study|Randomized but Not Treated|0|||
27755840|NCT01938430|54207181|FG002|Overall Study|Randomized but Not Treated|0|||
27755841|NCT01938430|54207182|FG003|Overall Study|Randomized but Not Treated|0|||
27755842|NCT01938430|54207183|FG004|Overall Study|Randomized but Not Treated|0|||
27755843|NCT01938430|54207184|FG005|Overall Study|Randomized but Not Treated|0|||
27755844|NCT01938430|54207185|FG006|Overall Study|Randomized but Not Treated|0|||
27755845|NCT01938430|54207186|FG007|Overall Study|Randomized but Not Treated|0|||
27755846|NCT01938430|54207187|FG008|Overall Study|Randomized but Not Treated|0|||
27755847|NCT01938430|54207188|FG009|Overall Study|Randomized but Not Treated|0|||
27755848|NCT01938430|54207189|FG010|Overall Study|Randomized but Not Treated|1|||
27755849|NCT01938430|54207190|FG011|Overall Study|Randomized but Not Treated|0|||
27755850|NCT01938430|54207191|FG012|Overall Study|Randomized but Not Treated|0|||
27755851|NCT01938430|54207192|FG013|Overall Study|Randomized but Not Treated|1|||
27755852|NCT01938430|54207179|FG000|Overall Study|Adverse Event|0|||
27755853|NCT01938430|54207180|FG001|Overall Study|Adverse Event|0|||
27755854|NCT01938430|54207181|FG002|Overall Study|Adverse Event|0|||
27755855|NCT01938430|54207182|FG003|Overall Study|Adverse Event|0|||
27755856|NCT01938430|54207183|FG004|Overall Study|Adverse Event|0|||
27755857|NCT01938430|54207184|FG005|Overall Study|Adverse Event|0|||
27755858|NCT01938430|54207185|FG006|Overall Study|Adverse Event|1|||
27755859|NCT01938430|54207186|FG007|Overall Study|Adverse Event|0|||
27755860|NCT01938430|54207187|FG008|Overall Study|Adverse Event|0|||
27755861|NCT01938430|54207188|FG009|Overall Study|Adverse Event|0|||
27755862|NCT01938430|54207189|FG010|Overall Study|Adverse Event|0|||
27755863|NCT01938430|54207190|FG011|Overall Study|Adverse Event|0|||
27755864|NCT01938430|54207191|FG012|Overall Study|Adverse Event|0|||
27755865|NCT01938430|54207192|FG013|Overall Study|Adverse Event|0|||
27755866|NCT01938430|54207179|FG000|Overall Study|Death|1|||
27755867|NCT01938430|54207180|FG001|Overall Study|Death|2|||
27755868|NCT01938430|54207181|FG002|Overall Study|Death|2|||
27755869|NCT01938430|54207182|FG003|Overall Study|Death|1|||
27755870|NCT01938430|54207183|FG004|Overall Study|Death|0|||
27755871|NCT01938430|54207184|FG005|Overall Study|Death|0|||
27755872|NCT01938430|54207185|FG006|Overall Study|Death|1|||
27755873|NCT01938430|54207186|FG007|Overall Study|Death|1|||
27755874|NCT01938430|54207187|FG008|Overall Study|Death|2|||
27755875|NCT01938430|54207188|FG009|Overall Study|Death|3|||
27755876|NCT01938430|54207189|FG010|Overall Study|Death|0|||
27755877|NCT01938430|54207190|FG011|Overall Study|Death|0|||
27755878|NCT01938430|54207191|FG012|Overall Study|Death|0|||
27755879|NCT01938430|54207192|FG013|Overall Study|Death|0|||
27755880|NCT01938430|54207179|FG000|Overall Study|Investigator's Discretion|0|||
27755881|NCT01938430|54207180|FG001|Overall Study|Investigator's Discretion|0|||
27755882|NCT01938430|54207181|FG002|Overall Study|Investigator's Discretion|1|||
27755883|NCT01938430|54207182|FG003|Overall Study|Investigator's Discretion|0|||
27755884|NCT01938430|54207183|FG004|Overall Study|Investigator's Discretion|0|||
27755885|NCT01938430|54207184|FG005|Overall Study|Investigator's Discretion|0|||
27755886|NCT01938430|54207185|FG006|Overall Study|Investigator's Discretion|0|||
27755887|NCT01938430|54207186|FG007|Overall Study|Investigator's Discretion|0|||
27755888|NCT01938430|54207187|FG008|Overall Study|Investigator's Discretion|0|||
27755889|NCT01938430|54207188|FG009|Overall Study|Investigator's Discretion|0|||
27755890|NCT01938430|54207189|FG010|Overall Study|Investigator's Discretion|0|||
27755891|NCT01938430|54207190|FG011|Overall Study|Investigator's Discretion|0|||
27755892|NCT01938430|54207191|FG012|Overall Study|Investigator's Discretion|0|||
27755893|NCT01938430|54207192|FG013|Overall Study|Investigator's Discretion|0|||
27755894|NCT01938430|54207179|FG000|Overall Study|Lack of Efficacy|3|||
27755895|NCT01938430|54207180|FG001|Overall Study|Lack of Efficacy|1|||
27755896|NCT01938430|54207181|FG002|Overall Study|Lack of Efficacy|1|||
27755897|NCT01938430|54207182|FG003|Overall Study|Lack of Efficacy|1|||
27755898|NCT01938430|54207183|FG004|Overall Study|Lack of Efficacy|0|||
27755899|NCT01938430|54207184|FG005|Overall Study|Lack of Efficacy|0|||
27839158|NCT01510717|54326426|FG001|Overall Study|Death|0|||
27755900|NCT01938430|54207185|FG006|Overall Study|Lack of Efficacy|0|||
27755901|NCT01938430|54207186|FG007|Overall Study|Lack of Efficacy|0|||
27755902|NCT01938430|54207187|FG008|Overall Study|Lack of Efficacy|1|||
27839159|NCT01510717|54326425|FG000|Overall Study|Lost to Follow-up|0|||
27839160|NCT01510717|54326426|FG001|Overall Study|Lost to Follow-up|1|||
27755903|NCT01938430|54207188|FG009|Overall Study|Lack of Efficacy|0|||
27755904|NCT01938430|54207189|FG010|Overall Study|Lack of Efficacy|2|||
27755905|NCT01938430|54207190|FG011|Overall Study|Lack of Efficacy|1|||
27755906|NCT01938430|54207191|FG012|Overall Study|Lack of Efficacy|0|||
27755907|NCT01938430|54207192|FG013|Overall Study|Lack of Efficacy|0|||
27755908|NCT01938430|54207179|FG000|Overall Study|Lost to Follow-up|0|||
27755909|NCT01938430|54207180|FG001|Overall Study|Lost to Follow-up|0|||
27755910|NCT01938430|54207181|FG002|Overall Study|Lost to Follow-up|1|||
27755911|NCT01938430|54207182|FG003|Overall Study|Lost to Follow-up|0|||
27755912|NCT01938430|54207183|FG004|Overall Study|Lost to Follow-up|0|||
27755913|NCT01938430|54207184|FG005|Overall Study|Lost to Follow-up|1|||
27755914|NCT01938430|54207185|FG006|Overall Study|Lost to Follow-up|0|||
27755915|NCT01938430|54207186|FG007|Overall Study|Lost to Follow-up|0|||
27755916|NCT01938430|54207187|FG008|Overall Study|Lost to Follow-up|0|||
27755917|NCT01938430|54207188|FG009|Overall Study|Lost to Follow-up|0|||
27755918|NCT01938430|54207189|FG010|Overall Study|Lost to Follow-up|0|||
27755919|NCT01938430|54207190|FG011|Overall Study|Lost to Follow-up|0|||
27755920|NCT01938430|54207191|FG012|Overall Study|Lost to Follow-up|0|||
27755921|NCT01938430|54207192|FG013|Overall Study|Lost to Follow-up|0|||
27755922|NCT01938430|54207179|FG000|Overall Study|Withdrew Consent|0|||
27755923|NCT01938430|54207180|FG001|Overall Study|Withdrew Consent|0|||
27755924|NCT01938430|54207181|FG002|Overall Study|Withdrew Consent|0|||
27755925|NCT01938430|54207182|FG003|Overall Study|Withdrew Consent|0|||
27755926|NCT01938430|54207183|FG004|Overall Study|Withdrew Consent|0|||
27755927|NCT01938430|54207184|FG005|Overall Study|Withdrew Consent|0|||
27755928|NCT01938430|54207185|FG006|Overall Study|Withdrew Consent|0|||
27755929|NCT01938430|54207186|FG007|Overall Study|Withdrew Consent|0|||
27755930|NCT01938430|54207187|FG008|Overall Study|Withdrew Consent|1|||
27755931|NCT01938430|54207188|FG009|Overall Study|Withdrew Consent|0|||
27755932|NCT01938430|54207189|FG010|Overall Study|Withdrew Consent|0|||
27755933|NCT01938430|54207190|FG011|Overall Study|Withdrew Consent|0|||
27755934|NCT01938430|54207191|FG012|Overall Study|Withdrew Consent|0|||
27755935|NCT01938430|54207192|FG013|Overall Study|Withdrew Consent|0|||
27755936|NCT01937884|54207249|FG000|Overall Study|Withdrawal by Subject|1|||
27755937|NCT01937884|54207250|FG001|Overall Study|Withdrawal by Subject|0|||
27755938|NCT01916824|54207260|FG000|Overall Study|Lost to Follow-up|3|||
27755939|NCT01916824|54207261|FG001|Overall Study|Lost to Follow-up|6|||
27755940|NCT01916824|54207260|FG000|Overall Study|Physician Decision|2|||
27755941|NCT01916824|54207261|FG001|Overall Study|Physician Decision|0|||
27755942|NCT01916824|54207260|FG000|Overall Study|Withdrawal by Subject|2|||
27755943|NCT01916824|54207261|FG001|Overall Study|Withdrawal by Subject|3|||
27755944|NCT01915732|54207269|FG000|Overall Study|Withdrawal by Subject|18|||
27755945|NCT01915732|54207270|FG001|Overall Study|Withdrawal by Subject|18|||
27755946|NCT01915732|54207269|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
27755947|NCT01915732|54207270|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
27755948|NCT01915732|54207269|FG000|Overall Study|Adverse Event|12|||
27755949|NCT01915732|54207270|FG001|Overall Study|Adverse Event|4|||
27755950|NCT01915732|54207269|FG000|Overall Study|Protocol Violation|5|||
27755951|NCT01915732|54207270|FG001|Overall Study|Protocol Violation|5|||
27755952|NCT01915732|54207269|FG000|Overall Study|Lack of Efficacy|6|||
27755953|NCT01915732|54207270|FG001|Overall Study|Lack of Efficacy|11|||
27755954|NCT01915732|54207269|FG000|Overall Study|Lost to Follow-up|22|||
27755955|NCT01915732|54207270|FG001|Overall Study|Lost to Follow-up|26|||
27755956|NCT01915732|54207269|FG000|Overall Study|Par. Improved, Voluntary (Vol) exit|1|||
27755957|NCT01915732|54207270|FG001|Overall Study|Par. Improved, Voluntary (Vol) exit|0|||
27755958|NCT01915732|54207269|FG000|Overall Study|Par. Conscious Ineffective Vol Exit|1|||
27755959|NCT01915732|54207270|FG001|Overall Study|Par. Conscious Ineffective Vol Exit|0|||
27755960|NCT01915732|54207269|FG000|Overall Study|Drug Release Error|1|||
27755961|NCT01915732|54207270|FG001|Overall Study|Drug Release Error|0|||
27755962|NCT01915732|54207269|FG000|Overall Study|Recovered|1|||
27755963|NCT01915732|54207270|FG001|Overall Study|Recovered|0|||
27755964|NCT01915732|54207269|FG000|Overall Study|Pregnancy|1|||
27755965|NCT01915732|54207270|FG001|Overall Study|Pregnancy|0|||
27755966|NCT01915732|54207269|FG000|Overall Study|Poor Perceived Efficacy|1|||
27839161|NCT01510717|54326425|FG000|Overall Study|Withdrawal by Subject|0|||
27755967|NCT01915732|54207270|FG001|Overall Study|Poor Perceived Efficacy|0|||
27755968|NCT01915732|54207269|FG000|Overall Study|Par. Unable to Come to the Hospital|0|||
27755969|NCT01915732|54207270|FG001|Overall Study|Par. Unable to Come to the Hospital|1|||
27755970|NCT01915732|54207269|FG000|Overall Study|Got Well|0|||
27755971|NCT01915732|54207270|FG001|Overall Study|Got Well|1|||
28159963|NCT02737475|54830038|FG016|Overall Study|Death|2|||
27755972|NCT01915732|54207269|FG000|Overall Study|Par. not Willing to Continue Treatment|0|||
27755973|NCT01915732|54207270|FG001|Overall Study|Par. not Willing to Continue Treatment|1|||
27755974|NCT01915732|54207269|FG000|Overall Study|Par. Refused to Hospital Visits|0|||
27755975|NCT01915732|54207270|FG001|Overall Study|Par. Refused to Hospital Visits|1|||
27755976|NCT01915732|54207269|FG000|Overall Study|Job Transfer|0|||
27755977|NCT01915732|54207270|FG001|Overall Study|Job Transfer|1|||
27755978|NCT01915732|54207269|FG000|Overall Study|Improper Facial Procedure|0|||
27755979|NCT01915732|54207270|FG001|Overall Study|Improper Facial Procedure|1|||
27755980|NCT01915732|54207269|FG000|Overall Study|Poor Conscious Effect|0|||
27755981|NCT01915732|54207270|FG001|Overall Study|Poor Conscious Effect|1|||
27755982|NCT01936948|54207280|FG000|Overall Study|no 30-day follow-up data|0|||
27755983|NCT01936948|54207281|FG001|Overall Study|no 30-day follow-up data|3|||
27755984|NCT01936948|54207282|FG002|Overall Study|no 30-day follow-up data|3|||
27755985|NCT01936948|54207283|FG003|Overall Study|no 30-day follow-up data|3|||
27755986|NCT01936870|54207291|FG000|Overall Study|No Visit After Treatment|176|||
27755987|NCT01936870|54207291|FG000|Overall Study|Protocol Violation|12|||
27755988|NCT01936870|54207291|FG000|Overall Study|No Drug Administration|1|||
27755989|NCT01618864|54207295|FG000|Overall Study|Withdrawal by Subject|2|||
27755990|NCT01618864|54207295|FG000|Overall Study|Lost to Follow-up|2|||
27755991|NCT01618708|54207306|FG000|Overall Study|Adverse Event|10|||
27839162|NCT01510717|54326426|FG001|Overall Study|Withdrawal by Subject|2|||
27755992|NCT01618708|54207307|FG001|Overall Study|Adverse Event|10|||
27755993|NCT01618708|54207306|FG000|Overall Study|Lost to Follow-up|3|||
27755994|NCT01618708|54207307|FG001|Overall Study|Lost to Follow-up|3|||
27755995|NCT01618708|54207306|FG000|Overall Study|Withdrawal by Subject|17|||
27755996|NCT01618708|54207307|FG001|Overall Study|Withdrawal by Subject|22|||
27755997|NCT01618708|54207306|FG000|Overall Study|Lack of Efficacy|8|||
27755998|NCT01618708|54207307|FG001|Overall Study|Lack of Efficacy|8|||
27755999|NCT01618708|54207306|FG000|Overall Study|Technical problems|2|||
27756000|NCT01618708|54207307|FG001|Overall Study|Technical problems|0|||
27756001|NCT01618708|54207306|FG000|Overall Study|Other than specified above|1|||
27756002|NCT01618708|54207307|FG001|Overall Study|Other than specified above|1|||
27756003|NCT01618708|54207306|FG000|Overall Study|Randomized but not treated|3|||
27756004|NCT01618708|54207307|FG001|Overall Study|Randomized but not treated|2|||
27756005|NCT00790933|54207323|FG000|Overall Study|Adverse Event|94|||
27756006|NCT00790933|54207324|FG001|Overall Study|Adverse Event|119|||
27756007|NCT00790933|54207325|FG002|Overall Study|Adverse Event|65|||
27756008|NCT00790933|54207326|FG003|Overall Study|Adverse Event|5|||
27756009|NCT00790933|54207327|FG004|Overall Study|Adverse Event|69|||
27756010|NCT00790933|54207323|FG000|Overall Study|Protocol Violation(s)|8|||
27756011|NCT00790933|54207324|FG001|Overall Study|Protocol Violation(s)|18|||
27756012|NCT00790933|54207325|FG002|Overall Study|Protocol Violation(s)|7|||
27756013|NCT00790933|54207326|FG003|Overall Study|Protocol Violation(s)|0|||
27756014|NCT00790933|54207327|FG004|Overall Study|Protocol Violation(s)|12|||
27756015|NCT00790933|54207323|FG000|Overall Study|Lack of Efficacy|192|||
27756016|NCT00790933|54207324|FG001|Overall Study|Lack of Efficacy|176|||
27756017|NCT00790933|54207325|FG002|Overall Study|Lack of Efficacy|130|||
27756018|NCT00790933|54207326|FG003|Overall Study|Lack of Efficacy|1|||
27756019|NCT00790933|54207327|FG004|Overall Study|Lack of Efficacy|121|||
27756020|NCT00790933|54207323|FG000|Overall Study|Study Terminated by Sponsor|0|||
27756021|NCT00790933|54207324|FG001|Overall Study|Study Terminated by Sponsor|0|||
27756022|NCT00790933|54207325|FG002|Overall Study|Study Terminated by Sponsor|1|||
27756023|NCT00790933|54207326|FG003|Overall Study|Study Terminated by Sponsor|0|||
27756024|NCT00790933|54207327|FG004|Overall Study|Study Terminated by Sponsor|0|||
27756025|NCT00790933|54207323|FG000|Overall Study|Withdrawal by Subject|123|||
27756026|NCT00790933|54207324|FG001|Overall Study|Withdrawal by Subject|120|||
27756027|NCT00790933|54207325|FG002|Overall Study|Withdrawal by Subject|52|||
27756028|NCT00790933|54207326|FG003|Overall Study|Withdrawal by Subject|6|||
27756029|NCT00790933|54207327|FG004|Overall Study|Withdrawal by Subject|50|||
27756030|NCT00790933|54207323|FG000|Overall Study|Lost to Follow-up|13|||
27756031|NCT00790933|54207324|FG001|Overall Study|Lost to Follow-up|31|||
27756032|NCT00790933|54207325|FG002|Overall Study|Lost to Follow-up|10|||
27756033|NCT00790933|54207326|FG003|Overall Study|Lost to Follow-up|1|||
27756034|NCT00790933|54207327|FG004|Overall Study|Lost to Follow-up|15|||
27756035|NCT00790933|54207323|FG000|Overall Study|Reason Not Specified|8|||
27756036|NCT00790933|54207324|FG001|Overall Study|Reason Not Specified|16|||
27756037|NCT00790933|54207325|FG002|Overall Study|Reason Not Specified|4|||
27756038|NCT00790933|54207326|FG003|Overall Study|Reason Not Specified|1|||
27756039|NCT00790933|54207327|FG004|Overall Study|Reason Not Specified|9|||
27756040|NCT02161211|54207346|FG000|Overall Study|Lost to Follow-up|21|||
27756041|NCT02161211|54207347|FG001|Overall Study|Lost to Follow-up|27|||
27756042|NCT02161211|54207348|FG002|Overall Study|Lost to Follow-up|21|||
27756043|NCT02161211|54207346|FG000|Overall Study|Dropped|12|||
27756044|NCT02161211|54207347|FG001|Overall Study|Dropped|5|||
27756045|NCT02161211|54207348|FG002|Overall Study|Dropped|9|||
27756046|NCT01676701|54207358|FG000|Overall Study|Protocol Violation|1|||
27756047|NCT01676701|54207359|FG001|Overall Study|Protocol Violation|0|||
27756048|NCT01676701|54207358|FG000|Overall Study|Sponsor Decision|3|||
27756049|NCT01676701|54207359|FG001|Overall Study|Sponsor Decision|4|||
27756050|NCT01670279|54207370|FG000|Overall Study|Adverse Event|0|||
27756051|NCT01670279|54207371|FG001|Overall Study|Adverse Event|1|||
27756052|NCT01670279|54207372|FG002|Overall Study|Adverse Event|0|||
27756053|NCT01670279|54207373|FG003|Overall Study|Adverse Event|0|||
27756054|NCT01670279|54207370|FG000|Overall Study|Physician Decision|0|||
27756055|NCT01670279|54207371|FG001|Overall Study|Physician Decision|1|||
27756056|NCT01670279|54207372|FG002|Overall Study|Physician Decision|0|||
27756057|NCT01670279|54207373|FG003|Overall Study|Physician Decision|0|||
27756058|NCT01670279|54207370|FG000|Overall Study|Participant met withdrawal criteria|0|||
27756059|NCT01670279|54207371|FG001|Overall Study|Participant met withdrawal criteria|0|||
27756060|NCT01670279|54207372|FG002|Overall Study|Participant met withdrawal criteria|0|||
27756061|NCT01670279|54207373|FG003|Overall Study|Participant met withdrawal criteria|1|||
27756062|NCT02627495|54207381|FG000|Overall Study|Withdrawal by Subject|4|||
27756063|NCT01670045|54207385|FG000|Overall Study|Withdrawal by Subject|3|||
27839163|NCT01473563|54326442|FG000|Overall Study|Lost to FU post tx discontinuation|1|||
27756064|NCT01670045|54207385|FG000|Overall Study|Adverse Event|1|||
27756065|NCT01670045|54207385|FG000|Overall Study|Death|1|||
27756066|NCT01670045|54207385|FG000|Overall Study|Lost to Follow-up|11|||
27756067|NCT01669421|54207389|FG000|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1|||
27756068|NCT01669421|54207389|FG000|Phase 1: Standard Dose Therapy|Physician Decision|1|||
27756069|NCT01671059|54207403|FG000|Overall Study|Adverse Event|4|||
27756070|NCT01671059|54207403|FG000|Overall Study|Lack of Efficacy|1|||
27756071|NCT01669811|54207419|FG000|Overall Study|Investigator decision|0|||
27756072|NCT01669811|54207420|FG001|Overall Study|Investigator decision|1|||
27756073|NCT01669811|54207419|FG000|Overall Study|Withdrawal by Subject|1|||
27756074|NCT01669811|54207420|FG001|Overall Study|Withdrawal by Subject|2|||
27756075|NCT01669811|54207419|FG000|Overall Study|Adverse Event|2|||
27756076|NCT01669811|54207420|FG001|Overall Study|Adverse Event|6|||
27756077|NCT01669811|54207419|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
27756078|NCT01669811|54207420|FG001|Overall Study|Eligibility Criteria Not Fulfilled|2|||
27756079|NCT01669577|54207426|FG000|Overall Study|Death|22|||
27756080|NCT01669577|54207426|FG000|Overall Study|Lost to Follow-up|78|||
27756081|NCT01669577|54207426|FG000|Overall Study|Physician Decision|34|||
27756082|NCT02658175|54207433|FG000|Treatment Period: Weeks 1 to 52|Investigator Judgment|1|||
27756083|NCT02658175|54207434|FG001|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
27756084|NCT02658175|54207435|FG002|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
27756085|NCT02658175|54207433|FG000|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|6|||
27756086|NCT02658175|54207434|FG001|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|2|||
27756087|NCT02658175|54207435|FG002|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|0|||
27756088|NCT02658175|54207433|FG000|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|8|||
27756089|NCT02658175|54207434|FG001|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|5|||
27756090|NCT02658175|54207435|FG002|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|0|||
27756091|NCT02658175|54207433|FG000|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|1|||
27756092|NCT02658175|54207434|FG001|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
27756093|NCT02658175|54207435|FG002|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
27756094|NCT02658175|54207433|FG000|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|4|||
27756095|NCT02658175|54207434|FG001|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|0|||
27756096|NCT02658175|54207435|FG002|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|1|||
27756097|NCT02658175|54207433|FG000|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|7|||
27756098|NCT02658175|54207434|FG001|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
27756099|NCT02658175|54207435|FG002|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
27756100|NCT02658175|54207433|FG000|1st Extended Treatment: Weeks 53 to 104|Other|1|||
27756101|NCT02658175|54207434|FG001|1st Extended Treatment: Weeks 53 to 104|Other|0|||
27756102|NCT02658175|54207435|FG002|1st Extended Treatment: Weeks 53 to 104|Other|1|||
27756103|NCT02658175|54207433|FG000|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|8|||
27756104|NCT02658175|54207434|FG001|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|2|||
27756105|NCT02658175|54207435|FG002|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|0|||
27756106|NCT02658175|54207433|FG000|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
27756107|NCT02658175|54207434|FG001|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
27756108|NCT02658175|54207435|FG002|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|1|||
27756109|NCT02658175|54207433|FG000|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|1|||
27756110|NCT02658175|54207434|FG001|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
27756111|NCT02658175|54207435|FG002|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
27756112|NCT02625623|54207445|FG000|Overall Study|Participants randomized but not treated|9|||
27756113|NCT02625623|54207446|FG001|Overall Study|Participants randomized but not treated|1|||
27756114|NCT02658019|54207454|FG000|Overall Study|Adverse Event|1|||
27756115|NCT02624687|54207460|FG000|Overall Study|Withdrawal by Subject|1|||
27756116|NCT02624687|54207461|FG001|Overall Study|Withdrawal by Subject|1|||
27756117|NCT02624687|54207460|FG000|Overall Study|medical leave from work|0|||
27756118|NCT02624687|54207461|FG001|Overall Study|medical leave from work|1|||
27756119|NCT01675765|54207469|FG000|Overall Study|Progressive disease|4|||
27756120|NCT01675765|54207470|FG001|Overall Study|Progressive disease|4|||
27756121|NCT01675765|54207469|FG000|Overall Study|Adverse Event|1|||
27756122|NCT01675765|54207470|FG001|Overall Study|Adverse Event|2|||
27756123|NCT01675765|54207469|FG000|Overall Study|Withdrawal by Subject|2|||
27756124|NCT01675765|54207470|FG001|Overall Study|Withdrawal by Subject|0|||
27756125|NCT01675765|54207469|FG000|Overall Study|Death|1|||
27756126|NCT01675765|54207470|FG001|Overall Study|Death|0|||
27756127|NCT01675765|54207469|FG000|Overall Study|Clinical progression|3|||
27756128|NCT01675765|54207470|FG001|Overall Study|Clinical progression|2|||
27756129|NCT02625233|54207478|FG000|Overall Study|Adverse Event|2|||
27756130|NCT02625233|54207479|FG001|Overall Study|Adverse Event|0|||
27756131|NCT02656693|54207488|FG000|Overall Study|Pregnancy|1|||
27756132|NCT02656693|54207489|FG001|Overall Study|Pregnancy|1|||
27756133|NCT02656693|54207490|FG002|Overall Study|Pregnancy|1|||
27756134|NCT02656693|54207488|FG000|Overall Study|Bariatric surgery|0|||
27756135|NCT02656693|54207489|FG001|Overall Study|Bariatric surgery|1|||
27756136|NCT02656693|54207490|FG002|Overall Study|Bariatric surgery|2|||
27756137|NCT02633293|54207498|FG000|Overall Study|Death|56|||
27756138|NCT02633293|54207498|FG000|Overall Study|Progressive Disease|12|||
27756139|NCT02633293|54207498|FG000|Overall Study|Adverse Event|29|||
27756140|NCT02633293|54207498|FG000|Overall Study|Withdrawal by Subject|41|||
27756141|NCT02633293|54207498|FG000|Overall Study|Protocol Violation|1|||
27756142|NCT02633293|54207498|FG000|Overall Study|Lost to Follow-up|1|||
27756143|NCT02633293|54207498|FG000|Overall Study|Study Terminated by Sponsor|24|||
27756144|NCT02633293|54207498|FG000|Overall Study|Withdrawal by Sponsor Prior to Dose Administration|1|||
27756145|NCT02633293|54207498|FG000|Overall Study|Lung Transplant|5|||
27756146|NCT02633293|54207498|FG000|Overall Study|Lack of Efficacy|2|||
27756147|NCT02633293|54207498|FG000|Overall Study|Principal Investigator Terminated Study Site|1|||
27756148|NCT02623829|54207504|FG000|Overall Study|Lost to Follow-up|1|||
27756149|NCT02623829|54207505|FG001|Overall Study|Lost to Follow-up|1|||
27756150|NCT02655679|54207516|FG000|Overall Study|Adverse Event|0|||
27756151|NCT02655679|54207517|FG001|Overall Study|Adverse Event|1|||
27756152|NCT02655679|54207518|FG002|Overall Study|Adverse Event|0|||
27756153|NCT02655679|54207519|FG003|Overall Study|Adverse Event|0|||
27756154|NCT02655679|54207520|FG004|Overall Study|Adverse Event|0|||
27756155|NCT02655679|54207516|FG000|Overall Study|Withdrawal by Subject|1|||
27756156|NCT02655679|54207517|FG001|Overall Study|Withdrawal by Subject|1|||
27756157|NCT02655679|54207518|FG002|Overall Study|Withdrawal by Subject|0|||
27756158|NCT02655679|54207519|FG003|Overall Study|Withdrawal by Subject|3|||
27756159|NCT02655679|54207520|FG004|Overall Study|Withdrawal by Subject|1|||
27756160|NCT02655679|54207516|FG000|Overall Study|Inability to Comply with the Protocol|1|||
27756161|NCT02655679|54207517|FG001|Overall Study|Inability to Comply with the Protocol|0|||
27756162|NCT02655679|54207518|FG002|Overall Study|Inability to Comply with the Protocol|0|||
27756163|NCT02655679|54207519|FG003|Overall Study|Inability to Comply with the Protocol|0|||
27756164|NCT02655679|54207520|FG004|Overall Study|Inability to Comply with the Protocol|0|||
27756165|NCT02655679|54207516|FG000|Overall Study|Lost to Follow-up|0|||
27756166|NCT02655679|54207517|FG001|Overall Study|Lost to Follow-up|1|||
27756167|NCT02655679|54207518|FG002|Overall Study|Lost to Follow-up|1|||
27756168|NCT02655679|54207519|FG003|Overall Study|Lost to Follow-up|1|||
27756169|NCT02655679|54207520|FG004|Overall Study|Lost to Follow-up|0|||
27756170|NCT02655679|54207516|FG000|Overall Study|Other Miscellaneous Reasons|1|||
27756171|NCT02655679|54207517|FG001|Overall Study|Other Miscellaneous Reasons|0|||
27756172|NCT02655679|54207518|FG002|Overall Study|Other Miscellaneous Reasons|0|||
27756173|NCT02655679|54207519|FG003|Overall Study|Other Miscellaneous Reasons|0|||
27756174|NCT02655679|54207520|FG004|Overall Study|Other Miscellaneous Reasons|0|||
27756175|NCT02623361|54207535|FG000|Overall Study|Protocol Violation|0|||
27756176|NCT02623361|54207536|FG001|Overall Study|Protocol Violation|1|||
27756177|NCT02623361|54207535|FG000|Overall Study|Withdrawal by Subject|0|||
27756178|NCT02623361|54207536|FG001|Overall Study|Withdrawal by Subject|1|||
27756179|NCT01675531|54207564|FG000|Overall Study|Adverse Event|9|||
27756180|NCT01675531|54207564|FG000|Overall Study|Withdrawal by Subject|7|||
27756181|NCT01675531|54207564|FG000|Overall Study|Lack of Efficacy|1|||
27756182|NCT01675531|54207564|FG000|Overall Study|Protocol Violation|8|||
27756183|NCT02532543|54207573|FG000|Overall Study|Lost to Follow-up|0|||
27756184|NCT02532543|54207574|FG001|Overall Study|Lost to Follow-up|0|||
27756185|NCT02532543|54207575|FG002|Overall Study|Lost to Follow-up|1|||
27756186|NCT02532543|54207576|FG003|Overall Study|Lost to Follow-up|0|||
27756187|NCT02532465|54207588|FG000|Overall Study|Protocol Violation|1|||
27756188|NCT02532465|54207589|FG001|Overall Study|Protocol Violation|0|||
27756189|NCT02532465|54207588|FG000|Overall Study|Lack of Efficacy|0|||
27756190|NCT02532465|54207589|FG001|Overall Study|Lack of Efficacy|1|||
27756191|NCT02528331|54207595|FG000|Overall Study|Withdrawal by Subject|2|||
27756192|NCT02654977|54207599|FG000|Overall Study|Death|1|||
27756193|NCT02654977|54207599|FG000|Overall Study|Lost to Follow-up|1|||
27756194|NCT02654977|54207599|FG000|Overall Study|Adverse Event|1|||
27756195|NCT02654977|54207599|FG000|Overall Study|Withdrawal by Subject|1|||
27756196|NCT02654977|54207599|FG000|Overall Study|Lack of Efficacy|3|||
27756197|NCT01362517|54207603|FG000|Overall Study|Protocol Violation|1|||
27756198|NCT01362517|54207603|FG000|Overall Study|Lost to Follow-up|1|||
27756199|NCT01362439|54207610|FG000|Overall Study|Adverse Event|1|||
27756200|NCT01362439|54207610|FG000|Overall Study|Lack of Efficacy|3|||
27756201|NCT01362439|54207610|FG000|Overall Study|Lost to Follow-up|2|||
27756202|NCT01362439|54207610|FG000|Overall Study|Study medication non-compliant|1|||
27756203|NCT01362439|54207610|FG000|Overall Study|Participant who withdrew consent|8|||
27756204|NCT02653495|54207617|FG000|Overall Study|Lost to Follow-up|2|||
27756205|NCT02653495|54207618|FG001|Overall Study|Lost to Follow-up|0|||
27756206|NCT02653495|54207617|FG000|Overall Study|Screening Failure|10|||
27756207|NCT02653495|54207618|FG001|Overall Study|Screening Failure|0|||
27756208|NCT01675141|54207624|FG000|Overall Study|Lenalidomide outside NIH|3|||
27756209|NCT01675141|54207624|FG000|Overall Study|Withdrawal by Subject|3|||
27756210|NCT01675141|54207624|FG000|Overall Study|Physician Decision|4|||
27756211|NCT01675141|54207624|FG000|Overall Study|No treatment, per protocol|1|||
27756212|NCT03367819|54207659|FG000|Overall Study|Adverse Event|4|||
27756213|NCT03367819|54207660|FG001|Overall Study|Adverse Event|4|||
27756214|NCT03367819|54207659|FG000|Overall Study|Progressive Disease|15|||
27756215|NCT03367819|54207660|FG001|Overall Study|Progressive Disease|13|||
27756216|NCT03367819|54207659|FG000|Overall Study|Withdrawal by Subject|1|||
27756217|NCT03367819|54207660|FG001|Overall Study|Withdrawal by Subject|0|||
27756218|NCT03367819|54207659|FG000|Overall Study|Other|4|||
27756219|NCT03367819|54207660|FG001|Overall Study|Other|2|||
27756220|NCT01597193|54207703|FG000|Stage 1: Dose Escalation (141 Days)|Disease progression|7|||
27756221|NCT01597193|54207704|FG001|Stage 1: Dose Escalation (141 Days)|Disease progression|8|||
27756222|NCT01597193|54207705|FG002|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
27756223|NCT01597193|54207706|FG003|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
27756224|NCT01597193|54207707|FG004|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
27756225|NCT01597193|54207708|FG005|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
27756226|NCT01597193|54207709|FG006|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
27756227|NCT01597193|54207703|FG000|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
27756228|NCT01597193|54207704|FG001|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
27756229|NCT01597193|54207705|FG002|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
27756230|NCT01597193|54207706|FG003|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1|||
27756231|NCT01597193|54207707|FG004|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2|||
27756232|NCT01597193|54207708|FG005|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3|||
27756233|NCT01597193|54207709|FG006|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
27756234|NCT01597193|54207703|FG000|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
27756235|NCT01597193|54207704|FG001|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
27756236|NCT01597193|54207705|FG002|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
27756237|NCT01597193|54207706|FG003|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
27756238|NCT01597193|54207707|FG004|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
27756239|NCT01597193|54207708|FG005|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
27756240|NCT01597193|54207709|FG006|Stage 2: Dose Expansion (1067 Days)|Disease progression|11|||
27756241|NCT01597193|54207703|FG000|Stage 2: Dose Expansion (1067 Days)|Other|0|||
27756242|NCT01597193|54207704|FG001|Stage 2: Dose Expansion (1067 Days)|Other|0|||
27756243|NCT01597193|54207705|FG002|Stage 2: Dose Expansion (1067 Days)|Other|0|||
27756244|NCT01597193|54207706|FG003|Stage 2: Dose Expansion (1067 Days)|Other|0|||
27756245|NCT01597193|54207707|FG004|Stage 2: Dose Expansion (1067 Days)|Other|0|||
27756246|NCT01597193|54207708|FG005|Stage 2: Dose Expansion (1067 Days)|Other|1|||
27756247|NCT01597193|54207709|FG006|Stage 2: Dose Expansion (1067 Days)|Other|0|||
27756248|NCT01597193|54207703|FG000|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
27756249|NCT01597193|54207704|FG001|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
27756250|NCT01597193|54207705|FG002|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
27756251|NCT01597193|54207706|FG003|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
27756252|NCT01597193|54207707|FG004|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
27756253|NCT01597193|54207708|FG005|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
27756254|NCT01597193|54207709|FG006|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
27756255|NCT02649439|54207732|FG000|Overall Study|Switched to alternative treatment|6|||
27756256|NCT02649439|54207733|FG001|Overall Study|Switched to alternative treatment|4|||
27756257|NCT02649439|54207732|FG000|Overall Study|Patient decision|1|||
27756258|NCT02649439|54207733|FG001|Overall Study|Patient decision|0|||
27756259|NCT02649439|54207732|FG000|Overall Study|Patient going out of country|1|||
27756260|NCT02649439|54207733|FG001|Overall Study|Patient going out of country|0|||
27756261|NCT02649439|54207732|FG000|Overall Study|To start finasteride|1|||
27756262|NCT02649439|54207733|FG001|Overall Study|To start finasteride|0|||
27756263|NCT02649439|54207732|FG000|Overall Study|Physician Decision|1|||
27756264|NCT02649439|54207733|FG001|Overall Study|Physician Decision|0|||
27756265|NCT02649439|54207732|FG000|Overall Study|Disease progression on study|12|||
27756266|NCT02649439|54207733|FG001|Overall Study|Disease progression on study|13|||
27756267|NCT02649439|54207732|FG000|Overall Study|Refused further treatment|1|||
27756268|NCT02649439|54207733|FG001|Overall Study|Refused further treatment|0|||
27756269|NCT02649439|54207732|FG000|Overall Study|Refused further follow up|2|||
27756270|NCT02649439|54207733|FG001|Overall Study|Refused further follow up|7|||
27756271|NCT02649439|54207732|FG000|Overall Study|Completed treatment phase but refused the protocol specified follow up|1|||
27756272|NCT02649439|54207733|FG001|Overall Study|Completed treatment phase but refused the protocol specified follow up|0|||
27756273|NCT02649439|54207732|FG000|Overall Study|No treatment, per protocol|1|||
27756274|NCT02649439|54207733|FG001|Overall Study|No treatment, per protocol|0|||
27756275|NCT02649439|54207732|FG000|Overall Study|PSA DT makes ineligible|0|||
27756276|NCT02649439|54207733|FG001|Overall Study|PSA DT makes ineligible|1|||
27756277|NCT02649439|54207732|FG000|Overall Study|Rising PSA No Mets|0|||
27756278|NCT02649439|54207733|FG001|Overall Study|Rising PSA No Mets|1|||
27756279|NCT02649439|54207732|FG000|Overall Study|Rising PSA|0|||
27756280|NCT02649439|54207733|FG001|Overall Study|Rising PSA|1|||
27756281|NCT02649439|54207732|FG000|Overall Study|Signed follow up protocol|0|||
27756282|NCT02649439|54207733|FG001|Overall Study|Signed follow up protocol|1|||
27756283|NCT02622113|54207748|FG000|Overall Study|Adverse Event|4|||
27756284|NCT02622113|54207749|FG001|Overall Study|Adverse Event|4|||
27756285|NCT02622113|54207748|FG000|Overall Study|Physician Decision|0|||
27756286|NCT02622113|54207749|FG001|Overall Study|Physician Decision|1|||
27756287|NCT02622113|54207748|FG000|Overall Study|Withdrawal by Subject|0|||
27756288|NCT02622113|54207749|FG001|Overall Study|Withdrawal by Subject|2|||
27756289|NCT02622113|54207748|FG000|Overall Study|Stopping Criteria|1|||
27756290|NCT02622113|54207749|FG001|Overall Study|Stopping Criteria|3|||
27756291|NCT02651467|54207758|FG000|Overall Study|Withdrawal by Subject|0|||
27756292|NCT02651467|54207759|FG001|Overall Study|Withdrawal by Subject|0|||
27756293|NCT02651467|54207760|FG002|Overall Study|Withdrawal by Subject|2|||
27756294|NCT02651467|54207758|FG000|Overall Study|Other (Not specified)|1|||
27756295|NCT02651467|54207759|FG001|Overall Study|Other (Not specified)|0|||
27756296|NCT02651467|54207760|FG002|Overall Study|Other (Not specified)|2|||
27756297|NCT02620787|54207789|FG000|Overall Study|Adverse Event|1|||
27756298|NCT02620787|54207790|FG001|Overall Study|Adverse Event|0|||
27756299|NCT02620787|54207789|FG000|Overall Study|Eligibility Criteria Not Met|1|||
27756300|NCT02620787|54207790|FG001|Overall Study|Eligibility Criteria Not Met|0|||
27756301|NCT02651155|54207798|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
27756302|NCT02651155|54207799|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
27756303|NCT02651155|54207798|FG000|Overall Study|Voluntary Withdrawal|5|||
27756304|NCT02651155|54207799|FG001|Overall Study|Voluntary Withdrawal|0|||
27756305|NCT02619617|54207805|FG000|Period 2 SOM230 - 2nd Attack|Protocol Violation|0|||
27756306|NCT02619617|54207806|FG001|Period 2 SOM230 - 2nd Attack|Protocol Violation|1|||
27756307|NCT02619617|54207805|FG000|Period 2 SOM230 - 2nd Attack|Physician Decision|0|||
27756308|NCT02619617|54207806|FG001|Period 2 SOM230 - 2nd Attack|Physician Decision|3|||
27756309|NCT02650921|54207827|FG000|Overall Study|Withdrawal by Subject|4|||
27756310|NCT02650921|54207827|FG000|Overall Study|Lost to Follow-up|2|||
27756311|NCT02650921|54207827|FG000|Overall Study|Adverse Event|1|||
27756312|NCT02650921|54207827|FG000|Overall Study|Due to Medical Condition|1|||
27756313|NCT01596335|54207835|FG000|Overall Study|exacerbation of primary disease|5|||
27756314|NCT01596335|54207836|FG001|Overall Study|exacerbation of primary disease|9|||
27756315|NCT02618759|54207844|FG000|Overall Study|Lost to Follow-up|0|||
27756316|NCT02618759|54207845|FG001|Overall Study|Lost to Follow-up|1|||
27756317|NCT02618759|54207844|FG000|Overall Study|Withdrawal by Subject|1|||
27756318|NCT02618759|54207845|FG001|Overall Study|Withdrawal by Subject|0|||
27756319|NCT02618759|54207844|FG000|Overall Study|Other Reasons|1|||
27756320|NCT02618759|54207845|FG001|Overall Study|Other Reasons|4|||
27756321|NCT02614079|54207860|FG000|Overall Study|Withdrawal by Subject|1|||
27756322|NCT02616029|54207866|FG000|Overall Study|Adverse Event|1|||
27756323|NCT02616029|54207867|FG001|Overall Study|Adverse Event|0|||
27756324|NCT02616029|54207866|FG000|Overall Study|Death|0|||
27756325|NCT02616029|54207867|FG001|Overall Study|Death|1|||
27756326|NCT02616029|54207866|FG000|Overall Study|Protocol Violation|1|||
27756327|NCT02616029|54207867|FG001|Overall Study|Protocol Violation|0|||
27756328|NCT02616029|54207866|FG000|Overall Study|Withdrew Consent|1|||
27756329|NCT02616029|54207867|FG001|Overall Study|Withdrew Consent|0|||
27756330|NCT02616029|54207866|FG000|Overall Study|Enrolled and Never Treated|1|||
27756331|NCT02616029|54207867|FG001|Overall Study|Enrolled and Never Treated|1|||
27756332|NCT02614859|54207875|FG000|Overall Study|Physician Decision|0|||
27756333|NCT02614859|54207876|FG001|Overall Study|Physician Decision|1|||
27756334|NCT02615249|54207884|FG000|Overall Study|Withdrawal by Subject|1|||
27756335|NCT02615171|54207891|FG000|Overall Study|Lost to Follow-up|2|||
27756336|NCT02615171|54207892|FG001|Overall Study|Lost to Follow-up|1|||
27756337|NCT02648347|54207900|FG000|Overall Study|Death|174|||
27756338|NCT02648347|54207901|FG001|Overall Study|Death|167|||
27756339|NCT02648347|54207900|FG000|Overall Study|Withdrawal by Subject|16|||
27756340|NCT02648347|54207901|FG001|Overall Study|Withdrawal by Subject|9|||
27756341|NCT02648347|54207900|FG000|Overall Study|Lost to Follow-up|18|||
27756342|NCT02648347|54207901|FG001|Overall Study|Lost to Follow-up|21|||
27756343|NCT02648347|54207900|FG000|Overall Study|Missing|1|||
27756344|NCT02648347|54207901|FG001|Overall Study|Missing|0|||
27756345|NCT02614703|54207909|FG000|Overall Study|Withdrawal by Subject|7|||
27756346|NCT02614703|54207910|FG001|Overall Study|Withdrawal by Subject|1|||
27756347|NCT01669343|54207916|FG000|Part A: All Patients|Withdrawal by Subject|7|||
28159964|NCT02737475|54830039|FG017|Overall Study|Death|2|||
27756348|NCT01669343|54207916|FG000|Part A: All Patients|Ineligibility discovered after enrollment|2|||
27756349|NCT01669343|54207916|FG000|Part B: Patients With BMI>=25|Withdrawal by Subject|13|||
27756350|NCT01669343|54207916|FG000|Part B: Patients With BMI>=25|Recruited during interim analysis|3|||
27756351|NCT01669343|54207916|FG000|Part B: Patients With BMI>=25|Ineligibility discovered after enrollment|1|||
27756352|NCT01594931|54207926|FG000|Overall Study|Adverse Event|3|||
27756353|NCT01594931|54207927|FG001|Overall Study|Adverse Event|1|||
27756354|NCT01594931|54207928|FG002|Overall Study|Adverse Event|1|||
27756355|NCT01594931|54207926|FG000|Overall Study|Withdrawal by Subject|2|||
27756356|NCT01594931|54207927|FG001|Overall Study|Withdrawal by Subject|1|||
27756357|NCT01594931|54207928|FG002|Overall Study|Withdrawal by Subject|1|||
27756358|NCT01594931|54207926|FG000|Overall Study|Lack of Efficacy|7|||
27756359|NCT01594931|54207927|FG001|Overall Study|Lack of Efficacy|2|||
27756360|NCT01594931|54207928|FG002|Overall Study|Lack of Efficacy|2|||
27756361|NCT01594931|54207926|FG000|Overall Study|Lost to Follow-up|4|||
27756362|NCT01594931|54207927|FG001|Overall Study|Lost to Follow-up|3|||
27756363|NCT01594931|54207928|FG002|Overall Study|Lost to Follow-up|3|||
27756364|NCT01594931|54207926|FG000|Overall Study|Protocol Violation|2|||
27756365|NCT01594931|54207927|FG001|Overall Study|Protocol Violation|1|||
27756366|NCT01594931|54207928|FG002|Overall Study|Protocol Violation|0|||
27756367|NCT01594931|54207926|FG000|Overall Study|No defiined|11|||
27756368|NCT01594931|54207927|FG001|Overall Study|No defiined|4|||
27756369|NCT01594931|54207928|FG002|Overall Study|No defiined|7|||
27756370|NCT01594853|54207938|FG000|Overall Study|Withdrawal by Subject|1|||
27756371|NCT01594853|54207939|FG001|Overall Study|Withdrawal by Subject|1|||
27756372|NCT01594853|54207938|FG000|Overall Study|Lost to Follow-up|1|||
27756373|NCT01594853|54207939|FG001|Overall Study|Lost to Follow-up|1|||
27756374|NCT01594853|54207938|FG000|Overall Study|noncompliance with exercise|0|||
27756375|NCT01594853|54207939|FG001|Overall Study|noncompliance with exercise|1|||
27756376|NCT01668797|54207956|FG000|Phase A (Conversion Phase)|Lost to Follow-up|3|||
27756377|NCT01668797|54207957|FG001|Phase A (Conversion Phase)|Lost to Follow-up|0|||
27756378|NCT01668797|54207958|FG002|Phase A (Conversion Phase)|Lost to Follow-up|0|||
27756379|NCT01668797|54207959|FG003|Phase A (Conversion Phase)|Lost to Follow-up|0|||
27756380|NCT01668797|54207956|FG000|Phase A (Conversion Phase)|Met Withdrawal Criteria|3|||
27756381|NCT01668797|54207957|FG001|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
27756382|NCT01668797|54207958|FG002|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
27756383|NCT01668797|54207959|FG003|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
27756384|NCT01668797|54207956|FG000|Phase A (Conversion Phase)|Physician Decision|2|||
27756385|NCT01668797|54207957|FG001|Phase A (Conversion Phase)|Physician Decision|0|||
27756386|NCT01668797|54207958|FG002|Phase A (Conversion Phase)|Physician Decision|0|||
27756387|NCT01668797|54207959|FG003|Phase A (Conversion Phase)|Physician Decision|0|||
27756388|NCT01668797|54207956|FG000|Phase A (Conversion Phase)|Withdrawal by Subject|16|||
27756389|NCT01668797|54207957|FG001|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
27756390|NCT01668797|54207958|FG002|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
27756391|NCT01668797|54207959|FG003|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
27756392|NCT01668797|54207956|FG000|Phase A (Conversion Phase)|Protocol Violation|2|||
27756393|NCT01668797|54207957|FG001|Phase A (Conversion Phase)|Protocol Violation|0|||
27756394|NCT01668797|54207958|FG002|Phase A (Conversion Phase)|Protocol Violation|0|||
27756395|NCT01668797|54207959|FG003|Phase A (Conversion Phase)|Protocol Violation|0|||
27756396|NCT01668797|54207956|FG000|Phase A (Conversion Phase)|Lack of Efficacy|7|||
27756397|NCT01668797|54207957|FG001|Phase A (Conversion Phase)|Lack of Efficacy|0|||
27756398|NCT01668797|54207958|FG002|Phase A (Conversion Phase)|Lack of Efficacy|0|||
27756399|NCT01668797|54207959|FG003|Phase A (Conversion Phase)|Lack of Efficacy|0|||
27756400|NCT01668797|54207956|FG000|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8|||
27756401|NCT01668797|54207957|FG001|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
27756402|NCT01668797|54207958|FG002|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
27756403|NCT01668797|54207959|FG003|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
27756404|NCT01668797|54207956|FG000|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19|||
27756405|NCT01668797|54207957|FG001|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
27756406|NCT01668797|54207958|FG002|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
27756407|NCT01668797|54207959|FG003|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
27756408|NCT01668797|54207956|FG000|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
27756409|NCT01668797|54207957|FG001|Phase B (Stabilization Phase)|Lost to Follow-up|16|||
27756410|NCT01668797|54207958|FG002|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
27756411|NCT01668797|54207959|FG003|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
27756412|NCT01668797|54207956|FG000|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
27756413|NCT01668797|54207957|FG001|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22|||
27756414|NCT01668797|54207958|FG002|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
27756415|NCT01668797|54207959|FG003|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
27756416|NCT01668797|54207956|FG000|Phase B (Stabilization Phase)|Physician Decision|0|||
27756417|NCT01668797|54207957|FG001|Phase B (Stabilization Phase)|Physician Decision|11|||
27756418|NCT01668797|54207958|FG002|Phase B (Stabilization Phase)|Physician Decision|0|||
27756419|NCT01668797|54207959|FG003|Phase B (Stabilization Phase)|Physician Decision|0|||
27756420|NCT01668797|54207956|FG000|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
27756421|NCT01668797|54207957|FG001|Phase B (Stabilization Phase)|Withdrawal by Subject|60|||
27756422|NCT01668797|54207958|FG002|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
27756423|NCT01668797|54207959|FG003|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
27756424|NCT01668797|54207956|FG000|Phase B (Stabilization Phase)|Protocol Violation|0|||
27756425|NCT01668797|54207957|FG001|Phase B (Stabilization Phase)|Protocol Violation|3|||
27756426|NCT01668797|54207958|FG002|Phase B (Stabilization Phase)|Protocol Violation|0|||
27756427|NCT01668797|54207959|FG003|Phase B (Stabilization Phase)|Protocol Violation|0|||
27756428|NCT01668797|54207956|FG000|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
27756429|NCT01668797|54207957|FG001|Phase B (Stabilization Phase)|Lack of Efficacy|21|||
27756430|NCT01668797|54207958|FG002|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
27756431|NCT01668797|54207959|FG003|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
27756432|NCT01668797|54207956|FG000|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
27756433|NCT01668797|54207957|FG001|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43|||
28159965|NCT02737475|54830040|FG018|Overall Study|Death|1|||
27756434|NCT01668797|54207958|FG002|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
27756435|NCT01668797|54207959|FG003|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
27756436|NCT01668797|54207956|FG000|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
27756437|NCT01668797|54207957|FG001|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86|||
27756438|NCT01668797|54207958|FG002|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
27756439|NCT01668797|54207959|FG003|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
27756440|NCT01668797|54207956|FG000|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
27756441|NCT01668797|54207957|FG001|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
27756442|NCT01668797|54207958|FG002|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4|||
27756443|NCT01668797|54207959|FG003|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6|||
27756444|NCT01668797|54207956|FG000|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
27756445|NCT01668797|54207957|FG001|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
27756446|NCT01668797|54207958|FG002|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
27756447|NCT01668797|54207959|FG003|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
27756448|NCT01668797|54207956|FG000|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
27756449|NCT01668797|54207957|FG001|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
27756450|NCT01668797|54207958|FG002|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5|||
27756451|NCT01668797|54207959|FG003|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2|||
27756452|NCT01668797|54207956|FG000|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
27756453|NCT01668797|54207957|FG001|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
27756454|NCT01668797|54207958|FG002|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3|||
27756455|NCT01668797|54207959|FG003|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5|||
27756456|NCT01668797|54207956|FG000|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
27756457|NCT01668797|54207957|FG001|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
27756458|NCT01668797|54207958|FG002|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2|||
27756459|NCT01668797|54207959|FG003|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
27756460|NCT01668797|54207956|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
27756461|NCT01668797|54207957|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
27756462|NCT01668797|54207958|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2|||
27756463|NCT01668797|54207959|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10|||
27756464|NCT01668797|54207956|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
27756465|NCT01668797|54207957|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
27756466|NCT01668797|54207958|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11|||
27756467|NCT01668797|54207959|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30|||
27756468|NCT01668797|54207956|FG000|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
27756469|NCT01668797|54207957|FG001|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
27756470|NCT01668797|54207958|FG002|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4|||
27756471|NCT01668797|54207959|FG003|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2|||
27756472|NCT01668797|54207956|FG000|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
27756473|NCT01668797|54207957|FG001|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
27756474|NCT01668797|54207958|FG002|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49|||
27756475|NCT01668797|54207959|FG003|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38|||
27756476|NCT02613221|54207966|FG000|Overall Study|Lack of efficacy (exacerbation)|50|||
27756477|NCT02613221|54207966|FG000|Overall Study|Adverse Event|2|||
27756478|NCT02613221|54207966|FG000|Overall Study|Voluntary Discontinuation|1|||
27756479|NCT02613221|54207966|FG000|Overall Study|Delayed Treatment|1|||
27756480|NCT02613221|54207966|FG000|Overall Study|Enrolled but Not Treated|1|||
27756481|NCT01362049|54207974|FG000|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
27756482|NCT01362049|54207975|FG001|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
27756483|NCT01362049|54207976|FG002|Follow-Up at 7 Weeks|Lost to Follow-up|2|||
27756484|NCT01362049|54207977|FG003|Follow-Up at 7 Weeks|Lost to Follow-up|1|||
27756485|NCT01362049|54207974|FG000|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5|||
27756486|NCT01362049|54207975|FG001|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
27756487|NCT01362049|54207976|FG002|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2|||
27756488|NCT01362049|54207977|FG003|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
27756489|NCT02612909|54208009|FG000|Phase 2|Withdrawal by Subject|2|||
27756490|NCT02612909|54208010|FG001|Phase 2|Withdrawal by Subject|5|||
27756491|NCT02612909|54208011|FG002|Phase 2|Withdrawal by Subject|0|||
27756492|NCT02612909|54208012|FG003|Phase 2|Withdrawal by Subject|0|||
27756493|NCT02612909|54208013|FG004|Phase 2|Withdrawal by Subject|0|||
27756494|NCT02612909|54208009|FG000|Phase 2|Pregnancy|0|||
27756495|NCT02612909|54208010|FG001|Phase 2|Pregnancy|0|||
27756496|NCT02612909|54208011|FG002|Phase 2|Pregnancy|1|||
27756497|NCT02612909|54208012|FG003|Phase 2|Pregnancy|0|||
27756498|NCT02612909|54208013|FG004|Phase 2|Pregnancy|0|||
27756499|NCT02612909|54208009|FG000|Phase 3|Withdrawal by Subject|0|||
27756500|NCT02612909|54208010|FG001|Phase 3|Withdrawal by Subject|0|||
27756501|NCT02612909|54208011|FG002|Phase 3|Withdrawal by Subject|0|||
27756502|NCT02612909|54208012|FG003|Phase 3|Withdrawal by Subject|1|||
27756503|NCT02612909|54208013|FG004|Phase 3|Withdrawal by Subject|0|||
27756504|NCT02612285|54208027|FG000|Overall Study|Withdrawal by Subject|1|||
27756505|NCT02609633|54208033|FG000|Overall Study|Consent Withdrawn|0|||
27756506|NCT02609633|54208034|FG001|Overall Study|Consent Withdrawn|1|||
27756507|NCT02609633|54208033|FG000|Overall Study|Protocol Deviation|1|||
27756508|NCT02609633|54208034|FG001|Overall Study|Protocol Deviation|0|||
27756509|NCT02609633|54208033|FG000|Overall Study|Non-Compliant with Study Procedures|2|||
27756510|NCT02609633|54208034|FG001|Overall Study|Non-Compliant with Study Procedures|0|||
27756511|NCT02609633|54208033|FG000|Overall Study|Reason not Specified|2|||
27756512|NCT02609633|54208034|FG001|Overall Study|Reason not Specified|1|||
27756513|NCT01371981|54208053|FG000|Overall Study|Adverse Event|12|||
27756514|NCT01371981|54208054|FG001|Overall Study|Adverse Event|17|||
27756515|NCT01371981|54208055|FG002|Overall Study|Adverse Event|0|||
27756516|NCT01371981|54208056|FG003|Overall Study|Adverse Event|4|||
27756517|NCT01371981|54208057|FG004|Overall Study|Adverse Event|1|||
27756518|NCT01371981|54208058|FG005|Overall Study|Adverse Event|0|||
27756519|NCT01371981|54208053|FG000|Overall Study|Death|22|||
27756520|NCT01371981|54208054|FG001|Overall Study|Death|16|||
27756521|NCT01371981|54208055|FG002|Overall Study|Death|0|||
27756522|NCT01371981|54208056|FG003|Overall Study|Death|0|||
27756523|NCT01371981|54208057|FG004|Overall Study|Death|2|||
27756524|NCT01371981|54208058|FG005|Overall Study|Death|2|||
27756525|NCT01371981|54208053|FG000|Overall Study|Lack of Efficacy|69|||
27756526|NCT01371981|54208054|FG001|Overall Study|Lack of Efficacy|61|||
27756527|NCT01371981|54208055|FG002|Overall Study|Lack of Efficacy|4|||
27756528|NCT01371981|54208056|FG003|Overall Study|Lack of Efficacy|8|||
27756529|NCT01371981|54208057|FG004|Overall Study|Lack of Efficacy|5|||
27756530|NCT01371981|54208058|FG005|Overall Study|Lack of Efficacy|0|||
27756531|NCT01371981|54208053|FG000|Overall Study|Physician Decision|48|||
27756532|NCT01371981|54208054|FG001|Overall Study|Physician Decision|63|||
27756533|NCT01371981|54208055|FG002|Overall Study|Physician Decision|1|||
27756534|NCT01371981|54208056|FG003|Overall Study|Physician Decision|7|||
27756535|NCT01371981|54208057|FG004|Overall Study|Physician Decision|14|||
27756536|NCT01371981|54208058|FG005|Overall Study|Physician Decision|3|||
27756537|NCT01371981|54208053|FG000|Overall Study|Withdrawal by Subject|12|||
27756538|NCT01371981|54208054|FG001|Overall Study|Withdrawal by Subject|19|||
27756539|NCT01371981|54208055|FG002|Overall Study|Withdrawal by Subject|1|||
27756540|NCT01371981|54208056|FG003|Overall Study|Withdrawal by Subject|2|||
27756541|NCT01371981|54208057|FG004|Overall Study|Withdrawal by Subject|10|||
27756542|NCT01371981|54208058|FG005|Overall Study|Withdrawal by Subject|3|||
27756543|NCT01371981|54208053|FG000|Overall Study|Ineligible|19|||
27756544|NCT01371981|54208054|FG001|Overall Study|Ineligible|13|||
27756545|NCT01371981|54208055|FG002|Overall Study|Ineligible|0|||
27756546|NCT01371981|54208056|FG003|Overall Study|Ineligible|0|||
27756547|NCT01371981|54208057|FG004|Overall Study|Ineligible|0|||
27756548|NCT01371981|54208058|FG005|Overall Study|Ineligible|4|||
27756549|NCT01371981|54208053|FG000|Overall Study|Did not start treatment|2|||
27756550|NCT01371981|54208054|FG001|Overall Study|Did not start treatment|3|||
27756551|NCT01371981|54208055|FG002|Overall Study|Did not start treatment|0|||
27756552|NCT01371981|54208056|FG003|Overall Study|Did not start treatment|0|||
27756553|NCT01371981|54208057|FG004|Overall Study|Did not start treatment|0|||
27756554|NCT01371981|54208058|FG005|Overall Study|Did not start treatment|2|||
27756555|NCT01597375|54208086|FG000|First Intervention (4 Weeks)|Uncontrolled Asthma|1|||
27756556|NCT01597375|54208087|FG001|First Intervention (4 Weeks)|Uncontrolled Asthma|0|||
27756557|NCT01597375|54208086|FG000|First Intervention (4 Weeks)|Needed surgery|1|||
27756558|NCT01597375|54208087|FG001|First Intervention (4 Weeks)|Needed surgery|0|||
27756559|NCT01597375|54208086|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
27756560|NCT01597375|54208087|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
27756561|NCT01597375|54208086|FG000|Washout (2 Weeks)|Adverse Event|1|||
27756562|NCT01597375|54208087|FG001|Washout (2 Weeks)|Adverse Event|0|||
27839164|NCT01484275|54326460|FG000|Overall Study|Study terminated by sponsor|28|||
27839165|NCT01484275|54326461|FG001|Overall Study|Study terminated by sponsor|32|||
27756563|NCT01597375|54208086|FG000|Second Intervention|Failed to react at both Aspirin|1|||
27756564|NCT01597375|54208087|FG001|Second Intervention|Failed to react at both Aspirin|1|||
27756565|NCT02527161|54208094|FG000|Overall Study|Failed MRI|52|||
27756566|NCT02527161|54208094|FG000|Overall Study|Withdrawal by Subject|19|||
27756567|NCT02527161|54208094|FG000|Overall Study|Delay in or unfit for surgery|16|||
27756568|NCT02527161|54208094|FG000|Overall Study|MRI contraindication|6|||
27756569|NCT02527161|54208094|FG000|Overall Study|Consent violation|4|||
27756570|NCT02527161|54208094|FG000|Overall Study|Only Recruited to Part A|27|||
27756571|NCT02527161|54208094|FG000|Overall Study|Physician Decision|1|||
27756572|NCT02527161|54208094|FG000|Overall Study|Adverse Event|1|||
27756573|NCT02527161|54208094|FG000|Overall Study|Lost to Follow-up|6|||
27756574|NCT02609399|54208101|FG000|Influenza Season 2015-2016|Lost to Follow-up|3|||
27756575|NCT02609399|54208102|FG001|Influenza Season 2015-2016|Lost to Follow-up|2|||
27756576|NCT02609399|54208101|FG000|Influenza Season 2016-2017|Lost to Follow-up|8|||
27756577|NCT02609399|54208102|FG001|Influenza Season 2016-2017|Lost to Follow-up|5|||
27756578|NCT02609399|54208101|FG000|Influenza Season 2016-2017|Found ineligible after randomization|1|||
27756579|NCT02609399|54208102|FG001|Influenza Season 2016-2017|Found ineligible after randomization|0|||
27756580|NCT02720185|54208110|FG000|Overall Study|Lost to Follow-up|1|||
27756581|NCT02526693|54208133|FG000|Overall Study|Physician Decision|3|||
27756582|NCT02526693|54208134|FG001|Overall Study|Physician Decision|1|||
27756583|NCT02710669|54208152|FG000|Overall Study|Physician Decision|2|||
27756584|NCT02710669|54208153|FG001|Overall Study|Physician Decision|1|||
27756585|NCT02710669|54208154|FG002|Overall Study|Physician Decision|0|||
27756586|NCT02710669|54208152|FG000|Overall Study|Institutional delays (including COVID)|2|||
27756587|NCT02710669|54208153|FG001|Overall Study|Institutional delays (including COVID)|2|||
27756588|NCT02710669|54208154|FG002|Overall Study|Institutional delays (including COVID)|0|||
27756589|NCT02710669|54208152|FG000|Overall Study|arrived in afib/aflutter|10|||
27756590|NCT02710669|54208153|FG001|Overall Study|arrived in afib/aflutter|8|||
27756591|NCT02710669|54208154|FG002|Overall Study|arrived in afib/aflutter|2|||
27756592|NCT02610725|54208162|FG000|Overall Study|Lost to Follow-up|197|||
27756593|NCT02610725|54208162|FG000|Overall Study|self-reported contraindication|9|||
27756594|NCT02684461|54208169|FG000|Overall Study|Adverse Event|1|||
27756595|NCT02684461|54208170|FG001|Overall Study|Adverse Event|0|||
27756596|NCT02684461|54208171|FG002|Overall Study|Adverse Event|0|||
27756597|NCT02684461|54208169|FG000|Overall Study|Lack of Efficacy|1|||
27756598|NCT02684461|54208170|FG001|Overall Study|Lack of Efficacy|2|||
27756599|NCT02684461|54208171|FG002|Overall Study|Lack of Efficacy|0|||
27756600|NCT02647645|54208196|FG000|Overall Study|Lost to Follow-up|2|||
27756601|NCT02647645|54208197|FG001|Overall Study|Lost to Follow-up|1|||
27756602|NCT02531373|54208212|FG000|Overall Study|Lack of Efficacy|0|||
27756603|NCT02531373|54208213|FG001|Overall Study|Lack of Efficacy|0|||
27756604|NCT02531373|54208214|FG002|Overall Study|Lack of Efficacy|0|||
27756605|NCT02531373|54208215|FG003|Overall Study|Lack of Efficacy|0|||
27756606|NCT02531373|54208216|FG004|Overall Study|Lack of Efficacy|3|||
27756607|NCT02531373|54208217|FG005|Overall Study|Lack of Efficacy|2|||
27756608|NCT02531373|54208218|FG006|Overall Study|Lack of Efficacy|4|||
27756609|NCT02531373|54208219|FG007|Overall Study|Lack of Efficacy|8|||
27756610|NCT02531373|54208220|FG008|Overall Study|Lack of Efficacy|5|||
27756611|NCT02531373|54208212|FG000|Overall Study|Lost to Follow-up|0|||
27756612|NCT02531373|54208213|FG001|Overall Study|Lost to Follow-up|0|||
27756613|NCT02531373|54208214|FG002|Overall Study|Lost to Follow-up|0|||
27756614|NCT02531373|54208215|FG003|Overall Study|Lost to Follow-up|0|||
27756615|NCT02531373|54208216|FG004|Overall Study|Lost to Follow-up|0|||
27756616|NCT02531373|54208217|FG005|Overall Study|Lost to Follow-up|2|||
27756617|NCT02531373|54208218|FG006|Overall Study|Lost to Follow-up|2|||
27756618|NCT02531373|54208219|FG007|Overall Study|Lost to Follow-up|0|||
27756619|NCT02531373|54208220|FG008|Overall Study|Lost to Follow-up|0|||
27756620|NCT02531373|54208212|FG000|Overall Study|Physician Decision|0|||
27756621|NCT02531373|54208213|FG001|Overall Study|Physician Decision|0|||
27756622|NCT02531373|54208214|FG002|Overall Study|Physician Decision|0|||
27756623|NCT02531373|54208215|FG003|Overall Study|Physician Decision|0|||
27756624|NCT02531373|54208216|FG004|Overall Study|Physician Decision|2|||
27756625|NCT02531373|54208217|FG005|Overall Study|Physician Decision|1|||
27756626|NCT02531373|54208218|FG006|Overall Study|Physician Decision|0|||
27839166|NCT01484275|54326460|FG000|Overall Study|Other|10|||
27839167|NCT01484275|54326461|FG001|Overall Study|Other|0|||
27839168|NCT01484275|54326460|FG000|Overall Study|Death|3|||
27839169|NCT01484275|54326461|FG001|Overall Study|Death|4|||
27756627|NCT02531373|54208219|FG007|Overall Study|Physician Decision|0|||
27756628|NCT02531373|54208220|FG008|Overall Study|Physician Decision|0|||
27756629|NCT02531373|54208212|FG000|Overall Study|Protocol Violation|0|||
27756630|NCT02531373|54208213|FG001|Overall Study|Protocol Violation|0|||
27756631|NCT02531373|54208214|FG002|Overall Study|Protocol Violation|0|||
27756632|NCT02531373|54208215|FG003|Overall Study|Protocol Violation|0|||
27756633|NCT02531373|54208216|FG004|Overall Study|Protocol Violation|0|||
27756634|NCT02531373|54208217|FG005|Overall Study|Protocol Violation|1|||
27756635|NCT02531373|54208218|FG006|Overall Study|Protocol Violation|1|||
27756636|NCT02531373|54208219|FG007|Overall Study|Protocol Violation|0|||
27756637|NCT02531373|54208220|FG008|Overall Study|Protocol Violation|1|||
28159966|NCT02737475|54830041|FG019|Overall Study|Death|0|||
27756638|NCT02531373|54208212|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
27756639|NCT02531373|54208213|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
27756640|NCT02531373|54208214|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
27756641|NCT02531373|54208215|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
27756642|NCT02531373|54208216|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
27756643|NCT02531373|54208217|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
27756644|NCT02531373|54208218|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
27756645|NCT02531373|54208219|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
27756646|NCT02531373|54208220|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
27756647|NCT02531373|54208212|FG000|Overall Study|Withdrawal by Subject|0|||
27756648|NCT02531373|54208213|FG001|Overall Study|Withdrawal by Subject|0|||
27756649|NCT02531373|54208214|FG002|Overall Study|Withdrawal by Subject|0|||
27756650|NCT02531373|54208215|FG003|Overall Study|Withdrawal by Subject|0|||
27756651|NCT02531373|54208216|FG004|Overall Study|Withdrawal by Subject|3|||
27756652|NCT02531373|54208217|FG005|Overall Study|Withdrawal by Subject|0|||
27756653|NCT02531373|54208218|FG006|Overall Study|Withdrawal by Subject|0|||
27756654|NCT02531373|54208219|FG007|Overall Study|Withdrawal by Subject|0|||
27756655|NCT02531373|54208220|FG008|Overall Study|Withdrawal by Subject|0|||
27756656|NCT02606279|54208243|FG000|Overall Study|Lost to Follow-up|0|||
27756657|NCT02606279|54208244|FG001|Overall Study|Lost to Follow-up|1|||
27756658|NCT02643355|54208258|FG000|Overall Study|Withdrawal by Subject|1|||
27756659|NCT02643355|54208259|FG001|Overall Study|Withdrawal by Subject|3|||
27756660|NCT02643355|54208258|FG000|Overall Study|Protocol Violation|0|||
27756661|NCT02643355|54208259|FG001|Overall Study|Protocol Violation|2|||
27756662|NCT02604017|54208267|FG000|Overall Study|Withdrew Consent|0|||
27756663|NCT02604017|54208268|FG001|Overall Study|Withdrew Consent|2|||
27756664|NCT02604017|54208267|FG000|Overall Study|Lost to Follow-up|5|||
27756665|NCT02604017|54208268|FG001|Overall Study|Lost to Follow-up|6|||
27756666|NCT02604017|54208267|FG000|Overall Study|Other|1|||
27756667|NCT02604017|54208268|FG001|Overall Study|Other|0|||
27756668|NCT02640547|54208274|FG000|Overall Study|Failure to Return|1|||
27756669|NCT02640547|54208274|FG000|Overall Study|Withdrawal by Subject|1|||
27756670|NCT02640547|54208274|FG000|Overall Study|Death|6|||
27756671|NCT02640547|54208274|FG000|Overall Study|Miscellaneous|3|||
27756672|NCT02530905|54208288|FG000|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
27756673|NCT02530905|54208289|FG001|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
27756674|NCT02530905|54208290|FG002|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|1|||
27756675|NCT02530671|54208314|FG000|Overall Study|Lost to Follow-up|2|||
27756676|NCT02530671|54208315|FG001|Overall Study|Lost to Follow-up|0|||
27756677|NCT02530671|54208314|FG000|Overall Study|Withdrawal by Subject|1|||
27756678|NCT02530671|54208315|FG001|Overall Study|Withdrawal by Subject|0|||
27756679|NCT02603393|54208323|FG000|Overall Study|Patient/guardian decision|32|||
27756680|NCT02603393|54208324|FG001|Overall Study|Patient/guardian decision|18|||
27756681|NCT02603393|54208323|FG000|Overall Study|Adverse Event|17|||
27756682|NCT02603393|54208324|FG001|Overall Study|Adverse Event|15|||
27756683|NCT02603393|54208323|FG000|Overall Study|Technical problems|4|||
27756684|NCT02603393|54208324|FG001|Overall Study|Technical problems|7|||
27756685|NCT02603393|54208323|FG000|Overall Study|Lack of Efficacy|7|||
27756686|NCT02603393|54208324|FG001|Overall Study|Lack of Efficacy|2|||
27756687|NCT02603393|54208323|FG000|Overall Study|Death|3|||
27756688|NCT02603393|54208324|FG001|Overall Study|Death|4|||
27756689|NCT02603393|54208323|FG000|Overall Study|Physician Decision|3|||
27756690|NCT02603393|54208324|FG001|Overall Study|Physician Decision|3|||
27756691|NCT02603393|54208323|FG000|Overall Study|Protocol deviation|2|||
27756692|NCT02603393|54208324|FG001|Overall Study|Protocol deviation|3|||
27756693|NCT02603393|54208323|FG000|Overall Study|Lost to Follow-up|1|||
27756694|NCT02603393|54208324|FG001|Overall Study|Lost to Follow-up|2|||
27756695|NCT02603393|54208323|FG000|Overall Study|Non-compliance with study treatment|1|||
27756696|NCT02603393|54208324|FG001|Overall Study|Non-compliance with study treatment|0|||
27756697|NCT02603393|54208323|FG000|Overall Study|Sponsor decision|1|||
27756698|NCT02603393|54208324|FG001|Overall Study|Sponsor decision|0|||
27756699|NCT02642653|54208332|FG000|Overall Study|Adverse Event|2|||
27756700|NCT02642653|54208333|FG001|Overall Study|Adverse Event|0|||
27756701|NCT01659567|54208339|FG000|Overall Study|Lack of Efficacy|22|||
27756702|NCT01659567|54208339|FG000|Overall Study|Switched to Pegferon|6|||
27756703|NCT01659567|54208339|FG000|Overall Study|Adverse Event|12|||
27756704|NCT01659567|54208339|FG000|Overall Study|Good result at early stage of treatment|5|||
27756705|NCT01659567|54208339|FG000|Overall Study|Withdrawal by Subject|64|||
27756706|NCT01659567|54208339|FG000|Overall Study|Progression of the main disease|1|||
27756707|NCT01659567|54208339|FG000|Overall Study|Other|13|||
27756708|NCT02605967|54208355|FG000|Overall Study|subject / guardian decision|1|||
27756709|NCT02605967|54208356|FG001|Overall Study|subject / guardian decision|2|||
27756710|NCT02605967|54208355|FG000|Overall Study|Physician Decision|10|||
27756711|NCT02605967|54208356|FG001|Overall Study|Physician Decision|1|||
27756712|NCT02605967|54208355|FG000|Overall Study|Death|4|||
27756713|NCT02605967|54208356|FG001|Overall Study|Death|2|||
27756714|NCT02605967|54208355|FG000|Overall Study|Adverse Event|1|||
27756715|NCT02605967|54208356|FG001|Overall Study|Adverse Event|0|||
27756716|NCT02605967|54208355|FG000|Overall Study|progressive disease|66|||
27756717|NCT02605967|54208356|FG001|Overall Study|progressive disease|35|||
27756718|NCT01668173|54208366|FG000|Overall Study|Adverse Event|3|||
27756719|NCT01668173|54208366|FG000|Overall Study|Trial suspension|4|||
27756720|NCT02600351|54208383|FG000|Overall Study|Lack of Efficacy|3|||
27756721|NCT02600351|54208384|FG001|Overall Study|Lack of Efficacy|0|||
27756722|NCT02600351|54208385|FG002|Overall Study|Lack of Efficacy|5|||
27756723|NCT02600351|54208386|FG003|Overall Study|Lack of Efficacy|2|||
27756724|NCT02600351|54208383|FG000|Overall Study|Lost to Follow-up|1|||
27756725|NCT02600351|54208384|FG001|Overall Study|Lost to Follow-up|0|||
27756726|NCT02600351|54208385|FG002|Overall Study|Lost to Follow-up|0|||
27756727|NCT02600351|54208386|FG003|Overall Study|Lost to Follow-up|0|||
27756728|NCT02600351|54208383|FG000|Overall Study|Randomized but Not Treated|1|||
27756729|NCT02600351|54208384|FG001|Overall Study|Randomized but Not Treated|0|||
27756730|NCT02600351|54208385|FG002|Overall Study|Randomized but Not Treated|1|||
27756731|NCT02600351|54208386|FG003|Overall Study|Randomized but Not Treated|3|||
27756732|NCT02640235|54208400|FG000|Overall Study|Withdrawal by Subject|7|||
27756733|NCT02640235|54208401|FG001|Overall Study|Withdrawal by Subject|6|||
27756734|NCT02640235|54208400|FG000|Overall Study|Lost to Follow-up|4|||
27756735|NCT02640235|54208401|FG001|Overall Study|Lost to Follow-up|3|||
27756736|NCT02640235|54208400|FG000|Overall Study|Death|2|||
27756737|NCT02640235|54208401|FG001|Overall Study|Death|3|||
27756738|NCT02640235|54208400|FG000|Overall Study|Other|1|||
27756739|NCT02640235|54208401|FG001|Overall Study|Other|2|||
27756740|NCT02599961|54208407|FG000|Overall Study|Withdrawal by Subject|1|||
27756741|NCT02599961|54208407|FG000|Overall Study|Subject Non-Compliance|2|||
27756742|NCT02599961|54208407|FG000|Overall Study|Discontinuation of Study by Sponsor|9|||
27756743|NCT02599961|54208407|FG000|Overall Study|Other, Not Specified|3|||
27756744|NCT02640157|54208432|FG000|Overall Study|Adverse Event|2|||
27756745|NCT02640157|54208433|FG001|Overall Study|Adverse Event|2|||
27756746|NCT02640157|54208434|FG002|Overall Study|Adverse Event|1|||
27756747|NCT02640157|54208432|FG000|Overall Study|Withdrew consent|2|||
27756748|NCT02640157|54208433|FG001|Overall Study|Withdrew consent|0|||
27756749|NCT02640157|54208434|FG002|Overall Study|Withdrew consent|2|||
27756750|NCT02640157|54208432|FG000|Overall Study|Lost to Follow-up|9|||
27756751|NCT02640157|54208433|FG001|Overall Study|Lost to Follow-up|2|||
27756752|NCT02640157|54208434|FG002|Overall Study|Lost to Follow-up|7|||
27756753|NCT02640157|54208432|FG000|Overall Study|Randomized in error; did not receive Tx|0|||
27756754|NCT02640157|54208433|FG001|Overall Study|Randomized in error; did not receive Tx|1|||
27756755|NCT02640157|54208434|FG002|Overall Study|Randomized in error; did not receive Tx|0|||
27756756|NCT01673347|54208443|FG000|Overall Study|failure of allograft|7|||
27756757|NCT02528253|54208452|FG000|Overall Study|Adverse Event|3|||
27756758|NCT02528253|54208453|FG001|Overall Study|Adverse Event|4|||
27756759|NCT02528253|54208454|FG002|Overall Study|Adverse Event|4|||
27756760|NCT02528253|54208455|FG003|Overall Study|Adverse Event|8|||
27756761|NCT02528253|54208456|FG004|Overall Study|Adverse Event|18|||
27756762|NCT02528253|54208452|FG000|Overall Study|Death|2|||
27756763|NCT02528253|54208453|FG001|Overall Study|Death|2|||
27756764|NCT02528253|54208454|FG002|Overall Study|Death|1|||
27756765|NCT02528253|54208455|FG003|Overall Study|Death|0|||
27756766|NCT02528253|54208456|FG004|Overall Study|Death|1|||
27756767|NCT02528253|54208452|FG000|Overall Study|Insufficient clinical response|7|||
27756768|NCT02528253|54208453|FG001|Overall Study|Insufficient clinical response|10|||
27756769|NCT02528253|54208454|FG002|Overall Study|Insufficient clinical response|13|||
27756770|NCT02528253|54208455|FG003|Overall Study|Insufficient clinical response|12|||
27756771|NCT02528253|54208456|FG004|Overall Study|Insufficient clinical response|16|||
27756772|NCT02528253|54208452|FG000|Overall Study|Lost to Follow-up|16|||
27756773|NCT02528253|54208453|FG001|Overall Study|Lost to Follow-up|9|||
27756774|NCT02528253|54208454|FG002|Overall Study|Lost to Follow-up|31|||
27756775|NCT02528253|54208455|FG003|Overall Study|Lost to Follow-up|16|||
27756776|NCT02528253|54208456|FG004|Overall Study|Lost to Follow-up|34|||
27756777|NCT02528253|54208452|FG000|Overall Study|Other|21|||
27756778|NCT02528253|54208453|FG001|Overall Study|Other|22|||
27756779|NCT02528253|54208454|FG002|Overall Study|Other|58|||
27756780|NCT02528253|54208455|FG003|Overall Study|Other|52|||
27756781|NCT02528253|54208456|FG004|Overall Study|Other|76|||
27756782|NCT02528253|54208452|FG000|Overall Study|Withdrawal by Subject|25|||
27756783|NCT02528253|54208453|FG001|Overall Study|Withdrawal by Subject|20|||
27756784|NCT02528253|54208454|FG002|Overall Study|Withdrawal by Subject|29|||
27756785|NCT02528253|54208455|FG003|Overall Study|Withdrawal by Subject|48|||
27756786|NCT02528253|54208456|FG004|Overall Study|Withdrawal by Subject|73|||
27756787|NCT02528253|54208452|FG000|Overall Study|Protocol Violation|1|||
27756788|NCT02528253|54208453|FG001|Overall Study|Protocol Violation|2|||
27756789|NCT02528253|54208454|FG002|Overall Study|Protocol Violation|4|||
27756790|NCT02528253|54208455|FG003|Overall Study|Protocol Violation|0|||
27756791|NCT02528253|54208456|FG004|Overall Study|Protocol Violation|4|||
27756792|NCT02528253|54208452|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
27756793|NCT02528253|54208453|FG001|Overall Study|Withdrawn Due to Pregnancy|1|||
27756794|NCT02528253|54208454|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
27756795|NCT02528253|54208455|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
27756796|NCT02528253|54208456|FG004|Overall Study|Withdrawn Due to Pregnancy|1|||
27756797|NCT01672957|54208487|FG000|Overall Study|Protocol Violation|48|||
27756798|NCT01672957|54208487|FG000|Overall Study|Death|2|||
27756799|NCT01672957|54208487|FG000|Overall Study|ICF Signed After Transplantation|5|||
27756800|NCT02525133|54208493|FG000|Overall Study|Adverse Event|0|||
27756801|NCT02525133|54208494|FG001|Overall Study|Adverse Event|1|||
27756802|NCT02525133|54208493|FG000|Overall Study|Death|0|||
27756803|NCT02525133|54208494|FG001|Overall Study|Death|1|||
27756804|NCT02525133|54208493|FG000|Overall Study|did not meet randomization criteria|1|||
27756805|NCT02525133|54208494|FG001|Overall Study|did not meet randomization criteria|0|||
27756806|NCT02525133|54208493|FG000|Overall Study|Lost to Follow-up|5|||
27756807|NCT02525133|54208494|FG001|Overall Study|Lost to Follow-up|1|||
27756808|NCT02525133|54208493|FG000|Overall Study|randomized not enrolled|3|||
27756809|NCT02525133|54208494|FG001|Overall Study|randomized not enrolled|0|||
27756810|NCT02525133|54208493|FG000|Overall Study|Withdrawal by Subject|1|||
27756811|NCT02525133|54208494|FG001|Overall Study|Withdrawal by Subject|0|||
27756812|NCT01659255|54208521|FG000|Overall Study|Adverse Event|0|||
27756813|NCT01659255|54208522|FG001|Overall Study|Adverse Event|0|||
27756814|NCT01659255|54208523|FG002|Overall Study|Adverse Event|0|||
27756815|NCT01659255|54208524|FG003|Overall Study|Adverse Event|0|||
27756816|NCT01659255|54208525|FG004|Overall Study|Adverse Event|0|||
27756817|NCT01659255|54208526|FG005|Overall Study|Adverse Event|1|||
27756818|NCT01659255|54208527|FG006|Overall Study|Adverse Event|1|||
27756819|NCT01659255|54208528|FG007|Overall Study|Adverse Event|0|||
27756820|NCT01659255|54208529|FG008|Overall Study|Adverse Event|0|||
27756821|NCT01659255|54208530|FG009|Overall Study|Adverse Event|1|||
27756822|NCT01659255|54208531|FG010|Overall Study|Adverse Event|0|||
27756823|NCT01659255|54208532|FG011|Overall Study|Adverse Event|1|||
27756824|NCT01659255|54208533|FG012|Overall Study|Adverse Event|0|||
27756825|NCT01659255|54208534|FG013|Overall Study|Adverse Event|2|||
27756826|NCT01659255|54208535|FG014|Overall Study|Adverse Event|0|||
27756827|NCT01659255|54208536|FG015|Overall Study|Adverse Event|1|||
27756828|NCT01659255|54208537|FG016|Overall Study|Adverse Event|0|||
27756829|NCT01659255|54208521|FG000|Overall Study|Death|0|||
27756830|NCT01659255|54208522|FG001|Overall Study|Death|1|||
27756831|NCT01659255|54208523|FG002|Overall Study|Death|0|||
27756832|NCT01659255|54208524|FG003|Overall Study|Death|0|||
27756833|NCT01659255|54208525|FG004|Overall Study|Death|0|||
27756834|NCT01659255|54208526|FG005|Overall Study|Death|0|||
27756835|NCT01659255|54208527|FG006|Overall Study|Death|0|||
27756836|NCT01659255|54208528|FG007|Overall Study|Death|1|||
27756837|NCT01659255|54208529|FG008|Overall Study|Death|1|||
27756838|NCT01659255|54208530|FG009|Overall Study|Death|0|||
27756839|NCT01659255|54208531|FG010|Overall Study|Death|0|||
27756840|NCT01659255|54208532|FG011|Overall Study|Death|0|||
27756841|NCT01659255|54208533|FG012|Overall Study|Death|1|||
27756842|NCT01659255|54208534|FG013|Overall Study|Death|1|||
27756843|NCT01659255|54208535|FG014|Overall Study|Death|2|||
27756844|NCT01659255|54208536|FG015|Overall Study|Death|1|||
27756845|NCT01659255|54208537|FG016|Overall Study|Death|0|||
27756846|NCT01659255|54208521|FG000|Overall Study|Progressive Disease|2|||
27756847|NCT01659255|54208522|FG001|Overall Study|Progressive Disease|0|||
27756848|NCT01659255|54208523|FG002|Overall Study|Progressive Disease|0|||
27756849|NCT01659255|54208524|FG003|Overall Study|Progressive Disease|0|||
27756850|NCT01659255|54208525|FG004|Overall Study|Progressive Disease|0|||
27756851|NCT01659255|54208526|FG005|Overall Study|Progressive Disease|0|||
27756852|NCT01659255|54208527|FG006|Overall Study|Progressive Disease|0|||
27756853|NCT01659255|54208528|FG007|Overall Study|Progressive Disease|1|||
27756854|NCT01659255|54208529|FG008|Overall Study|Progressive Disease|0|||
27756855|NCT01659255|54208530|FG009|Overall Study|Progressive Disease|2|||
27756856|NCT01659255|54208531|FG010|Overall Study|Progressive Disease|2|||
27756857|NCT01659255|54208532|FG011|Overall Study|Progressive Disease|3|||
27756858|NCT01659255|54208533|FG012|Overall Study|Progressive Disease|5|||
27756859|NCT01659255|54208534|FG013|Overall Study|Progressive Disease|13|||
27756860|NCT01659255|54208535|FG014|Overall Study|Progressive Disease|6|||
27756861|NCT01659255|54208536|FG015|Overall Study|Progressive Disease|2|||
27756862|NCT01659255|54208537|FG016|Overall Study|Progressive Disease|3|||
27756863|NCT01659255|54208521|FG000|Overall Study|Withdrew Consent|0|||
27756864|NCT01659255|54208522|FG001|Overall Study|Withdrew Consent|0|||
27756865|NCT01659255|54208523|FG002|Overall Study|Withdrew Consent|0|||
27756866|NCT01659255|54208524|FG003|Overall Study|Withdrew Consent|0|||
27756867|NCT01659255|54208525|FG004|Overall Study|Withdrew Consent|0|||
27756868|NCT01659255|54208526|FG005|Overall Study|Withdrew Consent|0|||
27756869|NCT01659255|54208527|FG006|Overall Study|Withdrew Consent|0|||
27756870|NCT01659255|54208528|FG007|Overall Study|Withdrew Consent|0|||
27756871|NCT01659255|54208529|FG008|Overall Study|Withdrew Consent|0|||
27756872|NCT01659255|54208530|FG009|Overall Study|Withdrew Consent|0|||
27756873|NCT01659255|54208531|FG010|Overall Study|Withdrew Consent|1|||
27756874|NCT01659255|54208532|FG011|Overall Study|Withdrew Consent|0|||
27756875|NCT01659255|54208533|FG012|Overall Study|Withdrew Consent|0|||
27756876|NCT01659255|54208534|FG013|Overall Study|Withdrew Consent|1|||
27756877|NCT01659255|54208535|FG014|Overall Study|Withdrew Consent|0|||
27756878|NCT01659255|54208536|FG015|Overall Study|Withdrew Consent|0|||
27756879|NCT01659255|54208537|FG016|Overall Study|Withdrew Consent|0|||
27756880|NCT01659255|54208521|FG000|Overall Study|Investigator Decision|0|||
27756881|NCT01659255|54208522|FG001|Overall Study|Investigator Decision|0|||
27756882|NCT01659255|54208523|FG002|Overall Study|Investigator Decision|0|||
27756883|NCT01659255|54208524|FG003|Overall Study|Investigator Decision|0|||
27756884|NCT01659255|54208525|FG004|Overall Study|Investigator Decision|0|||
27756885|NCT01659255|54208526|FG005|Overall Study|Investigator Decision|0|||
27756886|NCT01659255|54208527|FG006|Overall Study|Investigator Decision|0|||
27756887|NCT01659255|54208528|FG007|Overall Study|Investigator Decision|0|||
27756888|NCT01659255|54208529|FG008|Overall Study|Investigator Decision|0|||
27756889|NCT01659255|54208530|FG009|Overall Study|Investigator Decision|0|||
27756890|NCT01659255|54208531|FG010|Overall Study|Investigator Decision|0|||
27756891|NCT01659255|54208532|FG011|Overall Study|Investigator Decision|0|||
27756892|NCT01659255|54208533|FG012|Overall Study|Investigator Decision|1|||
27756893|NCT01659255|54208534|FG013|Overall Study|Investigator Decision|1|||
27756894|NCT01659255|54208535|FG014|Overall Study|Investigator Decision|0|||
27756895|NCT01659255|54208536|FG015|Overall Study|Investigator Decision|0|||
27756896|NCT01659255|54208537|FG016|Overall Study|Investigator Decision|0|||
27756897|NCT01659255|54208521|FG000|Overall Study|Sponsor's Decision|0|||
27756898|NCT01659255|54208522|FG001|Overall Study|Sponsor's Decision|0|||
27756899|NCT01659255|54208523|FG002|Overall Study|Sponsor's Decision|0|||
27756900|NCT01659255|54208524|FG003|Overall Study|Sponsor's Decision|0|||
27756901|NCT01659255|54208525|FG004|Overall Study|Sponsor's Decision|0|||
27756902|NCT01659255|54208526|FG005|Overall Study|Sponsor's Decision|0|||
27756903|NCT01659255|54208527|FG006|Overall Study|Sponsor's Decision|1|||
27756904|NCT01659255|54208528|FG007|Overall Study|Sponsor's Decision|0|||
27756905|NCT01659255|54208529|FG008|Overall Study|Sponsor's Decision|0|||
27756906|NCT01659255|54208530|FG009|Overall Study|Sponsor's Decision|0|||
27756907|NCT01659255|54208531|FG010|Overall Study|Sponsor's Decision|0|||
27756908|NCT01659255|54208532|FG011|Overall Study|Sponsor's Decision|0|||
27756909|NCT01659255|54208533|FG012|Overall Study|Sponsor's Decision|0|||
27756910|NCT01659255|54208534|FG013|Overall Study|Sponsor's Decision|0|||
27756911|NCT01659255|54208535|FG014|Overall Study|Sponsor's Decision|0|||
27756912|NCT01659255|54208536|FG015|Overall Study|Sponsor's Decision|0|||
27756913|NCT01659255|54208537|FG016|Overall Study|Sponsor's Decision|0|||
28159967|NCT02737475|54830042|FG020|Overall Study|Death|0|||
27756914|NCT01659255|54208521|FG000|Overall Study|Completed Treatment Per Protocol at the Time|0|||
27756915|NCT01659255|54208522|FG001|Overall Study|Completed Treatment Per Protocol at the Time|0|||
27756916|NCT01659255|54208523|FG002|Overall Study|Completed Treatment Per Protocol at the Time|0|||
27756917|NCT01659255|54208524|FG003|Overall Study|Completed Treatment Per Protocol at the Time|0|||
27756918|NCT01659255|54208525|FG004|Overall Study|Completed Treatment Per Protocol at the Time|0|||
27756919|NCT01659255|54208526|FG005|Overall Study|Completed Treatment Per Protocol at the Time|0|||
27756920|NCT01659255|54208527|FG006|Overall Study|Completed Treatment Per Protocol at the Time|0|||
27756921|NCT01659255|54208528|FG007|Overall Study|Completed Treatment Per Protocol at the Time|0|||
27756922|NCT01659255|54208529|FG008|Overall Study|Completed Treatment Per Protocol at the Time|0|||
27756923|NCT01659255|54208530|FG009|Overall Study|Completed Treatment Per Protocol at the Time|0|||
27756924|NCT01659255|54208531|FG010|Overall Study|Completed Treatment Per Protocol at the Time|0|||
27756925|NCT01659255|54208532|FG011|Overall Study|Completed Treatment Per Protocol at the Time|0|||
27756926|NCT01659255|54208533|FG012|Overall Study|Completed Treatment Per Protocol at the Time|0|||
27756927|NCT01659255|54208534|FG013|Overall Study|Completed Treatment Per Protocol at the Time|0|||
27756928|NCT01659255|54208535|FG014|Overall Study|Completed Treatment Per Protocol at the Time|0|||
27756929|NCT01659255|54208536|FG015|Overall Study|Completed Treatment Per Protocol at the Time|1|||
27756930|NCT01659255|54208537|FG016|Overall Study|Completed Treatment Per Protocol at the Time|0|||
27756931|NCT01659255|54208521|FG000|Overall Study|Participant Went on to Have an Allograft|0|||
27756932|NCT01659255|54208522|FG001|Overall Study|Participant Went on to Have an Allograft|0|||
27756933|NCT01659255|54208523|FG002|Overall Study|Participant Went on to Have an Allograft|0|||
27756934|NCT01659255|54208524|FG003|Overall Study|Participant Went on to Have an Allograft|0|||
27756935|NCT01659255|54208525|FG004|Overall Study|Participant Went on to Have an Allograft|0|||
27756936|NCT01659255|54208526|FG005|Overall Study|Participant Went on to Have an Allograft|0|||
27756937|NCT01659255|54208527|FG006|Overall Study|Participant Went on to Have an Allograft|0|||
27756938|NCT01659255|54208528|FG007|Overall Study|Participant Went on to Have an Allograft|0|||
27756939|NCT01659255|54208529|FG008|Overall Study|Participant Went on to Have an Allograft|0|||
27756940|NCT01659255|54208530|FG009|Overall Study|Participant Went on to Have an Allograft|0|||
27756941|NCT01659255|54208531|FG010|Overall Study|Participant Went on to Have an Allograft|0|||
27756942|NCT01659255|54208532|FG011|Overall Study|Participant Went on to Have an Allograft|0|||
27756943|NCT01659255|54208533|FG012|Overall Study|Participant Went on to Have an Allograft|1|||
27756944|NCT01659255|54208534|FG013|Overall Study|Participant Went on to Have an Allograft|0|||
27756945|NCT01659255|54208535|FG014|Overall Study|Participant Went on to Have an Allograft|0|||
27756946|NCT01659255|54208536|FG015|Overall Study|Participant Went on to Have an Allograft|0|||
27756947|NCT01659255|54208537|FG016|Overall Study|Participant Went on to Have an Allograft|0|||
27756948|NCT02637037|54208577|FG000|Overall Study|Positive drug screen at admission|1|||
27756949|NCT02637037|54208578|FG001|Overall Study|Positive drug screen at admission|0|||
27756950|NCT02637037|54208577|FG000|Overall Study|Withdrawal by Subject|2|||
27756951|NCT02637037|54208578|FG001|Overall Study|Withdrawal by Subject|1|||
27756952|NCT02637037|54208577|FG000|Overall Study|Adverse Event|1|||
27756953|NCT02637037|54208578|FG001|Overall Study|Adverse Event|0|||
27756954|NCT02637895|54208598|FG000|Overall Study|Lost to Follow-up|4|||
27756955|NCT02637895|54208599|FG001|Overall Study|Lost to Follow-up|0|||
27756956|NCT02637895|54208598|FG000|Overall Study|Protocol Violation|0|||
27756957|NCT02637895|54208599|FG001|Overall Study|Protocol Violation|1|||
27756958|NCT02637895|54208598|FG000|Overall Study|Lack of Efficacy|1|||
27756959|NCT02637895|54208599|FG001|Overall Study|Lack of Efficacy|0|||
27756960|NCT02637895|54208598|FG000|Overall Study|Withdrawal by Subject|1|||
27756961|NCT02637895|54208599|FG001|Overall Study|Withdrawal by Subject|1|||
27756962|NCT02637895|54208598|FG000|Overall Study|Abnormal baseline lab|0|||
27756963|NCT02637895|54208599|FG001|Overall Study|Abnormal baseline lab|1|||
27756964|NCT02522481|54208606|FG000|Overall Study|discontinued|1|||
27756965|NCT02522481|54208606|FG000|Overall Study|Not dosed|2|||
27756966|NCT02522403|54208619|FG000|Overall Study|Lost to Follow-up|2|||
27756967|NCT02522403|54208620|FG001|Overall Study|Lost to Follow-up|2|||
27756968|NCT02522403|54208619|FG000|Overall Study|Withdrawal by Subject|2|||
27756969|NCT02522403|54208620|FG001|Overall Study|Withdrawal by Subject|4|||
27756970|NCT02522325|54208626|FG000|Overall Study|Adverse Event|0|||
27756971|NCT02522325|54208627|FG001|Overall Study|Adverse Event|1|||
27756972|NCT01672879|54208636|FG000|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43|||
27756973|NCT01672879|54208637|FG001|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55|||
27756974|NCT01672879|54208638|FG002|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61|||
27756975|NCT01672879|54208636|FG000|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14|||
27756976|NCT01672879|54208637|FG001|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7|||
27756977|NCT01672879|54208638|FG002|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6|||
27839170|NCT01484275|54326460|FG000|Overall Study|Withdrawal by Subject|1|||
27839171|NCT01484275|54326461|FG001|Overall Study|Withdrawal by Subject|5|||
27756978|NCT01672879|54208636|FG000|Blinded Phase (Up to 240 Weeks)|Adverse Event|5|||
27839172|NCT01484275|54326460|FG000|Overall Study|Lost to Follow-up|1|||
27839173|NCT01484275|54326461|FG001|Overall Study|Lost to Follow-up|1|||
27756979|NCT01672879|54208637|FG001|Blinded Phase (Up to 240 Weeks)|Adverse Event|2|||
27756980|NCT01672879|54208638|FG002|Blinded Phase (Up to 240 Weeks)|Adverse Event|7|||
27756981|NCT01672879|54208636|FG000|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4|||
27756982|NCT01672879|54208637|FG001|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3|||
27756983|NCT01672879|54208638|FG002|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1|||
27756984|NCT01672879|54208636|FG000|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5|||
27756985|NCT01672879|54208637|FG001|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
27756986|NCT01672879|54208638|FG002|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2|||
27756987|NCT01672879|54208636|FG000|Blinded Phase (Up to 240 Weeks)|Death|0|||
27756988|NCT01672879|54208637|FG001|Blinded Phase (Up to 240 Weeks)|Death|2|||
27756989|NCT01672879|54208638|FG002|Blinded Phase (Up to 240 Weeks)|Death|0|||
27756990|NCT01672879|54208636|FG000|Blinded Phase (Up to 240 Weeks)|Missing|1|||
27756991|NCT01672879|54208637|FG001|Blinded Phase (Up to 240 Weeks)|Missing|0|||
27756992|NCT01672879|54208638|FG002|Blinded Phase (Up to 240 Weeks)|Missing|0|||
27756993|NCT01672879|54208636|FG000|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
27756994|NCT01672879|54208637|FG001|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
27756995|NCT01672879|54208638|FG002|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1|||
27756996|NCT01672879|54208636|FG000|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15|||
27756997|NCT01672879|54208637|FG001|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17|||
27756998|NCT01672879|54208638|FG002|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8|||
27756999|NCT01672879|54208636|FG000|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8|||
27757000|NCT01672879|54208637|FG001|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16|||
27757001|NCT01672879|54208638|FG002|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6|||
27757002|NCT01672879|54208636|FG000|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5|||
27757003|NCT01672879|54208637|FG001|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
27757004|NCT01672879|54208638|FG002|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
27757005|NCT01672879|54208636|FG000|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
27757006|NCT01672879|54208637|FG001|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
27757007|NCT01672879|54208638|FG002|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
27757008|NCT01672879|54208636|FG000|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1|||
27757009|NCT01672879|54208637|FG001|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
27757010|NCT01672879|54208638|FG002|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
27757011|NCT02601209|54208654|FG000|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
27757012|NCT02601209|54208655|FG001|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
27757013|NCT02601209|54208656|FG002|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
27757014|NCT02601209|54208657|FG003|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
27757015|NCT02601209|54208658|FG004|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
27757016|NCT02601209|54208659|FG005|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
27757017|NCT02601209|54208660|FG006|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
27757018|NCT02601209|54208661|FG007|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
27757019|NCT02601209|54208662|FG008|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
27757020|NCT02601209|54208654|FG000|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
27757021|NCT02601209|54208655|FG001|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
27757022|NCT02601209|54208656|FG002|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
27757023|NCT02601209|54208657|FG003|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
27757024|NCT02601209|54208658|FG004|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
27757025|NCT02601209|54208659|FG005|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2|||
27757026|NCT02601209|54208660|FG006|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
27757027|NCT02601209|54208661|FG007|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
27757028|NCT02601209|54208662|FG008|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
27757029|NCT01659021|54208678|FG000|Main Study|Adverse Event|2|||
27757030|NCT01659021|54208679|FG001|Main Study|Adverse Event|3|||
27757031|NCT01659021|54208678|FG000|Main Study|Lost to Follow-up|1|||
27757032|NCT01659021|54208679|FG001|Main Study|Lost to Follow-up|0|||
27757033|NCT01659021|54208678|FG000|Main Study|Unknown Reasons|2|||
27757034|NCT01659021|54208679|FG001|Main Study|Unknown Reasons|1|||
27757035|NCT01659021|54208678|FG000|Main Study|Physician Decision|34|||
27757036|NCT01659021|54208679|FG001|Main Study|Physician Decision|16|||
27757037|NCT01659021|54208678|FG000|Main Study|Withdrawal by Subject|19|||
27757038|NCT01659021|54208679|FG001|Main Study|Withdrawal by Subject|16|||
27757039|NCT01659021|54208678|FG000|Main Study|Study Terminated by Sponsor|16|||
27757040|NCT01659021|54208679|FG001|Main Study|Study Terminated by Sponsor|1|||
27757041|NCT01659021|54208678|FG000|Long-Term Follow Up|Lost to Follow-up|3|||
27757042|NCT01659021|54208679|FG001|Long-Term Follow Up|Lost to Follow-up|3|||
27757043|NCT01659021|54208678|FG000|Long-Term Follow Up|Withdrawal by Subject|2|||
27757044|NCT01659021|54208679|FG001|Long-Term Follow Up|Withdrawal by Subject|1|||
27757045|NCT02524665|54208689|FG000|Overall Study|Lost to Follow-up|1|||
27757046|NCT02638129|54208696|FG000|Overall Study|Study terminated|28|||
27757047|NCT02638129|54208697|FG001|Overall Study|Study terminated|30|||
27757048|NCT02524275|54208703|FG000|Overall Study|not evaluable, completed less than 2 courses of chemotherapy.|5|||
27757049|NCT01658943|54208709|FG000|Overall Study|Adverse Event|6|||
27757050|NCT01658943|54208710|FG001|Overall Study|Adverse Event|13|||
27757051|NCT01658943|54208709|FG000|Overall Study|Withdrawal by Subject|9|||
27757052|NCT01658943|54208710|FG001|Overall Study|Withdrawal by Subject|2|||
27757053|NCT01658943|54208709|FG000|Overall Study|Progression/Relapse|39|||
27757054|NCT01658943|54208710|FG001|Overall Study|Progression/Relapse|40|||
27757055|NCT01658943|54208709|FG000|Overall Study|Death|4|||
27757056|NCT01658943|54208710|FG001|Overall Study|Death|2|||
27757057|NCT01658943|54208709|FG000|Overall Study|not protocol specified|4|||
27757058|NCT01658943|54208710|FG001|Overall Study|not protocol specified|1|||
27757059|NCT01658943|54208709|FG000|Overall Study|Not eligible|7|||
27757060|NCT01658943|54208710|FG001|Overall Study|Not eligible|9|||
27757061|NCT01658943|54208709|FG000|Overall Study|Withdrew prior to beginning protocol Tx|1|||
27757062|NCT01658943|54208710|FG001|Overall Study|Withdrew prior to beginning protocol Tx|0|||
27757063|NCT02600819|54208716|FG000|GEN Phase|Adverse Event|2|||
27757064|NCT02600819|54208717|FG001|GEN Phase|Adverse Event|0|||
27757065|NCT02600819|54208716|FG000|GEN Phase|Death|2|||
27757066|NCT02600819|54208717|FG001|GEN Phase|Death|0|||
27757067|NCT02600819|54208716|FG000|GEN Phase|Investigator's Discretion|4|||
27757068|NCT02600819|54208717|FG001|GEN Phase|Investigator's Discretion|0|||
27757069|NCT02600819|54208716|FG000|GEN Phase|Non-Compliance with Study Drug|1|||
27757070|NCT02600819|54208717|FG001|GEN Phase|Non-Compliance with Study Drug|0|||
27757071|NCT02600819|54208716|FG000|GEN Phase|Withdrew Consent|5|||
27757072|NCT02600819|54208717|FG001|GEN Phase|Withdrew Consent|0|||
27757073|NCT02600819|54208716|FG000|GEN Phase|Lost to Follow-up|2|||
27757074|NCT02600819|54208717|FG001|GEN Phase|Lost to Follow-up|0|||
27757075|NCT02597933|54208725|FG000|Overall Study|Withdrawal by Subject|7|||
27757076|NCT02597933|54208726|FG001|Overall Study|Withdrawal by Subject|5|||
27757077|NCT02597933|54208725|FG000|Overall Study|Protocol Violation|2|||
27757078|NCT02597933|54208726|FG001|Overall Study|Protocol Violation|2|||
27757079|NCT02597933|54208725|FG000|Overall Study|Adverse Event|20|||
27757080|NCT02597933|54208726|FG001|Overall Study|Adverse Event|28|||
27757081|NCT02597933|54208725|FG000|Overall Study|Not treated|2|||
27757082|NCT02597933|54208726|FG001|Overall Study|Not treated|2|||
27757083|NCT02597933|54208725|FG000|Overall Study|Other than stated above|7|||
27757084|NCT02597933|54208726|FG001|Overall Study|Other than stated above|14|||
27757085|NCT02597855|54208734|FG000|Overall Study|Lost to Follow-up|2|||
27757086|NCT02597855|54208735|FG001|Overall Study|Lost to Follow-up|1|||
27757087|NCT02604407|54208744|FG000|Overall Study|Adverse Event|0|||
27839174|NCT01544335|54326467|FG000|Overall Study|Lost to Follow-up|27|||
27757088|NCT02604407|54208745|FG001|Overall Study|Adverse Event|7|||
27757089|NCT02604407|54208746|FG002|Overall Study|Adverse Event|5|||
27757090|NCT02604407|54208744|FG000|Overall Study|Protocol Violation|2|||
27757091|NCT02604407|54208745|FG001|Overall Study|Protocol Violation|0|||
27757092|NCT02604407|54208746|FG002|Overall Study|Protocol Violation|0|||
27757093|NCT02604407|54208744|FG000|Overall Study|Withdrawal by Subject|3|||
27757094|NCT02604407|54208745|FG001|Overall Study|Withdrawal by Subject|3|||
27757095|NCT02604407|54208746|FG002|Overall Study|Withdrawal by Subject|5|||
27757096|NCT02604407|54208744|FG000|Overall Study|Lost to Follow-up|2|||
27757097|NCT02604407|54208745|FG001|Overall Study|Lost to Follow-up|1|||
27757098|NCT02604407|54208746|FG002|Overall Study|Lost to Follow-up|2|||
27757099|NCT02604407|54208744|FG000|Overall Study|Lack of Efficacy|1|||
27757100|NCT02604407|54208745|FG001|Overall Study|Lack of Efficacy|0|||
27757101|NCT02604407|54208746|FG002|Overall Study|Lack of Efficacy|0|||
27757102|NCT02604407|54208744|FG000|Overall Study|Other|3|||
27757103|NCT02604407|54208745|FG001|Overall Study|Other|1|||
27757104|NCT02604407|54208746|FG002|Overall Study|Other|4|||
27757105|NCT02593097|54208756|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
27757106|NCT02593097|54208757|FG001|First Intervention (12 Weeks)|Lost to Follow-up|2|||
27757107|NCT02593097|54208756|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
27757108|NCT02593097|54208757|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
27757109|NCT02593097|54208756|FG000|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
27757110|NCT02593097|54208757|FG001|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
27757111|NCT02593097|54208756|FG000|Second Intervention (12 Weeks)|Lack of Efficacy|1|||
27757112|NCT02593097|54208757|FG001|Second Intervention (12 Weeks)|Lack of Efficacy|0|||
27757113|NCT02593097|54208756|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
27757114|NCT02593097|54208757|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
27757115|NCT01657461|54208765|FG000|Overall Study|Death|9|||
27757116|NCT01657461|54208766|FG001|Overall Study|Death|12|||
27757117|NCT01657461|54208765|FG000|Overall Study|Lost to Follow-up|0|||
27757118|NCT01657461|54208766|FG001|Overall Study|Lost to Follow-up|3|||
27757119|NCT01657461|54208765|FG000|Overall Study|Physician Decision|0|||
27757120|NCT01657461|54208766|FG001|Overall Study|Physician Decision|2|||
27757121|NCT01657461|54208765|FG000|Overall Study|Withdrawal by Subject|1|||
27757122|NCT01657461|54208766|FG001|Overall Study|Withdrawal by Subject|3|||
27757123|NCT02592551|54208775|FG000|Overall Study|Not evaluable|1|||
27757124|NCT02592551|54208776|FG001|Overall Study|Not evaluable|3|||
27757125|NCT02592551|54208777|FG002|Overall Study|Not evaluable|0|||
27757126|NCT02595749|54208788|FG000|Overall Study|Withdrawal by Subject|12|||
27757127|NCT02595749|54208789|FG001|Overall Study|Withdrawal by Subject|7|||
27757128|NCT01657305|54208795|FG000|Overall Study|Lack of Wound Closure at Day 28|15|||
27757129|NCT01657305|54208795|FG000|Overall Study|Withdrawal by Subject|4|||
27757130|NCT01657305|54208795|FG000|Overall Study|Adverse Event|1|||
27757131|NCT01657305|54208795|FG000|Overall Study|Lost to Follow-up|1|||
27757132|NCT01657305|54208795|FG000|Overall Study|Did not Adhere to Protocol/Procedures|4|||
27757133|NCT02634307|54208838|FG000|Overall Study|Adverse Event|50|||
27839175|NCT01544335|54326467|FG000|Overall Study|Death|4|||
27839176|NCT01544335|54326467|FG000|Overall Study|Disease progression|3|||
27839177|NCT01544335|54326467|FG000|Overall Study|Baseline Measurements not Available|19|||
27839178|NCT01484197|54326471|FG000|Treatment Period 1|Adverse Event|1|||
27839179|NCT01484197|54326472|FG001|Treatment Period 1|Adverse Event|0|||
27839180|NCT01484197|54326473|FG002|Treatment Period 1|Adverse Event|0|||
27839181|NCT01484197|54326474|FG003|Treatment Period 1|Adverse Event|0|||
27839182|NCT01484197|54326471|FG000|Treatment Period 2|Subject withdrew consent|0|||
27839183|NCT01484197|54326472|FG001|Treatment Period 2|Subject withdrew consent|0|||
27839184|NCT01484197|54326473|FG002|Treatment Period 2|Subject withdrew consent|0|||
27839185|NCT01484197|54326474|FG003|Treatment Period 2|Subject withdrew consent|1|||
27757134|NCT02634307|54208839|FG001|Overall Study|Adverse Event|24|||
27757135|NCT02634307|54208840|FG002|Overall Study|Adverse Event|14|||
27757136|NCT02634307|54208838|FG000|Overall Study|Lost to Follow-up|21|||
27757137|NCT02634307|54208839|FG001|Overall Study|Lost to Follow-up|5|||
27757138|NCT02634307|54208840|FG002|Overall Study|Lost to Follow-up|6|||
27757139|NCT02634307|54208838|FG000|Overall Study|Pregnancy|5|||
27757140|NCT02634307|54208839|FG001|Overall Study|Pregnancy|1|||
27757141|NCT02634307|54208840|FG002|Overall Study|Pregnancy|3|||
27839186|NCT01473407|54326486|FG000|Overall Study|Physician Decision|1|||
27839187|NCT01473407|54326487|FG001|Overall Study|Physician Decision|4|||
27757142|NCT02634307|54208838|FG000|Overall Study|Withdrawal by Subject|38|||
27757143|NCT02634307|54208839|FG001|Overall Study|Withdrawal by Subject|24|||
27757144|NCT02634307|54208840|FG002|Overall Study|Withdrawal by Subject|18|||
27757145|NCT02634307|54208838|FG000|Overall Study|Non-Compliance with Study Drug|0|||
27757146|NCT02634307|54208839|FG001|Overall Study|Non-Compliance with Study Drug|2|||
27757147|NCT02634307|54208840|FG002|Overall Study|Non-Compliance with Study Drug|2|||
27757148|NCT02634307|54208838|FG000|Overall Study|Lack of Efficacy|1|||
27757149|NCT02634307|54208839|FG001|Overall Study|Lack of Efficacy|5|||
27757150|NCT02634307|54208840|FG002|Overall Study|Lack of Efficacy|3|||
27757151|NCT02634307|54208838|FG000|Overall Study|Physician Decision|7|||
27757152|NCT02634307|54208839|FG001|Overall Study|Physician Decision|5|||
27839188|NCT01473407|54326486|FG000|Overall Study|Lost to Follow-up|10|||
27839189|NCT01473407|54326487|FG001|Overall Study|Lost to Follow-up|4|||
27757153|NCT02634307|54208840|FG002|Overall Study|Physician Decision|5|||
27757154|NCT02634307|54208838|FG000|Overall Study|Reason not Specified|3|||
27757155|NCT02634307|54208839|FG001|Overall Study|Reason not Specified|5|||
27757156|NCT02634307|54208840|FG002|Overall Study|Reason not Specified|10|||
27757157|NCT01365273|54208850|FG000|Overall Study|Lost to Follow-up|1|||
27757158|NCT01365273|54208851|FG001|Overall Study|Lost to Follow-up|0|||
27757159|NCT01365273|54208850|FG000|Overall Study|Protocol Violation|0|||
27757160|NCT01365273|54208851|FG001|Overall Study|Protocol Violation|1|||
27757161|NCT01365273|54208850|FG000|Overall Study|Physician Decision|1|||
27757162|NCT01365273|54208851|FG001|Overall Study|Physician Decision|0|||
27757163|NCT02595437|54208857|FG000|Triferic Via IV|Withdrawal by Subject|1|||
27757164|NCT02594735|54208878|FG000|Overall Study|Adverse Event|1|||
27757165|NCT02634151|54208886|FG000|Overall Study|Withdrawal by Subject|1|||
27757166|NCT02634151|54208887|FG001|Overall Study|Withdrawal by Subject|0|||
27757167|NCT02634151|54208886|FG000|Overall Study|Non-Compliance|0|||
27757168|NCT02634151|54208887|FG001|Overall Study|Non-Compliance|1|||
27757169|NCT02634151|54208886|FG000|Overall Study|Other|0|||
27757170|NCT02634151|54208887|FG001|Overall Study|Other|1|||
27757171|NCT01655823|54208898|FG000|Overall Study|Lost to Follow-up|0|||
27757172|NCT01655823|54208899|FG001|Overall Study|Lost to Follow-up|1|||
27757173|NCT01655823|54208900|FG002|Overall Study|Lost to Follow-up|0|||
27757174|NCT01655823|54208901|FG003|Overall Study|Lost to Follow-up|0|||
27757175|NCT01655823|54208902|FG004|Overall Study|Lost to Follow-up|1|||
27757176|NCT01655823|54208898|FG000|Overall Study|Withdrawal by Subject|0|||
27757177|NCT01655823|54208899|FG001|Overall Study|Withdrawal by Subject|1|||
27757178|NCT01655823|54208900|FG002|Overall Study|Withdrawal by Subject|0|||
27757179|NCT01655823|54208901|FG003|Overall Study|Withdrawal by Subject|1|||
27757180|NCT01655823|54208902|FG004|Overall Study|Withdrawal by Subject|0|||
27757181|NCT01360645|54208916|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16|||
27757182|NCT01360645|54208917|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
27757183|NCT01360645|54208918|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
27757184|NCT01360645|54208919|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
27757185|NCT01360645|54208916|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19|||
27757186|NCT01360645|54208917|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
27757187|NCT01360645|54208918|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
27757188|NCT01360645|54208919|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
27757189|NCT01360645|54208916|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16|||
27757190|NCT01360645|54208917|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
27757191|NCT01360645|54208918|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
27757192|NCT01360645|54208919|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
27757193|NCT01360645|54208916|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34|||
27757194|NCT01360645|54208917|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
27757195|NCT01360645|54208918|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
27757196|NCT01360645|54208919|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
27757197|NCT01360645|54208916|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24|||
27757198|NCT01360645|54208917|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
27757199|NCT01360645|54208918|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
27757200|NCT01360645|54208919|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
27757201|NCT01360645|54208916|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5|||
27757202|NCT01360645|54208917|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
27757203|NCT01360645|54208918|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
27757204|NCT01360645|54208919|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
27757205|NCT01360645|54208916|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
27757206|NCT01360645|54208917|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
27757207|NCT01360645|54208918|FG002|Phase B (6 Weeks)|Lost to Follow-up|0|||
27839190|NCT01473407|54326486|FG000|Overall Study|Adverse Event|8|||
27839191|NCT01473407|54326487|FG001|Overall Study|Adverse Event|8|||
27839192|NCT01473407|54326486|FG000|Overall Study|Randomization Error|3|||
27839193|NCT01473407|54326487|FG001|Overall Study|Randomization Error|1|||
27839194|NCT01473407|54326486|FG000|Overall Study|Withdrawal by Subject|4|||
27839195|NCT01473407|54326487|FG001|Overall Study|Withdrawal by Subject|7|||
27839196|NCT01473407|54326486|FG000|Overall Study|Kidney Transplant|7|||
27839197|NCT01473407|54326487|FG001|Overall Study|Kidney Transplant|6|||
27839198|NCT01473407|54326486|FG000|Overall Study|Vacation/Travel|1|||
27757208|NCT01360645|54208919|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
27757209|NCT01360645|54208916|FG000|Phase B (6 Weeks)|Adverse Event|0|||
27757210|NCT01360645|54208917|FG001|Phase B (6 Weeks)|Adverse Event|6|||
27757211|NCT01360645|54208918|FG002|Phase B (6 Weeks)|Adverse Event|0|||
27757212|NCT01360645|54208919|FG003|Phase B (6 Weeks)|Adverse Event|0|||
27839199|NCT01473407|54326487|FG001|Overall Study|Vacation/Travel|1|||
27839200|NCT01473407|54326486|FG000|Overall Study|Elevated Hemoglobin|1|||
27839201|NCT01473407|54326487|FG001|Overall Study|Elevated Hemoglobin|0|||
27839202|NCT01473407|54326486|FG000|Overall Study|Patient Received Aranesp|1|||
27757213|NCT01360645|54208916|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
27757214|NCT01360645|54208917|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|3|||
27757215|NCT01360645|54208918|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
27757216|NCT01360645|54208919|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
27757217|NCT01360645|54208916|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
27757218|NCT01360645|54208917|FG001|Phase B (6 Weeks)|Withdrawal by Subject|3|||
27757219|NCT01360645|54208918|FG002|Phase B (6 Weeks)|Withdrawal by Subject|8|||
27757220|NCT01360645|54208919|FG003|Phase B (6 Weeks)|Withdrawal by Subject|0|||
27757221|NCT01360645|54208916|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
27757222|NCT01360645|54208917|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
27757223|NCT01360645|54208918|FG002|Phase B (6 Weeks)|Protocol Deviation|3|||
27757224|NCT01360645|54208919|FG003|Phase B (6 Weeks)|Protocol Deviation|0|||
27757225|NCT01360645|54208916|FG000|Phase A+|Lost to Follow-up|0|||
27757226|NCT01360645|54208917|FG001|Phase A+|Lost to Follow-up|0|||
27757227|NCT01360645|54208918|FG002|Phase A+|Lost to Follow-up|0|||
27757228|NCT01360645|54208919|FG003|Phase A+|Lost to Follow-up|7|||
27757229|NCT01360645|54208916|FG000|Phase A+|Adverse Event|0|||
27757230|NCT01360645|54208917|FG001|Phase A+|Adverse Event|0|||
27757231|NCT01360645|54208918|FG002|Phase A+|Adverse Event|0|||
27757232|NCT01360645|54208919|FG003|Phase A+|Adverse Event|2|||
27757233|NCT01360645|54208916|FG000|Phase A+|Met Withdrawal Criteria|0|||
27757234|NCT01360645|54208917|FG001|Phase A+|Met Withdrawal Criteria|0|||
27757235|NCT01360645|54208918|FG002|Phase A+|Met Withdrawal Criteria|0|||
27757236|NCT01360645|54208919|FG003|Phase A+|Met Withdrawal Criteria|4|||
27757237|NCT01360645|54208916|FG000|Phase A+|Physician Decision|0|||
27757238|NCT01360645|54208917|FG001|Phase A+|Physician Decision|0|||
27757239|NCT01360645|54208918|FG002|Phase A+|Physician Decision|0|||
27757240|NCT01360645|54208919|FG003|Phase A+|Physician Decision|2|||
27757241|NCT01360645|54208916|FG000|Phase A+|Withdrawal by Subject|0|||
27757242|NCT01360645|54208917|FG001|Phase A+|Withdrawal by Subject|0|||
27757243|NCT01360645|54208918|FG002|Phase A+|Withdrawal by Subject|0|||
27757244|NCT01360645|54208919|FG003|Phase A+|Withdrawal by Subject|5|||
27757245|NCT01360645|54208916|FG000|Phase A+|Protocol Deviation|0|||
27757246|NCT01360645|54208917|FG001|Phase A+|Protocol Deviation|0|||
27757247|NCT01360645|54208918|FG002|Phase A+|Protocol Deviation|0|||
27757248|NCT01360645|54208919|FG003|Phase A+|Protocol Deviation|4|||
27757249|NCT02633527|54208934|FG000|Overall Study|Failed to meet eligibility|0|||
27757250|NCT02633527|54208935|FG001|Overall Study|Failed to meet eligibility|1|||
27757251|NCT02633527|54208936|FG002|Overall Study|Failed to meet eligibility|1|||
27757252|NCT02633527|54208937|FG003|Overall Study|Failed to meet eligibility|0|||
27757253|NCT02633527|54208938|FG004|Overall Study|Failed to meet eligibility|1|||
27757254|NCT02633527|54208934|FG000|Overall Study|Adverse Event|0|||
27757255|NCT02633527|54208935|FG001|Overall Study|Adverse Event|4|||
27757256|NCT02633527|54208936|FG002|Overall Study|Adverse Event|3|||
27757257|NCT02633527|54208937|FG003|Overall Study|Adverse Event|1|||
27757258|NCT02633527|54208938|FG004|Overall Study|Adverse Event|5|||
27757259|NCT02633527|54208934|FG000|Overall Study|Lost to Follow-up|1|||
27757260|NCT02633527|54208935|FG001|Overall Study|Lost to Follow-up|2|||
27757261|NCT02633527|54208936|FG002|Overall Study|Lost to Follow-up|5|||
27757262|NCT02633527|54208937|FG003|Overall Study|Lost to Follow-up|5|||
27757263|NCT02633527|54208938|FG004|Overall Study|Lost to Follow-up|4|||
27757264|NCT02633527|54208934|FG000|Overall Study|Withdrawal by Subject|0|||
27757265|NCT02633527|54208935|FG001|Overall Study|Withdrawal by Subject|3|||
27757266|NCT02633527|54208936|FG002|Overall Study|Withdrawal by Subject|5|||
27757267|NCT02633527|54208937|FG003|Overall Study|Withdrawal by Subject|4|||
27757268|NCT02633527|54208938|FG004|Overall Study|Withdrawal by Subject|4|||
27757269|NCT02633527|54208934|FG000|Overall Study|Protocol Violation|0|||
27757270|NCT02633527|54208935|FG001|Overall Study|Protocol Violation|1|||
27757271|NCT02633527|54208936|FG002|Overall Study|Protocol Violation|1|||
27757272|NCT02633527|54208937|FG003|Overall Study|Protocol Violation|1|||
27757273|NCT02633527|54208938|FG004|Overall Study|Protocol Violation|1|||
27757274|NCT02633527|54208934|FG000|Overall Study|Physician Decision|0|||
27757275|NCT02633527|54208935|FG001|Overall Study|Physician Decision|0|||
27757276|NCT02633527|54208936|FG002|Overall Study|Physician Decision|0|||
27757277|NCT02633527|54208937|FG003|Overall Study|Physician Decision|0|||
27757278|NCT02633527|54208938|FG004|Overall Study|Physician Decision|1|||
27757279|NCT02633527|54208934|FG000|Overall Study|Administrative reason|1|||
27757280|NCT02633527|54208935|FG001|Overall Study|Administrative reason|0|||
27757281|NCT02633527|54208936|FG002|Overall Study|Administrative reason|0|||
27757282|NCT02633527|54208937|FG003|Overall Study|Administrative reason|1|||
27757283|NCT02633527|54208938|FG004|Overall Study|Administrative reason|0|||
27757284|NCT02633527|54208934|FG000|Overall Study|Multiple reasons|1|||
27757285|NCT02633527|54208935|FG001|Overall Study|Multiple reasons|0|||
27757286|NCT02633527|54208936|FG002|Overall Study|Multiple reasons|2|||
27757287|NCT02633527|54208937|FG003|Overall Study|Multiple reasons|2|||
27757288|NCT02633527|54208938|FG004|Overall Study|Multiple reasons|1|||
27757289|NCT01667549|54208955|FG000|Overall Study|Withdrawal by Subject|3|||
27757290|NCT01667549|54208956|FG001|Overall Study|Withdrawal by Subject|5|||
27757291|NCT01667549|54208957|FG002|Overall Study|Withdrawal by Subject|7|||
27757292|NCT01667549|54208958|FG003|Overall Study|Withdrawal by Subject|6|||
27757293|NCT01667549|54208959|FG004|Overall Study|Withdrawal by Subject|1|||
27757294|NCT01672801|54208998|FG000|Overall Study|Screen Failure|0|||
27757295|NCT01672801|54208999|FG001|Overall Study|Screen Failure|1|||
27757296|NCT01655901|54209005|FG000|Third Intervention (Hour 3)|Lost to Follow-up|1|||
27757297|NCT01655901|54209006|FG001|Third Intervention (Hour 3)|Lost to Follow-up|1|||
27757298|NCT01655901|54209007|FG002|Third Intervention (Hour 3)|Lost to Follow-up|1|||
27757299|NCT01655901|54209008|FG003|Third Intervention (Hour 3)|Lost to Follow-up|0|||
27757300|NCT01655901|54209009|FG004|Third Intervention (Hour 3)|Lost to Follow-up|1|||
27757301|NCT01655901|54209010|FG005|Third Intervention (Hour 3)|Lost to Follow-up|0|||
27757302|NCT01656759|54209021|FG000|Overall Study|Protocol Violation|2|||
27757303|NCT01656759|54209022|FG001|Overall Study|Protocol Violation|3|||
27757304|NCT02631577|54209030|FG000|Overall Study|Death|1|||
27757305|NCT02631577|54209031|FG001|Overall Study|Death|7|||
27757306|NCT02631577|54209030|FG000|Overall Study|Withdrawal by Subject|0|||
27757307|NCT02631577|54209031|FG001|Overall Study|Withdrawal by Subject|3|||
27757308|NCT01667081|54209039|FG000|Overall Study|Death|43|||
27757309|NCT01667081|54209040|FG001|Overall Study|Death|3|||
27757310|NCT01667081|54209039|FG000|Overall Study|Lost to Follow-up|99|||
27757311|NCT01667081|54209040|FG001|Overall Study|Lost to Follow-up|48|||
27757312|NCT01667081|54209039|FG000|Overall Study|Physician Decision|16|||
27757313|NCT01667081|54209040|FG001|Overall Study|Physician Decision|2|||
27757314|NCT01667081|54209039|FG000|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|1529|||
27757315|NCT01667081|54209040|FG001|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|269|||
27757316|NCT01667081|54209039|FG000|Overall Study|Withdrawal by Subject|90|||
27757317|NCT01667081|54209040|FG001|Overall Study|Withdrawal by Subject|35|||
27757318|NCT04545619|54209057|FG000|Overall Study|due to equipment challenges|1|||
27757319|NCT02518971|54209063|FG000|Overall Study|Lost to Follow-up|0|||
27757320|NCT02518971|54209064|FG001|Overall Study|Lost to Follow-up|1|||
27757321|NCT02518971|54209063|FG000|Overall Study|Physician Decision|6|||
27757322|NCT02518971|54209064|FG001|Overall Study|Physician Decision|6|||
27757323|NCT02518971|54209063|FG000|Overall Study|Protocol Violation|6|||
27757324|NCT02518971|54209064|FG001|Overall Study|Protocol Violation|4|||
27757325|NCT02518971|54209063|FG000|Overall Study|Withdrawal by Subject|4|||
27757326|NCT02518971|54209064|FG001|Overall Study|Withdrawal by Subject|5|||
27757327|NCT02518971|54209063|FG000|Overall Study|Side effects|1|||
27757328|NCT02518971|54209064|FG001|Overall Study|Side effects|0|||
27757329|NCT02518971|54209063|FG000|Overall Study|medication lost in mail|0|||
27757330|NCT02518971|54209064|FG001|Overall Study|medication lost in mail|1|||
27757331|NCT02518971|54209063|FG000|Overall Study|eligibility criteria no longer met|6|||
27757332|NCT02518971|54209064|FG001|Overall Study|eligibility criteria no longer met|3|||
27757333|NCT01365039|54209073|FG000|Overall Study|Study related symptoms and complaints|1|||
27757334|NCT01365039|54209074|FG001|Overall Study|Study related symptoms and complaints|0|||
27757335|NCT01364727|54209081|FG000|Overall Study|Not Eligible|2|||
27757336|NCT02633215|54209089|FG000|Overall Study|Lost to Follow-up|2|||
27757337|NCT02633215|54209090|FG001|Overall Study|Lost to Follow-up|3|||
27757338|NCT01364649|54209098|FG000|Overall Study|Pretreatment Event or Adverse Event|20|||
27757339|NCT01364649|54209099|FG001|Overall Study|Pretreatment Event or Adverse Event|14|||
27757340|NCT01364649|54209098|FG000|Overall Study|Lack of Efficacy|6|||
27757341|NCT01364649|54209099|FG001|Overall Study|Lack of Efficacy|0|||
27757342|NCT01364649|54209098|FG000|Overall Study|Non-compliance with Investigational Drug|1|||
27757343|NCT01364649|54209099|FG001|Overall Study|Non-compliance with Investigational Drug|0|||
27757344|NCT01364649|54209098|FG000|Overall Study|Protocol Deviations|4|||
27757345|NCT01364649|54209099|FG001|Overall Study|Protocol Deviations|8|||
27757346|NCT01364649|54209098|FG000|Overall Study|Withdrawal of Consent|9|||
27757347|NCT01364649|54209099|FG001|Overall Study|Withdrawal of Consent|7|||
27757348|NCT01364649|54209098|FG000|Overall Study|Lost to Follow-up|12|||
27757349|NCT01364649|54209099|FG001|Overall Study|Lost to Follow-up|13|||
27757350|NCT01364649|54209098|FG000|Overall Study|Other|4|||
27757351|NCT01364649|54209099|FG001|Overall Study|Other|1|||
27757352|NCT02588261|54209107|FG000|Overall Study|Study Terminated by Sponsor|157|||
27757353|NCT02588261|54209108|FG001|Overall Study|Study Terminated by Sponsor|142|||
27757354|NCT02588261|54209107|FG000|Overall Study|Protocol Deviation|1|||
27757355|NCT02588261|54209108|FG001|Overall Study|Protocol Deviation|0|||
27757356|NCT02588261|54209107|FG000|Overall Study|Death|1|||
27757357|NCT02588261|54209108|FG001|Overall Study|Death|2|||
27757358|NCT02588261|54209107|FG000|Overall Study|Withdrawal by Subject|12|||
27757359|NCT02588261|54209108|FG001|Overall Study|Withdrawal by Subject|8|||
27757360|NCT02588261|54209107|FG000|Overall Study|Noncompliance with Study Drug|0|||
27839203|NCT01473407|54326487|FG001|Overall Study|Patient Received Aranesp|0|||
27839204|NCT01473407|54326486|FG000|Overall Study|Patient Lost Green Card Status|1|||
27757361|NCT02588261|54209108|FG001|Overall Study|Noncompliance with Study Drug|1|||
27757362|NCT02588261|54209107|FG000|Overall Study|Miscellaneous|5|||
27757363|NCT02588261|54209108|FG001|Overall Study|Miscellaneous|4|||
27757364|NCT02588261|54209107|FG000|Overall Study|Progressive Disease|61|||
27757365|NCT02588261|54209108|FG001|Overall Study|Progressive Disease|82|||
27757366|NCT02588261|54209107|FG000|Overall Study|Adverse Event|29|||
27757367|NCT02588261|54209108|FG001|Overall Study|Adverse Event|24|||
27757368|NCT02588261|54209107|FG000|Overall Study|Lost to Follow-up|1|||
27757369|NCT02588261|54209108|FG001|Overall Study|Lost to Follow-up|0|||
27757370|NCT01359449|54209116|FG000|Overall Study|Lost to Follow-up|1|||
27757371|NCT01359449|54209117|FG001|Overall Study|Lost to Follow-up|0|||
27757372|NCT01359449|54209116|FG000|Overall Study|Protocol Violation|0|||
27757373|NCT01359449|54209117|FG001|Overall Study|Protocol Violation|2|||
27757374|NCT01359449|54209116|FG000|Overall Study|Withdrawal by Subject|3|||
27757375|NCT01359449|54209117|FG001|Overall Study|Withdrawal by Subject|2|||
27757376|NCT01672723|54209123|FG000|First Intervention|Adverse Event|3|||
27757377|NCT01672723|54209124|FG001|First Intervention|Adverse Event|0|||
27757378|NCT02632747|54209132|FG000|Wash-out Period|Adverse Event|1|||
27757379|NCT02632747|54209133|FG001|Wash-out Period|Adverse Event|0|||
27757380|NCT02520531|54209152|FG000|Overall Study|Revision of study device components|2|||
27757381|NCT02520531|54209153|FG001|Overall Study|Revision of study device components|2|||
27757382|NCT02520531|54209152|FG000|Overall Study|Death|1|||
27757383|NCT02520531|54209153|FG001|Overall Study|Death|2|||
27757384|NCT02520531|54209152|FG000|Overall Study|Lost to Follow-up|1|||
27757385|NCT02520531|54209153|FG001|Overall Study|Lost to Follow-up|1|||
27757386|NCT02520531|54209152|FG000|Overall Study|Meet exclusion criterion|0|||
27757387|NCT02520531|54209153|FG001|Overall Study|Meet exclusion criterion|1|||
27757388|NCT02520531|54209152|FG000|Overall Study|Withdrawal by Subject|1|||
27757389|NCT02520531|54209153|FG001|Overall Study|Withdrawal by Subject|0|||
27757390|NCT02520531|54209152|FG000|Overall Study|Not study device|1|||
27757391|NCT02520531|54209153|FG001|Overall Study|Not study device|0|||
27757392|NCT01671319|54209159|FG000|Overall Study|Withdrawal by Subject|1|||
27757393|NCT01670539|54209163|FG000|Overall Study|Death|3|||
27757394|NCT01670539|54209164|FG001|Overall Study|Death|5|||
27757395|NCT01670539|54209163|FG000|Overall Study|Withdrawal by Subject|3|||
27757396|NCT01670539|54209164|FG001|Overall Study|Withdrawal by Subject|0|||
27757397|NCT02516163|54209171|FG000|Overall Study|Withdrawal by Subject|1|||
27757398|NCT02516163|54209171|FG000|Overall Study|Failed MRI/incorrect MRI protocol|11|||
27757399|NCT02516163|54209171|FG000|Overall Study|Unfit/delay in surgery|3|||
27757400|NCT02516163|54209171|FG000|Overall Study|Use of incorrect measurement technique|5|||
27757401|NCT02516163|54209171|FG000|Overall Study|Data not recorded|2|||
27757402|NCT02516163|54209171|FG000|Overall Study|MRI contraindication exclusion|6|||
27757403|NCT02589665|54209179|FG000|Induction Period|Did not receive drug|0|||
27757404|NCT02589665|54209180|FG001|Induction Period|Did not receive drug|0|||
27757405|NCT02589665|54209181|FG002|Induction Period|Did not receive drug|0|||
27757406|NCT02589665|54209182|FG003|Induction Period|Did not receive drug|1|||
27757407|NCT02589665|54209183|FG004|Induction Period|Did not receive drug|0|||
27757408|NCT02589665|54209184|FG005|Induction Period|Did not receive drug|0|||
27757409|NCT02589665|54209185|FG006|Induction Period|Did not receive drug|0|||
27757410|NCT02589665|54209186|FG007|Induction Period|Did not receive drug|0|||
27757411|NCT02589665|54209187|FG008|Induction Period|Did not receive drug|0|||
27757412|NCT02589665|54209188|FG009|Induction Period|Did not receive drug|0|||
27757413|NCT02589665|54209179|FG000|Induction Period|Adverse Event|3|||
27757414|NCT02589665|54209180|FG001|Induction Period|Adverse Event|0|||
27757415|NCT02589665|54209181|FG002|Induction Period|Adverse Event|2|||
27757416|NCT02589665|54209182|FG003|Induction Period|Adverse Event|2|||
27757417|NCT02589665|54209183|FG004|Induction Period|Adverse Event|0|||
27757418|NCT02589665|54209184|FG005|Induction Period|Adverse Event|0|||
27757419|NCT02589665|54209185|FG006|Induction Period|Adverse Event|0|||
27757420|NCT02589665|54209186|FG007|Induction Period|Adverse Event|0|||
27757421|NCT02589665|54209187|FG008|Induction Period|Adverse Event|0|||
27757422|NCT02589665|54209188|FG009|Induction Period|Adverse Event|0|||
27757423|NCT02589665|54209179|FG000|Induction Period|Withdrawal by Subject|0|||
27757424|NCT02589665|54209180|FG001|Induction Period|Withdrawal by Subject|1|||
27757425|NCT02589665|54209181|FG002|Induction Period|Withdrawal by Subject|0|||
27757426|NCT02589665|54209182|FG003|Induction Period|Withdrawal by Subject|1|||
27757427|NCT02589665|54209183|FG004|Induction Period|Withdrawal by Subject|0|||
27757428|NCT02589665|54209184|FG005|Induction Period|Withdrawal by Subject|0|||
27757429|NCT02589665|54209185|FG006|Induction Period|Withdrawal by Subject|0|||
27757430|NCT02589665|54209186|FG007|Induction Period|Withdrawal by Subject|0|||
27757431|NCT02589665|54209187|FG008|Induction Period|Withdrawal by Subject|0|||
27757432|NCT02589665|54209188|FG009|Induction Period|Withdrawal by Subject|0|||
27757433|NCT02589665|54209179|FG000|Induction Period|Protocol Violation|0|||
27757434|NCT02589665|54209180|FG001|Induction Period|Protocol Violation|1|||
27757435|NCT02589665|54209181|FG002|Induction Period|Protocol Violation|0|||
27757436|NCT02589665|54209182|FG003|Induction Period|Protocol Violation|0|||
27757437|NCT02589665|54209183|FG004|Induction Period|Protocol Violation|0|||
27757438|NCT02589665|54209184|FG005|Induction Period|Protocol Violation|0|||
27757439|NCT02589665|54209185|FG006|Induction Period|Protocol Violation|0|||
27757440|NCT02589665|54209186|FG007|Induction Period|Protocol Violation|0|||
27757441|NCT02589665|54209187|FG008|Induction Period|Protocol Violation|0|||
27757442|NCT02589665|54209188|FG009|Induction Period|Protocol Violation|0|||
27757443|NCT02589665|54209179|FG000|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
27757444|NCT02589665|54209180|FG001|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
27757445|NCT02589665|54209181|FG002|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
27757446|NCT02589665|54209182|FG003|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
27757447|NCT02589665|54209183|FG004|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7|||
27757448|NCT02589665|54209184|FG005|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41|||
27757449|NCT02589665|54209185|FG006|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39|||
27757450|NCT02589665|54209186|FG007|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
27757451|NCT02589665|54209187|FG008|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
27757452|NCT02589665|54209188|FG009|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
27757453|NCT02589665|54209179|FG000|Maintenance Period|Withdrawal by Subject|0|||
27757454|NCT02589665|54209180|FG001|Maintenance Period|Withdrawal by Subject|0|||
27757455|NCT02589665|54209181|FG002|Maintenance Period|Withdrawal by Subject|0|||
27757456|NCT02589665|54209182|FG003|Maintenance Period|Withdrawal by Subject|0|||
27757457|NCT02589665|54209183|FG004|Maintenance Period|Withdrawal by Subject|4|||
27757458|NCT02589665|54209184|FG005|Maintenance Period|Withdrawal by Subject|2|||
27757459|NCT02589665|54209185|FG006|Maintenance Period|Withdrawal by Subject|4|||
27757460|NCT02589665|54209186|FG007|Maintenance Period|Withdrawal by Subject|0|||
27757461|NCT02589665|54209187|FG008|Maintenance Period|Withdrawal by Subject|0|||
27757462|NCT02589665|54209188|FG009|Maintenance Period|Withdrawal by Subject|0|||
27757463|NCT02589665|54209179|FG000|Maintenance Period|Lack of Efficacy|0|||
27757464|NCT02589665|54209180|FG001|Maintenance Period|Lack of Efficacy|0|||
27757465|NCT02589665|54209181|FG002|Maintenance Period|Lack of Efficacy|0|||
27757466|NCT02589665|54209182|FG003|Maintenance Period|Lack of Efficacy|0|||
27757467|NCT02589665|54209183|FG004|Maintenance Period|Lack of Efficacy|2|||
27757468|NCT02589665|54209184|FG005|Maintenance Period|Lack of Efficacy|1|||
27757469|NCT02589665|54209185|FG006|Maintenance Period|Lack of Efficacy|0|||
27757470|NCT02589665|54209186|FG007|Maintenance Period|Lack of Efficacy|0|||
27757471|NCT02589665|54209187|FG008|Maintenance Period|Lack of Efficacy|0|||
27757472|NCT02589665|54209188|FG009|Maintenance Period|Lack of Efficacy|0|||
27757473|NCT02589665|54209179|FG000|Maintenance Period|Adverse Event|0|||
27757474|NCT02589665|54209180|FG001|Maintenance Period|Adverse Event|0|||
27757475|NCT02589665|54209181|FG002|Maintenance Period|Adverse Event|0|||
27757476|NCT02589665|54209182|FG003|Maintenance Period|Adverse Event|0|||
27757477|NCT02589665|54209183|FG004|Maintenance Period|Adverse Event|0|||
27757478|NCT02589665|54209184|FG005|Maintenance Period|Adverse Event|0|||
27757479|NCT02589665|54209185|FG006|Maintenance Period|Adverse Event|2|||
27757480|NCT02589665|54209186|FG007|Maintenance Period|Adverse Event|0|||
27757481|NCT02589665|54209187|FG008|Maintenance Period|Adverse Event|0|||
27757482|NCT02589665|54209188|FG009|Maintenance Period|Adverse Event|0|||
27757483|NCT02589665|54209179|FG000|Maintenance Period|Lost to Follow-up|0|||
27757484|NCT02589665|54209180|FG001|Maintenance Period|Lost to Follow-up|0|||
27757485|NCT02589665|54209181|FG002|Maintenance Period|Lost to Follow-up|0|||
27757486|NCT02589665|54209182|FG003|Maintenance Period|Lost to Follow-up|0|||
27757487|NCT02589665|54209183|FG004|Maintenance Period|Lost to Follow-up|0|||
27757488|NCT02589665|54209184|FG005|Maintenance Period|Lost to Follow-up|1|||
27757489|NCT02589665|54209185|FG006|Maintenance Period|Lost to Follow-up|0|||
27757490|NCT02589665|54209186|FG007|Maintenance Period|Lost to Follow-up|0|||
27757491|NCT02589665|54209187|FG008|Maintenance Period|Lost to Follow-up|0|||
27757492|NCT02589665|54209188|FG009|Maintenance Period|Lost to Follow-up|0|||
27757493|NCT02589665|54209179|FG000|Maintenance Period|Physician Decision|0|||
27757494|NCT02589665|54209180|FG001|Maintenance Period|Physician Decision|0|||
27757495|NCT02589665|54209181|FG002|Maintenance Period|Physician Decision|0|||
27757496|NCT02589665|54209182|FG003|Maintenance Period|Physician Decision|0|||
27757497|NCT02589665|54209183|FG004|Maintenance Period|Physician Decision|0|||
27757498|NCT02589665|54209184|FG005|Maintenance Period|Physician Decision|1|||
27757499|NCT02589665|54209185|FG006|Maintenance Period|Physician Decision|0|||
27757500|NCT02589665|54209186|FG007|Maintenance Period|Physician Decision|0|||
27757501|NCT02589665|54209187|FG008|Maintenance Period|Physician Decision|0|||
27757502|NCT02589665|54209188|FG009|Maintenance Period|Physician Decision|0|||
27757503|NCT02589665|54209179|FG000|Maintenance Period|Reason Not Collected|0|||
27757504|NCT02589665|54209180|FG001|Maintenance Period|Reason Not Collected|0|||
27757505|NCT02589665|54209181|FG002|Maintenance Period|Reason Not Collected|0|||
27839205|NCT01473407|54326487|FG001|Overall Study|Patient Lost Green Card Status|0|||
27839206|NCT01473407|54326486|FG000|Overall Study|Temperature Excursion|2|||
27757506|NCT02589665|54209182|FG003|Maintenance Period|Reason Not Collected|0|||
27757507|NCT02589665|54209183|FG004|Maintenance Period|Reason Not Collected|0|||
27757508|NCT02589665|54209184|FG005|Maintenance Period|Reason Not Collected|1|||
27757509|NCT02589665|54209185|FG006|Maintenance Period|Reason Not Collected|1|||
27757510|NCT02589665|54209186|FG007|Maintenance Period|Reason Not Collected|0|||
27757511|NCT02589665|54209187|FG008|Maintenance Period|Reason Not Collected|0|||
27757512|NCT02589665|54209188|FG009|Maintenance Period|Reason Not Collected|0|||
27757513|NCT02589665|54209179|FG000|Induction Extension Period|Adverse Event|0|||
27839207|NCT01473407|54326487|FG001|Overall Study|Temperature Excursion|3|||
27757514|NCT02589665|54209180|FG001|Induction Extension Period|Adverse Event|0|||
27757515|NCT02589665|54209181|FG002|Induction Extension Period|Adverse Event|0|||
27757516|NCT02589665|54209182|FG003|Induction Extension Period|Adverse Event|0|||
27757517|NCT02589665|54209183|FG004|Induction Extension Period|Adverse Event|0|||
27757518|NCT02589665|54209184|FG005|Induction Extension Period|Adverse Event|0|||
27757519|NCT02589665|54209185|FG006|Induction Extension Period|Adverse Event|0|||
27757520|NCT02589665|54209186|FG007|Induction Extension Period|Adverse Event|0|||
27757521|NCT02589665|54209187|FG008|Induction Extension Period|Adverse Event|4|||
27757522|NCT02589665|54209188|FG009|Induction Extension Period|Adverse Event|0|||
27757523|NCT02589665|54209179|FG000|Induction Extension Period|Lack of Efficacy|0|||
27757524|NCT02589665|54209180|FG001|Induction Extension Period|Lack of Efficacy|0|||
27757525|NCT02589665|54209181|FG002|Induction Extension Period|Lack of Efficacy|0|||
27757526|NCT02589665|54209182|FG003|Induction Extension Period|Lack of Efficacy|0|||
27757527|NCT02589665|54209183|FG004|Induction Extension Period|Lack of Efficacy|0|||
27757528|NCT02589665|54209184|FG005|Induction Extension Period|Lack of Efficacy|0|||
27757529|NCT02589665|54209185|FG006|Induction Extension Period|Lack of Efficacy|0|||
27757530|NCT02589665|54209186|FG007|Induction Extension Period|Lack of Efficacy|0|||
27757531|NCT02589665|54209187|FG008|Induction Extension Period|Lack of Efficacy|3|||
27757532|NCT02589665|54209188|FG009|Induction Extension Period|Lack of Efficacy|0|||
27757533|NCT02589665|54209179|FG000|Induction Extension Period|Withdrawal by Subject|0|||
27757534|NCT02589665|54209180|FG001|Induction Extension Period|Withdrawal by Subject|0|||
27757535|NCT02589665|54209181|FG002|Induction Extension Period|Withdrawal by Subject|0|||
27757536|NCT02589665|54209182|FG003|Induction Extension Period|Withdrawal by Subject|0|||
27757537|NCT02589665|54209183|FG004|Induction Extension Period|Withdrawal by Subject|0|||
27757538|NCT02589665|54209184|FG005|Induction Extension Period|Withdrawal by Subject|0|||
27757539|NCT02589665|54209185|FG006|Induction Extension Period|Withdrawal by Subject|0|||
27757540|NCT02589665|54209186|FG007|Induction Extension Period|Withdrawal by Subject|2|||
27757541|NCT02589665|54209187|FG008|Induction Extension Period|Withdrawal by Subject|3|||
27757542|NCT02589665|54209188|FG009|Induction Extension Period|Withdrawal by Subject|0|||
27757543|NCT02589665|54209179|FG000|Induction Extension Period|Physician Decision|0|||
27757544|NCT02589665|54209180|FG001|Induction Extension Period|Physician Decision|0|||
27757545|NCT02589665|54209181|FG002|Induction Extension Period|Physician Decision|0|||
27757546|NCT02589665|54209182|FG003|Induction Extension Period|Physician Decision|0|||
27757547|NCT02589665|54209183|FG004|Induction Extension Period|Physician Decision|0|||
27757548|NCT02589665|54209184|FG005|Induction Extension Period|Physician Decision|0|||
27757549|NCT02589665|54209185|FG006|Induction Extension Period|Physician Decision|0|||
27757550|NCT02589665|54209186|FG007|Induction Extension Period|Physician Decision|0|||
27757551|NCT02589665|54209187|FG008|Induction Extension Period|Physician Decision|1|||
27757552|NCT02589665|54209188|FG009|Induction Extension Period|Physician Decision|0|||
27757553|NCT02589665|54209179|FG000|Induction Extension Period|Reason Not Collected|0|||
27757554|NCT02589665|54209180|FG001|Induction Extension Period|Reason Not Collected|0|||
27757555|NCT02589665|54209181|FG002|Induction Extension Period|Reason Not Collected|0|||
27757556|NCT02589665|54209182|FG003|Induction Extension Period|Reason Not Collected|0|||
27757557|NCT02589665|54209183|FG004|Induction Extension Period|Reason Not Collected|0|||
27757558|NCT02589665|54209184|FG005|Induction Extension Period|Reason Not Collected|0|||
27757559|NCT02589665|54209185|FG006|Induction Extension Period|Reason Not Collected|0|||
27757560|NCT02589665|54209186|FG007|Induction Extension Period|Reason Not Collected|0|||
27757561|NCT02589665|54209187|FG008|Induction Extension Period|Reason Not Collected|1|||
27757562|NCT02589665|54209188|FG009|Induction Extension Period|Reason Not Collected|0|||
27757563|NCT02589665|54209179|FG000|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
27757564|NCT02589665|54209180|FG001|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
27757565|NCT02589665|54209181|FG002|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
27757566|NCT02589665|54209182|FG003|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
27757567|NCT02589665|54209183|FG004|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
27757568|NCT02589665|54209184|FG005|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
27757569|NCT02589665|54209185|FG006|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
27757570|NCT02589665|54209186|FG007|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
27757571|NCT02589665|54209187|FG008|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
27757572|NCT02589665|54209188|FG009|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57|||
27757573|NCT02589665|54209179|FG000|Maintenance Extension Period|Withdrawal by Subject|0|||
27757574|NCT02589665|54209180|FG001|Maintenance Extension Period|Withdrawal by Subject|0|||
27757575|NCT02589665|54209181|FG002|Maintenance Extension Period|Withdrawal by Subject|0|||
27757576|NCT02589665|54209182|FG003|Maintenance Extension Period|Withdrawal by Subject|0|||
27757577|NCT02589665|54209183|FG004|Maintenance Extension Period|Withdrawal by Subject|0|||
27757578|NCT02589665|54209184|FG005|Maintenance Extension Period|Withdrawal by Subject|0|||
27757579|NCT02589665|54209185|FG006|Maintenance Extension Period|Withdrawal by Subject|0|||
27757580|NCT02589665|54209186|FG007|Maintenance Extension Period|Withdrawal by Subject|0|||
27757581|NCT02589665|54209187|FG008|Maintenance Extension Period|Withdrawal by Subject|0|||
27839208|NCT01473407|54326486|FG000|Overall Study|Transfer to Another Facility/Unit|4|||
27839209|NCT01473407|54326487|FG001|Overall Study|Transfer to Another Facility/Unit|3|||
27839210|NCT01473407|54326486|FG000|Overall Study|Sponsor's Decision|10|||
27839211|NCT01473407|54326487|FG001|Overall Study|Sponsor's Decision|10|||
27839212|NCT01473407|54326486|FG000|Overall Study|Site Closure|1|||
27839213|NCT01473407|54326487|FG001|Overall Study|Site Closure|0|||
27839214|NCT01472939|54326497|FG000|Overall Study|Adverse Event|3|||
27839215|NCT01472939|54326498|FG001|Overall Study|Adverse Event|7|||
27839216|NCT01472939|54326499|FG002|Overall Study|Adverse Event|7|||
27839217|NCT01472939|54326500|FG003|Overall Study|Adverse Event|14|||
27839218|NCT01472939|54326497|FG000|Overall Study|Lack of Efficacy|1|||
27839219|NCT01472939|54326498|FG001|Overall Study|Lack of Efficacy|0|||
27839220|NCT01472939|54326499|FG002|Overall Study|Lack of Efficacy|0|||
27839221|NCT01472939|54326500|FG003|Overall Study|Lack of Efficacy|1|||
27839222|NCT01472939|54326497|FG000|Overall Study|Lost to Follow-up|3|||
27839223|NCT01472939|54326498|FG001|Overall Study|Lost to Follow-up|0|||
27839224|NCT01472939|54326499|FG002|Overall Study|Lost to Follow-up|2|||
27839225|NCT01472939|54326500|FG003|Overall Study|Lost to Follow-up|0|||
27839226|NCT01472939|54326497|FG000|Overall Study|Clinically Significant Pre-Dose ECG|0|||
27839227|NCT01472939|54326498|FG001|Overall Study|Clinically Significant Pre-Dose ECG|0|||
27839228|NCT01472939|54326499|FG002|Overall Study|Clinically Significant Pre-Dose ECG|1|||
27839229|NCT01472939|54326500|FG003|Overall Study|Clinically Significant Pre-Dose ECG|0|||
27839230|NCT01472939|54326497|FG000|Overall Study|Prohibited Medication|0|||
27839231|NCT01472939|54326498|FG001|Overall Study|Prohibited Medication|1|||
27839232|NCT01472939|54326499|FG002|Overall Study|Prohibited Medication|0|||
27839233|NCT01472939|54326500|FG003|Overall Study|Prohibited Medication|0|||
27839234|NCT01472939|54326497|FG000|Overall Study|Withdrawal By PI|1|||
27839235|NCT01472939|54326498|FG001|Overall Study|Withdrawal By PI|0|||
27839236|NCT01472939|54326499|FG002|Overall Study|Withdrawal By PI|0|||
27839237|NCT01472939|54326500|FG003|Overall Study|Withdrawal By PI|0|||
27839238|NCT01472939|54326497|FG000|Overall Study|Protocol Violation|3|||
27839239|NCT01472939|54326498|FG001|Overall Study|Protocol Violation|3|||
27839240|NCT01472939|54326499|FG002|Overall Study|Protocol Violation|0|||
27839241|NCT01472939|54326500|FG003|Overall Study|Protocol Violation|1|||
27839242|NCT01472939|54326497|FG000|Overall Study|Withdrawal by Subject|9|||
27839243|NCT01472939|54326498|FG001|Overall Study|Withdrawal by Subject|3|||
27839244|NCT01472939|54326499|FG002|Overall Study|Withdrawal by Subject|1|||
27839245|NCT01472939|54326500|FG003|Overall Study|Withdrawal by Subject|4|||
27839246|NCT01544179|54326515|FG000|Overall Study|Death|50|||
27839247|NCT01544179|54326516|FG001|Overall Study|Death|37|||
27839248|NCT01544179|54326515|FG000|Overall Study|Lost to Follow-up|0|||
27839249|NCT01544179|54326516|FG001|Overall Study|Lost to Follow-up|1|||
27839250|NCT01544179|54326515|FG000|Overall Study|Adverse Event|0|||
27839251|NCT01544179|54326516|FG001|Overall Study|Adverse Event|1|||
27839252|NCT01544179|54326515|FG000|Overall Study|Withdrawal by Subject|12|||
27839253|NCT01544179|54326516|FG001|Overall Study|Withdrawal by Subject|7|||
27839254|NCT01544179|54326515|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
27839255|NCT01544179|54326516|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
27839256|NCT01483651|54326522|FG000|Overall Study|Withdrawal by Subject|0|||
27839257|NCT01483651|54326523|FG001|Overall Study|Withdrawal by Subject|1|||
27839258|NCT01483651|54326524|FG002|Overall Study|Withdrawal by Subject|1|||
27839259|NCT01483651|54326525|FG003|Overall Study|Withdrawal by Subject|0|||
27839260|NCT01483651|54326526|FG004|Overall Study|Withdrawal by Subject|0|||
27839261|NCT01483651|54326527|FG005|Overall Study|Withdrawal by Subject|1|||
27839262|NCT01464307|54326537|FG000|Main Period|Death|0|||
27839263|NCT01464307|54326538|FG001|Main Period|Death|1|||
27839264|NCT01464307|54326537|FG000|Main Period|Adverse Event|6|||
27839265|NCT01464307|54326538|FG001|Main Period|Adverse Event|1|||
27839266|NCT01464307|54326537|FG000|Main Period|Lack of Efficacy|2|||
27839267|NCT01464307|54326538|FG001|Main Period|Lack of Efficacy|0|||
27839268|NCT01464307|54326537|FG000|Main Period|Withdrawal by Subject|5|||
27839269|NCT01464307|54326538|FG001|Main Period|Withdrawal by Subject|2|||
27839270|NCT01464307|54326537|FG000|Main Period|Predefined discontinuation criteria|2|||
27839271|NCT01464307|54326538|FG001|Main Period|Predefined discontinuation criteria|1|||
27839272|NCT01464307|54326537|FG000|Open-Label Extension Period|Adverse Event|15|||
27839273|NCT01464307|54326538|FG001|Open-Label Extension Period|Adverse Event|0|||
27839274|NCT01464307|54326537|FG000|Open-Label Extension Period|Withdrawal by Subject|14|||
27839275|NCT01464307|54326538|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
27839276|NCT01464307|54326537|FG000|Open-Label Extension Period|Lack of Efficacy|5|||
27839277|NCT01464307|54326538|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
27839278|NCT01464307|54326537|FG000|Open-Label Extension Period|Death|1|||
27839279|NCT01464307|54326538|FG001|Open-Label Extension Period|Death|0|||
27839280|NCT01464307|54326537|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
27839281|NCT01464307|54326538|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
27839282|NCT01464307|54326537|FG000|Open-Label Extension Period|Non-compliance|9|||
27839283|NCT01464307|54326538|FG001|Open-Label Extension Period|Non-compliance|0|||
27839284|NCT01464307|54326537|FG000|Open-Label Extension Period|Predefined discontinuation criteria|6|||
27839285|NCT01464307|54326538|FG001|Open-Label Extension Period|Predefined discontinuation criteria|0|||
27839286|NCT01483183|54326555|FG000|Overall Study|Physician Decision|0|||
27839287|NCT01483183|54326556|FG001|Overall Study|Physician Decision|0|||
27839288|NCT01483183|54326557|FG002|Overall Study|Physician Decision|0|||
27839289|NCT01483183|54326558|FG003|Overall Study|Physician Decision|0|||
27839290|NCT01483183|54326559|FG004|Overall Study|Physician Decision|0|||
27839291|NCT01483183|54326560|FG005|Overall Study|Physician Decision|0|||
27839292|NCT01483183|54326561|FG006|Overall Study|Physician Decision|2|||
27839293|NCT01483183|54326562|FG007|Overall Study|Physician Decision|0|||
27839294|NCT01483183|54326563|FG008|Overall Study|Physician Decision|0|||
27839295|NCT01483183|54326564|FG009|Overall Study|Physician Decision|0|||
27839296|NCT01483183|54326555|FG000|Overall Study|Withdrawal by Subject|0|||
27839297|NCT01483183|54326556|FG001|Overall Study|Withdrawal by Subject|0|||
27839298|NCT01483183|54326557|FG002|Overall Study|Withdrawal by Subject|0|||
27839299|NCT01483183|54326558|FG003|Overall Study|Withdrawal by Subject|0|||
27839300|NCT01483183|54326559|FG004|Overall Study|Withdrawal by Subject|0|||
27839301|NCT01483183|54326560|FG005|Overall Study|Withdrawal by Subject|0|||
27839302|NCT01483183|54326561|FG006|Overall Study|Withdrawal by Subject|0|||
27839303|NCT01483183|54326562|FG007|Overall Study|Withdrawal by Subject|0|||
27839304|NCT01483183|54326563|FG008|Overall Study|Withdrawal by Subject|0|||
27839305|NCT01483183|54326564|FG009|Overall Study|Withdrawal by Subject|1|||
27839306|NCT01483027|54326594|FG000|Overall Study|Administrative Reasons|2|||
27839307|NCT01483027|54326595|FG001|Overall Study|Administrative Reasons|1|||
27839308|NCT01483027|54326594|FG000|Overall Study|Withdrawal by Subject|21|||
27839309|NCT01483027|54326595|FG001|Overall Study|Withdrawal by Subject|32|||
27839310|NCT01483027|54326594|FG000|Overall Study|Discontinuation by Investigator or Sponsor for any reason|22|||
27839311|NCT01483027|54326595|FG001|Overall Study|Discontinuation by Investigator or Sponsor for any reason|24|||
27839312|NCT01483027|54326594|FG000|Overall Study|Lost to Follow-up|1|||
27839313|NCT01483027|54326595|FG001|Overall Study|Lost to Follow-up|1|||
27839314|NCT01483027|54326594|FG000|Overall Study|Adverse Event|0|||
27839315|NCT01483027|54326595|FG001|Overall Study|Adverse Event|1|||
27839316|NCT01483027|54326594|FG000|Overall Study|Withdrawal by Subject|0|||
27839317|NCT01483027|54326595|FG001|Overall Study|Withdrawal by Subject|1|||
27839318|NCT01463683|54326604|FG000|Overall Study|Adverse Event|2|||
27839319|NCT01463683|54326605|FG001|Overall Study|Adverse Event|0|||
27839320|NCT01463683|54326606|FG002|Overall Study|Adverse Event|0|||
27839321|NCT01463683|54326604|FG000|Overall Study|Lost to Follow-up|10|||
27839322|NCT01463683|54326605|FG001|Overall Study|Lost to Follow-up|9|||
27839323|NCT01463683|54326606|FG002|Overall Study|Lost to Follow-up|7|||
27839324|NCT01463683|54326604|FG000|Overall Study|Physician Decision|0|||
27839325|NCT01463683|54326605|FG001|Overall Study|Physician Decision|3|||
27839326|NCT01463683|54326606|FG002|Overall Study|Physician Decision|1|||
27839327|NCT01463683|54326604|FG000|Overall Study|Pregnancy|2|||
27839328|NCT01463683|54326605|FG001|Overall Study|Pregnancy|2|||
27839329|NCT01463683|54326606|FG002|Overall Study|Pregnancy|1|||
27839330|NCT01463683|54326604|FG000|Overall Study|Withdrawal by Subject|5|||
27839331|NCT01463683|54326605|FG001|Overall Study|Withdrawal by Subject|17|||
27839332|NCT01463683|54326606|FG002|Overall Study|Withdrawal by Subject|2|||
27839333|NCT01482169|54326614|FG000|Overall Study|Physician Decision|2|||
27839334|NCT01481779|54326623|FG000|Overall Study|Adverse Event|23|||
27839335|NCT01481779|54326624|FG001|Overall Study|Adverse Event|5|||
27839336|NCT01481779|54326623|FG000|Overall Study|Lost to Follow-up|3|||
27839337|NCT01481779|54326624|FG001|Overall Study|Lost to Follow-up|2|||
27839338|NCT01481779|54326623|FG000|Overall Study|Protocol Violation|2|||
27839339|NCT01481779|54326624|FG001|Overall Study|Protocol Violation|3|||
27839340|NCT01481779|54326623|FG000|Overall Study|Withdrawal by Subject|26|||
27839341|NCT01481779|54326624|FG001|Overall Study|Withdrawal by Subject|13|||
27839342|NCT01481779|54326623|FG000|Overall Study|Physician Decision|13|||
27839343|NCT01481779|54326624|FG001|Overall Study|Physician Decision|4|||
27839344|NCT01481779|54326623|FG000|Overall Study|Sponsor Decision|3|||
27839345|NCT01481779|54326624|FG001|Overall Study|Sponsor Decision|1|||
27839346|NCT01463527|54326632|FG000|Overall Study|Protocol Violation|1|||
27839347|NCT01463527|54326633|FG001|Overall Study|Protocol Violation|1|||
27839348|NCT01463527|54326632|FG000|Overall Study|Crying >20% of sedation|5|||
27839349|NCT01463527|54326633|FG001|Overall Study|Crying >20% of sedation|6|||
27839350|NCT01509547|54326641|FG000|Overall Study|Lost to Follow-up|24|||
27839351|NCT01509547|54326642|FG001|Overall Study|Lost to Follow-up|14|||
27839352|NCT01509547|54326641|FG000|Overall Study|Withdrawal by Subject|11|||
27839353|NCT01509547|54326642|FG001|Overall Study|Withdrawal by Subject|24|||
27839354|NCT01509547|54326641|FG000|Overall Study|Physician Decision|0|||
27839355|NCT01509547|54326642|FG001|Overall Study|Physician Decision|1|||
27839356|NCT01509079|54326650|FG000|Overall Study|Lack of Efficacy|0|||
27839357|NCT01509079|54326651|FG001|Overall Study|Lack of Efficacy|2|||
27839358|NCT01509079|54326650|FG000|Overall Study|started an excluded medication|0|||
27839359|NCT01509079|54326651|FG001|Overall Study|started an excluded medication|1|||
27839360|NCT01463293|54326660|FG000|Overall Study|Lost to Follow-up|1|||
27839361|NCT01463293|54326661|FG001|Overall Study|Lost to Follow-up|4|||
27839362|NCT01463293|54326662|FG002|Overall Study|Lost to Follow-up|5|||
27839363|NCT01463293|54326660|FG000|Overall Study|Adverse Event|1|||
27839364|NCT01463293|54326661|FG001|Overall Study|Adverse Event|2|||
27839365|NCT01463293|54326662|FG002|Overall Study|Adverse Event|0|||
27839366|NCT01463293|54326660|FG000|Overall Study|Withdrawal by Subject|4|||
27839367|NCT01463293|54326661|FG001|Overall Study|Withdrawal by Subject|10|||
27839368|NCT01463293|54326662|FG002|Overall Study|Withdrawal by Subject|5|||
27839369|NCT01463293|54326660|FG000|Overall Study|Other|0|||
27839370|NCT01463293|54326661|FG001|Overall Study|Other|0|||
27839371|NCT01463293|54326662|FG002|Overall Study|Other|2|||
27839372|NCT01479985|54326693|FG000|Overall Study|Tablet malfunction, no data saved|1|||
27839373|NCT01479985|54326694|FG001|Overall Study|Tablet malfunction, no data saved|1|||
27839374|NCT01479985|54326693|FG000|Overall Study|No decisional conflict scale responses|0|||
27839375|NCT01479985|54326694|FG001|Overall Study|No decisional conflict scale responses|2|||
27839376|NCT01479985|54326693|FG000|Overall Study|No post-visit survey|5|||
27839377|NCT01479985|54326694|FG001|Overall Study|No post-visit survey|3|||
27839378|NCT01462435|54326708|FG000|Overall Study|Lack of Efficacy|1|||
27839379|NCT01462435|54326709|FG001|Overall Study|Lack of Efficacy|0|||
27839380|NCT01462435|54326710|FG002|Overall Study|Lack of Efficacy|0|||
27839381|NCT01462435|54326711|FG003|Overall Study|Lack of Efficacy|3|||
27839382|NCT01462435|54326708|FG000|Overall Study|Physician Decision|0|||
27839383|NCT01462435|54326709|FG001|Overall Study|Physician Decision|0|||
27839384|NCT01462435|54326710|FG002|Overall Study|Physician Decision|1|||
27839385|NCT01462435|54326711|FG003|Overall Study|Physician Decision|0|||
27839386|NCT01462435|54326708|FG000|Overall Study|Withdrawal by Subject|0|||
27839387|NCT01462435|54326709|FG001|Overall Study|Withdrawal by Subject|0|||
27839388|NCT01462435|54326710|FG002|Overall Study|Withdrawal by Subject|0|||
27839389|NCT01462435|54326711|FG003|Overall Study|Withdrawal by Subject|1|||
27839390|NCT01462435|54326708|FG000|Overall Study|Lost to Follow-up|0|||
27839391|NCT01462435|54326709|FG001|Overall Study|Lost to Follow-up|0|||
27839392|NCT01462435|54326710|FG002|Overall Study|Lost to Follow-up|0|||
27839393|NCT01462435|54326711|FG003|Overall Study|Lost to Follow-up|1|||
27839394|NCT01472081|54326727|FG000|Overall Study|Continuing treatment at time of analysis|1|||
27839395|NCT01472081|54326728|FG001|Overall Study|Continuing treatment at time of analysis|4|||
27839396|NCT01472081|54326729|FG002|Overall Study|Continuing treatment at time of analysis|1|||
27839397|NCT01472081|54326730|FG003|Overall Study|Continuing treatment at time of analysis|8|||
27839398|NCT01472081|54326731|FG004|Overall Study|Continuing treatment at time of analysis|9|||
27839399|NCT01472081|54326732|FG005|Overall Study|Continuing treatment at time of analysis|0|||
27839400|NCT01472081|54326727|FG000|Overall Study|Disease Progression|4|||
27839401|NCT01472081|54326728|FG001|Overall Study|Disease Progression|10|||
27839402|NCT01472081|54326729|FG002|Overall Study|Disease Progression|12|||
27839403|NCT01472081|54326730|FG003|Overall Study|Disease Progression|31|||
27839404|NCT01472081|54326731|FG004|Overall Study|Disease Progression|22|||
27839405|NCT01472081|54326732|FG005|Overall Study|Disease Progression|3|||
27839406|NCT01472081|54326727|FG000|Overall Study|Study drug toxicity|2|||
27839407|NCT01472081|54326728|FG001|Overall Study|Study drug toxicity|9|||
27839408|NCT01472081|54326729|FG002|Overall Study|Study drug toxicity|4|||
27839409|NCT01472081|54326730|FG003|Overall Study|Study drug toxicity|6|||
27839410|NCT01472081|54326731|FG004|Overall Study|Study drug toxicity|13|||
27839411|NCT01472081|54326732|FG005|Overall Study|Study drug toxicity|2|||
27839412|NCT01472081|54326727|FG000|Overall Study|Death|0|||
27839413|NCT01472081|54326728|FG001|Overall Study|Death|0|||
27839414|NCT01472081|54326729|FG002|Overall Study|Death|0|||
27839415|NCT01472081|54326730|FG003|Overall Study|Death|0|||
27839416|NCT01472081|54326731|FG004|Overall Study|Death|1|||
27839417|NCT01472081|54326732|FG005|Overall Study|Death|0|||
27839418|NCT01472081|54326727|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
27839419|NCT01472081|54326728|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
27839420|NCT01472081|54326729|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
27839421|NCT01472081|54326730|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
27839422|NCT01472081|54326731|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
27839423|NCT01472081|54326732|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
27839424|NCT01472081|54326727|FG000|Overall Study|Withdrawal by Subject|0|||
27839425|NCT01472081|54326728|FG001|Overall Study|Withdrawal by Subject|0|||
27839426|NCT01472081|54326729|FG002|Overall Study|Withdrawal by Subject|0|||
27839427|NCT01472081|54326730|FG003|Overall Study|Withdrawal by Subject|0|||
27839428|NCT01472081|54326731|FG004|Overall Study|Withdrawal by Subject|0|||
27839429|NCT01472081|54326732|FG005|Overall Study|Withdrawal by Subject|1|||
27839430|NCT01472081|54326727|FG000|Overall Study|Poor/non-compliance|0|||
27839431|NCT01472081|54326728|FG001|Overall Study|Poor/non-compliance|0|||
27839432|NCT01472081|54326729|FG002|Overall Study|Poor/non-compliance|1|||
27757582|NCT02589665|54209188|FG009|Maintenance Extension Period|Withdrawal by Subject|4|||
27757583|NCT02589665|54209179|FG000|Maintenance Extension Period|Lack of Efficacy|0|||
27757584|NCT02589665|54209180|FG001|Maintenance Extension Period|Lack of Efficacy|0|||
27757585|NCT02589665|54209181|FG002|Maintenance Extension Period|Lack of Efficacy|0|||
27757586|NCT02589665|54209182|FG003|Maintenance Extension Period|Lack of Efficacy|0|||
27757587|NCT02589665|54209183|FG004|Maintenance Extension Period|Lack of Efficacy|0|||
27757588|NCT02589665|54209184|FG005|Maintenance Extension Period|Lack of Efficacy|0|||
27757589|NCT02589665|54209185|FG006|Maintenance Extension Period|Lack of Efficacy|0|||
27757590|NCT02589665|54209186|FG007|Maintenance Extension Period|Lack of Efficacy|0|||
27757591|NCT02589665|54209187|FG008|Maintenance Extension Period|Lack of Efficacy|0|||
27757592|NCT02589665|54209188|FG009|Maintenance Extension Period|Lack of Efficacy|4|||
27757593|NCT02589665|54209179|FG000|Maintenance Extension Period|Adverse Event|0|||
27757594|NCT02589665|54209180|FG001|Maintenance Extension Period|Adverse Event|0|||
27757595|NCT02589665|54209181|FG002|Maintenance Extension Period|Adverse Event|0|||
27757596|NCT02589665|54209182|FG003|Maintenance Extension Period|Adverse Event|0|||
27757597|NCT02589665|54209183|FG004|Maintenance Extension Period|Adverse Event|0|||
27757598|NCT02589665|54209184|FG005|Maintenance Extension Period|Adverse Event|0|||
27757599|NCT02589665|54209185|FG006|Maintenance Extension Period|Adverse Event|0|||
27757600|NCT02589665|54209186|FG007|Maintenance Extension Period|Adverse Event|0|||
27757601|NCT02589665|54209187|FG008|Maintenance Extension Period|Adverse Event|0|||
27757602|NCT02589665|54209188|FG009|Maintenance Extension Period|Adverse Event|2|||
27757603|NCT02589665|54209179|FG000|Maintenance Extension Period|Non-responder|0|||
27757604|NCT02589665|54209180|FG001|Maintenance Extension Period|Non-responder|0|||
27757605|NCT02589665|54209181|FG002|Maintenance Extension Period|Non-responder|0|||
27757606|NCT02589665|54209182|FG003|Maintenance Extension Period|Non-responder|0|||
27757607|NCT02589665|54209183|FG004|Maintenance Extension Period|Non-responder|0|||
27757608|NCT02589665|54209184|FG005|Maintenance Extension Period|Non-responder|0|||
27757609|NCT02589665|54209185|FG006|Maintenance Extension Period|Non-responder|0|||
27757610|NCT02589665|54209186|FG007|Maintenance Extension Period|Non-responder|0|||
27757611|NCT02589665|54209187|FG008|Maintenance Extension Period|Non-responder|0|||
27757612|NCT02589665|54209188|FG009|Maintenance Extension Period|Non-responder|1|||
27757613|NCT01905397|54209214|FG000|Overall Study|Death|0|||
27757614|NCT01905397|54209215|FG001|Overall Study|Death|1|||
27757615|NCT01905397|54209214|FG000|Overall Study|Withdrawal by Subject|2|||
27757616|NCT01905397|54209215|FG001|Overall Study|Withdrawal by Subject|0|||
27757617|NCT01905397|54209214|FG000|Overall Study|Surgery canceled/aborted|9|||
27757618|NCT01905397|54209215|FG001|Overall Study|Surgery canceled/aborted|5|||
27757619|NCT01905397|54209214|FG000|Overall Study|Incision < 7 cm|2|||
27757620|NCT01905397|54209215|FG001|Overall Study|Incision < 7 cm|0|||
27757621|NCT01905397|54209214|FG000|Overall Study|Wrong treatment|1|||
27757622|NCT01905397|54209215|FG001|Overall Study|Wrong treatment|1|||
27757623|NCT01905397|54209214|FG000|Overall Study|Device not applied|3|||
27757624|NCT01905397|54209215|FG001|Overall Study|Device not applied|0|||
27757625|NCT01905397|54209214|FG000|Overall Study|Dressing not applied in operating room|1|||
27757626|NCT01905397|54209215|FG001|Overall Study|Dressing not applied in operating room|0|||
27757627|NCT01905397|54209214|FG000|Overall Study|Wound vac turned off due to device alarm|1|||
27757628|NCT01905397|54209215|FG001|Overall Study|Wound vac turned off due to device alarm|0|||
27757629|NCT01362595|54209221|FG000|Overall Study|Screen failure|10|||
27757630|NCT01362595|54209221|FG000|Overall Study|Withdrawal by Subject|2|||
27757631|NCT02519595|54209228|FG000|Overall Study|Protocol Violation|8|||
27757632|NCT02519595|54209229|FG001|Overall Study|Protocol Violation|22|||
27757633|NCT02519595|54209230|FG002|Overall Study|Protocol Violation|16|||
27757634|NCT00660673|54209242|FG000|Overall Study|Adverse Event|84|||
27839433|NCT01472081|54326730|FG003|Overall Study|Poor/non-compliance|0|||
27839434|NCT01472081|54326731|FG004|Overall Study|Poor/non-compliance|1|||
27757635|NCT00660673|54209242|FG000|Overall Study|Lack of Efficacy|7|||
27757636|NCT00660673|54209242|FG000|Overall Study|Withdrawal by Subject|22|||
27757637|NCT00660673|54209242|FG000|Overall Study|Administrative|2|||
27757638|NCT00660673|54209242|FG000|Overall Study|Protocol Violation|2|||
27757639|NCT02630563|54209257|FG000|Overall Study|Administrative|1|||
27757640|NCT02588339|54209271|FG000|Overall Study|Withdrawal by Subject|1|||
27757641|NCT02588339|54209271|FG000|Overall Study|GVHD Progression prior to treatment|2|||
27757642|NCT02629159|54209278|FG000|Overall Study|Adverse Event|17|||
27757643|NCT02629159|54209279|FG001|Overall Study|Adverse Event|20|||
27757644|NCT02629159|54209280|FG002|Overall Study|Adverse Event|22|||
27757645|NCT02629159|54209278|FG000|Overall Study|Withdrawal by Subject|22|||
27757646|NCT02629159|54209279|FG001|Overall Study|Withdrawal by Subject|11|||
27757647|NCT02629159|54209280|FG002|Overall Study|Withdrawal by Subject|15|||
27757648|NCT02629159|54209278|FG000|Overall Study|Lost to Follow-up|7|||
27757649|NCT02629159|54209279|FG001|Overall Study|Lost to Follow-up|4|||
27757650|NCT02629159|54209280|FG002|Overall Study|Lost to Follow-up|5|||
27757651|NCT02629159|54209278|FG000|Overall Study|Lack of Efficacy|4|||
27757652|NCT02629159|54209279|FG001|Overall Study|Lack of Efficacy|0|||
27757653|NCT02629159|54209280|FG002|Overall Study|Lack of Efficacy|1|||
27757654|NCT02629159|54209278|FG000|Overall Study|Other|6|||
27757655|NCT02629159|54209279|FG001|Overall Study|Other|4|||
27757656|NCT02629159|54209280|FG002|Overall Study|Other|8|||
27757657|NCT02628769|54209291|FG000|First Intervention|Adverse Event|1|||
27757658|NCT02628769|54209292|FG001|First Intervention|Adverse Event|0|||
27757659|NCT02628769|54209291|FG000|First Intervention|Withdrawal by Subject|0|||
27757660|NCT02628769|54209292|FG001|First Intervention|Withdrawal by Subject|1|||
27757661|NCT02628769|54209291|FG000|Second Intervention|Adverse Event|2|||
27757662|NCT02628769|54209292|FG001|Second Intervention|Adverse Event|0|||
27757663|NCT02628769|54209291|FG000|Second Intervention|Physician Decision|0|||
27757664|NCT02628769|54209292|FG001|Second Intervention|Physician Decision|1|||
27757665|NCT02626819|54209300|FG000|Overall Study|Lost to Follow-up|3|||
27757666|NCT02626819|54209301|FG001|Overall Study|Lost to Follow-up|2|||
27757667|NCT02626819|54209300|FG000|Overall Study|Withdrawal by Subject|1|||
27757668|NCT02626819|54209301|FG001|Overall Study|Withdrawal by Subject|0|||
27757669|NCT02626819|54209300|FG000|Overall Study|Diagnosed w/ catastrophic illness|0|||
27757670|NCT02626819|54209301|FG001|Overall Study|Diagnosed w/ catastrophic illness|1|||
27757671|NCT02630251|54209311|FG000|Overall Study|Physician Decision|0|||
27757672|NCT02630251|54209312|FG001|Overall Study|Physician Decision|0|||
27757673|NCT02630251|54209313|FG002|Overall Study|Physician Decision|1|||
27757674|NCT02630251|54209314|FG003|Overall Study|Physician Decision|0|||
27757675|NCT02518113|54209328|FG000|Overall Study|Adverse Event|1|||
27757676|NCT02518113|54209329|FG001|Overall Study|Adverse Event|0|||
27757677|NCT02518113|54209330|FG002|Overall Study|Adverse Event|1|||
27757678|NCT02518113|54209331|FG003|Overall Study|Adverse Event|0|||
27757679|NCT02518113|54209328|FG000|Overall Study|Death|1|||
27757680|NCT02518113|54209329|FG001|Overall Study|Death|2|||
27757681|NCT02518113|54209330|FG002|Overall Study|Death|0|||
27757682|NCT02518113|54209331|FG003|Overall Study|Death|0|||
27757683|NCT02518113|54209328|FG000|Overall Study|Physician Decision|0|||
27757684|NCT02518113|54209329|FG001|Overall Study|Physician Decision|1|||
27757685|NCT02518113|54209330|FG002|Overall Study|Physician Decision|0|||
27757686|NCT02518113|54209331|FG003|Overall Study|Physician Decision|0|||
27757687|NCT02518113|54209328|FG000|Overall Study|Progressive Disease|1|||
27757688|NCT02518113|54209329|FG001|Overall Study|Progressive Disease|2|||
27757689|NCT02518113|54209330|FG002|Overall Study|Progressive Disease|3|||
27757690|NCT02518113|54209331|FG003|Overall Study|Progressive Disease|0|||
27757691|NCT02629861|54209347|FG000|Overall Study|Adverse Event|7|||
27757692|NCT02629861|54209348|FG001|Overall Study|Adverse Event|5|||
27757693|NCT02629861|54209349|FG002|Overall Study|Adverse Event|4|||
27757694|NCT02629861|54209347|FG000|Overall Study|Withdrawal by Subject|5|||
27757695|NCT02629861|54209348|FG001|Overall Study|Withdrawal by Subject|8|||
27757696|NCT02629861|54209349|FG002|Overall Study|Withdrawal by Subject|13|||
27757697|NCT02629861|54209347|FG000|Overall Study|Protocol Violation|2|||
27839435|NCT01472081|54326732|FG005|Overall Study|Poor/non-compliance|0|||
27757698|NCT02629861|54209348|FG001|Overall Study|Protocol Violation|3|||
27757699|NCT02629861|54209349|FG002|Overall Study|Protocol Violation|7|||
27757700|NCT02629861|54209347|FG000|Overall Study|Lost to Follow-up|12|||
27757701|NCT02629861|54209348|FG001|Overall Study|Lost to Follow-up|9|||
27757702|NCT02629861|54209349|FG002|Overall Study|Lost to Follow-up|4|||
27757703|NCT02629861|54209347|FG000|Overall Study|Other|1|||
27757704|NCT02629861|54209348|FG001|Overall Study|Other|1|||
27757705|NCT02629861|54209349|FG002|Overall Study|Other|0|||
27757706|NCT02629861|54209347|FG000|Overall Study|Pregnancy|2|||
27757707|NCT02629861|54209348|FG001|Overall Study|Pregnancy|1|||
27839436|NCT01472081|54326727|FG000|Overall Study|No longer meets study criteria|0|||
27839437|NCT01472081|54326728|FG001|Overall Study|No longer meets study criteria|0|||
27757708|NCT02629861|54209349|FG002|Overall Study|Pregnancy|0|||
27757709|NCT02482935|54209357|FG000|Period 1|Withdrawal by Subject|1|||
27757710|NCT02482935|54209358|FG001|Period 1|Withdrawal by Subject|0|||
27757711|NCT02513823|54209364|FG000|Overall Study|Lost to Follow-up|4|||
27757712|NCT02513823|54209364|FG000|Overall Study|Physician Decision|1|||
27757713|NCT02513745|54209370|FG000|Overall Study|Criteria at time of surgery not met.|3|||
27757714|NCT02513745|54209371|FG001|Overall Study|Criteria at time of surgery not met.|3|||
27757715|NCT02512965|54209379|FG000|Overall Study|Withdrawal by Subject|0|||
27757716|NCT02512965|54209380|FG001|Overall Study|Withdrawal by Subject|4|||
27757717|NCT02477553|54209388|FG000|Overall Study|Screening up-to-date|12|||
27757718|NCT02477553|54209389|FG001|Overall Study|Screening up-to-date|13|||
27839438|NCT01472081|54326729|FG002|Overall Study|No longer meets study criteria|1|||
27839439|NCT01472081|54326730|FG003|Overall Study|No longer meets study criteria|0|||
27839440|NCT01472081|54326731|FG004|Overall Study|No longer meets study criteria|0|||
27757719|NCT02477553|54209388|FG000|Overall Study|No MD visit|1|||
27757720|NCT02477553|54209389|FG001|Overall Study|No MD visit|1|||
27757721|NCT02477553|54209388|FG000|Overall Study|Workup consistent w/CRC|1|||
27757722|NCT02477553|54209389|FG001|Overall Study|Workup consistent w/CRC|1|||
27757723|NCT02477553|54209388|FG000|Overall Study|Technical issues with intervention|2|||
27757724|NCT02477553|54209389|FG001|Overall Study|Technical issues with intervention|0|||
27757725|NCT02477553|54209388|FG000|Overall Study|Elevated risk for CRC|2|||
27757726|NCT02477553|54209389|FG001|Overall Study|Elevated risk for CRC|2|||
27757727|NCT02477553|54209388|FG000|Overall Study|MD advised against screening|1|||
27757728|NCT02477553|54209389|FG001|Overall Study|MD advised against screening|3|||
27757729|NCT02477553|54209388|FG000|Overall Study|patient deceased|1|||
27757730|NCT02477553|54209389|FG001|Overall Study|patient deceased|0|||
27757731|NCT01665911|54209395|FG000|Overall Study|Protocol Violation|4|||
27757732|NCT01665911|54209395|FG000|Overall Study|Withdrawal by Subject|1|||
27757733|NCT01665911|54209395|FG000|Overall Study|Adverse Event|1|||
27757734|NCT02452359|54209400|FG000|Overall Study|Adverse Event|1|||
27757735|NCT02452359|54209400|FG000|Overall Study|Lost to Follow-up|15|||
27757736|NCT02452359|54209400|FG000|Overall Study|Pregnancy|1|||
27757737|NCT02452359|54209400|FG000|Overall Study|Withdrawal by Subject|4|||
27757738|NCT02476617|54209404|FG000|Overall Study|Adverse Event|1|||
27757739|NCT02476617|54209404|FG000|Overall Study|Lost to Follow-up|1|||
27757740|NCT01665599|54209421|FG000|Overall Study|Adverse Event|1|||
27757741|NCT01665599|54209421|FG000|Overall Study|Consent Withdrawn|1|||
27757742|NCT01665599|54209421|FG000|Overall Study|Investigator/Sponsor decision|1|||
27757743|NCT01665599|54209421|FG000|Overall Study|Death|1|||
27757744|NCT01665599|54209421|FG000|Overall Study|Lost to Follow-up|2|||
27757745|NCT01665599|54209421|FG000|Overall Study|Participant Left for More Than 3 Months|1|||
27757746|NCT01665599|54209421|FG000|Overall Study|Could Not Continue Due to Time Constrain|1|||
27757747|NCT01671085|54209427|FG000|Overall Study|Withdrawal by Subject|1|||
27757748|NCT01671085|54209428|FG001|Overall Study|Withdrawal by Subject|0|||
27757749|NCT02510001|54209443|FG000|Overall Study|Early disease progression|0|||
27757750|NCT02510001|54209444|FG001|Overall Study|Early disease progression|0|||
27757751|NCT02510001|54209445|FG002|Overall Study|Early disease progression|0|||
27757752|NCT02510001|54209446|FG003|Overall Study|Early disease progression|1|||
27757753|NCT02510001|54209447|FG004|Overall Study|Early disease progression|1|||
27757754|NCT02510001|54209448|FG005|Overall Study|Early disease progression|1|||
27757755|NCT02510001|54209449|FG006|Overall Study|Early disease progression|0|||
27757756|NCT02510001|54209450|FG007|Overall Study|Early disease progression|0|||
27757757|NCT02510001|54209443|FG000|Overall Study|Adverse Event|0|||
27757758|NCT02510001|54209444|FG001|Overall Study|Adverse Event|0|||
27757759|NCT02510001|54209445|FG002|Overall Study|Adverse Event|0|||
27757760|NCT02510001|54209446|FG003|Overall Study|Adverse Event|1|||
27757761|NCT02510001|54209447|FG004|Overall Study|Adverse Event|2|||
27757762|NCT02510001|54209448|FG005|Overall Study|Adverse Event|1|||
27757763|NCT02510001|54209449|FG006|Overall Study|Adverse Event|2|||
27757764|NCT02510001|54209450|FG007|Overall Study|Adverse Event|5|||
27839441|NCT01472081|54326732|FG005|Overall Study|No longer meets study criteria|0|||
27839442|NCT01472081|54326727|FG000|Overall Study|Subject request to discontinue treatment|0|||
27839443|NCT01472081|54326728|FG001|Overall Study|Subject request to discontinue treatment|3|||
27839444|NCT01472081|54326729|FG002|Overall Study|Subject request to discontinue treatment|1|||
27839445|NCT01472081|54326730|FG003|Overall Study|Subject request to discontinue treatment|1|||
27839446|NCT01472081|54326731|FG004|Overall Study|Subject request to discontinue treatment|0|||
27839447|NCT01472081|54326732|FG005|Overall Study|Subject request to discontinue treatment|0|||
27839448|NCT01471691|54326747|FG000|Overall Study|Lack of Efficacy|0|||
27839449|NCT01471691|54326748|FG001|Overall Study|Lack of Efficacy|1|||
27839450|NCT01471379|54326757|FG000|Overall Study|Adverse Event|1|||
27839451|NCT01471379|54326758|FG001|Overall Study|Adverse Event|0|||
27757765|NCT02510001|54209443|FG000|Overall Study|Physician Decision|0|||
27757766|NCT02510001|54209444|FG001|Overall Study|Physician Decision|0|||
27757767|NCT02510001|54209445|FG002|Overall Study|Physician Decision|0|||
27757768|NCT02510001|54209446|FG003|Overall Study|Physician Decision|0|||
27757769|NCT02510001|54209447|FG004|Overall Study|Physician Decision|1|||
27757770|NCT02510001|54209448|FG005|Overall Study|Physician Decision|0|||
27757771|NCT02510001|54209449|FG006|Overall Study|Physician Decision|0|||
27757772|NCT02510001|54209450|FG007|Overall Study|Physician Decision|0|||
27757773|NCT02510001|54209443|FG000|Overall Study|Withdrawal by Subject|0|||
27757774|NCT02510001|54209444|FG001|Overall Study|Withdrawal by Subject|0|||
27757775|NCT02510001|54209445|FG002|Overall Study|Withdrawal by Subject|0|||
27757776|NCT02510001|54209446|FG003|Overall Study|Withdrawal by Subject|0|||
27757777|NCT02510001|54209447|FG004|Overall Study|Withdrawal by Subject|0|||
27757778|NCT02510001|54209448|FG005|Overall Study|Withdrawal by Subject|0|||
27757779|NCT02510001|54209449|FG006|Overall Study|Withdrawal by Subject|0|||
27757780|NCT02510001|54209450|FG007|Overall Study|Withdrawal by Subject|2|||
27757781|NCT02452047|54209489|FG000|Overall Study|Adverse Event|0|||
27757782|NCT02452047|54209490|FG001|Overall Study|Adverse Event|1|||
27757783|NCT02452047|54209491|FG002|Overall Study|Adverse Event|1|||
27757784|NCT02452047|54209489|FG000|Overall Study|Death|1|||
27757785|NCT02452047|54209490|FG001|Overall Study|Death|3|||
27757786|NCT02452047|54209491|FG002|Overall Study|Death|1|||
27757787|NCT02452047|54209489|FG000|Overall Study|Physician Decision|1|||
27757788|NCT02452047|54209490|FG001|Overall Study|Physician Decision|0|||
27757789|NCT02452047|54209491|FG002|Overall Study|Physician Decision|0|||
27757790|NCT02452047|54209489|FG000|Overall Study|Lost to Follow-up|1|||
27757791|NCT02452047|54209490|FG001|Overall Study|Lost to Follow-up|1|||
27757792|NCT02452047|54209491|FG002|Overall Study|Lost to Follow-up|0|||
27757793|NCT02452047|54209489|FG000|Overall Study|Withdrawal by Subject|1|||
27757794|NCT02452047|54209490|FG001|Overall Study|Withdrawal by Subject|0|||
27757795|NCT02452047|54209491|FG002|Overall Study|Withdrawal by Subject|0|||
27757796|NCT02475369|54209499|FG000|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7|||
27757797|NCT02475369|54209500|FG001|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2|||
27757798|NCT02474589|54209513|FG000|Overall Study|Adverse Event|6|||
27757799|NCT02474589|54209514|FG001|Overall Study|Adverse Event|2|||
27757800|NCT02474589|54209513|FG000|Overall Study|Lost to Follow-up|6|||
27757801|NCT02474589|54209514|FG001|Overall Study|Lost to Follow-up|1|||
27757802|NCT02474589|54209513|FG000|Overall Study|Protocol Violation|4|||
27757803|NCT02474589|54209514|FG001|Overall Study|Protocol Violation|1|||
27757804|NCT02474589|54209513|FG000|Overall Study|Withdrawal by Subject|4|||
27757805|NCT02474589|54209514|FG001|Overall Study|Withdrawal by Subject|0|||
27757806|NCT02474589|54209513|FG000|Overall Study|Inability to complete study procedures|5|||
27757807|NCT02474589|54209514|FG001|Overall Study|Inability to complete study procedures|1|||
27757808|NCT02586233|54209527|FG000|Overall Study|Randomized but did not receive treatment|0|||
27757809|NCT02586233|54209528|FG001|Overall Study|Randomized but did not receive treatment|1|||
27757810|NCT02586233|54209529|FG002|Overall Study|Randomized but did not receive treatment|0|||
27757811|NCT02586233|54209530|FG003|Overall Study|Randomized but did not receive treatment|0|||
27757812|NCT02586233|54209531|FG004|Overall Study|Randomized but did not receive treatment|0|||
27757813|NCT02586233|54209532|FG005|Overall Study|Randomized but did not receive treatment|2|||
27757814|NCT02586233|54209533|FG006|Overall Study|Randomized but did not receive treatment|2|||
27757815|NCT02586233|54209527|FG000|Overall Study|Death|0|||
27757816|NCT02586233|54209528|FG001|Overall Study|Death|1|||
27757817|NCT02586233|54209529|FG002|Overall Study|Death|0|||
27757818|NCT02586233|54209530|FG003|Overall Study|Death|0|||
27757819|NCT02586233|54209531|FG004|Overall Study|Death|2|||
27757820|NCT02586233|54209532|FG005|Overall Study|Death|0|||
27757821|NCT02586233|54209533|FG006|Overall Study|Death|0|||
27757822|NCT02474355|54209553|FG000|Overall Study|Other|43|||
27757823|NCT02474355|54209553|FG000|Overall Study|Eligibility Criteria not Fulfilled|2|||
27757824|NCT02474355|54209553|FG000|Overall Study|Lost to Follow-up|98|||
27757825|NCT02474355|54209553|FG000|Overall Study|Withdrawal by Subject|124|||
27757826|NCT02474355|54209553|FG000|Overall Study|Death|1361|||
27757827|NCT02474199|54209559|FG000|Overall Study|Lost to Follow-up|1|||
27757828|NCT02474199|54209560|FG001|Overall Study|Lost to Follow-up|0|||
27757829|NCT02474199|54209561|FG002|Overall Study|Lost to Follow-up|0|||
27757830|NCT02474199|54209562|FG003|Overall Study|Lost to Follow-up|0|||
27757831|NCT02474199|54209559|FG000|Overall Study|Withdrawal by Subject|1|||
27757832|NCT02474199|54209560|FG001|Overall Study|Withdrawal by Subject|2|||
27757833|NCT02474199|54209561|FG002|Overall Study|Withdrawal by Subject|0|||
27757834|NCT02474199|54209562|FG003|Overall Study|Withdrawal by Subject|1|||
27757835|NCT02474199|54209559|FG000|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
27757836|NCT02474199|54209560|FG001|Overall Study|Did not receive Tregs due to insufficient manufacture|1|||
27757837|NCT02474199|54209561|FG002|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
27757838|NCT02474199|54209562|FG003|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
27757839|NCT02474199|54209559|FG000|Overall Study|Did not meet eligibility criteria|0|||
27757840|NCT02474199|54209560|FG001|Overall Study|Did not meet eligibility criteria|0|||
27757841|NCT02474199|54209561|FG002|Overall Study|Did not meet eligibility criteria|2|||
27757842|NCT02474199|54209562|FG003|Overall Study|Did not meet eligibility criteria|2|||
27757843|NCT02450487|54209569|FG000|Overall Study|Lost to Follow-up|3|||
27757844|NCT02473965|54209576|FG000|Overall Study|Adverse Event|6|||
27757845|NCT02473965|54209577|FG001|Overall Study|Adverse Event|4|||
27757846|NCT02473965|54209576|FG000|Overall Study|MG worsening|4|||
27757847|NCT02473965|54209577|FG001|Overall Study|MG worsening|1|||
27757848|NCT02473965|54209576|FG000|Overall Study|Withdrawal by Subject|2|||
27757849|NCT02473965|54209577|FG001|Overall Study|Withdrawal by Subject|3|||
27757850|NCT02473965|54209576|FG000|Overall Study|Physician Decision|0|||
27757851|NCT02473965|54209577|FG001|Overall Study|Physician Decision|2|||
27757852|NCT02472795|54209588|FG000|Overall Study|Adverse Event|0|||
27757853|NCT02472795|54209589|FG001|Overall Study|Adverse Event|1|||
27757854|NCT02472795|54209590|FG002|Overall Study|Adverse Event|0|||
27757855|NCT02472795|54209591|FG003|Overall Study|Adverse Event|0|||
27757856|NCT02472795|54209592|FG004|Overall Study|Adverse Event|2|||
27757857|NCT02472795|54209588|FG000|Overall Study|Withdrawal by Subject|0|||
27757858|NCT02472795|54209589|FG001|Overall Study|Withdrawal by Subject|0|||
27757859|NCT02472795|54209590|FG002|Overall Study|Withdrawal by Subject|0|||
27757860|NCT02472795|54209591|FG003|Overall Study|Withdrawal by Subject|0|||
27757861|NCT02472795|54209592|FG004|Overall Study|Withdrawal by Subject|1|||
27757862|NCT02507349|54209606|FG000|Overall Study|Death|12|||
27757863|NCT02507349|54209607|FG001|Overall Study|Death|16|||
27757864|NCT02507349|54209606|FG000|Overall Study|Withdrawal by Subject|1|||
27757865|NCT02507349|54209607|FG001|Overall Study|Withdrawal by Subject|1|||
27757866|NCT02507349|54209606|FG000|Overall Study|Lost to Follow-up|174|||
27757867|NCT02507349|54209607|FG001|Overall Study|Lost to Follow-up|144|||
27757868|NCT02506881|54209617|FG000|First Intervention (Day 1)|Protocol Violation|0|||
27757869|NCT02506881|54209618|FG001|First Intervention (Day 1)|Protocol Violation|0|||
27757870|NCT02506881|54209619|FG002|First Intervention (Day 1)|Protocol Violation|1|||
27757871|NCT02506881|54209620|FG003|First Intervention (Day 1)|Protocol Violation|0|||
27757872|NCT02506881|54209617|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
27757873|NCT02506881|54209618|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
27757874|NCT02506881|54209619|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
27757875|NCT02506881|54209620|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
27757876|NCT02506881|54209617|FG000|First Intervention (Day 1)|Violation of blood storage conditions|0|||
27757877|NCT02506881|54209618|FG001|First Intervention (Day 1)|Violation of blood storage conditions|0|||
27757878|NCT02506881|54209619|FG002|First Intervention (Day 1)|Violation of blood storage conditions|12|||
27757879|NCT02506881|54209620|FG003|First Intervention (Day 1)|Violation of blood storage conditions|12|||
27757880|NCT02506257|54209644|FG000|Overall Study|Adverse Event|0|||
27757881|NCT02506257|54209645|FG001|Overall Study|Adverse Event|2|||
27757882|NCT02506257|54209646|FG002|Overall Study|Adverse Event|3|||
27757883|NCT02506257|54209647|FG003|Overall Study|Adverse Event|0|||
27757884|NCT02506257|54209644|FG000|Overall Study|Protocol Violation|0|||
27757885|NCT02506257|54209645|FG001|Overall Study|Protocol Violation|0|||
27757886|NCT02506257|54209646|FG002|Overall Study|Protocol Violation|1|||
27757887|NCT02506257|54209647|FG003|Overall Study|Protocol Violation|0|||
27757888|NCT02506101|54209659|FG000|Overall Study|Transportation issues|1|||
27757889|NCT02506101|54209660|FG001|Overall Study|Transportation issues|0|||
27757890|NCT02506101|54209659|FG000|Overall Study|No enrollment and staff unavailability|1|||
27757891|NCT02506101|54209660|FG001|Overall Study|No enrollment and staff unavailability|0|||
27757892|NCT01671007|54209675|FG000|Overall Study|Other reasons than listed|166|||
27757893|NCT01671007|54209676|FG001|Overall Study|Other reasons than listed|373|||
27757894|NCT01671007|54209677|FG002|Overall Study|Other reasons than listed|197|||
27757895|NCT01671007|54209678|FG003|Overall Study|Other reasons than listed|228|||
27757896|NCT01671007|54209679|FG004|Overall Study|Other reasons than listed|14|||
27757897|NCT01671007|54209680|FG005|Overall Study|Other reasons than listed|71|||
27757898|NCT01671007|54209681|FG006|Overall Study|Other reasons than listed|17|||
27757899|NCT01671007|54209682|FG007|Overall Study|Other reasons than listed|66|||
27757900|NCT01671007|54209683|FG008|Overall Study|Other reasons than listed|0|||
27757901|NCT01671007|54209675|FG000|Overall Study|Withdrawal by Subject|36|||
27757902|NCT01671007|54209676|FG001|Overall Study|Withdrawal by Subject|59|||
27757903|NCT01671007|54209677|FG002|Overall Study|Withdrawal by Subject|53|||
27757904|NCT01671007|54209678|FG003|Overall Study|Withdrawal by Subject|58|||
27757905|NCT01671007|54209679|FG004|Overall Study|Withdrawal by Subject|4|||
27757906|NCT01671007|54209680|FG005|Overall Study|Withdrawal by Subject|15|||
27757907|NCT01671007|54209681|FG006|Overall Study|Withdrawal by Subject|1|||
27757908|NCT01671007|54209682|FG007|Overall Study|Withdrawal by Subject|19|||
27757909|NCT01671007|54209683|FG008|Overall Study|Withdrawal by Subject|0|||
27757910|NCT01671007|54209675|FG000|Overall Study|Lost to Follow-up|93|||
27757911|NCT01671007|54209676|FG001|Overall Study|Lost to Follow-up|142|||
27757912|NCT01671007|54209677|FG002|Overall Study|Lost to Follow-up|91|||
27757913|NCT01671007|54209678|FG003|Overall Study|Lost to Follow-up|63|||
27757914|NCT01671007|54209679|FG004|Overall Study|Lost to Follow-up|7|||
27757915|NCT01671007|54209680|FG005|Overall Study|Lost to Follow-up|20|||
27757916|NCT01671007|54209681|FG006|Overall Study|Lost to Follow-up|2|||
27757917|NCT01671007|54209682|FG007|Overall Study|Lost to Follow-up|28|||
27757918|NCT01671007|54209683|FG008|Overall Study|Lost to Follow-up|0|||
27757919|NCT01671007|54209675|FG000|Overall Study|No end of study case report form|3|||
27757920|NCT01671007|54209676|FG001|Overall Study|No end of study case report form|1|||
27757921|NCT01671007|54209677|FG002|Overall Study|No end of study case report form|0|||
27757922|NCT01671007|54209678|FG003|Overall Study|No end of study case report form|2|||
27757923|NCT01671007|54209679|FG004|Overall Study|No end of study case report form|0|||
27757924|NCT01671007|54209680|FG005|Overall Study|No end of study case report form|0|||
27757925|NCT01671007|54209681|FG006|Overall Study|No end of study case report form|0|||
27757926|NCT01671007|54209682|FG007|Overall Study|No end of study case report form|0|||
27757927|NCT01671007|54209683|FG008|Overall Study|No end of study case report form|0|||
27757928|NCT01671007|54209675|FG000|Overall Study|Not eligible|23|||
27757929|NCT01671007|54209676|FG001|Overall Study|Not eligible|76|||
27757930|NCT01671007|54209677|FG002|Overall Study|Not eligible|25|||
27757931|NCT01671007|54209678|FG003|Overall Study|Not eligible|17|||
27757932|NCT01671007|54209679|FG004|Overall Study|Not eligible|0|||
27757933|NCT01671007|54209680|FG005|Overall Study|Not eligible|6|||
27757934|NCT01671007|54209681|FG006|Overall Study|Not eligible|1|||
27757935|NCT01671007|54209682|FG007|Overall Study|Not eligible|19|||
27757936|NCT01671007|54209683|FG008|Overall Study|Not eligible|0|||
27757937|NCT02505945|54209696|FG000|Overall Study|Withdrawal by Subject|13|||
27757938|NCT02505945|54209697|FG001|Overall Study|Withdrawal by Subject|2|||
27757939|NCT02505945|54209696|FG000|Overall Study|Adverse Event|1|||
27757940|NCT02505945|54209697|FG001|Overall Study|Adverse Event|0|||
27757941|NCT02505945|54209696|FG000|Overall Study|Physician Decision|2|||
27757942|NCT02505945|54209697|FG001|Overall Study|Physician Decision|1|||
27757943|NCT02505945|54209696|FG000|Overall Study|Lost to Follow-up|6|||
27757944|NCT02505945|54209697|FG001|Overall Study|Lost to Follow-up|1|||
27757945|NCT02505867|54209705|FG000|Overall Study|Lack of Efficacy|6|||
27757946|NCT02505867|54209706|FG001|Overall Study|Lack of Efficacy|6|||
27757947|NCT02472639|54209714|FG000|Overall Study|Physician Decision|4|||
27757948|NCT02472639|54209715|FG001|Overall Study|Physician Decision|3|||
27757949|NCT02472405|54209721|FG000|Overall Study|Lost to Follow-up|9|||
27757950|NCT02472405|54209721|FG000|Overall Study|Adverse Event|1|||
27757951|NCT02448771|54209727|FG000|Overall Study|Disease Progression|30|||
27757952|NCT02448771|54209727|FG000|Overall Study|Unacceptable Toxicity|1|||
27757953|NCT02448771|54209727|FG000|Overall Study|Physician Decision|3|||
27757954|NCT02448771|54209727|FG000|Overall Study|Started new therapy|2|||
27757955|NCT02504541|54209732|FG000|Overall Study|Adverse Event|4|||
27757956|NCT02504541|54209732|FG000|Overall Study|Withdrawal by Subject|4|||
27757957|NCT02504541|54209732|FG000|Overall Study|Lost to Follow-up|1|||
27757958|NCT02504541|54209732|FG000|Overall Study|Met Stopping Criteria|1|||
27757959|NCT02504541|54209732|FG000|Overall Study|Protocol Violation|2|||
27757960|NCT02504541|54209732|FG000|Overall Study|Termination by Sponsor|1|||
27757961|NCT02504541|54209732|FG000|Overall Study|Other|2|||
27757962|NCT02504541|54209732|FG000|Overall Study|Multiple|5|||
27757963|NCT02725177|54209736|FG000|Overall Study|Physician Decision|4|||
27757964|NCT02725177|54209736|FG000|Overall Study|Adverse Event|1|||
27757965|NCT02448537|54209743|FG000|Overall Study|Withdrawal by Subject|1|||
27757966|NCT02448537|54209744|FG001|Overall Study|Withdrawal by Subject|1|||
27757967|NCT02448537|54209745|FG002|Overall Study|Withdrawal by Subject|1|||
27757968|NCT02504151|54209755|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
27757969|NCT02504151|54209756|FG001|First Intervention (4 Weeks)|Physician Decision|1|||
27757970|NCT02504151|54209755|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
27839452|NCT01471379|54326759|FG002|Overall Study|Adverse Event|0|||
27757971|NCT02504151|54209756|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
27757972|NCT02504151|54209755|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
27757973|NCT02504151|54209756|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
27757974|NCT02504151|54209755|FG000|Second Intervention (4 Weeks)|Physician Decision|2|||
27757975|NCT02504151|54209756|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
27757976|NCT02448381|54209764|FG000|Overall Study|Adverse Event|2|||
27757977|NCT02448381|54209765|FG001|Overall Study|Adverse Event|0|||
27757978|NCT02448381|54209764|FG000|Overall Study|Lost to Follow-up|16|||
27757979|NCT02448381|54209765|FG001|Overall Study|Lost to Follow-up|9|||
27757980|NCT02448381|54209764|FG000|Overall Study|Physician Decision|1|||
27757981|NCT02448381|54209765|FG001|Overall Study|Physician Decision|1|||
27757982|NCT02448381|54209764|FG000|Overall Study|Pregnancy|1|||
27757983|NCT02448381|54209765|FG001|Overall Study|Pregnancy|0|||
27757984|NCT02448381|54209764|FG000|Overall Study|Withdrawal by Subject|13|||
27757985|NCT02448381|54209765|FG001|Overall Study|Withdrawal by Subject|9|||
27757986|NCT02448381|54209764|FG000|Overall Study|Noncompliance with Study Procedures|2|||
27757987|NCT02448381|54209765|FG001|Overall Study|Noncompliance with Study Procedures|0|||
27757988|NCT02448225|54209777|FG000|Overall Study|Withdrawal by Subject|1|||
27757989|NCT02448225|54209777|FG000|Overall Study|Did not get FSPG scan|18|||
27757990|NCT02448225|54209777|FG000|Overall Study|Treated between the FDG and FSPG scan|1|||
27757991|NCT02503215|54209784|FG000|Overall Study|Unable to wear compression stockings|1|||
27757992|NCT02503215|54209784|FG000|Overall Study|Unable to use positive airway pressure|2|||
27757993|NCT02447991|54209790|FG000|Overall Study|Withdrawn by subject - no data|0|||
27757994|NCT02447991|54209791|FG001|Overall Study|Withdrawn by subject - no data|2|||
27757995|NCT02447991|54209790|FG000|Overall Study|Withdrawn by Subject - with data|4|||
27757996|NCT02447991|54209791|FG001|Overall Study|Withdrawn by Subject - with data|4|||
27757997|NCT02447991|54209790|FG000|Overall Study|Lost to Follow-up - no data|3|||
27757998|NCT02447991|54209791|FG001|Overall Study|Lost to Follow-up - no data|6|||
27757999|NCT02447991|54209790|FG000|Overall Study|Lost to follow-up - with data|0|||
27758000|NCT02447991|54209791|FG001|Overall Study|Lost to follow-up - with data|3|||
27758001|NCT02447991|54209790|FG000|Overall Study|End of study - no treatment results|3|||
27758002|NCT02447991|54209791|FG001|Overall Study|End of study - no treatment results|6|||
27758003|NCT02447991|54209790|FG000|Overall Study|End of study - partial treatment results|0|||
27758004|NCT02447991|54209791|FG001|Overall Study|End of study - partial treatment results|9|||
27758005|NCT02586155|54209803|FG000|Overall Study|Adverse Event|2|||
27758006|NCT02586155|54209804|FG001|Overall Study|Adverse Event|3|||
27758007|NCT02586155|54209803|FG000|Overall Study|Withdrawal by Subject|31|||
27758008|NCT02586155|54209804|FG001|Overall Study|Withdrawal by Subject|24|||
27758009|NCT02586155|54209803|FG000|Overall Study|Lost to Follow-up|7|||
27758010|NCT02586155|54209804|FG001|Overall Study|Lost to Follow-up|13|||
27758011|NCT02586155|54209803|FG000|Overall Study|Death|61|||
27758012|NCT02586155|54209804|FG001|Overall Study|Death|72|||
27758013|NCT02586155|54209803|FG000|Overall Study|Other reasons|26|||
27758014|NCT02586155|54209804|FG001|Overall Study|Other reasons|15|||
27758015|NCT02446743|54209812|FG000|Overall Study|Withdrawal by Subject|1|||
27758016|NCT02446743|54209813|FG001|Overall Study|Withdrawal by Subject|1|||
27758017|NCT02446743|54209812|FG000|Overall Study|Lost to Follow-up|1|||
27758018|NCT02446743|54209813|FG001|Overall Study|Lost to Follow-up|0|||
27758019|NCT02446743|54209812|FG000|Overall Study|Adverse Event|1|||
27758020|NCT02446743|54209813|FG001|Overall Study|Adverse Event|1|||
27758021|NCT02446743|54209812|FG000|Overall Study|Other|2|||
27758022|NCT02446743|54209813|FG001|Overall Study|Other|3|||
27758023|NCT02586077|54209828|FG000|Overall Study|Withdrawal by Subject|1|||
27758024|NCT02586077|54209828|FG000|Overall Study|Physician Decision|4|||
27758025|NCT02586077|54209828|FG000|Overall Study|Lost to Follow-up|3|||
27758026|NCT02583425|54209833|FG000|Screening|Did not meet entry criteria|12|||
27758027|NCT02583425|54209833|FG000|Baseline|Did not meet continued criteria|5|||
27758028|NCT02583425|54209833|FG000|Treatment Period|Adverse Event|1|||
27758029|NCT02581163|54209838|FG000|Overall Study|Failure to return|15|||
27758030|NCT02581163|54209838|FG000|Overall Study|Insufficient virological response|3|||
27758031|NCT02581163|54209838|FG000|Overall Study|Withdrew consent|1|||
27758032|NCT02581163|54209838|FG000|Overall Study|Death|1|||
27758033|NCT02581163|54209838|FG000|Overall Study|Other, not specified|9|||
27758034|NCT02627677|54209848|FG000|Overall Study|Adverse event (not progressive disease)|1|||
27758035|NCT02627677|54209849|FG001|Overall Study|Adverse event (not progressive disease)|4|||
27758036|NCT02627677|54209850|FG002|Overall Study|Adverse event (not progressive disease)|1|||
27758037|NCT02627677|54209848|FG000|Overall Study|Progressive disease|1|||
27758038|NCT02627677|54209849|FG001|Overall Study|Progressive disease|3|||
27758039|NCT02627677|54209850|FG002|Overall Study|Progressive disease|0|||
27758040|NCT02627677|54209848|FG000|Overall Study|Lack of Efficacy|1|||
27758041|NCT02627677|54209849|FG001|Overall Study|Lack of Efficacy|2|||
27839453|NCT01471379|54326757|FG000|Overall Study|Study terminated|0|||
27839454|NCT01471379|54326758|FG001|Overall Study|Study terminated|1|||
27758042|NCT02627677|54209850|FG002|Overall Study|Lack of Efficacy|0|||
27758043|NCT02627677|54209848|FG000|Overall Study|Lost to Follow-up|0|||
27758044|NCT02627677|54209849|FG001|Overall Study|Lost to Follow-up|0|||
27758045|NCT02627677|54209850|FG002|Overall Study|Lost to Follow-up|1|||
27758046|NCT02627677|54209848|FG000|Overall Study|Pregnancy|0|||
27758047|NCT02627677|54209849|FG001|Overall Study|Pregnancy|1|||
27758048|NCT02627677|54209850|FG002|Overall Study|Pregnancy|0|||
27758049|NCT02627677|54209848|FG000|Overall Study|Study Terminated by Sponsor|5|||
27758050|NCT02627677|54209849|FG001|Overall Study|Study Terminated by Sponsor|10|||
27758051|NCT02627677|54209850|FG002|Overall Study|Study Terminated by Sponsor|6|||
27758052|NCT02627677|54209848|FG000|Overall Study|Physician Decision|0|||
27758053|NCT02627677|54209849|FG001|Overall Study|Physician Decision|0|||
27758054|NCT02627677|54209850|FG002|Overall Study|Physician Decision|2|||
27758055|NCT02627677|54209848|FG000|Overall Study|Withdrawal by Subject|2|||
27758056|NCT02627677|54209849|FG001|Overall Study|Withdrawal by Subject|1|||
27758057|NCT02627677|54209850|FG002|Overall Study|Withdrawal by Subject|1|||
27758058|NCT02627677|54209848|FG000|Overall Study|Reason not Specified|0|||
27758059|NCT02627677|54209849|FG001|Overall Study|Reason not Specified|0|||
27758060|NCT02627677|54209850|FG002|Overall Study|Reason not Specified|1|||
27758061|NCT02627677|54209848|FG000|Overall Study|Randomized but not Treated|1|||
27758062|NCT02627677|54209849|FG001|Overall Study|Randomized but not Treated|0|||
27758063|NCT02627677|54209850|FG002|Overall Study|Randomized but not Treated|0|||
27758064|NCT02501811|54209863|FG000|Overall Study|Death|1|||
27758065|NCT02501811|54209864|FG001|Overall Study|Death|3|||
27758066|NCT02501811|54209865|FG002|Overall Study|Death|2|||
27758067|NCT02501811|54209866|FG003|Overall Study|Death|3|||
27758068|NCT02501811|54209863|FG000|Overall Study|Withdrawal by Subject|3|||
27758069|NCT02501811|54209864|FG001|Overall Study|Withdrawal by Subject|3|||
27758070|NCT02501811|54209865|FG002|Overall Study|Withdrawal by Subject|2|||
27758071|NCT02501811|54209866|FG003|Overall Study|Withdrawal by Subject|3|||
27758072|NCT02501811|54209863|FG000|Overall Study|Lost to Follow-up|0|||
27758073|NCT02501811|54209864|FG001|Overall Study|Lost to Follow-up|0|||
27758074|NCT02501811|54209865|FG002|Overall Study|Lost to Follow-up|2|||
27758075|NCT02501811|54209866|FG003|Overall Study|Lost to Follow-up|1|||
27758076|NCT02585999|54209876|FG000|Overall Study|Lost to Follow-up|1|||
27758077|NCT02585999|54209876|FG000|Overall Study|Protocol Violation|1|||
27758078|NCT02582255|54209883|FG000|Overall Study|Protocol Violation|0|||
27758079|NCT02582255|54209884|FG001|Overall Study|Protocol Violation|3|||
27758080|NCT02500719|54209893|FG000|Overall Study|Lost to Follow-up|2|||
27758081|NCT02500719|54209894|FG001|Overall Study|Lost to Follow-up|3|||
27758082|NCT02500719|54209893|FG000|Overall Study|Trauma history|1|||
27758083|NCT02500719|54209894|FG001|Overall Study|Trauma history|0|||
27758084|NCT02500719|54209893|FG000|Overall Study|MRI data found to be unusable during analysis|0|||
27758085|NCT02500719|54209894|FG001|Overall Study|MRI data found to be unusable during analysis|1|||
27758086|NCT02500719|54209893|FG000|Overall Study|Did not meet criteria for PTSD|0|||
27758087|NCT02500719|54209894|FG001|Overall Study|Did not meet criteria for PTSD|1|||
27758088|NCT02500719|54209893|FG000|Overall Study|Claustrophobia|0|||
27758089|NCT02500719|54209894|FG001|Overall Study|Claustrophobia|1|||
27758090|NCT02500719|54209893|FG000|Overall Study|History of head trauma|0|||
27758091|NCT02500719|54209894|FG001|Overall Study|History of head trauma|1|||
27758092|NCT02500641|54209902|FG000|Overall Study|Adverse Event|0|||
27758093|NCT02500641|54209903|FG001|Overall Study|Adverse Event|2|||
27758094|NCT02500641|54209902|FG000|Overall Study|Withdrawal by Subject|4|||
27758095|NCT02500641|54209903|FG001|Overall Study|Withdrawal by Subject|5|||
27758096|NCT02500641|54209902|FG000|Overall Study|Unable to follow study procedures|3|||
27758097|NCT02500641|54209903|FG001|Overall Study|Unable to follow study procedures|2|||
27758098|NCT02500641|54209902|FG000|Overall Study|Protocol Violation|1|||
27758099|NCT02500641|54209903|FG001|Overall Study|Protocol Violation|2|||
27758100|NCT02500641|54209902|FG000|Overall Study|Lost to Follow-up|1|||
27758101|NCT02500641|54209903|FG001|Overall Study|Lost to Follow-up|0|||
27758102|NCT02500641|54209902|FG000|Overall Study|Sponsor decision|1|||
27758103|NCT02500641|54209903|FG001|Overall Study|Sponsor decision|0|||
27758104|NCT02500641|54209902|FG000|Overall Study|Non compliance to study drug|0|||
27758105|NCT02500641|54209903|FG001|Overall Study|Non compliance to study drug|1|||
27758106|NCT02499783|54209911|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2|||
27758107|NCT02499783|54209912|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4|||
27758108|NCT02499783|54209913|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0|||
27758109|NCT02499783|54209911|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1|||
27758110|NCT02499783|54209912|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
27758111|NCT02499783|54209913|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
27758112|NCT02499783|54209911|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
27758113|NCT02499783|54209912|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
27758114|NCT02499783|54209913|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Other|0|||
27758115|NCT02499783|54209911|FG000|DB Period: Weeks 0-8|Adverse Event|8|||
27758116|NCT02499783|54209912|FG001|DB Period: Weeks 0-8|Adverse Event|6|||
27839455|NCT01471379|54326759|FG002|Overall Study|Study terminated|0|||
27758117|NCT02499783|54209913|FG002|DB Period: Weeks 0-8|Adverse Event|0|||
27758118|NCT02499783|54209911|FG000|DB Period: Weeks 0-8|Withdrew Consent|1|||
27758119|NCT02499783|54209912|FG001|DB Period: Weeks 0-8|Withdrew Consent|0|||
27758120|NCT02499783|54209913|FG002|DB Period: Weeks 0-8|Withdrew Consent|0|||
27758121|NCT02499783|54209911|FG000|DB Period: Weeks 0-8|Other|1|||
27839456|NCT01470989|54326770|FG000|Overall Study|Participants did not entered extension studies 1, 2 and 3|103|||
27758122|NCT02499783|54209912|FG001|DB Period: Weeks 0-8|Other|1|||
27758123|NCT02499783|54209913|FG002|DB Period: Weeks 0-8|Other|0|||
27758124|NCT02499783|54209911|FG000|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
27758125|NCT02499783|54209912|FG001|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
27758126|NCT02499783|54209913|FG002|Open Label Period: Weeks 8 to 26|Adverse Event|16|||
27926931|NCT01217229|54583415|FG000|Overall Study|Disease progression, deterioration|2|||
27839457|NCT01470989|54326771|FG001|Overall Study|Participants did not entered extension studies 1, 2 and 3|136|||
27839458|NCT01470989|54326770|FG000|Overall Study|Adverse Event|2|||
27839459|NCT01470989|54326771|FG001|Overall Study|Adverse Event|5|||
27839460|NCT01470989|54326770|FG000|Overall Study|Abnormal laboratory value|1|||
27839461|NCT01470989|54326771|FG001|Overall Study|Abnormal laboratory value|1|||
27839462|NCT01470989|54326770|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
27839463|NCT01470989|54326771|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
27839464|NCT01470989|54326770|FG000|Overall Study|Withdrawal by Subject|19|||
27758127|NCT02499783|54209911|FG000|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
27758128|NCT02499783|54209912|FG001|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
27758129|NCT02499783|54209913|FG002|Open Label Period: Weeks 8 to 26|Withdrew Consent|2|||
27758130|NCT02499783|54209911|FG000|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
27758131|NCT02499783|54209912|FG001|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
27758132|NCT02499783|54209913|FG002|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9|||
27758133|NCT02499783|54209911|FG000|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
27758134|NCT02499783|54209912|FG001|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
27758135|NCT02499783|54209913|FG002|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2|||
27758136|NCT02468193|54209923|FG000|Overall Study|Adverse Event|4|||
27758137|NCT02468193|54209923|FG000|Overall Study|Subject/ Guardian decision|2|||
27758138|NCT02466555|54209943|FG000|Overall Study|Lost to Follow-up|2|||
27758139|NCT02466399|54209950|FG000|Overall Study|Adverse Event|1|||
27758140|NCT02466399|54209951|FG001|Overall Study|Adverse Event|0|||
27758141|NCT02466399|54209950|FG000|Overall Study|Early exit due to family emergency|1|||
27758142|NCT02466399|54209951|FG001|Overall Study|Early exit due to family emergency|0|||
27758143|NCT02465931|54209959|FG000|Overall Study|Lost to Follow-up|9|||
27758144|NCT02465931|54209960|FG001|Overall Study|Lost to Follow-up|11|||
27758145|NCT02465931|54209959|FG000|Overall Study|Protocol Violation|1|||
27758146|NCT02465931|54209960|FG001|Overall Study|Protocol Violation|0|||
27758147|NCT02465931|54209959|FG000|Overall Study|Withdrawal by Subject|1|||
27758148|NCT02465931|54209960|FG001|Overall Study|Withdrawal by Subject|0|||
27758149|NCT02465463|54209968|FG000|Overall Study|Lost to Follow-up|2|||
27758150|NCT02465463|54209969|FG001|Overall Study|Lost to Follow-up|1|||
27758151|NCT02465463|54209968|FG000|Overall Study|Death|1|||
27758152|NCT02465463|54209969|FG001|Overall Study|Death|0|||
27758153|NCT02465463|54209968|FG000|Overall Study|Protocol Violation|1|||
27758154|NCT02465463|54209969|FG001|Overall Study|Protocol Violation|0|||
27758155|NCT02464059|54209976|FG000|Overall Study|Lost to Follow-up|6|||
27758156|NCT02463357|54209985|FG000|Overall Study|Withdrawal by Subject|1|||
27758157|NCT02463357|54209986|FG001|Overall Study|Withdrawal by Subject|0|||
27758158|NCT02463357|54209987|FG002|Overall Study|Withdrawal by Subject|0|||
27758159|NCT02463357|54209988|FG003|Overall Study|Withdrawal by Subject|0|||
27758160|NCT02463357|54209989|FG004|Overall Study|Withdrawal by Subject|0|||
27758161|NCT02463357|54209985|FG000|Overall Study|Withdrawal by Subject|0|||
27758162|NCT02463357|54209986|FG001|Overall Study|Withdrawal by Subject|0|||
27758163|NCT02463357|54209987|FG002|Overall Study|Withdrawal by Subject|0|||
27758164|NCT02463357|54209988|FG003|Overall Study|Withdrawal by Subject|0|||
27758165|NCT02463357|54209989|FG004|Overall Study|Withdrawal by Subject|1|||
27758166|NCT02579759|54210004|FG000|Overall Study|Protocol Violation|2|||
27758167|NCT02579759|54210005|FG001|Overall Study|Protocol Violation|0|||
27758168|NCT02579759|54210006|FG002|Overall Study|Protocol Violation|0|||
27758169|NCT02579759|54210004|FG000|Overall Study|Other (Sponsor stopped Dose 2)|0|||
27758170|NCT02579759|54210005|FG001|Overall Study|Other (Sponsor stopped Dose 2)|1|||
27758171|NCT02579759|54210006|FG002|Overall Study|Other (Sponsor stopped Dose 2)|0|||
27758172|NCT02579759|54210004|FG000|Overall Study|BfArM hold|13|||
27758173|NCT02579759|54210005|FG001|Overall Study|BfArM hold|12|||
27758174|NCT02579759|54210006|FG002|Overall Study|BfArM hold|12|||
27758175|NCT02579759|54210004|FG000|Overall Study|Sponsor stopped Dose 2|0|||
27758176|NCT02579759|54210005|FG001|Overall Study|Sponsor stopped Dose 2|41|||
27758177|NCT02579759|54210006|FG002|Overall Study|Sponsor stopped Dose 2|0|||
27758178|NCT02579759|54210004|FG000|Overall Study|Non compliance|0|||
27758179|NCT02579759|54210005|FG001|Overall Study|Non compliance|1|||
27839465|NCT01470989|54326771|FG001|Overall Study|Withdrawal by Subject|17|||
27839466|NCT01470989|54326770|FG000|Overall Study|Lost to Follow-up|18|||
27758180|NCT02579759|54210006|FG002|Overall Study|Non compliance|0|||
27758181|NCT02579759|54210004|FG000|Overall Study|Pregnancy|0|||
27758182|NCT02579759|54210005|FG001|Overall Study|Pregnancy|1|||
27758183|NCT02579759|54210006|FG002|Overall Study|Pregnancy|0|||
27758184|NCT02579759|54210004|FG000|Overall Study|Inclusion/exclusion criteria|0|||
27758185|NCT02579759|54210005|FG001|Overall Study|Inclusion/exclusion criteria|0|||
27758186|NCT02579759|54210006|FG002|Overall Study|Inclusion/exclusion criteria|1|||
27758187|NCT02579759|54210004|FG000|Overall Study|Adverse Event|4|||
27758188|NCT02579759|54210005|FG001|Overall Study|Adverse Event|3|||
27839467|NCT01470989|54326771|FG001|Overall Study|Lost to Follow-up|13|||
27839468|NCT01470989|54326770|FG000|Overall Study|Administrative problems|2|||
27758189|NCT02579759|54210006|FG002|Overall Study|Adverse Event|1|||
27758190|NCT02579759|54210004|FG000|Overall Study|Withdrawal by Subject|3|||
27758191|NCT02579759|54210005|FG001|Overall Study|Withdrawal by Subject|3|||
27758192|NCT02579759|54210006|FG002|Overall Study|Withdrawal by Subject|5|||
27758193|NCT02579759|54210004|FG000|Overall Study|Lost to Follow-up|2|||
27758194|NCT02579759|54210005|FG001|Overall Study|Lost to Follow-up|2|||
27758195|NCT02579759|54210006|FG002|Overall Study|Lost to Follow-up|2|||
27758196|NCT02445963|54210020|FG000|Overall Study|Lost to Follow-up|1|||
27758197|NCT02445963|54210021|FG001|Overall Study|Lost to Follow-up|0|||
27758198|NCT02445963|54210022|FG002|Overall Study|Lost to Follow-up|0|||
27758199|NCT02445963|54210023|FG003|Overall Study|Lost to Follow-up|0|||
27758200|NCT02445963|54210020|FG000|Overall Study|Change in employment|1|||
27758201|NCT02445963|54210021|FG001|Overall Study|Change in employment|0|||
27758202|NCT02445963|54210022|FG002|Overall Study|Change in employment|0|||
27758203|NCT02445963|54210023|FG003|Overall Study|Change in employment|0|||
27758204|NCT02445963|54210020|FG000|Overall Study|Symptoms post-vaccination|0|||
27758205|NCT02445963|54210021|FG001|Overall Study|Symptoms post-vaccination|0|||
27758206|NCT02445963|54210022|FG002|Overall Study|Symptoms post-vaccination|1|||
27758207|NCT02445963|54210023|FG003|Overall Study|Symptoms post-vaccination|0|||
27758208|NCT02499159|54210037|FG000|Randomization|Protocol Violation|1|||
27758209|NCT02499159|54210038|FG001|Randomization|Protocol Violation|1|||
27758210|NCT02499159|54210037|FG000|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
27758211|NCT02499159|54210038|FG001|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
27758212|NCT02499159|54210037|FG000|30-Day Follow-Up Phone Call|Lost to Follow-up|3|||
27758213|NCT02499159|54210038|FG001|30-Day Follow-Up Phone Call|Lost to Follow-up|1|||
27758214|NCT02499159|54210037|FG000|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2|||
27758215|NCT02499159|54210038|FG001|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0|||
27758216|NCT02499159|54210037|FG000|30-Day Follow-Up Phone Call|Other|1|||
27758217|NCT02499159|54210038|FG001|30-Day Follow-Up Phone Call|Other|0|||
27758218|NCT01664039|54210046|FG000|Overall Study|Adverse Event|3|||
27758219|NCT01664039|54210047|FG001|Overall Study|Adverse Event|4|||
27758220|NCT01664039|54210046|FG000|Overall Study|Lost to Follow-up|1|||
27758221|NCT01664039|54210047|FG001|Overall Study|Lost to Follow-up|1|||
27758222|NCT01664039|54210046|FG000|Overall Study|Withdrawal by Subject|1|||
27758223|NCT01664039|54210047|FG001|Overall Study|Withdrawal by Subject|3|||
27758224|NCT01664039|54210046|FG000|Overall Study|Noncompliance|1|||
27758225|NCT01664039|54210047|FG001|Overall Study|Noncompliance|1|||
27758226|NCT02445573|54210055|FG000|Overall Study|Withdrawal by Subject|1|||
27758227|NCT02445573|54210056|FG001|Overall Study|Withdrawal by Subject|1|||
27758228|NCT02445573|54210055|FG000|Overall Study|Lost to Follow-up|0|||
27758229|NCT02445573|54210056|FG001|Overall Study|Lost to Follow-up|1|||
27758230|NCT02445339|54210064|FG000|Overall Study|Physician Decision|1|||
27758231|NCT02445339|54210065|FG001|Overall Study|Physician Decision|0|||
27758232|NCT02445339|54210064|FG000|Overall Study|Lost to Follow-up|11|||
27758233|NCT02445339|54210065|FG001|Overall Study|Lost to Follow-up|15|||
27758234|NCT02579603|54210073|FG000|Overall Study|Not treated|1|||
27758235|NCT02579603|54210074|FG001|Overall Study|Not treated|0|||
27758236|NCT02579603|54210073|FG000|Overall Study|Adverse Event|2|||
27758237|NCT02579603|54210074|FG001|Overall Study|Adverse Event|2|||
27758238|NCT02579603|54210073|FG000|Overall Study|Other than stated|1|||
27758239|NCT02579603|54210074|FG001|Overall Study|Other than stated|0|||
27758240|NCT02625259|54210086|FG000|First Intervention (Day 1)|Other|0|||
27758241|NCT02625259|54210087|FG001|First Intervention (Day 1)|Other|0|||
27758242|NCT02625259|54210088|FG002|First Intervention (Day 1)|Other|1|||
27758243|NCT02625259|54210089|FG003|First Intervention (Day 1)|Other|0|||
27758244|NCT02625259|54210090|FG004|First Intervention (Day 1)|Other|0|||
27758245|NCT02625259|54210086|FG000|First Intervention (Day 1)|Adverse Event|2|||
27758246|NCT02625259|54210087|FG001|First Intervention (Day 1)|Adverse Event|1|||
27758247|NCT02625259|54210088|FG002|First Intervention (Day 1)|Adverse Event|0|||
27758248|NCT02625259|54210089|FG003|First Intervention (Day 1)|Adverse Event|0|||
27758249|NCT02625259|54210090|FG004|First Intervention (Day 1)|Adverse Event|0|||
27758250|NCT02625259|54210086|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
27758251|NCT02625259|54210087|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
27758252|NCT02625259|54210088|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
27758253|NCT02625259|54210089|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
27758254|NCT02625259|54210090|FG004|First Intervention (Day 1)|Withdrawal by Subject|0|||
27758255|NCT02577107|54210107|FG000|Overall Study|Protocol deviation|0|||
27758256|NCT02577107|54210108|FG001|Overall Study|Protocol deviation|1|||
27758257|NCT02444793|54210118|FG000|Overall Study|Lost to Follow-up|2|||
27758258|NCT02444793|54210119|FG001|Overall Study|Lost to Follow-up|2|||
27758259|NCT02444793|54210120|FG002|Overall Study|Lost to Follow-up|0|||
27758260|NCT02444793|54210121|FG003|Overall Study|Lost to Follow-up|0|||
27758261|NCT02444793|54210118|FG000|Overall Study|Death|0|||
27758262|NCT02444793|54210119|FG001|Overall Study|Death|3|||
27758263|NCT02444793|54210120|FG002|Overall Study|Death|0|||
27758264|NCT02444793|54210121|FG003|Overall Study|Death|0|||
27758265|NCT02444793|54210118|FG000|Overall Study|Other|0|||
27758266|NCT02444793|54210119|FG001|Overall Study|Other|0|||
27758267|NCT02444793|54210120|FG002|Overall Study|Other|2|||
27758268|NCT02444793|54210121|FG003|Overall Study|Other|0|||
27758269|NCT02444793|54210118|FG000|Overall Study|Objective progression or relapse|9|||
27758270|NCT02444793|54210119|FG001|Overall Study|Objective progression or relapse|1|||
27758271|NCT02444793|54210120|FG002|Overall Study|Objective progression or relapse|2|||
27758272|NCT02444793|54210121|FG003|Overall Study|Objective progression or relapse|3|||
27758273|NCT02624713|54210134|FG000|Overall Study|Lost to Follow-up|14|||
27758274|NCT02624713|54210135|FG001|Overall Study|Lost to Follow-up|0|||
27758275|NCT02624791|54210142|FG000|Overall Study|Withdrawal by Subject|2|||
27758276|NCT02624791|54210143|FG001|Overall Study|Withdrawal by Subject|0|||
27758277|NCT02624791|54210144|FG002|Overall Study|Withdrawal by Subject|0|||
27758278|NCT02624791|54210145|FG003|Overall Study|Withdrawal by Subject|0|||
27758279|NCT02624791|54210146|FG004|Overall Study|Withdrawal by Subject|0|||
27758280|NCT02624791|54210147|FG005|Overall Study|Withdrawal by Subject|0|||
27758281|NCT02577029|54210159|FG000|Overall Study|Adverse Event|1|||
27758282|NCT02577029|54210160|FG001|Overall Study|Adverse Event|0|||
27758283|NCT02577029|54210161|FG002|Overall Study|Adverse Event|2|||
27758284|NCT02577029|54210162|FG003|Overall Study|Adverse Event|0|||
27758285|NCT02577029|54210163|FG004|Overall Study|Adverse Event|1|||
27758286|NCT02577029|54210164|FG005|Overall Study|Adverse Event|0|||
27758287|NCT02577029|54210165|FG006|Overall Study|Adverse Event|0|||
27758288|NCT02577029|54210166|FG007|Overall Study|Adverse Event|0|||
27758289|NCT02577029|54210159|FG000|Overall Study|Withdrawal by Subject|0|||
27758290|NCT02577029|54210160|FG001|Overall Study|Withdrawal by Subject|0|||
27758291|NCT02577029|54210161|FG002|Overall Study|Withdrawal by Subject|0|||
27758292|NCT02577029|54210162|FG003|Overall Study|Withdrawal by Subject|0|||
27758293|NCT02577029|54210163|FG004|Overall Study|Withdrawal by Subject|0|||
27758294|NCT02577029|54210164|FG005|Overall Study|Withdrawal by Subject|1|||
27758295|NCT02577029|54210165|FG006|Overall Study|Withdrawal by Subject|0|||
27758296|NCT02577029|54210166|FG007|Overall Study|Withdrawal by Subject|0|||
27758297|NCT02577029|54210159|FG000|Overall Study|Sponsor Termination of the Study|9|||
27758298|NCT02577029|54210160|FG001|Overall Study|Sponsor Termination of the Study|2|||
27758299|NCT02577029|54210161|FG002|Overall Study|Sponsor Termination of the Study|5|||
27758300|NCT02577029|54210162|FG003|Overall Study|Sponsor Termination of the Study|12|||
27758301|NCT02577029|54210163|FG004|Overall Study|Sponsor Termination of the Study|10|||
27758302|NCT02577029|54210164|FG005|Overall Study|Sponsor Termination of the Study|12|||
27758303|NCT02577029|54210165|FG006|Overall Study|Sponsor Termination of the Study|12|||
27758304|NCT02577029|54210166|FG007|Overall Study|Sponsor Termination of the Study|12|||
27758305|NCT02577887|54210184|FG000|Overall Study|Death|93|||
27758306|NCT02577887|54210184|FG000|Overall Study|Protocol Violation|125|||
27758307|NCT02577887|54210184|FG000|Overall Study|Withdrawal by Subject|80|||
27758308|NCT03597347|54210191|FG000|Overall Study|Withdrawal by Subject|1|||
27758309|NCT03597347|54210192|FG001|Overall Study|Withdrawal by Subject|1|||
27758310|NCT03597347|54210193|FG002|Overall Study|Withdrawal by Subject|0|||
27758311|NCT03597347|54210191|FG000|Overall Study|Withdrawal due to Covid-19|3|||
27758312|NCT03597347|54210192|FG001|Overall Study|Withdrawal due to Covid-19|0|||
27758313|NCT03597347|54210193|FG002|Overall Study|Withdrawal due to Covid-19|0|||
27758314|NCT03597347|54210191|FG000|Overall Study|Sponsor decision to terminate study|3|||
27758315|NCT03597347|54210192|FG001|Overall Study|Sponsor decision to terminate study|2|||
27758316|NCT03597347|54210193|FG002|Overall Study|Sponsor decision to terminate study|4|||
27758317|NCT02576951|54210205|FG000|Overall Study|Lost to Follow-up|0|||
27758318|NCT02576951|54210206|FG001|Overall Study|Lost to Follow-up|0|||
27758319|NCT02576951|54210207|FG002|Overall Study|Lost to Follow-up|2|||
27758320|NCT02576951|54210208|FG003|Overall Study|Lost to Follow-up|2|||
27758321|NCT02576951|54210205|FG000|Overall Study|Withdrawal by Subject|1|||
27758322|NCT02576951|54210206|FG001|Overall Study|Withdrawal by Subject|0|||
27758323|NCT02576951|54210207|FG002|Overall Study|Withdrawal by Subject|0|||
27758324|NCT02576951|54210208|FG003|Overall Study|Withdrawal by Subject|2|||
27758325|NCT02576951|54210205|FG000|Overall Study|Protocol Violation|0|||
27758326|NCT02576951|54210206|FG001|Overall Study|Protocol Violation|0|||
27758327|NCT02576951|54210207|FG002|Overall Study|Protocol Violation|0|||
27758328|NCT02576951|54210208|FG003|Overall Study|Protocol Violation|1|||
27758329|NCT02621047|54210223|FG000|Overall Study|Adverse Event|0|||
27758330|NCT02621047|54210224|FG001|Overall Study|Adverse Event|0|||
27758331|NCT02621047|54210225|FG002|Overall Study|Adverse Event|1|||
27758332|NCT02443155|54210238|FG000|Overall Study|Adverse Event|3|||
27758333|NCT02443155|54210239|FG001|Overall Study|Adverse Event|4|||
27758334|NCT02443155|54210240|FG002|Overall Study|Adverse Event|1|||
27758335|NCT02443155|54210241|FG003|Overall Study|Adverse Event|2|||
27758336|NCT02443155|54210238|FG000|Overall Study|Unclassified|0|||
27758337|NCT02443155|54210239|FG001|Overall Study|Unclassified|0|||
27758338|NCT02443155|54210240|FG002|Overall Study|Unclassified|2|||
27758339|NCT02443155|54210241|FG003|Overall Study|Unclassified|1|||
27758340|NCT02443155|54210238|FG000|Overall Study|Withdrawal by Subject|4|||
27758341|NCT02443155|54210239|FG001|Overall Study|Withdrawal by Subject|7|||
27758342|NCT02443155|54210240|FG002|Overall Study|Withdrawal by Subject|3|||
27758343|NCT02443155|54210241|FG003|Overall Study|Withdrawal by Subject|9|||
27758344|NCT02443155|54210238|FG000|Overall Study|Pregnancy|3|||
27758345|NCT02443155|54210239|FG001|Overall Study|Pregnancy|1|||
27758346|NCT02443155|54210240|FG002|Overall Study|Pregnancy|1|||
27758347|NCT02443155|54210241|FG003|Overall Study|Pregnancy|2|||
27758348|NCT02443155|54210238|FG000|Overall Study|Lost to Follow-up|1|||
27758349|NCT02443155|54210239|FG001|Overall Study|Lost to Follow-up|2|||
27758350|NCT02443155|54210240|FG002|Overall Study|Lost to Follow-up|0|||
27758351|NCT02443155|54210241|FG003|Overall Study|Lost to Follow-up|1|||
27758352|NCT02443155|54210238|FG000|Overall Study|Protocol Violation|1|||
27758353|NCT02443155|54210239|FG001|Overall Study|Protocol Violation|0|||
27758354|NCT02443155|54210240|FG002|Overall Study|Protocol Violation|1|||
27758355|NCT02443155|54210241|FG003|Overall Study|Protocol Violation|1|||
27758356|NCT02443155|54210238|FG000|Overall Study|Death|0|||
27758357|NCT02443155|54210239|FG001|Overall Study|Death|0|||
27758358|NCT02443155|54210240|FG002|Overall Study|Death|1|||
27758359|NCT02443155|54210241|FG003|Overall Study|Death|0|||
27758360|NCT02460159|54210254|FG000|Overall Study|Adverse Event|4|||
27758361|NCT02460159|54210255|FG001|Overall Study|Adverse Event|1|||
27758362|NCT02460159|54210254|FG000|Overall Study|Withdrawal by Subject|2|||
27758363|NCT02460159|54210255|FG001|Overall Study|Withdrawal by Subject|0|||
27758364|NCT02498067|54210261|FG000|Overall Study|Lost to Follow-up|22|||
27758365|NCT02498067|54210261|FG000|Overall Study|Did not meet inclusion criteria|11|||
27758366|NCT02497755|54210269|FG000|Overall Study|Protocol Violation|1|||
27758367|NCT02497755|54210270|FG001|Overall Study|Protocol Violation|0|||
27758368|NCT02619175|54210279|FG000|Overall Study|Withdrawal by Subject|1|||
27758369|NCT02619175|54210280|FG001|Overall Study|Withdrawal by Subject|0|||
27758370|NCT02619175|54210279|FG000|Overall Study|foot pain|1|||
27758371|NCT02619175|54210280|FG001|Overall Study|foot pain|0|||
27758372|NCT01360021|54210297|FG000|Overall Study|Eligibility criteria + other|2|||
27758373|NCT01360021|54210298|FG001|Overall Study|Eligibility criteria + other|1|||
27758374|NCT01360021|54210299|FG002|Overall Study|Eligibility criteria + other|1|||
27758375|NCT01360021|54210297|FG000|Overall Study|Protocol Violation|0|||
27758376|NCT01360021|54210298|FG001|Overall Study|Protocol Violation|0|||
27758377|NCT01360021|54210299|FG002|Overall Study|Protocol Violation|1|||
27758378|NCT01360021|54210297|FG000|Overall Study|Withdrawal by Subject|4|||
27758379|NCT01360021|54210298|FG001|Overall Study|Withdrawal by Subject|0|||
27758380|NCT01360021|54210299|FG002|Overall Study|Withdrawal by Subject|2|||
27758381|NCT01360021|54210297|FG000|Overall Study|Adverse Event|2|||
27758382|NCT01360021|54210298|FG001|Overall Study|Adverse Event|3|||
27758383|NCT01360021|54210299|FG002|Overall Study|Adverse Event|3|||
27758384|NCT02497287|54210316|FG000|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84|||
27758385|NCT02497287|54210316|FG000|Induction Phase (4 Weeks)|Adverse Event|52|||
27758386|NCT02497287|54210316|FG000|Induction Phase (4 Weeks)|Withdrawal by Subject|22|||
27758387|NCT02497287|54210316|FG000|Induction Phase (4 Weeks)|Lack of Efficacy|21|||
27758388|NCT02497287|54210316|FG000|Induction Phase (4 Weeks)|Other|13|||
27758389|NCT02497287|54210316|FG000|Induction Phase (4 Weeks)|Lost to Follow-up|5|||
27758390|NCT02497287|54210316|FG000|Induction Phase (4 Weeks)|Protocol Violation|1|||
27758391|NCT02497287|54210316|FG000|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1|||
27758392|NCT02497287|54210316|FG000|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331|||
27758393|NCT02497287|54210316|FG000|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30|||
27758394|NCT02497287|54210316|FG000|Optimization/Maintenance (48 Weeks)|Adverse Event|25|||
27758395|NCT02497287|54210316|FG000|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25|||
27758396|NCT02497287|54210316|FG000|Optimization/Maintenance (48 Weeks)|Other|21|||
27758397|NCT02497287|54210316|FG000|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10|||
27758398|NCT02497287|54210316|FG000|Optimization/Maintenance (48 Weeks)|Protocol Violation|3|||
27758399|NCT02497287|54210316|FG000|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3|||
27758400|NCT02497287|54210316|FG000|Optimization/Maintenance (48 Weeks)|Pregnancy|2|||
27758401|NCT02497287|54210316|FG000|Optimization/Maintenance (48 Weeks)|Death|2|||
27758402|NCT02497287|54210316|FG000|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1|||
27758403|NCT02497287|54210316|FG000|Follow-up Phase (4 Week)|PI Decision|12|||
27758404|NCT02497287|54210316|FG000|Follow-up Phase (4 Week)|Withdrawal by Subject|10|||
27758405|NCT02497287|54210316|FG000|Follow-up Phase (4 Week)|Lost to Follow-up|5|||
27758406|NCT02497287|54210316|FG000|Follow-up Phase (4 Week)|Adverse Event|3|||
27758407|NCT02497287|54210316|FG000|Follow-up Phase (4 Week)|Other|1|||
27758408|NCT02458287|54210326|FG000|Overall Study|Adverse Event|0|||
27758409|NCT02458287|54210327|FG001|Overall Study|Adverse Event|0|||
27758410|NCT02458287|54210328|FG002|Overall Study|Adverse Event|0|||
27758411|NCT02458287|54210329|FG003|Overall Study|Adverse Event|1|||
27758412|NCT02458287|54210326|FG000|Overall Study|Lost to Follow-up|0|||
27758413|NCT02458287|54210327|FG001|Overall Study|Lost to Follow-up|1|||
27758414|NCT02458287|54210328|FG002|Overall Study|Lost to Follow-up|1|||
27758415|NCT02458287|54210329|FG003|Overall Study|Lost to Follow-up|0|||
27758416|NCT02458287|54210326|FG000|Overall Study|Protocol Violation|0|||
27758417|NCT02458287|54210327|FG001|Overall Study|Protocol Violation|1|||
27758418|NCT02458287|54210328|FG002|Overall Study|Protocol Violation|0|||
27758419|NCT02458287|54210329|FG003|Overall Study|Protocol Violation|0|||
27758420|NCT02458287|54210326|FG000|Overall Study|Withdrawal by Subject|0|||
27758421|NCT02458287|54210327|FG001|Overall Study|Withdrawal by Subject|2|||
27758422|NCT02458287|54210328|FG002|Overall Study|Withdrawal by Subject|2|||
27758423|NCT02458287|54210329|FG003|Overall Study|Withdrawal by Subject|1|||
27758424|NCT02458287|54210326|FG000|Overall Study|Relocated Out of State|0|||
27758425|NCT02458287|54210327|FG001|Overall Study|Relocated Out of State|0|||
27758426|NCT02458287|54210328|FG002|Overall Study|Relocated Out of State|0|||
27758427|NCT02458287|54210329|FG003|Overall Study|Relocated Out of State|1|||
27758428|NCT02441517|54210345|FG000|Overall Study|Lost to Follow-up|1|||
27758429|NCT02441517|54210345|FG000|Overall Study|Withdrawal by Subject|2|||
27758430|NCT02441517|54210345|FG000|Overall Study|Study Terminated by Sponsor|1|||
27758431|NCT02457819|54210349|FG000|Overall Study|reason not given|8|||
27758432|NCT02457819|54210349|FG000|Overall Study|Withdrawal by Subject|24|||
27758433|NCT02457819|54210349|FG000|Overall Study|Protocol Violation|1|||
27758434|NCT02457819|54210349|FG000|Overall Study|non compliance with study drug|4|||
27758435|NCT02457819|54210349|FG000|Overall Study|Lost to Follow-up|10|||
27758436|NCT02457819|54210349|FG000|Overall Study|Lack of Efficacy|19|||
27758437|NCT02457819|54210349|FG000|Overall Study|Adverse Event|33|||
27758438|NCT02496039|54210353|FG000|Overall Study|Adverse Event|3|||
27758439|NCT02496039|54210353|FG000|Overall Study|Protocol Violation|1|||
27758440|NCT02441283|54210357|FG000|Overall Study|Withdrew consent|15|||
27758441|NCT02441283|54210357|FG000|Overall Study|Lost to Follow-up|42|||
27758442|NCT02441283|54210357|FG000|Overall Study|Death|1|||
27758443|NCT02441283|54210357|FG000|Overall Study|Other, not specified|32|||
27758444|NCT02495883|54210363|FG000|Overall Study|Excessive head motion|1|||
27758445|NCT02495883|54210364|FG001|Overall Study|Excessive head motion|0|||
27758446|NCT02495025|54210371|FG000|Overall Study|Lost to Follow-up|21|||
27758447|NCT02495025|54210372|FG001|Overall Study|Lost to Follow-up|14|||
27758448|NCT02495025|54210371|FG000|Overall Study|Withdrawal by Subject|5|||
27758449|NCT02495025|54210372|FG001|Overall Study|Withdrawal by Subject|0|||
27758450|NCT02439957|54210380|FG000|Overall Study|Study Terminated|3|||
27758451|NCT02439957|54210381|FG001|Overall Study|Study Terminated|3|||
27758452|NCT02494401|54210389|FG000|Overall Study|Lost to Follow-up|22|||
27758453|NCT02494401|54210390|FG001|Overall Study|Lost to Follow-up|25|||
27758454|NCT02494401|54210389|FG000|Overall Study|Withdrawal by Subject|3|||
27758455|NCT02494401|54210390|FG001|Overall Study|Withdrawal by Subject|2|||
27758456|NCT02457195|54210396|FG000|Overall Study|Adverse Event|3|||
27758457|NCT02457195|54210396|FG000|Overall Study|Protocol Violation|2|||
27758458|NCT02457195|54210396|FG000|Overall Study|Withdrawal by Subject|4|||
27758459|NCT02456727|54210402|FG000|Overall Study|Lost to Follow-up|63|||
27758460|NCT02456727|54210403|FG001|Overall Study|Lost to Follow-up|65|||
27758461|NCT02456727|54210402|FG000|Overall Study|Death|2|||
27758462|NCT02456727|54210403|FG001|Overall Study|Death|1|||
27758463|NCT02456727|54210402|FG000|Overall Study|Withdrawal by Subject|1|||
27758464|NCT02456727|54210403|FG001|Overall Study|Withdrawal by Subject|10|||
27758465|NCT02456727|54210402|FG000|Overall Study|Never Initiated Treatment|43|||
27758466|NCT02456727|54210403|FG001|Overall Study|Never Initiated Treatment|30|||
27758467|NCT02456103|54210425|FG000|Overall Study|Study Closure|207|||
27758468|NCT02456103|54210425|FG000|Overall Study|Physician Decision|1|||
27758469|NCT02456103|54210425|FG000|Overall Study|Required prohibited medications|5|||
27758470|NCT02456103|54210425|FG000|Overall Study|Protocol Violation|1|||
27758471|NCT02456103|54210425|FG000|Overall Study|Adverse Event|5|||
27758472|NCT02456103|54210425|FG000|Overall Study|Abnormal Laboratory Value|2|||
27926932|NCT01217229|54583415|FG000|Overall Study|Disease progression, Cheson criteria|14|||
27758473|NCT02456103|54210425|FG000|Overall Study|Lost to Follow-up|1|||
27758474|NCT02456103|54210425|FG000|Overall Study|Withdrawal by Subject|24|||
27758475|NCT01653327|54210429|FG000|Overall Study|Withdrawal by Subject|1|||
27758476|NCT02493855|54210438|FG000|Overall Study|Non-compliance|1|||
27758477|NCT02493855|54210439|FG001|Overall Study|Non-compliance|0|||
27758478|NCT02493855|54210440|FG002|Overall Study|Non-compliance|0|||
27758479|NCT02493855|54210438|FG000|Overall Study|Adverse Event|0|||
27758480|NCT02493855|54210439|FG001|Overall Study|Adverse Event|1|||
27758481|NCT02493855|54210440|FG002|Overall Study|Adverse Event|0|||
27758482|NCT02493855|54210438|FG000|Overall Study|Withdrawal by Subject|1|||
27758483|NCT02493855|54210439|FG001|Overall Study|Withdrawal by Subject|0|||
27758484|NCT02493855|54210440|FG002|Overall Study|Withdrawal by Subject|0|||
27758485|NCT02438787|54210451|FG000|Overall Study|Adverse Event|1|||
27758486|NCT02438787|54210452|FG001|Overall Study|Adverse Event|0|||
27758487|NCT02438787|54210453|FG002|Overall Study|Adverse Event|2|||
27758488|NCT02438787|54210451|FG000|Overall Study|Lack of Efficacy|1|||
27758489|NCT02438787|54210452|FG001|Overall Study|Lack of Efficacy|2|||
27758490|NCT02438787|54210453|FG002|Overall Study|Lack of Efficacy|0|||
27758491|NCT02438787|54210451|FG000|Overall Study|Lost to Follow-up|0|||
27758492|NCT02438787|54210452|FG001|Overall Study|Lost to Follow-up|1|||
27758493|NCT02438787|54210453|FG002|Overall Study|Lost to Follow-up|0|||
27758494|NCT02438787|54210451|FG000|Overall Study|Protocol Violation|0|||
27758495|NCT02438787|54210452|FG001|Overall Study|Protocol Violation|0|||
27758496|NCT02438787|54210453|FG002|Overall Study|Protocol Violation|1|||
27758497|NCT02438787|54210451|FG000|Overall Study|Withdrawal by Subject|15|||
27758498|NCT02438787|54210452|FG001|Overall Study|Withdrawal by Subject|7|||
27758499|NCT02438787|54210453|FG002|Overall Study|Withdrawal by Subject|10|||
27758500|NCT02438787|54210451|FG000|Overall Study|Study discontinued by sponsor|64|||
27758501|NCT02438787|54210452|FG001|Overall Study|Study discontinued by sponsor|72|||
27758502|NCT02438787|54210453|FG002|Overall Study|Study discontinued by sponsor|69|||
27758503|NCT02438787|54210451|FG000|Overall Study|Other|0|||
27758504|NCT02438787|54210452|FG001|Overall Study|Other|1|||
27758505|NCT02438787|54210453|FG002|Overall Study|Other|0|||
27758506|NCT02438787|54210451|FG000|Overall Study|Site terminated by sponsor|0|||
27758507|NCT02438787|54210452|FG001|Overall Study|Site terminated by sponsor|0|||
27758508|NCT02438787|54210453|FG002|Overall Study|Site terminated by sponsor|1|||
27758509|NCT02493777|54210468|FG000|Overall Study|Lost to Follow-up|0|||
27758510|NCT02493777|54210469|FG001|Overall Study|Lost to Follow-up|1|||
27758511|NCT02616601|54210478|FG000|Overall Study|Withdrawal by Subject|4|||
27758512|NCT02616601|54210479|FG001|Overall Study|Withdrawal by Subject|4|||
27758513|NCT02616601|54210480|FG002|Overall Study|Withdrawal by Subject|3|||
27758514|NCT02616601|54210478|FG000|Overall Study|Adverse Event|2|||
27758515|NCT02616601|54210479|FG001|Overall Study|Adverse Event|0|||
27758516|NCT02616601|54210480|FG002|Overall Study|Adverse Event|2|||
27758517|NCT02616601|54210478|FG000|Overall Study|Death|1|||
27758518|NCT02616601|54210479|FG001|Overall Study|Death|0|||
27758519|NCT02616601|54210480|FG002|Overall Study|Death|0|||
27758520|NCT02616601|54210478|FG000|Overall Study|Lost to Follow-up|1|||
27758521|NCT02616601|54210479|FG001|Overall Study|Lost to Follow-up|0|||
27758522|NCT02616601|54210480|FG002|Overall Study|Lost to Follow-up|1|||
27758523|NCT02616601|54210478|FG000|Overall Study|Non-Compliance with Test Article|1|||
27758524|NCT02616601|54210479|FG001|Overall Study|Non-Compliance with Test Article|0|||
27758525|NCT02616601|54210480|FG002|Overall Study|Non-Compliance with Test Article|1|||
27758526|NCT02492997|54210490|FG000|Overall Study|Withdrawal by Subject|1|||
27758527|NCT02492997|54210491|FG001|Overall Study|Withdrawal by Subject|0|||
27758528|NCT02492997|54210490|FG000|Overall Study|Gained Weight|1|||
27758529|NCT02492997|54210491|FG001|Overall Study|Gained Weight|0|||
27758530|NCT02492997|54210490|FG000|Overall Study|Lost to Follow-up|0|||
27758531|NCT02492997|54210491|FG001|Overall Study|Lost to Follow-up|1|||
27758532|NCT02437305|54210499|FG000|Overall Study|Lost to Follow-up|18|||
27758533|NCT02437305|54210500|FG001|Overall Study|Lost to Follow-up|12|||
27758534|NCT02492841|54210509|FG000|Overall Study|Lost to Follow-up|34|||
27758535|NCT02492841|54210510|FG001|Overall Study|Lost to Follow-up|31|||
27758536|NCT02492841|54210511|FG002|Overall Study|Lost to Follow-up|35|||
27758537|NCT02436915|54210524|FG000|Overall Study|Withdrawal by Subject|0|||
27758538|NCT02436915|54210525|FG001|Overall Study|Withdrawal by Subject|1|||
27758539|NCT02492763|54210537|FG000|Overall Study|Withdrawal by Subject|0|||
27758540|NCT02492763|54210538|FG001|Overall Study|Withdrawal by Subject|2|||
27758541|NCT02492763|54210539|FG002|Overall Study|Withdrawal by Subject|1|||
27758542|NCT02492763|54210540|FG003|Overall Study|Withdrawal by Subject|0|||
27758543|NCT02492763|54210537|FG000|Overall Study|Adverse Event|3|||
27758544|NCT02492763|54210538|FG001|Overall Study|Adverse Event|1|||
27758545|NCT02492763|54210539|FG002|Overall Study|Adverse Event|1|||
27758546|NCT02492763|54210540|FG003|Overall Study|Adverse Event|2|||
27758547|NCT02492763|54210537|FG000|Overall Study|Death|0|||
27758548|NCT02492763|54210538|FG001|Overall Study|Death|0|||
27758549|NCT02492763|54210539|FG002|Overall Study|Death|1|||
27758550|NCT02492763|54210540|FG003|Overall Study|Death|0|||
27758551|NCT02492763|54210537|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
27758552|NCT02492763|54210538|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|1|||
27758553|NCT02492763|54210539|FG002|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
27758554|NCT02492763|54210540|FG003|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
27758555|NCT02492763|54210537|FG000|Overall Study|Lost to Follow-up|0|||
27758556|NCT02492763|54210538|FG001|Overall Study|Lost to Follow-up|0|||
27758557|NCT02492763|54210539|FG002|Overall Study|Lost to Follow-up|1|||
27758558|NCT02492763|54210540|FG003|Overall Study|Lost to Follow-up|0|||
27758559|NCT02492763|54210537|FG000|Overall Study|Non-Compliance With Study Drug|0|||
27758560|NCT02492763|54210538|FG001|Overall Study|Non-Compliance With Study Drug|1|||
27758561|NCT02492763|54210539|FG002|Overall Study|Non-Compliance With Study Drug|0|||
27758562|NCT02492763|54210540|FG003|Overall Study|Non-Compliance With Study Drug|0|||
27758563|NCT02492763|54210537|FG000|Overall Study|Screen Failure|0|||
27758564|NCT02492763|54210538|FG001|Overall Study|Screen Failure|0|||
27758565|NCT02492763|54210539|FG002|Overall Study|Screen Failure|0|||
27758566|NCT02492763|54210540|FG003|Overall Study|Screen Failure|1|||
27758567|NCT02492763|54210537|FG000|Overall Study|Study Terminated by Sponsor|13|||
27758568|NCT02492763|54210538|FG001|Overall Study|Study Terminated by Sponsor|10|||
27758569|NCT02492763|54210539|FG002|Overall Study|Study Terminated by Sponsor|6|||
27758570|NCT02492763|54210540|FG003|Overall Study|Study Terminated by Sponsor|10|||
27758571|NCT02491671|54210552|FG000|Overall Study|Adverse Event|6|||
27758572|NCT02491671|54210553|FG001|Overall Study|Adverse Event|8|||
27758573|NCT02491671|54210552|FG000|Overall Study|Death|0|||
27758574|NCT02491671|54210553|FG001|Overall Study|Death|2|||
27758575|NCT02491671|54210552|FG000|Overall Study|Use of sealants other than Hemopatch|5|||
27758576|NCT02491671|54210553|FG001|Overall Study|Use of sealants other than Hemopatch|3|||
27758577|NCT02453841|54210559|FG000|Overall Study|Protocol Violation|1|||
27758578|NCT02453841|54210559|FG000|Overall Study|Unable to obtain blood samples|2|||
27758579|NCT02453685|54210565|FG000|Overall Study|Adverse Event|0|||
27758580|NCT02453685|54210566|FG001|Overall Study|Adverse Event|1|||
27758581|NCT02453685|54210565|FG000|Overall Study|Protocol Violation|7|||
27758582|NCT02453685|54210566|FG001|Overall Study|Protocol Violation|4|||
27758583|NCT02453685|54210565|FG000|Overall Study|Lost to Follow-up|0|||
27758584|NCT02453685|54210566|FG001|Overall Study|Lost to Follow-up|1|||
27758585|NCT02453685|54210565|FG000|Overall Study|Withdrawal by Subject|8|||
27758586|NCT02453685|54210566|FG001|Overall Study|Withdrawal by Subject|4|||
27758587|NCT02453685|54210565|FG000|Overall Study|Unclassified|4|||
27758588|NCT02453685|54210566|FG001|Overall Study|Unclassified|2|||
27758589|NCT02436759|54210574|FG000|Overall Study|Adverse Event|3|||
27758590|NCT02436759|54210575|FG001|Overall Study|Adverse Event|0|||
27758591|NCT02436759|54210574|FG000|Overall Study|Protocol Violation|1|||
27758592|NCT02436759|54210575|FG001|Overall Study|Protocol Violation|0|||
27758593|NCT02436759|54210574|FG000|Overall Study|Withdrawal by Subject|0|||
27758594|NCT02436759|54210575|FG001|Overall Study|Withdrawal by Subject|1|||
27758595|NCT02436681|54210581|FG000|Overall Study|Lost to Follow-up|10|||
27758596|NCT02436681|54210581|FG000|Overall Study|Withdrawal by Subject|2|||
27758597|NCT02436681|54210581|FG000|Overall Study|Death|2|||
27758598|NCT02436135|54210587|FG000|Overall Study|Progressive Disease|3|||
27758599|NCT02436135|54210588|FG001|Overall Study|Progressive Disease|1|||
27758600|NCT02436135|54210587|FG000|Overall Study|Investigator Discretion|1|||
27758601|NCT02436135|54210588|FG001|Overall Study|Investigator Discretion|2|||
27758602|NCT02436135|54210587|FG000|Overall Study|Adverse Event|1|||
27758603|NCT02436135|54210588|FG001|Overall Study|Adverse Event|0|||
27758604|NCT02436135|54210587|FG000|Overall Study|Withdrawal by Participant|1|||
27758605|NCT02436135|54210588|FG001|Overall Study|Withdrawal by Participant|0|||
27758606|NCT02436135|54210587|FG000|Overall Study|Study Terminated By Sponsor|0|||
27758607|NCT02436135|54210588|FG001|Overall Study|Study Terminated By Sponsor|1|||
27758608|NCT02489799|54210596|FG000|Overall Study|Lost to Follow-up|4|||
27758609|NCT02489799|54210597|FG001|Overall Study|Lost to Follow-up|1|||
27758610|NCT02489799|54210596|FG000|Overall Study|Failure to Maintain Eligibility|4|||
27758611|NCT02489799|54210597|FG001|Overall Study|Failure to Maintain Eligibility|6|||
27758612|NCT02489799|54210596|FG000|Overall Study|Withdrawal by Subject|1|||
27758613|NCT02489799|54210597|FG001|Overall Study|Withdrawal by Subject|1|||
27758614|NCT02489799|54210596|FG000|Overall Study|Death|0|||
27758615|NCT02489799|54210597|FG001|Overall Study|Death|1|||
27758616|NCT02435277|54210607|FG000|Overall Study|Adverse Event|1|||
27758617|NCT02435277|54210608|FG001|Overall Study|Adverse Event|1|||
27758618|NCT02435277|54210609|FG002|Overall Study|Adverse Event|0|||
27758619|NCT02435277|54210610|FG003|Overall Study|Adverse Event|0|||
27758620|NCT02435277|54210607|FG000|Overall Study|Withdrawal by Subject|1|||
27758621|NCT02435277|54210608|FG001|Overall Study|Withdrawal by Subject|0|||
27758622|NCT02435277|54210609|FG002|Overall Study|Withdrawal by Subject|0|||
27758623|NCT02435277|54210610|FG003|Overall Study|Withdrawal by Subject|0|||
27758624|NCT02420223|54210622|FG000|Overall Study|Adverse Event|1|||
27758625|NCT02420223|54210623|FG001|Overall Study|Adverse Event|0|||
27758626|NCT02420223|54210622|FG000|Overall Study|Physician Decision|0|||
27758627|NCT02420223|54210623|FG001|Overall Study|Physician Decision|2|||
27758628|NCT02433483|54210629|FG000|Overall Study|Unacceptable toxicity|1|||
27926933|NCT01217229|54583415|FG000|Overall Study|Protocol Violation|1|||
27758629|NCT02433483|54210629|FG000|Overall Study|Other antineoplastic therapy/HSCT|1|||
27758630|NCT02419755|54210635|FG000|Overall Study|Death|1|||
27758631|NCT02419755|54210636|FG001|Overall Study|Death|3|||
27758632|NCT02419755|54210635|FG000|Overall Study|Relapse|0|||
27758633|NCT02419755|54210636|FG001|Overall Study|Relapse|1|||
27758634|NCT02419755|54210635|FG000|Overall Study|Ineligible|1|||
27758635|NCT02419755|54210636|FG001|Overall Study|Ineligible|0|||
27758636|NCT02419755|54210635|FG000|Overall Study|Withdrawal by Subject|1|||
27758637|NCT02419755|54210636|FG001|Overall Study|Withdrawal by Subject|0|||
27758638|NCT02488551|54210646|FG000|Overall Study|Lost to Follow-up|4|||
27758639|NCT02488551|54210647|FG001|Overall Study|Lost to Follow-up|7|||
27758640|NCT02488551|54210648|FG002|Overall Study|Lost to Follow-up|0|||
27758641|NCT02488551|54210649|FG003|Overall Study|Lost to Follow-up|0|||
27758642|NCT02488551|54210646|FG000|Overall Study|Military Deployment|1|||
27758643|NCT02488551|54210647|FG001|Overall Study|Military Deployment|1|||
27758644|NCT02488551|54210648|FG002|Overall Study|Military Deployment|0|||
27758645|NCT02488551|54210649|FG003|Overall Study|Military Deployment|0|||
27758646|NCT02488239|54210659|FG000|Overall Study|Death|3|||
27758647|NCT02488239|54210659|FG000|Overall Study|Withdrawal by Subject|3|||
27758648|NCT02488239|54210659|FG000|Overall Study|Physician Decision|2|||
27758649|NCT02488239|54210659|FG000|Overall Study|Consent ineligible|1|||
27758650|NCT02488239|54210659|FG000|Overall Study|Did not undergo implant procedure|1|||
27758651|NCT02488005|54210664|FG000|Overall Study|Lost to Follow-up|2|||
27758652|NCT02487771|54210670|FG000|Overall Study|Lost to Follow-up|2|||
27758653|NCT02487771|54210671|FG001|Overall Study|Lost to Follow-up|3|||
27758654|NCT02487771|54210670|FG000|Overall Study|Moved out of area|5|||
27758655|NCT02487771|54210671|FG001|Overall Study|Moved out of area|6|||
27758656|NCT02487771|54210670|FG000|Overall Study|Withdrawal by Subject|3|||
27758657|NCT02487771|54210671|FG001|Overall Study|Withdrawal by Subject|5|||
27758658|NCT01359943|54210680|FG000|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1|||
27758659|NCT01359943|54210681|FG001|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
27758660|NCT01359943|54210682|FG002|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
27758661|NCT01359943|54210680|FG000|Double-blind (Weeks 0 - 16)|Adverse Event|1|||
27758662|NCT01359943|54210681|FG001|Double-blind (Weeks 0 - 16)|Adverse Event|2|||
27758663|NCT01359943|54210682|FG002|Double-blind (Weeks 0 - 16)|Adverse Event|0|||
27758664|NCT01359943|54210680|FG000|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
27758665|NCT01359943|54210681|FG001|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2|||
27758666|NCT01359943|54210682|FG002|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
27758667|NCT01359943|54210680|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1|||
27758668|NCT01359943|54210681|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
27758669|NCT01359943|54210682|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
27758670|NCT01359943|54210680|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1|||
27758671|NCT01359943|54210681|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3|||
27758672|NCT01359943|54210682|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4|||
27758673|NCT01359943|54210680|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
27758674|NCT01359943|54210681|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1|||
27758675|NCT01359943|54210682|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
27758676|NCT01359943|54210680|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
27758677|NCT01359943|54210681|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
27758678|NCT01359943|54210682|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
27758679|NCT01359943|54210680|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
27758680|NCT01359943|54210681|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1|||
27758681|NCT01359943|54210682|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
27758682|NCT01359943|54210680|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3|||
27758683|NCT01359943|54210681|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5|||
27758684|NCT01359943|54210682|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1|||
27758685|NCT01359943|54210680|FG000|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1|||
27758686|NCT01359943|54210681|FG001|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5|||
27758687|NCT01359943|54210682|FG002|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4|||
27758688|NCT01359943|54210680|FG000|Follow-up (Weeks 52 - 60)|Administrative problems|1|||
27758689|NCT01359943|54210681|FG001|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
27758690|NCT01359943|54210682|FG002|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
27758691|NCT01359943|54210680|FG000|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
27758692|NCT01359943|54210681|FG001|Follow-up (Weeks 52 - 60)|Protocol deviation|1|||
27758693|NCT01359943|54210682|FG002|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
27839469|NCT01470989|54326771|FG001|Overall Study|Administrative problems|4|||
27839470|NCT01470989|54326770|FG000|Overall Study|Death|2|||
27758694|NCT01359943|54210680|FG000|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
27758695|NCT01359943|54210681|FG001|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
27758696|NCT01359943|54210682|FG002|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
27758697|NCT01359943|54210680|FG000|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
27758698|NCT01359943|54210681|FG001|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1|||
27758699|NCT01359943|54210682|FG002|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
27758700|NCT01359943|54210680|FG000|Follow-up (Weeks 52 - 60)|Adverse Event|3|||
27758701|NCT01359943|54210681|FG001|Follow-up (Weeks 52 - 60)|Adverse Event|5|||
27758702|NCT01359943|54210682|FG002|Follow-up (Weeks 52 - 60)|Adverse Event|1|||
27758703|NCT02432703|54210694|FG000|Overall Study|Adverse Event|1|||
27758704|NCT02432703|54210695|FG001|Overall Study|Adverse Event|4|||
27758705|NCT02432703|54210694|FG000|Overall Study|Lack of Efficacy|1|||
27758706|NCT02432703|54210695|FG001|Overall Study|Lack of Efficacy|0|||
27758707|NCT02432703|54210694|FG000|Overall Study|Lost to Follow-up|5|||
27758708|NCT02432703|54210695|FG001|Overall Study|Lost to Follow-up|3|||
27758709|NCT02432703|54210694|FG000|Overall Study|Withdrawal by Subject|9|||
27758710|NCT02432703|54210695|FG001|Overall Study|Withdrawal by Subject|6|||
27758711|NCT02432703|54210694|FG000|Overall Study|Other|6|||
27758712|NCT02432703|54210695|FG001|Overall Study|Other|5|||
27758713|NCT02486757|54210701|FG000|Overall Study|Lost to Follow-up|1|||
27758714|NCT02418819|54210709|FG000|Overall Study|Adverse Event|0|||
27758715|NCT02418819|54210710|FG001|Overall Study|Adverse Event|0|||
27758716|NCT02418819|54210711|FG002|Overall Study|Adverse Event|1|||
27758717|NCT02418819|54210712|FG003|Overall Study|Adverse Event|0|||
27758718|NCT02418819|54210709|FG000|Overall Study|Lost to Follow-up|1|||
27758719|NCT02418819|54210710|FG001|Overall Study|Lost to Follow-up|0|||
27758720|NCT02418819|54210711|FG002|Overall Study|Lost to Follow-up|0|||
27758721|NCT02418819|54210712|FG003|Overall Study|Lost to Follow-up|0|||
27758722|NCT02418819|54210709|FG000|Overall Study|No longer meets eligibility criteria|0|||
27758723|NCT02418819|54210710|FG001|Overall Study|No longer meets eligibility criteria|0|||
27758724|NCT02418819|54210711|FG002|Overall Study|No longer meets eligibility criteria|1|||
27758725|NCT02418819|54210712|FG003|Overall Study|No longer meets eligibility criteria|0|||
27758726|NCT02418819|54210709|FG000|Overall Study|No longer willing to participate|0|||
27758727|NCT02418819|54210710|FG001|Overall Study|No longer willing to participate|0|||
27758728|NCT02418819|54210711|FG002|Overall Study|No longer willing to participate|2|||
27758729|NCT02418819|54210712|FG003|Overall Study|No longer willing to participate|1|||
27758730|NCT02576639|54210727|FG000|Overall Study|Withdrawal by Subject|1|||
27758731|NCT02576639|54210728|FG001|Overall Study|Withdrawal by Subject|2|||
27758732|NCT02576639|54210729|FG002|Overall Study|Withdrawal by Subject|1|||
27758733|NCT02576639|54210730|FG003|Overall Study|Withdrawal by Subject|0|||
27758734|NCT02576639|54210731|FG004|Overall Study|Withdrawal by Subject|1|||
27758735|NCT02576639|54210727|FG000|Overall Study|Adverse Event|1|||
27758736|NCT02576639|54210728|FG001|Overall Study|Adverse Event|0|||
27758737|NCT02576639|54210729|FG002|Overall Study|Adverse Event|1|||
27758738|NCT02576639|54210730|FG003|Overall Study|Adverse Event|1|||
27758739|NCT02576639|54210731|FG004|Overall Study|Adverse Event|2|||
27758740|NCT02576639|54210727|FG000|Overall Study|Physician Decision|0|||
27758741|NCT02576639|54210728|FG001|Overall Study|Physician Decision|0|||
27758742|NCT02576639|54210729|FG002|Overall Study|Physician Decision|0|||
27758743|NCT02576639|54210730|FG003|Overall Study|Physician Decision|0|||
27758744|NCT02576639|54210731|FG004|Overall Study|Physician Decision|1|||
27758745|NCT02418585|54210749|FG000|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
27758746|NCT02418585|54210750|FG001|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
27758747|NCT02418585|54210749|FG000|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
27758748|NCT02418585|54210750|FG001|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
27758749|NCT02418585|54210749|FG000|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4|||
27758750|NCT02418585|54210750|FG001|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7|||
27758751|NCT02418585|54210749|FG000|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2|||
27758752|NCT02418585|54210750|FG001|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0|||
27758753|NCT02418585|54210749|FG000|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9|||
27758754|NCT02418585|54210750|FG001|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1|||
27758755|NCT02418585|54210749|FG000|Double Blind (DB) Phase (4 Weeks)|Other|0|||
27758756|NCT02418585|54210750|FG001|Double Blind (DB) Phase (4 Weeks)|Other|1|||
27758757|NCT02418585|54210749|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
27758758|NCT02418585|54210750|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
27758759|NCT02418585|54210749|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6|||
27758760|NCT02418585|54210750|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
27758761|NCT02418585|54210749|FG000|Follow-up Phase (24 Weeks)|Investigator Decision|6|||
27758762|NCT02418585|54210750|FG001|Follow-up Phase (24 Weeks)|Investigator Decision|17|||
27758763|NCT02418585|54210749|FG000|Follow-up Phase (24 Weeks)|Other|3|||
27758764|NCT02418585|54210750|FG001|Follow-up Phase (24 Weeks)|Other|2|||
27758765|NCT02417961|54210758|FG000|Overall Study|Adverse Event|1|||
27758766|NCT02417961|54210758|FG000|Overall Study|Lost to Follow-up|1|||
27758767|NCT02417961|54210758|FG000|Overall Study|Withdrawal by Subject|2|||
27758768|NCT01596127|54210762|FG000|Overall Study|Patient Ineligible|1|||
27758769|NCT01595581|54210768|FG000|Overall Study|Withdrawal by Subject|1|||
27758770|NCT01595581|54210769|FG001|Overall Study|Withdrawal by Subject|0|||
27758771|NCT01610687|54210777|FG000|Overall Study|Lack of Efficacy|26|||
27758772|NCT01610687|54210777|FG000|Overall Study|Adverse Event|18|||
27758773|NCT01610687|54210777|FG000|Overall Study|Moved out of area|6|||
27758774|NCT01610687|54210777|FG000|Overall Study|Withdrawal by Subject|7|||
27758775|NCT01610687|54210777|FG000|Overall Study|Lost to Follow-up|4|||
27758776|NCT01610687|54210777|FG000|Overall Study|Symptom control without study medication|2|||
27758777|NCT01610687|54210777|FG000|Overall Study|Unable to make journey|1|||
27758778|NCT01610687|54210777|FG000|Overall Study|Death|1|||
27758779|NCT01610687|54210777|FG000|Overall Study|Cannabis affecting job|1|||
27758780|NCT01610687|54210777|FG000|Overall Study|Felt more alter without study medication|1|||
27758781|NCT02615509|54210781|FG000|Overall Study|Lost to Follow-up|134|||
27758782|NCT02615509|54210781|FG000|Overall Study|Death|4|||
27758783|NCT02615509|54210781|FG000|Overall Study|Withdrawal by Subject|8|||
27758784|NCT02575079|54210787|FG000|Overall Study|Death|3|||
27758785|NCT02575079|54210788|FG001|Overall Study|Death|0|||
27758786|NCT02575079|54210787|FG000|Overall Study|Withdrawal by Subject|3|||
27758787|NCT02575079|54210788|FG001|Overall Study|Withdrawal by Subject|0|||
27758788|NCT02574845|54210799|FG000|Overall Study|Consent withdrawn further participation|0|||
27758789|NCT02574845|54210800|FG001|Overall Study|Consent withdrawn further participation|0|||
27758790|NCT02574845|54210801|FG002|Overall Study|Consent withdrawn further participation|0|||
27758791|NCT02574845|54210802|FG003|Overall Study|Consent withdrawn further participation|0|||
27758792|NCT02574845|54210803|FG004|Overall Study|Consent withdrawn further participation|1|||
27758793|NCT02574845|54210804|FG005|Overall Study|Consent withdrawn further participation|0|||
27758794|NCT02574845|54210799|FG000|Overall Study|Adverse Event|0|||
27758795|NCT02574845|54210800|FG001|Overall Study|Adverse Event|1|||
27758796|NCT02574845|54210801|FG002|Overall Study|Adverse Event|0|||
27758797|NCT02574845|54210802|FG003|Overall Study|Adverse Event|0|||
27758798|NCT02574845|54210803|FG004|Overall Study|Adverse Event|0|||
27758799|NCT02574845|54210804|FG005|Overall Study|Adverse Event|1|||
27758800|NCT02614183|54210821|FG000|Double Blind Treatment Phase|Adverse Event|10|||
27758801|NCT02614183|54210822|FG001|Double Blind Treatment Phase|Adverse Event|9|||
27758802|NCT02614183|54210823|FG002|Double Blind Treatment Phase|Adverse Event|7|||
27758803|NCT02614183|54210821|FG000|Double Blind Treatment Phase|Lack of Efficacy|10|||
27758804|NCT02614183|54210822|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
27758805|NCT02614183|54210823|FG002|Double Blind Treatment Phase|Lack of Efficacy|2|||
27758806|NCT02614183|54210821|FG000|Double Blind Treatment Phase|Lost to Follow-up|18|||
27758807|NCT02614183|54210822|FG001|Double Blind Treatment Phase|Lost to Follow-up|9|||
27758808|NCT02614183|54210823|FG002|Double Blind Treatment Phase|Lost to Follow-up|5|||
27758809|NCT02614183|54210821|FG000|Double Blind Treatment Phase|Physician Decision|7|||
27758810|NCT02614183|54210822|FG001|Double Blind Treatment Phase|Physician Decision|3|||
27758811|NCT02614183|54210823|FG002|Double Blind Treatment Phase|Physician Decision|2|||
27758812|NCT02614183|54210821|FG000|Double Blind Treatment Phase|Pregnancy|2|||
27758813|NCT02614183|54210822|FG001|Double Blind Treatment Phase|Pregnancy|1|||
27758814|NCT02614183|54210823|FG002|Double Blind Treatment Phase|Pregnancy|3|||
27758815|NCT02614183|54210821|FG000|Double Blind Treatment Phase|Protocol Violation|2|||
27758816|NCT02614183|54210822|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
27758817|NCT02614183|54210823|FG002|Double Blind Treatment Phase|Protocol Violation|2|||
27758818|NCT02614183|54210821|FG000|Double Blind Treatment Phase|Withdrawal by Subject|33|||
27758819|NCT02614183|54210822|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
27758820|NCT02614183|54210823|FG002|Double Blind Treatment Phase|Withdrawal by Subject|16|||
27758821|NCT02614183|54210821|FG000|Double Blind Treatment Phase|Did not receive study drug|1|||
27758822|NCT02614183|54210822|FG001|Double Blind Treatment Phase|Did not receive study drug|1|||
27758823|NCT02614183|54210823|FG002|Double Blind Treatment Phase|Did not receive study drug|2|||
27758824|NCT02614183|54210821|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
27758825|NCT02614183|54210822|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
27758826|NCT02614183|54210823|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
27758827|NCT02614183|54210821|FG000|Post Treatment Follow-up Phase|Physician Decision|5|||
27758828|NCT02614183|54210822|FG001|Post Treatment Follow-up Phase|Physician Decision|1|||
27758829|NCT02614183|54210823|FG002|Post Treatment Follow-up Phase|Physician Decision|2|||
27758830|NCT02614183|54210821|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
27758831|NCT02614183|54210822|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
27758832|NCT02614183|54210823|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
27758833|NCT02614183|54210821|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|7|||
27758834|NCT02614183|54210822|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|2|||
27758835|NCT02614183|54210823|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
27758836|NCT02612155|54210848|FG000|Overall Study|Death|1|||
27758837|NCT02612155|54210849|FG001|Overall Study|Death|1|||
27758838|NCT02612155|54210848|FG000|Overall Study|Lost to Follow-up|2|||
27758839|NCT02612155|54210849|FG001|Overall Study|Lost to Follow-up|2|||
27758840|NCT02614729|54210857|FG000|Overall Study|Withdrawal by Subject|1|||
27758841|NCT02614729|54210858|FG001|Overall Study|Withdrawal by Subject|0|||
27758842|NCT02613871|54210866|FG000|Overall Study|Death|2|||
27758843|NCT02613871|54210866|FG000|Overall Study|Withdrew Consent|1|||
27758844|NCT05021081|54210872|FG000|Phase 2|Subject enrolled in error|1|||
27758845|NCT05021081|54210873|FG001|Phase 2|Subject enrolled in error|1|||
27758846|NCT05021081|54210874|FG002|Phase 2|Subject enrolled in error|0|||
27758847|NCT02612077|54210890|FG000|Overall Study|Adverse Event|3|||
27758848|NCT02612077|54210890|FG000|Overall Study|Withdrawal by Subject|9|||
27758849|NCT02612077|54210890|FG000|Overall Study|Protocol Violation|28|||
27758850|NCT02612077|54210890|FG000|Overall Study|Lost to Follow-up|20|||
27758851|NCT02612077|54210890|FG000|Overall Study|Death|377|||
27758852|NCT02612077|54210890|FG000|Overall Study|Moved or Changed Medical Team|23|||
27758853|NCT02612077|54210890|FG000|Overall Study|Enrollment in a Clinical Trial|1|||
27758854|NCT02612077|54210890|FG000|Overall Study|Disease Progression|3|||
27758855|NCT02612077|54210890|FG000|Overall Study|Unknown reason|2|||
27758856|NCT02613481|54210897|FG000|Overall Study|Lost to Follow-up|7|||
27758857|NCT02613481|54210897|FG000|Overall Study|Withdrawal by Subject|2|||
27758858|NCT02613403|54210905|FG000|Overall Study|Lost to Follow-up|0|||
27758859|NCT02613403|54210906|FG001|Overall Study|Lost to Follow-up|1|||
27758860|NCT02613403|54210907|FG002|Overall Study|Lost to Follow-up|0|||
27758861|NCT02613403|54210908|FG003|Overall Study|Lost to Follow-up|0|||
27758862|NCT02613403|54210909|FG004|Overall Study|Lost to Follow-up|0|||
27758863|NCT02613403|54210905|FG000|Overall Study|Withdrawal by Subject|2|||
27758864|NCT02613403|54210906|FG001|Overall Study|Withdrawal by Subject|0|||
27758865|NCT02613403|54210907|FG002|Overall Study|Withdrawal by Subject|0|||
27758866|NCT02613403|54210908|FG003|Overall Study|Withdrawal by Subject|0|||
27758867|NCT02613403|54210909|FG004|Overall Study|Withdrawal by Subject|0|||
27758868|NCT02572817|54210921|FG000|Overall Study|Death|6|||
27758869|NCT02572817|54210922|FG001|Overall Study|Death|3|||
27758870|NCT02572817|54210921|FG000|Overall Study|Lost to Follow-up|3|||
27758871|NCT02572817|54210922|FG001|Overall Study|Lost to Follow-up|3|||
27758872|NCT02566109|54210928|FG000|Overall Study|Withdrawal by Subject|1|||
27758873|NCT02566031|54210934|FG000|Overall Study|Patient/guardian decision|14|||
27758874|NCT02566031|54210935|FG001|Overall Study|Patient/guardian decision|7|||
27758875|NCT02566031|54210934|FG000|Overall Study|Protocol deviation|2|||
27758876|NCT02566031|54210935|FG001|Overall Study|Protocol deviation|3|||
27758877|NCT02566031|54210934|FG000|Overall Study|Adverse Event|3|||
27758878|NCT02566031|54210935|FG001|Overall Study|Adverse Event|1|||
27758879|NCT02566031|54210934|FG000|Overall Study|Lost to Follow-up|1|||
27758880|NCT02566031|54210935|FG001|Overall Study|Lost to Follow-up|1|||
27758881|NCT02569853|54210944|FG000|Overall Study|Adverse Event|2|||
27758882|NCT02569853|54210945|FG001|Overall Study|Adverse Event|0|||
27758883|NCT02569853|54210944|FG000|Overall Study|Withdrawal by Subject|3|||
27758884|NCT02569853|54210945|FG001|Overall Study|Withdrawal by Subject|2|||
27839471|NCT01470989|54326771|FG001|Overall Study|Death|2|||
27839472|NCT01470989|54326770|FG000|Overall Study|Protocol deviation|1|||
27839473|NCT01470989|54326771|FG001|Overall Study|Protocol deviation|2|||
27839474|NCT01470599|54326781|FG000|Overall Study|Did not meet entrance criteria|1|||
27839475|NCT01470599|54326782|FG001|Overall Study|Did not meet entrance criteria|0|||
27839476|NCT01470599|54326781|FG000|Overall Study|Lost to Follow-up|2|||
27839477|NCT01470599|54326782|FG001|Overall Study|Lost to Follow-up|1|||
27839478|NCT01470599|54326781|FG000|Overall Study|Withdrawal by Subject|3|||
27839479|NCT01470599|54326782|FG001|Overall Study|Withdrawal by Subject|4|||
27839480|NCT01470599|54326781|FG000|Overall Study|Other|1|||
27839481|NCT01470599|54326782|FG001|Overall Study|Other|0|||
27839482|NCT01470599|54326781|FG000|Overall Study|Protocol Violation|3|||
27758885|NCT02569853|54210944|FG000|Overall Study|Lost to Follow-up|3|||
27758886|NCT02569853|54210945|FG001|Overall Study|Lost to Follow-up|3|||
27758887|NCT02569853|54210944|FG000|Overall Study|Protocol Violation|1|||
27758888|NCT02569853|54210945|FG001|Overall Study|Protocol Violation|1|||
27758889|NCT02569853|54210944|FG000|Overall Study|Did not experience migraine attack|10|||
27758890|NCT02569853|54210945|FG001|Overall Study|Did not experience migraine attack|7|||
27758891|NCT02569853|54210944|FG000|Overall Study|Physician Decision|1|||
27758892|NCT02569853|54210945|FG001|Overall Study|Physician Decision|1|||
27758893|NCT02570711|54210955|FG000|Overall Study|Death|1|||
27758894|NCT02570711|54210956|FG001|Overall Study|Death|0|||
27758895|NCT02570711|54210955|FG000|Overall Study|Early Termination of Study by Sponsor|0|||
27758896|NCT02570711|54210956|FG001|Overall Study|Early Termination of Study by Sponsor|2|||
27758897|NCT02570165|54210969|FG000|Overall Study|Adverse Event|1|||
27839483|NCT01470599|54326782|FG001|Overall Study|Protocol Violation|1|||
27839484|NCT01470599|54326781|FG000|Overall Study|Adverse event related to study drug|2|||
27839485|NCT01470599|54326782|FG001|Overall Study|Adverse event related to study drug|5|||
27839486|NCT01470599|54326781|FG000|Overall Study|Insufficient clinical response|6|||
27839487|NCT01470599|54326782|FG001|Overall Study|Insufficient clinical response|27|||
27839488|NCT01470599|54326781|FG000|Overall Study|Adverse event not related to study drug|1|||
27839489|NCT01470599|54326782|FG001|Overall Study|Adverse event not related to study drug|5|||
27758898|NCT02570165|54210970|FG001|Overall Study|Adverse Event|0|||
27758899|NCT02570165|54210971|FG002|Overall Study|Adverse Event|2|||
27758900|NCT02570165|54210972|FG003|Overall Study|Adverse Event|0|||
27758901|NCT02570165|54210973|FG004|Overall Study|Adverse Event|0|||
27758902|NCT02570165|54210974|FG005|Overall Study|Adverse Event|0|||
27758903|NCT02570165|54210975|FG006|Overall Study|Adverse Event|0|||
27758904|NCT02570165|54210969|FG000|Overall Study|Lack of Efficacy|0|||
27758905|NCT02570165|54210970|FG001|Overall Study|Lack of Efficacy|1|||
27758906|NCT02570165|54210971|FG002|Overall Study|Lack of Efficacy|0|||
27758907|NCT02570165|54210972|FG003|Overall Study|Lack of Efficacy|0|||
27758908|NCT02570165|54210973|FG004|Overall Study|Lack of Efficacy|4|||
27758909|NCT02570165|54210974|FG005|Overall Study|Lack of Efficacy|0|||
27758910|NCT02570165|54210975|FG006|Overall Study|Lack of Efficacy|0|||
27758911|NCT02570165|54210969|FG000|Overall Study|Par. Reached Stopping Criteria|1|||
27758912|NCT02570165|54210970|FG001|Overall Study|Par. Reached Stopping Criteria|1|||
27758913|NCT02570165|54210971|FG002|Overall Study|Par. Reached Stopping Criteria|0|||
27758914|NCT02570165|54210972|FG003|Overall Study|Par. Reached Stopping Criteria|2|||
27758915|NCT02570165|54210973|FG004|Overall Study|Par. Reached Stopping Criteria|1|||
27758916|NCT02570165|54210974|FG005|Overall Study|Par. Reached Stopping Criteria|1|||
27758917|NCT02570165|54210975|FG006|Overall Study|Par. Reached Stopping Criteria|0|||
27758918|NCT02570165|54210969|FG000|Overall Study|Lost to Follow-up|0|||
27758919|NCT02570165|54210970|FG001|Overall Study|Lost to Follow-up|0|||
27758920|NCT02570165|54210971|FG002|Overall Study|Lost to Follow-up|1|||
27758921|NCT02570165|54210972|FG003|Overall Study|Lost to Follow-up|1|||
27758922|NCT02570165|54210973|FG004|Overall Study|Lost to Follow-up|0|||
27758923|NCT02570165|54210974|FG005|Overall Study|Lost to Follow-up|0|||
27758924|NCT02570165|54210975|FG006|Overall Study|Lost to Follow-up|0|||
27758925|NCT02570165|54210969|FG000|Overall Study|Physician Decision|0|||
27758926|NCT02570165|54210970|FG001|Overall Study|Physician Decision|1|||
27758927|NCT02570165|54210971|FG002|Overall Study|Physician Decision|0|||
27758928|NCT02570165|54210972|FG003|Overall Study|Physician Decision|0|||
27758929|NCT02570165|54210973|FG004|Overall Study|Physician Decision|0|||
27758930|NCT02570165|54210974|FG005|Overall Study|Physician Decision|0|||
27839490|NCT01469819|54326788|FG000|Overall Study|Withdrawal by Subject|1|||
27839491|NCT01469819|54326788|FG000|Overall Study|Did not meet inclusionary criteria|2|||
27839492|NCT01469819|54326788|FG000|Overall Study|Could not swallow SmartPill|2|||
27839493|NCT01469819|54326788|FG000|Overall Study|Technical malfunction of SmartPill data|3|||
27839494|NCT01507831|54326800|FG000|Overall Study|Randomized but not treated|0|||
27839495|NCT01507831|54326801|FG001|Overall Study|Randomized but not treated|3|||
27839496|NCT01507831|54326800|FG000|Overall Study|Adverse Event|48|||
27758931|NCT02570165|54210975|FG006|Overall Study|Physician Decision|0|||
27758932|NCT02570165|54210969|FG000|Overall Study|Withdrawal by Subject|0|||
27758933|NCT02570165|54210970|FG001|Overall Study|Withdrawal by Subject|0|||
27758934|NCT02570165|54210971|FG002|Overall Study|Withdrawal by Subject|0|||
27839497|NCT01507831|54326801|FG001|Overall Study|Adverse Event|113|||
27839498|NCT01507831|54326800|FG000|Overall Study|Death|6|||
27839499|NCT01507831|54326801|FG001|Overall Study|Death|2|||
27839500|NCT01507831|54326800|FG000|Overall Study|Poor compliance to protocol|38|||
27758935|NCT02570165|54210972|FG003|Overall Study|Withdrawal by Subject|2|||
27758936|NCT02570165|54210973|FG004|Overall Study|Withdrawal by Subject|1|||
27758937|NCT02570165|54210974|FG005|Overall Study|Withdrawal by Subject|0|||
27758938|NCT02570165|54210975|FG006|Overall Study|Withdrawal by Subject|0|||
27758939|NCT02570165|54210969|FG000|Overall Study|Par. did not Meet Continuation Criteria|0|||
27758940|NCT02570165|54210970|FG001|Overall Study|Par. did not Meet Continuation Criteria|0|||
27839501|NCT01507831|54326801|FG001|Overall Study|Poor compliance to protocol|60|||
27839502|NCT01507831|54326800|FG000|Overall Study|Physician Decision|0|||
27758941|NCT02570165|54210971|FG002|Overall Study|Par. did not Meet Continuation Criteria|0|||
27758942|NCT02570165|54210972|FG003|Overall Study|Par. did not Meet Continuation Criteria|0|||
27758943|NCT02570165|54210973|FG004|Overall Study|Par. did not Meet Continuation Criteria|0|||
27758944|NCT02570165|54210974|FG005|Overall Study|Par. did not Meet Continuation Criteria|1|||
27758945|NCT02570165|54210975|FG006|Overall Study|Par. did not Meet Continuation Criteria|0|||
27758946|NCT02570165|54210969|FG000|Overall Study|Withdrawal Request by GSK|0|||
27758947|NCT02570165|54210970|FG001|Overall Study|Withdrawal Request by GSK|0|||
27758948|NCT02570165|54210971|FG002|Overall Study|Withdrawal Request by GSK|2|||
27758949|NCT02570165|54210972|FG003|Overall Study|Withdrawal Request by GSK|0|||
27758950|NCT02570165|54210973|FG004|Overall Study|Withdrawal Request by GSK|0|||
27758951|NCT02570165|54210974|FG005|Overall Study|Withdrawal Request by GSK|0|||
27758952|NCT02570165|54210975|FG006|Overall Study|Withdrawal Request by GSK|0|||
27758953|NCT02564471|54210995|FG000|Overall Study|Adverse Event|1|||
27758954|NCT02564471|54210996|FG001|Overall Study|Adverse Event|0|||
27758955|NCT02564471|54210997|FG002|Overall Study|Adverse Event|0|||
27758956|NCT02564471|54210998|FG003|Overall Study|Adverse Event|0|||
27758957|NCT02564471|54210995|FG000|Overall Study|Withdrawal by Subject|2|||
27758958|NCT02564471|54210996|FG001|Overall Study|Withdrawal by Subject|1|||
27758959|NCT02564471|54210997|FG002|Overall Study|Withdrawal by Subject|3|||
27758960|NCT02564471|54210998|FG003|Overall Study|Withdrawal by Subject|0|||
27758961|NCT02564471|54210995|FG000|Overall Study|Lost to Follow-up|0|||
27758962|NCT02564471|54210996|FG001|Overall Study|Lost to Follow-up|2|||
27758963|NCT02564471|54210997|FG002|Overall Study|Lost to Follow-up|0|||
27758964|NCT02564471|54210998|FG003|Overall Study|Lost to Follow-up|0|||
27758965|NCT02563067|54211011|FG000|Overall Study|Subject/guardian decision|14|||
27758966|NCT02563067|54211012|FG001|Overall Study|Subject/guardian decision|20|||
27758967|NCT02563067|54211013|FG002|Overall Study|Subject/guardian decision|16|||
27758968|NCT02563067|54211011|FG000|Overall Study|Physician Decision|0|||
27758969|NCT02563067|54211012|FG001|Overall Study|Physician Decision|1|||
27758970|NCT02563067|54211013|FG002|Overall Study|Physician Decision|3|||
27758971|NCT02563067|54211011|FG000|Overall Study|Lost to Follow-up|1|||
27758972|NCT02563067|54211012|FG001|Overall Study|Lost to Follow-up|2|||
27758973|NCT02563067|54211013|FG002|Overall Study|Lost to Follow-up|0|||
27758974|NCT02563067|54211011|FG000|Overall Study|Technical problems|0|||
27758975|NCT02563067|54211012|FG001|Overall Study|Technical problems|1|||
27758976|NCT02563067|54211013|FG002|Overall Study|Technical problems|0|||
27758977|NCT02563067|54211011|FG000|Overall Study|Lack of Efficacy|1|||
27758978|NCT02563067|54211012|FG001|Overall Study|Lack of Efficacy|0|||
27758979|NCT02563067|54211013|FG002|Overall Study|Lack of Efficacy|0|||
27758980|NCT02563067|54211011|FG000|Overall Study|Death|0|||
27758981|NCT02563067|54211012|FG001|Overall Study|Death|1|||
27758982|NCT02563067|54211013|FG002|Overall Study|Death|1|||
27758983|NCT02563067|54211011|FG000|Overall Study|Adverse Event|2|||
27758984|NCT02563067|54211012|FG001|Overall Study|Adverse Event|1|||
27758985|NCT02563067|54211013|FG002|Overall Study|Adverse Event|0|||
27758986|NCT02563067|54211011|FG000|Overall Study|Death post Treatment/safety period|1|||
27758987|NCT02563067|54211012|FG001|Overall Study|Death post Treatment/safety period|0|||
27758988|NCT02563067|54211013|FG002|Overall Study|Death post Treatment/safety period|0|||
27758989|NCT02568683|54211023|FG000|Overall Study|Death|0|||
27758990|NCT02568683|54211024|FG001|Overall Study|Death|2|||
27758991|NCT02568683|54211023|FG000|Overall Study|Withdrew Consent|1|||
27758992|NCT02568683|54211024|FG001|Overall Study|Withdrew Consent|0|||
27758993|NCT02568683|54211023|FG000|Overall Study|Study Terminated By Sponsor|5|||
27758994|NCT02568683|54211024|FG001|Overall Study|Study Terminated By Sponsor|2|||
27758995|NCT02563925|54211030|FG000|Overall Study|Withdrawal by Subject|2|||
27758996|NCT01663727|54211037|FG000|Overall Study|Death|161|||
27758997|NCT01663727|54211038|FG001|Overall Study|Death|155|||
27758998|NCT01663727|54211037|FG000|Overall Study|Lost to Follow-up|10|||
27758999|NCT01663727|54211038|FG001|Overall Study|Lost to Follow-up|8|||
27759000|NCT01663727|54211037|FG000|Overall Study|Withdrawal by Subject|18|||
27759001|NCT01663727|54211038|FG001|Overall Study|Withdrawal by Subject|25|||
27759002|NCT01663727|54211037|FG000|Overall Study|Study Terminated|51|||
27759003|NCT01663727|54211038|FG001|Overall Study|Study Terminated|50|||
27759004|NCT01663727|54211037|FG000|Overall Study|Withdrawal by subject and Adverse Event.|1|||
27759005|NCT01663727|54211038|FG001|Overall Study|Withdrawal by subject and Adverse Event.|0|||
27759006|NCT01663727|54211037|FG000|Overall Study|Withdrawal prior to dosing.|1|||
27759007|NCT01663727|54211038|FG001|Overall Study|Withdrawal prior to dosing.|0|||
27759008|NCT02614261|54211047|FG000|Double-Blind Treatment Phase|Adverse Event|7|||
27759009|NCT02614261|54211048|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
27759010|NCT02614261|54211049|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
27759011|NCT02614261|54211050|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
27759012|NCT02614261|54211047|FG000|Double-Blind Treatment Phase|Lack of Efficacy|4|||
27759013|NCT02614261|54211048|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
27759014|NCT02614261|54211049|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
27759015|NCT02614261|54211050|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
27759016|NCT02614261|54211047|FG000|Double-Blind Treatment Phase|Lost to Follow-up|9|||
27759017|NCT02614261|54211048|FG001|Double-Blind Treatment Phase|Lost to Follow-up|4|||
27839503|NCT01507831|54326801|FG001|Overall Study|Physician Decision|4|||
27759018|NCT02614261|54211049|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
27759019|NCT02614261|54211050|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
27759020|NCT02614261|54211047|FG000|Double-Blind Treatment Phase|Physician Decision|2|||
27759021|NCT02614261|54211048|FG001|Double-Blind Treatment Phase|Physician Decision|1|||
27759022|NCT02614261|54211049|FG002|Double-Blind Treatment Phase|Physician Decision|1|||
27759023|NCT02614261|54211050|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
27759024|NCT02614261|54211047|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
27759025|NCT02614261|54211048|FG001|Double-Blind Treatment Phase|Pregnancy|2|||
27759026|NCT02614261|54211049|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
27759027|NCT02614261|54211050|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
27759028|NCT02614261|54211047|FG000|Double-Blind Treatment Phase|Protocol Violation|6|||
27839504|NCT01507831|54326800|FG000|Overall Study|Participant moved|5|||
27759029|NCT02614261|54211048|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
27759030|NCT02614261|54211049|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
27759031|NCT02614261|54211050|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
27759032|NCT02614261|54211047|FG000|Double-Blind Treatment Phase|Screen failure|0|||
27759033|NCT02614261|54211048|FG001|Double-Blind Treatment Phase|Screen failure|1|||
27759034|NCT02614261|54211049|FG002|Double-Blind Treatment Phase|Screen failure|2|||
27759035|NCT02614261|54211050|FG003|Double-Blind Treatment Phase|Screen failure|0|||
27759036|NCT02614261|54211047|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|20|||
27759037|NCT02614261|54211048|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
27759038|NCT02614261|54211049|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|7|||
27759039|NCT02614261|54211050|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
27759040|NCT02614261|54211047|FG000|Open-Label Extension Phase|Adverse Event|23|||
27759041|NCT02614261|54211048|FG001|Open-Label Extension Phase|Adverse Event|12|||
27759042|NCT02614261|54211049|FG002|Open-Label Extension Phase|Adverse Event|11|||
27759043|NCT02614261|54211050|FG003|Open-Label Extension Phase|Adverse Event|0|||
27759044|NCT02614261|54211047|FG000|Open-Label Extension Phase|Lack of Efficacy|14|||
27759045|NCT02614261|54211048|FG001|Open-Label Extension Phase|Lack of Efficacy|12|||
27759046|NCT02614261|54211049|FG002|Open-Label Extension Phase|Lack of Efficacy|14|||
27759047|NCT02614261|54211050|FG003|Open-Label Extension Phase|Lack of Efficacy|0|||
27759048|NCT02614261|54211047|FG000|Open-Label Extension Phase|Lost to Follow-up|15|||
27759049|NCT02614261|54211048|FG001|Open-Label Extension Phase|Lost to Follow-up|7|||
27759050|NCT02614261|54211049|FG002|Open-Label Extension Phase|Lost to Follow-up|9|||
27759051|NCT02614261|54211050|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
27759052|NCT02614261|54211047|FG000|Open-Label Extension Phase|Physician Decision|2|||
27759053|NCT02614261|54211048|FG001|Open-Label Extension Phase|Physician Decision|0|||
27759054|NCT02614261|54211049|FG002|Open-Label Extension Phase|Physician Decision|0|||
27759055|NCT02614261|54211050|FG003|Open-Label Extension Phase|Physician Decision|0|||
27759056|NCT02614261|54211047|FG000|Open-Label Extension Phase|Pregnancy|1|||
27759057|NCT02614261|54211048|FG001|Open-Label Extension Phase|Pregnancy|2|||
27759058|NCT02614261|54211049|FG002|Open-Label Extension Phase|Pregnancy|1|||
27759059|NCT02614261|54211050|FG003|Open-Label Extension Phase|Pregnancy|0|||
27759060|NCT02614261|54211047|FG000|Open-Label Extension Phase|Protocol Violation|3|||
27759061|NCT02614261|54211048|FG001|Open-Label Extension Phase|Protocol Violation|4|||
27759062|NCT02614261|54211049|FG002|Open-Label Extension Phase|Protocol Violation|1|||
27759063|NCT02614261|54211050|FG003|Open-Label Extension Phase|Protocol Violation|0|||
27759064|NCT02614261|54211047|FG000|Open-Label Extension Phase|Withdrawal by Subject|30|||
27759065|NCT02614261|54211048|FG001|Open-Label Extension Phase|Withdrawal by Subject|18|||
27759066|NCT02614261|54211049|FG002|Open-Label Extension Phase|Withdrawal by Subject|18|||
27759067|NCT02614261|54211050|FG003|Open-Label Extension Phase|Withdrawal by Subject|0|||
27759068|NCT02614261|54211047|FG000|Follow-up Phase|Adverse Event|2|||
27759069|NCT02614261|54211048|FG001|Follow-up Phase|Adverse Event|0|||
27759070|NCT02614261|54211049|FG002|Follow-up Phase|Adverse Event|1|||
27759071|NCT02614261|54211050|FG003|Follow-up Phase|Adverse Event|0|||
27759072|NCT02614261|54211047|FG000|Follow-up Phase|Lost to Follow-up|12|||
27759073|NCT02614261|54211048|FG001|Follow-up Phase|Lost to Follow-up|5|||
27759074|NCT02614261|54211049|FG002|Follow-up Phase|Lost to Follow-up|2|||
27759075|NCT02614261|54211050|FG003|Follow-up Phase|Lost to Follow-up|0|||
27759076|NCT02614261|54211047|FG000|Follow-up Phase|Physician Decision|5|||
27759077|NCT02614261|54211048|FG001|Follow-up Phase|Physician Decision|1|||
27759078|NCT02614261|54211049|FG002|Follow-up Phase|Physician Decision|0|||
27759079|NCT02614261|54211050|FG003|Follow-up Phase|Physician Decision|0|||
27759080|NCT02614261|54211047|FG000|Follow-up Phase|Pregnancy|0|||
27759081|NCT02614261|54211048|FG001|Follow-up Phase|Pregnancy|1|||
27759082|NCT02614261|54211049|FG002|Follow-up Phase|Pregnancy|0|||
27759083|NCT02614261|54211050|FG003|Follow-up Phase|Pregnancy|0|||
27839505|NCT01507831|54326801|FG001|Overall Study|Participant moved|19|||
27759084|NCT02614261|54211047|FG000|Follow-up Phase|Protocol Violation|1|||
27759085|NCT02614261|54211048|FG001|Follow-up Phase|Protocol Violation|0|||
27759086|NCT02614261|54211049|FG002|Follow-up Phase|Protocol Violation|0|||
27839506|NCT01507831|54326800|FG000|Overall Study|Consent withdrawn by participant|34|||
27759087|NCT02614261|54211050|FG003|Follow-up Phase|Protocol Violation|0|||
27759088|NCT02614261|54211047|FG000|Follow-up Phase|Withdrawal by Subject|12|||
27759089|NCT02614261|54211048|FG001|Follow-up Phase|Withdrawal by Subject|4|||
27759090|NCT02614261|54211049|FG002|Follow-up Phase|Withdrawal by Subject|11|||
27759091|NCT02614261|54211050|FG003|Follow-up Phase|Withdrawal by Subject|0|||
27759092|NCT02614261|54211047|FG000|Israel Addendum|Withdrawal by Subject|0|||
27759093|NCT02614261|54211048|FG001|Israel Addendum|Withdrawal by Subject|0|||
27759094|NCT02614261|54211049|FG002|Israel Addendum|Withdrawal by Subject|0|||
27759095|NCT02614261|54211050|FG003|Israel Addendum|Withdrawal by Subject|4|||
27759096|NCT01594411|54211076|FG000|Overall Study|Lost to Follow-up|2|||
27759097|NCT01594333|54211085|FG000|Overall Study|Death|96|||
27759098|NCT01594333|54211086|FG001|Overall Study|Death|83|||
27759099|NCT01594333|54211085|FG000|Overall Study|Lost to Follow-up|5|||
27759100|NCT01594333|54211086|FG001|Overall Study|Lost to Follow-up|5|||
27759101|NCT01594333|54211085|FG000|Overall Study|Withdrawal by Subject|60|||
27759102|NCT01594333|54211086|FG001|Overall Study|Withdrawal by Subject|63|||
27759103|NCT02609659|54211092|FG000|Overall Study|Adverse Event|1|||
27759104|NCT02609659|54211092|FG000|Overall Study|Lost to Follow-up|6|||
27759105|NCT02609659|54211092|FG000|Overall Study|Other|1|||
27759106|NCT02612779|54211098|FG000|Overall Study|Administrative reason by sponsor|4|||
27759107|NCT02612779|54211099|FG001|Overall Study|Administrative reason by sponsor|1|||
27759108|NCT02612779|54211098|FG000|Overall Study|No longer meet study criteria|0|||
27759109|NCT02612779|54211099|FG001|Overall Study|No longer meet study criteria|1|||
27759110|NCT02612779|54211098|FG000|Overall Study|Disease progression|29|||
27759111|NCT02612779|54211099|FG001|Overall Study|Disease progression|2|||
27759112|NCT02612779|54211098|FG000|Overall Study|Study drug toxicity|10|||
27759113|NCT02612779|54211099|FG001|Overall Study|Study drug toxicity|1|||
27759114|NCT02612779|54211098|FG000|Overall Study|Death|1|||
27759115|NCT02612779|54211099|FG001|Overall Study|Death|0|||
27759116|NCT02612779|54211098|FG000|Overall Study|Adverse event unrelated to study drug|5|||
27759117|NCT02612779|54211099|FG001|Overall Study|Adverse event unrelated to study drug|0|||
27759118|NCT02612779|54211098|FG000|Overall Study|Participant withdrew consent|4|||
27759119|NCT02612779|54211099|FG001|Overall Study|Participant withdrew consent|0|||
27759120|NCT02612779|54211098|FG000|Overall Study|Lost to Follow-up|1|||
27759121|NCT02612779|54211099|FG001|Overall Study|Lost to Follow-up|0|||
27759122|NCT02612779|54211098|FG000|Overall Study|Maximum clinical benefit|10|||
27759123|NCT02612779|54211099|FG001|Overall Study|Maximum clinical benefit|1|||
27759124|NCT02612779|54211098|FG000|Overall Study|Other reasons|4|||
27759125|NCT02612779|54211099|FG001|Overall Study|Other reasons|0|||
27759126|NCT02612623|54211110|FG000|Overall Study|Withdrawal by Subject|0|||
27759127|NCT02612623|54211111|FG001|Overall Study|Withdrawal by Subject|1|||
27759128|NCT02612623|54211112|FG002|Overall Study|Withdrawal by Subject|0|||
27759129|NCT02612623|54211113|FG003|Overall Study|Withdrawal by Subject|0|||
27759130|NCT02612623|54211110|FG000|Overall Study|Adverse Event|1|||
27759131|NCT02612623|54211111|FG001|Overall Study|Adverse Event|0|||
27759132|NCT02612623|54211112|FG002|Overall Study|Adverse Event|1|||
27759133|NCT02612623|54211113|FG003|Overall Study|Adverse Event|0|||
27759134|NCT02607865|54211127|FG000|Overall Study|Lost to Follow-up|9|||
27759135|NCT02607865|54211128|FG001|Overall Study|Lost to Follow-up|7|||
27759136|NCT02607865|54211129|FG002|Overall Study|Lost to Follow-up|7|||
27759137|NCT02607865|54211130|FG003|Overall Study|Lost to Follow-up|5|||
27759138|NCT02607865|54211127|FG000|Overall Study|Withdrawal by Subject|18|||
27759139|NCT02607865|54211128|FG001|Overall Study|Withdrawal by Subject|18|||
27759140|NCT02607865|54211129|FG002|Overall Study|Withdrawal by Subject|17|||
27759141|NCT02607865|54211130|FG003|Overall Study|Withdrawal by Subject|8|||
27759142|NCT02607865|54211127|FG000|Overall Study|Death|5|||
27759143|NCT02607865|54211128|FG001|Overall Study|Death|4|||
27759144|NCT02607865|54211129|FG002|Overall Study|Death|1|||
27759145|NCT02607865|54211130|FG003|Overall Study|Death|3|||
27759146|NCT02607865|54211127|FG000|Overall Study|Unclassified|1|||
27759147|NCT02607865|54211128|FG001|Overall Study|Unclassified|1|||
27759148|NCT02607865|54211129|FG002|Overall Study|Unclassified|2|||
27759149|NCT02607865|54211130|FG003|Overall Study|Unclassified|0|||
27759150|NCT01668667|54211144|FG000|Overall Study|Adverse Event|3|||
27759151|NCT01668667|54211145|FG001|Overall Study|Adverse Event|6|||
27759152|NCT01668667|54211146|FG002|Overall Study|Adverse Event|4|||
27759153|NCT01668667|54211147|FG003|Overall Study|Adverse Event|4|||
27839507|NCT01507831|54326801|FG001|Overall Study|Consent withdrawn by participant|72|||
27759154|NCT01668667|54211144|FG000|Overall Study|Lack of Efficacy|3|||
27759155|NCT01668667|54211145|FG001|Overall Study|Lack of Efficacy|2|||
27759156|NCT01668667|54211146|FG002|Overall Study|Lack of Efficacy|2|||
27759157|NCT01668667|54211147|FG003|Overall Study|Lack of Efficacy|3|||
27759158|NCT01668667|54211144|FG000|Overall Study|Protocol Violation|6|||
27759159|NCT01668667|54211145|FG001|Overall Study|Protocol Violation|10|||
27759160|NCT01668667|54211146|FG002|Overall Study|Protocol Violation|12|||
27759161|NCT01668667|54211147|FG003|Overall Study|Protocol Violation|5|||
27759162|NCT01668667|54211144|FG000|Overall Study|Lost to Follow-up|9|||
27759163|NCT01668667|54211145|FG001|Overall Study|Lost to Follow-up|4|||
27759164|NCT01668667|54211146|FG002|Overall Study|Lost to Follow-up|7|||
27759165|NCT01668667|54211147|FG003|Overall Study|Lost to Follow-up|6|||
27759166|NCT01668667|54211144|FG000|Overall Study|Physician Decision|3|||
27759167|NCT01668667|54211145|FG001|Overall Study|Physician Decision|0|||
27759168|NCT01668667|54211146|FG002|Overall Study|Physician Decision|1|||
27759169|NCT01668667|54211147|FG003|Overall Study|Physician Decision|0|||
27759170|NCT01668667|54211144|FG000|Overall Study|Withdrawal by Subject|7|||
27759171|NCT01668667|54211145|FG001|Overall Study|Withdrawal by Subject|4|||
27759172|NCT01668667|54211146|FG002|Overall Study|Withdrawal by Subject|5|||
27759173|NCT01668667|54211147|FG003|Overall Study|Withdrawal by Subject|5|||
27759174|NCT02608879|54211160|FG000|Overall Study|Lost to Follow-up|1|||
27759175|NCT02608879|54211161|FG001|Overall Study|Lost to Follow-up|0|||
27759176|NCT02608879|54211162|FG002|Overall Study|Lost to Follow-up|0|||
27759177|NCT02608879|54211160|FG000|Overall Study|Did not meet continuation criteria|0|||
27759178|NCT02608879|54211161|FG001|Overall Study|Did not meet continuation criteria|0|||
27759179|NCT02608879|54211162|FG002|Overall Study|Did not meet continuation criteria|3|||
27759180|NCT02608099|54211172|FG000|Overall Study|Ablation procedure not initiated|3|||
27759181|NCT02608099|54211173|FG001|Overall Study|Ablation procedure not initiated|2|||
27759182|NCT01668589|54211183|FG000|Overall Study|Lost to Follow-up|29|||
27759183|NCT01668589|54211184|FG001|Overall Study|Lost to Follow-up|37|||
27759184|NCT01668589|54211185|FG002|Overall Study|Lost to Follow-up|15|||
27759185|NCT01668589|54211186|FG003|Overall Study|Lost to Follow-up|5|||
27759186|NCT01668589|54211183|FG000|Overall Study|Full Consent/Agreement Withdrawn|54|||
27759187|NCT01668589|54211184|FG001|Overall Study|Full Consent/Agreement Withdrawn|8|||
27759188|NCT01668589|54211185|FG002|Overall Study|Full Consent/Agreement Withdrawn|11|||
27759189|NCT01668589|54211186|FG003|Overall Study|Full Consent/Agreement Withdrawn|4|||
27759190|NCT01668589|54211183|FG000|Overall Study|Death|12|||
27759191|NCT01668589|54211184|FG001|Overall Study|Death|3|||
27759192|NCT01668589|54211185|FG002|Overall Study|Death|2|||
27759193|NCT01668589|54211186|FG003|Overall Study|Death|11|||
27759194|NCT01668589|54211183|FG000|Overall Study|Other|44|||
27759195|NCT01668589|54211184|FG001|Overall Study|Other|10|||
27759196|NCT01668589|54211185|FG002|Overall Study|Other|7|||
27759197|NCT01668589|54211186|FG003|Overall Study|Other|15|||
27759198|NCT02432235|54211208|FG000|Overall Study|Death|1|||
27759199|NCT02432235|54211209|FG001|Overall Study|Death|1|||
27759200|NCT02432235|54211210|FG002|Overall Study|Death|2|||
27759201|NCT02432235|54211211|FG003|Overall Study|Death|2|||
27759202|NCT02432235|54211212|FG004|Overall Study|Death|1|||
27759203|NCT02432235|54211213|FG005|Overall Study|Death|3|||
27759204|NCT02432235|54211214|FG006|Overall Study|Death|11|||
27759205|NCT02432235|54211215|FG007|Overall Study|Death|15|||
27759206|NCT02432235|54211216|FG008|Overall Study|Death|15|||
27759207|NCT02432235|54211217|FG009|Overall Study|Death|3|||
27759208|NCT02432235|54211218|FG010|Overall Study|Death|1|||
27759209|NCT02432235|54211219|FG011|Overall Study|Death|0|||
27759210|NCT02432235|54211208|FG000|Overall Study|Withdrawal by Subject|0|||
27759211|NCT02432235|54211209|FG001|Overall Study|Withdrawal by Subject|1|||
27759212|NCT02432235|54211210|FG002|Overall Study|Withdrawal by Subject|0|||
27759213|NCT02432235|54211211|FG003|Overall Study|Withdrawal by Subject|0|||
27759214|NCT02432235|54211212|FG004|Overall Study|Withdrawal by Subject|0|||
27759215|NCT02432235|54211213|FG005|Overall Study|Withdrawal by Subject|2|||
27759216|NCT02432235|54211214|FG006|Overall Study|Withdrawal by Subject|5|||
27759217|NCT02432235|54211215|FG007|Overall Study|Withdrawal by Subject|3|||
27759218|NCT02432235|54211216|FG008|Overall Study|Withdrawal by Subject|1|||
27759219|NCT02432235|54211217|FG009|Overall Study|Withdrawal by Subject|0|||
27759220|NCT02432235|54211218|FG010|Overall Study|Withdrawal by Subject|0|||
27759221|NCT02432235|54211219|FG011|Overall Study|Withdrawal by Subject|0|||
27759222|NCT02432235|54211208|FG000|Overall Study|Lost to Follow-up|0|||
27759223|NCT02432235|54211209|FG001|Overall Study|Lost to Follow-up|0|||
27759224|NCT02432235|54211210|FG002|Overall Study|Lost to Follow-up|0|||
27759225|NCT02432235|54211211|FG003|Overall Study|Lost to Follow-up|0|||
27759226|NCT02432235|54211212|FG004|Overall Study|Lost to Follow-up|0|||
27759227|NCT02432235|54211213|FG005|Overall Study|Lost to Follow-up|1|||
27759228|NCT02432235|54211214|FG006|Overall Study|Lost to Follow-up|0|||
27759229|NCT02432235|54211215|FG007|Overall Study|Lost to Follow-up|0|||
27759230|NCT02432235|54211216|FG008|Overall Study|Lost to Follow-up|1|||
27759231|NCT02432235|54211217|FG009|Overall Study|Lost to Follow-up|0|||
27759232|NCT02432235|54211218|FG010|Overall Study|Lost to Follow-up|0|||
27759233|NCT02432235|54211219|FG011|Overall Study|Lost to Follow-up|0|||
27759234|NCT02432235|54211208|FG000|Overall Study|Miscellaneous|0|||
27759235|NCT02432235|54211209|FG001|Overall Study|Miscellaneous|0|||
27759236|NCT02432235|54211210|FG002|Overall Study|Miscellaneous|0|||
27759237|NCT02432235|54211211|FG003|Overall Study|Miscellaneous|0|||
27759238|NCT02432235|54211212|FG004|Overall Study|Miscellaneous|1|||
27759239|NCT02432235|54211213|FG005|Overall Study|Miscellaneous|6|||
27759240|NCT02432235|54211214|FG006|Overall Study|Miscellaneous|2|||
27759241|NCT02432235|54211215|FG007|Overall Study|Miscellaneous|2|||
27759242|NCT02432235|54211216|FG008|Overall Study|Miscellaneous|4|||
27759243|NCT02432235|54211217|FG009|Overall Study|Miscellaneous|0|||
27759244|NCT02432235|54211218|FG010|Overall Study|Miscellaneous|0|||
27759245|NCT02432235|54211219|FG011|Overall Study|Miscellaneous|1|||
27759246|NCT02431533|54211249|FG000|Overall Study|Withdrawal by Subject|1|||
27759247|NCT02431533|54211250|FG001|Overall Study|Withdrawal by Subject|3|||
27759248|NCT02431533|54211249|FG000|Overall Study|Developed Exclusionary criteria|1|||
27759249|NCT02431533|54211250|FG001|Overall Study|Developed Exclusionary criteria|0|||
27759250|NCT02416791|54211259|FG000|6 Months|Lost to Follow-up|0|||
27759251|NCT02416791|54211260|FG001|6 Months|Lost to Follow-up|0|||
27759252|NCT02416791|54211261|FG002|6 Months|Lost to Follow-up|1|||
27759253|NCT02414841|54211271|FG000|Overall Study|Withdrawal by Subject|7|||
27759254|NCT02414841|54211272|FG001|Overall Study|Withdrawal by Subject|5|||
27759255|NCT02414841|54211271|FG000|Overall Study|Lost to Follow-up|13|||
27759256|NCT02414841|54211272|FG001|Overall Study|Lost to Follow-up|6|||
27759257|NCT02414841|54211271|FG000|Overall Study|Death|17|||
27759258|NCT02414841|54211272|FG001|Overall Study|Death|14|||
27759259|NCT02414841|54211271|FG000|Overall Study|Received a Kidney Transplant|13|||
27759260|NCT02414841|54211272|FG001|Overall Study|Received a Kidney Transplant|4|||
27759261|NCT02414841|54211271|FG000|Overall Study|Randomized But Not Treated|6|||
27759262|NCT02414841|54211272|FG001|Overall Study|Randomized But Not Treated|4|||
27759263|NCT02413593|54211280|FG000|Overall Study|Lost to Follow-up|3|||
27759264|NCT02413593|54211280|FG000|Overall Study|Adverse Event|1|||
27759265|NCT01652703|54211290|FG000|Overall Study|Withdrawal by Subject|0|||
27759266|NCT01652703|54211291|FG001|Overall Study|Withdrawal by Subject|1|||
27759267|NCT01652703|54211292|FG002|Overall Study|Withdrawal by Subject|3|||
27759268|NCT01652703|54211293|FG003|Overall Study|Withdrawal by Subject|1|||
27759269|NCT01652703|54211294|FG004|Overall Study|Withdrawal by Subject|0|||
27759270|NCT01652703|54211295|FG005|Overall Study|Withdrawal by Subject|1|||
27759271|NCT01652703|54211290|FG000|Overall Study|Other|0|||
27759272|NCT01652703|54211291|FG001|Overall Study|Other|0|||
27759273|NCT01652703|54211292|FG002|Overall Study|Other|0|||
27759274|NCT01652703|54211293|FG003|Overall Study|Other|1|||
27759275|NCT01652703|54211294|FG004|Overall Study|Other|1|||
27759276|NCT01652703|54211295|FG005|Overall Study|Other|1|||
27759277|NCT01652469|54211311|FG000|Overall Study|Withdrawal by Subject|1|||
27759278|NCT01652469|54211312|FG001|Overall Study|Withdrawal by Subject|4|||
27759279|NCT01652469|54211311|FG000|Overall Study|Lost to Follow-up|0|||
27759280|NCT01652469|54211312|FG001|Overall Study|Lost to Follow-up|2|||
27759281|NCT02429427|54211320|FG000|Overall Study|Adverse Event|220|||
27759282|NCT02429427|54211321|FG001|Overall Study|Adverse Event|92|||
27759283|NCT02429427|54211320|FG000|Overall Study|Protocol Violation|10|||
27759284|NCT02429427|54211321|FG001|Overall Study|Protocol Violation|6|||
27759285|NCT02429427|54211320|FG000|Overall Study|Lost to Follow-up|15|||
27759286|NCT02429427|54211321|FG001|Overall Study|Lost to Follow-up|6|||
27759287|NCT02429427|54211320|FG000|Overall Study|Withdrawal by Subject|64|||
27759288|NCT02429427|54211321|FG001|Overall Study|Withdrawal by Subject|34|||
27759289|NCT02429427|54211320|FG000|Overall Study|Other|62|||
27759290|NCT02429427|54211321|FG001|Overall Study|Other|41|||
27759291|NCT02412735|54211330|FG000|Overall Study|Adverse Event|0|||
27759292|NCT02412735|54211331|FG001|Overall Study|Adverse Event|1|||
27759293|NCT02412735|54211332|FG002|Overall Study|Adverse Event|2|||
27759294|NCT02412735|54211330|FG000|Overall Study|Withdrawal by Subject|23|||
27759295|NCT02412735|54211331|FG001|Overall Study|Withdrawal by Subject|27|||
27759296|NCT02412735|54211332|FG002|Overall Study|Withdrawal by Subject|22|||
27759297|NCT02412735|54211330|FG000|Overall Study|Investigator Decision|3|||
27759298|NCT02412735|54211331|FG001|Overall Study|Investigator Decision|3|||
27759299|NCT02412735|54211332|FG002|Overall Study|Investigator Decision|2|||
27759300|NCT02412735|54211330|FG000|Overall Study|Lost to Follow-up|17|||
27759301|NCT02412735|54211331|FG001|Overall Study|Lost to Follow-up|11|||
27759302|NCT02412735|54211332|FG002|Overall Study|Lost to Follow-up|18|||
27759303|NCT02412735|54211330|FG000|Overall Study|Reason not Specified|3|||
27759304|NCT02412735|54211331|FG001|Overall Study|Reason not Specified|2|||
27759305|NCT02412735|54211332|FG002|Overall Study|Reason not Specified|2|||
27759306|NCT02412657|54211343|FG000|Overall Study|Lost to Follow-up|1|||
27759307|NCT02412657|54211344|FG001|Overall Study|Lost to Follow-up|0|||
27759308|NCT02412657|54211345|FG002|Overall Study|Lost to Follow-up|0|||
27759309|NCT02412657|54211343|FG000|Overall Study|Protocol Violation|0|||
27759310|NCT02412657|54211344|FG001|Overall Study|Protocol Violation|2|||
27759311|NCT02412657|54211345|FG002|Overall Study|Protocol Violation|3|||
27759312|NCT02428413|54211355|FG000|Overall Study|Device to measure WAG malfunctioned|3|||
27759313|NCT02428413|54211356|FG001|Overall Study|Device to measure WAG malfunctioned|5|||
27759314|NCT02428413|54211355|FG000|Overall Study|Protocol Violation|1|||
27759315|NCT02428413|54211356|FG001|Overall Study|Protocol Violation|2|||
27839508|NCT01507831|54326800|FG000|Overall Study|Related to study drug administration|5|||
27839509|NCT01507831|54326801|FG001|Overall Study|Related to study drug administration|14|||
27759316|NCT02428413|54211355|FG000|Overall Study|Case Cancelled|2|||
27759317|NCT02428413|54211356|FG001|Overall Study|Case Cancelled|0|||
27759318|NCT02428413|54211355|FG000|Overall Study|Missed Cases|1|||
27759319|NCT02428413|54211356|FG001|Overall Study|Missed Cases|2|||
27759320|NCT02428413|54211355|FG000|Overall Study|Nurse Refusal|1|||
27759321|NCT02428413|54211356|FG001|Overall Study|Nurse Refusal|0|||
27839510|NCT01507831|54326800|FG000|Overall Study|Last visit outside protocol visit window|51|||
27759322|NCT02412111|54211364|FG000|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1|||
27759323|NCT02412111|54211365|FG001|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
27759324|NCT02412111|54211366|FG002|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
27759325|NCT02412111|54211364|FG000|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2|||
27759326|NCT02412111|54211365|FG001|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
27759327|NCT02412111|54211366|FG002|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
27759328|NCT02412111|54211364|FG000|Active Comparator Period (8 Weeks)|Adverse Event|0|||
27759329|NCT02412111|54211365|FG001|Active Comparator Period (8 Weeks)|Adverse Event|0|||
27759330|NCT02412111|54211366|FG002|Active Comparator Period (8 Weeks)|Adverse Event|2|||
27759331|NCT02412111|54211364|FG000|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
27759332|NCT02412111|54211365|FG001|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
27759333|NCT02412111|54211366|FG002|Active Comparator Period (8 Weeks)|Participants refused further dosing|1|||
27759334|NCT02412111|54211364|FG000|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
27759335|NCT02412111|54211365|FG001|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
27759336|NCT02412111|54211366|FG002|Active Comparator Period (8 Weeks)|Lost to Follow-up|1|||
27759337|NCT02412111|54211364|FG000|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
27759338|NCT02412111|54211365|FG001|Active Comparator Period (8 Weeks)|Other non-compliance|1|||
27759339|NCT02412111|54211366|FG002|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
27759340|NCT02412111|54211364|FG000|Active Comparator Period (8 Weeks)|Other|0|||
27759341|NCT02412111|54211365|FG001|Active Comparator Period (8 Weeks)|Other|0|||
27759342|NCT02412111|54211366|FG002|Active Comparator Period (8 Weeks)|Other|2|||
27759343|NCT02427477|54211378|FG000|Period 1|Adverse Event|1|||
27759344|NCT02427477|54211379|FG001|Period 1|Adverse Event|0|||
27759345|NCT02427399|54211390|FG000|Overall Study|Protocol Violation|14|||
27759346|NCT02427399|54211391|FG001|Overall Study|Protocol Violation|16|||
27759347|NCT02427399|54211392|FG002|Overall Study|Protocol Violation|12|||
27759348|NCT02427399|54211393|FG003|Overall Study|Protocol Violation|18|||
27759349|NCT02427399|54211394|FG004|Overall Study|Protocol Violation|15|||
27759350|NCT02426541|54211408|FG000|Overall Study|Protocol Violation|1|||
27759351|NCT02426541|54211409|FG001|Overall Study|Protocol Violation|0|||
27759352|NCT02484651|54211417|FG000|Overall Study|Patients' data files were corrupted.|1|||
27759353|NCT02484651|54211418|FG001|Overall Study|Patients' data files were corrupted.|1|||
27759354|NCT02484651|54211417|FG000|Overall Study|BIS monitoring failed.|1|||
27759355|NCT02484651|54211418|FG001|Overall Study|BIS monitoring failed.|1|||
27759356|NCT02484651|54211417|FG000|Overall Study|Time of the procedure less than 90 min.|1|||
27759357|NCT02484651|54211418|FG001|Overall Study|Time of the procedure less than 90 min.|2|||
27759358|NCT02410551|54211425|FG000|Overall Study|Adverse Event|1|||
27759359|NCT02410551|54211425|FG000|Overall Study|Withdrawal by Subject|1|||
27759360|NCT02410551|54211425|FG000|Overall Study|FDA Clinical hold-patients taken off|2|||
27759361|NCT02424591|54211432|FG000|Overall Study|Protocol Violation|2|||
27759362|NCT02424591|54211433|FG001|Overall Study|Protocol Violation|3|||
27759363|NCT02408523|54211441|FG000|Overall Study|Adverse Event|4|||
27759364|NCT02408523|54211442|FG001|Overall Study|Adverse Event|10|||
27759365|NCT02408523|54211441|FG000|Overall Study|Lack of Efficacy|0|||
27759366|NCT02408523|54211442|FG001|Overall Study|Lack of Efficacy|1|||
27759367|NCT02408523|54211441|FG000|Overall Study|Protocol Violation|1|||
27759368|NCT02408523|54211442|FG001|Overall Study|Protocol Violation|2|||
27759369|NCT02408523|54211441|FG000|Overall Study|Lost to Follow-up|2|||
27759370|NCT02408523|54211442|FG001|Overall Study|Lost to Follow-up|3|||
27759371|NCT02408523|54211441|FG000|Overall Study|Withdrawal by Subject|3|||
27759372|NCT02408523|54211442|FG001|Overall Study|Withdrawal by Subject|1|||
27759373|NCT02408523|54211441|FG000|Overall Study|Sponsor request|1|||
27759374|NCT02408523|54211442|FG001|Overall Study|Sponsor request|0|||
27759375|NCT02408523|54211441|FG000|Overall Study|Did not satisfy extension conditions|0|||
27759376|NCT02408523|54211442|FG001|Overall Study|Did not satisfy extension conditions|1|||
27759377|NCT02603419|54211462|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
27759378|NCT02603419|54211463|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Death|1|||
27759379|NCT02603419|54211464|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
27759380|NCT02603419|54211465|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
27759381|NCT02603419|54211466|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
27759382|NCT02603419|54211467|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
27759383|NCT02603419|54211462|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
27759384|NCT02603419|54211463|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
27759385|NCT02603419|54211464|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
27759386|NCT02603419|54211465|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
27759387|NCT02603419|54211466|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3|||
27759388|NCT02603419|54211467|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0|||
27759389|NCT02603419|54211462|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2|||
27759390|NCT02603419|54211463|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
27759391|NCT02603419|54211464|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3|||
27759392|NCT02603419|54211465|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
27759393|NCT02603419|54211466|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1|||
27759394|NCT02603419|54211467|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
27759395|NCT02603419|54211462|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
27759396|NCT02603419|54211463|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
27839511|NCT01507831|54326801|FG001|Overall Study|Last visit outside protocol visit window|143|||
27839512|NCT01507831|54326800|FG000|Overall Study|Selection criteria finally not met|0|||
27759397|NCT02603419|54211464|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
27759398|NCT02603419|54211465|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
27759399|NCT02603419|54211466|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1|||
27759400|NCT02603419|54211467|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
27759401|NCT02603419|54211462|FG000|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
27759402|NCT02603419|54211463|FG001|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1|||
27759403|NCT02603419|54211464|FG002|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
27759404|NCT02603419|54211465|FG003|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
27759405|NCT02603419|54211466|FG004|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
27759406|NCT02603419|54211467|FG005|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
27759407|NCT02603419|54211462|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Other|2|||
27759408|NCT02603419|54211463|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
27759409|NCT02603419|54211464|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
27759410|NCT02603419|54211465|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
27759411|NCT02603419|54211466|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
27759412|NCT02603419|54211467|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
27759413|NCT02603419|54211462|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
27759414|NCT02603419|54211463|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
27759415|NCT02603419|54211464|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
27759416|NCT02603419|54211465|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2|||
27759417|NCT02603419|54211466|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
27759418|NCT02603419|54211467|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
27759419|NCT02603419|54211462|FG000|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
27759420|NCT02603419|54211463|FG001|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
27759421|NCT02603419|54211464|FG002|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
27759422|NCT02603419|54211465|FG003|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
27759423|NCT02603419|54211466|FG004|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
27759424|NCT02603419|54211467|FG005|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1|||
27759425|NCT02603419|54211462|FG000|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
27759426|NCT02603419|54211463|FG001|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
27759427|NCT02603419|54211464|FG002|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
27759428|NCT02603419|54211465|FG003|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
27759429|NCT02603419|54211466|FG004|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
27759430|NCT02603419|54211467|FG005|Expansion Phase:Maximum Exposure:48Weeks|Death|1|||
27759431|NCT02603419|54211462|FG000|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
27759432|NCT02603419|54211463|FG001|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
27759433|NCT02603419|54211464|FG002|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
27759434|NCT02603419|54211465|FG003|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
27759435|NCT02603419|54211466|FG004|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
27759436|NCT02603419|54211467|FG005|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1|||
27759437|NCT01668355|54211484|FG000|Overall Study|Death|3|||
27759438|NCT01668355|54211485|FG001|Overall Study|Death|1|||
27759439|NCT01668355|54211484|FG000|Overall Study|Withdrawal by Subject|6|||
27759440|NCT01668355|54211485|FG001|Overall Study|Withdrawal by Subject|1|||
27759441|NCT01667731|54211497|FG000|Overall Study|Enrolled but not treated|0|||
27759442|NCT01667731|54211498|FG001|Overall Study|Enrolled but not treated|0|||
27759443|NCT01667731|54211499|FG002|Overall Study|Enrolled but not treated|0|||
27759444|NCT01667731|54211500|FG003|Overall Study|Enrolled but not treated|0|||
27759445|NCT01667731|54211501|FG004|Overall Study|Enrolled but not treated|1|||
27759446|NCT01667731|54211497|FG000|Overall Study|Efficacy Failure|1|||
27759447|NCT01667731|54211498|FG001|Overall Study|Efficacy Failure|12|||
27759448|NCT01667731|54211499|FG002|Overall Study|Efficacy Failure|0|||
27759449|NCT01667731|54211500|FG003|Overall Study|Efficacy Failure|1|||
27759450|NCT01667731|54211501|FG004|Overall Study|Efficacy Failure|24|||
27759451|NCT01667731|54211497|FG000|Overall Study|Lost to Follow-up|2|||
27759452|NCT01667731|54211498|FG001|Overall Study|Lost to Follow-up|3|||
27759453|NCT01667731|54211499|FG002|Overall Study|Lost to Follow-up|1|||
27759454|NCT01667731|54211500|FG003|Overall Study|Lost to Follow-up|1|||
27759455|NCT01667731|54211501|FG004|Overall Study|Lost to Follow-up|2|||
27759456|NCT01667731|54211497|FG000|Overall Study|Subject Withdrew Consent|2|||
27759457|NCT01667731|54211498|FG001|Overall Study|Subject Withdrew Consent|0|||
27759458|NCT01667731|54211499|FG002|Overall Study|Subject Withdrew Consent|1|||
27759459|NCT01667731|54211500|FG003|Overall Study|Subject Withdrew Consent|0|||
27759460|NCT01667731|54211501|FG004|Overall Study|Subject Withdrew Consent|1|||
27759461|NCT01667731|54211497|FG000|Overall Study|Death|0|||
27759462|NCT01667731|54211498|FG001|Overall Study|Death|1|||
27759463|NCT01667731|54211499|FG002|Overall Study|Death|0|||
27759464|NCT01667731|54211500|FG003|Overall Study|Death|0|||
27759465|NCT01667731|54211501|FG004|Overall Study|Death|0|||
27759466|NCT02605837|54211516|FG000|Overall Study|Adverse Event|3|||
27759467|NCT02605837|54211517|FG001|Overall Study|Adverse Event|1|||
27759468|NCT02605837|54211516|FG000|Overall Study|Non-Compliance with Study Drug|0|||
27759469|NCT02605837|54211517|FG001|Overall Study|Non-Compliance with Study Drug|1|||
27759470|NCT02605837|54211516|FG000|Overall Study|Withdrawal by Subject|8|||
27759471|NCT02605837|54211517|FG001|Overall Study|Withdrawal by Subject|8|||
27759472|NCT02605837|54211516|FG000|Overall Study|Physician Decision|0|||
27759473|NCT02605837|54211517|FG001|Overall Study|Physician Decision|1|||
27759474|NCT02423343|54211530|FG000|Overall Study|Withdrawal by Subject|0|||
27759475|NCT02423343|54211531|FG001|Overall Study|Withdrawal by Subject|1|||
27759476|NCT02423343|54211532|FG002|Overall Study|Withdrawal by Subject|0|||
27759477|NCT02423343|54211533|FG003|Overall Study|Withdrawal by Subject|0|||
27759478|NCT02423343|54211534|FG004|Overall Study|Withdrawal by Subject|0|||
27759479|NCT02423343|54211535|FG005|Overall Study|Withdrawal by Subject|0|||
27759480|NCT02423343|54211530|FG000|Overall Study|Progressive Disease|0|||
27759481|NCT02423343|54211531|FG001|Overall Study|Progressive Disease|0|||
27759482|NCT02423343|54211532|FG002|Overall Study|Progressive Disease|0|||
27759483|NCT02423343|54211533|FG003|Overall Study|Progressive Disease|0|||
27759484|NCT02423343|54211534|FG004|Overall Study|Progressive Disease|2|||
27759485|NCT02423343|54211535|FG005|Overall Study|Progressive Disease|0|||
27759486|NCT02423343|54211530|FG000|Overall Study|Adverse Event|0|||
27759487|NCT02423343|54211531|FG001|Overall Study|Adverse Event|0|||
27759488|NCT02423343|54211532|FG002|Overall Study|Adverse Event|0|||
27759489|NCT02423343|54211533|FG003|Overall Study|Adverse Event|0|||
27759490|NCT02423343|54211534|FG004|Overall Study|Adverse Event|2|||
27759491|NCT02423343|54211535|FG005|Overall Study|Adverse Event|0|||
27759492|NCT02423343|54211530|FG000|Overall Study|Death|0|||
27759493|NCT02423343|54211531|FG001|Overall Study|Death|0|||
27759494|NCT02423343|54211532|FG002|Overall Study|Death|0|||
27759495|NCT02423343|54211533|FG003|Overall Study|Death|0|||
27759496|NCT02423343|54211534|FG004|Overall Study|Death|1|||
27759497|NCT02423343|54211535|FG005|Overall Study|Death|0|||
27759498|NCT02605447|54211563|FG000|Overall Study|Death|66|||
27759499|NCT02605447|54211563|FG000|Overall Study|Physician Decision|1|||
27759500|NCT02605447|54211563|FG000|Overall Study|Lost to Follow-up|24|||
27759501|NCT02605447|54211563|FG000|Overall Study|Withdrawal by Subject|10|||
27759502|NCT02605447|54211563|FG000|Overall Study|Not disclosed|1|||
27759503|NCT02485899|54211570|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
27759504|NCT02485899|54211571|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
27759505|NCT02485899|54211570|FG000|Overall Study|Withdrawal by Subject|1|||
27759506|NCT02485899|54211571|FG001|Overall Study|Withdrawal by Subject|0|||
27759507|NCT02485899|54211570|FG000|Overall Study|Withdrawal by Parent/ Guardian|4|||
27759508|NCT02485899|54211571|FG001|Overall Study|Withdrawal by Parent/ Guardian|0|||
27759509|NCT02423109|54211577|FG000|Lens 1|Adverse Event|1|||
27759510|NCT02423109|54211578|FG001|Lens 1|Adverse Event|0|||
27759511|NCT02420691|54211586|FG000|Overall Study|Adverse Event|3|||
27759512|NCT02420691|54211586|FG000|Overall Study|Withdrawal by Subject|3|||
27759513|NCT02406651|54211590|FG000|Overall Study|30 subjects dosed based on initial screening. 3 subjects were removed because they screened fail.|3|||
27759514|NCT02406261|54211597|FG000|Period 1|Lost to Follow-up|2|||
27759515|NCT02406261|54211598|FG001|Period 1|Lost to Follow-up|0|||
27759516|NCT02406261|54211597|FG000|Period 1|Adverse Event|1|||
27759517|NCT02406261|54211598|FG001|Period 1|Adverse Event|0|||
27759518|NCT02406261|54211597|FG000|Period 2|Physician Decision|0|||
27759519|NCT02406261|54211598|FG001|Period 2|Physician Decision|1|||
27759520|NCT02406261|54211597|FG000|Period 2|Protocol Violation|0|||
27759521|NCT02406261|54211598|FG001|Period 2|Protocol Violation|1|||
27759522|NCT02406261|54211597|FG000|Period 2|Withdrawal by Subject|0|||
27759523|NCT02406261|54211598|FG001|Period 2|Withdrawal by Subject|1|||
27759524|NCT02405091|54211608|FG000|Overall Study|Adverse Event|16|||
27759525|NCT02405091|54211609|FG001|Overall Study|Adverse Event|10|||
27759526|NCT02405091|54211610|FG002|Overall Study|Adverse Event|0|||
27759527|NCT02405091|54211608|FG000|Overall Study|Protocol Violation|1|||
27759528|NCT02405091|54211609|FG001|Overall Study|Protocol Violation|0|||
27759529|NCT02405091|54211610|FG002|Overall Study|Protocol Violation|0|||
27759530|NCT02405091|54211608|FG000|Overall Study|Noncompliance|1|||
27759531|NCT02405091|54211609|FG001|Overall Study|Noncompliance|6|||
27759532|NCT02405091|54211610|FG002|Overall Study|Noncompliance|2|||
27839513|NCT01507831|54326801|FG001|Overall Study|Selection criteria finally not met|1|||
27759533|NCT02405091|54211608|FG000|Overall Study|Withdrawal by Subject|4|||
27759534|NCT02405091|54211609|FG001|Overall Study|Withdrawal by Subject|8|||
27759535|NCT02405091|54211610|FG002|Overall Study|Withdrawal by Subject|0|||
27759536|NCT02405091|54211608|FG000|Overall Study|Death|0|||
27759537|NCT02405091|54211609|FG001|Overall Study|Death|1|||
27759538|NCT02405091|54211610|FG002|Overall Study|Death|0|||
27759539|NCT02405091|54211608|FG000|Overall Study|Lost to Follow-up|5|||
27759540|NCT02405091|54211609|FG001|Overall Study|Lost to Follow-up|6|||
27759541|NCT02405091|54211610|FG002|Overall Study|Lost to Follow-up|0|||
27759542|NCT02405091|54211608|FG000|Overall Study|Physician Decision|2|||
27759543|NCT02405091|54211609|FG001|Overall Study|Physician Decision|2|||
27759544|NCT02405091|54211610|FG002|Overall Study|Physician Decision|0|||
27759545|NCT02485353|54211621|FG000|Overall Study|Death|1|||
27759546|NCT02485353|54211621|FG000|Overall Study|Disease Progression|1|||
27759547|NCT02603107|54211627|FG000|Randomized Phase|Withdrew consent|8|||
27759548|NCT02603107|54211628|FG001|Randomized Phase|Withdrew consent|15|||
27759549|NCT02603107|54211627|FG000|Randomized Phase|Lost to Follow-up|1|||
27759550|NCT02603107|54211628|FG001|Randomized Phase|Lost to Follow-up|3|||
27759551|NCT02603107|54211627|FG000|Randomized Phase|Adverse Event|2|||
27759552|NCT02603107|54211628|FG001|Randomized Phase|Adverse Event|0|||
27759553|NCT02603107|54211627|FG000|Randomized Phase|Death|1|||
27759554|NCT02603107|54211628|FG001|Randomized Phase|Death|1|||
27759555|NCT02603107|54211627|FG000|Randomized Phase|Non-compliance with study drug|1|||
27759556|NCT02603107|54211628|FG001|Randomized Phase|Non-compliance with study drug|1|||
27759557|NCT02603107|54211627|FG000|Randomized Phase|Investigator's discretion|0|||
27759558|NCT02603107|54211628|FG001|Randomized Phase|Investigator's discretion|1|||
27759559|NCT02603107|54211627|FG000|Randomized Phase|Lack of Efficacy|1|||
27759560|NCT02603107|54211628|FG001|Randomized Phase|Lack of Efficacy|0|||
27759561|NCT02603107|54211627|FG000|Randomized Phase|Protocol Violation|1|||
27759562|NCT02603107|54211628|FG001|Randomized Phase|Protocol Violation|0|||
27759563|NCT02603107|54211627|FG000|Optional Extension Phase|Lost to Follow-up|3|||
27759564|NCT02603107|54211628|FG001|Optional Extension Phase|Lost to Follow-up|3|||
27759565|NCT02603107|54211627|FG000|Optional Extension Phase|Withdrew consent|3|||
27759566|NCT02603107|54211628|FG001|Optional Extension Phase|Withdrew consent|2|||
27759567|NCT02603107|54211627|FG000|Optional Extension Phase|Investigator's discretion|2|||
27759568|NCT02603107|54211628|FG001|Optional Extension Phase|Investigator's discretion|2|||
27759569|NCT02603107|54211627|FG000|Optional Extension Phase|Pregnancy|0|||
27759570|NCT02603107|54211628|FG001|Optional Extension Phase|Pregnancy|3|||
27759571|NCT02603107|54211627|FG000|Optional Extension Phase|Adverse Event|0|||
27759572|NCT02603107|54211628|FG001|Optional Extension Phase|Adverse Event|2|||
27759573|NCT02603107|54211627|FG000|Optional Extension Phase|Not treated in extension phase|0|||
27759574|NCT02603107|54211628|FG001|Optional Extension Phase|Not treated in extension phase|1|||
27759575|NCT02603107|54211627|FG000|Optional Extension Phase|Protocol Violation|1|||
27759576|NCT02603107|54211628|FG001|Optional Extension Phase|Protocol Violation|0|||
27759577|NCT02484729|54211646|FG000|Overall Study|Failure of IntelliCap Error|0|||
27759578|NCT02484729|54211647|FG001|Overall Study|Failure of IntelliCap Error|0|||
27759579|NCT02484729|54211648|FG002|Overall Study|Failure of IntelliCap Error|0|||
27759580|NCT02484729|54211649|FG003|Overall Study|Failure of IntelliCap Error|0|||
27759581|NCT02484729|54211650|FG004|Overall Study|Failure of IntelliCap Error|0|||
27759582|NCT02484729|54211651|FG005|Overall Study|Failure of IntelliCap Error|0|||
27759583|NCT02484729|54211652|FG006|Overall Study|Failure of IntelliCap Error|0|||
27759584|NCT02484729|54211653|FG007|Overall Study|Failure of IntelliCap Error|0|||
27759585|NCT02484729|54211654|FG008|Overall Study|Failure of IntelliCap Error|0|||
27759586|NCT02484729|54211655|FG009|Overall Study|Failure of IntelliCap Error|1|||
27759587|NCT02601625|54211693|FG000|Overall Study|Lost to Follow-up|0|||
27759588|NCT02601625|54211694|FG001|Overall Study|Lost to Follow-up|0|||
27759589|NCT02601625|54211695|FG002|Overall Study|Lost to Follow-up|1|||
27759590|NCT02601625|54211696|FG003|Overall Study|Lost to Follow-up|1|||
27759591|NCT02601469|54211722|FG000|Overall Study|Enrolled in Error|1|||
27759592|NCT02601469|54211723|FG001|Overall Study|Enrolled in Error|0|||
27759593|NCT02604589|54211732|FG000|Overall Study|catheter dislodgement|0|||
27759594|NCT02604589|54211733|FG001|Overall Study|catheter dislodgement|0|||
27759595|NCT02604589|54211734|FG002|Overall Study|catheter dislodgement|1|||
27759596|NCT02601001|54211745|FG000|Dosing Period 2|Adverse Event|0|||
27759597|NCT02601001|54211746|FG001|Dosing Period 2|Adverse Event|0|||
27759598|NCT02601001|54211747|FG002|Dosing Period 2|Adverse Event|0|||
27759599|NCT02601001|54211748|FG003|Dosing Period 2|Adverse Event|0|||
27759600|NCT02601001|54211749|FG004|Dosing Period 2|Adverse Event|0|||
27759601|NCT02601001|54211750|FG005|Dosing Period 2|Adverse Event|0|||
27759602|NCT02601001|54211751|FG006|Dosing Period 2|Adverse Event|1|||
27759603|NCT02604199|54211776|FG000|Overall Study|Pregnancy|0|||
27759604|NCT02604199|54211777|FG001|Overall Study|Pregnancy|0|||
27759605|NCT02604199|54211778|FG002|Overall Study|Pregnancy|0|||
27759606|NCT02604199|54211779|FG003|Overall Study|Pregnancy|1|||
27759607|NCT02604199|54211776|FG000|Overall Study|Study terminated by sponsor|0|||
27759608|NCT02604199|54211777|FG001|Overall Study|Study terminated by sponsor|2|||
27759609|NCT02604199|54211778|FG002|Overall Study|Study terminated by sponsor|0|||
27759610|NCT02604199|54211779|FG003|Overall Study|Study terminated by sponsor|2|||
27759611|NCT02604199|54211776|FG000|Overall Study|Withdrawal by Subject|0|||
27759612|NCT02604199|54211777|FG001|Overall Study|Withdrawal by Subject|1|||
27759613|NCT02604199|54211778|FG002|Overall Study|Withdrawal by Subject|0|||
27759614|NCT02604199|54211779|FG003|Overall Study|Withdrawal by Subject|0|||
27759615|NCT02600845|54211792|FG000|Overall Study|Reason Not Specified|3|||
27759616|NCT02600845|54211792|FG000|Overall Study|Non-compliance with Study Procedures|10|||
27759617|NCT02600845|54211792|FG000|Overall Study|Consent Withdrawal|5|||
27759618|NCT02599129|54211798|FG000|Overall Study|Lack of Efficacy|2|||
27759619|NCT02599129|54211799|FG001|Overall Study|Lack of Efficacy|2|||
27759620|NCT02599129|54211798|FG000|Overall Study|Lost to Follow-up|1|||
27759621|NCT02599129|54211799|FG001|Overall Study|Lost to Follow-up|0|||
27759622|NCT02599129|54211798|FG000|Overall Study|Withdrawal by Subject|2|||
27759623|NCT02599129|54211799|FG001|Overall Study|Withdrawal by Subject|1|||
27759624|NCT02596711|54211808|FG000|Overall Study|Lost to Follow-up|1|||
27759625|NCT02596711|54211809|FG001|Overall Study|Lost to Follow-up|2|||
27759626|NCT02596711|54211810|FG002|Overall Study|Lost to Follow-up|3|||
27759627|NCT02596009|54211818|FG000|Overall Study|Administrative problems|0|||
27759628|NCT02596009|54211819|FG001|Overall Study|Administrative problems|1|||
27759629|NCT02596009|54211820|FG002|Overall Study|Administrative problems|0|||
27759630|NCT02596009|54211821|FG003|Overall Study|Administrative problems|0|||
27759631|NCT02596009|54211822|FG004|Overall Study|Administrative problems|0|||
27759632|NCT02596009|54211823|FG005|Overall Study|Administrative problems|0|||
27759633|NCT02590939|54211831|FG000|Overall Study|Withdrawal by Subject|3|||
27759634|NCT02590939|54211832|FG001|Overall Study|Withdrawal by Subject|1|||
27759635|NCT02590939|54211831|FG000|Overall Study|Failed the nociceptive test|2|||
27759636|NCT02590939|54211832|FG001|Overall Study|Failed the nociceptive test|1|||
27759637|NCT04351087|54211840|FG000|Overall Study|Lost to Follow-up|7|||
27759638|NCT04351087|54211841|FG001|Overall Study|Lost to Follow-up|3|||
27759639|NCT04351087|54211840|FG000|Overall Study|Withdrawal by Subject|3|||
27759640|NCT04351087|54211841|FG001|Overall Study|Withdrawal by Subject|4|||
27759641|NCT04351087|54211840|FG000|Overall Study|Lack of Efficacy|3|||
27759642|NCT04351087|54211841|FG001|Overall Study|Lack of Efficacy|2|||
27759643|NCT02598193|54211847|FG000|Overall Study|Adverse Event|13|||
27759644|NCT02598193|54211847|FG000|Overall Study|Withdrawal by Subject|1|||
27759645|NCT02598193|54211847|FG000|Overall Study|Listed in active lung transplant list|1|||
27759646|NCT02598193|54211847|FG000|Overall Study|Does not want to take Nintedanib|1|||
27759647|NCT02595073|54211853|FG000|Overall Study|Progressive Disease|0|||
27759648|NCT02595073|54211854|FG001|Overall Study|Progressive Disease|1|||
27759649|NCT02595073|54211853|FG000|Overall Study|Protocol Violation|2|||
27759650|NCT02595073|54211854|FG001|Overall Study|Protocol Violation|0|||
27759651|NCT02593825|54211862|FG000|Intervention|Lost to Follow-up|10|||
27759652|NCT02593825|54211863|FG001|Intervention|Lost to Follow-up|12|||
27759653|NCT02388165|54211873|FG000|Overall Study|Study terminated by sponsor|5|||
27759654|NCT02388165|54211874|FG001|Overall Study|Study terminated by sponsor|5|||
27759655|NCT02388165|54211873|FG000|Overall Study|Other|11|||
27759656|NCT02388165|54211874|FG001|Overall Study|Other|13|||
27759657|NCT02388165|54211873|FG000|Overall Study|No longer meet eligibility criteria|40|||
27759658|NCT02388165|54211874|FG001|Overall Study|No longer meet eligibility criteria|43|||
27759659|NCT02388165|54211873|FG000|Overall Study|Withdrawal of consent|31|||
27759660|NCT02388165|54211874|FG001|Overall Study|Withdrawal of consent|32|||
27759661|NCT02388165|54211873|FG000|Overall Study|Lost to Follow-up|19|||
27759662|NCT02388165|54211874|FG001|Overall Study|Lost to Follow-up|20|||
27759663|NCT02388165|54211873|FG000|Overall Study|Death|13|||
27759664|NCT02388165|54211874|FG001|Overall Study|Death|10|||
27759665|NCT02388165|54211873|FG000|Overall Study|Adverse Event|3|||
27759666|NCT02388165|54211874|FG001|Overall Study|Adverse Event|5|||
27759667|NCT02388165|54211873|FG000|Overall Study|Did not meet entrance criteria|5|||
27759668|NCT02388165|54211874|FG001|Overall Study|Did not meet entrance criteria|2|||
27759669|NCT02404545|54211882|FG000|Overall Study|Sponsor Termination|6|||
27759670|NCT02404545|54211883|FG001|Overall Study|Sponsor Termination|6|||
27759671|NCT02420379|54211892|FG000|Overall Study|Withdrawal by Subject|0|||
27759672|NCT02420379|54211893|FG001|Overall Study|Withdrawal by Subject|3|||
27759673|NCT02420379|54211892|FG000|Overall Study|Unable to complete due to schooling|0|||
27759674|NCT02420379|54211893|FG001|Overall Study|Unable to complete due to schooling|1|||
27759675|NCT02420379|54211892|FG000|Overall Study|Transitioned to commercial drug|1|||
27759676|NCT02420379|54211893|FG001|Overall Study|Transitioned to commercial drug|0|||
27759677|NCT02347761|54211902|FG000|All Collected|Death|1|||
27759678|NCT02347761|54211903|FG001|All Collected|Death|0|||
27759679|NCT02347761|54211904|FG002|All Collected|Death|0|||
27759680|NCT02347761|54211902|FG000|All Collected|Lost to Follow-up|3|||
27759681|NCT02347761|54211903|FG001|All Collected|Lost to Follow-up|2|||
27759682|NCT02347761|54211904|FG002|All Collected|Lost to Follow-up|3|||
27759683|NCT02347761|54211902|FG000|All Collected|Withdrawal by Subject|11|||
27759684|NCT02347761|54211903|FG001|All Collected|Withdrawal by Subject|11|||
27759685|NCT02347761|54211904|FG002|All Collected|Withdrawal by Subject|22|||
27759686|NCT02347761|54211902|FG000|All Collected|invetigator disretion|2|||
27759687|NCT02347761|54211903|FG001|All Collected|invetigator disretion|0|||
27759688|NCT02347761|54211904|FG002|All Collected|invetigator disretion|0|||
27759689|NCT02347761|54211902|FG000|All Collected|instillation site pain|0|||
27759690|NCT02347761|54211903|FG001|All Collected|instillation site pain|0|||
27759691|NCT02347761|54211904|FG002|All Collected|instillation site pain|1|||
27759692|NCT02347761|54211902|FG000|All Collected|exacerbation of COPD|0|||
27759693|NCT02347761|54211903|FG001|All Collected|exacerbation of COPD|0|||
27759694|NCT02347761|54211904|FG002|All Collected|exacerbation of COPD|1|||
27759695|NCT02347761|54211902|FG000|All Collected|moved/travel|0|||
27759696|NCT02347761|54211903|FG001|All Collected|moved/travel|1|||
27759697|NCT02347761|54211904|FG002|All Collected|moved/travel|0|||
27759698|NCT02347761|54211902|FG000|On Study Treatment|Lack of Efficacy|2|||
27759699|NCT02347761|54211903|FG001|On Study Treatment|Lack of Efficacy|3|||
27759700|NCT02347761|54211904|FG002|On Study Treatment|Lack of Efficacy|4|||
27759701|NCT02347761|54211902|FG000|On Study Treatment|non-compliance with study medication|0|||
27759702|NCT02347761|54211903|FG001|On Study Treatment|non-compliance with study medication|0|||
27759703|NCT02347761|54211904|FG002|On Study Treatment|non-compliance with study medication|2|||
27759704|NCT02347761|54211902|FG000|On Study Treatment|Withdrawal by Subject|7|||
27759705|NCT02347761|54211903|FG001|On Study Treatment|Withdrawal by Subject|3|||
27759706|NCT02347761|54211904|FG002|On Study Treatment|Withdrawal by Subject|5|||
27759707|NCT02347761|54211902|FG000|On Study Treatment|move/travel|2|||
27759708|NCT02347761|54211903|FG001|On Study Treatment|move/travel|6|||
27759709|NCT02347761|54211904|FG002|On Study Treatment|move/travel|5|||
27759710|NCT02347761|54211902|FG000|On Study Treatment|dissastisfaction with device|2|||
27759711|NCT02347761|54211903|FG001|On Study Treatment|dissastisfaction with device|1|||
27759712|NCT02347761|54211904|FG002|On Study Treatment|dissastisfaction with device|4|||
27759713|NCT02347761|54211902|FG000|On Study Treatment|Lost to Follow-up|2|||
27759714|NCT02347761|54211903|FG001|On Study Treatment|Lost to Follow-up|1|||
27759715|NCT02347761|54211904|FG002|On Study Treatment|Lost to Follow-up|1|||
27759716|NCT02347761|54211902|FG000|On Study Treatment|investigator discretion|2|||
27759717|NCT02347761|54211903|FG001|On Study Treatment|investigator discretion|0|||
27759718|NCT02347761|54211904|FG002|On Study Treatment|investigator discretion|0|||
27759719|NCT02347761|54211902|FG000|On Study Treatment|durg not working|0|||
27759720|NCT02347761|54211903|FG001|On Study Treatment|durg not working|1|||
27759721|NCT02347761|54211904|FG002|On Study Treatment|durg not working|1|||
27759722|NCT02347761|54211902|FG000|On Study Treatment|Adverse Event|10|||
27759723|NCT02347761|54211903|FG001|On Study Treatment|Adverse Event|8|||
27759724|NCT02347761|54211904|FG002|On Study Treatment|Adverse Event|20|||
27759725|NCT02596945|54211912|FG000|Overall Study|No documentation of study drug dosing|3|||
27759726|NCT02596945|54211912|FG000|Overall Study|Other|32|||
27759727|NCT02596945|54211912|FG000|Overall Study|Change to hemodialysis|15|||
27759728|NCT02596945|54211912|FG000|Overall Study|Other Erythropoietin stimulating agent|4|||
27759729|NCT02596945|54211912|FG000|Overall Study|Withdrawal by Subject|1|||
27759730|NCT02596945|54211912|FG000|Overall Study|Missing|1|||
27759731|NCT02404389|54211930|FG000|Overall Study|Adverse Event|1|||
27759732|NCT02404389|54211931|FG001|Overall Study|Adverse Event|0|||
27759733|NCT02404389|54211932|FG002|Overall Study|Adverse Event|1|||
27759734|NCT02404389|54211933|FG003|Overall Study|Adverse Event|0|||
27759735|NCT02404389|54211934|FG004|Overall Study|Adverse Event|2|||
27759736|NCT02404389|54211930|FG000|Overall Study|Subject/guardian decision|1|||
27759737|NCT02404389|54211931|FG001|Overall Study|Subject/guardian decision|0|||
27759738|NCT02404389|54211932|FG002|Overall Study|Subject/guardian decision|0|||
27759739|NCT02404389|54211933|FG003|Overall Study|Subject/guardian decision|1|||
27759740|NCT02404389|54211934|FG004|Overall Study|Subject/guardian decision|1|||
27759741|NCT01667419|54211952|FG000|Overall Study|Reason Not Specified|1|||
27759742|NCT01667419|54211953|FG001|Overall Study|Reason Not Specified|0|||
27759743|NCT01667419|54211954|FG002|Overall Study|Reason Not Specified|0|||
27759744|NCT01667419|54211955|FG003|Overall Study|Reason Not Specified|0|||
27759745|NCT01667419|54211952|FG000|Overall Study|Withdrawal by Subject|16|||
27759746|NCT01667419|54211953|FG001|Overall Study|Withdrawal by Subject|8|||
27759747|NCT01667419|54211954|FG002|Overall Study|Withdrawal by Subject|9|||
27759748|NCT01667419|54211955|FG003|Overall Study|Withdrawal by Subject|8|||
27759749|NCT01667419|54211952|FG000|Overall Study|Non-compliance|0|||
27759750|NCT01667419|54211953|FG001|Overall Study|Non-compliance|0|||
27759751|NCT01667419|54211954|FG002|Overall Study|Non-compliance|0|||
27759752|NCT01667419|54211955|FG003|Overall Study|Non-compliance|1|||
27759753|NCT01667419|54211952|FG000|Overall Study|Protocol Violation|1|||
27759754|NCT01667419|54211953|FG001|Overall Study|Protocol Violation|0|||
27759755|NCT01667419|54211954|FG002|Overall Study|Protocol Violation|0|||
27759756|NCT01667419|54211955|FG003|Overall Study|Protocol Violation|0|||
27759757|NCT01667419|54211952|FG000|Overall Study|Lost to Follow-up|7|||
27759758|NCT01667419|54211953|FG001|Overall Study|Lost to Follow-up|6|||
27839514|NCT01507831|54326800|FG000|Overall Study|Site closure|0|||
27839515|NCT01507831|54326801|FG001|Overall Study|Site closure|3|||
27839516|NCT01507831|54326800|FG000|Overall Study|Potential lost to follow-up|3|||
27759759|NCT01667419|54211954|FG002|Overall Study|Lost to Follow-up|2|||
27759760|NCT01667419|54211955|FG003|Overall Study|Lost to Follow-up|4|||
27759761|NCT01667419|54211952|FG000|Overall Study|Death|18|||
27759762|NCT01667419|54211953|FG001|Overall Study|Death|33|||
27759763|NCT01667419|54211954|FG002|Overall Study|Death|25|||
27759764|NCT01667419|54211955|FG003|Overall Study|Death|26|||
27759765|NCT02588833|54211972|FG000|Part 1|Withdrawal by Subject|1|||
27759766|NCT02588833|54211973|FG001|Part 1|Withdrawal by Subject|0|||
27759767|NCT02588833|54211972|FG000|Part 2A|Physician Decision|0|||
27759768|NCT02588833|54211973|FG001|Part 2A|Physician Decision|1|||
27759769|NCT02588833|54211972|FG000|Part 2A|Withdrawal by Subject|0|||
27759770|NCT02588833|54211973|FG001|Part 2A|Withdrawal by Subject|1|||
27759771|NCT02588833|54211972|FG000|Part 2B|Adverse Event|0|||
27759772|NCT02588833|54211973|FG001|Part 2B|Adverse Event|1|||
27759773|NCT02588833|54211972|FG000|Part 2C|Adverse Event|0|||
27759774|NCT02588833|54211973|FG001|Part 2C|Adverse Event|1|||
27759775|NCT02588833|54211972|FG000|Part 2C|Withdrawal by Subject|0|||
27759776|NCT02588833|54211973|FG001|Part 2C|Withdrawal by Subject|1|||
27759777|NCT02588833|54211972|FG000|Part 3 (Safety Follow-up)|Other|0|||
27759778|NCT02588833|54211973|FG001|Part 3 (Safety Follow-up)|Other|2|||
27759779|NCT01667107|54211982|FG000|Overall Study|Adverse Event|4|||
27759780|NCT01667107|54211983|FG001|Overall Study|Adverse Event|3|||
27759781|NCT01667107|54211982|FG000|Overall Study|Tolerability issues|0|||
27759782|NCT01667107|54211983|FG001|Overall Study|Tolerability issues|2|||
27759783|NCT01667107|54211982|FG000|Overall Study|Protocol Violation|0|||
27759784|NCT01667107|54211983|FG001|Overall Study|Protocol Violation|1|||
27759785|NCT01667107|54211982|FG000|Overall Study|Lack of Efficacy|0|||
27759786|NCT01667107|54211983|FG001|Overall Study|Lack of Efficacy|1|||
27759787|NCT02590003|54212007|FG000|Overall Study|Death|1|||
27759788|NCT02590003|54212008|FG001|Overall Study|Death|2|||
27759789|NCT02404311|54212037|FG000|Part A: Month 0-18|Death|2|||
27759790|NCT02404311|54212038|FG001|Part A: Month 0-18|Death|0|||
27759791|NCT02404311|54212039|FG002|Part A: Month 0-18|Death|0|||
27759792|NCT02404311|54212040|FG003|Part A: Month 0-18|Death|0|||
27759793|NCT02404311|54212041|FG004|Part A: Month 0-18|Death|0|||
27759794|NCT02404311|54212037|FG000|Part A: Month 0-18|Physician Decision|1|||
27759795|NCT02404311|54212038|FG001|Part A: Month 0-18|Physician Decision|0|||
27759796|NCT02404311|54212039|FG002|Part A: Month 0-18|Physician Decision|0|||
27759797|NCT02404311|54212040|FG003|Part A: Month 0-18|Physician Decision|0|||
27759798|NCT02404311|54212041|FG004|Part A: Month 0-18|Physician Decision|0|||
27759799|NCT02404311|54212037|FG000|Part A: Month 0-18|Lost to Follow-up|4|||
27759800|NCT02404311|54212038|FG001|Part A: Month 0-18|Lost to Follow-up|2|||
27759801|NCT02404311|54212039|FG002|Part A: Month 0-18|Lost to Follow-up|0|||
27759802|NCT02404311|54212040|FG003|Part A: Month 0-18|Lost to Follow-up|0|||
27759803|NCT02404311|54212041|FG004|Part A: Month 0-18|Lost to Follow-up|0|||
27759804|NCT02404311|54212037|FG000|Part A: Month 0-18|Withdrawal by Subject|6|||
27759805|NCT02404311|54212038|FG001|Part A: Month 0-18|Withdrawal by Subject|2|||
27759806|NCT02404311|54212039|FG002|Part A: Month 0-18|Withdrawal by Subject|0|||
27759807|NCT02404311|54212040|FG003|Part A: Month 0-18|Withdrawal by Subject|0|||
27759808|NCT02404311|54212041|FG004|Part A: Month 0-18|Withdrawal by Subject|0|||
27759809|NCT02404311|54212037|FG000|Part A: Month 0-18|HIV Infection|6|||
27759810|NCT02404311|54212038|FG001|Part A: Month 0-18|HIV Infection|2|||
27759811|NCT02404311|54212039|FG002|Part A: Month 0-18|HIV Infection|0|||
27759812|NCT02404311|54212040|FG003|Part A: Month 0-18|HIV Infection|0|||
27759813|NCT02404311|54212041|FG004|Part A: Month 0-18|HIV Infection|0|||
27759814|NCT02404311|54212037|FG000|Part A: Month 0-18|Participant unable to adhere|7|||
27759815|NCT02404311|54212038|FG001|Part A: Month 0-18|Participant unable to adhere|0|||
27759816|NCT02404311|54212039|FG002|Part A: Month 0-18|Participant unable to adhere|0|||
27759817|NCT02404311|54212040|FG003|Part A: Month 0-18|Participant unable to adhere|0|||
27759818|NCT02404311|54212041|FG004|Part A: Month 0-18|Participant unable to adhere|0|||
27759819|NCT01650519|54212055|FG000|Overall Study|Withdrawal by Subject|1|||
27759820|NCT01650519|54212056|FG001|Overall Study|Withdrawal by Subject|0|||
27759821|NCT01650285|54212062|FG000|Overall Study|Adverse Event|1|||
27759822|NCT02347527|54212070|FG000|Overall Study|MRI not completed due to technical difficulties|1|||
27759823|NCT02347527|54212071|FG001|Overall Study|MRI not completed due to technical difficulties|0|||
27759824|NCT02347527|54212072|FG002|Overall Study|MRI not completed due to technical difficulties|0|||
27759825|NCT02347527|54212073|FG003|Overall Study|MRI not completed due to technical difficulties|0|||
27759826|NCT02347527|54212070|FG000|Overall Study|MRI stopped due to participant anxiety|0|||
27759827|NCT02347527|54212071|FG001|Overall Study|MRI stopped due to participant anxiety|1|||
27759828|NCT02347527|54212072|FG002|Overall Study|MRI stopped due to participant anxiety|0|||
27759829|NCT02347527|54212073|FG003|Overall Study|MRI stopped due to participant anxiety|0|||
27759830|NCT02347527|54212070|FG000|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
27759831|NCT02347527|54212071|FG001|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
27759832|NCT02347527|54212072|FG002|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
27759833|NCT02347527|54212073|FG003|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
27759834|NCT02347527|54212070|FG000|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
27759835|NCT02347527|54212071|FG001|Overall Study|Excluded from analyses due to technical difficulties during the study visit|0|||
27759836|NCT02347527|54212072|FG002|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
27759837|NCT02347527|54212073|FG003|Overall Study|Excluded from analyses due to technical difficulties during the study visit|2|||
27759838|NCT02347527|54212070|FG000|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
27759839|NCT02347527|54212071|FG001|Overall Study|Excluded from analyses due to non-compliance with study procedures|1|||
27759840|NCT02347527|54212072|FG002|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
27759841|NCT02347527|54212073|FG003|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
27759842|NCT02386839|54212087|FG000|Overall Study|Death|1|||
27759843|NCT02386839|54212088|FG001|Overall Study|Death|0|||
27759844|NCT02386839|54212087|FG000|Overall Study|Withdrawal by Subject|9|||
27759845|NCT02386839|54212088|FG001|Overall Study|Withdrawal by Subject|10|||
27759846|NCT02386839|54212087|FG000|Overall Study|Lost to Follow-up|4|||
27759847|NCT02386839|54212088|FG001|Overall Study|Lost to Follow-up|4|||
27759848|NCT02386839|54212087|FG000|Overall Study|Other (Site Terminated by Sponsor)|1|||
27759849|NCT02386839|54212088|FG001|Overall Study|Other (Site Terminated by Sponsor)|0|||
27759850|NCT02386839|54212087|FG000|Overall Study|Other (Covid 19 Pandemic)|0|||
27759851|NCT02386839|54212088|FG001|Overall Study|Other (Covid 19 Pandemic)|1|||
27759852|NCT02386839|54212087|FG000|Overall Study|Other (unspecified)|1|||
27759853|NCT02386839|54212088|FG001|Overall Study|Other (unspecified)|0|||
27759854|NCT01649271|54212100|FG000|Overall Study|Progressive disease|4|||
27759855|NCT01649271|54212101|FG001|Overall Study|Progressive disease|5|||
27759856|NCT01649271|54212100|FG000|Overall Study|Other Adverse Event|0|||
27759857|NCT01649271|54212101|FG001|Overall Study|Other Adverse Event|2|||
27759858|NCT01649271|54212100|FG000|Overall Study|Withdrawal by Subject|1|||
27759859|NCT01649271|54212101|FG001|Overall Study|Withdrawal by Subject|0|||
27759860|NCT01649271|54212100|FG000|Overall Study|Other than stated above|1|||
27759861|NCT01649271|54212101|FG001|Overall Study|Other than stated above|0|||
27759862|NCT02385669|54212108|FG000|Overall Study|Adverse Event|2|||
27759863|NCT02402907|54212114|FG000|Overall Study|Delivered vaginally|9|||
27759864|NCT02402907|54212115|FG001|Overall Study|Delivered vaginally|3|||
27759865|NCT02402907|54212114|FG000|Overall Study|Delivered outside of Sinai|1|||
27759866|NCT02402907|54212115|FG001|Overall Study|Delivered outside of Sinai|1|||
27759867|NCT02402907|54212114|FG000|Overall Study|Lost to follow up after C-Section|10|||
27759868|NCT02402907|54212115|FG001|Overall Study|Lost to follow up after C-Section|23|||
27759869|NCT02345889|54212125|FG000|Overall Study|Inadequate Bowel Prep|17|||
27759870|NCT02345889|54212126|FG001|Overall Study|Inadequate Bowel Prep|16|||
27759871|NCT02345889|54212127|FG002|Overall Study|Inadequate Bowel Prep|18|||
27759872|NCT02345889|54212128|FG003|Overall Study|Inadequate Bowel Prep|14|||
27759873|NCT02345889|54212125|FG000|Overall Study|Polyposis identified during procedure|1|||
27759874|NCT02345889|54212126|FG001|Overall Study|Polyposis identified during procedure|1|||
27759875|NCT02345889|54212127|FG002|Overall Study|Polyposis identified during procedure|0|||
27759876|NCT02345889|54212128|FG003|Overall Study|Polyposis identified during procedure|1|||
27759877|NCT02345889|54212125|FG000|Overall Study|Recognized ineligible post-randomization|1|||
27759878|NCT02345889|54212126|FG001|Overall Study|Recognized ineligible post-randomization|0|||
27759879|NCT02345889|54212127|FG002|Overall Study|Recognized ineligible post-randomization|2|||
27759880|NCT02345889|54212128|FG003|Overall Study|Recognized ineligible post-randomization|1|||
27759881|NCT02345889|54212125|FG000|Overall Study|Ulcerative Colitis identified|1|||
27759882|NCT02345889|54212126|FG001|Overall Study|Ulcerative Colitis identified|0|||
27759883|NCT02345889|54212127|FG002|Overall Study|Ulcerative Colitis identified|0|||
27759884|NCT02345889|54212128|FG003|Overall Study|Ulcerative Colitis identified|0|||
27759885|NCT02345889|54212125|FG000|Overall Study|Cecum not intubated|1|||
27759886|NCT02345889|54212126|FG001|Overall Study|Cecum not intubated|0|||
27759887|NCT02345889|54212127|FG002|Overall Study|Cecum not intubated|0|||
27759888|NCT02345889|54212128|FG003|Overall Study|Cecum not intubated|0|||
27759889|NCT02345811|54212138|FG000|First Intervention|Withdrawal by Subject|1|||
27759890|NCT02345811|54212139|FG001|First Intervention|Withdrawal by Subject|1|||
27759891|NCT02344173|54212147|FG000|Procedure|Ablation Procedure Not Performed|7|||
27759892|NCT02344173|54212147|FG000|12-month Visit|Death|8|||
27759893|NCT02344173|54212147|FG000|12-month Visit|Withdrawal by Subject|30|||
27759894|NCT02344173|54212147|FG000|12-month Visit|Lost to Follow-up|58|||
27759895|NCT02586493|54212153|FG000|Overall Study|Adverse Event|4|||
27759896|NCT02586493|54212153|FG000|Overall Study|Protocol Violation|6|||
27759897|NCT02586493|54212153|FG000|Overall Study|Lost to Follow-up|1|||
27759898|NCT02586493|54212153|FG000|Overall Study|Withdrawal by Subject|1|||
27759899|NCT02400333|54212161|FG000|Overall Study|Withdrawal by Subject|0|||
27759900|NCT02400333|54212162|FG001|Overall Study|Withdrawal by Subject|1|||
27759901|NCT02400333|54212163|FG002|Overall Study|Withdrawal by Subject|0|||
27759902|NCT02400333|54212164|FG003|Overall Study|Withdrawal by Subject|1|||
27759903|NCT02400333|54212161|FG000|Overall Study|Protocol Violation|1|||
27759904|NCT02400333|54212162|FG001|Overall Study|Protocol Violation|0|||
27759905|NCT02400333|54212163|FG002|Overall Study|Protocol Violation|2|||
27759906|NCT02400333|54212164|FG003|Overall Study|Protocol Violation|1|||
27759907|NCT02399475|54212177|FG000|Overall Study|Physician Decision|1|||
27759908|NCT02399475|54212178|FG001|Overall Study|Physician Decision|0|||
27759909|NCT02399163|54212184|FG000|Overall Study|Adverse Event|2|||
27759910|NCT02399163|54212184|FG000|Overall Study|Protocol Deviation|2|||
27759911|NCT02399163|54212184|FG000|Overall Study|Withdrawal by Participant|5|||
27759912|NCT02398227|54212198|FG000|Overall Study|Lost to Follow-up|21|||
27759913|NCT02398227|54212199|FG001|Overall Study|Lost to Follow-up|12|||
27759914|NCT02398227|54212198|FG000|Overall Study|Withdrawal by Subject|5|||
27759915|NCT02398227|54212199|FG001|Overall Study|Withdrawal by Subject|6|||
27759916|NCT02398227|54212198|FG000|Overall Study|Removed from treatment and dropped out|1|||
27759917|NCT02398227|54212199|FG001|Overall Study|Removed from treatment and dropped out|0|||
27759918|NCT02397915|54212205|FG000|Period 1|Protocol Violation|0|||
27759919|NCT02397915|54212206|FG001|Period 1|Protocol Violation|1|||
27759920|NCT02397915|54212207|FG002|Period 1|Protocol Violation|0|||
27759921|NCT02397915|54212208|FG003|Period 1|Protocol Violation|0|||
27759922|NCT02397915|54212205|FG000|Period 1|Physician Decision|1|||
27759923|NCT02397915|54212206|FG001|Period 1|Physician Decision|0|||
27759924|NCT02397915|54212207|FG002|Period 1|Physician Decision|0|||
27759925|NCT02397915|54212208|FG003|Period 1|Physician Decision|0|||
27759926|NCT02397837|54212218|FG000|Overall Study|Withdrawal by Subject|6|||
27759927|NCT02397837|54212219|FG001|Overall Study|Withdrawal by Subject|5|||
27759928|NCT02397837|54212218|FG000|Overall Study|Physician Decision|1|||
27759929|NCT02397837|54212219|FG001|Overall Study|Physician Decision|1|||
27759930|NCT02586415|54212227|FG000|Overall Study|Death|13|||
27759931|NCT02586415|54212228|FG001|Overall Study|Death|23|||
27759932|NCT02586415|54212227|FG000|Overall Study|Lost to Follow-up|1|||
27759933|NCT02586415|54212228|FG001|Overall Study|Lost to Follow-up|2|||
27926934|NCT01217229|54583415|FG000|Overall Study|Disease progression not confirmed|2|||
27926935|NCT01013740|54583421|FG000|Overall Study|Lost to Follow-up|3|||
27759936|NCT02383017|54212246|FG000|Overall Study|Injury Sustained Outside Study|1|||
27759937|NCT02383017|54212247|FG001|Overall Study|Injury Sustained Outside Study|0|||
27759938|NCT02383017|54212246|FG000|Overall Study|Compliance|3|||
27759939|NCT02383017|54212247|FG001|Overall Study|Compliance|2|||
27759940|NCT02383017|54212246|FG000|Overall Study|Found to be Hypogonadal|1|||
27759941|NCT02383017|54212247|FG001|Overall Study|Found to be Hypogonadal|0|||
27759942|NCT02382939|54212255|FG000|Overall Study|Adverse Event|1|||
27759943|NCT02382939|54212256|FG001|Overall Study|Adverse Event|1|||
27759944|NCT02382939|54212255|FG000|Overall Study|Withdrawal by Subject|2|||
27759945|NCT02382939|54212256|FG001|Overall Study|Withdrawal by Subject|2|||
27759946|NCT02587819|54212263|FG000|Overall Study|Adverse Event|1|||
27759947|NCT02587819|54212263|FG000|Overall Study|Lost to Follow-up|1|||
27759948|NCT01666951|54212270|FG000|Overall Study|Not dosed|1|||
27759949|NCT01666951|54212271|FG001|Overall Study|Not dosed|1|||
27759950|NCT02586805|54212281|FG000|Overall Study|Withdrawal by Subject|3|||
27759951|NCT02586805|54212282|FG001|Overall Study|Withdrawal by Subject|1|||
27759952|NCT02586805|54212283|FG002|Overall Study|Withdrawal by Subject|1|||
27759953|NCT02586805|54212284|FG003|Overall Study|Withdrawal by Subject|2|||
27759954|NCT02586805|54212281|FG000|Overall Study|Adverse Event|2|||
27759955|NCT02586805|54212282|FG001|Overall Study|Adverse Event|0|||
27759956|NCT02586805|54212283|FG002|Overall Study|Adverse Event|1|||
27759957|NCT02586805|54212284|FG003|Overall Study|Adverse Event|0|||
27759958|NCT02586805|54212281|FG000|Overall Study|Lost to Follow-up|0|||
27759959|NCT02586805|54212282|FG001|Overall Study|Lost to Follow-up|0|||
27759960|NCT02586805|54212283|FG002|Overall Study|Lost to Follow-up|1|||
27759961|NCT02586805|54212284|FG003|Overall Study|Lost to Follow-up|0|||
27759962|NCT02586805|54212281|FG000|Overall Study|Physician Decision|1|||
27759963|NCT02586805|54212282|FG001|Overall Study|Physician Decision|0|||
27759964|NCT02586805|54212283|FG002|Overall Study|Physician Decision|0|||
27759965|NCT02586805|54212284|FG003|Overall Study|Physician Decision|0|||
27759966|NCT02586727|54212296|FG000|Overall Study|Lost to Follow-up|1|||
27759967|NCT02586727|54212297|FG001|Overall Study|Lost to Follow-up|0|||
27759968|NCT02580877|54212305|FG000|Overall Study|Withdrawal by Subject|1|||
27759969|NCT02580877|54212306|FG001|Overall Study|Withdrawal by Subject|3|||
27759970|NCT02580877|54212305|FG000|Overall Study|Adverse Event|0|||
27759971|NCT02580877|54212306|FG001|Overall Study|Adverse Event|1|||
27759972|NCT02582983|54212322|FG000|Overall Study|Death|3|||
27759973|NCT02582983|54212322|FG000|Overall Study|Withdrawal by Subject|2|||
27759974|NCT02582983|54212322|FG000|Overall Study|Adverse Event|1|||
27759975|NCT02582749|54212328|FG000|Overall Study|Study terminated by funder|5|||
27759976|NCT02582749|54212329|FG001|Overall Study|Study terminated by funder|10|||
27759977|NCT02582749|54212328|FG000|Overall Study|Withdrawal by Subject|0|||
27759978|NCT02582749|54212329|FG001|Overall Study|Withdrawal by Subject|1|||
27759979|NCT02582671|54212335|FG000|Overall Study|Failure to return|1|||
27759980|NCT02582671|54212335|FG000|Overall Study|Other, not specified|1|||
27759981|NCT02585713|54212342|FG000|Overall Study|Withdrew prior to treatment|2|||
27759982|NCT02585713|54212343|FG001|Overall Study|Withdrew prior to treatment|7|||
27759983|NCT02585713|54212342|FG000|Overall Study|Other|3|||
27759984|NCT02585713|54212343|FG001|Overall Study|Other|1|||
27839517|NCT01507831|54326801|FG001|Overall Study|Potential lost to follow-up|0|||
27839518|NCT01507831|54326800|FG000|Overall Study|Other|3|||
27839519|NCT01507831|54326801|FG001|Overall Study|Other|6|||
27839520|NCT01479595|54326809|FG000|Overall Study|Protocol deviation|0|||
27759985|NCT02579863|54212351|FG000|Overall Study|Final Disposition Unknown|2|||
27759986|NCT02579863|54212352|FG001|Overall Study|Final Disposition Unknown|1|||
27759987|NCT02579863|54212351|FG000|Overall Study|Adverse Event|18|||
27759988|NCT02579863|54212352|FG001|Overall Study|Adverse Event|11|||
27759989|NCT02579863|54212351|FG000|Overall Study|Death|31|||
27759990|NCT02579863|54212352|FG001|Overall Study|Death|29|||
27759991|NCT02579863|54212351|FG000|Overall Study|Lost to Follow-up|2|||
27759992|NCT02579863|54212352|FG001|Overall Study|Lost to Follow-up|1|||
27759993|NCT02579863|54212351|FG000|Overall Study|Physician Decision|1|||
27839521|NCT01479595|54326810|FG001|Overall Study|Protocol deviation|1|||
27759994|NCT02579863|54212352|FG001|Overall Study|Physician Decision|2|||
27759995|NCT02579863|54212351|FG000|Overall Study|Screen Failure|0|||
27759996|NCT02579863|54212352|FG001|Overall Study|Screen Failure|2|||
27759997|NCT02579863|54212351|FG000|Overall Study|Study Terminated at Selected Sites|82|||
27759998|NCT02579863|54212352|FG001|Overall Study|Study Terminated at Selected Sites|88|||
27759999|NCT02579863|54212351|FG000|Overall Study|Withdrawal by Subject|20|||
27760000|NCT02579863|54212352|FG001|Overall Study|Withdrawal by Subject|20|||
27760001|NCT02582515|54212360|FG000|Overall Study|Withdrawal by Subject|0|||
27760002|NCT02582515|54212361|FG001|Overall Study|Withdrawal by Subject|1|||
27760003|NCT02579629|54212370|FG000|Overall Study|Withdrawal by Subject|0|||
27760004|NCT02579629|54212371|FG001|Overall Study|Withdrawal by Subject|1|||
27760005|NCT02579629|54212372|FG002|Overall Study|Withdrawal by Subject|0|||
27760006|NCT02579629|54212370|FG000|Overall Study|Screen Failure|2|||
27760007|NCT02579629|54212371|FG001|Overall Study|Screen Failure|0|||
27760008|NCT02579629|54212372|FG002|Overall Study|Screen Failure|2|||
27760009|NCT02343939|54212389|FG000|Overall Study|Death|0|||
27760010|NCT02343939|54212390|FG001|Overall Study|Death|15|||
27760011|NCT02343939|54212391|FG002|Overall Study|Death|4|||
27760012|NCT02343939|54212392|FG003|Overall Study|Death|2|||
27760013|NCT02343939|54212393|FG004|Overall Study|Death|5|||
27760014|NCT02343939|54212394|FG005|Overall Study|Death|11|||
27760015|NCT02343939|54212395|FG006|Overall Study|Death|8|||
27760016|NCT02343939|54212396|FG007|Overall Study|Death|22|||
27760017|NCT02343939|54212397|FG008|Overall Study|Death|1|||
27760018|NCT02343939|54212389|FG000|Overall Study|Study terminated by sponsor|0|||
27760019|NCT02343939|54212390|FG001|Overall Study|Study terminated by sponsor|27|||
27760020|NCT02343939|54212391|FG002|Overall Study|Study terminated by sponsor|0|||
27760021|NCT02343939|54212392|FG003|Overall Study|Study terminated by sponsor|1|||
27760022|NCT02343939|54212393|FG004|Overall Study|Study terminated by sponsor|1|||
27760023|NCT02343939|54212394|FG005|Overall Study|Study terminated by sponsor|5|||
27760024|NCT02343939|54212395|FG006|Overall Study|Study terminated by sponsor|3|||
27760025|NCT02343939|54212396|FG007|Overall Study|Study terminated by sponsor|4|||
27760026|NCT02343939|54212397|FG008|Overall Study|Study terminated by sponsor|0|||
27760027|NCT02343939|54212389|FG000|Overall Study|Withdrew consent|3|||
27760028|NCT02343939|54212390|FG001|Overall Study|Withdrew consent|6|||
27760029|NCT02343939|54212391|FG002|Overall Study|Withdrew consent|1|||
27760030|NCT02343939|54212392|FG003|Overall Study|Withdrew consent|2|||
27760031|NCT02343939|54212393|FG004|Overall Study|Withdrew consent|2|||
27760032|NCT02343939|54212394|FG005|Overall Study|Withdrew consent|0|||
27760033|NCT02343939|54212395|FG006|Overall Study|Withdrew consent|0|||
27760034|NCT02343939|54212396|FG007|Overall Study|Withdrew consent|8|||
27760035|NCT02343939|54212397|FG008|Overall Study|Withdrew consent|6|||
27760036|NCT02343939|54212389|FG000|Overall Study|Treatment failure|0|||
27760037|NCT02343939|54212390|FG001|Overall Study|Treatment failure|0|||
27760038|NCT02343939|54212391|FG002|Overall Study|Treatment failure|0|||
27760039|NCT02343939|54212392|FG003|Overall Study|Treatment failure|0|||
27760040|NCT02343939|54212393|FG004|Overall Study|Treatment failure|0|||
27760041|NCT02343939|54212394|FG005|Overall Study|Treatment failure|0|||
27760042|NCT02343939|54212395|FG006|Overall Study|Treatment failure|2|||
27760043|NCT02343939|54212396|FG007|Overall Study|Treatment failure|1|||
27760044|NCT02343939|54212397|FG008|Overall Study|Treatment failure|0|||
27760045|NCT02343939|54212389|FG000|Overall Study|Investigator's discretion|0|||
27760046|NCT02343939|54212390|FG001|Overall Study|Investigator's discretion|0|||
27760047|NCT02343939|54212391|FG002|Overall Study|Investigator's discretion|0|||
27760048|NCT02343939|54212392|FG003|Overall Study|Investigator's discretion|1|||
27760049|NCT02343939|54212393|FG004|Overall Study|Investigator's discretion|0|||
27760050|NCT02343939|54212394|FG005|Overall Study|Investigator's discretion|0|||
27760051|NCT02343939|54212395|FG006|Overall Study|Investigator's discretion|1|||
27760052|NCT02343939|54212396|FG007|Overall Study|Investigator's discretion|0|||
27760053|NCT02343939|54212397|FG008|Overall Study|Investigator's discretion|0|||
27760054|NCT02343939|54212389|FG000|Overall Study|Adverse Event|0|||
27760055|NCT02343939|54212390|FG001|Overall Study|Adverse Event|0|||
27760056|NCT02343939|54212391|FG002|Overall Study|Adverse Event|0|||
27760057|NCT02343939|54212392|FG003|Overall Study|Adverse Event|0|||
27760058|NCT02343939|54212393|FG004|Overall Study|Adverse Event|0|||
27760059|NCT02343939|54212394|FG005|Overall Study|Adverse Event|1|||
27760060|NCT02343939|54212395|FG006|Overall Study|Adverse Event|0|||
27760061|NCT02343939|54212396|FG007|Overall Study|Adverse Event|0|||
27760062|NCT02343939|54212397|FG008|Overall Study|Adverse Event|0|||
27760063|NCT02343939|54212389|FG000|Overall Study|Never Treated With ENTO|0|||
27760064|NCT02343939|54212390|FG001|Overall Study|Never Treated With ENTO|0|||
27760065|NCT02343939|54212391|FG002|Overall Study|Never Treated With ENTO|0|||
27760066|NCT02343939|54212392|FG003|Overall Study|Never Treated With ENTO|0|||
27760067|NCT02343939|54212393|FG004|Overall Study|Never Treated With ENTO|0|||
27760068|NCT02343939|54212394|FG005|Overall Study|Never Treated With ENTO|0|||
27760069|NCT02343939|54212395|FG006|Overall Study|Never Treated With ENTO|1|||
27760070|NCT02343939|54212396|FG007|Overall Study|Never Treated With ENTO|2|||
27760071|NCT02343939|54212397|FG008|Overall Study|Never Treated With ENTO|0|||
27760072|NCT02397447|54212433|FG000|Overall Study|Lost to Follow-up|2|||
27760073|NCT02397447|54212434|FG001|Overall Study|Lost to Follow-up|2|||
27760074|NCT02397057|54212442|FG000|Overall Study|Withdrawal by Subject|6|||
27760075|NCT02397057|54212443|FG001|Overall Study|Withdrawal by Subject|7|||
27760076|NCT02397057|54212442|FG000|Overall Study|Lost to Follow-up|4|||
27760077|NCT02397057|54212443|FG001|Overall Study|Lost to Follow-up|3|||
27760078|NCT02397057|54212442|FG000|Overall Study|Death|1|||
27760079|NCT02397057|54212443|FG001|Overall Study|Death|0|||
27760080|NCT02397057|54212442|FG000|Overall Study|Adverse Event|0|||
27760081|NCT02397057|54212443|FG001|Overall Study|Adverse Event|1|||
27760082|NCT02397057|54212442|FG000|Overall Study|Physician Decision|0|||
27760083|NCT02397057|54212443|FG001|Overall Study|Physician Decision|1|||
27760084|NCT02397057|54212442|FG000|Overall Study|Subject did not receive study drug|0|||
27760085|NCT02397057|54212443|FG001|Overall Study|Subject did not receive study drug|1|||
27760086|NCT02343549|54212449|FG000|Overall Study|Death|11|||
27760087|NCT02343549|54212449|FG000|Overall Study|Withdrawal by Subject|2|||
27760088|NCT02343159|54212456|FG000|Overall Study|Early Study Termination|16|||
27760089|NCT02343159|54212457|FG001|Overall Study|Early Study Termination|19|||
27760090|NCT02343159|54212458|FG002|Overall Study|Early Study Termination|23|||
27760091|NCT02343159|54212456|FG000|Overall Study|Physician Decision|2|||
27760092|NCT02343159|54212457|FG001|Overall Study|Physician Decision|0|||
27760093|NCT02343159|54212458|FG002|Overall Study|Physician Decision|1|||
27760094|NCT02343159|54212456|FG000|Overall Study|Withdrawal by Subject|3|||
27760095|NCT02343159|54212457|FG001|Overall Study|Withdrawal by Subject|0|||
27760096|NCT02343159|54212458|FG002|Overall Study|Withdrawal by Subject|2|||
27760097|NCT02343159|54212456|FG000|Overall Study|Lost to Follow-up|0|||
27760098|NCT02343159|54212457|FG001|Overall Study|Lost to Follow-up|2|||
27760099|NCT02343159|54212458|FG002|Overall Study|Lost to Follow-up|2|||
27760100|NCT02343159|54212456|FG000|Overall Study|Adverse Event|4|||
27760101|NCT02343159|54212457|FG001|Overall Study|Adverse Event|4|||
27760102|NCT02343159|54212458|FG002|Overall Study|Adverse Event|2|||
27760103|NCT02343159|54212456|FG000|Overall Study|Sponsor Decision|0|||
27760104|NCT02343159|54212457|FG001|Overall Study|Sponsor Decision|1|||
27760105|NCT02343159|54212458|FG002|Overall Study|Sponsor Decision|0|||
27760106|NCT02343159|54212456|FG000|Overall Study|Enrollment Error|1|||
27760107|NCT02343159|54212457|FG001|Overall Study|Enrollment Error|0|||
27760108|NCT02343159|54212458|FG002|Overall Study|Enrollment Error|0|||
27760109|NCT02395653|54212467|FG000|Overall Study|Exclusion Criteria Met at Screening|4|||
27760110|NCT02395653|54212467|FG000|Overall Study|Consent Withdrawn at Screening|1|||
27760111|NCT02395653|54212467|FG000|Overall Study|SSEC Application But With 0 Dose|1|||
27760112|NCT02395653|54212467|FG000|Overall Study|Investigator Decision at Screening|1|||
27760113|NCT02395653|54212467|FG000|Overall Study|Inclusion Criteria Not Met at Screening|3|||
27760114|NCT02395653|54212467|FG000|Overall Study|Withdrawal by Subject|1|||
27760115|NCT02395653|54212467|FG000|Overall Study|Lost to Follow-up|1|||
27760116|NCT01664923|54212473|FG000|Period1:Double Blind Phase-29 Months|Death|8|||
27760117|NCT01664923|54212474|FG001|Period1:Double Blind Phase-29 Months|Death|6|||
27760118|NCT01664923|54212473|FG000|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0|||
27760119|NCT01664923|54212474|FG001|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1|||
27760120|NCT01664923|54212473|FG000|Period1:Double Blind Phase-29 Months|Protocol Violation|2|||
27760121|NCT01664923|54212474|FG001|Period1:Double Blind Phase-29 Months|Protocol Violation|0|||
27760122|NCT01664923|54212473|FG000|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12|||
27760123|NCT01664923|54212474|FG001|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8|||
27760124|NCT01664923|54212473|FG000|Period1:Double Blind Phase-29 Months|Disease Progression|65|||
27760125|NCT01664923|54212474|FG001|Period1:Double Blind Phase-29 Months|Disease Progression|132|||
27760126|NCT01664923|54212473|FG000|Period1:Double Blind Phase-29 Months|Adverse Event|14|||
27760127|NCT01664923|54212474|FG001|Period1:Double Blind Phase-29 Months|Adverse Event|9|||
27760128|NCT01664923|54212473|FG000|Period1:Double Blind Phase-29 Months|Other|3|||
27760129|NCT01664923|54212474|FG001|Period1:Double Blind Phase-29 Months|Other|4|||
27760130|NCT01664923|54212473|FG000|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1|||
27760131|NCT01664923|54212474|FG001|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0|||
27760132|NCT01664923|54212473|FG000|Period 2: Open-label Phase-36 Months|Death|3|||
27760133|NCT01664923|54212474|FG001|Period 2: Open-label Phase-36 Months|Death|1|||
27760134|NCT01664923|54212473|FG000|Period 2: Open-label Phase-36 Months|On Treatment|1|||
27760135|NCT01664923|54212474|FG001|Period 2: Open-label Phase-36 Months|On Treatment|1|||
27760136|NCT01664923|54212473|FG000|Period 2: Open-label Phase-36 Months|Disease progression|28|||
27760137|NCT01664923|54212474|FG001|Period 2: Open-label Phase-36 Months|Disease progression|9|||
27760138|NCT01664923|54212473|FG000|Period 2: Open-label Phase-36 Months|Other|3|||
27760139|NCT01664923|54212474|FG001|Period 2: Open-label Phase-36 Months|Other|1|||
27760140|NCT01664923|54212473|FG000|Period 2: Open-label Phase-36 Months|Adverse Event|4|||
27760141|NCT01664923|54212474|FG001|Period 2: Open-label Phase-36 Months|Adverse Event|7|||
27760142|NCT01664923|54212473|FG000|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2|||
27760143|NCT01664923|54212474|FG001|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4|||
27760144|NCT01664533|54212484|FG000|Overall Study|Death|42|||
27926936|NCT01013740|54583422|FG001|Overall Study|Lost to Follow-up|5|||
27760145|NCT01664533|54212484|FG000|Overall Study|Lost to Follow-up|3|||
27760146|NCT01664533|54212484|FG000|Overall Study|Study termination|9|||
27760147|NCT01664533|54212484|FG000|Overall Study|Protocol Violation|3|||
27760148|NCT02584855|54212489|FG000|Open-Label Treatment Period|Lack of Efficacy|61|||
27760149|NCT02584855|54212490|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
27760150|NCT02584855|54212491|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
27760151|NCT02584855|54212492|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
27760152|NCT02584855|54212493|FG004|Open-Label Treatment Period|Lack of Efficacy|0|||
27760153|NCT02584855|54212494|FG005|Open-Label Treatment Period|Lack of Efficacy|0|||
27760154|NCT02584855|54212489|FG000|Open-Label Treatment Period|Withdrawal by Subject|21|||
27760155|NCT02584855|54212490|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
27760156|NCT02584855|54212491|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
27760157|NCT02584855|54212492|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
27760158|NCT02584855|54212493|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
27760159|NCT02584855|54212494|FG005|Open-Label Treatment Period|Withdrawal by Subject|0|||
27760160|NCT02584855|54212489|FG000|Open-Label Treatment Period|Adverse Event|14|||
27760161|NCT02584855|54212490|FG001|Open-Label Treatment Period|Adverse Event|0|||
27760162|NCT02584855|54212491|FG002|Open-Label Treatment Period|Adverse Event|0|||
27760163|NCT02584855|54212492|FG003|Open-Label Treatment Period|Adverse Event|0|||
27760164|NCT02584855|54212493|FG004|Open-Label Treatment Period|Adverse Event|0|||
27760165|NCT02584855|54212494|FG005|Open-Label Treatment Period|Adverse Event|0|||
27760166|NCT02584855|54212489|FG000|Open-Label Treatment Period|Death|2|||
27760167|NCT02584855|54212490|FG001|Open-Label Treatment Period|Death|0|||
27760168|NCT02584855|54212491|FG002|Open-Label Treatment Period|Death|0|||
27760169|NCT02584855|54212492|FG003|Open-Label Treatment Period|Death|0|||
27760170|NCT02584855|54212493|FG004|Open-Label Treatment Period|Death|0|||
27760171|NCT02584855|54212494|FG005|Open-Label Treatment Period|Death|0|||
27760172|NCT02584855|54212489|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
27760173|NCT02584855|54212490|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
27760174|NCT02584855|54212491|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
27760175|NCT02584855|54212492|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
27760176|NCT02584855|54212493|FG004|Open-Label Treatment Period|Lost to Follow-up|0|||
27760177|NCT02584855|54212494|FG005|Open-Label Treatment Period|Lost to Follow-up|0|||
27760178|NCT02584855|54212489|FG000|Open-Label Treatment Period|Protocol Violation|1|||
27760179|NCT02584855|54212490|FG001|Open-Label Treatment Period|Protocol Violation|0|||
27760180|NCT02584855|54212491|FG002|Open-Label Treatment Period|Protocol Violation|0|||
27760181|NCT02584855|54212492|FG003|Open-Label Treatment Period|Protocol Violation|0|||
27760182|NCT02584855|54212493|FG004|Open-Label Treatment Period|Protocol Violation|0|||
27760183|NCT02584855|54212494|FG005|Open-Label Treatment Period|Protocol Violation|0|||
27760184|NCT02584855|54212489|FG000|Open-Label Treatment Period|No PI Available|2|||
27760185|NCT02584855|54212490|FG001|Open-Label Treatment Period|No PI Available|0|||
27760186|NCT02584855|54212491|FG002|Open-Label Treatment Period|No PI Available|0|||
27760187|NCT02584855|54212492|FG003|Open-Label Treatment Period|No PI Available|0|||
27760188|NCT02584855|54212493|FG004|Open-Label Treatment Period|No PI Available|0|||
27760189|NCT02584855|54212494|FG005|Open-Label Treatment Period|No PI Available|0|||
27760190|NCT02584855|54212489|FG000|Open-Label Treatment Period|Sponsor Decision|1|||
27760191|NCT02584855|54212490|FG001|Open-Label Treatment Period|Sponsor Decision|0|||
27760192|NCT02584855|54212491|FG002|Open-Label Treatment Period|Sponsor Decision|0|||
27760193|NCT02584855|54212492|FG003|Open-Label Treatment Period|Sponsor Decision|0|||
27760194|NCT02584855|54212493|FG004|Open-Label Treatment Period|Sponsor Decision|0|||
27760195|NCT02584855|54212494|FG005|Open-Label Treatment Period|Sponsor Decision|0|||
27760196|NCT02584855|54212489|FG000|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
27760197|NCT02584855|54212490|FG001|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
27760198|NCT02584855|54212491|FG002|Double-Blind Withdrawal Period|Withdrawal by Subject|2|||
27760199|NCT02584855|54212492|FG003|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
27760200|NCT02584855|54212493|FG004|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
27760201|NCT02584855|54212494|FG005|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
27760202|NCT02584855|54212489|FG000|Double-Blind Withdrawal Period|Adverse Event|0|||
27760203|NCT02584855|54212490|FG001|Double-Blind Withdrawal Period|Adverse Event|4|||
27760204|NCT02584855|54212491|FG002|Double-Blind Withdrawal Period|Adverse Event|0|||
27760205|NCT02584855|54212492|FG003|Double-Blind Withdrawal Period|Adverse Event|1|||
27760206|NCT02584855|54212493|FG004|Double-Blind Withdrawal Period|Adverse Event|0|||
27760207|NCT02584855|54212494|FG005|Double-Blind Withdrawal Period|Adverse Event|0|||
27760208|NCT02584855|54212489|FG000|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
27839522|NCT01479595|54326809|FG000|Overall Study|Adverse Event|2|||
27839523|NCT01479595|54326810|FG001|Overall Study|Adverse Event|1|||
27839524|NCT01462357|54326819|FG000|Overall Study|Death|0|||
27760209|NCT02584855|54212490|FG001|Double-Blind Withdrawal Period|Lack of Efficacy|10|||
27760210|NCT02584855|54212491|FG002|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
27760211|NCT02584855|54212492|FG003|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
27760212|NCT02584855|54212493|FG004|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
27839525|NCT01462357|54326820|FG001|Overall Study|Death|0|||
27760213|NCT02584855|54212494|FG005|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
27760214|NCT02584855|54212489|FG000|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
27760215|NCT02584855|54212490|FG001|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1|||
27760216|NCT02584855|54212491|FG002|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
27760217|NCT02584855|54212492|FG003|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
27760218|NCT02584855|54212493|FG004|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
27760219|NCT02584855|54212494|FG005|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
27760220|NCT02584855|54212489|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
27760221|NCT02584855|54212490|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
27760222|NCT02584855|54212491|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
27760223|NCT02584855|54212492|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
27760224|NCT02584855|54212493|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|7|||
27760225|NCT02584855|54212494|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
27760226|NCT02584855|54212489|FG000|Post Treatment Follow-up Period|Protocol Violation|0|||
27760227|NCT02584855|54212490|FG001|Post Treatment Follow-up Period|Protocol Violation|0|||
27760228|NCT02584855|54212491|FG002|Post Treatment Follow-up Period|Protocol Violation|0|||
27760229|NCT02584855|54212492|FG003|Post Treatment Follow-up Period|Protocol Violation|0|||
27760230|NCT02584855|54212493|FG004|Post Treatment Follow-up Period|Protocol Violation|1|||
27760231|NCT02584855|54212494|FG005|Post Treatment Follow-up Period|Protocol Violation|0|||
27760232|NCT02581891|54212509|FG000|Overall Study|Adverse Event|4|||
27760233|NCT02581891|54212510|FG001|Overall Study|Adverse Event|6|||
27760234|NCT02581891|54212509|FG000|Overall Study|Death|3|||
27760235|NCT02581891|54212510|FG001|Overall Study|Death|4|||
27760236|NCT02581891|54212509|FG000|Overall Study|Lost to Follow-up|1|||
27760237|NCT02581891|54212510|FG001|Overall Study|Lost to Follow-up|2|||
27760238|NCT02581891|54212509|FG000|Overall Study|Physician Decision|0|||
27760239|NCT02581891|54212510|FG001|Overall Study|Physician Decision|1|||
27760240|NCT02581891|54212509|FG000|Overall Study|Withdrawal by Subject|4|||
27760241|NCT02581891|54212510|FG001|Overall Study|Withdrawal by Subject|5|||
27760242|NCT02581891|54212509|FG000|Overall Study|Other Reasons|3|||
27760243|NCT02581891|54212510|FG001|Overall Study|Other Reasons|1|||
27760244|NCT02581891|54212509|FG000|Overall Study|Discontinued during followup|1|||
27760245|NCT02581891|54212510|FG001|Overall Study|Discontinued during followup|0|||
27760246|NCT02581345|54212519|FG000|Part 1: up to Week 16|Adverse Event|3|||
27760247|NCT02581345|54212520|FG001|Part 1: up to Week 16|Adverse Event|8|||
27760248|NCT02581345|54212521|FG002|Part 1: up to Week 16|Adverse Event|0|||
27760249|NCT02581345|54212522|FG003|Part 1: up to Week 16|Adverse Event|0|||
27760250|NCT02581345|54212519|FG000|Part 1: up to Week 16|Physician Decision|2|||
27760251|NCT02581345|54212520|FG001|Part 1: up to Week 16|Physician Decision|4|||
27760252|NCT02581345|54212521|FG002|Part 1: up to Week 16|Physician Decision|0|||
27760253|NCT02581345|54212522|FG003|Part 1: up to Week 16|Physician Decision|0|||
27760254|NCT02581345|54212519|FG000|Part 1: up to Week 16|Withdrawal by Subject|4|||
27760255|NCT02581345|54212520|FG001|Part 1: up to Week 16|Withdrawal by Subject|7|||
27760256|NCT02581345|54212521|FG002|Part 1: up to Week 16|Withdrawal by Subject|0|||
27760257|NCT02581345|54212522|FG003|Part 1: up to Week 16|Withdrawal by Subject|0|||
27760258|NCT02581345|54212519|FG000|Part 1: up to Week 16|Lost to Follow-up|2|||
27760259|NCT02581345|54212520|FG001|Part 1: up to Week 16|Lost to Follow-up|0|||
27760260|NCT02581345|54212521|FG002|Part 1: up to Week 16|Lost to Follow-up|0|||
27760261|NCT02581345|54212522|FG003|Part 1: up to Week 16|Lost to Follow-up|0|||
27760262|NCT02581345|54212519|FG000|Part 1: up to Week 16|Unspecified Reason|3|||
27760263|NCT02581345|54212520|FG001|Part 1: up to Week 16|Unspecified Reason|3|||
27760264|NCT02581345|54212521|FG002|Part 1: up to Week 16|Unspecified Reason|0|||
27760265|NCT02581345|54212522|FG003|Part 1: up to Week 16|Unspecified Reason|0|||
27760266|NCT02581345|54212519|FG000|Part 1: up to Week 16|Did Not Receive Treatment|1|||
27760267|NCT02581345|54212520|FG001|Part 1: up to Week 16|Did Not Receive Treatment|1|||
27760268|NCT02581345|54212521|FG002|Part 1: up to Week 16|Did Not Receive Treatment|0|||
27760269|NCT02581345|54212522|FG003|Part 1: up to Week 16|Did Not Receive Treatment|0|||
27760270|NCT02581345|54212519|FG000|Part 2: Week 17 to Week 47|Adverse Event|5|||
27760271|NCT02581345|54212520|FG001|Part 2: Week 17 to Week 47|Adverse Event|0|||
27760272|NCT02581345|54212521|FG002|Part 2: Week 17 to Week 47|Adverse Event|2|||
27760273|NCT02581345|54212522|FG003|Part 2: Week 17 to Week 47|Adverse Event|2|||
27760274|NCT02581345|54212519|FG000|Part 2: Week 17 to Week 47|Physician Decision|3|||
27760275|NCT02581345|54212520|FG001|Part 2: Week 17 to Week 47|Physician Decision|0|||
27760276|NCT02581345|54212521|FG002|Part 2: Week 17 to Week 47|Physician Decision|2|||
27760277|NCT02581345|54212522|FG003|Part 2: Week 17 to Week 47|Physician Decision|1|||
27760278|NCT02581345|54212519|FG000|Part 2: Week 17 to Week 47|Withdrawal by Subject|9|||
27760279|NCT02581345|54212520|FG001|Part 2: Week 17 to Week 47|Withdrawal by Subject|0|||
27760280|NCT02581345|54212521|FG002|Part 2: Week 17 to Week 47|Withdrawal by Subject|7|||
27760281|NCT02581345|54212522|FG003|Part 2: Week 17 to Week 47|Withdrawal by Subject|5|||
27839526|NCT01462357|54326821|FG002|Overall Study|Death|1|||
27839527|NCT01462357|54326819|FG000|Overall Study|Withdrawal by Subject|3|||
27760282|NCT02581345|54212519|FG000|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8|||
27760283|NCT02581345|54212520|FG001|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0|||
27760284|NCT02581345|54212521|FG002|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3|||
27760285|NCT02581345|54212522|FG003|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2|||
27760286|NCT02581345|54212519|FG000|Part 2: Week 17 to Week 47|Lost to Follow-up|2|||
27760287|NCT02581345|54212520|FG001|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
27760288|NCT02581345|54212521|FG002|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
27760289|NCT02581345|54212522|FG003|Part 2: Week 17 to Week 47|Lost to Follow-up|1|||
27760290|NCT02581345|54212519|FG000|Part 2: Week 17 to Week 47|Unspecified Reason|2|||
27760291|NCT02581345|54212520|FG001|Part 2: Week 17 to Week 47|Unspecified Reason|0|||
27760292|NCT02581345|54212521|FG002|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
27760293|NCT02581345|54212522|FG003|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
27760294|NCT02581189|54212540|FG000|Overall Study|Failure to return|36|||
27760295|NCT02581189|54212540|FG000|Overall Study|Withdrew consent|5|||
27760296|NCT02581189|54212540|FG000|Overall Study|Death|3|||
27760297|NCT02581189|54212540|FG000|Overall Study|Insufficient virological response|2|||
27760298|NCT02581189|54212540|FG000|Overall Study|Other, not specified|7|||
27760299|NCT00352027|54212547|FG000|Overall Study|Progressive disease|3|||
27760300|NCT02576977|54212575|FG000|Overall Study|Adverse Event|13|||
27760301|NCT02576977|54212576|FG001|Overall Study|Adverse Event|2|||
27760302|NCT02576977|54212575|FG000|Overall Study|Death|73|||
27760303|NCT02576977|54212576|FG001|Overall Study|Death|60|||
27760304|NCT02576977|54212575|FG000|Overall Study|Screen failure|1|||
27760305|NCT02576977|54212576|FG001|Overall Study|Screen failure|0|||
27760306|NCT02576977|54212575|FG000|Overall Study|Study Terminated at Selected Sites|27|||
27760307|NCT02576977|54212576|FG001|Overall Study|Study Terminated at Selected Sites|50|||
27760308|NCT02576977|54212575|FG000|Overall Study|Withdrawal by Subject|11|||
27760309|NCT02576977|54212576|FG001|Overall Study|Withdrawal by Subject|11|||
27760310|NCT02576977|54212575|FG000|Overall Study|Final Disposition Unknown|0|||
27760311|NCT02576977|54212576|FG001|Overall Study|Final Disposition Unknown|1|||
27760312|NCT02576977|54212575|FG000|Overall Study|Lost to Follow-up|1|||
27760313|NCT02576977|54212576|FG001|Overall Study|Lost to Follow-up|0|||
27760314|NCT02576977|54212575|FG000|Overall Study|Progressive Disease|0|||
27760315|NCT02576977|54212576|FG001|Overall Study|Progressive Disease|1|||
27760316|NCT05150964|54212582|FG000|Overall Study|Lost to Follow-up|2|||
27760317|NCT04952402|54212590|FG000|Overall Study|Lost to Follow-up|1|||
27760318|NCT04952402|54212591|FG001|Overall Study|Lost to Follow-up|3|||
27760319|NCT04952402|54212590|FG000|Overall Study|Lack Of Venous Access|0|||
27760320|NCT04952402|54212591|FG001|Overall Study|Lack Of Venous Access|1|||
27760321|NCT04378010|54212630|FG000|Overall Study|Adverse Event|8|||
27760322|NCT04378010|54212631|FG001|Overall Study|Adverse Event|14|||
27760323|NCT04378010|54212632|FG002|Overall Study|Adverse Event|4|||
27760324|NCT04378010|54212630|FG000|Overall Study|Withdrawal by Subject|0|||
27760325|NCT04378010|54212631|FG001|Overall Study|Withdrawal by Subject|2|||
27760326|NCT04378010|54212632|FG002|Overall Study|Withdrawal by Subject|1|||
27839528|NCT01462357|54326820|FG001|Overall Study|Withdrawal by Subject|11|||
27760327|NCT04378010|54212630|FG000|Overall Study|Protocol Violation|2|||
27760328|NCT04378010|54212631|FG001|Overall Study|Protocol Violation|1|||
27760329|NCT04378010|54212632|FG002|Overall Study|Protocol Violation|4|||
27760330|NCT04378010|54212630|FG000|Overall Study|Study terminated by Sponsor|22|||
27760331|NCT04378010|54212631|FG001|Overall Study|Study terminated by Sponsor|16|||
27760332|NCT04378010|54212632|FG002|Overall Study|Study terminated by Sponsor|22|||
27760333|NCT04378010|54212630|FG000|Overall Study|Subject inability to complete study visit|0|||
27760334|NCT04378010|54212631|FG001|Overall Study|Subject inability to complete study visit|0|||
27760335|NCT04378010|54212632|FG002|Overall Study|Subject inability to complete study visit|1|||
27760336|NCT04378010|54212630|FG000|Overall Study|Subject never dosed|0|||
27760337|NCT04378010|54212631|FG001|Overall Study|Subject never dosed|1|||
27760338|NCT04378010|54212632|FG002|Overall Study|Subject never dosed|0|||
27760339|NCT04349072|54212643|FG000|Randomization Period|Found ineligible post enrollment|0|||
27760340|NCT04349072|54212644|FG001|Randomization Period|Found ineligible post enrollment|1|||
27760341|NCT04349072|54212643|FG000|Treatment Period|Permanent Stopping Criteria Met|0|||
27760342|NCT04349072|54212644|FG001|Treatment Period|Permanent Stopping Criteria Met|2|||
27760343|NCT04349072|54212643|FG000|Treatment Period|Proceeding With Septal Reduction Therapy (SRT)|3|||
27760344|NCT04349072|54212644|FG001|Treatment Period|Proceeding With Septal Reduction Therapy (SRT)|5|||
27760345|NCT04349072|54212643|FG000|Treatment Period|Physician Decision|0|||
27760346|NCT04349072|54212644|FG001|Treatment Period|Physician Decision|1|||
27760347|NCT04349072|54212643|FG000|Treatment Period|Protocol Violation|0|||
27760348|NCT04349072|54212644|FG001|Treatment Period|Protocol Violation|1|||
27760349|NCT04349072|54212643|FG000|Treatment Period|Withdrawal by Subject|1|||
27760350|NCT04349072|54212644|FG001|Treatment Period|Withdrawal by Subject|1|||
27760351|NCT04240886|54212650|FG000|Treatment Phase|Death|4|||
27760352|NCT04240886|54212650|FG000|Treatment Phase|Discontinuation by Subject|1|||
27760353|NCT04240886|54212650|FG000|Treatment Phase|Adverse Event|5|||
27760354|NCT04240886|54212650|FG000|Follow-up Phase|Withdrawal by Subject|1|||
27760355|NCT04240886|54212650|FG000|Follow-up Phase|Discontinuation by Subject|1|||
27760356|NCT04240886|54212650|FG000|Follow-up Phase|Death|2|||
27760357|NCT04074161|54212666|FG000|Overall Study|Withdrawal by Subject|2|||
27760358|NCT04074161|54212667|FG001|Overall Study|Withdrawal by Subject|4|||
27760359|NCT04074161|54212668|FG002|Overall Study|Withdrawal by Subject|1|||
27760360|NCT04074161|54212666|FG000|Overall Study|Lost to Follow-up|4|||
27760361|NCT04074161|54212667|FG001|Overall Study|Lost to Follow-up|5|||
27760362|NCT04074161|54212668|FG002|Overall Study|Lost to Follow-up|3|||
27760363|NCT03966157|54212678|FG000|Overall Study|Physician Decision|1|||
27760364|NCT03966157|54212679|FG001|Overall Study|Physician Decision|0|||
27760365|NCT03733210|54212687|FG000|Overall Study|Lymph nodes not collected or not evaluable|4|||
27760366|NCT03733210|54212688|FG001|Overall Study|Lymph nodes not collected or not evaluable|2|||
27760367|NCT03698994|54212694|FG000|Overall Study|Adverse Event|2|||
27760368|NCT03698994|54212694|FG000|Overall Study|Death|1|||
27760369|NCT03698994|54212694|FG000|Overall Study|Physician Decision|1|||
27760370|NCT03698994|54212694|FG000|Overall Study|Withdrawal by Subject|3|||
27760371|NCT03698994|54212694|FG000|Overall Study|Progressive Disease|12|||
27760372|NCT03627468|54212700|FG000|Overall Study|Adverse Event|5|||
27760373|NCT03627468|54212701|FG001|Overall Study|Adverse Event|33|||
27760374|NCT03627468|54212700|FG000|Overall Study|Withdrawal by Subject|13|||
27760375|NCT03627468|54212701|FG001|Overall Study|Withdrawal by Subject|23|||
27760376|NCT03627468|54212700|FG000|Overall Study|Physician Decision|1|||
27760377|NCT03627468|54212701|FG001|Overall Study|Physician Decision|0|||
27760378|NCT03627468|54212700|FG000|Overall Study|Protocol Violation|0|||
27760379|NCT03627468|54212701|FG001|Overall Study|Protocol Violation|2|||
27760380|NCT03627468|54212700|FG000|Overall Study|Lost to Follow-up|10|||
27760381|NCT03627468|54212701|FG001|Overall Study|Lost to Follow-up|16|||
27760382|NCT03627468|54212700|FG000|Overall Study|Death|1|||
27760383|NCT03627468|54212701|FG001|Overall Study|Death|0|||
27760384|NCT03627468|54212700|FG000|Overall Study|Pregnancy|1|||
27760385|NCT03627468|54212701|FG001|Overall Study|Pregnancy|1|||
27760386|NCT03627468|54212700|FG000|Overall Study|Lack of Efficacy|0|||
27760387|NCT03627468|54212701|FG001|Overall Study|Lack of Efficacy|2|||
27760388|NCT03627468|54212700|FG000|Overall Study|Poor Compliance or Noncompliance|0|||
27760389|NCT03627468|54212701|FG001|Overall Study|Poor Compliance or Noncompliance|2|||
27760390|NCT03595176|54212709|FG000|Overall Study|Death|0|||
27760391|NCT03595176|54212710|FG001|Overall Study|Death|2|||
27760392|NCT03595176|54212709|FG000|Overall Study|Lost to Follow-up|0|||
27760393|NCT03595176|54212710|FG001|Overall Study|Lost to Follow-up|1|||
27760394|NCT03052816|54212719|FG000|Overall Study|Withdrawal by Subject|1|||
27760395|NCT03052816|54212720|FG001|Overall Study|Withdrawal by Subject|0|||
27760396|NCT03052816|54212719|FG000|Overall Study|Desired opioids|2|||
27760397|NCT03052816|54212720|FG001|Overall Study|Desired opioids|0|||
27760398|NCT02684058|54212740|FG000|Treatment Period|Treatment ongoing at the time of the cut-off, 23-Aug-2021|61|||
27760399|NCT02684058|54212741|FG001|Treatment Period|Treatment ongoing at the time of the cut-off, 23-Aug-2021|8|||
27760400|NCT02684058|54212742|FG002|Treatment Period|Treatment ongoing at the time of the cut-off, 23-Aug-2021|21|||
27760401|NCT02684058|54212740|FG000|Treatment Period|Progressive disease|5|||
27760402|NCT02684058|54212741|FG001|Treatment Period|Progressive disease|9|||
27760403|NCT02684058|54212742|FG002|Treatment Period|Progressive disease|16|||
27760404|NCT02684058|54212740|FG000|Treatment Period|Adverse Event|3|||
27760405|NCT02684058|54212741|FG001|Treatment Period|Adverse Event|6|||
27760406|NCT02684058|54212742|FG002|Treatment Period|Adverse Event|1|||
27760407|NCT02684058|54212740|FG000|Treatment Period|Physician Decision|2|||
27760408|NCT02684058|54212741|FG001|Treatment Period|Physician Decision|1|||
27760409|NCT02684058|54212742|FG002|Treatment Period|Physician Decision|1|||
27760410|NCT02684058|54212740|FG000|Treatment Period|New therapy for study indication|1|||
27760411|NCT02684058|54212741|FG001|Treatment Period|New therapy for study indication|0|||
27760412|NCT02684058|54212742|FG002|Treatment Period|New therapy for study indication|0|||
27760413|NCT02684058|54212740|FG000|Treatment Period|Protocol deviation|0|||
27760414|NCT02684058|54212741|FG001|Treatment Period|Protocol deviation|1|||
27760415|NCT02684058|54212742|FG002|Treatment Period|Protocol deviation|0|||
27760416|NCT02684058|54212740|FG000|Treatment Period|Patient/guardian decision|1|||
27760417|NCT02684058|54212741|FG001|Treatment Period|Patient/guardian decision|3|||
27760418|NCT02684058|54212742|FG002|Treatment Period|Patient/guardian decision|0|||
27760419|NCT02684058|54212740|FG000|Treatment Period|Death|0|||
27760420|NCT02684058|54212741|FG001|Treatment Period|Death|0|||
27760421|NCT02684058|54212742|FG002|Treatment Period|Death|2|||
27760422|NCT02684058|54212740|FG000|Post-treatment Efficacy Follow-up|Ongoing at the time of the cut-off, 23-Aug-2021|5|||
27760423|NCT02684058|54212741|FG001|Post-treatment Efficacy Follow-up|Ongoing at the time of the cut-off, 23-Aug-2021|13|||
27760424|NCT02684058|54212742|FG002|Post-treatment Efficacy Follow-up|Ongoing at the time of the cut-off, 23-Aug-2021|2|||
27760425|NCT02684058|54212740|FG000|Post-treatment Efficacy Follow-up|Physician Decision|0|||
27760426|NCT02684058|54212741|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
27760427|NCT02684058|54212742|FG002|Post-treatment Efficacy Follow-up|Physician Decision|0|||
27760428|NCT02684058|54212740|FG000|Post-treatment Efficacy Follow-up|Progressive disease|0|||
27760429|NCT02684058|54212741|FG001|Post-treatment Efficacy Follow-up|Progressive disease|1|||
27760430|NCT02684058|54212742|FG002|Post-treatment Efficacy Follow-up|Progressive disease|0|||
27760431|NCT02684058|54212740|FG000|Post-treatment Efficacy Follow-up|Patient/guardian decision|1|||
27760432|NCT02684058|54212741|FG001|Post-treatment Efficacy Follow-up|Patient/guardian decision|0|||
27760433|NCT02684058|54212742|FG002|Post-treatment Efficacy Follow-up|Patient/guardian decision|0|||
27760434|NCT02684058|54212740|FG000|Post-treatment Efficacy Follow-up|Death|0|||
27760435|NCT02684058|54212741|FG001|Post-treatment Efficacy Follow-up|Death|0|||
27760436|NCT02684058|54212742|FG002|Post-treatment Efficacy Follow-up|Death|3|||
27760437|NCT02684058|54212740|FG000|Survival Follow-up|Ongoing at the time of the cut-off, 23-Aug-2021|4|||
27760438|NCT02684058|54212741|FG001|Survival Follow-up|Ongoing at the time of the cut-off, 23-Aug-2021|0|||
27760439|NCT02684058|54212742|FG002|Survival Follow-up|Ongoing at the time of the cut-off, 23-Aug-2021|2|||
27760440|NCT02684058|54212740|FG000|Survival Follow-up|Other|2|||
27760441|NCT02684058|54212741|FG001|Survival Follow-up|Other|1|||
27760442|NCT02684058|54212742|FG002|Survival Follow-up|Other|0|||
27760443|NCT02684058|54212740|FG000|Survival Follow-up|Death|0|||
27760444|NCT02684058|54212741|FG001|Survival Follow-up|Death|0|||
27760445|NCT02684058|54212742|FG002|Survival Follow-up|Death|6|||
27760446|NCT02684058|54212740|FG000|Crossover Treatment Period|Treatment ongoing at the time of the cut-off, 23-Aug-2021|0|||
27760447|NCT02684058|54212741|FG001|Crossover Treatment Period|Treatment ongoing at the time of the cut-off, 23-Aug-2021|8|||
27760448|NCT02684058|54212742|FG002|Crossover Treatment Period|Treatment ongoing at the time of the cut-off, 23-Aug-2021|0|||
27760449|NCT02684058|54212740|FG000|Crossover Treatment Period|Progressive disease|0|||
27760450|NCT02684058|54212741|FG001|Crossover Treatment Period|Progressive disease|1|||
27760451|NCT02684058|54212742|FG002|Crossover Treatment Period|Progressive disease|0|||
27760452|NCT02684058|54212740|FG000|Crossover Survival Follow-up|Death|0|||
27760453|NCT02684058|54212741|FG001|Crossover Survival Follow-up|Death|1|||
27760454|NCT02684058|54212742|FG002|Crossover Survival Follow-up|Death|0|||
27760455|NCT02682238|54212758|FG000|Overall Study|Lost to Follow-up|0|||
27760456|NCT02682238|54212759|FG001|Overall Study|Lost to Follow-up|2|||
27760457|NCT02682238|54212758|FG000|Overall Study|Withdrawal by Subject|1|||
27760458|NCT02682238|54212759|FG001|Overall Study|Withdrawal by Subject|0|||
27760459|NCT02682238|54212758|FG000|Overall Study|Adverse Event|1|||
27760460|NCT02682238|54212759|FG001|Overall Study|Adverse Event|0|||
27760461|NCT02682238|54212758|FG000|Overall Study|Non-compliance with Study Drug|1|||
27760462|NCT02682238|54212759|FG001|Overall Study|Non-compliance with Study Drug|0|||
27760463|NCT02682238|54212758|FG000|Overall Study|Non-compliance with Protocol|0|||
27760464|NCT02682238|54212759|FG001|Overall Study|Non-compliance with Protocol|2|||
27760465|NCT02657356|54212783|FG000|Overall Study|Death|1|||
27760466|NCT02657356|54212784|FG001|Overall Study|Death|0|||
27760467|NCT02657356|54212783|FG000|Overall Study|Withdrawal by Subject|5|||
27760468|NCT02657356|54212784|FG001|Overall Study|Withdrawal by Subject|6|||
27760469|NCT02657356|54212783|FG000|Overall Study|Terminated by Sponsor|8|||
27760470|NCT02657356|54212784|FG001|Overall Study|Terminated by Sponsor|5|||
27760471|NCT02657356|54212783|FG000|Overall Study|Rolled over to EAP study|6|||
27760472|NCT02657356|54212784|FG001|Overall Study|Rolled over to EAP study|4|||
27760473|NCT01719562|54212810|FG000|Overall Study|Lost to Follow-up|1|||
27760474|NCT01719562|54212811|FG001|Overall Study|Lost to Follow-up|0|||
27760475|NCT01719562|54212810|FG000|Overall Study|Death|1|||
27760476|NCT01719562|54212811|FG001|Overall Study|Death|0|||
27760477|NCT01719562|54212810|FG000|Overall Study|New cancer diagnosis|1|||
27760478|NCT01719562|54212811|FG001|Overall Study|New cancer diagnosis|0|||
27760479|NCT01700439|54212817|FG000|Overall Study|Lost to Follow-up|47|||
27760480|NCT01700439|54212817|FG000|Overall Study|Withdrawal by Subject|183|||
27760481|NCT01700439|54212817|FG000|Overall Study|Death|186|||
27760482|NCT01433289|54212839|FG000|Overall Study|Pregnancy|0|||
27760483|NCT01433289|54212840|FG001|Overall Study|Pregnancy|1|||
27760484|NCT01433289|54212841|FG002|Overall Study|Pregnancy|0|||
27760485|NCT01433289|54212842|FG003|Overall Study|Pregnancy|0|||
27760486|NCT00980460|54212867|FG000|Overall Study|Death|0|||
27760487|NCT00980460|54212868|FG001|Overall Study|Death|0|||
27760488|NCT00980460|54212869|FG002|Overall Study|Death|1|||
27760489|NCT00980460|54212870|FG003|Overall Study|Death|2|||
27760490|NCT00980460|54212871|FG004|Overall Study|Death|1|||
27760491|NCT00980460|54212867|FG000|Overall Study|Lack of Efficacy|0|||
27760492|NCT00980460|54212868|FG001|Overall Study|Lack of Efficacy|0|||
27760493|NCT00980460|54212869|FG002|Overall Study|Lack of Efficacy|10|||
27760494|NCT00980460|54212870|FG003|Overall Study|Lack of Efficacy|6|||
27760495|NCT00980460|54212871|FG004|Overall Study|Lack of Efficacy|8|||
27760496|NCT00980460|54212867|FG000|Overall Study|Lost to Follow-up|0|||
27760497|NCT00980460|54212868|FG001|Overall Study|Lost to Follow-up|0|||
27760498|NCT00980460|54212869|FG002|Overall Study|Lost to Follow-up|0|||
27760499|NCT00980460|54212870|FG003|Overall Study|Lost to Follow-up|1|||
27760500|NCT00980460|54212871|FG004|Overall Study|Lost to Follow-up|0|||
27760501|NCT00980460|54212867|FG000|Overall Study|Physician Decision|0|||
27760502|NCT00980460|54212868|FG001|Overall Study|Physician Decision|0|||
27760503|NCT00980460|54212869|FG002|Overall Study|Physician Decision|11|||
27760504|NCT00980460|54212870|FG003|Overall Study|Physician Decision|5|||
27760505|NCT00980460|54212871|FG004|Overall Study|Physician Decision|3|||
27760506|NCT00980460|54212867|FG000|Overall Study|Withdrawal by Subject|0|||
27760507|NCT00980460|54212868|FG001|Overall Study|Withdrawal by Subject|0|||
27760508|NCT00980460|54212869|FG002|Overall Study|Withdrawal by Subject|1|||
27760509|NCT00980460|54212870|FG003|Overall Study|Withdrawal by Subject|0|||
27760510|NCT00980460|54212871|FG004|Overall Study|Withdrawal by Subject|0|||
27760511|NCT00980460|54212867|FG000|Overall Study|Ineligible|0|||
27760512|NCT00980460|54212868|FG001|Overall Study|Ineligible|2|||
27760513|NCT00980460|54212869|FG002|Overall Study|Ineligible|3|||
27760514|NCT00980460|54212870|FG003|Overall Study|Ineligible|1|||
27760515|NCT00980460|54212871|FG004|Overall Study|Ineligible|4|||
27760516|NCT00980460|54212867|FG000|Overall Study|Refusal of further therapy|0|||
27760517|NCT00980460|54212868|FG001|Overall Study|Refusal of further therapy|2|||
27760518|NCT00980460|54212869|FG002|Overall Study|Refusal of further therapy|3|||
27760519|NCT00980460|54212870|FG003|Overall Study|Refusal of further therapy|2|||
27760520|NCT00980460|54212871|FG004|Overall Study|Refusal of further therapy|0|||
27760521|NCT00980460|54212867|FG000|Overall Study|No therapy within 42 days of resection|0|||
27760522|NCT00980460|54212868|FG001|Overall Study|No therapy within 42 days of resection|0|||
27760523|NCT00980460|54212869|FG002|Overall Study|No therapy within 42 days of resection|3|||
27760524|NCT00980460|54212870|FG003|Overall Study|No therapy within 42 days of resection|1|||
27760525|NCT00980460|54212871|FG004|Overall Study|No therapy within 42 days of resection|0|||
27760526|NCT00980460|54212867|FG000|Overall Study|No transplant by protocol timepoints|0|||
27760527|NCT00980460|54212868|FG001|Overall Study|No transplant by protocol timepoints|0|||
27760528|NCT00980460|54212869|FG002|Overall Study|No transplant by protocol timepoints|3|||
27760529|NCT00980460|54212870|FG003|Overall Study|No transplant by protocol timepoints|0|||
27760530|NCT00980460|54212871|FG004|Overall Study|No transplant by protocol timepoints|0|||
27760531|NCT02576587|54212914|FG000|Baseline|Equipment failure|0|||
27760532|NCT02576587|54212915|FG001|Baseline|Equipment failure|1|||
27760533|NCT02576587|54212914|FG000|Follow up Period (Case Only)|Withdrawal by Subject|25|||
27760534|NCT02576587|54212915|FG001|Follow up Period (Case Only)|Withdrawal by Subject|0|||
27760535|NCT02576587|54212914|FG000|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92|||
27760536|NCT02576587|54212915|FG001|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0|||
27760537|NCT02576587|54212914|FG000|Follow up Period (Case Only)|Controls not eligible for followup|0|||
27760538|NCT02576587|54212915|FG001|Follow up Period (Case Only)|Controls not eligible for followup|155|||
27760539|NCT03016975|54212939|FG000|At 30 Days Follow-up|Subject is a Screen failure|1|||
27760540|NCT03016975|54212940|FG001|At 30 Days Follow-up|Subject is a Screen failure|0|||
27760541|NCT03016975|54212941|FG002|At 30 Days Follow-up|Subject is a Screen failure|0|||
27760542|NCT03016975|54212939|FG000|At 6 Months Follow-up|Death|2|||
27760543|NCT03016975|54212940|FG001|At 6 Months Follow-up|Death|0|||
27760544|NCT03016975|54212941|FG002|At 6 Months Follow-up|Death|0|||
27760545|NCT03016975|54212939|FG000|At 6 Months Follow-up|Subject withdrawn by investigator|1|||
27839529|NCT01462357|54326821|FG002|Overall Study|Withdrawal by Subject|3|||
27839530|NCT01462357|54326819|FG000|Overall Study|Migrated/moved from study area|2|||
27760546|NCT03016975|54212940|FG001|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
27760547|NCT03016975|54212941|FG002|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
27839531|NCT01462357|54326820|FG001|Overall Study|Migrated/moved from study area|3|||
27760548|NCT03016975|54212939|FG000|At 6 Months Follow-up|Re-attempt procedure|1|||
27760549|NCT03016975|54212940|FG001|At 6 Months Follow-up|Re-attempt procedure|0|||
27760550|NCT03016975|54212941|FG002|At 6 Months Follow-up|Re-attempt procedure|0|||
27760551|NCT03016975|54212939|FG000|At 6 Months Follow-up|Aborted implant|1|||
27760552|NCT03016975|54212940|FG001|At 6 Months Follow-up|Aborted implant|0|||
27760553|NCT03016975|54212941|FG002|At 6 Months Follow-up|Aborted implant|0|||
27760554|NCT03016975|54212939|FG000|At 2 Year Follow-up|Death|1|||
27760555|NCT03016975|54212940|FG001|At 2 Year Follow-up|Death|0|||
27760556|NCT03016975|54212941|FG002|At 2 Year Follow-up|Death|0|||
27760557|NCT03016975|54212939|FG000|At 3 Year Follow-up|Death|1|||
27760558|NCT03016975|54212940|FG001|At 3 Year Follow-up|Death|0|||
27760559|NCT03016975|54212941|FG002|At 3 Year Follow-up|Death|0|||
27760560|NCT03016975|54212939|FG000|At 3 Year Follow-up|Withdrawal by Subject|1|||
27760561|NCT03016975|54212940|FG001|At 3 Year Follow-up|Withdrawal by Subject|0|||
27760562|NCT03016975|54212941|FG002|At 3 Year Follow-up|Withdrawal by Subject|0|||
27760563|NCT05340751|54212995|FG000|Overall Study|Physician Decision|3|||
27760564|NCT02575807|54213004|FG000|Overall Study|Death|8|||
27760565|NCT02575807|54213005|FG001|Overall Study|Death|3|||
27760566|NCT02575807|54213006|FG002|Overall Study|Death|7|||
27760567|NCT02575807|54213007|FG003|Overall Study|Death|0|||
27760568|NCT02575807|54213008|FG004|Overall Study|Death|1|||
27760569|NCT02575807|54213004|FG000|Overall Study|Study terminated by Sponsor|0|||
27760570|NCT02575807|54213005|FG001|Overall Study|Study terminated by Sponsor|1|||
27760571|NCT02575807|54213006|FG002|Overall Study|Study terminated by Sponsor|7|||
27760572|NCT02575807|54213007|FG003|Overall Study|Study terminated by Sponsor|0|||
27760573|NCT02575807|54213008|FG004|Overall Study|Study terminated by Sponsor|1|||
27760574|NCT02575807|54213004|FG000|Overall Study|Terminated due to FDA clinical hold|1|||
27760575|NCT02575807|54213005|FG001|Overall Study|Terminated due to FDA clinical hold|0|||
27760576|NCT02575807|54213006|FG002|Overall Study|Terminated due to FDA clinical hold|0|||
27760577|NCT02575807|54213007|FG003|Overall Study|Terminated due to FDA clinical hold|0|||
27760578|NCT02575807|54213008|FG004|Overall Study|Terminated due to FDA clinical hold|0|||
27760579|NCT02575807|54213004|FG000|Overall Study|Terminated due to physician decision|0|||
27760580|NCT02575807|54213005|FG001|Overall Study|Terminated due to physician decision|0|||
27760581|NCT02575807|54213006|FG002|Overall Study|Terminated due to physician decision|1|||
27760582|NCT02575807|54213007|FG003|Overall Study|Terminated due to physician decision|0|||
27760583|NCT02575807|54213008|FG004|Overall Study|Terminated due to physician decision|0|||
27760584|NCT02575807|54213004|FG000|Overall Study|Subject ineligible - medical implant|0|||
27760585|NCT02575807|54213005|FG001|Overall Study|Subject ineligible - medical implant|0|||
27760586|NCT02575807|54213006|FG002|Overall Study|Subject ineligible - medical implant|0|||
27760587|NCT02575807|54213007|FG003|Overall Study|Subject ineligible - medical implant|1|||
27760588|NCT02575807|54213008|FG004|Overall Study|Subject ineligible - medical implant|0|||
27760589|NCT02575807|54213004|FG000|Overall Study|Withdrawal by Subject|0|||
27760590|NCT02575807|54213005|FG001|Overall Study|Withdrawal by Subject|0|||
27760591|NCT02575807|54213006|FG002|Overall Study|Withdrawal by Subject|1|||
27760592|NCT02575807|54213007|FG003|Overall Study|Withdrawal by Subject|1|||
27760593|NCT02575807|54213008|FG004|Overall Study|Withdrawal by Subject|2|||
27760594|NCT02575339|54213043|FG000|Study Treatment|Patient Withdrawal After Therapy Start|1|||
27760595|NCT02575339|54213044|FG001|Study Treatment|Patient Withdrawal After Therapy Start|0|||
27760596|NCT02575339|54213045|FG002|Study Treatment|Patient Withdrawal After Therapy Start|0|||
27760597|NCT02575339|54213043|FG000|Study Treatment|Disease Progression|5|||
27760598|NCT02575339|54213044|FG001|Study Treatment|Disease Progression|2|||
27760599|NCT02575339|54213045|FG002|Study Treatment|Disease Progression|0|||
27760600|NCT02575339|54213043|FG000|Study Treatment|Adverse Event|1|||
27760601|NCT02575339|54213044|FG001|Study Treatment|Adverse Event|2|||
27760602|NCT02575339|54213045|FG002|Study Treatment|Adverse Event|0|||
27760603|NCT02575339|54213043|FG000|Follow up|Death|6|||
27760604|NCT02575339|54213044|FG001|Follow up|Death|2|||
27760605|NCT02575339|54213045|FG002|Follow up|Death|0|||
27760606|NCT02575339|54213043|FG000|Follow up|Study Terminated|0|||
27760607|NCT02575339|54213044|FG001|Follow up|Study Terminated|2|||
27760608|NCT02575339|54213045|FG002|Follow up|Study Terminated|0|||
27760609|NCT02575339|54213043|FG000|Follow up|Death due to progressive disease after coming off treatment early|1|||
27760610|NCT02575339|54213044|FG001|Follow up|Death due to progressive disease after coming off treatment early|0|||
27760611|NCT02575339|54213045|FG002|Follow up|Death due to progressive disease after coming off treatment early|0|||
27760612|NCT01712659|54213058|FG000|Dose Escalation|Physician Decision|0|||
27760613|NCT01712659|54213059|FG001|Dose Escalation|Physician Decision|1|||
27760614|NCT01712659|54213060|FG002|Dose Escalation|Physician Decision|0|||
27760615|NCT01712659|54213061|FG003|Dose Escalation|Physician Decision|0|||
27760616|NCT01712659|54213062|FG004|Dose Escalation|Physician Decision|0|||
27760617|NCT01712659|54213058|FG000|Dose Escalation|Unable to take study drug|0|||
27760618|NCT01712659|54213059|FG001|Dose Escalation|Unable to take study drug|1|||
27760619|NCT01712659|54213060|FG002|Dose Escalation|Unable to take study drug|0|||
27760620|NCT01712659|54213061|FG003|Dose Escalation|Unable to take study drug|0|||
27760621|NCT01712659|54213062|FG004|Dose Escalation|Unable to take study drug|0|||
27760622|NCT01712659|54213058|FG000|Dose Expansion|Early disease progression|1|||
27760623|NCT01712659|54213059|FG001|Dose Expansion|Early disease progression|0|||
27760624|NCT01712659|54213060|FG002|Dose Expansion|Early disease progression|0|||
27760625|NCT01712659|54213061|FG003|Dose Expansion|Early disease progression|0|||
27760626|NCT01712659|54213062|FG004|Dose Expansion|Early disease progression|0|||
27760627|NCT01712659|54213058|FG000|Dose Expansion|Physician Decision|1|||
27760628|NCT01712659|54213059|FG001|Dose Expansion|Physician Decision|0|||
27760629|NCT01712659|54213060|FG002|Dose Expansion|Physician Decision|0|||
27760630|NCT01712659|54213061|FG003|Dose Expansion|Physician Decision|0|||
27760631|NCT01712659|54213062|FG004|Dose Expansion|Physician Decision|0|||
27760632|NCT01610713|54213088|FG000|Overall Study|Adverse Event|3|||
27760633|NCT01610713|54213089|FG001|Overall Study|Adverse Event|0|||
27760634|NCT01610713|54213088|FG000|Overall Study|Lack of Efficacy|1|||
27760635|NCT01610713|54213089|FG001|Overall Study|Lack of Efficacy|0|||
27760636|NCT01610713|54213088|FG000|Overall Study|low mood and poor motivation|1|||
27760637|NCT01610713|54213089|FG001|Overall Study|low mood and poor motivation|0|||
27760638|NCT01610713|54213088|FG000|Overall Study|adv. to use original dose/amitriptyline|1|||
27760639|NCT01610713|54213089|FG001|Overall Study|adv. to use original dose/amitriptyline|0|||
27760640|NCT01610713|54213088|FG000|Overall Study|Lost to Follow-up|0|||
27760641|NCT01610713|54213089|FG001|Overall Study|Lost to Follow-up|1|||
27760642|NCT01606189|54213095|FG000|Second Intenvention (14-20 Days)|Adverse Event|0|||
27760643|NCT01606189|54213096|FG001|Second Intenvention (14-20 Days)|Adverse Event|0|||
27760644|NCT01606189|54213097|FG002|Second Intenvention (14-20 Days)|Adverse Event|0|||
27760645|NCT01606189|54213098|FG003|Second Intenvention (14-20 Days)|Adverse Event|0|||
27760646|NCT01606189|54213099|FG004|Second Intenvention (14-20 Days)|Adverse Event|0|||
27760647|NCT01606189|54213100|FG005|Second Intenvention (14-20 Days)|Adverse Event|1|||
27760648|NCT01606189|54213095|FG000|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
27760649|NCT01606189|54213096|FG001|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
27760650|NCT01606189|54213097|FG002|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
27760651|NCT01606189|54213098|FG003|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
27760652|NCT01606189|54213099|FG004|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
27760653|NCT01606189|54213100|FG005|Third Intenvention (14-20 Days)|Withdrawal by Subject|1|||
27760654|NCT01663987|54213110|FG000|Overall Study|Adverse Event|7|||
27760655|NCT01663987|54213111|FG001|Overall Study|Adverse Event|2|||
27760656|NCT01663987|54213110|FG000|Overall Study|Lost to Follow-up|1|||
27760657|NCT01663987|54213111|FG001|Overall Study|Lost to Follow-up|1|||
27760658|NCT01663987|54213110|FG000|Overall Study|Withdrawal by Subject|2|||
27760659|NCT01663987|54213111|FG001|Overall Study|Withdrawal by Subject|3|||
27760660|NCT01663987|54213110|FG000|Overall Study|Other reason not defined above|3|||
27760661|NCT01663987|54213111|FG001|Overall Study|Other reason not defined above|0|||
27760662|NCT02380677|54213129|FG000|Overall Study|Adverse Event|0|||
27760663|NCT02380677|54213130|FG001|Overall Study|Adverse Event|0|||
27760664|NCT02380677|54213131|FG002|Overall Study|Adverse Event|0|||
27760665|NCT02380677|54213132|FG003|Overall Study|Adverse Event|1|||
27760666|NCT02380677|54213133|FG004|Overall Study|Adverse Event|1|||
27760667|NCT02380677|54213134|FG005|Overall Study|Adverse Event|4|||
27760668|NCT02380677|54213135|FG006|Overall Study|Adverse Event|2|||
27760669|NCT02380677|54213136|FG007|Overall Study|Adverse Event|2|||
27760670|NCT02380677|54213137|FG008|Overall Study|Adverse Event|2|||
27760671|NCT02380677|54213138|FG009|Overall Study|Adverse Event|1|||
27760672|NCT02380677|54213139|FG010|Overall Study|Adverse Event|2|||
27760673|NCT02380677|54213140|FG011|Overall Study|Adverse Event|1|||
27760674|NCT02380677|54213129|FG000|Overall Study|Physician Decision|1|||
27760675|NCT02380677|54213130|FG001|Overall Study|Physician Decision|0|||
27760676|NCT02380677|54213131|FG002|Overall Study|Physician Decision|1|||
27760677|NCT02380677|54213132|FG003|Overall Study|Physician Decision|1|||
27760678|NCT02380677|54213133|FG004|Overall Study|Physician Decision|0|||
27839532|NCT01462357|54326821|FG002|Overall Study|Migrated/moved from study area|1|||
27760679|NCT02380677|54213134|FG005|Overall Study|Physician Decision|0|||
27760680|NCT02380677|54213135|FG006|Overall Study|Physician Decision|0|||
27760681|NCT02380677|54213136|FG007|Overall Study|Physician Decision|0|||
27760682|NCT02380677|54213137|FG008|Overall Study|Physician Decision|0|||
27760683|NCT02380677|54213138|FG009|Overall Study|Physician Decision|0|||
27760684|NCT02380677|54213139|FG010|Overall Study|Physician Decision|0|||
27760685|NCT02380677|54213140|FG011|Overall Study|Physician Decision|0|||
27760686|NCT02380677|54213129|FG000|Overall Study|Lack of Efficacy|0|||
27760687|NCT02380677|54213130|FG001|Overall Study|Lack of Efficacy|1|||
27926937|NCT01013740|54583421|FG000|Overall Study|Physician Decision|2|||
27760688|NCT02380677|54213131|FG002|Overall Study|Lack of Efficacy|2|||
27760689|NCT02380677|54213132|FG003|Overall Study|Lack of Efficacy|0|||
27760690|NCT02380677|54213133|FG004|Overall Study|Lack of Efficacy|4|||
27760691|NCT02380677|54213134|FG005|Overall Study|Lack of Efficacy|1|||
27760692|NCT02380677|54213135|FG006|Overall Study|Lack of Efficacy|1|||
27760693|NCT02380677|54213136|FG007|Overall Study|Lack of Efficacy|2|||
27760694|NCT02380677|54213137|FG008|Overall Study|Lack of Efficacy|2|||
27760695|NCT02380677|54213138|FG009|Overall Study|Lack of Efficacy|0|||
27760696|NCT02380677|54213139|FG010|Overall Study|Lack of Efficacy|2|||
27760697|NCT02380677|54213140|FG011|Overall Study|Lack of Efficacy|1|||
27760698|NCT02380677|54213129|FG000|Overall Study|Withdrawal by Subject|0|||
27760699|NCT02380677|54213130|FG001|Overall Study|Withdrawal by Subject|0|||
27760700|NCT02380677|54213131|FG002|Overall Study|Withdrawal by Subject|0|||
27760701|NCT02380677|54213132|FG003|Overall Study|Withdrawal by Subject|0|||
27760702|NCT02380677|54213133|FG004|Overall Study|Withdrawal by Subject|0|||
27760703|NCT02380677|54213134|FG005|Overall Study|Withdrawal by Subject|0|||
27760704|NCT02380677|54213135|FG006|Overall Study|Withdrawal by Subject|0|||
27760705|NCT02380677|54213136|FG007|Overall Study|Withdrawal by Subject|0|||
27760706|NCT02380677|54213137|FG008|Overall Study|Withdrawal by Subject|0|||
27760707|NCT02380677|54213138|FG009|Overall Study|Withdrawal by Subject|1|||
27760708|NCT02380677|54213139|FG010|Overall Study|Withdrawal by Subject|0|||
27760709|NCT02380677|54213140|FG011|Overall Study|Withdrawal by Subject|3|||
27760710|NCT02380677|54213129|FG000|Overall Study|Other|0|||
27760711|NCT02380677|54213130|FG001|Overall Study|Other|0|||
27760712|NCT02380677|54213131|FG002|Overall Study|Other|0|||
27760713|NCT02380677|54213132|FG003|Overall Study|Other|1|||
27760714|NCT02380677|54213133|FG004|Overall Study|Other|1|||
27760715|NCT02380677|54213134|FG005|Overall Study|Other|1|||
27760716|NCT02380677|54213135|FG006|Overall Study|Other|0|||
27760717|NCT02380677|54213136|FG007|Overall Study|Other|0|||
27760718|NCT02380677|54213137|FG008|Overall Study|Other|0|||
27760719|NCT02380677|54213138|FG009|Overall Study|Other|0|||
27760720|NCT02380677|54213139|FG010|Overall Study|Other|0|||
27760721|NCT02380677|54213140|FG011|Overall Study|Other|0|||
27760722|NCT02380287|54213176|FG000|Overall Study|Adverse Event|0|||
27760723|NCT02380287|54213177|FG001|Overall Study|Adverse Event|0|||
27760724|NCT02380287|54213178|FG002|Overall Study|Adverse Event|1|||
27760725|NCT02380287|54213179|FG003|Overall Study|Adverse Event|0|||
27760726|NCT02380287|54213180|FG004|Overall Study|Adverse Event|0|||
27760727|NCT02380287|54213181|FG005|Overall Study|Adverse Event|0|||
27760728|NCT02380287|54213182|FG006|Overall Study|Adverse Event|0|||
27760729|NCT02380287|54213183|FG007|Overall Study|Adverse Event|0|||
27760730|NCT02343003|54213210|FG000|Overall Study|Withdrawal by Subject|9|||
27760731|NCT02343003|54213211|FG001|Overall Study|Withdrawal by Subject|4|||
27760732|NCT02343003|54213210|FG000|Overall Study|Lost to Follow-up|5|||
27760733|NCT02343003|54213211|FG001|Overall Study|Lost to Follow-up|1|||
27760734|NCT02343003|54213210|FG000|Overall Study|Protocol Violation|1|||
27760735|NCT02343003|54213211|FG001|Overall Study|Protocol Violation|0|||
27760736|NCT02343003|54213210|FG000|Overall Study|Death|0|||
27760737|NCT02343003|54213211|FG001|Overall Study|Death|1|||
27760738|NCT02343003|54213210|FG000|Overall Study|exclusion criteria met|1|||
27760739|NCT02343003|54213211|FG001|Overall Study|exclusion criteria met|1|||
27760740|NCT02343003|54213210|FG000|Overall Study|terminated by sponsor|2|||
27760741|NCT02343003|54213211|FG001|Overall Study|terminated by sponsor|0|||
27760742|NCT02394561|54213219|FG000|CORE Phase|Adverse Event|7|||
27760743|NCT02394561|54213220|FG001|CORE Phase|Adverse Event|9|||
27760744|NCT02394561|54213219|FG000|CORE Phase|Death|0|||
27760745|NCT02394561|54213220|FG001|CORE Phase|Death|1|||
27760746|NCT02394561|54213219|FG000|CORE Phase|Pregnancy|1|||
27760747|NCT02394561|54213220|FG001|CORE Phase|Pregnancy|0|||
27760748|NCT02394561|54213219|FG000|CORE Phase|Lost to Follow-up|1|||
27760749|NCT02394561|54213220|FG001|CORE Phase|Lost to Follow-up|0|||
27760750|NCT02394561|54213219|FG000|CORE Phase|Physician Decision|1|||
27760751|NCT02394561|54213220|FG001|CORE Phase|Physician Decision|1|||
27760752|NCT02394561|54213219|FG000|CORE Phase|Withdrawal by Subject|2|||
27760753|NCT02394561|54213220|FG001|CORE Phase|Withdrawal by Subject|2|||
27760754|NCT02394561|54213219|FG000|CORE Phase|Lack of Efficacy|1|||
27760755|NCT02394561|54213220|FG001|CORE Phase|Lack of Efficacy|6|||
27760756|NCT02394561|54213219|FG000|Extension Phase|Adverse Event|6|||
27760757|NCT02394561|54213220|FG001|Extension Phase|Adverse Event|1|||
27760758|NCT02394561|54213219|FG000|Extension Phase|Death|0|||
27760759|NCT02394561|54213220|FG001|Extension Phase|Death|1|||
27760760|NCT02394561|54213219|FG000|Extension Phase|Protocol Violation|1|||
27760761|NCT02394561|54213220|FG001|Extension Phase|Protocol Violation|0|||
27760762|NCT02394561|54213219|FG000|Extension Phase|Lost to Follow-up|1|||
27760763|NCT02394561|54213220|FG001|Extension Phase|Lost to Follow-up|0|||
27760764|NCT02394561|54213219|FG000|Extension Phase|Physician Decision|0|||
27760765|NCT02394561|54213220|FG001|Extension Phase|Physician Decision|2|||
27760766|NCT02394561|54213219|FG000|Extension Phase|Withdrawal by Subject|0|||
27760767|NCT02394561|54213220|FG001|Extension Phase|Withdrawal by Subject|5|||
27760768|NCT02394561|54213219|FG000|Extension Phase|Lack of Efficacy|3|||
27760769|NCT02394561|54213220|FG001|Extension Phase|Lack of Efficacy|3|||
27760770|NCT02342223|54213229|FG000|Overall Study|Lost to Follow-up|1|||
27760771|NCT02393547|54213233|FG000|Overall Study|Adverse Event|2|||
27760772|NCT02393547|54213233|FG000|Overall Study|Withdrawal by Subject|3|||
27760773|NCT02393547|54213233|FG000|Overall Study|Lost to Follow-up|1|||
27760774|NCT02574637|54213242|FG000|Double-blind Period|Adverse Event|1|||
27760775|NCT02574637|54213243|FG001|Double-blind Period|Adverse Event|0|||
27760776|NCT02574637|54213244|FG002|Double-blind Period|Adverse Event|0|||
27760777|NCT02574637|54213245|FG003|Double-blind Period|Adverse Event|0|||
27760778|NCT02574637|54213246|FG004|Double-blind Period|Adverse Event|0|||
27760779|NCT02574637|54213247|FG005|Double-blind Period|Adverse Event|0|||
27760780|NCT02574637|54213248|FG006|Double-blind Period|Adverse Event|0|||
27760781|NCT02574637|54213249|FG007|Double-blind Period|Adverse Event|0|||
27760782|NCT02574637|54213250|FG008|Double-blind Period|Adverse Event|0|||
27760783|NCT02574637|54213251|FG009|Double-blind Period|Adverse Event|0|||
27760784|NCT02574637|54213242|FG000|Double-blind Period|Lack of Efficacy|0|||
27760785|NCT02574637|54213243|FG001|Double-blind Period|Lack of Efficacy|0|||
27760786|NCT02574637|54213244|FG002|Double-blind Period|Lack of Efficacy|2|||
27760787|NCT02574637|54213245|FG003|Double-blind Period|Lack of Efficacy|0|||
27760788|NCT02574637|54213246|FG004|Double-blind Period|Lack of Efficacy|0|||
27760789|NCT02574637|54213247|FG005|Double-blind Period|Lack of Efficacy|0|||
27760790|NCT02574637|54213248|FG006|Double-blind Period|Lack of Efficacy|0|||
27760791|NCT02574637|54213249|FG007|Double-blind Period|Lack of Efficacy|0|||
27760792|NCT02574637|54213250|FG008|Double-blind Period|Lack of Efficacy|0|||
27760793|NCT02574637|54213251|FG009|Double-blind Period|Lack of Efficacy|0|||
27760794|NCT02574637|54213242|FG000|Double-blind Period|Protocol Deviation|1|||
27760795|NCT02574637|54213243|FG001|Double-blind Period|Protocol Deviation|0|||
27760796|NCT02574637|54213244|FG002|Double-blind Period|Protocol Deviation|0|||
27760797|NCT02574637|54213245|FG003|Double-blind Period|Protocol Deviation|0|||
27760798|NCT02574637|54213246|FG004|Double-blind Period|Protocol Deviation|0|||
27760799|NCT02574637|54213247|FG005|Double-blind Period|Protocol Deviation|0|||
27760800|NCT02574637|54213248|FG006|Double-blind Period|Protocol Deviation|0|||
27760801|NCT02574637|54213249|FG007|Double-blind Period|Protocol Deviation|0|||
27760802|NCT02574637|54213250|FG008|Double-blind Period|Protocol Deviation|0|||
27760803|NCT02574637|54213251|FG009|Double-blind Period|Protocol Deviation|0|||
27760804|NCT02574637|54213242|FG000|Double-blind Period|Non-Compliance With Study Drug|0|||
27760805|NCT02574637|54213243|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
27760806|NCT02574637|54213244|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
27760807|NCT02574637|54213245|FG003|Double-blind Period|Non-Compliance With Study Drug|1|||
27760808|NCT02574637|54213246|FG004|Double-blind Period|Non-Compliance With Study Drug|0|||
27760809|NCT02574637|54213247|FG005|Double-blind Period|Non-Compliance With Study Drug|0|||
27760810|NCT02574637|54213248|FG006|Double-blind Period|Non-Compliance With Study Drug|0|||
27760811|NCT02574637|54213249|FG007|Double-blind Period|Non-Compliance With Study Drug|0|||
27760812|NCT02574637|54213250|FG008|Double-blind Period|Non-Compliance With Study Drug|0|||
27760813|NCT02574637|54213251|FG009|Double-blind Period|Non-Compliance With Study Drug|0|||
27760814|NCT02574637|54213242|FG000|Double-blind Period|Study Terminated By Sponsor|1|||
27760815|NCT02574637|54213243|FG001|Double-blind Period|Study Terminated By Sponsor|1|||
27760816|NCT02574637|54213244|FG002|Double-blind Period|Study Terminated By Sponsor|5|||
27760817|NCT02574637|54213245|FG003|Double-blind Period|Study Terminated By Sponsor|2|||
27760818|NCT02574637|54213246|FG004|Double-blind Period|Study Terminated By Sponsor|2|||
27760819|NCT02574637|54213247|FG005|Double-blind Period|Study Terminated By Sponsor|0|||
27760820|NCT02574637|54213248|FG006|Double-blind Period|Study Terminated By Sponsor|0|||
27760821|NCT02574637|54213249|FG007|Double-blind Period|Study Terminated By Sponsor|0|||
27760822|NCT02574637|54213250|FG008|Double-blind Period|Study Terminated By Sponsor|0|||
27760823|NCT02574637|54213251|FG009|Double-blind Period|Study Terminated By Sponsor|0|||
27760824|NCT02574637|54213242|FG000|Double-blind Period|Reason Not Specified|0|||
27760825|NCT02574637|54213243|FG001|Double-blind Period|Reason Not Specified|0|||
27760826|NCT02574637|54213244|FG002|Double-blind Period|Reason Not Specified|0|||
27760827|NCT02574637|54213245|FG003|Double-blind Period|Reason Not Specified|1|||
27760828|NCT02574637|54213246|FG004|Double-blind Period|Reason Not Specified|0|||
27760829|NCT02574637|54213247|FG005|Double-blind Period|Reason Not Specified|0|||
27760830|NCT02574637|54213248|FG006|Double-blind Period|Reason Not Specified|0|||
27760831|NCT02574637|54213249|FG007|Double-blind Period|Reason Not Specified|0|||
27760832|NCT02574637|54213250|FG008|Double-blind Period|Reason Not Specified|0|||
27760833|NCT02574637|54213251|FG009|Double-blind Period|Reason Not Specified|0|||
27760834|NCT02574637|54213242|FG000|Open-label (OL) Period|Adverse Event|0|||
27760835|NCT02574637|54213243|FG001|Open-label (OL) Period|Adverse Event|0|||
27760836|NCT02574637|54213244|FG002|Open-label (OL) Period|Adverse Event|0|||
27760837|NCT02574637|54213245|FG003|Open-label (OL) Period|Adverse Event|0|||
27760838|NCT02574637|54213246|FG004|Open-label (OL) Period|Adverse Event|0|||
27760839|NCT02574637|54213247|FG005|Open-label (OL) Period|Adverse Event|0|||
27839533|NCT01462357|54326819|FG000|Overall Study|Lost to Follow-up|3|||
27760840|NCT02574637|54213248|FG006|Open-label (OL) Period|Adverse Event|0|||
27760841|NCT02574637|54213249|FG007|Open-label (OL) Period|Adverse Event|0|||
27760842|NCT02574637|54213250|FG008|Open-label (OL) Period|Adverse Event|1|||
27760843|NCT02574637|54213251|FG009|Open-label (OL) Period|Adverse Event|0|||
27760844|NCT02574637|54213242|FG000|Open-label (OL) Period|Withdrawal by Subject|0|||
27760845|NCT02574637|54213243|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
27760846|NCT02574637|54213244|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
27760847|NCT02574637|54213245|FG003|Open-label (OL) Period|Withdrawal by Subject|0|||
27760848|NCT02574637|54213246|FG004|Open-label (OL) Period|Withdrawal by Subject|0|||
27760849|NCT02574637|54213247|FG005|Open-label (OL) Period|Withdrawal by Subject|1|||
27760850|NCT02574637|54213248|FG006|Open-label (OL) Period|Withdrawal by Subject|0|||
27760851|NCT02574637|54213249|FG007|Open-label (OL) Period|Withdrawal by Subject|0|||
27760852|NCT02574637|54213250|FG008|Open-label (OL) Period|Withdrawal by Subject|0|||
27760853|NCT02574637|54213251|FG009|Open-label (OL) Period|Withdrawal by Subject|1|||
27760854|NCT02574637|54213242|FG000|Open-label (OL) Period|Study Terminated By Sponsor|0|||
27760855|NCT02574637|54213243|FG001|Open-label (OL) Period|Study Terminated By Sponsor|0|||
27760856|NCT02574637|54213244|FG002|Open-label (OL) Period|Study Terminated By Sponsor|0|||
27760857|NCT02574637|54213245|FG003|Open-label (OL) Period|Study Terminated By Sponsor|0|||
27760858|NCT02574637|54213246|FG004|Open-label (OL) Period|Study Terminated By Sponsor|0|||
27760859|NCT02574637|54213247|FG005|Open-label (OL) Period|Study Terminated By Sponsor|1|||
27760860|NCT02574637|54213248|FG006|Open-label (OL) Period|Study Terminated By Sponsor|2|||
27760861|NCT02574637|54213249|FG007|Open-label (OL) Period|Study Terminated By Sponsor|1|||
27760862|NCT02574637|54213250|FG008|Open-label (OL) Period|Study Terminated By Sponsor|1|||
27760863|NCT02574637|54213251|FG009|Open-label (OL) Period|Study Terminated By Sponsor|0|||
27760864|NCT02392611|54213281|FG000|Overall Study|Adverse Event|0|||
27760865|NCT02392611|54213282|FG001|Overall Study|Adverse Event|0|||
27760866|NCT02392611|54213283|FG002|Overall Study|Adverse Event|0|||
27760867|NCT02392611|54213284|FG003|Overall Study|Adverse Event|1|||
27760868|NCT02392611|54213285|FG004|Overall Study|Adverse Event|0|||
27760869|NCT02392611|54213286|FG005|Overall Study|Adverse Event|0|||
27760870|NCT02392611|54213287|FG006|Overall Study|Adverse Event|0|||
27760871|NCT02392611|54213288|FG007|Overall Study|Adverse Event|0|||
27760872|NCT02392611|54213289|FG008|Overall Study|Adverse Event|0|||
27760873|NCT02392611|54213281|FG000|Overall Study|Progressive disease|0|||
27760874|NCT02392611|54213282|FG001|Overall Study|Progressive disease|0|||
27760875|NCT02392611|54213283|FG002|Overall Study|Progressive disease|0|||
27760876|NCT02392611|54213284|FG003|Overall Study|Progressive disease|2|||
27760877|NCT02392611|54213285|FG004|Overall Study|Progressive disease|1|||
27760878|NCT02392611|54213286|FG005|Overall Study|Progressive disease|0|||
27760879|NCT02392611|54213287|FG006|Overall Study|Progressive disease|0|||
27760880|NCT02392611|54213288|FG007|Overall Study|Progressive disease|0|||
27760881|NCT02392611|54213289|FG008|Overall Study|Progressive disease|0|||
27760882|NCT02392611|54213281|FG000|Overall Study|Death|1|||
27760883|NCT02392611|54213282|FG001|Overall Study|Death|0|||
27760884|NCT02392611|54213283|FG002|Overall Study|Death|0|||
27760885|NCT02392611|54213284|FG003|Overall Study|Death|0|||
27760886|NCT02392611|54213285|FG004|Overall Study|Death|0|||
27760887|NCT02392611|54213286|FG005|Overall Study|Death|1|||
27760888|NCT02392611|54213287|FG006|Overall Study|Death|0|||
27760889|NCT02392611|54213288|FG007|Overall Study|Death|0|||
27760890|NCT02392611|54213289|FG008|Overall Study|Death|0|||
27760891|NCT02392611|54213281|FG000|Overall Study|Withdrawal by Subject|0|||
27760892|NCT02392611|54213282|FG001|Overall Study|Withdrawal by Subject|0|||
27760893|NCT02392611|54213283|FG002|Overall Study|Withdrawal by Subject|0|||
27760894|NCT02392611|54213284|FG003|Overall Study|Withdrawal by Subject|1|||
27760895|NCT02392611|54213285|FG004|Overall Study|Withdrawal by Subject|0|||
27760896|NCT02392611|54213286|FG005|Overall Study|Withdrawal by Subject|0|||
27760897|NCT02392611|54213287|FG006|Overall Study|Withdrawal by Subject|0|||
27760898|NCT02392611|54213288|FG007|Overall Study|Withdrawal by Subject|0|||
27760899|NCT02392611|54213289|FG008|Overall Study|Withdrawal by Subject|0|||
27760900|NCT02392611|54213281|FG000|Overall Study|Lost to Follow-up|0|||
27760901|NCT02392611|54213282|FG001|Overall Study|Lost to Follow-up|0|||
27760902|NCT02392611|54213283|FG002|Overall Study|Lost to Follow-up|0|||
27760903|NCT02392611|54213284|FG003|Overall Study|Lost to Follow-up|0|||
27760904|NCT02392611|54213285|FG004|Overall Study|Lost to Follow-up|0|||
27760905|NCT02392611|54213286|FG005|Overall Study|Lost to Follow-up|0|||
27760906|NCT02392611|54213287|FG006|Overall Study|Lost to Follow-up|1|||
27760907|NCT02392611|54213288|FG007|Overall Study|Lost to Follow-up|0|||
27760908|NCT02392611|54213289|FG008|Overall Study|Lost to Follow-up|0|||
27760909|NCT02392611|54213281|FG000|Overall Study|Enrolled, not treated|0|||
27760910|NCT02392611|54213282|FG001|Overall Study|Enrolled, not treated|0|||
27760911|NCT02392611|54213283|FG002|Overall Study|Enrolled, not treated|0|||
27760912|NCT02392611|54213284|FG003|Overall Study|Enrolled, not treated|2|||
27760913|NCT02392611|54213285|FG004|Overall Study|Enrolled, not treated|0|||
27760914|NCT02392611|54213286|FG005|Overall Study|Enrolled, not treated|0|||
27760915|NCT02392611|54213287|FG006|Overall Study|Enrolled, not treated|0|||
27760916|NCT02392611|54213288|FG007|Overall Study|Enrolled, not treated|0|||
27760917|NCT02392611|54213289|FG008|Overall Study|Enrolled, not treated|0|||
27760918|NCT02378961|54213313|FG000|Overall Study|Lack of Efficacy|4|||
27760919|NCT02378961|54213314|FG001|Overall Study|Lack of Efficacy|2|||
27760920|NCT02378961|54213315|FG002|Overall Study|Lack of Efficacy|0|||
27760921|NCT02378961|54213316|FG003|Overall Study|Lack of Efficacy|1|||
27760922|NCT02378961|54213313|FG000|Overall Study|Death|0|||
27760923|NCT02378961|54213314|FG001|Overall Study|Death|0|||
27760924|NCT02378961|54213315|FG002|Overall Study|Death|1|||
27760925|NCT02378961|54213316|FG003|Overall Study|Death|0|||
27760926|NCT02378883|54213326|FG000|Enrollment|Subject did not meet Inclusion criteria|6|||
27760927|NCT02378883|54213326|FG000|Enrollment|Attempt to use Apollo was not performed|3|||
27760928|NCT02378883|54213326|FG000|30 Day Follow-Up|Withdrawal by Subject|1|||
27760929|NCT02378883|54213326|FG000|30 Day Follow-Up|Physician Decision|2|||
27760930|NCT02378883|54213326|FG000|30 Day Follow-Up|Missed Visit|2|||
27760931|NCT02378883|54213326|FG000|30 Day Follow-Up|Death|1|||
27760932|NCT02378883|54213326|FG000|12 Months Follow-Up|Lost to Follow-up|3|||
27760933|NCT02378883|54213326|FG000|12 Months Follow-Up|Death|2|||
27760934|NCT02340975|54213337|FG000|Overall Study|Death|6|||
27760935|NCT02340975|54213338|FG001|Overall Study|Death|23|||
27760936|NCT02340975|54213339|FG002|Overall Study|Death|21|||
27760937|NCT02340975|54213340|FG003|Overall Study|Death|7|||
27760938|NCT02340975|54213341|FG004|Overall Study|Death|21|||
27760939|NCT02340975|54213342|FG005|Overall Study|Death|13|||
27760940|NCT02340975|54213337|FG000|Overall Study|Lost to Follow-up|0|||
27760941|NCT02340975|54213338|FG001|Overall Study|Lost to Follow-up|0|||
27760942|NCT02340975|54213339|FG002|Overall Study|Lost to Follow-up|0|||
27760943|NCT02340975|54213340|FG003|Overall Study|Lost to Follow-up|0|||
27760944|NCT02340975|54213341|FG004|Overall Study|Lost to Follow-up|2|||
27760945|NCT02340975|54213342|FG005|Overall Study|Lost to Follow-up|0|||
27760946|NCT02340975|54213337|FG000|Overall Study|Withdrawal by Subject|0|||
27760947|NCT02340975|54213338|FG001|Overall Study|Withdrawal by Subject|0|||
27760948|NCT02340975|54213339|FG002|Overall Study|Withdrawal by Subject|3|||
27760949|NCT02340975|54213340|FG003|Overall Study|Withdrawal by Subject|3|||
27760950|NCT02340975|54213341|FG004|Overall Study|Withdrawal by Subject|2|||
27760951|NCT02340975|54213342|FG005|Overall Study|Withdrawal by Subject|0|||
27760952|NCT02340975|54213337|FG000|Overall Study|Other|0|||
27760953|NCT02340975|54213338|FG001|Overall Study|Other|4|||
27760954|NCT02340975|54213339|FG002|Overall Study|Other|0|||
27760955|NCT02340975|54213340|FG003|Overall Study|Other|2|||
27760956|NCT02340975|54213341|FG004|Overall Study|Other|0|||
27760957|NCT02340975|54213342|FG005|Overall Study|Other|6|||
27760958|NCT02392377|54213359|FG000|Overall Study|Withdrawal by Subject|0|||
27760959|NCT02392377|54213360|FG001|Overall Study|Withdrawal by Subject|1|||
27760960|NCT02340819|54213368|FG000|Overall Study|Adverse Event|1|||
27760961|NCT02340819|54213368|FG000|Overall Study|Withdrawal by Subject|2|||
27760962|NCT02340819|54213368|FG000|Overall Study|Discontinued with other reason|1|||
27760963|NCT02340663|54213374|FG000|Overall Study|Lost to Follow-up|1|||
27760964|NCT02340663|54213375|FG001|Overall Study|Lost to Follow-up|0|||
27760965|NCT02340663|54213374|FG000|Overall Study|Protocol Violation|1|||
27760966|NCT02340663|54213375|FG001|Overall Study|Protocol Violation|0|||
27760967|NCT02340663|54213374|FG000|Overall Study|Withdrawal by Subject|3|||
27760968|NCT02340663|54213375|FG001|Overall Study|Withdrawal by Subject|1|||
27760969|NCT02573467|54213385|FG000|Double-blind Treatment Epoch|Lack of Efficacy|0|||
27760970|NCT02573467|54213386|FG001|Double-blind Treatment Epoch|Lack of Efficacy|0|||
27760971|NCT02573467|54213387|FG002|Double-blind Treatment Epoch|Lack of Efficacy|1|||
27760972|NCT02573467|54213388|FG003|Double-blind Treatment Epoch|Lack of Efficacy|0|||
27760973|NCT02573467|54213385|FG000|Double-blind Treatment Epoch|Adverse Event|1|||
27760974|NCT02573467|54213386|FG001|Double-blind Treatment Epoch|Adverse Event|0|||
27760975|NCT02573467|54213387|FG002|Double-blind Treatment Epoch|Adverse Event|1|||
27760976|NCT02573467|54213388|FG003|Double-blind Treatment Epoch|Adverse Event|0|||
27760977|NCT02573467|54213385|FG000|Double-blind Treatment Epoch|Withdrawal by Subject|2|||
27760978|NCT02573467|54213386|FG001|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
27760979|NCT02573467|54213387|FG002|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
27760980|NCT02573467|54213388|FG003|Double-blind Treatment Epoch|Withdrawal by Subject|0|||
27760981|NCT02573467|54213385|FG000|Double-blind Treatment Epoch|Study Terminated by sponsor|50|||
27760982|NCT02573467|54213386|FG001|Double-blind Treatment Epoch|Study Terminated by sponsor|51|||
27760983|NCT02573467|54213387|FG002|Double-blind Treatment Epoch|Study Terminated by sponsor|48|||
27760984|NCT02573467|54213388|FG003|Double-blind Treatment Epoch|Study Terminated by sponsor|55|||
27760985|NCT02573467|54213385|FG000|Post-treatment Follow up Epoch|Death|1|||
27760986|NCT02573467|54213386|FG001|Post-treatment Follow up Epoch|Death|1|||
27760987|NCT02573467|54213387|FG002|Post-treatment Follow up Epoch|Death|0|||
27760988|NCT02573467|54213388|FG003|Post-treatment Follow up Epoch|Death|1|||
27760989|NCT02573467|54213385|FG000|Post-treatment Follow up Epoch|Withdrawal by Subject|5|||
27760990|NCT02573467|54213386|FG001|Post-treatment Follow up Epoch|Withdrawal by Subject|4|||
27760991|NCT02573467|54213387|FG002|Post-treatment Follow up Epoch|Withdrawal by Subject|9|||
27760992|NCT02573467|54213388|FG003|Post-treatment Follow up Epoch|Withdrawal by Subject|2|||
27760993|NCT02573467|54213385|FG000|Post-treatment Follow up Epoch|Technical problems|0|||
27760994|NCT02573467|54213386|FG001|Post-treatment Follow up Epoch|Technical problems|0|||
27760995|NCT02573467|54213387|FG002|Post-treatment Follow up Epoch|Technical problems|1|||
27760996|NCT02573467|54213388|FG003|Post-treatment Follow up Epoch|Technical problems|0|||
27760997|NCT02337387|54213403|FG000|Overall Study|Adverse Event|0|||
27760998|NCT02337387|54213404|FG001|Overall Study|Adverse Event|1|||
27760999|NCT02337387|54213405|FG002|Overall Study|Adverse Event|0|||
27761000|NCT02337387|54213406|FG003|Overall Study|Adverse Event|0|||
27761001|NCT02337387|54213403|FG000|Overall Study|Sponsor Decision to Terminate Study|14|||
27761002|NCT02337387|54213404|FG001|Overall Study|Sponsor Decision to Terminate Study|7|||
27761003|NCT02337387|54213405|FG002|Overall Study|Sponsor Decision to Terminate Study|3|||
27761004|NCT02337387|54213406|FG003|Overall Study|Sponsor Decision to Terminate Study|3|||
27761005|NCT02574247|54213419|FG000|Overall Study|Withdrawal by Subject|1|||
27761006|NCT02574247|54213420|FG001|Overall Study|Withdrawal by Subject|0|||
27761007|NCT02574247|54213421|FG002|Overall Study|Withdrawal by Subject|0|||
27761008|NCT02574247|54213419|FG000|Overall Study|Did not meet inclusion criteria|4|||
27761009|NCT02574247|54213420|FG001|Overall Study|Did not meet inclusion criteria|3|||
27761010|NCT02574247|54213421|FG002|Overall Study|Did not meet inclusion criteria|5|||
27761011|NCT02391363|54213433|FG000|Overall Study|Lost to Follow-up|5|||
27761012|NCT02391363|54213434|FG001|Overall Study|Lost to Follow-up|5|||
27761013|NCT02391363|54213433|FG000|Overall Study|Withdrawal by Subject|6|||
27761014|NCT02391363|54213434|FG001|Overall Study|Withdrawal by Subject|3|||
27761015|NCT02569957|54213442|FG000|Overall Study|Withdrawal by Subject|0|||
27761016|NCT02569957|54213443|FG001|Overall Study|Withdrawal by Subject|1|||
27761017|NCT01649427|54213451|FG000|Overall Study|Adverse Event|1|||
27761018|NCT01649427|54213452|FG001|Overall Study|Adverse Event|1|||
27761019|NCT01649427|54213451|FG000|Overall Study|Withdrawal by Subject|8|||
27761020|NCT01649427|54213452|FG001|Overall Study|Withdrawal by Subject|7|||
27761021|NCT01649427|54213451|FG000|Overall Study|Lost to Follow-up|0|||
27761022|NCT01649427|54213452|FG001|Overall Study|Lost to Follow-up|1|||
27761023|NCT01649427|54213451|FG000|Overall Study|Graft loss|0|||
27761024|NCT01649427|54213452|FG001|Overall Study|Graft loss|1|||
27761025|NCT01649427|54213451|FG000|Overall Study|Surgical problems during nephrectomy|2|||
27761026|NCT01649427|54213452|FG001|Overall Study|Surgical problems during nephrectomy|2|||
27761027|NCT02375373|54213458|FG000|Overall Study|Withdrawal by Subject|11|||
27761028|NCT02336607|54213466|FG000|Overall Study|Physician Decision|1|||
27761029|NCT02336607|54213467|FG001|Overall Study|Physician Decision|4|||
27761030|NCT02336607|54213468|FG002|Overall Study|Physician Decision|3|||
27761031|NCT02336607|54213469|FG003|Overall Study|Physician Decision|15|||
27761032|NCT02336607|54213466|FG000|Overall Study|Lack of Efficacy|1|||
27761033|NCT02336607|54213467|FG001|Overall Study|Lack of Efficacy|0|||
27839534|NCT01462357|54326820|FG001|Overall Study|Lost to Follow-up|5|||
27761034|NCT02336607|54213468|FG002|Overall Study|Lack of Efficacy|0|||
27761035|NCT02336607|54213469|FG003|Overall Study|Lack of Efficacy|2|||
27761036|NCT02336607|54213466|FG000|Overall Study|Lost to Follow-up|2|||
27761037|NCT02336607|54213467|FG001|Overall Study|Lost to Follow-up|1|||
27839535|NCT01462357|54326821|FG002|Overall Study|Lost to Follow-up|7|||
27761038|NCT02336607|54213468|FG002|Overall Study|Lost to Follow-up|0|||
27761039|NCT02336607|54213469|FG003|Overall Study|Lost to Follow-up|21|||
27761040|NCT02336607|54213466|FG000|Overall Study|Protocol Violation|0|||
27761041|NCT02336607|54213467|FG001|Overall Study|Protocol Violation|1|||
27761042|NCT02336607|54213468|FG002|Overall Study|Protocol Violation|1|||
27761043|NCT02336607|54213469|FG003|Overall Study|Protocol Violation|3|||
27761044|NCT02336607|54213466|FG000|Overall Study|Adverse Event|0|||
27761045|NCT02336607|54213467|FG001|Overall Study|Adverse Event|2|||
27761046|NCT02336607|54213468|FG002|Overall Study|Adverse Event|2|||
27761047|NCT02336607|54213469|FG003|Overall Study|Adverse Event|26|||
27761048|NCT02336607|54213466|FG000|Overall Study|Withdrawal by Subject|0|||
27761049|NCT02336607|54213467|FG001|Overall Study|Withdrawal by Subject|2|||
27761050|NCT02336607|54213468|FG002|Overall Study|Withdrawal by Subject|0|||
27761051|NCT02336607|54213469|FG003|Overall Study|Withdrawal by Subject|20|||
27761052|NCT02374671|54213482|FG000|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
27761053|NCT02374671|54213483|FG001|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
27761054|NCT02374671|54213484|FG002|Observation (Deferred Implantation)|Withdrawal by Subject|4|||
27761055|NCT02374671|54213482|FG000|Observation (Deferred Implantation)|Adverse Event|0|||
27761056|NCT02374671|54213483|FG001|Observation (Deferred Implantation)|Adverse Event|0|||
27761057|NCT02374671|54213484|FG002|Observation (Deferred Implantation)|Adverse Event|1|||
27761058|NCT02374671|54213482|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17|||
27761059|NCT02374671|54213483|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
27761060|NCT02374671|54213484|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2|||
27761061|NCT02374671|54213482|FG000|Implantation- Nonrandomized & Randomized|Adverse Event|7|||
27761062|NCT02374671|54213483|FG001|Implantation- Nonrandomized & Randomized|Adverse Event|0|||
27761063|NCT02374671|54213484|FG002|Implantation- Nonrandomized & Randomized|Adverse Event|1|||
27761064|NCT02374671|54213482|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
27761065|NCT02374671|54213483|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
27761066|NCT02374671|54213484|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
27761067|NCT02569801|54213492|FG000|Overall Study|Withdrawal by Subject|9|||
27761068|NCT02569801|54213493|FG001|Overall Study|Withdrawal by Subject|9|||
27761069|NCT02569801|54213492|FG000|Overall Study|Sponsor Decision|13|||
27761070|NCT02569801|54213493|FG001|Overall Study|Sponsor Decision|14|||
27761071|NCT02569801|54213492|FG000|Overall Study|Progressive Disease|2|||
27761072|NCT02569801|54213493|FG001|Overall Study|Progressive Disease|7|||
27761073|NCT02569801|54213492|FG000|Overall Study|Lost to Follow-up|0|||
27761074|NCT02569801|54213493|FG001|Overall Study|Lost to Follow-up|1|||
27761075|NCT02569801|54213492|FG000|Overall Study|Death|12|||
27761076|NCT02569801|54213493|FG001|Overall Study|Death|4|||
27761077|NCT02573311|54213501|FG000|Disposition for Part 1|Withdrawal by Subject|7|||
27761078|NCT02573311|54213502|FG001|Disposition for Part 1|Withdrawal by Subject|3|||
27761079|NCT02573311|54213501|FG000|Disposition for Part 2|Physician Decision|25|||
27761080|NCT02573311|54213502|FG001|Disposition for Part 2|Physician Decision|7|||
27761081|NCT02573311|54213501|FG000|Disposition for Part 2|Adverse Event|36|||
27761082|NCT02573311|54213502|FG001|Disposition for Part 2|Adverse Event|5|||
27761083|NCT02573311|54213501|FG000|Disposition for Part 2|Lost to Follow-up|76|||
27761084|NCT02573311|54213502|FG001|Disposition for Part 2|Lost to Follow-up|7|||
27761085|NCT02573311|54213501|FG000|Disposition for Part 2|Withdrawal by Subject|60|||
27761086|NCT02573311|54213502|FG001|Disposition for Part 2|Withdrawal by Subject|3|||
27761087|NCT02573311|54213501|FG000|Disposition for Part 2|Investigator decision|0|||
27761088|NCT02573311|54213502|FG001|Disposition for Part 2|Investigator decision|1|||
27761089|NCT02573311|54213501|FG000|Disposition for Part 2|Other than specified above|13|||
27761090|NCT02573311|54213502|FG001|Disposition for Part 2|Other than specified above|3|||
27761091|NCT02571049|54213508|FG000|Screening|Did not meet entry criteria|2|||
27761092|NCT02571049|54213509|FG001|Screening|Did not meet entry criteria|2|||
27761093|NCT02571049|54213508|FG000|Randomization|No migraine attack|0|||
27761094|NCT02571049|54213509|FG001|Randomization|No migraine attack|1|||
27761095|NCT02571049|54213508|FG000|Randomization|Adverse Event|0|||
27761096|NCT02571049|54213509|FG001|Randomization|Adverse Event|1|||
27761097|NCT02573155|54213517|FG000|Washout Between Treatment Period 1 and 2|Physician Decision|0|||
27761098|NCT02573155|54213518|FG001|Washout Between Treatment Period 1 and 2|Physician Decision|1|||
27761099|NCT02573155|54213517|FG000|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0|||
27761100|NCT02573155|54213518|FG001|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1|||
27761101|NCT02573155|54213517|FG000|Washout Between Treatment Period 1 and 2|Adverse Event|0|||
27761102|NCT02573155|54213518|FG001|Washout Between Treatment Period 1 and 2|Adverse Event|3|||
27761103|NCT02573155|54213517|FG000|Washout Between Treatment Period 2 and 3|Sponsor's decision|1|||
27761104|NCT02573155|54213518|FG001|Washout Between Treatment Period 2 and 3|Sponsor's decision|0|||
27761105|NCT02573155|54213517|FG000|Washout Between Treatment Period 2 and 3|Adverse Event|0|||
27761106|NCT02573155|54213518|FG001|Washout Between Treatment Period 2 and 3|Adverse Event|2|||
27761107|NCT02573155|54213517|FG000|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0|||
27761108|NCT02573155|54213518|FG001|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1|||
27761109|NCT02573155|54213517|FG000|Washout Between Treatment Period 3 and 4|Adverse Event|0|||
27761110|NCT02573155|54213518|FG001|Washout Between Treatment Period 3 and 4|Adverse Event|1|||
27761111|NCT02573155|54213517|FG000|Washout Between Treatment Period 4 and 5|Adverse Event|0|||
27761112|NCT02573155|54213518|FG001|Washout Between Treatment Period 4 and 5|Adverse Event|1|||
27761113|NCT02568475|54213546|FG000|Overall Study|Lost to Follow-up|40|||
27761114|NCT02568475|54213547|FG001|Overall Study|Lost to Follow-up|39|||
27761115|NCT02568475|54213546|FG000|Overall Study|Withdrawal by Subject|2|||
27761116|NCT02568475|54213547|FG001|Overall Study|Withdrawal by Subject|0|||
27761117|NCT02568475|54213546|FG000|Overall Study|Discharged home|4|||
27761118|NCT02568475|54213547|FG001|Overall Study|Discharged home|4|||
27761119|NCT02568475|54213546|FG000|Overall Study|Short-term: Discharge location unknown|4|||
27761120|NCT02568475|54213547|FG001|Overall Study|Short-term: Discharge location unknown|0|||
27761121|NCT02568475|54213546|FG000|Overall Study|Transferred to another facility|1|||
27761122|NCT02568475|54213547|FG001|Overall Study|Transferred to another facility|0|||
27761123|NCT02568397|54213553|FG000|Period 2|Withdrawal by Subject|0|||
27761124|NCT02568397|54213554|FG001|Period 2|Withdrawal by Subject|1|||
27761125|NCT02568397|54213553|FG000|Period 2|Physician Decision|0|||
27761126|NCT02568397|54213554|FG001|Period 2|Physician Decision|1|||
27761127|NCT02566525|54213571|FG000|Overall Study|Protocol Violation|3|||
27761128|NCT02566525|54213572|FG001|Overall Study|Protocol Violation|5|||
27761129|NCT02567227|54213582|FG000|9 Weeks|Adverse Event|5|||
27761130|NCT02567227|54213583|FG001|9 Weeks|Adverse Event|5|||
27761131|NCT02567227|54213582|FG000|9 Weeks|Withdrawal by Subject|18|||
27761132|NCT02567227|54213583|FG001|9 Weeks|Withdrawal by Subject|8|||
27761133|NCT02567227|54213582|FG000|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
27761134|NCT02567227|54213583|FG001|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
27761135|NCT02567227|54213582|FG000|6 Month|Death|2|||
27761136|NCT02567227|54213583|FG001|6 Month|Death|0|||
27761137|NCT02567227|54213582|FG000|6 Month|Lost to Follow-up|43|||
27761138|NCT02567227|54213583|FG001|6 Month|Lost to Follow-up|40|||
27761139|NCT02567227|54213582|FG000|12 Months|Lost to Follow-up|31|||
27761140|NCT02567227|54213583|FG001|12 Months|Lost to Follow-up|32|||
27761141|NCT02567227|54213582|FG000|12 Months|Death|0|||
27761142|NCT02567227|54213583|FG001|12 Months|Death|2|||
27761143|NCT02336451|54213594|FG000|Overall Study|Adverse Event|1|||
27761144|NCT02336451|54213595|FG001|Overall Study|Adverse Event|2|||
27761145|NCT02336451|54213596|FG002|Overall Study|Adverse Event|0|||
27761146|NCT02336451|54213597|FG003|Overall Study|Adverse Event|6|||
27761147|NCT02336451|54213598|FG004|Overall Study|Adverse Event|4|||
27761148|NCT02336451|54213594|FG000|Overall Study|Death|6|||
27761149|NCT02336451|54213595|FG001|Overall Study|Death|2|||
27761150|NCT02336451|54213596|FG002|Overall Study|Death|3|||
27761151|NCT02336451|54213597|FG003|Overall Study|Death|6|||
27761152|NCT02336451|54213598|FG004|Overall Study|Death|6|||
27761153|NCT02336451|54213594|FG000|Overall Study|Physician Decision|9|||
27761154|NCT02336451|54213595|FG001|Overall Study|Physician Decision|6|||
27761155|NCT02336451|54213596|FG002|Overall Study|Physician Decision|7|||
27761156|NCT02336451|54213597|FG003|Overall Study|Physician Decision|16|||
27761157|NCT02336451|54213598|FG004|Overall Study|Physician Decision|3|||
27761158|NCT02336451|54213594|FG000|Overall Study|Progressive disease|23|||
27761159|NCT02336451|54213595|FG001|Overall Study|Progressive disease|26|||
27761160|NCT02336451|54213596|FG002|Overall Study|Progressive disease|2|||
27761161|NCT02336451|54213597|FG003|Overall Study|Progressive disease|14|||
27761162|NCT02336451|54213598|FG004|Overall Study|Progressive disease|4|||
27761163|NCT02336451|54213594|FG000|Overall Study|Protocol Violation|1|||
27761164|NCT02336451|54213595|FG001|Overall Study|Protocol Violation|0|||
27761165|NCT02336451|54213596|FG002|Overall Study|Protocol Violation|0|||
27839536|NCT01479439|54326832|FG000|Overall Study|Adverse Event|1|||
27761166|NCT02336451|54213597|FG003|Overall Study|Protocol Violation|0|||
27761167|NCT02336451|54213598|FG004|Overall Study|Protocol Violation|0|||
27761168|NCT02336451|54213594|FG000|Overall Study|Patient/guardian decision|2|||
27761169|NCT02336451|54213595|FG001|Overall Study|Patient/guardian decision|4|||
27761170|NCT02336451|54213596|FG002|Overall Study|Patient/guardian decision|0|||
27761171|NCT02336451|54213597|FG003|Overall Study|Patient/guardian decision|2|||
27761172|NCT02336451|54213598|FG004|Overall Study|Patient/guardian decision|1|||
27761173|NCT02374593|54213614|FG000|Overall Study|non-compliant|2|||
27761174|NCT02374593|54213615|FG001|Overall Study|non-compliant|0|||
27761175|NCT01648101|54213628|FG000|Titration Phase (4 Weeks)|Protocol Violation|2|||
27761176|NCT01648101|54213629|FG001|Titration Phase (4 Weeks)|Protocol Violation|1|||
27761177|NCT01648101|54213630|FG002|Titration Phase (4 Weeks)|Protocol Violation|2|||
27761178|NCT01648101|54213628|FG000|Titration Phase (4 Weeks)|Adverse Event|0|||
27761179|NCT01648101|54213629|FG001|Titration Phase (4 Weeks)|Adverse Event|2|||
27761180|NCT01648101|54213630|FG002|Titration Phase (4 Weeks)|Adverse Event|3|||
27761181|NCT01648101|54213628|FG000|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
27761182|NCT01648101|54213629|FG001|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
27761183|NCT01648101|54213630|FG002|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1|||
27761184|NCT01648101|54213628|FG000|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
27761185|NCT01648101|54213629|FG001|Maintenance Phase (12 Weeks)|Withdrew Consent|0|||
27761186|NCT01648101|54213630|FG002|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
27761187|NCT01648101|54213628|FG000|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
27761188|NCT01648101|54213629|FG001|Maintenance Phase (12 Weeks)|Lack of Efficacy|0|||
27761189|NCT01648101|54213630|FG002|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
27761190|NCT01648101|54213628|FG000|Maintenance Phase (12 Weeks)|Adverse Event|1|||
27761191|NCT01648101|54213629|FG001|Maintenance Phase (12 Weeks)|Adverse Event|3|||
27761192|NCT01648101|54213630|FG002|Maintenance Phase (12 Weeks)|Adverse Event|4|||
27761193|NCT01648101|54213628|FG000|Transition Phase (4 Weeks)|Adverse Event|4|||
27761194|NCT01648101|54213629|FG001|Transition Phase (4 Weeks)|Adverse Event|3|||
27761195|NCT01648101|54213630|FG002|Transition Phase (4 Weeks)|Adverse Event|2|||
27761196|NCT01648101|54213628|FG000|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
27761197|NCT01648101|54213629|FG001|Transition Phase (4 Weeks)|Lack of Efficacy|2|||
27761198|NCT01648101|54213630|FG002|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
27761199|NCT01648101|54213628|FG000|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
27761200|NCT01648101|54213629|FG001|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
27761201|NCT01648101|54213630|FG002|Transition Phase (4 Weeks)|Withdrawal by Subject|2|||
27761202|NCT01648101|54213628|FG000|Transition Phase (4 Weeks)|Study Terminated|1|||
27761203|NCT01648101|54213629|FG001|Transition Phase (4 Weeks)|Study Terminated|0|||
27761204|NCT01648101|54213630|FG002|Transition Phase (4 Weeks)|Study Terminated|0|||
27761205|NCT01648101|54213628|FG000|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
27761206|NCT01648101|54213629|FG001|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1|||
27761207|NCT01648101|54213630|FG002|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
27761208|NCT02336373|54213642|FG000|Overall Study|Protocol closed early|4|||
27761209|NCT02336373|54213642|FG000|Overall Study|Physician Decision|14|||
27761210|NCT02372799|54213651|FG000|Treatment Period|Adverse Event|3|||
27761211|NCT02372799|54213652|FG001|Treatment Period|Adverse Event|10|||
27761212|NCT02372799|54213653|FG002|Treatment Period|Adverse Event|6|||
27761213|NCT02372799|54213651|FG000|Treatment Period|Insufficient therapeutic response|2|||
27761214|NCT02372799|54213652|FG001|Treatment Period|Insufficient therapeutic response|2|||
27761215|NCT02372799|54213653|FG002|Treatment Period|Insufficient therapeutic response|0|||
27761216|NCT02372799|54213651|FG000|Treatment Period|Withdrawal by Subject|10|||
27761217|NCT02372799|54213652|FG001|Treatment Period|Withdrawal by Subject|10|||
27761218|NCT02372799|54213653|FG002|Treatment Period|Withdrawal by Subject|2|||
27761219|NCT02372799|54213651|FG000|Treatment Period|Lost to Follow-up|11|||
27761220|NCT02372799|54213652|FG001|Treatment Period|Lost to Follow-up|5|||
27761221|NCT02372799|54213653|FG002|Treatment Period|Lost to Follow-up|3|||
27761222|NCT02372799|54213651|FG000|Treatment Period|Protocol Violation|3|||
27761223|NCT02372799|54213652|FG001|Treatment Period|Protocol Violation|0|||
27761224|NCT02372799|54213653|FG002|Treatment Period|Protocol Violation|0|||
27761225|NCT02372799|54213651|FG000|Treatment Period|Non-compliance with study drug|4|||
27761226|NCT02372799|54213652|FG001|Treatment Period|Non-compliance with study drug|4|||
27761227|NCT02372799|54213653|FG002|Treatment Period|Non-compliance with study drug|4|||
27839537|NCT01479439|54326833|FG001|Overall Study|Adverse Event|0|||
27761228|NCT02372799|54213651|FG000|Treatment Period|Miscellaneous Reasons|1|||
27761229|NCT02372799|54213652|FG001|Treatment Period|Miscellaneous Reasons|1|||
27761230|NCT02372799|54213653|FG002|Treatment Period|Miscellaneous Reasons|0|||
27761231|NCT02372799|54213651|FG000|Down-taper Period|Lost to Follow-up|1|||
27761232|NCT02372799|54213652|FG001|Down-taper Period|Lost to Follow-up|2|||
27761233|NCT02372799|54213653|FG002|Down-taper Period|Lost to Follow-up|2|||
27839538|NCT01479439|54326834|FG002|Overall Study|Adverse Event|0|||
27839539|NCT01479439|54326832|FG000|Overall Study|Lost to Follow-up|0|||
27761234|NCT02566993|54213663|FG000|Overall Study|Randomized but not treated|5|||
27761235|NCT02566993|54213664|FG001|Overall Study|Randomized but not treated|16|||
27761236|NCT02566993|54213663|FG000|Overall Study|Progressive disease|213|||
27761237|NCT02566993|54213664|FG001|Overall Study|Progressive disease|152|||
27761238|NCT02566993|54213663|FG000|Overall Study|Withdrawal by Subject|12|||
27761239|NCT02566993|54213664|FG001|Overall Study|Withdrawal by Subject|28|||
27761240|NCT02566993|54213663|FG000|Overall Study|Death|17|||
27761241|NCT02566993|54213664|FG001|Overall Study|Death|23|||
27761242|NCT02566993|54213663|FG000|Overall Study|Physician Decision|10|||
27761243|NCT02566993|54213664|FG001|Overall Study|Physician Decision|17|||
27761244|NCT02566993|54213663|FG000|Overall Study|Study drug-related adverse event|20|||
27761245|NCT02566993|54213664|FG001|Overall Study|Study drug-related adverse event|41|||
27761246|NCT02566993|54213663|FG000|Overall Study|Non study drug-related adverse event|9|||
27761247|NCT02566993|54213664|FG001|Overall Study|Non study drug-related adverse event|9|||
27761248|NCT02566993|54213663|FG000|Overall Study|Symptomatic deterioration|9|||
27761249|NCT02566993|54213664|FG001|Overall Study|Symptomatic deterioration|16|||
27761250|NCT02566993|54213663|FG000|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|9|||
27761251|NCT02566993|54213664|FG001|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|1|||
27761252|NCT02566993|54213663|FG000|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
27761253|NCT02566993|54213664|FG001|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
27761254|NCT02566993|54213663|FG000|Overall Study|Screening failure|2|||
27761255|NCT02566993|54213664|FG001|Overall Study|Screening failure|0|||
27761256|NCT02566993|54213663|FG000|Overall Study|Lost to Follow-up|0|||
27761257|NCT02566993|54213664|FG001|Overall Study|Lost to Follow-up|1|||
27761258|NCT02566993|54213663|FG000|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|0|||
27761259|NCT02566993|54213664|FG001|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|1|||
27761260|NCT02311881|54213675|FG000|Overall Study|Did not meet the study criteria|2|||
27761261|NCT02311881|54213676|FG001|Overall Study|Did not meet the study criteria|2|||
27761262|NCT02311881|54213677|FG002|Overall Study|Did not meet the study criteria|0|||
27761263|NCT02311881|54213675|FG000|Overall Study|Adverse Event|7|||
27761264|NCT02311881|54213676|FG001|Overall Study|Adverse Event|15|||
27761265|NCT02311881|54213677|FG002|Overall Study|Adverse Event|8|||
27761266|NCT02311881|54213675|FG000|Overall Study|Lost to Follow-up|3|||
27761267|NCT02311881|54213676|FG001|Overall Study|Lost to Follow-up|3|||
27761268|NCT02311881|54213677|FG002|Overall Study|Lost to Follow-up|2|||
27761269|NCT02311881|54213675|FG000|Overall Study|Protocol Violation|1|||
27761270|NCT02311881|54213676|FG001|Overall Study|Protocol Violation|2|||
27761271|NCT02311881|54213677|FG002|Overall Study|Protocol Violation|3|||
27761272|NCT02311881|54213675|FG000|Overall Study|Withdrawal of consent|14|||
27761273|NCT02311881|54213676|FG001|Overall Study|Withdrawal of consent|16|||
27761274|NCT02311881|54213677|FG002|Overall Study|Withdrawal of consent|17|||
27761275|NCT02311881|54213675|FG000|Overall Study|Other|0|||
27761276|NCT02311881|54213676|FG001|Overall Study|Other|0|||
27761277|NCT02311881|54213677|FG002|Overall Study|Other|1|||
27761278|NCT02311881|54213675|FG000|Overall Study|Lack of Efficacy|1|||
27761279|NCT02311881|54213676|FG001|Overall Study|Lack of Efficacy|2|||
27761280|NCT02311881|54213677|FG002|Overall Study|Lack of Efficacy|0|||
27761281|NCT02311881|54213675|FG000|Overall Study|Subject has border line pregnancy test|1|||
27761282|NCT02311881|54213676|FG001|Overall Study|Subject has border line pregnancy test|0|||
27761283|NCT02311881|54213677|FG002|Overall Study|Subject has border line pregnancy test|0|||
27761284|NCT02311881|54213675|FG000|Overall Study|Withdrawal by Subject|3|||
27761285|NCT02311881|54213676|FG001|Overall Study|Withdrawal by Subject|1|||
27761286|NCT02311881|54213677|FG002|Overall Study|Withdrawal by Subject|4|||
27761287|NCT02311881|54213675|FG000|Overall Study|Sponsor Decision|1|||
27761288|NCT02311881|54213676|FG001|Overall Study|Sponsor Decision|1|||
27761289|NCT02311881|54213677|FG002|Overall Study|Sponsor Decision|1|||
27761290|NCT02311881|54213675|FG000|Overall Study|Protocol Deviation|1|||
27761291|NCT02311881|54213676|FG001|Overall Study|Protocol Deviation|0|||
27761292|NCT02311881|54213677|FG002|Overall Study|Protocol Deviation|0|||
27761293|NCT02311881|54213675|FG000|Overall Study|Non-Compliance|1|||
27761294|NCT02311881|54213676|FG001|Overall Study|Non-Compliance|0|||
27761295|NCT02311881|54213677|FG002|Overall Study|Non-Compliance|2|||
27761296|NCT02311881|54213675|FG000|Overall Study|Physician Decision|0|||
27761297|NCT02311881|54213676|FG001|Overall Study|Physician Decision|0|||
27761298|NCT02311881|54213677|FG002|Overall Study|Physician Decision|1|||
27761299|NCT02311881|54213675|FG000|Overall Study|Medical Monitor Discretion|0|||
27761300|NCT02311881|54213676|FG001|Overall Study|Medical Monitor Discretion|0|||
27761301|NCT02311881|54213677|FG002|Overall Study|Medical Monitor Discretion|1|||
27761302|NCT02311881|54213675|FG000|Overall Study|Participant taking another medication|0|||
27761303|NCT02311881|54213676|FG001|Overall Study|Participant taking another medication|0|||
27761304|NCT02311881|54213677|FG002|Overall Study|Participant taking another medication|1|||
27761305|NCT02311881|54213675|FG000|Overall Study|Serious Adverse Event|0|||
27761306|NCT02311881|54213676|FG001|Overall Study|Serious Adverse Event|1|||
27761307|NCT02311881|54213677|FG002|Overall Study|Serious Adverse Event|0|||
27761308|NCT02565511|54213692|FG000|Overall Study|Study terminated by Sponsor|35|||
27761309|NCT02565511|54213693|FG001|Overall Study|Study terminated by Sponsor|22|||
27761310|NCT02565511|54213694|FG002|Overall Study|Study terminated by Sponsor|235|||
27761311|NCT02565511|54213695|FG003|Overall Study|Study terminated by Sponsor|156|||
27761312|NCT02565511|54213692|FG000|Overall Study|Withdrawal by Subject|3|||
27761313|NCT02565511|54213693|FG001|Overall Study|Withdrawal by Subject|0|||
27761314|NCT02565511|54213694|FG002|Overall Study|Withdrawal by Subject|12|||
27761315|NCT02565511|54213695|FG003|Overall Study|Withdrawal by Subject|5|||
27761316|NCT02565511|54213692|FG000|Overall Study|Adverse Event|0|||
27761317|NCT02565511|54213693|FG001|Overall Study|Adverse Event|0|||
27761318|NCT02565511|54213694|FG002|Overall Study|Adverse Event|1|||
27761319|NCT02565511|54213695|FG003|Overall Study|Adverse Event|1|||
27761320|NCT02565511|54213692|FG000|Overall Study|Lost to Follow-up|4|||
27761321|NCT02565511|54213693|FG001|Overall Study|Lost to Follow-up|1|||
27761322|NCT02565511|54213694|FG002|Overall Study|Lost to Follow-up|0|||
27761323|NCT02565511|54213695|FG003|Overall Study|Lost to Follow-up|1|||
27761324|NCT02565511|54213692|FG000|Overall Study|Physician Decision|0|||
27761325|NCT02565511|54213693|FG001|Overall Study|Physician Decision|0|||
27761326|NCT02565511|54213694|FG002|Overall Study|Physician Decision|0|||
27761327|NCT02565511|54213695|FG003|Overall Study|Physician Decision|1|||
27761328|NCT02565511|54213692|FG000|Overall Study|Protocol deviation|0|||
27761329|NCT02565511|54213693|FG001|Overall Study|Protocol deviation|0|||
27761330|NCT02565511|54213694|FG002|Overall Study|Protocol deviation|3|||
27761331|NCT02565511|54213695|FG003|Overall Study|Protocol deviation|0|||
27761332|NCT02561455|54213709|FG000|Overall Study|Participant Transitioned to Commercial Drug|1|||
27761333|NCT02561455|54213710|FG001|Overall Study|Participant Transitioned to Commercial Drug|1|||
27761334|NCT02561455|54213711|FG002|Overall Study|Participant Transitioned to Commercial Drug|2|||
27761335|NCT02561455|54213712|FG003|Overall Study|Participant Transitioned to Commercial Drug|1|||
27761336|NCT02561455|54213709|FG000|Overall Study|Withdrawal by Subject|1|||
27761337|NCT02561455|54213710|FG001|Overall Study|Withdrawal by Subject|0|||
27761338|NCT02561455|54213711|FG002|Overall Study|Withdrawal by Subject|1|||
27761339|NCT02561455|54213712|FG003|Overall Study|Withdrawal by Subject|0|||
27761340|NCT02561455|54213709|FG000|Overall Study|Disease Progression|0|||
27761341|NCT02561455|54213710|FG001|Overall Study|Disease Progression|1|||
27761342|NCT02561455|54213711|FG002|Overall Study|Disease Progression|0|||
27761343|NCT02561455|54213712|FG003|Overall Study|Disease Progression|0|||
27761344|NCT02561299|54213724|FG000|Overall Study|Death|2|||
27761345|NCT02561299|54213725|FG001|Overall Study|Death|4|||
27761346|NCT02561299|54213724|FG000|Overall Study|Lost to Follow-up|1|||
27761347|NCT02561299|54213725|FG001|Overall Study|Lost to Follow-up|0|||
27761348|NCT02561299|54213724|FG000|Overall Study|Withdrawal by Subject|2|||
27761349|NCT02561299|54213725|FG001|Overall Study|Withdrawal by Subject|2|||
27761350|NCT02566759|54213748|FG000|All Parts|Withdrawal by Subject|0|||
27761351|NCT02566759|54213749|FG001|All Parts|Withdrawal by Subject|1|||
27761352|NCT02566759|54213750|FG002|All Parts|Withdrawal by Subject|0|||
27761353|NCT02566759|54213751|FG003|All Parts|Withdrawal by Subject|0|||
27761354|NCT02566759|54213752|FG004|All Parts|Withdrawal by Subject|0|||
27761355|NCT02566759|54213753|FG005|All Parts|Withdrawal by Subject|0|||
27761356|NCT02566759|54213754|FG006|All Parts|Withdrawal by Subject|0|||
27761357|NCT02566759|54213755|FG007|All Parts|Withdrawal by Subject|0|||
27761358|NCT02566759|54213756|FG008|All Parts|Withdrawal by Subject|0|||
27761359|NCT02566759|54213757|FG009|All Parts|Withdrawal by Subject|0|||
27761360|NCT02566759|54213758|FG010|All Parts|Withdrawal by Subject|0|||
27761361|NCT02566759|54213759|FG011|All Parts|Withdrawal by Subject|0|||
27761362|NCT02566759|54213760|FG012|All Parts|Withdrawal by Subject|0|||
27761363|NCT02566759|54213761|FG013|All Parts|Withdrawal by Subject|0|||
27761364|NCT02566759|54213762|FG014|All Parts|Withdrawal by Subject|0|||
27761365|NCT02566759|54213763|FG015|All Parts|Withdrawal by Subject|0|||
27761366|NCT02566759|54213764|FG016|All Parts|Withdrawal by Subject|0|||
27761367|NCT02566759|54213748|FG000|All Parts|Adverse Event|0|||
27761368|NCT02566759|54213749|FG001|All Parts|Adverse Event|0|||
27761369|NCT02566759|54213750|FG002|All Parts|Adverse Event|0|||
27761370|NCT02566759|54213751|FG003|All Parts|Adverse Event|0|||
27761371|NCT02566759|54213752|FG004|All Parts|Adverse Event|0|||
27761372|NCT02566759|54213753|FG005|All Parts|Adverse Event|0|||
27761373|NCT02566759|54213754|FG006|All Parts|Adverse Event|0|||
27761374|NCT02566759|54213755|FG007|All Parts|Adverse Event|0|||
27761375|NCT02566759|54213756|FG008|All Parts|Adverse Event|0|||
27761376|NCT02566759|54213757|FG009|All Parts|Adverse Event|0|||
27761377|NCT02566759|54213758|FG010|All Parts|Adverse Event|0|||
27761378|NCT02566759|54213759|FG011|All Parts|Adverse Event|0|||
27761379|NCT02566759|54213760|FG012|All Parts|Adverse Event|1|||
27761380|NCT02566759|54213761|FG013|All Parts|Adverse Event|3|||
27761381|NCT02566759|54213762|FG014|All Parts|Adverse Event|0|||
27761382|NCT02566759|54213763|FG015|All Parts|Adverse Event|0|||
27761383|NCT02566759|54213764|FG016|All Parts|Adverse Event|0|||
27761384|NCT02566759|54213748|FG000|All Parts|Other|0|||
27761385|NCT02566759|54213749|FG001|All Parts|Other|0|||
27761386|NCT02566759|54213750|FG002|All Parts|Other|0|||
27761387|NCT02566759|54213751|FG003|All Parts|Other|0|||
27761388|NCT02566759|54213752|FG004|All Parts|Other|0|||
27761389|NCT02566759|54213753|FG005|All Parts|Other|0|||
27761390|NCT02566759|54213754|FG006|All Parts|Other|0|||
27761391|NCT02566759|54213755|FG007|All Parts|Other|0|||
27761392|NCT02566759|54213756|FG008|All Parts|Other|0|||
27761393|NCT02566759|54213757|FG009|All Parts|Other|0|||
27761394|NCT02566759|54213758|FG010|All Parts|Other|0|||
27761395|NCT02566759|54213759|FG011|All Parts|Other|0|||
27761396|NCT02566759|54213760|FG012|All Parts|Other|0|||
27761397|NCT02566759|54213761|FG013|All Parts|Other|2|||
27761398|NCT02566759|54213762|FG014|All Parts|Other|0|||
27761399|NCT02566759|54213763|FG015|All Parts|Other|0|||
27761400|NCT02566759|54213764|FG016|All Parts|Other|0|||
27761401|NCT02566759|54213748|FG000|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
27761402|NCT02566759|54213749|FG001|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
27761403|NCT02566759|54213750|FG002|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
27761404|NCT02566759|54213751|FG003|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
27761405|NCT02566759|54213752|FG004|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
27761406|NCT02566759|54213753|FG005|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
27761407|NCT02566759|54213754|FG006|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
27761408|NCT02566759|54213755|FG007|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
27761409|NCT02566759|54213756|FG008|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
27761410|NCT02566759|54213757|FG009|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
27761411|NCT02566759|54213758|FG010|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
27761412|NCT02566759|54213759|FG011|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
27761413|NCT02566759|54213760|FG012|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
27761414|NCT02566759|54213761|FG013|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
27761415|NCT02566759|54213762|FG014|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
27761416|NCT02566759|54213763|FG015|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
27761417|NCT02566759|54213764|FG016|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1|||
27761418|NCT02335983|54213829|FG000|Overall Study|Sponsor Decision|0|||
27761419|NCT02335983|54213830|FG001|Overall Study|Sponsor Decision|0|||
27761420|NCT02335983|54213831|FG002|Overall Study|Sponsor Decision|1|||
27761421|NCT02335983|54213832|FG003|Overall Study|Sponsor Decision|1|||
27761422|NCT02335983|54213833|FG004|Overall Study|Sponsor Decision|0|||
27761423|NCT02335983|54213834|FG005|Overall Study|Sponsor Decision|1|||
27761424|NCT02335983|54213829|FG000|Overall Study|Withdrawal by Subject|3|||
27761425|NCT02335983|54213830|FG001|Overall Study|Withdrawal by Subject|2|||
27761426|NCT02335983|54213831|FG002|Overall Study|Withdrawal by Subject|2|||
27761427|NCT02335983|54213832|FG003|Overall Study|Withdrawal by Subject|1|||
27761428|NCT02335983|54213833|FG004|Overall Study|Withdrawal by Subject|3|||
27761429|NCT02335983|54213834|FG005|Overall Study|Withdrawal by Subject|9|||
27761430|NCT02335983|54213829|FG000|Overall Study|Death|0|||
27761431|NCT02335983|54213830|FG001|Overall Study|Death|0|||
27761432|NCT02335983|54213831|FG002|Overall Study|Death|2|||
27761433|NCT02335983|54213832|FG003|Overall Study|Death|0|||
27761434|NCT02335983|54213833|FG004|Overall Study|Death|0|||
27761435|NCT02335983|54213834|FG005|Overall Study|Death|0|||
27761436|NCT02335983|54213829|FG000|Overall Study|Lost to Follow-up|0|||
27761437|NCT02335983|54213830|FG001|Overall Study|Lost to Follow-up|0|||
27761438|NCT02335983|54213831|FG002|Overall Study|Lost to Follow-up|0|||
27761439|NCT02335983|54213832|FG003|Overall Study|Lost to Follow-up|0|||
27761440|NCT02335983|54213833|FG004|Overall Study|Lost to Follow-up|0|||
27761441|NCT02335983|54213834|FG005|Overall Study|Lost to Follow-up|1|||
27761442|NCT02335983|54213829|FG000|Overall Study|Protocol Specified Criteria|5|||
27761443|NCT02335983|54213830|FG001|Overall Study|Protocol Specified Criteria|7|||
27761444|NCT02335983|54213831|FG002|Overall Study|Protocol Specified Criteria|27|||
27761445|NCT02335983|54213832|FG003|Overall Study|Protocol Specified Criteria|7|||
27761446|NCT02335983|54213833|FG004|Overall Study|Protocol Specified Criteria|5|||
27761447|NCT02335983|54213834|FG005|Overall Study|Protocol Specified Criteria|21|||
27761448|NCT04640311|54213870|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
27761449|NCT04640311|54213871|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
27761450|NCT04640311|54213872|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
27761451|NCT04640311|54213873|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
27761452|NCT04640311|54213874|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
27761453|NCT04640311|54213875|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
27839540|NCT01479439|54326833|FG001|Overall Study|Lost to Follow-up|1|||
27839541|NCT01479439|54326834|FG002|Overall Study|Lost to Follow-up|0|||
27761454|NCT04640311|54213876|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
27761455|NCT04640311|54213877|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
27761456|NCT04640311|54213878|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
27761457|NCT04640311|54213879|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
27761458|NCT04640311|54213880|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
27761459|NCT04640311|54213881|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
27761460|NCT04640311|54213882|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
27839542|NCT01479439|54326832|FG000|Overall Study|Protocol Violation|0|||
27761461|NCT04640311|54213870|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
27761462|NCT04640311|54213871|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|1|||
27761463|NCT04640311|54213872|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
27761464|NCT04640311|54213873|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
27761465|NCT04640311|54213874|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
27761466|NCT04640311|54213875|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
27761467|NCT04640311|54213876|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
27761468|NCT04640311|54213877|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
27761469|NCT04640311|54213878|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
27761470|NCT04640311|54213879|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
27761471|NCT04640311|54213880|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
27761472|NCT04640311|54213881|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
27761473|NCT04640311|54213882|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
27761474|NCT04640311|54213870|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
27761475|NCT04640311|54213871|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|1|||
27761476|NCT04640311|54213872|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
27761477|NCT04640311|54213873|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
27761478|NCT04640311|54213874|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
27761479|NCT04640311|54213875|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
27761480|NCT04640311|54213876|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
27761481|NCT04640311|54213877|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
27761482|NCT04640311|54213878|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
27761483|NCT04640311|54213879|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
27761484|NCT04640311|54213880|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
27761485|NCT04640311|54213881|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
27761486|NCT04640311|54213882|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
27761487|NCT04640311|54213870|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|3|||
27761488|NCT04640311|54213871|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|5|||
27761489|NCT04640311|54213872|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|6|||
27761490|NCT04640311|54213873|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
27761491|NCT04640311|54213874|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
27761492|NCT04640311|54213875|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
27761493|NCT04640311|54213876|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
27761494|NCT04640311|54213877|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
27761495|NCT04640311|54213878|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
27761496|NCT04640311|54213879|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
27761497|NCT04640311|54213880|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
27761498|NCT04640311|54213881|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
27761499|NCT04640311|54213882|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
27761500|NCT04640311|54213870|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
27761501|NCT04640311|54213871|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
27761502|NCT04640311|54213872|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|2|||
27761503|NCT04640311|54213873|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
27761504|NCT04640311|54213874|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
27761505|NCT04640311|54213875|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
27761506|NCT04640311|54213876|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
27761507|NCT04640311|54213877|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
27761508|NCT04640311|54213878|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
27761509|NCT04640311|54213879|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
27761510|NCT04640311|54213880|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
27761511|NCT04640311|54213881|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
27761512|NCT04640311|54213882|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
27839543|NCT01479439|54326833|FG001|Overall Study|Protocol Violation|0|||
27839544|NCT01479439|54326834|FG002|Overall Study|Protocol Violation|2|||
27839545|NCT01478971|54326845|FG000|Standard of Care Period|Adverse Event|1|||
27761513|NCT04640311|54213870|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
27761514|NCT04640311|54213871|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
27761515|NCT04640311|54213872|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
27761516|NCT04640311|54213873|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
27761517|NCT04640311|54213874|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
27761518|NCT04640311|54213875|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
27761519|NCT04640311|54213876|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
27761520|NCT04640311|54213877|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
27761521|NCT04640311|54213878|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
27761522|NCT04640311|54213879|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
27761523|NCT04640311|54213880|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
27761524|NCT04640311|54213881|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
27761525|NCT04640311|54213882|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
27761526|NCT04640311|54213870|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
27761527|NCT04640311|54213871|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
27761528|NCT04640311|54213872|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
27761529|NCT04640311|54213873|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
27761530|NCT04640311|54213874|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
27761531|NCT04640311|54213875|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
27761532|NCT04640311|54213876|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
27761533|NCT04640311|54213877|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
27761534|NCT04640311|54213878|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|2|||
27761535|NCT04640311|54213879|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
27761536|NCT04640311|54213880|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
27761537|NCT04640311|54213881|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
27761538|NCT04640311|54213882|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
27761539|NCT04640311|54213870|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
27761540|NCT04640311|54213871|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
27761541|NCT04640311|54213872|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
27761542|NCT04640311|54213873|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
27761543|NCT04640311|54213874|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
27761544|NCT04640311|54213875|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
27761545|NCT04640311|54213876|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
27761546|NCT04640311|54213877|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
27761547|NCT04640311|54213878|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
27761548|NCT04640311|54213879|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
27761549|NCT04640311|54213880|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
27761550|NCT04640311|54213881|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
27761551|NCT04640311|54213882|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
27761552|NCT04640311|54213870|FG000|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
27761553|NCT04640311|54213871|FG001|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
27761554|NCT04640311|54213872|FG002|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
27761555|NCT04640311|54213873|FG003|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
27761556|NCT04640311|54213874|FG004|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
27761557|NCT04640311|54213875|FG005|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
27761558|NCT04640311|54213876|FG006|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
27761559|NCT04640311|54213877|FG007|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
27761560|NCT04640311|54213878|FG008|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
27761561|NCT04640311|54213879|FG009|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
27761562|NCT04640311|54213880|FG010|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
27761563|NCT04640311|54213881|FG011|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|1|||
27761564|NCT04640311|54213882|FG012|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
27761565|NCT02334423|54213913|FG000|Overall Study|Protocol Violation|10|||
27761566|NCT02334423|54213914|FG001|Overall Study|Protocol Violation|3|||
27761567|NCT02310789|54213920|FG000|Overall Study|Adverse Event|1|||
27761568|NCT02372253|54213926|FG000|Overall Study|Non Compliance|2|||
27761569|NCT02372253|54213927|FG001|Overall Study|Non Compliance|0|||
27761570|NCT02559895|54213939|FG000|Overall Study|Adverse Event|3|||
27761571|NCT02559895|54213940|FG001|Overall Study|Adverse Event|3|||
27761572|NCT02559895|54213941|FG002|Overall Study|Adverse Event|2|||
27761573|NCT02559895|54213942|FG003|Overall Study|Adverse Event|1|||
27761574|NCT02559895|54213939|FG000|Overall Study|Lack of Efficacy|2|||
27761575|NCT02559895|54213940|FG001|Overall Study|Lack of Efficacy|3|||
27761576|NCT02559895|54213941|FG002|Overall Study|Lack of Efficacy|2|||
27761577|NCT02559895|54213942|FG003|Overall Study|Lack of Efficacy|8|||
27761578|NCT02559895|54213939|FG000|Overall Study|Lost to Follow-up|22|||
27761579|NCT02559895|54213940|FG001|Overall Study|Lost to Follow-up|16|||
27761580|NCT02559895|54213941|FG002|Overall Study|Lost to Follow-up|12|||
27761581|NCT02559895|54213942|FG003|Overall Study|Lost to Follow-up|17|||
27761582|NCT02559895|54213939|FG000|Overall Study|Physician Decision|1|||
27761583|NCT02559895|54213940|FG001|Overall Study|Physician Decision|1|||
27761584|NCT02559895|54213941|FG002|Overall Study|Physician Decision|3|||
27761585|NCT02559895|54213942|FG003|Overall Study|Physician Decision|0|||
27761586|NCT02559895|54213939|FG000|Overall Study|Withdrawal by Subject|16|||
27761587|NCT02559895|54213940|FG001|Overall Study|Withdrawal by Subject|9|||
27761588|NCT02559895|54213941|FG002|Overall Study|Withdrawal by Subject|20|||
27761589|NCT02559895|54213942|FG003|Overall Study|Withdrawal by Subject|9|||
27761590|NCT02559895|54213939|FG000|Overall Study|Study Burden|10|||
27761591|NCT02559895|54213940|FG001|Overall Study|Study Burden|16|||
27761592|NCT02559895|54213941|FG002|Overall Study|Study Burden|12|||
27761593|NCT02559895|54213942|FG003|Overall Study|Study Burden|22|||
27761594|NCT02559895|54213939|FG000|Overall Study|Other|1|||
27761595|NCT02559895|54213940|FG001|Overall Study|Other|5|||
27761596|NCT02559895|54213941|FG002|Overall Study|Other|3|||
27761597|NCT02559895|54213942|FG003|Overall Study|Other|3|||
27761598|NCT02371629|54213954|FG000|Overall Study|Patient decision|14|||
27761599|NCT02371629|54213955|FG001|Overall Study|Patient decision|10|||
27761600|NCT02371629|54213954|FG000|Overall Study|Adverse Event|8|||
27761601|NCT02371629|54213955|FG001|Overall Study|Adverse Event|8|||
27761602|NCT02371629|54213954|FG000|Overall Study|Physician Decision|2|||
27761603|NCT02371629|54213955|FG001|Overall Study|Physician Decision|3|||
27761604|NCT02371629|54213954|FG000|Overall Study|Death|1|||
27761605|NCT02371629|54213955|FG001|Overall Study|Death|1|||
27761606|NCT02371629|54213954|FG000|Overall Study|Noncompliance with study treatment|1|||
27761607|NCT02371629|54213955|FG001|Overall Study|Noncompliance with study treatment|0|||
27761608|NCT02371629|54213954|FG000|Overall Study|Lack of Efficacy|0|||
27761609|NCT02371629|54213955|FG001|Overall Study|Lack of Efficacy|2|||
27761610|NCT02371629|54213954|FG000|Overall Study|Protocol deviation|0|||
27761611|NCT02371629|54213955|FG001|Overall Study|Protocol deviation|1|||
27761612|NCT02559817|54213966|FG000|Treatment Period|Adverse Event|1|||
27761613|NCT02559817|54213967|FG001|Treatment Period|Adverse Event|0|||
27761614|NCT02559817|54213968|FG002|Treatment Period|Adverse Event|1|||
27761615|NCT02559817|54213969|FG003|Treatment Period|Adverse Event|0|||
27761616|NCT02559817|54213970|FG004|Treatment Period|Adverse Event|0|||
27761617|NCT02559817|54213966|FG000|Treatment Period|Lack of Efficacy|0|||
27761618|NCT02559817|54213967|FG001|Treatment Period|Lack of Efficacy|1|||
27761619|NCT02559817|54213968|FG002|Treatment Period|Lack of Efficacy|0|||
27761620|NCT02559817|54213969|FG003|Treatment Period|Lack of Efficacy|0|||
27761621|NCT02559817|54213970|FG004|Treatment Period|Lack of Efficacy|0|||
27761622|NCT02559817|54213966|FG000|Treatment Period|Lost to Follow-up|0|||
27761623|NCT02559817|54213967|FG001|Treatment Period|Lost to Follow-up|1|||
27761624|NCT02559817|54213968|FG002|Treatment Period|Lost to Follow-up|0|||
27761625|NCT02559817|54213969|FG003|Treatment Period|Lost to Follow-up|1|||
27761626|NCT02559817|54213970|FG004|Treatment Period|Lost to Follow-up|0|||
27761627|NCT02559817|54213966|FG000|Treatment Period|Non-Compliance With Study Drug|0|||
27761628|NCT02559817|54213967|FG001|Treatment Period|Non-Compliance With Study Drug|0|||
27761629|NCT02559817|54213968|FG002|Treatment Period|Non-Compliance With Study Drug|1|||
27761630|NCT02559817|54213969|FG003|Treatment Period|Non-Compliance With Study Drug|0|||
27761631|NCT02559817|54213970|FG004|Treatment Period|Non-Compliance With Study Drug|0|||
27839546|NCT01478971|54326845|FG000|Standard of Care Period|Withdrawal by Subject|3|||
27761632|NCT02559817|54213966|FG000|Treatment Period|Protocol Violation|0|||
27761633|NCT02559817|54213967|FG001|Treatment Period|Protocol Violation|0|||
27761634|NCT02559817|54213968|FG002|Treatment Period|Protocol Violation|0|||
27761635|NCT02559817|54213969|FG003|Treatment Period|Protocol Violation|1|||
27761636|NCT02559817|54213970|FG004|Treatment Period|Protocol Violation|0|||
27761637|NCT02564887|54213984|FG000|Overall Study|Lost to Follow-up|6|||
27761638|NCT02564887|54213985|FG001|Overall Study|Lost to Follow-up|0|||
27761639|NCT02333487|54213996|FG000|Overall Study|Adverse Event|0|||
27761640|NCT02333487|54213997|FG001|Overall Study|Adverse Event|2|||
27761641|NCT02333487|54213998|FG002|Overall Study|Adverse Event|0|||
27761642|NCT02333331|54214011|FG000|Overall Study|Adverse Event|1|||
27761643|NCT02333331|54214012|FG001|Overall Study|Adverse Event|0|||
27761644|NCT02333331|54214013|FG002|Overall Study|Adverse Event|4|||
27761645|NCT02333331|54214014|FG003|Overall Study|Adverse Event|1|||
27761646|NCT02333331|54214011|FG000|Overall Study|Death|0|||
27761647|NCT02333331|54214012|FG001|Overall Study|Death|0|||
27761648|NCT02333331|54214013|FG002|Overall Study|Death|2|||
27761649|NCT02333331|54214014|FG003|Overall Study|Death|0|||
27761650|NCT02333331|54214011|FG000|Overall Study|Lost to Follow-up|0|||
27761651|NCT02333331|54214012|FG001|Overall Study|Lost to Follow-up|0|||
27761652|NCT02333331|54214013|FG002|Overall Study|Lost to Follow-up|1|||
27761653|NCT02333331|54214014|FG003|Overall Study|Lost to Follow-up|0|||
27761654|NCT02333331|54214011|FG000|Overall Study|Physician Decision|0|||
27761655|NCT02333331|54214012|FG001|Overall Study|Physician Decision|1|||
27761656|NCT02333331|54214013|FG002|Overall Study|Physician Decision|0|||
27761657|NCT02333331|54214014|FG003|Overall Study|Physician Decision|0|||
27761658|NCT02333331|54214011|FG000|Overall Study|Protocol Deviation|0|||
27761659|NCT02333331|54214012|FG001|Overall Study|Protocol Deviation|3|||
27761660|NCT02333331|54214013|FG002|Overall Study|Protocol Deviation|2|||
27761661|NCT02333331|54214014|FG003|Overall Study|Protocol Deviation|1|||
27761662|NCT02333331|54214011|FG000|Overall Study|Patient/Guardian Decision|1|||
27761663|NCT02333331|54214012|FG001|Overall Study|Patient/Guardian Decision|2|||
27761664|NCT02333331|54214013|FG002|Overall Study|Patient/Guardian Decision|9|||
27761665|NCT02333331|54214014|FG003|Overall Study|Patient/Guardian Decision|1|||
27761666|NCT02563561|54214027|FG000|Overall Study|Histology Other than Ta, G1-G2|3|||
27761667|NCT02563561|54214028|FG001|Overall Study|Histology Other than Ta, G1-G2|6|||
27761668|NCT02563561|54214029|FG002|Overall Study|Histology Other than Ta, G1-G2|6|||
27761669|NCT02563561|54214027|FG000|Overall Study|Withdrew of Consent|1|||
27761670|NCT02563561|54214028|FG001|Overall Study|Withdrew of Consent|1|||
27761671|NCT02563561|54214029|FG002|Overall Study|Withdrew of Consent|2|||
27761672|NCT02563561|54214027|FG000|Overall Study|Lost to Follow-up|1|||
27761673|NCT02563561|54214028|FG001|Overall Study|Lost to Follow-up|1|||
27761674|NCT02563561|54214029|FG002|Overall Study|Lost to Follow-up|0|||
27761675|NCT02563561|54214027|FG000|Overall Study|Participant Had Recurrence and Received Therapy|4|||
27761676|NCT02563561|54214028|FG001|Overall Study|Participant Had Recurrence and Received Therapy|2|||
27761677|NCT02563561|54214029|FG002|Overall Study|Participant Had Recurrence and Received Therapy|1|||
27761678|NCT02563561|54214027|FG000|Overall Study|Investigator Decision|3|||
27761679|NCT02563561|54214028|FG001|Overall Study|Investigator Decision|4|||
27761680|NCT02563561|54214029|FG002|Overall Study|Investigator Decision|2|||
27761681|NCT02563561|54214027|FG000|Overall Study|Sponsor Decision|5|||
27761682|NCT02563561|54214028|FG001|Overall Study|Sponsor Decision|2|||
27761683|NCT02563561|54214029|FG002|Overall Study|Sponsor Decision|4|||
27761684|NCT02563561|54214027|FG000|Overall Study|Other|1|||
27761685|NCT02563561|54214028|FG001|Overall Study|Other|5|||
27761686|NCT02563561|54214029|FG002|Overall Study|Other|2|||
27761687|NCT02559505|54214045|FG000|Overall Study|Lost to Follow-up|23|||
27761688|NCT02559505|54214046|FG001|Overall Study|Lost to Follow-up|20|||
27761689|NCT02559505|54214045|FG000|Overall Study|Withdrawal by Subject|4|||
27761690|NCT02559505|54214046|FG001|Overall Study|Withdrawal by Subject|2|||
27761691|NCT04191967|54214068|FG000|Screening & Thermocoagulation (Ablation)|Not considered candidates for thermocoagulation|86|||
27761692|NCT04191967|54214068|FG000|12 Month Follow-up|Pathology results for 12 month treatment efficacy not available for these participants|4|||
27761693|NCT02556307|54214074|FG000|Overall Study|Premature treatment interruption|11|||
27761694|NCT02556307|54214074|FG000|Overall Study|Lost to Follow-up|36|||
27761695|NCT02556307|54214074|FG000|Overall Study|Change to triple therapy|4|||
27761696|NCT02556307|54214074|FG000|Overall Study|Enrolled but not treated|2|||
27761697|NCT04364737|54214080|FG000|Overall Study|Withdrawal by Subject|4|||
27761698|NCT04364737|54214081|FG001|Overall Study|Withdrawal by Subject|9|||
27761699|NCT04364737|54214080|FG000|Overall Study|Lost to Follow-up|1|||
27761700|NCT04364737|54214081|FG001|Overall Study|Lost to Follow-up|1|||
27761701|NCT02559115|54214087|FG000|Overall Study|Withdrawal by Subject|3|||
27761702|NCT01662895|54214105|FG000|Overall Study|Lost to Follow-up|0|||
27761703|NCT01662895|54214106|FG001|Overall Study|Lost to Follow-up|1|||
27761704|NCT04147195|54214114|FG000|Overall Study|Adverse Event|0|||
27761705|NCT04147195|54214115|FG001|Overall Study|Adverse Event|3|||
27761706|NCT04147195|54214114|FG000|Overall Study|Study Terminated by Sponsor|4|||
27761707|NCT04147195|54214115|FG001|Overall Study|Study Terminated by Sponsor|2|||
27761708|NCT04147195|54214114|FG000|Overall Study|Withdrawal by Subject|0|||
27761709|NCT04147195|54214115|FG001|Overall Study|Withdrawal by Subject|1|||
27761710|NCT02557399|54214124|FG000|Overall Study|Adverse Event|6|||
27761711|NCT02557399|54214125|FG001|Overall Study|Adverse Event|5|||
27761712|NCT02557399|54214124|FG000|Overall Study|Protocol Violation|0|||
27761713|NCT02557399|54214125|FG001|Overall Study|Protocol Violation|1|||
27761714|NCT02557399|54214124|FG000|Overall Study|Protocol-defined stopping criteria|0|||
27761715|NCT02557399|54214125|FG001|Overall Study|Protocol-defined stopping criteria|1|||
27761716|NCT02557399|54214124|FG000|Overall Study|Withdrawal by Subject|1|||
27761717|NCT02557399|54214125|FG001|Overall Study|Withdrawal by Subject|1|||
27839547|NCT01478971|54326845|FG000|Standard of Care Period|Death|8|||
27761718|NCT02555371|54214134|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1|||
27761719|NCT02555371|54214135|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
27761720|NCT02555371|54214136|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
27761721|NCT02555371|54214137|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
27761722|NCT02555371|54214138|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
27761723|NCT02555371|54214134|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2|||
27761724|NCT02555371|54214135|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
27761725|NCT02555371|54214136|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
27761726|NCT02555371|54214137|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
27761727|NCT02555371|54214138|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
27761728|NCT02555371|54214134|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5|||
27761729|NCT02555371|54214135|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
27761730|NCT02555371|54214136|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
27761731|NCT02555371|54214137|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
27761732|NCT02555371|54214138|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
27761733|NCT02555371|54214134|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1|||
27761734|NCT02555371|54214135|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
27761735|NCT02555371|54214136|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
27761736|NCT02555371|54214137|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
27761737|NCT02555371|54214138|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
27761738|NCT02555371|54214134|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2|||
27761739|NCT02555371|54214135|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
27761740|NCT02555371|54214136|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
27761741|NCT02555371|54214137|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
27761742|NCT02555371|54214138|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
27761743|NCT02555371|54214134|FG000|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
27761744|NCT02555371|54214135|FG001|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84|||
27761745|NCT02555371|54214136|FG002|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45|||
27761746|NCT02555371|54214137|FG003|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
27761747|NCT02555371|54214138|FG004|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
27761748|NCT02555371|54214134|FG000|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
27761749|NCT02555371|54214135|FG001|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
27761750|NCT02555371|54214136|FG002|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
27761751|NCT02555371|54214137|FG003|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
27761752|NCT02555371|54214138|FG004|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
27761753|NCT02555371|54214134|FG000|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
27761754|NCT02555371|54214135|FG001|Part C (DB Period: Up to 52W)|Lack of Efficacy|1|||
27761755|NCT02555371|54214136|FG002|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
27761756|NCT02555371|54214137|FG003|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
27761757|NCT02555371|54214138|FG004|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
27761758|NCT02555371|54214134|FG000|Part C (DB Period: Up to 52W)|Adverse Event|0|||
27761759|NCT02555371|54214135|FG001|Part C (DB Period: Up to 52W)|Adverse Event|2|||
27761760|NCT02555371|54214136|FG002|Part C (DB Period: Up to 52W)|Adverse Event|1|||
27761761|NCT02555371|54214137|FG003|Part C (DB Period: Up to 52W)|Adverse Event|0|||
27761762|NCT02555371|54214138|FG004|Part C (DB Period: Up to 52W)|Adverse Event|0|||
27761763|NCT02555371|54214134|FG000|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
27761764|NCT02555371|54214135|FG001|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
27761765|NCT02555371|54214136|FG002|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
27761766|NCT02555371|54214137|FG003|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1|||
27761767|NCT02555371|54214138|FG004|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
27761768|NCT02555371|54214134|FG000|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
27761769|NCT02555371|54214135|FG001|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
27761770|NCT02555371|54214136|FG002|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
27761771|NCT02555371|54214137|FG003|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2|||
27761772|NCT02555371|54214138|FG004|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
27761773|NCT02555371|54214134|FG000|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
27761774|NCT02555371|54214135|FG001|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
27761775|NCT02555371|54214136|FG002|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
27761776|NCT02555371|54214137|FG003|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
27761777|NCT02555371|54214138|FG004|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2|||
27761778|NCT02555371|54214134|FG000|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
27761779|NCT02555371|54214135|FG001|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
27761780|NCT02555371|54214136|FG002|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
27761781|NCT02555371|54214137|FG003|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
27761782|NCT02555371|54214138|FG004|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1|||
27761783|NCT02555371|54214134|FG000|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
27761784|NCT02555371|54214135|FG001|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
27761785|NCT02555371|54214136|FG002|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
27761786|NCT02555371|54214137|FG003|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1|||
27761787|NCT02555371|54214138|FG004|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
27761788|NCT02555215|54214147|FG000|Overall Study|Other|1|||
27761789|NCT02555215|54214147|FG000|Overall Study|Investigator Decision|2|||
27761790|NCT02555683|54214154|FG000|Overall Study|Physician Decision|1|||
27761791|NCT02555683|54214155|FG001|Overall Study|Physician Decision|0|||
27761792|NCT02555683|54214156|FG002|Overall Study|Physician Decision|2|||
27761793|NCT02555683|54214154|FG000|Overall Study|Lost to Follow-up|2|||
27761794|NCT02555683|54214155|FG001|Overall Study|Lost to Follow-up|1|||
27761795|NCT02555683|54214156|FG002|Overall Study|Lost to Follow-up|2|||
27761796|NCT02555683|54214154|FG000|Overall Study|Technical Problems|1|||
27761797|NCT02555683|54214155|FG001|Overall Study|Technical Problems|1|||
27761798|NCT02555683|54214156|FG002|Overall Study|Technical Problems|0|||
27761799|NCT02555683|54214154|FG000|Overall Study|Protocol deviation|0|||
27761800|NCT02555683|54214155|FG001|Overall Study|Protocol deviation|1|||
27761801|NCT02555683|54214156|FG002|Overall Study|Protocol deviation|0|||
27761802|NCT02555683|54214154|FG000|Overall Study|Lack of Efficacy|2|||
27761803|NCT02555683|54214155|FG001|Overall Study|Lack of Efficacy|0|||
27761804|NCT02555683|54214156|FG002|Overall Study|Lack of Efficacy|0|||
27761805|NCT02555683|54214154|FG000|Overall Study|Death|0|||
27761806|NCT02555683|54214155|FG001|Overall Study|Death|1|||
27761807|NCT02555683|54214156|FG002|Overall Study|Death|2|||
27761808|NCT02555683|54214154|FG000|Overall Study|Adverse Event|1|||
27761809|NCT02555683|54214155|FG001|Overall Study|Adverse Event|0|||
27761810|NCT02555683|54214156|FG002|Overall Study|Adverse Event|1|||
27761811|NCT02555683|54214154|FG000|Overall Study|Subject/guardian decision|12|||
27761812|NCT02555683|54214155|FG001|Overall Study|Subject/guardian decision|12|||
27761813|NCT02555683|54214156|FG002|Overall Study|Subject/guardian decision|22|||
27761814|NCT02555683|54214154|FG000|Overall Study|Death post Treatment/safety period|0|||
27761815|NCT02555683|54214155|FG001|Overall Study|Death post Treatment/safety period|1|||
27761816|NCT02555683|54214156|FG002|Overall Study|Death post Treatment/safety period|0|||
27761817|NCT02554981|54214164|FG000|Overall Study|Adverse Event|1|||
27761818|NCT02554981|54214164|FG000|Overall Study|Administrative Reasons|1|||
27761819|NCT02554981|54214164|FG000|Overall Study|Other Miscellaneous Reasons|3|||
27761820|NCT02556775|54214172|FG000|Overall Study|Withdrawal by Subject|1|||
27761821|NCT02556775|54214173|FG001|Overall Study|Withdrawal by Subject|0|||
27761822|NCT02556775|54214174|FG002|Overall Study|Withdrawal by Subject|1|||
27761823|NCT02556775|54214175|FG003|Overall Study|Withdrawal by Subject|0|||
27761824|NCT02556775|54214172|FG000|Overall Study|Lost to Follow-up|1|||
27761825|NCT02556775|54214173|FG001|Overall Study|Lost to Follow-up|0|||
27761826|NCT02556775|54214174|FG002|Overall Study|Lost to Follow-up|0|||
27761827|NCT02556775|54214175|FG003|Overall Study|Lost to Follow-up|0|||
27761828|NCT01662505|54214190|FG000|Overall Study|Progressive disease|6|||
27761829|NCT01662505|54214191|FG001|Overall Study|Progressive disease|1|||
27761830|NCT01662505|54214192|FG002|Overall Study|Progressive disease|5|||
27761831|NCT01662505|54214190|FG000|Overall Study|Refused cont. medication|0|||
27761832|NCT01662505|54214191|FG001|Overall Study|Refused cont. medication|0|||
27761833|NCT01662505|54214192|FG002|Overall Study|Refused cont. medication|1|||
27761834|NCT01662505|54214190|FG000|Overall Study|Not specified above|1|||
27761835|NCT01662505|54214191|FG001|Overall Study|Not specified above|3|||
27761836|NCT01662505|54214192|FG002|Overall Study|Not specified above|2|||
27761837|NCT03796195|54214201|FG000|Overall Study|Study closed early|1|||
27761838|NCT02554513|54214235|FG000|First Treatment Phase (7 Weeks)|Withdrawal by Subject|0|||
27761839|NCT02554513|54214236|FG001|First Treatment Phase (7 Weeks)|Withdrawal by Subject|1|||
27761840|NCT02554279|54214250|FG000|Overall Study|Adverse Event|2|||
27761841|NCT02554279|54214251|FG001|Overall Study|Adverse Event|5|||
27761842|NCT02554279|54214250|FG000|Overall Study|Lost to Follow-up|3|||
27761843|NCT02554279|54214251|FG001|Overall Study|Lost to Follow-up|2|||
27761844|NCT02554279|54214250|FG000|Overall Study|Withdrawal by Subject|6|||
27761845|NCT02554279|54214251|FG001|Overall Study|Withdrawal by Subject|4|||
27761846|NCT02554279|54214250|FG000|Overall Study|Protocol Violation|2|||
27761847|NCT02554279|54214251|FG001|Overall Study|Protocol Violation|1|||
27761848|NCT02554279|54214250|FG000|Overall Study|Other reason|19|||
27761849|NCT02554279|54214251|FG001|Overall Study|Other reason|6|||
27761850|NCT02554903|54214266|FG000|Overall Study|Death|1|||
27761851|NCT02554903|54214267|FG001|Overall Study|Death|1|||
27761852|NCT02554903|54214266|FG000|Overall Study|Physician Decision|2|||
27761853|NCT02554903|54214267|FG001|Overall Study|Physician Decision|2|||
27761854|NCT02554903|54214266|FG000|Overall Study|Heart Transplant|1|||
27761855|NCT02554903|54214267|FG001|Overall Study|Heart Transplant|2|||
27761856|NCT02332707|54214292|FG000|Overall Study|Adverse Event|0|||
27761857|NCT02332707|54214293|FG001|Overall Study|Adverse Event|0|||
27761858|NCT02332707|54214294|FG002|Overall Study|Adverse Event|0|||
27761859|NCT02332707|54214295|FG003|Overall Study|Adverse Event|0|||
27761860|NCT02332707|54214296|FG004|Overall Study|Adverse Event|0|||
27761861|NCT02332707|54214297|FG005|Overall Study|Adverse Event|0|||
27761862|NCT02332707|54214298|FG006|Overall Study|Adverse Event|0|||
27761863|NCT02332707|54214299|FG007|Overall Study|Adverse Event|0|||
27761864|NCT02332707|54214300|FG008|Overall Study|Adverse Event|0|||
27761865|NCT02332707|54214301|FG009|Overall Study|Adverse Event|0|||
27761866|NCT02332707|54214302|FG010|Overall Study|Adverse Event|0|||
27761867|NCT02332707|54214303|FG011|Overall Study|Adverse Event|0|||
27761868|NCT02332707|54214304|FG012|Overall Study|Adverse Event|1|||
27761869|NCT02332707|54214305|FG013|Overall Study|Adverse Event|0|||
27761870|NCT02332707|54214306|FG014|Overall Study|Adverse Event|0|||
27761871|NCT02332707|54214307|FG015|Overall Study|Adverse Event|0|||
27761872|NCT02332707|54214308|FG016|Overall Study|Adverse Event|0|||
27761873|NCT02332707|54214309|FG017|Overall Study|Adverse Event|0|||
27761874|NCT02332707|54214292|FG000|Overall Study|Lost to Follow-up|0|||
27761875|NCT02332707|54214293|FG001|Overall Study|Lost to Follow-up|0|||
27761876|NCT02332707|54214294|FG002|Overall Study|Lost to Follow-up|0|||
27761877|NCT02332707|54214295|FG003|Overall Study|Lost to Follow-up|0|||
27761878|NCT02332707|54214296|FG004|Overall Study|Lost to Follow-up|0|||
27761879|NCT02332707|54214297|FG005|Overall Study|Lost to Follow-up|1|||
27761880|NCT02332707|54214298|FG006|Overall Study|Lost to Follow-up|0|||
27761881|NCT02332707|54214299|FG007|Overall Study|Lost to Follow-up|0|||
27761882|NCT02332707|54214300|FG008|Overall Study|Lost to Follow-up|0|||
27761883|NCT02332707|54214301|FG009|Overall Study|Lost to Follow-up|0|||
27761884|NCT02332707|54214302|FG010|Overall Study|Lost to Follow-up|2|||
27761885|NCT02332707|54214303|FG011|Overall Study|Lost to Follow-up|0|||
27761886|NCT02332707|54214304|FG012|Overall Study|Lost to Follow-up|3|||
27761887|NCT02332707|54214305|FG013|Overall Study|Lost to Follow-up|0|||
27761888|NCT02332707|54214306|FG014|Overall Study|Lost to Follow-up|0|||
27761889|NCT02332707|54214307|FG015|Overall Study|Lost to Follow-up|0|||
27761890|NCT02332707|54214308|FG016|Overall Study|Lost to Follow-up|0|||
27761891|NCT02332707|54214309|FG017|Overall Study|Lost to Follow-up|0|||
27761892|NCT02332707|54214292|FG000|Overall Study|Physician Decision|0|||
27761893|NCT02332707|54214293|FG001|Overall Study|Physician Decision|0|||
27761894|NCT02332707|54214294|FG002|Overall Study|Physician Decision|0|||
27761895|NCT02332707|54214295|FG003|Overall Study|Physician Decision|1|||
27761896|NCT02332707|54214296|FG004|Overall Study|Physician Decision|0|||
27761897|NCT02332707|54214297|FG005|Overall Study|Physician Decision|0|||
27761898|NCT02332707|54214298|FG006|Overall Study|Physician Decision|0|||
27761899|NCT02332707|54214299|FG007|Overall Study|Physician Decision|0|||
27761900|NCT02332707|54214300|FG008|Overall Study|Physician Decision|0|||
27761901|NCT02332707|54214301|FG009|Overall Study|Physician Decision|0|||
27761902|NCT02332707|54214302|FG010|Overall Study|Physician Decision|0|||
27761903|NCT02332707|54214303|FG011|Overall Study|Physician Decision|0|||
27761904|NCT02332707|54214304|FG012|Overall Study|Physician Decision|1|||
27761905|NCT02332707|54214305|FG013|Overall Study|Physician Decision|0|||
27761906|NCT02332707|54214306|FG014|Overall Study|Physician Decision|0|||
27761907|NCT02332707|54214307|FG015|Overall Study|Physician Decision|0|||
27761908|NCT02332707|54214308|FG016|Overall Study|Physician Decision|0|||
27761909|NCT02332707|54214309|FG017|Overall Study|Physician Decision|0|||
27761910|NCT02332707|54214292|FG000|Overall Study|Withdrawal by Subject|0|||
27761911|NCT02332707|54214293|FG001|Overall Study|Withdrawal by Subject|0|||
27761912|NCT02332707|54214294|FG002|Overall Study|Withdrawal by Subject|1|||
27761913|NCT02332707|54214295|FG003|Overall Study|Withdrawal by Subject|0|||
27761914|NCT02332707|54214296|FG004|Overall Study|Withdrawal by Subject|0|||
27761915|NCT02332707|54214297|FG005|Overall Study|Withdrawal by Subject|0|||
27761916|NCT02332707|54214298|FG006|Overall Study|Withdrawal by Subject|0|||
27761917|NCT02332707|54214299|FG007|Overall Study|Withdrawal by Subject|0|||
27761918|NCT02332707|54214300|FG008|Overall Study|Withdrawal by Subject|0|||
27761919|NCT02332707|54214301|FG009|Overall Study|Withdrawal by Subject|3|||
27761920|NCT02332707|54214302|FG010|Overall Study|Withdrawal by Subject|0|||
27761921|NCT02332707|54214303|FG011|Overall Study|Withdrawal by Subject|0|||
27761922|NCT02332707|54214304|FG012|Overall Study|Withdrawal by Subject|0|||
27839548|NCT01478971|54326845|FG000|Standard of Care Period|Lost to Follow-up|9|||
27839549|NCT01478971|54326845|FG000|Standard of Care Period|Other|4|||
27761923|NCT02332707|54214305|FG013|Overall Study|Withdrawal by Subject|0|||
27761924|NCT02332707|54214306|FG014|Overall Study|Withdrawal by Subject|0|||
27761925|NCT02332707|54214307|FG015|Overall Study|Withdrawal by Subject|0|||
27761926|NCT02332707|54214308|FG016|Overall Study|Withdrawal by Subject|0|||
27926938|NCT01013740|54583422|FG001|Overall Study|Physician Decision|0|||
27761927|NCT02332707|54214309|FG017|Overall Study|Withdrawal by Subject|0|||
27761928|NCT02370615|54214349|FG000|Overall Study|Adverse Event|1|||
27761929|NCT02370615|54214350|FG001|Overall Study|Adverse Event|0|||
27761930|NCT02307513|54214365|FG000|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4|||
27761931|NCT02307513|54214366|FG001|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3|||
27761932|NCT02307513|54214365|FG000|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8|||
27761933|NCT02307513|54214366|FG001|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0|||
27761934|NCT02307513|54214365|FG000|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1|||
27761935|NCT02307513|54214366|FG001|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0|||
27761936|NCT02307513|54214365|FG000|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5|||
27761937|NCT02307513|54214366|FG001|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4|||
27761938|NCT02307513|54214365|FG000|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1|||
27761939|NCT02307513|54214366|FG001|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0|||
27761940|NCT02307513|54214365|FG000|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
27761941|NCT02307513|54214366|FG001|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
27761942|NCT02307513|54214365|FG000|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0|||
27761943|NCT02307513|54214366|FG001|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1|||
27761944|NCT02307513|54214365|FG000|Active Treatment Phase (Weeks 13-64)|Adverse Event|4|||
27761945|NCT02307513|54214366|FG001|Active Treatment Phase (Weeks 13-64)|Adverse Event|9|||
27761946|NCT02307513|54214365|FG000|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
27761947|NCT02307513|54214366|FG001|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
27761948|NCT02307513|54214365|FG000|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
27761949|NCT02307513|54214366|FG001|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
27761950|NCT02307513|54214365|FG000|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
27761951|NCT02307513|54214366|FG001|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
27761952|NCT02307513|54214365|FG000|Active Treatment Phase (Weeks 13-64)|Pregnancy|1|||
27761953|NCT02307513|54214366|FG001|Active Treatment Phase (Weeks 13-64)|Pregnancy|0|||
27761954|NCT02307513|54214365|FG000|Long-term Extension|Physician Decision|1|||
27761955|NCT02307513|54214366|FG001|Long-term Extension|Physician Decision|0|||
27761956|NCT02332239|54214378|FG000|Overall Study|Lost to Follow-up|4|||
27761957|NCT02332239|54214379|FG001|Overall Study|Lost to Follow-up|6|||
27761958|NCT02370537|54214390|FG000|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
27761959|NCT02370537|54214391|FG001|Part A (Open-label Recruitment)|Withdrawal by Subject|1|||
27761960|NCT02370537|54214392|FG002|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
27761961|NCT02370537|54214390|FG000|Part A (Open-label Recruitment)|Adverse Event|0|||
27761962|NCT02370537|54214391|FG001|Part A (Open-label Recruitment)|Adverse Event|0|||
27761963|NCT02370537|54214392|FG002|Part A (Open-label Recruitment)|Adverse Event|1|||
27761964|NCT02370537|54214390|FG000|Part B|Not randomised to receive treatment|1|||
27761965|NCT02370537|54214391|FG001|Part B|Not randomised to receive treatment|2|||
27761966|NCT02370537|54214392|FG002|Part B|Not randomised to receive treatment|259|||
27761967|NCT02370537|54214390|FG000|Part B|Withdrawal by Subject|0|||
27761968|NCT02370537|54214391|FG001|Part B|Withdrawal by Subject|1|||
27761969|NCT02370537|54214392|FG002|Part B|Withdrawal by Subject|0|||
27761970|NCT02330055|54214411|FG000|Overall Study|technical issues|2|||
27761971|NCT02330055|54214412|FG001|Overall Study|technical issues|0|||
27761972|NCT02330055|54214411|FG000|Overall Study|participant forgot to wear device|5|||
27761973|NCT02330055|54214412|FG001|Overall Study|participant forgot to wear device|5|||
27761974|NCT02330055|54214411|FG000|Overall Study|data for less than 60 minutes|3|||
27761975|NCT02330055|54214412|FG001|Overall Study|data for less than 60 minutes|3|||
27761976|NCT02330055|54214411|FG000|Overall Study|participant did not sleep|0|||
27761977|NCT02330055|54214412|FG001|Overall Study|participant did not sleep|1|||
27761978|NCT02306265|54214418|FG000|Overall Study|Withdrawal by Subject|1|||
27761979|NCT02329743|54214426|FG000|Overall Study|Adverse Event|1|||
27761980|NCT02329743|54214427|FG001|Overall Study|Adverse Event|1|||
27761981|NCT02329743|54214428|FG002|Overall Study|Adverse Event|3|||
27761982|NCT02329743|54214426|FG000|Overall Study|Lost to Follow-up|1|||
27761983|NCT02329743|54214427|FG001|Overall Study|Lost to Follow-up|0|||
27761984|NCT02329743|54214428|FG002|Overall Study|Lost to Follow-up|1|||
27761985|NCT02329743|54214426|FG000|Overall Study|Withdrawal by Subject|4|||
27761986|NCT02329743|54214427|FG001|Overall Study|Withdrawal by Subject|4|||
27761987|NCT02329743|54214428|FG002|Overall Study|Withdrawal by Subject|1|||
27761988|NCT02329743|54214426|FG000|Overall Study|Other|0|||
27761989|NCT02329743|54214427|FG001|Overall Study|Other|2|||
27761990|NCT02329743|54214428|FG002|Overall Study|Other|3|||
27761991|NCT02329431|54214438|FG000|Overall Study|Lost to Follow-up|20|||
27761992|NCT02329431|54214439|FG001|Overall Study|Lost to Follow-up|13|||
27761993|NCT02328105|54214445|FG000|Overall Study|Death|6|||
27761994|NCT02328105|54214445|FG000|Overall Study|Withdrawal by Subject|1|||
27761995|NCT02328105|54214445|FG000|Overall Study|Still On Study in Follow-Up|4|||
27761996|NCT02305797|54214451|FG000|Overall Study|Adverse Event|11|||
27761997|NCT02305797|54214452|FG001|Overall Study|Adverse Event|2|||
27761998|NCT02305797|54214451|FG000|Overall Study|Withdrawal by Subject|9|||
27761999|NCT02305797|54214452|FG001|Overall Study|Withdrawal by Subject|10|||
27762000|NCT02305797|54214451|FG000|Overall Study|Lack of Efficacy|6|||
27762001|NCT02305797|54214452|FG001|Overall Study|Lack of Efficacy|0|||
27762002|NCT02305797|54214451|FG000|Overall Study|Lost to Follow-up|5|||
27762003|NCT02305797|54214452|FG001|Overall Study|Lost to Follow-up|11|||
27762004|NCT02305797|54214451|FG000|Overall Study|Pregnancy|0|||
27762005|NCT02305797|54214452|FG001|Overall Study|Pregnancy|2|||
27762006|NCT02305797|54214451|FG000|Overall Study|Noncompliance|14|||
27762007|NCT02305797|54214452|FG001|Overall Study|Noncompliance|12|||
27762008|NCT02305797|54214451|FG000|Overall Study|Reason not collected|0|||
27762009|NCT02305797|54214452|FG001|Overall Study|Reason not collected|1|||
27762010|NCT01646073|54214460|FG000|Period A (12 Weeks)|Adverse Event|0|||
27762011|NCT01646073|54214461|FG001|Period A (12 Weeks)|Adverse Event|2|||
27762012|NCT01646073|54214460|FG000|Period A (12 Weeks)|Withdrawal by Subject|1|||
27762013|NCT01646073|54214461|FG001|Period A (12 Weeks)|Withdrawal by Subject|1|||
27762014|NCT01646073|54214460|FG000|Period A (12 Weeks)|Lack of Efficacy|1|||
27762015|NCT01646073|54214461|FG001|Period A (12 Weeks)|Lack of Efficacy|0|||
27762016|NCT01646073|54214460|FG000|Period A (12 Weeks)|Protocol Violation|0|||
27762017|NCT01646073|54214461|FG001|Period A (12 Weeks)|Protocol Violation|1|||
27762018|NCT01646073|54214460|FG000|Period A (12 Weeks)|Other|0|||
27762019|NCT01646073|54214461|FG001|Period A (12 Weeks)|Other|1|||
27762020|NCT01646073|54214460|FG000|Period B (12 Weeks)|Adverse Event|0|||
27762021|NCT01646073|54214461|FG001|Period B (12 Weeks)|Adverse Event|7|||
27762022|NCT01646073|54214460|FG000|Period B (12 Weeks)|Withdrawal by Subject|1|||
27762023|NCT01646073|54214461|FG001|Period B (12 Weeks)|Withdrawal by Subject|5|||
27762024|NCT01646073|54214460|FG000|Period B (12 Weeks)|Lost to Follow-up|0|||
27762025|NCT01646073|54214461|FG001|Period B (12 Weeks)|Lost to Follow-up|1|||
27762026|NCT02328027|54214472|FG000|Overall Study|Withdrawal by Subject|0|||
27762027|NCT02328027|54214473|FG001|Overall Study|Withdrawal by Subject|1|||
27762028|NCT02551159|54214483|FG000|Overall Study|Death|352|||
27762029|NCT02551159|54214484|FG001|Overall Study|Death|174|||
27762030|NCT02551159|54214485|FG002|Overall Study|Death|161|||
27762031|NCT02551159|54214483|FG000|Overall Study|Withdrawal by Subject|8|||
27762032|NCT02551159|54214484|FG001|Overall Study|Withdrawal by Subject|5|||
27762033|NCT02551159|54214485|FG002|Overall Study|Withdrawal by Subject|16|||
27762034|NCT02551159|54214483|FG000|Overall Study|Patients alive or lost to follow-up at DCO|53|||
27762035|NCT02551159|54214484|FG001|Overall Study|Patients alive or lost to follow-up at DCO|25|||
27762036|NCT02551159|54214485|FG002|Overall Study|Patients alive or lost to follow-up at DCO|29|||
27762037|NCT02305563|54214498|FG000|Treatment Period|Disease progression|0|||
27762038|NCT02305563|54214499|FG001|Treatment Period|Disease progression|0|||
27762039|NCT02305563|54214500|FG002|Treatment Period|Disease progression|15|||
27762040|NCT02305563|54214501|FG003|Treatment Period|Disease progression|6|||
27762041|NCT02305563|54214502|FG004|Treatment Period|Disease progression|6|||
27762042|NCT02305563|54214498|FG000|Treatment Period|Study drug toxicity|0|||
27762043|NCT02305563|54214499|FG001|Treatment Period|Study drug toxicity|0|||
27762044|NCT02305563|54214500|FG002|Treatment Period|Study drug toxicity|0|||
27762045|NCT02305563|54214501|FG003|Treatment Period|Study drug toxicity|1|||
27762046|NCT02305563|54214502|FG004|Treatment Period|Study drug toxicity|2|||
27762047|NCT02305563|54214498|FG000|Treatment Period|Death|0|||
27762048|NCT02305563|54214499|FG001|Treatment Period|Death|0|||
27762049|NCT02305563|54214500|FG002|Treatment Period|Death|1|||
27762050|NCT02305563|54214501|FG003|Treatment Period|Death|2|||
27762051|NCT02305563|54214502|FG004|Treatment Period|Death|1|||
27762052|NCT02305563|54214498|FG000|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
27762053|NCT02305563|54214499|FG001|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
27762054|NCT02305563|54214500|FG002|Treatment Period|Adverse Event (AE) unrelated to drug|7|||
27762055|NCT02305563|54214501|FG003|Treatment Period|Adverse Event (AE) unrelated to drug|1|||
27762056|NCT02305563|54214502|FG004|Treatment Period|Adverse Event (AE) unrelated to drug|2|||
27762057|NCT02305563|54214498|FG000|Treatment Period|Participant request to stop therapy|0|||
27839550|NCT01478971|54326845|FG000|Peginesatide Treatment Period|Adverse Event|1|||
27839551|NCT01478971|54326845|FG000|Peginesatide Treatment Period|Withdrawal by Subject|1|||
27762058|NCT02305563|54214499|FG001|Treatment Period|Participant request to stop therapy|2|||
27762059|NCT02305563|54214500|FG002|Treatment Period|Participant request to stop therapy|0|||
27762060|NCT02305563|54214501|FG003|Treatment Period|Participant request to stop therapy|1|||
27762061|NCT02305563|54214502|FG004|Treatment Period|Participant request to stop therapy|0|||
27762062|NCT02305563|54214498|FG000|Treatment Period|Participant withdrew consent|0|||
27762063|NCT02305563|54214499|FG001|Treatment Period|Participant withdrew consent|0|||
27762064|NCT02305563|54214500|FG002|Treatment Period|Participant withdrew consent|1|||
27762065|NCT02305563|54214501|FG003|Treatment Period|Participant withdrew consent|1|||
27762066|NCT02305563|54214502|FG004|Treatment Period|Participant withdrew consent|1|||
27762067|NCT02305563|54214498|FG000|Treatment Period|Maximum clinical benefit|0|||
27762068|NCT02305563|54214499|FG001|Treatment Period|Maximum clinical benefit|0|||
27762069|NCT02305563|54214500|FG002|Treatment Period|Maximum clinical benefit|0|||
27762070|NCT02305563|54214501|FG003|Treatment Period|Maximum clinical benefit|0|||
27762071|NCT02305563|54214502|FG004|Treatment Period|Maximum clinical benefit|1|||
27762072|NCT02305563|54214498|FG000|Treatment Period|Poor/non-compliance|0|||
27762073|NCT02305563|54214499|FG001|Treatment Period|Poor/non-compliance|0|||
27762074|NCT02305563|54214500|FG002|Treatment Period|Poor/non-compliance|0|||
27762075|NCT02305563|54214501|FG003|Treatment Period|Poor/non-compliance|0|||
27762076|NCT02305563|54214502|FG004|Treatment Period|Poor/non-compliance|1|||
27762077|NCT02305563|54214498|FG000|Treatment Period|Administrative reason by Sponsor|0|||
27762078|NCT02305563|54214499|FG001|Treatment Period|Administrative reason by Sponsor|0|||
27762079|NCT02305563|54214500|FG002|Treatment Period|Administrative reason by Sponsor|0|||
27762080|NCT02305563|54214501|FG003|Treatment Period|Administrative reason by Sponsor|0|||
27762081|NCT02305563|54214502|FG004|Treatment Period|Administrative reason by Sponsor|1|||
27762082|NCT02305563|54214498|FG000|Treatment Period|other reason|2|||
27762083|NCT02305563|54214499|FG001|Treatment Period|other reason|0|||
27762084|NCT02305563|54214500|FG002|Treatment Period|other reason|2|||
27762085|NCT02305563|54214501|FG003|Treatment Period|other reason|2|||
27762086|NCT02305563|54214502|FG004|Treatment Period|other reason|1|||
27762087|NCT02305563|54214498|FG000|Treatment Period|Randomized but not treated|0|||
27762088|NCT02305563|54214499|FG001|Treatment Period|Randomized but not treated|0|||
27762089|NCT02305563|54214500|FG002|Treatment Period|Randomized but not treated|0|||
27762090|NCT02305563|54214501|FG003|Treatment Period|Randomized but not treated|0|||
27762091|NCT02305563|54214502|FG004|Treatment Period|Randomized but not treated|2|||
27762092|NCT02305563|54214498|FG000|Treatment Period|added ULO, then disease progression|0|||
27762093|NCT02305563|54214499|FG001|Treatment Period|added ULO, then disease progression|0|||
27762094|NCT02305563|54214500|FG002|Treatment Period|added ULO, then disease progression|0|||
27762095|NCT02305563|54214501|FG003|Treatment Period|added ULO, then disease progression|0|||
27762096|NCT02305563|54214502|FG004|Treatment Period|added ULO, then disease progression|4|||
27762097|NCT02305563|54214498|FG000|Treatment Period|added ULO; then other reason|0|||
27762098|NCT02305563|54214499|FG001|Treatment Period|added ULO; then other reason|0|||
27762099|NCT02305563|54214500|FG002|Treatment Period|added ULO; then other reason|0|||
27762100|NCT02305563|54214501|FG003|Treatment Period|added ULO; then other reason|0|||
27762101|NCT02305563|54214502|FG004|Treatment Period|added ULO; then other reason|1|||
27762102|NCT02305563|54214498|FG000|Treatment Period|added ULO, then request to stop|0|||
27762103|NCT02305563|54214499|FG001|Treatment Period|added ULO, then request to stop|0|||
27762104|NCT02305563|54214500|FG002|Treatment Period|added ULO, then request to stop|0|||
27762105|NCT02305563|54214501|FG003|Treatment Period|added ULO, then request to stop|0|||
27762106|NCT02305563|54214502|FG004|Treatment Period|added ULO, then request to stop|1|||
27762107|NCT02305563|54214498|FG000|Follow-up Period|Death|0|||
27762108|NCT02305563|54214499|FG001|Follow-up Period|Death|0|||
27762109|NCT02305563|54214500|FG002|Follow-up Period|Death|5|||
27762110|NCT02305563|54214501|FG003|Follow-up Period|Death|4|||
27762111|NCT02305563|54214502|FG004|Follow-up Period|Death|7|||
27762112|NCT02305563|54214498|FG000|Follow-up Period|Participant withdrew consent|0|||
27762113|NCT02305563|54214499|FG001|Follow-up Period|Participant withdrew consent|0|||
27762114|NCT02305563|54214500|FG002|Follow-up Period|Participant withdrew consent|2|||
27762115|NCT02305563|54214501|FG003|Follow-up Period|Participant withdrew consent|1|||
27762116|NCT02305563|54214502|FG004|Follow-up Period|Participant withdrew consent|0|||
27762117|NCT02305563|54214498|FG000|Follow-up Period|other reason|0|||
27762118|NCT02305563|54214499|FG001|Follow-up Period|other reason|0|||
27762119|NCT02305563|54214500|FG002|Follow-up Period|other reason|0|||
27762120|NCT02305563|54214501|FG003|Follow-up Period|other reason|0|||
27762121|NCT02305563|54214502|FG004|Follow-up Period|other reason|1|||
27762122|NCT02305563|54214498|FG000|Follow-up Period|Followup no longer required per protocol|3|||
27762123|NCT02305563|54214499|FG001|Follow-up Period|Followup no longer required per protocol|3|||
27762124|NCT02305563|54214500|FG002|Follow-up Period|Followup no longer required per protocol|4|||
27762125|NCT02305563|54214501|FG003|Follow-up Period|Followup no longer required per protocol|1|||
27762126|NCT02305563|54214502|FG004|Follow-up Period|Followup no longer required per protocol|4|||
27762127|NCT02327325|54214521|FG000|Overall Study|Withdrawal by Subject|1|||
27762128|NCT02327325|54214522|FG001|Overall Study|Withdrawal by Subject|4|||
27762129|NCT02327325|54214523|FG002|Overall Study|Withdrawal by Subject|4|||
27762130|NCT02327325|54214521|FG000|Overall Study|Excluded by Study Team|0|||
27762131|NCT02327325|54214522|FG001|Overall Study|Excluded by Study Team|0|||
27762132|NCT02327325|54214523|FG002|Overall Study|Excluded by Study Team|1|||
27762133|NCT02304705|54214533|FG000|Overall Study|Withdrawal by Subject|2|||
27762134|NCT02304705|54214534|FG001|Overall Study|Withdrawal by Subject|0|||
27762135|NCT02304705|54214533|FG000|Overall Study|Physician Decision|2|||
27762136|NCT02304705|54214534|FG001|Overall Study|Physician Decision|4|||
27762137|NCT02304705|54214533|FG000|Overall Study|Death|0|||
27762138|NCT02304705|54214534|FG001|Overall Study|Death|1|||
27762139|NCT02304705|54214533|FG000|Overall Study|Lost to Follow-up|0|||
27762140|NCT02304705|54214534|FG001|Overall Study|Lost to Follow-up|2|||
27762141|NCT02553499|54214554|FG000|Overall Study|Adverse Event|0|||
27762142|NCT02553499|54214555|FG001|Overall Study|Adverse Event|0|||
27762143|NCT02553499|54214556|FG002|Overall Study|Adverse Event|0|||
27762144|NCT02553499|54214557|FG003|Overall Study|Adverse Event|0|||
27762145|NCT02553499|54214558|FG004|Overall Study|Adverse Event|0|||
27762146|NCT02553499|54214559|FG005|Overall Study|Adverse Event|0|||
27762147|NCT02553499|54214560|FG006|Overall Study|Adverse Event|1|||
27762148|NCT02553499|54214561|FG007|Overall Study|Adverse Event|1|||
27762149|NCT02553499|54214562|FG008|Overall Study|Adverse Event|0|||
27762150|NCT02553499|54214563|FG009|Overall Study|Adverse Event|0|||
27762151|NCT02553499|54214564|FG010|Overall Study|Adverse Event|0|||
27762152|NCT02553499|54214565|FG011|Overall Study|Adverse Event|0|||
27762153|NCT02553499|54214566|FG012|Overall Study|Adverse Event|0|||
27762154|NCT02553499|54214567|FG013|Overall Study|Adverse Event|1|||
27762155|NCT02553499|54214554|FG000|Overall Study|Death|0|||
27762156|NCT02553499|54214555|FG001|Overall Study|Death|1|||
27762157|NCT02553499|54214556|FG002|Overall Study|Death|1|||
27762158|NCT02553499|54214557|FG003|Overall Study|Death|0|||
27762159|NCT02553499|54214558|FG004|Overall Study|Death|1|||
27762160|NCT02553499|54214559|FG005|Overall Study|Death|2|||
27762161|NCT02553499|54214560|FG006|Overall Study|Death|0|||
27762162|NCT02553499|54214561|FG007|Overall Study|Death|0|||
27762163|NCT02553499|54214562|FG008|Overall Study|Death|0|||
27762164|NCT02553499|54214563|FG009|Overall Study|Death|0|||
27762165|NCT02553499|54214564|FG010|Overall Study|Death|1|||
27762166|NCT02553499|54214565|FG011|Overall Study|Death|0|||
27762167|NCT02553499|54214566|FG012|Overall Study|Death|0|||
27762168|NCT02553499|54214567|FG013|Overall Study|Death|0|||
27762169|NCT02553499|54214554|FG000|Overall Study|Lost to Follow-up|0|||
27762170|NCT02553499|54214555|FG001|Overall Study|Lost to Follow-up|0|||
27762171|NCT02553499|54214556|FG002|Overall Study|Lost to Follow-up|0|||
27762172|NCT02553499|54214557|FG003|Overall Study|Lost to Follow-up|0|||
27762173|NCT02553499|54214558|FG004|Overall Study|Lost to Follow-up|0|||
27762174|NCT02553499|54214559|FG005|Overall Study|Lost to Follow-up|0|||
27762175|NCT02553499|54214560|FG006|Overall Study|Lost to Follow-up|1|||
27762176|NCT02553499|54214561|FG007|Overall Study|Lost to Follow-up|0|||
27762177|NCT02553499|54214562|FG008|Overall Study|Lost to Follow-up|0|||
27762178|NCT02553499|54214563|FG009|Overall Study|Lost to Follow-up|0|||
27762179|NCT02553499|54214564|FG010|Overall Study|Lost to Follow-up|0|||
27762180|NCT02553499|54214565|FG011|Overall Study|Lost to Follow-up|0|||
27762181|NCT02553499|54214566|FG012|Overall Study|Lost to Follow-up|0|||
27762182|NCT02553499|54214567|FG013|Overall Study|Lost to Follow-up|0|||
27762183|NCT02553499|54214554|FG000|Overall Study|Physician Decision|0|||
27762184|NCT02553499|54214555|FG001|Overall Study|Physician Decision|1|||
27762185|NCT02553499|54214556|FG002|Overall Study|Physician Decision|1|||
27762186|NCT02553499|54214557|FG003|Overall Study|Physician Decision|0|||
27762187|NCT02553499|54214558|FG004|Overall Study|Physician Decision|1|||
27762188|NCT02553499|54214559|FG005|Overall Study|Physician Decision|0|||
27762189|NCT02553499|54214560|FG006|Overall Study|Physician Decision|0|||
27762190|NCT02553499|54214561|FG007|Overall Study|Physician Decision|1|||
27762191|NCT02553499|54214562|FG008|Overall Study|Physician Decision|1|||
27762192|NCT02553499|54214563|FG009|Overall Study|Physician Decision|2|||
27762193|NCT02553499|54214564|FG010|Overall Study|Physician Decision|1|||
27762194|NCT02553499|54214565|FG011|Overall Study|Physician Decision|3|||
27762195|NCT02553499|54214566|FG012|Overall Study|Physician Decision|1|||
27762196|NCT02553499|54214567|FG013|Overall Study|Physician Decision|0|||
27762197|NCT02553499|54214554|FG000|Overall Study|Progressive Disease|0|||
27762198|NCT02553499|54214555|FG001|Overall Study|Progressive Disease|0|||
27762199|NCT02553499|54214556|FG002|Overall Study|Progressive Disease|0|||
27762200|NCT02553499|54214557|FG003|Overall Study|Progressive Disease|2|||
27762201|NCT02553499|54214558|FG004|Overall Study|Progressive Disease|1|||
27762202|NCT02553499|54214559|FG005|Overall Study|Progressive Disease|1|||
27762203|NCT02553499|54214560|FG006|Overall Study|Progressive Disease|1|||
27762204|NCT02553499|54214561|FG007|Overall Study|Progressive Disease|0|||
27762205|NCT02553499|54214562|FG008|Overall Study|Progressive Disease|0|||
27762206|NCT02553499|54214563|FG009|Overall Study|Progressive Disease|1|||
27762207|NCT02553499|54214564|FG010|Overall Study|Progressive Disease|0|||
27762208|NCT02553499|54214565|FG011|Overall Study|Progressive Disease|0|||
27762209|NCT02553499|54214566|FG012|Overall Study|Progressive Disease|2|||
27762210|NCT02553499|54214567|FG013|Overall Study|Progressive Disease|1|||
27762211|NCT02553499|54214554|FG000|Overall Study|Study Terminated by Sponsor|0|||
27762212|NCT02553499|54214555|FG001|Overall Study|Study Terminated by Sponsor|0|||
27762213|NCT02553499|54214556|FG002|Overall Study|Study Terminated by Sponsor|0|||
27762214|NCT02553499|54214557|FG003|Overall Study|Study Terminated by Sponsor|0|||
27762215|NCT02553499|54214558|FG004|Overall Study|Study Terminated by Sponsor|0|||
27762216|NCT02553499|54214559|FG005|Overall Study|Study Terminated by Sponsor|0|||
27762217|NCT02553499|54214560|FG006|Overall Study|Study Terminated by Sponsor|0|||
27762218|NCT02553499|54214561|FG007|Overall Study|Study Terminated by Sponsor|0|||
27762219|NCT02553499|54214562|FG008|Overall Study|Study Terminated by Sponsor|1|||
27762220|NCT02553499|54214563|FG009|Overall Study|Study Terminated by Sponsor|0|||
27762221|NCT02553499|54214564|FG010|Overall Study|Study Terminated by Sponsor|0|||
27762222|NCT02553499|54214565|FG011|Overall Study|Study Terminated by Sponsor|0|||
27762223|NCT02553499|54214566|FG012|Overall Study|Study Terminated by Sponsor|0|||
27762224|NCT02553499|54214567|FG013|Overall Study|Study Terminated by Sponsor|0|||
27762225|NCT02553499|54214554|FG000|Overall Study|Withdrawal by Subject|2|||
27762226|NCT02553499|54214555|FG001|Overall Study|Withdrawal by Subject|0|||
27762227|NCT02553499|54214556|FG002|Overall Study|Withdrawal by Subject|0|||
27762228|NCT02553499|54214557|FG003|Overall Study|Withdrawal by Subject|0|||
27762229|NCT02553499|54214558|FG004|Overall Study|Withdrawal by Subject|0|||
27762230|NCT02553499|54214559|FG005|Overall Study|Withdrawal by Subject|0|||
27762231|NCT02553499|54214560|FG006|Overall Study|Withdrawal by Subject|0|||
27762232|NCT02553499|54214561|FG007|Overall Study|Withdrawal by Subject|1|||
27762233|NCT02553499|54214562|FG008|Overall Study|Withdrawal by Subject|1|||
27762234|NCT02553499|54214563|FG009|Overall Study|Withdrawal by Subject|0|||
27762235|NCT02553499|54214564|FG010|Overall Study|Withdrawal by Subject|1|||
27762236|NCT02553499|54214565|FG011|Overall Study|Withdrawal by Subject|0|||
27762237|NCT02553499|54214566|FG012|Overall Study|Withdrawal by Subject|0|||
27762238|NCT02553499|54214567|FG013|Overall Study|Withdrawal by Subject|0|||
27762239|NCT02553421|54214600|FG000|Overall Study|Lost to Follow-up|21|||
27762240|NCT02553421|54214601|FG001|Overall Study|Lost to Follow-up|1|||
27762241|NCT02553421|54214600|FG000|Overall Study|Incomplete or Insufficient Data Collecte|5|||
27762242|NCT02553421|54214601|FG001|Overall Study|Incomplete or Insufficient Data Collecte|0|||
27762243|NCT02553421|54214600|FG000|Overall Study|Improper Device Placement|3|||
27762244|NCT02553421|54214601|FG001|Overall Study|Improper Device Placement|0|||
27762245|NCT02549287|54214610|FG000|Overall Study|Lost to Follow-up|65|||
27762246|NCT02549287|54214611|FG001|Overall Study|Lost to Follow-up|26|||
27762247|NCT02549287|54214610|FG000|Overall Study|Withdrawal by Subject|15|||
27762248|NCT02549287|54214611|FG001|Overall Study|Withdrawal by Subject|6|||
27762249|NCT02553265|54214617|FG000|Enrollment|Death|0|||
27762250|NCT02553265|54214618|FG001|Enrollment|Death|0|||
27762251|NCT02553265|54214619|FG002|Enrollment|Death|1|||
27762252|NCT02553265|54214617|FG000|First Intervention (28 Days)|Adverse Event|1|||
27762253|NCT02553265|54214618|FG001|First Intervention (28 Days)|Adverse Event|0|||
27762254|NCT02553265|54214619|FG002|First Intervention (28 Days)|Adverse Event|0|||
27762255|NCT02553265|54214617|FG000|First Intervention (28 Days)|Withdrawal by Subject|0|||
27762256|NCT02553265|54214618|FG001|First Intervention (28 Days)|Withdrawal by Subject|0|||
27762257|NCT02553265|54214619|FG002|First Intervention (28 Days)|Withdrawal by Subject|1|||
27762258|NCT02553265|54214617|FG000|Second Intervention (28 Days)|Adverse Event|1|||
27762259|NCT02553265|54214618|FG001|Second Intervention (28 Days)|Adverse Event|0|||
27762260|NCT02553265|54214619|FG002|Second Intervention (28 Days)|Adverse Event|0|||
27762261|NCT02553265|54214617|FG000|Third Intervention (28 Days)|Adverse Event|1|||
27762262|NCT02553265|54214618|FG001|Third Intervention (28 Days)|Adverse Event|0|||
27762263|NCT02553265|54214619|FG002|Third Intervention (28 Days)|Adverse Event|0|||
27762264|NCT02553265|54214617|FG000|Third Intervention (28 Days)|Lost to Follow-up|0|||
27762265|NCT02553265|54214618|FG001|Third Intervention (28 Days)|Lost to Follow-up|0|||
27762266|NCT02553265|54214619|FG002|Third Intervention (28 Days)|Lost to Follow-up|1|||
27762267|NCT02561195|54214636|FG000|Vaccination 1 to 3|Adverse Event|4|||
27762268|NCT02561195|54214637|FG001|Vaccination 1 to 3|Adverse Event|5|||
27762269|NCT02561195|54214638|FG002|Vaccination 1 to 3|Adverse Event|0|||
27762270|NCT02561195|54214639|FG003|Vaccination 1 to 3|Adverse Event|3|||
27762271|NCT02561195|54214640|FG004|Vaccination 1 to 3|Adverse Event|4|||
27762272|NCT02561195|54214641|FG005|Vaccination 1 to 3|Adverse Event|0|||
27762273|NCT02561195|54214642|FG006|Vaccination 1 to 3|Adverse Event|0|||
27762274|NCT02561195|54214643|FG007|Vaccination 1 to 3|Adverse Event|0|||
27762275|NCT02561195|54214644|FG008|Vaccination 1 to 3|Adverse Event|0|||
27762276|NCT02561195|54214645|FG009|Vaccination 1 to 3|Adverse Event|0|||
27762277|NCT02561195|54214646|FG010|Vaccination 1 to 3|Adverse Event|0|||
27762278|NCT02561195|54214647|FG011|Vaccination 1 to 3|Adverse Event|0|||
27762279|NCT02561195|54214648|FG012|Vaccination 1 to 3|Adverse Event|0|||
27762280|NCT02561195|54214649|FG013|Vaccination 1 to 3|Adverse Event|0|||
27762281|NCT02561195|54214636|FG000|Vaccination 1 to 3|Lost to Follow-up|3|||
27762282|NCT02561195|54214637|FG001|Vaccination 1 to 3|Lost to Follow-up|4|||
27762283|NCT02561195|54214638|FG002|Vaccination 1 to 3|Lost to Follow-up|0|||
27762284|NCT02561195|54214639|FG003|Vaccination 1 to 3|Lost to Follow-up|2|||
27762285|NCT02561195|54214640|FG004|Vaccination 1 to 3|Lost to Follow-up|3|||
27762286|NCT02561195|54214641|FG005|Vaccination 1 to 3|Lost to Follow-up|3|||
27762287|NCT02561195|54214642|FG006|Vaccination 1 to 3|Lost to Follow-up|0|||
27762288|NCT02561195|54214643|FG007|Vaccination 1 to 3|Lost to Follow-up|0|||
27762289|NCT02561195|54214644|FG008|Vaccination 1 to 3|Lost to Follow-up|0|||
27762290|NCT02561195|54214645|FG009|Vaccination 1 to 3|Lost to Follow-up|0|||
27762291|NCT02561195|54214646|FG010|Vaccination 1 to 3|Lost to Follow-up|0|||
27762292|NCT02561195|54214647|FG011|Vaccination 1 to 3|Lost to Follow-up|0|||
27762293|NCT02561195|54214648|FG012|Vaccination 1 to 3|Lost to Follow-up|0|||
27762294|NCT02561195|54214649|FG013|Vaccination 1 to 3|Lost to Follow-up|0|||
27762295|NCT02561195|54214636|FG000|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
27762296|NCT02561195|54214637|FG001|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
27762297|NCT02561195|54214638|FG002|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
27762298|NCT02561195|54214639|FG003|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
27762299|NCT02561195|54214640|FG004|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
27762300|NCT02561195|54214641|FG005|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
27762301|NCT02561195|54214642|FG006|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
27762302|NCT02561195|54214643|FG007|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
27762303|NCT02561195|54214644|FG008|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
27762304|NCT02561195|54214645|FG009|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
27762305|NCT02561195|54214646|FG010|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
27762306|NCT02561195|54214647|FG011|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
27762307|NCT02561195|54214648|FG012|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
27762308|NCT02561195|54214649|FG013|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
27762309|NCT02561195|54214636|FG000|Vaccination 1 to 3|No longer willing to participate|2|||
27762310|NCT02561195|54214637|FG001|Vaccination 1 to 3|No longer willing to participate|4|||
27762311|NCT02561195|54214638|FG002|Vaccination 1 to 3|No longer willing to participate|0|||
27762312|NCT02561195|54214639|FG003|Vaccination 1 to 3|No longer willing to participate|4|||
27762313|NCT02561195|54214640|FG004|Vaccination 1 to 3|No longer willing to participate|1|||
27762314|NCT02561195|54214641|FG005|Vaccination 1 to 3|No longer willing to participate|3|||
27762315|NCT02561195|54214642|FG006|Vaccination 1 to 3|No longer willing to participate|0|||
27762316|NCT02561195|54214643|FG007|Vaccination 1 to 3|No longer willing to participate|0|||
27762317|NCT02561195|54214644|FG008|Vaccination 1 to 3|No longer willing to participate|0|||
27762318|NCT02561195|54214645|FG009|Vaccination 1 to 3|No longer willing to participate|0|||
27762319|NCT02561195|54214646|FG010|Vaccination 1 to 3|No longer willing to participate|0|||
27762320|NCT02561195|54214647|FG011|Vaccination 1 to 3|No longer willing to participate|0|||
27762321|NCT02561195|54214648|FG012|Vaccination 1 to 3|No longer willing to participate|0|||
27762322|NCT02561195|54214649|FG013|Vaccination 1 to 3|No longer willing to participate|0|||
27762323|NCT02561195|54214636|FG000|Vaccination 1 to 3|Other|7|||
27762324|NCT02561195|54214637|FG001|Vaccination 1 to 3|Other|3|||
27762325|NCT02561195|54214638|FG002|Vaccination 1 to 3|Other|1|||
27762326|NCT02561195|54214639|FG003|Vaccination 1 to 3|Other|7|||
27762327|NCT02561195|54214640|FG004|Vaccination 1 to 3|Other|5|||
27762328|NCT02561195|54214641|FG005|Vaccination 1 to 3|Other|1|||
27762329|NCT02561195|54214642|FG006|Vaccination 1 to 3|Other|0|||
27762330|NCT02561195|54214643|FG007|Vaccination 1 to 3|Other|0|||
27762331|NCT02561195|54214644|FG008|Vaccination 1 to 3|Other|0|||
27762332|NCT02561195|54214645|FG009|Vaccination 1 to 3|Other|0|||
27762333|NCT02561195|54214646|FG010|Vaccination 1 to 3|Other|0|||
27762334|NCT02561195|54214647|FG011|Vaccination 1 to 3|Other|0|||
27762335|NCT02561195|54214648|FG012|Vaccination 1 to 3|Other|0|||
27762336|NCT02561195|54214649|FG013|Vaccination 1 to 3|Other|0|||
27762337|NCT02561195|54214636|FG000|Vaccination 1 to 3|Protocol Violation|1|||
27762338|NCT02561195|54214637|FG001|Vaccination 1 to 3|Protocol Violation|0|||
27762339|NCT02561195|54214638|FG002|Vaccination 1 to 3|Protocol Violation|1|||
27762340|NCT02561195|54214639|FG003|Vaccination 1 to 3|Protocol Violation|2|||
27762341|NCT02561195|54214640|FG004|Vaccination 1 to 3|Protocol Violation|5|||
27762342|NCT02561195|54214641|FG005|Vaccination 1 to 3|Protocol Violation|2|||
27762343|NCT02561195|54214642|FG006|Vaccination 1 to 3|Protocol Violation|0|||
27762344|NCT02561195|54214643|FG007|Vaccination 1 to 3|Protocol Violation|0|||
27762345|NCT02561195|54214644|FG008|Vaccination 1 to 3|Protocol Violation|0|||
27762346|NCT02561195|54214645|FG009|Vaccination 1 to 3|Protocol Violation|0|||
27762347|NCT02561195|54214646|FG010|Vaccination 1 to 3|Protocol Violation|0|||
27762348|NCT02561195|54214647|FG011|Vaccination 1 to 3|Protocol Violation|0|||
27762349|NCT02561195|54214648|FG012|Vaccination 1 to 3|Protocol Violation|0|||
27762350|NCT02561195|54214649|FG013|Vaccination 1 to 3|Protocol Violation|0|||
27762351|NCT02561195|54214636|FG000|Vaccination 1 to 3|Death|2|||
27762352|NCT02561195|54214637|FG001|Vaccination 1 to 3|Death|1|||
27762353|NCT02561195|54214638|FG002|Vaccination 1 to 3|Death|0|||
27762354|NCT02561195|54214639|FG003|Vaccination 1 to 3|Death|2|||
27762355|NCT02561195|54214640|FG004|Vaccination 1 to 3|Death|0|||
27762356|NCT02561195|54214641|FG005|Vaccination 1 to 3|Death|0|||
27762357|NCT02561195|54214642|FG006|Vaccination 1 to 3|Death|0|||
27762358|NCT02561195|54214643|FG007|Vaccination 1 to 3|Death|0|||
27762359|NCT02561195|54214644|FG008|Vaccination 1 to 3|Death|0|||
27762360|NCT02561195|54214645|FG009|Vaccination 1 to 3|Death|0|||
27762361|NCT02561195|54214646|FG010|Vaccination 1 to 3|Death|0|||
27762362|NCT02561195|54214647|FG011|Vaccination 1 to 3|Death|0|||
27762363|NCT02561195|54214648|FG012|Vaccination 1 to 3|Death|0|||
27762364|NCT02561195|54214649|FG013|Vaccination 1 to 3|Death|0|||
27762365|NCT02561195|54214636|FG000|Vaccination 1 to 3|Withdrawal by Subject|3|||
27762366|NCT02561195|54214637|FG001|Vaccination 1 to 3|Withdrawal by Subject|4|||
27762367|NCT02561195|54214638|FG002|Vaccination 1 to 3|Withdrawal by Subject|4|||
27762368|NCT02561195|54214639|FG003|Vaccination 1 to 3|Withdrawal by Subject|2|||
27762369|NCT02561195|54214640|FG004|Vaccination 1 to 3|Withdrawal by Subject|6|||
27762370|NCT02561195|54214641|FG005|Vaccination 1 to 3|Withdrawal by Subject|0|||
27762371|NCT02561195|54214642|FG006|Vaccination 1 to 3|Withdrawal by Subject|0|||
27762372|NCT02561195|54214643|FG007|Vaccination 1 to 3|Withdrawal by Subject|0|||
27762373|NCT02561195|54214644|FG008|Vaccination 1 to 3|Withdrawal by Subject|0|||
27762374|NCT02561195|54214645|FG009|Vaccination 1 to 3|Withdrawal by Subject|0|||
27762375|NCT02561195|54214646|FG010|Vaccination 1 to 3|Withdrawal by Subject|0|||
27762376|NCT02561195|54214647|FG011|Vaccination 1 to 3|Withdrawal by Subject|0|||
27762377|NCT02561195|54214648|FG012|Vaccination 1 to 3|Withdrawal by Subject|0|||
27762378|NCT02561195|54214649|FG013|Vaccination 1 to 3|Withdrawal by Subject|0|||
27762379|NCT02561195|54214636|FG000|Vaccination 1 to 3|Randomized but not treated|1|||
27762380|NCT02561195|54214637|FG001|Vaccination 1 to 3|Randomized but not treated|0|||
27762381|NCT02561195|54214638|FG002|Vaccination 1 to 3|Randomized but not treated|0|||
27762382|NCT02561195|54214639|FG003|Vaccination 1 to 3|Randomized but not treated|0|||
27762383|NCT02561195|54214640|FG004|Vaccination 1 to 3|Randomized but not treated|0|||
27762384|NCT02561195|54214641|FG005|Vaccination 1 to 3|Randomized but not treated|0|||
27762385|NCT02561195|54214642|FG006|Vaccination 1 to 3|Randomized but not treated|0|||
27762386|NCT02561195|54214643|FG007|Vaccination 1 to 3|Randomized but not treated|0|||
27762387|NCT02561195|54214644|FG008|Vaccination 1 to 3|Randomized but not treated|0|||
27762388|NCT02561195|54214645|FG009|Vaccination 1 to 3|Randomized but not treated|0|||
27762389|NCT02561195|54214646|FG010|Vaccination 1 to 3|Randomized but not treated|0|||
27762390|NCT02561195|54214647|FG011|Vaccination 1 to 3|Randomized but not treated|0|||
27762391|NCT02561195|54214648|FG012|Vaccination 1 to 3|Randomized but not treated|0|||
27762392|NCT02561195|54214649|FG013|Vaccination 1 to 3|Randomized but not treated|0|||
27762393|NCT02561195|54214636|FG000|Extension Stage (Vaccination 4)|Withdrew consent|0|||
27762394|NCT02561195|54214637|FG001|Extension Stage (Vaccination 4)|Withdrew consent|0|||
27762395|NCT02561195|54214638|FG002|Extension Stage (Vaccination 4)|Withdrew consent|0|||
27762396|NCT02561195|54214639|FG003|Extension Stage (Vaccination 4)|Withdrew consent|0|||
27762397|NCT02561195|54214640|FG004|Extension Stage (Vaccination 4)|Withdrew consent|0|||
27762398|NCT02561195|54214641|FG005|Extension Stage (Vaccination 4)|Withdrew consent|0|||
27762399|NCT02561195|54214642|FG006|Extension Stage (Vaccination 4)|Withdrew consent|0|||
27762400|NCT02561195|54214643|FG007|Extension Stage (Vaccination 4)|Withdrew consent|0|||
27762401|NCT02561195|54214644|FG008|Extension Stage (Vaccination 4)|Withdrew consent|3|||
27762402|NCT02561195|54214645|FG009|Extension Stage (Vaccination 4)|Withdrew consent|1|||
27762403|NCT02561195|54214646|FG010|Extension Stage (Vaccination 4)|Withdrew consent|2|||
27762404|NCT02561195|54214647|FG011|Extension Stage (Vaccination 4)|Withdrew consent|2|||
27762405|NCT02561195|54214648|FG012|Extension Stage (Vaccination 4)|Withdrew consent|3|||
27762406|NCT02561195|54214649|FG013|Extension Stage (Vaccination 4)|Withdrew consent|0|||
27762407|NCT02561195|54214636|FG000|Extension Stage (Vaccination 4)|Adverse Event|0|||
27762408|NCT02561195|54214637|FG001|Extension Stage (Vaccination 4)|Adverse Event|0|||
27762409|NCT02561195|54214638|FG002|Extension Stage (Vaccination 4)|Adverse Event|0|||
27762410|NCT02561195|54214639|FG003|Extension Stage (Vaccination 4)|Adverse Event|0|||
27762411|NCT02561195|54214640|FG004|Extension Stage (Vaccination 4)|Adverse Event|0|||
27762412|NCT02561195|54214641|FG005|Extension Stage (Vaccination 4)|Adverse Event|0|||
27762413|NCT02561195|54214642|FG006|Extension Stage (Vaccination 4)|Adverse Event|0|||
27762414|NCT02561195|54214643|FG007|Extension Stage (Vaccination 4)|Adverse Event|0|||
27762415|NCT02561195|54214644|FG008|Extension Stage (Vaccination 4)|Adverse Event|0|||
27762416|NCT02561195|54214645|FG009|Extension Stage (Vaccination 4)|Adverse Event|0|||
27762417|NCT02561195|54214646|FG010|Extension Stage (Vaccination 4)|Adverse Event|0|||
27762418|NCT02561195|54214647|FG011|Extension Stage (Vaccination 4)|Adverse Event|0|||
27762419|NCT02561195|54214648|FG012|Extension Stage (Vaccination 4)|Adverse Event|0|||
27762420|NCT02561195|54214649|FG013|Extension Stage (Vaccination 4)|Adverse Event|2|||
27762421|NCT02561195|54214636|FG000|Extension Stage (Vaccination 4)|Death|0|||
27762422|NCT02561195|54214637|FG001|Extension Stage (Vaccination 4)|Death|0|||
27762423|NCT02561195|54214638|FG002|Extension Stage (Vaccination 4)|Death|0|||
27762424|NCT02561195|54214639|FG003|Extension Stage (Vaccination 4)|Death|0|||
27762425|NCT02561195|54214640|FG004|Extension Stage (Vaccination 4)|Death|0|||
27762426|NCT02561195|54214641|FG005|Extension Stage (Vaccination 4)|Death|0|||
27762427|NCT02561195|54214642|FG006|Extension Stage (Vaccination 4)|Death|0|||
27762428|NCT02561195|54214643|FG007|Extension Stage (Vaccination 4)|Death|0|||
27762429|NCT02561195|54214644|FG008|Extension Stage (Vaccination 4)|Death|0|||
27762430|NCT02561195|54214645|FG009|Extension Stage (Vaccination 4)|Death|1|||
27762431|NCT02561195|54214646|FG010|Extension Stage (Vaccination 4)|Death|0|||
27762432|NCT02561195|54214647|FG011|Extension Stage (Vaccination 4)|Death|0|||
27762433|NCT02561195|54214648|FG012|Extension Stage (Vaccination 4)|Death|0|||
27762434|NCT02561195|54214649|FG013|Extension Stage (Vaccination 4)|Death|0|||
27926939|NCT01013740|54583421|FG000|Overall Study|Withdrawal by Subject|2|||
27762435|NCT02561195|54214636|FG000|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
27762436|NCT02561195|54214637|FG001|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
27762437|NCT02561195|54214638|FG002|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
27762438|NCT02561195|54214639|FG003|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
27762439|NCT02561195|54214640|FG004|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
27762440|NCT02561195|54214641|FG005|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
27762441|NCT02561195|54214642|FG006|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
27762442|NCT02561195|54214643|FG007|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
27762443|NCT02561195|54214644|FG008|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
27762444|NCT02561195|54214645|FG009|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
27762445|NCT02561195|54214646|FG010|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
27762446|NCT02561195|54214647|FG011|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
27762447|NCT02561195|54214648|FG012|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
27762448|NCT02561195|54214649|FG013|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
27762449|NCT02561195|54214636|FG000|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
27762450|NCT02561195|54214637|FG001|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
27762451|NCT02561195|54214638|FG002|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
27762452|NCT02561195|54214639|FG003|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
27762453|NCT02561195|54214640|FG004|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
27762454|NCT02561195|54214641|FG005|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
27762455|NCT02561195|54214642|FG006|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
27762456|NCT02561195|54214643|FG007|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
27762457|NCT02561195|54214644|FG008|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
27762458|NCT02561195|54214645|FG009|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
27762459|NCT02561195|54214646|FG010|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
27762460|NCT02561195|54214647|FG011|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
27762461|NCT02561195|54214648|FG012|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
27762462|NCT02561195|54214649|FG013|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
27762463|NCT02561195|54214636|FG000|Extension Stage (Vaccination 4)|Other|0|||
27762464|NCT02561195|54214637|FG001|Extension Stage (Vaccination 4)|Other|0|||
27762465|NCT02561195|54214638|FG002|Extension Stage (Vaccination 4)|Other|0|||
27762466|NCT02561195|54214639|FG003|Extension Stage (Vaccination 4)|Other|0|||
27762467|NCT02561195|54214640|FG004|Extension Stage (Vaccination 4)|Other|0|||
27762468|NCT02561195|54214641|FG005|Extension Stage (Vaccination 4)|Other|0|||
27762469|NCT02561195|54214642|FG006|Extension Stage (Vaccination 4)|Other|0|||
27762470|NCT02561195|54214643|FG007|Extension Stage (Vaccination 4)|Other|0|||
27762471|NCT02561195|54214644|FG008|Extension Stage (Vaccination 4)|Other|0|||
27762472|NCT02561195|54214645|FG009|Extension Stage (Vaccination 4)|Other|0|||
27762473|NCT02561195|54214646|FG010|Extension Stage (Vaccination 4)|Other|2|||
27762474|NCT02561195|54214647|FG011|Extension Stage (Vaccination 4)|Other|2|||
27762475|NCT02561195|54214648|FG012|Extension Stage (Vaccination 4)|Other|1|||
27762476|NCT02561195|54214649|FG013|Extension Stage (Vaccination 4)|Other|0|||
27762477|NCT02561195|54214636|FG000|Extension Stage (Vaccination 4)|Protocol Violation|0|||
27762478|NCT02561195|54214637|FG001|Extension Stage (Vaccination 4)|Protocol Violation|0|||
27762479|NCT02561195|54214638|FG002|Extension Stage (Vaccination 4)|Protocol Violation|0|||
27762480|NCT02561195|54214639|FG003|Extension Stage (Vaccination 4)|Protocol Violation|0|||
27762481|NCT02561195|54214640|FG004|Extension Stage (Vaccination 4)|Protocol Violation|0|||
27762482|NCT02561195|54214641|FG005|Extension Stage (Vaccination 4)|Protocol Violation|0|||
27762483|NCT02561195|54214642|FG006|Extension Stage (Vaccination 4)|Protocol Violation|1|||
27762484|NCT02561195|54214643|FG007|Extension Stage (Vaccination 4)|Protocol Violation|0|||
27762485|NCT02561195|54214644|FG008|Extension Stage (Vaccination 4)|Protocol Violation|0|||
27762486|NCT02561195|54214645|FG009|Extension Stage (Vaccination 4)|Protocol Violation|0|||
27762487|NCT02561195|54214646|FG010|Extension Stage (Vaccination 4)|Protocol Violation|2|||
27762488|NCT02561195|54214647|FG011|Extension Stage (Vaccination 4)|Protocol Violation|1|||
27762489|NCT02561195|54214648|FG012|Extension Stage (Vaccination 4)|Protocol Violation|0|||
27762490|NCT02561195|54214649|FG013|Extension Stage (Vaccination 4)|Protocol Violation|1|||
27762491|NCT01663103|54214683|FG000|Overall Study|Withdrawal by Subject|1|||
27762492|NCT01663103|54214684|FG001|Overall Study|Withdrawal by Subject|2|||
27762493|NCT01663103|54214683|FG000|Overall Study|Adverse Event|1|||
27762494|NCT01663103|54214684|FG001|Overall Study|Adverse Event|0|||
27762495|NCT01663103|54214683|FG000|Overall Study|dog bite|1|||
27762496|NCT01663103|54214684|FG001|Overall Study|dog bite|0|||
27762497|NCT02560025|54214703|FG000|Overall Study|Ineligible after consent/ registration|3|||
27762498|NCT02566889|54214718|FG000|Overall Study|Withdrawal by Subject|3|||
27762499|NCT02566889|54214719|FG001|Overall Study|Withdrawal by Subject|1|||
27762500|NCT02566889|54214718|FG000|Overall Study|Adverse Event|4|||
27762501|NCT02566889|54214719|FG001|Overall Study|Adverse Event|2|||
27762502|NCT02566889|54214718|FG000|Overall Study|Other|6|||
27762503|NCT02566889|54214719|FG001|Overall Study|Other|2|||
27839552|NCT01478971|54326845|FG000|Peginesatide Treatment Period|Death|4|||
27762504|NCT02566577|54214726|FG000|Overall Study|Withdrawal by Subject|1|||
27762505|NCT02566577|54214727|FG001|Overall Study|Withdrawal by Subject|1|||
27762506|NCT02566577|54214726|FG000|Overall Study|Equipment failure|1|||
27762507|NCT02566577|54214727|FG001|Overall Study|Equipment failure|1|||
27762508|NCT02566577|54214726|FG000|Overall Study|Physical limitation|1|||
27762509|NCT02566577|54214727|FG001|Overall Study|Physical limitation|0|||
27762510|NCT02559713|54214735|FG000|Overall Study|Pretreatment Event/ Adverse Event|1|||
27762511|NCT01358981|54214746|FG000|Period 1|Withdrawal by Subject|0|||
27762512|NCT01358981|54214747|FG001|Period 1|Withdrawal by Subject|0|||
27762513|NCT01358981|54214748|FG002|Period 1|Withdrawal by Subject|0|||
27762514|NCT01358981|54214749|FG003|Period 1|Withdrawal by Subject|1|||
27762515|NCT01358981|54214750|FG004|Period 1|Withdrawal by Subject|0|||
27762516|NCT01358981|54214751|FG005|Period 1|Withdrawal by Subject|0|||
27762517|NCT01358981|54214752|FG006|Period 1|Withdrawal by Subject|0|||
27762518|NCT02548585|54214784|FG000|Overall Study|Withdrawal by Subject|0|||
27762519|NCT02548585|54214785|FG001|Overall Study|Withdrawal by Subject|0|||
27762520|NCT02548585|54214786|FG002|Overall Study|Withdrawal by Subject|0|||
27762521|NCT02548585|54214787|FG003|Overall Study|Withdrawal by Subject|0|||
27762522|NCT02548585|54214788|FG004|Overall Study|Withdrawal by Subject|0|||
27762523|NCT02548585|54214789|FG005|Overall Study|Withdrawal by Subject|1|||
27762524|NCT02548585|54214790|FG006|Overall Study|Withdrawal by Subject|0|||
27762525|NCT02548585|54214784|FG000|Overall Study|Lost to Follow-up|1|||
27762526|NCT02548585|54214785|FG001|Overall Study|Lost to Follow-up|0|||
27762527|NCT02548585|54214786|FG002|Overall Study|Lost to Follow-up|0|||
27762528|NCT02548585|54214787|FG003|Overall Study|Lost to Follow-up|0|||
27762529|NCT02548585|54214788|FG004|Overall Study|Lost to Follow-up|0|||
27762530|NCT02548585|54214789|FG005|Overall Study|Lost to Follow-up|0|||
27762531|NCT02548585|54214790|FG006|Overall Study|Lost to Follow-up|0|||
27762532|NCT02548585|54214784|FG000|Overall Study|Other|1|||
27762533|NCT02548585|54214785|FG001|Overall Study|Other|0|||
27762534|NCT02548585|54214786|FG002|Overall Study|Other|0|||
27762535|NCT02548585|54214787|FG003|Overall Study|Other|2|||
27762536|NCT02548585|54214788|FG004|Overall Study|Other|3|||
27762537|NCT02548585|54214789|FG005|Overall Study|Other|0|||
27762538|NCT02548585|54214790|FG006|Overall Study|Other|1|||
27762539|NCT02548585|54214784|FG000|Overall Study|Randomized but not treated|0|||
27762540|NCT02548585|54214785|FG001|Overall Study|Randomized but not treated|0|||
27762541|NCT02548585|54214786|FG002|Overall Study|Randomized but not treated|0|||
27762542|NCT02548585|54214787|FG003|Overall Study|Randomized but not treated|0|||
27762543|NCT02548585|54214788|FG004|Overall Study|Randomized but not treated|0|||
27762544|NCT02548585|54214789|FG005|Overall Study|Randomized but not treated|1|||
27762545|NCT02548585|54214790|FG006|Overall Study|Randomized but not treated|0|||
27762546|NCT02547649|54214834|FG000|Overall Study|Lost to Follow-up|3|||
27762547|NCT02547649|54214835|FG001|Overall Study|Lost to Follow-up|1|||
27762548|NCT02547649|54214836|FG002|Overall Study|Lost to Follow-up|1|||
27762549|NCT02547649|54214834|FG000|Overall Study|Not vaccinated|0|||
27762550|NCT02547649|54214835|FG001|Overall Study|Not vaccinated|0|||
27762551|NCT02547649|54214836|FG002|Overall Study|Not vaccinated|1|||
27762552|NCT02547649|54214834|FG000|Overall Study|Withdrawal by Subject|0|||
27762553|NCT02547649|54214835|FG001|Overall Study|Withdrawal by Subject|4|||
27762554|NCT02547649|54214836|FG002|Overall Study|Withdrawal by Subject|2|||
27762555|NCT02535715|54214856|FG000|Overall Study|Withdrawal by Subject|0|||
27762556|NCT02535715|54214857|FG001|Overall Study|Withdrawal by Subject|0|||
27762557|NCT02535715|54214858|FG002|Overall Study|Withdrawal by Subject|1|||
27762558|NCT02336815|54214871|FG000|Overall Study|Disease Progression|45|||
27762559|NCT02336815|54214872|FG001|Overall Study|Disease Progression|70|||
27762560|NCT02336815|54214871|FG000|Overall Study|Adverse Event|18|||
27762561|NCT02336815|54214872|FG001|Overall Study|Adverse Event|39|||
27762562|NCT02336815|54214871|FG000|Overall Study|Physician Decision|11|||
27762563|NCT02336815|54214872|FG001|Overall Study|Physician Decision|4|||
27762564|NCT02336815|54214871|FG000|Overall Study|Withdrawal by Subject|3|||
27762565|NCT02336815|54214872|FG001|Overall Study|Withdrawal by Subject|2|||
27762566|NCT02336815|54214871|FG000|Overall Study|Lost to Follow-up|1|||
27762567|NCT02336815|54214872|FG001|Overall Study|Lost to Follow-up|3|||
27762568|NCT02336815|54214871|FG000|Overall Study|Other|1|||
27762569|NCT02336815|54214872|FG001|Overall Study|Other|5|||
27762570|NCT02543203|54214882|FG000|Overall Study|Unpalatable Fragrance|2|||
27839553|NCT01478971|54326845|FG000|Peginesatide Treatment Period|Lost to Follow-up|4|||
27762571|NCT02543203|54214883|FG001|Overall Study|Unpalatable Fragrance|2|||
27762572|NCT02543203|54214882|FG000|Overall Study|Lost to Follow-up|1|||
27762573|NCT02543203|54214883|FG001|Overall Study|Lost to Follow-up|0|||
27762574|NCT02543203|54214882|FG000|Overall Study|Increased Irritability|1|||
27762575|NCT02543203|54214883|FG001|Overall Study|Increased Irritability|0|||
27762576|NCT02543203|54214882|FG000|Overall Study|Family|1|||
27926940|NCT01013740|54583422|FG001|Overall Study|Withdrawal by Subject|10|||
27762577|NCT02543203|54214883|FG001|Overall Study|Family|2|||
27762578|NCT02543203|54214882|FG000|Overall Study|Negative Behavior|1|||
27762579|NCT02543203|54214883|FG001|Overall Study|Negative Behavior|0|||
27762580|NCT02543203|54214882|FG000|Overall Study|Withdrawal by Subject|0|||
27762581|NCT02543203|54214883|FG001|Overall Study|Withdrawal by Subject|1|||
27762582|NCT02546323|54214899|FG000|Overall Study|Withdrawal by Subject|36|||
27762583|NCT02546323|54214900|FG001|Overall Study|Withdrawal by Subject|33|||
27762584|NCT02546323|54214899|FG000|Overall Study|Eligibility Criteria not Fulfilled|0|||
27762585|NCT02546323|54214900|FG001|Overall Study|Eligibility Criteria not Fulfilled|1|||
27762586|NCT02546323|54214899|FG000|Overall Study|Adverse Event|17|||
27762587|NCT02546323|54214900|FG001|Overall Study|Adverse Event|11|||
27762588|NCT02546323|54214899|FG000|Overall Study|Patient Specific Reasons|1|||
27762589|NCT02546323|54214900|FG001|Overall Study|Patient Specific Reasons|2|||
27762590|NCT02546323|54214899|FG000|Overall Study|Lost to Follow-up|2|||
27762591|NCT02546323|54214900|FG001|Overall Study|Lost to Follow-up|3|||
27762592|NCT02546323|54214899|FG000|Overall Study|Non-compliance with Study Drug|2|||
27762593|NCT02546323|54214900|FG001|Overall Study|Non-compliance with Study Drug|2|||
27762594|NCT02546323|54214899|FG000|Overall Study|Met Withdrawal Criteria|2|||
27762595|NCT02546323|54214900|FG001|Overall Study|Met Withdrawal Criteria|14|||
27762596|NCT02545933|54214909|FG000|Overall Study|Adverse Event|3|||
27762597|NCT02545933|54214910|FG001|Overall Study|Adverse Event|0|||
27762598|NCT02545933|54214911|FG002|Overall Study|Adverse Event|0|||
27762599|NCT02545933|54214909|FG000|Overall Study|Withdrawal by Subject|2|||
27762600|NCT02545933|54214910|FG001|Overall Study|Withdrawal by Subject|3|||
27762601|NCT02545933|54214911|FG002|Overall Study|Withdrawal by Subject|3|||
27762602|NCT02545933|54214909|FG000|Overall Study|Protocol Violation|1|||
27762603|NCT02545933|54214910|FG001|Overall Study|Protocol Violation|0|||
27762604|NCT02545933|54214911|FG002|Overall Study|Protocol Violation|1|||
27762605|NCT01661179|54214919|FG000|Overall Study|Death|1|||
27762606|NCT01661179|54214919|FG000|Overall Study|Withdrawal by Subject|1|||
27762607|NCT01661179|54214919|FG000|Overall Study|Other Eligibility criteria|4|||
27762608|NCT02545543|54214925|FG000|Overall Study|Lost to Follow-up|67|||
27762609|NCT02545543|54214926|FG001|Overall Study|Lost to Follow-up|25|||
27762610|NCT02545543|54214925|FG000|Overall Study|Physician Decision|3|||
27762611|NCT02545543|54214926|FG001|Overall Study|Physician Decision|0|||
27762612|NCT02545543|54214925|FG000|Overall Study|Withdrawal by Subject|9|||
27762613|NCT02545543|54214926|FG001|Overall Study|Withdrawal by Subject|8|||
27762614|NCT02545543|54214925|FG000|Overall Study|Noncomplaince|1|||
27762615|NCT02545543|54214926|FG001|Overall Study|Noncomplaince|0|||
27762616|NCT02545543|54214925|FG000|Overall Study|Enrolment of subject at >1 study site|1|||
27762617|NCT02545543|54214926|FG001|Overall Study|Enrolment of subject at >1 study site|1|||
27762618|NCT02542267|54214934|FG000|Overall Study|Withdrawal by Subject|10|||
27762619|NCT02542267|54214934|FG000|Overall Study|Physician Decision|6|||
27762620|NCT02542267|54214934|FG000|Overall Study|Lost to Follow-up|4|||
27762621|NCT02542267|54214934|FG000|Overall Study|Death|13|||
27762622|NCT02542267|54214934|FG000|Overall Study|Surgical Bypass of All Study Devices|13|||
27762623|NCT02542267|54214934|FG000|Overall Study|Other|9|||
27762624|NCT02545075|54214940|FG000|Randomization|Lost to Follow-up|0|||
27762625|NCT02545075|54214941|FG001|Randomization|Lost to Follow-up|1|||
27762626|NCT02545075|54214940|FG000|Randomization|Withdrawal by Subject|0|||
27762627|NCT02545075|54214941|FG001|Randomization|Withdrawal by Subject|6|||
27762628|NCT02545075|54214940|FG000|Treatment|Disease progression|71|||
27762629|NCT02545075|54214941|FG001|Treatment|Disease progression|32|||
27762630|NCT02545075|54214940|FG000|Treatment|Participant dicontinued study treatment|7|||
27762631|NCT02545075|54214941|FG001|Treatment|Participant dicontinued study treatment|9|||
27762632|NCT02545075|54214940|FG000|Treatment|Withdrawal by Subject|1|||
27762633|NCT02545075|54214941|FG001|Treatment|Withdrawal by Subject|0|||
27762634|NCT02545075|54214940|FG000|Treatment|Adverse event not related to study drug|1|||
27762635|NCT02545075|54214941|FG001|Treatment|Adverse event not related to study drug|0|||
27762636|NCT02545075|54214940|FG000|Treatment|Death|1|||
27762637|NCT02545075|54214941|FG001|Treatment|Death|0|||
27762638|NCT02545075|54214940|FG000|Treatment|Participant drug toxicity|1|||
27762639|NCT02545075|54214941|FG001|Treatment|Participant drug toxicity|0|||
27762640|NCT02545075|54214940|FG000|Treatment|Completed treatment|40|||
27762641|NCT02545075|54214941|FG001|Treatment|Completed treatment|12|||
27762642|NCT03004183|54214956|FG000|Overall Study|Adverse Event|7|||
27762643|NCT03004183|54214956|FG000|Overall Study|Lost to Follow-up|1|||
27762644|NCT03004183|54214956|FG000|Overall Study|Physician Decision|40|||
27762645|NCT03004183|54214956|FG000|Overall Study|Withdrawal by Subject|1|||
27762646|NCT03004183|54214956|FG000|Overall Study|COVID-19|1|||
27762647|NCT02544763|54214963|FG000|Overall Study|Adverse Event|8|||
27762648|NCT02544763|54214964|FG001|Overall Study|Adverse Event|8|||
27762649|NCT02544763|54214965|FG002|Overall Study|Adverse Event|0|||
27762650|NCT02544763|54214963|FG000|Overall Study|Withdrawn by parent/guardian|1|||
27762651|NCT02544763|54214964|FG001|Overall Study|Withdrawn by parent/guardian|1|||
27762652|NCT02544763|54214965|FG002|Overall Study|Withdrawn by parent/guardian|1|||
27762653|NCT02544763|54214963|FG000|Overall Study|Met withdrawal criteria|0|||
27762654|NCT02544763|54214964|FG001|Overall Study|Met withdrawal criteria|2|||
27762655|NCT02544763|54214965|FG002|Overall Study|Met withdrawal criteria|0|||
27762656|NCT02544763|54214963|FG000|Overall Study|Physician Decision|0|||
27762657|NCT02544763|54214964|FG001|Overall Study|Physician Decision|1|||
27762658|NCT02544763|54214965|FG002|Overall Study|Physician Decision|0|||
27762659|NCT02544763|54214963|FG000|Overall Study|Difficulties taking IMP|1|||
27762660|NCT02544763|54214964|FG001|Overall Study|Difficulties taking IMP|0|||
27762661|NCT02544763|54214965|FG002|Overall Study|Difficulties taking IMP|0|||
27762662|NCT02556203|54214975|FG000|Overall Study|Withdrawal by Subject|21|||
27762663|NCT02556203|54214976|FG001|Overall Study|Withdrawal by Subject|21|||
27762664|NCT02556203|54214975|FG000|Overall Study|Lost to Follow-up|5|||
27762665|NCT02556203|54214976|FG001|Overall Study|Lost to Follow-up|5|||
27762666|NCT02556203|54214975|FG000|Overall Study|Adverse Event|1|||
27762667|NCT02556203|54214976|FG001|Overall Study|Adverse Event|0|||
27762668|NCT02558231|54214993|FG000|Overall Study|Death|4|||
27762669|NCT02558231|54214994|FG001|Overall Study|Death|12|||
27762670|NCT02558231|54214993|FG000|Overall Study|Lost to Follow-up|7|||
27762671|NCT02558231|54214994|FG001|Overall Study|Lost to Follow-up|4|||
27762672|NCT02558231|54214993|FG000|Overall Study|Withdrawal by Subject|7|||
27762673|NCT02558231|54214994|FG001|Overall Study|Withdrawal by Subject|4|||
27762674|NCT02558231|54214993|FG000|Overall Study|Physician Decision|7|||
27762675|NCT02558231|54214994|FG001|Overall Study|Physician Decision|5|||
27762676|NCT02558231|54214993|FG000|Overall Study|Sponsor Decision|0|||
27762677|NCT02558231|54214994|FG001|Overall Study|Sponsor Decision|1|||
27762678|NCT02554877|54215004|FG000|Overall Study|Adverse Event|2|||
27762679|NCT02554877|54215005|FG001|Overall Study|Adverse Event|0|||
27762680|NCT02554877|54215006|FG002|Overall Study|Adverse Event|0|||
27762681|NCT02554877|54215007|FG003|Overall Study|Adverse Event|1|||
27762682|NCT02554877|54215004|FG000|Overall Study|Lost to Follow-up|1|||
27762683|NCT02554877|54215005|FG001|Overall Study|Lost to Follow-up|1|||
27762684|NCT02554877|54215006|FG002|Overall Study|Lost to Follow-up|1|||
27762685|NCT02554877|54215007|FG003|Overall Study|Lost to Follow-up|2|||
27762686|NCT02554877|54215004|FG000|Overall Study|Did not meet entrance criteria|0|||
27762687|NCT02554877|54215005|FG001|Overall Study|Did not meet entrance criteria|0|||
27762688|NCT02554877|54215006|FG002|Overall Study|Did not meet entrance criteria|1|||
27762689|NCT02554877|54215007|FG003|Overall Study|Did not meet entrance criteria|0|||
27762690|NCT02554877|54215004|FG000|Overall Study|No longer met eligibility criteria|1|||
27762691|NCT02554877|54215005|FG001|Overall Study|No longer met eligibility criteria|0|||
27762692|NCT02554877|54215006|FG002|Overall Study|No longer met eligibility criteria|1|||
27762693|NCT02554877|54215007|FG003|Overall Study|No longer met eligibility criteria|1|||
27762694|NCT02554877|54215004|FG000|Overall Study|Protocol Violation|3|||
27762695|NCT02554877|54215005|FG001|Overall Study|Protocol Violation|1|||
27762696|NCT02554877|54215006|FG002|Overall Study|Protocol Violation|1|||
27762697|NCT02554877|54215007|FG003|Overall Study|Protocol Violation|0|||
27762698|NCT02554877|54215004|FG000|Overall Study|Other|1|||
27762699|NCT02554877|54215005|FG001|Overall Study|Other|3|||
27762700|NCT02554877|54215006|FG002|Overall Study|Other|0|||
27762701|NCT02554877|54215007|FG003|Overall Study|Other|3|||
27762702|NCT02554877|54215004|FG000|Overall Study|Insufficient clinical response|4|||
27762703|NCT02554877|54215005|FG001|Overall Study|Insufficient clinical response|0|||
27762704|NCT02554877|54215006|FG002|Overall Study|Insufficient clinical response|0|||
27839554|NCT01478971|54326845|FG000|Peginesatide Treatment Period|Other|4|||
27839555|NCT01507051|54326857|FG000|Overall Study|Withdrawal by Subject|1|||
27762705|NCT02554877|54215007|FG003|Overall Study|Insufficient clinical response|0|||
27762706|NCT02554877|54215004|FG000|Overall Study|No longer willing to participate|0|||
27762707|NCT02554877|54215005|FG001|Overall Study|No longer willing to participate|2|||
27762708|NCT02554877|54215006|FG002|Overall Study|No longer willing to participate|2|||
27762709|NCT02554877|54215007|FG003|Overall Study|No longer willing to participate|0|||
27762710|NCT02554721|54215022|FG000|Overall Study|Adverse Event|1|||
27762711|NCT02554721|54215023|FG001|Overall Study|Adverse Event|0|||
27762712|NCT02554721|54215024|FG002|Overall Study|Adverse Event|0|||
27762713|NCT02554721|54215025|FG003|Overall Study|Adverse Event|0|||
27762714|NCT02554721|54215026|FG004|Overall Study|Adverse Event|1|||
27762715|NCT02554721|54215022|FG000|Overall Study|Noncompliance|0|||
27762716|NCT02554721|54215023|FG001|Overall Study|Noncompliance|0|||
27762717|NCT02554721|54215024|FG002|Overall Study|Noncompliance|0|||
27762718|NCT02554721|54215025|FG003|Overall Study|Noncompliance|0|||
27762719|NCT02554721|54215026|FG004|Overall Study|Noncompliance|1|||
27762720|NCT02552225|54215037|FG000|Overall Study|Withdrawal by Subject|1|||
27762721|NCT02552225|54215038|FG001|Overall Study|Withdrawal by Subject|0|||
27762722|NCT02552147|54215044|FG000|First Intervention (7 Days)|Protocol Violation|1|||
27762723|NCT02552147|54215045|FG001|First Intervention (7 Days)|Protocol Violation|0|||
27762724|NCT02552147|54215044|FG000|Second Intervention (7 Days)|Protocol Violation|2|||
27762725|NCT02552147|54215045|FG001|Second Intervention (7 Days)|Protocol Violation|0|||
27762726|NCT01662635|54215051|FG000|Overall Study|scarce samples for evaluation|30|||
27762727|NCT02534935|54215060|FG000|Stage 1: 24 Months|Withdrawal by Subject|0|||
27762728|NCT02534935|54215061|FG001|Stage 1: 24 Months|Withdrawal by Subject|3|||
27762729|NCT02534935|54215062|FG002|Stage 1: 24 Months|Withdrawal by Subject|3|||
27762730|NCT02534935|54215060|FG000|Stage 1: 24 Months|No longer willing to participate in study|0|||
27762731|NCT02534935|54215061|FG001|Stage 1: 24 Months|No longer willing to participate in study|1|||
27762732|NCT02534935|54215062|FG002|Stage 1: 24 Months|No longer willing to participate in study|1|||
27762733|NCT02534935|54215060|FG000|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
27762734|NCT02534935|54215061|FG001|Stage 1: 24 Months|No longer meets eligibility criteria|3|||
27762735|NCT02534935|54215062|FG002|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
27762736|NCT02534935|54215060|FG000|Stage 1: 24 Months|Lost to Follow-up|0|||
27762737|NCT02534935|54215061|FG001|Stage 1: 24 Months|Lost to Follow-up|1|||
27762738|NCT02534935|54215062|FG002|Stage 1: 24 Months|Lost to Follow-up|1|||
27762739|NCT02534935|54215060|FG000|Stage 1: 24 Months|Adverse Event|0|||
27762740|NCT02534935|54215061|FG001|Stage 1: 24 Months|Adverse Event|2|||
27762741|NCT02534935|54215062|FG002|Stage 1: 24 Months|Adverse Event|0|||
27762742|NCT02534935|54215060|FG000|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
27762743|NCT02534935|54215061|FG001|Stage 2: 8 Months|Moved away/parents resigned from study|4|||
27762744|NCT02534935|54215062|FG002|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
27762745|NCT02534935|54215060|FG000|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
27762746|NCT02534935|54215061|FG001|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|1|||
27762747|NCT02534935|54215062|FG002|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
27762748|NCT02544451|54215091|FG000|Treatment Period 1 (96 Weeks)|Adverse Event|1|||
27762749|NCT02544451|54215092|FG001|Treatment Period 1 (96 Weeks)|Adverse Event|6|||
27762750|NCT02544451|54215093|FG002|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
27762751|NCT02544451|54215094|FG003|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
27762752|NCT02544451|54215091|FG000|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|3|||
27762753|NCT02544451|54215092|FG001|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|2|||
27762754|NCT02544451|54215093|FG002|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|1|||
27762755|NCT02544451|54215094|FG003|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|0|||
27762756|NCT02544451|54215091|FG000|Treatment Period 1 (96 Weeks)|Lost to Follow-up|2|||
27762757|NCT02544451|54215092|FG001|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
27762758|NCT02544451|54215093|FG002|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
27762759|NCT02544451|54215094|FG003|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
27762760|NCT02544451|54215091|FG000|Treatment Period 1 (96 Weeks)|Physician Decision|4|||
27762761|NCT02544451|54215092|FG001|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
27762762|NCT02544451|54215093|FG002|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
27762763|NCT02544451|54215094|FG003|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
27762764|NCT02544451|54215091|FG000|Treatment Period 1 (96 Weeks)|Other|4|||
27762765|NCT02544451|54215092|FG001|Treatment Period 1 (96 Weeks)|Other|4|||
27762766|NCT02544451|54215093|FG002|Treatment Period 1 (96 Weeks)|Other|0|||
27762767|NCT02544451|54215094|FG003|Treatment Period 1 (96 Weeks)|Other|0|||
27762768|NCT02544451|54215091|FG000|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
27762769|NCT02544451|54215092|FG001|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
27762770|NCT02544451|54215093|FG002|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
27762771|NCT02544451|54215094|FG003|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|10|||
27762772|NCT02544373|54215114|FG000|Overall Study|Lost to Follow-up|5|||
27762773|NCT02544373|54215115|FG001|Overall Study|Lost to Follow-up|3|||
27762774|NCT02544373|54215114|FG000|Overall Study|Withdrawal by Subject|8|||
27762775|NCT02544373|54215115|FG001|Overall Study|Withdrawal by Subject|2|||
27762776|NCT02551991|54215127|FG000|Overall Study|Death|5|||
27762777|NCT02551991|54215128|FG001|Overall Study|Death|7|||
27762778|NCT02551991|54215129|FG002|Overall Study|Death|8|||
27762779|NCT02551991|54215130|FG003|Overall Study|Death|7|||
27762780|NCT02551991|54215131|FG004|Overall Study|Death|17|||
27762781|NCT02551991|54215127|FG000|Overall Study|Withdrawal by Subject|1|||
27762782|NCT02551991|54215128|FG001|Overall Study|Withdrawal by Subject|0|||
27762783|NCT02551991|54215129|FG002|Overall Study|Withdrawal by Subject|0|||
27762784|NCT02551991|54215130|FG003|Overall Study|Withdrawal by Subject|0|||
27839556|NCT01507051|54326858|FG001|Overall Study|Withdrawal by Subject|3|||
28159968|NCT02737475|54830043|FG021|Overall Study|Death|0|||
27762785|NCT02551991|54215131|FG004|Overall Study|Withdrawal by Subject|2|||
27762786|NCT02551991|54215127|FG000|Overall Study|Lost to Follow-up|0|||
27762787|NCT02551991|54215128|FG001|Overall Study|Lost to Follow-up|0|||
27762788|NCT02551991|54215129|FG002|Overall Study|Lost to Follow-up|1|||
27762789|NCT02551991|54215130|FG003|Overall Study|Lost to Follow-up|0|||
27762790|NCT02551991|54215131|FG004|Overall Study|Lost to Follow-up|0|||
27762791|NCT02551991|54215127|FG000|Overall Study|Sponsor Decision|1|||
27762792|NCT02551991|54215128|FG001|Overall Study|Sponsor Decision|0|||
27762793|NCT02551991|54215129|FG002|Overall Study|Sponsor Decision|1|||
27762794|NCT02551991|54215130|FG003|Overall Study|Sponsor Decision|0|||
27762795|NCT02551991|54215131|FG004|Overall Study|Sponsor Decision|5|||
27762796|NCT02551991|54215127|FG000|Overall Study|Other|0|||
27762797|NCT02551991|54215128|FG001|Overall Study|Other|0|||
27762798|NCT02551991|54215129|FG002|Overall Study|Other|0|||
27762799|NCT02551991|54215130|FG003|Overall Study|Other|0|||
27762800|NCT02551991|54215131|FG004|Overall Study|Other|1|||
27762801|NCT01661933|54215144|FG000|Low-dose Gluten Challenge|Physician Decision|2|||
27762802|NCT01661933|54215144|FG000|High-dose Gluten Challenge|Withdrawal by Subject|2|||
27762803|NCT02544217|54215156|FG000|Overall Study|Withdrawal by Subject|1|||
27762804|NCT02544217|54215157|FG001|Overall Study|Withdrawal by Subject|1|||
27762805|NCT02544217|54215158|FG002|Overall Study|Withdrawal by Subject|0|||
27762806|NCT02544217|54215159|FG003|Overall Study|Withdrawal by Subject|0|||
27762807|NCT02544217|54215160|FG004|Overall Study|Withdrawal by Subject|0|||
27762808|NCT02544217|54215161|FG005|Overall Study|Withdrawal by Subject|0|||
27762809|NCT02533999|54215230|FG000|Overall Study|Lost to Follow-up|3|||
27762810|NCT02533999|54215231|FG001|Overall Study|Lost to Follow-up|5|||
27762811|NCT02533999|54215230|FG000|Overall Study|Protocol Violation|3|||
27762812|NCT02533999|54215231|FG001|Overall Study|Protocol Violation|0|||
27762813|NCT02533999|54215230|FG000|Overall Study|Adverse Event|0|||
27762814|NCT02533999|54215231|FG001|Overall Study|Adverse Event|1|||
27762815|NCT02533999|54215230|FG000|Overall Study|Randomized but intervention not received|0|||
27762816|NCT02533999|54215231|FG001|Overall Study|Randomized but intervention not received|1|||
27762817|NCT02533531|54215237|FG000|Overall Study|Device did not turn on|1|||
27762818|NCT02533453|54215241|FG000|Overall Study|Adverse Event|6|||
27762819|NCT02533453|54215241|FG000|Overall Study|Protocol Violation|1|||
27762820|NCT02533453|54215241|FG000|Overall Study|Withdrawal by Subject|2|||
27762821|NCT02533375|54215245|FG000|Overall Study|Lack of Efficacy|3|||
27762822|NCT02533375|54215245|FG000|Overall Study|Adverse Event|2|||
27762823|NCT01553149|54215251|FG000|Overall Study|Adverse Event|0|||
27762824|NCT01553149|54215252|FG001|Overall Study|Adverse Event|9|||
27762825|NCT01553149|54215251|FG000|Overall Study|Physician Decision|5|||
27762826|NCT01553149|54215252|FG001|Overall Study|Physician Decision|10|||
27762827|NCT01553149|54215251|FG000|Overall Study|Ineligible|0|||
27762828|NCT01553149|54215252|FG001|Overall Study|Ineligible|1|||
27762829|NCT02551055|54215265|FG000|Overall Study|Death|2|||
27762830|NCT02551055|54215266|FG001|Overall Study|Death|4|||
27762831|NCT02551055|54215267|FG002|Overall Study|Death|2|||
27762832|NCT02551055|54215268|FG003|Overall Study|Death|2|||
27762833|NCT02551055|54215269|FG004|Overall Study|Death|2|||
27762834|NCT02551055|54215270|FG005|Overall Study|Death|1|||
27762835|NCT02551055|54215271|FG006|Overall Study|Death|2|||
27762836|NCT02551055|54215272|FG007|Overall Study|Death|0|||
27762837|NCT02551055|54215265|FG000|Overall Study|Study Terminated by Sponsor|1|||
27762838|NCT02551055|54215266|FG001|Overall Study|Study Terminated by Sponsor|1|||
27762839|NCT02551055|54215267|FG002|Overall Study|Study Terminated by Sponsor|0|||
27762840|NCT02551055|54215268|FG003|Overall Study|Study Terminated by Sponsor|2|||
27762841|NCT02551055|54215269|FG004|Overall Study|Study Terminated by Sponsor|2|||
27762842|NCT02551055|54215270|FG005|Overall Study|Study Terminated by Sponsor|0|||
27762843|NCT02551055|54215271|FG006|Overall Study|Study Terminated by Sponsor|0|||
27762844|NCT02551055|54215272|FG007|Overall Study|Study Terminated by Sponsor|0|||
27762845|NCT02551055|54215265|FG000|Overall Study|Withdrawal by Subject|1|||
27762846|NCT02551055|54215266|FG001|Overall Study|Withdrawal by Subject|1|||
27762847|NCT02551055|54215267|FG002|Overall Study|Withdrawal by Subject|0|||
27762848|NCT02551055|54215268|FG003|Overall Study|Withdrawal by Subject|1|||
27762849|NCT02551055|54215269|FG004|Overall Study|Withdrawal by Subject|2|||
27762850|NCT02551055|54215270|FG005|Overall Study|Withdrawal by Subject|0|||
27839557|NCT01507051|54326859|FG002|Overall Study|Withdrawal by Subject|1|||
27762851|NCT02551055|54215271|FG006|Overall Study|Withdrawal by Subject|0|||
27762852|NCT02551055|54215272|FG007|Overall Study|Withdrawal by Subject|0|||
27762853|NCT02551055|54215265|FG000|Overall Study|Reason not specified|0|||
27762854|NCT02551055|54215266|FG001|Overall Study|Reason not specified|0|||
27762855|NCT02551055|54215267|FG002|Overall Study|Reason not specified|0|||
27762856|NCT02551055|54215268|FG003|Overall Study|Reason not specified|0|||
27762857|NCT02551055|54215269|FG004|Overall Study|Reason not specified|1|||
27762858|NCT02551055|54215270|FG005|Overall Study|Reason not specified|0|||
27762859|NCT02551055|54215271|FG006|Overall Study|Reason not specified|1|||
27762860|NCT02551055|54215272|FG007|Overall Study|Reason not specified|0|||
27762861|NCT02542943|54215293|FG000|Overall Study|Lost to Follow-up|1|||
27762862|NCT02542943|54215294|FG001|Overall Study|Lost to Follow-up|0|||
27762863|NCT02542943|54215295|FG002|Overall Study|Lost to Follow-up|0|||
27762864|NCT02542943|54215293|FG000|Overall Study|Withdrawal by Subject|0|||
27762865|NCT02542943|54215294|FG001|Overall Study|Withdrawal by Subject|1|||
27762866|NCT02542943|54215295|FG002|Overall Study|Withdrawal by Subject|0|||
27762867|NCT02542865|54215306|FG000|Overall Study|Identified as screen failure|1|||
27762868|NCT02542865|54215307|FG001|Overall Study|Identified as screen failure|0|||
27762869|NCT02542865|54215306|FG000|Overall Study|Withdrawal by Subject|16|||
27762870|NCT02542865|54215307|FG001|Overall Study|Withdrawal by Subject|0|||
27762871|NCT03644927|54215313|FG000|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|1|||
27762872|NCT03644927|54215314|FG001|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|0|||
27762873|NCT02542631|54215321|FG000|Overall Study|Adverse Event|1|||
27762874|NCT02542631|54215322|FG001|Overall Study|Adverse Event|1|||
27762875|NCT02542631|54215321|FG000|Overall Study|Sponsor Termination|1|||
27762876|NCT02542631|54215322|FG001|Overall Study|Sponsor Termination|0|||
27762877|NCT02542631|54215321|FG000|Overall Study|Withdrawal by Subject|11|||
27762878|NCT02542631|54215322|FG001|Overall Study|Withdrawal by Subject|16|||
27762879|NCT02542631|54215321|FG000|Overall Study|Protocol Violation|1|||
27762880|NCT02542631|54215322|FG001|Overall Study|Protocol Violation|1|||
27762881|NCT02542631|54215321|FG000|Overall Study|Physician Decision|6|||
27762882|NCT02542631|54215322|FG001|Overall Study|Physician Decision|4|||
27762883|NCT02542631|54215321|FG000|Overall Study|Lost to Follow-up|6|||
27762884|NCT02542631|54215322|FG001|Overall Study|Lost to Follow-up|5|||
27762885|NCT02542631|54215321|FG000|Overall Study|Death|1|||
27762886|NCT02542631|54215322|FG001|Overall Study|Death|2|||
27762887|NCT02542631|54215321|FG000|Overall Study|Other|2|||
27762888|NCT02542631|54215322|FG001|Overall Study|Other|1|||
27762889|NCT02542631|54215321|FG000|Overall Study|Used Prohibited Medication|2|||
27762890|NCT02542631|54215322|FG001|Overall Study|Used Prohibited Medication|1|||
27762891|NCT02549573|54215330|FG000|Overall Study|Withdrawal by Subject|0|||
27762892|NCT02549573|54215331|FG001|Overall Study|Withdrawal by Subject|2|||
27762893|NCT02549573|54215330|FG000|Overall Study|Protocol Violation|0|||
27762894|NCT02549573|54215331|FG001|Overall Study|Protocol Violation|1|||
27762895|NCT02542397|54215337|FG000|Overall Study|Death|2|||
27762896|NCT02542397|54215337|FG000|Overall Study|Physician Decision|6|||
27762897|NCT02542397|54215337|FG000|Overall Study|Withdrawal by Subject|6|||
27762898|NCT02542397|54215337|FG000|Overall Study|Lost to Follow-up|2|||
27762899|NCT02549339|54215344|FG000|3-day Treatment and 8-week Follow-up|Protocol Violation|2|||
27762900|NCT02549339|54215345|FG001|3-day Treatment and 8-week Follow-up|Protocol Violation|0|||
27762901|NCT02549339|54215344|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1|||
27762902|NCT02549339|54215345|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
27762903|NCT02549339|54215344|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
27762904|NCT02549339|54215345|FG001|3-day Treatment and 8-week Follow-up|Other|0|||
27762905|NCT02549339|54215344|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
27762906|NCT02549339|54215345|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2|||
27762907|NCT02549339|54215344|FG000|12-month Follow-up|Lack of Efficacy|0|||
27762908|NCT02549339|54215345|FG001|12-month Follow-up|Lack of Efficacy|2|||
27762909|NCT02549339|54215344|FG000|12-month Follow-up|Withdrawal by Subject|8|||
27762910|NCT02549339|54215345|FG001|12-month Follow-up|Withdrawal by Subject|3|||
27762911|NCT02549339|54215344|FG000|12-month Follow-up|Lost to Follow-up|1|||
27762912|NCT02549339|54215345|FG001|12-month Follow-up|Lost to Follow-up|3|||
27762913|NCT02549339|54215344|FG000|12-month Follow-up|Other|0|||
27762914|NCT02549339|54215345|FG001|12-month Follow-up|Other|3|||
27762915|NCT02549027|54215353|FG000|Washout After Period 4|Withdrawal by Subject|0|||
27762916|NCT02549027|54215354|FG001|Washout After Period 4|Withdrawal by Subject|1|||
27762917|NCT02549027|54215355|FG002|Washout After Period 4|Withdrawal by Subject|1|||
27762918|NCT02549027|54215356|FG003|Washout After Period 4|Withdrawal by Subject|1|||
27762919|NCT02549027|54215357|FG004|Washout After Period 4|Withdrawal by Subject|0|||
27762920|NCT02549027|54215358|FG005|Washout After Period 4|Withdrawal by Subject|0|||
27762921|NCT02549027|54215353|FG000|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
27762922|NCT02549027|54215354|FG001|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
27762923|NCT02549027|54215355|FG002|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
27762924|NCT02549027|54215356|FG003|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
27762925|NCT02549027|54215357|FG004|Period 5 - MK-6096 or Placebo|Protocol Violation|2|||
27762926|NCT02549027|54215358|FG005|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
27762927|NCT02529553|54215386|FG000|Overall Study|Progressive Disease|1|||
27762928|NCT02529553|54215387|FG001|Overall Study|Progressive Disease|0|||
27762929|NCT02529553|54215388|FG002|Overall Study|Progressive Disease|1|||
27762930|NCT02529553|54215389|FG003|Overall Study|Progressive Disease|3|||
27762931|NCT02529553|54215390|FG004|Overall Study|Progressive Disease|2|||
27762932|NCT02529553|54215391|FG005|Overall Study|Progressive Disease|3|||
27762933|NCT02529553|54215392|FG006|Overall Study|Progressive Disease|3|||
27762934|NCT02529553|54215393|FG007|Overall Study|Progressive Disease|5|||
27762935|NCT02529553|54215394|FG008|Overall Study|Progressive Disease|3|||
28159969|NCT02737475|54830044|FG022|Overall Study|Death|0|||
27762936|NCT02529553|54215386|FG000|Overall Study|Physician Decision|0|||
27762937|NCT02529553|54215387|FG001|Overall Study|Physician Decision|1|||
27762938|NCT02529553|54215388|FG002|Overall Study|Physician Decision|0|||
27762939|NCT02529553|54215389|FG003|Overall Study|Physician Decision|0|||
27762940|NCT02529553|54215390|FG004|Overall Study|Physician Decision|1|||
27762941|NCT02529553|54215391|FG005|Overall Study|Physician Decision|0|||
27762942|NCT02529553|54215392|FG006|Overall Study|Physician Decision|0|||
27762943|NCT02529553|54215393|FG007|Overall Study|Physician Decision|0|||
27762944|NCT02529553|54215394|FG008|Overall Study|Physician Decision|0|||
27762945|NCT02529553|54215386|FG000|Overall Study|Withdrawal by Subject|0|||
27762946|NCT02529553|54215387|FG001|Overall Study|Withdrawal by Subject|0|||
27762947|NCT02529553|54215388|FG002|Overall Study|Withdrawal by Subject|0|||
27762948|NCT02529553|54215389|FG003|Overall Study|Withdrawal by Subject|0|||
27762949|NCT02529553|54215390|FG004|Overall Study|Withdrawal by Subject|0|||
27762950|NCT02529553|54215391|FG005|Overall Study|Withdrawal by Subject|1|||
27762951|NCT02529553|54215392|FG006|Overall Study|Withdrawal by Subject|0|||
27762952|NCT02529553|54215393|FG007|Overall Study|Withdrawal by Subject|1|||
27762953|NCT02529553|54215394|FG008|Overall Study|Withdrawal by Subject|0|||
27762954|NCT02547935|54215418|FG000|Overall Study|Other|0|||
27762955|NCT02547935|54215419|FG001|Overall Study|Other|1|||
27762956|NCT02547935|54215420|FG002|Overall Study|Other|0|||
27762957|NCT02547935|54215418|FG000|Overall Study|Withdrawal by Subject|2|||
27762958|NCT02547935|54215419|FG001|Overall Study|Withdrawal by Subject|3|||
27762959|NCT02547935|54215420|FG002|Overall Study|Withdrawal by Subject|4|||
27762960|NCT02547935|54215418|FG000|Overall Study|Screen Failure|2|||
27762961|NCT02547935|54215419|FG001|Overall Study|Screen Failure|0|||
27762962|NCT02547935|54215420|FG002|Overall Study|Screen Failure|0|||
27762963|NCT02547935|54215418|FG000|Overall Study|Physician Decision|0|||
27762964|NCT02547935|54215419|FG001|Overall Study|Physician Decision|1|||
27762965|NCT02547935|54215420|FG002|Overall Study|Physician Decision|0|||
27762966|NCT02547935|54215418|FG000|Overall Study|Lost to Follow-up|0|||
27762967|NCT02547935|54215419|FG001|Overall Study|Lost to Follow-up|2|||
27762968|NCT02547935|54215420|FG002|Overall Study|Lost to Follow-up|1|||
27762969|NCT02547935|54215418|FG000|Overall Study|Death|1|||
27762970|NCT02547935|54215419|FG001|Overall Study|Death|1|||
27762971|NCT02547935|54215420|FG002|Overall Study|Death|0|||
27762972|NCT02554019|54215433|FG000|Overall Study|Withdrawal by Subject|1|||
27762973|NCT02554019|54215434|FG001|Overall Study|Withdrawal by Subject|0|||
27762974|NCT02554019|54215435|FG002|Overall Study|Withdrawal by Subject|2|||
27762975|NCT02554019|54215433|FG000|Overall Study|Adverse Event|1|||
27762976|NCT02554019|54215434|FG001|Overall Study|Adverse Event|0|||
27762977|NCT02554019|54215435|FG002|Overall Study|Adverse Event|0|||
27762978|NCT02327169|54215458|FG000|Overall Study|Progressive Disease|1|||
27762979|NCT02327169|54215459|FG001|Overall Study|Progressive Disease|3|||
27762980|NCT02327169|54215460|FG002|Overall Study|Progressive Disease|4|||
27762981|NCT02327169|54215461|FG003|Overall Study|Progressive Disease|3|||
27762982|NCT02327169|54215462|FG004|Overall Study|Progressive Disease|4|||
27762983|NCT02327169|54215463|FG005|Overall Study|Progressive Disease|3|||
27762984|NCT02327169|54215464|FG006|Overall Study|Progressive Disease|3|||
27762985|NCT02327169|54215465|FG007|Overall Study|Progressive Disease|3|||
27762986|NCT02327169|54215466|FG008|Overall Study|Progressive Disease|4|||
27762987|NCT02327169|54215467|FG009|Overall Study|Progressive Disease|4|||
27762988|NCT02327169|54215468|FG010|Overall Study|Progressive Disease|4|||
27762989|NCT02327169|54215469|FG011|Overall Study|Progressive Disease|3|||
27762990|NCT02327169|54215470|FG012|Overall Study|Progressive Disease|1|||
27762991|NCT02327169|54215471|FG013|Overall Study|Progressive Disease|3|||
27762992|NCT02327169|54215472|FG014|Overall Study|Progressive Disease|3|||
27762993|NCT02327169|54215458|FG000|Overall Study|Adverse Event|2|||
27762994|NCT02327169|54215459|FG001|Overall Study|Adverse Event|0|||
27762995|NCT02327169|54215460|FG002|Overall Study|Adverse Event|1|||
27762996|NCT02327169|54215461|FG003|Overall Study|Adverse Event|0|||
27762997|NCT02327169|54215462|FG004|Overall Study|Adverse Event|1|||
27839558|NCT01507051|54326860|FG003|Overall Study|Withdrawal by Subject|6|||
27762998|NCT02327169|54215463|FG005|Overall Study|Adverse Event|0|||
27762999|NCT02327169|54215464|FG006|Overall Study|Adverse Event|0|||
27763000|NCT02327169|54215465|FG007|Overall Study|Adverse Event|0|||
27763001|NCT02327169|54215466|FG008|Overall Study|Adverse Event|0|||
27763002|NCT02327169|54215467|FG009|Overall Study|Adverse Event|2|||
27763003|NCT02327169|54215468|FG010|Overall Study|Adverse Event|0|||
27763004|NCT02327169|54215469|FG011|Overall Study|Adverse Event|3|||
27763005|NCT02327169|54215470|FG012|Overall Study|Adverse Event|0|||
27763006|NCT02327169|54215471|FG013|Overall Study|Adverse Event|2|||
27763007|NCT02327169|54215472|FG014|Overall Study|Adverse Event|1|||
27763008|NCT02327169|54215458|FG000|Overall Study|Symptomatic Deterioration|0|||
27763009|NCT02327169|54215459|FG001|Overall Study|Symptomatic Deterioration|0|||
27763010|NCT02327169|54215460|FG002|Overall Study|Symptomatic Deterioration|1|||
27763011|NCT02327169|54215461|FG003|Overall Study|Symptomatic Deterioration|0|||
27763012|NCT02327169|54215462|FG004|Overall Study|Symptomatic Deterioration|1|||
27763013|NCT02327169|54215463|FG005|Overall Study|Symptomatic Deterioration|1|||
27839559|NCT01507051|54326857|FG000|Overall Study|Physician Decision|0|||
27763014|NCT02327169|54215464|FG006|Overall Study|Symptomatic Deterioration|0|||
27763015|NCT02327169|54215465|FG007|Overall Study|Symptomatic Deterioration|0|||
27763016|NCT02327169|54215466|FG008|Overall Study|Symptomatic Deterioration|2|||
27763017|NCT02327169|54215467|FG009|Overall Study|Symptomatic Deterioration|1|||
27763018|NCT02327169|54215468|FG010|Overall Study|Symptomatic Deterioration|0|||
27763019|NCT02327169|54215469|FG011|Overall Study|Symptomatic Deterioration|0|||
27763020|NCT02327169|54215470|FG012|Overall Study|Symptomatic Deterioration|0|||
27763021|NCT02327169|54215471|FG013|Overall Study|Symptomatic Deterioration|2|||
27763022|NCT02327169|54215472|FG014|Overall Study|Symptomatic Deterioration|1|||
27763023|NCT02327169|54215458|FG000|Overall Study|Reason Not Specified|0|||
27763024|NCT02327169|54215459|FG001|Overall Study|Reason Not Specified|0|||
27763025|NCT02327169|54215460|FG002|Overall Study|Reason Not Specified|1|||
27763026|NCT02327169|54215461|FG003|Overall Study|Reason Not Specified|0|||
27763027|NCT02327169|54215462|FG004|Overall Study|Reason Not Specified|0|||
27763028|NCT02327169|54215463|FG005|Overall Study|Reason Not Specified|0|||
27763029|NCT02327169|54215464|FG006|Overall Study|Reason Not Specified|0|||
27763030|NCT02327169|54215465|FG007|Overall Study|Reason Not Specified|0|||
27763031|NCT02327169|54215466|FG008|Overall Study|Reason Not Specified|0|||
27763032|NCT02327169|54215467|FG009|Overall Study|Reason Not Specified|1|||
27763033|NCT02327169|54215468|FG010|Overall Study|Reason Not Specified|2|||
27763034|NCT02327169|54215469|FG011|Overall Study|Reason Not Specified|1|||
27763035|NCT02327169|54215470|FG012|Overall Study|Reason Not Specified|0|||
27763036|NCT02327169|54215471|FG013|Overall Study|Reason Not Specified|0|||
27763037|NCT02327169|54215472|FG014|Overall Study|Reason Not Specified|2|||
27763038|NCT02327169|54215458|FG000|Overall Study|Withdrawal by Subject|1|||
27763039|NCT02327169|54215459|FG001|Overall Study|Withdrawal by Subject|0|||
27763040|NCT02327169|54215460|FG002|Overall Study|Withdrawal by Subject|0|||
27763041|NCT02327169|54215461|FG003|Overall Study|Withdrawal by Subject|0|||
27763042|NCT02327169|54215462|FG004|Overall Study|Withdrawal by Subject|1|||
27763043|NCT02327169|54215463|FG005|Overall Study|Withdrawal by Subject|0|||
27763044|NCT02327169|54215464|FG006|Overall Study|Withdrawal by Subject|0|||
27763045|NCT02327169|54215465|FG007|Overall Study|Withdrawal by Subject|1|||
27763046|NCT02327169|54215466|FG008|Overall Study|Withdrawal by Subject|0|||
27763047|NCT02327169|54215467|FG009|Overall Study|Withdrawal by Subject|0|||
27763048|NCT02327169|54215468|FG010|Overall Study|Withdrawal by Subject|0|||
27763049|NCT02327169|54215469|FG011|Overall Study|Withdrawal by Subject|0|||
27763050|NCT02327169|54215470|FG012|Overall Study|Withdrawal by Subject|0|||
27763051|NCT02327169|54215471|FG013|Overall Study|Withdrawal by Subject|0|||
27763052|NCT02327169|54215472|FG014|Overall Study|Withdrawal by Subject|3|||
27763053|NCT02327169|54215458|FG000|Overall Study|Lost to Follow-up|0|||
27763054|NCT02327169|54215459|FG001|Overall Study|Lost to Follow-up|0|||
27763055|NCT02327169|54215460|FG002|Overall Study|Lost to Follow-up|0|||
27763056|NCT02327169|54215461|FG003|Overall Study|Lost to Follow-up|0|||
27763057|NCT02327169|54215462|FG004|Overall Study|Lost to Follow-up|1|||
27763058|NCT02327169|54215463|FG005|Overall Study|Lost to Follow-up|0|||
27763059|NCT02327169|54215464|FG006|Overall Study|Lost to Follow-up|0|||
27763060|NCT02327169|54215465|FG007|Overall Study|Lost to Follow-up|0|||
27763061|NCT02327169|54215466|FG008|Overall Study|Lost to Follow-up|0|||
27763062|NCT02327169|54215467|FG009|Overall Study|Lost to Follow-up|0|||
27763063|NCT02327169|54215468|FG010|Overall Study|Lost to Follow-up|0|||
27763064|NCT02327169|54215469|FG011|Overall Study|Lost to Follow-up|0|||
27763065|NCT02327169|54215470|FG012|Overall Study|Lost to Follow-up|0|||
27763066|NCT02327169|54215471|FG013|Overall Study|Lost to Follow-up|0|||
27763067|NCT02327169|54215472|FG014|Overall Study|Lost to Follow-up|0|||
27763068|NCT02327013|54215517|FG000|Overall Study|Adverse Event|4|||
27763069|NCT02327013|54215518|FG001|Overall Study|Adverse Event|4|||
27763070|NCT02327013|54215519|FG002|Overall Study|Adverse Event|3|||
27763071|NCT02327013|54215520|FG003|Overall Study|Adverse Event|0|||
27763072|NCT02327013|54215521|FG004|Overall Study|Adverse Event|1|||
27763073|NCT02327013|54215517|FG000|Overall Study|Lack of Efficacy|2|||
27763074|NCT02327013|54215518|FG001|Overall Study|Lack of Efficacy|0|||
27763075|NCT02327013|54215519|FG002|Overall Study|Lack of Efficacy|5|||
27763076|NCT02327013|54215520|FG003|Overall Study|Lack of Efficacy|0|||
27763077|NCT02327013|54215521|FG004|Overall Study|Lack of Efficacy|1|||
27763078|NCT02327013|54215517|FG000|Overall Study|Non-compliance with IMP|1|||
27763079|NCT02327013|54215518|FG001|Overall Study|Non-compliance with IMP|2|||
27763080|NCT02327013|54215519|FG002|Overall Study|Non-compliance with IMP|7|||
27763081|NCT02327013|54215520|FG003|Overall Study|Non-compliance with IMP|0|||
27763082|NCT02327013|54215521|FG004|Overall Study|Non-compliance with IMP|0|||
27763083|NCT02327013|54215517|FG000|Overall Study|Withdrawal of Consent|1|||
27763084|NCT02327013|54215518|FG001|Overall Study|Withdrawal of Consent|0|||
27763085|NCT02327013|54215519|FG002|Overall Study|Withdrawal of Consent|3|||
27763086|NCT02327013|54215520|FG003|Overall Study|Withdrawal of Consent|0|||
27763087|NCT02327013|54215521|FG004|Overall Study|Withdrawal of Consent|0|||
27763088|NCT02327013|54215517|FG000|Overall Study|Lost to Follow-up|2|||
27763089|NCT02327013|54215518|FG001|Overall Study|Lost to Follow-up|4|||
28015988|NCT00357877|54675138|FG000|Overall Study|Withdrawal by Subject|3|||
27763090|NCT02327013|54215519|FG002|Overall Study|Lost to Follow-up|5|||
27763091|NCT02327013|54215520|FG003|Overall Study|Lost to Follow-up|0|||
27763092|NCT02327013|54215521|FG004|Overall Study|Lost to Follow-up|0|||
27763093|NCT02327013|54215517|FG000|Overall Study|Administrative or other reason(s)|1|||
27763094|NCT02327013|54215518|FG001|Overall Study|Administrative or other reason(s)|5|||
27763095|NCT02327013|54215519|FG002|Overall Study|Administrative or other reason(s)|11|||
27763096|NCT02327013|54215520|FG003|Overall Study|Administrative or other reason(s)|1|||
27763097|NCT02327013|54215521|FG004|Overall Study|Administrative or other reason(s)|1|||
27763098|NCT02327013|54215517|FG000|Overall Study|Protocol Violation|0|||
27763099|NCT02327013|54215518|FG001|Overall Study|Protocol Violation|0|||
27763100|NCT02327013|54215519|FG002|Overall Study|Protocol Violation|3|||
27763101|NCT02327013|54215520|FG003|Overall Study|Protocol Violation|0|||
27763102|NCT02327013|54215521|FG004|Overall Study|Protocol Violation|1|||
27763103|NCT02327013|54215517|FG000|Overall Study|Withdrawal before treatment|2|||
27763104|NCT02327013|54215518|FG001|Overall Study|Withdrawal before treatment|1|||
27763105|NCT02327013|54215519|FG002|Overall Study|Withdrawal before treatment|5|||
27763106|NCT02327013|54215520|FG003|Overall Study|Withdrawal before treatment|0|||
27763107|NCT02327013|54215521|FG004|Overall Study|Withdrawal before treatment|0|||
27763108|NCT02301975|54215544|FG000|Overall Study|Adverse Event|8|||
27763109|NCT02301975|54215545|FG001|Overall Study|Adverse Event|3|||
27763110|NCT02301975|54215546|FG002|Overall Study|Adverse Event|2|||
27763111|NCT02301975|54215544|FG000|Overall Study|Lack of Efficacy|1|||
27763112|NCT02301975|54215545|FG001|Overall Study|Lack of Efficacy|1|||
27763113|NCT02301975|54215546|FG002|Overall Study|Lack of Efficacy|1|||
27763114|NCT02301975|54215544|FG000|Overall Study|Protocol Violation|3|||
27763115|NCT02301975|54215545|FG001|Overall Study|Protocol Violation|5|||
27763116|NCT02301975|54215546|FG002|Overall Study|Protocol Violation|3|||
27763117|NCT02301975|54215544|FG000|Overall Study|Lost to Follow-up|0|||
27763118|NCT02301975|54215545|FG001|Overall Study|Lost to Follow-up|2|||
27763119|NCT02301975|54215546|FG002|Overall Study|Lost to Follow-up|2|||
27763120|NCT02301975|54215544|FG000|Overall Study|Physician Decision|4|||
27763121|NCT02301975|54215545|FG001|Overall Study|Physician Decision|2|||
27763122|NCT02301975|54215546|FG002|Overall Study|Physician Decision|3|||
27763123|NCT02301975|54215544|FG000|Overall Study|Withdrawal by Subject|15|||
27763124|NCT02301975|54215545|FG001|Overall Study|Withdrawal by Subject|12|||
27763125|NCT02301975|54215546|FG002|Overall Study|Withdrawal by Subject|11|||
27763126|NCT02301897|54215557|FG000|Treatment Course 1|Non-Compliance|0|||
27763127|NCT02301897|54215558|FG001|Treatment Course 1|Non-Compliance|0|||
27763128|NCT02301897|54215559|FG002|Treatment Course 1|Non-Compliance|1|||
27763129|NCT02301897|54215557|FG000|Treatment Course 1|Adverse Event|1|||
27763130|NCT02301897|54215558|FG001|Treatment Course 1|Adverse Event|1|||
27763131|NCT02301897|54215559|FG002|Treatment Course 1|Adverse Event|0|||
27763132|NCT02301897|54215557|FG000|Treatment Course 1|Lost to Follow-up|1|||
27763133|NCT02301897|54215558|FG001|Treatment Course 1|Lost to Follow-up|2|||
27763134|NCT02301897|54215559|FG002|Treatment Course 1|Lost to Follow-up|1|||
27763135|NCT02301897|54215557|FG000|Treatment Course 1|Withdrawal by Sponsor|0|||
27763136|NCT02301897|54215558|FG001|Treatment Course 1|Withdrawal by Sponsor|0|||
27763137|NCT02301897|54215559|FG002|Treatment Course 1|Withdrawal by Sponsor|2|||
27763138|NCT02301897|54215557|FG000|Treatment Course 1|Withdrawal by Subject|0|||
27763139|NCT02301897|54215558|FG001|Treatment Course 1|Withdrawal by Subject|0|||
27763140|NCT02301897|54215559|FG002|Treatment Course 1|Withdrawal by Subject|2|||
27763141|NCT02301897|54215557|FG000|Treatment Course 1|Other Miscellaneous Reasons|1|||
27763142|NCT02301897|54215558|FG001|Treatment Course 1|Other Miscellaneous Reasons|0|||
27763143|NCT02301897|54215559|FG002|Treatment Course 1|Other Miscellaneous Reasons|0|||
27839560|NCT01507051|54326858|FG001|Overall Study|Physician Decision|0|||
27763144|NCT02301897|54215557|FG000|Treatment Course 2|Lost to Follow-up|0|||
27763145|NCT02301897|54215558|FG001|Treatment Course 2|Lost to Follow-up|2|||
27763146|NCT02301897|54215559|FG002|Treatment Course 2|Lost to Follow-up|0|||
27763147|NCT02301897|54215557|FG000|Treatment Course 2|Pregnancy|0|||
27763148|NCT02301897|54215558|FG001|Treatment Course 2|Pregnancy|1|||
27763149|NCT02301897|54215559|FG002|Treatment Course 2|Pregnancy|1|||
27763150|NCT02301897|54215557|FG000|Treatment Course 2|Withdrawal by Subject|0|||
27763151|NCT02301897|54215558|FG001|Treatment Course 2|Withdrawal by Subject|2|||
27763152|NCT02301897|54215559|FG002|Treatment Course 2|Withdrawal by Subject|0|||
27763153|NCT02301897|54215557|FG000|Treatment Course 2|Other Miscellaneous Reasons|1|||
27763154|NCT02301897|54215558|FG001|Treatment Course 2|Other Miscellaneous Reasons|0|||
27763155|NCT02301897|54215559|FG002|Treatment Course 2|Other Miscellaneous Reasons|0|||
27763156|NCT02301429|54215567|FG000|Overall Study|not acceptable vascular anatomy|3|||
27763157|NCT02300259|54215574|FG000|Period 1|Adverse Event|0|||
27763158|NCT02300259|54215575|FG001|Period 1|Adverse Event|0|||
27763159|NCT02300259|54215576|FG002|Period 1|Adverse Event|1|||
27763160|NCT02300259|54215574|FG000|Period 1|Withdrawal by Subject|0|||
27763161|NCT02300259|54215575|FG001|Period 1|Withdrawal by Subject|0|||
27763162|NCT02300259|54215576|FG002|Period 1|Withdrawal by Subject|1|||
27763163|NCT02300259|54215574|FG000|Period 2|Adverse Event|1|||
27763164|NCT02300259|54215575|FG001|Period 2|Adverse Event|0|||
27839561|NCT01507051|54326859|FG002|Overall Study|Physician Decision|0|||
27763165|NCT02300259|54215576|FG002|Period 2|Adverse Event|0|||
27763166|NCT02300259|54215574|FG000|Period 2|Withdrawal by Subject|0|||
27763167|NCT02300259|54215575|FG001|Period 2|Withdrawal by Subject|0|||
27763168|NCT02300259|54215576|FG002|Period 2|Withdrawal by Subject|1|||
27763169|NCT02367885|54215598|FG000|Overall Study|Lost to Follow-up|1|||
27763170|NCT02367885|54215599|FG001|Overall Study|Lost to Follow-up|0|||
27763171|NCT02367885|54215600|FG002|Overall Study|Lost to Follow-up|0|||
27763172|NCT02367885|54215598|FG000|Overall Study|Withdrawal by Subject|1|||
27763173|NCT02367885|54215599|FG001|Overall Study|Withdrawal by Subject|0|||
27763174|NCT02367885|54215600|FG002|Overall Study|Withdrawal by Subject|0|||
27763175|NCT02367729|54215613|FG000|Overall Study|Organic disorder diagnosed|2|||
27763176|NCT02367729|54215614|FG001|Overall Study|Organic disorder diagnosed|1|||
27763177|NCT02367729|54215613|FG000|Overall Study|Adverse Event|1|||
27763178|NCT02367729|54215614|FG001|Overall Study|Adverse Event|2|||
27763179|NCT02367729|54215613|FG000|Overall Study|Withdrawal by Subject|0|||
27763180|NCT02367729|54215614|FG001|Overall Study|Withdrawal by Subject|5|||
27763181|NCT02366637|54215621|FG000|First Intervention Period|Adverse Event|0|||
27763182|NCT02366637|54215622|FG001|First Intervention Period|Adverse Event|1|||
27763183|NCT02366637|54215621|FG000|First Intervention Period|Study Terminated by Sponsor|6|||
27763184|NCT02366637|54215622|FG001|First Intervention Period|Study Terminated by Sponsor|4|||
27763185|NCT02366637|54215621|FG000|Second Intervention Period|Study Terminated by Sponsor|1|||
27763186|NCT02366637|54215622|FG001|Second Intervention Period|Study Terminated by Sponsor|1|||
27763187|NCT02300103|54215628|FG000|Overall Study|Lack of Efficacy|3|||
27763188|NCT02300103|54215628|FG000|Overall Study|Protocol Violation|1|||
27763189|NCT02300103|54215628|FG000|Overall Study|Withdrew Consent|2|||
27763190|NCT02326467|54215632|FG000|Overall Study|Withdrawal by Subject|1|||
27763191|NCT02299635|54215637|FG000|Overall Study|Adverse Event|2|||
27763192|NCT02299635|54215637|FG000|Overall Study|Death|1|||
27763193|NCT02299635|54215637|FG000|Overall Study|Global deterioration of health status|1|||
27763194|NCT02299635|54215637|FG000|Overall Study|Objective progression or relapse|10|||
27763195|NCT02299635|54215637|FG000|Overall Study|Withdrawal by Subject|2|||
27763196|NCT02299635|54215637|FG000|Overall Study|Other|3|||
27763197|NCT02366091|54215645|FG000|Overall Study|Withdrawal by Subject|3|||
27763198|NCT02366091|54215646|FG001|Overall Study|Withdrawal by Subject|7|||
27763199|NCT02366091|54215647|FG002|Overall Study|Withdrawal by Subject|3|||
27763200|NCT02366091|54215648|FG003|Overall Study|Withdrawal by Subject|1|||
27763201|NCT02326155|54215660|FG000|Overall Study|Adverse Event|21|||
27763202|NCT02326155|54215661|FG001|Overall Study|Adverse Event|5|||
27763203|NCT02326155|54215660|FG000|Overall Study|Death|3|||
27763204|NCT02326155|54215661|FG001|Overall Study|Death|0|||
27763205|NCT02326155|54215660|FG000|Overall Study|Lack of Efficacy|49|||
27763206|NCT02326155|54215661|FG001|Overall Study|Lack of Efficacy|5|||
27763207|NCT02326155|54215660|FG000|Overall Study|Lost to Follow-up|14|||
27763208|NCT02326155|54215661|FG001|Overall Study|Lost to Follow-up|3|||
27763209|NCT02326155|54215660|FG000|Overall Study|Protocol Violation|2|||
27763210|NCT02326155|54215661|FG001|Overall Study|Protocol Violation|0|||
27763211|NCT02326155|54215660|FG000|Overall Study|Withdrawal by Subject|34|||
27763212|NCT02326155|54215661|FG001|Overall Study|Withdrawal by Subject|11|||
27763213|NCT02326155|54215660|FG000|Overall Study|Disease progression|37|||
27763214|NCT02326155|54215661|FG001|Overall Study|Disease progression|4|||
27763215|NCT02326155|54215660|FG000|Overall Study|Study close|188|||
27763216|NCT02326155|54215661|FG001|Overall Study|Study close|21|||
27763217|NCT02326155|54215660|FG000|Overall Study|except for study close|46|||
27763218|NCT02326155|54215661|FG001|Overall Study|except for study close|13|||
27763219|NCT02299167|54215667|FG000|Overall Study|patients were excluded from the study|11|||
27763220|NCT01647711|54215676|FG000|Overall Study|Progressive disease|6|||
27763221|NCT01647711|54215677|FG001|Overall Study|Progressive disease|2|||
27763222|NCT01647711|54215678|FG002|Overall Study|Progressive disease|6|||
27763223|NCT01647711|54215679|FG003|Overall Study|Progressive disease|8|||
27763224|NCT01647711|54215680|FG004|Overall Study|Progressive disease|2|||
27763225|NCT01647711|54215676|FG000|Overall Study|Other adverse event|0|||
27763226|NCT01647711|54215677|FG001|Overall Study|Other adverse event|0|||
27763227|NCT01647711|54215678|FG002|Overall Study|Other adverse event|2|||
27763228|NCT01647711|54215679|FG003|Overall Study|Other adverse event|0|||
27763229|NCT01647711|54215680|FG004|Overall Study|Other adverse event|2|||
27763230|NCT01647711|54215676|FG000|Overall Study|Protocol Violation|0|||
27763231|NCT01647711|54215677|FG001|Overall Study|Protocol Violation|0|||
27763232|NCT01647711|54215678|FG002|Overall Study|Protocol Violation|0|||
27763233|NCT01647711|54215679|FG003|Overall Study|Protocol Violation|0|||
27763234|NCT01647711|54215680|FG004|Overall Study|Protocol Violation|1|||
27763235|NCT01647711|54215676|FG000|Overall Study|Refused to continue taking medication|0|||
27763236|NCT01647711|54215677|FG001|Overall Study|Refused to continue taking medication|0|||
27763237|NCT01647711|54215678|FG002|Overall Study|Refused to continue taking medication|0|||
27763238|NCT01647711|54215679|FG003|Overall Study|Refused to continue taking medication|2|||
27763239|NCT01647711|54215680|FG004|Overall Study|Refused to continue taking medication|1|||
27839562|NCT01507051|54326860|FG003|Overall Study|Physician Decision|1|||
27763240|NCT01647711|54215676|FG000|Overall Study|Other reason not defined|0|||
27763241|NCT01647711|54215677|FG001|Overall Study|Other reason not defined|1|||
27763242|NCT01647711|54215678|FG002|Overall Study|Other reason not defined|1|||
27763243|NCT01647711|54215679|FG003|Overall Study|Other reason not defined|1|||
27763244|NCT01647711|54215680|FG004|Overall Study|Other reason not defined|0|||
27763245|NCT02547233|54215696|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
27763246|NCT02547233|54215697|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
27763247|NCT02547233|54215696|FG000|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1|||
27763248|NCT02547233|54215697|FG001|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0|||
27763249|NCT02547233|54215696|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0|||
27763250|NCT02547233|54215697|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9|||
27763251|NCT02547233|54215696|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
27763252|NCT02547233|54215697|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
27763253|NCT02547233|54215696|FG000|12-month Follow-up|Withdrawal by Subject|10|||
27763254|NCT02547233|54215697|FG001|12-month Follow-up|Withdrawal by Subject|10|||
27763255|NCT02547233|54215696|FG000|12-month Follow-up|Lost to Follow-up|3|||
27763256|NCT02547233|54215697|FG001|12-month Follow-up|Lost to Follow-up|3|||
27763257|NCT02547233|54215696|FG000|12-month Follow-up|Lack of Efficacy|1|||
27763258|NCT02547233|54215697|FG001|12-month Follow-up|Lack of Efficacy|2|||
27763259|NCT02547233|54215696|FG000|12-month Follow-up|Protocol Violation|0|||
27763260|NCT02547233|54215697|FG001|12-month Follow-up|Protocol Violation|1|||
27763261|NCT02547233|54215696|FG000|12-month Follow-up|Other|0|||
27763262|NCT02547233|54215697|FG001|12-month Follow-up|Other|1|||
27763263|NCT02546765|54215709|FG000|Overall Study|Withdrawal by Subject|0|||
27763264|NCT02546765|54215710|FG001|Overall Study|Withdrawal by Subject|1|||
27763265|NCT02546765|54215711|FG002|Overall Study|Withdrawal by Subject|0|||
27763266|NCT02546765|54215712|FG003|Overall Study|Withdrawal by Subject|0|||
27763267|NCT02553629|54215735|FG000|Overall Study|Logistic reasons|3|||
27763268|NCT02553629|54215736|FG001|Overall Study|Logistic reasons|6|||
27763269|NCT02546609|54215745|FG000|Overall Study|Withdrawal by Subject|0|||
27763270|NCT02546609|54215746|FG001|Overall Study|Withdrawal by Subject|1|||
27763271|NCT02546609|54215747|FG002|Overall Study|Withdrawal by Subject|2|||
27763272|NCT02546609|54215745|FG000|Overall Study|Adverse Event|0|||
27763273|NCT02546609|54215746|FG001|Overall Study|Adverse Event|6|||
27763274|NCT02546609|54215747|FG002|Overall Study|Adverse Event|1|||
27763275|NCT02546609|54215745|FG000|Overall Study|Protocol Violation|0|||
27763276|NCT02546609|54215746|FG001|Overall Study|Protocol Violation|1|||
27763277|NCT02546609|54215747|FG002|Overall Study|Protocol Violation|1|||
27763278|NCT02546609|54215745|FG000|Overall Study|Lost to Follow-up|2|||
27763279|NCT02546609|54215746|FG001|Overall Study|Lost to Follow-up|3|||
27763280|NCT02546609|54215747|FG002|Overall Study|Lost to Follow-up|1|||
27763281|NCT02546609|54215745|FG000|Overall Study|travel or work schedule restriction|0|||
27763282|NCT02546609|54215746|FG001|Overall Study|travel or work schedule restriction|0|||
27763283|NCT02546609|54215747|FG002|Overall Study|travel or work schedule restriction|2|||
27763284|NCT02553317|54215757|FG000|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0|||
27763285|NCT02553317|54215758|FG001|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1|||
27763286|NCT02553317|54215757|FG000|Overall Treatment Period + Follow-up|Physician Decision|2|||
27763287|NCT02553317|54215758|FG001|Overall Treatment Period + Follow-up|Physician Decision|4|||
27763288|NCT02553317|54215757|FG000|Overall Treatment Period + Follow-up|Non-compliance with study drug|0|||
27763289|NCT02553317|54215758|FG001|Overall Treatment Period + Follow-up|Non-compliance with study drug|1|||
27763290|NCT02553317|54215757|FG000|Overall Treatment Period + Follow-up|Death|1|||
27763291|NCT02553317|54215758|FG001|Overall Treatment Period + Follow-up|Death|3|||
27763292|NCT02553317|54215757|FG000|Overall Treatment Period + Follow-up|Adverse Event|6|||
27763293|NCT02553317|54215758|FG001|Overall Treatment Period + Follow-up|Adverse Event|5|||
27763294|NCT02553317|54215757|FG000|Overall Treatment Period + Follow-up|Withdrawal by Subject|4|||
27763295|NCT02553317|54215758|FG001|Overall Treatment Period + Follow-up|Withdrawal by Subject|5|||
27763296|NCT02553317|54215757|FG000|Overall Treatment Period + Follow-up|Lost to Follow-up|0|||
27763297|NCT02553317|54215758|FG001|Overall Treatment Period + Follow-up|Lost to Follow-up|1|||
27763298|NCT02553317|54215757|FG000|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
27763299|NCT02553317|54215758|FG001|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
27763300|NCT02553317|54215757|FG000|Overall Treatment Period + Follow-up|Protocol Violation|0|||
27763301|NCT02553317|54215758|FG001|Overall Treatment Period + Follow-up|Protocol Violation|1|||
27763302|NCT02553317|54215757|FG000|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0|||
27763303|NCT02553317|54215758|FG001|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1|||
27763304|NCT02325219|54215768|FG000|Controlled Period (Week 0 - 16)|Adverse Event|6|||
27763305|NCT02325219|54215769|FG001|Controlled Period (Week 0 - 16)|Adverse Event|1|||
27763306|NCT02325219|54215770|FG002|Controlled Period (Week 0 - 16)|Adverse Event|0|||
27763307|NCT02325219|54215771|FG003|Controlled Period (Week 0 - 16)|Adverse Event|0|||
27763308|NCT02325219|54215772|FG004|Controlled Period (Week 0 - 16)|Adverse Event|0|||
27763309|NCT02325219|54215768|FG000|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6|||
27763310|NCT02325219|54215769|FG001|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
27839563|NCT01507051|54326857|FG000|Overall Study|Adverse Event|1|||
27763311|NCT02325219|54215770|FG002|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
27763312|NCT02325219|54215771|FG003|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
27763313|NCT02325219|54215772|FG004|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
27763314|NCT02325219|54215768|FG000|Controlled Period (Week 0 - 16)|Other|0|||
27763315|NCT02325219|54215769|FG001|Controlled Period (Week 0 - 16)|Other|0|||
27763316|NCT02325219|54215770|FG002|Controlled Period (Week 0 - 16)|Other|1|||
27763317|NCT02325219|54215771|FG003|Controlled Period (Week 0 - 16)|Other|0|||
27763318|NCT02325219|54215772|FG004|Controlled Period (Week 0 - 16)|Other|0|||
27763319|NCT02325219|54215768|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
27763320|NCT02325219|54215769|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
27763321|NCT02325219|54215770|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
27763322|NCT02325219|54215771|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
27763323|NCT02325219|54215772|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
27763324|NCT02325219|54215768|FG000|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
27763325|NCT02325219|54215769|FG001|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2|||
27763326|NCT02325219|54215770|FG002|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
27763327|NCT02325219|54215771|FG003|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
27763328|NCT02325219|54215772|FG004|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
27763329|NCT02325219|54215768|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
27763330|NCT02325219|54215769|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
27763331|NCT02325219|54215770|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
27763332|NCT02325219|54215771|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
27763333|NCT02325219|54215772|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
27763334|NCT02297841|54215788|FG000|Overall Study|Withdrawal by Subject|1|||
27763335|NCT02297841|54215788|FG000|Overall Study|Protocol Violation|7|||
27763336|NCT02365467|54215792|FG000|Overall Study|Death|3|||
27763337|NCT02324361|54215798|FG000|Overall Study|Lost to Follow-up|5|||
27763338|NCT02324361|54215799|FG001|Overall Study|Lost to Follow-up|2|||
27763339|NCT02365233|54215808|FG000|Overall Study|IRB withheld the data|1|||
27763340|NCT02365233|54215809|FG001|Overall Study|IRB withheld the data|2|||
27763341|NCT02365233|54215810|FG002|Overall Study|IRB withheld the data|2|||
27763342|NCT02324205|54215818|FG000|Overall Study|Withdrawal by Subject|37|||
27763343|NCT02324049|54215822|FG000|Part C|Study terminated|11|||
27763344|NCT02364999|54215828|FG000|Overall Study|Death|136|||
27763345|NCT02364999|54215829|FG001|Overall Study|Death|138|||
27763346|NCT02364999|54215828|FG000|Overall Study|Lost to Follow-up|10|||
27763347|NCT02364999|54215829|FG001|Overall Study|Lost to Follow-up|15|||
27763348|NCT02364999|54215828|FG000|Overall Study|Protocol Violation|3|||
27763349|NCT02364999|54215829|FG001|Overall Study|Protocol Violation|2|||
27763350|NCT02364999|54215828|FG000|Overall Study|Withdrawal by Subject|14|||
27763351|NCT02364999|54215829|FG001|Overall Study|Withdrawal by Subject|14|||
27763352|NCT02364999|54215828|FG000|Overall Study|Other|0|||
27763353|NCT02364999|54215829|FG001|Overall Study|Other|1|||
27763354|NCT02364999|54215828|FG000|Overall Study|Randomized but did not receive treatment|2|||
27763355|NCT02364999|54215829|FG001|Overall Study|Randomized but did not receive treatment|3|||
27763356|NCT02322879|54215838|FG000|First Intervention|Physician Decision|1|||
27763357|NCT02322879|54215839|FG001|First Intervention|Physician Decision|0|||
27763358|NCT02322411|54215847|FG000|Overall Study|Lost to Follow-up|4|||
27763359|NCT02322411|54215848|FG001|Overall Study|Lost to Follow-up|7|||
27763360|NCT02322411|54215847|FG000|Overall Study|Withdrawal by Subject|1|||
27763361|NCT02322411|54215848|FG001|Overall Study|Withdrawal by Subject|0|||
27763362|NCT02322021|54215858|FG000|Core Phase|Adverse Event|1|||
27763363|NCT02322021|54215859|FG001|Core Phase|Adverse Event|3|||
27763364|NCT02322021|54215860|FG002|Core Phase|Adverse Event|4|||
27763365|NCT02322021|54215861|FG003|Core Phase|Adverse Event|2|||
27763366|NCT02322021|54215862|FG004|Core Phase|Adverse Event|0|||
27763367|NCT02322021|54215858|FG000|Core Phase|Participant Choice|4|||
27763368|NCT02322021|54215859|FG001|Core Phase|Participant Choice|5|||
27763369|NCT02322021|54215860|FG002|Core Phase|Participant Choice|4|||
27763370|NCT02322021|54215861|FG003|Core Phase|Participant Choice|2|||
27763371|NCT02322021|54215862|FG004|Core Phase|Participant Choice|0|||
27763372|NCT02322021|54215858|FG000|Core Phase|Lost to Follow-up|0|||
27763373|NCT02322021|54215859|FG001|Core Phase|Lost to Follow-up|0|||
27763374|NCT02322021|54215860|FG002|Core Phase|Lost to Follow-up|0|||
27763375|NCT02322021|54215861|FG003|Core Phase|Lost to Follow-up|1|||
27763376|NCT02322021|54215862|FG004|Core Phase|Lost to Follow-up|0|||
27763377|NCT02322021|54215858|FG000|Core Phase|Other|0|||
27763378|NCT02322021|54215859|FG001|Core Phase|Other|0|||
27763379|NCT02322021|54215860|FG002|Core Phase|Other|1|||
27763380|NCT02322021|54215861|FG003|Core Phase|Other|0|||
27763381|NCT02322021|54215862|FG004|Core Phase|Other|0|||
27763382|NCT02322021|54215858|FG000|Extension Phase|Adverse Event|0|||
27763383|NCT02322021|54215859|FG001|Extension Phase|Adverse Event|0|||
27763384|NCT02322021|54215860|FG002|Extension Phase|Adverse Event|0|||
27763385|NCT02322021|54215861|FG003|Extension Phase|Adverse Event|0|||
27763386|NCT02322021|54215862|FG004|Extension Phase|Adverse Event|3|||
27763387|NCT02322021|54215858|FG000|Extension Phase|Participant Choice|0|||
27763388|NCT02322021|54215859|FG001|Extension Phase|Participant Choice|0|||
27763389|NCT02322021|54215860|FG002|Extension Phase|Participant Choice|0|||
27763390|NCT02322021|54215861|FG003|Extension Phase|Participant Choice|0|||
27763391|NCT02322021|54215862|FG004|Extension Phase|Participant Choice|6|||
27763392|NCT02322021|54215858|FG000|Extension Phase|Other|0|||
27763393|NCT02322021|54215859|FG001|Extension Phase|Other|0|||
27763394|NCT02322021|54215860|FG002|Extension Phase|Other|0|||
27763395|NCT02322021|54215861|FG003|Extension Phase|Other|0|||
27763396|NCT02322021|54215862|FG004|Extension Phase|Other|3|||
27763397|NCT02322021|54215858|FG000|Extension Phase|Lost to Follow-up|0|||
27763398|NCT02322021|54215859|FG001|Extension Phase|Lost to Follow-up|0|||
27763399|NCT02322021|54215860|FG002|Extension Phase|Lost to Follow-up|0|||
27763400|NCT02322021|54215861|FG003|Extension Phase|Lost to Follow-up|0|||
27763401|NCT02322021|54215862|FG004|Extension Phase|Lost to Follow-up|1|||
27763402|NCT02322021|54215858|FG000|Extension Phase|Study terminated by sponsor|0|||
27763403|NCT02322021|54215859|FG001|Extension Phase|Study terminated by sponsor|0|||
27763404|NCT02322021|54215860|FG002|Extension Phase|Study terminated by sponsor|0|||
27763405|NCT02322021|54215861|FG003|Extension Phase|Study terminated by sponsor|0|||
27763406|NCT02322021|54215862|FG004|Extension Phase|Study terminated by sponsor|28|||
27763407|NCT02363439|54215877|FG000|Overall Study|Lack of Efficacy|4|||
27763408|NCT02363283|54215881|FG000|Overall Study|Withdrawal by Subject|1|||
27763409|NCT02363283|54215881|FG000|Overall Study|Not eligible due to transaminitis|1|||
27763410|NCT02321319|54215885|FG000|Overall Study|Product discontinued|5|||
27763411|NCT02294175|54215891|FG000|Overall Study|Withdrawal by Subject|1|||
27763412|NCT02294175|54215892|FG001|Overall Study|Withdrawal by Subject|2|||
27763413|NCT02294175|54215891|FG000|Overall Study|pt taking excluded medication|3|||
27763414|NCT02294175|54215892|FG001|Overall Study|pt taking excluded medication|1|||
27763415|NCT02294175|54215891|FG000|Overall Study|Protocol Violation|1|||
27763416|NCT02294175|54215892|FG001|Overall Study|Protocol Violation|0|||
27763417|NCT02294175|54215891|FG000|Overall Study|Lost to Follow-up|0|||
27763418|NCT02294175|54215892|FG001|Overall Study|Lost to Follow-up|1|||
27763419|NCT02294175|54215891|FG000|Overall Study|wound healed|0|||
27763420|NCT02294175|54215892|FG001|Overall Study|wound healed|2|||
27763421|NCT02088541|54215903|FG000|Overall Study|Adverse Event|3|||
27763422|NCT02088541|54215904|FG001|Overall Study|Adverse Event|0|||
27763423|NCT02088541|54215905|FG002|Overall Study|Adverse Event|3|||
27763424|NCT02088541|54215906|FG003|Overall Study|Adverse Event|3|||
27763425|NCT02088541|54215907|FG004|Overall Study|Adverse Event|0|||
27763426|NCT02088541|54215903|FG000|Overall Study|Death|51|||
27763427|NCT02088541|54215904|FG001|Overall Study|Death|21|||
27763428|NCT02088541|54215905|FG002|Overall Study|Death|85|||
27763429|NCT02088541|54215906|FG003|Overall Study|Death|28|||
27763430|NCT02088541|54215907|FG004|Overall Study|Death|38|||
27763431|NCT02088541|54215903|FG000|Overall Study|Lost to Follow-up|2|||
27763432|NCT02088541|54215904|FG001|Overall Study|Lost to Follow-up|0|||
27763433|NCT02088541|54215905|FG002|Overall Study|Lost to Follow-up|1|||
27763434|NCT02088541|54215906|FG003|Overall Study|Lost to Follow-up|0|||
27763435|NCT02088541|54215907|FG004|Overall Study|Lost to Follow-up|0|||
27763436|NCT02088541|54215903|FG000|Overall Study|Physician Decision|2|||
27763437|NCT02088541|54215904|FG001|Overall Study|Physician Decision|1|||
27763438|NCT02088541|54215905|FG002|Overall Study|Physician Decision|2|||
27763439|NCT02088541|54215906|FG003|Overall Study|Physician Decision|0|||
27763440|NCT02088541|54215907|FG004|Overall Study|Physician Decision|2|||
27763441|NCT02088541|54215903|FG000|Overall Study|Disease progression|7|||
27763442|NCT02088541|54215904|FG001|Overall Study|Disease progression|1|||
27763443|NCT02088541|54215905|FG002|Overall Study|Disease progression|2|||
27763444|NCT02088541|54215906|FG003|Overall Study|Disease progression|3|||
27763445|NCT02088541|54215907|FG004|Overall Study|Disease progression|1|||
27763446|NCT02088541|54215903|FG000|Overall Study|Study terminated by sponsor|1|||
27763447|NCT02088541|54215904|FG001|Overall Study|Study terminated by sponsor|1|||
27763448|NCT02088541|54215905|FG002|Overall Study|Study terminated by sponsor|12|||
27763449|NCT02088541|54215906|FG003|Overall Study|Study terminated by sponsor|2|||
27763450|NCT02088541|54215907|FG004|Overall Study|Study terminated by sponsor|6|||
27763451|NCT02088541|54215903|FG000|Overall Study|Withdrawal by Subject|3|||
27763452|NCT02088541|54215904|FG001|Overall Study|Withdrawal by Subject|2|||
27763453|NCT02088541|54215905|FG002|Overall Study|Withdrawal by Subject|9|||
27763454|NCT02088541|54215906|FG003|Overall Study|Withdrawal by Subject|7|||
27763455|NCT02088541|54215907|FG004|Overall Study|Withdrawal by Subject|10|||
27763456|NCT02088541|54215903|FG000|Overall Study|Other|2|||
27763457|NCT02088541|54215904|FG001|Overall Study|Other|1|||
27763458|NCT02088541|54215905|FG002|Overall Study|Other|3|||
27763459|NCT02088541|54215906|FG003|Overall Study|Other|1|||
27763460|NCT02088541|54215907|FG004|Overall Study|Other|1|||
27763461|NCT02294019|54215917|FG000|Overall Study|Adverse Event|2|||
27763462|NCT02294019|54215917|FG000|Overall Study|Protocol Violation|68|||
27763463|NCT02294019|54215917|FG000|Overall Study|Lost to Follow-up|31|||
27763464|NCT02294019|54215917|FG000|Overall Study|Other|1|||
27763465|NCT02294019|54215917|FG000|Overall Study|Withdrawal by Subject|1|||
27763466|NCT02320149|54215923|FG000|Overall Study|Adverse Event|3|||
27763467|NCT02320149|54215924|FG001|Overall Study|Adverse Event|7|||
27763468|NCT02320149|54215923|FG000|Overall Study|Withdrawal of Consent|28|||
27763469|NCT02320149|54215924|FG001|Overall Study|Withdrawal of Consent|32|||
27763470|NCT02320149|54215923|FG000|Overall Study|Lost to Follow-up|21|||
27763471|NCT02320149|54215924|FG001|Overall Study|Lost to Follow-up|34|||
27763472|NCT02320149|54215923|FG000|Overall Study|Protocol Violation|2|||
27763473|NCT02320149|54215924|FG001|Overall Study|Protocol Violation|1|||
27763474|NCT02320149|54215923|FG000|Overall Study|Noncompliance with Study Treatment|7|||
27763475|NCT02320149|54215924|FG001|Overall Study|Noncompliance with Study Treatment|2|||
27763476|NCT02320149|54215923|FG000|Overall Study|Lack of Efficacy|0|||
27763477|NCT02320149|54215924|FG001|Overall Study|Lack of Efficacy|1|||
27763478|NCT02320149|54215923|FG000|Overall Study|Other Miscellaneous Reasons|2|||
27763479|NCT02320149|54215924|FG001|Overall Study|Other Miscellaneous Reasons|3|||
27763480|NCT02540083|54215930|FG000|Overall Study|Withdrawal by Subject|16|||
27763481|NCT02293863|54215937|FG000|Overall Study|Death|4|||
27763482|NCT02293863|54215938|FG001|Overall Study|Death|6|||
27763483|NCT02293863|54215939|FG002|Overall Study|Death|4|||
27763484|NCT02293863|54215937|FG000|Overall Study|Lost to Follow-up|2|||
27763485|NCT02293863|54215938|FG001|Overall Study|Lost to Follow-up|2|||
27763486|NCT02293863|54215939|FG002|Overall Study|Lost to Follow-up|2|||
27763487|NCT02293863|54215937|FG000|Overall Study|Withdrawal by Subject|3|||
27763488|NCT02293863|54215938|FG001|Overall Study|Withdrawal by Subject|3|||
27763489|NCT02293863|54215939|FG002|Overall Study|Withdrawal by Subject|1|||
27763490|NCT02293863|54215937|FG000|Overall Study|Reason Not Specified|0|||
27763491|NCT02293863|54215938|FG001|Overall Study|Reason Not Specified|2|||
27763492|NCT02293863|54215939|FG002|Overall Study|Reason Not Specified|2|||
27763493|NCT02293395|54215951|FG000|Overall Study|Lost to Follow-up|1|||
27763494|NCT02293395|54215952|FG001|Overall Study|Lost to Follow-up|0|||
27763495|NCT02293395|54215951|FG000|Overall Study|Withdrawal by Subject|8|||
27763496|NCT02293395|54215952|FG001|Overall Study|Withdrawal by Subject|7|||
27763497|NCT02025985|54215963|FG000|Overall Study|Consent withdrawn|0|||
27763498|NCT02025985|54215964|FG001|Overall Study|Consent withdrawn|0|||
27763499|NCT02025985|54215965|FG002|Overall Study|Consent withdrawn|1|||
27763500|NCT02025985|54215966|FG003|Overall Study|Consent withdrawn|0|||
27763501|NCT02025985|54215967|FG004|Overall Study|Consent withdrawn|0|||
27763502|NCT02025985|54215963|FG000|Overall Study|Termination of study by Sponsor|4|||
27763503|NCT02025985|54215964|FG001|Overall Study|Termination of study by Sponsor|3|||
27763504|NCT02025985|54215965|FG002|Overall Study|Termination of study by Sponsor|1|||
27763505|NCT02025985|54215966|FG003|Overall Study|Termination of study by Sponsor|1|||
27763506|NCT02025985|54215967|FG004|Overall Study|Termination of study by Sponsor|3|||
27763507|NCT02025985|54215963|FG000|Overall Study|Death|21|||
27763508|NCT02025985|54215964|FG001|Overall Study|Death|20|||
27763509|NCT02025985|54215965|FG002|Overall Study|Death|23|||
27763510|NCT02025985|54215966|FG003|Overall Study|Death|20|||
27763511|NCT02025985|54215967|FG004|Overall Study|Death|17|||
27763512|NCT02528305|54215981|FG000|Overall Study|Withdrawal by Subject|1|||
27763513|NCT02528305|54215981|FG000|Overall Study|Adverse Event|1|||
27763514|NCT02528305|54215981|FG000|Overall Study|Physician Decision|1|||
27763515|NCT02532517|54215987|FG000|Overall Study|Did not complete 24-Month visit|4|||
27763516|NCT02532517|54215987|FG000|Overall Study|Failed Angiographic eligibility|1|||
27763517|NCT02532517|54215987|FG000|Overall Study|Lost to Follow-up|4|||
27763518|NCT02532517|54215987|FG000|Overall Study|Withdrawal by Subject|4|||
27763519|NCT02532517|54215987|FG000|Overall Study|Death|4|||
27763520|NCT02545049|54215993|FG000|Overall Study|Withdrawal by Subject|1|||
27763521|NCT02545049|54215994|FG001|Overall Study|Withdrawal by Subject|7|||
27763522|NCT02545049|54215993|FG000|Overall Study|Lost to Follow-up|4|||
27763523|NCT02545049|54215994|FG001|Overall Study|Lost to Follow-up|6|||
27763524|NCT02545049|54215993|FG000|Overall Study|GCP violations|37|||
27763525|NCT02545049|54215994|FG001|Overall Study|GCP violations|48|||
27763526|NCT02532283|54216002|FG000|Overall Study|Adverse Event|0|||
27763527|NCT02532283|54216003|FG001|Overall Study|Adverse Event|1|||
27763528|NCT02532283|54216002|FG000|Overall Study|Death|1|||
27763529|NCT02532283|54216003|FG001|Overall Study|Death|0|||
27763530|NCT02532283|54216002|FG000|Overall Study|Lost to Follow-up|0|||
27763531|NCT02532283|54216003|FG001|Overall Study|Lost to Follow-up|1|||
27763532|NCT02532283|54216002|FG000|Overall Study|Withdrawal by Subject|8|||
27763533|NCT02532283|54216003|FG001|Overall Study|Withdrawal by Subject|3|||
27763534|NCT01349959|54216024|FG000|Overall Study|Adverse Event|7|||
27763535|NCT01295125|54216028|FG000|Overall Study|Study stopped prematurely|9|||
27763536|NCT02540291|54216036|FG000|Overall Study|Death|7|||
27763537|NCT02540291|54216037|FG001|Overall Study|Death|7|||
27763538|NCT02540291|54216038|FG002|Overall Study|Death|5|||
27763539|NCT02540291|54216039|FG003|Overall Study|Death|7|||
27763540|NCT02540291|54216036|FG000|Overall Study|Lost to Follow-up|0|||
27763541|NCT02540291|54216037|FG001|Overall Study|Lost to Follow-up|0|||
27763542|NCT02540291|54216038|FG002|Overall Study|Lost to Follow-up|1|||
27763543|NCT02540291|54216039|FG003|Overall Study|Lost to Follow-up|0|||
27763544|NCT02540291|54216036|FG000|Overall Study|Withdrawal Of Consent|0|||
27763545|NCT02540291|54216037|FG001|Overall Study|Withdrawal Of Consent|1|||
27763546|NCT02540291|54216038|FG002|Overall Study|Withdrawal Of Consent|0|||
27763547|NCT02540291|54216039|FG003|Overall Study|Withdrawal Of Consent|0|||
27763548|NCT02540291|54216036|FG000|Overall Study|Study Terminated By Sponsor|1|||
27763549|NCT02540291|54216037|FG001|Overall Study|Study Terminated By Sponsor|0|||
27763550|NCT02540291|54216038|FG002|Overall Study|Study Terminated By Sponsor|0|||
27763551|NCT02540291|54216039|FG003|Overall Study|Study Terminated By Sponsor|0|||
27763552|NCT02540291|54216036|FG000|Overall Study|Other|0|||
27763553|NCT02540291|54216037|FG001|Overall Study|Other|0|||
27763554|NCT02540291|54216038|FG002|Overall Study|Other|1|||
27763555|NCT02540291|54216039|FG003|Overall Study|Other|0|||
27763556|NCT02540213|54216051|FG000|Overall Study|Death/adverse event|18|||
27763557|NCT02540213|54216051|FG000|Overall Study|Administrative reasons|3|||
27763558|NCT02540213|54216051|FG000|Overall Study|Kidney transplant|3|||
27763559|NCT02540213|54216051|FG000|Overall Study|Lack of Efficacy|6|||
27763560|NCT02540213|54216051|FG000|Overall Study|Consent withdrawn|7|||
27763561|NCT02540213|54216051|FG000|Overall Study|Enrolled but not treated|2|||
27763562|NCT02544503|54216057|FG000|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|24|||
27763563|NCT02544503|54216058|FG001|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|3|||
27763564|NCT02544503|54216057|FG000|Overall Study|Lost to Follow-up|9|||
27763565|NCT02544503|54216058|FG001|Overall Study|Lost to Follow-up|0|||
27763566|NCT02544503|54216057|FG000|Overall Study|Withdrawal by Subject|1|||
27763567|NCT02544503|54216058|FG001|Overall Study|Withdrawal by Subject|0|||
27763568|NCT02552303|54216068|FG000|Allocation|Withdrawal by Subject|2|||
27763569|NCT02552303|54216069|FG001|Allocation|Withdrawal by Subject|1|||
27763570|NCT02552303|54216070|FG002|Allocation|Withdrawal by Subject|1|||
27763571|NCT02552303|54216071|FG003|Allocation|Withdrawal by Subject|1|||
27763572|NCT02552303|54216068|FG000|Allocation|ineligible|1|||
27763573|NCT02552303|54216069|FG001|Allocation|ineligible|1|||
27763574|NCT02552303|54216070|FG002|Allocation|ineligible|0|||
27763575|NCT02552303|54216071|FG003|Allocation|ineligible|0|||
27763576|NCT02552303|54216068|FG000|Follow-Up|Lost to Follow-up|0|||
27763577|NCT02552303|54216069|FG001|Follow-Up|Lost to Follow-up|0|||
27763578|NCT02552303|54216070|FG002|Follow-Up|Lost to Follow-up|1|||
27763579|NCT02552303|54216071|FG003|Follow-Up|Lost to Follow-up|0|||
27763580|NCT02552303|54216068|FG000|Follow-Up|ineligible|0|||
27763581|NCT02552303|54216069|FG001|Follow-Up|ineligible|2|||
27763582|NCT02552303|54216070|FG002|Follow-Up|ineligible|0|||
27763583|NCT02552303|54216071|FG003|Follow-Up|ineligible|0|||
27763584|NCT01660711|54216081|FG000|Overall Study|Adverse Event|7|||
27763585|NCT01660711|54216081|FG000|Overall Study|Withdrawal by Subject|1|||
27763586|NCT02544113|54216087|FG000|Overall Study|Death|3|||
27763587|NCT02544113|54216088|FG001|Overall Study|Death|4|||
27763588|NCT02538965|54216094|FG000|Treatment Period|Other = Death due to disease progression|1|||
27763589|NCT02538965|54216094|FG000|Treatment Period|Adverse Event|2|||
27763590|NCT02538965|54216094|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
27763591|NCT02538965|54216094|FG000|Treatment Period|Treatment Failure|9|||
27763592|NCT02538965|54216094|FG000|Treatment Period|Disease Progression|1|||
27763593|NCT02538965|54216094|FG000|Treatment Period|Physician Decision|2|||
27763594|NCT02538965|54216094|FG000|Follow-Up Period|Other = Death due to disease progression|13|||
27763595|NCT02538965|54216094|FG000|Follow-Up Period|Withdrawal by Parent|4|||
27763596|NCT02543801|54216102|FG000|Overall Study|Protocol Violation|1|||
27763597|NCT02543801|54216103|FG001|Overall Study|Protocol Violation|2|||
27763598|NCT02543801|54216104|FG002|Overall Study|Protocol Violation|0|||
27763599|NCT02543801|54216105|FG003|Overall Study|Protocol Violation|0|||
27763600|NCT02470091|54216117|FG000|Overall Study|Withdrawal by Subject|1|||
27763601|NCT02470091|54216118|FG001|Overall Study|Withdrawal by Subject|0|||
27763602|NCT02470091|54216117|FG000|Overall Study|Ineligible|0|||
27763603|NCT02470091|54216118|FG001|Overall Study|Ineligible|2|||
27763604|NCT02362503|54216129|FG000|Double-blind Period-Up to 8 Days|Adverse Event|0|||
27763605|NCT02362503|54216130|FG001|Double-blind Period-Up to 8 Days|Adverse Event|2|||
27763606|NCT02362503|54216131|FG002|Double-blind Period-Up to 8 Days|Adverse Event|0|||
27763607|NCT02362503|54216129|FG000|Double-blind Period-Up to 8 Days|Death|1|||
27763608|NCT02362503|54216130|FG001|Double-blind Period-Up to 8 Days|Death|0|||
27763609|NCT02362503|54216131|FG002|Double-blind Period-Up to 8 Days|Death|0|||
27763610|NCT02362503|54216129|FG000|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
27763611|NCT02362503|54216130|FG001|Double-blind Period-Up to 8 Days|Lost to Follow-up|1|||
27763612|NCT02362503|54216131|FG002|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
27763613|NCT02362503|54216129|FG000|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
27763614|NCT02362503|54216130|FG001|Double-blind Period-Up to 8 Days|No longer meets study criteria|1|||
27763615|NCT02362503|54216131|FG002|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
27763616|NCT02362503|54216129|FG000|Open Label Period-Up to 96 Weeks|Other|0|||
27763617|NCT02362503|54216130|FG001|Open Label Period-Up to 96 Weeks|Other|1|||
27763618|NCT02362503|54216131|FG002|Open Label Period-Up to 96 Weeks|Other|1|||
27763619|NCT02362503|54216129|FG000|Open Label Period-Up to 96 Weeks|No longer meets criteria|0|||
27839564|NCT01507051|54326858|FG001|Overall Study|Adverse Event|0|||
27763620|NCT02362503|54216130|FG001|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
27763621|NCT02362503|54216131|FG002|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
27763622|NCT02362503|54216129|FG000|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
27763623|NCT02362503|54216130|FG001|Open Label Period-Up to 96 Weeks|Pregnancy|1|||
27763624|NCT02362503|54216131|FG002|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
27763625|NCT02362503|54216129|FG000|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|3|||
27763626|NCT02362503|54216130|FG001|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|8|||
27763627|NCT02362503|54216131|FG002|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|6|||
27763628|NCT02362503|54216129|FG000|Open Label Period-Up to 96 Weeks|Lost to Follow-up|4|||
27763629|NCT02362503|54216130|FG001|Open Label Period-Up to 96 Weeks|Lost to Follow-up|3|||
27763630|NCT02362503|54216131|FG002|Open Label Period-Up to 96 Weeks|Lost to Follow-up|1|||
27763631|NCT02362503|54216129|FG000|Open Label Period-Up to 96 Weeks|Death|1|||
27763632|NCT02362503|54216130|FG001|Open Label Period-Up to 96 Weeks|Death|7|||
27763633|NCT02362503|54216131|FG002|Open Label Period-Up to 96 Weeks|Death|15|||
27763634|NCT02362503|54216129|FG000|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|0|||
27763635|NCT02362503|54216130|FG001|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|5|||
27763636|NCT02362503|54216131|FG002|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|1|||
27763637|NCT02362503|54216129|FG000|Open Label Period-Up to 96 Weeks|Adverse Event|3|||
27763638|NCT02362503|54216130|FG001|Open Label Period-Up to 96 Weeks|Adverse Event|2|||
27763639|NCT02362503|54216131|FG002|Open Label Period-Up to 96 Weeks|Adverse Event|4|||
27763640|NCT02362503|54216129|FG000|Open Label Period-Up to 96 Weeks|Lack of Efficacy|3|||
27763641|NCT02362503|54216130|FG001|Open Label Period-Up to 96 Weeks|Lack of Efficacy|9|||
27763642|NCT02362503|54216131|FG002|Open Label Period-Up to 96 Weeks|Lack of Efficacy|6|||
27763643|NCT02362503|54216129|FG000|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|54|||
27763644|NCT02362503|54216130|FG001|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|159|||
27763645|NCT02362503|54216131|FG002|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|61|||
27763646|NCT02535065|54216142|FG000|Overall Study|Death|13|||
27763647|NCT02535065|54216142|FG000|Overall Study|Lost to Follow-up|1|||
27763648|NCT02535065|54216142|FG000|Overall Study|Withdrawal by Subject|6|||
27763649|NCT02530619|54216146|FG000|Registered for Study|Withdrawal by Subject|2|||
27763650|NCT02530619|54216146|FG000|Continued Treatment Cycles 2 Through 6|Adverse Event|2|||
27763651|NCT02530619|54216146|FG000|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2|||
27763652|NCT02530619|54216146|FG000|Continued Treatment Cycles 2 Through 6|Progressive Disease|4|||
27763653|NCT02530619|54216146|FG000|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2|||
27763654|NCT02530619|54216146|FG000|Follow-up Period (6 Months)|Death|4|||
27763655|NCT02530619|54216146|FG000|Follow-up Period (6 Months)|Lost to Follow-up|2|||
27763656|NCT02530619|54216146|FG000|Follow-up Period (6 Months)|Withdrawal by Subject|5|||
27763657|NCT02530385|54216152|FG000|Overall Study|Withdrawal by Subject|0|||
27763658|NCT02530385|54216153|FG001|Overall Study|Withdrawal by Subject|1|||
27763659|NCT02362425|54216163|FG000|Phase 1 (up to 6 Months)|Withdrawal by Subject|2|||
27763660|NCT02362425|54216164|FG001|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
27763661|NCT02362425|54216165|FG002|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
27763662|NCT02362425|54216166|FG003|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
27763663|NCT02362425|54216163|FG000|Phase 1 (up to 6 Months)|Medicinal contraindication|1|||
27763664|NCT02362425|54216164|FG001|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
27763665|NCT02362425|54216165|FG002|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
27763666|NCT02362425|54216166|FG003|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
27763667|NCT02362425|54216163|FG000|Phase 1 (up to 6 Months)|Screening failure|1|||
27763668|NCT02362425|54216164|FG001|Phase 1 (up to 6 Months)|Screening failure|0|||
27763669|NCT02362425|54216165|FG002|Phase 1 (up to 6 Months)|Screening failure|0|||
27763670|NCT02362425|54216166|FG003|Phase 1 (up to 6 Months)|Screening failure|0|||
27763671|NCT02362425|54216163|FG000|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3|||
27763672|NCT02362425|54216164|FG001|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
27763673|NCT02362425|54216165|FG002|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
27763674|NCT02362425|54216166|FG003|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
27763675|NCT02362425|54216163|FG000|Phase 1 (up to 6 Months)|Study closure|9|||
27763676|NCT02362425|54216164|FG001|Phase 1 (up to 6 Months)|Study closure|0|||
27763677|NCT02362425|54216165|FG002|Phase 1 (up to 6 Months)|Study closure|0|||
27763678|NCT02362425|54216166|FG003|Phase 1 (up to 6 Months)|Study closure|0|||
27763679|NCT02362425|54216163|FG000|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
27763680|NCT02362425|54216164|FG001|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
27763681|NCT02362425|54216165|FG002|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
27763682|NCT02362425|54216166|FG003|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2|||
27763683|NCT02362425|54216163|FG000|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
27763684|NCT02362425|54216164|FG001|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
27839565|NCT01507051|54326859|FG002|Overall Study|Adverse Event|0|||
27839566|NCT01507051|54326860|FG003|Overall Study|Adverse Event|0|||
27763685|NCT02362425|54216165|FG002|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
27763686|NCT02362425|54216166|FG003|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1|||
27763687|NCT02362425|54216163|FG000|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
27763688|NCT02362425|54216164|FG001|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
27763689|NCT02362425|54216165|FG002|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1|||
27763690|NCT02362425|54216166|FG003|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
27763691|NCT02362269|54216179|FG000|Overall Study|Moved|1|||
27763692|NCT02362269|54216180|FG001|Overall Study|Moved|0|||
27763693|NCT02362269|54216179|FG000|Overall Study|Lost to Follow-up|0|||
27763694|NCT02362269|54216180|FG001|Overall Study|Lost to Follow-up|6|||
27763695|NCT02529995|54216188|FG000|Part A|Ongoing Study at Data Cut-off|14|||
27763696|NCT02529995|54216189|FG001|Part A|Ongoing Study at Data Cut-off|16|||
27763697|NCT02529995|54216188|FG000|Part A|Discontinued Study|1|||
27763698|NCT02529995|54216189|FG001|Part A|Discontinued Study|0|||
27763699|NCT02529995|54216188|FG000|Part B|Ongoing Study at Data Cut-off|0|||
27763700|NCT02529995|54216189|FG001|Part B|Ongoing Study at Data Cut-off|7|||
27763701|NCT02529995|54216188|FG000|Part B|Discontinued Study|6|||
27763702|NCT02529995|54216189|FG001|Part B|Discontinued Study|5|||
27763703|NCT02529137|54216195|FG000|Overall Study|Discontinuation for different reasons|8|||
27763704|NCT02319759|54216202|FG000|Week 0 - 16|Lack of Efficacy|1|||
27763705|NCT02319759|54216203|FG001|Week 0 - 16|Lack of Efficacy|0|||
27763706|NCT02319759|54216204|FG002|Week 0 - 16|Lack of Efficacy|0|||
27763707|NCT02319759|54216205|FG003|Week 0 - 16|Lack of Efficacy|0|||
27763708|NCT02319759|54216206|FG004|Week 0 - 16|Lack of Efficacy|0|||
27763709|NCT02319759|54216202|FG000|Week 0 - 16|Not met all Inclusion Criteria|0|||
27763710|NCT02319759|54216203|FG001|Week 0 - 16|Not met all Inclusion Criteria|0|||
27763711|NCT02319759|54216204|FG002|Week 0 - 16|Not met all Inclusion Criteria|1|||
27763712|NCT02319759|54216205|FG003|Week 0 - 16|Not met all Inclusion Criteria|0|||
27763713|NCT02319759|54216206|FG004|Week 0 - 16|Not met all Inclusion Criteria|0|||
27763714|NCT02319759|54216202|FG000|Week 16 - 24|Lack of Efficacy|1|||
27763715|NCT02319759|54216203|FG001|Week 16 - 24|Lack of Efficacy|0|||
27763716|NCT02319759|54216204|FG002|Week 16 - 24|Lack of Efficacy|1|||
27763717|NCT02319759|54216205|FG003|Week 16 - 24|Lack of Efficacy|0|||
27763718|NCT02319759|54216206|FG004|Week 16 - 24|Lack of Efficacy|0|||
27763719|NCT02319759|54216202|FG000|Week 16 - 24|Lost to Follow-up|1|||
27763720|NCT02319759|54216203|FG001|Week 16 - 24|Lost to Follow-up|0|||
27763721|NCT02319759|54216204|FG002|Week 16 - 24|Lost to Follow-up|0|||
27763722|NCT02319759|54216205|FG003|Week 16 - 24|Lost to Follow-up|0|||
27763723|NCT02319759|54216206|FG004|Week 16 - 24|Lost to Follow-up|0|||
27763724|NCT02319759|54216202|FG000|Week 16 - 24|Withdrawal by Subject|0|||
27763725|NCT02319759|54216203|FG001|Week 16 - 24|Withdrawal by Subject|0|||
27763726|NCT02319759|54216204|FG002|Week 16 - 24|Withdrawal by Subject|2|||
27763727|NCT02319759|54216205|FG003|Week 16 - 24|Withdrawal by Subject|0|||
27763728|NCT02319759|54216206|FG004|Week 16 - 24|Withdrawal by Subject|0|||
27763729|NCT02319759|54216202|FG000|Week 24 - 56|Adverse Event|0|||
27763730|NCT02319759|54216203|FG001|Week 24 - 56|Adverse Event|0|||
27763731|NCT02319759|54216204|FG002|Week 24 - 56|Adverse Event|2|||
27763732|NCT02319759|54216205|FG003|Week 24 - 56|Adverse Event|0|||
27763733|NCT02319759|54216206|FG004|Week 24 - 56|Adverse Event|0|||
27763734|NCT02319759|54216202|FG000|Week 24 - 56|Lack of Efficacy|0|||
27763735|NCT02319759|54216203|FG001|Week 24 - 56|Lack of Efficacy|0|||
27763736|NCT02319759|54216204|FG002|Week 24 - 56|Lack of Efficacy|0|||
27763737|NCT02319759|54216205|FG003|Week 24 - 56|Lack of Efficacy|2|||
27763738|NCT02319759|54216206|FG004|Week 24 - 56|Lack of Efficacy|1|||
27763739|NCT02319759|54216202|FG000|Week 24 - 56|Withdrawal by Subject|0|||
27763740|NCT02319759|54216203|FG001|Week 24 - 56|Withdrawal by Subject|1|||
27763741|NCT02319759|54216204|FG002|Week 24 - 56|Withdrawal by Subject|0|||
27763742|NCT02319759|54216205|FG003|Week 24 - 56|Withdrawal by Subject|0|||
27763743|NCT02319759|54216206|FG004|Week 24 - 56|Withdrawal by Subject|0|||
27763744|NCT02319759|54216202|FG000|Week 24 - 56|Lost to Follow-up|0|||
27763745|NCT02319759|54216203|FG001|Week 24 - 56|Lost to Follow-up|0|||
27763746|NCT02319759|54216204|FG002|Week 24 - 56|Lost to Follow-up|0|||
27763747|NCT02319759|54216205|FG003|Week 24 - 56|Lost to Follow-up|0|||
27763748|NCT02319759|54216206|FG004|Week 24 - 56|Lost to Follow-up|1|||
27763749|NCT02293005|54216219|FG000|Overall Study|Adverse Event|2|||
27763750|NCT02293005|54216219|FG000|Overall Study|Death|4|||
27763751|NCT02293005|54216219|FG000|Overall Study|Lost to Follow-up|1|||
27763752|NCT02293005|54216219|FG000|Overall Study|Withdrawal by Subject|2|||
27763753|NCT02293005|54216219|FG000|Overall Study|Progression|17|||
27763754|NCT02319525|54216225|FG000|Overall Study|Withdrawal by Subject|2|||
27763755|NCT02319525|54216226|FG001|Overall Study|Withdrawal by Subject|1|||
27763756|NCT02292927|54216234|FG000|Overall Study|Protocol Violation|13|||
27763757|NCT02292927|54216235|FG001|Overall Study|Protocol Violation|7|||
27763758|NCT02292849|54216247|FG000|Overall Study|Lost to Follow-up|0|||
27763759|NCT02292849|54216248|FG001|Overall Study|Lost to Follow-up|2|||
27763760|NCT02292849|54216249|FG002|Overall Study|Lost to Follow-up|2|||
27763761|NCT02292849|54216247|FG000|Overall Study|Physician Decision|4|||
27763762|NCT02292849|54216248|FG001|Overall Study|Physician Decision|0|||
27763763|NCT02292849|54216249|FG002|Overall Study|Physician Decision|0|||
27763764|NCT02318667|54216257|FG000|Overall Study|Adverse Event|1|||
27763765|NCT02318667|54216257|FG000|Overall Study|Lack of Efficacy|6|||
27763766|NCT02318667|54216257|FG000|Overall Study|Protocol Violation|2|||
27763767|NCT02292771|54216267|FG000|Overall Study|Withdrawal by Subject|2|||
27763768|NCT02292771|54216268|FG001|Overall Study|Withdrawal by Subject|1|||
27763769|NCT02292771|54216267|FG000|Overall Study|Lost to Follow-up|2|||
27763770|NCT02292771|54216268|FG001|Overall Study|Lost to Follow-up|1|||
27763771|NCT02291913|54216278|FG000|Overall Study|Progressive Disease|32|||
27763772|NCT02291913|54216278|FG000|Overall Study|Adverse Event|11|||
27763773|NCT02291913|54216278|FG000|Overall Study|Death|2|||
27763774|NCT02291913|54216278|FG000|Overall Study|Physician Decision|1|||
27763775|NCT02291913|54216278|FG000|Overall Study|Withdrawal by Subject|1|||
27763776|NCT02291913|54216278|FG000|Overall Study|Protocol Violation|1|||
27763777|NCT02291679|54216285|FG000|Overall Study|Adverse Event|2|||
27763778|NCT02291679|54216286|FG001|Overall Study|Adverse Event|12|||
27763779|NCT02291679|54216287|FG002|Overall Study|Adverse Event|19|||
27763780|NCT02291679|54216285|FG000|Overall Study|Protocol Violation|5|||
27763781|NCT02291679|54216286|FG001|Overall Study|Protocol Violation|1|||
27763782|NCT02291679|54216287|FG002|Overall Study|Protocol Violation|7|||
27763783|NCT02291679|54216285|FG000|Overall Study|Withdrew Consent|18|||
27763784|NCT02291679|54216286|FG001|Overall Study|Withdrew Consent|10|||
27763785|NCT02291679|54216287|FG002|Overall Study|Withdrew Consent|15|||
27763786|NCT02291679|54216285|FG000|Overall Study|Lost to Follow-up|12|||
27763787|NCT02291679|54216286|FG001|Overall Study|Lost to Follow-up|10|||
27763788|NCT02291679|54216287|FG002|Overall Study|Lost to Follow-up|9|||
27763789|NCT02291679|54216285|FG000|Overall Study|Insufficient Therapeutic Response|5|||
27763790|NCT02291679|54216286|FG001|Overall Study|Insufficient Therapeutic Response|5|||
27763791|NCT02291679|54216287|FG002|Overall Study|Insufficient Therapeutic Response|7|||
27763792|NCT02291679|54216285|FG000|Overall Study|Other|2|||
27763793|NCT02291679|54216286|FG001|Overall Study|Other|4|||
27763794|NCT02291679|54216287|FG002|Overall Study|Other|2|||
27763795|NCT02291601|54216294|FG000|Abdomen|Did not qualify|333|||
27763796|NCT02291601|54216295|FG001|Abdomen|Did not qualify|54|||
27763797|NCT02291601|54216296|FG002|Abdomen|Did not qualify|339|||
27763798|NCT02291601|54216294|FG000|Groin|Did not qualify|183|||
27763799|NCT02291601|54216295|FG001|Groin|Did not qualify|30|||
27763800|NCT02291601|54216296|FG002|Groin|Did not qualify|177|||
27763801|NCT02360475|54216311|FG000|Overall Study|Lost to Follow-up|4|||
27763802|NCT02360475|54216312|FG001|Overall Study|Lost to Follow-up|12|||
27763803|NCT02360475|54216313|FG002|Overall Study|Lost to Follow-up|6|||
27763804|NCT02360475|54216314|FG003|Overall Study|Lost to Follow-up|4|||
27763805|NCT02360475|54216311|FG000|Overall Study|Withdrawal by Subject|0|||
27763806|NCT02360475|54216312|FG001|Overall Study|Withdrawal by Subject|1|||
27763807|NCT02360475|54216313|FG002|Overall Study|Withdrawal by Subject|2|||
27763808|NCT02360475|54216314|FG003|Overall Study|Withdrawal by Subject|0|||
27763809|NCT02360475|54216311|FG000|Overall Study|Migrated/moved from study area|0|||
27763810|NCT02360475|54216312|FG001|Overall Study|Migrated/moved from study area|0|||
27763811|NCT02360475|54216313|FG002|Overall Study|Migrated/moved from study area|0|||
27763812|NCT02360475|54216314|FG003|Overall Study|Migrated/moved from study area|1|||
27763813|NCT02360397|54216324|FG000|Overall Study|Incomplete screening|3|||
27763814|NCT02360397|54216324|FG000|Overall Study|Adverse Event|1|||
27763815|NCT02317809|54216329|FG000|First Intervention Period (8 Days)|Protocol Non-Compliance|2|||
27763816|NCT02317809|54216330|FG001|First Intervention Period (8 Days)|Protocol Non-Compliance|0|||
27763817|NCT02317809|54216329|FG000|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1|||
27763818|NCT02317809|54216330|FG001|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0|||
27763819|NCT02359851|54216339|FG000|Overall Study|Death|1|||
27763820|NCT02359851|54216339|FG000|Overall Study|Disease progression|1|||
27763821|NCT01607905|54216350|FG000|Overall Study|Withdrawal by participant|7|||
27763822|NCT01607905|54216351|FG001|Overall Study|Withdrawal by participant|2|||
27763823|NCT01607905|54216352|FG002|Overall Study|Withdrawal by participant|4|||
27763824|NCT01607905|54216353|FG003|Overall Study|Withdrawal by participant|6|||
27763825|NCT01607905|54216354|FG004|Overall Study|Withdrawal by participant|0|||
27763826|NCT01607905|54216355|FG005|Overall Study|Withdrawal by participant|4|||
27763827|NCT01607905|54216356|FG006|Overall Study|Withdrawal by participant|12|||
27763828|NCT01607905|54216350|FG000|Overall Study|Incidence or severity of AEs|5|||
27763829|NCT01607905|54216351|FG001|Overall Study|Incidence or severity of AEs|1|||
27763830|NCT01607905|54216352|FG002|Overall Study|Incidence or severity of AEs|1|||
27763831|NCT01607905|54216353|FG003|Overall Study|Incidence or severity of AEs|3|||
27763832|NCT01607905|54216354|FG004|Overall Study|Incidence or severity of AEs|0|||
27763833|NCT01607905|54216355|FG005|Overall Study|Incidence or severity of AEs|2|||
27763834|NCT01607905|54216356|FG006|Overall Study|Incidence or severity of AEs|8|||
27763835|NCT01607905|54216350|FG000|Overall Study|Disease progression|44|||
27763836|NCT01607905|54216351|FG001|Overall Study|Disease progression|16|||
27763837|NCT01607905|54216352|FG002|Overall Study|Disease progression|15|||
27763838|NCT01607905|54216353|FG003|Overall Study|Disease progression|11|||
27763839|NCT01607905|54216354|FG004|Overall Study|Disease progression|6|||
27763840|NCT01607905|54216355|FG005|Overall Study|Disease progression|7|||
27763841|NCT01607905|54216356|FG006|Overall Study|Disease progression|21|||
27763842|NCT01607905|54216350|FG000|Overall Study|Non-compliance with study procedures|0|||
27763843|NCT01607905|54216351|FG001|Overall Study|Non-compliance with study procedures|0|||
27763844|NCT01607905|54216352|FG002|Overall Study|Non-compliance with study procedures|0|||
27763845|NCT01607905|54216353|FG003|Overall Study|Non-compliance with study procedures|0|||
27763846|NCT01607905|54216354|FG004|Overall Study|Non-compliance with study procedures|0|||
27763847|NCT01607905|54216355|FG005|Overall Study|Non-compliance with study procedures|0|||
27763848|NCT01607905|54216356|FG006|Overall Study|Non-compliance with study procedures|1|||
27763849|NCT01607905|54216350|FG000|Overall Study|Death|1|||
27763850|NCT01607905|54216351|FG001|Overall Study|Death|1|||
27763851|NCT01607905|54216352|FG002|Overall Study|Death|1|||
27763852|NCT01607905|54216353|FG003|Overall Study|Death|1|||
27763853|NCT01607905|54216354|FG004|Overall Study|Death|0|||
27763854|NCT01607905|54216355|FG005|Overall Study|Death|0|||
27763855|NCT01607905|54216356|FG006|Overall Study|Death|3|||
27763856|NCT01607905|54216350|FG000|Overall Study|Other treatments become available|1|||
27763857|NCT01607905|54216351|FG001|Overall Study|Other treatments become available|0|||
27763858|NCT01607905|54216352|FG002|Overall Study|Other treatments become available|0|||
27763859|NCT01607905|54216353|FG003|Overall Study|Other treatments become available|0|||
27763860|NCT01607905|54216354|FG004|Overall Study|Other treatments become available|0|||
27763861|NCT01607905|54216355|FG005|Overall Study|Other treatments become available|0|||
27763862|NCT01607905|54216356|FG006|Overall Study|Other treatments become available|1|||
27763863|NCT01607905|54216350|FG000|Overall Study|Investigator discretion|0|||
27763864|NCT01607905|54216351|FG001|Overall Study|Investigator discretion|0|||
27763865|NCT01607905|54216352|FG002|Overall Study|Investigator discretion|0|||
27763866|NCT01607905|54216353|FG003|Overall Study|Investigator discretion|0|||
27763867|NCT01607905|54216354|FG004|Overall Study|Investigator discretion|0|||
27763868|NCT01607905|54216355|FG005|Overall Study|Investigator discretion|1|||
27763869|NCT01607905|54216356|FG006|Overall Study|Investigator discretion|0|||
27763870|NCT01607905|54216350|FG000|Overall Study|Other|1|||
27763871|NCT01607905|54216351|FG001|Overall Study|Other|0|||
27763872|NCT01607905|54216352|FG002|Overall Study|Other|0|||
27763873|NCT01607905|54216353|FG003|Overall Study|Other|0|||
27763874|NCT01607905|54216354|FG004|Overall Study|Other|0|||
27763875|NCT01607905|54216355|FG005|Overall Study|Other|0|||
27763876|NCT01607905|54216356|FG006|Overall Study|Other|1|||
27763877|NCT01607905|54216350|FG000|Overall Study|Randomized but not treated|1|||
27763878|NCT01607905|54216351|FG001|Overall Study|Randomized but not treated|0|||
27763879|NCT01607905|54216352|FG002|Overall Study|Randomized but not treated|0|||
27763880|NCT01607905|54216353|FG003|Overall Study|Randomized but not treated|0|||
27763881|NCT01607905|54216354|FG004|Overall Study|Randomized but not treated|1|||
27763882|NCT01607905|54216355|FG005|Overall Study|Randomized but not treated|1|||
27763883|NCT01607905|54216356|FG006|Overall Study|Randomized but not treated|0|||
27763884|NCT02536963|54216414|FG000|Overall Study|Withdrawal by Subject|18|||
27763885|NCT00602641|54216420|FG000|Overall Study|Never started protocol therapy|6|||
27763886|NCT00602641|54216421|FG001|Overall Study|Never started protocol therapy|2|||
27763887|NCT00602641|54216420|FG000|Overall Study|Still on treatment at time of analysis|8|||
27763888|NCT00602641|54216421|FG001|Overall Study|Still on treatment at time of analysis|15|||
27763889|NCT00602641|54216420|FG000|Overall Study|Adverse Event|62|||
27763890|NCT00602641|54216421|FG001|Overall Study|Adverse Event|53|||
27763891|NCT00602641|54216420|FG000|Overall Study|Disease progression|38|||
27763892|NCT00602641|54216421|FG001|Overall Study|Disease progression|55|||
27763893|NCT00602641|54216420|FG000|Overall Study|Death|6|||
27763894|NCT00602641|54216421|FG001|Overall Study|Death|5|||
27763895|NCT00602641|54216420|FG000|Overall Study|Withdrawal by Subject|15|||
27763896|NCT00602641|54216421|FG001|Overall Study|Withdrawal by Subject|12|||
27763897|NCT00602641|54216420|FG000|Overall Study|Alternative therapy|5|||
27763898|NCT00602641|54216421|FG001|Overall Study|Alternative therapy|2|||
27763899|NCT00602641|54216420|FG000|Overall Study|Other Complicating Disease|5|||
27763900|NCT00602641|54216421|FG001|Overall Study|Other Complicating Disease|2|||
27763901|NCT00602641|54216420|FG000|Overall Study|Physician Decision|5|||
27763902|NCT00602641|54216421|FG001|Overall Study|Physician Decision|4|||
27763903|NCT00602641|54216420|FG000|Overall Study|Administrative Closure|1|||
27763904|NCT00602641|54216421|FG001|Overall Study|Administrative Closure|1|||
27763905|NCT00602641|54216420|FG000|Overall Study|Other|3|||
27763906|NCT00602641|54216421|FG001|Overall Study|Other|1|||
27763907|NCT02531035|54216429|FG000|Overall Study|Death|0|||
27763908|NCT02531035|54216430|FG001|Overall Study|Death|1|||
27763909|NCT02531035|54216429|FG000|Overall Study|Protocol Violation|1|||
27763910|NCT02531035|54216430|FG001|Overall Study|Protocol Violation|1|||
27763911|NCT02531035|54216429|FG000|Overall Study|Noncompliance with study drug|8|||
27763912|NCT02531035|54216430|FG001|Overall Study|Noncompliance with study drug|3|||
27763913|NCT02531035|54216429|FG000|Overall Study|Physician Decision|1|||
27763914|NCT02531035|54216430|FG001|Overall Study|Physician Decision|0|||
27763915|NCT02531035|54216429|FG000|Overall Study|Adverse Event|16|||
27763916|NCT02531035|54216430|FG001|Overall Study|Adverse Event|45|||
27763917|NCT02531035|54216429|FG000|Overall Study|Other|3|||
27763918|NCT02531035|54216430|FG001|Overall Study|Other|2|||
27763919|NCT02531035|54216429|FG000|Overall Study|Withdrawal by Subject|42|||
28159970|NCT02737475|54830045|FG023|Overall Study|Death|0|||
27763920|NCT02531035|54216430|FG001|Overall Study|Withdrawal by Subject|32|||
27763921|NCT02531035|54216429|FG000|Overall Study|Lost to Follow-up|8|||
27763922|NCT02531035|54216430|FG001|Overall Study|Lost to Follow-up|10|||
27763923|NCT02531035|54216429|FG000|Overall Study|Randomized, not treated|2|||
27763924|NCT02531035|54216430|FG001|Overall Study|Randomized, not treated|1|||
27763925|NCT01659853|54216446|FG000|Washout , 3 to 7 Days|Adverse Event|1|||
27763926|NCT01659853|54216447|FG001|Washout , 3 to 7 Days|Adverse Event|0|||
27763927|NCT01659853|54216446|FG000|Washout , 3 to 7 Days|Protocol Violation|1|||
27763928|NCT01659853|54216447|FG001|Washout , 3 to 7 Days|Protocol Violation|0|||
27763929|NCT01660243|54216459|FG000|Overall Study|Adverse Event|1|||
27763930|NCT01660243|54216460|FG001|Overall Study|Adverse Event|0|||
27763931|NCT01660243|54216461|FG002|Overall Study|Adverse Event|1|||
27763932|NCT01660243|54216462|FG003|Overall Study|Adverse Event|0|||
27763933|NCT01660243|54216459|FG000|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|1|||
27763934|NCT01660243|54216460|FG001|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
27763935|NCT01660243|54216461|FG002|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
27763936|NCT01660243|54216462|FG003|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
27763937|NCT01660243|54216459|FG000|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
27763938|NCT01660243|54216460|FG001|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
27763939|NCT01660243|54216461|FG002|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|1|||
27763940|NCT01660243|54216462|FG003|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
27763941|NCT01660243|54216459|FG000|Overall Study|Randomization error|0|||
27763942|NCT01660243|54216460|FG001|Overall Study|Randomization error|0|||
27763943|NCT01660243|54216461|FG002|Overall Study|Randomization error|0|||
27763944|NCT01660243|54216462|FG003|Overall Study|Randomization error|1|||
27763945|NCT02531113|54216472|FG000|Induction Period: Week 0 to 12|Adverse Event|4|||
27763946|NCT02531113|54216472|FG000|Induction Period: Week 0 to 12|Lack of Efficacy|4|||
27763947|NCT02531113|54216472|FG000|Induction Period: Week 0 to 12|Withdrawal by Subject|3|||
27763948|NCT02531113|54216472|FG000|Extension Period: Week 12 up to Week 160|Physician Decision|2|||
27763949|NCT02531113|54216472|FG000|Extension Period: Week 12 up to Week 160|Adverse Event|5|||
27763950|NCT02531113|54216472|FG000|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19|||
27763951|NCT02531113|54216472|FG000|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11|||
27763952|NCT02531113|54216472|FG000|Extension Period: Week 12 up to Week 160|Pregnancy|1|||
27763953|NCT02522767|54216482|FG000|Double-blind|Withdrawal by Subject|8|||
27763954|NCT02522767|54216483|FG001|Double-blind|Withdrawal by Subject|11|||
27763955|NCT02522767|54216482|FG000|Double-blind|Lost to Follow-up|1|||
27763956|NCT02522767|54216483|FG001|Double-blind|Lost to Follow-up|0|||
27763957|NCT02522767|54216482|FG000|Double-blind|Adverse Event|1|||
27763958|NCT02522767|54216483|FG001|Double-blind|Adverse Event|10|||
27763959|NCT02522767|54216482|FG000|Double-blind|Protocol Violation|0|||
27763960|NCT02522767|54216483|FG001|Double-blind|Protocol Violation|1|||
27763961|NCT02522767|54216482|FG000|Double-blind|Lack of Efficacy|0|||
27763962|NCT02522767|54216483|FG001|Double-blind|Lack of Efficacy|2|||
27763963|NCT02522767|54216482|FG000|Double-blind|Protocol Deviation|1|||
27763964|NCT02522767|54216483|FG001|Double-blind|Protocol Deviation|0|||
27763965|NCT02522767|54216482|FG000|Open-label|Withdrawal by Subject|2|||
27763966|NCT02522767|54216483|FG001|Open-label|Withdrawal by Subject|3|||
27763967|NCT02522767|54216482|FG000|Open-label|Lost to Follow-up|0|||
27763968|NCT02522767|54216483|FG001|Open-label|Lost to Follow-up|1|||
27763969|NCT02522767|54216482|FG000|Open-label|Adverse Event|2|||
27763970|NCT02522767|54216483|FG001|Open-label|Adverse Event|1|||
27763971|NCT02522767|54216482|FG000|Open-label|Lack of Efficacy|1|||
27763972|NCT02522767|54216483|FG001|Open-label|Lack of Efficacy|1|||
27763973|NCT02522767|54216482|FG000|Open-label|Protocol Violation|0|||
27763974|NCT02522767|54216483|FG001|Open-label|Protocol Violation|1|||
27763975|NCT02522377|54216493|FG000|Overall Study|Withdrawal by Subject|1|||
27763976|NCT02522377|54216494|FG001|Overall Study|Withdrawal by Subject|0|||
27763977|NCT02522377|54216493|FG000|Overall Study|Remission Achieved|3|||
27763978|NCT02522377|54216494|FG001|Overall Study|Remission Achieved|0|||
27763979|NCT01657903|54216500|FG000|Overall Study|Lost to Follow-up|1|||
27763980|NCT01657903|54216500|FG000|Overall Study|Withdrawal by Subject|1|||
27839567|NCT01478347|54326870|FG000|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1|||
27839568|NCT01478347|54326870|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4|||
27839569|NCT01478347|54326870|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4|||
27839570|NCT01478113|54326876|FG000|Overall Study|Withdrawal by Subject|0|||
27839571|NCT01478113|54326877|FG001|Overall Study|Withdrawal by Subject|1|||
27839572|NCT01478113|54326876|FG000|Overall Study|Physician Decision|1|||
27763981|NCT01656733|54216513|FG000|Overall Study|No permission to collect birth outcomes|0|||
27763982|NCT01656733|54216514|FG001|Overall Study|No permission to collect birth outcomes|1|||
27763983|NCT01656733|54216513|FG000|Overall Study|Delivery at another hospital|0|||
27763984|NCT01656733|54216514|FG001|Overall Study|Delivery at another hospital|2|||
27763985|NCT01656733|54216513|FG000|Overall Study|Spontaneous abortion|0|||
27763986|NCT01656733|54216514|FG001|Overall Study|Spontaneous abortion|1|||
27763987|NCT01656967|54216522|FG000|Overall Study|faulty monitor|1|||
27763988|NCT01656967|54216523|FG001|Overall Study|faulty monitor|0|||
27763989|NCT01656967|54216522|FG000|Overall Study|unsuccessful ETT insertion|3|||
27763990|NCT01656967|54216523|FG001|Overall Study|unsuccessful ETT insertion|2|||
27763991|NCT01656889|54216535|FG000|Treatment Period, 12 Weeks|Adverse Event|10|||
27763992|NCT01656889|54216536|FG001|Treatment Period, 12 Weeks|Adverse Event|4|||
27763993|NCT01656889|54216535|FG000|Treatment Period, 12 Weeks|Death|0|||
27763994|NCT01656889|54216536|FG001|Treatment Period, 12 Weeks|Death|1|||
27763995|NCT01656889|54216535|FG000|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
27763996|NCT01656889|54216536|FG001|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
27763997|NCT01656889|54216535|FG000|Treatment Period, 12 Weeks|Withdrawal by Subject|1|||
27763998|NCT01656889|54216536|FG001|Treatment Period, 12 Weeks|Withdrawal by Subject|2|||
27763999|NCT01656889|54216535|FG000|Treatment Period, 12 Weeks|Protocol Violation|0|||
27764000|NCT01656889|54216536|FG001|Treatment Period, 12 Weeks|Protocol Violation|1|||
27764001|NCT01656889|54216535|FG000|Treatment Period, 12 Weeks|Moved out of the area|0|||
27764002|NCT01656889|54216536|FG001|Treatment Period, 12 Weeks|Moved out of the area|2|||
27764003|NCT01656889|54216535|FG000|Post Treatment Follow-Up, 3 Months|Death|1|||
27764004|NCT01656889|54216536|FG001|Post Treatment Follow-Up, 3 Months|Death|5|||
27764005|NCT01656889|54216535|FG000|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1|||
27764006|NCT01656889|54216536|FG001|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2|||
27764007|NCT01656889|54216535|FG000|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2|||
27764008|NCT01656889|54216536|FG001|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1|||
27764009|NCT01656889|54216535|FG000|Post Treatment Follow-Up, 3 Months|Site Closure|0|||
27764010|NCT01656889|54216536|FG001|Post Treatment Follow-Up, 3 Months|Site Closure|1|||
27764011|NCT02522299|54216544|FG000|Overall Study|Adverse Event|2|||
27764012|NCT02522299|54216545|FG001|Overall Study|Adverse Event|0|||
27764013|NCT02522299|54216544|FG000|Overall Study|Physician Decision|0|||
27764014|NCT02522299|54216545|FG001|Overall Study|Physician Decision|1|||
27764015|NCT02522299|54216544|FG000|Overall Study|Withdrawal by Subject|2|||
27764016|NCT02522299|54216545|FG001|Overall Study|Withdrawal by Subject|0|||
27764017|NCT01365091|54216569|FG000|Period 1|Adverse Event|1|||
27764018|NCT01365091|54216570|FG001|Period 1|Adverse Event|0|||
27764019|NCT01365091|54216571|FG002|Period 1|Adverse Event|2|||
27764020|NCT01365091|54216572|FG003|Period 1|Adverse Event|3|||
27764021|NCT01365091|54216569|FG000|Period 1|Positive test result for drugs of abuse|1|||
27764022|NCT01365091|54216570|FG001|Period 1|Positive test result for drugs of abuse|0|||
27764023|NCT01365091|54216571|FG002|Period 1|Positive test result for drugs of abuse|0|||
27764024|NCT01365091|54216572|FG003|Period 1|Positive test result for drugs of abuse|0|||
27764025|NCT01365091|54216569|FG000|Period 1|No longer met study criteria|0|||
27764026|NCT01365091|54216570|FG001|Period 1|No longer met study criteria|1|||
27764027|NCT01365091|54216571|FG002|Period 1|No longer met study criteria|0|||
27764028|NCT01365091|54216572|FG003|Period 1|No longer met study criteria|0|||
27764029|NCT01365091|54216569|FG000|Period 1|Withdrawal by Subject|0|||
27764030|NCT01365091|54216570|FG001|Period 1|Withdrawal by Subject|1|||
27764031|NCT01365091|54216571|FG002|Period 1|Withdrawal by Subject|0|||
27764032|NCT01365091|54216572|FG003|Period 1|Withdrawal by Subject|0|||
27764033|NCT01365091|54216569|FG000|Period 1|Personal reasons|0|||
27764034|NCT01365091|54216570|FG001|Period 1|Personal reasons|0|||
27764035|NCT01365091|54216571|FG002|Period 1|Personal reasons|1|||
27764036|NCT01365091|54216572|FG003|Period 1|Personal reasons|0|||
27764037|NCT01365091|54216569|FG000|Period 2|Withdrawal by Subject|1|||
27764038|NCT01365091|54216570|FG001|Period 2|Withdrawal by Subject|0|||
27764039|NCT01365091|54216571|FG002|Period 2|Withdrawal by Subject|0|||
27764040|NCT01365091|54216572|FG003|Period 2|Withdrawal by Subject|0|||
27764041|NCT01365091|54216569|FG000|Period 2|Adverse Event|0|||
27839573|NCT01478113|54326877|FG001|Overall Study|Physician Decision|0|||
27839574|NCT01506271|54326888|FG000|Overall Study|Progressive disease|0|||
27839575|NCT01506271|54326889|FG001|Overall Study|Progressive disease|1|||
27764042|NCT01365091|54216570|FG001|Period 2|Adverse Event|0|||
27764043|NCT01365091|54216571|FG002|Period 2|Adverse Event|1|||
27764044|NCT01365091|54216572|FG003|Period 2|Adverse Event|0|||
27764045|NCT01364467|54216598|FG000|Overall Study|Lost to Follow-up|1|||
27764046|NCT01364467|54216599|FG001|Overall Study|Lost to Follow-up|2|||
27764047|NCT02520661|54216607|FG000|Overall Study|Lost to Follow-up|7|||
27764048|NCT02520661|54216608|FG001|Overall Study|Lost to Follow-up|3|||
27764049|NCT02520661|54216607|FG000|Overall Study|Admitted from ED|49|||
27764050|NCT02520661|54216608|FG001|Overall Study|Admitted from ED|48|||
27764051|NCT02520661|54216607|FG000|Overall Study|ED greater than 24 hours|29|||
27764052|NCT02520661|54216608|FG001|Overall Study|ED greater than 24 hours|38|||
27764053|NCT02520661|54216607|FG000|Overall Study|other ineligibility|14|||
27764054|NCT02520661|54216608|FG001|Overall Study|other ineligibility|22|||
27764055|NCT02520661|54216607|FG000|Overall Study|Withdrawal by Subject|7|||
27764056|NCT02520661|54216608|FG001|Overall Study|Withdrawal by Subject|16|||
27764057|NCT01364389|54216621|FG000|Overall Study|Withdrawal by Subject|0|||
27764058|NCT01364389|54216622|FG001|Overall Study|Withdrawal by Subject|1|||
27764059|NCT01364389|54216623|FG002|Overall Study|Withdrawal by Subject|0|||
27764060|NCT01364389|54216621|FG000|Overall Study|Protocol deviation|0|||
27764061|NCT01364389|54216622|FG001|Overall Study|Protocol deviation|0|||
27764062|NCT01364389|54216623|FG002|Overall Study|Protocol deviation|1|||
27764063|NCT01364389|54216621|FG000|Overall Study|Administrative problems|1|||
27764064|NCT01364389|54216622|FG001|Overall Study|Administrative problems|0|||
27764065|NCT01364389|54216623|FG002|Overall Study|Administrative problems|0|||
27764066|NCT01364389|54216621|FG000|Overall Study|Adverse Event|1|||
27764067|NCT01364389|54216622|FG001|Overall Study|Adverse Event|0|||
27764068|NCT01364389|54216623|FG002|Overall Study|Adverse Event|0|||
27764069|NCT01364233|54216631|FG000|Overall Study|Lost to Follow-up|1|||
27764070|NCT02291289|54216639|FG000|Induction Treatment|Not Dosed|2|||
27764071|NCT02291289|54216640|FG001|Induction Treatment|Not Dosed|0|||
27764072|NCT02291289|54216641|FG002|Induction Treatment|Not Dosed|0|||
27764073|NCT02291289|54216642|FG003|Induction Treatment|Not Dosed|9|||
27764074|NCT02291289|54216643|FG004|Induction Treatment|Not Dosed|0|||
27764075|NCT02291289|54216644|FG005|Induction Treatment|Not Dosed|0|||
27764076|NCT02291289|54216645|FG006|Induction Treatment|Not Dosed|0|||
27764077|NCT02291289|54216646|FG007|Induction Treatment|Not Dosed|0|||
27764078|NCT02291289|54216647|FG008|Induction Treatment|Not Dosed|0|||
27764079|NCT02291289|54216648|FG009|Induction Treatment|Not Dosed|1|||
27764080|NCT02291289|54216649|FG010|Induction Treatment|Not Dosed|0|||
27764081|NCT02291289|54216650|FG011|Induction Treatment|Not Dosed|0|||
27764082|NCT02291289|54216639|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
27764083|NCT02291289|54216640|FG001|Maintenance Treatment Phase|Withdrawal by Subject|0|||
27764084|NCT02291289|54216641|FG002|Maintenance Treatment Phase|Withdrawal by Subject|0|||
27764085|NCT02291289|54216642|FG003|Maintenance Treatment Phase|Withdrawal by Subject|0|||
27764086|NCT02291289|54216643|FG004|Maintenance Treatment Phase|Withdrawal by Subject|13|||
27764087|NCT02291289|54216644|FG005|Maintenance Treatment Phase|Withdrawal by Subject|11|||
27764088|NCT02291289|54216645|FG006|Maintenance Treatment Phase|Withdrawal by Subject|0|||
27764089|NCT02291289|54216646|FG007|Maintenance Treatment Phase|Withdrawal by Subject|0|||
27764090|NCT02291289|54216647|FG008|Maintenance Treatment Phase|Withdrawal by Subject|0|||
27764091|NCT02291289|54216648|FG009|Maintenance Treatment Phase|Withdrawal by Subject|0|||
27764092|NCT02291289|54216649|FG010|Maintenance Treatment Phase|Withdrawal by Subject|2|||
27764093|NCT02291289|54216650|FG011|Maintenance Treatment Phase|Withdrawal by Subject|3|||
27764094|NCT02291289|54216639|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
27764095|NCT02291289|54216640|FG001|Maintenance Treatment Phase|Protocol Violation|1|||
27764096|NCT02291289|54216641|FG002|Maintenance Treatment Phase|Protocol Violation|0|||
27764097|NCT02291289|54216642|FG003|Maintenance Treatment Phase|Protocol Violation|0|||
27764098|NCT02291289|54216643|FG004|Maintenance Treatment Phase|Protocol Violation|2|||
27764099|NCT02291289|54216644|FG005|Maintenance Treatment Phase|Protocol Violation|1|||
27764100|NCT02291289|54216645|FG006|Maintenance Treatment Phase|Protocol Violation|0|||
27764101|NCT02291289|54216646|FG007|Maintenance Treatment Phase|Protocol Violation|0|||
27764102|NCT02291289|54216647|FG008|Maintenance Treatment Phase|Protocol Violation|0|||
27764103|NCT02291289|54216648|FG009|Maintenance Treatment Phase|Protocol Violation|0|||
27764104|NCT02291289|54216649|FG010|Maintenance Treatment Phase|Protocol Violation|0|||
27764105|NCT02291289|54216650|FG011|Maintenance Treatment Phase|Protocol Violation|0|||
27764106|NCT02291289|54216639|FG000|Maintenance Treatment Phase|Death|0|||
27764107|NCT02291289|54216640|FG001|Maintenance Treatment Phase|Death|23|||
27764108|NCT02291289|54216641|FG002|Maintenance Treatment Phase|Death|13|||
27764109|NCT02291289|54216642|FG003|Maintenance Treatment Phase|Death|0|||
27764110|NCT02291289|54216643|FG004|Maintenance Treatment Phase|Death|185|||
27764111|NCT02291289|54216644|FG005|Maintenance Treatment Phase|Death|100|||
27764112|NCT02291289|54216645|FG006|Maintenance Treatment Phase|Death|0|||
27764113|NCT02291289|54216646|FG007|Maintenance Treatment Phase|Death|1|||
27764114|NCT02291289|54216647|FG008|Maintenance Treatment Phase|Death|1|||
27764115|NCT02291289|54216648|FG009|Maintenance Treatment Phase|Death|0|||
27764116|NCT02291289|54216649|FG010|Maintenance Treatment Phase|Death|26|||
27764117|NCT02291289|54216650|FG011|Maintenance Treatment Phase|Death|11|||
27764118|NCT02291289|54216639|FG000|Maintenance Treatment Phase|Adverse Event|0|||
27764119|NCT02291289|54216640|FG001|Maintenance Treatment Phase|Adverse Event|0|||
27764120|NCT02291289|54216641|FG002|Maintenance Treatment Phase|Adverse Event|0|||
27764121|NCT02291289|54216642|FG003|Maintenance Treatment Phase|Adverse Event|0|||
27764122|NCT02291289|54216643|FG004|Maintenance Treatment Phase|Adverse Event|1|||
27764123|NCT02291289|54216644|FG005|Maintenance Treatment Phase|Adverse Event|0|||
27764124|NCT02291289|54216645|FG006|Maintenance Treatment Phase|Adverse Event|0|||
27764125|NCT02291289|54216646|FG007|Maintenance Treatment Phase|Adverse Event|0|||
27839576|NCT01506271|54326890|FG002|Overall Study|Progressive disease|0|||
27839577|NCT01506271|54326888|FG000|Overall Study|Protocol Violation|3|||
27764126|NCT02291289|54216647|FG008|Maintenance Treatment Phase|Adverse Event|0|||
27764127|NCT02291289|54216648|FG009|Maintenance Treatment Phase|Adverse Event|0|||
27764128|NCT02291289|54216649|FG010|Maintenance Treatment Phase|Adverse Event|0|||
27764129|NCT02291289|54216650|FG011|Maintenance Treatment Phase|Adverse Event|0|||
27764130|NCT02291289|54216639|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
27764131|NCT02291289|54216640|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
27839578|NCT01506271|54326889|FG001|Overall Study|Protocol Violation|1|||
27839579|NCT01506271|54326890|FG002|Overall Study|Protocol Violation|0|||
27839580|NCT01506271|54326888|FG000|Overall Study|Death|0|||
27839581|NCT01506271|54326889|FG001|Overall Study|Death|1|||
27839582|NCT01506271|54326890|FG002|Overall Study|Death|0|||
27839583|NCT01506271|54326888|FG000|Overall Study|Adverse Event|0|||
27839584|NCT01506271|54326889|FG001|Overall Study|Adverse Event|2|||
27839585|NCT01506271|54326890|FG002|Overall Study|Adverse Event|0|||
27839586|NCT01506271|54326888|FG000|Overall Study|Insufficient supply of study drug|1|||
27839587|NCT01506271|54326889|FG001|Overall Study|Insufficient supply of study drug|0|||
27839588|NCT01506271|54326890|FG002|Overall Study|Insufficient supply of study drug|0|||
27764132|NCT02291289|54216641|FG002|Maintenance Treatment Phase|Lost to Follow-up|0|||
27764133|NCT02291289|54216642|FG003|Maintenance Treatment Phase|Lost to Follow-up|0|||
27764134|NCT02291289|54216643|FG004|Maintenance Treatment Phase|Lost to Follow-up|12|||
27764135|NCT02291289|54216644|FG005|Maintenance Treatment Phase|Lost to Follow-up|3|||
27764136|NCT02291289|54216645|FG006|Maintenance Treatment Phase|Lost to Follow-up|0|||
27764137|NCT02291289|54216646|FG007|Maintenance Treatment Phase|Lost to Follow-up|1|||
27764138|NCT02291289|54216647|FG008|Maintenance Treatment Phase|Lost to Follow-up|0|||
27764139|NCT02291289|54216648|FG009|Maintenance Treatment Phase|Lost to Follow-up|0|||
27764140|NCT02291289|54216649|FG010|Maintenance Treatment Phase|Lost to Follow-up|2|||
27764141|NCT02291289|54216650|FG011|Maintenance Treatment Phase|Lost to Follow-up|1|||
27764142|NCT02291289|54216639|FG000|Maintenance Treatment Phase|Other|0|||
27764143|NCT02291289|54216640|FG001|Maintenance Treatment Phase|Other|0|||
27764144|NCT02291289|54216641|FG002|Maintenance Treatment Phase|Other|1|||
27764145|NCT02291289|54216642|FG003|Maintenance Treatment Phase|Other|0|||
27764146|NCT02291289|54216643|FG004|Maintenance Treatment Phase|Other|29|||
27764147|NCT02291289|54216644|FG005|Maintenance Treatment Phase|Other|8|||
27764148|NCT02291289|54216645|FG006|Maintenance Treatment Phase|Other|0|||
27764149|NCT02291289|54216646|FG007|Maintenance Treatment Phase|Other|0|||
27764150|NCT02291289|54216647|FG008|Maintenance Treatment Phase|Other|1|||
27764151|NCT02291289|54216648|FG009|Maintenance Treatment Phase|Other|0|||
27764152|NCT02291289|54216649|FG010|Maintenance Treatment Phase|Other|0|||
27764153|NCT02291289|54216650|FG011|Maintenance Treatment Phase|Other|0|||
27764154|NCT02291289|54216639|FG000|Maintenance Treatment Phase|Physician Decision|0|||
27764155|NCT02291289|54216640|FG001|Maintenance Treatment Phase|Physician Decision|0|||
27764156|NCT02291289|54216641|FG002|Maintenance Treatment Phase|Physician Decision|0|||
27764157|NCT02291289|54216642|FG003|Maintenance Treatment Phase|Physician Decision|0|||
27764158|NCT02291289|54216643|FG004|Maintenance Treatment Phase|Physician Decision|2|||
27764159|NCT02291289|54216644|FG005|Maintenance Treatment Phase|Physician Decision|0|||
27764160|NCT02291289|54216645|FG006|Maintenance Treatment Phase|Physician Decision|0|||
27764161|NCT02291289|54216646|FG007|Maintenance Treatment Phase|Physician Decision|0|||
27764162|NCT02291289|54216647|FG008|Maintenance Treatment Phase|Physician Decision|0|||
27764163|NCT02291289|54216648|FG009|Maintenance Treatment Phase|Physician Decision|0|||
27764164|NCT02291289|54216649|FG010|Maintenance Treatment Phase|Physician Decision|0|||
27764165|NCT02291289|54216650|FG011|Maintenance Treatment Phase|Physician Decision|1|||
27764166|NCT02291289|54216639|FG000|Maintenance Treatment Phase|Multiple Reasons|0|||
27764167|NCT02291289|54216640|FG001|Maintenance Treatment Phase|Multiple Reasons|0|||
27764168|NCT02291289|54216641|FG002|Maintenance Treatment Phase|Multiple Reasons|0|||
27764169|NCT02291289|54216642|FG003|Maintenance Treatment Phase|Multiple Reasons|0|||
27764170|NCT02291289|54216643|FG004|Maintenance Treatment Phase|Multiple Reasons|4|||
27764171|NCT02291289|54216644|FG005|Maintenance Treatment Phase|Multiple Reasons|1|||
27764172|NCT02291289|54216645|FG006|Maintenance Treatment Phase|Multiple Reasons|0|||
27764173|NCT02291289|54216646|FG007|Maintenance Treatment Phase|Multiple Reasons|0|||
27764174|NCT02291289|54216647|FG008|Maintenance Treatment Phase|Multiple Reasons|0|||
27764175|NCT02291289|54216648|FG009|Maintenance Treatment Phase|Multiple Reasons|0|||
27764176|NCT02291289|54216649|FG010|Maintenance Treatment Phase|Multiple Reasons|0|||
27764177|NCT02291289|54216650|FG011|Maintenance Treatment Phase|Multiple Reasons|0|||
27764178|NCT02291289|54216639|FG000|Maintenance Treatment Phase|No Treatment Received|0|||
27764179|NCT02291289|54216640|FG001|Maintenance Treatment Phase|No Treatment Received|0|||
27764180|NCT02291289|54216641|FG002|Maintenance Treatment Phase|No Treatment Received|2|||
27764181|NCT02291289|54216642|FG003|Maintenance Treatment Phase|No Treatment Received|0|||
27764182|NCT02291289|54216643|FG004|Maintenance Treatment Phase|No Treatment Received|4|||
27764183|NCT02291289|54216644|FG005|Maintenance Treatment Phase|No Treatment Received|5|||
27764184|NCT02291289|54216645|FG006|Maintenance Treatment Phase|No Treatment Received|0|||
27764185|NCT02291289|54216646|FG007|Maintenance Treatment Phase|No Treatment Received|0|||
27764186|NCT02291289|54216647|FG008|Maintenance Treatment Phase|No Treatment Received|0|||
27764187|NCT02291289|54216648|FG009|Maintenance Treatment Phase|No Treatment Received|0|||
27764188|NCT02291289|54216649|FG010|Maintenance Treatment Phase|No Treatment Received|1|||
27764189|NCT02291289|54216650|FG011|Maintenance Treatment Phase|No Treatment Received|0|||
27764190|NCT02317575|54216675|FG000|Period 1|Difficulty with venous cannulation|0|||
27764191|NCT02317575|54216676|FG001|Period 1|Difficulty with venous cannulation|1|||
27764192|NCT02317575|54216677|FG002|Period 1|Difficulty with venous cannulation|0|||
27764193|NCT02317575|54216678|FG003|Period 1|Difficulty with venous cannulation|0|||
27764194|NCT02317575|54216679|FG004|Period 1|Difficulty with venous cannulation|0|||
27764195|NCT02317575|54216675|FG000|Period 1|Withdrawal by Subject|1|||
27764196|NCT02317575|54216676|FG001|Period 1|Withdrawal by Subject|0|||
27764197|NCT02317575|54216677|FG002|Period 1|Withdrawal by Subject|0|||
27764198|NCT02317575|54216678|FG003|Period 1|Withdrawal by Subject|0|||
27764199|NCT02317575|54216679|FG004|Period 1|Withdrawal by Subject|0|||
27764200|NCT02316717|54216700|FG000|Overall Study|Adverse Event|2|||
27764201|NCT02316717|54216701|FG001|Overall Study|Adverse Event|2|||
27764202|NCT02316717|54216702|FG002|Overall Study|Adverse Event|0|||
27764203|NCT02316717|54216700|FG000|Overall Study|Lost to Follow-up|1|||
27764204|NCT02316717|54216701|FG001|Overall Study|Lost to Follow-up|2|||
27764205|NCT02316717|54216702|FG002|Overall Study|Lost to Follow-up|1|||
27764206|NCT02316717|54216700|FG000|Overall Study|Non compliance|3|||
27764207|NCT02316717|54216701|FG001|Overall Study|Non compliance|1|||
27764208|NCT02316717|54216702|FG002|Overall Study|Non compliance|0|||
27764209|NCT02316717|54216700|FG000|Overall Study|Protocol Violation|2|||
27764210|NCT02316717|54216701|FG001|Overall Study|Protocol Violation|0|||
27764211|NCT02316717|54216702|FG002|Overall Study|Protocol Violation|0|||
27764212|NCT02316717|54216700|FG000|Overall Study|Withdrawal by Subject|2|||
27764213|NCT02316717|54216701|FG001|Overall Study|Withdrawal by Subject|1|||
27764214|NCT02316717|54216702|FG002|Overall Study|Withdrawal by Subject|1|||
27764215|NCT02316717|54216700|FG000|Overall Study|Death|0|||
27764216|NCT02316717|54216701|FG001|Overall Study|Death|0|||
27764217|NCT02316717|54216702|FG002|Overall Study|Death|1|||
27764218|NCT02316717|54216700|FG000|Overall Study|Physician Decision|0|||
27764219|NCT02316717|54216701|FG001|Overall Study|Physician Decision|1|||
27764220|NCT02316717|54216702|FG002|Overall Study|Physician Decision|0|||
27764221|NCT02316717|54216700|FG000|Overall Study|TBC|1|||
27764222|NCT02316717|54216701|FG001|Overall Study|TBC|0|||
27764223|NCT02316717|54216702|FG002|Overall Study|TBC|0|||
27764224|NCT02290821|54216715|FG000|Overall Study|Withdrawal by Subject|1|||
27764225|NCT02290821|54216716|FG001|Overall Study|Withdrawal by Subject|1|||
27764226|NCT02290821|54216715|FG000|Overall Study|Unable or unwilling to cooperate with|2|||
27764227|NCT02290821|54216716|FG001|Overall Study|Unable or unwilling to cooperate with|0|||
27764228|NCT02290821|54216715|FG000|Overall Study|Lost to Follow-up|3|||
27764229|NCT02290821|54216716|FG001|Overall Study|Lost to Follow-up|2|||
27764230|NCT02289963|54216724|FG000|Overall Study|Adverse Event|1|||
27764231|NCT02289963|54216725|FG001|Overall Study|Adverse Event|2|||
27764232|NCT02289963|54216724|FG000|Overall Study|Poor compliance to protocol|1|||
27764233|NCT02289963|54216725|FG001|Overall Study|Poor compliance to protocol|0|||
27764234|NCT02289963|54216724|FG000|Overall Study|Withdrawal by Subject|1|||
27764235|NCT02289963|54216725|FG001|Overall Study|Withdrawal by Subject|0|||
27764236|NCT02289963|54216724|FG000|Overall Study|Last injection missed|2|||
27764237|NCT02289963|54216725|FG001|Overall Study|Last injection missed|2|||
27764238|NCT02289963|54216724|FG000|Overall Study|End treatment visit outside visit window|0|||
27764239|NCT02289963|54216725|FG001|Overall Study|End treatment visit outside visit window|4|||
27764240|NCT02289963|54216724|FG000|Overall Study|Other than specified above|0|||
27764241|NCT02289963|54216725|FG001|Overall Study|Other than specified above|2|||
27764242|NCT02358369|54216734|FG000|Pre-Randomization Washout Period|Not Qualified for Randomization|35|||
27764243|NCT02358369|54216735|FG001|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
27764244|NCT02358369|54216736|FG002|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
27764245|NCT02358369|54216737|FG003|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
27764246|NCT02358369|54216738|FG004|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
27764247|NCT02358369|54216734|FG000|Treatment Period A/B|Adverse Event|0|||
27764248|NCT02358369|54216735|FG001|Treatment Period A/B|Adverse Event|0|||
27764249|NCT02358369|54216736|FG002|Treatment Period A/B|Adverse Event|1|||
27764250|NCT02358369|54216737|FG003|Treatment Period A/B|Adverse Event|2|||
27764251|NCT02358369|54216738|FG004|Treatment Period A/B|Adverse Event|0|||
27764252|NCT02358369|54216734|FG000|Treatment Period A/B|Death|0|||
27764253|NCT02358369|54216735|FG001|Treatment Period A/B|Death|0|||
27764254|NCT02358369|54216736|FG002|Treatment Period A/B|Death|1|||
27764255|NCT02358369|54216737|FG003|Treatment Period A/B|Death|0|||
27764256|NCT02358369|54216738|FG004|Treatment Period A/B|Death|0|||
27764257|NCT02358369|54216734|FG000|Treatment Period A/B|Withdrawal by Subject|0|||
27839589|NCT01506271|54326888|FG000|Overall Study|Withdrawal by Subject|0|||
27839590|NCT01506271|54326889|FG001|Overall Study|Withdrawal by Subject|1|||
27764258|NCT02358369|54216735|FG001|Treatment Period A/B|Withdrawal by Subject|2|||
27764259|NCT02358369|54216736|FG002|Treatment Period A/B|Withdrawal by Subject|0|||
27764260|NCT02358369|54216737|FG003|Treatment Period A/B|Withdrawal by Subject|2|||
27764261|NCT02358369|54216738|FG004|Treatment Period A/B|Withdrawal by Subject|0|||
27764262|NCT02358369|54216734|FG000|Treatment Period C|Adverse Event|0|||
27764263|NCT02358369|54216735|FG001|Treatment Period C|Adverse Event|0|||
27764264|NCT02358369|54216736|FG002|Treatment Period C|Adverse Event|0|||
27764265|NCT02358369|54216737|FG003|Treatment Period C|Adverse Event|0|||
27764266|NCT02358369|54216738|FG004|Treatment Period C|Adverse Event|7|||
27764267|NCT02316171|54216750|FG000|Overall Study|difficulties with urinary catheter|1|||
27764268|NCT02316171|54216751|FG001|Overall Study|difficulties with urinary catheter|0|||
27839591|NCT01506271|54326890|FG002|Overall Study|Withdrawal by Subject|1|||
27764269|NCT02316171|54216752|FG002|Overall Study|difficulties with urinary catheter|0|||
27764270|NCT02316171|54216753|FG003|Overall Study|difficulties with urinary catheter|0|||
27764271|NCT02289729|54216759|FG000|Overall Study|Lack of Efficacy|3|||
27764272|NCT02289729|54216759|FG000|Overall Study|Very Narrow Therapeutic Margin|1|||
27764273|NCT02289729|54216759|FG000|Overall Study|Withdrawal by Subject|1|||
27764274|NCT02289729|54216759|FG000|Overall Study|Death|1|||
27764275|NCT02315625|54216765|FG000|First Intervention|Disease Progression|1|||
27764276|NCT02315625|54216766|FG001|First Intervention|Disease Progression|0|||
27764277|NCT02315625|54216765|FG000|Second Intervention|Physician Decision|2|||
27764278|NCT02315625|54216766|FG001|Second Intervention|Physician Decision|1|||
27764279|NCT02315625|54216765|FG000|Second Intervention|Study closure|1|||
27764280|NCT02315625|54216766|FG001|Second Intervention|Study closure|0|||
27764281|NCT02315625|54216765|FG000|Second Intervention|Disease Progression|1|||
27764282|NCT02315625|54216766|FG001|Second Intervention|Disease Progression|0|||
27764283|NCT02357979|54216776|FG000|Overall Study|Lost to Follow-up|5|||
27764284|NCT02357979|54216777|FG001|Overall Study|Lost to Follow-up|5|||
27764285|NCT02357901|54216786|FG000|Run-In Period (Days -14 to Day -1)|Run-In failures|161|||
27764286|NCT02357901|54216787|FG001|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
27764287|NCT02357901|54216788|FG002|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
27764288|NCT02357901|54216789|FG003|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
27764289|NCT02357901|54216786|FG000|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0|||
27764290|NCT02357901|54216787|FG001|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26|||
27764291|NCT02357901|54216788|FG002|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23|||
27764292|NCT02357901|54216789|FG003|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12|||
27764293|NCT02357901|54216786|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
27764294|NCT02357901|54216787|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20|||
27764295|NCT02357901|54216788|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21|||
27764296|NCT02357901|54216789|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18|||
27764297|NCT02357901|54216786|FG000|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0|||
27764298|NCT02357901|54216787|FG001|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3|||
27764299|NCT02357901|54216788|FG002|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5|||
27764300|NCT02357901|54216789|FG003|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18|||
27764301|NCT02357901|54216786|FG000|Treatment Period (Day 1 to Week 24)|Adverse Event|0|||
27764302|NCT02357901|54216787|FG001|Treatment Period (Day 1 to Week 24)|Adverse Event|6|||
27764303|NCT02357901|54216788|FG002|Treatment Period (Day 1 to Week 24)|Adverse Event|10|||
27764304|NCT02357901|54216789|FG003|Treatment Period (Day 1 to Week 24)|Adverse Event|2|||
27764305|NCT02357901|54216786|FG000|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
27764306|NCT02357901|54216787|FG001|Treatment Period (Day 1 to Week 24)|Protocol Violation|2|||
27764307|NCT02357901|54216788|FG002|Treatment Period (Day 1 to Week 24)|Protocol Violation|5|||
27764308|NCT02357901|54216789|FG003|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
27764309|NCT02357901|54216786|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0|||
27764310|NCT02357901|54216787|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
27764311|NCT02357901|54216788|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
27764312|NCT02357901|54216789|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3|||
27764313|NCT02357901|54216786|FG000|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
27764314|NCT02357901|54216787|FG001|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
27764315|NCT02357901|54216788|FG002|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
27764316|NCT02357901|54216789|FG003|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
27764317|NCT02357901|54216786|FG000|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
27764318|NCT02357901|54216787|FG001|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1|||
27764319|NCT02357901|54216788|FG002|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
27764320|NCT02357901|54216789|FG003|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3|||
27764321|NCT02357901|54216786|FG000|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
27764322|NCT02357901|54216787|FG001|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
27764323|NCT02357901|54216788|FG002|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
27764324|NCT02357901|54216789|FG003|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
27764325|NCT02357901|54216786|FG000|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0|||
27764326|NCT02357901|54216787|FG001|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17|||
27764327|NCT02357901|54216788|FG002|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6|||
27764328|NCT02357901|54216789|FG003|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7|||
27764329|NCT01601847|54216799|FG000|Overall Study|Death|1|||
27764330|NCT01601847|54216800|FG001|Overall Study|Death|0|||
27764331|NCT01601847|54216799|FG000|Overall Study|Withdrawal by Subject|11|||
27764332|NCT01601847|54216800|FG001|Overall Study|Withdrawal by Subject|7|||
27764333|NCT01601847|54216799|FG000|Overall Study|Lost to Follow-up|1|||
27764334|NCT01601847|54216800|FG001|Overall Study|Lost to Follow-up|3|||
27764335|NCT02515669|54216810|FG000|228 Week Open-Label Phase|Other|0|||
27764336|NCT02515669|54216811|FG001|228 Week Open-Label Phase|Other|0|||
27764337|NCT02515669|54216812|FG002|228 Week Open-Label Phase|Other|1|||
27764338|NCT02515669|54216813|FG003|228 Week Open-Label Phase|Other|4|||
27764339|NCT02515669|54216810|FG000|228 Week Open-Label Phase|Lack of Efficacy|0|||
27764340|NCT02515669|54216811|FG001|228 Week Open-Label Phase|Lack of Efficacy|0|||
27764341|NCT02515669|54216812|FG002|228 Week Open-Label Phase|Lack of Efficacy|1|||
27764342|NCT02515669|54216813|FG003|228 Week Open-Label Phase|Lack of Efficacy|0|||
27764343|NCT02515669|54216810|FG000|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
27764344|NCT02515669|54216811|FG001|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
27764345|NCT02515669|54216812|FG002|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2|||
27764346|NCT02515669|54216813|FG003|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3|||
27764347|NCT02515669|54216810|FG000|228 Week Open-Label Phase|Administrative Reason by Sponsor|0|||
27764348|NCT02515669|54216811|FG001|228 Week Open-Label Phase|Administrative Reason by Sponsor|7|||
27764349|NCT02515669|54216812|FG002|228 Week Open-Label Phase|Administrative Reason by Sponsor|2|||
27764350|NCT02515669|54216813|FG003|228 Week Open-Label Phase|Administrative Reason by Sponsor|17|||
27764351|NCT02515669|54216810|FG000|228 Week Open-Label Phase|Missing|0|||
27764352|NCT02515669|54216811|FG001|228 Week Open-Label Phase|Missing|2|||
27764353|NCT02515669|54216812|FG002|228 Week Open-Label Phase|Missing|2|||
27764354|NCT02515669|54216813|FG003|228 Week Open-Label Phase|Missing|2|||
27764355|NCT02515279|54216843|FG000|Overall Study|Adverse Event|7|||
27764356|NCT02515279|54216843|FG000|Overall Study|Lack of Efficacy|31|||
27764357|NCT02515279|54216843|FG000|Overall Study|Lost to Follow-up|9|||
27764358|NCT02515279|54216843|FG000|Overall Study|Withdrawal by Subject|18|||
27764359|NCT02515279|54216843|FG000|Overall Study|End-of-treatment visit not attended|17|||
27764360|NCT02515279|54216843|FG000|Overall Study|Other|22|||
27764361|NCT02515045|54216849|FG000|Overall Study|Adverse Event|0|||
27764362|NCT02515045|54216850|FG001|Overall Study|Adverse Event|3|||
27764363|NCT02515045|54216851|FG002|Overall Study|Adverse Event|3|||
27764364|NCT02515045|54216849|FG000|Overall Study|Lost to Follow-up|0|||
27764365|NCT02515045|54216850|FG001|Overall Study|Lost to Follow-up|1|||
27764366|NCT02515045|54216851|FG002|Overall Study|Lost to Follow-up|1|||
27764367|NCT02514577|54216861|FG000|Overall Study|Lost to Follow-up|6|||
27764368|NCT02514577|54216862|FG001|Overall Study|Lost to Follow-up|6|||
27764369|NCT02514577|54216861|FG000|Overall Study|Protocol Violation|1|||
27764370|NCT02514577|54216862|FG001|Overall Study|Protocol Violation|0|||
27764371|NCT02514577|54216861|FG000|Overall Study|Withdrawal by Subject|6|||
27764372|NCT02514577|54216862|FG001|Overall Study|Withdrawal by Subject|6|||
27764373|NCT02514577|54216861|FG000|Overall Study|Adverse Event|1|||
27764374|NCT02514577|54216862|FG001|Overall Study|Adverse Event|1|||
27764375|NCT02513485|54216870|FG000|Overall Study|Adverse Event|1|||
27764376|NCT02513485|54216871|FG001|Overall Study|Adverse Event|0|||
27764377|NCT02289417|54216880|FG000|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3|||
27764378|NCT02289417|54216881|FG001|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
27764379|NCT02289417|54216882|FG002|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1|||
27764380|NCT02289417|54216883|FG003|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
27764381|NCT02289417|54216884|FG004|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
27764382|NCT02289417|54216885|FG005|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
27764383|NCT02289417|54216886|FG006|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
27764384|NCT02289417|54216887|FG007|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
27764385|NCT02289417|54216888|FG008|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
27764386|NCT02289417|54216880|FG000|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1|||
27764387|NCT02289417|54216881|FG001|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3|||
27764388|NCT02289417|54216882|FG002|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2|||
27764389|NCT02289417|54216883|FG003|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
27764390|NCT02289417|54216884|FG004|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
27764391|NCT02289417|54216885|FG005|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
27764392|NCT02289417|54216886|FG006|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
27764393|NCT02289417|54216887|FG007|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
27764394|NCT02289417|54216888|FG008|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
27764395|NCT02289417|54216880|FG000|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
27764396|NCT02289417|54216881|FG001|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1|||
27764397|NCT02289417|54216882|FG002|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
27764398|NCT02289417|54216883|FG003|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
27764399|NCT02289417|54216884|FG004|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
27764400|NCT02289417|54216885|FG005|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
27764401|NCT02289417|54216886|FG006|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
27764402|NCT02289417|54216887|FG007|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
27764403|NCT02289417|54216888|FG008|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
27764404|NCT02289417|54216880|FG000|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3|||
27764405|NCT02289417|54216881|FG001|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
27764406|NCT02289417|54216882|FG002|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
27764407|NCT02289417|54216883|FG003|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
27764408|NCT02289417|54216884|FG004|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
27764409|NCT02289417|54216885|FG005|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
27764410|NCT02289417|54216886|FG006|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
27764411|NCT02289417|54216887|FG007|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
27764412|NCT02289417|54216888|FG008|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
27764413|NCT02289417|54216880|FG000|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
27764414|NCT02289417|54216881|FG001|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
27764415|NCT02289417|54216882|FG002|Active Treatment Phase Weeks 12-52|Adverse Event|4|||
27764416|NCT02289417|54216883|FG003|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
27839592|NCT01506271|54326888|FG000|Overall Study|Lost to Follow-up|0|||
27839593|NCT01506271|54326889|FG001|Overall Study|Lost to Follow-up|1|||
27839594|NCT01506271|54326890|FG002|Overall Study|Lost to Follow-up|2|||
27839595|NCT01506193|54326901|FG000|Overall Study|Protocol Violation|1|||
27839596|NCT01506193|54326902|FG001|Overall Study|Protocol Violation|0|||
27839597|NCT01506193|54326903|FG002|Overall Study|Protocol Violation|1|||
27839598|NCT01506193|54326901|FG000|Overall Study|Migrated/moved from study area|0|||
27839599|NCT01506193|54326902|FG001|Overall Study|Migrated/moved from study area|0|||
27839600|NCT01506193|54326903|FG002|Overall Study|Migrated/moved from study area|1|||
27839601|NCT01506193|54326901|FG000|Overall Study|Adverse event, non-fatal|0|||
27839602|NCT01506193|54326902|FG001|Overall Study|Adverse event, non-fatal|0|||
28105476|NCT02793232|54762843|FG002|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
27764417|NCT02289417|54216884|FG004|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
27764418|NCT02289417|54216885|FG005|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
27764419|NCT02289417|54216886|FG006|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
27764420|NCT02289417|54216887|FG007|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
27764421|NCT02289417|54216888|FG008|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
27764422|NCT02289417|54216880|FG000|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
27764423|NCT02289417|54216881|FG001|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
27764424|NCT02289417|54216882|FG002|Active Treatment Phase Weeks 12-52|Pregnancy|1|||
28105477|NCT02793232|54762844|FG003|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
28105478|NCT02793232|54762845|FG004|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
27764425|NCT02289417|54216883|FG003|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
27764426|NCT02289417|54216884|FG004|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
27764427|NCT02289417|54216885|FG005|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
27764428|NCT02289417|54216886|FG006|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
27764429|NCT02289417|54216887|FG007|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
27764430|NCT02289417|54216888|FG008|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
27764431|NCT02289417|54216880|FG000|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
27764432|NCT02289417|54216881|FG001|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1|||
27764433|NCT02289417|54216882|FG002|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4|||
27764434|NCT02289417|54216883|FG003|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6|||
27764435|NCT02289417|54216884|FG004|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2|||
27764436|NCT02289417|54216885|FG005|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3|||
27764437|NCT02289417|54216886|FG006|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
27764438|NCT02289417|54216887|FG007|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
27764439|NCT02289417|54216888|FG008|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
27764440|NCT02289417|54216880|FG000|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
27764441|NCT02289417|54216881|FG001|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
27764442|NCT02289417|54216882|FG002|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
27764443|NCT02289417|54216883|FG003|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
27764444|NCT02289417|54216884|FG004|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
27764445|NCT02289417|54216885|FG005|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
27764446|NCT02289417|54216886|FG006|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
27764447|NCT02289417|54216887|FG007|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
27764448|NCT02289417|54216888|FG008|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
27764449|NCT02289417|54216880|FG000|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
27764450|NCT02289417|54216881|FG001|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
27764451|NCT02289417|54216882|FG002|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
27764452|NCT02289417|54216883|FG003|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
27764453|NCT02289417|54216884|FG004|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
27764454|NCT02289417|54216885|FG005|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
27764455|NCT02289417|54216886|FG006|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1|||
27839603|NCT01506193|54326903|FG002|Overall Study|Adverse event, non-fatal|1|||
28159971|NCT02737475|54830046|FG024|Overall Study|Death|0|||
27764456|NCT02289417|54216887|FG007|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
27764457|NCT02289417|54216888|FG008|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
27764458|NCT02289417|54216880|FG000|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
27764459|NCT02289417|54216881|FG001|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
27764460|NCT02289417|54216882|FG002|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
27764461|NCT02289417|54216883|FG003|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
27764462|NCT02289417|54216884|FG004|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
27764463|NCT02289417|54216885|FG005|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
27764464|NCT02289417|54216886|FG006|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
27764465|NCT02289417|54216887|FG007|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
27764466|NCT02289417|54216888|FG008|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
27764467|NCT02289417|54216880|FG000|Extension Phase Weeks 52-104|Adverse Event|0|||
27764468|NCT02289417|54216881|FG001|Extension Phase Weeks 52-104|Adverse Event|0|||
27764469|NCT02289417|54216882|FG002|Extension Phase Weeks 52-104|Adverse Event|0|||
27764470|NCT02289417|54216883|FG003|Extension Phase Weeks 52-104|Adverse Event|0|||
27764471|NCT02289417|54216884|FG004|Extension Phase Weeks 52-104|Adverse Event|0|||
27764472|NCT02289417|54216885|FG005|Extension Phase Weeks 52-104|Adverse Event|0|||
27764473|NCT02289417|54216886|FG006|Extension Phase Weeks 52-104|Adverse Event|0|||
27764474|NCT02289417|54216887|FG007|Extension Phase Weeks 52-104|Adverse Event|2|||
27764475|NCT02289417|54216888|FG008|Extension Phase Weeks 52-104|Adverse Event|3|||
27764476|NCT02289417|54216880|FG000|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
27764477|NCT02289417|54216881|FG001|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
27764478|NCT02289417|54216882|FG002|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
27764479|NCT02289417|54216883|FG003|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
27764480|NCT02289417|54216884|FG004|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
27764481|NCT02289417|54216885|FG005|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
27764482|NCT02289417|54216886|FG006|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
27764483|NCT02289417|54216887|FG007|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
27764484|NCT02289417|54216888|FG008|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
27764485|NCT02289417|54216880|FG000|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
27764486|NCT02289417|54216881|FG001|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
27764487|NCT02289417|54216882|FG002|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
27764488|NCT02289417|54216883|FG003|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
27764489|NCT02289417|54216884|FG004|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
27764490|NCT02289417|54216885|FG005|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
27764491|NCT02289417|54216886|FG006|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
27764492|NCT02289417|54216887|FG007|Extension Phase Weeks 52-104|Withdrawal by Subject|2|||
27764493|NCT02289417|54216888|FG008|Extension Phase Weeks 52-104|Withdrawal by Subject|1|||
27764494|NCT02289417|54216880|FG000|Extension Phase Weeks 52-104|Miscellaneous|0|||
27764495|NCT02289417|54216881|FG001|Extension Phase Weeks 52-104|Miscellaneous|0|||
27764496|NCT02289417|54216882|FG002|Extension Phase Weeks 52-104|Miscellaneous|0|||
27764497|NCT02289417|54216883|FG003|Extension Phase Weeks 52-104|Miscellaneous|0|||
27764498|NCT02289417|54216884|FG004|Extension Phase Weeks 52-104|Miscellaneous|0|||
27764499|NCT02289417|54216885|FG005|Extension Phase Weeks 52-104|Miscellaneous|0|||
27764500|NCT02289417|54216886|FG006|Extension Phase Weeks 52-104|Miscellaneous|0|||
27764501|NCT02289417|54216887|FG007|Extension Phase Weeks 52-104|Miscellaneous|1|||
27764502|NCT02289417|54216888|FG008|Extension Phase Weeks 52-104|Miscellaneous|0|||
27764503|NCT02512861|54216906|FG000|Overall Study|Protocol Violation|3|||
27764504|NCT02512861|54216907|FG001|Overall Study|Protocol Violation|7|||
27764505|NCT02512861|54216906|FG000|Overall Study|Physician Decision|3|||
27764506|NCT02512861|54216907|FG001|Overall Study|Physician Decision|1|||
27764507|NCT02512861|54216906|FG000|Overall Study|Withdrawal by Subject|0|||
27764508|NCT02512861|54216907|FG001|Overall Study|Withdrawal by Subject|1|||
27764509|NCT02288559|54216917|FG000|Overall Study|Adverse Event|1|||
27764510|NCT02288559|54216918|FG001|Overall Study|Adverse Event|1|||
27764511|NCT02288559|54216919|FG002|Overall Study|Adverse Event|5|||
27764512|NCT02288559|54216920|FG003|Overall Study|Adverse Event|0|||
27764513|NCT02288559|54216917|FG000|Overall Study|Death|0|||
27764514|NCT02288559|54216918|FG001|Overall Study|Death|0|||
27764515|NCT02288559|54216919|FG002|Overall Study|Death|1|||
27764516|NCT02288559|54216920|FG003|Overall Study|Death|0|||
27764517|NCT02288559|54216917|FG000|Overall Study|Lost to Follow-up|0|||
27764518|NCT02288559|54216918|FG001|Overall Study|Lost to Follow-up|0|||
27764519|NCT02288559|54216919|FG002|Overall Study|Lost to Follow-up|0|||
27764520|NCT02288559|54216920|FG003|Overall Study|Lost to Follow-up|1|||
27764521|NCT02288559|54216917|FG000|Overall Study|Withdrawal by Subject|0|||
27764522|NCT02288559|54216918|FG001|Overall Study|Withdrawal by Subject|0|||
27764523|NCT02288559|54216919|FG002|Overall Study|Withdrawal by Subject|2|||
27764524|NCT02288559|54216920|FG003|Overall Study|Withdrawal by Subject|1|||
27764525|NCT02288559|54216917|FG000|Overall Study|Reason Not Specified|0|||
27764526|NCT02288559|54216918|FG001|Overall Study|Reason Not Specified|0|||
27764527|NCT02288559|54216919|FG002|Overall Study|Reason Not Specified|3|||
27764528|NCT02288559|54216920|FG003|Overall Study|Reason Not Specified|0|||
27764529|NCT02288325|54216932|FG000|Run-in Period|Adverse Event|48|||
27764530|NCT02288325|54216933|FG001|Run-in Period|Adverse Event|0|||
27839604|NCT01506193|54326901|FG000|Overall Study|Withdrawal by Subject|5|||
27764531|NCT02288325|54216934|FG002|Run-in Period|Adverse Event|0|||
27764532|NCT02288325|54216932|FG000|Run-in Period|Lack of Efficacy|16|||
27764533|NCT02288325|54216933|FG001|Run-in Period|Lack of Efficacy|0|||
27764534|NCT02288325|54216934|FG002|Run-in Period|Lack of Efficacy|0|||
27764535|NCT02288325|54216932|FG000|Run-in Period|Withdrawal of Consent|28|||
27764536|NCT02288325|54216933|FG001|Run-in Period|Withdrawal of Consent|0|||
27764537|NCT02288325|54216934|FG002|Run-in Period|Withdrawal of Consent|0|||
27764538|NCT02288325|54216932|FG000|Run-in Period|Lost to Follow-up|25|||
27764539|NCT02288325|54216933|FG001|Run-in Period|Lost to Follow-up|0|||
27764540|NCT02288325|54216934|FG002|Run-in Period|Lost to Follow-up|0|||
27764541|NCT02288325|54216932|FG000|Run-in Period|Protocol Violation|17|||
27764542|NCT02288325|54216933|FG001|Run-in Period|Protocol Violation|0|||
27764543|NCT02288325|54216934|FG002|Run-in Period|Protocol Violation|0|||
27764544|NCT02288325|54216932|FG000|Run-in Period|Non-Compliance With Study Drug|3|||
27764545|NCT02288325|54216933|FG001|Run-in Period|Non-Compliance With Study Drug|0|||
27764546|NCT02288325|54216934|FG002|Run-in Period|Non-Compliance With Study Drug|0|||
27764547|NCT02288325|54216932|FG000|Run-in Period|Reason not Specified|8|||
27764548|NCT02288325|54216933|FG001|Run-in Period|Reason not Specified|0|||
27764549|NCT02288325|54216934|FG002|Run-in Period|Reason not Specified|0|||
27764550|NCT02288325|54216932|FG000|Stabilization Period|Adverse Event|13|||
27764551|NCT02288325|54216933|FG001|Stabilization Period|Adverse Event|0|||
27764552|NCT02288325|54216934|FG002|Stabilization Period|Adverse Event|0|||
27764553|NCT02288325|54216932|FG000|Stabilization Period|Lack of Efficacy|22|||
27764554|NCT02288325|54216933|FG001|Stabilization Period|Lack of Efficacy|0|||
27764555|NCT02288325|54216934|FG002|Stabilization Period|Lack of Efficacy|0|||
27764556|NCT02288325|54216932|FG000|Stabilization Period|Withdrawal of Consent|23|||
27764557|NCT02288325|54216933|FG001|Stabilization Period|Withdrawal of Consent|0|||
27764558|NCT02288325|54216934|FG002|Stabilization Period|Withdrawal of Consent|0|||
27764559|NCT02288325|54216932|FG000|Stabilization Period|Lost to Follow-up|12|||
27764560|NCT02288325|54216933|FG001|Stabilization Period|Lost to Follow-up|0|||
27764561|NCT02288325|54216934|FG002|Stabilization Period|Lost to Follow-up|0|||
27764562|NCT02288325|54216932|FG000|Stabilization Period|Protocol Violation|8|||
27764563|NCT02288325|54216933|FG001|Stabilization Period|Protocol Violation|0|||
27764564|NCT02288325|54216934|FG002|Stabilization Period|Protocol Violation|0|||
27764565|NCT02288325|54216932|FG000|Stabilization Period|Non-Compliance With Study Drug|5|||
27764566|NCT02288325|54216933|FG001|Stabilization Period|Non-Compliance With Study Drug|0|||
27764567|NCT02288325|54216934|FG002|Stabilization Period|Non-Compliance With Study Drug|0|||
27764568|NCT02288325|54216932|FG000|Stabilization Period|Reason not Specified|15|||
27764569|NCT02288325|54216933|FG001|Stabilization Period|Reason not Specified|0|||
27764570|NCT02288325|54216934|FG002|Stabilization Period|Reason not Specified|0|||
27764571|NCT02288325|54216932|FG000|Double-blind Treatment Period|Adverse Event|0|||
27764572|NCT02288325|54216933|FG001|Double-blind Treatment Period|Adverse Event|2|||
27764573|NCT02288325|54216934|FG002|Double-blind Treatment Period|Adverse Event|5|||
27764574|NCT02288325|54216932|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
27764575|NCT02288325|54216933|FG001|Double-blind Treatment Period|Withdrawal of Consent|8|||
27764576|NCT02288325|54216934|FG002|Double-blind Treatment Period|Withdrawal of Consent|8|||
27764577|NCT02288325|54216932|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
27764578|NCT02288325|54216933|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
27764579|NCT02288325|54216934|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
27764580|NCT02288325|54216932|FG000|Double-blind Treatment Period|Protocol Violation|0|||
27764581|NCT02288325|54216933|FG001|Double-blind Treatment Period|Protocol Violation|1|||
27764582|NCT02288325|54216934|FG002|Double-blind Treatment Period|Protocol Violation|2|||
27764583|NCT02288325|54216932|FG000|Double-blind Treatment Period|Non-Compliance With Study Drug|0|||
27764584|NCT02288325|54216933|FG001|Double-blind Treatment Period|Non-Compliance With Study Drug|1|||
27764585|NCT02288325|54216934|FG002|Double-blind Treatment Period|Non-Compliance With Study Drug|4|||
27764586|NCT02288325|54216932|FG000|Double-blind Treatment Period|Multiple Reasons|0|||
27764587|NCT02288325|54216933|FG001|Double-blind Treatment Period|Multiple Reasons|8|||
27764588|NCT02288325|54216934|FG002|Double-blind Treatment Period|Multiple Reasons|2|||
27764589|NCT02509117|54216951|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
27764590|NCT02509117|54216952|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1|||
27764591|NCT02509117|54216953|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
27764592|NCT02509117|54216954|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
27764593|NCT02509117|54216955|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
27764594|NCT02509117|54216956|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
27764595|NCT02509117|54216957|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
27764596|NCT02509117|54216958|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
27764597|NCT02509117|54216959|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
27764598|NCT02509117|54216960|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
27764599|NCT02509117|54216951|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
27764600|NCT02509117|54216952|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
27764601|NCT02509117|54216953|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
27831210|NCT01793051|54307468|FG001|Overall Study|Requested to be removed from the study|1|||
27764602|NCT02509117|54216954|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
27764603|NCT02509117|54216955|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
27764604|NCT02509117|54216956|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
27764605|NCT02509117|54216957|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
27764606|NCT02509117|54216958|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
27764607|NCT02509117|54216959|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
27764608|NCT02509117|54216960|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1|||
27764609|NCT02509117|54216951|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
27764610|NCT02509117|54216952|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
27764611|NCT02509117|54216953|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
27764612|NCT02509117|54216954|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
28159972|NCT02737475|54830047|FG025|Overall Study|Death|0|||
27764613|NCT02509117|54216955|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
27764614|NCT02509117|54216956|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
27764615|NCT02509117|54216957|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
27764616|NCT02509117|54216958|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
27764617|NCT02509117|54216959|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
27764618|NCT02509117|54216960|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1|||
27764619|NCT01654549|54217000|FG000|Overall Study|H.pylori eradication not successful|0|||
27764620|NCT01654549|54217001|FG001|Overall Study|H.pylori eradication not successful|1|||
27764621|NCT02508649|54217015|FG000|Overall Study|Withdrawal by Subject|4|||
27764622|NCT02508649|54217016|FG001|Overall Study|Withdrawal by Subject|6|||
27764623|NCT02508649|54217017|FG002|Overall Study|Withdrawal by Subject|5|||
27764624|NCT02508649|54217018|FG003|Overall Study|Withdrawal by Subject|6|||
27764625|NCT02508649|54217015|FG000|Overall Study|Investigator withdrew the subject|1|||
27764626|NCT02508649|54217016|FG001|Overall Study|Investigator withdrew the subject|2|||
27764627|NCT02508649|54217017|FG002|Overall Study|Investigator withdrew the subject|1|||
27764628|NCT02508649|54217018|FG003|Overall Study|Investigator withdrew the subject|0|||
27764629|NCT02508649|54217015|FG000|Overall Study|Post randomization screening failure|12|||
27764630|NCT02508649|54217016|FG001|Overall Study|Post randomization screening failure|4|||
27764631|NCT02508649|54217017|FG002|Overall Study|Post randomization screening failure|9|||
27764632|NCT02508649|54217018|FG003|Overall Study|Post randomization screening failure|3|||
27764633|NCT02508649|54217015|FG000|Overall Study|Lost to Follow-up|1|||
27764634|NCT02508649|54217016|FG001|Overall Study|Lost to Follow-up|1|||
27764635|NCT02508649|54217017|FG002|Overall Study|Lost to Follow-up|0|||
27764636|NCT02508649|54217018|FG003|Overall Study|Lost to Follow-up|1|||
27764637|NCT02505217|54217033|FG000|Overall Study|Withdrawal by Subject|1|||
27764638|NCT02505217|54217034|FG001|Overall Study|Withdrawal by Subject|2|||
27764639|NCT02504827|54217040|FG000|Overall Study|Could not produce sputum|1|||
27764640|NCT02504671|54217050|FG000|Overall Study|Withdrawal by Subject|1|||
27764641|NCT02504671|54217051|FG001|Overall Study|Withdrawal by Subject|5|||
27764642|NCT02504671|54217052|FG002|Overall Study|Withdrawal by Subject|4|||
27764643|NCT02504671|54217053|FG003|Overall Study|Withdrawal by Subject|4|||
27764644|NCT02504671|54217054|FG004|Overall Study|Withdrawal by Subject|5|||
27764645|NCT02504671|54217055|FG005|Overall Study|Withdrawal by Subject|3|||
27764646|NCT02504671|54217050|FG000|Overall Study|Lack of Efficacy|1|||
27764647|NCT02504671|54217051|FG001|Overall Study|Lack of Efficacy|3|||
27764648|NCT02504671|54217052|FG002|Overall Study|Lack of Efficacy|1|||
27764649|NCT02504671|54217053|FG003|Overall Study|Lack of Efficacy|0|||
27764650|NCT02504671|54217054|FG004|Overall Study|Lack of Efficacy|4|||
27764651|NCT02504671|54217055|FG005|Overall Study|Lack of Efficacy|4|||
27764652|NCT02504671|54217050|FG000|Overall Study|Adverse Event|1|||
27764653|NCT02504671|54217051|FG001|Overall Study|Adverse Event|1|||
27764654|NCT02504671|54217052|FG002|Overall Study|Adverse Event|0|||
27764655|NCT02504671|54217053|FG003|Overall Study|Adverse Event|1|||
27764656|NCT02504671|54217054|FG004|Overall Study|Adverse Event|0|||
27764657|NCT02504671|54217055|FG005|Overall Study|Adverse Event|2|||
27764658|NCT02504671|54217050|FG000|Overall Study|Protocol Violation|2|||
27764659|NCT02504671|54217051|FG001|Overall Study|Protocol Violation|1|||
27764660|NCT02504671|54217052|FG002|Overall Study|Protocol Violation|0|||
27764661|NCT02504671|54217053|FG003|Overall Study|Protocol Violation|0|||
27764662|NCT02504671|54217054|FG004|Overall Study|Protocol Violation|0|||
27764663|NCT02504671|54217055|FG005|Overall Study|Protocol Violation|1|||
27764664|NCT02504671|54217050|FG000|Overall Study|Lost to Follow-up|0|||
27764665|NCT02504671|54217051|FG001|Overall Study|Lost to Follow-up|0|||
27764666|NCT02504671|54217052|FG002|Overall Study|Lost to Follow-up|2|||
27764667|NCT02504671|54217053|FG003|Overall Study|Lost to Follow-up|0|||
27764668|NCT02504671|54217054|FG004|Overall Study|Lost to Follow-up|0|||
27764669|NCT02504671|54217055|FG005|Overall Study|Lost to Follow-up|1|||
27764670|NCT02504671|54217050|FG000|Overall Study|Protocol defined stopping criteria|7|||
27764671|NCT02504671|54217051|FG001|Overall Study|Protocol defined stopping criteria|4|||
27764672|NCT02504671|54217052|FG002|Overall Study|Protocol defined stopping criteria|3|||
27764673|NCT02504671|54217053|FG003|Overall Study|Protocol defined stopping criteria|5|||
27764674|NCT02504671|54217054|FG004|Overall Study|Protocol defined stopping criteria|3|||
27764675|NCT02504671|54217055|FG005|Overall Study|Protocol defined stopping criteria|3|||
27764676|NCT02314143|54217072|FG000|Overall Study|Adverse Event|0|||
27764677|NCT02314143|54217073|FG001|Overall Study|Adverse Event|6|||
27764678|NCT02314143|54217074|FG002|Overall Study|Adverse Event|4|||
27764679|NCT02314143|54217072|FG000|Overall Study|Other (Study Closed/Terminated)|5|||
27764680|NCT02314143|54217073|FG001|Overall Study|Other (Study Closed/Terminated)|3|||
27764681|NCT02314143|54217074|FG002|Overall Study|Other (Study Closed/Terminated)|4|||
27764682|NCT02314143|54217072|FG000|Overall Study|Physician Decision|2|||
27764683|NCT02314143|54217073|FG001|Overall Study|Physician Decision|1|||
27764684|NCT02314143|54217074|FG002|Overall Study|Physician Decision|0|||
27764685|NCT02314143|54217072|FG000|Overall Study|Withdrawal by Subject|1|||
27764686|NCT02314143|54217073|FG001|Overall Study|Withdrawal by Subject|0|||
27764687|NCT02314143|54217074|FG002|Overall Study|Withdrawal by Subject|1|||
27764688|NCT02288091|54217083|FG000|Overall Study|Lost to Follow-up|1|||
27764689|NCT02288091|54217083|FG000|Overall Study|Screen fail|7|||
27764690|NCT02503501|54217089|FG000|Overall Study|Physician Decision|1|||
27764691|NCT02503501|54217090|FG001|Overall Study|Physician Decision|0|||
27764692|NCT02503501|54217089|FG000|Overall Study|Protocol Violation|0|||
27764693|NCT02503501|54217090|FG001|Overall Study|Protocol Violation|1|||
27764694|NCT02503501|54217089|FG000|Overall Study|Withdrawal by Subject|0|||
27764695|NCT02503501|54217090|FG001|Overall Study|Withdrawal by Subject|2|||
27764696|NCT02502097|54217100|FG000|Period 1|Adverse Event|0|||
27764697|NCT02502097|54217101|FG001|Period 1|Adverse Event|0|||
27764698|NCT02502097|54217102|FG002|Period 1|Adverse Event|1|||
27764699|NCT02502097|54217103|FG003|Period 1|Adverse Event|0|||
27764700|NCT02502097|54217100|FG000|Wash Out Period|Adverse Event|0|||
27764701|NCT02502097|54217101|FG001|Wash Out Period|Adverse Event|1|||
27764702|NCT02502097|54217102|FG002|Wash Out Period|Adverse Event|1|||
27764703|NCT02502097|54217103|FG003|Wash Out Period|Adverse Event|1|||
27764704|NCT02502097|54217100|FG000|Period 2|Adverse Event|0|||
27764705|NCT02502097|54217101|FG001|Period 2|Adverse Event|0|||
27764706|NCT02502097|54217102|FG002|Period 2|Adverse Event|1|||
27764707|NCT02502097|54217103|FG003|Period 2|Adverse Event|0|||
27764708|NCT02501629|54217112|FG000|Overall Study|Death|0|||
27764709|NCT02501629|54217113|FG001|Overall Study|Death|1|||
27764710|NCT02501629|54217112|FG000|Overall Study|Withdrawn from study by sponsor|1|||
27764711|NCT02501629|54217113|FG001|Overall Study|Withdrawn from study by sponsor|0|||
27764712|NCT02501629|54217112|FG000|Overall Study|Early termination by sponsor|1|||
27764713|NCT02501629|54217113|FG001|Overall Study|Early termination by sponsor|0|||
27764714|NCT02501629|54217112|FG000|Overall Study|Withdrawal by Subject|3|||
27764715|NCT02501629|54217113|FG001|Overall Study|Withdrawal by Subject|5|||
27764716|NCT02501629|54217112|FG000|Overall Study|Subject did not return to site|0|||
27764717|NCT02501629|54217113|FG001|Overall Study|Subject did not return to site|1|||
27764718|NCT02501473|54217126|FG000|Overall Study|Study Terminated|2|||
27764719|NCT02501473|54217127|FG001|Overall Study|Study Terminated|3|||
27764720|NCT02501473|54217128|FG002|Overall Study|Study Terminated|7|||
27764721|NCT02501473|54217129|FG003|Overall Study|Study Terminated|9|||
27764722|NCT02501473|54217130|FG004|Overall Study|Study Terminated|2|||
27764723|NCT02501473|54217131|FG005|Overall Study|Study Terminated|10|||
27764724|NCT02501473|54217132|FG006|Overall Study|Study Terminated|1|||
27764725|NCT02501473|54217133|FG007|Overall Study|Study Terminated|0|||
27764726|NCT02501473|54217126|FG000|Overall Study|Withdrawal by Subject|0|||
27764727|NCT02501473|54217127|FG001|Overall Study|Withdrawal by Subject|0|||
27764728|NCT02501473|54217128|FG002|Overall Study|Withdrawal by Subject|3|||
27764729|NCT02501473|54217129|FG003|Overall Study|Withdrawal by Subject|3|||
27764730|NCT02501473|54217130|FG004|Overall Study|Withdrawal by Subject|2|||
27764731|NCT02501473|54217131|FG005|Overall Study|Withdrawal by Subject|2|||
27764732|NCT02501473|54217132|FG006|Overall Study|Withdrawal by Subject|0|||
27764733|NCT02501473|54217133|FG007|Overall Study|Withdrawal by Subject|0|||
27764734|NCT02501473|54217126|FG000|Overall Study|Death|0|||
27764735|NCT02501473|54217127|FG001|Overall Study|Death|0|||
27764736|NCT02501473|54217128|FG002|Overall Study|Death|1|||
27764737|NCT02501473|54217129|FG003|Overall Study|Death|1|||
27764738|NCT02501473|54217130|FG004|Overall Study|Death|0|||
27764739|NCT02501473|54217131|FG005|Overall Study|Death|1|||
27764740|NCT02501473|54217132|FG006|Overall Study|Death|0|||
27764741|NCT02501473|54217133|FG007|Overall Study|Death|0|||
27764742|NCT02501473|54217126|FG000|Overall Study|Lost to Follow-up|1|||
27764743|NCT02501473|54217127|FG001|Overall Study|Lost to Follow-up|0|||
27764744|NCT02501473|54217128|FG002|Overall Study|Lost to Follow-up|1|||
27764745|NCT02501473|54217129|FG003|Overall Study|Lost to Follow-up|0|||
27764746|NCT02501473|54217130|FG004|Overall Study|Lost to Follow-up|0|||
27764747|NCT02501473|54217131|FG005|Overall Study|Lost to Follow-up|1|||
27764748|NCT02501473|54217132|FG006|Overall Study|Lost to Follow-up|0|||
27764749|NCT02501473|54217133|FG007|Overall Study|Lost to Follow-up|0|||
27764750|NCT02501473|54217126|FG000|Overall Study|Reason not specified|0|||
27831211|NCT01816061|54307501|FG000|Overall Study|Lost to Follow-up|13|||
27764751|NCT02501473|54217127|FG001|Overall Study|Reason not specified|0|||
27764752|NCT02501473|54217128|FG002|Overall Study|Reason not specified|1|||
27764753|NCT02501473|54217129|FG003|Overall Study|Reason not specified|1|||
27764754|NCT02501473|54217130|FG004|Overall Study|Reason not specified|0|||
27764755|NCT02501473|54217131|FG005|Overall Study|Reason not specified|0|||
27764756|NCT02501473|54217132|FG006|Overall Study|Reason not specified|0|||
27764757|NCT02501473|54217133|FG007|Overall Study|Reason not specified|0|||
27764758|NCT02501161|54217151|FG000|Overall Study|Adverse Event|2|||
27764759|NCT02501161|54217152|FG001|Overall Study|Adverse Event|6|||
27764760|NCT02501161|54217151|FG000|Overall Study|Lost to Follow-up|7|||
27764761|NCT02501161|54217152|FG001|Overall Study|Lost to Follow-up|4|||
27764762|NCT02501161|54217151|FG000|Overall Study|Withdrawal by Subject|10|||
27764763|NCT02501161|54217152|FG001|Overall Study|Withdrawal by Subject|15|||
27764764|NCT02501161|54217151|FG000|Overall Study|Other|3|||
27764765|NCT02501161|54217152|FG001|Overall Study|Other|0|||
27764766|NCT02500537|54217160|FG000|Overall Study|Death|2|||
27764767|NCT02500537|54217161|FG001|Overall Study|Death|0|||
27764768|NCT02500537|54217160|FG000|Overall Study|Lost to Follow-up|0|||
27764769|NCT02500537|54217161|FG001|Overall Study|Lost to Follow-up|1|||
27764770|NCT02500537|54217160|FG000|Overall Study|Withdrawal by Subject|1|||
27764771|NCT02500537|54217161|FG001|Overall Study|Withdrawal by Subject|0|||
27764772|NCT02498821|54217170|FG000|Overall Study|Screen failure|3|||
27764773|NCT02498821|54217171|FG001|Overall Study|Screen failure|5|||
27764774|NCT02313909|54217179|FG000|Overall Study|Consent withdrawn by participant|33|||
27764775|NCT02313909|54217180|FG001|Overall Study|Consent withdrawn by participant|33|||
27764776|NCT02313909|54217179|FG000|Overall Study|Lost to Follow-up|24|||
27764777|NCT02313909|54217180|FG001|Overall Study|Lost to Follow-up|17|||
27764778|NCT02287467|54217188|FG000|Overall Study|Protocol Violation|12|||
27764779|NCT02287467|54217189|FG001|Overall Study|Protocol Violation|9|||
27764780|NCT02287233|54217201|FG000|Overall Study|Adverse Event Not Related to Progression|1|||
27764781|NCT02287233|54217202|FG001|Overall Study|Adverse Event Not Related to Progression|2|||
27764782|NCT02287233|54217203|FG002|Overall Study|Adverse Event Not Related to Progression|10|||
27764783|NCT02287233|54217201|FG000|Overall Study|Adverse Event Related to Progression|0|||
27764784|NCT02287233|54217202|FG001|Overall Study|Adverse Event Related to Progression|2|||
27764785|NCT02287233|54217203|FG002|Overall Study|Adverse Event Related to Progression|8|||
27764786|NCT02287233|54217201|FG000|Overall Study|Physician Decision|1|||
27764787|NCT02287233|54217202|FG001|Overall Study|Physician Decision|2|||
27764788|NCT02287233|54217203|FG002|Overall Study|Physician Decision|4|||
27764789|NCT02287233|54217201|FG000|Overall Study|Progressive Disease with Death|0|||
27764790|NCT02287233|54217202|FG001|Overall Study|Progressive Disease with Death|0|||
27764791|NCT02287233|54217203|FG002|Overall Study|Progressive Disease with Death|10|||
27764792|NCT02287233|54217201|FG000|Overall Study|Progressive Disease Without Death|2|||
27764793|NCT02287233|54217202|FG001|Overall Study|Progressive Disease Without Death|3|||
27764794|NCT02287233|54217203|FG002|Overall Study|Progressive Disease Without Death|20|||
27764795|NCT02287233|54217201|FG000|Overall Study|Withdrawal by Subject|1|||
27764796|NCT02287233|54217202|FG001|Overall Study|Withdrawal by Subject|1|||
27764797|NCT02287233|54217203|FG002|Overall Study|Withdrawal by Subject|7|||
27764798|NCT02287233|54217201|FG000|Overall Study|Other|3|||
27764799|NCT02287233|54217202|FG001|Overall Study|Other|0|||
27764800|NCT02287233|54217203|FG002|Overall Study|Other|15|||
27764801|NCT02287233|54217201|FG000|Overall Study|Did Not Receive Treatment|0|||
27764802|NCT02287233|54217202|FG001|Overall Study|Did Not Receive Treatment|0|||
27764803|NCT02287233|54217203|FG002|Overall Study|Did Not Receive Treatment|2|||
27764804|NCT01646385|54217216|FG000|Overall Study|Death|202|||
27764805|NCT01646385|54217217|FG001|Overall Study|Death|222|||
27764806|NCT01646385|54217216|FG000|Overall Study|Switched to alternate biologic|636|||
27764807|NCT01646385|54217217|FG001|Overall Study|Switched to alternate biologic|649|||
27764808|NCT02286843|54217223|FG000|Overall Study|Not Treated|4|||
27764809|NCT02286843|54217223|FG000|Overall Study|Protocol Violation|1|||
27764810|NCT02286843|54217223|FG000|Overall Study|Withdrawal by Subject|1|||
27764811|NCT02282163|54217227|FG000|Overall Study|Protocol Violation|1|||
27764812|NCT02281773|54217245|FG000|Overall Study|Adverse Event|6|||
27764813|NCT02281773|54217246|FG001|Overall Study|Adverse Event|1|||
27764814|NCT02281773|54217247|FG002|Overall Study|Adverse Event|4|||
27764815|NCT02281773|54217248|FG003|Overall Study|Adverse Event|8|||
27764816|NCT02281773|54217249|FG004|Overall Study|Adverse Event|9|||
27764817|NCT02281773|54217245|FG000|Overall Study|Protocol Violation|1|||
27764818|NCT02281773|54217246|FG001|Overall Study|Protocol Violation|0|||
27764819|NCT02281773|54217247|FG002|Overall Study|Protocol Violation|0|||
27764820|NCT02281773|54217248|FG003|Overall Study|Protocol Violation|2|||
27764821|NCT02281773|54217249|FG004|Overall Study|Protocol Violation|2|||
27764822|NCT02281773|54217245|FG000|Overall Study|Lost to Follow-up|2|||
27764823|NCT02281773|54217246|FG001|Overall Study|Lost to Follow-up|2|||
27764824|NCT02281773|54217247|FG002|Overall Study|Lost to Follow-up|6|||
27764825|NCT02281773|54217248|FG003|Overall Study|Lost to Follow-up|2|||
27764826|NCT02281773|54217249|FG004|Overall Study|Lost to Follow-up|10|||
28105479|NCT02793232|54762846|FG005|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
27764827|NCT02281773|54217245|FG000|Overall Study|Withdrawal by Subject|2|||
27764828|NCT02281773|54217246|FG001|Overall Study|Withdrawal by Subject|8|||
27764829|NCT02281773|54217247|FG002|Overall Study|Withdrawal by Subject|6|||
27764830|NCT02281773|54217248|FG003|Overall Study|Withdrawal by Subject|6|||
27764831|NCT02281773|54217249|FG004|Overall Study|Withdrawal by Subject|8|||
27764832|NCT02281773|54217245|FG000|Overall Study|Other Reason|0|||
27764833|NCT02281773|54217246|FG001|Overall Study|Other Reason|4|||
27764834|NCT02281773|54217247|FG002|Overall Study|Other Reason|2|||
27764835|NCT02281773|54217248|FG003|Overall Study|Other Reason|3|||
27764836|NCT02281773|54217249|FG004|Overall Study|Other Reason|1|||
27764837|NCT02285361|54217261|FG000|Overall Study|Protocol Violation|43|||
27764838|NCT02285361|54217261|FG000|Overall Study|Lost to Follow-up|5|||
27764839|NCT02285361|54217261|FG000|Overall Study|Not taken GIOTRIF|2|||
27764840|NCT02285361|54217261|FG000|Overall Study|Consented prior to the contract date|1|||
27764841|NCT02354235|54217267|FG000|Overall Study|Adverse Event|2|||
27764842|NCT02354235|54217268|FG001|Overall Study|Adverse Event|2|||
27764843|NCT02354235|54217267|FG000|Overall Study|Physician Decision|0|||
27764844|NCT02354235|54217268|FG001|Overall Study|Physician Decision|1|||
27764845|NCT02354235|54217267|FG000|Overall Study|Withdrawal by Subject|1|||
27764846|NCT02354235|54217268|FG001|Overall Study|Withdrawal by Subject|3|||
27764847|NCT02354235|54217267|FG000|Overall Study|Conflict with the stopping criteria|0|||
27764848|NCT02354235|54217268|FG001|Overall Study|Conflict with the stopping criteria|1|||
27764849|NCT02280291|54217278|FG000|Overall Study|Lost to Follow-up|2|||
27764850|NCT02280291|54217279|FG001|Overall Study|Lost to Follow-up|1|||
27764851|NCT02280291|54217280|FG002|Overall Study|Lost to Follow-up|3|||
27764852|NCT02280291|54217281|FG003|Overall Study|Lost to Follow-up|8|||
27764853|NCT02280291|54217278|FG000|Overall Study|Protocol Violation|1|||
27764854|NCT02280291|54217279|FG001|Overall Study|Protocol Violation|0|||
27764855|NCT02280291|54217280|FG002|Overall Study|Protocol Violation|0|||
27764856|NCT02280291|54217281|FG003|Overall Study|Protocol Violation|0|||
27764857|NCT02280291|54217278|FG000|Overall Study|Other|1|||
27764858|NCT02280291|54217279|FG001|Overall Study|Other|1|||
27764859|NCT02280291|54217280|FG002|Overall Study|Other|0|||
27764860|NCT02280291|54217281|FG003|Overall Study|Other|0|||
27764861|NCT02284893|54217295|FG000|26 Week (Short Term)|Adverse Event|1|||
27764862|NCT02284893|54217296|FG001|26 Week (Short Term)|Adverse Event|9|||
27764863|NCT02284893|54217295|FG000|26 Week (Short Term)|Discontinuation by the subject|2|||
27764864|NCT02284893|54217296|FG001|26 Week (Short Term)|Discontinuation by the subject|2|||
27764865|NCT02284893|54217295|FG000|26 Week (Short Term)|Withrawal of the consent by the subject|7|||
27764866|NCT02284893|54217296|FG001|26 Week (Short Term)|Withrawal of the consent by the subject|10|||
27764867|NCT02284893|54217295|FG000|26 Week (Short Term)|Lost to Follow-up|3|||
27764868|NCT02284893|54217296|FG001|26 Week (Short Term)|Lost to Follow-up|1|||
27764869|NCT02284893|54217295|FG000|26 Week (Short Term)|Subject no longer meets study criteria|5|||
27764870|NCT02284893|54217296|FG001|26 Week (Short Term)|Subject no longer meets study criteria|8|||
27764871|NCT02284893|54217295|FG000|26 Week (Short Term)|Other|1|||
27764872|NCT02284893|54217296|FG001|26 Week (Short Term)|Other|1|||
27764873|NCT02284893|54217295|FG000|52 Week (Long Term)|Adverse Event|3|||
27764874|NCT02284893|54217296|FG001|52 Week (Long Term)|Adverse Event|1|||
27764875|NCT02284893|54217295|FG000|52 Week (Long Term)|Subject no longer meets study criteria|0|||
27764876|NCT02284893|54217296|FG001|52 Week (Long Term)|Subject no longer meets study criteria|1|||
27764877|NCT02284893|54217295|FG000|52 Week (Long Term)|Withrawal of the consent by the subject|4|||
27764878|NCT02284893|54217296|FG001|52 Week (Long Term)|Withrawal of the consent by the subject|6|||
27764879|NCT02284893|54217295|FG000|52 Week (Long Term)|Lost to Follow-up|2|||
27764880|NCT02284893|54217296|FG001|52 Week (Long Term)|Lost to Follow-up|2|||
27764881|NCT02284893|54217295|FG000|52 Week (Long Term)|Non-Compliance|2|||
27764882|NCT02284893|54217296|FG001|52 Week (Long Term)|Non-Compliance|3|||
27764883|NCT02284347|54217302|FG000|Overall Study|Lost to Follow-up|2|||
27764884|NCT02284347|54217302|FG000|Overall Study|Withdrawn prior to treatment|1|||
27764885|NCT02279043|54217309|FG000|Overall Study|Post-rand. exclusion - not eligible|1|||
27764886|NCT02279043|54217310|FG001|Overall Study|Post-rand. exclusion - not eligible|1|||
27764887|NCT02279043|54217311|FG002|Overall Study|Post-rand. exclusion - not eligible|0|||
27764888|NCT02279043|54217309|FG000|Overall Study|Lost to Follow-up|46|||
27764889|NCT02279043|54217310|FG001|Overall Study|Lost to Follow-up|88|||
27764890|NCT02279043|54217311|FG002|Overall Study|Lost to Follow-up|0|||
27764891|NCT02283411|54217317|FG000|Overall Study|Withdrawal by Subject|3|||
27764892|NCT02283411|54217317|FG000|Overall Study|Screen Failed|28|||
27764893|NCT02351817|54217321|FG000|Period 1|Adverse Event|1|||
27764894|NCT02351817|54217322|FG001|Period 1|Adverse Event|2|||
27764895|NCT02351817|54217321|FG000|Period 1|Lack of Efficacy|0|||
27764896|NCT02351817|54217322|FG001|Period 1|Lack of Efficacy|1|||
27764897|NCT02351817|54217321|FG000|Period 2|Adverse Event|0|||
27764898|NCT02351817|54217322|FG001|Period 2|Adverse Event|2|||
27764899|NCT02351817|54217321|FG000|Period 2|Protocol Violation|1|||
27764900|NCT02351817|54217322|FG001|Period 2|Protocol Violation|0|||
27764901|NCT02351349|54217331|FG000|Overall Study|Withdrawal by Subject|2|||
27764902|NCT02351349|54217332|FG001|Overall Study|Withdrawal by Subject|3|||
27764903|NCT02484547|54217346|FG000|Placebo-Controlled Period|Adverse Event|10|||
27764904|NCT02484547|54217347|FG001|Placebo-Controlled Period|Adverse Event|13|||
27764905|NCT02484547|54217348|FG002|Placebo-Controlled Period|Adverse Event|20|||
27764906|NCT02484547|54217349|FG003|Placebo-Controlled Period|Adverse Event|0|||
27764907|NCT02484547|54217350|FG004|Placebo-Controlled Period|Adverse Event|0|||
27764908|NCT02484547|54217351|FG005|Placebo-Controlled Period|Adverse Event|0|||
27764909|NCT02484547|54217352|FG006|Placebo-Controlled Period|Adverse Event|0|||
27764910|NCT02484547|54217346|FG000|Placebo-Controlled Period|Change of Treatment|0|||
27764911|NCT02484547|54217347|FG001|Placebo-Controlled Period|Change of Treatment|0|||
27764912|NCT02484547|54217348|FG002|Placebo-Controlled Period|Change of Treatment|1|||
27764913|NCT02484547|54217349|FG003|Placebo-Controlled Period|Change of Treatment|0|||
27764914|NCT02484547|54217350|FG004|Placebo-Controlled Period|Change of Treatment|0|||
27764915|NCT02484547|54217351|FG005|Placebo-Controlled Period|Change of Treatment|0|||
27764916|NCT02484547|54217352|FG006|Placebo-Controlled Period|Change of Treatment|0|||
27764917|NCT02484547|54217346|FG000|Placebo-Controlled Period|Consent Withdrawn|15|||
27764918|NCT02484547|54217347|FG001|Placebo-Controlled Period|Consent Withdrawn|32|||
27764919|NCT02484547|54217348|FG002|Placebo-Controlled Period|Consent Withdrawn|26|||
27764920|NCT02484547|54217349|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
27764921|NCT02484547|54217350|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
27764922|NCT02484547|54217351|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
27764923|NCT02484547|54217352|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
27764924|NCT02484547|54217346|FG000|Placebo-Controlled Period|Death|5|||
27764925|NCT02484547|54217347|FG001|Placebo-Controlled Period|Death|0|||
27764926|NCT02484547|54217348|FG002|Placebo-Controlled Period|Death|6|||
27764927|NCT02484547|54217349|FG003|Placebo-Controlled Period|Death|0|||
27764928|NCT02484547|54217350|FG004|Placebo-Controlled Period|Death|0|||
27764929|NCT02484547|54217351|FG005|Placebo-Controlled Period|Death|0|||
27764930|NCT02484547|54217352|FG006|Placebo-Controlled Period|Death|0|||
27764931|NCT02484547|54217346|FG000|Placebo-Controlled Period|Disease Progression|2|||
27764932|NCT02484547|54217347|FG001|Placebo-Controlled Period|Disease Progression|0|||
27764933|NCT02484547|54217348|FG002|Placebo-Controlled Period|Disease Progression|1|||
27764934|NCT02484547|54217349|FG003|Placebo-Controlled Period|Disease Progression|0|||
27764935|NCT02484547|54217350|FG004|Placebo-Controlled Period|Disease Progression|0|||
27764936|NCT02484547|54217351|FG005|Placebo-Controlled Period|Disease Progression|0|||
27764937|NCT02484547|54217352|FG006|Placebo-Controlled Period|Disease Progression|0|||
27764938|NCT02484547|54217346|FG000|Placebo-Controlled Period|Investigator Decision|2|||
27764939|NCT02484547|54217347|FG001|Placebo-Controlled Period|Investigator Decision|2|||
27764940|NCT02484547|54217348|FG002|Placebo-Controlled Period|Investigator Decision|5|||
27764941|NCT02484547|54217349|FG003|Placebo-Controlled Period|Investigator Decision|0|||
27764942|NCT02484547|54217350|FG004|Placebo-Controlled Period|Investigator Decision|0|||
27764943|NCT02484547|54217351|FG005|Placebo-Controlled Period|Investigator Decision|0|||
27764944|NCT02484547|54217352|FG006|Placebo-Controlled Period|Investigator Decision|0|||
27764945|NCT02484547|54217346|FG000|Placebo-Controlled Period|Lost to Follow-up|3|||
27764946|NCT02484547|54217347|FG001|Placebo-Controlled Period|Lost to Follow-up|1|||
27764947|NCT02484547|54217348|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
27764948|NCT02484547|54217349|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
27764949|NCT02484547|54217350|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
27764950|NCT02484547|54217351|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
27764951|NCT02484547|54217352|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
27764952|NCT02484547|54217346|FG000|Placebo-Controlled Period|Relocation|1|||
27764953|NCT02484547|54217347|FG001|Placebo-Controlled Period|Relocation|1|||
27764954|NCT02484547|54217348|FG002|Placebo-Controlled Period|Relocation|1|||
27764955|NCT02484547|54217349|FG003|Placebo-Controlled Period|Relocation|0|||
27764956|NCT02484547|54217350|FG004|Placebo-Controlled Period|Relocation|0|||
27764957|NCT02484547|54217351|FG005|Placebo-Controlled Period|Relocation|0|||
27764958|NCT02484547|54217352|FG006|Placebo-Controlled Period|Relocation|0|||
27764959|NCT02484547|54217346|FG000|Placebo-Controlled Period|Study Visit Burden|2|||
27764960|NCT02484547|54217347|FG001|Placebo-Controlled Period|Study Visit Burden|8|||
27764961|NCT02484547|54217348|FG002|Placebo-Controlled Period|Study Visit Burden|5|||
27764962|NCT02484547|54217349|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
27764963|NCT02484547|54217350|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
27764964|NCT02484547|54217351|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
27764965|NCT02484547|54217352|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
27764966|NCT02484547|54217346|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|4|||
27764967|NCT02484547|54217347|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
27764968|NCT02484547|54217348|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
27764969|NCT02484547|54217349|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
27764970|NCT02484547|54217350|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
27764971|NCT02484547|54217351|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
27764972|NCT02484547|54217352|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
27764973|NCT02484547|54217346|FG000|Placebo-Controlled Period|Reason not Specified|216|||
27831212|NCT01816061|54307502|FG001|Overall Study|Lost to Follow-up|24|||
27764974|NCT02484547|54217347|FG001|Placebo-Controlled Period|Reason not Specified|194|||
27764975|NCT02484547|54217348|FG002|Placebo-Controlled Period|Reason not Specified|183|||
27764976|NCT02484547|54217349|FG003|Placebo-Controlled Period|Reason not Specified|0|||
27764977|NCT02484547|54217350|FG004|Placebo-Controlled Period|Reason not Specified|0|||
27764978|NCT02484547|54217351|FG005|Placebo-Controlled Period|Reason not Specified|0|||
27764979|NCT02484547|54217352|FG006|Placebo-Controlled Period|Reason not Specified|0|||
27764980|NCT02484547|54217346|FG000|Long-Term Extension Period|Adverse Event|0|||
27764981|NCT02484547|54217347|FG001|Long-Term Extension Period|Adverse Event|0|||
27764982|NCT02484547|54217348|FG002|Long-Term Extension Period|Adverse Event|0|||
27764983|NCT02484547|54217349|FG003|Long-Term Extension Period|Adverse Event|0|||
27764984|NCT02484547|54217350|FG004|Long-Term Extension Period|Adverse Event|1|||
27764985|NCT02484547|54217351|FG005|Long-Term Extension Period|Adverse Event|3|||
27764986|NCT02484547|54217352|FG006|Long-Term Extension Period|Adverse Event|2|||
27764987|NCT02484547|54217346|FG000|Long-Term Extension Period|Death|0|||
27764988|NCT02484547|54217347|FG001|Long-Term Extension Period|Death|0|||
27764989|NCT02484547|54217348|FG002|Long-Term Extension Period|Death|0|||
27764990|NCT02484547|54217349|FG003|Long-Term Extension Period|Death|0|||
27764991|NCT02484547|54217350|FG004|Long-Term Extension Period|Death|0|||
27764992|NCT02484547|54217351|FG005|Long-Term Extension Period|Death|3|||
27764993|NCT02484547|54217352|FG006|Long-Term Extension Period|Death|0|||
27764994|NCT02484547|54217346|FG000|Long-Term Extension Period|Disease Progression|0|||
27764995|NCT02484547|54217347|FG001|Long-Term Extension Period|Disease Progression|0|||
27764996|NCT02484547|54217348|FG002|Long-Term Extension Period|Disease Progression|0|||
27764997|NCT02484547|54217349|FG003|Long-Term Extension Period|Disease Progression|0|||
27764998|NCT02484547|54217350|FG004|Long-Term Extension Period|Disease Progression|2|||
27764999|NCT02484547|54217351|FG005|Long-Term Extension Period|Disease Progression|4|||
27765000|NCT02484547|54217352|FG006|Long-Term Extension Period|Disease Progression|0|||
27765001|NCT02484547|54217346|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
27765002|NCT02484547|54217347|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
27765003|NCT02484547|54217348|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
27765004|NCT02484547|54217349|FG003|Long-Term Extension Period|Lost to Follow-up|1|||
27765005|NCT02484547|54217350|FG004|Long-Term Extension Period|Lost to Follow-up|1|||
27765006|NCT02484547|54217351|FG005|Long-Term Extension Period|Lost to Follow-up|2|||
27765007|NCT02484547|54217352|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
27765008|NCT02484547|54217346|FG000|Long-Term Extension Period|Loss of Capacity|0|||
27765009|NCT02484547|54217347|FG001|Long-Term Extension Period|Loss of Capacity|0|||
27765010|NCT02484547|54217348|FG002|Long-Term Extension Period|Loss of Capacity|0|||
27765011|NCT02484547|54217349|FG003|Long-Term Extension Period|Loss of Capacity|0|||
27765012|NCT02484547|54217350|FG004|Long-Term Extension Period|Loss of Capacity|1|||
27765013|NCT02484547|54217351|FG005|Long-Term Extension Period|Loss of Capacity|0|||
27765014|NCT02484547|54217352|FG006|Long-Term Extension Period|Loss of Capacity|0|||
27765015|NCT02484547|54217346|FG000|Long-Term Extension Period|Change of Treatment|0|||
27765016|NCT02484547|54217347|FG001|Long-Term Extension Period|Change of Treatment|0|||
27765017|NCT02484547|54217348|FG002|Long-Term Extension Period|Change of Treatment|0|||
27765018|NCT02484547|54217349|FG003|Long-Term Extension Period|Change of Treatment|0|||
27765019|NCT02484547|54217350|FG004|Long-Term Extension Period|Change of Treatment|0|||
27765020|NCT02484547|54217351|FG005|Long-Term Extension Period|Change of Treatment|0|||
27765021|NCT02484547|54217352|FG006|Long-Term Extension Period|Change of Treatment|1|||
27765022|NCT02484547|54217346|FG000|Long-Term Extension Period|Consent Withdrawn|0|||
27765023|NCT02484547|54217347|FG001|Long-Term Extension Period|Consent Withdrawn|0|||
27765024|NCT02484547|54217348|FG002|Long-Term Extension Period|Consent Withdrawn|0|||
27765025|NCT02484547|54217349|FG003|Long-Term Extension Period|Consent Withdrawn|6|||
27765026|NCT02484547|54217350|FG004|Long-Term Extension Period|Consent Withdrawn|7|||
27765027|NCT02484547|54217351|FG005|Long-Term Extension Period|Consent Withdrawn|13|||
27765028|NCT02484547|54217352|FG006|Long-Term Extension Period|Consent Withdrawn|17|||
27765029|NCT02484547|54217346|FG000|Long-Term Extension Period|Investigator Decision|0|||
27765030|NCT02484547|54217347|FG001|Long-Term Extension Period|Investigator Decision|0|||
27765031|NCT02484547|54217348|FG002|Long-Term Extension Period|Investigator Decision|0|||
27765032|NCT02484547|54217349|FG003|Long-Term Extension Period|Investigator Decision|2|||
27765033|NCT02484547|54217350|FG004|Long-Term Extension Period|Investigator Decision|1|||
27765034|NCT02484547|54217351|FG005|Long-Term Extension Period|Investigator Decision|0|||
27765035|NCT02484547|54217352|FG006|Long-Term Extension Period|Investigator Decision|1|||
27765036|NCT02484547|54217346|FG000|Long-Term Extension Period|Relocation|0|||
27765037|NCT02484547|54217347|FG001|Long-Term Extension Period|Relocation|0|||
27765038|NCT02484547|54217348|FG002|Long-Term Extension Period|Relocation|0|||
27765039|NCT02484547|54217349|FG003|Long-Term Extension Period|Relocation|1|||
27765040|NCT02484547|54217350|FG004|Long-Term Extension Period|Relocation|1|||
27765041|NCT02484547|54217351|FG005|Long-Term Extension Period|Relocation|0|||
27765042|NCT02484547|54217352|FG006|Long-Term Extension Period|Relocation|0|||
27765043|NCT02484547|54217346|FG000|Long-Term Extension Period|Study Visit Burden|0|||
27765044|NCT02484547|54217347|FG001|Long-Term Extension Period|Study Visit Burden|0|||
27765045|NCT02484547|54217348|FG002|Long-Term Extension Period|Study Visit Burden|0|||
27765046|NCT02484547|54217349|FG003|Long-Term Extension Period|Study Visit Burden|2|||
27765047|NCT02484547|54217350|FG004|Long-Term Extension Period|Study Visit Burden|0|||
27765048|NCT02484547|54217351|FG005|Long-Term Extension Period|Study Visit Burden|0|||
27765049|NCT02484547|54217352|FG006|Long-Term Extension Period|Study Visit Burden|3|||
27765050|NCT02484547|54217346|FG000|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
27765051|NCT02484547|54217347|FG001|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
27765052|NCT02484547|54217348|FG002|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
27765053|NCT02484547|54217349|FG003|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
27765054|NCT02484547|54217350|FG004|Long-Term Extension Period|Withdrawal by Parent/Guardian|1|||
27765055|NCT02484547|54217351|FG005|Long-Term Extension Period|Withdrawal by Parent/Guardian|3|||
27765056|NCT02484547|54217352|FG006|Long-Term Extension Period|Withdrawal by Parent/Guardian|2|||
27765057|NCT02484547|54217346|FG000|Long-Term Extension Period|Reason not Specified|0|||
27765058|NCT02484547|54217347|FG001|Long-Term Extension Period|Reason not Specified|0|||
27765059|NCT02484547|54217348|FG002|Long-Term Extension Period|Reason not Specified|0|||
27765060|NCT02484547|54217349|FG003|Long-Term Extension Period|Reason not Specified|119|||
27765061|NCT02484547|54217350|FG004|Long-Term Extension Period|Reason not Specified|117|||
27765062|NCT02484547|54217351|FG005|Long-Term Extension Period|Reason not Specified|223|||
27765063|NCT02484547|54217352|FG006|Long-Term Extension Period|Reason not Specified|231|||
27765064|NCT02517541|54217364|FG000|Baseline Period (Own Product)|Protocol Violation|1|||
27765065|NCT02517541|54217364|FG000|Test Period (SenSura Mio Convex Soft)|Adverse Event|3|||
27765066|NCT02517541|54217364|FG000|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2|||
27765067|NCT02517541|54217364|FG000|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1|||
27765068|NCT02517541|54217364|FG000|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4|||
27765069|NCT02517541|54217364|FG000|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2|||
27765070|NCT02496091|54217370|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
27765071|NCT02483611|54217378|FG000|Overall Study|Protocol Violation|0|||
27765072|NCT02483611|54217379|FG001|Overall Study|Protocol Violation|0|||
27765073|NCT02483611|54217380|FG002|Overall Study|Protocol Violation|1|||
27765074|NCT02483533|54217390|FG000|Overall Study|Lack of Efficacy|50|||
27765075|NCT02483533|54217391|FG001|Overall Study|Lack of Efficacy|50|||
27765076|NCT02482129|54217399|FG000|Overall Study|Adverse Event-prior to treatment|0|||
27765077|NCT02482129|54217400|FG001|Overall Study|Adverse Event-prior to treatment|1|||
27765078|NCT02482129|54217399|FG000|Overall Study|Withdrawal by subject-prior to treatment|0|||
27839605|NCT01506193|54326902|FG001|Overall Study|Withdrawal by Subject|1|||
27765079|NCT02482129|54217400|FG001|Overall Study|Withdrawal by subject-prior to treatment|1|||
27765080|NCT02482129|54217399|FG000|Overall Study|Unable to draw blood-prior to treatment|1|||
27765081|NCT02482129|54217400|FG001|Overall Study|Unable to draw blood-prior to treatment|0|||
27839606|NCT01506193|54326903|FG002|Overall Study|Withdrawal by Subject|8|||
27765082|NCT02482129|54217399|FG000|Overall Study|Criteria not met-prior to treatment|1|||
27765083|NCT02482129|54217400|FG001|Overall Study|Criteria not met-prior to treatment|0|||
27765084|NCT02482129|54217399|FG000|Overall Study|Adverse Event|1|||
27765085|NCT02482129|54217400|FG001|Overall Study|Adverse Event|0|||
27765086|NCT02482129|54217399|FG000|Overall Study|Withdrawal by Subject|2|||
27765087|NCT02482129|54217400|FG001|Overall Study|Withdrawal by Subject|0|||
27765088|NCT02482129|54217399|FG000|Overall Study|Criteria not met|1|||
27765089|NCT02482129|54217400|FG001|Overall Study|Criteria not met|0|||
27765090|NCT02495857|54217411|FG000|Overall Study|Adverse Event|5|||
27839607|NCT01506193|54326901|FG000|Overall Study|Lost to Follow-up|8|||
27839608|NCT01506193|54326902|FG001|Overall Study|Lost to Follow-up|3|||
27765091|NCT02495857|54217412|FG001|Overall Study|Adverse Event|0|||
27765092|NCT02495857|54217413|FG002|Overall Study|Adverse Event|1|||
27765093|NCT02495857|54217411|FG000|Overall Study|Withdrawal by Subject|9|||
27839609|NCT01506193|54326903|FG002|Overall Study|Lost to Follow-up|3|||
27839610|NCT01505881|54326914|FG000|Overall Study|Adverse Event|0|||
27839611|NCT01505881|54326915|FG001|Overall Study|Adverse Event|1|||
27839612|NCT01505881|54326914|FG000|Overall Study|Lost to Follow-up|2|||
27839613|NCT01505881|54326915|FG001|Overall Study|Lost to Follow-up|0|||
27839614|NCT01505881|54326914|FG000|Overall Study|Withdrawal by Subject|2|||
27839615|NCT01505881|54326915|FG001|Overall Study|Withdrawal by Subject|0|||
27839616|NCT01462045|54326925|FG000|Overall Study|Family matter|0|||
27839617|NCT01462045|54326926|FG001|Overall Study|Family matter|1|||
27839618|NCT01462045|54326927|FG002|Overall Study|Family matter|0|||
27839619|NCT01505647|54326937|FG000|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1|||
27839620|NCT01505647|54326938|FG001|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0|||
27839621|NCT01505647|54326937|FG000|Day 1 Through Day 42 Follow-up|Physician Decision|1|||
27839622|NCT01505647|54326938|FG001|Day 1 Through Day 42 Follow-up|Physician Decision|0|||
27839623|NCT01505647|54326937|FG000|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1|||
27839624|NCT01505647|54326938|FG001|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0|||
27839625|NCT01505647|54326937|FG000|Day 43 Through Day 182 Follow-up|Death|0|||
27839626|NCT01505647|54326938|FG001|Day 43 Through Day 182 Follow-up|Death|1|||
27839627|NCT01505647|54326937|FG000|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1|||
27839628|NCT01505647|54326938|FG001|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2|||
27839629|NCT01477333|54326944|FG000|Overall Study|Adverse Event|1|||
27839630|NCT01477333|54326944|FG000|Overall Study|Withdrawal by Subject|1|||
27839631|NCT01477333|54326944|FG000|Overall Study|Clinical Deterioration|1|||
27839632|NCT01461811|54326954|FG000|Overall Study|Adverse Event|2|||
27839633|NCT01461811|54326955|FG001|Overall Study|Adverse Event|1|||
27839634|NCT01461811|54326954|FG000|Overall Study|Subject decision unrelated to an AE|1|||
27839635|NCT01461811|54326955|FG001|Overall Study|Subject decision unrelated to an AE|1|||
27839636|NCT01461811|54326954|FG000|Overall Study|Noncompliance|1|||
27839637|NCT01461811|54326955|FG001|Overall Study|Noncompliance|1|||
27839638|NCT01505491|54326964|FG000|Overall Study|Other reason not listed|1|||
27839639|NCT01505491|54326965|FG001|Overall Study|Other reason not listed|0|||
27839640|NCT01505491|54326966|FG002|Overall Study|Other reason not listed|0|||
27839641|NCT01505491|54326964|FG000|Overall Study|Withdrawal by Subject|1|||
27839642|NCT01505491|54326965|FG001|Overall Study|Withdrawal by Subject|1|||
27839643|NCT01505491|54326966|FG002|Overall Study|Withdrawal by Subject|4|||
27839644|NCT01505491|54326964|FG000|Overall Study|Lost to Follow-up|0|||
27839645|NCT01505491|54326965|FG001|Overall Study|Lost to Follow-up|0|||
27839646|NCT01505491|54326966|FG002|Overall Study|Lost to Follow-up|1|||
27839647|NCT01504867|54326976|FG000|Overall Study|Inclusion criteria not met|2|||
27839648|NCT01504867|54326977|FG001|Overall Study|Inclusion criteria not met|2|||
27839649|NCT01504867|54326976|FG000|Overall Study|Consent revoked|5|||
27839650|NCT01504867|54326977|FG001|Overall Study|Consent revoked|1|||
27839651|NCT01476475|54326985|FG000|Overall Study|Adverse Event|6|||
27839652|NCT01476475|54326986|FG001|Overall Study|Adverse Event|0|||
27839653|NCT01476475|54326985|FG000|Overall Study|Poor compliance to protocol|1|||
27839654|NCT01476475|54326986|FG001|Overall Study|Poor compliance to protocol|1|||
27839655|NCT01476475|54326985|FG000|Overall Study|Other reasons|4|||
27839656|NCT01476475|54326986|FG001|Overall Study|Other reasons|2|||
27839657|NCT01475851|54326995|FG000|Overall Study|Protocol defined stopping criteria|1|||
27839658|NCT01475851|54326996|FG001|Overall Study|Protocol defined stopping criteria|0|||
27839659|NCT01460719|54327002|FG000|Overall Study|Adverse Event|1|||
27839660|NCT01460719|54327002|FG000|Overall Study|Withdrawal by Subject|1|||
27839661|NCT01468181|54327072|FG000|Overall Study|Adverse Event|8|||
27839662|NCT01468181|54327073|FG001|Overall Study|Adverse Event|1|||
27839663|NCT01468181|54327074|FG002|Overall Study|Adverse Event|6|||
27839664|NCT01468181|54327075|FG003|Overall Study|Adverse Event|2|||
27839665|NCT01468181|54327076|FG004|Overall Study|Adverse Event|2|||
27839666|NCT01468181|54327072|FG000|Overall Study|Protocol Violation|2|||
27839667|NCT01468181|54327073|FG001|Overall Study|Protocol Violation|0|||
27839668|NCT01468181|54327074|FG002|Overall Study|Protocol Violation|1|||
27839669|NCT01468181|54327075|FG003|Overall Study|Protocol Violation|0|||
27839670|NCT01468181|54327076|FG004|Overall Study|Protocol Violation|1|||
27839671|NCT01468181|54327072|FG000|Overall Study|Physician Decision|0|||
27839672|NCT01468181|54327073|FG001|Overall Study|Physician Decision|0|||
27839673|NCT01468181|54327074|FG002|Overall Study|Physician Decision|0|||
27839674|NCT01468181|54327075|FG003|Overall Study|Physician Decision|1|||
27839675|NCT01468181|54327076|FG004|Overall Study|Physician Decision|1|||
27839676|NCT01468181|54327072|FG000|Overall Study|Lost to Follow-up|0|||
27839677|NCT01468181|54327073|FG001|Overall Study|Lost to Follow-up|0|||
27839678|NCT01468181|54327074|FG002|Overall Study|Lost to Follow-up|1|||
27839679|NCT01468181|54327075|FG003|Overall Study|Lost to Follow-up|0|||
27839680|NCT01468181|54327076|FG004|Overall Study|Lost to Follow-up|1|||
27839681|NCT01468181|54327072|FG000|Overall Study|Withdrawal by Subject|0|||
27839682|NCT01468181|54327073|FG001|Overall Study|Withdrawal by Subject|1|||
27765094|NCT02495857|54217412|FG001|Overall Study|Withdrawal by Subject|6|||
27765095|NCT02495857|54217413|FG002|Overall Study|Withdrawal by Subject|10|||
27765096|NCT02495857|54217411|FG000|Overall Study|Physician Decision|0|||
27765097|NCT02495857|54217412|FG001|Overall Study|Physician Decision|1|||
27765098|NCT02495857|54217413|FG002|Overall Study|Physician Decision|0|||
27765099|NCT02495857|54217411|FG000|Overall Study|Protocol Violation|1|||
27765100|NCT02495857|54217412|FG001|Overall Study|Protocol Violation|1|||
27765101|NCT02495857|54217413|FG002|Overall Study|Protocol Violation|2|||
27765102|NCT02495857|54217411|FG000|Overall Study|Lost to Follow-up|4|||
27765103|NCT02495857|54217412|FG001|Overall Study|Lost to Follow-up|5|||
27765104|NCT02495857|54217413|FG002|Overall Study|Lost to Follow-up|3|||
27765105|NCT02495857|54217411|FG000|Overall Study|Other|3|||
27765106|NCT02495857|54217412|FG001|Overall Study|Other|3|||
27765107|NCT02495857|54217413|FG002|Overall Study|Other|2|||
27765108|NCT02495389|54217421|FG000|Overall Study|Withdrawal by Subject|40|||
27765109|NCT02495233|54217427|FG000|Overall Study|Miscellaneous|0|||
27765110|NCT02495233|54217428|FG001|Overall Study|Miscellaneous|1|||
27765111|NCT02495077|54217436|FG000|Overall Study|Adverse Event|0|||
27765112|NCT02495077|54217437|FG001|Overall Study|Adverse Event|1|||
27765113|NCT02495077|54217438|FG002|Overall Study|Adverse Event|1|||
27765114|NCT02495077|54217439|FG003|Overall Study|Adverse Event|0|||
27765115|NCT02495077|54217436|FG000|Overall Study|Death|3|||
27765116|NCT02495077|54217437|FG001|Overall Study|Death|5|||
27765117|NCT02495077|54217438|FG002|Overall Study|Death|0|||
27765118|NCT02495077|54217439|FG003|Overall Study|Death|0|||
27765119|NCT02495077|54217436|FG000|Overall Study|Lost to Follow-up|6|||
27765120|NCT02495077|54217437|FG001|Overall Study|Lost to Follow-up|4|||
27765121|NCT02495077|54217438|FG002|Overall Study|Lost to Follow-up|0|||
27765122|NCT02495077|54217439|FG003|Overall Study|Lost to Follow-up|0|||
27765123|NCT02495077|54217436|FG000|Overall Study|Physician Decision|2|||
27765124|NCT02495077|54217437|FG001|Overall Study|Physician Decision|1|||
27765125|NCT02495077|54217438|FG002|Overall Study|Physician Decision|4|||
27765126|NCT02495077|54217439|FG003|Overall Study|Physician Decision|0|||
27765127|NCT02495077|54217436|FG000|Overall Study|Protocol Violation|0|||
27765128|NCT02495077|54217437|FG001|Overall Study|Protocol Violation|1|||
27765129|NCT02495077|54217438|FG002|Overall Study|Protocol Violation|0|||
27765130|NCT02495077|54217439|FG003|Overall Study|Protocol Violation|0|||
27765131|NCT02495077|54217436|FG000|Overall Study|Screen Failure|0|||
27765132|NCT02495077|54217437|FG001|Overall Study|Screen Failure|0|||
27765133|NCT02495077|54217438|FG002|Overall Study|Screen Failure|0|||
27765134|NCT02495077|54217439|FG003|Overall Study|Screen Failure|48|||
27765135|NCT02495077|54217436|FG000|Overall Study|Withdrawal by Subject|7|||
27765136|NCT02495077|54217437|FG001|Overall Study|Withdrawal by Subject|7|||
27765137|NCT02495077|54217438|FG002|Overall Study|Withdrawal by Subject|7|||
27765138|NCT02495077|54217439|FG003|Overall Study|Withdrawal by Subject|0|||
27765139|NCT02495077|54217436|FG000|Overall Study|Covid-19 research restrictions|1|||
27765140|NCT02495077|54217437|FG001|Overall Study|Covid-19 research restrictions|0|||
27765141|NCT02495077|54217438|FG002|Overall Study|Covid-19 research restrictions|0|||
27765142|NCT02495077|54217439|FG003|Overall Study|Covid-19 research restrictions|0|||
27765143|NCT02495077|54217436|FG000|Overall Study|Visit 14 scheduling difficulties|1|||
27765144|NCT02495077|54217437|FG001|Overall Study|Visit 14 scheduling difficulties|0|||
27765145|NCT02495077|54217438|FG002|Overall Study|Visit 14 scheduling difficulties|0|||
27765146|NCT02495077|54217439|FG003|Overall Study|Visit 14 scheduling difficulties|0|||
27765147|NCT02495077|54217436|FG000|Overall Study|Incarcerated|0|||
27765148|NCT02495077|54217437|FG001|Overall Study|Incarcerated|1|||
27765149|NCT02495077|54217438|FG002|Overall Study|Incarcerated|0|||
27765150|NCT02495077|54217439|FG003|Overall Study|Incarcerated|0|||
27765151|NCT02495077|54217436|FG000|Overall Study|Transplant nephrectomy, patient decision|0|||
27765152|NCT02495077|54217437|FG001|Overall Study|Transplant nephrectomy, patient decision|1|||
27765153|NCT02495077|54217438|FG002|Overall Study|Transplant nephrectomy, patient decision|0|||
27831213|NCT01792115|54307528|FG000|Overall Study|Lost to Follow-up|0|||
27765154|NCT02495077|54217439|FG003|Overall Study|Transplant nephrectomy, patient decision|0|||
27765155|NCT02495077|54217436|FG000|Overall Study|Timing of transplant and randomization|0|||
27765156|NCT02495077|54217437|FG001|Overall Study|Timing of transplant and randomization|0|||
27765157|NCT02495077|54217438|FG002|Overall Study|Timing of transplant and randomization|5|||
27765158|NCT02495077|54217439|FG003|Overall Study|Timing of transplant and randomization|0|||
27765159|NCT02278341|54217447|FG000|Overall Study|Randomized but never received study drug|1|||
27765160|NCT02278341|54217448|FG001|Overall Study|Randomized but never received study drug|1|||
27765161|NCT02278341|54217447|FG000|Overall Study|Adverse Event|3|||
27765162|NCT02278341|54217448|FG001|Overall Study|Adverse Event|0|||
27765163|NCT02278341|54217447|FG000|Overall Study|Death|68|||
27765164|NCT02278341|54217448|FG001|Overall Study|Death|56|||
27765165|NCT02278341|54217447|FG000|Overall Study|Withdrawal by Subject|30|||
27765166|NCT02278341|54217448|FG001|Overall Study|Withdrawal by Subject|19|||
27765167|NCT02278341|54217447|FG000|Overall Study|Lost to Follow-up|0|||
27765168|NCT02278341|54217448|FG001|Overall Study|Lost to Follow-up|1|||
27765169|NCT02278341|54217447|FG000|Overall Study|Physician Decision|1|||
27765170|NCT02278341|54217448|FG001|Overall Study|Physician Decision|1|||
27765171|NCT02278341|54217447|FG000|Overall Study|Miscellaneous|15|||
27765172|NCT02278341|54217448|FG001|Overall Study|Miscellaneous|14|||
27765173|NCT02282631|54217457|FG000|Overall Study|Lost to Follow-up|2|||
27765174|NCT02282631|54217458|FG001|Overall Study|Lost to Follow-up|0|||
27765175|NCT02278263|54217473|FG000|Overall Study|Protocol Violation|7|||
27765176|NCT02278263|54217474|FG001|Overall Study|Protocol Violation|0|||
27765177|NCT02278263|54217475|FG002|Overall Study|Protocol Violation|9|||
27765178|NCT02349789|54217486|FG000|Overall Study|Withdrawal by Subject|2|||
27765179|NCT02349711|54217492|FG000|Overall Study|Withdrawal by Subject|2|||
27765180|NCT02349711|54217493|FG001|Overall Study|Withdrawal by Subject|1|||
27765181|NCT02349711|54217492|FG000|Overall Study|Lost to Follow-up|1|||
27765182|NCT02349711|54217493|FG001|Overall Study|Lost to Follow-up|1|||
27765183|NCT02494921|54217504|FG000|Phase 1b, Dose Level I|Adverse Event|2|||
27765184|NCT02494921|54217505|FG001|Phase 1b, Dose Level I|Adverse Event|0|||
27765185|NCT02494921|54217506|FG002|Phase 1b, Dose Level I|Adverse Event|0|||
27765186|NCT02494921|54217507|FG003|Phase 1b, Dose Level I|Adverse Event|0|||
27765187|NCT02494921|54217508|FG004|Phase 1b, Dose Level I|Adverse Event|0|||
27765188|NCT02494921|54217504|FG000|Phase 1b, Dose Level IA|Adverse Event|0|||
27765189|NCT02494921|54217505|FG001|Phase 1b, Dose Level IA|Adverse Event|1|||
27765190|NCT02494921|54217506|FG002|Phase 1b, Dose Level IA|Adverse Event|0|||
27765191|NCT02494921|54217507|FG003|Phase 1b, Dose Level IA|Adverse Event|0|||
27765192|NCT02494921|54217508|FG004|Phase 1b, Dose Level IA|Adverse Event|0|||
27765193|NCT02494921|54217504|FG000|Phase 1b, Dose Level IIC|Physician Decision|0|||
27765194|NCT02494921|54217505|FG001|Phase 1b, Dose Level IIC|Physician Decision|0|||
27765195|NCT02494921|54217506|FG002|Phase 1b, Dose Level IIC|Physician Decision|1|||
27765196|NCT02494921|54217507|FG003|Phase 1b, Dose Level IIC|Physician Decision|0|||
27765197|NCT02494921|54217508|FG004|Phase 1b, Dose Level IIC|Physician Decision|0|||
27765198|NCT01653847|54217528|FG000|Overall Study|Withdrawal by Subject|1|||
27765199|NCT01653847|54217529|FG001|Overall Study|Withdrawal by Subject|0|||
27765200|NCT02493751|54217537|FG000|Overall Study|Withdrawal by Subject|2|||
27765201|NCT02493751|54217538|FG001|Overall Study|Withdrawal by Subject|8|||
27765202|NCT02493751|54217537|FG000|Overall Study|Death|6|||
27765203|NCT02493751|54217538|FG001|Overall Study|Death|13|||
27765204|NCT02493751|54217537|FG000|Overall Study|Lost to Follow-up|2|||
27765205|NCT02493751|54217538|FG001|Overall Study|Lost to Follow-up|3|||
27765206|NCT02493751|54217537|FG000|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|6|||
27765207|NCT02493751|54217538|FG001|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|15|||
27765208|NCT02493517|54217547|FG000|Overall Study|Protocol Violation|1|||
27765209|NCT02493517|54217548|FG001|Overall Study|Protocol Violation|2|||
27765210|NCT02493517|54217547|FG000|Overall Study|Withdrawal by Subject|1|||
27765211|NCT02493517|54217548|FG001|Overall Study|Withdrawal by Subject|2|||
27765212|NCT02493517|54217547|FG000|Overall Study|Adverse Event|0|||
27765213|NCT02493517|54217548|FG001|Overall Study|Adverse Event|2|||
27839683|NCT01468181|54327074|FG002|Overall Study|Withdrawal by Subject|0|||
27765214|NCT02493517|54217547|FG000|Overall Study|Missed study visit|0|||
27765215|NCT02493517|54217548|FG001|Overall Study|Missed study visit|1|||
27839684|NCT01468181|54327075|FG003|Overall Study|Withdrawal by Subject|0|||
27839685|NCT01468181|54327076|FG004|Overall Study|Withdrawal by Subject|0|||
27839686|NCT01693562|54327111|FG000|Escalation Phase|Withdrawal by Subject|0|||
27765216|NCT02493361|54217556|FG000|Overall Study|Withdrawal by Subject|3|||
27765217|NCT02493127|54217562|FG000|Overall Study|Lost to Follow-up|1|||
27765218|NCT02493127|54217563|FG001|Overall Study|Lost to Follow-up|1|||
27765219|NCT02478463|54217571|FG000|Treatment Period 1 (Up to Day 29)|Physician Decision|1|||
27765220|NCT02478463|54217571|FG000|Washout Period (Up to 42 Days)|Lost to Follow-up|1|||
27765221|NCT02478463|54217571|FG000|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1|||
27765222|NCT02491411|54217577|FG000|Overall Study|Physician Decision|4|||
27839687|NCT01693562|54327112|FG001|Escalation Phase|Withdrawal by Subject|1|||
27765223|NCT02517463|54217583|FG000|Overall Study|Lost to Follow-up|5|||
27765224|NCT02517463|54217584|FG001|Overall Study|Lost to Follow-up|2|||
27765225|NCT02516605|54217595|FG000|Overall Study|Protocol Violation|0|||
27765226|NCT02516605|54217596|FG001|Overall Study|Protocol Violation|0|||
27765227|NCT02516605|54217597|FG002|Overall Study|Protocol Violation|0|||
27765228|NCT02516605|54217598|FG003|Overall Study|Protocol Violation|0|||
27765229|NCT02516605|54217599|FG004|Overall Study|Protocol Violation|1|||
27765230|NCT02516605|54217595|FG000|Overall Study|Withdrawal by Subject|0|||
27765231|NCT02516605|54217596|FG001|Overall Study|Withdrawal by Subject|0|||
27765232|NCT02516605|54217597|FG002|Overall Study|Withdrawal by Subject|0|||
27765233|NCT02516605|54217598|FG003|Overall Study|Withdrawal by Subject|1|||
27765234|NCT02516605|54217599|FG004|Overall Study|Withdrawal by Subject|0|||
27765235|NCT02490475|54217619|FG000|Period 1: First 6 Cycles|Adverse Event|2|||
27765236|NCT02490475|54217620|FG001|Period 1: First 6 Cycles|Adverse Event|1|||
27765237|NCT02490475|54217621|FG002|Period 1: First 6 Cycles|Adverse Event|0|||
27765238|NCT02490475|54217622|FG003|Period 1: First 6 Cycles|Adverse Event|1|||
27765239|NCT02490475|54217619|FG000|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
27765240|NCT02490475|54217620|FG001|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0|||
27765241|NCT02490475|54217621|FG002|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
27765242|NCT02490475|54217622|FG003|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
27765243|NCT02490475|54217619|FG000|Period 1: First 6 Cycles|Refused Treatment|1|||
27765244|NCT02490475|54217620|FG001|Period 1: First 6 Cycles|Refused Treatment|0|||
27765245|NCT02490475|54217621|FG002|Period 1: First 6 Cycles|Refused Treatment|0|||
27765246|NCT02490475|54217622|FG003|Period 1: First 6 Cycles|Refused Treatment|0|||
27765247|NCT02490475|54217619|FG000|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
27765248|NCT02490475|54217620|FG001|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
27765249|NCT02490475|54217621|FG002|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4|||
27765250|NCT02490475|54217622|FG003|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2|||
27765251|NCT02490475|54217619|FG000|Period 2: Extension Phase|Insufficient Therapeutic Response|1|||
27765252|NCT02490475|54217620|FG001|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
27765253|NCT02490475|54217621|FG002|Period 2: Extension Phase|Insufficient Therapeutic Response|2|||
27765254|NCT02490475|54217622|FG003|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
27765255|NCT02490475|54217619|FG000|Period 2: Extension Phase|Refused Treatment|0|||
27765256|NCT02490475|54217620|FG001|Period 2: Extension Phase|Refused Treatment|0|||
27765257|NCT02490475|54217621|FG002|Period 2: Extension Phase|Refused Treatment|0|||
27765258|NCT02490475|54217622|FG003|Period 2: Extension Phase|Refused Treatment|1|||
27765259|NCT02490475|54217619|FG000|Period 2: Extension Phase|Adverse Event|0|||
27765260|NCT02490475|54217620|FG001|Period 2: Extension Phase|Adverse Event|0|||
27765261|NCT02490475|54217621|FG002|Period 2: Extension Phase|Adverse Event|1|||
27765262|NCT02490475|54217622|FG003|Period 2: Extension Phase|Adverse Event|0|||
27765263|NCT02477839|54217645|FG000|Overall Study|Adverse Event|0|||
27765264|NCT02477839|54217646|FG001|Overall Study|Adverse Event|1|||
27765265|NCT02477839|54217645|FG000|Overall Study|Protocol Violation|0|||
27765266|NCT02477839|54217646|FG001|Overall Study|Protocol Violation|2|||
27765267|NCT02477839|54217645|FG000|Overall Study|Withdrawal by Subject|3|||
27765268|NCT02477839|54217646|FG001|Overall Study|Withdrawal by Subject|3|||
27765269|NCT02477839|54217645|FG000|Overall Study|Participant had PGS during V6|0|||
27765270|NCT02477839|54217646|FG001|Overall Study|Participant had PGS during V6|1|||
27765271|NCT02477839|54217645|FG000|Overall Study|Parents decided to stop medication|0|||
27765272|NCT02477839|54217646|FG001|Overall Study|Parents decided to stop medication|1|||
27765273|NCT02477839|54217645|FG000|Overall Study|Lack of tolerability|0|||
27765274|NCT02477839|54217646|FG001|Overall Study|Lack of tolerability|1|||
27765275|NCT02477839|54217645|FG000|Overall Study|Exclusion criterion|0|||
27765276|NCT02477839|54217646|FG001|Overall Study|Exclusion criterion|1|||
27765277|NCT02489773|54217656|FG000|Overall Study|Lost to Follow-up|4|||
27765278|NCT02489773|54217657|FG001|Overall Study|Lost to Follow-up|1|||
27765279|NCT02489773|54217656|FG000|Overall Study|Physician Decision|1|||
27765280|NCT02489773|54217657|FG001|Overall Study|Physician Decision|0|||
27765281|NCT02489773|54217656|FG000|Overall Study|Withdrawal by Subject|1|||
27765282|NCT02489773|54217657|FG001|Overall Study|Withdrawal by Subject|0|||
27765283|NCT02489773|54217656|FG000|Overall Study|Leave the country or the state|1|||
27765284|NCT02489773|54217657|FG001|Overall Study|Leave the country or the state|1|||
27765285|NCT02488915|54217663|FG000|Overall Study|Death|21|||
27765286|NCT02488915|54217663|FG000|Overall Study|Lost to Follow-up|4|||
27765287|NCT02488915|54217663|FG000|Overall Study|Withdrawal by Subject|1|||
27765288|NCT02488681|54217667|FG000|Overall Study|Implant unsuccessful|7|||
27765289|NCT02477605|54217673|FG000|Overall Study|Discontinued prior to treatment|1|||
27765290|NCT02477605|54217674|FG001|Overall Study|Discontinued prior to treatment|0|||
27765291|NCT02477605|54217673|FG000|Overall Study|Lost to Follow-up|0|||
27765292|NCT02477605|54217674|FG001|Overall Study|Lost to Follow-up|2|||
27765293|NCT02477605|54217673|FG000|Overall Study|Withdrawal by Subject|0|||
27765294|NCT02477605|54217674|FG001|Overall Study|Withdrawal by Subject|1|||
27765295|NCT02477605|54217673|FG000|Overall Study|Administered gas during surgery|0|||
27765296|NCT02477605|54217674|FG001|Overall Study|Administered gas during surgery|1|||
27765297|NCT02477527|54217684|FG000|Overall Study|Lost to Follow-up|2|||
27765298|NCT02477527|54217684|FG000|Overall Study|Withdrawal by Subject|1|||
27765299|NCT02477527|54217684|FG000|Overall Study|Screen Failure|3|||
27765300|NCT02477215|54217692|FG000|Dose Escalation Phase|Physician Decision|1|||
27765301|NCT02477215|54217693|FG001|Dose Escalation Phase|Physician Decision|2|||
27765302|NCT02477215|54217694|FG002|Dose Escalation Phase|Physician Decision|0|||
27765303|NCT02477215|54217692|FG000|Fixed Dose Phase|Physician Decision|0|||
27765304|NCT02477215|54217693|FG001|Fixed Dose Phase|Physician Decision|7|||
27765305|NCT02477215|54217694|FG002|Fixed Dose Phase|Physician Decision|0|||
27765306|NCT02487199|54217707|FG000|Overall Study|Withdrew Consent|0|||
27765307|NCT02487199|54217708|FG001|Overall Study|Withdrew Consent|1|||
27765308|NCT02475733|54217716|FG000|Overall Study|Withdrawal by Subject|1|||
27765309|NCT02475733|54217717|FG001|Overall Study|Withdrawal by Subject|0|||
27765310|NCT02475733|54217716|FG000|Overall Study|Physician Decision|1|||
27765311|NCT02475733|54217717|FG001|Overall Study|Physician Decision|0|||
27765312|NCT02486653|54217725|FG000|Overall Study|Withdrawal by Subject|1|||
27765313|NCT02486653|54217726|FG001|Overall Study|Withdrawal by Subject|3|||
27765314|NCT02486653|54217725|FG000|Overall Study|Protocol Violation|1|||
27765315|NCT02486653|54217726|FG001|Overall Study|Protocol Violation|0|||
27765316|NCT02486653|54217725|FG000|Overall Study|surgery cancelled|4|||
27765317|NCT02486653|54217726|FG001|Overall Study|surgery cancelled|1|||
27765318|NCT02475655|54217734|FG000|Overall Study|Lost to Follow-up|0|||
27765319|NCT02475655|54217735|FG001|Overall Study|Lost to Follow-up|1|||
27765320|NCT02475265|54217741|FG000|Overall Study|Physician Decision|1|||
27765321|NCT02475265|54217741|FG000|Overall Study|Withdrawal by Subject|2|||
27765322|NCT02485717|54217748|FG000|Overall Study|Lost to Follow-up|6|||
27765323|NCT02485717|54217749|FG001|Overall Study|Lost to Follow-up|0|||
27765324|NCT02485717|54217750|FG002|Overall Study|Lost to Follow-up|0|||
27765325|NCT02485717|54217748|FG000|Overall Study|Withdrawal by Subject|0|||
27765326|NCT02485717|54217749|FG001|Overall Study|Withdrawal by Subject|0|||
27765327|NCT02485717|54217750|FG002|Overall Study|Withdrawal by Subject|1|||
27765328|NCT02485717|54217748|FG000|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
27765329|NCT02485717|54217749|FG001|Overall Study|Did Not Meet Exclusion Criteria #2|1|||
27765330|NCT02485717|54217750|FG002|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
27765331|NCT02485717|54217748|FG000|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
27765332|NCT02485717|54217749|FG001|Overall Study|Did Not Meet Exclusion Criteria #12|1|||
27765333|NCT02485717|54217750|FG002|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
27765334|NCT02451007|54217758|FG000|Overall Study|Withdrawal by Subject|4|||
27765335|NCT02451007|54217758|FG000|Overall Study|Adverse Event|1|||
27765336|NCT02451007|54217758|FG000|Overall Study|Disease Progression|2|||
27765337|NCT02485483|54217764|FG000|Overall Study|Depression at baseline|15|||
27765338|NCT02485483|54217765|FG001|Overall Study|Depression at baseline|0|||
27765339|NCT02485483|54217764|FG000|Overall Study|Discontinued after baseline|39|||
27765340|NCT02485483|54217765|FG001|Overall Study|Discontinued after baseline|0|||
27765341|NCT02473471|54217771|FG000|Overall Study|poor oral hygiene|2|||
27765342|NCT02473471|54217771|FG000|Overall Study|Lost to Follow-up|1|||
27765343|NCT02450539|54217783|FG000|Overall Study|Withdrawal by Subject|12|||
27765344|NCT02450539|54217784|FG001|Overall Study|Withdrawal by Subject|6|||
27765345|NCT02450539|54217783|FG000|Overall Study|Lost to Follow-up|4|||
27765346|NCT02450539|54217784|FG001|Overall Study|Lost to Follow-up|1|||
27765347|NCT02449915|54217795|FG000|Overall Study|Exclusion criteria - drug use|1|||
27765348|NCT02449915|54217796|FG001|Overall Study|Exclusion criteria - drug use|0|||
27765349|NCT02449915|54217795|FG000|Overall Study|Withdrawal by Subject|0|||
27765350|NCT02449915|54217796|FG001|Overall Study|Withdrawal by Subject|2|||
27765351|NCT02449915|54217795|FG000|Overall Study|Intraoperative surgical findings|1|||
27765352|NCT02449915|54217796|FG001|Overall Study|Intraoperative surgical findings|1|||
27765353|NCT02449915|54217795|FG000|Overall Study|Abnormal preop lab|0|||
27765354|NCT02449915|54217796|FG001|Overall Study|Abnormal preop lab|1|||
27765355|NCT02420119|54217802|FG000|Overall Study|insufficient laboratory data|5|||
27765356|NCT02473393|54217810|FG000|Overall Study|Adverse Event|0|||
27765357|NCT02473393|54217811|FG001|Overall Study|Adverse Event|0|||
27765358|NCT02473393|54217812|FG002|Overall Study|Adverse Event|1|||
27765359|NCT02473393|54217813|FG003|Overall Study|Adverse Event|0|||
27765360|NCT02473393|54217810|FG000|Overall Study|Withdrawal by Subject|0|||
27765361|NCT02473393|54217811|FG001|Overall Study|Withdrawal by Subject|0|||
27765362|NCT02473393|54217812|FG002|Overall Study|Withdrawal by Subject|1|||
27765363|NCT02473393|54217813|FG003|Overall Study|Withdrawal by Subject|1|||
27765364|NCT02419573|54217825|FG000|Overall Study|Lost to Follow-up|3|||
27765365|NCT02419573|54217826|FG001|Overall Study|Lost to Follow-up|0|||
27765366|NCT02419573|54217825|FG000|Overall Study|Withdrawal by Subject|1|||
27765367|NCT02419573|54217826|FG001|Overall Study|Withdrawal by Subject|0|||
27765368|NCT02472847|54217834|FG000|Overall Study|Withdrawal by Subject|1|||
27765369|NCT02472847|54217835|FG001|Overall Study|Withdrawal by Subject|5|||
27765370|NCT02472145|54217844|FG000|Overall Study|Death|10|||
27765371|NCT02472145|54217845|FG001|Overall Study|Death|101|||
27765372|NCT02472145|54217846|FG002|Overall Study|Death|99|||
27765373|NCT02472145|54217844|FG000|Overall Study|Lost to Follow-up|0|||
27765374|NCT02472145|54217845|FG001|Overall Study|Lost to Follow-up|1|||
27765375|NCT02472145|54217846|FG002|Overall Study|Lost to Follow-up|0|||
27765376|NCT02472145|54217844|FG000|Overall Study|Withdrawal by Subject|0|||
27765377|NCT02472145|54217845|FG001|Overall Study|Withdrawal by Subject|9|||
27765378|NCT02472145|54217846|FG002|Overall Study|Withdrawal by Subject|13|||
27765379|NCT02472145|54217844|FG000|Overall Study|Sponsor decision|0|||
27765380|NCT02472145|54217845|FG001|Overall Study|Sponsor decision|3|||
27765381|NCT02472145|54217846|FG002|Overall Study|Sponsor decision|2|||
27765382|NCT02472145|54217844|FG000|Overall Study|Other|0|||
27765383|NCT02472145|54217845|FG001|Overall Study|Other|45|||
27765384|NCT02472145|54217846|FG002|Overall Study|Other|43|||
27765385|NCT02418949|54217857|FG000|Overall Study|Withdrawal by Subject|1|||
27765386|NCT02418949|54217858|FG001|Overall Study|Withdrawal by Subject|0|||
27765387|NCT02418949|54217859|FG002|Overall Study|Withdrawal by Subject|1|||
27765388|NCT02418949|54217860|FG003|Overall Study|Withdrawal by Subject|1|||
27765389|NCT02418949|54217857|FG000|Overall Study|Lost to Follow-up|1|||
27765390|NCT02418949|54217858|FG001|Overall Study|Lost to Follow-up|0|||
27765391|NCT02418949|54217859|FG002|Overall Study|Lost to Follow-up|1|||
27765392|NCT02418949|54217860|FG003|Overall Study|Lost to Follow-up|0|||
27765393|NCT02418949|54217857|FG000|Overall Study|Physician Decision|1|||
27765394|NCT02418949|54217858|FG001|Overall Study|Physician Decision|1|||
27765395|NCT02418949|54217859|FG002|Overall Study|Physician Decision|1|||
27765396|NCT02418949|54217860|FG003|Overall Study|Physician Decision|0|||
27765397|NCT02448043|54217872|FG000|Overall Study|Withdrawal by Subject|2|||
27765398|NCT02448043|54217873|FG001|Overall Study|Withdrawal by Subject|2|||
27765399|NCT02448043|54217872|FG000|Overall Study|Protocol Violation|1|||
27765400|NCT02448043|54217873|FG001|Overall Study|Protocol Violation|2|||
27765401|NCT02447887|54217882|FG000|Overall Study|Study was terminated|3|||
27765402|NCT02471755|54217888|FG000|Overall Study|Withdrawal by Subject|1|||
27765403|NCT02471755|54217889|FG001|Overall Study|Withdrawal by Subject|0|||
27765404|NCT02471755|54217888|FG000|Overall Study|Lost to Follow-up|0|||
27765405|NCT02471755|54217889|FG001|Overall Study|Lost to Follow-up|1|||
27765406|NCT02470429|54217897|FG000|Overall Study|Adverse Event|1|||
27765407|NCT02470429|54217898|FG001|Overall Study|Adverse Event|0|||
27765408|NCT02470429|54217897|FG000|Overall Study|Withdrawal by Subject|1|||
27765409|NCT02470429|54217898|FG001|Overall Study|Withdrawal by Subject|0|||
27765410|NCT02447497|54217909|FG000|Overall Study|Did not meet treatment day baseline.|6|||
27765411|NCT02447497|54217910|FG001|Overall Study|Did not meet treatment day baseline.|5|||
27765412|NCT02447497|54217911|FG002|Overall Study|Did not meet treatment day baseline.|2|||
27765413|NCT02447497|54217912|FG003|Overall Study|Did not meet treatment day baseline.|2|||
27765414|NCT02447497|54217909|FG000|Overall Study|Dressing was compromised|0|||
27765415|NCT02447497|54217910|FG001|Overall Study|Dressing was compromised|1|||
27765416|NCT02447497|54217911|FG002|Overall Study|Dressing was compromised|0|||
27765417|NCT02447497|54217912|FG003|Overall Study|Dressing was compromised|0|||
27765418|NCT02417935|54217932|FG000|Treatment Period|Adverse Event|12|||
27765419|NCT02417935|54217933|FG001|Treatment Period|Adverse Event|10|||
27765420|NCT02417935|54217932|FG000|Treatment Period|Lost to Follow-up|1|||
27765421|NCT02417935|54217933|FG001|Treatment Period|Lost to Follow-up|0|||
27765422|NCT02417935|54217932|FG000|Treatment Period|Entry Criteria not met|0|||
27765423|NCT02417935|54217933|FG001|Treatment Period|Entry Criteria not met|1|||
27765424|NCT02417935|54217932|FG000|Treatment Period|Protocol Violation|2|||
27765425|NCT02417935|54217933|FG001|Treatment Period|Protocol Violation|1|||
27765426|NCT02417935|54217932|FG000|Treatment Period|Withdrawal by Subject|3|||
27765427|NCT02417935|54217933|FG001|Treatment Period|Withdrawal by Subject|3|||
27765428|NCT02417935|54217932|FG000|Treatment Period|Physician Decision|3|||
27765429|NCT02417935|54217933|FG001|Treatment Period|Physician Decision|1|||
27765430|NCT02417233|54217942|FG000|Overall Study|Death|4|||
27765431|NCT02417233|54217943|FG001|Overall Study|Death|10|||
27765432|NCT02417233|54217944|FG002|Overall Study|Death|14|||
27765433|NCT02417233|54217942|FG000|Overall Study|Lost to Follow-up|27|||
27765434|NCT02417233|54217943|FG001|Overall Study|Lost to Follow-up|39|||
27765435|NCT02417233|54217944|FG002|Overall Study|Lost to Follow-up|34|||
27765436|NCT02417233|54217942|FG000|Overall Study|Protocol Violation|2|||
27839688|NCT01693562|54327113|FG002|Escalation Phase|Withdrawal by Subject|0|||
27765437|NCT02417233|54217943|FG001|Overall Study|Protocol Violation|0|||
27765438|NCT02417233|54217944|FG002|Overall Study|Protocol Violation|2|||
27765439|NCT02417233|54217942|FG000|Overall Study|Withdrawal by Subject|2|||
27765440|NCT02417233|54217943|FG001|Overall Study|Withdrawal by Subject|1|||
27765441|NCT02417233|54217944|FG002|Overall Study|Withdrawal by Subject|8|||
27765442|NCT02417233|54217942|FG000|Overall Study|Relocation out of study area|1|||
27765443|NCT02417233|54217943|FG001|Overall Study|Relocation out of study area|0|||
27765444|NCT02417233|54217944|FG002|Overall Study|Relocation out of study area|1|||
27765445|NCT02417233|54217942|FG000|Overall Study|Mentally unstable|0|||
27765446|NCT02417233|54217943|FG001|Overall Study|Mentally unstable|1|||
27765447|NCT02417233|54217944|FG002|Overall Study|Mentally unstable|0|||
27765448|NCT02447029|54217955|FG000|Overall Study|Withdrawal by Subject|3|||
27765449|NCT02447029|54217956|FG001|Overall Study|Withdrawal by Subject|2|||
27765450|NCT02416453|54217973|FG000|Overall Study|Adverse Event|0|||
27765451|NCT02416453|54217974|FG001|Overall Study|Adverse Event|0|||
27765452|NCT02416453|54217975|FG002|Overall Study|Adverse Event|0|||
27765453|NCT02416453|54217976|FG003|Overall Study|Adverse Event|2|||
27765454|NCT02416453|54217977|FG004|Overall Study|Adverse Event|0|||
27765455|NCT02416453|54217978|FG005|Overall Study|Adverse Event|1|||
27765456|NCT02416453|54217979|FG006|Overall Study|Adverse Event|0|||
27765457|NCT02416453|54217980|FG007|Overall Study|Adverse Event|0|||
27765458|NCT02416453|54217981|FG008|Overall Study|Adverse Event|0|||
27765459|NCT02416453|54217982|FG009|Overall Study|Adverse Event|0|||
27765460|NCT02416453|54217983|FG010|Overall Study|Adverse Event|0|||
27765461|NCT02416453|54217973|FG000|Overall Study|Lost to Follow-up|1|||
27765462|NCT02416453|54217974|FG001|Overall Study|Lost to Follow-up|3|||
27765463|NCT02416453|54217975|FG002|Overall Study|Lost to Follow-up|0|||
27765464|NCT02416453|54217976|FG003|Overall Study|Lost to Follow-up|8|||
27765465|NCT02416453|54217977|FG004|Overall Study|Lost to Follow-up|0|||
27765466|NCT02416453|54217978|FG005|Overall Study|Lost to Follow-up|5|||
27765467|NCT02416453|54217979|FG006|Overall Study|Lost to Follow-up|1|||
27765468|NCT02416453|54217980|FG007|Overall Study|Lost to Follow-up|3|||
27765469|NCT02416453|54217981|FG008|Overall Study|Lost to Follow-up|1|||
27765470|NCT02416453|54217982|FG009|Overall Study|Lost to Follow-up|0|||
27765471|NCT02416453|54217983|FG010|Overall Study|Lost to Follow-up|0|||
27765472|NCT02416453|54217973|FG000|Overall Study|Physician Decision|0|||
27765473|NCT02416453|54217974|FG001|Overall Study|Physician Decision|0|||
27765474|NCT02416453|54217975|FG002|Overall Study|Physician Decision|0|||
27765475|NCT02416453|54217976|FG003|Overall Study|Physician Decision|0|||
27765476|NCT02416453|54217977|FG004|Overall Study|Physician Decision|0|||
27765477|NCT02416453|54217978|FG005|Overall Study|Physician Decision|1|||
27765478|NCT02416453|54217979|FG006|Overall Study|Physician Decision|1|||
27765479|NCT02416453|54217980|FG007|Overall Study|Physician Decision|1|||
27765480|NCT02416453|54217981|FG008|Overall Study|Physician Decision|0|||
27765481|NCT02416453|54217982|FG009|Overall Study|Physician Decision|0|||
27765482|NCT02416453|54217983|FG010|Overall Study|Physician Decision|0|||
27765483|NCT02416453|54217973|FG000|Overall Study|Withdrawal by Subject|2|||
27765484|NCT02416453|54217974|FG001|Overall Study|Withdrawal by Subject|0|||
27765485|NCT02416453|54217975|FG002|Overall Study|Withdrawal by Subject|0|||
27765486|NCT02416453|54217976|FG003|Overall Study|Withdrawal by Subject|5|||
27765487|NCT02416453|54217977|FG004|Overall Study|Withdrawal by Subject|1|||
27765488|NCT02416453|54217978|FG005|Overall Study|Withdrawal by Subject|8|||
27765489|NCT02416453|54217979|FG006|Overall Study|Withdrawal by Subject|0|||
27765490|NCT02416453|54217980|FG007|Overall Study|Withdrawal by Subject|8|||
27765491|NCT02416453|54217981|FG008|Overall Study|Withdrawal by Subject|4|||
27765492|NCT02416453|54217982|FG009|Overall Study|Withdrawal by Subject|0|||
27765493|NCT02416453|54217983|FG010|Overall Study|Withdrawal by Subject|0|||
27765494|NCT02416453|54217973|FG000|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
27765495|NCT02416453|54217974|FG001|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
27765496|NCT02416453|54217975|FG002|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1|||
27765497|NCT02416453|54217976|FG003|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
27765498|NCT02416453|54217977|FG004|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
27765499|NCT02416453|54217978|FG005|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
27765500|NCT02416453|54217979|FG006|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
27765501|NCT02416453|54217980|FG007|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
27765502|NCT02416453|54217981|FG008|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
27765503|NCT02416453|54217982|FG009|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
27765504|NCT02416453|54217983|FG010|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
27765505|NCT02416453|54217973|FG000|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
27765506|NCT02416453|54217974|FG001|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
27765507|NCT02416453|54217975|FG002|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
27765508|NCT02416453|54217976|FG003|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
27765509|NCT02416453|54217977|FG004|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
27765510|NCT02416453|54217978|FG005|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1|||
27765511|NCT02416453|54217979|FG006|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
27765512|NCT02416453|54217980|FG007|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
27765513|NCT02416453|54217981|FG008|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
27765514|NCT02416453|54217982|FG009|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
27765515|NCT02416453|54217983|FG010|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
27765516|NCT02469961|54218015|FG000|Overall Study|Physician Decision|4|||
27765517|NCT02469961|54218016|FG001|Overall Study|Physician Decision|1|||
27765518|NCT02415595|54218031|FG000|Overall Study|Administrative reason by sponsor|39|||
27765519|NCT02415595|54218032|FG001|Overall Study|Administrative reason by sponsor|40|||
27765520|NCT02415595|54218033|FG002|Overall Study|Administrative reason by sponsor|41|||
27765521|NCT02415595|54218034|FG003|Overall Study|Administrative reason by sponsor|39|||
27765522|NCT02415595|54218031|FG000|Overall Study|Adverse Event|1|||
27765523|NCT02415595|54218032|FG001|Overall Study|Adverse Event|3|||
27765524|NCT02415595|54218033|FG002|Overall Study|Adverse Event|5|||
27765525|NCT02415595|54218034|FG003|Overall Study|Adverse Event|10|||
27765526|NCT02415595|54218031|FG000|Overall Study|Lack of Efficacy|4|||
27765527|NCT02415595|54218032|FG001|Overall Study|Lack of Efficacy|4|||
27765528|NCT02415595|54218033|FG002|Overall Study|Lack of Efficacy|0|||
27765529|NCT02415595|54218034|FG003|Overall Study|Lack of Efficacy|0|||
27765530|NCT02415595|54218031|FG000|Overall Study|Lost to Follow-up|1|||
27765531|NCT02415595|54218032|FG001|Overall Study|Lost to Follow-up|3|||
27765532|NCT02415595|54218033|FG002|Overall Study|Lost to Follow-up|1|||
27765533|NCT02415595|54218034|FG003|Overall Study|Lost to Follow-up|1|||
27765534|NCT02415595|54218031|FG000|Overall Study|Poor/Non-compliance|1|||
27765535|NCT02415595|54218032|FG001|Overall Study|Poor/Non-compliance|0|||
27765536|NCT02415595|54218033|FG002|Overall Study|Poor/Non-compliance|1|||
27765537|NCT02415595|54218034|FG003|Overall Study|Poor/Non-compliance|0|||
27765538|NCT02415595|54218031|FG000|Overall Study|Reached stopping criteria|0|||
27765539|NCT02415595|54218032|FG001|Overall Study|Reached stopping criteria|1|||
27765540|NCT02415595|54218033|FG002|Overall Study|Reached stopping criteria|1|||
27765541|NCT02415595|54218034|FG003|Overall Study|Reached stopping criteria|0|||
27765542|NCT02415595|54218031|FG000|Overall Study|Withdrawal by Subject|4|||
27765543|NCT02415595|54218032|FG001|Overall Study|Withdrawal by Subject|0|||
27765544|NCT02415595|54218033|FG002|Overall Study|Withdrawal by Subject|1|||
27765545|NCT02415595|54218034|FG003|Overall Study|Withdrawal by Subject|3|||
27765546|NCT02415595|54218031|FG000|Overall Study|Other|0|||
27765547|NCT02415595|54218032|FG001|Overall Study|Other|1|||
27765548|NCT02415595|54218033|FG002|Overall Study|Other|1|||
27765549|NCT02415595|54218034|FG003|Overall Study|Other|0|||
27765550|NCT02446717|54218050|FG000|Overall Study|Adverse Event|0|||
27765551|NCT02446717|54218051|FG001|Overall Study|Adverse Event|0|||
27765552|NCT02446717|54218052|FG002|Overall Study|Adverse Event|1|||
27765553|NCT02446717|54218053|FG003|Overall Study|Adverse Event|0|||
27765554|NCT02446717|54218054|FG004|Overall Study|Adverse Event|0|||
27765555|NCT02446717|54218050|FG000|Overall Study|Lost to Follow-up|0|||
27765556|NCT02446717|54218051|FG001|Overall Study|Lost to Follow-up|1|||
27765557|NCT02446717|54218052|FG002|Overall Study|Lost to Follow-up|1|||
27765558|NCT02446717|54218053|FG003|Overall Study|Lost to Follow-up|0|||
27765559|NCT02446717|54218054|FG004|Overall Study|Lost to Follow-up|1|||
27765560|NCT02446717|54218050|FG000|Overall Study|Withdrew consent|0|||
27765561|NCT02446717|54218051|FG001|Overall Study|Withdrew consent|0|||
27765562|NCT02446717|54218052|FG002|Overall Study|Withdrew consent|0|||
27765563|NCT02446717|54218053|FG003|Overall Study|Withdrew consent|1|||
27765564|NCT02446717|54218054|FG004|Overall Study|Withdrew consent|0|||
27765565|NCT02469415|54218066|FG000|Overall Study|Withdrawal by Subject|1|||
27765566|NCT02469415|54218066|FG000|Overall Study|Investigational agent placed on hold|2|||
27765567|NCT02446171|54218074|FG000|Overall Study|Withdrawal by Subject|0|||
27765568|NCT02446171|54218075|FG001|Overall Study|Withdrawal by Subject|0|||
27765569|NCT02446171|54218076|FG002|Overall Study|Withdrawal by Subject|2|||
27765570|NCT02446171|54218077|FG003|Overall Study|Withdrawal by Subject|0|||
27765571|NCT02446015|54218091|FG000|Overall Study|Adverse Event|0|||
27765572|NCT02446015|54218092|FG001|Overall Study|Adverse Event|1|||
27765573|NCT02446015|54218091|FG000|Overall Study|Withdrawal by Subject|1|||
27765574|NCT02446015|54218092|FG001|Overall Study|Withdrawal by Subject|0|||
27765575|NCT02415127|54218101|FG000|Overall Study|Adverse Event|1|||
27765576|NCT02415127|54218102|FG001|Overall Study|Adverse Event|0|||
27765577|NCT02468557|54218108|FG000|Overall Study|Adverse Event|1|||
27765578|NCT02468557|54218108|FG000|Overall Study|Death|1|||
27765579|NCT02468557|54218108|FG000|Overall Study|Study Terminated by Sponsor, Regulatory Agency or Institutional Review Board/ Ethics Committee|10|||
27765580|NCT02468557|54218108|FG000|Overall Study|All Enrolled but Never Dosed|4|||
27765581|NCT02413489|54218119|FG000|Overall Study|Death|11|||
27765582|NCT02413489|54218120|FG001|Overall Study|Death|3|||
27765583|NCT02413489|54218121|FG002|Overall Study|Death|4|||
27765584|NCT02413489|54218119|FG000|Overall Study|Withdrawal by Subject|2|||
27765585|NCT02413489|54218120|FG001|Overall Study|Withdrawal by Subject|0|||
27765586|NCT02413489|54218121|FG002|Overall Study|Withdrawal by Subject|0|||
27765587|NCT02413489|54218119|FG000|Overall Study|Study Terminated By Sponsor|2|||
27765588|NCT02413489|54218120|FG001|Overall Study|Study Terminated By Sponsor|13|||
27765589|NCT02413489|54218121|FG002|Overall Study|Study Terminated By Sponsor|1|||
27765590|NCT02413333|54218133|FG000|Period 1|Adverse Event|1|||
27765591|NCT02413333|54218134|FG001|Period 1|Adverse Event|0|||
27765592|NCT02413333|54218133|FG000|Period 1|Reason Not Specified|0|||
27765593|NCT02413333|54218134|FG001|Period 1|Reason Not Specified|1|||
27765594|NCT02413333|54218133|FG000|Period 2|Protocol Deviation|1|||
27765595|NCT02413333|54218134|FG001|Period 2|Protocol Deviation|0|||
27765596|NCT02413255|54218157|FG000|Overall Study|Voluntary Withdrawal|0|||
27765597|NCT02413255|54218158|FG001|Overall Study|Voluntary Withdrawal|0|||
27765598|NCT02413255|54218159|FG002|Overall Study|Voluntary Withdrawal|0|||
27765599|NCT02413255|54218160|FG003|Overall Study|Voluntary Withdrawal|0|||
27765600|NCT02413255|54218161|FG004|Overall Study|Voluntary Withdrawal|0|||
27765601|NCT02413255|54218162|FG005|Overall Study|Voluntary Withdrawal|0|||
27765602|NCT02413255|54218163|FG006|Overall Study|Voluntary Withdrawal|0|||
27765603|NCT02413255|54218164|FG007|Overall Study|Voluntary Withdrawal|0|||
27765604|NCT02413255|54218165|FG008|Overall Study|Voluntary Withdrawal|0|||
27765605|NCT02413255|54218166|FG009|Overall Study|Voluntary Withdrawal|0|||
27765606|NCT02413255|54218167|FG010|Overall Study|Voluntary Withdrawal|0|||
27765607|NCT02413255|54218168|FG011|Overall Study|Voluntary Withdrawal|0|||
27765608|NCT02413255|54218169|FG012|Overall Study|Voluntary Withdrawal|0|||
27765609|NCT02413255|54218170|FG013|Overall Study|Voluntary Withdrawal|0|||
27765610|NCT02413255|54218171|FG014|Overall Study|Voluntary Withdrawal|1|||
27765611|NCT02413255|54218172|FG015|Overall Study|Voluntary Withdrawal|0|||
27765612|NCT02413255|54218173|FG016|Overall Study|Voluntary Withdrawal|0|||
27765613|NCT02444533|54218226|FG000|Overall Study|Not able to complete forms|0|||
27765614|NCT02444533|54218227|FG001|Overall Study|Not able to complete forms|2|||
27765615|NCT02444533|54218226|FG000|Overall Study|Only gave post-procedure complications|2|||
27765616|NCT02444533|54218227|FG001|Overall Study|Only gave post-procedure complications|2|||
27765617|NCT01651039|54218233|FG000|Overall Study|Non-evaluables|5|||
27765618|NCT01651039|54218233|FG000|Overall Study|Physician Decision|2|||
27765619|NCT01651039|54218233|FG000|Overall Study|Withdrawal by Subject|1|||
27765620|NCT01651039|54218233|FG000|Overall Study|Progressive Disease|22|||
27765621|NCT02349633|54218251|FG000|Overall Study|Death|0|||
27765622|NCT02349633|54218252|FG001|Overall Study|Death|1|||
27765623|NCT02349633|54218253|FG002|Overall Study|Death|0|||
27765624|NCT02349633|54218254|FG003|Overall Study|Death|0|||
27765625|NCT02349633|54218255|FG004|Overall Study|Death|0|||
27765626|NCT02349633|54218256|FG005|Overall Study|Death|1|||
27765627|NCT02349633|54218257|FG006|Overall Study|Death|1|||
27765628|NCT02349633|54218258|FG007|Overall Study|Death|1|||
27765629|NCT02349633|54218259|FG008|Overall Study|Death|0|||
27765630|NCT02349633|54218260|FG009|Overall Study|Death|1|||
27765631|NCT02349633|54218261|FG010|Overall Study|Death|0|||
27765632|NCT02349633|54218262|FG011|Overall Study|Death|0|||
27765633|NCT02349633|54218263|FG012|Overall Study|Death|0|||
27765634|NCT02349633|54218264|FG013|Overall Study|Death|0|||
27765635|NCT02349633|54218251|FG000|Overall Study|Withdrawal by Subject|0|||
27765636|NCT02349633|54218252|FG001|Overall Study|Withdrawal by Subject|0|||
27765637|NCT02349633|54218253|FG002|Overall Study|Withdrawal by Subject|0|||
27765638|NCT02349633|54218254|FG003|Overall Study|Withdrawal by Subject|1|||
27765639|NCT02349633|54218255|FG004|Overall Study|Withdrawal by Subject|0|||
27765640|NCT02349633|54218256|FG005|Overall Study|Withdrawal by Subject|0|||
27765641|NCT02349633|54218257|FG006|Overall Study|Withdrawal by Subject|0|||
27765642|NCT02349633|54218258|FG007|Overall Study|Withdrawal by Subject|2|||
27765643|NCT02349633|54218259|FG008|Overall Study|Withdrawal by Subject|2|||
27765644|NCT02349633|54218260|FG009|Overall Study|Withdrawal by Subject|1|||
27765645|NCT02349633|54218261|FG010|Overall Study|Withdrawal by Subject|0|||
27765646|NCT02349633|54218262|FG011|Overall Study|Withdrawal by Subject|0|||
27765647|NCT02349633|54218263|FG012|Overall Study|Withdrawal by Subject|0|||
27765648|NCT02349633|54218264|FG013|Overall Study|Withdrawal by Subject|0|||
27765649|NCT02349633|54218251|FG000|Overall Study|Withdrawal of informed consent|0|||
27765650|NCT02349633|54218252|FG001|Overall Study|Withdrawal of informed consent|0|||
27765651|NCT02349633|54218253|FG002|Overall Study|Withdrawal of informed consent|0|||
27765652|NCT02349633|54218254|FG003|Overall Study|Withdrawal of informed consent|1|||
27765653|NCT02349633|54218255|FG004|Overall Study|Withdrawal of informed consent|1|||
27765654|NCT02349633|54218256|FG005|Overall Study|Withdrawal of informed consent|0|||
27765655|NCT02349633|54218257|FG006|Overall Study|Withdrawal of informed consent|0|||
27765656|NCT02349633|54218258|FG007|Overall Study|Withdrawal of informed consent|3|||
27765657|NCT02349633|54218259|FG008|Overall Study|Withdrawal of informed consent|0|||
27765658|NCT02349633|54218260|FG009|Overall Study|Withdrawal of informed consent|0|||
27765659|NCT02349633|54218261|FG010|Overall Study|Withdrawal of informed consent|0|||
27765660|NCT02349633|54218262|FG011|Overall Study|Withdrawal of informed consent|0|||
27765661|NCT02349633|54218263|FG012|Overall Study|Withdrawal of informed consent|0|||
27765662|NCT02349633|54218264|FG013|Overall Study|Withdrawal of informed consent|0|||
27765663|NCT02349633|54218251|FG000|Overall Study|Transition to compassionate use|0|||
27765664|NCT02349633|54218252|FG001|Overall Study|Transition to compassionate use|0|||
27765665|NCT02349633|54218253|FG002|Overall Study|Transition to compassionate use|0|||
27765666|NCT02349633|54218254|FG003|Overall Study|Transition to compassionate use|0|||
27765667|NCT02349633|54218255|FG004|Overall Study|Transition to compassionate use|1|||
27765668|NCT02349633|54218256|FG005|Overall Study|Transition to compassionate use|0|||
27765669|NCT02349633|54218257|FG006|Overall Study|Transition to compassionate use|0|||
27765670|NCT02349633|54218258|FG007|Overall Study|Transition to compassionate use|3|||
27765671|NCT02349633|54218259|FG008|Overall Study|Transition to compassionate use|0|||
27765672|NCT02349633|54218260|FG009|Overall Study|Transition to compassionate use|1|||
27765673|NCT02349633|54218261|FG010|Overall Study|Transition to compassionate use|0|||
27765674|NCT02349633|54218262|FG011|Overall Study|Transition to compassionate use|0|||
27765675|NCT02349633|54218263|FG012|Overall Study|Transition to compassionate use|0|||
27765676|NCT02349633|54218264|FG013|Overall Study|Transition to compassionate use|0|||
27765677|NCT02349633|54218251|FG000|Overall Study|Early termination of survival follow-up|0|||
27765678|NCT02349633|54218252|FG001|Overall Study|Early termination of survival follow-up|0|||
27765679|NCT02349633|54218253|FG002|Overall Study|Early termination of survival follow-up|0|||
27765680|NCT02349633|54218254|FG003|Overall Study|Early termination of survival follow-up|0|||
27765681|NCT02349633|54218255|FG004|Overall Study|Early termination of survival follow-up|0|||
27765682|NCT02349633|54218256|FG005|Overall Study|Early termination of survival follow-up|0|||
27765683|NCT02349633|54218257|FG006|Overall Study|Early termination of survival follow-up|0|||
27765684|NCT02349633|54218258|FG007|Overall Study|Early termination of survival follow-up|4|||
27765685|NCT02349633|54218259|FG008|Overall Study|Early termination of survival follow-up|0|||
27765686|NCT02349633|54218260|FG009|Overall Study|Early termination of survival follow-up|0|||
27765687|NCT02349633|54218261|FG010|Overall Study|Early termination of survival follow-up|0|||
27765688|NCT02349633|54218262|FG011|Overall Study|Early termination of survival follow-up|0|||
27765689|NCT02349633|54218263|FG012|Overall Study|Early termination of survival follow-up|0|||
27765690|NCT02349633|54218264|FG013|Overall Study|Early termination of survival follow-up|0|||
27765691|NCT02349633|54218251|FG000|Overall Study|Termination by sponsor|0|||
27765692|NCT02349633|54218252|FG001|Overall Study|Termination by sponsor|0|||
27765693|NCT02349633|54218253|FG002|Overall Study|Termination by sponsor|0|||
27765694|NCT02349633|54218254|FG003|Overall Study|Termination by sponsor|0|||
27765695|NCT02349633|54218255|FG004|Overall Study|Termination by sponsor|0|||
27765696|NCT02349633|54218256|FG005|Overall Study|Termination by sponsor|0|||
27765697|NCT02349633|54218257|FG006|Overall Study|Termination by sponsor|0|||
27765698|NCT02349633|54218258|FG007|Overall Study|Termination by sponsor|1|||
27765699|NCT02349633|54218259|FG008|Overall Study|Termination by sponsor|0|||
27765700|NCT02349633|54218260|FG009|Overall Study|Termination by sponsor|2|||
27765701|NCT02349633|54218261|FG010|Overall Study|Termination by sponsor|0|||
27765702|NCT02349633|54218262|FG011|Overall Study|Termination by sponsor|0|||
27765703|NCT02349633|54218263|FG012|Overall Study|Termination by sponsor|0|||
27765704|NCT02349633|54218264|FG013|Overall Study|Termination by sponsor|0|||
27765705|NCT02349633|54218251|FG000|Overall Study|Other|0|||
27765706|NCT02349633|54218252|FG001|Overall Study|Other|0|||
27765707|NCT02349633|54218253|FG002|Overall Study|Other|0|||
27765708|NCT02349633|54218254|FG003|Overall Study|Other|0|||
27765709|NCT02349633|54218255|FG004|Overall Study|Other|0|||
27765710|NCT02349633|54218256|FG005|Overall Study|Other|0|||
27765711|NCT02349633|54218257|FG006|Overall Study|Other|0|||
27765712|NCT02349633|54218258|FG007|Overall Study|Other|2|||
27765713|NCT02349633|54218259|FG008|Overall Study|Other|0|||
27765714|NCT02349633|54218260|FG009|Overall Study|Other|0|||
27765715|NCT02349633|54218261|FG010|Overall Study|Other|0|||
27765716|NCT02349633|54218262|FG011|Overall Study|Other|0|||
27765717|NCT02349633|54218263|FG012|Overall Study|Other|0|||
27765718|NCT02349633|54218264|FG013|Overall Study|Other|0|||
27765719|NCT02275611|54218329|FG000|Inpatient Withdrawal|Withdrawal by Subject|1|||
27765720|NCT02275611|54218330|FG001|Inpatient Withdrawal|Withdrawal by Subject|0|||
27765721|NCT02275611|54218331|FG002|Inpatient Withdrawal|Withdrawal by Subject|0|||
27765722|NCT02275611|54218332|FG003|Inpatient Withdrawal|Withdrawal by Subject|0|||
27765723|NCT02275065|54218349|FG000|Overall Study|Randomized but not treated|1|||
27765724|NCT02275065|54218350|FG001|Overall Study|Randomized but not treated|0|||
27765725|NCT02275065|54218351|FG002|Overall Study|Randomized but not treated|1|||
27765726|NCT02275065|54218352|FG003|Overall Study|Randomized but not treated|1|||
27765727|NCT02275065|54218353|FG004|Overall Study|Randomized but not treated|0|||
27765728|NCT02273973|54218367|FG000|Overall Study|Adverse Event|4|||
27765729|NCT02273973|54218368|FG001|Overall Study|Adverse Event|0|||
27765730|NCT02273973|54218367|FG000|Overall Study|Withdrawal by Subject|2|||
27765731|NCT02273973|54218368|FG001|Overall Study|Withdrawal by Subject|3|||
27765732|NCT02273973|54218367|FG000|Overall Study|Death|1|||
27765733|NCT02273973|54218368|FG001|Overall Study|Death|0|||
27765734|NCT02273973|54218367|FG000|Overall Study|Non-compliance|1|||
27765735|NCT02273973|54218368|FG001|Overall Study|Non-compliance|0|||
27765736|NCT02273973|54218367|FG000|Overall Study|Protocol Violation|1|||
27765737|NCT02273973|54218368|FG001|Overall Study|Protocol Violation|0|||
27765738|NCT02273973|54218367|FG000|Overall Study|Progression of disease|0|||
27765739|NCT02273973|54218368|FG001|Overall Study|Progression of disease|2|||
27765740|NCT02273973|54218367|FG000|Overall Study|Lost to Follow-up|0|||
27765741|NCT02273973|54218368|FG001|Overall Study|Lost to Follow-up|1|||
27765742|NCT02273973|54218367|FG000|Overall Study|Physician Decision|0|||
27839689|NCT01693562|54327114|FG003|Escalation Phase|Withdrawal by Subject|0|||
27839690|NCT01693562|54327115|FG004|Escalation Phase|Withdrawal by Subject|0|||
27839691|NCT01693562|54327116|FG005|Escalation Phase|Withdrawal by Subject|2|||
27839692|NCT01693562|54327117|FG006|Escalation Phase|Withdrawal by Subject|0|||
27839693|NCT01693562|54327118|FG007|Escalation Phase|Withdrawal by Subject|0|||
27765743|NCT02273973|54218368|FG001|Overall Study|Physician Decision|1|||
27765744|NCT02273973|54218367|FG000|Overall Study|Reason not specified|0|||
27765745|NCT02273973|54218368|FG001|Overall Study|Reason not specified|1|||
27765746|NCT02273739|54218378|FG000|Overall Study|Progression of Disease|3|||
27765747|NCT02273739|54218379|FG001|Overall Study|Progression of Disease|4|||
27765748|NCT02273739|54218380|FG002|Overall Study|Progression of Disease|5|||
27765749|NCT02273739|54218381|FG003|Overall Study|Progression of Disease|2|||
27765750|NCT02273739|54218378|FG000|Overall Study|Death|0|||
27765751|NCT02273739|54218379|FG001|Overall Study|Death|0|||
27765752|NCT02273739|54218380|FG002|Overall Study|Death|0|||
27765753|NCT02273739|54218381|FG003|Overall Study|Death|2|||
27765754|NCT02273739|54218378|FG000|Overall Study|Adverse Event|0|||
27765755|NCT02273739|54218379|FG001|Overall Study|Adverse Event|0|||
27765756|NCT02273739|54218380|FG002|Overall Study|Adverse Event|0|||
27765757|NCT02273739|54218381|FG003|Overall Study|Adverse Event|1|||
27765758|NCT02273739|54218378|FG000|Overall Study|Withdrawal by Subject|0|||
27765759|NCT02273739|54218379|FG001|Overall Study|Withdrawal by Subject|0|||
27765760|NCT02273739|54218380|FG002|Overall Study|Withdrawal by Subject|2|||
27765761|NCT02273739|54218381|FG003|Overall Study|Withdrawal by Subject|1|||
27765762|NCT02273739|54218378|FG000|Overall Study|Physician Decision|0|||
27765763|NCT02273739|54218379|FG001|Overall Study|Physician Decision|0|||
27765764|NCT02273739|54218380|FG002|Overall Study|Physician Decision|0|||
27765765|NCT02273739|54218381|FG003|Overall Study|Physician Decision|1|||
27765766|NCT02273037|54218398|FG000|Overall Study|Lost to Follow-up|1|||
27765767|NCT02273037|54218399|FG001|Overall Study|Lost to Follow-up|0|||
27765768|NCT02273037|54218398|FG000|Overall Study|Delivered before monitoring initiated|1|||
27765769|NCT02273037|54218399|FG001|Overall Study|Delivered before monitoring initiated|3|||
27765770|NCT02273037|54218398|FG000|Overall Study|Breech delivery|2|||
27765771|NCT02273037|54218399|FG001|Overall Study|Breech delivery|3|||
27765772|NCT02273037|54218398|FG000|Overall Study|Multiple delivery|2|||
27765773|NCT02273037|54218399|FG001|Overall Study|Multiple delivery|2|||
27765774|NCT02273037|54218398|FG000|Overall Study|Other complication|2|||
27765775|NCT02273037|54218399|FG001|Overall Study|Other complication|0|||
27765776|NCT02465515|54218409|FG000|Overall Study|Investigator site closed|4|||
27765777|NCT02465515|54218410|FG001|Overall Study|Investigator site closed|5|||
27765778|NCT02465515|54218409|FG000|Overall Study|Withdrawal by Subject|74|||
27765779|NCT02465515|54218410|FG001|Overall Study|Withdrawal by Subject|43|||
27765780|NCT02465515|54218409|FG000|Overall Study|Physician Decision|8|||
27765781|NCT02465515|54218410|FG001|Overall Study|Physician Decision|12|||
27765782|NCT02465515|54218409|FG000|Overall Study|Lost to Follow-up|68|||
27765783|NCT02465515|54218410|FG001|Overall Study|Lost to Follow-up|51|||
27765784|NCT02412631|54218418|FG000|Overall Study|Adverse Event|1|||
27765785|NCT02412631|54218419|FG001|Overall Study|Adverse Event|2|||
27765786|NCT02412631|54218418|FG000|Overall Study|Lost to Follow-up|5|||
27765787|NCT02412631|54218419|FG001|Overall Study|Lost to Follow-up|9|||
27765788|NCT02412631|54218418|FG000|Overall Study|Withdrawal by Subject|9|||
27765789|NCT02412631|54218419|FG001|Overall Study|Withdrawal by Subject|3|||
27765790|NCT02412631|54218418|FG000|Overall Study|Early stop by FDA|5|||
27765791|NCT02412631|54218419|FG001|Overall Study|Early stop by FDA|2|||
27765792|NCT02412631|54218418|FG000|Overall Study|Unspecified reason|6|||
27765793|NCT02412631|54218419|FG001|Overall Study|Unspecified reason|8|||
27765794|NCT02272803|54218427|FG000|Overall Study|Disease progression|16|||
27765795|NCT02272803|54218428|FG001|Overall Study|Disease progression|8|||
27765796|NCT02272803|54218427|FG000|Overall Study|Adverse Event unrelated to study drug|3|||
27765797|NCT02272803|54218428|FG001|Overall Study|Adverse Event unrelated to study drug|5|||
27765798|NCT02272803|54218427|FG000|Overall Study|Study drug toxicity|4|||
27765799|NCT02272803|54218428|FG001|Overall Study|Study drug toxicity|9|||
27765800|NCT02272803|54218427|FG000|Overall Study|Participant request to discontinue study treatment|3|||
27765801|NCT02272803|54218428|FG001|Overall Study|Participant request to discontinue study treatment|7|||
27765802|NCT02272803|54218427|FG000|Overall Study|Maximum clinical benefit|4|||
27765803|NCT02272803|54218428|FG001|Overall Study|Maximum clinical benefit|2|||
27765804|NCT02272803|54218427|FG000|Overall Study|Poor/non-compliance|2|||
27765805|NCT02272803|54218428|FG001|Overall Study|Poor/non-compliance|2|||
27839694|NCT01693562|54327119|FG008|Escalation Phase|Withdrawal by Subject|0|||
27839695|NCT01693562|54327120|FG009|Escalation Phase|Withdrawal by Subject|0|||
27765806|NCT02272803|54218427|FG000|Overall Study|Withdrawal by Subject|2|||
27765807|NCT02272803|54218428|FG001|Overall Study|Withdrawal by Subject|1|||
27765808|NCT02272803|54218427|FG000|Overall Study|Death|0|||
27765809|NCT02272803|54218428|FG001|Overall Study|Death|1|||
27765810|NCT02272803|54218427|FG000|Overall Study|Other reasons|1|||
27765811|NCT02272803|54218428|FG001|Overall Study|Other reasons|3|||
27765812|NCT02272803|54218427|FG000|Overall Study|Administrative reason by sponsor|5|||
27765813|NCT02272803|54218428|FG001|Overall Study|Administrative reason by sponsor|4|||
27765814|NCT02272725|54218436|FG000|Overall Study|equipment malfunction|2|||
27765815|NCT02272725|54218437|FG001|Overall Study|equipment malfunction|0|||
27765816|NCT01650805|54218445|FG000|Overall Study|Withdrawal by Subject|1|||
27839696|NCT01693562|54327121|FG010|Escalation Phase|Withdrawal by Subject|0|||
27765817|NCT01650805|54218446|FG001|Overall Study|Withdrawal by Subject|0|||
27765818|NCT02442349|54218452|FG000|Overall Study|Death|14|||
27765819|NCT02442349|54218452|FG000|Overall Study|Withdrawal by Subject|8|||
27765820|NCT02442349|54218452|FG000|Overall Study|On-going Study at Data Cut-off|149|||
27765821|NCT02411539|54218458|FG000|Overall Study|Lost to Follow-up|2|||
27765822|NCT02411539|54218459|FG001|Overall Study|Lost to Follow-up|0|||
27765823|NCT02411539|54218458|FG000|Overall Study|Confounding medical condition|0|||
27765824|NCT02411539|54218459|FG001|Overall Study|Confounding medical condition|1|||
27765825|NCT02465437|54218472|FG000|Overall Study|Physician Decision|0|||
27765826|NCT02465437|54218473|FG001|Overall Study|Physician Decision|0|||
27765827|NCT02465437|54218474|FG002|Overall Study|Physician Decision|1|||
27765828|NCT02465437|54218475|FG003|Overall Study|Physician Decision|0|||
27765829|NCT02465437|54218472|FG000|Overall Study|Withdrawal by Subject|1|||
27765830|NCT02465437|54218473|FG001|Overall Study|Withdrawal by Subject|0|||
27765831|NCT02465437|54218474|FG002|Overall Study|Withdrawal by Subject|0|||
27765832|NCT02465437|54218475|FG003|Overall Study|Withdrawal by Subject|1|||
27765833|NCT02465437|54218472|FG000|Overall Study|Adverse Event|0|||
27765834|NCT02465437|54218473|FG001|Overall Study|Adverse Event|1|||
27765835|NCT02465437|54218474|FG002|Overall Study|Adverse Event|0|||
27765836|NCT02465437|54218475|FG003|Overall Study|Adverse Event|0|||
27765837|NCT02442271|54218483|FG000|Overall Study|Adverse Event|1|||
27765838|NCT02442271|54218483|FG000|Overall Study|Withdrew Consent|1|||
27765839|NCT02442271|54218483|FG000|Overall Study|Lost to Follow-up|1|||
27765840|NCT02442271|54218483|FG000|Overall Study|Other|1|||
27765841|NCT02465203|54218504|FG000|Overall Study|Protocol Violation|1|||
27765842|NCT02465203|54218505|FG001|Overall Study|Protocol Violation|1|||
27765843|NCT02465203|54218506|FG002|Overall Study|Protocol Violation|1|||
27765844|NCT02465203|54218504|FG000|Overall Study|Study terminated by sponsor|50|||
27765845|NCT02465203|54218505|FG001|Overall Study|Study terminated by sponsor|34|||
27765846|NCT02465203|54218506|FG002|Overall Study|Study terminated by sponsor|11|||
27765847|NCT02465203|54218504|FG000|Overall Study|New therapy for study indication|4|||
27765848|NCT02465203|54218505|FG001|Overall Study|New therapy for study indication|0|||
27765849|NCT02465203|54218506|FG002|Overall Study|New therapy for study indication|0|||
27765850|NCT02465203|54218504|FG000|Overall Study|Patient/guardian decision|1|||
27765851|NCT02465203|54218505|FG001|Overall Study|Patient/guardian decision|1|||
27765852|NCT02465203|54218506|FG002|Overall Study|Patient/guardian decision|1|||
27765853|NCT02463409|54218513|FG000|Overall Study|Withdrawal by Subject|1|||
27765854|NCT02463409|54218513|FG000|Overall Study|Screen failure|1|||
27765855|NCT02528357|54218536|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
27765856|NCT02528357|54218537|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|1|||
27765857|NCT02528357|54218538|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
27765858|NCT02528357|54218539|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
27765859|NCT02528357|54218540|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
27765860|NCT02528357|54218541|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
27765861|NCT02528357|54218542|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
27765862|NCT02528357|54218543|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
27765863|NCT02528357|54218544|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
27765864|NCT02528357|54218545|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
27765865|NCT02528357|54218546|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
27765866|NCT02528357|54218547|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
27765867|NCT02528357|54218548|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
27765868|NCT02528357|54218549|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
27765869|NCT02528357|54218550|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
27765870|NCT02528357|54218551|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
27765871|NCT02528357|54218552|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
27765872|NCT02528357|54218553|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
27765873|NCT02528357|54218554|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
27765874|NCT02528357|54218536|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
27765875|NCT02528357|54218537|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
27765876|NCT02528357|54218538|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
27765877|NCT02528357|54218539|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
27765878|NCT02528357|54218540|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
27765879|NCT02528357|54218541|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|2|||
27765880|NCT02528357|54218542|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
27765881|NCT02528357|54218543|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
27765882|NCT02528357|54218544|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
27765883|NCT02528357|54218545|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
27765884|NCT02528357|54218546|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
27765885|NCT02528357|54218547|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
27765886|NCT02528357|54218548|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
27765887|NCT02528357|54218549|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
27831214|NCT01792115|54307529|FG001|Overall Study|Lost to Follow-up|1|||
27765888|NCT02528357|54218550|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
27765889|NCT02528357|54218551|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
27765890|NCT02528357|54218552|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
27765891|NCT02528357|54218553|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
27765892|NCT02528357|54218554|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
27765893|NCT02528357|54218536|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
27765894|NCT02528357|54218537|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
27765895|NCT02528357|54218538|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
27765896|NCT02528357|54218539|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
27765897|NCT02528357|54218540|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|3|||
27765898|NCT02528357|54218541|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
27765899|NCT02528357|54218542|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
27765900|NCT02528357|54218543|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|1|||
27765901|NCT02528357|54218544|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
27765902|NCT02528357|54218545|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
27765903|NCT02528357|54218546|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
27765904|NCT02528357|54218547|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
27765905|NCT02528357|54218548|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
27765906|NCT02528357|54218549|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
27765907|NCT02528357|54218550|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
27765908|NCT02528357|54218551|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
27765909|NCT02528357|54218552|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
27765910|NCT02528357|54218553|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
27765911|NCT02528357|54218554|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
27765912|NCT02528357|54218536|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27765913|NCT02528357|54218537|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27765914|NCT02528357|54218538|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27765915|NCT02528357|54218539|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27765916|NCT02528357|54218540|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
27765917|NCT02528357|54218541|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27765918|NCT02528357|54218542|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27765919|NCT02528357|54218543|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27765920|NCT02528357|54218544|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27765921|NCT02528357|54218545|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27765922|NCT02528357|54218546|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27765923|NCT02528357|54218547|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27765924|NCT02528357|54218548|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27765925|NCT02528357|54218549|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27765926|NCT02528357|54218550|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27765927|NCT02528357|54218551|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27765928|NCT02528357|54218552|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27765929|NCT02528357|54218553|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27765930|NCT02528357|54218554|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27765931|NCT02528357|54218536|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
27765932|NCT02528357|54218537|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
27765933|NCT02528357|54218538|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
27765934|NCT02528357|54218539|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
27765935|NCT02528357|54218540|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
27765936|NCT02528357|54218541|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
27765937|NCT02528357|54218542|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
27765938|NCT02528357|54218543|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
27765939|NCT02528357|54218544|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
27765940|NCT02528357|54218545|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
27765941|NCT02528357|54218546|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
27765942|NCT02528357|54218547|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
27765943|NCT02528357|54218548|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
27765944|NCT02528357|54218549|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|1|||
27765945|NCT02528357|54218550|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|5|||
27765946|NCT02528357|54218551|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
27765947|NCT02528357|54218552|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
27765948|NCT02528357|54218553|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
27765949|NCT02528357|54218554|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
27765950|NCT02528357|54218536|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
27765951|NCT02528357|54218537|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
27765952|NCT02528357|54218538|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
27765953|NCT02528357|54218539|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
27765954|NCT02528357|54218540|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
27765955|NCT02528357|54218541|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
27765956|NCT02528357|54218542|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
27765957|NCT02528357|54218543|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
27765958|NCT02528357|54218544|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
27765959|NCT02528357|54218545|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
27765960|NCT02528357|54218546|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
27765961|NCT02528357|54218547|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
27765962|NCT02528357|54218548|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
27765963|NCT02528357|54218549|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|1|||
27765964|NCT02528357|54218550|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
27765965|NCT02528357|54218551|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
27765966|NCT02528357|54218552|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
27765967|NCT02528357|54218553|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
27765968|NCT02528357|54218554|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
27765969|NCT02528357|54218536|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
27765970|NCT02528357|54218537|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
27765971|NCT02528357|54218538|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
27765972|NCT02528357|54218539|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
27765973|NCT02528357|54218540|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
27765974|NCT02528357|54218541|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
27765975|NCT02528357|54218542|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
27765976|NCT02528357|54218543|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
27765977|NCT02528357|54218544|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
27765978|NCT02528357|54218545|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
27765979|NCT02528357|54218546|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
27765980|NCT02528357|54218547|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
27765981|NCT02528357|54218548|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
27765982|NCT02528357|54218549|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
27765983|NCT02528357|54218550|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
27765984|NCT02528357|54218551|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
27765985|NCT02528357|54218552|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
27765986|NCT02528357|54218553|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
27765987|NCT02528357|54218554|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
27765988|NCT02528357|54218536|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27765989|NCT02528357|54218537|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27765990|NCT02528357|54218538|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27765991|NCT02528357|54218539|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27765992|NCT02528357|54218540|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27765993|NCT02528357|54218541|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27765994|NCT02528357|54218542|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27765995|NCT02528357|54218543|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27765996|NCT02528357|54218544|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
27765997|NCT02528357|54218545|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
27765998|NCT02528357|54218546|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27765999|NCT02528357|54218547|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
27766000|NCT02528357|54218548|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
27766001|NCT02528357|54218549|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
27766002|NCT02528357|54218550|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
27766003|NCT02528357|54218551|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27766004|NCT02528357|54218552|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27766005|NCT02528357|54218553|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27766006|NCT02528357|54218554|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27766007|NCT02528357|54218536|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
27766008|NCT02528357|54218537|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
27766009|NCT02528357|54218538|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
27766010|NCT02528357|54218539|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
27766011|NCT02528357|54218540|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
27766012|NCT02528357|54218541|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
27766013|NCT02528357|54218542|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
27766014|NCT02528357|54218543|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
27766015|NCT02528357|54218544|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
27766016|NCT02528357|54218545|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
27766017|NCT02528357|54218546|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
27766018|NCT02528357|54218547|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
27766019|NCT02528357|54218548|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
27766020|NCT02528357|54218549|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
27766021|NCT02528357|54218550|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
27766022|NCT02528357|54218551|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
27766023|NCT02528357|54218552|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|2|||
27766024|NCT02528357|54218553|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
27766025|NCT02528357|54218554|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
27766026|NCT02528357|54218536|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27766027|NCT02528357|54218537|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27766028|NCT02528357|54218538|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27766029|NCT02528357|54218539|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27766030|NCT02528357|54218540|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27766031|NCT02528357|54218541|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27766032|NCT02528357|54218542|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27766033|NCT02528357|54218543|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27766034|NCT02528357|54218544|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27766035|NCT02528357|54218545|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27766036|NCT02528357|54218546|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27766037|NCT02528357|54218547|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27766038|NCT02528357|54218548|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27766039|NCT02528357|54218549|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27766040|NCT02528357|54218550|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27766041|NCT02528357|54218551|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27766042|NCT02528357|54218552|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
27766043|NCT02528357|54218553|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
27766044|NCT02528357|54218554|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
27766045|NCT02463331|54218596|FG000|Overall Study|Adverse Event|4|||
27766046|NCT02463331|54218597|FG001|Overall Study|Adverse Event|2|||
27766047|NCT02463331|54218596|FG000|Overall Study|Lost to Follow-up|1|||
27766048|NCT02463331|54218597|FG001|Overall Study|Lost to Follow-up|1|||
27766049|NCT02463331|54218596|FG000|Overall Study|Pregnancy|2|||
27766050|NCT02463331|54218597|FG001|Overall Study|Pregnancy|3|||
27766051|NCT02463331|54218596|FG000|Overall Study|Lack of Efficacy|6|||
27766052|NCT02463331|54218597|FG001|Overall Study|Lack of Efficacy|0|||
27766053|NCT02463331|54218596|FG000|Overall Study|Physician Decision|3|||
27766054|NCT02463331|54218597|FG001|Overall Study|Physician Decision|0|||
27766055|NCT02410837|54218603|FG000|Overall Study|Death|387|||
27766056|NCT02410837|54218603|FG000|Overall Study|Lost to Follow-up|50|||
27766057|NCT02410837|54218603|FG000|Overall Study|Withdrawal by Subject|44|||
27766058|NCT02410837|54218603|FG000|Overall Study|Physician Decision|6|||
27766059|NCT02410837|54218603|FG000|Overall Study|Moved to nursing home, cannot communicat|1|||
27766060|NCT02314247|54218609|FG000|Overall Study|Adverse Event|2|||
27766061|NCT02314247|54218610|FG001|Overall Study|Adverse Event|1|||
27766062|NCT02314247|54218611|FG002|Overall Study|Adverse Event|0|||
27766063|NCT02314247|54218609|FG000|Overall Study|Withdrawal by Subject|1|||
27766064|NCT02314247|54218610|FG001|Overall Study|Withdrawal by Subject|3|||
27766065|NCT02314247|54218611|FG002|Overall Study|Withdrawal by Subject|1|||
27766066|NCT02314247|54218609|FG000|Overall Study|Progression of Disease|6|||
27766067|NCT02314247|54218610|FG001|Overall Study|Progression of Disease|2|||
27766068|NCT02314247|54218611|FG002|Overall Study|Progression of Disease|0|||
27766069|NCT02463097|54218621|FG000|Overall Study|Withdrawal by Subject|1|||
27766070|NCT02441179|54218627|FG000|Overall Study|Withdrawal by Subject|1|||
27766071|NCT02441179|54218628|FG001|Overall Study|Withdrawal by Subject|1|||
27766072|NCT02462473|54218635|FG000|Overall Study|Death|1|||
27766073|NCT02462473|54218635|FG000|Overall Study|Other|3|||
27766074|NCT02440789|54218648|FG000|Overall Study|Withdrawal by Subject|3|||
27766075|NCT02440789|54218648|FG000|Overall Study|Not willing to adhere to reqs|1|||
27766076|NCT02462083|54218652|FG000|Overall Study|Sponsor request|39|||
27766077|NCT02462083|54218652|FG000|Overall Study|Withdrawal by Subject|87|||
27766078|NCT02462083|54218652|FG000|Overall Study|Lost to Follow-up|41|||
27766079|NCT02462083|54218652|FG000|Overall Study|Lack of Efficacy|151|||
27766080|NCT02462083|54218652|FG000|Overall Study|Pregnancy|1|||
27766081|NCT02462083|54218652|FG000|Overall Study|Protocol Violation|6|||
27766082|NCT02462083|54218652|FG000|Overall Study|Adverse Event|33|||
27766083|NCT02462083|54218652|FG000|Overall Study|Worsening condition|16|||
27766084|NCT02462083|54218652|FG000|Overall Study|Other than specified|45|||
27766085|NCT02538341|54218658|FG000|Overall Study|Lost to Follow-up|51|||
27766086|NCT02538341|54218659|FG001|Overall Study|Lost to Follow-up|46|||
27766087|NCT02538341|54218658|FG000|Overall Study|Withdrawal by Subject|3|||
27766088|NCT02538341|54218659|FG001|Overall Study|Withdrawal by Subject|1|||
27766089|NCT02538341|54218658|FG000|Overall Study|Death|2|||
27766090|NCT02538341|54218659|FG001|Overall Study|Death|0|||
27766091|NCT02538107|54218665|FG000|Overall Study|Did not receive any Mircera dose|11|||
27766092|NCT02538107|54218665|FG000|Overall Study|Missing|5|||
27766093|NCT02538107|54218665|FG000|Overall Study|Necessity of dialysis|20|||
27766094|NCT02538107|54218665|FG000|Overall Study|Administration of other ESA|11|||
27766095|NCT02538107|54218665|FG000|Overall Study|No further treatment necessary|18|||
27766096|NCT02538107|54218665|FG000|Overall Study|Withdrawal by Subject|17|||
27766097|NCT02538107|54218665|FG000|Overall Study|Death|4|||
27766098|NCT02538107|54218665|FG000|Overall Study|Administrative reason|5|||
27766099|NCT02538107|54218665|FG000|Overall Study|Adverse Event|4|||
27766100|NCT02538107|54218665|FG000|Overall Study|Surgery|1|||
27766101|NCT02538107|54218665|FG000|Overall Study|Other|7|||
27766102|NCT02538107|54218665|FG000|Overall Study|Not recorded|7|||
27766103|NCT02538029|54218682|FG000|Overall Study|unable to complete cognitive assessments|1|||
27766104|NCT02538029|54218683|FG001|Overall Study|unable to complete cognitive assessments|0|||
27766105|NCT02538029|54218684|FG002|Overall Study|unable to complete cognitive assessments|1|||
27766106|NCT02272413|54218696|FG000|Randomized Through Treatment Start|Not treated|3|||
27766107|NCT02272413|54218697|FG001|Randomized Through Treatment Start|Not treated|5|||
27766108|NCT02272413|54218696|FG000|Pre-switch Period|Adverse Event|38|||
27766109|NCT02272413|54218697|FG001|Pre-switch Period|Adverse Event|37|||
27766110|NCT02272413|54218696|FG000|Pre-switch Period|Death|26|||
27766111|NCT02272413|54218697|FG001|Pre-switch Period|Death|26|||
27766112|NCT02272413|54218696|FG000|Pre-switch Period|Withdrawal by Subject|27|||
27766113|NCT02272413|54218697|FG001|Pre-switch Period|Withdrawal by Subject|15|||
27766114|NCT02272413|54218696|FG000|Pre-switch Period|Physician Decision|6|||
27766115|NCT02272413|54218697|FG001|Pre-switch Period|Physician Decision|18|||
27766116|NCT02272413|54218696|FG000|Pre-switch Period|Progressive disease|185|||
27766117|NCT02272413|54218697|FG001|Pre-switch Period|Progressive disease|173|||
27766118|NCT02272413|54218696|FG000|Pre-switch Period|Lost to Follow-up|0|||
27766119|NCT02272413|54218697|FG001|Pre-switch Period|Lost to Follow-up|2|||
27766120|NCT02272413|54218696|FG000|Pre-switch Period|Protocol Violation|1|||
27766121|NCT02272413|54218697|FG001|Pre-switch Period|Protocol Violation|0|||
27766122|NCT02272413|54218696|FG000|Pre-switch Period|Other than listed|10|||
27766123|NCT02272413|54218697|FG001|Pre-switch Period|Other than listed|11|||
27766124|NCT02272413|54218696|FG000|Post-switch Period|Adverse Event|4|||
27766125|NCT02272413|54218697|FG001|Post-switch Period|Adverse Event|4|||
27766126|NCT02272413|54218696|FG000|Post-switch Period|Death|3|||
27766127|NCT02272413|54218697|FG001|Post-switch Period|Death|2|||
27766128|NCT02272413|54218696|FG000|Post-switch Period|Withdrawal by Subject|1|||
27766129|NCT02272413|54218697|FG001|Post-switch Period|Withdrawal by Subject|2|||
27766130|NCT02272413|54218696|FG000|Post-switch Period|Physician Decision|1|||
27766131|NCT02272413|54218697|FG001|Post-switch Period|Physician Decision|1|||
27766132|NCT02272413|54218696|FG000|Post-switch Period|Progressive disease|21|||
27766133|NCT02272413|54218697|FG001|Post-switch Period|Progressive disease|21|||
27766134|NCT02272413|54218696|FG000|Post-switch Period|Study terminated by sponsor|8|||
27766135|NCT02272413|54218697|FG001|Post-switch Period|Study terminated by sponsor|11|||
27766136|NCT02272413|54218696|FG000|Post-switch Period|Other than listed|4|||
27766137|NCT02272413|54218697|FG001|Post-switch Period|Other than listed|5|||
27766138|NCT02396381|54218709|FG000|Overall Study|Adverse Event|3|||
27766139|NCT02396381|54218710|FG001|Overall Study|Adverse Event|2|||
27766140|NCT02396381|54218709|FG000|Overall Study|Withdrawal by Subject|33|||
27766141|NCT02396381|54218710|FG001|Overall Study|Withdrawal by Subject|24|||
27766142|NCT02396381|54218709|FG000|Overall Study|Lost to Follow-up|49|||
27766143|NCT02396381|54218710|FG001|Overall Study|Lost to Follow-up|31|||
27766144|NCT02396381|54218709|FG000|Overall Study|Protocol Violation|1|||
27766145|NCT02396381|54218710|FG001|Overall Study|Protocol Violation|0|||
27766146|NCT02396381|54218709|FG000|Overall Study|Site terminated by sponsor|7|||
27766147|NCT02396381|54218710|FG001|Overall Study|Site terminated by sponsor|8|||
27766148|NCT02396381|54218709|FG000|Overall Study|Physician Decision|5|||
27766149|NCT02396381|54218710|FG001|Overall Study|Physician Decision|5|||
27766150|NCT02396381|54218709|FG000|Overall Study|Pregnancy|2|||
27766151|NCT02396381|54218710|FG001|Overall Study|Pregnancy|0|||
27766152|NCT02396381|54218709|FG000|Overall Study|Non-compliance with study procedures|1|||
27766153|NCT02396381|54218710|FG001|Overall Study|Non-compliance with study procedures|0|||
27766154|NCT02396381|54218709|FG000|Overall Study|Moved out of town/state|1|||
27766155|NCT02396381|54218710|FG001|Overall Study|Moved out of town/state|3|||
27766156|NCT02396381|54218709|FG000|Overall Study|Could not complete visit|1|||
27766157|NCT02396381|54218710|FG001|Overall Study|Could not complete visit|0|||
27766158|NCT02396381|54218709|FG000|Overall Study|Possible conflict of interest|1|||
27766159|NCT02396381|54218710|FG001|Overall Study|Possible conflict of interest|0|||
27766160|NCT02396381|54218709|FG000|Overall Study|Randomization/Screening Error|3|||
27766161|NCT02396381|54218710|FG001|Overall Study|Randomization/Screening Error|1|||
27766162|NCT02532647|54218722|FG000|Overall Study|Did not receive trial medication|1|||
27766163|NCT02532647|54218723|FG001|Overall Study|Did not receive trial medication|0|||
27766164|NCT02532647|54218724|FG002|Overall Study|Did not receive trial medication|1|||
27766165|NCT02537015|54218732|FG000|Overall Study|Adverse Event|3|||
27766166|NCT02537015|54218732|FG000|Overall Study|Withdrawal by Subject|2|||
27766167|NCT02537015|54218732|FG000|Overall Study|Other Miscellaneous Reasons|1|||
27766168|NCT02271945|54218738|FG000|Overall Study|Death|3|||
27766169|NCT02271945|54218739|FG001|Overall Study|Death|3|||
27766170|NCT02271945|54218738|FG000|Overall Study|Withdrawal by Subject|1|||
27766171|NCT02271945|54218739|FG001|Overall Study|Withdrawal by Subject|1|||
27766172|NCT02271945|54218738|FG000|Overall Study|Other|1|||
27766173|NCT02271945|54218739|FG001|Overall Study|Other|1|||
27766174|NCT01660763|54218747|FG000|Overall Study|Lack of Efficacy|45|||
27766175|NCT01660763|54218748|FG001|Overall Study|Lack of Efficacy|50|||
27766176|NCT01660763|54218747|FG000|Overall Study|Adverse Event|22|||
27766177|NCT01660763|54218748|FG001|Overall Study|Adverse Event|7|||
27766178|NCT01660763|54218747|FG000|Overall Study|Protocol Violation|1|||
27766179|NCT01660763|54218748|FG001|Overall Study|Protocol Violation|0|||
27766180|NCT01660763|54218747|FG000|Overall Study|Withdrawal by Subject|4|||
27766181|NCT01660763|54218748|FG001|Overall Study|Withdrawal by Subject|0|||
27766182|NCT01660763|54218747|FG000|Overall Study|Patient ready for early discharge|28|||
27766183|NCT01660763|54218748|FG001|Overall Study|Patient ready for early discharge|4|||
27766184|NCT01937117|54218754|FG000|Overall Study|Disease Progression|7|||
27766185|NCT01937117|54218754|FG000|Overall Study|Physician Decision|4|||
27766186|NCT01937117|54218754|FG000|Overall Study|Adverse Event|2|||
27766187|NCT02268045|54218760|FG000|Overall Study|Death|4|||
27766188|NCT02268045|54218761|FG001|Overall Study|Death|4|||
27766189|NCT02268045|54218760|FG000|Overall Study|Disease Progression|2|||
27766190|NCT02268045|54218761|FG001|Overall Study|Disease Progression|1|||
27766191|NCT02268045|54218760|FG000|Overall Study|Adverse Event|7|||
27766192|NCT02268045|54218761|FG001|Overall Study|Adverse Event|7|||
27766193|NCT02268045|54218760|FG000|Overall Study|Withdrawal by Subject|2|||
27766194|NCT02268045|54218761|FG001|Overall Study|Withdrawal by Subject|6|||
27766195|NCT02268045|54218760|FG000|Overall Study|Physician Decision|0|||
27766196|NCT02268045|54218761|FG001|Overall Study|Physician Decision|1|||
27766197|NCT02268045|54218760|FG000|Overall Study|Protocol Violation|1|||
27766198|NCT02268045|54218761|FG001|Overall Study|Protocol Violation|1|||
27766199|NCT02536781|54218771|FG000|Overall Study|Lost to Follow-up|2|||
27766200|NCT02536781|54218772|FG001|Overall Study|Lost to Follow-up|0|||
27766201|NCT02267187|54218778|FG000|Overall Study|Physician Decision|2|||
27766202|NCT02267187|54218778|FG000|Overall Study|Screen fail|3|||
27766203|NCT02532179|54218782|FG000|Overall Study|Lost to Follow-up|1|||
27766204|NCT02532179|54218782|FG000|Overall Study|Pregnancy|1|||
27766205|NCT02532179|54218782|FG000|Overall Study|Subject received depot steroid injection|1|||
27766206|NCT02409667|54218786|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6|||
27766207|NCT02409667|54218787|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
27766208|NCT02409667|54218788|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
27766209|NCT02409667|54218789|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
27766210|NCT02409667|54218790|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
27766211|NCT02409667|54218786|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6|||
27766212|NCT02409667|54218787|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
27766213|NCT02409667|54218788|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
27766214|NCT02409667|54218789|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
27766215|NCT02409667|54218790|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
27766216|NCT02409667|54218786|FG000|Treatment Period 1, Baseline to Week 24|Protocol deviation|20|||
27766217|NCT02409667|54218787|FG001|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
27766218|NCT02409667|54218788|FG002|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
27766219|NCT02409667|54218789|FG003|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
27766220|NCT02409667|54218790|FG004|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
27766221|NCT02409667|54218786|FG000|Treatment Period 1, Baseline to Week 24|Pregnancy|1|||
27766222|NCT02409667|54218787|FG001|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
27766223|NCT02409667|54218788|FG002|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
27766224|NCT02409667|54218789|FG003|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
27766225|NCT02409667|54218790|FG004|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
27766226|NCT02409667|54218786|FG000|Treatment Period 1, Baseline to Week 24|Physician Decision|4|||
27766227|NCT02409667|54218787|FG001|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
27766228|NCT02409667|54218788|FG002|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
27766229|NCT02409667|54218789|FG003|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
27766230|NCT02409667|54218790|FG004|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
27766231|NCT02409667|54218786|FG000|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5|||
27766232|NCT02409667|54218787|FG001|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
27766233|NCT02409667|54218788|FG002|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
27766234|NCT02409667|54218789|FG003|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
27766235|NCT02409667|54218790|FG004|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
27766236|NCT02409667|54218786|FG000|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6|||
27766237|NCT02409667|54218787|FG001|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
27766238|NCT02409667|54218788|FG002|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
27766239|NCT02409667|54218789|FG003|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
27766240|NCT02409667|54218790|FG004|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
27766241|NCT02409667|54218786|FG000|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48|||
27766242|NCT02409667|54218787|FG001|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
27766243|NCT02409667|54218788|FG002|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
27766244|NCT02409667|54218789|FG003|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
27766245|NCT02409667|54218790|FG004|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
27766246|NCT02409667|54218786|FG000|Treatment Period 1, Baseline to Week 24|Adverse Event|25|||
27766247|NCT02409667|54218787|FG001|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
27766248|NCT02409667|54218788|FG002|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
27766249|NCT02409667|54218789|FG003|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
27766250|NCT02409667|54218790|FG004|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
27766251|NCT02409667|54218786|FG000|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
27766252|NCT02409667|54218787|FG001|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7|||
27766253|NCT02409667|54218788|FG002|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4|||
27766254|NCT02409667|54218789|FG003|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3|||
27766255|NCT02409667|54218790|FG004|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
27766256|NCT02409667|54218786|FG000|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
27766257|NCT02409667|54218787|FG001|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
27766258|NCT02409667|54218788|FG002|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
27766259|NCT02409667|54218789|FG003|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2|||
27766260|NCT02409667|54218790|FG004|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
27766261|NCT02409667|54218786|FG000|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0|||
27766262|NCT02409667|54218787|FG001|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7|||
27766263|NCT02409667|54218788|FG002|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4|||
27766264|NCT02409667|54218789|FG003|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1|||
27766265|NCT02409667|54218790|FG004|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2|||
27766266|NCT02409667|54218786|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
27766267|NCT02409667|54218787|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5|||
27766268|NCT02409667|54218788|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4|||
27766269|NCT02409667|54218789|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
27766270|NCT02409667|54218790|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
27766271|NCT02409667|54218786|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
27766272|NCT02409667|54218787|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4|||
27766273|NCT02409667|54218788|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5|||
27766274|NCT02409667|54218789|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2|||
27766275|NCT02409667|54218790|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
27766276|NCT02409667|54218786|FG000|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
27766277|NCT02409667|54218787|FG001|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
27766278|NCT02409667|54218788|FG002|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
27766279|NCT02409667|54218789|FG003|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
27766280|NCT02409667|54218790|FG004|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
27766281|NCT02409667|54218786|FG000|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
27766282|NCT02409667|54218787|FG001|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
27766283|NCT02409667|54218788|FG002|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3|||
27766284|NCT02409667|54218789|FG003|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
27766285|NCT02409667|54218790|FG004|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
27766286|NCT01641939|54218804|FG000|Overall Study|Death|90|||
27766287|NCT01641939|54218805|FG001|Overall Study|Death|187|||
27766288|NCT01641939|54218806|FG002|Overall Study|Death|61|||
27766289|NCT01641939|54218804|FG000|Overall Study|Lost to Follow-up|3|||
27766290|NCT01641939|54218805|FG001|Overall Study|Lost to Follow-up|2|||
27766291|NCT01641939|54218806|FG002|Overall Study|Lost to Follow-up|1|||
27766292|NCT01641939|54218804|FG000|Overall Study|Withdrawal by Subject|14|||
27766293|NCT01641939|54218805|FG001|Overall Study|Withdrawal by Subject|11|||
27766294|NCT01641939|54218806|FG002|Overall Study|Withdrawal by Subject|5|||
27766295|NCT01641939|54218804|FG000|Overall Study|Study Terminated by Sponsor|10|||
27766296|NCT01641939|54218805|FG001|Overall Study|Study Terminated by Sponsor|28|||
27766297|NCT01641939|54218806|FG002|Overall Study|Study Terminated by Sponsor|3|||
27766298|NCT01641861|54218818|FG000|Overall Study|Lost to Follow-up|21|||
27766299|NCT01641861|54218819|FG001|Overall Study|Lost to Follow-up|16|||
27766300|NCT01641861|54218818|FG000|Overall Study|Lost the tooth due to normal exfoliation|14|||
27766301|NCT01641861|54218819|FG001|Overall Study|Lost the tooth due to normal exfoliation|8|||
27766302|NCT01641861|54218818|FG000|Overall Study|Died due to drowning|0|||
27766303|NCT01641861|54218819|FG001|Overall Study|Died due to drowning|1|||
27766304|NCT02409355|54218827|FG000|Overall Study|Withdrawal by Subject|1|||
27766305|NCT02409355|54218828|FG001|Overall Study|Withdrawal by Subject|0|||
27766306|NCT02409355|54218827|FG000|Overall Study|Death|1|||
27766307|NCT02409355|54218828|FG001|Overall Study|Death|1|||
27766308|NCT02409355|54218827|FG000|Overall Study|Study terminated by Sponsor|2|||
27766309|NCT02409355|54218828|FG001|Overall Study|Study terminated by Sponsor|3|||
27766310|NCT02408887|54218836|FG000|Overall Study|Participant was inevaluable due to advanced cancer|1|||
27766311|NCT02408887|54218837|FG001|Overall Study|Participant was inevaluable due to advanced cancer|0|||
27766312|NCT02408887|54218836|FG000|Overall Study|Participant was inevaluable due to benign pathology.|0|||
27766313|NCT02408887|54218837|FG001|Overall Study|Participant was inevaluable due to benign pathology.|1|||
27766314|NCT02266875|54218845|FG000|Overall Study|Withdrawal by Subject|9|||
27766315|NCT02266875|54218846|FG001|Overall Study|Withdrawal by Subject|0|||
27766316|NCT02266875|54218845|FG000|Overall Study|Lost to Follow-up|2|||
27766317|NCT02266875|54218846|FG001|Overall Study|Lost to Follow-up|0|||
27766318|NCT02438371|54218854|FG000|Overall Study|Lost to Follow-up|3|||
27766319|NCT02438371|54218855|FG001|Overall Study|Lost to Follow-up|2|||
27766320|NCT02438371|54218854|FG000|Overall Study|Withdrawal by Subject|1|||
27766321|NCT02438371|54218855|FG001|Overall Study|Withdrawal by Subject|1|||
27766322|NCT02438137|54218863|FG000|Overall Study|Lost to Follow-up|3|||
27766323|NCT02438137|54218864|FG001|Overall Study|Lost to Follow-up|2|||
27766324|NCT02438137|54218863|FG000|Overall Study|Adverse Event|1|||
27766325|NCT02438137|54218864|FG001|Overall Study|Adverse Event|0|||
27766326|NCT02438137|54218863|FG000|Overall Study|Withdrawal by Subject|4|||
27766327|NCT02438137|54218864|FG001|Overall Study|Withdrawal by Subject|3|||
27766328|NCT02438137|54218863|FG000|Overall Study|Physician Decision|0|||
27766329|NCT02438137|54218864|FG001|Overall Study|Physician Decision|1|||
27766330|NCT02437903|54218872|FG000|Overall Study|Adverse Event|1|||
27766331|NCT02437903|54218872|FG000|Overall Study|Withdrawal by Subject|1|||
27766332|NCT02437903|54218872|FG000|Overall Study|Lost to Follow-up|3|||
27766333|NCT02437513|54218877|FG000|Overall Study|Withdrawal by Subject|2|||
27766334|NCT02460991|54218883|FG000|Overall Study|Withdrawal by Subject|0|||
27766335|NCT02460991|54218884|FG001|Overall Study|Withdrawal by Subject|2|||
27766336|NCT02407249|54218895|FG000|Overall Study|Did not complete 12-month follow-up|13|||
27766337|NCT02407249|54218895|FG000|Overall Study|Not treated|13|||
27766338|NCT02460679|54218899|FG000|Overall Study|Investigator Decision|1|||
27766339|NCT02460679|54218899|FG000|Overall Study|Withdrawal by Subject|4|||
27766340|NCT02459899|54218907|FG000|Overall Study|Adverse Event|1|||
27766341|NCT02459899|54218908|FG001|Overall Study|Adverse Event|1|||
27766342|NCT02459899|54218909|FG002|Overall Study|Adverse Event|0|||
27766343|NCT02459899|54218910|FG003|Overall Study|Adverse Event|0|||
27766344|NCT02459899|54218907|FG000|Overall Study|Lost to Follow-up|1|||
27766345|NCT02459899|54218908|FG001|Overall Study|Lost to Follow-up|2|||
27766346|NCT02459899|54218909|FG002|Overall Study|Lost to Follow-up|0|||
27766347|NCT02459899|54218910|FG003|Overall Study|Lost to Follow-up|1|||
27766348|NCT02459899|54218907|FG000|Overall Study|Non-compliance with the treatment|0|||
27766349|NCT02459899|54218908|FG001|Overall Study|Non-compliance with the treatment|0|||
27766350|NCT02459899|54218909|FG002|Overall Study|Non-compliance with the treatment|0|||
27766351|NCT02459899|54218910|FG003|Overall Study|Non-compliance with the treatment|1|||
27766352|NCT02459899|54218907|FG000|Overall Study|Withdrawal by Subject|1|||
27766353|NCT02459899|54218908|FG001|Overall Study|Withdrawal by Subject|3|||
27766354|NCT02459899|54218909|FG002|Overall Study|Withdrawal by Subject|0|||
27766355|NCT02459899|54218910|FG003|Overall Study|Withdrawal by Subject|0|||
27766356|NCT02436889|54218922|FG000|Overall Study|No improvement in symptoms|1|||
27766357|NCT02436889|54218923|FG001|Overall Study|No improvement in symptoms|0|||
27766358|NCT02436889|54218922|FG000|Overall Study|Does not like/could not tolerate medicat|0|||
27766359|NCT02436889|54218923|FG001|Overall Study|Does not like/could not tolerate medicat|1|||
27766360|NCT02436811|54218932|FG000|Overall Study|Lost to Follow-up|2|||
27766361|NCT02436811|54218933|FG001|Overall Study|Lost to Follow-up|9|||
27766362|NCT02436811|54218934|FG002|Overall Study|Lost to Follow-up|7|||
27766363|NCT02436577|54218948|FG000|Overall Study|Protocol Deviation|0|||
27766364|NCT02436577|54218949|FG001|Overall Study|Protocol Deviation|1|||
27766365|NCT02436577|54218950|FG002|Overall Study|Protocol Deviation|0|||
27766366|NCT02436577|54218951|FG003|Overall Study|Protocol Deviation|0|||
27766367|NCT02436577|54218952|FG004|Overall Study|Protocol Deviation|0|||
27766368|NCT02436577|54218953|FG005|Overall Study|Protocol Deviation|0|||
27766369|NCT02265705|54218963|FG000|Treatment Period Week 0-24|Adverse Event|3|||
27766370|NCT02265705|54218964|FG001|Treatment Period Week 0-24|Adverse Event|2|||
27766371|NCT02265705|54218965|FG002|Treatment Period Week 0-24|Adverse Event|0|||
27766372|NCT02265705|54218966|FG003|Treatment Period Week 0-24|Adverse Event|0|||
27766373|NCT02265705|54218967|FG004|Treatment Period Week 0-24|Adverse Event|0|||
27766374|NCT02265705|54218968|FG005|Treatment Period Week 0-24|Adverse Event|0|||
27766375|NCT02265705|54218969|FG006|Treatment Period Week 0-24|Adverse Event|0|||
27766376|NCT02265705|54218963|FG000|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
27766377|NCT02265705|54218964|FG001|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
27766378|NCT02265705|54218965|FG002|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
27766379|NCT02265705|54218966|FG003|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
27766380|NCT02265705|54218967|FG004|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
27766381|NCT02265705|54218968|FG005|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
27766382|NCT02265705|54218969|FG006|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
27766383|NCT02265705|54218963|FG000|Treatment Period Week 0-24|Physician Decision|1|||
27766384|NCT02265705|54218964|FG001|Treatment Period Week 0-24|Physician Decision|0|||
27766385|NCT02265705|54218965|FG002|Treatment Period Week 0-24|Physician Decision|0|||
27766386|NCT02265705|54218966|FG003|Treatment Period Week 0-24|Physician Decision|0|||
27766387|NCT02265705|54218967|FG004|Treatment Period Week 0-24|Physician Decision|0|||
27766388|NCT02265705|54218968|FG005|Treatment Period Week 0-24|Physician Decision|0|||
27766389|NCT02265705|54218969|FG006|Treatment Period Week 0-24|Physician Decision|0|||
27766390|NCT02265705|54218963|FG000|Treatment Period Week 0-24|Withdrawal by Subject|7|||
27766391|NCT02265705|54218964|FG001|Treatment Period Week 0-24|Withdrawal by Subject|5|||
27766392|NCT02265705|54218965|FG002|Treatment Period Week 0-24|Withdrawal by Subject|0|||
27766393|NCT02265705|54218966|FG003|Treatment Period Week 0-24|Withdrawal by Subject|0|||
27766394|NCT02265705|54218967|FG004|Treatment Period Week 0-24|Withdrawal by Subject|0|||
27766395|NCT02265705|54218968|FG005|Treatment Period Week 0-24|Withdrawal by Subject|0|||
27766396|NCT02265705|54218969|FG006|Treatment Period Week 0-24|Withdrawal by Subject|0|||
27766397|NCT02265705|54218963|FG000|Treatment Period Week 0-24|Lack of Efficacy|0|||
27766398|NCT02265705|54218964|FG001|Treatment Period Week 0-24|Lack of Efficacy|1|||
27766399|NCT02265705|54218965|FG002|Treatment Period Week 0-24|Lack of Efficacy|0|||
27766400|NCT02265705|54218966|FG003|Treatment Period Week 0-24|Lack of Efficacy|0|||
27766401|NCT02265705|54218967|FG004|Treatment Period Week 0-24|Lack of Efficacy|0|||
27766402|NCT02265705|54218968|FG005|Treatment Period Week 0-24|Lack of Efficacy|0|||
27766403|NCT02265705|54218969|FG006|Treatment Period Week 0-24|Lack of Efficacy|0|||
27766404|NCT02265705|54218963|FG000|Rescue Period|Withdrawal by Subject|0|||
27766405|NCT02265705|54218964|FG001|Rescue Period|Withdrawal by Subject|0|||
27766406|NCT02265705|54218965|FG002|Rescue Period|Withdrawal by Subject|1|||
27766407|NCT02265705|54218966|FG003|Rescue Period|Withdrawal by Subject|0|||
27766408|NCT02265705|54218967|FG004|Rescue Period|Withdrawal by Subject|0|||
27766409|NCT02265705|54218968|FG005|Rescue Period|Withdrawal by Subject|0|||
27766410|NCT02265705|54218969|FG006|Rescue Period|Withdrawal by Subject|0|||
27766411|NCT02265705|54218963|FG000|Rescue Period|Death|0|||
27766412|NCT02265705|54218964|FG001|Rescue Period|Death|0|||
27766413|NCT02265705|54218965|FG002|Rescue Period|Death|1|||
27766414|NCT02265705|54218966|FG003|Rescue Period|Death|0|||
27766415|NCT02265705|54218967|FG004|Rescue Period|Death|0|||
27766416|NCT02265705|54218968|FG005|Rescue Period|Death|0|||
27766417|NCT02265705|54218969|FG006|Rescue Period|Death|0|||
27766418|NCT02265705|54218963|FG000|Rescue Period|Lack of Efficacy|0|||
27766419|NCT02265705|54218964|FG001|Rescue Period|Lack of Efficacy|0|||
27766420|NCT02265705|54218965|FG002|Rescue Period|Lack of Efficacy|1|||
27766421|NCT02265705|54218966|FG003|Rescue Period|Lack of Efficacy|0|||
27766422|NCT02265705|54218967|FG004|Rescue Period|Lack of Efficacy|0|||
27766423|NCT02265705|54218968|FG005|Rescue Period|Lack of Efficacy|0|||
27766424|NCT02265705|54218969|FG006|Rescue Period|Lack of Efficacy|0|||
27766425|NCT02265705|54218963|FG000|Open Label Period|Adverse Event|0|||
27766426|NCT02265705|54218964|FG001|Open Label Period|Adverse Event|0|||
27766427|NCT02265705|54218965|FG002|Open Label Period|Adverse Event|0|||
27766428|NCT02265705|54218966|FG003|Open Label Period|Adverse Event|2|||
27766429|NCT02265705|54218967|FG004|Open Label Period|Adverse Event|2|||
27766430|NCT02265705|54218968|FG005|Open Label Period|Adverse Event|0|||
27766431|NCT02265705|54218969|FG006|Open Label Period|Adverse Event|0|||
27766432|NCT02265705|54218963|FG000|Open Label Period|Physician Decision|0|||
27766433|NCT02265705|54218964|FG001|Open Label Period|Physician Decision|0|||
27766434|NCT02265705|54218965|FG002|Open Label Period|Physician Decision|0|||
27766435|NCT02265705|54218966|FG003|Open Label Period|Physician Decision|0|||
27766436|NCT02265705|54218967|FG004|Open Label Period|Physician Decision|1|||
27766437|NCT02265705|54218968|FG005|Open Label Period|Physician Decision|0|||
27766438|NCT02265705|54218969|FG006|Open Label Period|Physician Decision|0|||
27766439|NCT02265705|54218963|FG000|Open Label Period|Withdrawal by Subject|0|||
27766440|NCT02265705|54218964|FG001|Open Label Period|Withdrawal by Subject|0|||
27766441|NCT02265705|54218965|FG002|Open Label Period|Withdrawal by Subject|0|||
27766442|NCT02265705|54218966|FG003|Open Label Period|Withdrawal by Subject|0|||
27766443|NCT02265705|54218967|FG004|Open Label Period|Withdrawal by Subject|2|||
27766444|NCT02265705|54218968|FG005|Open Label Period|Withdrawal by Subject|0|||
27766445|NCT02265705|54218969|FG006|Open Label Period|Withdrawal by Subject|0|||
27766446|NCT02265705|54218963|FG000|Follow-up Period|Sponsor Decision|0|||
27766447|NCT02265705|54218964|FG001|Follow-up Period|Sponsor Decision|0|||
27766448|NCT02265705|54218965|FG002|Follow-up Period|Sponsor Decision|0|||
27766449|NCT02265705|54218966|FG003|Follow-up Period|Sponsor Decision|0|||
27766450|NCT02265705|54218967|FG004|Follow-up Period|Sponsor Decision|0|||
27766451|NCT02265705|54218968|FG005|Follow-up Period|Sponsor Decision|1|||
27766452|NCT02265705|54218969|FG006|Follow-up Period|Sponsor Decision|6|||
27766453|NCT02265705|54218963|FG000|Follow-up Period|Adverse Event|0|||
27766454|NCT02265705|54218964|FG001|Follow-up Period|Adverse Event|0|||
27766455|NCT02265705|54218965|FG002|Follow-up Period|Adverse Event|0|||
27766456|NCT02265705|54218966|FG003|Follow-up Period|Adverse Event|0|||
27766457|NCT02265705|54218967|FG004|Follow-up Period|Adverse Event|0|||
27766458|NCT02265705|54218968|FG005|Follow-up Period|Adverse Event|0|||
27766459|NCT02265705|54218969|FG006|Follow-up Period|Adverse Event|3|||
27766460|NCT02265705|54218963|FG000|Follow-up Period|Physician Decision|0|||
27766461|NCT02265705|54218964|FG001|Follow-up Period|Physician Decision|0|||
27766462|NCT02265705|54218965|FG002|Follow-up Period|Physician Decision|0|||
27766463|NCT02265705|54218966|FG003|Follow-up Period|Physician Decision|0|||
27766464|NCT02265705|54218967|FG004|Follow-up Period|Physician Decision|0|||
27766465|NCT02265705|54218968|FG005|Follow-up Period|Physician Decision|0|||
27766466|NCT02265705|54218969|FG006|Follow-up Period|Physician Decision|1|||
27766467|NCT02265705|54218963|FG000|Follow-up Period|Withdrawal by Subject|0|||
27766468|NCT02265705|54218964|FG001|Follow-up Period|Withdrawal by Subject|0|||
27766469|NCT02265705|54218965|FG002|Follow-up Period|Withdrawal by Subject|0|||
27766470|NCT02265705|54218966|FG003|Follow-up Period|Withdrawal by Subject|0|||
27766471|NCT02265705|54218967|FG004|Follow-up Period|Withdrawal by Subject|0|||
27766472|NCT02265705|54218968|FG005|Follow-up Period|Withdrawal by Subject|0|||
27766473|NCT02265705|54218969|FG006|Follow-up Period|Withdrawal by Subject|1|||
27766474|NCT02459665|54218984|FG000|Overall Study|Withdrawal by Subject|0|||
27766475|NCT02459665|54218985|FG001|Overall Study|Withdrawal by Subject|1|||
27766476|NCT02459665|54218986|FG002|Overall Study|Withdrawal by Subject|1|||
27766477|NCT02459665|54218987|FG003|Overall Study|Withdrawal by Subject|2|||
27766478|NCT02459587|54219006|FG000|3-Month Follow-up Assessment|Death|0|||
27766479|NCT02459587|54219007|FG001|3-Month Follow-up Assessment|Death|2|||
27766480|NCT02459587|54219006|FG000|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
27766481|NCT02459587|54219007|FG001|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
27766482|NCT02459587|54219006|FG000|3-Month Follow-up Assessment|Lost to Follow-up|27|||
27766483|NCT02459587|54219007|FG001|3-Month Follow-up Assessment|Lost to Follow-up|22|||
27766484|NCT02459587|54219006|FG000|3-Month Follow-up Assessment|Researcher withdrew|2|||
27766485|NCT02459587|54219007|FG001|3-Month Follow-up Assessment|Researcher withdrew|4|||
27766486|NCT02459587|54219006|FG000|6-month Follow-up Assessment|Death|2|||
27766487|NCT02459587|54219007|FG001|6-month Follow-up Assessment|Death|1|||
27766488|NCT02459587|54219006|FG000|6-month Follow-up Assessment|Withdrawal by Subject|1|||
27766489|NCT02459587|54219007|FG001|6-month Follow-up Assessment|Withdrawal by Subject|2|||
27766490|NCT02459587|54219006|FG000|6-month Follow-up Assessment|Lost to Follow-up|21|||
27766491|NCT02459587|54219007|FG001|6-month Follow-up Assessment|Lost to Follow-up|22|||
27766492|NCT02459587|54219006|FG000|12-month Follow-up Assessment|Death|2|||
27766493|NCT02459587|54219007|FG001|12-month Follow-up Assessment|Death|0|||
27766494|NCT02459587|54219006|FG000|12-month Follow-up Assessment|Withdrawal by Subject|2|||
27766495|NCT02459587|54219007|FG001|12-month Follow-up Assessment|Withdrawal by Subject|4|||
27766496|NCT02459587|54219006|FG000|12-month Follow-up Assessment|Lost to Follow-up|18|||
27766497|NCT02459587|54219007|FG001|12-month Follow-up Assessment|Lost to Follow-up|22|||
27766498|NCT02459587|54219006|FG000|12-month Follow-up Assessment|Researcher withdrew|0|||
27766499|NCT02459587|54219007|FG001|12-month Follow-up Assessment|Researcher withdrew|1|||
27766500|NCT02265237|54219018|FG000|As Treated (Overall Study)|Adverse Event|1|||
27766501|NCT02265237|54219019|FG001|As Treated (Overall Study)|Adverse Event|1|||
27766502|NCT02265237|54219020|FG002|As Treated (Overall Study)|Adverse Event|0|||
27766503|NCT02265237|54219021|FG003|As Treated (Overall Study)|Adverse Event|0|||
27766504|NCT02265237|54219018|FG000|As Treated (Overall Study)|Withdrawal by Subject|1|||
27766505|NCT02265237|54219019|FG001|As Treated (Overall Study)|Withdrawal by Subject|0|||
27766506|NCT02265237|54219020|FG002|As Treated (Overall Study)|Withdrawal by Subject|1|||
27766507|NCT02265237|54219021|FG003|As Treated (Overall Study)|Withdrawal by Subject|0|||
27766508|NCT02265237|54219018|FG000|As Treated (Overall Study)|Lost to Follow-up|1|||
27766509|NCT02265237|54219019|FG001|As Treated (Overall Study)|Lost to Follow-up|2|||
27766510|NCT02265237|54219020|FG002|As Treated (Overall Study)|Lost to Follow-up|6|||
27766511|NCT02265237|54219021|FG003|As Treated (Overall Study)|Lost to Follow-up|0|||
27766512|NCT02265237|54219018|FG000|As Treated (Overall Study)|Other|2|||
27766513|NCT02265237|54219019|FG001|As Treated (Overall Study)|Other|0|||
27766514|NCT02265237|54219020|FG002|As Treated (Overall Study)|Other|3|||
27766515|NCT02265237|54219021|FG003|As Treated (Overall Study)|Other|1|||
27766516|NCT02263365|54219034|FG000|Overall Study|Physician Decision|22|||
27766517|NCT02263365|54219035|FG001|Overall Study|Physician Decision|18|||
27766518|NCT02261493|54219045|FG000|Overall Study|Noncompliance|0|||
27766519|NCT02261493|54219046|FG001|Overall Study|Noncompliance|0|||
27766520|NCT02261493|54219047|FG002|Overall Study|Noncompliance|2|||
27766521|NCT02261493|54219045|FG000|Overall Study|Physician Decision|0|||
27766522|NCT02261493|54219046|FG001|Overall Study|Physician Decision|1|||
27766523|NCT02261493|54219047|FG002|Overall Study|Physician Decision|0|||
27766524|NCT02261493|54219045|FG000|Overall Study|Undisclosed alcohol abuse|0|||
27766525|NCT02261493|54219046|FG001|Overall Study|Undisclosed alcohol abuse|1|||
27766526|NCT02261493|54219047|FG002|Overall Study|Undisclosed alcohol abuse|0|||
27766527|NCT02261493|54219045|FG000|Overall Study|Protocol Violation|1|||
27766528|NCT02261493|54219046|FG001|Overall Study|Protocol Violation|0|||
27766529|NCT02261493|54219047|FG002|Overall Study|Protocol Violation|0|||
27766530|NCT02261493|54219045|FG000|Overall Study|Personal Reasons|14|||
27766531|NCT02261493|54219046|FG001|Overall Study|Personal Reasons|14|||
27766532|NCT02261493|54219047|FG002|Overall Study|Personal Reasons|16|||
27766533|NCT02261493|54219045|FG000|Overall Study|Lost to Follow-up|14|||
27766534|NCT02261493|54219046|FG001|Overall Study|Lost to Follow-up|27|||
27766535|NCT02261493|54219047|FG002|Overall Study|Lost to Follow-up|8|||
27766536|NCT02261493|54219045|FG000|Overall Study|Pregnancy|1|||
27766537|NCT02261493|54219046|FG001|Overall Study|Pregnancy|2|||
27766538|NCT02261493|54219047|FG002|Overall Study|Pregnancy|0|||
27766539|NCT02261493|54219045|FG000|Overall Study|Lack of Efficacy|0|||
27766540|NCT02261493|54219046|FG001|Overall Study|Lack of Efficacy|1|||
27766541|NCT02261493|54219047|FG002|Overall Study|Lack of Efficacy|0|||
27766542|NCT02261493|54219045|FG000|Overall Study|Adverse Event|0|||
27766543|NCT02261493|54219046|FG001|Overall Study|Adverse Event|1|||
27766544|NCT02261493|54219047|FG002|Overall Study|Adverse Event|0|||
27766545|NCT02260791|54219057|FG000|Overall Study|Lost to Follow-up|4|||
27766546|NCT02260791|54219058|FG001|Overall Study|Lost to Follow-up|4|||
27766547|NCT02260791|54219057|FG000|Overall Study|Lack of Efficacy|2|||
27766548|NCT02260791|54219058|FG001|Overall Study|Lack of Efficacy|1|||
27766549|NCT02260791|54219057|FG000|Overall Study|Adverse Event|13|||
27766550|NCT02260791|54219058|FG001|Overall Study|Adverse Event|9|||
27766551|NCT02260791|54219057|FG000|Overall Study|Death|1|||
27766552|NCT02260791|54219058|FG001|Overall Study|Death|0|||
27766553|NCT02260791|54219057|FG000|Overall Study|Withdrawal by Subject|11|||
27766554|NCT02260791|54219058|FG001|Overall Study|Withdrawal by Subject|16|||
27766555|NCT02260791|54219057|FG000|Overall Study|Screen failure|0|||
27766556|NCT02260791|54219058|FG001|Overall Study|Screen failure|1|||
27766557|NCT02260791|54219057|FG000|Overall Study|Protocol deviation|2|||
27766558|NCT02260791|54219058|FG001|Overall Study|Protocol deviation|3|||
27766559|NCT02260635|54219066|FG000|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1|||
27766560|NCT02260635|54219067|FG001|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2|||
27766561|NCT02260635|54219066|FG000|Open-Label Extension|Study Termination|25|||
27766562|NCT02260635|54219067|FG001|Open-Label Extension|Study Termination|25|||
27766563|NCT02260635|54219066|FG000|Open-Label Extension|Withdrawal by Subject|1|||
27766564|NCT02260635|54219067|FG001|Open-Label Extension|Withdrawal by Subject|0|||
27766565|NCT02259231|54219082|FG000|Overall Study|Adverse Event|1|||
27766566|NCT02259231|54219083|FG001|Overall Study|Adverse Event|1|||
27766567|NCT02259231|54219084|FG002|Overall Study|Adverse Event|2|||
27766568|NCT02259231|54219085|FG003|Overall Study|Adverse Event|0|||
27766569|NCT02259231|54219086|FG004|Overall Study|Adverse Event|0|||
27766570|NCT02259231|54219087|FG005|Overall Study|Adverse Event|0|||
27766571|NCT02259231|54219088|FG006|Overall Study|Adverse Event|0|||
27766572|NCT02259231|54219082|FG000|Overall Study|Progressive Disease|4|||
27766573|NCT02259231|54219083|FG001|Overall Study|Progressive Disease|5|||
27766574|NCT02259231|54219084|FG002|Overall Study|Progressive Disease|4|||
27766575|NCT02259231|54219085|FG003|Overall Study|Progressive Disease|5|||
27766576|NCT02259231|54219086|FG004|Overall Study|Progressive Disease|4|||
27766577|NCT02259231|54219087|FG005|Overall Study|Progressive Disease|5|||
27766578|NCT02259231|54219088|FG006|Overall Study|Progressive Disease|4|||
27766579|NCT02259231|54219082|FG000|Overall Study|Sponsor termination of study|1|||
27766580|NCT02259231|54219083|FG001|Overall Study|Sponsor termination of study|0|||
27766581|NCT02259231|54219084|FG002|Overall Study|Sponsor termination of study|0|||
27766582|NCT02259231|54219085|FG003|Overall Study|Sponsor termination of study|1|||
27766583|NCT02259231|54219086|FG004|Overall Study|Sponsor termination of study|2|||
27766584|NCT02259231|54219087|FG005|Overall Study|Sponsor termination of study|1|||
27766585|NCT02259231|54219088|FG006|Overall Study|Sponsor termination of study|1|||
27766586|NCT02258529|54219104|FG000|Overall Study|Study Terminated by Sponsor|9|||
27766587|NCT02258529|54219104|FG000|Overall Study|Adverse Event|1|||
27766588|NCT02256969|54219111|FG000|Overall Study|Screenfailed or withdrew|2|||
27766589|NCT02256969|54219112|FG001|Overall Study|Screenfailed or withdrew|1|||
27766590|NCT02256969|54219113|FG002|Overall Study|Screenfailed or withdrew|1|||
27766591|NCT02256891|54219123|FG000|Overall Study|Death|0|||
27766592|NCT02256891|54219124|FG001|Overall Study|Death|2|||
27766593|NCT02256891|54219123|FG000|Overall Study|Lost to Follow-up|0|||
27766594|NCT02256891|54219124|FG001|Overall Study|Lost to Follow-up|3|||
27766595|NCT02256891|54219123|FG000|Overall Study|Physician Decision|7|||
27766596|NCT02256891|54219124|FG001|Overall Study|Physician Decision|3|||
27766597|NCT02256891|54219123|FG000|Overall Study|Screen Fail|5|||
27766598|NCT02256891|54219124|FG001|Overall Study|Screen Fail|4|||
27766599|NCT02256891|54219123|FG000|Overall Study|Equipment Malfunction|0|||
27766600|NCT02256891|54219124|FG001|Overall Study|Equipment Malfunction|1|||
27766601|NCT02256267|54219132|FG000|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1|||
27766602|NCT02256267|54219132|FG000|Period 2 (Day 7 to Day 14)|Adverse Event|1|||
27766603|NCT01641471|54219141|FG000|Overall Study|Withdrawal by Subject|19|||
27766604|NCT01641471|54219142|FG001|Overall Study|Withdrawal by Subject|19|||
27766605|NCT01641471|54219141|FG000|Overall Study|Lost to Follow-up|2|||
27766606|NCT01641471|54219142|FG001|Overall Study|Lost to Follow-up|4|||
27766607|NCT01641471|54219141|FG000|Overall Study|Protocol Violation|2|||
27766608|NCT01641471|54219142|FG001|Overall Study|Protocol Violation|4|||
27766609|NCT02255565|54219151|FG000|Overall Study|Withdrawal by Subject|0|||
27766610|NCT02255565|54219152|FG001|Overall Study|Withdrawal by Subject|1|||
27766611|NCT02255565|54219153|FG002|Overall Study|Withdrawal by Subject|0|||
27766612|NCT01640301|54219196|FG000|Overall Study|Death|0|||
27766613|NCT01640301|54219197|FG001|Overall Study|Death|8|||
27766614|NCT01642407|54219205|FG000|Part 1 (Screening Till Week 16)|Insufficient clinical response|3|||
27766615|NCT01642407|54219205|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1|||
27766616|NCT01642407|54219205|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1|||
27766617|NCT02255097|54219209|FG000|Overall Study|Death|151|||
27766618|NCT02255097|54219209|FG000|Overall Study|Lost to Follow-up|5|||
27766619|NCT02255097|54219209|FG000|Overall Study|Participation in Study Discontinued by Sponsor|8|||
27766620|NCT02255097|54219209|FG000|Overall Study|Withdrawal by Subject|7|||
27766621|NCT02255097|54219209|FG000|Overall Study|Allocated but not treated|1|||
27766622|NCT02254551|54219214|FG000|Dose Escalation|Physician Decision|1|||
27766623|NCT02254551|54219214|FG000|Dose Escalation|Dose-limiting toxicity|2|||
27766624|NCT01641237|54219221|FG000|Period II|Withdrawal by Subject|1|||
27766625|NCT01641237|54219222|FG001|Period II|Withdrawal by Subject|0|||
27766626|NCT01641237|54219223|FG002|Period II|Withdrawal by Subject|0|||
27766627|NCT01641237|54219224|FG003|Period II|Withdrawal by Subject|0|||
27766628|NCT01641237|54219221|FG000|Period III|Lost to Follow-up|1|||
27766629|NCT01641237|54219222|FG001|Period III|Lost to Follow-up|0|||
27766630|NCT01641237|54219223|FG002|Period III|Lost to Follow-up|0|||
27766631|NCT01641237|54219224|FG003|Period III|Lost to Follow-up|0|||
27766632|NCT01639833|54219236|FG000|Overall Study|Death|4|||
27766633|NCT01639833|54219237|FG001|Overall Study|Death|2|||
27766634|NCT01639833|54219236|FG000|Overall Study|Withdrawal by Subject|2|||
27766635|NCT01639833|54219237|FG001|Overall Study|Withdrawal by Subject|2|||
27766636|NCT01639131|54219243|FG000|Overall Study|Disease Progression|6|||
27766637|NCT01641159|54219249|FG000|Overall Study|Lost to Follow-up|2|||
27766638|NCT01641159|54219250|FG001|Overall Study|Lost to Follow-up|1|||
27766639|NCT01641159|54219249|FG000|Overall Study|Withdrawal by Subject|0|||
27766640|NCT01641159|54219250|FG001|Overall Study|Withdrawal by Subject|1|||
27766641|NCT01641081|54219256|FG000|Period 1|Sponsor request (potential unblinding)|0|||
27766642|NCT01641081|54219257|FG001|Period 1|Sponsor request (potential unblinding)|0|||
27766643|NCT01641081|54219258|FG002|Period 1|Sponsor request (potential unblinding)|0|||
27766644|NCT01641081|54219259|FG003|Period 1|Sponsor request (potential unblinding)|0|||
27766645|NCT01641081|54219260|FG004|Period 1|Sponsor request (potential unblinding)|0|||
27766646|NCT01641081|54219261|FG005|Period 1|Sponsor request (potential unblinding)|0|||
27766647|NCT01641081|54219262|FG006|Period 1|Sponsor request (potential unblinding)|1|||
27766648|NCT01641081|54219263|FG007|Period 1|Sponsor request (potential unblinding)|0|||
27766649|NCT01641081|54219264|FG008|Period 1|Sponsor request (potential unblinding)|0|||
27766650|NCT01641081|54219265|FG009|Period 1|Sponsor request (potential unblinding)|0|||
27766651|NCT01641081|54219256|FG000|Period 1|Protocol Violation|0|||
27766652|NCT01641081|54219257|FG001|Period 1|Protocol Violation|0|||
27766653|NCT01641081|54219258|FG002|Period 1|Protocol Violation|0|||
27766654|NCT01641081|54219259|FG003|Period 1|Protocol Violation|0|||
27766655|NCT01641081|54219260|FG004|Period 1|Protocol Violation|1|||
27766656|NCT01641081|54219261|FG005|Period 1|Protocol Violation|0|||
27766657|NCT01641081|54219262|FG006|Period 1|Protocol Violation|0|||
27766658|NCT01641081|54219263|FG007|Period 1|Protocol Violation|1|||
27766659|NCT01641081|54219264|FG008|Period 1|Protocol Violation|0|||
27766660|NCT01641081|54219265|FG009|Period 1|Protocol Violation|0|||
27766661|NCT01641081|54219256|FG000|Period 1|Adverse Event|1|||
27766662|NCT01641081|54219257|FG001|Period 1|Adverse Event|0|||
27766663|NCT01641081|54219258|FG002|Period 1|Adverse Event|0|||
27766664|NCT01641081|54219259|FG003|Period 1|Adverse Event|0|||
27766665|NCT01641081|54219260|FG004|Period 1|Adverse Event|0|||
27766666|NCT01641081|54219261|FG005|Period 1|Adverse Event|0|||
27766667|NCT01641081|54219262|FG006|Period 1|Adverse Event|0|||
27766668|NCT01641081|54219263|FG007|Period 1|Adverse Event|2|||
27766669|NCT01641081|54219264|FG008|Period 1|Adverse Event|0|||
27766670|NCT01641081|54219265|FG009|Period 1|Adverse Event|0|||
27766671|NCT01641081|54219256|FG000|Period 2|Adverse Event|0|||
27766672|NCT01641081|54219257|FG001|Period 2|Adverse Event|0|||
27766673|NCT01641081|54219258|FG002|Period 2|Adverse Event|0|||
27766674|NCT01641081|54219259|FG003|Period 2|Adverse Event|0|||
27766675|NCT01641081|54219260|FG004|Period 2|Adverse Event|0|||
27766676|NCT01641081|54219261|FG005|Period 2|Adverse Event|1|||
27766677|NCT01641081|54219262|FG006|Period 2|Adverse Event|0|||
27766678|NCT01641081|54219263|FG007|Period 2|Adverse Event|0|||
27766679|NCT01641081|54219264|FG008|Period 2|Adverse Event|0|||
27766680|NCT01641081|54219265|FG009|Period 2|Adverse Event|0|||
27766681|NCT01641081|54219256|FG000|Period 2|Withdrawal by Subject|0|||
27766682|NCT01641081|54219257|FG001|Period 2|Withdrawal by Subject|0|||
27766683|NCT01641081|54219258|FG002|Period 2|Withdrawal by Subject|0|||
27766684|NCT01641081|54219259|FG003|Period 2|Withdrawal by Subject|1|||
27766685|NCT01641081|54219260|FG004|Period 2|Withdrawal by Subject|0|||
27766686|NCT01641081|54219261|FG005|Period 2|Withdrawal by Subject|0|||
27766687|NCT01641081|54219262|FG006|Period 2|Withdrawal by Subject|2|||
27766688|NCT01641081|54219263|FG007|Period 2|Withdrawal by Subject|0|||
27766689|NCT01641081|54219264|FG008|Period 2|Withdrawal by Subject|0|||
27766690|NCT01641081|54219265|FG009|Period 2|Withdrawal by Subject|0|||
27766691|NCT01641081|54219256|FG000|Period 2|Protocol Violation|1|||
27766692|NCT01641081|54219257|FG001|Period 2|Protocol Violation|0|||
27766693|NCT01641081|54219258|FG002|Period 2|Protocol Violation|0|||
27766694|NCT01641081|54219259|FG003|Period 2|Protocol Violation|0|||
27766695|NCT01641081|54219260|FG004|Period 2|Protocol Violation|0|||
27766696|NCT01641081|54219261|FG005|Period 2|Protocol Violation|0|||
27766697|NCT01641081|54219262|FG006|Period 2|Protocol Violation|0|||
27766698|NCT01641081|54219263|FG007|Period 2|Protocol Violation|0|||
27766699|NCT01641081|54219264|FG008|Period 2|Protocol Violation|0|||
27766700|NCT01641081|54219265|FG009|Period 2|Protocol Violation|0|||
27766701|NCT01641081|54219256|FG000|Period 3|Adverse Event|0|||
27766702|NCT01641081|54219257|FG001|Period 3|Adverse Event|0|||
27766703|NCT01641081|54219258|FG002|Period 3|Adverse Event|1|||
27766704|NCT01641081|54219259|FG003|Period 3|Adverse Event|0|||
27766705|NCT01641081|54219260|FG004|Period 3|Adverse Event|0|||
27766706|NCT01641081|54219261|FG005|Period 3|Adverse Event|0|||
27766707|NCT01641081|54219262|FG006|Period 3|Adverse Event|0|||
27766708|NCT01641081|54219263|FG007|Period 3|Adverse Event|0|||
27766709|NCT01641081|54219264|FG008|Period 3|Adverse Event|0|||
27766710|NCT01641081|54219265|FG009|Period 3|Adverse Event|0|||
27766711|NCT01641081|54219256|FG000|Period 3|Withdrawal by Subject|0|||
27766712|NCT01641081|54219257|FG001|Period 3|Withdrawal by Subject|0|||
27766713|NCT01641081|54219258|FG002|Period 3|Withdrawal by Subject|0|||
27766714|NCT01641081|54219259|FG003|Period 3|Withdrawal by Subject|0|||
27766715|NCT01641081|54219260|FG004|Period 3|Withdrawal by Subject|0|||
27766716|NCT01641081|54219261|FG005|Period 3|Withdrawal by Subject|0|||
27766717|NCT01641081|54219262|FG006|Period 3|Withdrawal by Subject|0|||
27766718|NCT01641081|54219263|FG007|Period 3|Withdrawal by Subject|0|||
27766719|NCT01641081|54219264|FG008|Period 3|Withdrawal by Subject|1|||
27766720|NCT01641081|54219265|FG009|Period 3|Withdrawal by Subject|0|||
27766721|NCT01641081|54219256|FG000|Period 4|Adverse Event|0|||
27766722|NCT01641081|54219257|FG001|Period 4|Adverse Event|1|||
27766723|NCT01641081|54219258|FG002|Period 4|Adverse Event|0|||
27766724|NCT01641081|54219259|FG003|Period 4|Adverse Event|1|||
27766725|NCT01641081|54219260|FG004|Period 4|Adverse Event|0|||
27766726|NCT01641081|54219261|FG005|Period 4|Adverse Event|0|||
27766727|NCT01641081|54219262|FG006|Period 4|Adverse Event|0|||
27766728|NCT01641081|54219263|FG007|Period 4|Adverse Event|0|||
27766729|NCT01641081|54219264|FG008|Period 4|Adverse Event|0|||
27766730|NCT01641081|54219265|FG009|Period 4|Adverse Event|0|||
27766731|NCT01641081|54219256|FG000|Period 5|Adverse Event|0|||
27766732|NCT01641081|54219257|FG001|Period 5|Adverse Event|0|||
27766733|NCT01641081|54219258|FG002|Period 5|Adverse Event|2|||
27766734|NCT01641081|54219259|FG003|Period 5|Adverse Event|0|||
27766735|NCT01641081|54219260|FG004|Period 5|Adverse Event|0|||
27766736|NCT01641081|54219261|FG005|Period 5|Adverse Event|0|||
27766737|NCT01641081|54219262|FG006|Period 5|Adverse Event|0|||
27766738|NCT01641081|54219263|FG007|Period 5|Adverse Event|0|||
27766739|NCT01641081|54219264|FG008|Period 5|Adverse Event|0|||
27766740|NCT01641081|54219265|FG009|Period 5|Adverse Event|0|||
27766741|NCT01640925|54219279|FG000|Overall Study|Withdrawal by Subject|1|||
27766742|NCT01640925|54219280|FG001|Overall Study|Withdrawal by Subject|0|||
27766743|NCT01640925|54219279|FG000|Overall Study|Previously enrolled in this trial|13|||
27766744|NCT01640925|54219280|FG001|Overall Study|Previously enrolled in this trial|11|||
27766745|NCT01638429|54219286|FG000|Overall Study|Withdrawal by Subject|1|||
27766746|NCT01639755|54219294|FG000|Overall Study|Study Ongoing|15|||
27766747|NCT01639755|54219294|FG000|Overall Study|Patient had device explantation|4|||
27766748|NCT01601535|54219304|FG000|Phase 1|Adverse Event|1|||
27766749|NCT01601535|54219305|FG001|Phase 1|Adverse Event|0|||
27766750|NCT01601535|54219306|FG002|Phase 1|Adverse Event|2|||
27766751|NCT01601535|54219307|FG003|Phase 1|Adverse Event|1|||
27766752|NCT01601535|54219308|FG004|Phase 1|Adverse Event|0|||
27766753|NCT01601535|54219309|FG005|Phase 1|Adverse Event|0|||
27766754|NCT01601535|54219304|FG000|Phase 1|Withdrawal by Subject|2|||
27766755|NCT01601535|54219305|FG001|Phase 1|Withdrawal by Subject|1|||
27766756|NCT01601535|54219306|FG002|Phase 1|Withdrawal by Subject|1|||
27766757|NCT01601535|54219307|FG003|Phase 1|Withdrawal by Subject|2|||
27766758|NCT01601535|54219308|FG004|Phase 1|Withdrawal by Subject|0|||
27766759|NCT01601535|54219309|FG005|Phase 1|Withdrawal by Subject|0|||
27766760|NCT01601535|54219304|FG000|Phase 1|Progressive Disease|2|||
27766761|NCT01601535|54219305|FG001|Phase 1|Progressive Disease|3|||
27766762|NCT01601535|54219306|FG002|Phase 1|Progressive Disease|2|||
27766763|NCT01601535|54219307|FG003|Phase 1|Progressive Disease|1|||
27766764|NCT01601535|54219308|FG004|Phase 1|Progressive Disease|0|||
27766765|NCT01601535|54219309|FG005|Phase 1|Progressive Disease|0|||
27766766|NCT01601535|54219304|FG000|Phase 1|Started Another Treatment|1|||
27766767|NCT01601535|54219305|FG001|Phase 1|Started Another Treatment|2|||
27766768|NCT01601535|54219306|FG002|Phase 1|Started Another Treatment|0|||
27766769|NCT01601535|54219307|FG003|Phase 1|Started Another Treatment|0|||
27766770|NCT01601535|54219308|FG004|Phase 1|Started Another Treatment|0|||
27766771|NCT01601535|54219309|FG005|Phase 1|Started Another Treatment|0|||
27766772|NCT01601535|54219304|FG000|Phase 2|Adverse Event|0|||
27766773|NCT01601535|54219305|FG001|Phase 2|Adverse Event|0|||
27766774|NCT01601535|54219306|FG002|Phase 2|Adverse Event|0|||
27766775|NCT01601535|54219307|FG003|Phase 2|Adverse Event|0|||
27766776|NCT01601535|54219308|FG004|Phase 2|Adverse Event|5|||
27766777|NCT01601535|54219309|FG005|Phase 2|Adverse Event|1|||
27766778|NCT01601535|54219304|FG000|Phase 2|Withdrawal by Subject|0|||
27766779|NCT01601535|54219305|FG001|Phase 2|Withdrawal by Subject|0|||
27766780|NCT01601535|54219306|FG002|Phase 2|Withdrawal by Subject|0|||
27766781|NCT01601535|54219307|FG003|Phase 2|Withdrawal by Subject|0|||
27766782|NCT01601535|54219308|FG004|Phase 2|Withdrawal by Subject|8|||
27766783|NCT01601535|54219309|FG005|Phase 2|Withdrawal by Subject|2|||
27766784|NCT01601535|54219304|FG000|Phase 2|Progressive Disease|0|||
27766785|NCT01601535|54219305|FG001|Phase 2|Progressive Disease|0|||
27766786|NCT01601535|54219306|FG002|Phase 2|Progressive Disease|0|||
27766787|NCT01601535|54219307|FG003|Phase 2|Progressive Disease|0|||
27766788|NCT01601535|54219308|FG004|Phase 2|Progressive Disease|5|||
27766789|NCT01601535|54219309|FG005|Phase 2|Progressive Disease|7|||
27766790|NCT01601535|54219304|FG000|Phase 2|Started Another Treatment|0|||
27766791|NCT01601535|54219305|FG001|Phase 2|Started Another Treatment|0|||
27766792|NCT01601535|54219306|FG002|Phase 2|Started Another Treatment|0|||
27766793|NCT01601535|54219307|FG003|Phase 2|Started Another Treatment|0|||
27766794|NCT01601535|54219308|FG004|Phase 2|Started Another Treatment|1|||
27766795|NCT01601535|54219309|FG005|Phase 2|Started Another Treatment|2|||
27766796|NCT01638819|54219334|FG000|Overall Study|Lost to Follow-up|1|||
27766797|NCT01638819|54219335|FG001|Overall Study|Lost to Follow-up|0|||
27766798|NCT01363713|54219340|FG000|Overall Study|Adverse Event|1|||
27766799|NCT01363713|54219340|FG000|Overall Study|Protocol Violation|3|||
27766800|NCT01363713|54219340|FG000|Overall Study|Withdrawal by Subject|2|||
27766801|NCT01637961|54219344|FG000|Overall Study|Ineligible: wrong primary|1|||
27766802|NCT01637961|54219344|FG000|Overall Study|Ineligible: inadequate pathology|1|||
27766803|NCT04183335|54219356|FG000|Overall Study|Adverse Event|1|||
27766804|NCT04183335|54219357|FG001|Overall Study|Adverse Event|0|||
27766805|NCT04183335|54219356|FG000|Overall Study|Withdrawal by Subject|12|||
27766806|NCT04183335|54219357|FG001|Overall Study|Withdrawal by Subject|3|||
27766807|NCT04199793|54219365|FG000|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
27766808|NCT04199793|54219366|FG001|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
27766809|NCT04199793|54219365|FG000|Overall Study|Withdrawal by Subject|1|||
27766810|NCT04199793|54219366|FG001|Overall Study|Withdrawal by Subject|1|||
27766811|NCT01636947|54219374|FG000|Overall Study|Not Treated|2|||
27766812|NCT01636947|54219375|FG001|Overall Study|Not Treated|2|||
27766813|NCT01636947|54219374|FG000|Overall Study|Lost to Follow-up|4|||
27766814|NCT01636947|54219375|FG001|Overall Study|Lost to Follow-up|0|||
27766815|NCT01636947|54219374|FG000|Overall Study|Protocol Violation|1|||
27766816|NCT01636947|54219375|FG001|Overall Study|Protocol Violation|1|||
27766817|NCT01636947|54219374|FG000|Overall Study|Withdrawal by Subject|3|||
27766818|NCT01636947|54219375|FG001|Overall Study|Withdrawal by Subject|3|||
27766819|NCT01636947|54219374|FG000|Overall Study|Adverse Event|1|||
27766820|NCT01636947|54219375|FG001|Overall Study|Adverse Event|1|||
27766821|NCT01636947|54219374|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
27766822|NCT01636947|54219375|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
27766823|NCT01635933|54219383|FG000|Overall Study|Adverse Event|1|||
27766824|NCT01635933|54219384|FG001|Overall Study|Adverse Event|0|||
27766825|NCT01635933|54219383|FG000|Overall Study|Lost to Follow-up|0|||
27766826|NCT01635933|54219384|FG001|Overall Study|Lost to Follow-up|5|||
27766827|NCT01635933|54219383|FG000|Overall Study|Subject decision|1|||
27766828|NCT01635933|54219384|FG001|Overall Study|Subject decision|1|||
27766829|NCT01635933|54219383|FG000|Overall Study|Noncompliance|0|||
27766830|NCT01635933|54219384|FG001|Overall Study|Noncompliance|1|||
27766831|NCT01635933|54219383|FG000|Overall Study|No longer had transportation|0|||
27766832|NCT01635933|54219384|FG001|Overall Study|No longer had transportation|1|||
27766833|NCT01635855|54219390|FG000|Overall Study|Withdrawal by Subject|4|||
27766834|NCT03052725|54219396|FG000|Overall Study|Adverse Event|2|||
27766835|NCT03052725|54219397|FG001|Overall Study|Adverse Event|0|||
27766836|NCT03052725|54219396|FG000|Overall Study|Withdrawal by Subject|3|||
27766837|NCT03052725|54219397|FG001|Overall Study|Withdrawal by Subject|4|||
27766838|NCT03052725|54219396|FG000|Overall Study|Pregnancy|0|||
27766839|NCT03052725|54219397|FG001|Overall Study|Pregnancy|1|||
27766840|NCT03052725|54219396|FG000|Overall Study|Site closure|0|||
27766841|NCT03052725|54219397|FG001|Overall Study|Site closure|1|||
27766842|NCT03052725|54219396|FG000|Overall Study|Study terminated by sponsor|143|||
27766843|NCT03052725|54219397|FG001|Overall Study|Study terminated by sponsor|144|||
27766844|NCT02775435|54219404|FG000|Overall Study|Adverse Event|48|||
27766845|NCT02775435|54219405|FG001|Overall Study|Adverse Event|25|||
27766846|NCT02775435|54219404|FG000|Overall Study|Lost to Follow-up|0|||
27766847|NCT02775435|54219405|FG001|Overall Study|Lost to Follow-up|2|||
27766848|NCT02775435|54219404|FG000|Overall Study|Physician Decision|5|||
27766849|NCT02775435|54219405|FG001|Overall Study|Physician Decision|6|||
27766850|NCT02775435|54219404|FG000|Overall Study|Withdrawal by Subject|5|||
27766851|NCT02775435|54219405|FG001|Overall Study|Withdrawal by Subject|9|||
27766852|NCT02775435|54219404|FG000|Overall Study|Progressive Disease|86|||
27766853|NCT02775435|54219405|FG001|Overall Study|Progressive Disease|140|||
27766854|NCT02775435|54219404|FG000|Overall Study|Clinical Progression|13|||
27766855|NCT02775435|54219405|FG001|Overall Study|Clinical Progression|26|||
27766856|NCT02775435|54219404|FG000|Overall Study|Ongoing in Study|121|||
27766857|NCT02775435|54219405|FG001|Overall Study|Ongoing in Study|72|||
27766858|NCT02775435|54219404|FG000|Overall Study|Not Treated|0|||
27766859|NCT02775435|54219405|FG001|Overall Study|Not Treated|1|||
27766860|NCT01635153|54219430|FG000|Overall Study|Lost to Follow-up|40|||
27766861|NCT01635153|54219431|FG001|Overall Study|Lost to Follow-up|43|||
27766862|NCT01636713|54219440|FG000|Overall Study|Adverse Event|16|||
27766863|NCT01636713|54219441|FG001|Overall Study|Adverse Event|16|||
27766864|NCT01636713|54219442|FG002|Overall Study|Adverse Event|7|||
27766865|NCT01636713|54219440|FG000|Overall Study|Lack of Efficacy|6|||
27766866|NCT01636713|54219441|FG001|Overall Study|Lack of Efficacy|6|||
27766867|NCT01636713|54219442|FG002|Overall Study|Lack of Efficacy|2|||
27766868|NCT01636713|54219440|FG000|Overall Study|Protocol Violation|3|||
27766869|NCT01636713|54219441|FG001|Overall Study|Protocol Violation|0|||
27766870|NCT01636713|54219442|FG002|Overall Study|Protocol Violation|1|||
27766871|NCT01636713|54219440|FG000|Overall Study|Lost to Follow-up|0|||
27766872|NCT01636713|54219441|FG001|Overall Study|Lost to Follow-up|0|||
27766873|NCT01636713|54219442|FG002|Overall Study|Lost to Follow-up|1|||
27766874|NCT01636713|54219440|FG000|Overall Study|Withdrawal by Subject|5|||
27766875|NCT01636713|54219441|FG001|Overall Study|Withdrawal by Subject|4|||
27766876|NCT01636713|54219442|FG002|Overall Study|Withdrawal by Subject|8|||
27766877|NCT01636713|54219440|FG000|Overall Study|Met Protocol-defined Stopping Criteria|2|||
27766878|NCT01636713|54219441|FG001|Overall Study|Met Protocol-defined Stopping Criteria|2|||
27766879|NCT01636713|54219442|FG002|Overall Study|Met Protocol-defined Stopping Criteria|4|||
27766880|NCT01600053|54219450|FG000|Overall Study|Adverse Event|2|||
27766881|NCT01600053|54219450|FG000|Overall Study|trial will not meet the interim endpoint|9|||
27766882|NCT01068249|54219454|FG000|Overall Study|Death|1|||
27766883|NCT01068249|54219454|FG000|Overall Study|Withdrawal by Subject|3|||
27766884|NCT02246673|54219473|FG000|Overall Study|Sponsor Decision|1|||
27766885|NCT02246673|54219474|FG001|Overall Study|Sponsor Decision|0|||
27766886|NCT02246673|54219475|FG002|Overall Study|Sponsor Decision|0|||
27766887|NCT02246673|54219476|FG003|Overall Study|Sponsor Decision|0|||
27766888|NCT02246673|54219477|FG004|Overall Study|Sponsor Decision|0|||
27766889|NCT02246673|54219473|FG000|Overall Study|Withdrawal by Subject|0|||
27766890|NCT02246673|54219474|FG001|Overall Study|Withdrawal by Subject|0|||
27766891|NCT02246673|54219475|FG002|Overall Study|Withdrawal by Subject|0|||
27766892|NCT02246673|54219476|FG003|Overall Study|Withdrawal by Subject|0|||
27766893|NCT02246673|54219477|FG004|Overall Study|Withdrawal by Subject|1|||
27766894|NCT02246673|54219473|FG000|Overall Study|Lost to Follow-up|0|||
27766895|NCT02246673|54219474|FG001|Overall Study|Lost to Follow-up|0|||
27766896|NCT02246673|54219475|FG002|Overall Study|Lost to Follow-up|0|||
27766897|NCT02246673|54219476|FG003|Overall Study|Lost to Follow-up|1|||
27766898|NCT02246673|54219477|FG004|Overall Study|Lost to Follow-up|0|||
27766899|NCT02246673|54219473|FG000|Overall Study|Protocol Violation|0|||
27766900|NCT02246673|54219474|FG001|Overall Study|Protocol Violation|0|||
27766901|NCT02246673|54219475|FG002|Overall Study|Protocol Violation|0|||
27766902|NCT02246673|54219476|FG003|Overall Study|Protocol Violation|1|||
27766903|NCT02246673|54219477|FG004|Overall Study|Protocol Violation|0|||
27766904|NCT02246439|54219539|FG000|Overall Study|Adverse Event|3|||
27766905|NCT02246439|54219540|FG001|Overall Study|Adverse Event|0|||
27766906|NCT02246439|54219539|FG000|Overall Study|Lost to Follow-up|7|||
27766907|NCT02246439|54219540|FG001|Overall Study|Lost to Follow-up|5|||
27766908|NCT02246439|54219539|FG000|Overall Study|Protocol Violation|0|||
27766909|NCT02246439|54219540|FG001|Overall Study|Protocol Violation|2|||
27766910|NCT02246439|54219539|FG000|Overall Study|Physician Decision|0|||
27766911|NCT02246439|54219540|FG001|Overall Study|Physician Decision|1|||
27766912|NCT02246439|54219539|FG000|Overall Study|Unkonwn|1|||
27766913|NCT02246439|54219540|FG001|Overall Study|Unkonwn|3|||
27766914|NCT02246439|54219539|FG000|Overall Study|Withdrawal by Subject|1|||
27766915|NCT02246439|54219540|FG001|Overall Study|Withdrawal by Subject|0|||
27766916|NCT02245737|54219549|FG000|Overall Study|Adverse Event|23|||
27766917|NCT02245737|54219550|FG001|Overall Study|Adverse Event|26|||
27766918|NCT02245737|54219551|FG002|Overall Study|Adverse Event|33|||
27766919|NCT02245737|54219549|FG000|Overall Study|Condition Worsened|9|||
27766920|NCT02245737|54219550|FG001|Overall Study|Condition Worsened|10|||
27766921|NCT02245737|54219551|FG002|Overall Study|Condition Worsened|9|||
27766922|NCT02245737|54219549|FG000|Overall Study|Death|2|||
27766923|NCT02245737|54219550|FG001|Overall Study|Death|4|||
27766924|NCT02245737|54219551|FG002|Overall Study|Death|4|||
27766925|NCT02245737|54219549|FG000|Overall Study|Eligibility Criteria No Longer Met|2|||
27766926|NCT02245737|54219550|FG001|Overall Study|Eligibility Criteria No Longer Met|4|||
27766927|NCT02245737|54219551|FG002|Overall Study|Eligibility Criteria No Longer Met|4|||
27766928|NCT02245737|54219549|FG000|Overall Study|Initiation of Symptomatic AD medication|2|||
27766929|NCT02245737|54219550|FG001|Overall Study|Initiation of Symptomatic AD medication|0|||
27766930|NCT02245737|54219551|FG002|Overall Study|Initiation of Symptomatic AD medication|0|||
27766931|NCT02245737|54219549|FG000|Overall Study|Lost to Follow-up|2|||
27766932|NCT02245737|54219550|FG001|Overall Study|Lost to Follow-up|5|||
27766933|NCT02245737|54219551|FG002|Overall Study|Lost to Follow-up|4|||
27766934|NCT02245737|54219549|FG000|Overall Study|Other-determined by Investigator|9|||
27766935|NCT02245737|54219550|FG001|Overall Study|Other-determined by Investigator|10|||
27766936|NCT02245737|54219551|FG002|Overall Study|Other-determined by Investigator|10|||
27766937|NCT02245737|54219549|FG000|Overall Study|Physician Decision|6|||
27766938|NCT02245737|54219550|FG001|Overall Study|Physician Decision|3|||
27766939|NCT02245737|54219551|FG002|Overall Study|Physician Decision|6|||
27766940|NCT02245737|54219549|FG000|Overall Study|Protocol Violation|3|||
27766941|NCT02245737|54219550|FG001|Overall Study|Protocol Violation|2|||
27766942|NCT02245737|54219551|FG002|Overall Study|Protocol Violation|3|||
27766943|NCT02245737|54219549|FG000|Overall Study|Withdrawal by Subject|40|||
27766944|NCT02245737|54219550|FG001|Overall Study|Withdrawal by Subject|41|||
27766945|NCT02245737|54219551|FG002|Overall Study|Withdrawal by Subject|44|||
27766946|NCT02245737|54219549|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|10|||
27766947|NCT02245737|54219550|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|20|||
27766948|NCT02245737|54219551|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|22|||
27766949|NCT02245737|54219549|FG000|Overall Study|Sponsor Decision|445|||
27766950|NCT02245737|54219550|FG001|Overall Study|Sponsor Decision|430|||
27766951|NCT02245737|54219551|FG002|Overall Study|Sponsor Decision|432|||
27766952|NCT02244957|54219563|FG000|Overall Study|Lack of Efficacy|1|||
27766953|NCT02244957|54219564|FG001|Overall Study|Lack of Efficacy|0|||
27766954|NCT02243865|54219574|FG000|Overall Study|Protocol Violation|1|||
27766955|NCT02243865|54219575|FG001|Overall Study|Protocol Violation|3|||
27766956|NCT02243865|54219574|FG000|Overall Study|Lost to Follow-up|1|||
27766957|NCT02243865|54219575|FG001|Overall Study|Lost to Follow-up|1|||
27766958|NCT02243865|54219574|FG000|Overall Study|Withdrawal by Subject|1|||
27766959|NCT02243865|54219575|FG001|Overall Study|Withdrawal by Subject|0|||
27766960|NCT02243865|54219574|FG000|Overall Study|Adverse Event|1|||
27766961|NCT02243865|54219575|FG001|Overall Study|Adverse Event|1|||
27766962|NCT02243631|54219585|FG000|Overall Study|no synovial fluid on second aspirate|0|||
27766963|NCT02243631|54219586|FG001|Overall Study|no synovial fluid on second aspirate|1|||
27766964|NCT02242305|54219594|FG000|Overall Study|Without spasm-like pain during 3 weeks|1|||
27766965|NCT02242305|54219595|FG001|Overall Study|Without spasm-like pain during 3 weeks|4|||
27766966|NCT02242305|54219594|FG000|Overall Study|Adverse Event|1|||
27766967|NCT02242305|54219595|FG001|Overall Study|Adverse Event|0|||
27766968|NCT02242305|54219594|FG000|Overall Study|Non-compliance dosing regimen or visit|2|||
27766969|NCT02242305|54219595|FG001|Overall Study|Non-compliance dosing regimen or visit|2|||
27766970|NCT02242305|54219594|FG000|Overall Study|Subject withdraws inform consent|0|||
27766971|NCT02242305|54219595|FG001|Overall Study|Subject withdraws inform consent|4|||
27766972|NCT02242305|54219594|FG000|Overall Study|Lost to Follow-up|2|||
27766973|NCT02242305|54219595|FG001|Overall Study|Lost to Follow-up|0|||
27766974|NCT02240121|54219603|FG000|Overall Study|Protocol Violation|1|||
27766975|NCT02240121|54219604|FG001|Overall Study|Protocol Violation|2|||
27766976|NCT02240121|54219603|FG000|Overall Study|Physician Decision|0|||
27766977|NCT02240121|54219604|FG001|Overall Study|Physician Decision|1|||
27766978|NCT02240121|54219603|FG000|Overall Study|Change in protocol interpretation|1|||
27766979|NCT02240121|54219604|FG001|Overall Study|Change in protocol interpretation|0|||
27766980|NCT02240121|54219603|FG000|Overall Study|Lack of Efficacy|2|||
27766981|NCT02240121|54219604|FG001|Overall Study|Lack of Efficacy|3|||
27766982|NCT02240121|54219603|FG000|Overall Study|Site closed|1|||
27766983|NCT02240121|54219604|FG001|Overall Study|Site closed|1|||
27766984|NCT02240121|54219603|FG000|Overall Study|Pregnancy|1|||
27766985|NCT02240121|54219604|FG001|Overall Study|Pregnancy|0|||
27766986|NCT02240121|54219603|FG000|Overall Study|Adverse Event|2|||
27766987|NCT02240121|54219604|FG001|Overall Study|Adverse Event|4|||
27766988|NCT02240121|54219603|FG000|Overall Study|Withdrawal by Subject|6|||
27766989|NCT02240121|54219604|FG001|Overall Study|Withdrawal by Subject|2|||
27766990|NCT02240121|54219603|FG000|Overall Study|Lost to Follow-up|3|||
27766991|NCT02240121|54219604|FG001|Overall Study|Lost to Follow-up|4|||
27766992|NCT02240121|54219603|FG000|Overall Study|Other than specified|1|||
27766993|NCT02240121|54219604|FG001|Overall Study|Other than specified|3|||
27766994|NCT02239263|54219610|FG000|Overall Study|Protocol Violation|6|||
27766995|NCT02238483|54219618|FG000|Overall Study|Withdrawal by Subject|2|||
27766996|NCT02238483|54219619|FG001|Overall Study|Withdrawal by Subject|7|||
27766997|NCT02238483|54219618|FG000|Overall Study|Lost to Follow-up|1|||
27766998|NCT02238483|54219619|FG001|Overall Study|Lost to Follow-up|1|||
27766999|NCT02238483|54219618|FG000|Overall Study|Protocol Violation|1|||
27767000|NCT02238483|54219619|FG001|Overall Study|Protocol Violation|2|||
27767001|NCT02238483|54219618|FG000|Overall Study|Death|1|||
27767002|NCT02238483|54219619|FG001|Overall Study|Death|0|||
27767003|NCT02238483|54219618|FG000|Overall Study|Adverse Event|7|||
27767004|NCT02238483|54219619|FG001|Overall Study|Adverse Event|3|||
27767005|NCT02238483|54219618|FG000|Overall Study|Withdrawn due to physician decision|1|||
27767006|NCT02238483|54219619|FG001|Overall Study|Withdrawn due to physician decision|0|||
27767007|NCT02238483|54219618|FG000|Overall Study|Completion status not recorded|1|||
27767008|NCT02238483|54219619|FG001|Overall Study|Completion status not recorded|1|||
27767009|NCT02238483|54219618|FG000|Overall Study|Illness in family member|1|||
27767010|NCT02238483|54219619|FG001|Overall Study|Illness in family member|0|||
27767011|NCT01632891|54219627|FG000|Overall Study|Lost to Follow-up|0|||
27767012|NCT01632891|54219628|FG001|Overall Study|Lost to Follow-up|1|||
27767013|NCT01632891|54219627|FG000|Overall Study|Withdrawal by Subject|1|||
27767014|NCT01632891|54219628|FG001|Overall Study|Withdrawal by Subject|0|||
27767015|NCT02208999|54219640|FG000|Overall Study|Lost to Follow-up|1|||
27767016|NCT02208843|54219659|FG000|Overall Study|Clinical symptoms of progression|2|||
27767017|NCT02208843|54219659|FG000|Overall Study|Progression disease according to RECIST|24|||
27767018|NCT02208843|54219659|FG000|Overall Study|Adverse Event|12|||
27767019|NCT02208843|54219659|FG000|Overall Study|Protocol Violation|1|||
27767020|NCT02208843|54219659|FG000|Overall Study|Withdrawal by Subject|1|||
27767021|NCT02208843|54219659|FG000|Overall Study|Switched to commercial afatinib|20|||
27767022|NCT02208063|54219665|FG000|Overall Study|Death|3|||
27767023|NCT02208063|54219666|FG001|Overall Study|Death|5|||
27767024|NCT02208063|54219665|FG000|Overall Study|Not Specified in report|3|||
27767025|NCT02208063|54219666|FG001|Overall Study|Not Specified in report|4|||
27767026|NCT02208063|54219665|FG000|Overall Study|Withdrawal by Subject|5|||
27767027|NCT02208063|54219666|FG001|Overall Study|Withdrawal by Subject|2|||
27767028|NCT02208063|54219665|FG000|Overall Study|Lost to Follow-up|1|||
27767029|NCT02208063|54219666|FG001|Overall Study|Lost to Follow-up|0|||
27767030|NCT02207907|54219674|FG000|Overall Study|Lost to Follow-up|3|||
27767031|NCT02207907|54219675|FG001|Overall Study|Lost to Follow-up|1|||
27767032|NCT02207907|54219674|FG000|Overall Study|Withdrawal by Subject|5|||
27767033|NCT02207907|54219675|FG001|Overall Study|Withdrawal by Subject|6|||
27767034|NCT02207907|54219674|FG000|Overall Study|Did not meet study criteria|3|||
27767035|NCT02207907|54219675|FG001|Overall Study|Did not meet study criteria|0|||
27767036|NCT02207907|54219674|FG000|Overall Study|Pregnancy|0|||
27767037|NCT02207907|54219675|FG001|Overall Study|Pregnancy|1|||
27767038|NCT02207829|54219684|FG000|Overall Study|Adverse Event|10|||
27767039|NCT02207829|54219685|FG001|Overall Study|Adverse Event|9|||
27767040|NCT02207829|54219684|FG000|Overall Study|Lack of Efficacy|7|||
27767041|NCT02207829|54219685|FG001|Overall Study|Lack of Efficacy|5|||
27767042|NCT02207829|54219684|FG000|Overall Study|Lost to Follow-up|2|||
27767043|NCT02207829|54219685|FG001|Overall Study|Lost to Follow-up|2|||
27767044|NCT02207829|54219684|FG000|Overall Study|Protocol deviation|5|||
27767045|NCT02207829|54219685|FG001|Overall Study|Protocol deviation|4|||
27767046|NCT02207829|54219684|FG000|Overall Study|Withdrew consent|18|||
27767047|NCT02207829|54219685|FG001|Overall Study|Withdrew consent|14|||
27767048|NCT02237157|54219691|FG000|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|3|||
27767049|NCT02237157|54219692|FG001|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
27767050|NCT02237157|54219693|FG002|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
27767051|NCT02237157|54219694|FG003|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
27767052|NCT02237157|54219691|FG000|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|1|||
27767053|NCT02237157|54219692|FG001|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
27767054|NCT02237157|54219693|FG002|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
27767055|NCT02237157|54219694|FG003|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
27767056|NCT02237001|54219701|FG000|Overall Study|Lost to Follow-up|2|||
27767057|NCT02237001|54219701|FG000|Overall Study|Withdrawal by Subject|1|||
27767058|NCT02237001|54219701|FG000|Overall Study|Eligibility criteria/Late Screen Failure|3|||
27767059|NCT02237001|54219701|FG000|Overall Study|Re-operation|4|||
27767060|NCT02237001|54219701|FG000|Overall Study|Incarceration|1|||
27767061|NCT02236611|54219707|FG000|Overall Study|Adverse Event|10|||
27767062|NCT02236611|54219708|FG001|Overall Study|Adverse Event|16|||
27767063|NCT02236611|54219707|FG000|Overall Study|Lack of Efficacy|4|||
27767064|NCT02236611|54219708|FG001|Overall Study|Lack of Efficacy|7|||
27767065|NCT02236611|54219707|FG000|Overall Study|Lost to Follow-up|0|||
27767066|NCT02236611|54219708|FG001|Overall Study|Lost to Follow-up|2|||
27767067|NCT02236611|54219707|FG000|Overall Study|Protocol deviation|3|||
27767068|NCT02236611|54219708|FG001|Overall Study|Protocol deviation|5|||
27767069|NCT02236611|54219707|FG000|Overall Study|Withdrew consent|9|||
27767070|NCT02236611|54219708|FG001|Overall Study|Withdrew consent|4|||
27767071|NCT02234583|54219716|FG000|Overall Study|Adverse Event|172|||
27767072|NCT02234583|54219717|FG001|Overall Study|Adverse Event|156|||
27767073|NCT02234583|54219716|FG000|Overall Study|Withdrawal by Subject|109|||
27767074|NCT02234583|54219717|FG001|Overall Study|Withdrawal by Subject|157|||
27767075|NCT02234583|54219716|FG000|Overall Study|Lost to Follow-up|0|||
27767076|NCT02234583|54219717|FG001|Overall Study|Lost to Follow-up|1|||
27767077|NCT02234583|54219716|FG000|Overall Study|Lack of Efficacy|58|||
27767078|NCT02234583|54219717|FG001|Overall Study|Lack of Efficacy|103|||
27767079|NCT02234583|54219716|FG000|Overall Study|Protocol Violation|35|||
27767080|NCT02234583|54219717|FG001|Overall Study|Protocol Violation|42|||
27767081|NCT02234583|54219716|FG000|Overall Study|Other|39|||
27767082|NCT02234583|54219717|FG001|Overall Study|Other|97|||
27767083|NCT03686397|54219731|FG000|Overall Study|Lack of Efficacy|3|||
27767084|NCT03686397|54219732|FG001|Overall Study|Lack of Efficacy|5|||
27767085|NCT03686397|54219731|FG000|Overall Study|Adverse Event|0|||
27767086|NCT03686397|54219732|FG001|Overall Study|Adverse Event|1|||
27767087|NCT03686397|54219731|FG000|Overall Study|Protocol Violation|0|||
27767088|NCT03686397|54219732|FG001|Overall Study|Protocol Violation|1|||
27767089|NCT03686397|54219731|FG000|Overall Study|Withdrawal by Subject|0|||
27767090|NCT03686397|54219732|FG001|Overall Study|Withdrawal by Subject|1|||
27767091|NCT03686397|54219731|FG000|Overall Study|covid pandemic, bacterial ear culture|2|||
27767092|NCT03686397|54219732|FG001|Overall Study|covid pandemic, bacterial ear culture|0|||
27767093|NCT02233803|54219738|FG000|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1|||
27767094|NCT02233803|54219739|FG001|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0|||
27767095|NCT02233803|54219738|FG000|Treatment Period 1 (4-Wks)|Adverse Event|0|||
27767096|NCT02233803|54219739|FG001|Treatment Period 1 (4-Wks)|Adverse Event|1|||
27767097|NCT02233803|54219738|FG000|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
27767098|NCT02233803|54219739|FG001|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
27767099|NCT02233803|54219738|FG000|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0|||
27767100|NCT02233803|54219739|FG001|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1|||
27767101|NCT02233803|54219738|FG000|Washout Period (4-Wks)|Lost to Follow-up|0|||
27767102|NCT02233803|54219739|FG001|Washout Period (4-Wks)|Lost to Follow-up|1|||
27767103|NCT02233803|54219738|FG000|Washout Period (4-Wks)|Physician Decision|1|||
27767104|NCT02233803|54219739|FG001|Washout Period (4-Wks)|Physician Decision|0|||
27767105|NCT02233803|54219738|FG000|Washout Period (4-Wks)|Withdrawal by Subject|1|||
27767106|NCT02233803|54219739|FG001|Washout Period (4-Wks)|Withdrawal by Subject|1|||
27767107|NCT02233803|54219738|FG000|Treatment Period 2 (4-Wks)|Lost to Follow-up|1|||
27767108|NCT02233803|54219739|FG001|Treatment Period 2 (4-Wks)|Lost to Follow-up|0|||
27767109|NCT02233803|54219738|FG000|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1|||
27767110|NCT02233803|54219739|FG001|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2|||
27767111|NCT02233647|54219747|FG000|Overall Study|Adverse Event|1|||
27767112|NCT02233413|54219753|FG000|Overall Study|Lost to Follow-up|7|||
27767113|NCT02233413|54219754|FG001|Overall Study|Lost to Follow-up|9|||
27767114|NCT02233413|54219753|FG000|Overall Study|Withdrawal by Subject|4|||
27767115|NCT02233413|54219754|FG001|Overall Study|Withdrawal by Subject|5|||
27767116|NCT01632579|54219760|FG000|Washout Period|Adverse Event|1|||
27767117|NCT01632579|54219761|FG001|Washout Period|Adverse Event|0|||
27767118|NCT01632579|54219762|FG002|Washout Period|Adverse Event|0|||
27767119|NCT01632579|54219763|FG003|Washout Period|Adverse Event|0|||
27767120|NCT01632579|54219764|FG004|Washout Period|Adverse Event|0|||
27767121|NCT01632579|54219765|FG005|Washout Period|Adverse Event|0|||
27767122|NCT01632579|54219766|FG006|Washout Period|Adverse Event|0|||
27767123|NCT01632579|54219767|FG007|Washout Period|Adverse Event|0|||
27767124|NCT01632579|54219768|FG008|Washout Period|Adverse Event|0|||
27767125|NCT01632579|54219760|FG000|Period 2 (Second Intervention)|Adverse Event|1|||
27767126|NCT01632579|54219761|FG001|Period 2 (Second Intervention)|Adverse Event|0|||
27767127|NCT01632579|54219762|FG002|Period 2 (Second Intervention)|Adverse Event|0|||
27767128|NCT01632579|54219763|FG003|Period 2 (Second Intervention)|Adverse Event|0|||
27767129|NCT01632579|54219764|FG004|Period 2 (Second Intervention)|Adverse Event|0|||
27767130|NCT01632579|54219765|FG005|Period 2 (Second Intervention)|Adverse Event|0|||
27767131|NCT01632579|54219766|FG006|Period 2 (Second Intervention)|Adverse Event|0|||
27767132|NCT01632579|54219767|FG007|Period 2 (Second Intervention)|Adverse Event|0|||
27767133|NCT01632579|54219768|FG008|Period 2 (Second Intervention)|Adverse Event|0|||
27767134|NCT01632345|54219797|FG000|Treatment: Part I|Adverse Event|1|||
27767135|NCT01632345|54219798|FG001|Treatment: Part I|Adverse Event|4|||
27767136|NCT01632345|54219799|FG002|Treatment: Part I|Adverse Event|2|||
27767137|NCT01632345|54219800|FG003|Treatment: Part I|Adverse Event|1|||
27767138|NCT01632345|54219801|FG004|Treatment: Part I|Adverse Event|3|||
27767139|NCT01632345|54219802|FG005|Treatment: Part I|Adverse Event|0|||
27767140|NCT01632345|54219803|FG006|Treatment: Part I|Adverse Event|0|||
27767141|NCT01632345|54219797|FG000|Treatment: Part I|Lack of Efficacy|0|||
27767142|NCT01632345|54219798|FG001|Treatment: Part I|Lack of Efficacy|1|||
27767143|NCT01632345|54219799|FG002|Treatment: Part I|Lack of Efficacy|0|||
27767144|NCT01632345|54219800|FG003|Treatment: Part I|Lack of Efficacy|1|||
27767145|NCT01632345|54219801|FG004|Treatment: Part I|Lack of Efficacy|1|||
27767146|NCT01632345|54219802|FG005|Treatment: Part I|Lack of Efficacy|0|||
27767147|NCT01632345|54219803|FG006|Treatment: Part I|Lack of Efficacy|0|||
27767148|NCT01632345|54219797|FG000|Treatment: Part I|Lost to Follow-up|3|||
27767149|NCT01632345|54219798|FG001|Treatment: Part I|Lost to Follow-up|2|||
27767150|NCT01632345|54219799|FG002|Treatment: Part I|Lost to Follow-up|1|||
27767151|NCT01632345|54219800|FG003|Treatment: Part I|Lost to Follow-up|3|||
27767152|NCT01632345|54219801|FG004|Treatment: Part I|Lost to Follow-up|4|||
27767153|NCT01632345|54219802|FG005|Treatment: Part I|Lost to Follow-up|0|||
27767154|NCT01632345|54219803|FG006|Treatment: Part I|Lost to Follow-up|0|||
27767155|NCT01632345|54219797|FG000|Treatment: Part I|Non-Compliance with Study Drug|3|||
27767156|NCT01632345|54219798|FG001|Treatment: Part I|Non-Compliance with Study Drug|2|||
27767157|NCT01632345|54219799|FG002|Treatment: Part I|Non-Compliance with Study Drug|2|||
27767158|NCT01632345|54219800|FG003|Treatment: Part I|Non-Compliance with Study Drug|1|||
27767159|NCT01632345|54219801|FG004|Treatment: Part I|Non-Compliance with Study Drug|0|||
27767160|NCT01632345|54219802|FG005|Treatment: Part I|Non-Compliance with Study Drug|0|||
27767161|NCT01632345|54219803|FG006|Treatment: Part I|Non-Compliance with Study Drug|0|||
27767162|NCT01632345|54219797|FG000|Treatment: Part I|Physician Decision|2|||
27767163|NCT01632345|54219798|FG001|Treatment: Part I|Physician Decision|1|||
27767164|NCT01632345|54219799|FG002|Treatment: Part I|Physician Decision|0|||
27767165|NCT01632345|54219800|FG003|Treatment: Part I|Physician Decision|0|||
27767166|NCT01632345|54219801|FG004|Treatment: Part I|Physician Decision|1|||
27767167|NCT01632345|54219802|FG005|Treatment: Part I|Physician Decision|0|||
27767168|NCT01632345|54219803|FG006|Treatment: Part I|Physician Decision|0|||
27767169|NCT01632345|54219797|FG000|Treatment: Part I|Pregnancy|0|||
27767170|NCT01632345|54219798|FG001|Treatment: Part I|Pregnancy|1|||
27767171|NCT01632345|54219799|FG002|Treatment: Part I|Pregnancy|0|||
27767172|NCT01632345|54219800|FG003|Treatment: Part I|Pregnancy|0|||
27767173|NCT01632345|54219801|FG004|Treatment: Part I|Pregnancy|0|||
27767174|NCT01632345|54219802|FG005|Treatment: Part I|Pregnancy|0|||
27767175|NCT01632345|54219803|FG006|Treatment: Part I|Pregnancy|0|||
27767176|NCT01632345|54219797|FG000|Treatment: Part I|Protocol Deviation|0|||
27767177|NCT01632345|54219798|FG001|Treatment: Part I|Protocol Deviation|0|||
27767178|NCT01632345|54219799|FG002|Treatment: Part I|Protocol Deviation|1|||
27767179|NCT01632345|54219800|FG003|Treatment: Part I|Protocol Deviation|1|||
27767180|NCT01632345|54219801|FG004|Treatment: Part I|Protocol Deviation|0|||
27767181|NCT01632345|54219802|FG005|Treatment: Part I|Protocol Deviation|0|||
27767182|NCT01632345|54219803|FG006|Treatment: Part I|Protocol Deviation|0|||
27767183|NCT01632345|54219797|FG000|Treatment: Part I|Withdrawal by Subject|3|||
27767184|NCT01632345|54219798|FG001|Treatment: Part I|Withdrawal by Subject|4|||
27767185|NCT01632345|54219799|FG002|Treatment: Part I|Withdrawal by Subject|4|||
27767186|NCT01632345|54219800|FG003|Treatment: Part I|Withdrawal by Subject|1|||
27767187|NCT01632345|54219801|FG004|Treatment: Part I|Withdrawal by Subject|4|||
27767188|NCT01632345|54219802|FG005|Treatment: Part I|Withdrawal by Subject|0|||
27767189|NCT01632345|54219803|FG006|Treatment: Part I|Withdrawal by Subject|0|||
27767190|NCT01632345|54219797|FG000|Treatment: Part II|Adverse Event|0|||
27767191|NCT01632345|54219798|FG001|Treatment: Part II|Adverse Event|0|||
27767192|NCT01632345|54219799|FG002|Treatment: Part II|Adverse Event|0|||
27767193|NCT01632345|54219800|FG003|Treatment: Part II|Adverse Event|0|||
27767194|NCT01632345|54219801|FG004|Treatment: Part II|Adverse Event|0|||
27767195|NCT01632345|54219802|FG005|Treatment: Part II|Adverse Event|3|||
27767196|NCT01632345|54219803|FG006|Treatment: Part II|Adverse Event|8|||
27767197|NCT01632345|54219797|FG000|Treatment: Part II|Lost to Follow-up|0|||
27767198|NCT01632345|54219798|FG001|Treatment: Part II|Lost to Follow-up|0|||
27767199|NCT01632345|54219799|FG002|Treatment: Part II|Lost to Follow-up|0|||
27767200|NCT01632345|54219800|FG003|Treatment: Part II|Lost to Follow-up|0|||
27767201|NCT01632345|54219801|FG004|Treatment: Part II|Lost to Follow-up|0|||
27767202|NCT01632345|54219802|FG005|Treatment: Part II|Lost to Follow-up|3|||
27767203|NCT01632345|54219803|FG006|Treatment: Part II|Lost to Follow-up|1|||
27767204|NCT01632345|54219797|FG000|Treatment: Part II|Non-Compliance with Study Drug|0|||
27767205|NCT01632345|54219798|FG001|Treatment: Part II|Non-Compliance with Study Drug|0|||
27767206|NCT01632345|54219799|FG002|Treatment: Part II|Non-Compliance with Study Drug|0|||
27767207|NCT01632345|54219800|FG003|Treatment: Part II|Non-Compliance with Study Drug|0|||
27767208|NCT01632345|54219801|FG004|Treatment: Part II|Non-Compliance with Study Drug|0|||
27767209|NCT01632345|54219802|FG005|Treatment: Part II|Non-Compliance with Study Drug|3|||
27767210|NCT01632345|54219803|FG006|Treatment: Part II|Non-Compliance with Study Drug|0|||
27767211|NCT01632345|54219797|FG000|Treatment: Part II|Withdrawal by Subject|0|||
27767212|NCT01632345|54219798|FG001|Treatment: Part II|Withdrawal by Subject|0|||
27767213|NCT01632345|54219799|FG002|Treatment: Part II|Withdrawal by Subject|0|||
27767214|NCT01632345|54219800|FG003|Treatment: Part II|Withdrawal by Subject|0|||
27767215|NCT01632345|54219801|FG004|Treatment: Part II|Withdrawal by Subject|0|||
27767216|NCT01632345|54219802|FG005|Treatment: Part II|Withdrawal by Subject|2|||
27767217|NCT01632345|54219803|FG006|Treatment: Part II|Withdrawal by Subject|2|||
27767218|NCT02232243|54219821|FG000|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
27767219|NCT02232243|54219822|FG001|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1|||
27767220|NCT02232243|54219823|FG002|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
27767221|NCT02205333|54219841|FG000|Overall Study|Death|5|||
27767222|NCT02205333|54219842|FG001|Overall Study|Death|6|||
27767223|NCT02205333|54219843|FG002|Overall Study|Death|2|||
27767224|NCT02205333|54219844|FG003|Overall Study|Death|6|||
27767225|NCT02205333|54219845|FG004|Overall Study|Death|5|||
27767226|NCT02205333|54219846|FG005|Overall Study|Death|3|||
27767227|NCT02205333|54219847|FG006|Overall Study|Death|3|||
27767228|NCT02205333|54219848|FG007|Overall Study|Death|2|||
27767229|NCT02205333|54219849|FG008|Overall Study|Death|0|||
27767230|NCT02205333|54219841|FG000|Overall Study|Withdrawal by Subject|1|||
27767231|NCT02205333|54219842|FG001|Overall Study|Withdrawal by Subject|0|||
27767232|NCT02205333|54219843|FG002|Overall Study|Withdrawal by Subject|0|||
27767233|NCT02205333|54219844|FG003|Overall Study|Withdrawal by Subject|1|||
27767234|NCT02205333|54219845|FG004|Overall Study|Withdrawal by Subject|0|||
27767235|NCT02205333|54219846|FG005|Overall Study|Withdrawal by Subject|0|||
27767236|NCT02205333|54219847|FG006|Overall Study|Withdrawal by Subject|2|||
27767237|NCT02205333|54219848|FG007|Overall Study|Withdrawal by Subject|0|||
27767238|NCT02205333|54219849|FG008|Overall Study|Withdrawal by Subject|0|||
27767239|NCT02230683|54219869|FG000|Overall Study|Adverse Event|1|||
27767240|NCT02230527|54219881|FG000|Overall Study|Withdrawal by Subject|1|||
27767241|NCT02230527|54219882|FG001|Overall Study|Withdrawal by Subject|1|||
27767242|NCT02230527|54219881|FG000|Overall Study|Death|1|||
27767243|NCT02230527|54219882|FG001|Overall Study|Death|0|||
27767244|NCT02230527|54219881|FG000|Overall Study|Lost to Follow-up|2|||
27767245|NCT02230527|54219882|FG001|Overall Study|Lost to Follow-up|1|||
27767246|NCT02230527|54219881|FG000|Overall Study|Other|1|||
27767247|NCT02230527|54219882|FG001|Overall Study|Other|0|||
27767248|NCT02204319|54219888|FG000|Overall Study|Pregnancy|1|||
27767249|NCT02204319|54219888|FG000|Overall Study|Withdrawal by Subject|2|||
27767250|NCT02204007|54219895|FG000|Overall Study|Surgery Canceled|1|||
27767251|NCT02204007|54219896|FG001|Overall Study|Surgery Canceled|1|||
27767252|NCT02203851|54219902|FG000|Overall Study|Lost to Follow-up|4|||
27767253|NCT02203851|54219902|FG000|Overall Study|Withdrawal by Subject|6|||
27767254|NCT02203851|54219902|FG000|Overall Study|Other|1|||
27767255|NCT02228967|54219915|FG000|Overall Study|Lost to Follow-up|146|||
27767256|NCT02228967|54219916|FG001|Overall Study|Lost to Follow-up|142|||
27767257|NCT02228967|54219915|FG000|Overall Study|Withdrawal by Subject|13|||
27767258|NCT02228967|54219916|FG001|Overall Study|Withdrawal by Subject|18|||
27767259|NCT02227875|54219924|FG000|Overall Study|Protocol Violation|10|||
27767260|NCT02227875|54219925|FG001|Overall Study|Protocol Violation|7|||
27767261|NCT02227875|54219924|FG000|Overall Study|Other|1|||
27767262|NCT02227875|54219925|FG001|Overall Study|Other|3|||
27767263|NCT02227875|54219924|FG000|Overall Study|Physician Decision|1|||
27767264|NCT02227875|54219925|FG001|Overall Study|Physician Decision|0|||
27767265|NCT02227875|54219924|FG000|Overall Study|Adverse Event|3|||
27767266|NCT02227875|54219925|FG001|Overall Study|Adverse Event|0|||
27767267|NCT02227875|54219924|FG000|Overall Study|Withdrawal by Subject|12|||
27767268|NCT02227875|54219925|FG001|Overall Study|Withdrawal by Subject|13|||
27767269|NCT02227875|54219924|FG000|Overall Study|Lost to Follow-up|10|||
27767270|NCT02227875|54219925|FG001|Overall Study|Lost to Follow-up|10|||
27767271|NCT02203149|54219936|FG000|Part 1|Adverse Event|0|||
27767272|NCT02203149|54219937|FG001|Part 1|Adverse Event|1|||
27767273|NCT02203149|54219938|FG002|Part 1|Adverse Event|0|||
27767274|NCT02203149|54219939|FG003|Part 1|Adverse Event|0|||
27767275|NCT02203149|54219940|FG004|Part 1|Adverse Event|0|||
27767276|NCT02203149|54219936|FG000|Part 2|Death|0|||
27767277|NCT02203149|54219937|FG001|Part 2|Death|0|||
27767278|NCT02203149|54219938|FG002|Part 2|Death|1|||
27767279|NCT02203149|54219939|FG003|Part 2|Death|1|||
27767280|NCT02203149|54219940|FG004|Part 2|Death|0|||
27767281|NCT02203149|54219936|FG000|Part 2|Withdrawal by Subject|0|||
27767282|NCT02203149|54219937|FG001|Part 2|Withdrawal by Subject|0|||
27767283|NCT02203149|54219938|FG002|Part 2|Withdrawal by Subject|0|||
27767284|NCT02203149|54219939|FG003|Part 2|Withdrawal by Subject|1|||
27767285|NCT02203149|54219940|FG004|Part 2|Withdrawal by Subject|0|||
27767286|NCT02203149|54219936|FG000|Part 2|Adverse Event|0|||
27767287|NCT02203149|54219937|FG001|Part 2|Adverse Event|0|||
27767288|NCT02203149|54219938|FG002|Part 2|Adverse Event|0|||
27767289|NCT02203149|54219939|FG003|Part 2|Adverse Event|1|||
27767290|NCT02203149|54219940|FG004|Part 2|Adverse Event|1|||
27767291|NCT02203071|54219964|FG000|Overall Study|Lost to Follow-up|3|||
27767292|NCT02203071|54219965|FG001|Overall Study|Lost to Follow-up|1|||
27767293|NCT02202837|54219973|FG000|Overall Study|Enbrel treatment discontinued|36|||
27767294|NCT02202837|54219974|FG001|Overall Study|Enbrel treatment discontinued|4|||
27767295|NCT02202837|54219973|FG000|Overall Study|Other|10|||
27767296|NCT02202837|54219974|FG001|Overall Study|Other|0|||
27767297|NCT02202837|54219973|FG000|Overall Study|Lost to Follow-up|7|||
27767298|NCT02202837|54219974|FG001|Overall Study|Lost to Follow-up|1|||
27767299|NCT02202759|54219983|FG000|Overall Study|Study Terminated by Sponsor|3|||
27767300|NCT02202759|54219984|FG001|Overall Study|Study Terminated by Sponsor|3|||
27767301|NCT02202759|54219985|FG002|Overall Study|Study Terminated by Sponsor|3|||
27767302|NCT02202759|54219983|FG000|Overall Study|Withdrawal by Subject|2|||
27767303|NCT02202759|54219984|FG001|Overall Study|Withdrawal by Subject|1|||
27767304|NCT02202759|54219985|FG002|Overall Study|Withdrawal by Subject|1|||
27767305|NCT02202759|54219983|FG000|Overall Study|Reason not Specified|4|||
27767306|NCT02202759|54219984|FG001|Overall Study|Reason not Specified|11|||
27767307|NCT02202759|54219985|FG002|Overall Study|Reason not Specified|10|||
27767308|NCT02226549|54219994|FG000|Overall Study|Randomized but Never Treated|1|||
27767309|NCT02226549|54219995|FG001|Overall Study|Randomized but Never Treated|0|||
27767310|NCT02226549|54219994|FG000|Overall Study|Lost to Follow-up|0|||
27767311|NCT02226549|54219995|FG001|Overall Study|Lost to Follow-up|1|||
27767312|NCT02226003|54220004|FG000|Overall Study|Lost to Follow-up|2|||
27767313|NCT02226003|54220005|FG001|Overall Study|Lost to Follow-up|1|||
27767314|NCT02226003|54220006|FG002|Overall Study|Lost to Follow-up|3|||
27767315|NCT02226003|54220004|FG000|Overall Study|Withdrawal by Subject|0|||
27767316|NCT02226003|54220005|FG001|Overall Study|Withdrawal by Subject|0|||
27767317|NCT02226003|54220006|FG002|Overall Study|Withdrawal by Subject|3|||
27767318|NCT02225223|54220016|FG000|Overall Study|Death|10|||
27767319|NCT02225223|54220017|FG001|Overall Study|Death|1|||
27767320|NCT02225223|54220016|FG000|Overall Study|Lost to Follow-up|5|||
27767321|NCT02225223|54220017|FG001|Overall Study|Lost to Follow-up|0|||
27767322|NCT02225223|54220016|FG000|Overall Study|Other|1|||
27767323|NCT02225223|54220017|FG001|Overall Study|Other|2|||
27767324|NCT02225223|54220016|FG000|Overall Study|Physician Decision|1|||
27767325|NCT02225223|54220017|FG001|Overall Study|Physician Decision|0|||
27767326|NCT02225223|54220016|FG000|Overall Study|Withdrawal by Subject|2|||
27767327|NCT02225223|54220017|FG001|Overall Study|Withdrawal by Subject|2|||
27767328|NCT01634139|54220026|FG000|Overall Study|Non compliant with protocol|1|||
27767329|NCT01634139|54220027|FG001|Overall Study|Non compliant with protocol|0|||
27767330|NCT01634139|54220028|FG002|Overall Study|Non compliant with protocol|0|||
27839697|NCT01693562|54327122|FG011|Escalation Phase|Withdrawal by Subject|0|||
27839698|NCT01693562|54327123|FG012|Escalation Phase|Withdrawal by Subject|0|||
27767331|NCT01634139|54220026|FG000|Overall Study|Consent withdrawn not due to AE|4|||
27767332|NCT01634139|54220027|FG001|Overall Study|Consent withdrawn not due to AE|3|||
27767333|NCT01634139|54220028|FG002|Overall Study|Consent withdrawn not due to AE|2|||
27767334|NCT01634139|54220026|FG000|Overall Study|Other|4|||
27767335|NCT01634139|54220027|FG001|Overall Study|Other|0|||
27767336|NCT01634139|54220028|FG002|Overall Study|Other|3|||
27767337|NCT01634139|54220026|FG000|Overall Study|Lost to Follow-up|0|||
27767338|NCT01634139|54220027|FG001|Overall Study|Lost to Follow-up|2|||
27767339|NCT01634139|54220028|FG002|Overall Study|Lost to Follow-up|0|||
27767340|NCT01634139|54220026|FG000|Overall Study|Not treated|1|||
27767341|NCT01634139|54220027|FG001|Overall Study|Not treated|1|||
27767342|NCT01634139|54220028|FG002|Overall Study|Not treated|0|||
27767343|NCT02224755|54220038|FG000|Randomization to Device Implant|Withdrawn prior to implant|7|||
27767344|NCT02224755|54220039|FG001|Randomization to Device Implant|Withdrawn prior to implant|1|||
27767345|NCT02224755|54220038|FG000|Two Year Follow up Post-implant|Death|103|||
27767346|NCT02224755|54220039|FG001|Two Year Follow up Post-implant|Death|98|||
27767347|NCT02224755|54220038|FG000|Two Year Follow up Post-implant|Heart transplant|137|||
27767348|NCT02224755|54220039|FG001|Two Year Follow up Post-implant|Heart transplant|119|||
27767349|NCT02224755|54220038|FG000|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
27767350|NCT02224755|54220039|FG001|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
27767351|NCT02224755|54220038|FG000|Two Year Follow up Post-implant|Withdrawn post-implant|15|||
27767352|NCT02224755|54220039|FG001|Two Year Follow up Post-implant|Withdrawn post-implant|6|||
27767353|NCT02404441|54220059|FG000|Phase 1 Part|Adverse Event|1|||
27767354|NCT02404441|54220060|FG001|Phase 1 Part|Adverse Event|0|||
27767355|NCT02404441|54220061|FG002|Phase 1 Part|Adverse Event|0|||
27767356|NCT02404441|54220062|FG003|Phase 1 Part|Adverse Event|0|||
27767357|NCT02404441|54220063|FG004|Phase 1 Part|Adverse Event|0|||
27767358|NCT02404441|54220064|FG005|Phase 1 Part|Adverse Event|0|||
27767359|NCT02404441|54220065|FG006|Phase 1 Part|Adverse Event|0|||
27767360|NCT02404441|54220066|FG007|Phase 1 Part|Adverse Event|0|||
27767361|NCT02404441|54220067|FG008|Phase 1 Part|Adverse Event|0|||
27767362|NCT02404441|54220068|FG009|Phase 1 Part|Adverse Event|0|||
27767363|NCT02404441|54220059|FG000|Phase 1 Part|Physician Decision|0|||
27767364|NCT02404441|54220060|FG001|Phase 1 Part|Physician Decision|1|||
27767365|NCT02404441|54220061|FG002|Phase 1 Part|Physician Decision|0|||
27767366|NCT02404441|54220062|FG003|Phase 1 Part|Physician Decision|0|||
27767367|NCT02404441|54220063|FG004|Phase 1 Part|Physician Decision|0|||
27767368|NCT02404441|54220064|FG005|Phase 1 Part|Physician Decision|0|||
27767369|NCT02404441|54220065|FG006|Phase 1 Part|Physician Decision|0|||
27767370|NCT02404441|54220066|FG007|Phase 1 Part|Physician Decision|0|||
27767371|NCT02404441|54220067|FG008|Phase 1 Part|Physician Decision|0|||
27767372|NCT02404441|54220068|FG009|Phase 1 Part|Physician Decision|0|||
27767373|NCT02404441|54220059|FG000|Phase 1 Part|Progressive Disease|14|||
27767374|NCT02404441|54220060|FG001|Phase 1 Part|Progressive Disease|11|||
27767375|NCT02404441|54220061|FG002|Phase 1 Part|Progressive Disease|7|||
27767376|NCT02404441|54220062|FG003|Phase 1 Part|Progressive Disease|6|||
27767377|NCT02404441|54220063|FG004|Phase 1 Part|Progressive Disease|9|||
27767378|NCT02404441|54220064|FG005|Phase 1 Part|Progressive Disease|0|||
27767379|NCT02404441|54220065|FG006|Phase 1 Part|Progressive Disease|0|||
27767380|NCT02404441|54220066|FG007|Phase 1 Part|Progressive Disease|0|||
27767381|NCT02404441|54220067|FG008|Phase 1 Part|Progressive Disease|0|||
27767382|NCT02404441|54220068|FG009|Phase 1 Part|Progressive Disease|0|||
27767383|NCT02404441|54220059|FG000|Phase 1 Part|Subject/Guardian Decision|0|||
27767384|NCT02404441|54220060|FG001|Phase 1 Part|Subject/Guardian Decision|2|||
27767385|NCT02404441|54220061|FG002|Phase 1 Part|Subject/Guardian Decision|3|||
27767386|NCT02404441|54220062|FG003|Phase 1 Part|Subject/Guardian Decision|0|||
27767387|NCT02404441|54220063|FG004|Phase 1 Part|Subject/Guardian Decision|0|||
27767388|NCT02404441|54220064|FG005|Phase 1 Part|Subject/Guardian Decision|0|||
27767389|NCT02404441|54220065|FG006|Phase 1 Part|Subject/Guardian Decision|0|||
27767390|NCT02404441|54220066|FG007|Phase 1 Part|Subject/Guardian Decision|0|||
27767391|NCT02404441|54220067|FG008|Phase 1 Part|Subject/Guardian Decision|0|||
27767392|NCT02404441|54220068|FG009|Phase 1 Part|Subject/Guardian Decision|0|||
27767393|NCT02404441|54220059|FG000|Phase 1 Part|Death|1|||
27767394|NCT02404441|54220060|FG001|Phase 1 Part|Death|1|||
27767395|NCT02404441|54220061|FG002|Phase 1 Part|Death|1|||
27767396|NCT02404441|54220062|FG003|Phase 1 Part|Death|0|||
27767397|NCT02404441|54220063|FG004|Phase 1 Part|Death|1|||
27767398|NCT02404441|54220064|FG005|Phase 1 Part|Death|0|||
27767399|NCT02404441|54220065|FG006|Phase 1 Part|Death|0|||
27767400|NCT02404441|54220066|FG007|Phase 1 Part|Death|0|||
27767401|NCT02404441|54220067|FG008|Phase 1 Part|Death|0|||
27767402|NCT02404441|54220068|FG009|Phase 1 Part|Death|0|||
27767403|NCT02404441|54220059|FG000|Phase 2 Part|Adverse Event|0|||
27767404|NCT02404441|54220060|FG001|Phase 2 Part|Adverse Event|0|||
27767405|NCT02404441|54220061|FG002|Phase 2 Part|Adverse Event|0|||
27767406|NCT02404441|54220062|FG003|Phase 2 Part|Adverse Event|0|||
27767407|NCT02404441|54220063|FG004|Phase 2 Part|Adverse Event|0|||
27767408|NCT02404441|54220064|FG005|Phase 2 Part|Adverse Event|2|||
27767409|NCT02404441|54220065|FG006|Phase 2 Part|Adverse Event|3|||
27767410|NCT02404441|54220066|FG007|Phase 2 Part|Adverse Event|3|||
27767411|NCT02404441|54220067|FG008|Phase 2 Part|Adverse Event|6|||
27839699|NCT01693562|54327124|FG013|Escalation Phase|Withdrawal by Subject|0|||
27839700|NCT01693562|54327125|FG014|Escalation Phase|Withdrawal by Subject|0|||
27767412|NCT02404441|54220068|FG009|Phase 2 Part|Adverse Event|1|||
27767413|NCT02404441|54220059|FG000|Phase 2 Part|Physician Decision|0|||
27767414|NCT02404441|54220060|FG001|Phase 2 Part|Physician Decision|0|||
27767415|NCT02404441|54220061|FG002|Phase 2 Part|Physician Decision|0|||
27767416|NCT02404441|54220062|FG003|Phase 2 Part|Physician Decision|0|||
27767417|NCT02404441|54220063|FG004|Phase 2 Part|Physician Decision|0|||
27839701|NCT01693562|54327126|FG015|Escalation Phase|Withdrawal by Subject|0|||
27767418|NCT02404441|54220064|FG005|Phase 2 Part|Physician Decision|7|||
27767419|NCT02404441|54220065|FG006|Phase 2 Part|Physician Decision|9|||
27767420|NCT02404441|54220066|FG007|Phase 2 Part|Physician Decision|2|||
27767421|NCT02404441|54220067|FG008|Phase 2 Part|Physician Decision|1|||
27767422|NCT02404441|54220068|FG009|Phase 2 Part|Physician Decision|3|||
27767423|NCT02404441|54220059|FG000|Phase 2 Part|Progressive disease|0|||
27767424|NCT02404441|54220060|FG001|Phase 2 Part|Progressive disease|0|||
27767425|NCT02404441|54220061|FG002|Phase 2 Part|Progressive disease|0|||
27767426|NCT02404441|54220062|FG003|Phase 2 Part|Progressive disease|0|||
27767427|NCT02404441|54220063|FG004|Phase 2 Part|Progressive disease|0|||
27767428|NCT02404441|54220064|FG005|Phase 2 Part|Progressive disease|43|||
27767429|NCT02404441|54220065|FG006|Phase 2 Part|Progressive disease|32|||
27767430|NCT02404441|54220066|FG007|Phase 2 Part|Progressive disease|31|||
27767431|NCT02404441|54220067|FG008|Phase 2 Part|Progressive disease|39|||
27767432|NCT02404441|54220068|FG009|Phase 2 Part|Progressive disease|27|||
27767433|NCT02404441|54220059|FG000|Phase 2 Part|Subject/guardian decision|0|||
27767434|NCT02404441|54220060|FG001|Phase 2 Part|Subject/guardian decision|0|||
27767435|NCT02404441|54220061|FG002|Phase 2 Part|Subject/guardian decision|0|||
27767436|NCT02404441|54220062|FG003|Phase 2 Part|Subject/guardian decision|0|||
27767437|NCT02404441|54220063|FG004|Phase 2 Part|Subject/guardian decision|0|||
27767438|NCT02404441|54220064|FG005|Phase 2 Part|Subject/guardian decision|3|||
27767439|NCT02404441|54220065|FG006|Phase 2 Part|Subject/guardian decision|9|||
27767440|NCT02404441|54220066|FG007|Phase 2 Part|Subject/guardian decision|0|||
27767441|NCT02404441|54220067|FG008|Phase 2 Part|Subject/guardian decision|3|||
27767442|NCT02404441|54220068|FG009|Phase 2 Part|Subject/guardian decision|2|||
27767443|NCT02404441|54220059|FG000|Phase 2 Part|Death|0|||
27767444|NCT02404441|54220060|FG001|Phase 2 Part|Death|0|||
27767445|NCT02404441|54220061|FG002|Phase 2 Part|Death|0|||
27767446|NCT02404441|54220062|FG003|Phase 2 Part|Death|0|||
27767447|NCT02404441|54220063|FG004|Phase 2 Part|Death|0|||
27767448|NCT02404441|54220064|FG005|Phase 2 Part|Death|4|||
27767449|NCT02404441|54220065|FG006|Phase 2 Part|Death|8|||
27767450|NCT02404441|54220066|FG007|Phase 2 Part|Death|4|||
27767451|NCT02404441|54220067|FG008|Phase 2 Part|Death|10|||
27767452|NCT02404441|54220068|FG009|Phase 2 Part|Death|9|||
27767453|NCT02101281|54220114|FG000|Overall Study|Adverse Event|0|||
27767454|NCT02101281|54220115|FG001|Overall Study|Adverse Event|1|||
27767455|NCT02224599|54220127|FG000|Overall Study|Physician Decision|1|||
27767456|NCT02224599|54220127|FG000|Overall Study|Progression of Disease|1|||
27767457|NCT02201901|54220134|FG000|Overall Study|Randomized but never treated|0|||
27767458|NCT02201901|54220135|FG001|Overall Study|Randomized but never treated|1|||
27767459|NCT02201901|54220136|FG002|Overall Study|Randomized but never treated|0|||
27767460|NCT02201901|54220134|FG000|Overall Study|Lack of Efficacy|7|||
27767461|NCT02201901|54220135|FG001|Overall Study|Lack of Efficacy|1|||
27767462|NCT02201901|54220136|FG002|Overall Study|Lack of Efficacy|6|||
27767463|NCT02201901|54220134|FG000|Overall Study|Death|3|||
27767464|NCT02201901|54220135|FG001|Overall Study|Death|3|||
27767465|NCT02201901|54220136|FG002|Overall Study|Death|3|||
27767466|NCT02201901|54220134|FG000|Overall Study|Lost to Follow-up|2|||
27767467|NCT02201901|54220135|FG001|Overall Study|Lost to Follow-up|3|||
27767468|NCT02201901|54220136|FG002|Overall Study|Lost to Follow-up|2|||
27767469|NCT02201901|54220134|FG000|Overall Study|Withdrew Consent|2|||
27767470|NCT02201901|54220135|FG001|Overall Study|Withdrew Consent|0|||
27767471|NCT02201901|54220136|FG002|Overall Study|Withdrew Consent|2|||
27767472|NCT02201901|54220134|FG000|Overall Study|Adverse Event|1|||
27767473|NCT02201901|54220135|FG001|Overall Study|Adverse Event|1|||
27767474|NCT02201901|54220136|FG002|Overall Study|Adverse Event|0|||
27767475|NCT02201277|54220147|FG000|Overall Study|Death|3|||
27767476|NCT02201277|54220148|FG001|Overall Study|Death|4|||
27767477|NCT02201277|54220147|FG000|Overall Study|Lost to Follow-up|2|||
27767478|NCT02201277|54220148|FG001|Overall Study|Lost to Follow-up|1|||
27767479|NCT02201277|54220147|FG000|Overall Study|Failed retrieval|1|||
27767480|NCT02201277|54220148|FG001|Overall Study|Failed retrieval|0|||
27767481|NCT02201277|54220147|FG000|Overall Study|Physician Decision|1|||
27767482|NCT02201277|54220148|FG001|Overall Study|Physician Decision|0|||
27767483|NCT02224053|54220158|FG000|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11|||
27767484|NCT02224053|54220158|FG000|AZD9291 and Omeprazole Co-administration|Protocol Violation|4|||
27767485|NCT02224053|54220158|FG000|AZD9291 and Omeprazole Co-administration|Adverse Event|3|||
27767486|NCT02224053|54220158|FG000|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1|||
27767487|NCT02224053|54220158|FG000|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2|||
27767488|NCT02457793|54220170|FG000|Overall Study|Reason not specified|0|||
27767489|NCT02457793|54220171|FG001|Overall Study|Reason not specified|0|||
27767490|NCT02457793|54220172|FG002|Overall Study|Reason not specified|0|||
27767491|NCT02457793|54220173|FG003|Overall Study|Reason not specified|1|||
27767492|NCT02457793|54220174|FG004|Overall Study|Reason not specified|1|||
27767493|NCT02457793|54220175|FG005|Overall Study|Reason not specified|1|||
27767494|NCT02457793|54220170|FG000|Overall Study|Withdrawal by Subject|0|||
27767495|NCT02457793|54220171|FG001|Overall Study|Withdrawal by Subject|4|||
27767496|NCT02457793|54220172|FG002|Overall Study|Withdrawal by Subject|2|||
27767497|NCT02457793|54220173|FG003|Overall Study|Withdrawal by Subject|2|||
27767498|NCT02457793|54220174|FG004|Overall Study|Withdrawal by Subject|2|||
27767499|NCT02457793|54220175|FG005|Overall Study|Withdrawal by Subject|2|||
27767500|NCT02457793|54220170|FG000|Overall Study|Adverse Event|0|||
27767501|NCT02457793|54220171|FG001|Overall Study|Adverse Event|0|||
27767502|NCT02457793|54220172|FG002|Overall Study|Adverse Event|0|||
27767503|NCT02457793|54220173|FG003|Overall Study|Adverse Event|1|||
27767504|NCT02457793|54220174|FG004|Overall Study|Adverse Event|0|||
27767505|NCT02457793|54220175|FG005|Overall Study|Adverse Event|0|||
27767506|NCT02457793|54220170|FG000|Overall Study|Physician Decision|1|||
27767507|NCT02457793|54220171|FG001|Overall Study|Physician Decision|0|||
27767508|NCT02457793|54220172|FG002|Overall Study|Physician Decision|1|||
27767509|NCT02457793|54220173|FG003|Overall Study|Physician Decision|1|||
27767510|NCT02457793|54220174|FG004|Overall Study|Physician Decision|1|||
27767511|NCT02457793|54220175|FG005|Overall Study|Physician Decision|3|||
27767512|NCT01650259|54220192|FG000|Overall Study|Improvement|105|||
27767513|NCT01650259|54220193|FG001|Overall Study|Improvement|0|||
27767514|NCT01650259|54220192|FG000|Overall Study|Adverse Event|127|||
27767515|NCT01650259|54220193|FG001|Overall Study|Adverse Event|0|||
27767516|NCT01650259|54220192|FG000|Overall Study|Lack of Efficacy|143|||
27767517|NCT01650259|54220193|FG001|Overall Study|Lack of Efficacy|0|||
27767518|NCT01650259|54220192|FG000|Overall Study|Lost to Follow-up|435|||
27767519|NCT01650259|54220193|FG001|Overall Study|Lost to Follow-up|0|||
27767520|NCT01650259|54220192|FG000|Overall Study|Patients had no visit after entry|70|||
27767521|NCT01650259|54220193|FG001|Overall Study|Patients had no visit after entry|0|||
27767522|NCT01650259|54220192|FG000|Overall Study|CRF not collected|98|||
27767523|NCT01650259|54220193|FG001|Overall Study|CRF not collected|82|||
27767524|NCT01650259|54220192|FG000|Overall Study|Not treated|1|||
27767525|NCT01650259|54220193|FG001|Overall Study|Not treated|7|||
27767526|NCT01650259|54220192|FG000|Overall Study|Other than listed|64|||
27767527|NCT01650259|54220193|FG001|Overall Study|Other than listed|146|||
27767528|NCT02434939|54220199|FG000|Overall Study|Lack of Efficacy|34|||
27767529|NCT02434939|54220200|FG001|Overall Study|Lack of Efficacy|48|||
27767530|NCT02434939|54220199|FG000|Overall Study|Withdrawal by Subject|3|||
27767531|NCT02434939|54220200|FG001|Overall Study|Withdrawal by Subject|0|||
27767532|NCT02434939|54220199|FG000|Overall Study|Adverse Event|0|||
27767533|NCT02434939|54220200|FG001|Overall Study|Adverse Event|1|||
27767534|NCT02434471|54220207|FG000|Overall Study|Physician Decision|9|||
27767535|NCT02457637|54220212|FG000|Clinic or Telephone Follow-up|Lost to Follow-up|71|||
27767536|NCT02457325|54220219|FG000|First Intervention (1 Day)|Lost to Follow-up|2|||
27767537|NCT02457325|54220220|FG001|First Intervention (1 Day)|Lost to Follow-up|2|||
27767538|NCT02434081|54220226|FG000|Overall Study|Death (never started treatment)|2|||
27767539|NCT02434081|54220226|FG000|Overall Study|Death|2|||
27767540|NCT02434081|54220226|FG000|Overall Study|Progression|20|||
27767541|NCT02434081|54220226|FG000|Overall Study|Adverse Event|20|||
27767542|NCT02434081|54220226|FG000|Overall Study|Physician Decision|2|||
27767543|NCT02434081|54220226|FG000|Overall Study|Withdrawal by Subject|1|||
27767544|NCT02434081|54220226|FG000|Overall Study|Patient did not receive treatment for more than six weeks|1|||
27767545|NCT02222493|54220232|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
27767546|NCT02222493|54220233|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
27767547|NCT02222493|54220232|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0|||
27767548|NCT02222493|54220233|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1|||
27767549|NCT02222493|54220232|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11|||
27767550|NCT02222493|54220233|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9|||
27767551|NCT02222493|54220232|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5|||
27767552|NCT02222493|54220233|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1|||
27767553|NCT02222493|54220232|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0|||
27767554|NCT02222493|54220233|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7|||
27767555|NCT02222493|54220232|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1|||
27767556|NCT02222493|54220233|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0|||
27767557|NCT02222493|54220232|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2|||
27767558|NCT02222493|54220233|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0|||
27767559|NCT02222493|54220232|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18|||
27767560|NCT02222493|54220233|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20|||
27767561|NCT02222493|54220232|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Other|4|||
27767562|NCT02222493|54220233|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Other|0|||
27767563|NCT02222493|54220232|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1|||
27767564|NCT02222493|54220233|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0|||
27767565|NCT02222493|54220232|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1|||
27767566|NCT02222493|54220233|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0|||
27767567|NCT02222493|54220232|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22|||
27767568|NCT02222493|54220233|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9|||
27767569|NCT02222493|54220232|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3|||
27767570|NCT02222493|54220233|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0|||
27767571|NCT02222493|54220232|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1|||
27767572|NCT02222493|54220233|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0|||
27767573|NCT02222493|54220232|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6|||
27767574|NCT02222493|54220233|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4|||
27767575|NCT02222493|54220232|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
27767576|NCT02222493|54220233|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
27767577|NCT02222493|54220232|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9|||
27767578|NCT02222493|54220233|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3|||
27767579|NCT02222493|54220232|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3|||
27767580|NCT02222493|54220233|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0|||
27767581|NCT02222493|54220232|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14|||
27767582|NCT02222493|54220233|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0|||
27767583|NCT02222493|54220232|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Other|4|||
27767584|NCT02222493|54220233|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Other|0|||
27767585|NCT02222493|54220232|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1|||
27767586|NCT02222493|54220233|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0|||
27767587|NCT02222493|54220232|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9|||
27767588|NCT02222493|54220233|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0|||
27767589|NCT02433379|54220252|FG000|Overall Study|Screen Failures|55|||
27767590|NCT02433379|54220252|FG000|Overall Study|Death|57|||
27767591|NCT02433379|54220252|FG000|Overall Study|Total Withdrawals|209|||
27767592|NCT02199795|54220260|FG000|Overall Study|no longer met inclusion criteria|1|||
27767593|NCT02199795|54220261|FG001|Overall Study|no longer met inclusion criteria|0|||
27767594|NCT02199795|54220260|FG000|Overall Study|withdrew due to shoulder pain|1|||
27767595|NCT02199795|54220261|FG001|Overall Study|withdrew due to shoulder pain|0|||
27767596|NCT02403817|54220269|FG000|Overall Study|Withdrawal by Subject|5|||
27767597|NCT02403817|54220270|FG001|Overall Study|Withdrawal by Subject|0|||
27767598|NCT02403271|54220276|FG000|Period 1|Other varied reasons|1|||
27767599|NCT02403271|54220277|FG001|Period 1|Other varied reasons|0|||
27767600|NCT02403271|54220276|FG000|Period 2|Withdrawal by Subject|0|||
27767601|NCT02403271|54220277|FG001|Period 2|Withdrawal by Subject|14|||
27767602|NCT02403271|54220276|FG000|Period 2|Death|0|||
27767603|NCT02403271|54220277|FG001|Period 2|Death|84|||
27767604|NCT02403271|54220276|FG000|Period 2|Lost to Follow-up|0|||
27767605|NCT02403271|54220277|FG001|Period 2|Lost to Follow-up|2|||
27767606|NCT02403271|54220276|FG000|Period 2|Study Terminated by Sponsor|0|||
27767607|NCT02403271|54220277|FG001|Period 2|Study Terminated by Sponsor|14|||
27767608|NCT02403271|54220276|FG000|Period 2|Other varied reasons|0|||
27767609|NCT02403271|54220277|FG001|Period 2|Other varied reasons|10|||
27767610|NCT02219685|54220285|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
27767611|NCT02219685|54220286|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
27767612|NCT02219685|54220285|FG000|Blinded Treatment Phase|Withdrew Consent|1|||
27767613|NCT02219685|54220286|FG001|Blinded Treatment Phase|Withdrew Consent|0|||
27767614|NCT02457247|54220298|FG000|Period 1|Pretreatment Event/Adverse Event|0|||
27767615|NCT02457247|54220299|FG001|Period 1|Pretreatment Event/Adverse Event|1|||
27767616|NCT02457247|54220300|FG002|Period 1|Pretreatment Event/Adverse Event|0|||
27767617|NCT02457247|54220301|FG003|Period 1|Pretreatment Event/Adverse Event|0|||
27767618|NCT02457247|54220298|FG000|Period 1|Significant Protocol Deviation|1|||
27767619|NCT02457247|54220299|FG001|Period 1|Significant Protocol Deviation|1|||
27767620|NCT02457247|54220300|FG002|Period 1|Significant Protocol Deviation|0|||
27767621|NCT02457247|54220301|FG003|Period 1|Significant Protocol Deviation|0|||
27767622|NCT02457247|54220298|FG000|Period 1|Voluntary Withdrawal|1|||
27767623|NCT02457247|54220299|FG001|Period 1|Voluntary Withdrawal|0|||
27767624|NCT02457247|54220300|FG002|Period 1|Voluntary Withdrawal|0|||
27767625|NCT02457247|54220301|FG003|Period 1|Voluntary Withdrawal|0|||
27767626|NCT02457247|54220298|FG000|Period 2|Pretreatment Event/Adverse Event|0|||
27767627|NCT02457247|54220299|FG001|Period 2|Pretreatment Event/Adverse Event|1|||
27767628|NCT02457247|54220300|FG002|Period 2|Pretreatment Event/Adverse Event|0|||
27767629|NCT02457247|54220301|FG003|Period 2|Pretreatment Event/Adverse Event|0|||
27839702|NCT01693562|54327127|FG016|Escalation Phase|Withdrawal by Subject|0|||
27767630|NCT02457247|54220298|FG000|Period 2|Significant Protocol Deviation|1|||
27767631|NCT02457247|54220299|FG001|Period 2|Significant Protocol Deviation|0|||
27767632|NCT02457247|54220300|FG002|Period 2|Significant Protocol Deviation|0|||
27839703|NCT01693562|54327128|FG017|Escalation Phase|Withdrawal by Subject|0|||
27839704|NCT01693562|54327129|FG018|Escalation Phase|Withdrawal by Subject|0|||
27767633|NCT02457247|54220301|FG003|Period 2|Significant Protocol Deviation|0|||
27767634|NCT02457247|54220298|FG000|Period 2|Lost to Follow-up|0|||
27767635|NCT02457247|54220299|FG001|Period 2|Lost to Follow-up|1|||
27767636|NCT02457247|54220300|FG002|Period 2|Lost to Follow-up|0|||
27767637|NCT02457247|54220301|FG003|Period 2|Lost to Follow-up|0|||
27767638|NCT02457247|54220298|FG000|Period 2|Voluntary Withdrawal|1|||
27767639|NCT02457247|54220299|FG001|Period 2|Voluntary Withdrawal|1|||
27767640|NCT02457247|54220300|FG002|Period 2|Voluntary Withdrawal|0|||
27767641|NCT02457247|54220301|FG003|Period 2|Voluntary Withdrawal|0|||
27767642|NCT02401867|54220317|FG000|Specimen Collection|Didn't receive 1 or more tests|10|||
27767643|NCT02401867|54220317|FG000|Analysis|Cervical assay could not be conducted|9|||
27767644|NCT02198235|54220325|FG000|Overall Study|Lost to Follow-up|3|||
27767645|NCT02198235|54220326|FG001|Overall Study|Lost to Follow-up|2|||
27767646|NCT02198235|54220327|FG002|Overall Study|Lost to Follow-up|2|||
27767647|NCT02253147|54220335|FG000|Overall Study|Protocol Violation|30|||
27767648|NCT02253147|54220335|FG000|Overall Study|Did not consent to study extension|9|||
27767649|NCT02253147|54220335|FG000|Overall Study|Conditional re-treatment at W52|5|||
27767650|NCT02253147|54220335|FG000|Overall Study|Lost to Follow-up|2|||
27767651|NCT02253147|54220335|FG000|Overall Study|Withdrawal by Subject|1|||
27767652|NCT02217501|54220343|FG000|Overall Study|Death|3|||
27767653|NCT02217501|54220344|FG001|Overall Study|Death|4|||
27767654|NCT01649869|54220352|FG000|Overall Study|Family member illness|1|||
27767655|NCT01649869|54220353|FG001|Overall Study|Family member illness|0|||
27767656|NCT01649869|54220352|FG000|Overall Study|Required treatment outside protocol|1|||
27767657|NCT01649869|54220353|FG001|Overall Study|Required treatment outside protocol|0|||
27767658|NCT01649869|54220352|FG000|Overall Study|Severe hearing loss borderline eligible|0|||
27767659|NCT01649869|54220353|FG001|Overall Study|Severe hearing loss borderline eligible|1|||
27767660|NCT02197377|54220363|FG000|Overall Study|Insertion Failure|0|||
27767661|NCT02197377|54220364|FG001|Overall Study|Insertion Failure|3|||
27767662|NCT02400307|54220372|FG000|Overall Study|Enrolled and Never Dosed|1|||
27767663|NCT02400307|54220373|FG001|Overall Study|Enrolled and Never Dosed|0|||
27767664|NCT02196675|54220382|FG000|Overall Study|Withdrawal by Subject|1|||
27767665|NCT02196675|54220383|FG001|Overall Study|Withdrawal by Subject|0|||
27767666|NCT02196675|54220384|FG002|Overall Study|Withdrawal by Subject|0|||
27767667|NCT02196675|54220382|FG000|Overall Study|Intra-operative surgical exclusion|1|||
27767668|NCT02196675|54220383|FG001|Overall Study|Intra-operative surgical exclusion|1|||
27767669|NCT02196675|54220384|FG002|Overall Study|Intra-operative surgical exclusion|0|||
27767670|NCT02196675|54220382|FG000|Overall Study|Protocol Violation|0|||
27767671|NCT02196675|54220383|FG001|Overall Study|Protocol Violation|1|||
27767672|NCT02196675|54220384|FG002|Overall Study|Protocol Violation|0|||
27767673|NCT02196675|54220382|FG000|Overall Study|Death|0|||
27767674|NCT02196675|54220383|FG001|Overall Study|Death|0|||
27767675|NCT02196675|54220384|FG002|Overall Study|Death|1|||
27767676|NCT02399449|54220394|FG000|Overall Study|Withdrawal by Subject|3|||
27767677|NCT02399449|54220395|FG001|Overall Study|Withdrawal by Subject|9|||
27767678|NCT02399449|54220394|FG000|Overall Study|Physician Decision|0|||
27767679|NCT02399449|54220395|FG001|Overall Study|Physician Decision|1|||
27767680|NCT02217345|54220403|FG000|Overall Study|Lost to Follow-up|2|||
27767681|NCT02217345|54220404|FG001|Overall Study|Lost to Follow-up|1|||
27767682|NCT02217345|54220403|FG000|Overall Study|Withdrawal by Subject|3|||
27767683|NCT02217345|54220404|FG001|Overall Study|Withdrawal by Subject|2|||
27767684|NCT02217345|54220403|FG000|Overall Study|Adverse Event|2|||
27839705|NCT01693562|54327130|FG019|Escalation Phase|Withdrawal by Subject|0|||
27839706|NCT01693562|54327131|FG020|Escalation Phase|Withdrawal by Subject|0|||
27839707|NCT01693562|54327132|FG021|Escalation Phase|Withdrawal by Subject|0|||
27839708|NCT01693562|54327133|FG022|Escalation Phase|Withdrawal by Subject|0|||
27839709|NCT01693562|54327111|FG000|Escalation Phase|Death|4|||
27839710|NCT01693562|54327112|FG001|Escalation Phase|Death|2|||
27839711|NCT01693562|54327113|FG002|Escalation Phase|Death|0|||
27767685|NCT02217345|54220404|FG001|Overall Study|Adverse Event|1|||
27767686|NCT02217345|54220403|FG000|Overall Study|Physician Decision|0|||
27767687|NCT02217345|54220404|FG001|Overall Study|Physician Decision|1|||
27767688|NCT01652287|54220412|FG000|Overall Study|Withdrawal by Subject|2|||
27767689|NCT01652287|54220413|FG001|Overall Study|Withdrawal by Subject|0|||
27767690|NCT02251743|54220421|FG000|Overall Study|Withdrawal by Subject|1|||
27767691|NCT02251743|54220422|FG001|Overall Study|Withdrawal by Subject|1|||
27767692|NCT02428855|54220428|FG000|Overall Study|Withdrawal by Subject|2|||
27767693|NCT02428699|54220432|FG000|Washout Period 1|Screen Failure|1|||
27767694|NCT02428699|54220433|FG001|Washout Period 1|Screen Failure|2|||
27767695|NCT02428231|54220446|FG000|Overall Study|Other|10|||
27767696|NCT02428231|54220447|FG001|Overall Study|Other|16|||
27767697|NCT02428231|54220446|FG000|Overall Study|Required Symptomatic Therapy|0|||
27767698|NCT02428231|54220447|FG001|Overall Study|Required Symptomatic Therapy|1|||
27767699|NCT02428231|54220446|FG000|Overall Study|Adverse Event|3|||
27767700|NCT02428231|54220447|FG001|Overall Study|Adverse Event|0|||
27767701|NCT02427841|54220453|FG000|Overall Study|Physician Decision|8|||
27767702|NCT02397889|54220459|FG000|Overall Study|Physician Decision|1|||
27767703|NCT02397889|54220460|FG001|Overall Study|Physician Decision|0|||
27767704|NCT02397655|54220466|FG000|Overall Study|data not completed|1301|||
27767705|NCT02396953|54220473|FG000|Overall Study|Withdrawal by Subject|0|||
27839712|NCT01693562|54327114|FG003|Escalation Phase|Death|3|||
27839713|NCT01693562|54327115|FG004|Escalation Phase|Death|6|||
27839714|NCT01693562|54327116|FG005|Escalation Phase|Death|4|||
27839715|NCT01693562|54327117|FG006|Escalation Phase|Death|0|||
27839716|NCT01693562|54327118|FG007|Escalation Phase|Death|0|||
27839717|NCT01693562|54327119|FG008|Escalation Phase|Death|0|||
27839718|NCT01693562|54327120|FG009|Escalation Phase|Death|0|||
27839719|NCT01693562|54327121|FG010|Escalation Phase|Death|0|||
27839720|NCT01693562|54327122|FG011|Escalation Phase|Death|0|||
27839721|NCT01693562|54327123|FG012|Escalation Phase|Death|0|||
27839722|NCT01693562|54327124|FG013|Escalation Phase|Death|0|||
27839723|NCT01693562|54327125|FG014|Escalation Phase|Death|0|||
27839724|NCT01693562|54327126|FG015|Escalation Phase|Death|0|||
27839725|NCT01693562|54327127|FG016|Escalation Phase|Death|0|||
27839726|NCT01693562|54327128|FG017|Escalation Phase|Death|0|||
27839727|NCT01693562|54327129|FG018|Escalation Phase|Death|0|||
27839728|NCT01693562|54327130|FG019|Escalation Phase|Death|0|||
27839729|NCT01693562|54327131|FG020|Escalation Phase|Death|0|||
27839730|NCT01693562|54327132|FG021|Escalation Phase|Death|0|||
27839731|NCT01693562|54327133|FG022|Escalation Phase|Death|0|||
27839732|NCT01693562|54327111|FG000|Escalation Phase|Lost to Follow-up|0|||
27839733|NCT01693562|54327112|FG001|Escalation Phase|Lost to Follow-up|1|||
27839734|NCT01693562|54327113|FG002|Escalation Phase|Lost to Follow-up|1|||
27839735|NCT01693562|54327114|FG003|Escalation Phase|Lost to Follow-up|0|||
27839736|NCT01693562|54327115|FG004|Escalation Phase|Lost to Follow-up|0|||
27839737|NCT01693562|54327116|FG005|Escalation Phase|Lost to Follow-up|0|||
27839738|NCT01693562|54327117|FG006|Escalation Phase|Lost to Follow-up|0|||
27839739|NCT01693562|54327118|FG007|Escalation Phase|Lost to Follow-up|0|||
27839740|NCT01693562|54327119|FG008|Escalation Phase|Lost to Follow-up|0|||
27839741|NCT01693562|54327120|FG009|Escalation Phase|Lost to Follow-up|0|||
27767706|NCT02396953|54220474|FG001|Overall Study|Withdrawal by Subject|0|||
27767707|NCT02396953|54220475|FG002|Overall Study|Withdrawal by Subject|1|||
27767708|NCT02396953|54220473|FG000|Overall Study|Insulin like Growth Factor-1 increased|3|||
27767709|NCT02396953|54220474|FG001|Overall Study|Insulin like Growth Factor-1 increased|2|||
27767710|NCT02396953|54220475|FG002|Overall Study|Insulin like Growth Factor-1 increased|2|||
27767711|NCT02396953|54220473|FG000|Overall Study|Personal Reasons|1|||
27767712|NCT02396953|54220474|FG001|Overall Study|Personal Reasons|1|||
27767713|NCT02396953|54220475|FG002|Overall Study|Personal Reasons|0|||
27767714|NCT02387983|54220490|FG000|Overall Study|Adverse Event|4|||
27767715|NCT02387983|54220490|FG000|Overall Study|Protocol Violation|1|||
27767716|NCT02387983|54220490|FG000|Overall Study|Withdrawal by Subject|2|||
27767717|NCT02395627|54220497|FG000|Overall Study|Withdrawal by Subject|0|||
27767718|NCT02395627|54220498|FG001|Overall Study|Withdrawal by Subject|2|||
27767719|NCT02395627|54220499|FG002|Overall Study|Withdrawal by Subject|0|||
27767720|NCT02395627|54220497|FG000|Overall Study|Did not receive pembrolizumab|3|||
27767721|NCT02395627|54220498|FG001|Overall Study|Did not receive pembrolizumab|1|||
27767722|NCT02395627|54220499|FG002|Overall Study|Did not receive pembrolizumab|0|||
27767723|NCT02395471|54220511|FG000|Overall Study|Lost to Follow-up|2|||
27767724|NCT02395471|54220512|FG001|Overall Study|Lost to Follow-up|0|||
27767725|NCT02395471|54220511|FG000|Overall Study|Withdrawal by Subject|2|||
27767726|NCT02395471|54220512|FG001|Overall Study|Withdrawal by Subject|1|||
27767727|NCT02395471|54220511|FG000|Overall Study|Physician Decision|1|||
27767728|NCT02395471|54220512|FG001|Overall Study|Physician Decision|0|||
27767729|NCT02395471|54220511|FG000|Overall Study|Protocol Violation|0|||
27767730|NCT02395471|54220512|FG001|Overall Study|Protocol Violation|1|||
27767731|NCT02395471|54220511|FG000|Overall Study|Failure to swollow sponge twice|1|||
27767732|NCT02395471|54220512|FG001|Overall Study|Failure to swollow sponge twice|0|||
27839742|NCT01693562|54327121|FG010|Escalation Phase|Lost to Follow-up|0|||
27839743|NCT01693562|54327122|FG011|Escalation Phase|Lost to Follow-up|0|||
27839744|NCT01693562|54327123|FG012|Escalation Phase|Lost to Follow-up|0|||
27839745|NCT01693562|54327124|FG013|Escalation Phase|Lost to Follow-up|0|||
27839746|NCT01693562|54327125|FG014|Escalation Phase|Lost to Follow-up|0|||
27839747|NCT01693562|54327126|FG015|Escalation Phase|Lost to Follow-up|0|||
27839748|NCT01693562|54327127|FG016|Escalation Phase|Lost to Follow-up|0|||
27839749|NCT01693562|54327128|FG017|Escalation Phase|Lost to Follow-up|0|||
27839750|NCT01693562|54327129|FG018|Escalation Phase|Lost to Follow-up|0|||
27839751|NCT01693562|54327130|FG019|Escalation Phase|Lost to Follow-up|0|||
27767733|NCT02395471|54220511|FG000|Overall Study|Patient did not return for procedure|0|||
27767734|NCT02395471|54220512|FG001|Overall Study|Patient did not return for procedure|1|||
27767735|NCT02395471|54220511|FG000|Overall Study|Subject not eligible|1|||
27839752|NCT01693562|54327131|FG020|Escalation Phase|Lost to Follow-up|0|||
27839753|NCT01693562|54327132|FG021|Escalation Phase|Lost to Follow-up|0|||
27839754|NCT01693562|54327133|FG022|Escalation Phase|Lost to Follow-up|0|||
27839755|NCT01693562|54327111|FG000|Escalation Phase|Other|0|||
27767736|NCT02395471|54220512|FG001|Overall Study|Subject not eligible|0|||
27767737|NCT02395081|54220530|FG000|Overall Study|Withdrawal by Subject|1|||
27839756|NCT01693562|54327112|FG001|Escalation Phase|Other|0|||
27839757|NCT01693562|54327113|FG002|Escalation Phase|Other|2|||
27839758|NCT01693562|54327114|FG003|Escalation Phase|Other|0|||
27839759|NCT01693562|54327115|FG004|Escalation Phase|Other|0|||
27839760|NCT01693562|54327116|FG005|Escalation Phase|Other|1|||
27839761|NCT01693562|54327117|FG006|Escalation Phase|Other|0|||
27839762|NCT01693562|54327118|FG007|Escalation Phase|Other|0|||
27767738|NCT02395081|54220531|FG001|Overall Study|Withdrawal by Subject|1|||
27767739|NCT02395081|54220532|FG002|Overall Study|Withdrawal by Subject|0|||
27767740|NCT02395081|54220530|FG000|Overall Study|Moved where blood couldn't be collected|4|||
27767741|NCT02395081|54220531|FG001|Overall Study|Moved where blood couldn't be collected|1|||
27767742|NCT02395081|54220532|FG002|Overall Study|Moved where blood couldn't be collected|3|||
27767743|NCT02395081|54220530|FG000|Overall Study|Fetal Loss|2|||
27767744|NCT02395081|54220531|FG001|Overall Study|Fetal Loss|3|||
27767745|NCT02395081|54220532|FG002|Overall Study|Fetal Loss|1|||
27767746|NCT02394925|54220543|FG000|Overall Study|Adverse Event|1|||
27767747|NCT02394925|54220543|FG000|Overall Study|Lens Discomfort|3|||
27767748|NCT02394925|54220543|FG000|Overall Study|Lens handling difficulities|5|||
27767749|NCT02394925|54220543|FG000|Overall Study|Lost to Follow-up|9|||
27767750|NCT02394925|54220543|FG000|Overall Study|Protocol Violation|5|||
27767751|NCT02394925|54220543|FG000|Overall Study|No longer meet eligibility criteria|1|||
27767752|NCT02394925|54220543|FG000|Overall Study|Unsatisfactory Visual Response|5|||
27767753|NCT02427607|54220547|FG000|Overall Study|Withdrawal by Subject|1|||
27767754|NCT02426125|54220553|FG000|Overall Study|Lost to Follow-up|12|||
27767755|NCT02426125|54220554|FG001|Overall Study|Lost to Follow-up|10|||
27767756|NCT02426125|54220553|FG000|Overall Study|Protocol Violation|1|||
27767757|NCT02426125|54220554|FG001|Overall Study|Protocol Violation|0|||
27767758|NCT02426125|54220553|FG000|Overall Study|Withdrawal by Subject|16|||
27767759|NCT02426125|54220554|FG001|Overall Study|Withdrawal by Subject|16|||
27767760|NCT02425111|54220562|FG000|Part A: Treatment Period|Pretreatment Event/Adverse Event|2|||
27767761|NCT02425111|54220562|FG000|Part A: Treatment Period|Lack of Efficacy|15|||
27767762|NCT02425111|54220562|FG000|Part A: Treatment Period|Voluntary Withdrawal|4|||
27767763|NCT02425111|54220562|FG000|Part A: Treatment Period|Lost to Follow-up|2|||
27767764|NCT02425111|54220562|FG000|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3|||
27767765|NCT02425111|54220562|FG000|Part B: Treatment Extension Period|Lack of Efficacy|7|||
27767766|NCT02424565|54220567|FG000|Period 1 (D0)|Protocol Violation|0|||
27767767|NCT02424565|54220568|FG001|Period 1 (D0)|Protocol Violation|1|||
27767768|NCT02424253|54220576|FG000|Overall Study|Other, unspecified|1|||
27767769|NCT02424253|54220577|FG001|Overall Study|Other, unspecified|0|||
27767770|NCT02424253|54220576|FG000|Overall Study|Compliance problems|1|||
27767771|NCT02424253|54220577|FG001|Overall Study|Compliance problems|0|||
27767772|NCT02424253|54220576|FG000|Overall Study|Physician Decision|2|||
27767773|NCT02424253|54220577|FG001|Overall Study|Physician Decision|0|||
27767774|NCT02424253|54220576|FG000|Overall Study|Lack of Efficacy|0|||
27767775|NCT02424253|54220577|FG001|Overall Study|Lack of Efficacy|7|||
27767776|NCT02424253|54220576|FG000|Overall Study|Adverse Event|2|||
27767777|NCT02424253|54220577|FG001|Overall Study|Adverse Event|0|||
27767778|NCT02424253|54220576|FG000|Overall Study|Consent withdrawn by subject|4|||
27767779|NCT02424253|54220577|FG001|Overall Study|Consent withdrawn by subject|1|||
27767780|NCT02424253|54220576|FG000|Overall Study|Lost to Follow-up|1|||
27767781|NCT02424253|54220577|FG001|Overall Study|Lost to Follow-up|1|||
27767782|NCT02393755|54220585|FG000|Overall Study|Withdrawal by Subject|0|||
27767783|NCT02393755|54220586|FG001|Overall Study|Withdrawal by Subject|3|||
27767784|NCT02393755|54220585|FG000|Overall Study|Adverse Event|0|||
27767785|NCT02393755|54220586|FG001|Overall Study|Adverse Event|2|||
27767786|NCT02393755|54220585|FG000|Overall Study|Physician Decision|0|||
27767787|NCT02393755|54220586|FG001|Overall Study|Physician Decision|2|||
27767788|NCT02393209|54220593|FG000|Overall Study|Study Terminated by Sponsor|1|||
27839763|NCT01693562|54327119|FG008|Escalation Phase|Other|0|||
27839764|NCT01693562|54327120|FG009|Escalation Phase|Other|0|||
27767789|NCT02393209|54220594|FG001|Overall Study|Study Terminated by Sponsor|1|||
27767790|NCT02393209|54220595|FG002|Overall Study|Study Terminated by Sponsor|0|||
27767791|NCT02393209|54220596|FG003|Overall Study|Study Terminated by Sponsor|0|||
27767792|NCT02393209|54220593|FG000|Overall Study|Withdrawal by Patient|1|||
27767793|NCT02393209|54220594|FG001|Overall Study|Withdrawal by Patient|0|||
27767794|NCT02393209|54220595|FG002|Overall Study|Withdrawal by Patient|0|||
27767795|NCT02393209|54220596|FG003|Overall Study|Withdrawal by Patient|0|||
27767796|NCT02393209|54220593|FG000|Overall Study|Death|2|||
27767797|NCT02393209|54220594|FG001|Overall Study|Death|2|||
27767798|NCT02393209|54220595|FG002|Overall Study|Death|0|||
27767799|NCT02393209|54220596|FG003|Overall Study|Death|0|||
27767800|NCT02393209|54220593|FG000|Overall Study|Death due to Disease Progression|2|||
27767801|NCT02393209|54220594|FG001|Overall Study|Death due to Disease Progression|2|||
27767802|NCT02393209|54220595|FG002|Overall Study|Death due to Disease Progression|0|||
27767803|NCT02393209|54220596|FG003|Overall Study|Death due to Disease Progression|0|||
27767804|NCT02393209|54220593|FG000|Overall Study|Death from Legionella Infection|0|||
27767805|NCT02393209|54220594|FG001|Overall Study|Death from Legionella Infection|1|||
27767806|NCT02393209|54220595|FG002|Overall Study|Death from Legionella Infection|0|||
27839765|NCT01693562|54327121|FG010|Escalation Phase|Other|0|||
27767807|NCT02393209|54220596|FG003|Overall Study|Death from Legionella Infection|0|||
27767808|NCT02393209|54220593|FG000|Overall Study|Patient Seen by Another Oncologist|0|||
27767809|NCT02393209|54220594|FG001|Overall Study|Patient Seen by Another Oncologist|1|||
27767810|NCT02393209|54220595|FG002|Overall Study|Patient Seen by Another Oncologist|0|||
27767811|NCT02393209|54220596|FG003|Overall Study|Patient Seen by Another Oncologist|0|||
27767812|NCT02393209|54220593|FG000|Overall Study|Lost to Follow-up|0|||
27767813|NCT02393209|54220594|FG001|Overall Study|Lost to Follow-up|1|||
27767814|NCT02393209|54220595|FG002|Overall Study|Lost to Follow-up|0|||
27767815|NCT02393209|54220596|FG003|Overall Study|Lost to Follow-up|0|||
27767816|NCT02424097|54220607|FG000|Overall Study|Lost to Follow-up|1|||
27767817|NCT02424097|54220608|FG001|Overall Study|Lost to Follow-up|2|||
27767818|NCT02392507|54220614|FG000|Induction Regimen|Death|3|||
27767819|NCT02392507|54220614|FG000|Induction Regimen|On Study Treatment at Study Conclusion|1|||
27767820|NCT02392507|54220614|FG000|Induction Regimen|Physician Decision|1|||
27767821|NCT02392507|54220614|FG000|Induction Regimen|Withdrawal by Subject|2|||
27767822|NCT02392507|54220614|FG000|Maintenance Regimen|Death|1|||
27767823|NCT02392507|54220614|FG000|Maintenance Regimen|On Study Treatment at Study Conclusion|1|||
27767824|NCT02386345|54220623|FG000|Overall Study|Not treated|14|||
27767825|NCT02386345|54220623|FG000|Overall Study|Lost to Follow-up|1|||
27767826|NCT02386345|54220623|FG000|Overall Study|Adverse Event|5|||
27767827|NCT02386345|54220623|FG000|Overall Study|Repeat Procedure|10|||
27767828|NCT02386345|54220623|FG000|Overall Study|Did not complete 12-month follow-up|72|||
27767829|NCT01651117|54220631|FG000|Overall Study|Death|2|||
27767830|NCT01651117|54220632|FG001|Overall Study|Death|3|||
27767831|NCT01651117|54220633|FG002|Overall Study|Death|2|||
27767832|NCT01651117|54220634|FG003|Overall Study|Death|2|||
27767833|NCT02386189|54220649|FG000|Overall Study|Lost to Follow-up|2|||
27767834|NCT02386189|54220650|FG001|Overall Study|Lost to Follow-up|3|||
27767835|NCT02386189|54220649|FG000|Overall Study|Withdrawal by Subject|1|||
27767836|NCT02386189|54220650|FG001|Overall Study|Withdrawal by Subject|0|||
27767837|NCT02386189|54220649|FG000|Overall Study|Death|1|||
27767838|NCT02386189|54220650|FG001|Overall Study|Death|0|||
27767839|NCT02385799|54220658|FG000|Overall Study|Lost to Follow-up|1|||
27767840|NCT02385799|54220659|FG001|Overall Study|Lost to Follow-up|2|||
27767841|NCT02385799|54220658|FG000|Overall Study|Adverse Event|4|||
27767842|NCT02385799|54220659|FG001|Overall Study|Adverse Event|2|||
27767843|NCT02385799|54220658|FG000|Overall Study|Withdrawal by Subject|0|||
27767844|NCT02385799|54220659|FG001|Overall Study|Withdrawal by Subject|4|||
27767845|NCT02422303|54220667|FG000|Overall Study|Lost to Follow-up|1|||
27767846|NCT02422303|54220668|FG001|Overall Study|Lost to Follow-up|1|||
27767847|NCT02392195|54220674|FG000|Overall Study|Lost to Follow-up|4|||
27767848|NCT02392195|54220674|FG000|Overall Study|Withdrawal by Subject|4|||
27767849|NCT02391961|54220680|FG000|First Intervention (4 Weeks)|Adverse Event|2|||
27767850|NCT02391961|54220681|FG001|First Intervention (4 Weeks)|Adverse Event|0|||
27767851|NCT02391961|54220680|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
27767852|NCT02391961|54220681|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
27767853|NCT02391961|54220680|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
27767854|NCT02391961|54220681|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
27767855|NCT02384941|54220690|FG000|Overall Study|Adverse Event|11|||
27767856|NCT02384941|54220691|FG001|Overall Study|Adverse Event|13|||
27767857|NCT02384941|54220692|FG002|Overall Study|Adverse Event|17|||
27767858|NCT02384941|54220690|FG000|Overall Study|Lost to Follow-up|3|||
27767859|NCT02384941|54220691|FG001|Overall Study|Lost to Follow-up|2|||
27767860|NCT02384941|54220692|FG002|Overall Study|Lost to Follow-up|1|||
27767861|NCT02384941|54220690|FG000|Overall Study|Non-Compliance With Study Drug|2|||
27767862|NCT02384941|54220691|FG001|Overall Study|Non-Compliance With Study Drug|0|||
27767863|NCT02384941|54220692|FG002|Overall Study|Non-Compliance With Study Drug|1|||
27767864|NCT02384941|54220690|FG000|Overall Study|Physician Decision|1|||
27767865|NCT02384941|54220691|FG001|Overall Study|Physician Decision|1|||
27767866|NCT02384941|54220692|FG002|Overall Study|Physician Decision|0|||
27767867|NCT02384941|54220690|FG000|Overall Study|Protocol Violation|3|||
27767868|NCT02384941|54220691|FG001|Overall Study|Protocol Violation|0|||
27767869|NCT02384941|54220692|FG002|Overall Study|Protocol Violation|0|||
27767870|NCT02384941|54220690|FG000|Overall Study|Withdrawal by Subject|26|||
27767871|NCT02384941|54220691|FG001|Overall Study|Withdrawal by Subject|19|||
27767872|NCT02384941|54220692|FG002|Overall Study|Withdrawal by Subject|20|||
27767873|NCT02384941|54220690|FG000|Overall Study|Pregnancy|0|||
27767874|NCT02384941|54220691|FG001|Overall Study|Pregnancy|0|||
27767875|NCT02384941|54220692|FG002|Overall Study|Pregnancy|1|||
27767876|NCT02384941|54220690|FG000|Overall Study|Other than specified above|4|||
27767877|NCT02384941|54220691|FG001|Overall Study|Other than specified above|0|||
27767878|NCT02384941|54220692|FG002|Overall Study|Other than specified above|1|||
27767879|NCT02384395|54220701|FG000|Overall Study|Physician Decision|4|||
27767880|NCT02384395|54220701|FG000|Overall Study|Withdrawal by Subject|3|||
27767881|NCT02384395|54220701|FG000|Overall Study|Lost to Follow-up|3|||
27767882|NCT02420353|54220707|FG000|Overall Study|Withdrawal by Subject|0|||
27767883|NCT02420353|54220708|FG001|Overall Study|Withdrawal by Subject|1|||
27767884|NCT02391337|54220716|FG000|6 Months Follow-up|Death|5|||
27767885|NCT02391337|54220717|FG001|6 Months Follow-up|Death|4|||
27767886|NCT02391337|54220716|FG000|6 Months Follow-up|Withdrawal by Subject|1|||
27767887|NCT02391337|54220717|FG001|6 Months Follow-up|Withdrawal by Subject|1|||
27767888|NCT02391337|54220716|FG000|12 Months Follow-up|Death|2|||
27767889|NCT02391337|54220717|FG001|12 Months Follow-up|Death|0|||
27767890|NCT02391337|54220716|FG000|12 Months Follow-up|Withdrawal by Subject|0|||
27767891|NCT02391337|54220717|FG001|12 Months Follow-up|Withdrawal by Subject|1|||
27767892|NCT02391337|54220716|FG000|12 Months Follow-up|Lost to Follow-up|0|||
27767893|NCT02391337|54220717|FG001|12 Months Follow-up|Lost to Follow-up|2|||
27767894|NCT02382991|54220725|FG000|Overall Study|Adverse Event|1|||
27767895|NCT02382991|54220726|FG001|Overall Study|Adverse Event|2|||
27767896|NCT02382991|54220725|FG000|Overall Study|Lost to Follow-up|1|||
27767897|NCT02382991|54220726|FG001|Overall Study|Lost to Follow-up|0|||
27767898|NCT02382991|54220725|FG000|Overall Study|Withdrawal by Subject|0|||
27767899|NCT02382991|54220726|FG001|Overall Study|Withdrawal by Subject|1|||
27767900|NCT02390557|54220734|FG000|Wave 2|Survey non-respondent|72|||
27767901|NCT02390557|54220735|FG001|Wave 2|Survey non-respondent|41|||
27767902|NCT02390557|54220736|FG002|Wave 2|Survey non-respondent|23|||
27767903|NCT01649791|54220744|FG000|Overall Study|Disease Progression|2|||
27767904|NCT01649791|54220744|FG000|Overall Study|Adverse Event|1|||
27767905|NCT01649557|54220751|FG000|Overall Study|Lost to Follow-up|5|||
27767906|NCT01649557|54220752|FG001|Overall Study|Lost to Follow-up|0|||
27767907|NCT01649557|54220753|FG002|Overall Study|Lost to Follow-up|3|||
27767908|NCT01649557|54220751|FG000|Overall Study|Adverse Event|7|||
27767909|NCT01649557|54220752|FG001|Overall Study|Adverse Event|5|||
27767910|NCT01649557|54220753|FG002|Overall Study|Adverse Event|1|||
27767911|NCT01649557|54220751|FG000|Overall Study|Met withdrawal criteria|4|||
27767912|NCT01649557|54220752|FG001|Overall Study|Met withdrawal criteria|0|||
27767913|NCT01649557|54220753|FG002|Overall Study|Met withdrawal criteria|0|||
27767914|NCT01649557|54220751|FG000|Overall Study|Physician Decision|8|||
27767915|NCT01649557|54220752|FG001|Overall Study|Physician Decision|2|||
27767916|NCT01649557|54220753|FG002|Overall Study|Physician Decision|1|||
27767917|NCT01649557|54220751|FG000|Overall Study|Withdrawal by Subject|15|||
27767918|NCT01649557|54220752|FG001|Overall Study|Withdrawal by Subject|5|||
27767919|NCT01649557|54220753|FG002|Overall Study|Withdrawal by Subject|4|||
27767920|NCT01649557|54220751|FG000|Overall Study|Protocol deviation|0|||
27767921|NCT01649557|54220752|FG001|Overall Study|Protocol deviation|2|||
27767922|NCT01649557|54220753|FG002|Overall Study|Protocol deviation|0|||
27767923|NCT01649557|54220751|FG000|Overall Study|Lack of Efficacy|5|||
27767924|NCT01649557|54220752|FG001|Overall Study|Lack of Efficacy|0|||
27767925|NCT01649557|54220753|FG002|Overall Study|Lack of Efficacy|0|||
27767926|NCT02390245|54220761|FG000|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|0|||
27767927|NCT02390245|54220762|FG001|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|103|||
27767928|NCT02390245|54220763|FG002|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|104|||
27767929|NCT02390245|54220761|FG000|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|0|||
27767930|NCT02390245|54220762|FG001|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|95|||
27767931|NCT02390245|54220763|FG002|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|106|||
27767932|NCT02390167|54220772|FG000|Overall Study|Lost to Follow-up|1|||
27767933|NCT02347657|54220782|FG000|Overall Study|Physician Decision|0|||
27767934|NCT02347657|54220783|FG001|Overall Study|Physician Decision|1|||
27767935|NCT02347657|54220782|FG000|Overall Study|Adverse Event|8|||
27767936|NCT02347657|54220783|FG001|Overall Study|Adverse Event|4|||
27767937|NCT02347657|54220782|FG000|Overall Study|Withdrawal by Subject|6|||
27767938|NCT02347657|54220783|FG001|Overall Study|Withdrawal by Subject|7|||
27767939|NCT02347657|54220782|FG000|Overall Study|Randomized but not treated|1|||
27767940|NCT02347657|54220783|FG001|Overall Study|Randomized but not treated|0|||
27767941|NCT02347657|54220782|FG000|Overall Study|Other|3|||
27767942|NCT02347657|54220783|FG001|Overall Study|Other|3|||
27767943|NCT02347189|54220790|FG000|Overall Study|No implant attempted of study device|9|||
27767944|NCT02347189|54220790|FG000|Overall Study|No primary outcome data available|2|||
27767945|NCT02382133|54220805|FG000|Overall Study|Death|22|||
27767946|NCT02382133|54220805|FG000|Overall Study|transfer out of ICU|4|||
27767947|NCT02382133|54220805|FG000|Overall Study|Physician Decision|2|||
27767948|NCT02382133|54220805|FG000|Overall Study|arterial catheter loss|4|||
27767949|NCT02382133|54220805|FG000|Overall Study|pressure injury both sites|1|||
27767950|NCT02346877|54220811|FG000|Overall Study|Adverse Event|1|||
27767951|NCT02346877|54220812|FG001|Overall Study|Adverse Event|0|||
27767952|NCT02346877|54220811|FG000|Overall Study|Administrative Decision|1|||
27767953|NCT02346877|54220812|FG001|Overall Study|Administrative Decision|0|||
27767954|NCT02346877|54220811|FG000|Overall Study|Sponsor Decision|12|||
27767955|NCT02346877|54220812|FG001|Overall Study|Sponsor Decision|0|||
27767956|NCT02346877|54220811|FG000|Overall Study|Missing|5|||
27767957|NCT02346877|54220812|FG001|Overall Study|Missing|0|||
27767958|NCT02346721|54220818|FG000|Overall Study|Withdrew Consent|3|||
27767959|NCT02346721|54220818|FG000|Overall Study|Lack of Efficacy|1|||
27767960|NCT02389621|54220826|FG000|Treatment Period|Withdrawal by Subject|1|||
27767961|NCT02389621|54220827|FG001|Treatment Period|Withdrawal by Subject|1|||
27767962|NCT02389621|54220826|FG000|Posttreatment Period|Adverse Event|3|||
27767963|NCT02389621|54220827|FG001|Posttreatment Period|Adverse Event|1|||
27767964|NCT02389621|54220826|FG000|Posttreatment Period|Withdrawal by Subject|3|||
27767965|NCT02389621|54220827|FG001|Posttreatment Period|Withdrawal by Subject|2|||
27767966|NCT02389621|54220826|FG000|Posttreatment Period|Lost to Follow-up|1|||
27767967|NCT02389621|54220827|FG001|Posttreatment Period|Lost to Follow-up|1|||
27767968|NCT02389621|54220826|FG000|Posttreatment Period|Other - Miscellaneous|2|||
27767969|NCT02389621|54220827|FG001|Posttreatment Period|Other - Miscellaneous|0|||
27767970|NCT02388997|54220839|FG000|Overall Study|Adverse Event|1|||
27767971|NCT02388997|54220840|FG001|Overall Study|Adverse Event|2|||
27767972|NCT02388997|54220839|FG000|Overall Study|Withdrawal by Subject|2|||
27767973|NCT02388997|54220840|FG001|Overall Study|Withdrawal by Subject|1|||
27767974|NCT02388997|54220839|FG000|Overall Study|Lung function exclusion criteria|0|||
27767975|NCT02388997|54220840|FG001|Overall Study|Lung function exclusion criteria|2|||
27767976|NCT02388997|54220839|FG000|Overall Study|Tested positive for virus during run-in|0|||
27767977|NCT02388997|54220840|FG001|Overall Study|Tested positive for virus during run-in|1|||
27767978|NCT02388763|54220846|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
27767979|NCT02388763|54220847|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
27767980|NCT02388763|54220846|FG000|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
27767981|NCT02388763|54220847|FG001|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
27767982|NCT02388295|54220859|FG000|Dose Escalation Week 1|Adverse Event|1|||
27767983|NCT02388295|54220860|FG001|Dose Escalation Week 1|Adverse Event|2|||
27767984|NCT02388295|54220861|FG002|Dose Escalation Week 1|Adverse Event|1|||
27767985|NCT02388295|54220859|FG000|Dose Escalation Week 1|Determined not eligible|1|||
27767986|NCT02388295|54220860|FG001|Dose Escalation Week 1|Determined not eligible|1|||
27767987|NCT02388295|54220861|FG002|Dose Escalation Week 1|Determined not eligible|1|||
27767988|NCT02388295|54220859|FG000|Dose Escalation Week 2|Protocol Violation|0|||
27767989|NCT02388295|54220860|FG001|Dose Escalation Week 2|Protocol Violation|1|||
27767990|NCT02388295|54220861|FG002|Dose Escalation Week 2|Protocol Violation|0|||
27767991|NCT02388295|54220859|FG000|Dose Escalation Week 2|Determined not eligible|1|||
27767992|NCT02388295|54220860|FG001|Dose Escalation Week 2|Determined not eligible|1|||
27767993|NCT02388295|54220861|FG002|Dose Escalation Week 2|Determined not eligible|1|||
27767994|NCT02388295|54220859|FG000|Treatment Weeks 3 to 12|Adverse Event|1|||
27767995|NCT02388295|54220860|FG001|Treatment Weeks 3 to 12|Adverse Event|1|||
27767996|NCT02388295|54220861|FG002|Treatment Weeks 3 to 12|Adverse Event|0|||
27767997|NCT02345161|54220871|FG000|Overall Study|Withdrawal by Subject|25|||
27767998|NCT02345161|54220872|FG001|Overall Study|Withdrawal by Subject|33|||
27767999|NCT02345161|54220871|FG000|Overall Study|Adverse Event|16|||
27768000|NCT02345161|54220872|FG001|Overall Study|Adverse Event|19|||
27768001|NCT02345161|54220871|FG000|Overall Study|Physician Decision|4|||
27768002|NCT02345161|54220872|FG001|Overall Study|Physician Decision|4|||
27768003|NCT02345161|54220871|FG000|Overall Study|Lost to Follow-up|0|||
27768004|NCT02345161|54220872|FG001|Overall Study|Lost to Follow-up|1|||
27768005|NCT02251275|54220888|FG000|Overall Study|Adverse Event|23|||
27768006|NCT02251275|54220889|FG001|Overall Study|Adverse Event|60|||
27768007|NCT02251275|54220890|FG002|Overall Study|Adverse Event|28|||
27768008|NCT02251275|54220891|FG003|Overall Study|Adverse Event|0|||
27768009|NCT02251275|54220892|FG004|Overall Study|Adverse Event|0|||
27768010|NCT02251275|54220888|FG000|Overall Study|Lost to Follow-up|5|||
27768011|NCT02251275|54220889|FG001|Overall Study|Lost to Follow-up|6|||
27768012|NCT02251275|54220890|FG002|Overall Study|Lost to Follow-up|4|||
27768013|NCT02251275|54220891|FG003|Overall Study|Lost to Follow-up|0|||
27768014|NCT02251275|54220892|FG004|Overall Study|Lost to Follow-up|0|||
27768015|NCT02251275|54220888|FG000|Overall Study|Physician Decision|19|||
27768016|NCT02251275|54220889|FG001|Overall Study|Physician Decision|30|||
27768017|NCT02251275|54220890|FG002|Overall Study|Physician Decision|26|||
27768018|NCT02251275|54220891|FG003|Overall Study|Physician Decision|0|||
27768019|NCT02251275|54220892|FG004|Overall Study|Physician Decision|1|||
27768020|NCT02251275|54220888|FG000|Overall Study|Protocol Deviation|0|||
27768021|NCT02251275|54220889|FG001|Overall Study|Protocol Deviation|0|||
27768022|NCT02251275|54220890|FG002|Overall Study|Protocol Deviation|1|||
27768023|NCT02251275|54220891|FG003|Overall Study|Protocol Deviation|0|||
27768024|NCT02251275|54220892|FG004|Overall Study|Protocol Deviation|0|||
27768025|NCT02251275|54220888|FG000|Overall Study|Withdrawal by Subject|25|||
27768026|NCT02251275|54220889|FG001|Overall Study|Withdrawal by Subject|51|||
27768027|NCT02251275|54220890|FG002|Overall Study|Withdrawal by Subject|35|||
27768028|NCT02251275|54220891|FG003|Overall Study|Withdrawal by Subject|1|||
27768029|NCT02251275|54220892|FG004|Overall Study|Withdrawal by Subject|0|||
27768030|NCT02379637|54220906|FG000|Overall Study|Protocol Violation|0|||
27768031|NCT02379637|54220907|FG001|Overall Study|Protocol Violation|1|||
27768032|NCT02379637|54220906|FG000|Overall Study|Adverse Event|1|||
27768033|NCT02379637|54220907|FG001|Overall Study|Adverse Event|0|||
27768034|NCT02379637|54220906|FG000|Overall Study|Withdrawal by Subject|1|||
27768035|NCT02379637|54220907|FG001|Overall Study|Withdrawal by Subject|0|||
27768036|NCT02195583|54220913|FG000|Overall Study|Lost to Follow-up|1|||
27768037|NCT02195583|54220913|FG000|Overall Study|Withdrawal by Subject|4|||
27768038|NCT02195583|54220913|FG000|Overall Study|Adverse Event|2|||
27768039|NCT02195583|54220913|FG000|Overall Study|Other Reason|2|||
27768040|NCT02379091|54220932|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
27768041|NCT02379091|54220933|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
27768042|NCT02379091|54220934|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
27768043|NCT02379091|54220935|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
27768044|NCT02379091|54220932|FG000|Overall Study|Principal Investigator Discretion|0|||
27768045|NCT02379091|54220933|FG001|Overall Study|Principal Investigator Discretion|1|||
27768046|NCT02379091|54220934|FG002|Overall Study|Principal Investigator Discretion|0|||
27768047|NCT02379091|54220935|FG003|Overall Study|Principal Investigator Discretion|0|||
27768048|NCT02379091|54220932|FG000|Overall Study|Lost to Follow-up|0|||
27768049|NCT02379091|54220933|FG001|Overall Study|Lost to Follow-up|0|||
27768050|NCT02379091|54220934|FG002|Overall Study|Lost to Follow-up|0|||
27768051|NCT02379091|54220935|FG003|Overall Study|Lost to Follow-up|1|||
27768052|NCT02379091|54220932|FG000|Overall Study|Voluntary Withdrawal|2|||
27768053|NCT02379091|54220933|FG001|Overall Study|Voluntary Withdrawal|5|||
27768054|NCT02379091|54220934|FG002|Overall Study|Voluntary Withdrawal|2|||
27768055|NCT02379091|54220935|FG003|Overall Study|Voluntary Withdrawal|4|||
27768056|NCT02379091|54220932|FG000|Overall Study|Study Termination|7|||
27768057|NCT02379091|54220933|FG001|Overall Study|Study Termination|2|||
27768058|NCT02379091|54220934|FG002|Overall Study|Study Termination|5|||
27768059|NCT02379091|54220935|FG003|Overall Study|Study Termination|8|||
27768060|NCT02379091|54220932|FG000|Overall Study|Lack of Efficacy|3|||
27768061|NCT02379091|54220933|FG001|Overall Study|Lack of Efficacy|0|||
27768062|NCT02379091|54220934|FG002|Overall Study|Lack of Efficacy|0|||
27768063|NCT02379091|54220935|FG003|Overall Study|Lack of Efficacy|0|||
27768064|NCT02378935|54220954|FG000|Overall Study|Lack of Efficacy|10|||
27768065|NCT02378935|54220955|FG001|Overall Study|Lack of Efficacy|0|||
27768066|NCT02378935|54220956|FG002|Overall Study|Lack of Efficacy|2|||
27768067|NCT02378935|54220957|FG003|Overall Study|Lack of Efficacy|6|||
27768068|NCT02378935|54220958|FG004|Overall Study|Lack of Efficacy|0|||
27768069|NCT02378935|54220959|FG005|Overall Study|Lack of Efficacy|0|||
27768070|NCT02378935|54220960|FG006|Overall Study|Lack of Efficacy|0|||
27768071|NCT02378935|54220954|FG000|Overall Study|Death|0|||
27768072|NCT02378935|54220955|FG001|Overall Study|Death|0|||
27768073|NCT02378935|54220956|FG002|Overall Study|Death|1|||
27768074|NCT02378935|54220957|FG003|Overall Study|Death|0|||
27768075|NCT02378935|54220958|FG004|Overall Study|Death|0|||
27768076|NCT02378935|54220959|FG005|Overall Study|Death|0|||
27768077|NCT02378935|54220960|FG006|Overall Study|Death|0|||
27768078|NCT02250651|54220979|FG000|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|0|||
27768079|NCT02250651|54220980|FG001|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
27768080|NCT02250651|54220981|FG002|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
27768081|NCT02250651|54220979|FG000|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
27768082|NCT02250651|54220980|FG001|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
27768083|NCT02250651|54220981|FG002|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
27768084|NCT02250651|54220979|FG000|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|2|||
27768085|NCT02250651|54220980|FG001|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|3|||
27768086|NCT02250651|54220981|FG002|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|5|||
27768087|NCT02250651|54220979|FG000|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|1|||
27768088|NCT02250651|54220980|FG001|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
27768089|NCT02250651|54220981|FG002|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
27768090|NCT02250651|54220979|FG000|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
27768091|NCT02250651|54220980|FG001|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
27768092|NCT02250651|54220981|FG002|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|1|||
27768093|NCT02250651|54220979|FG000|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
27768094|NCT02250651|54220980|FG001|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|1|||
27768095|NCT02250651|54220981|FG002|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|3|||
27768096|NCT02250651|54220979|FG000|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|4|||
27768097|NCT02250651|54220980|FG001|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|1|||
27768098|NCT02250651|54220981|FG002|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|0|||
27768099|NCT02250651|54220979|FG000|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
27768100|NCT02250651|54220980|FG001|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
27768101|NCT02250651|54220981|FG002|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|3|||
27768102|NCT02250651|54220979|FG000|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
27768103|NCT02250651|54220980|FG001|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|3|||
27768104|NCT02250651|54220981|FG002|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
27768105|NCT02250651|54220979|FG000|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
27768106|NCT02250651|54220980|FG001|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|1|||
27768107|NCT02250651|54220981|FG002|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
27768108|NCT02250651|54220979|FG000|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
27768109|NCT02250651|54220980|FG001|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|1|||
27831215|NCT01792115|54307530|FG002|Overall Study|Lost to Follow-up|0|||
27768110|NCT02250651|54220981|FG002|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
27768111|NCT02250651|54220979|FG000|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|4|||
27768112|NCT02250651|54220980|FG001|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
27768113|NCT02250651|54220981|FG002|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
27768114|NCT02250651|54220979|FG000|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
27768115|NCT02250651|54220980|FG001|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|2|||
27768116|NCT02250651|54220981|FG002|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
27768117|NCT02250651|54220979|FG000|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
27768118|NCT02250651|54220980|FG001|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|0|||
27768119|NCT02250651|54220981|FG002|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
27768120|NCT02250651|54220979|FG000|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|2|||
27768121|NCT02250651|54220980|FG001|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
27768122|NCT02250651|54220981|FG002|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
27768123|NCT02377921|54220991|FG000|Overall Study|Subject non-compliance|1|||
27768124|NCT02377921|54220992|FG001|Overall Study|Subject non-compliance|1|||
27768125|NCT02311153|54221000|FG000|Overall Study|Lost to Follow-up|5|||
27768126|NCT02311153|54221001|FG001|Overall Study|Lost to Follow-up|7|||
27768127|NCT02195427|54221009|FG000|Overall Study|Did not consent to study extension|13|||
27768128|NCT02195427|54221010|FG001|Overall Study|Did not consent to study extension|9|||
27768129|NCT02195427|54221009|FG000|Overall Study|Withdrawal by Subject|4|||
27768130|NCT02195427|54221010|FG001|Overall Study|Withdrawal by Subject|2|||
27768131|NCT02195427|54221009|FG000|Overall Study|Lost to Follow-up|0|||
27768132|NCT02195427|54221010|FG001|Overall Study|Lost to Follow-up|1|||
27768133|NCT02195427|54221009|FG000|Overall Study|Protocol Violation|7|||
27768134|NCT02195427|54221010|FG001|Overall Study|Protocol Violation|14|||
27768135|NCT02195427|54221009|FG000|Overall Study|Conditional re-treatment at W52|2|||
27768136|NCT02195427|54221010|FG001|Overall Study|Conditional re-treatment at W52|1|||
27768137|NCT02214225|54221023|FG000|Overall Study|Lost to Follow-up|46|||
27768138|NCT02214225|54221024|FG001|Overall Study|Lost to Follow-up|18|||
27768139|NCT02214225|54221025|FG002|Overall Study|Lost to Follow-up|18|||
27768140|NCT02214225|54221023|FG000|Overall Study|Withdrawal by Subject|2|||
27768141|NCT02214225|54221024|FG001|Overall Study|Withdrawal by Subject|0|||
27768142|NCT02214225|54221025|FG002|Overall Study|Withdrawal by Subject|2|||
27768143|NCT02214225|54221023|FG000|Overall Study|Death|5|||
27768144|NCT02214225|54221024|FG001|Overall Study|Death|0|||
27768145|NCT02214225|54221025|FG002|Overall Study|Death|1|||
27768146|NCT02214225|54221023|FG000|Overall Study|randomized in error, not vaccinated|2|||
27768147|NCT02214225|54221024|FG001|Overall Study|randomized in error, not vaccinated|1|||
27768148|NCT02214225|54221025|FG002|Overall Study|randomized in error, not vaccinated|1|||
27768149|NCT02250183|54221056|FG000|Overall Study|Withdrawal by Subject|2|||
27768150|NCT02250183|54221056|FG000|Overall Study|Adverse Event|5|||
27768151|NCT02250183|54221056|FG000|Overall Study|Lost to Follow-up|1|||
27768152|NCT02249949|54221063|FG000|Overall Study|Cancelled prior to treatment|2|||
27768153|NCT02249091|54221069|FG000|Overall Study|Lack of Efficacy|8|||
27768154|NCT02249091|54221070|FG001|Overall Study|Lack of Efficacy|3|||
27768155|NCT02249091|54221069|FG000|Overall Study|Physician Decision|4|||
27768156|NCT02249091|54221070|FG001|Overall Study|Physician Decision|1|||
27768157|NCT02249091|54221069|FG000|Overall Study|Withdrawal by Subject|2|||
27768158|NCT02249091|54221070|FG001|Overall Study|Withdrawal by Subject|2|||
27768159|NCT02249091|54221069|FG000|Overall Study|Death|3|||
27768160|NCT02249091|54221070|FG001|Overall Study|Death|4|||
27768161|NCT02249091|54221069|FG000|Overall Study|Adverse Event|1|||
27768162|NCT02249091|54221070|FG001|Overall Study|Adverse Event|0|||
27768163|NCT02249091|54221069|FG000|Overall Study|Stable disease with following SCT|0|||
27768164|NCT02249091|54221070|FG001|Overall Study|Stable disease with following SCT|1|||
27768165|NCT02249091|54221069|FG000|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|0|||
27768166|NCT02249091|54221070|FG001|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|1|||
27768167|NCT02249091|54221069|FG000|Overall Study|CR with subsequent donor lymphocyte infusion|1|||
27768168|NCT02249091|54221070|FG001|Overall Study|CR with subsequent donor lymphocyte infusion|0|||
27768169|NCT02249091|54221069|FG000|Overall Study|Refractory AML|1|||
27768170|NCT02249091|54221070|FG001|Overall Study|Refractory AML|1|||
27768171|NCT02248857|54221079|FG000|3 Month|Withdrawal by Subject|9|||
27768172|NCT02248857|54221080|FG001|3 Month|Withdrawal by Subject|3|||
27768173|NCT02248857|54221081|FG002|3 Month|Withdrawal by Subject|4|||
27768174|NCT02248857|54221079|FG000|3 Month|Unable to reach for 3 month|35|||
27768175|NCT02248857|54221080|FG001|3 Month|Unable to reach for 3 month|29|||
27768176|NCT02248857|54221081|FG002|3 Month|Unable to reach for 3 month|26|||
27768177|NCT02248857|54221079|FG000|3 Month|Partially completed, unable to finish|2|||
27768178|NCT02248857|54221080|FG001|3 Month|Partially completed, unable to finish|2|||
27768179|NCT02248857|54221081|FG002|3 Month|Partially completed, unable to finish|1|||
27768180|NCT02248857|54221079|FG000|6 Month|Lost to Follow-up|27|||
27768181|NCT02248857|54221080|FG001|6 Month|Lost to Follow-up|26|||
27768182|NCT02248857|54221081|FG002|6 Month|Lost to Follow-up|15|||
27768183|NCT02248857|54221079|FG000|6 Month|Partially completed, unable to finish|0|||
27768184|NCT02248857|54221080|FG001|6 Month|Partially completed, unable to finish|1|||
27768185|NCT02248857|54221081|FG002|6 Month|Partially completed, unable to finish|0|||
27768186|NCT02248857|54221079|FG000|6 Month|Withdrawal by Subject|0|||
27768187|NCT02248857|54221080|FG001|6 Month|Withdrawal by Subject|2|||
27768188|NCT02248857|54221081|FG002|6 Month|Withdrawal by Subject|2|||
27768189|NCT02248857|54221079|FG000|6 Month|Death|1|||
27768190|NCT02248857|54221080|FG001|6 Month|Death|0|||
27768191|NCT02248857|54221081|FG002|6 Month|Death|0|||
27768192|NCT02213055|54221091|FG000|Overall Study|Protocol was not Followed at Enrollment|5|||
27768193|NCT02213055|54221092|FG001|Overall Study|Protocol was not Followed at Enrollment|0|||
27768194|NCT02213055|54221091|FG000|Overall Study|Protocol was not Followed during Study|1|||
27768195|NCT02213055|54221092|FG001|Overall Study|Protocol was not Followed during Study|0|||
27768196|NCT02213055|54221091|FG000|Overall Study|Documentation Issue at Enrollment|1|||
27768197|NCT02213055|54221092|FG001|Overall Study|Documentation Issue at Enrollment|0|||
27768198|NCT02213055|54221091|FG000|Overall Study|Documentation Issue during Study|10|||
27768199|NCT02213055|54221092|FG001|Overall Study|Documentation Issue during Study|0|||
27768200|NCT02213055|54221091|FG000|Overall Study|Did not have Live Lice|8|||
27768201|NCT02213055|54221092|FG001|Overall Study|Did not have Live Lice|0|||
27768202|NCT02213055|54221091|FG000|Overall Study|Had another Treatment during the Study|3|||
27768203|NCT02213055|54221092|FG001|Overall Study|Had another Treatment during the Study|0|||
27768204|NCT02213055|54221091|FG000|Overall Study|Did not meet Inclusion Criteria|6|||
27768205|NCT02213055|54221092|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
27768206|NCT02213055|54221091|FG000|Overall Study|Did not Return to School|5|||
27768207|NCT02213055|54221092|FG001|Overall Study|Did not Return to School|0|||
27768208|NCT02310763|54221101|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
27768209|NCT02310763|54221102|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
27768210|NCT02310763|54221103|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
27768211|NCT02310763|54221101|FG000|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0|||
27768212|NCT02310763|54221102|FG001|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
27768213|NCT02310763|54221103|FG002|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
27768214|NCT02310763|54221101|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1|||
27768215|NCT02310763|54221102|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
27768216|NCT02310763|54221103|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
27768217|NCT02310763|54221101|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|1|||
27768218|NCT02310763|54221102|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
27768219|NCT02310763|54221103|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
27768220|NCT02310763|54221101|FG000|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
27768221|NCT02310763|54221102|FG001|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
27768222|NCT02310763|54221103|FG002|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
27768223|NCT02342743|54221129|FG000|Baseline Period|Withdrawal by Subject|3|||
27768224|NCT02342743|54221129|FG000|Baseline Period|Lost to Follow-up|2|||
27768225|NCT02342743|54221129|FG000|Baseline Period|Change in prophylactic medication|3|||
27768226|NCT02342743|54221129|FG000|Baseline Period|Screening failure regarding baseline|7|||
27768227|NCT02342743|54221129|FG000|Treatment Period|Withdrawal by Subject|2|||
27768228|NCT02342743|54221129|FG000|Treatment Period|Lost to Follow-up|8|||
27768229|NCT02342743|54221129|FG000|Treatment Period|Change in prophylactic medication|1|||
27768230|NCT02377063|54221133|FG000|Overall Study|Non-compliance|5|||
27768231|NCT02309515|54221139|FG000|Overall Study|Withdrawal by Subject|0|||
27768232|NCT02309515|54221140|FG001|Overall Study|Withdrawal by Subject|1|||
27768233|NCT02309359|54221151|FG000|Overall Study|Adverse Event|4|||
27768234|NCT02309359|54221152|FG001|Overall Study|Adverse Event|5|||
27768235|NCT02309359|54221153|FG002|Overall Study|Adverse Event|5|||
27768236|NCT02309359|54221154|FG003|Overall Study|Adverse Event|4|||
27768237|NCT02309359|54221155|FG004|Overall Study|Adverse Event|4|||
27768238|NCT02309359|54221151|FG000|Overall Study|Death|1|||
27768239|NCT02309359|54221152|FG001|Overall Study|Death|0|||
27768240|NCT02309359|54221153|FG002|Overall Study|Death|0|||
27768241|NCT02309359|54221154|FG003|Overall Study|Death|0|||
27768242|NCT02309359|54221155|FG004|Overall Study|Death|0|||
27768243|NCT02309359|54221151|FG000|Overall Study|Withdrawal by Subject|2|||
27768244|NCT02309359|54221152|FG001|Overall Study|Withdrawal by Subject|2|||
27768245|NCT02309359|54221153|FG002|Overall Study|Withdrawal by Subject|4|||
27768246|NCT02309359|54221154|FG003|Overall Study|Withdrawal by Subject|4|||
27768247|NCT02309359|54221155|FG004|Overall Study|Withdrawal by Subject|0|||
27768248|NCT02309359|54221151|FG000|Overall Study|Lack of Efficacy|3|||
27768249|NCT02309359|54221152|FG001|Overall Study|Lack of Efficacy|1|||
27768250|NCT02309359|54221153|FG002|Overall Study|Lack of Efficacy|0|||
27768251|NCT02309359|54221154|FG003|Overall Study|Lack of Efficacy|0|||
27768252|NCT02309359|54221155|FG004|Overall Study|Lack of Efficacy|3|||
27768253|NCT02309359|54221151|FG000|Overall Study|Lost to Follow-up|0|||
27768254|NCT02309359|54221152|FG001|Overall Study|Lost to Follow-up|0|||
27768255|NCT02309359|54221153|FG002|Overall Study|Lost to Follow-up|0|||
27839766|NCT01693562|54327122|FG011|Escalation Phase|Other|0|||
27839767|NCT01693562|54327123|FG012|Escalation Phase|Other|0|||
27839768|NCT01693562|54327124|FG013|Escalation Phase|Other|0|||
27768256|NCT02309359|54221154|FG003|Overall Study|Lost to Follow-up|1|||
27768257|NCT02309359|54221155|FG004|Overall Study|Lost to Follow-up|0|||
27768258|NCT02309359|54221151|FG000|Overall Study|Other|2|||
27768259|NCT02309359|54221152|FG001|Overall Study|Other|0|||
27768260|NCT02309359|54221153|FG002|Overall Study|Other|2|||
27768261|NCT02309359|54221154|FG003|Overall Study|Other|3|||
27768262|NCT02309359|54221155|FG004|Overall Study|Other|2|||
27768263|NCT02247531|54221171|FG000|Overall Study|Adverse Event|3|||
27768264|NCT02247531|54221172|FG001|Overall Study|Adverse Event|4|||
27768265|NCT02247531|54221173|FG002|Overall Study|Adverse Event|9|||
27768266|NCT02247531|54221171|FG000|Overall Study|Death|8|||
27768267|NCT02247531|54221172|FG001|Overall Study|Death|9|||
27768268|NCT02247531|54221173|FG002|Overall Study|Death|5|||
27768269|NCT02247531|54221171|FG000|Overall Study|Lost to Follow-up|1|||
27768270|NCT02247531|54221172|FG001|Overall Study|Lost to Follow-up|8|||
27768271|NCT02247531|54221173|FG002|Overall Study|Lost to Follow-up|3|||
27768272|NCT02247531|54221171|FG000|Overall Study|Non-compliance|2|||
27768273|NCT02247531|54221172|FG001|Overall Study|Non-compliance|2|||
27768274|NCT02247531|54221173|FG002|Overall Study|Non-compliance|0|||
27768275|NCT02247531|54221171|FG000|Overall Study|Withdrawal by Subject|26|||
27768276|NCT02247531|54221172|FG001|Overall Study|Withdrawal by Subject|31|||
27768277|NCT02247531|54221173|FG002|Overall Study|Withdrawal by Subject|25|||
27768278|NCT02247531|54221171|FG000|Overall Study|Study Terminated by Sponsor|64|||
27768279|NCT02247531|54221172|FG001|Overall Study|Study Terminated by Sponsor|66|||
27768280|NCT02247531|54221173|FG002|Overall Study|Study Terminated by Sponsor|62|||
27768281|NCT02247531|54221171|FG000|Overall Study|Physician Decision|0|||
27768282|NCT02247531|54221172|FG001|Overall Study|Physician Decision|2|||
27768283|NCT02247531|54221173|FG002|Overall Study|Physician Decision|2|||
27768284|NCT02247531|54221171|FG000|Overall Study|Unspecified Reason|2|||
27768285|NCT02247531|54221172|FG001|Overall Study|Unspecified Reason|3|||
27768286|NCT02247531|54221173|FG002|Overall Study|Unspecified Reason|4|||
27768287|NCT02375971|54221184|FG000|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
27768288|NCT02375971|54221185|FG001|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
27768289|NCT02375971|54221186|FG002|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2|||
27768290|NCT02375971|54221184|FG000|Treatment (Day 1 - Baseline)|Physician Decision|1|||
27768291|NCT02375971|54221185|FG001|Treatment (Day 1 - Baseline)|Physician Decision|1|||
27768292|NCT02375971|54221186|FG002|Treatment (Day 1 - Baseline)|Physician Decision|1|||
27768293|NCT02375971|54221184|FG000|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
27768294|NCT02375971|54221185|FG001|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
27768295|NCT02375971|54221186|FG002|Treatment (Day 1 - Baseline)|Lost to Follow-up|1|||
27768296|NCT02375971|54221184|FG000|Treatment (Day 1 - Baseline)|Adverse Event|0|||
27768297|NCT02375971|54221185|FG001|Treatment (Day 1 - Baseline)|Adverse Event|0|||
27768298|NCT02375971|54221186|FG002|Treatment (Day 1 - Baseline)|Adverse Event|1|||
27768299|NCT02375971|54221184|FG000|Follow-Up Phase (up to Day 169)|Adverse Event|1|||
27768300|NCT02375971|54221185|FG001|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
27768301|NCT02375971|54221186|FG002|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
27768302|NCT02375971|54221184|FG000|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
27768303|NCT02375971|54221185|FG001|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0|||
27768304|NCT02375971|54221186|FG002|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
27768305|NCT02375971|54221184|FG000|Follow-Up Phase (up to Day 169)|Death|4|||
27768306|NCT02375971|54221185|FG001|Follow-Up Phase (up to Day 169)|Death|4|||
27768307|NCT02375971|54221186|FG002|Follow-Up Phase (up to Day 169)|Death|4|||
27768308|NCT02375971|54221184|FG000|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
27768309|NCT02375971|54221185|FG001|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
27768310|NCT02375971|54221186|FG002|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0|||
27768311|NCT02308735|54221198|FG000|Overall Study|Physician Decision|2|||
27768312|NCT02308735|54221199|FG001|Overall Study|Physician Decision|0|||
27768313|NCT02308735|54221200|FG002|Overall Study|Physician Decision|0|||
27768314|NCT02308735|54221201|FG003|Overall Study|Physician Decision|2|||
27768315|NCT02212197|54221214|FG000|Overall Study|Need for radiotherapy|1|||
27768316|NCT02212197|54221215|FG001|Overall Study|Need for radiotherapy|0|||
27768317|NCT02212197|54221216|FG002|Overall Study|Need for radiotherapy|0|||
27768318|NCT02193165|54221227|FG000|4 Week Product Use|Lost to Follow-up|1|||
27768319|NCT02193165|54221228|FG001|4 Week Product Use|Lost to Follow-up|1|||
27768320|NCT02193165|54221229|FG002|4 Week Product Use|Lost to Follow-up|1|||
27768321|NCT02193165|54221227|FG000|6 Week Product Use|Lost to Follow-up|0|||
27768322|NCT02193165|54221228|FG001|6 Week Product Use|Lost to Follow-up|1|||
27768323|NCT02193165|54221229|FG002|6 Week Product Use|Lost to Follow-up|0|||
27768324|NCT01617460|54221237|FG000|Overall Study|Adverse Event|10|||
27768325|NCT01617460|54221237|FG000|Overall Study|Physician Decision|16|||
27768326|NCT01617460|54221237|FG000|Overall Study|Protocol Violation|5|||
27768327|NCT01617460|54221237|FG000|Overall Study|Withdrawal by Subject|9|||
27768328|NCT01890148|54221241|FG000|Overall Study|Adverse Event|1|||
27768329|NCT01889602|54221248|FG000|First Intervention|Adverse Event|1|||
27768330|NCT01889602|54221249|FG001|First Intervention|Adverse Event|1|||
27768331|NCT01889602|54221250|FG002|First Intervention|Adverse Event|1|||
27768332|NCT01889602|54221248|FG000|First Intervention|Protocol Violation|0|||
27768333|NCT01889602|54221249|FG001|First Intervention|Protocol Violation|1|||
27768334|NCT01889602|54221250|FG002|First Intervention|Protocol Violation|1|||
27768335|NCT01889602|54221248|FG000|First Intervention|Study ending|0|||
27768336|NCT01889602|54221249|FG001|First Intervention|Study ending|1|||
27768337|NCT01889602|54221250|FG002|First Intervention|Study ending|0|||
27768338|NCT01889602|54221248|FG000|Second Intervention|Adverse Event|0|||
27768339|NCT01889602|54221249|FG001|Second Intervention|Adverse Event|0|||
27768340|NCT01889602|54221250|FG002|Second Intervention|Adverse Event|1|||
27768341|NCT01889602|54221248|FG000|Second Intervention|Study ending|1|||
27768342|NCT01889602|54221249|FG001|Second Intervention|Study ending|0|||
27768343|NCT01889602|54221250|FG002|Second Intervention|Study ending|0|||
27768344|NCT01889602|54221248|FG000|Second Intervention|Withdrawal by Subject|0|||
27768345|NCT01889602|54221249|FG001|Second Intervention|Withdrawal by Subject|0|||
27768346|NCT01889602|54221250|FG002|Second Intervention|Withdrawal by Subject|1|||
27768347|NCT01889602|54221248|FG000|Third Intervention|Protocol Violation|1|||
27768348|NCT01889602|54221249|FG001|Third Intervention|Protocol Violation|0|||
27768349|NCT01889602|54221250|FG002|Third Intervention|Protocol Violation|0|||
27768350|NCT01889602|54221248|FG000|Third Intervention|Withdrawal by Subject|2|||
27768351|NCT01889602|54221249|FG001|Third Intervention|Withdrawal by Subject|2|||
27768352|NCT01889602|54221250|FG002|Third Intervention|Withdrawal by Subject|0|||
27768353|NCT01935700|54221268|FG000|Overall Study|Withdrawal by Subject|1|||
27768354|NCT01935700|54221269|FG001|Overall Study|Withdrawal by Subject|0|||
27768355|NCT01935700|54221268|FG000|Overall Study|Physician Decision|4|||
27768356|NCT01935700|54221269|FG001|Overall Study|Physician Decision|0|||
27768357|NCT01618162|54221279|FG000|Overall Study|Protocol Violation|13|||
27768358|NCT01618162|54221280|FG001|Overall Study|Protocol Violation|10|||
27768359|NCT01618162|54221279|FG000|Overall Study|Adverse Event|9|||
27768360|NCT01618162|54221280|FG001|Overall Study|Adverse Event|2|||
27768361|NCT01618162|54221279|FG000|Overall Study|Withdrawal Criteria|2|||
27768362|NCT01618162|54221280|FG001|Overall Study|Withdrawal Criteria|10|||
27768363|NCT01618162|54221279|FG000|Overall Study|Unclassified|14|||
27768364|NCT01618162|54221280|FG001|Overall Study|Unclassified|13|||
27768365|NCT02193087|54221290|FG000|Overall Study|Adverse Event|2|||
27768366|NCT02193087|54221291|FG001|Overall Study|Adverse Event|0|||
27768367|NCT02193087|54221292|FG002|Overall Study|Adverse Event|0|||
27768368|NCT02193087|54221293|FG003|Overall Study|Adverse Event|11|||
27768369|NCT02193087|54221290|FG000|Overall Study|Lost to Follow-up|14|||
27768370|NCT02193087|54221291|FG001|Overall Study|Lost to Follow-up|6|||
27768371|NCT02193087|54221292|FG002|Overall Study|Lost to Follow-up|4|||
27768372|NCT02193087|54221293|FG003|Overall Study|Lost to Follow-up|37|||
27768373|NCT02193087|54221290|FG000|Overall Study|Protocol Violation|2|||
27768374|NCT02193087|54221291|FG001|Overall Study|Protocol Violation|0|||
27768375|NCT02193087|54221292|FG002|Overall Study|Protocol Violation|1|||
27768376|NCT02193087|54221293|FG003|Overall Study|Protocol Violation|2|||
27768377|NCT02193087|54221290|FG000|Overall Study|Withdrawal by Subject|10|||
27768378|NCT02193087|54221291|FG001|Overall Study|Withdrawal by Subject|3|||
27768379|NCT02193087|54221292|FG002|Overall Study|Withdrawal by Subject|1|||
27768380|NCT02193087|54221293|FG003|Overall Study|Withdrawal by Subject|19|||
27768381|NCT02193087|54221290|FG000|Overall Study|Other Reason Not Specified|7|||
27768382|NCT02193087|54221291|FG001|Overall Study|Other Reason Not Specified|2|||
27768383|NCT02193087|54221292|FG002|Overall Study|Other Reason Not Specified|1|||
27768384|NCT02193087|54221293|FG003|Overall Study|Other Reason Not Specified|9|||
27768385|NCT02193087|54221290|FG000|Overall Study|Did Not Receive Any Vaccination|2|||
27768386|NCT02193087|54221291|FG001|Overall Study|Did Not Receive Any Vaccination|3|||
27768387|NCT02193087|54221292|FG002|Overall Study|Did Not Receive Any Vaccination|0|||
27768388|NCT02193087|54221293|FG003|Overall Study|Did Not Receive Any Vaccination|1|||
27768389|NCT01617070|54221310|FG000|BH4 and LNAA (4 Weeks)|started medication interfere with study|1|||
27768390|NCT02341417|54221323|FG000|Overall Study|Withdrawal by Subject|0|||
27839769|NCT01693562|54327125|FG014|Escalation Phase|Other|0|||
27839770|NCT01693562|54327126|FG015|Escalation Phase|Other|0|||
27839771|NCT01693562|54327127|FG016|Escalation Phase|Other|0|||
27768391|NCT02341417|54221324|FG001|Overall Study|Withdrawal by Subject|2|||
27768392|NCT02341417|54221325|FG002|Overall Study|Withdrawal by Subject|0|||
27768393|NCT02341417|54221323|FG000|Overall Study|Decision by sponsor|2|||
27768394|NCT02341417|54221324|FG001|Overall Study|Decision by sponsor|0|||
27768395|NCT02341417|54221325|FG002|Overall Study|Decision by sponsor|0|||
27768396|NCT02341417|54221323|FG000|Overall Study|Death|0|||
27768397|NCT02341417|54221324|FG001|Overall Study|Death|0|||
27839772|NCT01693562|54327128|FG017|Escalation Phase|Other|0|||
27768398|NCT02341417|54221325|FG002|Overall Study|Death|1|||
27768399|NCT01888900|54221336|FG000|Overall Study|failed treatment|0|||
27768400|NCT01888900|54221337|FG001|Overall Study|failed treatment|2|||
27768401|NCT02340949|54221347|FG000|Overall Study|Adverse Event|4|||
27768402|NCT02340949|54221348|FG001|Overall Study|Adverse Event|2|||
27768403|NCT02340949|54221347|FG000|Overall Study|Withdrawal by Subject|2|||
27768404|NCT02340949|54221348|FG001|Overall Study|Withdrawal by Subject|0|||
27768405|NCT02340949|54221347|FG000|Overall Study|Progression disease|6|||
27839773|NCT01693562|54327129|FG018|Escalation Phase|Other|0|||
27768406|NCT02340949|54221348|FG001|Overall Study|Progression disease|2|||
27768407|NCT02340949|54221347|FG000|Overall Study|Death|3|||
27768408|NCT02340949|54221348|FG001|Overall Study|Death|0|||
27768409|NCT02340949|54221347|FG000|Overall Study|Physician Decision|1|||
27768410|NCT02340949|54221348|FG001|Overall Study|Physician Decision|0|||
27768411|NCT01646203|54221357|FG000|Overall Study|Adverse Event|2|||
27768412|NCT01646203|54221358|FG001|Overall Study|Adverse Event|0|||
27768413|NCT01646203|54221359|FG002|Overall Study|Adverse Event|1|||
27768414|NCT01646203|54221357|FG000|Overall Study|Withdrawal by Subject|0|||
27768415|NCT01646203|54221358|FG001|Overall Study|Withdrawal by Subject|1|||
27768416|NCT01646203|54221359|FG002|Overall Study|Withdrawal by Subject|0|||
27768417|NCT01646203|54221357|FG000|Overall Study|Physician's Decision|0|||
27768418|NCT01646203|54221358|FG001|Overall Study|Physician's Decision|1|||
27768419|NCT01646203|54221359|FG002|Overall Study|Physician's Decision|0|||
27768420|NCT02375347|54221372|FG000|Overall Study|Protocol Violation|1|||
27768421|NCT02374957|54221378|FG000|Overall Study|Patient did not complete forms correctly|1|||
27768422|NCT02374957|54221379|FG001|Overall Study|Patient did not complete forms correctly|0|||
27768423|NCT02374255|54221389|FG000|Overall Study|Withdrawal by Subject|2|||
27768424|NCT02374255|54221390|FG001|Overall Study|Withdrawal by Subject|0|||
27768425|NCT02374255|54221391|FG002|Overall Study|Withdrawal by Subject|0|||
27768426|NCT02374255|54221392|FG003|Overall Study|Withdrawal by Subject|0|||
27768427|NCT02308033|54221410|FG000|Overall Study|Normal Gram stain at Baseline|13|||
27768428|NCT02308033|54221411|FG001|Overall Study|Normal Gram stain at Baseline|10|||
27768429|NCT02308033|54221410|FG000|Overall Study|Positive for STD at Baseline|7|||
27768430|NCT02308033|54221411|FG001|Overall Study|Positive for STD at Baseline|4|||
27768431|NCT02308033|54221410|FG000|Overall Study|Lost to Follow-up|6|||
27768432|NCT02308033|54221411|FG001|Overall Study|Lost to Follow-up|5|||
27768433|NCT02339155|54221419|FG000|Overall Study|Adverse Event|0|||
27768434|NCT02339155|54221420|FG001|Overall Study|Adverse Event|6|||
27768435|NCT02339155|54221419|FG000|Overall Study|Death|1|||
27768436|NCT02339155|54221420|FG001|Overall Study|Death|1|||
27768437|NCT02339155|54221419|FG000|Overall Study|Lost to Follow-up|8|||
27768438|NCT02339155|54221420|FG001|Overall Study|Lost to Follow-up|9|||
27768439|NCT02339155|54221419|FG000|Overall Study|Physician Decision|2|||
27768440|NCT02339155|54221420|FG001|Overall Study|Physician Decision|1|||
27768441|NCT02339155|54221419|FG000|Overall Study|Withdrawal by Subject|4|||
27768442|NCT02339155|54221420|FG001|Overall Study|Withdrawal by Subject|4|||
27768443|NCT02211261|54221439|FG000|Overall Study|Withdrawal by Subject|0|||
27768444|NCT02211261|54221440|FG001|Overall Study|Withdrawal by Subject|0|||
27768445|NCT02211261|54221441|FG002|Overall Study|Withdrawal by Subject|1|||
27768446|NCT02211261|54221442|FG003|Overall Study|Withdrawal by Subject|0|||
27768447|NCT02211261|54221443|FG004|Overall Study|Withdrawal by Subject|2|||
27768448|NCT02211261|54221444|FG005|Overall Study|Withdrawal by Subject|0|||
27768449|NCT02211261|54221445|FG006|Overall Study|Withdrawal by Subject|0|||
27768450|NCT02211261|54221446|FG007|Overall Study|Withdrawal by Subject|0|||
27768451|NCT02211261|54221447|FG008|Overall Study|Withdrawal by Subject|0|||
27768452|NCT02211261|54221448|FG009|Overall Study|Withdrawal by Subject|0|||
27768453|NCT02211261|54221449|FG010|Overall Study|Withdrawal by Subject|0|||
27768454|NCT02211261|54221439|FG000|Overall Study|Other|0|||
27768455|NCT02211261|54221440|FG001|Overall Study|Other|0|||
27768456|NCT02211261|54221441|FG002|Overall Study|Other|0|||
27768457|NCT02211261|54221442|FG003|Overall Study|Other|0|||
27768458|NCT02211261|54221443|FG004|Overall Study|Other|0|||
27768459|NCT02211261|54221444|FG005|Overall Study|Other|1|||
27768460|NCT02211261|54221445|FG006|Overall Study|Other|0|||
27768461|NCT02211261|54221446|FG007|Overall Study|Other|0|||
27768462|NCT02211261|54221447|FG008|Overall Study|Other|0|||
27768463|NCT02211261|54221448|FG009|Overall Study|Other|2|||
27768464|NCT02211261|54221449|FG010|Overall Study|Other|0|||
27768465|NCT02211261|54221439|FG000|Overall Study|Lost to Follow-up|0|||
27768466|NCT02211261|54221440|FG001|Overall Study|Lost to Follow-up|0|||
27768467|NCT02211261|54221441|FG002|Overall Study|Lost to Follow-up|0|||
27768468|NCT02211261|54221442|FG003|Overall Study|Lost to Follow-up|0|||
27768469|NCT02211261|54221443|FG004|Overall Study|Lost to Follow-up|0|||
27768470|NCT02211261|54221444|FG005|Overall Study|Lost to Follow-up|0|||
27768471|NCT02211261|54221445|FG006|Overall Study|Lost to Follow-up|0|||
27768472|NCT02211261|54221446|FG007|Overall Study|Lost to Follow-up|1|||
27768473|NCT02211261|54221447|FG008|Overall Study|Lost to Follow-up|0|||
27768474|NCT02211261|54221448|FG009|Overall Study|Lost to Follow-up|0|||
27768475|NCT02211261|54221449|FG010|Overall Study|Lost to Follow-up|0|||
27768476|NCT02170077|54221485|FG000|Overall Study|Withdrawal by Subject|3|||
27768477|NCT02170077|54221486|FG001|Overall Study|Withdrawal by Subject|4|||
27768478|NCT02170077|54221487|FG002|Overall Study|Withdrawal by Subject|2|||
27768479|NCT02170077|54221485|FG000|Overall Study|Adverse Event|4|||
27768480|NCT02170077|54221486|FG001|Overall Study|Adverse Event|4|||
27768481|NCT02170077|54221487|FG002|Overall Study|Adverse Event|4|||
27768482|NCT02170077|54221485|FG000|Overall Study|Lost to Follow-up|0|||
27768483|NCT02170077|54221486|FG001|Overall Study|Lost to Follow-up|1|||
27768484|NCT02170077|54221487|FG002|Overall Study|Lost to Follow-up|0|||
27768485|NCT02170077|54221485|FG000|Overall Study|Exclusion criteria|2|||
27768486|NCT02170077|54221486|FG001|Overall Study|Exclusion criteria|2|||
27768487|NCT02170077|54221487|FG002|Overall Study|Exclusion criteria|5|||
27768488|NCT02170077|54221485|FG000|Overall Study|Exacerbation of seizures|0|||
27768489|NCT02170077|54221486|FG001|Overall Study|Exacerbation of seizures|2|||
27768490|NCT02170077|54221487|FG002|Overall Study|Exacerbation of seizures|1|||
27768491|NCT02210091|54221497|FG000|Overall Study|Physician Decision|0|||
27768492|NCT02210091|54221498|FG001|Overall Study|Physician Decision|1|||
27768493|NCT02210091|54221497|FG000|Overall Study|Withdrawal by Sponsor|0|||
27768494|NCT02210091|54221498|FG001|Overall Study|Withdrawal by Sponsor|1|||
27768495|NCT02338999|54221522|FG000|First Intervention|Withdrawal by Subject|3|||
27768496|NCT02338999|54221523|FG001|First Intervention|Withdrawal by Subject|1|||
27768497|NCT02338999|54221522|FG000|Washout Period|Withdrawal by Subject|0|||
27768498|NCT02338999|54221523|FG001|Washout Period|Withdrawal by Subject|2|||
27768499|NCT02338999|54221522|FG000|Second Intervention|Withdrawal by Subject|0|||
27768500|NCT02338999|54221523|FG001|Second Intervention|Withdrawal by Subject|2|||
27768501|NCT02169219|54221529|FG000|Overall Study|Lack of Efficacy|6|||
27768502|NCT02191605|54221543|FG000|Overall Study|Lost to Follow-up|9|||
27768503|NCT02191605|54221544|FG001|Overall Study|Lost to Follow-up|4|||
27768504|NCT02191605|54221545|FG002|Overall Study|Lost to Follow-up|7|||
27768505|NCT02191605|54221546|FG003|Overall Study|Lost to Follow-up|3|||
27768506|NCT02191605|54221547|FG004|Overall Study|Lost to Follow-up|4|||
27768507|NCT02191137|54221559|FG000|Treatment|Death|4|||
27768508|NCT02191137|54221559|FG000|Treatment|Withdrawal by Subject|3|||
27768509|NCT02191137|54221559|FG000|Treatment|Adverse Event|2|||
27768510|NCT02191137|54221559|FG000|Treatment|Other|1|||
27768511|NCT02191137|54221559|FG000|Follow-up|Lost to Follow-up|2|||
27768512|NCT02191137|54221559|FG000|Follow-up|Ongoing/unknown|2|||
27768513|NCT02191137|54221559|FG000|Follow-up|Adverse Event|1|||
27768514|NCT02168439|54221565|FG000|Overall Study|Protocol Violation|0|||
27768515|NCT02168439|54221566|FG001|Overall Study|Protocol Violation|2|||
27768516|NCT02190591|54221574|FG000|Overall Study|Withdrawal by Subject|1|||
27768517|NCT02190591|54221575|FG001|Overall Study|Withdrawal by Subject|8|||
27768518|NCT02190591|54221574|FG000|Overall Study|Protocol Violation|1|||
27768519|NCT02190591|54221575|FG001|Overall Study|Protocol Violation|0|||
27768520|NCT02190591|54221574|FG000|Overall Study|did not use peanut ball as instructed|0|||
27768521|NCT02190591|54221575|FG001|Overall Study|did not use peanut ball as instructed|2|||
27768522|NCT02190591|54221574|FG000|Overall Study|face presentation so she was ineligible|0|||
27768523|NCT02190591|54221575|FG001|Overall Study|face presentation so she was ineligible|1|||
27768524|NCT02190435|54221583|FG000|Overall Study|First 12 patients were lead-ins|12|||
27768525|NCT02190435|54221584|FG001|Overall Study|First 12 patients were lead-ins|0|||
27768526|NCT02190435|54221583|FG000|Overall Study|3 consented screen fails|3|||
27768527|NCT02190435|54221584|FG001|Overall Study|3 consented screen fails|0|||
27768528|NCT02338843|54221592|FG000|Overall Study|Adverse Event|2|||
27768529|NCT02338843|54221593|FG001|Overall Study|Adverse Event|1|||
27768530|NCT02338843|54221592|FG000|Overall Study|Death|40|||
27768531|NCT02338843|54221593|FG001|Overall Study|Death|53|||
27768532|NCT02338843|54221592|FG000|Overall Study|Physician Decision|1|||
27768533|NCT02338843|54221593|FG001|Overall Study|Physician Decision|0|||
27768534|NCT02338843|54221592|FG000|Overall Study|Withdrawal by Subject|0|||
27768535|NCT02338843|54221593|FG001|Overall Study|Withdrawal by Subject|2|||
27768536|NCT02338843|54221592|FG000|Overall Study|Subject Recovered|0|||
27768537|NCT02338843|54221593|FG001|Overall Study|Subject Recovered|2|||
27768538|NCT02338843|54221592|FG000|Overall Study|Discontinued prior to randomizat|1|||
27768539|NCT02338843|54221593|FG001|Overall Study|Discontinued prior to randomizat|0|||
27768540|NCT02190279|54221602|FG000|Overall Study|Withdrawal consent|1|||
27768541|NCT02190279|54221603|FG001|Overall Study|Withdrawal consent|0|||
27768542|NCT02190279|54221604|FG002|Overall Study|Withdrawal consent|1|||
27768543|NCT02190279|54221602|FG000|Overall Study|Lost to Follow-up|2|||
27839774|NCT01693562|54327130|FG019|Escalation Phase|Other|0|||
27839775|NCT01693562|54327131|FG020|Escalation Phase|Other|0|||
27839776|NCT01693562|54327132|FG021|Escalation Phase|Other|0|||
27768544|NCT02190279|54221603|FG001|Overall Study|Lost to Follow-up|0|||
27768545|NCT02190279|54221604|FG002|Overall Study|Lost to Follow-up|0|||
27768546|NCT02190279|54221602|FG000|Overall Study|Refused further treatment|0|||
27768547|NCT02190279|54221603|FG001|Overall Study|Refused further treatment|0|||
27839777|NCT01693562|54327133|FG022|Escalation Phase|Other|0|||
27768548|NCT02190279|54221604|FG002|Overall Study|Refused further treatment|1|||
27839778|NCT01693562|54327111|FG000|Exploration Phase|Withdrawal by Subject|0|||
27839779|NCT01693562|54327112|FG001|Exploration Phase|Withdrawal by Subject|0|||
27768549|NCT02190279|54221602|FG000|Overall Study|Screening failure|0|||
27768550|NCT02190279|54221603|FG001|Overall Study|Screening failure|0|||
27768551|NCT02190279|54221604|FG002|Overall Study|Screening failure|1|||
27768552|NCT02135445|54221616|FG000|Overall Study|Lost to Follow-up|1|||
27768553|NCT02135445|54221617|FG001|Overall Study|Lost to Follow-up|0|||
28159973|NCT02737475|54830048|FG026|Overall Study|Death|0|||
27839780|NCT01693562|54327113|FG002|Exploration Phase|Withdrawal by Subject|0|||
27839781|NCT01693562|54327114|FG003|Exploration Phase|Withdrawal by Subject|0|||
27839782|NCT01693562|54327115|FG004|Exploration Phase|Withdrawal by Subject|0|||
27839783|NCT01693562|54327116|FG005|Exploration Phase|Withdrawal by Subject|0|||
27839784|NCT01693562|54327117|FG006|Exploration Phase|Withdrawal by Subject|2|||
27839785|NCT01693562|54327118|FG007|Exploration Phase|Withdrawal by Subject|0|||
27839786|NCT01693562|54327119|FG008|Exploration Phase|Withdrawal by Subject|0|||
27839787|NCT01693562|54327120|FG009|Exploration Phase|Withdrawal by Subject|0|||
27839788|NCT01693562|54327121|FG010|Exploration Phase|Withdrawal by Subject|0|||
27839789|NCT01693562|54327122|FG011|Exploration Phase|Withdrawal by Subject|0|||
27839790|NCT01693562|54327123|FG012|Exploration Phase|Withdrawal by Subject|0|||
27839791|NCT01693562|54327124|FG013|Exploration Phase|Withdrawal by Subject|0|||
27768554|NCT02135445|54221616|FG000|Overall Study|Withdrawal by Subject|1|||
27768555|NCT02135445|54221617|FG001|Overall Study|Withdrawal by Subject|0|||
27768556|NCT02374099|54221625|FG000|Overall Study|Adverse Event|1|||
27768557|NCT02374099|54221626|FG001|Overall Study|Adverse Event|0|||
27768558|NCT02374099|54221625|FG000|Overall Study|Progressive Disease|35|||
27768559|NCT02374099|54221626|FG001|Overall Study|Progressive Disease|40|||
27768560|NCT02374099|54221625|FG000|Overall Study|Withdrawal by Subject|5|||
27768561|NCT02374099|54221626|FG001|Overall Study|Withdrawal by Subject|1|||
27768562|NCT02374099|54221625|FG000|Overall Study|Miscellaneous|2|||
27768563|NCT02374099|54221626|FG001|Overall Study|Miscellaneous|3|||
27768564|NCT02374099|54221625|FG000|Overall Study|Randomized, but not treated|2|||
27768565|NCT02374099|54221626|FG001|Overall Study|Randomized, but not treated|1|||
27768566|NCT02374099|54221625|FG000|Overall Study|Study Terminated by Sponsor|3|||
27768567|NCT02374099|54221626|FG001|Overall Study|Study Terminated by Sponsor|4|||
27768568|NCT02134977|54221632|FG000|Overall Study|Protocol Deviation|102|||
27768569|NCT02374021|54221638|FG000|Overall Study|Adverse Event|1|||
27768570|NCT02374021|54221639|FG001|Overall Study|Adverse Event|0|||
27768571|NCT02374021|54221638|FG000|Overall Study|Lost to Follow-up|3|||
27768572|NCT02374021|54221639|FG001|Overall Study|Lost to Follow-up|2|||
27768573|NCT02374021|54221638|FG000|Overall Study|Physician Decision|0|||
27768574|NCT02374021|54221639|FG001|Overall Study|Physician Decision|3|||
27768575|NCT02374021|54221638|FG000|Overall Study|Withdrawal by Subject|6|||
27768576|NCT02374021|54221639|FG001|Overall Study|Withdrawal by Subject|5|||
27768577|NCT02374021|54221638|FG000|Overall Study|Poor Adherence|0|||
27768578|NCT02374021|54221639|FG001|Overall Study|Poor Adherence|1|||
27768579|NCT02374021|54221638|FG000|Overall Study|Scan protocol not followed|0|||
27768580|NCT02374021|54221639|FG001|Overall Study|Scan protocol not followed|1|||
27768581|NCT02374021|54221638|FG000|Overall Study|Poor quality scan/scan not able to be analyzed|13|||
27768582|NCT02374021|54221639|FG001|Overall Study|Poor quality scan/scan not able to be analyzed|9|||
27768583|NCT02372383|54221647|FG000|First Intervention (1 Day)|Unable to collect blood|0|||
27768584|NCT02372383|54221648|FG001|First Intervention (1 Day)|Unable to collect blood|1|||
27768585|NCT02372383|54221649|FG002|First Intervention (1 Day)|Unable to collect blood|0|||
27768586|NCT01648699|54221659|FG000|Overall Study|Death|1|||
27768587|NCT01648699|54221659|FG000|Overall Study|Lost to Follow-up|2|||
27768588|NCT01648699|54221659|FG000|Overall Study|Unspecified/unable to complete 4 visits|2|||
27768589|NCT02134353|54221674|FG000|Overall Study|Adverse Event|10|||
27768590|NCT02134353|54221675|FG001|Overall Study|Adverse Event|6|||
27768591|NCT02134353|54221674|FG000|Overall Study|Lost to Follow-up|1|||
27768592|NCT02134353|54221675|FG001|Overall Study|Lost to Follow-up|1|||
27768593|NCT02134353|54221674|FG000|Overall Study|Lack of Efficacy|2|||
27768594|NCT02134353|54221675|FG001|Overall Study|Lack of Efficacy|1|||
27768595|NCT02134353|54221674|FG000|Overall Study|Withdrawal by Subject|12|||
27768596|NCT02134353|54221675|FG001|Overall Study|Withdrawal by Subject|13|||
27768597|NCT02134353|54221674|FG000|Overall Study|Death|0|||
27768598|NCT02134353|54221675|FG001|Overall Study|Death|1|||
27768599|NCT02134353|54221674|FG000|Overall Study|Pregnancy|0|||
27768600|NCT02134353|54221675|FG001|Overall Study|Pregnancy|1|||
27768601|NCT02134353|54221674|FG000|Overall Study|Relocation|1|||
27768602|NCT02134353|54221675|FG001|Overall Study|Relocation|0|||
27768603|NCT02134353|54221674|FG000|Overall Study|Other - Patient's Choice|0|||
27768604|NCT02134353|54221675|FG001|Overall Study|Other - Patient's Choice|1|||
27768605|NCT01646125|54221683|FG000|Overall Study|Untreated|2|||
27768606|NCT01646125|54221684|FG001|Overall Study|Untreated|5|||
27768607|NCT01646125|54221683|FG000|Overall Study|Adverse Event|2|||
27768608|NCT01646125|54221684|FG001|Overall Study|Adverse Event|1|||
27768609|NCT01646125|54221683|FG000|Overall Study|Death|1|||
27768610|NCT01646125|54221684|FG001|Overall Study|Death|1|||
27768611|NCT01646125|54221683|FG000|Overall Study|Physician Decision|1|||
27839792|NCT01693562|54327125|FG014|Exploration Phase|Withdrawal by Subject|0|||
27839793|NCT01693562|54327126|FG015|Exploration Phase|Withdrawal by Subject|0|||
27839794|NCT01693562|54327127|FG016|Exploration Phase|Withdrawal by Subject|0|||
27768612|NCT01646125|54221684|FG001|Overall Study|Physician Decision|3|||
27768613|NCT01646125|54221683|FG000|Overall Study|Progressive disease|22|||
27768614|NCT01646125|54221684|FG001|Overall Study|Progressive disease|16|||
27768615|NCT01646125|54221683|FG000|Overall Study|Study terminated by sponsor|2|||
27768616|NCT01646125|54221684|FG001|Overall Study|Study terminated by sponsor|1|||
27768617|NCT01646125|54221683|FG000|Overall Study|Subject/Guardian decision|1|||
27768618|NCT01646125|54221684|FG001|Overall Study|Subject/Guardian decision|1|||
27768619|NCT01362790|54221697|FG000|Pilot Phase & Phase 2|Changed treatment, too early to assess|1|||
27768620|NCT01362790|54221698|FG001|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
27768621|NCT01362790|54221699|FG002|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
27768622|NCT01362790|54221700|FG003|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
27768623|NCT01362790|54221701|FG004|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
27768624|NCT01362790|54221702|FG005|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
27768625|NCT01362790|54221703|FG006|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
27768626|NCT01362790|54221697|FG000|Pilot Phase & Phase 2|Adverse Event|0|||
27768627|NCT01362790|54221698|FG001|Pilot Phase & Phase 2|Adverse Event|1|||
27768628|NCT01362790|54221699|FG002|Pilot Phase & Phase 2|Adverse Event|0|||
27768629|NCT01362790|54221700|FG003|Pilot Phase & Phase 2|Adverse Event|1|||
27768630|NCT01362790|54221701|FG004|Pilot Phase & Phase 2|Adverse Event|0|||
27768631|NCT01362790|54221702|FG005|Pilot Phase & Phase 2|Adverse Event|2|||
27768632|NCT01362790|54221703|FG006|Pilot Phase & Phase 2|Adverse Event|0|||
27768633|NCT01362790|54221697|FG000|Pilot Phase & Phase 2|Physician Decision|0|||
27768634|NCT01362790|54221698|FG001|Pilot Phase & Phase 2|Physician Decision|0|||
27768635|NCT01362790|54221699|FG002|Pilot Phase & Phase 2|Physician Decision|0|||
27768636|NCT01362790|54221700|FG003|Pilot Phase & Phase 2|Physician Decision|1|||
27768637|NCT01362790|54221701|FG004|Pilot Phase & Phase 2|Physician Decision|0|||
27768638|NCT01362790|54221702|FG005|Pilot Phase & Phase 2|Physician Decision|0|||
27768639|NCT01362790|54221703|FG006|Pilot Phase & Phase 2|Physician Decision|0|||
27768640|NCT01362790|54221697|FG000|Pilot Phase & Phase 2|Developed antibodies|7|||
27768641|NCT01362790|54221698|FG001|Pilot Phase & Phase 2|Developed antibodies|2|||
27768642|NCT01362790|54221699|FG002|Pilot Phase & Phase 2|Developed antibodies|3|||
27768643|NCT01362790|54221700|FG003|Pilot Phase & Phase 2|Developed antibodies|8|||
27768644|NCT01362790|54221701|FG004|Pilot Phase & Phase 2|Developed antibodies|0|||
27768645|NCT01362790|54221702|FG005|Pilot Phase & Phase 2|Developed antibodies|0|||
27768646|NCT01362790|54221703|FG006|Pilot Phase & Phase 2|Developed antibodies|0|||
27768647|NCT01362790|54221697|FG000|Pilot Phase & Phase 2|Refused further treatment|0|||
27768648|NCT01362790|54221698|FG001|Pilot Phase & Phase 2|Refused further treatment|1|||
27768649|NCT01362790|54221699|FG002|Pilot Phase & Phase 2|Refused further treatment|0|||
27768650|NCT01362790|54221700|FG003|Pilot Phase & Phase 2|Refused further treatment|0|||
27768651|NCT01362790|54221701|FG004|Pilot Phase & Phase 2|Refused further treatment|0|||
27768652|NCT01362790|54221702|FG005|Pilot Phase & Phase 2|Refused further treatment|0|||
27768653|NCT01362790|54221703|FG006|Pilot Phase & Phase 2|Refused further treatment|0|||
27768654|NCT01362790|54221697|FG000|Pilot Phase & Phase 2|Progressive disease|1|||
27768655|NCT01362790|54221698|FG001|Pilot Phase & Phase 2|Progressive disease|2|||
27768656|NCT01362790|54221699|FG002|Pilot Phase & Phase 2|Progressive disease|2|||
27768657|NCT01362790|54221700|FG003|Pilot Phase & Phase 2|Progressive disease|3|||
27768658|NCT01362790|54221701|FG004|Pilot Phase & Phase 2|Progressive disease|0|||
27768659|NCT01362790|54221702|FG005|Pilot Phase & Phase 2|Progressive disease|2|||
27768660|NCT01362790|54221703|FG006|Pilot Phase & Phase 2|Progressive disease|0|||
27768661|NCT01362790|54221697|FG000|Pilot Phase & Phase 2|Treatment delay >3 weeks|1|||
27768662|NCT01362790|54221698|FG001|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
27768663|NCT01362790|54221699|FG002|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
27768664|NCT01362790|54221700|FG003|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
27768665|NCT01362790|54221701|FG004|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
27768666|NCT01362790|54221702|FG005|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
27768667|NCT01362790|54221703|FG006|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
27768668|NCT01362790|54221697|FG000|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
27768669|NCT01362790|54221698|FG001|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2|||
27768670|NCT01362790|54221699|FG002|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
27768671|NCT01362790|54221700|FG003|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
27768672|NCT01362790|54221701|FG004|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
27768673|NCT01362790|54221702|FG005|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
27768674|NCT01362790|54221703|FG006|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
27839795|NCT01693562|54327128|FG017|Exploration Phase|Withdrawal by Subject|0|||
27839796|NCT01693562|54327129|FG018|Exploration Phase|Withdrawal by Subject|0|||
27839797|NCT01693562|54327130|FG019|Exploration Phase|Withdrawal by Subject|0|||
27839798|NCT01693562|54327131|FG020|Exploration Phase|Withdrawal by Subject|0|||
27839799|NCT01693562|54327132|FG021|Exploration Phase|Withdrawal by Subject|0|||
27839800|NCT01693562|54327133|FG022|Exploration Phase|Withdrawal by Subject|0|||
27768675|NCT01362790|54221697|FG000|Pilot Phase & Phase 2|Death on study|0|||
27768676|NCT01362790|54221698|FG001|Pilot Phase & Phase 2|Death on study|0|||
27768677|NCT01362790|54221699|FG002|Pilot Phase & Phase 2|Death on study|0|||
27768678|NCT01362790|54221700|FG003|Pilot Phase & Phase 2|Death on study|1|||
27768679|NCT01362790|54221701|FG004|Pilot Phase & Phase 2|Death on study|0|||
27768680|NCT01362790|54221702|FG005|Pilot Phase & Phase 2|Death on study|0|||
27839801|NCT01693562|54327111|FG000|Exploration Phase|Death|0|||
27768681|NCT01362790|54221703|FG006|Pilot Phase & Phase 2|Death on study|0|||
27768682|NCT01362790|54221697|FG000|Dose De-escalation of Regimen A|Adverse Event|0|||
27768683|NCT01362790|54221698|FG001|Dose De-escalation of Regimen A|Adverse Event|0|||
27768684|NCT01362790|54221699|FG002|Dose De-escalation of Regimen A|Adverse Event|0|||
27768685|NCT01362790|54221700|FG003|Dose De-escalation of Regimen A|Adverse Event|0|||
27768686|NCT01362790|54221701|FG004|Dose De-escalation of Regimen A|Adverse Event|1|||
27768687|NCT01362790|54221702|FG005|Dose De-escalation of Regimen A|Adverse Event|0|||
27768688|NCT01362790|54221703|FG006|Dose De-escalation of Regimen A|Adverse Event|0|||
27768689|NCT01362790|54221697|FG000|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
27768690|NCT01362790|54221698|FG001|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
27768691|NCT01362790|54221699|FG002|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
27768692|NCT01362790|54221700|FG003|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
27768693|NCT01362790|54221701|FG004|Dose De-escalation of Regimen A|Deveoped antibodies|3|||
27768694|NCT01362790|54221702|FG005|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
27768695|NCT01362790|54221703|FG006|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
27768696|NCT01362790|54221697|FG000|Dose De-escalation of Regimen A|Progressive disease|0|||
27768697|NCT01362790|54221698|FG001|Dose De-escalation of Regimen A|Progressive disease|0|||
27768698|NCT01362790|54221699|FG002|Dose De-escalation of Regimen A|Progressive disease|0|||
27768699|NCT01362790|54221700|FG003|Dose De-escalation of Regimen A|Progressive disease|0|||
27768700|NCT01362790|54221701|FG004|Dose De-escalation of Regimen A|Progressive disease|2|||
27768701|NCT01362790|54221702|FG005|Dose De-escalation of Regimen A|Progressive disease|0|||
27768702|NCT01362790|54221703|FG006|Dose De-escalation of Regimen A|Progressive disease|0|||
27768703|NCT02167893|54221723|FG000|Overall Study|Investigator transferred|85|||
27768704|NCT02167893|54221723|FG000|Overall Study|Investigator health reasons|10|||
27768705|NCT02167893|54221723|FG000|Overall Study|Case report forms not collected|68|||
27768706|NCT02167035|54221729|FG000|Overall Study|Adverse Event|2|||
27768707|NCT02167035|54221730|FG001|Overall Study|Adverse Event|2|||
27768708|NCT02167035|54221729|FG000|Overall Study|Lost to Follow-up|3|||
27768709|NCT02167035|54221730|FG001|Overall Study|Lost to Follow-up|3|||
27768710|NCT02167035|54221729|FG000|Overall Study|Randomized to incorrect Study Medication|0|||
27768711|NCT02167035|54221730|FG001|Overall Study|Randomized to incorrect Study Medication|1|||
27768712|NCT01615198|54221740|FG000|Overall Study|Withdrawal by Subject|5|||
27768713|NCT01615198|54221741|FG001|Overall Study|Withdrawal by Subject|5|||
27768714|NCT01615198|54221740|FG000|Overall Study|Protocol deviation|1|||
27768715|NCT01615198|54221741|FG001|Overall Study|Protocol deviation|1|||
27768716|NCT01615198|54221740|FG000|Overall Study|Physician Decision|5|||
27768717|NCT01615198|54221741|FG001|Overall Study|Physician Decision|1|||
27768718|NCT01615198|54221740|FG000|Overall Study|Lost to Follow-up|1|||
27768719|NCT01615198|54221741|FG001|Overall Study|Lost to Follow-up|1|||
27768720|NCT01615198|54221740|FG000|Overall Study|Lack of Efficacy|1|||
27768721|NCT01615198|54221741|FG001|Overall Study|Lack of Efficacy|6|||
27768722|NCT01615198|54221740|FG000|Overall Study|Adverse Event|11|||
27768723|NCT01615198|54221741|FG001|Overall Study|Adverse Event|5|||
27768724|NCT02337907|54221753|FG000|Overall Study|Other than listed|1|||
27768725|NCT02337907|54221754|FG001|Overall Study|Other than listed|0|||
27768726|NCT02337907|54221755|FG002|Overall Study|Other than listed|0|||
27768727|NCT02337907|54221756|FG003|Overall Study|Other than listed|1|||
27768728|NCT02337907|54221757|FG004|Overall Study|Other than listed|1|||
27768729|NCT02337907|54221758|FG005|Overall Study|Other than listed|0|||
27768730|NCT02337907|54221753|FG000|Overall Study|Withdrawal by Subject|2|||
27768731|NCT02337907|54221754|FG001|Overall Study|Withdrawal by Subject|3|||
27768732|NCT02337907|54221755|FG002|Overall Study|Withdrawal by Subject|0|||
27768733|NCT02337907|54221756|FG003|Overall Study|Withdrawal by Subject|2|||
27768734|NCT02337907|54221757|FG004|Overall Study|Withdrawal by Subject|5|||
27768735|NCT02337907|54221758|FG005|Overall Study|Withdrawal by Subject|0|||
27768736|NCT02337907|54221753|FG000|Overall Study|Lost to Follow-up|0|||
27768737|NCT02337907|54221754|FG001|Overall Study|Lost to Follow-up|0|||
27768738|NCT02337907|54221755|FG002|Overall Study|Lost to Follow-up|0|||
27768739|NCT02337907|54221756|FG003|Overall Study|Lost to Follow-up|0|||
27768740|NCT02337907|54221757|FG004|Overall Study|Lost to Follow-up|0|||
27768741|NCT02337907|54221758|FG005|Overall Study|Lost to Follow-up|1|||
27768742|NCT02337907|54221753|FG000|Overall Study|Adverse Event|1|||
27768743|NCT02337907|54221754|FG001|Overall Study|Adverse Event|1|||
27768744|NCT02337907|54221755|FG002|Overall Study|Adverse Event|1|||
27768745|NCT02337907|54221756|FG003|Overall Study|Adverse Event|1|||
27768746|NCT02337907|54221757|FG004|Overall Study|Adverse Event|4|||
27768747|NCT02337907|54221758|FG005|Overall Study|Adverse Event|0|||
27768748|NCT01913470|54221775|FG000|Overall Study|Lost to Follow-up|0|||
27768749|NCT01913470|54221776|FG001|Overall Study|Lost to Follow-up|1|||
27768750|NCT01913470|54221775|FG000|Overall Study|Physician Decision|0|||
27768751|NCT01913470|54221776|FG001|Overall Study|Physician Decision|1|||
27768752|NCT01913470|54221775|FG000|Overall Study|Withdrawal by Subject|0|||
27768753|NCT01913470|54221776|FG001|Overall Study|Withdrawal by Subject|1|||
27768754|NCT02372071|54221783|FG000|Overall Study|Protocol Violation|18|||
27768755|NCT02337751|54221790|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
27768756|NCT02337751|54221791|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
27768757|NCT02337751|54221790|FG000|Overall Study|Voluntary Withdrawal|6|||
27768758|NCT02337751|54221791|FG001|Overall Study|Voluntary Withdrawal|8|||
27768759|NCT02337751|54221790|FG000|Overall Study|Lack of Efficacy|2|||
27768760|NCT02337751|54221791|FG001|Overall Study|Lack of Efficacy|5|||
27768761|NCT02337751|54221790|FG000|Overall Study|Investigator's Judgement|1|||
27768762|NCT02337751|54221791|FG001|Overall Study|Investigator's Judgement|0|||
27768763|NCT02166333|54221802|FG000|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|4|||
27768764|NCT02166333|54221803|FG001|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
27768765|NCT02166333|54221804|FG002|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
27768766|NCT02166333|54221805|FG003|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
27768767|NCT02166333|54221806|FG004|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|3|||
27768768|NCT02166333|54221807|FG005|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|1|||
27768769|NCT02166333|54221802|FG000|Stage 1|Death|4|||
27768770|NCT02166333|54221803|FG001|Stage 1|Death|0|||
27768771|NCT02166333|54221804|FG002|Stage 1|Death|2|||
27768772|NCT02166333|54221805|FG003|Stage 1|Death|0|||
27768773|NCT02166333|54221806|FG004|Stage 1|Death|3|||
27768774|NCT02166333|54221807|FG005|Stage 1|Death|2|||
27768775|NCT02166333|54221802|FG000|Stage 1|Lost to Follow-up|12|||
27768776|NCT02166333|54221803|FG001|Stage 1|Lost to Follow-up|0|||
27768777|NCT02166333|54221804|FG002|Stage 1|Lost to Follow-up|6|||
27768778|NCT02166333|54221805|FG003|Stage 1|Lost to Follow-up|0|||
27768779|NCT02166333|54221806|FG004|Stage 1|Lost to Follow-up|3|||
27768780|NCT02166333|54221807|FG005|Stage 1|Lost to Follow-up|3|||
27768781|NCT02166333|54221802|FG000|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|180|||
27768782|NCT02166333|54221803|FG001|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
27768783|NCT02166333|54221804|FG002|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|63|||
27768784|NCT02166333|54221805|FG003|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
27768785|NCT02166333|54221806|FG004|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|54|||
27768786|NCT02166333|54221807|FG005|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|52|||
27768787|NCT02166333|54221802|FG000|Stage 2|Death|4|||
27768788|NCT02166333|54221803|FG001|Stage 2|Death|2|||
27768789|NCT02166333|54221804|FG002|Stage 2|Death|1|||
27768790|NCT02166333|54221805|FG003|Stage 2|Death|0|||
27768791|NCT02166333|54221806|FG004|Stage 2|Death|0|||
27768792|NCT02166333|54221807|FG005|Stage 2|Death|1|||
27768793|NCT02166333|54221802|FG000|Stage 2|Lost to Follow-up|23|||
27768794|NCT02166333|54221803|FG001|Stage 2|Lost to Follow-up|4|||
27768795|NCT02166333|54221804|FG002|Stage 2|Lost to Follow-up|11|||
27768796|NCT02166333|54221805|FG003|Stage 2|Lost to Follow-up|9|||
27768797|NCT02166333|54221806|FG004|Stage 2|Lost to Follow-up|3|||
27768798|NCT02166333|54221807|FG005|Stage 2|Lost to Follow-up|6|||
27768799|NCT02132949|54221821|FG000|Overall Study|Death|7|||
27768800|NCT02132949|54221822|FG001|Overall Study|Death|13|||
27768801|NCT02132949|54221821|FG000|Overall Study|Lost to Follow-up|14|||
27768802|NCT02132949|54221822|FG001|Overall Study|Lost to Follow-up|4|||
27768803|NCT02132949|54221821|FG000|Overall Study|Withdrawal by Subject|6|||
27768804|NCT02132949|54221822|FG001|Overall Study|Withdrawal by Subject|5|||
27768805|NCT02132949|54221821|FG000|Overall Study|Noncompliance|5|||
27768806|NCT02132949|54221822|FG001|Overall Study|Noncompliance|1|||
27768807|NCT02132949|54221821|FG000|Overall Study|Physician Decision|3|||
27768808|NCT02132949|54221822|FG001|Overall Study|Physician Decision|1|||
27768809|NCT02132949|54221821|FG000|Overall Study|Disease Progression|3|||
27768810|NCT02132949|54221822|FG001|Overall Study|Disease Progression|0|||
27768811|NCT02132949|54221821|FG000|Overall Study|Adverse Event|2|||
27768812|NCT02132949|54221822|FG001|Overall Study|Adverse Event|1|||
27768813|NCT02132949|54221821|FG000|Overall Study|Withdrew Prior to Treatment|1|||
27839802|NCT01693562|54327112|FG001|Exploration Phase|Death|0|||
27839803|NCT01693562|54327113|FG002|Exploration Phase|Death|0|||
27839804|NCT01693562|54327114|FG003|Exploration Phase|Death|0|||
27768814|NCT02132949|54221822|FG001|Overall Study|Withdrew Prior to Treatment|2|||
27768815|NCT02132949|54221821|FG000|Overall Study|Reason Unspecified|0|||
27768816|NCT02132949|54221822|FG001|Overall Study|Reason Unspecified|1|||
27768817|NCT02165397|54221831|FG000|Overall Study|Death|7|||
27768818|NCT02165397|54221832|FG001|Overall Study|Death|10|||
27768819|NCT02165397|54221833|FG002|Overall Study|Death|8|||
27768820|NCT02165397|54221831|FG000|Overall Study|Lost to Follow-up|1|||
27768821|NCT02165397|54221832|FG001|Overall Study|Lost to Follow-up|3|||
27768822|NCT02165397|54221833|FG002|Overall Study|Lost to Follow-up|0|||
27768823|NCT02165397|54221831|FG000|Overall Study|Withdrawal by Subject|6|||
27768824|NCT02165397|54221832|FG001|Overall Study|Withdrawal by Subject|6|||
27768825|NCT02165397|54221833|FG002|Overall Study|Withdrawal by Subject|1|||
27768826|NCT02165397|54221831|FG000|Overall Study|Other, Not Specified|0|||
27768827|NCT02165397|54221832|FG001|Overall Study|Other, Not Specified|0|||
27768828|NCT02165397|54221833|FG002|Overall Study|Other, Not Specified|1|||
27768829|NCT02132637|54221845|FG000|Study Period 1|Withdrawal by Subject|0|||
27768830|NCT02132637|54221846|FG001|Study Period 1|Withdrawal by Subject|4|||
27768831|NCT02132637|54221845|FG000|Study Period 1|Physician Decision|1|||
27768832|NCT02132637|54221846|FG001|Study Period 1|Physician Decision|0|||
27768833|NCT02132637|54221845|FG000|Study Period 2 (Crossover)|Adverse Event|0|||
27768834|NCT02132637|54221846|FG001|Study Period 2 (Crossover)|Adverse Event|1|||
27768835|NCT02132637|54221845|FG000|Study Period 2 (Crossover)|Physician Decision|2|||
27768836|NCT02132637|54221846|FG001|Study Period 2 (Crossover)|Physician Decision|0|||
27768837|NCT02164929|54221856|FG000|Overall Study|Converted to open procedure|1|||
27768838|NCT02164929|54221857|FG001|Overall Study|Converted to open procedure|0|||
27768839|NCT02164929|54221858|FG002|Overall Study|Converted to open procedure|0|||
27768840|NCT02164929|54221859|FG003|Overall Study|Converted to open procedure|2|||
27768841|NCT02164929|54221856|FG000|Overall Study|Failed regional block|0|||
27768842|NCT02164929|54221857|FG001|Overall Study|Failed regional block|0|||
27768843|NCT02164929|54221858|FG002|Overall Study|Failed regional block|1|||
27768844|NCT02164929|54221859|FG003|Overall Study|Failed regional block|0|||
27768845|NCT01888432|54221871|FG000|12-month Analysis (FAS)|Lost to Follow-up|0|||
27768846|NCT01888432|54221872|FG001|12-month Analysis (FAS)|Lost to Follow-up|2|||
27768847|NCT01888432|54221871|FG000|12-month Analysis (FAS)|Physician Decision|1|||
27768848|NCT01888432|54221872|FG001|12-month Analysis (FAS)|Physician Decision|1|||
27768849|NCT01888432|54221871|FG000|12-month Analysis (FAS)|Withdrawal by Subject|6|||
27768850|NCT01888432|54221872|FG001|12-month Analysis (FAS)|Withdrawal by Subject|3|||
27768851|NCT01888432|54221871|FG000|12-month Analysis (FAS)|Death|4|||
27768852|NCT01888432|54221872|FG001|12-month Analysis (FAS)|Death|3|||
27768853|NCT01888432|54221871|FG000|24-month Analysis (FAS)|Graft loss|0|||
27768854|NCT01888432|54221872|FG001|24-month Analysis (FAS)|Graft loss|1|||
27768855|NCT01888432|54221871|FG000|24-month Analysis (FAS)|Lost to Follow-up|0|||
27768856|NCT01888432|54221872|FG001|24-month Analysis (FAS)|Lost to Follow-up|2|||
27768857|NCT01888432|54221871|FG000|24-month Analysis (FAS)|Physician Decision|2|||
27768858|NCT01888432|54221872|FG001|24-month Analysis (FAS)|Physician Decision|4|||
27768859|NCT01888432|54221871|FG000|24-month Analysis (FAS)|Withdrawal by Subject|7|||
27768860|NCT01888432|54221872|FG001|24-month Analysis (FAS)|Withdrawal by Subject|6|||
27768861|NCT01888432|54221871|FG000|24-month Analysis (FAS)|Death|8|||
27768862|NCT01888432|54221872|FG001|24-month Analysis (FAS)|Death|4|||
27768863|NCT01888432|54221871|FG000|36-month Analysis (Extension)|Death|1|||
27768864|NCT01888432|54221872|FG001|36-month Analysis (Extension)|Death|0|||
27839805|NCT01693562|54327115|FG004|Exploration Phase|Death|0|||
27839806|NCT01693562|54327116|FG005|Exploration Phase|Death|0|||
27839807|NCT01693562|54327117|FG006|Exploration Phase|Death|17|||
27768865|NCT02188719|54221884|FG000|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
27768866|NCT02188719|54221885|FG001|Overall Study|Screen B Ineligible (Page 55, Protocol)|1|||
27768867|NCT02188719|54221886|FG002|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
27768868|NCT02188719|54221887|FG003|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
27768869|NCT01934140|54221897|FG000|Persistence Phase (Year 6-10)|Other|24|||
27768870|NCT01934140|54221898|FG001|Persistence Phase (Year 6-10)|Other|6|||
27839808|NCT01693562|54327118|FG007|Exploration Phase|Death|0|||
27768871|NCT01934140|54221897|FG000|Persistence Phase (Year 6-10)|Lost to Follow-up|5|||
27768872|NCT01934140|54221898|FG001|Persistence Phase (Year 6-10)|Lost to Follow-up|2|||
27768873|NCT01934140|54221897|FG000|Persistence Phase (Year 6-10)|Migrated/moved from study area|31|||
27768874|NCT01934140|54221898|FG001|Persistence Phase (Year 6-10)|Migrated/moved from study area|10|||
27768875|NCT01934140|54221897|FG000|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2|||
27768876|NCT01934140|54221898|FG001|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0|||
27768877|NCT01934140|54221897|FG000|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21|||
27768878|NCT01934140|54221898|FG001|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7|||
27768879|NCT01934140|54221897|FG000|Booster Phase (6 Months)|Lost to Follow-up|1|||
27768880|NCT01934140|54221898|FG001|Booster Phase (6 Months)|Lost to Follow-up|0|||
27768881|NCT01934140|54221897|FG000|Booster Phase (6 Months)|Missed at least 1 booster visit|2|||
27768882|NCT01934140|54221898|FG001|Booster Phase (6 Months)|Missed at least 1 booster visit|1|||
27768883|NCT01934140|54221897|FG000|Booster Phase (6 Months)|Migrated/moved from study area|2|||
27768884|NCT01934140|54221898|FG001|Booster Phase (6 Months)|Migrated/moved from study area|2|||
27768885|NCT01933672|54221906|FG000|Metformin Run-in Period|Adverse Event|1|||
27768886|NCT01933672|54221907|FG001|Metformin Run-in Period|Adverse Event|0|||
27768887|NCT01933672|54221908|FG002|Metformin Run-in Period|Adverse Event|0|||
27768888|NCT01933672|54221909|FG003|Metformin Run-in Period|Adverse Event|0|||
27768889|NCT01933672|54221910|FG004|Metformin Run-in Period|Adverse Event|0|||
27768890|NCT01933672|54221911|FG005|Metformin Run-in Period|Adverse Event|0|||
27768891|NCT01933672|54221912|FG006|Metformin Run-in Period|Adverse Event|0|||
27768892|NCT01933672|54221906|FG000|Metformin Run-in Period|No longer meets eligibility criteria|4|||
27768893|NCT01933672|54221907|FG001|Metformin Run-in Period|No longer meets eligibility criteria|0|||
27768894|NCT01933672|54221908|FG002|Metformin Run-in Period|No longer meets eligibility criteria|0|||
27768895|NCT01933672|54221909|FG003|Metformin Run-in Period|No longer meets eligibility criteria|0|||
27768896|NCT01933672|54221910|FG004|Metformin Run-in Period|No longer meets eligibility criteria|0|||
27768897|NCT01933672|54221911|FG005|Metformin Run-in Period|No longer meets eligibility criteria|0|||
27768898|NCT01933672|54221912|FG006|Metformin Run-in Period|No longer meets eligibility criteria|0|||
27768899|NCT01933672|54221906|FG000|Metformin Run-in Period|Other|5|||
27768900|NCT01933672|54221907|FG001|Metformin Run-in Period|Other|0|||
27768901|NCT01933672|54221908|FG002|Metformin Run-in Period|Other|0|||
27768902|NCT01933672|54221909|FG003|Metformin Run-in Period|Other|0|||
27768903|NCT01933672|54221910|FG004|Metformin Run-in Period|Other|0|||
27768904|NCT01933672|54221911|FG005|Metformin Run-in Period|Other|0|||
27768905|NCT01933672|54221912|FG006|Metformin Run-in Period|Other|0|||
27768906|NCT01933672|54221906|FG000|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
27768907|NCT01933672|54221907|FG001|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
27768908|NCT01933672|54221908|FG002|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
27768909|NCT01933672|54221909|FG003|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
27768910|NCT01933672|54221910|FG004|First Intervention Period (12-16 Days)|Lost to Follow-up|1|||
27768911|NCT01933672|54221911|FG005|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
27768912|NCT01933672|54221912|FG006|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
27768913|NCT01933672|54221906|FG000|First Intervention Period (12-16 Days)|Other|0|||
27768914|NCT01933672|54221907|FG001|First Intervention Period (12-16 Days)|Other|0|||
27768915|NCT01933672|54221908|FG002|First Intervention Period (12-16 Days)|Other|1|||
27768916|NCT01933672|54221909|FG003|First Intervention Period (12-16 Days)|Other|0|||
27768917|NCT01933672|54221910|FG004|First Intervention Period (12-16 Days)|Other|0|||
27768918|NCT01933672|54221911|FG005|First Intervention Period (12-16 Days)|Other|1|||
27768919|NCT01933672|54221912|FG006|First Intervention Period (12-16 Days)|Other|0|||
27768920|NCT01933672|54221906|FG000|Second Intervention Period (12-16 Days)|Other|0|||
27768921|NCT01933672|54221907|FG001|Second Intervention Period (12-16 Days)|Other|1|||
27768922|NCT01933672|54221908|FG002|Second Intervention Period (12-16 Days)|Other|1|||
27768923|NCT01933672|54221909|FG003|Second Intervention Period (12-16 Days)|Other|0|||
27768924|NCT01933672|54221910|FG004|Second Intervention Period (12-16 Days)|Other|0|||
27768925|NCT01933672|54221911|FG005|Second Intervention Period (12-16 Days)|Other|0|||
27768926|NCT01933672|54221912|FG006|Second Intervention Period (12-16 Days)|Other|0|||
27768927|NCT01933672|54221906|FG000|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
27768928|NCT01933672|54221907|FG001|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
27768929|NCT01933672|54221908|FG002|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
27768930|NCT01933672|54221909|FG003|Third Intervention Period (12-16 Days)|Lost to Follow-up|1|||
27768931|NCT01933672|54221910|FG004|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
27768932|NCT01933672|54221911|FG005|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
27768933|NCT01933672|54221912|FG006|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
27768934|NCT01933672|54221906|FG000|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
27768935|NCT01933672|54221907|FG001|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1|||
27768936|NCT01933672|54221908|FG002|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
27768937|NCT01933672|54221909|FG003|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
27768938|NCT01933672|54221910|FG004|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
27768939|NCT01933672|54221911|FG005|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
27768940|NCT01933672|54221912|FG006|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
27768941|NCT02164539|54221931|FG000|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
27768942|NCT02164539|54221932|FG001|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
27768943|NCT02164539|54221933|FG002|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
27768944|NCT02164539|54221934|FG003|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
27768945|NCT02164539|54221935|FG004|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3|||
27768946|NCT02164539|54221936|FG005|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
27768947|NCT02164539|54221937|FG006|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
27768948|NCT02164539|54221931|FG000|Treatment Phase B (1 Week)|Adverse Event|0|||
27768949|NCT02164539|54221932|FG001|Treatment Phase B (1 Week)|Adverse Event|0|||
27768950|NCT02164539|54221933|FG002|Treatment Phase B (1 Week)|Adverse Event|0|||
27768951|NCT02164539|54221934|FG003|Treatment Phase B (1 Week)|Adverse Event|0|||
27768952|NCT02164539|54221935|FG004|Treatment Phase B (1 Week)|Adverse Event|2|||
27768953|NCT02164539|54221936|FG005|Treatment Phase B (1 Week)|Adverse Event|0|||
27768954|NCT02164539|54221937|FG006|Treatment Phase B (1 Week)|Adverse Event|0|||
27768955|NCT02164539|54221931|FG000|Treatment Phase B (1 Week)|Physician Decision|0|||
27768956|NCT02164539|54221932|FG001|Treatment Phase B (1 Week)|Physician Decision|0|||
27768957|NCT02164539|54221933|FG002|Treatment Phase B (1 Week)|Physician Decision|0|||
27768958|NCT02164539|54221934|FG003|Treatment Phase B (1 Week)|Physician Decision|0|||
27768959|NCT02164539|54221935|FG004|Treatment Phase B (1 Week)|Physician Decision|1|||
27768960|NCT02164539|54221936|FG005|Treatment Phase B (1 Week)|Physician Decision|0|||
27768961|NCT02164539|54221937|FG006|Treatment Phase B (1 Week)|Physician Decision|1|||
27768962|NCT02164539|54221931|FG000|Treatment Phase C (1 Week)|Withdrawal by Subject|1|||
27768963|NCT02164539|54221932|FG001|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
27768964|NCT02164539|54221933|FG002|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
27768965|NCT02164539|54221934|FG003|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
27768966|NCT02164539|54221935|FG004|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
27768967|NCT02164539|54221936|FG005|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
27768968|NCT02164539|54221937|FG006|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
27768969|NCT02164539|54221931|FG000|Treatment Phase C (1 Week)|Adverse Event|0|||
27768970|NCT02164539|54221932|FG001|Treatment Phase C (1 Week)|Adverse Event|0|||
27768971|NCT02164539|54221933|FG002|Treatment Phase C (1 Week)|Adverse Event|0|||
27768972|NCT02164539|54221934|FG003|Treatment Phase C (1 Week)|Adverse Event|0|||
27768973|NCT02164539|54221935|FG004|Treatment Phase C (1 Week)|Adverse Event|0|||
27768974|NCT02164539|54221936|FG005|Treatment Phase C (1 Week)|Adverse Event|0|||
27768975|NCT02164539|54221937|FG006|Treatment Phase C (1 Week)|Adverse Event|1|||
27768976|NCT02164539|54221931|FG000|Treatment Phase C (1 Week)|Physician Decision|0|||
27768977|NCT02164539|54221932|FG001|Treatment Phase C (1 Week)|Physician Decision|0|||
27768978|NCT02164539|54221933|FG002|Treatment Phase C (1 Week)|Physician Decision|0|||
27768979|NCT02164539|54221934|FG003|Treatment Phase C (1 Week)|Physician Decision|0|||
27768980|NCT02164539|54221935|FG004|Treatment Phase C (1 Week)|Physician Decision|0|||
27768981|NCT02164539|54221936|FG005|Treatment Phase C (1 Week)|Physician Decision|0|||
27768982|NCT02164539|54221937|FG006|Treatment Phase C (1 Week)|Physician Decision|1|||
27768983|NCT02188485|54221954|FG000|Overall Study|Withdrawal by Subject|2|||
27768984|NCT02188485|54221955|FG001|Overall Study|Withdrawal by Subject|1|||
27768985|NCT02188485|54221954|FG000|Overall Study|PI withdrew, lack of capacity|0|||
27768986|NCT02188485|54221955|FG001|Overall Study|PI withdrew, lack of capacity|2|||
27768987|NCT02132247|54221963|FG000|Overall Study|Protocol Violation|1|||
27768988|NCT02132247|54221964|FG001|Overall Study|Protocol Violation|0|||
27768989|NCT01629381|54221972|FG000|Overall Study|Withdrawal by Subject|2|||
27768990|NCT01629381|54221973|FG001|Overall Study|Withdrawal by Subject|5|||
27768991|NCT02131311|54221983|FG000|Overall Study|Adverse Event|2|||
27768992|NCT02131311|54221983|FG000|Overall Study|Protocol Violation|1|||
27768993|NCT02131311|54221983|FG000|Overall Study|Lost to Follow-up|1|||
27768994|NCT01628913|54221990|FG000|Overall Study|Adverse Event|12|||
27768995|NCT01628913|54221991|FG001|Overall Study|Adverse Event|5|||
27768996|NCT01628913|54221990|FG000|Overall Study|Disease Progression|11|||
27768997|NCT01628913|54221991|FG001|Overall Study|Disease Progression|14|||
27768998|NCT01628913|54221990|FG000|Overall Study|Protocol Violation|1|||
27768999|NCT01628913|54221991|FG001|Overall Study|Protocol Violation|0|||
27769000|NCT01628913|54221990|FG000|Overall Study|Death|1|||
27769001|NCT01628913|54221991|FG001|Overall Study|Death|0|||
27769002|NCT01628913|54221990|FG000|Overall Study|study terminated by Sponsor|4|||
27839809|NCT01693562|54327119|FG008|Exploration Phase|Death|0|||
27839810|NCT01693562|54327120|FG009|Exploration Phase|Death|0|||
27839811|NCT01693562|54327121|FG010|Exploration Phase|Death|0|||
27839812|NCT01693562|54327122|FG011|Exploration Phase|Death|0|||
27839813|NCT01693562|54327123|FG012|Exploration Phase|Death|0|||
27839814|NCT01693562|54327124|FG013|Exploration Phase|Death|0|||
27839815|NCT01693562|54327125|FG014|Exploration Phase|Death|0|||
27769003|NCT01628913|54221991|FG001|Overall Study|study terminated by Sponsor|9|||
27769004|NCT01628913|54221990|FG000|Overall Study|Withdrawal by Subject|1|||
27839816|NCT01693562|54327126|FG015|Exploration Phase|Death|0|||
27839817|NCT01693562|54327127|FG016|Exploration Phase|Death|0|||
27769005|NCT01628913|54221991|FG001|Overall Study|Withdrawal by Subject|0|||
27769006|NCT01628913|54221990|FG000|Overall Study|Physician Decision|1|||
27769007|NCT01628913|54221991|FG001|Overall Study|Physician Decision|3|||
27769008|NCT02164383|54221999|FG000|Overall Study|Lost to Follow-up|1|||
27769009|NCT02164383|54222000|FG001|Overall Study|Lost to Follow-up|0|||
27769010|NCT02131233|54222008|FG000|Overall Study|Not Treated|2|||
27769011|NCT02131233|54222009|FG001|Overall Study|Not Treated|3|||
27769012|NCT02131233|54222008|FG000|Overall Study|Adverse Event|7|||
27769013|NCT02131233|54222009|FG001|Overall Study|Adverse Event|6|||
27769014|NCT02131233|54222008|FG000|Overall Study|Death|0|||
27769015|NCT02131233|54222009|FG001|Overall Study|Death|1|||
27769016|NCT02131233|54222008|FG000|Overall Study|Lack of Efficacy|6|||
27769017|NCT02131233|54222009|FG001|Overall Study|Lack of Efficacy|3|||
27769018|NCT02131233|54222008|FG000|Overall Study|Lost to Follow-up|14|||
27769019|NCT02131233|54222009|FG001|Overall Study|Lost to Follow-up|13|||
27769020|NCT02131233|54222008|FG000|Overall Study|Non-Compliance With Study Drug|8|||
27769021|NCT02131233|54222009|FG001|Overall Study|Non-Compliance With Study Drug|5|||
27769022|NCT02131233|54222008|FG000|Overall Study|Physician Decision|7|||
27769023|NCT02131233|54222009|FG001|Overall Study|Physician Decision|0|||
27769024|NCT02131233|54222008|FG000|Overall Study|Pregnancy|4|||
27769025|NCT02131233|54222009|FG001|Overall Study|Pregnancy|0|||
27769026|NCT02131233|54222008|FG000|Overall Study|Withdrawal by Subject|18|||
27769027|NCT02131233|54222009|FG001|Overall Study|Withdrawal by Subject|11|||
27769028|NCT02131155|54222017|FG000|Overall Study|Adverse Event|1|||
27769029|NCT02131155|54222018|FG001|Overall Study|Adverse Event|0|||
27769030|NCT02131155|54222017|FG000|Overall Study|Treatment completed|1|||
27769031|NCT02131155|54222018|FG001|Overall Study|Treatment completed|0|||
27769032|NCT02131155|54222017|FG000|Overall Study|Primary tumour recurrence|2|||
27769033|NCT02131155|54222018|FG001|Overall Study|Primary tumour recurrence|1|||
27769034|NCT02131155|54222017|FG000|Overall Study|Refused to continue study medication|1|||
27769035|NCT02131155|54222018|FG001|Overall Study|Refused to continue study medication|0|||
27769036|NCT02131155|54222017|FG000|Overall Study|Study early termination|20|||
27769037|NCT02131155|54222018|FG001|Overall Study|Study early termination|10|||
27769038|NCT01933594|54222030|FG000|Overall Study|Lost to Follow-up|1|||
27769039|NCT01933594|54222031|FG001|Overall Study|Lost to Follow-up|0|||
27769040|NCT01933594|54222032|FG002|Overall Study|Lost to Follow-up|0|||
27769041|NCT01933594|54222033|FG003|Overall Study|Lost to Follow-up|0|||
27769042|NCT01933594|54222034|FG004|Overall Study|Lost to Follow-up|1|||
27769043|NCT01933594|54222035|FG005|Overall Study|Lost to Follow-up|0|||
27769044|NCT01933594|54222030|FG000|Overall Study|Ineligible for subsequent study step|0|||
27769045|NCT01933594|54222031|FG001|Overall Study|Ineligible for subsequent study step|0|||
27769046|NCT01933594|54222032|FG002|Overall Study|Ineligible for subsequent study step|0|||
27769047|NCT01933594|54222033|FG003|Overall Study|Ineligible for subsequent study step|0|||
27769048|NCT01933594|54222034|FG004|Overall Study|Ineligible for subsequent study step|1|||
27769049|NCT01933594|54222035|FG005|Overall Study|Ineligible for subsequent study step|0|||
27769050|NCT01932970|54222053|FG000|Overall Study|Withdrawal by Subject|5|||
27769051|NCT01932970|54222053|FG000|Overall Study|Death|1|||
27769052|NCT01932970|54222053|FG000|Overall Study|Lost to Follow-up|2|||
27769053|NCT01932970|54222053|FG000|Overall Study|Protocol Specified Criteria|10|||
27769054|NCT01912768|54222059|FG000|Overall Study|Adverse Event|2|||
27769055|NCT01912768|54222060|FG001|Overall Study|Adverse Event|0|||
27769056|NCT01912768|54222059|FG000|Overall Study|Lost to Follow-up|2|||
27769057|NCT01912768|54222060|FG001|Overall Study|Lost to Follow-up|1|||
27769058|NCT01912768|54222059|FG000|Overall Study|Withdrawal by Subject|5|||
27769059|NCT01912768|54222060|FG001|Overall Study|Withdrawal by Subject|3|||
27769060|NCT01912768|54222059|FG000|Overall Study|Randomized in error|1|||
27769061|NCT01912768|54222060|FG001|Overall Study|Randomized in error|0|||
27769062|NCT02305849|54222070|FG000|Overall Study|Adverse Event|10|||
27769063|NCT02305849|54222071|FG001|Overall Study|Adverse Event|12|||
27769064|NCT02305849|54222072|FG002|Overall Study|Adverse Event|7|||
27769065|NCT02305849|54222073|FG003|Overall Study|Adverse Event|3|||
27769066|NCT02305849|54222070|FG000|Overall Study|Lack of Efficacy|10|||
27769067|NCT02305849|54222071|FG001|Overall Study|Lack of Efficacy|6|||
27769068|NCT02305849|54222072|FG002|Overall Study|Lack of Efficacy|3|||
27769069|NCT02305849|54222073|FG003|Overall Study|Lack of Efficacy|9|||
27769070|NCT02305849|54222070|FG000|Overall Study|Withdrawal by Subject|2|||
27769071|NCT02305849|54222071|FG001|Overall Study|Withdrawal by Subject|2|||
27769072|NCT02305849|54222072|FG002|Overall Study|Withdrawal by Subject|1|||
27769073|NCT02305849|54222073|FG003|Overall Study|Withdrawal by Subject|4|||
27769074|NCT02305849|54222070|FG000|Overall Study|Lost to Follow-up|0|||
27769075|NCT02305849|54222071|FG001|Overall Study|Lost to Follow-up|2|||
27769076|NCT02305849|54222072|FG002|Overall Study|Lost to Follow-up|0|||
27769077|NCT02305849|54222073|FG003|Overall Study|Lost to Follow-up|0|||
27769078|NCT02305849|54222070|FG000|Overall Study|Protocol Violation|3|||
27769079|NCT02305849|54222071|FG001|Overall Study|Protocol Violation|2|||
27769080|NCT02305849|54222072|FG002|Overall Study|Protocol Violation|1|||
27769081|NCT02305849|54222073|FG003|Overall Study|Protocol Violation|1|||
27769082|NCT02305849|54222070|FG000|Overall Study|Lab data met discontinuation criteria|0|||
27769083|NCT02305849|54222071|FG001|Overall Study|Lab data met discontinuation criteria|1|||
27769084|NCT02305849|54222072|FG002|Overall Study|Lab data met discontinuation criteria|2|||
27769085|NCT02305849|54222073|FG003|Overall Study|Lab data met discontinuation criteria|1|||
27769086|NCT02305849|54222070|FG000|Overall Study|Miscellaneous|1|||
27769087|NCT02305849|54222071|FG001|Overall Study|Miscellaneous|2|||
27769088|NCT02305849|54222072|FG002|Overall Study|Miscellaneous|4|||
27769089|NCT02305849|54222073|FG003|Overall Study|Miscellaneous|1|||
27769090|NCT02305849|54222070|FG000|Overall Study|Not fulfill eligibility criteria|1|||
27769091|NCT02305849|54222071|FG001|Overall Study|Not fulfill eligibility criteria|1|||
27769092|NCT02305849|54222072|FG002|Overall Study|Not fulfill eligibility criteria|0|||
27769093|NCT02305849|54222073|FG003|Overall Study|Not fulfill eligibility criteria|0|||
27769094|NCT02371759|54222112|FG000|Overall Study|Protocol Violation|3|||
27769095|NCT02371759|54222113|FG001|Overall Study|Protocol Violation|1|||
27769096|NCT02371759|54222114|FG002|Overall Study|Protocol Violation|1|||
27769097|NCT02371759|54222115|FG003|Overall Study|Protocol Violation|0|||
27769098|NCT02371759|54222116|FG004|Overall Study|Protocol Violation|3|||
27769099|NCT02371759|54222117|FG005|Overall Study|Protocol Violation|1|||
27769100|NCT02371759|54222118|FG006|Overall Study|Protocol Violation|0|||
27769101|NCT02371759|54222119|FG007|Overall Study|Protocol Violation|3|||
27769102|NCT02371759|54222112|FG000|Overall Study|Withdrawal by Subject|0|||
27769103|NCT02371759|54222113|FG001|Overall Study|Withdrawal by Subject|0|||
27769104|NCT02371759|54222114|FG002|Overall Study|Withdrawal by Subject|0|||
27769105|NCT02371759|54222115|FG003|Overall Study|Withdrawal by Subject|0|||
27769106|NCT02371759|54222116|FG004|Overall Study|Withdrawal by Subject|0|||
27769107|NCT02371759|54222117|FG005|Overall Study|Withdrawal by Subject|0|||
27769108|NCT02371759|54222118|FG006|Overall Study|Withdrawal by Subject|0|||
27769109|NCT02371759|54222119|FG007|Overall Study|Withdrawal by Subject|1|||
27769110|NCT02531633|54222142|FG000|Part A (52 Weeks)|Sponsor request|24|||
27769111|NCT02531633|54222143|FG001|Part A (52 Weeks)|Sponsor request|24|||
27769112|NCT02531633|54222144|FG002|Part A (52 Weeks)|Sponsor request|18|||
27769113|NCT02531633|54222145|FG003|Part A (52 Weeks)|Sponsor request|18|||
27769114|NCT02531633|54222146|FG004|Part A (52 Weeks)|Sponsor request|19|||
27769115|NCT02531633|54222147|FG005|Part A (52 Weeks)|Sponsor request|0|||
27769116|NCT02531633|54222148|FG006|Part A (52 Weeks)|Sponsor request|0|||
27769117|NCT02531633|54222149|FG007|Part A (52 Weeks)|Sponsor request|0|||
27769118|NCT02531633|54222150|FG008|Part A (52 Weeks)|Sponsor request|0|||
27769119|NCT02531633|54222151|FG009|Part A (52 Weeks)|Sponsor request|0|||
27769120|NCT02531633|54222142|FG000|Part A (52 Weeks)|Protocol Violation|1|||
27769121|NCT02531633|54222143|FG001|Part A (52 Weeks)|Protocol Violation|0|||
27769122|NCT02531633|54222144|FG002|Part A (52 Weeks)|Protocol Violation|0|||
27769123|NCT02531633|54222145|FG003|Part A (52 Weeks)|Protocol Violation|0|||
27769124|NCT02531633|54222146|FG004|Part A (52 Weeks)|Protocol Violation|0|||
27769125|NCT02531633|54222147|FG005|Part A (52 Weeks)|Protocol Violation|0|||
27769126|NCT02531633|54222148|FG006|Part A (52 Weeks)|Protocol Violation|0|||
27769127|NCT02531633|54222149|FG007|Part A (52 Weeks)|Protocol Violation|0|||
27769128|NCT02531633|54222150|FG008|Part A (52 Weeks)|Protocol Violation|0|||
27769129|NCT02531633|54222151|FG009|Part A (52 Weeks)|Protocol Violation|0|||
27769130|NCT02531633|54222142|FG000|Part A (52 Weeks)|Lost to Follow-up|0|||
27769131|NCT02531633|54222143|FG001|Part A (52 Weeks)|Lost to Follow-up|0|||
27769132|NCT02531633|54222144|FG002|Part A (52 Weeks)|Lost to Follow-up|0|||
27769133|NCT02531633|54222145|FG003|Part A (52 Weeks)|Lost to Follow-up|0|||
27769134|NCT02531633|54222146|FG004|Part A (52 Weeks)|Lost to Follow-up|1|||
27769135|NCT02531633|54222147|FG005|Part A (52 Weeks)|Lost to Follow-up|0|||
27769136|NCT02531633|54222148|FG006|Part A (52 Weeks)|Lost to Follow-up|0|||
27769137|NCT02531633|54222149|FG007|Part A (52 Weeks)|Lost to Follow-up|0|||
27769138|NCT02531633|54222150|FG008|Part A (52 Weeks)|Lost to Follow-up|0|||
27769139|NCT02531633|54222151|FG009|Part A (52 Weeks)|Lost to Follow-up|0|||
27769140|NCT02531633|54222142|FG000|Part A (52 Weeks)|Physician Decision|1|||
27769141|NCT02531633|54222143|FG001|Part A (52 Weeks)|Physician Decision|4|||
27769142|NCT02531633|54222144|FG002|Part A (52 Weeks)|Physician Decision|3|||
27769143|NCT02531633|54222145|FG003|Part A (52 Weeks)|Physician Decision|1|||
27769144|NCT02531633|54222146|FG004|Part A (52 Weeks)|Physician Decision|0|||
27769145|NCT02531633|54222147|FG005|Part A (52 Weeks)|Physician Decision|0|||
27769146|NCT02531633|54222148|FG006|Part A (52 Weeks)|Physician Decision|0|||
27769147|NCT02531633|54222149|FG007|Part A (52 Weeks)|Physician Decision|0|||
27769148|NCT02531633|54222150|FG008|Part A (52 Weeks)|Physician Decision|0|||
27769149|NCT02531633|54222151|FG009|Part A (52 Weeks)|Physician Decision|0|||
27769150|NCT02531633|54222142|FG000|Part A (52 Weeks)|Withdrawal by Subject|6|||
27769151|NCT02531633|54222143|FG001|Part A (52 Weeks)|Withdrawal by Subject|6|||
27769152|NCT02531633|54222144|FG002|Part A (52 Weeks)|Withdrawal by Subject|1|||
27769153|NCT02531633|54222145|FG003|Part A (52 Weeks)|Withdrawal by Subject|3|||
27769154|NCT02531633|54222146|FG004|Part A (52 Weeks)|Withdrawal by Subject|3|||
27769155|NCT02531633|54222147|FG005|Part A (52 Weeks)|Withdrawal by Subject|0|||
27769156|NCT02531633|54222148|FG006|Part A (52 Weeks)|Withdrawal by Subject|0|||
27769157|NCT02531633|54222149|FG007|Part A (52 Weeks)|Withdrawal by Subject|0|||
27769158|NCT02531633|54222150|FG008|Part A (52 Weeks)|Withdrawal by Subject|0|||
27769159|NCT02531633|54222151|FG009|Part A (52 Weeks)|Withdrawal by Subject|0|||
27769160|NCT02531633|54222142|FG000|Part A (52 Weeks)|Other|2|||
27769161|NCT02531633|54222143|FG001|Part A (52 Weeks)|Other|0|||
27769162|NCT02531633|54222144|FG002|Part A (52 Weeks)|Other|0|||
27769163|NCT02531633|54222145|FG003|Part A (52 Weeks)|Other|0|||
27769164|NCT02531633|54222146|FG004|Part A (52 Weeks)|Other|0|||
27769165|NCT02531633|54222147|FG005|Part A (52 Weeks)|Other|0|||
27769166|NCT02531633|54222148|FG006|Part A (52 Weeks)|Other|0|||
27769167|NCT02531633|54222149|FG007|Part A (52 Weeks)|Other|0|||
27769168|NCT02531633|54222150|FG008|Part A (52 Weeks)|Other|0|||
27769169|NCT02531633|54222151|FG009|Part A (52 Weeks)|Other|0|||
27769170|NCT02531633|54222142|FG000|Part B (104 Weeks)|Sponsor request|0|||
27769171|NCT02531633|54222143|FG001|Part B (104 Weeks)|Sponsor request|0|||
27769172|NCT02531633|54222144|FG002|Part B (104 Weeks)|Sponsor request|0|||
27769173|NCT02531633|54222145|FG003|Part B (104 Weeks)|Sponsor request|0|||
27769174|NCT02531633|54222146|FG004|Part B (104 Weeks)|Sponsor request|0|||
27769175|NCT02531633|54222147|FG005|Part B (104 Weeks)|Sponsor request|8|||
27769176|NCT02531633|54222148|FG006|Part B (104 Weeks)|Sponsor request|5|||
27769177|NCT02531633|54222149|FG007|Part B (104 Weeks)|Sponsor request|3|||
27769178|NCT02531633|54222150|FG008|Part B (104 Weeks)|Sponsor request|5|||
27769179|NCT02531633|54222151|FG009|Part B (104 Weeks)|Sponsor request|4|||
27769180|NCT02531633|54222142|FG000|Part B (104 Weeks)|Lost to Follow-up|0|||
27769181|NCT02531633|54222143|FG001|Part B (104 Weeks)|Lost to Follow-up|0|||
27769182|NCT02531633|54222144|FG002|Part B (104 Weeks)|Lost to Follow-up|0|||
27769183|NCT02531633|54222145|FG003|Part B (104 Weeks)|Lost to Follow-up|0|||
27769184|NCT02531633|54222146|FG004|Part B (104 Weeks)|Lost to Follow-up|0|||
27769185|NCT02531633|54222147|FG005|Part B (104 Weeks)|Lost to Follow-up|0|||
27769186|NCT02531633|54222148|FG006|Part B (104 Weeks)|Lost to Follow-up|0|||
27769187|NCT02531633|54222149|FG007|Part B (104 Weeks)|Lost to Follow-up|1|||
27769188|NCT02531633|54222150|FG008|Part B (104 Weeks)|Lost to Follow-up|0|||
27769189|NCT02531633|54222151|FG009|Part B (104 Weeks)|Lost to Follow-up|0|||
27769190|NCT02536313|54222193|FG000|Overall Study|Lack of Efficacy|0|||
27769191|NCT02536313|54222194|FG001|Overall Study|Lack of Efficacy|1|||
27769192|NCT02187861|54222206|FG000|Overall Study|Adverse Event|2|||
27769193|NCT02187861|54222207|FG001|Overall Study|Adverse Event|1|||
27769194|NCT02187861|54222208|FG002|Overall Study|Adverse Event|2|||
27769195|NCT02187861|54222209|FG003|Overall Study|Adverse Event|1|||
27769196|NCT02187861|54222206|FG000|Overall Study|Death|0|||
27769197|NCT02187861|54222207|FG001|Overall Study|Death|3|||
27769198|NCT02187861|54222208|FG002|Overall Study|Death|1|||
27769199|NCT02187861|54222209|FG003|Overall Study|Death|2|||
27769200|NCT02187861|54222206|FG000|Overall Study|Physician Decision|0|||
27769201|NCT02187861|54222207|FG001|Overall Study|Physician Decision|1|||
27769202|NCT02187861|54222208|FG002|Overall Study|Physician Decision|0|||
27769203|NCT02187861|54222209|FG003|Overall Study|Physician Decision|3|||
27769204|NCT02187861|54222206|FG000|Overall Study|Progressive Disease|4|||
27769205|NCT02187861|54222207|FG001|Overall Study|Progressive Disease|42|||
27769206|NCT02187861|54222208|FG002|Overall Study|Progressive Disease|19|||
27769207|NCT02187861|54222209|FG003|Overall Study|Progressive Disease|22|||
27769208|NCT02187861|54222206|FG000|Overall Study|Withdrawal by Subject|0|||
27769209|NCT02187861|54222207|FG001|Overall Study|Withdrawal by Subject|0|||
27769210|NCT02187861|54222208|FG002|Overall Study|Withdrawal by Subject|3|||
27769211|NCT02187861|54222209|FG003|Overall Study|Withdrawal by Subject|3|||
27769212|NCT02187861|54222206|FG000|Overall Study|Other|0|||
27769213|NCT02187861|54222207|FG001|Overall Study|Other|1|||
27769214|NCT02187861|54222208|FG002|Overall Study|Other|7|||
27769215|NCT02187861|54222209|FG003|Overall Study|Other|1|||
27769216|NCT02163993|54222224|FG000|Treatment Period|Adverse Event|0|||
27769217|NCT02163993|54222225|FG001|Treatment Period|Adverse Event|1|||
27769218|NCT02163993|54222226|FG002|Treatment Period|Adverse Event|0|||
27769219|NCT02163993|54222227|FG003|Treatment Period|Adverse Event|0|||
27769220|NCT02163993|54222228|FG004|Treatment Period|Adverse Event|1|||
27769221|NCT02163993|54222224|FG000|Treatment Period|Lost to Follow-up|2|||
27769222|NCT02163993|54222225|FG001|Treatment Period|Lost to Follow-up|3|||
27769223|NCT02163993|54222226|FG002|Treatment Period|Lost to Follow-up|1|||
27769224|NCT02163993|54222227|FG003|Treatment Period|Lost to Follow-up|3|||
27769225|NCT02163993|54222228|FG004|Treatment Period|Lost to Follow-up|1|||
27769226|NCT02163993|54222224|FG000|Treatment Period|Physician Decision|1|||
27769227|NCT02163993|54222225|FG001|Treatment Period|Physician Decision|0|||
27769228|NCT02163993|54222226|FG002|Treatment Period|Physician Decision|0|||
27769229|NCT02163993|54222227|FG003|Treatment Period|Physician Decision|0|||
27769230|NCT02163993|54222228|FG004|Treatment Period|Physician Decision|0|||
27769231|NCT02163993|54222224|FG000|Treatment Period|Protocol Violation|2|||
27769232|NCT02163993|54222225|FG001|Treatment Period|Protocol Violation|1|||
27769233|NCT02163993|54222226|FG002|Treatment Period|Protocol Violation|0|||
27769234|NCT02163993|54222227|FG003|Treatment Period|Protocol Violation|1|||
27769235|NCT02163993|54222228|FG004|Treatment Period|Protocol Violation|2|||
27769236|NCT02163993|54222224|FG000|Treatment Period|Withdrawal by Subject|6|||
27769237|NCT02163993|54222225|FG001|Treatment Period|Withdrawal by Subject|4|||
27769238|NCT02163993|54222226|FG002|Treatment Period|Withdrawal by Subject|1|||
27769239|NCT02163993|54222227|FG003|Treatment Period|Withdrawal by Subject|4|||
27769240|NCT02163993|54222228|FG004|Treatment Period|Withdrawal by Subject|1|||
27769241|NCT02163993|54222224|FG000|Treatment Period|Not treated|1|||
27769242|NCT02163993|54222225|FG001|Treatment Period|Not treated|0|||
27769243|NCT02163993|54222226|FG002|Treatment Period|Not treated|0|||
27769244|NCT02163993|54222227|FG003|Treatment Period|Not treated|1|||
27769245|NCT02163993|54222228|FG004|Treatment Period|Not treated|2|||
27769246|NCT02163993|54222224|FG000|Post-treatment Period|Adverse Event|0|||
27769247|NCT02163993|54222225|FG001|Post-treatment Period|Adverse Event|0|||
27769248|NCT02163993|54222226|FG002|Post-treatment Period|Adverse Event|1|||
27769249|NCT02163993|54222227|FG003|Post-treatment Period|Adverse Event|0|||
27769250|NCT02163993|54222228|FG004|Post-treatment Period|Adverse Event|0|||
27769251|NCT02163993|54222224|FG000|Post-treatment Period|Lost to Follow-up|2|||
27769252|NCT02163993|54222225|FG001|Post-treatment Period|Lost to Follow-up|2|||
27769253|NCT02163993|54222226|FG002|Post-treatment Period|Lost to Follow-up|3|||
27769254|NCT02163993|54222227|FG003|Post-treatment Period|Lost to Follow-up|1|||
27769255|NCT02163993|54222228|FG004|Post-treatment Period|Lost to Follow-up|0|||
27769256|NCT02163993|54222224|FG000|Post-treatment Period|Protocol Violation|0|||
27769257|NCT02163993|54222225|FG001|Post-treatment Period|Protocol Violation|0|||
27769258|NCT02163993|54222226|FG002|Post-treatment Period|Protocol Violation|0|||
27769259|NCT02163993|54222227|FG003|Post-treatment Period|Protocol Violation|0|||
27769260|NCT02163993|54222228|FG004|Post-treatment Period|Protocol Violation|1|||
27769261|NCT02163993|54222224|FG000|Post-treatment Period|Withdrawal by Subject|2|||
27769262|NCT02163993|54222225|FG001|Post-treatment Period|Withdrawal by Subject|4|||
27769263|NCT02163993|54222226|FG002|Post-treatment Period|Withdrawal by Subject|0|||
27769264|NCT02163993|54222227|FG003|Post-treatment Period|Withdrawal by Subject|1|||
27769265|NCT02163993|54222228|FG004|Post-treatment Period|Withdrawal by Subject|2|||
27769266|NCT02527421|54222251|FG000|Overall Study|Withdrawal by Subject|1|||
27769267|NCT02527421|54222252|FG001|Overall Study|Withdrawal by Subject|0|||
27769268|NCT02163915|54222263|FG000|Overall Study|Withdrawal by Subject|2|||
27769269|NCT02163915|54222264|FG001|Overall Study|Withdrawal by Subject|0|||
27769270|NCT02163915|54222265|FG002|Overall Study|Withdrawal by Subject|2|||
27769271|NCT02163915|54222266|FG003|Overall Study|Withdrawal by Subject|2|||
27769272|NCT02163915|54222267|FG004|Overall Study|Withdrawal by Subject|2|||
27769273|NCT02163915|54222263|FG000|Overall Study|Study termination|1|||
27769274|NCT02163915|54222264|FG001|Overall Study|Study termination|0|||
27769275|NCT02163915|54222265|FG002|Overall Study|Study termination|0|||
27769276|NCT02163915|54222266|FG003|Overall Study|Study termination|0|||
27769277|NCT02163915|54222267|FG004|Overall Study|Study termination|2|||
27769278|NCT02163915|54222263|FG000|Overall Study|Physician Decision|0|||
27769279|NCT02163915|54222264|FG001|Overall Study|Physician Decision|0|||
27769280|NCT02163915|54222265|FG002|Overall Study|Physician Decision|0|||
27769281|NCT02163915|54222266|FG003|Overall Study|Physician Decision|1|||
27769282|NCT02163915|54222267|FG004|Overall Study|Physician Decision|0|||
27769283|NCT02163759|54222286|FG000|Overall Study|Withdrawal by Subject|1|||
27769284|NCT02163759|54222287|FG001|Overall Study|Withdrawal by Subject|5|||
27769285|NCT02163759|54222288|FG002|Overall Study|Withdrawal by Subject|1|||
27769286|NCT02163759|54222286|FG000|Overall Study|Adverse Event|0|||
27769287|NCT02163759|54222287|FG001|Overall Study|Adverse Event|0|||
27769288|NCT02163759|54222288|FG002|Overall Study|Adverse Event|1|||
27769289|NCT02163759|54222286|FG000|Overall Study|Death|0|||
27769290|NCT02163759|54222287|FG001|Overall Study|Death|0|||
27769291|NCT02163759|54222288|FG002|Overall Study|Death|1|||
27769292|NCT02371369|54222301|FG000|Part 1|Physician Decision|0|||
27769293|NCT02371369|54222302|FG001|Part 1|Physician Decision|3|||
27769294|NCT02371369|54222301|FG000|Part 1|Adverse Event|8|||
27769295|NCT02371369|54222302|FG001|Part 1|Adverse Event|0|||
27769296|NCT02371369|54222301|FG000|Part 1|Withdrawal by Subject|1|||
27769297|NCT02371369|54222302|FG001|Part 1|Withdrawal by Subject|6|||
27769298|NCT02371369|54222301|FG000|Part 1|Disease progression|0|||
27769299|NCT02371369|54222302|FG001|Part 1|Disease progression|1|||
27769300|NCT02371369|54222301|FG000|Part 1|Protocol Violation|0|||
27769301|NCT02371369|54222302|FG001|Part 1|Protocol Violation|1|||
27769302|NCT02371369|54222301|FG000|Part 2|Adverse Event|6|||
27769303|NCT02371369|54222302|FG001|Part 2|Adverse Event|5|||
27769304|NCT02371369|54222301|FG000|Part 2|Withdrawal by Subject|16|||
27769305|NCT02371369|54222302|FG001|Part 2|Withdrawal by Subject|6|||
27769306|NCT02371369|54222301|FG000|Part 2|Investigator decision|1|||
27769307|NCT02371369|54222302|FG001|Part 2|Investigator decision|2|||
27769308|NCT02371369|54222301|FG000|Part 2|Death|0|||
27769309|NCT02371369|54222302|FG001|Part 2|Death|1|||
27769310|NCT02371369|54222301|FG000|Part 2|Disease progression|1|||
27769311|NCT02371369|54222302|FG001|Part 2|Disease progression|0|||
27769312|NCT02371369|54222301|FG000|Part 2|Subject Noncompliance|1|||
27769313|NCT02371369|54222302|FG001|Part 2|Subject Noncompliance|0|||
27769314|NCT02371369|54222301|FG000|Part 2|Lost to Follow-up|1|||
27769315|NCT02371369|54222302|FG001|Part 2|Lost to Follow-up|1|||
27769316|NCT02371369|54222301|FG000|Part 2|Subject transitioned to commercial supply|6|||
27769317|NCT02371369|54222302|FG001|Part 2|Subject transitioned to commercial supply|4|||
27769318|NCT02371369|54222301|FG000|Part 2|Subject transitioned to another DS pexidartinib protocol|15|||
27769319|NCT02371369|54222302|FG001|Part 2|Subject transitioned to another DS pexidartinib protocol|9|||
27769320|NCT02371369|54222301|FG000|Part 2|Surgical resection of tumor|1|||
27769321|NCT02371369|54222302|FG001|Part 2|Surgical resection of tumor|1|||
27769322|NCT02371369|54222301|FG000|Part 2|Other|0|||
27769323|NCT02371369|54222302|FG001|Part 2|Other|1|||
27769324|NCT02187783|54222324|FG000|Overall Study|Adverse Event|8|||
27769325|NCT02187783|54222324|FG000|Overall Study|Death|3|||
27769326|NCT02187783|54222324|FG000|Overall Study|Progressive disease|80|||
27769327|NCT02187783|54222324|FG000|Overall Study|Protocol Violation|3|||
27769328|NCT02187783|54222324|FG000|Overall Study|Physician Decision|2|||
27769329|NCT02187783|54222324|FG000|Overall Study|Withdrawal by Subject|9|||
27769330|NCT02187783|54222324|FG000|Overall Study|Study terminated by sponsor|1|||
27769331|NCT02337361|54222330|FG000|3-month Follow-up|Lost to Follow-up|19|||
27769332|NCT02337361|54222331|FG001|3-month Follow-up|Lost to Follow-up|14|||
27769333|NCT02337361|54222330|FG000|6-month Follow-up|Lost to Follow-up|2|||
27769334|NCT02337361|54222331|FG001|6-month Follow-up|Lost to Follow-up|4|||
27769335|NCT02336737|54222338|FG000|Overall Study|Withdrawal by Subject|5|||
27769336|NCT02336737|54222338|FG000|Overall Study|Physician Decision|8|||
27769337|NCT02130765|54222347|FG000|Overall Study|Did not receive treatment|4|||
27769338|NCT02130765|54222348|FG001|Overall Study|Did not receive treatment|0|||
27769339|NCT02130765|54222349|FG002|Overall Study|Did not receive treatment|0|||
27769340|NCT02130765|54222350|FG003|Overall Study|Did not receive treatment|0|||
27769341|NCT02305381|54222365|FG000|Overall Study|Unclassified|5|||
27769342|NCT02305381|54222366|FG001|Overall Study|Unclassified|5|||
27769343|NCT02305381|54222367|FG002|Overall Study|Unclassified|7|||
27769344|NCT02336425|54222379|FG000|Overall Study|Study terminated.|2|||
27769345|NCT02336425|54222380|FG001|Overall Study|Study terminated.|2|||
27769346|NCT02336425|54222381|FG002|Overall Study|Study terminated.|3|||
27769347|NCT02336425|54222382|FG003|Overall Study|Study terminated.|3|||
27769348|NCT02163447|54222395|FG000|Overall Study|Withdrawal by Subject|2|||
27769349|NCT02163447|54222396|FG001|Overall Study|Withdrawal by Subject|0|||
27769350|NCT02163447|54222397|FG002|Overall Study|Withdrawal by Subject|1|||
27769351|NCT02163447|54222395|FG000|Overall Study|Lost to Follow-up|1|||
27769352|NCT02163447|54222396|FG001|Overall Study|Lost to Follow-up|3|||
27769353|NCT02163447|54222397|FG002|Overall Study|Lost to Follow-up|0|||
27769354|NCT02163447|54222395|FG000|Overall Study|Moved out of study area|2|||
27769355|NCT02163447|54222396|FG001|Overall Study|Moved out of study area|3|||
27769356|NCT02163447|54222397|FG002|Overall Study|Moved out of study area|2|||
27769357|NCT02163447|54222395|FG000|Overall Study|Became HIV infected at time of delivery|1|||
27769358|NCT02163447|54222396|FG001|Overall Study|Became HIV infected at time of delivery|0|||
27769359|NCT02163447|54222397|FG002|Overall Study|Became HIV infected at time of delivery|0|||
27769360|NCT02370667|54222418|FG000|Overall Study|Lost to Follow-up|0|||
27769361|NCT02370667|54222419|FG001|Overall Study|Lost to Follow-up|1|||
27769362|NCT02370667|54222420|FG002|Overall Study|Lost to Follow-up|0|||
27769363|NCT02130297|54222428|FG000|Overall Study|Lost to Follow-up|4|||
27769364|NCT01931956|54222436|FG000|Overall Study|Death|42|||
27769365|NCT01931956|54222437|FG001|Overall Study|Death|7|||
27769366|NCT01931956|54222438|FG002|Overall Study|Death|379|||
27769367|NCT01931956|54222439|FG003|Overall Study|Death|96|||
27769368|NCT01931956|54222436|FG000|Overall Study|Withdrawal by Subject|5|||
27769369|NCT01931956|54222437|FG001|Overall Study|Withdrawal by Subject|0|||
27769370|NCT01931956|54222438|FG002|Overall Study|Withdrawal by Subject|70|||
27769371|NCT01931956|54222439|FG003|Overall Study|Withdrawal by Subject|30|||
27769372|NCT01931956|54222436|FG000|Overall Study|Lost to Follow-up|2|||
27769373|NCT01931956|54222437|FG001|Overall Study|Lost to Follow-up|0|||
27769374|NCT01931956|54222438|FG002|Overall Study|Lost to Follow-up|11|||
27769375|NCT01931956|54222439|FG003|Overall Study|Lost to Follow-up|7|||
27769376|NCT01931956|54222436|FG000|Overall Study|Expected|2|||
27769377|NCT01931956|54222437|FG001|Overall Study|Expected|0|||
27769378|NCT01931956|54222438|FG002|Overall Study|Expected|6|||
27769379|NCT01931956|54222439|FG003|Overall Study|Expected|0|||
27769380|NCT01931956|54222436|FG000|Overall Study|Not due|0|||
27769381|NCT01931956|54222437|FG001|Overall Study|Not due|0|||
27769382|NCT01931956|54222438|FG002|Overall Study|Not due|21|||
27769383|NCT01931956|54222439|FG003|Overall Study|Not due|0|||
27769384|NCT01887418|54222465|FG000|Overall Study|Travelling difficulties|0|||
27769385|NCT01887418|54222466|FG001|Overall Study|Travelling difficulties|0|||
27769386|NCT01887418|54222467|FG002|Overall Study|Travelling difficulties|1|||
27769387|NCT01886716|54222479|FG000|Week 1|Lost to Follow-up|0|||
27769388|NCT01886716|54222480|FG001|Week 1|Lost to Follow-up|0|||
27769389|NCT01886716|54222481|FG002|Week 1|Lost to Follow-up|2|||
27769390|NCT01886716|54222482|FG003|Week 1|Lost to Follow-up|2|||
27769391|NCT01886716|54222479|FG000|Week 2|Lost to Follow-up|3|||
27769392|NCT01886716|54222480|FG001|Week 2|Lost to Follow-up|2|||
27769393|NCT01886716|54222481|FG002|Week 2|Lost to Follow-up|1|||
27839818|NCT01693562|54327128|FG017|Exploration Phase|Death|0|||
27769394|NCT01886716|54222482|FG003|Week 2|Lost to Follow-up|3|||
27769395|NCT01886716|54222479|FG000|Week 3|Lost to Follow-up|1|||
27769396|NCT01886716|54222480|FG001|Week 3|Lost to Follow-up|1|||
27769397|NCT01886716|54222481|FG002|Week 3|Lost to Follow-up|0|||
27769398|NCT01886716|54222482|FG003|Week 3|Lost to Follow-up|1|||
27769399|NCT01912612|54222494|FG000|Overall Study|Adverse Event|4|||
27769400|NCT01912612|54222495|FG001|Overall Study|Adverse Event|0|||
27769401|NCT01912612|54222496|FG002|Overall Study|Adverse Event|0|||
27769402|NCT01912612|54222494|FG000|Overall Study|Withdrew consent|1|||
27769403|NCT01912612|54222495|FG001|Overall Study|Withdrew consent|0|||
27769404|NCT01912612|54222496|FG002|Overall Study|Withdrew consent|0|||
27769405|NCT01912612|54222494|FG000|Overall Study|Study design change|0|||
27769406|NCT01912612|54222495|FG001|Overall Study|Study design change|0|||
27769407|NCT01912612|54222496|FG002|Overall Study|Study design change|3|||
27769408|NCT02370511|54222505|FG000|Overall Study|Death|10|||
27769409|NCT02370511|54222506|FG001|Overall Study|Death|7|||
27769410|NCT02370511|54222507|FG002|Overall Study|Death|1|||
27769411|NCT02370511|54222505|FG000|Overall Study|Withdrawal by Subject|2|||
27769412|NCT02370511|54222506|FG001|Overall Study|Withdrawal by Subject|0|||
27769413|NCT02370511|54222507|FG002|Overall Study|Withdrawal by Subject|0|||
27769414|NCT02370511|54222505|FG000|Overall Study|Lost to Follow-up|0|||
27769415|NCT02370511|54222506|FG001|Overall Study|Lost to Follow-up|4|||
27769416|NCT02370511|54222507|FG002|Overall Study|Lost to Follow-up|0|||
27769417|NCT02303041|54222517|FG000|Overall Study|Adverse Event|1|||
27769418|NCT02303041|54222518|FG001|Overall Study|Adverse Event|2|||
27769419|NCT02302807|54222526|FG000|Overall Study|Withdrawal by Subject|28|||
27769420|NCT02302807|54222527|FG001|Overall Study|Withdrawal by Subject|11|||
27769421|NCT02302807|54222526|FG000|Overall Study|Lost to Follow-up|4|||
27769422|NCT02302807|54222527|FG001|Overall Study|Lost to Follow-up|6|||
27769423|NCT02302807|54222526|FG000|Overall Study|Death|397|||
27769424|NCT02302807|54222527|FG001|Overall Study|Death|385|||
27769425|NCT02302807|54222526|FG000|Overall Study|Study Terminated By Sponsor|35|||
27769426|NCT02302807|54222527|FG001|Overall Study|Study Terminated By Sponsor|64|||
27769427|NCT02302807|54222526|FG000|Overall Study|Physician Decision|0|||
27769428|NCT02302807|54222527|FG001|Overall Study|Physician Decision|1|||
27769429|NCT02335489|54222546|FG000|Overall Study|Sponsor terminated study|4|||
27769430|NCT02335489|54222546|FG000|Overall Study|Lost to Follow-up|1|||
27769431|NCT02335489|54222546|FG000|Overall Study|Withdrawal by Subject|2|||
27769432|NCT02335489|54222546|FG000|Overall Study|Physician Decision|2|||
27769433|NCT02335489|54222546|FG000|Overall Study|Lack of Efficacy|1|||
27769434|NCT02527343|54222552|FG000|RT Period: Weeks 1 to 52|Investigator Judgement|1|||
27769435|NCT02527343|54222553|FG001|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
27769436|NCT02527343|54222554|FG002|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
27769437|NCT02527343|54222555|FG003|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
27769438|NCT02527343|54222556|FG004|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
27769439|NCT02527343|54222557|FG005|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
27769440|NCT02527343|54222552|FG000|RT Period: Weeks 1 to 52|Voluntary withdrawal|1|||
27769441|NCT02527343|54222553|FG001|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
27769442|NCT02527343|54222554|FG002|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
27769443|NCT02527343|54222555|FG003|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
27769444|NCT02527343|54222556|FG004|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
27769445|NCT02527343|54222557|FG005|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
27769446|NCT02527343|54222552|FG000|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
27769447|NCT02527343|54222553|FG001|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|4|||
27769448|NCT02527343|54222554|FG002|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
27769449|NCT02527343|54222555|FG003|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
27769450|NCT02527343|54222556|FG004|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
27769451|NCT02527343|54222557|FG005|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
27769452|NCT02527343|54222552|FG000|RT Period: Weeks 1 to 52|Other|4|||
27769453|NCT02527343|54222553|FG001|RT Period: Weeks 1 to 52|Other|3|||
27769454|NCT02527343|54222554|FG002|RT Period: Weeks 1 to 52|Other|0|||
27769455|NCT02527343|54222555|FG003|RT Period: Weeks 1 to 52|Other|0|||
27769456|NCT02527343|54222556|FG004|RT Period: Weeks 1 to 52|Other|0|||
27769457|NCT02527343|54222557|FG005|RT Period: Weeks 1 to 52|Other|0|||
27769458|NCT02527343|54222552|FG000|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
27769459|NCT02527343|54222553|FG001|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
27839819|NCT01693562|54327129|FG018|Exploration Phase|Death|0|||
27769460|NCT02527343|54222554|FG002|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|1|||
27769461|NCT02527343|54222555|FG003|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
27769462|NCT02527343|54222556|FG004|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
27769463|NCT02527343|54222557|FG005|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
27769464|NCT02527343|54222552|FG000|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
27769465|NCT02527343|54222553|FG001|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
27769466|NCT02527343|54222554|FG002|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
27769467|NCT02527343|54222555|FG003|RT Post Treatment Follow-up: Weeks 54-65|Other|2|||
27769468|NCT02527343|54222556|FG004|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
27769469|NCT02527343|54222557|FG005|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
27769470|NCT02527343|54222552|FG000|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
27769471|NCT02527343|54222553|FG001|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
27769472|NCT02527343|54222554|FG002|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
27769473|NCT02527343|54222555|FG003|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
27769474|NCT02527343|54222556|FG004|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|1|||
27769475|NCT02527343|54222557|FG005|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
27769476|NCT02527343|54222552|FG000|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
27769477|NCT02527343|54222553|FG001|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
27769478|NCT02527343|54222554|FG002|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
27769479|NCT02527343|54222555|FG003|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
27769480|NCT02527343|54222556|FG004|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|3|||
27769481|NCT02527343|54222557|FG005|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|1|||
27769482|NCT02527343|54222552|FG000|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
27769483|NCT02527343|54222553|FG001|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
27769484|NCT02527343|54222554|FG002|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
27769485|NCT02527343|54222555|FG003|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
27769486|NCT02527343|54222556|FG004|OLE Period-Year 1: Week 53 to 104|AE or SAE|2|||
27769487|NCT02527343|54222557|FG005|OLE Period-Year 1: Week 53 to 104|AE or SAE|1|||
27769488|NCT02527343|54222552|FG000|OLE Period-Year 1: Week 53 to 104|Other|0|||
27769489|NCT02527343|54222553|FG001|OLE Period-Year 1: Week 53 to 104|Other|0|||
27769490|NCT02527343|54222554|FG002|OLE Period-Year 1: Week 53 to 104|Other|0|||
27769491|NCT02527343|54222555|FG003|OLE Period-Year 1: Week 53 to 104|Other|0|||
27769492|NCT02527343|54222556|FG004|OLE Period-Year 1: Week 53 to 104|Other|5|||
27769493|NCT02527343|54222557|FG005|OLE Period-Year 1: Week 53 to 104|Other|7|||
27769494|NCT02527343|54222552|FG000|OLE Period-Year 2: Week 105 to 156|Other|0|||
27769495|NCT02527343|54222553|FG001|OLE Period-Year 2: Week 105 to 156|Other|0|||
27769496|NCT02527343|54222554|FG002|OLE Period-Year 2: Week 105 to 156|Other|0|||
27769497|NCT02527343|54222555|FG003|OLE Period-Year 2: Week 105 to 156|Other|0|||
27769498|NCT02527343|54222556|FG004|OLE Period-Year 2: Week 105 to 156|Other|1|||
27769499|NCT02527343|54222557|FG005|OLE Period-Year 2: Week 105 to 156|Other|2|||
27769500|NCT02527343|54222552|FG000|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
27769501|NCT02527343|54222553|FG001|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
27769502|NCT02527343|54222554|FG002|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
27769503|NCT02527343|54222555|FG003|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
27769504|NCT02527343|54222556|FG004|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|1|||
27769505|NCT02527343|54222557|FG005|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
27769506|NCT02527343|54222552|FG000|PT Follow-up: Weeks 104 to 169|Other|0|||
27769507|NCT02527343|54222553|FG001|PT Follow-up: Weeks 104 to 169|Other|0|||
27769508|NCT02527343|54222554|FG002|PT Follow-up: Weeks 104 to 169|Other|0|||
27769509|NCT02527343|54222555|FG003|PT Follow-up: Weeks 104 to 169|Other|0|||
27769510|NCT02527343|54222556|FG004|PT Follow-up: Weeks 104 to 169|Other|0|||
27769511|NCT02527343|54222557|FG005|PT Follow-up: Weeks 104 to 169|Other|1|||
27769512|NCT01931566|54222575|FG000|Overall Study|Randomized But Not Treated|6|||
27769513|NCT01931566|54222576|FG001|Overall Study|Randomized But Not Treated|9|||
27769514|NCT01931566|54222577|FG002|Overall Study|Randomized But Not Treated|14|||
27769515|NCT01931566|54222575|FG000|Overall Study|Adverse Event|37|||
27769516|NCT01931566|54222576|FG001|Overall Study|Adverse Event|167|||
27769517|NCT01931566|54222577|FG002|Overall Study|Adverse Event|132|||
27769518|NCT01931566|54222575|FG000|Overall Study|Major Protocol Deviation|5|||
27769519|NCT01931566|54222576|FG001|Overall Study|Major Protocol Deviation|14|||
27769520|NCT01931566|54222577|FG002|Overall Study|Major Protocol Deviation|21|||
27769521|NCT01931566|54222575|FG000|Overall Study|Lost to Follow-up|3|||
27769522|NCT01931566|54222576|FG001|Overall Study|Lost to Follow-up|26|||
27769523|NCT01931566|54222577|FG002|Overall Study|Lost to Follow-up|23|||
27769524|NCT01931566|54222575|FG000|Overall Study|Voluntary Withdrawal|78|||
27769525|NCT01931566|54222576|FG001|Overall Study|Voluntary Withdrawal|245|||
27769526|NCT01931566|54222577|FG002|Overall Study|Voluntary Withdrawal|225|||
27769527|NCT01931566|54222575|FG000|Overall Study|Study Termination|289|||
27769528|NCT01931566|54222576|FG001|Overall Study|Study Termination|968|||
27769529|NCT01931566|54222577|FG002|Overall Study|Study Termination|1037|||
27769530|NCT01931566|54222575|FG000|Overall Study|Reason Not Specified|11|||
27769531|NCT01931566|54222576|FG001|Overall Study|Reason Not Specified|47|||
27769532|NCT01931566|54222577|FG002|Overall Study|Reason Not Specified|53|||
27769533|NCT01931566|54222575|FG000|Overall Study|Missing|0|||
27769534|NCT01931566|54222576|FG001|Overall Study|Missing|0|||
27769535|NCT01931566|54222577|FG002|Overall Study|Missing|1|||
27769536|NCT01912456|54222588|FG000|Period 1|Physician Decision|0|||
27769537|NCT01912456|54222589|FG001|Period 1|Physician Decision|0|||
27769538|NCT01912456|54222590|FG002|Period 1|Physician Decision|1|||
27769539|NCT01912456|54222591|FG003|Period 1|Physician Decision|0|||
27769540|NCT01912456|54222588|FG000|Period 1|non-compliance|1|||
27769541|NCT01912456|54222589|FG001|Period 1|non-compliance|0|||
27769542|NCT01912456|54222590|FG002|Period 1|non-compliance|0|||
27769543|NCT01912456|54222591|FG003|Period 1|non-compliance|1|||
27769544|NCT01912456|54222588|FG000|Period 1|Adverse Event|1|||
27769545|NCT01912456|54222589|FG001|Period 1|Adverse Event|0|||
27769546|NCT01912456|54222590|FG002|Period 1|Adverse Event|0|||
27769547|NCT01912456|54222591|FG003|Period 1|Adverse Event|1|||
27769548|NCT01912456|54222588|FG000|Period 1|Withdrawal by Subject|0|||
27769549|NCT01912456|54222589|FG001|Period 1|Withdrawal by Subject|1|||
27769550|NCT01912456|54222590|FG002|Period 1|Withdrawal by Subject|1|||
27769551|NCT01912456|54222591|FG003|Period 1|Withdrawal by Subject|1|||
27769552|NCT01912456|54222588|FG000|Period 2|Lack of Efficacy|0|||
27769553|NCT01912456|54222589|FG001|Period 2|Lack of Efficacy|2|||
27769554|NCT01912456|54222590|FG002|Period 2|Lack of Efficacy|0|||
27769555|NCT01912456|54222591|FG003|Period 2|Lack of Efficacy|0|||
27769556|NCT01912456|54222588|FG000|Period 2|Adverse Event|0|||
27769557|NCT01912456|54222589|FG001|Period 2|Adverse Event|0|||
27769558|NCT01912456|54222590|FG002|Period 2|Adverse Event|0|||
27769559|NCT01912456|54222591|FG003|Period 2|Adverse Event|1|||
27769560|NCT01885936|54222603|FG000|Overall Study|Withdrawal by Subject|1|||
27769561|NCT01885936|54222604|FG001|Overall Study|Withdrawal by Subject|0|||
27769562|NCT01912222|54222613|FG000|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1|||
27769563|NCT01912222|54222614|FG001|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
27769564|NCT01912222|54222615|FG002|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
27769565|NCT01912222|54222613|FG000|Part B: Treatment Period|Progressive disease|10|||
27769566|NCT01912222|54222614|FG001|Part B: Treatment Period|Progressive disease|12|||
27769567|NCT01912222|54222615|FG002|Part B: Treatment Period|Progressive disease|15|||
27769568|NCT01912222|54222613|FG000|Part B: Treatment Period|Adverse Event|1|||
27769569|NCT01912222|54222614|FG001|Part B: Treatment Period|Adverse Event|2|||
27769570|NCT01912222|54222615|FG002|Part B: Treatment Period|Adverse Event|3|||
27769571|NCT01912222|54222613|FG000|Part B: Treatment Period|Withdrawal by Subject|2|||
27769572|NCT01912222|54222614|FG001|Part B: Treatment Period|Withdrawal by Subject|1|||
27769573|NCT01912222|54222615|FG002|Part B: Treatment Period|Withdrawal by Subject|2|||
27769574|NCT02525861|54222626|FG000|Overall Study|Adverse Event|1|||
27769575|NCT02525861|54222627|FG001|Overall Study|Adverse Event|0|||
27769576|NCT02525861|54222626|FG000|Overall Study|Withdrawal by Subject|0|||
27769577|NCT02525861|54222627|FG001|Overall Study|Withdrawal by Subject|1|||
27769578|NCT02525861|54222626|FG000|Overall Study|Physician Decision|0|||
27769579|NCT02525861|54222627|FG001|Overall Study|Physician Decision|1|||
27769580|NCT02524847|54222635|FG000|Overall Study|Adverse Event|4|||
27769581|NCT02524847|54222635|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
27769582|NCT02524847|54222635|FG000|Overall Study|Condition no Longer Requires Treatment|4|||
27769583|NCT02524847|54222635|FG000|Overall Study|Death|1|||
27769584|NCT02524847|54222635|FG000|Overall Study|Reason not Specified|1|||
27769585|NCT02525627|54222642|FG000|Overall Study|Revision|1|||
27769586|NCT02525627|54222643|FG001|Overall Study|Revision|1|||
27769587|NCT02525627|54222642|FG000|Overall Study|Withdrawal by Subject|1|||
27769588|NCT02525627|54222643|FG001|Overall Study|Withdrawal by Subject|2|||
27769589|NCT02525627|54222642|FG000|Overall Study|Death|1|||
27769590|NCT02525627|54222643|FG001|Overall Study|Death|0|||
27769591|NCT02525627|54222642|FG000|Overall Study|Site terminated|11|||
27769592|NCT02525627|54222643|FG001|Overall Study|Site terminated|10|||
27769593|NCT02129205|54222659|FG000|Overall Study|Withdrawal by Subject|0|||
27769594|NCT02129205|54222660|FG001|Overall Study|Withdrawal by Subject|0|||
27769595|NCT02129205|54222661|FG002|Overall Study|Withdrawal by Subject|0|||
27769596|NCT02129205|54222662|FG003|Overall Study|Withdrawal by Subject|0|||
27769597|NCT02129205|54222663|FG004|Overall Study|Withdrawal by Subject|1|||
27769598|NCT02129205|54222664|FG005|Overall Study|Withdrawal by Subject|1|||
27769599|NCT02129205|54222665|FG006|Overall Study|Withdrawal by Subject|1|||
27769600|NCT02129205|54222666|FG007|Overall Study|Withdrawal by Subject|0|||
27769601|NCT02129205|54222667|FG008|Overall Study|Withdrawal by Subject|1|||
27769602|NCT02129205|54222668|FG009|Overall Study|Withdrawal by Subject|0|||
27769603|NCT02129205|54222659|FG000|Overall Study|Other|1|||
27769604|NCT02129205|54222660|FG001|Overall Study|Other|0|||
27769605|NCT02129205|54222661|FG002|Overall Study|Other|0|||
27769606|NCT02129205|54222662|FG003|Overall Study|Other|0|||
27769607|NCT02129205|54222663|FG004|Overall Study|Other|2|||
27769608|NCT02129205|54222664|FG005|Overall Study|Other|3|||
27769609|NCT02129205|54222665|FG006|Overall Study|Other|3|||
27769610|NCT02129205|54222666|FG007|Overall Study|Other|2|||
27769611|NCT02129205|54222667|FG008|Overall Study|Other|1|||
27769612|NCT02129205|54222668|FG009|Overall Study|Other|0|||
27839820|NCT01693562|54327130|FG019|Exploration Phase|Death|0|||
27769613|NCT02128269|54222692|FG000|Treatment Period|Adverse Event|1|||
27769614|NCT02128269|54222692|FG000|Treatment Period|Physician Decision|1|||
27769615|NCT01626885|54222696|FG000|Overall Study|Adverse Event|8|||
27769616|NCT01626885|54222696|FG000|Overall Study|Withdrawal by Subject|4|||
27769617|NCT02524379|54222700|FG000|Overall Study|Death|1|||
27769618|NCT02524145|54222707|FG000|Overall Study|Withdrawal by Subject|2|||
27769619|NCT02524145|54222708|FG001|Overall Study|Withdrawal by Subject|2|||
27769620|NCT02524145|54222709|FG002|Overall Study|Withdrawal by Subject|3|||
27769621|NCT01658813|54222717|FG000|Overall Study|Disease progression|3|||
27769622|NCT02187471|54222729|FG000|Overall Study|Protocol Violation|4|||
27769623|NCT02187471|54222730|FG001|Overall Study|Protocol Violation|5|||
27769624|NCT02187471|54222731|FG002|Overall Study|Protocol Violation|4|||
27769625|NCT02187471|54222732|FG003|Overall Study|Protocol Violation|4|||
27769626|NCT02187471|54222729|FG000|Overall Study|Missing|0|||
27769627|NCT02187471|54222730|FG001|Overall Study|Missing|0|||
27769628|NCT02187471|54222731|FG002|Overall Study|Missing|0|||
27769629|NCT02187471|54222732|FG003|Overall Study|Missing|1|||
27769630|NCT02187471|54222729|FG000|Overall Study|Lack of Efficacy|18|||
27769631|NCT02187471|54222730|FG001|Overall Study|Lack of Efficacy|9|||
27769632|NCT02187471|54222731|FG002|Overall Study|Lack of Efficacy|13|||
27769633|NCT02187471|54222732|FG003|Overall Study|Lack of Efficacy|11|||
27769634|NCT02187471|54222729|FG000|Overall Study|Adverse Event|24|||
27769635|NCT02187471|54222730|FG001|Overall Study|Adverse Event|34|||
27769636|NCT02187471|54222731|FG002|Overall Study|Adverse Event|44|||
27769637|NCT02187471|54222732|FG003|Overall Study|Adverse Event|36|||
27769638|NCT02187471|54222729|FG000|Overall Study|Withdrawal by Subject|23|||
27769639|NCT02187471|54222730|FG001|Overall Study|Withdrawal by Subject|29|||
27769640|NCT02187471|54222731|FG002|Overall Study|Withdrawal by Subject|22|||
27769641|NCT02187471|54222732|FG003|Overall Study|Withdrawal by Subject|24|||
27769642|NCT02187471|54222729|FG000|Overall Study|Other|7|||
27769643|NCT02187471|54222730|FG001|Overall Study|Other|5|||
27769644|NCT02187471|54222731|FG002|Overall Study|Other|3|||
27769645|NCT02187471|54222732|FG003|Overall Study|Other|4|||
27769646|NCT02525471|54222743|FG000|Overall Study|Screen Failure|6|||
27769647|NCT02525471|54222743|FG000|Overall Study|Withdrawal by Subject|4|||
27769648|NCT02525471|54222743|FG000|Overall Study|Death|1|||
27769649|NCT01658735|54222751|FG000|Overall Study|Lack of Efficacy|1|||
27769650|NCT01658735|54222752|FG001|Overall Study|Lack of Efficacy|0|||
27769651|NCT01658735|54222753|FG002|Overall Study|Lack of Efficacy|1|||
27769652|NCT01658735|54222751|FG000|Overall Study|Lost to Follow-up|1|||
27769653|NCT01658735|54222752|FG001|Overall Study|Lost to Follow-up|1|||
27769654|NCT01658735|54222753|FG002|Overall Study|Lost to Follow-up|0|||
27769655|NCT01658735|54222751|FG000|Overall Study|Protocol Violation|0|||
27769656|NCT01658735|54222752|FG001|Overall Study|Protocol Violation|1|||
27769657|NCT01658735|54222753|FG002|Overall Study|Protocol Violation|0|||
27769658|NCT01658735|54222751|FG000|Overall Study|Withdrawal by Subject|3|||
27769659|NCT01658735|54222752|FG001|Overall Study|Withdrawal by Subject|5|||
27769660|NCT01658735|54222753|FG002|Overall Study|Withdrawal by Subject|3|||
27769661|NCT02523599|54222763|FG000|Overall Study|Adverse Event|1|||
27769662|NCT02523599|54222764|FG001|Overall Study|Adverse Event|0|||
27769663|NCT02523599|54222763|FG000|Overall Study|Physician Decision|1|||
27769664|NCT02523599|54222764|FG001|Overall Study|Physician Decision|0|||
27769665|NCT02523599|54222763|FG000|Overall Study|Lost to Follow-up|4|||
27769666|NCT02523599|54222764|FG001|Overall Study|Lost to Follow-up|1|||
27769667|NCT02523599|54222763|FG000|Overall Study|Did not return for Day 30 visit|2|||
27769668|NCT02523599|54222764|FG001|Overall Study|Did not return for Day 30 visit|0|||
27769669|NCT02187159|54222774|FG000|Overall Study|Protocol Violation|4|||
27769670|NCT02187159|54222775|FG001|Overall Study|Protocol Violation|6|||
27769671|NCT02187159|54222776|FG002|Overall Study|Protocol Violation|3|||
27769672|NCT02187159|54222777|FG003|Overall Study|Protocol Violation|4|||
27769673|NCT02187159|54222774|FG000|Overall Study|Lack of Efficacy|10|||
27769674|NCT02187159|54222775|FG001|Overall Study|Lack of Efficacy|5|||
27769675|NCT02187159|54222776|FG002|Overall Study|Lack of Efficacy|4|||
27769676|NCT02187159|54222777|FG003|Overall Study|Lack of Efficacy|7|||
27769677|NCT02187159|54222774|FG000|Overall Study|Adverse Event|28|||
27769678|NCT02187159|54222775|FG001|Overall Study|Adverse Event|33|||
27769679|NCT02187159|54222776|FG002|Overall Study|Adverse Event|42|||
27769680|NCT02187159|54222777|FG003|Overall Study|Adverse Event|50|||
27769681|NCT02187159|54222774|FG000|Overall Study|Withdrawal by Subject|24|||
27769682|NCT02187159|54222775|FG001|Overall Study|Withdrawal by Subject|28|||
27769683|NCT02187159|54222776|FG002|Overall Study|Withdrawal by Subject|25|||
27769684|NCT02187159|54222777|FG003|Overall Study|Withdrawal by Subject|26|||
27769685|NCT02187159|54222774|FG000|Overall Study|Other|3|||
27769686|NCT02187159|54222775|FG001|Overall Study|Other|7|||
27769687|NCT02187159|54222776|FG002|Overall Study|Other|3|||
27769688|NCT02187159|54222777|FG003|Overall Study|Other|9|||
27769689|NCT02335411|54222790|FG000|Overall Study|Death|223|||
27769690|NCT02335411|54222791|FG001|Overall Study|Death|22|||
27769691|NCT02335411|54222792|FG002|Overall Study|Death|26|||
27769692|NCT02335411|54222790|FG000|Overall Study|Physician Decision|3|||
27769693|NCT02335411|54222791|FG001|Overall Study|Physician Decision|0|||
27769694|NCT02335411|54222792|FG002|Overall Study|Physician Decision|0|||
27769695|NCT02335411|54222790|FG000|Overall Study|Protocol Violation|1|||
27769696|NCT02335411|54222791|FG001|Overall Study|Protocol Violation|0|||
27769697|NCT02335411|54222792|FG002|Overall Study|Protocol Violation|0|||
27769698|NCT02335411|54222790|FG000|Overall Study|Withdrawal by Subject|11|||
27769699|NCT02335411|54222791|FG001|Overall Study|Withdrawal by Subject|0|||
27769700|NCT02335411|54222792|FG002|Overall Study|Withdrawal by Subject|3|||
27769701|NCT02335411|54222790|FG000|Overall Study|Sponsor Decision|12|||
27769702|NCT02335411|54222791|FG001|Overall Study|Sponsor Decision|3|||
27769703|NCT02335411|54222792|FG002|Overall Study|Sponsor Decision|2|||
27769704|NCT02335411|54222790|FG000|Overall Study|Adverse Event|9|||
27769705|NCT02335411|54222791|FG001|Overall Study|Adverse Event|0|||
27769706|NCT02335411|54222792|FG002|Overall Study|Adverse Event|0|||
27769707|NCT02186301|54222806|FG000|Overall Study|Progressive Disease|7|||
27769708|NCT02186301|54222807|FG001|Overall Study|Progressive Disease|22|||
27769709|NCT02186301|54222808|FG002|Overall Study|Progressive Disease|27|||
27769710|NCT02186301|54222806|FG000|Overall Study|Adverse Event|5|||
27769711|NCT02186301|54222807|FG001|Overall Study|Adverse Event|5|||
27769712|NCT02186301|54222808|FG002|Overall Study|Adverse Event|5|||
27769713|NCT02186301|54222806|FG000|Overall Study|Death|1|||
27769714|NCT02186301|54222807|FG001|Overall Study|Death|0|||
27769715|NCT02186301|54222808|FG002|Overall Study|Death|0|||
27769716|NCT02186301|54222806|FG000|Overall Study|Withdrawal by Subject|5|||
27769717|NCT02186301|54222807|FG001|Overall Study|Withdrawal by Subject|1|||
27769718|NCT02186301|54222808|FG002|Overall Study|Withdrawal by Subject|3|||
27769719|NCT02186301|54222806|FG000|Overall Study|Physician Decision|1|||
27769720|NCT02186301|54222807|FG001|Overall Study|Physician Decision|0|||
27769721|NCT02186301|54222808|FG002|Overall Study|Physician Decision|1|||
27769722|NCT02186301|54222806|FG000|Overall Study|Study Terminated by Sponsor|1|||
27769723|NCT02186301|54222807|FG001|Overall Study|Study Terminated by Sponsor|0|||
27769724|NCT02186301|54222808|FG002|Overall Study|Study Terminated by Sponsor|11|||
27769725|NCT02186301|54222806|FG000|Overall Study|Protocol Deviation|0|||
27769726|NCT02186301|54222807|FG001|Overall Study|Protocol Deviation|2|||
27769727|NCT02186301|54222808|FG002|Overall Study|Protocol Deviation|0|||
27769728|NCT02186301|54222806|FG000|Overall Study|Missing|0|||
27769729|NCT02186301|54222807|FG001|Overall Study|Missing|0|||
27769730|NCT02186301|54222808|FG002|Overall Study|Missing|2|||
27769731|NCT02186301|54222806|FG000|Overall Study|Other|0|||
27769732|NCT02186301|54222807|FG001|Overall Study|Other|0|||
27769733|NCT02186301|54222808|FG002|Overall Study|Other|1|||
27769734|NCT02186223|54222818|FG000|Overall Study|Not eligible for device placement|6|||
27769735|NCT02186223|54222818|FG000|Overall Study|Unable to obtain femoral access|3|||
27769736|NCT02186223|54222818|FG000|Overall Study|Death|3|||
27769737|NCT02186223|54222818|FG000|Overall Study|Device in place less than 48 hours|9|||
27769738|NCT02163057|54222825|FG000|Overall Study|Participant Refusal to Continue|2|||
27769739|NCT02163057|54222826|FG001|Overall Study|Participant Refusal to Continue|2|||
27769740|NCT02163057|54222825|FG000|Overall Study|Participant Significant Noncompliance|0|||
27769741|NCT02163057|54222826|FG001|Overall Study|Participant Significant Noncompliance|1|||
27769742|NCT02163057|54222825|FG000|Overall Study|Progression of Disease|1|||
27769743|NCT02163057|54222826|FG001|Overall Study|Progression of Disease|2|||
27769744|NCT02185521|54222834|FG000|Overall Study|Withdrawal by Subject|1|||
27769745|NCT02185521|54222834|FG000|Overall Study|Protocol Violation|1|||
27769746|NCT01599585|54222841|FG000|Overall Study|Withdrawal by Subject|16|||
27769747|NCT01599585|54222842|FG001|Overall Study|Withdrawal by Subject|9|||
27769748|NCT01599585|54222841|FG000|Overall Study|Lost to Follow-up|3|||
27769749|NCT01599585|54222842|FG001|Overall Study|Lost to Follow-up|5|||
27769750|NCT01599585|54222841|FG000|Overall Study|randomized did not start treatment|3|||
27769751|NCT01599585|54222842|FG001|Overall Study|randomized did not start treatment|3|||
27769752|NCT02185053|54222848|FG000|Solifenacin Dose Escalation Phase|Cardiac symptoms|1|||
27769753|NCT02185053|54222849|FG001|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
27769754|NCT02185053|54222850|FG002|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
27769755|NCT02185053|54222848|FG000|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2|||
27769756|NCT02185053|54222849|FG001|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
27769757|NCT02185053|54222850|FG002|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
27769758|NCT02185053|54222848|FG000|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
27769759|NCT02185053|54222849|FG001|Donepezil Dose Escalation Phase|Cardiac symptoms|1|||
27769760|NCT02185053|54222850|FG002|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
27769761|NCT02185053|54222848|FG000|Donepezil Dose Escalation Phase|Adverse Event|0|||
27769762|NCT02185053|54222849|FG001|Donepezil Dose Escalation Phase|Adverse Event|1|||
27769763|NCT02185053|54222850|FG002|Donepezil Dose Escalation Phase|Adverse Event|0|||
27769764|NCT02185053|54222848|FG000|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
27769765|NCT02185053|54222849|FG001|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2|||
27769766|NCT02185053|54222850|FG002|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
27769767|NCT02185053|54222848|FG000|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
27769768|NCT02185053|54222849|FG001|Donepezil Dose Escalation Phase|Withdrawal by Subject|1|||
27769769|NCT02185053|54222850|FG002|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
27769770|NCT02185053|54222848|FG000|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
27769771|NCT02185053|54222849|FG001|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
27769772|NCT02185053|54222850|FG002|Donepezil Dose Maintenance Phase|Cardiac symptoms|1|||
27769773|NCT02185053|54222848|FG000|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
27769774|NCT02185053|54222849|FG001|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
27769775|NCT02185053|54222850|FG002|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2|||
27769776|NCT02161731|54222859|FG000|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0|||
27769777|NCT02161731|54222860|FG001|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1|||
27769778|NCT02161731|54222859|FG000|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0|||
27769779|NCT02161731|54222860|FG001|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1|||
27769780|NCT02124759|54222870|FG000|Overall Study|Withdrawal by Subject|3|||
27769781|NCT02124759|54222871|FG001|Overall Study|Withdrawal by Subject|1|||
27769782|NCT02124759|54222872|FG002|Overall Study|Withdrawal by Subject|1|||
27769783|NCT02124759|54222870|FG000|Overall Study|Screen Fail|2|||
27839821|NCT01693562|54327131|FG020|Exploration Phase|Death|0|||
27839822|NCT01693562|54327132|FG021|Exploration Phase|Death|0|||
27839823|NCT01693562|54327133|FG022|Exploration Phase|Death|0|||
27839824|NCT01693562|54327111|FG000|Exploration Phase|Other|0|||
27839825|NCT01693562|54327112|FG001|Exploration Phase|Other|0|||
27839826|NCT01693562|54327113|FG002|Exploration Phase|Other|0|||
27839827|NCT01693562|54327114|FG003|Exploration Phase|Other|0|||
27839828|NCT01693562|54327115|FG004|Exploration Phase|Other|0|||
27839829|NCT01693562|54327116|FG005|Exploration Phase|Other|0|||
27839830|NCT01693562|54327117|FG006|Exploration Phase|Other|2|||
27839831|NCT01693562|54327118|FG007|Exploration Phase|Other|0|||
27839832|NCT01693562|54327119|FG008|Exploration Phase|Other|0|||
27839833|NCT01693562|54327120|FG009|Exploration Phase|Other|0|||
27839834|NCT01693562|54327121|FG010|Exploration Phase|Other|0|||
27839835|NCT01693562|54327122|FG011|Exploration Phase|Other|0|||
27839836|NCT01693562|54327123|FG012|Exploration Phase|Other|0|||
27839837|NCT01693562|54327124|FG013|Exploration Phase|Other|0|||
27839838|NCT01693562|54327125|FG014|Exploration Phase|Other|0|||
27839839|NCT01693562|54327126|FG015|Exploration Phase|Other|0|||
27839840|NCT01693562|54327127|FG016|Exploration Phase|Other|0|||
27839841|NCT01693562|54327128|FG017|Exploration Phase|Other|0|||
27839842|NCT01693562|54327129|FG018|Exploration Phase|Other|0|||
27839843|NCT01693562|54327130|FG019|Exploration Phase|Other|0|||
27839844|NCT01693562|54327131|FG020|Exploration Phase|Other|0|||
27839845|NCT01693562|54327132|FG021|Exploration Phase|Other|0|||
27839846|NCT01693562|54327133|FG022|Exploration Phase|Other|0|||
27839847|NCT01693562|54327111|FG000|Expansion Phase|Withdrawal by Subject|0|||
27839848|NCT01693562|54327112|FG001|Expansion Phase|Withdrawal by Subject|0|||
27839849|NCT01693562|54327113|FG002|Expansion Phase|Withdrawal by Subject|0|||
27839850|NCT01693562|54327114|FG003|Expansion Phase|Withdrawal by Subject|0|||
27839851|NCT01693562|54327115|FG004|Expansion Phase|Withdrawal by Subject|0|||
27839852|NCT01693562|54327116|FG005|Expansion Phase|Withdrawal by Subject|0|||
27839853|NCT01693562|54327117|FG006|Expansion Phase|Withdrawal by Subject|0|||
27839854|NCT01693562|54327118|FG007|Expansion Phase|Withdrawal by Subject|16|||
27839855|NCT01693562|54327119|FG008|Expansion Phase|Withdrawal by Subject|2|||
27839856|NCT01693562|54327120|FG009|Expansion Phase|Withdrawal by Subject|54|||
27839857|NCT01693562|54327121|FG010|Expansion Phase|Withdrawal by Subject|2|||
27839858|NCT01693562|54327122|FG011|Expansion Phase|Withdrawal by Subject|2|||
27769784|NCT02124759|54222871|FG001|Overall Study|Screen Fail|2|||
27839859|NCT01693562|54327123|FG012|Expansion Phase|Withdrawal by Subject|3|||
27839860|NCT01693562|54327124|FG013|Expansion Phase|Withdrawal by Subject|5|||
27839861|NCT01693562|54327125|FG014|Expansion Phase|Withdrawal by Subject|16|||
27839862|NCT01693562|54327126|FG015|Expansion Phase|Withdrawal by Subject|7|||
27839863|NCT01693562|54327127|FG016|Expansion Phase|Withdrawal by Subject|40|||
27839864|NCT01693562|54327128|FG017|Expansion Phase|Withdrawal by Subject|4|||
27839865|NCT01693562|54327129|FG018|Expansion Phase|Withdrawal by Subject|8|||
27839866|NCT01693562|54327130|FG019|Expansion Phase|Withdrawal by Subject|3|||
27839867|NCT01693562|54327131|FG020|Expansion Phase|Withdrawal by Subject|1|||
27839868|NCT01693562|54327132|FG021|Expansion Phase|Withdrawal by Subject|8|||
27839869|NCT01693562|54327133|FG022|Expansion Phase|Withdrawal by Subject|1|||
27839870|NCT01693562|54327111|FG000|Expansion Phase|Death|0|||
27839871|NCT01693562|54327112|FG001|Expansion Phase|Death|0|||
27839872|NCT01693562|54327113|FG002|Expansion Phase|Death|0|||
27839873|NCT01693562|54327114|FG003|Expansion Phase|Death|0|||
27839874|NCT01693562|54327115|FG004|Expansion Phase|Death|0|||
27769785|NCT02124759|54222872|FG002|Overall Study|Screen Fail|3|||
27769786|NCT02302339|54222889|FG000|Overall Study|Lost to Follow-up|1|||
27769787|NCT02302339|54222890|FG001|Overall Study|Lost to Follow-up|0|||
27769788|NCT02302339|54222891|FG002|Overall Study|Lost to Follow-up|0|||
27769789|NCT02302339|54222892|FG003|Overall Study|Lost to Follow-up|0|||
27769790|NCT02302339|54222889|FG000|Overall Study|Withdrawal by Subject|0|||
27769791|NCT02302339|54222890|FG001|Overall Study|Withdrawal by Subject|2|||
27769792|NCT02302339|54222891|FG002|Overall Study|Withdrawal by Subject|1|||
27769793|NCT02302339|54222892|FG003|Overall Study|Withdrawal by Subject|0|||
27769794|NCT02161575|54222903|FG000|Overall Study|Protocol Violation|8|||
27769795|NCT02161575|54222903|FG000|Overall Study|Lack of Efficacy|1|||
27769796|NCT02161575|54222903|FG000|Overall Study|Adverse Event|2|||
27769797|NCT02370121|54222909|FG000|Overall Study|Lost to Follow-up|1|||
27769798|NCT02370121|54222910|FG001|Overall Study|Lost to Follow-up|1|||
27769799|NCT02161185|54222916|FG000|Treatment Phase|Administrative/Other|7|||
27769800|NCT02159469|54222920|FG000|Overall Study|Missing Completion status|1|||
27769801|NCT02159469|54222920|FG000|Overall Study|Adverse Event|5|||
27769802|NCT02159469|54222920|FG000|Overall Study|Non-compliance|2|||
27769803|NCT02159469|54222920|FG000|Overall Study|Withdrawal by Subject|9|||
27769804|NCT02159469|54222920|FG000|Overall Study|Lost to Follow-up|1|||
27769805|NCT02159469|54222920|FG000|Overall Study|Sponsor's request|2|||
27769806|NCT02159469|54222920|FG000|Overall Study|Met Stopping Criteria|3|||
27769807|NCT02159469|54222920|FG000|Overall Study|Other|1|||
27769808|NCT02159469|54222920|FG000|Overall Study|Multiple|29|||
27769809|NCT02123511|54222927|FG000|Overall Study|Cancelled treatment|1|||
27769810|NCT02123511|54222928|FG001|Overall Study|Cancelled treatment|0|||
27769811|NCT02123511|54222927|FG000|Overall Study|Incomplete data|1|||
27769812|NCT02123511|54222928|FG001|Overall Study|Incomplete data|3|||
27769813|NCT02123511|54222927|FG000|Overall Study|Ineligible|0|||
27769814|NCT02123511|54222928|FG001|Overall Study|Ineligible|1|||
27769815|NCT02122887|54222936|FG000|Overall Study|Withdrawal by Subject|20|||
27769816|NCT02122887|54222937|FG001|Overall Study|Withdrawal by Subject|2|||
27769817|NCT02182947|54222943|FG000|Overall Study|Withdrawal by Subject|7|||
27769818|NCT02182947|54222943|FG000|Overall Study|Lost to Follow-up|3|||
27769819|NCT02182947|54222943|FG000|Overall Study|Failed screening activities|8|||
27769820|NCT02370043|54222947|FG000|Overall Study|Withdrawal by Subject|0|||
27769821|NCT02370043|54222948|FG001|Overall Study|Withdrawal by Subject|0|||
27769822|NCT02370043|54222949|FG002|Overall Study|Withdrawal by Subject|0|||
27769823|NCT02370043|54222950|FG003|Overall Study|Withdrawal by Subject|0|||
27769824|NCT02370043|54222951|FG004|Overall Study|Withdrawal by Subject|1|||
27769825|NCT02370043|54222952|FG005|Overall Study|Withdrawal by Subject|1|||
27769826|NCT02301403|54222982|FG000|Overall Study|Withdrawal by Subject|28|||
27769827|NCT02301403|54222983|FG001|Overall Study|Withdrawal by Subject|41|||
27769828|NCT02301169|54222991|FG000|Overall Study|Adverse Event|1|||
27769829|NCT02301169|54222992|FG001|Overall Study|Adverse Event|0|||
27769830|NCT02333383|54222998|FG000|Overall Study|Adalimumab discontinuation|21|||
27769831|NCT02333383|54222998|FG000|Overall Study|Lost to Follow-up|15|||
27769832|NCT02333383|54222998|FG000|Overall Study|Withdrawal by Subject|3|||
27769833|NCT02333383|54222998|FG000|Overall Study|Transfer to another hospital|2|||
27769834|NCT02332915|54223004|FG000|Overall Study|Moved out of region|3|||
27769835|NCT02332915|54223005|FG001|Overall Study|Moved out of region|0|||
27769836|NCT02332915|54223004|FG000|Overall Study|Unrelated illness|1|||
27769837|NCT02332915|54223005|FG001|Overall Study|Unrelated illness|1|||
27769838|NCT02332915|54223004|FG000|Overall Study|Travel distance prohibitive|0|||
27769839|NCT02332915|54223005|FG001|Overall Study|Travel distance prohibitive|1|||
27769840|NCT02332915|54223004|FG000|Overall Study|did not meet inclusion criteria|2|||
27769841|NCT02332915|54223005|FG001|Overall Study|did not meet inclusion criteria|4|||
27769842|NCT02369341|54223018|FG000|Overall Study|Migrated/moved from study area|1|||
27769843|NCT02369341|54223019|FG001|Overall Study|Migrated/moved from study area|0|||
27769844|NCT02121795|54223031|FG000|Double-Blind Phase|Randomized but Never Treated|1|||
27839875|NCT01693562|54327116|FG005|Expansion Phase|Death|0|||
27839876|NCT01693562|54327117|FG006|Expansion Phase|Death|0|||
27769845|NCT02121795|54223032|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
27769846|NCT02121795|54223031|FG000|Double-Blind Phase|Withdrawal by Subject|19|||
27769847|NCT02121795|54223032|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
27839877|NCT01693562|54327118|FG007|Expansion Phase|Death|42|||
27839878|NCT01693562|54327119|FG008|Expansion Phase|Death|17|||
27769848|NCT02121795|54223031|FG000|Double-Blind Phase|Lost to Follow-up|7|||
27769849|NCT02121795|54223032|FG001|Double-Blind Phase|Lost to Follow-up|4|||
27769850|NCT02121795|54223031|FG000|Double-Blind Phase|Physician Decision|2|||
27769851|NCT02121795|54223032|FG001|Double-Blind Phase|Physician Decision|5|||
27769852|NCT02121795|54223031|FG000|Double-Blind Phase|Adverse Event|5|||
27769853|NCT02121795|54223032|FG001|Double-Blind Phase|Adverse Event|0|||
27769854|NCT02121795|54223031|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
27769855|NCT02121795|54223032|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
27769856|NCT02121795|54223031|FG000|Double-Blind Phase|Protocol Violation|0|||
27769857|NCT02121795|54223032|FG001|Double-Blind Phase|Protocol Violation|3|||
27769858|NCT02121795|54223031|FG000|Double-Blind Phase|Death|1|||
27769859|NCT02121795|54223032|FG001|Double-Blind Phase|Death|1|||
27769860|NCT02121795|54223031|FG000|Open-Label Phase|Physician Decision|8|||
27769861|NCT02121795|54223032|FG001|Open-Label Phase|Physician Decision|8|||
27769862|NCT02121795|54223031|FG000|Open-Label Phase|Withdrawal by Subject|3|||
27769863|NCT02121795|54223032|FG001|Open-Label Phase|Withdrawal by Subject|2|||
27769864|NCT02121795|54223031|FG000|Open-Label Phase|Lost to Follow-up|1|||
27769865|NCT02121795|54223032|FG001|Open-Label Phase|Lost to Follow-up|0|||
27769866|NCT02158533|54223043|FG000|Stage 1|Adverse Event|6|||
27769867|NCT02158533|54223044|FG001|Stage 1|Adverse Event|4|||
27769868|NCT02158533|54223045|FG002|Stage 1|Adverse Event|7|||
27769869|NCT02158533|54223046|FG003|Stage 1|Adverse Event|0|||
27769870|NCT02158533|54223047|FG004|Stage 1|Adverse Event|0|||
27769871|NCT02158533|54223048|FG005|Stage 1|Adverse Event|0|||
27769872|NCT02158533|54223043|FG000|Stage 1|Withdrawal by Subject|3|||
27769873|NCT02158533|54223044|FG001|Stage 1|Withdrawal by Subject|2|||
27769874|NCT02158533|54223045|FG002|Stage 1|Withdrawal by Subject|1|||
27769875|NCT02158533|54223046|FG003|Stage 1|Withdrawal by Subject|0|||
27769876|NCT02158533|54223047|FG004|Stage 1|Withdrawal by Subject|0|||
27769877|NCT02158533|54223048|FG005|Stage 1|Withdrawal by Subject|0|||
27769878|NCT02158533|54223043|FG000|Stage 1|Lack of Efficacy|1|||
27769879|NCT02158533|54223044|FG001|Stage 1|Lack of Efficacy|0|||
27769880|NCT02158533|54223045|FG002|Stage 1|Lack of Efficacy|0|||
27769881|NCT02158533|54223046|FG003|Stage 1|Lack of Efficacy|0|||
27769882|NCT02158533|54223047|FG004|Stage 1|Lack of Efficacy|0|||
27769883|NCT02158533|54223048|FG005|Stage 1|Lack of Efficacy|0|||
27769884|NCT02158533|54223043|FG000|Stage 1|Lost to Follow-up|3|||
27769885|NCT02158533|54223044|FG001|Stage 1|Lost to Follow-up|1|||
27769886|NCT02158533|54223045|FG002|Stage 1|Lost to Follow-up|0|||
27769887|NCT02158533|54223046|FG003|Stage 1|Lost to Follow-up|0|||
27769888|NCT02158533|54223047|FG004|Stage 1|Lost to Follow-up|0|||
27769889|NCT02158533|54223048|FG005|Stage 1|Lost to Follow-up|0|||
27769890|NCT02158533|54223043|FG000|Stage 1|Failure to Meet Eligibility Criteria|0|||
27769891|NCT02158533|54223044|FG001|Stage 1|Failure to Meet Eligibility Criteria|1|||
27769892|NCT02158533|54223045|FG002|Stage 1|Failure to Meet Eligibility Criteria|0|||
27769893|NCT02158533|54223046|FG003|Stage 1|Failure to Meet Eligibility Criteria|0|||
27769894|NCT02158533|54223047|FG004|Stage 1|Failure to Meet Eligibility Criteria|0|||
27769895|NCT02158533|54223048|FG005|Stage 1|Failure to Meet Eligibility Criteria|0|||
27769896|NCT02158533|54223043|FG000|Stage 1|Non-compliance with study visits|1|||
27769897|NCT02158533|54223044|FG001|Stage 1|Non-compliance with study visits|0|||
27769898|NCT02158533|54223045|FG002|Stage 1|Non-compliance with study visits|0|||
27769899|NCT02158533|54223046|FG003|Stage 1|Non-compliance with study visits|0|||
27769900|NCT02158533|54223047|FG004|Stage 1|Non-compliance with study visits|0|||
27769901|NCT02158533|54223048|FG005|Stage 1|Non-compliance with study visits|0|||
27769902|NCT02158533|54223043|FG000|Stage 2|Adverse Event|0|||
27769903|NCT02158533|54223044|FG001|Stage 2|Adverse Event|0|||
27769904|NCT02158533|54223045|FG002|Stage 2|Adverse Event|0|||
27769905|NCT02158533|54223046|FG003|Stage 2|Adverse Event|0|||
27769906|NCT02158533|54223047|FG004|Stage 2|Adverse Event|0|||
27769907|NCT02158533|54223048|FG005|Stage 2|Adverse Event|1|||
27769908|NCT02158533|54223043|FG000|Stage 2|Lack of Efficacy|0|||
27769909|NCT02158533|54223044|FG001|Stage 2|Lack of Efficacy|0|||
27769910|NCT02158533|54223045|FG002|Stage 2|Lack of Efficacy|0|||
27769911|NCT02158533|54223046|FG003|Stage 2|Lack of Efficacy|0|||
27769912|NCT02158533|54223047|FG004|Stage 2|Lack of Efficacy|1|||
27769913|NCT02158533|54223048|FG005|Stage 2|Lack of Efficacy|0|||
27769914|NCT02158533|54223043|FG000|Stage 2|Lost to Follow-up|0|||
27769915|NCT02158533|54223044|FG001|Stage 2|Lost to Follow-up|0|||
27769916|NCT02158533|54223045|FG002|Stage 2|Lost to Follow-up|0|||
27769917|NCT02158533|54223046|FG003|Stage 2|Lost to Follow-up|1|||
27769918|NCT02158533|54223047|FG004|Stage 2|Lost to Follow-up|1|||
27769919|NCT02158533|54223048|FG005|Stage 2|Lost to Follow-up|2|||
27769920|NCT02158533|54223043|FG000|Stage 2|Withdrawal by Subject|0|||
27769921|NCT02158533|54223044|FG001|Stage 2|Withdrawal by Subject|0|||
27769922|NCT02158533|54223045|FG002|Stage 2|Withdrawal by Subject|0|||
27769923|NCT02158533|54223046|FG003|Stage 2|Withdrawal by Subject|0|||
27769924|NCT02158533|54223047|FG004|Stage 2|Withdrawal by Subject|1|||
27769925|NCT02158533|54223048|FG005|Stage 2|Withdrawal by Subject|2|||
27769926|NCT02158533|54223043|FG000|Stage 2|Physician Decision|0|||
27769927|NCT02158533|54223044|FG001|Stage 2|Physician Decision|0|||
27769928|NCT02158533|54223045|FG002|Stage 2|Physician Decision|0|||
27769929|NCT02158533|54223046|FG003|Stage 2|Physician Decision|0|||
27769930|NCT02158533|54223047|FG004|Stage 2|Physician Decision|1|||
27769931|NCT02158533|54223048|FG005|Stage 2|Physician Decision|0|||
27769932|NCT02158533|54223043|FG000|Stage 2|Pregnancy|0|||
27769933|NCT02158533|54223044|FG001|Stage 2|Pregnancy|0|||
27769934|NCT02158533|54223045|FG002|Stage 2|Pregnancy|0|||
27769935|NCT02158533|54223046|FG003|Stage 2|Pregnancy|1|||
27769936|NCT02158533|54223047|FG004|Stage 2|Pregnancy|0|||
27769937|NCT02158533|54223048|FG005|Stage 2|Pregnancy|0|||
27769938|NCT02158533|54223043|FG000|Stage 2|Psychiatrist decision to try new tx|0|||
27769939|NCT02158533|54223044|FG001|Stage 2|Psychiatrist decision to try new tx|0|||
27769940|NCT02158533|54223045|FG002|Stage 2|Psychiatrist decision to try new tx|0|||
27769941|NCT02158533|54223046|FG003|Stage 2|Psychiatrist decision to try new tx|1|||
27769942|NCT02158533|54223047|FG004|Stage 2|Psychiatrist decision to try new tx|0|||
27769943|NCT02158533|54223048|FG005|Stage 2|Psychiatrist decision to try new tx|0|||
27769944|NCT02158533|54223043|FG000|Stage 2|Non-adherence with study visits|0|||
27769945|NCT02158533|54223044|FG001|Stage 2|Non-adherence with study visits|0|||
27769946|NCT02158533|54223045|FG002|Stage 2|Non-adherence with study visits|0|||
27769947|NCT02158533|54223046|FG003|Stage 2|Non-adherence with study visits|0|||
27769948|NCT02158533|54223047|FG004|Stage 2|Non-adherence with study visits|0|||
27769949|NCT02158533|54223048|FG005|Stage 2|Non-adherence with study visits|1|||
27769950|NCT02120781|54223064|FG000|Overall Study|Physician Decision|2|||
27769951|NCT02120781|54223065|FG001|Overall Study|Physician Decision|0|||
27769952|NCT02120781|54223064|FG000|Overall Study|Completion not documented|2|||
27769953|NCT02120781|54223065|FG001|Overall Study|Completion not documented|1|||
27769954|NCT02120625|54223071|FG000|Overall Study|Physician Decision|2|||
27769955|NCT02120469|54223078|FG000|Overall Study|HER-2/neu-amplified|1|||
27769956|NCT02120469|54223079|FG001|Overall Study|HER-2/neu-amplified|0|||
27769957|NCT02120469|54223080|FG002|Overall Study|HER-2/neu-amplified|1|||
27769958|NCT02157519|54223093|FG000|Overall Study|Death|3|||
27769959|NCT02157519|54223094|FG001|Overall Study|Death|1|||
27769960|NCT02157519|54223093|FG000|Overall Study|Withdrawal by Subject|7|||
27769961|NCT02157519|54223094|FG001|Overall Study|Withdrawal by Subject|0|||
27769962|NCT02157519|54223093|FG000|Overall Study|Lost to Follow-up|1|||
27769963|NCT02157519|54223094|FG001|Overall Study|Lost to Follow-up|0|||
27769964|NCT02180061|54223102|FG000|Overall Study|Adverse Event|4|||
27769965|NCT02180061|54223103|FG001|Overall Study|Adverse Event|2|||
27769966|NCT02180061|54223102|FG000|Overall Study|Clinical Progression|5|||
27769967|NCT02180061|54223103|FG001|Overall Study|Clinical Progression|1|||
27769968|NCT02180061|54223102|FG000|Overall Study|Progressive Disease|15|||
27769969|NCT02180061|54223103|FG001|Overall Study|Progressive Disease|5|||
27769970|NCT02180061|54223102|FG000|Overall Study|Physician Decision|1|||
27769971|NCT02180061|54223103|FG001|Overall Study|Physician Decision|0|||
27769972|NCT02179515|54223112|FG000|Overall Study|switched to alternative treatment|0|||
27769973|NCT02179515|54223113|FG001|Overall Study|switched to alternative treatment|1|||
27769974|NCT02179515|54223114|FG002|Overall Study|switched to alternative treatment|1|||
27769975|NCT02179515|54223112|FG000|Overall Study|Death|0|||
27769976|NCT02179515|54223113|FG001|Overall Study|Death|1|||
27769977|NCT02179515|54223114|FG002|Overall Study|Death|1|||
27769978|NCT02179515|54223112|FG000|Overall Study|refused further treatment|0|||
27769979|NCT02179515|54223113|FG001|Overall Study|refused further treatment|3|||
27769980|NCT02179515|54223114|FG002|Overall Study|refused further treatment|4|||
27769981|NCT02179515|54223112|FG000|Overall Study|Disease progression on study|2|||
27769982|NCT02179515|54223113|FG001|Overall Study|Disease progression on study|11|||
27769983|NCT02179515|54223114|FG002|Overall Study|Disease progression on study|8|||
27769984|NCT02120157|54223126|FG000|Overall Study|Death|8|||
27769985|NCT02119299|54223132|FG000|Overall Study|Withdrawal by Subject|7|||
27769986|NCT02119299|54223132|FG000|Overall Study|Lack of Efficacy|1|||
27769987|NCT02119299|54223132|FG000|Overall Study|Pregnancy|1|||
27769988|NCT02156271|54223138|FG000|Overall Study|Physician Decision|4|||
27769989|NCT02156271|54223139|FG001|Overall Study|Physician Decision|3|||
27769990|NCT01365455|54223148|FG000|Induction Period|Adverse Event|5|||
27769991|NCT01365455|54223149|FG001|Induction Period|Adverse Event|3|||
27769992|NCT01365455|54223150|FG002|Induction Period|Adverse Event|4|||
27839879|NCT01693562|54327120|FG009|Expansion Phase|Death|208|||
27839880|NCT01693562|54327121|FG010|Expansion Phase|Death|30|||
27839881|NCT01693562|54327122|FG011|Expansion Phase|Death|8|||
27839882|NCT01693562|54327123|FG012|Expansion Phase|Death|19|||
27769993|NCT01365455|54223151|FG003|Induction Period|Adverse Event|0|||
27769994|NCT01365455|54223152|FG004|Induction Period|Adverse Event|0|||
27769995|NCT01365455|54223148|FG000|Induction Period|Lack of Efficacy|1|||
27769996|NCT01365455|54223149|FG001|Induction Period|Lack of Efficacy|1|||
27769997|NCT01365455|54223150|FG002|Induction Period|Lack of Efficacy|0|||
27769998|NCT01365455|54223151|FG003|Induction Period|Lack of Efficacy|0|||
27769999|NCT01365455|54223152|FG004|Induction Period|Lack of Efficacy|0|||
27770000|NCT01365455|54223148|FG000|Induction Period|Pregnancy|0|||
27770001|NCT01365455|54223149|FG001|Induction Period|Pregnancy|1|||
27770002|NCT01365455|54223150|FG002|Induction Period|Pregnancy|0|||
27770003|NCT01365455|54223151|FG003|Induction Period|Pregnancy|0|||
27770004|NCT01365455|54223152|FG004|Induction Period|Pregnancy|0|||
27770005|NCT01365455|54223148|FG000|Induction Period|Protocol deviation|0|||
27770006|NCT01365455|54223149|FG001|Induction Period|Protocol deviation|1|||
27770007|NCT01365455|54223150|FG002|Induction Period|Protocol deviation|1|||
27770008|NCT01365455|54223151|FG003|Induction Period|Protocol deviation|0|||
27770009|NCT01365455|54223152|FG004|Induction Period|Protocol deviation|0|||
27770010|NCT01365455|54223148|FG000|Induction Period|Subject/guardian decision|9|||
27770011|NCT01365455|54223149|FG001|Induction Period|Subject/guardian decision|1|||
27770012|NCT01365455|54223150|FG002|Induction Period|Subject/guardian decision|8|||
27770013|NCT01365455|54223151|FG003|Induction Period|Subject/guardian decision|0|||
27770014|NCT01365455|54223152|FG004|Induction Period|Subject/guardian decision|0|||
27770015|NCT01365455|54223148|FG000|Induction Period|Lost to Follow-up|0|||
27770016|NCT01365455|54223149|FG001|Induction Period|Lost to Follow-up|0|||
27770017|NCT01365455|54223150|FG002|Induction Period|Lost to Follow-up|3|||
27770018|NCT01365455|54223151|FG003|Induction Period|Lost to Follow-up|0|||
27770019|NCT01365455|54223152|FG004|Induction Period|Lost to Follow-up|0|||
27770020|NCT01365455|54223148|FG000|Maintenance Period|Adverse Event|12|||
27770021|NCT01365455|54223149|FG001|Maintenance Period|Adverse Event|5|||
27770022|NCT01365455|54223150|FG002|Maintenance Period|Adverse Event|1|||
27770023|NCT01365455|54223151|FG003|Maintenance Period|Adverse Event|2|||
27770024|NCT01365455|54223152|FG004|Maintenance Period|Adverse Event|4|||
27770025|NCT01365455|54223148|FG000|Maintenance Period|Lack of Efficacy|10|||
27770026|NCT01365455|54223149|FG001|Maintenance Period|Lack of Efficacy|2|||
27770027|NCT01365455|54223150|FG002|Maintenance Period|Lack of Efficacy|0|||
27770028|NCT01365455|54223151|FG003|Maintenance Period|Lack of Efficacy|2|||
27770029|NCT01365455|54223152|FG004|Maintenance Period|Lack of Efficacy|2|||
27770030|NCT01365455|54223148|FG000|Maintenance Period|Lost to Follow-up|2|||
27770031|NCT01365455|54223149|FG001|Maintenance Period|Lost to Follow-up|4|||
27770032|NCT01365455|54223150|FG002|Maintenance Period|Lost to Follow-up|0|||
27770033|NCT01365455|54223151|FG003|Maintenance Period|Lost to Follow-up|0|||
27770034|NCT01365455|54223152|FG004|Maintenance Period|Lost to Follow-up|3|||
27770035|NCT01365455|54223148|FG000|Maintenance Period|Non-compliance with study treatment|0|||
27770036|NCT01365455|54223149|FG001|Maintenance Period|Non-compliance with study treatment|0|||
27770037|NCT01365455|54223150|FG002|Maintenance Period|Non-compliance with study treatment|0|||
27770038|NCT01365455|54223151|FG003|Maintenance Period|Non-compliance with study treatment|1|||
27770039|NCT01365455|54223152|FG004|Maintenance Period|Non-compliance with study treatment|0|||
27770040|NCT01365455|54223148|FG000|Maintenance Period|Physician Decision|0|||
27770041|NCT01365455|54223149|FG001|Maintenance Period|Physician Decision|1|||
27770042|NCT01365455|54223150|FG002|Maintenance Period|Physician Decision|0|||
27770043|NCT01365455|54223151|FG003|Maintenance Period|Physician Decision|0|||
27770044|NCT01365455|54223152|FG004|Maintenance Period|Physician Decision|1|||
27770045|NCT01365455|54223148|FG000|Maintenance Period|Pregnancy|0|||
27770046|NCT01365455|54223149|FG001|Maintenance Period|Pregnancy|4|||
27770047|NCT01365455|54223150|FG002|Maintenance Period|Pregnancy|0|||
27770048|NCT01365455|54223151|FG003|Maintenance Period|Pregnancy|0|||
27770049|NCT01365455|54223152|FG004|Maintenance Period|Pregnancy|2|||
27770050|NCT01365455|54223148|FG000|Maintenance Period|Protocol deviation|1|||
27770051|NCT01365455|54223149|FG001|Maintenance Period|Protocol deviation|1|||
27770052|NCT01365455|54223150|FG002|Maintenance Period|Protocol deviation|0|||
27770053|NCT01365455|54223151|FG003|Maintenance Period|Protocol deviation|0|||
27770054|NCT01365455|54223152|FG004|Maintenance Period|Protocol deviation|0|||
27770055|NCT01365455|54223148|FG000|Maintenance Period|Subject/guardian decision|4|||
27770056|NCT01365455|54223149|FG001|Maintenance Period|Subject/guardian decision|6|||
27770057|NCT01365455|54223150|FG002|Maintenance Period|Subject/guardian decision|2|||
27770058|NCT01365455|54223151|FG003|Maintenance Period|Subject/guardian decision|4|||
27770059|NCT01365455|54223152|FG004|Maintenance Period|Subject/guardian decision|1|||
27770060|NCT02155881|54223172|FG000|Overall Study|Withdrawal by Subject|0|||
27770061|NCT02155881|54223173|FG001|Overall Study|Withdrawal by Subject|2|||
27770062|NCT02155881|54223172|FG000|Overall Study|Inappropriately randomized|2|||
27770063|NCT02155881|54223173|FG001|Overall Study|Inappropriately randomized|2|||
27770064|NCT01658579|54223183|FG000|Treatment Period A|Other|0|||
27770065|NCT01658579|54223184|FG001|Treatment Period A|Other|0|||
27770066|NCT01658579|54223185|FG002|Treatment Period A|Other|1|||
27770067|NCT01658579|54223186|FG003|Treatment Period A|Other|1|||
27770068|NCT01658579|54223183|FG000|Treatment Period A|Adverse Event|1|||
27770069|NCT01658579|54223184|FG001|Treatment Period A|Adverse Event|0|||
27770070|NCT01658579|54223185|FG002|Treatment Period A|Adverse Event|0|||
27770071|NCT01658579|54223186|FG003|Treatment Period A|Adverse Event|0|||
27770072|NCT01658579|54223183|FG000|Treatment Period B|Other|0|||
27770073|NCT01658579|54223184|FG001|Treatment Period B|Other|0|||
27770074|NCT01658579|54223185|FG002|Treatment Period B|Other|0|||
27770075|NCT01658579|54223186|FG003|Treatment Period B|Other|1|||
27770076|NCT02154087|54223192|FG000|Overall Study|Study Termination|1|||
27770077|NCT02118597|54223196|FG000|Overall Study|Sponsor terminated the study|14|||
27770078|NCT02118597|54223196|FG000|Overall Study|Serious Adverse Event|1|||
27770079|NCT02118597|54223196|FG000|Overall Study|Investigator's decision|1|||
27770080|NCT01659125|54223200|FG000|Overall Study|Withdrawal by Subject|2|||
27770081|NCT01659125|54223200|FG000|Overall Study|Lost to Follow-up|7|||
27770082|NCT01659125|54223200|FG000|Overall Study|Technical Problem|1|||
27770083|NCT01659125|54223200|FG000|Overall Study|Time Constraints|2|||
27770084|NCT01659125|54223200|FG000|Overall Study|Failed to Start Treatment|2|||
27770085|NCT01657253|54223206|FG000|Overall Study|Lost to Follow-up|6|||
27770086|NCT01657253|54223207|FG001|Overall Study|Lost to Follow-up|5|||
27770087|NCT01657253|54223206|FG000|Overall Study|Withdrawal by Subject|11|||
27770088|NCT01657253|54223207|FG001|Overall Study|Withdrawal by Subject|12|||
27770089|NCT01657253|54223206|FG000|Overall Study|Adverse Event|0|||
27770090|NCT01657253|54223207|FG001|Overall Study|Adverse Event|1|||
27770091|NCT02117427|54223216|FG000|Overall Study|Permanent need for exogenous EPO Tx|2|||
27770092|NCT02117427|54223217|FG001|Overall Study|Permanent need for exogenous EPO Tx|0|||
27770093|NCT02117427|54223218|FG002|Overall Study|Permanent need for exogenous EPO Tx|0|||
27770094|NCT02117427|54223216|FG000|Overall Study|Permanent need for exogenous ESA Tx|3|||
27770095|NCT02117427|54223217|FG001|Overall Study|Permanent need for exogenous ESA Tx|1|||
27770096|NCT02117427|54223218|FG002|Overall Study|Permanent need for exogenous ESA Tx|0|||
27770097|NCT02117427|54223216|FG000|Overall Study|Physician Decision|0|||
27770098|NCT02117427|54223217|FG001|Overall Study|Physician Decision|2|||
27770099|NCT02117427|54223218|FG002|Overall Study|Physician Decision|0|||
27770100|NCT02117427|54223216|FG000|Overall Study|No longer meets inclusion criteria|0|||
27770101|NCT02117427|54223217|FG001|Overall Study|No longer meets inclusion criteria|1|||
27770102|NCT02117427|54223218|FG002|Overall Study|No longer meets inclusion criteria|0|||
27770103|NCT02117427|54223216|FG000|Overall Study|Death|0|||
27770104|NCT02117427|54223217|FG001|Overall Study|Death|1|||
27770105|NCT02117427|54223218|FG002|Overall Study|Death|0|||
27770106|NCT02117349|54223226|FG000|Overall Study|Withdrawal by Subject|1|||
27839883|NCT01693562|54327124|FG013|Expansion Phase|Death|42|||
27839884|NCT01693562|54327125|FG014|Expansion Phase|Death|23|||
27770107|NCT02117349|54223227|FG001|Overall Study|Withdrawal by Subject|0|||
27770108|NCT02117349|54223226|FG000|Overall Study|Lost to Follow-up|1|||
27770109|NCT02117349|54223227|FG001|Overall Study|Lost to Follow-up|1|||
27770110|NCT02117349|54223226|FG000|Overall Study|Death|1|||
27770111|NCT02117349|54223227|FG001|Overall Study|Death|0|||
27770112|NCT01626495|54223233|FG000|Overall Study|Adverse Event|3|||
27839885|NCT01693562|54327126|FG015|Expansion Phase|Death|23|||
27770113|NCT01626495|54223233|FG000|Overall Study|Disease progression|27|||
27770114|NCT01626495|54223233|FG000|Overall Study|Withdrawal by Subject|1|||
27770115|NCT01626495|54223233|FG000|Overall Study|Administrative problem|1|||
27770116|NCT01626495|54223233|FG000|Overall Study|Death|2|||
27770117|NCT01626495|54223233|FG000|Overall Study|Physician Decision|1|||
27770118|NCT01626495|54223233|FG000|Overall Study|New cancer therapy|16|||
27770119|NCT01626495|54223233|FG000|Overall Study|Manufacturing failure|1|||
27770120|NCT02177175|54223239|FG000|Overall Study|stopped trastuzumab so was taken off study|1|||
27770121|NCT02177175|54223240|FG001|Overall Study|stopped trastuzumab so was taken off study|0|||
27770122|NCT02153073|54223246|FG000|Overall Study|Case Report Forms Uncollected|230|||
27770123|NCT02153073|54223246|FG000|Overall Study|Protocol Deviation|68|||
27770124|NCT01657877|54223250|FG000|Overall Study|Withdrawal by Subject|4|||
27770125|NCT01657877|54223250|FG000|Overall Study|Protocol Violation|6|||
27770126|NCT01657877|54223250|FG000|Overall Study|Adverse Event|2|||
27770127|NCT01657877|54223250|FG000|Overall Study|Other Reason|2|||
27770128|NCT02175771|54223275|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|23|||
27770129|NCT02175771|54223276|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
27770130|NCT02175771|54223277|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
27770131|NCT02175771|54223278|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
27770132|NCT02175771|54223279|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
27770133|NCT02175771|54223280|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
27770134|NCT02175771|54223281|FG006|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
27770135|NCT02175771|54223282|FG007|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
27770136|NCT02175771|54223283|FG008|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
27770137|NCT02175771|54223275|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|20|||
27770138|NCT02175771|54223276|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
27770139|NCT02175771|54223277|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
27770140|NCT02175771|54223278|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
27770141|NCT02175771|54223279|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
27770142|NCT02175771|54223280|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
27770143|NCT02175771|54223281|FG006|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
27770144|NCT02175771|54223282|FG007|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
27770145|NCT02175771|54223283|FG008|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
27770146|NCT02175771|54223275|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|11|||
27770147|NCT02175771|54223276|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
27770148|NCT02175771|54223277|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
27770149|NCT02175771|54223278|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
27770150|NCT02175771|54223279|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
27770151|NCT02175771|54223280|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
27770152|NCT02175771|54223281|FG006|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
27770153|NCT02175771|54223282|FG007|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
27770154|NCT02175771|54223283|FG008|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
27770155|NCT02175771|54223275|FG000|Run-In Period (Pre-assignment)|Adverse Event|9|||
27770156|NCT02175771|54223276|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
27770157|NCT02175771|54223277|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
27770158|NCT02175771|54223278|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
27770159|NCT02175771|54223279|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
27770160|NCT02175771|54223280|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
27770161|NCT02175771|54223281|FG006|Run-In Period (Pre-assignment)|Adverse Event|0|||
27770162|NCT02175771|54223282|FG007|Run-In Period (Pre-assignment)|Adverse Event|0|||
27770163|NCT02175771|54223283|FG008|Run-In Period (Pre-assignment)|Adverse Event|0|||
27770164|NCT02175771|54223275|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|7|||
27770165|NCT02175771|54223276|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
27770166|NCT02175771|54223277|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
27770167|NCT02175771|54223278|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
27770168|NCT02175771|54223279|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
27770169|NCT02175771|54223280|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
27770170|NCT02175771|54223281|FG006|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
27770171|NCT02175771|54223282|FG007|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
27770172|NCT02175771|54223283|FG008|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
27770173|NCT02175771|54223275|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
27770174|NCT02175771|54223276|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
27770175|NCT02175771|54223277|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
27770176|NCT02175771|54223278|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
27770177|NCT02175771|54223279|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
27770178|NCT02175771|54223280|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
27770179|NCT02175771|54223281|FG006|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
27770180|NCT02175771|54223282|FG007|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
27770181|NCT02175771|54223283|FG008|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
27770182|NCT02175771|54223275|FG000|Run-In Period (Pre-assignment)|Other|8|||
27770183|NCT02175771|54223276|FG001|Run-In Period (Pre-assignment)|Other|0|||
27770184|NCT02175771|54223277|FG002|Run-In Period (Pre-assignment)|Other|0|||
27770185|NCT02175771|54223278|FG003|Run-In Period (Pre-assignment)|Other|0|||
27770186|NCT02175771|54223279|FG004|Run-In Period (Pre-assignment)|Other|0|||
27770187|NCT02175771|54223280|FG005|Run-In Period (Pre-assignment)|Other|0|||
27770188|NCT02175771|54223281|FG006|Run-In Period (Pre-assignment)|Other|0|||
27770189|NCT02175771|54223282|FG007|Run-In Period (Pre-assignment)|Other|0|||
27770190|NCT02175771|54223283|FG008|Run-In Period (Pre-assignment)|Other|0|||
27770191|NCT02175771|54223275|FG000|Treatment Period|Adverse Event|0|||
27770192|NCT02175771|54223276|FG001|Treatment Period|Adverse Event|2|||
27770193|NCT02175771|54223277|FG002|Treatment Period|Adverse Event|1|||
27770194|NCT02175771|54223278|FG003|Treatment Period|Adverse Event|1|||
27770195|NCT02175771|54223279|FG004|Treatment Period|Adverse Event|1|||
27770196|NCT02175771|54223280|FG005|Treatment Period|Adverse Event|3|||
27770197|NCT02175771|54223281|FG006|Treatment Period|Adverse Event|2|||
27770198|NCT02175771|54223282|FG007|Treatment Period|Adverse Event|0|||
27770199|NCT02175771|54223283|FG008|Treatment Period|Adverse Event|1|||
27770200|NCT02175771|54223275|FG000|Treatment Period|Withdrawal by Subject|0|||
27770201|NCT02175771|54223276|FG001|Treatment Period|Withdrawal by Subject|9|||
27770202|NCT02175771|54223277|FG002|Treatment Period|Withdrawal by Subject|3|||
27770203|NCT02175771|54223278|FG003|Treatment Period|Withdrawal by Subject|6|||
27770204|NCT02175771|54223279|FG004|Treatment Period|Withdrawal by Subject|2|||
27770205|NCT02175771|54223280|FG005|Treatment Period|Withdrawal by Subject|4|||
27770206|NCT02175771|54223281|FG006|Treatment Period|Withdrawal by Subject|2|||
27770207|NCT02175771|54223282|FG007|Treatment Period|Withdrawal by Subject|9|||
27770208|NCT02175771|54223283|FG008|Treatment Period|Withdrawal by Subject|2|||
27770209|NCT02175771|54223275|FG000|Treatment Period|Noncompliance|0|||
27770210|NCT02175771|54223276|FG001|Treatment Period|Noncompliance|1|||
27770211|NCT02175771|54223277|FG002|Treatment Period|Noncompliance|2|||
27770212|NCT02175771|54223278|FG003|Treatment Period|Noncompliance|0|||
27770213|NCT02175771|54223279|FG004|Treatment Period|Noncompliance|0|||
27770214|NCT02175771|54223280|FG005|Treatment Period|Noncompliance|0|||
27770215|NCT02175771|54223281|FG006|Treatment Period|Noncompliance|0|||
27770216|NCT02175771|54223282|FG007|Treatment Period|Noncompliance|0|||
27770217|NCT02175771|54223283|FG008|Treatment Period|Noncompliance|1|||
27770218|NCT02175771|54223275|FG000|Treatment Period|Protocol Violation|0|||
27770219|NCT02175771|54223276|FG001|Treatment Period|Protocol Violation|0|||
27770220|NCT02175771|54223277|FG002|Treatment Period|Protocol Violation|0|||
27770221|NCT02175771|54223278|FG003|Treatment Period|Protocol Violation|0|||
27770222|NCT02175771|54223279|FG004|Treatment Period|Protocol Violation|0|||
27770223|NCT02175771|54223280|FG005|Treatment Period|Protocol Violation|0|||
27770224|NCT02175771|54223281|FG006|Treatment Period|Protocol Violation|0|||
27770225|NCT02175771|54223282|FG007|Treatment Period|Protocol Violation|1|||
27770226|NCT02175771|54223283|FG008|Treatment Period|Protocol Violation|0|||
27770227|NCT02175771|54223275|FG000|Treatment Period|Disease progression|0|||
27770228|NCT02175771|54223276|FG001|Treatment Period|Disease progression|0|||
27770229|NCT02175771|54223277|FG002|Treatment Period|Disease progression|0|||
27770230|NCT02175771|54223278|FG003|Treatment Period|Disease progression|0|||
27770231|NCT02175771|54223279|FG004|Treatment Period|Disease progression|0|||
27770232|NCT02175771|54223280|FG005|Treatment Period|Disease progression|0|||
27770233|NCT02175771|54223281|FG006|Treatment Period|Disease progression|0|||
27770234|NCT02175771|54223282|FG007|Treatment Period|Disease progression|2|||
27770235|NCT02175771|54223283|FG008|Treatment Period|Disease progression|0|||
27770236|NCT02175771|54223275|FG000|Treatment Period|Lost to Follow-up|0|||
27770237|NCT02175771|54223276|FG001|Treatment Period|Lost to Follow-up|3|||
27770238|NCT02175771|54223277|FG002|Treatment Period|Lost to Follow-up|1|||
27770239|NCT02175771|54223278|FG003|Treatment Period|Lost to Follow-up|3|||
27770240|NCT02175771|54223279|FG004|Treatment Period|Lost to Follow-up|1|||
27770241|NCT02175771|54223280|FG005|Treatment Period|Lost to Follow-up|2|||
27770242|NCT02175771|54223281|FG006|Treatment Period|Lost to Follow-up|1|||
27770243|NCT02175771|54223282|FG007|Treatment Period|Lost to Follow-up|2|||
27770244|NCT02175771|54223283|FG008|Treatment Period|Lost to Follow-up|2|||
27770245|NCT02175771|54223275|FG000|Treatment Period|Lack of Efficacy|0|||
27770246|NCT02175771|54223276|FG001|Treatment Period|Lack of Efficacy|0|||
27770247|NCT02175771|54223277|FG002|Treatment Period|Lack of Efficacy|0|||
27770248|NCT02175771|54223278|FG003|Treatment Period|Lack of Efficacy|0|||
27770249|NCT02175771|54223279|FG004|Treatment Period|Lack of Efficacy|0|||
27770250|NCT02175771|54223280|FG005|Treatment Period|Lack of Efficacy|1|||
27770251|NCT02175771|54223281|FG006|Treatment Period|Lack of Efficacy|0|||
27770252|NCT02175771|54223282|FG007|Treatment Period|Lack of Efficacy|1|||
27770253|NCT02175771|54223283|FG008|Treatment Period|Lack of Efficacy|0|||
27770254|NCT02175771|54223275|FG000|Treatment Period|Other|0|||
27770255|NCT02175771|54223276|FG001|Treatment Period|Other|1|||
27770256|NCT02175771|54223277|FG002|Treatment Period|Other|0|||
27770257|NCT02175771|54223278|FG003|Treatment Period|Other|3|||
27770258|NCT02175771|54223279|FG004|Treatment Period|Other|1|||
27770259|NCT02175771|54223280|FG005|Treatment Period|Other|0|||
27770260|NCT02175771|54223281|FG006|Treatment Period|Other|0|||
27770261|NCT02175771|54223282|FG007|Treatment Period|Other|2|||
27770262|NCT02175771|54223283|FG008|Treatment Period|Other|0|||
27770263|NCT01657799|54223304|FG000|Overall Study|Adverse Event Related to progression|6|||
27770264|NCT01657799|54223305|FG001|Overall Study|Adverse Event Related to progression|8|||
27770265|NCT01657799|54223306|FG002|Overall Study|Adverse Event Related to progression|12|||
27770266|NCT01657799|54223304|FG000|Overall Study|Adverse Event Not Related to Progression|5|||
27770267|NCT01657799|54223305|FG001|Overall Study|Adverse Event Not Related to Progression|4|||
27770268|NCT01657799|54223306|FG002|Overall Study|Adverse Event Not Related to Progression|4|||
27770269|NCT01657799|54223304|FG000|Overall Study|Withdrawal by Subject|13|||
27770270|NCT01657799|54223305|FG001|Overall Study|Withdrawal by Subject|10|||
27770271|NCT01657799|54223306|FG002|Overall Study|Withdrawal by Subject|10|||
27770272|NCT01657799|54223304|FG000|Overall Study|Lost to Follow-up|1|||
27770273|NCT01657799|54223305|FG001|Overall Study|Lost to Follow-up|0|||
27770274|NCT01657799|54223306|FG002|Overall Study|Lost to Follow-up|1|||
27770275|NCT01657799|54223304|FG000|Overall Study|Disease Progression|2|||
27770276|NCT01657799|54223305|FG001|Overall Study|Disease Progression|4|||
27770277|NCT01657799|54223306|FG002|Overall Study|Disease Progression|4|||
27770278|NCT01657799|54223304|FG000|Overall Study|Progressive Disease Clinical|7|||
27770279|NCT01657799|54223305|FG001|Overall Study|Progressive Disease Clinical|4|||
27770280|NCT01657799|54223306|FG002|Overall Study|Progressive Disease Clinical|7|||
27770281|NCT01657799|54223304|FG000|Overall Study|Radiographic & Clinical Progression|16|||
27770282|NCT01657799|54223305|FG001|Overall Study|Radiographic & Clinical Progression|11|||
27770283|NCT01657799|54223306|FG002|Overall Study|Radiographic & Clinical Progression|15|||
27770284|NCT01657799|54223304|FG000|Overall Study|Other|52|||
27770285|NCT01657799|54223305|FG001|Overall Study|Other|62|||
27770286|NCT01657799|54223306|FG002|Overall Study|Other|49|||
27770287|NCT02116803|54223316|FG000|Overall Study|Adverse Event|2|||
27770288|NCT02116803|54223317|FG001|Overall Study|Adverse Event|1|||
27770289|NCT02116803|54223316|FG000|Overall Study|Physician Decision|1|||
27770290|NCT02116803|54223317|FG001|Overall Study|Physician Decision|0|||
27770291|NCT02116803|54223316|FG000|Overall Study|Progressive disease|4|||
27770292|NCT02116803|54223317|FG001|Overall Study|Progressive disease|0|||
27770293|NCT02116803|54223316|FG000|Overall Study|Study terminated by sponsor|2|||
27770294|NCT02116803|54223317|FG001|Overall Study|Study terminated by sponsor|1|||
27770295|NCT02116803|54223316|FG000|Overall Study|Death|1|||
27770296|NCT02116803|54223317|FG001|Overall Study|Death|0|||
27770297|NCT02115321|54223325|FG000|Overall Study|Death|1|||
27770298|NCT02115321|54223326|FG001|Overall Study|Death|0|||
27770299|NCT02367781|54223334|FG000|Overall Study|Withdrawal by Subject|20|||
27770300|NCT02367781|54223335|FG001|Overall Study|Withdrawal by Subject|13|||
27770301|NCT02367781|54223334|FG000|Overall Study|Protocol Violation|0|||
27770302|NCT02367781|54223335|FG001|Overall Study|Protocol Violation|1|||
27770303|NCT02367781|54223334|FG000|Overall Study|Physician Decision|7|||
27770304|NCT02367781|54223335|FG001|Overall Study|Physician Decision|0|||
27770305|NCT02367781|54223334|FG000|Overall Study|Randomized in Error|5|||
27770306|NCT02367781|54223335|FG001|Overall Study|Randomized in Error|4|||
27770307|NCT02367781|54223334|FG000|Overall Study|Non-Compliance|1|||
27770308|NCT02367781|54223335|FG001|Overall Study|Non-Compliance|0|||
27770309|NCT02367781|54223334|FG000|Overall Study|Lost to Follow-up|1|||
27770310|NCT02367781|54223335|FG001|Overall Study|Lost to Follow-up|2|||
27770311|NCT02367781|54223334|FG000|Overall Study|Death|330|||
27839886|NCT01693562|54327127|FG016|Expansion Phase|Death|128|||
27839887|NCT01693562|54327128|FG017|Expansion Phase|Death|16|||
27839888|NCT01693562|54327129|FG018|Expansion Phase|Death|36|||
27839889|NCT01693562|54327130|FG019|Expansion Phase|Death|16|||
27839890|NCT01693562|54327131|FG020|Expansion Phase|Death|17|||
27839891|NCT01693562|54327132|FG021|Expansion Phase|Death|35|||
27839892|NCT01693562|54327133|FG022|Expansion Phase|Death|7|||
27839893|NCT01693562|54327111|FG000|Expansion Phase|Lost to Follow-up|0|||
27839894|NCT01693562|54327112|FG001|Expansion Phase|Lost to Follow-up|0|||
27839895|NCT01693562|54327113|FG002|Expansion Phase|Lost to Follow-up|0|||
27839896|NCT01693562|54327114|FG003|Expansion Phase|Lost to Follow-up|0|||
27839897|NCT01693562|54327115|FG004|Expansion Phase|Lost to Follow-up|0|||
27839898|NCT01693562|54327116|FG005|Expansion Phase|Lost to Follow-up|0|||
27839899|NCT01693562|54327117|FG006|Expansion Phase|Lost to Follow-up|0|||
27770312|NCT02367781|54223335|FG001|Overall Study|Death|176|||
27770313|NCT02367781|54223334|FG000|Overall Study|Patient Moving to Roll-Over Study|17|||
27839900|NCT01693562|54327118|FG007|Expansion Phase|Lost to Follow-up|1|||
27770314|NCT02367781|54223335|FG001|Overall Study|Patient Moving to Roll-Over Study|5|||
27770315|NCT02367781|54223334|FG000|Overall Study|Prolonged Hospitalization|1|||
27770316|NCT02367781|54223335|FG001|Overall Study|Prolonged Hospitalization|0|||
27770317|NCT02367781|54223334|FG000|Overall Study|Death Prior First Dose|1|||
27839901|NCT01693562|54327119|FG008|Expansion Phase|Lost to Follow-up|2|||
27839902|NCT01693562|54327120|FG009|Expansion Phase|Lost to Follow-up|10|||
27770318|NCT02367781|54223335|FG001|Overall Study|Death Prior First Dose|0|||
27770319|NCT02367781|54223334|FG000|Overall Study|Administrative-Change Facility|1|||
27839903|NCT01693562|54327121|FG010|Expansion Phase|Lost to Follow-up|4|||
27770320|NCT02367781|54223335|FG001|Overall Study|Administrative-Change Facility|0|||
27770321|NCT02367781|54223334|FG000|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|78|||
27770322|NCT02367781|54223335|FG001|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|29|||
27770323|NCT02367781|54223334|FG000|Overall Study|Patient Moved to Commercial Atezolizumab Use|14|||
27770324|NCT02367781|54223335|FG001|Overall Study|Patient Moved to Commercial Atezolizumab Use|9|||
27770325|NCT02367781|54223334|FG000|Overall Study|Study Terminated by Sponsor|3|||
27770326|NCT02367781|54223335|FG001|Overall Study|Study Terminated by Sponsor|1|||
27770327|NCT02367781|54223334|FG000|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|1|||
27770328|NCT02367781|54223335|FG001|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|0|||
27770329|NCT02367781|54223334|FG000|Overall Study|Sponsor Decision|2|||
27770330|NCT02367781|54223335|FG001|Overall Study|Sponsor Decision|0|||
27770331|NCT02367781|54223334|FG000|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|1|||
27770332|NCT02367781|54223335|FG001|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|0|||
27770333|NCT02152761|54223347|FG000|Epoch: Treatment Epoch|Technical problems|0|||
27770334|NCT02152761|54223348|FG001|Epoch: Treatment Epoch|Technical problems|0|||
27770335|NCT02152761|54223349|FG002|Epoch: Treatment Epoch|Technical problems|0|||
27770336|NCT02152761|54223350|FG003|Epoch: Treatment Epoch|Technical problems|1|||
27770337|NCT02152761|54223347|FG000|Epoch: Treatment Epoch|Lost to Follow-up|0|||
27770338|NCT02152761|54223348|FG001|Epoch: Treatment Epoch|Lost to Follow-up|2|||
27770339|NCT02152761|54223349|FG002|Epoch: Treatment Epoch|Lost to Follow-up|0|||
27770340|NCT02152761|54223350|FG003|Epoch: Treatment Epoch|Lost to Follow-up|0|||
27770341|NCT02152761|54223347|FG000|Epoch: Treatment Epoch|Withdrawal by Subject|7|||
27770342|NCT02152761|54223348|FG001|Epoch: Treatment Epoch|Withdrawal by Subject|8|||
27770343|NCT02152761|54223349|FG002|Epoch: Treatment Epoch|Withdrawal by Subject|3|||
27770344|NCT02152761|54223350|FG003|Epoch: Treatment Epoch|Withdrawal by Subject|5|||
27770345|NCT02152761|54223347|FG000|Epoch: Treatment Epoch|Adverse Event|3|||
27770346|NCT02152761|54223348|FG001|Epoch: Treatment Epoch|Adverse Event|6|||
27770347|NCT02152761|54223349|FG002|Epoch: Treatment Epoch|Adverse Event|1|||
27770348|NCT02152761|54223350|FG003|Epoch: Treatment Epoch|Adverse Event|2|||
27770349|NCT02152761|54223347|FG000|Epoch: Treatment Epoch|Death|0|||
27770350|NCT02152761|54223348|FG001|Epoch: Treatment Epoch|Death|3|||
27770351|NCT02152761|54223349|FG002|Epoch: Treatment Epoch|Death|1|||
27770352|NCT02152761|54223350|FG003|Epoch: Treatment Epoch|Death|0|||
27770353|NCT02152761|54223347|FG000|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
27770354|NCT02152761|54223348|FG001|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
27770355|NCT02152761|54223349|FG002|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
27770356|NCT02152761|54223350|FG003|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
27770357|NCT02152761|54223347|FG000|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
27770358|NCT02152761|54223348|FG001|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3|||
27770359|NCT02152761|54223349|FG002|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0|||
27770360|NCT02152761|54223350|FG003|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
27770361|NCT02152761|54223347|FG000|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1|||
27770362|NCT02152761|54223348|FG001|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4|||
27770363|NCT02152761|54223349|FG002|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
27770364|NCT02152761|54223350|FG003|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
27770365|NCT02152761|54223347|FG000|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1|||
27770366|NCT02152761|54223348|FG001|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
27770367|NCT02152761|54223349|FG002|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
27770368|NCT02152761|54223350|FG003|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
27770369|NCT02152761|54223347|FG000|Epoch: Post-treatment Follow-up Epoch|Death|1|||
27770370|NCT02152761|54223348|FG001|Epoch: Post-treatment Follow-up Epoch|Death|0|||
27770371|NCT02152761|54223349|FG002|Epoch: Post-treatment Follow-up Epoch|Death|0|||
27770372|NCT02152761|54223350|FG003|Epoch: Post-treatment Follow-up Epoch|Death|1|||
27770373|NCT02152605|54223372|FG000|Overall Study|Adverse Event|6|||
27770374|NCT02152605|54223373|FG001|Overall Study|Adverse Event|8|||
27770375|NCT02152605|54223372|FG000|Overall Study|Lack of Efficacy|7|||
27770376|NCT02152605|54223373|FG001|Overall Study|Lack of Efficacy|4|||
27770377|NCT02152605|54223372|FG000|Overall Study|Protocol deviation|1|||
27770378|NCT02152605|54223373|FG001|Overall Study|Protocol deviation|4|||
27770379|NCT02152605|54223372|FG000|Overall Study|Lost to Follow-up|1|||
27770380|NCT02152605|54223373|FG001|Overall Study|Lost to Follow-up|0|||
27770381|NCT02152605|54223372|FG000|Overall Study|Withdrew consent|4|||
27770382|NCT02152605|54223373|FG001|Overall Study|Withdrew consent|2|||
27770383|NCT02152371|54223382|FG000|Overall Study|Adverse Event|6|||
27770384|NCT02152371|54223383|FG001|Overall Study|Adverse Event|2|||
27770385|NCT02152371|54223382|FG000|Overall Study|Withdrawal by Subject|3|||
27770386|NCT02152371|54223383|FG001|Overall Study|Withdrawal by Subject|7|||
27770387|NCT02152371|54223382|FG000|Overall Study|Protocol Violation|2|||
27770388|NCT02152371|54223383|FG001|Overall Study|Protocol Violation|3|||
27770389|NCT02152371|54223382|FG000|Overall Study|Lost to Follow-up|1|||
27770390|NCT02152371|54223383|FG001|Overall Study|Lost to Follow-up|0|||
27770391|NCT02152371|54223382|FG000|Overall Study|Lack of Efficacy|0|||
27770392|NCT02152371|54223383|FG001|Overall Study|Lack of Efficacy|1|||
27770393|NCT02152371|54223382|FG000|Overall Study|Physician Decision|0|||
27770394|NCT02152371|54223383|FG001|Overall Study|Physician Decision|2|||
27770395|NCT02152371|54223382|FG000|Overall Study|Reason Not Given|0|||
27770396|NCT02152371|54223383|FG001|Overall Study|Reason Not Given|1|||
27770397|NCT02332291|54223391|FG000|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|3|||
27770398|NCT02332291|54223392|FG001|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|5|||
27770399|NCT02332291|54223391|FG000|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|0|||
27770400|NCT02332291|54223392|FG001|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|4|||
27770401|NCT02332291|54223391|FG000|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|1|||
27770402|NCT02332291|54223392|FG001|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|0|||
27770403|NCT02332291|54223391|FG000|Phase 2: Open-Label Bupropion|Adverse Event|2|||
27770404|NCT02332291|54223392|FG001|Phase 2: Open-Label Bupropion|Adverse Event|7|||
27770405|NCT02332291|54223391|FG000|Phase 2: Open-Label Bupropion|Worsening Depression|0|||
27770406|NCT02332291|54223392|FG001|Phase 2: Open-Label Bupropion|Worsening Depression|1|||
27770407|NCT02332291|54223391|FG000|Phase 2: Open-Label Bupropion|Lost to Follow-up|1|||
27770408|NCT02332291|54223392|FG001|Phase 2: Open-Label Bupropion|Lost to Follow-up|0|||
27770409|NCT01656395|54223408|FG000|Overall Study|Adverse Event|1|||
27770410|NCT01656395|54223409|FG001|Overall Study|Adverse Event|14|||
27770411|NCT01656395|54223410|FG002|Overall Study|Adverse Event|5|||
27770412|NCT01656395|54223411|FG003|Overall Study|Adverse Event|4|||
27770413|NCT01656395|54223412|FG004|Overall Study|Adverse Event|5|||
27770414|NCT01656395|54223413|FG005|Overall Study|Adverse Event|7|||
27770415|NCT01656395|54223414|FG006|Overall Study|Adverse Event|0|||
27770416|NCT01656395|54223415|FG007|Overall Study|Adverse Event|0|||
27770417|NCT01656395|54223408|FG000|Overall Study|Lack of Efficacy|1|||
27770418|NCT01656395|54223409|FG001|Overall Study|Lack of Efficacy|8|||
27770419|NCT01656395|54223410|FG002|Overall Study|Lack of Efficacy|6|||
27770420|NCT01656395|54223411|FG003|Overall Study|Lack of Efficacy|1|||
27770421|NCT01656395|54223412|FG004|Overall Study|Lack of Efficacy|1|||
27770422|NCT01656395|54223413|FG005|Overall Study|Lack of Efficacy|6|||
27770423|NCT01656395|54223414|FG006|Overall Study|Lack of Efficacy|0|||
27770424|NCT01656395|54223415|FG007|Overall Study|Lack of Efficacy|0|||
27770425|NCT01656395|54223408|FG000|Overall Study|Lost to Follow-up|1|||
27770426|NCT01656395|54223409|FG001|Overall Study|Lost to Follow-up|0|||
27770427|NCT01656395|54223410|FG002|Overall Study|Lost to Follow-up|0|||
27770428|NCT01656395|54223411|FG003|Overall Study|Lost to Follow-up|0|||
27770429|NCT01656395|54223412|FG004|Overall Study|Lost to Follow-up|0|||
27770430|NCT01656395|54223413|FG005|Overall Study|Lost to Follow-up|0|||
27770431|NCT01656395|54223414|FG006|Overall Study|Lost to Follow-up|0|||
27770432|NCT01656395|54223415|FG007|Overall Study|Lost to Follow-up|0|||
27770433|NCT01656395|54223408|FG000|Overall Study|Non-Compliance with Study Drug|1|||
27770434|NCT01656395|54223409|FG001|Overall Study|Non-Compliance with Study Drug|1|||
27770435|NCT01656395|54223410|FG002|Overall Study|Non-Compliance with Study Drug|0|||
27770436|NCT01656395|54223411|FG003|Overall Study|Non-Compliance with Study Drug|0|||
27770437|NCT01656395|54223412|FG004|Overall Study|Non-Compliance with Study Drug|1|||
27770438|NCT01656395|54223413|FG005|Overall Study|Non-Compliance with Study Drug|1|||
27770439|NCT01656395|54223414|FG006|Overall Study|Non-Compliance with Study Drug|0|||
27770440|NCT01656395|54223415|FG007|Overall Study|Non-Compliance with Study Drug|0|||
27770441|NCT01656395|54223408|FG000|Overall Study|Other|0|||
27770442|NCT01656395|54223409|FG001|Overall Study|Other|0|||
27770443|NCT01656395|54223410|FG002|Overall Study|Other|1|||
27770444|NCT01656395|54223411|FG003|Overall Study|Other|0|||
27770445|NCT01656395|54223412|FG004|Overall Study|Other|0|||
27770446|NCT01656395|54223413|FG005|Overall Study|Other|1|||
27770447|NCT01656395|54223414|FG006|Overall Study|Other|0|||
27770448|NCT01656395|54223415|FG007|Overall Study|Other|0|||
27770449|NCT01656395|54223408|FG000|Overall Study|Physician Decision|2|||
27770450|NCT01656395|54223409|FG001|Overall Study|Physician Decision|3|||
27770451|NCT01656395|54223410|FG002|Overall Study|Physician Decision|3|||
27770452|NCT01656395|54223411|FG003|Overall Study|Physician Decision|2|||
27770453|NCT01656395|54223412|FG004|Overall Study|Physician Decision|3|||
27839904|NCT01693562|54327122|FG011|Expansion Phase|Lost to Follow-up|4|||
27839905|NCT01693562|54327123|FG012|Expansion Phase|Lost to Follow-up|1|||
27839906|NCT01693562|54327124|FG013|Expansion Phase|Lost to Follow-up|3|||
27839907|NCT01693562|54327125|FG014|Expansion Phase|Lost to Follow-up|0|||
27770454|NCT01656395|54223413|FG005|Overall Study|Physician Decision|3|||
27770455|NCT01656395|54223414|FG006|Overall Study|Physician Decision|0|||
27770456|NCT01656395|54223415|FG007|Overall Study|Physician Decision|0|||
27770457|NCT01656395|54223408|FG000|Overall Study|Pregnancy|0|||
27770458|NCT01656395|54223409|FG001|Overall Study|Pregnancy|0|||
27839908|NCT01693562|54327126|FG015|Expansion Phase|Lost to Follow-up|1|||
27770459|NCT01656395|54223410|FG002|Overall Study|Pregnancy|1|||
27770460|NCT01656395|54223411|FG003|Overall Study|Pregnancy|0|||
27770461|NCT01656395|54223412|FG004|Overall Study|Pregnancy|0|||
27770462|NCT01656395|54223413|FG005|Overall Study|Pregnancy|0|||
27770463|NCT01656395|54223414|FG006|Overall Study|Pregnancy|0|||
27770464|NCT01656395|54223415|FG007|Overall Study|Pregnancy|0|||
27770465|NCT01656395|54223408|FG000|Overall Study|Progressive Disease|0|||
27770466|NCT01656395|54223409|FG001|Overall Study|Progressive Disease|0|||
27770467|NCT01656395|54223410|FG002|Overall Study|Progressive Disease|0|||
27770468|NCT01656395|54223411|FG003|Overall Study|Progressive Disease|0|||
27770469|NCT01656395|54223412|FG004|Overall Study|Progressive Disease|0|||
27770470|NCT01656395|54223413|FG005|Overall Study|Progressive Disease|1|||
27770471|NCT01656395|54223414|FG006|Overall Study|Progressive Disease|0|||
27770472|NCT01656395|54223415|FG007|Overall Study|Progressive Disease|0|||
27770473|NCT01656395|54223408|FG000|Overall Study|Protocol Violation|6|||
27770474|NCT01656395|54223409|FG001|Overall Study|Protocol Violation|6|||
27770475|NCT01656395|54223410|FG002|Overall Study|Protocol Violation|9|||
27770476|NCT01656395|54223411|FG003|Overall Study|Protocol Violation|2|||
27770477|NCT01656395|54223412|FG004|Overall Study|Protocol Violation|4|||
27770478|NCT01656395|54223413|FG005|Overall Study|Protocol Violation|10|||
27770479|NCT01656395|54223414|FG006|Overall Study|Protocol Violation|0|||
27770480|NCT01656395|54223415|FG007|Overall Study|Protocol Violation|0|||
27770481|NCT01656395|54223408|FG000|Overall Study|Screen Failure|2|||
27770482|NCT01656395|54223409|FG001|Overall Study|Screen Failure|1|||
27770483|NCT01656395|54223410|FG002|Overall Study|Screen Failure|7|||
27770484|NCT01656395|54223411|FG003|Overall Study|Screen Failure|1|||
27770485|NCT01656395|54223412|FG004|Overall Study|Screen Failure|0|||
27770486|NCT01656395|54223413|FG005|Overall Study|Screen Failure|8|||
27770487|NCT01656395|54223414|FG006|Overall Study|Screen Failure|0|||
27770488|NCT01656395|54223415|FG007|Overall Study|Screen Failure|0|||
27770489|NCT01656395|54223408|FG000|Overall Study|Withdrawal by Subject|3|||
27770490|NCT01656395|54223409|FG001|Overall Study|Withdrawal by Subject|1|||
27770491|NCT01656395|54223410|FG002|Overall Study|Withdrawal by Subject|4|||
27770492|NCT01656395|54223411|FG003|Overall Study|Withdrawal by Subject|2|||
27770493|NCT01656395|54223412|FG004|Overall Study|Withdrawal by Subject|0|||
27770494|NCT01656395|54223413|FG005|Overall Study|Withdrawal by Subject|3|||
27770495|NCT01656395|54223414|FG006|Overall Study|Withdrawal by Subject|0|||
27770496|NCT01656395|54223415|FG007|Overall Study|Withdrawal by Subject|0|||
27770497|NCT02114931|54223431|FG000|Overall Study|Withdrawal by Subject|15|||
27770498|NCT02114931|54223432|FG001|Overall Study|Withdrawal by Subject|18|||
27770499|NCT02114931|54223431|FG000|Overall Study|Adverse Event|4|||
27770500|NCT02114931|54223432|FG001|Overall Study|Adverse Event|6|||
27770501|NCT02114931|54223431|FG000|Overall Study|Lost to Follow-up|3|||
27770502|NCT02114931|54223432|FG001|Overall Study|Lost to Follow-up|3|||
27770503|NCT02114931|54223431|FG000|Overall Study|Physician Decision|1|||
27770504|NCT02114931|54223432|FG001|Overall Study|Physician Decision|2|||
27770505|NCT02114931|54223431|FG000|Overall Study|Other|2|||
27770506|NCT02114931|54223432|FG001|Overall Study|Other|1|||
27770507|NCT01657019|54223438|FG000|Overall Study|Withdrawal by Subject|65|||
27770508|NCT01657019|54223438|FG000|Overall Study|Adverse Event|55|||
27770509|NCT01657019|54223438|FG000|Overall Study|Lost to Follow-up|48|||
27770510|NCT01657019|54223438|FG000|Overall Study|Protocol Violation|6|||
27770511|NCT01657019|54223438|FG000|Overall Study|Lack of Efficacy|3|||
27770512|NCT01657019|54223438|FG000|Overall Study|Other|58|||
27770513|NCT02329327|54223444|FG000|Overall Study|Death|78|||
27770514|NCT02329327|54223445|FG001|Overall Study|Death|0|||
27770515|NCT02329327|54223444|FG000|Overall Study|Withdrawal by Subject|3|||
27770516|NCT02329327|54223445|FG001|Overall Study|Withdrawal by Subject|0|||
27770517|NCT02329327|54223444|FG000|Overall Study|Lost to Follow-up|4|||
27770518|NCT02329327|54223445|FG001|Overall Study|Lost to Follow-up|0|||
27770519|NCT02328937|54223464|FG000|Period 1|Lost to Follow-up|0|||
27770520|NCT02328937|54223465|FG001|Period 1|Lost to Follow-up|0|||
27770521|NCT02328937|54223466|FG002|Period 1|Lost to Follow-up|0|||
27770522|NCT02328937|54223467|FG003|Period 1|Lost to Follow-up|1|||
27770523|NCT02328937|54223468|FG004|Period 1|Lost to Follow-up|0|||
27770524|NCT02328937|54223469|FG005|Period 1|Lost to Follow-up|0|||
27839909|NCT01693562|54327127|FG016|Expansion Phase|Lost to Follow-up|1|||
27839910|NCT01693562|54327128|FG017|Expansion Phase|Lost to Follow-up|0|||
27770525|NCT02328937|54223464|FG000|Period 2|Adverse Event|0|||
27770526|NCT02328937|54223465|FG001|Period 2|Adverse Event|0|||
27770527|NCT02328937|54223466|FG002|Period 2|Adverse Event|1|||
27839911|NCT01693562|54327129|FG018|Expansion Phase|Lost to Follow-up|2|||
27839912|NCT01693562|54327130|FG019|Expansion Phase|Lost to Follow-up|1|||
27839913|NCT01693562|54327131|FG020|Expansion Phase|Lost to Follow-up|2|||
27770528|NCT02328937|54223467|FG003|Period 2|Adverse Event|0|||
27839914|NCT01693562|54327132|FG021|Expansion Phase|Lost to Follow-up|2|||
27770529|NCT02328937|54223468|FG004|Period 2|Adverse Event|0|||
27770530|NCT02328937|54223469|FG005|Period 2|Adverse Event|0|||
27770531|NCT02328547|54223479|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
27770532|NCT02328547|54223480|FG001|First Intervention (12 Weeks)|Lost to Follow-up|0|||
27770533|NCT02328547|54223479|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
27770534|NCT02328547|54223480|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
27770535|NCT02300311|54223494|FG000|Overall Study|Other than the reason specified|1|||
27770536|NCT02300311|54223495|FG001|Overall Study|Other than the reason specified|0|||
27770537|NCT02300311|54223494|FG000|Overall Study|Refused to continue taking medication|18|||
27770538|NCT02300311|54223495|FG001|Overall Study|Refused to continue taking medication|0|||
27770539|NCT02300233|54223504|FG000|Overall Study|Adverse Event or Serious Adverse Event|3|||
27770540|NCT02300233|54223505|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
27770541|NCT02300233|54223506|FG002|Overall Study|Adverse Event or Serious Adverse Event|14|||
27770542|NCT02300233|54223504|FG000|Overall Study|Withdrawal by Subject|1|||
27770543|NCT02300233|54223505|FG001|Overall Study|Withdrawal by Subject|0|||
27770544|NCT02300233|54223506|FG002|Overall Study|Withdrawal by Subject|3|||
27770545|NCT02300233|54223504|FG000|Overall Study|Investigator Judgement|0|||
27770546|NCT02300233|54223505|FG001|Overall Study|Investigator Judgement|0|||
27770547|NCT02300233|54223506|FG002|Overall Study|Investigator Judgement|1|||
27770548|NCT02300233|54223504|FG000|Overall Study|Reason Not Specified|0|||
27770549|NCT02300233|54223505|FG001|Overall Study|Reason Not Specified|0|||
27770550|NCT02300233|54223506|FG002|Overall Study|Reason Not Specified|5|||
27770551|NCT02175225|54223517|FG000|Overall Study|Withdrawal by Subject|1|||
27770552|NCT02175225|54223518|FG001|Overall Study|Withdrawal by Subject|2|||
27770553|NCT02175225|54223517|FG000|Overall Study|Lost to Follow-up|6|||
27770554|NCT02175225|54223518|FG001|Overall Study|Lost to Follow-up|7|||
27770555|NCT02175225|54223517|FG000|Overall Study|Study drug not administered|1|||
27770556|NCT02175225|54223518|FG001|Overall Study|Study drug not administered|2|||
27770557|NCT02299375|54223526|FG000|Overall Study|Adverse Event, serious fatal|1|||
27770558|NCT02299375|54223527|FG001|Overall Study|Adverse Event, serious fatal|3|||
27770559|NCT02299375|54223526|FG000|Overall Study|Adverse Event, non-fatal|8|||
27770560|NCT02299375|54223527|FG001|Overall Study|Adverse Event, non-fatal|9|||
27770561|NCT02299375|54223526|FG000|Overall Study|Lack of Efficacy|1|||
27770562|NCT02299375|54223527|FG001|Overall Study|Lack of Efficacy|3|||
27770563|NCT02299375|54223526|FG000|Overall Study|Protocol Violation|1|||
27770564|NCT02299375|54223527|FG001|Overall Study|Protocol Violation|3|||
27770565|NCT02299375|54223526|FG000|Overall Study|Other: Met stopping criteria|1|||
27770566|NCT02299375|54223527|FG001|Overall Study|Other: Met stopping criteria|0|||
27770567|NCT02299375|54223526|FG000|Overall Study|Other: Study closed/terminated|66|||
27770568|NCT02299375|54223527|FG001|Overall Study|Other: Study closed/terminated|55|||
27770569|NCT02299375|54223526|FG000|Overall Study|Lost to Follow-up|0|||
27770570|NCT02299375|54223527|FG001|Overall Study|Lost to Follow-up|2|||
27770571|NCT02299375|54223526|FG000|Overall Study|Physician Decision|1|||
27770572|NCT02299375|54223527|FG001|Overall Study|Physician Decision|1|||
27770573|NCT02299375|54223526|FG000|Overall Study|Withdrawal by Subject|1|||
27770574|NCT02299375|54223527|FG001|Overall Study|Withdrawal by Subject|4|||
27770575|NCT02151903|54223536|FG000|Overall Study|Withdrawal by Subject|1|||
27770576|NCT02151903|54223537|FG001|Overall Study|Withdrawal by Subject|0|||
27770577|NCT02151903|54223536|FG000|Overall Study|Progressive disease|2|||
27770578|NCT02151903|54223537|FG001|Overall Study|Progressive disease|1|||
27770579|NCT02151591|54223545|FG000|Overall Study|Lost to Follow-up|6|||
27770580|NCT02151591|54223546|FG001|Overall Study|Lost to Follow-up|3|||
27770581|NCT02174523|54223554|FG000|Overall Study|Withdrawal by Subject|1|||
27770582|NCT02174523|54223555|FG001|Overall Study|Withdrawal by Subject|0|||
27770583|NCT02297815|54223562|FG000|Overall Study|Lost to Follow-up|236|||
27770584|NCT02297815|54223563|FG001|Overall Study|Lost to Follow-up|140|||
27770585|NCT02114385|54223573|FG000|Overall Study|Withdrawal by Subject|3|||
27770586|NCT02114385|54223574|FG001|Overall Study|Withdrawal by Subject|2|||
27770587|NCT02114385|54223573|FG000|Overall Study|Lost to Follow-up|0|||
27770588|NCT02114385|54223574|FG001|Overall Study|Lost to Follow-up|6|||
27770589|NCT02114151|54223580|FG000|Overall Study|Death|1|||
27770590|NCT02114151|54223580|FG000|Overall Study|Lost to Follow-up|1|||
27770591|NCT02114151|54223580|FG000|Overall Study|Withdrawal by Subject|5|||
27770592|NCT02297503|54223586|FG000|Overall Study|Withdrawal by Subject|1|||
27770593|NCT02297503|54223587|FG001|Overall Study|Withdrawal by Subject|1|||
27770594|NCT02297503|54223586|FG000|Overall Study|Protocol Violation|1|||
27770595|NCT02297503|54223587|FG001|Overall Study|Protocol Violation|0|||
27770596|NCT02297503|54223586|FG000|Overall Study|Pregnancy|0|||
27770597|NCT02297503|54223587|FG001|Overall Study|Pregnancy|1|||
27770598|NCT02297503|54223586|FG000|Overall Study|Lost to Follow-up|0|||
27770599|NCT02297503|54223587|FG001|Overall Study|Lost to Follow-up|1|||
27770600|NCT02297503|54223586|FG000|Overall Study|Medical reason|0|||
27770601|NCT02297503|54223587|FG001|Overall Study|Medical reason|1|||
27770602|NCT02113449|54223602|FG000|Overall Study|Adverse Event|4|||
27770603|NCT02366923|54223610|FG000|Overall Study|Withdrawal by Subject|1|||
27770604|NCT02366923|54223610|FG000|Overall Study|Positive Slit Lamp Findings|2|||
27770605|NCT02366923|54223610|FG000|Overall Study|High Astigmatism|3|||
27770606|NCT02326597|54223617|FG000|Overall Study|Lost to Follow-up|42|||
27770607|NCT02326597|54223618|FG001|Overall Study|Lost to Follow-up|32|||
27770608|NCT02366767|54223628|FG000|Overall Study|left for home after 1 day at camp|1|||
27770609|NCT02366767|54223629|FG001|Overall Study|left for home after 1 day at camp|0|||
27770610|NCT02150343|54223639|FG000|Overall Study|Adverse Event|2|||
27770611|NCT02150343|54223640|FG001|Overall Study|Adverse Event|0|||
27770612|NCT02150343|54223641|FG002|Overall Study|Adverse Event|1|||
27770613|NCT02150343|54223642|FG003|Overall Study|Adverse Event|1|||
27770614|NCT02150343|54223639|FG000|Overall Study|Withdrawal by Subject|13|||
27770615|NCT02150343|54223640|FG001|Overall Study|Withdrawal by Subject|10|||
27770616|NCT02150343|54223641|FG002|Overall Study|Withdrawal by Subject|9|||
27770617|NCT02150343|54223642|FG003|Overall Study|Withdrawal by Subject|4|||
27770618|NCT02150343|54223639|FG000|Overall Study|Lost to Follow-up|4|||
27770619|NCT02150343|54223640|FG001|Overall Study|Lost to Follow-up|4|||
27770620|NCT02150343|54223641|FG002|Overall Study|Lost to Follow-up|2|||
27770621|NCT02150343|54223642|FG003|Overall Study|Lost to Follow-up|3|||
27770622|NCT02150343|54223639|FG000|Overall Study|Other|2|||
27770623|NCT02150343|54223640|FG001|Overall Study|Other|6|||
27770624|NCT02150343|54223641|FG002|Overall Study|Other|0|||
27770625|NCT02150343|54223642|FG003|Overall Study|Other|2|||
27770626|NCT02149875|54223655|FG000|Overall Study|Lost to Follow-up|3|||
27770627|NCT02149875|54223656|FG001|Overall Study|Lost to Follow-up|4|||
27770628|NCT02149875|54223657|FG002|Overall Study|Lost to Follow-up|5|||
27770629|NCT02149875|54223655|FG000|Overall Study|Withdrawal by Subject|3|||
27770630|NCT02149875|54223656|FG001|Overall Study|Withdrawal by Subject|2|||
27770631|NCT02149875|54223657|FG002|Overall Study|Withdrawal by Subject|2|||
27770632|NCT02149875|54223655|FG000|Overall Study|Physician Decision|1|||
27770633|NCT02149875|54223656|FG001|Overall Study|Physician Decision|2|||
27770634|NCT02149875|54223657|FG002|Overall Study|Physician Decision|2|||
27770635|NCT02112045|54223667|FG000|Overall Study|Withdrawal by Subject|1|||
27770636|NCT02112045|54223668|FG001|Overall Study|Withdrawal by Subject|0|||
27770637|NCT01629693|54223676|FG000|Overall Study|Lost to Follow-up|2|||
27770638|NCT01629693|54223677|FG001|Overall Study|Lost to Follow-up|4|||
27770639|NCT01629693|54223676|FG000|Overall Study|Withdrawal by Subject|2|||
27770640|NCT01629693|54223677|FG001|Overall Study|Withdrawal by Subject|2|||
27770641|NCT01629693|54223676|FG000|Overall Study|Adverse Event|1|||
27770642|NCT01629693|54223677|FG001|Overall Study|Adverse Event|0|||
27770643|NCT01629693|54223676|FG000|Overall Study|Investigator decision|0|||
27770644|NCT01629693|54223677|FG001|Overall Study|Investigator decision|1|||
27770645|NCT01629693|54223676|FG000|Overall Study|Poor comfort of study lenses|0|||
27770646|NCT01629693|54223677|FG001|Overall Study|Poor comfort of study lenses|2|||
27770647|NCT01629693|54223676|FG000|Overall Study|Subject decision unrelated to AE|0|||
27770648|NCT01629693|54223677|FG001|Overall Study|Subject decision unrelated to AE|1|||
27770649|NCT02147691|54223685|FG000|Overall Study|Withdrawal by Subject|2|||
27770650|NCT02147691|54223686|FG001|Overall Study|Withdrawal by Subject|0|||
27770651|NCT02147691|54223685|FG000|Overall Study|Adverse Event|2|||
27770652|NCT02147691|54223686|FG001|Overall Study|Adverse Event|0|||
27770653|NCT02147691|54223685|FG000|Overall Study|Lost to Follow-up|0|||
27770654|NCT02147691|54223686|FG001|Overall Study|Lost to Follow-up|1|||
27770655|NCT02111811|54223694|FG000|Treatment Phase|Lost to Follow-up|22|||
27770656|NCT02111811|54223695|FG001|Treatment Phase|Lost to Follow-up|18|||
27770657|NCT02111811|54223694|FG000|Treatment Phase|Death|2|||
27770658|NCT02111811|54223695|FG001|Treatment Phase|Death|0|||
27770659|NCT02111811|54223694|FG000|Follow up Period (Aim 2)|Lost to Follow-up|26|||
27770660|NCT02111811|54223695|FG001|Follow up Period (Aim 2)|Lost to Follow-up|17|||
27770661|NCT02111811|54223694|FG000|Follow up Period (Aim 2)|Death|2|||
27770662|NCT02111811|54223695|FG001|Follow up Period (Aim 2)|Death|0|||
27770663|NCT01655693|54223704|FG000|Overall Study|Progression of Disease|92|||
27770664|NCT01655693|54223705|FG001|Overall Study|Progression of Disease|76|||
27770665|NCT01655693|54223706|FG002|Overall Study|Progression of Disease|58|||
27770666|NCT01655693|54223704|FG000|Overall Study|Death|8|||
27770667|NCT01655693|54223705|FG001|Overall Study|Death|9|||
27770668|NCT01655693|54223706|FG002|Overall Study|Death|12|||
27770669|NCT01655693|54223704|FG000|Overall Study|Serious Adverse Event|3|||
27770670|NCT01655693|54223705|FG001|Overall Study|Serious Adverse Event|15|||
27770671|NCT01655693|54223706|FG002|Overall Study|Serious Adverse Event|11|||
27770672|NCT01655693|54223704|FG000|Overall Study|Withdrawal by Subject|3|||
27770673|NCT01655693|54223705|FG001|Overall Study|Withdrawal by Subject|2|||
27770674|NCT01655693|54223706|FG002|Overall Study|Withdrawal by Subject|20|||
27770675|NCT01655693|54223704|FG000|Overall Study|Adverse Event|3|||
27770676|NCT01655693|54223705|FG001|Overall Study|Adverse Event|11|||
27770677|NCT01655693|54223706|FG002|Overall Study|Adverse Event|3|||
27770678|NCT01655693|54223704|FG000|Overall Study|Aggravation of Liver Dysfunction|5|||
27770679|NCT01655693|54223705|FG001|Overall Study|Aggravation of Liver Dysfunction|4|||
27770680|NCT01655693|54223706|FG002|Overall Study|Aggravation of Liver Dysfunction|0|||
27770681|NCT01655693|54223704|FG000|Overall Study|Non-Compliance|0|||
27770682|NCT01655693|54223705|FG001|Overall Study|Non-Compliance|0|||
27770683|NCT01655693|54223706|FG002|Overall Study|Non-Compliance|7|||
27770684|NCT01655693|54223704|FG000|Overall Study|No Respect of Criteria for Continuing Treatment|1|||
27770685|NCT01655693|54223705|FG001|Overall Study|No Respect of Criteria for Continuing Treatment|3|||
27770686|NCT01655693|54223706|FG002|Overall Study|No Respect of Criteria for Continuing Treatment|0|||
27770687|NCT01655693|54223704|FG000|Overall Study|Protocol Violation|1|||
27770688|NCT01655693|54223705|FG001|Overall Study|Protocol Violation|0|||
27770689|NCT01655693|54223706|FG002|Overall Study|Protocol Violation|3|||
27770690|NCT01655693|54223704|FG000|Overall Study|Lost to Follow-up|1|||
27770691|NCT01655693|54223705|FG001|Overall Study|Lost to Follow-up|0|||
27770692|NCT01655693|54223706|FG002|Overall Study|Lost to Follow-up|1|||
27770693|NCT01655693|54223704|FG000|Overall Study|Screening Failure|1|||
27770694|NCT01655693|54223705|FG001|Overall Study|Screening Failure|0|||
27770695|NCT01655693|54223706|FG002|Overall Study|Screening Failure|0|||
27770696|NCT01655693|54223704|FG000|Overall Study|Other|8|||
27770697|NCT01655693|54223705|FG001|Overall Study|Other|6|||
27770698|NCT01655693|54223706|FG002|Overall Study|Other|15|||
27770699|NCT01655381|54223724|FG000|Overall Study|Investigator Decision|1|||
27770700|NCT01655381|54223724|FG000|Overall Study|Moved to Another City|1|||
27770701|NCT01655381|54223724|FG000|Overall Study|Insufficient Treatment Response|1|||
27770702|NCT01656161|54223729|FG000|Overall Study|Death|3|||
27770703|NCT01656161|54223729|FG000|Overall Study|Adverse Event|2|||
27770704|NCT01656161|54223729|FG000|Overall Study|Protocol Violation|1|||
27770705|NCT01656161|54223729|FG000|Overall Study|Withdrawal by Subject|1|||
27770706|NCT02111577|54223738|FG000|Overall Study|Protocol Violation|2|||
27770707|NCT02111577|54223739|FG001|Overall Study|Protocol Violation|0|||
27770708|NCT02111577|54223738|FG000|Overall Study|Unable to tolerate leukapheresis|1|||
27770709|NCT02111577|54223739|FG001|Overall Study|Unable to tolerate leukapheresis|0|||
27770710|NCT02111577|54223738|FG000|Overall Study|Failure to produce study treatment|6|||
27770711|NCT02111577|54223739|FG001|Overall Study|Failure to produce study treatment|0|||
27770712|NCT02111577|54223738|FG000|Overall Study|Death|518|||
27770713|NCT02111577|54223739|FG001|Overall Study|Death|254|||
27770714|NCT02111577|54223738|FG000|Overall Study|Medical monitor's decision (active hepatitis B)|1|||
27770715|NCT02111577|54223739|FG001|Overall Study|Medical monitor's decision (active hepatitis B)|0|||
27770716|NCT02111577|54223738|FG000|Overall Study|Adverse Event|1|||
27770717|NCT02111577|54223739|FG001|Overall Study|Adverse Event|1|||
27770718|NCT02111577|54223738|FG000|Overall Study|Withdrawal by Subject|51|||
27770719|NCT02111577|54223739|FG001|Overall Study|Withdrawal by Subject|23|||
27770720|NCT02111577|54223738|FG000|Overall Study|Disease progression|0|||
27770721|NCT02111577|54223739|FG001|Overall Study|Disease progression|1|||
27770722|NCT02111577|54223738|FG000|Overall Study|Lost to Follow-up|19|||
27770723|NCT02111577|54223739|FG001|Overall Study|Lost to Follow-up|10|||
27770724|NCT02170779|54223749|FG000|Overall Study|Withdrawal by Subject|1|||
27770725|NCT02170779|54223750|FG001|Overall Study|Withdrawal by Subject|0|||
27770726|NCT02170779|54223749|FG000|Overall Study|Lost to Follow-up|0|||
27770727|NCT02170779|54223750|FG001|Overall Study|Lost to Follow-up|1|||
27770728|NCT02147067|54223758|FG000|Overall Study|Withdrawal by Subject|2|||
27770729|NCT02147067|54223759|FG001|Overall Study|Withdrawal by Subject|2|||
27770730|NCT02170389|54223765|FG000|Overall Study|Study terminated prior to start of treat|1|||
27770731|NCT02146599|54223769|FG000|Overall Study|Failed to meet inclusion criteria|5|||
27770732|NCT02146365|54223779|FG000|Overall Study|Lost to Follow-up|2|||
27770733|NCT02146365|54223780|FG001|Overall Study|Lost to Follow-up|1|||
27770734|NCT02146365|54223781|FG002|Overall Study|Lost to Follow-up|3|||
27770735|NCT02146365|54223782|FG003|Overall Study|Lost to Follow-up|3|||
27770736|NCT02146365|54223783|FG004|Overall Study|Lost to Follow-up|1|||
27770737|NCT02146365|54223784|FG005|Overall Study|Lost to Follow-up|1|||
27770738|NCT02146365|54223785|FG006|Overall Study|Lost to Follow-up|0|||
27770739|NCT02146365|54223786|FG007|Overall Study|Lost to Follow-up|1|||
27770740|NCT02146365|54223779|FG000|Overall Study|Withdrawal by Subject|1|||
27770741|NCT02146365|54223780|FG001|Overall Study|Withdrawal by Subject|2|||
27770742|NCT02146365|54223781|FG002|Overall Study|Withdrawal by Subject|1|||
27770743|NCT02146365|54223782|FG003|Overall Study|Withdrawal by Subject|5|||
27770744|NCT02146365|54223783|FG004|Overall Study|Withdrawal by Subject|1|||
27770745|NCT02146365|54223784|FG005|Overall Study|Withdrawal by Subject|0|||
27770746|NCT02146365|54223785|FG006|Overall Study|Withdrawal by Subject|0|||
27770747|NCT02146365|54223786|FG007|Overall Study|Withdrawal by Subject|0|||
27770748|NCT02146365|54223779|FG000|Overall Study|Unable to Comply with Protocol|0|||
27770749|NCT02146365|54223780|FG001|Overall Study|Unable to Comply with Protocol|1|||
27770750|NCT02146365|54223781|FG002|Overall Study|Unable to Comply with Protocol|1|||
27770751|NCT02146365|54223782|FG003|Overall Study|Unable to Comply with Protocol|0|||
27770752|NCT02146365|54223783|FG004|Overall Study|Unable to Comply with Protocol|0|||
27770753|NCT02146365|54223784|FG005|Overall Study|Unable to Comply with Protocol|0|||
27770754|NCT02146365|54223785|FG006|Overall Study|Unable to Comply with Protocol|0|||
27770755|NCT02146365|54223786|FG007|Overall Study|Unable to Comply with Protocol|0|||
27770756|NCT02146365|54223779|FG000|Overall Study|Other|1|||
27770757|NCT02146365|54223780|FG001|Overall Study|Other|0|||
27770758|NCT02146365|54223781|FG002|Overall Study|Other|2|||
27770759|NCT02146365|54223782|FG003|Overall Study|Other|1|||
27770760|NCT02146365|54223783|FG004|Overall Study|Other|0|||
27770761|NCT02146365|54223784|FG005|Overall Study|Other|0|||
27770762|NCT02146365|54223785|FG006|Overall Study|Other|0|||
27770763|NCT02146365|54223786|FG007|Overall Study|Other|0|||
27770764|NCT02146131|54223806|FG000|Overall Study|Physician Decision|61|||
27770765|NCT02146131|54223807|FG001|Overall Study|Physician Decision|56|||
27839915|NCT01693562|54327133|FG022|Expansion Phase|Lost to Follow-up|1|||
27770766|NCT02107131|54223815|FG000|Overall Study|Lost to Follow-up|4|||
27770767|NCT02107131|54223816|FG001|Overall Study|Lost to Follow-up|4|||
27770768|NCT02107131|54223815|FG000|Overall Study|Physician Decision|1|||
27770769|NCT02107131|54223816|FG001|Overall Study|Physician Decision|0|||
27770770|NCT02107131|54223815|FG000|Overall Study|Withdrawal by Subject|2|||
27770771|NCT02107131|54223816|FG001|Overall Study|Withdrawal by Subject|0|||
27770772|NCT02107131|54223815|FG000|Overall Study|mental instability|1|||
27770773|NCT02107131|54223816|FG001|Overall Study|mental instability|0|||
27770774|NCT02107131|54223815|FG000|Overall Study|Death|0|||
27770775|NCT02107131|54223816|FG001|Overall Study|Death|1|||
27770776|NCT02107131|54223815|FG000|Overall Study|Protocol Violation|0|||
27770777|NCT02107131|54223816|FG001|Overall Study|Protocol Violation|4|||
27770778|NCT02106975|54223826|FG000|Overall Study|Death|25|||
27770779|NCT02106975|54223827|FG001|Overall Study|Death|39|||
27770780|NCT02145429|54223835|FG000|Overall Study|Death|4|||
27770781|NCT02145429|54223836|FG001|Overall Study|Death|5|||
27770782|NCT02145429|54223835|FG000|Overall Study|Lost to Follow-up|4|||
27770783|NCT02145429|54223836|FG001|Overall Study|Lost to Follow-up|3|||
27770784|NCT02145429|54223835|FG000|Overall Study|Withdrawal by Subject|8|||
27770785|NCT02145429|54223836|FG001|Overall Study|Withdrawal by Subject|3|||
27770786|NCT02144337|54223844|FG000|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
27770787|NCT02144337|54223845|FG001|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
27770788|NCT02144337|54223844|FG000|T2 Follow-up (Post-intervention)|Lost to Follow-up|2|||
27770789|NCT02144337|54223845|FG001|T2 Follow-up (Post-intervention)|Lost to Follow-up|0|||
27770790|NCT02144337|54223844|FG000|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1|||
27770791|NCT02144337|54223845|FG001|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0|||
27770792|NCT02144337|54223844|FG000|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2|||
27770793|NCT02144337|54223845|FG001|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0|||
27770794|NCT02144337|54223844|FG000|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1|||
27770795|NCT02144337|54223845|FG001|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0|||
27770796|NCT02520011|54223855|FG000|Overall Study|Adverse Event|0|||
27770797|NCT02520011|54223856|FG001|Overall Study|Adverse Event|1|||
27770798|NCT02520011|54223857|FG002|Overall Study|Adverse Event|2|||
27770799|NCT02520011|54223855|FG000|Overall Study|Death|0|||
27770800|NCT02520011|54223856|FG001|Overall Study|Death|8|||
27770801|NCT02520011|54223857|FG002|Overall Study|Death|1|||
27770802|NCT02520011|54223855|FG000|Overall Study|Lack of Efficacy|4|||
27770803|NCT02520011|54223856|FG001|Overall Study|Lack of Efficacy|26|||
27770804|NCT02520011|54223857|FG002|Overall Study|Lack of Efficacy|4|||
27770805|NCT02520011|54223855|FG000|Overall Study|Physician Decision|0|||
27770806|NCT02520011|54223856|FG001|Overall Study|Physician Decision|2|||
27770807|NCT02520011|54223857|FG002|Overall Study|Physician Decision|0|||
27770808|NCT02520011|54223855|FG000|Overall Study|Withdrawal by Subject|1|||
27770809|NCT02520011|54223856|FG001|Overall Study|Withdrawal by Subject|3|||
27770810|NCT02520011|54223857|FG002|Overall Study|Withdrawal by Subject|0|||
27770811|NCT02520011|54223855|FG000|Overall Study|Protocol Deviation|0|||
27770812|NCT02520011|54223856|FG001|Overall Study|Protocol Deviation|1|||
27770813|NCT02520011|54223857|FG002|Overall Study|Protocol Deviation|0|||
27770814|NCT02520011|54223855|FG000|Overall Study|Patient went to hospice|0|||
27770815|NCT02520011|54223856|FG001|Overall Study|Patient went to hospice|1|||
27770816|NCT02520011|54223857|FG002|Overall Study|Patient went to hospice|0|||
27770817|NCT02520011|54223855|FG000|Overall Study|Progressive disease following response|0|||
27770818|NCT02520011|54223856|FG001|Overall Study|Progressive disease following response|4|||
27770819|NCT02520011|54223857|FG002|Overall Study|Progressive disease following response|2|||
27770820|NCT02519231|54223872|FG000|Overall Study|Lost to Follow-up|2|||
27770821|NCT02519231|54223873|FG001|Overall Study|Lost to Follow-up|5|||
27770822|NCT02519231|54223872|FG000|Overall Study|Withdrawal by Subject|0|||
27770823|NCT02519231|54223873|FG001|Overall Study|Withdrawal by Subject|1|||
27770824|NCT02106351|54223884|FG000|Treatment Cycle 1|Adverse Event|2|||
27839916|NCT01693562|54327111|FG000|Expansion Phase|Other|0|||
27770825|NCT02106351|54223885|FG001|Treatment Cycle 1|Adverse Event|0|||
27770826|NCT02106351|54223886|FG002|Treatment Cycle 1|Adverse Event|0|||
27770827|NCT02106351|54223884|FG000|Treatment Cycle 1|Consent withdrawn|1|||
27770828|NCT02106351|54223885|FG001|Treatment Cycle 1|Consent withdrawn|0|||
27770829|NCT02106351|54223886|FG002|Treatment Cycle 1|Consent withdrawn|2|||
27770830|NCT02106351|54223884|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
27770831|NCT02106351|54223885|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
27770832|NCT02106351|54223886|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
27770833|NCT02106351|54223884|FG000|Treatment Cycle 1|Other|0|||
27770834|NCT02106351|54223885|FG001|Treatment Cycle 1|Other|3|||
27770835|NCT02106351|54223886|FG002|Treatment Cycle 1|Other|1|||
27770836|NCT02106351|54223884|FG000|Treatment Cycle 1|Randomised but not treated|1|||
27770837|NCT02106351|54223885|FG001|Treatment Cycle 1|Randomised but not treated|0|||
27770838|NCT02106351|54223886|FG002|Treatment Cycle 1|Randomised but not treated|1|||
27770839|NCT02106351|54223884|FG000|Treatment Cycle 2|Adverse Event|0|||
27770840|NCT02106351|54223885|FG001|Treatment Cycle 2|Adverse Event|2|||
27770841|NCT02106351|54223886|FG002|Treatment Cycle 2|Adverse Event|0|||
27770842|NCT02106351|54223884|FG000|Treatment Cycle 2|Consent withdrawn|0|||
27770843|NCT02106351|54223885|FG001|Treatment Cycle 2|Consent withdrawn|1|||
27839917|NCT01693562|54327112|FG001|Expansion Phase|Other|0|||
27770844|NCT02106351|54223886|FG002|Treatment Cycle 2|Consent withdrawn|1|||
27770845|NCT02106351|54223884|FG000|Treatment Cycle 2|Other|0|||
27770846|NCT02106351|54223885|FG001|Treatment Cycle 2|Other|2|||
27770847|NCT02106351|54223886|FG002|Treatment Cycle 2|Other|2|||
27770848|NCT02106351|54223884|FG000|Treatment Cycle 3|Adverse Event|0|||
27770849|NCT02106351|54223885|FG001|Treatment Cycle 3|Adverse Event|1|||
27770850|NCT02106351|54223886|FG002|Treatment Cycle 3|Adverse Event|0|||
27770851|NCT02106351|54223884|FG000|Treatment Cycle 3|Consent withdrawn|0|||
27770852|NCT02106351|54223885|FG001|Treatment Cycle 3|Consent withdrawn|0|||
27770853|NCT02106351|54223886|FG002|Treatment Cycle 3|Consent withdrawn|2|||
27770854|NCT02106351|54223884|FG000|Treatment Cycle 3|Lost to Follow-up|0|||
27770855|NCT02106351|54223885|FG001|Treatment Cycle 3|Lost to Follow-up|1|||
27770856|NCT02106351|54223886|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
27770857|NCT02106351|54223884|FG000|Treatment Cycle 3|Other|0|||
27770858|NCT02106351|54223885|FG001|Treatment Cycle 3|Other|2|||
27770859|NCT02106351|54223886|FG002|Treatment Cycle 3|Other|3|||
27770860|NCT02106351|54223884|FG000|Treatment Cycle 4|Consent withdrawn|0|||
27770861|NCT02106351|54223885|FG001|Treatment Cycle 4|Consent withdrawn|0|||
27770862|NCT02106351|54223886|FG002|Treatment Cycle 4|Consent withdrawn|2|||
27770863|NCT02106351|54223884|FG000|Treatment Cycle 4|Other|0|||
27770864|NCT02106351|54223885|FG001|Treatment Cycle 4|Other|1|||
27770865|NCT02106351|54223886|FG002|Treatment Cycle 4|Other|0|||
27770866|NCT02143947|54223902|FG000|Overall Study|Lost to Follow-up|4|||
27770867|NCT02143947|54223903|FG001|Overall Study|Lost to Follow-up|2|||
27770868|NCT02075073|54223914|FG000|Overall Study|Withdrawal by Subject|0|||
27770869|NCT02075073|54223915|FG001|Overall Study|Withdrawal by Subject|1|||
27770870|NCT02075073|54223916|FG002|Overall Study|Withdrawal by Subject|0|||
27770871|NCT02074059|54223930|FG000|Overall Study|Death|0|||
27770872|NCT02074059|54223931|FG001|Overall Study|Death|0|||
27770873|NCT02074059|54223932|FG002|Overall Study|Death|0|||
27770874|NCT02074059|54223933|FG003|Overall Study|Death|0|||
27770875|NCT02074059|54223934|FG004|Overall Study|Death|1|||
27770876|NCT02074059|54223935|FG005|Overall Study|Death|1|||
27770877|NCT01364597|54223954|FG000|Overall Study|Adverse Event|4|||
27770878|NCT01364597|54223955|FG001|Overall Study|Adverse Event|5|||
27770879|NCT01364597|54223956|FG002|Overall Study|Adverse Event|16|||
27770880|NCT01364597|54223957|FG003|Overall Study|Adverse Event|7|||
27770881|NCT01364597|54223954|FG000|Overall Study|Lack of Efficacy|4|||
27770882|NCT01364597|54223955|FG001|Overall Study|Lack of Efficacy|4|||
27770883|NCT01364597|54223956|FG002|Overall Study|Lack of Efficacy|23|||
27770884|NCT01364597|54223957|FG003|Overall Study|Lack of Efficacy|8|||
27770885|NCT01364597|54223954|FG000|Overall Study|Protocol Violation|0|||
27770886|NCT01364597|54223955|FG001|Overall Study|Protocol Violation|0|||
27770887|NCT01364597|54223956|FG002|Overall Study|Protocol Violation|2|||
27770888|NCT01364597|54223957|FG003|Overall Study|Protocol Violation|0|||
27770889|NCT01364597|54223954|FG000|Overall Study|Lost to Follow-up|0|||
27770890|NCT01364597|54223955|FG001|Overall Study|Lost to Follow-up|0|||
27770891|NCT01364597|54223956|FG002|Overall Study|Lost to Follow-up|5|||
27770892|NCT01364597|54223957|FG003|Overall Study|Lost to Follow-up|3|||
27770893|NCT01364597|54223954|FG000|Overall Study|Withdrawal by Subject|4|||
27770894|NCT01364597|54223955|FG001|Overall Study|Withdrawal by Subject|1|||
27770895|NCT01364597|54223956|FG002|Overall Study|Withdrawal by Subject|18|||
27770896|NCT01364597|54223957|FG003|Overall Study|Withdrawal by Subject|6|||
27770897|NCT01364597|54223954|FG000|Overall Study|Non compliance|1|||
27770898|NCT01364597|54223955|FG001|Overall Study|Non compliance|0|||
27770899|NCT01364597|54223956|FG002|Overall Study|Non compliance|1|||
27770900|NCT01364597|54223957|FG003|Overall Study|Non compliance|0|||
27770901|NCT01364597|54223954|FG000|Overall Study|Lack of compliance|1|||
27770902|NCT01364597|54223955|FG001|Overall Study|Lack of compliance|0|||
27770903|NCT01364597|54223956|FG002|Overall Study|Lack of compliance|0|||
27770904|NCT01364597|54223957|FG003|Overall Study|Lack of compliance|0|||
27770905|NCT01364597|54223954|FG000|Overall Study|End of treatment epilepsy|1|||
27770906|NCT01364597|54223955|FG001|Overall Study|End of treatment epilepsy|0|||
27770907|NCT01364597|54223956|FG002|Overall Study|End of treatment epilepsy|0|||
27770908|NCT01364597|54223957|FG003|Overall Study|End of treatment epilepsy|0|||
27770909|NCT01364597|54223954|FG000|Overall Study|No Seizures|1|||
27770910|NCT01364597|54223955|FG001|Overall Study|No Seizures|0|||
27770911|NCT01364597|54223956|FG002|Overall Study|No Seizures|0|||
27770912|NCT01364597|54223957|FG003|Overall Study|No Seizures|0|||
27770913|NCT01364597|54223954|FG000|Overall Study|Lack of reliability from the subject's caregiver|1|||
27770914|NCT01364597|54223955|FG001|Overall Study|Lack of reliability from the subject's caregiver|0|||
27770915|NCT01364597|54223956|FG002|Overall Study|Lack of reliability from the subject's caregiver|0|||
27770916|NCT01364597|54223957|FG003|Overall Study|Lack of reliability from the subject's caregiver|0|||
27770917|NCT01364597|54223954|FG000|Overall Study|Cure|1|||
27770918|NCT01364597|54223955|FG001|Overall Study|Cure|0|||
27770919|NCT01364597|54223956|FG002|Overall Study|Cure|0|||
27770920|NCT01364597|54223957|FG003|Overall Study|Cure|0|||
27770921|NCT01364597|54223954|FG000|Overall Study|Patient was moving|0|||
27770922|NCT01364597|54223955|FG001|Overall Study|Patient was moving|1|||
27770923|NCT01364597|54223956|FG002|Overall Study|Patient was moving|0|||
27770924|NCT01364597|54223957|FG003|Overall Study|Patient was moving|0|||
27770925|NCT01364597|54223954|FG000|Overall Study|Seizures resolved|0|||
27770926|NCT01364597|54223955|FG001|Overall Study|Seizures resolved|0|||
27770927|NCT01364597|54223956|FG002|Overall Study|Seizures resolved|1|||
27770928|NCT01364597|54223957|FG003|Overall Study|Seizures resolved|0|||
27770929|NCT01364597|54223954|FG000|Overall Study|Patient became seizure-free after surgery|0|||
27770930|NCT01364597|54223955|FG001|Overall Study|Patient became seizure-free after surgery|0|||
27770931|NCT01364597|54223956|FG002|Overall Study|Patient became seizure-free after surgery|1|||
27770932|NCT01364597|54223957|FG003|Overall Study|Patient became seizure-free after surgery|0|||
27770933|NCT01364597|54223954|FG000|Overall Study|5 year without seizures. Treatment is finish|0|||
27770934|NCT01364597|54223955|FG001|Overall Study|5 year without seizures. Treatment is finish|0|||
27770935|NCT01364597|54223956|FG002|Overall Study|5 year without seizures. Treatment is finish|1|||
27770936|NCT01364597|54223957|FG003|Overall Study|5 year without seizures. Treatment is finish|0|||
27770937|NCT01364597|54223954|FG000|Overall Study|Patient cured from Epilepsy|0|||
27770938|NCT01364597|54223955|FG001|Overall Study|Patient cured from Epilepsy|0|||
27770939|NCT01364597|54223956|FG002|Overall Study|Patient cured from Epilepsy|1|||
27770940|NCT01364597|54223957|FG003|Overall Study|Patient cured from Epilepsy|0|||
27770941|NCT01364597|54223954|FG000|Overall Study|Investigator decision|0|||
27770942|NCT01364597|54223955|FG001|Overall Study|Investigator decision|0|||
27770943|NCT01364597|54223956|FG002|Overall Study|Investigator decision|1|||
27770944|NCT01364597|54223957|FG003|Overall Study|Investigator decision|0|||
27770945|NCT01364597|54223954|FG000|Overall Study|Sponsor recommended discontinuation|0|||
27770946|NCT01364597|54223955|FG001|Overall Study|Sponsor recommended discontinuation|0|||
27770947|NCT01364597|54223956|FG002|Overall Study|Sponsor recommended discontinuation|0|||
27770948|NCT01364597|54223957|FG003|Overall Study|Sponsor recommended discontinuation|1|||
27770949|NCT01364597|54223954|FG000|Overall Study|Parents went abroad with the patient|0|||
27770950|NCT01364597|54223955|FG001|Overall Study|Parents went abroad with the patient|0|||
27770951|NCT01364597|54223956|FG002|Overall Study|Parents went abroad with the patient|1|||
27770952|NCT01364597|54223957|FG003|Overall Study|Parents went abroad with the patient|0|||
27770953|NCT01364597|54223954|FG000|Overall Study|BRV discontinued as no seizures during 2 years|0|||
27770954|NCT01364597|54223955|FG001|Overall Study|BRV discontinued as no seizures during 2 years|0|||
27770955|NCT01364597|54223956|FG002|Overall Study|BRV discontinued as no seizures during 2 years|1|||
27770956|NCT01364597|54223957|FG003|Overall Study|BRV discontinued as no seizures during 2 years|0|||
27770957|NCT01364597|54223954|FG000|Overall Study|BRV administration dropout|0|||
27770958|NCT01364597|54223955|FG001|Overall Study|BRV administration dropout|0|||
27770959|NCT01364597|54223956|FG002|Overall Study|BRV administration dropout|1|||
27770960|NCT01364597|54223957|FG003|Overall Study|BRV administration dropout|0|||
27770961|NCT01364597|54223954|FG000|Overall Study|Dropout|0|||
27770962|NCT01364597|54223955|FG001|Overall Study|Dropout|0|||
27770963|NCT01364597|54223956|FG002|Overall Study|Dropout|3|||
27770964|NCT01364597|54223957|FG003|Overall Study|Dropout|1|||
27770965|NCT01364597|54223954|FG000|Overall Study|Unreliable subject|0|||
27770966|NCT01364597|54223955|FG001|Overall Study|Unreliable subject|0|||
27770967|NCT01364597|54223956|FG002|Overall Study|Unreliable subject|0|||
27770968|NCT01364597|54223957|FG003|Overall Study|Unreliable subject|1|||
27770969|NCT01364597|54223954|FG000|Overall Study|Other|0|||
27770970|NCT01364597|54223955|FG001|Overall Study|Other|0|||
27770971|NCT01364597|54223956|FG002|Overall Study|Other|0|||
27770972|NCT01364597|54223957|FG003|Overall Study|Other|1|||
27770973|NCT02143713|54223974|FG000|Treatment Period (6 Months)|Withdrawal by Subject|1|||
27770974|NCT02143713|54223975|FG001|Treatment Period (6 Months)|Withdrawal by Subject|2|||
27770975|NCT02143713|54223976|FG002|Treatment Period (6 Months)|Withdrawal by Subject|5|||
27770976|NCT02143713|54223977|FG003|Treatment Period (6 Months)|Withdrawal by Subject|4|||
27770977|NCT02143713|54223974|FG000|Treatment Period (6 Months)|Adverse Event|7|||
27770978|NCT02143713|54223975|FG001|Treatment Period (6 Months)|Adverse Event|8|||
27770979|NCT02143713|54223976|FG002|Treatment Period (6 Months)|Adverse Event|8|||
27770980|NCT02143713|54223977|FG003|Treatment Period (6 Months)|Adverse Event|9|||
27770981|NCT02143713|54223974|FG000|Treatment Period (6 Months)|Lost to Follow-up|3|||
27770982|NCT02143713|54223975|FG001|Treatment Period (6 Months)|Lost to Follow-up|0|||
27770983|NCT02143713|54223976|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
27770984|NCT02143713|54223977|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
27770985|NCT02143713|54223974|FG000|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
27770986|NCT02143713|54223975|FG001|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
27770987|NCT02143713|54223976|FG002|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
27770988|NCT02143713|54223977|FG003|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
27770989|NCT02143713|54223974|FG000|Treatment Period (6 Months)|Pregnancy|0|||
27770990|NCT02143713|54223975|FG001|Treatment Period (6 Months)|Pregnancy|2|||
27770991|NCT02143713|54223976|FG002|Treatment Period (6 Months)|Pregnancy|2|||
27839918|NCT01693562|54327113|FG002|Expansion Phase|Other|0|||
27770992|NCT02143713|54223977|FG003|Treatment Period (6 Months)|Pregnancy|0|||
27770993|NCT02143713|54223974|FG000|Treatment Period (6 Months)|Non-compliance|1|||
27770994|NCT02143713|54223975|FG001|Treatment Period (6 Months)|Non-compliance|0|||
27770995|NCT02143713|54223976|FG002|Treatment Period (6 Months)|Non-compliance|0|||
27770996|NCT02143713|54223977|FG003|Treatment Period (6 Months)|Non-compliance|3|||
27770997|NCT02143713|54223974|FG000|Treatment Period (6 Months)|Other|3|||
27770998|NCT02143713|54223975|FG001|Treatment Period (6 Months)|Other|0|||
27770999|NCT02143713|54223976|FG002|Treatment Period (6 Months)|Other|3|||
27771000|NCT02143713|54223977|FG003|Treatment Period (6 Months)|Other|2|||
27771001|NCT02143713|54223974|FG000|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
27771002|NCT02143713|54223975|FG001|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
27771003|NCT02143713|54223976|FG002|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
27771004|NCT02143713|54223977|FG003|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4|||
27771005|NCT02143713|54223974|FG000|Treatment Period (6 Months)|Exclusionary Medication|2|||
27771006|NCT02143713|54223975|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
27771007|NCT02143713|54223976|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
27771008|NCT02143713|54223977|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
27771009|NCT02143713|54223974|FG000|Treatment Period (6 Months)|Lack of Efficacy|1|||
27771010|NCT02143713|54223975|FG001|Treatment Period (6 Months)|Lack of Efficacy|0|||
27771011|NCT02143713|54223976|FG002|Treatment Period (6 Months)|Lack of Efficacy|0|||
27771012|NCT02143713|54223977|FG003|Treatment Period (6 Months)|Lack of Efficacy|1|||
27771013|NCT02143713|54223974|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
27771014|NCT02143713|54223975|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7|||
27771015|NCT02143713|54223976|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
27771016|NCT02143713|54223977|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10|||
27771017|NCT02143713|54223974|FG000|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
27771018|NCT02143713|54223975|FG001|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
27771019|NCT02143713|54223976|FG002|Post-treatment Follow-up (12 Months)|Adverse Event|1|||
27771020|NCT02143713|54223977|FG003|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
27771021|NCT02143713|54223974|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3|||
27771022|NCT02143713|54223975|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
27771023|NCT02143713|54223976|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11|||
27771024|NCT02143713|54223977|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
27771025|NCT02143713|54223974|FG000|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2|||
27771026|NCT02143713|54223975|FG001|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
27771027|NCT02143713|54223976|FG002|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
27771028|NCT02143713|54223977|FG003|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1|||
27771029|NCT02143713|54223974|FG000|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
27771030|NCT02143713|54223975|FG001|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
27771031|NCT02143713|54223976|FG002|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
27771032|NCT02143713|54223977|FG003|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
27771033|NCT02143713|54223974|FG000|Post-treatment Follow-up (12 Months)|Other|3|||
27771034|NCT02143713|54223975|FG001|Post-treatment Follow-up (12 Months)|Other|4|||
27771035|NCT02143713|54223976|FG002|Post-treatment Follow-up (12 Months)|Other|7|||
27771036|NCT02143713|54223977|FG003|Post-treatment Follow-up (12 Months)|Other|7|||
27771037|NCT02519855|54223990|FG000|Overall Study|Adverse Event|0|||
27771038|NCT02519855|54223991|FG001|Overall Study|Adverse Event|1|||
27771039|NCT02519855|54223990|FG000|Overall Study|Lost to Follow-up|3|||
27771040|NCT02519855|54223991|FG001|Overall Study|Lost to Follow-up|3|||
27771041|NCT02142387|54223999|FG000|Overall Study|<19 years old|49|||
27771042|NCT02142387|54224000|FG001|Overall Study|<19 years old|326|||
27771043|NCT02142387|54223999|FG000|Overall Study|non-cardiac etiology|504|||
27771044|NCT02142387|54224000|FG001|Overall Study|non-cardiac etiology|3431|||
27771045|NCT02142387|54223999|FG000|Overall Study|CPR not performed|74|||
27771046|NCT02142387|54224000|FG001|Overall Study|CPR not performed|473|||
27771047|NCT02142387|54223999|FG000|Overall Study|witnessed by paramedic|139|||
27771048|NCT02142387|54224000|FG001|Overall Study|witnessed by paramedic|917|||
27771049|NCT02142387|54223999|FG000|Overall Study|incomplete data|1|||
27771050|NCT02142387|54224000|FG001|Overall Study|incomplete data|9|||
27771051|NCT02142387|54223999|FG000|Overall Study|occurred not at home|298|||
27771052|NCT02142387|54224000|FG001|Overall Study|occurred not at home|2474|||
27771053|NCT02518919|54224009|FG000|Overall Study|Protocol Violation|1|||
27771054|NCT02518919|54224010|FG001|Overall Study|Protocol Violation|1|||
27771055|NCT02518919|54224011|FG002|Overall Study|Protocol Violation|2|||
27771056|NCT02518685|54224021|FG000|Overall Study|Adverse Event|29|||
27771057|NCT02518685|54224022|FG001|Overall Study|Adverse Event|1|||
27771058|NCT02518685|54224021|FG000|Overall Study|Withdrawal by Subject|10|||
27771059|NCT02518685|54224022|FG001|Overall Study|Withdrawal by Subject|3|||
27771060|NCT02518685|54224021|FG000|Overall Study|relocation, study fatigue|7|||
27839919|NCT01693562|54327114|FG003|Expansion Phase|Other|0|||
27839920|NCT01693562|54327115|FG004|Expansion Phase|Other|0|||
27839921|NCT01693562|54327116|FG005|Expansion Phase|Other|0|||
27839922|NCT01693562|54327117|FG006|Expansion Phase|Other|0|||
27839923|NCT01693562|54327118|FG007|Expansion Phase|Other|3|||
27771061|NCT02518685|54224022|FG001|Overall Study|relocation, study fatigue|2|||
27771062|NCT02518685|54224021|FG000|Overall Study|Pregnancy|1|||
27771063|NCT02518685|54224022|FG001|Overall Study|Pregnancy|0|||
27771064|NCT02518685|54224021|FG000|Overall Study|Physician Decision|1|||
27771065|NCT02518685|54224022|FG001|Overall Study|Physician Decision|0|||
27771066|NCT02518685|54224021|FG000|Overall Study|Lost to Follow-up|1|||
27771067|NCT02518685|54224022|FG001|Overall Study|Lost to Follow-up|4|||
27771068|NCT02520089|54224031|FG000|Overall Study|Lost to Follow-up|3|||
27771069|NCT02520089|54224032|FG001|Overall Study|Lost to Follow-up|4|||
27771070|NCT02105961|54224041|FG000|Overall Study|Adverse Event|18|||
27771071|NCT02105961|54224042|FG001|Overall Study|Adverse Event|7|||
27771072|NCT02105961|54224043|FG002|Overall Study|Adverse Event|13|||
27771073|NCT02105961|54224041|FG000|Overall Study|Lack of Efficacy|3|||
27771074|NCT02105961|54224042|FG001|Overall Study|Lack of Efficacy|0|||
27771075|NCT02105961|54224043|FG002|Overall Study|Lack of Efficacy|3|||
27771076|NCT02105961|54224041|FG000|Overall Study|Lost to Follow-up|2|||
27771077|NCT02105961|54224042|FG001|Overall Study|Lost to Follow-up|0|||
27771078|NCT02105961|54224043|FG002|Overall Study|Lost to Follow-up|1|||
27771079|NCT02105961|54224041|FG000|Overall Study|Physician Decision|3|||
27771080|NCT02105961|54224042|FG001|Overall Study|Physician Decision|3|||
27771081|NCT02105961|54224043|FG002|Overall Study|Physician Decision|2|||
27771082|NCT02105961|54224041|FG000|Overall Study|Withdrawal by Subject|15|||
27771083|NCT02105961|54224042|FG001|Overall Study|Withdrawal by Subject|7|||
27771084|NCT02105961|54224043|FG002|Overall Study|Withdrawal by Subject|11|||
27771085|NCT02141997|54224056|FG000|Overall Study|Adverse Event|0|||
27771086|NCT02141997|54224057|FG001|Overall Study|Adverse Event|2|||
27771087|NCT02141997|54224058|FG002|Overall Study|Adverse Event|0|||
27771088|NCT02141997|54224059|FG003|Overall Study|Adverse Event|1|||
27771089|NCT02141997|54224056|FG000|Overall Study|Participant noncompliance|1|||
27771090|NCT02141997|54224057|FG001|Overall Study|Participant noncompliance|0|||
27771091|NCT02141997|54224058|FG002|Overall Study|Participant noncompliance|0|||
27771092|NCT02141997|54224059|FG003|Overall Study|Participant noncompliance|0|||
27771093|NCT02141997|54224056|FG000|Overall Study|Withdrew consent|1|||
27771094|NCT02141997|54224057|FG001|Overall Study|Withdrew consent|0|||
27771095|NCT02141997|54224058|FG002|Overall Study|Withdrew consent|3|||
27771096|NCT02141997|54224059|FG003|Overall Study|Withdrew consent|0|||
27771097|NCT02141997|54224056|FG000|Overall Study|Other|1|||
27771098|NCT02141997|54224057|FG001|Overall Study|Other|4|||
27771099|NCT02141997|54224058|FG002|Overall Study|Other|0|||
27771100|NCT02141997|54224059|FG003|Overall Study|Other|0|||
27771101|NCT01628367|54224071|FG000|Overall Study|Adverse Event|1|||
27771102|NCT01628367|54224072|FG001|Overall Study|Adverse Event|0|||
27771103|NCT01627899|54224078|FG000|Overall Study|Study terminated early by sponsor.|5|||
27771104|NCT02519777|54224085|FG000|Overall Study|Death|1|||
27771105|NCT02519777|54224086|FG001|Overall Study|Death|0|||
27771106|NCT02519777|54224087|FG002|Overall Study|Death|0|||
27771107|NCT02519777|54224085|FG000|Overall Study|Lost to Follow-up|0|||
27771108|NCT02519777|54224086|FG001|Overall Study|Lost to Follow-up|4|||
27771109|NCT02519777|54224087|FG002|Overall Study|Lost to Follow-up|2|||
27771110|NCT02519777|54224085|FG000|Overall Study|Withdrawal by Subject|3|||
27771111|NCT02519777|54224086|FG001|Overall Study|Withdrawal by Subject|1|||
27771112|NCT02519777|54224087|FG002|Overall Study|Withdrawal by Subject|0|||
27771113|NCT02519777|54224085|FG000|Overall Study|Severe Debilitation|1|||
27771114|NCT02519777|54224086|FG001|Overall Study|Severe Debilitation|1|||
27771115|NCT02519777|54224087|FG002|Overall Study|Severe Debilitation|1|||
27771116|NCT02519777|54224085|FG000|Overall Study|Not able to get to clinic|1|||
27771117|NCT02519777|54224086|FG001|Overall Study|Not able to get to clinic|2|||
27771118|NCT02519777|54224087|FG002|Overall Study|Not able to get to clinic|1|||
27771119|NCT02515331|54224098|FG000|Overall Study|Withdrawal by Subject|0|||
27771120|NCT02515331|54224099|FG001|Overall Study|Withdrawal by Subject|0|||
27771121|NCT02515331|54224100|FG002|Overall Study|Withdrawal by Subject|1|||
27839924|NCT01693562|54327119|FG008|Expansion Phase|Other|1|||
27839925|NCT01693562|54327120|FG009|Expansion Phase|Other|28|||
27839926|NCT01693562|54327121|FG010|Expansion Phase|Other|4|||
27771122|NCT02515331|54224098|FG000|Overall Study|Protocol deviation|0|||
27771123|NCT02515331|54224099|FG001|Overall Study|Protocol deviation|0|||
27771124|NCT02515331|54224100|FG002|Overall Study|Protocol deviation|3|||
27771125|NCT02515331|54224098|FG000|Overall Study|Adverse Event|2|||
27771126|NCT02515331|54224099|FG001|Overall Study|Adverse Event|0|||
27771127|NCT02515331|54224100|FG002|Overall Study|Adverse Event|0|||
27771128|NCT02515097|54224110|FG000|Overall Study|Lost to Follow-up|4|||
27771129|NCT02515097|54224111|FG001|Overall Study|Lost to Follow-up|2|||
27771130|NCT02515097|54224110|FG000|Overall Study|Withdrawal by Subject|1|||
27771131|NCT02515097|54224111|FG001|Overall Study|Withdrawal by Subject|3|||
27771132|NCT02515097|54224110|FG000|Overall Study|Adverse Event|2|||
27771133|NCT02515097|54224111|FG001|Overall Study|Adverse Event|1|||
27771134|NCT02141295|54224120|FG000|Overall Study|Adverse Event|1|||
27771135|NCT02141295|54224121|FG001|Overall Study|Adverse Event|18|||
27771136|NCT02141295|54224122|FG002|Overall Study|Adverse Event|11|||
27771137|NCT02141295|54224120|FG000|Overall Study|Physician Decision|2|||
27839927|NCT01693562|54327122|FG011|Expansion Phase|Other|7|||
27771138|NCT02141295|54224121|FG001|Overall Study|Physician Decision|19|||
27771139|NCT02141295|54224122|FG002|Overall Study|Physician Decision|14|||
27771140|NCT02141295|54224120|FG000|Overall Study|Study terminated by sponsor|0|||
27771141|NCT02141295|54224121|FG001|Overall Study|Study terminated by sponsor|6|||
27771142|NCT02141295|54224122|FG002|Overall Study|Study terminated by sponsor|6|||
27771143|NCT02141295|54224120|FG000|Overall Study|Non-compliance|0|||
27771144|NCT02141295|54224121|FG001|Overall Study|Non-compliance|1|||
27771145|NCT02141295|54224122|FG002|Overall Study|Non-compliance|0|||
27771146|NCT02141295|54224120|FG000|Overall Study|Progressive disease|3|||
27771147|NCT02141295|54224121|FG001|Overall Study|Progressive disease|32|||
27771148|NCT02141295|54224122|FG002|Overall Study|Progressive disease|50|||
27771149|NCT02141295|54224120|FG000|Overall Study|Reason not specified|0|||
27771150|NCT02141295|54224121|FG001|Overall Study|Reason not specified|9|||
27771151|NCT02141295|54224122|FG002|Overall Study|Reason not specified|10|||
27771152|NCT02141295|54224120|FG000|Overall Study|Withdrawal by Subject|0|||
27771153|NCT02141295|54224121|FG001|Overall Study|Withdrawal by Subject|9|||
27771154|NCT02141295|54224122|FG002|Overall Study|Withdrawal by Subject|4|||
27771155|NCT02514551|54224134|FG000|Overall Study|Lost to Follow-up|0|||
27771156|NCT02514551|54224135|FG001|Overall Study|Lost to Follow-up|1|||
27771157|NCT02514551|54224134|FG000|Overall Study|Participant Never Treated|0|||
27771158|NCT02514551|54224135|FG001|Overall Study|Participant Never Treated|2|||
27771159|NCT02141217|54224144|FG000|Overall Study|Adverse Event|1|||
27771160|NCT02141217|54224145|FG001|Overall Study|Adverse Event|2|||
27771161|NCT02141217|54224144|FG000|Overall Study|Protocol Violation|1|||
27771162|NCT02141217|54224145|FG001|Overall Study|Protocol Violation|4|||
27771163|NCT02141217|54224144|FG000|Overall Study|Withdrawal by Subject|6|||
27771164|NCT02141217|54224145|FG001|Overall Study|Withdrawal by Subject|0|||
27771165|NCT02141217|54224144|FG000|Overall Study|Lost to Follow-up|1|||
27771166|NCT02141217|54224145|FG001|Overall Study|Lost to Follow-up|1|||
27771167|NCT02141217|54224144|FG000|Overall Study|Physician Decision|1|||
27771168|NCT02141217|54224145|FG001|Overall Study|Physician Decision|0|||
27771169|NCT02141217|54224144|FG000|Overall Study|Surgical Intervention|1|||
27771170|NCT02141217|54224145|FG001|Overall Study|Surgical Intervention|1|||
27771171|NCT02138253|54224156|FG000|Overall Study|Adverse Event|3|||
27771172|NCT02138253|54224157|FG001|Overall Study|Adverse Event|3|||
27771173|NCT02138253|54224156|FG000|Overall Study|Lost to Follow-up|2|||
27771174|NCT02138253|54224157|FG001|Overall Study|Lost to Follow-up|1|||
27771175|NCT02138253|54224156|FG000|Overall Study|Physician Decision|2|||
27771176|NCT02138253|54224157|FG001|Overall Study|Physician Decision|0|||
27771177|NCT02138253|54224156|FG000|Overall Study|Non compliance|1|||
27771178|NCT02138253|54224157|FG001|Overall Study|Non compliance|0|||
27771179|NCT02138253|54224156|FG000|Overall Study|Withdrawal by Subject|1|||
27771180|NCT02138253|54224157|FG001|Overall Study|Withdrawal by Subject|0|||
27771181|NCT02514473|54224165|FG000|Overall Study|Adverse Event|0|||
27771182|NCT02514473|54224166|FG001|Overall Study|Adverse Event|2|||
27771183|NCT02514473|54224165|FG000|Overall Study|Withdrawal by Subject|2|||
27771184|NCT02514473|54224166|FG001|Overall Study|Withdrawal by Subject|1|||
27771185|NCT02514473|54224165|FG000|Overall Study|Lost to Follow-up|0|||
27771186|NCT02514473|54224166|FG001|Overall Study|Lost to Follow-up|1|||
27771187|NCT02514473|54224165|FG000|Overall Study|Other|1|||
27771188|NCT02514473|54224166|FG001|Overall Study|Other|1|||
27771189|NCT02513771|54224175|FG000|Overall Study|Lost to Follow-up|1|||
27771190|NCT02513771|54224176|FG001|Overall Study|Lost to Follow-up|1|||
27771191|NCT02513771|54224175|FG000|Overall Study|Not being able to get to clinic|1|||
27771192|NCT02513771|54224176|FG001|Overall Study|Not being able to get to clinic|0|||
27771193|NCT02104947|54224184|FG000|Overall Study|Withdrawal by Subject|10|||
27771194|NCT02104947|54224185|FG001|Overall Study|Withdrawal by Subject|3|||
27771195|NCT02104947|54224184|FG000|Overall Study|Lost to Follow-up|4|||
27771196|NCT02104947|54224185|FG001|Overall Study|Lost to Follow-up|4|||
27771197|NCT02104947|54224184|FG000|Overall Study|Protocol Violation|6|||
27771198|NCT02104947|54224185|FG001|Overall Study|Protocol Violation|8|||
27771199|NCT02104947|54224184|FG000|Overall Study|Adverse Event|57|||
27771200|NCT02104947|54224185|FG001|Overall Study|Adverse Event|38|||
27771201|NCT02104947|54224184|FG000|Overall Study|Other than stated above|2|||
27771202|NCT02104947|54224185|FG001|Overall Study|Other than stated above|3|||
27771203|NCT02513459|54224195|FG000|Overall Study|Adverse Event|7|||
27771204|NCT02513459|54224195|FG000|Overall Study|Withdrew consent|5|||
27771205|NCT02513459|54224195|FG000|Overall Study|Loss of efficacy|2|||
27839928|NCT01693562|54327123|FG012|Expansion Phase|Other|0|||
27771206|NCT02513459|54224195|FG000|Overall Study|Pregnancy|2|||
27771207|NCT02513459|54224195|FG000|Overall Study|Subject decision|2|||
27771208|NCT02513459|54224195|FG000|Overall Study|Lack of response|1|||
27771209|NCT02513459|54224195|FG000|Overall Study|Reproductive plans|1|||
27771210|NCT02513459|54224195|FG000|Overall Study|Surgery planned-- not done|1|||
27771211|NCT02104557|54224204|FG000|Overall Study|Adverse Event|24|||
27771212|NCT02104557|54224204|FG000|Overall Study|Lost to Follow-up|34|||
27771213|NCT02104557|54224204|FG000|Overall Study|Violated the usage and dosage|14|||
27771214|NCT02104557|54224204|FG000|Overall Study|No longer met inclusion/exclusion criteria|1|||
27771215|NCT02104557|54224204|FG000|Overall Study|Administered Sayana prior to the contract|1|||
27771216|NCT02104557|54224204|FG000|Overall Study|Other|17|||
27771217|NCT02104557|54224204|FG000|Overall Study|Change to other contraception methods|5|||
27771218|NCT02104557|54224204|FG000|Overall Study|Discontinuation due to no pain|1|||
27771219|NCT02104557|54224204|FG000|Overall Study|Withdrawal consent|2|||
27771220|NCT02104557|54224204|FG000|Overall Study|Refusal of administration due to unknown reasons|69|||
27771221|NCT02104557|54224204|FG000|Overall Study|Discontinuation of contraception|9|||
27771222|NCT02069379|54224210|FG000|Baseline Measurements|Lost to Follow-up|1|||
27771223|NCT02069379|54224211|FG001|Baseline Measurements|Lost to Follow-up|0|||
27771224|NCT02069379|54224212|FG002|Baseline Measurements|Lost to Follow-up|0|||
27771225|NCT02069379|54224213|FG003|Baseline Measurements|Lost to Follow-up|0|||
27771226|NCT02069379|54224210|FG000|Baseline Measurements|Ineligible based on initial assessments|2|||
27771227|NCT02069379|54224211|FG001|Baseline Measurements|Ineligible based on initial assessments|0|||
27771228|NCT02069379|54224212|FG002|Baseline Measurements|Ineligible based on initial assessments|0|||
27771229|NCT02069379|54224213|FG003|Baseline Measurements|Ineligible based on initial assessments|2|||
27771230|NCT02069379|54224210|FG000|First Treatment Arm|Lost to Follow-up|0|||
27771231|NCT02069379|54224211|FG001|First Treatment Arm|Lost to Follow-up|1|||
27771232|NCT02069379|54224212|FG002|First Treatment Arm|Lost to Follow-up|1|||
27771233|NCT02069379|54224213|FG003|First Treatment Arm|Lost to Follow-up|0|||
27771234|NCT02069379|54224210|FG000|Washout Period (4 Weeks)|Lost to Follow-up|0|||
27771235|NCT02069379|54224211|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
27771236|NCT02069379|54224212|FG002|Washout Period (4 Weeks)|Lost to Follow-up|0|||
27771237|NCT02069379|54224213|FG003|Washout Period (4 Weeks)|Lost to Follow-up|0|||
27771238|NCT02069379|54224210|FG000|Washout Period (4 Weeks)|Unrelated event|0|||
27771239|NCT02069379|54224211|FG001|Washout Period (4 Weeks)|Unrelated event|1|||
27771240|NCT02069379|54224212|FG002|Washout Period (4 Weeks)|Unrelated event|0|||
27771241|NCT02069379|54224213|FG003|Washout Period (4 Weeks)|Unrelated event|0|||
27771242|NCT02069379|54224210|FG000|Second Treatment Arm|Lost to Follow-up|0|||
27771243|NCT02069379|54224211|FG001|Second Treatment Arm|Lost to Follow-up|0|||
27771244|NCT02069379|54224212|FG002|Second Treatment Arm|Lost to Follow-up|1|||
27771245|NCT02069379|54224213|FG003|Second Treatment Arm|Lost to Follow-up|0|||
27771246|NCT02511431|54224229|FG000|Treatment|Lost to Follow-up|0|||
27771247|NCT02511431|54224230|FG001|Treatment|Lost to Follow-up|0|||
27771248|NCT02511431|54224231|FG002|Treatment|Lost to Follow-up|1|||
27771249|NCT02511431|54224232|FG003|Treatment|Lost to Follow-up|0|||
27771250|NCT02511431|54224233|FG004|Treatment|Lost to Follow-up|0|||
27771251|NCT02511431|54224234|FG005|Treatment|Lost to Follow-up|1|||
27771252|NCT02137785|54224251|FG000|Overall Study|Lost to Follow-up|1|||
27771253|NCT02137785|54224252|FG001|Overall Study|Lost to Follow-up|0|||
27771254|NCT02137785|54224251|FG000|Overall Study|Withdrawal by Subject|1|||
27771255|NCT02137785|54224252|FG001|Overall Study|Withdrawal by Subject|4|||
27771256|NCT02137785|54224251|FG000|Overall Study|subject moved out of state|1|||
27771257|NCT02137785|54224252|FG001|Overall Study|subject moved out of state|0|||
27771258|NCT01655069|54224262|FG000|Overall Study|Physician Decision|0|||
27771259|NCT01655069|54224263|FG001|Overall Study|Physician Decision|0|||
27771260|NCT01655069|54224264|FG002|Overall Study|Physician Decision|0|||
27771261|NCT01655069|54224265|FG003|Overall Study|Physician Decision|1|||
27771262|NCT01655069|54224262|FG000|Overall Study|Adverse Event|6|||
27771263|NCT01655069|54224263|FG001|Overall Study|Adverse Event|7|||
27771264|NCT01655069|54224264|FG002|Overall Study|Adverse Event|2|||
27771265|NCT01655069|54224265|FG003|Overall Study|Adverse Event|3|||
27771266|NCT01655069|54224262|FG000|Overall Study|Lack of Efficacy|0|||
27771267|NCT01655069|54224263|FG001|Overall Study|Lack of Efficacy|1|||
27771268|NCT01655069|54224264|FG002|Overall Study|Lack of Efficacy|0|||
27771269|NCT01655069|54224265|FG003|Overall Study|Lack of Efficacy|0|||
27771270|NCT01655069|54224262|FG000|Overall Study|No Treatment Needed|0|||
27771271|NCT01655069|54224263|FG001|Overall Study|No Treatment Needed|1|||
27771272|NCT01655069|54224264|FG002|Overall Study|No Treatment Needed|0|||
27771273|NCT01655069|54224265|FG003|Overall Study|No Treatment Needed|0|||
27771274|NCT01655069|54224262|FG000|Overall Study|Withdrawal by Subject|2|||
27771275|NCT01655069|54224263|FG001|Overall Study|Withdrawal by Subject|3|||
27771276|NCT01655069|54224264|FG002|Overall Study|Withdrawal by Subject|0|||
27771277|NCT01655069|54224265|FG003|Overall Study|Withdrawal by Subject|0|||
27771278|NCT02068599|54224276|FG000|Overall Study|Adverse Event|4|||
27771279|NCT02068599|54224277|FG001|Overall Study|Adverse Event|1|||
27771280|NCT02068599|54224278|FG002|Overall Study|Adverse Event|1|||
27771281|NCT02068599|54224276|FG000|Overall Study|Withdrawal by Subject|2|||
27771282|NCT02068599|54224277|FG001|Overall Study|Withdrawal by Subject|7|||
27771283|NCT02068599|54224278|FG002|Overall Study|Withdrawal by Subject|5|||
27771284|NCT02068599|54224276|FG000|Overall Study|Protocol Violation|4|||
27771285|NCT02068599|54224277|FG001|Overall Study|Protocol Violation|2|||
27771286|NCT02068599|54224278|FG002|Overall Study|Protocol Violation|3|||
27771287|NCT02068599|54224276|FG000|Overall Study|Lost to Follow-up|1|||
27771288|NCT02068599|54224277|FG001|Overall Study|Lost to Follow-up|0|||
27771289|NCT02068599|54224278|FG002|Overall Study|Lost to Follow-up|0|||
27771290|NCT02068599|54224276|FG000|Overall Study|Lack of Efficacy|0|||
27771291|NCT02068599|54224277|FG001|Overall Study|Lack of Efficacy|0|||
27771292|NCT02068599|54224278|FG002|Overall Study|Lack of Efficacy|3|||
27771293|NCT02068599|54224276|FG000|Overall Study|Noncompliance|0|||
27771294|NCT02068599|54224277|FG001|Overall Study|Noncompliance|0|||
27771295|NCT02068599|54224278|FG002|Overall Study|Noncompliance|1|||
27771296|NCT01654601|54224288|FG000|1st Administration|Withdrawal by Subject|2|||
27771297|NCT01654601|54224289|FG001|1st Administration|Withdrawal by Subject|0|||
27771298|NCT01654601|54224288|FG000|1st Administration|Protocol Violation|0|||
27771299|NCT01654601|54224289|FG001|1st Administration|Protocol Violation|2|||
27771300|NCT01654601|54224288|FG000|2nd Administration|Adverse Event|1|||
27771301|NCT01654601|54224289|FG001|2nd Administration|Adverse Event|0|||
27771302|NCT01654601|54224288|FG000|2nd Administration|Protocol Violation|0|||
27771303|NCT01654601|54224289|FG001|2nd Administration|Protocol Violation|1|||
27771304|NCT01654523|54224295|FG000|Overall Study|Withdrawal by Subject|1|||
27771305|NCT02068443|54224302|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
27771306|NCT02068443|54224303|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
27771307|NCT02068443|54224304|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
27771308|NCT02068443|54224302|FG000|Overall Study|Voluntary Withdrawal|4|||
27771309|NCT02068443|54224303|FG001|Overall Study|Voluntary Withdrawal|0|||
27771310|NCT02068443|54224304|FG002|Overall Study|Voluntary Withdrawal|1|||
27771311|NCT02068443|54224302|FG000|Overall Study|Lack of Efficacy|2|||
27771312|NCT02068443|54224303|FG001|Overall Study|Lack of Efficacy|1|||
27771313|NCT02068443|54224304|FG002|Overall Study|Lack of Efficacy|0|||
27771314|NCT02068443|54224302|FG000|Overall Study|Other Reason Not Specified|1|||
27771315|NCT02068443|54224303|FG001|Overall Study|Other Reason Not Specified|0|||
27771316|NCT02068443|54224304|FG002|Overall Study|Other Reason Not Specified|0|||
27771317|NCT02508935|54224312|FG000|Overall Study|Withdrawal by Subject|1|||
27771318|NCT02508935|54224312|FG000|Overall Study|Withdrawal by Caregiver|8|||
27771319|NCT02508935|54224312|FG000|Overall Study|Pain Score <4|1|||
27771320|NCT02508935|54224312|FG000|Overall Study|Emesis|3|||
27771321|NCT02508935|54224312|FG000|Overall Study|Adverse Event|3|||
27771322|NCT02508935|54224312|FG000|Overall Study|Protocol Violation|1|||
27771323|NCT02508935|54224312|FG000|Overall Study|Physician Decision|1|||
27771324|NCT02508935|54224312|FG000|Overall Study|Trial terminated by sponsor|5|||
27771325|NCT02508701|54224322|FG000|Overall Study|Lost to Follow-up|9|||
27771326|NCT02508701|54224323|FG001|Overall Study|Lost to Follow-up|5|||
27771327|NCT02508701|54224324|FG002|Overall Study|Lost to Follow-up|5|||
27771328|NCT02508701|54224325|FG003|Overall Study|Lost to Follow-up|3|||
27771329|NCT02507375|54224341|FG000|Overall Study|Progressive Disease|4|||
27771330|NCT02507375|54224342|FG001|Overall Study|Progressive Disease|5|||
27771331|NCT02507375|54224341|FG000|Overall Study|Death|0|||
27771332|NCT02507375|54224342|FG001|Overall Study|Death|1|||
27771333|NCT02507375|54224341|FG000|Overall Study|Refused treatment|0|||
27771334|NCT02507375|54224342|FG001|Overall Study|Refused treatment|1|||
27771335|NCT02507375|54224341|FG000|Overall Study|Adverse Event|0|||
27771336|NCT02507375|54224342|FG001|Overall Study|Adverse Event|1|||
27771337|NCT02507219|54224352|FG000|Overall Study|Physician Decision|1|||
27771338|NCT02507219|54224353|FG001|Overall Study|Physician Decision|0|||
27771339|NCT02507219|54224354|FG002|Overall Study|Physician Decision|0|||
27771340|NCT02507219|54224355|FG003|Overall Study|Physician Decision|0|||
27771341|NCT02507219|54224356|FG004|Overall Study|Physician Decision|0|||
27771342|NCT02507219|54224357|FG005|Overall Study|Physician Decision|0|||
27771343|NCT02507219|54224352|FG000|Overall Study|Withdrawal by Subject|0|||
27771344|NCT02507219|54224353|FG001|Overall Study|Withdrawal by Subject|0|||
27771345|NCT02507219|54224354|FG002|Overall Study|Withdrawal by Subject|0|||
27771346|NCT02507219|54224355|FG003|Overall Study|Withdrawal by Subject|0|||
27771347|NCT02507219|54224356|FG004|Overall Study|Withdrawal by Subject|1|||
27771348|NCT02507219|54224357|FG005|Overall Study|Withdrawal by Subject|0|||
27771349|NCT02483975|54224367|FG000|Overall Study|Adverse Event|0|||
27771350|NCT02483975|54224368|FG001|Overall Study|Adverse Event|1|||
27771351|NCT02483975|54224367|FG000|Overall Study|Lost to Follow-up|0|||
27771352|NCT02483975|54224368|FG001|Overall Study|Lost to Follow-up|1|||
27771353|NCT02483975|54224367|FG000|Overall Study|Physician Decision|2|||
27771354|NCT02483975|54224368|FG001|Overall Study|Physician Decision|0|||
27771355|NCT02047227|54224379|FG000|Overall Study|Adverse Event|2|||
27771356|NCT02047227|54224380|FG001|Overall Study|Adverse Event|4|||
27771357|NCT02047227|54224379|FG000|Overall Study|Lost to Follow-up|0|||
27771358|NCT02047227|54224380|FG001|Overall Study|Lost to Follow-up|3|||
27771359|NCT02047227|54224379|FG000|Overall Study|Protocol Violation|1|||
27771360|NCT02047227|54224380|FG001|Overall Study|Protocol Violation|0|||
27839929|NCT01693562|54327124|FG013|Expansion Phase|Other|1|||
27771361|NCT02047227|54224379|FG000|Overall Study|Spontaneous pregnancy|1|||
27771362|NCT02047227|54224380|FG001|Overall Study|Spontaneous pregnancy|0|||
27771363|NCT02047227|54224379|FG000|Overall Study|Lack of ovarian response to stimulation|35|||
27771364|NCT02047227|54224380|FG001|Overall Study|Lack of ovarian response to stimulation|32|||
27771365|NCT02047227|54224379|FG000|Overall Study|No oocytes retrieved|21|||
27771366|NCT02047227|54224380|FG001|Overall Study|No oocytes retrieved|20|||
27771367|NCT02047227|54224379|FG000|Overall Study|No fertilization|61|||
27771368|NCT02047227|54224380|FG001|Overall Study|No fertilization|51|||
27839930|NCT01693562|54327125|FG014|Expansion Phase|Other|1|||
27771369|NCT02047227|54224379|FG000|Overall Study|Intention to freeze all embryos|1|||
27771370|NCT02047227|54224380|FG001|Overall Study|Intention to freeze all embryos|0|||
27771371|NCT02047227|54224379|FG000|Overall Study|All embryos discarded|12|||
27771372|NCT02047227|54224380|FG001|Overall Study|All embryos discarded|11|||
27771373|NCT02047227|54224379|FG000|Overall Study|Other|10|||
27771374|NCT02047227|54224380|FG001|Overall Study|Other|9|||
27771375|NCT02483585|54224388|FG000|Double-blind Treatment Phase|Decision by Sponsor|1|||
27771376|NCT02483585|54224389|FG001|Double-blind Treatment Phase|Decision by Sponsor|1|||
27771377|NCT02483585|54224388|FG000|Double-blind Treatment Phase|Withdrawal by Subject|12|||
27771378|NCT02483585|54224389|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
27771379|NCT02483585|54224388|FG000|Double-blind Treatment Phase|Lost to Follow-up|3|||
27771380|NCT02483585|54224389|FG001|Double-blind Treatment Phase|Lost to Follow-up|2|||
27771381|NCT02483585|54224388|FG000|Open-label Treatment Phase|Protocol-specified Criteria|6|||
27771382|NCT02483585|54224389|FG001|Open-label Treatment Phase|Protocol-specified Criteria|5|||
27771383|NCT02483585|54224388|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
27771384|NCT02483585|54224389|FG001|Open-label Treatment Phase|Decision by Sponsor|1|||
27771385|NCT02483585|54224388|FG000|Open-label Treatment Phase|Withdrawal by Subject|18|||
27771386|NCT02483585|54224389|FG001|Open-label Treatment Phase|Withdrawal by Subject|14|||
27771387|NCT02483585|54224388|FG000|Open-label Treatment Phase|Lost to Follow-up|3|||
27771388|NCT02483585|54224389|FG001|Open-label Treatment Phase|Lost to Follow-up|5|||
27771389|NCT02046993|54224401|FG000|Overall Study|Withdrawal by Subject|2|||
27771390|NCT02046993|54224402|FG001|Overall Study|Withdrawal by Subject|10|||
27771391|NCT02046993|54224401|FG000|Overall Study|Lost to Follow-up|1|||
27771392|NCT02046993|54224402|FG001|Overall Study|Lost to Follow-up|1|||
27771393|NCT02101983|54224412|FG000|Overall Study|Physician Decision|1|||
27771394|NCT02101983|54224413|FG001|Overall Study|Physician Decision|0|||
27771395|NCT02482805|54224422|FG000|Overall Study|Lost to Follow-up|4|||
27771396|NCT02482805|54224423|FG001|Overall Study|Lost to Follow-up|4|||
27771397|NCT02482805|54224424|FG002|Overall Study|Lost to Follow-up|0|||
27771398|NCT02503865|54224435|FG000|Overall Study|Moved out of area|1|||
27771399|NCT02503865|54224436|FG001|Overall Study|Moved out of area|8|||
27771400|NCT02503865|54224437|FG002|Overall Study|Moved out of area|0|||
27771401|NCT02503865|54224435|FG000|Overall Study|Refused treatment|4|||
27771402|NCT02503865|54224436|FG001|Overall Study|Refused treatment|39|||
27771403|NCT02503865|54224437|FG002|Overall Study|Refused treatment|2|||
27771404|NCT01623531|54224448|FG000|Overall Study|Death|1|||
27771405|NCT01623531|54224449|FG001|Overall Study|Death|0|||
27771406|NCT01623531|54224448|FG000|Overall Study|Protocol Violation|2|||
27771407|NCT01623531|54224449|FG001|Overall Study|Protocol Violation|1|||
27771408|NCT01623531|54224448|FG000|Overall Study|Missing data at primary outcome time poi|1|||
27771409|NCT01623531|54224449|FG001|Overall Study|Missing data at primary outcome time poi|1|||
27771410|NCT02503787|54224458|FG000|Enrollment|Withdrawal by Subject|6|||
27771411|NCT02503787|54224458|FG000|Enrollment|Inclusion/exclusion criteria not met|4|||
27771412|NCT02503787|54224458|FG000|Enrollment|Physician Decision|2|||
27771413|NCT02503787|54224458|FG000|Enrollment|Insurance issue|2|||
27771414|NCT02503787|54224458|FG000|Enrollment|Lost to Follow-up|1|||
27771415|NCT02503787|54224458|FG000|Enrollment|Study closure|1|||
27771416|NCT02503787|54224458|FG000|Enrollment|Adverse Event|1|||
27771417|NCT02503787|54224458|FG000|Enrollment|Protocol Violation|1|||
27771418|NCT02503787|54224458|FG000|Enrollment|Inability to implant system|1|||
27771419|NCT02503787|54224458|FG000|Enrollment|Unable to be programmed|1|||
27771420|NCT02503787|54224458|FG000|Device Trial (HD Programming Trial)|Lack of Efficacy|6|||
27771421|NCT02503787|54224458|FG000|Device Trial (HD Programming Trial)|Withdrawal by Subject|1|||
27771422|NCT02503787|54224458|FG000|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3|||
27771423|NCT02503787|54224458|FG000|Successful Trial (≥50% Pain Relief)|Physician Decision|2|||
27771424|NCT02503787|54224458|FG000|Implant to 3 Month Endpoint|Adverse Event|2|||
27771425|NCT02503787|54224458|FG000|Implant to 3 Month Endpoint|Withdrawal by Subject|1|||
27771426|NCT02482571|54224462|FG000|Overall Study|Adverse Event|1|||
27771427|NCT02482571|54224462|FG000|Overall Study|Scanner or Respiract failure|3|||
27771428|NCT02482571|54224462|FG000|Overall Study|Withdrawal by Subject|4|||
27771429|NCT02481947|54224469|FG000|Overall Study|Withdrawal by Subject|24|||
27771430|NCT02481947|54224470|FG001|Overall Study|Withdrawal by Subject|10|||
27771431|NCT02481947|54224469|FG000|Overall Study|Lost to Follow-up|11|||
27771432|NCT02481947|54224470|FG001|Overall Study|Lost to Follow-up|5|||
27771433|NCT02481947|54224469|FG000|Overall Study|Adverse Event|6|||
27771434|NCT02481947|54224470|FG001|Overall Study|Adverse Event|11|||
27771435|NCT02481947|54224469|FG000|Overall Study|Physician Decision|4|||
27771436|NCT02481947|54224470|FG001|Overall Study|Physician Decision|5|||
27839931|NCT01693562|54327126|FG015|Expansion Phase|Other|0|||
27839932|NCT01693562|54327127|FG016|Expansion Phase|Other|28|||
27771437|NCT02481947|54224469|FG000|Overall Study|Protocol Violation|1|||
27771438|NCT02481947|54224470|FG001|Overall Study|Protocol Violation|5|||
27771439|NCT02503085|54224476|FG000|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
27771440|NCT02503085|54224477|FG001|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
27771441|NCT02503085|54224478|FG002|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
27839933|NCT01693562|54327128|FG017|Expansion Phase|Other|0|||
27771442|NCT02503085|54224479|FG003|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
27771443|NCT02481869|54224488|FG000|Overall Study|Lost to Follow-up|3|||
27771444|NCT02481869|54224489|FG001|Overall Study|Lost to Follow-up|4|||
27771445|NCT02481869|54224488|FG000|Overall Study|Withdrawal by Subject|2|||
27771446|NCT02481869|54224489|FG001|Overall Study|Withdrawal by Subject|0|||
27771447|NCT02502149|54224496|FG000|Intermediate|Discontinued prematurely|1|||
27771448|NCT02502149|54224497|FG001|Intermediate|Discontinued prematurely|0|||
27771449|NCT02502149|54224498|FG002|Intermediate|Discontinued prematurely|0|||
27771450|NCT02502149|54224499|FG003|Intermediate|Discontinued prematurely|0|||
27771451|NCT02502149|54224500|FG004|Intermediate|Discontinued prematurely|0|||
27771452|NCT02480621|54224519|FG000|Randomization|Withdrawal by Subject|1|||
27771453|NCT02480621|54224520|FG001|Randomization|Withdrawal by Subject|0|||
27771454|NCT02480621|54224519|FG000|Randomization|Surgeon did not give intervention|0|||
27771455|NCT02480621|54224520|FG001|Randomization|Surgeon did not give intervention|1|||
27771456|NCT02480621|54224519|FG000|Follow Up|Lost to Follow-up|4|||
27771457|NCT02480621|54224520|FG001|Follow Up|Lost to Follow-up|2|||
27771458|NCT02046603|54224528|FG000|Overall Study|Other|11|||
27771459|NCT02046603|54224529|FG001|Overall Study|Other|66|||
27771460|NCT02046603|54224528|FG000|Overall Study|Protocol Violation|0|||
27771461|NCT02046603|54224529|FG001|Overall Study|Protocol Violation|1|||
27771462|NCT02046603|54224528|FG000|Overall Study|Participant/legal guardian decision|1|||
27771463|NCT02046603|54224529|FG001|Overall Study|Participant/legal guardian decision|3|||
27771464|NCT02046603|54224528|FG000|Overall Study|Physician Decision|2|||
27771465|NCT02046603|54224529|FG001|Overall Study|Physician Decision|1|||
27771466|NCT02046603|54224528|FG000|Overall Study|Lost to Follow-up|1|||
27771467|NCT02046603|54224529|FG001|Overall Study|Lost to Follow-up|2|||
27771468|NCT02046603|54224528|FG000|Overall Study|Death|0|||
27771469|NCT02046603|54224529|FG001|Overall Study|Death|1|||
27771470|NCT02046603|54224528|FG000|Overall Study|Adverse Event|0|||
27771471|NCT02046603|54224529|FG001|Overall Study|Adverse Event|1|||
27771472|NCT01885078|54224544|FG000|Treatment Period|Adverse Event|52|||
27771473|NCT01885078|54224545|FG001|Treatment Period|Adverse Event|136|||
27771474|NCT01885078|54224546|FG002|Treatment Period|Adverse Event|30|||
27771475|NCT01885078|54224547|FG003|Treatment Period|Adverse Event|73|||
27771476|NCT01885078|54224548|FG004|Treatment Period|Adverse Event|17|||
27771477|NCT01885078|54224549|FG005|Treatment Period|Adverse Event|72|||
27771478|NCT01885078|54224550|FG006|Treatment Period|Adverse Event|24|||
27771479|NCT01885078|54224551|FG007|Treatment Period|Adverse Event|5|||
27771480|NCT01885078|54224552|FG008|Treatment Period|Adverse Event|0|||
27771481|NCT01885078|54224553|FG009|Treatment Period|Adverse Event|0|||
27771482|NCT01885078|54224544|FG000|Treatment Period|Death|13|||
27771483|NCT01885078|54224545|FG001|Treatment Period|Death|33|||
27771484|NCT01885078|54224546|FG002|Treatment Period|Death|5|||
27771485|NCT01885078|54224547|FG003|Treatment Period|Death|9|||
27771486|NCT01885078|54224548|FG004|Treatment Period|Death|2|||
27771487|NCT01885078|54224549|FG005|Treatment Period|Death|10|||
27771488|NCT01885078|54224550|FG006|Treatment Period|Death|3|||
27771489|NCT01885078|54224551|FG007|Treatment Period|Death|2|||
27771490|NCT01885078|54224552|FG008|Treatment Period|Death|0|||
27771491|NCT01885078|54224553|FG009|Treatment Period|Death|0|||
27771492|NCT01885078|54224544|FG000|Treatment Period|Lack of Efficacy|12|||
27771493|NCT01885078|54224545|FG001|Treatment Period|Lack of Efficacy|33|||
27771494|NCT01885078|54224546|FG002|Treatment Period|Lack of Efficacy|10|||
27771495|NCT01885078|54224547|FG003|Treatment Period|Lack of Efficacy|23|||
27771496|NCT01885078|54224548|FG004|Treatment Period|Lack of Efficacy|24|||
27771497|NCT01885078|54224549|FG005|Treatment Period|Lack of Efficacy|58|||
27771498|NCT01885078|54224550|FG006|Treatment Period|Lack of Efficacy|9|||
27771499|NCT01885078|54224551|FG007|Treatment Period|Lack of Efficacy|5|||
27771500|NCT01885078|54224552|FG008|Treatment Period|Lack of Efficacy|0|||
27771501|NCT01885078|54224553|FG009|Treatment Period|Lack of Efficacy|0|||
27771502|NCT01885078|54224544|FG000|Treatment Period|Lost to Follow-up|16|||
27771503|NCT01885078|54224545|FG001|Treatment Period|Lost to Follow-up|19|||
27771504|NCT01885078|54224546|FG002|Treatment Period|Lost to Follow-up|7|||
27771505|NCT01885078|54224547|FG003|Treatment Period|Lost to Follow-up|9|||
27771506|NCT01885078|54224548|FG004|Treatment Period|Lost to Follow-up|2|||
27771507|NCT01885078|54224549|FG005|Treatment Period|Lost to Follow-up|8|||
27771508|NCT01885078|54224550|FG006|Treatment Period|Lost to Follow-up|2|||
27771509|NCT01885078|54224551|FG007|Treatment Period|Lost to Follow-up|0|||
27771510|NCT01885078|54224552|FG008|Treatment Period|Lost to Follow-up|0|||
27771511|NCT01885078|54224553|FG009|Treatment Period|Lost to Follow-up|0|||
27771512|NCT01885078|54224544|FG000|Treatment Period|Physician Decision|19|||
27771513|NCT01885078|54224545|FG001|Treatment Period|Physician Decision|21|||
27771514|NCT01885078|54224546|FG002|Treatment Period|Physician Decision|5|||
27771515|NCT01885078|54224547|FG003|Treatment Period|Physician Decision|12|||
27771516|NCT01885078|54224548|FG004|Treatment Period|Physician Decision|9|||
27771517|NCT01885078|54224549|FG005|Treatment Period|Physician Decision|24|||
27771518|NCT01885078|54224550|FG006|Treatment Period|Physician Decision|4|||
27771519|NCT01885078|54224551|FG007|Treatment Period|Physician Decision|3|||
27771520|NCT01885078|54224552|FG008|Treatment Period|Physician Decision|0|||
27771521|NCT01885078|54224553|FG009|Treatment Period|Physician Decision|0|||
27771522|NCT01885078|54224544|FG000|Treatment Period|Protocol Violation|3|||
27771523|NCT01885078|54224545|FG001|Treatment Period|Protocol Violation|5|||
27771524|NCT01885078|54224546|FG002|Treatment Period|Protocol Violation|0|||
27771525|NCT01885078|54224547|FG003|Treatment Period|Protocol Violation|3|||
27771526|NCT01885078|54224548|FG004|Treatment Period|Protocol Violation|1|||
27771527|NCT01885078|54224549|FG005|Treatment Period|Protocol Violation|6|||
27771528|NCT01885078|54224550|FG006|Treatment Period|Protocol Violation|0|||
27771529|NCT01885078|54224551|FG007|Treatment Period|Protocol Violation|0|||
27771530|NCT01885078|54224552|FG008|Treatment Period|Protocol Violation|0|||
27771531|NCT01885078|54224553|FG009|Treatment Period|Protocol Violation|0|||
27771532|NCT01885078|54224544|FG000|Treatment Period|Sponsor Decision|245|||
27771533|NCT01885078|54224545|FG001|Treatment Period|Sponsor Decision|648|||
27771534|NCT01885078|54224546|FG002|Treatment Period|Sponsor Decision|49|||
27771535|NCT01885078|54224547|FG003|Treatment Period|Sponsor Decision|90|||
27771536|NCT01885078|54224548|FG004|Treatment Period|Sponsor Decision|20|||
27771537|NCT01885078|54224549|FG005|Treatment Period|Sponsor Decision|38|||
27771538|NCT01885078|54224550|FG006|Treatment Period|Sponsor Decision|162|||
27771539|NCT01885078|54224551|FG007|Treatment Period|Sponsor Decision|3|||
27771540|NCT01885078|54224552|FG008|Treatment Period|Sponsor Decision|0|||
27771541|NCT01885078|54224553|FG009|Treatment Period|Sponsor Decision|0|||
27771542|NCT01885078|54224544|FG000|Treatment Period|Withdrawal by Subject|72|||
27771543|NCT01885078|54224545|FG001|Treatment Period|Withdrawal by Subject|132|||
27771544|NCT01885078|54224546|FG002|Treatment Period|Withdrawal by Subject|25|||
27771545|NCT01885078|54224547|FG003|Treatment Period|Withdrawal by Subject|63|||
27771546|NCT01885078|54224548|FG004|Treatment Period|Withdrawal by Subject|15|||
27771547|NCT01885078|54224549|FG005|Treatment Period|Withdrawal by Subject|34|||
27771548|NCT01885078|54224550|FG006|Treatment Period|Withdrawal by Subject|17|||
27771549|NCT01885078|54224551|FG007|Treatment Period|Withdrawal by Subject|10|||
27771550|NCT01885078|54224552|FG008|Treatment Period|Withdrawal by Subject|0|||
27771551|NCT01885078|54224553|FG009|Treatment Period|Withdrawal by Subject|0|||
27771552|NCT01885078|54224544|FG000|Treatment Period|Other|0|||
27771553|NCT01885078|54224545|FG001|Treatment Period|Other|0|||
27771554|NCT01885078|54224546|FG002|Treatment Period|Other|0|||
27771555|NCT01885078|54224547|FG003|Treatment Period|Other|1|||
27771556|NCT01885078|54224548|FG004|Treatment Period|Other|0|||
27771557|NCT01885078|54224549|FG005|Treatment Period|Other|0|||
27771558|NCT01885078|54224550|FG006|Treatment Period|Other|0|||
27771559|NCT01885078|54224551|FG007|Treatment Period|Other|0|||
27771560|NCT01885078|54224552|FG008|Treatment Period|Other|0|||
27771561|NCT01885078|54224553|FG009|Treatment Period|Other|0|||
27771562|NCT01885078|54224544|FG000|Step-down Period|Sponsor Decision|0|||
27771563|NCT01885078|54224545|FG001|Step-down Period|Sponsor Decision|0|||
27771564|NCT01885078|54224546|FG002|Step-down Period|Sponsor Decision|0|||
27771565|NCT01885078|54224547|FG003|Step-down Period|Sponsor Decision|0|||
27771566|NCT01885078|54224548|FG004|Step-down Period|Sponsor Decision|0|||
27771567|NCT01885078|54224549|FG005|Step-down Period|Sponsor Decision|0|||
27771568|NCT01885078|54224550|FG006|Step-down Period|Sponsor Decision|0|||
27771569|NCT01885078|54224551|FG007|Step-down Period|Sponsor Decision|0|||
27771570|NCT01885078|54224552|FG008|Step-down Period|Sponsor Decision|1|||
27771571|NCT01885078|54224553|FG009|Step-down Period|Sponsor Decision|1|||
27771572|NCT01885078|54224544|FG000|Step-down Period|Adverse Event|0|||
27771573|NCT01885078|54224545|FG001|Step-down Period|Adverse Event|0|||
27771574|NCT01885078|54224546|FG002|Step-down Period|Adverse Event|0|||
27771575|NCT01885078|54224547|FG003|Step-down Period|Adverse Event|0|||
27771576|NCT01885078|54224548|FG004|Step-down Period|Adverse Event|0|||
27771577|NCT01885078|54224549|FG005|Step-down Period|Adverse Event|0|||
27771578|NCT01885078|54224550|FG006|Step-down Period|Adverse Event|0|||
27771579|NCT01885078|54224551|FG007|Step-down Period|Adverse Event|0|||
27771580|NCT01885078|54224552|FG008|Step-down Period|Adverse Event|29|||
27771581|NCT01885078|54224553|FG009|Step-down Period|Adverse Event|38|||
27771582|NCT01885078|54224544|FG000|Step-down Period|Withdrawal by Subject|0|||
27771583|NCT01885078|54224545|FG001|Step-down Period|Withdrawal by Subject|0|||
27771584|NCT01885078|54224546|FG002|Step-down Period|Withdrawal by Subject|0|||
27771585|NCT01885078|54224547|FG003|Step-down Period|Withdrawal by Subject|0|||
27771586|NCT01885078|54224548|FG004|Step-down Period|Withdrawal by Subject|0|||
27839934|NCT01693562|54327129|FG018|Expansion Phase|Other|1|||
27771587|NCT01885078|54224549|FG005|Step-down Period|Withdrawal by Subject|0|||
27771588|NCT01885078|54224550|FG006|Step-down Period|Withdrawal by Subject|0|||
27771589|NCT01885078|54224551|FG007|Step-down Period|Withdrawal by Subject|0|||
27771590|NCT01885078|54224552|FG008|Step-down Period|Withdrawal by Subject|25|||
27771591|NCT01885078|54224553|FG009|Step-down Period|Withdrawal by Subject|15|||
27771592|NCT01885078|54224544|FG000|Step-down Period|Physician Decision|0|||
27771593|NCT01885078|54224545|FG001|Step-down Period|Physician Decision|0|||
27771594|NCT01885078|54224546|FG002|Step-down Period|Physician Decision|0|||
27771595|NCT01885078|54224547|FG003|Step-down Period|Physician Decision|0|||
27771596|NCT01885078|54224548|FG004|Step-down Period|Physician Decision|0|||
27771597|NCT01885078|54224549|FG005|Step-down Period|Physician Decision|0|||
27771598|NCT01885078|54224550|FG006|Step-down Period|Physician Decision|0|||
27771599|NCT01885078|54224551|FG007|Step-down Period|Physician Decision|0|||
27771600|NCT01885078|54224552|FG008|Step-down Period|Physician Decision|7|||
27771601|NCT01885078|54224553|FG009|Step-down Period|Physician Decision|2|||
27771602|NCT01885078|54224544|FG000|Step-down Period|Death|0|||
27771603|NCT01885078|54224545|FG001|Step-down Period|Death|0|||
27771604|NCT01885078|54224546|FG002|Step-down Period|Death|0|||
27771605|NCT01885078|54224547|FG003|Step-down Period|Death|0|||
27771606|NCT01885078|54224548|FG004|Step-down Period|Death|0|||
27771607|NCT01885078|54224549|FG005|Step-down Period|Death|0|||
27771608|NCT01885078|54224550|FG006|Step-down Period|Death|0|||
27771609|NCT01885078|54224551|FG007|Step-down Period|Death|0|||
27771610|NCT01885078|54224552|FG008|Step-down Period|Death|4|||
27771611|NCT01885078|54224553|FG009|Step-down Period|Death|3|||
27771612|NCT01885078|54224544|FG000|Step-down Period|Lost to Follow-up|0|||
27771613|NCT01885078|54224545|FG001|Step-down Period|Lost to Follow-up|0|||
27771614|NCT01885078|54224546|FG002|Step-down Period|Lost to Follow-up|0|||
27771615|NCT01885078|54224547|FG003|Step-down Period|Lost to Follow-up|0|||
27771616|NCT01885078|54224548|FG004|Step-down Period|Lost to Follow-up|0|||
27771617|NCT01885078|54224549|FG005|Step-down Period|Lost to Follow-up|0|||
27771618|NCT01885078|54224550|FG006|Step-down Period|Lost to Follow-up|0|||
27771619|NCT01885078|54224551|FG007|Step-down Period|Lost to Follow-up|0|||
27771620|NCT01885078|54224552|FG008|Step-down Period|Lost to Follow-up|1|||
27771621|NCT01885078|54224553|FG009|Step-down Period|Lost to Follow-up|1|||
27771622|NCT01885078|54224544|FG000|Step-down Period|Lack of Efficacy|0|||
27771623|NCT01885078|54224545|FG001|Step-down Period|Lack of Efficacy|0|||
27771624|NCT01885078|54224546|FG002|Step-down Period|Lack of Efficacy|0|||
27771625|NCT01885078|54224547|FG003|Step-down Period|Lack of Efficacy|0|||
27771626|NCT01885078|54224548|FG004|Step-down Period|Lack of Efficacy|0|||
27771627|NCT01885078|54224549|FG005|Step-down Period|Lack of Efficacy|0|||
27771628|NCT01885078|54224550|FG006|Step-down Period|Lack of Efficacy|0|||
27771629|NCT01885078|54224551|FG007|Step-down Period|Lack of Efficacy|0|||
27771630|NCT01885078|54224552|FG008|Step-down Period|Lack of Efficacy|1|||
27771631|NCT01885078|54224553|FG009|Step-down Period|Lack of Efficacy|0|||
27771632|NCT01885078|54224544|FG000|Step-down Period|Protocol Violation|0|||
27771633|NCT01885078|54224545|FG001|Step-down Period|Protocol Violation|0|||
27771634|NCT01885078|54224546|FG002|Step-down Period|Protocol Violation|0|||
27771635|NCT01885078|54224547|FG003|Step-down Period|Protocol Violation|0|||
27771636|NCT01885078|54224548|FG004|Step-down Period|Protocol Violation|0|||
27771637|NCT01885078|54224549|FG005|Step-down Period|Protocol Violation|0|||
27771638|NCT01885078|54224550|FG006|Step-down Period|Protocol Violation|0|||
27771639|NCT01885078|54224551|FG007|Step-down Period|Protocol Violation|0|||
27771640|NCT01885078|54224552|FG008|Step-down Period|Protocol Violation|1|||
27771641|NCT01885078|54224553|FG009|Step-down Period|Protocol Violation|1|||
27771642|NCT02046369|54224576|FG000|Overall Study|Adverse Event|3|||
27771643|NCT02046369|54224577|FG001|Overall Study|Adverse Event|3|||
27771644|NCT02046369|54224576|FG000|Overall Study|Lack of Efficacy|3|||
27771645|NCT02046369|54224577|FG001|Overall Study|Lack of Efficacy|3|||
27771646|NCT02046369|54224576|FG000|Overall Study|Lost to Follow-up|3|||
27771647|NCT02046369|54224577|FG001|Overall Study|Lost to Follow-up|3|||
27771648|NCT02046369|54224576|FG000|Overall Study|Protocol Violation|1|||
27771649|NCT02046369|54224577|FG001|Overall Study|Protocol Violation|2|||
27771650|NCT02046369|54224576|FG000|Overall Study|Withdrawal by Subject|3|||
27771651|NCT02046369|54224577|FG001|Overall Study|Withdrawal by Subject|6|||
27771652|NCT02046369|54224576|FG000|Overall Study|never received study drug|0|||
27771653|NCT02046369|54224577|FG001|Overall Study|never received study drug|1|||
27771654|NCT02046369|54224576|FG000|Overall Study|non compliance|1|||
27771655|NCT02046369|54224577|FG001|Overall Study|non compliance|0|||
27771656|NCT02101359|54224585|FG000|Overall Study|Not included|23|||
27771657|NCT02101359|54224586|FG001|Overall Study|Not included|13|||
27771658|NCT02101359|54224585|FG000|Overall Study|Withdrawal by Subject|5|||
27771659|NCT02101359|54224586|FG001|Overall Study|Withdrawal by Subject|4|||
27771660|NCT02101359|54224585|FG000|Overall Study|Lost to Follow-up|1|||
27771661|NCT02101359|54224586|FG001|Overall Study|Lost to Follow-up|0|||
27771662|NCT02101359|54224585|FG000|Overall Study|Protocol Violation|0|||
27771663|NCT02101359|54224586|FG001|Overall Study|Protocol Violation|2|||
27839935|NCT01693562|54327130|FG019|Expansion Phase|Other|0|||
27771664|NCT02100969|54224592|FG000|Overall Study|Did not pass screening phase|1|||
27771665|NCT01885000|54224599|FG000|Overall Study|Adverse Event|1|||
27771666|NCT01885000|54224600|FG001|Overall Study|Adverse Event|0|||
27771667|NCT01885000|54224599|FG000|Overall Study|Withdrawal by Subject|1|||
27839936|NCT01693562|54327131|FG020|Expansion Phase|Other|1|||
27771668|NCT01885000|54224600|FG001|Overall Study|Withdrawal by Subject|1|||
27771669|NCT01885000|54224599|FG000|Overall Study|Protocol Violation|0|||
27771670|NCT01885000|54224600|FG001|Overall Study|Protocol Violation|1|||
27771671|NCT01884688|54224606|FG000|Overall Study|Screen Failure|2|||
27771672|NCT01883362|54224612|FG000|Treatment|Adverse Event|1|||
27771673|NCT01883362|54224613|FG001|Treatment|Adverse Event|8|||
27771674|NCT01883362|54224612|FG000|Treatment|Withdrawal by Subject|6|||
27771675|NCT01883362|54224613|FG001|Treatment|Withdrawal by Subject|2|||
27839937|NCT01693562|54327132|FG021|Expansion Phase|Other|17|||
27771676|NCT01883362|54224612|FG000|Treatment|Administrative problems|4|||
27771677|NCT01883362|54224613|FG001|Treatment|Administrative problems|1|||
27771678|NCT01883362|54224612|FG000|Treatment|Relapse|4|||
27771679|NCT01883362|54224613|FG001|Treatment|Relapse|2|||
27771680|NCT01883362|54224612|FG000|Treatment|Randomized, not treated|1|||
27771681|NCT01883362|54224613|FG001|Treatment|Randomized, not treated|1|||
27771682|NCT01883362|54224612|FG000|Post Treatment Follow-up|Protocol Violation|0|||
27771683|NCT01883362|54224613|FG001|Post Treatment Follow-up|Protocol Violation|1|||
27771684|NCT01883362|54224612|FG000|Post Treatment Follow-up|Withdrawal by Subject|4|||
27771685|NCT01883362|54224613|FG001|Post Treatment Follow-up|Withdrawal by Subject|3|||
27771686|NCT01883362|54224612|FG000|Post Treatment Follow-up|Lost to Follow-up|1|||
27771687|NCT01883362|54224613|FG001|Post Treatment Follow-up|Lost to Follow-up|4|||
27771688|NCT01883362|54224612|FG000|Post Treatment Follow-up|Administrative problems|2|||
27771689|NCT01883362|54224613|FG001|Post Treatment Follow-up|Administrative problems|0|||
27771690|NCT01883362|54224612|FG000|Post Treatment Follow-up|Death|8|||
27771691|NCT01883362|54224613|FG001|Post Treatment Follow-up|Death|4|||
27771692|NCT01883362|54224612|FG000|Post Treatment Follow-up|Relapse|1|||
27771693|NCT01883362|54224613|FG001|Post Treatment Follow-up|Relapse|2|||
27771694|NCT02100813|54224631|FG000|Overall Study|Adverse Event|0|||
27771695|NCT02100813|54224632|FG001|Overall Study|Adverse Event|0|||
27771696|NCT02100813|54224633|FG002|Overall Study|Adverse Event|0|||
27771697|NCT02100813|54224634|FG003|Overall Study|Adverse Event|0|||
27771698|NCT02100813|54224635|FG004|Overall Study|Adverse Event|0|||
27771699|NCT02100813|54224636|FG005|Overall Study|Adverse Event|0|||
27771700|NCT02100813|54224637|FG006|Overall Study|Adverse Event|0|||
27771701|NCT02100813|54224638|FG007|Overall Study|Adverse Event|1|||
27771702|NCT01930162|54224660|FG000|Overall Study|Abnormal test procedure result(s)|4|||
27771703|NCT01930162|54224660|FG000|Overall Study|Death|1|||
27771704|NCT02045979|54224668|FG000|Overall Study|Informed Consent Withdrawn|2|||
27771705|NCT02045979|54224669|FG001|Overall Study|Informed Consent Withdrawn|0|||
27771706|NCT02045979|54224670|FG002|Overall Study|Informed Consent Withdrawn|1|||
27771707|NCT02045979|54224668|FG000|Overall Study|not specified above|0|||
27771708|NCT02045979|54224669|FG001|Overall Study|not specified above|1|||
27771709|NCT02045979|54224670|FG002|Overall Study|not specified above|0|||
27771710|NCT01929226|54224680|FG000|Overall Study|Lost to Follow-up|4|||
27771711|NCT01929226|54224681|FG001|Overall Study|Lost to Follow-up|0|||
27771712|NCT01929226|54224680|FG000|Overall Study|Withdrawal by Subject|1|||
27771713|NCT01929226|54224681|FG001|Overall Study|Withdrawal by Subject|1|||
27771714|NCT02045433|54224688|FG000|Overall Study|Withdrawal by Subject|1|||
27771715|NCT01911442|54224695|FG000|Overall Study|Adverse Event|2|||
27771716|NCT01911442|54224696|FG001|Overall Study|Adverse Event|2|||
27771717|NCT01911442|54224697|FG002|Overall Study|Adverse Event|4|||
27771718|NCT01911442|54224695|FG000|Overall Study|Lack of Efficacy|1|||
27771719|NCT01911442|54224696|FG001|Overall Study|Lack of Efficacy|1|||
27771720|NCT01911442|54224697|FG002|Overall Study|Lack of Efficacy|1|||
27771721|NCT01911442|54224695|FG000|Overall Study|Lost to Follow-up|2|||
27771722|NCT01911442|54224696|FG001|Overall Study|Lost to Follow-up|0|||
27771723|NCT01911442|54224697|FG002|Overall Study|Lost to Follow-up|1|||
27771724|NCT01911442|54224695|FG000|Overall Study|Withdrawal by Subject|1|||
27771725|NCT01911442|54224696|FG001|Overall Study|Withdrawal by Subject|0|||
27771726|NCT01911442|54224697|FG002|Overall Study|Withdrawal by Subject|6|||
27771727|NCT01911442|54224695|FG000|Overall Study|Mother's Work Schedule|0|||
27771728|NCT01911442|54224696|FG001|Overall Study|Mother's Work Schedule|1|||
27771729|NCT01911442|54224697|FG002|Overall Study|Mother's Work Schedule|0|||
27771730|NCT01928758|54224711|FG000|Overall Study|Lost to Follow-up|14|||
27771731|NCT01928758|54224712|FG001|Overall Study|Lost to Follow-up|9|||
27771732|NCT01928758|54224711|FG000|Overall Study|Withdrawal by Subject|5|||
27771733|NCT01928758|54224712|FG001|Overall Study|Withdrawal by Subject|2|||
27771734|NCT01928758|54224711|FG000|Overall Study|Adverse Event|3|||
27771735|NCT01928758|54224712|FG001|Overall Study|Adverse Event|5|||
27771736|NCT01928758|54224711|FG000|Overall Study|Protocol Violation|3|||
27771737|NCT01928758|54224712|FG001|Overall Study|Protocol Violation|4|||
27771738|NCT01910116|54224721|FG000|Overall Study|Adverse Event|0|||
27771739|NCT01910116|54224722|FG001|Overall Study|Adverse Event|3|||
27771740|NCT01910116|54224721|FG000|Overall Study|Lack of Efficacy|3|||
27771741|NCT01910116|54224722|FG001|Overall Study|Lack of Efficacy|4|||
27771742|NCT01910116|54224721|FG000|Overall Study|Lost to Follow-up|1|||
27771743|NCT01910116|54224722|FG001|Overall Study|Lost to Follow-up|0|||
27771744|NCT01910116|54224721|FG000|Overall Study|Protocol Violation|1|||
27771745|NCT01910116|54224722|FG001|Overall Study|Protocol Violation|2|||
27771746|NCT01910116|54224721|FG000|Overall Study|Withdrawal by Subject|8|||
27771747|NCT01910116|54224722|FG001|Overall Study|Withdrawal by Subject|3|||
27771748|NCT01910116|54224721|FG000|Overall Study|uncertain allocation|1|||
27771749|NCT01910116|54224722|FG001|Overall Study|uncertain allocation|3|||
27771750|NCT01910116|54224721|FG000|Overall Study|incomplete data|0|||
27771751|NCT01910116|54224722|FG001|Overall Study|incomplete data|1|||
27771752|NCT01614886|54224730|FG000|Overall Study|Adverse Event|15|||
27771753|NCT01614886|54224731|FG001|Overall Study|Adverse Event|20|||
27771754|NCT01614886|54224730|FG000|Overall Study|Withdrawal by Subject|4|||
27771755|NCT01614886|54224731|FG001|Overall Study|Withdrawal by Subject|4|||
27771756|NCT01614886|54224730|FG000|Overall Study|Death|1|||
27771757|NCT01614886|54224731|FG001|Overall Study|Death|0|||
27771758|NCT01614886|54224730|FG000|Overall Study|Protocol deviation|0|||
27771759|NCT01614886|54224731|FG001|Overall Study|Protocol deviation|2|||
27771760|NCT01880554|54224737|FG000|Overall Study|Protocol Violation|14|||
27771761|NCT01880554|54224737|FG000|Overall Study|Simon's design requirements|2|||
27771762|NCT02100657|54224745|FG000|Cohort 1: Dose Level 1|Progressive disease|6|||
27771763|NCT02100657|54224746|FG001|Cohort 1: Dose Level 1|Progressive disease|0|||
27771764|NCT02100657|54224747|FG002|Cohort 1: Dose Level 1|Progressive disease|0|||
27771765|NCT02100657|54224745|FG000|Cohort 1: Dose Level 1|Treatment-related adverse event|1|||
27771766|NCT02100657|54224746|FG001|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
27771767|NCT02100657|54224747|FG002|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
27771768|NCT02100657|54224745|FG000|Cohort 1: Dose Level 1|Withdrawal by Subject|1|||
27771769|NCT02100657|54224746|FG001|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
27771770|NCT02100657|54224747|FG002|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
27771771|NCT02100657|54224745|FG000|Cohort 2: Dose Level 2|Progressive disease|0|||
27771772|NCT02100657|54224746|FG001|Cohort 2: Dose Level 2|Progressive disease|2|||
27771773|NCT02100657|54224747|FG002|Cohort 2: Dose Level 2|Progressive disease|0|||
27771774|NCT02100657|54224745|FG000|Cohort 2: Dose Level 2|Physician Decision|0|||
27771775|NCT02100657|54224746|FG001|Cohort 2: Dose Level 2|Physician Decision|1|||
27771776|NCT02100657|54224747|FG002|Cohort 2: Dose Level 2|Physician Decision|0|||
27771777|NCT02100657|54224745|FG000|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
27771778|NCT02100657|54224746|FG001|Cohort 2: Dose Level 2|Treatment-related adverse event|1|||
27771779|NCT02100657|54224747|FG002|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
27771780|NCT02100657|54224745|FG000|Cohort 3: Dose Level 3|Progressive disease|0|||
27771781|NCT02100657|54224746|FG001|Cohort 3: Dose Level 3|Progressive disease|0|||
27771782|NCT02100657|54224747|FG002|Cohort 3: Dose Level 3|Progressive disease|15|||
27771783|NCT02100657|54224745|FG000|Cohort 3: Dose Level 3|Death|0|||
27771784|NCT02100657|54224746|FG001|Cohort 3: Dose Level 3|Death|0|||
27771785|NCT02100657|54224747|FG002|Cohort 3: Dose Level 3|Death|1|||
27771786|NCT02100657|54224745|FG000|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
27771787|NCT02100657|54224746|FG001|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
27771788|NCT02100657|54224747|FG002|Cohort 3: Dose Level 3|Non-treatment related adverse event|1|||
27771789|NCT02100657|54224745|FG000|Cohort 3: Dose Level 3|Physician Decision|0|||
27771790|NCT02100657|54224746|FG001|Cohort 3: Dose Level 3|Physician Decision|0|||
27771791|NCT02100657|54224747|FG002|Cohort 3: Dose Level 3|Physician Decision|1|||
27771792|NCT02100657|54224745|FG000|Cohort 3: Dose Level 3|Never were treated|0|||
27771793|NCT02100657|54224746|FG001|Cohort 3: Dose Level 3|Never were treated|0|||
27771794|NCT02100657|54224747|FG002|Cohort 3: Dose Level 3|Never were treated|3|||
27771795|NCT02100657|54224745|FG000|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
27771796|NCT02100657|54224746|FG001|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
27771797|NCT02100657|54224747|FG002|Cohort 3: Dose Level 3|Treatment-related adverse event|3|||
27771798|NCT02100657|54224745|FG000|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
27771799|NCT02100657|54224746|FG001|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
27771800|NCT02100657|54224747|FG002|Cohort 3: Dose Level 3|Withdrawal by Subject|3|||
27771801|NCT02067663|54224758|FG000|Overall Study|Lost to Follow-up|13|||
27771802|NCT02067663|54224759|FG001|Overall Study|Lost to Follow-up|14|||
27771803|NCT01909804|54224777|FG000|Overall Study|Randomized but Never Treated|0|||
27771804|NCT01909804|54224778|FG001|Overall Study|Randomized but Never Treated|0|||
27771805|NCT01909804|54224779|FG002|Overall Study|Randomized but Never Treated|0|||
27771806|NCT01909804|54224780|FG003|Overall Study|Randomized but Never Treated|0|||
27771807|NCT01909804|54224781|FG004|Overall Study|Randomized but Never Treated|0|||
27771808|NCT01909804|54224782|FG005|Overall Study|Randomized but Never Treated|0|||
27771809|NCT01909804|54224783|FG006|Overall Study|Randomized but Never Treated|1|||
27771810|NCT01909804|54224784|FG007|Overall Study|Randomized but Never Treated|0|||
27771811|NCT01909804|54224785|FG008|Overall Study|Randomized but Never Treated|0|||
27771812|NCT01909804|54224786|FG009|Overall Study|Randomized but Never Treated|0|||
27771813|NCT01909804|54224787|FG010|Overall Study|Randomized but Never Treated|0|||
27771814|NCT01909804|54224788|FG011|Overall Study|Randomized but Never Treated|1|||
27771815|NCT01909804|54224777|FG000|Overall Study|Death|0|||
27839938|NCT01693562|54327133|FG022|Expansion Phase|Other|1|||
27771816|NCT01909804|54224778|FG001|Overall Study|Death|0|||
27771817|NCT01909804|54224779|FG002|Overall Study|Death|0|||
27771818|NCT01909804|54224780|FG003|Overall Study|Death|0|||
27771819|NCT01909804|54224781|FG004|Overall Study|Death|0|||
27771820|NCT01909804|54224782|FG005|Overall Study|Death|0|||
27771821|NCT01909804|54224783|FG006|Overall Study|Death|0|||
27771822|NCT01909804|54224784|FG007|Overall Study|Death|0|||
27771823|NCT01909804|54224785|FG008|Overall Study|Death|0|||
27771824|NCT01909804|54224786|FG009|Overall Study|Death|0|||
27839939|NCT01467713|54327230|FG000|Overall Study|Pretreatment Event or Adverse Event|9|||
27839940|NCT01467713|54327231|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
27771825|NCT01909804|54224787|FG010|Overall Study|Death|1|||
27771826|NCT01909804|54224788|FG011|Overall Study|Death|0|||
27771827|NCT01909804|54224777|FG000|Overall Study|Lack of Efficacy|4|||
27771828|NCT01909804|54224778|FG001|Overall Study|Lack of Efficacy|1|||
27771829|NCT01909804|54224779|FG002|Overall Study|Lack of Efficacy|0|||
27771830|NCT01909804|54224780|FG003|Overall Study|Lack of Efficacy|0|||
27771831|NCT01909804|54224781|FG004|Overall Study|Lack of Efficacy|7|||
27771832|NCT01909804|54224782|FG005|Overall Study|Lack of Efficacy|3|||
27771833|NCT01909804|54224783|FG006|Overall Study|Lack of Efficacy|1|||
27771834|NCT01909804|54224784|FG007|Overall Study|Lack of Efficacy|1|||
27771835|NCT01909804|54224785|FG008|Overall Study|Lack of Efficacy|0|||
27771836|NCT01909804|54224786|FG009|Overall Study|Lack of Efficacy|1|||
27771837|NCT01909804|54224787|FG010|Overall Study|Lack of Efficacy|0|||
27771838|NCT01909804|54224788|FG011|Overall Study|Lack of Efficacy|1|||
27771839|NCT01909804|54224777|FG000|Overall Study|Withdrew Consent|0|||
27771840|NCT01909804|54224778|FG001|Overall Study|Withdrew Consent|0|||
27771841|NCT01909804|54224779|FG002|Overall Study|Withdrew Consent|0|||
27771842|NCT01909804|54224780|FG003|Overall Study|Withdrew Consent|0|||
27771843|NCT01909804|54224781|FG004|Overall Study|Withdrew Consent|1|||
27771844|NCT01909804|54224782|FG005|Overall Study|Withdrew Consent|1|||
27771845|NCT01909804|54224783|FG006|Overall Study|Withdrew Consent|0|||
27771846|NCT01909804|54224784|FG007|Overall Study|Withdrew Consent|0|||
27771847|NCT01909804|54224785|FG008|Overall Study|Withdrew Consent|0|||
27771848|NCT01909804|54224786|FG009|Overall Study|Withdrew Consent|0|||
27771849|NCT01909804|54224787|FG010|Overall Study|Withdrew Consent|0|||
27771850|NCT01909804|54224788|FG011|Overall Study|Withdrew Consent|0|||
27771851|NCT01909804|54224777|FG000|Overall Study|Protocol Violation|0|||
27771852|NCT01909804|54224778|FG001|Overall Study|Protocol Violation|0|||
27771853|NCT01909804|54224779|FG002|Overall Study|Protocol Violation|0|||
27771854|NCT01909804|54224780|FG003|Overall Study|Protocol Violation|0|||
27771855|NCT01909804|54224781|FG004|Overall Study|Protocol Violation|0|||
27771856|NCT01909804|54224782|FG005|Overall Study|Protocol Violation|0|||
27771857|NCT01909804|54224783|FG006|Overall Study|Protocol Violation|0|||
27771858|NCT01909804|54224784|FG007|Overall Study|Protocol Violation|0|||
27771859|NCT01909804|54224785|FG008|Overall Study|Protocol Violation|0|||
27771860|NCT01909804|54224786|FG009|Overall Study|Protocol Violation|0|||
27771861|NCT01909804|54224787|FG010|Overall Study|Protocol Violation|0|||
27771862|NCT01909804|54224788|FG011|Overall Study|Protocol Violation|1|||
27771863|NCT01880086|54224812|FG000|Overall Study|Lost to Follow-up|1|||
27771864|NCT01880086|54224813|FG001|Overall Study|Lost to Follow-up|1|||
27771865|NCT01879852|54224821|FG000|Overall Study|Withdrawal by Subject|2|||
27771866|NCT01879852|54224822|FG001|Overall Study|Withdrawal by Subject|0|||
27771867|NCT01879618|54224828|FG000|Overall Study|Does not meet entrance criteria|1|||
27771868|NCT01879618|54224828|FG000|Overall Study|Withdrawal by Subject|1|||
27771869|NCT01879618|54224828|FG000|Overall Study|Surgery;changed schedule; not available|8|||
27771870|NCT01879618|54224828|FG000|Overall Study|Protocol Violation|6|||
27771871|NCT01879618|54224828|FG000|Overall Study|Adverse Event|5|||
27771872|NCT01926886|54224832|FG000|Overall Study|Administrative/other|1|||
27771873|NCT01926886|54224833|FG001|Overall Study|Administrative/other|0|||
27771874|NCT01926886|54224832|FG000|Overall Study|Adverse event/intercurrent illness|4|||
27771875|NCT01926886|54224833|FG001|Overall Study|Adverse event/intercurrent illness|0|||
27771876|NCT01926886|54224832|FG000|Overall Study|Disease progression/recurrence|4|||
27771877|NCT01926886|54224833|FG001|Overall Study|Disease progression/recurrence|0|||
27771878|NCT01926886|54224832|FG000|Overall Study|Withdrawal by Subject|15|||
27771879|NCT01926886|54224833|FG001|Overall Study|Withdrawal by Subject|0|||
27771880|NCT01926886|54224832|FG000|Overall Study|Failure to return|3|||
27771881|NCT01926886|54224833|FG001|Overall Study|Failure to return|0|||
27771882|NCT01926886|54224832|FG000|Overall Study|Recurrence of disease|1|||
27771883|NCT01926886|54224833|FG001|Overall Study|Recurrence of disease|0|||
27771884|NCT01926886|54224832|FG000|Overall Study|Progression of disease|2|||
27771885|NCT01926886|54224833|FG001|Overall Study|Progression of disease|0|||
27771886|NCT01926886|54224832|FG000|Overall Study|Death|1|||
27771887|NCT01926886|54224833|FG001|Overall Study|Death|0|||
27771888|NCT01926886|54224832|FG000|Overall Study|Did not cooperate|1|||
27771889|NCT01926886|54224833|FG001|Overall Study|Did not cooperate|0|||
27771890|NCT01909336|54224842|FG000|Overall Study|Lost to Follow-up|4|||
27771891|NCT01909336|54224843|FG001|Overall Study|Lost to Follow-up|2|||
27771892|NCT01909336|54224844|FG002|Overall Study|Lost to Follow-up|2|||
27771893|NCT01909336|54224842|FG000|Overall Study|Physician Decision|0|||
27771894|NCT01909336|54224843|FG001|Overall Study|Physician Decision|1|||
27771895|NCT01909336|54224844|FG002|Overall Study|Physician Decision|1|||
27771896|NCT01926028|54224855|FG000|Overall Study|Lost to Follow-up|7|||
27771897|NCT01926028|54224856|FG001|Overall Study|Lost to Follow-up|6|||
27771898|NCT01926028|54224857|FG002|Overall Study|Lost to Follow-up|0|||
27771899|NCT01926028|54224855|FG000|Overall Study|Physician Decision|1|||
27771900|NCT01926028|54224856|FG001|Overall Study|Physician Decision|5|||
27771901|NCT01926028|54224857|FG002|Overall Study|Physician Decision|0|||
27771902|NCT01926028|54224855|FG000|Overall Study|Withdrawal by Subject|9|||
27771903|NCT01926028|54224856|FG001|Overall Study|Withdrawal by Subject|9|||
27771904|NCT01926028|54224857|FG002|Overall Study|Withdrawal by Subject|2|||
27771905|NCT01926028|54224855|FG000|Overall Study|Non compliance or other reasons|4|||
27771906|NCT01926028|54224856|FG001|Overall Study|Non compliance or other reasons|2|||
27771907|NCT01926028|54224857|FG002|Overall Study|Non compliance or other reasons|0|||
27771908|NCT01925950|54224868|FG000|Part 2|Withdrawal by Subject|1|||
27771909|NCT01925950|54224869|FG001|Part 2|Withdrawal by Subject|0|||
27771910|NCT01878292|54224878|FG000|Randomized|Protocol Violation|1|||
27771911|NCT01878292|54224879|FG001|Randomized|Protocol Violation|0|||
27771912|NCT01878292|54224880|FG002|Randomized|Protocol Violation|0|||
27771913|NCT01878292|54224878|FG000|Randomized|Lost to Follow-up|1|||
27771914|NCT01878292|54224879|FG001|Randomized|Lost to Follow-up|0|||
27771915|NCT01878292|54224880|FG002|Randomized|Lost to Follow-up|0|||
27771916|NCT01878292|54224878|FG000|Randomized|Adverse Event|1|||
27771917|NCT01878292|54224879|FG001|Randomized|Adverse Event|0|||
27771918|NCT01878292|54224880|FG002|Randomized|Adverse Event|0|||
27771919|NCT01878292|54224878|FG000|Double-blind Treatment Period|Other Reasons|2|||
27771920|NCT01878292|54224879|FG001|Double-blind Treatment Period|Other Reasons|0|||
27771921|NCT01878292|54224880|FG002|Double-blind Treatment Period|Other Reasons|0|||
27771922|NCT01878292|54224878|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
27771923|NCT01878292|54224879|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
27771924|NCT01878292|54224880|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
27771925|NCT01878292|54224878|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
27771926|NCT01878292|54224879|FG001|Double-blind Treatment Period|Withdrawal by Subject|7|||
27771927|NCT01878292|54224880|FG002|Double-blind Treatment Period|Withdrawal by Subject|8|||
27771928|NCT01878292|54224878|FG000|Double-blind Treatment Period|Protocol Violation|3|||
27771929|NCT01878292|54224879|FG001|Double-blind Treatment Period|Protocol Violation|4|||
27771930|NCT01878292|54224880|FG002|Double-blind Treatment Period|Protocol Violation|2|||
27771931|NCT01878292|54224878|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
27771932|NCT01878292|54224879|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
27771933|NCT01878292|54224880|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
27771934|NCT01878292|54224878|FG000|Double-blind Treatment Period|Adverse Event|4|||
27771935|NCT01878292|54224879|FG001|Double-blind Treatment Period|Adverse Event|9|||
27771936|NCT01878292|54224880|FG002|Double-blind Treatment Period|Adverse Event|8|||
27771937|NCT01878292|54224878|FG000|Double-blind Down-Taper Period|Withdrawal by Subject|5|||
27771938|NCT01878292|54224879|FG001|Double-blind Down-Taper Period|Withdrawal by Subject|8|||
27771939|NCT01878292|54224880|FG002|Double-blind Down-Taper Period|Withdrawal by Subject|4|||
27771940|NCT01908634|54224888|FG000|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1|||
27771941|NCT01908634|54224888|FG000|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5|||
27771942|NCT01878214|54224898|FG000|Overall Study|Withdrawal by Subject|18|||
27771943|NCT01878214|54224899|FG001|Overall Study|Withdrawal by Subject|7|||
27771944|NCT01878214|54224898|FG000|Overall Study|Death|0|||
27771945|NCT01878214|54224899|FG001|Overall Study|Death|1|||
27771946|NCT01878214|54224898|FG000|Overall Study|Lost to Follow-up|35|||
27771947|NCT01878214|54224899|FG001|Overall Study|Lost to Follow-up|36|||
27771948|NCT01907854|54224907|FG000|Overall Study|Protocol Violation|1|||
27771949|NCT01907854|54224908|FG001|Overall Study|Protocol Violation|1|||
27771950|NCT01907854|54224907|FG000|Overall Study|Withdrawal by Subject|9|||
27771951|NCT01907854|54224908|FG001|Overall Study|Withdrawal by Subject|7|||
27771952|NCT01907854|54224907|FG000|Overall Study|Lost to Follow-up|2|||
27771953|NCT01907854|54224908|FG001|Overall Study|Lost to Follow-up|2|||
27771954|NCT01907854|54224907|FG000|Overall Study|Unclassified|4|||
27771955|NCT01907854|54224908|FG001|Overall Study|Unclassified|3|||
27771956|NCT02480153|54224916|FG000|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
27771957|NCT02480153|54224917|FG001|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1|||
27771958|NCT02480153|54224918|FG002|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
27771959|NCT02480153|54224916|FG000|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
27771960|NCT02480153|54224917|FG001|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1|||
27771961|NCT02480153|54224918|FG002|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
27771962|NCT02480153|54224916|FG000|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1|||
27771963|NCT02480153|54224917|FG001|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2|||
27771964|NCT02480153|54224918|FG002|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0|||
27771965|NCT02480153|54224916|FG000|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3|||
27771966|NCT02480153|54224917|FG001|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8|||
27771967|NCT02480153|54224918|FG002|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0|||
27771968|NCT02480153|54224916|FG000|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
27771969|NCT02480153|54224917|FG001|Period 1: First Dose to Week 26 Pre-dose|Other|1|||
27771970|NCT02480153|54224918|FG002|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
27771971|NCT02480153|54224916|FG000|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
27771972|NCT02480153|54224917|FG001|Period 1: First Dose to Week 26 Pre-dose|Death|1|||
27771973|NCT02480153|54224918|FG002|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
27771974|NCT02480153|54224916|FG000|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
27771975|NCT02480153|54224917|FG001|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2|||
27771976|NCT02480153|54224918|FG002|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
27771977|NCT02480153|54224916|FG000|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4|||
27771978|NCT02480153|54224917|FG001|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1|||
27771979|NCT02480153|54224918|FG002|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3|||
27771980|NCT02480153|54224916|FG000|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
27771981|NCT02480153|54224917|FG001|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1|||
27771982|NCT02480153|54224918|FG002|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
27771983|NCT02480153|54224916|FG000|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8|||
27771984|NCT02480153|54224917|FG001|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3|||
27771985|NCT02480153|54224918|FG002|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1|||
27771986|NCT02480153|54224916|FG000|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6|||
27771987|NCT02480153|54224917|FG001|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7|||
27771988|NCT02480153|54224918|FG002|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3|||
27771989|NCT02480153|54224916|FG000|Period 2: Week 26 to Week 52 Pre-dose|Other|2|||
27771990|NCT02480153|54224917|FG001|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
27771991|NCT02480153|54224918|FG002|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
27771992|NCT02480153|54224916|FG000|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
27771993|NCT02480153|54224917|FG001|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1|||
27771994|NCT02480153|54224918|FG002|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
27771995|NCT02480153|54224916|FG000|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3|||
27771996|NCT02480153|54224917|FG001|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2|||
27771997|NCT02480153|54224918|FG002|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1|||
27771998|NCT02480153|54224916|FG000|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4|||
27771999|NCT02480153|54224917|FG001|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0|||
27772000|NCT02480153|54224918|FG002|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1|||
27772001|NCT02480153|54224916|FG000|Period 3: Week 52 Dosing to Week 78|Other|0|||
27772002|NCT02480153|54224917|FG001|Period 3: Week 52 Dosing to Week 78|Other|0|||
27772003|NCT02480153|54224918|FG002|Period 3: Week 52 Dosing to Week 78|Other|1|||
27772004|NCT02480153|54224916|FG000|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
27772005|NCT02480153|54224917|FG001|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
27772006|NCT02480153|54224918|FG002|Period 3: Week 52 Dosing to Week 78|Adverse Event|1|||
27772007|NCT02480153|54224916|FG000|Period 3: Week 52 Dosing to Week 78|Death|0|||
27772008|NCT02480153|54224917|FG001|Period 3: Week 52 Dosing to Week 78|Death|1|||
27772009|NCT02480153|54224918|FG002|Period 3: Week 52 Dosing to Week 78|Death|0|||
27772010|NCT02500979|54224943|FG000|Period 1|Hyperglycemia|1|||
27772011|NCT02500979|54224944|FG001|Period 1|Hyperglycemia|0|||
27772012|NCT02500979|54224943|FG000|Period 1|Severe non-compliance to protocol|0|||
27772013|NCT02500979|54224944|FG001|Period 1|Severe non-compliance to protocol|1|||
27772014|NCT02500979|54224943|FG000|Period 1|Adverse Event|1|||
27772015|NCT02500979|54224944|FG001|Period 1|Adverse Event|0|||
27772016|NCT02500979|54224943|FG000|Period 1|Subject decision|2|||
27772017|NCT02500979|54224944|FG001|Period 1|Subject decision|0|||
27772018|NCT02500979|54224943|FG000|Period 2|Change in risk|1|||
27772019|NCT02500979|54224944|FG001|Period 2|Change in risk|0|||
27772020|NCT02500901|54224950|FG000|Overall Study|Disease ProgressionDD|2|||
27772021|NCT02479139|54224960|FG000|Overall Study|Lost to Follow-up|2|||
27772022|NCT02479139|54224961|FG001|Overall Study|Lost to Follow-up|4|||
27772023|NCT02479139|54224962|FG002|Overall Study|Lost to Follow-up|4|||
27772024|NCT02479139|54224963|FG003|Overall Study|Lost to Follow-up|2|||
27772025|NCT02479139|54224964|FG004|Overall Study|Lost to Follow-up|3|||
27772026|NCT02479139|54224965|FG005|Overall Study|Lost to Follow-up|5|||
27772027|NCT02479139|54224960|FG000|Overall Study|Withdrew Consent|5|||
27772028|NCT02479139|54224961|FG001|Overall Study|Withdrew Consent|6|||
27772029|NCT02479139|54224962|FG002|Overall Study|Withdrew Consent|1|||
27772030|NCT02479139|54224963|FG003|Overall Study|Withdrew Consent|4|||
27772031|NCT02479139|54224964|FG004|Overall Study|Withdrew Consent|1|||
27772032|NCT02479139|54224965|FG005|Overall Study|Withdrew Consent|1|||
27772033|NCT02479139|54224960|FG000|Overall Study|Treatment Failure/Lack of Efficacy|0|||
27772034|NCT02479139|54224961|FG001|Overall Study|Treatment Failure/Lack of Efficacy|0|||
27772035|NCT02479139|54224962|FG002|Overall Study|Treatment Failure/Lack of Efficacy|1|||
27772036|NCT02479139|54224963|FG003|Overall Study|Treatment Failure/Lack of Efficacy|0|||
27772037|NCT02479139|54224964|FG004|Overall Study|Treatment Failure/Lack of Efficacy|0|||
27772038|NCT02479139|54224965|FG005|Overall Study|Treatment Failure/Lack of Efficacy|0|||
27772039|NCT02479139|54224960|FG000|Overall Study|Other Miscellaneous Reasons|1|||
27839941|NCT01467713|54327232|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
27839942|NCT01467713|54327233|FG003|Overall Study|Pretreatment Event or Adverse Event|5|||
27839943|NCT01467713|54327230|FG000|Overall Study|Major Protocol Deviation|2|||
27772040|NCT02479139|54224961|FG001|Overall Study|Other Miscellaneous Reasons|0|||
27772041|NCT02479139|54224962|FG002|Overall Study|Other Miscellaneous Reasons|1|||
27839944|NCT01467713|54327231|FG001|Overall Study|Major Protocol Deviation|4|||
27772042|NCT02479139|54224963|FG003|Overall Study|Other Miscellaneous Reasons|1|||
27772043|NCT02479139|54224964|FG004|Overall Study|Other Miscellaneous Reasons|1|||
27772044|NCT02479139|54224965|FG005|Overall Study|Other Miscellaneous Reasons|0|||
27772045|NCT02478359|54224981|FG000|Overall Study|Disenrolled from health plan|106|||
27772046|NCT02478359|54224982|FG001|Overall Study|Disenrolled from health plan|65|||
27772047|NCT01877668|54224995|FG000|Overall Study|Death|0|||
27772048|NCT01877668|54224996|FG001|Overall Study|Death|0|||
27772049|NCT01877668|54224997|FG002|Overall Study|Death|0|||
27772050|NCT01877668|54224998|FG003|Overall Study|Death|1|||
27772051|NCT01877668|54224999|FG004|Overall Study|Death|0|||
27772052|NCT01877668|54224995|FG000|Overall Study|No longer met study criteria|1|||
27772053|NCT01877668|54224996|FG001|Overall Study|No longer met study criteria|0|||
27772054|NCT01877668|54224997|FG002|Overall Study|No longer met study criteria|1|||
27772055|NCT01877668|54224998|FG003|Overall Study|No longer met study criteria|0|||
27772056|NCT01877668|54224999|FG004|Overall Study|No longer met study criteria|0|||
27772057|NCT01877668|54224995|FG000|Overall Study|Insufficient clinical response|0|||
27772058|NCT01877668|54224996|FG001|Overall Study|Insufficient clinical response|1|||
27772059|NCT01877668|54224997|FG002|Overall Study|Insufficient clinical response|2|||
27772060|NCT01877668|54224998|FG003|Overall Study|Insufficient clinical response|2|||
27772061|NCT01877668|54224999|FG004|Overall Study|Insufficient clinical response|0|||
27772062|NCT01877668|54224995|FG000|Overall Study|Lost to Follow-up|0|||
27772063|NCT01877668|54224996|FG001|Overall Study|Lost to Follow-up|2|||
27772064|NCT01877668|54224997|FG002|Overall Study|Lost to Follow-up|1|||
27772065|NCT01877668|54224998|FG003|Overall Study|Lost to Follow-up|0|||
27772066|NCT01877668|54224999|FG004|Overall Study|Lost to Follow-up|0|||
27772067|NCT01877668|54224995|FG000|Overall Study|Withdrawal by Subject|2|||
27772068|NCT01877668|54224996|FG001|Overall Study|Withdrawal by Subject|0|||
27772069|NCT01877668|54224997|FG002|Overall Study|Withdrawal by Subject|3|||
27772070|NCT01877668|54224998|FG003|Overall Study|Withdrawal by Subject|2|||
27772071|NCT01877668|54224999|FG004|Overall Study|Withdrawal by Subject|2|||
27772072|NCT01877668|54224995|FG000|Overall Study|Other|1|||
27772073|NCT01877668|54224996|FG001|Overall Study|Other|1|||
27772074|NCT01877668|54224997|FG002|Overall Study|Other|1|||
27772075|NCT01877668|54224998|FG003|Overall Study|Other|1|||
27772076|NCT01877668|54224999|FG004|Overall Study|Other|3|||
27772077|NCT01877668|54224995|FG000|Overall Study|Protocol Violation|1|||
27772078|NCT01877668|54224996|FG001|Overall Study|Protocol Violation|1|||
27772079|NCT01877668|54224997|FG002|Overall Study|Protocol Violation|0|||
27772080|NCT01877668|54224998|FG003|Overall Study|Protocol Violation|0|||
27772081|NCT01877668|54224999|FG004|Overall Study|Protocol Violation|3|||
27772082|NCT01877668|54224995|FG000|Overall Study|Adverse event related to study drug|2|||
27772083|NCT01877668|54224996|FG001|Overall Study|Adverse event related to study drug|2|||
27772084|NCT01877668|54224997|FG002|Overall Study|Adverse event related to study drug|2|||
27772085|NCT01877668|54224998|FG003|Overall Study|Adverse event related to study drug|2|||
27772086|NCT01877668|54224999|FG004|Overall Study|Adverse event related to study drug|1|||
27772087|NCT01877668|54224995|FG000|Overall Study|Adverse event unrelated to study drug|4|||
27772088|NCT01877668|54224996|FG001|Overall Study|Adverse event unrelated to study drug|1|||
27772089|NCT01877668|54224997|FG002|Overall Study|Adverse event unrelated to study drug|2|||
27772090|NCT01877668|54224998|FG003|Overall Study|Adverse event unrelated to study drug|0|||
27772091|NCT01877668|54224999|FG004|Overall Study|Adverse event unrelated to study drug|1|||
27772092|NCT01877278|54225017|FG000|Overall Study|Lost to Follow-up|3|||
27772093|NCT01877278|54225018|FG001|Overall Study|Lost to Follow-up|3|||
27772094|NCT01906372|54225024|FG000|Overall Study|Withdrawal by Subject|2|||
27772095|NCT01925170|54225029|FG000|Overall Study|Unverified cancer status|53|||
27772096|NCT01925014|54225037|FG000|Overall Study|Inappropriate enrollment|4|||
27772097|NCT01925014|54225038|FG001|Overall Study|Inappropriate enrollment|6|||
27772098|NCT01925014|54225037|FG000|Overall Study|Withdrawal by Subject|5|||
27772099|NCT01925014|54225038|FG001|Overall Study|Withdrawal by Subject|13|||
27839945|NCT01467713|54327232|FG002|Overall Study|Major Protocol Deviation|4|||
27772100|NCT01876810|54225044|FG000|Overall Study|Physician Decision|0|||
27772101|NCT01876810|54225045|FG001|Overall Study|Physician Decision|1|||
27772102|NCT01876732|54225054|FG000|Overall Study|MMA was not over 800mg/dL|75|||
27772103|NCT01905592|54225061|FG000|Overall Study|Disease Progression|51|||
27772104|NCT01905592|54225062|FG001|Overall Study|Disease Progression|110|||
27839946|NCT01467713|54327233|FG003|Overall Study|Major Protocol Deviation|1|||
27839947|NCT01467713|54327230|FG000|Overall Study|Lost to Follow-up|9|||
27839948|NCT01467713|54327231|FG001|Overall Study|Lost to Follow-up|12|||
27839949|NCT01467713|54327232|FG002|Overall Study|Lost to Follow-up|6|||
27839950|NCT01467713|54327233|FG003|Overall Study|Lost to Follow-up|9|||
27772105|NCT01905592|54225061|FG000|Overall Study|Toxicity|1|||
27839951|NCT01467713|54327230|FG000|Overall Study|Voluntary Withdrawal|18|||
27772106|NCT01905592|54225062|FG001|Overall Study|Toxicity|16|||
27772107|NCT01905592|54225061|FG000|Overall Study|Physician Decision|0|||
27772108|NCT01905592|54225062|FG001|Overall Study|Physician Decision|2|||
27839952|NCT01467713|54327231|FG001|Overall Study|Voluntary Withdrawal|14|||
27839953|NCT01467713|54327232|FG002|Overall Study|Voluntary Withdrawal|21|||
27839954|NCT01467713|54327233|FG003|Overall Study|Voluntary Withdrawal|20|||
27839955|NCT01467713|54327230|FG000|Overall Study|Study Termination|23|||
27839956|NCT01467713|54327231|FG001|Overall Study|Study Termination|33|||
27839957|NCT01467713|54327232|FG002|Overall Study|Study Termination|28|||
27839958|NCT01467713|54327233|FG003|Overall Study|Study Termination|29|||
27839959|NCT01467713|54327230|FG000|Overall Study|Pregnancy|0|||
27772109|NCT01905592|54225061|FG000|Overall Study|Start of New anti-cancer Treatment|1|||
27772110|NCT01905592|54225062|FG001|Overall Study|Start of New anti-cancer Treatment|0|||
27772111|NCT01905592|54225061|FG000|Overall Study|Protocol Violation|0|||
27772112|NCT01905592|54225062|FG001|Overall Study|Protocol Violation|1|||
27772113|NCT01905592|54225061|FG000|Overall Study|Sponsor's decision|1|||
27772114|NCT01905592|54225062|FG001|Overall Study|Sponsor's decision|1|||
27772115|NCT01905592|54225061|FG000|Overall Study|Not treated|7|||
27772116|NCT01905592|54225062|FG001|Overall Study|Not treated|3|||
27772117|NCT01905592|54225061|FG000|Overall Study|Withdrawal by Subject|10|||
27772118|NCT01905592|54225062|FG001|Overall Study|Withdrawal by Subject|2|||
27772119|NCT01876420|54225068|FG000|Overall Study|Missed 30 day visit|1|||
27772120|NCT01875874|54225072|FG000|Overall Study|Death|3|||
27772121|NCT02500121|54225079|FG000|Overall Study|Lost to Follow-up|0|||
27772122|NCT02500121|54225080|FG001|Overall Study|Lost to Follow-up|1|||
27839960|NCT01467713|54327231|FG001|Overall Study|Pregnancy|1|||
27839961|NCT01467713|54327232|FG002|Overall Study|Pregnancy|1|||
27839962|NCT01467713|54327233|FG003|Overall Study|Pregnancy|3|||
27839963|NCT01467713|54327230|FG000|Overall Study|Relapse|35|||
27839964|NCT01467713|54327231|FG001|Overall Study|Relapse|25|||
27839965|NCT01467713|54327232|FG002|Overall Study|Relapse|28|||
27839966|NCT01467713|54327233|FG003|Overall Study|Relapse|35|||
27839967|NCT01467713|54327230|FG000|Overall Study|Reason not Specified|6|||
27772123|NCT02500121|54225079|FG000|Overall Study|Withdrawal by Subject|1|||
27772124|NCT02500121|54225080|FG001|Overall Study|Withdrawal by Subject|1|||
27772125|NCT02500121|54225079|FG000|Overall Study|Death|26|||
27772126|NCT02500121|54225080|FG001|Overall Study|Death|24|||
27772127|NCT01875250|54225090|FG000|Overall Study|Adverse Event|2|||
27772128|NCT01875250|54225091|FG001|Overall Study|Adverse Event|0|||
27772129|NCT01904032|54225101|FG000|Overall Study|Adverse Event|3|||
27772130|NCT01904032|54225102|FG001|Overall Study|Adverse Event|1|||
27772131|NCT01904032|54225101|FG000|Overall Study|Lost to Follow-up|4|||
27772132|NCT01904032|54225102|FG001|Overall Study|Lost to Follow-up|2|||
27772133|NCT01903876|54225110|FG000|Baseline to Post-Intervention Period|Lost to Follow-up|184|||
27772134|NCT01903876|54225111|FG001|Baseline to Post-Intervention Period|Lost to Follow-up|108|||
27772135|NCT01903876|54225110|FG000|Six-Month Follow-up Period|Lost to Follow-up|91|||
27772136|NCT01903876|54225111|FG001|Six-Month Follow-up Period|Lost to Follow-up|145|||
27772137|NCT01921348|54225119|FG000|Overall Study|Withdrawal by Subject|1|||
27772138|NCT01921348|54225120|FG001|Overall Study|Withdrawal by Subject|0|||
27772139|NCT01921348|54225119|FG000|Overall Study|Lost to Follow-up|0|||
27772140|NCT01921348|54225120|FG001|Overall Study|Lost to Follow-up|2|||
27772141|NCT01921270|54225126|FG000|Overall Study|Withdrawal by Subject|1|||
27772142|NCT02325739|54225141|FG000|Phase I Part|Adverse Event|1|||
27772143|NCT02325739|54225142|FG001|Phase I Part|Adverse Event|0|||
27772144|NCT02325739|54225143|FG002|Phase I Part|Adverse Event|1|||
27772145|NCT02325739|54225144|FG003|Phase I Part|Adverse Event|2|||
27772146|NCT02325739|54225145|FG004|Phase I Part|Adverse Event|3|||
27772147|NCT02325739|54225146|FG005|Phase I Part|Adverse Event|1|||
27772148|NCT02325739|54225147|FG006|Phase I Part|Adverse Event|0|||
27772149|NCT02325739|54225148|FG007|Phase I Part|Adverse Event|2|||
27772150|NCT02325739|54225149|FG008|Phase I Part|Adverse Event|0|||
27772151|NCT02325739|54225150|FG009|Phase I Part|Adverse Event|0|||
27772152|NCT02325739|54225151|FG010|Phase I Part|Adverse Event|0|||
27772153|NCT02325739|54225141|FG000|Phase I Part|Progressive disease|9|||
27772154|NCT02325739|54225142|FG001|Phase I Part|Progressive disease|6|||
27772155|NCT02325739|54225143|FG002|Phase I Part|Progressive disease|3|||
27772156|NCT02325739|54225144|FG003|Phase I Part|Progressive disease|23|||
27772157|NCT02325739|54225145|FG004|Phase I Part|Progressive disease|14|||
27772158|NCT02325739|54225146|FG005|Phase I Part|Progressive disease|6|||
27772159|NCT02325739|54225147|FG006|Phase I Part|Progressive disease|6|||
27772160|NCT02325739|54225148|FG007|Phase I Part|Progressive disease|3|||
27839968|NCT01467713|54327231|FG001|Overall Study|Reason not Specified|11|||
27839969|NCT01467713|54327232|FG002|Overall Study|Reason not Specified|8|||
27839970|NCT01467713|54327233|FG003|Overall Study|Reason not Specified|7|||
27772161|NCT02325739|54225149|FG008|Phase I Part|Progressive disease|0|||
27772162|NCT02325739|54225150|FG009|Phase I Part|Progressive disease|0|||
27772163|NCT02325739|54225151|FG010|Phase I Part|Progressive disease|0|||
27772164|NCT02325739|54225141|FG000|Phase I Part|Subject/guardian decision|1|||
27772165|NCT02325739|54225142|FG001|Phase I Part|Subject/guardian decision|0|||
27772166|NCT02325739|54225143|FG002|Phase I Part|Subject/guardian decision|1|||
27772167|NCT02325739|54225144|FG003|Phase I Part|Subject/guardian decision|1|||
27772168|NCT02325739|54225145|FG004|Phase I Part|Subject/guardian decision|0|||
27772169|NCT02325739|54225146|FG005|Phase I Part|Subject/guardian decision|0|||
27772170|NCT02325739|54225147|FG006|Phase I Part|Subject/guardian decision|0|||
27839971|NCT01693250|54327263|FG000|Overall Study|Lost to Follow-up|2|||
27839972|NCT01693250|54327264|FG001|Overall Study|Lost to Follow-up|2|||
27772171|NCT02325739|54225148|FG007|Phase I Part|Subject/guardian decision|1|||
27772172|NCT02325739|54225149|FG008|Phase I Part|Subject/guardian decision|0|||
27772173|NCT02325739|54225150|FG009|Phase I Part|Subject/guardian decision|0|||
27772174|NCT02325739|54225151|FG010|Phase I Part|Subject/guardian decision|0|||
27772175|NCT02325739|54225141|FG000|Phase I Part|Death|0|||
27772176|NCT02325739|54225142|FG001|Phase I Part|Death|0|||
27772177|NCT02325739|54225143|FG002|Phase I Part|Death|0|||
27772178|NCT02325739|54225144|FG003|Phase I Part|Death|0|||
27772179|NCT02325739|54225145|FG004|Phase I Part|Death|2|||
27772180|NCT02325739|54225146|FG005|Phase I Part|Death|0|||
27772181|NCT02325739|54225147|FG006|Phase I Part|Death|0|||
27772182|NCT02325739|54225148|FG007|Phase I Part|Death|0|||
27772183|NCT02325739|54225149|FG008|Phase I Part|Death|0|||
27839973|NCT01590758|54327287|FG000|Overall Study|Withdrawal by Subject|0|||
27839974|NCT01590758|54327288|FG001|Overall Study|Withdrawal by Subject|3|||
27839975|NCT01590758|54327287|FG000|Overall Study|Physician Decision|1|||
27839976|NCT01590758|54327288|FG001|Overall Study|Physician Decision|2|||
27839977|NCT01590758|54327287|FG000|Overall Study|Lost to Follow-up|4|||
27839978|NCT01590758|54327288|FG001|Overall Study|Lost to Follow-up|2|||
27839979|NCT01590212|54327297|FG000|Overall Study|Withdrawal by Subject|2|||
27839980|NCT01590212|54327298|FG001|Overall Study|Withdrawal by Subject|2|||
27839981|NCT01590212|54327299|FG002|Overall Study|Withdrawal by Subject|2|||
27839982|NCT01590212|54327297|FG000|Overall Study|Lost to Follow-up|1|||
27839983|NCT01590212|54327298|FG001|Overall Study|Lost to Follow-up|2|||
27772184|NCT02325739|54225150|FG009|Phase I Part|Death|0|||
27772185|NCT02325739|54225151|FG010|Phase I Part|Death|0|||
27772186|NCT02325739|54225141|FG000|Phase II Part|Adverse Event|0|||
27772187|NCT02325739|54225142|FG001|Phase II Part|Adverse Event|0|||
27772188|NCT02325739|54225143|FG002|Phase II Part|Adverse Event|0|||
27772189|NCT02325739|54225144|FG003|Phase II Part|Adverse Event|0|||
27772190|NCT02325739|54225145|FG004|Phase II Part|Adverse Event|0|||
27772191|NCT02325739|54225146|FG005|Phase II Part|Adverse Event|0|||
27772192|NCT02325739|54225147|FG006|Phase II Part|Adverse Event|0|||
27772193|NCT02325739|54225148|FG007|Phase II Part|Adverse Event|0|||
27772194|NCT02325739|54225149|FG008|Phase II Part|Adverse Event|4|||
27772195|NCT02325739|54225150|FG009|Phase II Part|Adverse Event|5|||
27772196|NCT02325739|54225151|FG010|Phase II Part|Adverse Event|1|||
27772197|NCT02325739|54225141|FG000|Phase II Part|Physician Decision|0|||
27772198|NCT02325739|54225142|FG001|Phase II Part|Physician Decision|0|||
27772199|NCT02325739|54225143|FG002|Phase II Part|Physician Decision|0|||
27772200|NCT02325739|54225144|FG003|Phase II Part|Physician Decision|0|||
27772201|NCT02325739|54225145|FG004|Phase II Part|Physician Decision|0|||
27772202|NCT02325739|54225146|FG005|Phase II Part|Physician Decision|0|||
27772203|NCT02325739|54225147|FG006|Phase II Part|Physician Decision|0|||
27772204|NCT02325739|54225148|FG007|Phase II Part|Physician Decision|0|||
27772205|NCT02325739|54225149|FG008|Phase II Part|Physician Decision|0|||
27772206|NCT02325739|54225150|FG009|Phase II Part|Physician Decision|1|||
27772207|NCT02325739|54225151|FG010|Phase II Part|Physician Decision|0|||
27772208|NCT02325739|54225141|FG000|Phase II Part|Progressive disease|0|||
27772209|NCT02325739|54225142|FG001|Phase II Part|Progressive disease|0|||
27772210|NCT02325739|54225143|FG002|Phase II Part|Progressive disease|0|||
27772211|NCT02325739|54225144|FG003|Phase II Part|Progressive disease|0|||
27772212|NCT02325739|54225145|FG004|Phase II Part|Progressive disease|0|||
27772213|NCT02325739|54225146|FG005|Phase II Part|Progressive disease|0|||
27772214|NCT02325739|54225147|FG006|Phase II Part|Progressive disease|0|||
27772215|NCT02325739|54225148|FG007|Phase II Part|Progressive disease|0|||
27772216|NCT02325739|54225149|FG008|Phase II Part|Progressive disease|22|||
27772217|NCT02325739|54225150|FG009|Phase II Part|Progressive disease|29|||
27772218|NCT02325739|54225151|FG010|Phase II Part|Progressive disease|18|||
27772219|NCT02325739|54225141|FG000|Phase II Part|Subject/guardian decision|0|||
27772220|NCT02325739|54225142|FG001|Phase II Part|Subject/guardian decision|0|||
27772221|NCT02325739|54225143|FG002|Phase II Part|Subject/guardian decision|0|||
27772222|NCT02325739|54225144|FG003|Phase II Part|Subject/guardian decision|0|||
27839984|NCT01590212|54327299|FG002|Overall Study|Lost to Follow-up|3|||
27839985|NCT01692938|54327310|FG000|Overall Study|Protocol Deviation|1|||
27839986|NCT01692938|54327311|FG001|Overall Study|Protocol Deviation|1|||
27839987|NCT01692938|54327310|FG000|Overall Study|Study completed prior to site completion|3|||
27839988|NCT01692938|54327311|FG001|Overall Study|Study completed prior to site completion|3|||
27839989|NCT01692782|54327324|FG000|Overall Study|Adverse Event|12|||
27839990|NCT01692782|54327325|FG001|Overall Study|Adverse Event|32|||
27839991|NCT01692782|54327326|FG002|Overall Study|Adverse Event|2|||
27839992|NCT01692782|54327324|FG000|Overall Study|Lack of Efficacy|1|||
27839993|NCT01692782|54327325|FG001|Overall Study|Lack of Efficacy|2|||
27839994|NCT01692782|54327326|FG002|Overall Study|Lack of Efficacy|0|||
27772223|NCT02325739|54225145|FG004|Phase II Part|Subject/guardian decision|0|||
27772224|NCT02325739|54225146|FG005|Phase II Part|Subject/guardian decision|0|||
27772225|NCT02325739|54225147|FG006|Phase II Part|Subject/guardian decision|0|||
27772226|NCT02325739|54225148|FG007|Phase II Part|Subject/guardian decision|0|||
27772227|NCT02325739|54225149|FG008|Phase II Part|Subject/guardian decision|4|||
27839995|NCT01692782|54327324|FG000|Overall Study|Lost to Follow-up|2|||
27772228|NCT02325739|54225150|FG009|Phase II Part|Subject/guardian decision|1|||
27772229|NCT02325739|54225151|FG010|Phase II Part|Subject/guardian decision|1|||
27772230|NCT01903720|54225196|FG000|Overall Study|Inclusion / exclusion criteria not met|6|||
27772231|NCT01903720|54225196|FG000|Overall Study|Adverse Event|1|||
27772232|NCT01903720|54225196|FG000|Overall Study|Rescinding of informed consent|2|||
27772233|NCT01903720|54225196|FG000|Overall Study|Lost to Follow-up|2|||
27772234|NCT01903720|54225196|FG000|Overall Study|Treatment with alternative drug|1|||
27772235|NCT02366689|54225203|FG000|Overall Study|Withdrawal by Subject|1|||
27772236|NCT02366689|54225204|FG001|Overall Study|Withdrawal by Subject|0|||
27772237|NCT02366689|54225205|FG002|Overall Study|Withdrawal by Subject|1|||
27772238|NCT02366689|54225203|FG000|Overall Study|Lost to Follow-up|3|||
27772239|NCT02366689|54225204|FG001|Overall Study|Lost to Follow-up|2|||
27772240|NCT02366689|54225205|FG002|Overall Study|Lost to Follow-up|0|||
27772241|NCT02366689|54225203|FG000|Overall Study|Pregnancy|0|||
27772242|NCT02366689|54225204|FG001|Overall Study|Pregnancy|1|||
27772243|NCT02366689|54225205|FG002|Overall Study|Pregnancy|1|||
27772244|NCT01903252|54225215|FG000|Double-Blind Induction|Adverse Event|20|||
27772245|NCT01903252|54225216|FG001|Double-Blind Induction|Adverse Event|18|||
27772246|NCT01903252|54225217|FG002|Double-Blind Induction|Adverse Event|0|||
27772247|NCT01903252|54225218|FG003|Double-Blind Induction|Adverse Event|0|||
27772248|NCT01903252|54225219|FG004|Double-Blind Induction|Adverse Event|0|||
27772249|NCT01903252|54225220|FG005|Double-Blind Induction|Adverse Event|0|||
27772250|NCT01903252|54225215|FG000|Double-Blind Induction|Withdrawal by Subject|10|||
27772251|NCT01903252|54225216|FG001|Double-Blind Induction|Withdrawal by Subject|13|||
27772252|NCT01903252|54225217|FG002|Double-Blind Induction|Withdrawal by Subject|0|||
27772253|NCT01903252|54225218|FG003|Double-Blind Induction|Withdrawal by Subject|0|||
27772254|NCT01903252|54225219|FG004|Double-Blind Induction|Withdrawal by Subject|0|||
27772255|NCT01903252|54225220|FG005|Double-Blind Induction|Withdrawal by Subject|0|||
27772256|NCT01903252|54225215|FG000|Double-Blind Induction|Physician Decision|2|||
27772257|NCT01903252|54225216|FG001|Double-Blind Induction|Physician Decision|3|||
27772258|NCT01903252|54225217|FG002|Double-Blind Induction|Physician Decision|0|||
27772259|NCT01903252|54225218|FG003|Double-Blind Induction|Physician Decision|0|||
27772260|NCT01903252|54225219|FG004|Double-Blind Induction|Physician Decision|0|||
27772261|NCT01903252|54225220|FG005|Double-Blind Induction|Physician Decision|0|||
27772262|NCT01903252|54225215|FG000|Double-Blind Induction|non-compliance,|7|||
27772263|NCT01903252|54225216|FG001|Double-Blind Induction|non-compliance,|7|||
27772264|NCT01903252|54225217|FG002|Double-Blind Induction|non-compliance,|0|||
27772265|NCT01903252|54225218|FG003|Double-Blind Induction|non-compliance,|0|||
27772266|NCT01903252|54225219|FG004|Double-Blind Induction|non-compliance,|0|||
27772267|NCT01903252|54225220|FG005|Double-Blind Induction|non-compliance,|0|||
27772268|NCT01903252|54225215|FG000|Extended Induction, Open-Label|Adverse Event|0|||
27772269|NCT01903252|54225216|FG001|Extended Induction, Open-Label|Adverse Event|0|||
27772270|NCT01903252|54225217|FG002|Extended Induction, Open-Label|Adverse Event|17|||
27772271|NCT01903252|54225218|FG003|Extended Induction, Open-Label|Adverse Event|0|||
27772272|NCT01903252|54225219|FG004|Extended Induction, Open-Label|Adverse Event|0|||
27772273|NCT01903252|54225220|FG005|Extended Induction, Open-Label|Adverse Event|0|||
27839996|NCT01692782|54327325|FG001|Overall Study|Lost to Follow-up|7|||
27839997|NCT01692782|54327326|FG002|Overall Study|Lost to Follow-up|1|||
27772274|NCT01903252|54225215|FG000|Extended Induction, Open-Label|Withdrawal by Subject|0|||
27772275|NCT01903252|54225216|FG001|Extended Induction, Open-Label|Withdrawal by Subject|0|||
27772276|NCT01903252|54225217|FG002|Extended Induction, Open-Label|Withdrawal by Subject|5|||
27772277|NCT01903252|54225218|FG003|Extended Induction, Open-Label|Withdrawal by Subject|0|||
27772278|NCT01903252|54225219|FG004|Extended Induction, Open-Label|Withdrawal by Subject|0|||
27772279|NCT01903252|54225220|FG005|Extended Induction, Open-Label|Withdrawal by Subject|0|||
27772280|NCT01903252|54225215|FG000|Extended Induction, Open-Label|Physician Decision|0|||
27772281|NCT01903252|54225216|FG001|Extended Induction, Open-Label|Physician Decision|0|||
27772282|NCT01903252|54225217|FG002|Extended Induction, Open-Label|Physician Decision|1|||
27772283|NCT01903252|54225218|FG003|Extended Induction, Open-Label|Physician Decision|0|||
27772284|NCT01903252|54225219|FG004|Extended Induction, Open-Label|Physician Decision|0|||
27772285|NCT01903252|54225220|FG005|Extended Induction, Open-Label|Physician Decision|0|||
27772286|NCT01903252|54225215|FG000|Maintenance, Open-Label|Adverse Event|0|||
27772287|NCT01903252|54225216|FG001|Maintenance, Open-Label|Adverse Event|0|||
27772288|NCT01903252|54225217|FG002|Maintenance, Open-Label|Adverse Event|0|||
27772289|NCT01903252|54225218|FG003|Maintenance, Open-Label|Adverse Event|3|||
27772290|NCT01903252|54225219|FG004|Maintenance, Open-Label|Adverse Event|9|||
27772291|NCT01903252|54225220|FG005|Maintenance, Open-Label|Adverse Event|14|||
27772292|NCT01903252|54225215|FG000|Maintenance, Open-Label|Withdrawal by Subject|0|||
27839998|NCT01692782|54327324|FG000|Overall Study|Pregnancy|1|||
27772293|NCT01903252|54225216|FG001|Maintenance, Open-Label|Withdrawal by Subject|0|||
27772294|NCT01903252|54225217|FG002|Maintenance, Open-Label|Withdrawal by Subject|0|||
27772295|NCT01903252|54225218|FG003|Maintenance, Open-Label|Withdrawal by Subject|1|||
27772296|NCT01903252|54225219|FG004|Maintenance, Open-Label|Withdrawal by Subject|6|||
27772297|NCT01903252|54225220|FG005|Maintenance, Open-Label|Withdrawal by Subject|2|||
27772298|NCT01903252|54225215|FG000|Maintenance, Open-Label|Other|0|||
27772299|NCT01903252|54225216|FG001|Maintenance, Open-Label|Other|0|||
27772300|NCT01903252|54225217|FG002|Maintenance, Open-Label|Other|0|||
27772301|NCT01903252|54225218|FG003|Maintenance, Open-Label|Other|2|||
27772302|NCT01903252|54225219|FG004|Maintenance, Open-Label|Other|6|||
27772303|NCT01903252|54225220|FG005|Maintenance, Open-Label|Other|2|||
27772304|NCT01920958|54225238|FG000|Overall Study|Did Not Fulfill Inclusion Criteria|5|||
27772305|NCT01613716|54225242|FG000|Overall Study|screen failures|3|||
27772306|NCT01613716|54225242|FG000|Overall Study|Lost to Follow-up|4|||
27772307|NCT01872910|54225252|FG000|Overall Study|Lost to Follow-up|2|||
27772308|NCT01872910|54225253|FG001|Overall Study|Lost to Follow-up|0|||
27772309|NCT01872910|54225254|FG002|Overall Study|Lost to Follow-up|2|||
27772310|NCT01872910|54225255|FG003|Overall Study|Lost to Follow-up|0|||
27772311|NCT01872910|54225256|FG004|Overall Study|Lost to Follow-up|0|||
27772312|NCT01872910|54225257|FG005|Overall Study|Lost to Follow-up|0|||
27772313|NCT01920568|54225272|FG000|Overall Study|Adverse Event|27|||
27772314|NCT01920568|54225273|FG001|Overall Study|Adverse Event|8|||
27772315|NCT01920568|54225272|FG000|Overall Study|Protocol Violation|5|||
27772316|NCT01920568|54225273|FG001|Overall Study|Protocol Violation|3|||
27772317|NCT01920568|54225272|FG000|Overall Study|Lost to Follow-up|2|||
27772318|NCT01920568|54225273|FG001|Overall Study|Lost to Follow-up|2|||
27772319|NCT01920568|54225272|FG000|Overall Study|Physician Decision|13|||
27772320|NCT01920568|54225273|FG001|Overall Study|Physician Decision|4|||
27772321|NCT01920568|54225272|FG000|Overall Study|Withdrawal by Subject|79|||
27772322|NCT01920568|54225273|FG001|Overall Study|Withdrawal by Subject|55|||
27772323|NCT01920568|54225272|FG000|Overall Study|Death due to disease progression|25|||
27772324|NCT01920568|54225273|FG001|Overall Study|Death due to disease progression|12|||
27772325|NCT01902628|54225280|FG000|Overall Study|Withdrawal of participant's consent|7|||
27772326|NCT01902628|54225280|FG000|Overall Study|Adverse Event|41|||
27772327|NCT01902628|54225280|FG000|Overall Study|Lost to Follow-up|35|||
27772328|NCT01920178|54225286|FG000|Overall Study|Lost to Follow-up|2|||
27772329|NCT01920178|54225287|FG001|Overall Study|Lost to Follow-up|1|||
27772330|NCT01901848|54225295|FG000|Randomized and Treated|Lost to Follow-up|3|||
27772331|NCT01901848|54225296|FG001|Randomized and Treated|Lost to Follow-up|6|||
27772332|NCT01901848|54225295|FG000|Removed From Analyses|CPT practice cases to establish fidelity|10|||
27772333|NCT01901848|54225296|FG001|Removed From Analyses|CPT practice cases to establish fidelity|0|||
27772334|NCT01901614|54225304|FG000|Overall Study|Adverse Event|0|||
27772335|NCT01901614|54225305|FG001|Overall Study|Adverse Event|1|||
27772336|NCT01901614|54225304|FG000|Overall Study|Lost to Follow-up|1|||
27772337|NCT01901614|54225305|FG001|Overall Study|Lost to Follow-up|0|||
27772338|NCT01901614|54225304|FG000|Overall Study|Screen Fail|1|||
27772339|NCT01901614|54225305|FG001|Overall Study|Screen Fail|0|||
27772340|NCT01901302|54225313|FG000|Overall Study|Adverse Event|2|||
27772341|NCT01901302|54225314|FG001|Overall Study|Adverse Event|1|||
27772342|NCT01901302|54225313|FG000|Overall Study|Lack of Efficacy|0|||
27772343|NCT01901302|54225314|FG001|Overall Study|Lack of Efficacy|2|||
27772344|NCT01901302|54225313|FG000|Overall Study|Study Terminated by Sponsor|23|||
27772345|NCT01901302|54225314|FG001|Overall Study|Study Terminated by Sponsor|20|||
27772346|NCT01901302|54225313|FG000|Overall Study|Withdrawal by Subject|2|||
27772347|NCT01901302|54225314|FG001|Overall Study|Withdrawal by Subject|0|||
27772348|NCT01919398|54225323|FG000|Overall Study|Progressive Disease|0|||
27772349|NCT01919398|54225324|FG001|Overall Study|Progressive Disease|0|||
27772350|NCT01919398|54225325|FG002|Overall Study|Progressive Disease|4|||
27772351|NCT02500043|54225335|FG000|Overall Study|Randomized, but not Treated|2|||
27772352|NCT02500043|54225336|FG001|Overall Study|Randomized, but not Treated|2|||
27772353|NCT02500043|54225335|FG000|Overall Study|Ongoing at Date of Cut-Off|19|||
27772354|NCT02500043|54225336|FG001|Overall Study|Ongoing at Date of Cut-Off|3|||
27772355|NCT02500043|54225335|FG000|Overall Study|Adverse Event|33|||
27839999|NCT01692782|54327325|FG001|Overall Study|Pregnancy|0|||
27772356|NCT02500043|54225336|FG001|Overall Study|Adverse Event|11|||
27772357|NCT02500043|54225335|FG000|Overall Study|Clinical Progression|54|||
27772358|NCT02500043|54225336|FG001|Overall Study|Clinical Progression|35|||
27772359|NCT02500043|54225335|FG000|Overall Study|Radiological Progression|192|||
27840000|NCT01692782|54327326|FG002|Overall Study|Pregnancy|0|||
27772360|NCT02500043|54225336|FG001|Overall Study|Radiological Progression|110|||
27772361|NCT02500043|54225335|FG000|Overall Study|Physician's Decision|11|||
27772362|NCT02500043|54225336|FG001|Overall Study|Physician's Decision|3|||
27772363|NCT02500043|54225335|FG000|Overall Study|Withdrawal by Subject|14|||
27772364|NCT02500043|54225336|FG001|Overall Study|Withdrawal by Subject|4|||
27772365|NCT02500043|54225335|FG000|Overall Study|Death|11|||
27772366|NCT02500043|54225336|FG001|Overall Study|Death|2|||
27772367|NCT02500043|54225335|FG000|Overall Study|Protocol Deviation|1|||
27772368|NCT02500043|54225336|FG001|Overall Study|Protocol Deviation|0|||
27772369|NCT02499575|54225344|FG000|Overall Study|Protocol Violation|0|||
27772370|NCT02499575|54225345|FG001|Overall Study|Protocol Violation|1|||
27772371|NCT02065791|54225353|FG000|Overall Study|Closed Site|1|||
27772372|NCT02065791|54225354|FG001|Overall Study|Closed Site|1|||
27772373|NCT02065791|54225353|FG000|Overall Study|Withdrawal by Subject|11|||
27840001|NCT01692782|54327324|FG000|Overall Study|Protocol Violation|1|||
27772374|NCT02065791|54225354|FG001|Overall Study|Withdrawal by Subject|5|||
27772375|NCT02065791|54225353|FG000|Overall Study|Lost to Follow-up|13|||
27772376|NCT02065791|54225354|FG001|Overall Study|Lost to Follow-up|9|||
27772377|NCT02499263|54225360|FG000|Overall Study|Lost to Follow-up|9|||
27772378|NCT02499263|54225360|FG000|Overall Study|Participant's withdrawal of consent|4|||
27772379|NCT02499263|54225360|FG000|Overall Study|Lack of Efficacy|22|||
27772380|NCT02499263|54225360|FG000|Overall Study|investigator's judgment|12|||
27772381|NCT02499263|54225360|FG000|Overall Study|Adverse Events/Serious Adverse Events|11|||
27840002|NCT01692782|54327325|FG001|Overall Study|Protocol Violation|0|||
27840003|NCT01692782|54327326|FG002|Overall Study|Protocol Violation|2|||
27840004|NCT01692782|54327324|FG000|Overall Study|Non-complance with study drug|0|||
27840005|NCT01692782|54327325|FG001|Overall Study|Non-complance with study drug|4|||
27840006|NCT01692782|54327326|FG002|Overall Study|Non-complance with study drug|1|||
27840007|NCT01692782|54327324|FG000|Overall Study|Non-compliant with study visits|0|||
27840008|NCT01692782|54327325|FG001|Overall Study|Non-compliant with study visits|0|||
27840009|NCT01692782|54327326|FG002|Overall Study|Non-compliant with study visits|1|||
27840010|NCT01692782|54327324|FG000|Overall Study|SAE not related to study drug|0|||
27840011|NCT01692782|54327325|FG001|Overall Study|SAE not related to study drug|1|||
27840012|NCT01692782|54327326|FG002|Overall Study|SAE not related to study drug|0|||
27840013|NCT01692782|54327324|FG000|Overall Study|Withdrawal by Subject|3|||
27840014|NCT01692782|54327325|FG001|Overall Study|Withdrawal by Subject|10|||
27840015|NCT01692782|54327326|FG002|Overall Study|Withdrawal by Subject|3|||
27840016|NCT01692626|54327334|FG000|Overall Study|Death|0|||
27840017|NCT01692626|54327335|FG001|Overall Study|Death|1|||
27840018|NCT01692626|54327334|FG000|Overall Study|Adverse Event|2|||
27840019|NCT01692626|54327335|FG001|Overall Study|Adverse Event|3|||
27840020|NCT01692626|54327334|FG000|Overall Study|Protocol Violation|1|||
27840021|NCT01692626|54327335|FG001|Overall Study|Protocol Violation|2|||
27840022|NCT01692626|54327334|FG000|Overall Study|Withdrawal by Subject|1|||
27840023|NCT01692626|54327335|FG001|Overall Study|Withdrawal by Subject|0|||
27840024|NCT01475461|54327361|FG000|Run-in Period|Not meet eligibility criteria|16|||
27840025|NCT01475461|54327362|FG001|Run-in Period|Not meet eligibility criteria|0|||
27840026|NCT01475461|54327363|FG002|Run-in Period|Not meet eligibility criteria|0|||
27840027|NCT01475461|54327364|FG003|Run-in Period|Not meet eligibility criteria|0|||
27840028|NCT01475461|54327365|FG004|Run-in Period|Not meet eligibility criteria|0|||
27840029|NCT01475461|54327366|FG005|Run-in Period|Not meet eligibility criteria|0|||
27840030|NCT01475461|54327367|FG006|Run-in Period|Not meet eligibility criteria|0|||
27840031|NCT01475461|54327361|FG000|Run-in Period|Lost to Follow-up|7|||
27840032|NCT01475461|54327362|FG001|Run-in Period|Lost to Follow-up|0|||
27840033|NCT01475461|54327363|FG002|Run-in Period|Lost to Follow-up|0|||
27840034|NCT01475461|54327364|FG003|Run-in Period|Lost to Follow-up|0|||
27840035|NCT01475461|54327365|FG004|Run-in Period|Lost to Follow-up|0|||
27840036|NCT01475461|54327366|FG005|Run-in Period|Lost to Follow-up|0|||
27840037|NCT01475461|54327367|FG006|Run-in Period|Lost to Follow-up|0|||
27840038|NCT01475461|54327361|FG000|Run-in Period|Withdrawal by Subject|11|||
27840039|NCT01475461|54327362|FG001|Run-in Period|Withdrawal by Subject|0|||
27840040|NCT01475461|54327363|FG002|Run-in Period|Withdrawal by Subject|0|||
27840041|NCT01475461|54327364|FG003|Run-in Period|Withdrawal by Subject|0|||
27840042|NCT01475461|54327365|FG004|Run-in Period|Withdrawal by Subject|0|||
27840043|NCT01475461|54327366|FG005|Run-in Period|Withdrawal by Subject|0|||
27840044|NCT01475461|54327367|FG006|Run-in Period|Withdrawal by Subject|0|||
27840045|NCT01475461|54327361|FG000|Run-in Period|Other|3|||
27840046|NCT01475461|54327362|FG001|Run-in Period|Other|0|||
27840047|NCT01475461|54327363|FG002|Run-in Period|Other|0|||
27840048|NCT01475461|54327364|FG003|Run-in Period|Other|0|||
27840049|NCT01475461|54327365|FG004|Run-in Period|Other|0|||
27840050|NCT01475461|54327366|FG005|Run-in Period|Other|0|||
27840051|NCT01475461|54327367|FG006|Run-in Period|Other|0|||
27840052|NCT01475461|54327361|FG000|Run-in Period|Protocol Violation|4|||
27840053|NCT01475461|54327362|FG001|Run-in Period|Protocol Violation|0|||
27840054|NCT01475461|54327363|FG002|Run-in Period|Protocol Violation|0|||
27840055|NCT01475461|54327364|FG003|Run-in Period|Protocol Violation|0|||
27840056|NCT01475461|54327365|FG004|Run-in Period|Protocol Violation|0|||
27840057|NCT01475461|54327366|FG005|Run-in Period|Protocol Violation|0|||
27840058|NCT01475461|54327367|FG006|Run-in Period|Protocol Violation|0|||
27840059|NCT01475461|54327361|FG000|Treatment Period|Death|0|||
27840060|NCT01475461|54327362|FG001|Treatment Period|Death|0|||
27840061|NCT01475461|54327363|FG002|Treatment Period|Death|0|||
27840062|NCT01475461|54327364|FG003|Treatment Period|Death|1|||
27840063|NCT01475461|54327365|FG004|Treatment Period|Death|0|||
27840064|NCT01475461|54327366|FG005|Treatment Period|Death|0|||
27840065|NCT01475461|54327367|FG006|Treatment Period|Death|0|||
27772382|NCT02499263|54225360|FG000|Overall Study|Participant's decision|3|||
27772383|NCT02499263|54225360|FG000|Overall Study|Pregnancy|1|||
27772384|NCT01654289|54225367|FG000|Overall Study|Withdrawal by Subject|10|||
27772385|NCT01654289|54225368|FG001|Overall Study|Withdrawal by Subject|8|||
27772386|NCT01654289|54225369|FG002|Overall Study|Withdrawal by Subject|5|||
27772387|NCT01654289|54225367|FG000|Overall Study|Withdrew from intervention only|17|||
27772388|NCT01654289|54225368|FG001|Overall Study|Withdrew from intervention only|20|||
27772389|NCT01654289|54225369|FG002|Overall Study|Withdrew from intervention only|0|||
27772390|NCT02499029|54225379|FG000|Overall Study|Lost to Follow-up|2|||
27772391|NCT02499029|54225380|FG001|Overall Study|Lost to Follow-up|2|||
27772392|NCT02499029|54225379|FG000|Overall Study|Physician Decision|2|||
27772393|NCT02499029|54225380|FG001|Overall Study|Physician Decision|1|||
27772394|NCT02499029|54225379|FG000|Overall Study|Death|1|||
27772395|NCT02499029|54225380|FG001|Overall Study|Death|0|||
27926941|NCT01013740|54583421|FG000|Overall Study|study close / terminated : done in error|2|||
27926942|NCT01013740|54583422|FG001|Overall Study|study close / terminated : done in error|1|||
27772399|NCT04968353|54225396|FG000|Overall Study|Non-compliance|1|||
27772400|NCT04968353|54225397|FG001|Overall Study|Non-compliance|0|||
27772401|NCT04968353|54225398|FG002|Overall Study|Non-compliance|2|||
27772402|NCT04968353|54225399|FG003|Overall Study|Non-compliance|0|||
27772403|NCT02065713|54225411|FG000|Overall Study|Adverse Event|0|||
27772404|NCT02065713|54225412|FG001|Overall Study|Adverse Event|1|||
27772405|NCT02065713|54225411|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
27772406|NCT02065713|54225412|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
27772407|NCT02497781|54225420|FG000|Overall Study|Withdrawal by Subject|2|||
27772408|NCT02497781|54225421|FG001|Overall Study|Withdrawal by Subject|0|||
27772409|NCT02497781|54225420|FG000|Overall Study|Lack of Efficacy|0|||
27772410|NCT02497781|54225421|FG001|Overall Study|Lack of Efficacy|1|||
27772411|NCT02497781|54225420|FG000|Overall Study|Randomised but not treated|1|||
27772412|NCT02497781|54225421|FG001|Overall Study|Randomised but not treated|1|||
27772413|NCT02497781|54225420|FG000|Overall Study|Lost to Follow-up|1|||
27772414|NCT02497781|54225421|FG001|Overall Study|Lost to Follow-up|1|||
27772415|NCT02497469|54225429|FG000|Overall Study|Randomized but not Treated|0|||
27772416|NCT02497469|54225430|FG001|Overall Study|Randomized but not Treated|2|||
27772417|NCT02497469|54225429|FG000|Overall Study|Pretreatment Event/Adverse Event|18|||
27772418|NCT02497469|54225430|FG001|Overall Study|Pretreatment Event/Adverse Event|16|||
27772419|NCT02497469|54225429|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
27772420|NCT02497469|54225430|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
27772421|NCT02497469|54225429|FG000|Overall Study|Significant Protocol Deviation|4|||
27772422|NCT02497469|54225430|FG001|Overall Study|Significant Protocol Deviation|5|||
27772423|NCT02497469|54225429|FG000|Overall Study|Lost to Follow-up|14|||
27772424|NCT02497469|54225430|FG001|Overall Study|Lost to Follow-up|4|||
27772425|NCT02497469|54225429|FG000|Overall Study|Voluntary Withdrawal|39|||
27772426|NCT02497469|54225430|FG001|Overall Study|Voluntary Withdrawal|41|||
27772427|NCT02497469|54225429|FG000|Overall Study|Pregnancy|1|||
27772428|NCT02497469|54225430|FG001|Overall Study|Pregnancy|1|||
27772429|NCT02497469|54225429|FG000|Overall Study|Lack of Efficacy|86|||
27772430|NCT02497469|54225430|FG001|Overall Study|Lack of Efficacy|40|||
27772431|NCT02497469|54225429|FG000|Overall Study|Reason not Specified|6|||
27772432|NCT02497469|54225430|FG001|Overall Study|Reason not Specified|6|||
27772433|NCT02497391|54225436|FG000|Period 2 (14 Days)|Withdrawal by Subject|1|||
27772434|NCT02497391|54225437|FG001|Period 2 (14 Days)|Withdrawal by Subject|0|||
27772435|NCT02497391|54225438|FG002|Period 2 (14 Days)|Withdrawal by Subject|1|||
27772436|NCT02497391|54225439|FG003|Period 2 (14 Days)|Withdrawal by Subject|0|||
27772437|NCT02497391|54225440|FG004|Period 2 (14 Days)|Withdrawal by Subject|0|||
27772438|NCT02497391|54225441|FG005|Period 2 (14 Days)|Withdrawal by Subject|0|||
27840066|NCT01475461|54327361|FG000|Treatment Period|Lost to Follow-up|0|||
27840067|NCT01475461|54327362|FG001|Treatment Period|Lost to Follow-up|3|||
27772439|NCT02497391|54225436|FG000|Period 2 (14 Days)|Sponsor Decision|3|||
27772440|NCT02497391|54225437|FG001|Period 2 (14 Days)|Sponsor Decision|1|||
27840068|NCT01475461|54327363|FG002|Treatment Period|Lost to Follow-up|2|||
27772441|NCT02497391|54225438|FG002|Period 2 (14 Days)|Sponsor Decision|2|||
27772442|NCT02497391|54225439|FG003|Period 2 (14 Days)|Sponsor Decision|3|||
27772443|NCT02497391|54225440|FG004|Period 2 (14 Days)|Sponsor Decision|2|||
27772444|NCT02497391|54225441|FG005|Period 2 (14 Days)|Sponsor Decision|3|||
27772445|NCT02497391|54225436|FG000|Period 3 (14 Days)|Adverse Event|0|||
27772446|NCT02497391|54225437|FG001|Period 3 (14 Days)|Adverse Event|1|||
27772447|NCT02497391|54225438|FG002|Period 3 (14 Days)|Adverse Event|0|||
27840069|NCT01475461|54327364|FG003|Treatment Period|Lost to Follow-up|3|||
27840070|NCT01475461|54327365|FG004|Treatment Period|Lost to Follow-up|1|||
27840071|NCT01475461|54327366|FG005|Treatment Period|Lost to Follow-up|2|||
27772448|NCT02497391|54225439|FG003|Period 3 (14 Days)|Adverse Event|0|||
27772449|NCT02497391|54225440|FG004|Period 3 (14 Days)|Adverse Event|0|||
27772450|NCT02497391|54225441|FG005|Period 3 (14 Days)|Adverse Event|0|||
27772451|NCT02497391|54225436|FG000|Period 3 (14 Days)|Sponsor Decision|0|||
27772452|NCT02497391|54225437|FG001|Period 3 (14 Days)|Sponsor Decision|0|||
27772453|NCT02497391|54225438|FG002|Period 3 (14 Days)|Sponsor Decision|0|||
27772454|NCT02497391|54225439|FG003|Period 3 (14 Days)|Sponsor Decision|0|||
27772455|NCT02497391|54225440|FG004|Period 3 (14 Days)|Sponsor Decision|1|||
27772456|NCT02497391|54225441|FG005|Period 3 (14 Days)|Sponsor Decision|0|||
27772457|NCT02497391|54225436|FG000|Period 3 (14 Days)|Withdrawal by Subject|0|||
27772458|NCT02497391|54225437|FG001|Period 3 (14 Days)|Withdrawal by Subject|0|||
27772459|NCT02497391|54225438|FG002|Period 3 (14 Days)|Withdrawal by Subject|1|||
27772460|NCT02497391|54225439|FG003|Period 3 (14 Days)|Withdrawal by Subject|0|||
27772461|NCT02497391|54225440|FG004|Period 3 (14 Days)|Withdrawal by Subject|0|||
27772462|NCT02497391|54225441|FG005|Period 3 (14 Days)|Withdrawal by Subject|0|||
27772463|NCT02476175|54225449|FG000|Overall Study|Adverse Event|2|||
27772464|NCT02065557|54225456|FG000|Induction Period|Withdrawal by Subject|2|||
27772465|NCT02065557|54225457|FG001|Induction Period|Withdrawal by Subject|1|||
27772466|NCT02065557|54225458|FG002|Induction Period|Withdrawal by Subject|0|||
27772467|NCT02065557|54225459|FG003|Induction Period|Withdrawal by Subject|0|||
27772468|NCT02065557|54225460|FG004|Induction Period|Withdrawal by Subject|0|||
27772469|NCT02065557|54225461|FG005|Induction Period|Withdrawal by Subject|0|||
27772470|NCT02065557|54225456|FG000|Induction Period|Lack of Efficacy|2|||
27772471|NCT02065557|54225457|FG001|Induction Period|Lack of Efficacy|1|||
27772472|NCT02065557|54225458|FG002|Induction Period|Lack of Efficacy|1|||
27772473|NCT02065557|54225459|FG003|Induction Period|Lack of Efficacy|0|||
27772474|NCT02065557|54225460|FG004|Induction Period|Lack of Efficacy|0|||
27772475|NCT02065557|54225461|FG005|Induction Period|Lack of Efficacy|0|||
27772476|NCT02065557|54225456|FG000|Induction Period|Requires Alternative/Prohibited Therapy|1|||
27772477|NCT02065557|54225457|FG001|Induction Period|Requires Alternative/Prohibited Therapy|1|||
27772478|NCT02065557|54225458|FG002|Induction Period|Requires Alternative/Prohibited Therapy|1|||
27772479|NCT02065557|54225459|FG003|Induction Period|Requires Alternative/Prohibited Therapy|0|||
27772480|NCT02065557|54225460|FG004|Induction Period|Requires Alternative/Prohibited Therapy|0|||
27772481|NCT02065557|54225461|FG005|Induction Period|Requires Alternative/Prohibited Therapy|0|||
27772482|NCT02065557|54225456|FG000|Induction Period|Non-Responder at Week 8|4|||
27772483|NCT02065557|54225457|FG001|Induction Period|Non-Responder at Week 8|4|||
27772484|NCT02065557|54225458|FG002|Induction Period|Non-Responder at Week 8|0|||
27772485|NCT02065557|54225459|FG003|Induction Period|Non-Responder at Week 8|0|||
27772486|NCT02065557|54225460|FG004|Induction Period|Non-Responder at Week 8|0|||
27772487|NCT02065557|54225461|FG005|Induction Period|Non-Responder at Week 8|0|||
27772488|NCT02065557|54225456|FG000|Induction Period|Adverse Event|1|||
27772489|NCT02065557|54225457|FG001|Induction Period|Adverse Event|1|||
27772490|NCT02065557|54225458|FG002|Induction Period|Adverse Event|0|||
27772491|NCT02065557|54225459|FG003|Induction Period|Adverse Event|0|||
27772492|NCT02065557|54225460|FG004|Induction Period|Adverse Event|0|||
27772493|NCT02065557|54225461|FG005|Induction Period|Adverse Event|0|||
27772494|NCT02065557|54225456|FG000|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
27772495|NCT02065557|54225457|FG001|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
27772496|NCT02065557|54225458|FG002|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
27772497|NCT02065557|54225459|FG003|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
27772498|NCT02065557|54225460|FG004|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
27772499|NCT02065557|54225461|FG005|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
27772500|NCT02065557|54225456|FG000|Maintenance Period|Withdrawal by Subject|0|||
27772501|NCT02065557|54225457|FG001|Maintenance Period|Withdrawal by Subject|0|||
27772502|NCT02065557|54225458|FG002|Maintenance Period|Withdrawal by Subject|0|||
27772503|NCT02065557|54225459|FG003|Maintenance Period|Withdrawal by Subject|0|||
27772504|NCT02065557|54225460|FG004|Maintenance Period|Withdrawal by Subject|2|||
27772505|NCT02065557|54225461|FG005|Maintenance Period|Withdrawal by Subject|1|||
27772506|NCT02065557|54225456|FG000|Maintenance Period|Lack of Efficacy|0|||
27772507|NCT02065557|54225457|FG001|Maintenance Period|Lack of Efficacy|0|||
27772508|NCT02065557|54225458|FG002|Maintenance Period|Lack of Efficacy|0|||
27772509|NCT02065557|54225459|FG003|Maintenance Period|Lack of Efficacy|0|||
27772510|NCT02065557|54225460|FG004|Maintenance Period|Lack of Efficacy|5|||
27772511|NCT02065557|54225461|FG005|Maintenance Period|Lack of Efficacy|2|||
27772512|NCT02065557|54225456|FG000|Maintenance Period|Subject Non-Compliance|0|||
27772513|NCT02065557|54225457|FG001|Maintenance Period|Subject Non-Compliance|0|||
27772514|NCT02065557|54225458|FG002|Maintenance Period|Subject Non-Compliance|0|||
27772515|NCT02065557|54225459|FG003|Maintenance Period|Subject Non-Compliance|0|||
27772516|NCT02065557|54225460|FG004|Maintenance Period|Subject Non-Compliance|0|||
27772517|NCT02065557|54225461|FG005|Maintenance Period|Subject Non-Compliance|1|||
27772518|NCT02065245|54225493|FG000|Infusion 1|Lost to Follow-up|0|||
27772519|NCT02065245|54225494|FG001|Infusion 1|Lost to Follow-up|0|||
27772520|NCT02065245|54225495|FG002|Infusion 1|Lost to Follow-up|0|||
27772521|NCT02065245|54225496|FG003|Infusion 1|Lost to Follow-up|0|||
27772522|NCT02065245|54225497|FG004|Infusion 1|Lost to Follow-up|0|||
27772523|NCT02065245|54225498|FG005|Infusion 1|Lost to Follow-up|0|||
27772524|NCT02065245|54225499|FG006|Infusion 1|Lost to Follow-up|1|||
27772525|NCT02065245|54225493|FG000|Infusion 1|Death|0|||
27772526|NCT02065245|54225494|FG001|Infusion 1|Death|0|||
27772527|NCT02065245|54225495|FG002|Infusion 1|Death|1|||
27772528|NCT02065245|54225496|FG003|Infusion 1|Death|0|||
27772529|NCT02065245|54225497|FG004|Infusion 1|Death|1|||
27772530|NCT02065245|54225498|FG005|Infusion 1|Death|0|||
27772531|NCT02065245|54225499|FG006|Infusion 1|Death|0|||
27772532|NCT02065245|54225493|FG000|Infusion 2|Death|0|||
27772533|NCT02065245|54225494|FG001|Infusion 2|Death|0|||
27772534|NCT02065245|54225495|FG002|Infusion 2|Death|0|||
27772535|NCT02065245|54225496|FG003|Infusion 2|Death|0|||
27772536|NCT02065245|54225497|FG004|Infusion 2|Death|0|||
27772537|NCT02065245|54225498|FG005|Infusion 2|Death|0|||
27772538|NCT02065245|54225499|FG006|Infusion 2|Death|1|||
27772539|NCT02065245|54225493|FG000|Infusion 3|Lost to Follow-up|1|||
27772540|NCT02065245|54225494|FG001|Infusion 3|Lost to Follow-up|1|||
27772541|NCT02065245|54225495|FG002|Infusion 3|Lost to Follow-up|0|||
27772542|NCT02065245|54225496|FG003|Infusion 3|Lost to Follow-up|0|||
27772543|NCT02065245|54225497|FG004|Infusion 3|Lost to Follow-up|0|||
27772544|NCT02065245|54225498|FG005|Infusion 3|Lost to Follow-up|0|||
27772545|NCT02065245|54225499|FG006|Infusion 3|Lost to Follow-up|0|||
27772546|NCT02043015|54225515|FG000|Overall Study|Lost to Follow-up|4|||
27772547|NCT02043015|54225515|FG000|Overall Study|Withdrawal by Subject|4|||
27772548|NCT02043015|54225515|FG000|Overall Study|Removed once target enrollment reached|15|||
27772549|NCT02043015|54225515|FG000|Overall Study|Participant moved away from study city|4|||
27772550|NCT02043015|54225515|FG000|Overall Study|Incarceration|1|||
27772551|NCT02064231|54225521|FG000|First Test Period (Test A or Test C)|Lack of Efficacy|5|||
27772552|NCT02064231|54225522|FG001|First Test Period (Test A or Test C)|Lack of Efficacy|3|||
27772553|NCT02064231|54225523|FG002|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
27772554|NCT02064231|54225524|FG003|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
27772555|NCT02064231|54225521|FG000|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
27772556|NCT02064231|54225522|FG001|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
27772557|NCT02064231|54225523|FG002|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
27772558|NCT02064231|54225524|FG003|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
27772559|NCT02064231|54225521|FG000|First Test Period (Test A or Test C)|Adverse Event|1|||
27772560|NCT02064231|54225522|FG001|First Test Period (Test A or Test C)|Adverse Event|0|||
27772561|NCT02064231|54225523|FG002|First Test Period (Test A or Test C)|Adverse Event|1|||
27772562|NCT02064231|54225524|FG003|First Test Period (Test A or Test C)|Adverse Event|0|||
27772563|NCT02064231|54225521|FG000|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
27772564|NCT02064231|54225522|FG001|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
27772565|NCT02064231|54225523|FG002|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
27772566|NCT02064231|54225524|FG003|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
27772567|NCT02063217|54225539|FG000|Overall Study|Withdrawal by Subject|1|||
27772568|NCT02063217|54225540|FG001|Overall Study|Withdrawal by Subject|0|||
27772569|NCT02063217|54225541|FG002|Overall Study|Withdrawal by Subject|0|||
27772570|NCT02497001|54225553|FG000|Overall Study|Lost to Follow-up|10|||
27772571|NCT02497001|54225554|FG001|Overall Study|Lost to Follow-up|2|||
27772572|NCT02497001|54225555|FG002|Overall Study|Lost to Follow-up|0|||
27772573|NCT02497001|54225556|FG003|Overall Study|Lost to Follow-up|2|||
27772574|NCT02497001|54225553|FG000|Overall Study|Adverse Event|28|||
27772575|NCT02497001|54225554|FG001|Overall Study|Adverse Event|30|||
27772576|NCT02497001|54225555|FG002|Overall Study|Adverse Event|11|||
27772577|NCT02497001|54225556|FG003|Overall Study|Adverse Event|11|||
27772578|NCT02497001|54225553|FG000|Overall Study|Withdrawal by Subject|14|||
27772579|NCT02497001|54225554|FG001|Overall Study|Withdrawal by Subject|37|||
27772580|NCT02497001|54225555|FG002|Overall Study|Withdrawal by Subject|19|||
27772581|NCT02497001|54225556|FG003|Overall Study|Withdrawal by Subject|15|||
27772582|NCT02497001|54225553|FG000|Overall Study|Physician Decision|5|||
27772583|NCT02497001|54225554|FG001|Overall Study|Physician Decision|11|||
27772584|NCT02497001|54225555|FG002|Overall Study|Physician Decision|5|||
27772585|NCT02497001|54225556|FG003|Overall Study|Physician Decision|1|||
27772586|NCT02497001|54225553|FG000|Overall Study|subjects that were not treated|1|||
27772587|NCT02497001|54225554|FG001|Overall Study|subjects that were not treated|2|||
27840072|NCT01475461|54327367|FG006|Treatment Period|Lost to Follow-up|1|||
27840073|NCT01475461|54327361|FG000|Treatment Period|Withdrawal by Subject|0|||
27840074|NCT01475461|54327362|FG001|Treatment Period|Withdrawal by Subject|2|||
27772588|NCT02497001|54225555|FG002|Overall Study|subjects that were not treated|2|||
27772589|NCT02497001|54225556|FG003|Overall Study|subjects that were not treated|1|||
27840075|NCT01475461|54327363|FG002|Treatment Period|Withdrawal by Subject|2|||
27772590|NCT02497001|54225553|FG000|Overall Study|Major Protocol Deviation|3|||
27772591|NCT02497001|54225554|FG001|Overall Study|Major Protocol Deviation|4|||
27772592|NCT02497001|54225555|FG002|Overall Study|Major Protocol Deviation|4|||
27772593|NCT02497001|54225556|FG003|Overall Study|Major Protocol Deviation|4|||
27772594|NCT02497001|54225553|FG000|Overall Study|Lack of Efficacy|10|||
27772595|NCT02497001|54225554|FG001|Overall Study|Lack of Efficacy|16|||
27772596|NCT02497001|54225555|FG002|Overall Study|Lack of Efficacy|6|||
27772597|NCT02497001|54225556|FG003|Overall Study|Lack of Efficacy|6|||
27772598|NCT02497001|54225553|FG000|Overall Study|Protocol Violation|3|||
27772599|NCT02497001|54225554|FG001|Overall Study|Protocol Violation|1|||
27772600|NCT02497001|54225555|FG002|Overall Study|Protocol Violation|3|||
27772601|NCT02497001|54225556|FG003|Overall Study|Protocol Violation|1|||
27772602|NCT02366143|54225572|FG000|Overall Study|Death|307|||
27772603|NCT02366143|54225573|FG001|Overall Study|Death|278|||
27772604|NCT02366143|54225574|FG002|Overall Study|Death|280|||
27772605|NCT02366143|54225572|FG000|Overall Study|Lost to Follow-up|2|||
27772606|NCT02366143|54225573|FG001|Overall Study|Lost to Follow-up|4|||
27772607|NCT02366143|54225574|FG002|Overall Study|Lost to Follow-up|2|||
27772608|NCT02366143|54225572|FG000|Overall Study|Physician Decision|1|||
27772609|NCT02366143|54225573|FG001|Overall Study|Physician Decision|2|||
27772610|NCT02366143|54225574|FG002|Overall Study|Physician Decision|1|||
27772611|NCT02366143|54225572|FG000|Overall Study|Protocol Violation|0|||
27772612|NCT02366143|54225573|FG001|Overall Study|Protocol Violation|0|||
27772613|NCT02366143|54225574|FG002|Overall Study|Protocol Violation|2|||
27772614|NCT02366143|54225572|FG000|Overall Study|Withdrawal by Subject|16|||
27772615|NCT02366143|54225573|FG001|Overall Study|Withdrawal by Subject|17|||
27772616|NCT02366143|54225574|FG002|Overall Study|Withdrawal by Subject|22|||
27772617|NCT02366143|54225572|FG000|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
27772618|NCT02366143|54225573|FG001|Overall Study|Sponsor request to withdraw/discontinue patient|6|||
27772619|NCT02366143|54225574|FG002|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
27772620|NCT02366143|54225572|FG000|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
27772621|NCT02366143|54225573|FG001|Overall Study|Increased Microscopic RBCS on Urinalysis|1|||
27772622|NCT02366143|54225574|FG002|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
27772623|NCT02366143|54225572|FG000|Overall Study|Randomization Error|1|||
27772624|NCT02366143|54225573|FG001|Overall Study|Randomization Error|0|||
27772625|NCT02366143|54225574|FG002|Overall Study|Randomization Error|0|||
27772626|NCT02366143|54225572|FG000|Overall Study|PI Move and Site Closure|1|||
27772627|NCT02366143|54225573|FG001|Overall Study|PI Move and Site Closure|0|||
27772628|NCT02366143|54225574|FG002|Overall Study|PI Move and Site Closure|1|||
27772629|NCT02366143|54225572|FG000|Overall Study|Study Terminated By Sponsor|0|||
27772630|NCT02366143|54225573|FG001|Overall Study|Study Terminated By Sponsor|0|||
27772631|NCT02366143|54225574|FG002|Overall Study|Study Terminated By Sponsor|2|||
27772632|NCT02366143|54225572|FG000|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|70|||
27772633|NCT02366143|54225573|FG001|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|57|||
27772634|NCT02366143|54225574|FG002|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|52|||
27772635|NCT02366143|54225572|FG000|Overall Study|Patient moved to roll-over study|1|||
27772636|NCT02366143|54225573|FG001|Overall Study|Patient moved to roll-over study|19|||
27772637|NCT02366143|54225574|FG002|Overall Study|Patient moved to roll-over study|28|||
27772638|NCT02366143|54225572|FG000|Overall Study|Patient moved to commercial stock|0|||
27772639|NCT02366143|54225573|FG001|Overall Study|Patient moved to commercial stock|0|||
27772640|NCT02366143|54225574|FG002|Overall Study|Patient moved to commercial stock|1|||
27772641|NCT02366143|54225572|FG000|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
27772642|NCT02366143|54225573|FG001|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
27772643|NCT02366143|54225574|FG002|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|1|||
27772644|NCT02366143|54225572|FG000|Overall Study|Patient rolling over to patient assistance program|0|||
27772645|NCT02366143|54225573|FG001|Overall Study|Patient rolling over to patient assistance program|0|||
27772646|NCT02366143|54225574|FG002|Overall Study|Patient rolling over to patient assistance program|1|||
27772647|NCT02366143|54225572|FG000|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
27772648|NCT02366143|54225573|FG001|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
27772649|NCT02366143|54225574|FG002|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|1|||
27772650|NCT02366143|54225572|FG000|Overall Study|Requester's instructions|1|||
27772651|NCT02366143|54225573|FG001|Overall Study|Requester's instructions|1|||
27772652|NCT02366143|54225574|FG002|Overall Study|Requester's instructions|1|||
27772653|NCT02366143|54225572|FG000|Overall Study|Uneligible|0|||
27772654|NCT02366143|54225573|FG001|Overall Study|Uneligible|1|||
27772655|NCT02366143|54225574|FG002|Overall Study|Uneligible|0|||
27772656|NCT02366143|54225572|FG000|Overall Study|Post Trial Migration|0|||
27772657|NCT02366143|54225573|FG001|Overall Study|Post Trial Migration|1|||
27772658|NCT02366143|54225574|FG002|Overall Study|Post Trial Migration|0|||
27772659|NCT02366143|54225572|FG000|Overall Study|Patient moving onto PTAP commercial stock|0|||
27772660|NCT02366143|54225573|FG001|Overall Study|Patient moving onto PTAP commercial stock|1|||
27772661|NCT02366143|54225574|FG002|Overall Study|Patient moving onto PTAP commercial stock|0|||
27772662|NCT02366143|54225572|FG000|Overall Study|Patient switched to PTAP|0|||
27772663|NCT02366143|54225573|FG001|Overall Study|Patient switched to PTAP|1|||
27772664|NCT02366143|54225574|FG002|Overall Study|Patient switched to PTAP|0|||
27772665|NCT02366143|54225572|FG000|Overall Study|Patient moved to commercial atezolizumab use|0|||
27772666|NCT02366143|54225573|FG001|Overall Study|Patient moved to commercial atezolizumab use|11|||
27772667|NCT02366143|54225574|FG002|Overall Study|Patient moved to commercial atezolizumab use|7|||
27772668|NCT02098395|54225590|FG000|Overall Study|Protocol Violation|2|||
27772669|NCT02098395|54225591|FG001|Overall Study|Protocol Violation|2|||
27772670|NCT02098395|54225592|FG002|Overall Study|Protocol Violation|0|||
27772671|NCT02098395|54225593|FG003|Overall Study|Protocol Violation|7|||
27772672|NCT02098395|54225590|FG000|Overall Study|Withdrawal by Subject|10|||
27772673|NCT02098395|54225591|FG001|Overall Study|Withdrawal by Subject|10|||
27772674|NCT02098395|54225592|FG002|Overall Study|Withdrawal by Subject|5|||
27772675|NCT02098395|54225593|FG003|Overall Study|Withdrawal by Subject|13|||
27772676|NCT02098395|54225590|FG000|Overall Study|Adverse Event|12|||
27772677|NCT02098395|54225591|FG001|Overall Study|Adverse Event|19|||
27772678|NCT02098395|54225592|FG002|Overall Study|Adverse Event|34|||
27772679|NCT02098395|54225593|FG003|Overall Study|Adverse Event|2|||
27772680|NCT02098395|54225590|FG000|Overall Study|Lost to Follow-up|2|||
27772681|NCT02098395|54225591|FG001|Overall Study|Lost to Follow-up|1|||
27772682|NCT02098395|54225592|FG002|Overall Study|Lost to Follow-up|0|||
27772683|NCT02098395|54225593|FG003|Overall Study|Lost to Follow-up|3|||
27772684|NCT02098395|54225590|FG000|Overall Study|Unclassified|0|||
27772685|NCT02098395|54225591|FG001|Overall Study|Unclassified|0|||
27772686|NCT02098395|54225592|FG002|Overall Study|Unclassified|3|||
27772687|NCT02098395|54225593|FG003|Overall Study|Unclassified|2|||
27772688|NCT02041923|54225605|FG000|Overall Study|Lost to Follow-up|26|||
27772689|NCT02041923|54225606|FG001|Overall Study|Lost to Follow-up|30|||
27772690|NCT02062437|54225614|FG000|Overall Study|Pt. didn't want to come for the 2y visit|31|||
27772691|NCT02062437|54225614|FG000|Overall Study|Patient not available for the 2y visit|18|||
27772692|NCT02062437|54225614|FG000|Overall Study|Death|2|||
27772693|NCT02062437|54225614|FG000|Overall Study|Pt. couldn't come due to med. condition|1|||
27772694|NCT02365519|54225620|FG000|Randomized and Treated|Adverse Event|0|||
27772695|NCT02365519|54225621|FG001|Randomized and Treated|Adverse Event|1|||
27772696|NCT02365519|54225622|FG002|Randomized and Treated|Adverse Event|0|||
27772697|NCT02365519|54225620|FG000|Randomized and Treated|Withdrawal by Subject|0|||
27772698|NCT02365519|54225621|FG001|Randomized and Treated|Withdrawal by Subject|1|||
27772699|NCT02365519|54225622|FG002|Randomized and Treated|Withdrawal by Subject|1|||
27772700|NCT02061813|54225631|FG000|Overall Study|Withdrawal by Subject|1|||
27772701|NCT02061813|54225631|FG000|Overall Study|Protocol Violation|2|||
27772702|NCT02096835|54225641|FG000|Overall Study|Withdrawal by Subject|1|||
27772703|NCT02096835|54225642|FG001|Overall Study|Withdrawal by Subject|0|||
27772704|NCT02096835|54225643|FG002|Overall Study|Withdrawal by Subject|0|||
27772705|NCT02096835|54225641|FG000|Overall Study|converted to open procedures|1|||
27772706|NCT02096835|54225642|FG001|Overall Study|converted to open procedures|0|||
27772707|NCT02096835|54225643|FG002|Overall Study|converted to open procedures|0|||
27772708|NCT02096835|54225641|FG000|Overall Study|Lost to Follow-up|1|||
27772709|NCT02096835|54225642|FG001|Overall Study|Lost to Follow-up|0|||
27772710|NCT02096835|54225643|FG002|Overall Study|Lost to Follow-up|1|||
27772711|NCT02324569|54225653|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
27772712|NCT02324569|54225654|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
27772713|NCT02324569|54225653|FG000|Overall Study|Voluntary Withdrawal|3|||
27772714|NCT02324569|54225654|FG001|Overall Study|Voluntary Withdrawal|6|||
27772715|NCT02324569|54225653|FG000|Overall Study|Lack of Efficacy|2|||
27772716|NCT02324569|54225654|FG001|Overall Study|Lack of Efficacy|3|||
27772717|NCT02324569|54225653|FG000|Overall Study|Change Insulin Dosage Exceeding Criteria|0|||
27772718|NCT02324569|54225654|FG001|Overall Study|Change Insulin Dosage Exceeding Criteria|2|||
27772719|NCT02324569|54225653|FG000|Overall Study|Inconvenient Schedule|2|||
27772720|NCT02324569|54225654|FG001|Overall Study|Inconvenient Schedule|0|||
27772721|NCT02294773|54225662|FG000|Overall Study|Withdrawal by Subject|0|||
27772722|NCT02294773|54225663|FG001|Overall Study|Withdrawal by Subject|2|||
27772723|NCT02365285|54225673|FG000|Overall Study|Physician Decision|0|||
27772724|NCT02365285|54225674|FG001|Overall Study|Physician Decision|1|||
27772725|NCT02365285|54225675|FG002|Overall Study|Physician Decision|1|||
27772726|NCT02365285|54225676|FG003|Overall Study|Physician Decision|0|||
27772727|NCT02365285|54225673|FG000|Overall Study|Adverse Event|0|||
27772728|NCT02365285|54225674|FG001|Overall Study|Adverse Event|0|||
27772729|NCT02365285|54225675|FG002|Overall Study|Adverse Event|0|||
27772730|NCT02365285|54225676|FG003|Overall Study|Adverse Event|2|||
27772731|NCT02041299|54225690|FG000|Overall Study|Adverse Event|9|||
27772732|NCT02041299|54225691|FG001|Overall Study|Adverse Event|3|||
27772733|NCT02041299|54225690|FG000|Overall Study|Lost to Follow-up|4|||
27772734|NCT02041299|54225691|FG001|Overall Study|Lost to Follow-up|1|||
27772735|NCT02041299|54225690|FG000|Overall Study|Physician Decision|1|||
27772736|NCT02041299|54225691|FG001|Overall Study|Physician Decision|1|||
27772737|NCT02041299|54225690|FG000|Overall Study|Withdrawal by Subject|13|||
27772738|NCT02041299|54225691|FG001|Overall Study|Withdrawal by Subject|7|||
27772739|NCT02041299|54225690|FG000|Overall Study|Protocol Violation|11|||
27772740|NCT02041299|54225691|FG001|Overall Study|Protocol Violation|4|||
27772741|NCT02041299|54225690|FG000|Overall Study|Termination of the study|7|||
27772742|NCT02041299|54225691|FG001|Overall Study|Termination of the study|3|||
27772743|NCT02041299|54225690|FG000|Overall Study|Required bone marrow transplant|0|||
27772744|NCT02041299|54225691|FG001|Overall Study|Required bone marrow transplant|1|||
27772745|NCT02041299|54225690|FG000|Overall Study|Patient stopped dosing on unknown date|1|||
27772746|NCT02041299|54225691|FG001|Overall Study|Patient stopped dosing on unknown date|0|||
27772747|NCT01645735|54225703|FG000|Overall Study|Physician Decision|2|||
27772748|NCT01645735|54225704|FG001|Overall Study|Physician Decision|0|||
27772749|NCT01645735|54225703|FG000|Overall Study|Withdrawal by Subject|1|||
27772750|NCT01645735|54225704|FG001|Overall Study|Withdrawal by Subject|0|||
27772751|NCT01645735|54225703|FG000|Overall Study|Protocol Violation|1|||
27772752|NCT01645735|54225704|FG001|Overall Study|Protocol Violation|0|||
27772753|NCT01645735|54225703|FG000|Overall Study|Adverse Event|0|||
27772754|NCT01645735|54225704|FG001|Overall Study|Adverse Event|1|||
27772755|NCT02365207|54225711|FG000|Overall Study|Withdrawal by Subject|1|||
27772756|NCT02365207|54225711|FG000|Overall Study|Physician Decision|1|||
27772757|NCT01645111|54225715|FG000|Overall Study|Did not require Clevidipine|15|||
27772758|NCT02364037|54225721|FG000|Overall Study|Withdrawal by Subject|7|||
27772759|NCT02364037|54225722|FG001|Overall Study|Withdrawal by Subject|4|||
27772760|NCT02364037|54225721|FG000|Overall Study|Lost to Follow-up|37|||
27772761|NCT02364037|54225722|FG001|Overall Study|Lost to Follow-up|49|||
27772762|NCT01919164|54225733|FG000|Overall Study|Adverse Event|6|||
27772763|NCT01919164|54225734|FG001|Overall Study|Adverse Event|4|||
27772764|NCT01919164|54225735|FG002|Overall Study|Adverse Event|9|||
27772765|NCT01919164|54225736|FG003|Overall Study|Adverse Event|3|||
27772766|NCT01919164|54225737|FG004|Overall Study|Adverse Event|2|||
27772767|NCT01919164|54225733|FG000|Overall Study|Lost to Follow-up|2|||
27772768|NCT01919164|54225734|FG001|Overall Study|Lost to Follow-up|2|||
27772769|NCT01919164|54225735|FG002|Overall Study|Lost to Follow-up|2|||
27772770|NCT01919164|54225736|FG003|Overall Study|Lost to Follow-up|0|||
27772771|NCT01919164|54225737|FG004|Overall Study|Lost to Follow-up|4|||
27772772|NCT01919164|54225733|FG000|Overall Study|Death|1|||
27772773|NCT01919164|54225734|FG001|Overall Study|Death|0|||
27772774|NCT01919164|54225735|FG002|Overall Study|Death|0|||
27772775|NCT01919164|54225736|FG003|Overall Study|Death|0|||
27772776|NCT01919164|54225737|FG004|Overall Study|Death|0|||
27772777|NCT01919164|54225733|FG000|Overall Study|Protocol Violation|6|||
27772778|NCT01919164|54225734|FG001|Overall Study|Protocol Violation|0|||
27772779|NCT01919164|54225735|FG002|Overall Study|Protocol Violation|3|||
27772780|NCT01919164|54225736|FG003|Overall Study|Protocol Violation|2|||
27772781|NCT01919164|54225737|FG004|Overall Study|Protocol Violation|2|||
27772782|NCT01919164|54225733|FG000|Overall Study|Disease progression|2|||
27772783|NCT01919164|54225734|FG001|Overall Study|Disease progression|2|||
27772784|NCT01919164|54225735|FG002|Overall Study|Disease progression|1|||
27772785|NCT01919164|54225736|FG003|Overall Study|Disease progression|2|||
27772786|NCT01919164|54225737|FG004|Overall Study|Disease progression|1|||
27772787|NCT01919164|54225733|FG000|Overall Study|Withdrew consent|13|||
27772788|NCT01919164|54225734|FG001|Overall Study|Withdrew consent|13|||
27772789|NCT01919164|54225735|FG002|Overall Study|Withdrew consent|14|||
27772790|NCT01919164|54225736|FG003|Overall Study|Withdrew consent|14|||
27772791|NCT01919164|54225737|FG004|Overall Study|Withdrew consent|9|||
27772792|NCT01919164|54225733|FG000|Overall Study|Other Un-specified|13|||
27772793|NCT01919164|54225734|FG001|Overall Study|Other Un-specified|9|||
27772794|NCT01919164|54225735|FG002|Overall Study|Other Un-specified|8|||
27772795|NCT01919164|54225736|FG003|Overall Study|Other Un-specified|7|||
27772796|NCT01919164|54225737|FG004|Overall Study|Other Un-specified|15|||
27772797|NCT01901224|54225749|FG000|Overall Study|study was not funded and terminated|2|||
27772798|NCT01901146|54225755|FG000|Neoadjuvant Phase|Death|1|||
27772799|NCT01901146|54225756|FG001|Neoadjuvant Phase|Death|2|||
27772800|NCT01901146|54225757|FG002|Neoadjuvant Phase|Death|0|||
27772801|NCT01901146|54225758|FG003|Neoadjuvant Phase|Death|0|||
27772802|NCT01901146|54225759|FG004|Neoadjuvant Phase|Death|0|||
27840076|NCT01475461|54327364|FG003|Treatment Period|Withdrawal by Subject|0|||
27840077|NCT01475461|54327365|FG004|Treatment Period|Withdrawal by Subject|2|||
27772803|NCT01901146|54225755|FG000|Neoadjuvant Phase|Disease Progression or Recurrence|2|||
27772804|NCT01901146|54225756|FG001|Neoadjuvant Phase|Disease Progression or Recurrence|3|||
27772805|NCT01901146|54225757|FG002|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
27772806|NCT01901146|54225758|FG003|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
27772807|NCT01901146|54225759|FG004|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
27772808|NCT01901146|54225755|FG000|Neoadjuvant Phase|Lost to Follow-up|0|||
27772809|NCT01901146|54225756|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
27772810|NCT01901146|54225757|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
27840078|NCT01475461|54327366|FG005|Treatment Period|Withdrawal by Subject|2|||
27772811|NCT01901146|54225758|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
27772812|NCT01901146|54225759|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
27772813|NCT01901146|54225755|FG000|Neoadjuvant Phase|Physician Decision|1|||
27772814|NCT01901146|54225756|FG001|Neoadjuvant Phase|Physician Decision|2|||
27772815|NCT01901146|54225757|FG002|Neoadjuvant Phase|Physician Decision|0|||
27772816|NCT01901146|54225758|FG003|Neoadjuvant Phase|Physician Decision|0|||
27772817|NCT01901146|54225759|FG004|Neoadjuvant Phase|Physician Decision|0|||
27772818|NCT01901146|54225755|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
27772819|NCT01901146|54225756|FG001|Neoadjuvant Phase|Withdrawal by Subject|5|||
27772820|NCT01901146|54225757|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
27772821|NCT01901146|54225758|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
27772822|NCT01901146|54225759|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
27772823|NCT01901146|54225755|FG000|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
27772824|NCT01901146|54225756|FG001|Neoadjuvant Phase|Requirement for Alternative Therapy|1|||
27772825|NCT01901146|54225757|FG002|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
27772826|NCT01901146|54225758|FG003|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
27772827|NCT01901146|54225759|FG004|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
27772828|NCT01901146|54225755|FG000|Adjuvant Phase|Other|0|||
27772829|NCT01901146|54225756|FG001|Adjuvant Phase|Other|0|||
27772830|NCT01901146|54225757|FG002|Adjuvant Phase|Other|1|||
27772831|NCT01901146|54225758|FG003|Adjuvant Phase|Other|0|||
27772832|NCT01901146|54225759|FG004|Adjuvant Phase|Other|0|||
27772833|NCT01901146|54225755|FG000|Adjuvant Phase|Death|0|||
27772834|NCT01901146|54225756|FG001|Adjuvant Phase|Death|0|||
27772835|NCT01901146|54225757|FG002|Adjuvant Phase|Death|0|||
27772836|NCT01901146|54225758|FG003|Adjuvant Phase|Death|0|||
27772837|NCT01901146|54225759|FG004|Adjuvant Phase|Death|3|||
27772838|NCT01901146|54225755|FG000|Adjuvant Phase|Disease Progression or Recurrence|0|||
27772839|NCT01901146|54225756|FG001|Adjuvant Phase|Disease Progression or Recurrence|0|||
27772840|NCT01901146|54225757|FG002|Adjuvant Phase|Disease Progression or Recurrence|12|||
27772841|NCT01901146|54225758|FG003|Adjuvant Phase|Disease Progression or Recurrence|4|||
27772842|NCT01901146|54225759|FG004|Adjuvant Phase|Disease Progression or Recurrence|3|||
27772843|NCT01901146|54225755|FG000|Adjuvant Phase|Physician Decision|0|||
27772844|NCT01901146|54225756|FG001|Adjuvant Phase|Physician Decision|0|||
27772845|NCT01901146|54225757|FG002|Adjuvant Phase|Physician Decision|9|||
27772846|NCT01901146|54225758|FG003|Adjuvant Phase|Physician Decision|2|||
27772847|NCT01901146|54225759|FG004|Adjuvant Phase|Physician Decision|4|||
27772848|NCT01901146|54225755|FG000|Adjuvant Phase|Withdrawal by Subject|0|||
27772849|NCT01901146|54225756|FG001|Adjuvant Phase|Withdrawal by Subject|0|||
27772850|NCT01901146|54225757|FG002|Adjuvant Phase|Withdrawal by Subject|4|||
27772851|NCT01901146|54225758|FG003|Adjuvant Phase|Withdrawal by Subject|1|||
27772852|NCT01901146|54225759|FG004|Adjuvant Phase|Withdrawal by Subject|4|||
27772853|NCT01644643|54225772|FG000|Overall Study|Death|1|||
27772854|NCT01644643|54225773|FG001|Overall Study|Death|0|||
27840079|NCT01475461|54327367|FG006|Treatment Period|Withdrawal by Subject|0|||
27840080|NCT01475461|54327361|FG000|Treatment Period|Other|0|||
27840081|NCT01475461|54327362|FG001|Treatment Period|Other|1|||
27840082|NCT01475461|54327363|FG002|Treatment Period|Other|0|||
27840083|NCT01475461|54327364|FG003|Treatment Period|Other|0|||
27840084|NCT01475461|54327365|FG004|Treatment Period|Other|0|||
27772855|NCT01644643|54225774|FG002|Overall Study|Death|3|||
27772856|NCT01644643|54225775|FG003|Overall Study|Death|3|||
27772857|NCT01644643|54225772|FG000|Overall Study|Lost to Follow-up|0|||
27772858|NCT01644643|54225773|FG001|Overall Study|Lost to Follow-up|0|||
27772859|NCT01644643|54225774|FG002|Overall Study|Lost to Follow-up|0|||
27772860|NCT01644643|54225775|FG003|Overall Study|Lost to Follow-up|4|||
27840085|NCT01475461|54327366|FG005|Treatment Period|Other|0|||
27840086|NCT01475461|54327367|FG006|Treatment Period|Other|0|||
27840087|NCT01475461|54327361|FG000|Treatment Period|Protocol Violation|0|||
27840088|NCT01475461|54327362|FG001|Treatment Period|Protocol Violation|1|||
27840089|NCT01475461|54327363|FG002|Treatment Period|Protocol Violation|0|||
27840090|NCT01475461|54327364|FG003|Treatment Period|Protocol Violation|0|||
27840091|NCT01475461|54327365|FG004|Treatment Period|Protocol Violation|0|||
27840092|NCT01475461|54327366|FG005|Treatment Period|Protocol Violation|0|||
27840093|NCT01475461|54327367|FG006|Treatment Period|Protocol Violation|1|||
27840094|NCT01475461|54327361|FG000|Treatment Period|Lack of Efficacy|0|||
27840095|NCT01475461|54327362|FG001|Treatment Period|Lack of Efficacy|2|||
27840096|NCT01475461|54327363|FG002|Treatment Period|Lack of Efficacy|0|||
27840097|NCT01475461|54327364|FG003|Treatment Period|Lack of Efficacy|2|||
27840098|NCT01475461|54327365|FG004|Treatment Period|Lack of Efficacy|1|||
27840099|NCT01475461|54327366|FG005|Treatment Period|Lack of Efficacy|1|||
27840100|NCT01475461|54327367|FG006|Treatment Period|Lack of Efficacy|0|||
27840101|NCT01475461|54327361|FG000|Treatment Period|Medication Error|0|||
27840102|NCT01475461|54327362|FG001|Treatment Period|Medication Error|0|||
27840103|NCT01475461|54327363|FG002|Treatment Period|Medication Error|0|||
27772861|NCT01644643|54225772|FG000|Overall Study|Withdrawal by Subject|1|||
27772862|NCT01644643|54225773|FG001|Overall Study|Withdrawal by Subject|0|||
27772863|NCT01644643|54225774|FG002|Overall Study|Withdrawal by Subject|2|||
27840104|NCT01475461|54327364|FG003|Treatment Period|Medication Error|1|||
27840105|NCT01475461|54327365|FG004|Treatment Period|Medication Error|0|||
27840106|NCT01475461|54327366|FG005|Treatment Period|Medication Error|0|||
27840107|NCT01475461|54327367|FG006|Treatment Period|Medication Error|0|||
27840108|NCT01475461|54327361|FG000|Treatment Period|Adverse Event|0|||
27840109|NCT01475461|54327362|FG001|Treatment Period|Adverse Event|0|||
27840110|NCT01475461|54327363|FG002|Treatment Period|Adverse Event|0|||
27840111|NCT01475461|54327364|FG003|Treatment Period|Adverse Event|1|||
27840112|NCT01475461|54327365|FG004|Treatment Period|Adverse Event|0|||
27840113|NCT01475461|54327366|FG005|Treatment Period|Adverse Event|0|||
27840114|NCT01475461|54327367|FG006|Treatment Period|Adverse Event|0|||
27772864|NCT01644643|54225775|FG003|Overall Study|Withdrawal by Subject|1|||
27772865|NCT01644643|54225772|FG000|Overall Study|Other Eligibility criteria|0|||
27772866|NCT01644643|54225773|FG001|Overall Study|Other Eligibility criteria|0|||
27772867|NCT01644643|54225774|FG002|Overall Study|Other Eligibility criteria|0|||
27772868|NCT01644643|54225775|FG003|Overall Study|Other Eligibility criteria|2|||
27772869|NCT01864564|54225793|FG000|Overall Study|Lost to Follow-up|17|||
27772870|NCT01864564|54225794|FG001|Overall Study|Lost to Follow-up|23|||
27772871|NCT01864564|54225793|FG000|Overall Study|Withdrawal by Subject|20|||
27772872|NCT01864564|54225794|FG001|Overall Study|Withdrawal by Subject|11|||
27772873|NCT01864564|54225793|FG000|Overall Study|Protocol Violation|0|||
27772874|NCT01864564|54225794|FG001|Overall Study|Protocol Violation|27|||
27772875|NCT01864564|54225793|FG000|Overall Study|not reported|0|||
27772876|NCT01864564|54225794|FG001|Overall Study|not reported|34|||
27772877|NCT01864174|54225802|FG000|Double Blind Treatment - All Treated|Removed due to site non-compliance|15|||
27772878|NCT01864174|54225803|FG001|Double Blind Treatment - All Treated|Removed due to site non-compliance|14|||
27772879|NCT01864174|54225802|FG000|Double Blind - Compliant Randomized|Adverse Event|6|||
27772880|NCT01864174|54225803|FG001|Double Blind - Compliant Randomized|Adverse Event|1|||
27772881|NCT01864174|54225802|FG000|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2|||
27772882|NCT01864174|54225803|FG001|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0|||
27772883|NCT01864174|54225802|FG000|Double Blind - Compliant Randomized|Subject Withdrew Consent|4|||
27772884|NCT01864174|54225803|FG001|Double Blind - Compliant Randomized|Subject Withdrew Consent|5|||
27772885|NCT01864174|54225802|FG000|Double Blind - Compliant Randomized|Death|1|||
27772886|NCT01864174|54225803|FG001|Double Blind - Compliant Randomized|Death|0|||
27772887|NCT01864174|54225802|FG000|Double Blind - Compliant Randomized|Lost to Follow-up|3|||
27772888|NCT01864174|54225803|FG001|Double Blind - Compliant Randomized|Lost to Follow-up|10|||
27772889|NCT01864174|54225802|FG000|Double Blind - Compliant Randomized|Poor/Non-compliance|1|||
27772890|NCT01864174|54225803|FG001|Double Blind - Compliant Randomized|Poor/Non-compliance|0|||
27772891|NCT01864174|54225802|FG000|Double Blind - Compliant Randomized|Other|6|||
27772892|NCT01864174|54225803|FG001|Double Blind - Compliant Randomized|Other|10|||
27772893|NCT01864174|54225802|FG000|Off Treatment Follow-Up|Other|2|||
27772894|NCT01864174|54225803|FG001|Off Treatment Follow-Up|Other|0|||
27772895|NCT01864174|54225802|FG000|Off Treatment Follow-Up|Subject Withdrew Consent|1|||
27772896|NCT01864174|54225803|FG001|Off Treatment Follow-Up|Subject Withdrew Consent|0|||
27772897|NCT01900444|54225809|FG000|Overall Study|Protocol Violation|2|||
27772898|NCT01900444|54225809|FG000|Overall Study|Lost to Follow-up|1|||
27772899|NCT02294227|54225816|FG000|Overall Study|Death|0|||
27772900|NCT02294227|54225817|FG001|Overall Study|Death|0|||
27772901|NCT02294227|54225818|FG002|Overall Study|Death|1|||
27772902|NCT02294227|54225816|FG000|Overall Study|Subject/Guardian Decision|6|||
27772903|NCT02294227|54225817|FG001|Overall Study|Subject/Guardian Decision|3|||
27772904|NCT02294227|54225818|FG002|Overall Study|Subject/Guardian Decision|7|||
27772905|NCT02294227|54225816|FG000|Overall Study|Physician Decision|1|||
27772906|NCT02294227|54225817|FG001|Overall Study|Physician Decision|2|||
27772907|NCT02294227|54225818|FG002|Overall Study|Physician Decision|1|||
27772908|NCT02294227|54225816|FG000|Overall Study|Lost to Follow-up|1|||
27772909|NCT02294227|54225817|FG001|Overall Study|Lost to Follow-up|0|||
27772910|NCT02294227|54225818|FG002|Overall Study|Lost to Follow-up|0|||
27772911|NCT02294227|54225816|FG000|Overall Study|Lack of Efficacy|11|||
27772912|NCT02294227|54225817|FG001|Overall Study|Lack of Efficacy|12|||
27840115|NCT01589822|54327403|FG000|Overall Study|Withdrawal by Subject|1|||
27840116|NCT01589822|54327404|FG001|Overall Study|Withdrawal by Subject|2|||
27840117|NCT01589822|54327405|FG002|Overall Study|Withdrawal by Subject|0|||
27840118|NCT01589822|54327403|FG000|Overall Study|Death|1|||
27840119|NCT01589822|54327404|FG001|Overall Study|Death|0|||
27840120|NCT01589822|54327405|FG002|Overall Study|Death|0|||
27840121|NCT01589822|54327403|FG000|Overall Study|Missed 90 day visit|2|||
27840122|NCT01589822|54327404|FG001|Overall Study|Missed 90 day visit|1|||
27840123|NCT01589822|54327405|FG002|Overall Study|Missed 90 day visit|1|||
27840124|NCT01565642|54327417|FG000|Overall Study|Withdrawal by Subject|2|||
27840125|NCT01565642|54327418|FG001|Overall Study|Withdrawal by Subject|1|||
27840126|NCT01475071|54327424|FG000|Overall Study|Physician Decision|1|||
27840127|NCT01475071|54327424|FG000|Overall Study|Withdrawal by Subject|6|||
27840128|NCT01475071|54327424|FG000|Overall Study|Lost to Follow-up|1|||
27840129|NCT01474993|54327432|FG000|Overall Study|Lost to Follow-up|1|||
27840130|NCT01474993|54327433|FG001|Overall Study|Lost to Follow-up|2|||
27840131|NCT01474993|54327432|FG000|Overall Study|Adverse Event|0|||
27840132|NCT01474993|54327433|FG001|Overall Study|Adverse Event|1|||
27772913|NCT02294227|54225818|FG002|Overall Study|Lack of Efficacy|8|||
27840133|NCT01691768|54327443|FG000|Overall Study|Death|0|||
27772914|NCT02294227|54225816|FG000|Overall Study|Adverse Event|6|||
27772915|NCT02294227|54225817|FG001|Overall Study|Adverse Event|8|||
27772916|NCT02294227|54225818|FG002|Overall Study|Adverse Event|2|||
27772917|NCT02496767|54225832|FG000|Open-label Lead-in Phase|Adverse Event|176|||
27772918|NCT02496767|54225833|FG001|Open-label Lead-in Phase|Adverse Event|0|||
27772919|NCT02496767|54225834|FG002|Open-label Lead-in Phase|Adverse Event|0|||
27772920|NCT02496767|54225835|FG003|Open-label Lead-in Phase|Adverse Event|0|||
27772921|NCT02496767|54225836|FG004|Open-label Lead-in Phase|Adverse Event|0|||
27772922|NCT02496767|54225837|FG005|Open-label Lead-in Phase|Adverse Event|0|||
27772923|NCT02496767|54225838|FG006|Open-label Lead-in Phase|Adverse Event|0|||
27772924|NCT02496767|54225839|FG007|Open-label Lead-in Phase|Adverse Event|0|||
27772925|NCT02496767|54225832|FG000|Open-label Lead-in Phase|Protocol Violation|2|||
27772926|NCT02496767|54225833|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
27772927|NCT02496767|54225834|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
27772928|NCT02496767|54225835|FG003|Open-label Lead-in Phase|Protocol Violation|0|||
27772929|NCT02496767|54225836|FG004|Open-label Lead-in Phase|Protocol Violation|0|||
27772930|NCT02496767|54225837|FG005|Open-label Lead-in Phase|Protocol Violation|0|||
27772931|NCT02496767|54225838|FG006|Open-label Lead-in Phase|Protocol Violation|0|||
27772932|NCT02496767|54225839|FG007|Open-label Lead-in Phase|Protocol Violation|0|||
27772933|NCT02496767|54225832|FG000|Open-label Lead-in Phase|Lost to Follow-up|1|||
27772934|NCT02496767|54225833|FG001|Open-label Lead-in Phase|Lost to Follow-up|0|||
27772935|NCT02496767|54225834|FG002|Open-label Lead-in Phase|Lost to Follow-up|0|||
27772936|NCT02496767|54225835|FG003|Open-label Lead-in Phase|Lost to Follow-up|0|||
27772937|NCT02496767|54225836|FG004|Open-label Lead-in Phase|Lost to Follow-up|0|||
27772938|NCT02496767|54225837|FG005|Open-label Lead-in Phase|Lost to Follow-up|0|||
27772939|NCT02496767|54225838|FG006|Open-label Lead-in Phase|Lost to Follow-up|0|||
27772940|NCT02496767|54225839|FG007|Open-label Lead-in Phase|Lost to Follow-up|0|||
27772941|NCT02496767|54225832|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
27772942|NCT02496767|54225833|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|13|||
27772943|NCT02496767|54225834|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|23|||
27772944|NCT02496767|54225835|FG003|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
27772945|NCT02496767|54225836|FG004|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
27772946|NCT02496767|54225837|FG005|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
27772947|NCT02496767|54225838|FG006|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
27772948|NCT02496767|54225839|FG007|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
27772949|NCT02496767|54225832|FG000|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
27772950|NCT02496767|54225833|FG001|Double-blind, Placebo-controlled Phase|Progressive disease|13|||
27772951|NCT02496767|54225834|FG002|Double-blind, Placebo-controlled Phase|Progressive disease|9|||
27772952|NCT02496767|54225835|FG003|Double-blind, Placebo-controlled Phase|Progressive disease|8|||
27772953|NCT02496767|54225836|FG004|Double-blind, Placebo-controlled Phase|Progressive disease|14|||
27772954|NCT02496767|54225837|FG005|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
27772955|NCT02496767|54225838|FG006|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
27772956|NCT02496767|54225839|FG007|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
27772957|NCT02496767|54225832|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
27772958|NCT02496767|54225833|FG001|Double-blind, Placebo-controlled Phase|Death|10|||
27840134|NCT01691768|54327444|FG001|Overall Study|Death|2|||
27840135|NCT01691768|54327443|FG000|Overall Study|Lost to Follow-up|4|||
27840136|NCT01691768|54327444|FG001|Overall Study|Lost to Follow-up|3|||
27840137|NCT01691768|54327443|FG000|Overall Study|Withdrawal by Subject|10|||
27840138|NCT01691768|54327444|FG001|Overall Study|Withdrawal by Subject|9|||
27840139|NCT01691768|54327443|FG000|Overall Study|Relocated|0|||
27840140|NCT01691768|54327444|FG001|Overall Study|Relocated|1|||
27840141|NCT01691768|54327443|FG000|Overall Study|Investigator decision|1|||
27840142|NCT01691768|54327444|FG001|Overall Study|Investigator decision|1|||
27840143|NCT01503229|54327451|FG000|Overall Study|Withdrew consent|1|||
27840144|NCT01691612|54327455|FG000|Overall Study|deemed ineligible after 1st visit|6|||
27840145|NCT01691612|54327455|FG000|Overall Study|Adverse Event|1|||
27840146|NCT01565564|54327461|FG000|Overall Study|Lost to Follow-up|5|||
27840147|NCT01565564|54327462|FG001|Overall Study|Lost to Follow-up|1|||
27840148|NCT01460407|54327468|FG000|Period 2: Day 6 to Day 14|Adverse Event|0|||
27772959|NCT02496767|54225834|FG002|Double-blind, Placebo-controlled Phase|Death|6|||
27772960|NCT02496767|54225835|FG003|Double-blind, Placebo-controlled Phase|Death|2|||
27772961|NCT02496767|54225836|FG004|Double-blind, Placebo-controlled Phase|Death|4|||
27772962|NCT02496767|54225837|FG005|Double-blind, Placebo-controlled Phase|Death|0|||
27772963|NCT02496767|54225838|FG006|Double-blind, Placebo-controlled Phase|Death|0|||
27772964|NCT02496767|54225839|FG007|Double-blind, Placebo-controlled Phase|Death|0|||
27772965|NCT02496767|54225832|FG000|Double-blind, Placebo-controlled Phase|Various|0|||
27840149|NCT01460407|54327469|FG001|Period 2: Day 6 to Day 14|Adverse Event|1|||
27851609|NCT02616900|54350962|FG000|Overall Study|Withdrawal by Subject|3|||
27851610|NCT02616900|54350962|FG000|Overall Study|Incomplete data|6|||
27851611|NCT00985673|54351074|FG000|Overall Study|Lost to Follow-up|6|||
27851612|NCT00985673|54351075|FG001|Overall Study|Lost to Follow-up|7|||
27772966|NCT02496767|54225833|FG001|Double-blind, Placebo-controlled Phase|Various|9|||
27772967|NCT02496767|54225834|FG002|Double-blind, Placebo-controlled Phase|Various|4|||
27772968|NCT02496767|54225835|FG003|Double-blind, Placebo-controlled Phase|Various|5|||
27772969|NCT02496767|54225836|FG004|Double-blind, Placebo-controlled Phase|Various|2|||
27772970|NCT02496767|54225837|FG005|Double-blind, Placebo-controlled Phase|Various|0|||
27772971|NCT02496767|54225838|FG006|Double-blind, Placebo-controlled Phase|Various|0|||
27772972|NCT02496767|54225839|FG007|Double-blind, Placebo-controlled Phase|Various|0|||
27772973|NCT02496767|54225832|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
27772974|NCT02496767|54225833|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4|||
27772975|NCT02496767|54225834|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3|||
27772976|NCT02496767|54225835|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1|||
27772977|NCT02496767|54225836|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2|||
27772978|NCT02496767|54225837|FG005|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
27772979|NCT02496767|54225838|FG006|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
27772980|NCT02496767|54225839|FG007|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
27772981|NCT02496767|54225832|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
27772982|NCT02496767|54225833|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|4|||
27772983|NCT02496767|54225834|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|1|||
27772984|NCT02496767|54225835|FG003|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
27772985|NCT02496767|54225836|FG004|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
27772986|NCT02496767|54225837|FG005|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
27772987|NCT02496767|54225838|FG006|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
27772988|NCT02496767|54225839|FG007|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
27772989|NCT02496767|54225832|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
27772990|NCT02496767|54225833|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
27772991|NCT02496767|54225834|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
27772992|NCT02496767|54225835|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
27772993|NCT02496767|54225836|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1|||
27772994|NCT02496767|54225837|FG005|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
27772995|NCT02496767|54225838|FG006|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
27772996|NCT02496767|54225839|FG007|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
27772997|NCT02496767|54225832|FG000|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
27772998|NCT02496767|54225833|FG001|Double-blind, Placebo-controlled Phase|Protocol Violation|1|||
27772999|NCT02496767|54225834|FG002|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
27773000|NCT02496767|54225835|FG003|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
27773001|NCT02496767|54225836|FG004|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
27773002|NCT02496767|54225837|FG005|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
27773003|NCT02496767|54225838|FG006|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
27773004|NCT02496767|54225839|FG007|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
27773005|NCT02496767|54225832|FG000|Double-blind, Withdrawal Phase|Progressive disease|0|||
27773006|NCT02496767|54225833|FG001|Double-blind, Withdrawal Phase|Progressive disease|0|||
27773007|NCT02496767|54225834|FG002|Double-blind, Withdrawal Phase|Progressive disease|0|||
27773008|NCT02496767|54225835|FG003|Double-blind, Withdrawal Phase|Progressive disease|0|||
27773009|NCT02496767|54225836|FG004|Double-blind, Withdrawal Phase|Progressive disease|0|||
27773010|NCT02496767|54225837|FG005|Double-blind, Withdrawal Phase|Progressive disease|4|||
27773011|NCT02496767|54225838|FG006|Double-blind, Withdrawal Phase|Progressive disease|0|||
27773012|NCT02496767|54225839|FG007|Double-blind, Withdrawal Phase|Progressive disease|1|||
27773013|NCT02496767|54225832|FG000|Double-blind, Withdrawal Phase|Adverse Event|0|||
27773014|NCT02496767|54225833|FG001|Double-blind, Withdrawal Phase|Adverse Event|0|||
27773015|NCT02496767|54225834|FG002|Double-blind, Withdrawal Phase|Adverse Event|0|||
27773016|NCT02496767|54225835|FG003|Double-blind, Withdrawal Phase|Adverse Event|0|||
27773017|NCT02496767|54225836|FG004|Double-blind, Withdrawal Phase|Adverse Event|0|||
27773018|NCT02496767|54225837|FG005|Double-blind, Withdrawal Phase|Adverse Event|1|||
27773019|NCT02496767|54225838|FG006|Double-blind, Withdrawal Phase|Adverse Event|2|||
27773020|NCT02496767|54225839|FG007|Double-blind, Withdrawal Phase|Adverse Event|1|||
27773021|NCT02496767|54225832|FG000|Double-blind, Withdrawal Phase|Death|0|||
27773022|NCT02496767|54225833|FG001|Double-blind, Withdrawal Phase|Death|0|||
27773023|NCT02496767|54225834|FG002|Double-blind, Withdrawal Phase|Death|0|||
27773024|NCT02496767|54225835|FG003|Double-blind, Withdrawal Phase|Death|0|||
27773025|NCT02496767|54225836|FG004|Double-blind, Withdrawal Phase|Death|0|||
27773026|NCT02496767|54225837|FG005|Double-blind, Withdrawal Phase|Death|0|||
27773027|NCT02496767|54225838|FG006|Double-blind, Withdrawal Phase|Death|1|||
27773028|NCT02496767|54225839|FG007|Double-blind, Withdrawal Phase|Death|2|||
27773029|NCT02496767|54225832|FG000|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
27773030|NCT02496767|54225833|FG001|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
27773031|NCT02496767|54225834|FG002|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
27840150|NCT01502371|54327481|FG000|Overall Study|Withdrawal by Subject|1|||
27773032|NCT02496767|54225835|FG003|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
27773033|NCT02496767|54225836|FG004|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
27773034|NCT02496767|54225837|FG005|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
27773035|NCT02496767|54225838|FG006|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
27773036|NCT02496767|54225839|FG007|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
27773037|NCT02496533|54225855|FG000|Overall Study|Lack of data on outcome|3|||
27773038|NCT02496533|54225856|FG001|Overall Study|Lack of data on outcome|0|||
27773039|NCT02496533|54225855|FG000|Overall Study|Patient did not complete all measures|0|||
27773040|NCT02496533|54225856|FG001|Overall Study|Patient did not complete all measures|4|||
27773041|NCT02496533|54225855|FG000|Overall Study|Late for radiologic testing|0|||
27773042|NCT02496533|54225856|FG001|Overall Study|Late for radiologic testing|2|||
27773043|NCT02496221|54225862|FG000|Treatment Period 2 - 4 Days|Adverse Event|0|||
27773044|NCT02496221|54225863|FG001|Treatment Period 2 - 4 Days|Adverse Event|1|||
27773045|NCT02496221|54225862|FG000|Treatment Period 2 - 4 Days|Protocol Violation|1|||
27773046|NCT02496221|54225863|FG001|Treatment Period 2 - 4 Days|Protocol Violation|0|||
27773047|NCT02496221|54225862|FG000|Treatment Period 2 - 4 Days|Physician Decision|1|||
27773048|NCT02496221|54225863|FG001|Treatment Period 2 - 4 Days|Physician Decision|0|||
27773049|NCT02475629|54225871|FG000|Overall Study|Adverse Event|1|||
27773050|NCT02475629|54225871|FG000|Overall Study|Death|4|||
27773051|NCT02475629|54225871|FG000|Overall Study|Physician Decision|1|||
27773052|NCT02475629|54225871|FG000|Overall Study|Withdrawal by Subject|1|||
27773053|NCT02475629|54225871|FG000|Overall Study|Lost to Follow-up|1|||
27773054|NCT02475629|54225871|FG000|Overall Study|Subject non-compliance|1|||
27773055|NCT02475395|54225877|FG000|Overall Study|Protocol Violation|30|||
27773056|NCT02475395|54225878|FG001|Overall Study|Protocol Violation|3|||
27773057|NCT01653743|54225886|FG000|Overall Study|Withdrawal by Subject|1|||
27773058|NCT01653743|54225887|FG001|Overall Study|Withdrawal by Subject|0|||
27773059|NCT01653743|54225886|FG000|Overall Study|Investigator discretion|3|||
27773060|NCT01653743|54225887|FG001|Overall Study|Investigator discretion|0|||
27773061|NCT02293993|54225897|FG000|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
27773062|NCT02293993|54225898|FG001|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
27773063|NCT02293993|54225899|FG002|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
27773064|NCT02293993|54225900|FG003|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
27773065|NCT02293993|54225897|FG000|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
27773066|NCT02293993|54225898|FG001|Course ≥2 (Extended Treatment Period)|Physician Decision|2|||
27773067|NCT02293993|54225899|FG002|Course ≥2 (Extended Treatment Period)|Physician Decision|1|||
27773068|NCT02293993|54225900|FG003|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
27773069|NCT02293993|54225897|FG000|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
27773070|NCT02293993|54225898|FG001|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
27773071|NCT02293993|54225899|FG002|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|1|||
27773072|NCT02293993|54225900|FG003|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
27773073|NCT02293993|54225897|FG000|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
27773074|NCT02293993|54225898|FG001|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
27773075|NCT02293993|54225899|FG002|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|3|||
27773076|NCT02293993|54225900|FG003|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|1|||
27773077|NCT02293993|54225897|FG000|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
27773078|NCT02293993|54225898|FG001|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|1|||
27773079|NCT02293993|54225899|FG002|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
27773080|NCT02293993|54225900|FG003|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
27831216|NCT01791803|54307542|FG000|Overall Study|Withdrawal by Subject|0|||
27831217|NCT01791803|54307543|FG001|Overall Study|Withdrawal by Subject|0|||
27831218|NCT01791803|54307544|FG002|Overall Study|Withdrawal by Subject|0|||
27831219|NCT01791803|54307545|FG003|Overall Study|Withdrawal by Subject|2|||
27831220|NCT01791803|54307542|FG000|Overall Study|Physician Decision|0|||
27831221|NCT01791803|54307543|FG001|Overall Study|Physician Decision|2|||
27831222|NCT01791803|54307544|FG002|Overall Study|Physician Decision|0|||
27831223|NCT01791803|54307545|FG003|Overall Study|Physician Decision|1|||
27831224|NCT01791803|54307542|FG000|Overall Study|Death|0|||
27831225|NCT01791803|54307543|FG001|Overall Study|Death|0|||
27831226|NCT01791803|54307544|FG002|Overall Study|Death|2|||
27831227|NCT01791803|54307545|FG003|Overall Study|Death|2|||
27831228|NCT01791725|54307570|FG000|Overall Study|Withdrawal by Subject|0|||
27831229|NCT01791725|54307571|FG001|Overall Study|Withdrawal by Subject|1|||
27831230|NCT01791725|54307572|FG002|Overall Study|Withdrawal by Subject|0|||
27831231|NCT01791413|54307582|FG000|Overall Study|Lost to Follow-up|5|||
27831232|NCT01791413|54307583|FG001|Overall Study|Lost to Follow-up|1|||
27831233|NCT01610063|54307596|FG000|Overall Study|Lost to Follow-up|42|||
27773081|NCT02322775|54225920|FG000|Overall Study|Adverse Event|1|||
27773082|NCT02322775|54225921|FG001|Overall Study|Adverse Event|0|||
27773083|NCT02322775|54225920|FG000|Overall Study|Lost to Follow-up|0|||
27773084|NCT02322775|54225921|FG001|Overall Study|Lost to Follow-up|1|||
27773085|NCT02322775|54225920|FG000|Overall Study|Protocol Violation|1|||
27773086|NCT02322775|54225921|FG001|Overall Study|Protocol Violation|0|||
27773087|NCT02322775|54225920|FG000|Overall Study|Withdrawal by Subject|3|||
27773088|NCT02322775|54225921|FG001|Overall Study|Withdrawal by Subject|4|||
27773089|NCT02322775|54225920|FG000|Overall Study|Not willing to perform all FU visits|0|||
27773090|NCT02322775|54225921|FG001|Overall Study|Not willing to perform all FU visits|1|||
27773091|NCT02322229|54225927|FG000|Overall Study|Physician Decision|2|||
27773092|NCT02363959|54225934|FG000|Overall Study|Medical instability|1|||
27773093|NCT02363959|54225935|FG001|Overall Study|Medical instability|0|||
27773094|NCT02362789|54225943|FG000|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1|||
27773095|NCT02362789|54225944|FG001|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
27773096|NCT02362789|54225945|FG002|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
27773097|NCT02362789|54225943|FG000|Run-in Phase (Week 0 to 16)|Adverse Event|1|||
27773098|NCT02362789|54225944|FG001|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
27773099|NCT02362789|54225945|FG002|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
27773100|NCT02362789|54225943|FG000|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0|||
27773101|NCT02362789|54225944|FG001|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2|||
27773102|NCT02362789|54225945|FG002|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6|||
27773103|NCT02362789|54225943|FG000|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0|||
27773104|NCT02362789|54225944|FG001|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1|||
27773105|NCT02362789|54225945|FG002|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4|||
27773106|NCT02362789|54225943|FG000|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0|||
27773107|NCT02362789|54225944|FG001|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1|||
27773108|NCT02362789|54225945|FG002|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2|||
27773109|NCT01646827|54225954|FG000|Overall Study|Lost to Follow-up|0|||
27773110|NCT01646827|54225955|FG001|Overall Study|Lost to Follow-up|3|||
27773111|NCT01646827|54225954|FG000|Overall Study|Physician Decision|1|||
27773112|NCT01646827|54225955|FG001|Overall Study|Physician Decision|2|||
27773113|NCT01646827|54225954|FG000|Overall Study|Withdrawal by Subject|1|||
27773114|NCT01646827|54225955|FG001|Overall Study|Withdrawal by Subject|0|||
27773115|NCT02293837|54225965|FG000|Overall Study|Lost to Follow-up|0|||
27773116|NCT02293837|54225966|FG001|Overall Study|Lost to Follow-up|2|||
27773117|NCT02293837|54225967|FG002|Overall Study|Lost to Follow-up|1|||
27773118|NCT02293837|54225968|FG003|Overall Study|Lost to Follow-up|0|||
27773119|NCT02293837|54225965|FG000|Overall Study|Withdrawal by Subject|2|||
27773120|NCT02293837|54225966|FG001|Overall Study|Withdrawal by Subject|1|||
27773121|NCT02293837|54225967|FG002|Overall Study|Withdrawal by Subject|2|||
27773122|NCT02293837|54225968|FG003|Overall Study|Withdrawal by Subject|1|||
27773123|NCT02293837|54225965|FG000|Overall Study|COVID-19 Related|1|||
27773124|NCT02293837|54225966|FG001|Overall Study|COVID-19 Related|1|||
27773125|NCT02293837|54225967|FG002|Overall Study|COVID-19 Related|0|||
27773126|NCT02293837|54225968|FG003|Overall Study|COVID-19 Related|0|||
27773127|NCT02293837|54225965|FG000|Overall Study|Participant ill and could not be infused|0|||
27773128|NCT02293837|54225966|FG001|Overall Study|Participant ill and could not be infused|0|||
27773129|NCT02293837|54225967|FG002|Overall Study|Participant ill and could not be infused|1|||
27773130|NCT02293837|54225968|FG003|Overall Study|Participant ill and could not be infused|0|||
27773131|NCT02361307|54225984|FG000|Overall Study|Unstable medical condition.|0|||
27773132|NCT02361307|54225985|FG001|Overall Study|Unstable medical condition.|1|||
27773133|NCT02320903|54225994|FG000|Overall Study|Withdrawal by Subject|0|||
27773134|NCT02320903|54225995|FG001|Overall Study|Withdrawal by Subject|9|||
27773135|NCT02320903|54225996|FG002|Overall Study|Withdrawal by Subject|9|||
27773136|NCT02320903|54225994|FG000|Overall Study|Exited therapy; no longer eligible|8|||
27773137|NCT02320903|54225995|FG001|Overall Study|Exited therapy; no longer eligible|2|||
27773138|NCT02320903|54225996|FG002|Overall Study|Exited therapy; no longer eligible|2|||
27773139|NCT02320903|54225994|FG000|Overall Study|Lost to Follow-up|0|||
27773140|NCT02320903|54225995|FG001|Overall Study|Lost to Follow-up|5|||
27773141|NCT02320903|54225996|FG002|Overall Study|Lost to Follow-up|5|||
27773142|NCT02320123|54226007|FG000|Overall Study|Lost to Follow-up|4|||
27773143|NCT02320123|54226008|FG001|Overall Study|Lost to Follow-up|6|||
27773144|NCT02320123|54226007|FG000|Overall Study|Death|6|||
27773145|NCT02320123|54226008|FG001|Overall Study|Death|5|||
27773146|NCT02360995|54226021|FG000|Overall Study|Lost to Follow-up|2|||
27773147|NCT02360995|54226022|FG001|Overall Study|Lost to Follow-up|0|||
27773148|NCT02360995|54226023|FG002|Overall Study|Lost to Follow-up|2|||
27773149|NCT02360995|54226021|FG000|Overall Study|Withdrawal by Subject|0|||
27773150|NCT02360995|54226022|FG001|Overall Study|Withdrawal by Subject|1|||
27773151|NCT02360995|54226023|FG002|Overall Study|Withdrawal by Subject|0|||
27773152|NCT02360605|54226033|FG000|Overall Study|Withdrawal by Subject|4|||
27773153|NCT02360605|54226034|FG001|Overall Study|Withdrawal by Subject|9|||
27773154|NCT02360605|54226033|FG000|Overall Study|Lost to Follow-up|7|||
27773155|NCT02360605|54226034|FG001|Overall Study|Lost to Follow-up|8|||
27773156|NCT02360605|54226033|FG000|Overall Study|Death|0|||
27773157|NCT02360605|54226034|FG001|Overall Study|Death|1|||
27773158|NCT02360293|54226044|FG000|Overall Study|Lost to Follow-up|73|||
27773159|NCT02360293|54226045|FG001|Overall Study|Lost to Follow-up|95|||
27773160|NCT02360293|54226044|FG000|Overall Study|Withdrawal by Subject|2|||
27773161|NCT02360293|54226045|FG001|Overall Study|Withdrawal by Subject|1|||
27773162|NCT02360293|54226044|FG000|Overall Study|Excluded|1|||
27773163|NCT02360293|54226045|FG001|Overall Study|Excluded|0|||
27773164|NCT02359903|54226053|FG000|Overall Study|Adverse Event|0|||
27773165|NCT02359903|54226054|FG001|Overall Study|Adverse Event|2|||
27773166|NCT02291419|54226062|FG000|Overall Study|Early study termination|1|||
27773167|NCT02291419|54226063|FG001|Overall Study|Early study termination|5|||
27773168|NCT02319031|54226071|FG000|Treatment Period|Death|1|||
27773169|NCT02319031|54226072|FG001|Treatment Period|Death|0|||
27773170|NCT02318797|54226080|FG000|Overall Study|Death|3|||
27773171|NCT02318797|54226081|FG001|Overall Study|Death|6|||
27773172|NCT02318797|54226080|FG000|Overall Study|Lost to Follow-up|85|||
27773173|NCT02318797|54226081|FG001|Overall Study|Lost to Follow-up|96|||
27773174|NCT02359435|54226089|FG000|Overall Study|Lost to Follow-up|4|||
27773175|NCT02359435|54226090|FG001|Overall Study|Lost to Follow-up|4|||
27773176|NCT02318719|54226100|FG000|Double-blind Phase|Adverse Event|7|||
27773177|NCT02318719|54226101|FG001|Double-blind Phase|Adverse Event|6|||
27773178|NCT02318719|54226102|FG002|Double-blind Phase|Adverse Event|12|||
27773179|NCT02318719|54226103|FG003|Double-blind Phase|Adverse Event|4|||
27773180|NCT02318719|54226104|FG004|Double-blind Phase|Adverse Event|0|||
27773181|NCT02318719|54226100|FG000|Double-blind Phase|Lack of Efficacy|5|||
27773182|NCT02318719|54226101|FG001|Double-blind Phase|Lack of Efficacy|0|||
27773183|NCT02318719|54226102|FG002|Double-blind Phase|Lack of Efficacy|1|||
27773184|NCT02318719|54226103|FG003|Double-blind Phase|Lack of Efficacy|1|||
27773185|NCT02318719|54226104|FG004|Double-blind Phase|Lack of Efficacy|0|||
27773186|NCT02318719|54226100|FG000|Double-blind Phase|Protocol Violation|0|||
27773187|NCT02318719|54226101|FG001|Double-blind Phase|Protocol Violation|1|||
27773188|NCT02318719|54226102|FG002|Double-blind Phase|Protocol Violation|3|||
27773189|NCT02318719|54226103|FG003|Double-blind Phase|Protocol Violation|0|||
27773190|NCT02318719|54226104|FG004|Double-blind Phase|Protocol Violation|0|||
27773191|NCT02318719|54226100|FG000|Double-blind Phase|Withdrawal by Subject|25|||
27773192|NCT02318719|54226101|FG001|Double-blind Phase|Withdrawal by Subject|7|||
27773193|NCT02318719|54226102|FG002|Double-blind Phase|Withdrawal by Subject|9|||
27773194|NCT02318719|54226103|FG003|Double-blind Phase|Withdrawal by Subject|10|||
27773195|NCT02318719|54226104|FG004|Double-blind Phase|Withdrawal by Subject|0|||
27773196|NCT02318719|54226100|FG000|Double-blind Phase|Other|1|||
27773197|NCT02318719|54226101|FG001|Double-blind Phase|Other|2|||
27773198|NCT02318719|54226102|FG002|Double-blind Phase|Other|0|||
27773199|NCT02318719|54226103|FG003|Double-blind Phase|Other|0|||
27773200|NCT02318719|54226104|FG004|Double-blind Phase|Other|0|||
27773201|NCT02318719|54226100|FG000|Open-label Extension Phase|Adverse Event|0|||
27773202|NCT02318719|54226101|FG001|Open-label Extension Phase|Adverse Event|0|||
27773203|NCT02318719|54226102|FG002|Open-label Extension Phase|Adverse Event|0|||
27773204|NCT02318719|54226103|FG003|Open-label Extension Phase|Adverse Event|0|||
27773205|NCT02318719|54226104|FG004|Open-label Extension Phase|Adverse Event|15|||
27773206|NCT02318719|54226100|FG000|Open-label Extension Phase|Death|0|||
27773207|NCT02318719|54226101|FG001|Open-label Extension Phase|Death|0|||
27773208|NCT02318719|54226102|FG002|Open-label Extension Phase|Death|0|||
27773209|NCT02318719|54226103|FG003|Open-label Extension Phase|Death|0|||
27773210|NCT02318719|54226104|FG004|Open-label Extension Phase|Death|1|||
27773211|NCT02318719|54226100|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
27773212|NCT02318719|54226101|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
27773213|NCT02318719|54226102|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
27773214|NCT02318719|54226103|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
27773215|NCT02318719|54226104|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
27773216|NCT02318719|54226100|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
27773217|NCT02318719|54226101|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
27773218|NCT02318719|54226102|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
27773219|NCT02318719|54226103|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
27773220|NCT02318719|54226104|FG004|Open-label Extension Phase|Withdrawal by Subject|31|||
27773221|NCT02318719|54226100|FG000|Open-label Extension Phase|Other|0|||
27773222|NCT02318719|54226101|FG001|Open-label Extension Phase|Other|0|||
27773223|NCT02318719|54226102|FG002|Open-label Extension Phase|Other|0|||
27773224|NCT02318719|54226103|FG003|Open-label Extension Phase|Other|0|||
27773225|NCT02318719|54226104|FG004|Open-label Extension Phase|Other|7|||
27773226|NCT01870726|54226123|FG000|Overall Study|Withdrawal of informed consent|0|||
27773227|NCT01870726|54226124|FG001|Overall Study|Withdrawal of informed consent|0|||
27773228|NCT01870726|54226125|FG002|Overall Study|Withdrawal of informed consent|0|||
27773229|NCT01870726|54226126|FG003|Overall Study|Withdrawal of informed consent|1|||
27773230|NCT01870726|54226127|FG004|Overall Study|Withdrawal of informed consent|0|||
27773231|NCT01870726|54226128|FG005|Overall Study|Withdrawal of informed consent|0|||
27773232|NCT01870726|54226129|FG006|Overall Study|Withdrawal of informed consent|0|||
27773233|NCT01870726|54226123|FG000|Overall Study|Withdrawal by Subject|0|||
27773234|NCT01870726|54226124|FG001|Overall Study|Withdrawal by Subject|1|||
27773235|NCT01870726|54226125|FG002|Overall Study|Withdrawal by Subject|0|||
27840151|NCT01502371|54327482|FG001|Overall Study|Withdrawal by Subject|2|||
27840152|NCT01502371|54327483|FG002|Overall Study|Withdrawal by Subject|1|||
27773236|NCT01870726|54226126|FG003|Overall Study|Withdrawal by Subject|0|||
27773237|NCT01870726|54226127|FG004|Overall Study|Withdrawal by Subject|0|||
27773238|NCT01870726|54226128|FG005|Overall Study|Withdrawal by Subject|0|||
27773239|NCT01870726|54226129|FG006|Overall Study|Withdrawal by Subject|0|||
27773240|NCT01870726|54226123|FG000|Overall Study|Adverse Event|0|||
27773241|NCT01870726|54226124|FG001|Overall Study|Adverse Event|0|||
27773242|NCT01870726|54226125|FG002|Overall Study|Adverse Event|0|||
27773243|NCT01870726|54226126|FG003|Overall Study|Adverse Event|0|||
27773244|NCT01870726|54226127|FG004|Overall Study|Adverse Event|1|||
27773245|NCT01870726|54226128|FG005|Overall Study|Adverse Event|1|||
27773246|NCT01870726|54226129|FG006|Overall Study|Adverse Event|0|||
27773247|NCT01870726|54226123|FG000|Overall Study|Progressive disease|5|||
27773248|NCT01870726|54226124|FG001|Overall Study|Progressive disease|5|||
27773249|NCT01870726|54226125|FG002|Overall Study|Progressive disease|4|||
27773250|NCT01870726|54226126|FG003|Overall Study|Progressive disease|5|||
27773251|NCT01870726|54226127|FG004|Overall Study|Progressive disease|6|||
27773252|NCT01870726|54226128|FG005|Overall Study|Progressive disease|4|||
27773253|NCT01870726|54226129|FG006|Overall Study|Progressive disease|10|||
27773254|NCT01900054|54226154|FG000|Overall Study|Physician Decision|1|||
27773255|NCT01900054|54226154|FG000|Overall Study|Withdrawal by Subject|1|||
27773256|NCT01612156|54226160|FG000|Overall Study|Protocol Violation|2|||
27773257|NCT01612156|54226161|FG001|Overall Study|Protocol Violation|0|||
27773258|NCT01899742|54226169|FG000|Overall Study|Adverse Event|5|||
27773259|NCT01899742|54226170|FG001|Overall Study|Adverse Event|4|||
27773260|NCT01899742|54226169|FG000|Overall Study|Lack of Efficacy|1|||
27773261|NCT01899742|54226170|FG001|Overall Study|Lack of Efficacy|5|||
27773262|NCT01899742|54226169|FG000|Overall Study|Protocol Violation|2|||
27773263|NCT01899742|54226170|FG001|Overall Study|Protocol Violation|2|||
27773264|NCT01899742|54226169|FG000|Overall Study|Withdrawal by Subject|9|||
27773265|NCT01899742|54226170|FG001|Overall Study|Withdrawal by Subject|5|||
27773266|NCT01615822|54226179|FG000|Period 1|Withdrawal by Subject|0|||
27773267|NCT01615822|54226180|FG001|Period 1|Withdrawal by Subject|1|||
27773268|NCT01615822|54226181|FG002|Period 1|Withdrawal by Subject|0|||
27773269|NCT01615822|54226179|FG000|Period 1|Adverse Event|1|||
27773270|NCT01615822|54226180|FG001|Period 1|Adverse Event|1|||
27773271|NCT01615822|54226181|FG002|Period 1|Adverse Event|0|||
27773272|NCT01615822|54226179|FG000|Period 2|Lost to Follow-up|0|||
27773273|NCT01615822|54226180|FG001|Period 2|Lost to Follow-up|1|||
27773274|NCT01615822|54226181|FG002|Period 2|Lost to Follow-up|2|||
27773275|NCT01898884|54226197|FG000|Multiple Dose Period|Adverse Event|0|||
27773276|NCT01898884|54226198|FG001|Multiple Dose Period|Adverse Event|0|||
27773277|NCT01898884|54226199|FG002|Multiple Dose Period|Adverse Event|0|||
27773278|NCT01898884|54226200|FG003|Multiple Dose Period|Adverse Event|0|||
27773279|NCT01898884|54226201|FG004|Multiple Dose Period|Adverse Event|0|||
27773280|NCT01898884|54226202|FG005|Multiple Dose Period|Adverse Event|0|||
27773281|NCT01898884|54226203|FG006|Multiple Dose Period|Adverse Event|1|||
27773282|NCT01898884|54226204|FG007|Multiple Dose Period|Adverse Event|0|||
27773283|NCT01898884|54226205|FG008|Multiple Dose Period|Adverse Event|0|||
27773284|NCT01898884|54226197|FG000|Multiple Dose Period|Randomized Not Treated|0|||
27773285|NCT01898884|54226198|FG001|Multiple Dose Period|Randomized Not Treated|0|||
27773286|NCT01898884|54226199|FG002|Multiple Dose Period|Randomized Not Treated|0|||
27773287|NCT01898884|54226200|FG003|Multiple Dose Period|Randomized Not Treated|0|||
27773288|NCT01898884|54226201|FG004|Multiple Dose Period|Randomized Not Treated|0|||
27773289|NCT01898884|54226202|FG005|Multiple Dose Period|Randomized Not Treated|0|||
27773290|NCT01898884|54226203|FG006|Multiple Dose Period|Randomized Not Treated|0|||
27773291|NCT01898884|54226204|FG007|Multiple Dose Period|Randomized Not Treated|0|||
27773292|NCT01898884|54226205|FG008|Multiple Dose Period|Randomized Not Treated|1|||
27773293|NCT01613326|54226243|FG000|Overall Study|Adverse Event|7|||
27773294|NCT01613326|54226244|FG001|Overall Study|Adverse Event|5|||
27773295|NCT01613326|54226243|FG000|Overall Study|Withdrawal by Subject|3|||
27773296|NCT01613326|54226244|FG001|Overall Study|Withdrawal by Subject|4|||
27773297|NCT01613326|54226243|FG000|Overall Study|Abnormal test procedure result(s)|2|||
27773298|NCT01613326|54226244|FG001|Overall Study|Abnormal test procedure result(s)|0|||
27773299|NCT01613326|54226243|FG000|Overall Study|inability to use device|1|||
27773300|NCT01613326|54226244|FG001|Overall Study|inability to use device|0|||
27840153|NCT01502371|54327484|FG003|Overall Study|Withdrawal by Subject|1|||
27773301|NCT01613326|54226243|FG000|Overall Study|Lack of Efficacy|0|||
27773302|NCT01613326|54226244|FG001|Overall Study|Lack of Efficacy|1|||
27773303|NCT01613326|54226243|FG000|Overall Study|Lost to Follow-up|0|||
27773304|NCT01613326|54226244|FG001|Overall Study|Lost to Follow-up|1|||
27773305|NCT01613326|54226243|FG000|Overall Study|Administrative|0|||
27773306|NCT01613326|54226244|FG001|Overall Study|Administrative|2|||
27773307|NCT01613326|54226243|FG000|Overall Study|Protocol Violation|0|||
27773308|NCT01613326|54226244|FG001|Overall Study|Protocol Violation|1|||
27773309|NCT01613248|54226256|FG000|Overall Study|Adverse Event|0|||
27773310|NCT01613248|54226257|FG001|Overall Study|Adverse Event|0|||
27773311|NCT01613248|54226258|FG002|Overall Study|Adverse Event|0|||
27773312|NCT01613248|54226259|FG003|Overall Study|Adverse Event|1|||
27773313|NCT01613248|54226260|FG004|Overall Study|Adverse Event|0|||
27773314|NCT01613248|54226261|FG005|Overall Study|Adverse Event|0|||
27773315|NCT01613248|54226256|FG000|Overall Study|Withdrawal by Subject|3|||
27773316|NCT01613248|54226257|FG001|Overall Study|Withdrawal by Subject|2|||
27773317|NCT01613248|54226258|FG002|Overall Study|Withdrawal by Subject|2|||
27773318|NCT01613248|54226259|FG003|Overall Study|Withdrawal by Subject|5|||
27773319|NCT01613248|54226260|FG004|Overall Study|Withdrawal by Subject|0|||
27773320|NCT01613248|54226261|FG005|Overall Study|Withdrawal by Subject|1|||
27773321|NCT01613248|54226256|FG000|Overall Study|Lost to Follow-up|5|||
27773322|NCT01613248|54226257|FG001|Overall Study|Lost to Follow-up|7|||
27773323|NCT01613248|54226258|FG002|Overall Study|Lost to Follow-up|4|||
27773324|NCT01613248|54226259|FG003|Overall Study|Lost to Follow-up|8|||
27773325|NCT01613248|54226260|FG004|Overall Study|Lost to Follow-up|4|||
27773326|NCT01613248|54226261|FG005|Overall Study|Lost to Follow-up|2|||
27773327|NCT01613248|54226256|FG000|Overall Study|Study Terminated by Sponsor|4|||
27773328|NCT01613248|54226257|FG001|Overall Study|Study Terminated by Sponsor|6|||
27773329|NCT01613248|54226258|FG002|Overall Study|Study Terminated by Sponsor|8|||
27773330|NCT01613248|54226259|FG003|Overall Study|Study Terminated by Sponsor|8|||
27773331|NCT01613248|54226260|FG004|Overall Study|Study Terminated by Sponsor|9|||
27773332|NCT01613248|54226261|FG005|Overall Study|Study Terminated by Sponsor|11|||
27773333|NCT01613248|54226256|FG000|Overall Study|Physician Decision|8|||
27773334|NCT01613248|54226257|FG001|Overall Study|Physician Decision|8|||
27773335|NCT01613248|54226258|FG002|Overall Study|Physician Decision|9|||
27773336|NCT01613248|54226259|FG003|Overall Study|Physician Decision|4|||
27773337|NCT01613248|54226260|FG004|Overall Study|Physician Decision|7|||
27773338|NCT01613248|54226261|FG005|Overall Study|Physician Decision|6|||
27773339|NCT01613248|54226256|FG000|Overall Study|Lack of Qualifying Event|9|||
27773340|NCT01613248|54226257|FG001|Overall Study|Lack of Qualifying Event|11|||
27773341|NCT01613248|54226258|FG002|Overall Study|Lack of Qualifying Event|10|||
27773342|NCT01613248|54226259|FG003|Overall Study|Lack of Qualifying Event|11|||
27773343|NCT01613248|54226260|FG004|Overall Study|Lack of Qualifying Event|15|||
27773344|NCT01613248|54226261|FG005|Overall Study|Lack of Qualifying Event|18|||
27773345|NCT01613248|54226256|FG000|Overall Study|Pregnancy|0|||
27773346|NCT01613248|54226257|FG001|Overall Study|Pregnancy|0|||
27773347|NCT01613248|54226258|FG002|Overall Study|Pregnancy|0|||
27773348|NCT01613248|54226259|FG003|Overall Study|Pregnancy|1|||
27773349|NCT01613248|54226260|FG004|Overall Study|Pregnancy|0|||
27773350|NCT01613248|54226261|FG005|Overall Study|Pregnancy|0|||
27773351|NCT01898806|54226275|FG000|Overall Study|Withdrawal by Subject|2|||
27773352|NCT01898806|54226275|FG000|Overall Study|Physician Decision|1|||
27773353|NCT02291029|54226285|FG000|Overall Study|Withdrawal by Subject|0|||
27773354|NCT02291029|54226286|FG001|Overall Study|Withdrawal by Subject|0|||
27773355|NCT02291029|54226287|FG002|Overall Study|Withdrawal by Subject|1|||
27773356|NCT02291029|54226288|FG003|Overall Study|Withdrawal by Subject|0|||
27840154|NCT01502371|54327485|FG004|Overall Study|Withdrawal by Subject|1|||
27773357|NCT02291029|54226289|FG004|Overall Study|Withdrawal by Subject|0|||
27773358|NCT02291029|54226290|FG005|Overall Study|Withdrawal by Subject|0|||
27773359|NCT02291029|54226285|FG000|Overall Study|Adverse Event|0|||
27773360|NCT02291029|54226286|FG001|Overall Study|Adverse Event|1|||
27840155|NCT01502371|54327481|FG000|Overall Study|Adverse Event|2|||
27773361|NCT02291029|54226287|FG002|Overall Study|Adverse Event|0|||
27773362|NCT02291029|54226288|FG003|Overall Study|Adverse Event|0|||
27773363|NCT02291029|54226289|FG004|Overall Study|Adverse Event|0|||
27773364|NCT02291029|54226290|FG005|Overall Study|Adverse Event|0|||
27840156|NCT01502371|54327482|FG001|Overall Study|Adverse Event|1|||
27773365|NCT02290873|54226307|FG000|Overall Study|Withdrawal by Subject|0|||
27773366|NCT02290873|54226308|FG001|Overall Study|Withdrawal by Subject|1|||
27773367|NCT02290873|54226309|FG002|Overall Study|Withdrawal by Subject|1|||
27773368|NCT02290873|54226307|FG000|Overall Study|Nellcor device error|1|||
27773369|NCT02290873|54226308|FG001|Overall Study|Nellcor device error|0|||
27773370|NCT02290873|54226309|FG002|Overall Study|Nellcor device error|0|||
27773371|NCT02290873|54226307|FG000|Overall Study|Esophagogastroduodenoscopy was added|1|||
27773372|NCT02290873|54226308|FG001|Overall Study|Esophagogastroduodenoscopy was added|0|||
27773373|NCT02290873|54226309|FG002|Overall Study|Esophagogastroduodenoscopy was added|0|||
27773374|NCT02290873|54226307|FG000|Overall Study|Protocol Violation|0|||
27773375|NCT02290873|54226308|FG001|Overall Study|Protocol Violation|0|||
27773376|NCT02290873|54226309|FG002|Overall Study|Protocol Violation|1|||
27773377|NCT02290405|54226320|FG000|Overall Study|Withdrawal by Subject|1|||
27773378|NCT02290405|54226321|FG001|Overall Study|Withdrawal by Subject|0|||
27773379|NCT02359045|54226329|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
27773380|NCT02359045|54226330|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
27773381|NCT02359045|54226329|FG000|Overall Study|Lost to Follow-up|1|||
27773382|NCT02359045|54226330|FG001|Overall Study|Lost to Follow-up|1|||
27773383|NCT02359045|54226329|FG000|Overall Study|Adverse Event|0|||
27773384|NCT02359045|54226330|FG001|Overall Study|Adverse Event|1|||
27773385|NCT02358343|54226351|FG000|Screening Intervention|Death|0|||
27773386|NCT02358343|54226352|FG001|Screening Intervention|Death|2|||
27773387|NCT02358343|54226353|FG002|Screening Intervention|Death|0|||
27773388|NCT02358343|54226354|FG003|Screening Intervention|Death|0|||
27773389|NCT02358343|54226355|FG004|Screening Intervention|Death|0|||
27773390|NCT02358343|54226351|FG000|Screening Intervention|Withdrawal by Subject|1|||
27773391|NCT02358343|54226352|FG001|Screening Intervention|Withdrawal by Subject|0|||
27773392|NCT02358343|54226353|FG002|Screening Intervention|Withdrawal by Subject|0|||
27773393|NCT02358343|54226354|FG003|Screening Intervention|Withdrawal by Subject|0|||
27773394|NCT02358343|54226355|FG004|Screening Intervention|Withdrawal by Subject|0|||
27773395|NCT02358343|54226351|FG000|Screening Intervention|Determined Ineligible|5|||
27773396|NCT02358343|54226352|FG001|Screening Intervention|Determined Ineligible|6|||
27773397|NCT02358343|54226353|FG002|Screening Intervention|Determined Ineligible|0|||
27773398|NCT02358343|54226354|FG003|Screening Intervention|Determined Ineligible|0|||
27773399|NCT02358343|54226355|FG004|Screening Intervention|Determined Ineligible|0|||
27773400|NCT02358343|54226351|FG000|Comparative Efficacy Trial / Observation|Death|0|||
27773401|NCT02358343|54226352|FG001|Comparative Efficacy Trial / Observation|Death|0|||
27773402|NCT02358343|54226353|FG002|Comparative Efficacy Trial / Observation|Death|2|||
27773403|NCT02358343|54226354|FG003|Comparative Efficacy Trial / Observation|Death|0|||
27773404|NCT02358343|54226355|FG004|Comparative Efficacy Trial / Observation|Death|0|||
27773405|NCT02358343|54226351|FG000|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
27773406|NCT02358343|54226352|FG001|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
27773407|NCT02358343|54226353|FG002|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
27773408|NCT02358343|54226354|FG003|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
27773409|NCT02358343|54226355|FG004|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
27773410|NCT02358343|54226351|FG000|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
27773411|NCT02358343|54226352|FG001|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
27773412|NCT02358343|54226353|FG002|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1|||
27773413|NCT02358343|54226354|FG003|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
27773414|NCT02358343|54226355|FG004|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
27773415|NCT02356783|54226368|FG000|Overall Study|Lost to Follow-up|1|||
27773416|NCT02356783|54226369|FG001|Overall Study|Lost to Follow-up|3|||
27773417|NCT02289469|54226377|FG000|Overall Study|Unable to match a control|6|||
27773418|NCT02289469|54226378|FG001|Overall Study|Unable to match a control|0|||
27773419|NCT02318095|54226384|FG000|Overall Study|Adverse Event|1|||
27773420|NCT02317705|54226389|FG000|Overall Study|Withdrawal by Subject|3|||
27773421|NCT02317705|54226389|FG000|Overall Study|Physician Decision|1|||
27773422|NCT02317705|54226389|FG000|Overall Study|Drug not usable|1|||
27773423|NCT02474069|54226393|FG000|Selection Phase (SP)|Adverse Event|8|||
27773424|NCT02474069|54226394|FG001|Selection Phase (SP)|Adverse Event|0|||
27773425|NCT02474069|54226395|FG002|Selection Phase (SP)|Adverse Event|0|||
27773426|NCT02474069|54226393|FG000|Selection Phase (SP)|Lack of Efficacy|1|||
27773427|NCT02474069|54226394|FG001|Selection Phase (SP)|Lack of Efficacy|0|||
27773428|NCT02474069|54226395|FG002|Selection Phase (SP)|Lack of Efficacy|0|||
27773429|NCT02474069|54226393|FG000|Selection Phase (SP)|Lost to Follow-up|4|||
27773430|NCT02474069|54226394|FG001|Selection Phase (SP)|Lost to Follow-up|0|||
27773431|NCT02474069|54226395|FG002|Selection Phase (SP)|Lost to Follow-up|0|||
27773432|NCT02474069|54226393|FG000|Selection Phase (SP)|Physician Decision|1|||
27773433|NCT02474069|54226394|FG001|Selection Phase (SP)|Physician Decision|0|||
27773434|NCT02474069|54226395|FG002|Selection Phase (SP)|Physician Decision|0|||
27773435|NCT02474069|54226393|FG000|Selection Phase (SP)|Protocol Violation|1|||
27773436|NCT02474069|54226394|FG001|Selection Phase (SP)|Protocol Violation|0|||
27773437|NCT02474069|54226395|FG002|Selection Phase (SP)|Protocol Violation|0|||
27773438|NCT02474069|54226393|FG000|Selection Phase (SP)|No longer requires treatment|1|||
27773439|NCT02474069|54226394|FG001|Selection Phase (SP)|No longer requires treatment|0|||
27773440|NCT02474069|54226395|FG002|Selection Phase (SP)|No longer requires treatment|0|||
27773441|NCT02474069|54226393|FG000|Selection Phase (SP)|Technical Problem|1|||
27773442|NCT02474069|54226394|FG001|Selection Phase (SP)|Technical Problem|0|||
27773443|NCT02474069|54226395|FG002|Selection Phase (SP)|Technical Problem|0|||
27773444|NCT02474069|54226393|FG000|Selection Phase (SP)|Withdrawal by Subject|3|||
27773445|NCT02474069|54226394|FG001|Selection Phase (SP)|Withdrawal by Subject|0|||
27773446|NCT02474069|54226395|FG002|Selection Phase (SP)|Withdrawal by Subject|0|||
27773447|NCT02474069|54226393|FG000|Selection Phase (SP)|Withdrawal of Informed Consent|3|||
27773448|NCT02474069|54226394|FG001|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
27773449|NCT02474069|54226395|FG002|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
27773450|NCT02474069|54226393|FG000|Comparative Dosing Phase (CDP)|Adverse Event|0|||
27773451|NCT02474069|54226394|FG001|Comparative Dosing Phase (CDP)|Adverse Event|3|||
27773452|NCT02474069|54226395|FG002|Comparative Dosing Phase (CDP)|Adverse Event|2|||
27773453|NCT02474069|54226393|FG000|Comparative Dosing Phase (CDP)|Lost to Follow-up|0|||
27773454|NCT02474069|54226394|FG001|Comparative Dosing Phase (CDP)|Lost to Follow-up|4|||
27773455|NCT02474069|54226395|FG002|Comparative Dosing Phase (CDP)|Lost to Follow-up|1|||
27773456|NCT02474069|54226393|FG000|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
27773457|NCT02474069|54226394|FG001|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
27773458|NCT02474069|54226395|FG002|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1|||
27773459|NCT02474069|54226393|FG000|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0|||
27773460|NCT02474069|54226394|FG001|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
27773461|NCT02474069|54226395|FG002|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
27773462|NCT02317627|54226408|FG000|Overall Study|Withdrawal by Subject|0|||
27773463|NCT02317627|54226409|FG001|Overall Study|Withdrawal by Subject|1|||
27773464|NCT02317627|54226410|FG002|Overall Study|Withdrawal by Subject|1|||
27773465|NCT02317627|54226408|FG000|Overall Study|Lost to Follow-up|2|||
27773466|NCT02317627|54226409|FG001|Overall Study|Lost to Follow-up|0|||
27773467|NCT02317627|54226410|FG002|Overall Study|Lost to Follow-up|0|||
27773468|NCT02317627|54226408|FG000|Overall Study|Stopped by Investigator|0|||
27773469|NCT02317627|54226409|FG001|Overall Study|Stopped by Investigator|1|||
27773470|NCT02317627|54226410|FG002|Overall Study|Stopped by Investigator|0|||
27773471|NCT02317627|54226408|FG000|Overall Study|Adverse Event|0|||
27773472|NCT02317627|54226409|FG001|Overall Study|Adverse Event|2|||
27773473|NCT02317627|54226410|FG002|Overall Study|Adverse Event|3|||
27773474|NCT02317627|54226408|FG000|Overall Study|Non-compliance with study drug|0|||
27773475|NCT02317627|54226409|FG001|Overall Study|Non-compliance with study drug|1|||
27773476|NCT02317627|54226410|FG002|Overall Study|Non-compliance with study drug|0|||
27773477|NCT02517905|54226426|FG000|Overall Study|Lost to Follow-up|4|||
27773478|NCT02517905|54226427|FG001|Overall Study|Lost to Follow-up|0|||
27773479|NCT02517905|54226426|FG000|Overall Study|Withdrawal by Subject|4|||
27773480|NCT02517905|54226427|FG001|Overall Study|Withdrawal by Subject|0|||
27773481|NCT02517905|54226426|FG000|Overall Study|Screen failure|2|||
27773482|NCT02517905|54226427|FG001|Overall Study|Screen failure|2|||
27773483|NCT02473913|54226435|FG000|Overall Study|Lost to Follow-up|3|||
27773484|NCT02473913|54226436|FG001|Overall Study|Lost to Follow-up|3|||
27773485|NCT02316847|54226444|FG000|Overall Study|Adverse Event|0|||
27773486|NCT02316847|54226445|FG001|Overall Study|Adverse Event|3|||
27773487|NCT02316847|54226444|FG000|Overall Study|Lost to Follow-up|0|||
27773488|NCT02316847|54226445|FG001|Overall Study|Lost to Follow-up|2|||
27773489|NCT02316847|54226444|FG000|Overall Study|Physician Decision|0|||
27773490|NCT02316847|54226445|FG001|Overall Study|Physician Decision|1|||
27773491|NCT02316847|54226444|FG000|Overall Study|Pregnancy|0|||
27773492|NCT02316847|54226445|FG001|Overall Study|Pregnancy|1|||
27773493|NCT02316847|54226444|FG000|Overall Study|Withdrawal by Subject|2|||
27773494|NCT02316847|54226445|FG001|Overall Study|Withdrawal by Subject|9|||
27773495|NCT02316847|54226444|FG000|Overall Study|Noncompliance with study drug|0|||
27773496|NCT02316847|54226445|FG001|Overall Study|Noncompliance with study drug|3|||
27773497|NCT02316847|54226444|FG000|Overall Study|Withdrawn due to termination by Sponsor|7|||
27773498|NCT02316847|54226445|FG001|Overall Study|Withdrawn due to termination by Sponsor|67|||
27773499|NCT02473523|54226453|FG000|Overall Study|Death|1|||
27773500|NCT02473523|54226453|FG000|Overall Study|Lost to Follow-up|1|||
27773501|NCT02316769|54226459|FG000|Overall Study|Physician Decision|1|||
27773502|NCT02316769|54226460|FG001|Overall Study|Physician Decision|0|||
27773503|NCT02316769|54226459|FG000|Overall Study|Withdrawal by Subject|1|||
27773504|NCT02316769|54226460|FG001|Overall Study|Withdrawal by Subject|0|||
27840157|NCT01502371|54327483|FG002|Overall Study|Adverse Event|0|||
27773505|NCT02473445|54226466|FG000|Overall Study|Withdrawal by Subject|2|||
27840158|NCT01502371|54327484|FG003|Overall Study|Adverse Event|4|||
27840159|NCT01502371|54327485|FG004|Overall Study|Adverse Event|3|||
27773506|NCT02473445|54226466|FG000|Overall Study|Sponsor Decision|20|||
27773507|NCT02473367|54226470|FG000|Wait 1|Withdrawal by Subject|1|||
27773508|NCT02473367|54226470|FG000|Period 4|Lost to Follow-up|1|||
27840160|NCT01502371|54327481|FG000|Overall Study|Treatment Failure|22|||
27773509|NCT02316613|54226480|FG000|Overall Study|Death|63|||
27773510|NCT02316613|54226480|FG000|Overall Study|Lost to Follow-up|9|||
27773511|NCT02316613|54226480|FG000|Overall Study|Lymphoma transformation|2|||
27773512|NCT02316613|54226480|FG000|Overall Study|Participant moved/changed medical team|11|||
27773513|NCT02316613|54226480|FG000|Overall Study|No data and duplicate cases|5|||
27773514|NCT02316613|54226480|FG000|Overall Study|Did not met selection criteria|14|||
27773515|NCT02492165|54226499|FG000|Overall Study|Withdrawal by Subject|0|||
27773516|NCT02492165|54226500|FG001|Overall Study|Withdrawal by Subject|1|||
27773517|NCT02492165|54226501|FG002|Overall Study|Withdrawal by Subject|0|||
27773518|NCT02492165|54226502|FG003|Overall Study|Withdrawal by Subject|0|||
27773519|NCT02355691|54226514|FG000|Overall Study|Loss of Research Personnel|7|||
27773520|NCT02355691|54226515|FG001|Overall Study|Loss of Research Personnel|9|||
27773521|NCT02473289|54226523|FG000|Overall Study|Adverse Event|2|||
27773522|NCT02473289|54226524|FG001|Overall Study|Adverse Event|3|||
27773523|NCT02473289|54226523|FG000|Overall Study|Lost to Follow-up|1|||
27773524|NCT02473289|54226524|FG001|Overall Study|Lost to Follow-up|1|||
27773525|NCT02473289|54226523|FG000|Overall Study|Protocol Violation|0|||
27773526|NCT02473289|54226524|FG001|Overall Study|Protocol Violation|1|||
27773527|NCT02473289|54226523|FG000|Overall Study|Withdrawal of consent|6|||
27773528|NCT02473289|54226524|FG001|Overall Study|Withdrawal of consent|7|||
27773529|NCT02473289|54226523|FG000|Overall Study|Treatment Unblinded + Adverse event|0|||
27773530|NCT02473289|54226524|FG001|Overall Study|Treatment Unblinded + Adverse event|1|||
27773531|NCT02473289|54226523|FG000|Overall Study|Other|2|||
27773532|NCT02473289|54226524|FG001|Overall Study|Other|0|||
27773533|NCT02354599|54226536|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
27773534|NCT02354599|54226537|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
27773535|NCT02354599|54226538|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
27773536|NCT02354599|54226539|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
27773537|NCT02354599|54226540|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
27773538|NCT02354599|54226541|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
27773539|NCT02354599|54226536|FG000|Overall Study|Withdrawal by Subject|1|||
27773540|NCT02354599|54226537|FG001|Overall Study|Withdrawal by Subject|1|||
27773541|NCT02354599|54226538|FG002|Overall Study|Withdrawal by Subject|0|||
27773542|NCT02354599|54226539|FG003|Overall Study|Withdrawal by Subject|0|||
27773543|NCT02354599|54226540|FG004|Overall Study|Withdrawal by Subject|0|||
27773544|NCT02354599|54226541|FG005|Overall Study|Withdrawal by Subject|0|||
27773545|NCT02316223|54226564|FG000|Overall Study|Lack of Efficacy|0|||
27773546|NCT02316223|54226565|FG001|Overall Study|Lack of Efficacy|1|||
27773547|NCT02316223|54226566|FG002|Overall Study|Lack of Efficacy|1|||
27773548|NCT02316223|54226564|FG000|Overall Study|Lost to Follow-up|27|||
27773549|NCT02316223|54226565|FG001|Overall Study|Lost to Follow-up|34|||
27773550|NCT02316223|54226566|FG002|Overall Study|Lost to Follow-up|36|||
27773551|NCT02316223|54226564|FG000|Overall Study|COPD Diagnosis|3|||
27773552|NCT02316223|54226565|FG001|Overall Study|COPD Diagnosis|2|||
27773553|NCT02316223|54226566|FG002|Overall Study|COPD Diagnosis|3|||
27773554|NCT02316223|54226564|FG000|Overall Study|Reside outside study area|1|||
27773555|NCT02316223|54226565|FG001|Overall Study|Reside outside study area|1|||
27773556|NCT02316223|54226566|FG002|Overall Study|Reside outside study area|1|||
27773557|NCT02316223|54226564|FG000|Overall Study|No asthma|2|||
27773558|NCT02316223|54226565|FG001|Overall Study|No asthma|0|||
27773559|NCT02316223|54226566|FG002|Overall Study|No asthma|0|||
27773560|NCT02316223|54226564|FG000|Overall Study|Discontinued by PI|11|||
27773561|NCT02316223|54226565|FG001|Overall Study|Discontinued by PI|19|||
27773562|NCT02316223|54226566|FG002|Overall Study|Discontinued by PI|3|||
27773563|NCT02286895|54226576|FG000|Assessed for Measles Seroconversion|Protocol Violation|1|||
27773564|NCT02286895|54226577|FG001|Assessed for Measles Seroconversion|Protocol Violation|4|||
27773565|NCT02286895|54226576|FG000|Assessed for Measles Seroconversion|Missing measurement|6|||
27773566|NCT02286895|54226577|FG001|Assessed for Measles Seroconversion|Missing measurement|3|||
27773567|NCT02286895|54226576|FG000|Assessed for Measles Seroconversion|Baseline measure non-negative|41|||
27773568|NCT02286895|54226577|FG001|Assessed for Measles Seroconversion|Baseline measure non-negative|32|||
27773569|NCT02472977|54226586|FG000|Overall Study|Disease progression|4|||
27773570|NCT02472977|54226587|FG001|Overall Study|Disease progression|25|||
27773571|NCT02472977|54226588|FG002|Overall Study|Disease progression|6|||
27773572|NCT02472977|54226586|FG000|Overall Study|Withdrawal by Subject|0|||
27773573|NCT02472977|54226587|FG001|Overall Study|Withdrawal by Subject|1|||
27773574|NCT02472977|54226588|FG002|Overall Study|Withdrawal by Subject|0|||
27773575|NCT02472977|54226586|FG000|Overall Study|Study drug toxicity|2|||
27773576|NCT02472977|54226587|FG001|Overall Study|Study drug toxicity|0|||
27773577|NCT02472977|54226588|FG002|Overall Study|Study drug toxicity|2|||
27773578|NCT02472977|54226586|FG000|Overall Study|Subject request to discontinue treatment|0|||
27773579|NCT02472977|54226587|FG001|Overall Study|Subject request to discontinue treatment|1|||
27773580|NCT02472977|54226588|FG002|Overall Study|Subject request to discontinue treatment|0|||
27773581|NCT02060487|54226599|FG000|Overall Study|Other|1|||
27773582|NCT02060487|54226600|FG001|Overall Study|Other|2|||
27773583|NCT02060487|54226601|FG002|Overall Study|Other|1|||
27773584|NCT02060487|54226599|FG000|Overall Study|Lack of Efficacy|0|||
27773585|NCT02060487|54226600|FG001|Overall Study|Lack of Efficacy|1|||
27773586|NCT02060487|54226601|FG002|Overall Study|Lack of Efficacy|0|||
27773587|NCT02060487|54226599|FG000|Overall Study|Withdrawal by Subject|3|||
27773588|NCT02060487|54226600|FG001|Overall Study|Withdrawal by Subject|10|||
27773589|NCT02060487|54226601|FG002|Overall Study|Withdrawal by Subject|4|||
27773590|NCT02060487|54226599|FG000|Overall Study|Study Terminated By Sponsor|87|||
27773591|NCT02060487|54226600|FG001|Overall Study|Study Terminated By Sponsor|89|||
27773592|NCT02060487|54226601|FG002|Overall Study|Study Terminated By Sponsor|100|||
27773593|NCT02060487|54226599|FG000|Overall Study|Randomized in error|1|||
27773594|NCT02060487|54226600|FG001|Overall Study|Randomized in error|0|||
27773595|NCT02060487|54226601|FG002|Overall Study|Randomized in error|0|||
27773596|NCT02060487|54226599|FG000|Overall Study|Protocol Violation|0|||
27773597|NCT02060487|54226600|FG001|Overall Study|Protocol Violation|1|||
27773598|NCT02060487|54226601|FG002|Overall Study|Protocol Violation|1|||
27773599|NCT02060487|54226599|FG000|Overall Study|Lost to Follow-up|3|||
27773600|NCT02060487|54226600|FG001|Overall Study|Lost to Follow-up|0|||
27773601|NCT02060487|54226601|FG002|Overall Study|Lost to Follow-up|2|||
27773602|NCT02060487|54226599|FG000|Overall Study|Death|34|||
27773603|NCT02060487|54226600|FG001|Overall Study|Death|25|||
27773604|NCT02060487|54226601|FG002|Overall Study|Death|19|||
27773605|NCT02060487|54226599|FG000|Overall Study|Adverse Event|0|||
27773606|NCT02060487|54226600|FG001|Overall Study|Adverse Event|0|||
27773607|NCT02060487|54226601|FG002|Overall Study|Adverse Event|1|||
27773608|NCT02059395|54226611|FG000|Overall Study|Lost to Follow-up|2|||
27773609|NCT02059395|54226612|FG001|Overall Study|Lost to Follow-up|4|||
27773610|NCT02059239|54226620|FG000|Overall Study|Progressive Disease after Bendamustine|1|||
27773611|NCT02059239|54226621|FG001|Overall Study|Progressive Disease after Bendamustine|3|||
27773612|NCT02059239|54226620|FG000|Overall Study|Physician Decision|1|||
27773613|NCT02059239|54226621|FG001|Overall Study|Physician Decision|0|||
27773614|NCT02059161|54226630|FG000|Overall Study|Pregnancy|0|||
27773615|NCT02059161|54226631|FG001|Overall Study|Pregnancy|2|||
27773616|NCT02059161|54226630|FG000|Overall Study|Adverse Event|2|||
27773617|NCT02059161|54226631|FG001|Overall Study|Adverse Event|6|||
27773618|NCT02059161|54226630|FG000|Overall Study|Lost to Follow-up|20|||
27773619|NCT02059161|54226631|FG001|Overall Study|Lost to Follow-up|12|||
27773620|NCT02059161|54226630|FG000|Overall Study|Physician Decision|4|||
27773621|NCT02059161|54226631|FG001|Overall Study|Physician Decision|4|||
27773622|NCT02059161|54226630|FG000|Overall Study|Protocol Violation|1|||
27773623|NCT02059161|54226631|FG001|Overall Study|Protocol Violation|1|||
27773624|NCT02059161|54226630|FG000|Overall Study|Withdrawal by Subject|16|||
27773625|NCT02059161|54226631|FG001|Overall Study|Withdrawal by Subject|13|||
27773626|NCT02059161|54226630|FG000|Overall Study|Randomized in error, no study drug|0|||
27773627|NCT02059161|54226631|FG001|Overall Study|Randomized in error, no study drug|1|||
27773628|NCT02059161|54226630|FG000|Overall Study|Non-compliance with study drug|6|||
27773629|NCT02059161|54226631|FG001|Overall Study|Non-compliance with study drug|2|||
27773630|NCT01897714|54226643|FG000|Phase I (Dose Escalation)|Disease progression|3|||
27773631|NCT01897714|54226644|FG001|Phase I (Dose Escalation)|Disease progression|5|||
27773632|NCT01897714|54226645|FG002|Phase I (Dose Escalation)|Disease progression|1|||
27773633|NCT01897714|54226646|FG003|Phase I (Dose Escalation)|Disease progression|3|||
27773634|NCT01897714|54226647|FG004|Phase I (Dose Escalation)|Disease progression|0|||
27773635|NCT01897714|54226648|FG005|Phase I (Dose Escalation)|Disease progression|0|||
27773636|NCT01897714|54226643|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
27773637|NCT01897714|54226644|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
27773638|NCT01897714|54226645|FG002|Phase I (Dose Escalation)|Adverse Event|4|||
27773639|NCT01897714|54226646|FG003|Phase I (Dose Escalation)|Adverse Event|3|||
27773640|NCT01897714|54226647|FG004|Phase I (Dose Escalation)|Adverse Event|0|||
27773641|NCT01897714|54226648|FG005|Phase I (Dose Escalation)|Adverse Event|0|||
27773642|NCT01897714|54226643|FG000|Phase I (Dose Escalation)|Other|0|||
27773643|NCT01897714|54226644|FG001|Phase I (Dose Escalation)|Other|1|||
27773644|NCT01897714|54226645|FG002|Phase I (Dose Escalation)|Other|0|||
27773645|NCT01897714|54226646|FG003|Phase I (Dose Escalation)|Other|0|||
27773646|NCT01897714|54226647|FG004|Phase I (Dose Escalation)|Other|0|||
27773647|NCT01897714|54226648|FG005|Phase I (Dose Escalation)|Other|0|||
27773648|NCT01897714|54226643|FG000|Phase II (MTD)|Withdrawal by Subject|0|||
27773649|NCT01897714|54226644|FG001|Phase II (MTD)|Withdrawal by Subject|0|||
27773650|NCT01897714|54226645|FG002|Phase II (MTD)|Withdrawal by Subject|0|||
27773651|NCT01897714|54226646|FG003|Phase II (MTD)|Withdrawal by Subject|0|||
27840161|NCT01502371|54327482|FG001|Overall Study|Treatment Failure|20|||
27773652|NCT01897714|54226647|FG004|Phase II (MTD)|Withdrawal by Subject|0|||
27773653|NCT01897714|54226648|FG005|Phase II (MTD)|Withdrawal by Subject|1|||
27773654|NCT01897714|54226643|FG000|Phase II (MTD)|Lost to Follow-up|0|||
27773655|NCT01897714|54226644|FG001|Phase II (MTD)|Lost to Follow-up|0|||
27773656|NCT01897714|54226645|FG002|Phase II (MTD)|Lost to Follow-up|0|||
27773657|NCT01897714|54226646|FG003|Phase II (MTD)|Lost to Follow-up|0|||
27773658|NCT01897714|54226647|FG004|Phase II (MTD)|Lost to Follow-up|1|||
27773659|NCT01897714|54226648|FG005|Phase II (MTD)|Lost to Follow-up|0|||
27773660|NCT01897714|54226643|FG000|Phase II (MTD)|Death|0|||
27773661|NCT01897714|54226644|FG001|Phase II (MTD)|Death|0|||
27773662|NCT01897714|54226645|FG002|Phase II (MTD)|Death|0|||
27773663|NCT01897714|54226646|FG003|Phase II (MTD)|Death|0|||
27773664|NCT01897714|54226647|FG004|Phase II (MTD)|Death|25|||
27773665|NCT01897714|54226648|FG005|Phase II (MTD)|Death|10|||
27773666|NCT01897714|54226643|FG000|Phase II (MTD)|Study terminated with patient alive|0|||
27773667|NCT01897714|54226644|FG001|Phase II (MTD)|Study terminated with patient alive|0|||
27773668|NCT01897714|54226645|FG002|Phase II (MTD)|Study terminated with patient alive|0|||
27773669|NCT01897714|54226646|FG003|Phase II (MTD)|Study terminated with patient alive|0|||
27773670|NCT01897714|54226647|FG004|Phase II (MTD)|Study terminated with patient alive|1|||
27773671|NCT01897714|54226648|FG005|Phase II (MTD)|Study terminated with patient alive|0|||
27773672|NCT01897714|54226643|FG000|Phase II (MTD)|Other|0|||
27773673|NCT01897714|54226644|FG001|Phase II (MTD)|Other|0|||
27773674|NCT01897714|54226645|FG002|Phase II (MTD)|Other|0|||
27773675|NCT01897714|54226646|FG003|Phase II (MTD)|Other|0|||
27773676|NCT01897714|54226647|FG004|Phase II (MTD)|Other|3|||
27773677|NCT01897714|54226648|FG005|Phase II (MTD)|Other|0|||
27773678|NCT01861522|54226666|FG000|Overall Study|Adverse Event|1|||
27773679|NCT01861522|54226667|FG001|Overall Study|Adverse Event|0|||
27773680|NCT01861522|54226666|FG000|Overall Study|Withdrawal by Subject|2|||
27773681|NCT01861522|54226667|FG001|Overall Study|Withdrawal by Subject|0|||
27773682|NCT01860976|54226675|FG000|Blinded Treatment|Adverse Event|1|||
27773683|NCT01860976|54226676|FG001|Blinded Treatment|Adverse Event|3|||
27773684|NCT01860976|54226675|FG000|Blinded Treatment|Lack of Efficacy|5|||
27773685|NCT01860976|54226676|FG001|Blinded Treatment|Lack of Efficacy|12|||
27773686|NCT01860976|54226675|FG000|Blinded Treatment|Subject request to discontinue treatment|2|||
27773687|NCT01860976|54226676|FG001|Blinded Treatment|Subject request to discontinue treatment|3|||
27773688|NCT01860976|54226675|FG000|Blinded Treatment|Withdrawal by Subject|3|||
27773689|NCT01860976|54226676|FG001|Blinded Treatment|Withdrawal by Subject|5|||
27773690|NCT01860976|54226675|FG000|Blinded Treatment|Subject no longer met criteria|1|||
27773691|NCT01860976|54226676|FG001|Blinded Treatment|Subject no longer met criteria|0|||
27773692|NCT01860976|54226675|FG000|Blinded Treatment|Entered Open-Label in error|0|||
27773693|NCT01860976|54226676|FG001|Blinded Treatment|Entered Open-Label in error|1|||
27773694|NCT01860976|54226675|FG000|Blinded Treatment|Early Escape: Transitioned to OL period|76|||
27773695|NCT01860976|54226676|FG001|Blinded Treatment|Early Escape: Transitioned to OL period|89|||
27773696|NCT01860976|54226675|FG000|Open-Label|Adverse Event|2|||
27773697|NCT01860976|54226676|FG001|Open-Label|Adverse Event|4|||
27773698|NCT01860976|54226675|FG000|Open-Label|Lack of Efficacy|16|||
27773699|NCT01860976|54226676|FG001|Open-Label|Lack of Efficacy|8|||
27773700|NCT01860976|54226675|FG000|Open-Label|Lost to Follow-up|1|||
27773701|NCT01860976|54226676|FG001|Open-Label|Lost to Follow-up|2|||
27773702|NCT01860976|54226675|FG000|Open-Label|Subject request discontinue treatment|4|||
27773703|NCT01860976|54226676|FG001|Open-Label|Subject request discontinue treatment|3|||
27773704|NCT01860976|54226675|FG000|Open-Label|Withdrawal by Subject|4|||
27773705|NCT01860976|54226676|FG001|Open-Label|Withdrawal by Subject|1|||
27773706|NCT01860976|54226675|FG000|Open-Label|Other Reasons|1|||
27773707|NCT01860976|54226676|FG001|Open-Label|Other Reasons|1|||
27773708|NCT01860976|54226675|FG000|Long Term Extension|Adverse Event|4|||
27773709|NCT01860976|54226676|FG001|Long Term Extension|Adverse Event|0|||
27773710|NCT01860976|54226675|FG000|Long Term Extension|Lack of Efficacy|2|||
27773711|NCT01860976|54226676|FG001|Long Term Extension|Lack of Efficacy|0|||
27773712|NCT01860976|54226675|FG000|Long Term Extension|Subject request to discontinue treatment|10|||
27773713|NCT01860976|54226676|FG001|Long Term Extension|Subject request to discontinue treatment|0|||
27773714|NCT01860976|54226675|FG000|Long Term Extension|Lost to Follow-up|2|||
27773715|NCT01860976|54226676|FG001|Long Term Extension|Lost to Follow-up|0|||
27773716|NCT01860976|54226675|FG000|Long Term Extension|subject withdrew consent|7|||
27773717|NCT01860976|54226676|FG001|Long Term Extension|subject withdrew consent|0|||
27773718|NCT01860040|54226687|FG000|Overall Study|Withdrawal by Subject|1|||
27773719|NCT01860040|54226688|FG001|Overall Study|Withdrawal by Subject|0|||
27840162|NCT01502371|54327483|FG002|Overall Study|Treatment Failure|12|||
27773720|NCT01896934|54226693|FG000|Overall Study|Adverse Event|1|||
27773721|NCT01896934|54226693|FG000|Overall Study|Withdrawal by Subject|1|||
27773722|NCT02039505|54226700|FG000|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2|||
27773723|NCT02039505|54226701|FG001|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8|||
27773724|NCT02039505|54226702|FG002|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7|||
27773725|NCT02039505|54226703|FG003|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
27773726|NCT02039505|54226704|FG004|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
27773727|NCT02039505|54226705|FG005|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
27831234|NCT01610063|54307597|FG001|Overall Study|Lost to Follow-up|20|||
27831235|NCT01813721|54307603|FG000|Overall Study|Ineligibility determined|63|||
27831236|NCT01813721|54307603|FG000|Overall Study|Withdrawal by Subject|1|||
27831237|NCT01790633|54307627|FG000|Overall Study|Protocol Violation|1|||
27831238|NCT01790633|54307628|FG001|Overall Study|Protocol Violation|2|||
27831239|NCT01790633|54307627|FG000|Overall Study|Did not have serology performed|47|||
27831240|NCT01790633|54307628|FG001|Overall Study|Did not have serology performed|0|||
27773728|NCT02039505|54226706|FG006|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
27773729|NCT02039505|54226700|FG000|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
27773730|NCT02039505|54226701|FG001|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
27773731|NCT02039505|54226702|FG002|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3|||
27773732|NCT02039505|54226703|FG003|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
27773733|NCT02039505|54226704|FG004|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
27773734|NCT02039505|54226705|FG005|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
27773735|NCT02039505|54226706|FG006|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
27773736|NCT02039505|54226700|FG000|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1|||
27773737|NCT02039505|54226701|FG001|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
27773738|NCT02039505|54226702|FG002|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
27773739|NCT02039505|54226703|FG003|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
27773740|NCT02039505|54226704|FG004|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
27773741|NCT02039505|54226705|FG005|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
27773742|NCT02039505|54226706|FG006|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
27773743|NCT02039505|54226700|FG000|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
27773744|NCT02039505|54226701|FG001|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
27773745|NCT02039505|54226702|FG002|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
27773746|NCT02039505|54226703|FG003|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13|||
27773747|NCT02039505|54226704|FG004|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8|||
27773748|NCT02039505|54226705|FG005|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12|||
27773749|NCT02039505|54226706|FG006|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
27773750|NCT02039505|54226700|FG000|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
27773751|NCT02039505|54226701|FG001|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
27773752|NCT02039505|54226702|FG002|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
27773753|NCT02039505|54226703|FG003|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6|||
27773754|NCT02039505|54226704|FG004|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
27773755|NCT02039505|54226705|FG005|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
27773756|NCT02039505|54226706|FG006|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
27773757|NCT02039505|54226700|FG000|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
27773758|NCT02039505|54226701|FG001|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
27773759|NCT02039505|54226702|FG002|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
27773760|NCT02039505|54226703|FG003|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3|||
27773761|NCT02039505|54226704|FG004|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2|||
27773762|NCT02039505|54226705|FG005|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1|||
27773763|NCT02039505|54226706|FG006|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
27773764|NCT02039505|54226700|FG000|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
27773765|NCT02039505|54226701|FG001|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
27773766|NCT02039505|54226702|FG002|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
27773767|NCT02039505|54226703|FG003|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2|||
27773768|NCT02039505|54226704|FG004|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
27773769|NCT02039505|54226705|FG005|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
27773770|NCT02039505|54226706|FG006|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
27773771|NCT02039505|54226700|FG000|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
27773772|NCT02039505|54226701|FG001|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
27773773|NCT02039505|54226702|FG002|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
27773774|NCT02039505|54226703|FG003|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
27773775|NCT02039505|54226704|FG004|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
27773776|NCT02039505|54226705|FG005|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
27773777|NCT02039505|54226706|FG006|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44|||
27773778|NCT02039505|54226700|FG000|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
27773779|NCT02039505|54226701|FG001|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
27773780|NCT02039505|54226702|FG002|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
27773781|NCT02039505|54226703|FG003|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
27773782|NCT02039505|54226704|FG004|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
27773783|NCT02039505|54226705|FG005|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
27773784|NCT02039505|54226706|FG006|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19|||
27773785|NCT02039505|54226700|FG000|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
27773786|NCT02039505|54226701|FG001|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
27773787|NCT02039505|54226702|FG002|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
27773788|NCT02039505|54226703|FG003|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
27773789|NCT02039505|54226704|FG004|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
27773790|NCT02039505|54226705|FG005|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
27773791|NCT02039505|54226706|FG006|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7|||
27773792|NCT02039505|54226700|FG000|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
27773793|NCT02039505|54226701|FG001|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
27773794|NCT02039505|54226702|FG002|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
27773795|NCT02039505|54226703|FG003|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
27773796|NCT02039505|54226704|FG004|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
27773797|NCT02039505|54226705|FG005|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
27773798|NCT02039505|54226706|FG006|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1|||
27773799|NCT02095197|54226728|FG000|Overall Study|Lost to Follow-up|0|||
27773800|NCT02095197|54226729|FG001|Overall Study|Lost to Follow-up|3|||
27773801|NCT02039427|54226739|FG000|Overall Study|Duration of surgery > 3h|1|||
27773802|NCT02039427|54226740|FG001|Overall Study|Duration of surgery > 3h|1|||
27773803|NCT02039427|54226741|FG002|Overall Study|Duration of surgery > 3h|0|||
27773804|NCT02039427|54226742|FG003|Overall Study|Duration of surgery > 3h|0|||
27773805|NCT02039427|54226739|FG000|Overall Study|Withdrawal on concent|0|||
27773806|NCT02039427|54226740|FG001|Overall Study|Withdrawal on concent|0|||
27773807|NCT02039427|54226741|FG002|Overall Study|Withdrawal on concent|0|||
27773808|NCT02039427|54226742|FG003|Overall Study|Withdrawal on concent|1|||
27773809|NCT02039427|54226739|FG000|Overall Study|Cancellation of surgery|0|||
27773810|NCT02039427|54226740|FG001|Overall Study|Cancellation of surgery|0|||
27773811|NCT02039427|54226741|FG002|Overall Study|Cancellation of surgery|1|||
27773812|NCT02039427|54226742|FG003|Overall Study|Cancellation of surgery|0|||
27773813|NCT02039427|54226739|FG000|Overall Study|Loss of follow - up|1|||
27773814|NCT02039427|54226740|FG001|Overall Study|Loss of follow - up|0|||
27773815|NCT02039427|54226741|FG002|Overall Study|Loss of follow - up|2|||
27773816|NCT02039427|54226742|FG003|Overall Study|Loss of follow - up|4|||
27773817|NCT02039427|54226739|FG000|Overall Study|Steroid Use|1|||
27773818|NCT02039427|54226740|FG001|Overall Study|Steroid Use|0|||
27773819|NCT02039427|54226741|FG002|Overall Study|Steroid Use|0|||
27773820|NCT02039427|54226742|FG003|Overall Study|Steroid Use|0|||
27773821|NCT02094885|54226758|FG000|Overall Study|Death|1|||
27773822|NCT02094885|54226759|FG001|Overall Study|Death|5|||
27773823|NCT02094885|54226758|FG000|Overall Study|Withdrawn due to age|1|||
27773824|NCT02094885|54226759|FG001|Overall Study|Withdrawn due to age|0|||
27773825|NCT01896856|54226771|FG000|Overall Study|Transportation issues / Non-compliance|0|||
27773826|NCT01896856|54226772|FG001|Overall Study|Transportation issues / Non-compliance|0|||
27773827|NCT01896856|54226773|FG002|Overall Study|Transportation issues / Non-compliance|1|||
27773828|NCT01896856|54226774|FG003|Overall Study|Transportation issues / Non-compliance|0|||
27773829|NCT01896856|54226775|FG004|Overall Study|Transportation issues / Non-compliance|0|||
27773830|NCT01896856|54226776|FG005|Overall Study|Transportation issues / Non-compliance|0|||
27773831|NCT02038959|54226793|FG000|Overall Study|Withdrawal by Subject|6|||
27773832|NCT02038959|54226794|FG001|Overall Study|Withdrawal by Subject|8|||
27773833|NCT01896700|54226802|FG000|Overall Study|Adverse Event|4|||
27773834|NCT01896700|54226803|FG001|Overall Study|Adverse Event|5|||
27773835|NCT01896700|54226802|FG000|Overall Study|Withdrawal by Subject|0|||
27773836|NCT01896700|54226803|FG001|Overall Study|Withdrawal by Subject|1|||
27773837|NCT02352493|54226827|FG000|Overall Study|Pregnancy|0|||
27773838|NCT02352493|54226828|FG001|Overall Study|Pregnancy|0|||
27773839|NCT02352493|54226829|FG002|Overall Study|Pregnancy|0|||
27773840|NCT02352493|54226830|FG003|Overall Study|Pregnancy|0|||
27773841|NCT02352493|54226831|FG004|Overall Study|Pregnancy|0|||
27773842|NCT02352493|54226832|FG005|Overall Study|Pregnancy|0|||
27773843|NCT02352493|54226833|FG006|Overall Study|Pregnancy|1|||
27773844|NCT02352493|54226834|FG007|Overall Study|Pregnancy|0|||
27773845|NCT02352493|54226835|FG008|Overall Study|Pregnancy|1|||
27773846|NCT02352493|54226836|FG009|Overall Study|Pregnancy|0|||
27773847|NCT02352493|54226837|FG010|Overall Study|Pregnancy|0|||
27773848|NCT02352493|54226838|FG011|Overall Study|Pregnancy|0|||
27773849|NCT02352493|54226839|FG012|Overall Study|Pregnancy|0|||
27773850|NCT02352493|54226840|FG013|Overall Study|Pregnancy|0|||
27773851|NCT02352493|54226841|FG014|Overall Study|Pregnancy|0|||
27773852|NCT02352493|54226842|FG015|Overall Study|Pregnancy|0|||
27773853|NCT02352493|54226843|FG016|Overall Study|Pregnancy|0|||
27773854|NCT02352493|54226844|FG017|Overall Study|Pregnancy|0|||
27773855|NCT02352493|54226827|FG000|Overall Study|Withdrawal by Subject|0|||
27773856|NCT02352493|54226828|FG001|Overall Study|Withdrawal by Subject|0|||
27773857|NCT02352493|54226829|FG002|Overall Study|Withdrawal by Subject|0|||
27773858|NCT02352493|54226830|FG003|Overall Study|Withdrawal by Subject|0|||
27773859|NCT02352493|54226831|FG004|Overall Study|Withdrawal by Subject|0|||
27773860|NCT02352493|54226832|FG005|Overall Study|Withdrawal by Subject|0|||
27773861|NCT02352493|54226833|FG006|Overall Study|Withdrawal by Subject|0|||
27773862|NCT02352493|54226834|FG007|Overall Study|Withdrawal by Subject|0|||
27773863|NCT02352493|54226835|FG008|Overall Study|Withdrawal by Subject|1|||
27773864|NCT02352493|54226836|FG009|Overall Study|Withdrawal by Subject|0|||
27773865|NCT02352493|54226837|FG010|Overall Study|Withdrawal by Subject|0|||
27773866|NCT02352493|54226838|FG011|Overall Study|Withdrawal by Subject|0|||
27773867|NCT02352493|54226839|FG012|Overall Study|Withdrawal by Subject|0|||
27773868|NCT02352493|54226840|FG013|Overall Study|Withdrawal by Subject|0|||
27773869|NCT02352493|54226841|FG014|Overall Study|Withdrawal by Subject|1|||
27773870|NCT02352493|54226842|FG015|Overall Study|Withdrawal by Subject|0|||
27773871|NCT02352493|54226843|FG016|Overall Study|Withdrawal by Subject|0|||
27773872|NCT02352493|54226844|FG017|Overall Study|Withdrawal by Subject|0|||
27773873|NCT02352493|54226827|FG000|Overall Study|Lost to Follow-up|0|||
27773874|NCT02352493|54226828|FG001|Overall Study|Lost to Follow-up|0|||
27773875|NCT02352493|54226829|FG002|Overall Study|Lost to Follow-up|0|||
27773876|NCT02352493|54226830|FG003|Overall Study|Lost to Follow-up|0|||
27773877|NCT02352493|54226831|FG004|Overall Study|Lost to Follow-up|0|||
27773878|NCT02352493|54226832|FG005|Overall Study|Lost to Follow-up|0|||
27773879|NCT02352493|54226833|FG006|Overall Study|Lost to Follow-up|0|||
27773880|NCT02352493|54226834|FG007|Overall Study|Lost to Follow-up|0|||
27773881|NCT02352493|54226835|FG008|Overall Study|Lost to Follow-up|0|||
27773882|NCT02352493|54226836|FG009|Overall Study|Lost to Follow-up|1|||
27773883|NCT02352493|54226837|FG010|Overall Study|Lost to Follow-up|0|||
27773884|NCT02352493|54226838|FG011|Overall Study|Lost to Follow-up|0|||
27773885|NCT02352493|54226839|FG012|Overall Study|Lost to Follow-up|1|||
27773886|NCT02352493|54226840|FG013|Overall Study|Lost to Follow-up|2|||
27773887|NCT02352493|54226841|FG014|Overall Study|Lost to Follow-up|0|||
27773888|NCT02352493|54226842|FG015|Overall Study|Lost to Follow-up|0|||
27773889|NCT02352493|54226843|FG016|Overall Study|Lost to Follow-up|0|||
27773890|NCT02352493|54226844|FG017|Overall Study|Lost to Follow-up|0|||
27773891|NCT02286193|54226899|FG000|Overall Study|Referred: CRS unable to make contact|62|||
27773892|NCT02286193|54226899|FG000|Overall Study|Referred: unable to reach/resource sent|104|||
27773893|NCT02286193|54226899|FG000|Overall Study|Referred: Declined service|38|||
27773894|NCT01896232|54226906|FG000|Overall Study|Death|6|||
27773895|NCT01896232|54226907|FG001|Overall Study|Death|10|||
27773896|NCT01896232|54226906|FG000|Overall Study|Withdrawal by Subject|32|||
27773897|NCT01896232|54226907|FG001|Overall Study|Withdrawal by Subject|31|||
27773898|NCT01896232|54226906|FG000|Overall Study|Sponsor Decision|2|||
27773899|NCT01896232|54226907|FG001|Overall Study|Sponsor Decision|0|||
27773900|NCT01896232|54226906|FG000|Overall Study|Lost to Follow-up|9|||
27773901|NCT01896232|54226907|FG001|Overall Study|Lost to Follow-up|12|||
27773902|NCT02460224|54226942|FG000|Overall Study|Adverse Event|0|||
27773903|NCT02460224|54226943|FG001|Overall Study|Adverse Event|0|||
27773904|NCT02460224|54226944|FG002|Overall Study|Adverse Event|0|||
27773905|NCT02460224|54226945|FG003|Overall Study|Adverse Event|0|||
27773906|NCT02460224|54226946|FG004|Overall Study|Adverse Event|0|||
27773907|NCT02460224|54226947|FG005|Overall Study|Adverse Event|0|||
27773908|NCT02460224|54226948|FG006|Overall Study|Adverse Event|1|||
27773909|NCT02460224|54226949|FG007|Overall Study|Adverse Event|0|||
27773910|NCT02460224|54226950|FG008|Overall Study|Adverse Event|0|||
27773911|NCT02460224|54226951|FG009|Overall Study|Adverse Event|0|||
27773912|NCT02460224|54226952|FG010|Overall Study|Adverse Event|0|||
27773913|NCT02460224|54226953|FG011|Overall Study|Adverse Event|0|||
27773914|NCT02460224|54226954|FG012|Overall Study|Adverse Event|1|||
27773915|NCT02460224|54226955|FG013|Overall Study|Adverse Event|0|||
27773916|NCT02460224|54226956|FG014|Overall Study|Adverse Event|0|||
27773917|NCT02460224|54226957|FG015|Overall Study|Adverse Event|0|||
27773918|NCT02460224|54226958|FG016|Overall Study|Adverse Event|1|||
27773919|NCT02460224|54226959|FG017|Overall Study|Adverse Event|0|||
27773920|NCT02460224|54226960|FG018|Overall Study|Adverse Event|1|||
27773921|NCT02460224|54226961|FG019|Overall Study|Adverse Event|0|||
27773922|NCT02460224|54226962|FG020|Overall Study|Adverse Event|1|||
27773923|NCT02460224|54226963|FG021|Overall Study|Adverse Event|1|||
27773924|NCT02460224|54226964|FG022|Overall Study|Adverse Event|1|||
27773925|NCT02460224|54226965|FG023|Overall Study|Adverse Event|0|||
27773926|NCT02460224|54226966|FG024|Overall Study|Adverse Event|0|||
27773927|NCT02460224|54226967|FG025|Overall Study|Adverse Event|0|||
27773928|NCT02460224|54226968|FG026|Overall Study|Adverse Event|11|||
27773929|NCT02460224|54226969|FG027|Overall Study|Adverse Event|1|||
27773930|NCT02460224|54226970|FG028|Overall Study|Adverse Event|6|||
27773931|NCT02460224|54226942|FG000|Overall Study|Death|0|||
27773932|NCT02460224|54226943|FG001|Overall Study|Death|0|||
27773933|NCT02460224|54226944|FG002|Overall Study|Death|0|||
27773934|NCT02460224|54226945|FG003|Overall Study|Death|0|||
27773935|NCT02460224|54226946|FG004|Overall Study|Death|0|||
27773936|NCT02460224|54226947|FG005|Overall Study|Death|2|||
27773937|NCT02460224|54226948|FG006|Overall Study|Death|1|||
27773938|NCT02460224|54226949|FG007|Overall Study|Death|0|||
27773939|NCT02460224|54226950|FG008|Overall Study|Death|0|||
27773940|NCT02460224|54226951|FG009|Overall Study|Death|1|||
27773941|NCT02460224|54226952|FG010|Overall Study|Death|0|||
27773942|NCT02460224|54226953|FG011|Overall Study|Death|0|||
27773943|NCT02460224|54226954|FG012|Overall Study|Death|0|||
27773944|NCT02460224|54226955|FG013|Overall Study|Death|1|||
27773945|NCT02460224|54226956|FG014|Overall Study|Death|0|||
27773946|NCT02460224|54226957|FG015|Overall Study|Death|0|||
27773947|NCT02460224|54226958|FG016|Overall Study|Death|2|||
27773948|NCT02460224|54226959|FG017|Overall Study|Death|1|||
27773949|NCT02460224|54226960|FG018|Overall Study|Death|0|||
27773950|NCT02460224|54226961|FG019|Overall Study|Death|2|||
27773951|NCT02460224|54226962|FG020|Overall Study|Death|0|||
27773952|NCT02460224|54226963|FG021|Overall Study|Death|0|||
27773953|NCT02460224|54226964|FG022|Overall Study|Death|0|||
27773954|NCT02460224|54226965|FG023|Overall Study|Death|0|||
27773955|NCT02460224|54226966|FG024|Overall Study|Death|1|||
27773956|NCT02460224|54226967|FG025|Overall Study|Death|1|||
27773957|NCT02460224|54226968|FG026|Overall Study|Death|5|||
27773958|NCT02460224|54226969|FG027|Overall Study|Death|0|||
27773959|NCT02460224|54226970|FG028|Overall Study|Death|1|||
27773960|NCT02460224|54226942|FG000|Overall Study|Lost to Follow-up|0|||
27773961|NCT02460224|54226943|FG001|Overall Study|Lost to Follow-up|0|||
27773962|NCT02460224|54226944|FG002|Overall Study|Lost to Follow-up|0|||
27773963|NCT02460224|54226945|FG003|Overall Study|Lost to Follow-up|0|||
27773964|NCT02460224|54226946|FG004|Overall Study|Lost to Follow-up|0|||
27773965|NCT02460224|54226947|FG005|Overall Study|Lost to Follow-up|0|||
27773966|NCT02460224|54226948|FG006|Overall Study|Lost to Follow-up|0|||
27773967|NCT02460224|54226949|FG007|Overall Study|Lost to Follow-up|0|||
27773968|NCT02460224|54226950|FG008|Overall Study|Lost to Follow-up|0|||
27773969|NCT02460224|54226951|FG009|Overall Study|Lost to Follow-up|0|||
27773970|NCT02460224|54226952|FG010|Overall Study|Lost to Follow-up|0|||
27773971|NCT02460224|54226953|FG011|Overall Study|Lost to Follow-up|0|||
27773972|NCT02460224|54226954|FG012|Overall Study|Lost to Follow-up|0|||
27773973|NCT02460224|54226955|FG013|Overall Study|Lost to Follow-up|0|||
27773974|NCT02460224|54226956|FG014|Overall Study|Lost to Follow-up|0|||
27773975|NCT02460224|54226957|FG015|Overall Study|Lost to Follow-up|0|||
27773976|NCT02460224|54226958|FG016|Overall Study|Lost to Follow-up|0|||
27773977|NCT02460224|54226959|FG017|Overall Study|Lost to Follow-up|0|||
27773978|NCT02460224|54226960|FG018|Overall Study|Lost to Follow-up|0|||
27773979|NCT02460224|54226961|FG019|Overall Study|Lost to Follow-up|0|||
27773980|NCT02460224|54226962|FG020|Overall Study|Lost to Follow-up|0|||
27773981|NCT02460224|54226963|FG021|Overall Study|Lost to Follow-up|0|||
27773982|NCT02460224|54226964|FG022|Overall Study|Lost to Follow-up|1|||
27773983|NCT02460224|54226965|FG023|Overall Study|Lost to Follow-up|0|||
27773984|NCT02460224|54226966|FG024|Overall Study|Lost to Follow-up|0|||
27773985|NCT02460224|54226967|FG025|Overall Study|Lost to Follow-up|0|||
27773986|NCT02460224|54226968|FG026|Overall Study|Lost to Follow-up|0|||
27773987|NCT02460224|54226969|FG027|Overall Study|Lost to Follow-up|0|||
27773988|NCT02460224|54226970|FG028|Overall Study|Lost to Follow-up|0|||
27773989|NCT02460224|54226942|FG000|Overall Study|Physician Decision|0|||
27773990|NCT02460224|54226943|FG001|Overall Study|Physician Decision|1|||
27773991|NCT02460224|54226944|FG002|Overall Study|Physician Decision|0|||
27773992|NCT02460224|54226945|FG003|Overall Study|Physician Decision|0|||
27773993|NCT02460224|54226946|FG004|Overall Study|Physician Decision|1|||
27773994|NCT02460224|54226947|FG005|Overall Study|Physician Decision|0|||
27773995|NCT02460224|54226948|FG006|Overall Study|Physician Decision|0|||
27773996|NCT02460224|54226949|FG007|Overall Study|Physician Decision|1|||
27773997|NCT02460224|54226950|FG008|Overall Study|Physician Decision|0|||
27773998|NCT02460224|54226951|FG009|Overall Study|Physician Decision|0|||
27773999|NCT02460224|54226952|FG010|Overall Study|Physician Decision|0|||
27774000|NCT02460224|54226953|FG011|Overall Study|Physician Decision|1|||
27774001|NCT02460224|54226954|FG012|Overall Study|Physician Decision|0|||
27774002|NCT02460224|54226955|FG013|Overall Study|Physician Decision|1|||
27774003|NCT02460224|54226956|FG014|Overall Study|Physician Decision|0|||
27774004|NCT02460224|54226957|FG015|Overall Study|Physician Decision|0|||
27774005|NCT02460224|54226958|FG016|Overall Study|Physician Decision|2|||
27774006|NCT02460224|54226959|FG017|Overall Study|Physician Decision|1|||
27774007|NCT02460224|54226960|FG018|Overall Study|Physician Decision|1|||
27774008|NCT02460224|54226961|FG019|Overall Study|Physician Decision|2|||
27774009|NCT02460224|54226962|FG020|Overall Study|Physician Decision|1|||
27774010|NCT02460224|54226963|FG021|Overall Study|Physician Decision|1|||
27774011|NCT02460224|54226964|FG022|Overall Study|Physician Decision|0|||
27774012|NCT02460224|54226965|FG023|Overall Study|Physician Decision|0|||
27774013|NCT02460224|54226966|FG024|Overall Study|Physician Decision|1|||
27774014|NCT02460224|54226967|FG025|Overall Study|Physician Decision|0|||
27774015|NCT02460224|54226968|FG026|Overall Study|Physician Decision|14|||
27774016|NCT02460224|54226969|FG027|Overall Study|Physician Decision|1|||
27774017|NCT02460224|54226970|FG028|Overall Study|Physician Decision|6|||
27774018|NCT02460224|54226942|FG000|Overall Study|Progressive disease|15|||
27774019|NCT02460224|54226943|FG001|Overall Study|Progressive disease|11|||
27774020|NCT02460224|54226944|FG002|Overall Study|Progressive disease|5|||
27774021|NCT02460224|54226945|FG003|Overall Study|Progressive disease|6|||
27774022|NCT02460224|54226946|FG004|Overall Study|Progressive disease|3|||
27774023|NCT02460224|54226947|FG005|Overall Study|Progressive disease|26|||
27774024|NCT02460224|54226948|FG006|Overall Study|Progressive disease|28|||
27774025|NCT02460224|54226949|FG007|Overall Study|Progressive disease|4|||
27774026|NCT02460224|54226950|FG008|Overall Study|Progressive disease|5|||
27774027|NCT02460224|54226951|FG009|Overall Study|Progressive disease|9|||
27774028|NCT02460224|54226952|FG010|Overall Study|Progressive disease|5|||
27774029|NCT02460224|54226953|FG011|Overall Study|Progressive disease|4|||
27774030|NCT02460224|54226954|FG012|Overall Study|Progressive disease|5|||
27774031|NCT02460224|54226955|FG013|Overall Study|Progressive disease|4|||
27774032|NCT02460224|54226956|FG014|Overall Study|Progressive disease|5|||
27774033|NCT02460224|54226957|FG015|Overall Study|Progressive disease|5|||
27774034|NCT02460224|54226958|FG016|Overall Study|Progressive disease|15|||
27774035|NCT02460224|54226959|FG017|Overall Study|Progressive disease|3|||
27774036|NCT02460224|54226960|FG018|Overall Study|Progressive disease|8|||
27774037|NCT02460224|54226961|FG019|Overall Study|Progressive disease|3|||
27774038|NCT02460224|54226962|FG020|Overall Study|Progressive disease|4|||
27774039|NCT02460224|54226963|FG021|Overall Study|Progressive disease|9|||
27774040|NCT02460224|54226964|FG022|Overall Study|Progressive disease|4|||
27774041|NCT02460224|54226965|FG023|Overall Study|Progressive disease|11|||
27774042|NCT02460224|54226966|FG024|Overall Study|Progressive disease|4|||
27774043|NCT02460224|54226967|FG025|Overall Study|Progressive disease|5|||
27774044|NCT02460224|54226968|FG026|Overall Study|Progressive disease|85|||
27774045|NCT02460224|54226969|FG027|Overall Study|Progressive disease|17|||
27774046|NCT02460224|54226970|FG028|Overall Study|Progressive disease|77|||
27774047|NCT02460224|54226942|FG000|Overall Study|Subject/guardian decision|2|||
27774048|NCT02460224|54226943|FG001|Overall Study|Subject/guardian decision|0|||
27774049|NCT02460224|54226944|FG002|Overall Study|Subject/guardian decision|1|||
27774050|NCT02460224|54226945|FG003|Overall Study|Subject/guardian decision|0|||
27774051|NCT02460224|54226946|FG004|Overall Study|Subject/guardian decision|2|||
27774052|NCT02460224|54226947|FG005|Overall Study|Subject/guardian decision|2|||
27774053|NCT02460224|54226948|FG006|Overall Study|Subject/guardian decision|0|||
27774054|NCT02460224|54226949|FG007|Overall Study|Subject/guardian decision|0|||
27774055|NCT02460224|54226950|FG008|Overall Study|Subject/guardian decision|1|||
27774056|NCT02460224|54226951|FG009|Overall Study|Subject/guardian decision|1|||
27774057|NCT02460224|54226952|FG010|Overall Study|Subject/guardian decision|0|||
27774058|NCT02460224|54226953|FG011|Overall Study|Subject/guardian decision|1|||
27774059|NCT02460224|54226954|FG012|Overall Study|Subject/guardian decision|0|||
27774060|NCT02460224|54226955|FG013|Overall Study|Subject/guardian decision|0|||
27774061|NCT02460224|54226956|FG014|Overall Study|Subject/guardian decision|0|||
27774062|NCT02460224|54226957|FG015|Overall Study|Subject/guardian decision|1|||
27774063|NCT02460224|54226958|FG016|Overall Study|Subject/guardian decision|0|||
27774064|NCT02460224|54226959|FG017|Overall Study|Subject/guardian decision|1|||
27774065|NCT02460224|54226960|FG018|Overall Study|Subject/guardian decision|2|||
27774066|NCT02460224|54226961|FG019|Overall Study|Subject/guardian decision|0|||
27774067|NCT02460224|54226962|FG020|Overall Study|Subject/guardian decision|0|||
27774068|NCT02460224|54226963|FG021|Overall Study|Subject/guardian decision|1|||
27774069|NCT02460224|54226964|FG022|Overall Study|Subject/guardian decision|0|||
27774070|NCT02460224|54226965|FG023|Overall Study|Subject/guardian decision|0|||
27774071|NCT02460224|54226966|FG024|Overall Study|Subject/guardian decision|0|||
27774072|NCT02460224|54226967|FG025|Overall Study|Subject/guardian decision|0|||
27774073|NCT02460224|54226968|FG026|Overall Study|Subject/guardian decision|6|||
27774074|NCT02460224|54226969|FG027|Overall Study|Subject/guardian decision|2|||
27774075|NCT02460224|54226970|FG028|Overall Study|Subject/guardian decision|3|||
27774076|NCT02094573|54227044|FG000|Overall Study|Adverse Event|4|||
27774077|NCT02094573|54227045|FG001|Overall Study|Adverse Event|14|||
27774078|NCT02094573|54227044|FG000|Overall Study|Clinical Progressive Disease|9|||
27774079|NCT02094573|54227045|FG001|Overall Study|Clinical Progressive Disease|13|||
27774080|NCT02094573|54227044|FG000|Overall Study|Death|11|||
27774081|NCT02094573|54227045|FG001|Overall Study|Death|3|||
27774082|NCT02094573|54227044|FG000|Overall Study|Documented Progressive Disease (RECIST 1.1)|63|||
27774083|NCT02094573|54227045|FG001|Overall Study|Documented Progressive Disease (RECIST 1.1)|50|||
27774084|NCT02094573|54227044|FG000|Overall Study|Non-compliance with Study Drug|1|||
27774085|NCT02094573|54227045|FG001|Overall Study|Non-compliance with Study Drug|1|||
27774086|NCT02094573|54227044|FG000|Overall Study|Subject Received a New Systemic Anticancer Therapy|1|||
27774087|NCT02094573|54227045|FG001|Overall Study|Subject Received a New Systemic Anticancer Therapy|0|||
27774088|NCT02094573|54227044|FG000|Overall Study|Physician Decision|4|||
27774089|NCT02094573|54227045|FG001|Overall Study|Physician Decision|4|||
27774090|NCT02094573|54227044|FG000|Overall Study|Site Terminated by Sponsor|10|||
27774091|NCT02094573|54227045|FG001|Overall Study|Site Terminated by Sponsor|17|||
27774092|NCT02094573|54227044|FG000|Overall Study|Withdrawal by Subject|6|||
27774093|NCT02094573|54227045|FG001|Overall Study|Withdrawal by Subject|8|||
27774094|NCT02094573|54227044|FG000|Overall Study|Randomized but not Treated|3|||
27774095|NCT02094573|54227045|FG001|Overall Study|Randomized but not Treated|0|||
27774096|NCT01859494|54227051|FG000|Overall Study|Adverse Event|1|||
27774097|NCT01858636|54227055|FG000|Overall Study|No Device Deployment Attempted|24|||
27774098|NCT01858636|54227055|FG000|Overall Study|Physician Decision|1|||
27774099|NCT01858636|54227055|FG000|Overall Study|Death|1|||
27774100|NCT01858636|54227055|FG000|Overall Study|Lost to Follow-up|1|||
27774101|NCT01858636|54227055|FG000|Overall Study|Withdrawal by Subject|1|||
27774102|NCT02058849|54227062|FG000|Overall Study|Hospitalization|1|||
27774103|NCT02058849|54227063|FG001|Overall Study|Hospitalization|1|||
27774104|NCT02058849|54227062|FG000|Overall Study|Death|1|||
27774105|NCT02058849|54227063|FG001|Overall Study|Death|0|||
27774106|NCT02058849|54227062|FG000|Overall Study|Lost to Follow-up|1|||
27774107|NCT02058849|54227063|FG001|Overall Study|Lost to Follow-up|0|||
27774108|NCT02058849|54227062|FG000|Overall Study|Withdrawal by Subject|4|||
27774109|NCT02058849|54227063|FG001|Overall Study|Withdrawal by Subject|0|||
27774110|NCT01858558|54227071|FG000|Overall Study|Death|1|||
27774111|NCT01858558|54227072|FG001|Overall Study|Death|1|||
27774112|NCT01858558|54227071|FG000|Overall Study|Lost to Follow-up|1|||
27774113|NCT01858558|54227072|FG001|Overall Study|Lost to Follow-up|0|||
27774114|NCT01858558|54227071|FG000|Overall Study|Disease progression|3|||
27774115|NCT01858558|54227072|FG001|Overall Study|Disease progression|1|||
27774116|NCT01858558|54227071|FG000|Overall Study|Product contamination|2|||
27774117|NCT01858558|54227072|FG001|Overall Study|Product contamination|0|||
27774118|NCT01858558|54227071|FG000|Overall Study|Failed expansion of cell product|2|||
27774119|NCT01858558|54227072|FG001|Overall Study|Failed expansion of cell product|0|||
27774120|NCT02058537|54227078|FG000|Overall Study|Withdrawal by Subject|1|||
27774121|NCT01612000|54227086|FG000|Overall Study|Lost to Follow-up|6|||
27774122|NCT01612000|54227087|FG001|Overall Study|Lost to Follow-up|4|||
27774123|NCT01612000|54227088|FG002|Overall Study|Lost to Follow-up|4|||
27774124|NCT01612000|54227089|FG003|Overall Study|Lost to Follow-up|8|||
27774125|NCT01612000|54227086|FG000|Overall Study|Physician Decision|0|||
27774126|NCT01612000|54227087|FG001|Overall Study|Physician Decision|0|||
27774127|NCT01612000|54227088|FG002|Overall Study|Physician Decision|1|||
27774128|NCT01612000|54227089|FG003|Overall Study|Physician Decision|0|||
27774129|NCT01612000|54227086|FG000|Overall Study|Withdrawal by Subject|3|||
27774130|NCT01612000|54227087|FG001|Overall Study|Withdrawal by Subject|1|||
27774131|NCT01612000|54227088|FG002|Overall Study|Withdrawal by Subject|2|||
27774132|NCT01612000|54227089|FG003|Overall Study|Withdrawal by Subject|2|||
27774133|NCT01895608|54227103|FG000|Overall Study|change in health status|0|||
27774134|NCT01895608|54227104|FG001|Overall Study|change in health status|1|||
27774135|NCT01895608|54227105|FG002|Overall Study|change in health status|1|||
27774136|NCT01895608|54227106|FG003|Overall Study|change in health status|0|||
27774137|NCT01895608|54227103|FG000|Overall Study|Withdrawal by Subject|0|||
27774138|NCT01895608|54227104|FG001|Overall Study|Withdrawal by Subject|0|||
27774139|NCT01895608|54227105|FG002|Overall Study|Withdrawal by Subject|2|||
27774140|NCT01895608|54227106|FG003|Overall Study|Withdrawal by Subject|0|||
27774141|NCT02409680|54227118|FG000|Overall Study|Lost to Follow-up|15|||
27774142|NCT02409680|54227119|FG001|Overall Study|Lost to Follow-up|30|||
27774143|NCT01895452|54227127|FG000|Overall Study|Adverse Event|1|||
27774144|NCT01895452|54227128|FG001|Overall Study|Adverse Event|4|||
27774145|NCT01895452|54227127|FG000|Overall Study|Lost to Follow-up|1|||
27774146|NCT01895452|54227128|FG001|Overall Study|Lost to Follow-up|5|||
27774147|NCT01895452|54227127|FG000|Overall Study|Pregnancy|0|||
27774148|NCT01895452|54227128|FG001|Overall Study|Pregnancy|1|||
27774149|NCT01895452|54227127|FG000|Overall Study|Withdrawal by Subject|2|||
27774150|NCT01895452|54227128|FG001|Overall Study|Withdrawal by Subject|14|||
27774151|NCT01895452|54227127|FG000|Overall Study|Underlying disease|0|||
27774152|NCT01895452|54227128|FG001|Overall Study|Underlying disease|3|||
27774153|NCT01895452|54227127|FG000|Overall Study|Noncompliance with study drug|0|||
27774154|NCT01895452|54227128|FG001|Overall Study|Noncompliance with study drug|1|||
27774155|NCT02094417|54227138|FG000|Overall Study|Adverse Event|0|||
27774156|NCT02094417|54227139|FG001|Overall Study|Adverse Event|0|||
27774157|NCT02094417|54227140|FG002|Overall Study|Adverse Event|0|||
27774158|NCT02094417|54227141|FG003|Overall Study|Adverse Event|1|||
27774159|NCT02094417|54227138|FG000|Overall Study|Eligibility criteria|0|||
27774160|NCT02094417|54227139|FG001|Overall Study|Eligibility criteria|1|||
27774161|NCT02094417|54227140|FG002|Overall Study|Eligibility criteria|0|||
27774162|NCT02094417|54227141|FG003|Overall Study|Eligibility criteria|0|||
27774163|NCT02094417|54227138|FG000|Overall Study|No responder|4|||
27774164|NCT02094417|54227139|FG001|Overall Study|No responder|4|||
27774165|NCT02094417|54227140|FG002|Overall Study|No responder|4|||
27774166|NCT02094417|54227141|FG003|Overall Study|No responder|3|||
27774167|NCT02094417|54227138|FG000|Overall Study|Unable to conduct observations or assess|0|||
27774168|NCT02094417|54227139|FG001|Overall Study|Unable to conduct observations or assess|1|||
27774169|NCT02094417|54227140|FG002|Overall Study|Unable to conduct observations or assess|0|||
27774170|NCT02094417|54227141|FG003|Overall Study|Unable to conduct observations or assess|0|||
27774171|NCT02094417|54227138|FG000|Overall Study|Withdrawal by Subject|1|||
27774172|NCT02094417|54227139|FG001|Overall Study|Withdrawal by Subject|2|||
27774173|NCT02094417|54227140|FG002|Overall Study|Withdrawal by Subject|1|||
27774174|NCT02094417|54227141|FG003|Overall Study|Withdrawal by Subject|3|||
27774175|NCT01894984|54227153|FG000|Overall Study|Other|314|||
27840163|NCT01502371|54327484|FG003|Overall Study|Treatment Failure|19|||
27840164|NCT01502371|54327485|FG004|Overall Study|Treatment Failure|30|||
27774176|NCT01894984|54227154|FG001|Overall Study|Other|175|||
27774177|NCT02375672|54227160|FG000|Overall Study|remain on follow up|20|||
27774178|NCT01894516|54227168|FG000|Period 1 (Baseline up to Week 12)|Other|0|||
27774179|NCT01894516|54227169|FG001|Period 1 (Baseline up to Week 12)|Other|1|||
27774180|NCT01894516|54227170|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
27774181|NCT01894516|54227171|FG003|Period 1 (Baseline up to Week 12)|Other|0|||
27774182|NCT01894516|54227168|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2|||
27774183|NCT01894516|54227169|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
27774184|NCT01894516|54227170|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
27774185|NCT01894516|54227171|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
27774186|NCT01894516|54227168|FG000|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
27774187|NCT01894516|54227169|FG001|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
27774188|NCT01894516|54227170|FG002|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
27774189|NCT01894516|54227171|FG003|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
27774190|NCT01894516|54227168|FG000|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
27774191|NCT01894516|54227169|FG001|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
27774192|NCT01894516|54227170|FG002|Period 1 (Baseline up to Week 12)|Treatment failure|1|||
27840165|NCT01502371|54327481|FG000|Overall Study|Lack of Efficacy|3|||
27774193|NCT01894516|54227171|FG003|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
27774194|NCT01894516|54227168|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
27774195|NCT01894516|54227169|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
27774196|NCT01894516|54227170|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
27774197|NCT01894516|54227171|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
27774198|NCT01894516|54227168|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
27774199|NCT01894516|54227169|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
27774200|NCT01894516|54227170|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1|||
27774201|NCT01894516|54227171|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
27774202|NCT01894516|54227168|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
27774203|NCT01894516|54227169|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
27774204|NCT01894516|54227170|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
27774205|NCT01894516|54227171|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
27774206|NCT01894516|54227168|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
27774207|NCT01894516|54227169|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
27774208|NCT01894516|54227170|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
27774209|NCT01894516|54227171|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
27774210|NCT02491463|54227189|FG000|Overall Study|Withdrawal by Subject|1|||
27774211|NCT02491463|54227190|FG001|Overall Study|Withdrawal by Subject|2|||
27774212|NCT02491463|54227191|FG002|Overall Study|Withdrawal by Subject|0|||
27774213|NCT02491463|54227192|FG003|Overall Study|Withdrawal by Subject|0|||
27774214|NCT02491463|54227189|FG000|Overall Study|Migrated/moved from study area|1|||
27774215|NCT02491463|54227190|FG001|Overall Study|Migrated/moved from study area|5|||
27774216|NCT02491463|54227191|FG002|Overall Study|Migrated/moved from study area|1|||
27774217|NCT02491463|54227192|FG003|Overall Study|Migrated/moved from study area|1|||
27774218|NCT02491463|54227189|FG000|Overall Study|Lost to Follow-up|0|||
27774219|NCT02491463|54227190|FG001|Overall Study|Lost to Follow-up|3|||
27840166|NCT01502371|54327482|FG001|Overall Study|Lack of Efficacy|3|||
27840167|NCT01502371|54327483|FG002|Overall Study|Lack of Efficacy|2|||
27840168|NCT01502371|54327484|FG003|Overall Study|Lack of Efficacy|2|||
27840169|NCT01502371|54327485|FG004|Overall Study|Lack of Efficacy|4|||
27840170|NCT01502371|54327481|FG000|Overall Study|Physician Decision|3|||
27840171|NCT01502371|54327482|FG001|Overall Study|Physician Decision|0|||
27840172|NCT01502371|54327483|FG002|Overall Study|Physician Decision|0|||
27840173|NCT01502371|54327484|FG003|Overall Study|Physician Decision|0|||
27840174|NCT01502371|54327485|FG004|Overall Study|Physician Decision|1|||
27840175|NCT01502371|54327481|FG000|Overall Study|Noncompliance with Study Drug|0|||
27840176|NCT01502371|54327482|FG001|Overall Study|Noncompliance with Study Drug|0|||
27840177|NCT01502371|54327483|FG002|Overall Study|Noncompliance with Study Drug|1|||
27840178|NCT01502371|54327484|FG003|Overall Study|Noncompliance with Study Drug|2|||
27840179|NCT01502371|54327485|FG004|Overall Study|Noncompliance with Study Drug|1|||
27774220|NCT02491463|54227191|FG002|Overall Study|Lost to Follow-up|3|||
27840180|NCT01502371|54327481|FG000|Overall Study|Technical Problems|1|||
27840181|NCT01502371|54327482|FG001|Overall Study|Technical Problems|0|||
27840182|NCT01502371|54327483|FG002|Overall Study|Technical Problems|2|||
27840183|NCT01502371|54327484|FG003|Overall Study|Technical Problems|4|||
27840184|NCT01502371|54327485|FG004|Overall Study|Technical Problems|1|||
27774221|NCT02491463|54227192|FG003|Overall Study|Lost to Follow-up|0|||
27774222|NCT02038881|54227205|FG000|Overall Study|Withdrawal by Subject|0|||
27774223|NCT02038881|54227206|FG001|Overall Study|Withdrawal by Subject|0|||
27774224|NCT02038881|54227207|FG002|Overall Study|Withdrawal by Subject|1|||
27774225|NCT02038881|54227205|FG000|Overall Study|Lost to Follow-up|2|||
27840185|NCT01502371|54327481|FG000|Overall Study|Protocol Violation|9|||
27840186|NCT01502371|54327482|FG001|Overall Study|Protocol Violation|5|||
27840187|NCT01502371|54327483|FG002|Overall Study|Protocol Violation|6|||
27840188|NCT01502371|54327484|FG003|Overall Study|Protocol Violation|5|||
27840189|NCT01502371|54327485|FG004|Overall Study|Protocol Violation|10|||
27840190|NCT01502371|54327481|FG000|Overall Study|Excluded Medication|0|||
27774226|NCT02038881|54227206|FG001|Overall Study|Lost to Follow-up|0|||
27774227|NCT02038881|54227207|FG002|Overall Study|Lost to Follow-up|0|||
27774228|NCT02038881|54227205|FG000|Overall Study|incarcerated|1|||
27774229|NCT02038881|54227206|FG001|Overall Study|incarcerated|0|||
27774230|NCT02038881|54227207|FG002|Overall Study|incarcerated|0|||
27774231|NCT01857622|54227220|FG000|Overall Study|Adverse Event|5|||
27774232|NCT01857622|54227221|FG001|Overall Study|Adverse Event|0|||
27774233|NCT01857622|54227222|FG002|Overall Study|Adverse Event|2|||
27774234|NCT01857622|54227220|FG000|Overall Study|Physician Decision|1|||
27774235|NCT01857622|54227221|FG001|Overall Study|Physician Decision|0|||
27774236|NCT01857622|54227222|FG002|Overall Study|Physician Decision|0|||
27774237|NCT01857622|54227220|FG000|Overall Study|Protocol Violation|4|||
27774238|NCT01857622|54227221|FG001|Overall Study|Protocol Violation|1|||
27774239|NCT01857622|54227222|FG002|Overall Study|Protocol Violation|0|||
27774240|NCT01857622|54227220|FG000|Overall Study|Withdrawal by Subject|1|||
27774241|NCT01857622|54227221|FG001|Overall Study|Withdrawal by Subject|0|||
27774242|NCT01857622|54227222|FG002|Overall Study|Withdrawal by Subject|0|||
27774243|NCT01857310|54227232|FG000|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315|||
27774244|NCT01857310|54227233|FG001|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282|||
27774245|NCT02472353|54227241|FG000|Overall Study|Lost to Follow-up|1|||
27774246|NCT02472353|54227242|FG001|Overall Study|Lost to Follow-up|1|||
27774247|NCT02472353|54227241|FG000|Overall Study|Withdrawal by Subject|2|||
27840191|NCT01502371|54327482|FG001|Overall Study|Excluded Medication|1|||
27774248|NCT02472353|54227242|FG001|Overall Study|Withdrawal by Subject|1|||
27774249|NCT02472353|54227241|FG000|Overall Study|Study Termination|1|||
27774250|NCT02472353|54227242|FG001|Overall Study|Study Termination|4|||
27774251|NCT02491073|54227250|FG000|Overall Study|screen failure|1|||
27774252|NCT02491073|54227251|FG001|Overall Study|screen failure|0|||
27774253|NCT02314117|54227275|FG000|Overall Study|Lost to Follow-up|9|||
27774254|NCT02314117|54227276|FG001|Overall Study|Lost to Follow-up|14|||
27774255|NCT02314117|54227275|FG000|Overall Study|Withdrawal by Subject|3|||
27774256|NCT02314117|54227276|FG001|Overall Study|Withdrawal by Subject|2|||
27774257|NCT01893346|54227287|FG000|Overall Study|Lost to Follow-up|0|||
27774258|NCT01893346|54227288|FG001|Overall Study|Lost to Follow-up|1|||
27774259|NCT01893346|54227289|FG002|Overall Study|Lost to Follow-up|0|||
27774260|NCT01893346|54227290|FG003|Overall Study|Lost to Follow-up|0|||
27774261|NCT01893346|54227287|FG000|Overall Study|Protocol Violation|1|||
27774262|NCT01893346|54227288|FG001|Overall Study|Protocol Violation|0|||
27774263|NCT01893346|54227289|FG002|Overall Study|Protocol Violation|0|||
27774264|NCT01893346|54227290|FG003|Overall Study|Protocol Violation|0|||
27774265|NCT01893346|54227287|FG000|Overall Study|Withdrawal by Subject|2|||
27774266|NCT01893346|54227288|FG001|Overall Study|Withdrawal by Subject|0|||
27774267|NCT01893346|54227289|FG002|Overall Study|Withdrawal by Subject|0|||
27774268|NCT01893346|54227290|FG003|Overall Study|Withdrawal by Subject|0|||
27774269|NCT02490371|54227302|FG000|Overall Study|Lost to Follow-up|1|||
27774270|NCT02490371|54227303|FG001|Overall Study|Lost to Follow-up|1|||
27774271|NCT01856686|54227311|FG000|Overall Study|Lost to Follow-up|5|||
27774272|NCT01856686|54227312|FG001|Overall Study|Lost to Follow-up|11|||
27774273|NCT02058147|54227321|FG000|Overall Study|Randomized but not treated|0|||
27774274|NCT02058147|54227322|FG001|Overall Study|Randomized but not treated|0|||
27774275|NCT02058147|54227323|FG002|Overall Study|Randomized but not treated|1|||
27774276|NCT02058147|54227321|FG000|Overall Study|Adverse Event|12|||
27774277|NCT02058147|54227322|FG001|Overall Study|Adverse Event|9|||
27774278|NCT02058147|54227323|FG002|Overall Study|Adverse Event|21|||
27774279|NCT02058147|54227321|FG000|Overall Study|Lack of Efficacy|1|||
27774280|NCT02058147|54227322|FG001|Overall Study|Lack of Efficacy|0|||
27774281|NCT02058147|54227323|FG002|Overall Study|Lack of Efficacy|3|||
27774282|NCT02058147|54227321|FG000|Overall Study|Poor compliance to protocol|8|||
27774283|NCT02058147|54227322|FG001|Overall Study|Poor compliance to protocol|9|||
27774284|NCT02058147|54227323|FG002|Overall Study|Poor compliance to protocol|4|||
27774285|NCT02058147|54227321|FG000|Overall Study|Other than specified|8|||
27774286|NCT02058147|54227322|FG001|Overall Study|Other than specified|9|||
27774287|NCT02058147|54227323|FG002|Overall Study|Other than specified|0|||
27774288|NCT02489981|54227331|FG000|Overall Study|Adverse Event|21|||
27774289|NCT02489981|54227331|FG000|Overall Study|Insufficient effectiveness|16|||
27774290|NCT02489981|54227331|FG000|Overall Study|Improved|31|||
27774291|NCT02489981|54227331|FG000|Overall Study|Lost to Follow-up|31|||
27774292|NCT02489981|54227331|FG000|Overall Study|Other than listed|28|||
27774293|NCT02471183|54227335|FG000|Main Treatment Period|Adverse Event|1|||
27774294|NCT02471183|54227335|FG000|Main Treatment Period|Withdrawal by Subject|1|||
27774295|NCT02471183|54227335|FG000|Extended Treatment Period|Lack of Efficacy|1|||
27840192|NCT01502371|54327483|FG002|Overall Study|Excluded Medication|1|||
27840193|NCT01502371|54327484|FG003|Overall Study|Excluded Medication|0|||
27774296|NCT01855828|54227339|FG000|Overall Study|Adverse Event|1|||
27774297|NCT01855828|54227339|FG000|Overall Study|Withdrawal by Subject|1|||
27774298|NCT02489279|54227350|FG000|Overall Study|Lost to Follow-up|12|||
27840194|NCT01502371|54327485|FG004|Overall Study|Excluded Medication|1|||
27840195|NCT01588496|54327501|FG000|Overall Study|Withdrawal by Subject|0|||
27851613|NCT00985673|54351076|FG002|Overall Study|Lost to Follow-up|6|||
27774299|NCT02489279|54227351|FG001|Overall Study|Lost to Follow-up|10|||
27774300|NCT02489045|54227357|FG000|Overall Study|unable to collect usable data|53|||
27774301|NCT02489045|54227357|FG000|Follow-up|Lost to Follow-up|10|||
27774302|NCT02488109|54227363|FG000|Treatment in Hospital|Withdrawal by Subject|0|||
27774303|NCT02488109|54227364|FG001|Treatment in Hospital|Withdrawal by Subject|5|||
27774304|NCT02488109|54227363|FG000|12-month Follow-Up|Lost to Follow-up|4|||
27774305|NCT02488109|54227364|FG001|12-month Follow-Up|Lost to Follow-up|7|||
27774306|NCT02351167|54227375|FG000|Overall Study|Withdrawal by Subject|19|||
27774307|NCT02351167|54227376|FG001|Overall Study|Withdrawal by Subject|18|||
27774308|NCT02351167|54227377|FG002|Overall Study|Withdrawal by Subject|21|||
27774309|NCT02350309|54227392|FG000|Treatment Period 1 (2 Days)|Physician Decision|0|||
27774310|NCT02350309|54227393|FG001|Treatment Period 1 (2 Days)|Physician Decision|0|||
27774311|NCT02350309|54227394|FG002|Treatment Period 1 (2 Days)|Physician Decision|1|||
27774312|NCT02350309|54227395|FG003|Treatment Period 1 (2 Days)|Physician Decision|0|||
27774313|NCT02350309|54227396|FG004|Treatment Period 1 (2 Days)|Physician Decision|0|||
27774314|NCT02350309|54227397|FG005|Treatment Period 1 (2 Days)|Physician Decision|0|||
27774315|NCT02350309|54227392|FG000|Treatment Period 4 (2 Days)|Death in the Family|0|||
27774316|NCT02350309|54227393|FG001|Treatment Period 4 (2 Days)|Death in the Family|0|||
27774317|NCT02350309|54227394|FG002|Treatment Period 4 (2 Days)|Death in the Family|0|||
27774318|NCT02350309|54227395|FG003|Treatment Period 4 (2 Days)|Death in the Family|0|||
27774319|NCT02350309|54227396|FG004|Treatment Period 4 (2 Days)|Death in the Family|0|||
27774320|NCT02350309|54227397|FG005|Treatment Period 4 (2 Days)|Death in the Family|1|||
27774321|NCT02038647|54227414|FG000|Overall Study|Progressive Disease|50|||
27774322|NCT02038647|54227415|FG001|Overall Study|Progressive Disease|59|||
27774323|NCT02038647|54227414|FG000|Overall Study|Adverse Event|18|||
27774324|NCT02038647|54227415|FG001|Overall Study|Adverse Event|10|||
27774325|NCT02038647|54227414|FG000|Overall Study|Symptomatic Deterioration|7|||
27774326|NCT02038647|54227415|FG001|Overall Study|Symptomatic Deterioration|7|||
27774327|NCT02038647|54227414|FG000|Overall Study|Withdrawal by Subject|5|||
27774328|NCT02038647|54227415|FG001|Overall Study|Withdrawal by Subject|2|||
27774329|NCT02038647|54227414|FG000|Overall Study|Not Reported|0|||
27774330|NCT02038647|54227415|FG001|Overall Study|Not Reported|1|||
27774331|NCT02038647|54227414|FG000|Overall Study|Ongoing at Datacut|9|||
27774332|NCT02038647|54227415|FG001|Overall Study|Ongoing at Datacut|10|||
27774333|NCT02058069|54227421|FG000|Overall Study|Exclusion due to implant size|5|||
27774334|NCT02058069|54227421|FG000|Overall Study|Withdrawal by Subject|6|||
27774335|NCT02057835|54227435|FG000|Overall Study|Withdrawal by Subject|0|||
27774336|NCT02057835|54227436|FG001|Overall Study|Withdrawal by Subject|2|||
27774337|NCT02057835|54227437|FG002|Overall Study|Withdrawal by Subject|0|||
27774338|NCT02057835|54227438|FG003|Overall Study|Withdrawal by Subject|0|||
27774339|NCT02057835|54227439|FG004|Overall Study|Withdrawal by Subject|0|||
27774340|NCT02057835|54227440|FG005|Overall Study|Withdrawal by Subject|0|||
27774341|NCT02057835|54227441|FG006|Overall Study|Withdrawal by Subject|0|||
27774342|NCT02057835|54227442|FG007|Overall Study|Withdrawal by Subject|0|||
27774343|NCT02057835|54227443|FG008|Overall Study|Withdrawal by Subject|0|||
27774344|NCT02057835|54227444|FG009|Overall Study|Withdrawal by Subject|0|||
27774345|NCT02057757|54227475|FG000|Overall Study|Withdrawal by Subject|3|||
27774346|NCT02057757|54227476|FG001|Overall Study|Withdrawal by Subject|5|||
27774347|NCT02057757|54227475|FG000|Overall Study|Death|2|||
27774348|NCT02057757|54227476|FG001|Overall Study|Death|0|||
27774349|NCT02057757|54227475|FG000|Overall Study|Lost to Follow-up|8|||
27774350|NCT02057757|54227476|FG001|Overall Study|Lost to Follow-up|3|||
27774351|NCT02057757|54227475|FG000|Overall Study|Non-compliance|1|||
27774352|NCT02057757|54227476|FG001|Overall Study|Non-compliance|0|||
27774353|NCT02037477|54227490|FG000|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
27774354|NCT02037477|54227491|FG001|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
27774355|NCT02037477|54227492|FG002|Treatment Period 1|Pre-treatment Event/Adverse Event|1|||
27774356|NCT02037477|54227493|FG003|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
27774357|NCT02057523|54227503|FG000|Overall Study|Withdrawal by Subject|1|||
27774358|NCT02057523|54227503|FG000|Overall Study|Lack of Efficacy|1|||
27774359|NCT02037165|54227512|FG000|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
27774360|NCT02037165|54227513|FG001|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
27774361|NCT02037165|54227514|FG002|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
27774362|NCT02037165|54227515|FG003|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
27774363|NCT02037165|54227516|FG004|Washout Period 4 (6 Days)|Withdrawal by Subject|1|||
27774364|NCT02470403|54227537|FG000|Overall Study|Adverse Event|1|||
27774365|NCT02470403|54227538|FG001|Overall Study|Adverse Event|0|||
27774366|NCT02470403|54227539|FG002|Overall Study|Adverse Event|0|||
27774367|NCT02470403|54227540|FG003|Overall Study|Adverse Event|0|||
27774368|NCT02470403|54227541|FG004|Overall Study|Adverse Event|0|||
27774369|NCT02470403|54227537|FG000|Overall Study|Lost to Follow-up|0|||
27774370|NCT02470403|54227538|FG001|Overall Study|Lost to Follow-up|1|||
27774371|NCT02470403|54227539|FG002|Overall Study|Lost to Follow-up|0|||
27774372|NCT02470403|54227540|FG003|Overall Study|Lost to Follow-up|0|||
27774373|NCT02470403|54227541|FG004|Overall Study|Lost to Follow-up|0|||
27774374|NCT02470403|54227537|FG000|Overall Study|Subject/guardian decision|1|||
27774375|NCT02470403|54227538|FG001|Overall Study|Subject/guardian decision|0|||
27774376|NCT02470403|54227539|FG002|Overall Study|Subject/guardian decision|0|||
27774377|NCT02470403|54227540|FG003|Overall Study|Subject/guardian decision|4|||
27774378|NCT02470403|54227541|FG004|Overall Study|Subject/guardian decision|0|||
27774379|NCT01855750|54227558|FG000|Overall Study|Death|78|||
27774380|NCT01855750|54227559|FG001|Overall Study|Death|78|||
27774381|NCT01855750|54227558|FG000|Overall Study|Lost to Follow-up|9|||
27774382|NCT01855750|54227559|FG001|Overall Study|Lost to Follow-up|23|||
27774383|NCT01855750|54227558|FG000|Overall Study|Withdrawal by Subject|35|||
27774384|NCT01855750|54227559|FG001|Overall Study|Withdrawal by Subject|28|||
27774385|NCT01855750|54227558|FG000|Overall Study|Sponsor ends the study|297|||
27774386|NCT01855750|54227559|FG001|Overall Study|Sponsor ends the study|290|||
27774387|NCT01855126|54227567|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|4|||
27774388|NCT01855126|54227568|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|6|||
27774389|NCT01855126|54227567|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
27774390|NCT01855126|54227568|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
27774391|NCT01622673|54227584|FG000|Treatment Period 1|Withdrawal by Subject|0|||
27774392|NCT01622673|54227585|FG001|Treatment Period 1|Withdrawal by Subject|0|||
27774393|NCT01622673|54227586|FG002|Treatment Period 1|Withdrawal by Subject|0|||
27774394|NCT01622673|54227587|FG003|Treatment Period 1|Withdrawal by Subject|1|||
27774395|NCT01622673|54227588|FG004|Treatment Period 1|Withdrawal by Subject|0|||
27774396|NCT01622673|54227589|FG005|Treatment Period 1|Withdrawal by Subject|0|||
27774397|NCT01622673|54227584|FG000|Treatment Period 1|Protocol Violation|0|||
27774398|NCT01622673|54227585|FG001|Treatment Period 1|Protocol Violation|1|||
27774399|NCT01622673|54227586|FG002|Treatment Period 1|Protocol Violation|0|||
27774400|NCT01622673|54227587|FG003|Treatment Period 1|Protocol Violation|0|||
27774401|NCT01622673|54227588|FG004|Treatment Period 1|Protocol Violation|0|||
27774402|NCT01622673|54227589|FG005|Treatment Period 1|Protocol Violation|0|||
27774403|NCT01622673|54227584|FG000|Treatment Period 2|Withdrawal by Subject|0|||
27774404|NCT01622673|54227585|FG001|Treatment Period 2|Withdrawal by Subject|0|||
27774405|NCT01622673|54227586|FG002|Treatment Period 2|Withdrawal by Subject|0|||
27774406|NCT01622673|54227587|FG003|Treatment Period 2|Withdrawal by Subject|1|||
27774407|NCT01622673|54227588|FG004|Treatment Period 2|Withdrawal by Subject|0|||
27774408|NCT01622673|54227589|FG005|Treatment Period 2|Withdrawal by Subject|0|||
27774409|NCT01622673|54227584|FG000|Treatment Period 3|Protocol Violation|0|||
27774410|NCT01622673|54227585|FG001|Treatment Period 3|Protocol Violation|1|||
27774411|NCT01622673|54227586|FG002|Treatment Period 3|Protocol Violation|0|||
27774412|NCT01622673|54227587|FG003|Treatment Period 3|Protocol Violation|0|||
27774413|NCT01622673|54227588|FG004|Treatment Period 3|Protocol Violation|0|||
27774414|NCT01622673|54227589|FG005|Treatment Period 3|Protocol Violation|0|||
27774415|NCT01855048|54227614|FG000|Overall Study|Withdrawal by Subject|0|||
27774416|NCT01855048|54227615|FG001|Overall Study|Withdrawal by Subject|1|||
27774417|NCT01855048|54227616|FG002|Overall Study|Withdrawal by Subject|0|||
27774418|NCT01855048|54227617|FG003|Overall Study|Withdrawal by Subject|0|||
27774419|NCT01855048|54227618|FG004|Overall Study|Withdrawal by Subject|1|||
27774420|NCT01855048|54227619|FG005|Overall Study|Withdrawal by Subject|0|||
27774421|NCT02469857|54227645|FG000|Overall Study|Death|24|||
27774422|NCT02469857|54227646|FG001|Overall Study|Death|29|||
27774423|NCT02469857|54227645|FG000|Overall Study|Discontinuation|1|||
27774424|NCT02469857|54227646|FG001|Overall Study|Discontinuation|3|||
27774425|NCT02036853|54227656|FG000|Overall Study|Adverse Event|0|||
27774426|NCT02036853|54227657|FG001|Overall Study|Adverse Event|2|||
27774427|NCT02036853|54227656|FG000|Overall Study|Lack of Efficacy|0|||
27774428|NCT02036853|54227657|FG001|Overall Study|Lack of Efficacy|2|||
27774429|NCT02036853|54227656|FG000|Overall Study|Physician Decision|0|||
27774430|NCT02036853|54227657|FG001|Overall Study|Physician Decision|1|||
27774431|NCT02036853|54227656|FG000|Overall Study|Withdrawal by Subject|0|||
27774432|NCT02036853|54227657|FG001|Overall Study|Withdrawal by Subject|1|||
27774433|NCT02469623|54227663|FG000|Overall Study|Not consented for long-term follow-up|4|||
27774434|NCT02469623|54227663|FG000|Overall Study|Lost to Follow-up|4|||
27774435|NCT02469623|54227663|FG000|Overall Study|Withdrawal by Subject|2|||
27774436|NCT02469623|54227663|FG000|Overall Study|Death|3|||
27774437|NCT02469077|54227670|FG000|Post Randomization/Intervention Period|Scheduling issues|3|||
27774438|NCT02469077|54227671|FG001|Post Randomization/Intervention Period|Scheduling issues|2|||
27774439|NCT02469077|54227670|FG000|Post Randomization/Intervention Period|Relocated|1|||
27774440|NCT02469077|54227671|FG001|Post Randomization/Intervention Period|Relocated|1|||
27774441|NCT02469077|54227670|FG000|Post Randomization/Intervention Period|Conflicting health issues|0|||
27774442|NCT02469077|54227671|FG001|Post Randomization/Intervention Period|Conflicting health issues|1|||
27774443|NCT02469077|54227670|FG000|Post Intervention /Followup|Withdrawal by Subject|2|||
27774444|NCT02469077|54227671|FG001|Post Intervention /Followup|Withdrawal by Subject|1|||
27774445|NCT02486627|54227683|FG000|Overall Study|Death|1|||
27774446|NCT02486627|54227684|FG001|Overall Study|Death|0|||
27774447|NCT02486627|54227683|FG000|Overall Study|Other Unspecified|0|||
27774448|NCT02486627|54227684|FG001|Overall Study|Other Unspecified|2|||
27774449|NCT02486627|54227683|FG000|Overall Study|Consent Withdrawn by Participant|4|||
27774450|NCT02486627|54227684|FG001|Overall Study|Consent Withdrawn by Participant|3|||
27774451|NCT02486627|54227683|FG000|Overall Study|Significant Participant Noncompliance|1|||
27774452|NCT02486627|54227684|FG001|Overall Study|Significant Participant Noncompliance|1|||
27774453|NCT02486627|54227683|FG000|Overall Study|Lost to Follow-up|1|||
27774454|NCT02486627|54227684|FG001|Overall Study|Lost to Follow-up|3|||
27774455|NCT01644565|54227690|FG000|Overall Study|Undisclosed Medical History|1|||
27774456|NCT01644565|54227691|FG001|Overall Study|Undisclosed Medical History|0|||
27774457|NCT01644565|54227692|FG002|Overall Study|Undisclosed Medical History|0|||
27774458|NCT01644565|54227693|FG003|Overall Study|Undisclosed Medical History|0|||
27774459|NCT01644565|54227694|FG004|Overall Study|Undisclosed Medical History|0|||
27774460|NCT01644565|54227695|FG005|Overall Study|Undisclosed Medical History|0|||
27774461|NCT01644565|54227696|FG006|Overall Study|Undisclosed Medical History|0|||
27774462|NCT01644565|54227697|FG007|Overall Study|Undisclosed Medical History|0|||
27774463|NCT01644565|54227698|FG008|Overall Study|Undisclosed Medical History|0|||
27774464|NCT01644565|54227690|FG000|Overall Study|Lost to Follow-up|0|||
27774465|NCT01644565|54227691|FG001|Overall Study|Lost to Follow-up|0|||
27774466|NCT01644565|54227692|FG002|Overall Study|Lost to Follow-up|0|||
27774467|NCT01644565|54227693|FG003|Overall Study|Lost to Follow-up|1|||
27774468|NCT01644565|54227694|FG004|Overall Study|Lost to Follow-up|0|||
27774469|NCT01644565|54227695|FG005|Overall Study|Lost to Follow-up|0|||
27774470|NCT01644565|54227696|FG006|Overall Study|Lost to Follow-up|0|||
27774471|NCT01644565|54227697|FG007|Overall Study|Lost to Follow-up|2|||
27774472|NCT01644565|54227698|FG008|Overall Study|Lost to Follow-up|0|||
27774473|NCT01644565|54227690|FG000|Overall Study|Family emergency|0|||
27774474|NCT01644565|54227691|FG001|Overall Study|Family emergency|0|||
27774475|NCT01644565|54227692|FG002|Overall Study|Family emergency|0|||
27774476|NCT01644565|54227693|FG003|Overall Study|Family emergency|0|||
27774477|NCT01644565|54227694|FG004|Overall Study|Family emergency|1|||
27774478|NCT01644565|54227695|FG005|Overall Study|Family emergency|0|||
27774479|NCT01644565|54227696|FG006|Overall Study|Family emergency|0|||
27774480|NCT01644565|54227697|FG007|Overall Study|Family emergency|0|||
27774481|NCT01644565|54227698|FG008|Overall Study|Family emergency|0|||
27774482|NCT01644565|54227690|FG000|Overall Study|Relocation|0|||
27774483|NCT01644565|54227691|FG001|Overall Study|Relocation|0|||
27774484|NCT01644565|54227692|FG002|Overall Study|Relocation|0|||
27774485|NCT01644565|54227693|FG003|Overall Study|Relocation|0|||
27774486|NCT01644565|54227694|FG004|Overall Study|Relocation|0|||
27774487|NCT01644565|54227695|FG005|Overall Study|Relocation|0|||
27774488|NCT01644565|54227696|FG006|Overall Study|Relocation|0|||
27774489|NCT01644565|54227697|FG007|Overall Study|Relocation|0|||
27774490|NCT01644565|54227698|FG008|Overall Study|Relocation|1|||
27774491|NCT02485925|54227718|FG000|Overall Study|Withdrawal by Subject|3|||
27774492|NCT02485925|54227718|FG000|Overall Study|Death|1|||
27774493|NCT02485925|54227718|FG000|Overall Study|Lost to Follow-up|11|||
27774494|NCT02282293|54227724|FG000|Overall Study|Lost to Follow-up|2|||
27774495|NCT02282293|54227725|FG001|Overall Study|Lost to Follow-up|2|||
27774496|NCT02282293|54227724|FG000|Overall Study|Unable to comply with study procedures|1|||
27774497|NCT02282293|54227725|FG001|Overall Study|Unable to comply with study procedures|0|||
27774498|NCT02282293|54227724|FG000|Overall Study|Moved out of study area|0|||
27774499|NCT02282293|54227725|FG001|Overall Study|Moved out of study area|1|||
27774500|NCT01854658|54227735|FG000|Overall Study|Protocol Violation|6|||
27774501|NCT01854658|54227736|FG001|Overall Study|Protocol Violation|2|||
27774502|NCT01854658|54227737|FG002|Overall Study|Protocol Violation|2|||
27774503|NCT01854658|54227738|FG003|Overall Study|Protocol Violation|1|||
27774504|NCT01854658|54227735|FG000|Overall Study|Physician Decision|7|||
27774505|NCT01854658|54227736|FG001|Overall Study|Physician Decision|5|||
27774506|NCT01854658|54227737|FG002|Overall Study|Physician Decision|2|||
27774507|NCT01854658|54227738|FG003|Overall Study|Physician Decision|4|||
27774508|NCT01854658|54227735|FG000|Overall Study|Lost to Follow-up|8|||
27774509|NCT01854658|54227736|FG001|Overall Study|Lost to Follow-up|9|||
27840196|NCT01588496|54327502|FG001|Overall Study|Withdrawal by Subject|1|||
27840197|NCT01588496|54327503|FG002|Overall Study|Withdrawal by Subject|0|||
27774510|NCT01854658|54227737|FG002|Overall Study|Lost to Follow-up|8|||
27774511|NCT01854658|54227738|FG003|Overall Study|Lost to Follow-up|4|||
27774512|NCT01854658|54227735|FG000|Overall Study|Withdrawal by Subject|28|||
27774513|NCT01854658|54227736|FG001|Overall Study|Withdrawal by Subject|21|||
27774514|NCT01854658|54227737|FG002|Overall Study|Withdrawal by Subject|29|||
27774515|NCT01854658|54227738|FG003|Overall Study|Withdrawal by Subject|15|||
27774516|NCT01854658|54227735|FG000|Overall Study|Protocol-specified criteria|15|||
27774517|NCT01854658|54227736|FG001|Overall Study|Protocol-specified criteria|15|||
27840198|NCT01502293|54327514|FG000|Overall Study|Progressive Disease|20|||
27774518|NCT01854658|54227737|FG002|Overall Study|Protocol-specified criteria|10|||
27774519|NCT01854658|54227738|FG003|Overall Study|Protocol-specified criteria|7|||
27774520|NCT01854658|54227735|FG000|Overall Study|Lack of Efficacy|3|||
27774521|NCT01854658|54227736|FG001|Overall Study|Lack of Efficacy|8|||
27774522|NCT01854658|54227737|FG002|Overall Study|Lack of Efficacy|4|||
27774523|NCT01854658|54227738|FG003|Overall Study|Lack of Efficacy|7|||
27774524|NCT01854658|54227735|FG000|Overall Study|Adverse Event|21|||
27774525|NCT01854658|54227736|FG001|Overall Study|Adverse Event|14|||
27774526|NCT01854658|54227737|FG002|Overall Study|Adverse Event|23|||
27774527|NCT01854658|54227738|FG003|Overall Study|Adverse Event|19|||
27774528|NCT01854658|54227735|FG000|Overall Study|Administrative reasons|5|||
27774529|NCT01854658|54227736|FG001|Overall Study|Administrative reasons|1|||
27774530|NCT01854658|54227737|FG002|Overall Study|Administrative reasons|2|||
27774531|NCT01854658|54227738|FG003|Overall Study|Administrative reasons|2|||
27774532|NCT01892020|54227748|FG000|Period 1|Adverse Event|1|||
27774533|NCT01892020|54227749|FG001|Period 1|Adverse Event|1|||
27774534|NCT01892020|54227748|FG000|Period 1|Protocol Violation|2|||
27774535|NCT01892020|54227749|FG001|Period 1|Protocol Violation|4|||
27774536|NCT01892020|54227748|FG000|Period 1|Unclassified|0|||
27774537|NCT01892020|54227749|FG001|Period 1|Unclassified|1|||
27774538|NCT01892020|54227748|FG000|Period 2|Protocol Violation|1|||
27774539|NCT01892020|54227749|FG001|Period 2|Protocol Violation|0|||
27774540|NCT02485691|54227757|FG000|Overall Study|Adverse Event|25|||
27774541|NCT02485691|54227758|FG001|Overall Study|Adverse Event|11|||
27774542|NCT02485691|54227757|FG000|Overall Study|Poor compliance to protocol|0|||
27774543|NCT02485691|54227758|FG001|Overall Study|Poor compliance to protocol|1|||
27774544|NCT02485691|54227757|FG000|Overall Study|Disease progression|57|||
27774545|NCT02485691|54227758|FG001|Overall Study|Disease progression|92|||
27774546|NCT02485691|54227757|FG000|Overall Study|Investigator's decision|23|||
27774547|NCT02485691|54227758|FG001|Overall Study|Investigator's decision|5|||
27774548|NCT02485691|54227757|FG000|Overall Study|Participant's request|13|||
27774549|NCT02485691|54227758|FG001|Overall Study|Participant's request|6|||
27774550|NCT02485691|54227757|FG000|Overall Study|Other reason|8|||
27774551|NCT02485691|54227758|FG001|Overall Study|Other reason|9|||
27774552|NCT02485691|54227757|FG000|Overall Study|Randomized and not treated|3|||
27774553|NCT02485691|54227758|FG001|Overall Study|Randomized and not treated|2|||
27774554|NCT02517515|54227767|FG000|Overall Study|Adverse Event|0|||
27774555|NCT02517515|54227768|FG001|Overall Study|Adverse Event|1|||
27774556|NCT02517515|54227767|FG000|Overall Study|Withdrew Consent|0|||
27774557|NCT02517515|54227768|FG001|Overall Study|Withdrew Consent|1|||
27774558|NCT02517515|54227767|FG000|Overall Study|Lost to Follow-up|1|||
27774559|NCT02517515|54227768|FG001|Overall Study|Lost to Follow-up|0|||
27774560|NCT02517515|54227767|FG000|Overall Study|Other|1|||
27774561|NCT02517515|54227768|FG001|Overall Study|Other|0|||
27774562|NCT02466659|54227777|FG000|Overall Study|Lost to Follow-up|5|||
27774563|NCT02466659|54227778|FG001|Overall Study|Lost to Follow-up|2|||
27774564|NCT01891864|54227786|FG000|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
27774565|NCT01891864|54227787|FG001|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
27774566|NCT01891864|54227788|FG002|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
27774567|NCT01891864|54227789|FG003|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
27774568|NCT01891864|54227790|FG004|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
27774569|NCT01891864|54227791|FG005|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
27774570|NCT01891864|54227786|FG000|Treatment Period 1|Physician Decision|0|||
27774571|NCT01891864|54227787|FG001|Treatment Period 1|Physician Decision|1|||
27774572|NCT01891864|54227788|FG002|Treatment Period 1|Physician Decision|0|||
27774573|NCT01891864|54227789|FG003|Treatment Period 1|Physician Decision|0|||
27774574|NCT01891864|54227790|FG004|Treatment Period 1|Physician Decision|0|||
27774575|NCT01891864|54227791|FG005|Treatment Period 1|Physician Decision|0|||
27774576|NCT01891864|54227786|FG000|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
27774577|NCT01891864|54227787|FG001|Treatment Period 1|Adverse Event, Serious, Fatal|1|||
27774578|NCT01891864|54227788|FG002|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
27774579|NCT01891864|54227789|FG003|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
27774580|NCT01891864|54227790|FG004|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
27774581|NCT01891864|54227791|FG005|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
27774582|NCT01891864|54227786|FG000|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
27774583|NCT01891864|54227787|FG001|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
27774584|NCT01891864|54227788|FG002|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
27774585|NCT01891864|54227789|FG003|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
27774586|NCT01891864|54227790|FG004|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
27774587|NCT01891864|54227791|FG005|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
27774588|NCT01891864|54227786|FG000|Treatment Period 1|Withdrawal by Subject|2|||
27774589|NCT01891864|54227787|FG001|Treatment Period 1|Withdrawal by Subject|5|||
27774590|NCT01891864|54227788|FG002|Treatment Period 1|Withdrawal by Subject|0|||
27774591|NCT01891864|54227789|FG003|Treatment Period 1|Withdrawal by Subject|0|||
27774592|NCT01891864|54227790|FG004|Treatment Period 1|Withdrawal by Subject|0|||
27774593|NCT01891864|54227791|FG005|Treatment Period 1|Withdrawal by Subject|0|||
27840199|NCT01502293|54327515|FG001|Overall Study|Progressive Disease|12|||
27774594|NCT01891864|54227786|FG000|Treatment Period 1|Lost to Follow-up|1|||
27774595|NCT01891864|54227787|FG001|Treatment Period 1|Lost to Follow-up|0|||
27774596|NCT01891864|54227788|FG002|Treatment Period 1|Lost to Follow-up|0|||
27774597|NCT01891864|54227789|FG003|Treatment Period 1|Lost to Follow-up|0|||
27774598|NCT01891864|54227790|FG004|Treatment Period 1|Lost to Follow-up|0|||
27774599|NCT01891864|54227791|FG005|Treatment Period 1|Lost to Follow-up|0|||
27774600|NCT01891864|54227786|FG000|Treatment Period 2|Protocol Violation|0|||
27774601|NCT01891864|54227787|FG001|Treatment Period 2|Protocol Violation|0|||
27774602|NCT01891864|54227788|FG002|Treatment Period 2|Protocol Violation|0|||
27774603|NCT01891864|54227789|FG003|Treatment Period 2|Protocol Violation|1|||
27774604|NCT01891864|54227790|FG004|Treatment Period 2|Protocol Violation|0|||
27774605|NCT01891864|54227791|FG005|Treatment Period 2|Protocol Violation|0|||
27774606|NCT01891864|54227786|FG000|Treatment Period 2|Physician Decision|0|||
27774607|NCT01891864|54227787|FG001|Treatment Period 2|Physician Decision|0|||
27774608|NCT01891864|54227788|FG002|Treatment Period 2|Physician Decision|1|||
27774609|NCT01891864|54227789|FG003|Treatment Period 2|Physician Decision|0|||
27774610|NCT01891864|54227790|FG004|Treatment Period 2|Physician Decision|0|||
27774611|NCT01891864|54227791|FG005|Treatment Period 2|Physician Decision|0|||
27774612|NCT01891864|54227786|FG000|Treatment Period 2|Site Termination|0|||
27774613|NCT01891864|54227787|FG001|Treatment Period 2|Site Termination|0|||
27774614|NCT01891864|54227788|FG002|Treatment Period 2|Site Termination|1|||
27774615|NCT01891864|54227789|FG003|Treatment Period 2|Site Termination|2|||
27774616|NCT01891864|54227790|FG004|Treatment Period 2|Site Termination|0|||
27774617|NCT01891864|54227791|FG005|Treatment Period 2|Site Termination|0|||
27774618|NCT01891864|54227786|FG000|Treatment Period 2|Lack of Efficacy|0|||
27774619|NCT01891864|54227787|FG001|Treatment Period 2|Lack of Efficacy|0|||
27774620|NCT01891864|54227788|FG002|Treatment Period 2|Lack of Efficacy|1|||
27774621|NCT01891864|54227789|FG003|Treatment Period 2|Lack of Efficacy|0|||
27774622|NCT01891864|54227790|FG004|Treatment Period 2|Lack of Efficacy|1|||
27774623|NCT01891864|54227791|FG005|Treatment Period 2|Lack of Efficacy|0|||
27774624|NCT01891864|54227786|FG000|Treatment Period 2|Adverse Event|0|||
27774625|NCT01891864|54227787|FG001|Treatment Period 2|Adverse Event|0|||
27774626|NCT01891864|54227788|FG002|Treatment Period 2|Adverse Event|1|||
27774627|NCT01891864|54227789|FG003|Treatment Period 2|Adverse Event|2|||
27774628|NCT01891864|54227790|FG004|Treatment Period 2|Adverse Event|0|||
27774629|NCT01891864|54227791|FG005|Treatment Period 2|Adverse Event|4|||
27774630|NCT01891864|54227786|FG000|Treatment Period 2|Termination of Site|0|||
27774631|NCT01891864|54227787|FG001|Treatment Period 2|Termination of Site|0|||
27774632|NCT01891864|54227788|FG002|Treatment Period 2|Termination of Site|0|||
27840200|NCT01502293|54327516|FG002|Overall Study|Progressive Disease|2|||
27774633|NCT01891864|54227789|FG003|Treatment Period 2|Termination of Site|0|||
27774634|NCT01891864|54227790|FG004|Treatment Period 2|Termination of Site|2|||
27774635|NCT01891864|54227791|FG005|Treatment Period 2|Termination of Site|0|||
27774636|NCT01891864|54227786|FG000|Treatment Period 2|Withdrawal by Subject|0|||
27774637|NCT01891864|54227787|FG001|Treatment Period 2|Withdrawal by Subject|0|||
27774638|NCT01891864|54227788|FG002|Treatment Period 2|Withdrawal by Subject|3|||
27774639|NCT01891864|54227789|FG003|Treatment Period 2|Withdrawal by Subject|4|||
27774640|NCT01891864|54227790|FG004|Treatment Period 2|Withdrawal by Subject|1|||
27774641|NCT01891864|54227791|FG005|Treatment Period 2|Withdrawal by Subject|1|||
27774642|NCT01891864|54227786|FG000|Extension Period|Lack of Efficacy|0|||
27774643|NCT01891864|54227787|FG001|Extension Period|Lack of Efficacy|0|||
27774644|NCT01891864|54227788|FG002|Extension Period|Lack of Efficacy|0|||
27774645|NCT01891864|54227789|FG003|Extension Period|Lack of Efficacy|1|||
27774646|NCT01891864|54227790|FG004|Extension Period|Lack of Efficacy|1|||
27774647|NCT01891864|54227791|FG005|Extension Period|Lack of Efficacy|0|||
27774648|NCT01891864|54227786|FG000|Extension Period|Pregnancy|0|||
27774649|NCT01891864|54227787|FG001|Extension Period|Pregnancy|0|||
27774650|NCT01891864|54227788|FG002|Extension Period|Pregnancy|1|||
27774651|NCT01891864|54227789|FG003|Extension Period|Pregnancy|0|||
27774652|NCT01891864|54227790|FG004|Extension Period|Pregnancy|0|||
27774653|NCT01891864|54227791|FG005|Extension Period|Pregnancy|0|||
27774654|NCT01891864|54227786|FG000|Extension Period|Adverse Event|0|||
27774655|NCT01891864|54227787|FG001|Extension Period|Adverse Event|0|||
27774656|NCT01891864|54227788|FG002|Extension Period|Adverse Event|4|||
27840201|NCT01502293|54327514|FG000|Overall Study|Withdrawal by Subject|3|||
27840202|NCT01502293|54327515|FG001|Overall Study|Withdrawal by Subject|3|||
27840203|NCT01502293|54327516|FG002|Overall Study|Withdrawal by Subject|1|||
27840204|NCT01502293|54327514|FG000|Overall Study|Adverse Event|0|||
27926943|NCT01013740|54583421|FG000|Overall Study|Missing|2|||
27774657|NCT01891864|54227789|FG003|Extension Period|Adverse Event|2|||
27774658|NCT01891864|54227790|FG004|Extension Period|Adverse Event|2|||
27774659|NCT01891864|54227791|FG005|Extension Period|Adverse Event|0|||
27774660|NCT01891864|54227786|FG000|Extension Period|Withdrawal by Subject|0|||
27774661|NCT01891864|54227787|FG001|Extension Period|Withdrawal by Subject|0|||
27774662|NCT01891864|54227788|FG002|Extension Period|Withdrawal by Subject|1|||
27774663|NCT01891864|54227789|FG003|Extension Period|Withdrawal by Subject|2|||
27774664|NCT01891864|54227790|FG004|Extension Period|Withdrawal by Subject|4|||
27774665|NCT01891864|54227791|FG005|Extension Period|Withdrawal by Subject|0|||
27774666|NCT01891864|54227786|FG000|Extension Period|Lost to Follow-up|0|||
27840205|NCT01502293|54327515|FG001|Overall Study|Adverse Event|2|||
27774667|NCT01891864|54227787|FG001|Extension Period|Lost to Follow-up|0|||
27774668|NCT01891864|54227788|FG002|Extension Period|Lost to Follow-up|2|||
27774669|NCT01891864|54227789|FG003|Extension Period|Lost to Follow-up|0|||
27774670|NCT01891864|54227790|FG004|Extension Period|Lost to Follow-up|0|||
27774671|NCT01891864|54227791|FG005|Extension Period|Lost to Follow-up|0|||
27774672|NCT02485301|54227805|FG000|Overall Study|Serious Adverse Events|2|||
27774673|NCT02485301|54227806|FG001|Overall Study|Serious Adverse Events|1|||
27774674|NCT02485301|54227805|FG000|Overall Study|Protocol Violation|0|||
27774675|NCT02485301|54227806|FG001|Overall Study|Protocol Violation|1|||
27774676|NCT02485301|54227805|FG000|Overall Study|Withdrawal by Subject|6|||
27774677|NCT02485301|54227806|FG001|Overall Study|Withdrawal by Subject|7|||
27774678|NCT02485301|54227805|FG000|Overall Study|Migrated/moved from study area|10|||
27774679|NCT02485301|54227806|FG001|Overall Study|Migrated/moved from study area|19|||
27774680|NCT02485301|54227805|FG000|Overall Study|Lost to Follow-up|17|||
27774681|NCT02485301|54227806|FG001|Overall Study|Lost to Follow-up|17|||
27774682|NCT02485301|54227805|FG000|Overall Study|Other|3|||
27774683|NCT02485301|54227806|FG001|Overall Study|Other|4|||
27774684|NCT02484911|54227814|FG000|Overall Study|Withdrawal by Subject|2|||
27774685|NCT02484911|54227815|FG001|Overall Study|Withdrawal by Subject|1|||
27774686|NCT02484911|54227814|FG000|Overall Study|Protocol Violation|2|||
27774687|NCT02484911|54227815|FG001|Overall Study|Protocol Violation|1|||
27774688|NCT02466425|54227824|FG000|Overall Study|Adverse Event|3|||
27774689|NCT02466425|54227825|FG001|Overall Study|Adverse Event|11|||
27774690|NCT02466425|54227824|FG000|Overall Study|Lack of Efficacy|4|||
27774691|NCT02466425|54227825|FG001|Overall Study|Lack of Efficacy|1|||
27774692|NCT02466425|54227824|FG000|Overall Study|Lost to Follow-up|3|||
27774693|NCT02466425|54227825|FG001|Overall Study|Lost to Follow-up|0|||
27774694|NCT02466425|54227824|FG000|Overall Study|Protocol Violation|1|||
27774695|NCT02466425|54227825|FG001|Overall Study|Protocol Violation|0|||
27774696|NCT02466425|54227824|FG000|Overall Study|Withdrawal by Subject|0|||
27774697|NCT02466425|54227825|FG001|Overall Study|Withdrawal by Subject|1|||
27774698|NCT02466425|54227824|FG000|Overall Study|Other|1|||
27774699|NCT02466425|54227825|FG001|Overall Study|Other|3|||
27774700|NCT02466425|54227824|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
27774701|NCT02466425|54227825|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
27774702|NCT02451917|54227833|FG000|First Intervention (24 Weeks)|Lost to Follow-up|2|||
27774703|NCT02451917|54227834|FG001|First Intervention (24 Weeks)|Lost to Follow-up|0|||
27774704|NCT02451917|54227833|FG000|First Intervention (24 Weeks)|Death|0|||
27774705|NCT02451917|54227834|FG001|First Intervention (24 Weeks)|Death|1|||
27774706|NCT02451917|54227833|FG000|First Intervention (24 Weeks)|Adverse Event|0|||
27774707|NCT02451917|54227834|FG001|First Intervention (24 Weeks)|Adverse Event|2|||
27774708|NCT02349451|54227847|FG000|Overall Study|Withdrawal by Subject|0|||
27774709|NCT02349451|54227848|FG001|Overall Study|Withdrawal by Subject|1|||
27774710|NCT02349451|54227849|FG002|Overall Study|Withdrawal by Subject|2|||
27774711|NCT02349451|54227850|FG003|Overall Study|Withdrawal by Subject|1|||
27774712|NCT02409368|54227867|FG000|ECOG Reclassification|Adverse event unrelated to study drug|17|||
27774713|NCT02409368|54227868|FG001|ECOG Reclassification|Adverse event unrelated to study drug|49|||
27774714|NCT02409368|54227869|FG002|ECOG Reclassification|Adverse event unrelated to study drug|12|||
27774715|NCT02409368|54227870|FG003|ECOG Reclassification|Adverse event unrelated to study drug|0|||
27774716|NCT02409368|54227867|FG000|ECOG Reclassification|Death|1|||
27774717|NCT02409368|54227868|FG001|ECOG Reclassification|Death|5|||
27774718|NCT02409368|54227869|FG002|ECOG Reclassification|Death|0|||
27774719|NCT02409368|54227870|FG003|ECOG Reclassification|Death|0|||
27774720|NCT02409368|54227867|FG000|ECOG Reclassification|Disease Progression|113|||
27774721|NCT02409368|54227868|FG001|ECOG Reclassification|Disease Progression|382|||
27774722|NCT02409368|54227869|FG002|ECOG Reclassification|Disease Progression|70|||
27774723|NCT02409368|54227870|FG003|ECOG Reclassification|Disease Progression|1|||
27774724|NCT02409368|54227867|FG000|ECOG Reclassification|Lost to Follow-up|1|||
27774725|NCT02409368|54227868|FG001|ECOG Reclassification|Lost to Follow-up|5|||
27774726|NCT02409368|54227869|FG002|ECOG Reclassification|Lost to Follow-up|0|||
27774727|NCT02409368|54227870|FG003|ECOG Reclassification|Lost to Follow-up|0|||
27774728|NCT02409368|54227867|FG000|ECOG Reclassification|Maximum clinical benefit|6|||
27774729|NCT02409368|54227868|FG001|ECOG Reclassification|Maximum clinical benefit|5|||
27774730|NCT02409368|54227869|FG002|ECOG Reclassification|Maximum clinical benefit|0|||
27774731|NCT02409368|54227870|FG003|ECOG Reclassification|Maximum clinical benefit|0|||
27774732|NCT02409368|54227867|FG000|ECOG Reclassification|Poor/non-compliance|0|||
27774733|NCT02409368|54227868|FG001|ECOG Reclassification|Poor/non-compliance|3|||
27840206|NCT01502293|54327516|FG002|Overall Study|Adverse Event|0|||
27774734|NCT02409368|54227869|FG002|ECOG Reclassification|Poor/non-compliance|2|||
27774735|NCT02409368|54227870|FG003|ECOG Reclassification|Poor/non-compliance|0|||
27774736|NCT02409368|54227867|FG000|ECOG Reclassification|Study drug toxicity|17|||
27774737|NCT02409368|54227868|FG001|ECOG Reclassification|Study drug toxicity|42|||
27774738|NCT02409368|54227869|FG002|ECOG Reclassification|Study drug toxicity|7|||
27774739|NCT02409368|54227870|FG003|ECOG Reclassification|Study drug toxicity|0|||
27774740|NCT02409368|54227867|FG000|ECOG Reclassification|Participant no longer meets study criteria|3|||
27774741|NCT02409368|54227868|FG001|ECOG Reclassification|Participant no longer meets study criteria|8|||
27774742|NCT02409368|54227869|FG002|ECOG Reclassification|Participant no longer meets study criteria|3|||
27774743|NCT02409368|54227870|FG003|ECOG Reclassification|Participant no longer meets study criteria|0|||
27774744|NCT02409368|54227867|FG000|ECOG Reclassification|Participant request to discontinue study treatment|6|||
27774745|NCT02409368|54227868|FG001|ECOG Reclassification|Participant request to discontinue study treatment|6|||
27774746|NCT02409368|54227869|FG002|ECOG Reclassification|Participant request to discontinue study treatment|2|||
27774747|NCT02409368|54227870|FG003|ECOG Reclassification|Participant request to discontinue study treatment|0|||
27774748|NCT02409368|54227867|FG000|ECOG Reclassification|Participant withdrew consent|2|||
27774749|NCT02409368|54227868|FG001|ECOG Reclassification|Participant withdrew consent|3|||
27774750|NCT02409368|54227869|FG002|ECOG Reclassification|Participant withdrew consent|4|||
27774751|NCT02409368|54227870|FG003|ECOG Reclassification|Participant withdrew consent|0|||
27774752|NCT02409368|54227867|FG000|ECOG Reclassification|Other Reasons|5|||
27774753|NCT02409368|54227868|FG001|ECOG Reclassification|Other Reasons|26|||
27774754|NCT02409368|54227869|FG002|ECOG Reclassification|Other Reasons|2|||
27774755|NCT02409368|54227870|FG003|ECOG Reclassification|Other Reasons|0|||
27774756|NCT02409368|54227867|FG000|ECOG Reclassification|Administrative reason by sponsor|1|||
27774757|NCT02409368|54227868|FG001|ECOG Reclassification|Administrative reason by sponsor|3|||
27774758|NCT02409368|54227869|FG002|ECOG Reclassification|Administrative reason by sponsor|0|||
27774759|NCT02409368|54227870|FG003|ECOG Reclassification|Administrative reason by sponsor|0|||
27774760|NCT01853878|54227883|FG000|Overall Study|Recurrence|2|||
27774761|NCT01853878|54227884|FG001|Overall Study|Recurrence|0|||
27774762|NCT01853878|54227883|FG000|Overall Study|Adverse Event|2|||
27774763|NCT01853878|54227884|FG001|Overall Study|Adverse Event|0|||
27774764|NCT01853878|54227883|FG000|Overall Study|Withdrawal by Subject|3|||
27774765|NCT01853878|54227884|FG001|Overall Study|Withdrawal by Subject|1|||
27774766|NCT01853878|54227883|FG000|Overall Study|Migrated/moved from the study area|1|||
27774767|NCT01853878|54227884|FG001|Overall Study|Migrated/moved from the study area|0|||
27774768|NCT01853878|54227883|FG000|Overall Study|Other|55|||
27774769|NCT01853878|54227884|FG001|Overall Study|Other|43|||
27774770|NCT02342678|54227892|FG000|Overall Study|Lost to Follow-up|0|||
27774771|NCT02342678|54227893|FG001|Overall Study|Lost to Follow-up|1|||
27774772|NCT02342678|54227892|FG000|Overall Study|Too busy to complete study|0|||
27774773|NCT02342678|54227893|FG001|Overall Study|Too busy to complete study|2|||
27774774|NCT02342678|54227892|FG000|Overall Study|Family illness/emergency|0|||
27774775|NCT02342678|54227893|FG001|Overall Study|Family illness/emergency|1|||
27774776|NCT02342678|54227892|FG000|Overall Study|Illness/medical reason|1|||
27774777|NCT02342678|54227893|FG001|Overall Study|Illness/medical reason|1|||
27774778|NCT02408120|54227901|FG000|Overall Study|Withdrawal by Subject|0|||
27774779|NCT02408120|54227902|FG001|Overall Study|Withdrawal by Subject|1|||
27774780|NCT02408120|54227901|FG000|Overall Study|Treatment Refusal|1|||
27774781|NCT02408120|54227902|FG001|Overall Study|Treatment Refusal|0|||
27774782|NCT02408120|54227901|FG000|Overall Study|Received Steroids|1|||
27774783|NCT02408120|54227902|FG001|Overall Study|Received Steroids|1|||
27774784|NCT02408120|54227901|FG000|Overall Study|Discharged same day|1|||
27774785|NCT02408120|54227902|FG001|Overall Study|Discharged same day|1|||
27774786|NCT02408120|54227901|FG000|Overall Study|Did not receive insulin|1|||
27774787|NCT02408120|54227902|FG001|Overall Study|Did not receive insulin|2|||
27774788|NCT02342288|54227910|FG000|Overall Study|no protocol anesthesiologist available|3|||
27774789|NCT02342288|54227911|FG001|Overall Study|no protocol anesthesiologist available|2|||
27774790|NCT02342288|54227910|FG000|Overall Study|anesthesia leak in system|1|||
27774791|NCT02342288|54227911|FG001|Overall Study|anesthesia leak in system|0|||
27774792|NCT02342288|54227910|FG000|Overall Study|Withdrawal by Subject|1|||
27774793|NCT02342288|54227911|FG001|Overall Study|Withdrawal by Subject|0|||
27774794|NCT02342288|54227910|FG000|Overall Study|coordinator contaminated with blood|0|||
27774795|NCT02342288|54227911|FG001|Overall Study|coordinator contaminated with blood|1|||
27774796|NCT02342288|54227910|FG000|Overall Study|subject cannot tolerate numbing drops|0|||
27774797|NCT02342288|54227911|FG001|Overall Study|subject cannot tolerate numbing drops|1|||
27774798|NCT02342288|54227910|FG000|Overall Study|coordinator not available|0|||
27774799|NCT02342288|54227911|FG001|Overall Study|coordinator not available|2|||
27774800|NCT01853644|54227917|FG000|Registration and Treatment Start|Did not start treatment|1|||
27774801|NCT01853644|54227917|FG000|Reached First Response/Complete 2 Cycles|Adverse Event|2|||
27774802|NCT01853644|54227917|FG000|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1|||
27774803|NCT01853644|54227917|FG000|Reached First Response/Complete 2 Cycles|Other|1|||
27774804|NCT01853644|54227917|FG000|Reached First Response/Complete 2 Cycles|Progressive Disease|2|||
27840207|NCT01502293|54327514|FG000|Overall Study|Reason Not Specified|2|||
27840208|NCT01502293|54327515|FG001|Overall Study|Reason Not Specified|0|||
27774805|NCT01853644|54227917|FG000|Continued Treatment After First Response|Adverse Event|2|||
27774806|NCT01853644|54227917|FG000|Continued Treatment After First Response|Progressive Diseaes|10|||
27774807|NCT02374346|54227921|FG000|Overall Study|operated or discharged during weekend|48|||
27774808|NCT01853254|54227927|FG000|Overall Study|Abnormal Laboratory Test|1|||
27774809|NCT01853254|54227927|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
27774810|NCT01853254|54227927|FG000|Overall Study|Death|1|||
27774811|NCT01853254|54227927|FG000|Overall Study|Failure to Return|43|||
27774812|NCT01853254|54227927|FG000|Overall Study|Insufficient Therapeutic Response|22|||
27774813|NCT01853254|54227927|FG000|Overall Study|Refusal of Treatment|1|||
27774814|NCT01853254|54227927|FG000|Overall Study|Other Protocol Violation|1|||
27774815|NCT01853254|54227927|FG000|Overall Study|Withdrawal of Consent|16|||
27774816|NCT01853254|54227927|FG000|Overall Study|Administrative/Other|16|||
27774817|NCT02373098|54227933|FG000|Overall Study|Lost to Follow-up|1|||
27774818|NCT02373098|54227934|FG001|Overall Study|Lost to Follow-up|0|||
27774819|NCT02373098|54227933|FG000|Overall Study|Protocol Violation|3|||
27774820|NCT02373098|54227934|FG001|Overall Study|Protocol Violation|0|||
27774821|NCT02373098|54227933|FG000|Overall Study|Withdrawal by Subject|5|||
27774822|NCT02373098|54227934|FG001|Overall Study|Withdrawal by Subject|0|||
27774823|NCT02373098|54227933|FG000|Overall Study|Adverse Event|3|||
27774824|NCT02373098|54227934|FG001|Overall Study|Adverse Event|0|||
27774825|NCT01853176|54227948|FG000|Overall Study|Study terminated|4|||
27774826|NCT01853176|54227949|FG001|Overall Study|Study terminated|0|||
27774827|NCT02372396|54227957|FG000|Overall Study|Lost to Follow-up|7|||
27774828|NCT02372396|54227958|FG001|Overall Study|Lost to Follow-up|9|||
27774829|NCT01835548|54227966|FG000|Dose Optimization Period|Adverse Event|0|||
27774830|NCT01835548|54227967|FG001|Dose Optimization Period|Adverse Event|0|||
27774831|NCT01835548|54227968|FG002|Dose Optimization Period|Adverse Event|1|||
27774832|NCT01835548|54227966|FG000|Dose Optimization Period|Withdrawal by Subject|0|||
27774833|NCT01835548|54227967|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
27774834|NCT01835548|54227968|FG002|Dose Optimization Period|Withdrawal by Subject|1|||
27774835|NCT01835548|54227966|FG000|Double-Blind Treatment Period|Adverse Event|0|||
27774836|NCT01835548|54227967|FG001|Double-Blind Treatment Period|Adverse Event|1|||
27774837|NCT01835548|54227968|FG002|Double-Blind Treatment Period|Adverse Event|0|||
27774838|NCT01835548|54227966|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
27774839|NCT01835548|54227967|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
27774840|NCT01835548|54227968|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
27774841|NCT01852942|54227982|FG000|Overall Study|Physician Decision|1|||
27774842|NCT01852942|54227983|FG001|Overall Study|Physician Decision|0|||
27774843|NCT01852942|54227982|FG000|Overall Study|Death|1|||
27774844|NCT01852942|54227983|FG001|Overall Study|Death|1|||
27774845|NCT01852942|54227982|FG000|Overall Study|Withdrawal by Subject|2|||
27774846|NCT01852942|54227983|FG001|Overall Study|Withdrawal by Subject|3|||
27774847|NCT01852942|54227982|FG000|Overall Study|Lost to Follow-up|1|||
27774848|NCT01852942|54227983|FG001|Overall Study|Lost to Follow-up|2|||
27774849|NCT01852162|54227992|FG000|Overall Study|Adverse Event|1|||
27774850|NCT01852162|54227993|FG001|Overall Study|Adverse Event|0|||
27774851|NCT01852162|54227992|FG000|Overall Study|Withdrawal by Subject|3|||
27774852|NCT01852162|54227993|FG001|Overall Study|Withdrawal by Subject|1|||
27774853|NCT01835470|54227999|FG000|Long Term Treatment Period|Subject Request to Discontinue|1|||
27774854|NCT01835470|54227999|FG000|Long Term Treatment Period|Lack of Efficacy|3|||
27774855|NCT02451137|54228006|FG000|Overall Study|Randomized but not treated|19|||
27774856|NCT02451137|54228007|FG001|Overall Study|Randomized but not treated|27|||
27774857|NCT02451137|54228006|FG000|Overall Study|Adverse Event|43|||
27774858|NCT02451137|54228007|FG001|Overall Study|Adverse Event|42|||
27774859|NCT02451137|54228006|FG000|Overall Study|Lack of Efficacy|4|||
27840209|NCT01502293|54327516|FG002|Overall Study|Reason Not Specified|0|||
27774860|NCT02451137|54228007|FG001|Overall Study|Lack of Efficacy|9|||
27774861|NCT02451137|54228006|FG000|Overall Study|Participant decision:discontinue insulin|41|||
27774862|NCT02451137|54228007|FG001|Overall Study|Participant decision:discontinue insulin|43|||
27774863|NCT02451137|54228006|FG000|Overall Study|Hypoglycemia|2|||
27774864|NCT02451137|54228007|FG001|Overall Study|Hypoglycemia|1|||
27774865|NCT02451137|54228006|FG000|Overall Study|Investigator's decision|23|||
27774866|NCT02451137|54228007|FG001|Overall Study|Investigator's decision|19|||
27774867|NCT02451137|54228006|FG000|Overall Study|Lost to Follow-up|53|||
27774868|NCT02451137|54228007|FG001|Overall Study|Lost to Follow-up|61|||
27774869|NCT02451137|54228006|FG000|Overall Study|Physician Decision|6|||
27774870|NCT02451137|54228007|FG001|Overall Study|Physician Decision|5|||
27774871|NCT02451137|54228006|FG000|Overall Study|Sponsor decision|13|||
27840210|NCT01502293|54327514|FG000|Overall Study|Physician Decision|0|||
27840211|NCT01502293|54327515|FG001|Overall Study|Physician Decision|0|||
27840212|NCT01502293|54327516|FG002|Overall Study|Physician Decision|1|||
27774872|NCT02451137|54228007|FG001|Overall Study|Sponsor decision|25|||
27774873|NCT02451137|54228006|FG000|Overall Study|Withdrawal by Subject|40|||
27774874|NCT02451137|54228007|FG001|Overall Study|Withdrawal by Subject|63|||
27774875|NCT02451137|54228006|FG000|Overall Study|Other than specified above|2|||
27774876|NCT02451137|54228007|FG001|Overall Study|Other than specified above|3|||
27774877|NCT02372006|54228016|FG000|Overall Study|Progressive disease|8|||
27774878|NCT02372006|54228017|FG001|Overall Study|Progressive disease|7|||
27774879|NCT02372006|54228018|FG002|Overall Study|Progressive disease|34|||
27774880|NCT02372006|54228016|FG000|Overall Study|Dose limiting toxicity|0|||
27774881|NCT02372006|54228017|FG001|Overall Study|Dose limiting toxicity|1|||
27774882|NCT02372006|54228018|FG002|Overall Study|Dose limiting toxicity|0|||
27774883|NCT02372006|54228016|FG000|Overall Study|Adverse Event|0|||
27774884|NCT02372006|54228017|FG001|Overall Study|Adverse Event|0|||
27774885|NCT02372006|54228018|FG002|Overall Study|Adverse Event|3|||
27774886|NCT02372006|54228016|FG000|Overall Study|Withdrawal by Subject|0|||
27774887|NCT02372006|54228017|FG001|Overall Study|Withdrawal by Subject|1|||
27774888|NCT02372006|54228018|FG002|Overall Study|Withdrawal by Subject|1|||
27774889|NCT02372006|54228016|FG000|Overall Study|Other reason for not completing|0|||
27774890|NCT02372006|54228017|FG001|Overall Study|Other reason for not completing|0|||
27774891|NCT02372006|54228018|FG002|Overall Study|Other reason for not completing|1|||
27774892|NCT02406248|54228027|FG000|Overall Study|Death|7|||
27774893|NCT02406248|54228027|FG000|Overall Study|Withdrawal by Subject|2|||
27774894|NCT02450903|54228031|FG000|Overall Study|Adverse Event|3|||
27774895|NCT02450903|54228031|FG000|Overall Study|Progressive disease|15|||
27774896|NCT02450903|54228031|FG000|Overall Study|Switched to commercial drug|1|||
27774897|NCT02450903|54228031|FG000|Overall Study|Subject/guardian decision|1|||
27774898|NCT02371616|54228037|FG000|Overall Study|Protocol Violation|2|||
27774899|NCT02371616|54228038|FG001|Overall Study|Protocol Violation|1|||
27774900|NCT02371616|54228037|FG000|Overall Study|Adverse Event|0|||
27774901|NCT02371616|54228038|FG001|Overall Study|Adverse Event|1|||
27774902|NCT02371616|54228037|FG000|Overall Study|Withdrawal of Consent|1|||
27774903|NCT02371616|54228038|FG001|Overall Study|Withdrawal of Consent|0|||
27774904|NCT02371616|54228037|FG000|Overall Study|Other (Not specified)|1|||
27774905|NCT02371616|54228038|FG001|Overall Study|Other (Not specified)|5|||
27774906|NCT02370914|54228044|FG000|Overall Study|Protocol Violation|2|||
27774907|NCT02370602|54228054|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
27774908|NCT02370602|54228055|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
27774909|NCT02370602|54228056|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
27774910|NCT02370602|54228057|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
27774911|NCT02370602|54228058|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
27774912|NCT02370602|54228059|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
27774913|NCT02370368|54228078|FG000|Overall Study|Adverse Event|1|||
27774914|NCT02370368|54228079|FG001|Overall Study|Adverse Event|2|||
27774915|NCT02370368|54228078|FG000|Overall Study|Withdrawal by Subject|5|||
27774916|NCT02370368|54228079|FG001|Overall Study|Withdrawal by Subject|4|||
27774917|NCT02340806|54228087|FG000|Overall Study|Protocol Violation|2|||
27774918|NCT02340806|54228088|FG001|Overall Study|Protocol Violation|0|||
27774919|NCT02340806|54228087|FG000|Overall Study|epidural catheter replaced|2|||
27774920|NCT02340806|54228088|FG001|Overall Study|epidural catheter replaced|1|||
27774921|NCT02340806|54228087|FG000|Overall Study|history of chronic pain medication|1|||
27774922|NCT02340806|54228088|FG001|Overall Study|history of chronic pain medication|0|||
27774923|NCT02340806|54228087|FG000|Overall Study|re-dose < 90 min of CSE|1|||
27774924|NCT02340806|54228088|FG001|Overall Study|re-dose < 90 min of CSE|3|||
27774925|NCT02338154|54228094|FG000|Overall Study|Death|46|||
27774926|NCT02338154|54228094|FG000|Overall Study|Valve Implant Failure|17|||
27774927|NCT02338154|54228094|FG000|Overall Study|Valve Explant|11|||
27774928|NCT02338154|54228094|FG000|Overall Study|Withdrawal by Subject or by Investigator|10|||
27774929|NCT02338154|54228094|FG000|Overall Study|Lost to Follow-up|8|||
27774930|NCT02338154|54228094|FG000|Overall Study|Other Reason|3|||
27774931|NCT02338154|54228094|FG000|Overall Study|Patients Without Exit Form|47|||
27774932|NCT02338154|54228094|FG000|Overall Study|Missing Exit Reason on Exit Form|1|||
27774933|NCT01835158|54228108|FG000|Overall Study|Withdrawal by Subject|1|||
27774934|NCT01835158|54228109|FG001|Overall Study|Withdrawal by Subject|6|||
27774935|NCT02337764|54228115|FG000|Overall Study|Pretreatment Event/Adverse Event|46|||
27774936|NCT02337764|54228115|FG000|Overall Study|Voluntary Withdrawal|12|||
27774937|NCT02337764|54228115|FG000|Overall Study|Lack of Efficacy|2|||
27774938|NCT01834222|54228119|FG000|Overall Study|Not meet inclusion/exclusion criteria|1|||
27774939|NCT01833832|54228123|FG000|Overall Study|Pt could not be cytoreduced for HIPEC|1|||
27774940|NCT01833520|54228129|FG000|Overall Study|Lack of Efficacy|3|||
27774941|NCT01833520|54228130|FG001|Overall Study|Lack of Efficacy|3|||
27774942|NCT01833520|54228131|FG002|Overall Study|Lack of Efficacy|8|||
27774943|NCT01833520|54228132|FG003|Overall Study|Lack of Efficacy|3|||
27774944|NCT01850602|54228146|FG000|Overall Study|Adverse Event|7|||
27774945|NCT01850602|54228147|FG001|Overall Study|Adverse Event|10|||
27774946|NCT01850602|54228146|FG000|Overall Study|Physician Decision|2|||
27774947|NCT01850602|54228147|FG001|Overall Study|Physician Decision|1|||
27774948|NCT01850602|54228146|FG000|Overall Study|Withdrawal by Subject|2|||
27774949|NCT01850602|54228147|FG001|Overall Study|Withdrawal by Subject|4|||
27774950|NCT01850602|54228146|FG000|Overall Study|Decrease in serum calcium|2|||
27840213|NCT01474681|54327529|FG000|Overall Study|Death|0|||
27774951|NCT01850602|54228147|FG001|Overall Study|Decrease in serum calcium|3|||
27774952|NCT01850602|54228146|FG000|Overall Study|Increase in serum ferritin|1|||
27774953|NCT01850602|54228147|FG001|Overall Study|Increase in serum ferritin|0|||
27774954|NCT01832818|54228153|FG000|Overall Study|Lost to Follow-up|6|||
27774955|NCT02405780|54228161|FG000|Period I|Adverse Event|8|||
27774956|NCT02405780|54228162|FG001|Period I|Adverse Event|0|||
27840214|NCT01474681|54327530|FG001|Overall Study|Death|3|||
27774957|NCT02405780|54228163|FG002|Period I|Adverse Event|3|||
27774958|NCT02405780|54228164|FG003|Period I|Adverse Event|7|||
27774959|NCT02405780|54228161|FG000|Period I|Medical reasons|1|||
27774960|NCT02405780|54228162|FG001|Period I|Medical reasons|1|||
27774961|NCT02405780|54228163|FG002|Period I|Medical reasons|0|||
27774962|NCT02405780|54228164|FG003|Period I|Medical reasons|1|||
27774963|NCT02405780|54228161|FG000|Period I|Screening Failure|1|||
27774964|NCT02405780|54228162|FG001|Period I|Screening Failure|0|||
27774965|NCT02405780|54228163|FG002|Period I|Screening Failure|1|||
27774966|NCT02405780|54228164|FG003|Period I|Screening Failure|0|||
27774967|NCT02405780|54228161|FG000|Period I|Withdrawal by Subject|9|||
27774968|NCT02405780|54228162|FG001|Period I|Withdrawal by Subject|1|||
27774969|NCT02405780|54228163|FG002|Period I|Withdrawal by Subject|3|||
27774970|NCT02405780|54228164|FG003|Period I|Withdrawal by Subject|4|||
27774971|NCT02405780|54228161|FG000|Period I|Non-compliance with study procedures|8|||
27774972|NCT02405780|54228162|FG001|Period I|Non-compliance with study procedures|6|||
27774973|NCT02405780|54228163|FG002|Period I|Non-compliance with study procedures|8|||
27774974|NCT02405780|54228164|FG003|Period I|Non-compliance with study procedures|11|||
27774975|NCT02405780|54228161|FG000|Period II|Adverse Event|3|||
27774976|NCT02405780|54228162|FG001|Period II|Adverse Event|5|||
27774977|NCT02405780|54228163|FG002|Period II|Adverse Event|4|||
27774978|NCT02405780|54228164|FG003|Period II|Adverse Event|11|||
27774979|NCT02405780|54228161|FG000|Period II|Medical reason|0|||
27774980|NCT02405780|54228162|FG001|Period II|Medical reason|1|||
27774981|NCT02405780|54228163|FG002|Period II|Medical reason|0|||
27774982|NCT02405780|54228164|FG003|Period II|Medical reason|0|||
27774983|NCT02405780|54228161|FG000|Period II|Pregnancy|0|||
27774984|NCT02405780|54228162|FG001|Period II|Pregnancy|0|||
27774985|NCT02405780|54228163|FG002|Period II|Pregnancy|1|||
27774986|NCT02405780|54228164|FG003|Period II|Pregnancy|0|||
27774987|NCT02405780|54228161|FG000|Period II|Withdrawal by Subject|7|||
27774988|NCT02405780|54228162|FG001|Period II|Withdrawal by Subject|4|||
27774989|NCT02405780|54228163|FG002|Period II|Withdrawal by Subject|0|||
27774990|NCT02405780|54228164|FG003|Period II|Withdrawal by Subject|3|||
27774991|NCT02405780|54228161|FG000|Period II|Non-compliance with study procedures|5|||
27774992|NCT02405780|54228162|FG001|Period II|Non-compliance with study procedures|2|||
27774993|NCT02405780|54228163|FG002|Period II|Non-compliance with study procedures|7|||
27774994|NCT02405780|54228164|FG003|Period II|Non-compliance with study procedures|4|||
27774995|NCT02369510|54228192|FG000|Overall Study|Spilled Medication|1|||
27774996|NCT02369510|54228193|FG001|Overall Study|Spilled Medication|2|||
27774997|NCT02369510|54228194|FG002|Overall Study|Spilled Medication|1|||
27774998|NCT02369510|54228192|FG000|Overall Study|Epidural Activation|1|||
27774999|NCT02369510|54228193|FG001|Overall Study|Epidural Activation|1|||
27775000|NCT02369510|54228194|FG002|Overall Study|Epidural Activation|5|||
27775001|NCT01650194|54228202|FG000|Overall Study|Progressive Disease (PD)|35|||
27775002|NCT01650194|54228202|FG000|Overall Study|Withdrawal by Subject|2|||
27775003|NCT01650194|54228202|FG000|Overall Study|Miscellaneous|10|||
27775004|NCT02367716|54228207|FG000|Overall Study|Patient did not meet inclusion criteria|1|||
27775005|NCT02366936|54228212|FG000|Overall Study|Withdrawal by Subject|2|||
27775006|NCT02366936|54228212|FG000|Overall Study|Lost to Follow-up|4|||
27775007|NCT02366936|54228212|FG000|Overall Study|Physician Decision|2|||
27775008|NCT01648166|54228218|FG000|Overall Study|inadequate toenail samples|53|||
27775009|NCT01648166|54228219|FG001|Overall Study|inadequate toenail samples|100|||
27775010|NCT02336282|54228225|FG000|Overall Study|Unrelated illness|1|||
27775011|NCT02336282|54228225|FG000|Overall Study|Uncomfortable with technology|1|||
27775012|NCT02336282|54228225|FG000|Overall Study|Lost to Follow-up|1|||
27775013|NCT02336282|54228225|FG000|Overall Study|Not enough time to complete sessions|2|||
27775014|NCT02404220|54228241|FG000|Overall Study|Adverse Event|0|||
27775015|NCT02404220|54228242|FG001|Overall Study|Adverse Event|0|||
27775016|NCT02404220|54228243|FG002|Overall Study|Adverse Event|1|||
27775017|NCT02404220|54228244|FG003|Overall Study|Adverse Event|0|||
27775018|NCT02404220|54228241|FG000|Overall Study|Death|5|||
27775019|NCT02404220|54228242|FG001|Overall Study|Death|5|||
27775020|NCT02404220|54228243|FG002|Overall Study|Death|3|||
27775021|NCT02404220|54228244|FG003|Overall Study|Death|8|||
27775022|NCT02404220|54228241|FG000|Overall Study|Progressive Disease|0|||
27775023|NCT02404220|54228242|FG001|Overall Study|Progressive Disease|0|||
27775024|NCT02404220|54228243|FG002|Overall Study|Progressive Disease|1|||
27775025|NCT02404220|54228244|FG003|Overall Study|Progressive Disease|1|||
27775026|NCT02404220|54228241|FG000|Overall Study|Study Terminated by Sponsor|0|||
27775027|NCT02404220|54228242|FG001|Overall Study|Study Terminated by Sponsor|0|||
27775028|NCT02404220|54228243|FG002|Overall Study|Study Terminated by Sponsor|2|||
27775029|NCT02404220|54228244|FG003|Overall Study|Study Terminated by Sponsor|1|||
27775030|NCT02404220|54228241|FG000|Overall Study|Withdrawal by Subject|0|||
27775031|NCT02404220|54228242|FG001|Overall Study|Withdrawal by Subject|1|||
27775032|NCT02404220|54228243|FG002|Overall Study|Withdrawal by Subject|0|||
27775033|NCT02404220|54228244|FG003|Overall Study|Withdrawal by Subject|0|||
27775034|NCT02404220|54228241|FG000|Overall Study|Enrolled but Never Treated|0|||
27775035|NCT02404220|54228242|FG001|Overall Study|Enrolled but Never Treated|2|||
27775036|NCT02404220|54228243|FG002|Overall Study|Enrolled but Never Treated|0|||
27775037|NCT02404220|54228244|FG003|Overall Study|Enrolled but Never Treated|0|||
27775038|NCT02335658|54228256|FG000|Overall Study|Adverse Event|18|||
27775039|NCT02335658|54228257|FG001|Overall Study|Adverse Event|12|||
27775040|NCT02335658|54228256|FG000|Overall Study|Lack of Efficacy|4|||
27775041|NCT02335658|54228257|FG001|Overall Study|Lack of Efficacy|5|||
27775042|NCT02335658|54228256|FG000|Overall Study|Pregnancy|1|||
27775043|NCT02335658|54228257|FG001|Overall Study|Pregnancy|0|||
27775044|NCT02335658|54228256|FG000|Overall Study|Withdrawal by Subject|13|||
27775045|NCT02335658|54228257|FG001|Overall Study|Withdrawal by Subject|21|||
27775046|NCT02335658|54228256|FG000|Overall Study|non-compliance|2|||
27775047|NCT02335658|54228257|FG001|Overall Study|non-compliance|3|||
27775048|NCT02335658|54228256|FG000|Overall Study|other reason|2|||
27775049|NCT02335658|54228257|FG001|Overall Study|other reason|3|||
27775050|NCT02366468|54228267|FG000|Overall Study|Adverse Event|2|||
27775051|NCT02366468|54228268|FG001|Overall Study|Adverse Event|0|||
27775052|NCT02366468|54228267|FG000|Overall Study|Withdrawal by Subject|1|||
27775053|NCT02366468|54228268|FG001|Overall Study|Withdrawal by Subject|5|||
27775054|NCT02366468|54228267|FG000|Overall Study|Lost to Follow-up|2|||
27775055|NCT02366468|54228268|FG001|Overall Study|Lost to Follow-up|0|||
27775056|NCT02366468|54228267|FG000|Overall Study|Death|1|||
27775057|NCT02366468|54228268|FG001|Overall Study|Death|2|||
27775058|NCT02366468|54228267|FG000|Overall Study|Other|0|||
27775059|NCT02366468|54228268|FG001|Overall Study|Other|2|||
27775060|NCT02366312|54228276|FG000|Overall Study|Lost to Follow-up|0|||
27775061|NCT02366312|54228277|FG001|Overall Study|Lost to Follow-up|1|||
27775062|NCT02335346|54228283|FG000|Overall Study|Adverse Event|11|||
27775063|NCT02335346|54228283|FG000|Overall Study|Withdrawal by Subject|1|||
27775064|NCT02403674|54228289|FG000|Overall Study|Adverse Event|10|||
27775065|NCT02403674|54228290|FG001|Overall Study|Adverse Event|23|||
27775066|NCT02403674|54228289|FG000|Overall Study|Death|1|||
27775067|NCT02403674|54228290|FG001|Overall Study|Death|3|||
27775068|NCT02403674|54228289|FG000|Overall Study|Lack of Efficacy|18|||
27775069|NCT02403674|54228290|FG001|Overall Study|Lack of Efficacy|10|||
27775070|NCT02403674|54228289|FG000|Overall Study|Lost to Follow-up|6|||
27775071|NCT02403674|54228290|FG001|Overall Study|Lost to Follow-up|7|||
27775072|NCT02403674|54228289|FG000|Overall Study|Noncompliance with study drug|1|||
27775073|NCT02403674|54228290|FG001|Overall Study|Noncompliance with study drug|2|||
27775074|NCT02403674|54228289|FG000|Overall Study|Withdrawal by Subject|8|||
27775075|NCT02403674|54228290|FG001|Overall Study|Withdrawal by Subject|11|||
27775076|NCT02403674|54228289|FG000|Overall Study|Physician Decision|2|||
27775077|NCT02403674|54228290|FG001|Overall Study|Physician Decision|2|||
27775078|NCT02403674|54228289|FG000|Overall Study|Not treated with study drug|4|||
27775079|NCT02403674|54228290|FG001|Overall Study|Not treated with study drug|2|||
27775080|NCT02403674|54228289|FG000|Overall Study|Pregnancy|1|||
27775081|NCT02403674|54228290|FG001|Overall Study|Pregnancy|1|||
27775082|NCT02403674|54228289|FG000|Overall Study|Protocol Violation|4|||
27775083|NCT02403674|54228290|FG001|Overall Study|Protocol Violation|2|||
27775084|NCT02403206|54228298|FG000|Overall Study|Lost to Follow-up|4|||
27775085|NCT02403206|54228299|FG001|Overall Study|Lost to Follow-up|3|||
27775086|NCT02403206|54228298|FG000|Overall Study|Physician Decision|2|||
27775087|NCT02403206|54228299|FG001|Overall Study|Physician Decision|0|||
27775088|NCT02403206|54228298|FG000|Overall Study|Withdrawal by Subject|3|||
27775089|NCT02403206|54228299|FG001|Overall Study|Withdrawal by Subject|3|||
27775090|NCT02403206|54228298|FG000|Overall Study|Reason not given|2|||
27775091|NCT02403206|54228299|FG001|Overall Study|Reason not given|4|||
27775092|NCT02333630|54228308|FG000|Overall Study|Lost to Follow-up|5|||
27775093|NCT02333630|54228309|FG001|Overall Study|Lost to Follow-up|2|||
27775094|NCT02401412|54228321|FG000|Overall Study|Lost to Follow-up|1|||
27775095|NCT02401412|54228322|FG001|Overall Study|Lost to Follow-up|0|||
27775096|NCT02401412|54228321|FG000|Overall Study|Discontinued Intervention|15|||
27775097|NCT02401412|54228322|FG001|Overall Study|Discontinued Intervention|21|||
27775098|NCT02401412|54228321|FG000|Overall Study|Withdrawal by Subject|4|||
27775099|NCT02401412|54228322|FG001|Overall Study|Withdrawal by Subject|4|||
27775100|NCT02401412|54228321|FG000|Overall Study|Subject withdrawal prior to intervention|0|||
27775101|NCT02401412|54228322|FG001|Overall Study|Subject withdrawal prior to intervention|1|||
27775102|NCT02401412|54228321|FG000|Overall Study|Improper Enrollment per In/Ex Criteria|10|||
27775103|NCT02401412|54228322|FG001|Overall Study|Improper Enrollment per In/Ex Criteria|6|||
27775104|NCT02365298|54228328|FG000|Period 2|incorrect Rx dispensed|1|||
27775105|NCT02365298|54228329|FG001|Period 2|incorrect Rx dispensed|0|||
27775106|NCT02365298|54228328|FG000|Period 2|Discontinued at request of Sponsor|1|||
27775107|NCT02365298|54228329|FG001|Period 2|Discontinued at request of Sponsor|0|||
27775108|NCT02365298|54228328|FG000|Period 2|Test Article longer available|0|||
27775109|NCT02365298|54228329|FG001|Period 2|Test Article longer available|1|||
27775110|NCT02365298|54228328|FG000|Period 2|Protocol Violation|0|||
27775111|NCT02365298|54228329|FG001|Period 2|Protocol Violation|1|||
27775112|NCT02365064|54228337|FG000|Overall Study|Patients met baseline exclusion requirem|2|||
27775113|NCT02365064|54228338|FG001|Overall Study|Patients met baseline exclusion requirem|15|||
27775114|NCT02365064|54228337|FG000|Overall Study|Withdrawal by Subject|6|||
27775115|NCT02365064|54228338|FG001|Overall Study|Withdrawal by Subject|9|||
27775116|NCT02365064|54228337|FG000|Overall Study|Treatment intolerance|2|||
27775117|NCT02365064|54228338|FG001|Overall Study|Treatment intolerance|4|||
27775118|NCT02401256|54228344|FG000|Overall Study|Adverse Event|5|||
27775119|NCT02401256|54228344|FG000|Overall Study|Withdrawal by Subject|12|||
27775120|NCT02349295|54228353|FG000|Double Blind Treatment (Week 0-24)|Adverse Event|7|||
27775121|NCT02349295|54228354|FG001|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
27775122|NCT02349295|54228355|FG002|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
27775123|NCT02349295|54228356|FG003|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
27775124|NCT02349295|54228357|FG004|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
27775125|NCT02349295|54228358|FG005|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
27775126|NCT02349295|54228359|FG006|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
27775127|NCT02349295|54228360|FG007|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
27775128|NCT02349295|54228361|FG008|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
27775129|NCT02349295|54228362|FG009|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
27775130|NCT02349295|54228363|FG010|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
27775131|NCT02349295|54228364|FG011|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
27775132|NCT02349295|54228365|FG012|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
27775133|NCT02349295|54228366|FG013|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
27775134|NCT02349295|54228353|FG000|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4|||
27775135|NCT02349295|54228354|FG001|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2|||
27775136|NCT02349295|54228355|FG002|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9|||
27775137|NCT02349295|54228356|FG003|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
27775138|NCT02349295|54228357|FG004|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
27775139|NCT02349295|54228358|FG005|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
27775140|NCT02349295|54228359|FG006|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
27775141|NCT02349295|54228360|FG007|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
27775142|NCT02349295|54228361|FG008|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
27775143|NCT02349295|54228362|FG009|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
27775144|NCT02349295|54228363|FG010|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
27775145|NCT02349295|54228364|FG011|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
27775146|NCT02349295|54228365|FG012|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
27775147|NCT02349295|54228366|FG013|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
27775148|NCT02349295|54228353|FG000|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
27775149|NCT02349295|54228354|FG001|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
27775150|NCT02349295|54228355|FG002|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7|||
27775151|NCT02349295|54228356|FG003|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
27775152|NCT02349295|54228357|FG004|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
27775153|NCT02349295|54228358|FG005|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
27775154|NCT02349295|54228359|FG006|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
27775155|NCT02349295|54228360|FG007|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
27775156|NCT02349295|54228361|FG008|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
27775157|NCT02349295|54228362|FG009|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
27775158|NCT02349295|54228363|FG010|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
27775159|NCT02349295|54228364|FG011|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
27775160|NCT02349295|54228365|FG012|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
27775161|NCT02349295|54228366|FG013|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
27775162|NCT02349295|54228353|FG000|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
27775163|NCT02349295|54228354|FG001|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
27775164|NCT02349295|54228355|FG002|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2|||
27775165|NCT02349295|54228356|FG003|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
27775166|NCT02349295|54228357|FG004|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
27775167|NCT02349295|54228358|FG005|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
27775168|NCT02349295|54228359|FG006|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
27775169|NCT02349295|54228360|FG007|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
27775170|NCT02349295|54228361|FG008|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
27775171|NCT02349295|54228362|FG009|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
27775172|NCT02349295|54228363|FG010|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
27775173|NCT02349295|54228364|FG011|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
27775174|NCT02349295|54228365|FG012|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
27775175|NCT02349295|54228366|FG013|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
27775176|NCT02349295|54228353|FG000|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
27775177|NCT02349295|54228354|FG001|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
27775178|NCT02349295|54228355|FG002|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
27775179|NCT02349295|54228356|FG003|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
27775180|NCT02349295|54228357|FG004|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
27775181|NCT02349295|54228358|FG005|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
27775182|NCT02349295|54228359|FG006|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
27775183|NCT02349295|54228360|FG007|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
27775184|NCT02349295|54228361|FG008|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
27775185|NCT02349295|54228362|FG009|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
27775186|NCT02349295|54228363|FG010|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
27775187|NCT02349295|54228364|FG011|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
27775188|NCT02349295|54228365|FG012|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
27775189|NCT02349295|54228366|FG013|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
27775190|NCT02349295|54228353|FG000|IR (Week 16-24)|Lack of Efficacy|0|||
27775191|NCT02349295|54228354|FG001|IR (Week 16-24)|Lack of Efficacy|0|||
27775192|NCT02349295|54228355|FG002|IR (Week 16-24)|Lack of Efficacy|0|||
27775193|NCT02349295|54228356|FG003|IR (Week 16-24)|Lack of Efficacy|1|||
27775194|NCT02349295|54228357|FG004|IR (Week 16-24)|Lack of Efficacy|0|||
27775195|NCT02349295|54228358|FG005|IR (Week 16-24)|Lack of Efficacy|0|||
27775196|NCT02349295|54228359|FG006|IR (Week 16-24)|Lack of Efficacy|0|||
27775197|NCT02349295|54228360|FG007|IR (Week 16-24)|Lack of Efficacy|0|||
27775198|NCT02349295|54228361|FG008|IR (Week 16-24)|Lack of Efficacy|0|||
27775199|NCT02349295|54228362|FG009|IR (Week 16-24)|Lack of Efficacy|0|||
27775200|NCT02349295|54228363|FG010|IR (Week 16-24)|Lack of Efficacy|0|||
27775201|NCT02349295|54228364|FG011|IR (Week 16-24)|Lack of Efficacy|0|||
27775202|NCT02349295|54228365|FG012|IR (Week 16-24)|Lack of Efficacy|0|||
27775203|NCT02349295|54228366|FG013|IR (Week 16-24)|Lack of Efficacy|0|||
27775204|NCT02349295|54228353|FG000|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
27775205|NCT02349295|54228354|FG001|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
27775206|NCT02349295|54228355|FG002|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
27775207|NCT02349295|54228356|FG003|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
27775208|NCT02349295|54228357|FG004|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
27775209|NCT02349295|54228358|FG005|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
27775210|NCT02349295|54228359|FG006|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
27775211|NCT02349295|54228360|FG007|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32|||
27775212|NCT02349295|54228361|FG008|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25|||
27775213|NCT02349295|54228362|FG009|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19|||
27775214|NCT02349295|54228363|FG010|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18|||
27775215|NCT02349295|54228364|FG011|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
27775216|NCT02349295|54228365|FG012|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
27775217|NCT02349295|54228366|FG013|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
27775218|NCT02349295|54228353|FG000|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
27775219|NCT02349295|54228354|FG001|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
27775220|NCT02349295|54228355|FG002|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
27775221|NCT02349295|54228356|FG003|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
27775222|NCT02349295|54228357|FG004|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
27775223|NCT02349295|54228358|FG005|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
27775224|NCT02349295|54228359|FG006|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
27775225|NCT02349295|54228360|FG007|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
27775226|NCT02349295|54228361|FG008|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
27775227|NCT02349295|54228362|FG009|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
27775228|NCT02349295|54228363|FG010|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
27775229|NCT02349295|54228364|FG011|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
27775230|NCT02349295|54228365|FG012|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
27840215|NCT01474681|54327531|FG002|Overall Study|Death|2|||
27840216|NCT01474681|54327532|FG003|Overall Study|Death|6|||
27840217|NCT01459783|54327548|FG000|Baseline to 6 Months|Death|1|||
27840218|NCT01459783|54327549|FG001|Baseline to 6 Months|Death|0|||
27840219|NCT01459783|54327548|FG000|Baseline to 6 Months|Withdrawal by Subject|12|||
27840220|NCT01459783|54327549|FG001|Baseline to 6 Months|Withdrawal by Subject|6|||
27840221|NCT01459783|54327548|FG000|Baseline to 6 Months|Lost to Follow-up|19|||
27840222|NCT01459783|54327549|FG001|Baseline to 6 Months|Lost to Follow-up|14|||
27840223|NCT01459783|54327548|FG000|6 Months to 12 Months|Death|0|||
27775231|NCT02349295|54228366|FG013|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
27775232|NCT02349295|54228353|FG000|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
27775233|NCT02349295|54228354|FG001|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
27775234|NCT02349295|54228355|FG002|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
27775235|NCT02349295|54228356|FG003|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
27775236|NCT02349295|54228357|FG004|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
27840224|NCT01459783|54327549|FG001|6 Months to 12 Months|Death|1|||
27775237|NCT02349295|54228358|FG005|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
27840225|NCT01459783|54327548|FG000|6 Months to 12 Months|Withdrawal by Subject|6|||
27840226|NCT01459783|54327549|FG001|6 Months to 12 Months|Withdrawal by Subject|5|||
27840227|NCT01459783|54327548|FG000|6 Months to 12 Months|Lost to Follow-up|2|||
27840228|NCT01459783|54327549|FG001|6 Months to 12 Months|Lost to Follow-up|7|||
27840229|NCT01459783|54327548|FG000|6 Months to 12 Months|Study ended before 12-month follow-up|11|||
27840230|NCT01459783|54327549|FG001|6 Months to 12 Months|Study ended before 12-month follow-up|17|||
27840231|NCT01588184|54327561|FG000|Overall Study|Death|1|||
27840232|NCT01588184|54327562|FG001|Overall Study|Death|0|||
27840233|NCT01588184|54327563|FG002|Overall Study|Death|0|||
27840234|NCT01588184|54327564|FG003|Overall Study|Death|1|||
27840235|NCT01588184|54327565|FG004|Overall Study|Death|1|||
27840236|NCT01588184|54327566|FG005|Overall Study|Death|1|||
27840237|NCT01588184|54327561|FG000|Overall Study|Withdrawal by Subject|2|||
27840238|NCT01588184|54327562|FG001|Overall Study|Withdrawal by Subject|4|||
27840239|NCT01588184|54327563|FG002|Overall Study|Withdrawal by Subject|0|||
27840240|NCT01588184|54327564|FG003|Overall Study|Withdrawal by Subject|1|||
27840241|NCT01588184|54327565|FG004|Overall Study|Withdrawal by Subject|0|||
27840242|NCT01588184|54327566|FG005|Overall Study|Withdrawal by Subject|0|||
27840243|NCT01588184|54327561|FG000|Overall Study|Bevacizumab treatment provision changed|0|||
27840244|NCT01588184|54327562|FG001|Overall Study|Bevacizumab treatment provision changed|6|||
27840245|NCT01588184|54327563|FG002|Overall Study|Bevacizumab treatment provision changed|2|||
27840246|NCT01588184|54327564|FG003|Overall Study|Bevacizumab treatment provision changed|0|||
27840247|NCT01588184|54327565|FG004|Overall Study|Bevacizumab treatment provision changed|1|||
27840248|NCT01588184|54327566|FG005|Overall Study|Bevacizumab treatment provision changed|3|||
27840249|NCT01588184|54327561|FG000|Overall Study|multiple reasons|0|||
27840250|NCT01588184|54327562|FG001|Overall Study|multiple reasons|3|||
27840251|NCT01588184|54327563|FG002|Overall Study|multiple reasons|0|||
27840252|NCT01588184|54327564|FG003|Overall Study|multiple reasons|1|||
27840253|NCT01588184|54327565|FG004|Overall Study|multiple reasons|0|||
27775238|NCT02349295|54228359|FG006|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
27775239|NCT02349295|54228360|FG007|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2|||
27775240|NCT02349295|54228361|FG008|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
27775241|NCT02349295|54228362|FG009|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3|||
27775242|NCT02349295|54228363|FG010|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
27775243|NCT02349295|54228364|FG011|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
27775244|NCT02349295|54228365|FG012|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
27775245|NCT02349295|54228366|FG013|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
27775246|NCT02349295|54228353|FG000|Long-Term Extension Period (Week 24-156)|Death|0|||
27775247|NCT02349295|54228354|FG001|Long-Term Extension Period (Week 24-156)|Death|0|||
27775248|NCT02349295|54228355|FG002|Long-Term Extension Period (Week 24-156)|Death|0|||
27775249|NCT02349295|54228356|FG003|Long-Term Extension Period (Week 24-156)|Death|0|||
27775250|NCT02349295|54228357|FG004|Long-Term Extension Period (Week 24-156)|Death|0|||
27775251|NCT02349295|54228358|FG005|Long-Term Extension Period (Week 24-156)|Death|0|||
27775252|NCT02349295|54228359|FG006|Long-Term Extension Period (Week 24-156)|Death|0|||
27775253|NCT02349295|54228360|FG007|Long-Term Extension Period (Week 24-156)|Death|1|||
27775254|NCT02349295|54228361|FG008|Long-Term Extension Period (Week 24-156)|Death|1|||
27775255|NCT02349295|54228362|FG009|Long-Term Extension Period (Week 24-156)|Death|1|||
27775256|NCT02349295|54228363|FG010|Long-Term Extension Period (Week 24-156)|Death|0|||
27775257|NCT02349295|54228364|FG011|Long-Term Extension Period (Week 24-156)|Death|0|||
27775258|NCT02349295|54228365|FG012|Long-Term Extension Period (Week 24-156)|Death|0|||
27775259|NCT02349295|54228366|FG013|Long-Term Extension Period (Week 24-156)|Death|0|||
27775260|NCT02349295|54228353|FG000|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
27775261|NCT02349295|54228354|FG001|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
27775262|NCT02349295|54228355|FG002|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
27775263|NCT02349295|54228356|FG003|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
27775264|NCT02349295|54228357|FG004|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
27775265|NCT02349295|54228358|FG005|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
27775266|NCT02349295|54228359|FG006|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
27775267|NCT02349295|54228360|FG007|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4|||
27775268|NCT02349295|54228361|FG008|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2|||
27775269|NCT02349295|54228362|FG009|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1|||
27840254|NCT01588184|54327566|FG005|Overall Study|multiple reasons|0|||
27840255|NCT01588106|54327582|FG000|Overall Study|Withdrawal by Subject|5|||
27775270|NCT02349295|54228363|FG010|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3|||
27775271|NCT02349295|54228364|FG011|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
27840256|NCT01588106|54327583|FG001|Overall Study|Withdrawal by Subject|4|||
27840257|NCT01564862|54327592|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
27840258|NCT01564862|54327593|FG001|Overall Study|Pretreatment Event or Adverse Event|12|||
27840259|NCT01564862|54327594|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
27840260|NCT01564862|54327592|FG000|Overall Study|Major Protocol Deviation|3|||
27840261|NCT01564862|54327593|FG001|Overall Study|Major Protocol Deviation|3|||
27775272|NCT02349295|54228365|FG012|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
27775273|NCT02349295|54228366|FG013|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
27775274|NCT02349295|54228353|FG000|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
27775275|NCT02349295|54228354|FG001|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
27775276|NCT02349295|54228355|FG002|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
27775277|NCT02349295|54228356|FG003|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
27775278|NCT02349295|54228357|FG004|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
27775279|NCT02349295|54228358|FG005|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
27775280|NCT02349295|54228359|FG006|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
27775281|NCT02349295|54228360|FG007|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
27775282|NCT02349295|54228361|FG008|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
27775283|NCT02349295|54228362|FG009|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
27775284|NCT02349295|54228363|FG010|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
27775285|NCT02349295|54228364|FG011|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
27775286|NCT02349295|54228365|FG012|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
27775287|NCT02349295|54228366|FG013|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
27775288|NCT02349295|54228353|FG000|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
27775289|NCT02349295|54228354|FG001|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
27775290|NCT02349295|54228355|FG002|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
27775291|NCT02349295|54228356|FG003|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
27775292|NCT02349295|54228357|FG004|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
27775293|NCT02349295|54228358|FG005|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
27775294|NCT02349295|54228359|FG006|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
27775295|NCT02349295|54228360|FG007|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
27775296|NCT02349295|54228361|FG008|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
27775297|NCT02349295|54228362|FG009|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
27775298|NCT02349295|54228363|FG010|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
27775299|NCT02349295|54228364|FG011|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
27775300|NCT02349295|54228365|FG012|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
27775301|NCT02349295|54228366|FG013|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
27775302|NCT02349295|54228353|FG000|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
27775303|NCT02349295|54228354|FG001|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
27775304|NCT02349295|54228355|FG002|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
27775305|NCT02349295|54228356|FG003|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
27775306|NCT02349295|54228357|FG004|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
27775307|NCT02349295|54228358|FG005|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
27775308|NCT02349295|54228359|FG006|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
27775309|NCT02349295|54228360|FG007|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
27775310|NCT02349295|54228361|FG008|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
27775311|NCT02349295|54228362|FG009|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
27775312|NCT02349295|54228363|FG010|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
27775313|NCT02349295|54228364|FG011|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
27775314|NCT02349295|54228365|FG012|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5|||
27775315|NCT02349295|54228366|FG013|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
27775316|NCT02349295|54228353|FG000|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
27775317|NCT02349295|54228354|FG001|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
27775318|NCT02349295|54228355|FG002|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
27775319|NCT02349295|54228356|FG003|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
27775320|NCT02349295|54228357|FG004|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
27775321|NCT02349295|54228358|FG005|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
27775322|NCT02349295|54228359|FG006|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
27775323|NCT02349295|54228360|FG007|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
27775324|NCT02349295|54228361|FG008|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
27775325|NCT02349295|54228362|FG009|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
27775326|NCT02349295|54228363|FG010|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
27775327|NCT02349295|54228364|FG011|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1|||
27775328|NCT02349295|54228365|FG012|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2|||
27775329|NCT02349295|54228366|FG013|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
27775330|NCT02349295|54228353|FG000|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
27775331|NCT02349295|54228354|FG001|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
27775332|NCT02349295|54228355|FG002|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
27775333|NCT02349295|54228356|FG003|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
27775334|NCT02349295|54228357|FG004|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
27775335|NCT02349295|54228358|FG005|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
27775336|NCT02349295|54228359|FG006|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
27775337|NCT02349295|54228360|FG007|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
27775338|NCT02349295|54228361|FG008|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
27775339|NCT02349295|54228362|FG009|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
27775340|NCT02349295|54228363|FG010|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
27775341|NCT02349295|54228364|FG011|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
27775342|NCT02349295|54228365|FG012|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
27775343|NCT02349295|54228366|FG013|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
27775344|NCT02349295|54228353|FG000|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
27775345|NCT02349295|54228354|FG001|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
27775346|NCT02349295|54228355|FG002|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
27775347|NCT02349295|54228356|FG003|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
27775348|NCT02349295|54228357|FG004|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
27775349|NCT02349295|54228358|FG005|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
27775350|NCT02349295|54228359|FG006|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
27775351|NCT02349295|54228360|FG007|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
27775352|NCT02349295|54228361|FG008|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
27775353|NCT02349295|54228362|FG009|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
27775354|NCT02349295|54228363|FG010|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
27775355|NCT02349295|54228364|FG011|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2|||
27775356|NCT02349295|54228365|FG012|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
27775357|NCT02349295|54228366|FG013|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
27775358|NCT02349295|54228353|FG000|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
27775359|NCT02349295|54228354|FG001|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
27775360|NCT02349295|54228355|FG002|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
27775361|NCT02349295|54228356|FG003|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
27775362|NCT02349295|54228357|FG004|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
27775363|NCT02349295|54228358|FG005|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
27775364|NCT02349295|54228359|FG006|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
27775365|NCT02349295|54228360|FG007|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
27775366|NCT02349295|54228361|FG008|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
27775367|NCT02349295|54228362|FG009|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
27775368|NCT02349295|54228363|FG010|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
27775369|NCT02349295|54228364|FG011|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4|||
27775370|NCT02349295|54228365|FG012|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
27775371|NCT02349295|54228366|FG013|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
27775372|NCT02281357|54228393|FG000|Overall Study|Adverse Event|2|||
27775373|NCT02281357|54228394|FG001|Overall Study|Adverse Event|1|||
27775374|NCT02281357|54228393|FG000|Overall Study|Lost to Follow-up|1|||
27775375|NCT02281357|54228394|FG001|Overall Study|Lost to Follow-up|0|||
27775376|NCT02281357|54228393|FG000|Overall Study|Withdrawal by Subject|4|||
27775377|NCT02281357|54228394|FG001|Overall Study|Withdrawal by Subject|3|||
27775378|NCT02284243|54228402|FG000|Overall Study|Lack of Efficacy|3|||
27775379|NCT02284243|54228403|FG001|Overall Study|Lack of Efficacy|3|||
27775380|NCT02284243|54228402|FG000|Overall Study|Adverse Event|1|||
27775381|NCT02284243|54228403|FG001|Overall Study|Adverse Event|0|||
27775382|NCT02284009|54228411|FG000|Overall Study|Adverse Event|3|||
27775383|NCT02284009|54228412|FG001|Overall Study|Adverse Event|0|||
27775384|NCT02284009|54228411|FG000|Overall Study|Lost to Follow-up|1|||
27775385|NCT02284009|54228412|FG001|Overall Study|Lost to Follow-up|3|||
27775386|NCT02284009|54228411|FG000|Overall Study|Physician Decision|0|||
27775387|NCT02284009|54228412|FG001|Overall Study|Physician Decision|2|||
27775388|NCT02284009|54228411|FG000|Overall Study|Withdrawal by Subject|2|||
27775389|NCT02284009|54228412|FG001|Overall Study|Withdrawal by Subject|5|||
27775390|NCT02280499|54228420|FG000|Overall Study|Death|14|||
27775391|NCT02280499|54228420|FG000|Overall Study|Lost to Follow-up|42|||
27775392|NCT02280499|54228420|FG000|Overall Study|Adverse Event|5|||
27775393|NCT02400476|54228430|FG000|Overall Study|Adverse Event|57|||
27775394|NCT02400476|54228431|FG001|Overall Study|Adverse Event|10|||
27775395|NCT02400476|54228432|FG002|Overall Study|Adverse Event|22|||
27775396|NCT02400476|54228433|FG003|Overall Study|Adverse Event|19|||
27775397|NCT02400476|54228434|FG004|Overall Study|Adverse Event|5|||
27775398|NCT02400476|54228435|FG005|Overall Study|Adverse Event|8|||
27775399|NCT02400476|54228430|FG000|Overall Study|Withdrawal by Subject|4|||
27775400|NCT02400476|54228431|FG001|Overall Study|Withdrawal by Subject|1|||
27775401|NCT02400476|54228432|FG002|Overall Study|Withdrawal by Subject|12|||
27775402|NCT02400476|54228433|FG003|Overall Study|Withdrawal by Subject|7|||
27851614|NCT00985673|54351077|FG003|Overall Study|Lost to Follow-up|10|||
27775403|NCT02400476|54228434|FG004|Overall Study|Withdrawal by Subject|5|||
27775404|NCT02400476|54228435|FG005|Overall Study|Withdrawal by Subject|5|||
27775405|NCT02400476|54228430|FG000|Overall Study|Lost to Follow-up|0|||
27775406|NCT02400476|54228431|FG001|Overall Study|Lost to Follow-up|0|||
27775407|NCT02400476|54228432|FG002|Overall Study|Lost to Follow-up|0|||
27775408|NCT02400476|54228433|FG003|Overall Study|Lost to Follow-up|1|||
27775409|NCT02400476|54228434|FG004|Overall Study|Lost to Follow-up|3|||
27775410|NCT02400476|54228435|FG005|Overall Study|Lost to Follow-up|1|||
27775411|NCT02400476|54228430|FG000|Overall Study|Physician Decision|0|||
27775412|NCT02400476|54228431|FG001|Overall Study|Physician Decision|0|||
27775413|NCT02400476|54228432|FG002|Overall Study|Physician Decision|1|||
27775414|NCT02400476|54228433|FG003|Overall Study|Physician Decision|1|||
27775415|NCT02400476|54228434|FG004|Overall Study|Physician Decision|0|||
27775416|NCT02400476|54228435|FG005|Overall Study|Physician Decision|1|||
27775417|NCT02400476|54228430|FG000|Overall Study|Other, Disease Progression|0|||
27775418|NCT02400476|54228431|FG001|Overall Study|Other, Disease Progression|1|||
27775419|NCT02400476|54228432|FG002|Overall Study|Other, Disease Progression|2|||
27775420|NCT02400476|54228433|FG003|Overall Study|Other, Disease Progression|1|||
27775421|NCT02400476|54228434|FG004|Overall Study|Other, Disease Progression|2|||
27775422|NCT02400476|54228435|FG005|Overall Study|Other, Disease Progression|1|||
27775423|NCT02400476|54228430|FG000|Overall Study|Other, Decreased Quality of Life|0|||
27775424|NCT02400476|54228431|FG001|Overall Study|Other, Decreased Quality of Life|0|||
27775425|NCT02400476|54228432|FG002|Overall Study|Other, Decreased Quality of Life|2|||
27775426|NCT02400476|54228433|FG003|Overall Study|Other, Decreased Quality of Life|0|||
27775427|NCT02400476|54228434|FG004|Overall Study|Other, Decreased Quality of Life|0|||
27775428|NCT02400476|54228435|FG005|Overall Study|Other, Decreased Quality of Life|0|||
27775429|NCT02400476|54228430|FG000|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
27775430|NCT02400476|54228431|FG001|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
27775431|NCT02400476|54228432|FG002|Overall Study|Other, Noncompliance to Protocol Requirements|2|||
27775432|NCT02400476|54228433|FG003|Overall Study|Other, Noncompliance to Protocol Requirements|1|||
27775433|NCT02400476|54228434|FG004|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
27775434|NCT02400476|54228435|FG005|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
27775435|NCT02363738|54228451|FG000|Overall Study|Adverse Event|5|||
27775436|NCT02363738|54228452|FG001|Overall Study|Adverse Event|2|||
27775437|NCT02363738|54228451|FG000|Overall Study|Lack of Efficacy|1|||
27775438|NCT02363738|54228452|FG001|Overall Study|Lack of Efficacy|2|||
27775439|NCT02363738|54228451|FG000|Overall Study|Lost to Follow-up|2|||
27775440|NCT02363738|54228452|FG001|Overall Study|Lost to Follow-up|1|||
27775441|NCT02331680|54228461|FG000|Overall Study|Adverse Event|3|||
27775442|NCT02331680|54228462|FG001|Overall Study|Adverse Event|0|||
27775443|NCT02331680|54228463|FG002|Overall Study|Adverse Event|2|||
27775444|NCT02331680|54228461|FG000|Overall Study|Physician Decision|1|||
27775445|NCT02331680|54228462|FG001|Overall Study|Physician Decision|1|||
27775446|NCT02331680|54228463|FG002|Overall Study|Physician Decision|2|||
27775447|NCT02331680|54228461|FG000|Overall Study|Withdrawal by Subject|0|||
27775448|NCT02331680|54228462|FG001|Overall Study|Withdrawal by Subject|1|||
27775449|NCT02331680|54228463|FG002|Overall Study|Withdrawal by Subject|2|||
27775450|NCT02331680|54228461|FG000|Overall Study|Met withdrawal criteria|2|||
27775451|NCT02331680|54228462|FG001|Overall Study|Met withdrawal criteria|2|||
27775452|NCT02331680|54228463|FG002|Overall Study|Met withdrawal criteria|5|||
27775453|NCT02331680|54228461|FG000|Overall Study|Non-compliance with study drug|0|||
27775454|NCT02331680|54228462|FG001|Overall Study|Non-compliance with study drug|0|||
27775455|NCT02331680|54228463|FG002|Overall Study|Non-compliance with study drug|1|||
27775456|NCT02331680|54228461|FG000|Overall Study|Protocol Violation|0|||
27775457|NCT02331680|54228462|FG001|Overall Study|Protocol Violation|0|||
27775458|NCT02331680|54228463|FG002|Overall Study|Protocol Violation|3|||
27775459|NCT02331446|54228475|FG000|Overall Study|Lost to Follow-up|2|||
27775460|NCT02331446|54228476|FG001|Overall Study|Lost to Follow-up|1|||
27775461|NCT02331446|54228477|FG002|Overall Study|Lost to Follow-up|0|||
27775462|NCT02331446|54228478|FG003|Overall Study|Lost to Follow-up|1|||
27775463|NCT02331446|54228475|FG000|Overall Study|Personal Problem|2|||
27775464|NCT02331446|54228476|FG001|Overall Study|Personal Problem|0|||
27775465|NCT02331446|54228477|FG002|Overall Study|Personal Problem|0|||
27775466|NCT02331446|54228478|FG003|Overall Study|Personal Problem|0|||
27775467|NCT02331446|54228475|FG000|Overall Study|Disease|0|||
27840262|NCT01564862|54327594|FG002|Overall Study|Major Protocol Deviation|4|||
27775468|NCT02331446|54228476|FG001|Overall Study|Disease|2|||
27775469|NCT02331446|54228477|FG002|Overall Study|Disease|2|||
27775470|NCT02331446|54228478|FG003|Overall Study|Disease|1|||
27775471|NCT02331446|54228475|FG000|Overall Study|Physician Decision|0|||
27775472|NCT02331446|54228476|FG001|Overall Study|Physician Decision|1|||
27775473|NCT02331446|54228477|FG002|Overall Study|Physician Decision|0|||
27775474|NCT02331446|54228478|FG003|Overall Study|Physician Decision|1|||
27775475|NCT02331446|54228475|FG000|Overall Study|Lost before baseline analysis|0|||
27775476|NCT02331446|54228476|FG001|Overall Study|Lost before baseline analysis|1|||
27775477|NCT02331446|54228477|FG002|Overall Study|Lost before baseline analysis|1|||
27775478|NCT02331446|54228478|FG003|Overall Study|Lost before baseline analysis|0|||
27840263|NCT01564862|54327592|FG000|Overall Study|Lost to Follow-up|10|||
27775479|NCT02349061|54228490|FG000|Main Study: PCP (Up to Week 24)|Adverse Event|4|||
27775480|NCT02349061|54228491|FG001|Main Study: PCP (Up to Week 24)|Adverse Event|3|||
27775481|NCT02349061|54228492|FG002|Main Study: PCP (Up to Week 24)|Adverse Event|0|||
27775482|NCT02349061|54228490|FG000|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1|||
27775483|NCT02349061|54228491|FG001|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
27775484|NCT02349061|54228492|FG002|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
27775485|NCT02349061|54228490|FG000|Main Study: PCP (Up to Week 24)|Physician Decision|1|||
27775486|NCT02349061|54228491|FG001|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
27775487|NCT02349061|54228492|FG002|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
27775488|NCT02349061|54228490|FG000|Main Study: PCP (Up to Week 24)|Other|1|||
27775489|NCT02349061|54228491|FG001|Main Study: PCP (Up to Week 24)|Other|1|||
27775490|NCT02349061|54228492|FG002|Main Study: PCP (Up to Week 24)|Other|0|||
27775491|NCT02349061|54228490|FG000|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2|||
27775492|NCT02349061|54228491|FG001|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
27775493|NCT02349061|54228492|FG002|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
27775494|NCT02349061|54228490|FG000|Main Study: Week 24 to 56|Adverse Event|0|||
27775495|NCT02349061|54228491|FG001|Main Study: Week 24 to 56|Adverse Event|2|||
27775496|NCT02349061|54228492|FG002|Main Study: Week 24 to 56|Adverse Event|1|||
27775497|NCT02349061|54228490|FG000|Main Study: Week 24 to 56|Lack of Efficacy|0|||
27775498|NCT02349061|54228491|FG001|Main Study: Week 24 to 56|Lack of Efficacy|1|||
27775499|NCT02349061|54228492|FG002|Main Study: Week 24 to 56|Lack of Efficacy|0|||
27775500|NCT02349061|54228490|FG000|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
27775501|NCT02349061|54228491|FG001|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
27775502|NCT02349061|54228492|FG002|Main Study: Week 24 to 56|Withdrawal by Subject|1|||
27775503|NCT02349061|54228490|FG000|Main Study: Week 24 to 56|Physician Decision|0|||
27775504|NCT02349061|54228491|FG001|Main Study: Week 24 to 56|Physician Decision|0|||
27775505|NCT02349061|54228492|FG002|Main Study: Week 24 to 56|Physician Decision|1|||
27775506|NCT02349061|54228490|FG000|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
27775507|NCT02349061|54228491|FG001|Study Extension (Week 56 to Week 120)|Adverse Event|3|||
27775508|NCT02349061|54228492|FG002|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
27775509|NCT02349061|54228490|FG000|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
27775510|NCT02349061|54228491|FG001|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
27775511|NCT02349061|54228492|FG002|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1|||
27775512|NCT02349061|54228490|FG000|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0|||
27775513|NCT02349061|54228491|FG001|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2|||
27775514|NCT02349061|54228492|FG002|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1|||
27775515|NCT02349061|54228490|FG000|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
27775516|NCT02349061|54228491|FG001|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
27775517|NCT02349061|54228492|FG002|Study Extension (Week 56 to Week 120)|Physician Decision|1|||
27775518|NCT02331368|54228502|FG000|Overall Study|Withdrawal by Subject|3|||
27775519|NCT02362724|54228508|FG000|Overall Study|Withdrawal by Subject|3|||
27775520|NCT02362724|54228509|FG001|Overall Study|Withdrawal by Subject|1|||
27775521|NCT02362724|54228508|FG000|Overall Study|Adverse Event|3|||
27775522|NCT02362724|54228509|FG001|Overall Study|Adverse Event|0|||
27775523|NCT02362646|54228517|FG000|Overall Study|Death|15|||
27775524|NCT02362646|54228518|FG001|Overall Study|Death|8|||
27775525|NCT02362646|54228517|FG000|Overall Study|Withdrawal by Subject|2|||
27775526|NCT02362646|54228518|FG001|Overall Study|Withdrawal by Subject|2|||
27775527|NCT02362646|54228517|FG000|Overall Study|received transplant|21|||
27775528|NCT02362646|54228518|FG001|Overall Study|received transplant|14|||
27775529|NCT02280421|54228528|FG000|Washout (2 Weeks)|Adverse Event|0|||
27775530|NCT02280421|54228529|FG001|Washout (2 Weeks)|Adverse Event|1|||
27775531|NCT02280421|54228528|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
27775532|NCT02280421|54228529|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
27775533|NCT02362412|54228547|FG000|Treatment Period III|Lost to Follow-up|0|||
27775534|NCT02362412|54228548|FG001|Treatment Period III|Lost to Follow-up|1|||
27775535|NCT02280187|54228560|FG000|Overall Study|Lost to Follow-up|218|||
27775536|NCT02347813|54228566|FG000|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
27775537|NCT02347813|54228567|FG001|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
27775538|NCT02347813|54228566|FG000|First Intervention, 24 Weeks|Adverse Event|1|||
27775539|NCT02347813|54228567|FG001|First Intervention, 24 Weeks|Adverse Event|1|||
27775540|NCT02329730|54228577|FG000|Overall Study|Protocol Violation|0|||
27775541|NCT02329730|54228578|FG001|Overall Study|Protocol Violation|0|||
27775542|NCT02329730|54228579|FG002|Overall Study|Protocol Violation|0|||
27775543|NCT02329730|54228580|FG003|Overall Study|Protocol Violation|0|||
27775544|NCT02329730|54228581|FG004|Overall Study|Protocol Violation|2|||
27775545|NCT02329730|54228582|FG005|Overall Study|Protocol Violation|2|||
27775546|NCT02329730|54228583|FG006|Overall Study|Protocol Violation|0|||
27775547|NCT02329730|54228584|FG007|Overall Study|Protocol Violation|0|||
27775548|NCT02329730|54228585|FG008|Overall Study|Protocol Violation|0|||
27775549|NCT02329730|54228586|FG009|Overall Study|Protocol Violation|0|||
27775550|NCT02329730|54228587|FG010|Overall Study|Protocol Violation|0|||
27775551|NCT02329730|54228588|FG011|Overall Study|Protocol Violation|0|||
27840264|NCT01564862|54327593|FG001|Overall Study|Lost to Follow-up|8|||
27775552|NCT02329730|54228577|FG000|Overall Study|Withdrawal by Subject|0|||
27775553|NCT02329730|54228578|FG001|Overall Study|Withdrawal by Subject|0|||
27775554|NCT02329730|54228579|FG002|Overall Study|Withdrawal by Subject|0|||
27775555|NCT02329730|54228580|FG003|Overall Study|Withdrawal by Subject|0|||
27775556|NCT02329730|54228581|FG004|Overall Study|Withdrawal by Subject|1|||
27775557|NCT02329730|54228582|FG005|Overall Study|Withdrawal by Subject|0|||
27775558|NCT02329730|54228583|FG006|Overall Study|Withdrawal by Subject|1|||
27775559|NCT02329730|54228584|FG007|Overall Study|Withdrawal by Subject|1|||
27775560|NCT02329730|54228585|FG008|Overall Study|Withdrawal by Subject|1|||
27775561|NCT02329730|54228586|FG009|Overall Study|Withdrawal by Subject|1|||
27775562|NCT02329730|54228587|FG010|Overall Study|Withdrawal by Subject|0|||
27775563|NCT02329730|54228588|FG011|Overall Study|Withdrawal by Subject|0|||
27775564|NCT02328326|54228608|FG000|Overall Study|Withdrawal by Subject|10|||
27775565|NCT02328326|54228609|FG001|Overall Study|Withdrawal by Subject|3|||
27775566|NCT02328326|54228608|FG000|Overall Study|Death|2|||
27775567|NCT02328326|54228609|FG001|Overall Study|Death|1|||
27775568|NCT02328326|54228608|FG000|Overall Study|Lost to Follow-up|10|||
27775569|NCT02328326|54228609|FG001|Overall Study|Lost to Follow-up|4|||
27775570|NCT01649804|54228617|FG000|Overall Study|Administrative/Other|8|||
27775571|NCT02397278|54228623|FG000|Overall Study|Withdrawal by Subject|0|||
27775572|NCT02397278|54228624|FG001|Overall Study|Withdrawal by Subject|2|||
27775573|NCT02397278|54228623|FG000|Overall Study|Deemed ineligible following surgery|1|||
27775574|NCT02397278|54228624|FG001|Overall Study|Deemed ineligible following surgery|1|||
27775575|NCT02360228|54228633|FG000|Overall Study|Withdrawal by Subject|1|||
27775576|NCT02360228|54228634|FG001|Overall Study|Withdrawal by Subject|0|||
27775577|NCT02360228|54228635|FG002|Overall Study|Withdrawal by Subject|0|||
27775578|NCT02360228|54228633|FG000|Overall Study|Self-discontinued medication|0|||
27775579|NCT02360228|54228634|FG001|Overall Study|Self-discontinued medication|1|||
27775580|NCT02360228|54228635|FG002|Overall Study|Self-discontinued medication|0|||
27775581|NCT02360228|54228633|FG000|Overall Study|Unstable symptoms during screening|0|||
27775582|NCT02360228|54228634|FG001|Overall Study|Unstable symptoms during screening|0|||
27775583|NCT02360228|54228635|FG002|Overall Study|Unstable symptoms during screening|1|||
27775584|NCT02359994|54228645|FG000|Overall Population Study|Adverse Event|1|||
27775585|NCT02359994|54228646|FG001|Overall Population Study|Adverse Event|1|||
27775586|NCT02359994|54228645|FG000|Overall Population Study|Death|1|||
27775587|NCT02359994|54228646|FG001|Overall Population Study|Death|5|||
27775588|NCT02359994|54228645|FG000|Overall Population Study|Lost to Follow-up|1|||
27775589|NCT02359994|54228646|FG001|Overall Population Study|Lost to Follow-up|1|||
27775590|NCT02359994|54228645|FG000|Overall Population Study|Withdrawal by Subject|1|||
27775591|NCT02359994|54228646|FG001|Overall Population Study|Withdrawal by Subject|0|||
27775592|NCT02359994|54228645|FG000|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|1|||
27775593|NCT02359994|54228646|FG001|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|0|||
27775594|NCT02359994|54228645|FG000|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|0|||
27775595|NCT02359994|54228646|FG001|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|1|||
27775596|NCT02359994|54228645|FG000|Extended Oncology 24-Month Survival|Death|19|||
27775597|NCT02359994|54228646|FG001|Extended Oncology 24-Month Survival|Death|21|||
27775598|NCT02359994|54228645|FG000|Extended Oncology 24-Month Survival|Lost to Follow-up|1|||
27775599|NCT02359994|54228646|FG001|Extended Oncology 24-Month Survival|Lost to Follow-up|0|||
27775600|NCT02326298|54228655|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
27775601|NCT02326298|54228656|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
27775602|NCT02326298|54228657|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
27775603|NCT02326298|54228658|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
27775604|NCT02326298|54228659|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
27775605|NCT02326298|54228660|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
27775606|NCT02326298|54228661|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
27775607|NCT02326298|54228662|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
27775608|NCT02326298|54228663|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
27775609|NCT02326298|54228664|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
27775610|NCT02326298|54228665|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
27775611|NCT02326298|54228666|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
27775612|NCT02326298|54228667|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
27775613|NCT02326298|54228668|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
27840265|NCT01564862|54327594|FG002|Overall Study|Lost to Follow-up|6|||
27775614|NCT02326298|54228655|FG000|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1|||
27775615|NCT02326298|54228656|FG001|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
27775616|NCT02326298|54228657|FG002|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
27775617|NCT02326298|54228658|FG003|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
27775618|NCT02326298|54228659|FG004|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
27775619|NCT02326298|54228660|FG005|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
27840266|NCT01564862|54327592|FG000|Overall Study|Voluntary Withdrawal|9|||
27775620|NCT02326298|54228661|FG006|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
27775621|NCT02326298|54228662|FG007|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
27775622|NCT02326298|54228663|FG008|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
27775623|NCT02326298|54228664|FG009|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
27775624|NCT02326298|54228665|FG010|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
27775625|NCT02326298|54228666|FG011|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
27775626|NCT02326298|54228667|FG012|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
27775627|NCT02326298|54228668|FG013|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
27775628|NCT02326298|54228655|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
27775629|NCT02326298|54228656|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
27775630|NCT02326298|54228657|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
27775631|NCT02326298|54228658|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
27775632|NCT02326298|54228659|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
27775633|NCT02326298|54228660|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
27775634|NCT02326298|54228661|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
27775635|NCT02326298|54228662|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
27775636|NCT02326298|54228663|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
27775637|NCT02326298|54228664|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
27775638|NCT02326298|54228665|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
27775639|NCT02326298|54228666|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
27775640|NCT02326298|54228667|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
27775641|NCT02326298|54228668|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
27775642|NCT02326298|54228655|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
27775643|NCT02326298|54228656|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
27775644|NCT02326298|54228657|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
27775645|NCT02326298|54228658|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
27775646|NCT02326298|54228659|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
27775647|NCT02326298|54228660|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
27775648|NCT02326298|54228661|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
27775649|NCT02326298|54228662|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
27775650|NCT02326298|54228663|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
27775651|NCT02326298|54228664|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
27775652|NCT02326298|54228665|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
27775653|NCT02326298|54228666|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
27775654|NCT02326298|54228667|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
27775655|NCT02326298|54228668|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
27775656|NCT02326298|54228655|FG000|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
27775657|NCT02326298|54228656|FG001|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
27775658|NCT02326298|54228657|FG002|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2|||
27775659|NCT02326298|54228658|FG003|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
27775660|NCT02326298|54228659|FG004|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
27775661|NCT02326298|54228660|FG005|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
27775662|NCT02326298|54228661|FG006|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
27775663|NCT02326298|54228662|FG007|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
27775664|NCT02326298|54228663|FG008|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
27775665|NCT02326298|54228664|FG009|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
27775666|NCT02326298|54228665|FG010|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
27775667|NCT02326298|54228666|FG011|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
27775668|NCT02326298|54228667|FG012|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
27775669|NCT02326298|54228668|FG013|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
27775670|NCT02326298|54228655|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27775671|NCT02326298|54228656|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27775672|NCT02326298|54228657|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27775673|NCT02326298|54228658|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27775674|NCT02326298|54228659|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27775675|NCT02326298|54228660|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
27775676|NCT02326298|54228661|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
27775677|NCT02326298|54228662|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
27775678|NCT02326298|54228663|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
27775679|NCT02326298|54228664|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
27775680|NCT02326298|54228665|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27775681|NCT02326298|54228666|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27775682|NCT02326298|54228667|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27775683|NCT02326298|54228668|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27775684|NCT02326298|54228655|FG000|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
27775685|NCT02326298|54228656|FG001|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
27775686|NCT02326298|54228657|FG002|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
27775687|NCT02326298|54228658|FG003|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
27775688|NCT02326298|54228659|FG004|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
27775689|NCT02326298|54228660|FG005|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1|||
27775690|NCT02326298|54228661|FG006|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2|||
27775691|NCT02326298|54228662|FG007|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
27775692|NCT02326298|54228663|FG008|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4|||
27775693|NCT02326298|54228664|FG009|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
27775694|NCT02326298|54228665|FG010|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
27775695|NCT02326298|54228666|FG011|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
27775696|NCT02326298|54228667|FG012|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
27775697|NCT02326298|54228668|FG013|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
27775698|NCT02326298|54228655|FG000|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
27775699|NCT02326298|54228656|FG001|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
27775700|NCT02326298|54228657|FG002|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
27775701|NCT02326298|54228658|FG003|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
27775702|NCT02326298|54228659|FG004|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
27775703|NCT02326298|54228660|FG005|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1|||
27775704|NCT02326298|54228661|FG006|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
27775705|NCT02326298|54228662|FG007|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
27775706|NCT02326298|54228663|FG008|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
27775707|NCT02326298|54228664|FG009|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
27775708|NCT02326298|54228665|FG010|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
27775709|NCT02326298|54228666|FG011|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
27775710|NCT02326298|54228667|FG012|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
27775711|NCT02326298|54228668|FG013|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
27775712|NCT02326298|54228655|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
27775713|NCT02326298|54228656|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
27775714|NCT02326298|54228657|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
27775715|NCT02326298|54228658|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
27775716|NCT02326298|54228659|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
27775717|NCT02326298|54228660|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
27775718|NCT02326298|54228661|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
27775719|NCT02326298|54228662|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
27775720|NCT02326298|54228663|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
27775721|NCT02326298|54228664|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
27775722|NCT02326298|54228665|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
27775723|NCT02326298|54228666|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
27775724|NCT02326298|54228667|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
27775725|NCT02326298|54228668|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
27775726|NCT02326298|54228655|FG000|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
27775727|NCT02326298|54228656|FG001|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
27775728|NCT02326298|54228657|FG002|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
27775729|NCT02326298|54228658|FG003|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
27775730|NCT02326298|54228659|FG004|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
27775731|NCT02326298|54228660|FG005|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
27775732|NCT02326298|54228661|FG006|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
27775733|NCT02326298|54228662|FG007|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1|||
27775734|NCT02326298|54228663|FG008|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
27775735|NCT02326298|54228664|FG009|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
27775736|NCT02326298|54228665|FG010|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
27775737|NCT02326298|54228666|FG011|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
27775738|NCT02326298|54228667|FG012|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
27775739|NCT02326298|54228668|FG013|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
27775740|NCT02326298|54228655|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27775741|NCT02326298|54228656|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27775742|NCT02326298|54228657|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27775743|NCT02326298|54228658|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27775744|NCT02326298|54228659|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27775745|NCT02326298|54228660|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27775746|NCT02326298|54228661|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
27775747|NCT02326298|54228662|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
27775748|NCT02326298|54228663|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27775749|NCT02326298|54228664|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27775750|NCT02326298|54228665|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27775751|NCT02326298|54228666|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27775752|NCT02326298|54228667|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27775753|NCT02326298|54228668|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27775754|NCT02326298|54228655|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27775755|NCT02326298|54228656|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27775756|NCT02326298|54228657|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27775757|NCT02326298|54228658|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27775758|NCT02326298|54228659|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27775759|NCT02326298|54228660|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27775760|NCT02326298|54228661|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27775761|NCT02326298|54228662|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
27775762|NCT02326298|54228663|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27775763|NCT02326298|54228664|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27775764|NCT02326298|54228665|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27775765|NCT02326298|54228666|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27775766|NCT02326298|54228667|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27775767|NCT02326298|54228668|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27775768|NCT02326298|54228655|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
27775769|NCT02326298|54228656|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
27775770|NCT02326298|54228657|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
27775771|NCT02326298|54228658|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
27775772|NCT02326298|54228659|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
27775773|NCT02326298|54228660|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2|||
27775774|NCT02326298|54228661|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
27775775|NCT02326298|54228662|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
27775776|NCT02326298|54228663|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
27775777|NCT02326298|54228664|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
27775778|NCT02326298|54228665|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
27775779|NCT02326298|54228666|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
27775780|NCT02326298|54228667|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
27775781|NCT02326298|54228668|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
27775782|NCT02326298|54228655|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
27775783|NCT02326298|54228656|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
27775784|NCT02326298|54228657|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
27775785|NCT02326298|54228658|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
27775786|NCT02326298|54228659|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
27775787|NCT02326298|54228660|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
27775788|NCT02326298|54228661|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
27775789|NCT02326298|54228662|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
27775790|NCT02326298|54228663|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
27775791|NCT02326298|54228664|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
27775792|NCT02326298|54228665|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
27775793|NCT02326298|54228666|FG011|Open-label Period (Week 48 to Week 144)|Death|1|||
27775794|NCT02326298|54228667|FG012|Open-label Period (Week 48 to Week 144)|Death|0|||
27775795|NCT02326298|54228668|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
27775796|NCT02326298|54228655|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
27775797|NCT02326298|54228656|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
27775798|NCT02326298|54228657|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
27775799|NCT02326298|54228658|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
27775800|NCT02326298|54228659|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
27775801|NCT02326298|54228660|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
27775802|NCT02326298|54228661|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
27840267|NCT01564862|54327593|FG001|Overall Study|Voluntary Withdrawal|6|||
27840268|NCT01564862|54327594|FG002|Overall Study|Voluntary Withdrawal|8|||
27775803|NCT02326298|54228662|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
27775804|NCT02326298|54228663|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
27775805|NCT02326298|54228664|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
27775806|NCT02326298|54228665|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
27775807|NCT02326298|54228666|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
27775808|NCT02326298|54228667|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
27775809|NCT02326298|54228668|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
27775810|NCT02326298|54228655|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27775811|NCT02326298|54228656|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27775812|NCT02326298|54228657|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27775813|NCT02326298|54228658|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27775814|NCT02326298|54228659|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27775815|NCT02326298|54228660|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27775816|NCT02326298|54228661|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27775817|NCT02326298|54228662|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27775818|NCT02326298|54228663|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27775819|NCT02326298|54228664|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27775820|NCT02326298|54228665|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27775821|NCT02326298|54228666|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
27775822|NCT02326298|54228667|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
27775823|NCT02326298|54228668|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27775824|NCT02326298|54228655|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
27775825|NCT02326298|54228656|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
27775826|NCT02326298|54228657|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
27775827|NCT02326298|54228658|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
27775828|NCT02326298|54228659|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
27775829|NCT02326298|54228660|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
27775830|NCT02326298|54228661|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
27775831|NCT02326298|54228662|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
27775832|NCT02326298|54228663|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
27775833|NCT02326298|54228664|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
27775834|NCT02326298|54228665|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
27775835|NCT02326298|54228666|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
27775836|NCT02326298|54228667|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
27775837|NCT02326298|54228668|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|2|||
27775838|NCT02326298|54228655|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27775839|NCT02326298|54228656|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27775840|NCT02326298|54228657|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27775841|NCT02326298|54228658|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27775842|NCT02326298|54228659|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27775843|NCT02326298|54228660|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27775844|NCT02326298|54228661|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27775845|NCT02326298|54228662|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27775846|NCT02326298|54228663|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27775847|NCT02326298|54228664|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27775848|NCT02326298|54228665|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27775849|NCT02326298|54228666|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7|||
27775850|NCT02326298|54228667|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
27775851|NCT02326298|54228668|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
27775852|NCT02326298|54228655|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
27775853|NCT02326298|54228656|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
27775854|NCT02326298|54228657|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
27775855|NCT02326298|54228658|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
27775856|NCT02326298|54228659|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
27775857|NCT02326298|54228660|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
27775858|NCT02326298|54228661|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
27775859|NCT02326298|54228662|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
27775860|NCT02326298|54228663|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
27775861|NCT02326298|54228664|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
27775862|NCT02326298|54228665|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
27840269|NCT01564862|54327592|FG000|Overall Study|Lack of Efficacy|1|||
27840270|NCT01564862|54327593|FG001|Overall Study|Lack of Efficacy|5|||
27840271|NCT01564862|54327594|FG002|Overall Study|Lack of Efficacy|6|||
27840272|NCT01564862|54327592|FG000|Overall Study|Other reason(s)|1|||
27775863|NCT02326298|54228666|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2|||
27775864|NCT02326298|54228667|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7|||
27775865|NCT02326298|54228668|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
27775866|NCT02326298|54228655|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27775867|NCT02326298|54228656|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27775868|NCT02326298|54228657|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27775869|NCT02326298|54228658|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27775870|NCT02326298|54228659|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27775871|NCT02326298|54228660|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27775872|NCT02326298|54228661|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27775873|NCT02326298|54228662|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27775874|NCT02326298|54228663|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27775875|NCT02326298|54228664|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27775876|NCT02326298|54228665|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27775877|NCT02326298|54228666|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
27775878|NCT02326298|54228667|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
27775879|NCT02326298|54228668|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
27775880|NCT02396420|54228677|FG000|Overall Study|Death|1|||
27775881|NCT02279719|54228689|FG000|Overall Study|Patients randomized but never treated|0|||
27775882|NCT02279719|54228690|FG001|Overall Study|Patients randomized but never treated|0|||
27775883|NCT02279719|54228691|FG002|Overall Study|Patients randomized but never treated|0|||
27775884|NCT02279719|54228692|FG003|Overall Study|Patients randomized but never treated|0|||
27775885|NCT02279719|54228693|FG004|Overall Study|Patients randomized but never treated|3|||
27775886|NCT02279719|54228694|FG005|Overall Study|Patients randomized but never treated|0|||
27775887|NCT02279719|54228695|FG006|Overall Study|Patients randomized but never treated|3|||
27775888|NCT02279407|54228732|FG000|Overall Study|Couldn't swallow IP; noncompliance|0|||
27775889|NCT02279407|54228733|FG001|Overall Study|Couldn't swallow IP; noncompliance|0|||
27775890|NCT02279407|54228734|FG002|Overall Study|Couldn't swallow IP; noncompliance|2|||
27775891|NCT02279407|54228735|FG003|Overall Study|Couldn't swallow IP; noncompliance|0|||
27775892|NCT02279407|54228732|FG000|Overall Study|Withdrawal by Subject|1|||
27775893|NCT02279407|54228733|FG001|Overall Study|Withdrawal by Subject|0|||
27775894|NCT02279407|54228734|FG002|Overall Study|Withdrawal by Subject|1|||
27775895|NCT02279407|54228735|FG003|Overall Study|Withdrawal by Subject|1|||
27775896|NCT02279407|54228732|FG000|Overall Study|Adverse Event|1|||
27775897|NCT02279407|54228733|FG001|Overall Study|Adverse Event|1|||
27775898|NCT02279407|54228734|FG002|Overall Study|Adverse Event|2|||
27775899|NCT02279407|54228735|FG003|Overall Study|Adverse Event|0|||
27775900|NCT02326220|54228747|FG000|Double-blind Treatment Period|Adverse Event|1|||
27775901|NCT02326220|54228748|FG001|Double-blind Treatment Period|Adverse Event|2|||
27775902|NCT02326220|54228749|FG002|Double-blind Treatment Period|Adverse Event|0|||
27775903|NCT02326220|54228747|FG000|Double-blind Treatment Period|Protocol Violation|0|||
27775904|NCT02326220|54228748|FG001|Double-blind Treatment Period|Protocol Violation|1|||
27775905|NCT02326220|54228749|FG002|Double-blind Treatment Period|Protocol Violation|0|||
27775906|NCT02326220|54228747|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
27775907|NCT02326220|54228748|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
27775908|NCT02326220|54228749|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
27775909|NCT02326220|54228747|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
27775910|NCT02326220|54228748|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
27775911|NCT02326220|54228749|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
27775912|NCT02326220|54228747|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
27775913|NCT02326220|54228748|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
27775914|NCT02326220|54228749|FG002|Open-label Treatment Period|Lost to Follow-up|1|||
27775915|NCT02279173|54228759|FG000|Overall Study|Protocol-specified Criteria|67|||
27775916|NCT02279173|54228759|FG000|Overall Study|Withdrawal by Subject|20|||
27775917|NCT02279173|54228759|FG000|Overall Study|Decision by Sponsor|4|||
27775918|NCT02279173|54228759|FG000|Overall Study|Lost to Follow-up|3|||
27775919|NCT02282917|54228765|FG000|Overall Study|Withdrawal by Subject|1|||
27775920|NCT02282917|54228765|FG000|Overall Study|Screen Failure/Not Eligible|1|||
27775921|NCT02358668|54228772|FG000|Overall Study|Adverse Event|2|||
27775922|NCT02358668|54228773|FG001|Overall Study|Adverse Event|0|||
27775923|NCT02358668|54228774|FG002|Overall Study|Adverse Event|0|||
27775924|NCT02358668|54228772|FG000|Overall Study|Withdrawal by Subject|0|||
27775925|NCT02358668|54228773|FG001|Overall Study|Withdrawal by Subject|1|||
27775926|NCT02358668|54228774|FG002|Overall Study|Withdrawal by Subject|0|||
27775927|NCT02282605|54228785|FG000|Overall Study|negative SA result on Day -1|3|||
27775928|NCT02282605|54228786|FG001|Overall Study|negative SA result on Day -1|0|||
27775929|NCT02282605|54228787|FG002|Overall Study|negative SA result on Day -1|0|||
27840273|NCT01564862|54327593|FG001|Overall Study|Other reason(s)|0|||
27775930|NCT02282527|54228797|FG000|Overall Study|Lost to Follow-up|0|||
27775931|NCT02282527|54228798|FG001|Overall Study|Lost to Follow-up|1|||
27840274|NCT01564862|54327594|FG002|Overall Study|Other reason(s)|0|||
27775932|NCT02282527|54228797|FG000|Overall Study|Lack of home health aid|1|||
27775933|NCT02282527|54228798|FG001|Overall Study|Lack of home health aid|0|||
27775934|NCT02278939|54228809|FG000|Overall Study|lack of time|1|||
27775935|NCT02278939|54228810|FG001|Overall Study|lack of time|0|||
27775936|NCT02278939|54228809|FG000|Overall Study|Lost to Follow-up|1|||
27775937|NCT02278939|54228810|FG001|Overall Study|Lost to Follow-up|1|||
27775938|NCT02278939|54228809|FG000|Overall Study|death in family|1|||
27775939|NCT02278939|54228810|FG001|Overall Study|death in family|0|||
27775940|NCT02278939|54228809|FG000|Overall Study|family emergency unable to commit|2|||
27775941|NCT02278939|54228810|FG001|Overall Study|family emergency unable to commit|0|||
27775942|NCT02278471|54228818|FG000|Overall Study|Lost to Follow-up|6|||
27775943|NCT02278471|54228819|FG001|Overall Study|Lost to Follow-up|15|||
27775944|NCT02278471|54228818|FG000|Overall Study|Death|2|||
27775945|NCT02278471|54228819|FG001|Overall Study|Death|2|||
27775946|NCT02278471|54228818|FG000|Overall Study|Withdrawal by Subject|0|||
27775947|NCT02278471|54228819|FG001|Overall Study|Withdrawal by Subject|3|||
27775948|NCT02278003|54228828|FG000|Overall Study|Withdrawal by Subject|11|||
27775949|NCT02278003|54228829|FG001|Overall Study|Withdrawal by Subject|0|||
27775950|NCT02278003|54228828|FG000|Overall Study|Not Treated|1|||
27775951|NCT02278003|54228829|FG001|Overall Study|Not Treated|0|||
27775952|NCT02278003|54228828|FG000|Overall Study|Recognition task improperly completed|7|||
27775953|NCT02278003|54228829|FG001|Overall Study|Recognition task improperly completed|0|||
27775954|NCT02277769|54228838|FG000|Overall Study|Protocol Violation|3|||
27775955|NCT02277769|54228839|FG001|Overall Study|Protocol Violation|3|||
27775956|NCT02277769|54228840|FG002|Overall Study|Protocol Violation|5|||
27775957|NCT02277769|54228838|FG000|Overall Study|Lack of Efficacy|17|||
27775958|NCT02277769|54228839|FG001|Overall Study|Lack of Efficacy|0|||
27775959|NCT02277769|54228840|FG002|Overall Study|Lack of Efficacy|4|||
27775960|NCT02277769|54228838|FG000|Overall Study|Adverse Event|14|||
27775961|NCT02277769|54228839|FG001|Overall Study|Adverse Event|2|||
27775962|NCT02277769|54228840|FG002|Overall Study|Adverse Event|4|||
27775963|NCT02277769|54228838|FG000|Overall Study|Other than specified above|12|||
27775964|NCT02277769|54228839|FG001|Overall Study|Other than specified above|8|||
27775965|NCT02277769|54228840|FG002|Overall Study|Other than specified above|5|||
27775966|NCT01641991|54228852|FG000|Overall Study|Physician Decision|0|||
27775967|NCT01641991|54228853|FG001|Overall Study|Physician Decision|1|||
27775968|NCT01641991|54228854|FG002|Overall Study|Physician Decision|7|||
27775969|NCT01641991|54228855|FG003|Overall Study|Physician Decision|5|||
27775970|NCT01641991|54228852|FG000|Overall Study|Withdrawal by Subject|4|||
27775971|NCT01641991|54228853|FG001|Overall Study|Withdrawal by Subject|2|||
27775972|NCT01641991|54228854|FG002|Overall Study|Withdrawal by Subject|1|||
27775973|NCT01641991|54228855|FG003|Overall Study|Withdrawal by Subject|5|||
27775974|NCT01641991|54228852|FG000|Overall Study|Adverse Event|2|||
27775975|NCT01641991|54228853|FG001|Overall Study|Adverse Event|1|||
27775976|NCT01641991|54228854|FG002|Overall Study|Adverse Event|2|||
27775977|NCT01641991|54228855|FG003|Overall Study|Adverse Event|1|||
27775978|NCT01641991|54228852|FG000|Overall Study|Lost to Follow-up|0|||
27775979|NCT01641991|54228853|FG001|Overall Study|Lost to Follow-up|2|||
27775980|NCT01641991|54228854|FG002|Overall Study|Lost to Follow-up|3|||
27775981|NCT01641991|54228855|FG003|Overall Study|Lost to Follow-up|1|||
27775982|NCT01641991|54228852|FG000|Overall Study|Protocol Violation|1|||
27775983|NCT01641991|54228853|FG001|Overall Study|Protocol Violation|1|||
27775984|NCT01641991|54228854|FG002|Overall Study|Protocol Violation|3|||
27775985|NCT01641991|54228855|FG003|Overall Study|Protocol Violation|0|||
27775986|NCT01641991|54228852|FG000|Overall Study|Pregnancy|0|||
27775987|NCT01641991|54228853|FG001|Overall Study|Pregnancy|0|||
27775988|NCT01641991|54228854|FG002|Overall Study|Pregnancy|1|||
27775989|NCT01641991|54228855|FG003|Overall Study|Pregnancy|0|||
27775990|NCT01641991|54228852|FG000|Overall Study|no longer eligible|2|||
27775991|NCT01641991|54228853|FG001|Overall Study|no longer eligible|1|||
27775992|NCT01641991|54228854|FG002|Overall Study|no longer eligible|0|||
27775993|NCT01641991|54228855|FG003|Overall Study|no longer eligible|4|||
27775994|NCT02277691|54228868|FG000|Overall Study|Pretreatment Event/Adverse Event|33|||
27775995|NCT02277691|54228868|FG000|Overall Study|Voluntary Withdrawal|7|||
27775996|NCT02277691|54228868|FG000|Overall Study|Lack of Efficacy|5|||
27775997|NCT02277691|54228868|FG000|Overall Study|Used Other Antihypertensive Drug|1|||
27775998|NCT02395172|54228874|FG000|Overall Study|Participants randomized but not treated|3|||
27775999|NCT02395172|54228875|FG001|Overall Study|Participants randomized but not treated|31|||
27776000|NCT02276053|54228881|FG000|Overall Study|Death|2|||
27840275|NCT01691378|54327604|FG000|Overall Study|Withdrawal by Subject|2|||
27840276|NCT01691378|54327605|FG001|Overall Study|Withdrawal by Subject|0|||
27840277|NCT01691378|54327604|FG000|Overall Study|Lost to Follow-up|5|||
27776001|NCT02276053|54228881|FG000|Overall Study|Adverse Event|5|||
27776002|NCT02276053|54228881|FG000|Overall Study|Lack of Efficacy|2|||
27776003|NCT02276053|54228881|FG000|Overall Study|Withdrawal by Subject|1|||
27776004|NCT02276053|54228881|FG000|Overall Study|Patient does not meet selection criteria|3|||
27776005|NCT02276053|54228881|FG000|Overall Study|Patient needs to increase baseline AED|1|||
27776006|NCT02275819|54228888|FG000|Overall Study|Adverse Event|0|||
27776007|NCT02275819|54228889|FG001|Overall Study|Adverse Event|1|||
27776008|NCT02358044|54228897|FG000|Overall Study|Adverse Event|0|||
27776009|NCT02358044|54228898|FG001|Overall Study|Adverse Event|1|||
27776010|NCT02358044|54228897|FG000|Overall Study|Lost to Follow-up|2|||
27776011|NCT02358044|54228898|FG001|Overall Study|Lost to Follow-up|1|||
27776012|NCT02358044|54228897|FG000|Overall Study|Physician Decision|0|||
27776013|NCT02358044|54228898|FG001|Overall Study|Physician Decision|1|||
27776014|NCT02358044|54228897|FG000|Overall Study|Withdrawal by Subject|0|||
27776015|NCT02358044|54228898|FG001|Overall Study|Withdrawal by Subject|4|||
27776016|NCT02275117|54228909|FG000|Overall Study|Adverse Event|0|||
27776017|NCT02275117|54228910|FG001|Overall Study|Adverse Event|0|||
27776018|NCT02275117|54228911|FG002|Overall Study|Adverse Event|0|||
27776019|NCT02275117|54228912|FG003|Overall Study|Adverse Event|0|||
27776020|NCT02275117|54228913|FG004|Overall Study|Adverse Event|1|||
27776021|NCT02275117|54228909|FG000|Overall Study|Lack of Efficacy|6|||
27776022|NCT02275117|54228910|FG001|Overall Study|Lack of Efficacy|7|||
27776023|NCT02275117|54228911|FG002|Overall Study|Lack of Efficacy|5|||
27776024|NCT02275117|54228912|FG003|Overall Study|Lack of Efficacy|2|||
27776025|NCT02275117|54228913|FG004|Overall Study|Lack of Efficacy|10|||
27776026|NCT02275117|54228909|FG000|Overall Study|Lost to Follow-up|11|||
27776027|NCT02275117|54228910|FG001|Overall Study|Lost to Follow-up|16|||
27776028|NCT02275117|54228911|FG002|Overall Study|Lost to Follow-up|15|||
27776029|NCT02275117|54228912|FG003|Overall Study|Lost to Follow-up|16|||
27776030|NCT02275117|54228913|FG004|Overall Study|Lost to Follow-up|8|||
27776031|NCT02275117|54228909|FG000|Overall Study|Physician Decision|0|||
27776032|NCT02275117|54228910|FG001|Overall Study|Physician Decision|1|||
27776033|NCT02275117|54228911|FG002|Overall Study|Physician Decision|1|||
27776034|NCT02275117|54228912|FG003|Overall Study|Physician Decision|0|||
27776035|NCT02275117|54228913|FG004|Overall Study|Physician Decision|1|||
27776036|NCT02275117|54228909|FG000|Overall Study|Protocol Violation|1|||
27776037|NCT02275117|54228910|FG001|Overall Study|Protocol Violation|0|||
27776038|NCT02275117|54228911|FG002|Overall Study|Protocol Violation|1|||
27776039|NCT02275117|54228912|FG003|Overall Study|Protocol Violation|1|||
27776040|NCT02275117|54228913|FG004|Overall Study|Protocol Violation|0|||
27776041|NCT02275117|54228909|FG000|Overall Study|Withdrawal by Subject|6|||
27776042|NCT02275117|54228910|FG001|Overall Study|Withdrawal by Subject|4|||
27776043|NCT02275117|54228911|FG002|Overall Study|Withdrawal by Subject|7|||
27776044|NCT02275117|54228912|FG003|Overall Study|Withdrawal by Subject|3|||
27776045|NCT02275117|54228913|FG004|Overall Study|Withdrawal by Subject|3|||
27776046|NCT02275117|54228909|FG000|Overall Study|Terminated by Sponsor|4|||
27776047|NCT02275117|54228910|FG001|Overall Study|Terminated by Sponsor|4|||
27776048|NCT02275117|54228911|FG002|Overall Study|Terminated by Sponsor|4|||
27776049|NCT02275117|54228912|FG003|Overall Study|Terminated by Sponsor|6|||
27776050|NCT02275117|54228913|FG004|Overall Study|Terminated by Sponsor|4|||
27776051|NCT02275117|54228909|FG000|Overall Study|Worsening of Study Indication|0|||
27776052|NCT02275117|54228910|FG001|Overall Study|Worsening of Study Indication|1|||
27776053|NCT02275117|54228911|FG002|Overall Study|Worsening of Study Indication|2|||
27776054|NCT02275117|54228912|FG003|Overall Study|Worsening of Study Indication|0|||
27776055|NCT02275117|54228913|FG004|Overall Study|Worsening of Study Indication|0|||
27776056|NCT02275117|54228909|FG000|Overall Study|Study Burden|5|||
27776057|NCT02275117|54228910|FG001|Overall Study|Study Burden|4|||
27776058|NCT02275117|54228911|FG002|Overall Study|Study Burden|7|||
27776059|NCT02275117|54228912|FG003|Overall Study|Study Burden|5|||
27776060|NCT02275117|54228913|FG004|Overall Study|Study Burden|7|||
27776061|NCT02275117|54228909|FG000|Overall Study|Other|1|||
27776062|NCT02275117|54228910|FG001|Overall Study|Other|0|||
27776063|NCT02275117|54228911|FG002|Overall Study|Other|0|||
27776064|NCT02275117|54228912|FG003|Overall Study|Other|0|||
27776065|NCT02275117|54228913|FG004|Overall Study|Other|2|||
27776066|NCT02274493|54228925|FG000|Overall Study|Withdrawal by Subject|1|||
27776067|NCT02273167|54228932|FG000|Overall Study|Adverse Event|1|||
27776068|NCT02273167|54228933|FG001|Overall Study|Adverse Event|0|||
27776069|NCT02273167|54228934|FG002|Overall Study|Adverse Event|0|||
27776070|NCT02273167|54228932|FG000|Overall Study|Protocol Violation|3|||
27776071|NCT02273167|54228933|FG001|Overall Study|Protocol Violation|1|||
27776072|NCT02273167|54228934|FG002|Overall Study|Protocol Violation|1|||
27776073|NCT02273167|54228932|FG000|Overall Study|Lost to Follow-up|0|||
27776074|NCT02273167|54228933|FG001|Overall Study|Lost to Follow-up|1|||
27776075|NCT02273167|54228934|FG002|Overall Study|Lost to Follow-up|1|||
27776076|NCT02273167|54228932|FG000|Overall Study|Withdrawal by Subject|10|||
27776077|NCT02273167|54228933|FG001|Overall Study|Withdrawal by Subject|12|||
27776078|NCT02273167|54228934|FG002|Overall Study|Withdrawal by Subject|11|||
27776079|NCT02273167|54228932|FG000|Overall Study|Various|10|||
27776080|NCT02273167|54228933|FG001|Overall Study|Various|9|||
27776081|NCT02273167|54228934|FG002|Overall Study|Various|8|||
27776082|NCT02272777|54228945|FG000|Overall Study|Adverse Event|0|||
27776083|NCT02272777|54228946|FG001|Overall Study|Adverse Event|1|||
27776084|NCT02272777|54228945|FG000|Overall Study|Withdrawal by Subject|0|||
27776085|NCT02272777|54228946|FG001|Overall Study|Withdrawal by Subject|3|||
27776086|NCT02272777|54228945|FG000|Overall Study|Lost to Follow-up|2|||
27776087|NCT02272777|54228946|FG001|Overall Study|Lost to Follow-up|0|||
27776088|NCT02272777|54228945|FG000|Overall Study|Other|2|||
27776089|NCT02272777|54228946|FG001|Overall Study|Other|0|||
27776090|NCT02357810|54228952|FG000|Registered and Started Treatment|Withdrawal by Subject|1|||
27776091|NCT02357810|54228952|FG000|Registered and Started Treatment|Found not to be eligible for the study|26|||
27776092|NCT02357810|54228952|FG000|Reached 12 Weeks Response|Adverse Event|5|||
27776093|NCT02357810|54228952|FG000|Reached 12 Weeks Response|Progressive Disease|39|||
27776094|NCT02357810|54228952|FG000|Reached 12 Weeks Response|Withdrawal by Subject|8|||
27776095|NCT02357810|54228952|FG000|Reached 12 Weeks Response|Protocol Violation|1|||
27776096|NCT02357810|54228952|FG000|Reached 12 Weeks Response|Death|1|||
27776097|NCT02357810|54228952|FG000|Reached 12 Weeks Response|Physician Decision|1|||
27776098|NCT02357810|54228952|FG000|Reached 12 Weeks Response|Other|1|||
27776099|NCT02357810|54228952|FG000|12 Week Response and Further Treatment|Adverse Event|5|||
27776100|NCT02357810|54228952|FG000|12 Week Response and Further Treatment|Withdrawal by Subject|1|||
27776101|NCT02357810|54228952|FG000|12 Week Response and Further Treatment|Progressive Disease|15|||
27776102|NCT02357810|54228952|FG000|12 Week Response and Further Treatment|Wound Complications|1|||
27776103|NCT02357810|54228952|FG000|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4|||
27776104|NCT02357810|54228952|FG000|Follow-up at Treatment Discontinuation|Lost to Follow-up|3|||
27776105|NCT02357576|54228958|FG000|Treatment Period|Withdrawal by Subject|0|||
27776106|NCT02357576|54228959|FG001|Treatment Period|Withdrawal by Subject|1|||
27776107|NCT02357576|54228958|FG000|Treatment Period|Physician Decision|0|||
27776108|NCT02357576|54228959|FG001|Treatment Period|Physician Decision|1|||
27776109|NCT02357576|54228958|FG000|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
27776110|NCT02357576|54228959|FG001|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
27776111|NCT02357576|54228958|FG000|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1|||
27776112|NCT02357576|54228959|FG001|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0|||
27776113|NCT02357576|54228958|FG000|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1|||
27776114|NCT02357576|54228959|FG001|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4|||
27776115|NCT02357576|54228958|FG000|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2|||
27776116|NCT02357576|54228959|FG001|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0|||
27776117|NCT01850446|54228967|FG000|Overall Study|Lack of Efficacy|1|||
27776118|NCT01850446|54228968|FG001|Overall Study|Lack of Efficacy|0|||
27776119|NCT01850446|54228967|FG000|Overall Study|Withdrawal by Subject|4|||
27776120|NCT01850446|54228968|FG001|Overall Study|Withdrawal by Subject|0|||
27776121|NCT01850446|54228967|FG000|Overall Study|Protocol Violation|0|||
27776122|NCT01850446|54228968|FG001|Overall Study|Protocol Violation|2|||
27776123|NCT02465567|54228978|FG000|Overall Study|Adverse Event|118|||
27776124|NCT02465567|54228979|FG001|Overall Study|Adverse Event|113|||
27776125|NCT02465567|54228980|FG002|Overall Study|Adverse Event|147|||
27776126|NCT02465567|54228981|FG003|Overall Study|Adverse Event|138|||
27776127|NCT02465567|54228978|FG000|Overall Study|Lack of Efficacy|103|||
27776128|NCT02465567|54228979|FG001|Overall Study|Lack of Efficacy|102|||
27776129|NCT02465567|54228980|FG002|Overall Study|Lack of Efficacy|171|||
27776130|NCT02465567|54228981|FG003|Overall Study|Lack of Efficacy|135|||
27776131|NCT02465567|54228978|FG000|Overall Study|Withdrawal by Subject|104|||
27776132|NCT02465567|54228979|FG001|Overall Study|Withdrawal by Subject|94|||
27776133|NCT02465567|54228980|FG002|Overall Study|Withdrawal by Subject|123|||
27776134|NCT02465567|54228981|FG003|Overall Study|Withdrawal by Subject|130|||
27776135|NCT02465567|54228978|FG000|Overall Study|Physician Decision|23|||
27776136|NCT02465567|54228979|FG001|Overall Study|Physician Decision|33|||
27776137|NCT02465567|54228980|FG002|Overall Study|Physician Decision|38|||
27776138|NCT02465567|54228981|FG003|Overall Study|Physician Decision|28|||
27776139|NCT02465567|54228978|FG000|Overall Study|Major Protocol Deviation|24|||
27776140|NCT02465567|54228979|FG001|Overall Study|Major Protocol Deviation|26|||
27776141|NCT02465567|54228980|FG002|Overall Study|Major Protocol Deviation|22|||
27776142|NCT02465567|54228981|FG003|Overall Study|Major Protocol Deviation|25|||
27776143|NCT02465567|54228978|FG000|Overall Study|Lost to Follow-up|25|||
27776144|NCT02465567|54228979|FG001|Overall Study|Lost to Follow-up|21|||
27776145|NCT02465567|54228980|FG002|Overall Study|Lost to Follow-up|19|||
27776146|NCT02465567|54228981|FG003|Overall Study|Lost to Follow-up|15|||
27776147|NCT02465567|54228978|FG000|Overall Study|Protocol Specified Criteria|20|||
27776148|NCT02465567|54228979|FG001|Overall Study|Protocol Specified Criteria|10|||
27776149|NCT02465567|54228980|FG002|Overall Study|Protocol Specified Criteria|9|||
27776150|NCT02465567|54228981|FG003|Overall Study|Protocol Specified Criteria|12|||
27776151|NCT02465567|54228978|FG000|Overall Study|Administrative Reasons|12|||
27776152|NCT02465567|54228979|FG001|Overall Study|Administrative Reasons|9|||
27776153|NCT02465567|54228980|FG002|Overall Study|Administrative Reasons|11|||
27776154|NCT02465567|54228981|FG003|Overall Study|Administrative Reasons|5|||
27776155|NCT02465567|54228978|FG000|Overall Study|Randomized but not treated|1|||
27776156|NCT02465567|54228979|FG001|Overall Study|Randomized but not treated|5|||
27776157|NCT02465567|54228980|FG002|Overall Study|Randomized but not treated|4|||
27776158|NCT02465567|54228981|FG003|Overall Study|Randomized but not treated|5|||
27776159|NCT02465567|54228978|FG000|Overall Study|enrolled in >1 studies|18|||
27776160|NCT02465567|54228979|FG001|Overall Study|enrolled in >1 studies|11|||
27776161|NCT02465567|54228980|FG002|Overall Study|enrolled in >1 studies|19|||
27776162|NCT02465567|54228981|FG003|Overall Study|enrolled in >1 studies|15|||
27776163|NCT02465567|54228978|FG000|Overall Study|missing PI Signature|1|||
27776164|NCT02465567|54228979|FG001|Overall Study|missing PI Signature|0|||
27776165|NCT02465567|54228980|FG002|Overall Study|missing PI Signature|0|||
27776166|NCT02465567|54228981|FG003|Overall Study|missing PI Signature|0|||
27776167|NCT01644175|54228993|FG000|Overall Study|Randomized But Not Treated|0|||
27776168|NCT01644175|54228994|FG001|Overall Study|Randomized But Not Treated|2|||
27776169|NCT01644175|54228993|FG000|Overall Study|Adverse Event|8|||
27776170|NCT01644175|54228994|FG001|Overall Study|Adverse Event|13|||
27776171|NCT01644175|54228993|FG000|Overall Study|Death|1|||
27776172|NCT01644175|54228994|FG001|Overall Study|Death|2|||
27776173|NCT01644175|54228993|FG000|Overall Study|Poor compliance to protocol|9|||
27776174|NCT01644175|54228994|FG001|Overall Study|Poor compliance to protocol|10|||
27776175|NCT01644175|54228993|FG000|Overall Study|Physician Decision|1|||
27776176|NCT01644175|54228994|FG001|Overall Study|Physician Decision|2|||
27776177|NCT01644175|54228993|FG000|Overall Study|Participant Moved|1|||
27776178|NCT01644175|54228994|FG001|Overall Study|Participant Moved|2|||
27776179|NCT01644175|54228993|FG000|Overall Study|Consent withdrawn by participant|3|||
27776180|NCT01644175|54228994|FG001|Overall Study|Consent withdrawn by participant|4|||
27776181|NCT01644175|54228993|FG000|Overall Study|Related to Autoinjector Administration|2|||
27776182|NCT01644175|54228994|FG001|Overall Study|Related to Autoinjector Administration|1|||
27776183|NCT01644175|54228993|FG000|Overall Study|Last visit outside protocol visit window|4|||
27776184|NCT01644175|54228994|FG001|Overall Study|Last visit outside protocol visit window|11|||
27776185|NCT01644175|54228993|FG000|Overall Study|Selection criteria finally not met|0|||
27776186|NCT01644175|54228994|FG001|Overall Study|Selection criteria finally not met|1|||
27776187|NCT01644175|54228993|FG000|Overall Study|Site closure|2|||
27776188|NCT01644175|54228994|FG001|Overall Study|Site closure|2|||
27776189|NCT01644175|54228993|FG000|Overall Study|Lost to Follow-up|1|||
27776190|NCT01644175|54228994|FG001|Overall Study|Lost to Follow-up|0|||
27776191|NCT01644175|54228993|FG000|Overall Study|Other than specified above|0|||
27776192|NCT01644175|54228994|FG001|Overall Study|Other than specified above|3|||
27776193|NCT02357420|54229004|FG000|Overall Study|Adverse Event|3|||
27776194|NCT02357420|54229005|FG001|Overall Study|Adverse Event|3|||
27776195|NCT02357420|54229006|FG002|Overall Study|Adverse Event|8|||
27776196|NCT02357420|54229007|FG003|Overall Study|Adverse Event|9|||
27776197|NCT02357420|54229004|FG000|Overall Study|Investigator Decision|1|||
27776198|NCT02357420|54229005|FG001|Overall Study|Investigator Decision|0|||
27776199|NCT02357420|54229006|FG002|Overall Study|Investigator Decision|0|||
27776200|NCT02357420|54229007|FG003|Overall Study|Investigator Decision|0|||
27776201|NCT02357420|54229004|FG000|Overall Study|Prohibited Medication|1|||
27776202|NCT02357420|54229005|FG001|Overall Study|Prohibited Medication|1|||
27776203|NCT02357420|54229006|FG002|Overall Study|Prohibited Medication|0|||
27776204|NCT02357420|54229007|FG003|Overall Study|Prohibited Medication|0|||
27776205|NCT02357420|54229004|FG000|Overall Study|Protocol Non-compliance|0|||
27776206|NCT02357420|54229005|FG001|Overall Study|Protocol Non-compliance|0|||
27776207|NCT02357420|54229006|FG002|Overall Study|Protocol Non-compliance|0|||
27776208|NCT02357420|54229007|FG003|Overall Study|Protocol Non-compliance|1|||
27776209|NCT02357420|54229004|FG000|Overall Study|Withdrawn Consent|4|||
27776210|NCT02357420|54229005|FG001|Overall Study|Withdrawn Consent|8|||
27776211|NCT02357420|54229006|FG002|Overall Study|Withdrawn Consent|6|||
27776212|NCT02357420|54229007|FG003|Overall Study|Withdrawn Consent|6|||
27776213|NCT02357420|54229004|FG000|Overall Study|Lost to Follow-up|3|||
27776214|NCT02357420|54229005|FG001|Overall Study|Lost to Follow-up|0|||
27776215|NCT02357420|54229006|FG002|Overall Study|Lost to Follow-up|2|||
27776216|NCT02357420|54229007|FG003|Overall Study|Lost to Follow-up|3|||
27776217|NCT01832038|54229017|FG000|Overall Study|Death|5|||
27776218|NCT01832038|54229017|FG000|Overall Study|Adverse Event|50|||
27776219|NCT01832038|54229017|FG000|Overall Study|Lack of Efficacy|81|||
27776220|NCT01832038|54229017|FG000|Overall Study|Protocol Violation|7|||
27776221|NCT01832038|54229017|FG000|Overall Study|Lost to Follow-up|10|||
27776222|NCT01832038|54229017|FG000|Overall Study|Withdrawal by Subject|49|||
27776223|NCT01832038|54229017|FG000|Overall Study|Visit non-compliance|2|||
27776224|NCT01832038|54229017|FG000|Overall Study|Subject refused to return visit|2|||
27776225|NCT01832038|54229017|FG000|Overall Study|Not convenient to come back to site|2|||
27776226|NCT01832038|54229017|FG000|Overall Study|Participant was asked to quit|5|||
27776227|NCT01832038|54229017|FG000|Overall Study|Back home|1|||
27776228|NCT01832038|54229017|FG000|Overall Study|Pregnancy|1|||
27776229|NCT01832038|54229017|FG000|Overall Study|Low compliance|3|||
27776230|NCT01832038|54229017|FG000|Overall Study|Prohibit procedure|2|||
27776231|NCT01832038|54229017|FG000|Overall Study|Not possible to visit the hospital|1|||
27776232|NCT01832038|54229017|FG000|Overall Study|Changes of implementation system|3|||
27776233|NCT01832038|54229017|FG000|Overall Study|Plan to pregnancy|7|||
27776234|NCT01832038|54229017|FG000|Overall Study|Bad mood and has suicidal thought|1|||
27776235|NCT01832038|54229017|FG000|Overall Study|Prohibited concomitant medication|1|||
27840278|NCT01691378|54327605|FG001|Overall Study|Lost to Follow-up|2|||
27776236|NCT01832038|54229017|FG000|Overall Study|Pregnancy and abortion in EP0008 study|1|||
27776237|NCT01832038|54229017|FG000|Overall Study|Subject considered the efficacy was poor|1|||
27776238|NCT01849588|54229022|FG000|Overall Study|Lack of Efficacy|3|||
27776239|NCT02357342|54229028|FG000|First 6 Months|Death|2|||
27776240|NCT02357342|54229029|FG001|First 6 Months|Death|0|||
27776241|NCT02271529|54229035|FG000|Overall Study|Withdrawal by Subject|1|||
27776242|NCT02325518|54229041|FG000|Overall Study|Adverse Event|4|||
27776243|NCT02325518|54229042|FG001|Overall Study|Adverse Event|1|||
27776244|NCT02325518|54229041|FG000|Overall Study|Physician Decision|0|||
27776245|NCT02325518|54229042|FG001|Overall Study|Physician Decision|1|||
27776246|NCT02325518|54229041|FG000|Overall Study|Withdrawal by Subject|0|||
27776247|NCT02325518|54229042|FG001|Overall Study|Withdrawal by Subject|1|||
27776248|NCT02270983|54229052|FG000|Overall Study|Adverse Event|3|||
27776249|NCT02270983|54229053|FG001|Overall Study|Adverse Event|2|||
27776250|NCT02270983|54229054|FG002|Overall Study|Adverse Event|6|||
27776251|NCT02270983|54229052|FG000|Overall Study|Lack of Efficacy|2|||
27776252|NCT02270983|54229053|FG001|Overall Study|Lack of Efficacy|1|||
27776253|NCT02270983|54229054|FG002|Overall Study|Lack of Efficacy|1|||
27776254|NCT02270983|54229052|FG000|Overall Study|Withdrawal by Subject|1|||
27776255|NCT02270983|54229053|FG001|Overall Study|Withdrawal by Subject|0|||
27776256|NCT02270983|54229054|FG002|Overall Study|Withdrawal by Subject|2|||
27776257|NCT02270983|54229052|FG000|Overall Study|Lost to Follow-up|1|||
27776258|NCT02270983|54229053|FG001|Overall Study|Lost to Follow-up|1|||
27776259|NCT02270983|54229054|FG002|Overall Study|Lost to Follow-up|2|||
27776260|NCT02270983|54229052|FG000|Overall Study|Protocol Violation|1|||
27776261|NCT02270983|54229053|FG001|Overall Study|Protocol Violation|1|||
27776262|NCT02270983|54229054|FG002|Overall Study|Protocol Violation|1|||
27776263|NCT02270983|54229052|FG000|Overall Study|family emergency|0|||
27776264|NCT02270983|54229053|FG001|Overall Study|family emergency|1|||
27776265|NCT02270983|54229054|FG002|Overall Study|family emergency|0|||
27776266|NCT02270983|54229052|FG000|Overall Study|study procedure non-compliance|1|||
27776267|NCT02270983|54229053|FG001|Overall Study|study procedure non-compliance|0|||
27776268|NCT02270983|54229054|FG002|Overall Study|study procedure non-compliance|0|||
27776269|NCT02270983|54229052|FG000|Overall Study|moved away from study site|0|||
27776270|NCT02270983|54229053|FG001|Overall Study|moved away from study site|1|||
27776271|NCT02270983|54229054|FG002|Overall Study|moved away from study site|0|||
27776272|NCT02449889|54229065|FG000|Overall Study|Adverse Event|1|||
27776273|NCT02449889|54229066|FG001|Overall Study|Adverse Event|2|||
27776274|NCT02449889|54229067|FG002|Overall Study|Adverse Event|0|||
27776275|NCT02449889|54229065|FG000|Overall Study|Protocol Violation|0|||
27776276|NCT02449889|54229066|FG001|Overall Study|Protocol Violation|4|||
27776277|NCT02449889|54229067|FG002|Overall Study|Protocol Violation|1|||
27776278|NCT01831804|54229084|FG000|Overall Study|Adverse Event|0|||
27776279|NCT01831804|54229085|FG001|Overall Study|Adverse Event|0|||
27776280|NCT01831804|54229086|FG002|Overall Study|Adverse Event|0|||
27776281|NCT01831804|54229087|FG003|Overall Study|Adverse Event|0|||
27776282|NCT01831804|54229088|FG004|Overall Study|Adverse Event|0|||
27776283|NCT01831804|54229089|FG005|Overall Study|Adverse Event|0|||
27776284|NCT01831804|54229090|FG006|Overall Study|Adverse Event|1|||
27776285|NCT01831804|54229091|FG007|Overall Study|Adverse Event|0|||
27840279|NCT01467479|54327614|FG000|Overall Study|No Study Medication|1|||
27840280|NCT01467479|54327615|FG001|Overall Study|No Study Medication|0|||
27840281|NCT01467479|54327616|FG002|Overall Study|No Study Medication|2|||
27840282|NCT01467479|54327614|FG000|Overall Study|Adverse Event|1|||
27840283|NCT01467479|54327615|FG001|Overall Study|Adverse Event|2|||
27840284|NCT01467479|54327616|FG002|Overall Study|Adverse Event|0|||
27840285|NCT01467479|54327614|FG000|Overall Study|Death|0|||
27840286|NCT01467479|54327615|FG001|Overall Study|Death|0|||
27840287|NCT01467479|54327616|FG002|Overall Study|Death|1|||
27840288|NCT01467479|54327614|FG000|Overall Study|Lost to Follow-up|2|||
27840289|NCT01467479|54327615|FG001|Overall Study|Lost to Follow-up|5|||
27840290|NCT01467479|54327616|FG002|Overall Study|Lost to Follow-up|3|||
27840291|NCT01467479|54327614|FG000|Overall Study|Withdrawal of Consent|3|||
27840292|NCT01467479|54327615|FG001|Overall Study|Withdrawal of Consent|7|||
27840293|NCT01467479|54327616|FG002|Overall Study|Withdrawal of Consent|7|||
27840294|NCT01467479|54327614|FG000|Overall Study|Study Terminated by Sponsor|1|||
27840295|NCT01467479|54327615|FG001|Overall Study|Study Terminated by Sponsor|3|||
27840296|NCT01467479|54327616|FG002|Overall Study|Study Terminated by Sponsor|3|||
27840297|NCT01467479|54327614|FG000|Overall Study|Other|1|||
27840298|NCT01467479|54327615|FG001|Overall Study|Other|0|||
27840299|NCT01467479|54327616|FG002|Overall Study|Other|0|||
27840300|NCT01466387|54327631|FG000|Overall Study|Adverse Event|0|||
27776286|NCT01831804|54229092|FG008|Overall Study|Adverse Event|1|||
27776287|NCT01831804|54229084|FG000|Overall Study|Protocol Violation|0|||
27776288|NCT01831804|54229085|FG001|Overall Study|Protocol Violation|0|||
27840301|NCT01466387|54327632|FG001|Overall Study|Adverse Event|0|||
27840302|NCT01466387|54327633|FG002|Overall Study|Adverse Event|1|||
27840303|NCT01466387|54327634|FG003|Overall Study|Adverse Event|1|||
27840304|NCT01466387|54327635|FG004|Overall Study|Adverse Event|0|||
27840305|NCT01466387|54327636|FG005|Overall Study|Adverse Event|0|||
27776289|NCT01831804|54229086|FG002|Overall Study|Protocol Violation|2|||
27776290|NCT01831804|54229087|FG003|Overall Study|Protocol Violation|0|||
27776291|NCT01831804|54229088|FG004|Overall Study|Protocol Violation|0|||
27776292|NCT01831804|54229089|FG005|Overall Study|Protocol Violation|0|||
27776293|NCT01831804|54229090|FG006|Overall Study|Protocol Violation|0|||
27776294|NCT01831804|54229091|FG007|Overall Study|Protocol Violation|0|||
27776295|NCT01831804|54229092|FG008|Overall Study|Protocol Violation|0|||
27776296|NCT01831804|54229084|FG000|Overall Study|Protocol defined stopping criteria|1|||
27776297|NCT01831804|54229085|FG001|Overall Study|Protocol defined stopping criteria|1|||
27776298|NCT01831804|54229086|FG002|Overall Study|Protocol defined stopping criteria|3|||
27776299|NCT01831804|54229087|FG003|Overall Study|Protocol defined stopping criteria|0|||
27776300|NCT01831804|54229088|FG004|Overall Study|Protocol defined stopping criteria|1|||
27776301|NCT01831804|54229089|FG005|Overall Study|Protocol defined stopping criteria|0|||
27776302|NCT01831804|54229090|FG006|Overall Study|Protocol defined stopping criteria|0|||
27776303|NCT01831804|54229091|FG007|Overall Study|Protocol defined stopping criteria|0|||
27776304|NCT01831804|54229092|FG008|Overall Study|Protocol defined stopping criteria|0|||
27776305|NCT01831804|54229084|FG000|Overall Study|Lost to Follow-up|0|||
27776306|NCT01831804|54229085|FG001|Overall Study|Lost to Follow-up|0|||
27776307|NCT01831804|54229086|FG002|Overall Study|Lost to Follow-up|1|||
27776308|NCT01831804|54229087|FG003|Overall Study|Lost to Follow-up|0|||
27776309|NCT01831804|54229088|FG004|Overall Study|Lost to Follow-up|0|||
27776310|NCT01831804|54229089|FG005|Overall Study|Lost to Follow-up|0|||
27776311|NCT01831804|54229090|FG006|Overall Study|Lost to Follow-up|0|||
27776312|NCT01831804|54229091|FG007|Overall Study|Lost to Follow-up|0|||
27776313|NCT01831804|54229092|FG008|Overall Study|Lost to Follow-up|1|||
27776314|NCT01831804|54229084|FG000|Overall Study|Investigator discretion|0|||
27776315|NCT01831804|54229085|FG001|Overall Study|Investigator discretion|0|||
27776316|NCT01831804|54229086|FG002|Overall Study|Investigator discretion|0|||
27776317|NCT01831804|54229087|FG003|Overall Study|Investigator discretion|0|||
27776318|NCT01831804|54229088|FG004|Overall Study|Investigator discretion|1|||
27776319|NCT01831804|54229089|FG005|Overall Study|Investigator discretion|0|||
27776320|NCT01831804|54229090|FG006|Overall Study|Investigator discretion|0|||
27776321|NCT01831804|54229091|FG007|Overall Study|Investigator discretion|1|||
27776322|NCT01831804|54229092|FG008|Overall Study|Investigator discretion|0|||
27776323|NCT01831804|54229084|FG000|Overall Study|Withdrew Consent|0|||
27776324|NCT01831804|54229085|FG001|Overall Study|Withdrew Consent|1|||
27776325|NCT01831804|54229086|FG002|Overall Study|Withdrew Consent|0|||
27776326|NCT01831804|54229087|FG003|Overall Study|Withdrew Consent|0|||
27776327|NCT01831804|54229088|FG004|Overall Study|Withdrew Consent|0|||
27776328|NCT01831804|54229089|FG005|Overall Study|Withdrew Consent|0|||
27776329|NCT01831804|54229090|FG006|Overall Study|Withdrew Consent|0|||
27776330|NCT01831804|54229091|FG007|Overall Study|Withdrew Consent|2|||
27776331|NCT01831804|54229092|FG008|Overall Study|Withdrew Consent|0|||
27776332|NCT02270671|54229123|FG000|Overall Study|Withdrawal by Subject|1|||
27776333|NCT02270671|54229124|FG001|Overall Study|Withdrawal by Subject|1|||
27776334|NCT02270671|54229123|FG000|Overall Study|Protocol Violation|0|||
27776335|NCT02270671|54229124|FG001|Overall Study|Protocol Violation|1|||
27776336|NCT02270671|54229123|FG000|Overall Study|Missed Post-intervention Data Collection|2|||
27776337|NCT02270671|54229124|FG001|Overall Study|Missed Post-intervention Data Collection|2|||
27776338|NCT02270671|54229123|FG000|Overall Study|Lost to Follow-up|2|||
27776339|NCT02270671|54229124|FG001|Overall Study|Lost to Follow-up|1|||
27776340|NCT02324270|54229133|FG000|Overall Study|Withdrawal by Subject|0|||
27776341|NCT02324270|54229134|FG001|Overall Study|Withdrawal by Subject|1|||
27776342|NCT02324270|54229135|FG002|Overall Study|Withdrawal by Subject|0|||
27776343|NCT02324270|54229133|FG000|Overall Study|Lost to Follow-up|4|||
27776344|NCT02324270|54229134|FG001|Overall Study|Lost to Follow-up|3|||
27776345|NCT02324270|54229135|FG002|Overall Study|Lost to Follow-up|4|||
27776346|NCT02324270|54229133|FG000|Overall Study|Protocol Violation|0|||
27776347|NCT02324270|54229134|FG001|Overall Study|Protocol Violation|1|||
27776348|NCT02324270|54229135|FG002|Overall Study|Protocol Violation|1|||
27776349|NCT02324270|54229133|FG000|Overall Study|Non Compliance with Study Drug|1|||
27776350|NCT02324270|54229134|FG001|Overall Study|Non Compliance with Study Drug|2|||
27776351|NCT02324270|54229135|FG002|Overall Study|Non Compliance with Study Drug|0|||
27776352|NCT02270515|54229143|FG000|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1|||
27776353|NCT02270515|54229143|FG000|Intervention Period 1: 0-6 Months|No longer patient at study site|5|||
27776354|NCT02270515|54229143|FG000|Intervention Period 1: 0-6 Months|Received transplant|3|||
27776355|NCT02270515|54229143|FG000|Intervention Period 1: 0-6 Months|Death|7|||
27776356|NCT02270515|54229143|FG000|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2|||
27776357|NCT02270515|54229143|FG000|Intervention Period 2: 6-12 Months|No longer patient at study site|7|||
27776358|NCT02270515|54229143|FG000|Intervention Period 2: 6-12 Months|Received transplant|1|||
27776359|NCT02270515|54229143|FG000|Intervention Period 2: 6-12 Months|Death|5|||
27776360|NCT02270515|54229143|FG000|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17|||
27840306|NCT01466387|54327631|FG000|Overall Study|Lost to Follow-up|0|||
27776361|NCT02270515|54229143|FG000|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1|||
27776362|NCT02270515|54229143|FG000|Intervention Period 3: 12-18 Months|No longer patient at study site|2|||
27776363|NCT02270515|54229143|FG000|Intervention Period 3: 12-18 Months|Received transplant|2|||
27776364|NCT02270515|54229143|FG000|Intervention Period 3: 12-18 Months|Death|3|||
27776365|NCT02270515|54229143|FG000|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16|||
27776366|NCT02448875|54229157|FG000|Overall Study|Adverse Event|2|||
27776367|NCT02448875|54229158|FG001|Overall Study|Adverse Event|1|||
27776368|NCT02448875|54229159|FG002|Overall Study|Adverse Event|0|||
27776369|NCT02448875|54229157|FG000|Overall Study|Lost to Follow-up|1|||
27776370|NCT02448875|54229158|FG001|Overall Study|Lost to Follow-up|0|||
27776371|NCT02448875|54229159|FG002|Overall Study|Lost to Follow-up|0|||
27776372|NCT02448875|54229157|FG000|Overall Study|Investigator Decision|3|||
27776373|NCT02448875|54229158|FG001|Overall Study|Investigator Decision|0|||
27776374|NCT02448875|54229159|FG002|Overall Study|Investigator Decision|1|||
27776375|NCT02448875|54229157|FG000|Overall Study|Withdrawal by Subject|1|||
27776376|NCT02448875|54229158|FG001|Overall Study|Withdrawal by Subject|0|||
27776377|NCT02448875|54229159|FG002|Overall Study|Withdrawal by Subject|0|||
27776378|NCT01831726|54229170|FG000|Overall Study|Adverse Event|16|||
27776379|NCT01831726|54229170|FG000|Overall Study|Death|7|||
27776380|NCT01831726|54229170|FG000|Overall Study|Disease Progression|49|||
27776381|NCT01831726|54229170|FG000|Overall Study|Physician Decision|1|||
27776382|NCT01831726|54229170|FG000|Overall Study|Subject/guardian decision|7|||
27776383|NCT01831258|54229174|FG000|Overall Study|Withdrawal by Subject|2|||
27776384|NCT01831258|54229175|FG001|Overall Study|Withdrawal by Subject|1|||
27776385|NCT01831258|54229174|FG000|Overall Study|Lost to Follow-up|3|||
27776386|NCT01831258|54229175|FG001|Overall Study|Lost to Follow-up|2|||
27776387|NCT01849276|54229183|FG000|Followed for Survival for 5 Years|Death|1|||
27776388|NCT01849276|54229183|FG000|Followed for Survival for 5 Years|Early termination of the study|1|||
27776389|NCT02465489|54229187|FG000|Overall Study|Adverse Event|5|||
27776390|NCT01829464|54229202|FG000|Overall Study|Adverse Event|1|||
27776391|NCT01829464|54229203|FG001|Overall Study|Adverse Event|0|||
27776392|NCT01829464|54229204|FG002|Overall Study|Adverse Event|0|||
27776393|NCT01829464|54229202|FG000|Overall Study|Lost to Follow-up|0|||
27776394|NCT01829464|54229203|FG001|Overall Study|Lost to Follow-up|0|||
27776395|NCT01829464|54229204|FG002|Overall Study|Lost to Follow-up|1|||
27776396|NCT01829464|54229202|FG000|Overall Study|Withdrawal by Subject|2|||
27776397|NCT01829464|54229203|FG001|Overall Study|Withdrawal by Subject|0|||
27776398|NCT01829464|54229204|FG002|Overall Study|Withdrawal by Subject|0|||
27776399|NCT01829464|54229202|FG000|Overall Study|Study terminated by sponsor|25|||
27776400|NCT01829464|54229203|FG001|Overall Study|Study terminated by sponsor|28|||
27776401|NCT01829464|54229204|FG002|Overall Study|Study terminated by sponsor|25|||
27776402|NCT01829464|54229202|FG000|Overall Study|Lack of Efficacy|0|||
27776403|NCT01829464|54229203|FG001|Overall Study|Lack of Efficacy|1|||
27776404|NCT01829464|54229204|FG002|Overall Study|Lack of Efficacy|0|||
27776405|NCT01847092|54229214|FG000|Overall Study|Adverse Event|12|||
27776406|NCT01847092|54229215|FG001|Overall Study|Adverse Event|3|||
27776407|NCT01847092|54229214|FG000|Overall Study|Withdrawal by Subject|5|||
27776408|NCT01847092|54229215|FG001|Overall Study|Withdrawal by Subject|5|||
27776409|NCT01847092|54229214|FG000|Overall Study|Protocol Specified|8|||
27776410|NCT01847092|54229215|FG001|Overall Study|Protocol Specified|0|||
27776411|NCT01847092|54229214|FG000|Overall Study|Physician Decision|1|||
27776412|NCT01847092|54229215|FG001|Overall Study|Physician Decision|1|||
27776413|NCT01847092|54229214|FG000|Overall Study|Protocol Violation|0|||
27776414|NCT01847092|54229215|FG001|Overall Study|Protocol Violation|2|||
27776415|NCT01601821|54229223|FG000|Overall Study|Death|2|||
27776416|NCT01601821|54229224|FG001|Overall Study|Death|5|||
27776417|NCT01601821|54229223|FG000|Overall Study|Protocol Violation|2|||
27776418|NCT01601821|54229224|FG001|Overall Study|Protocol Violation|2|||
27776419|NCT01601821|54229223|FG000|Overall Study|Lost to Follow-up|6|||
27776420|NCT01601821|54229224|FG001|Overall Study|Lost to Follow-up|14|||
27776421|NCT01601821|54229223|FG000|Overall Study|Withdrawal by Subject|1|||
27776422|NCT01601821|54229224|FG001|Overall Study|Withdrawal by Subject|0|||
27776423|NCT01601821|54229223|FG000|Overall Study|Graft Loss|6|||
27776424|NCT01601821|54229224|FG001|Overall Study|Graft Loss|6|||
27776425|NCT01601821|54229223|FG000|Overall Study|Study Events|7|||
27776426|NCT01601821|54229224|FG001|Overall Study|Study Events|1|||
27776427|NCT01601821|54229223|FG000|Overall Study|Other|5|||
27776428|NCT01601821|54229224|FG001|Overall Study|Other|1|||
27776429|NCT02323646|54229233|FG000|Treatment Course 1|Adverse Event|1|||
27776430|NCT02323646|54229234|FG001|Treatment Course 1|Adverse Event|0|||
27776431|NCT02323646|54229235|FG002|Treatment Course 1|Adverse Event|1|||
27776432|NCT02323646|54229233|FG000|Treatment Course 1|Heavy Bleeding|1|||
27776433|NCT02323646|54229234|FG001|Treatment Course 1|Heavy Bleeding|1|||
27776434|NCT02323646|54229235|FG002|Treatment Course 1|Heavy Bleeding|0|||
27776435|NCT02323646|54229233|FG000|Treatment Course 1|Lost to Follow-up|1|||
27776436|NCT02323646|54229234|FG001|Treatment Course 1|Lost to Follow-up|0|||
27776437|NCT02323646|54229235|FG002|Treatment Course 1|Lost to Follow-up|2|||
27776438|NCT02323646|54229233|FG000|Treatment Course 1|Withdrawal by Subject|0|||
27776439|NCT02323646|54229234|FG001|Treatment Course 1|Withdrawal by Subject|2|||
27776440|NCT02323646|54229235|FG002|Treatment Course 1|Withdrawal by Subject|0|||
27776441|NCT02323646|54229233|FG000|Treatment Course 2|Adverse Event|1|||
27776442|NCT02323646|54229234|FG001|Treatment Course 2|Adverse Event|0|||
27776443|NCT02323646|54229235|FG002|Treatment Course 2|Adverse Event|1|||
27776444|NCT02323646|54229233|FG000|Treatment Course 2|Lost to Follow-up|0|||
27776445|NCT02323646|54229234|FG001|Treatment Course 2|Lost to Follow-up|0|||
27776446|NCT02323646|54229235|FG002|Treatment Course 2|Lost to Follow-up|1|||
27776447|NCT02323646|54229233|FG000|Treatment Course 2|Non-compliance|0|||
27776448|NCT02323646|54229234|FG001|Treatment Course 2|Non-compliance|1|||
27776449|NCT02323646|54229235|FG002|Treatment Course 2|Non-compliance|1|||
27776450|NCT01846624|54229243|FG000|Overall Study|Died during induction, no midostaurin|1|||
27776451|NCT01829230|54229249|FG000|Overall Study|Protocol Violation|0|||
27776452|NCT01829230|54229250|FG001|Overall Study|Protocol Violation|2|||
27776453|NCT01829230|54229249|FG000|Overall Study|Withdrawal by Subject|0|||
27776454|NCT01829230|54229250|FG001|Overall Study|Withdrawal by Subject|1|||
27776455|NCT01829230|54229249|FG000|Overall Study|Lost to Follow-up|1|||
27776456|NCT01829230|54229250|FG001|Overall Study|Lost to Follow-up|1|||
27776457|NCT02269657|54229256|FG000|Overall Study|Protocol Violation|3|||
27776458|NCT02269423|54229266|FG000|Overall Study|Discontinued due to change in residence|0|||
27776459|NCT02269423|54229267|FG001|Overall Study|Discontinued due to change in residence|1|||
27776460|NCT02269423|54229268|FG002|Overall Study|Discontinued due to change in residence|0|||
27776461|NCT02269423|54229269|FG003|Overall Study|Discontinued due to change in residence|1|||
27776462|NCT01827670|54229281|FG000|Overall Study|Withdrawal of Consent|3|||
27776463|NCT01827670|54229282|FG001|Overall Study|Withdrawal of Consent|2|||
27776464|NCT01827670|54229281|FG000|Overall Study|Lost to Follow-up|0|||
27776465|NCT01827670|54229282|FG001|Overall Study|Lost to Follow-up|1|||
27776466|NCT02267317|54229296|FG000|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1|||
27776467|NCT02267317|54229297|FG001|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
27776468|NCT02267317|54229298|FG002|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
27776469|NCT02267317|54229299|FG003|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
27776470|NCT02267317|54229300|FG004|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
27776471|NCT02267317|54229301|FG005|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
27776472|NCT02267317|54229296|FG000|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1|||
27776473|NCT02267317|54229297|FG001|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
27776474|NCT02267317|54229298|FG002|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
27776475|NCT02267317|54229299|FG003|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
27776476|NCT02267317|54229300|FG004|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
27776477|NCT02267317|54229301|FG005|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
27776478|NCT01844830|54229317|FG000|Overall Study|Withdrawal by Subject|1|||
27776479|NCT01844830|54229318|FG001|Overall Study|Withdrawal by Subject|0|||
27776480|NCT01827592|54229327|FG000|Overall Study|Adverse Event|11|||
27776481|NCT01827592|54229328|FG001|Overall Study|Adverse Event|9|||
27776482|NCT01827592|54229329|FG002|Overall Study|Adverse Event|2|||
27776483|NCT01827592|54229327|FG000|Overall Study|Physician Decision|0|||
27776484|NCT01827592|54229328|FG001|Overall Study|Physician Decision|2|||
27776485|NCT01827592|54229329|FG002|Overall Study|Physician Decision|1|||
27776486|NCT01827592|54229327|FG000|Overall Study|Protocol Violation|2|||
27776487|NCT01827592|54229328|FG001|Overall Study|Protocol Violation|1|||
27776488|NCT01827592|54229329|FG002|Overall Study|Protocol Violation|0|||
27776489|NCT01827592|54229327|FG000|Overall Study|Lost to Follow-up|1|||
27776490|NCT01827592|54229328|FG001|Overall Study|Lost to Follow-up|2|||
27776491|NCT01827592|54229329|FG002|Overall Study|Lost to Follow-up|2|||
27840307|NCT01466387|54327632|FG001|Overall Study|Lost to Follow-up|0|||
27840308|NCT01466387|54327633|FG002|Overall Study|Lost to Follow-up|0|||
27776492|NCT01827592|54229327|FG000|Overall Study|Withdrawal by Subject|12|||
27776493|NCT01827592|54229328|FG001|Overall Study|Withdrawal by Subject|11|||
27776494|NCT01827592|54229329|FG002|Overall Study|Withdrawal by Subject|11|||
27776495|NCT01827592|54229327|FG000|Overall Study|Patient's substantial non-compliance|1|||
27776496|NCT01827592|54229328|FG001|Overall Study|Patient's substantial non-compliance|1|||
27840309|NCT01466387|54327634|FG003|Overall Study|Lost to Follow-up|0|||
27840310|NCT01466387|54327635|FG004|Overall Study|Lost to Follow-up|0|||
27840311|NCT01466387|54327636|FG005|Overall Study|Lost to Follow-up|1|||
27840312|NCT01466387|54327631|FG000|Overall Study|Protocol Violation|1|||
27840313|NCT01466387|54327632|FG001|Overall Study|Protocol Violation|0|||
27840314|NCT01466387|54327633|FG002|Overall Study|Protocol Violation|0|||
27840315|NCT01466387|54327634|FG003|Overall Study|Protocol Violation|1|||
27840316|NCT01466387|54327635|FG004|Overall Study|Protocol Violation|0|||
27776497|NCT01827592|54229329|FG002|Overall Study|Patient's substantial non-compliance|6|||
27776498|NCT01827592|54229327|FG000|Overall Study|Trial terminated by Sponsor|47|||
27776499|NCT01827592|54229328|FG001|Overall Study|Trial terminated by Sponsor|53|||
27776500|NCT01827592|54229329|FG002|Overall Study|Trial terminated by Sponsor|51|||
27776501|NCT01827592|54229327|FG000|Overall Study|Others|0|||
27776502|NCT01827592|54229328|FG001|Overall Study|Others|1|||
27776503|NCT01827592|54229329|FG002|Overall Study|Others|3|||
27776504|NCT02323334|54229347|FG000|Period 3|Lost to Follow-up|0|||
27776505|NCT02323334|54229348|FG001|Period 3|Lost to Follow-up|0|||
27840317|NCT01466387|54327636|FG005|Overall Study|Protocol Violation|0|||
27776506|NCT02323334|54229349|FG002|Period 3|Lost to Follow-up|1|||
27776507|NCT02323334|54229350|FG003|Period 3|Lost to Follow-up|0|||
27776508|NCT02323334|54229351|FG004|Period 3|Lost to Follow-up|0|||
27776509|NCT02323334|54229352|FG005|Period 3|Lost to Follow-up|0|||
27776510|NCT02323334|54229353|FG006|Period 3|Lost to Follow-up|0|||
27776511|NCT02323334|54229354|FG007|Period 3|Lost to Follow-up|0|||
27776512|NCT02323334|54229355|FG008|Period 3|Lost to Follow-up|0|||
27776513|NCT02323334|54229356|FG009|Period 3|Lost to Follow-up|0|||
27776514|NCT02323334|54229357|FG010|Period 3|Lost to Follow-up|0|||
27776515|NCT02323334|54229358|FG011|Period 3|Lost to Follow-up|0|||
27776516|NCT02323334|54229359|FG012|Period 3|Lost to Follow-up|0|||
27776517|NCT02323334|54229360|FG013|Period 3|Lost to Follow-up|0|||
27776518|NCT02323334|54229361|FG014|Period 3|Lost to Follow-up|0|||
27776519|NCT02323334|54229362|FG015|Period 3|Lost to Follow-up|0|||
27776520|NCT02323334|54229363|FG016|Period 3|Lost to Follow-up|0|||
27776521|NCT02323334|54229347|FG000|Period 3|Withdrawal by Subject|1|||
27776522|NCT02323334|54229348|FG001|Period 3|Withdrawal by Subject|0|||
27776523|NCT02323334|54229349|FG002|Period 3|Withdrawal by Subject|0|||
27776524|NCT02323334|54229350|FG003|Period 3|Withdrawal by Subject|0|||
27776525|NCT02323334|54229351|FG004|Period 3|Withdrawal by Subject|0|||
27776526|NCT02323334|54229352|FG005|Period 3|Withdrawal by Subject|0|||
27776527|NCT02323334|54229353|FG006|Period 3|Withdrawal by Subject|0|||
27776528|NCT02323334|54229354|FG007|Period 3|Withdrawal by Subject|0|||
27776529|NCT02323334|54229355|FG008|Period 3|Withdrawal by Subject|0|||
27776530|NCT02323334|54229356|FG009|Period 3|Withdrawal by Subject|0|||
27776531|NCT02323334|54229357|FG010|Period 3|Withdrawal by Subject|0|||
27776532|NCT02323334|54229358|FG011|Period 3|Withdrawal by Subject|0|||
27776533|NCT02323334|54229359|FG012|Period 3|Withdrawal by Subject|0|||
27776534|NCT02323334|54229360|FG013|Period 3|Withdrawal by Subject|0|||
27776535|NCT02323334|54229361|FG014|Period 3|Withdrawal by Subject|0|||
27776536|NCT02323334|54229362|FG015|Period 3|Withdrawal by Subject|0|||
27776537|NCT02323334|54229363|FG016|Period 3|Withdrawal by Subject|0|||
27776538|NCT02448719|54229436|FG000|Overall Study|Withdrawal by Subject|0|||
27776539|NCT02448719|54229437|FG001|Overall Study|Withdrawal by Subject|0|||
27776540|NCT02448719|54229438|FG002|Overall Study|Withdrawal by Subject|0|||
27776541|NCT02448719|54229439|FG003|Overall Study|Withdrawal by Subject|0|||
27776542|NCT02448719|54229440|FG004|Overall Study|Withdrawal by Subject|1|||
27776543|NCT02448719|54229441|FG005|Overall Study|Withdrawal by Subject|0|||
27776544|NCT02448719|54229442|FG006|Overall Study|Withdrawal by Subject|0|||
27776545|NCT02448719|54229443|FG007|Overall Study|Withdrawal by Subject|0|||
27776546|NCT02448719|54229444|FG008|Overall Study|Withdrawal by Subject|0|||
27776547|NCT02448719|54229445|FG009|Overall Study|Withdrawal by Subject|0|||
27776548|NCT02448719|54229446|FG010|Overall Study|Withdrawal by Subject|0|||
27776549|NCT02322866|54229509|FG000|Overall Study|Adverse Event|6|||
27776550|NCT02322866|54229510|FG001|Overall Study|Adverse Event|11|||
27776551|NCT02322866|54229509|FG000|Overall Study|Withdrawal of Consent|16|||
27776552|NCT02322866|54229510|FG001|Overall Study|Withdrawal of Consent|25|||
27776553|NCT02322866|54229509|FG000|Overall Study|Lost to Follow-up|36|||
27776554|NCT02322866|54229510|FG001|Overall Study|Lost to Follow-up|39|||
27776555|NCT02322866|54229509|FG000|Overall Study|Protocol Violation|1|||
27776556|NCT02322866|54229510|FG001|Overall Study|Protocol Violation|0|||
27776557|NCT02322866|54229509|FG000|Overall Study|Noncompliance with Treatment|3|||
27776558|NCT02322866|54229510|FG001|Overall Study|Noncompliance with Treatment|4|||
27776559|NCT02322866|54229509|FG000|Overall Study|Lack of Efficacy|3|||
27776560|NCT02322866|54229510|FG001|Overall Study|Lack of Efficacy|1|||
27776561|NCT02322866|54229509|FG000|Overall Study|Other Miscellaneous Reasons|6|||
27776562|NCT02322866|54229510|FG001|Overall Study|Other Miscellaneous Reasons|6|||
27776563|NCT01640353|54229516|FG000|Overall Study|Withdrew prior to treatment|10|||
27776564|NCT01640353|54229516|FG000|Overall Study|Withdrawn from analysis at term site|12|||
27776565|NCT01640353|54229516|FG000|Overall Study|Withdrawal by Subject|5|||
27776566|NCT01640353|54229516|FG000|Overall Study|Death|2|||
27776567|NCT01640353|54229516|FG000|Overall Study|Early site termination|3|||
27776568|NCT01640353|54229516|FG000|Overall Study|Lost to Follow-up|12|||
27776569|NCT01640353|54229516|FG000|Overall Study|Physician Decision|1|||
27840318|NCT01564784|54327767|FG000|Overall Study|Other|1|||
27840319|NCT01564784|54327768|FG001|Overall Study|Other|0|||
27776570|NCT02463071|54229523|FG000|Overall Study|Adverse Event|3|||
27776571|NCT02463071|54229524|FG001|Overall Study|Adverse Event|5|||
27776572|NCT02463071|54229525|FG002|Overall Study|Adverse Event|1|||
27776573|NCT02463071|54229523|FG000|Overall Study|Death|1|||
27840320|NCT01564784|54327767|FG000|Overall Study|Subject refused further follow-up|1|||
27776574|NCT02463071|54229524|FG001|Overall Study|Death|0|||
27776575|NCT02463071|54229525|FG002|Overall Study|Death|0|||
27776576|NCT02463071|54229523|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
27840321|NCT01564784|54327768|FG001|Overall Study|Subject refused further follow-up|6|||
27776577|NCT02463071|54229524|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
27776578|NCT02463071|54229525|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
27776579|NCT02463071|54229523|FG000|Overall Study|Reason not specified|7|||
27840322|NCT01564784|54327767|FG000|Overall Study|Lost to Follow-up|1|||
27776580|NCT02463071|54229524|FG001|Overall Study|Reason not specified|9|||
27776581|NCT02463071|54229525|FG002|Overall Study|Reason not specified|4|||
27776582|NCT02463071|54229523|FG000|Overall Study|Protocol Violation|0|||
27776583|NCT02463071|54229524|FG001|Overall Study|Protocol Violation|2|||
27776584|NCT02463071|54229525|FG002|Overall Study|Protocol Violation|0|||
27776585|NCT02463071|54229523|FG000|Overall Study|Lost to Follow-up|0|||
27776586|NCT02463071|54229524|FG001|Overall Study|Lost to Follow-up|0|||
27776587|NCT02463071|54229525|FG002|Overall Study|Lost to Follow-up|1|||
27776588|NCT02266381|54229536|FG000|Overall Study|Physician Decision|3|||
27776589|NCT02266381|54229537|FG001|Overall Study|Physician Decision|5|||
27776590|NCT02266381|54229538|FG002|Overall Study|Physician Decision|4|||
27776591|NCT01827046|54229550|FG000|Overall Study|Lost to Follow-up|1|||
27776592|NCT01827046|54229551|FG001|Overall Study|Lost to Follow-up|5|||
27776593|NCT01827046|54229550|FG000|Overall Study|Withdrawal by Subject|0|||
27776594|NCT01827046|54229551|FG001|Overall Study|Withdrawal by Subject|4|||
27776595|NCT02356562|54229559|FG000|Overall Study|Withdrawal by Subject|0|||
27776596|NCT02356562|54229560|FG001|Overall Study|Withdrawal by Subject|1|||
27776597|NCT02356562|54229559|FG000|Overall Study|Re-entered treatment in a previous study|1|||
27776598|NCT02356562|54229560|FG001|Overall Study|Re-entered treatment in a previous study|0|||
27776599|NCT02356562|54229559|FG000|Overall Study|site closure|1|||
27776600|NCT02356562|54229560|FG001|Overall Study|site closure|0|||
27776601|NCT02448563|54229571|FG000|Overall Study|Lost to Follow-up|16|||
27776602|NCT02448563|54229572|FG001|Overall Study|Lost to Follow-up|10|||
27776603|NCT02448563|54229571|FG000|Overall Study|Withdrawal by Subject|0|||
27776604|NCT02448563|54229572|FG001|Overall Study|Withdrawal by Subject|1|||
27776605|NCT02266225|54229582|FG000|Overall Study|Lost to Follow-up|2|||
27776606|NCT02266225|54229582|FG000|Overall Study|Death|1|||
27776607|NCT02266225|54229582|FG000|Overall Study|Withdrawal by Subject|13|||
27776608|NCT02354690|54229587|FG000|Overall Study|Physician Decision|1|||
27776609|NCT02354222|54229593|FG000|Overall Study|Adverse Event|0|||
27776610|NCT02354222|54229594|FG001|Overall Study|Adverse Event|3|||
27776611|NCT02354222|54229593|FG000|Overall Study|Physician Decision|1|||
27776612|NCT02354222|54229594|FG001|Overall Study|Physician Decision|1|||
27776613|NCT02354222|54229593|FG000|Overall Study|Pregnancy|1|||
27776614|NCT02354222|54229594|FG001|Overall Study|Pregnancy|0|||
27776615|NCT02354222|54229593|FG000|Overall Study|Withdrawal by Subject|2|||
27776616|NCT02354222|54229594|FG001|Overall Study|Withdrawal by Subject|3|||
27776617|NCT02354222|54229593|FG000|Overall Study|Conflict with the stopping criteria|0|||
27776618|NCT02354222|54229594|FG001|Overall Study|Conflict with the stopping criteria|4|||
27776619|NCT02353442|54229602|FG000|Overall Study|Withdrawal by Subject|3|||
27776620|NCT02353442|54229603|FG001|Overall Study|Withdrawal by Subject|4|||
27776621|NCT02351960|54229611|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
27776622|NCT02351960|54229612|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
27776623|NCT02351960|54229611|FG000|Overall Study|Voluntary Withdrawal|5|||
27776624|NCT02351960|54229612|FG001|Overall Study|Voluntary Withdrawal|4|||
27776625|NCT02351960|54229611|FG000|Overall Study|Significant Protocol Deviation|0|||
27776626|NCT02351960|54229612|FG001|Overall Study|Significant Protocol Deviation|5|||
27776627|NCT02351180|54229621|FG000|Overall Study|Withdrawal by Subject|1|||
27776628|NCT02351180|54229622|FG001|Overall Study|Withdrawal by Subject|0|||
27776629|NCT02350478|54229630|FG000|Overall Study|Lost to Follow-up|5|||
27776630|NCT02350478|54229631|FG001|Overall Study|Lost to Follow-up|1|||
27776631|NCT02349542|54229637|FG000|Overall Study|Withdrawal by Subject|5|||
27776632|NCT02321930|54229641|FG000|Overall Study|Lost to Follow-up|1|||
27776633|NCT01647542|54229648|FG000|Overall Study|Major Protocol Deviation|1|||
27776634|NCT01647542|54229649|FG001|Overall Study|Major Protocol Deviation|0|||
27776635|NCT01647542|54229650|FG002|Overall Study|Major Protocol Deviation|0|||
27776636|NCT01647542|54229648|FG000|Overall Study|Adverse Event|4|||
27776637|NCT01647542|54229649|FG001|Overall Study|Adverse Event|5|||
27776638|NCT01647542|54229650|FG002|Overall Study|Adverse Event|4|||
27776639|NCT01647542|54229648|FG000|Overall Study|Lost to Follow-up|0|||
27776640|NCT01647542|54229649|FG001|Overall Study|Lost to Follow-up|2|||
27776641|NCT01647542|54229650|FG002|Overall Study|Lost to Follow-up|2|||
27776642|NCT01647542|54229648|FG000|Overall Study|Withdrawal by Subject|6|||
27776643|NCT01647542|54229649|FG001|Overall Study|Withdrawal by Subject|4|||
27776644|NCT01647542|54229650|FG002|Overall Study|Withdrawal by Subject|0|||
27776645|NCT01647542|54229648|FG000|Overall Study|Study Termination|64|||
27776646|NCT01647542|54229649|FG001|Overall Study|Study Termination|61|||
27776647|NCT01647542|54229650|FG002|Overall Study|Study Termination|65|||
27776648|NCT01647542|54229648|FG000|Overall Study|Lack of Efficacy|1|||
27776649|NCT01647542|54229649|FG001|Overall Study|Lack of Efficacy|1|||
27776650|NCT01647542|54229650|FG002|Overall Study|Lack of Efficacy|0|||
27776651|NCT01647542|54229648|FG000|Overall Study|Death|0|||
27776652|NCT01647542|54229649|FG001|Overall Study|Death|0|||
27776653|NCT01647542|54229650|FG002|Overall Study|Death|1|||
27776654|NCT02321462|54229660|FG000|Overall Study|Withdrawal by Subject|5|||
27776655|NCT02321462|54229661|FG001|Overall Study|Withdrawal by Subject|2|||
27776656|NCT02321462|54229660|FG000|Overall Study|Subject withdrawn before any treatment|1|||
27776657|NCT02321462|54229661|FG001|Overall Study|Subject withdrawn before any treatment|1|||
27776658|NCT02391584|54229670|FG000|Primary Endpoint (6-weeks)|Lost to Follow-up|1|||
27776659|NCT02391584|54229671|FG001|Primary Endpoint (6-weeks)|Lost to Follow-up|2|||
27776660|NCT02391584|54229670|FG000|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1|||
27776661|NCT02391584|54229671|FG001|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0|||
27776662|NCT02391584|54229670|FG000|3 Month|Lost to Follow-up|1|||
27776663|NCT02391584|54229671|FG001|3 Month|Lost to Follow-up|0|||
27776664|NCT02391584|54229670|FG000|6 Month|Withdrawal by Subject|1|||
27776665|NCT02391584|54229671|FG001|6 Month|Withdrawal by Subject|0|||
27776666|NCT02391584|54229670|FG000|12 Month (End of Study)|Lost to Follow-up|2|||
27776667|NCT02391584|54229671|FG001|12 Month (End of Study)|Lost to Follow-up|0|||
27776668|NCT02266147|54229684|FG000|PART 1: Dose Escalation|Physician Decision|0|||
27776669|NCT02266147|54229685|FG001|PART 1: Dose Escalation|Physician Decision|0|||
27776670|NCT02266147|54229686|FG002|PART 1: Dose Escalation|Physician Decision|1|||
27776671|NCT02266147|54229687|FG003|PART 1: Dose Escalation|Physician Decision|0|||
27776672|NCT02266147|54229684|FG000|PART 1: Dose Escalation|Lack of Efficacy|0|||
27776673|NCT02266147|54229685|FG001|PART 1: Dose Escalation|Lack of Efficacy|2|||
27776674|NCT02266147|54229686|FG002|PART 1: Dose Escalation|Lack of Efficacy|1|||
27776675|NCT02266147|54229687|FG003|PART 1: Dose Escalation|Lack of Efficacy|1|||
27776676|NCT02266147|54229684|FG000|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
27776677|NCT02266147|54229685|FG001|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
27776678|NCT02266147|54229686|FG002|PART 1: Dose Escalation|Study Terminated by Sponsor|1|||
27776679|NCT02266147|54229687|FG003|PART 1: Dose Escalation|Study Terminated by Sponsor|3|||
27776680|NCT02266147|54229684|FG000|PART 1: Dose Escalation|Other|1|||
27776681|NCT02266147|54229685|FG001|PART 1: Dose Escalation|Other|1|||
27776682|NCT02266147|54229686|FG002|PART 1: Dose Escalation|Other|0|||
27776683|NCT02266147|54229687|FG003|PART 1: Dose Escalation|Other|0|||
27776684|NCT02266147|54229684|FG000|PART 2: Dose Expansion|Lack of Efficacy|1|||
27776685|NCT02266147|54229685|FG001|PART 2: Dose Expansion|Lack of Efficacy|0|||
27776686|NCT02266147|54229686|FG002|PART 2: Dose Expansion|Lack of Efficacy|0|||
27776687|NCT02266147|54229687|FG003|PART 2: Dose Expansion|Lack of Efficacy|1|||
27776688|NCT02266147|54229684|FG000|PART 2: Dose Expansion|Study Terminated by Sponsor|6|||
27776689|NCT02266147|54229685|FG001|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
27776690|NCT02266147|54229686|FG002|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
27776691|NCT02266147|54229687|FG003|PART 2: Dose Expansion|Study Terminated by Sponsor|8|||
27776692|NCT02264977|54229699|FG000|Overall Study|Death|3|||
27776693|NCT02264977|54229699|FG000|Overall Study|Physician Decision|1|||
27776694|NCT02264977|54229699|FG000|Overall Study|Refuse to return|1|||
27776695|NCT02264821|54229706|FG000|Overall Study|Protocol Violation|1|||
27776696|NCT02264821|54229707|FG001|Overall Study|Protocol Violation|3|||
27776697|NCT02264821|54229708|FG002|Overall Study|Protocol Violation|6|||
27776698|NCT02261467|54229718|FG000|Overall Study|Enrolled in Error|1|||
27776699|NCT02261467|54229719|FG001|Overall Study|Enrolled in Error|0|||
27776700|NCT02261467|54229718|FG000|Overall Study|Protocol Violation|0|||
27776701|NCT02261467|54229719|FG001|Overall Study|Protocol Violation|1|||
27776702|NCT02261467|54229718|FG000|Overall Study|Personal Reasons|17|||
27776703|NCT02261467|54229719|FG001|Overall Study|Personal Reasons|22|||
27776704|NCT02261467|54229718|FG000|Overall Study|Lost to Follow-up|2|||
27776705|NCT02261467|54229719|FG001|Overall Study|Lost to Follow-up|13|||
27776706|NCT02261467|54229718|FG000|Overall Study|Adverse Event|1|||
27776707|NCT02261467|54229719|FG001|Overall Study|Adverse Event|1|||
27776708|NCT01643473|54229727|FG000|Overall Study|Lost to Follow-up|1|||
27776709|NCT01643473|54229728|FG001|Overall Study|Lost to Follow-up|0|||
27776710|NCT02258659|54229734|FG000|Overall Study|Withdrawal by Subject|1|||
27776711|NCT02320058|54229740|FG000|Overall Study|Death|25|||
27776712|NCT02320058|54229741|FG001|Overall Study|Death|10|||
27776713|NCT02320058|54229740|FG000|Overall Study|Lost to Follow-up|4|||
27776714|NCT02320058|54229741|FG001|Overall Study|Lost to Follow-up|0|||
27776715|NCT02320058|54229740|FG000|Overall Study|Other reasons|4|||
27776716|NCT02320058|54229741|FG001|Overall Study|Other reasons|1|||
27776717|NCT02320058|54229740|FG000|Overall Study|Withdrawal by Subject|8|||
27776718|NCT02320058|54229741|FG001|Overall Study|Withdrawal by Subject|2|||
27776719|NCT02320058|54229740|FG000|Overall Study|Not reported|1|||
27840323|NCT01564784|54327768|FG001|Overall Study|Lost to Follow-up|1|||
27840324|NCT01564784|54327767|FG000|Overall Study|Death|131|||
27776720|NCT02320058|54229741|FG001|Overall Study|Not reported|0|||
27776721|NCT02319668|54229749|FG000|Overall Study|Other (Not specified)|0|||
27776722|NCT02319668|54229750|FG001|Overall Study|Other (Not specified)|2|||
27776723|NCT02092467|54229762|FG000|Overall Study|Death|49|||
27776724|NCT02092467|54229763|FG001|Overall Study|Death|66|||
27776725|NCT02092467|54229764|FG002|Overall Study|Death|38|||
27776726|NCT02092467|54229762|FG000|Overall Study|Lost to Follow-up|38|||
27776727|NCT02092467|54229763|FG001|Overall Study|Lost to Follow-up|35|||
27776728|NCT02092467|54229764|FG002|Overall Study|Lost to Follow-up|40|||
27776729|NCT02092467|54229762|FG000|Overall Study|Global Deterioration of Health Status|1|||
27776730|NCT02092467|54229763|FG001|Overall Study|Global Deterioration of Health Status|0|||
27776731|NCT02092467|54229764|FG002|Overall Study|Global Deterioration of Health Status|0|||
27840325|NCT01564784|54327768|FG001|Overall Study|Death|126|||
27776732|NCT02092467|54229762|FG000|Overall Study|Other|32|||
27776733|NCT02092467|54229763|FG001|Overall Study|Other|30|||
27776734|NCT02092467|54229764|FG002|Overall Study|Other|24|||
27776735|NCT02092467|54229762|FG000|Overall Study|Withdrawal by Subject|282|||
27776736|NCT02092467|54229763|FG001|Overall Study|Withdrawal by Subject|327|||
27840326|NCT01564394|54327819|FG000|Overall Study|Withdrawal by Subject|6|||
27840327|NCT01564394|54327820|FG001|Overall Study|Withdrawal by Subject|10|||
27840328|NCT01690988|54327834|FG000|Overall Study|Withdrawal by Subject|2|||
27840329|NCT01690988|54327835|FG001|Overall Study|Withdrawal by Subject|2|||
27840330|NCT01690988|54327836|FG002|Overall Study|Withdrawal by Subject|3|||
27840331|NCT01690988|54327834|FG000|Overall Study|Physician Decision|0|||
27840332|NCT01690988|54327835|FG001|Overall Study|Physician Decision|0|||
27840333|NCT01690988|54327836|FG002|Overall Study|Physician Decision|1|||
27840334|NCT01690988|54327834|FG000|Overall Study|Operation Cancelled|1|||
27840335|NCT01690988|54327835|FG001|Overall Study|Operation Cancelled|1|||
27840336|NCT01690988|54327836|FG002|Overall Study|Operation Cancelled|0|||
27840337|NCT01690988|54327834|FG000|Overall Study|Determined ineligible|1|||
27840338|NCT01690988|54327835|FG001|Overall Study|Determined ineligible|0|||
27840339|NCT01690988|54327836|FG002|Overall Study|Determined ineligible|0|||
27840340|NCT01690988|54327834|FG000|Overall Study|Death|1|||
27840341|NCT01690988|54327835|FG001|Overall Study|Death|1|||
27840342|NCT01690988|54327836|FG002|Overall Study|Death|1|||
27840343|NCT01690988|54327834|FG000|Overall Study|Sedated|1|||
27840344|NCT01690988|54327835|FG001|Overall Study|Sedated|1|||
27840345|NCT01690988|54327836|FG002|Overall Study|Sedated|2|||
27840346|NCT01466153|54327867|FG000|Overall Study|Disease Progression|2|||
27840347|NCT01466153|54327868|FG001|Overall Study|Disease Progression|2|||
27840348|NCT01466153|54327869|FG002|Overall Study|Disease Progression|0|||
27840349|NCT01466153|54327867|FG000|Overall Study|Adverse Event|14|||
27840350|NCT01466153|54327868|FG001|Overall Study|Adverse Event|13|||
27840351|NCT01466153|54327869|FG002|Overall Study|Adverse Event|17|||
27840352|NCT01466153|54327867|FG000|Overall Study|Withdrawal of Consent|2|||
27840353|NCT01466153|54327868|FG001|Overall Study|Withdrawal of Consent|0|||
27840354|NCT01466153|54327869|FG002|Overall Study|Withdrawal of Consent|0|||
27840355|NCT01466153|54327867|FG000|Overall Study|Investigator Discretion|3|||
27840356|NCT01466153|54327868|FG001|Overall Study|Investigator Discretion|2|||
27840357|NCT01466153|54327869|FG002|Overall Study|Investigator Discretion|2|||
27840358|NCT01466153|54327867|FG000|Overall Study|Randomized-Not Treated|2|||
27840359|NCT01466153|54327868|FG001|Overall Study|Randomized-Not Treated|3|||
27840360|NCT01466153|54327869|FG002|Overall Study|Randomized-Not Treated|4|||
27840361|NCT01466153|54327867|FG000|Overall Study|Other-Unspecified|6|||
27840362|NCT01466153|54327868|FG001|Overall Study|Other-Unspecified|4|||
27840363|NCT01466153|54327869|FG002|Overall Study|Other-Unspecified|2|||
27840364|NCT01474291|54327890|FG000|Overall Study|Not Evaluable for Efficacy|26|||
27840365|NCT01474291|54327890|FG000|Overall Study|Lack of Treatment Efficacy|88|||
27840366|NCT01474291|54327890|FG000|Overall Study|Adverse Event|53|||
27840367|NCT01474291|54327890|FG000|Overall Study|Lost to Follow-up|29|||
27840368|NCT01474291|54327890|FG000|Overall Study|Patient No Longer Wanted to Participate|12|||
27840369|NCT01474291|54327890|FG000|Overall Study|No Reason Reported|10|||
27840370|NCT01474291|54327890|FG000|Overall Study|Death|2|||
27840371|NCT01465997|54327899|FG000|Overall Study|Adverse Event|12|||
27840372|NCT01465997|54327900|FG001|Overall Study|Adverse Event|22|||
27840373|NCT01465997|54327899|FG000|Overall Study|Lack of Efficacy|13|||
27840374|NCT01465997|54327900|FG001|Overall Study|Lack of Efficacy|1|||
27840375|NCT01465997|54327899|FG000|Overall Study|Protocol Violation|1|||
27840376|NCT01465997|54327900|FG001|Overall Study|Protocol Violation|4|||
27840377|NCT01465997|54327899|FG000|Overall Study|Lost to Follow-up|6|||
27840378|NCT01465997|54327900|FG001|Overall Study|Lost to Follow-up|9|||
27840379|NCT01465997|54327899|FG000|Overall Study|Withdrawal by Subject|32|||
27840380|NCT01465997|54327900|FG001|Overall Study|Withdrawal by Subject|35|||
27840381|NCT01465997|54327899|FG000|Overall Study|investigator's decision|1|||
27840382|NCT01465997|54327900|FG001|Overall Study|investigator's decision|1|||
27840383|NCT01465997|54327899|FG000|Overall Study|Death|0|||
27840384|NCT01465997|54327900|FG001|Overall Study|Death|1|||
27840385|NCT01465997|54327899|FG000|Overall Study|sponsor's decision|1|||
27840386|NCT01465997|54327900|FG001|Overall Study|sponsor's decision|1|||
27840387|NCT01465997|54327899|FG000|Overall Study|subject withdrew consent|1|||
27840388|NCT01465997|54327900|FG001|Overall Study|subject withdrew consent|0|||
27840389|NCT01465997|54327899|FG000|Overall Study|local lab unblinded site|1|||
27840390|NCT01465997|54327900|FG001|Overall Study|local lab unblinded site|0|||
27840391|NCT01465997|54327899|FG000|Overall Study|withdrew before follow-up|0|||
27840392|NCT01465997|54327900|FG001|Overall Study|withdrew before follow-up|13|||
27840393|NCT01465997|54327899|FG000|Overall Study|decision by site staff|0|||
27840394|NCT01465997|54327900|FG001|Overall Study|decision by site staff|1|||
27840395|NCT01465997|54327899|FG000|Overall Study|subject left participation SP0993|0|||
27840396|NCT01465997|54327900|FG001|Overall Study|subject left participation SP0993|1|||
27840397|NCT01465763|54327921|FG000|Overall Study|Withdrawal by Subject|4|||
27840398|NCT01465763|54327922|FG001|Overall Study|Withdrawal by Subject|0|||
27840399|NCT01465763|54327923|FG002|Overall Study|Withdrawal by Subject|1|||
27840400|NCT01465763|54327921|FG000|Overall Study|Insufficient Clinical Response|11|||
27840401|NCT01465763|54327922|FG001|Overall Study|Insufficient Clinical Response|0|||
27840402|NCT01465763|54327923|FG002|Overall Study|Insufficient Clinical Response|1|||
27840403|NCT01465763|54327921|FG000|Overall Study|Adverse Event|9|||
27840404|NCT01465763|54327922|FG001|Overall Study|Adverse Event|0|||
27840405|NCT01465763|54327923|FG002|Overall Study|Adverse Event|1|||
27840406|NCT01465763|54327921|FG000|Overall Study|Other|2|||
27840407|NCT01465763|54327922|FG001|Overall Study|Other|0|||
27840408|NCT01465763|54327923|FG002|Overall Study|Other|0|||
27776737|NCT02092467|54229764|FG002|Overall Study|Withdrawal by Subject|289|||
27776738|NCT02092467|54229762|FG000|Overall Study|Randomized but not treated|2|||
27776739|NCT02092467|54229763|FG001|Overall Study|Randomized but not treated|1|||
27776740|NCT02092467|54229764|FG002|Overall Study|Randomized but not treated|7|||
27840409|NCT01465763|54327921|FG000|Overall Study|Protocol Violation|4|||
27840410|NCT01465763|54327922|FG001|Overall Study|Protocol Violation|1|||
27840411|NCT01465763|54327923|FG002|Overall Study|Protocol Violation|1|||
27840412|NCT01465763|54327921|FG000|Overall Study|Death|1|||
27840413|NCT01465763|54327922|FG001|Overall Study|Death|0|||
27840414|NCT01465763|54327923|FG002|Overall Study|Death|0|||
27840415|NCT01690520|54327956|FG000|Overall Study|Death|25|||
27840416|NCT01690520|54327957|FG001|Overall Study|Death|21|||
27840417|NCT01690520|54327956|FG000|Overall Study|Lost to Follow-up|2|||
27840418|NCT01690520|54327957|FG001|Overall Study|Lost to Follow-up|3|||
27840419|NCT01690520|54327956|FG000|Overall Study|Withdrawal by Subject|2|||
27840420|NCT01690520|54327957|FG001|Overall Study|Withdrawal by Subject|0|||
27840421|NCT01690520|54327956|FG000|Overall Study|Relapse|0|||
27840422|NCT01690520|54327957|FG001|Overall Study|Relapse|1|||
27840423|NCT01690520|54327956|FG000|Overall Study|Other|0|||
27840424|NCT01690520|54327957|FG001|Overall Study|Other|1|||
27840425|NCT01690520|54327956|FG000|Overall Study|Ongoing Follow-Up at time of Analysis|22|||
27840426|NCT01690520|54327957|FG001|Overall Study|Ongoing Follow-Up at time of Analysis|21|||
27840427|NCT01563536|54327978|FG000|Overall Study|Withdrawal by Subject|0|||
27840428|NCT01563536|54327979|FG001|Overall Study|Withdrawal by Subject|2|||
27840429|NCT01563536|54327978|FG000|Overall Study|Lost to Follow-up|1|||
27776741|NCT02462759|54229776|FG000|Part 1: Double Blind|Death|1|||
27776742|NCT02462759|54229777|FG001|Part 1: Double Blind|Death|0|||
27776743|NCT02462759|54229778|FG002|Part 1: Double Blind|Death|0|||
27776744|NCT02349386|54229793|FG000|24-Week Double-Blind Main Study|Adverse Event|0|||
27776745|NCT02349386|54229794|FG001|24-Week Double-Blind Main Study|Adverse Event|0|||
27776746|NCT02349386|54229795|FG002|24-Week Double-Blind Main Study|Adverse Event|1|||
27776747|NCT02349386|54229796|FG003|24-Week Double-Blind Main Study|Adverse Event|1|||
27776748|NCT02349386|54229793|FG000|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
27776749|NCT02349386|54229794|FG001|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
27776750|NCT02349386|54229795|FG002|24-Week Double-Blind Main Study|Lack of Efficacy|2|||
27776751|NCT02349386|54229796|FG003|24-Week Double-Blind Main Study|Lack of Efficacy|7|||
27776752|NCT02349386|54229793|FG000|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
27776753|NCT02349386|54229794|FG001|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
27776754|NCT02349386|54229795|FG002|24-Week Double-Blind Main Study|Withdrawal by Subject|1|||
27776755|NCT02349386|54229796|FG003|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
27776756|NCT02349386|54229793|FG000|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
27776757|NCT02349386|54229794|FG001|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
27776758|NCT02349386|54229795|FG002|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|1|||
27776759|NCT02349386|54229796|FG003|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
27776760|NCT02349386|54229793|FG000|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
27776761|NCT02349386|54229794|FG001|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
27776762|NCT02349386|54229795|FG002|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
27776763|NCT02349386|54229796|FG003|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
27776764|NCT02349386|54229793|FG000|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
27776765|NCT02349386|54229794|FG001|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
27776766|NCT02349386|54229795|FG002|28-Week Double-Blind Optional Extension|Withdrawal by Subject|1|||
27776767|NCT02349386|54229796|FG003|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
27776768|NCT02036775|54229806|FG000|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
27776769|NCT02036775|54229807|FG001|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
27776770|NCT02036775|54229808|FG002|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
27776771|NCT02036775|54229809|FG003|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
27776772|NCT02036775|54229810|FG004|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
27840430|NCT01563536|54327979|FG001|Overall Study|Lost to Follow-up|0|||
27840431|NCT01690130|54327987|FG000|Overall Study|Subject have cancelled visit.|1|||
27840432|NCT01690130|54327988|FG001|Overall Study|Subject have cancelled visit.|0|||
27840433|NCT01690052|54327994|FG000|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1|||
27840434|NCT01690052|54327995|FG001|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2|||
27776773|NCT02036775|54229811|FG005|Treatment Period 2 (6 Days)|Withdrawal by Subject|1|||
27776774|NCT02092389|54229819|FG000|Overall Study|Adverse Event|1|||
27776775|NCT02092389|54229819|FG000|Overall Study|Other|5|||
27776776|NCT02034591|54229823|FG000|Overall Study|Withdrawal by Subject|0|||
27776777|NCT02034591|54229824|FG001|Overall Study|Withdrawal by Subject|0|||
27776778|NCT02034591|54229825|FG002|Overall Study|Withdrawal by Subject|0|||
27776779|NCT02034591|54229826|FG003|Overall Study|Withdrawal by Subject|0|||
27776780|NCT02034591|54229827|FG004|Overall Study|Withdrawal by Subject|1|||
27776781|NCT02034591|54229828|FG005|Overall Study|Withdrawal by Subject|0|||
27776782|NCT02391116|54229837|FG000|Treatment|Withdrawal by Subject|1|||
27776783|NCT02391116|54229837|FG000|Treatment|Protocol Violation|1|||
27776784|NCT02391116|54229837|FG000|Treatment|Adverse Event (AE) Without Clinical PD|9|||
27776785|NCT02391116|54229837|FG000|Treatment|AE with Clinical PD|3|||
27776786|NCT02391116|54229837|FG000|Safety Follow-up|Adverse Event|1|||
27776787|NCT02391116|54229837|FG000|Safety Follow-up|Withdrawal by Subject|4|||
27776788|NCT02391116|54229837|FG000|Safety Follow-up|Switching to Other Therapy|4|||
27776789|NCT02391116|54229837|FG000|Safety Follow-up|No Follow Up|1|||
27776790|NCT02391116|54229837|FG000|Safety Follow-up|Deterioration of General Conditions|3|||
27776791|NCT02391116|54229837|FG000|Active Follow-up|Withdrawal by Subject|1|||
27776792|NCT02391116|54229837|FG000|Active Follow-up|Switching to Other Therapy|2|||
27776793|NCT02391116|54229837|FG000|Survival Follow-up|Withdrawal by Subject|3|||
27776794|NCT02391116|54229837|FG000|Survival Follow-up|Switching to Other Therapy|1|||
27776795|NCT02091921|54229848|FG000|Overall Study|Adverse Event|3|||
27776796|NCT02447081|54229855|FG000|Overall Study|Death|161|||
27776797|NCT02447081|54229855|FG000|Overall Study|Lost to Follow-up|36|||
27776798|NCT02447081|54229855|FG000|Overall Study|Visit not completed|17|||
27776799|NCT02447081|54229855|FG000|Overall Study|unsuccessful implant procedure|10|||
27776800|NCT02391038|54229859|FG000|Overall Study|Progressive disease|3|||
27776801|NCT02391038|54229860|FG001|Overall Study|Progressive disease|3|||
27776802|NCT02391038|54229861|FG002|Overall Study|Progressive disease|6|||
27776803|NCT02260921|54229872|FG000|Overall Study|Adverse Event|1|||
27776804|NCT02260921|54229873|FG001|Overall Study|Adverse Event|0|||
27776805|NCT02260921|54229872|FG000|Overall Study|Lost to Follow-up|4|||
27776806|NCT02260921|54229873|FG001|Overall Study|Lost to Follow-up|3|||
27776807|NCT02260921|54229872|FG000|Overall Study|Withdraw Consent|4|||
27776808|NCT02260921|54229873|FG001|Overall Study|Withdraw Consent|1|||
27776809|NCT02260921|54229872|FG000|Overall Study|Death|1|||
27776810|NCT02260921|54229873|FG001|Overall Study|Death|0|||
27776811|NCT02260921|54229872|FG000|Overall Study|Prohibited Treatment for Knee Pain|4|||
27776812|NCT02260921|54229873|FG001|Overall Study|Prohibited Treatment for Knee Pain|0|||
27776813|NCT02462603|54229879|FG000|Overall Study|Investigator Decision|1|||
27776814|NCT02462603|54229879|FG000|Overall Study|Non-Compliance|1|||
27776815|NCT02462603|54229879|FG000|Overall Study|Withdrawal by Subject|2|||
27776816|NCT02034513|54229885|FG000|Overall Study|Adverse Event|11|||
27776817|NCT02034513|54229886|FG001|Overall Study|Adverse Event|10|||
27776818|NCT02034513|54229885|FG000|Overall Study|Lack of Efficacy|0|||
27776819|NCT02034513|54229886|FG001|Overall Study|Lack of Efficacy|1|||
27776820|NCT02034513|54229885|FG000|Overall Study|Lost to Follow-up|6|||
27776821|NCT02034513|54229886|FG001|Overall Study|Lost to Follow-up|7|||
27776822|NCT02034513|54229885|FG000|Overall Study|Pregnancy|0|||
27776823|NCT02034513|54229886|FG001|Overall Study|Pregnancy|3|||
27776824|NCT02034513|54229885|FG000|Overall Study|Protocol Violation|7|||
27776825|NCT02034513|54229886|FG001|Overall Study|Protocol Violation|10|||
27776826|NCT02034513|54229885|FG000|Overall Study|Withdrawal by Subject|25|||
27776827|NCT02034513|54229886|FG001|Overall Study|Withdrawal by Subject|25|||
27776828|NCT02034513|54229885|FG000|Overall Study|Unclassified|0|||
27776829|NCT02034513|54229886|FG001|Overall Study|Unclassified|1|||
27776830|NCT02348840|54229898|FG000|Overall Study|Withdrawal by Subject|2|||
27776831|NCT02348840|54229899|FG001|Overall Study|Withdrawal by Subject|1|||
27840435|NCT01689974|54328022|FG000|Overall Study|Termination of Study|5|||
27840436|NCT01689974|54328023|FG001|Overall Study|Termination of Study|5|||
27776832|NCT02348840|54229900|FG002|Overall Study|Withdrawal by Subject|0|||
27776833|NCT02348840|54229901|FG003|Overall Study|Withdrawal by Subject|0|||
27776834|NCT02462057|54229916|FG000|Overall Study|Left Vitality|32|||
27776835|NCT02462057|54229917|FG001|Overall Study|Left Vitality|27|||
27776836|NCT02462057|54229918|FG002|Overall Study|Left Vitality|23|||
27776837|NCT02462057|54229919|FG003|Overall Study|Left Vitality|35|||
27776838|NCT02462057|54229920|FG004|Overall Study|Left Vitality|33|||
27776839|NCT02462057|54229916|FG000|Overall Study|Joined HealthyFood Before Intervention|22|||
27776840|NCT02462057|54229917|FG001|Overall Study|Joined HealthyFood Before Intervention|13|||
27776841|NCT02462057|54229918|FG002|Overall Study|Joined HealthyFood Before Intervention|23|||
27776842|NCT02462057|54229919|FG003|Overall Study|Joined HealthyFood Before Intervention|16|||
27776843|NCT02462057|54229920|FG004|Overall Study|Joined HealthyFood Before Intervention|17|||
27776844|NCT02461745|54229934|FG000|Overall Study|Lack of Efficacy|9|||
27776845|NCT02461745|54229935|FG001|Overall Study|Lack of Efficacy|1|||
27776846|NCT02461745|54229934|FG000|Overall Study|Lost to Follow-up|2|||
27776847|NCT02461745|54229935|FG001|Overall Study|Lost to Follow-up|2|||
27840437|NCT01587014|54328029|FG000|Overall Study|Death|2|||
27776848|NCT02461745|54229934|FG000|Overall Study|Withdrawal by Subject|3|||
27776849|NCT02461745|54229935|FG001|Overall Study|Withdrawal by Subject|1|||
27776850|NCT02034435|54229945|FG000|Overall Study|Withdrawal by Subject|1|||
27776851|NCT02034435|54229946|FG001|Overall Study|Withdrawal by Subject|0|||
27776852|NCT02034435|54229947|FG002|Overall Study|Withdrawal by Subject|0|||
27776853|NCT02034435|54229948|FG003|Overall Study|Withdrawal by Subject|0|||
27776854|NCT02034435|54229945|FG000|Overall Study|Illness|0|||
27776855|NCT02034435|54229946|FG001|Overall Study|Illness|2|||
27776856|NCT02034435|54229947|FG002|Overall Study|Illness|0|||
27776857|NCT02034435|54229948|FG003|Overall Study|Illness|0|||
27776858|NCT02034435|54229945|FG000|Overall Study|Inadequate IV access|1|||
27776859|NCT02034435|54229946|FG001|Overall Study|Inadequate IV access|0|||
27776860|NCT02034435|54229947|FG002|Overall Study|Inadequate IV access|0|||
27776861|NCT02034435|54229948|FG003|Overall Study|Inadequate IV access|1|||
27776862|NCT02033889|54229961|FG000|Overall Study|Adverse Event|3|||
27776863|NCT02033889|54229962|FG001|Overall Study|Adverse Event|1|||
27776864|NCT02033889|54229963|FG002|Overall Study|Adverse Event|3|||
27776865|NCT02033889|54229961|FG000|Overall Study|Death|3|||
27776866|NCT02033889|54229962|FG001|Overall Study|Death|1|||
27776867|NCT02033889|54229963|FG002|Overall Study|Death|2|||
27776868|NCT02033889|54229961|FG000|Overall Study|Excluded Medication|1|||
27776869|NCT02033889|54229962|FG001|Overall Study|Excluded Medication|1|||
27776870|NCT02033889|54229963|FG002|Overall Study|Excluded Medication|0|||
27776871|NCT02033889|54229961|FG000|Overall Study|Lost to Follow-up|8|||
27776872|NCT02033889|54229962|FG001|Overall Study|Lost to Follow-up|5|||
27776873|NCT02033889|54229963|FG002|Overall Study|Lost to Follow-up|6|||
27776874|NCT02033889|54229961|FG000|Overall Study|Non-Compliance With Study Drug|1|||
27776875|NCT02033889|54229962|FG001|Overall Study|Non-Compliance With Study Drug|0|||
27776876|NCT02033889|54229963|FG002|Overall Study|Non-Compliance With Study Drug|0|||
27776877|NCT02033889|54229961|FG000|Overall Study|Physician Decision|0|||
27776878|NCT02033889|54229962|FG001|Overall Study|Physician Decision|1|||
27776879|NCT02033889|54229963|FG002|Overall Study|Physician Decision|1|||
27776880|NCT02033889|54229961|FG000|Overall Study|Participant moved|0|||
27776881|NCT02033889|54229962|FG001|Overall Study|Participant moved|1|||
27776882|NCT02033889|54229963|FG002|Overall Study|Participant moved|0|||
27776883|NCT02033889|54229961|FG000|Overall Study|Withdrawal by Subject|18|||
27776884|NCT02033889|54229962|FG001|Overall Study|Withdrawal by Subject|10|||
27776885|NCT02033889|54229963|FG002|Overall Study|Withdrawal by Subject|13|||
27776886|NCT02447003|54229973|FG000|Overall Study|Other|0|||
27840438|NCT01458535|54328141|FG000|Overall Study|Other|0|||
27840439|NCT01458535|54328142|FG001|Overall Study|Other|0|||
27840440|NCT01458535|54328143|FG002|Overall Study|Other|0|||
27840441|NCT01458535|54328144|FG003|Overall Study|Other|0|||
27840442|NCT01458535|54328145|FG004|Overall Study|Other|1|||
27840443|NCT01458535|54328146|FG005|Overall Study|Other|1|||
27840444|NCT01458535|54328141|FG000|Overall Study|Withdrawal by Subject|0|||
27840445|NCT01458535|54328142|FG001|Overall Study|Withdrawal by Subject|0|||
27840446|NCT01458535|54328143|FG002|Overall Study|Withdrawal by Subject|2|||
27840447|NCT01458535|54328144|FG003|Overall Study|Withdrawal by Subject|0|||
27840448|NCT01458535|54328145|FG004|Overall Study|Withdrawal by Subject|1|||
27840449|NCT01458535|54328146|FG005|Overall Study|Withdrawal by Subject|1|||
27840450|NCT01458535|54328141|FG000|Overall Study|Lost to Follow-up|0|||
27840451|NCT01458535|54328142|FG001|Overall Study|Lost to Follow-up|2|||
27840452|NCT01458535|54328143|FG002|Overall Study|Lost to Follow-up|0|||
27840453|NCT01458535|54328144|FG003|Overall Study|Lost to Follow-up|3|||
27840454|NCT01458535|54328145|FG004|Overall Study|Lost to Follow-up|2|||
27840455|NCT01458535|54328146|FG005|Overall Study|Lost to Follow-up|2|||
27840456|NCT01458535|54328141|FG000|Overall Study|Adverse Event|0|||
27840457|NCT01458535|54328142|FG001|Overall Study|Adverse Event|0|||
27776887|NCT02447003|54229974|FG001|Overall Study|Other|4|||
27776888|NCT02447003|54229973|FG000|Overall Study|Site discontinued|0|||
27776889|NCT02447003|54229974|FG001|Overall Study|Site discontinued|2|||
27776890|NCT02447003|54229973|FG000|Overall Study|Physician Decision|0|||
27776891|NCT02447003|54229974|FG001|Overall Study|Physician Decision|1|||
27776892|NCT02447003|54229973|FG000|Overall Study|Withdrawal by Subject|4|||
27776893|NCT02447003|54229974|FG001|Overall Study|Withdrawal by Subject|3|||
27776894|NCT02447003|54229973|FG000|Overall Study|Sponsor Decision|6|||
27776895|NCT02447003|54229974|FG001|Overall Study|Sponsor Decision|11|||
27776896|NCT02447003|54229973|FG000|Overall Study|Progressive Disease|1|||
27776897|NCT02447003|54229974|FG001|Overall Study|Progressive Disease|0|||
27776898|NCT02447003|54229973|FG000|Overall Study|Lost to Follow-up|5|||
27776899|NCT02447003|54229974|FG001|Overall Study|Lost to Follow-up|0|||
27776900|NCT02447003|54229973|FG000|Overall Study|Death|154|||
27776901|NCT02447003|54229974|FG001|Overall Study|Death|63|||
27776902|NCT01844284|54229984|FG000|Overall Study|Lost to Follow-up|12|||
27776903|NCT01844284|54229985|FG001|Overall Study|Lost to Follow-up|7|||
27840458|NCT01458535|54328143|FG002|Overall Study|Adverse Event|0|||
27840459|NCT01458535|54328144|FG003|Overall Study|Adverse Event|1|||
27840460|NCT01458535|54328145|FG004|Overall Study|Adverse Event|0|||
27840461|NCT01458535|54328146|FG005|Overall Study|Adverse Event|0|||
27776904|NCT02054715|54229993|FG000|Baseline/Follow-up 1|Refused|1|||
27776905|NCT02054715|54229994|FG001|Baseline/Follow-up 1|Refused|3|||
27776906|NCT02054715|54229993|FG000|Baseline/Follow-up 1|Medical|0|||
27776907|NCT02054715|54229994|FG001|Baseline/Follow-up 1|Medical|1|||
27776908|NCT02054715|54229993|FG000|Baseline/Follow-up 1|Changed MD/Facility|0|||
27776909|NCT02054715|54229994|FG001|Baseline/Follow-up 1|Changed MD/Facility|1|||
27776910|NCT02054715|54229993|FG000|Baseline/Follow-up 1|Disliked Procedure|0|||
27776911|NCT02054715|54229994|FG001|Baseline/Follow-up 1|Disliked Procedure|1|||
27776912|NCT02054715|54229993|FG000|Baseline/Follow-up 1|No Reason|0|||
27776913|NCT02054715|54229994|FG001|Baseline/Follow-up 1|No Reason|1|||
27776914|NCT02054715|54229993|FG000|Baseline/Follow-up 1|Overwhelmed|2|||
27776915|NCT02054715|54229994|FG001|Baseline/Follow-up 1|Overwhelmed|0|||
27776916|NCT02054715|54229993|FG000|Baseline/Follow-up 1|Ineligible|3|||
27776917|NCT02054715|54229994|FG001|Baseline/Follow-up 1|Ineligible|0|||
27776918|NCT02054715|54229993|FG000|Baseline/Follow-up 1|Hospitalization|1|||
27776919|NCT02054715|54229994|FG001|Baseline/Follow-up 1|Hospitalization|0|||
27776920|NCT02054715|54229993|FG000|Baseline/Follow-up 1|Changed Mind|1|||
27776921|NCT02054715|54229994|FG001|Baseline/Follow-up 1|Changed Mind|0|||
27776922|NCT02054715|54229993|FG000|Follow-up 2|Lost to Followup|3|||
27776923|NCT02054715|54229994|FG001|Follow-up 2|Lost to Followup|1|||
27776924|NCT02054715|54229993|FG000|Follow-up 2|Refused|3|||
27776925|NCT02054715|54229994|FG001|Follow-up 2|Refused|2|||
27776926|NCT02054715|54229993|FG000|Follow-up 2|Followup Not Completed|3|||
27776927|NCT02054715|54229994|FG001|Follow-up 2|Followup Not Completed|4|||
27776928|NCT02054715|54229993|FG000|Follow-up 2|Ineligible|4|||
27776929|NCT02054715|54229994|FG001|Follow-up 2|Ineligible|5|||
27776930|NCT02054715|54229993|FG000|Follow-up 2|Death|3|||
27776931|NCT02054715|54229994|FG001|Follow-up 2|Death|3|||
27776932|NCT02054715|54229993|FG000|Follow-up 2|Hospitalization|0|||
27776933|NCT02054715|54229994|FG001|Follow-up 2|Hospitalization|2|||
27776934|NCT02054715|54229993|FG000|Follow-up 2|Changed MD/Facility|0|||
27776935|NCT02054715|54229994|FG001|Follow-up 2|Changed MD/Facility|1|||
27776936|NCT02054715|54229993|FG000|Follow-up 2|Changed Mind|0|||
27776937|NCT02054715|54229994|FG001|Follow-up 2|Changed Mind|1|||
27776938|NCT02054715|54229993|FG000|Follow-up 2|No Reason|2|||
27776939|NCT02054715|54229994|FG001|Follow-up 2|No Reason|0|||
27776940|NCT02054715|54229993|FG000|Follow-up 2|Treatment Change or Delay|1|||
27776941|NCT02054715|54229994|FG001|Follow-up 2|Treatment Change or Delay|0|||
27776942|NCT02446769|54230000|FG000|Screening Period|Screen Failure|11|||
27776943|NCT02446769|54230001|FG001|Screening Period|Screen Failure|0|||
27776944|NCT02446769|54230002|FG002|Screening Period|Screen Failure|0|||
27776945|NCT02446769|54230000|FG000|Study Period|Randomized in Error|0|||
27776946|NCT02446769|54230001|FG001|Study Period|Randomized in Error|2|||
27776947|NCT02446769|54230002|FG002|Study Period|Randomized in Error|0|||
27776948|NCT02420093|54230011|FG000|Overall Study|Withdrawal by Subject|1|||
27776949|NCT02420093|54230012|FG001|Overall Study|Withdrawal by Subject|1|||
27776950|NCT02419937|54230020|FG000|Overall Study|Lost to Follow-up|1|||
27776951|NCT02419937|54230021|FG001|Overall Study|Lost to Follow-up|0|||
27776952|NCT02054481|54230031|FG000|Overall Study|Adverse Event|1|||
27776953|NCT02054481|54230032|FG001|Overall Study|Adverse Event|1|||
27776954|NCT02054481|54230033|FG002|Overall Study|Adverse Event|0|||
27776955|NCT02054481|54230034|FG003|Overall Study|Adverse Event|1|||
27776956|NCT02054481|54230031|FG000|Overall Study|Lost to Follow-up|1|||
27776957|NCT02054481|54230032|FG001|Overall Study|Lost to Follow-up|0|||
27776958|NCT02054481|54230033|FG002|Overall Study|Lost to Follow-up|0|||
27776959|NCT02054481|54230034|FG003|Overall Study|Lost to Follow-up|0|||
27776960|NCT02054481|54230031|FG000|Overall Study|Other reason|2|||
27840462|NCT01464827|54328174|FG000|Overall Study|Adverse Event|0|||
27776961|NCT02054481|54230032|FG001|Overall Study|Other reason|1|||
27776962|NCT02054481|54230033|FG002|Overall Study|Other reason|2|||
27776963|NCT02054481|54230034|FG003|Overall Study|Other reason|0|||
27776964|NCT01610752|54230048|FG000|Overall Study|Miscarriage/Pregnancy loss|0|||
27776965|NCT01610752|54230049|FG001|Overall Study|Miscarriage/Pregnancy loss|0|||
27776966|NCT01610752|54230050|FG002|Overall Study|Miscarriage/Pregnancy loss|4|||
27776967|NCT02054325|54230060|FG000|Overall Study|Lost to Follow-up|8|||
27776968|NCT02054325|54230061|FG001|Overall Study|Lost to Follow-up|5|||
27776969|NCT02446691|54230067|FG000|Overall Study|Withdrawal by Subject|2|||
27776970|NCT02446691|54230067|FG000|Overall Study|Lost to Follow-up|8|||
27776971|NCT02446691|54230067|FG000|Overall Study|Protocol Violation|1|||
27776972|NCT02091375|54230073|FG000|Overall Study|Adverse Event|8|||
27776973|NCT02091375|54230074|FG001|Overall Study|Adverse Event|1|||
27776974|NCT02091375|54230073|FG000|Overall Study|Lost to Follow-up|0|||
27776975|NCT02091375|54230074|FG001|Overall Study|Lost to Follow-up|1|||
27776976|NCT02091375|54230073|FG000|Overall Study|Withdrawal by Subject|0|||
27776977|NCT02091375|54230074|FG001|Overall Study|Withdrawal by Subject|1|||
27776978|NCT02091375|54230073|FG000|Overall Study|Withdrawn by the investigator|1|||
27776979|NCT02091375|54230074|FG001|Overall Study|Withdrawn by the investigator|0|||
27776980|NCT02032875|54230082|FG000|Treatment Period|Adverse Event|1|||
27776981|NCT02032875|54230083|FG001|Treatment Period|Adverse Event|0|||
27776982|NCT02032875|54230082|FG000|Treatment Period|Liver transplant, No extension needed|0|||
27776983|NCT02032875|54230083|FG001|Treatment Period|Liver transplant, No extension needed|1|||
27776984|NCT02032875|54230082|FG000|Treatment Period|Liver transplant, Treatment extension|0|||
27776985|NCT02032875|54230083|FG001|Treatment Period|Liver transplant, Treatment extension|3|||
27776986|NCT02032875|54230082|FG000|Follow-up Period|Death|0|||
27776987|NCT02032875|54230083|FG001|Follow-up Period|Death|1|||
27776988|NCT02032875|54230082|FG000|Follow-up Period|Virologic Relapse|3|||
27776989|NCT02032875|54230083|FG001|Follow-up Period|Virologic Relapse|10|||
27776990|NCT02032407|54230090|FG000|Overall Study|Lost to Follow-up|2|||
27776991|NCT02032407|54230090|FG000|Overall Study|Pregnancy|1|||
27776992|NCT02032407|54230090|FG000|Overall Study|Other Miscellaneous Reasons|2|||
27776993|NCT01843972|54230108|FG000|Overall Study|Withdrawal by Subject|0|||
27776994|NCT01843972|54230109|FG001|Overall Study|Withdrawal by Subject|0|||
27776995|NCT01843972|54230110|FG002|Overall Study|Withdrawal by Subject|0|||
27776996|NCT01843972|54230111|FG003|Overall Study|Withdrawal by Subject|0|||
27776997|NCT01843972|54230112|FG004|Overall Study|Withdrawal by Subject|1|||
27776998|NCT01843972|54230113|FG005|Overall Study|Withdrawal by Subject|0|||
27776999|NCT01843972|54230114|FG006|Overall Study|Withdrawal by Subject|0|||
27777000|NCT01843972|54230115|FG007|Overall Study|Withdrawal by Subject|0|||
27777001|NCT01843972|54230116|FG008|Overall Study|Withdrawal by Subject|0|||
27777002|NCT01843972|54230117|FG009|Overall Study|Withdrawal by Subject|0|||
27777003|NCT01826422|54230155|FG000|Overall Study|Withdrawal by Subject|1|||
27777004|NCT01826422|54230156|FG001|Overall Study|Withdrawal by Subject|3|||
27777005|NCT01843660|54230162|FG000|Overall Study|Other|30|||
27777006|NCT02090283|54230169|FG000|Overall Study|Withdrawal by Subject|6|||
27777007|NCT02090283|54230170|FG001|Overall Study|Withdrawal by Subject|6|||
27777008|NCT02090283|54230171|FG002|Overall Study|Withdrawal by Subject|6|||
27777009|NCT02090283|54230169|FG000|Overall Study|Sponsor Terminated Study|6|||
27777010|NCT02090283|54230170|FG001|Overall Study|Sponsor Terminated Study|6|||
27777011|NCT02090283|54230171|FG002|Overall Study|Sponsor Terminated Study|1|||
27777012|NCT02090283|54230169|FG000|Overall Study|Lost to Follow-up|2|||
27777013|NCT02090283|54230170|FG001|Overall Study|Lost to Follow-up|2|||
27777014|NCT02090283|54230171|FG002|Overall Study|Lost to Follow-up|3|||
27777015|NCT02090283|54230169|FG000|Overall Study|Adverse Event|1|||
27777016|NCT02090283|54230170|FG001|Overall Study|Adverse Event|1|||
27777017|NCT02090283|54230171|FG002|Overall Study|Adverse Event|0|||
27777018|NCT02090283|54230169|FG000|Overall Study|Protocol Violation|2|||
27777019|NCT02090283|54230170|FG001|Overall Study|Protocol Violation|0|||
27777020|NCT02090283|54230171|FG002|Overall Study|Protocol Violation|0|||
27777021|NCT02032173|54230179|FG000|Overall Study|Discontinuation due to sponsor decision|31|||
27777022|NCT02031471|54230183|FG000|24 Week Treatment Period|Adverse Event|6|||
27777023|NCT02031471|54230183|FG000|24 Week Treatment Period|Participant Decision to Withdraw|2|||
27777024|NCT02031471|54230183|FG000|24 Week Treatment Period|Protocol Violation|1|||
27777025|NCT02031471|54230183|FG000|24 Week Treatment Period|Insufficient Therapeutic Response|1|||
27777026|NCT02031471|54230183|FG000|24 Week Treatment Period|Hypersensitivity Reaction|1|||
27777027|NCT02031471|54230183|FG000|Long Term Extension (LTE) Period|Adverse Event|1|||
27777028|NCT02031471|54230183|FG000|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1|||
27777029|NCT02461589|54230197|FG000|Overall Study|Withdrawal by Subject|5|||
27777030|NCT02461589|54230198|FG001|Overall Study|Withdrawal by Subject|1|||
27777031|NCT02461589|54230199|FG002|Overall Study|Withdrawal by Subject|3|||
27777032|NCT02461589|54230200|FG003|Overall Study|Withdrawal by Subject|2|||
27777033|NCT02461589|54230201|FG004|Overall Study|Withdrawal by Subject|1|||
27777034|NCT02461589|54230202|FG005|Overall Study|Withdrawal by Subject|2|||
27777035|NCT02461589|54230203|FG006|Overall Study|Withdrawal by Subject|1|||
27777036|NCT02461589|54230204|FG007|Overall Study|Withdrawal by Subject|3|||
27777037|NCT02461589|54230205|FG008|Overall Study|Withdrawal by Subject|3|||
27777038|NCT02461589|54230206|FG009|Overall Study|Withdrawal by Subject|1|||
27777039|NCT02461589|54230197|FG000|Overall Study|Lost to Follow-up|0|||
27777040|NCT02461589|54230198|FG001|Overall Study|Lost to Follow-up|0|||
27777041|NCT02461589|54230199|FG002|Overall Study|Lost to Follow-up|2|||
27777042|NCT02461589|54230200|FG003|Overall Study|Lost to Follow-up|3|||
27777043|NCT02461589|54230201|FG004|Overall Study|Lost to Follow-up|1|||
27777044|NCT02461589|54230202|FG005|Overall Study|Lost to Follow-up|1|||
27777045|NCT02461589|54230203|FG006|Overall Study|Lost to Follow-up|3|||
27777046|NCT02461589|54230204|FG007|Overall Study|Lost to Follow-up|1|||
27777047|NCT02461589|54230205|FG008|Overall Study|Lost to Follow-up|3|||
27777048|NCT02461589|54230206|FG009|Overall Study|Lost to Follow-up|1|||
27777049|NCT02461589|54230197|FG000|Overall Study|Death|0|||
27777050|NCT02461589|54230198|FG001|Overall Study|Death|0|||
27777051|NCT02461589|54230199|FG002|Overall Study|Death|0|||
27777052|NCT02461589|54230200|FG003|Overall Study|Death|0|||
27777053|NCT02461589|54230201|FG004|Overall Study|Death|0|||
27777054|NCT02461589|54230202|FG005|Overall Study|Death|0|||
27777055|NCT02461589|54230203|FG006|Overall Study|Death|0|||
27777056|NCT02461589|54230204|FG007|Overall Study|Death|1|||
27777057|NCT02461589|54230205|FG008|Overall Study|Death|0|||
27777058|NCT02461589|54230206|FG009|Overall Study|Death|0|||
27777059|NCT02461589|54230197|FG000|Overall Study|Unclassified|0|||
27777060|NCT02461589|54230198|FG001|Overall Study|Unclassified|0|||
27777061|NCT02461589|54230199|FG002|Overall Study|Unclassified|0|||
27777062|NCT02461589|54230200|FG003|Overall Study|Unclassified|0|||
27777063|NCT02461589|54230201|FG004|Overall Study|Unclassified|0|||
27777064|NCT02461589|54230202|FG005|Overall Study|Unclassified|0|||
27777065|NCT02461589|54230203|FG006|Overall Study|Unclassified|1|||
27777066|NCT02461589|54230204|FG007|Overall Study|Unclassified|0|||
27777067|NCT02461589|54230205|FG008|Overall Study|Unclassified|0|||
27777068|NCT02461589|54230206|FG009|Overall Study|Unclassified|2|||
27777069|NCT02461589|54230197|FG000|Overall Study|Missing follow-up information|1|||
27777070|NCT02461589|54230198|FG001|Overall Study|Missing follow-up information|1|||
27777071|NCT02461589|54230199|FG002|Overall Study|Missing follow-up information|0|||
27777072|NCT02461589|54230200|FG003|Overall Study|Missing follow-up information|0|||
27777073|NCT02461589|54230201|FG004|Overall Study|Missing follow-up information|0|||
27777074|NCT02461589|54230202|FG005|Overall Study|Missing follow-up information|0|||
27777075|NCT02461589|54230203|FG006|Overall Study|Missing follow-up information|1|||
27777076|NCT02461589|54230204|FG007|Overall Study|Missing follow-up information|0|||
27777077|NCT02461589|54230205|FG008|Overall Study|Missing follow-up information|0|||
27777078|NCT02461589|54230206|FG009|Overall Study|Missing follow-up information|0|||
27777079|NCT02461589|54230197|FG000|Overall Study|Withdrawal from trial before exposure|0|||
27777080|NCT02461589|54230198|FG001|Overall Study|Withdrawal from trial before exposure|0|||
27777081|NCT02461589|54230199|FG002|Overall Study|Withdrawal from trial before exposure|0|||
27777082|NCT02461589|54230200|FG003|Overall Study|Withdrawal from trial before exposure|0|||
27777083|NCT02461589|54230201|FG004|Overall Study|Withdrawal from trial before exposure|0|||
27777084|NCT02461589|54230202|FG005|Overall Study|Withdrawal from trial before exposure|0|||
27777085|NCT02461589|54230203|FG006|Overall Study|Withdrawal from trial before exposure|0|||
27777086|NCT02461589|54230204|FG007|Overall Study|Withdrawal from trial before exposure|0|||
27777087|NCT02461589|54230205|FG008|Overall Study|Withdrawal from trial before exposure|0|||
27777088|NCT02461589|54230206|FG009|Overall Study|Withdrawal from trial before exposure|1|||
27777089|NCT02089737|54230228|FG000|Overall Study|Survey form not completed|5|||
27777090|NCT02089737|54230228|FG000|Overall Study|Not treated|1|||
27777091|NCT02460575|54230235|FG000|Overall Study|Lost to Follow-up|1|||
27777092|NCT02460575|54230236|FG001|Overall Study|Lost to Follow-up|0|||
27777093|NCT02089347|54230244|FG000|Overall Study|Protocol Violation|1|||
27777094|NCT02089347|54230245|FG001|Overall Study|Protocol Violation|0|||
27777095|NCT02445755|54230251|FG000|Overall Study|Withdrawal by Subject|2|||
27777096|NCT02445755|54230251|FG000|Overall Study|Protocol Violation|6|||
27777097|NCT02445755|54230251|FG000|Overall Study|Screen Failure|5|||
27777098|NCT02419469|54230258|FG000|Overall Study|Withdrawal by Subject|1|||
27777099|NCT02419313|54230262|FG000|First Intervention|Lost to Follow-up|2|||
27777100|NCT02419313|54230263|FG001|First Intervention|Lost to Follow-up|0|||
27777101|NCT02419313|54230262|FG000|Second Intervention|Lost to Follow-up|1|||
27777102|NCT02419313|54230263|FG001|Second Intervention|Lost to Follow-up|0|||
27777103|NCT02419001|54230271|FG000|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1|||
27777104|NCT02419001|54230272|FG001|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0|||
27777105|NCT02031237|54230280|FG000|Overall Study|Death|1|||
27777106|NCT02031237|54230281|FG001|Overall Study|Death|5|||
27777107|NCT02031237|54230282|FG002|Overall Study|Death|0|||
27777108|NCT02031237|54230280|FG000|Overall Study|Physician Decision|0|||
27777109|NCT02031237|54230281|FG001|Overall Study|Physician Decision|1|||
27777110|NCT02031237|54230282|FG002|Overall Study|Physician Decision|0|||
27777111|NCT02031237|54230280|FG000|Overall Study|Withdrawal by Subject|2|||
27777112|NCT02031237|54230281|FG001|Overall Study|Withdrawal by Subject|2|||
27777113|NCT02031237|54230282|FG002|Overall Study|Withdrawal by Subject|0|||
27777114|NCT02031237|54230280|FG000|Overall Study|Protocol Violation|2|||
27777115|NCT02031237|54230281|FG001|Overall Study|Protocol Violation|6|||
27777116|NCT02031237|54230282|FG002|Overall Study|Protocol Violation|0|||
27777117|NCT02031237|54230280|FG000|Overall Study|Alternate Treatment Given|0|||
27777118|NCT02031237|54230281|FG001|Overall Study|Alternate Treatment Given|0|||
27777119|NCT02031237|54230282|FG002|Overall Study|Alternate Treatment Given|3|||
27777120|NCT02088957|54230289|FG000|Overall Study|Lack of Efficacy|1|||
27777121|NCT02088957|54230290|FG001|Overall Study|Lack of Efficacy|0|||
27777122|NCT02418845|54230298|FG000|Overall Study|Lost to Follow-up|7|||
27777123|NCT02418845|54230299|FG001|Overall Study|Lost to Follow-up|2|||
27777124|NCT02418845|54230298|FG000|Overall Study|Lack of Efficacy|0|||
27777125|NCT02418845|54230299|FG001|Overall Study|Lack of Efficacy|3|||
27777126|NCT02418845|54230298|FG000|Overall Study|Physician Decision|5|||
27777127|NCT02418845|54230299|FG001|Overall Study|Physician Decision|5|||
27777128|NCT02418845|54230298|FG000|Overall Study|Protocol Violation|1|||
27777129|NCT02418845|54230299|FG001|Overall Study|Protocol Violation|0|||
27777130|NCT02418845|54230298|FG000|Overall Study|Withdrawal by Subject|3|||
27777131|NCT02418845|54230299|FG001|Overall Study|Withdrawal by Subject|2|||
27777132|NCT02088177|54230305|FG000|Overall Study|Lost to Follow-up|3|||
27777133|NCT02030535|54230309|FG000|Washout Period 1 (21 Days)|Adverse Event|1|||
27777134|NCT02029989|54230325|FG000|Overall Study|Withdrawal by Subject|1|||
27777135|NCT02029989|54230326|FG001|Overall Study|Withdrawal by Subject|0|||
27777136|NCT02029989|54230325|FG000|Overall Study|Withdrawal: Fear of needles|1|||
27777137|NCT02029989|54230326|FG001|Overall Study|Withdrawal: Fear of needles|0|||
27777138|NCT02029989|54230325|FG000|Overall Study|Change of location|2|||
27777139|NCT02029989|54230326|FG001|Overall Study|Change of location|3|||
27777140|NCT02029989|54230325|FG000|Overall Study|Physician Decision|2|||
27777141|NCT02029989|54230326|FG001|Overall Study|Physician Decision|0|||
27777142|NCT02029989|54230325|FG000|Overall Study|Lost to Follow-up|9|||
27777143|NCT02029989|54230326|FG001|Overall Study|Lost to Follow-up|7|||
27777144|NCT02029989|54230325|FG000|Overall Study|Death|0|||
27777145|NCT02029989|54230326|FG001|Overall Study|Death|1|||
27777146|NCT02029989|54230325|FG000|Overall Study|Protocol Violation|1|||
27777147|NCT02029989|54230326|FG001|Overall Study|Protocol Violation|0|||
27777148|NCT02048241|54230334|FG000|Overall Study|Withdrawal by Subject|0|||
27777149|NCT02048241|54230335|FG001|Overall Study|Withdrawal by Subject|1|||
27777150|NCT02087943|54230344|FG000|Placebo-Controlled Phase Week 0-12|Adverse Event|1|||
27777151|NCT02087943|54230345|FG001|Placebo-Controlled Phase Week 0-12|Adverse Event|2|||
27777152|NCT02087943|54230346|FG002|Placebo-Controlled Phase Week 0-12|Adverse Event|6|||
27777153|NCT02087943|54230347|FG003|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
27777154|NCT02087943|54230348|FG004|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
27777155|NCT02087943|54230344|FG000|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8|||
27777156|NCT02087943|54230345|FG001|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7|||
27777157|NCT02087943|54230346|FG002|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4|||
27777158|NCT02087943|54230347|FG003|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
27777159|NCT02087943|54230348|FG004|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
27777160|NCT02087943|54230344|FG000|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4|||
27777161|NCT02087943|54230345|FG001|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
27777162|NCT02087943|54230346|FG002|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
27777163|NCT02087943|54230347|FG003|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
27777164|NCT02087943|54230348|FG004|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
27777165|NCT02087943|54230344|FG000|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
27777166|NCT02087943|54230345|FG001|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
27777167|NCT02087943|54230346|FG002|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
27777168|NCT02087943|54230347|FG003|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
27777169|NCT02087943|54230348|FG004|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
27777170|NCT02087943|54230344|FG000|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
27840463|NCT01464827|54328175|FG001|Overall Study|Adverse Event|0|||
27840464|NCT01464827|54328176|FG002|Overall Study|Adverse Event|0|||
27840465|NCT01464827|54328177|FG003|Overall Study|Adverse Event|0|||
27840466|NCT01464827|54328178|FG004|Overall Study|Adverse Event|0|||
27840467|NCT01464827|54328179|FG005|Overall Study|Adverse Event|0|||
27840468|NCT01464827|54328180|FG006|Overall Study|Adverse Event|0|||
27777171|NCT02087943|54230345|FG001|Placebo-Controlled Phase Week 0-12|Protocol Violation|1|||
27777172|NCT02087943|54230346|FG002|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
27777173|NCT02087943|54230347|FG003|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
27777174|NCT02087943|54230348|FG004|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
27777175|NCT02087943|54230344|FG000|Active Treatment Phase Week 12-24|Adverse Event|0|||
27777176|NCT02087943|54230345|FG001|Active Treatment Phase Week 12-24|Adverse Event|1|||
27777177|NCT02087943|54230346|FG002|Active Treatment Phase Week 12-24|Adverse Event|2|||
27777178|NCT02087943|54230347|FG003|Active Treatment Phase Week 12-24|Adverse Event|0|||
27777179|NCT02087943|54230348|FG004|Active Treatment Phase Week 12-24|Adverse Event|1|||
27777180|NCT02087943|54230344|FG000|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
27777181|NCT02087943|54230345|FG001|Active Treatment Phase Week 12-24|Lack of Efficacy|3|||
27777182|NCT02087943|54230346|FG002|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
27777183|NCT02087943|54230347|FG003|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
27840469|NCT01464827|54328181|FG007|Overall Study|Adverse Event|0|||
27840470|NCT01464827|54328182|FG008|Overall Study|Adverse Event|0|||
27840471|NCT01464827|54328183|FG009|Overall Study|Adverse Event|0|||
27840472|NCT01464827|54328184|FG010|Overall Study|Adverse Event|0|||
27777184|NCT02087943|54230348|FG004|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
27777185|NCT02087943|54230344|FG000|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
27777186|NCT02087943|54230345|FG001|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
27777187|NCT02087943|54230346|FG002|Active Treatment Phase Week 12-24|Withdrawal by Subject|1|||
27777188|NCT02087943|54230347|FG003|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
27777189|NCT02087943|54230348|FG004|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
27840473|NCT01464827|54328185|FG011|Overall Study|Adverse Event|0|||
27840474|NCT01464827|54328186|FG012|Overall Study|Adverse Event|1|||
27840475|NCT01464827|54328187|FG013|Overall Study|Adverse Event|0|||
27777190|NCT02087943|54230344|FG000|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
27777191|NCT02087943|54230345|FG001|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
27777192|NCT02087943|54230346|FG002|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
27777193|NCT02087943|54230347|FG003|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
27777194|NCT02087943|54230348|FG004|Active Treatment Phase Week 12-24|Lost to Follow-up|1|||
27777195|NCT02087943|54230344|FG000|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
27777196|NCT02087943|54230345|FG001|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
27777197|NCT02087943|54230346|FG002|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
27777198|NCT02087943|54230347|FG003|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
27777199|NCT02087943|54230348|FG004|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
27777200|NCT02029521|54230362|FG000|Overall Study|Protocol Violation|1|||
27777201|NCT02029521|54230363|FG001|Overall Study|Protocol Violation|0|||
27777202|NCT02029521|54230362|FG000|Overall Study|Withdrawal by Subject|1|||
27777203|NCT02029521|54230363|FG001|Overall Study|Withdrawal by Subject|1|||
27777204|NCT02443883|54230384|FG000|Overall Study|Adverse Event|0|||
27777205|NCT02443883|54230385|FG001|Overall Study|Adverse Event|1|||
27777206|NCT02443883|54230386|FG002|Overall Study|Adverse Event|0|||
27777207|NCT02443883|54230387|FG003|Overall Study|Adverse Event|0|||
27777208|NCT02443883|54230384|FG000|Overall Study|Lost to Follow-up|3|||
27777209|NCT02443883|54230385|FG001|Overall Study|Lost to Follow-up|2|||
27777210|NCT02443883|54230386|FG002|Overall Study|Lost to Follow-up|1|||
27777211|NCT02443883|54230387|FG003|Overall Study|Lost to Follow-up|0|||
27777212|NCT02443883|54230384|FG000|Overall Study|Physician Decision|1|||
27777213|NCT02443883|54230385|FG001|Overall Study|Physician Decision|1|||
27777214|NCT02443883|54230386|FG002|Overall Study|Physician Decision|0|||
27777215|NCT02443883|54230387|FG003|Overall Study|Physician Decision|3|||
27777216|NCT02443883|54230384|FG000|Overall Study|Withdrawal by Subject|1|||
27777217|NCT02443883|54230385|FG001|Overall Study|Withdrawal by Subject|0|||
27777218|NCT02443883|54230386|FG002|Overall Study|Withdrawal by Subject|0|||
27777219|NCT02443883|54230387|FG003|Overall Study|Withdrawal by Subject|2|||
27777220|NCT02443883|54230384|FG000|Overall Study|Randomized, but never treated|1|||
27777221|NCT02443883|54230385|FG001|Overall Study|Randomized, but never treated|0|||
27777222|NCT02443883|54230386|FG002|Overall Study|Randomized, but never treated|0|||
27777223|NCT02443883|54230387|FG003|Overall Study|Randomized, but never treated|0|||
27777224|NCT02460263|54230397|FG000|Transition Period|Withdrawal by Subject|1|||
27777225|NCT02460263|54230397|FG000|Transition Period|Death|1|||
27777226|NCT02443805|54230407|FG000|Overall Study|Adverse Event|100|||
27777227|NCT02443805|54230408|FG001|Overall Study|Adverse Event|18|||
27777228|NCT02443805|54230407|FG000|Overall Study|Withdrawal by Subject|73|||
27777229|NCT02443805|54230408|FG001|Overall Study|Withdrawal by Subject|74|||
27777230|NCT02443805|54230407|FG000|Overall Study|Lost to Follow-up|19|||
27777231|NCT02443805|54230408|FG001|Overall Study|Lost to Follow-up|14|||
27777232|NCT02443805|54230407|FG000|Overall Study|Pregnancy|6|||
27777233|NCT02443805|54230408|FG001|Overall Study|Pregnancy|5|||
27777234|NCT02443805|54230407|FG000|Overall Study|Protocol Violation|2|||
27777235|NCT02443805|54230408|FG001|Overall Study|Protocol Violation|4|||
27777236|NCT02443805|54230407|FG000|Overall Study|Lack of Efficacy|1|||
27777237|NCT02443805|54230408|FG001|Overall Study|Lack of Efficacy|1|||
27777238|NCT02443805|54230407|FG000|Overall Study|Non-compliance with study drug|6|||
27777239|NCT02443805|54230408|FG001|Overall Study|Non-compliance with study drug|4|||
27777240|NCT02443805|54230407|FG000|Overall Study|Withdrawal by parent/guardian|3|||
27777241|NCT02443805|54230408|FG001|Overall Study|Withdrawal by parent/guardian|5|||
27777242|NCT02443805|54230407|FG000|Overall Study|Any other reason not above-mentioned|3|||
27777243|NCT02443805|54230408|FG001|Overall Study|Any other reason not above-mentioned|2|||
27777244|NCT01652885|54230414|FG000|Overall Study|Adverse Event|1|||
27777245|NCT02459951|54230418|FG000|Overall Study|Unable to meet holding requirement|1|||
27777246|NCT02087241|54230427|FG000|Overall Study|Death|2|||
27777247|NCT02087241|54230428|FG001|Overall Study|Death|1|||
27777248|NCT02087241|54230429|FG002|Overall Study|Death|1|||
27777249|NCT02087241|54230430|FG003|Overall Study|Death|1|||
27777250|NCT02087241|54230427|FG000|Overall Study|Withdrawal by Subject|1|||
27777251|NCT02087241|54230428|FG001|Overall Study|Withdrawal by Subject|0|||
27777252|NCT02087241|54230429|FG002|Overall Study|Withdrawal by Subject|0|||
27777253|NCT02087241|54230430|FG003|Overall Study|Withdrawal by Subject|1|||
27777254|NCT02087241|54230427|FG000|Overall Study|Progressive Disease|0|||
27777255|NCT02087241|54230428|FG001|Overall Study|Progressive Disease|0|||
27777256|NCT02087241|54230429|FG002|Overall Study|Progressive Disease|0|||
27840476|NCT01464827|54328174|FG000|Overall Study|Withdrawal by Subject|1|||
27777257|NCT02087241|54230430|FG003|Overall Study|Progressive Disease|1|||
27777258|NCT02087241|54230427|FG000|Overall Study|Study Terminated by Sponsor|0|||
27777259|NCT02087241|54230428|FG001|Overall Study|Study Terminated by Sponsor|2|||
27777260|NCT02087241|54230429|FG002|Overall Study|Study Terminated by Sponsor|0|||
27777261|NCT02087241|54230430|FG003|Overall Study|Study Terminated by Sponsor|4|||
27777262|NCT02087085|54230446|FG000|Overall Study|Adverse Event|10|||
27777263|NCT02087085|54230447|FG001|Overall Study|Adverse Event|14|||
27777264|NCT02087085|54230446|FG000|Overall Study|Lack of Efficacy|4|||
27777265|NCT02087085|54230447|FG001|Overall Study|Lack of Efficacy|3|||
27777266|NCT02087085|54230446|FG000|Overall Study|Lost to Follow-up|6|||
27777267|NCT02087085|54230447|FG001|Overall Study|Lost to Follow-up|4|||
27777268|NCT02087085|54230446|FG000|Overall Study|Withdrawal by Subject|9|||
27777269|NCT02087085|54230447|FG001|Overall Study|Withdrawal by Subject|11|||
27777270|NCT02087085|54230446|FG000|Overall Study|Protocol Violation|1|||
27777271|NCT02087085|54230447|FG001|Overall Study|Protocol Violation|0|||
27777272|NCT02087085|54230446|FG000|Overall Study|Study Terminated by Sponsor|87|||
27777273|NCT02087085|54230447|FG001|Overall Study|Study Terminated by Sponsor|80|||
27777274|NCT02087085|54230446|FG000|Overall Study|Other Miscellaneous Reasons|3|||
27777275|NCT02087085|54230447|FG001|Overall Study|Other Miscellaneous Reasons|4|||
27777276|NCT02443337|54230455|FG000|Overall Study|Adverse Event|0|||
27777277|NCT02443337|54230456|FG001|Overall Study|Adverse Event|1|||
27777278|NCT02443337|54230455|FG000|Overall Study|Clinical Progressive Disease|3|||
27777279|NCT02443337|54230456|FG001|Overall Study|Clinical Progressive Disease|0|||
27777280|NCT02443337|54230455|FG000|Overall Study|Withdrawal by Subject|2|||
27777281|NCT02443337|54230456|FG001|Overall Study|Withdrawal by Subject|1|||
27777282|NCT02443103|54230467|FG000|Overall Study|Adverse Event|2|||
27777283|NCT02443103|54230467|FG000|Overall Study|Noncompliance|1|||
27777284|NCT02022657|54230471|FG000|Overall Study|Withdrawal by Subject|2|||
27777285|NCT02022657|54230472|FG001|Overall Study|Withdrawal by Subject|0|||
27777286|NCT02022657|54230473|FG002|Overall Study|Withdrawal by Subject|1|||
27777287|NCT02022657|54230474|FG003|Overall Study|Withdrawal by Subject|0|||
27777288|NCT02022657|54230475|FG004|Overall Study|Withdrawal by Subject|0|||
27777289|NCT02022657|54230476|FG005|Overall Study|Withdrawal by Subject|0|||
27777290|NCT02022657|54230471|FG000|Overall Study|Physician Decision|0|||
27777291|NCT02022657|54230472|FG001|Overall Study|Physician Decision|0|||
27777292|NCT02022657|54230473|FG002|Overall Study|Physician Decision|0|||
27777293|NCT02022657|54230474|FG003|Overall Study|Physician Decision|0|||
27777294|NCT02022657|54230475|FG004|Overall Study|Physician Decision|0|||
27777295|NCT02022657|54230476|FG005|Overall Study|Physician Decision|1|||
27777296|NCT02418455|54230482|FG000|48-Week Treatment Period|Other- Not Specified|1|||
27777297|NCT02418455|54230482|FG000|Continuation Period|Sponsor Decision|7|||
27777298|NCT02417753|54230488|FG000|Overall Study|Death|1|||
27777299|NCT02417441|54230494|FG000|Overall Study|Inconclusive due to missing data|52|||
27777300|NCT02417441|54230495|FG001|Overall Study|Inconclusive due to missing data|19|||
27777301|NCT02021643|54230508|FG000|Overall Study|Enrolled but Never Treated|1|||
27777302|NCT02021643|54230509|FG001|Overall Study|Enrolled but Never Treated|0|||
27777303|NCT02021643|54230510|FG002|Overall Study|Enrolled but Never Treated|0|||
27777304|NCT02021643|54230511|FG003|Overall Study|Enrolled but Never Treated|0|||
27777305|NCT02021643|54230508|FG000|Overall Study|Adverse Event|0|||
27777306|NCT02021643|54230509|FG001|Overall Study|Adverse Event|1|||
27777307|NCT02021643|54230510|FG002|Overall Study|Adverse Event|0|||
27777308|NCT02021643|54230511|FG003|Overall Study|Adverse Event|0|||
27777309|NCT02021643|54230508|FG000|Overall Study|Death|0|||
27777310|NCT02021643|54230509|FG001|Overall Study|Death|1|||
27777311|NCT02021643|54230510|FG002|Overall Study|Death|0|||
27777312|NCT02021643|54230511|FG003|Overall Study|Death|0|||
27777313|NCT02021643|54230508|FG000|Overall Study|Investigator's Discretion|1|||
27777314|NCT02021643|54230509|FG001|Overall Study|Investigator's Discretion|0|||
27777315|NCT02021643|54230510|FG002|Overall Study|Investigator's Discretion|0|||
27777316|NCT02021643|54230511|FG003|Overall Study|Investigator's Discretion|0|||
27777317|NCT02021643|54230508|FG000|Overall Study|Lack of Efficacy|7|||
27777318|NCT02021643|54230509|FG001|Overall Study|Lack of Efficacy|6|||
27777319|NCT02021643|54230510|FG002|Overall Study|Lack of Efficacy|0|||
27777320|NCT02021643|54230511|FG003|Overall Study|Lack of Efficacy|12|||
27777321|NCT02021643|54230508|FG000|Overall Study|Lost to Follow-up|0|||
27777322|NCT02021643|54230509|FG001|Overall Study|Lost to Follow-up|1|||
27777323|NCT02021643|54230510|FG002|Overall Study|Lost to Follow-up|0|||
27777324|NCT02021643|54230511|FG003|Overall Study|Lost to Follow-up|0|||
27777325|NCT02021643|54230508|FG000|Overall Study|Withdrew Consent|0|||
27777326|NCT02021643|54230509|FG001|Overall Study|Withdrew Consent|1|||
27777327|NCT02021643|54230510|FG002|Overall Study|Withdrew Consent|0|||
27777328|NCT02021643|54230511|FG003|Overall Study|Withdrew Consent|0|||
27777329|NCT02415959|54230532|FG000|Overall Study|Adverse Event|0|||
27777330|NCT02415959|54230533|FG001|Overall Study|Adverse Event|1|||
27777331|NCT02415959|54230534|FG002|Overall Study|Adverse Event|0|||
27777332|NCT02415959|54230535|FG003|Overall Study|Adverse Event|0|||
27777333|NCT02415959|54230536|FG004|Overall Study|Adverse Event|0|||
27777334|NCT02415959|54230532|FG000|Overall Study|Protocol Violation|0|||
27777335|NCT02415959|54230533|FG001|Overall Study|Protocol Violation|0|||
27777336|NCT02415959|54230534|FG002|Overall Study|Protocol Violation|0|||
27777337|NCT02415959|54230535|FG003|Overall Study|Protocol Violation|1|||
27777338|NCT02415959|54230536|FG004|Overall Study|Protocol Violation|0|||
27777339|NCT02021565|54230550|FG000|Baseline Through Intervention|Death|0|||
27777340|NCT02021565|54230551|FG001|Baseline Through Intervention|Death|1|||
27777341|NCT02021565|54230550|FG000|Baseline Through Intervention|Withdrawal by Subject|8|||
27777342|NCT02021565|54230551|FG001|Baseline Through Intervention|Withdrawal by Subject|8|||
27777343|NCT02021565|54230550|FG000|Baseline Through Intervention|Protocol Violation|0|||
27777344|NCT02021565|54230551|FG001|Baseline Through Intervention|Protocol Violation|7|||
27777345|NCT02021565|54230550|FG000|Baseline Through Intervention|Lost to Follow-up|4|||
27777346|NCT02021565|54230551|FG001|Baseline Through Intervention|Lost to Follow-up|2|||
27777347|NCT02021565|54230550|FG000|3-month Follow-up|Death|3|||
27777348|NCT02021565|54230551|FG001|3-month Follow-up|Death|0|||
27777349|NCT02021565|54230550|FG000|3-month Follow-up|Withdrawal by Subject|4|||
27777350|NCT02021565|54230551|FG001|3-month Follow-up|Withdrawal by Subject|0|||
27777351|NCT02021565|54230550|FG000|3-month Follow-up|Protocol Violation|3|||
27777352|NCT02021565|54230551|FG001|3-month Follow-up|Protocol Violation|2|||
27777353|NCT02021331|54230561|FG000|Overall Study|Adverse Event|0|||
27777354|NCT02021331|54230562|FG001|Overall Study|Adverse Event|2|||
27777355|NCT02085135|54230570|FG000|Overall Study|Adverse Event|4|||
27777356|NCT02085135|54230571|FG001|Overall Study|Adverse Event|7|||
27777357|NCT02085135|54230570|FG000|Overall Study|Lost to Follow-up|2|||
27777358|NCT02085135|54230571|FG001|Overall Study|Lost to Follow-up|2|||
27777359|NCT02085135|54230570|FG000|Overall Study|Withdrawal by Subject|3|||
27777360|NCT02085135|54230571|FG001|Overall Study|Withdrawal by Subject|0|||
27777361|NCT02085135|54230570|FG000|Overall Study|Lack of Efficacy|2|||
27777362|NCT02085135|54230571|FG001|Overall Study|Lack of Efficacy|0|||
27777363|NCT02441309|54230580|FG000|Overall Study|Disease progression|2|||
27777364|NCT02441309|54230581|FG001|Overall Study|Disease progression|1|||
27777365|NCT02441309|54230582|FG002|Overall Study|Disease progression|2|||
27777366|NCT02441309|54230580|FG000|Overall Study|Adverse Event|0|||
27777367|NCT02441309|54230581|FG001|Overall Study|Adverse Event|1|||
27777368|NCT02441309|54230582|FG002|Overall Study|Adverse Event|0|||
27777369|NCT02441309|54230580|FG000|Overall Study|Withdrawal by Subject|1|||
27777370|NCT02441309|54230581|FG001|Overall Study|Withdrawal by Subject|0|||
27777371|NCT02441309|54230582|FG002|Overall Study|Withdrawal by Subject|1|||
27777372|NCT02027025|54230596|FG000|Overall Study|Adverse Event|0|||
27777373|NCT02027025|54230597|FG001|Overall Study|Adverse Event|1|||
27777374|NCT02027025|54230598|FG002|Overall Study|Adverse Event|1|||
27777375|NCT02027025|54230596|FG000|Overall Study|Protocol Violation|1|||
27777376|NCT02027025|54230597|FG001|Overall Study|Protocol Violation|0|||
27777377|NCT02027025|54230598|FG002|Overall Study|Protocol Violation|0|||
27777378|NCT02027025|54230596|FG000|Overall Study|Lost to Follow-up|0|||
27777379|NCT02027025|54230597|FG001|Overall Study|Lost to Follow-up|2|||
27777380|NCT02027025|54230598|FG002|Overall Study|Lost to Follow-up|0|||
27777381|NCT02027025|54230596|FG000|Overall Study|Withdrawal by Subject|0|||
27777382|NCT02027025|54230597|FG001|Overall Study|Withdrawal by Subject|1|||
27777383|NCT02027025|54230598|FG002|Overall Study|Withdrawal by Subject|0|||
27777384|NCT02027025|54230596|FG000|Overall Study|Sponsor's decision|0|||
27777385|NCT02027025|54230597|FG001|Overall Study|Sponsor's decision|1|||
27777386|NCT02027025|54230598|FG002|Overall Study|Sponsor's decision|0|||
27777387|NCT01652729|54230620|FG000|Overall Study|Withdrawal by Subject|14|||
27777388|NCT01652729|54230621|FG001|Overall Study|Withdrawal by Subject|7|||
27777389|NCT01652729|54230622|FG002|Overall Study|Withdrawal by Subject|7|||
27777390|NCT01652729|54230620|FG000|Overall Study|Adverse Event|4|||
27777391|NCT01652729|54230621|FG001|Overall Study|Adverse Event|0|||
27777392|NCT01652729|54230622|FG002|Overall Study|Adverse Event|3|||
27777393|NCT01652729|54230620|FG000|Overall Study|Physician Decision|1|||
27777394|NCT01652729|54230621|FG001|Overall Study|Physician Decision|0|||
27777395|NCT01652729|54230622|FG002|Overall Study|Physician Decision|1|||
27777396|NCT01652729|54230620|FG000|Overall Study|Protocol Violation|1|||
27777397|NCT01652729|54230621|FG001|Overall Study|Protocol Violation|0|||
27777398|NCT01652729|54230622|FG002|Overall Study|Protocol Violation|0|||
27777399|NCT01652729|54230620|FG000|Overall Study|Lost to Follow-up|6|||
27777400|NCT01652729|54230621|FG001|Overall Study|Lost to Follow-up|6|||
27777401|NCT01652729|54230622|FG002|Overall Study|Lost to Follow-up|3|||
27777402|NCT01652729|54230620|FG000|Overall Study|Administrative|1|||
27777403|NCT01652729|54230621|FG001|Overall Study|Administrative|0|||
27777404|NCT01652729|54230622|FG002|Overall Study|Administrative|0|||
27777405|NCT02083965|54230632|FG000|Treatment Period|Other|1|||
27777406|NCT02083965|54230633|FG001|Treatment Period|Other|0|||
27777407|NCT02438813|54230641|FG000|Overall Study|Patient Decision|59|||
27777408|NCT02438813|54230641|FG000|Overall Study|Patient Lost to Follow-Up|137|||
27777409|NCT02438813|54230641|FG000|Overall Study|Study Ended by Sponsor|80|||
27777410|NCT02438813|54230641|FG000|Overall Study|Patients Not Treated/No EOT Visit|249|||
27777411|NCT02437409|54230655|FG000|Overall Study|Withdrawal by Subject|3|||
27777412|NCT02437409|54230655|FG000|Overall Study|Screening failure|12|||
27777413|NCT02459093|54230662|FG000|Overall Study|Protocol Violation|6|||
27777414|NCT02459093|54230663|FG001|Overall Study|Protocol Violation|11|||
27777415|NCT02459093|54230662|FG000|Overall Study|Lost to Follow-up|6|||
27777416|NCT02459093|54230663|FG001|Overall Study|Lost to Follow-up|7|||
27777417|NCT02458469|54230669|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
27777418|NCT02458469|54230670|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
27777419|NCT02458469|54230671|FG002|First Intervention (2 Weeks)|Lost to Follow-up|1|||
27777420|NCT02458469|54230672|FG003|First Intervention (2 Weeks)|Lost to Follow-up|0|||
27851615|NCT00985673|54351078|FG004|Overall Study|Lost to Follow-up|5|||
27777421|NCT02458469|54230673|FG004|First Intervention (2 Weeks)|Lost to Follow-up|0|||
27777422|NCT02458469|54230674|FG005|First Intervention (2 Weeks)|Lost to Follow-up|0|||
27777423|NCT02458469|54230669|FG000|First Intervention (2 Weeks)|Physician Decision|1|||
27777424|NCT02458469|54230670|FG001|First Intervention (2 Weeks)|Physician Decision|0|||
27777425|NCT02458469|54230671|FG002|First Intervention (2 Weeks)|Physician Decision|0|||
27777426|NCT02458469|54230672|FG003|First Intervention (2 Weeks)|Physician Decision|0|||
27777427|NCT02458469|54230673|FG004|First Intervention (2 Weeks)|Physician Decision|0|||
27777428|NCT02458469|54230674|FG005|First Intervention (2 Weeks)|Physician Decision|0|||
27777429|NCT02458469|54230669|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
27777430|NCT02458469|54230670|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
27777431|NCT02458469|54230671|FG002|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
27777432|NCT02458469|54230672|FG003|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
27777433|NCT02458469|54230673|FG004|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
27777434|NCT02458469|54230674|FG005|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
27777435|NCT01843348|54230685|FG000|Overall Study|Withdrawal by Subject|4|||
27777436|NCT01843348|54230686|FG001|Overall Study|Withdrawal by Subject|16|||
27777437|NCT01843348|54230687|FG002|Overall Study|Withdrawal by Subject|18|||
27777438|NCT01843348|54230685|FG000|Overall Study|Lost to Follow-up|5|||
27777439|NCT01843348|54230686|FG001|Overall Study|Lost to Follow-up|4|||
27777440|NCT01843348|54230687|FG002|Overall Study|Lost to Follow-up|2|||
27840477|NCT01464827|54328175|FG001|Overall Study|Withdrawal by Subject|0|||
27840478|NCT01464827|54328176|FG002|Overall Study|Withdrawal by Subject|0|||
27840479|NCT01464827|54328177|FG003|Overall Study|Withdrawal by Subject|0|||
27840480|NCT01464827|54328178|FG004|Overall Study|Withdrawal by Subject|1|||
27840481|NCT01464827|54328179|FG005|Overall Study|Withdrawal by Subject|0|||
27840482|NCT01464827|54328180|FG006|Overall Study|Withdrawal by Subject|0|||
27840483|NCT01464827|54328181|FG007|Overall Study|Withdrawal by Subject|1|||
27840484|NCT01464827|54328182|FG008|Overall Study|Withdrawal by Subject|0|||
27840485|NCT01464827|54328183|FG009|Overall Study|Withdrawal by Subject|0|||
27840486|NCT01464827|54328184|FG010|Overall Study|Withdrawal by Subject|0|||
27777441|NCT01843348|54230685|FG000|Overall Study|Death|5|||
27777442|NCT01843348|54230686|FG001|Overall Study|Death|3|||
27777443|NCT01843348|54230687|FG002|Overall Study|Death|4|||
27777444|NCT01843348|54230685|FG000|Overall Study|Graft loss/retransplantation|5|||
27777445|NCT01843348|54230686|FG001|Overall Study|Graft loss/retransplantation|8|||
27777446|NCT01843348|54230687|FG002|Overall Study|Graft loss/retransplantation|11|||
27777447|NCT01843348|54230685|FG000|Overall Study|Various reasons|4|||
27777448|NCT01843348|54230686|FG001|Overall Study|Various reasons|9|||
27777449|NCT01843348|54230687|FG002|Overall Study|Various reasons|6|||
27777450|NCT01843192|54230700|FG000|Overall Study|Intra-operative exclusions per protocol|2|||
27777451|NCT01843192|54230701|FG001|Overall Study|Intra-operative exclusions per protocol|6|||
27777452|NCT01843192|54230702|FG002|Overall Study|Intra-operative exclusions per protocol|2|||
27777453|NCT01825876|54230710|FG000|Period 2|Withdrawal by Subject|0|||
27777454|NCT01825876|54230711|FG001|Period 2|Withdrawal by Subject|1|||
27777455|NCT01842958|54230722|FG000|Overall Study|Lost to Follow-up|1|||
27777456|NCT01842958|54230723|FG001|Overall Study|Lost to Follow-up|1|||
27777457|NCT02413229|54230737|FG000|Overall Study|Adverse Event|0|||
27777458|NCT02413229|54230738|FG001|Overall Study|Adverse Event|0|||
27777459|NCT02413229|54230739|FG002|Overall Study|Adverse Event|0|||
27777460|NCT02413229|54230740|FG003|Overall Study|Adverse Event|1|||
27777461|NCT02413229|54230741|FG004|Overall Study|Adverse Event|0|||
27777462|NCT02413229|54230742|FG005|Overall Study|Adverse Event|0|||
27777463|NCT02413229|54230743|FG006|Overall Study|Adverse Event|0|||
27777464|NCT02413229|54230744|FG007|Overall Study|Adverse Event|1|||
27777465|NCT02413229|54230737|FG000|Overall Study|Lost to Follow-up|0|||
27777466|NCT02413229|54230738|FG001|Overall Study|Lost to Follow-up|0|||
27777467|NCT02413229|54230739|FG002|Overall Study|Lost to Follow-up|1|||
27777468|NCT02413229|54230740|FG003|Overall Study|Lost to Follow-up|0|||
27777469|NCT02413229|54230741|FG004|Overall Study|Lost to Follow-up|2|||
27777470|NCT02413229|54230742|FG005|Overall Study|Lost to Follow-up|0|||
27777471|NCT02413229|54230743|FG006|Overall Study|Lost to Follow-up|0|||
27777472|NCT02413229|54230744|FG007|Overall Study|Lost to Follow-up|0|||
27777473|NCT02413229|54230737|FG000|Overall Study|Withdrawal by Subject|1|||
27777474|NCT02413229|54230738|FG001|Overall Study|Withdrawal by Subject|1|||
27777475|NCT02413229|54230739|FG002|Overall Study|Withdrawal by Subject|0|||
27777476|NCT02413229|54230740|FG003|Overall Study|Withdrawal by Subject|0|||
27777477|NCT02413229|54230741|FG004|Overall Study|Withdrawal by Subject|1|||
27777478|NCT02413229|54230742|FG005|Overall Study|Withdrawal by Subject|0|||
27777479|NCT02413229|54230743|FG006|Overall Study|Withdrawal by Subject|0|||
27840487|NCT01464827|54328185|FG011|Overall Study|Withdrawal by Subject|0|||
27777480|NCT02413229|54230744|FG007|Overall Study|Withdrawal by Subject|2|||
27777481|NCT02413229|54230737|FG000|Overall Study|Progressive Disease|0|||
27777482|NCT02413229|54230738|FG001|Overall Study|Progressive Disease|0|||
27777483|NCT02413229|54230739|FG002|Overall Study|Progressive Disease|0|||
27777484|NCT02413229|54230740|FG003|Overall Study|Progressive Disease|0|||
27840488|NCT01464827|54328186|FG012|Overall Study|Withdrawal by Subject|0|||
27777485|NCT02413229|54230741|FG004|Overall Study|Progressive Disease|0|||
27777486|NCT02413229|54230742|FG005|Overall Study|Progressive Disease|0|||
27777487|NCT02413229|54230743|FG006|Overall Study|Progressive Disease|0|||
27777488|NCT02413229|54230744|FG007|Overall Study|Progressive Disease|1|||
27777489|NCT01825798|54230764|FG000|Overall Study|Adverse Event|1|||
27777490|NCT01825798|54230765|FG001|Overall Study|Adverse Event|5|||
27777491|NCT01825798|54230764|FG000|Overall Study|Lost to Follow-up|1|||
27777492|NCT01825798|54230765|FG001|Overall Study|Lost to Follow-up|0|||
27777493|NCT01824472|54230774|FG000|Overall Study|Lost to Follow-up|0|||
27777494|NCT01824472|54230775|FG001|Overall Study|Lost to Follow-up|0|||
27777495|NCT01824472|54230776|FG002|Overall Study|Lost to Follow-up|1|||
27777496|NCT01824472|54230774|FG000|Overall Study|Withdrawal by Subject|1|||
27777497|NCT01824472|54230775|FG001|Overall Study|Withdrawal by Subject|5|||
27777498|NCT01824472|54230776|FG002|Overall Study|Withdrawal by Subject|3|||
27777499|NCT01824472|54230774|FG000|Overall Study|Ineligible post randomization&screening|0|||
27777500|NCT01824472|54230775|FG001|Overall Study|Ineligible post randomization&screening|2|||
27777501|NCT01824472|54230776|FG002|Overall Study|Ineligible post randomization&screening|0|||
27777502|NCT02412761|54230784|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
27777503|NCT02412761|54230785|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
27777504|NCT02412761|54230786|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
27777505|NCT02412761|54230787|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
27777506|NCT02412761|54230788|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
27777507|NCT02412761|54230789|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
27777508|NCT01842334|54230799|FG000|Overall Study|Withdrawal by Subject|3|||
27777509|NCT01842334|54230800|FG001|Overall Study|Withdrawal by Subject|3|||
27777510|NCT01842334|54230799|FG000|Overall Study|Moved away mid-study|0|||
27777511|NCT01842334|54230800|FG001|Overall Study|Moved away mid-study|1|||
27777512|NCT02457611|54230806|FG000|Overall Study|Lost to Follow-up|3|||
27777513|NCT02457065|54230812|FG000|Overall Study|Lost to Follow-up|9|||
27777514|NCT02457065|54230813|FG001|Overall Study|Lost to Follow-up|11|||
27777515|NCT02083653|54230822|FG000|Overall Study|Randomized but not Treated|0|||
27777516|NCT02083653|54230823|FG001|Overall Study|Randomized but not Treated|2|||
27777517|NCT02083653|54230824|FG002|Overall Study|Randomized but not Treated|7|||
27777518|NCT02083653|54230822|FG000|Overall Study|Adverse Event|12|||
27777519|NCT02083653|54230823|FG001|Overall Study|Adverse Event|5|||
27777520|NCT02083653|54230824|FG002|Overall Study|Adverse Event|4|||
27777521|NCT02083653|54230822|FG000|Overall Study|Lost to Follow-up|1|||
27777522|NCT02083653|54230823|FG001|Overall Study|Lost to Follow-up|0|||
27777523|NCT02083653|54230824|FG002|Overall Study|Lost to Follow-up|0|||
27777524|NCT02083653|54230822|FG000|Overall Study|Death|2|||
27777525|NCT02083653|54230823|FG001|Overall Study|Death|2|||
27777526|NCT02083653|54230824|FG002|Overall Study|Death|2|||
27777527|NCT02083653|54230822|FG000|Overall Study|Progressive Disease|65|||
27777528|NCT02083653|54230823|FG001|Overall Study|Progressive Disease|73|||
27777529|NCT02083653|54230824|FG002|Overall Study|Progressive Disease|63|||
27777530|NCT02083653|54230822|FG000|Overall Study|Withdrawal by Subject|2|||
27777531|NCT02083653|54230823|FG001|Overall Study|Withdrawal by Subject|1|||
27777532|NCT02083653|54230824|FG002|Overall Study|Withdrawal by Subject|2|||
27777533|NCT02083653|54230822|FG000|Overall Study|Other Events|0|||
27777534|NCT02083653|54230823|FG001|Overall Study|Other Events|2|||
27777535|NCT02083653|54230824|FG002|Overall Study|Other Events|2|||
27777536|NCT02083653|54230822|FG000|Overall Study|Reason Missing|0|||
27777537|NCT02083653|54230823|FG001|Overall Study|Reason Missing|0|||
27777538|NCT02083653|54230824|FG002|Overall Study|Reason Missing|4|||
27777539|NCT02436239|54230836|FG000|Open-Lable Treatment Period|Adverse Event|12|||
27777540|NCT02436239|54230837|FG001|Open-Lable Treatment Period|Adverse Event|3|||
27777541|NCT02436239|54230838|FG002|Open-Lable Treatment Period|Adverse Event|4|||
27777542|NCT02436239|54230839|FG003|Open-Lable Treatment Period|Adverse Event|2|||
27777543|NCT02436239|54230836|FG000|Open-Lable Treatment Period|Lack of Efficacy|1|||
27777544|NCT02436239|54230837|FG001|Open-Lable Treatment Period|Lack of Efficacy|6|||
27777545|NCT02436239|54230838|FG002|Open-Lable Treatment Period|Lack of Efficacy|6|||
27777546|NCT02436239|54230839|FG003|Open-Lable Treatment Period|Lack of Efficacy|1|||
27840489|NCT01464827|54328187|FG013|Overall Study|Withdrawal by Subject|0|||
27777547|NCT02436239|54230836|FG000|Open-Lable Treatment Period|Withdrawal by Subject|10|||
27777548|NCT02436239|54230837|FG001|Open-Lable Treatment Period|Withdrawal by Subject|15|||
27777549|NCT02436239|54230838|FG002|Open-Lable Treatment Period|Withdrawal by Subject|9|||
27777550|NCT02436239|54230839|FG003|Open-Lable Treatment Period|Withdrawal by Subject|0|||
27777551|NCT02436239|54230836|FG000|Open-Lable Treatment Period|Lost to Follow-up|4|||
27777552|NCT02436239|54230837|FG001|Open-Lable Treatment Period|Lost to Follow-up|2|||
27777553|NCT02436239|54230838|FG002|Open-Lable Treatment Period|Lost to Follow-up|4|||
27777554|NCT02436239|54230839|FG003|Open-Lable Treatment Period|Lost to Follow-up|1|||
27777555|NCT02436239|54230836|FG000|Open-Lable Treatment Period|Protocol Violation|0|||
27777556|NCT02436239|54230837|FG001|Open-Lable Treatment Period|Protocol Violation|1|||
27777557|NCT02436239|54230838|FG002|Open-Lable Treatment Period|Protocol Violation|1|||
27777558|NCT02436239|54230839|FG003|Open-Lable Treatment Period|Protocol Violation|0|||
27777559|NCT02436239|54230836|FG000|Open-Lable Treatment Period|Noncompliance with Study Drug|5|||
27777560|NCT02436239|54230837|FG001|Open-Lable Treatment Period|Noncompliance with Study Drug|6|||
27777561|NCT02436239|54230838|FG002|Open-Lable Treatment Period|Noncompliance with Study Drug|3|||
27777562|NCT02436239|54230839|FG003|Open-Lable Treatment Period|Noncompliance with Study Drug|1|||
27777563|NCT02436239|54230836|FG000|Open-Lable Treatment Period|Other Reason|1|||
27777564|NCT02436239|54230837|FG001|Open-Lable Treatment Period|Other Reason|1|||
27777565|NCT02436239|54230838|FG002|Open-Lable Treatment Period|Other Reason|0|||
27777566|NCT02436239|54230839|FG003|Open-Lable Treatment Period|Other Reason|0|||
27777567|NCT02436239|54230836|FG000|Down-Taper Period|Withdrawal by Subject|4|||
27777568|NCT02436239|54230837|FG001|Down-Taper Period|Withdrawal by Subject|4|||
27777569|NCT02436239|54230838|FG002|Down-Taper Period|Withdrawal by Subject|1|||
27777570|NCT02436239|54230839|FG003|Down-Taper Period|Withdrawal by Subject|2|||
27777571|NCT02026011|54230851|FG000|Allocation 1 (First Set of Medication)|Side Effects|6|||
27777572|NCT02026011|54230852|FG001|Allocation 1 (First Set of Medication)|Side Effects|0|||
27777573|NCT02026011|54230851|FG000|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1|||
27777574|NCT02026011|54230852|FG001|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2|||
27777575|NCT02026011|54230851|FG000|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1|||
27777576|NCT02026011|54230852|FG001|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0|||
27777577|NCT02026011|54230851|FG000|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1|||
27777578|NCT02026011|54230852|FG001|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2|||
27777579|NCT02436005|54230861|FG000|Second Intervention|Adverse Event|0|||
27777580|NCT02436005|54230862|FG001|Second Intervention|Adverse Event|1|||
27777581|NCT02456909|54230870|FG000|Overall Study|Did not receive allocated intervention|24|||
27777582|NCT02456909|54230871|FG001|Overall Study|Did not receive allocated intervention|26|||
27777583|NCT02456909|54230870|FG000|Overall Study|Did not complete the primary outcome|0|||
27777584|NCT02456909|54230871|FG001|Overall Study|Did not complete the primary outcome|1|||
27777585|NCT02025621|54230879|FG000|Overall Study|Withdrawal by Subject|1|||
27777586|NCT02025621|54230880|FG001|Overall Study|Withdrawal by Subject|0|||
27777587|NCT02025621|54230879|FG000|Overall Study|Death|0|||
27777588|NCT02025621|54230880|FG001|Overall Study|Death|1|||
27777589|NCT02025621|54230879|FG000|Overall Study|No longer eligible|10|||
27777590|NCT02025621|54230880|FG001|Overall Study|No longer eligible|15|||
27777591|NCT02025621|54230879|FG000|Overall Study|Surgery initiated before infusion|3|||
27777592|NCT02025621|54230880|FG001|Overall Study|Surgery initiated before infusion|3|||
27777593|NCT02020941|54230886|FG000|Overall Study|Adverse Event|1|||
27777594|NCT02020941|54230886|FG000|Overall Study|Physician Decision|2|||
27777595|NCT02020941|54230886|FG000|Overall Study|Withdrawal by Subject|1|||
27777596|NCT02020941|54230886|FG000|Overall Study|Disease Progression|4|||
27777597|NCT02024529|54230892|FG000|Overall Study|Withdrawal by Subject|11|||
27777598|NCT02024529|54230893|FG001|Overall Study|Withdrawal by Subject|21|||
27777599|NCT02024529|54230892|FG000|Overall Study|Lost to Follow-up|2|||
27777600|NCT02024529|54230893|FG001|Overall Study|Lost to Follow-up|4|||
27777601|NCT02020863|54230901|FG000|Overall Study|Discovery of Metastatic disease|4|||
27777602|NCT02020863|54230901|FG000|Overall Study|Team chose not to place an a line|1|||
27777603|NCT01824394|54230908|FG000|Overall Study|Early Termination|1|||
27777604|NCT01824394|54230909|FG001|Overall Study|Early Termination|1|||
27777605|NCT01824394|54230910|FG002|Overall Study|Early Termination|3|||
27777606|NCT01824394|54230908|FG000|Overall Study|Withdrawn due to Study Termination|91|||
27777607|NCT01824394|54230909|FG001|Overall Study|Withdrawn due to Study Termination|83|||
27777608|NCT01824394|54230910|FG002|Overall Study|Withdrawn due to Study Termination|41|||
27777609|NCT01824394|54230908|FG000|Overall Study|Lost to Follow-up|0|||
27777610|NCT01824394|54230909|FG001|Overall Study|Lost to Follow-up|9|||
27777611|NCT01824394|54230910|FG002|Overall Study|Lost to Follow-up|3|||
27777612|NCT01824394|54230908|FG000|Overall Study|Death|3|||
27777613|NCT01824394|54230909|FG001|Overall Study|Death|2|||
27777614|NCT01824394|54230910|FG002|Overall Study|Death|4|||
27777615|NCT01824394|54230908|FG000|Overall Study|Discontinued Subjects|1|||
27777616|NCT01824394|54230909|FG001|Overall Study|Discontinued Subjects|1|||
27777617|NCT01824394|54230910|FG002|Overall Study|Discontinued Subjects|2|||
27777618|NCT01824394|54230908|FG000|Overall Study|Excluded Subjects(No catheter inserted)|23|||
27777619|NCT01824394|54230909|FG001|Overall Study|Excluded Subjects(No catheter inserted)|20|||
27777620|NCT01824394|54230910|FG002|Overall Study|Excluded Subjects(No catheter inserted)|21|||
27777621|NCT01823536|54230924|FG000|Overall Study|Lost to Follow-up|1|||
27777622|NCT01823536|54230925|FG001|Overall Study|Lost to Follow-up|0|||
27777623|NCT01823536|54230926|FG002|Overall Study|Lost to Follow-up|0|||
27777624|NCT01823536|54230927|FG003|Overall Study|Lost to Follow-up|1|||
27777625|NCT01823536|54230928|FG004|Overall Study|Lost to Follow-up|1|||
27777626|NCT01823536|54230929|FG005|Overall Study|Lost to Follow-up|0|||
27777627|NCT01823536|54230924|FG000|Overall Study|Protocol Violation|0|||
27777628|NCT01823536|54230925|FG001|Overall Study|Protocol Violation|1|||
27777629|NCT01823536|54230926|FG002|Overall Study|Protocol Violation|0|||
27777630|NCT01823536|54230927|FG003|Overall Study|Protocol Violation|0|||
27777631|NCT01823536|54230928|FG004|Overall Study|Protocol Violation|0|||
27777632|NCT01823536|54230929|FG005|Overall Study|Protocol Violation|0|||
27777633|NCT01823536|54230924|FG000|Overall Study|Withdrawal by Subject|1|||
27777634|NCT01823536|54230925|FG001|Overall Study|Withdrawal by Subject|1|||
27777635|NCT01823536|54230926|FG002|Overall Study|Withdrawal by Subject|0|||
27777636|NCT01823536|54230927|FG003|Overall Study|Withdrawal by Subject|0|||
27777637|NCT01823536|54230928|FG004|Overall Study|Withdrawal by Subject|0|||
27777638|NCT01823536|54230929|FG005|Overall Study|Withdrawal by Subject|0|||
27777639|NCT01823536|54230924|FG000|Overall Study|Visit 1 delayed, unable to reschedule|0|||
27777640|NCT01823536|54230925|FG001|Overall Study|Visit 1 delayed, unable to reschedule|0|||
27777641|NCT01823536|54230926|FG002|Overall Study|Visit 1 delayed, unable to reschedule|1|||
27777642|NCT01823536|54230927|FG003|Overall Study|Visit 1 delayed, unable to reschedule|0|||
27777643|NCT01823536|54230928|FG004|Overall Study|Visit 1 delayed, unable to reschedule|0|||
27777644|NCT01823536|54230929|FG005|Overall Study|Visit 1 delayed, unable to reschedule|0|||
27777645|NCT01823536|54230924|FG000|Overall Study|Met exclusion criterion No 6|0|||
27777646|NCT01823536|54230925|FG001|Overall Study|Met exclusion criterion No 6|0|||
27777647|NCT01823536|54230926|FG002|Overall Study|Met exclusion criterion No 6|0|||
27777648|NCT01823536|54230927|FG003|Overall Study|Met exclusion criterion No 6|1|||
27777649|NCT01823536|54230928|FG004|Overall Study|Met exclusion criterion No 6|0|||
27777650|NCT01823536|54230929|FG005|Overall Study|Met exclusion criterion No 6|0|||
27777651|NCT01823536|54230924|FG000|Overall Study|Subject moved out of the state|0|||
27777652|NCT01823536|54230925|FG001|Overall Study|Subject moved out of the state|0|||
27777653|NCT01823536|54230926|FG002|Overall Study|Subject moved out of the state|0|||
27777654|NCT01823536|54230927|FG003|Overall Study|Subject moved out of the state|0|||
27777655|NCT01823536|54230928|FG004|Overall Study|Subject moved out of the state|1|||
27777656|NCT01823536|54230929|FG005|Overall Study|Subject moved out of the state|0|||
27777657|NCT01841554|54230942|FG000|Overall Study|Death|7|||
27777658|NCT01841554|54230942|FG000|Overall Study|No Implantation|1|||
27777659|NCT01841554|54230942|FG000|Overall Study|Discontinued Follow Up|5|||
27777660|NCT01841554|54230942|FG000|Overall Study|Study exit due to secondary intervention|6|||
27777661|NCT01823224|54230948|FG000|Overall Study|Lost to Follow-up|5|||
27777662|NCT01823224|54230949|FG001|Overall Study|Lost to Follow-up|6|||
27777663|NCT01823224|54230948|FG000|Overall Study|didn't qualify|1|||
27777664|NCT01823224|54230949|FG001|Overall Study|didn't qualify|2|||
27777665|NCT01823224|54230948|FG000|Overall Study|pharmacy error|0|||
27777666|NCT01823224|54230949|FG001|Overall Study|pharmacy error|1|||
27777667|NCT01823224|54230948|FG000|Overall Study|missed med dose|0|||
27777668|NCT01823224|54230949|FG001|Overall Study|missed med dose|1|||
27777669|NCT01823224|54230948|FG000|Overall Study|Withdrawal by Subject|0|||
27777670|NCT01823224|54230949|FG001|Overall Study|Withdrawal by Subject|1|||
27777671|NCT01840228|54230959|FG000|Overall Study|Lost to Follow-up|1|||
27777672|NCT01840228|54230960|FG001|Overall Study|Lost to Follow-up|1|||
27777673|NCT01839916|54230970|FG000|Overall Study|Death|9|||
27777674|NCT01839916|54230970|FG000|Overall Study|Physician Decision|17|||
27777675|NCT01839916|54230970|FG000|Overall Study|Relapse|12|||
27777676|NCT01839916|54230970|FG000|Overall Study|GVHD|2|||
27777677|NCT01839916|54230970|FG000|Overall Study|Graft Failure|1|||
27777678|NCT01823146|54230976|FG000|Overall Study|Withdrawal by Subject|0|||
27777679|NCT01823146|54230977|FG001|Overall Study|Withdrawal by Subject|1|||
27777680|NCT01823146|54230976|FG000|Overall Study|Lost to Follow-up|2|||
27777681|NCT01823146|54230977|FG001|Overall Study|Lost to Follow-up|1|||
27777682|NCT02083185|54230986|FG000|Overall Study|Lost to Follow-up|0|||
27777683|NCT02083185|54230987|FG001|Overall Study|Lost to Follow-up|3|||
27777684|NCT02083185|54230988|FG002|Overall Study|Lost to Follow-up|0|||
27777685|NCT02083185|54230986|FG000|Overall Study|Withdrawal by Subject|9|||
27777686|NCT02083185|54230987|FG001|Overall Study|Withdrawal by Subject|15|||
27777687|NCT02083185|54230988|FG002|Overall Study|Withdrawal by Subject|1|||
27777688|NCT02083185|54230986|FG000|Overall Study|Death|2|||
27777689|NCT02083185|54230987|FG001|Overall Study|Death|2|||
27777690|NCT02083185|54230988|FG002|Overall Study|Death|1|||
27777691|NCT02083185|54230986|FG000|Overall Study|Reason not Specified|9|||
27777692|NCT02083185|54230987|FG001|Overall Study|Reason not Specified|6|||
27777693|NCT02083185|54230988|FG002|Overall Study|Reason not Specified|5|||
27777694|NCT02083185|54230986|FG000|Overall Study|Study Terminated by Sponsor|0|||
27777695|NCT02083185|54230987|FG001|Overall Study|Study Terminated by Sponsor|1|||
27777696|NCT02083185|54230988|FG002|Overall Study|Study Terminated by Sponsor|0|||
27777697|NCT02083185|54230986|FG000|Overall Study|Did not Receive Study Drug|0|||
27777698|NCT02083185|54230987|FG001|Overall Study|Did not Receive Study Drug|2|||
27777699|NCT02083185|54230988|FG002|Overall Study|Did not Receive Study Drug|0|||
27777700|NCT02019927|54231002|FG000|Overall Study|Lost to Follow-up|2|||
27777701|NCT02019927|54231003|FG001|Overall Study|Lost to Follow-up|4|||
27777702|NCT02019927|54231004|FG002|Overall Study|Lost to Follow-up|1|||
27777703|NCT02019927|54231005|FG003|Overall Study|Lost to Follow-up|2|||
27777704|NCT02019927|54231006|FG004|Overall Study|Lost to Follow-up|3|||
27777705|NCT02019927|54231007|FG005|Overall Study|Lost to Follow-up|1|||
27777706|NCT02412371|54231031|FG000|Overall Study|Withdrawal by Subject|0|||
27777707|NCT02412371|54231032|FG001|Overall Study|Withdrawal by Subject|2|||
27777708|NCT02412371|54231033|FG002|Overall Study|Withdrawal by Subject|0|||
27777709|NCT02412371|54231034|FG003|Overall Study|Withdrawal by Subject|1|||
27777710|NCT02412371|54231035|FG004|Overall Study|Withdrawal by Subject|1|||
27777711|NCT02412371|54231036|FG005|Overall Study|Withdrawal by Subject|0|||
27777712|NCT02412371|54231031|FG000|Overall Study|Sponsor Discontinued Study|1|||
27777713|NCT02412371|54231032|FG001|Overall Study|Sponsor Discontinued Study|4|||
27777714|NCT02412371|54231033|FG002|Overall Study|Sponsor Discontinued Study|6|||
27777715|NCT02412371|54231034|FG003|Overall Study|Sponsor Discontinued Study|4|||
27777716|NCT02412371|54231035|FG004|Overall Study|Sponsor Discontinued Study|5|||
27777717|NCT02412371|54231036|FG005|Overall Study|Sponsor Discontinued Study|0|||
27777718|NCT02412371|54231031|FG000|Overall Study|Death|4|||
27777719|NCT02412371|54231032|FG001|Overall Study|Death|2|||
27777720|NCT02412371|54231033|FG002|Overall Study|Death|1|||
27777721|NCT02412371|54231034|FG003|Overall Study|Death|3|||
27777722|NCT02412371|54231035|FG004|Overall Study|Death|5|||
27777723|NCT02412371|54231036|FG005|Overall Study|Death|2|||
27777724|NCT02412371|54231031|FG000|Overall Study|Other|2|||
27777725|NCT02412371|54231032|FG001|Overall Study|Other|1|||
27777726|NCT02412371|54231033|FG002|Overall Study|Other|0|||
27777727|NCT02412371|54231034|FG003|Overall Study|Other|0|||
27777728|NCT02412371|54231035|FG004|Overall Study|Other|1|||
27777729|NCT02412371|54231036|FG005|Overall Study|Other|3|||
27777730|NCT02411747|54231053|FG000|Overall Study|Withdrawal by Subject|1|||
27777731|NCT02411747|54231054|FG001|Overall Study|Withdrawal by Subject|0|||
27777732|NCT02411747|54231053|FG000|Overall Study|Protocol Violation|2|||
27777733|NCT02411747|54231054|FG001|Overall Study|Protocol Violation|4|||
27777734|NCT01822756|54231065|FG000|Overall Study|Adverse Event|0|||
27777735|NCT01822756|54231066|FG001|Overall Study|Adverse Event|0|||
27777736|NCT01822756|54231067|FG002|Overall Study|Adverse Event|0|||
27777737|NCT01822756|54231068|FG003|Overall Study|Adverse Event|2|||
27777738|NCT01822756|54231069|FG004|Overall Study|Adverse Event|0|||
27777739|NCT01822756|54231065|FG000|Overall Study|Disease progression|11|||
27777740|NCT01822756|54231066|FG001|Overall Study|Disease progression|1|||
27777741|NCT01822756|54231067|FG002|Overall Study|Disease progression|7|||
27777742|NCT01822756|54231068|FG003|Overall Study|Disease progression|2|||
27777743|NCT01822756|54231069|FG004|Overall Study|Disease progression|6|||
27777744|NCT01822756|54231065|FG000|Overall Study|Death|2|||
27777745|NCT01822756|54231066|FG001|Overall Study|Death|2|||
27777746|NCT01822756|54231067|FG002|Overall Study|Death|1|||
27777747|NCT01822756|54231068|FG003|Overall Study|Death|0|||
27777748|NCT01822756|54231069|FG004|Overall Study|Death|0|||
27777749|NCT01822756|54231065|FG000|Overall Study|Lost to Follow-up|1|||
27777750|NCT01822756|54231066|FG001|Overall Study|Lost to Follow-up|0|||
27777751|NCT01822756|54231067|FG002|Overall Study|Lost to Follow-up|1|||
27777752|NCT01822756|54231068|FG003|Overall Study|Lost to Follow-up|0|||
27777753|NCT01822756|54231069|FG004|Overall Study|Lost to Follow-up|1|||
27840490|NCT01464827|54328174|FG000|Overall Study|Lost to Follow-up|0|||
27840491|NCT01464827|54328175|FG001|Overall Study|Lost to Follow-up|2|||
27840492|NCT01464827|54328176|FG002|Overall Study|Lost to Follow-up|0|||
27840493|NCT01464827|54328177|FG003|Overall Study|Lost to Follow-up|2|||
27840494|NCT01464827|54328178|FG004|Overall Study|Lost to Follow-up|3|||
27840495|NCT01464827|54328179|FG005|Overall Study|Lost to Follow-up|1|||
27840496|NCT01464827|54328180|FG006|Overall Study|Lost to Follow-up|2|||
27840497|NCT01464827|54328181|FG007|Overall Study|Lost to Follow-up|2|||
27840498|NCT01464827|54328182|FG008|Overall Study|Lost to Follow-up|0|||
27840499|NCT01464827|54328183|FG009|Overall Study|Lost to Follow-up|0|||
27840500|NCT01464827|54328184|FG010|Overall Study|Lost to Follow-up|0|||
27777754|NCT01822756|54231065|FG000|Overall Study|Physician Decision|0|||
27777755|NCT01822756|54231066|FG001|Overall Study|Physician Decision|1|||
27777756|NCT01822756|54231067|FG002|Overall Study|Physician Decision|0|||
27777757|NCT01822756|54231068|FG003|Overall Study|Physician Decision|0|||
27777758|NCT01822756|54231069|FG004|Overall Study|Physician Decision|0|||
27777759|NCT01822756|54231065|FG000|Overall Study|disease progression & patient preference|2|||
27777760|NCT01822756|54231066|FG001|Overall Study|disease progression & patient preference|0|||
27777761|NCT01822756|54231067|FG002|Overall Study|disease progression & patient preference|1|||
27777762|NCT01822756|54231068|FG003|Overall Study|disease progression & patient preference|0|||
27840501|NCT01464827|54328185|FG011|Overall Study|Lost to Follow-up|1|||
27840502|NCT01464827|54328186|FG012|Overall Study|Lost to Follow-up|0|||
27777763|NCT01822756|54231069|FG004|Overall Study|disease progression & patient preference|0|||
27777764|NCT01822678|54231084|FG000|Overall Study|Withdrawal by Subject|5|||
27777765|NCT01822678|54231085|FG001|Overall Study|Withdrawal by Subject|4|||
27777766|NCT01822678|54231086|FG002|Overall Study|Withdrawal by Subject|4|||
27777767|NCT01822678|54231084|FG000|Overall Study|Adverse Event|4|||
27777768|NCT01822678|54231085|FG001|Overall Study|Adverse Event|3|||
27777769|NCT01822678|54231086|FG002|Overall Study|Adverse Event|1|||
27777770|NCT01822678|54231084|FG000|Overall Study|Lack of Efficacy|3|||
27777771|NCT01822678|54231085|FG001|Overall Study|Lack of Efficacy|6|||
27777772|NCT01822678|54231086|FG002|Overall Study|Lack of Efficacy|5|||
27777773|NCT01822678|54231084|FG000|Overall Study|Lost to Follow-up|0|||
27777774|NCT01822678|54231085|FG001|Overall Study|Lost to Follow-up|2|||
27777775|NCT01822678|54231086|FG002|Overall Study|Lost to Follow-up|1|||
27777776|NCT01822366|54231098|FG000|Overall Study|Lost to Follow-up|5|||
27777777|NCT01822366|54231099|FG001|Overall Study|Lost to Follow-up|1|||
27777778|NCT01822366|54231100|FG002|Overall Study|Lost to Follow-up|5|||
27777779|NCT01822366|54231101|FG003|Overall Study|Lost to Follow-up|1|||
27777780|NCT01822366|54231098|FG000|Overall Study|Withdrawal by Subject|0|||
27777781|NCT01822366|54231099|FG001|Overall Study|Withdrawal by Subject|6|||
27777782|NCT01822366|54231100|FG002|Overall Study|Withdrawal by Subject|0|||
27777783|NCT01822366|54231101|FG003|Overall Study|Withdrawal by Subject|6|||
27777784|NCT01822366|54231098|FG000|Overall Study|Partial Intervention Completion|0|||
27777785|NCT01822366|54231099|FG001|Overall Study|Partial Intervention Completion|15|||
27777786|NCT01822366|54231100|FG002|Overall Study|Partial Intervention Completion|0|||
27777787|NCT01822366|54231101|FG003|Overall Study|Partial Intervention Completion|15|||
27777788|NCT01838590|54231133|FG000|Overall Study|Lack of Efficacy|12|||
27777789|NCT01838590|54231134|FG001|Overall Study|Lack of Efficacy|4|||
27777790|NCT01838590|54231133|FG000|Overall Study|Lost to Follow-up|0|||
27777791|NCT01838590|54231134|FG001|Overall Study|Lost to Follow-up|1|||
27777792|NCT01611454|54231146|FG000|Overall Study|Lack of Efficacy|18|||
27777793|NCT01611454|54231147|FG001|Overall Study|Lack of Efficacy|10|||
27777794|NCT01611298|54231157|FG000|Overall Study|Relapsed|2|||
27777795|NCT01822132|54231163|FG000|Overall Study|Lost to Follow-up|4|||
27777796|NCT01822132|54231164|FG001|Overall Study|Lost to Follow-up|2|||
27777797|NCT01821898|54231178|FG000|Overall Study|Withdrawal by Subject|2|||
27777798|NCT01821898|54231179|FG001|Overall Study|Withdrawal by Subject|1|||
27777799|NCT02411591|54231189|FG000|Overall Study|Adverse Event|0|||
27777800|NCT02411591|54231190|FG001|Overall Study|Adverse Event|4|||
27777801|NCT02411591|54231191|FG002|Overall Study|Adverse Event|2|||
27777802|NCT02411591|54231189|FG000|Overall Study|Withdrawal by Subject|0|||
27777803|NCT02411591|54231190|FG001|Overall Study|Withdrawal by Subject|3|||
27777804|NCT02411591|54231191|FG002|Overall Study|Withdrawal by Subject|0|||
27777805|NCT02411591|54231189|FG000|Overall Study|Physician Decision|0|||
27777806|NCT02411591|54231190|FG001|Overall Study|Physician Decision|3|||
27777807|NCT02411591|54231191|FG002|Overall Study|Physician Decision|1|||
27777808|NCT02454959|54231207|FG000|Overall Study|Protocol-Specified Criteria|3|||
27777809|NCT02454959|54231207|FG000|Overall Study|Physician Decision|1|||
27777810|NCT02454959|54231207|FG000|Overall Study|Withdrawal by Subject|3|||
27777811|NCT02454959|54231207|FG000|Overall Study|Adverse Event|2|||
27777812|NCT01821118|54231215|FG000|Overall Study|Death|0|||
27777813|NCT01821118|54231216|FG001|Overall Study|Death|1|||
27777814|NCT01650779|54231222|FG000|Overall Study|Withdrawal by Subject|1|||
27777815|NCT02411201|54231226|FG000|Overall Study|Adverse Event|2|||
27777816|NCT02411201|54231226|FG000|Overall Study|Withdrawal by Subject|2|||
27777817|NCT02411201|54231226|FG000|Overall Study|Age group completed|2|||
27777818|NCT01838044|54231234|FG000|Overall Study|Adverse Event|4|||
27777819|NCT01838044|54231235|FG001|Overall Study|Adverse Event|6|||
27777820|NCT01838044|54231234|FG000|Overall Study|Protocol Violation|3|||
27777821|NCT01838044|54231235|FG001|Overall Study|Protocol Violation|3|||
27777822|NCT01838044|54231234|FG000|Overall Study|Withdrawal by Subject|0|||
27777823|NCT01838044|54231235|FG001|Overall Study|Withdrawal by Subject|2|||
27777824|NCT01838044|54231234|FG000|Overall Study|Insufficient clinical response|1|||
27777825|NCT01838044|54231235|FG001|Overall Study|Insufficient clinical response|2|||
27777826|NCT01838044|54231234|FG000|Overall Study|Medication error without associated AE|0|||
27777827|NCT01838044|54231235|FG001|Overall Study|Medication error without associated AE|1|||
27777828|NCT01838044|54231234|FG000|Overall Study|Lost to Follow-up|0|||
27777829|NCT01838044|54231235|FG001|Overall Study|Lost to Follow-up|2|||
27777830|NCT02410811|54231246|FG000|Overall Study|Withdrawal by Subject|0|||
27777831|NCT02410811|54231247|FG001|Overall Study|Withdrawal by Subject|0|||
27777832|NCT02410811|54231248|FG002|Overall Study|Withdrawal by Subject|1|||
27777833|NCT02410811|54231249|FG003|Overall Study|Withdrawal by Subject|0|||
27777834|NCT02435381|54231259|FG000|Overall Study|Lost to Follow-up|2|||
27777835|NCT02435381|54231260|FG001|Overall Study|Lost to Follow-up|1|||
27777836|NCT01837966|54231276|FG000|Overall Study|Withdrawal by Subject|2|||
27777837|NCT01837966|54231277|FG001|Overall Study|Withdrawal by Subject|1|||
27777838|NCT02435147|54231283|FG000|Overall Study|non-evaluable DXA scan|11|||
27777839|NCT02435069|54231287|FG000|Dose Response - First Intervention|Adverse Event|0|||
27840503|NCT01464827|54328187|FG013|Overall Study|Lost to Follow-up|1|||
27777840|NCT02435069|54231288|FG001|Dose Response - First Intervention|Adverse Event|1|||
27777841|NCT02435069|54231289|FG002|Dose Response - First Intervention|Adverse Event|1|||
27777842|NCT02435069|54231290|FG003|Dose Response - First Intervention|Adverse Event|0|||
27777843|NCT02435069|54231291|FG004|Dose Response - First Intervention|Adverse Event|0|||
27777844|NCT02435069|54231287|FG000|Effectiveness - Second Intervention|Lack of Efficacy|0|||
27777845|NCT02435069|54231288|FG001|Effectiveness - Second Intervention|Lack of Efficacy|0|||
27777846|NCT02435069|54231289|FG002|Effectiveness - Second Intervention|Lack of Efficacy|0|||
27777847|NCT02435069|54231290|FG003|Effectiveness - Second Intervention|Lack of Efficacy|0|||
27777848|NCT02435069|54231291|FG004|Effectiveness - Second Intervention|Lack of Efficacy|1|||
27777849|NCT02454101|54231313|FG000|Overall Study|Adverse Event|2|||
27777850|NCT02454101|54231314|FG001|Overall Study|Adverse Event|3|||
27777851|NCT02454101|54231313|FG000|Overall Study|Lost to Follow-up|3|||
27777852|NCT02454101|54231314|FG001|Overall Study|Lost to Follow-up|4|||
27777853|NCT02409719|54231322|FG000|Overall Study|Lost to Follow-up|3|||
27777854|NCT02409719|54231323|FG001|Overall Study|Lost to Follow-up|3|||
27777855|NCT01820572|54231331|FG000|Randomization|Not Treated|2|||
27777856|NCT01820572|54231332|FG001|Randomization|Not Treated|1|||
27777857|NCT01820572|54231331|FG000|Treatment Period|Adverse Event|12|||
27777858|NCT01820572|54231332|FG001|Treatment Period|Adverse Event|7|||
27777859|NCT01820572|54231331|FG000|Treatment Period|Death|3|||
27777860|NCT01820572|54231332|FG001|Treatment Period|Death|3|||
27777861|NCT01820572|54231331|FG000|Treatment Period|Lack of Efficacy|1|||
27777862|NCT01820572|54231332|FG001|Treatment Period|Lack of Efficacy|0|||
27777863|NCT01820572|54231331|FG000|Treatment Period|poor/non compliance|0|||
27777864|NCT01820572|54231332|FG001|Treatment Period|poor/non compliance|3|||
27777865|NCT01820572|54231331|FG000|Treatment Period|request to discontinue|6|||
27777866|NCT01820572|54231332|FG001|Treatment Period|request to discontinue|11|||
27777867|NCT01820572|54231331|FG000|Treatment Period|No longer meets study criteria|3|||
27777868|NCT01820572|54231332|FG001|Treatment Period|No longer meets study criteria|10|||
27777869|NCT01820572|54231331|FG000|Treatment Period|withdrew consent|1|||
27777870|NCT01820572|54231332|FG001|Treatment Period|withdrew consent|2|||
27777871|NCT01820260|54231352|FG000|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
27777872|NCT01820260|54231353|FG001|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
27777873|NCT01820260|54231354|FG002|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
27777874|NCT01820260|54231355|FG003|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
27777875|NCT01820260|54231356|FG004|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
27777876|NCT01820260|54231357|FG005|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
27777877|NCT01820260|54231358|FG006|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|1|||
27777878|NCT01820260|54231359|FG007|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
27777879|NCT01820260|54231360|FG008|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
27777880|NCT01820260|54231361|FG009|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
27777881|NCT01820260|54231362|FG010|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
27777882|NCT01820260|54231363|FG011|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
27777883|NCT01820260|54231364|FG012|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
27777884|NCT01820260|54231365|FG013|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
27777885|NCT01820260|54231352|FG000|Phase 2 (Part 2)|Withdrawal by Subject|0|||
27777886|NCT01820260|54231353|FG001|Phase 2 (Part 2)|Withdrawal by Subject|0|||
27777887|NCT01820260|54231354|FG002|Phase 2 (Part 2)|Withdrawal by Subject|0|||
27777888|NCT01820260|54231355|FG003|Phase 2 (Part 2)|Withdrawal by Subject|0|||
27840504|NCT01464827|54328174|FG000|Overall Study|Other|2|||
27840505|NCT01464827|54328175|FG001|Overall Study|Other|3|||
27777889|NCT01820260|54231356|FG004|Phase 2 (Part 2)|Withdrawal by Subject|0|||
27777890|NCT01820260|54231357|FG005|Phase 2 (Part 2)|Withdrawal by Subject|0|||
27777891|NCT01820260|54231358|FG006|Phase 2 (Part 2)|Withdrawal by Subject|0|||
27777892|NCT01820260|54231359|FG007|Phase 2 (Part 2)|Withdrawal by Subject|0|||
27777893|NCT01820260|54231360|FG008|Phase 2 (Part 2)|Withdrawal by Subject|0|||
27777894|NCT01820260|54231361|FG009|Phase 2 (Part 2)|Withdrawal by Subject|1|||
27777895|NCT01820260|54231362|FG010|Phase 2 (Part 2)|Withdrawal by Subject|0|||
27777896|NCT01820260|54231363|FG011|Phase 2 (Part 2)|Withdrawal by Subject|0|||
27777897|NCT01820260|54231364|FG012|Phase 2 (Part 2)|Withdrawal by Subject|0|||
27777898|NCT01820260|54231365|FG013|Phase 2 (Part 2)|Withdrawal by Subject|0|||
27777899|NCT01610596|54231403|FG000|Overall Study|Lost to Follow-up|0|||
27777900|NCT01610596|54231404|FG001|Overall Study|Lost to Follow-up|1|||
27777901|NCT01818700|54231410|FG000|Overall Study|Adverse Event|67|||
27777902|NCT01818700|54231410|FG000|Overall Study|Lack of Efficacy|2|||
27777903|NCT01818700|54231410|FG000|Overall Study|Lost to Follow-up|5|||
27777904|NCT01818700|54231410|FG000|Overall Study|Withdrawal by Subject|27|||
27777905|NCT01818700|54231410|FG000|Overall Study|Protocol Violation|2|||
27777906|NCT01818700|54231410|FG000|Overall Study|Other|1|||
27777907|NCT01817764|54231418|FG000|Overall Study|Adverse Event|7|||
27777908|NCT01817764|54231419|FG001|Overall Study|Adverse Event|10|||
27777909|NCT01817764|54231418|FG000|Overall Study|Lack of Efficacy|9|||
27777910|NCT01817764|54231419|FG001|Overall Study|Lack of Efficacy|7|||
27777911|NCT01817764|54231418|FG000|Overall Study|Protocol Violation|7|||
27777912|NCT01817764|54231419|FG001|Overall Study|Protocol Violation|5|||
27777913|NCT01817764|54231418|FG000|Overall Study|Lost to Follow-up|1|||
27777914|NCT01817764|54231419|FG001|Overall Study|Lost to Follow-up|4|||
27777915|NCT01817764|54231418|FG000|Overall Study|Withdrawal by Subject|10|||
27777916|NCT01817764|54231419|FG001|Overall Study|Withdrawal by Subject|12|||
27777917|NCT01803880|54231428|FG000|Overall Study|Adverse Event|1|||
27777918|NCT01803880|54231429|FG001|Overall Study|Adverse Event|0|||
27777919|NCT01803880|54231430|FG002|Overall Study|Adverse Event|0|||
27777920|NCT01803880|54231428|FG000|Overall Study|Withdrawal by Subject|1|||
27777921|NCT01803880|54231429|FG001|Overall Study|Withdrawal by Subject|1|||
27777922|NCT01803880|54231430|FG002|Overall Study|Withdrawal by Subject|4|||
27777923|NCT01803880|54231428|FG000|Overall Study|Physician Decision|0|||
27777924|NCT01803880|54231429|FG001|Overall Study|Physician Decision|0|||
27777925|NCT01803880|54231430|FG002|Overall Study|Physician Decision|1|||
27777926|NCT01803880|54231428|FG000|Overall Study|Unable to return for follow-up visits|0|||
27777927|NCT01803880|54231429|FG001|Overall Study|Unable to return for follow-up visits|1|||
27777928|NCT01803880|54231430|FG002|Overall Study|Unable to return for follow-up visits|2|||
27777929|NCT01803880|54231428|FG000|Overall Study|Lost to Follow-up|1|||
27777930|NCT01803880|54231429|FG001|Overall Study|Lost to Follow-up|2|||
27777931|NCT01803880|54231430|FG002|Overall Study|Lost to Follow-up|3|||
27777932|NCT01803880|54231428|FG000|Overall Study|Protocol Violation|1|||
27777933|NCT01803880|54231429|FG001|Overall Study|Protocol Violation|0|||
27777934|NCT01803880|54231430|FG002|Overall Study|Protocol Violation|0|||
27777935|NCT01803880|54231428|FG000|Overall Study|Early study termination|0|||
27777936|NCT01803880|54231429|FG001|Overall Study|Early study termination|6|||
27777937|NCT01803880|54231430|FG002|Overall Study|Early study termination|5|||
27777938|NCT01803880|54231428|FG000|Overall Study|Incomplete data entry by sites|2|||
27777939|NCT01803880|54231429|FG001|Overall Study|Incomplete data entry by sites|0|||
27777940|NCT01803880|54231430|FG002|Overall Study|Incomplete data entry by sites|0|||
27777941|NCT01803646|54231442|FG000|Overall Study|Protocol Violation|1|||
27777942|NCT01803646|54231443|FG001|Overall Study|Protocol Violation|0|||
27777943|NCT01803646|54231442|FG000|Overall Study|Adverse Event|1|||
27777944|NCT01803646|54231443|FG001|Overall Study|Adverse Event|1|||
27777945|NCT01803646|54231442|FG000|Overall Study|Withdrawal by Subject|9|||
27777946|NCT01803646|54231443|FG001|Overall Study|Withdrawal by Subject|6|||
27777947|NCT01803646|54231442|FG000|Overall Study|Randomization error|1|||
27777948|NCT01803646|54231443|FG001|Overall Study|Randomization error|2|||
27777949|NCT01803646|54231442|FG000|Overall Study|Lost to Follow-up|5|||
27777950|NCT01803646|54231443|FG001|Overall Study|Lost to Follow-up|1|||
27777951|NCT01817530|54231457|FG000|Overall Study|Exclusionary Medication Received|0|||
27777952|NCT01817530|54231458|FG001|Overall Study|Exclusionary Medication Received|0|||
27777953|NCT01817530|54231459|FG002|Overall Study|Exclusionary Medication Received|0|||
27777954|NCT01817530|54231460|FG003|Overall Study|Exclusionary Medication Received|0|||
27777955|NCT01817530|54231461|FG004|Overall Study|Exclusionary Medication Received|1|||
27777956|NCT01817530|54231462|FG005|Overall Study|Exclusionary Medication Received|0|||
27777957|NCT01817530|54231463|FG006|Overall Study|Exclusionary Medication Received|0|||
27777958|NCT01817530|54231464|FG007|Overall Study|Exclusionary Medication Received|0|||
27777959|NCT01817530|54231457|FG000|Overall Study|Adverse Event|6|||
27777960|NCT01817530|54231458|FG001|Overall Study|Adverse Event|3|||
27777961|NCT01817530|54231459|FG002|Overall Study|Adverse Event|2|||
27777962|NCT01817530|54231460|FG003|Overall Study|Adverse Event|5|||
27777963|NCT01817530|54231461|FG004|Overall Study|Adverse Event|0|||
27777964|NCT01817530|54231462|FG005|Overall Study|Adverse Event|10|||
27777965|NCT01817530|54231463|FG006|Overall Study|Adverse Event|5|||
27777966|NCT01817530|54231464|FG007|Overall Study|Adverse Event|8|||
27777967|NCT01817530|54231457|FG000|Overall Study|Subject Noncompliant|3|||
27777968|NCT01817530|54231458|FG001|Overall Study|Subject Noncompliant|1|||
27777969|NCT01817530|54231459|FG002|Overall Study|Subject Noncompliant|0|||
27777970|NCT01817530|54231460|FG003|Overall Study|Subject Noncompliant|4|||
27777971|NCT01817530|54231461|FG004|Overall Study|Subject Noncompliant|0|||
27777972|NCT01817530|54231462|FG005|Overall Study|Subject Noncompliant|1|||
27777973|NCT01817530|54231463|FG006|Overall Study|Subject Noncompliant|1|||
27777974|NCT01817530|54231464|FG007|Overall Study|Subject Noncompliant|1|||
27777975|NCT01817530|54231457|FG000|Overall Study|Lack of Efficacy|1|||
27777976|NCT01817530|54231458|FG001|Overall Study|Lack of Efficacy|0|||
27777977|NCT01817530|54231459|FG002|Overall Study|Lack of Efficacy|0|||
27777978|NCT01817530|54231460|FG003|Overall Study|Lack of Efficacy|0|||
27777979|NCT01817530|54231461|FG004|Overall Study|Lack of Efficacy|0|||
27777980|NCT01817530|54231462|FG005|Overall Study|Lack of Efficacy|1|||
27777981|NCT01817530|54231463|FG006|Overall Study|Lack of Efficacy|0|||
27777982|NCT01817530|54231464|FG007|Overall Study|Lack of Efficacy|1|||
27777983|NCT01817530|54231457|FG000|Overall Study|Pregnancy|0|||
27777984|NCT01817530|54231458|FG001|Overall Study|Pregnancy|0|||
27777985|NCT01817530|54231459|FG002|Overall Study|Pregnancy|0|||
27777986|NCT01817530|54231460|FG003|Overall Study|Pregnancy|0|||
27777987|NCT01817530|54231461|FG004|Overall Study|Pregnancy|0|||
27777988|NCT01817530|54231462|FG005|Overall Study|Pregnancy|1|||
27777989|NCT01817530|54231463|FG006|Overall Study|Pregnancy|0|||
27777990|NCT01817530|54231464|FG007|Overall Study|Pregnancy|0|||
27777991|NCT01817530|54231457|FG000|Overall Study|Other|0|||
27777992|NCT01817530|54231458|FG001|Overall Study|Other|1|||
27777993|NCT01817530|54231459|FG002|Overall Study|Other|0|||
27777994|NCT01817530|54231460|FG003|Overall Study|Other|0|||
27777995|NCT01817530|54231461|FG004|Overall Study|Other|1|||
27777996|NCT01817530|54231462|FG005|Overall Study|Other|0|||
27777997|NCT01817530|54231463|FG006|Overall Study|Other|5|||
27777998|NCT01817530|54231464|FG007|Overall Study|Other|0|||
27777999|NCT01817530|54231457|FG000|Overall Study|Surgery or Invasive Intervention|1|||
27778000|NCT01817530|54231458|FG001|Overall Study|Surgery or Invasive Intervention|0|||
27778001|NCT01817530|54231459|FG002|Overall Study|Surgery or Invasive Intervention|0|||
27778002|NCT01817530|54231460|FG003|Overall Study|Surgery or Invasive Intervention|0|||
27778003|NCT01817530|54231461|FG004|Overall Study|Surgery or Invasive Intervention|1|||
27778004|NCT01817530|54231462|FG005|Overall Study|Surgery or Invasive Intervention|1|||
27778005|NCT01817530|54231463|FG006|Overall Study|Surgery or Invasive Intervention|1|||
27778006|NCT01817530|54231464|FG007|Overall Study|Surgery or Invasive Intervention|0|||
27778007|NCT01817530|54231457|FG000|Overall Study|Consent Withdrawn by Subject|3|||
27778008|NCT01817530|54231458|FG001|Overall Study|Consent Withdrawn by Subject|4|||
27778009|NCT01817530|54231459|FG002|Overall Study|Consent Withdrawn by Subject|7|||
27778010|NCT01817530|54231460|FG003|Overall Study|Consent Withdrawn by Subject|3|||
27778011|NCT01817530|54231461|FG004|Overall Study|Consent Withdrawn by Subject|5|||
27778012|NCT01817530|54231462|FG005|Overall Study|Consent Withdrawn by Subject|3|||
27778013|NCT01817530|54231463|FG006|Overall Study|Consent Withdrawn by Subject|3|||
27778014|NCT01817530|54231464|FG007|Overall Study|Consent Withdrawn by Subject|10|||
27778015|NCT01817530|54231457|FG000|Overall Study|Lost to Follow-up|1|||
27778016|NCT01817530|54231458|FG001|Overall Study|Lost to Follow-up|4|||
27778017|NCT01817530|54231459|FG002|Overall Study|Lost to Follow-up|2|||
27778018|NCT01817530|54231460|FG003|Overall Study|Lost to Follow-up|1|||
27778019|NCT01817530|54231461|FG004|Overall Study|Lost to Follow-up|3|||
27778020|NCT01817530|54231462|FG005|Overall Study|Lost to Follow-up|2|||
27778021|NCT01817530|54231463|FG006|Overall Study|Lost to Follow-up|8|||
27778022|NCT01817530|54231464|FG007|Overall Study|Lost to Follow-up|4|||
27778023|NCT01816984|54231482|FG000|Overall Study|declining health status|1|||
27778024|NCT01816906|54231488|FG000|Six Months|Did Not Show Up for Baseline Measurement|7|||
27778025|NCT01816906|54231489|FG001|Six Months|Did Not Show Up for Baseline Measurement|6|||
27778026|NCT01816906|54231488|FG000|Six Months|Lost to Follow-up|14|||
27778027|NCT01816906|54231489|FG001|Six Months|Lost to Follow-up|16|||
27778028|NCT01816906|54231488|FG000|12 Months|Adverse Event|2|||
27778029|NCT01816906|54231489|FG001|12 Months|Adverse Event|2|||
27778030|NCT01816906|54231488|FG000|12 Months|Death|0|||
27778031|NCT01816906|54231489|FG001|12 Months|Death|2|||
27778032|NCT01816906|54231488|FG000|12 Months|Lost to Follow-up|2|||
27778033|NCT01816906|54231489|FG001|12 Months|Lost to Follow-up|1|||
27778034|NCT01816594|54231498|FG000|Overall Study|Local Progress|0|||
27778035|NCT01816594|54231499|FG001|Overall Study|Local Progress|2|||
27778036|NCT01816594|54231498|FG000|Overall Study|Adverse Event|9|||
27778037|NCT01816594|54231499|FG001|Overall Study|Adverse Event|0|||
27778038|NCT01816594|54231498|FG000|Overall Study|Withdrawal by Subject|1|||
27778039|NCT01816594|54231499|FG001|Overall Study|Withdrawal by Subject|0|||
27778040|NCT01816594|54231498|FG000|Overall Study|Physician Decision|1|||
27778041|NCT01816594|54231499|FG001|Overall Study|Physician Decision|0|||
27778042|NCT01802320|54231511|FG000|Overall Study|Death|1|||
27778043|NCT01802320|54231511|FG000|Overall Study|Withdrawal by Subject|1|||
27778044|NCT02453711|54231524|FG000|Overall Study|Withdrawal by Subject|5|||
27778045|NCT02453711|54231525|FG001|Overall Study|Withdrawal by Subject|4|||
27778046|NCT02453711|54231526|FG002|Overall Study|Withdrawal by Subject|6|||
27778047|NCT02453711|54231527|FG003|Overall Study|Withdrawal by Subject|4|||
27778048|NCT02453711|54231528|FG004|Overall Study|Withdrawal by Subject|1|||
27778049|NCT02453711|54231529|FG005|Overall Study|Withdrawal by Subject|1|||
27778050|NCT02453711|54231530|FG006|Overall Study|Withdrawal by Subject|0|||
27778051|NCT02453711|54231531|FG007|Overall Study|Withdrawal by Subject|1|||
27778052|NCT02453711|54231532|FG008|Overall Study|Withdrawal by Subject|7|||
27778053|NCT02453711|54231524|FG000|Overall Study|Lost to Follow-up|5|||
27840506|NCT01464827|54328176|FG002|Overall Study|Other|0|||
27778054|NCT02453711|54231525|FG001|Overall Study|Lost to Follow-up|3|||
27778055|NCT02453711|54231526|FG002|Overall Study|Lost to Follow-up|2|||
27840507|NCT01464827|54328177|FG003|Overall Study|Other|2|||
27778056|NCT02453711|54231527|FG003|Overall Study|Lost to Follow-up|3|||
27778057|NCT02453711|54231528|FG004|Overall Study|Lost to Follow-up|1|||
27840508|NCT01464827|54328178|FG004|Overall Study|Other|3|||
27778058|NCT02453711|54231529|FG005|Overall Study|Lost to Follow-up|5|||
27778059|NCT02453711|54231530|FG006|Overall Study|Lost to Follow-up|2|||
27778060|NCT02453711|54231531|FG007|Overall Study|Lost to Follow-up|6|||
27778061|NCT02453711|54231532|FG008|Overall Study|Lost to Follow-up|6|||
27840509|NCT01464827|54328179|FG005|Overall Study|Other|0|||
27778062|NCT02453711|54231524|FG000|Overall Study|Death|0|||
27778063|NCT02453711|54231525|FG001|Overall Study|Death|0|||
27778064|NCT02453711|54231526|FG002|Overall Study|Death|0|||
27778065|NCT02453711|54231527|FG003|Overall Study|Death|0|||
27778066|NCT02453711|54231528|FG004|Overall Study|Death|0|||
27778067|NCT02453711|54231529|FG005|Overall Study|Death|0|||
27778068|NCT02453711|54231530|FG006|Overall Study|Death|1|||
27778069|NCT02453711|54231531|FG007|Overall Study|Death|0|||
27778070|NCT02453711|54231532|FG008|Overall Study|Death|0|||
27778071|NCT02453711|54231524|FG000|Overall Study|Unclassified|1|||
27778072|NCT02453711|54231525|FG001|Overall Study|Unclassified|0|||
27778073|NCT02453711|54231526|FG002|Overall Study|Unclassified|1|||
27778074|NCT02453711|54231527|FG003|Overall Study|Unclassified|0|||
27778075|NCT02453711|54231528|FG004|Overall Study|Unclassified|0|||
27778076|NCT02453711|54231529|FG005|Overall Study|Unclassified|0|||
27778077|NCT02453711|54231530|FG006|Overall Study|Unclassified|0|||
27778078|NCT02453711|54231531|FG007|Overall Study|Unclassified|0|||
27778079|NCT02453711|54231532|FG008|Overall Study|Unclassified|0|||
27778080|NCT02453555|54231554|FG000|24-week Double-blind Treatment Period|Adverse Event|2|||
27778081|NCT02453555|54231555|FG001|24-week Double-blind Treatment Period|Adverse Event|0|||
27778082|NCT02453555|54231556|FG002|24-week Double-blind Treatment Period|Adverse Event|0|||
27778083|NCT02453555|54231557|FG003|24-week Double-blind Treatment Period|Adverse Event|0|||
27778084|NCT02453555|54231558|FG004|24-week Double-blind Treatment Period|Adverse Event|0|||
27778085|NCT02453555|54231559|FG005|24-week Double-blind Treatment Period|Adverse Event|0|||
27778086|NCT02453555|54231554|FG000|24-week Double-blind Treatment Period|Lost to Follow-up|1|||
27778087|NCT02453555|54231555|FG001|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
27778088|NCT02453555|54231556|FG002|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
27778089|NCT02453555|54231557|FG003|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
27778090|NCT02453555|54231558|FG004|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
27778091|NCT02453555|54231559|FG005|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
27778092|NCT02453555|54231554|FG000|24-week Double-blind Treatment Period|Withdrawal by Subject|2|||
27778093|NCT02453555|54231555|FG001|24-week Double-blind Treatment Period|Withdrawal by Subject|4|||
27778094|NCT02453555|54231556|FG002|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
27778095|NCT02453555|54231557|FG003|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
27778096|NCT02453555|54231558|FG004|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
27778097|NCT02453555|54231559|FG005|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
27778098|NCT02453555|54231554|FG000|24-week Double-blind Treatment Period|Other than specified above|0|||
27778099|NCT02453555|54231555|FG001|24-week Double-blind Treatment Period|Other than specified above|3|||
27778100|NCT02453555|54231556|FG002|24-week Double-blind Treatment Period|Other than specified above|0|||
27778101|NCT02453555|54231557|FG003|24-week Double-blind Treatment Period|Other than specified above|0|||
27778102|NCT02453555|54231558|FG004|24-week Double-blind Treatment Period|Other than specified above|0|||
27778103|NCT02453555|54231559|FG005|24-week Double-blind Treatment Period|Other than specified above|0|||
27778104|NCT02453555|54231554|FG000|Extension Period|Adverse Event|0|||
27778105|NCT02453555|54231555|FG001|Extension Period|Adverse Event|0|||
27778106|NCT02453555|54231556|FG002|Extension Period|Adverse Event|1|||
27778107|NCT02453555|54231557|FG003|Extension Period|Adverse Event|2|||
27778108|NCT02453555|54231558|FG004|Extension Period|Adverse Event|1|||
27778109|NCT02453555|54231559|FG005|Extension Period|Adverse Event|1|||
27778110|NCT02453555|54231554|FG000|Extension Period|Protocol Violation|0|||
27778111|NCT02453555|54231555|FG001|Extension Period|Protocol Violation|0|||
27778112|NCT02453555|54231556|FG002|Extension Period|Protocol Violation|1|||
27778113|NCT02453555|54231557|FG003|Extension Period|Protocol Violation|0|||
27778114|NCT02453555|54231558|FG004|Extension Period|Protocol Violation|0|||
27778115|NCT02453555|54231559|FG005|Extension Period|Protocol Violation|0|||
27778116|NCT02453555|54231554|FG000|Extension Period|Withdrawal by Subject|0|||
27778117|NCT02453555|54231555|FG001|Extension Period|Withdrawal by Subject|0|||
27778118|NCT02453555|54231556|FG002|Extension Period|Withdrawal by Subject|1|||
27778119|NCT02453555|54231557|FG003|Extension Period|Withdrawal by Subject|0|||
27778120|NCT02453555|54231558|FG004|Extension Period|Withdrawal by Subject|0|||
27840510|NCT01464827|54328180|FG006|Overall Study|Other|1|||
27840511|NCT01464827|54328181|FG007|Overall Study|Other|0|||
27840512|NCT01464827|54328182|FG008|Overall Study|Other|3|||
27840513|NCT01464827|54328183|FG009|Overall Study|Other|1|||
27840514|NCT01464827|54328184|FG010|Overall Study|Other|2|||
27840515|NCT01464827|54328185|FG011|Overall Study|Other|0|||
27840516|NCT01464827|54328186|FG012|Overall Study|Other|1|||
27840517|NCT01464827|54328187|FG013|Overall Study|Other|0|||
27778121|NCT02453555|54231559|FG005|Extension Period|Withdrawal by Subject|0|||
27778122|NCT02453321|54231572|FG000|Overall Study|Weakness|1|||
27778123|NCT02453321|54231573|FG001|Overall Study|Weakness|1|||
27778124|NCT02453321|54231574|FG002|Overall Study|Weakness|2|||
27778125|NCT02453321|54231572|FG000|Overall Study|Deep Venous Thrombosis|0|||
27778126|NCT02453321|54231573|FG001|Overall Study|Deep Venous Thrombosis|1|||
27840518|NCT01464827|54328174|FG000|Overall Study|Not Treated|0|||
27840519|NCT01464827|54328175|FG001|Overall Study|Not Treated|2|||
27840520|NCT01464827|54328176|FG002|Overall Study|Not Treated|0|||
27840521|NCT01464827|54328177|FG003|Overall Study|Not Treated|0|||
27840522|NCT01464827|54328178|FG004|Overall Study|Not Treated|1|||
27778127|NCT02453321|54231574|FG002|Overall Study|Deep Venous Thrombosis|0|||
27778128|NCT01610284|54231587|FG000|Randomization Phase|Adverse Event|1|||
27778129|NCT01610284|54231588|FG001|Randomization Phase|Adverse Event|0|||
27778130|NCT01610284|54231587|FG000|Randomization Phase|Physician Decision|1|||
27778131|NCT01610284|54231588|FG001|Randomization Phase|Physician Decision|1|||
27778132|NCT01610284|54231587|FG000|Randomization Phase|Death|0|||
27778133|NCT01610284|54231588|FG001|Randomization Phase|Death|1|||
27778134|NCT01610284|54231587|FG000|Treatment Phase|Adverse Event|80|||
27778135|NCT01610284|54231588|FG001|Treatment Phase|Adverse Event|12|||
27778136|NCT01610284|54231587|FG000|Treatment Phase|Lost to Follow-up|1|||
27778137|NCT01610284|54231588|FG001|Treatment Phase|Lost to Follow-up|0|||
27778138|NCT01610284|54231587|FG000|Treatment Phase|Non-compliance with Study Treatment|8|||
27778139|NCT01610284|54231588|FG001|Treatment Phase|Non-compliance with Study Treatment|1|||
27778140|NCT01610284|54231587|FG000|Treatment Phase|Physician Decision|27|||
27778141|NCT01610284|54231588|FG001|Treatment Phase|Physician Decision|24|||
27778142|NCT01610284|54231587|FG000|Treatment Phase|Progressive Disease|377|||
27778143|NCT01610284|54231588|FG001|Treatment Phase|Progressive Disease|486|||
27778144|NCT01610284|54231587|FG000|Treatment Phase|Protocol Deviation|2|||
27778145|NCT01610284|54231588|FG001|Treatment Phase|Protocol Deviation|3|||
27778146|NCT01610284|54231587|FG000|Treatment Phase|Study terminated by Sponsor|18|||
27778147|NCT01610284|54231588|FG001|Treatment Phase|Study terminated by Sponsor|15|||
27778148|NCT01610284|54231587|FG000|Treatment Phase|Subject/Guardian Decision|55|||
27778149|NCT01610284|54231588|FG001|Treatment Phase|Subject/Guardian Decision|23|||
27778150|NCT01610284|54231587|FG000|Treatment Phase|Death|6|||
27778151|NCT01610284|54231588|FG001|Treatment Phase|Death|5|||
27778152|NCT01610284|54231587|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
27778153|NCT01610284|54231588|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
27778154|NCT01610284|54231587|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10|||
27778155|NCT01610284|54231588|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3|||
27778156|NCT01610284|54231587|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24|||
27778157|NCT01610284|54231588|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8|||
27778158|NCT01610284|54231587|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11|||
27778159|NCT01610284|54231588|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
27778160|NCT01610284|54231587|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
27778161|NCT01610284|54231588|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
27778162|NCT01610284|54231587|FG000|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38|||
27778163|NCT01610284|54231588|FG001|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13|||
27778164|NCT02452463|54231597|FG000|Overall Study|Death|1|||
27778165|NCT02452463|54231598|FG001|Overall Study|Death|0|||
27778166|NCT02452463|54231599|FG002|Overall Study|Death|0|||
27778167|NCT02452463|54231597|FG000|Overall Study|Study Suspended|1|||
27778168|NCT02452463|54231598|FG001|Overall Study|Study Suspended|0|||
27778169|NCT02452463|54231599|FG002|Overall Study|Study Suspended|0|||
27778170|NCT02452463|54231597|FG000|Overall Study|Recommended by DSMB|0|||
27778171|NCT02452463|54231598|FG001|Overall Study|Recommended by DSMB|1|||
27778172|NCT02452463|54231599|FG002|Overall Study|Recommended by DSMB|0|||
27778173|NCT02452463|54231597|FG000|Overall Study|Withdrawal by Subject|0|||
27778174|NCT02452463|54231598|FG001|Overall Study|Withdrawal by Subject|1|||
27778175|NCT02452463|54231599|FG002|Overall Study|Withdrawal by Subject|0|||
27778176|NCT02432105|54231610|FG000|Overall Study|Lost to Follow-up|1|||
27778177|NCT02432105|54231611|FG001|Overall Study|Lost to Follow-up|1|||
27778178|NCT02432105|54231612|FG002|Overall Study|Lost to Follow-up|0|||
27778179|NCT02432105|54231610|FG000|Overall Study|Withdrawal by Subject|1|||
27778180|NCT02432105|54231611|FG001|Overall Study|Withdrawal by Subject|0|||
27778181|NCT02432105|54231612|FG002|Overall Study|Withdrawal by Subject|1|||
27778182|NCT02432105|54231610|FG000|Overall Study|Culture positive for yeast|0|||
27778183|NCT02432105|54231611|FG001|Overall Study|Culture positive for yeast|1|||
27778184|NCT02432105|54231612|FG002|Overall Study|Culture positive for yeast|0|||
27778185|NCT02432105|54231610|FG000|Overall Study|Randomized in error|0|||
27778186|NCT02432105|54231611|FG001|Overall Study|Randomized in error|0|||
27778187|NCT02432105|54231612|FG002|Overall Study|Randomized in error|2|||
27840523|NCT01464827|54328179|FG005|Overall Study|Not Treated|0|||
27840524|NCT01464827|54328180|FG006|Overall Study|Not Treated|1|||
27840525|NCT01464827|54328181|FG007|Overall Study|Not Treated|0|||
27778188|NCT02431793|54231624|FG000|Overall Study|Ineligible doe to not filling Rx|11|||
27778189|NCT02431793|54231625|FG001|Overall Study|Ineligible doe to not filling Rx|7|||
27778190|NCT02431793|54231626|FG002|Overall Study|Ineligible doe to not filling Rx|8|||
27778191|NCT02431793|54231624|FG000|Overall Study|Withdrawal by Subject|7|||
27778192|NCT02431793|54231625|FG001|Overall Study|Withdrawal by Subject|5|||
27778193|NCT02431793|54231626|FG002|Overall Study|Withdrawal by Subject|5|||
27778194|NCT02431793|54231624|FG000|Overall Study|Lost to Follow-up|101|||
27778195|NCT02431793|54231625|FG001|Overall Study|Lost to Follow-up|122|||
27840526|NCT01464827|54328182|FG008|Overall Study|Not Treated|0|||
27778196|NCT02431793|54231626|FG002|Overall Study|Lost to Follow-up|104|||
27778197|NCT01801930|54231638|FG000|Overall Study|Clear progression of the primary disease is observed|6|||
27778198|NCT01801930|54231639|FG001|Overall Study|Clear progression of the primary disease is observed|5|||
27778199|NCT01801930|54231640|FG002|Overall Study|Clear progression of the primary disease is observed|6|||
27778200|NCT01801930|54231641|FG003|Overall Study|Clear progression of the primary disease is observed|6|||
27778201|NCT01801930|54231638|FG000|Overall Study|DLT occurs|0|||
27778202|NCT01801930|54231639|FG001|Overall Study|DLT occurs|1|||
27778203|NCT01801930|54231640|FG002|Overall Study|DLT occurs|0|||
27778204|NCT01801930|54231641|FG003|Overall Study|DLT occurs|0|||
27778205|NCT01610206|54231653|FG000|Overall Study|Adverse Event|10|||
27778206|NCT01610206|54231654|FG001|Overall Study|Adverse Event|30|||
27778207|NCT01816048|54231660|FG000|Overall Study|Adverse Event|1|||
27778208|NCT01816048|54231660|FG000|Overall Study|Death|1|||
27778209|NCT01816048|54231660|FG000|Overall Study|Withdrawal by Subject|1|||
27778210|NCT01816048|54231660|FG000|Overall Study|Disease Progression|3|||
27778211|NCT01612858|54231667|FG000|Overall Study|Withdrawal by Subject|5|||
27778212|NCT01612858|54231668|FG001|Overall Study|Withdrawal by Subject|1|||
27778213|NCT01612780|54231674|FG000|Overall Study|Treatment not completed|1|||
27778214|NCT01612780|54231674|FG000|Overall Study|Withdrawal by Subject|5|||
27778215|NCT01612702|54231680|FG000|Overall Study|Protocol Violation|11|||
27778216|NCT01612702|54231681|FG001|Overall Study|Protocol Violation|11|||
27778217|NCT02431559|54231691|FG000|Overall Study|Adverse Event|0|||
27778218|NCT02431559|54231692|FG001|Overall Study|Adverse Event|1|||
27778219|NCT02431559|54231693|FG002|Overall Study|Adverse Event|0|||
27778220|NCT02431559|54231694|FG003|Overall Study|Adverse Event|4|||
27778221|NCT02431559|54231691|FG000|Overall Study|Progressive disease|2|||
27778222|NCT02431559|54231692|FG001|Overall Study|Progressive disease|1|||
27778223|NCT02431559|54231693|FG002|Overall Study|Progressive disease|4|||
27778224|NCT02431559|54231694|FG003|Overall Study|Progressive disease|22|||
27778225|NCT02431559|54231691|FG000|Overall Study|Withdrawal by Subject|0|||
27778226|NCT02431559|54231692|FG001|Overall Study|Withdrawal by Subject|1|||
27778227|NCT02431559|54231693|FG002|Overall Study|Withdrawal by Subject|0|||
27778228|NCT02431559|54231694|FG003|Overall Study|Withdrawal by Subject|4|||
27778229|NCT02431559|54231691|FG000|Overall Study|Physician Decision|0|||
27778230|NCT02431559|54231692|FG001|Overall Study|Physician Decision|0|||
27778231|NCT02431559|54231693|FG002|Overall Study|Physician Decision|0|||
27778232|NCT02431559|54231694|FG003|Overall Study|Physician Decision|1|||
27778233|NCT02388269|54231708|FG000|Overall Study|Adverse Event|2|||
27778234|NCT02388269|54231709|FG001|Overall Study|Adverse Event|0|||
27778235|NCT02388269|54231710|FG002|Overall Study|Adverse Event|0|||
27778236|NCT02388269|54231708|FG000|Overall Study|Withdrawal by Subject|1|||
27778237|NCT02388269|54231709|FG001|Overall Study|Withdrawal by Subject|2|||
27778238|NCT02388269|54231710|FG002|Overall Study|Withdrawal by Subject|0|||
27778239|NCT02388269|54231708|FG000|Overall Study|less than 50% stimulations|1|||
27778240|NCT02388269|54231709|FG001|Overall Study|less than 50% stimulations|0|||
27778241|NCT02388269|54231710|FG002|Overall Study|less than 50% stimulations|0|||
27778242|NCT02388269|54231708|FG000|Overall Study|no diary data|3|||
27778243|NCT02388269|54231709|FG001|Overall Study|no diary data|0|||
27778244|NCT02388269|54231710|FG002|Overall Study|no diary data|0|||
27778245|NCT02388269|54231708|FG000|Overall Study|Protocol Violation|2|||
27778246|NCT02388269|54231709|FG001|Overall Study|Protocol Violation|0|||
27778247|NCT02388269|54231710|FG002|Overall Study|Protocol Violation|0|||
27778248|NCT02388269|54231708|FG000|Overall Study|Screen Failure|0|||
27778249|NCT02388269|54231709|FG001|Overall Study|Screen Failure|0|||
27778250|NCT02388269|54231710|FG002|Overall Study|Screen Failure|10|||
27778251|NCT01652573|54231736|FG000|Overall Study|Adverse Event|0|||
27778252|NCT01652573|54231737|FG001|Overall Study|Adverse Event|1|||
27778253|NCT02388191|54231745|FG000|Overall Study|Patient did not receive IUD|1|||
27778254|NCT02388191|54231746|FG001|Overall Study|Patient did not receive IUD|0|||
27778255|NCT01815736|54231754|FG000|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|11|||
27778256|NCT01815736|54231755|FG001|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|17|||
27778257|NCT01815736|54231754|FG000|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|10|||
27778258|NCT01815736|54231755|FG001|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|9|||
27778259|NCT01815736|54231754|FG000|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|11|||
27778260|NCT01815736|54231755|FG001|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|2|||
27778261|NCT01815736|54231754|FG000|Randomized Treatment Phase-Up to Week 96|Adverse Event|7|||
27778262|NCT01815736|54231755|FG001|Randomized Treatment Phase-Up to Week 96|Adverse Event|4|||
27778263|NCT01815736|54231754|FG000|Randomized Treatment Phase-Up to Week 96|Death|4|||
27778264|NCT01815736|54231755|FG001|Randomized Treatment Phase-Up to Week 96|Death|0|||
27778265|NCT01815736|54231754|FG000|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|1|||
27778266|NCT01815736|54231755|FG001|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|0|||
27778267|NCT01815736|54231754|FG000|Randomized Treatment Phase-Up to Week 96|Pregnancy|1|||
27778268|NCT01815736|54231755|FG001|Randomized Treatment Phase-Up to Week 96|Pregnancy|0|||
27778269|NCT01815736|54231754|FG000|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|4|||
27778270|NCT01815736|54231755|FG001|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|3|||
27778271|NCT01815736|54231754|FG000|Extension Treatment Phase- After Week 96|Investigator's Discretion|31|||
27778272|NCT01815736|54231755|FG001|Extension Treatment Phase- After Week 96|Investigator's Discretion|15|||
27778273|NCT01815736|54231754|FG000|Extension Treatment Phase- After Week 96|Lost to Follow-up|13|||
27778274|NCT01815736|54231755|FG001|Extension Treatment Phase- After Week 96|Lost to Follow-up|9|||
27778275|NCT01815736|54231754|FG000|Extension Treatment Phase- After Week 96|Withdrew Consent|5|||
27778276|NCT01815736|54231755|FG001|Extension Treatment Phase- After Week 96|Withdrew Consent|1|||
27778277|NCT01815736|54231754|FG000|Extension Treatment Phase- After Week 96|Adverse Event|1|||
27778278|NCT01815736|54231755|FG001|Extension Treatment Phase- After Week 96|Adverse Event|1|||
27778279|NCT01815736|54231754|FG000|Extension Treatment Phase- After Week 96|Death|1|||
27778280|NCT01815736|54231755|FG001|Extension Treatment Phase- After Week 96|Death|0|||
27778281|NCT01651949|54231766|FG000|Overall Study|Unknown status|4|||
27778282|NCT01651949|54231767|FG001|Overall Study|Unknown status|4|||
27778283|NCT01651949|54231768|FG002|Overall Study|Unknown status|0|||
27778284|NCT01651949|54231766|FG000|Overall Study|Lost to Follow-up|30|||
27778285|NCT01651949|54231767|FG001|Overall Study|Lost to Follow-up|56|||
27778286|NCT01651949|54231768|FG002|Overall Study|Lost to Follow-up|20|||
27778287|NCT01651949|54231766|FG000|Overall Study|Protocol Violation|0|||
27778288|NCT01651949|54231767|FG001|Overall Study|Protocol Violation|2|||
27778289|NCT01651949|54231768|FG002|Overall Study|Protocol Violation|1|||
27778290|NCT01651949|54231766|FG000|Overall Study|Physician Decision|0|||
27778291|NCT01651949|54231767|FG001|Overall Study|Physician Decision|2|||
27778292|NCT01651949|54231768|FG002|Overall Study|Physician Decision|0|||
27778293|NCT01651949|54231766|FG000|Overall Study|Adverse Event|0|||
27778294|NCT01651949|54231767|FG001|Overall Study|Adverse Event|2|||
27778295|NCT01651949|54231768|FG002|Overall Study|Adverse Event|1|||
27778296|NCT01651949|54231766|FG000|Overall Study|Screen failure|2|||
27778297|NCT01651949|54231767|FG001|Overall Study|Screen failure|2|||
27778298|NCT01651949|54231768|FG002|Overall Study|Screen failure|0|||
27778299|NCT01651949|54231766|FG000|Overall Study|Withdrawal by Subject|17|||
27778300|NCT01651949|54231767|FG001|Overall Study|Withdrawal by Subject|18|||
27778301|NCT01651949|54231768|FG002|Overall Study|Withdrawal by Subject|9|||
27778302|NCT02387957|54231779|FG000|Overall Study|The study was discontinued|21|||
27778303|NCT02387957|54231780|FG001|Overall Study|The study was discontinued|21|||
27778304|NCT02387957|54231781|FG002|Overall Study|The study was discontinued|20|||
27778305|NCT01800916|54231789|FG000|Test Period 1 (1 Week)|Convex product user|0|||
27778306|NCT01800916|54231790|FG001|Test Period 1 (1 Week)|Convex product user|0|||
27778307|NCT01800916|54231791|FG002|Test Period 1 (1 Week)|Convex product user|0|||
27778308|NCT01800916|54231792|FG003|Test Period 1 (1 Week)|Convex product user|1|||
27778309|NCT01800916|54231793|FG004|Test Period 1 (1 Week)|Convex product user|0|||
27778310|NCT01800916|54231794|FG005|Test Period 1 (1 Week)|Convex product user|0|||
27778311|NCT01800916|54231795|FG006|Test Period 1 (1 Week)|Convex product user|0|||
27778312|NCT01800916|54231796|FG007|Test Period 1 (1 Week)|Convex product user|0|||
27778313|NCT01800916|54231797|FG008|Test Period 1 (1 Week)|Convex product user|0|||
27778314|NCT01800916|54231789|FG000|Test Period 1 (1 Week)|Adverse Event|0|||
27778315|NCT01800916|54231790|FG001|Test Period 1 (1 Week)|Adverse Event|0|||
27778316|NCT01800916|54231791|FG002|Test Period 1 (1 Week)|Adverse Event|0|||
27778317|NCT01800916|54231792|FG003|Test Period 1 (1 Week)|Adverse Event|0|||
27778318|NCT01800916|54231793|FG004|Test Period 1 (1 Week)|Adverse Event|1|||
27778319|NCT01800916|54231794|FG005|Test Period 1 (1 Week)|Adverse Event|0|||
27778320|NCT01800916|54231795|FG006|Test Period 1 (1 Week)|Adverse Event|0|||
27778321|NCT01800916|54231796|FG007|Test Period 1 (1 Week)|Adverse Event|0|||
27778322|NCT01800916|54231797|FG008|Test Period 1 (1 Week)|Adverse Event|0|||
27778323|NCT01800058|54231807|FG000|Overall Study|Lost to Follow-up|1|||
27778324|NCT01815580|54231814|FG000|Overall Study|Lost to Follow-up|4|||
27778325|NCT01815580|54231815|FG001|Overall Study|Lost to Follow-up|7|||
27778326|NCT01815580|54231814|FG000|Overall Study|Withdrawal by Subject|3|||
27778327|NCT01815580|54231815|FG001|Overall Study|Withdrawal by Subject|4|||
27778328|NCT01815580|54231814|FG000|Overall Study|Excluded from analysis|5|||
27778329|NCT01815580|54231815|FG001|Overall Study|Excluded from analysis|4|||
27778330|NCT01651403|54231828|FG000|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
27778331|NCT01651403|54231829|FG001|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
27778332|NCT01651403|54231828|FG000|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
27778333|NCT01651403|54231829|FG001|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
27778334|NCT01651403|54231828|FG000|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|0|||
27778335|NCT01651403|54231829|FG001|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|1|||
27778336|NCT01651403|54231828|FG000|Open-Label Phase (Weeks 49/73-192)|Continuing Study|13|||
27778337|NCT01651403|54231829|FG001|Open-Label Phase (Weeks 49/73-192)|Continuing Study|9|||
27778338|NCT01651403|54231828|FG000|Open-Label Phase (Weeks 49/73-192)|Investigator decision|2|||
27778339|NCT01651403|54231829|FG001|Open-Label Phase (Weeks 49/73-192)|Investigator decision|1|||
27778340|NCT01651403|54231828|FG000|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|6|||
27778341|NCT01651403|54231829|FG001|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|4|||
27778342|NCT01799590|54231843|FG000|Overall Study|Adverse Event|13|||
27778343|NCT01799590|54231844|FG001|Overall Study|Adverse Event|7|||
27778344|NCT01799590|54231845|FG002|Overall Study|Adverse Event|5|||
27778345|NCT01799590|54231843|FG000|Overall Study|Pregnancy|2|||
27778346|NCT01799590|54231844|FG001|Overall Study|Pregnancy|0|||
27778347|NCT01799590|54231845|FG002|Overall Study|Pregnancy|0|||
27778348|NCT01799590|54231843|FG000|Overall Study|Lack of Efficacy|3|||
27778349|NCT01799590|54231844|FG001|Overall Study|Lack of Efficacy|1|||
27778350|NCT01799590|54231845|FG002|Overall Study|Lack of Efficacy|3|||
27778351|NCT01799590|54231843|FG000|Overall Study|Participants convenience|4|||
27778352|NCT01799590|54231844|FG001|Overall Study|Participants convenience|4|||
27778353|NCT01799590|54231845|FG002|Overall Study|Participants convenience|2|||
27778354|NCT01799590|54231843|FG000|Overall Study|Aggravation of complications|0|||
27778355|NCT01799590|54231844|FG001|Overall Study|Aggravation of complications|1|||
27778356|NCT01799590|54231845|FG002|Overall Study|Aggravation of complications|1|||
27778357|NCT01799590|54231843|FG000|Overall Study|Using drugs with restricted days of use|0|||
27778358|NCT01799590|54231844|FG001|Overall Study|Using drugs with restricted days of use|3|||
27778359|NCT01799590|54231845|FG002|Overall Study|Using drugs with restricted days of use|2|||
27778360|NCT01799590|54231843|FG000|Overall Study|Use of prohibited concomitant drugs|1|||
27778361|NCT01799590|54231844|FG001|Overall Study|Use of prohibited concomitant drugs|0|||
27778362|NCT01799590|54231845|FG002|Overall Study|Use of prohibited concomitant drugs|0|||
27778363|NCT01799590|54231843|FG000|Overall Study|Other|3|||
27778364|NCT01799590|54231844|FG001|Overall Study|Other|0|||
27778365|NCT01799590|54231845|FG002|Overall Study|Other|1|||
27778366|NCT01815424|54231856|FG000|Week 0 to 16|Adverse Event|1|||
27778367|NCT01815424|54231857|FG001|Week 0 to 16|Adverse Event|3|||
27778368|NCT01815424|54231858|FG002|Week 0 to 16|Adverse Event|3|||
27778369|NCT01815424|54231859|FG003|Week 0 to 16|Adverse Event|0|||
27778370|NCT01815424|54231860|FG004|Week 0 to 16|Adverse Event|0|||
27778371|NCT01815424|54231856|FG000|Week 0 to 16|Does Not Meet Entrance Criteria|2|||
27778372|NCT01815424|54231857|FG001|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
27778373|NCT01815424|54231858|FG002|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
27778374|NCT01815424|54231859|FG003|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
27778375|NCT01815424|54231860|FG004|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
27778376|NCT01815424|54231856|FG000|Week 0 to 16|Lost to Follow-up|0|||
27778377|NCT01815424|54231857|FG001|Week 0 to 16|Lost to Follow-up|1|||
27778378|NCT01815424|54231858|FG002|Week 0 to 16|Lost to Follow-up|0|||
27778379|NCT01815424|54231859|FG003|Week 0 to 16|Lost to Follow-up|0|||
27778380|NCT01815424|54231860|FG004|Week 0 to 16|Lost to Follow-up|0|||
27778381|NCT01815424|54231856|FG000|Week 0 to 16|Withdrawal by Subject|0|||
27778382|NCT01815424|54231857|FG001|Week 0 to 16|Withdrawal by Subject|0|||
27778383|NCT01815424|54231858|FG002|Week 0 to 16|Withdrawal by Subject|1|||
27778384|NCT01815424|54231859|FG003|Week 0 to 16|Withdrawal by Subject|0|||
27778385|NCT01815424|54231860|FG004|Week 0 to 16|Withdrawal by Subject|0|||
27778386|NCT01815424|54231856|FG000|Week 0 to 16|Other|1|||
27778387|NCT01815424|54231857|FG001|Week 0 to 16|Other|0|||
27778388|NCT01815424|54231858|FG002|Week 0 to 16|Other|3|||
27778389|NCT01815424|54231859|FG003|Week 0 to 16|Other|0|||
27778390|NCT01815424|54231860|FG004|Week 0 to 16|Other|0|||
27778391|NCT01815424|54231856|FG000|Week 0 to 16|Protocol Violation|1|||
27778392|NCT01815424|54231857|FG001|Week 0 to 16|Protocol Violation|0|||
27778393|NCT01815424|54231858|FG002|Week 0 to 16|Protocol Violation|0|||
27778394|NCT01815424|54231859|FG003|Week 0 to 16|Protocol Violation|0|||
27778395|NCT01815424|54231860|FG004|Week 0 to 16|Protocol Violation|0|||
27778396|NCT01815424|54231856|FG000|Week 0 to 16|Insufficient Clinical Response|2|||
27778397|NCT01815424|54231857|FG001|Week 0 to 16|Insufficient Clinical Response|0|||
27778398|NCT01815424|54231858|FG002|Week 0 to 16|Insufficient Clinical Response|4|||
27778399|NCT01815424|54231859|FG003|Week 0 to 16|Insufficient Clinical Response|0|||
27778400|NCT01815424|54231860|FG004|Week 0 to 16|Insufficient Clinical Response|0|||
27778401|NCT01815424|54231856|FG000|Week 16 to 52|Other|0|||
27778402|NCT01815424|54231857|FG001|Week 16 to 52|Other|1|||
27778403|NCT01815424|54231858|FG002|Week 16 to 52|Other|0|||
27778404|NCT01815424|54231859|FG003|Week 16 to 52|Other|0|||
27778405|NCT01815424|54231860|FG004|Week 16 to 52|Other|0|||
27778406|NCT01815424|54231856|FG000|Week 16 to 52|Adverse Event|0|||
27778407|NCT01815424|54231857|FG001|Week 16 to 52|Adverse Event|0|||
27778408|NCT01815424|54231858|FG002|Week 16 to 52|Adverse Event|0|||
27778409|NCT01815424|54231859|FG003|Week 16 to 52|Adverse Event|0|||
27778410|NCT01815424|54231860|FG004|Week 16 to 52|Adverse Event|1|||
27778411|NCT01815424|54231856|FG000|Week 16 to 52|Insufficient Clinical Response|1|||
27778412|NCT01815424|54231857|FG001|Week 16 to 52|Insufficient Clinical Response|0|||
27778413|NCT01815424|54231858|FG002|Week 16 to 52|Insufficient Clinical Response|0|||
27778414|NCT01815424|54231859|FG003|Week 16 to 52|Insufficient Clinical Response|1|||
27778415|NCT01815424|54231860|FG004|Week 16 to 52|Insufficient Clinical Response|1|||
27778416|NCT01815424|54231856|FG000|Week 16 to 52|Lost to Follow-up|0|||
27778417|NCT01815424|54231857|FG001|Week 16 to 52|Lost to Follow-up|2|||
27778418|NCT01815424|54231858|FG002|Week 16 to 52|Lost to Follow-up|0|||
27778419|NCT01815424|54231859|FG003|Week 16 to 52|Lost to Follow-up|2|||
27778420|NCT01815424|54231860|FG004|Week 16 to 52|Lost to Follow-up|1|||
27778421|NCT01815424|54231856|FG000|Week 16 to 52|Withdrawal by Subject|1|||
27778422|NCT01815424|54231857|FG001|Week 16 to 52|Withdrawal by Subject|2|||
27778423|NCT01815424|54231858|FG002|Week 16 to 52|Withdrawal by Subject|0|||
27778424|NCT01815424|54231859|FG003|Week 16 to 52|Withdrawal by Subject|0|||
27778425|NCT01815424|54231860|FG004|Week 16 to 52|Withdrawal by Subject|0|||
27778426|NCT02431247|54231875|FG000|BL to EOE-Test and BL to Switch- Control|Other|11|||
27778427|NCT02431247|54231876|FG001|BL to EOE-Test and BL to Switch- Control|Other|2|||
27778428|NCT02431247|54231877|FG002|BL to EOE-Test and BL to Switch- Control|Other|0|||
27778429|NCT02431247|54231875|FG000|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|17|||
27778430|NCT02431247|54231876|FG001|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|8|||
27778431|NCT02431247|54231877|FG002|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|0|||
27778432|NCT02431247|54231875|FG000|BL to EOE-Test and BL to Switch- Control|Physician Decision|9|||
27778433|NCT02431247|54231876|FG001|BL to EOE-Test and BL to Switch- Control|Physician Decision|4|||
27778434|NCT02431247|54231877|FG002|BL to EOE-Test and BL to Switch- Control|Physician Decision|0|||
27778435|NCT02431247|54231875|FG000|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
27778436|NCT02431247|54231876|FG001|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
27778437|NCT02431247|54231877|FG002|BL to EOE-Test and BL to Switch- Control|Pregnancy|0|||
27778438|NCT02431247|54231875|FG000|BL to EOE-Test and BL to Switch- Control|Adverse Event|12|||
27778439|NCT02431247|54231876|FG001|BL to EOE-Test and BL to Switch- Control|Adverse Event|16|||
27778440|NCT02431247|54231877|FG002|BL to EOE-Test and BL to Switch- Control|Adverse Event|0|||
27778441|NCT02431247|54231875|FG000|BL to EOE-Test and BL to Switch- Control|Death|0|||
27778442|NCT02431247|54231876|FG001|BL to EOE-Test and BL to Switch- Control|Death|1|||
27778443|NCT02431247|54231877|FG002|BL to EOE-Test and BL to Switch- Control|Death|0|||
27778444|NCT02431247|54231875|FG000|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|14|||
27778445|NCT02431247|54231876|FG001|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|9|||
27778446|NCT02431247|54231877|FG002|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|0|||
27778447|NCT02431247|54231875|FG000|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|2|||
27778448|NCT02431247|54231876|FG001|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
27778449|NCT02431247|54231877|FG002|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
27778450|NCT02431247|54231875|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
27778451|NCT02431247|54231876|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
27778452|NCT02431247|54231877|FG002|Switch to D/C/F/TAF (Until EOE)|Other|4|||
27778453|NCT02431247|54231875|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
27778454|NCT02431247|54231876|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
27778455|NCT02431247|54231877|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|12|||
27778456|NCT02431247|54231875|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
27778457|NCT02431247|54231876|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
27778458|NCT02431247|54231877|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
27778459|NCT02431247|54231875|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
27778460|NCT02431247|54231876|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
27778461|NCT02431247|54231877|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|5|||
27778462|NCT02431247|54231875|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
27778463|NCT02431247|54231876|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
27778464|NCT02431247|54231877|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
27778465|NCT02431247|54231875|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
27778466|NCT02431247|54231876|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
27778467|NCT02431247|54231877|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|10|||
27778468|NCT01814878|54231891|FG000|Overall Study|Adverse Event|16|||
27778469|NCT01814878|54231892|FG001|Overall Study|Adverse Event|5|||
27778470|NCT01814878|54231891|FG000|Overall Study|Withdrawal by Subject|20|||
27778471|NCT01814878|54231892|FG001|Overall Study|Withdrawal by Subject|16|||
27778472|NCT01814878|54231891|FG000|Overall Study|Protocol Violation|5|||
27778473|NCT01814878|54231892|FG001|Overall Study|Protocol Violation|5|||
27778474|NCT01814878|54231891|FG000|Overall Study|Physician Decision|3|||
27778475|NCT01814878|54231892|FG001|Overall Study|Physician Decision|1|||
27778476|NCT01814878|54231891|FG000|Overall Study|Screening failure (drop-out)|0|||
27778477|NCT01814878|54231892|FG001|Overall Study|Screening failure (drop-out)|3|||
27778478|NCT01814878|54231891|FG000|Overall Study|Other|2|||
27778479|NCT01814878|54231892|FG001|Overall Study|Other|0|||
27778480|NCT02407457|54231900|FG000|1 Month|Death|3|||
27778481|NCT02407457|54231901|FG001|1 Month|Death|0|||
27778482|NCT02407457|54231900|FG000|1 Month|Lost to Follow-up|1|||
27778483|NCT02407457|54231901|FG001|1 Month|Lost to Follow-up|1|||
27778484|NCT02407457|54231900|FG000|1 Month|missed visit|2|||
27778485|NCT02407457|54231901|FG001|1 Month|missed visit|6|||
27840527|NCT01464827|54328183|FG009|Overall Study|Not Treated|2|||
27778486|NCT02407457|54231900|FG000|6-Month|Death|2|||
27778487|NCT02407457|54231901|FG001|6-Month|Death|8|||
27840528|NCT01464827|54328184|FG010|Overall Study|Not Treated|0|||
27840529|NCT01464827|54328185|FG011|Overall Study|Not Treated|1|||
27778488|NCT02407457|54231900|FG000|6-Month|Lost to Follow-up|2|||
27778489|NCT02407457|54231901|FG001|6-Month|Lost to Follow-up|2|||
27778490|NCT02407457|54231900|FG000|6-Month|missed visit|15|||
27778491|NCT02407457|54231901|FG001|6-Month|missed visit|12|||
27778492|NCT02407457|54231900|FG000|6-Month|Over Due|1|||
27778493|NCT02407457|54231901|FG001|6-Month|Over Due|2|||
27778494|NCT02407457|54231900|FG000|6-Month|Open Repair|0|||
27778495|NCT02407457|54231901|FG001|6-Month|Open Repair|1|||
27778496|NCT02407457|54231900|FG000|1 Year|Death|6|||
27778497|NCT02407457|54231901|FG001|1 Year|Death|11|||
27778498|NCT02407457|54231900|FG000|1 Year|Lost to Follow-up|3|||
27778499|NCT02407457|54231901|FG001|1 Year|Lost to Follow-up|2|||
27778500|NCT02407457|54231900|FG000|1 Year|Missed Visit|18|||
27778501|NCT02407457|54231901|FG001|1 Year|Missed Visit|10|||
27778502|NCT02407457|54231900|FG000|1 Year|Over Due|6|||
27778503|NCT02407457|54231901|FG001|1 Year|Over Due|4|||
27778504|NCT02407457|54231900|FG000|1 Year|Open Repair|0|||
27778505|NCT02407457|54231901|FG001|1 Year|Open Repair|1|||
27778506|NCT02407457|54231900|FG000|2-year|Death|14|||
27778507|NCT02407457|54231901|FG001|2-year|Death|8|||
27778508|NCT02407457|54231900|FG000|2-year|Lost to Follow-up|6|||
27778509|NCT02407457|54231901|FG001|2-year|Lost to Follow-up|9|||
27778510|NCT02407457|54231900|FG000|2-year|Missed Visit|13|||
27778511|NCT02407457|54231901|FG001|2-year|Missed Visit|11|||
27778512|NCT02407457|54231900|FG000|2-year|Over Due|1|||
27778513|NCT02407457|54231901|FG001|2-year|Over Due|5|||
27778514|NCT02407457|54231900|FG000|2-year|Open Repair|0|||
27778515|NCT02407457|54231901|FG001|2-year|Open Repair|2|||
27778516|NCT02407457|54231900|FG000|3-year|Death|11|||
27778517|NCT02407457|54231901|FG001|3-year|Death|10|||
27778518|NCT02407457|54231900|FG000|3-year|Lost to Follow-up|6|||
27778519|NCT02407457|54231901|FG001|3-year|Lost to Follow-up|9|||
27778520|NCT02407457|54231900|FG000|3-year|Missed Visit|21|||
27778521|NCT02407457|54231901|FG001|3-year|Missed Visit|16|||
27778522|NCT02407457|54231900|FG000|3-year|Over Due|4|||
27778523|NCT02407457|54231901|FG001|3-year|Over Due|3|||
27778524|NCT02407457|54231900|FG000|4-year|Death|14|||
27778525|NCT02407457|54231901|FG001|4-year|Death|7|||
27778526|NCT02407457|54231900|FG000|4-year|Lost to Follow-up|9|||
27778527|NCT02407457|54231901|FG001|4-year|Lost to Follow-up|12|||
27778528|NCT02407457|54231900|FG000|4-year|Over Due|10|||
27778529|NCT02407457|54231901|FG001|4-year|Over Due|5|||
27778530|NCT02407457|54231900|FG000|4-year|Missed Visit|13|||
27778531|NCT02407457|54231901|FG001|4-year|Missed Visit|13|||
27778532|NCT02407457|54231900|FG000|4-year|Pending visit|19|||
27778533|NCT02407457|54231901|FG001|4-year|Pending visit|14|||
27778534|NCT02407457|54231900|FG000|4-year|Not Due|16|||
27778535|NCT02407457|54231901|FG001|4-year|Not Due|10|||
27778536|NCT02407457|54231900|FG000|5-year|Death|6|||
27778537|NCT02407457|54231901|FG001|5-year|Death|1|||
27778538|NCT02407457|54231900|FG000|5-year|Lost to Follow-up|4|||
27778539|NCT02407457|54231901|FG001|5-year|Lost to Follow-up|4|||
27778540|NCT02407457|54231900|FG000|5-year|Missed Visit|10|||
27778541|NCT02407457|54231901|FG001|5-year|Missed Visit|9|||
27778542|NCT02407457|54231900|FG000|5-year|Pending Visit|18|||
27778543|NCT02407457|54231901|FG001|5-year|Pending Visit|17|||
27778544|NCT02407457|54231900|FG000|5-year|Not Due|54|||
27778545|NCT02407457|54231901|FG001|5-year|Not Due|46|||
27778546|NCT01814800|54231907|FG000|Overall Study|Adverse Event|2|||
27778547|NCT01814800|54231907|FG000|Overall Study|Pregnancy|1|||
27778548|NCT01814800|54231907|FG000|Overall Study|Sponsor decision|1|||
27778549|NCT01814800|54231907|FG000|Overall Study|Subject relocation|1|||
27778550|NCT01814332|54231913|FG000|Overall Study|Adverse Event|8|||
27778551|NCT01814332|54231914|FG001|Overall Study|Adverse Event|3|||
27778552|NCT01814332|54231913|FG000|Overall Study|Withdrawal by Subject|3|||
27778553|NCT01814332|54231914|FG001|Overall Study|Withdrawal by Subject|8|||
27778554|NCT01814332|54231913|FG000|Overall Study|Protocol Violation|0|||
27778555|NCT01814332|54231914|FG001|Overall Study|Protocol Violation|4|||
27840530|NCT01464827|54328186|FG012|Overall Study|Not Treated|0|||
27778556|NCT01814332|54231913|FG000|Overall Study|Lost to Follow-up|5|||
27778557|NCT01814332|54231914|FG001|Overall Study|Lost to Follow-up|1|||
27778558|NCT02407223|54231923|FG000|Overall Study|Adverse Event|1|||
27778559|NCT02407223|54231924|FG001|Overall Study|Adverse Event|0|||
27778560|NCT02407223|54231925|FG002|Overall Study|Adverse Event|1|||
27778561|NCT02407223|54231923|FG000|Overall Study|Lack of Efficacy|6|||
27778562|NCT02407223|54231924|FG001|Overall Study|Lack of Efficacy|6|||
27778563|NCT02407223|54231925|FG002|Overall Study|Lack of Efficacy|4|||
27778564|NCT02407223|54231923|FG000|Overall Study|Lost to Follow-up|1|||
27778565|NCT02407223|54231924|FG001|Overall Study|Lost to Follow-up|0|||
27778566|NCT02407223|54231925|FG002|Overall Study|Lost to Follow-up|2|||
27778567|NCT02407223|54231923|FG000|Overall Study|Withdrawal by Subject|2|||
27778568|NCT02407223|54231924|FG001|Overall Study|Withdrawal by Subject|4|||
27778569|NCT02407223|54231925|FG002|Overall Study|Withdrawal by Subject|4|||
27778570|NCT02407223|54231923|FG000|Overall Study|Study Terminated by Sponsor|77|||
27778571|NCT02407223|54231924|FG001|Overall Study|Study Terminated by Sponsor|80|||
27778572|NCT02407223|54231925|FG002|Overall Study|Study Terminated by Sponsor|86|||
27778573|NCT02407223|54231923|FG000|Overall Study|Subject Refused Further Study Treatment|0|||
27778574|NCT02407223|54231924|FG001|Overall Study|Subject Refused Further Study Treatment|1|||
27778575|NCT02407223|54231925|FG002|Overall Study|Subject Refused Further Study Treatment|0|||
27778576|NCT02407223|54231923|FG000|Overall Study|Other|29|||
27778577|NCT02407223|54231924|FG001|Overall Study|Other|27|||
27778578|NCT02407223|54231925|FG002|Overall Study|Other|25|||
27778579|NCT01797562|54231935|FG000|Overall Study|Protocol Violation|5|||
27778580|NCT01813474|54231943|FG000|Overall Study|Withdrawal by Subject|0|||
27778581|NCT01813474|54231944|FG001|Overall Study|Withdrawal by Subject|0|||
27778582|NCT01813474|54231945|FG002|Overall Study|Withdrawal by Subject|1|||
27778583|NCT01813474|54231943|FG000|Overall Study|Adverse Event|1|||
27778584|NCT01813474|54231944|FG001|Overall Study|Adverse Event|1|||
27778585|NCT01813474|54231945|FG002|Overall Study|Adverse Event|0|||
27778586|NCT01813474|54231943|FG000|Overall Study|Lack of Efficacy|2|||
27778587|NCT01813474|54231944|FG001|Overall Study|Lack of Efficacy|6|||
27778588|NCT01813474|54231945|FG002|Overall Study|Lack of Efficacy|9|||
27778589|NCT01813474|54231943|FG000|Overall Study|Death|0|||
27778590|NCT01813474|54231944|FG001|Overall Study|Death|0|||
27778591|NCT01813474|54231945|FG002|Overall Study|Death|1|||
27778592|NCT01868542|54231956|FG000|Overall Study|Protocol Violation|0|||
27778593|NCT01868542|54231957|FG001|Overall Study|Protocol Violation|1|||
27778594|NCT01868542|54231956|FG000|Overall Study|Unclassified|0|||
27778595|NCT01868542|54231957|FG001|Overall Study|Unclassified|1|||
27778596|NCT01797094|54231965|FG000|Overall Study|Adverse Event|1|||
27778597|NCT01797094|54231966|FG001|Overall Study|Adverse Event|1|||
27778598|NCT01797094|54231965|FG000|Overall Study|Personal Reasons|4|||
27778599|NCT01797094|54231966|FG001|Overall Study|Personal Reasons|0|||
27778600|NCT01797094|54231965|FG000|Overall Study|Protocol Violation|0|||
27778601|NCT01797094|54231966|FG001|Overall Study|Protocol Violation|1|||
27778602|NCT01797094|54231965|FG000|Overall Study|Other Miscellaneous Reasons|1|||
27778603|NCT01797094|54231966|FG001|Overall Study|Other Miscellaneous Reasons|0|||
27778604|NCT02383589|54231974|FG000|Treatment Period|Adverse Event|1|||
27778605|NCT02383589|54231975|FG001|Treatment Period|Adverse Event|3|||
27778606|NCT02383589|54231974|FG000|Treatment Period|Lost to Follow-up|0|||
27778607|NCT02383589|54231975|FG001|Treatment Period|Lost to Follow-up|1|||
27778608|NCT02383589|54231974|FG000|Treatment Period|Withdrawal by Subject|0|||
27778609|NCT02383589|54231975|FG001|Treatment Period|Withdrawal by Subject|5|||
27778610|NCT02383589|54231974|FG000|Treatment Period|Non-compliance with study drug|0|||
27778611|NCT02383589|54231975|FG001|Treatment Period|Non-compliance with study drug|1|||
27778612|NCT02383589|54231974|FG000|Safety Follow-up (SFU)|Lost to Follow-up|2|||
27778613|NCT02383589|54231975|FG001|Safety Follow-up (SFU)|Lost to Follow-up|4|||
27778614|NCT02383589|54231974|FG000|Safety Follow-up (SFU)|Withdrawal by Subject|5|||
27778615|NCT02383589|54231975|FG001|Safety Follow-up (SFU)|Withdrawal by Subject|0|||
27778616|NCT02383589|54231974|FG000|Safety Follow-up (SFU)|Treated by not accepted treatment|0|||
27778617|NCT02383589|54231975|FG001|Safety Follow-up (SFU)|Treated by not accepted treatment|1|||
27778618|NCT01810432|54231983|FG000|Washout|Protocol Violation|0|||
27778619|NCT01810432|54231984|FG001|Washout|Protocol Violation|1|||
27778620|NCT01810432|54231983|FG000|Washout|Adverse Event|1|||
27778621|NCT01810432|54231984|FG001|Washout|Adverse Event|0|||
27778622|NCT01810432|54231983|FG000|Period 2|Withdrawal by Subject|2|||
27778623|NCT01810432|54231984|FG001|Period 2|Withdrawal by Subject|1|||
27778624|NCT01810432|54231983|FG000|Period 2|Physician Decision|1|||
27778625|NCT01810432|54231984|FG001|Period 2|Physician Decision|0|||
27778626|NCT01810432|54231983|FG000|Period 2|Lost to Follow-up|1|||
27778627|NCT01810432|54231984|FG001|Period 2|Lost to Follow-up|1|||
27778628|NCT01796860|54231990|FG000|Overall Study|Withdrawal by Subject|3|||
27778629|NCT01796548|54231994|FG000|Overall Study|Lost to Follow-up|1|||
27778630|NCT01796548|54231994|FG000|Overall Study|Other|2|||
27778631|NCT02406677|54232000|FG000|Overall Study|Death|16|||
27778632|NCT02406677|54232001|FG001|Overall Study|Death|8|||
27778633|NCT02406677|54232000|FG000|Overall Study|Discharged without P2Y12|1|||
27778634|NCT02406677|54232001|FG001|Overall Study|Discharged without P2Y12|3|||
27778635|NCT02406677|54232000|FG000|Overall Study|Discharged on prasugrel|283|||
27778636|NCT02406677|54232001|FG001|Overall Study|Discharged on prasugrel|587|||
27778637|NCT02406677|54232000|FG000|Overall Study|Withdrawal by Subject|1|||
27778638|NCT02406677|54232001|FG001|Overall Study|Withdrawal by Subject|0|||
27778639|NCT02404805|54232017|FG000|Overall Study|Withdrawal by Subject|1|||
27840531|NCT01464827|54328187|FG013|Overall Study|Not Treated|2|||
27840532|NCT01463111|54328228|FG000|Overall Study|Withdrawal by Subject|2|||
27778640|NCT02404805|54232018|FG001|Overall Study|Withdrawal by Subject|0|||
27778641|NCT02404805|54232019|FG002|Overall Study|Withdrawal by Subject|0|||
27840533|NCT01463111|54328228|FG000|Overall Study|Lost to Follow-up|5|||
27840534|NCT01463111|54328228|FG000|Overall Study|Physician Decision|2|||
27778642|NCT02404805|54232020|FG003|Overall Study|Withdrawal by Subject|0|||
27840535|NCT01463033|54328234|FG000|Overall Study|Lost to Follow-up|4|||
27778643|NCT02404805|54232021|FG004|Overall Study|Withdrawal by Subject|0|||
27778644|NCT02404805|54232022|FG005|Overall Study|Withdrawal by Subject|0|||
27778645|NCT02430311|54232033|FG000|Part A|Adverse Event|0|||
27778646|NCT02430311|54232034|FG001|Part A|Adverse Event|1|||
27840536|NCT01463033|54328235|FG001|Overall Study|Lost to Follow-up|4|||
27778647|NCT02430311|54232033|FG000|Part A|Withdrawal by Subject|1|||
27778648|NCT02430311|54232034|FG001|Part A|Withdrawal by Subject|0|||
27778649|NCT02430311|54232033|FG000|Part B|Meet study-specific withdrawal criteria|6|||
27778650|NCT02430311|54232034|FG001|Part B|Meet study-specific withdrawal criteria|6|||
27778651|NCT02430311|54232033|FG000|Part B|Withdrawal by Subject|2|||
27778652|NCT02430311|54232034|FG001|Part B|Withdrawal by Subject|2|||
27778653|NCT02430311|54232033|FG000|Part B|Adverse Event|1|||
27778654|NCT02430311|54232034|FG001|Part B|Adverse Event|0|||
27778655|NCT02430311|54232033|FG000|Part B|Death|1|||
27778656|NCT02430311|54232034|FG001|Part B|Death|0|||
27778657|NCT02383433|54232049|FG000|Overall Study|Disease progression|2|||
27778658|NCT02404649|54232055|FG000|Overall Study|Adverse Event|1|||
27778659|NCT02404649|54232056|FG001|Overall Study|Adverse Event|2|||
27778660|NCT02383355|54232064|FG000|Overall Study|Adverse Event|2|||
27778661|NCT02383355|54232065|FG001|Overall Study|Adverse Event|0|||
27778662|NCT02381795|54232071|FG000|Overall Study|Withdrawal by Subject|1|||
27778663|NCT02381795|54232071|FG000|Overall Study|Study Terminated|2|||
27778664|NCT02404493|54232077|FG000|Overall Study|Adverse Event|1|||
27778665|NCT02404493|54232078|FG001|Overall Study|Adverse Event|1|||
27778666|NCT02380859|54232086|FG000|Overall Study|Withdrawal by Subject|2|||
27778667|NCT02380859|54232087|FG001|Overall Study|Withdrawal by Subject|0|||
27778668|NCT02380703|54232095|FG000|Overall Study|Withdrawal by Subject|12|||
27778669|NCT02380703|54232096|FG001|Overall Study|Withdrawal by Subject|9|||
27778670|NCT02380703|54232095|FG000|Overall Study|Lost to Follow-up|12|||
27778671|NCT02380703|54232096|FG001|Overall Study|Lost to Follow-up|12|||
27778672|NCT02380703|54232095|FG000|Overall Study|Caregiver death|1|||
27778673|NCT02380703|54232096|FG001|Overall Study|Caregiver death|0|||
27778674|NCT02380703|54232095|FG000|Overall Study|Person with dementia (PWD) death|7|||
27778675|NCT02380703|54232096|FG001|Overall Study|Person with dementia (PWD) death|8|||
27778676|NCT02380703|54232095|FG000|Overall Study|Entered Long-term Care|4|||
27778677|NCT02380703|54232096|FG001|Overall Study|Entered Long-term Care|7|||
27778678|NCT02379923|54232102|FG000|Overall Study|Death|5|||
27778679|NCT02379221|54232109|FG000|Overall Study|Lost to Follow-up|1|||
27778680|NCT02404103|54232120|FG000|Overall Study|Adverse Event|1|||
27778681|NCT02404103|54232121|FG001|Overall Study|Adverse Event|0|||
27778682|NCT02404103|54232120|FG000|Overall Study|Lost to Follow-up|3|||
27778683|NCT02404103|54232121|FG001|Overall Study|Lost to Follow-up|3|||
27778684|NCT02404025|54232137|FG000|Overall Study|Adverse Event|1|||
27778685|NCT02404025|54232137|FG000|Overall Study|Lack of Efficacy|3|||
27778686|NCT02377817|54232143|FG000|Overall Study|Transportation/childcare barriers.|2|||
27778687|NCT02377817|54232144|FG001|Overall Study|Transportation/childcare barriers.|0|||
27778688|NCT02377817|54232143|FG000|Overall Study|Unrelated injury prevented lateral sleep|1|||
27778689|NCT02377817|54232144|FG001|Overall Study|Unrelated injury prevented lateral sleep|0|||
27778690|NCT02403635|54232152|FG000|Overall Study|Not eligible|9|||
27778691|NCT02402933|54232172|FG000|Overall Study|Withdrawal by Subject|4|||
27778692|NCT02402933|54232172|FG000|Overall Study|Discontinued; Site Termination|10|||
27778693|NCT01796470|54232181|FG000|Overall Study|Adverse Event|4|||
27778694|NCT01796470|54232182|FG001|Overall Study|Adverse Event|2|||
27778695|NCT01796470|54232183|FG002|Overall Study|Adverse Event|2|||
27778696|NCT01796470|54232184|FG003|Overall Study|Adverse Event|1|||
27778697|NCT01796470|54232185|FG004|Overall Study|Adverse Event|3|||
27778698|NCT01796470|54232181|FG000|Overall Study|Death|2|||
27778699|NCT01796470|54232182|FG001|Overall Study|Death|0|||
27778700|NCT01796470|54232183|FG002|Overall Study|Death|0|||
27778701|NCT01796470|54232184|FG003|Overall Study|Death|0|||
27778702|NCT01796470|54232185|FG004|Overall Study|Death|1|||
27778703|NCT01796470|54232181|FG000|Overall Study|Initiated New Therapy|9|||
27778704|NCT01796470|54232182|FG001|Overall Study|Initiated New Therapy|0|||
27778705|NCT01796470|54232183|FG002|Overall Study|Initiated New Therapy|0|||
27778706|NCT01796470|54232184|FG003|Overall Study|Initiated New Therapy|0|||
27778707|NCT01796470|54232185|FG004|Overall Study|Initiated New Therapy|2|||
27778708|NCT01796470|54232181|FG000|Overall Study|Lost to Follow-up|0|||
27778709|NCT01796470|54232182|FG001|Overall Study|Lost to Follow-up|1|||
27778710|NCT01796470|54232183|FG002|Overall Study|Lost to Follow-up|0|||
27778711|NCT01796470|54232184|FG003|Overall Study|Lost to Follow-up|0|||
27778712|NCT01796470|54232185|FG004|Overall Study|Lost to Follow-up|0|||
27778713|NCT01796470|54232181|FG000|Overall Study|Physician Decision|5|||
27778714|NCT01796470|54232182|FG001|Overall Study|Physician Decision|4|||
27778715|NCT01796470|54232183|FG002|Overall Study|Physician Decision|1|||
27778716|NCT01796470|54232184|FG003|Overall Study|Physician Decision|0|||
27778717|NCT01796470|54232185|FG004|Overall Study|Physician Decision|1|||
27778718|NCT01796470|54232181|FG000|Overall Study|Progressive Disease|7|||
27778719|NCT01796470|54232182|FG001|Overall Study|Progressive Disease|7|||
27778720|NCT01796470|54232183|FG002|Overall Study|Progressive Disease|3|||
27778721|NCT01796470|54232184|FG003|Overall Study|Progressive Disease|2|||
27778722|NCT01796470|54232185|FG004|Overall Study|Progressive Disease|0|||
27778723|NCT01796470|54232181|FG000|Overall Study|Protocol Criteria for Withdrawal|1|||
27778724|NCT01796470|54232182|FG001|Overall Study|Protocol Criteria for Withdrawal|0|||
27778725|NCT01796470|54232183|FG002|Overall Study|Protocol Criteria for Withdrawal|0|||
27778726|NCT01796470|54232184|FG003|Overall Study|Protocol Criteria for Withdrawal|0|||
27778727|NCT01796470|54232185|FG004|Overall Study|Protocol Criteria for Withdrawal|0|||
27778728|NCT01796470|54232181|FG000|Overall Study|Withdrawal by Subject|7|||
27778729|NCT01796470|54232182|FG001|Overall Study|Withdrawal by Subject|0|||
27778730|NCT01796470|54232183|FG002|Overall Study|Withdrawal by Subject|0|||
27778731|NCT01796470|54232184|FG003|Overall Study|Withdrawal by Subject|0|||
27778732|NCT01796470|54232185|FG004|Overall Study|Withdrawal by Subject|1|||
27778733|NCT01868074|54232203|FG000|Overall Study|Lost to Follow-up|3|||
27778734|NCT01868074|54232204|FG001|Overall Study|Lost to Follow-up|2|||
27778735|NCT01868074|54232203|FG000|Overall Study|Withdrawal by Subject|4|||
27778736|NCT01868074|54232204|FG001|Overall Study|Withdrawal by Subject|2|||
27778737|NCT01810042|54232210|FG000|Overall Study|Lost to Follow-up|10|||
27778738|NCT02424539|54232217|FG000|Overall Study|Adverse Event|0|||
27778739|NCT02424539|54232218|FG001|Overall Study|Adverse Event|0|||
27778740|NCT02424539|54232219|FG002|Overall Study|Adverse Event|1|||
27778741|NCT02424539|54232217|FG000|Overall Study|Physician Decision|0|||
27778742|NCT02424539|54232218|FG001|Overall Study|Physician Decision|0|||
27778743|NCT02424539|54232219|FG002|Overall Study|Physician Decision|1|||
27778744|NCT02424539|54232217|FG000|Overall Study|Withdrawal by Subject|3|||
27778745|NCT02424539|54232218|FG001|Overall Study|Withdrawal by Subject|1|||
27778746|NCT02424539|54232219|FG002|Overall Study|Withdrawal by Subject|0|||
27778747|NCT02424539|54232217|FG000|Overall Study|Other: Reached stopping criteria|11|||
27778748|NCT02424539|54232218|FG001|Overall Study|Other: Reached stopping criteria|7|||
27778749|NCT02424539|54232219|FG002|Overall Study|Other: Reached stopping criteria|6|||
27778750|NCT01809262|54232227|FG000|Period 1 (First Dose + Washout)|Adverse Event|0|||
27778751|NCT01809262|54232228|FG001|Period 1 (First Dose + Washout)|Adverse Event|0|||
27778752|NCT01809262|54232229|FG002|Period 1 (First Dose + Washout)|Adverse Event|0|||
27778753|NCT01809262|54232230|FG003|Period 1 (First Dose + Washout)|Adverse Event|0|||
27778754|NCT01809262|54232231|FG004|Period 1 (First Dose + Washout)|Adverse Event|1|||
27778755|NCT01809262|54232232|FG005|Period 1 (First Dose + Washout)|Adverse Event|0|||
27778756|NCT01809262|54232233|FG006|Period 1 (First Dose + Washout)|Adverse Event|0|||
27778757|NCT01809262|54232234|FG007|Period 1 (First Dose + Washout)|Adverse Event|0|||
27778758|NCT01809262|54232235|FG008|Period 1 (First Dose + Washout)|Adverse Event|0|||
27778759|NCT01809262|54232236|FG009|Period 1 (First Dose + Washout)|Adverse Event|0|||
27778760|NCT01809262|54232227|FG000|Period 3 (Third Dose + Washout)|Adverse Event|0|||
27778761|NCT01809262|54232228|FG001|Period 3 (Third Dose + Washout)|Adverse Event|1|||
27778762|NCT01809262|54232229|FG002|Period 3 (Third Dose + Washout)|Adverse Event|0|||
27778763|NCT01809262|54232230|FG003|Period 3 (Third Dose + Washout)|Adverse Event|0|||
27778764|NCT01809262|54232231|FG004|Period 3 (Third Dose + Washout)|Adverse Event|0|||
27778765|NCT01809262|54232232|FG005|Period 3 (Third Dose + Washout)|Adverse Event|0|||
27778766|NCT01809262|54232233|FG006|Period 3 (Third Dose + Washout)|Adverse Event|0|||
27778767|NCT01809262|54232234|FG007|Period 3 (Third Dose + Washout)|Adverse Event|0|||
27778768|NCT01809262|54232235|FG008|Period 3 (Third Dose + Washout)|Adverse Event|0|||
27778769|NCT01809262|54232236|FG009|Period 3 (Third Dose + Washout)|Adverse Event|0|||
27778770|NCT01808248|54232250|FG000|Overall Study|Lack of Efficacy|3|||
27778771|NCT01808248|54232250|FG000|Overall Study|Withdrawal by Subject|1|||
27778772|NCT01808248|54232250|FG000|Overall Study|Lost to Follow-up|1|||
27778773|NCT02424383|54232256|FG000|Overall Study|Withdrawal by Subject|32|||
27778774|NCT02424383|54232256|FG000|Overall Study|Death|170|||
27778775|NCT02424383|54232256|FG000|Overall Study|Sponsor's decision|3|||
27778776|NCT02424383|54232256|FG000|Overall Study|Investigator's decision|44|||
27778777|NCT02424383|54232256|FG000|Overall Study|Lost to Follow-up|81|||
27778778|NCT02424383|54232256|FG000|Overall Study|Other|7|||
27778779|NCT02424383|54232256|FG000|Overall Study|Ineligible for Major Protocol Deviation|39|||
27778780|NCT01867294|54232264|FG000|Overall Study|Withdrawal by Subject|1|||
27778781|NCT01867294|54232265|FG001|Overall Study|Withdrawal by Subject|1|||
27778782|NCT01867294|54232266|FG002|Overall Study|Withdrawal by Subject|0|||
27778783|NCT01867294|54232267|FG003|Overall Study|Withdrawal by Subject|0|||
27778784|NCT02424149|54232277|FG000|Overall Study|surgery cancelled|2|||
27778785|NCT02424149|54232278|FG001|Overall Study|surgery cancelled|0|||
27778786|NCT02424149|54232277|FG000|Overall Study|Withdrawal by Subject|0|||
27778787|NCT02424149|54232278|FG001|Overall Study|Withdrawal by Subject|1|||
27778788|NCT02423291|54232284|FG000|Overall Study|Lack of Efficacy|14|||
27778789|NCT02423291|54232284|FG000|Overall Study|Adverse Event|1|||
27778790|NCT02401529|54232290|FG000|Overall Study|Lost to Follow-up|2|||
27778791|NCT02401529|54232291|FG001|Overall Study|Lost to Follow-up|1|||
27778792|NCT02401529|54232290|FG000|Overall Study|Physician Decision|2|||
27778793|NCT02401529|54232291|FG001|Overall Study|Physician Decision|6|||
27778794|NCT02401529|54232290|FG000|Overall Study|Protocol Violation|5|||
27778795|NCT02401529|54232291|FG001|Overall Study|Protocol Violation|0|||
27778796|NCT01867216|54232305|FG000|Overall Study|Withdrawal by Subject|2|||
27778797|NCT01867216|54232306|FG001|Overall Study|Withdrawal by Subject|0|||
27778798|NCT01867216|54232307|FG002|Overall Study|Withdrawal by Subject|0|||
27778799|NCT01867216|54232308|FG003|Overall Study|Withdrawal by Subject|0|||
27778800|NCT01867216|54232309|FG004|Overall Study|Withdrawal by Subject|1|||
27778801|NCT01867216|54232310|FG005|Overall Study|Withdrawal by Subject|0|||
27778802|NCT01867216|54232311|FG006|Overall Study|Withdrawal by Subject|1|||
27778803|NCT01867216|54232305|FG000|Overall Study|Physician Decision|1|||
27778804|NCT01867216|54232306|FG001|Overall Study|Physician Decision|0|||
27778805|NCT01867216|54232307|FG002|Overall Study|Physician Decision|0|||
27778806|NCT01867216|54232308|FG003|Overall Study|Physician Decision|0|||
27778807|NCT01867216|54232309|FG004|Overall Study|Physician Decision|0|||
27778808|NCT01867216|54232310|FG005|Overall Study|Physician Decision|0|||
27778809|NCT01867216|54232311|FG006|Overall Study|Physician Decision|0|||
27778810|NCT01867216|54232305|FG000|Overall Study|Unable to Place Catheter for Blood Draws|1|||
27778811|NCT01867216|54232306|FG001|Overall Study|Unable to Place Catheter for Blood Draws|0|||
27778812|NCT01867216|54232307|FG002|Overall Study|Unable to Place Catheter for Blood Draws|0|||
27778813|NCT01867216|54232308|FG003|Overall Study|Unable to Place Catheter for Blood Draws|0|||
27778814|NCT01867216|54232309|FG004|Overall Study|Unable to Place Catheter for Blood Draws|0|||
27778815|NCT01867216|54232310|FG005|Overall Study|Unable to Place Catheter for Blood Draws|0|||
27778816|NCT01867216|54232311|FG006|Overall Study|Unable to Place Catheter for Blood Draws|0|||
27778817|NCT01866826|54232333|FG000|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1|||
27778818|NCT01866826|54232334|FG001|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0|||
27778819|NCT01866826|54232333|FG000|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0|||
27778820|NCT01866826|54232334|FG001|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2|||
27778821|NCT01866826|54232333|FG000|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0|||
27778822|NCT01866826|54232334|FG001|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1|||
27778823|NCT01791244|54232351|FG000|Overall Study|Adverse Event|5|||
27778824|NCT01791244|54232352|FG001|Overall Study|Adverse Event|7|||
27778825|NCT01791244|54232351|FG000|Overall Study|Insufficient clinical response|10|||
27778826|NCT01791244|54232352|FG001|Overall Study|Insufficient clinical response|10|||
27778827|NCT01791244|54232351|FG000|Overall Study|Laboratory Abnormality|0|||
27778828|NCT01791244|54232352|FG001|Overall Study|Laboratory Abnormality|1|||
27778829|NCT01865812|54232360|FG000|Primary Treatment Phase|Adverse Event|2|||
27840537|NCT01463033|54328234|FG000|Overall Study|Death|3|||
27840538|NCT01463033|54328235|FG001|Overall Study|Death|2|||
27840539|NCT01461707|54328244|FG000|Overall Study|Withdrawal by Subject|1|||
27778830|NCT01865812|54232361|FG001|Primary Treatment Phase|Adverse Event|0|||
27778831|NCT01865812|54232360|FG000|Long-term Safety Extension Phase|Withdrawal by Subject|0|||
27778832|NCT01865812|54232361|FG001|Long-term Safety Extension Phase|Withdrawal by Subject|1|||
27778833|NCT01865812|54232360|FG000|Long-term Safety Extension Phase|Pruritus|0|||
27778834|NCT01865812|54232361|FG001|Long-term Safety Extension Phase|Pruritus|3|||
27778835|NCT01865812|54232360|FG000|Long-term Safety Extension Phase|Physician Decision|0|||
27778836|NCT01865812|54232361|FG001|Long-term Safety Extension Phase|Physician Decision|1|||
27778837|NCT01865812|54232360|FG000|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|0|||
27778838|NCT01865812|54232361|FG001|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|1|||
27778839|NCT01808092|54232370|FG000|Overall Study|Death|39|||
27778840|NCT01808092|54232371|FG001|Overall Study|Death|29|||
27778841|NCT01808092|54232370|FG000|Overall Study|Lost to Follow-up|3|||
27778842|NCT01808092|54232371|FG001|Overall Study|Lost to Follow-up|7|||
27778843|NCT01808092|54232370|FG000|Overall Study|Withdrawal by Subject|9|||
27778844|NCT01808092|54232371|FG001|Overall Study|Withdrawal by Subject|4|||
27778845|NCT01808092|54232370|FG000|Overall Study|Other Eligibility criteria|3|||
27778846|NCT01808092|54232371|FG001|Overall Study|Other Eligibility criteria|5|||
27778847|NCT01774084|54232379|FG000|Overall Study|Personal reasons|1|||
27778848|NCT01774084|54232380|FG001|Overall Study|Personal reasons|0|||
27778849|NCT01807234|54232392|FG000|Overall Study|Lost to Follow-up|2|||
27778850|NCT01807234|54232393|FG001|Overall Study|Lost to Follow-up|5|||
27778851|NCT01807234|54232394|FG002|Overall Study|Lost to Follow-up|1|||
27778852|NCT01807234|54232395|FG003|Overall Study|Lost to Follow-up|1|||
27778853|NCT01807234|54232396|FG004|Overall Study|Lost to Follow-up|1|||
27778854|NCT01807234|54232397|FG005|Overall Study|Lost to Follow-up|2|||
27778855|NCT01807234|54232392|FG000|Overall Study|Withdrawal by Subject|3|||
27778856|NCT01807234|54232393|FG001|Overall Study|Withdrawal by Subject|1|||
27778857|NCT01807234|54232394|FG002|Overall Study|Withdrawal by Subject|1|||
27778858|NCT01807234|54232395|FG003|Overall Study|Withdrawal by Subject|1|||
27840540|NCT01461707|54328245|FG001|Overall Study|Withdrawal by Subject|0|||
27778859|NCT01807234|54232396|FG004|Overall Study|Withdrawal by Subject|2|||
27778860|NCT01807234|54232397|FG005|Overall Study|Withdrawal by Subject|1|||
27778861|NCT01807234|54232392|FG000|Overall Study|Lack of Efficacy|0|||
27778862|NCT01807234|54232393|FG001|Overall Study|Lack of Efficacy|0|||
27778863|NCT01807234|54232394|FG002|Overall Study|Lack of Efficacy|0|||
27778864|NCT01807234|54232395|FG003|Overall Study|Lack of Efficacy|0|||
27778865|NCT01807234|54232396|FG004|Overall Study|Lack of Efficacy|1|||
27840541|NCT01461551|54328254|FG000|Overall Study|Physician Decision|2|||
27778866|NCT01807234|54232397|FG005|Overall Study|Lack of Efficacy|1|||
27778867|NCT01790932|54232407|FG000|Overall Study|Disease Progression|41|||
27778868|NCT01790932|54232407|FG000|Overall Study|Adverse Event|7|||
27778869|NCT01790932|54232407|FG000|Overall Study|Physician Decision|1|||
27778870|NCT01790932|54232407|FG000|Overall Study|Withdrawal by Subject|1|||
27778871|NCT02377427|54232413|FG000|Part A (Up to Week 20)|Physician Decision|1|||
27778872|NCT02377427|54232414|FG001|Part A (Up to Week 20)|Physician Decision|0|||
27778873|NCT02377427|54232415|FG002|Part A (Up to Week 20)|Physician Decision|0|||
27778874|NCT02377427|54232416|FG003|Part A (Up to Week 20)|Physician Decision|0|||
27778875|NCT02377427|54232417|FG004|Part A (Up to Week 20)|Physician Decision|0|||
27778876|NCT02377427|54232413|FG000|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1|||
27778877|NCT02377427|54232414|FG001|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
27778878|NCT02377427|54232415|FG002|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
27778879|NCT02377427|54232416|FG003|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
27778880|NCT02377427|54232417|FG004|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
27778881|NCT02377427|54232413|FG000|Part A (Up to Week 20)|Withdrawal by Subject|2|||
27778882|NCT02377427|54232414|FG001|Part A (Up to Week 20)|Withdrawal by Subject|0|||
27778883|NCT02377427|54232415|FG002|Part A (Up to Week 20)|Withdrawal by Subject|0|||
27778884|NCT02377427|54232416|FG003|Part A (Up to Week 20)|Withdrawal by Subject|0|||
27778885|NCT02377427|54232417|FG004|Part A (Up to Week 20)|Withdrawal by Subject|0|||
27778886|NCT02377427|54232413|FG000|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
27778887|NCT02377427|54232414|FG001|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
27778888|NCT02377427|54232415|FG002|Part B (From Week 20 and up to Week 80)|Protocol Violation|1|||
27778889|NCT02377427|54232416|FG003|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
27778890|NCT02377427|54232417|FG004|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
27778891|NCT02421887|54232432|FG000|Overall Study|Lost to Follow-up|5|||
27778892|NCT02421887|54232433|FG001|Overall Study|Lost to Follow-up|0|||
27778893|NCT02421887|54232432|FG000|Overall Study|Withdrawal by Subject|8|||
27778894|NCT02421887|54232433|FG001|Overall Study|Withdrawal by Subject|5|||
27778895|NCT02421887|54232432|FG000|Overall Study|Physician Decision|2|||
27778896|NCT02421887|54232433|FG001|Overall Study|Physician Decision|4|||
27778897|NCT02421887|54232432|FG000|Overall Study|Adverse Event|2|||
27778898|NCT02421887|54232433|FG001|Overall Study|Adverse Event|0|||
27778899|NCT01609582|54232441|FG000|Overall Study|Adverse Event|20|||
27778900|NCT01609582|54232442|FG001|Overall Study|Adverse Event|18|||
27778901|NCT01609582|54232441|FG000|Overall Study|Lost to Follow-up|10|||
27778902|NCT01609582|54232442|FG001|Overall Study|Lost to Follow-up|10|||
27778903|NCT01609582|54232441|FG000|Overall Study|Withdrawal by Subject|21|||
27778904|NCT01609582|54232442|FG001|Overall Study|Withdrawal by Subject|15|||
27778905|NCT01609582|54232441|FG000|Overall Study|Study Terminated by Sponsor|1543|||
27778906|NCT01609582|54232442|FG001|Overall Study|Study Terminated by Sponsor|1548|||
27778907|NCT01609582|54232441|FG000|Overall Study|Other|9|||
27778908|NCT01609582|54232442|FG001|Overall Study|Other|10|||
27778909|NCT01609582|54232441|FG000|Overall Study|Randomized, but not treated|0|||
27778910|NCT01609582|54232442|FG001|Overall Study|Randomized, but not treated|3|||
27778911|NCT01789606|54232450|FG000|Overall Study|Participant not Purchased the Product|0|||
27778912|NCT01789606|54232451|FG001|Overall Study|Participant not Purchased the Product|20|||
27778913|NCT01789606|54232450|FG000|Overall Study|Withdrawal by Subject|0|||
27778914|NCT01789606|54232451|FG001|Overall Study|Withdrawal by Subject|1|||
27778915|NCT01789606|54232450|FG000|Overall Study|Ineligible|6|||
27778916|NCT01789606|54232451|FG001|Overall Study|Ineligible|2|||
27778917|NCT01789606|54232450|FG000|Overall Study|Administrative Reasons|17|||
27778918|NCT01789606|54232451|FG001|Overall Study|Administrative Reasons|6|||
27778919|NCT01789606|54232450|FG000|Overall Study|No Study Medication Taken|0|||
27778920|NCT01789606|54232451|FG001|Overall Study|No Study Medication Taken|1|||
27778921|NCT01789606|54232450|FG000|Overall Study|Protocol Violation|0|||
27778922|NCT01789606|54232451|FG001|Overall Study|Protocol Violation|55|||
27778923|NCT01789606|54232450|FG000|Overall Study|Adverse Event|0|||
27778924|NCT01789606|54232451|FG001|Overall Study|Adverse Event|3|||
27778925|NCT01789606|54232450|FG000|Overall Study|Lost to Follow-up|0|||
27778926|NCT01789606|54232451|FG001|Overall Study|Lost to Follow-up|14|||
27778927|NCT01789606|54232450|FG000|Overall Study|Ineligible or not Willing to Continue|0|||
27778928|NCT01789606|54232451|FG001|Overall Study|Ineligible or not Willing to Continue|348|||
27778929|NCT01788358|54232456|FG000|Overall Study|Other|11|||
27778930|NCT01788358|54232456|FG000|Overall Study|Logistical difficulties|1|||
27778931|NCT01788358|54232456|FG000|Overall Study|Lost to Follow-up|5|||
27778932|NCT01788358|54232456|FG000|Overall Study|Protocol Violation|3|||
27778933|NCT01788358|54232456|FG000|Overall Study|Withdrawal by Subject|26|||
27778934|NCT01788358|54232456|FG000|Overall Study|Lack of Efficacy|1|||
27778935|NCT01788358|54232456|FG000|Overall Study|Adverse Event|51|||
27778936|NCT01773226|54232460|FG000|Overall Study|Withdrawal by Subject|1|||
27778937|NCT01773070|54232464|FG000|Overall Study|Withdrawal by Subject|24|||
27778938|NCT01773070|54232464|FG000|Overall Study|Lost to Follow-up|39|||
27778939|NCT01773070|54232464|FG000|Overall Study|Other|15|||
27778940|NCT01773070|54232464|FG000|Overall Study|Death (unrelated to study procedures)|3|||
27778941|NCT01772368|54232468|FG000|Overall Study|Adverse Event|1|||
27778942|NCT01772368|54232468|FG000|Overall Study|Withdrawal by Subject|3|||
27778943|NCT01772368|54232468|FG000|Overall Study|Protocol Violation|2|||
27778944|NCT01772368|54232468|FG000|Overall Study|Other|1|||
27778945|NCT01788046|54232486|FG000|Overall Study|Withdrawal by Subject|12|||
27778946|NCT01788046|54232487|FG001|Overall Study|Withdrawal by Subject|12|||
27778947|NCT01788046|54232486|FG000|Overall Study|Lost to Follow-up|12|||
27778948|NCT01788046|54232487|FG001|Overall Study|Lost to Follow-up|19|||
27778949|NCT01788046|54232486|FG000|Overall Study|Death|7|||
27778950|NCT01788046|54232487|FG001|Overall Study|Death|5|||
27778951|NCT01788046|54232486|FG000|Overall Study|Protocol Specified Criteria|25|||
27778952|NCT01788046|54232487|FG001|Overall Study|Protocol Specified Criteria|1|||
27778953|NCT01806298|54232493|FG000|Overall Study|Adverse Event|3|||
27778954|NCT01806298|54232493|FG000|Overall Study|Protocol Non-compliance|1|||
27778955|NCT01806298|54232493|FG000|Overall Study|Withdrawal by Subject|1|||
27778956|NCT01806298|54232493|FG000|Overall Study|Other|5|||
27778957|NCT01772134|54232500|FG000|Overall Study|Adverse Event|6|||
27778958|NCT01772134|54232501|FG001|Overall Study|Adverse Event|5|||
27778959|NCT01772134|54232502|FG002|Overall Study|Adverse Event|10|||
27778960|NCT01772134|54232500|FG000|Overall Study|Withdrew Consent|3|||
27778961|NCT01772134|54232501|FG001|Overall Study|Withdrew Consent|1|||
27778962|NCT01772134|54232502|FG002|Overall Study|Withdrew Consent|5|||
27778963|NCT01772134|54232500|FG000|Overall Study|Lost to Follow-up|2|||
27778964|NCT01772134|54232501|FG001|Overall Study|Lost to Follow-up|0|||
27778965|NCT01772134|54232502|FG002|Overall Study|Lost to Follow-up|0|||
27778966|NCT01772134|54232500|FG000|Overall Study|Protocol Deviation|4|||
27778967|NCT01772134|54232501|FG001|Overall Study|Protocol Deviation|3|||
27778968|NCT01772134|54232502|FG002|Overall Study|Protocol Deviation|3|||
27778969|NCT01772134|54232500|FG000|Overall Study|Lack of Efficacy|11|||
27778970|NCT01772134|54232501|FG001|Overall Study|Lack of Efficacy|5|||
27778971|NCT01772134|54232502|FG002|Overall Study|Lack of Efficacy|3|||
27778972|NCT01772134|54232500|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
27778973|NCT01772134|54232501|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
27778974|NCT01772134|54232502|FG002|Overall Study|Protocol-defined Stopping Criteria|0|||
27778975|NCT01772134|54232500|FG000|Overall Study|Randomized Study Medication Not Received|2|||
27778976|NCT01772134|54232501|FG001|Overall Study|Randomized Study Medication Not Received|0|||
27778977|NCT01772134|54232502|FG002|Overall Study|Randomized Study Medication Not Received|1|||
27778978|NCT01994889|54232513|FG000|Overall Study|Adverse Event|5|||
27778979|NCT01994889|54232514|FG001|Overall Study|Adverse Event|12|||
27778980|NCT01994889|54232515|FG002|Overall Study|Adverse Event|11|||
27778981|NCT01994889|54232513|FG000|Overall Study|Cardiac Device Implantation|0|||
27778982|NCT01994889|54232514|FG001|Overall Study|Cardiac Device Implantation|2|||
27778983|NCT01994889|54232515|FG002|Overall Study|Cardiac Device Implantation|0|||
27778984|NCT01994889|54232513|FG000|Overall Study|Organ Transplantation|1|||
27778985|NCT01994889|54232514|FG001|Overall Study|Organ Transplantation|5|||
27778986|NCT01994889|54232515|FG002|Overall Study|Organ Transplantation|5|||
27778987|NCT01994889|54232513|FG000|Overall Study|No longer willing to participate|8|||
27778988|NCT01994889|54232514|FG001|Overall Study|No longer willing to participate|17|||
27778989|NCT01994889|54232515|FG002|Overall Study|No longer willing to participate|37|||
27778990|NCT01994889|54232513|FG000|Overall Study|Lost to Follow-up|0|||
27778991|NCT01994889|54232514|FG001|Overall Study|Lost to Follow-up|1|||
27778992|NCT01994889|54232515|FG002|Overall Study|Lost to Follow-up|0|||
27778993|NCT01994889|54232513|FG000|Overall Study|Protocol Violation|0|||
27778994|NCT01994889|54232514|FG001|Overall Study|Protocol Violation|1|||
27778995|NCT01994889|54232515|FG002|Overall Study|Protocol Violation|1|||
27778996|NCT01994889|54232513|FG000|Overall Study|Death|14|||
27778997|NCT01994889|54232514|FG001|Overall Study|Death|25|||
27778998|NCT01994889|54232515|FG002|Overall Study|Death|38|||
27778999|NCT02082483|54232524|FG000|Overall Study|Lost to Follow-up|1|||
27779000|NCT02082483|54232525|FG001|Overall Study|Lost to Follow-up|1|||
27779001|NCT02082483|54232524|FG000|Overall Study|Withdrawal by Subject|2|||
27779002|NCT02082483|54232525|FG001|Overall Study|Withdrawal by Subject|1|||
27779003|NCT02082483|54232524|FG000|Overall Study|Physician Decision|1|||
27779004|NCT02082483|54232525|FG001|Overall Study|Physician Decision|1|||
27779005|NCT02082483|54232524|FG000|Overall Study|Death|2|||
27779006|NCT02082483|54232525|FG001|Overall Study|Death|3|||
27779007|NCT02017899|54232538|FG000|Overall Study|Withdrawal by Subject|0|||
27779008|NCT02017899|54232539|FG001|Overall Study|Withdrawal by Subject|0|||
27779009|NCT02017899|54232540|FG002|Overall Study|Withdrawal by Subject|0|||
27779010|NCT02017899|54232541|FG003|Overall Study|Withdrawal by Subject|1|||
27779011|NCT02017899|54232542|FG004|Overall Study|Withdrawal by Subject|1|||
27779012|NCT02017899|54232543|FG005|Overall Study|Withdrawal by Subject|0|||
27779013|NCT01993329|54232563|FG000|Period 2|Adverse Event|0|||
27779014|NCT01993329|54232564|FG001|Period 2|Adverse Event|0|||
27779015|NCT01993329|54232565|FG002|Period 2|Adverse Event|0|||
27779016|NCT01993329|54232566|FG003|Period 2|Adverse Event|0|||
27779017|NCT01993329|54232567|FG004|Period 2|Adverse Event|0|||
27779018|NCT01993329|54232568|FG005|Period 2|Adverse Event|1|||
27779019|NCT01993329|54232563|FG000|Wash-out|Personal reasons|0|||
27779020|NCT01993329|54232564|FG001|Wash-out|Personal reasons|1|||
27779021|NCT01993329|54232565|FG002|Wash-out|Personal reasons|0|||
27779022|NCT01993329|54232566|FG003|Wash-out|Personal reasons|0|||
27779023|NCT01993329|54232567|FG004|Wash-out|Personal reasons|0|||
27779024|NCT01993329|54232568|FG005|Wash-out|Personal reasons|0|||
27779025|NCT02016183|54232580|FG000|Overall Study|Case Report Forms Uncollected|13|||
27779026|NCT02016183|54232580|FG000|Overall Study|Protocol Violation|52|||
27779027|NCT02377349|54232586|FG000|Overall Study|Serious Adverse Event|1|||
27779028|NCT02377349|54232587|FG001|Overall Study|Serious Adverse Event|0|||
27779029|NCT02377349|54232586|FG000|Overall Study|Protocol Violation|3|||
27779030|NCT02377349|54232587|FG001|Overall Study|Protocol Violation|2|||
27779031|NCT02377349|54232586|FG000|Overall Study|Withdrawal by Subject|5|||
27779032|NCT02377349|54232587|FG001|Overall Study|Withdrawal by Subject|3|||
27779033|NCT02377349|54232586|FG000|Overall Study|Lost to follow-up (partial vaccination)|1|||
27779034|NCT02377349|54232587|FG001|Overall Study|Lost to follow-up (partial vaccination)|0|||
27779035|NCT02377349|54232586|FG000|Overall Study|Lost to follow-up (complete vaccination)|6|||
27779036|NCT02377349|54232587|FG001|Overall Study|Lost to follow-up (complete vaccination)|5|||
27779037|NCT02377349|54232586|FG000|Overall Study|Other|0|||
27779038|NCT02377349|54232587|FG001|Overall Study|Other|1|||
27779039|NCT02421419|54232605|FG000|Overall Study|Physician Decision|0|||
27779040|NCT02421419|54232606|FG001|Overall Study|Physician Decision|0|||
27779041|NCT02421419|54232607|FG002|Overall Study|Physician Decision|1|||
27779042|NCT02420717|54232618|FG000|Overall Study|Did not receive all study medication|2|||
27779043|NCT02420717|54232619|FG001|Overall Study|Did not receive all study medication|0|||
27779044|NCT02420717|54232620|FG002|Overall Study|Did not receive all study medication|0|||
27779045|NCT02016105|54232630|FG000|TREATMENT PERIOD 1|Protocol Violation|2|||
27779046|NCT02016105|54232631|FG001|TREATMENT PERIOD 1|Protocol Violation|8|||
27779047|NCT02016105|54232632|FG002|TREATMENT PERIOD 1|Protocol Violation|0|||
27779048|NCT02016105|54232633|FG003|TREATMENT PERIOD 1|Protocol Violation|0|||
27779049|NCT02016105|54232634|FG004|TREATMENT PERIOD 1|Protocol Violation|0|||
27779050|NCT02016105|54232635|FG005|TREATMENT PERIOD 1|Protocol Violation|0|||
27779051|NCT02016105|54232630|FG000|TREATMENT PERIOD 1|Physician Decision|0|||
27779052|NCT02016105|54232631|FG001|TREATMENT PERIOD 1|Physician Decision|2|||
27779053|NCT02016105|54232632|FG002|TREATMENT PERIOD 1|Physician Decision|0|||
27779054|NCT02016105|54232633|FG003|TREATMENT PERIOD 1|Physician Decision|0|||
27779055|NCT02016105|54232634|FG004|TREATMENT PERIOD 1|Physician Decision|0|||
27779056|NCT02016105|54232635|FG005|TREATMENT PERIOD 1|Physician Decision|0|||
27779057|NCT02016105|54232630|FG000|TREATMENT PERIOD 1|Lack of Efficacy|4|||
27779058|NCT02016105|54232631|FG001|TREATMENT PERIOD 1|Lack of Efficacy|2|||
27779059|NCT02016105|54232632|FG002|TREATMENT PERIOD 1|Lack of Efficacy|0|||
27779060|NCT02016105|54232633|FG003|TREATMENT PERIOD 1|Lack of Efficacy|0|||
27779061|NCT02016105|54232634|FG004|TREATMENT PERIOD 1|Lack of Efficacy|0|||
27779062|NCT02016105|54232635|FG005|TREATMENT PERIOD 1|Lack of Efficacy|0|||
27779063|NCT02016105|54232630|FG000|TREATMENT PERIOD 1|Pregnancy|0|||
27779064|NCT02016105|54232631|FG001|TREATMENT PERIOD 1|Pregnancy|1|||
27779065|NCT02016105|54232632|FG002|TREATMENT PERIOD 1|Pregnancy|0|||
27779066|NCT02016105|54232633|FG003|TREATMENT PERIOD 1|Pregnancy|0|||
27779067|NCT02016105|54232634|FG004|TREATMENT PERIOD 1|Pregnancy|0|||
27779068|NCT02016105|54232635|FG005|TREATMENT PERIOD 1|Pregnancy|0|||
27779069|NCT02016105|54232630|FG000|TREATMENT PERIOD 1|Adverse Event|3|||
27779070|NCT02016105|54232631|FG001|TREATMENT PERIOD 1|Adverse Event|5|||
27779071|NCT02016105|54232632|FG002|TREATMENT PERIOD 1|Adverse Event|0|||
27779072|NCT02016105|54232633|FG003|TREATMENT PERIOD 1|Adverse Event|0|||
27779073|NCT02016105|54232634|FG004|TREATMENT PERIOD 1|Adverse Event|0|||
27779074|NCT02016105|54232635|FG005|TREATMENT PERIOD 1|Adverse Event|0|||
27779075|NCT02016105|54232630|FG000|TREATMENT PERIOD 1|Withdrawal by Subject|15|||
27779076|NCT02016105|54232631|FG001|TREATMENT PERIOD 1|Withdrawal by Subject|11|||
27840542|NCT01461551|54328255|FG001|Overall Study|Physician Decision|1|||
27779077|NCT02016105|54232632|FG002|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
27779078|NCT02016105|54232633|FG003|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
27779079|NCT02016105|54232634|FG004|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
27779080|NCT02016105|54232635|FG005|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
27779081|NCT02016105|54232630|FG000|TREATMENT PERIOD 1|Lost to Follow-up|6|||
27779082|NCT02016105|54232631|FG001|TREATMENT PERIOD 1|Lost to Follow-up|4|||
27779083|NCT02016105|54232632|FG002|TREATMENT PERIOD 1|Lost to Follow-up|0|||
27779084|NCT02016105|54232633|FG003|TREATMENT PERIOD 1|Lost to Follow-up|0|||
27779085|NCT02016105|54232634|FG004|TREATMENT PERIOD 1|Lost to Follow-up|0|||
27779086|NCT02016105|54232635|FG005|TREATMENT PERIOD 1|Lost to Follow-up|0|||
27779087|NCT02016105|54232630|FG000|TREATMENT PERIOD 2|Non compliance study medication|0|||
27779088|NCT02016105|54232631|FG001|TREATMENT PERIOD 2|Non compliance study medication|0|||
27779089|NCT02016105|54232632|FG002|TREATMENT PERIOD 2|Non compliance study medication|0|||
27779090|NCT02016105|54232633|FG003|TREATMENT PERIOD 2|Non compliance study medication|0|||
27779091|NCT02016105|54232634|FG004|TREATMENT PERIOD 2|Non compliance study medication|0|||
27779092|NCT02016105|54232635|FG005|TREATMENT PERIOD 2|Non compliance study medication|1|||
27779093|NCT02016105|54232630|FG000|TREATMENT PERIOD 2|Lack of Efficacy|0|||
27779094|NCT02016105|54232631|FG001|TREATMENT PERIOD 2|Lack of Efficacy|0|||
27779095|NCT02016105|54232632|FG002|TREATMENT PERIOD 2|Lack of Efficacy|2|||
27779096|NCT02016105|54232633|FG003|TREATMENT PERIOD 2|Lack of Efficacy|6|||
27779097|NCT02016105|54232634|FG004|TREATMENT PERIOD 2|Lack of Efficacy|3|||
27779098|NCT02016105|54232635|FG005|TREATMENT PERIOD 2|Lack of Efficacy|2|||
27779099|NCT02016105|54232630|FG000|TREATMENT PERIOD 2|Pregnancy|0|||
27779100|NCT02016105|54232631|FG001|TREATMENT PERIOD 2|Pregnancy|0|||
27779101|NCT02016105|54232632|FG002|TREATMENT PERIOD 2|Pregnancy|0|||
27779102|NCT02016105|54232633|FG003|TREATMENT PERIOD 2|Pregnancy|0|||
27779103|NCT02016105|54232634|FG004|TREATMENT PERIOD 2|Pregnancy|0|||
27779104|NCT02016105|54232635|FG005|TREATMENT PERIOD 2|Pregnancy|1|||
27779105|NCT02016105|54232630|FG000|TREATMENT PERIOD 2|Death|0|||
27779106|NCT02016105|54232631|FG001|TREATMENT PERIOD 2|Death|0|||
27779107|NCT02016105|54232632|FG002|TREATMENT PERIOD 2|Death|0|||
27779108|NCT02016105|54232633|FG003|TREATMENT PERIOD 2|Death|0|||
27779109|NCT02016105|54232634|FG004|TREATMENT PERIOD 2|Death|0|||
27779110|NCT02016105|54232635|FG005|TREATMENT PERIOD 2|Death|1|||
27779111|NCT02016105|54232630|FG000|TREATMENT PERIOD 2|Adverse Event|0|||
27779112|NCT02016105|54232631|FG001|TREATMENT PERIOD 2|Adverse Event|0|||
27779113|NCT02016105|54232632|FG002|TREATMENT PERIOD 2|Adverse Event|0|||
27779114|NCT02016105|54232633|FG003|TREATMENT PERIOD 2|Adverse Event|4|||
27779115|NCT02016105|54232634|FG004|TREATMENT PERIOD 2|Adverse Event|0|||
27779116|NCT02016105|54232635|FG005|TREATMENT PERIOD 2|Adverse Event|1|||
27779117|NCT02016105|54232630|FG000|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
27779118|NCT02016105|54232631|FG001|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
27779119|NCT02016105|54232632|FG002|TREATMENT PERIOD 2|Withdrawal by Subject|3|||
27779120|NCT02016105|54232633|FG003|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
27779121|NCT02016105|54232634|FG004|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
27779122|NCT02016105|54232635|FG005|TREATMENT PERIOD 2|Withdrawal by Subject|7|||
27779123|NCT02016105|54232630|FG000|TREATMENT PERIOD 2|Lost to Follow-up|0|||
27779124|NCT02016105|54232631|FG001|TREATMENT PERIOD 2|Lost to Follow-up|0|||
27779125|NCT02016105|54232632|FG002|TREATMENT PERIOD 2|Lost to Follow-up|1|||
27779126|NCT02016105|54232633|FG003|TREATMENT PERIOD 2|Lost to Follow-up|0|||
27779127|NCT02016105|54232634|FG004|TREATMENT PERIOD 2|Lost to Follow-up|0|||
27779128|NCT02016105|54232635|FG005|TREATMENT PERIOD 2|Lost to Follow-up|1|||
27779129|NCT02016105|54232630|FG000|EXTENSION PERIOD|New therapy for study indication|0|||
27779130|NCT02016105|54232631|FG001|EXTENSION PERIOD|New therapy for study indication|0|||
27779131|NCT02016105|54232632|FG002|EXTENSION PERIOD|New therapy for study indication|0|||
27779132|NCT02016105|54232633|FG003|EXTENSION PERIOD|New therapy for study indication|0|||
27779133|NCT02016105|54232634|FG004|EXTENSION PERIOD|New therapy for study indication|1|||
27779134|NCT02016105|54232635|FG005|EXTENSION PERIOD|New therapy for study indication|1|||
27779135|NCT02016105|54232630|FG000|EXTENSION PERIOD|Lack of Efficacy|0|||
27779136|NCT02016105|54232631|FG001|EXTENSION PERIOD|Lack of Efficacy|0|||
27779137|NCT02016105|54232632|FG002|EXTENSION PERIOD|Lack of Efficacy|1|||
27779138|NCT02016105|54232633|FG003|EXTENSION PERIOD|Lack of Efficacy|3|||
27779139|NCT02016105|54232634|FG004|EXTENSION PERIOD|Lack of Efficacy|1|||
27779140|NCT02016105|54232635|FG005|EXTENSION PERIOD|Lack of Efficacy|1|||
27779141|NCT02016105|54232630|FG000|EXTENSION PERIOD|Adverse Event|0|||
27779142|NCT02016105|54232631|FG001|EXTENSION PERIOD|Adverse Event|0|||
27779143|NCT02016105|54232632|FG002|EXTENSION PERIOD|Adverse Event|2|||
27779144|NCT02016105|54232633|FG003|EXTENSION PERIOD|Adverse Event|0|||
27779145|NCT02016105|54232634|FG004|EXTENSION PERIOD|Adverse Event|1|||
27779146|NCT02016105|54232635|FG005|EXTENSION PERIOD|Adverse Event|0|||
27779147|NCT02016105|54232630|FG000|EXTENSION PERIOD|Withdrawal by Subject|0|||
27779148|NCT02016105|54232631|FG001|EXTENSION PERIOD|Withdrawal by Subject|0|||
27779149|NCT02016105|54232632|FG002|EXTENSION PERIOD|Withdrawal by Subject|2|||
27779150|NCT02016105|54232633|FG003|EXTENSION PERIOD|Withdrawal by Subject|2|||
27779151|NCT02016105|54232634|FG004|EXTENSION PERIOD|Withdrawal by Subject|2|||
27779152|NCT02016105|54232635|FG005|EXTENSION PERIOD|Withdrawal by Subject|2|||
27779153|NCT02016105|54232630|FG000|EXTENSION PERIOD|Non-compliance with study indication|0|||
27779154|NCT02016105|54232631|FG001|EXTENSION PERIOD|Non-compliance with study indication|0|||
27779155|NCT02016105|54232632|FG002|EXTENSION PERIOD|Non-compliance with study indication|0|||
27779156|NCT02016105|54232633|FG003|EXTENSION PERIOD|Non-compliance with study indication|0|||
27779157|NCT02016105|54232634|FG004|EXTENSION PERIOD|Non-compliance with study indication|1|||
27779158|NCT02016105|54232635|FG005|EXTENSION PERIOD|Non-compliance with study indication|0|||
27779159|NCT02016105|54232630|FG000|EXTENSION PERIOD|Lost to Follow-up|0|||
27779160|NCT02016105|54232631|FG001|EXTENSION PERIOD|Lost to Follow-up|0|||
27779161|NCT02016105|54232632|FG002|EXTENSION PERIOD|Lost to Follow-up|0|||
27840543|NCT01461551|54328256|FG002|Overall Study|Physician Decision|2|||
27779162|NCT02016105|54232633|FG003|EXTENSION PERIOD|Lost to Follow-up|0|||
27779163|NCT02016105|54232634|FG004|EXTENSION PERIOD|Lost to Follow-up|0|||
27779164|NCT02016105|54232635|FG005|EXTENSION PERIOD|Lost to Follow-up|2|||
27779165|NCT02400905|54232649|FG000|Overall Study|Death|24|||
27779166|NCT02400905|54232649|FG000|Overall Study|Lost to Follow-up|18|||
27779167|NCT02400905|54232649|FG000|Overall Study|Withdrawal by Subject|16|||
27779168|NCT02400905|54232649|FG000|Overall Study|Physician Decision|4|||
27779169|NCT02400905|54232649|FG000|Overall Study|Other|1|||
27779170|NCT02400749|54232656|FG000|Week 0 -16|Withdrawal by Subject|5|||
27779171|NCT02400749|54232657|FG001|Week 0 -16|Withdrawal by Subject|5|||
27779172|NCT02400749|54232656|FG000|Week 0 -16|Adverse Event|3|||
27779173|NCT02400749|54232657|FG001|Week 0 -16|Adverse Event|1|||
27779174|NCT02400749|54232656|FG000|Week 0 -16|Lost to Follow-up|2|||
27779175|NCT02400749|54232657|FG001|Week 0 -16|Lost to Follow-up|0|||
27779176|NCT02400749|54232656|FG000|Week 0 -16|Protocol Violation|1|||
27779177|NCT02400749|54232657|FG001|Week 0 -16|Protocol Violation|0|||
27779178|NCT02400749|54232656|FG000|Week 17 - 32|Withdrawal by Subject|3|||
27779179|NCT02400749|54232657|FG001|Week 17 - 32|Withdrawal by Subject|2|||
27779180|NCT02400749|54232656|FG000|Week 17 - 32|Adverse Event|2|||
27779181|NCT02400749|54232657|FG001|Week 17 - 32|Adverse Event|1|||
27779182|NCT02420327|54232663|FG000|Overall Study|Adverse Event|7|||
27779183|NCT02420327|54232663|FG000|Overall Study|Pregnancy|1|||
27779184|NCT02420327|54232663|FG000|Overall Study|Withdrawal by Subject|6|||
27779185|NCT02420327|54232663|FG000|Overall Study|Lost to Follow-up|1|||
27779186|NCT02420327|54232663|FG000|Overall Study|Protocol Violation|1|||
27779187|NCT02374853|54232675|FG000|Overall Study|Surgery Cancelled|5|||
27779188|NCT02374853|54232676|FG001|Overall Study|Surgery Cancelled|11|||
27779189|NCT02015793|54232684|FG000|Overall Study|Adverse Event|3|||
27779190|NCT02015793|54232685|FG001|Overall Study|Adverse Event|3|||
27779191|NCT02015793|54232684|FG000|Overall Study|Withdrawal by Subject|1|||
27779192|NCT02015793|54232685|FG001|Overall Study|Withdrawal by Subject|1|||
27779193|NCT02347631|54232699|FG000|First Intervention (2 Months)|Adverse Event|1|||
27779194|NCT02347631|54232700|FG001|First Intervention (2 Months)|Adverse Event|1|||
27779195|NCT02347631|54232699|FG000|First Intervention (2 Months)|Pregnancy|1|||
27779196|NCT02347631|54232700|FG001|First Intervention (2 Months)|Pregnancy|0|||
27779197|NCT02347631|54232699|FG000|First Intervention (2 Months)|Moved out of area|0|||
27779198|NCT02347631|54232700|FG001|First Intervention (2 Months)|Moved out of area|2|||
27779199|NCT02347631|54232699|FG000|First Intervention (2 Months)|Lost to Follow-up|5|||
27779200|NCT02347631|54232700|FG001|First Intervention (2 Months)|Lost to Follow-up|3|||
27779201|NCT02347631|54232699|FG000|Washout 2 (1 Month)|Withdrawal by Subject|2|||
27779202|NCT02347631|54232700|FG001|Washout 2 (1 Month)|Withdrawal by Subject|2|||
27779203|NCT02347631|54232699|FG000|Washout 2 (1 Month)|Lost to Follow-up|0|||
27779204|NCT02347631|54232700|FG001|Washout 2 (1 Month)|Lost to Follow-up|1|||
27779205|NCT02347631|54232699|FG000|Second Intervention (2 Months)|Lost to Follow-up|7|||
27779206|NCT02347631|54232700|FG001|Second Intervention (2 Months)|Lost to Follow-up|4|||
27779207|NCT02347631|54232699|FG000|Second Intervention (2 Months)|Withdrawal by Subject|6|||
27779208|NCT02347631|54232700|FG001|Second Intervention (2 Months)|Withdrawal by Subject|0|||
27779209|NCT02015637|54232710|FG000|Overall Study|Lost to Follow-up|3|||
27779210|NCT02015637|54232711|FG001|Overall Study|Lost to Follow-up|5|||
27779211|NCT02015637|54232710|FG000|Overall Study|Adverse Event|3|||
27779212|NCT02015637|54232711|FG001|Overall Study|Adverse Event|0|||
27779213|NCT02015637|54232710|FG000|Overall Study|Did not take study drug|2|||
27779214|NCT02015637|54232711|FG001|Overall Study|Did not take study drug|0|||
27779215|NCT02347085|54232717|FG000|Overall Study|Adverse Event|2|||
27779216|NCT02347085|54232717|FG000|Overall Study|Lack of Efficacy|1|||
27779217|NCT02347085|54232717|FG000|Overall Study|Withdrawal by Subject|4|||
27779218|NCT02347085|54232717|FG000|Overall Study|Lost to Follow-up|1|||
27779219|NCT02347085|54232717|FG000|Overall Study|Protocol Criteria|2|||
27779220|NCT02374463|54232725|FG000|Overall Study|Withdrawal by Subject|3|||
27779221|NCT02374463|54232726|FG001|Overall Study|Withdrawal by Subject|3|||
27779222|NCT02015481|54232733|FG000|Overall Study|Death|1|||
27779223|NCT02374307|54232740|FG000|3-months Follow-up|Lost to Follow-up|1|||
27779224|NCT02374307|54232741|FG001|3-months Follow-up|Lost to Follow-up|2|||
27779225|NCT02374307|54232740|FG000|3-months Follow-up|Withdrawal by Subject|1|||
27840544|NCT01461005|54328264|FG000|Overall Study|FDA reclassified Dynamic Stabilization D|1|||
27840545|NCT01460381|54328271|FG000|Period 2 (Days 8-15)|Lost to Follow-up|1|||
27779226|NCT02374307|54232741|FG001|3-months Follow-up|Withdrawal by Subject|4|||
27779227|NCT02374307|54232740|FG000|3-months Follow-up|Death|1|||
27779228|NCT02374307|54232741|FG001|3-months Follow-up|Death|2|||
27779229|NCT02374307|54232740|FG000|3-months Follow-up|Missed first follow-up|5|||
27779230|NCT02374307|54232741|FG001|3-months Follow-up|Missed first follow-up|1|||
27779231|NCT02374307|54232740|FG000|6-months Follow-up|Lost to Follow-up|1|||
27779232|NCT02374307|54232741|FG001|6-months Follow-up|Lost to Follow-up|2|||
27779233|NCT02374307|54232740|FG000|6-months Follow-up|Death|2|||
27779234|NCT02374307|54232741|FG001|6-months Follow-up|Death|1|||
27779235|NCT02374307|54232740|FG000|6-months Follow-up|Withdrawal by Subject|0|||
27779236|NCT02374307|54232741|FG001|6-months Follow-up|Withdrawal by Subject|3|||
27779237|NCT02397473|54232749|FG000|Treatment Phase|Adverse Event|1|||
27779238|NCT02397473|54232750|FG001|Treatment Phase|Adverse Event|2|||
27779239|NCT02397473|54232749|FG000|Treatment Phase|Lack of Efficacy|8|||
27779240|NCT02397473|54232750|FG001|Treatment Phase|Lack of Efficacy|1|||
27779241|NCT02397473|54232749|FG000|Treatment Phase|Lost to Follow-up|1|||
27779242|NCT02397473|54232750|FG001|Treatment Phase|Lost to Follow-up|0|||
27779243|NCT02397473|54232749|FG000|Treatment Phase|Withdrawal by Subject|2|||
27779244|NCT02397473|54232750|FG001|Treatment Phase|Withdrawal by Subject|1|||
27779245|NCT02397473|54232749|FG000|Treatment Phase|Protocol Violation(did not receive drug)|0|||
27779246|NCT02397473|54232750|FG001|Treatment Phase|Protocol Violation(did not receive drug)|3|||
27779247|NCT02397473|54232749|FG000|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
27779248|NCT02397473|54232750|FG001|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
27779249|NCT02397473|54232749|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
27779250|NCT02397473|54232750|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
27779251|NCT02397473|54232749|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
27779252|NCT02397473|54232750|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
27779253|NCT02397473|54232749|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
27779254|NCT02397473|54232750|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
27779255|NCT02344745|54232761|FG000|Overall Study|Data collection sheets were lost|2|||
27779256|NCT02344745|54232762|FG001|Overall Study|Data collection sheets were lost|0|||
27779257|NCT02370641|54232770|FG000|Overall Study|dropped study|4|||
27779258|NCT02370641|54232771|FG001|Overall Study|dropped study|2|||
27779259|NCT01621191|54232777|FG000|Overall Study|Adverse Event|9|||
27779260|NCT01621191|54232777|FG000|Overall Study|Withdrawal by Subject|8|||
27779261|NCT01621191|54232777|FG000|Overall Study|Lack of Efficacy|6|||
27779262|NCT01621191|54232777|FG000|Overall Study|Lost to Follow-up|1|||
27779263|NCT01621191|54232777|FG000|Overall Study|Site Removed From Study|1|||
27779264|NCT02343263|54232785|FG000|Overall Study|Physician Decision|5|||
27779265|NCT02343263|54232786|FG001|Overall Study|Physician Decision|3|||
27779266|NCT02343263|54232787|FG002|Overall Study|Physician Decision|1|||
27779267|NCT02081859|54232801|FG000|Overall Study|No fertilization|2|||
27779268|NCT02081859|54232802|FG001|Overall Study|No fertilization|2|||
27779269|NCT02081859|54232801|FG000|Overall Study|No sperm|1|||
27779270|NCT02081859|54232802|FG001|Overall Study|No sperm|0|||
27779271|NCT02081859|54232801|FG000|Overall Study|Unanticipated freeze all cycle|2|||
27779272|NCT02081859|54232802|FG001|Overall Study|Unanticipated freeze all cycle|6|||
27779273|NCT02081859|54232801|FG000|Overall Study|< 4 embryos|27|||
27779274|NCT02081859|54232802|FG001|Overall Study|< 4 embryos|23|||
27779275|NCT02081859|54232801|FG000|Overall Study|Other reasons|2|||
27779276|NCT02081859|54232802|FG001|Overall Study|Other reasons|0|||
27779277|NCT02342639|54232810|FG000|Overall Study|Acute illness, unrelated to study drug|2|||
27779278|NCT02342639|54232811|FG001|Overall Study|Acute illness, unrelated to study drug|3|||
27779279|NCT02342639|54232810|FG000|Overall Study|Protocol Violation|0|||
27779280|NCT02342639|54232811|FG001|Overall Study|Protocol Violation|2|||
27779281|NCT01625091|54232821|FG000|Intervention|Death|1|||
27779282|NCT01625091|54232822|FG001|Intervention|Death|1|||
27779283|NCT01625091|54232821|FG000|Intervention|Withdrawal by Subject|4|||
27779284|NCT01625091|54232822|FG001|Intervention|Withdrawal by Subject|1|||
27779285|NCT01625091|54232821|FG000|Intervention|Adverse Event|0|||
27779286|NCT01625091|54232822|FG001|Intervention|Adverse Event|2|||
27779287|NCT01625091|54232821|FG000|Intervention|Lost to Follow-up|4|||
27779288|NCT01625091|54232822|FG001|Intervention|Lost to Follow-up|4|||
27779289|NCT01625091|54232821|FG000|Intervention|Study termination|2|||
27779290|NCT01625091|54232822|FG001|Intervention|Study termination|3|||
27779291|NCT01625091|54232821|FG000|Post-intervention|Death|0|||
27779292|NCT01625091|54232822|FG001|Post-intervention|Death|1|||
27779293|NCT01625091|54232821|FG000|Post-intervention|Lost to Follow-up|2|||
27779294|NCT01625091|54232822|FG001|Post-intervention|Lost to Follow-up|0|||
27779295|NCT01625091|54232821|FG000|Post-intervention|Study termination|2|||
27779296|NCT01625091|54232822|FG001|Post-intervention|Study termination|1|||
27779297|NCT02396849|54232830|FG000|Overall Study|Lost to Follow-up|1|||
27779298|NCT02396849|54232831|FG001|Overall Study|Lost to Follow-up|1|||
27779299|NCT02396849|54232830|FG000|Overall Study|Did not tolerate intervention|1|||
27779300|NCT02396849|54232831|FG001|Overall Study|Did not tolerate intervention|1|||
27779301|NCT02370251|54232839|FG000|Overall Study|Received less than 8 days of Omegaven|7|||
27779302|NCT02370251|54232839|FG000|Overall Study|Death|4|||
27779303|NCT02396537|54232845|FG000|Overall Study|Protocol Violation|0|||
27779304|NCT02396537|54232846|FG001|Overall Study|Protocol Violation|1|||
27779305|NCT02342171|54232854|FG000|Overall Study|Death|4|||
27779306|NCT02342171|54232855|FG001|Overall Study|Death|87|||
27779307|NCT02342171|54232854|FG000|Overall Study|Received favipiravir|10|||
27779308|NCT02342171|54232855|FG001|Overall Study|Received favipiravir|0|||
27779309|NCT02342171|54232854|FG000|Overall Study|Missing cycle treshold value|1|||
27779310|NCT02342171|54232855|FG001|Overall Study|Missing cycle treshold value|0|||
27779311|NCT02342171|54232854|FG000|Overall Study|Unknown outcome|0|||
27779312|NCT02342171|54232855|FG001|Overall Study|Unknown outcome|1|||
27779313|NCT02342171|54232854|FG000|Overall Study|Missing age data|0|||
27779314|NCT02342171|54232855|FG001|Overall Study|Missing age data|1|||
27779315|NCT01624467|54232860|FG000|Overall Study|Withdrawal by Subject|2|||
27779316|NCT01624467|54232860|FG000|Overall Study|Lost to Follow-up|1|||
27779317|NCT01624467|54232860|FG000|Overall Study|Adverse Event|7|||
27779318|NCT01624467|54232860|FG000|Overall Study|Progressive Disease|19|||
27779319|NCT01624467|54232860|FG000|Overall Study|Per Sponsor Requirement|1|||
27779320|NCT01624467|54232860|FG000|Overall Study|Subject Withdrew from Treatment|1|||
27779321|NCT01624233|54232866|FG000|Period 2 - Induction|Adverse Event|1|||
27779322|NCT01624233|54232866|FG000|Period 3 - Maintenance|Adverse Event|2|||
27779323|NCT01624233|54232866|FG000|Period 3 - Maintenance|Lack of Efficacy|1|||
27779324|NCT01624233|54232866|FG000|Period 3 - Maintenance|Physician Decision|2|||
27779325|NCT01624233|54232866|FG000|Period 3 - Maintenance|Withdrawal by Subject|2|||
27779326|NCT01624233|54232866|FG000|Period 4 - Drug Free Period|Relapsed|61|||
27779327|NCT01624233|54232866|FG000|Period 5 - Retreatment Period|Adverse Event|5|||
27779328|NCT01624233|54232866|FG000|Period 5 - Retreatment Period|Lack of Efficacy|1|||
27779329|NCT01624233|54232866|FG000|Period 5 - Retreatment Period|Physician Decision|1|||
27779330|NCT01624233|54232866|FG000|Period 5 - Retreatment Period|Withdrawal by Subject|3|||
27779331|NCT01624233|54232866|FG000|Period 6: Follow-up|Adverse Event|3|||
27779332|NCT01624233|54232866|FG000|Period 6: Follow-up|Lack of Efficacy|2|||
27779333|NCT01624233|54232866|FG000|Period 6: Follow-up|Physician Decision|1|||
27779334|NCT01624233|54232866|FG000|Period 6: Follow-up|Withdrawal by Subject|3|||
27779335|NCT01993017|54232877|FG000|Overall Study|Death|23|||
27779336|NCT01993017|54232878|FG001|Overall Study|Death|26|||
27779337|NCT01993017|54232879|FG002|Overall Study|Death|18|||
27779338|NCT01993017|54232877|FG000|Overall Study|Could not be contacted|43|||
27779339|NCT01993017|54232878|FG001|Overall Study|Could not be contacted|42|||
27779340|NCT01993017|54232879|FG002|Overall Study|Could not be contacted|38|||
27779341|NCT01993017|54232877|FG000|Overall Study|Dropped out|19|||
27779342|NCT01993017|54232878|FG001|Overall Study|Dropped out|6|||
27779343|NCT01993017|54232879|FG002|Overall Study|Dropped out|11|||
27779344|NCT01993017|54232877|FG000|Overall Study|Other reasons|17|||
27779345|NCT01993017|54232878|FG001|Overall Study|Other reasons|11|||
27779346|NCT01993017|54232879|FG002|Overall Study|Other reasons|7|||
27779347|NCT01993017|54232877|FG000|Overall Study|Ineligible after randomization|4|||
27779348|NCT01993017|54232878|FG001|Overall Study|Ineligible after randomization|5|||
27779349|NCT01993017|54232879|FG002|Overall Study|Ineligible after randomization|5|||
27779350|NCT01992549|54232888|FG000|Overall Study|Lost to Follow-up|2|||
27779351|NCT01992549|54232888|FG000|Overall Study|Serious Adverse Event|1|||
27779352|NCT01992549|54232888|FG000|Overall Study|Product Switch to Extend Half Life|1|||
27779353|NCT01992159|54232902|FG000|Overall Study|Withdrawal by Subject|4|||
27779354|NCT01992159|54232903|FG001|Overall Study|Withdrawal by Subject|7|||
27779355|NCT01992159|54232904|FG002|Overall Study|Withdrawal by Subject|0|||
27779356|NCT01992159|54232905|FG003|Overall Study|Withdrawal by Subject|3|||
27779357|NCT01992159|54232902|FG000|Overall Study|Adverse Event|0|||
27779358|NCT01992159|54232903|FG001|Overall Study|Adverse Event|1|||
27779359|NCT01992159|54232904|FG002|Overall Study|Adverse Event|0|||
27779360|NCT01992159|54232905|FG003|Overall Study|Adverse Event|1|||
27779361|NCT01992159|54232902|FG000|Overall Study|Death|0|||
27779362|NCT01992159|54232903|FG001|Overall Study|Death|0|||
27779363|NCT01992159|54232904|FG002|Overall Study|Death|1|||
27779364|NCT01992159|54232905|FG003|Overall Study|Death|0|||
27779365|NCT01988493|54232920|FG000|Overall Study|Randomized but not treated|0|||
27779366|NCT01988493|54232921|FG001|Overall Study|Randomized but not treated|0|||
27779367|NCT01988493|54232922|FG002|Overall Study|Randomized but not treated|0|||
27779368|NCT01988493|54232923|FG003|Overall Study|Randomized but not treated|0|||
27779369|NCT01988493|54232924|FG004|Overall Study|Randomized but not treated|1|||
27779370|NCT02081079|54232940|FG000|Overall Study|Lack of Efficacy|3|||
27779371|NCT02081079|54232941|FG001|Overall Study|Lack of Efficacy|2|||
27779372|NCT02081079|54232940|FG000|Overall Study|Lost to Follow-up|1|||
27779373|NCT02081079|54232941|FG001|Overall Study|Lost to Follow-up|0|||
27840546|NCT01460381|54328272|FG001|Period 2 (Days 8-15)|Lost to Follow-up|0|||
27840547|NCT01473589|54328356|FG000|Overall Study|Adverse Event|1|||
27779374|NCT02081001|54232953|FG000|Overall Study|Adverse Event|0|||
27779375|NCT02081001|54232954|FG001|Overall Study|Adverse Event|0|||
27779376|NCT02081001|54232955|FG002|Overall Study|Adverse Event|0|||
27779377|NCT02081001|54232956|FG003|Overall Study|Adverse Event|0|||
27779378|NCT02081001|54232957|FG004|Overall Study|Adverse Event|1|||
27779379|NCT02081001|54232958|FG005|Overall Study|Adverse Event|0|||
27779380|NCT02081001|54232959|FG006|Overall Study|Adverse Event|0|||
27779381|NCT02081001|54232960|FG007|Overall Study|Adverse Event|0|||
27779382|NCT02081001|54232961|FG008|Overall Study|Adverse Event|0|||
27779383|NCT02081001|54232962|FG009|Overall Study|Adverse Event|0|||
27779384|NCT02081001|54232963|FG010|Overall Study|Adverse Event|0|||
27779385|NCT02081001|54232964|FG011|Overall Study|Adverse Event|0|||
27779386|NCT02080221|54232975|FG000|Overall Study|Withdrawal by Subject|1|||
27779387|NCT02080221|54232975|FG000|Overall Study|Clinical Progression of Disease|1|||
27779388|NCT02079909|54232982|FG000|Overall Study|Adverse Event|23|||
27779389|NCT02079909|54232983|FG001|Overall Study|Adverse Event|23|||
27779390|NCT02079909|54232984|FG002|Overall Study|Adverse Event|7|||
27779391|NCT02079909|54232982|FG000|Overall Study|Withdrawal by Subject|9|||
27779392|NCT02079909|54232983|FG001|Overall Study|Withdrawal by Subject|17|||
27779393|NCT02079909|54232984|FG002|Overall Study|Withdrawal by Subject|4|||
27779394|NCT02079909|54232982|FG000|Overall Study|Lost to Follow-up|2|||
27779395|NCT02079909|54232983|FG001|Overall Study|Lost to Follow-up|3|||
27779396|NCT02079909|54232984|FG002|Overall Study|Lost to Follow-up|1|||
27779397|NCT02079909|54232982|FG000|Overall Study|Death|2|||
27779398|NCT02079909|54232983|FG001|Overall Study|Death|2|||
27779399|NCT02079909|54232984|FG002|Overall Study|Death|0|||
27779400|NCT02079909|54232982|FG000|Overall Study|Lack of Efficacy|0|||
27779401|NCT02079909|54232983|FG001|Overall Study|Lack of Efficacy|0|||
27779402|NCT02079909|54232984|FG002|Overall Study|Lack of Efficacy|1|||
27779403|NCT02079909|54232982|FG000|Overall Study|Protocol Violation|0|||
27779404|NCT02079909|54232983|FG001|Overall Study|Protocol Violation|1|||
27779405|NCT02079909|54232984|FG002|Overall Study|Protocol Violation|1|||
27779406|NCT02079909|54232982|FG000|Overall Study|Physician Decision|0|||
27779407|NCT02079909|54232983|FG001|Overall Study|Physician Decision|1|||
27779408|NCT02079909|54232984|FG002|Overall Study|Physician Decision|1|||
27779409|NCT02079909|54232982|FG000|Overall Study|Relocation etc.|2|||
27779410|NCT02079909|54232983|FG001|Overall Study|Relocation etc.|2|||
27779411|NCT02079909|54232984|FG002|Overall Study|Relocation etc.|3|||
27779412|NCT02014467|54232994|FG000|Overall Study|Adverse Event|4|||
27779413|NCT02014467|54232995|FG001|Overall Study|Adverse Event|0|||
27779414|NCT02014467|54232994|FG000|Overall Study|Protocol Violation|3|||
27779415|NCT02014467|54232995|FG001|Overall Study|Protocol Violation|0|||
27779416|NCT02014467|54232994|FG000|Overall Study|Physician Decision|2|||
27779417|NCT02014467|54232995|FG001|Overall Study|Physician Decision|3|||
27779418|NCT02014467|54232994|FG000|Overall Study|Withdrawal by Subject|16|||
27779419|NCT02014467|54232995|FG001|Overall Study|Withdrawal by Subject|4|||
27779420|NCT02013765|54233001|FG000|Overall Study|Trial was terminated by sponsor|1|||
27779421|NCT02013687|54233009|FG000|Overall Study|Lost to Follow-up|0|||
27779422|NCT02013687|54233010|FG001|Overall Study|Lost to Follow-up|0|||
27779423|NCT02013687|54233011|FG002|Overall Study|Lost to Follow-up|1|||
27779424|NCT02013687|54233012|FG003|Overall Study|Lost to Follow-up|0|||
27779425|NCT02013687|54233009|FG000|Overall Study|Protocol Violation|0|||
27779426|NCT02013687|54233010|FG001|Overall Study|Protocol Violation|0|||
27779427|NCT02013687|54233011|FG002|Overall Study|Protocol Violation|0|||
27779428|NCT02013687|54233012|FG003|Overall Study|Protocol Violation|1|||
27779429|NCT02013687|54233009|FG000|Overall Study|Withdrawal by Subject|0|||
27779430|NCT02013687|54233010|FG001|Overall Study|Withdrawal by Subject|0|||
27779431|NCT02013687|54233011|FG002|Overall Study|Withdrawal by Subject|0|||
27779432|NCT02013687|54233012|FG003|Overall Study|Withdrawal by Subject|1|||
27779433|NCT02013687|54233009|FG000|Overall Study|Missed visits due to patient travel|0|||
27779434|NCT02013687|54233010|FG001|Overall Study|Missed visits due to patient travel|0|||
27779435|NCT02013687|54233011|FG002|Overall Study|Missed visits due to patient travel|1|||
27779436|NCT02013687|54233012|FG003|Overall Study|Missed visits due to patient travel|0|||
27779437|NCT02013609|54233026|FG000|Overall Study|Withdrawal by Subject|9|||
27779438|NCT02013609|54233026|FG000|Overall Study|Lost to Follow-up|3|||
27779439|NCT02013609|54233026|FG000|Overall Study|Adverse Event|3|||
27779440|NCT02013609|54233026|FG000|Overall Study|Met Withdrawal Criteria|3|||
27779441|NCT01988337|54233030|FG000|Overall Study|Study was terminated due to insufficient recruitment before 36 month follow up could be completed|56|||
27779442|NCT02013531|54233036|FG000|Overall Study|Lost to Follow-up|3|||
27779443|NCT02013531|54233036|FG000|Overall Study|Met Withdrawal Criteria|1|||
27779444|NCT02013531|54233036|FG000|Overall Study|Withdrawal by Subject|1|||
27779445|NCT01988103|54233043|FG000|Placebo-Controlled Phase Week 0-16|Adverse Event|3|||
27779446|NCT01988103|54233044|FG001|Placebo-Controlled Phase Week 0-16|Adverse Event|10|||
27779447|NCT01988103|54233045|FG002|Placebo-Controlled Phase Week 0-16|Adverse Event|6|||
27779448|NCT01988103|54233046|FG003|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
27779449|NCT01988103|54233047|FG004|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
27779450|NCT01988103|54233043|FG000|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1|||
27779451|NCT01988103|54233044|FG001|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
27779452|NCT01988103|54233045|FG002|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
27779453|NCT01988103|54233046|FG003|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
27779454|NCT01988103|54233047|FG004|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
27779455|NCT01988103|54233043|FG000|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8|||
27779456|NCT01988103|54233044|FG001|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4|||
27779457|NCT01988103|54233045|FG002|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1|||
27779458|NCT01988103|54233046|FG003|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
27779459|NCT01988103|54233047|FG004|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
27779460|NCT01988103|54233043|FG000|Active Treatment Phase (Weeks 16-68)|Adverse Event|0|||
27779461|NCT01988103|54233044|FG001|Active Treatment Phase (Weeks 16-68)|Adverse Event|6|||
27779462|NCT01988103|54233045|FG002|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
27840548|NCT01473589|54328357|FG001|Overall Study|Adverse Event|1|||
27840549|NCT01473589|54328356|FG000|Overall Study|Death|2|||
27779463|NCT01988103|54233046|FG003|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
27779464|NCT01988103|54233047|FG004|Active Treatment Phase (Weeks 16-68)|Adverse Event|2|||
27779465|NCT01988103|54233043|FG000|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
27779466|NCT01988103|54233044|FG001|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1|||
27779467|NCT01988103|54233045|FG002|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2|||
27779468|NCT01988103|54233046|FG003|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
27779469|NCT01988103|54233047|FG004|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
27779470|NCT01988103|54233043|FG000|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
27779471|NCT01988103|54233044|FG001|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5|||
27779472|NCT01988103|54233045|FG002|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4|||
27779473|NCT01988103|54233046|FG003|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
27779474|NCT01988103|54233047|FG004|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1|||
27779475|NCT01988103|54233043|FG000|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
27779476|NCT01988103|54233044|FG001|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1|||
27779477|NCT01988103|54233045|FG002|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
27779478|NCT01988103|54233046|FG003|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
27779479|NCT01988103|54233047|FG004|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
27779480|NCT02013375|54233062|FG000|Overall Study|Did not engraft|1|||
27779481|NCT02013375|54233062|FG000|Overall Study|Did not engraft|1|||
27779482|NCT02079519|54233067|FG000|Overall Study|Disease Progression|9|||
27779483|NCT02079519|54233067|FG000|Overall Study|Adverse Event|1|||
27779484|NCT01987557|54233074|FG000|Overall Study|Protocol Violation|1|||
27779485|NCT01987557|54233075|FG001|Overall Study|Protocol Violation|0|||
27779486|NCT01987557|54233076|FG002|Overall Study|Protocol Violation|1|||
27779487|NCT01987557|54233074|FG000|Overall Study|Withdrawal by Subject|2|||
27779488|NCT01987557|54233075|FG001|Overall Study|Withdrawal by Subject|1|||
27779489|NCT01987557|54233076|FG002|Overall Study|Withdrawal by Subject|2|||
27779490|NCT01987557|54233074|FG000|Overall Study|Adverse Event|0|||
27779491|NCT01987557|54233075|FG001|Overall Study|Adverse Event|2|||
27779492|NCT01987557|54233076|FG002|Overall Study|Adverse Event|0|||
27779493|NCT02078817|54233084|FG000|Overall Study|Withdrawal by Subject|1|||
27779494|NCT02011893|54233088|FG000|Enrollment to Randomization|Adverse Event|2|||
27779495|NCT02011893|54233089|FG001|Enrollment to Randomization|Adverse Event|0|||
27779496|NCT02011893|54233090|FG002|Enrollment to Randomization|Adverse Event|0|||
27779497|NCT02011893|54233088|FG000|Enrollment to Randomization|Physician Decision|10|||
27779498|NCT02011893|54233089|FG001|Enrollment to Randomization|Physician Decision|0|||
27779499|NCT02011893|54233090|FG002|Enrollment to Randomization|Physician Decision|0|||
27779500|NCT02011893|54233088|FG000|Enrollment to Randomization|Withdrawal by Subject|21|||
27779501|NCT02011893|54233089|FG001|Enrollment to Randomization|Withdrawal by Subject|0|||
27779502|NCT02011893|54233090|FG002|Enrollment to Randomization|Withdrawal by Subject|0|||
27779503|NCT02011893|54233088|FG000|Enrollment to Randomization|Screening Failure|29|||
27779504|NCT02011893|54233089|FG001|Enrollment to Randomization|Screening Failure|0|||
27779505|NCT02011893|54233090|FG002|Enrollment to Randomization|Screening Failure|0|||
27779506|NCT02011893|54233088|FG000|Enrollment to Randomization|Temporary Trial Stimulation Failure|9|||
27779507|NCT02011893|54233089|FG001|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
27779508|NCT02011893|54233090|FG002|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
27779509|NCT02011893|54233088|FG000|Enrollment to Randomization|Insurance/Financial Reasons|2|||
27779510|NCT02011893|54233089|FG001|Enrollment to Randomization|Insurance/Financial Reasons|0|||
27779511|NCT02011893|54233090|FG002|Enrollment to Randomization|Insurance/Financial Reasons|0|||
27779512|NCT02011893|54233088|FG000|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
27779513|NCT02011893|54233089|FG001|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
27779514|NCT02011893|54233090|FG002|Period 1 (Randomization to 12 Weeks)|Physician Decision|1|||
27779515|NCT02011893|54233088|FG000|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
27779516|NCT02011893|54233089|FG001|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
27779517|NCT02011893|54233090|FG002|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2|||
27779518|NCT02011893|54233088|FG000|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
27779519|NCT02011893|54233089|FG001|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
27779520|NCT02011893|54233090|FG002|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1|||
27779521|NCT02011113|54233095|FG000|Overall Study|Adverse Event|4|||
27840550|NCT01473589|54328357|FG001|Overall Study|Death|0|||
27840551|NCT01473589|54328356|FG000|Overall Study|Lost to Follow-up|2|||
27840552|NCT01473589|54328357|FG001|Overall Study|Lost to Follow-up|2|||
27840553|NCT01473589|54328356|FG000|Overall Study|Protocol Violation|1|||
27840554|NCT01473589|54328357|FG001|Overall Study|Protocol Violation|0|||
27779522|NCT02011113|54233095|FG000|Overall Study|Disease Progression (DP)|16|||
27779523|NCT02011113|54233095|FG000|Overall Study|Death|1|||
27779524|NCT02011113|54233095|FG000|Overall Study|Insufficient effect of Pomalidomide|1|||
27840555|NCT01473589|54328356|FG000|Overall Study|Withdrawal by Subject|5|||
27840556|NCT01473589|54328357|FG001|Overall Study|Withdrawal by Subject|11|||
27779525|NCT02011113|54233095|FG000|Overall Study|Investigator's judgement- DP|3|||
27779526|NCT02011113|54233095|FG000|Overall Study|Study terminated by sponsor|11|||
27779527|NCT01807156|54233100|FG000|Overall Study|Physician Decision|1|||
27779528|NCT01987479|54233104|FG000|Overall Study|Protocol Violation|1|||
27779529|NCT01987479|54233104|FG000|Overall Study|Physician Decision|2|||
27779530|NCT01987479|54233104|FG000|Overall Study|Participant/legal guardian decision|1|||
27779531|NCT01987479|54233104|FG000|Overall Study|Other|5|||
27779532|NCT01987479|54233104|FG000|Overall Study|Lost to Follow-up|1|||
27779533|NCT01987479|54233104|FG000|Overall Study|Adverse Event|7|||
27779534|NCT01620489|54233110|FG000|Overall Study|Adverse Event|17|||
27779535|NCT01620489|54233111|FG001|Overall Study|Adverse Event|4|||
27779536|NCT01620489|54233110|FG000|Overall Study|Protocol Violation|0|||
27779537|NCT01620489|54233111|FG001|Overall Study|Protocol Violation|3|||
27779538|NCT01620489|54233110|FG000|Overall Study|Withdrawal Criteria|17|||
27779539|NCT01620489|54233111|FG001|Overall Study|Withdrawal Criteria|25|||
27779540|NCT01620489|54233110|FG000|Overall Study|Unclassified|1|||
27779541|NCT01620489|54233111|FG001|Overall Study|Unclassified|2|||
27779542|NCT02076165|54233119|FG000|Overall Study|Lost to Follow-up|7|||
27779543|NCT02076165|54233120|FG001|Overall Study|Lost to Follow-up|5|||
27779544|NCT02076165|54233119|FG000|Overall Study|Refused follow-up assessment|1|||
27779545|NCT02076165|54233120|FG001|Overall Study|Refused follow-up assessment|1|||
27779546|NCT01620255|54233131|FG000|Overall Study|Withdrawal by Subject|4|||
27779547|NCT01620255|54233132|FG001|Overall Study|Withdrawal by Subject|1|||
27779548|NCT01620255|54233133|FG002|Overall Study|Withdrawal by Subject|1|||
27779549|NCT01620255|54233134|FG003|Overall Study|Withdrawal by Subject|2|||
27779550|NCT01620255|54233135|FG004|Overall Study|Withdrawal by Subject|4|||
27779551|NCT01620255|54233131|FG000|Overall Study|Participant underwent fecal transplant|0|||
27779552|NCT01620255|54233132|FG001|Overall Study|Participant underwent fecal transplant|0|||
27779553|NCT01620255|54233133|FG002|Overall Study|Participant underwent fecal transplant|1|||
27779554|NCT01620255|54233134|FG003|Overall Study|Participant underwent fecal transplant|0|||
27779555|NCT01620255|54233135|FG004|Overall Study|Participant underwent fecal transplant|0|||
27779556|NCT01620255|54233131|FG000|Overall Study|Non-compliance|0|||
27779557|NCT01620255|54233132|FG001|Overall Study|Non-compliance|1|||
27779558|NCT01620255|54233133|FG002|Overall Study|Non-compliance|0|||
27779559|NCT01620255|54233134|FG003|Overall Study|Non-compliance|0|||
27779560|NCT01620255|54233135|FG004|Overall Study|Non-compliance|0|||
27779561|NCT01620255|54233131|FG000|Overall Study|Adverse Event|0|||
27779562|NCT01620255|54233132|FG001|Overall Study|Adverse Event|4|||
27779563|NCT01620255|54233133|FG002|Overall Study|Adverse Event|0|||
27779564|NCT01620255|54233134|FG003|Overall Study|Adverse Event|1|||
27779565|NCT01620255|54233135|FG004|Overall Study|Adverse Event|1|||
27840557|NCT01473589|54328356|FG000|Overall Study|Physician Decision|0|||
27840558|NCT01473589|54328357|FG001|Overall Study|Physician Decision|1|||
27840559|NCT01473589|54328356|FG000|Overall Study|Entry criteria not met|0|||
27840560|NCT01473589|54328357|FG001|Overall Study|Entry criteria not met|1|||
27840561|NCT01500187|54328376|FG000|Overall Study|Lost to Follow-up|6|||
27840562|NCT01500187|54328377|FG001|Overall Study|Lost to Follow-up|0|||
27840563|NCT01500031|54328395|FG000|Overall Study|Death|1|||
27840564|NCT01500031|54328395|FG000|Overall Study|Withdrawal by Subject|4|||
27840565|NCT01473355|54328408|FG000|Overall Study|Protocol Violation|2|||
27840566|NCT01473355|54328408|FG000|Overall Study|Adverse Event|2|||
27840567|NCT01473355|54328408|FG000|Overall Study|Lost to Follow-up|2|||
27840568|NCT01472965|54328418|FG000|Overall Study|Withdrawal by Subject|1|||
27840569|NCT01472965|54328419|FG001|Overall Study|Withdrawal by Subject|0|||
27840570|NCT01457053|54328429|FG000|Overall Study|Unable to undergo selected treatment|1|||
27840571|NCT01457053|54328430|FG001|Overall Study|Unable to undergo selected treatment|1|||
27840572|NCT01472341|54328445|FG000|Overall Study|Started insulin therapy|55|||
27840573|NCT01472341|54328445|FG000|Overall Study|Started therapy with a DPP-IV/GLP-1|92|||
27840574|NCT01472341|54328445|FG000|Overall Study|Withdrawal by Subject|39|||
27840575|NCT01472341|54328445|FG000|Overall Study|Lost to Follow-up|52|||
27840576|NCT01472341|54328445|FG000|Overall Study|Laboratory parameters unavailable|25|||
27840577|NCT01472341|54328445|FG000|Overall Study|Death|9|||
27840578|NCT01472185|54328451|FG000|Overall Study|Randomized but Not Treated|0|||
27840579|NCT01472185|54328452|FG001|Overall Study|Randomized but Not Treated|1|||
27840580|NCT01472185|54328451|FG000|Overall Study|Adverse Event Other than Hyperglycemia|3|||
27840581|NCT01472185|54328452|FG001|Overall Study|Adverse Event Other than Hyperglycemia|10|||
27840582|NCT01472185|54328451|FG000|Overall Study|Hyperglycemia|5|||
27840583|NCT01472185|54328452|FG001|Overall Study|Hyperglycemia|2|||
27840584|NCT01472185|54328451|FG000|Overall Study|Investigator's Discretion|3|||
27840585|NCT01472185|54328452|FG001|Overall Study|Investigator's Discretion|1|||
27840586|NCT01472185|54328451|FG000|Overall Study|Lost to Follow-up|4|||
27840587|NCT01472185|54328452|FG001|Overall Study|Lost to Follow-up|1|||
27840588|NCT01472185|54328451|FG000|Overall Study|Protocol Violation|5|||
27840589|NCT01472185|54328452|FG001|Overall Study|Protocol Violation|1|||
27840590|NCT01472185|54328451|FG000|Overall Study|Subject Noncompliance|8|||
27840591|NCT01472185|54328452|FG001|Overall Study|Subject Noncompliance|15|||
27840592|NCT01472185|54328451|FG000|Overall Study|Subject Withdrew Consent|6|||
27840593|NCT01472185|54328452|FG001|Overall Study|Subject Withdrew Consent|3|||
27840594|NCT01456897|54328473|FG000|Overall Study|Adverse Event|19|||
27840595|NCT01456897|54328474|FG001|Overall Study|Adverse Event|22|||
27840596|NCT01456897|54328473|FG000|Overall Study|Protocol Violation|3|||
27840597|NCT01456897|54328474|FG001|Overall Study|Protocol Violation|4|||
27840598|NCT01456897|54328473|FG000|Overall Study|Physician Decision|5|||
27840599|NCT01456897|54328474|FG001|Overall Study|Physician Decision|3|||
27840600|NCT01456897|54328473|FG000|Overall Study|Withdrawal by Subject|44|||
27840601|NCT01456897|54328474|FG001|Overall Study|Withdrawal by Subject|17|||
27840602|NCT01456897|54328473|FG000|Overall Study|Lack of Efficacy|4|||
27840603|NCT01456897|54328474|FG001|Overall Study|Lack of Efficacy|11|||
27840604|NCT01456195|54328487|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
27840605|NCT01456195|54328488|FG001|Overall Study|Pretreatment Event/Adverse Event|4|||
27840606|NCT01456195|54328489|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
27840607|NCT01456195|54328487|FG000|Overall Study|Lost to Follow-up|3|||
27840608|NCT01456195|54328488|FG001|Overall Study|Lost to Follow-up|1|||
27840609|NCT01456195|54328489|FG002|Overall Study|Lost to Follow-up|3|||
27840610|NCT01456195|54328487|FG000|Overall Study|Voluntary Withdrawal|5|||
27840611|NCT01456195|54328488|FG001|Overall Study|Voluntary Withdrawal|3|||
27840612|NCT01456195|54328489|FG002|Overall Study|Voluntary Withdrawal|7|||
27840613|NCT01456195|54328487|FG000|Overall Study|Lack of Efficacy|0|||
27840614|NCT01456195|54328488|FG001|Overall Study|Lack of Efficacy|1|||
27840615|NCT01456195|54328489|FG002|Overall Study|Lack of Efficacy|0|||
27840616|NCT01456195|54328487|FG000|Overall Study|Other Reasons|2|||
27840617|NCT01456195|54328488|FG001|Overall Study|Other Reasons|1|||
27840618|NCT01456195|54328489|FG002|Overall Study|Other Reasons|3|||
27840619|NCT01456039|54328557|FG000|Phase 1 (First Step)|Disease Progression|1|||
27840620|NCT01456039|54328558|FG001|Phase 1 (First Step)|Disease Progression|1|||
27840621|NCT01456039|54328559|FG002|Phase 1 (First Step)|Disease Progression|0|||
27840622|NCT01456039|54328557|FG000|Phase 1 (First Step)|Withdrawal by Subject|1|||
27840623|NCT01456039|54328558|FG001|Phase 1 (First Step)|Withdrawal by Subject|2|||
27840624|NCT01456039|54328559|FG002|Phase 1 (First Step)|Withdrawal by Subject|0|||
27779566|NCT01620255|54233131|FG000|Overall Study|Withdrawn at discretion of investigator|0|||
27779567|NCT01620255|54233132|FG001|Overall Study|Withdrawn at discretion of investigator|0|||
27779568|NCT01620255|54233133|FG002|Overall Study|Withdrawn at discretion of investigator|0|||
27851616|NCT00985673|54351079|FG005|Overall Study|Lost to Follow-up|3|||
27779569|NCT01620255|54233134|FG003|Overall Study|Withdrawn at discretion of investigator|0|||
27779570|NCT01620255|54233135|FG004|Overall Study|Withdrawn at discretion of investigator|1|||
27779571|NCT02010567|54233152|FG000|Overall Study|Adverse Event|0|||
27779572|NCT02010567|54233153|FG001|Overall Study|Adverse Event|0|||
27779573|NCT02010567|54233154|FG002|Overall Study|Adverse Event|1|||
27779574|NCT02010567|54233155|FG003|Overall Study|Adverse Event|0|||
27779575|NCT02010567|54233156|FG004|Overall Study|Adverse Event|1|||
27779576|NCT01806064|54233171|FG000|Overall Study|Randomized Not Enrolled|0|||
27779577|NCT01806064|54233172|FG001|Overall Study|Randomized Not Enrolled|0|||
27779578|NCT01806064|54233173|FG002|Overall Study|Randomized Not Enrolled|0|||
27779579|NCT01806064|54233174|FG003|Overall Study|Randomized Not Enrolled|1|||
27779580|NCT01806064|54233175|FG004|Overall Study|Randomized Not Enrolled|2|||
27779581|NCT01804582|54233193|FG000|Overall Study|Lost to Follow-up|47|||
27779582|NCT01804582|54233194|FG001|Overall Study|Lost to Follow-up|56|||
27779583|NCT01804582|54233193|FG000|Overall Study|Physician Decision|2|||
27779584|NCT01804582|54233194|FG001|Overall Study|Physician Decision|0|||
27779585|NCT01787188|54233204|FG000|Overall Study|Adverse Event|2|||
27779586|NCT01787188|54233205|FG001|Overall Study|Adverse Event|4|||
27779587|NCT01787188|54233206|FG002|Overall Study|Adverse Event|6|||
27779588|NCT01787188|54233204|FG000|Overall Study|Lack of Efficacy|7|||
27779589|NCT01787188|54233205|FG001|Overall Study|Lack of Efficacy|3|||
27779590|NCT01787188|54233206|FG002|Overall Study|Lack of Efficacy|5|||
27779591|NCT01787188|54233204|FG000|Overall Study|Non-compliance with Study Drug|0|||
27779592|NCT01787188|54233205|FG001|Overall Study|Non-compliance with Study Drug|1|||
27779593|NCT01787188|54233206|FG002|Overall Study|Non-compliance with Study Drug|0|||
27779594|NCT01787188|54233204|FG000|Overall Study|Withdrawal by Subject|4|||
27779595|NCT01787188|54233205|FG001|Overall Study|Withdrawal by Subject|3|||
27779596|NCT01787188|54233206|FG002|Overall Study|Withdrawal by Subject|2|||
27779597|NCT01787188|54233204|FG000|Overall Study|Protocol Violation|3|||
27779598|NCT01787188|54233205|FG001|Overall Study|Protocol Violation|2|||
27779599|NCT01787188|54233206|FG002|Overall Study|Protocol Violation|3|||
27779600|NCT01787188|54233204|FG000|Overall Study|Lost to Follow-up|1|||
27779601|NCT01787188|54233205|FG001|Overall Study|Lost to Follow-up|2|||
27779602|NCT01787188|54233206|FG002|Overall Study|Lost to Follow-up|2|||
27779603|NCT01787188|54233204|FG000|Overall Study|Other, including patient moved|0|||
27779604|NCT01787188|54233205|FG001|Overall Study|Other, including patient moved|3|||
27779605|NCT01787188|54233206|FG002|Overall Study|Other, including patient moved|0|||
27779606|NCT01787032|54233220|FG000|Overall Study|Protocol Violation|0|||
27779607|NCT01787032|54233221|FG001|Overall Study|Protocol Violation|0|||
27779608|NCT01787032|54233222|FG002|Overall Study|Protocol Violation|0|||
27779609|NCT01787032|54233223|FG003|Overall Study|Protocol Violation|0|||
27779610|NCT01787032|54233224|FG004|Overall Study|Protocol Violation|1|||
27779611|NCT01787032|54233225|FG005|Overall Study|Protocol Violation|1|||
27779612|NCT01737268|54233235|FG000|Overall Study|Adverse Event|6|||
27779613|NCT01737268|54233235|FG000|Overall Study|Worsening of Target Disease|2|||
27779614|NCT01737268|54233235|FG000|Overall Study|In consideration of the patient's safety|1|||
27779615|NCT01769404|54233240|FG000|Treatment Period 1|Did not meet eligibility criteria|1|||
27779616|NCT01769404|54233241|FG001|Treatment Period 1|Did not meet eligibility criteria|0|||
27779617|NCT01769404|54233240|FG000|Treatment Period 1|Withdrawal by Subject|3|||
27779618|NCT01769404|54233241|FG001|Treatment Period 1|Withdrawal by Subject|0|||
27779619|NCT01769404|54233240|FG000|Treatment Period 1|Sponsor decision|1|||
27779620|NCT01769404|54233241|FG001|Treatment Period 1|Sponsor decision|0|||
27779621|NCT01769404|54233240|FG000|Treatment Period 2|Sponsor decision|7|||
27779622|NCT01769404|54233241|FG001|Treatment Period 2|Sponsor decision|0|||
27779623|NCT01769326|54233253|FG000|Overall Study|Lost to Follow-up|1|||
27779624|NCT01769326|54233254|FG001|Overall Study|Lost to Follow-up|2|||
27779625|NCT01769326|54233255|FG002|Overall Study|Lost to Follow-up|0|||
27779626|NCT01769326|54233256|FG003|Overall Study|Lost to Follow-up|0|||
27779627|NCT01769326|54233253|FG000|Overall Study|unrelated injry|1|||
27779628|NCT01769326|54233254|FG001|Overall Study|unrelated injry|1|||
27779629|NCT01769326|54233255|FG002|Overall Study|unrelated injry|0|||
27779630|NCT01769326|54233256|FG003|Overall Study|unrelated injry|0|||
27779631|NCT01769326|54233253|FG000|Overall Study|got a job|0|||
27779632|NCT01769326|54233254|FG001|Overall Study|got a job|1|||
27779633|NCT01769326|54233255|FG002|Overall Study|got a job|0|||
27779634|NCT01769326|54233256|FG003|Overall Study|got a job|0|||
27779635|NCT01769326|54233253|FG000|Overall Study|Got sick and could not complete study|0|||
27779636|NCT01769326|54233254|FG001|Overall Study|Got sick and could not complete study|0|||
27779637|NCT01769326|54233255|FG002|Overall Study|Got sick and could not complete study|1|||
27779638|NCT01769326|54233256|FG003|Overall Study|Got sick and could not complete study|0|||
27779639|NCT01786564|54233266|FG000|Overall Study|Lost to Follow-up|47|||
27779640|NCT01786564|54233266|FG000|Overall Study|Ineligible|17|||
27779641|NCT01786330|54233272|FG000|Overall Study|Withdrawal by Subject|0|||
27779642|NCT01786330|54233273|FG001|Overall Study|Withdrawal by Subject|1|||
27779643|NCT01786330|54233272|FG000|Overall Study|Lost to Follow-up|0|||
27779644|NCT01786330|54233273|FG001|Overall Study|Lost to Follow-up|1|||
27779645|NCT01786330|54233272|FG000|Overall Study|Excluded intraoperatively|0|||
27779646|NCT01786330|54233273|FG001|Overall Study|Excluded intraoperatively|1|||
27779647|NCT01786330|54233272|FG000|Overall Study|Protocol Violation|1|||
27779648|NCT01786330|54233273|FG001|Overall Study|Protocol Violation|0|||
27779649|NCT01786174|54233281|FG000|Overall Study|Discontinued Study Drug|2|||
27779650|NCT01786174|54233282|FG001|Overall Study|Discontinued Study Drug|0|||
27779651|NCT01736566|54233293|FG000|Long Term Follow-up|Still collecting data|42|||
27779652|NCT01736566|54233294|FG001|Long Term Follow-up|Still collecting data|0|||
27779653|NCT01736566|54233295|FG002|Long Term Follow-up|Still collecting data|49|||
27779654|NCT01736566|54233296|FG003|Long Term Follow-up|Still collecting data|0|||
27779655|NCT01736566|54233297|FG004|Long Term Follow-up|Still collecting data|1|||
27779656|NCT01768858|54233322|FG000|Overall Study|Lost to Follow-up|9|||
27779657|NCT01768858|54233322|FG000|Overall Study|Lack of Efficacy|8|||
27779658|NCT01768858|54233322|FG000|Overall Study|Serious Adverse Event|1|||
27779659|NCT01768858|54233322|FG000|Overall Study|Participant moved to Germany|1|||
27779660|NCT01768858|54233322|FG000|Overall Study|Aggravation of NY Heart Assoc 3 status|1|||
27779661|NCT01768858|54233322|FG000|Overall Study|Exanthema|1|||
27779662|NCT01768858|54233322|FG000|Overall Study|Withdrawal by Subject|1|||
27779663|NCT01736254|54233326|FG000|Period 2 (Days 2 to 12)|Adverse Event|3|||
27779664|NCT01736254|54233326|FG000|Period 3 (Days 13 to 23)|Adverse Event|1|||
27779665|NCT01767376|54233337|FG000|Overall Study|Lost to Follow-up|3|||
27779666|NCT01767376|54233338|FG001|Overall Study|Lost to Follow-up|2|||
27779667|NCT01767376|54233339|FG002|Overall Study|Lost to Follow-up|0|||
27779668|NCT01767376|54233337|FG000|Overall Study|Withdrawal by Subject|1|||
27779669|NCT01767376|54233338|FG001|Overall Study|Withdrawal by Subject|1|||
27779670|NCT01767376|54233339|FG002|Overall Study|Withdrawal by Subject|0|||
27779671|NCT01767142|54233349|FG000|Overall Study|Lost to Follow-up|3|||
27779672|NCT01785628|54233355|FG000|Overall Study|Lost to Follow-up|2|||
27779673|NCT01785628|54233356|FG001|Overall Study|Lost to Follow-up|3|||
27779674|NCT01785472|54233365|FG000|Overall Study|Adverse Event|5|||
27779675|NCT01785472|54233366|FG001|Overall Study|Adverse Event|4|||
27779676|NCT01785472|54233367|FG002|Overall Study|Adverse Event|6|||
27779677|NCT01785472|54233365|FG000|Overall Study|Lack of Efficacy|2|||
27779678|NCT01785472|54233366|FG001|Overall Study|Lack of Efficacy|0|||
27779679|NCT01785472|54233367|FG002|Overall Study|Lack of Efficacy|1|||
27779680|NCT01785472|54233365|FG000|Overall Study|Lost to Follow-up|1|||
27779681|NCT01785472|54233366|FG001|Overall Study|Lost to Follow-up|2|||
27779682|NCT01785472|54233367|FG002|Overall Study|Lost to Follow-up|0|||
27779683|NCT01785472|54233365|FG000|Overall Study|Physician Decision|1|||
27779684|NCT01785472|54233366|FG001|Overall Study|Physician Decision|1|||
27779685|NCT01785472|54233367|FG002|Overall Study|Physician Decision|1|||
27779686|NCT01785472|54233365|FG000|Overall Study|Protocol deviation|0|||
27779687|NCT01785472|54233366|FG001|Overall Study|Protocol deviation|2|||
27779688|NCT01785472|54233367|FG002|Overall Study|Protocol deviation|2|||
27779689|NCT01785472|54233365|FG000|Overall Study|Subject/guardian decision|15|||
27779690|NCT01785472|54233366|FG001|Overall Study|Subject/guardian decision|10|||
27779691|NCT01785472|54233367|FG002|Overall Study|Subject/guardian decision|11|||
27779692|NCT01785472|54233365|FG000|Overall Study|Technical problems|0|||
27779693|NCT01785472|54233366|FG001|Overall Study|Technical problems|0|||
27779694|NCT01785472|54233367|FG002|Overall Study|Technical problems|1|||
27779695|NCT01785160|54233377|FG000|Treatment Period 1: Raltegravir|Not treated|1|||
27779696|NCT01785160|54233377|FG000|Washout Period of at Least 7 Days|Consent withdrawn|1|||
27779697|NCT01736176|54233383|FG000|Overall Study|Adverse Event|3|||
27779698|NCT01736176|54233383|FG000|Overall Study|Withdrawal by Subject|4|||
27779699|NCT01736176|54233383|FG000|Overall Study|Lack of Efficacy|3|||
27779700|NCT01736176|54233383|FG000|Overall Study|Unable to Complete PEG Placement|1|||
27779701|NCT01735630|54233393|FG000|Overall Study|Adverse Event|8|||
27779702|NCT01735630|54233394|FG001|Overall Study|Adverse Event|7|||
27779703|NCT01735630|54233393|FG000|Overall Study|Lost to Follow-up|1|||
27779704|NCT01735630|54233394|FG001|Overall Study|Lost to Follow-up|0|||
27779705|NCT01735630|54233393|FG000|Overall Study|Physician Decision|0|||
27779706|NCT01735630|54233394|FG001|Overall Study|Physician Decision|1|||
27779707|NCT01735630|54233393|FG000|Overall Study|Sponsor Decision|2|||
27779708|NCT01735630|54233394|FG001|Overall Study|Sponsor Decision|1|||
27779709|NCT01735630|54233393|FG000|Overall Study|Withdrawal by Subject|7|||
27779710|NCT01735630|54233394|FG001|Overall Study|Withdrawal by Subject|9|||
27779711|NCT01735396|54233400|FG000|Overall Study|not evaluable|1|||
27779712|NCT01766206|54233404|FG000|Overall Study|Withdrawal by Subject|22|||
27779713|NCT01766206|54233404|FG000|Overall Study|Lost to Follow-up|10|||
27779714|NCT01766206|54233404|FG000|Overall Study|Inappropriate enrollment|18|||
27779715|NCT01766206|54233404|FG000|Overall Study|Withdrawal and inappropriate enrollment|1|||
27779716|NCT01734850|54233411|FG000|Overall Study|Continued to Week 48 but recommenced ART|3|||
27779717|NCT01734850|54233412|FG001|Overall Study|Continued to Week 48 but recommenced ART|2|||
27779718|NCT01734850|54233413|FG002|Overall Study|Continued to Week 48 but recommenced ART|3|||
27779719|NCT01734850|54233411|FG000|Overall Study|Not infused due to manufacturing failure|0|||
27779720|NCT01734850|54233412|FG001|Overall Study|Not infused due to manufacturing failure|0|||
27779721|NCT01734850|54233413|FG002|Overall Study|Not infused due to manufacturing failure|1|||
27779722|NCT01766050|54233424|FG000|Overall Study|Adverse Event|1|||
27779723|NCT01766050|54233424|FG000|Overall Study|Lost to Follow-up|1|||
27779724|NCT01766050|54233424|FG000|Overall Study|Withdrawal by Subject|2|||
27779725|NCT02341625|54233452|FG000|Overall Study|Disease Progression|2|||
27779726|NCT02341625|54233453|FG001|Overall Study|Disease Progression|2|||
27779727|NCT02341625|54233454|FG002|Overall Study|Disease Progression|3|||
27779728|NCT02341625|54233455|FG003|Overall Study|Disease Progression|6|||
27779729|NCT02341625|54233456|FG004|Overall Study|Disease Progression|7|||
27779730|NCT02341625|54233457|FG005|Overall Study|Disease Progression|7|||
27779731|NCT02341625|54233458|FG006|Overall Study|Disease Progression|28|||
27779732|NCT02341625|54233459|FG007|Overall Study|Disease Progression|5|||
27779733|NCT02341625|54233460|FG008|Overall Study|Disease Progression|4|||
27779734|NCT02341625|54233461|FG009|Overall Study|Disease Progression|19|||
27779735|NCT02341625|54233452|FG000|Overall Study|Study Drug Toxicity|0|||
27779736|NCT02341625|54233453|FG001|Overall Study|Study Drug Toxicity|0|||
27779737|NCT02341625|54233454|FG002|Overall Study|Study Drug Toxicity|0|||
27779738|NCT02341625|54233455|FG003|Overall Study|Study Drug Toxicity|1|||
27779739|NCT02341625|54233456|FG004|Overall Study|Study Drug Toxicity|0|||
27779740|NCT02341625|54233457|FG005|Overall Study|Study Drug Toxicity|3|||
27779741|NCT02341625|54233458|FG006|Overall Study|Study Drug Toxicity|10|||
27779742|NCT02341625|54233459|FG007|Overall Study|Study Drug Toxicity|0|||
27779743|NCT02341625|54233460|FG008|Overall Study|Study Drug Toxicity|0|||
27779744|NCT02341625|54233461|FG009|Overall Study|Study Drug Toxicity|3|||
27779745|NCT02341625|54233452|FG000|Overall Study|Adverse Event Unrelated to Study Drug|0|||
27779746|NCT02341625|54233453|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
27779747|NCT02341625|54233454|FG002|Overall Study|Adverse Event Unrelated to Study Drug|0|||
27779748|NCT02341625|54233455|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
27779749|NCT02341625|54233456|FG004|Overall Study|Adverse Event Unrelated to Study Drug|0|||
27779750|NCT02341625|54233457|FG005|Overall Study|Adverse Event Unrelated to Study Drug|0|||
27779751|NCT02341625|54233458|FG006|Overall Study|Adverse Event Unrelated to Study Drug|2|||
27779752|NCT02341625|54233459|FG007|Overall Study|Adverse Event Unrelated to Study Drug|1|||
27779753|NCT02341625|54233460|FG008|Overall Study|Adverse Event Unrelated to Study Drug|0|||
27779754|NCT02341625|54233461|FG009|Overall Study|Adverse Event Unrelated to Study Drug|2|||
27779755|NCT02341625|54233452|FG000|Overall Study|Participant Request to Discontinue Study Treatment|0|||
27779756|NCT02341625|54233453|FG001|Overall Study|Participant Request to Discontinue Study Treatment|0|||
27779757|NCT02341625|54233454|FG002|Overall Study|Participant Request to Discontinue Study Treatment|0|||
27779758|NCT02341625|54233455|FG003|Overall Study|Participant Request to Discontinue Study Treatment|0|||
27779759|NCT02341625|54233456|FG004|Overall Study|Participant Request to Discontinue Study Treatment|0|||
27779760|NCT02341625|54233457|FG005|Overall Study|Participant Request to Discontinue Study Treatment|0|||
27779761|NCT02341625|54233458|FG006|Overall Study|Participant Request to Discontinue Study Treatment|6|||
27779762|NCT02341625|54233459|FG007|Overall Study|Participant Request to Discontinue Study Treatment|2|||
27779763|NCT02341625|54233460|FG008|Overall Study|Participant Request to Discontinue Study Treatment|0|||
27779764|NCT02341625|54233461|FG009|Overall Study|Participant Request to Discontinue Study Treatment|0|||
27779765|NCT02341625|54233452|FG000|Overall Study|Participant Withdrew Consent|0|||
27779766|NCT02341625|54233453|FG001|Overall Study|Participant Withdrew Consent|0|||
27779767|NCT02341625|54233454|FG002|Overall Study|Participant Withdrew Consent|0|||
27779768|NCT02341625|54233455|FG003|Overall Study|Participant Withdrew Consent|1|||
27779769|NCT02341625|54233456|FG004|Overall Study|Participant Withdrew Consent|0|||
27779770|NCT02341625|54233457|FG005|Overall Study|Participant Withdrew Consent|0|||
27779771|NCT02341625|54233458|FG006|Overall Study|Participant Withdrew Consent|0|||
27779772|NCT02341625|54233459|FG007|Overall Study|Participant Withdrew Consent|0|||
27779773|NCT02341625|54233460|FG008|Overall Study|Participant Withdrew Consent|0|||
27779774|NCT02341625|54233461|FG009|Overall Study|Participant Withdrew Consent|0|||
27779775|NCT02341625|54233452|FG000|Overall Study|Completed Treatment as per Protocol|0|||
27779776|NCT02341625|54233453|FG001|Overall Study|Completed Treatment as per Protocol|0|||
27779777|NCT02341625|54233454|FG002|Overall Study|Completed Treatment as per Protocol|0|||
27779778|NCT02341625|54233455|FG003|Overall Study|Completed Treatment as per Protocol|0|||
27779779|NCT02341625|54233456|FG004|Overall Study|Completed Treatment as per Protocol|0|||
27779780|NCT02341625|54233457|FG005|Overall Study|Completed Treatment as per Protocol|0|||
27779781|NCT02341625|54233458|FG006|Overall Study|Completed Treatment as per Protocol|0|||
27779782|NCT02341625|54233459|FG007|Overall Study|Completed Treatment as per Protocol|0|||
27779783|NCT02341625|54233460|FG008|Overall Study|Completed Treatment as per Protocol|0|||
27779784|NCT02341625|54233461|FG009|Overall Study|Completed Treatment as per Protocol|1|||
27779785|NCT02341625|54233452|FG000|Overall Study|Other Reasons|0|||
27779786|NCT02341625|54233453|FG001|Overall Study|Other Reasons|0|||
27779787|NCT02341625|54233454|FG002|Overall Study|Other Reasons|0|||
27779788|NCT02341625|54233455|FG003|Overall Study|Other Reasons|0|||
27779789|NCT02341625|54233456|FG004|Overall Study|Other Reasons|1|||
27779790|NCT02341625|54233457|FG005|Overall Study|Other Reasons|0|||
27779791|NCT02341625|54233458|FG006|Overall Study|Other Reasons|5|||
27779792|NCT02341625|54233459|FG007|Overall Study|Other Reasons|0|||
27779793|NCT02341625|54233460|FG008|Overall Study|Other Reasons|0|||
27779794|NCT02341625|54233461|FG009|Overall Study|Other Reasons|2|||
27840625|NCT01456039|54328557|FG000|Phase 1 (First Step)|Adverse Event|0|||
27840626|NCT01456039|54328558|FG001|Phase 1 (First Step)|Adverse Event|3|||
27840627|NCT01456039|54328559|FG002|Phase 1 (First Step)|Adverse Event|0|||
27840628|NCT01456039|54328557|FG000|Phase 1 (First Step)|Other|0|||
27840629|NCT01456039|54328558|FG001|Phase 1 (First Step)|Other|1|||
27840630|NCT01456039|54328559|FG002|Phase 1 (First Step)|Other|0|||
27840631|NCT01456039|54328557|FG000|Phase 2 (Second Step)|Disease Progression|0|||
27840632|NCT01456039|54328558|FG001|Phase 2 (Second Step)|Disease Progression|0|||
27840633|NCT01456039|54328559|FG002|Phase 2 (Second Step)|Disease Progression|17|||
27840634|NCT01456039|54328557|FG000|Phase 2 (Second Step)|Adverse Event|0|||
27840635|NCT01456039|54328558|FG001|Phase 2 (Second Step)|Adverse Event|0|||
27840636|NCT01456039|54328559|FG002|Phase 2 (Second Step)|Adverse Event|10|||
27840637|NCT01456039|54328557|FG000|Phase 2 (Second Step)|Withdrawal by Subject|0|||
27840638|NCT01456039|54328558|FG001|Phase 2 (Second Step)|Withdrawal by Subject|0|||
27840639|NCT01456039|54328559|FG002|Phase 2 (Second Step)|Withdrawal by Subject|4|||
27840640|NCT01456039|54328557|FG000|Phase 2 (Second Step)|Protocol Violation|0|||
27840641|NCT01456039|54328558|FG001|Phase 2 (Second Step)|Protocol Violation|0|||
27840642|NCT01456039|54328559|FG002|Phase 2 (Second Step)|Protocol Violation|1|||
27840643|NCT01456039|54328557|FG000|Phase 2 (Second Step)|Other|0|||
27840644|NCT01456039|54328558|FG001|Phase 2 (Second Step)|Other|0|||
27840645|NCT01456039|54328559|FG002|Phase 2 (Second Step)|Other|1|||
27840646|NCT01455415|54328577|FG000|Period 1|Adverse Event (AE) Related to Study Drug|9|||
27840647|NCT01455415|54328578|FG001|Period 1|Adverse Event (AE) Related to Study Drug|6|||
27840648|NCT01455415|54328577|FG000|Period 1|Lost To Follow-up Related to Study Drug|3|||
27840649|NCT01455415|54328578|FG001|Period 1|Lost To Follow-up Related to Study Drug|3|||
27840650|NCT01455415|54328577|FG000|Period 1|Drug Error not Associated to AE|0|||
27840651|NCT01455415|54328578|FG001|Period 1|Drug Error not Associated to AE|1|||
27840652|NCT01455415|54328577|FG000|Period 1|AE Not Related to Study Drug|2|||
27840653|NCT01455415|54328578|FG001|Period 1|AE Not Related to Study Drug|6|||
27840654|NCT01455415|54328577|FG000|Period 1|Withdrawal by Subject|4|||
27840655|NCT01455415|54328578|FG001|Period 1|Withdrawal by Subject|5|||
27779795|NCT02341625|54233452|FG000|Overall Study|Not Reported|0|||
27779796|NCT02341625|54233453|FG001|Overall Study|Not Reported|0|||
27779797|NCT02341625|54233454|FG002|Overall Study|Not Reported|0|||
27779798|NCT02341625|54233455|FG003|Overall Study|Not Reported|0|||
27779799|NCT02341625|54233456|FG004|Overall Study|Not Reported|0|||
27779800|NCT02341625|54233457|FG005|Overall Study|Not Reported|0|||
27779801|NCT02341625|54233458|FG006|Overall Study|Not Reported|0|||
27779802|NCT02341625|54233459|FG007|Overall Study|Not Reported|0|||
27779803|NCT02341625|54233460|FG008|Overall Study|Not Reported|0|||
27779804|NCT02341625|54233461|FG009|Overall Study|Not Reported|3|||
27779805|NCT02370095|54233508|FG000|Overall Study|Withdrawal by Subject|0|||
27779806|NCT02370095|54233509|FG001|Overall Study|Withdrawal by Subject|1|||
27779807|NCT01783678|54233521|FG000|Overall Study|Randomized but Not Treated|0|||
27779808|NCT01783678|54233522|FG001|Overall Study|Randomized but Not Treated|0|||
27779809|NCT01783678|54233523|FG002|Overall Study|Randomized but Not Treated|0|||
27779810|NCT01783678|54233524|FG003|Overall Study|Randomized but Not Treated|1|||
27779811|NCT01783678|54233525|FG004|Overall Study|Randomized but Not Treated|0|||
27779812|NCT01783678|54233526|FG005|Overall Study|Randomized but Not Treated|0|||
27779813|NCT01783678|54233521|FG000|Overall Study|Lack of Efficacy|1|||
27779814|NCT01783678|54233522|FG001|Overall Study|Lack of Efficacy|13|||
27779815|NCT01783678|54233523|FG002|Overall Study|Lack of Efficacy|1|||
27779816|NCT01783678|54233524|FG003|Overall Study|Lack of Efficacy|3|||
27779817|NCT01783678|54233525|FG004|Overall Study|Lack of Efficacy|6|||
27779818|NCT01783678|54233526|FG005|Overall Study|Lack of Efficacy|5|||
27779819|NCT01783678|54233521|FG000|Overall Study|Lost to Follow-up|0|||
27779820|NCT01783678|54233522|FG001|Overall Study|Lost to Follow-up|4|||
27779821|NCT01783678|54233523|FG002|Overall Study|Lost to Follow-up|0|||
27779822|NCT01783678|54233524|FG003|Overall Study|Lost to Follow-up|2|||
27779823|NCT01783678|54233525|FG004|Overall Study|Lost to Follow-up|1|||
27779824|NCT01783678|54233526|FG005|Overall Study|Lost to Follow-up|0|||
27779825|NCT01783678|54233521|FG000|Overall Study|Withdrew Consent|1|||
27779826|NCT01783678|54233522|FG001|Overall Study|Withdrew Consent|1|||
27779827|NCT01783678|54233523|FG002|Overall Study|Withdrew Consent|0|||
27779828|NCT01783678|54233524|FG003|Overall Study|Withdrew Consent|2|||
27779829|NCT01783678|54233525|FG004|Overall Study|Withdrew Consent|0|||
27779830|NCT01783678|54233526|FG005|Overall Study|Withdrew Consent|0|||
27779831|NCT01734772|54233543|FG000|Overall Study|Adverse Event|1|||
27840656|NCT01455415|54328577|FG000|Period 1|Unspecified Reason|1|||
27779832|NCT01734772|54233544|FG001|Overall Study|Adverse Event|2|||
27779833|NCT01734772|54233543|FG000|Overall Study|Withdrawal by Subject|0|||
27779834|NCT01734772|54233544|FG001|Overall Study|Withdrawal by Subject|1|||
27840657|NCT01455415|54328578|FG001|Period 1|Unspecified Reason|1|||
27840658|NCT01455415|54328577|FG000|Period 1|Protocol Violation|0|||
27840659|NCT01455415|54328578|FG001|Period 1|Protocol Violation|2|||
27779835|NCT02340221|54233558|FG000|Overall Study|Death|100|||
27779836|NCT02340221|54233559|FG001|Overall Study|Death|197|||
27779837|NCT02340221|54233558|FG000|Overall Study|Withdrawal by Participant|24|||
27779838|NCT02340221|54233559|FG001|Overall Study|Withdrawal by Participant|37|||
27779839|NCT02340221|54233558|FG000|Overall Study|Lost to Follow-up|4|||
27779840|NCT02340221|54233559|FG001|Overall Study|Lost to Follow-up|15|||
27779841|NCT02340221|54233558|FG000|Overall Study|Reason Not Specified|85|||
27779842|NCT02340221|54233559|FG001|Overall Study|Reason Not Specified|165|||
27779843|NCT02340221|54233558|FG000|Overall Study|Study Terminated by Sponsor|1|||
27779844|NCT02340221|54233559|FG001|Overall Study|Study Terminated by Sponsor|3|||
27779845|NCT02339909|54233569|FG000|Overall Study|Became ineligible after randomisation|89|||
27779846|NCT02339909|54233570|FG001|Overall Study|Became ineligible after randomisation|63|||
27779847|NCT02339909|54233571|FG002|Overall Study|Became ineligible after randomisation|71|||
27779848|NCT02395133|54233583|FG000|Overall Study|Adverse Event|4|||
27779849|NCT02395133|54233584|FG001|Overall Study|Adverse Event|1|||
27779850|NCT02395133|54233585|FG002|Overall Study|Adverse Event|3|||
27779851|NCT02395133|54233586|FG003|Overall Study|Adverse Event|0|||
27779852|NCT02395133|54233583|FG000|Overall Study|Lack of Efficacy|1|||
27779853|NCT02395133|54233584|FG001|Overall Study|Lack of Efficacy|0|||
27779854|NCT02395133|54233585|FG002|Overall Study|Lack of Efficacy|1|||
27779855|NCT02395133|54233586|FG003|Overall Study|Lack of Efficacy|1|||
27779856|NCT02395133|54233583|FG000|Overall Study|Protocol Violation|1|||
27779857|NCT02395133|54233584|FG001|Overall Study|Protocol Violation|1|||
27779858|NCT02395133|54233585|FG002|Overall Study|Protocol Violation|0|||
27779859|NCT02395133|54233586|FG003|Overall Study|Protocol Violation|3|||
27779860|NCT02395133|54233583|FG000|Overall Study|Lost to Follow-up|0|||
27779861|NCT02395133|54233584|FG001|Overall Study|Lost to Follow-up|1|||
27779862|NCT02395133|54233585|FG002|Overall Study|Lost to Follow-up|1|||
27779863|NCT02395133|54233586|FG003|Overall Study|Lost to Follow-up|0|||
27779864|NCT02395133|54233583|FG000|Overall Study|Pregnancy|0|||
27779865|NCT02395133|54233584|FG001|Overall Study|Pregnancy|0|||
27779866|NCT02395133|54233585|FG002|Overall Study|Pregnancy|3|||
27779867|NCT02395133|54233586|FG003|Overall Study|Pregnancy|0|||
27779868|NCT02395133|54233583|FG000|Overall Study|Consent withdrawn with no reason given|1|||
27779869|NCT02395133|54233584|FG001|Overall Study|Consent withdrawn with no reason given|3|||
27779870|NCT02395133|54233585|FG002|Overall Study|Consent withdrawn with no reason given|0|||
27779871|NCT02395133|54233586|FG003|Overall Study|Consent withdrawn with no reason given|2|||
27779872|NCT02395133|54233583|FG000|Overall Study|Consent withdrawn with personal reason|0|||
27779873|NCT02395133|54233584|FG001|Overall Study|Consent withdrawn with personal reason|1|||
27779874|NCT02395133|54233585|FG002|Overall Study|Consent withdrawn with personal reason|0|||
27779875|NCT02395133|54233586|FG003|Overall Study|Consent withdrawn with personal reason|3|||
27779876|NCT02395133|54233583|FG000|Overall Study|Sponsor decision|2|||
27779877|NCT02395133|54233584|FG001|Overall Study|Sponsor decision|0|||
27779878|NCT02395133|54233585|FG002|Overall Study|Sponsor decision|0|||
27779879|NCT02395133|54233586|FG003|Overall Study|Sponsor decision|1|||
27779880|NCT02395133|54233583|FG000|Overall Study|Other than specified above|5|||
27779881|NCT02395133|54233584|FG001|Overall Study|Other than specified above|2|||
27779882|NCT02395133|54233585|FG002|Overall Study|Other than specified above|2|||
27779883|NCT02395133|54233586|FG003|Overall Study|Other than specified above|4|||
27779884|NCT02395055|54233598|FG000|Overall Study|Withdrawal by Subject|7|||
27779885|NCT02395055|54233599|FG001|Overall Study|Withdrawal by Subject|3|||
27779886|NCT02369159|54233607|FG000|Overall Study|Adverse Event|0|||
27779887|NCT02369159|54233608|FG001|Overall Study|Adverse Event|1|||
27779888|NCT02369159|54233607|FG000|Overall Study|Lost to Follow-up|1|||
27779889|NCT02369159|54233608|FG001|Overall Study|Lost to Follow-up|1|||
27779890|NCT02369159|54233607|FG000|Overall Study|Withdrawal by Subject|7|||
27779891|NCT02369159|54233608|FG001|Overall Study|Withdrawal by Subject|0|||
27779892|NCT02368691|54233625|FG000|Overall Study|Death|13|||
27779893|NCT02368691|54233625|FG000|Overall Study|Lack of Efficacy|15|||
27779894|NCT02368691|54233625|FG000|Overall Study|Physician Decision|4|||
27779895|NCT02394665|54233632|FG000|Overall Study|Physician Decision|1|||
27779896|NCT02394665|54233633|FG001|Overall Study|Physician Decision|0|||
27779897|NCT02394665|54233634|FG002|Overall Study|Physician Decision|0|||
27779898|NCT02367911|54233644|FG000|Overall Study|Withdrawal by Subject|3|||
27779899|NCT02367911|54233645|FG001|Overall Study|Withdrawal by Subject|2|||
27779900|NCT02367911|54233644|FG000|Overall Study|Lost to Follow-up|2|||
27840660|NCT01455415|54328577|FG000|Washout|AE Related to Study Drug|2|||
27840661|NCT01455415|54328578|FG001|Washout|AE Related to Study Drug|0|||
27840662|NCT01455415|54328577|FG000|Washout|Lost to Follow-up|1|||
27779901|NCT02367911|54233645|FG001|Overall Study|Lost to Follow-up|2|||
27779902|NCT02339285|54233654|FG000|Overall Study|Withdrawal by Subject|0|||
27779903|NCT02339285|54233655|FG001|Overall Study|Withdrawal by Subject|1|||
27779904|NCT02339285|54233656|FG002|Overall Study|Withdrawal by Subject|1|||
27779905|NCT02339285|54233654|FG000|Overall Study|Lost to Follow-up|1|||
27779906|NCT02339285|54233655|FG001|Overall Study|Lost to Follow-up|1|||
27779907|NCT02339285|54233656|FG002|Overall Study|Lost to Follow-up|1|||
27779908|NCT02339285|54233654|FG000|Overall Study|Protocol Deviation|0|||
27779909|NCT02339285|54233655|FG001|Overall Study|Protocol Deviation|1|||
27779910|NCT02339285|54233656|FG002|Overall Study|Protocol Deviation|0|||
27779911|NCT02367833|54233667|FG000|Overall Study|Withdrawal by Subject|1|||
27840663|NCT01455415|54328578|FG001|Washout|Lost to Follow-up|0|||
27779912|NCT02367833|54233668|FG001|Overall Study|Withdrawal by Subject|1|||
27779913|NCT02367833|54233669|FG002|Overall Study|Withdrawal by Subject|0|||
27779914|NCT02367521|54233679|FG000|Overall Study|severe headache after intervention|2|||
27779915|NCT02367521|54233680|FG001|Overall Study|severe headache after intervention|0|||
27779916|NCT02367521|54233679|FG000|Overall Study|unable to find transportation|2|||
27779917|NCT02367521|54233680|FG001|Overall Study|unable to find transportation|0|||
27779918|NCT02338193|54233689|FG000|Overall Study|Withdrawal by Subject|0|||
27779919|NCT02338193|54233690|FG001|Overall Study|Withdrawal by Subject|0|||
27779920|NCT02338193|54233691|FG002|Overall Study|Withdrawal by Subject|2|||
27779921|NCT02338193|54233689|FG000|Overall Study|Pregnancy|0|||
27779922|NCT02338193|54233690|FG001|Overall Study|Pregnancy|1|||
27779923|NCT02338193|54233691|FG002|Overall Study|Pregnancy|1|||
27779924|NCT02338193|54233689|FG000|Overall Study|Noncompliant with visits|2|||
27779925|NCT02338193|54233690|FG001|Overall Study|Noncompliant with visits|2|||
27779926|NCT02338193|54233691|FG002|Overall Study|Noncompliant with visits|7|||
27779927|NCT02338193|54233689|FG000|Overall Study|moved out of state|0|||
27779928|NCT02338193|54233690|FG001|Overall Study|moved out of state|1|||
27779929|NCT02338193|54233691|FG002|Overall Study|moved out of state|0|||
27779930|NCT02338193|54233689|FG000|Overall Study|intolerant of side effects|1|||
27779931|NCT02338193|54233690|FG001|Overall Study|intolerant of side effects|0|||
27779932|NCT02338193|54233691|FG002|Overall Study|intolerant of side effects|0|||
27779933|NCT01783444|54233702|FG000|Treatment Phase|Adverse Event|9|||
27779934|NCT01783444|54233703|FG001|Treatment Phase|Adverse Event|20|||
27779935|NCT01783444|54233704|FG002|Treatment Phase|Adverse Event|19|||
27779936|NCT01783444|54233702|FG000|Treatment Phase|Disease Progression|76|||
27779937|NCT01783444|54233703|FG001|Treatment Phase|Disease Progression|66|||
27779938|NCT01783444|54233704|FG002|Treatment Phase|Disease Progression|64|||
27779939|NCT01783444|54233702|FG000|Treatment Phase|Death|2|||
27779940|NCT01783444|54233703|FG001|Treatment Phase|Death|2|||
27779941|NCT01783444|54233704|FG002|Treatment Phase|Death|2|||
27779942|NCT01783444|54233702|FG000|Treatment Phase|Protocol Violation|1|||
27779943|NCT01783444|54233703|FG001|Treatment Phase|Protocol Violation|1|||
27779944|NCT01783444|54233704|FG002|Treatment Phase|Protocol Violation|2|||
27779945|NCT01783444|54233702|FG000|Treatment Phase|Withdrawal by Subject|6|||
27779946|NCT01783444|54233703|FG001|Treatment Phase|Withdrawal by Subject|8|||
27779947|NCT01783444|54233704|FG002|Treatment Phase|Withdrawal by Subject|9|||
27779948|NCT01783444|54233702|FG000|Treatment Phase|Administrative problems|2|||
27779949|NCT01783444|54233703|FG001|Treatment Phase|Administrative problems|0|||
27779950|NCT01783444|54233704|FG002|Treatment Phase|Administrative problems|1|||
27779951|NCT01783444|54233702|FG000|Treatment Phase|Physician Decision|8|||
27779952|NCT01783444|54233703|FG001|Treatment Phase|Physician Decision|6|||
27779953|NCT01783444|54233704|FG002|Treatment Phase|Physician Decision|5|||
27779954|NCT01783444|54233702|FG000|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7|||
27779955|NCT01783444|54233703|FG001|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8|||
27779956|NCT01783444|54233704|FG002|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11|||
27779957|NCT01783444|54233702|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|9|||
27779958|NCT01783444|54233703|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|7|||
27779959|NCT01783444|54233704|FG002|Post-Treatment Efficacy Follow-Up Phase|Death|5|||
27779960|NCT01783444|54233702|FG000|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4|||
27779961|NCT01783444|54233703|FG001|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
27779962|NCT01783444|54233704|FG002|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
27779963|NCT01783444|54233702|FG000|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
27779964|NCT01783444|54233703|FG001|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1|||
27779965|NCT01783444|54233704|FG002|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
27779966|NCT01783444|54233702|FG000|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7|||
27779967|NCT01783444|54233703|FG001|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16|||
27779968|NCT01783444|54233704|FG002|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15|||
27779969|NCT01783444|54233702|FG000|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69|||
27779970|NCT01783444|54233703|FG001|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53|||
27779971|NCT01783444|54233704|FG002|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52|||
27779972|NCT02367131|54233713|FG000|Overall Study|Adverse Event|64|||
27779973|NCT02367131|54233713|FG000|Overall Study|No visit since the first visit|4|||
27779974|NCT02367131|54233713|FG000|Overall Study|Request by patient|54|||
27779975|NCT02367131|54233713|FG000|Overall Study|Improvement/remission|2|||
27779976|NCT02367131|54233713|FG000|Overall Study|No change/progressive disease|78|||
27779977|NCT02367131|54233713|FG000|Overall Study|Other than stated above|20|||
27779978|NCT02394275|54233717|FG000|Overall Study|Adverse Event|22|||
27779979|NCT02394275|54233717|FG000|Overall Study|Lost to Follow-up|7|||
27779980|NCT01608724|54233722|FG000|Overall Study|Withdrawal by Subject|131|||
27779981|NCT01608724|54233722|FG000|Overall Study|Lost to Follow-up|41|||
27779982|NCT01608724|54233722|FG000|Overall Study|Study-specific discontinuation criteria|32|||
27779983|NCT01608724|54233722|FG000|Overall Study|Adverse Event|29|||
27779984|NCT01608724|54233722|FG000|Overall Study|Protocol Violation|6|||
27779985|NCT01608724|54233722|FG000|Overall Study|bood sugar too high, etc.|3|||
27779986|NCT01608724|54233722|FG000|Overall Study|Safety reasons|1|||
27779987|NCT02366195|54233726|FG000|Overall Study|Protocol-specified criteria|3|||
27779988|NCT02366195|54233726|FG000|Overall Study|Withdrawal by Subject|9|||
27779989|NCT02366195|54233726|FG000|Overall Study|Lost to Follow-up|1|||
27779990|NCT02366195|54233726|FG000|Overall Study|Death|41|||
27779991|NCT02364947|54233733|FG000|Overall Study|Withdrawal by Subject|10|||
27779992|NCT02364947|54233734|FG001|Overall Study|Withdrawal by Subject|8|||
27779993|NCT02364947|54233735|FG002|Overall Study|Withdrawal by Subject|9|||
27779994|NCT02364947|54233733|FG000|Overall Study|Adverse Event|45|||
27779995|NCT02364947|54233734|FG001|Overall Study|Adverse Event|33|||
27779996|NCT02364947|54233735|FG002|Overall Study|Adverse Event|11|||
27779997|NCT02364947|54233733|FG000|Overall Study|Protocol Violation|1|||
27779998|NCT02364947|54233734|FG001|Overall Study|Protocol Violation|1|||
27779999|NCT02364947|54233735|FG002|Overall Study|Protocol Violation|1|||
27780000|NCT02364947|54233733|FG000|Overall Study|Physician Decision|3|||
27780001|NCT02364947|54233734|FG001|Overall Study|Physician Decision|2|||
27780002|NCT02364947|54233735|FG002|Overall Study|Physician Decision|5|||
27780003|NCT02364947|54233733|FG000|Overall Study|Death|0|||
27780004|NCT02364947|54233734|FG001|Overall Study|Death|1|||
27780005|NCT02364947|54233735|FG002|Overall Study|Death|0|||
27780006|NCT02392481|54233747|FG000|Overall Study|Adverse Event|0|||
27780007|NCT02392481|54233748|FG001|Overall Study|Adverse Event|0|||
27780008|NCT02392481|54233749|FG002|Overall Study|Adverse Event|1|||
27780009|NCT02392481|54233750|FG003|Overall Study|Adverse Event|2|||
27780010|NCT02392481|54233747|FG000|Overall Study|Withdrawal by Subject|0|||
27780011|NCT02392481|54233748|FG001|Overall Study|Withdrawal by Subject|0|||
27780012|NCT02392481|54233749|FG002|Overall Study|Withdrawal by Subject|1|||
27780013|NCT02392481|54233750|FG003|Overall Study|Withdrawal by Subject|0|||
27780014|NCT02392403|54233760|FG000|Overall Study|Adverse Event|1|||
27780015|NCT02392403|54233760|FG000|Overall Study|Death|1|||
27780016|NCT02392403|54233760|FG000|Overall Study|Withdrawal by Subject|1|||
27780017|NCT02392247|54233764|FG000|Overall Study|Withdrawal by Subject|1|||
27780018|NCT02392247|54233764|FG000|Overall Study|Surgery cancelled; no data|1|||
27780019|NCT02337725|54233770|FG000|Overall Study|Pretreatment Event/AE before Treatment|0|||
27780020|NCT02337725|54233771|FG001|Overall Study|Pretreatment Event/AE before Treatment|1|||
27780021|NCT02337725|54233770|FG000|Overall Study|Pretreatment Event/AE in Treatment|8|||
27780022|NCT02337725|54233771|FG001|Overall Study|Pretreatment Event/AE in Treatment|3|||
27780023|NCT02337725|54233770|FG000|Overall Study|Major Protocol Deviation|0|||
27780024|NCT02337725|54233771|FG001|Overall Study|Major Protocol Deviation|1|||
27780025|NCT02337725|54233770|FG000|Overall Study|Voluntary Withdrawal|14|||
27780026|NCT02337725|54233771|FG001|Overall Study|Voluntary Withdrawal|3|||
27780027|NCT02337725|54233770|FG000|Overall Study|Lack of Efficacy|4|||
27780028|NCT02337725|54233771|FG001|Overall Study|Lack of Efficacy|0|||
27780029|NCT02337491|54233779|FG000|Overall Study|Death|1|||
27780030|NCT02337491|54233780|FG001|Overall Study|Death|1|||
27780031|NCT02337491|54233779|FG000|Overall Study|Adverse Event|0|||
27780032|NCT02337491|54233780|FG001|Overall Study|Adverse Event|1|||
27780033|NCT02337491|54233779|FG000|Overall Study|Withdrawal by Subject|3|||
27780034|NCT02337491|54233780|FG001|Overall Study|Withdrawal by Subject|0|||
27780035|NCT02337491|54233779|FG000|Overall Study|Progressive Disease|44|||
27780036|NCT02337491|54233780|FG001|Overall Study|Progressive Disease|28|||
27780037|NCT02337491|54233779|FG000|Overall Study|On Treatment|2|||
27780038|NCT02337491|54233780|FG001|Overall Study|On Treatment|0|||
27780039|NCT01765582|54233790|FG000|Overall Study|Other|3|||
27780040|NCT01765582|54233791|FG001|Overall Study|Other|6|||
27780041|NCT01765582|54233792|FG002|Overall Study|Other|9|||
27780042|NCT01765582|54233790|FG000|Overall Study|Lost to Follow-up|2|||
27780043|NCT01765582|54233791|FG001|Overall Study|Lost to Follow-up|2|||
27780044|NCT01765582|54233792|FG002|Overall Study|Lost to Follow-up|1|||
27840664|NCT01455415|54328577|FG000|Washout|Drug Error not Associated to AE|2|||
27780045|NCT01765582|54233790|FG000|Overall Study|Death|31|||
27780046|NCT01765582|54233791|FG001|Overall Study|Death|36|||
27780047|NCT01765582|54233792|FG002|Overall Study|Death|33|||
27780048|NCT01765582|54233790|FG000|Overall Study|Sponsor Decision|46|||
27780049|NCT01765582|54233791|FG001|Overall Study|Sponsor Decision|42|||
27840665|NCT01455415|54328578|FG001|Washout|Drug Error not Associated to AE|1|||
27780050|NCT01765582|54233792|FG002|Overall Study|Sponsor Decision|42|||
27780051|NCT01765582|54233790|FG000|Overall Study|Withdrawal of Consent|11|||
27780052|NCT01765582|54233791|FG001|Overall Study|Withdrawal of Consent|6|||
27780053|NCT01765582|54233792|FG002|Overall Study|Withdrawal of Consent|10|||
27780054|NCT01649375|54233804|FG000|Up to Week 16|Adverse Event|2|||
27780055|NCT01649375|54233805|FG001|Up to Week 16|Adverse Event|5|||
27780056|NCT01649375|54233806|FG002|Up to Week 16|Adverse Event|4|||
27780057|NCT01649375|54233807|FG003|Up to Week 16|Adverse Event|0|||
27780058|NCT01649375|54233808|FG004|Up to Week 16|Adverse Event|0|||
27780059|NCT01649375|54233804|FG000|Up to Week 16|Lack of Efficacy|0|||
27780060|NCT01649375|54233805|FG001|Up to Week 16|Lack of Efficacy|0|||
27780061|NCT01649375|54233806|FG002|Up to Week 16|Lack of Efficacy|1|||
27780062|NCT01649375|54233807|FG003|Up to Week 16|Lack of Efficacy|0|||
27780063|NCT01649375|54233808|FG004|Up to Week 16|Lack of Efficacy|0|||
27780064|NCT01649375|54233804|FG000|Up to Week 16|Physician Decision|0|||
27780065|NCT01649375|54233805|FG001|Up to Week 16|Physician Decision|0|||
27780066|NCT01649375|54233806|FG002|Up to Week 16|Physician Decision|1|||
27780067|NCT01649375|54233807|FG003|Up to Week 16|Physician Decision|0|||
27780068|NCT01649375|54233808|FG004|Up to Week 16|Physician Decision|0|||
27780069|NCT01649375|54233804|FG000|Up to Week 16|Withdrawal by Subject|2|||
27780070|NCT01649375|54233805|FG001|Up to Week 16|Withdrawal by Subject|1|||
27780071|NCT01649375|54233806|FG002|Up to Week 16|Withdrawal by Subject|2|||
27780072|NCT01649375|54233807|FG003|Up to Week 16|Withdrawal by Subject|0|||
27780073|NCT01649375|54233808|FG004|Up to Week 16|Withdrawal by Subject|0|||
27780074|NCT01649375|54233804|FG000|Up to Week 16|Death|1|||
27780075|NCT01649375|54233805|FG001|Up to Week 16|Death|0|||
27780076|NCT01649375|54233806|FG002|Up to Week 16|Death|0|||
27780077|NCT01649375|54233807|FG003|Up to Week 16|Death|0|||
27780078|NCT01649375|54233808|FG004|Up to Week 16|Death|0|||
27780079|NCT01649375|54233804|FG000|Week 16 up to Week 260|Lack of Efficacy|7|||
27780080|NCT01649375|54233805|FG001|Week 16 up to Week 260|Lack of Efficacy|4|||
27780081|NCT01649375|54233806|FG002|Week 16 up to Week 260|Lack of Efficacy|0|||
27780082|NCT01649375|54233807|FG003|Week 16 up to Week 260|Lack of Efficacy|4|||
27780083|NCT01649375|54233808|FG004|Week 16 up to Week 260|Lack of Efficacy|2|||
27780084|NCT01649375|54233804|FG000|Week 16 up to Week 260|Non-compliance|0|||
27780085|NCT01649375|54233805|FG001|Week 16 up to Week 260|Non-compliance|1|||
27780086|NCT01649375|54233806|FG002|Week 16 up to Week 260|Non-compliance|0|||
27780087|NCT01649375|54233807|FG003|Week 16 up to Week 260|Non-compliance|1|||
27780088|NCT01649375|54233808|FG004|Week 16 up to Week 260|Non-compliance|0|||
27780089|NCT01649375|54233804|FG000|Week 16 up to Week 260|Physician Decision|0|||
27780090|NCT01649375|54233805|FG001|Week 16 up to Week 260|Physician Decision|2|||
27780091|NCT01649375|54233806|FG002|Week 16 up to Week 260|Physician Decision|0|||
27780092|NCT01649375|54233807|FG003|Week 16 up to Week 260|Physician Decision|0|||
27780093|NCT01649375|54233808|FG004|Week 16 up to Week 260|Physician Decision|0|||
27780094|NCT01649375|54233804|FG000|Week 16 up to Week 260|Technical issues|0|||
27780095|NCT01649375|54233805|FG001|Week 16 up to Week 260|Technical issues|1|||
27780096|NCT01649375|54233806|FG002|Week 16 up to Week 260|Technical issues|0|||
27780097|NCT01649375|54233807|FG003|Week 16 up to Week 260|Technical issues|1|||
27780098|NCT01649375|54233808|FG004|Week 16 up to Week 260|Technical issues|0|||
27780099|NCT01649375|54233804|FG000|Week 16 up to Week 260|Withdrawal by Subject|7|||
27780100|NCT01649375|54233805|FG001|Week 16 up to Week 260|Withdrawal by Subject|2|||
27780101|NCT01649375|54233806|FG002|Week 16 up to Week 260|Withdrawal by Subject|0|||
27780102|NCT01649375|54233807|FG003|Week 16 up to Week 260|Withdrawal by Subject|3|||
27780103|NCT01649375|54233808|FG004|Week 16 up to Week 260|Withdrawal by Subject|1|||
27780104|NCT01649375|54233804|FG000|Week 16 up to Week 260|Death|1|||
27780105|NCT01649375|54233805|FG001|Week 16 up to Week 260|Death|1|||
27780106|NCT01649375|54233806|FG002|Week 16 up to Week 260|Death|0|||
27780107|NCT01649375|54233807|FG003|Week 16 up to Week 260|Death|0|||
27780108|NCT01649375|54233808|FG004|Week 16 up to Week 260|Death|0|||
27780109|NCT01649375|54233804|FG000|Week 16 up to Week 260|Adverse Event|5|||
27780110|NCT01649375|54233805|FG001|Week 16 up to Week 260|Adverse Event|2|||
27780111|NCT01649375|54233806|FG002|Week 16 up to Week 260|Adverse Event|0|||
27780112|NCT01649375|54233807|FG003|Week 16 up to Week 260|Adverse Event|3|||
27780113|NCT01649375|54233808|FG004|Week 16 up to Week 260|Adverse Event|2|||
27780114|NCT02336555|54233818|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
27780115|NCT02336555|54233819|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
27780116|NCT02336555|54233818|FG000|Treatment Period 1 (28 Days)|Physician Decision|2|||
27780117|NCT02336555|54233819|FG001|Treatment Period 1 (28 Days)|Physician Decision|0|||
27780118|NCT02336555|54233818|FG000|Treatment Period 2 (28 Days)|Adverse Event|0|||
27780119|NCT02336555|54233819|FG001|Treatment Period 2 (28 Days)|Adverse Event|1|||
27780120|NCT01648283|54233825|FG000|Overall Study|Withdrawal by Subject|14|||
27780121|NCT01649297|54233836|FG000|Overall Study|Adverse Event|5|||
27780122|NCT01649297|54233837|FG001|Overall Study|Adverse Event|5|||
27780123|NCT01649297|54233838|FG002|Overall Study|Adverse Event|4|||
27780124|NCT01649297|54233839|FG003|Overall Study|Adverse Event|13|||
27926944|NCT01013740|54583422|FG001|Overall Study|Missing|1|||
27780125|NCT01649297|54233840|FG004|Overall Study|Adverse Event|1|||
27780126|NCT01649297|54233836|FG000|Overall Study|Lack of Efficacy|0|||
27780127|NCT01649297|54233837|FG001|Overall Study|Lack of Efficacy|0|||
27780128|NCT01649297|54233838|FG002|Overall Study|Lack of Efficacy|0|||
27780129|NCT01649297|54233839|FG003|Overall Study|Lack of Efficacy|0|||
27780130|NCT01649297|54233840|FG004|Overall Study|Lack of Efficacy|1|||
27780131|NCT01649297|54233836|FG000|Overall Study|Non compliant with Protocol|1|||
27780132|NCT01649297|54233837|FG001|Overall Study|Non compliant with Protocol|0|||
27780133|NCT01649297|54233838|FG002|Overall Study|Non compliant with Protocol|3|||
27780134|NCT01649297|54233839|FG003|Overall Study|Non compliant with Protocol|2|||
27780135|NCT01649297|54233840|FG004|Overall Study|Non compliant with Protocol|1|||
27780136|NCT01649297|54233836|FG000|Overall Study|Lost to Follow-up|1|||
27780137|NCT01649297|54233837|FG001|Overall Study|Lost to Follow-up|1|||
27780138|NCT01649297|54233838|FG002|Overall Study|Lost to Follow-up|4|||
27780139|NCT01649297|54233839|FG003|Overall Study|Lost to Follow-up|3|||
27780140|NCT01649297|54233840|FG004|Overall Study|Lost to Follow-up|0|||
27780141|NCT01649297|54233836|FG000|Overall Study|Patient withdrawal (not due to AE)|3|||
27780142|NCT01649297|54233837|FG001|Overall Study|Patient withdrawal (not due to AE)|6|||
27780143|NCT01649297|54233838|FG002|Overall Study|Patient withdrawal (not due to AE)|4|||
27780144|NCT01649297|54233839|FG003|Overall Study|Patient withdrawal (not due to AE)|1|||
27780145|NCT01649297|54233840|FG004|Overall Study|Patient withdrawal (not due to AE)|1|||
27780146|NCT01649297|54233836|FG000|Overall Study|For other reason|4|||
27780147|NCT01649297|54233837|FG001|Overall Study|For other reason|1|||
27780148|NCT01649297|54233838|FG002|Overall Study|For other reason|2|||
27780149|NCT01649297|54233839|FG003|Overall Study|For other reason|0|||
27780150|NCT01649297|54233840|FG004|Overall Study|For other reason|0|||
27780151|NCT01648205|54233852|FG000|Placebo|Pregnancy|1|||
27780152|NCT01648205|54233852|FG000|Placebo|Withdrawal by Subject|1|||
27780153|NCT01648205|54233852|FG000|Placebo|Protocol Violation|2|||
27780154|NCT01648205|54233852|FG000|Ranolazine|Death|1|||
27780155|NCT01648205|54233852|FG000|Ranolazine|Withdrawal by Subject|1|||
27780156|NCT01648205|54233852|FG000|Ranolazine|Protocol Violation|3|||
27780157|NCT02391545|54233862|FG000|Overall Study|Death|0|||
27780158|NCT02391545|54233863|FG001|Overall Study|Death|2|||
27780159|NCT02391545|54233862|FG000|Overall Study|Lost to Follow-up|0|||
27780160|NCT02391545|54233863|FG001|Overall Study|Lost to Follow-up|1|||
27780161|NCT02391545|54233862|FG000|Overall Study|Termination of study by sponsor|20|||
27780162|NCT02391545|54233863|FG001|Overall Study|Termination of study by sponsor|20|||
27780163|NCT02391545|54233862|FG000|Overall Study|Withdrawal by Subject|0|||
27780164|NCT02391545|54233863|FG001|Overall Study|Withdrawal by Subject|1|||
27780165|NCT02391545|54233862|FG000|Overall Study|Other Reasons|6|||
27780166|NCT02391545|54233863|FG001|Overall Study|Other Reasons|4|||
27780167|NCT02362451|54233872|FG000|Overall Study|Withdrawal by Subject|0|||
27780168|NCT02362451|54233873|FG001|Overall Study|Withdrawal by Subject|1|||
27780169|NCT02362451|54233872|FG000|Overall Study|Lack of Efficacy|2|||
27780170|NCT02362451|54233873|FG001|Overall Study|Lack of Efficacy|0|||
27780171|NCT02362451|54233872|FG000|Overall Study|Progression|1|||
27780172|NCT02362451|54233873|FG001|Overall Study|Progression|0|||
27780173|NCT02362451|54233872|FG000|Overall Study|Participant chose other therapy.|1|||
27780174|NCT02362451|54233873|FG001|Overall Study|Participant chose other therapy.|0|||
27780175|NCT01734382|54233882|FG000|Part 1|Adverse Event|2|||
27780176|NCT01734382|54233883|FG001|Part 1|Adverse Event|0|||
27780177|NCT01734382|54233884|FG002|Part 1|Adverse Event|0|||
27780178|NCT01734382|54233882|FG000|Part 2|Adverse Event|0|||
27780179|NCT01734382|54233883|FG001|Part 2|Adverse Event|0|||
27780180|NCT01734382|54233884|FG002|Part 2|Adverse Event|1|||
27780181|NCT01734382|54233882|FG000|Part 2|Lack of Efficacy|0|||
27780182|NCT01734382|54233883|FG001|Part 2|Lack of Efficacy|1|||
27780183|NCT01734382|54233884|FG002|Part 2|Lack of Efficacy|1|||
27780184|NCT01734382|54233882|FG000|Part 2|Other|0|||
27780185|NCT01734382|54233883|FG001|Part 2|Other|0|||
27780186|NCT01734382|54233884|FG002|Part 2|Other|1|||
27780187|NCT01734382|54233882|FG000|Part 2|Physician Decision|0|||
27780188|NCT01734382|54233883|FG001|Part 2|Physician Decision|0|||
27780189|NCT01734382|54233884|FG002|Part 2|Physician Decision|3|||
27780190|NCT01734382|54233882|FG000|Part 2|Protocol Violation|0|||
27780191|NCT01734382|54233883|FG001|Part 2|Protocol Violation|1|||
27780192|NCT01734382|54233884|FG002|Part 2|Protocol Violation|0|||
27780193|NCT01734382|54233882|FG000|Part 2|Withdrawal by Subject|0|||
27780194|NCT01734382|54233883|FG001|Part 2|Withdrawal by Subject|0|||
27780195|NCT01734382|54233884|FG002|Part 2|Withdrawal by Subject|1|||
27780196|NCT02391311|54233898|FG000|Overall Study|Lost to Follow-up|2|||
27780197|NCT02391311|54233899|FG001|Overall Study|Lost to Follow-up|1|||
27780198|NCT02391311|54233898|FG000|Overall Study|deemed ineligible after baseline|1|||
27780199|NCT02391311|54233899|FG001|Overall Study|deemed ineligible after baseline|1|||
27780200|NCT01765426|54233909|FG000|Overall Study|Lost to Follow-up|0|||
27780201|NCT01765426|54233910|FG001|Overall Study|Lost to Follow-up|1|||
27840666|NCT01455415|54328577|FG000|Washout|AE Not Related to Study Drug|2|||
27840667|NCT01455415|54328578|FG001|Washout|AE Not Related to Study Drug|3|||
27780202|NCT01765426|54233911|FG002|Overall Study|Lost to Follow-up|0|||
27780203|NCT01765426|54233912|FG003|Overall Study|Lost to Follow-up|0|||
27780204|NCT01765270|54233924|FG000|Overall Study|Physician Decision|1|||
27780205|NCT01765270|54233925|FG001|Overall Study|Physician Decision|0|||
27840668|NCT01455415|54328577|FG000|Washout|Unspecified Reason|1|||
27840669|NCT01455415|54328578|FG001|Washout|Unspecified Reason|2|||
27780206|NCT01765270|54233924|FG000|Overall Study|Withdrawal by Subject|0|||
27780207|NCT01765270|54233925|FG001|Overall Study|Withdrawal by Subject|1|||
27780208|NCT01733758|54233936|FG000|Overall Study|Adverse Event|5|||
27780209|NCT01733758|54233937|FG001|Overall Study|Adverse Event|7|||
27780210|NCT01733758|54233938|FG002|Overall Study|Adverse Event|8|||
27780211|NCT01733758|54233939|FG003|Overall Study|Adverse Event|1|||
27780212|NCT01733758|54233936|FG000|Overall Study|Withdrawal by Subject|1|||
27780213|NCT01733758|54233937|FG001|Overall Study|Withdrawal by Subject|1|||
27780214|NCT01733758|54233938|FG002|Overall Study|Withdrawal by Subject|5|||
27780215|NCT01733758|54233939|FG003|Overall Study|Withdrawal by Subject|3|||
27780216|NCT01733758|54233936|FG000|Overall Study|Persistent Hyperglycemia|3|||
27780217|NCT01733758|54233937|FG001|Overall Study|Persistent Hyperglycemia|2|||
27780218|NCT01733758|54233938|FG002|Overall Study|Persistent Hyperglycemia|0|||
27780219|NCT01733758|54233939|FG003|Overall Study|Persistent Hyperglycemia|0|||
27780220|NCT01733758|54233936|FG000|Overall Study|Protocol Violation|0|||
27780221|NCT01733758|54233937|FG001|Overall Study|Protocol Violation|1|||
27780222|NCT01733758|54233938|FG002|Overall Study|Protocol Violation|2|||
27780223|NCT01733758|54233939|FG003|Overall Study|Protocol Violation|2|||
27780224|NCT01733758|54233936|FG000|Overall Study|Non-compliance|1|||
27780225|NCT01733758|54233937|FG001|Overall Study|Non-compliance|0|||
27780226|NCT01733758|54233938|FG002|Overall Study|Non-compliance|0|||
27780227|NCT01733758|54233939|FG003|Overall Study|Non-compliance|0|||
27780228|NCT01733758|54233936|FG000|Overall Study|Intro of New Anti-Diabetic Medication|4|||
27780229|NCT01733758|54233937|FG001|Overall Study|Intro of New Anti-Diabetic Medication|0|||
27780230|NCT01733758|54233938|FG002|Overall Study|Intro of New Anti-Diabetic Medication|0|||
27780231|NCT01733758|54233939|FG003|Overall Study|Intro of New Anti-Diabetic Medication|1|||
27780232|NCT01733758|54233936|FG000|Overall Study|Inv Decision, HbA1c not controlled|1|||
27780233|NCT01733758|54233937|FG001|Overall Study|Inv Decision, HbA1c not controlled|1|||
27780234|NCT01733758|54233938|FG002|Overall Study|Inv Decision, HbA1c not controlled|0|||
27780235|NCT01733758|54233939|FG003|Overall Study|Inv Decision, HbA1c not controlled|1|||
27780236|NCT01607554|54233951|FG000|Overall Study|Disease progression|2|||
27780237|NCT01607476|54233958|FG000|Overall Study|Withdrawal by Subject|1|||
27780238|NCT01607476|54233959|FG001|Overall Study|Withdrawal by Subject|0|||
27780239|NCT01607476|54233960|FG002|Overall Study|Withdrawal by Subject|1|||
27780240|NCT01607476|54233958|FG000|Overall Study|Lost to Follow-up|0|||
27780241|NCT01607476|54233959|FG001|Overall Study|Lost to Follow-up|0|||
27780242|NCT01607476|54233960|FG002|Overall Study|Lost to Follow-up|2|||
27780243|NCT01765192|54233970|FG000|Treatment Period 1|Adverse Event|0|||
27780244|NCT01765192|54233971|FG001|Treatment Period 1|Adverse Event|1|||
27780245|NCT01765192|54233970|FG000|Washout Period|Voluntary Withdrawal|1|||
27780246|NCT01765192|54233971|FG001|Washout Period|Voluntary Withdrawal|1|||
27780247|NCT01765192|54233970|FG000|Washout Period|Reason not specified|1|||
27780248|NCT01765192|54233971|FG001|Washout Period|Reason not specified|0|||
27780249|NCT01765192|54233970|FG000|Treatment Period 2|Reason not specified|0|||
27780250|NCT01765192|54233971|FG001|Treatment Period 2|Reason not specified|2|||
27780251|NCT01765192|54233970|FG000|End of Treatment Period 2 to Final Visit|Adverse Event|0|||
27780252|NCT01765192|54233971|FG001|End of Treatment Period 2 to Final Visit|Adverse Event|1|||
27780253|NCT01733680|54233979|FG000|Overall Study|Withdrawal by Subject|0|||
27780254|NCT01733680|54233980|FG001|Overall Study|Withdrawal by Subject|1|||
27780255|NCT02348216|54233997|FG000|Overall Study|Death|4|||
27780256|NCT02348216|54233998|FG001|Overall Study|Death|27|||
27780257|NCT02348216|54233999|FG002|Overall Study|Death|3|||
27780258|NCT02348216|54234000|FG003|Overall Study|Death|18|||
27780259|NCT02348216|54234001|FG004|Overall Study|Death|9|||
27780260|NCT02348216|54234002|FG005|Overall Study|Death|23|||
27780261|NCT02348216|54234003|FG006|Overall Study|Death|6|||
27780262|NCT02348216|54233997|FG000|Overall Study|Full consent withdrawal|0|||
27780263|NCT02348216|54233998|FG001|Overall Study|Full consent withdrawal|0|||
27780264|NCT02348216|54233999|FG002|Overall Study|Full consent withdrawal|0|||
27780265|NCT02348216|54234000|FG003|Overall Study|Full consent withdrawal|1|||
27780266|NCT02348216|54234001|FG004|Overall Study|Full consent withdrawal|0|||
27780267|NCT02348216|54234002|FG005|Overall Study|Full consent withdrawal|0|||
27780268|NCT02348216|54234003|FG006|Overall Study|Full consent withdrawal|1|||
27780269|NCT02348216|54233997|FG000|Overall Study|Lost to Follow-up|0|||
27780270|NCT02348216|54233998|FG001|Overall Study|Lost to Follow-up|0|||
27780271|NCT02348216|54233999|FG002|Overall Study|Lost to Follow-up|0|||
27780272|NCT02348216|54234000|FG003|Overall Study|Lost to Follow-up|0|||
27780273|NCT02348216|54234001|FG004|Overall Study|Lost to Follow-up|0|||
27780274|NCT02348216|54234002|FG005|Overall Study|Lost to Follow-up|0|||
27780275|NCT02348216|54234003|FG006|Overall Study|Lost to Follow-up|1|||
27780276|NCT02348216|54233997|FG000|Overall Study|Still on study|3|||
27780277|NCT02348216|54233998|FG001|Overall Study|Still on study|50|||
27840670|NCT01455415|54328577|FG000|Washout|Protocol Violation|0|||
27840671|NCT01455415|54328578|FG001|Washout|Protocol Violation|1|||
27780278|NCT02348216|54233999|FG002|Overall Study|Still on study|21|||
27780279|NCT02348216|54234000|FG003|Overall Study|Still on study|19|||
27780280|NCT02348216|54234001|FG004|Overall Study|Still on study|32|||
27780281|NCT02348216|54234002|FG005|Overall Study|Still on study|27|||
27780282|NCT02348216|54234003|FG006|Overall Study|Still on study|32|||
27780283|NCT02348216|54233997|FG000|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|1|||
27780284|NCT02348216|54233998|FG001|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
27780285|NCT02348216|54233999|FG002|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|6|||
27780286|NCT02348216|54234000|FG003|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
27780287|NCT02348216|54234001|FG004|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|5|||
27780288|NCT02348216|54234002|FG005|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|8|||
27780289|NCT02348216|54234003|FG006|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|2|||
27780290|NCT02336165|54234046|FG000|Overall Study|Death|3|||
27780291|NCT02336165|54234047|FG001|Overall Study|Death|0|||
27780292|NCT02336165|54234048|FG002|Overall Study|Death|0|||
27780293|NCT02336165|54234049|FG003|Overall Study|Death|0|||
27780294|NCT02336165|54234050|FG004|Overall Study|Death|1|||
27780295|NCT02336165|54234046|FG000|Overall Study|Physician Decision|2|||
27780296|NCT02336165|54234047|FG001|Overall Study|Physician Decision|2|||
27780297|NCT02336165|54234048|FG002|Overall Study|Physician Decision|1|||
27780298|NCT02336165|54234049|FG003|Overall Study|Physician Decision|1|||
27780299|NCT02336165|54234050|FG004|Overall Study|Physician Decision|0|||
27780300|NCT02336165|54234046|FG000|Overall Study|Withdrawal by Subject|0|||
27780301|NCT02336165|54234047|FG001|Overall Study|Withdrawal by Subject|0|||
27780302|NCT02336165|54234048|FG002|Overall Study|Withdrawal by Subject|1|||
27780303|NCT02336165|54234049|FG003|Overall Study|Withdrawal by Subject|0|||
27780304|NCT02336165|54234050|FG004|Overall Study|Withdrawal by Subject|1|||
27780305|NCT02336165|54234046|FG000|Overall Study|Adverse Event|4|||
27780306|NCT02336165|54234047|FG001|Overall Study|Adverse Event|1|||
27780307|NCT02336165|54234048|FG002|Overall Study|Adverse Event|2|||
27780308|NCT02336165|54234049|FG003|Overall Study|Adverse Event|4|||
27780309|NCT02336165|54234050|FG004|Overall Study|Adverse Event|1|||
27780310|NCT02336165|54234046|FG000|Overall Study|Progressive disease|23|||
27780311|NCT02336165|54234047|FG001|Overall Study|Progressive disease|22|||
27780312|NCT02336165|54234048|FG002|Overall Study|Progressive disease|27|||
27780313|NCT02336165|54234049|FG003|Overall Study|Progressive disease|24|||
27780314|NCT02336165|54234050|FG004|Overall Study|Progressive disease|19|||
27780315|NCT02336165|54234046|FG000|Overall Study|Non-compliance|1|||
27780316|NCT02336165|54234047|FG001|Overall Study|Non-compliance|0|||
27780317|NCT02336165|54234048|FG002|Overall Study|Non-compliance|0|||
27780318|NCT02336165|54234049|FG003|Overall Study|Non-compliance|1|||
27780319|NCT02336165|54234050|FG004|Overall Study|Non-compliance|0|||
27780320|NCT02336165|54234046|FG000|Overall Study|Other|1|||
27780321|NCT02336165|54234047|FG001|Overall Study|Other|0|||
27780322|NCT02336165|54234048|FG002|Overall Study|Other|0|||
27780323|NCT02336165|54234049|FG003|Overall Study|Other|1|||
27780324|NCT02336165|54234050|FG004|Overall Study|Other|0|||
27780325|NCT02360111|54234066|FG000|Overall Study|Death|2|||
27780326|NCT02334683|54234072|FG000|First 12 Week Period|Lost to Follow-up|1|||
27780327|NCT02334683|54234073|FG001|First 12 Week Period|Lost to Follow-up|0|||
27780328|NCT02334683|54234072|FG000|Second 12 Week Period|Adverse Event|0|||
27780329|NCT02334683|54234073|FG001|Second 12 Week Period|Adverse Event|1|||
27780330|NCT02319044|54234082|FG000|Overall Study|Death, PI/sponsor decision, med history|0|||
27780331|NCT02319044|54234083|FG001|Overall Study|Death, PI/sponsor decision, med history|1|||
27780332|NCT02319044|54234084|FG002|Overall Study|Death, PI/sponsor decision, med history|4|||
27780333|NCT02319044|54234082|FG000|Overall Study|Withdrawal by Subject|3|||
27780334|NCT02319044|54234083|FG001|Overall Study|Withdrawal by Subject|3|||
27780335|NCT02319044|54234084|FG002|Overall Study|Withdrawal by Subject|6|||
27780336|NCT02319044|54234082|FG000|Overall Study|Condition under investigation worsened|100|||
27780337|NCT02319044|54234083|FG001|Overall Study|Condition under investigation worsened|50|||
27780338|NCT02319044|54234084|FG002|Overall Study|Condition under investigation worsened|46|||
27780339|NCT02319044|54234082|FG000|Overall Study|Adverse Event|17|||
27780340|NCT02319044|54234083|FG001|Overall Study|Adverse Event|2|||
27780341|NCT02319044|54234084|FG002|Overall Study|Adverse Event|8|||
27780342|NCT02319044|54234082|FG000|Overall Study|Study specific discontinuation criteria|2|||
27780343|NCT02319044|54234083|FG001|Overall Study|Study specific discontinuation criteria|2|||
27780344|NCT02319044|54234084|FG002|Overall Study|Study specific discontinuation criteria|1|||
27780345|NCT02319044|54234082|FG000|Overall Study|Not treated|0|||
27780346|NCT02319044|54234083|FG001|Overall Study|Not treated|2|||
27780347|NCT02319044|54234084|FG002|Overall Study|Not treated|2|||
27840672|NCT01455415|54328577|FG000|Period 2|AE Related to Study Drug|1|||
27840673|NCT01455415|54328578|FG001|Period 2|AE Related to Study Drug|2|||
27840674|NCT01455415|54328577|FG000|Period 2|Lost to Follow-up|2|||
27840675|NCT01455415|54328578|FG001|Period 2|Lost to Follow-up|1|||
27780348|NCT01649765|54234095|FG000|Overall Study|Adverse Event|5|||
27780349|NCT01649765|54234096|FG001|Overall Study|Adverse Event|3|||
27780350|NCT01649765|54234095|FG000|Overall Study|Lack of Efficacy|1|||
27780351|NCT01649765|54234096|FG001|Overall Study|Lack of Efficacy|1|||
27780352|NCT01649765|54234095|FG000|Overall Study|Physician Decision|0|||
27780353|NCT01649765|54234096|FG001|Overall Study|Physician Decision|3|||
27780354|NCT01649765|54234095|FG000|Overall Study|Protocol Violation|1|||
27780355|NCT01649765|54234096|FG001|Overall Study|Protocol Violation|0|||
27780356|NCT01649765|54234095|FG000|Overall Study|Withdrawal by Subject|2|||
27840676|NCT01455415|54328577|FG000|Period 2|AE Not Related to Study Drug|2|||
27780357|NCT01649765|54234096|FG001|Overall Study|Withdrawal by Subject|1|||
27780358|NCT02317562|54234103|FG000|Overall Study|Physician Decision|1|||
27780359|NCT02317562|54234103|FG000|Overall Study|early termination of the study|8|||
27780360|NCT02317562|54234103|FG000|Overall Study|Lack of Efficacy|4|||
27780361|NCT02317562|54234103|FG000|Overall Study|Withdrawal by Subject|1|||
27780362|NCT02317016|54234107|FG000|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1|||
27780363|NCT02317016|54234107|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1|||
27780364|NCT02317016|54234107|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1|||
27780365|NCT02317016|54234107|FG000|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23|||
27780366|NCT02317016|54234107|FG000|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1|||
27780367|NCT02317016|54234107|FG000|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2|||
27780368|NCT02317016|54234107|FG000|Part B: Day 35 to End Part B (AZD9291)|Death|5|||
27780369|NCT02311478|54234115|FG000|Overall Study|Withdrawal by Subject|1|||
27780370|NCT02311478|54234115|FG000|Overall Study|Lost to Follow-up|5|||
27780371|NCT02311478|54234115|FG000|Overall Study|Failed IUD Insertion|1|||
27780372|NCT02388932|54234120|FG000|Overall Study|Death|1|||
27780373|NCT02388776|54234125|FG000|Overall Study|Death|1|||
27780374|NCT02388776|54234125|FG000|Overall Study|Lost to Follow-up|1|||
27780375|NCT02316548|54234132|FG000|Overall Study|Protocol Violation|0|||
27780376|NCT02316548|54234133|FG001|Overall Study|Protocol Violation|1|||
27780377|NCT02281760|54234139|FG000|Overall Study|Withdrawal by Subject|1|||
27780378|NCT02390531|54234151|FG000|Overall Study|Death|0|||
27780379|NCT02390531|54234152|FG001|Overall Study|Death|2|||
27780380|NCT02390531|54234153|FG002|Overall Study|Death|0|||
27780381|NCT02390531|54234154|FG003|Overall Study|Death|1|||
27780382|NCT02390531|54234155|FG004|Overall Study|Death|0|||
27780383|NCT02390531|54234156|FG005|Overall Study|Death|0|||
27780384|NCT02390531|54234157|FG006|Overall Study|Death|0|||
27780385|NCT02390531|54234158|FG007|Overall Study|Death|1|||
27780386|NCT02390531|54234151|FG000|Overall Study|Protocol Violation|0|||
27780387|NCT02390531|54234152|FG001|Overall Study|Protocol Violation|0|||
27780388|NCT02390531|54234153|FG002|Overall Study|Protocol Violation|0|||
27780389|NCT02390531|54234154|FG003|Overall Study|Protocol Violation|0|||
27780390|NCT02390531|54234155|FG004|Overall Study|Protocol Violation|1|||
27780391|NCT02390531|54234156|FG005|Overall Study|Protocol Violation|0|||
27780392|NCT02390531|54234157|FG006|Overall Study|Protocol Violation|2|||
27780393|NCT02390531|54234158|FG007|Overall Study|Protocol Violation|0|||
27780394|NCT02390219|54234194|FG000|Overall Study|Death|1|||
27780395|NCT02390219|54234194|FG000|Overall Study|Physician Decision|1|||
27780396|NCT02390219|54234194|FG000|Overall Study|Adverse Event|6|||
27780397|NCT02390219|54234194|FG000|Overall Study|Withdrawal by Subject|1|||
27780398|NCT02390219|54234194|FG000|Overall Study|Lost to Follow-up|2|||
27780399|NCT02390219|54234194|FG000|Overall Study|Other|2|||
27780400|NCT02334215|54234201|FG000|Overall Study|Death|1|||
27780401|NCT02334215|54234202|FG001|Overall Study|Death|1|||
27780402|NCT02334215|54234203|FG002|Overall Study|Death|0|||
27780403|NCT02334215|54234201|FG000|Overall Study|Lost to Follow-up|1|||
27780404|NCT02334215|54234202|FG001|Overall Study|Lost to Follow-up|0|||
27780405|NCT02334215|54234203|FG002|Overall Study|Lost to Follow-up|4|||
27780406|NCT02334215|54234201|FG000|Overall Study|Withdrawal by Subject|2|||
27780407|NCT02334215|54234202|FG001|Overall Study|Withdrawal by Subject|2|||
27780408|NCT02334215|54234203|FG002|Overall Study|Withdrawal by Subject|1|||
27780409|NCT02334215|54234201|FG000|Overall Study|Not released from incarceration on time|3|||
27780410|NCT02334215|54234202|FG001|Overall Study|Not released from incarceration on time|3|||
27780411|NCT02334215|54234203|FG002|Overall Study|Not released from incarceration on time|3|||
27780412|NCT02334215|54234201|FG000|Overall Study|Incarcerated|0|||
27780413|NCT02334215|54234202|FG001|Overall Study|Incarcerated|0|||
27780414|NCT02334215|54234203|FG002|Overall Study|Incarcerated|7|||
27780415|NCT02359877|54234215|FG000|Overall Study|Withdrawal by Subject|1|||
27780416|NCT02359877|54234216|FG001|Overall Study|Withdrawal by Subject|0|||
27780417|NCT02359877|54234217|FG002|Overall Study|Withdrawal by Subject|0|||
27780418|NCT02359877|54234218|FG003|Overall Study|Withdrawal by Subject|2|||
27780419|NCT02359877|54234215|FG000|Overall Study|Adverse Event|0|||
27780420|NCT02359877|54234216|FG001|Overall Study|Adverse Event|0|||
27780421|NCT02359877|54234217|FG002|Overall Study|Adverse Event|0|||
27780422|NCT02359877|54234218|FG003|Overall Study|Adverse Event|1|||
27780423|NCT02389829|54234248|FG000|Overall Study|Lost to Follow-up|0|||
27780424|NCT02389829|54234249|FG001|Overall Study|Lost to Follow-up|1|||
27780425|NCT02358863|54234255|FG000|Overall Study|Physician Decision|3|||
27780426|NCT02358473|54234259|FG000|Overall Study|Disease Progession|6|||
27780427|NCT02358473|54234259|FG000|Overall Study|Adverse Event|3|||
27780428|NCT02358473|54234259|FG000|Overall Study|Withdrawal by Subject|2|||
27840677|NCT01455415|54328578|FG001|Period 2|AE Not Related to Study Drug|1|||
27780429|NCT02358473|54234259|FG000|Overall Study|Physician Decision|2|||
27780430|NCT02357459|54234266|FG000|Overall Study|Adverse Event|0|||
27780431|NCT02357459|54234267|FG001|Overall Study|Adverse Event|1|||
27780432|NCT02357459|54234268|FG002|Overall Study|Adverse Event|1|||
27780433|NCT02357459|54234266|FG000|Overall Study|Withdrawal by Subject|5|||
27780434|NCT02357459|54234267|FG001|Overall Study|Withdrawal by Subject|3|||
27780435|NCT02357459|54234268|FG002|Overall Study|Withdrawal by Subject|3|||
27780436|NCT02357459|54234266|FG000|Overall Study|Physician Decision|0|||
27780437|NCT02357459|54234267|FG001|Overall Study|Physician Decision|2|||
27780438|NCT02357459|54234268|FG002|Overall Study|Physician Decision|0|||
27780439|NCT02357459|54234266|FG000|Overall Study|Protocol Violation|1|||
27780440|NCT02357459|54234267|FG001|Overall Study|Protocol Violation|1|||
27780441|NCT02357459|54234268|FG002|Overall Study|Protocol Violation|0|||
27780442|NCT02357459|54234266|FG000|Overall Study|Lost to Follow-up|1|||
27780443|NCT02357459|54234267|FG001|Overall Study|Lost to Follow-up|3|||
27780444|NCT02357459|54234268|FG002|Overall Study|Lost to Follow-up|0|||
27780445|NCT02357459|54234266|FG000|Overall Study|Lack of Efficacy|7|||
27780446|NCT02357459|54234267|FG001|Overall Study|Lack of Efficacy|4|||
27780447|NCT02357459|54234268|FG002|Overall Study|Lack of Efficacy|4|||
27780448|NCT02357459|54234266|FG000|Overall Study|Patient Relocated|2|||
27780449|NCT02357459|54234267|FG001|Overall Study|Patient Relocated|0|||
27780450|NCT02357459|54234268|FG002|Overall Study|Patient Relocated|0|||
27780451|NCT02357459|54234266|FG000|Overall Study|Instruction from PCP|1|||
27780452|NCT02357459|54234267|FG001|Overall Study|Instruction from PCP|0|||
27780453|NCT02357459|54234268|FG002|Overall Study|Instruction from PCP|0|||
27780454|NCT02357459|54234266|FG000|Overall Study|Incarceration|0|||
27780455|NCT02357459|54234267|FG001|Overall Study|Incarceration|0|||
27780456|NCT02357459|54234268|FG002|Overall Study|Incarceration|1|||
27780457|NCT02357459|54234266|FG000|Overall Study|Pre-planned Knee surgery|0|||
27780458|NCT02357459|54234267|FG001|Overall Study|Pre-planned Knee surgery|0|||
27780459|NCT02357459|54234268|FG002|Overall Study|Pre-planned Knee surgery|2|||
27780460|NCT02357459|54234266|FG000|Overall Study|Job Commitments|0|||
27780461|NCT02357459|54234267|FG001|Overall Study|Job Commitments|0|||
27780462|NCT02357459|54234268|FG002|Overall Study|Job Commitments|1|||
27780463|NCT02332889|54234279|FG000|Overall Study|Physician Decision|1|||
27780464|NCT02357147|54234285|FG000|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
27780465|NCT02357147|54234286|FG001|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
27780466|NCT02357147|54234285|FG000|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0|||
27780467|NCT02357147|54234286|FG001|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1|||
27780468|NCT02357147|54234285|FG000|Combination Treatment Phase|Investigator Discretion|1|||
27780469|NCT02357147|54234286|FG001|Combination Treatment Phase|Investigator Discretion|1|||
27780470|NCT02357147|54234285|FG000|Combination Treatment Phase|Withdrawal by Subject|4|||
27780471|NCT02357147|54234286|FG001|Combination Treatment Phase|Withdrawal by Subject|2|||
27780472|NCT02357147|54234285|FG000|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4|||
27780473|NCT02357147|54234286|FG001|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1|||
27780474|NCT02357147|54234285|FG000|Combination Treatment Phase|Adverse Event|12|||
27780475|NCT02357147|54234286|FG001|Combination Treatment Phase|Adverse Event|4|||
27780476|NCT02357147|54234285|FG000|Combination Treatment Phase|Death|1|||
27780477|NCT02357147|54234286|FG001|Combination Treatment Phase|Death|1|||
27780478|NCT02357147|54234285|FG000|Combination Treatment Phase|Sponsor Decision|0|||
27780479|NCT02357147|54234286|FG001|Combination Treatment Phase|Sponsor Decision|12|||
27780480|NCT02357147|54234285|FG000|Combination Treatment Phase|Other|1|||
27780481|NCT02357147|54234286|FG001|Combination Treatment Phase|Other|0|||
27780482|NCT02357147|54234285|FG000|Combination Treatment Phase|Not treated|0|||
27780483|NCT02357147|54234286|FG001|Combination Treatment Phase|Not treated|2|||
27780484|NCT02357147|54234285|FG000|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15|||
27780485|NCT02357147|54234286|FG001|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10|||
27780486|NCT02357147|54234285|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
27780487|NCT02357147|54234286|FG001|Maintenance Treatment Phase|Withdrawal by Subject|1|||
27780488|NCT02357147|54234285|FG000|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10|||
27780489|NCT02357147|54234286|FG001|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0|||
27780490|NCT02357147|54234285|FG000|Maintenance Treatment Phase|Adverse Event|0|||
27780491|NCT02357147|54234286|FG001|Maintenance Treatment Phase|Adverse Event|3|||
27780492|NCT02357147|54234285|FG000|Maintenance Treatment Phase|Sponsor Decision|0|||
27780493|NCT02357147|54234286|FG001|Maintenance Treatment Phase|Sponsor Decision|15|||
27780494|NCT02357147|54234285|FG000|Maintenance Treatment Phase|Not Treated|1|||
27780495|NCT02357147|54234286|FG001|Maintenance Treatment Phase|Not Treated|0|||
27780496|NCT02356211|54234298|FG000|Overall Study|Withdrawal by Subject|2|||
27780497|NCT02356211|54234299|FG001|Overall Study|Withdrawal by Subject|2|||
27780498|NCT02356211|54234298|FG000|Overall Study|ineligible|1|||
27780499|NCT02356211|54234299|FG001|Overall Study|ineligible|8|||
27780500|NCT02332655|54234305|FG000|Overall Study|Lack of Efficacy|1|||
27780501|NCT02388737|54234312|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
27780502|NCT02388737|54234313|FG001|Overall Study|Pretreatment Event/Adverse Event|11|||
27780503|NCT02388737|54234314|FG002|Overall Study|Pretreatment Event/Adverse Event|12|||
27780504|NCT02388737|54234312|FG000|Overall Study|Major Protocol Deviation|18|||
27780505|NCT02388737|54234313|FG001|Overall Study|Major Protocol Deviation|25|||
27780506|NCT02388737|54234314|FG002|Overall Study|Major Protocol Deviation|22|||
27780507|NCT02388737|54234312|FG000|Overall Study|Lost to Follow-up|5|||
27780508|NCT02388737|54234313|FG001|Overall Study|Lost to Follow-up|1|||
27780509|NCT02388737|54234314|FG002|Overall Study|Lost to Follow-up|4|||
27780510|NCT02388737|54234312|FG000|Overall Study|Voluntary Withdrawal|10|||
27840678|NCT01455415|54328577|FG000|Period 2|Lack of Efficacy|2|||
27780511|NCT02388737|54234313|FG001|Overall Study|Voluntary Withdrawal|18|||
27780512|NCT02388737|54234314|FG002|Overall Study|Voluntary Withdrawal|17|||
27780513|NCT02388737|54234312|FG000|Overall Study|Lack of Efficacy|3|||
27780514|NCT02388737|54234313|FG001|Overall Study|Lack of Efficacy|0|||
27780515|NCT02388737|54234314|FG002|Overall Study|Lack of Efficacy|3|||
27780516|NCT02388737|54234312|FG000|Overall Study|Reason Not Specified|5|||
27780517|NCT02388737|54234313|FG001|Overall Study|Reason Not Specified|5|||
27780518|NCT02388737|54234314|FG002|Overall Study|Reason Not Specified|4|||
27780519|NCT02355743|54234322|FG000|Overall Study|Withdrawal by Subject|1|||
27780520|NCT02355743|54234322|FG000|Overall Study|Lost to Follow-up|1|||
27780521|NCT02388347|54234331|FG000|Overall Study|Withdrawal by Subject|0|||
27780522|NCT02388347|54234332|FG001|Overall Study|Withdrawal by Subject|0|||
27780523|NCT02388347|54234333|FG002|Overall Study|Withdrawal by Subject|1|||
27780524|NCT02388347|54234334|FG003|Overall Study|Withdrawal by Subject|0|||
27780525|NCT02388347|54234335|FG004|Overall Study|Withdrawal by Subject|0|||
27780526|NCT02355665|54234353|FG000|Overall Study|Adverse Event|16|||
27780527|NCT02355665|54234354|FG001|Overall Study|Adverse Event|24|||
27780528|NCT02355665|54234353|FG000|Overall Study|Protocol Violation|2|||
27780529|NCT02355665|54234354|FG001|Overall Study|Protocol Violation|0|||
27780530|NCT02355665|54234353|FG000|Overall Study|Withdrawal by Subject|90|||
27780531|NCT02355665|54234354|FG001|Overall Study|Withdrawal by Subject|100|||
27780532|NCT02355665|54234353|FG000|Overall Study|Lost to Follow-up|131|||
27780533|NCT02355665|54234354|FG001|Overall Study|Lost to Follow-up|103|||
27780534|NCT02355665|54234353|FG000|Overall Study|Death|4|||
27780535|NCT02355665|54234354|FG001|Overall Study|Death|2|||
27780536|NCT02355665|54234353|FG000|Overall Study|Compliance, PI decision, move, eligible|6|||
27780537|NCT02355665|54234354|FG001|Overall Study|Compliance, PI decision, move, eligible|3|||
27780538|NCT02010255|54234374|FG000|Overall Study|Death|0|||
27780539|NCT02010255|54234375|FG001|Overall Study|Death|1|||
27780540|NCT02010255|54234376|FG002|Overall Study|Death|4|||
27780541|NCT02010255|54234377|FG003|Overall Study|Death|4|||
27780542|NCT02010255|54234378|FG004|Overall Study|Death|2|||
27780543|NCT02010255|54234379|FG005|Overall Study|Death|0|||
27780544|NCT02010255|54234380|FG006|Overall Study|Death|1|||
27780545|NCT02010255|54234381|FG007|Overall Study|Death|1|||
27780546|NCT02010255|54234382|FG008|Overall Study|Death|1|||
27780547|NCT02010255|54234383|FG009|Overall Study|Death|0|||
27780548|NCT02010255|54234384|FG010|Overall Study|Death|1|||
27780549|NCT02010255|54234385|FG011|Overall Study|Death|1|||
27780550|NCT02010255|54234386|FG012|Overall Study|Death|0|||
27780551|NCT02010255|54234387|FG013|Overall Study|Death|0|||
27780552|NCT02010255|54234374|FG000|Overall Study|Lack of Efficacy|4|||
27780553|NCT02010255|54234375|FG001|Overall Study|Lack of Efficacy|1|||
27780554|NCT02010255|54234376|FG002|Overall Study|Lack of Efficacy|2|||
27780555|NCT02010255|54234377|FG003|Overall Study|Lack of Efficacy|1|||
27780556|NCT02010255|54234378|FG004|Overall Study|Lack of Efficacy|1|||
27780557|NCT02010255|54234379|FG005|Overall Study|Lack of Efficacy|0|||
27780558|NCT02010255|54234380|FG006|Overall Study|Lack of Efficacy|0|||
27780559|NCT02010255|54234381|FG007|Overall Study|Lack of Efficacy|0|||
27780560|NCT02010255|54234382|FG008|Overall Study|Lack of Efficacy|0|||
27780561|NCT02010255|54234383|FG009|Overall Study|Lack of Efficacy|0|||
27780562|NCT02010255|54234384|FG010|Overall Study|Lack of Efficacy|1|||
27780563|NCT02010255|54234385|FG011|Overall Study|Lack of Efficacy|0|||
27780564|NCT02010255|54234386|FG012|Overall Study|Lack of Efficacy|0|||
27780565|NCT02010255|54234387|FG013|Overall Study|Lack of Efficacy|0|||
27780566|NCT02010255|54234374|FG000|Overall Study|Withdrew Consent|1|||
27780567|NCT02010255|54234375|FG001|Overall Study|Withdrew Consent|0|||
27780568|NCT02010255|54234376|FG002|Overall Study|Withdrew Consent|0|||
27780569|NCT02010255|54234377|FG003|Overall Study|Withdrew Consent|1|||
27780570|NCT02010255|54234378|FG004|Overall Study|Withdrew Consent|0|||
27780571|NCT02010255|54234379|FG005|Overall Study|Withdrew Consent|0|||
27780572|NCT02010255|54234380|FG006|Overall Study|Withdrew Consent|0|||
27780573|NCT02010255|54234381|FG007|Overall Study|Withdrew Consent|0|||
27780574|NCT02010255|54234382|FG008|Overall Study|Withdrew Consent|0|||
27780575|NCT02010255|54234383|FG009|Overall Study|Withdrew Consent|0|||
27780576|NCT02010255|54234384|FG010|Overall Study|Withdrew Consent|0|||
27780577|NCT02010255|54234385|FG011|Overall Study|Withdrew Consent|0|||
27780578|NCT02010255|54234386|FG012|Overall Study|Withdrew Consent|0|||
27780579|NCT02010255|54234387|FG013|Overall Study|Withdrew Consent|0|||
27780580|NCT02010255|54234374|FG000|Overall Study|Adverse Event|1|||
27780581|NCT02010255|54234375|FG001|Overall Study|Adverse Event|0|||
27780582|NCT02010255|54234376|FG002|Overall Study|Adverse Event|0|||
27780583|NCT02010255|54234377|FG003|Overall Study|Adverse Event|0|||
27780584|NCT02010255|54234378|FG004|Overall Study|Adverse Event|0|||
27780585|NCT02010255|54234379|FG005|Overall Study|Adverse Event|0|||
27780586|NCT02010255|54234380|FG006|Overall Study|Adverse Event|0|||
27780587|NCT02010255|54234381|FG007|Overall Study|Adverse Event|0|||
27780588|NCT02010255|54234382|FG008|Overall Study|Adverse Event|0|||
27780589|NCT02010255|54234383|FG009|Overall Study|Adverse Event|0|||
27780590|NCT02010255|54234384|FG010|Overall Study|Adverse Event|0|||
27780591|NCT02010255|54234385|FG011|Overall Study|Adverse Event|0|||
27780592|NCT02010255|54234386|FG012|Overall Study|Adverse Event|0|||
27780593|NCT02010255|54234387|FG013|Overall Study|Adverse Event|0|||
27780594|NCT02010255|54234374|FG000|Overall Study|Lost to Follow-up|0|||
27780595|NCT02010255|54234375|FG001|Overall Study|Lost to Follow-up|0|||
27780596|NCT02010255|54234376|FG002|Overall Study|Lost to Follow-up|1|||
27780597|NCT02010255|54234377|FG003|Overall Study|Lost to Follow-up|0|||
27780598|NCT02010255|54234378|FG004|Overall Study|Lost to Follow-up|1|||
27780599|NCT02010255|54234379|FG005|Overall Study|Lost to Follow-up|0|||
27780600|NCT02010255|54234380|FG006|Overall Study|Lost to Follow-up|0|||
27780601|NCT02010255|54234381|FG007|Overall Study|Lost to Follow-up|0|||
27780602|NCT02010255|54234382|FG008|Overall Study|Lost to Follow-up|0|||
27780603|NCT02010255|54234383|FG009|Overall Study|Lost to Follow-up|0|||
27780604|NCT02010255|54234384|FG010|Overall Study|Lost to Follow-up|0|||
27780605|NCT02010255|54234385|FG011|Overall Study|Lost to Follow-up|0|||
27780606|NCT02010255|54234386|FG012|Overall Study|Lost to Follow-up|0|||
27780607|NCT02010255|54234387|FG013|Overall Study|Lost to Follow-up|0|||
27780608|NCT02010255|54234374|FG000|Overall Study|Randomized but Not Treated|0|||
27780609|NCT02010255|54234375|FG001|Overall Study|Randomized but Not Treated|0|||
27780610|NCT02010255|54234376|FG002|Overall Study|Randomized but Not Treated|0|||
27780611|NCT02010255|54234377|FG003|Overall Study|Randomized but Not Treated|0|||
27780612|NCT02010255|54234378|FG004|Overall Study|Randomized but Not Treated|0|||
27780613|NCT02010255|54234379|FG005|Overall Study|Randomized but Not Treated|0|||
27780614|NCT02010255|54234380|FG006|Overall Study|Randomized but Not Treated|0|||
27780615|NCT02010255|54234381|FG007|Overall Study|Randomized but Not Treated|0|||
27780616|NCT02010255|54234382|FG008|Overall Study|Randomized but Not Treated|0|||
27780617|NCT02010255|54234383|FG009|Overall Study|Randomized but Not Treated|0|||
27780618|NCT02010255|54234384|FG010|Overall Study|Randomized but Not Treated|0|||
27780619|NCT02010255|54234385|FG011|Overall Study|Randomized but Not Treated|0|||
27780620|NCT02010255|54234386|FG012|Overall Study|Randomized but Not Treated|0|||
27780621|NCT02010255|54234387|FG013|Overall Study|Randomized but Not Treated|1|||
27780622|NCT02354417|54234442|FG000|Overall Study|Physician Decision|1|||
27780623|NCT02332187|54234448|FG000|Overall Study|Withdrawal by Subject|2|||
27780624|NCT02332187|54234449|FG001|Overall Study|Withdrawal by Subject|2|||
27780625|NCT02332187|54234448|FG000|Overall Study|Adverse Event|0|||
27780626|NCT02332187|54234449|FG001|Overall Study|Adverse Event|1|||
27780627|NCT02330549|54234457|FG000|Overall Study|Adverse Event|1|||
27780628|NCT02330549|54234458|FG001|Overall Study|Adverse Event|0|||
27780629|NCT02330549|54234457|FG000|Overall Study|Subject withdrew consent|2|||
27780630|NCT02330549|54234458|FG001|Overall Study|Subject withdrew consent|1|||
27780631|NCT02330549|54234457|FG000|Overall Study|Failure to meet randomization criteria|1|||
27780632|NCT02330549|54234458|FG001|Overall Study|Failure to meet randomization criteria|0|||
27780633|NCT02009865|54234466|FG000|Overall Study|Adverse Event|0|||
27780634|NCT02009865|54234467|FG001|Overall Study|Adverse Event|2|||
27780635|NCT02009865|54234466|FG000|Overall Study|Protocol Violation|0|||
27780636|NCT02009865|54234467|FG001|Overall Study|Protocol Violation|2|||
27780637|NCT02009865|54234466|FG000|Overall Study|Withdrawal by Subject|1|||
27780638|NCT02009865|54234467|FG001|Overall Study|Withdrawal by Subject|1|||
27780639|NCT01620177|54234473|FG000|Overall Study|Failure at Screening Visit|43|||
27780640|NCT01620177|54234473|FG000|Overall Study|Withdrawal by Subject|26|||
27780641|NCT01620177|54234473|FG000|Overall Study|Lost to Follow-up|7|||
27780642|NCT01620177|54234473|FG000|Overall Study|Physician Decision|2|||
27780643|NCT01620177|54234473|FG000|Overall Study|Randomized, Not Active due to Scheduling|1|||
27780644|NCT02075541|54234492|FG000|Overall Study|Serious Adverse Event|1|||
27780645|NCT02075541|54234493|FG001|Overall Study|Serious Adverse Event|4|||
27780646|NCT02075541|54234492|FG000|Overall Study|Protocol Violation|1|||
27780647|NCT02075541|54234493|FG001|Overall Study|Protocol Violation|0|||
27780648|NCT02075541|54234492|FG000|Overall Study|Withdrawal by Subject|1|||
27780649|NCT02075541|54234493|FG001|Overall Study|Withdrawal by Subject|3|||
27780650|NCT02075541|54234492|FG000|Overall Study|Sponsor study termination|0|||
27780651|NCT02075541|54234493|FG001|Overall Study|Sponsor study termination|1|||
27780652|NCT02075541|54234492|FG000|Overall Study|Other- unable to perform study procedure|1|||
27780653|NCT02075541|54234493|FG001|Overall Study|Other- unable to perform study procedure|0|||
27780654|NCT02330081|54234499|FG000|Overall Study|Adverse Event|1|||
27780655|NCT02330081|54234499|FG000|Overall Study|Donation did not meet criteria|1|||
27780656|NCT02330081|54234499|FG000|Overall Study|Protocol Violation|6|||
27780657|NCT01986855|54234509|FG000|Overall Study|Adverse Event|1|||
27840679|NCT01455415|54328578|FG001|Period 2|Lack of Efficacy|0|||
27840680|NCT01455415|54328577|FG000|Period 2|Withdrawal by Subject|2|||
27840681|NCT01455415|54328578|FG001|Period 2|Withdrawal by Subject|3|||
27840682|NCT01455415|54328577|FG000|Period 2|Unspecified Reason|2|||
27840683|NCT01455415|54328578|FG001|Period 2|Unspecified Reason|3|||
27840684|NCT01455415|54328577|FG000|Period 2|Protocol Violation|2|||
27840685|NCT01455415|54328578|FG001|Period 2|Protocol Violation|0|||
27780658|NCT01986855|54234510|FG001|Overall Study|Adverse Event|0|||
27780659|NCT01986855|54234511|FG002|Overall Study|Adverse Event|0|||
27780660|NCT01986855|54234509|FG000|Overall Study|Death|3|||
27780661|NCT01986855|54234510|FG001|Overall Study|Death|4|||
27780662|NCT01986855|54234511|FG002|Overall Study|Death|4|||
27780663|NCT01986855|54234509|FG000|Overall Study|Lost to Follow-up|2|||
27780664|NCT01986855|54234510|FG001|Overall Study|Lost to Follow-up|1|||
27780665|NCT01986855|54234511|FG002|Overall Study|Lost to Follow-up|0|||
27780666|NCT01986855|54234509|FG000|Overall Study|Screen Failure|0|||
27780667|NCT01986855|54234510|FG001|Overall Study|Screen Failure|1|||
27780668|NCT01986855|54234511|FG002|Overall Study|Screen Failure|0|||
27780669|NCT01986855|54234509|FG000|Overall Study|Participant Moved|0|||
27780670|NCT01986855|54234510|FG001|Overall Study|Participant Moved|0|||
27780671|NCT01986855|54234511|FG002|Overall Study|Participant Moved|2|||
27780672|NCT01986855|54234509|FG000|Overall Study|Withdrawal by Subject|7|||
27780673|NCT01986855|54234510|FG001|Overall Study|Withdrawal by Subject|8|||
27780674|NCT01986855|54234511|FG002|Overall Study|Withdrawal by Subject|5|||
27780675|NCT02075463|54234519|FG000|Overall Study|Adverse Event|3|||
27780676|NCT02075463|54234519|FG000|Overall Study|Par. reached stopping criteria|4|||
27780677|NCT02075463|54234519|FG000|Overall Study|Withdrawal by Subject|1|||
27780678|NCT02353871|54234526|FG000|Overall Study|Protocol deviation|0|||
27780679|NCT02353871|54234527|FG001|Overall Study|Protocol deviation|1|||
27780680|NCT02353871|54234526|FG000|Overall Study|Consent withdrawn|1|||
27780681|NCT02353871|54234527|FG001|Overall Study|Consent withdrawn|8|||
27780682|NCT02353871|54234526|FG000|Overall Study|Lost to Follow-up|2|||
27780683|NCT02353871|54234527|FG001|Overall Study|Lost to Follow-up|0|||
27780684|NCT02009397|54234533|FG000|Overall Study|Protocol Violation|6|||
27780685|NCT02009397|54234533|FG000|Overall Study|Death|8|||
27780686|NCT02009397|54234533|FG000|Overall Study|Lost to Follow-up|6|||
27780687|NCT02312219|54234539|FG000|Overall Study|Withdrawal by Subject|1|||
27780688|NCT02312219|54234540|FG001|Overall Study|Withdrawal by Subject|2|||
27780689|NCT02312219|54234539|FG000|Overall Study|could not schedule imaging in time|0|||
27780690|NCT02312219|54234540|FG001|Overall Study|could not schedule imaging in time|2|||
27780691|NCT02312219|54234539|FG000|Overall Study|Other|0|||
27780692|NCT02312219|54234540|FG001|Overall Study|Other|1|||
27780693|NCT02312219|54234539|FG000|Overall Study|Not randomized. Ineligible|0|||
27780694|NCT02312219|54234540|FG001|Overall Study|Not randomized. Ineligible|1|||
27780695|NCT01986231|54234546|FG000|Overall Study|Adverse Event|1|||
27780696|NCT02312063|54234552|FG000|Overall Study|Withdrawal by Subject|0|||
27780697|NCT02312063|54234553|FG001|Overall Study|Withdrawal by Subject|1|||
27780698|NCT02353169|54234564|FG000|Overall Study|QTc > 450 msec|1|||
27780699|NCT02353169|54234565|FG001|Overall Study|QTc > 450 msec|1|||
27780700|NCT02353169|54234566|FG002|Overall Study|QTc > 450 msec|1|||
27780701|NCT02353169|54234567|FG003|Overall Study|QTc > 450 msec|1|||
27780702|NCT02353169|54234564|FG000|Overall Study|OR team declined|2|||
27780703|NCT02353169|54234565|FG001|Overall Study|OR team declined|0|||
27780704|NCT02353169|54234566|FG002|Overall Study|OR team declined|0|||
27780705|NCT02353169|54234567|FG003|Overall Study|OR team declined|0|||
27780706|NCT02353169|54234564|FG000|Overall Study|Inhalational induction|0|||
27780707|NCT02353169|54234565|FG001|Overall Study|Inhalational induction|2|||
27780708|NCT02353169|54234566|FG002|Overall Study|Inhalational induction|0|||
27780709|NCT02353169|54234567|FG003|Overall Study|Inhalational induction|0|||
27780710|NCT02353169|54234564|FG000|Overall Study|ECG data error|0|||
27780711|NCT02353169|54234565|FG001|Overall Study|ECG data error|3|||
27780712|NCT02353169|54234566|FG002|Overall Study|ECG data error|2|||
27780713|NCT02353169|54234567|FG003|Overall Study|ECG data error|2|||
27780714|NCT02353169|54234564|FG000|Overall Study|Pre-op medication|0|||
27780715|NCT02353169|54234565|FG001|Overall Study|Pre-op medication|0|||
27780716|NCT02353169|54234566|FG002|Overall Study|Pre-op medication|1|||
27780717|NCT02353169|54234567|FG003|Overall Study|Pre-op medication|0|||
27780718|NCT02009163|54234577|FG000|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48|||
27780719|NCT02009163|54234578|FG001|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
27780720|NCT02009163|54234579|FG002|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
27780721|NCT02009163|54234577|FG000|Open-label Period (Non-randomized)|Withdrawal by Subject|29|||
27780722|NCT02009163|54234578|FG001|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
27780723|NCT02009163|54234579|FG002|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
27780724|NCT02009163|54234577|FG000|Open-label Period (Non-randomized)|Adverse Event|22|||
27780725|NCT02009163|54234578|FG001|Open-label Period (Non-randomized)|Adverse Event|0|||
27780726|NCT02009163|54234579|FG002|Open-label Period (Non-randomized)|Adverse Event|0|||
27780727|NCT02009163|54234577|FG000|Open-label Period (Non-randomized)|Lost to Follow-up|20|||
27840686|NCT01455415|54328577|FG000|Follow-up|AE Related to Study Drug|0|||
27780728|NCT02009163|54234578|FG001|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
27780729|NCT02009163|54234579|FG002|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
27840687|NCT01455415|54328578|FG001|Follow-up|AE Related to Study Drug|1|||
27840688|NCT01455415|54328577|FG000|Follow-up|Lack of Efficacy|0|||
27780730|NCT02009163|54234577|FG000|Open-label Period (Non-randomized)|Protocol Violation|10|||
27780731|NCT02009163|54234578|FG001|Open-label Period (Non-randomized)|Protocol Violation|0|||
27780732|NCT02009163|54234579|FG002|Open-label Period (Non-randomized)|Protocol Violation|0|||
27780733|NCT02009163|54234577|FG000|Open-label Period (Non-randomized)|Pregnancy|1|||
27840689|NCT01455415|54328578|FG001|Follow-up|Lack of Efficacy|1|||
27840690|NCT01455415|54328577|FG000|Follow-up|Withdrawal by Subject|2|||
27780734|NCT02009163|54234578|FG001|Open-label Period (Non-randomized)|Pregnancy|0|||
27780735|NCT02009163|54234579|FG002|Open-label Period (Non-randomized)|Pregnancy|0|||
27780736|NCT02009163|54234577|FG000|Open-label Period (Non-randomized)|Other|13|||
27780737|NCT02009163|54234578|FG001|Open-label Period (Non-randomized)|Other|0|||
27780738|NCT02009163|54234579|FG002|Open-label Period (Non-randomized)|Other|0|||
27780739|NCT02009163|54234577|FG000|Randomized-withdrawal Period|Withdrawal by Subject|0|||
27780740|NCT02009163|54234578|FG001|Randomized-withdrawal Period|Withdrawal by Subject|25|||
27780741|NCT02009163|54234579|FG002|Randomized-withdrawal Period|Withdrawal by Subject|9|||
27780742|NCT02009163|54234577|FG000|Randomized-withdrawal Period|Lost to Follow-up|0|||
27780743|NCT02009163|54234578|FG001|Randomized-withdrawal Period|Lost to Follow-up|13|||
27780744|NCT02009163|54234579|FG002|Randomized-withdrawal Period|Lost to Follow-up|6|||
27780745|NCT02009163|54234577|FG000|Randomized-withdrawal Period|Adverse Event|0|||
27780746|NCT02009163|54234578|FG001|Randomized-withdrawal Period|Adverse Event|0|||
27780747|NCT02009163|54234579|FG002|Randomized-withdrawal Period|Adverse Event|6|||
27780748|NCT02009163|54234577|FG000|Randomized-withdrawal Period|Relapse Criteria Met|0|||
27780749|NCT02009163|54234578|FG001|Randomized-withdrawal Period|Relapse Criteria Met|40|||
27780750|NCT02009163|54234579|FG002|Randomized-withdrawal Period|Relapse Criteria Met|5|||
27780751|NCT02009163|54234577|FG000|Randomized-withdrawal Period|Protocol Violation|0|||
27780752|NCT02009163|54234578|FG001|Randomized-withdrawal Period|Protocol Violation|1|||
27780753|NCT02009163|54234579|FG002|Randomized-withdrawal Period|Protocol Violation|2|||
27780754|NCT02009163|54234577|FG000|Randomized-withdrawal Period|Pregnancy|0|||
27780755|NCT02009163|54234578|FG001|Randomized-withdrawal Period|Pregnancy|0|||
27780756|NCT02009163|54234579|FG002|Randomized-withdrawal Period|Pregnancy|2|||
27780757|NCT02009163|54234577|FG000|Randomized-withdrawal Period|Other|0|||
27780758|NCT02009163|54234578|FG001|Randomized-withdrawal Period|Other|9|||
27780759|NCT02009163|54234579|FG002|Randomized-withdrawal Period|Other|5|||
27780760|NCT01983969|54234592|FG000|Overall Study|Disease Progression|0|||
27780761|NCT01983969|54234593|FG001|Overall Study|Disease Progression|1|||
27780762|NCT01983969|54234594|FG002|Overall Study|Disease Progression|0|||
27780763|NCT02008773|54234610|FG000|Overall Study|Adverse Event|3|||
27780764|NCT02008773|54234611|FG001|Overall Study|Adverse Event|3|||
27780765|NCT02008773|54234612|FG002|Overall Study|Adverse Event|1|||
27780766|NCT02008773|54234613|FG003|Overall Study|Adverse Event|2|||
27780767|NCT02008773|54234610|FG000|Overall Study|Medication Non-compliance|2|||
27780768|NCT02008773|54234611|FG001|Overall Study|Medication Non-compliance|1|||
27780769|NCT02008773|54234612|FG002|Overall Study|Medication Non-compliance|3|||
27780770|NCT02008773|54234613|FG003|Overall Study|Medication Non-compliance|2|||
27780771|NCT02008773|54234610|FG000|Overall Study|Withdrawal by Subject|8|||
27780772|NCT02008773|54234611|FG001|Overall Study|Withdrawal by Subject|4|||
27780773|NCT02008773|54234612|FG002|Overall Study|Withdrawal by Subject|7|||
27780774|NCT02008773|54234613|FG003|Overall Study|Withdrawal by Subject|6|||
27780775|NCT02008773|54234610|FG000|Overall Study|Lost to Follow-up|0|||
27780776|NCT02008773|54234611|FG001|Overall Study|Lost to Follow-up|1|||
27780777|NCT02008773|54234612|FG002|Overall Study|Lost to Follow-up|3|||
27780778|NCT02008773|54234613|FG003|Overall Study|Lost to Follow-up|2|||
27780779|NCT02257567|54234632|FG000|Overall Study|Adverse Event|0|||
27780780|NCT02257567|54234633|FG001|Overall Study|Adverse Event|0|||
27780781|NCT02257567|54234634|FG002|Overall Study|Adverse Event|0|||
27780782|NCT02257567|54234635|FG003|Overall Study|Adverse Event|1|||
27780783|NCT02257567|54234636|FG004|Overall Study|Adverse Event|1|||
27780784|NCT02257567|54234637|FG005|Overall Study|Adverse Event|0|||
27780785|NCT02257567|54234638|FG006|Overall Study|Adverse Event|0|||
27780786|NCT02257567|54234639|FG007|Overall Study|Adverse Event|0|||
27780787|NCT02257567|54234640|FG008|Overall Study|Adverse Event|1|||
27780788|NCT02257567|54234641|FG009|Overall Study|Adverse Event|0|||
27780789|NCT02257567|54234642|FG010|Overall Study|Adverse Event|0|||
27780790|NCT02257567|54234632|FG000|Overall Study|Death|2|||
27780791|NCT02257567|54234633|FG001|Overall Study|Death|2|||
27780792|NCT02257567|54234634|FG002|Overall Study|Death|2|||
27840691|NCT01455415|54328578|FG001|Follow-up|Withdrawal by Subject|0|||
27780793|NCT02257567|54234635|FG003|Overall Study|Death|4|||
27780794|NCT02257567|54234636|FG004|Overall Study|Death|15|||
27780795|NCT02257567|54234637|FG005|Overall Study|Death|11|||
27780796|NCT02257567|54234638|FG006|Overall Study|Death|26|||
27780797|NCT02257567|54234639|FG007|Overall Study|Death|30|||
27780798|NCT02257567|54234640|FG008|Overall Study|Death|2|||
27780799|NCT02257567|54234641|FG009|Overall Study|Death|18|||
27780800|NCT02257567|54234642|FG010|Overall Study|Death|65|||
27780801|NCT02257567|54234632|FG000|Overall Study|Lost to Follow-up|0|||
27780802|NCT02257567|54234633|FG001|Overall Study|Lost to Follow-up|0|||
27840692|NCT01455415|54328577|FG000|Follow-up|Unspecified Reason|1|||
27780803|NCT02257567|54234634|FG002|Overall Study|Lost to Follow-up|0|||
27780804|NCT02257567|54234635|FG003|Overall Study|Lost to Follow-up|0|||
27780805|NCT02257567|54234636|FG004|Overall Study|Lost to Follow-up|2|||
27780806|NCT02257567|54234637|FG005|Overall Study|Lost to Follow-up|2|||
27780807|NCT02257567|54234638|FG006|Overall Study|Lost to Follow-up|0|||
27780808|NCT02257567|54234639|FG007|Overall Study|Lost to Follow-up|0|||
27780809|NCT02257567|54234640|FG008|Overall Study|Lost to Follow-up|0|||
27780810|NCT02257567|54234641|FG009|Overall Study|Lost to Follow-up|1|||
27780811|NCT02257567|54234642|FG010|Overall Study|Lost to Follow-up|1|||
27780812|NCT02257567|54234632|FG000|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
27780813|NCT02257567|54234633|FG001|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
27780814|NCT02257567|54234634|FG002|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
27780815|NCT02257567|54234635|FG003|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
27780816|NCT02257567|54234636|FG004|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|1|||
27780817|NCT02257567|54234637|FG005|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
27780818|NCT02257567|54234638|FG006|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|2|||
27780819|NCT02257567|54234639|FG007|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
27780820|NCT02257567|54234640|FG008|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
27780821|NCT02257567|54234641|FG009|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
27780822|NCT02257567|54234642|FG010|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
27840693|NCT01455415|54328578|FG001|Follow-up|Unspecified Reason|0|||
27840694|NCT01471171|54328584|FG000|Treatment Period 1|Adverse Event|4|||
27840695|NCT01471171|54328585|FG001|Treatment Period 1|Adverse Event|1|||
27840696|NCT01471171|54328584|FG000|Treatment Period 2|Adverse Event|1|||
27840697|NCT01471171|54328585|FG001|Treatment Period 2|Adverse Event|0|||
27840698|NCT01471093|54328593|FG000|Overall Study|Adverse Event|1|||
27840699|NCT01471093|54328594|FG001|Overall Study|Adverse Event|0|||
27840700|NCT01471093|54328595|FG002|Overall Study|Adverse Event|0|||
27840701|NCT01471093|54328596|FG003|Overall Study|Adverse Event|0|||
27840702|NCT01471015|54328605|FG000|Overall Study|Death|0|||
27840703|NCT01471015|54328606|FG001|Overall Study|Death|1|||
27840704|NCT01471015|54328607|FG002|Overall Study|Death|1|||
27840705|NCT01497067|54328615|FG000|Overall Study|Lost to Follow-up|56|||
27840706|NCT01497067|54328615|FG000|Overall Study|Adverse Event|3|||
27840707|NCT01497067|54328615|FG000|Overall Study|Patient decision unrel to Adverse Event|10|||
27840708|NCT01497067|54328615|FG000|Overall Study|Other|13|||
27840709|NCT01470469|54328645|FG000|Overall Study|Withdrawal by Subject|4|||
27840710|NCT01470469|54328646|FG001|Overall Study|Withdrawal by Subject|6|||
27840711|NCT01470469|54328645|FG000|Overall Study|Lack of Efficacy|1|||
27840712|NCT01470469|54328646|FG001|Overall Study|Lack of Efficacy|7|||
27840713|NCT01470469|54328645|FG000|Overall Study|Adverse Event|0|||
27840714|NCT01470469|54328646|FG001|Overall Study|Adverse Event|7|||
27840715|NCT01470469|54328645|FG000|Overall Study|Lost to Follow-up|2|||
27840716|NCT01470469|54328646|FG001|Overall Study|Lost to Follow-up|2|||
27840717|NCT01470469|54328645|FG000|Overall Study|Protocol Violation|1|||
27840718|NCT01470469|54328646|FG001|Overall Study|Protocol Violation|1|||
27840719|NCT01470469|54328645|FG000|Overall Study|Other|2|||
27840720|NCT01470469|54328646|FG001|Overall Study|Other|1|||
27840721|NCT01470001|54328654|FG000|Overall Study|Lost to Follow-up|1|||
27840722|NCT01470001|54328655|FG001|Overall Study|Lost to Follow-up|1|||
27840723|NCT01470001|54328654|FG000|Overall Study|Physician Decision|2|||
27840724|NCT01470001|54328655|FG001|Overall Study|Physician Decision|0|||
27840725|NCT01470001|54328654|FG000|Overall Study|Withdrawal by Subject|2|||
27840726|NCT01470001|54328655|FG001|Overall Study|Withdrawal by Subject|1|||
27840727|NCT01469377|54328664|FG000|Overall Study|Protocol Deviation|7|||
27840728|NCT01469377|54328665|FG001|Overall Study|Protocol Deviation|10|||
27840729|NCT01469377|54328666|FG002|Overall Study|Protocol Deviation|10|||
27840730|NCT01469377|54328664|FG000|Overall Study|Lost to Follow-up|3|||
27840731|NCT01469377|54328665|FG001|Overall Study|Lost to Follow-up|2|||
27840732|NCT01469377|54328666|FG002|Overall Study|Lost to Follow-up|5|||
27840733|NCT01469377|54328664|FG000|Overall Study|Withdrawal of Consent|12|||
27840734|NCT01469377|54328665|FG001|Overall Study|Withdrawal of Consent|14|||
27840735|NCT01469377|54328666|FG002|Overall Study|Withdrawal of Consent|15|||
27840736|NCT01469377|54328664|FG000|Overall Study|Adverse Event|8|||
27840737|NCT01469377|54328665|FG001|Overall Study|Adverse Event|18|||
27840738|NCT01469377|54328666|FG002|Overall Study|Adverse Event|36|||
27840739|NCT01469377|54328664|FG000|Overall Study|Insufficient Therapeutic Response|3|||
27840740|NCT01469377|54328665|FG001|Overall Study|Insufficient Therapeutic Response|4|||
27840741|NCT01469377|54328666|FG002|Overall Study|Insufficient Therapeutic Response|0|||
27840742|NCT01469377|54328664|FG000|Overall Study|Other Miscellaneous Reasons|2|||
27840743|NCT01469377|54328665|FG001|Overall Study|Other Miscellaneous Reasons|0|||
27840744|NCT01469377|54328666|FG002|Overall Study|Other Miscellaneous Reasons|0|||
27840745|NCT01469221|54328676|FG000|Double Blind Phase|Protocol Violation|1|||
27840746|NCT01469221|54328677|FG001|Double Blind Phase|Protocol Violation|0|||
27840747|NCT01469221|54328678|FG002|Double Blind Phase|Protocol Violation|0|||
27840748|NCT01469221|54328676|FG000|Double Blind Phase|Physician Decision|1|||
27780823|NCT02257567|54234632|FG000|Overall Study|Physician Decision|0|||
27780824|NCT02257567|54234633|FG001|Overall Study|Physician Decision|0|||
27780825|NCT02257567|54234634|FG002|Overall Study|Physician Decision|0|||
27780826|NCT02257567|54234635|FG003|Overall Study|Physician Decision|0|||
27780827|NCT02257567|54234636|FG004|Overall Study|Physician Decision|0|||
27780828|NCT02257567|54234637|FG005|Overall Study|Physician Decision|0|||
27780829|NCT02257567|54234638|FG006|Overall Study|Physician Decision|0|||
27780830|NCT02257567|54234639|FG007|Overall Study|Physician Decision|2|||
27780831|NCT02257567|54234640|FG008|Overall Study|Physician Decision|0|||
27780832|NCT02257567|54234641|FG009|Overall Study|Physician Decision|1|||
27780833|NCT02257567|54234642|FG010|Overall Study|Physician Decision|0|||
27780834|NCT02257567|54234632|FG000|Overall Study|Withdrawal by Subject|0|||
27780835|NCT02257567|54234633|FG001|Overall Study|Withdrawal by Subject|0|||
27780836|NCT02257567|54234634|FG002|Overall Study|Withdrawal by Subject|2|||
27780837|NCT02257567|54234635|FG003|Overall Study|Withdrawal by Subject|0|||
27780838|NCT02257567|54234636|FG004|Overall Study|Withdrawal by Subject|0|||
27780839|NCT02257567|54234637|FG005|Overall Study|Withdrawal by Subject|6|||
27780840|NCT02257567|54234638|FG006|Overall Study|Withdrawal by Subject|6|||
27780841|NCT02257567|54234639|FG007|Overall Study|Withdrawal by Subject|6|||
27780842|NCT02257567|54234640|FG008|Overall Study|Withdrawal by Subject|1|||
27780843|NCT02257567|54234641|FG009|Overall Study|Withdrawal by Subject|1|||
27780844|NCT02257567|54234642|FG010|Overall Study|Withdrawal by Subject|10|||
27780845|NCT01642615|54234699|FG000|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1|||
27780846|NCT01642615|54234700|FG001|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
27780847|NCT01642615|54234701|FG002|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
27780848|NCT01642615|54234699|FG000|Open Label Maintenance Phase|Major Protocol Deviation|1|||
27780849|NCT01642615|54234700|FG001|Open Label Maintenance Phase|Major Protocol Deviation|0|||
27780850|NCT01642615|54234701|FG002|Open Label Maintenance Phase|Major Protocol Deviation|0|||
27780851|NCT01642615|54234699|FG000|Open Label Maintenance Phase|Lost to Follow-up|1|||
27780852|NCT01642615|54234700|FG001|Open Label Maintenance Phase|Lost to Follow-up|0|||
27780853|NCT01642615|54234701|FG002|Open Label Maintenance Phase|Lost to Follow-up|0|||
27780854|NCT01642615|54234699|FG000|Open Label Maintenance Phase|Voluntary Withdrawal|1|||
27780855|NCT01642615|54234700|FG001|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
27780856|NCT01642615|54234701|FG002|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
27780857|NCT01642615|54234699|FG000|Open Label Maintenance Phase|Did not receive treatment|1|||
27780858|NCT01642615|54234700|FG001|Open Label Maintenance Phase|Did not receive treatment|0|||
27780859|NCT01642615|54234701|FG002|Open Label Maintenance Phase|Did not receive treatment|0|||
27780860|NCT01642615|54234699|FG000|Double Blind Maintenance Phase|Lack of Efficacy|0|||
27780861|NCT01642615|54234700|FG001|Double Blind Maintenance Phase|Lack of Efficacy|1|||
27780862|NCT01642615|54234701|FG002|Double Blind Maintenance Phase|Lack of Efficacy|3|||
27780863|NCT01642615|54234699|FG000|Double Blind Maintenance Phase|Voluntary Withdrawal|0|||
27780864|NCT01642615|54234700|FG001|Double Blind Maintenance Phase|Voluntary Withdrawal|5|||
27780865|NCT01642615|54234701|FG002|Double Blind Maintenance Phase|Voluntary Withdrawal|2|||
27780866|NCT01642615|54234699|FG000|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
27780867|NCT01642615|54234700|FG001|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1|||
27780868|NCT01642615|54234701|FG002|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
27780869|NCT01642615|54234699|FG000|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
27780870|NCT01642615|54234700|FG001|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
27780871|NCT01642615|54234701|FG002|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1|||
27780872|NCT02311361|54234713|FG000|Overall Study|Did not receive treatment|0|||
27780873|NCT02311361|54234714|FG001|Overall Study|Did not receive treatment|1|||
27780874|NCT02311361|54234715|FG002|Overall Study|Did not receive treatment|0|||
27780875|NCT02311361|54234716|FG003|Overall Study|Did not receive treatment|1|||
27780876|NCT02352779|54234733|FG000|Overall Study|Personal Issues|1|||
27780877|NCT02352779|54234734|FG001|Overall Study|Personal Issues|1|||
27780878|NCT02352779|54234735|FG002|Overall Study|Personal Issues|0|||
27780879|NCT02352779|54234733|FG000|Overall Study|Too Many Forms|2|||
27780880|NCT02352779|54234734|FG001|Overall Study|Too Many Forms|0|||
27780881|NCT02352779|54234735|FG002|Overall Study|Too Many Forms|0|||
27780882|NCT02352779|54234733|FG000|Overall Study|Feeling Overwhelmed|1|||
27780883|NCT02352779|54234734|FG001|Overall Study|Feeling Overwhelmed|0|||
27780884|NCT02352779|54234735|FG002|Overall Study|Feeling Overwhelmed|0|||
27780885|NCT02352779|54234733|FG000|Overall Study|Disliked Intervention|1|||
27780886|NCT02352779|54234734|FG001|Overall Study|Disliked Intervention|0|||
27780887|NCT02352779|54234735|FG002|Overall Study|Disliked Intervention|0|||
27780888|NCT02352779|54234733|FG000|Overall Study|Changed Mind|1|||
27780889|NCT02352779|54234734|FG001|Overall Study|Changed Mind|0|||
27780890|NCT02352779|54234735|FG002|Overall Study|Changed Mind|0|||
27780891|NCT02352779|54234733|FG000|Overall Study|Study Related Symptoms|1|||
27780892|NCT02352779|54234734|FG001|Overall Study|Study Related Symptoms|0|||
27780893|NCT02352779|54234735|FG002|Overall Study|Study Related Symptoms|0|||
27780894|NCT02352779|54234733|FG000|Overall Study|Absence of Symptoms|1|||
27780895|NCT02352779|54234734|FG001|Overall Study|Absence of Symptoms|0|||
27780896|NCT02352779|54234735|FG002|Overall Study|Absence of Symptoms|0|||
27780897|NCT02352779|54234733|FG000|Overall Study|Other Medical Reason|0|||
27780898|NCT02352779|54234734|FG001|Overall Study|Other Medical Reason|0|||
27780899|NCT02352779|54234735|FG002|Overall Study|Other Medical Reason|1|||
27780900|NCT02352779|54234733|FG000|Overall Study|No Reason|0|||
27780901|NCT02352779|54234734|FG001|Overall Study|No Reason|0|||
27780902|NCT02352779|54234735|FG002|Overall Study|No Reason|1|||
27780903|NCT02257489|54234752|FG000|Overall Study|Withdrawal by Subject|0|||
27780904|NCT02257489|54234753|FG001|Overall Study|Withdrawal by Subject|0|||
27780905|NCT02257489|54234754|FG002|Overall Study|Withdrawal by Subject|0|||
27780906|NCT02257489|54234755|FG003|Overall Study|Withdrawal by Subject|1|||
27780907|NCT02257489|54234756|FG004|Overall Study|Withdrawal by Subject|0|||
27780908|NCT02257489|54234757|FG005|Overall Study|Withdrawal by Subject|0|||
27780909|NCT02257489|54234758|FG006|Overall Study|Withdrawal by Subject|0|||
27780910|NCT02257489|54234759|FG007|Overall Study|Withdrawal by Subject|0|||
27780911|NCT02257489|54234760|FG008|Overall Study|Withdrawal by Subject|0|||
27780912|NCT02329223|54234783|FG000|Overall Study|Withdrawal by Subject|1|||
27780913|NCT02329223|54234784|FG001|Overall Study|Withdrawal by Subject|2|||
27780914|NCT02329223|54234785|FG002|Overall Study|Withdrawal by Subject|5|||
27780915|NCT02329223|54234783|FG000|Overall Study|Physician Decision|0|||
27780916|NCT02329223|54234784|FG001|Overall Study|Physician Decision|0|||
27780917|NCT02329223|54234785|FG002|Overall Study|Physician Decision|1|||
27780918|NCT02329223|54234783|FG000|Overall Study|Adverse Event|0|||
27780919|NCT02329223|54234784|FG001|Overall Study|Adverse Event|1|||
27780920|NCT02329223|54234785|FG002|Overall Study|Adverse Event|0|||
27780921|NCT01641601|54234795|FG000|Overall Study|Study discontinued.|3|||
27780922|NCT01641601|54234796|FG001|Overall Study|Study discontinued.|5|||
27780923|NCT02350127|54234804|FG000|4-Month Assessment|Withdrawal by Subject|10|||
27780924|NCT02350127|54234805|FG001|4-Month Assessment|Withdrawal by Subject|9|||
27780925|NCT02350127|54234804|FG000|4-Month Assessment|Death|1|||
27780926|NCT02350127|54234805|FG001|4-Month Assessment|Death|0|||
27780927|NCT02350127|54234804|FG000|8-Month Assessment|Death|1|||
27780928|NCT02350127|54234805|FG001|8-Month Assessment|Death|1|||
27780929|NCT02350127|54234804|FG000|8-Month Assessment|Withdrawal by Subject|5|||
27780930|NCT02350127|54234805|FG001|8-Month Assessment|Withdrawal by Subject|8|||
27780931|NCT02256553|54234812|FG000|Period I|Adverse Event|5|||
27780932|NCT02256553|54234812|FG000|Period I|Protocol Violation|1|||
27780933|NCT02256553|54234812|FG000|Period II|Adverse Event|1|||
27780934|NCT02256553|54234812|FG000|Period II|Subject Moved|1|||
27780935|NCT02256553|54234812|FG000|Period III|Adverse Event|3|||
27780936|NCT02349425|54234822|FG000|Period 1|Adverse Event|1|||
27780937|NCT02349425|54234823|FG001|Period 1|Adverse Event|1|||
27780938|NCT02349425|54234824|FG002|Period 1|Adverse Event|0|||
27780939|NCT02349425|54234825|FG003|Period 1|Adverse Event|0|||
27780940|NCT02349425|54234822|FG000|Period 2|Adverse Event|0|||
27780941|NCT02349425|54234823|FG001|Period 2|Adverse Event|1|||
27780942|NCT02349425|54234824|FG002|Period 2|Adverse Event|1|||
27780943|NCT02349425|54234825|FG003|Period 2|Adverse Event|0|||
27780944|NCT02310581|54234867|FG000|Overall Study|Adverse Event|1|||
27780945|NCT02310581|54234868|FG001|Overall Study|Adverse Event|1|||
27780946|NCT02310581|54234869|FG002|Overall Study|Adverse Event|1|||
27780947|NCT02310581|54234870|FG003|Overall Study|Adverse Event|0|||
27780948|NCT02310581|54234867|FG000|Overall Study|Withdrawal by Subject|2|||
27780949|NCT02310581|54234868|FG001|Overall Study|Withdrawal by Subject|1|||
27780950|NCT02310581|54234869|FG002|Overall Study|Withdrawal by Subject|0|||
27780951|NCT02310581|54234870|FG003|Overall Study|Withdrawal by Subject|1|||
27780952|NCT02309723|54234883|FG000|Overall Study|Withdrawal by Subject|24|||
27780953|NCT02309723|54234884|FG001|Overall Study|Withdrawal by Subject|23|||
27780954|NCT02309723|54234885|FG002|Overall Study|Withdrawal by Subject|24|||
27780955|NCT02309411|54234896|FG000|Overall Study|Physician Decision|1|||
27780956|NCT02309411|54234897|FG001|Overall Study|Physician Decision|0|||
27840749|NCT01469221|54328677|FG001|Double Blind Phase|Physician Decision|1|||
27780957|NCT02309411|54234898|FG002|Overall Study|Physician Decision|0|||
27780958|NCT02309411|54234896|FG000|Overall Study|Withdrawal by Subject|1|||
27780959|NCT02309411|54234897|FG001|Overall Study|Withdrawal by Subject|1|||
27780960|NCT02309411|54234898|FG002|Overall Study|Withdrawal by Subject|0|||
27780961|NCT02008227|54234907|FG000|Overall Study|Lost to Follow-up|7|||
27780962|NCT02008227|54234908|FG001|Overall Study|Lost to Follow-up|9|||
27780963|NCT02008227|54234907|FG000|Overall Study|Death|494|||
27780964|NCT02008227|54234908|FG001|Overall Study|Death|485|||
27780965|NCT02008227|54234907|FG000|Overall Study|Withdrawal by Subject|67|||
27780966|NCT02008227|54234908|FG001|Overall Study|Withdrawal by Subject|36|||
27780967|NCT02008227|54234907|FG000|Overall Study|Study Terminated By Sponsor|44|||
27780968|NCT02008227|54234908|FG001|Overall Study|Study Terminated By Sponsor|83|||
27780969|NCT02006979|54234917|FG000|Overall Study|Withdrawal by Subject|1|||
27780970|NCT02006979|54234918|FG001|Overall Study|Withdrawal by Subject|1|||
27780971|NCT02006979|54234917|FG000|Overall Study|Protocol Violation|0|||
27780972|NCT02006979|54234918|FG001|Overall Study|Protocol Violation|1|||
27780973|NCT02348723|54234926|FG000|Overall Study|No ablation|21|||
27780974|NCT02348723|54234927|FG001|Overall Study|No ablation|20|||
27780975|NCT02348723|54234926|FG000|Overall Study|Non-compliant with Protocol|1|||
27780976|NCT02348723|54234927|FG001|Overall Study|Non-compliant with Protocol|0|||
27780977|NCT02348723|54234926|FG000|Overall Study|Lost to Follow-up|1|||
27780978|NCT02348723|54234927|FG001|Overall Study|Lost to Follow-up|1|||
27780979|NCT02348723|54234926|FG000|Overall Study|Consent withdrawn|1|||
27780980|NCT02348723|54234927|FG001|Overall Study|Consent withdrawn|3|||
27780981|NCT02348723|54234926|FG000|Overall Study|Reason other than specified|1|||
27780982|NCT02348723|54234927|FG001|Overall Study|Reason other than specified|1|||
27780983|NCT02348723|54234926|FG000|Overall Study|Adverse Event|3|||
27780984|NCT02348723|54234927|FG001|Overall Study|Adverse Event|1|||
27780985|NCT01967277|54234935|FG000|Overall Study|Lost to Follow-up|1|||
27780986|NCT01967277|54234936|FG001|Overall Study|Lost to Follow-up|2|||
27780987|NCT01967277|54234935|FG000|Overall Study|Unrelated illness|0|||
27780988|NCT01967277|54234936|FG001|Overall Study|Unrelated illness|1|||
27780989|NCT02326883|54234945|FG000|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|84|||
27780990|NCT02326883|54234946|FG001|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|85|||
27780991|NCT02326883|54234947|FG002|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|69|||
27780992|NCT02006667|54234955|FG000|Overall Study|Adverse Event|3|||
27780993|NCT02006667|54234955|FG000|Overall Study|Death|2|||
27780994|NCT02006667|54234955|FG000|Overall Study|Withdrawal by Subject|1|||
27780995|NCT01983111|54234961|FG000|Overall Study|Withdrawal by Subject|8|||
27780996|NCT01983111|54234962|FG001|Overall Study|Withdrawal by Subject|6|||
27780997|NCT01983111|54234961|FG000|Overall Study|Adverse Event|4|||
27780998|NCT01983111|54234962|FG001|Overall Study|Adverse Event|0|||
27780999|NCT01983111|54234961|FG000|Overall Study|Protocol Violation|0|||
27781000|NCT01983111|54234962|FG001|Overall Study|Protocol Violation|1|||
27781001|NCT02348489|54234970|FG000|Overall Study|Death|336|||
27781002|NCT02348489|54234971|FG001|Overall Study|Death|335|||
27781003|NCT02348489|54234970|FG000|Overall Study|Withdrawal by Subject|14|||
27781004|NCT02348489|54234971|FG001|Overall Study|Withdrawal by Subject|27|||
27781005|NCT02348489|54234970|FG000|Overall Study|Lost to Follow-up|3|||
27781006|NCT02348489|54234971|FG001|Overall Study|Lost to Follow-up|5|||
27781007|NCT02309099|54234981|FG000|Overall Study|Adverse Event|2|||
27781008|NCT02309099|54234982|FG001|Overall Study|Adverse Event|0|||
27781009|NCT01966107|54234990|FG000|Overall Study|excluded from FAS|21|||
27781010|NCT01966107|54234991|FG001|Overall Study|excluded from FAS|20|||
27781011|NCT01966107|54234990|FG000|Overall Study|discontinued treatment|345|||
27781012|NCT01966107|54234991|FG001|Overall Study|discontinued treatment|372|||
27781013|NCT01966107|54234990|FG000|Overall Study|due to study closure|164|||
27781014|NCT01966107|54234991|FG001|Overall Study|due to study closure|186|||
27781015|NCT01966107|54234990|FG000|Overall Study|withdrew from the study|272|||
27781016|NCT01966107|54234991|FG001|Overall Study|withdrew from the study|303|||
27781017|NCT02347943|54235000|FG000|Overall Study|Study was cancelled|140|||
27781018|NCT02347943|54235001|FG001|Overall Study|Study was cancelled|67|||
27781019|NCT02347943|54235002|FG002|Overall Study|Study was cancelled|45|||
27781020|NCT01982331|54235012|FG000|Received Vaccination 2|Adverse Event|1|||
27781021|NCT01982331|54235013|FG001|Received Vaccination 2|Adverse Event|2|||
27781022|NCT01982331|54235012|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
27781023|NCT01982331|54235013|FG001|Received Vaccination 2|Withdrawal by Subject|1|||
27781024|NCT01982331|54235012|FG000|Completed Study (Day 112)|Withdrawal by Subject|2|||
27781025|NCT01982331|54235013|FG001|Completed Study (Day 112)|Withdrawal by Subject|0|||
27781026|NCT02326025|54235021|FG000|Overall Study|Adverse Event|3|||
27781027|NCT02326025|54235022|FG001|Overall Study|Adverse Event|0|||
27781028|NCT02326025|54235021|FG000|Overall Study|Physician Decision|1|||
27781029|NCT02326025|54235022|FG001|Overall Study|Physician Decision|2|||
27840750|NCT01469221|54328678|FG002|Double Blind Phase|Physician Decision|0|||
27781030|NCT02326025|54235021|FG000|Overall Study|Physician and Participant Decision|1|||
27781031|NCT02326025|54235022|FG001|Overall Study|Physician and Participant Decision|0|||
27781032|NCT02326025|54235021|FG000|Overall Study|Withdrawal by Subject|0|||
27781033|NCT02326025|54235022|FG001|Overall Study|Withdrawal by Subject|2|||
27781034|NCT02326025|54235021|FG000|Overall Study|Protocol Violation|0|||
27781035|NCT02326025|54235022|FG001|Overall Study|Protocol Violation|1|||
27781036|NCT01619865|54235041|FG000|Overall Study|Adverse Event|1|||
27781037|NCT01619865|54235041|FG000|Overall Study|Death|2|||
27781038|NCT01619865|54235041|FG000|Overall Study|subject not able to comply|1|||
27781039|NCT02006121|54235048|FG000|Double Blind Phase|Adverse Event|6|||
27781040|NCT02006121|54235049|FG001|Double Blind Phase|Adverse Event|0|||
27781041|NCT02006121|54235048|FG000|Double Blind Phase|Lack of Efficacy|1|||
27781042|NCT02006121|54235049|FG001|Double Blind Phase|Lack of Efficacy|16|||
27781043|NCT02006121|54235048|FG000|Double Blind Phase|Withdrawal by Subject|3|||
27781044|NCT02006121|54235049|FG001|Double Blind Phase|Withdrawal by Subject|4|||
27781045|NCT02006121|54235048|FG000|Double Blind Phase|Non-compliance with study drug|1|||
27781046|NCT02006121|54235049|FG001|Double Blind Phase|Non-compliance with study drug|3|||
27781047|NCT02006121|54235048|FG000|Double Blind Phase|Minimum infusion rate poorly tolerated|1|||
27781048|NCT02006121|54235049|FG001|Double Blind Phase|Minimum infusion rate poorly tolerated|0|||
27781049|NCT02006121|54235048|FG000|Double Blind Phase|Inconvenience of infusion system|0|||
27781050|NCT02006121|54235049|FG001|Double Blind Phase|Inconvenience of infusion system|1|||
27781051|NCT02006121|54235048|FG000|Open Label Phase|Adverse Event|15|||
27781052|NCT02006121|54235049|FG001|Open Label Phase|Adverse Event|0|||
27781053|NCT02006121|54235048|FG000|Open Label Phase|Lack of Efficacy|2|||
27781054|NCT02006121|54235049|FG001|Open Label Phase|Lack of Efficacy|0|||
27781055|NCT02006121|54235048|FG000|Open Label Phase|Protocol Violation|2|||
27781056|NCT02006121|54235049|FG001|Open Label Phase|Protocol Violation|0|||
27781057|NCT02006121|54235048|FG000|Open Label Phase|Withdrawal by Subject|3|||
27781058|NCT02006121|54235049|FG001|Open Label Phase|Withdrawal by Subject|0|||
27781059|NCT02006121|54235048|FG000|Open Label Phase|Non-compliance with study drug|3|||
27781060|NCT02006121|54235049|FG001|Open Label Phase|Non-compliance with study drug|0|||
27781061|NCT02005887|54235061|FG000|Overall Study|Protocol Violation|0|||
27781062|NCT02005887|54235062|FG001|Overall Study|Protocol Violation|2|||
27781063|NCT01982253|54235071|FG000|Overall Study|Withdrawal by Subject|1|||
27781064|NCT01982253|54235072|FG001|Overall Study|Withdrawal by Subject|0|||
27781065|NCT01982253|54235073|FG002|Overall Study|Withdrawal by Subject|0|||
27781066|NCT01982253|54235071|FG000|Overall Study|Study terminated by sponsor|1|||
27781067|NCT01982253|54235072|FG001|Overall Study|Study terminated by sponsor|4|||
27781068|NCT01982253|54235073|FG002|Overall Study|Study terminated by sponsor|4|||
27781069|NCT01619787|54235083|FG000|Overall Study|Lost to Follow-up|5|||
27781070|NCT01981473|54235092|FG000|Overall Study|Incorrect diagnosis of RA|0|||
27781071|NCT01981473|54235093|FG001|Overall Study|Incorrect diagnosis of RA|0|||
27781072|NCT01981473|54235094|FG002|Overall Study|Incorrect diagnosis of RA|1|||
27781073|NCT01981473|54235092|FG000|Overall Study|Received treatment for < 6 months|0|||
27781074|NCT01981473|54235093|FG001|Overall Study|Received treatment for < 6 months|0|||
27781075|NCT01981473|54235094|FG002|Overall Study|Received treatment for < 6 months|1|||
27781076|NCT01981473|54235092|FG000|Overall Study|Received treatment for >24 months|2|||
27781077|NCT01981473|54235093|FG001|Overall Study|Received treatment for >24 months|0|||
27781078|NCT01981473|54235094|FG002|Overall Study|Received treatment for >24 months|6|||
27781079|NCT02005029|54235107|FG000|First Intervention (1 Day)|participant withdrawn for noncompliance|1|||
27781080|NCT02005029|54235108|FG001|First Intervention (1 Day)|participant withdrawn for noncompliance|0|||
27781081|NCT02325791|54235136|FG000|Overall Study|Adverse Event|0|||
27781082|NCT02325791|54235137|FG001|Overall Study|Adverse Event|1|||
27781083|NCT02325791|54235138|FG002|Overall Study|Adverse Event|1|||
27781084|NCT02325791|54235139|FG003|Overall Study|Adverse Event|0|||
27781085|NCT02325791|54235136|FG000|Overall Study|Death|0|||
27781086|NCT02325791|54235137|FG001|Overall Study|Death|3|||
27781087|NCT02325791|54235138|FG002|Overall Study|Death|0|||
27781088|NCT02325791|54235139|FG003|Overall Study|Death|1|||
27781089|NCT02325791|54235136|FG000|Overall Study|Lost to Follow-up|0|||
27781090|NCT02325791|54235137|FG001|Overall Study|Lost to Follow-up|15|||
27781091|NCT02325791|54235138|FG002|Overall Study|Lost to Follow-up|14|||
27781092|NCT02325791|54235139|FG003|Overall Study|Lost to Follow-up|9|||
27781093|NCT02325791|54235136|FG000|Overall Study|Physician Decision|0|||
27781094|NCT02325791|54235137|FG001|Overall Study|Physician Decision|1|||
27781095|NCT02325791|54235138|FG002|Overall Study|Physician Decision|1|||
27781096|NCT02325791|54235139|FG003|Overall Study|Physician Decision|0|||
27781097|NCT02325791|54235136|FG000|Overall Study|Protocol Violation|0|||
27781098|NCT02325791|54235137|FG001|Overall Study|Protocol Violation|0|||
27781099|NCT02325791|54235138|FG002|Overall Study|Protocol Violation|1|||
27781100|NCT02325791|54235139|FG003|Overall Study|Protocol Violation|0|||
27781101|NCT02325791|54235136|FG000|Overall Study|Withdrawal by Subject|0|||
27781102|NCT02325791|54235137|FG001|Overall Study|Withdrawal by Subject|5|||
27781103|NCT02325791|54235138|FG002|Overall Study|Withdrawal by Subject|8|||
27781104|NCT02325791|54235139|FG003|Overall Study|Withdrawal by Subject|16|||
27781105|NCT02004873|54235152|FG000|Overall Study|Implant unsuccessful|6|||
27781106|NCT02004873|54235152|FG000|Overall Study|Awaiting 6-month visit|390|||
27781107|NCT02004873|54235152|FG000|Overall Study|Missed 6-month visit|4|||
27781108|NCT02004873|54235152|FG000|Overall Study|Death|23|||
27781109|NCT02004873|54235152|FG000|Overall Study|Withdrawal by Subject|1|||
27781110|NCT02347787|54235161|FG000|6 Month Follow-Up|Lost to Follow-up|63|||
27781111|NCT02347787|54235162|FG001|6 Month Follow-Up|Lost to Follow-up|47|||
27781112|NCT02347787|54235161|FG000|6 Month Follow-Up|Withdrawal by Subject|3|||
27781113|NCT02347787|54235162|FG001|6 Month Follow-Up|Withdrawal by Subject|9|||
27781114|NCT02347787|54235161|FG000|9 Month Follow-Up|Lost to Follow-up|52|||
27781115|NCT02347787|54235162|FG001|9 Month Follow-Up|Lost to Follow-up|59|||
27781116|NCT02347787|54235161|FG000|9 Month Follow-Up|Withdrawal by Subject|9|||
27781117|NCT02347787|54235162|FG001|9 Month Follow-Up|Withdrawal by Subject|12|||
27781118|NCT01979835|54235173|FG000|Primary Outcome SA Measurment|failed insertion|18|||
27781119|NCT01979835|54235173|FG000|Follow-up|Lost to Follow-up|32|||
27781120|NCT02282345|54235179|FG000|Overall Study|Progression|0|||
27781121|NCT02282345|54235180|FG001|Overall Study|Progression|1|||
27781122|NCT01732822|54235191|FG000|Overall Study|Withdrawal by Subject|123|||
27781123|NCT01732822|54235192|FG001|Overall Study|Withdrawal by Subject|113|||
27781124|NCT02004093|54235222|FG000|Overall Study|Death|2|||
27781125|NCT02004093|54235223|FG001|Overall Study|Death|1|||
27781126|NCT02004093|54235222|FG000|Overall Study|Lack of Efficacy|66|||
27781127|NCT02004093|54235223|FG001|Overall Study|Lack of Efficacy|62|||
27781128|NCT02004093|54235222|FG000|Overall Study|Protocol Violation|0|||
27781129|NCT02004093|54235223|FG001|Overall Study|Protocol Violation|1|||
27781130|NCT02004093|54235222|FG000|Overall Study|Lost to Follow-up|0|||
27781131|NCT02004093|54235223|FG001|Overall Study|Lost to Follow-up|1|||
27781132|NCT02004093|54235222|FG000|Overall Study|Withdrawal by Subject|3|||
27781133|NCT02004093|54235223|FG001|Overall Study|Withdrawal by Subject|7|||
27781134|NCT02004093|54235222|FG000|Overall Study|Other|3|||
27781135|NCT02004093|54235223|FG001|Overall Study|Other|1|||
27781136|NCT01641367|54235238|FG000|Cohorts|Death|18|||
27781137|NCT01641367|54235239|FG001|Cohorts|Death|1|||
27781138|NCT01641367|54235240|FG002|Cohorts|Death|2|||
27781139|NCT01641367|54235241|FG003|Cohorts|Death|0|||
27781140|NCT01641367|54235242|FG004|Cohorts|Death|1|||
27781141|NCT01641367|54235243|FG005|Cohorts|Death|1|||
27781142|NCT01641367|54235244|FG006|Cohorts|Death|0|||
27781143|NCT01641367|54235245|FG007|Cohorts|Death|0|||
27781144|NCT01641367|54235238|FG000|Cohorts|Lost to Follow-up|16|||
27781145|NCT01641367|54235239|FG001|Cohorts|Lost to Follow-up|0|||
27781146|NCT01641367|54235240|FG002|Cohorts|Lost to Follow-up|2|||
27781147|NCT01641367|54235241|FG003|Cohorts|Lost to Follow-up|0|||
27781148|NCT01641367|54235242|FG004|Cohorts|Lost to Follow-up|2|||
27781149|NCT01641367|54235243|FG005|Cohorts|Lost to Follow-up|0|||
27781150|NCT01641367|54235244|FG006|Cohorts|Lost to Follow-up|0|||
27781151|NCT01641367|54235245|FG007|Cohorts|Lost to Follow-up|0|||
27781152|NCT01641367|54235238|FG000|Randomized Adherence Intervention|Death|0|||
27781153|NCT01641367|54235239|FG001|Randomized Adherence Intervention|Death|0|||
27781154|NCT01641367|54235240|FG002|Randomized Adherence Intervention|Death|0|||
27781155|NCT01641367|54235241|FG003|Randomized Adherence Intervention|Death|0|||
27781156|NCT01641367|54235242|FG004|Randomized Adherence Intervention|Death|0|||
27781157|NCT01641367|54235243|FG005|Randomized Adherence Intervention|Death|0|||
27781158|NCT01641367|54235244|FG006|Randomized Adherence Intervention|Death|11|||
27781159|NCT01641367|54235245|FG007|Randomized Adherence Intervention|Death|12|||
27781160|NCT01641367|54235238|FG000|Randomized Adherence Intervention|Lost to Follow-up|0|||
27781161|NCT01641367|54235239|FG001|Randomized Adherence Intervention|Lost to Follow-up|0|||
27781162|NCT01641367|54235240|FG002|Randomized Adherence Intervention|Lost to Follow-up|0|||
27781163|NCT01641367|54235241|FG003|Randomized Adherence Intervention|Lost to Follow-up|0|||
27781164|NCT01641367|54235242|FG004|Randomized Adherence Intervention|Lost to Follow-up|0|||
27781165|NCT01641367|54235243|FG005|Randomized Adherence Intervention|Lost to Follow-up|0|||
27781166|NCT01641367|54235244|FG006|Randomized Adherence Intervention|Lost to Follow-up|8|||
27781167|NCT01641367|54235245|FG007|Randomized Adherence Intervention|Lost to Follow-up|12|||
27781168|NCT02325713|54235284|FG000|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
27781169|NCT02325713|54235285|FG001|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
27781170|NCT02325713|54235286|FG002|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
27781171|NCT02325713|54235287|FG003|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
27781172|NCT02325713|54235288|FG004|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
27781173|NCT02325713|54235289|FG005|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
27781174|NCT02325713|54235290|FG006|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
27781175|NCT02325713|54235291|FG007|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
27781176|NCT02325713|54235292|FG008|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
27781177|NCT02325713|54235293|FG009|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
27781178|NCT02325713|54235294|FG010|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1|||
27781179|NCT02325713|54235295|FG011|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
27781180|NCT02325713|54235296|FG012|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
27781181|NCT02325713|54235297|FG013|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
27781182|NCT02325713|54235298|FG014|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
27781183|NCT02325713|54235299|FG015|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
27781184|NCT02325713|54235284|FG000|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1|||
27781185|NCT02325713|54235285|FG001|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
27781186|NCT02325713|54235286|FG002|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
27781187|NCT02325713|54235287|FG003|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
27840751|NCT01469221|54328676|FG000|Double Blind Phase|Sponsor Terminate Study|12|||
27840752|NCT01469221|54328677|FG001|Double Blind Phase|Sponsor Terminate Study|16|||
27781188|NCT02325713|54235288|FG004|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
27781189|NCT02325713|54235289|FG005|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
27781190|NCT02325713|54235290|FG006|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
27781191|NCT02325713|54235291|FG007|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
27781192|NCT02325713|54235292|FG008|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
27781193|NCT02325713|54235293|FG009|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
27781194|NCT02325713|54235294|FG010|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
27781195|NCT02325713|54235295|FG011|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
27781196|NCT02325713|54235296|FG012|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
27781197|NCT02325713|54235297|FG013|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
27781198|NCT02325713|54235298|FG014|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
27781199|NCT02325713|54235299|FG015|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
27781200|NCT02325713|54235284|FG000|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
27781201|NCT02325713|54235285|FG001|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
27781202|NCT02325713|54235286|FG002|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
27781203|NCT02325713|54235287|FG003|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
27781204|NCT02325713|54235288|FG004|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
27781205|NCT02325713|54235289|FG005|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
27781206|NCT02325713|54235290|FG006|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
27781207|NCT02325713|54235291|FG007|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
27781208|NCT02325713|54235292|FG008|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
27781209|NCT02325713|54235293|FG009|Intervention Period 3 (2 Days)|Withdrawal by Subject|1|||
27781210|NCT02325713|54235294|FG010|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
27781211|NCT02325713|54235295|FG011|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
27781212|NCT02325713|54235296|FG012|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
27781213|NCT02325713|54235297|FG013|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
27781214|NCT02325713|54235298|FG014|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
27781215|NCT02325713|54235299|FG015|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
27781216|NCT02325401|54235314|FG000|Overall Study|Withdrawal by Subject|0|||
27781217|NCT02325401|54235315|FG001|Overall Study|Withdrawal by Subject|1|||
27781218|NCT02325401|54235316|FG002|Overall Study|Withdrawal by Subject|1|||
27781219|NCT02324699|54235330|FG000|Overall Study|study terminated|1|||
27781220|NCT01764256|54235338|FG000|Received All Vaccinations|Adverse Event|1|||
27781221|NCT01764256|54235339|FG001|Received All Vaccinations|Adverse Event|1|||
27781222|NCT01764256|54235340|FG002|Received All Vaccinations|Adverse Event|0|||
27781223|NCT01764256|54235341|FG003|Received All Vaccinations|Adverse Event|0|||
27781224|NCT01764256|54235338|FG000|Received All Vaccinations|Did not meet inclusion criteria|0|||
27781225|NCT01764256|54235339|FG001|Received All Vaccinations|Did not meet inclusion criteria|0|||
27781226|NCT01764256|54235340|FG002|Received All Vaccinations|Did not meet inclusion criteria|1|||
27781227|NCT01764256|54235341|FG003|Received All Vaccinations|Did not meet inclusion criteria|0|||
27781228|NCT01764256|54235338|FG000|Received All Vaccinations|Lost to Follow-up|1|||
27781229|NCT01764256|54235339|FG001|Received All Vaccinations|Lost to Follow-up|0|||
27781230|NCT01764256|54235340|FG002|Received All Vaccinations|Lost to Follow-up|0|||
27781231|NCT01764256|54235341|FG003|Received All Vaccinations|Lost to Follow-up|0|||
27781232|NCT01764256|54235338|FG000|Completed Study|Lost to Follow-up|0|||
27781233|NCT01764256|54235339|FG001|Completed Study|Lost to Follow-up|0|||
27781234|NCT01764256|54235340|FG002|Completed Study|Lost to Follow-up|0|||
27781235|NCT01764256|54235341|FG003|Completed Study|Lost to Follow-up|1|||
27781236|NCT01979523|54235357|FG000|Overall Study|Withdrawal by Subject|1|||
27781237|NCT01979523|54235358|FG001|Overall Study|Withdrawal by Subject|0|||
27781238|NCT02255461|54235370|FG000|Overall Study|Adverse Event|0|||
27781239|NCT02255461|54235371|FG001|Overall Study|Adverse Event|1|||
27781240|NCT02255461|54235372|FG002|Overall Study|Adverse Event|0|||
27781241|NCT02255461|54235373|FG003|Overall Study|Adverse Event|0|||
27781242|NCT02255461|54235374|FG004|Overall Study|Adverse Event|1|||
27781243|NCT02255461|54235370|FG000|Overall Study|Withdrawal by Subject|0|||
27781244|NCT02255461|54235371|FG001|Overall Study|Withdrawal by Subject|0|||
27781245|NCT02255461|54235372|FG002|Overall Study|Withdrawal by Subject|1|||
27781246|NCT02255461|54235373|FG003|Overall Study|Withdrawal by Subject|0|||
27781247|NCT02255461|54235374|FG004|Overall Study|Withdrawal by Subject|1|||
27781248|NCT02255461|54235370|FG000|Overall Study|Not meet dose reduction BSA requirement|0|||
27781249|NCT02255461|54235371|FG001|Overall Study|Not meet dose reduction BSA requirement|1|||
27781250|NCT02255461|54235372|FG002|Overall Study|Not meet dose reduction BSA requirement|0|||
27781251|NCT02255461|54235373|FG003|Overall Study|Not meet dose reduction BSA requirement|0|||
27781252|NCT02255461|54235374|FG004|Overall Study|Not meet dose reduction BSA requirement|0|||
27781253|NCT02255149|54235391|FG000|Overall Study|Lost to Follow-up|2|||
27781254|NCT02255149|54235391|FG000|Overall Study|Withdrawal by Subject|1|||
27781255|NCT02255149|54235391|FG000|Overall Study|Withdrawal by PI|1|||
27781256|NCT02255149|54235391|FG000|Overall Study|Implant Failure|1|||
27781257|NCT01764022|54235397|FG000|Overall Study|Death|3|||
27781258|NCT01764022|54235398|FG001|Overall Study|Death|5|||
27781259|NCT01764022|54235397|FG000|Overall Study|Withdrawal by Subject|2|||
27781260|NCT01764022|54235398|FG001|Overall Study|Withdrawal by Subject|6|||
27781261|NCT01764022|54235397|FG000|Overall Study|Lack of Efficacy|0|||
27781262|NCT01764022|54235398|FG001|Overall Study|Lack of Efficacy|1|||
27781263|NCT01764022|54235397|FG000|Overall Study|Physician Decision|0|||
27781264|NCT01764022|54235398|FG001|Overall Study|Physician Decision|2|||
27781265|NCT01764022|54235397|FG000|Overall Study|Lost to Follow-up|2|||
27781266|NCT01764022|54235398|FG001|Overall Study|Lost to Follow-up|0|||
27781267|NCT01764022|54235397|FG000|Overall Study|Protocol Violation|1|||
27781268|NCT01764022|54235398|FG001|Overall Study|Protocol Violation|0|||
27781269|NCT02003391|54235408|FG000|Overall Study|Withdrawal by Subject|2|||
27781270|NCT02003391|54235409|FG001|Overall Study|Withdrawal by Subject|1|||
27781271|NCT02003391|54235408|FG000|Overall Study|Protocol Violation|0|||
27781272|NCT02003391|54235409|FG001|Overall Study|Protocol Violation|1|||
27781273|NCT02003391|54235408|FG000|Overall Study|Adverse Event|1|||
27781274|NCT02003391|54235409|FG001|Overall Study|Adverse Event|0|||
27781275|NCT02254681|54235415|FG000|Overall Study|Lack of Efficacy|6|||
27781276|NCT01965327|54235420|FG000|Overall Study|Physician Decision|2|||
27781277|NCT02002689|54235424|FG000|Overall Study|Disease Progression|7|||
27781278|NCT02002689|54235424|FG000|Overall Study|Adverse Event|3|||
27781279|NCT01639729|54235428|FG000|Overall Study|Withdrawal by Subject|1|||
27781280|NCT01639729|54235429|FG001|Overall Study|Withdrawal by Subject|0|||
27781281|NCT01639729|54235430|FG002|Overall Study|Withdrawal by Subject|1|||
27781282|NCT01639729|54235431|FG003|Overall Study|Withdrawal by Subject|1|||
27781283|NCT01639729|54235432|FG004|Overall Study|Withdrawal by Subject|0|||
27781284|NCT01639729|54235433|FG005|Overall Study|Withdrawal by Subject|0|||
27781285|NCT02002533|54235445|FG000|Overall Study|Withdrawal by Subject|6|||
27781286|NCT02002533|54235446|FG001|Overall Study|Withdrawal by Subject|13|||
27781287|NCT02002533|54235445|FG000|Overall Study|Protocol Violation|0|||
27781288|NCT02002533|54235446|FG001|Overall Study|Protocol Violation|1|||
27781289|NCT02002533|54235445|FG000|Overall Study|Adverse Event|0|||
27781290|NCT02002533|54235446|FG001|Overall Study|Adverse Event|3|||
27781291|NCT02002533|54235445|FG000|Overall Study|Lost to Follow-up|0|||
27781292|NCT02002533|54235446|FG001|Overall Study|Lost to Follow-up|1|||
27781293|NCT02002221|54235455|FG000|Overall Study|Adverse Event|2|||
27781294|NCT02002221|54235456|FG001|Overall Study|Adverse Event|1|||
27781295|NCT02002221|54235455|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
27781296|NCT02002221|54235456|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
27781297|NCT02002221|54235455|FG000|Overall Study|Patient withdrew consent|0|||
27781298|NCT02002221|54235456|FG001|Overall Study|Patient withdrew consent|1|||
27781299|NCT01639495|54235462|FG000|Overall Study|Lost to Follow-up|6|||
27781300|NCT01639495|54235462|FG000|Overall Study|Consented but didn't have study catheter|4|||
27781301|NCT01639495|54235462|FG000|Overall Study|Not meeting inclusion/exclusion criteria|4|||
27781302|NCT01639495|54235462|FG000|Overall Study|No radiofrequency energy applied|2|||
27781303|NCT02001987|54235466|FG000|Core Study Period (24 Weeks)|Adverse Event|9|||
27781304|NCT02001987|54235466|FG000|Core Study Period (24 Weeks)|Death|1|||
27781305|NCT02001987|54235466|FG000|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2|||
27781306|NCT02001987|54235466|FG000|Core Study Period (24 Weeks)|Physician Decision|1|||
27781307|NCT02001987|54235466|FG000|Core Study Period (24 Weeks)|Withdrawal by Subject|4|||
27781308|NCT02001987|54235466|FG000|Core Study Period (24 Weeks)|Protocol Violation|3|||
27781309|NCT02001987|54235466|FG000|Core Study Period (24 Weeks)|Lack of Efficacy|3|||
27781310|NCT02001987|54235466|FG000|LTE Period (52 Weeks)|Lost to Follow-up|2|||
27781311|NCT02001987|54235466|FG000|LTE Period (52 Weeks)|Physician Decision|2|||
27781312|NCT02001987|54235466|FG000|LTE Period (52 Weeks)|Withdrawal by Subject|1|||
27781313|NCT02001987|54235466|FG000|LTE Period (52 Weeks)|Lack of Efficacy|1|||
27781314|NCT02001987|54235466|FG000|LTE Period (52 Weeks)|Other|3|||
27781315|NCT01363765|54235477|FG000|Overall Study|non-diagnostic|2621|||
27781316|NCT01363765|54235478|FG001|Overall Study|non-diagnostic|1124|||
27781317|NCT01363765|54235477|FG000|Overall Study|duplicate records|736|||
27781318|NCT01363765|54235478|FG001|Overall Study|duplicate records|3177|||
27781319|NCT01363765|54235477|FG000|Overall Study|non-resident|156|||
27781320|NCT01363765|54235478|FG001|Overall Study|non-resident|76|||
27781321|NCT01363765|54235477|FG000|Overall Study|age not recorded (used for cross-linkage|117|||
27781322|NCT01363765|54235478|FG001|Overall Study|age not recorded (used for cross-linkage|354|||
27781323|NCT01363765|54235477|FG000|Overall Study|smear during intervention|2170|||
27781324|NCT01363765|54235478|FG001|Overall Study|smear during intervention|0|||
27781325|NCT02001051|54235488|FG000|Overall Study|Deemed not eligible following enrollment|0|||
27781326|NCT02001051|54235489|FG001|Overall Study|Deemed not eligible following enrollment|1|||
27781327|NCT01763164|54235497|FG000|Treatment Phase|Participant/Guardian decision|26|||
27781328|NCT01763164|54235498|FG001|Treatment Phase|Participant/Guardian decision|14|||
27781329|NCT01763164|54235497|FG000|Treatment Phase|Protocol Violation|1|||
27781330|NCT01763164|54235498|FG001|Treatment Phase|Protocol Violation|1|||
27781331|NCT01763164|54235497|FG000|Treatment Phase|Progressive Disease|142|||
27781332|NCT01763164|54235498|FG001|Treatment Phase|Progressive Disease|76|||
27840753|NCT01469221|54328678|FG002|Double Blind Phase|Sponsor Terminate Study|0|||
27781333|NCT01763164|54235497|FG000|Treatment Phase|Physician Decision|24|||
27781334|NCT01763164|54235498|FG001|Treatment Phase|Physician Decision|13|||
27781335|NCT01763164|54235497|FG000|Treatment Phase|Death|10|||
27781336|NCT01763164|54235498|FG001|Treatment Phase|Death|1|||
27781337|NCT01763164|54235497|FG000|Treatment Phase|Adverse Event|66|||
27781338|NCT01763164|54235498|FG001|Treatment Phase|Adverse Event|8|||
27781339|NCT01763164|54235497|FG000|Treatment Phase|Randomized but not Treated|0|||
27781340|NCT01763164|54235498|FG001|Treatment Phase|Randomized but not Treated|19|||
27781341|NCT01763164|54235497|FG000|Treatment Phase|Other|0|||
27781342|NCT01763164|54235498|FG001|Treatment Phase|Other|1|||
27781343|NCT01763164|54235497|FG000|Follow up Phase|New therapy for study indication|12|||
27781344|NCT01763164|54235498|FG001|Follow up Phase|New therapy for study indication|3|||
27781345|NCT01763164|54235497|FG000|Follow up Phase|Death|21|||
27781346|NCT01763164|54235498|FG001|Follow up Phase|Death|4|||
27781347|NCT01763164|54235497|FG000|Follow up Phase|Subject/guardian decision|9|||
27781348|NCT01763164|54235498|FG001|Follow up Phase|Subject/guardian decision|2|||
27781349|NCT01763164|54235497|FG000|Follow up Phase|Progressive disease|127|||
27781350|NCT01763164|54235498|FG001|Follow up Phase|Progressive disease|62|||
27781351|NCT01763164|54235497|FG000|Follow up Phase|Physician Decision|10|||
27781352|NCT01763164|54235498|FG001|Follow up Phase|Physician Decision|3|||
27781353|NCT01763164|54235497|FG000|Follow up Phase|Lost to Follow-up|1|||
27781354|NCT01763164|54235498|FG001|Follow up Phase|Lost to Follow-up|0|||
27781355|NCT01763164|54235497|FG000|Follow up Phase|Adverse Event|17|||
27781356|NCT01763164|54235498|FG001|Follow up Phase|Adverse Event|1|||
27781357|NCT01782742|54235506|FG000|Double-blind Treatment Phase|Adverse Event|1|||
27781358|NCT01782742|54235507|FG001|Double-blind Treatment Phase|Adverse Event|0|||
27781359|NCT01782664|54235521|FG000|Overall Study|Adverse Event|2|||
27781360|NCT01782664|54235522|FG001|Overall Study|Adverse Event|2|||
27781361|NCT01782664|54235523|FG002|Overall Study|Adverse Event|2|||
27781362|NCT01782664|54235524|FG003|Overall Study|Adverse Event|2|||
27781363|NCT01782664|54235525|FG004|Overall Study|Adverse Event|0|||
27781364|NCT01782664|54235526|FG005|Overall Study|Adverse Event|0|||
27781365|NCT01782664|54235521|FG000|Overall Study|Lack of Efficacy|2|||
27781366|NCT01782664|54235522|FG001|Overall Study|Lack of Efficacy|0|||
27781367|NCT01782664|54235523|FG002|Overall Study|Lack of Efficacy|2|||
27781368|NCT01782664|54235524|FG003|Overall Study|Lack of Efficacy|2|||
27781369|NCT01782664|54235525|FG004|Overall Study|Lack of Efficacy|0|||
27781370|NCT01782664|54235526|FG005|Overall Study|Lack of Efficacy|0|||
27781371|NCT01782664|54235521|FG000|Overall Study|Protocol Violation|0|||
27781372|NCT01782664|54235522|FG001|Overall Study|Protocol Violation|1|||
27781373|NCT01782664|54235523|FG002|Overall Study|Protocol Violation|0|||
27781374|NCT01782664|54235524|FG003|Overall Study|Protocol Violation|1|||
27781375|NCT01782664|54235525|FG004|Overall Study|Protocol Violation|0|||
27781376|NCT01782664|54235526|FG005|Overall Study|Protocol Violation|0|||
27781377|NCT01782664|54235521|FG000|Overall Study|Withdrawal by Subject|2|||
27781378|NCT01782664|54235522|FG001|Overall Study|Withdrawal by Subject|2|||
27781379|NCT01782664|54235523|FG002|Overall Study|Withdrawal by Subject|0|||
27781380|NCT01782664|54235524|FG003|Overall Study|Withdrawal by Subject|0|||
27781381|NCT01782664|54235525|FG004|Overall Study|Withdrawal by Subject|0|||
27781382|NCT01782664|54235526|FG005|Overall Study|Withdrawal by Subject|0|||
27781383|NCT01732588|54235543|FG000|First Intervention (7 Days)|Adverse Event|0|||
27781384|NCT01732588|54235544|FG001|First Intervention (7 Days)|Adverse Event|1|||
27781385|NCT01732588|54235545|FG002|First Intervention (7 Days)|Adverse Event|0|||
27781386|NCT01781962|54235553|FG000|Overall Study|Other Miscellaneous Reasons|5|||
27781387|NCT01639339|54235559|FG000|Double-blind Period (Up to Week 104)|Withdrawal by Subject|26|||
27781388|NCT01639339|54235560|FG001|Double-blind Period (Up to Week 104)|Withdrawal by Subject|19|||
27781389|NCT01639339|54235559|FG000|Double-blind Period (Up to Week 104)|Physician Decision|11|||
27781390|NCT01639339|54235560|FG001|Double-blind Period (Up to Week 104)|Physician Decision|5|||
27781391|NCT01639339|54235559|FG000|Double-blind Period (Up to Week 104)|Lost to Follow-up|5|||
27781392|NCT01639339|54235560|FG001|Double-blind Period (Up to Week 104)|Lost to Follow-up|4|||
27781393|NCT01639339|54235559|FG000|Double-blind Period (Up to Week 104)|Protocol Violation|0|||
27781394|NCT01639339|54235560|FG001|Double-blind Period (Up to Week 104)|Protocol Violation|2|||
27781395|NCT01639339|54235559|FG000|Double-blind Period (Up to Week 104)|Lack of Efficacy|2|||
27781396|NCT01639339|54235560|FG001|Double-blind Period (Up to Week 104)|Lack of Efficacy|1|||
27781397|NCT01639339|54235559|FG000|Double-blind Period (Up to Week 104)|Adverse Event|10|||
27781398|NCT01639339|54235560|FG001|Double-blind Period (Up to Week 104)|Adverse Event|7|||
27781399|NCT01639339|54235559|FG000|Open-label Period (Up to Week 28)|Withdrawal by Subject|0|||
27781400|NCT01639339|54235560|FG001|Open-label Period (Up to Week 28)|Withdrawal by Subject|2|||
27781401|NCT01639339|54235559|FG000|Open-label Period (Up to Week 28)|Lost to Follow-up|0|||
27781402|NCT01639339|54235560|FG001|Open-label Period (Up to Week 28)|Lost to Follow-up|1|||
27781403|NCT01639339|54235559|FG000|Open-label Period (Up to Week 28)|Protocol Violation|0|||
27781404|NCT01639339|54235560|FG001|Open-label Period (Up to Week 28)|Protocol Violation|1|||
27781405|NCT01639339|54235559|FG000|Open-label Period (Up to Week 28)|Adverse Event|1|||
27781406|NCT01639339|54235560|FG001|Open-label Period (Up to Week 28)|Adverse Event|4|||
27781407|NCT02000817|54235574|FG000|Overall Study|Withdrawal by Subject|2|||
27781408|NCT02000817|54235575|FG001|Overall Study|Withdrawal by Subject|0|||
27781409|NCT02000817|54235576|FG002|Overall Study|Withdrawal by Subject|0|||
27781410|NCT02000817|54235577|FG003|Overall Study|Withdrawal by Subject|0|||
27781411|NCT02000817|54235574|FG000|Overall Study|Adverse Event|0|||
27781412|NCT02000817|54235575|FG001|Overall Study|Adverse Event|1|||
27781413|NCT02000817|54235576|FG002|Overall Study|Adverse Event|0|||
27781414|NCT02000817|54235577|FG003|Overall Study|Adverse Event|0|||
27781415|NCT02000817|54235574|FG000|Overall Study|Lost to Follow-up|0|||
27781416|NCT02000817|54235575|FG001|Overall Study|Lost to Follow-up|0|||
27781417|NCT02000817|54235576|FG002|Overall Study|Lost to Follow-up|1|||
27781418|NCT02000817|54235577|FG003|Overall Study|Lost to Follow-up|0|||
27781419|NCT01641133|54235593|FG000|Overall Study|Protocol Violation|0|||
27781420|NCT01641133|54235594|FG001|Overall Study|Protocol Violation|1|||
27781421|NCT01641133|54235595|FG002|Overall Study|Protocol Violation|1|||
27781422|NCT01641133|54235593|FG000|Overall Study|Migrated/moved from study area|5|||
27781423|NCT01641133|54235594|FG001|Overall Study|Migrated/moved from study area|3|||
27781424|NCT01641133|54235595|FG002|Overall Study|Migrated/moved from study area|1|||
27781425|NCT01641133|54235593|FG000|Overall Study|Adverse Event|0|||
27781426|NCT01641133|54235594|FG001|Overall Study|Adverse Event|0|||
27781427|NCT01641133|54235595|FG002|Overall Study|Adverse Event|1|||
27781428|NCT01641133|54235593|FG000|Overall Study|Withdrawal by Subject|5|||
27781429|NCT01641133|54235594|FG001|Overall Study|Withdrawal by Subject|3|||
27781430|NCT01641133|54235595|FG002|Overall Study|Withdrawal by Subject|3|||
27781431|NCT01641133|54235593|FG000|Overall Study|Lost to Follow-up|0|||
27781432|NCT01641133|54235594|FG001|Overall Study|Lost to Follow-up|2|||
27781433|NCT01641133|54235595|FG002|Overall Study|Lost to Follow-up|2|||
27781434|NCT02000427|54235603|FG000|Overall Study|Death|22|||
27781435|NCT01600885|54235607|FG000|First Period|Adverse Event|1|||
27781436|NCT01600885|54235608|FG001|First Period|Adverse Event|1|||
27781437|NCT01600885|54235607|FG000|First Period|moved out of area|1|||
27781438|NCT01600885|54235608|FG001|First Period|moved out of area|0|||
27781439|NCT01732510|54235621|FG000|Overall Study|Adverse Event|0|||
27781440|NCT01732510|54235622|FG001|Overall Study|Adverse Event|1|||
27781441|NCT01732510|54235623|FG002|Overall Study|Adverse Event|1|||
27781442|NCT01732510|54235624|FG003|Overall Study|Adverse Event|0|||
27781443|NCT01732510|54235625|FG004|Overall Study|Adverse Event|0|||
27781444|NCT01732510|54235626|FG005|Overall Study|Adverse Event|0|||
27781445|NCT01732510|54235627|FG006|Overall Study|Adverse Event|1|||
27781446|NCT01732510|54235621|FG000|Overall Study|Protocol Violation|0|||
27781447|NCT01732510|54235622|FG001|Overall Study|Protocol Violation|0|||
27781448|NCT01732510|54235623|FG002|Overall Study|Protocol Violation|0|||
27781449|NCT01732510|54235624|FG003|Overall Study|Protocol Violation|1|||
27781450|NCT01732510|54235625|FG004|Overall Study|Protocol Violation|0|||
27781451|NCT01732510|54235626|FG005|Overall Study|Protocol Violation|0|||
27781452|NCT01732510|54235627|FG006|Overall Study|Protocol Violation|0|||
27781453|NCT01732510|54235621|FG000|Overall Study|Withdrawal by Subject|1|||
27781454|NCT01732510|54235622|FG001|Overall Study|Withdrawal by Subject|3|||
27781455|NCT01732510|54235623|FG002|Overall Study|Withdrawal by Subject|2|||
27781456|NCT01732510|54235624|FG003|Overall Study|Withdrawal by Subject|1|||
27781457|NCT01732510|54235625|FG004|Overall Study|Withdrawal by Subject|5|||
27781458|NCT01732510|54235626|FG005|Overall Study|Withdrawal by Subject|0|||
27781459|NCT01732510|54235627|FG006|Overall Study|Withdrawal by Subject|1|||
27781460|NCT01732510|54235621|FG000|Overall Study|Lost to Follow-up|0|||
27781461|NCT01732510|54235622|FG001|Overall Study|Lost to Follow-up|0|||
27781462|NCT01732510|54235623|FG002|Overall Study|Lost to Follow-up|1|||
27781463|NCT01732510|54235624|FG003|Overall Study|Lost to Follow-up|1|||
27781464|NCT01732510|54235625|FG004|Overall Study|Lost to Follow-up|0|||
27781465|NCT01732510|54235626|FG005|Overall Study|Lost to Follow-up|1|||
27781466|NCT01732510|54235627|FG006|Overall Study|Lost to Follow-up|0|||
27781467|NCT01732510|54235621|FG000|Overall Study|Physician Decision|0|||
27781468|NCT01732510|54235622|FG001|Overall Study|Physician Decision|1|||
27781469|NCT01732510|54235623|FG002|Overall Study|Physician Decision|0|||
27781470|NCT01732510|54235624|FG003|Overall Study|Physician Decision|0|||
27781471|NCT01732510|54235625|FG004|Overall Study|Physician Decision|0|||
27781472|NCT01732510|54235626|FG005|Overall Study|Physician Decision|0|||
27781473|NCT01732510|54235627|FG006|Overall Study|Physician Decision|0|||
27781474|NCT01732510|54235621|FG000|Overall Study|Pregnancy|0|||
27781475|NCT01732510|54235622|FG001|Overall Study|Pregnancy|0|||
27781476|NCT01732510|54235623|FG002|Overall Study|Pregnancy|0|||
27781477|NCT01732510|54235624|FG003|Overall Study|Pregnancy|1|||
27781478|NCT01732510|54235625|FG004|Overall Study|Pregnancy|0|||
27781479|NCT01732510|54235626|FG005|Overall Study|Pregnancy|0|||
27781480|NCT01732510|54235627|FG006|Overall Study|Pregnancy|0|||
27840754|NCT01453855|54328687|FG000|Overall Study|Adverse Event|3|||
27781481|NCT01732510|54235621|FG000|Overall Study|Study Terminated By Sponsor|0|||
27781482|NCT01732510|54235622|FG001|Overall Study|Study Terminated By Sponsor|0|||
27781483|NCT01732510|54235623|FG002|Overall Study|Study Terminated By Sponsor|0|||
27781484|NCT01732510|54235624|FG003|Overall Study|Study Terminated By Sponsor|1|||
27781485|NCT01732510|54235625|FG004|Overall Study|Study Terminated By Sponsor|0|||
27781486|NCT01732510|54235626|FG005|Overall Study|Study Terminated By Sponsor|12|||
27781487|NCT01732510|54235627|FG006|Overall Study|Study Terminated By Sponsor|6|||
27781488|NCT01637077|54235648|FG000|Overall Study|Cancel|1|||
27781489|NCT01637077|54235649|FG001|Overall Study|Cancel|1|||
27781490|NCT01637077|54235648|FG000|Overall Study|Withdrawal by Subject|1|||
27781491|NCT01637077|54235649|FG001|Overall Study|Withdrawal by Subject|0|||
27781492|NCT01637077|54235648|FG000|Overall Study|No cycle 1 questionnaire data|2|||
27781493|NCT01637077|54235649|FG001|Overall Study|No cycle 1 questionnaire data|0|||
27840755|NCT01453855|54328688|FG001|Overall Study|Adverse Event|4|||
27781494|NCT02308163|54235659|FG000|Overall Study|Not fulfill eligible criteria|1|||
27781495|NCT02308163|54235660|FG001|Overall Study|Not fulfill eligible criteria|2|||
27781496|NCT02308163|54235661|FG002|Overall Study|Not fulfill eligible criteria|0|||
27781497|NCT02308163|54235662|FG003|Overall Study|Not fulfill eligible criteria|1|||
27781498|NCT02308163|54235663|FG004|Overall Study|Not fulfill eligible criteria|1|||
27781499|NCT02308163|54235659|FG000|Overall Study|Adverse Event|9|||
27781500|NCT02308163|54235660|FG001|Overall Study|Adverse Event|5|||
27781501|NCT02308163|54235661|FG002|Overall Study|Adverse Event|2|||
27781502|NCT02308163|54235662|FG003|Overall Study|Adverse Event|2|||
27781503|NCT02308163|54235663|FG004|Overall Study|Adverse Event|11|||
27781504|NCT02308163|54235659|FG000|Overall Study|Lack of Efficacy|11|||
27781505|NCT02308163|54235660|FG001|Overall Study|Lack of Efficacy|3|||
27781506|NCT02308163|54235661|FG002|Overall Study|Lack of Efficacy|8|||
27781507|NCT02308163|54235662|FG003|Overall Study|Lack of Efficacy|4|||
27781508|NCT02308163|54235663|FG004|Overall Study|Lack of Efficacy|6|||
27781509|NCT02308163|54235659|FG000|Overall Study|Withdrawal of consent|2|||
27781510|NCT02308163|54235660|FG001|Overall Study|Withdrawal of consent|3|||
27781511|NCT02308163|54235661|FG002|Overall Study|Withdrawal of consent|0|||
27781512|NCT02308163|54235662|FG003|Overall Study|Withdrawal of consent|2|||
27781513|NCT02308163|54235663|FG004|Overall Study|Withdrawal of consent|6|||
27781514|NCT02308163|54235659|FG000|Overall Study|Protocol Violation|3|||
27781515|NCT02308163|54235660|FG001|Overall Study|Protocol Violation|3|||
27781516|NCT02308163|54235661|FG002|Overall Study|Protocol Violation|3|||
27781517|NCT02308163|54235662|FG003|Overall Study|Protocol Violation|2|||
27781518|NCT02308163|54235663|FG004|Overall Study|Protocol Violation|5|||
27781519|NCT02308163|54235659|FG000|Overall Study|Lab data met discontinuation criteria|3|||
27781520|NCT02308163|54235660|FG001|Overall Study|Lab data met discontinuation criteria|0|||
27781521|NCT02308163|54235661|FG002|Overall Study|Lab data met discontinuation criteria|0|||
27781522|NCT02308163|54235662|FG003|Overall Study|Lab data met discontinuation criteria|2|||
27781523|NCT02308163|54235663|FG004|Overall Study|Lab data met discontinuation criteria|0|||
27781524|NCT02308163|54235659|FG000|Overall Study|Miscellaneous|2|||
27781525|NCT02308163|54235660|FG001|Overall Study|Miscellaneous|2|||
27781526|NCT02308163|54235661|FG002|Overall Study|Miscellaneous|1|||
27781527|NCT02308163|54235662|FG003|Overall Study|Miscellaneous|0|||
27781528|NCT02308163|54235663|FG004|Overall Study|Miscellaneous|5|||
27781529|NCT02000115|54235693|FG000|Overall Study|Death|56|||
27781530|NCT02000115|54235694|FG001|Overall Study|Death|45|||
27781531|NCT02000115|54235695|FG002|Overall Study|Death|0|||
27781532|NCT02000115|54235696|FG003|Overall Study|Death|0|||
27781533|NCT02000115|54235693|FG000|Overall Study|Missed Visit|6|||
27781534|NCT02000115|54235694|FG001|Overall Study|Missed Visit|8|||
27781535|NCT02000115|54235695|FG002|Overall Study|Missed Visit|1|||
27781536|NCT02000115|54235696|FG003|Overall Study|Missed Visit|0|||
27781537|NCT02000115|54235693|FG000|Overall Study|Protocol Violation|2|||
27781538|NCT02000115|54235694|FG001|Overall Study|Protocol Violation|1|||
27781539|NCT02000115|54235695|FG002|Overall Study|Protocol Violation|0|||
27781540|NCT02000115|54235696|FG003|Overall Study|Protocol Violation|0|||
27781541|NCT02000115|54235693|FG000|Overall Study|Physician Decision|2|||
27781542|NCT02000115|54235694|FG001|Overall Study|Physician Decision|0|||
27781543|NCT02000115|54235695|FG002|Overall Study|Physician Decision|0|||
27781544|NCT02000115|54235696|FG003|Overall Study|Physician Decision|0|||
27781545|NCT02000115|54235693|FG000|Overall Study|Withdrawal by Subject|11|||
27781546|NCT02000115|54235694|FG001|Overall Study|Withdrawal by Subject|11|||
27781547|NCT02000115|54235695|FG002|Overall Study|Withdrawal by Subject|0|||
27781548|NCT02000115|54235696|FG003|Overall Study|Withdrawal by Subject|0|||
27781549|NCT02000115|54235693|FG000|Overall Study|Lost to Follow-up|0|||
27781550|NCT02000115|54235694|FG001|Overall Study|Lost to Follow-up|1|||
27781551|NCT02000115|54235695|FG002|Overall Study|Lost to Follow-up|0|||
27781552|NCT02000115|54235696|FG003|Overall Study|Lost to Follow-up|0|||
27781553|NCT02000115|54235693|FG000|Overall Study|Non-compliance|2|||
27781554|NCT02000115|54235694|FG001|Overall Study|Non-compliance|1|||
27781555|NCT02000115|54235695|FG002|Overall Study|Non-compliance|0|||
27781556|NCT02000115|54235696|FG003|Overall Study|Non-compliance|0|||
27781557|NCT02000115|54235693|FG000|Overall Study|Withdrawn on day of randomization|0|||
27781558|NCT02000115|54235694|FG001|Overall Study|Withdrawn on day of randomization|1|||
27781559|NCT02000115|54235695|FG002|Overall Study|Withdrawn on day of randomization|0|||
27781560|NCT02000115|54235696|FG003|Overall Study|Withdrawn on day of randomization|0|||
27781561|NCT02000115|54235693|FG000|Overall Study|Still on Study|0|||
27781562|NCT02000115|54235694|FG001|Overall Study|Still on Study|0|||
27781563|NCT02000115|54235695|FG002|Overall Study|Still on Study|0|||
27781564|NCT02000115|54235696|FG003|Overall Study|Still on Study|53|||
27781565|NCT01999335|54235710|FG000|Overall Study|Discontinued before receiving treatment|0|||
27840756|NCT01453855|54328687|FG000|Overall Study|Lost to Follow-up|2|||
27781566|NCT01999335|54235711|FG001|Overall Study|Discontinued before receiving treatment|0|||
27781567|NCT01999335|54235712|FG002|Overall Study|Discontinued before receiving treatment|0|||
27781568|NCT01999335|54235713|FG003|Overall Study|Discontinued before receiving treatment|0|||
27840757|NCT01453855|54328688|FG001|Overall Study|Lost to Follow-up|1|||
27781569|NCT01999335|54235714|FG004|Overall Study|Discontinued before receiving treatment|2|||
27781570|NCT01978119|54235729|FG000|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1|||
27781571|NCT01978119|54235730|FG001|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0|||
27781572|NCT01978119|54235729|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
27781573|NCT01978119|54235730|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
27781574|NCT01978119|54235729|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
27781575|NCT01978119|54235730|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
27781576|NCT01999179|54235736|FG000|Overall Study|Adverse Event|1|||
27781577|NCT01999179|54235736|FG000|Overall Study|Lost to Follow-up|1|||
27781578|NCT01999179|54235736|FG000|Overall Study|Change in Therapy|3|||
27781579|NCT01999179|54235736|FG000|Overall Study|New catheter|2|||
27781580|NCT01977729|54235740|FG000|Overall Study|Study terminated|1|||
27781581|NCT01998477|54235748|FG000|Overall Study|Lost to Follow-up|4|||
27781582|NCT01998477|54235749|FG001|Overall Study|Lost to Follow-up|5|||
27781583|NCT01998477|54235748|FG000|Overall Study|Withdrawal by Subject|6|||
27781584|NCT01998477|54235749|FG001|Overall Study|Withdrawal by Subject|0|||
27781585|NCT01998399|54235782|FG000|Overall Study|Lost to Follow-up|1|||
27781586|NCT01998399|54235783|FG001|Overall Study|Lost to Follow-up|3|||
27781587|NCT01998399|54235782|FG000|Overall Study|Death|4|||
27781588|NCT01998399|54235783|FG001|Overall Study|Death|2|||
27781589|NCT01998399|54235782|FG000|Overall Study|Study stopped before dosing completed|3|||
27781590|NCT01998399|54235783|FG001|Overall Study|Study stopped before dosing completed|3|||
27781591|NCT01998399|54235782|FG000|Overall Study|Withdrawal by Subject|0|||
27781592|NCT01998399|54235783|FG001|Overall Study|Withdrawal by Subject|1|||
27781593|NCT01781572|54235800|FG000|MEK162 45mg BID+LEE011 200mg|Adverse Event|7|||
27781594|NCT01781572|54235801|FG001|MEK162 45mg BID+LEE011 200mg|Adverse Event|0|||
27781595|NCT01781572|54235802|FG002|MEK162 45mg BID+LEE011 200mg|Adverse Event|11|||
27781596|NCT01781572|54235800|FG000|MEK162 45mg BID+LEE011 200mg|Progressive disease|8|||
27781597|NCT01781572|54235801|FG001|MEK162 45mg BID+LEE011 200mg|Progressive disease|6|||
27781598|NCT01781572|54235802|FG002|MEK162 45mg BID+LEE011 200mg|Progressive disease|23|||
27781599|NCT01781572|54235800|FG000|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1|||
27781600|NCT01781572|54235801|FG001|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0|||
27781601|NCT01781572|54235802|FG002|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2|||
27781602|NCT01781572|54235800|FG000|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
27781603|NCT01781572|54235801|FG001|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
27781604|NCT01781572|54235802|FG002|MEK162 45mg BID+LEE011 200mg|Physician Decision|4|||
27781605|NCT01781572|54235800|FG000|MEK162 45mg BID+LEE011 200mg|Death|0|||
27781606|NCT01781572|54235801|FG001|MEK162 45mg BID+LEE011 200mg|Death|0|||
27781607|NCT01781572|54235802|FG002|MEK162 45mg BID+LEE011 200mg|Death|1|||
27781608|NCT01781572|54235800|FG000|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2|||
27781609|NCT01781572|54235801|FG001|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
27781610|NCT01781572|54235802|FG002|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
27781611|NCT01781572|54235800|FG000|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1|||
27781612|NCT01781572|54235801|FG001|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
27781613|NCT01781572|54235802|FG002|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
27781614|NCT01781572|54235800|FG000|MEK162 30mg BID+LEE011 300mg|Adverse Event|1|||
27781615|NCT01781572|54235801|FG001|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
27781616|NCT01781572|54235802|FG002|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
27781617|NCT01781572|54235800|FG000|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3|||
27781618|NCT01781572|54235801|FG001|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2|||
27781619|NCT01781572|54235802|FG002|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0|||
27781620|NCT01781572|54235800|FG000|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
27781621|NCT01781572|54235801|FG001|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
27781622|NCT01781572|54235802|FG002|MEK162 45mg BID+LEE011 300mg|Adverse Event|0|||
27781623|NCT01781572|54235800|FG000|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4|||
27781624|NCT01781572|54235801|FG001|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3|||
27781625|NCT01781572|54235802|FG002|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0|||
27781626|NCT01781572|54235800|FG000|MEK162 45mg BID+LEE011 300mg|Death|1|||
27781627|NCT01781572|54235801|FG001|MEK162 45mg BID+LEE011 300mg|Death|0|||
27781628|NCT01781572|54235802|FG002|MEK162 45mg BID+LEE011 300mg|Death|0|||
27781629|NCT01781572|54235800|FG000|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
27781630|NCT01781572|54235801|FG001|MEK162 30mg LEE011 200mg|Progressive Disease|5|||
27781631|NCT01781572|54235802|FG002|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
27781632|NCT01781572|54235800|FG000|MEK162 45mg LEE011 450mg|Adverse Event|0|||
27781633|NCT01781572|54235801|FG001|MEK162 45mg LEE011 450mg|Adverse Event|1|||
27781634|NCT01781572|54235802|FG002|MEK162 45mg LEE011 450mg|Adverse Event|0|||
27781635|NCT01781572|54235800|FG000|MEK162 45mg LEE011 450mg|Physician Decision|0|||
27781636|NCT01781572|54235801|FG001|MEK162 45mg LEE011 450mg|Physician Decision|2|||
27781637|NCT01781572|54235802|FG002|MEK162 45mg LEE011 450mg|Physician Decision|0|||
27781638|NCT01781572|54235800|FG000|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
27781639|NCT01781572|54235801|FG001|MEK162 45mg LEE011 450mg|Progressive Disease|6|||
27781640|NCT01781572|54235802|FG002|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
27781641|NCT01781572|54235800|FG000|MEK162 45mg LEE011 600mg|Adverse Event|0|||
27781642|NCT01781572|54235801|FG001|MEK162 45mg LEE011 600mg|Adverse Event|1|||
27781643|NCT01781572|54235802|FG002|MEK162 45mg LEE011 600mg|Adverse Event|0|||
27781644|NCT01781572|54235800|FG000|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
27781645|NCT01781572|54235801|FG001|MEK162 45mg LEE011 600mg|Progressive Disease|5|||
27781646|NCT01781572|54235802|FG002|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
27781647|NCT01977651|54235831|FG000|4 Month Treatment Period|Adverse Event|34|||
27781648|NCT01977651|54235831|FG000|4 Month Treatment Period|Death|3|||
27781649|NCT01977651|54235831|FG000|4 Month Treatment Period|Progressive Disease|43|||
27781650|NCT01977651|54235831|FG000|4 Month Treatment Period|Withdrawal by Subject|17|||
27781651|NCT01977651|54235831|FG000|4 Month Treatment Period|Physician Decision|4|||
27781652|NCT01977651|54235831|FG000|1 Year Extension Period|Adverse Event|14|||
27781653|NCT01977651|54235831|FG000|1 Year Extension Period|Death|10|||
27781654|NCT01977651|54235831|FG000|1 Year Extension Period|Lost to Follow-up|2|||
27781655|NCT01977651|54235831|FG000|1 Year Extension Period|Progressive Disease|86|||
27781656|NCT01977651|54235831|FG000|1 Year Extension Period|Withdrawal by Subject|11|||
27781657|NCT01977651|54235831|FG000|1 Year Extension Period|Physician Decision|6|||
27781658|NCT01977651|54235831|FG000|1 Year Extension Period|Miscellaneous|1|||
27781659|NCT01977651|54235831|FG000|Post 1 Year Extension Period|Adverse Event|5|||
27781660|NCT01977651|54235831|FG000|Post 1 Year Extension Period|Death|13|||
27781661|NCT01977651|54235831|FG000|Post 1 Year Extension Period|Progressive Disease|60|||
27781662|NCT01977651|54235831|FG000|Post 1 Year Extension Period|Withdrawal by Subject|13|||
27781663|NCT01977651|54235831|FG000|Post 1 Year Extension Period|Physician Decision|4|||
27781664|NCT01977651|54235831|FG000|Post 1 Year Extension Period|Miscellaneous|49|||
27781665|NCT01998243|54235837|FG000|Overall Study|Pregnancy|0|||
27781666|NCT01998243|54235838|FG001|Overall Study|Pregnancy|1|||
27781667|NCT01998243|54235837|FG000|Overall Study|Protocol Violation|5|||
27781668|NCT01998243|54235838|FG001|Overall Study|Protocol Violation|2|||
27781669|NCT01998243|54235837|FG000|Overall Study|Withdrawal by Subject|3|||
27781670|NCT01998243|54235838|FG001|Overall Study|Withdrawal by Subject|4|||
27781671|NCT01977573|54235850|FG000|Overall Study|Adverse Event|7|||
27781672|NCT01977573|54235851|FG001|Overall Study|Adverse Event|0|||
27781673|NCT01977573|54235852|FG002|Overall Study|Adverse Event|2|||
27781674|NCT01977573|54235853|FG003|Overall Study|Adverse Event|1|||
27781675|NCT01977573|54235850|FG000|Overall Study|Lost to Follow-up|1|||
27781676|NCT01977573|54235851|FG001|Overall Study|Lost to Follow-up|0|||
27781677|NCT01977573|54235852|FG002|Overall Study|Lost to Follow-up|0|||
27781678|NCT01977573|54235853|FG003|Overall Study|Lost to Follow-up|1|||
27781679|NCT01977573|54235850|FG000|Overall Study|Physician Decision|1|||
27781680|NCT01977573|54235851|FG001|Overall Study|Physician Decision|0|||
27781681|NCT01977573|54235852|FG002|Overall Study|Physician Decision|0|||
27781682|NCT01977573|54235853|FG003|Overall Study|Physician Decision|0|||
27781683|NCT01977573|54235850|FG000|Overall Study|Protocol Violation|3|||
27781684|NCT01977573|54235851|FG001|Overall Study|Protocol Violation|1|||
27781685|NCT01977573|54235852|FG002|Overall Study|Protocol Violation|0|||
27781686|NCT01977573|54235853|FG003|Overall Study|Protocol Violation|0|||
27781687|NCT01977573|54235850|FG000|Overall Study|Reached Defined Stopping Criteria|2|||
27781688|NCT01977573|54235851|FG001|Overall Study|Reached Defined Stopping Criteria|1|||
27781689|NCT01977573|54235852|FG002|Overall Study|Reached Defined Stopping Criteria|1|||
27781690|NCT01977573|54235853|FG003|Overall Study|Reached Defined Stopping Criteria|0|||
27781691|NCT01977573|54235850|FG000|Overall Study|Withdrawal by Subject|6|||
27781692|NCT01977573|54235851|FG001|Overall Study|Withdrawal by Subject|1|||
27781693|NCT01977573|54235852|FG002|Overall Study|Withdrawal by Subject|1|||
27781694|NCT01977573|54235853|FG003|Overall Study|Withdrawal by Subject|1|||
27781695|NCT01963767|54235866|FG000|Overall Study|Withdrawal by Subject|4|||
27781696|NCT01963767|54235867|FG001|Overall Study|Withdrawal by Subject|2|||
27781697|NCT01963767|54235866|FG000|Overall Study|Adverse Event|2|||
27781698|NCT01963767|54235867|FG001|Overall Study|Adverse Event|0|||
27781699|NCT01761292|54235876|FG000|Part 1|Adverse Event|1|||
27781700|NCT01761292|54235876|FG000|Part 1|not receiving treatment in Part 1|1|||
27781701|NCT01761292|54235876|FG000|Extension 1|Withdrawal by Subject|1|||
27781702|NCT01731886|54235889|FG000|Overall Study|Death|1|||
27781703|NCT01731886|54235890|FG001|Overall Study|Death|0|||
27781704|NCT01731886|54235889|FG000|Overall Study|Never started treatment|0|||
27781705|NCT01731886|54235890|FG001|Overall Study|Never started treatment|1|||
27781706|NCT01731886|54235889|FG000|Overall Study|Non-compliant|1|||
27781707|NCT01731886|54235890|FG001|Overall Study|Non-compliant|0|||
27781708|NCT01759420|54235897|FG000|Overall Study|Screen failure|5|||
27781709|NCT01759420|54235897|FG000|Overall Study|Inaccurate EKG machine readings|1|||
27781710|NCT01781026|54235901|FG000|Overall Study|Lack of Efficacy|2|||
27781711|NCT01607398|54235907|FG000|Overall Study|Adverse Event|0|||
27781712|NCT01607398|54235908|FG001|Overall Study|Adverse Event|2|||
27781713|NCT01607398|54235907|FG000|Overall Study|Severe COPD|2|||
27781714|NCT01607398|54235908|FG001|Overall Study|Severe COPD|0|||
27781715|NCT01779856|54235914|FG000|Overall Study|Withdrawal by Subject|15|||
27781716|NCT01779856|54235914|FG000|Overall Study|Death|3|||
27781717|NCT01779856|54235914|FG000|Overall Study|Physician Decision|1|||
27781718|NCT01779856|54235914|FG000|Overall Study|Inclusion/Exclusion Not Met|2|||
27781719|NCT01779856|54235914|FG000|Overall Study|Delays in scheduling implant|1|||
27781720|NCT01779856|54235914|FG000|Overall Study|Subject ineligible for Implant|2|||
27781721|NCT01729156|54235928|FG000|Overall Study|Withdrawal by Subject|1|||
27781722|NCT01729156|54235929|FG001|Overall Study|Withdrawal by Subject|0|||
27781723|NCT01729156|54235930|FG002|Overall Study|Withdrawal by Subject|0|||
27781724|NCT01779700|54235941|FG000|Overall Study|Adverse Event|4|||
27781725|NCT01779700|54235942|FG001|Overall Study|Adverse Event|3|||
27781726|NCT01779700|54235941|FG000|Overall Study|Withdrawal by Subject|0|||
27781727|NCT01779700|54235942|FG001|Overall Study|Withdrawal by Subject|2|||
27781728|NCT01778530|54235948|FG000|Overall Study|Progression on study|1|||
27781729|NCT01778530|54235948|FG000|Overall Study|Adverse event/side effect|1|||
27781730|NCT01778062|54235954|FG000|Overall Study|Adverse Event|1|||
27781731|NCT01778062|54235955|FG001|Overall Study|Adverse Event|3|||
27781732|NCT01778062|54235954|FG000|Overall Study|Consent Withdrawal|1|||
27781733|NCT01778062|54235955|FG001|Overall Study|Consent Withdrawal|5|||
27781734|NCT01778062|54235954|FG000|Overall Study|major protocol deviation|4|||
27781735|NCT01778062|54235955|FG001|Overall Study|major protocol deviation|3|||
27781736|NCT01759264|54235961|FG000|Overall Study|Serious Adverse Events (SAEs)|1|||
27781737|NCT01759264|54235961|FG000|Overall Study|Adverse Event|1|||
27781738|NCT01759264|54235961|FG000|Overall Study|Other|2|||
27781739|NCT01759264|54235961|FG000|Overall Study|Lost to Follow-up|2|||
27781740|NCT01759264|54235961|FG000|Overall Study|Withdrawal by Subject|3|||
27781741|NCT01759264|54235961|FG000|Overall Study|Discontinued Humira Due to Business Trip|1|||
27781742|NCT01757704|54235968|FG000|Overall Study|Protocol Violation|1|||
27781743|NCT01757704|54235969|FG001|Overall Study|Protocol Violation|3|||
27781744|NCT01757392|54235975|FG000|Overall Study|Withdrawal by Subject|1|||
27840758|NCT01453855|54328687|FG000|Overall Study|Patient Decision Unrel to Adverse Event|3|||
27840759|NCT01453855|54328688|FG001|Overall Study|Patient Decision Unrel to Adverse Event|3|||
27781745|NCT01757392|54235975|FG000|Overall Study|Screen Fail|3|||
27781746|NCT01756846|54235981|FG000|Overall Study|Lost to Follow-up|5|||
27781747|NCT01756846|54235982|FG001|Overall Study|Lost to Follow-up|10|||
27781748|NCT01756846|54235981|FG000|Overall Study|Withdrawal by Subject|1|||
27781749|NCT01756846|54235982|FG001|Overall Study|Withdrawal by Subject|2|||
27781750|NCT01963611|54235993|FG000|Overall Study|Adverse Event|1|||
27781751|NCT01963611|54235994|FG001|Overall Study|Adverse Event|1|||
27781752|NCT01963611|54235995|FG002|Overall Study|Adverse Event|3|||
27781753|NCT01963611|54235996|FG003|Overall Study|Adverse Event|4|||
27781754|NCT01963611|54235997|FG004|Overall Study|Adverse Event|3|||
27781755|NCT01963611|54235993|FG000|Overall Study|Protocol Violation|0|||
27781756|NCT01963611|54235994|FG001|Overall Study|Protocol Violation|0|||
27781757|NCT01963611|54235995|FG002|Overall Study|Protocol Violation|0|||
27781758|NCT01963611|54235996|FG003|Overall Study|Protocol Violation|1|||
27781759|NCT01963611|54235997|FG004|Overall Study|Protocol Violation|0|||
27781760|NCT01963611|54235993|FG000|Overall Study|Lack of Efficacy|0|||
27781761|NCT01963611|54235994|FG001|Overall Study|Lack of Efficacy|0|||
27781762|NCT01963611|54235995|FG002|Overall Study|Lack of Efficacy|0|||
27781763|NCT01963611|54235996|FG003|Overall Study|Lack of Efficacy|1|||
27781764|NCT01963611|54235997|FG004|Overall Study|Lack of Efficacy|0|||
27781765|NCT01963611|54235993|FG000|Overall Study|Withdrawal by Subject|3|||
27781766|NCT01963611|54235994|FG001|Overall Study|Withdrawal by Subject|2|||
27781767|NCT01963611|54235995|FG002|Overall Study|Withdrawal by Subject|1|||
27781768|NCT01963611|54235996|FG003|Overall Study|Withdrawal by Subject|1|||
27781769|NCT01963611|54235997|FG004|Overall Study|Withdrawal by Subject|3|||
27781770|NCT01963611|54235993|FG000|Overall Study|Other|47|||
27781771|NCT01963611|54235994|FG001|Overall Study|Other|46|||
27781772|NCT01963611|54235995|FG002|Overall Study|Other|48|||
27781773|NCT01963611|54235996|FG003|Overall Study|Other|45|||
27781774|NCT01963611|54235997|FG004|Overall Study|Other|45|||
27781775|NCT01975701|54236010|FG000|Overall Study|Lost to Follow-up|1|||
27781776|NCT01975701|54236010|FG000|Overall Study|Death|23|||
27781777|NCT01975701|54236010|FG000|Overall Study|Physician Decision|1|||
27781778|NCT01962987|54236017|FG000|Overall Study|Adverse Event|4|||
27781779|NCT01962987|54236018|FG001|Overall Study|Adverse Event|4|||
27781780|NCT01962987|54236019|FG002|Overall Study|Adverse Event|0|||
27781781|NCT01962987|54236017|FG000|Overall Study|Lost to Follow-up|0|||
27781782|NCT01962987|54236018|FG001|Overall Study|Lost to Follow-up|0|||
27781783|NCT01962987|54236019|FG002|Overall Study|Lost to Follow-up|1|||
27781784|NCT01962987|54236017|FG000|Overall Study|Non compliance with dosing requirements|4|||
27781785|NCT01962987|54236018|FG001|Overall Study|Non compliance with dosing requirements|2|||
27781786|NCT01962987|54236019|FG002|Overall Study|Non compliance with dosing requirements|0|||
27781787|NCT01962987|54236017|FG000|Overall Study|Miscellaneous|1|||
27781788|NCT01962987|54236018|FG001|Overall Study|Miscellaneous|9|||
27781789|NCT01962987|54236019|FG002|Overall Study|Miscellaneous|2|||
27781790|NCT01962987|54236017|FG000|Overall Study|Restricted medication|5|||
27781791|NCT01962987|54236018|FG001|Overall Study|Restricted medication|1|||
27781792|NCT01962987|54236019|FG002|Overall Study|Restricted medication|1|||
27781793|NCT01962987|54236017|FG000|Overall Study|Serious Adverse Event|1|||
27781794|NCT01962987|54236018|FG001|Overall Study|Serious Adverse Event|0|||
27781795|NCT01962987|54236019|FG002|Overall Study|Serious Adverse Event|0|||
27781796|NCT01962987|54236017|FG000|Overall Study|Withdrawal by Subject|11|||
27781797|NCT01962987|54236018|FG001|Overall Study|Withdrawal by Subject|10|||
27781798|NCT01962987|54236019|FG002|Overall Study|Withdrawal by Subject|6|||
27781799|NCT01962987|54236017|FG000|Overall Study|Randomized in Error|4|||
27781800|NCT01962987|54236018|FG001|Overall Study|Randomized in Error|2|||
27781801|NCT01962987|54236019|FG002|Overall Study|Randomized in Error|2|||
27781802|NCT01962441|54236030|FG000|Randomized Period|Randomized but Never Treated|4|||
27781803|NCT01962441|54236031|FG001|Randomized Period|Randomized but Never Treated|2|||
27781804|NCT01962441|54236032|FG002|Randomized Period|Randomized but Never Treated|3|||
27781805|NCT01962441|54236030|FG000|Randomized Period|Lost to Follow-up|2|||
27781806|NCT01962441|54236031|FG001|Randomized Period|Lost to Follow-up|4|||
27781807|NCT01962441|54236032|FG002|Randomized Period|Lost to Follow-up|4|||
27781808|NCT01962441|54236030|FG000|Randomized Period|Withdrew Consent|3|||
27781809|NCT01962441|54236031|FG001|Randomized Period|Withdrew Consent|3|||
27781810|NCT01962441|54236032|FG002|Randomized Period|Withdrew Consent|2|||
27781811|NCT01962441|54236030|FG000|Randomized Period|Adverse Event|1|||
27781812|NCT01962441|54236031|FG001|Randomized Period|Adverse Event|1|||
27781813|NCT01962441|54236032|FG002|Randomized Period|Adverse Event|0|||
27781814|NCT01962441|54236030|FG000|Randomized Period|Death|0|||
27781815|NCT01962441|54236031|FG001|Randomized Period|Death|0|||
27781816|NCT01962441|54236032|FG002|Randomized Period|Death|2|||
27781817|NCT01962441|54236030|FG000|Randomized Period|Protocol Violation|0|||
27781818|NCT01962441|54236031|FG001|Randomized Period|Protocol Violation|1|||
27781819|NCT01962441|54236032|FG002|Randomized Period|Protocol Violation|0|||
27781820|NCT01962441|54236030|FG000|Retreatment Substudy|Lack of Efficacy|1|||
27781821|NCT01962441|54236031|FG001|Retreatment Substudy|Lack of Efficacy|0|||
27781822|NCT01962441|54236032|FG002|Retreatment Substudy|Lack of Efficacy|0|||
27781823|NCT01962441|54236030|FG000|Retreatment Substudy|Lost to Follow-up|1|||
27781824|NCT01962441|54236031|FG001|Retreatment Substudy|Lost to Follow-up|0|||
27781825|NCT01962441|54236032|FG002|Retreatment Substudy|Lost to Follow-up|0|||
27781826|NCT01638013|54236044|FG000|Overall Study|Adverse Event|36|||
27781827|NCT01638013|54236045|FG001|Overall Study|Adverse Event|29|||
27781828|NCT01638013|54236046|FG002|Overall Study|Adverse Event|48|||
27781829|NCT01638013|54236044|FG000|Overall Study|Lack of Efficacy|39|||
27781830|NCT01638013|54236045|FG001|Overall Study|Lack of Efficacy|11|||
27781831|NCT01638013|54236046|FG002|Overall Study|Lack of Efficacy|14|||
27781832|NCT01638013|54236044|FG000|Overall Study|Protocol Violation|10|||
27781833|NCT01638013|54236045|FG001|Overall Study|Protocol Violation|7|||
27781834|NCT01638013|54236046|FG002|Overall Study|Protocol Violation|11|||
27781835|NCT01638013|54236044|FG000|Overall Study|Met discontinuation criteria|4|||
27781836|NCT01638013|54236045|FG001|Overall Study|Met discontinuation criteria|0|||
27781837|NCT01638013|54236046|FG002|Overall Study|Met discontinuation criteria|7|||
27781838|NCT01638013|54236044|FG000|Overall Study|Subject Lost to Follow up|1|||
27781839|NCT01638013|54236045|FG001|Overall Study|Subject Lost to Follow up|0|||
27781840|NCT01638013|54236046|FG002|Overall Study|Subject Lost to Follow up|1|||
27781841|NCT01638013|54236044|FG000|Overall Study|Miscellaneous|25|||
27781842|NCT01638013|54236045|FG001|Overall Study|Miscellaneous|19|||
27781843|NCT01638013|54236046|FG002|Overall Study|Miscellaneous|23|||
27781844|NCT01638013|54236044|FG000|Overall Study|Withdrawal of Consent|16|||
27781845|NCT01638013|54236045|FG001|Overall Study|Withdrawal of Consent|12|||
27781846|NCT01638013|54236046|FG002|Overall Study|Withdrawal of Consent|16|||
27781847|NCT01638013|54236044|FG000|Overall Study|Not met inclusion or exclusion criteria|0|||
27781848|NCT01638013|54236045|FG001|Overall Study|Not met inclusion or exclusion criteria|0|||
27781849|NCT01638013|54236046|FG002|Overall Study|Not met inclusion or exclusion criteria|1|||
27781850|NCT01637623|54236061|FG000|Overall Study|Lost to Follow-up|0|||
27781851|NCT01637623|54236062|FG001|Overall Study|Lost to Follow-up|0|||
27781852|NCT01637623|54236063|FG002|Overall Study|Lost to Follow-up|2|||
27781853|NCT01637623|54236061|FG000|Overall Study|Physician Decision|1|||
27781854|NCT01637623|54236062|FG001|Overall Study|Physician Decision|0|||
27781855|NCT01637623|54236063|FG002|Overall Study|Physician Decision|1|||
27781856|NCT01962207|54236075|FG000|Persistence Phase (5 Years)|Lost to Follow-up|2|||
27781857|NCT01962207|54236076|FG001|Persistence Phase (5 Years)|Lost to Follow-up|1|||
27781858|NCT01962207|54236077|FG002|Persistence Phase (5 Years)|Lost to Follow-up|5|||
27781859|NCT01962207|54236078|FG003|Persistence Phase (5 Years)|Lost to Follow-up|2|||
27781860|NCT01962207|54236075|FG000|Persistence Phase (5 Years)|Migrated/moved from study area|2|||
27781861|NCT01962207|54236076|FG001|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
27781862|NCT01962207|54236077|FG002|Persistence Phase (5 Years)|Migrated/moved from study area|4|||
27781863|NCT01962207|54236078|FG003|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
27781864|NCT01962207|54236075|FG000|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
27781865|NCT01962207|54236076|FG001|Persistence Phase (5 Years)|Withdrawal by Subject|5|||
27781866|NCT01962207|54236077|FG002|Persistence Phase (5 Years)|Withdrawal by Subject|18|||
27781867|NCT01962207|54236078|FG003|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
27781868|NCT01962207|54236075|FG000|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
27781869|NCT01962207|54236076|FG001|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
27781870|NCT01962207|54236077|FG002|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3|||
27781871|NCT01962207|54236078|FG003|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1|||
27781872|NCT01962207|54236075|FG000|Persistence Phase (5 Years)|Adverse Event|0|||
27781873|NCT01962207|54236076|FG001|Persistence Phase (5 Years)|Adverse Event|0|||
27781874|NCT01962207|54236077|FG002|Persistence Phase (5 Years)|Adverse Event|1|||
27781875|NCT01962207|54236078|FG003|Persistence Phase (5 Years)|Adverse Event|0|||
27781876|NCT01962207|54236075|FG000|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21|||
27781877|NCT01962207|54236076|FG001|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7|||
27781878|NCT01962207|54236077|FG002|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13|||
27781879|NCT01962207|54236078|FG003|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5|||
27781880|NCT01995825|54236094|FG000|Overall Study|Withdrawal by Subject|1|||
27840760|NCT01453855|54328687|FG000|Overall Study|Noncompliance|1|||
27840761|NCT01453855|54328688|FG001|Overall Study|Noncompliance|0|||
27840762|NCT01453855|54328687|FG000|Overall Study|Inadequate Control of IOP|1|||
27840763|NCT01453855|54328688|FG001|Overall Study|Inadequate Control of IOP|5|||
27840764|NCT01453855|54328687|FG000|Overall Study|Other|0|||
27840765|NCT01453855|54328688|FG001|Overall Study|Other|1|||
27840766|NCT01469065|54328699|FG000|Overall Study|Lack of Efficacy|0|||
27840767|NCT01469065|54328700|FG001|Overall Study|Lack of Efficacy|0|||
27840768|NCT01469065|54328701|FG002|Overall Study|Lack of Efficacy|0|||
27840769|NCT01469065|54328702|FG003|Overall Study|Lack of Efficacy|0|||
27840770|NCT01469065|54328703|FG004|Overall Study|Lack of Efficacy|1|||
27840771|NCT01469065|54328699|FG000|Overall Study|Other|0|||
27840772|NCT01469065|54328700|FG001|Overall Study|Other|1|||
27840773|NCT01469065|54328701|FG002|Overall Study|Other|0|||
27840774|NCT01469065|54328702|FG003|Overall Study|Other|0|||
27840775|NCT01469065|54328703|FG004|Overall Study|Other|0|||
27840776|NCT01586624|54328727|FG000|Overall Study|Adverse Event|3|||
27840777|NCT01586624|54328728|FG001|Overall Study|Adverse Event|0|||
27840778|NCT01586624|54328729|FG002|Overall Study|Adverse Event|2|||
27840779|NCT01586624|54328730|FG003|Overall Study|Adverse Event|1|||
27840780|NCT01586624|54328731|FG004|Overall Study|Adverse Event|3|||
27840781|NCT01586624|54328732|FG005|Overall Study|Adverse Event|3|||
27840782|NCT01586624|54328733|FG006|Overall Study|Adverse Event|2|||
27840783|NCT01586624|54328734|FG007|Overall Study|Adverse Event|3|||
27840784|NCT01586624|54328727|FG000|Overall Study|Physician Decision|0|||
27840785|NCT01586624|54328728|FG001|Overall Study|Physician Decision|1|||
27840786|NCT01586624|54328729|FG002|Overall Study|Physician Decision|1|||
27840787|NCT01586624|54328730|FG003|Overall Study|Physician Decision|0|||
27840788|NCT01586624|54328731|FG004|Overall Study|Physician Decision|2|||
27840789|NCT01586624|54328732|FG005|Overall Study|Physician Decision|0|||
27840790|NCT01586624|54328733|FG006|Overall Study|Physician Decision|1|||
27840791|NCT01586624|54328734|FG007|Overall Study|Physician Decision|1|||
27840792|NCT01586624|54328727|FG000|Overall Study|Withdrawal by Subject|0|||
27840793|NCT01586624|54328728|FG001|Overall Study|Withdrawal by Subject|0|||
27840794|NCT01586624|54328729|FG002|Overall Study|Withdrawal by Subject|0|||
27840795|NCT01586624|54328730|FG003|Overall Study|Withdrawal by Subject|1|||
27840796|NCT01586624|54328731|FG004|Overall Study|Withdrawal by Subject|0|||
27840797|NCT01586624|54328732|FG005|Overall Study|Withdrawal by Subject|0|||
27840798|NCT01586624|54328733|FG006|Overall Study|Withdrawal by Subject|0|||
27840799|NCT01586624|54328734|FG007|Overall Study|Withdrawal by Subject|0|||
27840800|NCT01586624|54328727|FG000|Overall Study|Evidence of disease progression|1|||
27840801|NCT01586624|54328728|FG001|Overall Study|Evidence of disease progression|3|||
27840802|NCT01586624|54328729|FG002|Overall Study|Evidence of disease progression|2|||
27840803|NCT01586624|54328730|FG003|Overall Study|Evidence of disease progression|5|||
27840804|NCT01586624|54328731|FG004|Overall Study|Evidence of disease progression|3|||
27840805|NCT01586624|54328732|FG005|Overall Study|Evidence of disease progression|5|||
27840806|NCT01586624|54328733|FG006|Overall Study|Evidence of disease progression|4|||
27840807|NCT01586624|54328734|FG007|Overall Study|Evidence of disease progression|6|||
27840808|NCT01586624|54328727|FG000|Overall Study|Screen failure (no treatment received)|0|||
27840809|NCT01586624|54328728|FG001|Overall Study|Screen failure (no treatment received)|0|||
27840810|NCT01586624|54328729|FG002|Overall Study|Screen failure (no treatment received)|0|||
27840811|NCT01586624|54328730|FG003|Overall Study|Screen failure (no treatment received)|0|||
27840812|NCT01586624|54328731|FG004|Overall Study|Screen failure (no treatment received)|0|||
27840813|NCT01586624|54328732|FG005|Overall Study|Screen failure (no treatment received)|0|||
27840814|NCT01586624|54328733|FG006|Overall Study|Screen failure (no treatment received)|1|||
27840815|NCT01586624|54328734|FG007|Overall Study|Screen failure (no treatment received)|0|||
27840816|NCT01586156|54328756|FG000|Overall Study|Pregnancy|0|||
27840817|NCT01586156|54328757|FG001|Overall Study|Pregnancy|1|||
27840818|NCT01586156|54328758|FG002|Overall Study|Pregnancy|0|||
27840819|NCT01459913|54328770|FG000|Overall Study|Adverse Event|0|||
27840820|NCT01459913|54328771|FG001|Overall Study|Adverse Event|0|||
27840821|NCT01459913|54328772|FG002|Overall Study|Adverse Event|0|||
27840822|NCT01459913|54328773|FG003|Overall Study|Adverse Event|3|||
27840823|NCT01459913|54328770|FG000|Overall Study|Withdrawal by Subject|4|||
27840824|NCT01459913|54328771|FG001|Overall Study|Withdrawal by Subject|0|||
27781881|NCT01995825|54236095|FG001|Overall Study|Withdrawal by Subject|0|||
27781882|NCT01995357|54236101|FG000|Period 5|Lack of Efficacy|1|||
27781883|NCT01995357|54236102|FG001|Period 5|Lack of Efficacy|0|||
27781884|NCT01995357|54236103|FG002|Period 5|Lack of Efficacy|0|||
27781885|NCT01995357|54236104|FG003|Period 5|Lack of Efficacy|0|||
27781886|NCT01995357|54236105|FG004|Period 5|Lack of Efficacy|0|||
27781887|NCT01995357|54236106|FG005|Period 5|Lack of Efficacy|0|||
27781888|NCT01995357|54236101|FG000|Period 5|Adverse Event|1|||
27781889|NCT01995357|54236102|FG001|Period 5|Adverse Event|0|||
27781890|NCT01995357|54236103|FG002|Period 5|Adverse Event|1|||
27781891|NCT01995357|54236104|FG003|Period 5|Adverse Event|0|||
27781892|NCT01995357|54236105|FG004|Period 5|Adverse Event|0|||
27781893|NCT01995357|54236106|FG005|Period 5|Adverse Event|0|||
27840825|NCT01459913|54328772|FG002|Overall Study|Withdrawal by Subject|0|||
27840826|NCT01459913|54328773|FG003|Overall Study|Withdrawal by Subject|5|||
27840827|NCT01459913|54328770|FG000|Overall Study|Lost to Follow-up|7|||
27840828|NCT01459913|54328771|FG001|Overall Study|Lost to Follow-up|4|||
27840829|NCT01459913|54328772|FG002|Overall Study|Lost to Follow-up|1|||
27840830|NCT01459913|54328773|FG003|Overall Study|Lost to Follow-up|8|||
27840831|NCT01459913|54328770|FG000|Overall Study|Death|0|||
27840832|NCT01459913|54328771|FG001|Overall Study|Death|0|||
27840833|NCT01459913|54328772|FG002|Overall Study|Death|0|||
27840834|NCT01459913|54328773|FG003|Overall Study|Death|1|||
27781894|NCT01638559|54236122|FG000|Overall Study|Lost to Follow-up|1|||
27781895|NCT01638559|54236122|FG000|Overall Study|Withdrawal by Subject|1|||
27840835|NCT01459913|54328770|FG000|Overall Study|Non- Compliance|0|||
27840836|NCT01459913|54328771|FG001|Overall Study|Non- Compliance|0|||
27840837|NCT01459913|54328772|FG002|Overall Study|Non- Compliance|0|||
27840838|NCT01459913|54328773|FG003|Overall Study|Non- Compliance|3|||
27840839|NCT01459913|54328770|FG000|Overall Study|Physician Decision|0|||
27840840|NCT01459913|54328771|FG001|Overall Study|Physician Decision|1|||
27840841|NCT01459913|54328772|FG002|Overall Study|Physician Decision|0|||
27840842|NCT01459913|54328773|FG003|Overall Study|Physician Decision|0|||
27840843|NCT01459913|54328770|FG000|Overall Study|Study Terminated by Sponsor|30|||
27840844|NCT01459913|54328771|FG001|Overall Study|Study Terminated by Sponsor|15|||
27840845|NCT01459913|54328772|FG002|Overall Study|Study Terminated by Sponsor|9|||
27840846|NCT01459913|54328773|FG003|Overall Study|Study Terminated by Sponsor|11|||
27781896|NCT01638559|54236122|FG000|Overall Study|Subject declined to travel for biopsy|1|||
27840847|NCT01459913|54328770|FG000|Overall Study|Other|0|||
27840848|NCT01459913|54328771|FG001|Overall Study|Other|0|||
27781897|NCT01756456|54236143|FG000|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
27840849|NCT01459913|54328772|FG002|Overall Study|Other|3|||
27781898|NCT01756456|54236144|FG001|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
27781899|NCT01756456|54236145|FG002|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
27781900|NCT01756456|54236146|FG003|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
27781901|NCT01756456|54236147|FG004|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
27781902|NCT01756456|54236148|FG005|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
27781903|NCT01756456|54236143|FG000|Treatment Period: Phase I/II|Lack of Efficacy|0|||
27781904|NCT01756456|54236144|FG001|Treatment Period: Phase I/II|Lack of Efficacy|0|||
27781905|NCT01756456|54236145|FG002|Treatment Period: Phase I/II|Lack of Efficacy|0|||
27781906|NCT01756456|54236146|FG003|Treatment Period: Phase I/II|Lack of Efficacy|2|||
27781907|NCT01756456|54236147|FG004|Treatment Period: Phase I/II|Lack of Efficacy|1|||
27781908|NCT01756456|54236148|FG005|Treatment Period: Phase I/II|Lack of Efficacy|0|||
27781909|NCT01756456|54236143|FG000|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
27781910|NCT01756456|54236144|FG001|Treatment Period: Phase I/II|Withdrawal by Subject|1|||
27781911|NCT01756456|54236145|FG002|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
27781912|NCT01756456|54236146|FG003|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
27781913|NCT01756456|54236147|FG004|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
27781914|NCT01756456|54236148|FG005|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
27781915|NCT01756456|54236143|FG000|Treatment Period: Phase I/II|Adverse Event|1|||
27781916|NCT01756456|54236144|FG001|Treatment Period: Phase I/II|Adverse Event|0|||
27781917|NCT01756456|54236145|FG002|Treatment Period: Phase I/II|Adverse Event|2|||
27781918|NCT01756456|54236146|FG003|Treatment Period: Phase I/II|Adverse Event|3|||
27781919|NCT01756456|54236147|FG004|Treatment Period: Phase I/II|Adverse Event|9|||
27781920|NCT01756456|54236148|FG005|Treatment Period: Phase I/II|Adverse Event|1|||
27781921|NCT01756456|54236143|FG000|Treatment Period: Phase I/II|Other causes|0|||
27781922|NCT01756456|54236144|FG001|Treatment Period: Phase I/II|Other causes|0|||
27781923|NCT01756456|54236145|FG002|Treatment Period: Phase I/II|Other causes|0|||
27781924|NCT01756456|54236146|FG003|Treatment Period: Phase I/II|Other causes|1|||
27781925|NCT01756456|54236147|FG004|Treatment Period: Phase I/II|Other causes|2|||
27781926|NCT01756456|54236148|FG005|Treatment Period: Phase I/II|Other causes|2|||
27781927|NCT01756456|54236143|FG000|Follow Up Period Phase I/II|still in study after week 20|0|||
27781928|NCT01756456|54236144|FG001|Follow Up Period Phase I/II|still in study after week 20|0|||
27781929|NCT01756456|54236145|FG002|Follow Up Period Phase I/II|still in study after week 20|0|||
27781930|NCT01756456|54236146|FG003|Follow Up Period Phase I/II|still in study after week 20|25|||
27781931|NCT01756456|54236147|FG004|Follow Up Period Phase I/II|still in study after week 20|23|||
27781932|NCT01756456|54236148|FG005|Follow Up Period Phase I/II|still in study after week 20|25|||
27781933|NCT01756456|54236143|FG000|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
27781934|NCT01756456|54236144|FG001|Follow Up Period Phase I/II|parent withdrew the consent to continue|1|||
27781935|NCT01756456|54236145|FG002|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
27781936|NCT01756456|54236146|FG003|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
27781937|NCT01756456|54236147|FG004|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
27781938|NCT01756456|54236148|FG005|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
27781939|NCT01756456|54236143|FG000|Follow Up Period Phase I/II|Lack of Efficacy|0|||
27781940|NCT01756456|54236144|FG001|Follow Up Period Phase I/II|Lack of Efficacy|0|||
27781941|NCT01756456|54236145|FG002|Follow Up Period Phase I/II|Lack of Efficacy|0|||
27781942|NCT01756456|54236146|FG003|Follow Up Period Phase I/II|Lack of Efficacy|0|||
27781943|NCT01756456|54236147|FG004|Follow Up Period Phase I/II|Lack of Efficacy|0|||
27781944|NCT01756456|54236148|FG005|Follow Up Period Phase I/II|Lack of Efficacy|1|||
27781945|NCT01756456|54236143|FG000|Follow Up Period Phase I/II|Adverse Event|1|||
27781946|NCT01756456|54236144|FG001|Follow Up Period Phase I/II|Adverse Event|0|||
27781947|NCT01756456|54236145|FG002|Follow Up Period Phase I/II|Adverse Event|0|||
27781948|NCT01756456|54236146|FG003|Follow Up Period Phase I/II|Adverse Event|5|||
27781949|NCT01756456|54236147|FG004|Follow Up Period Phase I/II|Adverse Event|0|||
27781950|NCT01756456|54236148|FG005|Follow Up Period Phase I/II|Adverse Event|1|||
27781951|NCT01756456|54236143|FG000|Follow Up Period Phase I/II|Lost to Follow-up|0|||
27781952|NCT01756456|54236144|FG001|Follow Up Period Phase I/II|Lost to Follow-up|0|||
27781953|NCT01756456|54236145|FG002|Follow Up Period Phase I/II|Lost to Follow-up|1|||
27781954|NCT01756456|54236146|FG003|Follow Up Period Phase I/II|Lost to Follow-up|2|||
27781955|NCT01756456|54236147|FG004|Follow Up Period Phase I/II|Lost to Follow-up|0|||
27781956|NCT01756456|54236148|FG005|Follow Up Period Phase I/II|Lost to Follow-up|1|||
27781957|NCT01756456|54236143|FG000|Follow Up Period Phase I/II|Other causes|0|||
27781958|NCT01756456|54236144|FG001|Follow Up Period Phase I/II|Other causes|0|||
27781959|NCT01756456|54236145|FG002|Follow Up Period Phase I/II|Other causes|0|||
27781960|NCT01756456|54236146|FG003|Follow Up Period Phase I/II|Other causes|1|||
27781961|NCT01756456|54236147|FG004|Follow Up Period Phase I/II|Other causes|3|||
27781962|NCT01756456|54236148|FG005|Follow Up Period Phase I/II|Other causes|5|||
27781963|NCT01756300|54236171|FG000|Overall Study|Death|1|||
27781964|NCT01756300|54236171|FG000|Overall Study|Withdrawal by Subject|1|||
27781965|NCT01995201|54236194|FG000|From Baseline Until Week 24|Adverse Event|4|||
27781966|NCT01995201|54236195|FG001|From Baseline Until Week 24|Adverse Event|15|||
27781967|NCT01995201|54236196|FG002|From Baseline Until Week 24|Adverse Event|0|||
27781968|NCT01995201|54236197|FG003|From Baseline Until Week 24|Adverse Event|0|||
27781969|NCT01995201|54236198|FG004|From Baseline Until Week 24|Adverse Event|0|||
27781970|NCT01995201|54236199|FG005|From Baseline Until Week 24|Adverse Event|0|||
27781971|NCT01995201|54236200|FG006|From Baseline Until Week 24|Adverse Event|0|||
27781972|NCT01995201|54236194|FG000|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
27781973|NCT01995201|54236195|FG001|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3|||
27781974|NCT01995201|54236196|FG002|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
27781975|NCT01995201|54236197|FG003|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
27781976|NCT01995201|54236198|FG004|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
27781977|NCT01995201|54236199|FG005|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
27781978|NCT01995201|54236200|FG006|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
27781979|NCT01995201|54236194|FG000|From Baseline Until Week 24|Death|0|||
27781980|NCT01995201|54236195|FG001|From Baseline Until Week 24|Death|1|||
27781981|NCT01995201|54236196|FG002|From Baseline Until Week 24|Death|0|||
27781982|NCT01995201|54236197|FG003|From Baseline Until Week 24|Death|0|||
27781983|NCT01995201|54236198|FG004|From Baseline Until Week 24|Death|0|||
27781984|NCT01995201|54236199|FG005|From Baseline Until Week 24|Death|0|||
27781985|NCT01995201|54236200|FG006|From Baseline Until Week 24|Death|0|||
27781986|NCT01995201|54236194|FG000|From Baseline Until Week 24|Lack of Efficacy|2|||
27781987|NCT01995201|54236195|FG001|From Baseline Until Week 24|Lack of Efficacy|5|||
27781988|NCT01995201|54236196|FG002|From Baseline Until Week 24|Lack of Efficacy|0|||
27781989|NCT01995201|54236197|FG003|From Baseline Until Week 24|Lack of Efficacy|0|||
27781990|NCT01995201|54236198|FG004|From Baseline Until Week 24|Lack of Efficacy|0|||
27781991|NCT01995201|54236199|FG005|From Baseline Until Week 24|Lack of Efficacy|0|||
27781992|NCT01995201|54236200|FG006|From Baseline Until Week 24|Lack of Efficacy|0|||
27781993|NCT01995201|54236194|FG000|From Baseline Until Week 24|Lost to Follow-up|2|||
27781994|NCT01995201|54236195|FG001|From Baseline Until Week 24|Lost to Follow-up|3|||
27781995|NCT01995201|54236196|FG002|From Baseline Until Week 24|Lost to Follow-up|0|||
27781996|NCT01995201|54236197|FG003|From Baseline Until Week 24|Lost to Follow-up|0|||
27781997|NCT01995201|54236198|FG004|From Baseline Until Week 24|Lost to Follow-up|0|||
27781998|NCT01995201|54236199|FG005|From Baseline Until Week 24|Lost to Follow-up|0|||
27781999|NCT01995201|54236200|FG006|From Baseline Until Week 24|Lost to Follow-up|0|||
27782000|NCT01995201|54236194|FG000|From Baseline Until Week 24|Withdrawal by Subject|2|||
27782001|NCT01995201|54236195|FG001|From Baseline Until Week 24|Withdrawal by Subject|8|||
27782002|NCT01995201|54236196|FG002|From Baseline Until Week 24|Withdrawal by Subject|0|||
27782003|NCT01995201|54236197|FG003|From Baseline Until Week 24|Withdrawal by Subject|0|||
27782004|NCT01995201|54236198|FG004|From Baseline Until Week 24|Withdrawal by Subject|0|||
27782005|NCT01995201|54236199|FG005|From Baseline Until Week 24|Withdrawal by Subject|0|||
27782006|NCT01995201|54236200|FG006|From Baseline Until Week 24|Withdrawal by Subject|0|||
27782007|NCT01995201|54236194|FG000|From Baseline Until Week 24|Physician Decision|0|||
27782008|NCT01995201|54236195|FG001|From Baseline Until Week 24|Physician Decision|2|||
27782009|NCT01995201|54236196|FG002|From Baseline Until Week 24|Physician Decision|0|||
27782010|NCT01995201|54236197|FG003|From Baseline Until Week 24|Physician Decision|0|||
27782011|NCT01995201|54236198|FG004|From Baseline Until Week 24|Physician Decision|0|||
27782012|NCT01995201|54236199|FG005|From Baseline Until Week 24|Physician Decision|0|||
27782013|NCT01995201|54236200|FG006|From Baseline Until Week 24|Physician Decision|0|||
27782014|NCT01995201|54236194|FG000|From Baseline Until Week 24|Protocol Violation|0|||
27782015|NCT01995201|54236195|FG001|From Baseline Until Week 24|Protocol Violation|9|||
27782016|NCT01995201|54236196|FG002|From Baseline Until Week 24|Protocol Violation|0|||
27782017|NCT01995201|54236197|FG003|From Baseline Until Week 24|Protocol Violation|0|||
27782018|NCT01995201|54236198|FG004|From Baseline Until Week 24|Protocol Violation|0|||
27782019|NCT01995201|54236199|FG005|From Baseline Until Week 24|Protocol Violation|0|||
27782020|NCT01995201|54236200|FG006|From Baseline Until Week 24|Protocol Violation|0|||
27782021|NCT01995201|54236194|FG000|From Week 24 Until Week 48|Adverse Event|0|||
27782022|NCT01995201|54236195|FG001|From Week 24 Until Week 48|Adverse Event|0|||
27782023|NCT01995201|54236196|FG002|From Week 24 Until Week 48|Adverse Event|2|||
27782024|NCT01995201|54236197|FG003|From Week 24 Until Week 48|Adverse Event|1|||
27782025|NCT01995201|54236198|FG004|From Week 24 Until Week 48|Adverse Event|1|||
27782026|NCT01995201|54236199|FG005|From Week 24 Until Week 48|Adverse Event|3|||
27782027|NCT01995201|54236200|FG006|From Week 24 Until Week 48|Adverse Event|1|||
27782028|NCT01995201|54236194|FG000|From Week 24 Until Week 48|Death|0|||
27782029|NCT01995201|54236195|FG001|From Week 24 Until Week 48|Death|0|||
27782030|NCT01995201|54236196|FG002|From Week 24 Until Week 48|Death|0|||
27782031|NCT01995201|54236197|FG003|From Week 24 Until Week 48|Death|0|||
27782032|NCT01995201|54236198|FG004|From Week 24 Until Week 48|Death|0|||
27782033|NCT01995201|54236199|FG005|From Week 24 Until Week 48|Death|2|||
27782034|NCT01995201|54236200|FG006|From Week 24 Until Week 48|Death|0|||
27782035|NCT01995201|54236194|FG000|From Week 24 Until Week 48|Lack of Efficacy|0|||
27782036|NCT01995201|54236195|FG001|From Week 24 Until Week 48|Lack of Efficacy|0|||
27782037|NCT01995201|54236196|FG002|From Week 24 Until Week 48|Lack of Efficacy|1|||
27782038|NCT01995201|54236197|FG003|From Week 24 Until Week 48|Lack of Efficacy|0|||
27782039|NCT01995201|54236198|FG004|From Week 24 Until Week 48|Lack of Efficacy|0|||
27782040|NCT01995201|54236199|FG005|From Week 24 Until Week 48|Lack of Efficacy|2|||
27782041|NCT01995201|54236200|FG006|From Week 24 Until Week 48|Lack of Efficacy|1|||
27782042|NCT01995201|54236194|FG000|From Week 24 Until Week 48|Lost to Follow-up|0|||
27782043|NCT01995201|54236195|FG001|From Week 24 Until Week 48|Lost to Follow-up|0|||
27782044|NCT01995201|54236196|FG002|From Week 24 Until Week 48|Lost to Follow-up|0|||
27782045|NCT01995201|54236197|FG003|From Week 24 Until Week 48|Lost to Follow-up|0|||
27782046|NCT01995201|54236198|FG004|From Week 24 Until Week 48|Lost to Follow-up|1|||
27782047|NCT01995201|54236199|FG005|From Week 24 Until Week 48|Lost to Follow-up|1|||
27782048|NCT01995201|54236200|FG006|From Week 24 Until Week 48|Lost to Follow-up|0|||
27782049|NCT01995201|54236194|FG000|From Week 24 Until Week 48|Withdrawal by Subject|0|||
27782050|NCT01995201|54236195|FG001|From Week 24 Until Week 48|Withdrawal by Subject|0|||
27782051|NCT01995201|54236196|FG002|From Week 24 Until Week 48|Withdrawal by Subject|1|||
27782052|NCT01995201|54236197|FG003|From Week 24 Until Week 48|Withdrawal by Subject|0|||
27782053|NCT01995201|54236198|FG004|From Week 24 Until Week 48|Withdrawal by Subject|1|||
27782054|NCT01995201|54236199|FG005|From Week 24 Until Week 48|Withdrawal by Subject|0|||
27782055|NCT01995201|54236200|FG006|From Week 24 Until Week 48|Withdrawal by Subject|0|||
27782056|NCT01995201|54236194|FG000|From Week 24 Until Week 48|Physician Decision|0|||
27782057|NCT01995201|54236195|FG001|From Week 24 Until Week 48|Physician Decision|0|||
27782058|NCT01995201|54236196|FG002|From Week 24 Until Week 48|Physician Decision|0|||
27782059|NCT01995201|54236197|FG003|From Week 24 Until Week 48|Physician Decision|0|||
27782060|NCT01995201|54236198|FG004|From Week 24 Until Week 48|Physician Decision|1|||
27782061|NCT01995201|54236199|FG005|From Week 24 Until Week 48|Physician Decision|0|||
27782062|NCT01995201|54236200|FG006|From Week 24 Until Week 48|Physician Decision|0|||
27782063|NCT01995201|54236194|FG000|From Week 24 Until Week 48|Protocol Violation|0|||
27782064|NCT01995201|54236195|FG001|From Week 24 Until Week 48|Protocol Violation|0|||
27782065|NCT01995201|54236196|FG002|From Week 24 Until Week 48|Protocol Violation|1|||
27782066|NCT01995201|54236197|FG003|From Week 24 Until Week 48|Protocol Violation|0|||
27782067|NCT01995201|54236198|FG004|From Week 24 Until Week 48|Protocol Violation|2|||
27782068|NCT01995201|54236199|FG005|From Week 24 Until Week 48|Protocol Violation|0|||
27782069|NCT01995201|54236200|FG006|From Week 24 Until Week 48|Protocol Violation|0|||
27782070|NCT01728454|54236224|FG000|Stage 1 and 2|Pregnancy|1|||
27782071|NCT01728454|54236225|FG001|Stage 1 and 2|Pregnancy|0|||
27782072|NCT01728454|54236226|FG002|Stage 1 and 2|Pregnancy|0|||
27782073|NCT01728454|54236224|FG000|Stage 1 and 2|Non-compliance with Protocol|0|||
27782074|NCT01728454|54236225|FG001|Stage 1 and 2|Non-compliance with Protocol|0|||
27782075|NCT01728454|54236226|FG002|Stage 1 and 2|Non-compliance with Protocol|1|||
27782076|NCT01728454|54236224|FG000|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1|||
27782077|NCT01728454|54236225|FG001|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
27782078|NCT01728454|54236226|FG002|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
27782079|NCT01728454|54236224|FG000|Stage 1 and 2|Lost to Follow-up|1|||
27782080|NCT01728454|54236225|FG001|Stage 1 and 2|Lost to Follow-up|1|||
27782081|NCT01728454|54236226|FG002|Stage 1 and 2|Lost to Follow-up|0|||
27782082|NCT01728454|54236224|FG000|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2|||
27782083|NCT01728454|54236225|FG001|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
27782084|NCT01728454|54236226|FG002|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
27782085|NCT01728454|54236224|FG000|Stage 3|Reason Missing|0|||
27782086|NCT01728454|54236225|FG001|Stage 3|Reason Missing|0|||
27782087|NCT01728454|54236226|FG002|Stage 3|Reason Missing|1|||
27782088|NCT01728454|54236224|FG000|Stage 3|Subject Required Other Treatment|0|||
27782089|NCT01728454|54236225|FG001|Stage 3|Subject Required Other Treatment|1|||
27782090|NCT01728454|54236226|FG002|Stage 3|Subject Required Other Treatment|0|||
27782091|NCT01728454|54236224|FG000|Stage 3|Pregnancy|1|||
27782092|NCT01728454|54236225|FG001|Stage 3|Pregnancy|0|||
27782093|NCT01728454|54236226|FG002|Stage 3|Pregnancy|0|||
27782094|NCT01728454|54236224|FG000|Stage 3|Withdrew Consent|1|||
27782095|NCT01728454|54236225|FG001|Stage 3|Withdrew Consent|0|||
27782096|NCT01728454|54236226|FG002|Stage 3|Withdrew Consent|1|||
27782097|NCT01728454|54236224|FG000|Stage 3|Non-compliance with Protocol|0|||
27782098|NCT01728454|54236225|FG001|Stage 3|Non-compliance with Protocol|0|||
27782099|NCT01728454|54236226|FG002|Stage 3|Non-compliance with Protocol|1|||
27782100|NCT01728454|54236224|FG000|Stage 3|Lost to Follow-up|0|||
27782101|NCT01728454|54236225|FG001|Stage 3|Lost to Follow-up|3|||
27782102|NCT01728454|54236226|FG002|Stage 3|Lost to Follow-up|1|||
27782103|NCT01728454|54236224|FG000|Stage 3|Withdrew due to Adverse Events/Toxicity|1|||
27782104|NCT01728454|54236225|FG001|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
27782105|NCT01728454|54236226|FG002|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
27782106|NCT01636687|54236240|FG000|Induction Period|Withdrawal by Subject|1|||
27782107|NCT01636687|54236241|FG001|Induction Period|Withdrawal by Subject|0|||
27782108|NCT01636687|54236242|FG002|Induction Period|Withdrawal by Subject|0|||
27782109|NCT01636687|54236243|FG003|Induction Period|Withdrawal by Subject|0|||
27782110|NCT01636687|54236244|FG004|Induction Period|Withdrawal by Subject|0|||
27782111|NCT01636687|54236240|FG000|Induction Period|Adverse Event|1|||
27782112|NCT01636687|54236241|FG001|Induction Period|Adverse Event|0|||
27782113|NCT01636687|54236242|FG002|Induction Period|Adverse Event|0|||
27782114|NCT01636687|54236243|FG003|Induction Period|Adverse Event|0|||
27782115|NCT01636687|54236244|FG004|Induction Period|Adverse Event|1|||
27782116|NCT01636687|54236240|FG000|Induction Period|Lack of Efficacy|0|||
27782117|NCT01636687|54236241|FG001|Induction Period|Lack of Efficacy|0|||
27782118|NCT01636687|54236242|FG002|Induction Period|Lack of Efficacy|0|||
27782119|NCT01636687|54236243|FG003|Induction Period|Lack of Efficacy|0|||
27782120|NCT01636687|54236244|FG004|Induction Period|Lack of Efficacy|1|||
27782121|NCT01636687|54236240|FG000|Induction Period|Physician Decision|1|||
27782122|NCT01636687|54236241|FG001|Induction Period|Physician Decision|0|||
27782123|NCT01636687|54236242|FG002|Induction Period|Physician Decision|0|||
27782124|NCT01636687|54236243|FG003|Induction Period|Physician Decision|0|||
27782125|NCT01636687|54236244|FG004|Induction Period|Physician Decision|0|||
27782126|NCT01636687|54236240|FG000|Maintenance Period|Withdrawal by Subject|2|||
27782127|NCT01636687|54236241|FG001|Maintenance Period|Withdrawal by Subject|0|||
27782128|NCT01636687|54236242|FG002|Maintenance Period|Withdrawal by Subject|2|||
27782129|NCT01636687|54236243|FG003|Maintenance Period|Withdrawal by Subject|0|||
27782130|NCT01636687|54236244|FG004|Maintenance Period|Withdrawal by Subject|0|||
27782131|NCT01636687|54236240|FG000|Maintenance Period|Adverse Event|1|||
27782132|NCT01636687|54236241|FG001|Maintenance Period|Adverse Event|0|||
27782133|NCT01636687|54236242|FG002|Maintenance Period|Adverse Event|0|||
27782134|NCT01636687|54236243|FG003|Maintenance Period|Adverse Event|0|||
27782135|NCT01636687|54236244|FG004|Maintenance Period|Adverse Event|0|||
27782136|NCT01636687|54236240|FG000|Maintenance Period|Lack of Efficacy|4|||
27782137|NCT01636687|54236241|FG001|Maintenance Period|Lack of Efficacy|1|||
27782138|NCT01636687|54236242|FG002|Maintenance Period|Lack of Efficacy|0|||
27782139|NCT01636687|54236243|FG003|Maintenance Period|Lack of Efficacy|0|||
27782140|NCT01636687|54236244|FG004|Maintenance Period|Lack of Efficacy|0|||
27782141|NCT01636687|54236240|FG000|Maintenance Period|Lost to Follow-up|1|||
27782142|NCT01636687|54236241|FG001|Maintenance Period|Lost to Follow-up|1|||
27782143|NCT01636687|54236242|FG002|Maintenance Period|Lost to Follow-up|0|||
27782144|NCT01636687|54236243|FG003|Maintenance Period|Lost to Follow-up|0|||
27782145|NCT01636687|54236244|FG004|Maintenance Period|Lost to Follow-up|1|||
27782146|NCT01636687|54236240|FG000|Maintenance Period|Physician Decision|0|||
27782147|NCT01636687|54236241|FG001|Maintenance Period|Physician Decision|0|||
27782148|NCT01636687|54236242|FG002|Maintenance Period|Physician Decision|0|||
27782149|NCT01636687|54236243|FG003|Maintenance Period|Physician Decision|0|||
27782150|NCT01636687|54236244|FG004|Maintenance Period|Physician Decision|1|||
27782151|NCT01636687|54236240|FG000|Extension Period|technical problems|0|||
27782152|NCT01636687|54236241|FG001|Extension Period|technical problems|1|||
27782153|NCT01636687|54236242|FG002|Extension Period|technical problems|2|||
27782154|NCT01636687|54236243|FG003|Extension Period|technical problems|1|||
27782155|NCT01636687|54236244|FG004|Extension Period|technical problems|0|||
27782156|NCT01636687|54236240|FG000|Extension Period|Adverse Event|4|||
27782157|NCT01636687|54236241|FG001|Extension Period|Adverse Event|3|||
27782158|NCT01636687|54236242|FG002|Extension Period|Adverse Event|2|||
27782159|NCT01636687|54236243|FG003|Extension Period|Adverse Event|1|||
27782160|NCT01636687|54236244|FG004|Extension Period|Adverse Event|0|||
27782161|NCT01636687|54236240|FG000|Extension Period|Lack of Efficacy|7|||
27782162|NCT01636687|54236241|FG001|Extension Period|Lack of Efficacy|0|||
27782163|NCT01636687|54236242|FG002|Extension Period|Lack of Efficacy|2|||
27782164|NCT01636687|54236243|FG003|Extension Period|Lack of Efficacy|1|||
27782165|NCT01636687|54236244|FG004|Extension Period|Lack of Efficacy|0|||
27782166|NCT01636687|54236240|FG000|Extension Period|Lost to Follow-up|1|||
27782167|NCT01636687|54236241|FG001|Extension Period|Lost to Follow-up|0|||
27782168|NCT01636687|54236242|FG002|Extension Period|Lost to Follow-up|1|||
27782169|NCT01636687|54236243|FG003|Extension Period|Lost to Follow-up|0|||
27782170|NCT01636687|54236244|FG004|Extension Period|Lost to Follow-up|0|||
27782171|NCT01636687|54236240|FG000|Extension Period|Physician Decision|1|||
27782172|NCT01636687|54236241|FG001|Extension Period|Physician Decision|0|||
27782173|NCT01636687|54236242|FG002|Extension Period|Physician Decision|0|||
27782174|NCT01636687|54236243|FG003|Extension Period|Physician Decision|1|||
27782175|NCT01636687|54236244|FG004|Extension Period|Physician Decision|0|||
27782176|NCT01636687|54236240|FG000|Extension Period|study terminated by sponsor|33|||
27782177|NCT01636687|54236241|FG001|Extension Period|study terminated by sponsor|50|||
27782178|NCT01636687|54236242|FG002|Extension Period|study terminated by sponsor|17|||
27782179|NCT01636687|54236243|FG003|Extension Period|study terminated by sponsor|23|||
27782180|NCT01636687|54236244|FG004|Extension Period|study terminated by sponsor|0|||
27782181|NCT01636687|54236240|FG000|Extension Period|Withdrawal by Subject|1|||
27782182|NCT01636687|54236241|FG001|Extension Period|Withdrawal by Subject|0|||
27782183|NCT01636687|54236242|FG002|Extension Period|Withdrawal by Subject|1|||
27782184|NCT01636687|54236243|FG003|Extension Period|Withdrawal by Subject|1|||
27782185|NCT01636687|54236244|FG004|Extension Period|Withdrawal by Subject|0|||
27782186|NCT01636687|54236240|FG000|Follow-up Period|Withdrawal by Subject|1|||
27782187|NCT01636687|54236241|FG001|Follow-up Period|Withdrawal by Subject|0|||
27782188|NCT01636687|54236242|FG002|Follow-up Period|Withdrawal by Subject|0|||
27782189|NCT01636687|54236243|FG003|Follow-up Period|Withdrawal by Subject|0|||
27782190|NCT01636687|54236244|FG004|Follow-up Period|Withdrawal by Subject|1|||
27782191|NCT01634659|54236264|FG000|Period 2 - Second 8 Days of Wear|Adverse Event|2|||
27782192|NCT01634659|54236265|FG001|Period 2 - Second 8 Days of Wear|Adverse Event|0|||
27782193|NCT01634659|54236264|FG000|Period 2 - Second 8 Days of Wear|Physician Decision|1|||
27782194|NCT01634659|54236265|FG001|Period 2 - Second 8 Days of Wear|Physician Decision|0|||
27782195|NCT04863248|54236277|FG000|Overall Study|Sponsor Terminated|4|||
27782196|NCT04863248|54236278|FG001|Overall Study|Sponsor Terminated|1|||
27782197|NCT04863248|54236277|FG000|Overall Study|Death|0|||
27782198|NCT04863248|54236278|FG001|Overall Study|Death|1|||
27782199|NCT04863248|54236277|FG000|Overall Study|Withdrawal by Subject|0|||
27782200|NCT04863248|54236278|FG001|Overall Study|Withdrawal by Subject|1|||
27782201|NCT04498832|54236286|FG000|Overall Study|Adverse Event|1|||
27782202|NCT04498832|54236287|FG001|Overall Study|Adverse Event|3|||
27782203|NCT04498832|54236286|FG000|Overall Study|Withdrawal by Subject|0|||
27782204|NCT04498832|54236287|FG001|Overall Study|Withdrawal by Subject|1|||
27782205|NCT04285229|54236295|FG000|Double-Blind Treatment Period|Withdrawal by Subject|2|||
27782206|NCT04285229|54236296|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
27782207|NCT04285229|54236297|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
27782208|NCT04285229|54236298|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
27782209|NCT04285229|54236299|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
27782210|NCT04285229|54236300|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
27782211|NCT04285229|54236295|FG000|Extended Treatment Period|Withdrawal by Subject|0|||
27782212|NCT04285229|54236296|FG001|Extended Treatment Period|Withdrawal by Subject|0|||
27782213|NCT04285229|54236297|FG002|Extended Treatment Period|Withdrawal by Subject|0|||
27782214|NCT04285229|54236298|FG003|Extended Treatment Period|Withdrawal by Subject|7|||
27782215|NCT04285229|54236299|FG004|Extended Treatment Period|Withdrawal by Subject|0|||
27782216|NCT04285229|54236300|FG005|Extended Treatment Period|Withdrawal by Subject|0|||
27782217|NCT04285229|54236295|FG000|Extended Treatment Period|Adverse Event|0|||
27782218|NCT04285229|54236296|FG001|Extended Treatment Period|Adverse Event|0|||
27782219|NCT04285229|54236297|FG002|Extended Treatment Period|Adverse Event|0|||
27782220|NCT04285229|54236298|FG003|Extended Treatment Period|Adverse Event|1|||
27782221|NCT04285229|54236299|FG004|Extended Treatment Period|Adverse Event|0|||
27782222|NCT04285229|54236300|FG005|Extended Treatment Period|Adverse Event|0|||
27782223|NCT04285229|54236295|FG000|Extended Treatment Period|Physician Decision|0|||
27782224|NCT04285229|54236296|FG001|Extended Treatment Period|Physician Decision|0|||
27782225|NCT04285229|54236297|FG002|Extended Treatment Period|Physician Decision|1|||
27782226|NCT04285229|54236298|FG003|Extended Treatment Period|Physician Decision|0|||
27782227|NCT04285229|54236299|FG004|Extended Treatment Period|Physician Decision|0|||
27782228|NCT04285229|54236300|FG005|Extended Treatment Period|Physician Decision|0|||
27782229|NCT04285229|54236295|FG000|Follow-up Period|Adverse Event|0|||
27782230|NCT04285229|54236296|FG001|Follow-up Period|Adverse Event|0|||
27782231|NCT04285229|54236297|FG002|Follow-up Period|Adverse Event|0|||
27782232|NCT04285229|54236298|FG003|Follow-up Period|Adverse Event|0|||
27782233|NCT04285229|54236299|FG004|Follow-up Period|Adverse Event|1|||
27782234|NCT04285229|54236300|FG005|Follow-up Period|Adverse Event|4|||
27782235|NCT04285229|54236295|FG000|Follow-up Period|Withdrawal by Subject|0|||
27782236|NCT04285229|54236296|FG001|Follow-up Period|Withdrawal by Subject|0|||
27782237|NCT04285229|54236297|FG002|Follow-up Period|Withdrawal by Subject|0|||
27782238|NCT04285229|54236298|FG003|Follow-up Period|Withdrawal by Subject|0|||
27782239|NCT04285229|54236299|FG004|Follow-up Period|Withdrawal by Subject|0|||
27782240|NCT04285229|54236300|FG005|Follow-up Period|Withdrawal by Subject|5|||
27782241|NCT04285229|54236295|FG000|Follow-up Period|Covid-19|0|||
27782242|NCT04285229|54236296|FG001|Follow-up Period|Covid-19|0|||
27782243|NCT04285229|54236297|FG002|Follow-up Period|Covid-19|0|||
27782244|NCT04285229|54236298|FG003|Follow-up Period|Covid-19|0|||
27782245|NCT04285229|54236299|FG004|Follow-up Period|Covid-19|0|||
27782246|NCT04285229|54236300|FG005|Follow-up Period|Covid-19|2|||
27782247|NCT04285229|54236295|FG000|Follow-up Period|Physician Decision|0|||
27782248|NCT04285229|54236296|FG001|Follow-up Period|Physician Decision|0|||
27782249|NCT04285229|54236297|FG002|Follow-up Period|Physician Decision|0|||
27782250|NCT04285229|54236298|FG003|Follow-up Period|Physician Decision|0|||
27782251|NCT04285229|54236299|FG004|Follow-up Period|Physician Decision|0|||
27782252|NCT04285229|54236300|FG005|Follow-up Period|Physician Decision|1|||
27782253|NCT04263454|54236317|FG000|Overall Study|Adverse Event|0|||
27782254|NCT04263454|54236318|FG001|Overall Study|Adverse Event|2|||
27782255|NCT04263454|54236317|FG000|Overall Study|Physician Decision|3|||
27782256|NCT04263454|54236318|FG001|Overall Study|Physician Decision|5|||
27782257|NCT04263454|54236317|FG000|Overall Study|Poor Data Quality|0|||
27782258|NCT04263454|54236318|FG001|Overall Study|Poor Data Quality|1|||
27782259|NCT04155463|54236328|FG000|First Intervention (1 Week)|out of town during dietary intervention|0|||
27782260|NCT04155463|54236329|FG001|First Intervention (1 Week)|out of town during dietary intervention|1|||
27782261|NCT04056611|54236335|FG000|Overall Study|Physician Decision|1|||
27782262|NCT04001803|54236339|FG000|Intervention Phase (Up to Month 12)|Adverse Event|5|||
27782263|NCT04001803|54236339|FG000|Intervention Phase (Up to Month 12)|Protocol Violation|3|||
27782264|NCT04001803|54236339|FG000|Intervention Phase (Up to Month 12)|Physician Decision|1|||
27782265|NCT04001803|54236339|FG000|Intervention Phase (Up to Month 12)|Withdrawal by Subject|4|||
27782266|NCT04001803|54236339|FG000|Extension Phase (From Months 13 to 30)|Adverse Event|2|||
27782267|NCT04001803|54236339|FG000|Extension Phase (From Months 13 to 30)|Protocol Violation|1|||
27782268|NCT04001803|54236339|FG000|Extension Phase (From Months 13 to 30)|Lost to Follow-up|1|||
27782269|NCT04001803|54236339|FG000|Extension Phase (From Months 13 to 30)|Withdrawal by Subject|2|||
27782270|NCT04001803|54236339|FG000|Long-term Follow-up Phase(Up to Week 52)|Lost to Follow-up|1|||
27782271|NCT04001803|54236339|FG000|Long-term Follow-up Phase(Up to Week 52)|Withdrawal by Subject|2|||
27782272|NCT03768427|54236348|FG000|Overall Study|Death|0|||
27782273|NCT03768427|54236349|FG001|Overall Study|Death|0|||
27782274|NCT03768427|54236350|FG002|Overall Study|Death|1|||
27782275|NCT03768427|54236351|FG003|Overall Study|Death|0|||
27782276|NCT03768427|54236348|FG000|Overall Study|Lost to Follow-up|2|||
27782277|NCT03768427|54236349|FG001|Overall Study|Lost to Follow-up|0|||
27782278|NCT03768427|54236350|FG002|Overall Study|Lost to Follow-up|0|||
27782279|NCT03768427|54236351|FG003|Overall Study|Lost to Follow-up|0|||
27782280|NCT03768427|54236348|FG000|Overall Study|Physician Decision|3|||
27782281|NCT03768427|54236349|FG001|Overall Study|Physician Decision|2|||
27782282|NCT03768427|54236350|FG002|Overall Study|Physician Decision|4|||
27782283|NCT03768427|54236351|FG003|Overall Study|Physician Decision|4|||
27782284|NCT03768427|54236348|FG000|Overall Study|Withdrawal by Subject|7|||
27782285|NCT03768427|54236349|FG001|Overall Study|Withdrawal by Subject|2|||
27782286|NCT03768427|54236350|FG002|Overall Study|Withdrawal by Subject|6|||
27782287|NCT03768427|54236351|FG003|Overall Study|Withdrawal by Subject|7|||
27782288|NCT03595228|54236365|FG000|Overall Study|Death|2|||
27782289|NCT03595228|54236365|FG000|Overall Study|Lack of Efficacy|13|||
27782290|NCT03595228|54236365|FG000|Overall Study|Withdrawal by Subject|3|||
27782291|NCT03595228|54236365|FG000|Overall Study|Withdrawal by Sponsor|1|||
27782292|NCT03572933|54236371|FG000|Overall Study|Adverse Event|4|||
27782293|NCT03572933|54236372|FG001|Overall Study|Adverse Event|1|||
27782294|NCT03572933|54236371|FG000|Overall Study|Withdrawal by Subject|0|||
27782295|NCT03572933|54236372|FG001|Overall Study|Withdrawal by Subject|1|||
27782296|NCT03558152|54236383|FG000|Overall Study|Adverse Event|0|||
27782297|NCT03558152|54236384|FG001|Overall Study|Adverse Event|0|||
27782298|NCT03558152|54236385|FG002|Overall Study|Adverse Event|1|||
27782299|NCT03558152|54236386|FG003|Overall Study|Adverse Event|1|||
27782300|NCT03558152|54236387|FG004|Overall Study|Adverse Event|2|||
27782301|NCT03558152|54236388|FG005|Overall Study|Adverse Event|1|||
27782302|NCT03558152|54236389|FG006|Overall Study|Adverse Event|1|||
27782303|NCT03558152|54236390|FG007|Overall Study|Adverse Event|0|||
27782304|NCT03558152|54236383|FG000|Overall Study|Death|0|||
27782305|NCT03558152|54236384|FG001|Overall Study|Death|0|||
27782306|NCT03558152|54236385|FG002|Overall Study|Death|0|||
27782307|NCT03558152|54236386|FG003|Overall Study|Death|0|||
27782308|NCT03558152|54236387|FG004|Overall Study|Death|1|||
27782309|NCT03558152|54236388|FG005|Overall Study|Death|0|||
27782310|NCT03558152|54236389|FG006|Overall Study|Death|0|||
27782311|NCT03558152|54236390|FG007|Overall Study|Death|0|||
27782312|NCT03558152|54236383|FG000|Overall Study|Rolled over in GA40209 due to worsening of disease|1|||
27782313|NCT03558152|54236384|FG001|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
27782314|NCT03558152|54236385|FG002|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
27782315|NCT03558152|54236386|FG003|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
27782316|NCT03558152|54236387|FG004|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
27782317|NCT03558152|54236388|FG005|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
27782318|NCT03558152|54236389|FG006|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
27782319|NCT03558152|54236390|FG007|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
27782320|NCT03558152|54236383|FG000|Overall Study|Miscalculation in mmcs|0|||
27782321|NCT03558152|54236384|FG001|Overall Study|Miscalculation in mmcs|0|||
27782322|NCT03558152|54236385|FG002|Overall Study|Miscalculation in mmcs|0|||
27782323|NCT03558152|54236386|FG003|Overall Study|Miscalculation in mmcs|0|||
27782324|NCT03558152|54236387|FG004|Overall Study|Miscalculation in mmcs|0|||
27782325|NCT03558152|54236388|FG005|Overall Study|Miscalculation in mmcs|0|||
27782326|NCT03558152|54236389|FG006|Overall Study|Miscalculation in mmcs|1|||
27782327|NCT03558152|54236390|FG007|Overall Study|Miscalculation in mmcs|0|||
27782328|NCT03558152|54236383|FG000|Overall Study|Mistake in calculation|0|||
27782329|NCT03558152|54236384|FG001|Overall Study|Mistake in calculation|0|||
27782330|NCT03558152|54236385|FG002|Overall Study|Mistake in calculation|0|||
27782331|NCT03558152|54236386|FG003|Overall Study|Mistake in calculation|1|||
27782332|NCT03558152|54236387|FG004|Overall Study|Mistake in calculation|0|||
27782333|NCT03558152|54236388|FG005|Overall Study|Mistake in calculation|0|||
27782334|NCT03558152|54236389|FG006|Overall Study|Mistake in calculation|0|||
27782335|NCT03558152|54236390|FG007|Overall Study|Mistake in calculation|0|||
27782336|NCT03558152|54236383|FG000|Overall Study|Mistake in evaluation of disease status|0|||
27782337|NCT03558152|54236384|FG001|Overall Study|Mistake in evaluation of disease status|0|||
27782338|NCT03558152|54236385|FG002|Overall Study|Mistake in evaluation of disease status|0|||
27782339|NCT03558152|54236386|FG003|Overall Study|Mistake in evaluation of disease status|0|||
27782340|NCT03558152|54236387|FG004|Overall Study|Mistake in evaluation of disease status|0|||
27782341|NCT03558152|54236388|FG005|Overall Study|Mistake in evaluation of disease status|0|||
27782342|NCT03558152|54236389|FG006|Overall Study|Mistake in evaluation of disease status|0|||
27782343|NCT03558152|54236390|FG007|Overall Study|Mistake in evaluation of disease status|1|||
27782344|NCT03558152|54236383|FG000|Overall Study|Physician Decision|0|||
27782345|NCT03558152|54236384|FG001|Overall Study|Physician Decision|0|||
27782346|NCT03558152|54236385|FG002|Overall Study|Physician Decision|0|||
27782347|NCT03558152|54236386|FG003|Overall Study|Physician Decision|0|||
27782348|NCT03558152|54236387|FG004|Overall Study|Physician Decision|0|||
27782349|NCT03558152|54236388|FG005|Overall Study|Physician Decision|0|||
27782350|NCT03558152|54236389|FG006|Overall Study|Physician Decision|1|||
27782351|NCT03558152|54236390|FG007|Overall Study|Physician Decision|0|||
27782352|NCT03558152|54236383|FG000|Overall Study|Withdrawal by Subject|2|||
27782353|NCT03558152|54236384|FG001|Overall Study|Withdrawal by Subject|3|||
27782354|NCT03558152|54236385|FG002|Overall Study|Withdrawal by Subject|2|||
27782355|NCT03558152|54236386|FG003|Overall Study|Withdrawal by Subject|1|||
27782356|NCT03558152|54236387|FG004|Overall Study|Withdrawal by Subject|1|||
27782357|NCT03558152|54236388|FG005|Overall Study|Withdrawal by Subject|1|||
27782358|NCT03558152|54236389|FG006|Overall Study|Withdrawal by Subject|3|||
27782359|NCT03558152|54236390|FG007|Overall Study|Withdrawal by Subject|2|||
27782360|NCT03558152|54236383|FG000|Overall Study|Lack of Efficacy|11|||
27782361|NCT03558152|54236384|FG001|Overall Study|Lack of Efficacy|11|||
27782362|NCT03558152|54236385|FG002|Overall Study|Lack of Efficacy|10|||
27782363|NCT03558152|54236386|FG003|Overall Study|Lack of Efficacy|11|||
27782364|NCT03558152|54236387|FG004|Overall Study|Lack of Efficacy|14|||
27782365|NCT03558152|54236388|FG005|Overall Study|Lack of Efficacy|12|||
27782366|NCT03558152|54236389|FG006|Overall Study|Lack of Efficacy|14|||
27782367|NCT03558152|54236390|FG007|Overall Study|Lack of Efficacy|13|||
27782368|NCT03558152|54236383|FG000|Overall Study|Protocol Violation|1|||
27782369|NCT03558152|54236384|FG001|Overall Study|Protocol Violation|1|||
27782370|NCT03558152|54236385|FG002|Overall Study|Protocol Violation|0|||
27782371|NCT03558152|54236386|FG003|Overall Study|Protocol Violation|1|||
27782372|NCT03558152|54236387|FG004|Overall Study|Protocol Violation|1|||
27782373|NCT03558152|54236388|FG005|Overall Study|Protocol Violation|0|||
27782374|NCT03558152|54236389|FG006|Overall Study|Protocol Violation|2|||
27782375|NCT03558152|54236390|FG007|Overall Study|Protocol Violation|0|||
27782376|NCT03461406|54236430|FG000|Overall Study|Death|1|||
27782377|NCT03461406|54236431|FG001|Overall Study|Death|2|||
27782378|NCT03461406|54236430|FG000|Overall Study|Consent Withdrawn by Participant|0|||
27782379|NCT03461406|54236431|FG001|Overall Study|Consent Withdrawn by Participant|1|||
27782380|NCT03461406|54236430|FG000|Overall Study|Screen Failure|3|||
27782381|NCT03461406|54236431|FG001|Overall Study|Screen Failure|1|||
27782382|NCT03461406|54236430|FG000|Overall Study|Reason not Specified|1|||
27782383|NCT03461406|54236431|FG001|Overall Study|Reason not Specified|3|||
27782384|NCT03461406|54236430|FG000|Overall Study|Lost to Follow-up|3|||
27782385|NCT03461406|54236431|FG001|Overall Study|Lost to Follow-up|0|||
27782386|NCT03408899|54236446|FG000|PC-1005 Gel: 4 mL Dose|Lost to Follow-up|1|||
27782387|NCT03317496|54236459|FG000|Phase 1b Lead-in: Treatment|Adverse Event|2|||
27782388|NCT03317496|54236460|FG001|Phase 1b Lead-in: Treatment|Adverse Event|4|||
27782389|NCT03317496|54236461|FG002|Phase 1b Lead-in: Treatment|Adverse Event|1|||
27782390|NCT03317496|54236462|FG003|Phase 1b Lead-in: Treatment|Adverse Event|0|||
27782391|NCT03317496|54236463|FG004|Phase 1b Lead-in: Treatment|Adverse Event|0|||
27782392|NCT03317496|54236459|FG000|Phase 1b Lead-in: Treatment|Physician Decision|1|||
27782393|NCT03317496|54236460|FG001|Phase 1b Lead-in: Treatment|Physician Decision|1|||
27782394|NCT03317496|54236461|FG002|Phase 1b Lead-in: Treatment|Physician Decision|0|||
27782395|NCT03317496|54236462|FG003|Phase 1b Lead-in: Treatment|Physician Decision|0|||
27782396|NCT03317496|54236463|FG004|Phase 1b Lead-in: Treatment|Physician Decision|0|||
27782397|NCT03317496|54236459|FG000|Phase 1b Lead-in: Treatment|Death|0|||
27782398|NCT03317496|54236460|FG001|Phase 1b Lead-in: Treatment|Death|0|||
27782399|NCT03317496|54236461|FG002|Phase 1b Lead-in: Treatment|Death|1|||
27782400|NCT03317496|54236462|FG003|Phase 1b Lead-in: Treatment|Death|0|||
27782401|NCT03317496|54236463|FG004|Phase 1b Lead-in: Treatment|Death|0|||
27782402|NCT03317496|54236459|FG000|Phase 1b Lead-in: Treatment|Progressive Disease|1|||
27782403|NCT03317496|54236460|FG001|Phase 1b Lead-in: Treatment|Progressive Disease|6|||
27782404|NCT03317496|54236461|FG002|Phase 1b Lead-in: Treatment|Progressive Disease|3|||
27782405|NCT03317496|54236462|FG003|Phase 1b Lead-in: Treatment|Progressive Disease|4|||
27782406|NCT03317496|54236463|FG004|Phase 1b Lead-in: Treatment|Progressive Disease|0|||
27782407|NCT03317496|54236459|FG000|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
27782408|NCT03317496|54236460|FG001|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
27782409|NCT03317496|54236461|FG002|Phase 1b Lead-in: Treatment|Global deterioration of health status|1|||
27782410|NCT03317496|54236462|FG003|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
27782411|NCT03317496|54236463|FG004|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
27782412|NCT03317496|54236459|FG000|Phase 1b Lead-in: Treatment|Other|0|||
27782413|NCT03317496|54236460|FG001|Phase 1b Lead-in: Treatment|Other|1|||
27782414|NCT03317496|54236461|FG002|Phase 1b Lead-in: Treatment|Other|0|||
27782415|NCT03317496|54236462|FG003|Phase 1b Lead-in: Treatment|Other|0|||
27782416|NCT03317496|54236463|FG004|Phase 1b Lead-in: Treatment|Other|0|||
27782417|NCT03317496|54236459|FG000|Phase 1b Lead-in: Treatment|Ongoing|2|||
27782418|NCT03317496|54236460|FG001|Phase 1b Lead-in: Treatment|Ongoing|1|||
27782419|NCT03317496|54236461|FG002|Phase 1b Lead-in: Treatment|Ongoing|0|||
27782420|NCT03317496|54236462|FG003|Phase 1b Lead-in: Treatment|Ongoing|2|||
27782421|NCT03317496|54236463|FG004|Phase 1b Lead-in: Treatment|Ongoing|0|||
27782422|NCT03317496|54236459|FG000|Phase 1b Lead-in: Follow-up|Death|2|||
27782423|NCT03317496|54236460|FG001|Phase 1b Lead-in: Follow-up|Death|7|||
27782424|NCT03317496|54236461|FG002|Phase 1b Lead-in: Follow-up|Death|4|||
27782425|NCT03317496|54236462|FG003|Phase 1b Lead-in: Follow-up|Death|3|||
27782426|NCT03317496|54236463|FG004|Phase 1b Lead-in: Follow-up|Death|0|||
27782427|NCT03317496|54236459|FG000|Phase 1b Lead-in: Follow-up|Lost to Follow-up|1|||
27782428|NCT03317496|54236460|FG001|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
27782429|NCT03317496|54236461|FG002|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
27782430|NCT03317496|54236462|FG003|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
27782431|NCT03317496|54236463|FG004|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
27782432|NCT03317496|54236459|FG000|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
27782433|NCT03317496|54236460|FG001|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
27782434|NCT03317496|54236461|FG002|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|1|||
27782435|NCT03317496|54236462|FG003|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
27782436|NCT03317496|54236463|FG004|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
27782437|NCT03317496|54236459|FG000|Phase 1b Lead-in: Follow-up|Other|1|||
27782438|NCT03317496|54236460|FG001|Phase 1b Lead-in: Follow-up|Other|3|||
27782439|NCT03317496|54236461|FG002|Phase 1b Lead-in: Follow-up|Other|0|||
27782440|NCT03317496|54236462|FG003|Phase 1b Lead-in: Follow-up|Other|1|||
27782441|NCT03317496|54236463|FG004|Phase 1b Lead-in: Follow-up|Other|0|||
27782442|NCT03317496|54236459|FG000|Phase 1b Lead-in: Follow-up|Ongoing|0|||
27782443|NCT03317496|54236460|FG001|Phase 1b Lead-in: Follow-up|Ongoing|1|||
27782444|NCT03317496|54236461|FG002|Phase 1b Lead-in: Follow-up|Ongoing|0|||
27782445|NCT03317496|54236462|FG003|Phase 1b Lead-in: Follow-up|Ongoing|0|||
27782446|NCT03317496|54236463|FG004|Phase 1b Lead-in: Follow-up|Ongoing|0|||
27782447|NCT03317496|54236459|FG000|Phase 2: Treatment|Adverse Event|0|||
27782448|NCT03317496|54236460|FG001|Phase 2: Treatment|Adverse Event|0|||
27782449|NCT03317496|54236461|FG002|Phase 2: Treatment|Adverse Event|0|||
27782450|NCT03317496|54236462|FG003|Phase 2: Treatment|Adverse Event|0|||
27782451|NCT03317496|54236463|FG004|Phase 2: Treatment|Adverse Event|4|||
27782452|NCT03317496|54236459|FG000|Phase 2: Treatment|Death|0|||
27782453|NCT03317496|54236460|FG001|Phase 2: Treatment|Death|0|||
27782454|NCT03317496|54236461|FG002|Phase 2: Treatment|Death|0|||
27782455|NCT03317496|54236462|FG003|Phase 2: Treatment|Death|0|||
27782456|NCT03317496|54236463|FG004|Phase 2: Treatment|Death|1|||
27782457|NCT03317496|54236459|FG000|Phase 2: Treatment|Physician Decision|0|||
27782458|NCT03317496|54236460|FG001|Phase 2: Treatment|Physician Decision|0|||
27782459|NCT03317496|54236461|FG002|Phase 2: Treatment|Physician Decision|0|||
27782460|NCT03317496|54236462|FG003|Phase 2: Treatment|Physician Decision|0|||
27782461|NCT03317496|54236463|FG004|Phase 2: Treatment|Physician Decision|1|||
27782462|NCT03317496|54236459|FG000|Phase 2: Treatment|Progressive Disease|0|||
27782463|NCT03317496|54236460|FG001|Phase 2: Treatment|Progressive Disease|0|||
27782464|NCT03317496|54236461|FG002|Phase 2: Treatment|Progressive Disease|0|||
27782465|NCT03317496|54236462|FG003|Phase 2: Treatment|Progressive Disease|0|||
27782466|NCT03317496|54236463|FG004|Phase 2: Treatment|Progressive Disease|18|||
27782467|NCT03317496|54236459|FG000|Phase 2: Treatment|Withdrawal by Subject|0|||
27782468|NCT03317496|54236460|FG001|Phase 2: Treatment|Withdrawal by Subject|0|||
27782469|NCT03317496|54236461|FG002|Phase 2: Treatment|Withdrawal by Subject|0|||
27782470|NCT03317496|54236462|FG003|Phase 2: Treatment|Withdrawal by Subject|0|||
27782471|NCT03317496|54236463|FG004|Phase 2: Treatment|Withdrawal by Subject|1|||
27782472|NCT03317496|54236459|FG000|Phase 2: Treatment|Other|0|||
27782473|NCT03317496|54236460|FG001|Phase 2: Treatment|Other|0|||
27782474|NCT03317496|54236461|FG002|Phase 2: Treatment|Other|0|||
27782475|NCT03317496|54236462|FG003|Phase 2: Treatment|Other|0|||
27782476|NCT03317496|54236463|FG004|Phase 2: Treatment|Other|2|||
27782477|NCT03317496|54236459|FG000|Phase 2: Treatment|Ongoing|0|||
27782478|NCT03317496|54236460|FG001|Phase 2: Treatment|Ongoing|0|||
27782479|NCT03317496|54236461|FG002|Phase 2: Treatment|Ongoing|0|||
27782480|NCT03317496|54236462|FG003|Phase 2: Treatment|Ongoing|0|||
27782481|NCT03317496|54236463|FG004|Phase 2: Treatment|Ongoing|8|||
27782482|NCT03317496|54236459|FG000|Phase 2: Follow-up|Death|0|||
27782483|NCT03317496|54236460|FG001|Phase 2: Follow-up|Death|0|||
27782484|NCT03317496|54236461|FG002|Phase 2: Follow-up|Death|0|||
27782485|NCT03317496|54236462|FG003|Phase 2: Follow-up|Death|0|||
27782486|NCT03317496|54236463|FG004|Phase 2: Follow-up|Death|16|||
27782487|NCT03317496|54236459|FG000|Phase 2: Follow-up|Withdrawal by Subject|0|||
27782488|NCT03317496|54236460|FG001|Phase 2: Follow-up|Withdrawal by Subject|0|||
27782489|NCT03317496|54236461|FG002|Phase 2: Follow-up|Withdrawal by Subject|0|||
27782490|NCT03317496|54236462|FG003|Phase 2: Follow-up|Withdrawal by Subject|0|||
27782491|NCT03317496|54236463|FG004|Phase 2: Follow-up|Withdrawal by Subject|1|||
27782492|NCT03317496|54236459|FG000|Phase 2: Follow-up|Lost to Follow-up|0|||
27782493|NCT03317496|54236460|FG001|Phase 2: Follow-up|Lost to Follow-up|0|||
27782494|NCT03317496|54236461|FG002|Phase 2: Follow-up|Lost to Follow-up|0|||
27782495|NCT03317496|54236462|FG003|Phase 2: Follow-up|Lost to Follow-up|0|||
27782496|NCT03317496|54236463|FG004|Phase 2: Follow-up|Lost to Follow-up|1|||
27782497|NCT03317496|54236459|FG000|Phase 2: Follow-up|Other|0|||
27782498|NCT03317496|54236460|FG001|Phase 2: Follow-up|Other|0|||
27782499|NCT03317496|54236461|FG002|Phase 2: Follow-up|Other|0|||
27782500|NCT03317496|54236462|FG003|Phase 2: Follow-up|Other|0|||
27782501|NCT03317496|54236463|FG004|Phase 2: Follow-up|Other|6|||
27782502|NCT03317496|54236459|FG000|Phase 2: Follow-up|Ongoing|0|||
27782503|NCT03317496|54236460|FG001|Phase 2: Follow-up|Ongoing|0|||
27782504|NCT03317496|54236461|FG002|Phase 2: Follow-up|Ongoing|0|||
27782505|NCT03317496|54236462|FG003|Phase 2: Follow-up|Ongoing|0|||
27782506|NCT03317496|54236463|FG004|Phase 2: Follow-up|Ongoing|1|||
27782507|NCT02528643|54236490|FG000|DB (Median Duration up to 14.65 Months)|Adverse Event|5|||
27782508|NCT02528643|54236491|FG001|DB (Median Duration up to 14.65 Months)|Adverse Event|8|||
27782509|NCT02528643|54236490|FG000|DB (Median Duration up to 14.65 Months)|Death|1|||
27782510|NCT02528643|54236491|FG001|DB (Median Duration up to 14.65 Months)|Death|6|||
27782511|NCT02528643|54236490|FG000|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|0|||
27782512|NCT02528643|54236491|FG001|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|1|||
27782513|NCT02528643|54236490|FG000|DB (Median Duration up to 14.65 Months)|Progressive Disease|44|||
27782514|NCT02528643|54236491|FG001|DB (Median Duration up to 14.65 Months)|Progressive Disease|82|||
27782515|NCT02528643|54236490|FG000|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|2|||
27782516|NCT02528643|54236491|FG001|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|8|||
27782517|NCT02528643|54236490|FG000|DB (Median Duration up to 14.65 Months)|Miscellaneous|3|||
27782518|NCT02528643|54236491|FG001|DB (Median Duration up to 14.65 Months)|Miscellaneous|5|||
27782519|NCT02528643|54236490|FG000|OL (Median Duration up to 27.56 Months)|Progressive Disease|0|||
27782520|NCT02528643|54236491|FG001|OL (Median Duration up to 27.56 Months)|Progressive Disease|1|||
27782521|NCT02175680|54236534|FG000|Overall Study|non-compliance|1|||
27782522|NCT02175680|54236534|FG000|Overall Study|other non-medical reason|1|||
27782523|NCT01983462|54236548|FG000|Overall Study|Adverse Event|1|||
27782524|NCT01983462|54236549|FG001|Overall Study|Adverse Event|0|||
27782525|NCT01983462|54236550|FG002|Overall Study|Adverse Event|0|||
27782526|NCT01559935|54236581|FG000|Car Phase|Toxicity|4|||
27782527|NCT01559935|54236581|FG000|Car Phase|Death|1|||
27782528|NCT01559935|54236581|FG000|Car Phase|Lack of Efficacy|2|||
27782529|NCT01559935|54236581|FG000|Car Phase|Lost to Follow-up|1|||
27782530|NCT01559935|54236581|FG000|Car Phase|Physician Decision|1|||
27782531|NCT01559935|54236581|FG000|Car Phase|Withdrawal by Subject|2|||
27782532|NCT01559935|54236581|FG000|Car Phase|Per protocol|1|||
27782533|NCT01559935|54236581|FG000|Car Phase|Insurance|1|||
27782534|NCT01559935|54236581|FG000|Car Phase|non-compliance|1|||
27782535|NCT01559935|54236581|FG000|BiRD Phase|Toxicity|1|||
27782536|NCT01559935|54236581|FG000|BiRD Phase|Lack of Efficacy|1|||
27782537|NCT01559935|54236581|FG000|BiRD Phase|Withdrawal by Subject|2|||
27782538|NCT01559935|54236581|FG000|Maintenance Phase|Remains on study|28|||
27782539|NCT01559935|54236581|FG000|Maintenance Phase|Toxicity|1|||
27782540|NCT01559935|54236581|FG000|Maintenance Phase|Lack of Efficacy|18|||
27782541|NCT01559935|54236581|FG000|Maintenance Phase|Withdrawal by Subject|5|||
27782542|NCT01559935|54236581|FG000|Maintenance Phase|Non-compliance|2|||
27782543|NCT00981058|54236587|FG000|Overall Study|Adverse Event|1|||
27782544|NCT00981058|54236588|FG001|Overall Study|Adverse Event|1|||
27782545|NCT00981058|54236587|FG000|Overall Study|Progressive Disease|61|||
27782546|NCT00981058|54236588|FG001|Overall Study|Progressive Disease|49|||
27782547|NCT00981058|54236587|FG000|Overall Study|Lost to Follow-up|16|||
27782548|NCT00981058|54236588|FG001|Overall Study|Lost to Follow-up|15|||
27782549|NCT00981058|54236587|FG000|Overall Study|New Anticancer Therapy|6|||
27782550|NCT00981058|54236588|FG001|Overall Study|New Anticancer Therapy|6|||
27782551|NCT00981058|54236587|FG000|Overall Study|Noncompliance|1|||
27782552|NCT00981058|54236588|FG001|Overall Study|Noncompliance|0|||
27782553|NCT00981058|54236587|FG000|Overall Study|Radiologist Error|0|||
27782554|NCT00981058|54236588|FG001|Overall Study|Radiologist Error|1|||
27782555|NCT00981058|54236587|FG000|Overall Study|Randomization Error|1|||
27782556|NCT00981058|54236588|FG001|Overall Study|Randomization Error|2|||
27782557|NCT00981058|54236587|FG000|Overall Study|Withdrawal by Subject|25|||
27782558|NCT00981058|54236588|FG001|Overall Study|Withdrawal by Subject|23|||
27782559|NCT00981058|54236587|FG000|Overall Study|On study treatment at conclusion|9|||
27782560|NCT00981058|54236588|FG001|Overall Study|On study treatment at conclusion|0|||
27782561|NCT00565851|54236602|FG000|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
27782562|NCT00565851|54236603|FG001|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
27782563|NCT00565851|54236604|FG002|Chemotherapy Assignment|Never Initiated Chemotherapy|3|||
27782564|NCT00565851|54236605|FG003|Chemotherapy Assignment|Never Initiated Chemotherapy|18|||
27782565|NCT00565851|54236606|FG004|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
27782566|NCT00565851|54236607|FG005|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
27782567|NCT00565851|54236608|FG006|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
27782568|NCT00565851|54236609|FG007|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
27782569|NCT00565851|54236602|FG000|Chemotherapy Assignment|Still On Chemotherapy|0|||
27782570|NCT00565851|54236603|FG001|Chemotherapy Assignment|Still On Chemotherapy|14|||
27782571|NCT00565851|54236604|FG002|Chemotherapy Assignment|Still On Chemotherapy|0|||
27782572|NCT00565851|54236605|FG003|Chemotherapy Assignment|Still On Chemotherapy|18|||
27782573|NCT00565851|54236606|FG004|Chemotherapy Assignment|Still On Chemotherapy|0|||
27782574|NCT00565851|54236607|FG005|Chemotherapy Assignment|Still On Chemotherapy|1|||
27782575|NCT00565851|54236608|FG006|Chemotherapy Assignment|Still On Chemotherapy|0|||
27782576|NCT00565851|54236609|FG007|Chemotherapy Assignment|Still On Chemotherapy|1|||
27782577|NCT00305227|54236633|FG000|Overall Study|Lost to Follow-up|7|||
27782578|NCT00305227|54236634|FG001|Overall Study|Lost to Follow-up|6|||
27782579|NCT01599793|54236642|FG000|Overall Study|Adverse Event|2|||
27782580|NCT01755598|54236657|FG000|Overall Study|Other|109|||
27782581|NCT01755598|54236658|FG001|Overall Study|Other|109|||
27782582|NCT01755598|54236657|FG000|Overall Study|Lost to Follow-up|32|||
27782583|NCT01755598|54236658|FG001|Overall Study|Lost to Follow-up|43|||
27782584|NCT01755598|54236657|FG000|Overall Study|Migrated/moved from study area|76|||
27782585|NCT01755598|54236658|FG001|Overall Study|Migrated/moved from study area|65|||
27782586|NCT01755598|54236657|FG000|Overall Study|Withdrawal by Subject|22|||
27782587|NCT01755598|54236658|FG001|Overall Study|Withdrawal by Subject|31|||
27782588|NCT01755598|54236657|FG000|Overall Study|Protocol Violation|7|||
27782589|NCT01755598|54236658|FG001|Overall Study|Protocol Violation|7|||
27782590|NCT01755598|54236657|FG000|Overall Study|Adverse Event|19|||
27782591|NCT01755598|54236658|FG001|Overall Study|Adverse Event|28|||
27782592|NCT01606306|54236670|FG000|Overall Study|Lack of Efficacy|2|||
27782593|NCT01606306|54236671|FG001|Overall Study|Lack of Efficacy|1|||
27782594|NCT01606306|54236672|FG002|Overall Study|Lack of Efficacy|4|||
27782595|NCT01606306|54236673|FG003|Overall Study|Lack of Efficacy|4|||
27782596|NCT01606306|54236674|FG004|Overall Study|Lack of Efficacy|1|||
27782597|NCT01606306|54236675|FG005|Overall Study|Lack of Efficacy|2|||
27782598|NCT01606306|54236670|FG000|Overall Study|Adverse Event|1|||
27782599|NCT01606306|54236671|FG001|Overall Study|Adverse Event|0|||
27782600|NCT01606306|54236672|FG002|Overall Study|Adverse Event|1|||
27782601|NCT01606306|54236673|FG003|Overall Study|Adverse Event|1|||
27782602|NCT01606306|54236674|FG004|Overall Study|Adverse Event|2|||
27782603|NCT01606306|54236675|FG005|Overall Study|Adverse Event|0|||
27782604|NCT01606306|54236670|FG000|Overall Study|Lost to Follow-up|7|||
27782605|NCT01606306|54236671|FG001|Overall Study|Lost to Follow-up|4|||
27782606|NCT01606306|54236672|FG002|Overall Study|Lost to Follow-up|5|||
27782607|NCT01606306|54236673|FG003|Overall Study|Lost to Follow-up|4|||
27782608|NCT01606306|54236674|FG004|Overall Study|Lost to Follow-up|3|||
27782609|NCT01606306|54236675|FG005|Overall Study|Lost to Follow-up|5|||
27782610|NCT01606306|54236670|FG000|Overall Study|Withdrawal by Subject|4|||
27782611|NCT01606306|54236671|FG001|Overall Study|Withdrawal by Subject|3|||
27782612|NCT01606306|54236672|FG002|Overall Study|Withdrawal by Subject|4|||
27782613|NCT01606306|54236673|FG003|Overall Study|Withdrawal by Subject|4|||
27782614|NCT01606306|54236674|FG004|Overall Study|Withdrawal by Subject|5|||
27782615|NCT01606306|54236675|FG005|Overall Study|Withdrawal by Subject|4|||
27782616|NCT01606306|54236670|FG000|Overall Study|Physician Decision|1|||
27782617|NCT01606306|54236671|FG001|Overall Study|Physician Decision|2|||
27782618|NCT01606306|54236672|FG002|Overall Study|Physician Decision|0|||
27782619|NCT01606306|54236673|FG003|Overall Study|Physician Decision|0|||
27782620|NCT01606306|54236674|FG004|Overall Study|Physician Decision|0|||
27782621|NCT01606306|54236675|FG005|Overall Study|Physician Decision|0|||
27782622|NCT01754194|54236683|FG000|Overall Study|Lost to Follow-up|39|||
27782623|NCT01754194|54236684|FG001|Overall Study|Lost to Follow-up|14|||
27782624|NCT01754194|54236683|FG000|Overall Study|Withdrawal by Subject|4|||
27782625|NCT01754194|54236684|FG001|Overall Study|Withdrawal by Subject|5|||
27782626|NCT01754194|54236683|FG000|Overall Study|Other|9|||
27782627|NCT01754194|54236684|FG001|Overall Study|Other|8|||
27782628|NCT01753570|54236695|FG000|Overall Study|Adverse Event|1|||
27782629|NCT01753570|54236696|FG001|Overall Study|Adverse Event|0|||
27782630|NCT01753570|54236697|FG002|Overall Study|Adverse Event|1|||
27782631|NCT01753570|54236695|FG000|Overall Study|Physician Decision|0|||
27782632|NCT01753570|54236696|FG001|Overall Study|Physician Decision|1|||
27782633|NCT01753570|54236697|FG002|Overall Study|Physician Decision|0|||
27782634|NCT01753570|54236695|FG000|Overall Study|Withdrawal by Subject|1|||
27782635|NCT01753570|54236696|FG001|Overall Study|Withdrawal by Subject|4|||
27840850|NCT01459913|54328773|FG003|Overall Study|Other|1|||
27782636|NCT01753570|54236697|FG002|Overall Study|Withdrawal by Subject|0|||
27782637|NCT01753336|54236706|FG000|Overall Study|Patient decision|12|||
27782638|NCT01753336|54236706|FG000|Overall Study|Lost to Follow-up|3|||
27782639|NCT01753336|54236706|FG000|Overall Study|Physician Decision|2|||
27782640|NCT01753336|54236706|FG000|Overall Study|Sponsor's decision|2|||
27782641|NCT01753336|54236706|FG000|Overall Study|Withdrawal by Subject|1|||
27782642|NCT01777282|54236715|FG000|Overall Study|Persistent Hyperglycemia|0|||
27782643|NCT01777282|54236716|FG001|Overall Study|Persistent Hyperglycemia|0|||
27782644|NCT01777282|54236717|FG002|Overall Study|Persistent Hyperglycemia|1|||
27782645|NCT01777282|54236718|FG003|Overall Study|Persistent Hyperglycemia|0|||
27782646|NCT01777282|54236719|FG004|Overall Study|Persistent Hyperglycemia|0|||
27782647|NCT01777282|54236715|FG000|Overall Study|New Antidiabetic Medication|0|||
27782648|NCT01777282|54236716|FG001|Overall Study|New Antidiabetic Medication|0|||
27782649|NCT01777282|54236717|FG002|Overall Study|New Antidiabetic Medication|1|||
27782650|NCT01777282|54236718|FG003|Overall Study|New Antidiabetic Medication|0|||
27782651|NCT01777282|54236719|FG004|Overall Study|New Antidiabetic Medication|0|||
27782652|NCT01777282|54236715|FG000|Overall Study|Adverse Event|4|||
27782653|NCT01777282|54236716|FG001|Overall Study|Adverse Event|4|||
27782654|NCT01777282|54236717|FG002|Overall Study|Adverse Event|2|||
27782655|NCT01777282|54236718|FG003|Overall Study|Adverse Event|1|||
27782656|NCT01777282|54236719|FG004|Overall Study|Adverse Event|3|||
27782657|NCT01777282|54236715|FG000|Overall Study|Withdrawal by Subject|4|||
27782658|NCT01777282|54236716|FG001|Overall Study|Withdrawal by Subject|0|||
27782659|NCT01777282|54236717|FG002|Overall Study|Withdrawal by Subject|0|||
27782660|NCT01777282|54236718|FG003|Overall Study|Withdrawal by Subject|1|||
27782661|NCT01777282|54236719|FG004|Overall Study|Withdrawal by Subject|2|||
27782662|NCT01777282|54236715|FG000|Overall Study|Protocol Violation|2|||
27782663|NCT01777282|54236716|FG001|Overall Study|Protocol Violation|0|||
27782664|NCT01777282|54236717|FG002|Overall Study|Protocol Violation|1|||
27782665|NCT01777282|54236718|FG003|Overall Study|Protocol Violation|0|||
27782666|NCT01777282|54236719|FG004|Overall Study|Protocol Violation|2|||
27782667|NCT01777282|54236715|FG000|Overall Study|Moved, transfer abroad, did not enter FU|1|||
27782668|NCT01777282|54236716|FG001|Overall Study|Moved, transfer abroad, did not enter FU|0|||
27782669|NCT01777282|54236717|FG002|Overall Study|Moved, transfer abroad, did not enter FU|1|||
27782670|NCT01777282|54236718|FG003|Overall Study|Moved, transfer abroad, did not enter FU|0|||
27782671|NCT01777282|54236719|FG004|Overall Study|Moved, transfer abroad, did not enter FU|0|||
27782672|NCT01975389|54236733|FG000|Overall Study|Adverse Event|10|||
27782673|NCT01975389|54236734|FG001|Overall Study|Adverse Event|6|||
27782674|NCT01975389|54236733|FG000|Overall Study|Death|61|||
27782675|NCT01975389|54236734|FG001|Overall Study|Death|54|||
27782676|NCT01975389|54236733|FG000|Overall Study|Lost to Follow-up|81|||
27782677|NCT01975389|54236734|FG001|Overall Study|Lost to Follow-up|86|||
27782678|NCT01975389|54236733|FG000|Overall Study|Withdrawal by Subject|90|||
27782679|NCT01975389|54236734|FG001|Overall Study|Withdrawal by Subject|76|||
27782680|NCT01975389|54236733|FG000|Overall Study|Other|6|||
27782681|NCT01975389|54236734|FG001|Overall Study|Other|9|||
27782682|NCT01975389|54236733|FG000|Overall Study|Randomized, not treated|4|||
27782683|NCT01975389|54236734|FG001|Overall Study|Randomized, not treated|5|||
27782684|NCT01974141|54236742|FG000|Overall Study|Other Reasons|28|||
27782685|NCT01974141|54236743|FG001|Overall Study|Other Reasons|18|||
27782686|NCT01974141|54236742|FG000|Overall Study|Protocol Violation|2|||
27782687|NCT01974141|54236743|FG001|Overall Study|Protocol Violation|6|||
27782688|NCT01974141|54236742|FG000|Overall Study|Personal Reasons|21|||
27782689|NCT01974141|54236743|FG001|Overall Study|Personal Reasons|20|||
27782690|NCT01974141|54236742|FG000|Overall Study|Lost to Follow-up|38|||
27782691|NCT01974141|54236743|FG001|Overall Study|Lost to Follow-up|29|||
27782692|NCT01974141|54236742|FG000|Overall Study|Pregnancy|3|||
27782693|NCT01974141|54236743|FG001|Overall Study|Pregnancy|3|||
27782694|NCT01974141|54236742|FG000|Overall Study|Lack of Efficacy|0|||
27782695|NCT01974141|54236743|FG001|Overall Study|Lack of Efficacy|1|||
27782696|NCT01974141|54236742|FG000|Overall Study|Adverse Event|4|||
27782697|NCT01974141|54236743|FG001|Overall Study|Adverse Event|5|||
27782698|NCT01945593|54236753|FG000|Overall Study|Adverse Event|0|||
27782699|NCT01945593|54236754|FG001|Overall Study|Adverse Event|0|||
27782700|NCT01945593|54236755|FG002|Overall Study|Adverse Event|0|||
27782701|NCT01945593|54236756|FG003|Overall Study|Adverse Event|5|||
27782702|NCT01945593|54236753|FG000|Overall Study|Physician Decision|0|||
27782703|NCT01945593|54236754|FG001|Overall Study|Physician Decision|0|||
27782704|NCT01945593|54236755|FG002|Overall Study|Physician Decision|1|||
27782705|NCT01945593|54236756|FG003|Overall Study|Physician Decision|1|||
27782706|NCT01945593|54236753|FG000|Overall Study|Withdrawal by Subject|0|||
27782707|NCT01945593|54236754|FG001|Overall Study|Withdrawal by Subject|2|||
27782708|NCT01945593|54236755|FG002|Overall Study|Withdrawal by Subject|0|||
27782709|NCT01945593|54236756|FG003|Overall Study|Withdrawal by Subject|4|||
27782710|NCT01945593|54236753|FG000|Overall Study|Protocol Violation|0|||
27782711|NCT01945593|54236754|FG001|Overall Study|Protocol Violation|2|||
27782712|NCT01945593|54236755|FG002|Overall Study|Protocol Violation|1|||
27782713|NCT01945593|54236756|FG003|Overall Study|Protocol Violation|3|||
27782714|NCT01945593|54236753|FG000|Overall Study|Death|0|||
27782715|NCT01945593|54236754|FG001|Overall Study|Death|0|||
27782716|NCT01945593|54236755|FG002|Overall Study|Death|1|||
27782717|NCT01945593|54236756|FG003|Overall Study|Death|0|||
27782718|NCT01945593|54236753|FG000|Overall Study|Other: Terminated|0|||
27782719|NCT01945593|54236754|FG001|Overall Study|Other: Terminated|0|||
27782720|NCT01945593|54236755|FG002|Overall Study|Other: Terminated|0|||
27782721|NCT01945593|54236756|FG003|Overall Study|Other: Terminated|1|||
27782722|NCT01945593|54236753|FG000|Overall Study|Other: Surgical Procedure|0|||
27782723|NCT01945593|54236754|FG001|Overall Study|Other: Surgical Procedure|2|||
27782724|NCT01945593|54236755|FG002|Overall Study|Other: Surgical Procedure|0|||
27782725|NCT01945593|54236756|FG003|Overall Study|Other: Surgical Procedure|6|||
27782726|NCT01945593|54236753|FG000|Overall Study|Other: Screen Failure|0|||
27782727|NCT01945593|54236754|FG001|Overall Study|Other: Screen Failure|2|||
27782728|NCT01945593|54236755|FG002|Overall Study|Other: Screen Failure|0|||
27782729|NCT01945593|54236756|FG003|Overall Study|Other: Screen Failure|0|||
27782730|NCT01945281|54236773|FG000|Overall Study|Adverse Event|1|||
27782731|NCT01945281|54236774|FG001|Overall Study|Adverse Event|0|||
27782732|NCT01945281|54236773|FG000|Overall Study|Death|3|||
27782733|NCT01945281|54236774|FG001|Overall Study|Death|3|||
27782734|NCT01945281|54236773|FG000|Overall Study|Physician Decision|1|||
27782735|NCT01945281|54236774|FG001|Overall Study|Physician Decision|1|||
27782736|NCT01945281|54236773|FG000|Overall Study|Technical Problems|1|||
27782737|NCT01945281|54236774|FG001|Overall Study|Technical Problems|0|||
27782738|NCT01961349|54236783|FG000|Overall Study|Withdrawal by Subject|1|||
27782739|NCT01961349|54236784|FG001|Overall Study|Withdrawal by Subject|4|||
27782740|NCT01961349|54236785|FG002|Overall Study|Withdrawal by Subject|0|||
27782741|NCT01961349|54236783|FG000|Overall Study|Adverse Event|0|||
27782742|NCT01961349|54236784|FG001|Overall Study|Adverse Event|0|||
27782743|NCT01961349|54236785|FG002|Overall Study|Adverse Event|1|||
27782744|NCT01961349|54236783|FG000|Overall Study|registration error, personal reason etc|2|||
27782745|NCT01961349|54236784|FG001|Overall Study|registration error, personal reason etc|2|||
27782746|NCT01961349|54236785|FG002|Overall Study|registration error, personal reason etc|1|||
27782747|NCT01973595|54236797|FG000|Washout|Withdrawal by Subject|1|||
27782748|NCT01973595|54236798|FG001|Washout|Withdrawal by Subject|0|||
27782749|NCT01973595|54236799|FG002|Washout|Withdrawal by Subject|1|||
27782750|NCT01973595|54236800|FG003|Washout|Withdrawal by Subject|0|||
27782751|NCT01944969|54236811|FG000|Overall Study|Adverse Event|1|||
27782752|NCT01944969|54236811|FG000|Overall Study|Lack of Efficacy|1|||
27782753|NCT01944969|54236811|FG000|Overall Study|Non-compliance with IMP|1|||
27782754|NCT01944969|54236811|FG000|Overall Study|Administrative or other reasons|23|||
27782755|NCT01961115|54236820|FG000|Overall Study|Disease Progression|1|||
27782756|NCT01961115|54236821|FG001|Overall Study|Disease Progression|0|||
27782757|NCT01961115|54236822|FG002|Overall Study|Disease Progression|3|||
27782758|NCT01961115|54236820|FG000|Overall Study|Adverse Event|1|||
27782759|NCT01961115|54236821|FG001|Overall Study|Adverse Event|0|||
27782760|NCT01961115|54236822|FG002|Overall Study|Adverse Event|1|||
27782761|NCT01973439|54236830|FG000|Overall Study|Lost samples from one PK Day|2|||
27782762|NCT01973439|54236830|FG000|Overall Study|Vomiting after commencing once daily|1|||
27782763|NCT01973439|54236830|FG000|Overall Study|PK curve incomplete|2|||
27782764|NCT01973283|54236834|FG000|Overall Study|Lost to Follow-up|4|||
27782765|NCT01943799|54236844|FG000|Overall Study|Lost to Follow-up|0|||
27782766|NCT01943799|54236845|FG001|Overall Study|Lost to Follow-up|1|||
27782767|NCT01943799|54236846|FG002|Overall Study|Lost to Follow-up|1|||
27782768|NCT01943799|54236847|FG003|Overall Study|Lost to Follow-up|0|||
27782769|NCT01943799|54236844|FG000|Overall Study|Protocol Violation|1|||
27782770|NCT01943799|54236845|FG001|Overall Study|Protocol Violation|0|||
27782771|NCT01943799|54236846|FG002|Overall Study|Protocol Violation|0|||
27782772|NCT01943799|54236847|FG003|Overall Study|Protocol Violation|0|||
27782773|NCT01943799|54236844|FG000|Overall Study|Withdrawal by Subject|4|||
27782774|NCT01943799|54236845|FG001|Overall Study|Withdrawal by Subject|2|||
27782775|NCT01943799|54236846|FG002|Overall Study|Withdrawal by Subject|1|||
27782776|NCT01943799|54236847|FG003|Overall Study|Withdrawal by Subject|0|||
27782777|NCT01972659|54236859|FG000|Overall Study|Protocol Violation|2|||
27840851|NCT01459913|54328770|FG000|Overall Study|Did Not Meet Inclusion Criteria|0|||
27840852|NCT01459913|54328771|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
27840853|NCT01459913|54328772|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
27840854|NCT01459913|54328773|FG003|Overall Study|Did Not Meet Inclusion Criteria|1|||
27782778|NCT01972659|54236860|FG001|Overall Study|Protocol Violation|2|||
27782779|NCT01972659|54236859|FG000|Overall Study|problems realted to acceleromyograph|2|||
27782780|NCT01972659|54236860|FG001|Overall Study|problems realted to acceleromyograph|1|||
27782781|NCT01971723|54236868|FG000|Overall Study|Withdrawal by Subject|1|||
27782782|NCT01971723|54236869|FG001|Overall Study|Withdrawal by Subject|1|||
27782783|NCT01971723|54236868|FG000|Overall Study|Protocol Violation|1|||
27782784|NCT01971723|54236869|FG001|Overall Study|Protocol Violation|2|||
27782785|NCT01942785|54236875|FG000|Overall Study|Adverse Event|2|||
27782786|NCT01942785|54236875|FG000|Overall Study|Withdrawal by Subject|1|||
27782787|NCT01942785|54236875|FG000|Overall Study|Protocol Violation|1|||
27782788|NCT01774786|54236883|FG000|Overall Study|Death|300|||
27782789|NCT01774786|54236884|FG001|Overall Study|Death|319|||
27782790|NCT01774786|54236883|FG000|Overall Study|Lost to Follow-up|6|||
27782791|NCT01774786|54236884|FG001|Overall Study|Lost to Follow-up|7|||
27782792|NCT01774786|54236883|FG000|Overall Study|Withdrawal by Subject|18|||
27782793|NCT01774786|54236884|FG001|Overall Study|Withdrawal by Subject|14|||
27782794|NCT01774786|54236883|FG000|Overall Study|Physician Decision|2|||
27782795|NCT01774786|54236884|FG001|Overall Study|Physician Decision|0|||
27782796|NCT01774786|54236883|FG000|Overall Study|Non-compliance|0|||
27782797|NCT01774786|54236884|FG001|Overall Study|Non-compliance|1|||
27782798|NCT01774786|54236883|FG000|Overall Study|Reason Not Specified|2|||
27782799|NCT01774786|54236884|FG001|Overall Study|Reason Not Specified|5|||
27782800|NCT01960725|54236892|FG000|Overall Study|Lost to Follow-up|4|||
27782801|NCT01960725|54236893|FG001|Overall Study|Lost to Follow-up|3|||
27782802|NCT01960725|54236892|FG000|Overall Study|Withdrawal by Subject|1|||
27782803|NCT01960725|54236893|FG001|Overall Study|Withdrawal by Subject|0|||
27782804|NCT01960725|54236892|FG000|Overall Study|unable to obtain blood sample|1|||
27782805|NCT01960725|54236893|FG001|Overall Study|unable to obtain blood sample|2|||
27782806|NCT01942161|54236902|FG000|Overall Study|Adverse Event|1|||
27782807|NCT01942161|54236903|FG001|Overall Study|Adverse Event|2|||
27782808|NCT01942161|54236904|FG002|Overall Study|Adverse Event|5|||
27782809|NCT01942161|54236902|FG000|Overall Study|Physician Decision|3|||
27782810|NCT01942161|54236903|FG001|Overall Study|Physician Decision|1|||
27782811|NCT01942161|54236904|FG002|Overall Study|Physician Decision|0|||
27782812|NCT01942161|54236902|FG000|Overall Study|Protocol Violation|1|||
27782813|NCT01942161|54236903|FG001|Overall Study|Protocol Violation|0|||
27782814|NCT01942161|54236904|FG002|Overall Study|Protocol Violation|0|||
27782815|NCT01942161|54236902|FG000|Overall Study|Withdrawal by Subject|3|||
27782816|NCT01942161|54236903|FG001|Overall Study|Withdrawal by Subject|3|||
27782817|NCT01942161|54236904|FG002|Overall Study|Withdrawal by Subject|1|||
27782818|NCT01971645|54236915|FG000|Overall Study|Adverse Event|1|||
27782819|NCT01971645|54236916|FG001|Overall Study|Adverse Event|0|||
27782820|NCT01971645|54236917|FG002|Overall Study|Adverse Event|0|||
27782821|NCT01971645|54236915|FG000|Overall Study|Lost to Follow-up|1|||
27782822|NCT01971645|54236916|FG001|Overall Study|Lost to Follow-up|0|||
27782823|NCT01971645|54236917|FG002|Overall Study|Lost to Follow-up|1|||
27782824|NCT01971645|54236915|FG000|Overall Study|Protocol Violation|0|||
27782825|NCT01971645|54236916|FG001|Overall Study|Protocol Violation|0|||
27782826|NCT01971645|54236917|FG002|Overall Study|Protocol Violation|1|||
27782827|NCT01941537|54236927|FG000|Overall Study|Lack of Efficacy|1|||
27782828|NCT01941537|54236928|FG001|Overall Study|Lack of Efficacy|2|||
27782829|NCT01941537|54236927|FG000|Overall Study|Lost to Follow-up|1|||
27782830|NCT01941537|54236928|FG001|Overall Study|Lost to Follow-up|0|||
27782831|NCT01941537|54236927|FG000|Overall Study|Pregnancy|1|||
27782832|NCT01941537|54236928|FG001|Overall Study|Pregnancy|0|||
27782833|NCT01941537|54236927|FG000|Overall Study|Adverse Event|1|||
27782834|NCT01941537|54236928|FG001|Overall Study|Adverse Event|0|||
27782835|NCT01941537|54236927|FG000|Overall Study|Withdrawal by Subject|0|||
27782836|NCT01941537|54236928|FG001|Overall Study|Withdrawal by Subject|1|||
27782837|NCT01971567|54236937|FG000|Overall Study|Withdrawal by Subject|3|||
27782838|NCT01971567|54236938|FG001|Overall Study|Withdrawal by Subject|2|||
27782839|NCT01971567|54236937|FG000|Overall Study|Lost to Follow-up|1|||
27782840|NCT01971567|54236938|FG001|Overall Study|Lost to Follow-up|0|||
27782841|NCT01960413|54236946|FG000|Overall Study|Withdrawal by Subject|1|||
27782842|NCT01960413|54236947|FG001|Overall Study|Withdrawal by Subject|1|||
27782843|NCT01960413|54236946|FG000|Overall Study|Physician Decision|1|||
27782844|NCT01960413|54236947|FG001|Overall Study|Physician Decision|0|||
27782845|NCT01960413|54236946|FG000|Overall Study|Lost to Follow-up|2|||
27782846|NCT01960413|54236947|FG001|Overall Study|Lost to Follow-up|0|||
27782847|NCT01970475|54236955|FG000|Overall Study|Withdrawal by Subject|11|||
27782848|NCT01970475|54236956|FG001|Overall Study|Withdrawal by Subject|6|||
27782849|NCT01970475|54236955|FG000|Overall Study|Adverse Event|7|||
27782850|NCT01970475|54236956|FG001|Overall Study|Adverse Event|3|||
27782851|NCT01970475|54236955|FG000|Overall Study|Lost to Follow-up|2|||
27782852|NCT01970475|54236956|FG001|Overall Study|Lost to Follow-up|2|||
27782853|NCT01970475|54236955|FG000|Overall Study|Protocol Violation|1|||
27782854|NCT01970475|54236956|FG001|Overall Study|Protocol Violation|0|||
27782855|NCT01939977|54236964|FG000|Overall Study|Adverse Event|4|||
27782856|NCT01939977|54236965|FG001|Overall Study|Adverse Event|3|||
27782857|NCT01939977|54236964|FG000|Overall Study|Lack of Efficacy|3|||
27782858|NCT01939977|54236965|FG001|Overall Study|Lack of Efficacy|0|||
27782859|NCT01939977|54236964|FG000|Overall Study|Physician Decision|1|||
27782860|NCT01939977|54236965|FG001|Overall Study|Physician Decision|1|||
27782861|NCT01939977|54236964|FG000|Overall Study|Withdrawal by Subject|0|||
27782862|NCT01939977|54236965|FG001|Overall Study|Withdrawal by Subject|2|||
27782863|NCT01939977|54236964|FG000|Overall Study|Did not meet inclusion criteria|1|||
27782864|NCT01939977|54236965|FG001|Overall Study|Did not meet inclusion criteria|0|||
27782865|NCT01939977|54236964|FG000|Overall Study|Did not receive study medication|0|||
27840855|NCT01458587|54328787|FG000|Overall Study|Withdrawal by Subject|1|||
27782866|NCT01939977|54236965|FG001|Overall Study|Did not receive study medication|1|||
27782867|NCT01939899|54236976|FG000|Lead-in Dose Finding Phase|Death|0|||
27782868|NCT01939899|54236977|FG001|Lead-in Dose Finding Phase|Death|3|||
27782869|NCT01939899|54236978|FG002|Lead-in Dose Finding Phase|Death|1|||
27782870|NCT01939899|54236979|FG003|Lead-in Dose Finding Phase|Death|0|||
27782871|NCT01939899|54236980|FG004|Lead-in Dose Finding Phase|Death|0|||
27782872|NCT01939899|54236976|FG000|Lead-in Dose Finding Phase|Disease Progression|2|||
27782873|NCT01939899|54236977|FG001|Lead-in Dose Finding Phase|Disease Progression|4|||
27782874|NCT01939899|54236978|FG002|Lead-in Dose Finding Phase|Disease Progression|3|||
27782875|NCT01939899|54236979|FG003|Lead-in Dose Finding Phase|Disease Progression|0|||
27782876|NCT01939899|54236980|FG004|Lead-in Dose Finding Phase|Disease Progression|0|||
27782877|NCT01939899|54236976|FG000|Lead-in Dose Finding Phase|Other|0|||
27782878|NCT01939899|54236977|FG001|Lead-in Dose Finding Phase|Other|0|||
27782879|NCT01939899|54236978|FG002|Lead-in Dose Finding Phase|Other|1|||
27782880|NCT01939899|54236979|FG003|Lead-in Dose Finding Phase|Other|0|||
27782881|NCT01939899|54236980|FG004|Lead-in Dose Finding Phase|Other|0|||
27782882|NCT01939899|54236976|FG000|Phase 2|Withdrawal by Subject|0|||
27782883|NCT01939899|54236977|FG001|Phase 2|Withdrawal by Subject|0|||
27782884|NCT01939899|54236978|FG002|Phase 2|Withdrawal by Subject|0|||
27782885|NCT01939899|54236979|FG003|Phase 2|Withdrawal by Subject|2|||
27782886|NCT01939899|54236980|FG004|Phase 2|Withdrawal by Subject|0|||
27782887|NCT01939899|54236976|FG000|Phase 2|Disease Progression|0|||
27782888|NCT01939899|54236977|FG001|Phase 2|Disease Progression|0|||
27782889|NCT01939899|54236978|FG002|Phase 2|Disease Progression|0|||
27782890|NCT01939899|54236979|FG003|Phase 2|Disease Progression|9|||
27782891|NCT01939899|54236980|FG004|Phase 2|Disease Progression|1|||
27782892|NCT01970397|54237000|FG000|Overall Study|Adverse Event|0|||
27782893|NCT01970397|54237001|FG001|Overall Study|Adverse Event|1|||
27782894|NCT01970397|54237000|FG000|Overall Study|Lost to Follow-up|0|||
27782895|NCT01970397|54237001|FG001|Overall Study|Lost to Follow-up|1|||
27782896|NCT01970397|54237000|FG000|Overall Study|Personal Reasons|1|||
27782897|NCT01970397|54237001|FG001|Overall Study|Personal Reasons|2|||
27782898|NCT01970397|54237000|FG000|Overall Study|Protocol Violation|1|||
27782899|NCT01970397|54237001|FG001|Overall Study|Protocol Violation|1|||
27782900|NCT01970241|54237009|FG000|Overall Study|Withdrawal by Subject|2|||
27782901|NCT01970241|54237010|FG001|Overall Study|Withdrawal by Subject|0|||
27782902|NCT01970241|54237009|FG000|Overall Study|Steroid d/c;discharge<48 hrs.|15|||
27782903|NCT01970241|54237010|FG001|Overall Study|Steroid d/c;discharge<48 hrs.|8|||
27782904|NCT01939353|54237018|FG000|Placebo Run-in (1 Week)|Withdrew Consent|3|||
27782905|NCT01939353|54237018|FG000|Placebo Run-in (1 Week)|Lost to Follow-up|1|||
27782906|NCT01939353|54237018|FG000|CTN SR Treatment Phase (4 Weeks)|Treatment Emergent Adverse Event (TEAE)/Serious Adverse Event (SAE)|2|||
27782907|NCT01939353|54237018|FG000|CTN SR Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
27782908|NCT01939353|54237018|FG000|CTN SR Treatment Phase (4 Weeks)|Withdrew Consent|1|||
27782909|NCT01970007|54237022|FG000|Overall Study|Death|5|||
27782910|NCT01970007|54237022|FG000|Overall Study|Withdrawal by Subject|23|||
27782911|NCT01970007|54237022|FG000|Overall Study|Lost to Follow-up|24|||
27782912|NCT01970007|54237022|FG000|Overall Study|"Other endpoint"|3|||
27782913|NCT01728376|54237032|FG000|Overall Study|Adverse Event|1|||
27782914|NCT01728376|54237033|FG001|Overall Study|Adverse Event|1|||
27782915|NCT01728376|54237034|FG002|Overall Study|Adverse Event|1|||
27782916|NCT01728376|54237035|FG003|Overall Study|Adverse Event|1|||
27782917|NCT01728376|54237036|FG004|Overall Study|Adverse Event|1|||
27782918|NCT01728376|54237037|FG005|Overall Study|Adverse Event|0|||
27782919|NCT01728376|54237032|FG000|Overall Study|Persistent Positive Blood Cultures|1|||
27782920|NCT01728376|54237033|FG001|Overall Study|Persistent Positive Blood Cultures|0|||
27782921|NCT01728376|54237034|FG002|Overall Study|Persistent Positive Blood Cultures|1|||
27782922|NCT01728376|54237035|FG003|Overall Study|Persistent Positive Blood Cultures|0|||
27782923|NCT01728376|54237036|FG004|Overall Study|Persistent Positive Blood Cultures|0|||
27782924|NCT01728376|54237037|FG005|Overall Study|Persistent Positive Blood Cultures|0|||
27782925|NCT01728376|54237032|FG000|Overall Study|No relevant bacteria|2|||
27782926|NCT01728376|54237033|FG001|Overall Study|No relevant bacteria|0|||
27782927|NCT01728376|54237034|FG002|Overall Study|No relevant bacteria|0|||
27782928|NCT01728376|54237035|FG003|Overall Study|No relevant bacteria|0|||
27782929|NCT01728376|54237036|FG004|Overall Study|No relevant bacteria|1|||
27782930|NCT01728376|54237037|FG005|Overall Study|No relevant bacteria|1|||
27782931|NCT01728376|54237032|FG000|Overall Study|Did not receive treatment|0|||
27782932|NCT01728376|54237033|FG001|Overall Study|Did not receive treatment|1|||
27782933|NCT01728376|54237034|FG002|Overall Study|Did not receive treatment|0|||
27782934|NCT01728376|54237035|FG003|Overall Study|Did not receive treatment|0|||
27782935|NCT01728376|54237036|FG004|Overall Study|Did not receive treatment|0|||
27782936|NCT01728376|54237037|FG005|Overall Study|Did not receive treatment|0|||
27782937|NCT01728376|54237032|FG000|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
27782938|NCT01728376|54237033|FG001|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
27782939|NCT01728376|54237034|FG002|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
27782940|NCT01728376|54237035|FG003|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
27782941|NCT01728376|54237036|FG004|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
27782942|NCT01728376|54237037|FG005|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
27782943|NCT01708174|54237054|FG000|Treatment Period|Withdrawal by Subject|1|||
27782944|NCT01708174|54237055|FG001|Treatment Period|Withdrawal by Subject|0|||
27782945|NCT01708174|54237056|FG002|Treatment Period|Withdrawal by Subject|0|||
27782946|NCT01708174|54237054|FG000|Treatment Period|Progressive disease|0|||
27782947|NCT01708174|54237055|FG001|Treatment Period|Progressive disease|1|||
27782948|NCT01708174|54237056|FG002|Treatment Period|Progressive disease|0|||
27782949|NCT01708174|54237054|FG000|Treatment Period|Death|0|||
27782950|NCT01708174|54237055|FG001|Treatment Period|Death|0|||
27782951|NCT01708174|54237056|FG002|Treatment Period|Death|1|||
27782952|NCT01708174|54237054|FG000|Treatment Period|Adverse Event|0|||
27782953|NCT01708174|54237055|FG001|Treatment Period|Adverse Event|1|||
27782954|NCT01708174|54237056|FG002|Treatment Period|Adverse Event|0|||
27782955|NCT02488759|54237071|FG000|Overall Study|Disease progression|74|||
27782956|NCT02488759|54237072|FG001|Overall Study|Disease progression|110|||
27782957|NCT02488759|54237073|FG002|Overall Study|Disease progression|62|||
27782958|NCT02488759|54237074|FG003|Overall Study|Disease progression|7|||
27782959|NCT02488759|54237075|FG004|Overall Study|Disease progression|4|||
27782960|NCT02488759|54237076|FG005|Overall Study|Disease progression|2|||
27782961|NCT02488759|54237071|FG000|Overall Study|Study drug toxicity|11|||
27782962|NCT02488759|54237072|FG001|Overall Study|Study drug toxicity|33|||
27782963|NCT02488759|54237073|FG002|Overall Study|Study drug toxicity|31|||
27782964|NCT02488759|54237074|FG003|Overall Study|Study drug toxicity|0|||
27782965|NCT02488759|54237075|FG004|Overall Study|Study drug toxicity|0|||
27782966|NCT02488759|54237076|FG005|Overall Study|Study drug toxicity|2|||
27782967|NCT02488759|54237071|FG000|Overall Study|Adverse event unrelated to study drug|9|||
27782968|NCT02488759|54237072|FG001|Overall Study|Adverse event unrelated to study drug|11|||
27782969|NCT02488759|54237073|FG002|Overall Study|Adverse event unrelated to study drug|7|||
27782970|NCT02488759|54237074|FG003|Overall Study|Adverse event unrelated to study drug|0|||
27782971|NCT02488759|54237075|FG004|Overall Study|Adverse event unrelated to study drug|1|||
27782972|NCT02488759|54237076|FG005|Overall Study|Adverse event unrelated to study drug|0|||
27782973|NCT02488759|54237071|FG000|Overall Study|Participant request to discontinue study treatment|7|||
27782974|NCT02488759|54237072|FG001|Overall Study|Participant request to discontinue study treatment|8|||
27782975|NCT02488759|54237073|FG002|Overall Study|Participant request to discontinue study treatment|4|||
27782976|NCT02488759|54237074|FG003|Overall Study|Participant request to discontinue study treatment|0|||
27782977|NCT02488759|54237075|FG004|Overall Study|Participant request to discontinue study treatment|0|||
27782978|NCT02488759|54237076|FG005|Overall Study|Participant request to discontinue study treatment|0|||
27782979|NCT02488759|54237071|FG000|Overall Study|Withdrawal by Subject|2|||
27782980|NCT02488759|54237072|FG001|Overall Study|Withdrawal by Subject|0|||
27782981|NCT02488759|54237073|FG002|Overall Study|Withdrawal by Subject|3|||
27782982|NCT02488759|54237074|FG003|Overall Study|Withdrawal by Subject|0|||
27782983|NCT02488759|54237075|FG004|Overall Study|Withdrawal by Subject|0|||
27782984|NCT02488759|54237076|FG005|Overall Study|Withdrawal by Subject|2|||
27782985|NCT02488759|54237071|FG000|Overall Study|Lost to Follow-up|0|||
27782986|NCT02488759|54237072|FG001|Overall Study|Lost to Follow-up|1|||
27782987|NCT02488759|54237073|FG002|Overall Study|Lost to Follow-up|2|||
27782988|NCT02488759|54237074|FG003|Overall Study|Lost to Follow-up|0|||
27782989|NCT02488759|54237075|FG004|Overall Study|Lost to Follow-up|0|||
27782990|NCT02488759|54237076|FG005|Overall Study|Lost to Follow-up|0|||
27782991|NCT02488759|54237071|FG000|Overall Study|Maximum clinical benefit|3|||
27782992|NCT02488759|54237072|FG001|Overall Study|Maximum clinical benefit|0|||
27782993|NCT02488759|54237073|FG002|Overall Study|Maximum clinical benefit|1|||
27782994|NCT02488759|54237074|FG003|Overall Study|Maximum clinical benefit|0|||
27782995|NCT02488759|54237075|FG004|Overall Study|Maximum clinical benefit|0|||
27782996|NCT02488759|54237076|FG005|Overall Study|Maximum clinical benefit|0|||
27782997|NCT02488759|54237071|FG000|Overall Study|Completed treatment|0|||
27782998|NCT02488759|54237072|FG001|Overall Study|Completed treatment|0|||
27782999|NCT02488759|54237073|FG002|Overall Study|Completed treatment|0|||
27783000|NCT02488759|54237074|FG003|Overall Study|Completed treatment|0|||
27783001|NCT02488759|54237075|FG004|Overall Study|Completed treatment|0|||
27783002|NCT02488759|54237076|FG005|Overall Study|Completed treatment|116|||
27783003|NCT02488759|54237071|FG000|Overall Study|Other reasons|5|||
27783004|NCT02488759|54237072|FG001|Overall Study|Other reasons|32|||
27783005|NCT02488759|54237073|FG002|Overall Study|Other reasons|21|||
27783006|NCT02488759|54237074|FG003|Overall Study|Other reasons|1|||
27783007|NCT02488759|54237075|FG004|Overall Study|Other reasons|1|||
27783008|NCT02488759|54237076|FG005|Overall Study|Other reasons|1|||
27783009|NCT01605916|54237095|FG000|Overall Study|Adverse Event|1|||
27783010|NCT01605916|54237096|FG001|Overall Study|Adverse Event|0|||
27783011|NCT01605916|54237097|FG002|Overall Study|Adverse Event|0|||
27783012|NCT01605916|54237098|FG003|Overall Study|Adverse Event|1|||
27783013|NCT01605916|54237099|FG004|Overall Study|Adverse Event|0|||
27783014|NCT01605916|54237095|FG000|Overall Study|Lack of Efficacy|2|||
27783015|NCT01605916|54237096|FG001|Overall Study|Lack of Efficacy|3|||
27783016|NCT01605916|54237097|FG002|Overall Study|Lack of Efficacy|3|||
27783017|NCT01605916|54237098|FG003|Overall Study|Lack of Efficacy|5|||
27783018|NCT01605916|54237099|FG004|Overall Study|Lack of Efficacy|4|||
27783019|NCT01605916|54237095|FG000|Overall Study|Withdrawal by Subject|1|||
27783020|NCT01605916|54237096|FG001|Overall Study|Withdrawal by Subject|1|||
27783021|NCT01605916|54237097|FG002|Overall Study|Withdrawal by Subject|0|||
27783022|NCT01605916|54237098|FG003|Overall Study|Withdrawal by Subject|0|||
27783023|NCT01605916|54237099|FG004|Overall Study|Withdrawal by Subject|2|||
27783024|NCT01635283|54237112|FG000|Overall Study|Tumor Progression|3|||
27783025|NCT01635283|54237112|FG000|Overall Study|Lost to Follow-up|1|||
27783026|NCT01707004|54237119|FG000|Overall Study|Physician Decision|3|||
27783027|NCT01939197|54237131|FG000|Overall Study|Withdrawal by Subject|1|||
27783028|NCT01939197|54237132|FG001|Overall Study|Withdrawal by Subject|0|||
27783029|NCT01939197|54237133|FG002|Overall Study|Withdrawal by Subject|0|||
27783030|NCT01939197|54237134|FG003|Overall Study|Withdrawal by Subject|0|||
27783031|NCT01939197|54237135|FG004|Overall Study|Withdrawal by Subject|1|||
27783032|NCT01939197|54237136|FG005|Overall Study|Withdrawal by Subject|0|||
27783033|NCT01939197|54237137|FG006|Overall Study|Withdrawal by Subject|0|||
27783034|NCT01939197|54237131|FG000|Overall Study|Lost to Follow-up|0|||
27783035|NCT01939197|54237132|FG001|Overall Study|Lost to Follow-up|1|||
27783036|NCT01939197|54237133|FG002|Overall Study|Lost to Follow-up|0|||
27783037|NCT01939197|54237134|FG003|Overall Study|Lost to Follow-up|1|||
27783038|NCT01939197|54237135|FG004|Overall Study|Lost to Follow-up|3|||
27783039|NCT01939197|54237136|FG005|Overall Study|Lost to Follow-up|1|||
27783040|NCT01939197|54237137|FG006|Overall Study|Lost to Follow-up|2|||
27783041|NCT01969851|54237170|FG000|Overall Study|Adverse Event|0|||
27783042|NCT01969851|54237171|FG001|Overall Study|Adverse Event|0|||
27783043|NCT01969851|54237172|FG002|Overall Study|Adverse Event|3|||
27783044|NCT01969851|54237170|FG000|Overall Study|Lack of Efficacy|0|||
27783045|NCT01969851|54237171|FG001|Overall Study|Lack of Efficacy|3|||
27783046|NCT01969851|54237172|FG002|Overall Study|Lack of Efficacy|1|||
27783047|NCT01969851|54237170|FG000|Overall Study|Withdrawal by Subject|1|||
27783048|NCT01969851|54237171|FG001|Overall Study|Withdrawal by Subject|0|||
27783049|NCT01969851|54237172|FG002|Overall Study|Withdrawal by Subject|1|||
27783050|NCT01969851|54237170|FG000|Overall Study|No effective dose in Titration period|0|||
27783051|NCT01969851|54237171|FG001|Overall Study|No effective dose in Titration period|0|||
27783052|NCT01969851|54237172|FG002|Overall Study|No effective dose in Titration period|1|||
27783053|NCT01969851|54237170|FG000|Overall Study|Sponsor decision|0|||
27783054|NCT01969851|54237171|FG001|Overall Study|Sponsor decision|0|||
27783055|NCT01969851|54237172|FG002|Overall Study|Sponsor decision|1|||
27783056|NCT01938573|54237180|FG000|Overall Study|Lack of Efficacy|1|||
27783057|NCT01938573|54237181|FG001|Overall Study|Lack of Efficacy|0|||
27783058|NCT01938573|54237180|FG000|Overall Study|Operation at other hospital|1|||
27783059|NCT01938573|54237181|FG001|Overall Study|Operation at other hospital|0|||
27783060|NCT01937871|54237189|FG000|Overall Study|Adverse Event|6|||
27783061|NCT01937871|54237190|FG001|Overall Study|Adverse Event|6|||
27783062|NCT01937871|54237191|FG002|Overall Study|Adverse Event|2|||
27783063|NCT01937871|54237189|FG000|Overall Study|Lost to Follow-up|8|||
27783064|NCT01937871|54237190|FG001|Overall Study|Lost to Follow-up|2|||
27783065|NCT01937871|54237191|FG002|Overall Study|Lost to Follow-up|4|||
27783066|NCT01937871|54237189|FG000|Overall Study|Withdrawal by Subject|9|||
27783067|NCT01937871|54237190|FG001|Overall Study|Withdrawal by Subject|6|||
27783068|NCT01937871|54237191|FG002|Overall Study|Withdrawal by Subject|4|||
27783069|NCT01937871|54237189|FG000|Overall Study|Physician Decision|0|||
27783070|NCT01937871|54237190|FG001|Overall Study|Physician Decision|1|||
27783071|NCT01937871|54237191|FG002|Overall Study|Physician Decision|0|||
27783072|NCT01937871|54237189|FG000|Overall Study|Entry Criteria Not Met|1|||
27783073|NCT01937871|54237190|FG001|Overall Study|Entry Criteria Not Met|2|||
27783074|NCT01937871|54237191|FG002|Overall Study|Entry Criteria Not Met|1|||
27783075|NCT01269463|54237223|FG000|First Intervention|Withdrawal by Subject|1|||
27783076|NCT01269463|54237224|FG001|First Intervention|Withdrawal by Subject|0|||
27783077|NCT01269463|54237223|FG000|First Intervention|Adverse Event|1|||
27783078|NCT01269463|54237224|FG001|First Intervention|Adverse Event|0|||
27783079|NCT01269463|54237223|FG000|First Intervention|Lack of Efficacy|0|||
27783080|NCT01269463|54237224|FG001|First Intervention|Lack of Efficacy|1|||
27783081|NCT01269463|54237223|FG000|First Intervention|Physician Decision|0|||
27783082|NCT01269463|54237224|FG001|First Intervention|Physician Decision|1|||
27783083|NCT01706926|54237239|FG000|Overall Study|Lost to Follow-up|0|||
27783084|NCT01706926|54237240|FG001|Overall Study|Lost to Follow-up|0|||
27783085|NCT01706926|54237241|FG002|Overall Study|Lost to Follow-up|1|||
27783086|NCT01706926|54237242|FG003|Overall Study|Lost to Follow-up|0|||
27783087|NCT01706926|54237239|FG000|Overall Study|Withdrawal by Subject|2|||
27783088|NCT01706926|54237240|FG001|Overall Study|Withdrawal by Subject|0|||
27783089|NCT01706926|54237241|FG002|Overall Study|Withdrawal by Subject|1|||
27783090|NCT01706926|54237242|FG003|Overall Study|Withdrawal by Subject|2|||
27783091|NCT01706926|54237239|FG000|Overall Study|Other|4|||
27783092|NCT01706926|54237240|FG001|Overall Study|Other|4|||
27783093|NCT01706926|54237241|FG002|Overall Study|Other|4|||
27783094|NCT01706926|54237242|FG003|Overall Study|Other|3|||
27783095|NCT01634113|54237258|FG000|Overall Study|Not treated|0|||
27783096|NCT01634113|54237259|FG001|Overall Study|Not treated|0|||
27783097|NCT01634113|54237260|FG002|Overall Study|Not treated|1|||
27783098|NCT01706770|54237270|FG000|Overall Study|Lost to Follow-up|1|||
27783099|NCT01706770|54237271|FG001|Overall Study|Lost to Follow-up|0|||
27783100|NCT01706770|54237270|FG000|Overall Study|Physician Decision|1|||
27783101|NCT01706770|54237271|FG001|Overall Study|Physician Decision|0|||
27783102|NCT01937715|54237282|FG000|Overall Study|Death|0|||
27783103|NCT01937715|54237283|FG001|Overall Study|Death|0|||
27783104|NCT01937715|54237284|FG002|Overall Study|Death|0|||
27783105|NCT01937715|54237285|FG003|Overall Study|Death|1|||
27783106|NCT01937715|54237286|FG004|Overall Study|Death|0|||
27783107|NCT01937715|54237282|FG000|Overall Study|Withdrawal by Subject|0|||
27783108|NCT01937715|54237283|FG001|Overall Study|Withdrawal by Subject|1|||
27783109|NCT01937715|54237284|FG002|Overall Study|Withdrawal by Subject|0|||
27783110|NCT01937715|54237285|FG003|Overall Study|Withdrawal by Subject|0|||
27783111|NCT01937715|54237286|FG004|Overall Study|Withdrawal by Subject|2|||
27783112|NCT01937715|54237282|FG000|Overall Study|Other|0|||
27783113|NCT01937715|54237283|FG001|Overall Study|Other|0|||
27783114|NCT01937715|54237284|FG002|Overall Study|Other|0|||
27783115|NCT01937715|54237285|FG003|Overall Study|Other|3|||
27783116|NCT01937715|54237286|FG004|Overall Study|Other|0|||
27783117|NCT01937559|54237301|FG000|Overall Study|Physician Decision|3|||
27783118|NCT01937559|54237302|FG001|Overall Study|Physician Decision|3|||
27783119|NCT01937559|54237303|FG002|Overall Study|Physician Decision|0|||
27840856|NCT01458587|54328788|FG001|Overall Study|Withdrawal by Subject|0|||
27783120|NCT01937559|54237301|FG000|Overall Study|Withdrawal by Subject|6|||
27783121|NCT01937559|54237302|FG001|Overall Study|Withdrawal by Subject|4|||
27783122|NCT01937559|54237303|FG002|Overall Study|Withdrawal by Subject|0|||
27783123|NCT01937559|54237301|FG000|Overall Study|screen fail|2|||
27783124|NCT01937559|54237302|FG001|Overall Study|screen fail|4|||
27783125|NCT01937559|54237303|FG002|Overall Study|screen fail|0|||
27783126|NCT01960257|54237315|FG000|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|12|||
27783127|NCT01960257|54237316|FG001|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
27783128|NCT01960257|54237317|FG002|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
27783129|NCT01960257|54237315|FG000|Stage 1 (1-3 Weeks)|Withdrawal by Subject|3|||
27783130|NCT01960257|54237316|FG001|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
27783131|NCT01960257|54237317|FG002|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
27783132|NCT01960257|54237315|FG000|Stage 1 (1-3 Weeks)|Adverse Event|1|||
27783133|NCT01960257|54237316|FG001|Stage 1 (1-3 Weeks)|Adverse Event|0|||
27783134|NCT01960257|54237317|FG002|Stage 1 (1-3 Weeks)|Adverse Event|0|||
27783135|NCT01918371|54237329|FG000|Overall Study|Missing Data|1|||
27783136|NCT01918371|54237330|FG001|Overall Study|Missing Data|1|||
27783137|NCT01917747|54237338|FG000|Overall Study|Withdrawal by Subject|1|||
27783138|NCT01917747|54237339|FG001|Overall Study|Withdrawal by Subject|2|||
27783139|NCT01917747|54237338|FG000|Overall Study|Lost to Follow-up|18|||
27783140|NCT01917747|54237339|FG001|Overall Study|Lost to Follow-up|9|||
27783141|NCT01597791|54237351|FG000|Overall Study|Physician Decision|2|||
27783142|NCT01597791|54237352|FG001|Overall Study|Physician Decision|1|||
27783143|NCT01597791|54237351|FG000|Overall Study|Cesarean Section|6|||
27783144|NCT01597791|54237352|FG001|Overall Study|Cesarean Section|7|||
27783145|NCT01597791|54237351|FG000|Overall Study|Subject withdrawal|0|||
27783146|NCT01597791|54237352|FG001|Overall Study|Subject withdrawal|1|||
27783147|NCT01597791|54237351|FG000|Overall Study|Protocol Violation|0|||
27783148|NCT01597791|54237352|FG001|Overall Study|Protocol Violation|1|||
27783149|NCT01916967|54237361|FG000|Overall Study|Adverse Event|0|||
27783150|NCT01916967|54237362|FG001|Overall Study|Adverse Event|0|||
27783151|NCT01916967|54237363|FG002|Overall Study|Adverse Event|2|||
27783152|NCT01916967|54237361|FG000|Overall Study|Lack of Efficacy|0|||
27783153|NCT01916967|54237362|FG001|Overall Study|Lack of Efficacy|0|||
27783154|NCT01916967|54237363|FG002|Overall Study|Lack of Efficacy|6|||
27783155|NCT01916967|54237361|FG000|Overall Study|Physician Decision|0|||
27783156|NCT01916967|54237362|FG001|Overall Study|Physician Decision|0|||
27783157|NCT01916967|54237363|FG002|Overall Study|Physician Decision|1|||
27783158|NCT01916967|54237361|FG000|Overall Study|Protocol Violation|0|||
27783159|NCT01916967|54237362|FG001|Overall Study|Protocol Violation|1|||
27783160|NCT01916967|54237363|FG002|Overall Study|Protocol Violation|0|||
27783161|NCT01936623|54237375|FG000|Overall Study|Lost to Follow-up|0|||
27783162|NCT01936623|54237376|FG001|Overall Study|Lost to Follow-up|5|||
27783163|NCT01959243|54237384|FG000|Overall Study|Investigator Decision|3|||
27783164|NCT01959243|54237385|FG001|Overall Study|Investigator Decision|0|||
27783165|NCT01959243|54237384|FG000|Overall Study|Adverse Event|5|||
27783166|NCT01959243|54237385|FG001|Overall Study|Adverse Event|2|||
27783167|NCT01959243|54237384|FG000|Overall Study|Administrative reasons|2|||
27783168|NCT01959243|54237385|FG001|Overall Study|Administrative reasons|1|||
27783169|NCT01959243|54237384|FG000|Overall Study|Lost to Follow-up|3|||
27783170|NCT01959243|54237385|FG001|Overall Study|Lost to Follow-up|1|||
27783171|NCT01959165|54237395|FG000|Overall Study|Adverse Event|0|||
27783172|NCT01959165|54237396|FG001|Overall Study|Adverse Event|0|||
27783173|NCT01959165|54237397|FG002|Overall Study|Adverse Event|0|||
27783174|NCT01959165|54237398|FG003|Overall Study|Adverse Event|1|||
27783175|NCT01959165|54237395|FG000|Overall Study|Lack of Efficacy|1|||
27783176|NCT01959165|54237396|FG001|Overall Study|Lack of Efficacy|0|||
27783177|NCT01959165|54237397|FG002|Overall Study|Lack of Efficacy|0|||
27783178|NCT01959165|54237398|FG003|Overall Study|Lack of Efficacy|0|||
27783179|NCT01959165|54237395|FG000|Overall Study|overdose|0|||
27783180|NCT01959165|54237396|FG001|Overall Study|overdose|0|||
27783181|NCT01959165|54237397|FG002|Overall Study|overdose|0|||
27783182|NCT01959165|54237398|FG003|Overall Study|overdose|1|||
27783183|NCT01959165|54237395|FG000|Overall Study|Welfare recipient|0|||
27783184|NCT01959165|54237396|FG001|Overall Study|Welfare recipient|1|||
27783185|NCT01959165|54237397|FG002|Overall Study|Welfare recipient|0|||
27783186|NCT01959165|54237398|FG003|Overall Study|Welfare recipient|0|||
27783187|NCT01916109|54237408|FG000|Overall Study|Withdrawal by Subject|1|||
27783188|NCT01915095|54237419|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
27783189|NCT01915095|54237420|FG001|Overall Study|Some subjects were unable to commit to the training study.|0|||
27783190|NCT01915095|54237421|FG002|Overall Study|Some subjects were unable to commit to the training study.|0|||
27783191|NCT01915095|54237422|FG003|Overall Study|Some subjects were unable to commit to the training study.|4|||
27783192|NCT01915095|54237423|FG004|Overall Study|Some subjects were unable to commit to the training study.|6|||
27783193|NCT01958619|54237448|FG000|Overall Study|Protocol Violation|2|||
27783194|NCT01958619|54237449|FG001|Overall Study|Protocol Violation|0|||
27783195|NCT01958619|54237450|FG002|Overall Study|Protocol Violation|1|||
27783196|NCT01958619|54237451|FG003|Overall Study|Protocol Violation|0|||
27783197|NCT01752634|54237467|FG000|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
27783198|NCT01752634|54237468|FG001|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
27783199|NCT01752634|54237469|FG002|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
27783200|NCT01752634|54237470|FG003|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
27783201|NCT01752634|54237471|FG004|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
27783202|NCT01752634|54237472|FG005|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3|||
27783203|NCT01752634|54237467|FG000|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
27783204|NCT01752634|54237468|FG001|Up to Week 24 (Primary Analysis)|Physician Decision|1|||
27783205|NCT01752634|54237469|FG002|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
27783206|NCT01752634|54237470|FG003|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
27783207|NCT01752634|54237471|FG004|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
27783208|NCT01752634|54237472|FG005|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
27783209|NCT01752634|54237467|FG000|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2|||
27783210|NCT01752634|54237468|FG001|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
27783211|NCT01752634|54237469|FG002|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
27783212|NCT01752634|54237470|FG003|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
27783213|NCT01752634|54237471|FG004|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
27783214|NCT01752634|54237472|FG005|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
27783215|NCT01752634|54237467|FG000|Up to Week 24 (Primary Analysis)|Adverse Event|3|||
27783216|NCT01752634|54237468|FG001|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
27783217|NCT01752634|54237469|FG002|Up to Week 24 (Primary Analysis)|Adverse Event|2|||
27783218|NCT01752634|54237470|FG003|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
27783219|NCT01752634|54237471|FG004|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
27783220|NCT01752634|54237472|FG005|Up to Week 24 (Primary Analysis)|Adverse Event|4|||
27783221|NCT01752634|54237467|FG000|Week 24 to Week 260|Lack of Efficacy|15|||
27783222|NCT01752634|54237468|FG001|Week 24 to Week 260|Lack of Efficacy|7|||
27783223|NCT01752634|54237469|FG002|Week 24 to Week 260|Lack of Efficacy|7|||
27783224|NCT01752634|54237470|FG003|Week 24 to Week 260|Lack of Efficacy|3|||
27783225|NCT01752634|54237471|FG004|Week 24 to Week 260|Lack of Efficacy|4|||
27783226|NCT01752634|54237472|FG005|Week 24 to Week 260|Lack of Efficacy|0|||
27783227|NCT01752634|54237467|FG000|Week 24 to Week 260|Subject/guardian decision|12|||
27783228|NCT01752634|54237468|FG001|Week 24 to Week 260|Subject/guardian decision|10|||
27783229|NCT01752634|54237469|FG002|Week 24 to Week 260|Subject/guardian decision|9|||
27783230|NCT01752634|54237470|FG003|Week 24 to Week 260|Subject/guardian decision|5|||
27783231|NCT01752634|54237471|FG004|Week 24 to Week 260|Subject/guardian decision|5|||
27783232|NCT01752634|54237472|FG005|Week 24 to Week 260|Subject/guardian decision|0|||
27783233|NCT01752634|54237467|FG000|Week 24 to Week 260|Physician Decision|1|||
27783234|NCT01752634|54237468|FG001|Week 24 to Week 260|Physician Decision|2|||
27783235|NCT01752634|54237469|FG002|Week 24 to Week 260|Physician Decision|4|||
27783236|NCT01752634|54237470|FG003|Week 24 to Week 260|Physician Decision|2|||
27783237|NCT01752634|54237471|FG004|Week 24 to Week 260|Physician Decision|1|||
27783238|NCT01752634|54237472|FG005|Week 24 to Week 260|Physician Decision|0|||
27783239|NCT01752634|54237467|FG000|Week 24 to Week 260|Death|0|||
27783240|NCT01752634|54237468|FG001|Week 24 to Week 260|Death|1|||
27783241|NCT01752634|54237469|FG002|Week 24 to Week 260|Death|0|||
27783242|NCT01752634|54237470|FG003|Week 24 to Week 260|Death|0|||
27783243|NCT01752634|54237471|FG004|Week 24 to Week 260|Death|0|||
27783244|NCT01752634|54237472|FG005|Week 24 to Week 260|Death|0|||
27783245|NCT01752634|54237467|FG000|Week 24 to Week 260|Pregnancy|0|||
27783246|NCT01752634|54237468|FG001|Week 24 to Week 260|Pregnancy|0|||
27783247|NCT01752634|54237469|FG002|Week 24 to Week 260|Pregnancy|1|||
27783248|NCT01752634|54237470|FG003|Week 24 to Week 260|Pregnancy|0|||
27783249|NCT01752634|54237471|FG004|Week 24 to Week 260|Pregnancy|0|||
27783250|NCT01752634|54237472|FG005|Week 24 to Week 260|Pregnancy|0|||
27783251|NCT01752634|54237467|FG000|Week 24 to Week 260|Noncompliance with study treatment|0|||
27783252|NCT01752634|54237468|FG001|Week 24 to Week 260|Noncompliance with study treatment|0|||
27783253|NCT01752634|54237469|FG002|Week 24 to Week 260|Noncompliance with study treatment|1|||
27783254|NCT01752634|54237470|FG003|Week 24 to Week 260|Noncompliance with study treatment|0|||
27783255|NCT01752634|54237471|FG004|Week 24 to Week 260|Noncompliance with study treatment|0|||
27783256|NCT01752634|54237472|FG005|Week 24 to Week 260|Noncompliance with study treatment|0|||
27783257|NCT01752634|54237467|FG000|Week 24 to Week 260|Lost to Follow-up|2|||
27783258|NCT01752634|54237468|FG001|Week 24 to Week 260|Lost to Follow-up|2|||
27783259|NCT01752634|54237469|FG002|Week 24 to Week 260|Lost to Follow-up|3|||
27783260|NCT01752634|54237470|FG003|Week 24 to Week 260|Lost to Follow-up|0|||
27783261|NCT01752634|54237471|FG004|Week 24 to Week 260|Lost to Follow-up|2|||
27783262|NCT01752634|54237472|FG005|Week 24 to Week 260|Lost to Follow-up|0|||
27783263|NCT01752634|54237467|FG000|Week 24 to Week 260|Adverse Event|4|||
27783264|NCT01752634|54237468|FG001|Week 24 to Week 260|Adverse Event|8|||
27783265|NCT01752634|54237469|FG002|Week 24 to Week 260|Adverse Event|8|||
27783266|NCT01752634|54237470|FG003|Week 24 to Week 260|Adverse Event|4|||
27783267|NCT01752634|54237471|FG004|Week 24 to Week 260|Adverse Event|2|||
27783268|NCT01752634|54237472|FG005|Week 24 to Week 260|Adverse Event|0|||
27783269|NCT01933113|54237482|FG000|Overall Study|Fractured nonfunctioning lead.|1|||
27783270|NCT01726270|54237486|FG000|Part 1, Self-Selection Phase|Withdrawal by Subject|10|||
27783271|NCT01726270|54237486|FG000|Eligibility for Part 2|Eligible but did not enter Part 2|20|||
27783272|NCT01726270|54237486|FG000|Part 2, Actual-Use Phase|Withdrawal by Subject|21|||
27783273|NCT01726270|54237486|FG000|Part 2, Actual-Use Phase|Adverse Event|6|||
27783274|NCT01726270|54237486|FG000|Part 2, Actual-Use Phase|Lost to Follow-up|5|||
27783275|NCT01726270|54237486|FG000|Part 2, Actual-Use Phase|Other than reason specified above|7|||
27783276|NCT00942331|54237494|FG000|Overall Study|Did not start treatment|15|||
27783277|NCT00942331|54237495|FG001|Overall Study|Did not start treatment|22|||
27783278|NCT01914393|54237504|FG000|Overall Study|Protocol Violation|11|||
27783279|NCT01914393|54237505|FG001|Overall Study|Protocol Violation|3|||
27783280|NCT01914393|54237506|FG002|Overall Study|Protocol Violation|19|||
27783281|NCT01914393|54237504|FG000|Overall Study|Lack of Efficacy|11|||
27783282|NCT01914393|54237505|FG001|Overall Study|Lack of Efficacy|16|||
27783283|NCT01914393|54237506|FG002|Overall Study|Lack of Efficacy|5|||
27783284|NCT01914393|54237504|FG000|Overall Study|no reason given|14|||
27783285|NCT01914393|54237505|FG001|Overall Study|no reason given|8|||
27783286|NCT01914393|54237506|FG002|Overall Study|no reason given|16|||
27783287|NCT01914393|54237504|FG000|Overall Study|Adverse Event|29|||
27783288|NCT01914393|54237505|FG001|Overall Study|Adverse Event|18|||
27783289|NCT01914393|54237506|FG002|Overall Study|Adverse Event|31|||
27783290|NCT01914393|54237504|FG000|Overall Study|Withdrawal by Subject|38|||
27783291|NCT01914393|54237505|FG001|Overall Study|Withdrawal by Subject|20|||
27783292|NCT01914393|54237506|FG002|Overall Study|Withdrawal by Subject|47|||
27783293|NCT01914393|54237504|FG000|Overall Study|Lost to Follow-up|12|||
27783294|NCT01914393|54237505|FG001|Overall Study|Lost to Follow-up|6|||
27783295|NCT01914393|54237506|FG002|Overall Study|Lost to Follow-up|19|||
27783296|NCT01914393|54237504|FG000|Overall Study|subject never dosed|0|||
27783297|NCT01914393|54237505|FG001|Overall Study|subject never dosed|0|||
27783298|NCT01914393|54237506|FG002|Overall Study|subject never dosed|1|||
27783299|NCT01931865|54237518|FG000|Overall Study|Lost to Follow-up|2|||
27783300|NCT01931865|54237518|FG000|Overall Study|Withdrawal by Subject|2|||
27783301|NCT01617447|54237525|FG000|Overall Study|Adverse Event|0|||
27783302|NCT01617447|54237526|FG001|Overall Study|Adverse Event|1|||
27783303|NCT01617447|54237525|FG000|Overall Study|Physician Decision|0|||
27783304|NCT01617447|54237526|FG001|Overall Study|Physician Decision|2|||
27783305|NCT00432679|54237534|FG000|Overall Study|Adverse Event|2|||
27783306|NCT00432679|54237535|FG001|Overall Study|Adverse Event|1|||
27783307|NCT00432679|54237534|FG000|Overall Study|Withdrawal by Subject|3|||
27783308|NCT00432679|54237535|FG001|Overall Study|Withdrawal by Subject|2|||
27783309|NCT01600105|54237543|FG000|Total Participants|Withdrawal by Subject|1|||
27783310|NCT01600105|54237544|FG001|Total Participants|Withdrawal by Subject|0|||
27783311|NCT01600105|54237543|FG000|Total Participants|No images in PACS|10|||
27783312|NCT01600105|54237544|FG001|Total Participants|No images in PACS|0|||
27783313|NCT01600105|54237543|FG000|Total Participants|Insufficient image quality|30|||
27783314|NCT01600105|54237544|FG001|Total Participants|Insufficient image quality|10|||
27783315|NCT01600105|54237543|FG000|Sub Study I|Insufficient image quality|0|||
27783316|NCT01600105|54237544|FG001|Sub Study I|Insufficient image quality|10|||
27783317|NCT01600105|54237543|FG000|Sub Study II|Withdrawal by Subject|1|||
27783318|NCT01600105|54237544|FG001|Sub Study II|Withdrawal by Subject|0|||
27783319|NCT01600105|54237543|FG000|Sub Study II|No images in PACS|1|||
27783320|NCT01600105|54237544|FG001|Sub Study II|No images in PACS|0|||
27783321|NCT01600105|54237543|FG000|Sub Study II|Insufficient image quality|3|||
27783322|NCT01600105|54237544|FG001|Sub Study II|Insufficient image quality|0|||
27783323|NCT01600105|54237543|FG000|Sub Study III|Insufficient image quality|5|||
27783324|NCT01600105|54237544|FG001|Sub Study III|Insufficient image quality|0|||
27783325|NCT01600105|54237543|FG000|Sub Study V|Poor Image Quality|2|||
27783326|NCT01600105|54237544|FG001|Sub Study V|Poor Image Quality|0|||
27783327|NCT02246647|54237556|FG000|Overall Study|Withdrawal by Subject|1|||
27783328|NCT02246647|54237557|FG001|Overall Study|Withdrawal by Subject|1|||
27783329|NCT02244619|54237579|FG000|Overall Study|Did not receive study intervention|8|||
27783330|NCT02244619|54237580|FG001|Overall Study|Did not receive study intervention|21|||
27783331|NCT02243371|54237588|FG000|Overall Study|Progressive Disease (clinic & radio)|35|||
27783332|NCT02243371|54237589|FG001|Overall Study|Progressive Disease (clinic & radio)|24|||
27783333|NCT02243371|54237588|FG000|Overall Study|Death (unrelated)|2|||
27783334|NCT02243371|54237589|FG001|Overall Study|Death (unrelated)|4|||
27783335|NCT02243371|54237588|FG000|Overall Study|Adverse Event (unrelated)|0|||
27783336|NCT02243371|54237589|FG001|Overall Study|Adverse Event (unrelated)|1|||
27783337|NCT02243371|54237588|FG000|Overall Study|Lack of Clinical Benefit|0|||
27783338|NCT02243371|54237589|FG001|Overall Study|Lack of Clinical Benefit|1|||
27783339|NCT02243371|54237588|FG000|Overall Study|Withdrawal by Subject|0|||
27783340|NCT02243371|54237589|FG001|Overall Study|Withdrawal by Subject|2|||
27783341|NCT01931475|54237597|FG000|Period 1: Double-Blind Treatment Phase|Adverse Event|20|||
27783342|NCT01931475|54237598|FG001|Period 1: Double-Blind Treatment Phase|Adverse Event|10|||
27783343|NCT01931475|54237597|FG000|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1|||
27783344|NCT01931475|54237598|FG001|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0|||
27783345|NCT01931475|54237597|FG000|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16|||
27783346|NCT01931475|54237598|FG001|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12|||
27783347|NCT01931475|54237597|FG000|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2|||
27783348|NCT01931475|54237598|FG001|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3|||
27783349|NCT01931475|54237597|FG000|Period 1: Double-Blind Treatment Phase|Physician Decision|0|||
27783350|NCT01931475|54237598|FG001|Period 1: Double-Blind Treatment Phase|Physician Decision|1|||
27783351|NCT01931475|54237597|FG000|Period 2: Extension Treatment Phase|Adverse Event|0|||
27783352|NCT01931475|54237598|FG001|Period 2: Extension Treatment Phase|Adverse Event|8|||
27783353|NCT01931475|54237597|FG000|Period 2: Extension Treatment Phase|Protocol Violation|1|||
27783354|NCT01931475|54237598|FG001|Period 2: Extension Treatment Phase|Protocol Violation|0|||
27783355|NCT01931475|54237597|FG000|Period 2: Extension Treatment Phase|Withdrawal by Subject|0|||
27783356|NCT01931475|54237598|FG001|Period 2: Extension Treatment Phase|Withdrawal by Subject|9|||
27783357|NCT01931475|54237597|FG000|Period 2: Extension Treatment Phase|Physician Decision|1|||
27783358|NCT01931475|54237598|FG001|Period 2: Extension Treatment Phase|Physician Decision|1|||
27783359|NCT01931475|54237597|FG000|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1|||
27783360|NCT01931475|54237598|FG001|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0|||
27783361|NCT01931475|54237597|FG000|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
27783362|NCT01931475|54237598|FG001|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
27783363|NCT01931397|54237609|FG000|Overall Study|Physician Decision|2|||
27783364|NCT01931397|54237609|FG000|Overall Study|Withdrawal by Subject|8|||
27783365|NCT01931397|54237609|FG000|Overall Study|moved out of state|1|||
27783366|NCT01929993|54237619|FG000|Overall Study|Protocol Violation|4|||
27783367|NCT01929993|54237620|FG001|Overall Study|Protocol Violation|6|||
27783368|NCT01929993|54237619|FG000|Overall Study|Absent CIN, invasion present or artifact|26|||
27783369|NCT01929993|54237620|FG001|Overall Study|Absent CIN, invasion present or artifact|22|||
27783370|NCT01912599|54237628|FG000|Overall Study|Withdrawal by Subject|0|||
27783371|NCT01912599|54237629|FG001|Overall Study|Withdrawal by Subject|1|||
27783372|NCT01929681|54237637|FG000|Overall Study|Withdrawal by Subject|1|||
27783373|NCT01929681|54237638|FG001|Overall Study|Withdrawal by Subject|0|||
27783374|NCT01929681|54237637|FG000|Overall Study|Physician Decision|1|||
27783375|NCT01929681|54237638|FG001|Overall Study|Physician Decision|1|||
27783376|NCT01646177|54237648|FG000|Blinded Induction Dosing (Week 0-12)|Adverse Event|2|||
27783377|NCT01646177|54237649|FG001|Blinded Induction Dosing (Week 0-12)|Adverse Event|4|||
27783378|NCT01646177|54237650|FG002|Blinded Induction Dosing (Week 0-12)|Adverse Event|9|||
27783379|NCT01646177|54237651|FG003|Blinded Induction Dosing (Week 0-12)|Adverse Event|8|||
27783380|NCT01646177|54237652|FG004|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
27783381|NCT01646177|54237653|FG005|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
27783382|NCT01646177|54237654|FG006|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
27783383|NCT01646177|54237655|FG007|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
27783384|NCT01646177|54237656|FG008|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
27783385|NCT01646177|54237657|FG009|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
27783386|NCT01646177|54237658|FG010|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
27783387|NCT01646177|54237659|FG011|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
27783388|NCT01646177|54237648|FG000|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1|||
27783389|NCT01646177|54237649|FG001|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3|||
27783390|NCT01646177|54237650|FG002|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8|||
27783391|NCT01646177|54237651|FG003|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7|||
27783392|NCT01646177|54237652|FG004|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
27783393|NCT01646177|54237653|FG005|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
27783394|NCT01646177|54237654|FG006|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
27783395|NCT01646177|54237655|FG007|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
27783396|NCT01646177|54237656|FG008|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
27783397|NCT01646177|54237657|FG009|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
27783398|NCT01646177|54237658|FG010|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
27783399|NCT01646177|54237659|FG011|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
27783400|NCT01646177|54237648|FG000|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3|||
27783401|NCT01646177|54237649|FG001|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2|||
27783402|NCT01646177|54237650|FG002|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
27783403|NCT01646177|54237651|FG003|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
27783404|NCT01646177|54237652|FG004|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
27783405|NCT01646177|54237653|FG005|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
27783406|NCT01646177|54237654|FG006|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
27783407|NCT01646177|54237655|FG007|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
27783408|NCT01646177|54237656|FG008|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
27783409|NCT01646177|54237657|FG009|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
27783410|NCT01646177|54237658|FG010|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
27783411|NCT01646177|54237659|FG011|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
27783412|NCT01646177|54237648|FG000|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
27783413|NCT01646177|54237649|FG001|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
27783414|NCT01646177|54237650|FG002|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
27783415|NCT01646177|54237651|FG003|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
27783416|NCT01646177|54237652|FG004|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
27783417|NCT01646177|54237653|FG005|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
27783418|NCT01646177|54237654|FG006|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
27783419|NCT01646177|54237655|FG007|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
27783420|NCT01646177|54237656|FG008|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
27783421|NCT01646177|54237657|FG009|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
27783422|NCT01646177|54237658|FG010|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
27783423|NCT01646177|54237659|FG011|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
27783424|NCT01646177|54237648|FG000|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
27783425|NCT01646177|54237649|FG001|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
27783426|NCT01646177|54237650|FG002|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2|||
27783427|NCT01646177|54237651|FG003|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1|||
27783428|NCT01646177|54237652|FG004|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
27783429|NCT01646177|54237653|FG005|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
27783430|NCT01646177|54237654|FG006|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
27783431|NCT01646177|54237655|FG007|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
27783432|NCT01646177|54237656|FG008|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
27783433|NCT01646177|54237657|FG009|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
27783434|NCT01646177|54237658|FG010|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
27783435|NCT01646177|54237659|FG011|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
27783436|NCT01646177|54237648|FG000|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3|||
27783437|NCT01646177|54237649|FG001|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
27783438|NCT01646177|54237650|FG002|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
27783439|NCT01646177|54237651|FG003|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
27783440|NCT01646177|54237652|FG004|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
27783441|NCT01646177|54237653|FG005|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
27783442|NCT01646177|54237654|FG006|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
27783443|NCT01646177|54237655|FG007|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
27783444|NCT01646177|54237656|FG008|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
27783445|NCT01646177|54237657|FG009|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
27783446|NCT01646177|54237658|FG010|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
27783447|NCT01646177|54237659|FG011|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
27783448|NCT01646177|54237648|FG000|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
27783449|NCT01646177|54237649|FG001|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
27783450|NCT01646177|54237650|FG002|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
27783451|NCT01646177|54237651|FG003|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
27840857|NCT01458275|54328799|FG000|Overall Study|Adverse Event|3|||
27840858|NCT01458275|54328800|FG001|Overall Study|Adverse Event|4|||
27840859|NCT01458275|54328801|FG002|Overall Study|Adverse Event|1|||
27840860|NCT01458275|54328799|FG000|Overall Study|Lost to Follow-up|3|||
27840861|NCT01458275|54328800|FG001|Overall Study|Lost to Follow-up|2|||
27840862|NCT01458275|54328801|FG002|Overall Study|Lost to Follow-up|5|||
27783452|NCT01646177|54237652|FG004|Long-Term Extension Period (Week 12-264)|Adverse Event|16|||
27783453|NCT01646177|54237653|FG005|Long-Term Extension Period (Week 12-264)|Adverse Event|34|||
27783454|NCT01646177|54237654|FG006|Long-Term Extension Period (Week 12-264)|Adverse Event|43|||
27783455|NCT01646177|54237655|FG007|Long-Term Extension Period (Week 12-264)|Adverse Event|30|||
27783456|NCT01646177|54237656|FG008|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
27783457|NCT01646177|54237657|FG009|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
27783458|NCT01646177|54237658|FG010|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
27783459|NCT01646177|54237659|FG011|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
27783460|NCT01646177|54237648|FG000|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
27840863|NCT01458275|54328799|FG000|Overall Study|Protocol Violation|5|||
27840864|NCT01458275|54328800|FG001|Overall Study|Protocol Violation|5|||
27840865|NCT01458275|54328801|FG002|Overall Study|Protocol Violation|2|||
27840866|NCT01458275|54328799|FG000|Overall Study|Withdrawal by Subject|3|||
27840867|NCT01458275|54328800|FG001|Overall Study|Withdrawal by Subject|2|||
27840868|NCT01458275|54328801|FG002|Overall Study|Withdrawal by Subject|1|||
27840869|NCT01458119|54328811|FG000|Overall Study|Physician Decision|4|||
27840870|NCT01458119|54328811|FG000|Overall Study|Withdrawal Due to Nonamenable Mutation|1|||
27840871|NCT01458119|54328811|FG000|Overall Study|Pregnancy|1|||
27840872|NCT01458119|54328811|FG000|Overall Study|Death|2|||
27840873|NCT01458119|54328811|FG000|Overall Study|Adverse Event|1|||
27840874|NCT01458119|54328811|FG000|Overall Study|Consent Withdrawn by Participant|8|||
27840875|NCT01458119|54328811|FG000|Overall Study|Non-compliance With Study Drug|3|||
27840876|NCT01688882|54328826|FG000|Overall Study|Adverse Event|1|||
27840877|NCT01688882|54328827|FG001|Overall Study|Adverse Event|0|||
27840878|NCT01688882|54328826|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
27840879|NCT01688882|54328827|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
27840880|NCT01688882|54328826|FG000|Overall Study|Administrative problems|1|||
27840881|NCT01688882|54328827|FG001|Overall Study|Administrative problems|0|||
27840882|NCT01688726|54328839|FG000|Overall Study|Adverse Event|1|||
27840883|NCT01688726|54328840|FG001|Overall Study|Adverse Event|0|||
27840884|NCT01688726|54328839|FG000|Overall Study|Relocated abroad|0|||
27840885|NCT01688726|54328840|FG001|Overall Study|Relocated abroad|1|||
27840886|NCT01585766|54328856|FG000|Overall Study|Withdrawal by Subject|0|||
27840887|NCT01585766|54328857|FG001|Overall Study|Withdrawal by Subject|1|||
27840888|NCT01585766|54328858|FG002|Overall Study|Withdrawal by Subject|1|||
27840889|NCT01585766|54328859|FG003|Overall Study|Withdrawal by Subject|0|||
27840890|NCT01585766|54328860|FG004|Overall Study|Withdrawal by Subject|0|||
27840891|NCT01585766|54328861|FG005|Overall Study|Withdrawal by Subject|0|||
27840892|NCT01585766|54328856|FG000|Overall Study|Death|0|||
27840893|NCT01585766|54328857|FG001|Overall Study|Death|1|||
27840894|NCT01585766|54328858|FG002|Overall Study|Death|0|||
27840895|NCT01585766|54328859|FG003|Overall Study|Death|0|||
27840896|NCT01585766|54328860|FG004|Overall Study|Death|0|||
27840897|NCT01585766|54328861|FG005|Overall Study|Death|0|||
27840898|NCT01585766|54328856|FG000|Overall Study|Physician Decision|0|||
27840899|NCT01585766|54328857|FG001|Overall Study|Physician Decision|0|||
27840900|NCT01585766|54328858|FG002|Overall Study|Physician Decision|1|||
27840901|NCT01585766|54328859|FG003|Overall Study|Physician Decision|0|||
27840902|NCT01585766|54328860|FG004|Overall Study|Physician Decision|0|||
27840903|NCT01585766|54328861|FG005|Overall Study|Physician Decision|0|||
27840904|NCT01562444|54328885|FG000|Overall Study|Did not meet entry criteria|2|||
27840905|NCT01562444|54328886|FG001|Overall Study|Did not meet entry criteria|0|||
27840906|NCT01562444|54328887|FG002|Overall Study|Did not meet entry criteria|3|||
27783461|NCT01646177|54237649|FG001|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
27783462|NCT01646177|54237650|FG002|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
27783463|NCT01646177|54237651|FG003|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
27840907|NCT01562444|54328885|FG000|Overall Study|Did not comply with blood draw schedule|1|||
27840908|NCT01562444|54328886|FG001|Overall Study|Did not comply with blood draw schedule|0|||
27840909|NCT01562444|54328887|FG002|Overall Study|Did not comply with blood draw schedule|1|||
27840910|NCT01562444|54328885|FG000|Overall Study|Unavailable serological results|0|||
27840911|NCT01562444|54328886|FG001|Overall Study|Unavailable serological results|2|||
27840912|NCT01562444|54328887|FG002|Overall Study|Unavailable serological results|2|||
27840913|NCT01562444|54328885|FG000|Overall Study|Protocol forbidden concomitant vaccine|1|||
27840914|NCT01562444|54328886|FG001|Overall Study|Protocol forbidden concomitant vaccine|0|||
27840915|NCT01562444|54328887|FG002|Overall Study|Protocol forbidden concomitant vaccine|1|||
27840916|NCT01562444|54328885|FG000|Overall Study|Protocol forbidden medication|1|||
27840917|NCT01562444|54328886|FG001|Overall Study|Protocol forbidden medication|0|||
27840918|NCT01562444|54328887|FG002|Overall Study|Protocol forbidden medication|0|||
27840919|NCT01457339|54328897|FG000|Period 3 (100 mg)|Adverse Event|0|||
27840920|NCT01457339|54328898|FG001|Period 3 (100 mg)|Adverse Event|1|||
27840921|NCT01457339|54328897|FG000|Period 5 (200 mg)|Met stopping criteria for PANSS score|0|||
27840922|NCT01457339|54328898|FG001|Period 5 (200 mg)|Met stopping criteria for PANSS score|1|||
27783464|NCT01646177|54237652|FG004|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11|||
27783465|NCT01646177|54237653|FG005|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30|||
27783466|NCT01646177|54237654|FG006|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29|||
27783467|NCT01646177|54237655|FG007|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27|||
27783468|NCT01646177|54237656|FG008|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
27783469|NCT01646177|54237657|FG009|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
27783470|NCT01646177|54237658|FG010|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
27783471|NCT01646177|54237659|FG011|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
28105480|NCT02793232|54762847|FG006|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
28105481|NCT02793232|54762848|FG007|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
28105482|NCT02793232|54762849|FG008|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
28105483|NCT04584645|54762885|FG000|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18995|||
28105484|NCT04584645|54762886|FG001|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18906|||
28105485|NCT03695367|54762912|FG000|Overall Study|Missed the Day 28 visit.|1|||
28105486|NCT03695367|54762913|FG001|Overall Study|Missed the Day 28 visit.|0|||
28105487|NCT03695367|54762912|FG000|Overall Study|Lost to Follow-up|0|||
28105488|NCT03695367|54762913|FG001|Overall Study|Lost to Follow-up|1|||
28105489|NCT03695367|54762912|FG000|Overall Study|Withdrawal by Subject|0|||
28105490|NCT03695367|54762913|FG001|Overall Study|Withdrawal by Subject|1|||
28105491|NCT03695367|54762912|FG000|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|0|||
28105492|NCT03695367|54762913|FG001|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|2|||
28105493|NCT02794480|54762921|FG000|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
28105494|NCT02794480|54762922|FG001|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
28105495|NCT02794480|54762923|FG002|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1|||
28105496|NCT02794480|54762924|FG003|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
28105497|NCT02794480|54762921|FG000|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
28105498|NCT02794480|54762922|FG001|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
28105499|NCT02794480|54762923|FG002|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1|||
28105500|NCT02794480|54762924|FG003|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
28105501|NCT02794480|54762921|FG000|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
28105502|NCT02794480|54762922|FG001|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
28105503|NCT02794480|54762923|FG002|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
28105504|NCT02794480|54762924|FG003|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2|||
28105505|NCT02794480|54762921|FG000|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
28105506|NCT02794480|54762922|FG001|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2|||
28105507|NCT02794480|54762923|FG002|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
28105508|NCT02794480|54762924|FG003|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
28105509|NCT02794480|54762921|FG000|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
28105510|NCT02794480|54762922|FG001|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
28105511|NCT02794480|54762923|FG002|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
28105512|NCT02794480|54762924|FG003|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
28105513|NCT04558125|54762932|FG000|Overall Study|Death|1|||
28105514|NCT02793622|54762938|FG000|Overall Study|Lost to Follow-up|31|||
28105515|NCT02793622|54762939|FG001|Overall Study|Lost to Follow-up|19|||
28105516|NCT02793622|54762938|FG000|Overall Study|Withdrawal by Subject|21|||
28105517|NCT02793622|54762939|FG001|Overall Study|Withdrawal by Subject|17|||
28105518|NCT02793622|54762938|FG000|Overall Study|Adverse Event|0|||
28105519|NCT02793622|54762939|FG001|Overall Study|Adverse Event|1|||
28105520|NCT02793622|54762938|FG000|Overall Study|Protocol Violation|1|||
28105521|NCT02793622|54762939|FG001|Overall Study|Protocol Violation|5|||
28105522|NCT04493931|54762952|FG000|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|1|||
28105523|NCT04493931|54762953|FG001|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
28105524|NCT04493931|54762954|FG002|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
28105525|NCT04493931|54762955|FG003|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
28105526|NCT04493931|54762956|FG004|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
28105527|NCT04493931|54762957|FG005|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
28105528|NCT04493931|54762958|FG006|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
28105529|NCT04493931|54762952|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
28105530|NCT04493931|54762953|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|2|||
28105531|NCT04493931|54762954|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
28105532|NCT04493931|54762955|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
28105533|NCT04493931|54762956|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
28105534|NCT04493931|54762957|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
28105535|NCT04493931|54762958|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
28105536|NCT04493931|54762952|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
28105537|NCT04493931|54762953|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|1|||
28105538|NCT04493931|54762954|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
28105539|NCT04493931|54762955|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
28105540|NCT04493931|54762956|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
28105541|NCT04493931|54762957|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
28105542|NCT04493931|54762958|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
28105543|NCT04493931|54762952|FG000|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
28105544|NCT04493931|54762953|FG001|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
28105545|NCT04493931|54762954|FG002|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|1|||
27783472|NCT01646177|54237648|FG000|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
27783473|NCT01646177|54237649|FG001|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
27783474|NCT01646177|54237650|FG002|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
27783475|NCT01646177|54237651|FG003|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
27783476|NCT01646177|54237652|FG004|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6|||
27783477|NCT01646177|54237653|FG005|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17|||
27783478|NCT01646177|54237654|FG006|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23|||
27783479|NCT01646177|54237655|FG007|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18|||
27783480|NCT01646177|54237656|FG008|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
27783481|NCT01646177|54237657|FG009|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
27783482|NCT01646177|54237658|FG010|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
27783483|NCT01646177|54237659|FG011|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
27783484|NCT01646177|54237648|FG000|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
27783485|NCT01646177|54237649|FG001|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
27783486|NCT01646177|54237650|FG002|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
27783487|NCT01646177|54237651|FG003|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
27783488|NCT01646177|54237652|FG004|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6|||
27783489|NCT01646177|54237653|FG005|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14|||
27783490|NCT01646177|54237654|FG006|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10|||
27783491|NCT01646177|54237655|FG007|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11|||
27783492|NCT01646177|54237656|FG008|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
27783493|NCT01646177|54237657|FG009|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
27783494|NCT01646177|54237658|FG010|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
27783495|NCT01646177|54237659|FG011|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
27783496|NCT01646177|54237648|FG000|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
27783497|NCT01646177|54237649|FG001|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
27783498|NCT01646177|54237650|FG002|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
27783499|NCT01646177|54237651|FG003|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
27783500|NCT01646177|54237652|FG004|Long-Term Extension Period (Week 12-264)|Physician Decision|3|||
27783501|NCT01646177|54237653|FG005|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
27783502|NCT01646177|54237654|FG006|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
27783503|NCT01646177|54237655|FG007|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
27783504|NCT01646177|54237656|FG008|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
27783505|NCT01646177|54237657|FG009|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
27783506|NCT01646177|54237658|FG010|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
27783507|NCT01646177|54237659|FG011|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
27783508|NCT01646177|54237648|FG000|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
27783509|NCT01646177|54237649|FG001|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
27783510|NCT01646177|54237650|FG002|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
27783511|NCT01646177|54237651|FG003|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
27783512|NCT01646177|54237652|FG004|Long-Term Extension Period (Week 12-264)|Protocol Violation|1|||
27783513|NCT01646177|54237653|FG005|Long-Term Extension Period (Week 12-264)|Protocol Violation|4|||
27783514|NCT01646177|54237654|FG006|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
27783515|NCT01646177|54237655|FG007|Long-Term Extension Period (Week 12-264)|Protocol Violation|5|||
27783516|NCT01646177|54237656|FG008|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
27783517|NCT01646177|54237657|FG009|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
27783518|NCT01646177|54237658|FG010|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
27783519|NCT01646177|54237659|FG011|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
27783520|NCT01646177|54237648|FG000|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
27783521|NCT01646177|54237649|FG001|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
27783522|NCT01646177|54237650|FG002|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
27783523|NCT01646177|54237651|FG003|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
27783524|NCT01646177|54237652|FG004|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3|||
27783525|NCT01646177|54237653|FG005|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
27783526|NCT01646177|54237654|FG006|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
27783527|NCT01646177|54237655|FG007|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
27783528|NCT01646177|54237656|FG008|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
27783529|NCT01646177|54237657|FG009|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
27783530|NCT01646177|54237658|FG010|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
27783531|NCT01646177|54237659|FG011|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
27783532|NCT01646177|54237648|FG000|Long-Term Extension Period (Week 12-264)|Death|0|||
27783533|NCT01646177|54237649|FG001|Long-Term Extension Period (Week 12-264)|Death|0|||
27783534|NCT01646177|54237650|FG002|Long-Term Extension Period (Week 12-264)|Death|0|||
27783535|NCT01646177|54237651|FG003|Long-Term Extension Period (Week 12-264)|Death|0|||
27783536|NCT01646177|54237652|FG004|Long-Term Extension Period (Week 12-264)|Death|1|||
27783537|NCT01646177|54237653|FG005|Long-Term Extension Period (Week 12-264)|Death|3|||
27783538|NCT01646177|54237654|FG006|Long-Term Extension Period (Week 12-264)|Death|1|||
27783539|NCT01646177|54237655|FG007|Long-Term Extension Period (Week 12-264)|Death|3|||
27783540|NCT01646177|54237656|FG008|Long-Term Extension Period (Week 12-264)|Death|0|||
27783541|NCT01646177|54237657|FG009|Long-Term Extension Period (Week 12-264)|Death|0|||
27783542|NCT01646177|54237658|FG010|Long-Term Extension Period (Week 12-264)|Death|0|||
27783543|NCT01646177|54237659|FG011|Long-Term Extension Period (Week 12-264)|Death|0|||
27783544|NCT01646177|54237648|FG000|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
27783545|NCT01646177|54237649|FG001|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
27783546|NCT01646177|54237650|FG002|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
27783547|NCT01646177|54237651|FG003|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
27783548|NCT01646177|54237652|FG004|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
27783549|NCT01646177|54237653|FG005|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
27783550|NCT01646177|54237654|FG006|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
27783551|NCT01646177|54237655|FG007|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4|||
27783552|NCT01646177|54237656|FG008|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
27783553|NCT01646177|54237657|FG009|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
27783554|NCT01646177|54237658|FG010|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
27783555|NCT01646177|54237659|FG011|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
27783556|NCT01646177|54237648|FG000|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
27783557|NCT01646177|54237649|FG001|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
27783558|NCT01646177|54237650|FG002|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
27783559|NCT01646177|54237651|FG003|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
27783560|NCT01646177|54237652|FG004|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
27783561|NCT01646177|54237653|FG005|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
27783562|NCT01646177|54237654|FG006|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
27783563|NCT01646177|54237655|FG007|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1|||
27783564|NCT01646177|54237656|FG008|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
27783565|NCT01646177|54237657|FG009|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
27783566|NCT01646177|54237658|FG010|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
27783567|NCT01646177|54237659|FG011|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
27783568|NCT01646177|54237648|FG000|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
27783569|NCT01646177|54237649|FG001|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
27783570|NCT01646177|54237650|FG002|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
27783571|NCT01646177|54237651|FG003|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
27783572|NCT01646177|54237652|FG004|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
27783573|NCT01646177|54237653|FG005|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3|||
27783574|NCT01646177|54237654|FG006|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2|||
27783575|NCT01646177|54237655|FG007|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1|||
27783576|NCT01646177|54237656|FG008|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
27783577|NCT01646177|54237657|FG009|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
27783578|NCT01646177|54237658|FG010|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
27783579|NCT01646177|54237659|FG011|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
27783580|NCT01646177|54237648|FG000|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
27783581|NCT01646177|54237649|FG001|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
27783582|NCT01646177|54237650|FG002|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
27783583|NCT01646177|54237651|FG003|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
27783584|NCT01646177|54237652|FG004|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
27783585|NCT01646177|54237653|FG005|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
27783586|NCT01646177|54237654|FG006|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
27783587|NCT01646177|54237655|FG007|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
27840923|NCT01457339|54328897|FG000|Period 6 (250 mg)|Family Emergency|1|||
27783588|NCT01646177|54237656|FG008|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13|||
27783589|NCT01646177|54237657|FG009|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28|||
27783590|NCT01646177|54237658|FG010|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34|||
27783591|NCT01646177|54237659|FG011|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30|||
27783592|NCT01646177|54237648|FG000|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
27783593|NCT01646177|54237649|FG001|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
27783594|NCT01646177|54237650|FG002|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
27783595|NCT01646177|54237651|FG003|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
27783596|NCT01646177|54237652|FG004|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
27783597|NCT01646177|54237653|FG005|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
27783598|NCT01646177|54237654|FG006|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
27783599|NCT01646177|54237655|FG007|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
27783600|NCT01646177|54237656|FG008|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7|||
27783601|NCT01646177|54237657|FG009|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21|||
27783602|NCT01646177|54237658|FG010|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
27783603|NCT01646177|54237659|FG011|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
27783604|NCT01646177|54237648|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
27783605|NCT01646177|54237649|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
27783606|NCT01646177|54237650|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
27783607|NCT01646177|54237651|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
27783608|NCT01646177|54237652|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
27783609|NCT01646177|54237653|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
27783610|NCT01646177|54237654|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
27783611|NCT01646177|54237655|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
27783612|NCT01646177|54237656|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4|||
27783613|NCT01646177|54237657|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8|||
27783614|NCT01646177|54237658|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
27783615|NCT01646177|54237659|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
27783616|NCT01646177|54237648|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
27783617|NCT01646177|54237649|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
27783618|NCT01646177|54237650|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
27783619|NCT01646177|54237651|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
27783620|NCT01646177|54237652|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
27783621|NCT01646177|54237653|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
27783622|NCT01646177|54237654|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
27783623|NCT01646177|54237655|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
27783624|NCT01646177|54237656|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4|||
27783625|NCT01646177|54237657|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
27783626|NCT01646177|54237658|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8|||
27783627|NCT01646177|54237659|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
27783628|NCT01646177|54237648|FG000|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
27783629|NCT01646177|54237649|FG001|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
27783630|NCT01646177|54237650|FG002|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
27783631|NCT01646177|54237651|FG003|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
27783632|NCT01646177|54237652|FG004|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
27783633|NCT01646177|54237653|FG005|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
27783634|NCT01646177|54237654|FG006|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
27783635|NCT01646177|54237655|FG007|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
27783636|NCT01646177|54237656|FG008|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1|||
27783637|NCT01646177|54237657|FG009|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6|||
27783638|NCT01646177|54237658|FG010|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4|||
27783639|NCT01646177|54237659|FG011|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7|||
27783640|NCT01646177|54237648|FG000|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
27783641|NCT01646177|54237649|FG001|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
27783642|NCT01646177|54237650|FG002|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
27783643|NCT01646177|54237651|FG003|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
27783644|NCT01646177|54237652|FG004|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
27783645|NCT01646177|54237653|FG005|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
27783646|NCT01646177|54237654|FG006|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
27783647|NCT01646177|54237655|FG007|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
27783648|NCT01646177|54237656|FG008|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1|||
27783649|NCT01646177|54237657|FG009|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
27840924|NCT01457339|54328898|FG001|Period 6 (250 mg)|Family Emergency|0|||
27783650|NCT01646177|54237658|FG010|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
27783651|NCT01646177|54237659|FG011|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3|||
27783652|NCT01646177|54237648|FG000|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
27783653|NCT01646177|54237649|FG001|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
27783654|NCT01646177|54237650|FG002|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
27783655|NCT01646177|54237651|FG003|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
27783656|NCT01646177|54237652|FG004|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
27783657|NCT01646177|54237653|FG005|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
27783658|NCT01646177|54237654|FG006|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
27783659|NCT01646177|54237655|FG007|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
27783660|NCT01646177|54237656|FG008|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
27783661|NCT01646177|54237657|FG009|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
27783662|NCT01646177|54237658|FG010|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
27783663|NCT01646177|54237659|FG011|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3|||
27783664|NCT01646177|54237648|FG000|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
27783665|NCT01646177|54237649|FG001|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
27783666|NCT01646177|54237650|FG002|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
27783667|NCT01646177|54237651|FG003|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
27783668|NCT01646177|54237652|FG004|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
27783669|NCT01646177|54237653|FG005|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
27783670|NCT01646177|54237654|FG006|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
27783671|NCT01646177|54237655|FG007|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
27783672|NCT01646177|54237656|FG008|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
27783673|NCT01646177|54237657|FG009|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
27783674|NCT01646177|54237658|FG010|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
27783675|NCT01646177|54237659|FG011|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
27783676|NCT01646177|54237648|FG000|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
27783677|NCT01646177|54237649|FG001|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
27783678|NCT01646177|54237650|FG002|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
27783679|NCT01646177|54237651|FG003|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
27783680|NCT01646177|54237652|FG004|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
27783681|NCT01646177|54237653|FG005|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
27783682|NCT01646177|54237654|FG006|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
27783683|NCT01646177|54237655|FG007|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
27783684|NCT01646177|54237656|FG008|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
27783685|NCT01646177|54237657|FG009|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
27783686|NCT01646177|54237658|FG010|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
27783687|NCT01646177|54237659|FG011|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
27783688|NCT01646177|54237648|FG000|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
27783689|NCT01646177|54237649|FG001|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
27783690|NCT01646177|54237650|FG002|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
27783691|NCT01646177|54237651|FG003|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
27783692|NCT01646177|54237652|FG004|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
27783693|NCT01646177|54237653|FG005|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
27783694|NCT01646177|54237654|FG006|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
27783695|NCT01646177|54237655|FG007|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
27783696|NCT01646177|54237656|FG008|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
27783697|NCT01646177|54237657|FG009|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
27783698|NCT01646177|54237658|FG010|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
27783699|NCT01646177|54237659|FG011|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
27783700|NCT01912287|54237682|FG000|Overall Study|Ineligible|1|||
27783701|NCT01912287|54237683|FG001|Overall Study|Ineligible|0|||
27783702|NCT01912287|54237684|FG002|Overall Study|Ineligible|1|||
27783703|NCT01912287|54237682|FG000|Overall Study|No-show|0|||
27783704|NCT01912287|54237683|FG001|Overall Study|No-show|0|||
27783705|NCT01912287|54237684|FG002|Overall Study|No-show|1|||
27783706|NCT01912287|54237682|FG000|Overall Study|Dissatisfaction with assigned treatment|4|||
27783707|NCT01912287|54237683|FG001|Overall Study|Dissatisfaction with assigned treatment|2|||
27783708|NCT01912287|54237684|FG002|Overall Study|Dissatisfaction with assigned treatment|1|||
27783709|NCT01912287|54237682|FG000|Overall Study|Felt treatment no longer needed|0|||
27783710|NCT01912287|54237683|FG001|Overall Study|Felt treatment no longer needed|1|||
27783711|NCT01912287|54237684|FG002|Overall Study|Felt treatment no longer needed|0|||
27783712|NCT01912287|54237682|FG000|Overall Study|Life circumstances|4|||
27783713|NCT01912287|54237683|FG001|Overall Study|Life circumstances|2|||
27783714|NCT01912287|54237684|FG002|Overall Study|Life circumstances|0|||
27783715|NCT01912287|54237682|FG000|Overall Study|Lost Interest|1|||
27783716|NCT01912287|54237683|FG001|Overall Study|Lost Interest|0|||
27783717|NCT01912287|54237684|FG002|Overall Study|Lost Interest|0|||
27783718|NCT01912287|54237682|FG000|Overall Study|Uknown reason - subject drop out|5|||
27783719|NCT01912287|54237683|FG001|Overall Study|Uknown reason - subject drop out|7|||
27783720|NCT01912287|54237684|FG002|Overall Study|Uknown reason - subject drop out|3|||
27783721|NCT01912287|54237682|FG000|Overall Study|Missed Assesment|1|||
27783722|NCT01912287|54237683|FG001|Overall Study|Missed Assesment|1|||
27783723|NCT01912287|54237684|FG002|Overall Study|Missed Assesment|1|||
27783724|NCT01912287|54237682|FG000|Overall Study|Scheduling/change in availability|17|||
27783725|NCT01912287|54237683|FG001|Overall Study|Scheduling/change in availability|10|||
27783726|NCT01912287|54237684|FG002|Overall Study|Scheduling/change in availability|8|||
27783727|NCT01929135|54237694|FG000|Overall Study|Lost to Follow-up|1|||
27783728|NCT01929135|54237695|FG001|Overall Study|Lost to Follow-up|1|||
27783729|NCT01911819|54237706|FG000|Overall Study|Adverse Event|0|||
27783730|NCT01911819|54237707|FG001|Overall Study|Adverse Event|1|||
27783731|NCT01911819|54237708|FG002|Overall Study|Adverse Event|0|||
27783732|NCT01911819|54237706|FG000|Overall Study|Withdrawal by Subject|1|||
27783733|NCT01911819|54237707|FG001|Overall Study|Withdrawal by Subject|1|||
27783734|NCT01911819|54237708|FG002|Overall Study|Withdrawal by Subject|0|||
27840925|NCT01457339|54328897|FG000|Period 6 (250 mg)|Personal appointment|0|||
27840926|NCT01457339|54328898|FG001|Period 6 (250 mg)|Personal appointment|1|||
27840927|NCT01456949|54328921|FG000|Enrollment|PI death- incomplete data|6|||
27840928|NCT01456949|54328921|FG000|Enrollment|Death|1|||
27840929|NCT01456949|54328921|FG000|Enrollment|I/E criteria not met prior to procedure|13|||
27840930|NCT01456949|54328921|FG000|Enrollment|Physician Decision|10|||
27840931|NCT01456949|54328921|FG000|Enrollment|Withdrawal by Subject|7|||
27840932|NCT01456949|54328921|FG000|Study Cryoablation Procedure & Follow-up|Death|5|||
27783735|NCT02280863|54237718|FG000|Integrated Platform|Met stopping criteria|0|||
27783736|NCT02280863|54237719|FG001|Integrated Platform|Met stopping criteria|1|||
27783737|NCT01911429|54237732|FG000|Overall Study|Adverse Event|5|||
27783738|NCT01911429|54237733|FG001|Overall Study|Adverse Event|3|||
27783739|NCT01911429|54237734|FG002|Overall Study|Adverse Event|9|||
27783740|NCT01911429|54237732|FG000|Overall Study|Lack of Efficacy|1|||
27783741|NCT01911429|54237733|FG001|Overall Study|Lack of Efficacy|2|||
27783742|NCT01911429|54237734|FG002|Overall Study|Lack of Efficacy|4|||
27783743|NCT01911429|54237732|FG000|Overall Study|Lost to Follow-up|0|||
27783744|NCT01911429|54237733|FG001|Overall Study|Lost to Follow-up|0|||
27783745|NCT01911429|54237734|FG002|Overall Study|Lost to Follow-up|1|||
27783746|NCT01911429|54237732|FG000|Overall Study|Protocol Violation|0|||
27783747|NCT01911429|54237733|FG001|Overall Study|Protocol Violation|0|||
27783748|NCT01911429|54237734|FG002|Overall Study|Protocol Violation|1|||
27783749|NCT01911429|54237732|FG000|Overall Study|Withdrawal by Subject|5|||
27783750|NCT01911429|54237733|FG001|Overall Study|Withdrawal by Subject|5|||
27783751|NCT01911429|54237734|FG002|Overall Study|Withdrawal by Subject|4|||
27783752|NCT01911429|54237732|FG000|Overall Study|Accidental randomization|0|||
27783753|NCT01911429|54237733|FG001|Overall Study|Accidental randomization|0|||
27783754|NCT01911429|54237734|FG002|Overall Study|Accidental randomization|1|||
27783755|NCT01911429|54237732|FG000|Overall Study|subject left study|1|||
27783756|NCT01911429|54237733|FG001|Overall Study|subject left study|0|||
27783757|NCT01911429|54237734|FG002|Overall Study|subject left study|0|||
27783758|NCT02324465|54237744|FG000|Overall Study|device failure|0|||
27783759|NCT02324465|54237745|FG001|Overall Study|device failure|1|||
27783760|NCT02324153|54237753|FG000|Overall Study|Withdrawal by Subject|4|||
27783761|NCT02324153|54237754|FG001|Overall Study|Withdrawal by Subject|1|||
27783762|NCT02324153|54237753|FG000|Overall Study|Surgery postponed after randomization|3|||
27783763|NCT02324153|54237754|FG001|Overall Study|Surgery postponed after randomization|0|||
27783764|NCT02324153|54237753|FG000|Overall Study|Developed delirium preoperatively|1|||
27783765|NCT02324153|54237754|FG001|Overall Study|Developed delirium preoperatively|0|||
27783766|NCT02280473|54237762|FG000|Overall Study|Adverse Event|1|||
27783767|NCT02280473|54237763|FG001|Overall Study|Adverse Event|1|||
27783768|NCT02280473|54237762|FG000|Overall Study|Lack of Efficacy|0|||
27783769|NCT02280473|54237763|FG001|Overall Study|Lack of Efficacy|1|||
27783770|NCT02280473|54237762|FG000|Overall Study|Lost to Follow-up|0|||
27783771|NCT02280473|54237763|FG001|Overall Study|Lost to Follow-up|1|||
27783772|NCT01911273|54237771|FG000|Overall Study|Progression of Disease|1|||
27783773|NCT01911273|54237772|FG001|Overall Study|Progression of Disease|0|||
27783774|NCT01911273|54237771|FG000|Overall Study|Withdrawal by Subject|0|||
27783775|NCT01911273|54237772|FG001|Overall Study|Withdrawal by Subject|2|||
27783776|NCT02308007|54237781|FG000|Overall Study|Normal Gram stain or neg yeast culture|66|||
27840933|NCT01456949|54328921|FG000|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23|||
27840934|NCT01456949|54328921|FG000|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11|||
27783777|NCT02308007|54237782|FG001|Overall Study|Normal Gram stain or neg yeast culture|64|||
27783778|NCT02308007|54237783|FG002|Overall Study|Normal Gram stain or neg yeast culture|67|||
27783779|NCT02308007|54237781|FG000|Overall Study|Positive for STD at Baseline|7|||
27783780|NCT02308007|54237782|FG001|Overall Study|Positive for STD at Baseline|11|||
27783781|NCT02308007|54237783|FG002|Overall Study|Positive for STD at Baseline|7|||
27783782|NCT02308007|54237781|FG000|Overall Study|Lost to Follow-up|3|||
27783783|NCT02308007|54237782|FG001|Overall Study|Lost to Follow-up|0|||
27840935|NCT01456949|54328921|FG000|Study Cryoablation Procedure & Follow-up|Physician Decision|1|||
27783784|NCT02308007|54237783|FG002|Overall Study|Lost to Follow-up|1|||
27783785|NCT02278367|54237793|FG000|Overall Study|Physician Decision|5|||
27783786|NCT02278367|54237794|FG001|Overall Study|Physician Decision|0|||
27783787|NCT02278367|54237793|FG000|Overall Study|Withdrawal by Subject|5|||
27783788|NCT02278367|54237794|FG001|Overall Study|Withdrawal by Subject|0|||
27783789|NCT01910181|54237800|FG000|Overall Study|Death|37|||
27783790|NCT01910181|54237800|FG000|Overall Study|Lost to Follow-up|3|||
27783791|NCT01910181|54237800|FG000|Overall Study|Study Terminated by Sponsor|6|||
27783792|NCT01957215|54237807|FG000|Overall Study|Adverse Event|2|||
27783793|NCT01957215|54237808|FG001|Overall Study|Adverse Event|2|||
27783794|NCT01957215|54237807|FG000|Overall Study|Lost to Follow-up|3|||
27783795|NCT01957215|54237808|FG001|Overall Study|Lost to Follow-up|3|||
27783796|NCT01957215|54237807|FG000|Overall Study|Protocol Violation|1|||
27783797|NCT01957215|54237808|FG001|Overall Study|Protocol Violation|2|||
27783798|NCT01957215|54237807|FG000|Overall Study|Withdrawal by Subject|7|||
27783799|NCT01957215|54237808|FG001|Overall Study|Withdrawal by Subject|5|||
27783800|NCT02322749|54237818|FG000|Period 2|Adverse Event|0|||
27783801|NCT02322749|54237819|FG001|Period 2|Adverse Event|0|||
27783802|NCT02322749|54237820|FG002|Period 2|Adverse Event|0|||
27783803|NCT02322749|54237821|FG003|Period 2|Adverse Event|1|||
27783804|NCT02322749|54237822|FG004|Period 2|Adverse Event|0|||
27783805|NCT02322749|54237823|FG005|Period 2|Adverse Event|0|||
27783806|NCT02322749|54237818|FG000|Period 2|Withdrawal by Subject|0|||
27783807|NCT02322749|54237819|FG001|Period 2|Withdrawal by Subject|0|||
27783808|NCT02322749|54237820|FG002|Period 2|Withdrawal by Subject|0|||
27783809|NCT02322749|54237821|FG003|Period 2|Withdrawal by Subject|1|||
27783810|NCT02322749|54237822|FG004|Period 2|Withdrawal by Subject|0|||
27783811|NCT02322749|54237823|FG005|Period 2|Withdrawal by Subject|0|||
27783812|NCT02322749|54237818|FG000|Period 3|Withdrawal by Subject|0|||
27783813|NCT02322749|54237819|FG001|Period 3|Withdrawal by Subject|0|||
27783814|NCT02322749|54237820|FG002|Period 3|Withdrawal by Subject|1|||
27840936|NCT01456949|54328921|FG000|Study Cryoablation Procedure & Follow-up|Subject Relocation|10|||
27840937|NCT01456949|54328921|FG000|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2|||
27840938|NCT01456949|54328921|FG000|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6|||
27840939|NCT01456949|54328921|FG000|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4|||
27840940|NCT01456169|54328928|FG000|Overall Study|Adverse Event|1|||
27840941|NCT01456169|54328929|FG001|Overall Study|Adverse Event|2|||
27840942|NCT01456169|54328930|FG002|Overall Study|Adverse Event|7|||
27783815|NCT02322749|54237821|FG003|Period 3|Withdrawal by Subject|0|||
27840943|NCT01456169|54328928|FG000|Overall Study|Major Protocol Deviation|3|||
27840944|NCT01456169|54328929|FG001|Overall Study|Major Protocol Deviation|2|||
27783816|NCT02322749|54237822|FG004|Period 3|Withdrawal by Subject|0|||
27840945|NCT01456169|54328930|FG002|Overall Study|Major Protocol Deviation|3|||
27783817|NCT02322749|54237823|FG005|Period 3|Withdrawal by Subject|0|||
27783818|NCT01957137|54237832|FG000|Randomized Portion|Adverse Event|1|||
27783819|NCT01957137|54237832|FG000|Randomized Portion|Withdrawal by Subject|1|||
27783820|NCT01928433|54237847|FG000|Overall Study|Adverse Event|5|||
27783821|NCT01928433|54237848|FG001|Overall Study|Adverse Event|2|||
27783822|NCT01928433|54237849|FG002|Overall Study|Adverse Event|5|||
27783823|NCT01928433|54237847|FG000|Overall Study|Protocol Violation|0|||
27783824|NCT01928433|54237848|FG001|Overall Study|Protocol Violation|0|||
27783825|NCT01928433|54237849|FG002|Overall Study|Protocol Violation|2|||
27783826|NCT01928433|54237847|FG000|Overall Study|Lack of Efficacy|5|||
27783827|NCT01928433|54237848|FG001|Overall Study|Lack of Efficacy|4|||
27840946|NCT01456169|54328928|FG000|Overall Study|Voluntary Withdrawal|3|||
27840947|NCT01456169|54328929|FG001|Overall Study|Voluntary Withdrawal|0|||
27840948|NCT01456169|54328930|FG002|Overall Study|Voluntary Withdrawal|2|||
27840949|NCT01456169|54328928|FG000|Overall Study|Lack of Efficacy|2|||
27840950|NCT01456169|54328929|FG001|Overall Study|Lack of Efficacy|0|||
27840951|NCT01456169|54328930|FG002|Overall Study|Lack of Efficacy|0|||
27840952|NCT01456169|54328928|FG000|Overall Study|Other|1|||
27783828|NCT01928433|54237849|FG002|Overall Study|Lack of Efficacy|4|||
27783829|NCT01928433|54237847|FG000|Overall Study|Withdrawal by Subject|0|||
27783830|NCT01928433|54237848|FG001|Overall Study|Withdrawal by Subject|4|||
27840953|NCT01456169|54328929|FG001|Overall Study|Other|1|||
27783831|NCT01928433|54237849|FG002|Overall Study|Withdrawal by Subject|0|||
27783832|NCT01928433|54237847|FG000|Overall Study|Negative screening urine culture|7|||
27783833|NCT01928433|54237848|FG001|Overall Study|Negative screening urine culture|6|||
27783834|NCT01928433|54237849|FG002|Overall Study|Negative screening urine culture|10|||
27840954|NCT01456169|54328930|FG002|Overall Study|Other|0|||
27783835|NCT01928433|54237847|FG000|Overall Study|Lost to Follow-up|0|||
27783836|NCT01928433|54237848|FG001|Overall Study|Lost to Follow-up|2|||
27783837|NCT01928433|54237849|FG002|Overall Study|Lost to Follow-up|3|||
27783838|NCT01928433|54237847|FG000|Overall Study|Other reasons|3|||
27783839|NCT01928433|54237848|FG001|Overall Study|Other reasons|3|||
27783840|NCT01928433|54237849|FG002|Overall Study|Other reasons|4|||
27783841|NCT02322281|54237863|FG000|Overall Study|Progressive Disease|42|||
27840955|NCT01454531|54328939|FG000|Overall Study|Adverse Event|14|||
27783842|NCT02322281|54237864|FG001|Overall Study|Progressive Disease|14|||
27783843|NCT02322281|54237865|FG002|Overall Study|Progressive Disease|49|||
27783844|NCT02322281|54237863|FG000|Overall Study|Adverse Event|3|||
27783845|NCT02322281|54237864|FG001|Overall Study|Adverse Event|4|||
27783846|NCT02322281|54237865|FG002|Overall Study|Adverse Event|6|||
27783847|NCT02322281|54237863|FG000|Overall Study|Death|3|||
27783848|NCT02322281|54237864|FG001|Overall Study|Death|3|||
27783849|NCT02322281|54237865|FG002|Overall Study|Death|3|||
27783850|NCT02322281|54237863|FG000|Overall Study|Withdrawal by Subject|1|||
27783851|NCT02322281|54237864|FG001|Overall Study|Withdrawal by Subject|1|||
27783852|NCT02322281|54237865|FG002|Overall Study|Withdrawal by Subject|6|||
27783853|NCT02322281|54237863|FG000|Overall Study|Physician Decision|2|||
27783854|NCT02322281|54237864|FG001|Overall Study|Physician Decision|0|||
27783855|NCT02322281|54237865|FG002|Overall Study|Physician Decision|5|||
27783856|NCT02322281|54237863|FG000|Overall Study|Study Terminated by Sponsor|2|||
27783857|NCT02322281|54237864|FG001|Overall Study|Study Terminated by Sponsor|0|||
27783858|NCT02322281|54237865|FG002|Overall Study|Study Terminated by Sponsor|0|||
27783859|NCT02322281|54237863|FG000|Overall Study|Missing|0|||
27783860|NCT02322281|54237864|FG001|Overall Study|Missing|0|||
27783861|NCT02322281|54237865|FG002|Overall Study|Missing|1|||
27783862|NCT02322281|54237863|FG000|Overall Study|Miscellaneous|0|||
27783863|NCT02322281|54237864|FG001|Overall Study|Miscellaneous|0|||
27783864|NCT02322281|54237865|FG002|Overall Study|Miscellaneous|4|||
27783865|NCT02322125|54237875|FG000|Overall Study|Withdrawal by Subject|2|||
27783866|NCT02243293|54237896|FG000|Overall Study|Adverse Event|1|||
27783867|NCT02243293|54237897|FG001|Overall Study|Adverse Event|0|||
27783868|NCT02243293|54237898|FG002|Overall Study|Adverse Event|0|||
27783869|NCT02243293|54237899|FG003|Overall Study|Adverse Event|0|||
27783870|NCT02243293|54237900|FG004|Overall Study|Adverse Event|0|||
27783871|NCT02243293|54237901|FG005|Overall Study|Adverse Event|0|||
27783872|NCT02243293|54237902|FG006|Overall Study|Adverse Event|0|||
27783873|NCT02243293|54237903|FG007|Overall Study|Adverse Event|0|||
27783874|NCT02243293|54237904|FG008|Overall Study|Adverse Event|0|||
27783875|NCT02243293|54237905|FG009|Overall Study|Adverse Event|0|||
27783876|NCT02243293|54237906|FG010|Overall Study|Adverse Event|0|||
27783877|NCT02243293|54237907|FG011|Overall Study|Adverse Event|0|||
27783878|NCT02243293|54237908|FG012|Overall Study|Adverse Event|0|||
27783879|NCT02243293|54237909|FG013|Overall Study|Adverse Event|0|||
27783880|NCT02243293|54237910|FG014|Overall Study|Adverse Event|0|||
27783881|NCT02243293|54237911|FG015|Overall Study|Adverse Event|1|||
27783882|NCT02243293|54237912|FG016|Overall Study|Adverse Event|0|||
27783883|NCT02243293|54237913|FG017|Overall Study|Adverse Event|0|||
27783884|NCT02243293|54237914|FG018|Overall Study|Adverse Event|0|||
27783885|NCT02243293|54237915|FG019|Overall Study|Adverse Event|0|||
27783886|NCT02243293|54237916|FG020|Overall Study|Adverse Event|1|||
27783887|NCT02243293|54237917|FG021|Overall Study|Adverse Event|0|||
27783888|NCT02243293|54237896|FG000|Overall Study|Withdrawal by Subject|1|||
27783889|NCT02243293|54237897|FG001|Overall Study|Withdrawal by Subject|0|||
27783890|NCT02243293|54237898|FG002|Overall Study|Withdrawal by Subject|0|||
27783891|NCT02243293|54237899|FG003|Overall Study|Withdrawal by Subject|0|||
27783892|NCT02243293|54237900|FG004|Overall Study|Withdrawal by Subject|0|||
27783893|NCT02243293|54237901|FG005|Overall Study|Withdrawal by Subject|0|||
27783894|NCT02243293|54237902|FG006|Overall Study|Withdrawal by Subject|0|||
27783895|NCT02243293|54237903|FG007|Overall Study|Withdrawal by Subject|0|||
27783896|NCT02243293|54237904|FG008|Overall Study|Withdrawal by Subject|0|||
27783897|NCT02243293|54237905|FG009|Overall Study|Withdrawal by Subject|1|||
27783898|NCT02243293|54237906|FG010|Overall Study|Withdrawal by Subject|0|||
27783899|NCT02243293|54237907|FG011|Overall Study|Withdrawal by Subject|1|||
27783900|NCT02243293|54237908|FG012|Overall Study|Withdrawal by Subject|0|||
27783901|NCT02243293|54237909|FG013|Overall Study|Withdrawal by Subject|0|||
27783902|NCT02243293|54237910|FG014|Overall Study|Withdrawal by Subject|0|||
27783903|NCT02243293|54237911|FG015|Overall Study|Withdrawal by Subject|0|||
27783904|NCT02243293|54237912|FG016|Overall Study|Withdrawal by Subject|0|||
27783905|NCT02243293|54237913|FG017|Overall Study|Withdrawal by Subject|0|||
27783906|NCT02243293|54237914|FG018|Overall Study|Withdrawal by Subject|0|||
27783907|NCT02243293|54237915|FG019|Overall Study|Withdrawal by Subject|0|||
27783908|NCT02243293|54237916|FG020|Overall Study|Withdrawal by Subject|0|||
27783909|NCT02243293|54237917|FG021|Overall Study|Withdrawal by Subject|1|||
27783910|NCT02243293|54237896|FG000|Overall Study|Lost to Follow-up|0|||
27783911|NCT02243293|54237897|FG001|Overall Study|Lost to Follow-up|1|||
27783912|NCT02243293|54237898|FG002|Overall Study|Lost to Follow-up|1|||
27783913|NCT02243293|54237899|FG003|Overall Study|Lost to Follow-up|1|||
27783914|NCT02243293|54237900|FG004|Overall Study|Lost to Follow-up|0|||
27840956|NCT01454531|54328939|FG000|Overall Study|Withdrawal by Subject|5|||
27783915|NCT02243293|54237901|FG005|Overall Study|Lost to Follow-up|0|||
27783916|NCT02243293|54237902|FG006|Overall Study|Lost to Follow-up|3|||
27783917|NCT02243293|54237903|FG007|Overall Study|Lost to Follow-up|0|||
27783918|NCT02243293|54237904|FG008|Overall Study|Lost to Follow-up|0|||
27783919|NCT02243293|54237905|FG009|Overall Study|Lost to Follow-up|0|||
27783920|NCT02243293|54237906|FG010|Overall Study|Lost to Follow-up|0|||
27783921|NCT02243293|54237907|FG011|Overall Study|Lost to Follow-up|2|||
27783922|NCT02243293|54237908|FG012|Overall Study|Lost to Follow-up|0|||
27783923|NCT02243293|54237909|FG013|Overall Study|Lost to Follow-up|0|||
27783924|NCT02243293|54237910|FG014|Overall Study|Lost to Follow-up|0|||
27783925|NCT02243293|54237911|FG015|Overall Study|Lost to Follow-up|0|||
27783926|NCT02243293|54237912|FG016|Overall Study|Lost to Follow-up|3|||
27783927|NCT02243293|54237913|FG017|Overall Study|Lost to Follow-up|1|||
27783928|NCT02243293|54237914|FG018|Overall Study|Lost to Follow-up|0|||
27783929|NCT02243293|54237915|FG019|Overall Study|Lost to Follow-up|0|||
27783930|NCT02243293|54237916|FG020|Overall Study|Lost to Follow-up|1|||
27783931|NCT02243293|54237917|FG021|Overall Study|Lost to Follow-up|2|||
27783932|NCT02243293|54237896|FG000|Overall Study|Enrolled into a Re-treatment Study|0|||
27783933|NCT02243293|54237897|FG001|Overall Study|Enrolled into a Re-treatment Study|0|||
27783934|NCT02243293|54237898|FG002|Overall Study|Enrolled into a Re-treatment Study|0|||
27783935|NCT02243293|54237899|FG003|Overall Study|Enrolled into a Re-treatment Study|0|||
27783936|NCT02243293|54237900|FG004|Overall Study|Enrolled into a Re-treatment Study|0|||
27783937|NCT02243293|54237901|FG005|Overall Study|Enrolled into a Re-treatment Study|0|||
27783938|NCT02243293|54237902|FG006|Overall Study|Enrolled into a Re-treatment Study|0|||
27783939|NCT02243293|54237903|FG007|Overall Study|Enrolled into a Re-treatment Study|0|||
27783940|NCT02243293|54237904|FG008|Overall Study|Enrolled into a Re-treatment Study|0|||
27783941|NCT02243293|54237905|FG009|Overall Study|Enrolled into a Re-treatment Study|0|||
27783942|NCT02243293|54237906|FG010|Overall Study|Enrolled into a Re-treatment Study|0|||
27783943|NCT02243293|54237907|FG011|Overall Study|Enrolled into a Re-treatment Study|0|||
27783944|NCT02243293|54237908|FG012|Overall Study|Enrolled into a Re-treatment Study|0|||
27783945|NCT02243293|54237909|FG013|Overall Study|Enrolled into a Re-treatment Study|0|||
27783946|NCT02243293|54237910|FG014|Overall Study|Enrolled into a Re-treatment Study|1|||
27783947|NCT02243293|54237911|FG015|Overall Study|Enrolled into a Re-treatment Study|0|||
27783948|NCT02243293|54237912|FG016|Overall Study|Enrolled into a Re-treatment Study|0|||
27783949|NCT02243293|54237913|FG017|Overall Study|Enrolled into a Re-treatment Study|0|||
27783950|NCT02243293|54237914|FG018|Overall Study|Enrolled into a Re-treatment Study|0|||
27783951|NCT02243293|54237915|FG019|Overall Study|Enrolled into a Re-treatment Study|0|||
27783952|NCT02243293|54237916|FG020|Overall Study|Enrolled into a Re-treatment Study|0|||
27783953|NCT02243293|54237917|FG021|Overall Study|Enrolled into a Re-treatment Study|0|||
27783954|NCT02243293|54237896|FG000|Overall Study|Randomized but did'nt receive study drug|0|||
27783955|NCT02243293|54237897|FG001|Overall Study|Randomized but did'nt receive study drug|0|||
27783956|NCT02243293|54237898|FG002|Overall Study|Randomized but did'nt receive study drug|0|||
27783957|NCT02243293|54237899|FG003|Overall Study|Randomized but did'nt receive study drug|0|||
27783958|NCT02243293|54237900|FG004|Overall Study|Randomized but did'nt receive study drug|1|||
27783959|NCT02243293|54237901|FG005|Overall Study|Randomized but did'nt receive study drug|0|||
27783960|NCT02243293|54237902|FG006|Overall Study|Randomized but did'nt receive study drug|0|||
27783961|NCT02243293|54237903|FG007|Overall Study|Randomized but did'nt receive study drug|0|||
27783962|NCT02243293|54237904|FG008|Overall Study|Randomized but did'nt receive study drug|0|||
27783963|NCT02243293|54237905|FG009|Overall Study|Randomized but did'nt receive study drug|1|||
27783964|NCT02243293|54237906|FG010|Overall Study|Randomized but did'nt receive study drug|0|||
27783965|NCT02243293|54237907|FG011|Overall Study|Randomized but did'nt receive study drug|0|||
27783966|NCT02243293|54237908|FG012|Overall Study|Randomized but did'nt receive study drug|0|||
27783967|NCT02243293|54237909|FG013|Overall Study|Randomized but did'nt receive study drug|0|||
27783968|NCT02243293|54237910|FG014|Overall Study|Randomized but did'nt receive study drug|0|||
27783969|NCT02243293|54237911|FG015|Overall Study|Randomized but did'nt receive study drug|0|||
27783970|NCT02243293|54237912|FG016|Overall Study|Randomized but did'nt receive study drug|0|||
27783971|NCT02243293|54237913|FG017|Overall Study|Randomized but did'nt receive study drug|0|||
27783972|NCT02243293|54237914|FG018|Overall Study|Randomized but did'nt receive study drug|0|||
27783973|NCT02243293|54237915|FG019|Overall Study|Randomized but did'nt receive study drug|1|||
27783974|NCT02243293|54237916|FG020|Overall Study|Randomized but did'nt receive study drug|0|||
27783975|NCT02243293|54237917|FG021|Overall Study|Randomized but did'nt receive study drug|0|||
27783976|NCT02322047|54237958|FG000|Overall Study|Physician Decision|1|||
27783977|NCT02322047|54237959|FG001|Overall Study|Physician Decision|0|||
27783978|NCT02322047|54237960|FG002|Overall Study|Physician Decision|0|||
27783979|NCT02322047|54237961|FG003|Overall Study|Physician Decision|0|||
27783980|NCT02322047|54237958|FG000|Overall Study|Withdrawal by Subject|1|||
27783981|NCT02322047|54237959|FG001|Overall Study|Withdrawal by Subject|0|||
27783982|NCT02322047|54237960|FG002|Overall Study|Withdrawal by Subject|0|||
27783983|NCT02322047|54237961|FG003|Overall Study|Withdrawal by Subject|1|||
27783984|NCT02322047|54237958|FG000|Overall Study|Adverse Event|0|||
27783985|NCT02322047|54237959|FG001|Overall Study|Adverse Event|1|||
27783986|NCT02322047|54237960|FG002|Overall Study|Adverse Event|0|||
27783987|NCT02322047|54237961|FG003|Overall Study|Adverse Event|0|||
27783988|NCT02322047|54237958|FG000|Overall Study|Lost to Follow-up|0|||
27783989|NCT02322047|54237959|FG001|Overall Study|Lost to Follow-up|0|||
27783990|NCT02322047|54237960|FG002|Overall Study|Lost to Follow-up|1|||
27783991|NCT02322047|54237961|FG003|Overall Study|Lost to Follow-up|1|||
27783992|NCT02254291|54237974|FG000|Overall Study|Withdrawal by Subject|0|||
27783993|NCT02254291|54237975|FG001|Overall Study|Withdrawal by Subject|3|||
27783994|NCT02254291|54237976|FG002|Overall Study|Withdrawal by Subject|1|||
27783995|NCT02254291|54237974|FG000|Overall Study|Missing follow-up information|0|||
27783996|NCT02254291|54237975|FG001|Overall Study|Missing follow-up information|0|||
27783997|NCT02254291|54237976|FG002|Overall Study|Missing follow-up information|1|||
27783998|NCT02253433|54237986|FG000|Overall Study|Unable to Contact|9|||
27783999|NCT02253433|54237987|FG001|Overall Study|Unable to Contact|16|||
27784000|NCT02253433|54237986|FG000|Overall Study|Death|1|||
27784001|NCT02253433|54237987|FG001|Overall Study|Death|1|||
27784002|NCT02253433|54237986|FG000|Overall Study|No Longer Interested|3|||
27784003|NCT02253433|54237987|FG001|Overall Study|No Longer Interested|15|||
27784004|NCT02253433|54237986|FG000|Overall Study|Out of Study Area|2|||
27784005|NCT02253433|54237987|FG001|Overall Study|Out of Study Area|7|||
27784006|NCT02253433|54237986|FG000|Overall Study|Uncomfortable with home visitors|0|||
27784007|NCT02253433|54237987|FG001|Overall Study|Uncomfortable with home visitors|3|||
27840957|NCT01454531|54328939|FG000|Overall Study|Lost to Follow-up|1|||
27784008|NCT02253433|54237986|FG000|Overall Study|Unstable Housing/Homeless|0|||
27784009|NCT02253433|54237987|FG001|Overall Study|Unstable Housing/Homeless|7|||
27784010|NCT02253433|54237986|FG000|Overall Study|Too Busy|0|||
27784011|NCT02253433|54237987|FG001|Overall Study|Too Busy|4|||
27784012|NCT02253433|54237986|FG000|Overall Study|Medical or Other Concerns|1|||
27784013|NCT02253433|54237987|FG001|Overall Study|Medical or Other Concerns|2|||
27784014|NCT02242981|54237994|FG000|Overall Study|Withdrawal by Subject|1|||
27784015|NCT02277743|54238001|FG000|Overall Study|Protocol Violation|1|||
27784016|NCT02277743|54238002|FG001|Overall Study|Protocol Violation|1|||
27784017|NCT02277743|54238003|FG002|Overall Study|Protocol Violation|1|||
27784018|NCT02277743|54238001|FG000|Overall Study|Adverse Event|10|||
27784019|NCT02277743|54238002|FG001|Overall Study|Adverse Event|6|||
27784020|NCT02277743|54238003|FG002|Overall Study|Adverse Event|6|||
27784021|NCT02277743|54238001|FG000|Overall Study|Lack of Efficacy|11|||
27784022|NCT02277743|54238002|FG001|Overall Study|Lack of Efficacy|4|||
27784023|NCT02277743|54238003|FG002|Overall Study|Lack of Efficacy|3|||
27784024|NCT02277743|54238001|FG000|Overall Study|Other than specified above|18|||
27784025|NCT02277743|54238002|FG001|Overall Study|Other than specified above|5|||
27784026|NCT02277743|54238003|FG002|Overall Study|Other than specified above|16|||
27784027|NCT02242903|54238018|FG000|Overall Study|Withdrawal by Subject|1|||
27784028|NCT02242903|54238019|FG001|Overall Study|Withdrawal by Subject|0|||
27784029|NCT02242903|54238020|FG002|Overall Study|Withdrawal by Subject|0|||
27784030|NCT02242903|54238021|FG003|Overall Study|Withdrawal by Subject|0|||
27784031|NCT02242903|54238022|FG004|Overall Study|Withdrawal by Subject|0|||
27784032|NCT02242903|54238023|FG005|Overall Study|Withdrawal by Subject|0|||
27784033|NCT02242903|54238024|FG006|Overall Study|Withdrawal by Subject|0|||
27784034|NCT02320721|54238048|FG000|Overall Study|Adverse Event|6|||
27784035|NCT02320721|54238049|FG001|Overall Study|Adverse Event|6|||
27784036|NCT02320721|54238048|FG000|Overall Study|Lack of Efficacy|2|||
27784037|NCT02320721|54238049|FG001|Overall Study|Lack of Efficacy|0|||
27784038|NCT02320721|54238048|FG000|Overall Study|Poor compliance to protocol|3|||
27784039|NCT02320721|54238049|FG001|Overall Study|Poor compliance to protocol|7|||
27784040|NCT02320721|54238048|FG000|Overall Study|Randomized but not treated|0|||
27784041|NCT02320721|54238049|FG001|Overall Study|Randomized but not treated|1|||
27784042|NCT02320721|54238048|FG000|Overall Study|Hypoglycemia|1|||
27784043|NCT02320721|54238049|FG001|Overall Study|Hypoglycemia|0|||
27784044|NCT02320721|54238048|FG000|Overall Study|Other than specified above|15|||
27784045|NCT02320721|54238049|FG001|Overall Study|Other than specified above|20|||
27784046|NCT02320487|54238055|FG000|Overall Study|Reason not Specified|1|||
27784047|NCT02320487|54238055|FG000|Overall Study|Physician Decision|5|||
27784048|NCT02320487|54238055|FG000|Overall Study|Withdrawal by Subject|1|||
27784049|NCT02320487|54238055|FG000|Overall Study|Death|3|||
27784050|NCT02320487|54238055|FG000|Overall Study|Adverse Event|11|||
27784051|NCT02277119|54238062|FG000|Overall Study|Lack of Efficacy|1|||
27784052|NCT02277119|54238063|FG001|Overall Study|Lack of Efficacy|1|||
27784053|NCT02277119|54238064|FG002|Overall Study|Lack of Efficacy|1|||
27784054|NCT02277119|54238062|FG000|Overall Study|Protocol Violation|2|||
27784055|NCT02277119|54238063|FG001|Overall Study|Protocol Violation|3|||
27784056|NCT02277119|54238064|FG002|Overall Study|Protocol Violation|7|||
27784057|NCT02320253|54238075|FG000|Overall Study|Withdrawal by Subject|3|||
27784058|NCT02320253|54238076|FG001|Overall Study|Withdrawal by Subject|0|||
27784059|NCT02320253|54238077|FG002|Overall Study|Withdrawal by Subject|0|||
27784060|NCT02320253|54238075|FG000|Overall Study|Lost to Follow-up|2|||
27784061|NCT02320253|54238076|FG001|Overall Study|Lost to Follow-up|2|||
27784062|NCT02320253|54238077|FG002|Overall Study|Lost to Follow-up|1|||
27784063|NCT02320253|54238075|FG000|Overall Study|Death|1|||
27784064|NCT02320253|54238076|FG001|Overall Study|Death|0|||
27784065|NCT02320253|54238077|FG002|Overall Study|Death|1|||
27784066|NCT02276807|54238087|FG000|Overall Study|Withdrawal by Subject|8|||
27784067|NCT02276807|54238088|FG001|Overall Study|Withdrawal by Subject|7|||
27784068|NCT02276807|54238087|FG000|Overall Study|Lost to Follow-up|10|||
27784069|NCT02276807|54238088|FG001|Overall Study|Lost to Follow-up|10|||
27784070|NCT02252965|54238096|FG000|Overall Study|Adverse Event|9|||
27784071|NCT02252965|54238097|FG001|Overall Study|Adverse Event|14|||
27784072|NCT02252965|54238096|FG000|Overall Study|Lost to Follow-up|16|||
27784073|NCT02252965|54238097|FG001|Overall Study|Lost to Follow-up|8|||
27784074|NCT02252965|54238096|FG000|Overall Study|Protocol Violation|4|||
27784075|NCT02252965|54238097|FG001|Overall Study|Protocol Violation|5|||
27784076|NCT02252965|54238096|FG000|Overall Study|Lack of Efficacy|0|||
27784077|NCT02252965|54238097|FG001|Overall Study|Lack of Efficacy|2|||
27784078|NCT02252965|54238096|FG000|Overall Study|Withdrawal by Subject|7|||
27784079|NCT02252965|54238097|FG001|Overall Study|Withdrawal by Subject|9|||
27784080|NCT02252965|54238096|FG000|Overall Study|Other|4|||
27784081|NCT02252965|54238097|FG001|Overall Study|Other|5|||
27784082|NCT02242435|54238107|FG000|Overall Study|Lost to Follow-up|3|||
27784083|NCT02242435|54238108|FG001|Overall Study|Lost to Follow-up|4|||
27784084|NCT02242435|54238107|FG000|Overall Study|Adverse Event|3|||
27784085|NCT02242435|54238108|FG001|Overall Study|Adverse Event|2|||
27784086|NCT02242435|54238107|FG000|Overall Study|Withdrawal by Subject|13|||
27784087|NCT02242435|54238108|FG001|Overall Study|Withdrawal by Subject|8|||
27784088|NCT02242435|54238107|FG000|Overall Study|Death|0|||
27784089|NCT02242435|54238108|FG001|Overall Study|Death|1|||
27784090|NCT02242435|54238107|FG000|Overall Study|Protocol Violation|1|||
27784091|NCT02242435|54238108|FG001|Overall Study|Protocol Violation|0|||
27784092|NCT02242435|54238107|FG000|Overall Study|Physician Decision|0|||
27784093|NCT02242435|54238108|FG001|Overall Study|Physician Decision|1|||
27784094|NCT02251717|54238116|FG000|Overall Study|Adverse Event|0|||
27784095|NCT02251717|54238117|FG001|Overall Study|Adverse Event|1|||
27784096|NCT02251717|54238116|FG000|Overall Study|Withdrew Consent|1|||
27784097|NCT02251717|54238117|FG001|Overall Study|Withdrew Consent|0|||
27784098|NCT02242201|54238126|FG000|Overall Study|preoperative identified neuropathy|2|||
27784099|NCT02242201|54238127|FG001|Overall Study|preoperative identified neuropathy|0|||
27784100|NCT02242201|54238128|FG002|Overall Study|preoperative identified neuropathy|0|||
27784101|NCT02242201|54238126|FG000|Overall Study|planned post-op anticoagulation|1|||
27784102|NCT02242201|54238127|FG001|Overall Study|planned post-op anticoagulation|0|||
27784103|NCT02242201|54238128|FG002|Overall Study|planned post-op anticoagulation|0|||
27784104|NCT02242201|54238126|FG000|Overall Study|changed surgical procedure|1|||
27784105|NCT02242201|54238127|FG001|Overall Study|changed surgical procedure|0|||
27784106|NCT02242201|54238128|FG002|Overall Study|changed surgical procedure|0|||
27784107|NCT02242201|54238126|FG000|Overall Study|postponed surgery|0|||
27784108|NCT02242201|54238127|FG001|Overall Study|postponed surgery|0|||
27784109|NCT02242201|54238128|FG002|Overall Study|postponed surgery|1|||
27784110|NCT02242201|54238126|FG000|Overall Study|preoperative opioid consumption|0|||
27784111|NCT02242201|54238127|FG001|Overall Study|preoperative opioid consumption|1|||
27784112|NCT02242201|54238128|FG002|Overall Study|preoperative opioid consumption|0|||
27784113|NCT02242045|54238136|FG000|Overall Study|Investigator's Discretion|1|||
27784114|NCT02242045|54238136|FG000|Overall Study|Progressive Disease|2|||
27784115|NCT02242045|54238136|FG000|Overall Study|Unable to tolerate rechallenge with idelalisib|1|||
27784116|NCT02242045|54238136|FG000|Overall Study|Initiated another anti-cancer or experimental therapy|2|||
27784117|NCT02241889|54238140|FG000|Overall Study|device issues|0|||
27784118|NCT02241889|54238141|FG001|Overall Study|device issues|0|||
27784119|NCT02241889|54238142|FG002|Overall Study|device issues|1|||
27784120|NCT02241889|54238143|FG003|Overall Study|device issues|0|||
27784121|NCT02241889|54238144|FG004|Overall Study|device issues|0|||
27784122|NCT02241889|54238145|FG005|Overall Study|device issues|0|||
27784123|NCT02241889|54238140|FG000|Overall Study|Withdrawal by Subject|0|||
27784124|NCT02241889|54238141|FG001|Overall Study|Withdrawal by Subject|0|||
27784125|NCT02241889|54238142|FG002|Overall Study|Withdrawal by Subject|0|||
27784126|NCT02241889|54238143|FG003|Overall Study|Withdrawal by Subject|0|||
27784127|NCT02241889|54238144|FG004|Overall Study|Withdrawal by Subject|0|||
27784128|NCT02241889|54238145|FG005|Overall Study|Withdrawal by Subject|1|||
27784129|NCT02241733|54238155|FG000|Overall Study|Lost to Follow-up|9|||
27840958|NCT01454531|54328939|FG000|Overall Study|Physician Decision|1|||
27840959|NCT01454531|54328939|FG000|Overall Study|Delay in IMP administration|1|||
27840960|NCT01454531|54328939|FG000|Overall Study|Other|1|||
27784130|NCT02241733|54238156|FG001|Overall Study|Lost to Follow-up|4|||
27784131|NCT02241733|54238155|FG000|Overall Study|Physician Decision|6|||
27784132|NCT02241733|54238156|FG001|Overall Study|Physician Decision|2|||
27784133|NCT02241733|54238155|FG000|Overall Study|Withdrawal by Subject|0|||
27784134|NCT02241733|54238156|FG001|Overall Study|Withdrawal by Subject|2|||
27784135|NCT02241733|54238155|FG000|Overall Study|Death|0|||
27784136|NCT02241733|54238156|FG001|Overall Study|Death|2|||
27784137|NCT02241343|54238162|FG000|Overall Study|Adverse Event|1|||
27784138|NCT02241187|54238167|FG000|Overall Study|Protocol closed due to lack of accrual.|2|||
27784139|NCT02249767|54238174|FG000|Overall Study|Did not use medication|8|||
27784140|NCT02249767|54238175|FG001|Overall Study|Did not use medication|9|||
27784141|NCT02249767|54238176|FG002|Overall Study|Did not use medication|8|||
27784142|NCT02239939|54238186|FG000|Overall Study|Adverse Event|1|||
27784143|NCT02239939|54238187|FG001|Overall Study|Adverse Event|0|||
27784144|NCT02239939|54238186|FG000|Overall Study|Withdrawal by Subject|1|||
27784145|NCT02239939|54238187|FG001|Overall Study|Withdrawal by Subject|1|||
27784146|NCT02239939|54238186|FG000|Overall Study|Lost to Follow-up|0|||
27784147|NCT02239939|54238187|FG001|Overall Study|Lost to Follow-up|1|||
27784148|NCT02248675|54238197|FG000|Overall Study|Lost to Follow-up|3|||
27784149|NCT02248675|54238198|FG001|Overall Study|Lost to Follow-up|1|||
27784150|NCT02207725|54238208|FG000|Overall Study|Did Not Receive Treatment|0|||
27784151|NCT02207725|54238209|FG001|Overall Study|Did Not Receive Treatment|1|||
27784152|NCT02207725|54238210|FG002|Overall Study|Did Not Receive Treatment|1|||
27784153|NCT02207725|54238211|FG003|Overall Study|Did Not Receive Treatment|1|||
27784154|NCT02238379|54238225|FG000|Overall Study|Lost to Follow-up|1|||
27784155|NCT02238379|54238226|FG001|Overall Study|Lost to Follow-up|0|||
27784156|NCT02238067|54238232|FG000|Overall Study|Not completed survey at Month 6|45|||
27784157|NCT02237911|54238239|FG000|Overall Study|Withdrawal by Subject|4|||
27784158|NCT02237911|54238240|FG001|Overall Study|Withdrawal by Subject|7|||
27784159|NCT02237911|54238241|FG002|Overall Study|Withdrawal by Subject|2|||
27784160|NCT02237911|54238239|FG000|Overall Study|Lost to Follow-up|3|||
27784161|NCT02237911|54238240|FG001|Overall Study|Lost to Follow-up|1|||
27784162|NCT02237911|54238241|FG002|Overall Study|Lost to Follow-up|1|||
27784163|NCT02234479|54238251|FG000|Overall Study|Withdrawal by Subject|1|||
27784164|NCT02234479|54238252|FG001|Overall Study|Withdrawal by Subject|3|||
27784165|NCT02207491|54238260|FG000|Overall Study|Adverse Event|20|||
27784166|NCT02207491|54238261|FG001|Overall Study|Adverse Event|4|||
27784167|NCT02207491|54238260|FG000|Overall Study|Withdrawal by Subject|3|||
27784168|NCT02207491|54238261|FG001|Overall Study|Withdrawal by Subject|2|||
27784169|NCT02207491|54238260|FG000|Overall Study|Non-compliant|0|||
27784170|NCT02207491|54238261|FG001|Overall Study|Non-compliant|1|||
27784171|NCT02207491|54238260|FG000|Overall Study|Lost to Follow-up|0|||
27784172|NCT02207491|54238261|FG001|Overall Study|Lost to Follow-up|1|||
27784173|NCT02207491|54238260|FG000|Overall Study|Lack of Efficacy|3|||
27784174|NCT02207491|54238261|FG001|Overall Study|Lack of Efficacy|0|||
27784175|NCT02207491|54238260|FG000|Overall Study|Physician Decision|2|||
27784176|NCT02207491|54238261|FG001|Overall Study|Physician Decision|0|||
27784177|NCT02207491|54238260|FG000|Overall Study|Protocol Violation|3|||
27784178|NCT02207491|54238261|FG001|Overall Study|Protocol Violation|5|||
27784179|NCT02315066|54238281|FG000|Overall Study|Lost to Follow-up|0|||
27784180|NCT02315066|54238282|FG001|Overall Study|Lost to Follow-up|1|||
27784181|NCT02315066|54238283|FG002|Overall Study|Lost to Follow-up|1|||
27784182|NCT02315066|54238284|FG003|Overall Study|Lost to Follow-up|0|||
27784183|NCT02315066|54238285|FG004|Overall Study|Lost to Follow-up|1|||
27784184|NCT02315066|54238286|FG005|Overall Study|Lost to Follow-up|0|||
27784185|NCT02315066|54238287|FG006|Overall Study|Lost to Follow-up|2|||
27784186|NCT02315066|54238288|FG007|Overall Study|Lost to Follow-up|1|||
27784187|NCT02315066|54238289|FG008|Overall Study|Lost to Follow-up|0|||
27784188|NCT02315066|54238290|FG009|Overall Study|Lost to Follow-up|0|||
27784189|NCT02315066|54238291|FG010|Overall Study|Lost to Follow-up|1|||
27784190|NCT02315066|54238292|FG011|Overall Study|Lost to Follow-up|2|||
27784191|NCT02315066|54238293|FG012|Overall Study|Lost to Follow-up|0|||
27784192|NCT02315066|54238294|FG013|Overall Study|Lost to Follow-up|4|||
27784193|NCT02315066|54238281|FG000|Overall Study|Death|2|||
27784194|NCT02315066|54238282|FG001|Overall Study|Death|7|||
27784195|NCT02315066|54238283|FG002|Overall Study|Death|6|||
27784196|NCT02315066|54238284|FG003|Overall Study|Death|11|||
27784197|NCT02315066|54238285|FG004|Overall Study|Death|10|||
27784198|NCT02315066|54238286|FG005|Overall Study|Death|3|||
27784199|NCT02315066|54238287|FG006|Overall Study|Death|9|||
27784200|NCT02315066|54238288|FG007|Overall Study|Death|9|||
27784201|NCT02315066|54238289|FG008|Overall Study|Death|10|||
27784202|NCT02315066|54238290|FG009|Overall Study|Death|8|||
27784203|NCT02315066|54238291|FG010|Overall Study|Death|10|||
27840961|NCT01454063|54328945|FG000|Randomized|Adverse Event|1|||
27784204|NCT02315066|54238292|FG011|Overall Study|Death|7|||
27784205|NCT02315066|54238293|FG012|Overall Study|Death|8|||
27784206|NCT02315066|54238294|FG013|Overall Study|Death|21|||
27840962|NCT01454063|54328946|FG001|Randomized|Adverse Event|1|||
27840963|NCT01454063|54328945|FG000|Randomized|Protocol Violation|0|||
27784207|NCT02315066|54238281|FG000|Overall Study|Other|0|||
27784208|NCT02315066|54238282|FG001|Overall Study|Other|0|||
27784209|NCT02315066|54238283|FG002|Overall Study|Other|0|||
27784210|NCT02315066|54238284|FG003|Overall Study|Other|0|||
27784211|NCT02315066|54238285|FG004|Overall Study|Other|0|||
27784212|NCT02315066|54238286|FG005|Overall Study|Other|0|||
27784213|NCT02315066|54238287|FG006|Overall Study|Other|0|||
27784214|NCT02315066|54238288|FG007|Overall Study|Other|1|||
27784215|NCT02315066|54238289|FG008|Overall Study|Other|1|||
27784216|NCT02315066|54238290|FG009|Overall Study|Other|2|||
27784217|NCT02315066|54238291|FG010|Overall Study|Other|0|||
27784218|NCT02315066|54238292|FG011|Overall Study|Other|0|||
27784219|NCT02315066|54238293|FG012|Overall Study|Other|0|||
27784220|NCT02315066|54238294|FG013|Overall Study|Other|0|||
27784221|NCT02315066|54238281|FG000|Overall Study|Subject refused further follow-up|0|||
27840964|NCT01454063|54328946|FG001|Randomized|Protocol Violation|1|||
27784222|NCT02315066|54238282|FG001|Overall Study|Subject refused further follow-up|2|||
27784223|NCT02315066|54238283|FG002|Overall Study|Subject refused further follow-up|2|||
27784224|NCT02315066|54238284|FG003|Overall Study|Subject refused further follow-up|0|||
27784225|NCT02315066|54238285|FG004|Overall Study|Subject refused further follow-up|0|||
27784226|NCT02315066|54238286|FG005|Overall Study|Subject refused further follow-up|0|||
27784227|NCT02315066|54238287|FG006|Overall Study|Subject refused further follow-up|2|||
27784228|NCT02315066|54238288|FG007|Overall Study|Subject refused further follow-up|3|||
27784229|NCT02315066|54238289|FG008|Overall Study|Subject refused further follow-up|0|||
27784230|NCT02315066|54238290|FG009|Overall Study|Subject refused further follow-up|1|||
27784231|NCT02315066|54238291|FG010|Overall Study|Subject refused further follow-up|1|||
27784232|NCT02315066|54238292|FG011|Overall Study|Subject refused further follow-up|2|||
27784233|NCT02315066|54238293|FG012|Overall Study|Subject refused further follow-up|2|||
27784234|NCT02315066|54238294|FG013|Overall Study|Subject refused further follow-up|4|||
27784235|NCT02315066|54238281|FG000|Overall Study|Study ongoing at date of cut-off|0|||
27784236|NCT02315066|54238282|FG001|Overall Study|Study ongoing at date of cut-off|0|||
27784237|NCT02315066|54238283|FG002|Overall Study|Study ongoing at date of cut-off|0|||
27784238|NCT02315066|54238284|FG003|Overall Study|Study ongoing at date of cut-off|0|||
27784239|NCT02315066|54238285|FG004|Overall Study|Study ongoing at date of cut-off|0|||
27784240|NCT02315066|54238286|FG005|Overall Study|Study ongoing at date of cut-off|0|||
27784241|NCT02315066|54238287|FG006|Overall Study|Study ongoing at date of cut-off|0|||
27784242|NCT02315066|54238288|FG007|Overall Study|Study ongoing at date of cut-off|0|||
27784243|NCT02315066|54238289|FG008|Overall Study|Study ongoing at date of cut-off|0|||
27784244|NCT02315066|54238290|FG009|Overall Study|Study ongoing at date of cut-off|0|||
27784245|NCT02315066|54238291|FG010|Overall Study|Study ongoing at date of cut-off|0|||
27784246|NCT02315066|54238292|FG011|Overall Study|Study ongoing at date of cut-off|0|||
27784247|NCT02315066|54238293|FG012|Overall Study|Study ongoing at date of cut-off|0|||
27784248|NCT02315066|54238294|FG013|Overall Study|Study ongoing at date of cut-off|1|||
27784249|NCT02207413|54238330|FG000|Overall Study|Withdrawal by Subject|1|||
27784250|NCT02207413|54238331|FG001|Overall Study|Withdrawal by Subject|0|||
27784251|NCT02207413|54238332|FG002|Overall Study|Withdrawal by Subject|0|||
27784252|NCT02207413|54238333|FG003|Overall Study|Withdrawal by Subject|0|||
27784253|NCT02207413|54238334|FG004|Overall Study|Withdrawal by Subject|3|||
27784254|NCT02207413|54238335|FG005|Overall Study|Withdrawal by Subject|7|||
27784255|NCT02207413|54238330|FG000|Overall Study|Lost to Follow-up|0|||
27784256|NCT02207413|54238331|FG001|Overall Study|Lost to Follow-up|0|||
27784257|NCT02207413|54238332|FG002|Overall Study|Lost to Follow-up|0|||
27784258|NCT02207413|54238333|FG003|Overall Study|Lost to Follow-up|1|||
27784259|NCT02207413|54238334|FG004|Overall Study|Lost to Follow-up|1|||
27784260|NCT02207413|54238335|FG005|Overall Study|Lost to Follow-up|5|||
27784261|NCT02207413|54238330|FG000|Overall Study|Adverse Event|0|||
27784262|NCT02207413|54238331|FG001|Overall Study|Adverse Event|0|||
27784263|NCT02207413|54238332|FG002|Overall Study|Adverse Event|0|||
27784264|NCT02207413|54238333|FG003|Overall Study|Adverse Event|0|||
27784265|NCT02207413|54238334|FG004|Overall Study|Adverse Event|2|||
27784266|NCT02207413|54238335|FG005|Overall Study|Adverse Event|1|||
27784267|NCT02207413|54238330|FG000|Overall Study|Migrated/moved from study area|0|||
27784268|NCT02207413|54238331|FG001|Overall Study|Migrated/moved from study area|0|||
27784269|NCT02207413|54238332|FG002|Overall Study|Migrated/moved from study area|0|||
27784270|NCT02207413|54238333|FG003|Overall Study|Migrated/moved from study area|0|||
27784271|NCT02207413|54238334|FG004|Overall Study|Migrated/moved from study area|1|||
27784272|NCT02207413|54238335|FG005|Overall Study|Migrated/moved from study area|0|||
27784273|NCT02309372|54238357|FG000|Overall Study|Lost to Follow-up|3|||
27784274|NCT02309372|54238358|FG001|Overall Study|Lost to Follow-up|2|||
27784275|NCT02276027|54238368|FG000|Overall Study|Death|1|||
27840965|NCT01453595|54328955|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
27840966|NCT01453595|54328956|FG001|Overall Study|Dose Limiting Toxicity (DLT)|1|||
27840967|NCT01453595|54328957|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
27784276|NCT02276027|54238369|FG001|Overall Study|Death|0|||
27784277|NCT02276027|54238370|FG002|Overall Study|Death|0|||
27784278|NCT02276027|54238371|FG003|Overall Study|Death|2|||
27840968|NCT01453439|54328965|FG000|Treatment Phase|Withdrawal by Subject|13|||
27784279|NCT02276027|54238368|FG000|Overall Study|Physician Decision|0|||
27784280|NCT02276027|54238369|FG001|Overall Study|Physician Decision|0|||
27784281|NCT02276027|54238370|FG002|Overall Study|Physician Decision|0|||
27784282|NCT02276027|54238371|FG003|Overall Study|Physician Decision|1|||
27784283|NCT02276027|54238368|FG000|Overall Study|Progressive disease|1|||
27784284|NCT02276027|54238369|FG001|Overall Study|Progressive disease|13|||
27784285|NCT02276027|54238370|FG002|Overall Study|Progressive disease|12|||
27784286|NCT02276027|54238371|FG003|Overall Study|Progressive disease|14|||
27784287|NCT02276027|54238368|FG000|Overall Study|Subject/guardian decision|0|||
27840969|NCT01453439|54328966|FG001|Treatment Phase|Withdrawal by Subject|10|||
27784288|NCT02276027|54238369|FG001|Overall Study|Subject/guardian decision|1|||
27784289|NCT02276027|54238370|FG002|Overall Study|Subject/guardian decision|0|||
27784290|NCT02276027|54238371|FG003|Overall Study|Subject/guardian decision|3|||
27840970|NCT01453439|54328965|FG000|Treatment Phase|Suicidal Ideation|2|||
27784291|NCT02276027|54238368|FG000|Overall Study|Adverse Event|0|||
27784292|NCT02276027|54238369|FG001|Overall Study|Adverse Event|2|||
27784293|NCT02276027|54238370|FG002|Overall Study|Adverse Event|8|||
27784294|NCT02276027|54238371|FG003|Overall Study|Adverse Event|2|||
27784295|NCT02309294|54238381|FG000|Overall Study|Withdrawal by Subject|2|||
27784296|NCT02233543|54238385|FG000|Period 1|Withdrawal by Subject|1|||
27784297|NCT02233543|54238386|FG001|Period 1|Withdrawal by Subject|0|||
27784298|NCT02233543|54238385|FG000|Period 1|Participants required other treatment.|2|||
27784299|NCT02233543|54238386|FG001|Period 1|Participants required other treatment.|3|||
27784300|NCT02233543|54238385|FG000|Period 2|Adverse Event|1|||
27784301|NCT02233543|54238386|FG001|Period 2|Adverse Event|0|||
27784302|NCT02233543|54238385|FG000|Period 2|Participant required other treatment.|0|||
27784303|NCT02233543|54238386|FG001|Period 2|Participant required other treatment.|1|||
27784304|NCT02233543|54238385|FG000|Period 2|COPD exacerbation|1|||
27784305|NCT02233543|54238386|FG001|Period 2|COPD exacerbation|0|||
27784306|NCT02309138|54238394|FG000|Overall Study|Withdrawal by Subject|44|||
27784307|NCT02309138|54238395|FG001|Overall Study|Withdrawal by Subject|15|||
27784308|NCT02309138|54238394|FG000|Overall Study|Protocol Violation|4|||
27784309|NCT02309138|54238395|FG001|Overall Study|Protocol Violation|2|||
27784310|NCT02309138|54238394|FG000|Overall Study|delivered before visit 2|0|||
27784311|NCT02309138|54238395|FG001|Overall Study|delivered before visit 2|1|||
27784312|NCT02233309|54238411|FG000|Overall Study|Physician Decision|5|||
27784313|NCT02204917|54238415|FG000|Overall Study|Protocol Violation|1|||
27784314|NCT02280044|54238424|FG000|Overall Study|Planned alternate|0|||
27784315|NCT02280044|54238425|FG001|Overall Study|Planned alternate|2|||
27784316|NCT02308748|54238431|FG000|Period 1|Withdrawal by Subject|0|||
27784317|NCT02308748|54238432|FG001|Period 1|Withdrawal by Subject|0|||
27784318|NCT02308748|54238433|FG002|Period 1|Withdrawal by Subject|1|||
27784319|NCT02308748|54238434|FG003|Period 1|Withdrawal by Subject|0|||
27784320|NCT02308748|54238435|FG004|Period 1|Withdrawal by Subject|0|||
27784321|NCT02308748|54238436|FG005|Period 1|Withdrawal by Subject|0|||
27784322|NCT02308748|54238437|FG006|Period 1|Withdrawal by Subject|0|||
27784323|NCT02308748|54238438|FG007|Period 1|Withdrawal by Subject|0|||
27784324|NCT02308748|54238439|FG008|Period 1|Withdrawal by Subject|0|||
27784325|NCT02308748|54238440|FG009|Period 1|Withdrawal by Subject|0|||
27784326|NCT02308748|54238431|FG000|Period 2|Adverse Event|0|||
27784327|NCT02308748|54238432|FG001|Period 2|Adverse Event|0|||
27784328|NCT02308748|54238433|FG002|Period 2|Adverse Event|0|||
27784329|NCT02308748|54238434|FG003|Period 2|Adverse Event|0|||
27784330|NCT02308748|54238435|FG004|Period 2|Adverse Event|0|||
27784331|NCT02308748|54238436|FG005|Period 2|Adverse Event|0|||
27784332|NCT02308748|54238437|FG006|Period 2|Adverse Event|0|||
27784333|NCT02308748|54238438|FG007|Period 2|Adverse Event|1|||
27784334|NCT02308748|54238439|FG008|Period 2|Adverse Event|0|||
27784335|NCT02308748|54238440|FG009|Period 2|Adverse Event|0|||
27784336|NCT02308748|54238431|FG000|Period 3|Protocol Violation|0|||
27784337|NCT02308748|54238432|FG001|Period 3|Protocol Violation|0|||
27784338|NCT02308748|54238433|FG002|Period 3|Protocol Violation|0|||
27784339|NCT02308748|54238434|FG003|Period 3|Protocol Violation|0|||
27784340|NCT02308748|54238435|FG004|Period 3|Protocol Violation|0|||
27784341|NCT02308748|54238436|FG005|Period 3|Protocol Violation|0|||
27784342|NCT02308748|54238437|FG006|Period 3|Protocol Violation|0|||
27784343|NCT02308748|54238438|FG007|Period 3|Protocol Violation|0|||
27784344|NCT02308748|54238439|FG008|Period 3|Protocol Violation|0|||
27784345|NCT02308748|54238440|FG009|Period 3|Protocol Violation|1|||
27784346|NCT02308748|54238431|FG000|Period 5|Adverse Event|1|||
27784347|NCT02308748|54238432|FG001|Period 5|Adverse Event|0|||
27784348|NCT02308748|54238433|FG002|Period 5|Adverse Event|0|||
27784349|NCT02308748|54238434|FG003|Period 5|Adverse Event|0|||
27784350|NCT02308748|54238435|FG004|Period 5|Adverse Event|0|||
27784351|NCT02308748|54238436|FG005|Period 5|Adverse Event|0|||
27784352|NCT02308748|54238437|FG006|Period 5|Adverse Event|0|||
27784353|NCT02308748|54238438|FG007|Period 5|Adverse Event|0|||
27784354|NCT02308748|54238439|FG008|Period 5|Adverse Event|1|||
27784355|NCT02308748|54238440|FG009|Period 5|Adverse Event|0|||
27784356|NCT01646216|54238454|FG000|Overall Study|Baseline step length difference (<5cm)|10|||
27784357|NCT01646216|54238455|FG001|Overall Study|Baseline step length difference (<5cm)|10|||
27784358|NCT01646216|54238454|FG000|Overall Study|Did not complete training|0|||
27784359|NCT01646216|54238455|FG001|Overall Study|Did not complete training|2|||
27784360|NCT01646216|54238454|FG000|Overall Study|Investigator decision|1|||
27784361|NCT01646216|54238455|FG001|Overall Study|Investigator decision|1|||
27784362|NCT02308124|54238468|FG000|Overall Study|Lost to Follow-up|6|||
27784363|NCT02308124|54238469|FG001|Overall Study|Lost to Follow-up|6|||
27784364|NCT02308124|54238470|FG002|Overall Study|Lost to Follow-up|6|||
27784365|NCT02308124|54238468|FG000|Overall Study|Adverse Event|0|||
27784366|NCT02308124|54238469|FG001|Overall Study|Adverse Event|2|||
27784367|NCT02308124|54238470|FG002|Overall Study|Adverse Event|2|||
27784368|NCT02232061|54238478|FG000|Overall Study|Administrative problems|1|||
27784369|NCT02232061|54238478|FG000|Overall Study|Withdrawal by Subject|1|||
27784370|NCT02275481|54238484|FG000|Overall Study|Death|2|||
27784371|NCT02275481|54238485|FG001|Overall Study|Death|1|||
27784372|NCT02275481|54238484|FG000|Overall Study|Lost to Follow-up|2|||
27784373|NCT02275481|54238485|FG001|Overall Study|Lost to Follow-up|0|||
27784374|NCT02275481|54238484|FG000|Overall Study|Withdrawal by Subject|3|||
27784375|NCT02275481|54238485|FG001|Overall Study|Withdrawal by Subject|0|||
27784376|NCT02275481|54238484|FG000|Overall Study|all other reasons combined|2|||
27784377|NCT02275481|54238485|FG001|Overall Study|all other reasons combined|1|||
27784378|NCT02275481|54238484|FG000|Overall Study|Physician Decision|0|||
27784379|NCT02275481|54238485|FG001|Overall Study|Physician Decision|1|||
27784380|NCT02204449|54238493|FG000|Overall Study|Lost to Follow-up|7|||
27784381|NCT02204449|54238494|FG001|Overall Study|Lost to Follow-up|9|||
27784382|NCT02204449|54238493|FG000|Overall Study|Death|0|||
27784383|NCT02204449|54238494|FG001|Overall Study|Death|1|||
27784384|NCT02204449|54238493|FG000|Overall Study|Withdrawal by Subject|0|||
27784385|NCT02204449|54238494|FG001|Overall Study|Withdrawal by Subject|1|||
27784386|NCT02308046|54238502|FG000|Overall Study|Negative yeast culture at Baseline|32|||
27784387|NCT02308046|54238503|FG001|Overall Study|Negative yeast culture at Baseline|33|||
27784388|NCT02308046|54238502|FG000|Overall Study|Positive for STD at Baseline|1|||
27784389|NCT02308046|54238503|FG001|Overall Study|Positive for STD at Baseline|2|||
27784390|NCT02308046|54238502|FG000|Overall Study|Lost to Follow-up|1|||
27784391|NCT02308046|54238503|FG001|Overall Study|Lost to Follow-up|3|||
27784392|NCT02318693|54238511|FG000|Overall Study|Protocol Violation|0|||
27784393|NCT02318693|54238512|FG001|Overall Study|Protocol Violation|1|||
27784394|NCT02230891|54238521|FG000|Baseline|Did not meet inclusion|0|||
27784395|NCT02230891|54238522|FG001|Baseline|Did not meet inclusion|1|||
27784396|NCT02230891|54238523|FG002|Baseline|Did not meet inclusion|1|||
27784397|NCT02230891|54238521|FG000|2 Week|Withdrawal by Subject|2|||
27784398|NCT02230891|54238522|FG001|2 Week|Withdrawal by Subject|2|||
27784399|NCT02230891|54238523|FG002|2 Week|Withdrawal by Subject|0|||
27784400|NCT02230891|54238521|FG000|2 Week|Consent withdrawn|1|||
27784401|NCT02230891|54238522|FG001|2 Week|Consent withdrawn|0|||
27784402|NCT02230891|54238523|FG002|2 Week|Consent withdrawn|0|||
27784403|NCT02230891|54238521|FG000|6 Month|Withdrawal by Subject|1|||
27784404|NCT02230891|54238522|FG001|6 Month|Withdrawal by Subject|1|||
27784405|NCT02230891|54238523|FG002|6 Month|Withdrawal by Subject|1|||
27784406|NCT02230891|54238521|FG000|6 Month|Physician Decision|0|||
27784407|NCT02230891|54238522|FG001|6 Month|Physician Decision|2|||
27784408|NCT02230891|54238523|FG002|6 Month|Physician Decision|0|||
27784409|NCT02230891|54238521|FG000|12 Month|Death|1|||
27784410|NCT02230891|54238522|FG001|12 Month|Death|0|||
27784411|NCT02230891|54238523|FG002|12 Month|Death|0|||
27784412|NCT02230891|54238521|FG000|12 Month|Lost to Follow-up|0|||
27784413|NCT02230891|54238522|FG001|12 Month|Lost to Follow-up|1|||
27784414|NCT02230891|54238523|FG002|12 Month|Lost to Follow-up|0|||
27784415|NCT02230891|54238521|FG000|12 Month|Withdrawal by Subject|0|||
27784416|NCT02230891|54238522|FG001|12 Month|Withdrawal by Subject|2|||
27784417|NCT02230891|54238523|FG002|12 Month|Withdrawal by Subject|0|||
27784418|NCT02230891|54238521|FG000|18 Month End of Study|Death|0|||
27784419|NCT02230891|54238522|FG001|18 Month End of Study|Death|0|||
27784420|NCT02230891|54238523|FG002|18 Month End of Study|Death|1|||
27784421|NCT02230891|54238521|FG000|18 Month End of Study|Hear failure, lost to follow up|1|||
27784422|NCT02230891|54238522|FG001|18 Month End of Study|Hear failure, lost to follow up|0|||
27784423|NCT02230891|54238523|FG002|18 Month End of Study|Hear failure, lost to follow up|0|||
27784424|NCT01646138|54238538|FG000|Overall Study|Lost to Follow-up|0|||
27784425|NCT01646138|54238539|FG001|Overall Study|Lost to Follow-up|0|||
27784426|NCT01646138|54238540|FG002|Overall Study|Lost to Follow-up|0|||
27784427|NCT01646138|54238541|FG003|Overall Study|Lost to Follow-up|0|||
27784428|NCT01646138|54238542|FG004|Overall Study|Lost to Follow-up|2|||
27784429|NCT02204371|54238554|FG000|Overall Study|Adverse Event|1|||
27784430|NCT02274857|54238560|FG000|Overall Study|Adverse Event|1|||
27784431|NCT02274857|54238561|FG001|Overall Study|Adverse Event|0|||
27784432|NCT02274857|54238560|FG000|Overall Study|Death|1|||
27784433|NCT02274857|54238561|FG001|Overall Study|Death|2|||
27784434|NCT02274857|54238560|FG000|Overall Study|Lost to Follow-up|3|||
27784435|NCT02274857|54238561|FG001|Overall Study|Lost to Follow-up|0|||
27784436|NCT02274857|54238560|FG000|Overall Study|Physician Decision|2|||
27784437|NCT02274857|54238561|FG001|Overall Study|Physician Decision|0|||
27784438|NCT02274857|54238560|FG000|Overall Study|Trial screen failure|0|||
27784439|NCT02274857|54238561|FG001|Overall Study|Trial screen failure|2|||
27784440|NCT02274857|54238560|FG000|Overall Study|Withdrawal by Subject|11|||
27784441|NCT02274857|54238561|FG001|Overall Study|Withdrawal by Subject|2|||
27784442|NCT02274857|54238560|FG000|Overall Study|Other|2|||
27784443|NCT02274857|54238561|FG001|Overall Study|Other|0|||
27784444|NCT02302859|54238570|FG000|Overall Study|Lost Phone|1|||
27784445|NCT02302859|54238571|FG001|Overall Study|Lost Phone|1|||
27784446|NCT02302859|54238570|FG000|Overall Study|Withdrawal by Subject|0|||
27784447|NCT02302859|54238571|FG001|Overall Study|Withdrawal by Subject|1|||
27784448|NCT02274311|54238577|FG000|Three Months of Clomiphene Wash-out|Lost to Follow-up|1|||
27784449|NCT02316353|54238585|FG000|Overall Study|Pregnancy|1|||
27784450|NCT02316353|54238586|FG001|Overall Study|Pregnancy|3|||
27784451|NCT02316353|54238585|FG000|Overall Study|Adverse Event|1|||
27784452|NCT02316353|54238586|FG001|Overall Study|Adverse Event|3|||
27784453|NCT02316353|54238585|FG000|Overall Study|Withdrawal by Subject|6|||
27840971|NCT01453439|54328966|FG001|Treatment Phase|Suicidal Ideation|0|||
27840972|NCT01453439|54328965|FG000|Treatment Phase|Need for higher level of care|1|||
27840973|NCT01453439|54328966|FG001|Treatment Phase|Need for higher level of care|1|||
27840974|NCT01453439|54328965|FG000|Treatment Phase|Therapist conflict of interest|1|||
27840975|NCT01453439|54328966|FG001|Treatment Phase|Therapist conflict of interest|0|||
27840976|NCT01453439|54328965|FG000|Follow-up|Withdrawal by Subject|0|||
27840977|NCT01453439|54328966|FG001|Follow-up|Withdrawal by Subject|1|||
27840978|NCT01453439|54328965|FG000|Follow-up|Lost to Follow-up|5|||
27840979|NCT01453439|54328966|FG001|Follow-up|Lost to Follow-up|10|||
27840980|NCT01453361|54328972|FG000|Overall Study|Disease Progression|6|||
27840981|NCT01453361|54328972|FG000|Overall Study|Screen-Failures|10|||
27840982|NCT01585298|54328976|FG000|Overall Study|Study completion was not documented.|1|||
27840983|NCT01585298|54328976|FG000|Overall Study|Protocol deviation|1|||
27840984|NCT01585298|54328976|FG000|Overall Study|Administrative problems|4|||
27840985|NCT01585298|54328976|FG000|Overall Study|Lost to Follow-up|2|||
27840986|NCT01585298|54328976|FG000|Overall Study|Withdrawal by Subject|4|||
27840987|NCT01585298|54328976|FG000|Overall Study|Abnormal test procedure results|1|||
27840988|NCT01585298|54328976|FG000|Overall Study|Adverse Event|24|||
27840989|NCT01453205|54328983|FG000|Overall Study|Lost to Follow-up|3|||
27840990|NCT01453205|54328984|FG001|Overall Study|Lost to Follow-up|0|||
27840991|NCT01453205|54328985|FG002|Overall Study|Lost to Follow-up|1|||
27840992|NCT01453205|54328983|FG000|Overall Study|Withdrawal by Subject|8|||
27840993|NCT01453205|54328984|FG001|Overall Study|Withdrawal by Subject|3|||
27840994|NCT01453205|54328985|FG002|Overall Study|Withdrawal by Subject|0|||
27840995|NCT01453205|54328983|FG000|Overall Study|Death|24|||
27840996|NCT01453205|54328984|FG001|Overall Study|Death|22|||
27840997|NCT01453205|54328985|FG002|Overall Study|Death|18|||
27840998|NCT01453205|54328983|FG000|Overall Study|Other|45|||
27840999|NCT01453205|54328984|FG001|Overall Study|Other|27|||
27841000|NCT01453205|54328985|FG002|Overall Study|Other|35|||
27784454|NCT02316353|54238586|FG001|Overall Study|Withdrawal by Subject|2|||
27784455|NCT02273141|54238597|FG000|Overall Study|Adverse Event|0|||
27784456|NCT02273141|54238598|FG001|Overall Study|Adverse Event|1|||
27784457|NCT02273141|54238597|FG000|Overall Study|Lost to Follow-up|1|||
27784458|NCT02273141|54238598|FG001|Overall Study|Lost to Follow-up|3|||
27784459|NCT02273141|54238597|FG000|Overall Study|Withdrawal by Subject|10|||
27784460|NCT02273141|54238598|FG001|Overall Study|Withdrawal by Subject|15|||
27841001|NCT01453049|54328998|FG000|Overall Study|Protocol Violation|2|||
27841002|NCT01453049|54328999|FG001|Overall Study|Protocol Violation|5|||
27841003|NCT01453049|54328998|FG000|Overall Study|Lost to Follow-up|2|||
27841004|NCT01453049|54328999|FG001|Overall Study|Lost to Follow-up|1|||
27841005|NCT01453049|54328998|FG000|Overall Study|Withdrawn When Sponsor Terminated Study|35|||
27841006|NCT01453049|54328999|FG001|Overall Study|Withdrawn When Sponsor Terminated Study|36|||
27841007|NCT01453049|54328998|FG000|Overall Study|Withdrawal by Subject|1|||
27841008|NCT01453049|54328999|FG001|Overall Study|Withdrawal by Subject|0|||
27841009|NCT01453049|54328998|FG000|Overall Study|Randomized in Error|1|||
27841010|NCT01453049|54328999|FG001|Overall Study|Randomized in Error|0|||
27841011|NCT01452347|54329007|FG000|Overall Study|Adverse Event|2|||
27841012|NCT01452347|54329008|FG001|Overall Study|Adverse Event|1|||
27841013|NCT01452347|54329007|FG000|Overall Study|Non compliance protocol|2|||
27841014|NCT01452347|54329008|FG001|Overall Study|Non compliance protocol|0|||
27841015|NCT01452347|54329007|FG000|Overall Study|Lost to Follow-up|2|||
27841016|NCT01452347|54329008|FG001|Overall Study|Lost to Follow-up|0|||
27841017|NCT01452347|54329007|FG000|Overall Study|Withdrawal by Subject|3|||
27841018|NCT01452347|54329008|FG001|Overall Study|Withdrawal by Subject|3|||
27841019|NCT01452347|54329007|FG000|Overall Study|Not treated|6|||
27841020|NCT01452347|54329008|FG001|Overall Study|Not treated|3|||
27841021|NCT01452347|54329007|FG000|Overall Study|Other reason not defined above|2|||
27841022|NCT01452347|54329008|FG001|Overall Study|Other reason not defined above|0|||
27841023|NCT01451723|54329018|FG000|Overall Study|study halted|6|||
27841024|NCT01451723|54329019|FG001|Overall Study|study halted|5|||
27841025|NCT01451645|54329027|FG000|Overall Study|Protocol Violation|1|||
27841026|NCT01451645|54329028|FG001|Overall Study|Protocol Violation|0|||
27841027|NCT01451645|54329027|FG000|Overall Study|Adverse Event|0|||
27784461|NCT02273141|54238597|FG000|Overall Study|Various|6|||
27784462|NCT02273141|54238598|FG001|Overall Study|Various|6|||
27784463|NCT02314052|54238604|FG000|Cycle One|Adverse Event|0|||
27841028|NCT01451645|54329028|FG001|Overall Study|Adverse Event|3|||
27841029|NCT01451645|54329027|FG000|Overall Study|Withdrawal by Subject|4|||
27841030|NCT01451645|54329028|FG001|Overall Study|Withdrawal by Subject|2|||
27841031|NCT01451645|54329027|FG000|Overall Study|Lost to Follow-up|4|||
27841032|NCT01451645|54329028|FG001|Overall Study|Lost to Follow-up|3|||
27841033|NCT01450943|54329037|FG000|Overall Study|Screen failure, loss to follow-up|2|||
27841034|NCT01450943|54329038|FG001|Overall Study|Screen failure, loss to follow-up|7|||
27841035|NCT01450943|54329039|FG002|Overall Study|Screen failure, loss to follow-up|6|||
27841036|NCT01450631|54329053|FG000|Overall Study|Lost to Follow-up|2|||
27784464|NCT02314052|54238605|FG001|Cycle One|Adverse Event|0|||
27784465|NCT02314052|54238606|FG002|Cycle One|Adverse Event|0|||
27784466|NCT02314052|54238607|FG003|Cycle One|Adverse Event|1|||
27784467|NCT02314052|54238608|FG004|Cycle One|Adverse Event|0|||
27784468|NCT02314052|54238609|FG005|Cycle One|Adverse Event|0|||
27784469|NCT02279732|54238625|FG000|Overall Study|Death|23|||
27784470|NCT02279732|54238626|FG001|Overall Study|Death|20|||
27784471|NCT02279732|54238625|FG000|Overall Study|Disease Progression|13|||
27784472|NCT02279732|54238626|FG001|Overall Study|Disease Progression|3|||
27784473|NCT02279732|54238625|FG000|Overall Study|Withdrawal by Subject|2|||
27784474|NCT02279732|54238626|FG001|Overall Study|Withdrawal by Subject|7|||
27784475|NCT02279732|54238625|FG000|Overall Study|Adverse Event|1|||
27784476|NCT02279732|54238626|FG001|Overall Study|Adverse Event|2|||
27841037|NCT01450631|54329054|FG001|Overall Study|Lost to Follow-up|4|||
27841038|NCT01450631|54329053|FG000|Overall Study|Withdrawal by Subject|1|||
27841039|NCT01450631|54329054|FG001|Overall Study|Withdrawal by Subject|0|||
27841040|NCT01450007|54329063|FG000|Overall Study|Late exclusion before treatment|2|||
27841041|NCT01450007|54329064|FG001|Overall Study|Late exclusion before treatment|3|||
27841042|NCT01450007|54329065|FG002|Overall Study|Late exclusion before treatment|2|||
27841043|NCT01450007|54329063|FG000|Overall Study|Protocol Violation|0|||
27841044|NCT01450007|54329064|FG001|Overall Study|Protocol Violation|1|||
27841045|NCT01450007|54329065|FG002|Overall Study|Protocol Violation|1|||
27841046|NCT01450007|54329063|FG000|Overall Study|Adverse Event|0|||
27841047|NCT01450007|54329064|FG001|Overall Study|Adverse Event|1|||
27784477|NCT02279732|54238625|FG000|Overall Study|Administrative Reason By Sponsor|0|||
27784478|NCT02279732|54238626|FG001|Overall Study|Administrative Reason By Sponsor|2|||
27784479|NCT02279732|54238625|FG000|Overall Study|Study Drug Toxicity|2|||
27784480|NCT02279732|54238626|FG001|Overall Study|Study Drug Toxicity|0|||
27784481|NCT02279732|54238625|FG000|Overall Study|Lost to Follow-up|0|||
27784482|NCT02279732|54238626|FG001|Overall Study|Lost to Follow-up|1|||
27784483|NCT02279732|54238625|FG000|Overall Study|Maximum Clinical Benefit|1|||
27784484|NCT02279732|54238626|FG001|Overall Study|Maximum Clinical Benefit|0|||
27784485|NCT02279732|54238625|FG000|Overall Study|Subject Requested to Discontinue|0|||
27784486|NCT02279732|54238626|FG001|Overall Study|Subject Requested to Discontinue|1|||
27784487|NCT02279732|54238625|FG000|Overall Study|Other|53|||
27784488|NCT02279732|54238626|FG001|Overall Study|Other|67|||
27784489|NCT02279732|54238625|FG000|Overall Study|Other|3|||
27784490|NCT02279732|54238626|FG001|Overall Study|Other|3|||
27784491|NCT02279498|54238634|FG000|Overall Study|Adverse Event|3|||
27784492|NCT02279498|54238635|FG001|Overall Study|Adverse Event|0|||
27784493|NCT02279498|54238634|FG000|Overall Study|Lack of Efficacy|4|||
27784494|NCT02279498|54238635|FG001|Overall Study|Lack of Efficacy|0|||
27784495|NCT02279498|54238634|FG000|Overall Study|Lost to Follow-up|0|||
27784496|NCT02279498|54238635|FG001|Overall Study|Lost to Follow-up|1|||
27784497|NCT02279498|54238634|FG000|Overall Study|Withdrawal by Subject|9|||
27784498|NCT02279498|54238635|FG001|Overall Study|Withdrawal by Subject|2|||
27784499|NCT02279498|54238634|FG000|Overall Study|Undefined|2|||
27784500|NCT02279498|54238635|FG001|Overall Study|Undefined|1|||
27784501|NCT02307266|54238645|FG000|Overall Study|Adverse Event|3|||
27784502|NCT02307266|54238646|FG001|Overall Study|Adverse Event|1|||
27784503|NCT02307266|54238647|FG002|Overall Study|Adverse Event|5|||
27784504|NCT02307266|54238645|FG000|Overall Study|Withdrawal by Subject|2|||
27784505|NCT02307266|54238646|FG001|Overall Study|Withdrawal by Subject|0|||
27784506|NCT02307266|54238647|FG002|Overall Study|Withdrawal by Subject|1|||
27784507|NCT02307266|54238645|FG000|Overall Study|Lost to Follow-up|3|||
27784508|NCT02307266|54238646|FG001|Overall Study|Lost to Follow-up|0|||
27784509|NCT02307266|54238647|FG002|Overall Study|Lost to Follow-up|0|||
27784510|NCT02279420|54238655|FG000|Overall Study|Lost to Follow-up|23|||
27784511|NCT02278952|54238659|FG000|Overall Study|Insufficient Sample|6|||
27784512|NCT02278328|54238669|FG000|Neuropsych Screening|found ineligible on neuropsych|1|||
27784513|NCT02278328|54238670|FG001|Neuropsych Screening|found ineligible on neuropsych|0|||
27784514|NCT02278328|54238671|FG002|Neuropsych Screening|found ineligible on neuropsych|0|||
27841048|NCT01450007|54329065|FG002|Overall Study|Adverse Event|0|||
27841049|NCT01496365|54329080|FG000|Overall Study|Adverse Event|2|||
27784515|NCT02278328|54238669|FG000|Neuropsych Screening|Withdrawal by Subject|0|||
27784516|NCT02278328|54238670|FG001|Neuropsych Screening|Withdrawal by Subject|1|||
27784517|NCT02278328|54238671|FG002|Neuropsych Screening|Withdrawal by Subject|0|||
27784518|NCT02278328|54238669|FG000|Neuropsych Screening|incomplete consent|0|||
27784519|NCT02278328|54238670|FG001|Neuropsych Screening|incomplete consent|0|||
27841050|NCT01496365|54329081|FG001|Overall Study|Adverse Event|3|||
27841051|NCT01496365|54329082|FG002|Overall Study|Adverse Event|3|||
27841052|NCT01496365|54329083|FG003|Overall Study|Adverse Event|2|||
27784520|NCT02278328|54238671|FG002|Neuropsych Screening|incomplete consent|2|||
27784521|NCT02314637|54238679|FG000|Overall Study|Adverse Event|4|||
27784522|NCT02314637|54238680|FG001|Overall Study|Adverse Event|8|||
27784523|NCT02314637|54238679|FG000|Overall Study|Lack of Efficacy|1|||
27784524|NCT02314637|54238680|FG001|Overall Study|Lack of Efficacy|0|||
27784525|NCT02314637|54238679|FG000|Overall Study|Physician Decision|5|||
27784526|NCT02314637|54238680|FG001|Overall Study|Physician Decision|2|||
27784527|NCT02314637|54238679|FG000|Overall Study|Withdrawal by Subject|5|||
27784528|NCT02314637|54238680|FG001|Overall Study|Withdrawal by Subject|4|||
27784529|NCT02314637|54238679|FG000|Overall Study|Other Reason|1|||
27784530|NCT02314637|54238680|FG001|Overall Study|Other Reason|0|||
27784531|NCT01646645|54238686|FG000|Overall Study|No Treated|1|||
27784532|NCT01646645|54238686|FG000|Overall Study|Inevaluable Donor|29|||
27784533|NCT02272985|54238690|FG000|Overall Study|Withdrawal by Subject|1|||
27784534|NCT02272985|54238690|FG000|Overall Study|hip fracture|1|||
27784535|NCT02272985|54238690|FG000|Overall Study|kidney transplantation|1|||
27784536|NCT01644149|54238697|FG000|Overall Study|Withdrawal by Subject|1|||
27784537|NCT01644149|54238698|FG001|Overall Study|Withdrawal by Subject|0|||
27784538|NCT01644149|54238697|FG000|Overall Study|Lost to Follow-up|3|||
27784539|NCT01644149|54238698|FG001|Overall Study|Lost to Follow-up|1|||
27784540|NCT02313233|54238707|FG000|Overall Study|Withdrawal by Subject|1|||
27784541|NCT02313233|54238708|FG001|Overall Study|Withdrawal by Subject|2|||
27784542|NCT02313233|54238707|FG000|Overall Study|Administrative reason|1|||
27784543|NCT02313233|54238708|FG001|Overall Study|Administrative reason|1|||
27784544|NCT02305238|54238719|FG000|Overall Study|Death|2|||
27784545|NCT02305238|54238720|FG001|Overall Study|Death|1|||
27784546|NCT02305238|54238721|FG002|Overall Study|Death|0|||
27784547|NCT02305238|54238719|FG000|Overall Study|Progressive disease|4|||
27784548|NCT02305238|54238720|FG001|Overall Study|Progressive disease|4|||
27784549|NCT02305238|54238721|FG002|Overall Study|Progressive disease|0|||
27784550|NCT02305238|54238719|FG000|Overall Study|Logistical difficulties|1|||
27784551|NCT02305238|54238720|FG001|Overall Study|Logistical difficulties|3|||
27784552|NCT02305238|54238721|FG002|Overall Study|Logistical difficulties|0|||
27784553|NCT02305238|54238719|FG000|Overall Study|Protocol Violation|0|||
27784554|NCT02305238|54238720|FG001|Overall Study|Protocol Violation|3|||
27784555|NCT02305238|54238721|FG002|Overall Study|Protocol Violation|0|||
27784556|NCT02305238|54238719|FG000|Overall Study|Physician Decision|2|||
27784557|NCT02305238|54238720|FG001|Overall Study|Physician Decision|1|||
27784558|NCT02305238|54238721|FG002|Overall Study|Physician Decision|0|||
27784559|NCT02305238|54238719|FG000|Overall Study|Adverse Event|4|||
27784560|NCT02305238|54238720|FG001|Overall Study|Adverse Event|2|||
27784561|NCT02305238|54238721|FG002|Overall Study|Adverse Event|0|||
27784562|NCT02305238|54238719|FG000|Overall Study|Withdrawal by Subject|3|||
27784563|NCT02305238|54238720|FG001|Overall Study|Withdrawal by Subject|4|||
27784564|NCT02305238|54238721|FG002|Overall Study|Withdrawal by Subject|0|||
27784565|NCT02305238|54238719|FG000|Overall Study|Randomized failure|0|||
27784566|NCT02305238|54238720|FG001|Overall Study|Randomized failure|0|||
27784567|NCT02305238|54238721|FG002|Overall Study|Randomized failure|8|||
27784568|NCT02305238|54238719|FG000|Overall Study|Required procedure failed|0|||
27784569|NCT02305238|54238720|FG001|Overall Study|Required procedure failed|1|||
27784570|NCT02305238|54238721|FG002|Overall Study|Required procedure failed|0|||
27784571|NCT02313155|54238730|FG000|Overall Study|Lost to Follow-up|0|||
27784572|NCT02313155|54238731|FG001|Overall Study|Lost to Follow-up|1|||
27784573|NCT02204293|54238739|FG000|Core Study Part I|Met one or more exclusion criteria|1|||
27784574|NCT02204293|54238740|FG001|Core Study Part I|Met one or more exclusion criteria|0|||
27784575|NCT02204293|54238741|FG002|Core Study Part I|Met one or more exclusion criteria|0|||
27784576|NCT02204293|54238742|FG003|Core Study Part I|Met one or more exclusion criteria|0|||
27784577|NCT02204293|54238743|FG004|Core Study Part I|Met one or more exclusion criteria|0|||
27784578|NCT02204293|54238744|FG005|Core Study Part I|Met one or more exclusion criteria|0|||
27784579|NCT02204293|54238739|FG000|Core Study Part I|Adverse Event|1|||
27784580|NCT02204293|54238740|FG001|Core Study Part I|Adverse Event|0|||
27784581|NCT02204293|54238741|FG002|Core Study Part I|Adverse Event|0|||
27784582|NCT02204293|54238742|FG003|Core Study Part I|Adverse Event|0|||
27784583|NCT02204293|54238743|FG004|Core Study Part I|Adverse Event|0|||
27784584|NCT02204293|54238744|FG005|Core Study Part I|Adverse Event|0|||
27784585|NCT02204293|54238739|FG000|Core Study Part I|Physician Decision|0|||
27784586|NCT02204293|54238740|FG001|Core Study Part I|Physician Decision|3|||
27784587|NCT02204293|54238741|FG002|Core Study Part I|Physician Decision|0|||
27784588|NCT02204293|54238742|FG003|Core Study Part I|Physician Decision|0|||
27784589|NCT02204293|54238743|FG004|Core Study Part I|Physician Decision|0|||
27784590|NCT02204293|54238744|FG005|Core Study Part I|Physician Decision|0|||
27784591|NCT02204293|54238739|FG000|LTE Phase|Study Suspended|0|||
27841053|NCT01496365|54329084|FG004|Overall Study|Adverse Event|5|||
27784592|NCT02204293|54238740|FG001|LTE Phase|Study Suspended|0|||
27784593|NCT02204293|54238741|FG002|LTE Phase|Study Suspended|0|||
27784594|NCT02204293|54238742|FG003|LTE Phase|Study Suspended|0|||
27784595|NCT02204293|54238743|FG004|LTE Phase|Study Suspended|0|||
27784596|NCT02204293|54238744|FG005|LTE Phase|Study Suspended|7|||
27784597|NCT02304926|54238760|FG000|Overall Study|Lost to Follow-up|2|||
27784598|NCT02304926|54238761|FG001|Overall Study|Lost to Follow-up|1|||
27784599|NCT01646255|54238771|FG000|Overall Study|Adverse Event|7|||
27841054|NCT01496365|54329085|FG005|Overall Study|Adverse Event|6|||
27784600|NCT01646255|54238772|FG001|Overall Study|Adverse Event|8|||
27784601|NCT01646255|54238771|FG000|Overall Study|Lack of Efficacy|2|||
27784602|NCT01646255|54238772|FG001|Overall Study|Lack of Efficacy|0|||
27841055|NCT01496365|54329086|FG006|Overall Study|Adverse Event|4|||
27784603|NCT01646255|54238771|FG000|Overall Study|Withdrawal by Subject|10|||
27784604|NCT01646255|54238772|FG001|Overall Study|Withdrawal by Subject|6|||
27784605|NCT01646255|54238771|FG000|Overall Study|Compliance is not well|1|||
27784606|NCT01646255|54238772|FG001|Overall Study|Compliance is not well|0|||
27784607|NCT01646255|54238771|FG000|Overall Study|Inclusion Criteria Deviation|1|||
27784608|NCT01646255|54238772|FG001|Overall Study|Inclusion Criteria Deviation|0|||
27784609|NCT02304380|54238785|FG000|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
27784610|NCT02304380|54238786|FG001|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
27784611|NCT02304380|54238787|FG002|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
27784612|NCT02304380|54238788|FG003|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34|||
27784613|NCT02304380|54238789|FG004|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
27784614|NCT02304380|54238790|FG005|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
27784615|NCT02203591|54238812|FG000|Overall Study|Did not meet treatment day baseline|147|||
27784616|NCT02203591|54238813|FG001|Overall Study|Did not meet treatment day baseline|141|||
27784617|NCT02203591|54238814|FG002|Overall Study|Did not meet treatment day baseline|150|||
27784618|NCT02203591|54238815|FG003|Overall Study|Did not meet treatment day baseline|45|||
27784619|NCT02203591|54238816|FG004|Overall Study|Did not meet treatment day baseline|33|||
27784620|NCT02203591|54238817|FG005|Overall Study|Did not meet treatment day baseline|35|||
27784621|NCT02203591|54238818|FG006|Overall Study|Did not meet treatment day baseline|29|||
27784622|NCT02203591|54238819|FG007|Overall Study|Did not meet treatment day baseline|12|||
27784623|NCT02203591|54238812|FG000|Overall Study|Discontinued early due to compromised test sites|0|||
27784624|NCT02203591|54238813|FG001|Overall Study|Discontinued early due to compromised test sites|1|||
27784625|NCT02203591|54238814|FG002|Overall Study|Discontinued early due to compromised test sites|1|||
27784626|NCT02203591|54238815|FG003|Overall Study|Discontinued early due to compromised test sites|0|||
27784627|NCT02203591|54238816|FG004|Overall Study|Discontinued early due to compromised test sites|1|||
27784628|NCT02203591|54238817|FG005|Overall Study|Discontinued early due to compromised test sites|0|||
27784629|NCT02203591|54238818|FG006|Overall Study|Discontinued early due to compromised test sites|0|||
27784630|NCT02203591|54238819|FG007|Overall Study|Discontinued early due to compromised test sites|1|||
27784631|NCT01642277|54238843|FG000|Overall Study|Adverse Event|10|||
27784632|NCT01642277|54238844|FG001|Overall Study|Adverse Event|0|||
27784633|NCT01642277|54238843|FG000|Overall Study|Physician Decision|2|||
27784634|NCT01642277|54238844|FG001|Overall Study|Physician Decision|0|||
27784635|NCT01642277|54238843|FG000|Overall Study|Protocol Violation|1|||
27784636|NCT01642277|54238844|FG001|Overall Study|Protocol Violation|0|||
27784637|NCT01642277|54238843|FG000|Overall Study|Withdrawal by Subject|11|||
27784638|NCT01642277|54238844|FG001|Overall Study|Withdrawal by Subject|0|||
27784639|NCT02230189|54238854|FG000|Overall Study|Withdrawal by Subject|3|||
27784640|NCT02230189|54238855|FG001|Overall Study|Withdrawal by Subject|0|||
27784641|NCT02230189|54238856|FG002|Overall Study|Withdrawal by Subject|1|||
27784642|NCT02230189|54238854|FG000|Overall Study|Lost to Follow-up|1|||
27784643|NCT02230189|54238855|FG001|Overall Study|Lost to Follow-up|0|||
27784644|NCT02230189|54238856|FG002|Overall Study|Lost to Follow-up|0|||
27784645|NCT02230189|54238854|FG000|Overall Study|Physician Decision|1|||
27784646|NCT02230189|54238855|FG001|Overall Study|Physician Decision|0|||
27784647|NCT02230189|54238856|FG002|Overall Study|Physician Decision|0|||
27784648|NCT02304302|54238867|FG000|Overall Study|Adverse Event|2|||
27784649|NCT02304302|54238868|FG001|Overall Study|Adverse Event|3|||
27784650|NCT02304302|54238867|FG000|Overall Study|Lost to Follow-up|1|||
27784651|NCT02304302|54238868|FG001|Overall Study|Lost to Follow-up|4|||
27784652|NCT02304302|54238867|FG000|Overall Study|Removed from analysis due to low medication compliance|0|||
27784653|NCT02304302|54238868|FG001|Overall Study|Removed from analysis due to low medication compliance|1|||
27784654|NCT02276612|54238880|FG000|Overall Study|Death|1|||
27784655|NCT02276612|54238881|FG001|Overall Study|Death|0|||
27784656|NCT02276612|54238880|FG000|Overall Study|Pregnancy|1|||
27784657|NCT02276612|54238881|FG001|Overall Study|Pregnancy|0|||
27784658|NCT02276612|54238880|FG000|Overall Study|Withdrew Consent|1|||
27784659|NCT02276612|54238881|FG001|Overall Study|Withdrew Consent|0|||
27784660|NCT02276612|54238880|FG000|Overall Study|Lost to Follow-up|1|||
27784661|NCT02276612|54238881|FG001|Overall Study|Lost to Follow-up|0|||
27784662|NCT02301143|54238887|FG000|Induction Period|Enrolled But Not Treated|1|||
27784663|NCT02301143|54238888|FG001|Induction Period|Enrolled But Not Treated|0|||
27784664|NCT02301143|54238887|FG000|Induction Period|Death|1|||
27784665|NCT02301143|54238888|FG001|Induction Period|Death|0|||
27784666|NCT02301143|54238887|FG000|Induction Period|Adverse Event|22|||
27784667|NCT02301143|54238888|FG001|Induction Period|Adverse Event|0|||
27784668|NCT02301143|54238887|FG000|Induction Period|Progressive Disease|8|||
27841056|NCT01496365|54329080|FG000|Overall Study|Withdrawal by Subject|6|||
27784669|NCT02301143|54238888|FG001|Induction Period|Progressive Disease|0|||
27784670|NCT02301143|54238887|FG000|Induction Period|Withdrawal by Subject|3|||
27784671|NCT02301143|54238888|FG001|Induction Period|Withdrawal by Subject|0|||
27784672|NCT02301143|54238887|FG000|Induction Period|Noncompliance with Study Drug|1|||
27784673|NCT02301143|54238888|FG001|Induction Period|Noncompliance with Study Drug|0|||
27841057|NCT01496365|54329081|FG001|Overall Study|Withdrawal by Subject|6|||
27784674|NCT02301143|54238887|FG000|Induction Period|Physician Decision|4|||
27784675|NCT02301143|54238888|FG001|Induction Period|Physician Decision|0|||
27784676|NCT02301143|54238887|FG000|Induction Period|Symptomatic Deterioration|2|||
27784677|NCT02301143|54238888|FG001|Induction Period|Symptomatic Deterioration|0|||
27784678|NCT02301143|54238887|FG000|Induction Period|Protocol Violation|2|||
27784679|NCT02301143|54238888|FG001|Induction Period|Protocol Violation|0|||
27784680|NCT02301143|54238887|FG000|Induction Period|Other|1|||
27784681|NCT02301143|54238888|FG001|Induction Period|Other|0|||
27784682|NCT02301143|54238887|FG000|Investigator's Choice|Adverse Event|0|||
27784683|NCT02301143|54238888|FG001|Investigator's Choice|Adverse Event|3|||
27784684|NCT02301143|54238887|FG000|Investigator's Choice|Progressive Disease|0|||
27784685|NCT02301143|54238888|FG001|Investigator's Choice|Progressive Disease|3|||
27784686|NCT02301143|54238887|FG000|Investigator's Choice|Noncompliance With Study Drug|0|||
27784687|NCT02301143|54238888|FG001|Investigator's Choice|Noncompliance With Study Drug|1|||
27784688|NCT02301143|54238887|FG000|Investigator's Choice|Symptomatic Deterioration|0|||
27784689|NCT02301143|54238888|FG001|Investigator's Choice|Symptomatic Deterioration|1|||
27784690|NCT02301143|54238887|FG000|Investigator's Choice|Other|0|||
27784691|NCT02301143|54238888|FG001|Investigator's Choice|Other|1|||
27784692|NCT02301143|54238887|FG000|Investigator's Choice|Unresectable Surgery|0|||
27784693|NCT02301143|54238888|FG001|Investigator's Choice|Unresectable Surgery|1|||
27784694|NCT02276222|54238901|FG000|Overall Study|Adverse Event|62|||
27784695|NCT02276222|54238902|FG001|Overall Study|Adverse Event|11|||
27784696|NCT02276222|54238901|FG000|Overall Study|Death|3|||
27784697|NCT02276222|54238902|FG001|Overall Study|Death|4|||
27784698|NCT02276222|54238901|FG000|Overall Study|Lack of Efficacy|13|||
27784699|NCT02276222|54238902|FG001|Overall Study|Lack of Efficacy|3|||
27784700|NCT02276222|54238901|FG000|Overall Study|Protocol Violation|3|||
27784701|NCT02276222|54238902|FG001|Overall Study|Protocol Violation|2|||
27784702|NCT02276222|54238901|FG000|Overall Study|Withdrawal by Subject|79|||
27784703|NCT02276222|54238902|FG001|Overall Study|Withdrawal by Subject|33|||
27784704|NCT02276222|54238901|FG000|Overall Study|non compliance with study medication|6|||
27784705|NCT02276222|54238902|FG001|Overall Study|non compliance with study medication|2|||
27784706|NCT02276222|54238901|FG000|Overall Study|sponsor decision|0|||
27784707|NCT02276222|54238902|FG001|Overall Study|sponsor decision|3|||
27784708|NCT02276222|54238901|FG000|Overall Study|Lost to Follow-up|15|||
27784709|NCT02276222|54238902|FG001|Overall Study|Lost to Follow-up|5|||
27784710|NCT02276222|54238901|FG000|Overall Study|Physician Decision|2|||
27784711|NCT02276222|54238902|FG001|Overall Study|Physician Decision|1|||
27784712|NCT02276222|54238901|FG000|Overall Study|sheduling conflict|1|||
27784713|NCT02276222|54238902|FG001|Overall Study|sheduling conflict|0|||
27784714|NCT02276222|54238901|FG000|Overall Study|subject withdrew after randomization|1|||
27784715|NCT02276222|54238902|FG001|Overall Study|subject withdrew after randomization|0|||
27784716|NCT02275364|54238908|FG000|Period 1|Withdrawal by Subject|1|||
27784717|NCT02275364|54238909|FG001|Period 1|Withdrawal by Subject|0|||
27784718|NCT02275364|54238908|FG000|Period 1|Other reason|1|||
27784719|NCT02275364|54238909|FG001|Period 1|Other reason|0|||
27784720|NCT02275052|54238926|FG000|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
27784721|NCT02275052|54238927|FG001|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
27784722|NCT02275052|54238928|FG002|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
27784723|NCT02275052|54238929|FG003|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
27784724|NCT02275052|54238926|FG000|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
27784725|NCT02275052|54238927|FG001|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1|||
27784726|NCT02275052|54238928|FG002|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
27784727|NCT02275052|54238929|FG003|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
27784728|NCT02275052|54238926|FG000|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6|||
27784729|NCT02275052|54238927|FG001|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4|||
27784730|NCT02275052|54238928|FG002|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
27784731|NCT02275052|54238929|FG003|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
27784732|NCT02275052|54238926|FG000|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1|||
27784733|NCT02275052|54238927|FG001|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
27841058|NCT01496365|54329082|FG002|Overall Study|Withdrawal by Subject|0|||
27841059|NCT01496365|54329083|FG003|Overall Study|Withdrawal by Subject|1|||
27841060|NCT01496365|54329084|FG004|Overall Study|Withdrawal by Subject|3|||
27784734|NCT02275052|54238928|FG002|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
27784735|NCT02275052|54238929|FG003|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
27784736|NCT02275052|54238926|FG000|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2|||
27784737|NCT02275052|54238927|FG001|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
27784738|NCT02275052|54238928|FG002|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
27784739|NCT02275052|54238929|FG003|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
27841061|NCT01496365|54329085|FG005|Overall Study|Withdrawal by Subject|2|||
27784740|NCT02275052|54238926|FG000|Washout Period (12-17 Days)|Withdrawal by Subject|3|||
27841062|NCT01496365|54329086|FG006|Overall Study|Withdrawal by Subject|1|||
27784741|NCT02275052|54238927|FG001|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
27784742|NCT02275052|54238928|FG002|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
27784743|NCT02275052|54238929|FG003|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
27784744|NCT02275052|54238926|FG000|Washout Period (12-17 Days)|Lack of Efficacy|1|||
27784745|NCT02275052|54238927|FG001|Washout Period (12-17 Days)|Lack of Efficacy|0|||
27784746|NCT02275052|54238928|FG002|Washout Period (12-17 Days)|Lack of Efficacy|0|||
27784747|NCT02275052|54238929|FG003|Washout Period (12-17 Days)|Lack of Efficacy|0|||
27784748|NCT02275052|54238926|FG000|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
27784749|NCT02275052|54238927|FG001|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
27784750|NCT02275052|54238928|FG002|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3|||
27784751|NCT02275052|54238929|FG003|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2|||
27784752|NCT02275052|54238926|FG000|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
27784753|NCT02275052|54238927|FG001|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
27784754|NCT02275052|54238928|FG002|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
27784755|NCT02275052|54238929|FG003|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4|||
27784756|NCT02275052|54238926|FG000|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
27784757|NCT02275052|54238927|FG001|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
27784758|NCT02275052|54238928|FG002|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
27784759|NCT02275052|54238929|FG003|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6|||
27784760|NCT02275052|54238926|FG000|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
27784761|NCT02275052|54238927|FG001|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
27784762|NCT02275052|54238928|FG002|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
27784763|NCT02275052|54238929|FG003|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2|||
27784764|NCT02274038|54238935|FG000|Overall Study|Death|1|||
27784765|NCT02300558|54238941|FG000|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6|||
27784766|NCT02300558|54238941|FG000|Open-Label (OL) Extension Phase|Lack of Efficacy|2|||
27784767|NCT02300558|54238941|FG000|Open-Label (OL) Extension Phase|Withdrew Consent|1|||
27784768|NCT02300558|54238941|FG000|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29|||
27784769|NCT02273960|54238953|FG000|Short Term Period|Lost to Follow-up|1|||
27784770|NCT02273960|54238954|FG001|Short Term Period|Lost to Follow-up|0|||
27784771|NCT02273960|54238955|FG002|Short Term Period|Lost to Follow-up|0|||
27784772|NCT02273960|54238956|FG003|Short Term Period|Lost to Follow-up|0|||
27784773|NCT02273960|54238953|FG000|Short Term Period|Lack of Efficacy|0|||
27784774|NCT02273960|54238954|FG001|Short Term Period|Lack of Efficacy|0|||
27784775|NCT02273960|54238955|FG002|Short Term Period|Lack of Efficacy|0|||
27784776|NCT02273960|54238956|FG003|Short Term Period|Lack of Efficacy|1|||
27784777|NCT02273960|54238953|FG000|Short Term Period|ST complete, not entering LTE|4|||
27784778|NCT02273960|54238954|FG001|Short Term Period|ST complete, not entering LTE|6|||
27784779|NCT02273960|54238955|FG002|Short Term Period|ST complete, not entering LTE|4|||
27784780|NCT02273960|54238956|FG003|Short Term Period|ST complete, not entering LTE|5|||
27784781|NCT02273960|54238953|FG000|Long Term Extension|Death|0|||
27784782|NCT02273960|54238954|FG001|Long Term Extension|Death|0|||
27784783|NCT02273960|54238955|FG002|Long Term Extension|Death|0|||
27784784|NCT02273960|54238956|FG003|Long Term Extension|Death|1|||
27784785|NCT01646021|54238968|FG000|Overall Study|Death|77|||
27784786|NCT01646021|54238969|FG001|Overall Study|Death|83|||
27784787|NCT01646021|54238968|FG000|Overall Study|Study Terminated by Sponsor|50|||
27784788|NCT01646021|54238969|FG001|Overall Study|Study Terminated by Sponsor|41|||
27784789|NCT01646021|54238968|FG000|Overall Study|Lost to Follow-up|2|||
27784790|NCT01646021|54238969|FG001|Overall Study|Lost to Follow-up|2|||
27784791|NCT01646021|54238968|FG000|Overall Study|Withdrawal by Subject|10|||
27784792|NCT01646021|54238969|FG001|Overall Study|Withdrawal by Subject|15|||
27784793|NCT01750918|54238986|FG000|Overall Study|Last patient transitioned to a rollover protocol|0|||
27784794|NCT01750918|54238987|FG001|Overall Study|Last patient transitioned to a rollover protocol|0|||
27784795|NCT01750918|54238988|FG002|Overall Study|Last patient transitioned to a rollover protocol|5|||
27784796|NCT01750918|54238989|FG003|Overall Study|Last patient transitioned to a rollover protocol|2|||
27784797|NCT01750918|54238990|FG004|Overall Study|Last patient transitioned to a rollover protocol|0|||
27784798|NCT01750918|54238991|FG005|Overall Study|Last patient transitioned to a rollover protocol|2|||
27784799|NCT01750918|54238992|FG006|Overall Study|Last patient transitioned to a rollover protocol|1|||
27784800|NCT01750918|54238993|FG007|Overall Study|Last patient transitioned to a rollover protocol|1|||
27784801|NCT01750918|54238986|FG000|Overall Study|Lost to Follow-up|0|||
27784802|NCT01750918|54238987|FG001|Overall Study|Lost to Follow-up|0|||
27784803|NCT01750918|54238988|FG002|Overall Study|Lost to Follow-up|2|||
27784804|NCT01750918|54238989|FG003|Overall Study|Lost to Follow-up|2|||
27784805|NCT01750918|54238990|FG004|Overall Study|Lost to Follow-up|0|||
27784806|NCT01750918|54238991|FG005|Overall Study|Lost to Follow-up|0|||
27784807|NCT01750918|54238992|FG006|Overall Study|Lost to Follow-up|0|||
27784808|NCT01750918|54238993|FG007|Overall Study|Lost to Follow-up|1|||
27784809|NCT01750918|54238986|FG000|Overall Study|Withdrawal by Subject|0|||
27784810|NCT01750918|54238987|FG001|Overall Study|Withdrawal by Subject|0|||
27784811|NCT01750918|54238988|FG002|Overall Study|Withdrawal by Subject|1|||
27784812|NCT01750918|54238989|FG003|Overall Study|Withdrawal by Subject|2|||
27784813|NCT01750918|54238990|FG004|Overall Study|Withdrawal by Subject|1|||
27784814|NCT01750918|54238991|FG005|Overall Study|Withdrawal by Subject|1|||
27784815|NCT01750918|54238992|FG006|Overall Study|Withdrawal by Subject|2|||
27784816|NCT01750918|54238993|FG007|Overall Study|Withdrawal by Subject|2|||
27784817|NCT02300987|54239025|FG000|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1|||
27784818|NCT02300987|54239026|FG001|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0|||
27784819|NCT02300987|54239025|FG000|Primary Phase : Prior to Cross-over|Physician Decision|2|||
27784820|NCT02300987|54239026|FG001|Primary Phase : Prior to Cross-over|Physician Decision|0|||
27784821|NCT02300987|54239025|FG000|Primary Phase : Prior to Cross-over|progressive disease|3|||
27784822|NCT02300987|54239026|FG001|Primary Phase : Prior to Cross-over|progressive disease|2|||
27784823|NCT02300987|54239025|FG000|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1|||
27784824|NCT02300987|54239026|FG001|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0|||
27784825|NCT02300987|54239025|FG000|Secondary Phase : Cross-over to LEE011|Adverse Event|0|||
27784826|NCT02300987|54239026|FG001|Secondary Phase : Cross-over to LEE011|Adverse Event|1|||
27784827|NCT01750840|54239033|FG000|Overall Study|Lost to Follow-up|4|||
27784828|NCT01606228|54239038|FG000|Overall Study|Lost to Follow-up|20|||
27784829|NCT01606228|54239038|FG000|Overall Study|Withdrawal by Subject|3|||
27784830|NCT01606228|54239038|FG000|Overall Study|Non-compliant|3|||
27784831|NCT01606228|54239038|FG000|Overall Study|Lack of Efficacy|2|||
27784832|NCT01606228|54239038|FG000|Overall Study|Adverse Event|1|||
27784833|NCT01706536|54239047|FG000|Overall Study|Withdrawal by Subject|1|||
27784834|NCT01706536|54239048|FG001|Overall Study|Withdrawal by Subject|0|||
27784835|NCT01706536|54239049|FG002|Overall Study|Withdrawal by Subject|1|||
27784836|NCT01706536|54239050|FG003|Overall Study|Withdrawal by Subject|0|||
27784837|NCT01706536|54239051|FG004|Overall Study|Withdrawal by Subject|0|||
27784838|NCT01706536|54239047|FG000|Overall Study|Adverse Event|2|||
27784839|NCT01706536|54239048|FG001|Overall Study|Adverse Event|3|||
27784840|NCT01706536|54239049|FG002|Overall Study|Adverse Event|4|||
27784841|NCT01706536|54239050|FG003|Overall Study|Adverse Event|3|||
27784842|NCT01706536|54239051|FG004|Overall Study|Adverse Event|2|||
27784843|NCT01706536|54239047|FG000|Overall Study|Lack of Efficacy|1|||
27784844|NCT01706536|54239048|FG001|Overall Study|Lack of Efficacy|0|||
27784845|NCT01706536|54239049|FG002|Overall Study|Lack of Efficacy|0|||
27784846|NCT01706536|54239050|FG003|Overall Study|Lack of Efficacy|1|||
27784847|NCT01706536|54239051|FG004|Overall Study|Lack of Efficacy|0|||
27784848|NCT01706536|54239047|FG000|Overall Study|non compliance|0|||
27784849|NCT01706536|54239048|FG001|Overall Study|non compliance|1|||
27784850|NCT01706536|54239049|FG002|Overall Study|non compliance|0|||
27784851|NCT01706536|54239050|FG003|Overall Study|non compliance|0|||
27784852|NCT01706536|54239051|FG004|Overall Study|non compliance|0|||
27784853|NCT02269943|54239066|FG000|Treatment Period|Death|0|||
27784854|NCT02269943|54239067|FG001|Treatment Period|Death|1|||
27784855|NCT02269943|54239066|FG000|Treatment Period|Adverse Event|1|||
27784856|NCT02269943|54239067|FG001|Treatment Period|Adverse Event|10|||
27784857|NCT02269943|54239066|FG000|Treatment Period|Progressive Disease|5|||
27784858|NCT02269943|54239067|FG001|Treatment Period|Progressive Disease|17|||
27784859|NCT02269943|54239066|FG000|Treatment Period|Symptomatic Deterioration|0|||
27784860|NCT02269943|54239067|FG001|Treatment Period|Symptomatic Deterioration|2|||
27784861|NCT02269943|54239066|FG000|Follow-Up Survival Period|Death|3|||
27784862|NCT02269943|54239067|FG001|Follow-Up Survival Period|Death|16|||
27784863|NCT02269943|54239066|FG000|Follow-Up Survival Period|Lost to Follow-up|0|||
27784864|NCT02269943|54239067|FG001|Follow-Up Survival Period|Lost to Follow-up|2|||
27784865|NCT02269943|54239066|FG000|Follow-Up Survival Period|Alive|2|||
27784866|NCT02269943|54239067|FG001|Follow-Up Survival Period|Alive|8|||
27784867|NCT01706458|54239075|FG000|Overall Study|Physician Decision|3|||
27784868|NCT01706458|54239076|FG001|Overall Study|Physician Decision|4|||
27784869|NCT02269787|54239084|FG000|Overall Study|Lost to Follow-up|20|||
27784870|NCT02269787|54239085|FG001|Overall Study|Lost to Follow-up|6|||
27784871|NCT02269787|54239084|FG000|Overall Study|Death|2|||
27784872|NCT02269787|54239085|FG001|Overall Study|Death|3|||
27784873|NCT02269787|54239084|FG000|Overall Study|Incapacitated|0|||
27784874|NCT02269787|54239085|FG001|Overall Study|Incapacitated|1|||
27784875|NCT01605370|54239093|FG000|Overall Study|Adverse Event|1|||
27784876|NCT01605370|54239094|FG001|Overall Study|Adverse Event|0|||
27784877|NCT02269709|54239100|FG000|Time of Enrollment|Withdrawal by Subject|3|||
27784878|NCT02269709|54239100|FG000|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1|||
27784879|NCT02269709|54239100|FG000|Six Month Follow-up|Lost to Follow-up|12|||
27784880|NCT02269475|54239107|FG000|Overall Study|Meet Exclusion Criteria No. 17|3|||
27784881|NCT02269475|54239108|FG001|Overall Study|Meet Exclusion Criteria No. 17|0|||
27784882|NCT02269475|54239107|FG000|Overall Study|Withdrawal by Subject|0|||
27784883|NCT02269475|54239108|FG001|Overall Study|Withdrawal by Subject|1|||
27784884|NCT01605136|54239117|FG000|Study Period|Withdrawal by Subject|2|||
27784885|NCT01605136|54239118|FG001|Study Period|Withdrawal by Subject|0|||
27784886|NCT01605136|54239117|FG000|Study Period|Physician Decision|1|||
27784887|NCT01605136|54239118|FG001|Study Period|Physician Decision|1|||
27784888|NCT01605136|54239117|FG000|Study Period|Lost to Follow-up|0|||
27784889|NCT01605136|54239118|FG001|Study Period|Lost to Follow-up|2|||
27784890|NCT01605136|54239117|FG000|Safety Follow-Up Period|Withdrawal by Subject|1|||
27784891|NCT01605136|54239118|FG001|Safety Follow-Up Period|Withdrawal by Subject|2|||
27784892|NCT01706146|54239124|FG000|Overall Study|Withdrawal by Subject|1|||
27784893|NCT01706146|54239124|FG000|Overall Study|Adverse Event|3|||
27784894|NCT01706146|54239124|FG000|Overall Study|Developed AF and need for antiplatelets|2|||
27784895|NCT02269241|54239128|FG000|Overall Study|Lost to Follow-up|269|||
27784896|NCT02269241|54239128|FG000|Overall Study|Withdrawal by Subject|155|||
27784897|NCT02269241|54239128|FG000|Overall Study|Protocol Violation|1|||
27784898|NCT02269241|54239128|FG000|Overall Study|Physician Decision|7|||
27784899|NCT02269241|54239128|FG000|Overall Study|Pregnancy|15|||
27784900|NCT02269241|54239128|FG000|Overall Study|Wish for pregnancy|5|||
27784901|NCT02269241|54239128|FG000|Overall Study|Development of an exclusion criteria|16|||
27784902|NCT02269241|54239128|FG000|Overall Study|Adverse Event|113|||
27784903|NCT02269241|54239128|FG000|Overall Study|At the specific request of the sponsor|20|||
27784904|NCT02269241|54239128|FG000|Overall Study|Several reasons not classified|53|||
27784905|NCT02269241|54239128|FG000|Overall Study|Screening failures|546|||
27784906|NCT01750684|54239135|FG000|Overall Study|Death|1|||
27784907|NCT01750684|54239136|FG001|Overall Study|Death|0|||
27784908|NCT01750684|54239135|FG000|Overall Study|Non-compliance with Study Drug|0|||
27784909|NCT01750684|54239136|FG001|Overall Study|Non-compliance with Study Drug|1|||
27784910|NCT01750684|54239135|FG000|Overall Study|Withdrawn by Sponsor|0|||
27784911|NCT01750684|54239136|FG001|Overall Study|Withdrawn by Sponsor|1|||
27784912|NCT01750684|54239135|FG000|Overall Study|Protocol Violation|1|||
27784913|NCT01750684|54239136|FG001|Overall Study|Protocol Violation|0|||
27784914|NCT01750294|54239143|FG000|Overall Study|Withdrawal by Subject|1|||
27784915|NCT01750294|54239143|FG000|Overall Study|Safety Endpoint|1|||
27784916|NCT01749982|54239151|FG000|Overall Study|Physician Decision|0|||
27784917|NCT01749982|54239152|FG001|Overall Study|Physician Decision|0|||
27784918|NCT01749982|54239153|FG002|Overall Study|Physician Decision|0|||
27784919|NCT01749982|54239154|FG003|Overall Study|Physician Decision|1|||
27784920|NCT01749982|54239151|FG000|Overall Study|Lost to Follow-up|0|||
27784921|NCT01749982|54239152|FG001|Overall Study|Lost to Follow-up|0|||
27784922|NCT01749982|54239153|FG002|Overall Study|Lost to Follow-up|0|||
27784923|NCT01749982|54239154|FG003|Overall Study|Lost to Follow-up|1|||
27784924|NCT01749982|54239151|FG000|Overall Study|Withdrawal by Subject|0|||
27784925|NCT01749982|54239152|FG001|Overall Study|Withdrawal by Subject|0|||
27784926|NCT01749982|54239153|FG002|Overall Study|Withdrawal by Subject|0|||
27784927|NCT01749982|54239154|FG003|Overall Study|Withdrawal by Subject|1|||
27784928|NCT02269163|54239166|FG000|Overall Study|Lost to Follow-up|1|||
27784929|NCT02269163|54239167|FG001|Overall Study|Lost to Follow-up|0|||
27784930|NCT02269163|54239166|FG000|Overall Study|Major protocol violation|0|||
27784931|NCT02269163|54239167|FG001|Overall Study|Major protocol violation|1|||
27784932|NCT02269163|54239166|FG000|Overall Study|Other|2|||
27784933|NCT02269163|54239167|FG001|Overall Study|Other|2|||
27784934|NCT02269163|54239166|FG000|Overall Study|Withdrawal by Subject|0|||
27784935|NCT02269163|54239167|FG001|Overall Study|Withdrawal by Subject|3|||
27784936|NCT02269163|54239166|FG000|Overall Study|Physician Decision|0|||
27784937|NCT02269163|54239167|FG001|Overall Study|Physician Decision|1|||
27784938|NCT01749826|54239177|FG000|Overall Study|Study Terminated|20|||
27784939|NCT01749826|54239178|FG001|Overall Study|Study Terminated|0|||
27784940|NCT02300129|54239184|FG000|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
27784941|NCT02300129|54239185|FG001|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1|||
27784942|NCT02300129|54239186|FG002|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
27784943|NCT02300129|54239187|FG003|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
27784944|NCT02300129|54239184|FG000|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
27784945|NCT02300129|54239185|FG001|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
27784946|NCT02300129|54239186|FG002|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
27784947|NCT02300129|54239187|FG003|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1|||
27784948|NCT02300129|54239184|FG000|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1|||
27784949|NCT02300129|54239185|FG001|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
27784950|NCT02300129|54239186|FG002|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
27784951|NCT02300129|54239187|FG003|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
27784952|NCT02267135|54239199|FG000|Period 1 (Randomized Set)|Withdrawal by Subject|1|||
27784953|NCT02267135|54239200|FG001|Period 1 (Randomized Set)|Withdrawal by Subject|3|||
27784954|NCT02267135|54239199|FG000|Period 1 (Randomized Set)|Lost to Follow-up|0|||
27784955|NCT02267135|54239200|FG001|Period 1 (Randomized Set)|Lost to Follow-up|1|||
27784956|NCT02267135|54239199|FG000|Period 2 (Randomized Set)|Lost to Follow-up|1|||
27784957|NCT02267135|54239200|FG001|Period 2 (Randomized Set)|Lost to Follow-up|1|||
27784958|NCT02267135|54239199|FG000|Period 2 (Randomized Set)|Adverse Event|2|||
27784959|NCT02267135|54239200|FG001|Period 2 (Randomized Set)|Adverse Event|0|||
27784960|NCT02267135|54239199|FG000|Period 2 (Randomized Set)|Withdrawal by Subject|1|||
27784961|NCT02267135|54239200|FG001|Period 2 (Randomized Set)|Withdrawal by Subject|0|||
27784962|NCT02299427|54239211|FG000|Overall Study|Withdrawal by Subject|1|||
27784963|NCT02299427|54239212|FG001|Overall Study|Withdrawal by Subject|0|||
27784964|NCT02299427|54239211|FG000|Overall Study|Lost to Follow-up|1|||
27784965|NCT02299427|54239212|FG001|Overall Study|Lost to Follow-up|3|||
27784966|NCT02299427|54239211|FG000|Overall Study|not adherent to dog website use|21|||
27784967|NCT02299427|54239212|FG001|Overall Study|not adherent to dog website use|0|||
27784968|NCT01724866|54239222|FG000|Overall Study|Adverse Event|0|||
27784969|NCT01724866|54239223|FG001|Overall Study|Adverse Event|0|||
27784970|NCT01724866|54239224|FG002|Overall Study|Adverse Event|1|||
27784971|NCT01724866|54239225|FG003|Overall Study|Adverse Event|1|||
27784972|NCT01724866|54239222|FG000|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
27784973|NCT01724866|54239223|FG001|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|2|||
27784974|NCT01724866|54239224|FG002|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
27784975|NCT01724866|54239225|FG003|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
27784976|NCT01724866|54239222|FG000|Overall Study|Investigator's Discretion|0|||
27784977|NCT01724866|54239223|FG001|Overall Study|Investigator's Discretion|1|||
27784978|NCT01724866|54239224|FG002|Overall Study|Investigator's Discretion|1|||
27784979|NCT01724866|54239225|FG003|Overall Study|Investigator's Discretion|0|||
27784980|NCT01724866|54239222|FG000|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|1|||
27784981|NCT01724866|54239223|FG001|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
27784982|NCT01724866|54239224|FG002|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
27784983|NCT01724866|54239225|FG003|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
27784984|NCT01724866|54239222|FG000|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
27784985|NCT01724866|54239223|FG001|Overall Study|Participant Refused Further Treatment or Withdrew Consent|2|||
27784986|NCT01724866|54239224|FG002|Overall Study|Participant Refused Further Treatment or Withdrew Consent|1|||
27784987|NCT01724866|54239225|FG003|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
27784988|NCT02266433|54239237|FG000|Overall Study|Lost to Follow-up|54|||
27784989|NCT02266433|54239238|FG001|Overall Study|Lost to Follow-up|46|||
27784990|NCT02266433|54239237|FG000|Overall Study|Withdrawal by Subject|5|||
27784991|NCT02266433|54239238|FG001|Overall Study|Withdrawal by Subject|7|||
27784992|NCT01748890|54239245|FG000|Overall Study|Insufficient recruitment for analysis|4|||
27784993|NCT01747876|54239252|FG000|Overall Study|Adverse Event|1|||
27784994|NCT01747876|54239253|FG001|Overall Study|Adverse Event|0|||
27784995|NCT01747876|54239254|FG002|Overall Study|Adverse Event|2|||
27784996|NCT01747876|54239252|FG000|Overall Study|Withdrawal by Subject|0|||
27784997|NCT01747876|54239253|FG001|Overall Study|Withdrawal by Subject|1|||
27784998|NCT01747876|54239254|FG002|Overall Study|Withdrawal by Subject|1|||
27784999|NCT01747876|54239252|FG000|Overall Study|Disease progression|4|||
27785000|NCT01747876|54239253|FG001|Overall Study|Disease progression|13|||
27785001|NCT01747876|54239254|FG002|Overall Study|Disease progression|8|||
27785002|NCT01747876|54239252|FG000|Overall Study|Trtment duration compl. as per protocol|0|||
27785003|NCT01747876|54239253|FG001|Overall Study|Trtment duration compl. as per protocol|1|||
27785004|NCT01747876|54239254|FG002|Overall Study|Trtment duration compl. as per protocol|1|||
27785005|NCT02273726|54239267|FG000|Overall Study|Death|70|||
27785006|NCT02273726|54239268|FG001|Overall Study|Death|62|||
27785007|NCT02273726|54239267|FG000|Overall Study|Withdrawal by Subject|41|||
27785008|NCT02273726|54239268|FG001|Overall Study|Withdrawal by Subject|29|||
27785009|NCT02273726|54239267|FG000|Overall Study|Kidney transplant|31|||
27785010|NCT02273726|54239268|FG001|Overall Study|Kidney transplant|39|||
27785011|NCT02273726|54239267|FG000|Overall Study|Physician Decision|30|||
27785012|NCT02273726|54239268|FG001|Overall Study|Physician Decision|15|||
27785013|NCT02273726|54239267|FG000|Overall Study|Adverse Event|27|||
27785014|NCT02273726|54239268|FG001|Overall Study|Adverse Event|9|||
27785015|NCT02273726|54239267|FG000|Overall Study|Lost to Follow-up|6|||
27785016|NCT02273726|54239268|FG001|Overall Study|Lost to Follow-up|3|||
27785017|NCT02273726|54239267|FG000|Overall Study|Lack of Efficacy|6|||
27785018|NCT02273726|54239268|FG001|Overall Study|Lack of Efficacy|1|||
27785019|NCT02273726|54239267|FG000|Overall Study|Protocol Violation|4|||
27785020|NCT02273726|54239268|FG001|Overall Study|Protocol Violation|0|||
27785021|NCT02273726|54239267|FG000|Overall Study|Other than specified|28|||
27785022|NCT02273726|54239268|FG001|Overall Study|Other than specified|30|||
27785023|NCT01723228|54239276|FG000|Overall Study|Adverse Event|2|||
27785024|NCT01723228|54239277|FG001|Overall Study|Adverse Event|6|||
27785025|NCT01723228|54239276|FG000|Overall Study|Withdrawal by Subject|2|||
27785026|NCT01723228|54239277|FG001|Overall Study|Withdrawal by Subject|1|||
27785027|NCT01723228|54239276|FG000|Overall Study|Protocol Violation|0|||
27785028|NCT01723228|54239277|FG001|Overall Study|Protocol Violation|2|||
27785029|NCT01723228|54239276|FG000|Overall Study|Lost to Follow-up|2|||
27785030|NCT01723228|54239277|FG001|Overall Study|Lost to Follow-up|1|||
27785031|NCT01723228|54239276|FG000|Overall Study|Other|2|||
27785032|NCT01723228|54239277|FG001|Overall Study|Other|1|||
27785033|NCT02273180|54239285|FG000|Overall Study|Adverse Event|2|||
27785034|NCT02273180|54239286|FG001|Overall Study|Adverse Event|2|||
27785035|NCT02273180|54239285|FG000|Overall Study|Lack of Efficacy|1|||
27785036|NCT02273180|54239286|FG001|Overall Study|Lack of Efficacy|0|||
27785037|NCT02273180|54239285|FG000|Overall Study|Protocol Violation|1|||
27785038|NCT02273180|54239286|FG001|Overall Study|Protocol Violation|7|||
27785039|NCT02273180|54239285|FG000|Overall Study|Randomized but not treated|1|||
27785040|NCT02273180|54239286|FG001|Overall Study|Randomized but not treated|0|||
27785041|NCT02273180|54239285|FG000|Overall Study|Hypoglycemia(not reported as serious AE)|1|||
27785042|NCT02273180|54239286|FG001|Overall Study|Hypoglycemia(not reported as serious AE)|0|||
27785043|NCT02273180|54239285|FG000|Overall Study|Other than specified above|21|||
27785044|NCT02273180|54239286|FG001|Overall Study|Other than specified above|10|||
27785045|NCT01746862|54239294|FG000|Overall Study|Withdrawal by Subject|1|||
27785046|NCT01746862|54239295|FG001|Overall Study|Withdrawal by Subject|1|||
27785047|NCT01746862|54239294|FG000|Overall Study|Protocol Violation|1|||
27785048|NCT01746862|54239295|FG001|Overall Study|Protocol Violation|0|||
27785049|NCT01746862|54239294|FG000|Overall Study|Consent withdrawal by parent's guardian|5|||
27785050|NCT01746862|54239295|FG001|Overall Study|Consent withdrawal by parent's guardian|2|||
27785051|NCT01746862|54239294|FG000|Overall Study|Entered puberty during the study|1|||
27785052|NCT01746862|54239295|FG001|Overall Study|Entered puberty during the study|0|||
27785053|NCT01745848|54239302|FG000|Overall Study|Adverse Event|6|||
27785054|NCT01745380|54239308|FG000|Overall Study|Lost to Follow-up|1|||
27785055|NCT01745380|54239309|FG001|Overall Study|Lost to Follow-up|0|||
27785056|NCT01745380|54239308|FG000|Overall Study|Lack of Efficacy|0|||
27785057|NCT01745380|54239309|FG001|Overall Study|Lack of Efficacy|1|||
27785058|NCT01745146|54239317|FG000|Overall Study|Withdrawal by Subject|1|||
27785059|NCT01745146|54239318|FG001|Overall Study|Withdrawal by Subject|3|||
27785060|NCT01745146|54239317|FG000|Overall Study|Lost to Follow-up|2|||
27785061|NCT01745146|54239318|FG001|Overall Study|Lost to Follow-up|0|||
27785062|NCT02203513|54239330|FG000|Overall Study|Refused further treatment|2|||
27785063|NCT02203513|54239331|FG001|Overall Study|Refused further treatment|0|||
27785064|NCT02203513|54239332|FG002|Overall Study|Refused further treatment|1|||
27785065|NCT02203513|54239333|FG003|Overall Study|Refused further treatment|0|||
27785066|NCT02203513|54239334|FG004|Overall Study|Refused further treatment|0|||
27785067|NCT02203513|54239330|FG000|Overall Study|Switched to alternative treatment|3|||
27785068|NCT02203513|54239331|FG001|Overall Study|Switched to alternative treatment|4|||
27785069|NCT02203513|54239332|FG002|Overall Study|Switched to alternative treatment|0|||
27785070|NCT02203513|54239333|FG003|Overall Study|Switched to alternative treatment|0|||
27785071|NCT02203513|54239334|FG004|Overall Study|Switched to alternative treatment|4|||
27785072|NCT02203513|54239330|FG000|Overall Study|Did not receive investigational product (IP)|0|||
27785073|NCT02203513|54239331|FG001|Overall Study|Did not receive investigational product (IP)|1|||
27785074|NCT02203513|54239332|FG002|Overall Study|Did not receive investigational product (IP)|0|||
27785075|NCT02203513|54239333|FG003|Overall Study|Did not receive investigational product (IP)|0|||
27785076|NCT02203513|54239334|FG004|Overall Study|Did not receive investigational product (IP)|0|||
27785077|NCT02203513|54239330|FG000|Overall Study|Death (unrelated to study therapy)|1|||
27785078|NCT02203513|54239331|FG001|Overall Study|Death (unrelated to study therapy)|3|||
27785079|NCT02203513|54239332|FG002|Overall Study|Death (unrelated to study therapy)|1|||
27785080|NCT02203513|54239333|FG003|Overall Study|Death (unrelated to study therapy)|0|||
27785081|NCT02203513|54239334|FG004|Overall Study|Death (unrelated to study therapy)|2|||
27785082|NCT02203513|54239330|FG000|Overall Study|Lost to Follow-up|0|||
27785083|NCT02203513|54239331|FG001|Overall Study|Lost to Follow-up|0|||
27785084|NCT02203513|54239332|FG002|Overall Study|Lost to Follow-up|1|||
27785085|NCT02203513|54239333|FG003|Overall Study|Lost to Follow-up|1|||
27785086|NCT02203513|54239334|FG004|Overall Study|Lost to Follow-up|0|||
27785087|NCT02299934|54239348|FG000|Overall Study|Termination of study|13|||
27785088|NCT01703260|54239355|FG000|Overall Study|Adverse Event|1|||
27785089|NCT01703260|54239356|FG001|Overall Study|Adverse Event|2|||
27785090|NCT01703260|54239357|FG002|Overall Study|Adverse Event|2|||
27785091|NCT01703260|54239355|FG000|Overall Study|Lost to Follow-up|1|||
27785092|NCT01703260|54239356|FG001|Overall Study|Lost to Follow-up|0|||
27785093|NCT01703260|54239357|FG002|Overall Study|Lost to Follow-up|0|||
27785094|NCT01703260|54239355|FG000|Overall Study|Withdrawal by Subject|0|||
27785095|NCT01703260|54239356|FG001|Overall Study|Withdrawal by Subject|0|||
27785096|NCT01703260|54239357|FG002|Overall Study|Withdrawal by Subject|1|||
27785097|NCT01703260|54239355|FG000|Overall Study|Study Termination|1|||
27785098|NCT01703260|54239356|FG001|Overall Study|Study Termination|2|||
27785099|NCT01703260|54239357|FG002|Overall Study|Study Termination|0|||
27785100|NCT02203357|54239368|FG000|Overall Study|Lost to Follow-up|58|||
27785101|NCT02203357|54239369|FG001|Overall Study|Lost to Follow-up|66|||
27785102|NCT02203357|54239370|FG002|Overall Study|Lost to Follow-up|70|||
27785103|NCT02299388|54239383|FG000|Overall Study|Withdrawal by Subject|0|||
27785104|NCT02299388|54239384|FG001|Overall Study|Withdrawal by Subject|1|||
27785105|NCT02202577|54239392|FG000|Overall Study|Lost to Follow-up|6|||
27785106|NCT02202577|54239393|FG001|Overall Study|Lost to Follow-up|16|||
27785107|NCT02202577|54239392|FG000|Overall Study|Protocol Violation|7|||
27785108|NCT02202577|54239393|FG001|Overall Study|Protocol Violation|3|||
27785109|NCT02299076|54239401|FG000|Overall Study|Fraudulent Entries|20|||
27785110|NCT02299076|54239402|FG001|Overall Study|Fraudulent Entries|14|||
27785111|NCT01723072|54239410|FG000|Overall Study|Withdrawal by Subject|7|||
27785112|NCT01723072|54239411|FG001|Overall Study|Withdrawal by Subject|13|||
27785113|NCT01723072|54239410|FG000|Overall Study|Discon for rescue medication after wk 24|0|||
27785114|NCT01723072|54239411|FG001|Overall Study|Discon for rescue medication after wk 24|5|||
27785115|NCT01723072|54239410|FG000|Overall Study|Other|4|||
27785116|NCT01723072|54239411|FG001|Overall Study|Other|3|||
27785117|NCT01722994|54239419|FG000|Overall Study|Missing data|25|||
27785118|NCT01722994|54239420|FG001|Overall Study|Missing data|17|||
27785119|NCT02228395|54239428|FG000|First Intervention Period|No longer willing to participate|1|||
27785120|NCT02228395|54239429|FG001|First Intervention Period|No longer willing to participate|0|||
27785121|NCT02228395|54239430|FG002|First Intervention Period|No longer willing to participate|0|||
27785122|NCT02228395|54239428|FG000|First Intervention Period|Unable to comply with study dates|0|||
27785123|NCT02228395|54239429|FG001|First Intervention Period|Unable to comply with study dates|1|||
27785124|NCT02228395|54239430|FG002|First Intervention Period|Unable to comply with study dates|1|||
27785125|NCT02170051|54239442|FG000|Overall Study|Withdrawal by Subject|10|||
27785126|NCT02170051|54239443|FG001|Overall Study|Withdrawal by Subject|10|||
27785127|NCT02170051|54239442|FG000|Overall Study|Lost to Follow-up|1|||
27785128|NCT02170051|54239443|FG001|Overall Study|Lost to Follow-up|3|||
27785129|NCT02169739|54239451|FG000|Overall Study|Lost to Follow-up|0|||
27785130|NCT02169739|54239452|FG001|Overall Study|Lost to Follow-up|4|||
27785131|NCT02169505|54239459|FG000|Overall Study|Withdrawal by Subject|1|||
27785132|NCT01909791|54239466|FG000|Overall Study|Death|9|||
27785133|NCT01909791|54239467|FG001|Overall Study|Death|8|||
27785134|NCT01909791|54239468|FG002|Overall Study|Death|4|||
27785135|NCT01909791|54239466|FG000|Overall Study|Withdrawal by Subject|5|||
27785136|NCT01909791|54239467|FG001|Overall Study|Withdrawal by Subject|9|||
27785137|NCT01909791|54239468|FG002|Overall Study|Withdrawal by Subject|13|||
27785138|NCT01909791|54239466|FG000|Overall Study|Lost to Follow-up|5|||
27785139|NCT01909791|54239467|FG001|Overall Study|Lost to Follow-up|11|||
27785140|NCT01909791|54239468|FG002|Overall Study|Lost to Follow-up|10|||
27785141|NCT01909791|54239466|FG000|Overall Study|Missed Visit|2|||
27785142|NCT01909791|54239467|FG001|Overall Study|Missed Visit|0|||
27785143|NCT01909791|54239468|FG002|Overall Study|Missed Visit|1|||
27785144|NCT02202499|54239484|FG000|Overall Study|Cancer diagnosis|0|||
27785145|NCT02202499|54239485|FG001|Overall Study|Cancer diagnosis|0|||
27785146|NCT02202499|54239486|FG002|Overall Study|Cancer diagnosis|1|||
27785147|NCT02202499|54239484|FG000|Overall Study|Moved from area|0|||
27785148|NCT02202499|54239485|FG001|Overall Study|Moved from area|0|||
27785149|NCT02202499|54239486|FG002|Overall Study|Moved from area|1|||
27785150|NCT02202499|54239484|FG000|Overall Study|Declined before randomization|1|||
27785151|NCT02202499|54239485|FG001|Overall Study|Declined before randomization|0|||
27785152|NCT02202499|54239486|FG002|Overall Study|Declined before randomization|0|||
27785153|NCT02202499|54239484|FG000|Overall Study|Auto accident|1|||
27785154|NCT02202499|54239485|FG001|Overall Study|Auto accident|0|||
27785155|NCT02202499|54239486|FG002|Overall Study|Auto accident|0|||
27785156|NCT02202109|54239501|FG000|Overall Study|Lost to Follow-up|88|||
27785157|NCT02202109|54239502|FG001|Overall Study|Lost to Follow-up|87|||
27785158|NCT02202109|54239501|FG000|Overall Study|Withdrawal by Subject|2|||
27785159|NCT02202109|54239502|FG001|Overall Study|Withdrawal by Subject|0|||
27785160|NCT02227849|54239508|FG000|Overall Study|Adverse Event|4|||
27785161|NCT02227849|54239508|FG000|Overall Study|Physician Decision|1|||
27785162|NCT02227849|54239508|FG000|Overall Study|Withdrawal by Subject|3|||
27785163|NCT01927497|54239514|FG000|Overall Study|Death|0|||
27785164|NCT01927497|54239515|FG001|Overall Study|Death|1|||
27785165|NCT01927497|54239514|FG000|Overall Study|Protocol Violation|2|||
27785166|NCT01927497|54239515|FG001|Overall Study|Protocol Violation|0|||
27785167|NCT02169271|54239523|FG000|Overall Study|Protocol Violation|1|||
27785168|NCT02169271|54239524|FG001|Overall Study|Protocol Violation|2|||
27785169|NCT02202031|54239532|FG000|Overall Study|Lost to Follow-up|1|||
27785170|NCT02202031|54239533|FG001|Overall Study|Lost to Follow-up|0|||
27785171|NCT02202031|54239532|FG000|Overall Study|Too Busy|1|||
27785172|NCT02202031|54239533|FG001|Overall Study|Too Busy|3|||
27785173|NCT02202031|54239532|FG000|Overall Study|Illness/Medical Reason|0|||
27785174|NCT02202031|54239533|FG001|Overall Study|Illness/Medical Reason|2|||
27785175|NCT02202031|54239532|FG000|Overall Study|Intolerance/Lack of Improvement|3|||
27785176|NCT02202031|54239533|FG001|Overall Study|Intolerance/Lack of Improvement|0|||
27785177|NCT01644188|54239541|FG000|Overall Study|Adverse Event|44|||
27785178|NCT01644188|54239542|FG001|Overall Study|Adverse Event|20|||
27785179|NCT01644188|54239541|FG000|Overall Study|Poor compliance to protocol|26|||
27785180|NCT01644188|54239542|FG001|Overall Study|Poor compliance to protocol|14|||
27785181|NCT01644188|54239541|FG000|Overall Study|Physician Decision|1|||
27785182|NCT01644188|54239542|FG001|Overall Study|Physician Decision|3|||
27785183|NCT01644188|54239541|FG000|Overall Study|Participant moved|7|||
27785184|NCT01644188|54239542|FG001|Overall Study|Participant moved|2|||
27785185|NCT01644188|54239541|FG000|Overall Study|Related to auto-injector administration|2|||
27785186|NCT01644188|54239542|FG001|Overall Study|Related to auto-injector administration|2|||
27785187|NCT01644188|54239541|FG000|Overall Study|Consent withdrawn by participant|14|||
27785188|NCT01644188|54239542|FG001|Overall Study|Consent withdrawn by participant|7|||
27785189|NCT01644188|54239541|FG000|Overall Study|Selection criteria finally not met|2|||
27785190|NCT01644188|54239542|FG001|Overall Study|Selection criteria finally not met|0|||
27785191|NCT01644188|54239541|FG000|Overall Study|Lost to Follow-up|1|||
27785192|NCT01644188|54239542|FG001|Overall Study|Lost to Follow-up|0|||
27785193|NCT01644188|54239541|FG000|Overall Study|Death|4|||
27785194|NCT01644188|54239542|FG001|Overall Study|Death|3|||
27785195|NCT01644188|54239541|FG000|Overall Study|Last visit outside protocol visit window|14|||
27785196|NCT01644188|54239542|FG001|Overall Study|Last visit outside protocol visit window|16|||
27785197|NCT01644188|54239541|FG000|Overall Study|Site closure|1|||
27785198|NCT01644188|54239542|FG001|Overall Study|Site closure|1|||
27785199|NCT01644188|54239541|FG000|Overall Study|Other than specified above|6|||
27785200|NCT01644188|54239542|FG001|Overall Study|Other than specified above|7|||
27785201|NCT02201953|54239550|FG000|Overall Study|Randomized but Never Treated|1|||
27785202|NCT02201953|54239551|FG001|Overall Study|Randomized but Never Treated|5|||
27785203|NCT02201953|54239550|FG000|Overall Study|Lack of Efficacy|9|||
27785204|NCT02201953|54239551|FG001|Overall Study|Lack of Efficacy|30|||
27785205|NCT02201953|54239550|FG000|Overall Study|Lost to Follow-up|8|||
27785206|NCT02201953|54239551|FG001|Overall Study|Lost to Follow-up|8|||
27785207|NCT02201953|54239550|FG000|Overall Study|Withdrew Consent|2|||
27785208|NCT02201953|54239551|FG001|Overall Study|Withdrew Consent|5|||
27785209|NCT02201953|54239550|FG000|Overall Study|Adverse Event|0|||
27785210|NCT02201953|54239551|FG001|Overall Study|Adverse Event|5|||
27785211|NCT02201953|54239550|FG000|Overall Study|Death|0|||
27785212|NCT02201953|54239551|FG001|Overall Study|Death|3|||
27785213|NCT02271854|54239557|FG000|Overall Study|Withdrawal by Subject|2|||
27785214|NCT02271854|54239557|FG000|Overall Study|Unable or unwilling to cooperate with st|1|||
27785215|NCT02271854|54239557|FG000|Overall Study|Lost to Follow-up|1|||
27785216|NCT02296892|54239565|FG000|Overall Study|Exclusion Criteria at Day of Procedure|7|||
27785217|NCT02296892|54239566|FG001|Overall Study|Exclusion Criteria at Day of Procedure|4|||
27785218|NCT02296892|54239567|FG002|Overall Study|Exclusion Criteria at Day of Procedure|4|||
27785219|NCT02296892|54239565|FG000|Overall Study|Lost to Follow-up|5|||
27785220|NCT02296892|54239566|FG001|Overall Study|Lost to Follow-up|0|||
27785221|NCT02296892|54239567|FG002|Overall Study|Lost to Follow-up|1|||
27785222|NCT02270684|54239577|FG000|Overall Study|Lost to Follow-up|0|||
27785223|NCT02270684|54239578|FG001|Overall Study|Lost to Follow-up|3|||
27785224|NCT02270684|54239577|FG000|Overall Study|Study terminated|1|||
27785225|NCT02270684|54239578|FG001|Overall Study|Study terminated|0|||
27785226|NCT02168803|54239587|FG000|Overall Study|Lost to Follow-up|1|||
27785227|NCT02168803|54239588|FG001|Overall Study|Lost to Follow-up|0|||
27785228|NCT02168803|54239589|FG002|Overall Study|Lost to Follow-up|1|||
27785229|NCT02168803|54239587|FG000|Overall Study|Withdrawal by Subject|1|||
27785230|NCT02168803|54239588|FG001|Overall Study|Withdrawal by Subject|1|||
27785231|NCT02168803|54239589|FG002|Overall Study|Withdrawal by Subject|2|||
27785232|NCT02168803|54239587|FG000|Overall Study|Physician Decision|0|||
27785233|NCT02168803|54239588|FG001|Overall Study|Physician Decision|1|||
27785234|NCT02168803|54239589|FG002|Overall Study|Physician Decision|0|||
27785235|NCT02168803|54239587|FG000|Overall Study|Adverse Event|0|||
27785236|NCT02168803|54239588|FG001|Overall Study|Adverse Event|1|||
27785237|NCT02168803|54239589|FG002|Overall Study|Adverse Event|1|||
27785238|NCT02168803|54239587|FG000|Overall Study|Death|0|||
27785239|NCT02168803|54239588|FG001|Overall Study|Death|0|||
27785240|NCT02168803|54239589|FG002|Overall Study|Death|1|||
27785241|NCT02168803|54239587|FG000|Overall Study|Sponsor Decision|0|||
27785242|NCT02168803|54239588|FG001|Overall Study|Sponsor Decision|0|||
27785243|NCT02168803|54239589|FG002|Overall Study|Sponsor Decision|1|||
27785244|NCT02201329|54239604|FG000|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3|||
27785245|NCT02201329|54239604|FG000|Overall Study|Withdrawal by Subject|2|||
27785246|NCT01927419|54239610|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
27785247|NCT01927419|54239611|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
27841063|NCT01496365|54329080|FG000|Overall Study|Protocol Violation|2|||
27841064|NCT01496365|54329081|FG001|Overall Study|Protocol Violation|1|||
27785248|NCT01927419|54239610|FG000|Pre-Treatment Period|Participants no longer meeting study criteria|1|||
27785249|NCT01927419|54239611|FG001|Pre-Treatment Period|Participants no longer meeting study criteria|0|||
27785250|NCT01927419|54239610|FG000|Treatment Period|Disease progression|17|||
27785251|NCT01927419|54239611|FG001|Treatment Period|Disease progression|20|||
27785252|NCT01927419|54239610|FG000|Treatment Period|Study drug toxicity|48|||
27785253|NCT01927419|54239611|FG001|Treatment Period|Study drug toxicity|10|||
27785254|NCT01927419|54239610|FG000|Treatment Period|Death|0|||
27785255|NCT01927419|54239611|FG001|Treatment Period|Death|1|||
27785256|NCT01927419|54239610|FG000|Treatment Period|Adverse event unrelated to study drug|6|||
27785257|NCT01927419|54239611|FG001|Treatment Period|Adverse event unrelated to study drug|3|||
27841065|NCT01496365|54329082|FG002|Overall Study|Protocol Violation|1|||
27785258|NCT01927419|54239610|FG000|Treatment Period|Participant request to discontinue|12|||
27785259|NCT01927419|54239611|FG001|Treatment Period|Participant request to discontinue|4|||
27785260|NCT01927419|54239610|FG000|Treatment Period|Withdrawal by Subject|1|||
27785261|NCT01927419|54239611|FG001|Treatment Period|Withdrawal by Subject|1|||
27785262|NCT01927419|54239610|FG000|Treatment Period|Maximum Clinical Benefit|6|||
27785263|NCT01927419|54239611|FG001|Treatment Period|Maximum Clinical Benefit|2|||
27785264|NCT01927419|54239610|FG000|Treatment Period|Other reasons|3|||
27785265|NCT01927419|54239611|FG001|Treatment Period|Other reasons|4|||
27785266|NCT01927419|54239610|FG000|Treatment Period|Not Reported|1|||
27785267|NCT01927419|54239611|FG001|Treatment Period|Not Reported|1|||
27785268|NCT02168491|54239617|FG000|Overall Study|Withdrawal by Subject|1|||
27785269|NCT02225743|54239621|FG000|Overall Study|Withdrawal by Subject|18|||
27785270|NCT01721746|54239627|FG000|Pre-Treatment|Participant request to discontinue Study treatment|0|||
27785271|NCT01721746|54239628|FG001|Pre-Treatment|Participant request to discontinue Study treatment|13|||
27785272|NCT01721746|54239627|FG000|Pre-Treatment|Withdrawal by Subject|1|||
27785273|NCT01721746|54239628|FG001|Pre-Treatment|Withdrawal by Subject|16|||
27785274|NCT01721746|54239627|FG000|Pre-Treatment|Poor/Non-compliance|1|||
27785275|NCT01721746|54239628|FG001|Pre-Treatment|Poor/Non-compliance|0|||
27785276|NCT01721746|54239627|FG000|Pre-Treatment|Participant no longer met study criteria|2|||
27785277|NCT01721746|54239628|FG001|Pre-Treatment|Participant no longer met study criteria|2|||
27785278|NCT01721746|54239627|FG000|Treatment|Disease Progression|192|||
27785279|NCT01721746|54239628|FG001|Treatment|Disease Progression|74|||
27785280|NCT01721746|54239627|FG000|Treatment|Study Drug Toxicity|19|||
27785281|NCT01721746|54239628|FG001|Treatment|Study Drug Toxicity|11|||
27785282|NCT01721746|54239627|FG000|Treatment|Adverse Event unrelated to Study Drug|6|||
27785283|NCT01721746|54239628|FG001|Treatment|Adverse Event unrelated to Study Drug|3|||
27785284|NCT01721746|54239627|FG000|Treatment|Participant request to discontinue Study treatment|26|||
27785285|NCT01721746|54239628|FG001|Treatment|Participant request to discontinue Study treatment|7|||
27785286|NCT01721746|54239627|FG000|Treatment|Participant withdrew consent|4|||
27785287|NCT01721746|54239628|FG001|Treatment|Participant withdrew consent|2|||
27785288|NCT01721746|54239627|FG000|Treatment|Maximum Clinical Benefit|9|||
27785289|NCT01721746|54239628|FG001|Treatment|Maximum Clinical Benefit|3|||
27785290|NCT01721746|54239627|FG000|Treatment|Poor/Non-compliance|2|||
27785291|NCT01721746|54239628|FG001|Treatment|Poor/Non-compliance|0|||
27785292|NCT01721746|54239627|FG000|Treatment|Participant no longer met Study criteria|4|||
27785293|NCT01721746|54239628|FG001|Treatment|Participant no longer met Study criteria|0|||
27785294|NCT01721746|54239627|FG000|Treatment|Other reasons|6|||
27785295|NCT01721746|54239628|FG001|Treatment|Other reasons|2|||
27785296|NCT02225665|54239637|FG000|Overall Study|Subject moved from area and finds it difficult to return for visits.|1|||
27785297|NCT02225665|54239638|FG001|Overall Study|Subject moved from area and finds it difficult to return for visits.|0|||
27785298|NCT02225665|54239637|FG000|Overall Study|Subject restarted HAART prior to month 18.|0|||
27785299|NCT02225665|54239638|FG001|Overall Study|Subject restarted HAART prior to month 18.|1|||
27785300|NCT01721200|54239646|FG000|Overall Study|Lost to Follow-up|3|||
27785301|NCT01721200|54239647|FG001|Overall Study|Lost to Follow-up|5|||
27785302|NCT02225587|54239660|FG000|Overall Study|Adverse Event|5|||
27785303|NCT02225587|54239661|FG001|Overall Study|Adverse Event|5|||
27785304|NCT02225587|54239660|FG000|Overall Study|Lost to Follow-up|5|||
27785305|NCT02225587|54239661|FG001|Overall Study|Lost to Follow-up|5|||
27785306|NCT02225587|54239660|FG000|Overall Study|Non-Compliance With Study Drug|1|||
27785307|NCT02225587|54239661|FG001|Overall Study|Non-Compliance With Study Drug|0|||
27785308|NCT02225587|54239660|FG000|Overall Study|Physician Decision|2|||
27785309|NCT02225587|54239661|FG001|Overall Study|Physician Decision|0|||
27785310|NCT02225587|54239660|FG000|Overall Study|Protocol Violation|1|||
27785311|NCT02225587|54239661|FG001|Overall Study|Protocol Violation|0|||
27785312|NCT02225587|54239660|FG000|Overall Study|Participant Moved|1|||
27785313|NCT02225587|54239661|FG001|Overall Study|Participant Moved|0|||
27785314|NCT02225587|54239660|FG000|Overall Study|Withdrawal by Subject|13|||
27785315|NCT02225587|54239661|FG001|Overall Study|Withdrawal by Subject|28|||
27785316|NCT02296424|54239669|FG000|Part 1|New therapy for study indication|0|||
27785317|NCT02296424|54239670|FG001|Part 1|New therapy for study indication|1|||
27785318|NCT02296424|54239671|FG002|Part 1|New therapy for study indication|0|||
27785319|NCT02296424|54239672|FG003|Part 1|New therapy for study indication|0|||
27785320|NCT02296424|54239669|FG000|Part 1|Protocol Violation|0|||
27785321|NCT02296424|54239670|FG001|Part 1|Protocol Violation|1|||
27785322|NCT02296424|54239671|FG002|Part 1|Protocol Violation|0|||
27785323|NCT02296424|54239672|FG003|Part 1|Protocol Violation|0|||
27785324|NCT02296424|54239669|FG000|Part 1|Withdrawal by Subject|0|||
27785325|NCT02296424|54239670|FG001|Part 1|Withdrawal by Subject|2|||
27785326|NCT02296424|54239671|FG002|Part 1|Withdrawal by Subject|0|||
27785327|NCT02296424|54239672|FG003|Part 1|Withdrawal by Subject|0|||
27785328|NCT02296424|54239669|FG000|Part 1|Study terminated by sponsor|0|||
27785329|NCT02296424|54239670|FG001|Part 1|Study terminated by sponsor|1|||
27785330|NCT02296424|54239671|FG002|Part 1|Study terminated by sponsor|0|||
27785331|NCT02296424|54239672|FG003|Part 1|Study terminated by sponsor|0|||
27785332|NCT02296424|54239669|FG000|Part 1|Adverse Event|2|||
27785333|NCT02296424|54239670|FG001|Part 1|Adverse Event|11|||
27785334|NCT02296424|54239671|FG002|Part 1|Adverse Event|0|||
27785335|NCT02296424|54239672|FG003|Part 1|Adverse Event|0|||
27785336|NCT02296424|54239669|FG000|Part 1|Lack of Efficacy|5|||
27785337|NCT02296424|54239670|FG001|Part 1|Lack of Efficacy|17|||
27785338|NCT02296424|54239671|FG002|Part 1|Lack of Efficacy|0|||
27785339|NCT02296424|54239672|FG003|Part 1|Lack of Efficacy|0|||
27785340|NCT02296424|54239669|FG000|Part 1|16 directly started part II|16|||
27785341|NCT02296424|54239670|FG001|Part 1|16 directly started part II|0|||
27785342|NCT02296424|54239671|FG002|Part 1|16 directly started part II|0|||
27785343|NCT02296424|54239672|FG003|Part 1|16 directly started part II|0|||
27785344|NCT02296424|54239669|FG000|Part 2|Lack of Efficacy|0|||
27785345|NCT02296424|54239670|FG001|Part 2|Lack of Efficacy|0|||
27785346|NCT02296424|54239671|FG002|Part 2|Lack of Efficacy|1|||
27785347|NCT02296424|54239672|FG003|Part 2|Lack of Efficacy|0|||
27785348|NCT02296424|54239669|FG000|Part 2|Adverse Event|0|||
27785349|NCT02296424|54239670|FG001|Part 2|Adverse Event|0|||
27785350|NCT02296424|54239671|FG002|Part 2|Adverse Event|1|||
27785351|NCT02296424|54239672|FG003|Part 2|Adverse Event|0|||
27785352|NCT02296424|54239669|FG000|Part 2|Lost to Follow-up|0|||
27785353|NCT02296424|54239670|FG001|Part 2|Lost to Follow-up|0|||
27785354|NCT02296424|54239671|FG002|Part 2|Lost to Follow-up|1|||
27785355|NCT02296424|54239672|FG003|Part 2|Lost to Follow-up|0|||
27785356|NCT02296190|54239686|FG000|Overall Study|Lost to Follow-up|0|||
27785357|NCT02296190|54239687|FG001|Overall Study|Lost to Follow-up|0|||
27785358|NCT02296190|54239688|FG002|Overall Study|Lost to Follow-up|0|||
27785359|NCT02296190|54239689|FG003|Overall Study|Lost to Follow-up|0|||
27785360|NCT02296190|54239690|FG004|Overall Study|Lost to Follow-up|1|||
27785361|NCT02296190|54239691|FG005|Overall Study|Lost to Follow-up|0|||
27785362|NCT02296190|54239686|FG000|Overall Study|Failure to induce PSVT|6|||
27785363|NCT02296190|54239687|FG001|Overall Study|Failure to induce PSVT|10|||
27785364|NCT02296190|54239688|FG002|Overall Study|Failure to induce PSVT|5|||
27785365|NCT02296190|54239689|FG003|Overall Study|Failure to induce PSVT|13|||
27785366|NCT02296190|54239690|FG004|Overall Study|Failure to induce PSVT|8|||
27785367|NCT02296190|54239691|FG005|Overall Study|Failure to induce PSVT|0|||
27785368|NCT02296190|54239686|FG000|Overall Study|Physician Decision|1|||
27785369|NCT02296190|54239687|FG001|Overall Study|Physician Decision|1|||
27785370|NCT02296190|54239688|FG002|Overall Study|Physician Decision|0|||
27785371|NCT02296190|54239689|FG003|Overall Study|Physician Decision|1|||
27785372|NCT02296190|54239690|FG004|Overall Study|Physician Decision|2|||
27785373|NCT02296190|54239691|FG005|Overall Study|Physician Decision|0|||
27785374|NCT02296190|54239686|FG000|Overall Study|Withdrawal by Subject|0|||
27785375|NCT02296190|54239687|FG001|Overall Study|Withdrawal by Subject|1|||
27785376|NCT02296190|54239688|FG002|Overall Study|Withdrawal by Subject|0|||
27785377|NCT02296190|54239689|FG003|Overall Study|Withdrawal by Subject|0|||
27785378|NCT02296190|54239690|FG004|Overall Study|Withdrawal by Subject|0|||
27785379|NCT02296190|54239691|FG005|Overall Study|Withdrawal by Subject|0|||
27785380|NCT02296190|54239686|FG000|Overall Study|PSVT < 5 minutes|5|||
27785381|NCT02296190|54239687|FG001|Overall Study|PSVT < 5 minutes|6|||
27785382|NCT02296190|54239688|FG002|Overall Study|PSVT < 5 minutes|6|||
27785383|NCT02296190|54239689|FG003|Overall Study|PSVT < 5 minutes|6|||
27785384|NCT02296190|54239690|FG004|Overall Study|PSVT < 5 minutes|5|||
27785385|NCT02296190|54239691|FG005|Overall Study|PSVT < 5 minutes|0|||
27785386|NCT02296190|54239686|FG000|Overall Study|Patient was given Propofol|0|||
27785387|NCT02296190|54239687|FG001|Overall Study|Patient was given Propofol|1|||
27785388|NCT02296190|54239688|FG002|Overall Study|Patient was given Propofol|0|||
27785389|NCT02296190|54239689|FG003|Overall Study|Patient was given Propofol|1|||
27785390|NCT02296190|54239690|FG004|Overall Study|Patient was given Propofol|0|||
27785391|NCT02296190|54239691|FG005|Overall Study|Patient was given Propofol|0|||
27785392|NCT02296190|54239686|FG000|Overall Study|Patient with Atrial Tachycardia|0|||
27785393|NCT02296190|54239687|FG001|Overall Study|Patient with Atrial Tachycardia|0|||
27785394|NCT02296190|54239688|FG002|Overall Study|Patient with Atrial Tachycardia|0|||
27785395|NCT02296190|54239689|FG003|Overall Study|Patient with Atrial Tachycardia|1|||
27785396|NCT02296190|54239690|FG004|Overall Study|Patient with Atrial Tachycardia|0|||
27785397|NCT02296190|54239691|FG005|Overall Study|Patient with Atrial Tachycardia|0|||
27785398|NCT02296190|54239686|FG000|Overall Study|Blood pressure <100 after sedation|0|||
27785399|NCT02296190|54239687|FG001|Overall Study|Blood pressure <100 after sedation|0|||
27785400|NCT02296190|54239688|FG002|Overall Study|Blood pressure <100 after sedation|0|||
27785401|NCT02296190|54239689|FG003|Overall Study|Blood pressure <100 after sedation|1|||
27785402|NCT02296190|54239690|FG004|Overall Study|Blood pressure <100 after sedation|0|||
27785403|NCT02296190|54239691|FG005|Overall Study|Blood pressure <100 after sedation|0|||
27785404|NCT02296190|54239686|FG000|Overall Study|Atrial Tachycardia induced not PSVT|0|||
27785405|NCT02296190|54239687|FG001|Overall Study|Atrial Tachycardia induced not PSVT|1|||
27785406|NCT02296190|54239688|FG002|Overall Study|Atrial Tachycardia induced not PSVT|1|||
27785407|NCT02296190|54239689|FG003|Overall Study|Atrial Tachycardia induced not PSVT|0|||
27785408|NCT02296190|54239690|FG004|Overall Study|Atrial Tachycardia induced not PSVT|0|||
27785409|NCT02296190|54239691|FG005|Overall Study|Atrial Tachycardia induced not PSVT|0|||
27785410|NCT02296190|54239686|FG000|Overall Study|Patient on antiarrhythmic medication|1|||
27785411|NCT02296190|54239687|FG001|Overall Study|Patient on antiarrhythmic medication|0|||
27785412|NCT02296190|54239688|FG002|Overall Study|Patient on antiarrhythmic medication|0|||
27785413|NCT02296190|54239689|FG003|Overall Study|Patient on antiarrhythmic medication|0|||
27785414|NCT02296190|54239690|FG004|Overall Study|Patient on antiarrhythmic medication|0|||
27785415|NCT02296190|54239691|FG005|Overall Study|Patient on antiarrhythmic medication|0|||
27785416|NCT02296190|54239686|FG000|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
27785417|NCT02296190|54239687|FG001|Overall Study|Failed PSVT with mechanism of AVNRT|1|||
27785418|NCT02296190|54239688|FG002|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
27785419|NCT02296190|54239689|FG003|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
27785420|NCT02296190|54239690|FG004|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
27785421|NCT02296190|54239691|FG005|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
27785422|NCT02296190|54239686|FG000|Overall Study|Lab result not available in time|1|||
27785423|NCT02296190|54239687|FG001|Overall Study|Lab result not available in time|0|||
27785424|NCT02296190|54239688|FG002|Overall Study|Lab result not available in time|0|||
27785425|NCT02296190|54239689|FG003|Overall Study|Lab result not available in time|0|||
27785426|NCT02296190|54239690|FG004|Overall Study|Lab result not available in time|0|||
27785427|NCT02296190|54239691|FG005|Overall Study|Lab result not available in time|0|||
27785428|NCT02296112|54239704|FG000|Overall Study|Disease progression|7|||
27785429|NCT02296112|54239704|FG000|Overall Study|Toxicity|1|||
27785430|NCT02296112|54239704|FG000|Overall Study|Began an alternate therapy|1|||
27785431|NCT02295644|54239717|FG000|Overall Study|Did not meet inclusion criterion|0|||
27785432|NCT02295644|54239718|FG001|Overall Study|Did not meet inclusion criterion|0|||
27785433|NCT02295644|54239719|FG002|Overall Study|Did not meet inclusion criterion|1|||
27785434|NCT02295644|54239720|FG003|Overall Study|Did not meet inclusion criterion|2|||
27785435|NCT02269670|54239730|FG000|Overall Study|All subjects have not completed all research related interventions|3|||
27785436|NCT02225353|54239737|FG000|Overall Study|Lost to Follow-up|0|||
27785437|NCT02225353|54239738|FG001|Overall Study|Lost to Follow-up|1|||
27785438|NCT02225353|54239739|FG002|Overall Study|Lost to Follow-up|3|||
27785439|NCT02225353|54239737|FG000|Overall Study|Protocol Violation|4|||
27785440|NCT02225353|54239738|FG001|Overall Study|Protocol Violation|5|||
27785441|NCT02225353|54239739|FG002|Overall Study|Protocol Violation|12|||
27785442|NCT01641926|54239754|FG000|Overall Study|Adverse Event|5|||
27785443|NCT01641926|54239755|FG001|Overall Study|Adverse Event|2|||
27785444|NCT01641926|54239756|FG002|Overall Study|Adverse Event|3|||
27785445|NCT01641926|54239757|FG003|Overall Study|Adverse Event|1|||
27785446|NCT01641926|54239754|FG000|Overall Study|Lost to Follow-up|2|||
27785447|NCT01641926|54239755|FG001|Overall Study|Lost to Follow-up|2|||
27785448|NCT01641926|54239756|FG002|Overall Study|Lost to Follow-up|1|||
27785449|NCT01641926|54239757|FG003|Overall Study|Lost to Follow-up|0|||
27785450|NCT01641926|54239754|FG000|Overall Study|Physician Decision|6|||
27785451|NCT01641926|54239755|FG001|Overall Study|Physician Decision|5|||
27785452|NCT01641926|54239756|FG002|Overall Study|Physician Decision|0|||
27785453|NCT01641926|54239757|FG003|Overall Study|Physician Decision|1|||
27785454|NCT01641926|54239754|FG000|Overall Study|Protocol Violation|1|||
27785455|NCT01641926|54239755|FG001|Overall Study|Protocol Violation|0|||
27785456|NCT01641926|54239756|FG002|Overall Study|Protocol Violation|0|||
27785457|NCT01641926|54239757|FG003|Overall Study|Protocol Violation|1|||
27785458|NCT01641926|54239754|FG000|Overall Study|Withdrawal by Subject|13|||
27785459|NCT01641926|54239755|FG001|Overall Study|Withdrawal by Subject|5|||
27785460|NCT01641926|54239756|FG002|Overall Study|Withdrawal by Subject|6|||
27785461|NCT01641926|54239757|FG003|Overall Study|Withdrawal by Subject|1|||
27785462|NCT01641926|54239754|FG000|Overall Study|Not Treated|1|||
27785463|NCT01641926|54239755|FG001|Overall Study|Not Treated|1|||
27785464|NCT01641926|54239756|FG002|Overall Study|Not Treated|1|||
27785465|NCT01641926|54239757|FG003|Overall Study|Not Treated|0|||
27785466|NCT02295020|54239769|FG000|Overall Study|Adverse Event|0|||
27785467|NCT02295020|54239770|FG001|Overall Study|Adverse Event|1|||
27785468|NCT02295020|54239769|FG000|Overall Study|Withdrawal by Subject|3|||
27785469|NCT02295020|54239770|FG001|Overall Study|Withdrawal by Subject|2|||
27785470|NCT02200939|54239784|FG000|Overall Study|Participant withdrew consent|0|||
27785471|NCT02200939|54239785|FG001|Overall Study|Participant withdrew consent|1|||
27785472|NCT02200939|54239784|FG000|Overall Study|Lost to Follow-up|2|||
27785473|NCT02200939|54239785|FG001|Overall Study|Lost to Follow-up|9|||
27785474|NCT02200939|54239784|FG000|Overall Study|Subject moved out of town and unable to make it back to study|0|||
27785475|NCT02200939|54239785|FG001|Overall Study|Subject moved out of town and unable to make it back to study|1|||
27785476|NCT02294786|54239797|FG000|Overall Study|Withdrawal by Subject|0|||
27785477|NCT02294786|54239798|FG001|Overall Study|Withdrawal by Subject|1|||
27785478|NCT02294786|54239797|FG000|Overall Study|Physician Decision|6|||
27785479|NCT02294786|54239798|FG001|Overall Study|Physician Decision|7|||
27785480|NCT02294786|54239797|FG000|Overall Study|Lost to Follow-up|1|||
27785481|NCT02294786|54239798|FG001|Overall Study|Lost to Follow-up|2|||
27785482|NCT02294786|54239797|FG000|Overall Study|Protocol Violation|1|||
27785483|NCT02294786|54239798|FG001|Overall Study|Protocol Violation|0|||
27785484|NCT02294786|54239797|FG000|Overall Study|Adverse Event|1|||
27785485|NCT02294786|54239798|FG001|Overall Study|Adverse Event|1|||
27785486|NCT02294786|54239797|FG000|Overall Study|Death|2|||
27785487|NCT02294786|54239798|FG001|Overall Study|Death|3|||
27785488|NCT02269124|54239807|FG000|Overall Study|Lost to Follow-up|1|||
27785489|NCT02269124|54239808|FG001|Overall Study|Lost to Follow-up|0|||
27785490|NCT02269124|54239807|FG000|Overall Study|Withdrawal by Subject|0|||
27785491|NCT02269124|54239808|FG001|Overall Study|Withdrawal by Subject|2|||
27785492|NCT01927341|54239820|FG000|Phase 1b|Lost to Follow-up|1|||
27785493|NCT01927341|54239821|FG001|Phase 1b|Lost to Follow-up|0|||
27785494|NCT01927341|54239822|FG002|Phase 1b|Lost to Follow-up|0|||
27785495|NCT01927341|54239823|FG003|Phase 1b|Lost to Follow-up|0|||
27785496|NCT01927341|54239824|FG004|Phase 1b|Lost to Follow-up|0|||
27785497|NCT01927341|54239820|FG000|Phase 1b|Death|2|||
27785498|NCT01927341|54239821|FG001|Phase 1b|Death|0|||
27785499|NCT01927341|54239822|FG002|Phase 1b|Death|0|||
27785500|NCT01927341|54239823|FG003|Phase 1b|Death|0|||
27785501|NCT01927341|54239824|FG004|Phase 1b|Death|0|||
27785502|NCT01927341|54239820|FG000|Phase 1b|Follow-up completed|7|||
27785503|NCT01927341|54239821|FG001|Phase 1b|Follow-up completed|0|||
27785504|NCT01927341|54239822|FG002|Phase 1b|Follow-up completed|0|||
27785505|NCT01927341|54239823|FG003|Phase 1b|Follow-up completed|0|||
27785506|NCT01927341|54239824|FG004|Phase 1b|Follow-up completed|0|||
27785507|NCT01927341|54239820|FG000|Phase 2|Lost to Follow-up|0|||
27785508|NCT01927341|54239821|FG001|Phase 2|Lost to Follow-up|1|||
27785509|NCT01927341|54239822|FG002|Phase 2|Lost to Follow-up|0|||
27785510|NCT01927341|54239823|FG003|Phase 2|Lost to Follow-up|0|||
27785511|NCT01927341|54239824|FG004|Phase 2|Lost to Follow-up|0|||
27785512|NCT01927341|54239820|FG000|Phase 2|Participant withdrew consent|0|||
27785513|NCT01927341|54239821|FG001|Phase 2|Participant withdrew consent|2|||
27785514|NCT01927341|54239822|FG002|Phase 2|Participant withdrew consent|1|||
27785515|NCT01927341|54239823|FG003|Phase 2|Participant withdrew consent|2|||
27785516|NCT01927341|54239824|FG004|Phase 2|Participant withdrew consent|3|||
27785517|NCT01927341|54239820|FG000|Phase 2|Death|0|||
27785518|NCT01927341|54239821|FG001|Phase 2|Death|4|||
27785519|NCT01927341|54239822|FG002|Phase 2|Death|0|||
27785520|NCT01927341|54239823|FG003|Phase 2|Death|3|||
27785521|NCT01927341|54239824|FG004|Phase 2|Death|2|||
27785522|NCT01927341|54239820|FG000|Phase 2|New cancer therapy|0|||
27785523|NCT01927341|54239821|FG001|Phase 2|New cancer therapy|1|||
27785524|NCT01927341|54239822|FG002|Phase 2|New cancer therapy|0|||
27785525|NCT01927341|54239823|FG003|Phase 2|New cancer therapy|4|||
27785526|NCT01927341|54239824|FG004|Phase 2|New cancer therapy|1|||
27785527|NCT01927341|54239820|FG000|Phase 2|Disease progression|0|||
27785528|NCT01927341|54239821|FG001|Phase 2|Disease progression|1|||
27785529|NCT01927341|54239822|FG002|Phase 2|Disease progression|1|||
27785530|NCT01927341|54239823|FG003|Phase 2|Disease progression|1|||
27785531|NCT01927341|54239824|FG004|Phase 2|Disease progression|0|||
27785532|NCT01927341|54239820|FG000|Phase 2|Follow-up completed|0|||
27785533|NCT01927341|54239821|FG001|Phase 2|Follow-up completed|6|||
27785534|NCT01927341|54239822|FG002|Phase 2|Follow-up completed|3|||
27785535|NCT01927341|54239823|FG003|Phase 2|Follow-up completed|5|||
27785536|NCT01927341|54239824|FG004|Phase 2|Follow-up completed|2|||
27785537|NCT02294474|54239842|FG000|Overall Study|Adverse Event|7|||
27785538|NCT02294474|54239843|FG001|Overall Study|Adverse Event|7|||
27785539|NCT02294474|54239842|FG000|Overall Study|Lack of Efficacy|2|||
27785540|NCT02294474|54239843|FG001|Overall Study|Lack of Efficacy|1|||
27785541|NCT02294474|54239842|FG000|Overall Study|Protocol Violation|4|||
27785542|NCT02294474|54239843|FG001|Overall Study|Protocol Violation|2|||
27785543|NCT02294474|54239842|FG000|Overall Study|Other than specified above|12|||
27785544|NCT02294474|54239843|FG001|Overall Study|Other than specified above|12|||
27785545|NCT02168101|54239853|FG000|Overall Study|Death|2|||
27785546|NCT02168101|54239854|FG001|Overall Study|Death|2|||
27785547|NCT02168101|54239855|FG002|Overall Study|Death|1|||
27785548|NCT01956123|54239866|FG000|COS Cycle 2|Protocol Violation|8|||
27785549|NCT01956123|54239867|FG001|COS Cycle 2|Protocol Violation|3|||
27785550|NCT01956123|54239868|FG002|COS Cycle 2|Protocol Violation|0|||
27841066|NCT01496365|54329083|FG003|Overall Study|Protocol Violation|0|||
27785551|NCT01956123|54239869|FG003|COS Cycle 2|Protocol Violation|0|||
27785552|NCT01956123|54239866|FG000|COS Cycle 2|Adverse Event|3|||
27785553|NCT01956123|54239867|FG001|COS Cycle 2|Adverse Event|4|||
27785554|NCT01956123|54239868|FG002|COS Cycle 2|Adverse Event|0|||
27785555|NCT01956123|54239869|FG003|COS Cycle 2|Adverse Event|0|||
27785556|NCT01956123|54239866|FG000|COS Cycle 2|Personal Reasons|2|||
27841067|NCT01496365|54329084|FG004|Overall Study|Protocol Violation|0|||
27785557|NCT01956123|54239867|FG001|COS Cycle 2|Personal Reasons|0|||
27785558|NCT01956123|54239868|FG002|COS Cycle 2|Personal Reasons|0|||
27785559|NCT01956123|54239869|FG003|COS Cycle 2|Personal Reasons|0|||
27785560|NCT01956123|54239866|FG000|COS Cycle 2|Withdrawal by Subject|1|||
27785561|NCT01956123|54239867|FG001|COS Cycle 2|Withdrawal by Subject|0|||
27785562|NCT01956123|54239868|FG002|COS Cycle 2|Withdrawal by Subject|0|||
27785563|NCT01956123|54239869|FG003|COS Cycle 2|Withdrawal by Subject|0|||
27785564|NCT01956123|54239866|FG000|COS Cycle 3|Protocol Violation|0|||
27785565|NCT01956123|54239867|FG001|COS Cycle 3|Protocol Violation|0|||
27785566|NCT01956123|54239868|FG002|COS Cycle 3|Protocol Violation|2|||
27785567|NCT01956123|54239869|FG003|COS Cycle 3|Protocol Violation|1|||
27785568|NCT01956123|54239866|FG000|COS Cycle 3|Adverse Event|0|||
27785569|NCT01956123|54239867|FG001|COS Cycle 3|Adverse Event|0|||
27785570|NCT01956123|54239868|FG002|COS Cycle 3|Adverse Event|3|||
27785571|NCT01956123|54239869|FG003|COS Cycle 3|Adverse Event|0|||
27785572|NCT01956123|54239866|FG000|COS Cycle 3|Personal Reasons|0|||
27785573|NCT01956123|54239867|FG001|COS Cycle 3|Personal Reasons|0|||
27785574|NCT01956123|54239868|FG002|COS Cycle 3|Personal Reasons|1|||
27785575|NCT01956123|54239869|FG003|COS Cycle 3|Personal Reasons|0|||
27785576|NCT01956123|54239866|FG000|COS Cycle 3|Withdrawal by Subject|0|||
27785577|NCT01956123|54239867|FG001|COS Cycle 3|Withdrawal by Subject|0|||
27785578|NCT01956123|54239868|FG002|COS Cycle 3|Withdrawal by Subject|0|||
27785579|NCT01956123|54239869|FG003|COS Cycle 3|Withdrawal by Subject|1|||
27785580|NCT02298179|54239892|FG000|Overall Study|Lost to Follow-up|0|||
27785581|NCT02298179|54239893|FG001|Overall Study|Lost to Follow-up|0|||
27785582|NCT02298179|54239894|FG002|Overall Study|Lost to Follow-up|1|||
27785583|NCT02298179|54239895|FG003|Overall Study|Lost to Follow-up|0|||
27785584|NCT02298179|54239896|FG004|Overall Study|Lost to Follow-up|0|||
27841068|NCT01496365|54329085|FG005|Overall Study|Protocol Violation|1|||
27841069|NCT01496365|54329086|FG006|Overall Study|Protocol Violation|0|||
27841070|NCT01496365|54329080|FG000|Overall Study|Lack of Efficacy|1|||
27841071|NCT01496365|54329081|FG001|Overall Study|Lack of Efficacy|0|||
27841072|NCT01496365|54329082|FG002|Overall Study|Lack of Efficacy|0|||
27841073|NCT01496365|54329083|FG003|Overall Study|Lack of Efficacy|0|||
27841074|NCT01496365|54329084|FG004|Overall Study|Lack of Efficacy|0|||
27841075|NCT01496365|54329085|FG005|Overall Study|Lack of Efficacy|1|||
27841076|NCT01496365|54329086|FG006|Overall Study|Lack of Efficacy|0|||
27841077|NCT01496365|54329080|FG000|Overall Study|Lost to Follow-up|0|||
27841078|NCT01496365|54329081|FG001|Overall Study|Lost to Follow-up|1|||
27841079|NCT01496365|54329082|FG002|Overall Study|Lost to Follow-up|0|||
27841080|NCT01496365|54329083|FG003|Overall Study|Lost to Follow-up|0|||
27841081|NCT01496365|54329084|FG004|Overall Study|Lost to Follow-up|2|||
27841082|NCT01496365|54329085|FG005|Overall Study|Lost to Follow-up|0|||
27841083|NCT01496365|54329086|FG006|Overall Study|Lost to Follow-up|0|||
27841084|NCT01496365|54329080|FG000|Overall Study|Other|4|||
27841085|NCT01496365|54329081|FG001|Overall Study|Other|4|||
27841086|NCT01496365|54329082|FG002|Overall Study|Other|2|||
27841087|NCT01496365|54329083|FG003|Overall Study|Other|1|||
27841088|NCT01496365|54329084|FG004|Overall Study|Other|3|||
27841089|NCT01496365|54329085|FG005|Overall Study|Other|0|||
27841090|NCT01496365|54329086|FG006|Overall Study|Other|1|||
27841091|NCT01496287|54329102|FG000|Overall Study|Lost to Follow-up|1|||
27841092|NCT01496287|54329102|FG000|Overall Study|Incomplete anesthesia|5|||
27841093|NCT01495975|54329109|FG000|Overall Study|Lost to Follow-up|1|||
27841094|NCT01495975|54329110|FG001|Overall Study|Lost to Follow-up|0|||
27841095|NCT01468987|54329118|FG000|Overall Study|Adverse Event|12|||
27841096|NCT01468987|54329119|FG001|Overall Study|Adverse Event|9|||
27841097|NCT01468987|54329118|FG000|Overall Study|Death|4|||
27841098|NCT01468987|54329119|FG001|Overall Study|Death|1|||
27841099|NCT01468987|54329118|FG000|Overall Study|Lost to Follow-up|10|||
27841100|NCT01468987|54329119|FG001|Overall Study|Lost to Follow-up|5|||
27841101|NCT01468987|54329118|FG000|Overall Study|Protocol Violation|8|||
27841102|NCT01468987|54329119|FG001|Overall Study|Protocol Violation|2|||
27841103|NCT01468987|54329118|FG000|Overall Study|Withdrawal by Subject|28|||
27841104|NCT01468987|54329119|FG001|Overall Study|Withdrawal by Subject|28|||
27841105|NCT01468987|54329118|FG000|Overall Study|Physician Decision|8|||
27841106|NCT01468987|54329119|FG001|Overall Study|Physician Decision|15|||
27841107|NCT01468987|54329118|FG000|Overall Study|Sponsor Decision|1|||
27841108|NCT01468987|54329119|FG001|Overall Study|Sponsor Decision|0|||
27841109|NCT01687712|54329129|FG000|Cycle 1|Not Biochemically Pregnant|386|||
27841110|NCT01687712|54329130|FG001|Cycle 1|Not Biochemically Pregnant|348|||
27841111|NCT01687712|54329129|FG000|Cycle 1|Early Pregnancy Loss|43|||
27841112|NCT01687712|54329130|FG001|Cycle 1|Early Pregnancy Loss|60|||
27841113|NCT01687712|54329129|FG000|Cycle 1|Ectopic Pregnancy|5|||
27841114|NCT01687712|54329130|FG001|Cycle 1|Ectopic Pregnancy|5|||
27841115|NCT01687712|54329129|FG000|Cycle 1|Heterotropic Pregnancy|1|||
27785585|NCT02298179|54239897|FG005|Overall Study|Lost to Follow-up|0|||
27785586|NCT02298179|54239898|FG006|Overall Study|Lost to Follow-up|0|||
27841116|NCT01687712|54329130|FG001|Cycle 1|Heterotropic Pregnancy|0|||
27841117|NCT01687712|54329129|FG000|Cycle 1|Miscarriage/Spontaneous Abortion|9|||
27841118|NCT01687712|54329130|FG001|Cycle 1|Miscarriage/Spontaneous Abortion|14|||
27841119|NCT01687712|54329129|FG000|Cycle 1|Abortion|3|||
27841120|NCT01687712|54329130|FG001|Cycle 1|Abortion|0|||
27841121|NCT01687712|54329129|FG000|Cycle 1|Intrauterine Fetal Death|0|||
27841122|NCT01687712|54329130|FG001|Cycle 1|Intrauterine Fetal Death|1|||
27841123|NCT01687712|54329129|FG000|Cycle 1|Lost to Follow-up|1|||
27785587|NCT02298179|54239899|FG007|Overall Study|Lost to Follow-up|1|||
27785588|NCT02298179|54239900|FG008|Overall Study|Lost to Follow-up|0|||
27841124|NCT01687712|54329130|FG001|Cycle 1|Lost to Follow-up|1|||
27841125|NCT01687712|54329129|FG000|Cycle 2|Not Biochemically Pregnant|74|||
27841126|NCT01687712|54329130|FG001|Cycle 2|Not Biochemically Pregnant|77|||
27841127|NCT01687712|54329129|FG000|Cycle 2|Early Pregnancy Loss|18|||
27785589|NCT02298179|54239901|FG009|Overall Study|Lost to Follow-up|0|||
28105546|NCT04493931|54762955|FG003|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
28105547|NCT04493931|54762956|FG004|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
28105548|NCT04493931|54762957|FG005|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
28105549|NCT04493931|54762958|FG006|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
28105550|NCT03437278|54762991|FG000|Overall Study|Adverse Event|0|||
27785590|NCT02298179|54239902|FG010|Overall Study|Lost to Follow-up|0|||
27785591|NCT02298179|54239903|FG011|Overall Study|Lost to Follow-up|0|||
27785592|NCT02298023|54239932|FG000|Overall Study|Withdrawal by Subject|1|||
27785593|NCT02298023|54239933|FG001|Overall Study|Withdrawal by Subject|0|||
27785594|NCT02298023|54239934|FG002|Overall Study|Withdrawal by Subject|0|||
27785595|NCT02296931|54239947|FG000|Overall Study|Protocol Violation|0|||
27785596|NCT02296931|54239948|FG001|Overall Study|Protocol Violation|2|||
27785597|NCT02166697|54239954|FG000|Overall Study|Protocol Violation|347|||
27785598|NCT01909479|54239960|FG000|From Baseline to Week 26|Adverse Event|3|||
27785599|NCT01909479|54239961|FG001|From Baseline to Week 26|Adverse Event|2|||
27785600|NCT01909479|54239960|FG000|From Baseline to Week 26|Withdrawal by Subject|3|||
27785601|NCT01909479|54239961|FG001|From Baseline to Week 26|Withdrawal by Subject|6|||
27785602|NCT01909479|54239960|FG000|From Baseline to Week 26|Site and study closed by PI|0|||
27785603|NCT01909479|54239961|FG001|From Baseline to Week 26|Site and study closed by PI|1|||
27785604|NCT01909479|54239960|FG000|26 - 52 Weeks|Adverse Event|0|||
27785605|NCT01909479|54239961|FG001|26 - 52 Weeks|Adverse Event|1|||
27785606|NCT01909479|54239960|FG000|26 - 52 Weeks|Withdrawal by Subject|2|||
27785607|NCT01909479|54239961|FG001|26 - 52 Weeks|Withdrawal by Subject|1|||
27785608|NCT01909479|54239960|FG000|26 - 52 Weeks|Lost to Follow-up|1|||
27785609|NCT01909479|54239961|FG001|26 - 52 Weeks|Lost to Follow-up|0|||
27785610|NCT01909479|54239960|FG000|52 Weeks to End of Study|Withdrawal by Subject|18|||
27785611|NCT01909479|54239961|FG001|52 Weeks to End of Study|Withdrawal by Subject|8|||
27785612|NCT01909479|54239960|FG000|52 Weeks to End of Study|Adverse Event|2|||
27785613|NCT01909479|54239961|FG001|52 Weeks to End of Study|Adverse Event|1|||
27785614|NCT01909479|54239960|FG000|52 Weeks to End of Study|Death|0|||
27785615|NCT01909479|54239961|FG001|52 Weeks to End of Study|Death|1|||
27785616|NCT01909479|54239960|FG000|52 Weeks to End of Study|Lost to Follow-up|1|||
27785617|NCT01909479|54239961|FG001|52 Weeks to End of Study|Lost to Follow-up|0|||
27785618|NCT01909479|54239960|FG000|52 Weeks to End of Study|Protocol Violation|1|||
27841128|NCT01687712|54329130|FG001|Cycle 2|Early Pregnancy Loss|16|||
27841129|NCT01687712|54329129|FG000|Cycle 2|Ectopic Pregnancy|0|||
27841130|NCT01687712|54329130|FG001|Cycle 2|Ectopic Pregnancy|1|||
27841131|NCT01687712|54329129|FG000|Cycle 2|Still Birth|1|||
27841132|NCT01687712|54329130|FG001|Cycle 2|Still Birth|0|||
27841133|NCT01687712|54329129|FG000|Cycle 2|Miscarriage/Spontaneous Abortion|0|||
27841134|NCT01687712|54329130|FG001|Cycle 2|Miscarriage/Spontaneous Abortion|1|||
27841135|NCT01687712|54329129|FG000|Cycle 3|Not Biochemically Pregnant|21|||
27841136|NCT01687712|54329130|FG001|Cycle 3|Not Biochemically Pregnant|22|||
27841137|NCT01687712|54329129|FG000|Cycle 3|Early Pregnancy Loss|1|||
27841138|NCT01687712|54329130|FG001|Cycle 3|Early Pregnancy Loss|2|||
27841139|NCT01687712|54329129|FG000|Cycle 3|Ectopic Pregnancy|1|||
27841140|NCT01687712|54329130|FG001|Cycle 3|Ectopic Pregnancy|0|||
27841141|NCT01687712|54329129|FG000|Cycle 3|Miscarriage/Spontaneous Abortion|1|||
27841142|NCT01687712|54329130|FG001|Cycle 3|Miscarriage/Spontaneous Abortion|0|||
27841143|NCT01603628|54329143|FG000|Overall Study|Personal Reasons|1|||
27841144|NCT01603628|54329144|FG001|Overall Study|Personal Reasons|1|||
27841145|NCT01603628|54329145|FG002|Overall Study|Personal Reasons|2|||
27841146|NCT01603628|54329143|FG000|Overall Study|Protocol Violation|1|||
27841147|NCT01603628|54329144|FG001|Overall Study|Protocol Violation|1|||
27841148|NCT01603628|54329145|FG002|Overall Study|Protocol Violation|0|||
27841149|NCT01603628|54329143|FG000|Overall Study|Lost to Follow-up|0|||
27841150|NCT01603628|54329144|FG001|Overall Study|Lost to Follow-up|1|||
27841151|NCT01603628|54329145|FG002|Overall Study|Lost to Follow-up|0|||
27841152|NCT01603628|54329143|FG000|Overall Study|Other Miscellaneous Reason|1|||
27841153|NCT01603628|54329144|FG001|Overall Study|Other Miscellaneous Reason|0|||
27841154|NCT01603628|54329145|FG002|Overall Study|Other Miscellaneous Reason|0|||
27841155|NCT01453153|54329156|FG000|Overall Study|Physician Decision|0|||
27841156|NCT01453153|54329157|FG001|Overall Study|Physician Decision|0|||
27841157|NCT01453153|54329158|FG002|Overall Study|Physician Decision|1|||
28105551|NCT03437278|54762992|FG001|Overall Study|Adverse Event|0|||
27785619|NCT01909479|54239961|FG001|52 Weeks to End of Study|Protocol Violation|0|||
27841158|NCT01453153|54329156|FG000|Overall Study|Progressive Disease|3|||
27841159|NCT01453153|54329157|FG001|Overall Study|Progressive Disease|2|||
27841160|NCT01453153|54329158|FG002|Overall Study|Progressive Disease|16|||
27841161|NCT01453153|54329156|FG000|Overall Study|Withdrawal by Subject|0|||
27841162|NCT01453153|54329157|FG001|Overall Study|Withdrawal by Subject|1|||
27841163|NCT01453153|54329158|FG002|Overall Study|Withdrawal by Subject|2|||
27841164|NCT01453153|54329156|FG000|Overall Study|Adverse Event|1|||
27841165|NCT01453153|54329157|FG001|Overall Study|Adverse Event|1|||
27841166|NCT01453153|54329158|FG002|Overall Study|Adverse Event|1|||
27841167|NCT01584440|54329172|FG000|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|1|||
27785620|NCT01909479|54239960|FG000|52 Weeks to End of Study|Progressive disease|1|||
27785621|NCT01909479|54239961|FG001|52 Weeks to End of Study|Progressive disease|1|||
27785622|NCT01909479|54239960|FG000|52 Weeks to End of Study|Personal reasons|2|||
27785623|NCT01909479|54239961|FG001|52 Weeks to End of Study|Personal reasons|1|||
27785624|NCT01909479|54239960|FG000|52 Weeks to End of Study|Sponsor's decision|1|||
27785625|NCT01909479|54239961|FG001|52 Weeks to End of Study|Sponsor's decision|1|||
27785626|NCT01909479|54239960|FG000|52 Weeks to End of Study|Study termination by sponsor|0|||
27785627|NCT01909479|54239961|FG001|52 Weeks to End of Study|Study termination by sponsor|1|||
27785628|NCT01909479|54239960|FG000|52 Weeks to End of Study|Lack of contact|1|||
27785629|NCT01909479|54239961|FG001|52 Weeks to End of Study|Lack of contact|0|||
27785630|NCT01909479|54239960|FG000|52 Weeks to End of Study|Occurrence of malignancy|1|||
27785631|NCT01909479|54239961|FG001|52 Weeks to End of Study|Occurrence of malignancy|0|||
27785632|NCT01909479|54239960|FG000|52 Weeks to End of Study|Diabetes not controlled|0|||
27785633|NCT01909479|54239961|FG001|52 Weeks to End of Study|Diabetes not controlled|1|||
27785634|NCT01955733|54239974|FG000|Period 1|Lost to Follow-up|1|||
27785635|NCT01955733|54239975|FG001|Period 1|Lost to Follow-up|0|||
27785636|NCT01955733|54239976|FG002|Period 1|Lost to Follow-up|0|||
27785637|NCT01955733|54239974|FG000|Period 2|Adverse Event|1|||
27785638|NCT01955733|54239975|FG001|Period 2|Adverse Event|0|||
27785639|NCT01955733|54239976|FG002|Period 2|Adverse Event|0|||
27785640|NCT01955733|54239974|FG000|Period 2|Physician Decision|0|||
27785641|NCT01955733|54239975|FG001|Period 2|Physician Decision|0|||
27785642|NCT01955733|54239976|FG002|Period 2|Physician Decision|1|||
27785643|NCT01955733|54239974|FG000|Period 2|Withdrawal by Subject|1|||
27785644|NCT01955733|54239975|FG001|Period 2|Withdrawal by Subject|3|||
27785645|NCT01955733|54239976|FG002|Period 2|Withdrawal by Subject|2|||
27785646|NCT01955733|54239974|FG000|Period 2|Study terminated by sponsor|8|||
27785647|NCT01955733|54239975|FG001|Period 2|Study terminated by sponsor|14|||
27785648|NCT01955733|54239976|FG002|Period 2|Study terminated by sponsor|16|||
27785649|NCT01955733|54239974|FG000|Period 2|Lost to Follow-up|2|||
27785650|NCT01955733|54239975|FG001|Period 2|Lost to Follow-up|0|||
27785651|NCT01955733|54239976|FG002|Period 2|Lost to Follow-up|0|||
27785652|NCT01955733|54239974|FG000|Period 2|Other not defined above|0|||
27785653|NCT01955733|54239975|FG001|Period 2|Other not defined above|2|||
27785654|NCT01955733|54239976|FG002|Period 2|Other not defined above|2|||
27785655|NCT02197897|54239984|FG000|Overall Study|not eligible|1|||
27785656|NCT02223793|54239991|FG000|Overall Study|Lost to Follow-up|10|||
27785657|NCT02223793|54239992|FG001|Overall Study|Lost to Follow-up|1|||
27785658|NCT02223793|54239993|FG002|Overall Study|Lost to Follow-up|2|||
27785659|NCT02223793|54239991|FG000|Overall Study|Withdrawal by Subject|3|||
27785660|NCT02223793|54239992|FG001|Overall Study|Withdrawal by Subject|2|||
27785661|NCT02223793|54239993|FG002|Overall Study|Withdrawal by Subject|3|||
27785662|NCT02223793|54239991|FG000|Overall Study|Moved/studycenter unable to participate|4|||
27785663|NCT02223793|54239992|FG001|Overall Study|Moved/studycenter unable to participate|6|||
27785664|NCT02223793|54239993|FG002|Overall Study|Moved/studycenter unable to participate|8|||
27785665|NCT01926015|54240003|FG000|Overall Study|Withdrawal by parent/guardian|0|||
27785666|NCT01926015|54240004|FG001|Overall Study|Withdrawal by parent/guardian|1|||
27785667|NCT01926015|54240003|FG000|Overall Study|Randomized not treated|2|||
27785668|NCT01926015|54240004|FG001|Overall Study|Randomized not treated|0|||
27785669|NCT02223715|54240010|FG000|Overall Study|Death|31|||
27785670|NCT02223715|54240010|FG000|Overall Study|Lost to Follow-up|73|||
27785671|NCT02196259|54240020|FG000|Overall Study|Researcher choice|0|||
27785672|NCT02196259|54240021|FG001|Overall Study|Researcher choice|0|||
27785673|NCT02196259|54240022|FG002|Overall Study|Researcher choice|1|||
27785674|NCT02196259|54240020|FG000|Overall Study|Partial data analysis|0|||
27785675|NCT02196259|54240021|FG001|Overall Study|Partial data analysis|3|||
27785676|NCT02196259|54240022|FG002|Overall Study|Partial data analysis|0|||
27785677|NCT02294396|54240033|FG000|Overall Study|Adverse Event|26|||
27785678|NCT02294396|54240034|FG001|Overall Study|Adverse Event|25|||
27785679|NCT02294396|54240035|FG002|Overall Study|Adverse Event|21|||
27785680|NCT02294396|54240036|FG003|Overall Study|Adverse Event|24|||
27785681|NCT02294396|54240033|FG000|Overall Study|Electrocardiogram adviser's judgment|1|||
27785682|NCT02294396|54240034|FG001|Overall Study|Electrocardiogram adviser's judgment|0|||
27785683|NCT02294396|54240035|FG002|Overall Study|Electrocardiogram adviser's judgment|0|||
27785684|NCT02294396|54240036|FG003|Overall Study|Electrocardiogram adviser's judgment|1|||
27785685|NCT02294396|54240033|FG000|Overall Study|Withdrawal by Subject|8|||
27785686|NCT02294396|54240034|FG001|Overall Study|Withdrawal by Subject|6|||
27785687|NCT02294396|54240035|FG002|Overall Study|Withdrawal by Subject|6|||
27785688|NCT02294396|54240036|FG003|Overall Study|Withdrawal by Subject|8|||
27785689|NCT02294396|54240033|FG000|Overall Study|Lost to Follow-up|0|||
27785690|NCT02294396|54240034|FG001|Overall Study|Lost to Follow-up|0|||
27785691|NCT02294396|54240035|FG002|Overall Study|Lost to Follow-up|1|||
27785692|NCT02294396|54240036|FG003|Overall Study|Lost to Follow-up|1|||
27785693|NCT02294396|54240033|FG000|Overall Study|Protocol Deviation|3|||
27785694|NCT02294396|54240034|FG001|Overall Study|Protocol Deviation|2|||
27785695|NCT02294396|54240035|FG002|Overall Study|Protocol Deviation|2|||
27785696|NCT02294396|54240036|FG003|Overall Study|Protocol Deviation|1|||
27785697|NCT02294396|54240033|FG000|Overall Study|Miscellaneous|2|||
27785698|NCT02294396|54240034|FG001|Overall Study|Miscellaneous|0|||
27785699|NCT02294396|54240035|FG002|Overall Study|Miscellaneous|5|||
27785700|NCT02294396|54240036|FG003|Overall Study|Miscellaneous|2|||
27785701|NCT01721044|54240049|FG000|Treatment Period|Adverse Event|7|||
27785702|NCT01721044|54240050|FG001|Treatment Period|Adverse Event|7|||
27785703|NCT01721044|54240051|FG002|Treatment Period|Adverse Event|10|||
27785704|NCT01721044|54240049|FG000|Treatment Period|Death|0|||
27785705|NCT01721044|54240050|FG001|Treatment Period|Death|0|||
27785706|NCT01721044|54240051|FG002|Treatment Period|Death|1|||
27785707|NCT01721044|54240049|FG000|Treatment Period|Lack of Efficacy|16|||
27785708|NCT01721044|54240050|FG001|Treatment Period|Lack of Efficacy|4|||
27785709|NCT01721044|54240051|FG002|Treatment Period|Lack of Efficacy|4|||
27785710|NCT01721044|54240049|FG000|Treatment Period|Lost to Follow-up|0|||
27785711|NCT01721044|54240050|FG001|Treatment Period|Lost to Follow-up|0|||
27785712|NCT01721044|54240051|FG002|Treatment Period|Lost to Follow-up|1|||
27785713|NCT01721044|54240049|FG000|Treatment Period|Physician Decision|1|||
27785714|NCT01721044|54240050|FG001|Treatment Period|Physician Decision|0|||
27785715|NCT01721044|54240051|FG002|Treatment Period|Physician Decision|2|||
27785716|NCT01721044|54240049|FG000|Treatment Period|Protocol Violation|1|||
27785717|NCT01721044|54240050|FG001|Treatment Period|Protocol Violation|0|||
27785718|NCT01721044|54240051|FG002|Treatment Period|Protocol Violation|0|||
27785719|NCT01721044|54240049|FG000|Treatment Period|Withdrawal by Subject|7|||
27785720|NCT01721044|54240050|FG001|Treatment Period|Withdrawal by Subject|6|||
27785721|NCT01721044|54240051|FG002|Treatment Period|Withdrawal by Subject|1|||
27785722|NCT02164981|54240073|FG000|Started|Withdrawal by Subject|2|||
27785723|NCT02164981|54240074|FG001|Started|Withdrawal by Subject|1|||
27785724|NCT02164981|54240075|FG002|Started|Withdrawal by Subject|0|||
27785725|NCT02164981|54240073|FG000|Started|Protocol Violation|2|||
27785726|NCT02164981|54240074|FG001|Started|Protocol Violation|0|||
27785727|NCT02164981|54240075|FG002|Started|Protocol Violation|0|||
27785728|NCT02164981|54240073|FG000|Started|Adverse Event|1|||
27785729|NCT02164981|54240074|FG001|Started|Adverse Event|2|||
27785730|NCT02164981|54240075|FG002|Started|Adverse Event|0|||
27785731|NCT02164981|54240073|FG000|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
27785732|NCT02164981|54240074|FG001|Phase 1 (Day 0 - Day 14)|Adverse Event|2|||
27785733|NCT02164981|54240075|FG002|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
27785734|NCT02164981|54240073|FG000|Phase 2 (Day 14 - Day 28)|Adverse Event|2|||
27785735|NCT02164981|54240074|FG001|Phase 2 (Day 14 - Day 28)|Adverse Event|1|||
27785736|NCT02164981|54240075|FG002|Phase 2 (Day 14 - Day 28)|Adverse Event|0|||
27785737|NCT02164981|54240073|FG000|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
27785738|NCT02164981|54240074|FG001|Phase 2 (Day 14 - Day 28)|Protocol Violation|1|||
27785739|NCT02164981|54240075|FG002|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
27785740|NCT02195869|54240096|FG000|Overall Study|cGVHD Progression|5|||
27785741|NCT02195869|54240096|FG000|Overall Study|Malignancy Progression/relapse|2|||
27785742|NCT02195869|54240096|FG000|Overall Study|Adverse Event|15|||
27785743|NCT02195869|54240096|FG000|Overall Study|Withdrawal by Subject|7|||
27785744|NCT02195869|54240096|FG000|Overall Study|Physician Decision|4|||
27785745|NCT02195869|54240096|FG000|Overall Study|Study Terminated by Sponsor|7|||
27785746|NCT02195869|54240096|FG000|Overall Study|Noncompliance with study drug|2|||
27785747|NCT01908699|54240105|FG000|Overall Study|Adverse Event|8|||
27785748|NCT01908699|54240106|FG001|Overall Study|Adverse Event|12|||
27785749|NCT01908699|54240105|FG000|Overall Study|Lack of Efficacy|2|||
27785750|NCT01908699|54240106|FG001|Overall Study|Lack of Efficacy|2|||
27785751|NCT01908699|54240105|FG000|Overall Study|Lost to Follow-up|2|||
27785752|NCT01908699|54240106|FG001|Overall Study|Lost to Follow-up|4|||
27785753|NCT01908699|54240105|FG000|Overall Study|Physician Decision|8|||
27785754|NCT01908699|54240106|FG001|Overall Study|Physician Decision|8|||
27785755|NCT01908699|54240105|FG000|Overall Study|Withdrawal by Subject|15|||
27785756|NCT01908699|54240106|FG001|Overall Study|Withdrawal by Subject|10|||
27785757|NCT01908699|54240105|FG000|Overall Study|Pregnancy|0|||
27785758|NCT01908699|54240106|FG001|Overall Study|Pregnancy|1|||
27785759|NCT01908699|54240105|FG000|Overall Study|Randomized in Error|1|||
27785760|NCT01908699|54240106|FG001|Overall Study|Randomized in Error|0|||
27785761|NCT01908699|54240105|FG000|Overall Study|Death|9|||
27785762|NCT01908699|54240106|FG001|Overall Study|Death|12|||
27785763|NCT01908699|54240105|FG000|Overall Study|Progressive Disease|30|||
27785764|NCT01908699|54240106|FG001|Overall Study|Progressive Disease|29|||
27785765|NCT01599637|54240115|FG000|Overall Study|administrative problems|0|||
27785766|NCT01599637|54240116|FG001|Overall Study|administrative problems|2|||
27785767|NCT01599637|54240117|FG002|Overall Study|administrative problems|0|||
27785768|NCT01599637|54240115|FG000|Overall Study|Adverse Event|1|||
27785769|NCT01599637|54240116|FG001|Overall Study|Adverse Event|0|||
27785770|NCT01599637|54240117|FG002|Overall Study|Adverse Event|0|||
27785771|NCT02264639|54240132|FG000|Overall Study|Death (after completing single-dose phase)|1|||
27785772|NCT02264639|54240133|FG001|Overall Study|Death (after completing single-dose phase)|0|||
27785773|NCT02264639|54240134|FG002|Overall Study|Death (after completing single-dose phase)|0|||
27785774|NCT02264639|54240135|FG003|Overall Study|Death (after completing single-dose phase)|0|||
27785775|NCT02264639|54240136|FG004|Overall Study|Death (after completing single-dose phase)|0|||
27785776|NCT02264639|54240132|FG000|Overall Study|Withdrawal by subject (during multiple-dose phase)|1|||
27785777|NCT02264639|54240133|FG001|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
27785778|NCT02264639|54240134|FG002|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
27785779|NCT02264639|54240135|FG003|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
27785780|NCT02264639|54240136|FG004|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
27785781|NCT02264639|54240132|FG000|Overall Study|Pregnancy (during multiple-dose phase)|0|||
27785782|NCT02264639|54240133|FG001|Overall Study|Pregnancy (during multiple-dose phase)|0|||
27785783|NCT02264639|54240134|FG002|Overall Study|Pregnancy (during multiple-dose phase)|1|||
27785784|NCT02264639|54240135|FG003|Overall Study|Pregnancy (during multiple-dose phase)|0|||
27785785|NCT02264639|54240136|FG004|Overall Study|Pregnancy (during multiple-dose phase)|0|||
27785786|NCT02264639|54240132|FG000|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
27785787|NCT02264639|54240133|FG001|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
27785788|NCT02264639|54240134|FG002|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
27785789|NCT02264639|54240135|FG003|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
27785790|NCT02264639|54240136|FG004|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1|||
27785791|NCT01363011|54240153|FG000|Main Study|Adverse Event|2|||
27785792|NCT01363011|54240154|FG001|Main Study|Adverse Event|3|||
27785793|NCT01363011|54240153|FG000|Main Study|Investigator's Discretion|1|||
27785794|NCT01363011|54240154|FG001|Main Study|Investigator's Discretion|1|||
27785795|NCT01363011|54240153|FG000|Main Study|Withdrew Consent|1|||
27785796|NCT01363011|54240154|FG001|Main Study|Withdrew Consent|4|||
27785797|NCT01363011|54240153|FG000|Main Study|Protocol Violation|0|||
27785798|NCT01363011|54240154|FG001|Main Study|Protocol Violation|1|||
27841168|NCT01584440|54329173|FG001|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
27841169|NCT01584440|54329174|FG002|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
27785799|NCT01363011|54240153|FG000|Extension Phase|Adverse Event|1|||
27785800|NCT01363011|54240154|FG001|Extension Phase|Adverse Event|1|||
27785801|NCT01363011|54240153|FG000|Extension Phase|Lack of Efficacy|0|||
27785802|NCT01363011|54240154|FG001|Extension Phase|Lack of Efficacy|1|||
27785803|NCT01363011|54240153|FG000|Extension Phase|Investigator's Discretion|2|||
27785804|NCT01363011|54240154|FG001|Extension Phase|Investigator's Discretion|2|||
27785805|NCT01363011|54240153|FG000|Extension Phase|Withdrew Consent|0|||
27785806|NCT01363011|54240154|FG001|Extension Phase|Withdrew Consent|1|||
27785807|NCT01363011|54240153|FG000|Extension Phase|Lost to Follow-up|0|||
27785808|NCT01363011|54240154|FG001|Extension Phase|Lost to Follow-up|2|||
27785809|NCT01363011|54240153|FG000|Extension Phase|Rolled Over to Another Gilead Study|2|||
27785810|NCT01363011|54240154|FG001|Extension Phase|Rolled Over to Another Gilead Study|1|||
27785811|NCT02263547|54240160|FG000|Overall Study|Adverse Event|1|||
27785812|NCT02263547|54240160|FG000|Overall Study|Lost to Follow-up|2|||
27785813|NCT01925703|54240164|FG000|Overall Study|Physician Decision|1|||
27841170|NCT01584440|54329175|FG003|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
27841171|NCT01584440|54329176|FG004|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
27785814|NCT01925703|54240164|FG000|Overall Study|Lost to Follow-up|2|||
27785815|NCT01925703|54240164|FG000|Overall Study|Discharge prior to full iron repletion|1|||
27785816|NCT02195011|54240170|FG000|Overall Study|Adverse Event|4|||
27785817|NCT02195011|54240171|FG001|Overall Study|Adverse Event|0|||
27785818|NCT02195011|54240170|FG000|Overall Study|Progressive Disease|18|||
27785819|NCT02195011|54240171|FG001|Overall Study|Progressive Disease|1|||
27785820|NCT02195011|54240170|FG000|Overall Study|Withdrawal by Subject|3|||
27785821|NCT02195011|54240171|FG001|Overall Study|Withdrawal by Subject|0|||
27785822|NCT01617681|54240181|FG000|Period 1 Double Blind|Adverse Event|2|||
27785823|NCT01617681|54240182|FG001|Period 1 Double Blind|Adverse Event|0|||
27785824|NCT01617681|54240183|FG002|Period 1 Double Blind|Adverse Event|0|||
27785825|NCT01617681|54240184|FG003|Period 1 Double Blind|Adverse Event|2|||
27785826|NCT01617681|54240185|FG004|Period 1 Double Blind|Adverse Event|0|||
27785827|NCT01617681|54240181|FG000|Period 1 Double Blind|Withdrawal by Subject|1|||
27785828|NCT01617681|54240182|FG001|Period 1 Double Blind|Withdrawal by Subject|1|||
27785829|NCT01617681|54240183|FG002|Period 1 Double Blind|Withdrawal by Subject|1|||
27785830|NCT01617681|54240184|FG003|Period 1 Double Blind|Withdrawal by Subject|0|||
27785831|NCT01617681|54240185|FG004|Period 1 Double Blind|Withdrawal by Subject|0|||
27785832|NCT01617681|54240181|FG000|Period 2 Open Label|Adverse Event|0|||
27785833|NCT01617681|54240182|FG001|Period 2 Open Label|Adverse Event|0|||
27785834|NCT01617681|54240183|FG002|Period 2 Open Label|Adverse Event|0|||
27785835|NCT01617681|54240184|FG003|Period 2 Open Label|Adverse Event|0|||
27785836|NCT01617681|54240185|FG004|Period 2 Open Label|Adverse Event|3|||
27785837|NCT01617681|54240181|FG000|Period 2 Open Label|Withdrawal by Subject|0|||
27785838|NCT01617681|54240182|FG001|Period 2 Open Label|Withdrawal by Subject|0|||
27785839|NCT01617681|54240183|FG002|Period 2 Open Label|Withdrawal by Subject|0|||
27785840|NCT01617681|54240184|FG003|Period 2 Open Label|Withdrawal by Subject|0|||
27785841|NCT01617681|54240185|FG004|Period 2 Open Label|Withdrawal by Subject|3|||
27785842|NCT02263079|54240197|FG000|Overall Study|Physician Decision|1|||
27785843|NCT02263079|54240198|FG001|Overall Study|Physician Decision|0|||
27785844|NCT02263079|54240199|FG002|Overall Study|Physician Decision|0|||
27785845|NCT02263079|54240197|FG000|Overall Study|Withdrawal by Subject|2|||
27785846|NCT02263079|54240198|FG001|Overall Study|Withdrawal by Subject|8|||
27785847|NCT02263079|54240199|FG002|Overall Study|Withdrawal by Subject|0|||
27785848|NCT02295995|54240209|FG000|Overall Study|Lost to Follow-up|5|||
27785849|NCT02295995|54240210|FG001|Overall Study|Lost to Follow-up|1|||
27785850|NCT02294981|54240217|FG000|Overall Study|Lost to Follow-up|1|||
27785851|NCT02262377|54240223|FG000|Overall Study|Lost to Follow-up|5|||
27785852|NCT02262377|54240224|FG001|Overall Study|Lost to Follow-up|6|||
27785853|NCT02262377|54240223|FG000|Overall Study|Found ineligible after enrollment|3|||
27785854|NCT02262377|54240224|FG001|Overall Study|Found ineligible after enrollment|0|||
27785855|NCT02262377|54240223|FG000|Overall Study|Withdrawal by Subject|4|||
27785856|NCT02262377|54240224|FG001|Overall Study|Withdrawal by Subject|0|||
27785857|NCT02260817|54240233|FG000|Overall Study|Lost to Follow-up|0|||
27785858|NCT02260817|54240234|FG001|Overall Study|Lost to Follow-up|14|||
27785859|NCT02260817|54240233|FG000|Overall Study|Androgen deprivation therapy, no biopsy|0|||
27785860|NCT02260817|54240234|FG001|Overall Study|Androgen deprivation therapy, no biopsy|7|||
27785861|NCT02260817|54240233|FG000|Overall Study|Observation, no biopsy|0|||
27785862|NCT02260817|54240234|FG001|Overall Study|Observation, no biopsy|1|||
27785863|NCT02260817|54240233|FG000|Overall Study|Biopsy infeasible, ADT & rad. therapy|0|||
27785864|NCT02260817|54240234|FG001|Overall Study|Biopsy infeasible, ADT & rad. therapy|1|||
27785865|NCT02260817|54240233|FG000|Overall Study|Protocol Violation|0|||
27785866|NCT02260817|54240234|FG001|Overall Study|Protocol Violation|14|||
27785867|NCT01642589|54240242|FG000|Overall Study|Withdrawal by Subject|1|||
27785868|NCT01642589|54240243|FG001|Overall Study|Withdrawal by Subject|1|||
27785869|NCT02268812|54240253|FG000|Overall Study|Adverse Event|8|||
27785870|NCT02268812|54240254|FG001|Overall Study|Adverse Event|26|||
27785871|NCT02268812|54240255|FG002|Overall Study|Adverse Event|7|||
27785872|NCT02268812|54240256|FG003|Overall Study|Adverse Event|10|||
27785873|NCT02268812|54240253|FG000|Overall Study|Protocol deviation|0|||
27785874|NCT02268812|54240254|FG001|Overall Study|Protocol deviation|0|||
27785875|NCT02268812|54240255|FG002|Overall Study|Protocol deviation|1|||
27785876|NCT02268812|54240256|FG003|Overall Study|Protocol deviation|0|||
27785877|NCT02268812|54240253|FG000|Overall Study|Withdrawal by Subject|0|||
27785878|NCT02268812|54240254|FG001|Overall Study|Withdrawal by Subject|1|||
27841172|NCT01584440|54329172|FG000|Stage 1 (5 Weeks)|Adverse Event|5|||
27785879|NCT02268812|54240255|FG002|Overall Study|Withdrawal by Subject|0|||
27785880|NCT02268812|54240256|FG003|Overall Study|Withdrawal by Subject|0|||
27785881|NCT02268812|54240253|FG000|Overall Study|Physician Decision|3|||
27785882|NCT02268812|54240254|FG001|Overall Study|Physician Decision|1|||
27785883|NCT02268812|54240255|FG002|Overall Study|Physician Decision|0|||
27785884|NCT02268812|54240256|FG003|Overall Study|Physician Decision|1|||
27785885|NCT02268812|54240253|FG000|Overall Study|Other|5|||
27785886|NCT02268812|54240254|FG001|Overall Study|Other|4|||
27785887|NCT02268812|54240255|FG002|Overall Study|Other|1|||
27785888|NCT02268812|54240256|FG003|Overall Study|Other|3|||
27785889|NCT01954251|54240268|FG000|Overall Study|Adverse Event|5|||
27785890|NCT01954251|54240269|FG001|Overall Study|Adverse Event|7|||
27785891|NCT01954251|54240268|FG000|Overall Study|Lost to Follow-up|6|||
27785892|NCT01954251|54240269|FG001|Overall Study|Lost to Follow-up|6|||
27785893|NCT01954251|54240268|FG000|Overall Study|Withdrawal by Subject|2|||
27785894|NCT01954251|54240269|FG001|Overall Study|Withdrawal by Subject|6|||
27785895|NCT01644617|54240279|FG000|Overall Study|Withdrawal by Subject|3|||
27785896|NCT01644617|54240280|FG001|Overall Study|Withdrawal by Subject|4|||
27785897|NCT01644617|54240281|FG002|Overall Study|Withdrawal by Subject|1|||
27785898|NCT01644617|54240279|FG000|Overall Study|Lost to Follow-up|0|||
27785899|NCT01644617|54240280|FG001|Overall Study|Lost to Follow-up|1|||
27785900|NCT01644617|54240281|FG002|Overall Study|Lost to Follow-up|0|||
27785901|NCT01644617|54240279|FG000|Overall Study|Adverse Event|3|||
27785902|NCT01644617|54240280|FG001|Overall Study|Adverse Event|0|||
27785903|NCT01644617|54240281|FG002|Overall Study|Adverse Event|6|||
27785904|NCT02294318|54240291|FG000|Overall Study|Worsening of drinking|3|||
27785905|NCT02294318|54240292|FG001|Overall Study|Worsening of drinking|0|||
27785906|NCT02294318|54240291|FG000|Overall Study|Not exposed to intervention|0|||
27785907|NCT02294318|54240292|FG001|Overall Study|Not exposed to intervention|2|||
27785908|NCT02293499|54240301|FG000|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
27785909|NCT02293499|54240302|FG001|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
27785910|NCT02293499|54240303|FG002|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|10|||
27785911|NCT02293499|54240301|FG000|Intervention - Camp|Withdrawal by Subject|3|||
27785912|NCT02293499|54240302|FG001|Intervention - Camp|Withdrawal by Subject|6|||
27785913|NCT02293499|54240303|FG002|Intervention - Camp|Withdrawal by Subject|2|||
27785914|NCT02293499|54240301|FG000|Intervention - Camp|these are those not showing up at camp|24|||
27785915|NCT02293499|54240302|FG001|Intervention - Camp|these are those not showing up at camp|28|||
27785916|NCT02293499|54240303|FG002|Intervention - Camp|these are those not showing up at camp|4|||
27785917|NCT02293499|54240301|FG000|3 Month Follow Up|Withdrawal by Subject|1|||
27785918|NCT02293499|54240302|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
27785919|NCT02293499|54240303|FG002|3 Month Follow Up|Withdrawal by Subject|4|||
27785920|NCT02293499|54240301|FG000|3 Month Follow Up|Lost to Follow-up|14|||
27785921|NCT02293499|54240302|FG001|3 Month Follow Up|Lost to Follow-up|15|||
27785922|NCT02293499|54240303|FG002|3 Month Follow Up|Lost to Follow-up|6|||
27785923|NCT02293499|54240301|FG000|6 Month Follow Up|Lost to Follow-up|17|||
27785924|NCT02293499|54240302|FG001|6 Month Follow Up|Lost to Follow-up|27|||
27785925|NCT02293499|54240303|FG002|6 Month Follow Up|Lost to Follow-up|6|||
27785926|NCT02293499|54240301|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
27785927|NCT02293499|54240302|FG001|6 Month Follow Up|Withdrawal by Subject|0|||
27785928|NCT02293499|54240303|FG002|6 Month Follow Up|Withdrawal by Subject|1|||
27785929|NCT02293499|54240301|FG000|9 Month Follow Up|Withdrawal by Subject|2|||
27785930|NCT02293499|54240302|FG001|9 Month Follow Up|Withdrawal by Subject|0|||
27785931|NCT02293499|54240303|FG002|9 Month Follow Up|Withdrawal by Subject|0|||
27785932|NCT02293499|54240301|FG000|9 Month Follow Up|Lost to Follow-up|24|||
27785933|NCT02293499|54240302|FG001|9 Month Follow Up|Lost to Follow-up|28|||
27785934|NCT02293499|54240303|FG002|9 Month Follow Up|Lost to Follow-up|4|||
27785935|NCT02293499|54240301|FG000|12 Month Follow Up|Lost to Follow-up|26|||
27785936|NCT02293499|54240302|FG001|12 Month Follow Up|Lost to Follow-up|25|||
27785937|NCT02293499|54240303|FG002|12 Month Follow Up|Lost to Follow-up|6|||
27785938|NCT02293499|54240301|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
27785939|NCT02293499|54240302|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
27785940|NCT02293499|54240303|FG002|12 Month Follow Up|Withdrawal by Subject|0|||
27785941|NCT02293499|54240301|FG000|15 Month Follow Up|Lost to Follow-up|22|||
27785942|NCT02293499|54240302|FG001|15 Month Follow Up|Lost to Follow-up|22|||
27785943|NCT02293499|54240303|FG002|15 Month Follow Up|Lost to Follow-up|7|||
27785944|NCT02257385|54240314|FG000|Overall Study|Adverse Event|12|||
27785945|NCT02257385|54240315|FG001|Overall Study|Adverse Event|8|||
27785946|NCT02257385|54240314|FG000|Overall Study|Lack of Efficacy|1|||
27785947|NCT02257385|54240315|FG001|Overall Study|Lack of Efficacy|2|||
27785948|NCT02257385|54240314|FG000|Overall Study|Protocol Violation|5|||
27785949|NCT02257385|54240315|FG001|Overall Study|Protocol Violation|7|||
27785950|NCT02257385|54240314|FG000|Overall Study|Lost to Follow-up|0|||
27785951|NCT02257385|54240315|FG001|Overall Study|Lost to Follow-up|1|||
27785952|NCT02257385|54240314|FG000|Overall Study|Withdrawal by Subject|4|||
27785953|NCT02257385|54240315|FG001|Overall Study|Withdrawal by Subject|4|||
27785954|NCT01629667|54240324|FG000|Overall Study|Lost to Follow-up|0|||
27785955|NCT01629667|54240325|FG001|Overall Study|Lost to Follow-up|1|||
27785956|NCT01629667|54240326|FG002|Overall Study|Lost to Follow-up|1|||
27785957|NCT01629667|54240324|FG000|Overall Study|Withdrawal by Subject|31|||
27785958|NCT01629667|54240325|FG001|Overall Study|Withdrawal by Subject|20|||
27785959|NCT01629667|54240326|FG002|Overall Study|Withdrawal by Subject|28|||
27785960|NCT01629667|54240324|FG000|Overall Study|Death|1|||
27785961|NCT01629667|54240325|FG001|Overall Study|Death|5|||
27785962|NCT01629667|54240326|FG002|Overall Study|Death|3|||
27785963|NCT01629667|54240324|FG000|Overall Study|Randomized, not treated|2|||
27785964|NCT01629667|54240325|FG001|Overall Study|Randomized, not treated|1|||
27785965|NCT01629667|54240326|FG002|Overall Study|Randomized, not treated|0|||
27785966|NCT01629667|54240324|FG000|Overall Study|Ongoing AE worsening right heart failure|0|||
27785967|NCT01629667|54240325|FG001|Overall Study|Ongoing AE worsening right heart failure|1|||
27785968|NCT01629667|54240326|FG002|Overall Study|Ongoing AE worsening right heart failure|0|||
27785969|NCT01629667|54240324|FG000|Overall Study|Requiring lung transplant|2|||
27785970|NCT01629667|54240325|FG001|Overall Study|Requiring lung transplant|1|||
27785971|NCT01629667|54240326|FG002|Overall Study|Requiring lung transplant|3|||
27785972|NCT01629667|54240324|FG000|Overall Study|Early tretmt termntd, cmpltd safety f-up|9|||
27785973|NCT01629667|54240325|FG001|Overall Study|Early tretmt termntd, cmpltd safety f-up|11|||
27785974|NCT01629667|54240326|FG002|Overall Study|Early tretmt termntd, cmpltd safety f-up|8|||
27785975|NCT01629667|54240324|FG000|Overall Study|Started other medicine|1|||
27785976|NCT01629667|54240325|FG001|Overall Study|Started other medicine|0|||
27785977|NCT01629667|54240326|FG002|Overall Study|Started other medicine|1|||
27785978|NCT01629667|54240324|FG000|Overall Study|Site error in safety follow-up|0|||
27785979|NCT01629667|54240325|FG001|Overall Study|Site error in safety follow-up|0|||
27785980|NCT01629667|54240326|FG002|Overall Study|Site error in safety follow-up|1|||
27785981|NCT01629667|54240324|FG000|Overall Study|Enrolled in another clinical study|0|||
27785982|NCT01629667|54240325|FG001|Overall Study|Enrolled in another clinical study|1|||
27785983|NCT01629667|54240326|FG002|Overall Study|Enrolled in another clinical study|0|||
27785984|NCT01629667|54240324|FG000|Overall Study|Code break|1|||
27785985|NCT01629667|54240325|FG001|Overall Study|Code break|0|||
27785986|NCT01629667|54240326|FG002|Overall Study|Code break|0|||
27785987|NCT01645280|54240341|FG000|Overall Study|Death|0|||
27785988|NCT01645280|54240342|FG001|Overall Study|Death|1|||
27785989|NCT01645280|54240343|FG002|Overall Study|Death|0|||
27785990|NCT01645280|54240344|FG003|Overall Study|Death|0|||
27785991|NCT01645280|54240345|FG004|Overall Study|Death|0|||
27785992|NCT01645280|54240341|FG000|Overall Study|Withdrawal by Subject|4|||
27785993|NCT01645280|54240342|FG001|Overall Study|Withdrawal by Subject|0|||
27841173|NCT01584440|54329173|FG001|Stage 1 (5 Weeks)|Adverse Event|3|||
27841174|NCT01584440|54329174|FG002|Stage 1 (5 Weeks)|Adverse Event|0|||
27841175|NCT01584440|54329175|FG003|Stage 1 (5 Weeks)|Adverse Event|0|||
27841176|NCT01584440|54329176|FG004|Stage 1 (5 Weeks)|Adverse Event|0|||
27841177|NCT01584440|54329172|FG000|Stage 1 (5 Weeks)|Lost to Follow-up|1|||
27841178|NCT01584440|54329173|FG001|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
27841179|NCT01584440|54329174|FG002|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
27841180|NCT01584440|54329175|FG003|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
27841181|NCT01584440|54329176|FG004|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
27785994|NCT01645280|54240343|FG002|Overall Study|Withdrawal by Subject|2|||
27785995|NCT01645280|54240344|FG003|Overall Study|Withdrawal by Subject|4|||
27785996|NCT01645280|54240345|FG004|Overall Study|Withdrawal by Subject|5|||
27785997|NCT01645280|54240341|FG000|Overall Study|Lost to Follow-up|0|||
27785998|NCT01645280|54240342|FG001|Overall Study|Lost to Follow-up|0|||
27785999|NCT01645280|54240343|FG002|Overall Study|Lost to Follow-up|0|||
27786000|NCT01645280|54240344|FG003|Overall Study|Lost to Follow-up|2|||
27786001|NCT01645280|54240345|FG004|Overall Study|Lost to Follow-up|1|||
27786002|NCT01645280|54240341|FG000|Overall Study|Other|1|||
27786003|NCT01645280|54240342|FG001|Overall Study|Other|1|||
27786004|NCT01645280|54240343|FG002|Overall Study|Other|2|||
27786005|NCT01645280|54240344|FG003|Overall Study|Other|0|||
27786006|NCT01645280|54240345|FG004|Overall Study|Other|0|||
27786007|NCT01645280|54240341|FG000|Overall Study|Treatment not completed/Completed f/u|1|||
27786008|NCT01645280|54240342|FG001|Overall Study|Treatment not completed/Completed f/u|1|||
27786009|NCT01645280|54240343|FG002|Overall Study|Treatment not completed/Completed f/u|2|||
27841182|NCT01584440|54329172|FG000|Stage 1 (5 Weeks)|Protocol Violation|2|||
27841183|NCT01584440|54329173|FG001|Stage 1 (5 Weeks)|Protocol Violation|3|||
27841184|NCT01584440|54329174|FG002|Stage 1 (5 Weeks)|Protocol Violation|0|||
27841185|NCT01584440|54329175|FG003|Stage 1 (5 Weeks)|Protocol Violation|0|||
27841186|NCT01584440|54329176|FG004|Stage 1 (5 Weeks)|Protocol Violation|0|||
27841187|NCT01584440|54329172|FG000|Stage 1 (5 Weeks)|Withdrawal by Subject|1|||
27841188|NCT01584440|54329173|FG001|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
27841189|NCT01584440|54329174|FG002|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
27841190|NCT01584440|54329175|FG003|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
27841191|NCT01584440|54329176|FG004|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
27841192|NCT01584440|54329172|FG000|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
27841193|NCT01584440|54329173|FG001|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|2|||
27841194|NCT01584440|54329174|FG002|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
27841195|NCT01584440|54329175|FG003|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
27926945|NCT01013740|54583421|FG000|Overall Study|Ongoing: Study records not completed|0|||
27926946|NCT01013740|54583422|FG001|Overall Study|Ongoing: Study records not completed|2|||
27926947|NCT01013350|54583432|FG000|Overall Study|Lost to Follow-up|15|||
27926948|NCT01013350|54583433|FG001|Overall Study|Lost to Follow-up|95|||
27926949|NCT01013350|54583432|FG000|Overall Study|Adverse Event|0|||
27926950|NCT01013350|54583433|FG001|Overall Study|Adverse Event|1|||
27926951|NCT01013350|54583432|FG000|Overall Study|Physician Decision|4|||
27926952|NCT01013350|54583433|FG001|Overall Study|Physician Decision|20|||
27926953|NCT01013350|54583432|FG000|Overall Study|Withdrawal by Subject|15|||
27926954|NCT01013350|54583433|FG001|Overall Study|Withdrawal by Subject|38|||
27786010|NCT01645280|54240344|FG003|Overall Study|Treatment not completed/Completed f/u|0|||
27786011|NCT01645280|54240345|FG004|Overall Study|Treatment not completed/Completed f/u|2|||
27786012|NCT02256917|54240358|FG000|Prophylactic Treatment Phase I|Lost to Follow-up|1|||
27841196|NCT01584440|54329176|FG004|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
27841197|NCT01584440|54329172|FG000|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
27841198|NCT01584440|54329173|FG001|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
27841199|NCT01584440|54329174|FG002|Stage 2 (5 Weeks)|Withdrawal by Subject|1|||
27841200|NCT01584440|54329175|FG003|Stage 2 (5 Weeks)|Withdrawal by Subject|2|||
27926955|NCT01013350|54583432|FG000|Overall Study|Death|3|||
27926956|NCT01013350|54583433|FG001|Overall Study|Death|5|||
27926957|NCT01013350|54583432|FG000|Overall Study|Participant entered interventional study|0|||
27926958|NCT01013350|54583433|FG001|Overall Study|Participant entered interventional study|8|||
27926959|NCT01013350|54583432|FG000|Overall Study|Other|1|||
27926960|NCT01013350|54583433|FG001|Overall Study|Other|25|||
27926961|NCT01018030|54583443|FG000|Overall Study|Adverse Event|10|||
27926962|NCT01018030|54583444|FG001|Overall Study|Adverse Event|5|||
27926963|NCT01018030|54583445|FG002|Overall Study|Adverse Event|5|||
27786013|NCT02256917|54240358|FG000|Prophylactic Treatment Phase II|Lost to Follow-up|1|||
27926964|NCT01018030|54583443|FG000|Overall Study|Withdrawal by Subject|2|||
27926965|NCT01018030|54583444|FG001|Overall Study|Withdrawal by Subject|2|||
27926966|NCT01018030|54583445|FG002|Overall Study|Withdrawal by Subject|4|||
27926967|NCT01018030|54583443|FG000|Overall Study|Lost to Follow-up|2|||
27926968|NCT01018030|54583444|FG001|Overall Study|Lost to Follow-up|0|||
27926969|NCT01018030|54583445|FG002|Overall Study|Lost to Follow-up|3|||
27926970|NCT01018030|54583443|FG000|Overall Study|Protocol Violation|2|||
27926971|NCT01018030|54583444|FG001|Overall Study|Protocol Violation|1|||
27926972|NCT01018030|54583445|FG002|Overall Study|Protocol Violation|0|||
27926973|NCT01018030|54583443|FG000|Overall Study|Physician Decision|1|||
27926974|NCT01018030|54583444|FG001|Overall Study|Physician Decision|0|||
27926975|NCT01018030|54583445|FG002|Overall Study|Physician Decision|1|||
27926976|NCT01018030|54583443|FG000|Overall Study|Lack of Efficacy|1|||
27926977|NCT01018030|54583444|FG001|Overall Study|Lack of Efficacy|0|||
27926978|NCT01018030|54583445|FG002|Overall Study|Lack of Efficacy|0|||
27926979|NCT01018030|54583443|FG000|Overall Study|Did Not Receive Study Drug|1|||
27926980|NCT01018030|54583444|FG001|Overall Study|Did Not Receive Study Drug|3|||
27926981|NCT01018030|54583445|FG002|Overall Study|Did Not Receive Study Drug|0|||
27926982|NCT01217073|54583461|FG000|Base Period|Adverse Event|1|||
27926983|NCT01217073|54583462|FG001|Base Period|Adverse Event|0|||
27926984|NCT01217073|54583463|FG002|Base Period|Adverse Event|1|||
27926985|NCT01217073|54583464|FG003|Base Period|Adverse Event|0|||
27926986|NCT01217073|54583465|FG004|Base Period|Adverse Event|4|||
27926987|NCT01217073|54583466|FG005|Base Period|Adverse Event|1|||
27926988|NCT01217073|54583467|FG006|Base Period|Adverse Event|0|||
27926989|NCT01217073|54583468|FG007|Base Period|Adverse Event|0|||
27926990|NCT01217073|54583461|FG000|Base Period|Alanine aminotransferase (ALT)/AST|1|||
27926991|NCT01217073|54583462|FG001|Base Period|Alanine aminotransferase (ALT)/AST|0|||
27926992|NCT01217073|54583463|FG002|Base Period|Alanine aminotransferase (ALT)/AST|0|||
27926993|NCT01217073|54583464|FG003|Base Period|Alanine aminotransferase (ALT)/AST|0|||
27926994|NCT01217073|54583465|FG004|Base Period|Alanine aminotransferase (ALT)/AST|0|||
27926995|NCT01217073|54583466|FG005|Base Period|Alanine aminotransferase (ALT)/AST|0|||
27926996|NCT01217073|54583467|FG006|Base Period|Alanine aminotransferase (ALT)/AST|0|||
27926997|NCT01217073|54583468|FG007|Base Period|Alanine aminotransferase (ALT)/AST|0|||
27926998|NCT01217073|54583461|FG000|Base Period|Excluded medication|0|||
27926999|NCT01217073|54583462|FG001|Base Period|Excluded medication|0|||
27927000|NCT01217073|54583463|FG002|Base Period|Excluded medication|0|||
27927001|NCT01217073|54583464|FG003|Base Period|Excluded medication|0|||
27927002|NCT01217073|54583465|FG004|Base Period|Excluded medication|1|||
27927003|NCT01217073|54583466|FG005|Base Period|Excluded medication|0|||
27927004|NCT01217073|54583467|FG006|Base Period|Excluded medication|0|||
27927005|NCT01217073|54583468|FG007|Base Period|Excluded medication|0|||
27927006|NCT01217073|54583461|FG000|Base Period|Lack of Efficacy|0|||
27927007|NCT01217073|54583462|FG001|Base Period|Lack of Efficacy|0|||
27927008|NCT01217073|54583463|FG002|Base Period|Lack of Efficacy|0|||
27927009|NCT01217073|54583464|FG003|Base Period|Lack of Efficacy|0|||
27927010|NCT01217073|54583465|FG004|Base Period|Lack of Efficacy|0|||
27927011|NCT01217073|54583466|FG005|Base Period|Lack of Efficacy|1|||
27927012|NCT01217073|54583467|FG006|Base Period|Lack of Efficacy|0|||
27927013|NCT01217073|54583468|FG007|Base Period|Lack of Efficacy|0|||
27927014|NCT01217073|54583461|FG000|Base Period|Lost to Follow-up|0|||
27927015|NCT01217073|54583462|FG001|Base Period|Lost to Follow-up|0|||
27927016|NCT01217073|54583463|FG002|Base Period|Lost to Follow-up|1|||
27927017|NCT01217073|54583464|FG003|Base Period|Lost to Follow-up|1|||
27927018|NCT01217073|54583465|FG004|Base Period|Lost to Follow-up|3|||
27927019|NCT01217073|54583466|FG005|Base Period|Lost to Follow-up|0|||
27927020|NCT01217073|54583467|FG006|Base Period|Lost to Follow-up|0|||
27927021|NCT01217073|54583468|FG007|Base Period|Lost to Follow-up|0|||
27927022|NCT01217073|54583461|FG000|Base Period|Physician Decision|0|||
27927023|NCT01217073|54583462|FG001|Base Period|Physician Decision|0|||
27927024|NCT01217073|54583463|FG002|Base Period|Physician Decision|0|||
27927025|NCT01217073|54583464|FG003|Base Period|Physician Decision|0|||
27927026|NCT01217073|54583465|FG004|Base Period|Physician Decision|1|||
27927027|NCT01217073|54583466|FG005|Base Period|Physician Decision|0|||
27927028|NCT01217073|54583467|FG006|Base Period|Physician Decision|0|||
27927029|NCT01217073|54583468|FG007|Base Period|Physician Decision|0|||
27927030|NCT01217073|54583461|FG000|Base Period|Protocol Violation|1|||
27927031|NCT01217073|54583462|FG001|Base Period|Protocol Violation|0|||
27927032|NCT01217073|54583463|FG002|Base Period|Protocol Violation|0|||
27927033|NCT01217073|54583464|FG003|Base Period|Protocol Violation|0|||
27927034|NCT01217073|54583465|FG004|Base Period|Protocol Violation|1|||
27927035|NCT01217073|54583466|FG005|Base Period|Protocol Violation|2|||
27927036|NCT01217073|54583467|FG006|Base Period|Protocol Violation|0|||
27927037|NCT01217073|54583468|FG007|Base Period|Protocol Violation|0|||
27927038|NCT01217073|54583461|FG000|Base Period|Withdrawal by Subject|4|||
27927039|NCT01217073|54583462|FG001|Base Period|Withdrawal by Subject|5|||
27927040|NCT01217073|54583463|FG002|Base Period|Withdrawal by Subject|5|||
27927041|NCT01217073|54583464|FG003|Base Period|Withdrawal by Subject|1|||
27927042|NCT01217073|54583465|FG004|Base Period|Withdrawal by Subject|5|||
27927043|NCT01217073|54583466|FG005|Base Period|Withdrawal by Subject|5|||
27927044|NCT01217073|54583467|FG006|Base Period|Withdrawal by Subject|0|||
27927045|NCT01217073|54583468|FG007|Base Period|Withdrawal by Subject|0|||
27927046|NCT01217073|54583461|FG000|Extension Period|Adverse Event|0|||
27927047|NCT01217073|54583462|FG001|Extension Period|Adverse Event|0|||
27927048|NCT01217073|54583463|FG002|Extension Period|Adverse Event|0|||
27927049|NCT01217073|54583464|FG003|Extension Period|Adverse Event|0|||
27927050|NCT01217073|54583465|FG004|Extension Period|Adverse Event|0|||
27927051|NCT01217073|54583466|FG005|Extension Period|Adverse Event|0|||
27927052|NCT01217073|54583467|FG006|Extension Period|Adverse Event|19|||
27927053|NCT01217073|54583468|FG007|Extension Period|Adverse Event|5|||
27927054|NCT01217073|54583461|FG000|Extension Period|ALT/AST|0|||
27927055|NCT01217073|54583462|FG001|Extension Period|ALT/AST|0|||
27927056|NCT01217073|54583463|FG002|Extension Period|ALT/AST|0|||
27927057|NCT01217073|54583464|FG003|Extension Period|ALT/AST|0|||
27927058|NCT01217073|54583465|FG004|Extension Period|ALT/AST|0|||
27927059|NCT01217073|54583466|FG005|Extension Period|ALT/AST|0|||
27927060|NCT01217073|54583467|FG006|Extension Period|ALT/AST|2|||
27927061|NCT01217073|54583468|FG007|Extension Period|ALT/AST|0|||
27927062|NCT01217073|54583461|FG000|Extension Period|Contraindication to study medication|0|||
27927063|NCT01217073|54583462|FG001|Extension Period|Contraindication to study medication|0|||
27927064|NCT01217073|54583463|FG002|Extension Period|Contraindication to study medication|0|||
27927065|NCT01217073|54583464|FG003|Extension Period|Contraindication to study medication|0|||
27927066|NCT01217073|54583465|FG004|Extension Period|Contraindication to study medication|0|||
27927067|NCT01217073|54583466|FG005|Extension Period|Contraindication to study medication|0|||
27927068|NCT01217073|54583467|FG006|Extension Period|Contraindication to study medication|1|||
27927069|NCT01217073|54583468|FG007|Extension Period|Contraindication to study medication|0|||
27927070|NCT01217073|54583461|FG000|Extension Period|Creatinine/eGFR|0|||
27927071|NCT01217073|54583462|FG001|Extension Period|Creatinine/eGFR|0|||
27927072|NCT01217073|54583463|FG002|Extension Period|Creatinine/eGFR|0|||
27927073|NCT01217073|54583464|FG003|Extension Period|Creatinine/eGFR|0|||
27927074|NCT01217073|54583465|FG004|Extension Period|Creatinine/eGFR|0|||
27927075|NCT01217073|54583466|FG005|Extension Period|Creatinine/eGFR|0|||
27927076|NCT01217073|54583467|FG006|Extension Period|Creatinine/eGFR|11|||
27927077|NCT01217073|54583468|FG007|Extension Period|Creatinine/eGFR|1|||
27927078|NCT01217073|54583461|FG000|Extension Period|Death|0|||
27927079|NCT01217073|54583462|FG001|Extension Period|Death|0|||
27927080|NCT01217073|54583463|FG002|Extension Period|Death|0|||
27927081|NCT01217073|54583464|FG003|Extension Period|Death|0|||
27927082|NCT01217073|54583465|FG004|Extension Period|Death|0|||
27927083|NCT01217073|54583466|FG005|Extension Period|Death|0|||
27927084|NCT01217073|54583467|FG006|Extension Period|Death|1|||
27927085|NCT01217073|54583468|FG007|Extension Period|Death|0|||
27927086|NCT01217073|54583461|FG000|Extension Period|Excluded medication|0|||
27927087|NCT01217073|54583462|FG001|Extension Period|Excluded medication|0|||
27927088|NCT01217073|54583463|FG002|Extension Period|Excluded medication|0|||
27927089|NCT01217073|54583464|FG003|Extension Period|Excluded medication|0|||
27927090|NCT01217073|54583465|FG004|Extension Period|Excluded medication|0|||
27927091|NCT01217073|54583466|FG005|Extension Period|Excluded medication|0|||
27927092|NCT01217073|54583467|FG006|Extension Period|Excluded medication|2|||
27927093|NCT01217073|54583468|FG007|Extension Period|Excluded medication|0|||
27927094|NCT01217073|54583461|FG000|Extension Period|Lack of Efficacy|0|||
27927095|NCT01217073|54583462|FG001|Extension Period|Lack of Efficacy|0|||
27927096|NCT01217073|54583463|FG002|Extension Period|Lack of Efficacy|0|||
27927097|NCT01217073|54583464|FG003|Extension Period|Lack of Efficacy|0|||
27927098|NCT01217073|54583465|FG004|Extension Period|Lack of Efficacy|0|||
27927099|NCT01217073|54583466|FG005|Extension Period|Lack of Efficacy|0|||
27927100|NCT01217073|54583467|FG006|Extension Period|Lack of Efficacy|3|||
27927101|NCT01217073|54583468|FG007|Extension Period|Lack of Efficacy|0|||
27927102|NCT01217073|54583461|FG000|Extension Period|Lost to Follow-up|0|||
27927103|NCT01217073|54583462|FG001|Extension Period|Lost to Follow-up|0|||
27927104|NCT01217073|54583463|FG002|Extension Period|Lost to Follow-up|0|||
27927105|NCT01217073|54583464|FG003|Extension Period|Lost to Follow-up|0|||
27927106|NCT01217073|54583465|FG004|Extension Period|Lost to Follow-up|0|||
27927107|NCT01217073|54583466|FG005|Extension Period|Lost to Follow-up|0|||
27927108|NCT01217073|54583467|FG006|Extension Period|Lost to Follow-up|9|||
27927109|NCT01217073|54583468|FG007|Extension Period|Lost to Follow-up|1|||
27927110|NCT01217073|54583461|FG000|Extension Period|Non-compliance with study drug|0|||
27927111|NCT01217073|54583462|FG001|Extension Period|Non-compliance with study drug|0|||
27927112|NCT01217073|54583463|FG002|Extension Period|Non-compliance with study drug|0|||
27927113|NCT01217073|54583464|FG003|Extension Period|Non-compliance with study drug|0|||
27927114|NCT01217073|54583465|FG004|Extension Period|Non-compliance with study drug|0|||
27927115|NCT01217073|54583466|FG005|Extension Period|Non-compliance with study drug|0|||
27927116|NCT01217073|54583467|FG006|Extension Period|Non-compliance with study drug|0|||
27927117|NCT01217073|54583468|FG007|Extension Period|Non-compliance with study drug|1|||
27927118|NCT01217073|54583461|FG000|Extension Period|Physician Decision|0|||
27927119|NCT01217073|54583462|FG001|Extension Period|Physician Decision|0|||
27927120|NCT01217073|54583463|FG002|Extension Period|Physician Decision|0|||
27927121|NCT01217073|54583464|FG003|Extension Period|Physician Decision|0|||
27927122|NCT01217073|54583465|FG004|Extension Period|Physician Decision|0|||
27927123|NCT01217073|54583466|FG005|Extension Period|Physician Decision|0|||
27927124|NCT01217073|54583467|FG006|Extension Period|Physician Decision|4|||
27927125|NCT01217073|54583468|FG007|Extension Period|Physician Decision|1|||
27927126|NCT01217073|54583461|FG000|Extension Period|Protocol Violation|0|||
27927127|NCT01217073|54583462|FG001|Extension Period|Protocol Violation|0|||
27927128|NCT01217073|54583463|FG002|Extension Period|Protocol Violation|0|||
27927129|NCT01217073|54583464|FG003|Extension Period|Protocol Violation|0|||
27927130|NCT01217073|54583465|FG004|Extension Period|Protocol Violation|0|||
27927131|NCT01217073|54583466|FG005|Extension Period|Protocol Violation|0|||
27927132|NCT01217073|54583467|FG006|Extension Period|Protocol Violation|2|||
27927133|NCT01217073|54583468|FG007|Extension Period|Protocol Violation|1|||
27927134|NCT01217073|54583461|FG000|Extension Period|Site discontinued study participation|0|||
27927135|NCT01217073|54583462|FG001|Extension Period|Site discontinued study participation|0|||
27927136|NCT01217073|54583463|FG002|Extension Period|Site discontinued study participation|0|||
27927137|NCT01217073|54583464|FG003|Extension Period|Site discontinued study participation|0|||
27927138|NCT01217073|54583465|FG004|Extension Period|Site discontinued study participation|0|||
27927139|NCT01217073|54583466|FG005|Extension Period|Site discontinued study participation|0|||
27927140|NCT01217073|54583467|FG006|Extension Period|Site discontinued study participation|7|||
27927141|NCT01217073|54583468|FG007|Extension Period|Site discontinued study participation|2|||
27927142|NCT01217073|54583461|FG000|Extension Period|Withdrawal by Subject|0|||
27927143|NCT01217073|54583462|FG001|Extension Period|Withdrawal by Subject|0|||
27927144|NCT01217073|54583463|FG002|Extension Period|Withdrawal by Subject|0|||
27927145|NCT01217073|54583464|FG003|Extension Period|Withdrawal by Subject|0|||
27927146|NCT01217073|54583465|FG004|Extension Period|Withdrawal by Subject|0|||
27927147|NCT01217073|54583466|FG005|Extension Period|Withdrawal by Subject|0|||
27927148|NCT01217073|54583467|FG006|Extension Period|Withdrawal by Subject|30|||
27927149|NCT01217073|54583468|FG007|Extension Period|Withdrawal by Subject|8|||
27927150|NCT00985621|54583496|FG000|Overall Study|Adverse Event|2|||
27927151|NCT00985621|54583497|FG001|Overall Study|Adverse Event|3|||
27927152|NCT00985621|54583498|FG002|Overall Study|Adverse Event|4|||
27927153|NCT00985621|54583499|FG003|Overall Study|Adverse Event|16|||
27927154|NCT00985621|54583496|FG000|Overall Study|Lack of Efficacy|10|||
27927155|NCT00985621|54583497|FG001|Overall Study|Lack of Efficacy|6|||
27927156|NCT00985621|54583498|FG002|Overall Study|Lack of Efficacy|5|||
27927157|NCT00985621|54583499|FG003|Overall Study|Lack of Efficacy|12|||
27927158|NCT00985621|54583496|FG000|Overall Study|Lost to Follow-up|2|||
27927159|NCT00985621|54583497|FG001|Overall Study|Lost to Follow-up|3|||
27927160|NCT00985621|54583498|FG002|Overall Study|Lost to Follow-up|4|||
27927161|NCT00985621|54583499|FG003|Overall Study|Lost to Follow-up|4|||
27927162|NCT00985621|54583496|FG000|Overall Study|Study Terminated by Sponsor|89|||
27927163|NCT00985621|54583497|FG001|Overall Study|Study Terminated by Sponsor|108|||
27927164|NCT00985621|54583498|FG002|Overall Study|Study Terminated by Sponsor|99|||
27927165|NCT00985621|54583499|FG003|Overall Study|Study Terminated by Sponsor|92|||
27927166|NCT00985621|54583496|FG000|Overall Study|Protocol Violation|1|||
27927167|NCT00985621|54583497|FG001|Overall Study|Protocol Violation|1|||
27927168|NCT00985621|54583498|FG002|Overall Study|Protocol Violation|1|||
27927169|NCT00985621|54583499|FG003|Overall Study|Protocol Violation|0|||
27927170|NCT00985621|54583496|FG000|Overall Study|Withdrawal by Subject|8|||
27927171|NCT00985621|54583497|FG001|Overall Study|Withdrawal by Subject|10|||
27927172|NCT00985621|54583498|FG002|Overall Study|Withdrawal by Subject|8|||
27927173|NCT00985621|54583499|FG003|Overall Study|Withdrawal by Subject|12|||
27927174|NCT00985621|54583496|FG000|Overall Study|Other|1|||
27927175|NCT00985621|54583497|FG001|Overall Study|Other|0|||
27927176|NCT00985621|54583498|FG002|Overall Study|Other|0|||
27927177|NCT00985621|54583499|FG003|Overall Study|Other|0|||
27927178|NCT00985621|54583496|FG000|Overall Study|Randomized but not Treated|1|||
27927179|NCT00985621|54583497|FG001|Overall Study|Randomized but not Treated|0|||
27927180|NCT00985621|54583498|FG002|Overall Study|Randomized but not Treated|2|||
27927181|NCT00985621|54583499|FG003|Overall Study|Randomized but not Treated|1|||
27927182|NCT01215981|54583513|FG000|Overall Study|Physician Decision|0|||
27927183|NCT01215981|54583514|FG001|Overall Study|Physician Decision|1|||
27927184|NCT01215981|54583513|FG000|Overall Study|Protocol Violation|1|||
27927185|NCT01215981|54583514|FG001|Overall Study|Protocol Violation|0|||
27927186|NCT01215981|54583513|FG000|Overall Study|Withdrawal by Subject|1|||
27927187|NCT01215981|54583514|FG001|Overall Study|Withdrawal by Subject|0|||
27927188|NCT01215513|54583520|FG000|Overall Study|Not completed CS42|9|||
27927189|NCT01215513|54583520|FG000|Overall Study|Not enrolled from CS42 to CS42A|21|||
27927190|NCT01215513|54583520|FG000|Overall Study|Adverse event (CS42A)|2|||
27927191|NCT01215513|54583520|FG000|Overall Study|Physician decision (CS42A)|6|||
27927192|NCT01215513|54583520|FG000|Overall Study|Withdrawal by subject (CS42A)|5|||
27927193|NCT01215513|54583520|FG000|Overall Study|Miscellaneous reasons (CS42A)|2|||
27927194|NCT01215435|54583527|FG000|Overall Study|Adverse Event|1|||
27927195|NCT01215435|54583528|FG001|Overall Study|Adverse Event|0|||
27927196|NCT01215435|54583527|FG000|Overall Study|Protocol Violation|2|||
27927197|NCT01215435|54583528|FG001|Overall Study|Protocol Violation|0|||
27927198|NCT01215435|54583527|FG000|Overall Study|Withdrawal Criteria|8|||
27927199|NCT01215435|54583528|FG001|Overall Study|Withdrawal Criteria|11|||
27927200|NCT01215435|54583527|FG000|Overall Study|Lost to Follow-up|3|||
27927201|NCT01215435|54583528|FG001|Overall Study|Lost to Follow-up|0|||
27927202|NCT01215435|54583527|FG000|Overall Study|Unclassified|5|||
27927203|NCT01215435|54583528|FG001|Overall Study|Unclassified|5|||
27927204|NCT01215357|54583534|FG000|Overall Study|Withdrawal by Subject|3|||
27927205|NCT01215357|54583534|FG000|Overall Study|Protocol Violation|9|||
27927206|NCT00984295|54583541|FG000|Overall Study|Lost to Follow-up|31|||
27927207|NCT00984295|54583542|FG001|Overall Study|Lost to Follow-up|12|||
27927208|NCT00984295|54583543|FG002|Overall Study|Lost to Follow-up|13|||
27927209|NCT00984295|54583541|FG000|Overall Study|Protocol Violation|2|||
27927210|NCT00984295|54583542|FG001|Overall Study|Protocol Violation|1|||
27927211|NCT00984295|54583543|FG002|Overall Study|Protocol Violation|4|||
27927212|NCT00984295|54583541|FG000|Overall Study|Withdrawal by Subject|18|||
27927213|NCT00984295|54583542|FG001|Overall Study|Withdrawal by Subject|9|||
27927214|NCT00984295|54583543|FG002|Overall Study|Withdrawal by Subject|12|||
27927215|NCT00984295|54583541|FG000|Overall Study|CAE - discontinued test vaccine|0|||
27927216|NCT00984295|54583542|FG001|Overall Study|CAE - discontinued test vaccine|1|||
27927217|NCT00984295|54583543|FG002|Overall Study|CAE - discontinued test vaccine|3|||
27927218|NCT00984295|54583541|FG000|Overall Study|Missed one or more blood samplings|3|||
27927219|NCT00984295|54583542|FG001|Overall Study|Missed one or more blood samplings|7|||
27927220|NCT00984295|54583543|FG002|Overall Study|Missed one or more blood samplings|2|||
27927221|NCT00984295|54583541|FG000|Overall Study|Incomplete safety follow-up|11|||
27927222|NCT00984295|54583542|FG001|Overall Study|Incomplete safety follow-up|2|||
27927223|NCT00984295|54583543|FG002|Overall Study|Incomplete safety follow-up|3|||
27927224|NCT01017952|54583555|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356|||
27786014|NCT02256917|54240358|FG000|Prophylactic Treatment Phase II|Withdrawn Consent|1|||
27786015|NCT02256917|54240358|FG000|Prophylactic Treatment Phase II|Did not attend completion visit|1|||
27786016|NCT02256917|54240358|FG000|Prophylactic Treatment Phase II|Discontinued medication|1|||
27927225|NCT01017952|54583556|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
27927226|NCT01017952|54583557|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
27927227|NCT01017952|54583558|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
27927228|NCT01017952|54583559|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
27927229|NCT01017952|54583555|FG000|4-week, Open-label Run-In Period|Adverse Event|23|||
27927230|NCT01017952|54583556|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
27927231|NCT01017952|54583557|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
27927232|NCT01017952|54583558|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
27927233|NCT01017952|54583559|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
27927234|NCT01017952|54583555|FG000|4-week, Open-label Run-In Period|Study Closed/Tterminated|1|||
27927235|NCT01017952|54583556|FG001|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
27927236|NCT01017952|54583557|FG002|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
27927237|NCT01017952|54583558|FG003|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
27927238|NCT01017952|54583559|FG004|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
27927239|NCT01017952|54583555|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
27927240|NCT01017952|54583556|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
27927241|NCT01017952|54583557|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
27927242|NCT01017952|54583558|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
27927243|NCT01017952|54583559|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
27927244|NCT01017952|54583555|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
27927245|NCT01017952|54583556|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
27927246|NCT01017952|54583557|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
27927247|NCT01017952|54583558|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
27927248|NCT01017952|54583559|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
27927249|NCT01017952|54583555|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|63|||
27927250|NCT01017952|54583556|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
27927251|NCT01017952|54583557|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
27927252|NCT01017952|54583558|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
27927253|NCT01017952|54583559|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
27927254|NCT01017952|54583555|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
27927255|NCT01017952|54583556|FG001|52-week, Double-blind Treatment Period|Adverse Event|25|||
27927256|NCT01017952|54583557|FG002|52-week, Double-blind Treatment Period|Adverse Event|32|||
27927257|NCT01017952|54583558|FG003|52-week, Double-blind Treatment Period|Adverse Event|35|||
27927258|NCT01017952|54583559|FG004|52-week, Double-blind Treatment Period|Adverse Event|30|||
27927259|NCT01017952|54583555|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
27927260|NCT01017952|54583556|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|30|||
27786017|NCT01629589|54240371|FG000|Overall Study|Protocol Violation|4|||
27786018|NCT01629589|54240372|FG001|Overall Study|Protocol Violation|2|||
27927261|NCT01017952|54583557|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
27927262|NCT01017952|54583558|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
27927263|NCT01017952|54583559|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
27927264|NCT01017952|54583555|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
27927265|NCT01017952|54583556|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|35|||
27927266|NCT01017952|54583557|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
27927267|NCT01017952|54583558|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
27927268|NCT01017952|54583559|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
27927269|NCT01017952|54583555|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
27927270|NCT01017952|54583556|FG001|52-week, Double-blind Treatment Period|Protocol Violation|7|||
27927271|NCT01017952|54583557|FG002|52-week, Double-blind Treatment Period|Protocol Violation|11|||
27927272|NCT01017952|54583558|FG003|52-week, Double-blind Treatment Period|Protocol Violation|9|||
27927273|NCT01017952|54583559|FG004|52-week, Double-blind Treatment Period|Protocol Violation|8|||
27927274|NCT01017952|54583555|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
27927275|NCT01017952|54583556|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
27927276|NCT01017952|54583557|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
27927277|NCT01017952|54583558|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12|||
27927278|NCT01017952|54583559|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
27927279|NCT01017952|54583555|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
27927280|NCT01017952|54583556|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
27927281|NCT01017952|54583557|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
27927282|NCT01017952|54583558|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
27927283|NCT01017952|54583559|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
27927284|NCT01017952|54583555|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
27927285|NCT01017952|54583556|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
27927286|NCT01017952|54583557|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|8|||
27927287|NCT01017952|54583558|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
27927288|NCT01017952|54583559|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|10|||
27927289|NCT01017952|54583555|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
27927290|NCT01017952|54583556|FG001|52-week, Double-blind Treatment Period|Physician Decision|10|||
27927291|NCT01017952|54583557|FG002|52-week, Double-blind Treatment Period|Physician Decision|8|||
27927292|NCT01017952|54583558|FG003|52-week, Double-blind Treatment Period|Physician Decision|9|||
27927293|NCT01017952|54583559|FG004|52-week, Double-blind Treatment Period|Physician Decision|7|||
27927294|NCT01214655|54583572|FG000|Part A|Progressive Disease|7|||
27927295|NCT01214655|54583573|FG001|Part A|Progressive Disease|0|||
27927296|NCT01214655|54583574|FG002|Part A|Progressive Disease|0|||
27927297|NCT01214655|54583572|FG000|Part A|Physician Decision|1|||
27927298|NCT01214655|54583573|FG001|Part A|Physician Decision|0|||
27927299|NCT01214655|54583574|FG002|Part A|Physician Decision|0|||
27927300|NCT01214655|54583572|FG000|Part B|Progressive disease|0|||
27927301|NCT01214655|54583573|FG001|Part B|Progressive disease|10|||
27927302|NCT01214655|54583574|FG002|Part B|Progressive disease|0|||
27927303|NCT01214655|54583572|FG000|Part B|Death|0|||
27927304|NCT01214655|54583573|FG001|Part B|Death|1|||
27927305|NCT01214655|54583574|FG002|Part B|Death|0|||
27927306|NCT01214655|54583572|FG000|Part B|Withdrawal by Subject|0|||
27927307|NCT01214655|54583573|FG001|Part B|Withdrawal by Subject|2|||
27927308|NCT01214655|54583574|FG002|Part B|Withdrawal by Subject|0|||
27927309|NCT01214655|54583572|FG000|Part C|Progressive Disease|0|||
27927310|NCT01214655|54583573|FG001|Part C|Progressive Disease|0|||
27927311|NCT01214655|54583574|FG002|Part C|Progressive Disease|5|||
27927312|NCT01214655|54583572|FG000|Part C|Death|0|||
27927313|NCT01214655|54583573|FG001|Part C|Death|0|||
27927314|NCT01214655|54583574|FG002|Part C|Death|1|||
27927315|NCT01214655|54583572|FG000|Part C|Physician Decision|0|||
27927316|NCT01214655|54583573|FG001|Part C|Physician Decision|0|||
27927317|NCT01214655|54583574|FG002|Part C|Physician Decision|1|||
27927318|NCT01017874|54583622|FG000|Overall Study|Withdrawal by Subject|23|||
27927319|NCT01017874|54583623|FG001|Overall Study|Withdrawal by Subject|20|||
27927320|NCT01017874|54583622|FG000|Overall Study|Sponsor decision|3|||
27927321|NCT01017874|54583623|FG001|Overall Study|Sponsor decision|1|||
27927322|NCT01017874|54583622|FG000|Overall Study|Lost to Follow-up|3|||
27927323|NCT01017874|54583623|FG001|Overall Study|Lost to Follow-up|2|||
27927324|NCT01017874|54583622|FG000|Overall Study|Physician Decision|1|||
27927325|NCT01017874|54583623|FG001|Overall Study|Physician Decision|3|||
27927326|NCT01015768|54583629|FG000|Overall Study|Some subject data unuseable|4|||
27927327|NCT01015768|54583630|FG001|Overall Study|Some subject data unuseable|4|||
27927328|NCT04426630|54583638|FG000|Overall Study|Death|4|||
27927329|NCT04426630|54583638|FG000|Overall Study|Lost to Follow-up|2|||
27927330|NCT01010230|54583644|FG000|Overall Study|Withdrawal by Subject|6|||
27927331|NCT01010230|54583645|FG001|Overall Study|Withdrawal by Subject|5|||
27927332|NCT01010230|54583644|FG000|Overall Study|Lost to Follow-up|4|||
27927333|NCT01010230|54583645|FG001|Overall Study|Lost to Follow-up|2|||
27927334|NCT01009840|54583651|FG000|Overall Study|Lost to Follow-up|1|||
27927335|NCT01009840|54583651|FG000|Overall Study|Adverse Event|4|||
27927336|NCT01009840|54583651|FG000|Overall Study|Subject Met Withdrawal Criteria|7|||
27927337|NCT01009840|54583651|FG000|Overall Study|Subject was Withdrawn by Investigator|1|||
27927338|NCT01009840|54583651|FG000|Overall Study|Subject Withdrew Consent to Participate|1|||
27927339|NCT00982657|54583659|FG000|Overall Study|Death|1|||
27927340|NCT00982657|54583660|FG001|Overall Study|Death|0|||
27927341|NCT00982657|54583661|FG002|Overall Study|Death|1|||
27927342|NCT00982657|54583662|FG003|Overall Study|Death|1|||
27927343|NCT00982657|54583659|FG000|Overall Study|Withdrawal by Subject|0|||
27927344|NCT00982657|54583660|FG001|Overall Study|Withdrawal by Subject|0|||
27927345|NCT00982657|54583661|FG002|Overall Study|Withdrawal by Subject|1|||
27927346|NCT00982657|54583662|FG003|Overall Study|Withdrawal by Subject|3|||
27927347|NCT00982657|54583659|FG000|Overall Study|Other|0|||
27927348|NCT00982657|54583660|FG001|Overall Study|Other|0|||
27927349|NCT00982657|54583661|FG002|Overall Study|Other|0|||
27927350|NCT00982657|54583662|FG003|Overall Study|Other|4|||
27927351|NCT00982657|54583659|FG000|Overall Study|On going at date of cut-off|0|||
27927352|NCT00982657|54583660|FG001|Overall Study|On going at date of cut-off|0|||
27927353|NCT00982657|54583661|FG002|Overall Study|On going at date of cut-off|0|||
27927354|NCT00982657|54583662|FG003|Overall Study|On going at date of cut-off|1|||
27927355|NCT01005316|54583685|FG000|Overall Study|Adverse Event|0|||
27927356|NCT01005316|54583686|FG001|Overall Study|Adverse Event|0|||
27927357|NCT01005316|54583687|FG002|Overall Study|Adverse Event|0|||
27927358|NCT01005316|54583688|FG003|Overall Study|Adverse Event|1|||
27927359|NCT01005316|54583685|FG000|Overall Study|Death|20|||
27927360|NCT01005316|54583686|FG001|Overall Study|Death|5|||
27927361|NCT01005316|54583687|FG002|Overall Study|Death|1|||
27927362|NCT01005316|54583688|FG003|Overall Study|Death|15|||
27927363|NCT01005316|54583685|FG000|Overall Study|Study Termination|5|||
27927364|NCT01005316|54583686|FG001|Overall Study|Study Termination|63|||
27927365|NCT01005316|54583687|FG002|Overall Study|Study Termination|9|||
27927366|NCT01005316|54583688|FG003|Overall Study|Study Termination|85|||
27927367|NCT01005316|54583685|FG000|Overall Study|Lost to Follow-up|1|||
27927368|NCT01005316|54583686|FG001|Overall Study|Lost to Follow-up|3|||
27927369|NCT01005316|54583687|FG002|Overall Study|Lost to Follow-up|0|||
27927370|NCT01005316|54583688|FG003|Overall Study|Lost to Follow-up|2|||
27927371|NCT01005316|54583685|FG000|Overall Study|Physician Decision|6|||
27927372|NCT01005316|54583686|FG001|Overall Study|Physician Decision|0|||
27927373|NCT01005316|54583687|FG002|Overall Study|Physician Decision|0|||
27927374|NCT01005316|54583688|FG003|Overall Study|Physician Decision|0|||
27927375|NCT01005316|54583685|FG000|Overall Study|Sponsor Decision|6|||
27927376|NCT01005316|54583686|FG001|Overall Study|Sponsor Decision|3|||
27927377|NCT01005316|54583687|FG002|Overall Study|Sponsor Decision|0|||
27927378|NCT01005316|54583688|FG003|Overall Study|Sponsor Decision|0|||
27927379|NCT01005316|54583685|FG000|Overall Study|Withdrawal by Subject|1|||
27927380|NCT01005316|54583686|FG001|Overall Study|Withdrawal by Subject|1|||
27927381|NCT01005316|54583687|FG002|Overall Study|Withdrawal by Subject|0|||
27927382|NCT01005316|54583688|FG003|Overall Study|Withdrawal by Subject|2|||
27927383|NCT01005316|54583685|FG000|Overall Study|Consented to Another Study|2|||
27927384|NCT01005316|54583686|FG001|Overall Study|Consented to Another Study|0|||
27927385|NCT01005316|54583687|FG002|Overall Study|Consented to Another Study|0|||
27927386|NCT01005316|54583688|FG003|Overall Study|Consented to Another Study|0|||
27927387|NCT01005316|54583685|FG000|Overall Study|Delisted|8|||
27927388|NCT01005316|54583686|FG001|Overall Study|Delisted|0|||
27927389|NCT01005316|54583687|FG002|Overall Study|Delisted|0|||
27927390|NCT01005316|54583688|FG003|Overall Study|Delisted|0|||
27927391|NCT01005316|54583685|FG000|Overall Study|Transferred Care|1|||
27927392|NCT01005316|54583686|FG001|Overall Study|Transferred Care|0|||
27927393|NCT01005316|54583687|FG002|Overall Study|Transferred Care|1|||
27927394|NCT01005316|54583688|FG003|Overall Study|Transferred Care|3|||
27927395|NCT01005316|54583685|FG000|Overall Study|Retransplanted|0|||
27927396|NCT01005316|54583686|FG001|Overall Study|Retransplanted|1|||
27927397|NCT01005316|54583687|FG002|Overall Study|Retransplanted|0|||
27927398|NCT01005316|54583688|FG003|Overall Study|Retransplanted|0|||
27927399|NCT01004848|54583701|FG000|Overall Study|Lost to Follow-up|55|||
27927400|NCT01004848|54583702|FG001|Overall Study|Lost to Follow-up|45|||
27927401|NCT01009294|54583710|FG000|Overall Study|Study discontinued by Sponsor|6|||
27927402|NCT01009060|54583716|FG000|Overall Study|Adverse Event|1|||
27927403|NCT01009060|54583717|FG001|Overall Study|Adverse Event|2|||
27927404|NCT01009060|54583716|FG000|Overall Study|Protocol Violation|0|||
27927405|NCT01009060|54583717|FG001|Overall Study|Protocol Violation|1|||
27927406|NCT01009060|54583716|FG000|Overall Study|Lost to Follow-up|1|||
27927407|NCT01009060|54583717|FG001|Overall Study|Lost to Follow-up|0|||
27927408|NCT01009060|54583716|FG000|Overall Study|Physician Decision|1|||
27927409|NCT01009060|54583717|FG001|Overall Study|Physician Decision|1|||
27927410|NCT01009060|54583716|FG000|Overall Study|Withdrawal by Subject|1|||
27927411|NCT01009060|54583717|FG001|Overall Study|Withdrawal by Subject|1|||
27927412|NCT00988429|54583730|FG000|Overall Study|Adverse Event|9|||
27927413|NCT00988429|54583731|FG001|Overall Study|Adverse Event|21|||
27927414|NCT00988429|54583732|FG002|Overall Study|Adverse Event|45|||
27927415|NCT00988429|54583730|FG000|Overall Study|Lack of Efficacy|0|||
27927416|NCT00988429|54583731|FG001|Overall Study|Lack of Efficacy|0|||
27927417|NCT00988429|54583732|FG002|Overall Study|Lack of Efficacy|1|||
27927418|NCT00988429|54583730|FG000|Overall Study|Non-Compliance with Study Drug|5|||
27927419|NCT00988429|54583731|FG001|Overall Study|Non-Compliance with Study Drug|1|||
27927420|NCT00988429|54583732|FG002|Overall Study|Non-Compliance with Study Drug|3|||
27927421|NCT00988429|54583730|FG000|Overall Study|Physician Decision|1|||
27927422|NCT00988429|54583731|FG001|Overall Study|Physician Decision|0|||
27927423|NCT00988429|54583732|FG002|Overall Study|Physician Decision|3|||
27786019|NCT01629589|54240371|FG000|Overall Study|Lost to Follow-up|2|||
27786020|NCT01629589|54240372|FG001|Overall Study|Lost to Follow-up|1|||
27786021|NCT01629589|54240371|FG000|Overall Study|Withdrawal by Subject|2|||
27927424|NCT00988429|54583730|FG000|Overall Study|Pregnancy|2|||
27927425|NCT00988429|54583731|FG001|Overall Study|Pregnancy|1|||
27927426|NCT00988429|54583732|FG002|Overall Study|Pregnancy|0|||
27927427|NCT00988429|54583730|FG000|Overall Study|Protocol Violation|4|||
27927428|NCT00988429|54583731|FG001|Overall Study|Protocol Violation|3|||
27927429|NCT00988429|54583732|FG002|Overall Study|Protocol Violation|3|||
27927430|NCT00988429|54583730|FG000|Overall Study|Withdrawal by Subject|7|||
27927431|NCT00988429|54583731|FG001|Overall Study|Withdrawal by Subject|7|||
27927432|NCT00988429|54583732|FG002|Overall Study|Withdrawal by Subject|12|||
27927433|NCT00988429|54583730|FG000|Overall Study|Administrative Reasons|1|||
27927434|NCT00988429|54583731|FG001|Overall Study|Administrative Reasons|2|||
27927435|NCT00988429|54583732|FG002|Overall Study|Administrative Reasons|1|||
27927436|NCT00988429|54583730|FG000|Overall Study|other reasons|8|||
27927437|NCT00988429|54583731|FG001|Overall Study|other reasons|8|||
27927438|NCT00988429|54583732|FG002|Overall Study|other reasons|1|||
27927439|NCT01008904|54583741|FG000|Overall Study|Lost to Follow-up|1|||
27927440|NCT01008904|54583741|FG000|Overall Study|Adverse Event|2|||
27927441|NCT01008904|54583741|FG000|Overall Study|unexpected unrelated surgery|1|||
27927442|NCT01004614|54583749|FG000|Washout|Withdrawal by Subject|0|||
27786022|NCT01629589|54240372|FG001|Overall Study|Withdrawal by Subject|3|||
27927443|NCT01004614|54583750|FG001|Washout|Withdrawal by Subject|1|||
27927444|NCT01004614|54583751|FG002|Washout|Withdrawal by Subject|0|||
27927445|NCT01004614|54583752|FG003|Washout|Withdrawal by Subject|0|||
27927446|NCT00981409|54583764|FG000|Overall Study|Adverse Event|4|||
27927447|NCT00981409|54583765|FG001|Overall Study|Adverse Event|0|||
27927448|NCT00981409|54583764|FG000|Overall Study|Protocol Violation|0|||
27927449|NCT00981409|54583765|FG001|Overall Study|Protocol Violation|1|||
27927450|NCT00981409|54583764|FG000|Overall Study|Prostate Cancer Treatment before Trial|2|||
27927451|NCT00981409|54583765|FG001|Overall Study|Prostate Cancer Treatment before Trial|0|||
27927452|NCT01008748|54583771|FG000|Overall Study|Lost to Follow-up|80|||
27927453|NCT01008748|54583771|FG000|Overall Study|Other|1|||
27927454|NCT01004146|54583777|FG000|Overall Study|Withdrawal by Subject|4|||
27927455|NCT01004146|54583778|FG001|Overall Study|Withdrawal by Subject|5|||
27927456|NCT01012414|54583784|FG000|Overall Study|Withdrawal by Subject|2|||
27927457|NCT01012414|54583784|FG000|Overall Study|Lost to Follow-up|1|||
27927458|NCT01012414|54583784|FG000|Overall Study|Trial was stopped before completed|7|||
27927459|NCT00975715|54583792|FG000|Titration Period|Adverse Event|6|||
27927460|NCT00975715|54583793|FG001|Titration Period|Adverse Event|0|||
27786023|NCT01629589|54240371|FG000|Overall Study|Did not receive study vaccine|0|||
27786024|NCT01629589|54240372|FG001|Overall Study|Did not receive study vaccine|1|||
27786025|NCT02256839|54240380|FG000|Overall Study|Did not meet Eligibility Criteria|2|||
27786026|NCT02256839|54240381|FG001|Overall Study|Did not meet Eligibility Criteria|3|||
27927461|NCT00975715|54583792|FG000|Titration Period|Protocol Violation|1|||
27927462|NCT00975715|54583793|FG001|Titration Period|Protocol Violation|0|||
27927463|NCT00975715|54583792|FG000|Maintenance Period|Adverse Event|2|||
27927464|NCT00975715|54583793|FG001|Maintenance Period|Adverse Event|1|||
27786027|NCT02220907|54240387|FG000|Overall Study|Adverse Event|7|||
27927465|NCT03962491|54583801|FG000|Overall Study|Lost to Follow-up|4|||
27927466|NCT03962491|54583802|FG001|Overall Study|Lost to Follow-up|5|||
27927467|NCT00978757|54583810|FG000|Overall Study|Physician Decision|1|||
27927468|NCT00978757|54583811|FG001|Overall Study|Physician Decision|3|||
27927469|NCT01214421|54583821|FG000|Overall Study|Lost to Follow-up|7|||
28105552|NCT03437278|54762993|FG002|Overall Study|Adverse Event|1|||
27927470|NCT01214421|54583822|FG001|Overall Study|Lost to Follow-up|3|||
27927471|NCT01214421|54583823|FG002|Overall Study|Lost to Follow-up|7|||
27927472|NCT01214421|54583824|FG003|Overall Study|Lost to Follow-up|3|||
27927473|NCT01214421|54583821|FG000|Overall Study|Adverse Event|16|||
27927474|NCT01214421|54583822|FG001|Overall Study|Adverse Event|35|||
27927475|NCT01214421|54583823|FG002|Overall Study|Adverse Event|14|||
27927476|NCT01214421|54583824|FG003|Overall Study|Adverse Event|3|||
27927477|NCT01214421|54583821|FG000|Overall Study|Sponsor Discontinued Site|1|||
27927478|NCT01214421|54583822|FG001|Overall Study|Sponsor Discontinued Site|2|||
27927479|NCT01214421|54583823|FG002|Overall Study|Sponsor Discontinued Site|0|||
27927480|NCT01214421|54583824|FG003|Overall Study|Sponsor Discontinued Site|0|||
27927481|NCT01214421|54583821|FG000|Overall Study|Withdrawal Criteria Met|3|||
27927482|NCT01214421|54583822|FG001|Overall Study|Withdrawal Criteria Met|0|||
27927483|NCT01214421|54583823|FG002|Overall Study|Withdrawal Criteria Met|2|||
27927484|NCT01214421|54583824|FG003|Overall Study|Withdrawal Criteria Met|1|||
27927485|NCT01214421|54583821|FG000|Overall Study|Physician Decision|2|||
27927486|NCT01214421|54583822|FG001|Overall Study|Physician Decision|0|||
27927487|NCT01214421|54583823|FG002|Overall Study|Physician Decision|4|||
27927488|NCT01214421|54583824|FG003|Overall Study|Physician Decision|0|||
27927489|NCT01214421|54583821|FG000|Overall Study|Withdrawal by Subject|21|||
27927490|NCT01214421|54583822|FG001|Overall Study|Withdrawal by Subject|18|||
27927491|NCT01214421|54583823|FG002|Overall Study|Withdrawal by Subject|11|||
27927492|NCT01214421|54583824|FG003|Overall Study|Withdrawal by Subject|2|||
27927493|NCT04102111|54583836|FG000|Overall Study|Withdrawal by Subject|2|||
27927494|NCT04102111|54583837|FG001|Overall Study|Withdrawal by Subject|3|||
27927495|NCT04102111|54583836|FG000|Overall Study|Adverse Event|1|||
27927496|NCT04102111|54583837|FG001|Overall Study|Adverse Event|1|||
27927497|NCT04102111|54583836|FG000|Overall Study|Study terminated by sponsor|1|||
27927498|NCT04102111|54583837|FG001|Overall Study|Study terminated by sponsor|3|||
27927499|NCT01214187|54583845|FG000|Overall Study|Adverse Event|6|||
27927500|NCT01214187|54583846|FG001|Overall Study|Adverse Event|2|||
27927501|NCT01214187|54583845|FG000|Overall Study|Death|1|||
27927502|NCT01214187|54583846|FG001|Overall Study|Death|1|||
27927503|NCT01214187|54583845|FG000|Overall Study|Withdrawal by Subject|0|||
27927504|NCT01214187|54583846|FG001|Overall Study|Withdrawal by Subject|3|||
27927505|NCT01003990|54583855|FG000|Overall Study|Adverse Event|8|||
27927506|NCT01003990|54583856|FG001|Overall Study|Adverse Event|5|||
27927507|NCT01003990|54583857|FG002|Overall Study|Adverse Event|11|||
27927508|NCT01003990|54583855|FG000|Overall Study|Death|0|||
27927509|NCT01003990|54583856|FG001|Overall Study|Death|8|||
27927510|NCT01003990|54583857|FG002|Overall Study|Death|1|||
27927511|NCT01003990|54583855|FG000|Overall Study|Lack of Efficacy|10|||
27927512|NCT01003990|54583856|FG001|Overall Study|Lack of Efficacy|2|||
27927513|NCT01003990|54583857|FG002|Overall Study|Lack of Efficacy|3|||
27927514|NCT01003990|54583855|FG000|Overall Study|Lost to Follow-up|30|||
27927515|NCT01003990|54583856|FG001|Overall Study|Lost to Follow-up|12|||
27927516|NCT01003990|54583857|FG002|Overall Study|Lost to Follow-up|7|||
27927517|NCT01003990|54583855|FG000|Overall Study|Reasons Not Identified|14|||
27927518|NCT01003990|54583856|FG001|Overall Study|Reasons Not Identified|13|||
27927519|NCT01003990|54583857|FG002|Overall Study|Reasons Not Identified|8|||
27927520|NCT01003990|54583855|FG000|Overall Study|Poor/Non-compliance|4|||
27927521|NCT01003990|54583856|FG001|Overall Study|Poor/Non-compliance|3|||
27927522|NCT01003990|54583857|FG002|Overall Study|Poor/Non-compliance|2|||
27927523|NCT01003990|54583855|FG000|Overall Study|Pregnancy|10|||
27927524|NCT01003990|54583856|FG001|Overall Study|Pregnancy|2|||
27927525|NCT01003990|54583857|FG002|Overall Study|Pregnancy|4|||
27927526|NCT01003990|54583855|FG000|Overall Study|No Longer Met Study Criteria|4|||
27927527|NCT01003990|54583856|FG001|Overall Study|No Longer Met Study Criteria|1|||
27927528|NCT01003990|54583857|FG002|Overall Study|No Longer Met Study Criteria|0|||
27927529|NCT01003990|54583855|FG000|Overall Study|Subject Withdrew Consent|12|||
27927530|NCT01003990|54583856|FG001|Overall Study|Subject Withdrew Consent|5|||
27927531|NCT01003990|54583857|FG002|Overall Study|Subject Withdrew Consent|7|||
27927532|NCT01003210|54583867|FG000|Overall Study|Lost to Follow-up|1|||
27786028|NCT02220907|54240387|FG000|Overall Study|Physician Decision|1|||
27786029|NCT02220907|54240387|FG000|Overall Study|Withdrawal by Subject|2|||
27786030|NCT02220907|54240387|FG000|Overall Study|Conflict with the stopping criteria|1|||
27786031|NCT02255981|54240391|FG000|Overall Study|Lost to Follow-up|3|||
27786032|NCT02255981|54240391|FG000|Overall Study|Withdrawal by Subject|1|||
27786033|NCT01601873|54240403|FG000|Overall Study|Lost to Follow-up|2|||
27786034|NCT01601873|54240404|FG001|Overall Study|Lost to Follow-up|3|||
27786035|NCT02194933|54240412|FG000|Overall Study|Lost to Follow-up|1|||
27786036|NCT02194933|54240413|FG001|Overall Study|Lost to Follow-up|2|||
27786037|NCT02194933|54240412|FG000|Overall Study|Participant met withdrawal criteria|1|||
27841201|NCT01584440|54329176|FG004|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
27786038|NCT02194933|54240413|FG001|Overall Study|Participant met withdrawal criteria|3|||
27841202|NCT01584440|54329172|FG000|Stage 2 (5 Weeks)|Adverse Event|0|||
27841203|NCT01584440|54329173|FG001|Stage 2 (5 Weeks)|Adverse Event|0|||
27841204|NCT01584440|54329174|FG002|Stage 2 (5 Weeks)|Adverse Event|1|||
27841205|NCT01584440|54329175|FG003|Stage 2 (5 Weeks)|Adverse Event|2|||
27841206|NCT01584440|54329176|FG004|Stage 2 (5 Weeks)|Adverse Event|1|||
27841207|NCT01584440|54329172|FG000|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
27841208|NCT01584440|54329173|FG001|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
27841209|NCT01584440|54329174|FG002|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|1|||
27841210|NCT01584440|54329175|FG003|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
27927533|NCT01003210|54583868|FG001|Overall Study|Lost to Follow-up|3|||
27927534|NCT01002820|54583874|FG000|Overall Study|Adverse Event|1|||
27927535|NCT01002820|54583874|FG000|Overall Study|Withdrawal by Subject|2|||
27927536|NCT01002820|54583874|FG000|Overall Study|Lack of Efficacy|1|||
27927537|NCT01012258|54583878|FG000|Overall Study|Death|14|||
27927538|NCT01012258|54583878|FG000|Overall Study|Lost to Follow-up|1|||
27927539|NCT01012258|54583878|FG000|Overall Study|Adverse Event|1|||
27927540|NCT01012258|54583878|FG000|Overall Study|Progressive Disease (PD)|18|||
27927541|NCT01012258|54583878|FG000|Overall Study|Symptomatic Deterioration|1|||
27927542|NCT01012258|54583878|FG000|Overall Study|Another Anti-cancer Drug Received|1|||
27927543|NCT01012258|54583878|FG000|Overall Study|Another Tumor Discovered|1|||
27927544|NCT01012258|54583878|FG000|Overall Study|Ongoing|29|||
27927545|NCT01011946|54583883|FG000|Overall Study|Transferred to another hospital|2|||
27927546|NCT01011946|54583883|FG000|Overall Study|No pathological lab value|1|||
27927547|NCT00975481|54583887|FG000|Second Intervention Period|Adverse Event|2|||
27927548|NCT00975481|54583888|FG001|Second Intervention Period|Adverse Event|1|||
27927549|NCT00975481|54583889|FG002|Second Intervention Period|Adverse Event|0|||
27927550|NCT00975481|54583890|FG003|Second Intervention Period|Adverse Event|0|||
27927551|NCT00975481|54583891|FG004|Second Intervention Period|Adverse Event|0|||
27927552|NCT00975481|54583892|FG005|Second Intervention Period|Adverse Event|0|||
27927553|NCT00975481|54583887|FG000|Second Intervention Period|Withdrawal by Subject|0|||
27927554|NCT00975481|54583888|FG001|Second Intervention Period|Withdrawal by Subject|0|||
27927555|NCT00975481|54583889|FG002|Second Intervention Period|Withdrawal by Subject|1|||
27927556|NCT00975481|54583890|FG003|Second Intervention Period|Withdrawal by Subject|0|||
27927557|NCT00975481|54583891|FG004|Second Intervention Period|Withdrawal by Subject|0|||
27927558|NCT00975481|54583892|FG005|Second Intervention Period|Withdrawal by Subject|0|||
27927559|NCT00975481|54583887|FG000|Fourth Intervention Period|Withdrawal by Subject|0|||
27927560|NCT00975481|54583888|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
27927561|NCT00975481|54583889|FG002|Fourth Intervention Period|Withdrawal by Subject|1|||
27927562|NCT00975481|54583890|FG003|Fourth Intervention Period|Withdrawal by Subject|1|||
27927563|NCT00975481|54583891|FG004|Fourth Intervention Period|Withdrawal by Subject|0|||
27927564|NCT00975481|54583892|FG005|Fourth Intervention Period|Withdrawal by Subject|0|||
27927565|NCT00975481|54583887|FG000|Fifth Intervention Period|Withdrawal by Subject|0|||
27927566|NCT00975481|54583888|FG001|Fifth Intervention Period|Withdrawal by Subject|0|||
27927567|NCT00975481|54583889|FG002|Fifth Intervention Period|Withdrawal by Subject|0|||
27927568|NCT00975481|54583890|FG003|Fifth Intervention Period|Withdrawal by Subject|0|||
27927569|NCT00975481|54583891|FG004|Fifth Intervention Period|Withdrawal by Subject|1|||
27927570|NCT00975481|54583892|FG005|Fifth Intervention Period|Withdrawal by Subject|0|||
27927571|NCT01011868|54583913|FG000|After Week 18 Follow-up|Adverse Event|8|||
27927572|NCT01011868|54583914|FG001|After Week 18 Follow-up|Adverse Event|6|||
27927573|NCT01011868|54583915|FG002|After Week 18 Follow-up|Adverse Event|13|||
27927574|NCT01011868|54583913|FG000|After Week 18 Follow-up|Lack of Efficacy|1|||
27927575|NCT01011868|54583914|FG001|After Week 18 Follow-up|Lack of Efficacy|0|||
27927576|NCT01011868|54583915|FG002|After Week 18 Follow-up|Lack of Efficacy|0|||
27927577|NCT01011868|54583913|FG000|After Week 18 Follow-up|Protocol Violation|1|||
27927578|NCT01011868|54583914|FG001|After Week 18 Follow-up|Protocol Violation|1|||
27927579|NCT01011868|54583915|FG002|After Week 18 Follow-up|Protocol Violation|1|||
27927580|NCT01011868|54583913|FG000|After Week 18 Follow-up|Lost to Follow-up|5|||
27927581|NCT01011868|54583914|FG001|After Week 18 Follow-up|Lost to Follow-up|3|||
27927582|NCT01011868|54583915|FG002|After Week 18 Follow-up|Lost to Follow-up|0|||
27927583|NCT01011868|54583913|FG000|After Week 18 Follow-up|Withdrawal by Subject|6|||
27927584|NCT01011868|54583914|FG001|After Week 18 Follow-up|Withdrawal by Subject|3|||
27927585|NCT01011868|54583915|FG002|After Week 18 Follow-up|Withdrawal by Subject|0|||
27927586|NCT01011868|54583913|FG000|After Week 18 Follow-up|Other reason not defined above|2|||
27927587|NCT01011868|54583914|FG001|After Week 18 Follow-up|Other reason not defined above|3|||
27927588|NCT01011868|54583915|FG002|After Week 18 Follow-up|Other reason not defined above|12|||
27927589|NCT01011868|54583913|FG000|After Week 78 Follow-up|Adverse Event|14|||
27927590|NCT01011868|54583914|FG001|After Week 78 Follow-up|Adverse Event|18|||
27927591|NCT01011868|54583915|FG002|After Week 78 Follow-up|Adverse Event|21|||
27927592|NCT01011868|54583913|FG000|After Week 78 Follow-up|Lack of Efficacy|4|||
27927593|NCT01011868|54583914|FG001|After Week 78 Follow-up|Lack of Efficacy|0|||
27927594|NCT01011868|54583915|FG002|After Week 78 Follow-up|Lack of Efficacy|0|||
27927595|NCT01011868|54583913|FG000|After Week 78 Follow-up|Protocol Violation|9|||
27927596|NCT01011868|54583914|FG001|After Week 78 Follow-up|Protocol Violation|1|||
27927597|NCT01011868|54583915|FG002|After Week 78 Follow-up|Protocol Violation|2|||
27927598|NCT01011868|54583913|FG000|After Week 78 Follow-up|Lost to Follow-up|11|||
27927599|NCT01011868|54583914|FG001|After Week 78 Follow-up|Lost to Follow-up|6|||
27927600|NCT01011868|54583915|FG002|After Week 78 Follow-up|Lost to Follow-up|4|||
27927601|NCT01011868|54583913|FG000|After Week 78 Follow-up|Withdrawal by Subject|9|||
27927602|NCT01011868|54583914|FG001|After Week 78 Follow-up|Withdrawal by Subject|8|||
27927603|NCT01011868|54583915|FG002|After Week 78 Follow-up|Withdrawal by Subject|1|||
27927604|NCT01011868|54583913|FG000|After Week 78 Follow-up|Other reason not defined above|5|||
27927605|NCT01011868|54583914|FG001|After Week 78 Follow-up|Other reason not defined above|5|||
27927606|NCT01011868|54583915|FG002|After Week 78 Follow-up|Other reason not defined above|16|||
27927607|NCT01213251|54583926|FG000|Overall Study|Death|2|||
27927608|NCT01213251|54583927|FG001|Overall Study|Death|1|||
27927609|NCT01213251|54583928|FG002|Overall Study|Death|2|||
27927610|NCT01213251|54583926|FG000|Overall Study|Exit|3|||
27927611|NCT01213251|54583927|FG001|Overall Study|Exit|2|||
27927612|NCT01213251|54583928|FG002|Overall Study|Exit|8|||
27927613|NCT01213251|54583926|FG000|Overall Study|Protocol Violation|1|||
27927614|NCT01213251|54583927|FG001|Overall Study|Protocol Violation|1|||
27927615|NCT01213251|54583928|FG002|Overall Study|Protocol Violation|0|||
27927616|NCT01213251|54583926|FG000|Overall Study|Missed 18-Month Follow-up|0|||
27927617|NCT01213251|54583927|FG001|Overall Study|Missed 18-Month Follow-up|0|||
27927618|NCT01213251|54583928|FG002|Overall Study|Missed 18-Month Follow-up|1|||
27927619|NCT01213173|54583943|FG000|Overall Study|Protocol Violation|2|||
27927620|NCT01213173|54583944|FG001|Overall Study|Protocol Violation|0|||
27927621|NCT01213173|54583943|FG000|Overall Study|Adverse Event|4|||
27927622|NCT01213173|54583944|FG001|Overall Study|Adverse Event|8|||
27927623|NCT01213173|54583943|FG000|Overall Study|Withdrawal by Subject|5|||
27927624|NCT01213173|54583944|FG001|Overall Study|Withdrawal by Subject|5|||
27927625|NCT01213173|54583943|FG000|Overall Study|Incorrect Enrollment|1|||
27927626|NCT01213173|54583944|FG001|Overall Study|Incorrect Enrollment|3|||
27927627|NCT01212159|54583952|FG000|Overall Study|Withdrawal by Subject|12|||
27927628|NCT01212159|54583953|FG001|Overall Study|Withdrawal by Subject|12|||
27927629|NCT00973765|54583961|FG000|Overall Study|Lost to Follow-up|8|||
27927630|NCT00973765|54583962|FG001|Overall Study|Lost to Follow-up|14|||
27927631|NCT01211769|54583972|FG000|Overall Study|Lost to Follow-up|7|||
27927632|NCT01211769|54583973|FG001|Overall Study|Lost to Follow-up|9|||
27927633|NCT01211769|54583974|FG002|Overall Study|Lost to Follow-up|5|||
27927634|NCT01211769|54583975|FG003|Overall Study|Lost to Follow-up|9|||
27927635|NCT01211769|54583972|FG000|Overall Study|Physician Decision|2|||
27927636|NCT01211769|54583973|FG001|Overall Study|Physician Decision|0|||
27927637|NCT01211769|54583974|FG002|Overall Study|Physician Decision|2|||
27927638|NCT01211769|54583975|FG003|Overall Study|Physician Decision|1|||
27927639|NCT01211769|54583972|FG000|Overall Study|Adverse Event|0|||
27927640|NCT01211769|54583973|FG001|Overall Study|Adverse Event|1|||
27927641|NCT01211769|54583974|FG002|Overall Study|Adverse Event|1|||
27927642|NCT01211769|54583975|FG003|Overall Study|Adverse Event|1|||
27927643|NCT01211613|54583988|FG000|Overall Study|Lost to Follow-up|2|||
27927644|NCT01211613|54583989|FG001|Overall Study|Lost to Follow-up|2|||
27927645|NCT01211613|54583990|FG002|Overall Study|Lost to Follow-up|2|||
27927646|NCT01211613|54583988|FG000|Overall Study|Withdrawal by Subject|1|||
27927647|NCT01211613|54583989|FG001|Overall Study|Withdrawal by Subject|0|||
27927648|NCT01211613|54583990|FG002|Overall Study|Withdrawal by Subject|0|||
27927649|NCT01211535|54584000|FG000|Overall Study|Adverse Event|0|||
27927650|NCT01211535|54584001|FG001|Overall Study|Adverse Event|1|||
27927651|NCT01011556|54584011|FG000|Overall Study|Adverse Event|1|||
27927652|NCT01011556|54584012|FG001|Overall Study|Adverse Event|3|||
27927653|NCT01011556|54584013|FG002|Overall Study|Adverse Event|2|||
27927654|NCT01011556|54584014|FG003|Overall Study|Adverse Event|1|||
27927655|NCT01011556|54584011|FG000|Overall Study|Lost to Follow-up|1|||
27927656|NCT01011556|54584012|FG001|Overall Study|Lost to Follow-up|0|||
27927657|NCT01011556|54584013|FG002|Overall Study|Lost to Follow-up|0|||
27927658|NCT01011556|54584014|FG003|Overall Study|Lost to Follow-up|0|||
27927659|NCT01011556|54584011|FG000|Overall Study|Physician Decision|1|||
27927660|NCT01011556|54584012|FG001|Overall Study|Physician Decision|0|||
27927661|NCT01011556|54584013|FG002|Overall Study|Physician Decision|0|||
27927662|NCT01011556|54584014|FG003|Overall Study|Physician Decision|1|||
27927663|NCT01011556|54584011|FG000|Overall Study|Protocol Violation|0|||
27927664|NCT01011556|54584012|FG001|Overall Study|Protocol Violation|1|||
27927665|NCT01011556|54584013|FG002|Overall Study|Protocol Violation|0|||
27927666|NCT01011556|54584014|FG003|Overall Study|Protocol Violation|0|||
27927667|NCT01011556|54584011|FG000|Overall Study|Withdrawal by Subject|1|||
27927668|NCT01011556|54584012|FG001|Overall Study|Withdrawal by Subject|2|||
27927669|NCT01011556|54584013|FG002|Overall Study|Withdrawal by Subject|4|||
27927670|NCT01011556|54584014|FG003|Overall Study|Withdrawal by Subject|4|||
27927671|NCT01011556|54584011|FG000|Overall Study|Sponsor decision|0|||
27927672|NCT01011556|54584012|FG001|Overall Study|Sponsor decision|1|||
27927673|NCT01011556|54584013|FG002|Overall Study|Sponsor decision|1|||
27927674|NCT01011556|54584014|FG003|Overall Study|Sponsor decision|2|||
27927675|NCT01011556|54584011|FG000|Overall Study|Inclusion/exclusion criteria not met|2|||
27927676|NCT01011556|54584012|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
27927677|NCT01011556|54584013|FG002|Overall Study|Inclusion/exclusion criteria not met|3|||
27927678|NCT01011556|54584014|FG003|Overall Study|Inclusion/exclusion criteria not met|5|||
27927679|NCT01211145|54584031|FG000|Overall Study|Reason not specified|3|||
27927680|NCT01211145|54584032|FG001|Overall Study|Reason not specified|2|||
27927681|NCT01211145|54584033|FG002|Overall Study|Reason not specified|2|||
27927682|NCT01211145|54584034|FG003|Overall Study|Reason not specified|1|||
27927683|NCT01211145|54584031|FG000|Overall Study|Lost to Follow-up|3|||
27927684|NCT01211145|54584032|FG001|Overall Study|Lost to Follow-up|2|||
27927685|NCT01211145|54584033|FG002|Overall Study|Lost to Follow-up|1|||
27927686|NCT01211145|54584034|FG003|Overall Study|Lost to Follow-up|2|||
27927687|NCT01211145|54584031|FG000|Overall Study|Study-specific withdrawal criteria|1|||
27927688|NCT01211145|54584032|FG001|Overall Study|Study-specific withdrawal criteria|0|||
27927689|NCT01211145|54584033|FG002|Overall Study|Study-specific withdrawal criteria|0|||
27927690|NCT01211145|54584034|FG003|Overall Study|Study-specific withdrawal criteria|0|||
27927691|NCT01211145|54584031|FG000|Overall Study|Severe noncompliance to protocol|1|||
27927692|NCT01211145|54584032|FG001|Overall Study|Severe noncompliance to protocol|0|||
27927693|NCT01211145|54584033|FG002|Overall Study|Severe noncompliance to protocol|0|||
27927694|NCT01211145|54584034|FG003|Overall Study|Severe noncompliance to protocol|0|||
27927695|NCT01211145|54584031|FG000|Overall Study|Eligibility criteria not fulfilled|16|||
27927696|NCT01211145|54584032|FG001|Overall Study|Eligibility criteria not fulfilled|12|||
27927697|NCT01211145|54584033|FG002|Overall Study|Eligibility criteria not fulfilled|10|||
27927698|NCT01211145|54584034|FG003|Overall Study|Eligibility criteria not fulfilled|15|||
27927699|NCT01211145|54584031|FG000|Overall Study|Patient decision|2|||
27927700|NCT01211145|54584032|FG001|Overall Study|Patient decision|1|||
27927701|NCT01211145|54584033|FG002|Overall Study|Patient decision|0|||
27927702|NCT01211145|54584034|FG003|Overall Study|Patient decision|2|||
27927703|NCT00977665|54584046|FG000|Overall Study|Withdrawal by Subject|1|||
27927704|NCT00977665|54584047|FG001|Overall Study|Withdrawal by Subject|3|||
27927705|NCT00977665|54584046|FG000|Overall Study|Physician Decision|2|||
27927706|NCT00977665|54584047|FG001|Overall Study|Physician Decision|1|||
27927707|NCT00977665|54584046|FG000|Overall Study|Sponsor requested withdrawal|0|||
27927708|NCT00977665|54584047|FG001|Overall Study|Sponsor requested withdrawal|1|||
27927709|NCT00977665|54584046|FG000|Overall Study|Lost to Follow-up|1|||
27927710|NCT00977665|54584047|FG001|Overall Study|Lost to Follow-up|0|||
27927711|NCT00977665|54584046|FG000|Overall Study|Death|3|||
27927712|NCT00977665|54584047|FG001|Overall Study|Death|2|||
27927713|NCT00977665|54584046|FG000|Overall Study|Adverse Event|14|||
27927714|NCT00977665|54584047|FG001|Overall Study|Adverse Event|7|||
27927715|NCT00977665|54584046|FG000|Overall Study|Treatment failure|0|||
27927716|NCT00977665|54584047|FG001|Overall Study|Treatment failure|1|||
27927717|NCT01210443|54584053|FG000|Overall Study|Study terminated by sponsor|2|||
27927718|NCT01007812|54584057|FG000|Period 1, One Week|Lost to Follow-up|0|||
27927719|NCT01007812|54584058|FG001|Period 1, One Week|Lost to Follow-up|1|||
27927720|NCT01007812|54584057|FG000|Period 1, One Week|Discomfort|1|||
27927721|NCT01007812|54584058|FG001|Period 1, One Week|Discomfort|0|||
27927722|NCT01208961|54584064|FG000|High-Fat Period III|Protocol Violation|1|||
27927723|NCT01208961|54584065|FG001|High-Fat Period III|Protocol Violation|0|||
27927724|NCT01001572|54584072|FG000|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32|||
27927725|NCT01001572|54584073|FG001|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
27927726|NCT01001572|54584074|FG002|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
27927727|NCT01001572|54584072|FG000|Single-Blind Valsartan 160 mg|Adverse Event|11|||
27927728|NCT01001572|54584073|FG001|Single-Blind Valsartan 160 mg|Adverse Event|0|||
27927729|NCT01001572|54584074|FG002|Single-Blind Valsartan 160 mg|Adverse Event|0|||
27927730|NCT01001572|54584072|FG000|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96|||
27927731|NCT01001572|54584073|FG001|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
27927732|NCT01001572|54584074|FG002|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
27927733|NCT01001572|54584072|FG000|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7|||
27927734|NCT01001572|54584073|FG001|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
27927735|NCT01001572|54584074|FG002|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
27927736|NCT01001572|54584072|FG000|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1|||
27927737|NCT01001572|54584073|FG001|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
27927738|NCT01001572|54584074|FG002|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
27927739|NCT01001572|54584072|FG000|Single-Blind Valsartan 160 mg|Lost to Follow-up|4|||
27927740|NCT01001572|54584073|FG001|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
27927741|NCT01001572|54584074|FG002|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
27927742|NCT01001572|54584072|FG000|Single-Blind Valsartan 160 mg|Administrative problems|82|||
27927743|NCT01001572|54584073|FG001|Single-Blind Valsartan 160 mg|Administrative problems|0|||
27927744|NCT01001572|54584074|FG002|Single-Blind Valsartan 160 mg|Administrative problems|0|||
27927745|NCT01001572|54584072|FG000|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45|||
27927746|NCT01001572|54584073|FG001|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
27927747|NCT01001572|54584074|FG002|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
27927748|NCT01001572|54584072|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
27927749|NCT01001572|54584073|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
27927750|NCT01001572|54584074|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
27927751|NCT01001572|54584072|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
27927752|NCT01001572|54584073|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|8|||
27927753|NCT01001572|54584074|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
27927754|NCT01001572|54584072|FG000|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
27927755|NCT01001572|54584073|FG001|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
27927756|NCT01001572|54584074|FG002|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1|||
27927757|NCT01001572|54584072|FG000|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
27927758|NCT01001572|54584073|FG001|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
27927759|NCT01001572|54584074|FG002|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1|||
27927760|NCT01001572|54584072|FG000|Double-Blind Treatment Phase|Protocol deviation|0|||
27927761|NCT01001572|54584073|FG001|Double-Blind Treatment Phase|Protocol deviation|0|||
27927762|NCT01001572|54584074|FG002|Double-Blind Treatment Phase|Protocol deviation|1|||
27927763|NCT01001572|54584072|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
27927764|NCT01001572|54584073|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
27927765|NCT01001572|54584074|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
27927766|NCT01208415|54584080|FG000|Overall Study|Death|1|||
27927767|NCT01208415|54584080|FG000|Overall Study|Lost to Follow-up|2|||
27927768|NCT01208415|54584080|FG000|Overall Study|Withdrawal by Subject|3|||
27927769|NCT01208415|54584080|FG000|Overall Study|Device not placed|1|||
27927770|NCT01208415|54584080|FG000|Overall Study|Still be eligible for follow-up|33|||
27927771|NCT01208337|54584084|FG000|Overall Study|Death|3|||
27927772|NCT01208181|54584100|FG000|Part 1|Withdrawal by Subject|11|||
27927773|NCT01208181|54584101|FG001|Part 1|Withdrawal by Subject|10|||
27927774|NCT01208181|54584102|FG002|Part 1|Withdrawal by Subject|0|||
27927775|NCT01208181|54584103|FG003|Part 1|Withdrawal by Subject|0|||
27927776|NCT01208181|54584104|FG004|Part 1|Withdrawal by Subject|0|||
27927777|NCT01208181|54584100|FG000|Part 1|Technical problem|5|||
27927778|NCT01208181|54584101|FG001|Part 1|Technical problem|0|||
27927779|NCT01208181|54584102|FG002|Part 1|Technical problem|0|||
27927780|NCT01208181|54584103|FG003|Part 1|Technical problem|0|||
27927781|NCT01208181|54584104|FG004|Part 1|Technical problem|0|||
27927782|NCT01208181|54584100|FG000|Part 1|Protocol Violation|10|||
27927783|NCT01208181|54584101|FG001|Part 1|Protocol Violation|5|||
27927784|NCT01208181|54584102|FG002|Part 1|Protocol Violation|0|||
27927785|NCT01208181|54584103|FG003|Part 1|Protocol Violation|0|||
27927786|NCT01208181|54584104|FG004|Part 1|Protocol Violation|0|||
27927787|NCT01208181|54584100|FG000|Part 1|Physician Decision|4|||
27927788|NCT01208181|54584101|FG001|Part 1|Physician Decision|0|||
27927789|NCT01208181|54584102|FG002|Part 1|Physician Decision|0|||
27927790|NCT01208181|54584103|FG003|Part 1|Physician Decision|0|||
27927791|NCT01208181|54584104|FG004|Part 1|Physician Decision|0|||
27927792|NCT01208181|54584100|FG000|Part 1|Non-compliance with study drug|1|||
27927793|NCT01208181|54584101|FG001|Part 1|Non-compliance with study drug|1|||
27927794|NCT01208181|54584102|FG002|Part 1|Non-compliance with study drug|0|||
27927795|NCT01208181|54584103|FG003|Part 1|Non-compliance with study drug|0|||
27927796|NCT01208181|54584104|FG004|Part 1|Non-compliance with study drug|0|||
27927797|NCT01208181|54584100|FG000|Part 1|Lost to Follow-up|5|||
27927798|NCT01208181|54584101|FG001|Part 1|Lost to Follow-up|3|||
27927799|NCT01208181|54584102|FG002|Part 1|Lost to Follow-up|0|||
27927800|NCT01208181|54584103|FG003|Part 1|Lost to Follow-up|0|||
27927801|NCT01208181|54584104|FG004|Part 1|Lost to Follow-up|1|||
27927802|NCT01208181|54584100|FG000|Part 1|Lack of Efficacy|37|||
27927803|NCT01208181|54584101|FG001|Part 1|Lack of Efficacy|12|||
27927804|NCT01208181|54584102|FG002|Part 1|Lack of Efficacy|0|||
27927805|NCT01208181|54584103|FG003|Part 1|Lack of Efficacy|0|||
27927806|NCT01208181|54584104|FG004|Part 1|Lack of Efficacy|17|||
27927807|NCT01208181|54584100|FG000|Part 1|Adverse Event|26|||
27927808|NCT01208181|54584101|FG001|Part 1|Adverse Event|24|||
27927809|NCT01208181|54584102|FG002|Part 1|Adverse Event|0|||
27927810|NCT01208181|54584103|FG003|Part 1|Adverse Event|0|||
27927811|NCT01208181|54584104|FG004|Part 1|Adverse Event|4|||
27927812|NCT01208181|54584100|FG000|Part 2|Adverse Event|0|||
27927813|NCT01208181|54584101|FG001|Part 2|Adverse Event|0|||
27927814|NCT01208181|54584102|FG002|Part 2|Adverse Event|6|||
27927815|NCT01208181|54584103|FG003|Part 2|Adverse Event|7|||
27927816|NCT01208181|54584104|FG004|Part 2|Adverse Event|0|||
27927817|NCT01208181|54584100|FG000|Part 2|Withdrawal by Subject|0|||
27927818|NCT01208181|54584101|FG001|Part 2|Withdrawal by Subject|0|||
27927819|NCT01208181|54584102|FG002|Part 2|Withdrawal by Subject|1|||
27927820|NCT01208181|54584103|FG003|Part 2|Withdrawal by Subject|1|||
27927821|NCT01208181|54584104|FG004|Part 2|Withdrawal by Subject|0|||
27927822|NCT01208181|54584100|FG000|Part 2|Protocol Violation|0|||
27927823|NCT01208181|54584101|FG001|Part 2|Protocol Violation|0|||
27927824|NCT01208181|54584102|FG002|Part 2|Protocol Violation|1|||
27927825|NCT01208181|54584103|FG003|Part 2|Protocol Violation|0|||
27927826|NCT01208181|54584104|FG004|Part 2|Protocol Violation|0|||
27927827|NCT01208181|54584100|FG000|Part 2|Physician Decision|0|||
27927828|NCT01208181|54584101|FG001|Part 2|Physician Decision|0|||
27927829|NCT01208181|54584102|FG002|Part 2|Physician Decision|1|||
27927830|NCT01208181|54584103|FG003|Part 2|Physician Decision|2|||
27927831|NCT01208181|54584104|FG004|Part 2|Physician Decision|0|||
27927832|NCT01208181|54584100|FG000|Part 2|Non-compliance with study drug|0|||
27927833|NCT01208181|54584101|FG001|Part 2|Non-compliance with study drug|0|||
27927834|NCT01208181|54584102|FG002|Part 2|Non-compliance with study drug|1|||
27927835|NCT01208181|54584103|FG003|Part 2|Non-compliance with study drug|1|||
27927836|NCT01208181|54584104|FG004|Part 2|Non-compliance with study drug|0|||
27927837|NCT01208181|54584100|FG000|Part 2|Lost to Follow-up|0|||
27927838|NCT01208181|54584101|FG001|Part 2|Lost to Follow-up|0|||
27927839|NCT01208181|54584102|FG002|Part 2|Lost to Follow-up|1|||
27927840|NCT01208181|54584103|FG003|Part 2|Lost to Follow-up|2|||
27927841|NCT01208181|54584104|FG004|Part 2|Lost to Follow-up|0|||
27927842|NCT01208181|54584100|FG000|Part 2|Lack of Efficacy|0|||
27927843|NCT01208181|54584101|FG001|Part 2|Lack of Efficacy|0|||
27927844|NCT01208181|54584102|FG002|Part 2|Lack of Efficacy|5|||
27927845|NCT01208181|54584103|FG003|Part 2|Lack of Efficacy|7|||
27927846|NCT01208181|54584104|FG004|Part 2|Lack of Efficacy|0|||
27927847|NCT01208103|54584121|FG000|Overall Study|Adverse Event|1|||
27927848|NCT01208103|54584121|FG000|Overall Study|Withdrawal by Subject|1|||
27927849|NCT01206777|54584126|FG000|Overall Study|Death|1|||
27927850|NCT01206777|54584126|FG000|Overall Study|Adverse Event|1|||
27927851|NCT01001494|54584133|FG000|Overall Study|Adverse Event|8|||
27927852|NCT01001494|54584134|FG001|Overall Study|Adverse Event|4|||
27927853|NCT01001494|54584135|FG002|Overall Study|Adverse Event|6|||
27927854|NCT01001494|54584133|FG000|Overall Study|Protocol Violation|0|||
27927855|NCT01001494|54584134|FG001|Overall Study|Protocol Violation|1|||
27927856|NCT01001494|54584135|FG002|Overall Study|Protocol Violation|1|||
27927857|NCT01001494|54584133|FG000|Overall Study|Lost to Follow-up|2|||
27927858|NCT01001494|54584134|FG001|Overall Study|Lost to Follow-up|0|||
27927859|NCT01001494|54584135|FG002|Overall Study|Lost to Follow-up|1|||
27927860|NCT01001494|54584133|FG000|Overall Study|Withdrawal by Subject|9|||
27927861|NCT01001494|54584134|FG001|Overall Study|Withdrawal by Subject|7|||
27927862|NCT01001494|54584135|FG002|Overall Study|Withdrawal by Subject|17|||
27927863|NCT01001494|54584133|FG000|Overall Study|COPD exacerbation|3|||
27927864|NCT01001494|54584134|FG001|Overall Study|COPD exacerbation|4|||
27927865|NCT01001494|54584135|FG002|Overall Study|COPD exacerbation|5|||
27841211|NCT01584440|54329176|FG004|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
27841212|NCT01687478|54329191|FG000|Overall Study|Adverse Event|3|||
27841213|NCT01687478|54329192|FG001|Overall Study|Adverse Event|10|||
27927866|NCT01001494|54584133|FG000|Overall Study|Lack of Efficacy|2|||
27927867|NCT01001494|54584134|FG001|Overall Study|Lack of Efficacy|0|||
27927868|NCT01001494|54584135|FG002|Overall Study|Lack of Efficacy|8|||
27927869|NCT01001494|54584133|FG000|Overall Study|Other|0|||
27927870|NCT01001494|54584134|FG001|Overall Study|Other|1|||
27927871|NCT01001494|54584135|FG002|Overall Study|Other|3|||
27927872|NCT01205685|54584143|FG000|Overall Study|Disease Progression|10|||
27927873|NCT01205685|54584143|FG000|Overall Study|Withdrawal by Subject|1|||
27927874|NCT01205529|54584147|FG000|Overall Study|Procedure Cancelled|4|||
27927875|NCT01205529|54584147|FG000|Overall Study|Withdrawal by Subject|2|||
27927876|NCT01205529|54584147|FG000|Overall Study|Physician Decision|4|||
27927877|NCT01205529|54584147|FG000|Overall Study|Unstable post op|15|||
27927878|NCT01205529|54584147|FG000|Overall Study|No longer met criteria|30|||
27927879|NCT01205451|54584153|FG000|Overall Study|Lost to Follow-up|1|||
27927880|NCT01205451|54584154|FG001|Overall Study|Lost to Follow-up|1|||
27927881|NCT01205451|54584153|FG000|Overall Study|Withdrawal by Subject|5|||
27927882|NCT01205451|54584154|FG001|Overall Study|Withdrawal by Subject|9|||
27927883|NCT01001104|54584164|FG000|Overall Study|Adverse Event|2|||
27927884|NCT01001104|54584165|FG001|Overall Study|Adverse Event|1|||
27927885|NCT01001104|54584166|FG002|Overall Study|Adverse Event|0|||
27927886|NCT01001104|54584167|FG003|Overall Study|Adverse Event|0|||
27927887|NCT01001104|54584164|FG000|Overall Study|Lost to Follow-up|0|||
27927888|NCT01001104|54584165|FG001|Overall Study|Lost to Follow-up|0|||
27927889|NCT01001104|54584166|FG002|Overall Study|Lost to Follow-up|1|||
27927890|NCT01001104|54584167|FG003|Overall Study|Lost to Follow-up|0|||
27927891|NCT01001104|54584164|FG000|Overall Study|Entry Criteria Not Met|0|||
27927892|NCT01001104|54584165|FG001|Overall Study|Entry Criteria Not Met|0|||
27841214|NCT01687478|54329191|FG000|Overall Study|Lost to Follow-up|1|||
27841215|NCT01687478|54329192|FG001|Overall Study|Lost to Follow-up|3|||
27841216|NCT01687478|54329191|FG000|Overall Study|Protocol Violation|0|||
27841217|NCT01687478|54329192|FG001|Overall Study|Protocol Violation|2|||
27841218|NCT01687478|54329191|FG000|Overall Study|Withdrawal by Subject|21|||
27841219|NCT01687478|54329192|FG001|Overall Study|Withdrawal by Subject|19|||
27841220|NCT01687478|54329191|FG000|Overall Study|Physician Decision|1|||
27841221|NCT01687478|54329192|FG001|Overall Study|Physician Decision|3|||
27841222|NCT01687478|54329191|FG000|Overall Study|Entry Criteria Not Met|6|||
27841223|NCT01687478|54329192|FG001|Overall Study|Entry Criteria Not Met|2|||
27841224|NCT01468909|54329200|FG000|Overall Study|Never Treated|2|||
27927893|NCT01001104|54584166|FG002|Overall Study|Entry Criteria Not Met|0|||
27841225|NCT01468909|54329201|FG001|Overall Study|Never Treated|2|||
27841226|NCT01468597|54329207|FG000|Overall Study|Found ineligible|17|||
27927894|NCT01001104|54584167|FG003|Overall Study|Entry Criteria Not Met|1|||
27927895|NCT01001104|54584164|FG000|Overall Study|Withdrawal by Subject|0|||
27927896|NCT01001104|54584165|FG001|Overall Study|Withdrawal by Subject|0|||
27927897|NCT01001104|54584166|FG002|Overall Study|Withdrawal by Subject|0|||
27927898|NCT01001104|54584167|FG003|Overall Study|Withdrawal by Subject|2|||
27927899|NCT00998764|54584182|FG000|Overall Study|Lack of Efficacy|3|||
27927900|NCT00998764|54584183|FG001|Overall Study|Lack of Efficacy|6|||
27927901|NCT00998764|54584182|FG000|Overall Study|Adverse Event|17|||
27927902|NCT00998764|54584183|FG001|Overall Study|Adverse Event|12|||
27927903|NCT00998764|54584182|FG000|Overall Study|Withdrawal by Subject|19|||
27927904|NCT00998764|54584183|FG001|Overall Study|Withdrawal by Subject|25|||
27927905|NCT00998764|54584182|FG000|Overall Study|Physician Decision|3|||
27927906|NCT00998764|54584183|FG001|Overall Study|Physician Decision|3|||
27927907|NCT00998764|54584182|FG000|Overall Study|Death|3|||
27927908|NCT00998764|54584183|FG001|Overall Study|Death|1|||
27927909|NCT00998764|54584182|FG000|Overall Study|Discontinuation of Study by Sponsor|164|||
27927910|NCT00998764|54584183|FG001|Overall Study|Discontinuation of Study by Sponsor|217|||
27927911|NCT00998764|54584182|FG000|Overall Study|Protocol Violation|0|||
27927912|NCT00998764|54584183|FG001|Overall Study|Protocol Violation|1|||
27927913|NCT00998764|54584182|FG000|Overall Study|Failed to Return|1|||
27927914|NCT00998764|54584183|FG001|Overall Study|Failed to Return|1|||
27927915|NCT00998764|54584182|FG000|Overall Study|Lost to Follow-up|1|||
27927916|NCT00998764|54584183|FG001|Overall Study|Lost to Follow-up|1|||
27927917|NCT00998764|54584182|FG000|Overall Study|Loss of Caregiver|0|||
27927918|NCT00998764|54584183|FG001|Overall Study|Loss of Caregiver|3|||
27927919|NCT00998764|54584182|FG000|Overall Study|Other|4|||
27927920|NCT00998764|54584183|FG001|Overall Study|Other|4|||
27927921|NCT00998764|54584182|FG000|Overall Study|Recurrent Episode of vasogenic edema|1|||
27927922|NCT00998764|54584183|FG001|Overall Study|Recurrent Episode of vasogenic edema|0|||
27927923|NCT01204671|54584196|FG000|Overall Study|Adverse Event|4|||
27927924|NCT01204671|54584197|FG001|Overall Study|Adverse Event|3|||
27927925|NCT01204671|54584198|FG002|Overall Study|Adverse Event|3|||
27927926|NCT01204671|54584199|FG003|Overall Study|Adverse Event|3|||
27927927|NCT01204671|54584200|FG004|Overall Study|Adverse Event|1|||
27927928|NCT01204671|54584196|FG000|Overall Study|Withdrawal by Subject|2|||
27927929|NCT01204671|54584197|FG001|Overall Study|Withdrawal by Subject|3|||
27927930|NCT01204671|54584198|FG002|Overall Study|Withdrawal by Subject|4|||
27927931|NCT01204671|54584199|FG003|Overall Study|Withdrawal by Subject|5|||
27927932|NCT01204671|54584200|FG004|Overall Study|Withdrawal by Subject|3|||
27927933|NCT01204671|54584196|FG000|Overall Study|Lost to Follow-up|7|||
27927934|NCT01204671|54584197|FG001|Overall Study|Lost to Follow-up|8|||
27927935|NCT01204671|54584198|FG002|Overall Study|Lost to Follow-up|6|||
27927936|NCT01204671|54584199|FG003|Overall Study|Lost to Follow-up|4|||
27927937|NCT01204671|54584200|FG004|Overall Study|Lost to Follow-up|0|||
27927938|NCT01204671|54584196|FG000|Overall Study|Unknown Completion Status|1|||
27927939|NCT01204671|54584197|FG001|Overall Study|Unknown Completion Status|1|||
27786039|NCT02194933|54240412|FG000|Overall Study|Withdrawal by Subject|0|||
27786040|NCT02194933|54240413|FG001|Overall Study|Withdrawal by Subject|2|||
27786041|NCT02194933|54240412|FG000|Overall Study|Lack of Efficacy|1|||
27786042|NCT02194933|54240413|FG001|Overall Study|Lack of Efficacy|2|||
27786043|NCT01644890|54240423|FG000|Overall Study|Adverse Event|7|||
27786044|NCT01644890|54240424|FG001|Overall Study|Adverse Event|20|||
27786045|NCT01644890|54240423|FG000|Overall Study|Death|1|||
27786046|NCT01644890|54240424|FG001|Overall Study|Death|3|||
27786047|NCT01644890|54240423|FG000|Overall Study|Physician Decision|3|||
27786048|NCT01644890|54240424|FG001|Overall Study|Physician Decision|9|||
27786049|NCT01644890|54240423|FG000|Overall Study|Protocol Violation|6|||
27786050|NCT01644890|54240424|FG001|Overall Study|Protocol Violation|7|||
27786051|NCT01644890|54240423|FG000|Overall Study|Withdrawal by Subject|19|||
27786052|NCT01644890|54240424|FG001|Overall Study|Withdrawal by Subject|27|||
27786053|NCT01644890|54240423|FG000|Overall Study|Progression Disease|160|||
27786054|NCT01644890|54240424|FG001|Overall Study|Progression Disease|131|||
27786055|NCT01644890|54240423|FG000|Overall Study|Clinical Progression|6|||
27786056|NCT01644890|54240424|FG001|Overall Study|Clinical Progression|6|||
27786057|NCT01644890|54240423|FG000|Overall Study|> 28 days since last dose of study drug|6|||
27786058|NCT01644890|54240424|FG001|Overall Study|> 28 days since last dose of study drug|3|||
27786059|NCT01644890|54240423|FG000|Overall Study|Other|8|||
27927940|NCT01204671|54584198|FG002|Overall Study|Unknown Completion Status|0|||
27927941|NCT01204671|54584199|FG003|Overall Study|Unknown Completion Status|0|||
27927942|NCT01204671|54584200|FG004|Overall Study|Unknown Completion Status|0|||
27927943|NCT01204671|54584196|FG000|Overall Study|Physician Decision|0|||
27927944|NCT01204671|54584197|FG001|Overall Study|Physician Decision|0|||
27927945|NCT01204671|54584198|FG002|Overall Study|Physician Decision|0|||
27927946|NCT01204671|54584199|FG003|Overall Study|Physician Decision|1|||
27786060|NCT01644890|54240424|FG001|Overall Study|Other|9|||
27786061|NCT01628965|54240430|FG000|Overall Study|Adverse Event|30|||
27786062|NCT01628965|54240430|FG000|Overall Study|Lack of Efficacy|7|||
27927947|NCT01204671|54584200|FG004|Overall Study|Physician Decision|0|||
27927948|NCT01202955|54584218|FG000|Period 1: 10 Days|Withdrawal by Subject|0|||
27927949|NCT01202955|54584219|FG001|Period 1: 10 Days|Withdrawal by Subject|2|||
27927950|NCT01202877|54584228|FG000|Overall Study|Disease Progression|0|||
27927951|NCT01202877|54584229|FG001|Overall Study|Disease Progression|1|||
27927952|NCT01202877|54584230|FG002|Overall Study|Disease Progression|2|||
27927953|NCT01202877|54584228|FG000|Overall Study|Adverse Event|0|||
27927954|NCT01202877|54584229|FG001|Overall Study|Adverse Event|0|||
27927955|NCT01202877|54584230|FG002|Overall Study|Adverse Event|2|||
27786063|NCT01628965|54240430|FG000|Overall Study|Withdrawal by Subject|3|||
27786064|NCT01628965|54240430|FG000|Overall Study|Lost to Follow-up|1|||
27786065|NCT01628965|54240430|FG000|Overall Study|Discontinuation criteria|8|||
27786066|NCT01644734|54240434|FG000|Overall Study|Adverse Event|4|||
27786067|NCT01644734|54240434|FG000|Overall Study|Lost to Follow-up|17|||
27927956|NCT01202877|54584228|FG000|Overall Study|Withdrawal by Subject|0|||
27927957|NCT01202877|54584229|FG001|Overall Study|Withdrawal by Subject|0|||
27927958|NCT01202877|54584230|FG002|Overall Study|Withdrawal by Subject|1|||
27927959|NCT01202877|54584228|FG000|Overall Study|Death|0|||
27927960|NCT01202877|54584229|FG001|Overall Study|Death|0|||
27927961|NCT01202877|54584230|FG002|Overall Study|Death|1|||
27927962|NCT01202409|54584238|FG000|Overall Study|Adverse Event|1|||
27927963|NCT01202409|54584238|FG000|Overall Study|Ineligible - KRAS mutants|7|||
27927964|NCT01202175|54584244|FG000|Overall Study|Lost to Follow-up|2|||
27927965|NCT01202175|54584244|FG000|Overall Study|Withdrawal by Subject|1|||
27927966|NCT01202175|54584244|FG000|Overall Study|Adverse Event|2|||
27927967|NCT01201785|54584249|FG000|Overall Study|Lost to Follow-up|16|||
27927968|NCT01201317|54584256|FG000|Overall Study|Withdrawal by Subject|5|||
27927969|NCT01201317|54584257|FG001|Overall Study|Withdrawal by Subject|0|||
27927970|NCT01201317|54584258|FG002|Overall Study|Withdrawal by Subject|3|||
27927971|NCT01201317|54584256|FG000|Overall Study|Adverse Event|2|||
27927972|NCT01201317|54584257|FG001|Overall Study|Adverse Event|2|||
27927973|NCT01201317|54584258|FG002|Overall Study|Adverse Event|2|||
27927974|NCT01201317|54584256|FG000|Overall Study|Screen failure|1|||
27927975|NCT01201317|54584257|FG001|Overall Study|Screen failure|1|||
27927976|NCT01201317|54584258|FG002|Overall Study|Screen failure|0|||
27927977|NCT01201317|54584256|FG000|Overall Study|Protocol Violation|0|||
27927978|NCT01201317|54584257|FG001|Overall Study|Protocol Violation|1|||
27927979|NCT01201317|54584258|FG002|Overall Study|Protocol Violation|1|||
27927980|NCT01201317|54584256|FG000|Overall Study|Death|0|||
27927981|NCT01201317|54584257|FG001|Overall Study|Death|1|||
27927982|NCT01201317|54584258|FG002|Overall Study|Death|0|||
27927983|NCT01201317|54584256|FG000|Overall Study|Study-specific withdrawal criteria|0|||
27927984|NCT01201317|54584257|FG001|Overall Study|Study-specific withdrawal criteria|0|||
27927985|NCT01201317|54584258|FG002|Overall Study|Study-specific withdrawal criteria|1|||
27927986|NCT01201317|54584256|FG000|Overall Study|Painful Diabetic Neuropathy worsening|0|||
27927987|NCT01201317|54584257|FG001|Overall Study|Painful Diabetic Neuropathy worsening|1|||
27927988|NCT01201317|54584258|FG002|Overall Study|Painful Diabetic Neuropathy worsening|0|||
27927989|NCT01201317|54584256|FG000|Overall Study|Decrease in renal function|0|||
27927990|NCT01201317|54584257|FG001|Overall Study|Decrease in renal function|1|||
27927991|NCT01201317|54584258|FG002|Overall Study|Decrease in renal function|0|||
27927992|NCT01201317|54584256|FG000|Overall Study|Lack of Efficacy|1|||
27927993|NCT01201317|54584257|FG001|Overall Study|Lack of Efficacy|0|||
27927994|NCT01201317|54584258|FG002|Overall Study|Lack of Efficacy|0|||
27927995|NCT01201317|54584256|FG000|Overall Study|Safety, possible history of tuberculosis|0|||
27927996|NCT01201317|54584257|FG001|Overall Study|Safety, possible history of tuberculosis|0|||
27927997|NCT01201317|54584258|FG002|Overall Study|Safety, possible history of tuberculosis|1|||
27927998|NCT01200069|54584268|FG000|Overall Study|Withdrawal by Subject|0|||
27927999|NCT01200069|54584269|FG001|Overall Study|Withdrawal by Subject|1|||
27928000|NCT01199601|54584320|FG000|Overall Study|Lost to Follow-up|47|||
27928001|NCT01199601|54584321|FG001|Overall Study|Lost to Follow-up|66|||
27928002|NCT01199601|54584320|FG000|Overall Study|Withdrawal by Subject|15|||
27928003|NCT01199601|54584321|FG001|Overall Study|Withdrawal by Subject|3|||
27928004|NCT01199601|54584320|FG000|Overall Study|Insecurity prevented staff interviewing.|7|||
27928005|NCT01199601|54584321|FG001|Overall Study|Insecurity prevented staff interviewing.|9|||
27786068|NCT01644734|54240434|FG000|Overall Study|Reasons other than stated above|7|||
27786069|NCT01644734|54240434|FG000|Overall Study|Missing documentation|238|||
27786070|NCT02255279|54240440|FG000|Overall Study|Lost to Follow-up|2|||
27928006|NCT01199289|54584331|FG000|Overall Study|Ineligibility determined|2|||
27928007|NCT01199289|54584332|FG001|Overall Study|Ineligibility determined|1|||
27786071|NCT02255279|54240441|FG001|Overall Study|Lost to Follow-up|2|||
27786072|NCT02255279|54240440|FG000|Overall Study|Protocol Violation|0|||
27786073|NCT02255279|54240441|FG001|Overall Study|Protocol Violation|1|||
27786074|NCT02255279|54240440|FG000|Overall Study|Withdrawal by Subject|3|||
27786075|NCT02255279|54240441|FG001|Overall Study|Withdrawal by Subject|6|||
27786076|NCT01643798|54240461|FG000|Pretreatment 1 and Stimulation|Withdrawal by Subject|1|||
27928008|NCT01199289|54584333|FG002|Overall Study|Ineligibility determined|0|||
27928009|NCT01199289|54584334|FG003|Overall Study|Ineligibility determined|0|||
27928010|NCT01199289|54584331|FG000|Overall Study|Protocol Violation|1|||
27928011|NCT01199289|54584332|FG001|Overall Study|Protocol Violation|0|||
27928012|NCT01199289|54584333|FG002|Overall Study|Protocol Violation|0|||
27928013|NCT01199289|54584334|FG003|Overall Study|Protocol Violation|1|||
27928014|NCT01199289|54584331|FG000|Overall Study|Noncompliance|1|||
27928015|NCT01199289|54584332|FG001|Overall Study|Noncompliance|0|||
27928016|NCT01199289|54584333|FG002|Overall Study|Noncompliance|2|||
27928017|NCT01199289|54584334|FG003|Overall Study|Noncompliance|0|||
27786077|NCT01643798|54240462|FG001|Pretreatment 1 and Stimulation|Withdrawal by Subject|0|||
27928018|NCT01199289|54584331|FG000|Overall Study|Adverse Event|0|||
27928019|NCT01199289|54584332|FG001|Overall Study|Adverse Event|3|||
27928020|NCT01199289|54584333|FG002|Overall Study|Adverse Event|1|||
27928021|NCT01199289|54584334|FG003|Overall Study|Adverse Event|4|||
27928022|NCT01199289|54584331|FG000|Overall Study|Full consent withdrawn|2|||
27928023|NCT01199289|54584332|FG001|Overall Study|Full consent withdrawn|2|||
27928024|NCT01199289|54584333|FG002|Overall Study|Full consent withdrawn|2|||
27928025|NCT01199289|54584334|FG003|Overall Study|Full consent withdrawn|3|||
27928026|NCT01199289|54584331|FG000|Overall Study|Administrative decision|0|||
27928027|NCT01199289|54584332|FG001|Overall Study|Administrative decision|0|||
27928028|NCT01199289|54584333|FG002|Overall Study|Administrative decision|0|||
27928029|NCT01199289|54584334|FG003|Overall Study|Administrative decision|1|||
27928030|NCT01199289|54584331|FG000|Overall Study|Lost to Follow-up|0|||
27928031|NCT01199289|54584332|FG001|Overall Study|Lost to Follow-up|0|||
27928032|NCT01199289|54584333|FG002|Overall Study|Lost to Follow-up|0|||
27928033|NCT01199289|54584334|FG003|Overall Study|Lost to Follow-up|1|||
27928034|NCT01199289|54584331|FG000|Overall Study|Protocol-specified criteria|3|||
27928035|NCT01199289|54584332|FG001|Overall Study|Protocol-specified criteria|0|||
27928036|NCT01199289|54584333|FG002|Overall Study|Protocol-specified criteria|0|||
27928037|NCT01199289|54584334|FG003|Overall Study|Protocol-specified criteria|1|||
27928038|NCT01199289|54584331|FG000|Overall Study|Pregnancy|0|||
27928039|NCT01199289|54584332|FG001|Overall Study|Pregnancy|1|||
27928040|NCT01199289|54584333|FG002|Overall Study|Pregnancy|0|||
27928041|NCT01199289|54584334|FG003|Overall Study|Pregnancy|1|||
27928042|NCT01199055|54584350|FG000|Overall Study|Death|0|||
27928043|NCT01199055|54584351|FG001|Overall Study|Death|1|||
27928044|NCT01199055|54584352|FG002|Overall Study|Death|0|||
27928045|NCT01199055|54584350|FG000|Overall Study|Physician Decision|0|||
27841227|NCT01468597|54329207|FG000|Overall Study|concomitant valves|12|||
27841228|NCT01468597|54329207|FG000|Overall Study|off-pump CABG|1|||
27841229|NCT01468597|54329207|FG000|Overall Study|no platelet function data|5|||
27928046|NCT01199055|54584351|FG001|Overall Study|Physician Decision|1|||
27928047|NCT01199055|54584352|FG002|Overall Study|Physician Decision|1|||
27928048|NCT01199055|54584350|FG000|Overall Study|Progressive disease|2|||
27928049|NCT01199055|54584351|FG001|Overall Study|Progressive disease|1|||
27928050|NCT01199055|54584352|FG002|Overall Study|Progressive disease|2|||
27928051|NCT01199055|54584350|FG000|Overall Study|Withdrawal by Subject|0|||
27928052|NCT01199055|54584351|FG001|Overall Study|Withdrawal by Subject|0|||
27928053|NCT01199055|54584352|FG002|Overall Study|Withdrawal by Subject|1|||
27928054|NCT01198977|54584364|FG000|Overall Study|Lost to Follow-up|1|||
27928055|NCT01198977|54584365|FG001|Overall Study|Lost to Follow-up|0|||
27928056|NCT01198587|54584377|FG000|Overall Study|Lost to Follow-up|8|||
27841230|NCT01687166|54329215|FG000|Overall Study|Attempt subject|2|||
27841231|NCT01687166|54329216|FG001|Overall Study|Attempt subject|3|||
27841232|NCT01687166|54329217|FG002|Overall Study|Attempt subject|2|||
27841233|NCT01687166|54329218|FG003|Overall Study|Attempt subject|0|||
27841234|NCT01687166|54329215|FG000|Overall Study|Did not meet eligibility criteria|4|||
27841235|NCT01687166|54329216|FG001|Overall Study|Did not meet eligibility criteria|6|||
27841236|NCT01687166|54329217|FG002|Overall Study|Did not meet eligibility criteria|1|||
27841237|NCT01687166|54329218|FG003|Overall Study|Did not meet eligibility criteria|1|||
27841238|NCT01687166|54329215|FG000|Overall Study|Adverse Event|2|||
27841239|NCT01687166|54329216|FG001|Overall Study|Adverse Event|1|||
27841240|NCT01687166|54329217|FG002|Overall Study|Adverse Event|0|||
27841241|NCT01687166|54329218|FG003|Overall Study|Adverse Event|0|||
27928057|NCT01198587|54584378|FG001|Overall Study|Lost to Follow-up|0|||
27928058|NCT01198587|54584379|FG002|Overall Study|Lost to Follow-up|9|||
27928059|NCT01198587|54584380|FG003|Overall Study|Lost to Follow-up|0|||
27928060|NCT01198509|54584401|FG000|Overall Study|Withdrawal by Subject|1|||
27928061|NCT01198509|54584402|FG001|Overall Study|Withdrawal by Subject|0|||
27928062|NCT01198509|54584403|FG002|Overall Study|Withdrawal by Subject|0|||
27928063|NCT01198509|54584404|FG003|Overall Study|Withdrawal by Subject|0|||
27841242|NCT01687166|54329215|FG000|Overall Study|Physician Decision|3|||
27841243|NCT01687166|54329216|FG001|Overall Study|Physician Decision|2|||
27841244|NCT01687166|54329217|FG002|Overall Study|Physician Decision|1|||
27928064|NCT01198509|54584405|FG004|Overall Study|Withdrawal by Subject|0|||
27928065|NCT01198509|54584406|FG005|Overall Study|Withdrawal by Subject|0|||
27928066|NCT01198275|54584420|FG000|Overall Study|Adverse Event|2|||
27928067|NCT01198275|54584421|FG001|Overall Study|Adverse Event|3|||
27928068|NCT01198275|54584420|FG000|Overall Study|spontaneous return to sinus rhythm|4|||
27928069|NCT01198275|54584421|FG001|Overall Study|spontaneous return to sinus rhythm|2|||
27928070|NCT01197417|54584429|FG000|Overall Study|Physician Decision|3|||
27928071|NCT01197417|54584430|FG001|Overall Study|Physician Decision|2|||
27928072|NCT01197417|54584429|FG000|Overall Study|Withdrawal by Subject|2|||
27928073|NCT01197417|54584430|FG001|Overall Study|Withdrawal by Subject|4|||
27928074|NCT01197417|54584429|FG000|Overall Study|Site miscommunication|0|||
27928075|NCT01197417|54584430|FG001|Overall Study|Site miscommunication|1|||
27928076|NCT01197417|54584429|FG000|Overall Study|Subject transferred to intensive care|0|||
27928077|NCT01197417|54584430|FG001|Overall Study|Subject transferred to intensive care|1|||
27928078|NCT01197417|54584429|FG000|Overall Study|Not consented in time to receive drug|0|||
27928079|NCT01197417|54584430|FG001|Overall Study|Not consented in time to receive drug|1|||
27928080|NCT01197417|54584429|FG000|Overall Study|Hypotension|1|||
27928081|NCT01197417|54584430|FG001|Overall Study|Hypotension|2|||
27928082|NCT01197417|54584429|FG000|Overall Study|Found to be ineligible|2|||
27928083|NCT01197417|54584430|FG001|Overall Study|Found to be ineligible|5|||
27928084|NCT01197417|54584429|FG000|Overall Study|No 25-hour magnesium level|0|||
27928085|NCT01197417|54584430|FG001|Overall Study|No 25-hour magnesium level|2|||
27928086|NCT00977431|54584441|FG000|Overall Study|Other than listed|1|||
27928087|NCT00977431|54584442|FG001|Overall Study|Other than listed|0|||
27928088|NCT00977431|54584443|FG002|Overall Study|Other than listed|0|||
27928089|NCT00977431|54584444|FG003|Overall Study|Other than listed|0|||
27928090|NCT00977431|54584445|FG004|Overall Study|Other than listed|2|||
27928091|NCT00977431|54584441|FG000|Overall Study|Protocol Violation|0|||
27928092|NCT00977431|54584442|FG001|Overall Study|Protocol Violation|0|||
27928093|NCT00977431|54584443|FG002|Overall Study|Protocol Violation|1|||
27928094|NCT00977431|54584444|FG003|Overall Study|Protocol Violation|0|||
27928095|NCT00977431|54584445|FG004|Overall Study|Protocol Violation|0|||
27928096|NCT00977431|54584441|FG000|Overall Study|Adverse Event|3|||
27928097|NCT00977431|54584442|FG001|Overall Study|Adverse Event|0|||
27928098|NCT00977431|54584443|FG002|Overall Study|Adverse Event|4|||
27928099|NCT00977431|54584444|FG003|Overall Study|Adverse Event|0|||
27928100|NCT00977431|54584445|FG004|Overall Study|Adverse Event|6|||
27928101|NCT00977431|54584441|FG000|Overall Study|Dose-limiting toxicity (DLT)|1|||
27928102|NCT00977431|54584442|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
27928103|NCT00977431|54584443|FG002|Overall Study|Dose-limiting toxicity (DLT)|1|||
27928104|NCT00977431|54584444|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
27928105|NCT00977431|54584445|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
27928106|NCT00977431|54584441|FG000|Overall Study|Progressive disease|2|||
27928107|NCT00977431|54584442|FG001|Overall Study|Progressive disease|6|||
27928108|NCT00977431|54584443|FG002|Overall Study|Progressive disease|1|||
27928109|NCT00977431|54584444|FG003|Overall Study|Progressive disease|3|||
27928110|NCT00977431|54584445|FG004|Overall Study|Progressive disease|5|||
27928111|NCT00977197|54584463|FG000|Overall Study|Withdrawal by Subject|3|||
27928112|NCT00977197|54584464|FG001|Overall Study|Withdrawal by Subject|4|||
27928113|NCT00977197|54584463|FG000|Overall Study|Adverse Event|3|||
27928114|NCT00977197|54584464|FG001|Overall Study|Adverse Event|1|||
27928115|NCT00977197|54584463|FG000|Overall Study|Lack of Efficacy|1|||
27928116|NCT00977197|54584464|FG001|Overall Study|Lack of Efficacy|0|||
27928117|NCT00977197|54584463|FG000|Overall Study|Lost to Follow-up|1|||
27928118|NCT00977197|54584464|FG001|Overall Study|Lost to Follow-up|3|||
27928119|NCT00977197|54584463|FG000|Overall Study|Nonadherence|1|||
27928120|NCT00977197|54584464|FG001|Overall Study|Nonadherence|1|||
27928121|NCT00974311|54584472|FG000|DB Phase (up to 24 Months)|Lost to Follow-up|5|||
27928122|NCT00974311|54584473|FG001|DB Phase (up to 24 Months)|Lost to Follow-up|2|||
27928123|NCT00974311|54584472|FG000|DB Phase (up to 24 Months)|Death|561|||
27928124|NCT00974311|54584473|FG001|DB Phase (up to 24 Months)|Death|298|||
27928125|NCT00974311|54584472|FG000|DB Phase (up to 24 Months)|Withdrawal by Subject|16|||
27928126|NCT00974311|54584473|FG001|DB Phase (up to 24 Months)|Withdrawal by Subject|7|||
27928127|NCT00974311|54584472|FG000|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108|||
27928128|NCT00974311|54584473|FG001|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42|||
27928129|NCT00974311|54584472|FG000|DB Phase (up to 24 Months)|Other|1|||
27928130|NCT00974311|54584473|FG001|DB Phase (up to 24 Months)|Other|0|||
27928131|NCT00974311|54584472|FG000|OLE Phase (up to 77 Months)|Death|14|||
27928132|NCT00974311|54584473|FG001|OLE Phase (up to 77 Months)|Death|21|||
27928133|NCT00974311|54584472|FG000|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78|||
27928134|NCT00974311|54584473|FG001|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26|||
27928135|NCT00974311|54584472|FG000|OLE Phase (up to 77 Months)|Other|15|||
27928136|NCT00974311|54584473|FG001|OLE Phase (up to 77 Months)|Other|2|||
27928137|NCT00974311|54584472|FG000|OLE Phase (up to 77 Months)|Withdrawal by Subject|2|||
27928138|NCT00974311|54584473|FG001|OLE Phase (up to 77 Months)|Withdrawal by Subject|1|||
27928139|NCT00974233|54584482|FG000|Induction Chemoimmunotherapy|Death|2|||
27928140|NCT00974233|54584482|FG000|Induction Chemoimmunotherapy|Lack of Efficacy|5|||
27928141|NCT00974233|54584482|FG000|Induction Chemoimmunotherapy|Adverse Event|7|||
27928142|NCT00974233|54584482|FG000|Induction Chemoimmunotherapy|Withdrawal by Subject|1|||
27928143|NCT00974233|54584482|FG000|Maintenance Lenalidomide|Lack of Efficacy|5|||
27928144|NCT00974233|54584482|FG000|Maintenance Lenalidomide|Adverse Event|8|||
27928145|NCT00973921|54584494|FG000|Overall Study|IVUS results were not available|9|||
27928146|NCT00972595|54584498|FG000|Period 1|Adverse Event|1|||
27928147|NCT00972595|54584499|FG001|Period 1|Adverse Event|0|||
27928148|NCT01196091|54584508|FG000|Overall Study|Adverse Event|22|||
27928149|NCT01196091|54584509|FG001|Overall Study|Adverse Event|27|||
27786078|NCT02194699|54240475|FG000|Randomised|Did not receive treatment|1|||
27786079|NCT02194699|54240476|FG001|Randomised|Did not receive treatment|5|||
27786080|NCT02194699|54240475|FG000|Randomised|Without potential for 52 weeks of IP|5|||
27928150|NCT01196091|54584510|FG002|Overall Study|Adverse Event|26|||
27928151|NCT01196091|54584508|FG000|Overall Study|Death|3|||
27928152|NCT01196091|54584509|FG001|Overall Study|Death|2|||
27928153|NCT01196091|54584510|FG002|Overall Study|Death|2|||
27928154|NCT01196091|54584508|FG000|Overall Study|Entry Criteria Not Met|11|||
27928155|NCT01196091|54584509|FG001|Overall Study|Entry Criteria Not Met|11|||
27928156|NCT01196091|54584510|FG002|Overall Study|Entry Criteria Not Met|10|||
27928157|NCT01196091|54584508|FG000|Overall Study|Lack of Efficacy|15|||
27928158|NCT01196091|54584509|FG001|Overall Study|Lack of Efficacy|12|||
27928159|NCT01196091|54584510|FG002|Overall Study|Lack of Efficacy|17|||
27928160|NCT01196091|54584508|FG000|Overall Study|Lost to Follow-up|5|||
27786081|NCT02194699|54240476|FG001|Randomised|Without potential for 52 weeks of IP|5|||
27786082|NCT02194699|54240475|FG000|Randomised|Duplicate patient|2|||
27786083|NCT02194699|54240476|FG001|Randomised|Duplicate patient|1|||
27786084|NCT02194699|54240475|FG000|With Potential to Receive 52 Weeks of IP|Adverse Event|4|||
27786085|NCT02194699|54240476|FG001|With Potential to Receive 52 Weeks of IP|Adverse Event|3|||
27786086|NCT02194699|54240475|FG000|With Potential to Receive 52 Weeks of IP|Death|1|||
27786087|NCT02194699|54240476|FG001|With Potential to Receive 52 Weeks of IP|Death|3|||
27786088|NCT02194699|54240475|FG000|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5|||
27786089|NCT02194699|54240476|FG001|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8|||
27786090|NCT02194699|54240475|FG000|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
27786091|NCT02194699|54240476|FG001|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
27786092|NCT02194699|54240475|FG000|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14|||
27786093|NCT02194699|54240476|FG001|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20|||
27786094|NCT02194699|54240475|FG000|With Potential to Receive 52 Weeks of IP|Other|24|||
27786095|NCT02194699|54240476|FG001|With Potential to Receive 52 Weeks of IP|Other|16|||
27786096|NCT02293538|54240492|FG000|Overall Study|Adverse Event|0|||
27786097|NCT02293538|54240493|FG001|Overall Study|Adverse Event|1|||
27786098|NCT02293538|54240492|FG000|Overall Study|Lost to Follow-up|1|||
27786099|NCT02293538|54240493|FG001|Overall Study|Lost to Follow-up|0|||
27786100|NCT02293538|54240492|FG000|Overall Study|Withdrawal by Subject|0|||
27786101|NCT02293538|54240493|FG001|Overall Study|Withdrawal by Subject|1|||
27786102|NCT02194621|54240503|FG000|Overall Study|6 withdrew prior to randomization|2|||
27786103|NCT02194621|54240504|FG001|Overall Study|6 withdrew prior to randomization|2|||
27786104|NCT02194621|54240505|FG002|Overall Study|6 withdrew prior to randomization|2|||
27786105|NCT02194621|54240503|FG000|Overall Study|Withdrawal by Subject|4|||
27786106|NCT02194621|54240504|FG001|Overall Study|Withdrawal by Subject|4|||
27786107|NCT02194621|54240505|FG002|Overall Study|Withdrawal by Subject|7|||
27786108|NCT02220205|54240515|FG000|Overall Study|Withdrawal by Subject|1|||
27786109|NCT02220205|54240516|FG001|Overall Study|Withdrawal by Subject|0|||
27786110|NCT02266706|54240531|FG000|Overall Study|Withdrawal by Subject|0|||
27786111|NCT02266706|54240532|FG001|Overall Study|Withdrawal by Subject|1|||
27786112|NCT02266706|54240533|FG002|Overall Study|Withdrawal by Subject|1|||
27786113|NCT02266706|54240534|FG003|Overall Study|Withdrawal by Subject|0|||
27786114|NCT02266706|54240535|FG004|Overall Study|Withdrawal by Subject|0|||
27786115|NCT02266706|54240536|FG005|Overall Study|Withdrawal by Subject|1|||
27786116|NCT02266706|54240537|FG006|Overall Study|Withdrawal by Subject|0|||
27786117|NCT02266706|54240538|FG007|Overall Study|Withdrawal by Subject|0|||
27786118|NCT02266706|54240539|FG008|Overall Study|Withdrawal by Subject|0|||
27786119|NCT02266706|54240531|FG000|Overall Study|Screen failure|0|||
27786120|NCT02266706|54240532|FG001|Overall Study|Screen failure|0|||
27786121|NCT02266706|54240533|FG002|Overall Study|Screen failure|0|||
27786122|NCT02266706|54240534|FG003|Overall Study|Screen failure|0|||
27928161|NCT01196091|54584509|FG001|Overall Study|Lost to Follow-up|5|||
27928162|NCT01196091|54584510|FG002|Overall Study|Lost to Follow-up|6|||
27928163|NCT01196091|54584508|FG000|Overall Study|Parent/Caregiver Decision|0|||
27928164|NCT01196091|54584509|FG001|Overall Study|Parent/Caregiver Decision|0|||
27928165|NCT01196091|54584510|FG002|Overall Study|Parent/Caregiver Decision|1|||
28105553|NCT03437278|54762991|FG000|Overall Study|Progressive disease|1|||
27928166|NCT01196091|54584508|FG000|Overall Study|Withdrawal by Subject|16|||
27928167|NCT01196091|54584509|FG001|Overall Study|Withdrawal by Subject|19|||
27928168|NCT01196091|54584510|FG002|Overall Study|Withdrawal by Subject|22|||
27928169|NCT01196091|54584508|FG000|Overall Study|Physician Decision|3|||
27928170|NCT01196091|54584509|FG001|Overall Study|Physician Decision|3|||
27928171|NCT01196091|54584510|FG002|Overall Study|Physician Decision|4|||
27928172|NCT01196091|54584508|FG000|Overall Study|Protocol Violation|1|||
27928173|NCT01196091|54584509|FG001|Overall Study|Protocol Violation|3|||
27928174|NCT01196091|54584510|FG002|Overall Study|Protocol Violation|3|||
27928175|NCT01196091|54584508|FG000|Overall Study|Sponsor Decision|6|||
27928176|NCT01196091|54584509|FG001|Overall Study|Sponsor Decision|5|||
27928177|NCT01196091|54584510|FG002|Overall Study|Sponsor Decision|4|||
27928178|NCT01196091|54584508|FG000|Overall Study|Excluded Site|5|||
27928179|NCT01196091|54584509|FG001|Overall Study|Excluded Site|11|||
27928180|NCT01196091|54584510|FG002|Overall Study|Excluded Site|8|||
27928181|NCT01196091|54584508|FG000|Overall Study|Randomized, No Study Drug Received|1|||
27928182|NCT01196091|54584509|FG001|Overall Study|Randomized, No Study Drug Received|0|||
27928183|NCT01196091|54584510|FG002|Overall Study|Randomized, No Study Drug Received|1|||
27928184|NCT01195623|54584525|FG000|Overall Study|Lost to Follow-up|35|||
27928185|NCT01195623|54584526|FG001|Overall Study|Lost to Follow-up|37|||
27928186|NCT01195545|54584532|FG000|Overall Study|Protocol Violation|4|||
27928187|NCT01194999|54584536|FG000|Overall Study|Lost to Follow-up|17|||
27928188|NCT01194531|54584542|FG000|Overall Study|Withdrawal by Subject|1|||
27928189|NCT01194531|54584543|FG001|Overall Study|Withdrawal by Subject|0|||
27928190|NCT01194531|54584542|FG000|Overall Study|Protocol Violation|4|||
27928191|NCT01194531|54584543|FG001|Overall Study|Protocol Violation|1|||
27928192|NCT01194531|54584542|FG000|Overall Study|Physician Decision|0|||
27928193|NCT01194531|54584543|FG001|Overall Study|Physician Decision|2|||
27928194|NCT00972517|54584549|FG000|Overall Study|Adverse Event|0|||
27928195|NCT00972517|54584550|FG001|Overall Study|Adverse Event|0|||
27928196|NCT00972517|54584551|FG002|Overall Study|Adverse Event|0|||
27928197|NCT00972517|54584552|FG003|Overall Study|Adverse Event|1|||
27928198|NCT00972517|54584553|FG004|Overall Study|Adverse Event|0|||
27928199|NCT00972517|54584554|FG005|Overall Study|Adverse Event|0|||
27928200|NCT00972517|54584549|FG000|Overall Study|Withdrawal by Subject|0|||
27928201|NCT00972517|54584550|FG001|Overall Study|Withdrawal by Subject|1|||
27928202|NCT00972517|54584551|FG002|Overall Study|Withdrawal by Subject|0|||
27928203|NCT00972517|54584552|FG003|Overall Study|Withdrawal by Subject|2|||
27928204|NCT00972517|54584553|FG004|Overall Study|Withdrawal by Subject|1|||
27928205|NCT00972517|54584554|FG005|Overall Study|Withdrawal by Subject|0|||
27928206|NCT00972283|54584576|FG000|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31|||
27928207|NCT00972283|54584577|FG001|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9|||
27928208|NCT00972283|54584576|FG000|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3|||
27928209|NCT00972283|54584577|FG001|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0|||
27928210|NCT00972283|54584576|FG000|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23|||
27928211|NCT00972283|54584577|FG001|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12|||
27928212|NCT00972283|54584576|FG000|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8|||
27928213|NCT00972283|54584577|FG001|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2|||
27928214|NCT00972283|54584576|FG000|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72|||
27928215|NCT00972283|54584577|FG001|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17|||
27928216|NCT00972283|54584576|FG000|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4|||
27928217|NCT00972283|54584577|FG001|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0|||
27928218|NCT00972283|54584576|FG000|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
27928219|NCT00972283|54584577|FG001|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
27928220|NCT00972283|54584576|FG000|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5|||
27928221|NCT00972283|54584577|FG001|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0|||
27786123|NCT02266706|54240535|FG004|Overall Study|Screen failure|0|||
27786124|NCT02266706|54240536|FG005|Overall Study|Screen failure|1|||
27786125|NCT02266706|54240537|FG006|Overall Study|Screen failure|1|||
27786126|NCT02266706|54240538|FG007|Overall Study|Screen failure|0|||
27786127|NCT02266706|54240539|FG008|Overall Study|Screen failure|0|||
27786128|NCT02266706|54240531|FG000|Overall Study|Enrollment in another study|0|||
27786129|NCT02266706|54240532|FG001|Overall Study|Enrollment in another study|0|||
27786130|NCT02266706|54240533|FG002|Overall Study|Enrollment in another study|0|||
27786131|NCT02266706|54240534|FG003|Overall Study|Enrollment in another study|1|||
27786132|NCT02266706|54240535|FG004|Overall Study|Enrollment in another study|0|||
27928222|NCT00972283|54584576|FG000|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6|||
27928223|NCT00972283|54584577|FG001|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2|||
27786133|NCT02266706|54240536|FG005|Overall Study|Enrollment in another study|0|||
27928224|NCT00972283|54584576|FG000|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11|||
27928225|NCT00972283|54584577|FG001|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5|||
27928226|NCT00969709|54584587|FG000|Overall Study|Adverse Event|3|||
27928227|NCT00969709|54584588|FG001|Overall Study|Adverse Event|13|||
27928228|NCT00969709|54584589|FG002|Overall Study|Adverse Event|26|||
27786134|NCT02266706|54240537|FG006|Overall Study|Enrollment in another study|0|||
27786135|NCT02266706|54240538|FG007|Overall Study|Enrollment in another study|0|||
27786136|NCT02266706|54240539|FG008|Overall Study|Enrollment in another study|0|||
27786137|NCT02293460|54240559|FG000|Overall Study|Protocol Violation|1|||
27786138|NCT02293460|54240559|FG000|Overall Study|Lack of Efficacy|2|||
27786139|NCT02293460|54240559|FG000|Overall Study|Adverse Event|2|||
27786140|NCT02293460|54240559|FG000|Overall Study|Withdrawal by Subject|1|||
27786141|NCT02266004|54240563|FG000|Overall Study|unrelated adverse event|1|||
27786142|NCT02266004|54240563|FG000|Overall Study|Physician Decision|1|||
27786143|NCT02292719|54240573|FG000|Overall Study|Withdrawal by Subject|0|||
27786144|NCT02292719|54240574|FG001|Overall Study|Withdrawal by Subject|0|||
27786145|NCT02292719|54240575|FG002|Overall Study|Withdrawal by Subject|0|||
27786146|NCT02292719|54240576|FG003|Overall Study|Withdrawal by Subject|1|||
27786147|NCT02292719|54240577|FG004|Overall Study|Withdrawal by Subject|1|||
27786148|NCT02292719|54240578|FG005|Overall Study|Withdrawal by Subject|0|||
27786149|NCT02292719|54240573|FG000|Overall Study|Subject enrolled in new study.|0|||
27786150|NCT02292719|54240574|FG001|Overall Study|Subject enrolled in new study.|0|||
27786151|NCT02292719|54240575|FG002|Overall Study|Subject enrolled in new study.|1|||
27786152|NCT02292719|54240576|FG003|Overall Study|Subject enrolled in new study.|0|||
27786153|NCT02292719|54240577|FG004|Overall Study|Subject enrolled in new study.|0|||
27786154|NCT02292719|54240578|FG005|Overall Study|Subject enrolled in new study.|0|||
27786155|NCT02291861|54240596|FG000|Overall Study|Adverse Event|2|||
27786156|NCT02291861|54240597|FG001|Overall Study|Adverse Event|4|||
27786157|NCT02291861|54240598|FG002|Overall Study|Adverse Event|1|||
27786158|NCT02291861|54240599|FG003|Overall Study|Adverse Event|2|||
27786159|NCT02291861|54240596|FG000|Overall Study|Death|0|||
27786160|NCT02291861|54240597|FG001|Overall Study|Death|0|||
27786161|NCT02291861|54240598|FG002|Overall Study|Death|1|||
27786162|NCT02291861|54240599|FG003|Overall Study|Death|1|||
27786163|NCT02291861|54240596|FG000|Overall Study|Protocol Violation|1|||
27786164|NCT02291861|54240597|FG001|Overall Study|Protocol Violation|0|||
27928229|NCT00969709|54584590|FG003|Overall Study|Adverse Event|12|||
27928230|NCT00969709|54584587|FG000|Overall Study|Lack of Efficacy|7|||
27928231|NCT00969709|54584588|FG001|Overall Study|Lack of Efficacy|4|||
27928232|NCT00969709|54584589|FG002|Overall Study|Lack of Efficacy|1|||
27928233|NCT00969709|54584590|FG003|Overall Study|Lack of Efficacy|3|||
27928234|NCT00969709|54584587|FG000|Overall Study|Protocol Violation|9|||
27928235|NCT00969709|54584588|FG001|Overall Study|Protocol Violation|5|||
27928236|NCT00969709|54584589|FG002|Overall Study|Protocol Violation|9|||
27928237|NCT00969709|54584590|FG003|Overall Study|Protocol Violation|10|||
27928238|NCT00969709|54584587|FG000|Overall Study|Withdrawal by Subject|9|||
27928239|NCT00969709|54584588|FG001|Overall Study|Withdrawal by Subject|12|||
27928240|NCT00969709|54584589|FG002|Overall Study|Withdrawal by Subject|11|||
27928241|NCT00969709|54584590|FG003|Overall Study|Withdrawal by Subject|23|||
27928242|NCT00969709|54584587|FG000|Overall Study|Lost to Follow-up|10|||
27928243|NCT00969709|54584588|FG001|Overall Study|Lost to Follow-up|14|||
27928244|NCT00969709|54584589|FG002|Overall Study|Lost to Follow-up|8|||
27928245|NCT00969709|54584590|FG003|Overall Study|Lost to Follow-up|15|||
27928246|NCT00969709|54584587|FG000|Overall Study|Other reasons|0|||
27928247|NCT00969709|54584588|FG001|Overall Study|Other reasons|0|||
27928248|NCT00969709|54584589|FG002|Overall Study|Other reasons|3|||
27928249|NCT00969709|54584590|FG003|Overall Study|Other reasons|0|||
27928250|NCT01193517|54584607|FG000|Overall Study|Early Progression|1|||
27928251|NCT01193517|54584608|FG001|Overall Study|Early Progression|0|||
27928252|NCT01193517|54584609|FG002|Overall Study|Early Progression|0|||
27928253|NCT01193283|54584618|FG000|Overall Study|Death|1|||
27928254|NCT00971425|54584624|FG000|Overall Study|Adverse Event|1|||
27928255|NCT00971425|54584625|FG001|Overall Study|Adverse Event|1|||
27928256|NCT00971425|54584624|FG000|Overall Study|Withdrawal by Subject|0|||
27928257|NCT00971425|54584625|FG001|Overall Study|Withdrawal by Subject|1|||
27928258|NCT01193127|54584635|FG000|Randomized|Surgery Cancelled|0|||
27928259|NCT01193127|54584636|FG001|Randomized|Surgery Cancelled|0|||
27928260|NCT01193127|54584637|FG002|Randomized|Surgery Cancelled|0|||
27928261|NCT01193127|54584638|FG003|Randomized|Surgery Cancelled|1|||
27928262|NCT01193127|54584635|FG000|Treated|Withdrawal by Subject|0|||
27928263|NCT01193127|54584636|FG001|Treated|Withdrawal by Subject|0|||
27928264|NCT01193127|54584637|FG002|Treated|Withdrawal by Subject|0|||
27786165|NCT02291861|54240598|FG002|Overall Study|Protocol Violation|0|||
27786166|NCT02291861|54240599|FG003|Overall Study|Protocol Violation|1|||
27786167|NCT02291861|54240596|FG000|Overall Study|Withdrawal by Subject|1|||
27786168|NCT02291861|54240597|FG001|Overall Study|Withdrawal by Subject|2|||
27786169|NCT02291861|54240598|FG002|Overall Study|Withdrawal by Subject|1|||
27786170|NCT02291861|54240599|FG003|Overall Study|Withdrawal by Subject|4|||
27786171|NCT02291861|54240596|FG000|Overall Study|Noncompliance|1|||
27928265|NCT01193127|54584638|FG003|Treated|Withdrawal by Subject|1|||
27928266|NCT01192815|54584650|FG000|Overall Study|Withdrawal by Subject|1|||
27928267|NCT01192815|54584650|FG000|Overall Study|Lack of Efficacy|1|||
27928268|NCT01192347|54584654|FG000|Overall Study|Death|3|||
27928269|NCT01192347|54584654|FG000|Overall Study|Lost to Follow-up|3|||
27928270|NCT01192347|54584654|FG000|Overall Study|Withdrawal by Subject|1|||
27928271|NCT01192347|54584654|FG000|Overall Study|Adverse Event|1|||
27928272|NCT01192347|54584654|FG000|Overall Study|Suspected serious adverse drug reaction|1|||
27928273|NCT01192347|54584654|FG000|Overall Study|Patient seen in different hospital|1|||
27928274|NCT01192347|54584654|FG000|Overall Study|Patient not visiting hospital regularly|1|||
27928275|NCT01192347|54584654|FG000|Overall Study|Patient did not show up for visits|1|||
27928276|NCT01192191|54584660|FG000|Overall Study|Adverse Event|7|||
27928277|NCT01192191|54584661|FG001|Overall Study|Adverse Event|12|||
27928278|NCT01192191|54584660|FG000|Overall Study|Participants Reached Stopping Criteria|3|||
27928279|NCT01192191|54584661|FG001|Overall Study|Participants Reached Stopping Criteria|2|||
27928280|NCT01192191|54584660|FG000|Overall Study|Lost to Follow-up|0|||
27928281|NCT01192191|54584661|FG001|Overall Study|Lost to Follow-up|1|||
27928282|NCT01192191|54584660|FG000|Overall Study|Withdrawal by Subject|1|||
27928283|NCT01192191|54584661|FG001|Overall Study|Withdrawal by Subject|6|||
27928284|NCT01307267|54584690|FG000|Overall Study|Death|4|||
27928285|NCT01307267|54584691|FG001|Overall Study|Death|3|||
27928286|NCT01307267|54584692|FG002|Overall Study|Death|5|||
27928287|NCT01307267|54584693|FG003|Overall Study|Death|3|||
27928288|NCT01307267|54584694|FG004|Overall Study|Death|1|||
27928289|NCT01307267|54584695|FG005|Overall Study|Death|26|||
27928290|NCT01307267|54584696|FG006|Overall Study|Death|2|||
27928291|NCT01307267|54584697|FG007|Overall Study|Death|2|||
27928292|NCT01307267|54584698|FG008|Overall Study|Death|21|||
27928293|NCT01307267|54584699|FG009|Overall Study|Death|2|||
27928294|NCT01307267|54584700|FG010|Overall Study|Death|3|||
27928295|NCT01307267|54584701|FG011|Overall Study|Death|9|||
27928296|NCT01307267|54584702|FG012|Overall Study|Death|0|||
27928297|NCT01307267|54584703|FG013|Overall Study|Death|0|||
27928298|NCT01307267|54584704|FG014|Overall Study|Death|0|||
27928299|NCT01307267|54584705|FG015|Overall Study|Death|0|||
27928300|NCT01307267|54584706|FG016|Overall Study|Death|1|||
27928301|NCT01307267|54584707|FG017|Overall Study|Death|1|||
27928302|NCT01307267|54584708|FG018|Overall Study|Death|2|||
27928303|NCT01307267|54584709|FG019|Overall Study|Death|8|||
27928304|NCT01307267|54584710|FG020|Overall Study|Death|1|||
27928305|NCT01307267|54584711|FG021|Overall Study|Death|2|||
27786172|NCT02291861|54240597|FG001|Overall Study|Noncompliance|1|||
27786173|NCT02291861|54240598|FG002|Overall Study|Noncompliance|2|||
27786174|NCT02291861|54240599|FG003|Overall Study|Noncompliance|1|||
27786175|NCT02291861|54240596|FG000|Overall Study|Lost to Follow-up|2|||
27786176|NCT02291861|54240597|FG001|Overall Study|Lost to Follow-up|1|||
27786177|NCT02291861|54240598|FG002|Overall Study|Lost to Follow-up|4|||
27786178|NCT02291861|54240599|FG003|Overall Study|Lost to Follow-up|0|||
27786179|NCT02291861|54240596|FG000|Overall Study|Other|0|||
27786180|NCT02291861|54240597|FG001|Overall Study|Other|0|||
27786181|NCT02291861|54240598|FG002|Overall Study|Other|0|||
27786182|NCT02291861|54240599|FG003|Overall Study|Other|1|||
27786183|NCT02291549|54240611|FG000|Overall Study|Lost to Follow-up|1|||
27786184|NCT02291549|54240612|FG001|Overall Study|Lost to Follow-up|0|||
27786185|NCT02291549|54240611|FG000|Overall Study|Withdrawal by Subject|0|||
27786186|NCT02291549|54240612|FG001|Overall Study|Withdrawal by Subject|1|||
27786187|NCT02264990|54240622|FG000|Overall Study|Death|255|||
27786188|NCT02264990|54240623|FG001|Overall Study|Death|250|||
27786189|NCT02264990|54240622|FG000|Overall Study|Withdrawal by Subject|4|||
27786190|NCT02264990|54240623|FG001|Overall Study|Withdrawal by Subject|5|||
27786191|NCT02264990|54240622|FG000|Overall Study|Lost to Follow-up|1|||
27786192|NCT02264990|54240623|FG001|Overall Study|Lost to Follow-up|3|||
27786193|NCT02264990|54240622|FG000|Overall Study|Other|0|||
27786194|NCT02264990|54240623|FG001|Overall Study|Other|1|||
27786195|NCT02291237|54240632|FG000|Overall Study|Study Terminated by Sponsor|72|||
27786196|NCT02291237|54240633|FG001|Overall Study|Study Terminated by Sponsor|67|||
27786197|NCT02291237|54240632|FG000|Overall Study|Adverse Event|1|||
27928306|NCT01307267|54584712|FG022|Overall Study|Death|2|||
27928307|NCT01307267|54584690|FG000|Overall Study|Lost to Follow-up|0|||
27928308|NCT01307267|54584691|FG001|Overall Study|Lost to Follow-up|0|||
27786198|NCT02291237|54240633|FG001|Overall Study|Adverse Event|3|||
27786199|NCT02291237|54240632|FG000|Overall Study|Investigator's Discretion|0|||
27786200|NCT02291237|54240633|FG001|Overall Study|Investigator's Discretion|3|||
27786201|NCT02291237|54240632|FG000|Overall Study|Withdrew Consent|11|||
27786202|NCT02291237|54240633|FG001|Overall Study|Withdrew Consent|11|||
27786203|NCT02291237|54240632|FG000|Overall Study|Lost to Follow-up|0|||
27786204|NCT02291237|54240633|FG001|Overall Study|Lost to Follow-up|2|||
27786205|NCT02291237|54240632|FG000|Overall Study|Subject Required Prohibited Medication|2|||
27786206|NCT02291237|54240633|FG001|Overall Study|Subject Required Prohibited Medication|0|||
27928309|NCT01307267|54584692|FG002|Overall Study|Lost to Follow-up|0|||
27928310|NCT01307267|54584693|FG003|Overall Study|Lost to Follow-up|0|||
27928311|NCT01307267|54584694|FG004|Overall Study|Lost to Follow-up|0|||
27786207|NCT02292446|54240639|FG000|Overall Study|Adverse Event|12|||
27928312|NCT01307267|54584695|FG005|Overall Study|Lost to Follow-up|7|||
27928313|NCT01307267|54584696|FG006|Overall Study|Lost to Follow-up|0|||
27928314|NCT01307267|54584697|FG007|Overall Study|Lost to Follow-up|0|||
27928315|NCT01307267|54584698|FG008|Overall Study|Lost to Follow-up|1|||
27928316|NCT01307267|54584699|FG009|Overall Study|Lost to Follow-up|2|||
27928317|NCT01307267|54584700|FG010|Overall Study|Lost to Follow-up|1|||
27928318|NCT01307267|54584701|FG011|Overall Study|Lost to Follow-up|0|||
27928319|NCT01307267|54584702|FG012|Overall Study|Lost to Follow-up|0|||
27928320|NCT01307267|54584703|FG013|Overall Study|Lost to Follow-up|0|||
27928321|NCT01307267|54584704|FG014|Overall Study|Lost to Follow-up|0|||
27928322|NCT01307267|54584705|FG015|Overall Study|Lost to Follow-up|0|||
27928323|NCT01307267|54584706|FG016|Overall Study|Lost to Follow-up|0|||
27928324|NCT01307267|54584707|FG017|Overall Study|Lost to Follow-up|0|||
27928325|NCT01307267|54584708|FG018|Overall Study|Lost to Follow-up|0|||
27928326|NCT01307267|54584709|FG019|Overall Study|Lost to Follow-up|2|||
27928327|NCT01307267|54584710|FG020|Overall Study|Lost to Follow-up|0|||
27928328|NCT01307267|54584711|FG021|Overall Study|Lost to Follow-up|0|||
27928329|NCT01307267|54584712|FG022|Overall Study|Lost to Follow-up|0|||
27928330|NCT01307267|54584690|FG000|Overall Study|Withdrawal by Subject|0|||
27928331|NCT01307267|54584691|FG001|Overall Study|Withdrawal by Subject|0|||
27928332|NCT01307267|54584692|FG002|Overall Study|Withdrawal by Subject|0|||
27928333|NCT01307267|54584693|FG003|Overall Study|Withdrawal by Subject|0|||
27928334|NCT01307267|54584694|FG004|Overall Study|Withdrawal by Subject|0|||
27928335|NCT01307267|54584695|FG005|Overall Study|Withdrawal by Subject|1|||
27928336|NCT01307267|54584696|FG006|Overall Study|Withdrawal by Subject|0|||
27786208|NCT02292446|54240639|FG000|Overall Study|Death|1|||
27786209|NCT02292446|54240639|FG000|Overall Study|Disease progression|2|||
27786210|NCT02292446|54240639|FG000|Overall Study|Subject/guardian decision|2|||
27786211|NCT02292446|54240639|FG000|Overall Study|Withdrawal by Subject|3|||
27786212|NCT02290925|54240648|FG000|First Period of Three Months|Lost to Follow-up|2|||
27928337|NCT01307267|54584697|FG007|Overall Study|Withdrawal by Subject|1|||
27928338|NCT01307267|54584698|FG008|Overall Study|Withdrawal by Subject|5|||
27928339|NCT01307267|54584699|FG009|Overall Study|Withdrawal by Subject|1|||
27928340|NCT01307267|54584700|FG010|Overall Study|Withdrawal by Subject|1|||
27928341|NCT01307267|54584701|FG011|Overall Study|Withdrawal by Subject|1|||
27928342|NCT01307267|54584702|FG012|Overall Study|Withdrawal by Subject|0|||
27928343|NCT01307267|54584703|FG013|Overall Study|Withdrawal by Subject|0|||
27928344|NCT01307267|54584704|FG014|Overall Study|Withdrawal by Subject|0|||
27928345|NCT01307267|54584705|FG015|Overall Study|Withdrawal by Subject|0|||
27928346|NCT01307267|54584706|FG016|Overall Study|Withdrawal by Subject|0|||
27928347|NCT01307267|54584707|FG017|Overall Study|Withdrawal by Subject|0|||
27928348|NCT01307267|54584708|FG018|Overall Study|Withdrawal by Subject|0|||
27928349|NCT01307267|54584709|FG019|Overall Study|Withdrawal by Subject|3|||
27928350|NCT01307267|54584710|FG020|Overall Study|Withdrawal by Subject|0|||
27928351|NCT01307267|54584711|FG021|Overall Study|Withdrawal by Subject|0|||
27928352|NCT01307267|54584712|FG022|Overall Study|Withdrawal by Subject|0|||
27786213|NCT02290925|54240649|FG001|First Period of Three Months|Lost to Follow-up|1|||
27786214|NCT02290925|54240648|FG000|First Period of Three Months|Death|1|||
27786215|NCT02290925|54240649|FG001|First Period of Three Months|Death|0|||
27786216|NCT02290925|54240648|FG000|First Period of Three Months|Insulin Started|1|||
27786217|NCT02290925|54240649|FG001|First Period of Three Months|Insulin Started|1|||
27786218|NCT02290925|54240648|FG000|Second Period of 3 Months|Lost to Follow-up|1|||
27786219|NCT02290925|54240649|FG001|Second Period of 3 Months|Lost to Follow-up|3|||
27786220|NCT02290925|54240648|FG000|Second Period of 3 Months|insulin started|0|||
27786221|NCT02290925|54240649|FG001|Second Period of 3 Months|insulin started|1|||
27841245|NCT01687166|54329218|FG003|Overall Study|Physician Decision|0|||
27841246|NCT01687166|54329215|FG000|Overall Study|Withdrawal by Subject|11|||
27841247|NCT01687166|54329216|FG001|Overall Study|Withdrawal by Subject|4|||
27841248|NCT01687166|54329217|FG002|Overall Study|Withdrawal by Subject|3|||
27841249|NCT01687166|54329218|FG003|Overall Study|Withdrawal by Subject|0|||
27841250|NCT01687166|54329215|FG000|Overall Study|Lost to Follow-up|2|||
27841251|NCT01687166|54329216|FG001|Overall Study|Lost to Follow-up|5|||
27841252|NCT01687166|54329217|FG002|Overall Study|Lost to Follow-up|1|||
27841253|NCT01687166|54329218|FG003|Overall Study|Lost to Follow-up|0|||
27841254|NCT01687166|54329215|FG000|Overall Study|Equipment/Device Availability|0|||
27841255|NCT01687166|54329216|FG001|Overall Study|Equipment/Device Availability|1|||
27841256|NCT01687166|54329217|FG002|Overall Study|Equipment/Device Availability|0|||
27841257|NCT01687166|54329218|FG003|Overall Study|Equipment/Device Availability|0|||
27841258|NCT01687166|54329215|FG000|Overall Study|Death|1|||
27841259|NCT01687166|54329216|FG001|Overall Study|Death|1|||
27841260|NCT01687166|54329217|FG002|Overall Study|Death|0|||
27928353|NCT01307267|54584690|FG000|Overall Study|Other|0|||
27928354|NCT01307267|54584691|FG001|Overall Study|Other|0|||
27928355|NCT01307267|54584692|FG002|Overall Study|Other|0|||
27928356|NCT01307267|54584693|FG003|Overall Study|Other|0|||
27841261|NCT01687166|54329218|FG003|Overall Study|Death|0|||
27841262|NCT01687166|54329215|FG000|Overall Study|Protocol Violation|1|||
27928357|NCT01307267|54584694|FG004|Overall Study|Other|0|||
27928358|NCT01307267|54584695|FG005|Overall Study|Other|7|||
27928359|NCT01307267|54584696|FG006|Overall Study|Other|0|||
27841263|NCT01687166|54329216|FG001|Overall Study|Protocol Violation|1|||
27928360|NCT01307267|54584697|FG007|Overall Study|Other|1|||
27928361|NCT01307267|54584698|FG008|Overall Study|Other|3|||
27928362|NCT01307267|54584699|FG009|Overall Study|Other|0|||
27928363|NCT01307267|54584700|FG010|Overall Study|Other|1|||
27928364|NCT01307267|54584701|FG011|Overall Study|Other|1|||
27928365|NCT01307267|54584702|FG012|Overall Study|Other|1|||
27928366|NCT01307267|54584703|FG013|Overall Study|Other|0|||
27928367|NCT01307267|54584704|FG014|Overall Study|Other|2|||
27928368|NCT01307267|54584705|FG015|Overall Study|Other|1|||
27928369|NCT01307267|54584706|FG016|Overall Study|Other|0|||
27928370|NCT01307267|54584707|FG017|Overall Study|Other|0|||
27928371|NCT01307267|54584708|FG018|Overall Study|Other|0|||
27928372|NCT01307267|54584709|FG019|Overall Study|Other|19|||
27928373|NCT01307267|54584710|FG020|Overall Study|Other|2|||
27928374|NCT01307267|54584711|FG021|Overall Study|Other|3|||
27928375|NCT01307267|54584712|FG022|Overall Study|Other|2|||
27928376|NCT01307111|54584774|FG000|IUD Insertion|Lost to Follow-up|2|||
27928377|NCT01307111|54584775|FG001|IUD Insertion|Lost to Follow-up|0|||
27928378|NCT01307111|54584774|FG000|1-2 Week IUD Check up|IUD expulsion/removal|2|||
27928379|NCT01307111|54584775|FG001|1-2 Week IUD Check up|IUD expulsion/removal|2|||
27928380|NCT01306877|54584783|FG000|Overall Study|Lost to Follow-up|3|||
27928381|NCT01306877|54584784|FG001|Overall Study|Lost to Follow-up|3|||
27786222|NCT02290691|54240659|FG000|Overall Study|Noncompliance|0|||
27786223|NCT02290691|54240660|FG001|Overall Study|Noncompliance|1|||
27786224|NCT02290691|54240659|FG000|Overall Study|Withdrawal by Subject|1|||
27786225|NCT02290691|54240660|FG001|Overall Study|Withdrawal by Subject|1|||
27786226|NCT02290691|54240659|FG000|Overall Study|Lost to Follow-up|7|||
27786227|NCT02290691|54240660|FG001|Overall Study|Lost to Follow-up|7|||
27928382|NCT01306877|54584783|FG000|Overall Study|Physician Decision|0|||
27928383|NCT01306877|54584784|FG001|Overall Study|Physician Decision|1|||
27786228|NCT02292212|54240666|FG000|ViE Phase|Withdrawal by Subject|1|||
27786229|NCT02292212|54240666|FG000|ViE Phase|Protocol Violation|2|||
27786230|NCT02291510|54240681|FG000|Overall Study|Adverse Event|0|||
27786231|NCT02291510|54240682|FG001|Overall Study|Adverse Event|0|||
27786232|NCT02291510|54240683|FG002|Overall Study|Adverse Event|0|||
27786233|NCT02291510|54240684|FG003|Overall Study|Adverse Event|1|||
27786234|NCT02290223|54240696|FG000|6 Months|Lost to Follow-up|9|||
27786235|NCT02290223|54240697|FG001|6 Months|Lost to Follow-up|6|||
27786236|NCT02290223|54240696|FG000|6 Months|Withdrawal by Subject|5|||
27786237|NCT02290223|54240697|FG001|6 Months|Withdrawal by Subject|0|||
27786238|NCT02290223|54240696|FG000|6 Months|deceased (not related to study)|2|||
27786239|NCT02290223|54240697|FG001|6 Months|deceased (not related to study)|0|||
27786240|NCT02290223|54240696|FG000|12 Months|Lost to Follow-up|16|||
27786241|NCT02290223|54240697|FG001|12 Months|Lost to Follow-up|10|||
27786242|NCT02290223|54240696|FG000|12 Months|Refusal|0|||
27786243|NCT02290223|54240697|FG001|12 Months|Refusal|1|||
27786244|NCT02289833|54240705|FG000|Overall Study|Study discontinuation|0|||
27786245|NCT02289833|54240706|FG001|Overall Study|Study discontinuation|1|||
27786246|NCT02289833|54240705|FG000|Overall Study|Lost to Follow-up|4|||
27786247|NCT02289833|54240706|FG001|Overall Study|Lost to Follow-up|0|||
27786248|NCT02289833|54240705|FG000|Overall Study|Death|23|||
27786249|NCT02289833|54240706|FG001|Overall Study|Death|16|||
27786250|NCT01702558|54240719|FG000|Overall Study|Withdrawal by Subject|0|||
27786251|NCT01702558|54240720|FG001|Overall Study|Withdrawal by Subject|0|||
27841264|NCT01687166|54329217|FG002|Overall Study|Protocol Violation|1|||
27841265|NCT01687166|54329218|FG003|Overall Study|Protocol Violation|0|||
27786252|NCT01702558|54240721|FG002|Overall Study|Withdrawal by Subject|0|||
27786253|NCT01702558|54240722|FG003|Overall Study|Withdrawal by Subject|12|||
27786254|NCT01702558|54240723|FG004|Overall Study|Withdrawal by Subject|4|||
27841266|NCT01687166|54329215|FG000|Overall Study|Subject moved out of state|0|||
27841267|NCT01687166|54329216|FG001|Overall Study|Subject moved out of state|1|||
27841268|NCT01687166|54329217|FG002|Overall Study|Subject moved out of state|0|||
27841269|NCT01687166|54329218|FG003|Overall Study|Subject moved out of state|0|||
27841270|NCT01687166|54329215|FG000|Overall Study|Patient unable to be compliant|1|||
27841271|NCT01687166|54329216|FG001|Overall Study|Patient unable to be compliant|0|||
27841272|NCT01687166|54329217|FG002|Overall Study|Patient unable to be compliant|0|||
27841273|NCT01687166|54329218|FG003|Overall Study|Patient unable to be compliant|0|||
27841274|NCT01687166|54329215|FG000|Overall Study|Physician choice to use different device|1|||
27928384|NCT01191801|54584792|FG000|Overall Study|Death|36|||
27786255|NCT01702558|54240719|FG000|Overall Study|Lost to Follow-up|0|||
27841275|NCT01687166|54329216|FG001|Overall Study|Physician choice to use different device|2|||
27928385|NCT01191801|54584793|FG001|Overall Study|Death|12|||
27928386|NCT01191801|54584792|FG000|Overall Study|Lack of Efficacy|176|||
27928387|NCT01191801|54584793|FG001|Overall Study|Lack of Efficacy|258|||
27928388|NCT01191801|54584792|FG000|Overall Study|Adverse Event|9|||
27928389|NCT01191801|54584793|FG001|Overall Study|Adverse Event|8|||
27928390|NCT01191801|54584792|FG000|Overall Study|Protocol Violation|2|||
27928391|NCT01191801|54584793|FG001|Overall Study|Protocol Violation|4|||
27928392|NCT01191801|54584792|FG000|Overall Study|Physician Decision|47|||
27786256|NCT01702558|54240720|FG001|Overall Study|Lost to Follow-up|0|||
27786257|NCT01702558|54240721|FG002|Overall Study|Lost to Follow-up|0|||
27786258|NCT01702558|54240722|FG003|Overall Study|Lost to Follow-up|3|||
27786259|NCT01702558|54240723|FG004|Overall Study|Lost to Follow-up|0|||
27786260|NCT01702558|54240719|FG000|Overall Study|Death|4|||
27786261|NCT01702558|54240720|FG001|Overall Study|Death|3|||
27786262|NCT01702558|54240721|FG002|Overall Study|Death|3|||
27786263|NCT01702558|54240722|FG003|Overall Study|Death|16|||
27786264|NCT01702558|54240723|FG004|Overall Study|Death|20|||
27786265|NCT01702558|54240719|FG000|Overall Study|Safety Follow-Up less than 3 Months|0|||
27786266|NCT01702558|54240720|FG001|Overall Study|Safety Follow-Up less than 3 Months|0|||
27786267|NCT01702558|54240721|FG002|Overall Study|Safety Follow-Up less than 3 Months|2|||
27786268|NCT01702558|54240722|FG003|Overall Study|Safety Follow-Up less than 3 Months|0|||
27786269|NCT01702558|54240723|FG004|Overall Study|Safety Follow-Up less than 3 Months|0|||
27786270|NCT01702558|54240719|FG000|Overall Study|Study Terminated by Sponsor|0|||
27786271|NCT01702558|54240720|FG001|Overall Study|Study Terminated by Sponsor|1|||
27786272|NCT01702558|54240721|FG002|Overall Study|Study Terminated by Sponsor|0|||
27786273|NCT01702558|54240722|FG003|Overall Study|Study Terminated by Sponsor|0|||
27786274|NCT01702558|54240723|FG004|Overall Study|Study Terminated by Sponsor|1|||
27786275|NCT01702558|54240719|FG000|Overall Study|Other|0|||
27786276|NCT01702558|54240720|FG001|Overall Study|Other|0|||
27928393|NCT01191801|54584793|FG001|Overall Study|Physician Decision|24|||
27928394|NCT01191801|54584792|FG000|Overall Study|Withdrawal by Subject|1|||
27928395|NCT01191801|54584793|FG001|Overall Study|Withdrawal by Subject|4|||
27928396|NCT01191801|54584792|FG000|Overall Study|Not Provided|45|||
27928397|NCT01191801|54584793|FG001|Overall Study|Not Provided|27|||
27928398|NCT01306643|54584799|FG000|Overall Study|Adverse Event|5|||
27786277|NCT01702558|54240721|FG002|Overall Study|Other|0|||
27786278|NCT01702558|54240722|FG003|Overall Study|Other|16|||
27786279|NCT01702558|54240723|FG004|Overall Study|Other|17|||
27786280|NCT02287883|54240738|FG000|Overall Study|Death|8|||
27928399|NCT01306643|54584799|FG000|Overall Study|Disease Progression|7|||
27928400|NCT01306643|54584799|FG000|Overall Study|Other: Change in Eligibility Status|1|||
27786281|NCT02287883|54240739|FG001|Overall Study|Death|7|||
27928401|NCT01306331|54584805|FG000|Overall Study|Adverse Event|28|||
27928402|NCT01306331|54584806|FG001|Overall Study|Adverse Event|25|||
27928403|NCT01306331|54584805|FG000|Overall Study|Lost to Follow-up|321|||
27928404|NCT01306331|54584806|FG001|Overall Study|Lost to Follow-up|323|||
27928405|NCT01306331|54584805|FG000|Overall Study|Physician Decision|26|||
27928406|NCT01306331|54584806|FG001|Overall Study|Physician Decision|22|||
27928407|NCT01306331|54584805|FG000|Overall Study|Pregnancy|136|||
27928408|NCT01306331|54584806|FG001|Overall Study|Pregnancy|151|||
27928409|NCT01306331|54584805|FG000|Overall Study|Protocol Violation|154|||
27928410|NCT01306331|54584806|FG001|Overall Study|Protocol Violation|124|||
27928411|NCT01306331|54584805|FG000|Overall Study|Withdrawal by Subject|163|||
27928412|NCT01306331|54584806|FG001|Overall Study|Withdrawal by Subject|152|||
27928413|NCT01306331|54584805|FG000|Overall Study|Not sexually active|29|||
27928414|NCT01306331|54584806|FG001|Overall Study|Not sexually active|28|||
27928415|NCT01306331|54584805|FG000|Overall Study|Meth. no longer prim. meth. birth cntrl|10|||
27928416|NCT01306331|54584806|FG001|Overall Study|Meth. no longer prim. meth. birth cntrl|20|||
27928417|NCT01306331|54584805|FG000|Overall Study|Other|34|||
27928418|NCT01306331|54584806|FG001|Overall Study|Other|32|||
27928419|NCT01306253|54584814|FG000|Overall Study|Lost to Follow-up|1|||
27928420|NCT01306253|54584815|FG001|Overall Study|Lost to Follow-up|1|||
27928421|NCT01305941|54584821|FG000|Overall Study|Adverse Event|6|||
27928422|NCT01305941|54584821|FG000|Overall Study|Clinical decline|2|||
27928423|NCT01305941|54584821|FG000|Overall Study|Withdrawal by Subject|1|||
27928424|NCT01305941|54584821|FG000|Overall Study|Death|1|||
27928425|NCT01305239|54584825|FG000|Overall Study|Adverse Event|22|||
27928426|NCT01305239|54584825|FG000|Overall Study|Exemestane taken prior to inclusion only|1|||
27928427|NCT01194219|54584831|FG000|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23|||
27928428|NCT01194219|54584832|FG001|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5|||
27928429|NCT01194219|54584833|FG002|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
27928430|NCT01194219|54584834|FG003|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
27928431|NCT01194219|54584835|FG004|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
27928432|NCT01194219|54584836|FG005|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
27928433|NCT01194219|54584837|FG006|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
27928434|NCT01194219|54584838|FG007|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
27928435|NCT01194219|54584839|FG008|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
27928436|NCT01194219|54584840|FG009|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
27928437|NCT01194219|54584831|FG000|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2|||
27928438|NCT01194219|54584832|FG001|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7|||
27928439|NCT01194219|54584833|FG002|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
27928440|NCT01194219|54584834|FG003|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
27928441|NCT01194219|54584835|FG004|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
27928442|NCT01194219|54584836|FG005|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
27928443|NCT01194219|54584837|FG006|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
27928444|NCT01194219|54584838|FG007|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
27928445|NCT01194219|54584839|FG008|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
27928446|NCT01194219|54584840|FG009|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
27928447|NCT01194219|54584831|FG000|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7|||
27928448|NCT01194219|54584832|FG001|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
27928449|NCT01194219|54584833|FG002|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
27928450|NCT01194219|54584834|FG003|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
27928451|NCT01194219|54584835|FG004|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
27928452|NCT01194219|54584836|FG005|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
27928453|NCT01194219|54584837|FG006|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
27928454|NCT01194219|54584838|FG007|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
27928455|NCT01194219|54584839|FG008|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
27928456|NCT01194219|54584840|FG009|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
27928457|NCT01194219|54584831|FG000|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12|||
27928458|NCT01194219|54584832|FG001|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9|||
27928459|NCT01194219|54584833|FG002|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
27928460|NCT01194219|54584834|FG003|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
27928461|NCT01194219|54584835|FG004|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
27928462|NCT01194219|54584836|FG005|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
27928463|NCT01194219|54584837|FG006|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
27928464|NCT01194219|54584838|FG007|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
27928465|NCT01194219|54584839|FG008|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
27928466|NCT01194219|54584840|FG009|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
27928467|NCT01194219|54584831|FG000|Placebo-Controlled Phase Weeks 0-16|Death|0|||
27928468|NCT01194219|54584832|FG001|Placebo-Controlled Phase Weeks 0-16|Death|1|||
27928469|NCT01194219|54584833|FG002|Placebo-Controlled Phase Weeks 0-16|Death|0|||
27928470|NCT01194219|54584834|FG003|Placebo-Controlled Phase Weeks 0-16|Death|0|||
27928471|NCT01194219|54584835|FG004|Placebo-Controlled Phase Weeks 0-16|Death|0|||
27928472|NCT01194219|54584836|FG005|Placebo-Controlled Phase Weeks 0-16|Death|0|||
27928473|NCT01194219|54584837|FG006|Placebo-Controlled Phase Weeks 0-16|Death|0|||
27928474|NCT01194219|54584838|FG007|Placebo-Controlled Phase Weeks 0-16|Death|0|||
27928475|NCT01194219|54584839|FG008|Placebo-Controlled Phase Weeks 0-16|Death|0|||
27841276|NCT01687166|54329217|FG002|Overall Study|Physician choice to use different device|4|||
27841277|NCT01687166|54329218|FG003|Overall Study|Physician choice to use different device|0|||
27841278|NCT01687166|54329215|FG000|Overall Study|Insurance|0|||
27841279|NCT01687166|54329216|FG001|Overall Study|Insurance|0|||
27841280|NCT01687166|54329217|FG002|Overall Study|Insurance|1|||
27841281|NCT01687166|54329218|FG003|Overall Study|Insurance|1|||
27841282|NCT01561976|54329232|FG000|Period 1|Adverse Event|0|||
27841283|NCT01561976|54329233|FG001|Period 1|Adverse Event|0|||
27841284|NCT01561976|54329234|FG002|Period 1|Adverse Event|1|||
27841285|NCT01561976|54329235|FG003|Period 1|Adverse Event|0|||
27841286|NCT01561976|54329236|FG004|Period 1|Adverse Event|0|||
27841287|NCT01561976|54329237|FG005|Period 1|Adverse Event|0|||
27841288|NCT01561976|54329232|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
27841289|NCT01561976|54329233|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
27841290|NCT01561976|54329234|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
27841291|NCT01561976|54329235|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
27841292|NCT01561976|54329236|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
27841293|NCT01561976|54329237|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
27841294|NCT01561976|54329232|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
27841295|NCT01561976|54329233|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
27841296|NCT01561976|54329234|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
27841297|NCT01561976|54329235|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
27841298|NCT01561976|54329236|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
27841299|NCT01561976|54329237|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
27841300|NCT01561976|54329232|FG000|Washout Period 2 (7 Days)|Non-compliance|1|||
27841301|NCT01561976|54329233|FG001|Washout Period 2 (7 Days)|Non-compliance|0|||
27841302|NCT01561976|54329234|FG002|Washout Period 2 (7 Days)|Non-compliance|1|||
27841303|NCT01561976|54329235|FG003|Washout Period 2 (7 Days)|Non-compliance|0|||
27841304|NCT01561976|54329236|FG004|Washout Period 2 (7 Days)|Non-compliance|0|||
27841305|NCT01561976|54329237|FG005|Washout Period 2 (7 Days)|Non-compliance|0|||
27841306|NCT01686932|54329247|FG000|Period 1|Adverse Event|1|||
27841307|NCT01686932|54329248|FG001|Period 1|Adverse Event|1|||
27841308|NCT01468207|54329256|FG000|Treatment Period 1|Adverse Event|1|||
27841309|NCT01468207|54329257|FG001|Treatment Period 1|Adverse Event|0|||
27841310|NCT01468207|54329258|FG002|Treatment Period 1|Adverse Event|0|||
27841311|NCT01468207|54329259|FG003|Treatment Period 1|Adverse Event|0|||
27841312|NCT01468207|54329260|FG004|Treatment Period 1|Adverse Event|0|||
27841313|NCT01468207|54329261|FG005|Treatment Period 1|Adverse Event|0|||
27841314|NCT01468207|54329256|FG000|Treatment Period 1|Protocol Violation|1|||
27841315|NCT01468207|54329257|FG001|Treatment Period 1|Protocol Violation|1|||
27841316|NCT01468207|54329258|FG002|Treatment Period 1|Protocol Violation|0|||
27841317|NCT01468207|54329259|FG003|Treatment Period 1|Protocol Violation|0|||
27841318|NCT01468207|54329260|FG004|Treatment Period 1|Protocol Violation|0|||
27841319|NCT01468207|54329261|FG005|Treatment Period 1|Protocol Violation|0|||
27841320|NCT01468207|54329256|FG000|Treatment Period 1|Withdrawal by Subject|5|||
27841321|NCT01468207|54329257|FG001|Treatment Period 1|Withdrawal by Subject|4|||
27841322|NCT01468207|54329258|FG002|Treatment Period 1|Withdrawal by Subject|0|||
27841323|NCT01468207|54329259|FG003|Treatment Period 1|Withdrawal by Subject|0|||
27841324|NCT01468207|54329260|FG004|Treatment Period 1|Withdrawal by Subject|0|||
27841325|NCT01468207|54329261|FG005|Treatment Period 1|Withdrawal by Subject|0|||
27841326|NCT01468207|54329256|FG000|Treatment Period 1|Lost to Follow-up|2|||
27841327|NCT01468207|54329257|FG001|Treatment Period 1|Lost to Follow-up|1|||
27841328|NCT01468207|54329258|FG002|Treatment Period 1|Lost to Follow-up|0|||
27841329|NCT01468207|54329259|FG003|Treatment Period 1|Lost to Follow-up|0|||
27841330|NCT01468207|54329260|FG004|Treatment Period 1|Lost to Follow-up|0|||
27841331|NCT01468207|54329261|FG005|Treatment Period 1|Lost to Follow-up|0|||
27841332|NCT01468207|54329256|FG000|Treatment Period 1|Other|0|||
27841333|NCT01468207|54329257|FG001|Treatment Period 1|Other|2|||
27841334|NCT01468207|54329258|FG002|Treatment Period 1|Other|0|||
27841335|NCT01468207|54329259|FG003|Treatment Period 1|Other|0|||
27841336|NCT01468207|54329260|FG004|Treatment Period 1|Other|0|||
27841337|NCT01468207|54329261|FG005|Treatment Period 1|Other|0|||
27841338|NCT01468207|54329256|FG000|Treatment Period 2|Adverse Event|0|||
27841339|NCT01468207|54329257|FG001|Treatment Period 2|Adverse Event|0|||
27841340|NCT01468207|54329258|FG002|Treatment Period 2|Adverse Event|6|||
27841341|NCT01468207|54329259|FG003|Treatment Period 2|Adverse Event|1|||
27841342|NCT01468207|54329260|FG004|Treatment Period 2|Adverse Event|2|||
27841343|NCT01468207|54329261|FG005|Treatment Period 2|Adverse Event|1|||
27841344|NCT01468207|54329256|FG000|Treatment Period 2|Lack of Efficacy|0|||
27841345|NCT01468207|54329257|FG001|Treatment Period 2|Lack of Efficacy|0|||
27928476|NCT01194219|54584840|FG009|Placebo-Controlled Phase Weeks 0-16|Death|0|||
27841346|NCT01468207|54329258|FG002|Treatment Period 2|Lack of Efficacy|1|||
27841347|NCT01468207|54329259|FG003|Treatment Period 2|Lack of Efficacy|1|||
27841348|NCT01468207|54329260|FG004|Treatment Period 2|Lack of Efficacy|0|||
27928477|NCT01194219|54584831|FG000|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7|||
27928478|NCT01194219|54584832|FG001|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9|||
27928479|NCT01194219|54584833|FG002|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
27928480|NCT01194219|54584834|FG003|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
27928481|NCT01194219|54584835|FG004|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
27928482|NCT01194219|54584836|FG005|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
27928483|NCT01194219|54584837|FG006|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
27928484|NCT01194219|54584838|FG007|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
27928485|NCT01194219|54584839|FG008|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
27928486|NCT01194219|54584840|FG009|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
27928487|NCT01194219|54584831|FG000|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7|||
27928488|NCT01194219|54584832|FG001|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1|||
27928489|NCT01194219|54584833|FG002|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
27928490|NCT01194219|54584834|FG003|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
27928491|NCT01194219|54584835|FG004|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
27928492|NCT01194219|54584836|FG005|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
27928493|NCT01194219|54584837|FG006|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
27928494|NCT01194219|54584838|FG007|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
27928495|NCT01194219|54584839|FG008|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
27928496|NCT01194219|54584840|FG009|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
27928497|NCT01194219|54584831|FG000|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
27928498|NCT01194219|54584832|FG001|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
27928499|NCT01194219|54584833|FG002|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
27928500|NCT01194219|54584834|FG003|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
27928501|NCT01194219|54584835|FG004|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
27928502|NCT01194219|54584836|FG005|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
27928503|NCT01194219|54584837|FG006|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
27928504|NCT01194219|54584838|FG007|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
27928505|NCT01194219|54584839|FG008|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
27928506|NCT01194219|54584840|FG009|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
27928507|NCT01194219|54584831|FG000|Maintenance Phase Weeks16-32|Adverse Event|0|||
27928508|NCT01194219|54584832|FG001|Maintenance Phase Weeks16-32|Adverse Event|0|||
27928509|NCT01194219|54584833|FG002|Maintenance Phase Weeks16-32|Adverse Event|8|||
27928510|NCT01194219|54584834|FG003|Maintenance Phase Weeks16-32|Adverse Event|9|||
27928511|NCT01194219|54584835|FG004|Maintenance Phase Weeks16-32|Adverse Event|0|||
27928512|NCT01194219|54584836|FG005|Maintenance Phase Weeks16-32|Adverse Event|0|||
27928513|NCT01194219|54584837|FG006|Maintenance Phase Weeks16-32|Adverse Event|0|||
27928514|NCT01194219|54584838|FG007|Maintenance Phase Weeks16-32|Adverse Event|0|||
27928515|NCT01194219|54584839|FG008|Maintenance Phase Weeks16-32|Adverse Event|0|||
27928516|NCT01194219|54584840|FG009|Maintenance Phase Weeks16-32|Adverse Event|0|||
27928517|NCT01194219|54584831|FG000|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
27928518|NCT01194219|54584832|FG001|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
27928519|NCT01194219|54584833|FG002|Maintenance Phase Weeks16-32|Lack of Efficacy|37|||
27928520|NCT01194219|54584834|FG003|Maintenance Phase Weeks16-32|Lack of Efficacy|15|||
27928521|NCT01194219|54584835|FG004|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
27928522|NCT01194219|54584836|FG005|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
27928523|NCT01194219|54584837|FG006|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
27928524|NCT01194219|54584838|FG007|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
27928525|NCT01194219|54584839|FG008|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
27928526|NCT01194219|54584840|FG009|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
27928527|NCT01194219|54584831|FG000|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
27928528|NCT01194219|54584832|FG001|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
27928529|NCT01194219|54584833|FG002|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2|||
27928530|NCT01194219|54584834|FG003|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1|||
27928531|NCT01194219|54584835|FG004|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
27928532|NCT01194219|54584836|FG005|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
27928533|NCT01194219|54584837|FG006|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
27928534|NCT01194219|54584838|FG007|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
27928535|NCT01194219|54584839|FG008|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
27928536|NCT01194219|54584840|FG009|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
27928537|NCT01194219|54584831|FG000|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
27928538|NCT01194219|54584832|FG001|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
27928539|NCT01194219|54584833|FG002|Maintenance Phase Weeks16-32|Withdrawal by Subject|12|||
27928540|NCT01194219|54584834|FG003|Maintenance Phase Weeks16-32|Withdrawal by Subject|3|||
27928541|NCT01194219|54584835|FG004|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
28105554|NCT03437278|54762992|FG001|Overall Study|Progressive disease|0|||
28105555|NCT03437278|54762993|FG002|Overall Study|Progressive disease|0|||
27928542|NCT01194219|54584836|FG005|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
27928543|NCT01194219|54584837|FG006|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
27928544|NCT01194219|54584838|FG007|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
27928545|NCT01194219|54584839|FG008|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
27928546|NCT01194219|54584840|FG009|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
27928547|NCT01194219|54584831|FG000|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
27928548|NCT01194219|54584832|FG001|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
27928549|NCT01194219|54584833|FG002|Maintenance Phase Weeks16-32|Lost to Follow-up|9|||
27928550|NCT01194219|54584834|FG003|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
27928551|NCT01194219|54584835|FG004|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
27928552|NCT01194219|54584836|FG005|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
27928553|NCT01194219|54584837|FG006|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
27928554|NCT01194219|54584838|FG007|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
27928555|NCT01194219|54584839|FG008|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
27928556|NCT01194219|54584840|FG009|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
27928557|NCT01194219|54584831|FG000|Maintenance Phase Weeks16-32|Protocol Violation|0|||
27928558|NCT01194219|54584832|FG001|Maintenance Phase Weeks16-32|Protocol Violation|0|||
27928559|NCT01194219|54584833|FG002|Maintenance Phase Weeks16-32|Protocol Violation|0|||
27928560|NCT01194219|54584834|FG003|Maintenance Phase Weeks16-32|Protocol Violation|1|||
27928561|NCT01194219|54584835|FG004|Maintenance Phase Weeks16-32|Protocol Violation|0|||
27928562|NCT01194219|54584836|FG005|Maintenance Phase Weeks16-32|Protocol Violation|0|||
27928563|NCT01194219|54584837|FG006|Maintenance Phase Weeks16-32|Protocol Violation|0|||
27928564|NCT01194219|54584838|FG007|Maintenance Phase Weeks16-32|Protocol Violation|0|||
27928565|NCT01194219|54584839|FG008|Maintenance Phase Weeks16-32|Protocol Violation|0|||
27928566|NCT01194219|54584840|FG009|Maintenance Phase Weeks16-32|Protocol Violation|0|||
27928567|NCT01194219|54584831|FG000|Maintenance Phase Weeks16-32|Other|0|||
27928568|NCT01194219|54584832|FG001|Maintenance Phase Weeks16-32|Other|0|||
27928569|NCT01194219|54584833|FG002|Maintenance Phase Weeks16-32|Other|2|||
27928570|NCT01194219|54584834|FG003|Maintenance Phase Weeks16-32|Other|1|||
27928571|NCT01194219|54584835|FG004|Maintenance Phase Weeks16-32|Other|0|||
27928572|NCT01194219|54584836|FG005|Maintenance Phase Weeks16-32|Other|0|||
27928573|NCT01194219|54584837|FG006|Maintenance Phase Weeks16-32|Other|0|||
27928574|NCT01194219|54584838|FG007|Maintenance Phase Weeks16-32|Other|0|||
27928575|NCT01194219|54584839|FG008|Maintenance Phase Weeks16-32|Other|0|||
27928576|NCT01194219|54584840|FG009|Maintenance Phase Weeks16-32|Other|0|||
27928577|NCT01194219|54584831|FG000|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
27928578|NCT01194219|54584832|FG001|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
27928579|NCT01194219|54584833|FG002|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
27928580|NCT01194219|54584834|FG003|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
27928581|NCT01194219|54584835|FG004|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
27928582|NCT01194219|54584836|FG005|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1|||
27928583|NCT01194219|54584837|FG006|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6|||
27928584|NCT01194219|54584838|FG007|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5|||
27928585|NCT01194219|54584839|FG008|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
27928586|NCT01194219|54584840|FG009|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
27928587|NCT01194219|54584831|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
27928588|NCT01194219|54584832|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
27928589|NCT01194219|54584833|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
27928590|NCT01194219|54584834|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
27928591|NCT01194219|54584835|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
27928592|NCT01194219|54584836|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
27928593|NCT01194219|54584837|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35|||
27928594|NCT01194219|54584838|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33|||
27928595|NCT01194219|54584839|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
27928596|NCT01194219|54584840|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
27928597|NCT01194219|54584831|FG000|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
27928598|NCT01194219|54584832|FG001|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
27928599|NCT01194219|54584833|FG002|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
27928600|NCT01194219|54584834|FG003|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
27928601|NCT01194219|54584835|FG004|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1|||
27928602|NCT01194219|54584836|FG005|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
27928603|NCT01194219|54584837|FG006|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2|||
27928604|NCT01194219|54584838|FG007|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
27928605|NCT01194219|54584839|FG008|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
27928606|NCT01194219|54584840|FG009|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
27928607|NCT01194219|54584831|FG000|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
27928608|NCT01194219|54584832|FG001|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
27928609|NCT01194219|54584833|FG002|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
27928610|NCT01194219|54584834|FG003|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
27928611|NCT01194219|54584835|FG004|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1|||
27928612|NCT01194219|54584836|FG005|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
27928613|NCT01194219|54584837|FG006|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12|||
27928614|NCT01194219|54584838|FG007|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6|||
27928615|NCT01194219|54584839|FG008|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
27928616|NCT01194219|54584840|FG009|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
27928617|NCT01194219|54584831|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
27928618|NCT01194219|54584832|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
27928619|NCT01194219|54584833|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
27928620|NCT01194219|54584834|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
27928621|NCT01194219|54584835|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1|||
27928622|NCT01194219|54584836|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2|||
27928623|NCT01194219|54584837|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5|||
27928624|NCT01194219|54584838|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
27928625|NCT01194219|54584839|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
27928626|NCT01194219|54584840|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
27928627|NCT01194219|54584831|FG000|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
27928628|NCT01194219|54584832|FG001|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
27928629|NCT01194219|54584833|FG002|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
27928630|NCT01194219|54584834|FG003|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
27928631|NCT01194219|54584835|FG004|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
27928632|NCT01194219|54584836|FG005|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
27928633|NCT01194219|54584837|FG006|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
27928634|NCT01194219|54584838|FG007|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1|||
27928635|NCT01194219|54584839|FG008|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
27928636|NCT01194219|54584840|FG009|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
27928637|NCT01194219|54584831|FG000|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
27928638|NCT01194219|54584832|FG001|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
27928639|NCT01194219|54584833|FG002|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
27928640|NCT01194219|54584834|FG003|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
27928641|NCT01194219|54584835|FG004|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
27928642|NCT01194219|54584836|FG005|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
27928643|NCT01194219|54584837|FG006|Randomized Withdrawal Phase-Weeks 32-52|Other|1|||
27928644|NCT01194219|54584838|FG007|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
27928645|NCT01194219|54584839|FG008|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
27928646|NCT01194219|54584840|FG009|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
27928647|NCT01194219|54584831|FG000|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
27928648|NCT01194219|54584832|FG001|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
27928649|NCT01194219|54584833|FG002|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
27928650|NCT01194219|54584834|FG003|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
27928651|NCT01194219|54584835|FG004|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
27928652|NCT01194219|54584836|FG005|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
27928653|NCT01194219|54584837|FG006|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
27928654|NCT01194219|54584838|FG007|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
27928655|NCT01194219|54584839|FG008|Long-Term Extension Weeks 52 to 260|Adverse Event|25|||
27928656|NCT01194219|54584840|FG009|Long-Term Extension Weeks 52 to 260|Adverse Event|14|||
27928657|NCT01194219|54584831|FG000|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
27928658|NCT01194219|54584832|FG001|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
27928659|NCT01194219|54584833|FG002|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
27928660|NCT01194219|54584834|FG003|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
27928661|NCT01194219|54584835|FG004|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
27928662|NCT01194219|54584836|FG005|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
27928663|NCT01194219|54584837|FG006|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
27928664|NCT01194219|54584838|FG007|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
27928665|NCT01194219|54584839|FG008|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81|||
27928666|NCT01194219|54584840|FG009|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49|||
27928667|NCT01194219|54584831|FG000|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
27928668|NCT01194219|54584832|FG001|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
27928669|NCT01194219|54584833|FG002|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
27928670|NCT01194219|54584834|FG003|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
27928671|NCT01194219|54584835|FG004|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
28105556|NCT03437278|54762991|FG000|Overall Study|Physician Decision|1|||
27928672|NCT01194219|54584836|FG005|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
27928673|NCT01194219|54584837|FG006|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
27928674|NCT01194219|54584838|FG007|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
27928675|NCT01194219|54584839|FG008|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9|||
27928676|NCT01194219|54584840|FG009|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4|||
27928677|NCT01194219|54584831|FG000|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
27928678|NCT01194219|54584832|FG001|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
27928679|NCT01194219|54584833|FG002|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
27928680|NCT01194219|54584834|FG003|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
27928681|NCT01194219|54584835|FG004|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
27928682|NCT01194219|54584836|FG005|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
27928683|NCT01194219|54584837|FG006|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
27928684|NCT01194219|54584838|FG007|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
27928685|NCT01194219|54584839|FG008|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66|||
27928686|NCT01194219|54584840|FG009|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32|||
27928687|NCT01194219|54584831|FG000|Long-Term Extension Weeks 52 to 260|Death|0|||
27928688|NCT01194219|54584832|FG001|Long-Term Extension Weeks 52 to 260|Death|0|||
27928689|NCT01194219|54584833|FG002|Long-Term Extension Weeks 52 to 260|Death|0|||
27786282|NCT02287883|54240738|FG000|Overall Study|No longer eligible|222|||
27786283|NCT02287883|54240739|FG001|Overall Study|No longer eligible|182|||
27786284|NCT02287883|54240738|FG000|Overall Study|Non-response to survey|229|||
27786285|NCT02287883|54240739|FG001|Overall Study|Non-response to survey|237|||
27786286|NCT01743040|54240745|FG000|Overall Study|Death|1|||
27786287|NCT01743040|54240745|FG000|Overall Study|Lost to Follow-up|66|||
27928690|NCT01194219|54584834|FG003|Long-Term Extension Weeks 52 to 260|Death|0|||
27928691|NCT01194219|54584835|FG004|Long-Term Extension Weeks 52 to 260|Death|0|||
27928692|NCT01194219|54584836|FG005|Long-Term Extension Weeks 52 to 260|Death|0|||
27928693|NCT01194219|54584837|FG006|Long-Term Extension Weeks 52 to 260|Death|0|||
27928694|NCT01194219|54584838|FG007|Long-Term Extension Weeks 52 to 260|Death|0|||
27928695|NCT01194219|54584839|FG008|Long-Term Extension Weeks 52 to 260|Death|1|||
27928696|NCT01194219|54584840|FG009|Long-Term Extension Weeks 52 to 260|Death|1|||
27928697|NCT01194219|54584831|FG000|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
27928698|NCT01194219|54584832|FG001|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
27928699|NCT01194219|54584833|FG002|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
27928700|NCT01194219|54584834|FG003|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
27928701|NCT01194219|54584835|FG004|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
27928702|NCT01194219|54584836|FG005|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
27928703|NCT01194219|54584837|FG006|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
27928704|NCT01194219|54584838|FG007|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
27928705|NCT01194219|54584839|FG008|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24|||
27928706|NCT01194219|54584840|FG009|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10|||
27928707|NCT01194219|54584831|FG000|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
27928708|NCT01194219|54584832|FG001|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
27928709|NCT01194219|54584833|FG002|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
27786288|NCT01743040|54240745|FG000|Overall Study|Physician Decision|40|||
27786289|NCT01743040|54240745|FG000|Overall Study|Protocol Violation|1|||
27786290|NCT01743040|54240745|FG000|Overall Study|Withdrawal by Subject|121|||
27786291|NCT02194465|54240756|FG000|Overall Study|Adverse Event|6|||
27928710|NCT01194219|54584834|FG003|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
27928711|NCT01194219|54584835|FG004|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
27928712|NCT01194219|54584836|FG005|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
27928713|NCT01194219|54584837|FG006|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
27928714|NCT01194219|54584838|FG007|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
27928715|NCT01194219|54584839|FG008|Long-Term Extension Weeks 52 to 260|Protocol Violation|3|||
27928716|NCT01194219|54584840|FG009|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
27928717|NCT01194219|54584831|FG000|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
27928718|NCT01194219|54584832|FG001|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
27928719|NCT01194219|54584833|FG002|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
27928720|NCT01194219|54584834|FG003|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
27928721|NCT01194219|54584835|FG004|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
27928722|NCT01194219|54584836|FG005|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
27928723|NCT01194219|54584837|FG006|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
27928724|NCT01194219|54584838|FG007|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
27928725|NCT01194219|54584839|FG008|Long-Term Extension Weeks 52 to 260|Miscellaneous|11|||
27928726|NCT01194219|54584840|FG009|Long-Term Extension Weeks 52 to 260|Miscellaneous|2|||
27928727|NCT01304693|54584868|FG000|Overall Study|Adverse Event|0|||
28105557|NCT03437278|54762992|FG001|Overall Study|Physician Decision|0|||
27786292|NCT02194465|54240757|FG001|Overall Study|Adverse Event|1|||
27786293|NCT02194465|54240758|FG002|Overall Study|Adverse Event|4|||
27928728|NCT01304693|54584869|FG001|Overall Study|Adverse Event|0|||
27928729|NCT01304693|54584870|FG002|Overall Study|Adverse Event|0|||
27928730|NCT01304693|54584871|FG003|Overall Study|Adverse Event|0|||
27928731|NCT01304693|54584872|FG004|Overall Study|Adverse Event|1|||
27928732|NCT01304693|54584868|FG000|Overall Study|Decision Unrelated to an Adverse Event|0|||
27928733|NCT01304693|54584869|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
27928734|NCT01304693|54584870|FG002|Overall Study|Decision Unrelated to an Adverse Event|1|||
27928735|NCT01304693|54584871|FG003|Overall Study|Decision Unrelated to an Adverse Event|1|||
27928736|NCT01304693|54584872|FG004|Overall Study|Decision Unrelated to an Adverse Event|0|||
27928737|NCT01304147|54584884|FG000|Second Intervention (7days)|Withdrawal by Subject|1|||
27928738|NCT01304147|54584885|FG001|Second Intervention (7days)|Withdrawal by Subject|1|||
27928739|NCT01303445|54584891|FG000|First Intervention (7 Days)|Withdrawal by Subject|1|||
27928740|NCT01303445|54584892|FG001|First Intervention (7 Days)|Withdrawal by Subject|0|||
27928741|NCT01303445|54584891|FG000|Second Intervention (7 Days)|Adverse Event|0|||
27928742|NCT01303445|54584892|FG001|Second Intervention (7 Days)|Adverse Event|2|||
27928743|NCT01303445|54584891|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
27928744|NCT01303445|54584892|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
27928745|NCT01303445|54584891|FG000|Washout (14 Days)|Protocol Violation|1|||
27928746|NCT01303445|54584892|FG001|Washout (14 Days)|Protocol Violation|0|||
27928747|NCT01303445|54584891|FG000|Washout (14 Days)|Lost to Follow-up|0|||
27928748|NCT01303445|54584892|FG001|Washout (14 Days)|Lost to Follow-up|2|||
27928749|NCT01303445|54584891|FG000|Fourth Intervention (7 Days)|Withdrawal by Subject|1|||
27928750|NCT01303445|54584892|FG001|Fourth Intervention (7 Days)|Withdrawal by Subject|0|||
27928751|NCT01303445|54584891|FG000|Follow-up Period (14 Days)|Withdrawal by Subject|0|||
27928752|NCT01303445|54584892|FG001|Follow-up Period (14 Days)|Withdrawal by Subject|1|||
27928753|NCT01188681|54584906|FG000|Overall Study|bladder cancer|0|||
27928754|NCT01188681|54584907|FG001|Overall Study|bladder cancer|0|||
27928755|NCT01188681|54584908|FG002|Overall Study|bladder cancer|1|||
27928756|NCT01188681|54584909|FG003|Overall Study|bladder cancer|0|||
27928757|NCT01188681|54584906|FG000|Overall Study|Withdrawal by Subject|0|||
27928758|NCT01188681|54584907|FG001|Overall Study|Withdrawal by Subject|0|||
27928759|NCT01188681|54584908|FG002|Overall Study|Withdrawal by Subject|0|||
27928760|NCT01188681|54584909|FG003|Overall Study|Withdrawal by Subject|1|||
27928761|NCT01302899|54584925|FG000|Period 2 (Weeks 7 to 12)|Protocol Deviation|1|||
27928762|NCT01302899|54584926|FG001|Period 2 (Weeks 7 to 12)|Protocol Deviation|0|||
27928763|NCT01302899|54584925|FG000|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0|||
27928764|NCT01302899|54584926|FG001|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1|||
27841349|NCT01468207|54329261|FG005|Treatment Period 2|Lack of Efficacy|2|||
27841350|NCT01468207|54329256|FG000|Treatment Period 2|Withdrawal by Subject|0|||
27841351|NCT01468207|54329257|FG001|Treatment Period 2|Withdrawal by Subject|0|||
27841352|NCT01468207|54329258|FG002|Treatment Period 2|Withdrawal by Subject|5|||
27841353|NCT01468207|54329259|FG003|Treatment Period 2|Withdrawal by Subject|0|||
27841354|NCT01468207|54329260|FG004|Treatment Period 2|Withdrawal by Subject|0|||
27841355|NCT01468207|54329261|FG005|Treatment Period 2|Withdrawal by Subject|2|||
27841356|NCT01468207|54329256|FG000|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
27841357|NCT01468207|54329257|FG001|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
27841358|NCT01468207|54329258|FG002|Treatment Period 2|Loss/abscence of response (per protocol)|30|||
27841359|NCT01468207|54329259|FG003|Treatment Period 2|Loss/abscence of response (per protocol)|23|||
27841360|NCT01468207|54329260|FG004|Treatment Period 2|Loss/abscence of response (per protocol)|18|||
27841361|NCT01468207|54329261|FG005|Treatment Period 2|Loss/abscence of response (per protocol)|13|||
27841362|NCT01468207|54329256|FG000|Treatment Period 2|Lost to Follow-up|0|||
27841363|NCT01468207|54329257|FG001|Treatment Period 2|Lost to Follow-up|0|||
27841364|NCT01468207|54329258|FG002|Treatment Period 2|Lost to Follow-up|5|||
27841365|NCT01468207|54329259|FG003|Treatment Period 2|Lost to Follow-up|1|||
27841366|NCT01468207|54329260|FG004|Treatment Period 2|Lost to Follow-up|0|||
27841367|NCT01468207|54329261|FG005|Treatment Period 2|Lost to Follow-up|0|||
27841368|NCT01468207|54329256|FG000|Treatment Period 2|Other|0|||
27841369|NCT01468207|54329257|FG001|Treatment Period 2|Other|0|||
27841370|NCT01468207|54329258|FG002|Treatment Period 2|Other|5|||
27928765|NCT01187901|54584938|FG000|Overall Study|Protocol Violation|1|||
27928766|NCT01187901|54584939|FG001|Overall Study|Protocol Violation|0|||
27928767|NCT01187901|54584938|FG000|Overall Study|Lost to Follow-up|1|||
27928768|NCT01187901|54584939|FG001|Overall Study|Lost to Follow-up|2|||
27928769|NCT01187901|54584938|FG000|Overall Study|Unrelated Health Reasons|1|||
27928770|NCT01187901|54584939|FG001|Overall Study|Unrelated Health Reasons|2|||
27928771|NCT01187901|54584938|FG000|Overall Study|Suspected Allergic Reaction|1|||
27928772|NCT01187901|54584939|FG001|Overall Study|Suspected Allergic Reaction|1|||
27928773|NCT01187901|54584938|FG000|Overall Study|Adverse Event|3|||
27928774|NCT01187901|54584939|FG001|Overall Study|Adverse Event|0|||
27928775|NCT01187901|54584938|FG000|Overall Study|No Endpoint due to Early Study Halt|2|||
27928776|NCT01187901|54584939|FG001|Overall Study|No Endpoint due to Early Study Halt|3|||
27928777|NCT01187901|54584938|FG000|Overall Study|Pregnancy|0|||
27928778|NCT01187901|54584939|FG001|Overall Study|Pregnancy|2|||
27928779|NCT01302119|54584947|FG000|Overall Study|Withdrawal by Subject|30|||
27928780|NCT01302119|54584948|FG001|Overall Study|Withdrawal by Subject|20|||
27928781|NCT01302119|54584947|FG000|Overall Study|Lost to Follow-up|10|||
27928782|NCT01302119|54584948|FG001|Overall Study|Lost to Follow-up|4|||
27928783|NCT01302119|54584947|FG000|Overall Study|Adverse Event|2|||
27928784|NCT01302119|54584948|FG001|Overall Study|Adverse Event|1|||
27928785|NCT01302119|54584947|FG000|Overall Study|Non-compliance|4|||
27928786|NCT01302119|54584948|FG001|Overall Study|Non-compliance|2|||
27928787|NCT01302119|54584947|FG000|Overall Study|Non-specific|4|||
27928788|NCT01302119|54584948|FG001|Overall Study|Non-specific|1|||
27928789|NCT05038982|54584956|FG000|Overall Study|Withdrawal by Subject|0|||
27928790|NCT05038982|54584957|FG001|Overall Study|Withdrawal by Subject|2|||
27928791|NCT04964128|54584968|FG000|Phase 1|Withdrawal by Subject|1|||
27928792|NCT04964128|54584968|FG000|Phase 2|Physician Decision|1|||
27928793|NCT04867785|54584984|FG000|Overall Study|Adverse Event|1|||
27928794|NCT04867785|54584985|FG001|Overall Study|Adverse Event|0|||
27928795|NCT04867785|54584986|FG002|Overall Study|Adverse Event|1|||
27928796|NCT04867785|54584987|FG003|Overall Study|Adverse Event|0|||
27928797|NCT04867785|54584988|FG004|Overall Study|Adverse Event|0|||
27928798|NCT04867785|54584989|FG005|Overall Study|Adverse Event|0|||
27928799|NCT04867785|54584990|FG006|Overall Study|Adverse Event|0|||
27928800|NCT04867785|54584991|FG007|Overall Study|Adverse Event|2|||
27928801|NCT04867785|54584984|FG000|Overall Study|Lost to Follow-up|4|||
27928802|NCT04867785|54584985|FG001|Overall Study|Lost to Follow-up|4|||
27928803|NCT04867785|54584986|FG002|Overall Study|Lost to Follow-up|3|||
27928804|NCT04867785|54584987|FG003|Overall Study|Lost to Follow-up|2|||
27928805|NCT04867785|54584988|FG004|Overall Study|Lost to Follow-up|0|||
27928806|NCT04867785|54584989|FG005|Overall Study|Lost to Follow-up|1|||
27928807|NCT04867785|54584990|FG006|Overall Study|Lost to Follow-up|0|||
27928808|NCT04867785|54584991|FG007|Overall Study|Lost to Follow-up|1|||
27928809|NCT04867785|54584984|FG000|Overall Study|Withdrawal by Subject|6|||
27928810|NCT04867785|54584985|FG001|Overall Study|Withdrawal by Subject|2|||
27928811|NCT04867785|54584986|FG002|Overall Study|Withdrawal by Subject|2|||
27928812|NCT04867785|54584987|FG003|Overall Study|Withdrawal by Subject|1|||
27928813|NCT04867785|54584988|FG004|Overall Study|Withdrawal by Subject|2|||
27928814|NCT04867785|54584989|FG005|Overall Study|Withdrawal by Subject|0|||
27928815|NCT04867785|54584990|FG006|Overall Study|Withdrawal by Subject|2|||
27928816|NCT04867785|54584991|FG007|Overall Study|Withdrawal by Subject|5|||
27928817|NCT04867785|54584984|FG000|Overall Study|Physician Decision|0|||
27928818|NCT04867785|54584985|FG001|Overall Study|Physician Decision|0|||
27928819|NCT04867785|54584986|FG002|Overall Study|Physician Decision|0|||
27928820|NCT04867785|54584987|FG003|Overall Study|Physician Decision|0|||
27928821|NCT04867785|54584988|FG004|Overall Study|Physician Decision|0|||
27928822|NCT04867785|54584989|FG005|Overall Study|Physician Decision|0|||
27928823|NCT04867785|54584990|FG006|Overall Study|Physician Decision|0|||
27928824|NCT04867785|54584991|FG007|Overall Study|Physician Decision|1|||
27928825|NCT04867785|54584984|FG000|Overall Study|Inadvertent Enrollment|0|||
27928826|NCT04867785|54584985|FG001|Overall Study|Inadvertent Enrollment|0|||
27928827|NCT04867785|54584986|FG002|Overall Study|Inadvertent Enrollment|0|||
27928828|NCT04867785|54584987|FG003|Overall Study|Inadvertent Enrollment|1|||
27928829|NCT04867785|54584988|FG004|Overall Study|Inadvertent Enrollment|1|||
27928830|NCT04867785|54584989|FG005|Overall Study|Inadvertent Enrollment|0|||
27928831|NCT04867785|54584990|FG006|Overall Study|Inadvertent Enrollment|0|||
27928832|NCT04867785|54584991|FG007|Overall Study|Inadvertent Enrollment|1|||
27928833|NCT04867785|54584984|FG000|Overall Study|Eligibility Criteria Not Met|0|||
27928834|NCT04867785|54584985|FG001|Overall Study|Eligibility Criteria Not Met|0|||
27928835|NCT04867785|54584986|FG002|Overall Study|Eligibility Criteria Not Met|0|||
27928836|NCT04867785|54584987|FG003|Overall Study|Eligibility Criteria Not Met|0|||
27928837|NCT04867785|54584988|FG004|Overall Study|Eligibility Criteria Not Met|0|||
27928838|NCT04867785|54584989|FG005|Overall Study|Eligibility Criteria Not Met|0|||
27928839|NCT04867785|54584990|FG006|Overall Study|Eligibility Criteria Not Met|0|||
27928840|NCT04867785|54584991|FG007|Overall Study|Eligibility Criteria Not Met|1|||
27928841|NCT04541004|54585028|FG000|Overall Study|Adverse Event|2|||
27928842|NCT04295499|54585035|FG000|Overall Study|moving out of state|1|||
27928843|NCT04295499|54585036|FG001|Overall Study|moving out of state|0|||
27928844|NCT04295499|54585035|FG000|Overall Study|traveling overseas for business prior to the study completion|1|||
27928845|NCT04295499|54585036|FG001|Overall Study|traveling overseas for business prior to the study completion|0|||
27928846|NCT04091646|54585044|FG000|Overall Study|Adverse Event|2|||
27928847|NCT04091646|54585045|FG001|Overall Study|Adverse Event|1|||
27928848|NCT04091646|54585044|FG000|Overall Study|Lost to Follow-up|6|||
27928849|NCT04091646|54585045|FG001|Overall Study|Lost to Follow-up|2|||
27928850|NCT04091646|54585044|FG000|Overall Study|Protocol Violation|0|||
27928851|NCT04091646|54585045|FG001|Overall Study|Protocol Violation|1|||
27928852|NCT04091646|54585044|FG000|Overall Study|Withdrawal by Subject|4|||
27928853|NCT04091646|54585045|FG001|Overall Study|Withdrawal by Subject|1|||
27928854|NCT04091646|54585044|FG000|Overall Study|Participant Incarcerated|1|||
27928855|NCT04091646|54585045|FG001|Overall Study|Participant Incarcerated|0|||
27928856|NCT04040933|54585057|FG000|Overall Study|Protocol Violation|1|||
27928857|NCT04040933|54585057|FG000|Overall Study|Withdrawal by Subject|2|||
27928858|NCT03995355|54585070|FG000|Overall Study|Adverse Event|1|||
27928859|NCT03995355|54585071|FG001|Overall Study|Adverse Event|0|||
27928860|NCT03995355|54585070|FG000|Overall Study|Withdrawal by Subject|1|||
27928861|NCT03995355|54585071|FG001|Overall Study|Withdrawal by Subject|0|||
27928862|NCT03995355|54585070|FG000|Overall Study|Scheduling Issues|0|||
27928863|NCT03995355|54585071|FG001|Overall Study|Scheduling Issues|1|||
27928864|NCT03933397|54585079|FG000|Overall Study|No emergency department visit|65|||
27928865|NCT03933397|54585080|FG001|Overall Study|No emergency department visit|71|||
27928866|NCT03933397|54585079|FG000|Overall Study|Missed emergency department visit|25|||
27928867|NCT03933397|54585080|FG001|Overall Study|Missed emergency department visit|30|||
27928868|NCT03933397|54585079|FG000|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|18|||
27928869|NCT03933397|54585080|FG001|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|15|||
27928870|NCT03933397|54585079|FG000|Overall Study|Withdrawal by Subject|1|||
27928871|NCT03933397|54585080|FG001|Overall Study|Withdrawal by Subject|0|||
27928872|NCT03933397|54585079|FG000|Overall Study|Physician Decision|1|||
27928873|NCT03933397|54585080|FG001|Overall Study|Physician Decision|1|||
27928874|NCT03933397|54585079|FG000|Overall Study|missing pain score|1|||
27928875|NCT03933397|54585080|FG001|Overall Study|missing pain score|1|||
27928876|NCT03933397|54585079|FG000|Overall Study|Confirmed COVID-19|1|||
27928877|NCT03933397|54585080|FG001|Overall Study|Confirmed COVID-19|2|||
27928878|NCT03818035|54585096|FG000|Part 1 (Up to 28 Weeks)|Death|1|||
27928879|NCT03818035|54585097|FG001|Part 1 (Up to 28 Weeks)|Death|0|||
27928880|NCT03818035|54585098|FG002|Part 1 (Up to 28 Weeks)|Death|0|||
27928881|NCT03818035|54585099|FG003|Part 1 (Up to 28 Weeks)|Death|0|||
27928882|NCT03818035|54585096|FG000|Part 1 (Up to 28 Weeks)|Lack of Efficacy|3|||
27928883|NCT03818035|54585097|FG001|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
27928884|NCT03818035|54585098|FG002|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
27928885|NCT03818035|54585099|FG003|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
27928886|NCT03818035|54585096|FG000|Part 1 (Up to 28 Weeks)|Lost to Follow-up|10|||
27928887|NCT03818035|54585097|FG001|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
27928888|NCT03818035|54585098|FG002|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
27928889|NCT03818035|54585099|FG003|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
27928890|NCT03818035|54585096|FG000|Part 1 (Up to 28 Weeks)|Protocol Violation|10|||
27928891|NCT03818035|54585097|FG001|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
27928892|NCT03818035|54585098|FG002|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
27928893|NCT03818035|54585099|FG003|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
27928894|NCT03818035|54585096|FG000|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|8|||
27928895|NCT03818035|54585097|FG001|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
27928896|NCT03818035|54585098|FG002|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
27928897|NCT03818035|54585099|FG003|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
27928898|NCT03818035|54585096|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|1|||
27928899|NCT03818035|54585097|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
27928900|NCT03818035|54585098|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
27928901|NCT03818035|54585099|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
27928902|NCT03818035|54585096|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Other|16|||
27928903|NCT03818035|54585097|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
27928904|NCT03818035|54585098|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
27928905|NCT03818035|54585099|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
27928906|NCT03818035|54585096|FG000|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|1|||
27928907|NCT03818035|54585097|FG001|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
27928908|NCT03818035|54585098|FG002|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
27928909|NCT03818035|54585099|FG003|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
27928910|NCT03818035|54585096|FG000|Part 1 (Up to 28 Weeks)|Other|7|||
27928911|NCT03818035|54585097|FG001|Part 1 (Up to 28 Weeks)|Other|0|||
27928912|NCT03818035|54585098|FG002|Part 1 (Up to 28 Weeks)|Other|0|||
27928913|NCT03818035|54585099|FG003|Part 1 (Up to 28 Weeks)|Other|0|||
27928914|NCT03818035|54585096|FG000|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
27928915|NCT03818035|54585097|FG001|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
27928916|NCT03818035|54585098|FG002|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
27928917|NCT03818035|54585099|FG003|Part 2 (Week 28 to Week 68)|Lack of Efficacy|4|||
27928918|NCT03818035|54585096|FG000|Part 2 (Week 28 to Week 68)|Lost to Follow-up|0|||
27928919|NCT03818035|54585097|FG001|Part 2 (Week 28 to Week 68)|Lost to Follow-up|6|||
27928920|NCT03818035|54585098|FG002|Part 2 (Week 28 to Week 68)|Lost to Follow-up|1|||
27928921|NCT03818035|54585099|FG003|Part 2 (Week 28 to Week 68)|Lost to Follow-up|9|||
27928922|NCT03818035|54585096|FG000|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
27928923|NCT03818035|54585097|FG001|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
27928924|NCT03818035|54585098|FG002|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
27928925|NCT03818035|54585099|FG003|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|8|||
27928926|NCT03818035|54585096|FG000|Part 2 (Week 28 to Week 68)|Other Adverse Events|0|||
27928927|NCT03818035|54585097|FG001|Part 2 (Week 28 to Week 68)|Other Adverse Events|3|||
27928928|NCT03818035|54585098|FG002|Part 2 (Week 28 to Week 68)|Other Adverse Events|4|||
27928929|NCT03818035|54585099|FG003|Part 2 (Week 28 to Week 68)|Other Adverse Events|7|||
27928930|NCT03818035|54585096|FG000|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
27928931|NCT03818035|54585097|FG001|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|1|||
27928932|NCT03818035|54585098|FG002|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|2|||
27928933|NCT03818035|54585099|FG003|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
27928934|NCT03818035|54585096|FG000|Part 2 (Week 28 to Week 68)|Other|0|||
27928935|NCT03818035|54585097|FG001|Part 2 (Week 28 to Week 68)|Other|1|||
27928936|NCT03818035|54585098|FG002|Part 2 (Week 28 to Week 68)|Other|1|||
27928937|NCT03818035|54585099|FG003|Part 2 (Week 28 to Week 68)|Other|1|||
27928938|NCT03775486|54585124|FG000|Initial Therapy Phase|Other reason provided|0|||
27928939|NCT03775486|54585125|FG001|Initial Therapy Phase|Other reason provided|15|||
27928940|NCT03775486|54585124|FG000|Initial Therapy Phase|Condition under investigation worsened|0|||
27928941|NCT03775486|54585125|FG001|Initial Therapy Phase|Condition under investigation worsened|67|||
27928942|NCT03775486|54585124|FG000|Initial Therapy Phase|Protocol Violation|0|||
27928943|NCT03775486|54585125|FG001|Initial Therapy Phase|Protocol Violation|2|||
27928944|NCT03775486|54585124|FG000|Initial Therapy Phase|Adverse Event|0|||
27928945|NCT03775486|54585125|FG001|Initial Therapy Phase|Adverse Event|34|||
27928946|NCT03775486|54585124|FG000|Initial Therapy Phase|Withdrawal by Subject|0|||
27928947|NCT03775486|54585125|FG001|Initial Therapy Phase|Withdrawal by Subject|14|||
27928948|NCT03775486|54585124|FG000|Maintenance Phase|Withdrawal by Subject|13|||
27928949|NCT03775486|54585125|FG001|Maintenance Phase|Withdrawal by Subject|12|||
27928950|NCT03775486|54585124|FG000|Maintenance Phase|Death|44|||
27928951|NCT03775486|54585125|FG001|Maintenance Phase|Death|45|||
27928952|NCT03624881|54585143|FG000|Overall Study|Screen Failure|14|||
27928953|NCT03624881|54585144|FG001|Overall Study|Screen Failure|0|||
27928954|NCT03624881|54585143|FG000|Overall Study|No Catheter Inserted|6|||
27928955|NCT03624881|54585144|FG001|Overall Study|No Catheter Inserted|1|||
27928956|NCT03624881|54585143|FG000|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|2|||
27928957|NCT03624881|54585144|FG001|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|0|||
27928958|NCT03624881|54585143|FG000|Overall Study|Death|2|||
27928959|NCT03624881|54585144|FG001|Overall Study|Death|0|||
27841371|NCT01468207|54329259|FG003|Treatment Period 2|Other|1|||
27841372|NCT01468207|54329260|FG004|Treatment Period 2|Other|1|||
27841373|NCT01468207|54329261|FG005|Treatment Period 2|Other|2|||
27841374|NCT01494649|54329281|FG000|Overall Study|Lost to Follow-up|0|||
27841375|NCT01494649|54329282|FG001|Overall Study|Lost to Follow-up|1|||
27841376|NCT01686152|54329293|FG000|Overall Study|Withdrawal by Subject|11|||
27841377|NCT01686152|54329294|FG001|Overall Study|Withdrawal by Subject|11|||
27841378|NCT01686152|54329295|FG002|Overall Study|Withdrawal by Subject|3|||
27841379|NCT01686152|54329293|FG000|Overall Study|Drug Code Unblinded|0|||
27841380|NCT01686152|54329294|FG001|Overall Study|Drug Code Unblinded|1|||
27841381|NCT01686152|54329295|FG002|Overall Study|Drug Code Unblinded|0|||
27841382|NCT01686152|54329293|FG000|Overall Study|Protocol Violation|6|||
27841383|NCT01686152|54329294|FG001|Overall Study|Protocol Violation|1|||
27841384|NCT01686152|54329295|FG002|Overall Study|Protocol Violation|0|||
27841385|NCT01686152|54329293|FG000|Overall Study|Adverse Event|12|||
27841386|NCT01686152|54329294|FG001|Overall Study|Adverse Event|11|||
27841387|NCT01686152|54329295|FG002|Overall Study|Adverse Event|0|||
27841388|NCT01686152|54329293|FG000|Overall Study|Lack of Efficacy|0|||
27841389|NCT01686152|54329294|FG001|Overall Study|Lack of Efficacy|0|||
27841390|NCT01686152|54329295|FG002|Overall Study|Lack of Efficacy|1|||
27841391|NCT01686152|54329293|FG000|Overall Study|IP Non-compliance|5|||
27841392|NCT01686152|54329294|FG001|Overall Study|IP Non-compliance|5|||
27841393|NCT01686152|54329295|FG002|Overall Study|IP Non-compliance|0|||
27841394|NCT01686152|54329293|FG000|Overall Study|Lost to Follow-up|7|||
27928960|NCT03624881|54585143|FG000|Overall Study|Lost to Follow-up|10|||
27928961|NCT03624881|54585144|FG001|Overall Study|Lost to Follow-up|4|||
27928962|NCT03624881|54585143|FG000|Overall Study|Withdrawal by Subject|12|||
27928963|NCT03624881|54585144|FG001|Overall Study|Withdrawal by Subject|1|||
27928964|NCT03462719|54585169|FG000|Overall Study|Withdrawal by Subject|4|||
27841395|NCT01686152|54329294|FG001|Overall Study|Lost to Follow-up|6|||
27841396|NCT01686152|54329295|FG002|Overall Study|Lost to Follow-up|5|||
27841397|NCT01452919|54329303|FG000|Open-Label Treatment|Adverse Event|5|||
27928965|NCT03462719|54585170|FG001|Overall Study|Withdrawal by Subject|3|||
27928966|NCT03462719|54585169|FG000|Overall Study|Ongoing|87|||
27928967|NCT03462719|54585170|FG001|Overall Study|Ongoing|72|||
27928968|NCT03428997|54585176|FG000|Overall Study|Sponsor decision.|1|||
27928969|NCT03428997|54585176|FG000|Overall Study|Withdrawal by Subject|3|||
27928970|NCT03428997|54585176|FG000|Overall Study|Lost to Follow-up|4|||
27928971|NCT03118674|54585209|FG000|Overall Study|Lost to Follow-up|2|||
27928972|NCT03118674|54585209|FG000|Overall Study|Screen Faliure|8|||
27928973|NCT03118674|54585209|FG000|Overall Study|Withdrawal by Subject|5|||
27928974|NCT03069352|54585215|FG000|Overall Study|Ongoing|12|||
27928975|NCT03069352|54585216|FG001|Overall Study|Ongoing|40|||
27928976|NCT02993523|54585227|FG000|Overall Study|Withdrew Consent|0|||
27928977|NCT02993523|54585228|FG001|Overall Study|Withdrew Consent|0|||
27928978|NCT02993523|54585229|FG002|Overall Study|Withdrew Consent|2|||
27928979|NCT02993523|54585230|FG003|Overall Study|Withdrew Consent|9|||
27928980|NCT02993523|54585231|FG004|Overall Study|Withdrew Consent|0|||
27928981|NCT02993523|54585227|FG000|Overall Study|Lost to Follow-up|0|||
27928982|NCT02993523|54585228|FG001|Overall Study|Lost to Follow-up|0|||
27928983|NCT02993523|54585229|FG002|Overall Study|Lost to Follow-up|3|||
27928984|NCT02993523|54585230|FG003|Overall Study|Lost to Follow-up|6|||
27928985|NCT02993523|54585231|FG004|Overall Study|Lost to Follow-up|0|||
27928986|NCT02993523|54585227|FG000|Overall Study|Death|1|||
27928987|NCT02993523|54585228|FG001|Overall Study|Death|1|||
27928988|NCT02993523|54585229|FG002|Overall Study|Death|138|||
27928989|NCT02993523|54585230|FG003|Overall Study|Death|222|||
27928990|NCT02993523|54585231|FG004|Overall Study|Death|6|||
27928991|NCT02993523|54585227|FG000|Overall Study|Reason not Specified|0|||
27928992|NCT02993523|54585228|FG001|Overall Study|Reason not Specified|0|||
27928993|NCT02993523|54585229|FG002|Overall Study|Reason not Specified|1|||
27928994|NCT02993523|54585230|FG003|Overall Study|Reason not Specified|1|||
27928995|NCT02993523|54585231|FG004|Overall Study|Reason not Specified|0|||
27928996|NCT02795429|54585244|FG000|Overall Study|Adverse Event|1|||
27928997|NCT02795429|54585245|FG001|Overall Study|Adverse Event|2|||
27928998|NCT02795429|54585246|FG002|Overall Study|Adverse Event|1|||
27928999|NCT02795429|54585247|FG003|Overall Study|Adverse Event|2|||
27929000|NCT02795429|54585248|FG004|Overall Study|Adverse Event|1|||
27929001|NCT02795429|54585244|FG000|Overall Study|Death|1|||
27929002|NCT02795429|54585245|FG001|Overall Study|Death|0|||
27929003|NCT02795429|54585246|FG002|Overall Study|Death|1|||
27929004|NCT02795429|54585247|FG003|Overall Study|Death|2|||
27929005|NCT02795429|54585248|FG004|Overall Study|Death|1|||
27929006|NCT02795429|54585244|FG000|Overall Study|Physician Decision|0|||
27929007|NCT02795429|54585245|FG001|Overall Study|Physician Decision|0|||
27929008|NCT02795429|54585246|FG002|Overall Study|Physician Decision|2|||
27929009|NCT02795429|54585247|FG003|Overall Study|Physician Decision|1|||
27929010|NCT02795429|54585248|FG004|Overall Study|Physician Decision|5|||
27929011|NCT02795429|54585244|FG000|Overall Study|Progressive disease|3|||
27929012|NCT02795429|54585245|FG001|Overall Study|Progressive disease|7|||
27929013|NCT02795429|54585246|FG002|Overall Study|Progressive disease|6|||
27929014|NCT02795429|54585247|FG003|Overall Study|Progressive disease|26|||
27929015|NCT02795429|54585248|FG004|Overall Study|Progressive disease|20|||
27929016|NCT02795429|54585244|FG000|Overall Study|Subject/guardian decision|1|||
27929017|NCT02795429|54585245|FG001|Overall Study|Subject/guardian decision|1|||
27929018|NCT02795429|54585246|FG002|Overall Study|Subject/guardian decision|1|||
27929019|NCT02795429|54585247|FG003|Overall Study|Subject/guardian decision|1|||
27929020|NCT02795429|54585248|FG004|Overall Study|Subject/guardian decision|3|||
27929021|NCT02652949|54585271|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
27929022|NCT02652949|54585271|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
27929023|NCT02652949|54585271|FG000|6-Month Follow-up Secondary Endpoint|Death|5|||
27929024|NCT02652949|54585271|FG000|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
27929025|NCT02652949|54585271|FG000|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
27929026|NCT02652949|54585271|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
27929027|NCT02652949|54585271|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
27929028|NCT02652949|54585271|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
27929029|NCT02652949|54585271|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
27929030|NCT02652949|54585271|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
27929031|NCT02652949|54585271|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
27929032|NCT02652949|54585271|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
27929033|NCT02652949|54585271|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
27929034|NCT02652949|54585271|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
27929035|NCT02652949|54585271|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
27929036|NCT02632344|54585282|FG000|Overall Study|Adverse Event|3|||
27929037|NCT02632344|54585282|FG000|Overall Study|Lack of Efficacy|3|||
27929038|NCT02632344|54585282|FG000|Overall Study|Withdrawal by Subject|2|||
27929039|NCT02625324|54585286|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
27929040|NCT02625324|54585286|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
27929041|NCT02625324|54585286|FG000|6-Month Follow-up Subject Accountability|Death|5|||
27929042|NCT02625324|54585286|FG000|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2|||
27929043|NCT02625324|54585286|FG000|6-Month Follow-up Subject Accountability|Lost to Follow-up|1|||
27929044|NCT02625324|54585286|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
27929045|NCT02625324|54585286|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
27929046|NCT02625324|54585286|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
27929047|NCT02625324|54585286|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
27929048|NCT02625324|54585286|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
27929049|NCT02625324|54585286|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
27929050|NCT02625324|54585286|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
27929051|NCT02625324|54585286|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
27929052|NCT02625324|54585286|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
27929053|NCT02625324|54585286|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
27929054|NCT02576509|54585300|FG000|Pre-Treatment Period|Participant request to stop therapy|0|||
27929055|NCT02576509|54585301|FG001|Pre-Treatment Period|Participant request to stop therapy|2|||
27929056|NCT02576509|54585300|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
27929057|NCT02576509|54585301|FG001|Pre-Treatment Period|Participant withdrew consent|5|||
27929058|NCT02576509|54585300|FG000|Pre-Treatment Period|Participant no longer meets criteria|3|||
27929059|NCT02576509|54585301|FG001|Pre-Treatment Period|Participant no longer meets criteria|2|||
27929060|NCT02576509|54585300|FG000|Treatment Period|Disease progression|245|||
27929061|NCT02576509|54585301|FG001|Treatment Period|Disease progression|240|||
27929062|NCT02576509|54585300|FG000|Treatment Period|Study drug toxicity|32|||
27929063|NCT02576509|54585301|FG001|Treatment Period|Study drug toxicity|41|||
27929064|NCT02576509|54585300|FG000|Treatment Period|Death|1|||
27929065|NCT02576509|54585301|FG001|Treatment Period|Death|1|||
27929066|NCT02576509|54585300|FG000|Treatment Period|Adverse event unrelated to study drug|37|||
27929067|NCT02576509|54585301|FG001|Treatment Period|Adverse event unrelated to study drug|40|||
27929068|NCT02576509|54585300|FG000|Treatment Period|Participant request to stop treatment|8|||
27929069|NCT02576509|54585301|FG001|Treatment Period|Participant request to stop treatment|17|||
27929070|NCT02576509|54585300|FG000|Treatment Period|Participant withdrew consent|2|||
27929071|NCT02576509|54585301|FG001|Treatment Period|Participant withdrew consent|7|||
27929072|NCT02576509|54585300|FG000|Treatment Period|Lost to Follow-up|0|||
27929073|NCT02576509|54585301|FG001|Treatment Period|Lost to Follow-up|1|||
27929074|NCT02576509|54585300|FG000|Treatment Period|Maximum clinical benefit|1|||
27929075|NCT02576509|54585301|FG001|Treatment Period|Maximum clinical benefit|0|||
27929076|NCT02576509|54585300|FG000|Treatment Period|Poor/non-compliance|0|||
27929077|NCT02576509|54585301|FG001|Treatment Period|Poor/non-compliance|1|||
27929078|NCT02576509|54585300|FG000|Treatment Period|Participant no longer meets criteria|1|||
27929079|NCT02576509|54585301|FG001|Treatment Period|Participant no longer meets criteria|0|||
27929080|NCT02576509|54585300|FG000|Treatment Period|Other reason|2|||
27929081|NCT02576509|54585301|FG001|Treatment Period|Other reason|7|||
27929082|NCT02576509|54585300|FG000|Follow-up Period|Death|41|||
27929083|NCT02576509|54585301|FG001|Follow-up Period|Death|35|||
27929084|NCT02576509|54585300|FG000|Follow-up Period|Participant withdrew consent|7|||
27929085|NCT02576509|54585301|FG001|Follow-up Period|Participant withdrew consent|14|||
27929086|NCT02576509|54585300|FG000|Follow-up Period|Lost to Follow-up|0|||
27929087|NCT02576509|54585301|FG001|Follow-up Period|Lost to Follow-up|1|||
27929088|NCT02576509|54585300|FG000|Follow-up Period|Other reason|1|||
27929089|NCT02576509|54585301|FG001|Follow-up Period|Other reason|2|||
27929090|NCT02477696|54585324|FG000|Overall Study|Adverse Event|40|||
27929091|NCT02477696|54585325|FG001|Overall Study|Adverse Event|59|||
27929092|NCT02477696|54585324|FG000|Overall Study|CLL Disease Progression|82|||
27929093|NCT02477696|54585325|FG001|Overall Study|CLL Disease Progression|68|||
27929094|NCT02477696|54585324|FG000|Overall Study|Includes Non-compliance, Relocation, Subject's Decision and Medical Monitor's Decision.|2|||
27929095|NCT02477696|54585325|FG001|Overall Study|Includes Non-compliance, Relocation, Subject's Decision and Medical Monitor's Decision.|10|||
27929096|NCT02477696|54585324|FG000|Overall Study|Death|5|||
27929097|NCT02477696|54585325|FG001|Overall Study|Death|6|||
27929098|NCT02477696|54585324|FG000|Overall Study|Withdrawal by Subject|7|||
27929099|NCT02477696|54585325|FG001|Overall Study|Withdrawal by Subject|7|||
27929100|NCT02477696|54585324|FG000|Overall Study|Physician Decision|5|||
27929101|NCT02477696|54585325|FG001|Overall Study|Physician Decision|5|||
27929102|NCT02471144|54585335|FG000|Induction Period (Up to Week 12)|Adverse Event|0|||
27929103|NCT02471144|54585336|FG001|Induction Period (Up to Week 12)|Adverse Event|1|||
27929104|NCT02471144|54585337|FG002|Induction Period (Up to Week 12)|Adverse Event|1|||
27929105|NCT02471144|54585338|FG003|Induction Period (Up to Week 12)|Adverse Event|0|||
27929106|NCT02471144|54585339|FG004|Induction Period (Up to Week 12)|Adverse Event|0|||
27929107|NCT02471144|54585340|FG005|Induction Period (Up to Week 12)|Adverse Event|0|||
27929108|NCT02471144|54585341|FG006|Induction Period (Up to Week 12)|Adverse Event|0|||
27929109|NCT02471144|54585342|FG007|Induction Period (Up to Week 12)|Adverse Event|0|||
27929110|NCT02471144|54585343|FG008|Induction Period (Up to Week 12)|Adverse Event|0|||
27929111|NCT02471144|54585344|FG009|Induction Period (Up to Week 12)|Adverse Event|0|||
28105558|NCT03437278|54762993|FG002|Overall Study|Physician Decision|1|||
27929112|NCT02471144|54585345|FG010|Induction Period (Up to Week 12)|Adverse Event|0|||
27929113|NCT02471144|54585335|FG000|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
27929114|NCT02471144|54585336|FG001|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
27929115|NCT02471144|54585337|FG002|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
27929116|NCT02471144|54585338|FG003|Induction Period (Up to Week 12)|Lack of Efficacy|1|||
27929117|NCT02471144|54585339|FG004|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
27929118|NCT02471144|54585340|FG005|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
27929119|NCT02471144|54585341|FG006|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
27929120|NCT02471144|54585342|FG007|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
27929121|NCT02471144|54585343|FG008|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
27929122|NCT02471144|54585344|FG009|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
27929123|NCT02471144|54585345|FG010|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
27929124|NCT02471144|54585335|FG000|Induction Period (Up to Week 12)|Protocol Deviation|0|||
27929125|NCT02471144|54585336|FG001|Induction Period (Up to Week 12)|Protocol Deviation|0|||
27929126|NCT02471144|54585337|FG002|Induction Period (Up to Week 12)|Protocol Deviation|1|||
27929127|NCT02471144|54585338|FG003|Induction Period (Up to Week 12)|Protocol Deviation|0|||
27929128|NCT02471144|54585339|FG004|Induction Period (Up to Week 12)|Protocol Deviation|0|||
27929129|NCT02471144|54585340|FG005|Induction Period (Up to Week 12)|Protocol Deviation|0|||
27929130|NCT02471144|54585341|FG006|Induction Period (Up to Week 12)|Protocol Deviation|0|||
27929131|NCT02471144|54585342|FG007|Induction Period (Up to Week 12)|Protocol Deviation|0|||
27929132|NCT02471144|54585343|FG008|Induction Period (Up to Week 12)|Protocol Deviation|0|||
27929133|NCT02471144|54585344|FG009|Induction Period (Up to Week 12)|Protocol Deviation|0|||
27929134|NCT02471144|54585345|FG010|Induction Period (Up to Week 12)|Protocol Deviation|0|||
27929135|NCT02471144|54585335|FG000|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
27929136|NCT02471144|54585336|FG001|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
27929137|NCT02471144|54585337|FG002|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
27786294|NCT02194465|54240759|FG003|Overall Study|Adverse Event|4|||
27786295|NCT02194465|54240760|FG004|Overall Study|Adverse Event|4|||
27786296|NCT02194465|54240761|FG005|Overall Study|Adverse Event|2|||
27786297|NCT02194465|54240762|FG006|Overall Study|Adverse Event|0|||
27786298|NCT02194465|54240756|FG000|Overall Study|Lost to Follow-up|0|||
27786299|NCT02194465|54240757|FG001|Overall Study|Lost to Follow-up|0|||
27786300|NCT02194465|54240758|FG002|Overall Study|Lost to Follow-up|0|||
27786301|NCT02194465|54240759|FG003|Overall Study|Lost to Follow-up|1|||
27786302|NCT02194465|54240760|FG004|Overall Study|Lost to Follow-up|0|||
27786303|NCT02194465|54240761|FG005|Overall Study|Lost to Follow-up|1|||
27786304|NCT02194465|54240762|FG006|Overall Study|Lost to Follow-up|0|||
27786305|NCT02194465|54240756|FG000|Overall Study|Physician Decision|1|||
27786306|NCT02194465|54240757|FG001|Overall Study|Physician Decision|0|||
27786307|NCT02194465|54240758|FG002|Overall Study|Physician Decision|0|||
27786308|NCT02194465|54240759|FG003|Overall Study|Physician Decision|0|||
27786309|NCT02194465|54240760|FG004|Overall Study|Physician Decision|0|||
27786310|NCT02194465|54240761|FG005|Overall Study|Physician Decision|0|||
27786311|NCT02194465|54240762|FG006|Overall Study|Physician Decision|0|||
27786312|NCT02194465|54240756|FG000|Overall Study|Protocol Violation|1|||
27786313|NCT02194465|54240757|FG001|Overall Study|Protocol Violation|1|||
27786314|NCT02194465|54240758|FG002|Overall Study|Protocol Violation|2|||
27786315|NCT02194465|54240759|FG003|Overall Study|Protocol Violation|1|||
27929138|NCT02471144|54585338|FG003|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
27929139|NCT02471144|54585339|FG004|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
27929140|NCT02471144|54585340|FG005|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
27929141|NCT02471144|54585341|FG006|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
27929142|NCT02471144|54585342|FG007|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
27929143|NCT02471144|54585343|FG008|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
27929144|NCT02471144|54585344|FG009|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
27929145|NCT02471144|54585345|FG010|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
27929146|NCT02471144|54585335|FG000|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
27929147|NCT02471144|54585336|FG001|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
27929148|NCT02471144|54585337|FG002|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
27929149|NCT02471144|54585338|FG003|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
27929150|NCT02471144|54585339|FG004|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
27929151|NCT02471144|54585340|FG005|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
27929152|NCT02471144|54585341|FG006|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
27929153|NCT02471144|54585342|FG007|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
27786316|NCT02194465|54240760|FG004|Overall Study|Protocol Violation|1|||
27786317|NCT02194465|54240761|FG005|Overall Study|Protocol Violation|0|||
27786318|NCT02194465|54240762|FG006|Overall Study|Protocol Violation|0|||
27786319|NCT02194465|54240756|FG000|Overall Study|Withdrawal by Subject|1|||
27786320|NCT02194465|54240757|FG001|Overall Study|Withdrawal by Subject|3|||
27786321|NCT02194465|54240758|FG002|Overall Study|Withdrawal by Subject|1|||
27786322|NCT02194465|54240759|FG003|Overall Study|Withdrawal by Subject|2|||
27929154|NCT02471144|54585343|FG008|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
27929155|NCT02471144|54585344|FG009|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
27929156|NCT02471144|54585345|FG010|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
27929157|NCT02471144|54585335|FG000|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
27929158|NCT02471144|54585336|FG001|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
27929159|NCT02471144|54585337|FG002|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
27929160|NCT02471144|54585338|FG003|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
27929161|NCT02471144|54585339|FG004|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
27929162|NCT02471144|54585340|FG005|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|1|||
27929163|NCT02471144|54585341|FG006|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
27929164|NCT02471144|54585342|FG007|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
27929165|NCT02471144|54585343|FG008|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|3|||
27929166|NCT02471144|54585344|FG009|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
27929167|NCT02471144|54585345|FG010|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
27929168|NCT02471144|54585335|FG000|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
27929169|NCT02471144|54585336|FG001|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
27929170|NCT02471144|54585337|FG002|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
27929171|NCT02471144|54585338|FG003|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
27929172|NCT02471144|54585339|FG004|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
27929173|NCT02471144|54585340|FG005|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
27929174|NCT02471144|54585341|FG006|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
27929175|NCT02471144|54585342|FG007|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
27929176|NCT02471144|54585343|FG008|Maintenance Period (Week 12 to Week 52)|Pregnancy|1|||
27929177|NCT02471144|54585344|FG009|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
27929178|NCT02471144|54585345|FG010|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
27929179|NCT02471144|54585335|FG000|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
27929180|NCT02471144|54585336|FG001|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
27929181|NCT02471144|54585337|FG002|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
27929182|NCT02471144|54585338|FG003|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
27929183|NCT02471144|54585339|FG004|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
27929184|NCT02471144|54585340|FG005|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
27929185|NCT02471144|54585341|FG006|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
27929186|NCT02471144|54585342|FG007|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|2|||
27929187|NCT02471144|54585343|FG008|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|1|||
27929188|NCT02471144|54585344|FG009|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
27929189|NCT02471144|54585345|FG010|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
27929190|NCT02471144|54585335|FG000|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
27929191|NCT02471144|54585336|FG001|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
27929192|NCT02471144|54585337|FG002|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
27929193|NCT02471144|54585338|FG003|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
27929194|NCT02471144|54585339|FG004|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
27929195|NCT02471144|54585340|FG005|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
27929196|NCT02471144|54585341|FG006|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
27929197|NCT02471144|54585342|FG007|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
27929198|NCT02471144|54585343|FG008|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
27929199|NCT02471144|54585344|FG009|Extension Period (Week 52 to Week 236)|Lack of Efficacy|5|||
27929200|NCT02471144|54585345|FG010|Extension Period (Week 52 to Week 236)|Lack of Efficacy|2|||
27929201|NCT02471144|54585335|FG000|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
27929202|NCT02471144|54585336|FG001|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
27929203|NCT02471144|54585337|FG002|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
27786323|NCT02194465|54240760|FG004|Overall Study|Withdrawal by Subject|2|||
27786324|NCT02194465|54240761|FG005|Overall Study|Withdrawal by Subject|1|||
27929204|NCT02471144|54585338|FG003|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
27929205|NCT02471144|54585339|FG004|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
27929206|NCT02471144|54585340|FG005|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
27929207|NCT02471144|54585341|FG006|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
27929208|NCT02471144|54585342|FG007|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
27929209|NCT02471144|54585343|FG008|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
27929210|NCT02471144|54585344|FG009|Extension Period (Week 52 to Week 236)|Pregnancy|2|||
27929211|NCT02471144|54585345|FG010|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
27929212|NCT02471144|54585335|FG000|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
27929213|NCT02471144|54585336|FG001|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
27929214|NCT02471144|54585337|FG002|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
27929215|NCT02471144|54585338|FG003|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
27929216|NCT02471144|54585339|FG004|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
27929217|NCT02471144|54585340|FG005|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
27929218|NCT02471144|54585341|FG006|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
27929219|NCT02471144|54585342|FG007|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
27929220|NCT02471144|54585343|FG008|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
27929221|NCT02471144|54585344|FG009|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
27929222|NCT02471144|54585345|FG010|Extension Period (Week 52 to Week 236)|Lost to Follow-up|2|||
27929223|NCT02470585|54585364|FG000|Overall Study|Death|82|||
27929224|NCT02470585|54585365|FG001|Overall Study|Death|87|||
27929225|NCT02470585|54585366|FG002|Overall Study|Death|86|||
27929226|NCT02470585|54585364|FG000|Overall Study|Withdrawal by Subject|19|||
27929227|NCT02470585|54585365|FG001|Overall Study|Withdrawal by Subject|21|||
27929228|NCT02470585|54585366|FG002|Overall Study|Withdrawal by Subject|29|||
27929229|NCT02470585|54585364|FG000|Overall Study|Lost to Follow-up|2|||
27929230|NCT02470585|54585365|FG001|Overall Study|Lost to Follow-up|5|||
27929231|NCT02470585|54585366|FG002|Overall Study|Lost to Follow-up|4|||
27929232|NCT02470585|54585364|FG000|Overall Study|Other|4|||
27929233|NCT02470585|54585365|FG001|Overall Study|Other|4|||
27929234|NCT02470585|54585366|FG002|Overall Study|Other|6|||
27929235|NCT02213328|54585383|FG000|Overall Study|Withdrawal by Subject|10|||
27929236|NCT02213328|54585383|FG000|Overall Study|Physician Decision|2|||
27929237|NCT02213328|54585383|FG000|Overall Study|Lost to Follow-up|16|||
27929238|NCT02195479|54585391|FG000|Overall Study|Lost to Follow-up|3|||
27929239|NCT02195479|54585392|FG001|Overall Study|Lost to Follow-up|0|||
27929240|NCT02195479|54585391|FG000|Overall Study|Death|48|||
27929241|NCT02195479|54585392|FG001|Overall Study|Death|45|||
27929242|NCT02195479|54585391|FG000|Overall Study|Physician Decision|1|||
27929243|NCT02195479|54585392|FG001|Overall Study|Physician Decision|0|||
27929244|NCT02195479|54585391|FG000|Overall Study|Withdrawal by Subject|11|||
27929245|NCT02195479|54585392|FG001|Overall Study|Withdrawal by Subject|6|||
27929246|NCT02195479|54585391|FG000|Overall Study|Other|2|||
27929247|NCT02195479|54585392|FG001|Overall Study|Other|2|||
27929248|NCT02195479|54585391|FG000|Overall Study|Ongoing|291|||
27929249|NCT02195479|54585392|FG001|Overall Study|Ongoing|297|||
27929250|NCT02085408|54585421|FG000|Step 1: Induction|Disease Progression|19|||
27929251|NCT02085408|54585422|FG001|Step 1: Induction|Disease Progression|19|||
27929252|NCT02085408|54585421|FG000|Step 1: Induction|Adverse Event|18|||
27929253|NCT02085408|54585422|FG001|Step 1: Induction|Adverse Event|17|||
27929254|NCT02085408|54585421|FG000|Step 1: Induction|Death|33|||
27929255|NCT02085408|54585422|FG001|Step 1: Induction|Death|30|||
27929256|NCT02085408|54585421|FG000|Step 1: Induction|Withdrawal by Subject|16|||
27929257|NCT02085408|54585422|FG001|Step 1: Induction|Withdrawal by Subject|8|||
27929258|NCT02085408|54585421|FG000|Step 1: Induction|Alternative Therapy|15|||
27929259|NCT02085408|54585422|FG001|Step 1: Induction|Alternative Therapy|19|||
27929260|NCT02085408|54585421|FG000|Step 1: Induction|Complicating Disease|2|||
27929261|NCT02085408|54585422|FG001|Step 1: Induction|Complicating Disease|3|||
27929262|NCT02085408|54585421|FG000|Step 1: Induction|Other|27|||
27929263|NCT02085408|54585422|FG001|Step 1: Induction|Other|39|||
27929264|NCT02085408|54585421|FG000|Step 1: Induction|Never started treatment|6|||
27929265|NCT02085408|54585422|FG001|Step 1: Induction|Never started treatment|4|||
27929266|NCT02085408|54585421|FG000|Step 2: Consolidation|Disease Progression|5|||
27929267|NCT02085408|54585422|FG001|Step 2: Consolidation|Disease Progression|20|||
27929268|NCT02085408|54585421|FG000|Step 2: Consolidation|Adverse Event|9|||
27929269|NCT02085408|54585422|FG001|Step 2: Consolidation|Adverse Event|8|||
27929270|NCT02085408|54585421|FG000|Step 2: Consolidation|Death|4|||
27929271|NCT02085408|54585422|FG001|Step 2: Consolidation|Death|3|||
27929272|NCT02085408|54585421|FG000|Step 2: Consolidation|Withdrawal by Subject|8|||
27929273|NCT02085408|54585422|FG001|Step 2: Consolidation|Withdrawal by Subject|5|||
27929274|NCT02085408|54585421|FG000|Step 2: Consolidation|Alternative Therapy|9|||
27929275|NCT02085408|54585422|FG001|Step 2: Consolidation|Alternative Therapy|3|||
27929276|NCT02085408|54585421|FG000|Step 2: Consolidation|Complicating Disease|0|||
27929277|NCT02085408|54585422|FG001|Step 2: Consolidation|Complicating Disease|2|||
27929278|NCT02085408|54585421|FG000|Step 2: Consolidation|Other|6|||
27929279|NCT02085408|54585422|FG001|Step 2: Consolidation|Other|6|||
27929280|NCT02085408|54585421|FG000|Step 2: Consolidation|Never started treatment|4|||
27929281|NCT02085408|54585422|FG001|Step 2: Consolidation|Never started treatment|3|||
27929282|NCT02085408|54585421|FG000|Step 3: Maintenance|Disease Progression|13|||
27929283|NCT02085408|54585422|FG001|Step 3: Maintenance|Disease Progression|11|||
27929284|NCT02085408|54585421|FG000|Step 3: Maintenance|Adverse Event|2|||
27929285|NCT02085408|54585422|FG001|Step 3: Maintenance|Adverse Event|4|||
27929286|NCT02085408|54585421|FG000|Step 3: Maintenance|Death|1|||
27929287|NCT02085408|54585422|FG001|Step 3: Maintenance|Death|2|||
27929288|NCT02085408|54585421|FG000|Step 3: Maintenance|Alternative Therapy|1|||
27929289|NCT02085408|54585422|FG001|Step 3: Maintenance|Alternative Therapy|1|||
27929290|NCT02085408|54585421|FG000|Step 3: Maintenance|Complicating Disease|0|||
27929291|NCT02085408|54585422|FG001|Step 3: Maintenance|Complicating Disease|1|||
27929292|NCT02085408|54585421|FG000|Step 3: Maintenance|Other|3|||
27929293|NCT02085408|54585422|FG001|Step 3: Maintenance|Other|2|||
27929294|NCT02085408|54585421|FG000|Step 3: Maintenance|Never started treatment|5|||
27929295|NCT02085408|54585422|FG001|Step 3: Maintenance|Never started treatment|1|||
27929296|NCT01867606|54585439|FG000|Overall Study|Withdrawal by Subject|10|||
27929297|NCT01867606|54585440|FG001|Overall Study|Withdrawal by Subject|14|||
27929298|NCT01867606|54585439|FG000|Overall Study|Protocol Violation|0|||
27929299|NCT01867606|54585440|FG001|Overall Study|Protocol Violation|1|||
27929300|NCT01730937|54585454|FG000|Overall Study|Protocol Violation|5|||
27929301|NCT01730937|54585455|FG001|Overall Study|Protocol Violation|11|||
27929302|NCT01496976|54585461|FG000|Overall Study|Withdrew - received stem cell transplant|1|||
27929303|NCT01475786|54585468|FG000|Overall Study|Adverse Event|0|||
27929304|NCT01475786|54585469|FG001|Overall Study|Adverse Event|1|||
27929305|NCT01475786|54585470|FG002|Overall Study|Adverse Event|0|||
27929306|NCT01475786|54585468|FG000|Overall Study|Lost to Follow-up|1|||
27929307|NCT01475786|54585469|FG001|Overall Study|Lost to Follow-up|2|||
27929308|NCT01475786|54585470|FG002|Overall Study|Lost to Follow-up|1|||
27929309|NCT01475786|54585468|FG000|Overall Study|Withdrawal by Subject|0|||
27929310|NCT01475786|54585469|FG001|Overall Study|Withdrawal by Subject|1|||
27929311|NCT01475786|54585470|FG002|Overall Study|Withdrawal by Subject|1|||
27929312|NCT01475786|54585468|FG000|Overall Study|Subject discontinued prior to study treatment|1|||
27929313|NCT01475786|54585469|FG001|Overall Study|Subject discontinued prior to study treatment|0|||
27929314|NCT01475786|54585470|FG002|Overall Study|Subject discontinued prior to study treatment|0|||
27929315|NCT01290692|54585478|FG000|Overall Study|Lack of sufficient efficacy as patients were immunocompromised|7|||
27929316|NCT00700882|54585514|FG000|Overall Study|Never received treatment|6|||
27929317|NCT00700882|54585514|FG000|Overall Study|Ineligible|2|||
27929318|NCT00700882|54585514|FG000|Overall Study|No KIT mutation|51|||
27929319|NCT00666835|54585552|FG000|Overall Study|Withdrawal by Subject|5|||
27929320|NCT00666835|54585553|FG001|Overall Study|Withdrawal by Subject|2|||
27929321|NCT00666835|54585552|FG000|Overall Study|Lack of Efficacy|0|||
27929322|NCT00666835|54585553|FG001|Overall Study|Lack of Efficacy|1|||
27929323|NCT00666835|54585552|FG000|Overall Study|Incl./excl. not fulfilled|7|||
27929324|NCT00666835|54585553|FG001|Overall Study|Incl./excl. not fulfilled|2|||
27929325|NCT00666835|54585552|FG000|Overall Study|Adverse Event|7|||
27929326|NCT00666835|54585553|FG001|Overall Study|Adverse Event|6|||
27929327|NCT00666835|54585552|FG000|Overall Study|Protocol Violation|2|||
27929328|NCT00666835|54585553|FG001|Overall Study|Protocol Violation|0|||
27929329|NCT00666835|54585552|FG000|Overall Study|Death|15|||
27929330|NCT00666835|54585553|FG001|Overall Study|Death|4|||
27929331|NCT00666835|54585552|FG000|Overall Study|Kidney Transplantation (NTX)|10|||
27786325|NCT02194465|54240762|FG006|Overall Study|Withdrawal by Subject|2|||
27786326|NCT02194465|54240756|FG000|Overall Study|Discontinued follow-up period|0|||
27786327|NCT02194465|54240757|FG001|Overall Study|Discontinued follow-up period|2|||
27786328|NCT02194465|54240758|FG002|Overall Study|Discontinued follow-up period|1|||
27786329|NCT02194465|54240759|FG003|Overall Study|Discontinued follow-up period|0|||
27786330|NCT02194465|54240760|FG004|Overall Study|Discontinued follow-up period|2|||
27786331|NCT02194465|54240761|FG005|Overall Study|Discontinued follow-up period|0|||
27786332|NCT02194465|54240762|FG006|Overall Study|Discontinued follow-up period|0|||
27929332|NCT00666835|54585553|FG001|Overall Study|Kidney Transplantation (NTX)|2|||
27929333|NCT00666835|54585552|FG000|Overall Study|Hemoglobulin concentration|4|||
27929334|NCT00666835|54585553|FG001|Overall Study|Hemoglobulin concentration|3|||
27786333|NCT02287025|54240784|FG000|Overall Study|Not treated|2|||
27786334|NCT02287025|54240785|FG001|Overall Study|Not treated|0|||
27786335|NCT02287025|54240784|FG000|Overall Study|Progression of disease|3|||
27786336|NCT02287025|54240785|FG001|Overall Study|Progression of disease|2|||
27786337|NCT02287025|54240784|FG000|Overall Study|Adverse Event|2|||
27841398|NCT01452919|54329304|FG001|Open-Label Treatment|Adverse Event|0|||
27841399|NCT01452919|54329305|FG002|Open-Label Treatment|Adverse Event|0|||
27841400|NCT01452919|54329303|FG000|Open-Label Treatment|Lost to Follow-up|4|||
27841401|NCT01452919|54329304|FG001|Open-Label Treatment|Lost to Follow-up|0|||
27841402|NCT01452919|54329305|FG002|Open-Label Treatment|Lost to Follow-up|0|||
27841403|NCT01452919|54329303|FG000|Open-Label Treatment|Perceived lack of efficacy|3|||
27841404|NCT01452919|54329304|FG001|Open-Label Treatment|Perceived lack of efficacy|0|||
27841405|NCT01452919|54329305|FG002|Open-Label Treatment|Perceived lack of efficacy|0|||
27841406|NCT01452919|54329303|FG000|Open-Label Treatment|Protocol Violation|4|||
27841407|NCT01452919|54329304|FG001|Open-Label Treatment|Protocol Violation|0|||
27929335|NCT00666835|54585552|FG000|Overall Study|Planned operation|2|||
27929336|NCT00666835|54585553|FG001|Overall Study|Planned operation|0|||
27929337|NCT00666835|54585552|FG000|Overall Study|Physician Decision|1|||
27929338|NCT00666835|54585553|FG001|Overall Study|Physician Decision|2|||
27929339|NCT00551759|54585560|FG000|Overall Study|Adverse Event|7|||
27786338|NCT02287025|54240785|FG001|Overall Study|Adverse Event|4|||
27929340|NCT00551759|54585560|FG000|Overall Study|Death|5|||
27786339|NCT02287025|54240784|FG000|Overall Study|Withdrawal by Subject|2|||
27929341|NCT00551759|54585560|FG000|Overall Study|Ineligible|1|||
27929342|NCT00335140|54585564|FG000|Overall Study|Ineligible|1|||
27786340|NCT02287025|54240785|FG001|Overall Study|Withdrawal by Subject|2|||
27786341|NCT02287025|54240784|FG000|Overall Study|Screening failed|1|||
27786342|NCT02287025|54240785|FG001|Overall Study|Screening failed|1|||
27786343|NCT01720264|54240789|FG000|Transplant With Sitagliptin for 15 Days|Adverse Event|1|||
27786344|NCT01720264|54240789|FG000|Post-transplant (Day 16) to 1 Year|Death|8|||
27786345|NCT01720264|54240789|FG000|Post-transplant (Day 16) to 1 Year|Disease Progression|4|||
27786346|NCT01702246|54240793|FG000|Overall Study|Lost to Follow-up|2|||
27786347|NCT01702246|54240793|FG000|Overall Study|Withdrawal by Subject|2|||
27786348|NCT01702246|54240793|FG000|Overall Study|Physician Decision|1|||
27786349|NCT01631227|54240802|FG000|Overall Study|withdrawn consent|27|||
27786350|NCT01631227|54240803|FG001|Overall Study|withdrawn consent|21|||
27786351|NCT01631227|54240802|FG000|Overall Study|Adverse Event|1|||
27786352|NCT01631227|54240803|FG001|Overall Study|Adverse Event|0|||
27786353|NCT01631227|54240802|FG000|Overall Study|administrative|2|||
27786354|NCT01631227|54240803|FG001|Overall Study|administrative|1|||
27786355|NCT01719172|54240809|FG000|Overall Study|Lost to Follow-up|1|||
27786356|NCT01719172|54240809|FG000|Overall Study|Death|1|||
27786357|NCT02286947|54240813|FG000|Overall Study|Withdrawal by Subject|2|||
27786358|NCT02286713|54240821|FG000|One Week Follow-Up|Death|1|||
27786359|NCT02286713|54240822|FG001|One Week Follow-Up|Death|0|||
27786360|NCT02286713|54240821|FG000|One Week Follow-Up|Lost to Follow-up|17|||
27786361|NCT02286713|54240822|FG001|One Week Follow-Up|Lost to Follow-up|21|||
27786362|NCT02286713|54240821|FG000|One Week Follow-Up|Withdrawal by Subject|6|||
27786363|NCT02286713|54240822|FG001|One Week Follow-Up|Withdrawal by Subject|3|||
27786364|NCT02286713|54240821|FG000|Three Month Follow-Up|Death|1|||
27786365|NCT02286713|54240822|FG001|Three Month Follow-Up|Death|1|||
27786366|NCT02286713|54240821|FG000|Three Month Follow-Up|Lost to Follow-up|26|||
27786367|NCT02286713|54240822|FG001|Three Month Follow-Up|Lost to Follow-up|24|||
27786368|NCT02286713|54240821|FG000|Three Month Follow-Up|Withdrawal by Subject|1|||
27786369|NCT02286713|54240822|FG001|Three Month Follow-Up|Withdrawal by Subject|1|||
27786370|NCT02286713|54240821|FG000|Six Month Follow-Up|Death|2|||
27786371|NCT02286713|54240822|FG001|Six Month Follow-Up|Death|0|||
27786372|NCT02286713|54240821|FG000|Six Month Follow-Up|Lost to Follow-up|30|||
27786373|NCT02286713|54240822|FG001|Six Month Follow-Up|Lost to Follow-up|27|||
27786374|NCT02285855|54240830|FG000|Overall Study|Withdrawal by Subject|2|||
27786375|NCT02285855|54240831|FG001|Overall Study|Withdrawal by Subject|1|||
27786376|NCT02285777|54240839|FG000|Overall Study|Withdrawal by Subject|1|||
27929343|NCT00304239|54585570|FG000|Overall Study|Protocol Deviations/Violations|15|||
27929344|NCT00304239|54585571|FG001|Overall Study|Protocol Deviations/Violations|0|||
27929345|NCT00304239|54585570|FG000|Overall Study|Adverse Event|2|||
27929346|NCT00304239|54585571|FG001|Overall Study|Adverse Event|0|||
27786377|NCT02285777|54240840|FG001|Overall Study|Withdrawal by Subject|1|||
27841408|NCT01452919|54329305|FG002|Open-Label Treatment|Protocol Violation|0|||
27786378|NCT02285777|54240839|FG000|Overall Study|Lost to Follow-up|4|||
27786379|NCT02285777|54240840|FG001|Overall Study|Lost to Follow-up|2|||
27786380|NCT02285153|54240848|FG000|Overall Study|Adverse Event|1|||
27786381|NCT02285153|54240849|FG001|Overall Study|Adverse Event|0|||
27786382|NCT02284373|54240858|FG000|Overall Study|Withdrawal by Subject|0|||
27786383|NCT02284373|54240859|FG001|Overall Study|Withdrawal by Subject|1|||
27786384|NCT02284373|54240860|FG002|Overall Study|Withdrawal by Subject|0|||
27786385|NCT02284373|54240858|FG000|Overall Study|Other|0|||
27786386|NCT02284373|54240859|FG001|Overall Study|Other|1|||
27786387|NCT02284373|54240860|FG002|Overall Study|Other|0|||
27841409|NCT01452919|54329303|FG000|Open-Label Treatment|Sponsor Decision|1|||
27841410|NCT01452919|54329304|FG001|Open-Label Treatment|Sponsor Decision|0|||
27841411|NCT01452919|54329305|FG002|Open-Label Treatment|Sponsor Decision|0|||
27841412|NCT01452919|54329303|FG000|Open-Label Treatment|Withdrawal by Subject|2|||
27841413|NCT01452919|54329304|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
27841414|NCT01452919|54329305|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
27841415|NCT01452919|54329303|FG000|Open-Label Treatment|Subject is moving or has moved|1|||
27841416|NCT01452919|54329304|FG001|Open-Label Treatment|Subject is moving or has moved|0|||
27841417|NCT01452919|54329305|FG002|Open-Label Treatment|Subject is moving or has moved|0|||
27841418|NCT01452919|54329303|FG000|Randomization Treatment|Adverse Event|0|||
27841419|NCT01452919|54329304|FG001|Randomization Treatment|Adverse Event|0|||
27841420|NCT01452919|54329305|FG002|Randomization Treatment|Adverse Event|2|||
27841421|NCT01452919|54329303|FG000|Randomization Treatment|Sponsor Decision|0|||
27841422|NCT01452919|54329304|FG001|Randomization Treatment|Sponsor Decision|1|||
27841423|NCT01452919|54329305|FG002|Randomization Treatment|Sponsor Decision|0|||
27841424|NCT01452919|54329303|FG000|Randomization Treatment|Withdrawal by Subject|0|||
27841425|NCT01452919|54329304|FG001|Randomization Treatment|Withdrawal by Subject|1|||
27841426|NCT01452919|54329305|FG002|Randomization Treatment|Withdrawal by Subject|0|||
27841427|NCT01452919|54329303|FG000|Randomization Treatment|Subject is moving or has moved|0|||
27841428|NCT01452919|54329304|FG001|Randomization Treatment|Subject is moving or has moved|1|||
27929347|NCT00101283|54585579|FG000|Overall Study|Withdrawal by Subject|0|||
27929348|NCT00101283|54585580|FG001|Overall Study|Withdrawal by Subject|1|||
27929349|NCT00101283|54585579|FG000|Overall Study|Insurance Refusal|0|||
27929350|NCT00101283|54585580|FG001|Overall Study|Insurance Refusal|1|||
27929351|NCT00101283|54585579|FG000|Overall Study|Prostate Cancer Recurrence|0|||
27929352|NCT00101283|54585580|FG001|Overall Study|Prostate Cancer Recurrence|1|||
27929353|NCT01302041|54585586|FG000|Overall Study|Death|5|||
27929354|NCT01302041|54585586|FG000|Overall Study|Withdrawal by Subject|4|||
27929355|NCT01302041|54585586|FG000|Overall Study|Other-Transitioned to 9785-CL-0123|29|||
27929356|NCT01302041|54585586|FG000|Overall Study|Other-Miscellaneous Reason|2|||
27929357|NCT01301729|54585591|FG000|Overall Study|Withdrawal by Subject|2|||
27929358|NCT01301729|54585591|FG000|Overall Study|Participant did not Return for Treatment|1|||
27929359|NCT01301729|54585591|FG000|Overall Study|Violated Selection Criteria|1|||
27929360|NCT01187043|54585601|FG000|Overall Study|Adverse Event|0|||
27929361|NCT01187043|54585602|FG001|Overall Study|Adverse Event|0|||
27929362|NCT01187043|54585603|FG002|Overall Study|Adverse Event|0|||
27786388|NCT02284373|54240858|FG000|Overall Study|Lost to Follow-up|0|||
27786389|NCT02284373|54240859|FG001|Overall Study|Lost to Follow-up|1|||
27786390|NCT02284373|54240860|FG002|Overall Study|Lost to Follow-up|0|||
27786391|NCT01632241|54240870|FG000|Double-blinded (Up to Week 52)|Site Closed|3|||
27786392|NCT01632241|54240871|FG001|Double-blinded (Up to Week 52)|Site Closed|5|||
27786393|NCT01632241|54240870|FG000|Double-blinded (Up to Week 52)|Protocol Violation|2|||
27786394|NCT01632241|54240871|FG001|Double-blinded (Up to Week 52)|Protocol Violation|6|||
27786395|NCT01632241|54240870|FG000|Double-blinded (Up to Week 52)|Lost to Follow-up|1|||
27786396|NCT01632241|54240871|FG001|Double-blinded (Up to Week 52)|Lost to Follow-up|8|||
27786397|NCT01632241|54240870|FG000|Double-blinded (Up to Week 52)|Physician Decision|9|||
27786398|NCT01632241|54240871|FG001|Double-blinded (Up to Week 52)|Physician Decision|12|||
27786399|NCT01632241|54240870|FG000|Double-blinded (Up to Week 52)|Lack of Efficacy|9|||
27786400|NCT01632241|54240871|FG001|Double-blinded (Up to Week 52)|Lack of Efficacy|15|||
27786401|NCT01632241|54240870|FG000|Double-blinded (Up to Week 52)|Withdrawal by Subject|10|||
27786402|NCT01632241|54240871|FG001|Double-blinded (Up to Week 52)|Withdrawal by Subject|14|||
27786403|NCT01632241|54240870|FG000|Double-blinded (Up to Week 52)|Adverse Event|10|||
27786404|NCT01632241|54240871|FG001|Double-blinded (Up to Week 52)|Adverse Event|19|||
27786405|NCT01632241|54240870|FG000|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5|||
27786406|NCT01632241|54240871|FG001|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2|||
27841429|NCT01452919|54329305|FG002|Randomization Treatment|Subject is moving or has moved|0|||
27841430|NCT01582178|54329317|FG000|Overall Study|Physician Decision|6|||
27841431|NCT01582178|54329318|FG001|Overall Study|Physician Decision|5|||
27841432|NCT01561898|54329328|FG000|Overall Study|Withdrawal by Subject|0|||
27841433|NCT01561898|54329329|FG001|Overall Study|Withdrawal by Subject|8|||
27841434|NCT01561898|54329330|FG002|Overall Study|Withdrawal by Subject|12|||
27841435|NCT01561898|54329331|FG003|Overall Study|Withdrawal by Subject|5|||
27841436|NCT01561898|54329328|FG000|Overall Study|Lack of Efficacy|0|||
27841437|NCT01561898|54329329|FG001|Overall Study|Lack of Efficacy|8|||
27841438|NCT01561898|54329330|FG002|Overall Study|Lack of Efficacy|10|||
27841439|NCT01561898|54329331|FG003|Overall Study|Lack of Efficacy|5|||
27841440|NCT01561898|54329328|FG000|Overall Study|Worsening of complications|0|||
27841441|NCT01561898|54329329|FG001|Overall Study|Worsening of complications|1|||
27841442|NCT01561898|54329330|FG002|Overall Study|Worsening of complications|0|||
27841443|NCT01561898|54329331|FG003|Overall Study|Worsening of complications|0|||
27841444|NCT01561898|54329328|FG000|Overall Study|Lost to Follow-up|0|||
27841445|NCT01561898|54329329|FG001|Overall Study|Lost to Follow-up|0|||
27841446|NCT01561898|54329330|FG002|Overall Study|Lost to Follow-up|1|||
27841447|NCT01561898|54329331|FG003|Overall Study|Lost to Follow-up|0|||
27841448|NCT01561898|54329328|FG000|Overall Study|Adverse Event|1|||
27841449|NCT01561898|54329329|FG001|Overall Study|Adverse Event|19|||
27841450|NCT01561898|54329330|FG002|Overall Study|Adverse Event|14|||
27841451|NCT01561898|54329331|FG003|Overall Study|Adverse Event|9|||
27841452|NCT01561898|54329328|FG000|Overall Study|Physician Decision|1|||
27841453|NCT01561898|54329329|FG001|Overall Study|Physician Decision|5|||
27841454|NCT01561898|54329330|FG002|Overall Study|Physician Decision|7|||
27841455|NCT01561898|54329331|FG003|Overall Study|Physician Decision|1|||
27841456|NCT01685840|54329341|FG000|Overall Study|Death|77|||
27929363|NCT01187043|54585604|FG003|Overall Study|Adverse Event|0|||
27929364|NCT01187043|54585605|FG004|Overall Study|Adverse Event|1|||
27929365|NCT01187043|54585601|FG000|Overall Study|Unable to make scheduled visits|1|||
27929366|NCT01187043|54585602|FG001|Overall Study|Unable to make scheduled visits|0|||
27929367|NCT01187043|54585603|FG002|Overall Study|Unable to make scheduled visits|4|||
27929368|NCT01187043|54585604|FG003|Overall Study|Unable to make scheduled visits|0|||
27929369|NCT01187043|54585605|FG004|Overall Study|Unable to make scheduled visits|1|||
27929370|NCT01186809|54585617|FG000|Overall Study|Death|30|||
27929371|NCT01186419|54585623|FG000|Overall Study|Withdrawal by Subject|5|||
27929372|NCT01186419|54585624|FG001|Overall Study|Withdrawal by Subject|3|||
27929373|NCT01186419|54585623|FG000|Overall Study|Adverse Event|1|||
27929374|NCT01186419|54585624|FG001|Overall Study|Adverse Event|2|||
27929375|NCT01186419|54585623|FG000|Overall Study|Physician Decision|0|||
27929376|NCT01186419|54585624|FG001|Overall Study|Physician Decision|3|||
27929377|NCT01186419|54585623|FG000|Overall Study|Other|1|||
27929378|NCT01186419|54585624|FG001|Overall Study|Other|1|||
27929379|NCT01301027|54585631|FG000|Overall Study|Physician Decision|2|||
27929380|NCT01301027|54585632|FG001|Overall Study|Physician Decision|0|||
27929381|NCT01301027|54585631|FG000|Overall Study|Withdrawal by Subject|2|||
27929382|NCT01301027|54585632|FG001|Overall Study|Withdrawal by Subject|3|||
27929383|NCT01301027|54585631|FG000|Overall Study|Adverse Event|0|||
27929384|NCT01301027|54585632|FG001|Overall Study|Adverse Event|2|||
27929385|NCT01301027|54585631|FG000|Overall Study|Fracture|1|||
27929386|NCT01301027|54585632|FG001|Overall Study|Fracture|3|||
27929387|NCT01301027|54585631|FG000|Overall Study|Transplant|0|||
27929388|NCT01301027|54585632|FG001|Overall Study|Transplant|2|||
27929389|NCT01301027|54585631|FG000|Overall Study|Volume Overload|3|||
27929390|NCT01301027|54585632|FG001|Overall Study|Volume Overload|0|||
27929391|NCT01185639|54585638|FG000|Overall Study|Progressed and didn't receive therapy|2|||
27929392|NCT01185561|54585644|FG000|Overall Study|Lost to Follow-up|0|||
27929393|NCT01185561|54585645|FG001|Overall Study|Lost to Follow-up|4|||
27841457|NCT01685840|54329342|FG001|Overall Study|Death|66|||
27841458|NCT01685840|54329341|FG000|Overall Study|Lost to Follow-up|27|||
27841459|NCT01685840|54329342|FG001|Overall Study|Lost to Follow-up|25|||
27841460|NCT01685840|54329341|FG000|Overall Study|Physician Decision|3|||
27929394|NCT01185561|54585644|FG000|Overall Study|Withdrawal by Subject|2|||
27929395|NCT01185561|54585645|FG001|Overall Study|Withdrawal by Subject|8|||
27929396|NCT01185249|54585651|FG000|Overall Study|Patients discharged or change in status|42|||
27929397|NCT01184859|54585661|FG000|Period 1: Single Dose|Insufficient urine production|0|||
27929398|NCT01184859|54585662|FG001|Period 1: Single Dose|Insufficient urine production|1|||
27929399|NCT01184859|54585663|FG002|Period 1: Single Dose|Insufficient urine production|0|||
27929400|NCT01184859|54585664|FG003|Period 1: Single Dose|Insufficient urine production|0|||
27929401|NCT01184859|54585665|FG004|Period 1: Single Dose|Insufficient urine production|0|||
27929402|NCT01184859|54585661|FG000|Period 1: Single Dose|Protocol Violation|0|||
27929403|NCT01184859|54585662|FG001|Period 1: Single Dose|Protocol Violation|1|||
27929404|NCT01184859|54585663|FG002|Period 1: Single Dose|Protocol Violation|0|||
27929405|NCT01184859|54585664|FG003|Period 1: Single Dose|Protocol Violation|0|||
27929406|NCT01184859|54585665|FG004|Period 1: Single Dose|Protocol Violation|0|||
27929407|NCT01184859|54585661|FG000|Period 1: Single Dose|Adverse Event|0|||
27929408|NCT01184859|54585662|FG001|Period 1: Single Dose|Adverse Event|0|||
27929409|NCT01184859|54585663|FG002|Period 1: Single Dose|Adverse Event|0|||
27841461|NCT01685840|54329342|FG001|Overall Study|Physician Decision|7|||
27841462|NCT01685840|54329341|FG000|Overall Study|Withdrawal by Subject|14|||
27841463|NCT01685840|54329342|FG001|Overall Study|Withdrawal by Subject|17|||
27841464|NCT01685840|54329341|FG000|Overall Study|Futility|197|||
27841465|NCT01685840|54329342|FG001|Overall Study|Futility|200|||
27929410|NCT01184859|54585664|FG003|Period 1: Single Dose|Adverse Event|0|||
27929411|NCT01184859|54585665|FG004|Period 1: Single Dose|Adverse Event|1|||
27929412|NCT01184859|54585661|FG000|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
27929413|NCT01184859|54585662|FG001|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
27841466|NCT01685840|54329341|FG000|Overall Study|Had VAD, Dialysis or Transplant|11|||
27841467|NCT01685840|54329342|FG001|Overall Study|Had VAD, Dialysis or Transplant|17|||
27929414|NCT01184859|54585663|FG002|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
27786407|NCT01632241|54240870|FG000|Open-label (Week 52 to Week 76)|Physician Decision|1|||
27786408|NCT01632241|54240871|FG001|Open-label (Week 52 to Week 76)|Physician Decision|4|||
27786409|NCT01632241|54240870|FG000|Open-label (Week 52 to Week 76)|Lost to Follow-up|1|||
27786410|NCT01632241|54240871|FG001|Open-label (Week 52 to Week 76)|Lost to Follow-up|4|||
27786411|NCT01632241|54240870|FG000|Open-label (Week 52 to Week 76)|Site Closed|2|||
27786412|NCT01632241|54240871|FG001|Open-label (Week 52 to Week 76)|Site Closed|8|||
27786413|NCT01632241|54240870|FG000|Open-label (Week 52 to Week 76)|Protocol Violation|0|||
27786414|NCT01632241|54240871|FG001|Open-label (Week 52 to Week 76)|Protocol Violation|2|||
27786415|NCT01632241|54240870|FG000|Open-label (Week 52 to Week 76)|Lack of Efficacy|0|||
27786416|NCT01632241|54240871|FG001|Open-label (Week 52 to Week 76)|Lack of Efficacy|2|||
27786417|NCT01632241|54240870|FG000|Open-label (Week 52 to Week 76)|Adverse Event|1|||
27786418|NCT01632241|54240871|FG001|Open-label (Week 52 to Week 76)|Adverse Event|0|||
27786419|NCT02263508|54240886|FG000|Overall Study|Withdrawal by Subject|1|||
27786420|NCT02263508|54240887|FG001|Overall Study|Withdrawal by Subject|23|||
27786421|NCT02263508|54240888|FG002|Overall Study|Withdrawal by Subject|17|||
27786422|NCT02263508|54240886|FG000|Overall Study|Sponsor Decision|12|||
27786423|NCT02263508|54240887|FG001|Overall Study|Sponsor Decision|165|||
27786424|NCT02263508|54240888|FG002|Overall Study|Sponsor Decision|182|||
27786425|NCT02263508|54240886|FG000|Overall Study|Lost to Follow-up|2|||
27786426|NCT02263508|54240887|FG001|Overall Study|Lost to Follow-up|7|||
27786427|NCT02263508|54240888|FG002|Overall Study|Lost to Follow-up|7|||
27786428|NCT02263508|54240886|FG000|Overall Study|Death|6|||
27786429|NCT02263508|54240887|FG001|Overall Study|Death|151|||
27786430|NCT02263508|54240888|FG002|Overall Study|Death|140|||
27786431|NCT02291432|54240899|FG000|Overall Study|Withdrawal by Subject|2|||
27786432|NCT02290340|54240907|FG000|Overall Study|Lost to Follow-up|0|||
27786433|NCT02290340|54240908|FG001|Overall Study|Lost to Follow-up|0|||
27786434|NCT02290340|54240909|FG002|Overall Study|Lost to Follow-up|0|||
27786435|NCT02290340|54240910|FG003|Overall Study|Lost to Follow-up|1|||
27786436|NCT02290340|54240907|FG000|Overall Study|Withdrawal by Subject|1|||
27786437|NCT02290340|54240908|FG001|Overall Study|Withdrawal by Subject|0|||
27786438|NCT02290340|54240909|FG002|Overall Study|Withdrawal by Subject|0|||
27786439|NCT02290340|54240910|FG003|Overall Study|Withdrawal by Subject|0|||
27786440|NCT02290340|54240907|FG000|Overall Study|Other|1|||
27786441|NCT02290340|54240908|FG001|Overall Study|Other|0|||
27786442|NCT02290340|54240909|FG002|Overall Study|Other|0|||
27786443|NCT02290340|54240910|FG003|Overall Study|Other|1|||
27786444|NCT02290028|54240923|FG000|Overall Study|Death|217|||
27786445|NCT02290028|54240923|FG000|Overall Study|Sentus lead or required CRT-D was not implanted|186|||
27786446|NCT02290028|54240923|FG000|Overall Study|No longer under care of study physician|76|||
27786447|NCT02290028|54240923|FG000|Overall Study|Sentus lead or required CRT-D explanted|55|||
27786448|NCT02290028|54240923|FG000|Overall Study|Withdrawal by Subject|52|||
27786449|NCT02290028|54240923|FG000|Overall Study|Study site closure|44|||
27786450|NCT02290028|54240923|FG000|Overall Study|Lost to Follow-up|34|||
27786451|NCT02290028|54240923|FG000|Overall Study|Miscellaneous|10|||
27786452|NCT02290028|54240923|FG000|Overall Study|Transition to EP PASSION|1295|||
27786453|NCT02290028|54240923|FG000|Overall Study|Planned study completion at 12 months|257|||
27786454|NCT01741792|54240933|FG000|Overall Study|Death|6|||
27786455|NCT01741792|54240934|FG001|Overall Study|Death|1|||
27841468|NCT01452529|54329352|FG000|Run-in Period|Adverse Event|96|||
27929415|NCT01184859|54585664|FG003|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
27929416|NCT01184859|54585665|FG004|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1|||
27841469|NCT01452529|54329353|FG001|Run-in Period|Adverse Event|0|||
27841470|NCT01452529|54329354|FG002|Run-in Period|Adverse Event|0|||
27841471|NCT01452529|54329352|FG000|Run-in Period|Withdrawal by Subject|49|||
27841472|NCT01452529|54329353|FG001|Run-in Period|Withdrawal by Subject|0|||
27841473|NCT01452529|54329354|FG002|Run-in Period|Withdrawal by Subject|0|||
27841474|NCT01452529|54329352|FG000|Run-in Period|Lost to Follow-up|19|||
27841475|NCT01452529|54329353|FG001|Run-in Period|Lost to Follow-up|0|||
27841476|NCT01452529|54329354|FG002|Run-in Period|Lost to Follow-up|0|||
27841477|NCT01452529|54329352|FG000|Run-in Period|Lack of Efficacy|46|||
27841478|NCT01452529|54329353|FG001|Run-in Period|Lack of Efficacy|0|||
27841479|NCT01452529|54329354|FG002|Run-in Period|Lack of Efficacy|0|||
27841480|NCT01452529|54329352|FG000|Run-in Period|Confirmed or suspected diversion|23|||
27841481|NCT01452529|54329353|FG001|Run-in Period|Confirmed or suspected diversion|0|||
27841482|NCT01452529|54329354|FG002|Run-in Period|Confirmed or suspected diversion|0|||
27929417|NCT01184859|54585661|FG000|Period 2: Daily Dose for 28 Days|Adverse Event|1|||
27786456|NCT01741792|54240935|FG002|Overall Study|Death|12|||
27841483|NCT01452529|54329352|FG000|Run-in Period|Administrative|21|||
27929418|NCT01184859|54585662|FG001|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
27786457|NCT02289950|54240951|FG000|Overall Study|Progressive disease by RECIST 1.1|99|||
27786458|NCT02289950|54240952|FG001|Overall Study|Progressive disease by RECIST 1.1|52|||
27786459|NCT02289950|54240951|FG000|Overall Study|Progressive disease by Clinical Assessment|4|||
27786460|NCT02289950|54240952|FG001|Overall Study|Progressive disease by Clinical Assessment|4|||
27786461|NCT02289950|54240951|FG000|Overall Study|Lost to Follow-up|1|||
27786462|NCT02289950|54240952|FG001|Overall Study|Lost to Follow-up|0|||
27929419|NCT01184859|54585663|FG002|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
27929420|NCT01184859|54585664|FG003|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
27929421|NCT01184859|54585665|FG004|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
27929422|NCT01184079|54585684|FG000|Overall Study|Lost to Follow-up|14|||
27929423|NCT01184079|54585685|FG001|Overall Study|Lost to Follow-up|2|||
27929424|NCT01190865|54585693|FG000|Overall Study|Withdrawal by Subject|1|||
27929425|NCT01190865|54585693|FG000|Overall Study|Non-compliance|2|||
27929426|NCT01190475|54585700|FG000|Overall Study|Withdrawal by Subject|0|||
27929427|NCT01190475|54585701|FG001|Overall Study|Withdrawal by Subject|0|||
27929428|NCT01190475|54585702|FG002|Overall Study|Withdrawal by Subject|1|||
27929429|NCT01289990|54585725|FG000|Overall Study|Death|0|||
27929430|NCT01289990|54585726|FG001|Overall Study|Death|0|||
27929431|NCT01289990|54585727|FG002|Overall Study|Death|0|||
27929432|NCT01289990|54585728|FG003|Overall Study|Death|1|||
27929433|NCT01289990|54585729|FG004|Overall Study|Death|2|||
27929434|NCT01289990|54585730|FG005|Overall Study|Death|1|||
27929435|NCT01289990|54585731|FG006|Overall Study|Death|0|||
27929436|NCT01289990|54585732|FG007|Overall Study|Death|0|||
27929437|NCT01289990|54585733|FG008|Overall Study|Death|0|||
27929438|NCT01289990|54585734|FG009|Overall Study|Death|0|||
27929439|NCT01289990|54585735|FG010|Overall Study|Death|0|||
27929440|NCT01289990|54585736|FG011|Overall Study|Death|1|||
27929441|NCT01289990|54585737|FG012|Overall Study|Death|0|||
27929442|NCT01289990|54585725|FG000|Overall Study|Lost to Follow-up|3|||
27929443|NCT01289990|54585726|FG001|Overall Study|Lost to Follow-up|2|||
27929444|NCT01289990|54585727|FG002|Overall Study|Lost to Follow-up|5|||
27929445|NCT01289990|54585728|FG003|Overall Study|Lost to Follow-up|5|||
27929446|NCT01289990|54585729|FG004|Overall Study|Lost to Follow-up|3|||
27929447|NCT01289990|54585730|FG005|Overall Study|Lost to Follow-up|4|||
27929448|NCT01289990|54585731|FG006|Overall Study|Lost to Follow-up|2|||
27929449|NCT01289990|54585732|FG007|Overall Study|Lost to Follow-up|2|||
27929450|NCT01289990|54585733|FG008|Overall Study|Lost to Follow-up|1|||
27929451|NCT01289990|54585734|FG009|Overall Study|Lost to Follow-up|4|||
27929452|NCT01289990|54585735|FG010|Overall Study|Lost to Follow-up|2|||
27929453|NCT01289990|54585736|FG011|Overall Study|Lost to Follow-up|1|||
27929454|NCT01289990|54585737|FG012|Overall Study|Lost to Follow-up|2|||
27929455|NCT01289990|54585725|FG000|Overall Study|Withdrawal by Subject|15|||
27929456|NCT01289990|54585726|FG001|Overall Study|Withdrawal by Subject|14|||
27929457|NCT01289990|54585727|FG002|Overall Study|Withdrawal by Subject|12|||
27929458|NCT01289990|54585728|FG003|Overall Study|Withdrawal by Subject|13|||
27929459|NCT01289990|54585729|FG004|Overall Study|Withdrawal by Subject|8|||
27929460|NCT01289990|54585730|FG005|Overall Study|Withdrawal by Subject|7|||
27929461|NCT01289990|54585731|FG006|Overall Study|Withdrawal by Subject|13|||
27929462|NCT01289990|54585732|FG007|Overall Study|Withdrawal by Subject|9|||
27929463|NCT01289990|54585733|FG008|Overall Study|Withdrawal by Subject|12|||
27929464|NCT01289990|54585734|FG009|Overall Study|Withdrawal by Subject|13|||
27929465|NCT01289990|54585735|FG010|Overall Study|Withdrawal by Subject|11|||
27929466|NCT01289990|54585736|FG011|Overall Study|Withdrawal by Subject|13|||
27929467|NCT01289990|54585737|FG012|Overall Study|Withdrawal by Subject|16|||
27929468|NCT01289990|54585725|FG000|Overall Study|discontinued in preceding trial|18|||
27929469|NCT01289990|54585726|FG001|Overall Study|discontinued in preceding trial|20|||
27929470|NCT01289990|54585727|FG002|Overall Study|discontinued in preceding trial|41|||
27929471|NCT01289990|54585728|FG003|Overall Study|discontinued in preceding trial|17|||
27929472|NCT01289990|54585729|FG004|Overall Study|discontinued in preceding trial|11|||
27929473|NCT01289990|54585730|FG005|Overall Study|discontinued in preceding trial|12|||
27929474|NCT01289990|54585731|FG006|Overall Study|discontinued in preceding trial|18|||
27929475|NCT01289990|54585732|FG007|Overall Study|discontinued in preceding trial|8|||
27929476|NCT01289990|54585733|FG008|Overall Study|discontinued in preceding trial|17|||
27929477|NCT01289990|54585734|FG009|Overall Study|discontinued in preceding trial|21|||
27929478|NCT01289990|54585735|FG010|Overall Study|discontinued in preceding trial|17|||
27929479|NCT01289990|54585736|FG011|Overall Study|discontinued in preceding trial|17|||
27929480|NCT01289990|54585737|FG012|Overall Study|discontinued in preceding trial|24|||
27929481|NCT01289990|54585725|FG000|Overall Study|did not continue in extension|41|||
27929482|NCT01289990|54585726|FG001|Overall Study|did not continue in extension|45|||
27929483|NCT01289990|54585727|FG002|Overall Study|did not continue in extension|51|||
27929484|NCT01289990|54585728|FG003|Overall Study|did not continue in extension|51|||
27929485|NCT01289990|54585729|FG004|Overall Study|did not continue in extension|48|||
27929486|NCT01289990|54585730|FG005|Overall Study|did not continue in extension|50|||
27929487|NCT01289990|54585731|FG006|Overall Study|did not continue in extension|54|||
27929488|NCT01289990|54585732|FG007|Overall Study|did not continue in extension|36|||
27929489|NCT01289990|54585733|FG008|Overall Study|did not continue in extension|44|||
27929490|NCT01289990|54585734|FG009|Overall Study|did not continue in extension|48|||
27929491|NCT01289990|54585735|FG010|Overall Study|did not continue in extension|45|||
27929492|NCT01289990|54585736|FG011|Overall Study|did not continue in extension|34|||
27929493|NCT01289990|54585737|FG012|Overall Study|did not continue in extension|56|||
27929494|NCT01289990|54585725|FG000|Overall Study|Not treated|0|||
27929495|NCT01289990|54585726|FG001|Overall Study|Not treated|0|||
27929496|NCT01289990|54585727|FG002|Overall Study|Not treated|0|||
27929497|NCT01289990|54585728|FG003|Overall Study|Not treated|0|||
27929498|NCT01289990|54585729|FG004|Overall Study|Not treated|0|||
27929499|NCT01289990|54585730|FG005|Overall Study|Not treated|0|||
27929500|NCT01289990|54585731|FG006|Overall Study|Not treated|1|||
27929501|NCT01289990|54585732|FG007|Overall Study|Not treated|0|||
27929502|NCT01289990|54585733|FG008|Overall Study|Not treated|1|||
27929503|NCT01289990|54585734|FG009|Overall Study|Not treated|0|||
27929504|NCT01289990|54585735|FG010|Overall Study|Not treated|1|||
27929505|NCT01289990|54585736|FG011|Overall Study|Not treated|2|||
27929506|NCT01289990|54585737|FG012|Overall Study|Not treated|0|||
27929507|NCT01190007|54585765|FG000|Overall Study|Withdrawal by Subject|4|||
27929508|NCT01190007|54585765|FG000|Overall Study|Adverse Event|8|||
27929509|NCT01190007|54585765|FG000|Overall Study|Difficulty of visit for complications|1|||
27929510|NCT01190007|54585765|FG000|Overall Study|Participant was arrested|1|||
27929511|NCT01189461|54585769|FG000|Overall Study|Lack of Efficacy|13|||
27929512|NCT01189461|54585769|FG000|Overall Study|Lost to Follow-up|1|||
27929513|NCT01189461|54585769|FG000|Overall Study|Withdrawal by Subject|6|||
27929514|NCT01189461|54585769|FG000|Overall Study|Protocol Violation|1|||
27929515|NCT01189461|54585769|FG000|Overall Study|Adverse Event|2|||
27929516|NCT01189461|54585769|FG000|Overall Study|Did not meet entrance criteria|3|||
27929517|NCT01189461|54585769|FG000|Overall Study|Other|8|||
27929518|NCT01189227|54585775|FG000|Overall Study|Study terminated due to low accrual|6|||
27929519|NCT01189227|54585776|FG001|Overall Study|Study terminated due to low accrual|3|||
27929520|NCT01300247|54585784|FG000|Overall Study|Death|1|||
27929521|NCT01300247|54585785|FG001|Overall Study|Death|1|||
27929522|NCT01300247|54585784|FG000|Overall Study|Lost to Follow-up|2|||
27929523|NCT01300247|54585785|FG001|Overall Study|Lost to Follow-up|0|||
27929524|NCT01300247|54585784|FG000|Overall Study|Withdrawal by Subject|1|||
27929525|NCT01300247|54585785|FG001|Overall Study|Withdrawal by Subject|0|||
27929526|NCT01300247|54585784|FG000|Overall Study|Non-Compliance|0|||
27929527|NCT01300247|54585785|FG001|Overall Study|Non-Compliance|1|||
27929528|NCT01289678|54585791|FG000|Overall Study|Physician Decision|6|||
27929529|NCT01289210|54585795|FG000|Overall Study|Adverse Event|1|||
27929530|NCT01183221|54585801|FG000|3 Weeks Wash Out|Lost to Follow-up|1|||
27929531|NCT01183221|54585802|FG001|3 Weeks Wash Out|Lost to Follow-up|1|||
27929532|NCT01183143|54585808|FG000|Overall Study|Protocol Violation|115|||
27929533|NCT01183143|54585808|FG000|Overall Study|Withdrawal by Subject|19|||
27929534|NCT01183143|54585808|FG000|Overall Study|Subject Questionnaires not returned|5|||
27929535|NCT01183143|54585808|FG000|Overall Study|Subjects enrolled, but not treated|11|||
27929536|NCT01183065|54585812|FG000|Overall Study|Patient no longer fits eligibility crite|1|||
27929537|NCT01182441|54585818|FG000|Overall Study|Patient Still in Follow-up|152|||
27929538|NCT01182441|54585819|FG001|Overall Study|Patient Still in Follow-up|72|||
27929539|NCT01182441|54585818|FG000|Overall Study|Death|37|||
27929540|NCT01182441|54585819|FG001|Overall Study|Death|25|||
27929541|NCT01182441|54585818|FG000|Overall Study|Implant Attempt Unsuccessful|13|||
27929542|NCT01182441|54585819|FG001|Overall Study|Implant Attempt Unsuccessful|0|||
27929543|NCT01182441|54585818|FG000|Overall Study|Lost to Follow-up|5|||
27929544|NCT01182441|54585819|FG001|Overall Study|Lost to Follow-up|8|||
27929545|NCT01182441|54585818|FG000|Overall Study|Withdrawal by Subject|6|||
27929546|NCT01182441|54585819|FG001|Overall Study|Withdrawal by Subject|13|||
27929547|NCT01182441|54585818|FG000|Overall Study|Implant Not Attempted|4|||
27929548|NCT01182441|54585819|FG001|Overall Study|Implant Not Attempted|0|||
27929549|NCT01182441|54585818|FG000|Overall Study|Adverse Event|2|||
27929550|NCT01182441|54585819|FG001|Overall Study|Adverse Event|0|||
27929551|NCT01182441|54585818|FG000|Overall Study|Physician Decision|1|||
27929552|NCT01182441|54585819|FG001|Overall Study|Physician Decision|1|||
27929553|NCT01182285|54585825|FG000|First Intervention Week 1-10|Disease progression|1|||
27929554|NCT01182285|54585826|FG001|First Intervention Week 1-10|Disease progression|0|||
27929555|NCT01182285|54585827|FG002|First Intervention Week 1-10|Disease progression|0|||
27929556|NCT01182285|54585825|FG000|First Intervention Week 1-10|Adverse Event|1|||
27929557|NCT01182285|54585826|FG001|First Intervention Week 1-10|Adverse Event|0|||
27929558|NCT01182285|54585827|FG002|First Intervention Week 1-10|Adverse Event|0|||
27929559|NCT01182285|54585825|FG000|First Intervention Week 1-10|Non-compliance|1|||
27929560|NCT01182285|54585826|FG001|First Intervention Week 1-10|Non-compliance|0|||
27929561|NCT01182285|54585827|FG002|First Intervention Week 1-10|Non-compliance|0|||
27929562|NCT01182285|54585825|FG000|Third Intervention Week 11-52|Disease Progression|0|||
27929563|NCT01182285|54585826|FG001|Third Intervention Week 11-52|Disease Progression|0|||
27929564|NCT01182285|54585827|FG002|Third Intervention Week 11-52|Disease Progression|6|||
27929565|NCT01182285|54585825|FG000|Third Intervention Week 11-52|Other|0|||
27929566|NCT01182285|54585826|FG001|Third Intervention Week 11-52|Other|0|||
27929567|NCT01182285|54585827|FG002|Third Intervention Week 11-52|Other|2|||
27929568|NCT01182207|54585836|FG000|First Intervention|Positive Hepatitis Results|0|||
27929569|NCT01182207|54585837|FG001|First Intervention|Positive Hepatitis Results|1|||
27929570|NCT01182207|54585836|FG000|Second Intervention|Emeses within 1 hour of dosing|1|||
27929571|NCT01182207|54585837|FG001|Second Intervention|Emeses within 1 hour of dosing|0|||
27929572|NCT01181895|54585846|FG000|Overall Study|Adverse Event|3|||
27929573|NCT01181895|54585847|FG001|Overall Study|Adverse Event|1|||
27929574|NCT01181895|54585848|FG002|Overall Study|Adverse Event|1|||
27929575|NCT01181895|54585846|FG000|Overall Study|Lack of Efficacy|8|||
27929576|NCT01181895|54585847|FG001|Overall Study|Lack of Efficacy|9|||
27929577|NCT01181895|54585848|FG002|Overall Study|Lack of Efficacy|9|||
27929578|NCT01181895|54585846|FG000|Overall Study|Protocol Violation|2|||
27929579|NCT01181895|54585847|FG001|Overall Study|Protocol Violation|1|||
27929580|NCT01181895|54585848|FG002|Overall Study|Protocol Violation|0|||
27929581|NCT01181895|54585846|FG000|Overall Study|Lost to Follow-up|0|||
27929582|NCT01181895|54585847|FG001|Overall Study|Lost to Follow-up|1|||
27929583|NCT01181895|54585848|FG002|Overall Study|Lost to Follow-up|2|||
27929584|NCT01181895|54585846|FG000|Overall Study|Investigator Discretion|1|||
27929585|NCT01181895|54585847|FG001|Overall Study|Investigator Discretion|2|||
27929586|NCT01181895|54585848|FG002|Overall Study|Investigator Discretion|1|||
27929587|NCT01181895|54585846|FG000|Overall Study|Withdrawal by Subject|3|||
27929588|NCT01181895|54585847|FG001|Overall Study|Withdrawal by Subject|0|||
27929589|NCT01181895|54585848|FG002|Overall Study|Withdrawal by Subject|5|||
27929590|NCT01181271|54585856|FG000|Evaluation for Allogeneic Transplant|Lack of Efficacy|6|||
27929591|NCT01181271|54585856|FG000|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4|||
27929592|NCT01181271|54585856|FG000|Evaluation for Allogeneic Transplant|No suitable donor|2|||
27929593|NCT01181271|54585856|FG000|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1|||
27929594|NCT01180647|54585862|FG000|Overall Study|Lost to Follow-up|5|||
27929595|NCT01180647|54585863|FG001|Overall Study|Lost to Follow-up|6|||
27929596|NCT00969553|54585878|FG000|Overall Study|Progressive disease (PD)|2|||
27929597|NCT00969553|54585879|FG001|Overall Study|Progressive disease (PD)|2|||
27929598|NCT00969553|54585880|FG002|Overall Study|Progressive disease (PD)|6|||
27929599|NCT00969553|54585881|FG003|Overall Study|Progressive disease (PD)|9|||
27929600|NCT00969553|54585882|FG004|Overall Study|Progressive disease (PD)|2|||
27929601|NCT00969553|54585883|FG005|Overall Study|Progressive disease (PD)|4|||
27929602|NCT00969553|54585884|FG006|Overall Study|Progressive disease (PD)|2|||
27929603|NCT00969553|54585885|FG007|Overall Study|Progressive disease (PD)|12|||
27929604|NCT00969553|54585886|FG008|Overall Study|Progressive disease (PD)|3|||
27929605|NCT00969553|54585878|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
27929606|NCT00969553|54585879|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
27929607|NCT00969553|54585880|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
27929608|NCT00969553|54585881|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
27929609|NCT00969553|54585882|FG004|Overall Study|Dose limiting Toxicity (DLT)|1|||
27929610|NCT00969553|54585883|FG005|Overall Study|Dose limiting Toxicity (DLT)|0|||
27929611|NCT00969553|54585884|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
27929612|NCT00969553|54585885|FG007|Overall Study|Dose limiting Toxicity (DLT)|0|||
27929613|NCT00969553|54585886|FG008|Overall Study|Dose limiting Toxicity (DLT)|0|||
27929614|NCT00969553|54585878|FG000|Overall Study|Other Adverse Event|0|||
27929615|NCT00969553|54585879|FG001|Overall Study|Other Adverse Event|0|||
27929616|NCT00969553|54585880|FG002|Overall Study|Other Adverse Event|0|||
27929617|NCT00969553|54585881|FG003|Overall Study|Other Adverse Event|1|||
27929618|NCT00969553|54585882|FG004|Overall Study|Other Adverse Event|0|||
27929619|NCT00969553|54585883|FG005|Overall Study|Other Adverse Event|0|||
27929620|NCT00969553|54585884|FG006|Overall Study|Other Adverse Event|1|||
27929621|NCT00969553|54585885|FG007|Overall Study|Other Adverse Event|0|||
27929622|NCT00969553|54585886|FG008|Overall Study|Other Adverse Event|0|||
27929623|NCT00969553|54585878|FG000|Overall Study|Refused cont. medication|1|||
27929624|NCT00969553|54585879|FG001|Overall Study|Refused cont. medication|1|||
27929625|NCT00969553|54585880|FG002|Overall Study|Refused cont. medication|0|||
27929626|NCT00969553|54585881|FG003|Overall Study|Refused cont. medication|2|||
27929627|NCT00969553|54585882|FG004|Overall Study|Refused cont. medication|0|||
27929628|NCT00969553|54585883|FG005|Overall Study|Refused cont. medication|0|||
27929629|NCT00969553|54585884|FG006|Overall Study|Refused cont. medication|0|||
27929630|NCT00969553|54585885|FG007|Overall Study|Refused cont. medication|1|||
27929631|NCT00969553|54585886|FG008|Overall Study|Refused cont. medication|0|||
27929632|NCT00969553|54585878|FG000|Overall Study|Not specified above|0|||
27929633|NCT00969553|54585879|FG001|Overall Study|Not specified above|0|||
27929634|NCT00969553|54585880|FG002|Overall Study|Not specified above|0|||
27929635|NCT00969553|54585881|FG003|Overall Study|Not specified above|4|||
27929636|NCT00969553|54585882|FG004|Overall Study|Not specified above|0|||
27929637|NCT00969553|54585883|FG005|Overall Study|Not specified above|0|||
27786463|NCT02289950|54240951|FG000|Overall Study|Physician Decision|9|||
27929638|NCT00969553|54585884|FG006|Overall Study|Not specified above|1|||
27929639|NCT00969553|54585885|FG007|Overall Study|Not specified above|1|||
27929640|NCT00969553|54585886|FG008|Overall Study|Not specified above|0|||
27929641|NCT01179477|54585914|FG000|Overall Study|Death|542|||
27929642|NCT01179477|54585914|FG000|Overall Study|Unsuccessful implant|80|||
27929643|NCT01179477|54585914|FG000|Overall Study|Non-death withdrawal|438|||
27929644|NCT01179477|54585914|FG000|Overall Study|Did not complete final visit|27|||
27929645|NCT01179399|54585918|FG000|Overall Study|Adverse Event|1|||
27929646|NCT01179399|54585918|FG000|Overall Study|Lack of Efficacy|30|||
27929647|NCT01179399|54585918|FG000|Overall Study|Withdrawal by Subject|1|||
27929648|NCT01178853|54585924|FG000|Period 1 (Warfarin Titration)|INR Out of Range|1|||
27929649|NCT01178853|54585925|FG001|Period 1 (Warfarin Titration)|INR Out of Range|2|||
27929650|NCT01178853|54585924|FG000|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
27929651|NCT01178853|54585925|FG001|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
27929652|NCT01178853|54585924|FG000|Period 3 (Warfarin Titration)|Adverse Event|1|||
27929653|NCT01178853|54585925|FG001|Period 3 (Warfarin Titration)|Adverse Event|0|||
27929654|NCT01178853|54585924|FG000|Period 4 (Warfarin + Study Drug)|Adverse Event|0|||
27929655|NCT01178853|54585925|FG001|Period 4 (Warfarin + Study Drug)|Adverse Event|2|||
27929656|NCT01178853|54585924|FG000|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
27929657|NCT01178853|54585925|FG001|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
27929658|NCT01178385|54585933|FG000|Overall Study|Withdrawal by Subject|2|||
27929659|NCT01178385|54585934|FG001|Overall Study|Withdrawal by Subject|0|||
27929660|NCT01288976|54585943|FG000|Overall Study|Withdrawal by Subject|58|||
27929661|NCT01288976|54585944|FG001|Overall Study|Withdrawal by Subject|12|||
27929662|NCT01288976|54585945|FG002|Overall Study|Withdrawal by Subject|9|||
27929663|NCT01288976|54585943|FG000|Overall Study|Death|98|||
27929664|NCT01288976|54585944|FG001|Overall Study|Death|6|||
27929665|NCT01288976|54585945|FG002|Overall Study|Death|4|||
27929666|NCT01288976|54585943|FG000|Overall Study|Data unavailable|22|||
27929667|NCT01288976|54585944|FG001|Overall Study|Data unavailable|9|||
27929668|NCT01288976|54585945|FG002|Overall Study|Data unavailable|7|||
27929669|NCT00970489|54585953|FG000|Overall Study|Death/Withdrew/Criteria Violation|54|||
27929670|NCT00970489|54585954|FG001|Overall Study|Death/Withdrew/Criteria Violation|41|||
27929671|NCT00968617|54585960|FG000|Overall Study|Study terminated by sponsor|6|||
27929672|NCT00968539|54585966|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
27929673|NCT00968539|54585967|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
27929674|NCT00976573|54585976|FG000|Overall Study|Ineligible|0|||
27929675|NCT00976573|54585977|FG001|Overall Study|Ineligible|1|||
27929676|NCT00976573|54585976|FG000|Overall Study|Cancel prior to receiving treatment|4|||
27929677|NCT00976573|54585977|FG001|Overall Study|Cancel prior to receiving treatment|2|||
27929678|NCT03661723|54585985|FG000|Overall Study|Disease Progression|4|||
27929679|NCT03661723|54585986|FG001|Overall Study|Disease Progression|24|||
27929680|NCT03661723|54585987|FG002|Overall Study|Disease Progression|4|||
27929681|NCT03661723|54585988|FG003|Overall Study|Disease Progression|19|||
27929682|NCT03661723|54585985|FG000|Overall Study|Withdrawal by Subject|1|||
27929683|NCT03661723|54585986|FG001|Overall Study|Withdrawal by Subject|0|||
27929684|NCT03661723|54585987|FG002|Overall Study|Withdrawal by Subject|2|||
27929685|NCT03661723|54585988|FG003|Overall Study|Withdrawal by Subject|4|||
27929686|NCT03661723|54585985|FG000|Overall Study|Physician Decision|1|||
27929687|NCT03661723|54585986|FG001|Overall Study|Physician Decision|0|||
27929688|NCT03661723|54585987|FG002|Overall Study|Physician Decision|0|||
27929689|NCT03661723|54585988|FG003|Overall Study|Physician Decision|0|||
27929690|NCT03661723|54585985|FG000|Overall Study|Clinical Deterioration|0|||
27929691|NCT03661723|54585986|FG001|Overall Study|Clinical Deterioration|0|||
27929692|NCT03661723|54585987|FG002|Overall Study|Clinical Deterioration|0|||
27929693|NCT03661723|54585988|FG003|Overall Study|Clinical Deterioration|1|||
27929694|NCT00976495|54585997|FG000|Overall Study|Withdrawal by Subject|0|||
27929695|NCT00976495|54585998|FG001|Overall Study|Withdrawal by Subject|1|||
27929696|NCT00976495|54585999|FG002|Overall Study|Withdrawal by Subject|0|||
27929697|NCT01288430|54586017|FG000|Part 1|Progressive disease|2|||
27929698|NCT01288430|54586018|FG001|Part 1|Progressive disease|1|||
27929699|NCT01288430|54586019|FG002|Part 1|Progressive disease|1|||
27929700|NCT01288430|54586020|FG003|Part 1|Progressive disease|6|||
27929701|NCT01288430|54586021|FG004|Part 1|Progressive disease|2|||
27929702|NCT01288430|54586022|FG005|Part 1|Progressive disease|4|||
27929703|NCT01288430|54586023|FG006|Part 1|Progressive disease|2|||
27929704|NCT01288430|54586024|FG007|Part 1|Progressive disease|0|||
27929705|NCT01288430|54586025|FG008|Part 1|Progressive disease|0|||
27786464|NCT02289950|54240952|FG001|Overall Study|Physician Decision|3|||
27841484|NCT01452529|54329353|FG001|Run-in Period|Administrative|0|||
27841485|NCT01452529|54329354|FG002|Run-in Period|Administrative|0|||
27841486|NCT01452529|54329352|FG000|Run-in Period|Did not qualify for Double-Blind Phase|59|||
27841487|NCT01452529|54329353|FG001|Run-in Period|Did not qualify for Double-Blind Phase|0|||
27841488|NCT01452529|54329354|FG002|Run-in Period|Did not qualify for Double-Blind Phase|0|||
27841489|NCT01452529|54329352|FG000|Double-blind (DB) Period|Adverse Event|0|||
27841490|NCT01452529|54329353|FG001|Double-blind (DB) Period|Adverse Event|18|||
27841491|NCT01452529|54329354|FG002|Double-blind (DB) Period|Adverse Event|11|||
27841492|NCT01452529|54329352|FG000|Double-blind (DB) Period|Withdrawal by Subject|0|||
27841493|NCT01452529|54329353|FG001|Double-blind (DB) Period|Withdrawal by Subject|15|||
27841494|NCT01452529|54329354|FG002|Double-blind (DB) Period|Withdrawal by Subject|14|||
27841495|NCT01452529|54329352|FG000|Double-blind (DB) Period|Lost to Follow-up|0|||
27841496|NCT01452529|54329353|FG001|Double-blind (DB) Period|Lost to Follow-up|5|||
27929706|NCT01288430|54586026|FG009|Part 1|Progressive disease|0|||
27929707|NCT01288430|54586017|FG000|Part 1|Clinical disease progression|0|||
27929708|NCT01288430|54586018|FG001|Part 1|Clinical disease progression|0|||
27929709|NCT01288430|54586019|FG002|Part 1|Clinical disease progression|1|||
27929710|NCT01288430|54586020|FG003|Part 1|Clinical disease progression|0|||
27929711|NCT01288430|54586021|FG004|Part 1|Clinical disease progression|0|||
27929712|NCT01288430|54586022|FG005|Part 1|Clinical disease progression|2|||
27929713|NCT01288430|54586023|FG006|Part 1|Clinical disease progression|2|||
27929714|NCT01288430|54586024|FG007|Part 1|Clinical disease progression|0|||
27929715|NCT01288430|54586025|FG008|Part 1|Clinical disease progression|0|||
27929716|NCT01288430|54586026|FG009|Part 1|Clinical disease progression|0|||
27929717|NCT01288430|54586017|FG000|Part 1|Death due to disease progression|0|||
27929718|NCT01288430|54586018|FG001|Part 1|Death due to disease progression|0|||
27929719|NCT01288430|54586019|FG002|Part 1|Death due to disease progression|0|||
27929720|NCT01288430|54586020|FG003|Part 1|Death due to disease progression|0|||
27929721|NCT01288430|54586021|FG004|Part 1|Death due to disease progression|1|||
27929722|NCT01288430|54586022|FG005|Part 1|Death due to disease progression|0|||
27929723|NCT01288430|54586023|FG006|Part 1|Death due to disease progression|0|||
27929724|NCT01288430|54586024|FG007|Part 1|Death due to disease progression|0|||
27929725|NCT01288430|54586025|FG008|Part 1|Death due to disease progression|0|||
27929726|NCT01288430|54586026|FG009|Part 1|Death due to disease progression|0|||
27929727|NCT01288430|54586017|FG000|Part 1|Adverse Event|0|||
27929728|NCT01288430|54586018|FG001|Part 1|Adverse Event|0|||
27929729|NCT01288430|54586019|FG002|Part 1|Adverse Event|3|||
27929730|NCT01288430|54586020|FG003|Part 1|Adverse Event|1|||
27929731|NCT01288430|54586021|FG004|Part 1|Adverse Event|0|||
27929732|NCT01288430|54586022|FG005|Part 1|Adverse Event|0|||
27929733|NCT01288430|54586023|FG006|Part 1|Adverse Event|2|||
27929734|NCT01288430|54586024|FG007|Part 1|Adverse Event|0|||
27929735|NCT01288430|54586025|FG008|Part 1|Adverse Event|0|||
27929736|NCT01288430|54586026|FG009|Part 1|Adverse Event|0|||
27929737|NCT01288430|54586017|FG000|Part 1|Other|0|||
27929738|NCT01288430|54586018|FG001|Part 1|Other|2|||
27929739|NCT01288430|54586019|FG002|Part 1|Other|0|||
27929740|NCT01288430|54586020|FG003|Part 1|Other|0|||
27929741|NCT01288430|54586021|FG004|Part 1|Other|0|||
27929742|NCT01288430|54586022|FG005|Part 1|Other|0|||
27929743|NCT01288430|54586023|FG006|Part 1|Other|1|||
27929744|NCT01288430|54586024|FG007|Part 1|Other|0|||
27929745|NCT01288430|54586025|FG008|Part 1|Other|0|||
27929746|NCT01288430|54586026|FG009|Part 1|Other|0|||
27929747|NCT01288430|54586017|FG000|Part 2|Progressive disease|0|||
27929748|NCT01288430|54586018|FG001|Part 2|Progressive disease|0|||
27929749|NCT01288430|54586019|FG002|Part 2|Progressive disease|0|||
27929750|NCT01288430|54586020|FG003|Part 2|Progressive disease|0|||
27929751|NCT01288430|54586021|FG004|Part 2|Progressive disease|0|||
27929752|NCT01288430|54586022|FG005|Part 2|Progressive disease|0|||
27929753|NCT01288430|54586023|FG006|Part 2|Progressive disease|0|||
27929754|NCT01288430|54586024|FG007|Part 2|Progressive disease|8|||
27929755|NCT01288430|54586025|FG008|Part 2|Progressive disease|7|||
27929756|NCT01288430|54586026|FG009|Part 2|Progressive disease|2|||
27929757|NCT01288430|54586017|FG000|Part 2|Clinical disease progression|0|||
27929758|NCT01288430|54586018|FG001|Part 2|Clinical disease progression|0|||
27841497|NCT01452529|54329354|FG002|Double-blind (DB) Period|Lost to Follow-up|3|||
27841498|NCT01452529|54329352|FG000|Double-blind (DB) Period|Lack of Efficacy|0|||
27841499|NCT01452529|54329353|FG001|Double-blind (DB) Period|Lack of Efficacy|16|||
27841500|NCT01452529|54329354|FG002|Double-blind (DB) Period|Lack of Efficacy|44|||
27841501|NCT01452529|54329352|FG000|Double-blind (DB) Period|Confirmed or suspected diversion|0|||
27841502|NCT01452529|54329353|FG001|Double-blind (DB) Period|Confirmed or suspected diversion|2|||
27841503|NCT01452529|54329354|FG002|Double-blind (DB) Period|Confirmed or suspected diversion|3|||
27841504|NCT01452529|54329352|FG000|Double-blind (DB) Period|Administrative|0|||
27841505|NCT01452529|54329353|FG001|Double-blind (DB) Period|Administrative|11|||
27841506|NCT01452529|54329354|FG002|Double-blind (DB) Period|Administrative|7|||
27841507|NCT01560416|54329363|FG000|Randomized Phase|Crossover Participants|7|||
27841508|NCT01560416|54329364|FG001|Randomized Phase|Crossover Participants|0|||
27841509|NCT01685606|54329372|FG000|Overall Study|Withdrawal by Subject|1|||
27841510|NCT01685372|54329378|FG000|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3|||
27841511|NCT01685372|54329379|FG001|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4|||
27841512|NCT01685216|54329385|FG000|Overall Study|Did not receive study drug|1|||
27841513|NCT01685138|54329389|FG000|Overall Study|Lost to Follow-up|1|||
27841514|NCT01685138|54329389|FG000|Overall Study|Protocol Violation|1|||
27841515|NCT01685138|54329389|FG000|Overall Study|No longer requires treatment|1|||
27841516|NCT01685138|54329389|FG000|Overall Study|Subject/guardian decision|2|||
27841517|NCT01685138|54329389|FG000|Overall Study|Physician Decision|6|||
27841518|NCT01685138|54329389|FG000|Overall Study|Death|10|||
27841519|NCT01685138|54329389|FG000|Overall Study|Adverse Event|18|||
27841520|NCT01685138|54329389|FG000|Overall Study|Progressive disease|53|||
27929759|NCT01288430|54586019|FG002|Part 2|Clinical disease progression|0|||
27929760|NCT01288430|54586020|FG003|Part 2|Clinical disease progression|0|||
27929761|NCT01288430|54586021|FG004|Part 2|Clinical disease progression|0|||
27929762|NCT01288430|54586022|FG005|Part 2|Clinical disease progression|0|||
27929763|NCT01288430|54586023|FG006|Part 2|Clinical disease progression|0|||
27929764|NCT01288430|54586024|FG007|Part 2|Clinical disease progression|2|||
27929765|NCT01288430|54586025|FG008|Part 2|Clinical disease progression|0|||
27929766|NCT01288430|54586026|FG009|Part 2|Clinical disease progression|0|||
27929767|NCT01288430|54586017|FG000|Part 2|Withdrawal by Subject|0|||
27929768|NCT01288430|54586018|FG001|Part 2|Withdrawal by Subject|0|||
27929769|NCT01288430|54586019|FG002|Part 2|Withdrawal by Subject|0|||
27786465|NCT02289950|54240951|FG000|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|9|||
27929770|NCT01288430|54586020|FG003|Part 2|Withdrawal by Subject|0|||
27929771|NCT01288430|54586021|FG004|Part 2|Withdrawal by Subject|0|||
27929772|NCT01288430|54586022|FG005|Part 2|Withdrawal by Subject|0|||
27929773|NCT01288430|54586023|FG006|Part 2|Withdrawal by Subject|0|||
27929774|NCT01288430|54586024|FG007|Part 2|Withdrawal by Subject|1|||
27929775|NCT01288430|54586025|FG008|Part 2|Withdrawal by Subject|4|||
27929776|NCT01288430|54586026|FG009|Part 2|Withdrawal by Subject|0|||
27929777|NCT01288430|54586017|FG000|Part 2|Adverse Event|0|||
27929778|NCT01288430|54586018|FG001|Part 2|Adverse Event|0|||
27786466|NCT02289950|54240952|FG001|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|2|||
27786467|NCT02289950|54240951|FG000|Overall Study|Withdrawal by Subject|1|||
27786468|NCT02289950|54240952|FG001|Overall Study|Withdrawal by Subject|3|||
27929779|NCT01288430|54586019|FG002|Part 2|Adverse Event|0|||
27929780|NCT01288430|54586020|FG003|Part 2|Adverse Event|0|||
27929781|NCT01288430|54586021|FG004|Part 2|Adverse Event|0|||
27929782|NCT01288430|54586022|FG005|Part 2|Adverse Event|0|||
27929783|NCT01288430|54586023|FG006|Part 2|Adverse Event|0|||
27929784|NCT01288430|54586024|FG007|Part 2|Adverse Event|1|||
27929785|NCT01288430|54586025|FG008|Part 2|Adverse Event|1|||
27929786|NCT01288430|54586026|FG009|Part 2|Adverse Event|0|||
27929787|NCT01288430|54586017|FG000|Part 2|Other|0|||
27929788|NCT01288430|54586018|FG001|Part 2|Other|0|||
27929789|NCT01288430|54586019|FG002|Part 2|Other|0|||
27929790|NCT01288430|54586020|FG003|Part 2|Other|0|||
27929791|NCT01288430|54586021|FG004|Part 2|Other|0|||
27929792|NCT01288430|54586022|FG005|Part 2|Other|0|||
27929793|NCT01288430|54586023|FG006|Part 2|Other|0|||
27929794|NCT01288430|54586024|FG007|Part 2|Other|0|||
27929795|NCT01288430|54586025|FG008|Part 2|Other|0|||
27929796|NCT01288430|54586026|FG009|Part 2|Other|1|||
27929797|NCT01287416|54586055|FG000|Pre-post Training|Withdrawal by Subject|17|||
27929798|NCT01287416|54586056|FG001|Pre-post Training|Withdrawal by Subject|24|||
27929799|NCT01287416|54586055|FG000|Pre-post Training|Lost to Follow-up|5|||
27929800|NCT01287416|54586056|FG001|Pre-post Training|Lost to Follow-up|1|||
27929801|NCT01287416|54586055|FG000|6 Month Follow-up|Lost to Follow-up|3|||
27929802|NCT01287416|54586056|FG001|6 Month Follow-up|Lost to Follow-up|2|||
27929803|NCT00998296|54586073|FG000|Overall Study|Progressive disease|0|||
27929804|NCT00998296|54586074|FG001|Overall Study|Progressive disease|1|||
27929805|NCT00998296|54586075|FG002|Overall Study|Progressive disease|0|||
27929806|NCT00998296|54586076|FG003|Overall Study|Progressive disease|0|||
27929807|NCT00998296|54586077|FG004|Overall Study|Progressive disease|0|||
27929808|NCT00998296|54586078|FG005|Overall Study|Progressive disease|0|||
27786469|NCT02289950|54240951|FG000|Overall Study|Test article held for greater than 28 days|0|||
27841521|NCT01685060|54329393|FG000|Overall Study|Rollover patients|16|||
27929809|NCT00998296|54586079|FG006|Overall Study|Progressive disease|1|||
27929810|NCT00998296|54586080|FG007|Overall Study|Progressive disease|0|||
27929811|NCT00998296|54586081|FG008|Overall Study|Progressive disease|0|||
27929812|NCT00998296|54586082|FG009|Overall Study|Progressive disease|14|||
27929813|NCT00998296|54586083|FG010|Overall Study|Progressive disease|5|||
27929814|NCT00998296|54586073|FG000|Overall Study|Dose limiting or dose reducing toxicity|0|||
27929815|NCT00998296|54586074|FG001|Overall Study|Dose limiting or dose reducing toxicity|0|||
27929816|NCT00998296|54586075|FG002|Overall Study|Dose limiting or dose reducing toxicity|0|||
27841522|NCT01685060|54329393|FG000|Overall Study|Adverse Event|12|||
27929817|NCT00998296|54586076|FG003|Overall Study|Dose limiting or dose reducing toxicity|0|||
27929818|NCT00998296|54586077|FG004|Overall Study|Dose limiting or dose reducing toxicity|1|||
27929819|NCT00998296|54586078|FG005|Overall Study|Dose limiting or dose reducing toxicity|0|||
27929820|NCT00998296|54586079|FG006|Overall Study|Dose limiting or dose reducing toxicity|0|||
27841523|NCT01685060|54329393|FG000|Overall Study|Progressive disease|69|||
27841524|NCT01685060|54329393|FG000|Overall Study|Physician Decision|14|||
27841525|NCT01685060|54329393|FG000|Overall Study|Subject/guardian decision|20|||
27841526|NCT01685060|54329393|FG000|Overall Study|Lost to Follow-up|1|||
27841527|NCT01685060|54329393|FG000|Overall Study|Death|8|||
27841528|NCT01582100|54329397|FG000|Overall Study|Adverse Event|1|||
27841529|NCT01582100|54329397|FG000|Overall Study|Withdrawal by Subject|1|||
27841530|NCT01579916|54329403|FG000|Overall Study|Lost to Follow-up|6|||
27841531|NCT01579916|54329404|FG001|Overall Study|Lost to Follow-up|1|||
27841532|NCT01579916|54329403|FG000|Overall Study|Withdrawal by Subject|1|||
27841533|NCT01579916|54329404|FG001|Overall Study|Withdrawal by Subject|1|||
27841534|NCT01579916|54329403|FG000|Overall Study|Death|1|||
27929821|NCT00998296|54586080|FG007|Overall Study|Dose limiting or dose reducing toxicity|2|||
27929822|NCT00998296|54586081|FG008|Overall Study|Dose limiting or dose reducing toxicity|2|||
27929823|NCT00998296|54586082|FG009|Overall Study|Dose limiting or dose reducing toxicity|0|||
27929824|NCT00998296|54586083|FG010|Overall Study|Dose limiting or dose reducing toxicity|0|||
27929825|NCT00998296|54586073|FG000|Overall Study|Other adverse event|0|||
27929826|NCT00998296|54586074|FG001|Overall Study|Other adverse event|0|||
27929827|NCT00998296|54586075|FG002|Overall Study|Other adverse event|0|||
27929828|NCT00998296|54586076|FG003|Overall Study|Other adverse event|0|||
27929829|NCT00998296|54586077|FG004|Overall Study|Other adverse event|1|||
27929830|NCT00998296|54586078|FG005|Overall Study|Other adverse event|0|||
27929831|NCT00998296|54586079|FG006|Overall Study|Other adverse event|0|||
27929832|NCT00998296|54586080|FG007|Overall Study|Other adverse event|0|||
27929833|NCT00998296|54586081|FG008|Overall Study|Other adverse event|0|||
27929834|NCT00998296|54586082|FG009|Overall Study|Other adverse event|1|||
27929835|NCT00998296|54586083|FG010|Overall Study|Other adverse event|2|||
27929836|NCT00998296|54586073|FG000|Overall Study|Refused to continue taking trial med.|0|||
27929837|NCT00998296|54586074|FG001|Overall Study|Refused to continue taking trial med.|0|||
27929838|NCT00998296|54586075|FG002|Overall Study|Refused to continue taking trial med.|0|||
27929839|NCT00998296|54586076|FG003|Overall Study|Refused to continue taking trial med.|0|||
27929840|NCT00998296|54586077|FG004|Overall Study|Refused to continue taking trial med.|0|||
27929841|NCT00998296|54586078|FG005|Overall Study|Refused to continue taking trial med.|0|||
27929842|NCT00998296|54586079|FG006|Overall Study|Refused to continue taking trial med.|0|||
27929843|NCT00998296|54586080|FG007|Overall Study|Refused to continue taking trial med.|0|||
27929844|NCT00998296|54586081|FG008|Overall Study|Refused to continue taking trial med.|0|||
27929845|NCT00998296|54586082|FG009|Overall Study|Refused to continue taking trial med.|2|||
27929846|NCT00998296|54586083|FG010|Overall Study|Refused to continue taking trial med.|0|||
27929847|NCT00998296|54586073|FG000|Overall Study|Reason other than those specified above|0|||
27929848|NCT00998296|54586074|FG001|Overall Study|Reason other than those specified above|0|||
27929849|NCT00998296|54586075|FG002|Overall Study|Reason other than those specified above|0|||
27929850|NCT00998296|54586076|FG003|Overall Study|Reason other than those specified above|0|||
27929851|NCT00998296|54586077|FG004|Overall Study|Reason other than those specified above|0|||
27929852|NCT00998296|54586078|FG005|Overall Study|Reason other than those specified above|0|||
27929853|NCT00998296|54586079|FG006|Overall Study|Reason other than those specified above|0|||
27929854|NCT00998296|54586080|FG007|Overall Study|Reason other than those specified above|0|||
27841535|NCT01579916|54329404|FG001|Overall Study|Death|0|||
27841536|NCT01684202|54329414|FG000|Dose-escalation Period|Adverse Event|0|||
27841537|NCT01684202|54329415|FG001|Dose-escalation Period|Adverse Event|1|||
27841538|NCT01684202|54329416|FG002|Dose-escalation Period|Adverse Event|0|||
27841539|NCT01684202|54329417|FG003|Dose-escalation Period|Adverse Event|0|||
27841540|NCT01684202|54329414|FG000|Dose-escalation Period|Withdrawal by Subject|1|||
27841541|NCT01684202|54329415|FG001|Dose-escalation Period|Withdrawal by Subject|0|||
27841542|NCT01684202|54329416|FG002|Dose-escalation Period|Withdrawal by Subject|0|||
27841543|NCT01684202|54329417|FG003|Dose-escalation Period|Withdrawal by Subject|0|||
27929855|NCT00998296|54586081|FG008|Overall Study|Reason other than those specified above|0|||
27929856|NCT00998296|54586082|FG009|Overall Study|Reason other than those specified above|1|||
27929857|NCT00998296|54586083|FG010|Overall Study|Reason other than those specified above|0|||
27929858|NCT01178073|54586115|FG000|Overall Study|Adverse Event|34|||
27929859|NCT01178073|54586116|FG001|Overall Study|Adverse Event|27|||
27929860|NCT01178073|54586117|FG002|Overall Study|Adverse Event|24|||
27929861|NCT01178073|54586115|FG000|Overall Study|Protocol Violation|1|||
27929862|NCT01178073|54586116|FG001|Overall Study|Protocol Violation|1|||
27929863|NCT01178073|54586117|FG002|Overall Study|Protocol Violation|1|||
27929864|NCT01178073|54586115|FG000|Overall Study|Lost to Follow-up|2|||
27929865|NCT01178073|54586116|FG001|Overall Study|Lost to Follow-up|0|||
27929866|NCT01178073|54586117|FG002|Overall Study|Lost to Follow-up|3|||
27929867|NCT01178073|54586115|FG000|Overall Study|Physician Decision|14|||
27929868|NCT01178073|54586116|FG001|Overall Study|Physician Decision|10|||
27929869|NCT01178073|54586117|FG002|Overall Study|Physician Decision|10|||
27929870|NCT01178073|54586115|FG000|Overall Study|Withdrawal by Subject|10|||
27929871|NCT01178073|54586116|FG001|Overall Study|Withdrawal by Subject|6|||
27786470|NCT02289950|54240952|FG001|Overall Study|Test article held for greater than 28 days|1|||
27786471|NCT02289950|54240951|FG000|Overall Study|Adverse Event|11|||
27786472|NCT02289950|54240952|FG001|Overall Study|Adverse Event|3|||
27786473|NCT02289950|54240951|FG000|Overall Study|Death|1|||
27786474|NCT02289950|54240952|FG001|Overall Study|Death|1|||
27786475|NCT02289950|54240951|FG000|Overall Study|Other|5|||
27929872|NCT01178073|54586117|FG002|Overall Study|Withdrawal by Subject|8|||
27929873|NCT01178073|54586115|FG000|Overall Study|Missing Completion Status|1|||
27786476|NCT02289950|54240952|FG001|Overall Study|Other|2|||
27786477|NCT02289950|54240951|FG000|Overall Study|Not Treated|2|||
27786478|NCT02289950|54240952|FG001|Overall Study|Not Treated|1|||
27786479|NCT01741012|54240958|FG000|Overall Study|Lost to Follow-up|1|||
27786480|NCT01741012|54240958|FG000|Overall Study|Withdrawal by Subject|2|||
27786481|NCT02288312|54240966|FG000|Overall Study|Pregnancy|1|||
27786482|NCT02288312|54240967|FG001|Overall Study|Pregnancy|0|||
27786483|NCT02288312|54240968|FG002|Overall Study|Pregnancy|0|||
27786484|NCT01740388|54240978|FG000|Overall Study|Withdrawal by Subject|1|||
27786485|NCT01740388|54240979|FG001|Overall Study|Withdrawal by Subject|2|||
27786486|NCT01740388|54240978|FG000|Overall Study|Lost to Follow-up|2|||
27786487|NCT01740388|54240979|FG001|Overall Study|Lost to Follow-up|0|||
27786488|NCT01740388|54240978|FG000|Overall Study|Physician Decision|2|||
27929874|NCT01178073|54586116|FG001|Overall Study|Missing Completion Status|0|||
27929875|NCT01178073|54586117|FG002|Overall Study|Missing Completion Status|0|||
27929876|NCT00997984|54586129|FG000|Overall Study|Adverse Event|1|||
27929877|NCT00997984|54586130|FG001|Overall Study|Adverse Event|8|||
27929878|NCT00997984|54586131|FG002|Overall Study|Adverse Event|8|||
27929879|NCT00997984|54586129|FG000|Overall Study|Protocol Violation|1|||
27929880|NCT00997984|54586130|FG001|Overall Study|Protocol Violation|3|||
27929881|NCT00997984|54586131|FG002|Overall Study|Protocol Violation|0|||
27929882|NCT00997984|54586129|FG000|Overall Study|Withdrawal by Subject|6|||
27929883|NCT00997984|54586130|FG001|Overall Study|Withdrawal by Subject|9|||
27929884|NCT00997984|54586131|FG002|Overall Study|Withdrawal by Subject|5|||
27929885|NCT00997984|54586129|FG000|Overall Study|Lost to Follow-up|8|||
27929886|NCT00997984|54586130|FG001|Overall Study|Lost to Follow-up|5|||
27929887|NCT00997984|54586131|FG002|Overall Study|Lost to Follow-up|4|||
27929888|NCT00997984|54586129|FG000|Overall Study|Lack of Efficacy|20|||
27929889|NCT00997984|54586130|FG001|Overall Study|Lack of Efficacy|6|||
27929890|NCT00997984|54586131|FG002|Overall Study|Lack of Efficacy|3|||
27929891|NCT00997984|54586129|FG000|Overall Study|Met exclusion criteria|1|||
27929892|NCT00997984|54586130|FG001|Overall Study|Met exclusion criteria|0|||
27929893|NCT00997984|54586131|FG002|Overall Study|Met exclusion criteria|0|||
27929894|NCT00997984|54586129|FG000|Overall Study|non-compliance|0|||
27929895|NCT00997984|54586130|FG001|Overall Study|non-compliance|2|||
27929896|NCT00997984|54586131|FG002|Overall Study|non-compliance|3|||
27929897|NCT00997984|54586129|FG000|Overall Study|Wrong medication dispensed|0|||
27929898|NCT00997984|54586130|FG001|Overall Study|Wrong medication dispensed|1|||
27929899|NCT00997984|54586131|FG002|Overall Study|Wrong medication dispensed|0|||
27786489|NCT01740388|54240979|FG001|Overall Study|Physician Decision|6|||
27786490|NCT01740388|54240978|FG000|Overall Study|Subjects missing data, completed|41|||
27786491|NCT01740388|54240979|FG001|Overall Study|Subjects missing data, completed|36|||
27929900|NCT00997984|54586129|FG000|Overall Study|Suicidal ideation|0|||
27929901|NCT00997984|54586130|FG001|Overall Study|Suicidal ideation|0|||
27929902|NCT00997984|54586131|FG002|Overall Study|Suicidal ideation|1|||
27929903|NCT00997984|54586129|FG000|Overall Study|Work schedule|0|||
27929904|NCT00997984|54586130|FG001|Overall Study|Work schedule|0|||
27929905|NCT00997984|54586131|FG002|Overall Study|Work schedule|2|||
27929906|NCT01177293|54586141|FG000|Washout Period (of 14 Days)|Lost to Follow-up|0|||
27929907|NCT01177293|54586142|FG001|Washout Period (of 14 Days)|Lost to Follow-up|1|||
27929908|NCT01177137|54586151|FG000|Overall Study|Withdrawal by Subject|10|||
27929909|NCT01177137|54586152|FG001|Overall Study|Withdrawal by Subject|10|||
27929910|NCT01177137|54586153|FG002|Overall Study|Withdrawal by Subject|2|||
27786492|NCT01740154|54240985|FG000|Overall Study|Adverse Event|1|||
27929911|NCT01177059|54586164|FG000|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30|||
27929912|NCT01177059|54586164|FG000|Overall Study|Withdrew consent|2|||
27929913|NCT01177059|54586164|FG000|Overall Study|Lost to Follow-up|18|||
27929914|NCT01176513|54586168|FG000|Overall Study|Withdrew subjects prior to dosing|3|||
27929915|NCT01299389|54586174|FG000|Double-blind|Adverse Event|45|||
27929916|NCT01299389|54586175|FG001|Double-blind|Adverse Event|27|||
27929917|NCT01299389|54586176|FG002|Double-blind|Adverse Event|0|||
27929918|NCT01299389|54586177|FG003|Double-blind|Adverse Event|0|||
27929919|NCT01299389|54586174|FG000|Double-blind|Lack of Efficacy|45|||
27929920|NCT01299389|54586175|FG001|Double-blind|Lack of Efficacy|21|||
27929921|NCT01299389|54586176|FG002|Double-blind|Lack of Efficacy|0|||
27929922|NCT01299389|54586177|FG003|Double-blind|Lack of Efficacy|0|||
27929923|NCT01299389|54586174|FG000|Double-blind|Lost to Follow-up|2|||
27929924|NCT01299389|54586175|FG001|Double-blind|Lost to Follow-up|1|||
27929925|NCT01299389|54586176|FG002|Double-blind|Lost to Follow-up|0|||
27929926|NCT01299389|54586177|FG003|Double-blind|Lost to Follow-up|0|||
27929927|NCT01299389|54586174|FG000|Double-blind|Withdrawal by Subject|16|||
27929928|NCT01299389|54586175|FG001|Double-blind|Withdrawal by Subject|13|||
27929929|NCT01299389|54586176|FG002|Double-blind|Withdrawal by Subject|0|||
27929930|NCT01299389|54586177|FG003|Double-blind|Withdrawal by Subject|0|||
27929931|NCT01299389|54586174|FG000|Double-blind|Other|1|||
27929932|NCT01299389|54586175|FG001|Double-blind|Other|1|||
27929933|NCT01299389|54586176|FG002|Double-blind|Other|0|||
27929934|NCT01299389|54586177|FG003|Double-blind|Other|0|||
27929935|NCT01299389|54586174|FG000|Double-blind|"fail to meet study population criteria"|0|||
27929936|NCT01299389|54586175|FG001|Double-blind|"fail to meet study population criteria"|1|||
27929937|NCT01299389|54586176|FG002|Double-blind|"fail to meet study population criteria"|0|||
27786493|NCT02287922|54240993|FG000|Overall Study|Adverse Event|1|||
27786494|NCT02287922|54240994|FG001|Overall Study|Adverse Event|1|||
27786495|NCT02287922|54240995|FG002|Overall Study|Adverse Event|3|||
27786496|NCT02287922|54240996|FG003|Overall Study|Adverse Event|4|||
27786497|NCT02287922|54240993|FG000|Overall Study|Withdrawal by Subject|1|||
27786498|NCT02287922|54240994|FG001|Overall Study|Withdrawal by Subject|1|||
27786499|NCT02287922|54240995|FG002|Overall Study|Withdrawal by Subject|1|||
27786500|NCT02287922|54240996|FG003|Overall Study|Withdrawal by Subject|2|||
27786501|NCT02287922|54240993|FG000|Overall Study|Lost to Follow-up|0|||
27786502|NCT02287922|54240994|FG001|Overall Study|Lost to Follow-up|0|||
27786503|NCT02287922|54240995|FG002|Overall Study|Lost to Follow-up|1|||
27786504|NCT02287922|54240996|FG003|Overall Study|Lost to Follow-up|0|||
27786505|NCT02287922|54240993|FG000|Overall Study|Sponsor's decision|0|||
27786506|NCT02287922|54240994|FG001|Overall Study|Sponsor's decision|0|||
27786507|NCT02287922|54240995|FG002|Overall Study|Sponsor's decision|0|||
27786508|NCT02287922|54240996|FG003|Overall Study|Sponsor's decision|1|||
27786509|NCT02287922|54240993|FG000|Overall Study|Other|1|||
27786510|NCT02287922|54240994|FG001|Overall Study|Other|0|||
27786511|NCT02287922|54240995|FG002|Overall Study|Other|2|||
27786512|NCT02287922|54240996|FG003|Overall Study|Other|0|||
27786513|NCT02287610|54241007|FG000|Overall Study|Lost to Follow-up|3|||
27786514|NCT02287610|54241007|FG000|Overall Study|Withdrawal by Subject|8|||
27786515|NCT02287610|54241007|FG000|Overall Study|Excluded-investigator non-responsiveness|5|||
27786516|NCT02262728|54241013|FG000|Follow-up Phase (3 Years)|Death|0|||
27786517|NCT02262728|54241014|FG001|Follow-up Phase (3 Years)|Death|1|||
27786518|NCT02262728|54241013|FG000|Follow-up Phase (3 Years)|Lost to Follow-up|4|||
27786519|NCT02262728|54241014|FG001|Follow-up Phase (3 Years)|Lost to Follow-up|1|||
27786520|NCT02262728|54241013|FG000|Follow-up Phase (3 Years)|Withdrawal by Subject|0|||
27786521|NCT02262728|54241014|FG001|Follow-up Phase (3 Years)|Withdrawal by Subject|1|||
27786522|NCT02262260|54241022|FG000|Overall Study|Adverse Event|4|||
27929938|NCT01299389|54586177|FG003|Double-blind|"fail to meet study population criteria"|0|||
27929939|NCT01299389|54586174|FG000|Post-observational|Other|0|||
27929940|NCT01299389|54586175|FG001|Post-observational|Other|0|||
27929941|NCT01299389|54586176|FG002|Post-observational|Other|12|||
27929942|NCT01299389|54586177|FG003|Post-observational|Other|6|||
27929943|NCT01298999|54586188|FG000|Overall Study|Physician Decision|0|||
27929944|NCT01298999|54586189|FG001|Overall Study|Physician Decision|1|||
27929945|NCT01298999|54586188|FG000|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|3|||
27786523|NCT02262260|54241023|FG001|Overall Study|Adverse Event|1|||
27786524|NCT02262260|54241022|FG000|Overall Study|Withdrawal of consent|4|||
27929946|NCT01298999|54586189|FG001|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|0|||
27929947|NCT01007032|54586199|FG000|Overall Study|On Study Treatment at Cut-off Date|0|||
27786525|NCT02262260|54241023|FG001|Overall Study|Withdrawal of consent|2|||
27929948|NCT01007032|54586200|FG001|Overall Study|On Study Treatment at Cut-off Date|1|||
27929949|NCT01007032|54586201|FG002|Overall Study|On Study Treatment at Cut-off Date|1|||
27929950|NCT01007032|54586202|FG003|Overall Study|On Study Treatment at Cut-off Date|0|||
27929951|NCT01007032|54586199|FG000|Overall Study|Withdrawal by Subject|0|||
27929952|NCT01007032|54586200|FG001|Overall Study|Withdrawal by Subject|0|||
27929953|NCT01007032|54586201|FG002|Overall Study|Withdrawal by Subject|0|||
27929954|NCT01007032|54586202|FG003|Overall Study|Withdrawal by Subject|1|||
27929955|NCT00976027|54586219|FG000|Overall Study|Serious Adverse Event|36|||
27929956|NCT00976027|54586220|FG001|Overall Study|Serious Adverse Event|17|||
27929957|NCT00976027|54586219|FG000|Overall Study|Adverse Event|0|||
27929958|NCT00976027|54586220|FG001|Overall Study|Adverse Event|2|||
27929959|NCT00976027|54586219|FG000|Overall Study|Protocol Violation|60|||
27929960|NCT00976027|54586220|FG001|Overall Study|Protocol Violation|27|||
27929961|NCT00976027|54586219|FG000|Overall Study|Lost to Follow-up|208|||
27929962|NCT00976027|54586220|FG001|Overall Study|Lost to Follow-up|103|||
27929963|NCT00976027|54586219|FG000|Overall Study|Withdrawal by Subject|107|||
27929964|NCT00976027|54586220|FG001|Overall Study|Withdrawal by Subject|66|||
27929965|NCT01298765|54586226|FG000|Titration Period|Adverse Event|26|||
27929966|NCT01298765|54586226|FG000|Titration Period|Death|1|||
27929967|NCT01298765|54586226|FG000|Titration Period|Lack of Efficacy|21|||
27929968|NCT01298765|54586226|FG000|Titration Period|Lost to Follow-up|9|||
27929969|NCT01298765|54586226|FG000|Titration Period|Physician Decision|1|||
27929970|NCT01298765|54586226|FG000|Titration Period|Withdrawal by Subject|10|||
27929971|NCT01298765|54586226|FG000|Titration Period|Other: Not Lack of Analgesic Effect|8|||
27929972|NCT01298765|54586226|FG000|Long-Term Treatment Period|Adverse Event|19|||
27929973|NCT01298765|54586226|FG000|Long-Term Treatment Period|Lack of Efficacy|6|||
27929974|NCT01298765|54586226|FG000|Long-Term Treatment Period|Lost to Follow-up|8|||
27929975|NCT01298765|54586226|FG000|Long-Term Treatment Period|Withdrawal by Subject|19|||
27929976|NCT01298765|54586226|FG000|Long-Term Treatment Period|Physician Decision|1|||
27929977|NCT01298765|54586226|FG000|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46|||
27943428|NCT01179737|54600361|FG003|Cohort 1 & Cohort 2|Withdrew consent|0|||
27943429|NCT01179737|54600358|FG000|Cohort 1 & Cohort 2|Administrative problems|0|||
27943430|NCT01179737|54600359|FG001|Cohort 1 & Cohort 2|Administrative problems|0|||
27943431|NCT01179737|54600360|FG002|Cohort 1 & Cohort 2|Administrative problems|2|||
27943432|NCT01179737|54600361|FG003|Cohort 1 & Cohort 2|Administrative problems|4|||
27943433|NCT01179737|54600358|FG000|Cohort 1 & Cohort 2|Death|0|||
27943434|NCT01179737|54600359|FG001|Cohort 1 & Cohort 2|Death|0|||
27943435|NCT01179737|54600360|FG002|Cohort 1 & Cohort 2|Death|1|||
27943436|NCT01179737|54600361|FG003|Cohort 1 & Cohort 2|Death|0|||
27943437|NCT01179737|54600358|FG000|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
27943438|NCT01179737|54600359|FG001|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1|||
27943439|NCT01179737|54600360|FG002|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
27943440|NCT01179737|54600361|FG003|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
27943441|NCT01179737|54600358|FG000|Cohort 1 & Cohort 2 Expansion|Death|1|||
27943442|NCT01179737|54600359|FG001|Cohort 1 & Cohort 2 Expansion|Death|0|||
27943443|NCT01179737|54600360|FG002|Cohort 1 & Cohort 2 Expansion|Death|0|||
27943444|NCT01179737|54600361|FG003|Cohort 1 & Cohort 2 Expansion|Death|0|||
27943445|NCT01179737|54600358|FG000|Extension|The study was terminated|3|||
27943446|NCT01179737|54600359|FG001|Extension|The study was terminated|0|||
27943447|NCT01179737|54600360|FG002|Extension|The study was terminated|0|||
27943448|NCT01179737|54600361|FG003|Extension|The study was terminated|0|||
27943449|NCT00929110|54600373|FG000|Overall Study|Adverse Event|40|||
27943450|NCT00929110|54600374|FG001|Overall Study|Adverse Event|29|||
27943451|NCT00929110|54600375|FG002|Overall Study|Adverse Event|18|||
27943452|NCT00929110|54600373|FG000|Overall Study|Subject withdrew consent|40|||
27943453|NCT00929110|54600374|FG001|Overall Study|Subject withdrew consent|23|||
27943454|NCT00929110|54600375|FG002|Overall Study|Subject withdrew consent|26|||
27943455|NCT00929110|54600373|FG000|Overall Study|Unsatisfactory therapeutic effect|20|||
27943456|NCT00929110|54600374|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
27943457|NCT00929110|54600375|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
27943458|NCT00929110|54600373|FG000|Overall Study|Lost to Follow-up|7|||
27943459|NCT00929110|54600374|FG001|Overall Study|Lost to Follow-up|7|||
27943460|NCT00929110|54600375|FG002|Overall Study|Lost to Follow-up|3|||
27943461|NCT00929110|54600373|FG000|Overall Study|Protocol deviation|5|||
27943462|NCT00929110|54600374|FG001|Overall Study|Protocol deviation|2|||
27943463|NCT00929110|54600375|FG002|Overall Study|Protocol deviation|4|||
27943464|NCT00929110|54600373|FG000|Overall Study|Administrative problems|4|||
27943465|NCT00929110|54600374|FG001|Overall Study|Administrative problems|1|||
27943466|NCT00929110|54600375|FG002|Overall Study|Administrative problems|2|||
27943467|NCT00929110|54600373|FG000|Overall Study|Death|2|||
27943468|NCT00929110|54600374|FG001|Overall Study|Death|2|||
27943469|NCT00929110|54600375|FG002|Overall Study|Death|2|||
27786526|NCT02262260|54241022|FG000|Overall Study|Lost to Follow-up|1|||
27943470|NCT00929110|54600373|FG000|Overall Study|Abnormal laboratory value(s)|0|||
27943471|NCT00929110|54600374|FG001|Overall Study|Abnormal laboratory value(s)|1|||
27943472|NCT00929110|54600375|FG002|Overall Study|Abnormal laboratory value(s)|0|||
27943473|NCT00929110|54600373|FG000|Overall Study|Abnormal test procedure result(s)|0|||
27943474|NCT00929110|54600374|FG001|Overall Study|Abnormal test procedure result(s)|1|||
27929978|NCT00997438|54586233|FG000|Overall Study|Blood draw difficulty|2|||
27929979|NCT00997438|54586234|FG001|Overall Study|Blood draw difficulty|0|||
27929980|NCT00997438|54586235|FG002|Overall Study|Blood draw difficulty|1|||
27929981|NCT00997438|54586233|FG000|Overall Study|Withdrawal by Subject|1|||
27929982|NCT00997438|54586234|FG001|Overall Study|Withdrawal by Subject|1|||
27929983|NCT00997438|54586235|FG002|Overall Study|Withdrawal by Subject|0|||
27929984|NCT00997438|54586233|FG000|Overall Study|Exclusion criteria at visit 1|2|||
27929985|NCT00997438|54586234|FG001|Overall Study|Exclusion criteria at visit 1|2|||
27929986|NCT00997438|54586235|FG002|Overall Study|Exclusion criteria at visit 1|3|||
27929987|NCT00997126|54586246|FG000|Overall Study|Physician Decision|7|||
27929988|NCT00997126|54586247|FG001|Overall Study|Physician Decision|11|||
27929989|NCT01000636|54586253|FG000|Overall Study|Withdrawal by Subject|1|||
27929990|NCT01000636|54586253|FG000|Overall Study|Adverse Event|1|||
27929991|NCT00965419|54586257|FG000|Open Label Treatment for Responders|Adverse Event|33|||
27929992|NCT00965419|54586257|FG000|Open Label Treatment for Responders|Entry Criteria Not Met|1|||
27929993|NCT00965419|54586257|FG000|Open Label Treatment for Responders|Protocol Violation|21|||
27929994|NCT00965419|54586257|FG000|Open Label Treatment for Responders|Withdrawal by Subject|27|||
27929995|NCT00965419|54586257|FG000|Open Label Treatment for Responders|Physician Decision|6|||
27929996|NCT00965419|54586257|FG000|Open Label Treatment for Responders|Sponsor Decision|5|||
27929997|NCT00965419|54586257|FG000|Open Label Treatment for Responders|Parent/Caregiver Decision|41|||
27929998|NCT00965419|54586257|FG000|Open Label Treatment for Responders|Lack of Efficacy|67|||
27929999|NCT00965419|54586257|FG000|Open Label Treatment for Responders|Lost to Follow-up|46|||
27930000|NCT00965419|54586257|FG000|Follow-up Phase|Adverse Event|9|||
27930001|NCT00965419|54586257|FG000|Follow-up Phase|Protocol Violation|4|||
27930002|NCT00965419|54586257|FG000|Follow-up Phase|Withdrawal by Subject|8|||
27930003|NCT00965419|54586257|FG000|Follow-up Phase|Physician Decision|4|||
27930004|NCT00965419|54586257|FG000|Follow-up Phase|Parent/Caregiver Decision|9|||
27930005|NCT00965419|54586257|FG000|Follow-up Phase|Lack of Efficacy|28|||
27930006|NCT01000480|54586262|FG000|Induction Phase|Adverse Event|2|||
27930007|NCT01000480|54586262|FG000|Induction Phase|Lost to Follow-up|1|||
27930008|NCT01000480|54586262|FG000|Induction Phase|Physician Decision|1|||
27930009|NCT01000480|54586262|FG000|Induction Phase|Entry Criteria Not Met|3|||
27930010|NCT01000480|54586262|FG000|Concurrent Therapy Phase|Adverse Event|4|||
27930011|NCT01000480|54586262|FG000|Concurrent Therapy Phase|Protocol Violation|2|||
27930012|NCT01000480|54586262|FG000|Concurrent Therapy Phase|Withdrawal by Subject|3|||
27930013|NCT01000480|54586262|FG000|Concurrent Therapy Phase|Physician Decision|1|||
27930014|NCT00965341|54586268|FG000|Overall Study|Withdrew consent|1|||
27930015|NCT00965341|54586269|FG001|Overall Study|Withdrew consent|5|||
27930016|NCT00965341|54586268|FG000|Overall Study|Lost to Follow-up|1|||
27930017|NCT00965341|54586269|FG001|Overall Study|Lost to Follow-up|0|||
27930018|NCT00965341|54586268|FG000|Overall Study|Transportation issues|4|||
27786527|NCT02262260|54241023|FG001|Overall Study|Lost to Follow-up|2|||
27786528|NCT02262260|54241022|FG000|Overall Study|Protocol deviation|2|||
27786529|NCT02262260|54241023|FG001|Overall Study|Protocol deviation|5|||
27786530|NCT02285270|54241029|FG000|Overall Study|Lost to Follow-up|1|||
27786531|NCT02285270|54241029|FG000|Overall Study|Physician Decision|3|||
27786532|NCT02285270|54241029|FG000|Overall Study|Determined to be ineligible|1|||
27786533|NCT01717768|54241043|FG000|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
27786534|NCT01717768|54241044|FG001|Part 1 (Duration of 15 Days)|Lost to Follow-up|1|||
27786535|NCT01717768|54241045|FG002|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
27786536|NCT01717768|54241046|FG003|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
27786537|NCT01717768|54241047|FG004|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
27786538|NCT01717768|54241048|FG005|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
27786539|NCT01717768|54241049|FG006|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
27786540|NCT01717768|54241050|FG007|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
27786541|NCT01717768|54241051|FG008|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
27786542|NCT01717768|54241052|FG009|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
27786543|NCT01717768|54241053|FG010|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
27786544|NCT01717768|54241054|FG011|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
27841544|NCT01684202|54329414|FG000|Maintenance Period|Adverse Event|1|||
27841545|NCT01684202|54329415|FG001|Maintenance Period|Adverse Event|1|||
27841546|NCT01684202|54329416|FG002|Maintenance Period|Adverse Event|1|||
27841547|NCT01684202|54329417|FG003|Maintenance Period|Adverse Event|1|||
27841548|NCT01684202|54329414|FG000|Maintenance Period|Physician Decision|0|||
27841549|NCT01684202|54329415|FG001|Maintenance Period|Physician Decision|1|||
27841550|NCT01684202|54329416|FG002|Maintenance Period|Physician Decision|0|||
27841551|NCT01684202|54329417|FG003|Maintenance Period|Physician Decision|0|||
27841552|NCT01684202|54329414|FG000|Maintenance Period|Withdrawal by Subject|0|||
27841553|NCT01684202|54329415|FG001|Maintenance Period|Withdrawal by Subject|1|||
27841554|NCT01684202|54329416|FG002|Maintenance Period|Withdrawal by Subject|0|||
27841555|NCT01684202|54329417|FG003|Maintenance Period|Withdrawal by Subject|0|||
27841556|NCT01684046|54329427|FG000|Period 1, First 30 Days|Adverse Event|0|||
27841557|NCT01684046|54329428|FG001|Period 1, First 30 Days|Adverse Event|2|||
27786545|NCT01717768|54241043|FG000|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
27786546|NCT01717768|54241044|FG001|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
27786547|NCT01717768|54241045|FG002|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
27786548|NCT01717768|54241046|FG003|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
27786549|NCT01717768|54241047|FG004|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
27786550|NCT01717768|54241048|FG005|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
27786551|NCT01717768|54241049|FG006|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
27786552|NCT01717768|54241050|FG007|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
27786553|NCT01717768|54241051|FG008|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
27786554|NCT01717768|54241052|FG009|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
27786555|NCT01717768|54241053|FG010|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
27786556|NCT01717768|54241054|FG011|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1|||
27786557|NCT01717768|54241043|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
27786558|NCT01717768|54241044|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
27786559|NCT01717768|54241045|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
27786560|NCT01717768|54241046|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
27786561|NCT01717768|54241047|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
27786562|NCT01717768|54241048|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
27786563|NCT01717768|54241049|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
27786564|NCT01717768|54241050|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2|||
27786565|NCT01717768|54241051|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
27786566|NCT01717768|54241052|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
27786567|NCT01717768|54241053|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
27786568|NCT01717768|54241054|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
27786569|NCT01717768|54241043|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
27786570|NCT01717768|54241044|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
27786571|NCT01717768|54241045|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
27786572|NCT01717768|54241046|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
27786573|NCT01717768|54241047|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
27786574|NCT01717768|54241048|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
27786575|NCT01717768|54241049|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
27786576|NCT01717768|54241050|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
27786577|NCT01717768|54241051|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
27786578|NCT01717768|54241052|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1|||
27786579|NCT01717768|54241053|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
27786580|NCT01717768|54241054|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
27786581|NCT02260934|54241082|FG000|Overall Study|Lost to Follow-up|2|||
27786582|NCT02260934|54241083|FG001|Overall Study|Lost to Follow-up|1|||
27786583|NCT02260934|54241082|FG000|Overall Study|Withdrawal by Subject|0|||
27786584|NCT02260934|54241083|FG001|Overall Study|Withdrawal by Subject|2|||
27930019|NCT00965341|54586269|FG001|Overall Study|Transportation issues|3|||
27930020|NCT01175811|54586277|FG000|Overall Study|Adverse Event|1|||
27930021|NCT01175811|54586278|FG001|Overall Study|Adverse Event|1|||
27930022|NCT01175811|54586277|FG000|Overall Study|Entry criteria not met|3|||
27930023|NCT01175811|54586278|FG001|Overall Study|Entry criteria not met|1|||
27930024|NCT01175811|54586277|FG000|Overall Study|Lack of Efficacy|1|||
27930025|NCT01175811|54586278|FG001|Overall Study|Lack of Efficacy|0|||
27930026|NCT01175811|54586277|FG000|Overall Study|Lost to Follow-up|3|||
27930027|NCT01175811|54586278|FG001|Overall Study|Lost to Follow-up|2|||
27930028|NCT01175811|54586277|FG000|Overall Study|Physician Decision|1|||
27930029|NCT01175811|54586278|FG001|Overall Study|Physician Decision|1|||
27930030|NCT01175811|54586277|FG000|Overall Study|Protocol Violation|1|||
27930031|NCT01175811|54586278|FG001|Overall Study|Protocol Violation|2|||
27930032|NCT01175811|54586277|FG000|Overall Study|Withdrawal by Subject|6|||
27930033|NCT01175811|54586278|FG001|Overall Study|Withdrawal by Subject|7|||
27930034|NCT00965263|54586286|FG000|Overall Study|Physician Decision|2|||
27930035|NCT00965263|54586287|FG001|Overall Study|Physician Decision|0|||
27930036|NCT00965263|54586286|FG000|Overall Study|Family emergency|0|||
27930037|NCT00965263|54586287|FG001|Overall Study|Family emergency|1|||
27930038|NCT00965263|54586286|FG000|Overall Study|Protocol Violation|0|||
27930039|NCT00965263|54586287|FG001|Overall Study|Protocol Violation|2|||
27930040|NCT00965185|54586313|FG000|Overall Study|Lost to Follow-up|2|||
27930041|NCT00965185|54586314|FG001|Overall Study|Lost to Follow-up|0|||
27930042|NCT00965185|54586313|FG000|Overall Study|Withdrawal by Subject|0|||
27930043|NCT00965185|54586314|FG001|Overall Study|Withdrawal by Subject|1|||
27930044|NCT01174563|54586322|FG000|Overall Study|Progressive Disease|45|||
27930045|NCT01174563|54586322|FG000|Overall Study|Death|5|||
27930046|NCT01174563|54586322|FG000|Overall Study|Investigator's Discretion|5|||
27930047|NCT01174563|54586322|FG000|Overall Study|Participant Withdrew Consent|3|||
27930048|NCT01174563|54586322|FG000|Overall Study|Rash Adverse Event|1|||
27930049|NCT01174563|54586322|FG000|Overall Study|Sponsor's decision|1|||
27930050|NCT01298531|54586328|FG000|Overall Study|Lack of Efficacy|0|||
27930051|NCT01298531|54586329|FG001|Overall Study|Lack of Efficacy|1|||
27930052|NCT01298531|54586328|FG000|Overall Study|Lost to Follow-up|2|||
27930053|NCT01298531|54586329|FG001|Overall Study|Lost to Follow-up|0|||
27930054|NCT01298531|54586328|FG000|Overall Study|Protocol Violation|1|||
27930055|NCT01298531|54586329|FG001|Overall Study|Protocol Violation|1|||
27930056|NCT01298531|54586328|FG000|Overall Study|Adverse Event|4|||
27930057|NCT01298531|54586329|FG001|Overall Study|Adverse Event|3|||
27930058|NCT01298531|54586328|FG000|Overall Study|Does not meet entrance criteria|0|||
27930059|NCT01298531|54586329|FG001|Overall Study|Does not meet entrance criteria|1|||
27930060|NCT01298531|54586328|FG000|Overall Study|Other|2|||
27930061|NCT01298531|54586329|FG001|Overall Study|Other|1|||
27930062|NCT01174173|54586336|FG000|Overall Study|drug-drug interaction|1|||
27930063|NCT00964795|54586341|FG000|Overall Study|Withdrawal by Subject|79|||
27930064|NCT00964795|54586341|FG000|Overall Study|Adverse Event|12|||
27930065|NCT00964795|54586341|FG000|Overall Study|Death|14|||
27930066|NCT00964795|54586341|FG000|Overall Study|Lost to Follow-up|7|||
27930067|NCT00964795|54586341|FG000|Overall Study|Termination of Study by Sponsor|169|||
27930068|NCT00964795|54586341|FG000|Overall Study|Unwilling to sign ICF for amendment 4|3|||
27930069|NCT00964795|54586341|FG000|Overall Study|Other|23|||
27930070|NCT01173471|54586350|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
27930071|NCT01173471|54586351|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
27930072|NCT01173471|54586352|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
27930073|NCT01173471|54586353|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
27930074|NCT01173471|54586350|FG000|Overall Study|Condition under investigation worsened|2|||
27930075|NCT01173471|54586351|FG001|Overall Study|Condition under investigation worsened|0|||
27930076|NCT01173471|54586352|FG002|Overall Study|Condition under investigation worsened|0|||
27930077|NCT01173471|54586353|FG003|Overall Study|Condition under investigation worsened|0|||
27930078|NCT01173471|54586350|FG000|Overall Study|Lost to Follow-up|0|||
27930079|NCT01173471|54586351|FG001|Overall Study|Lost to Follow-up|0|||
27930080|NCT01173471|54586352|FG002|Overall Study|Lost to Follow-up|1|||
27930081|NCT01173471|54586353|FG003|Overall Study|Lost to Follow-up|0|||
27930082|NCT01173471|54586350|FG000|Overall Study|Reason given as Other|0|||
27930083|NCT01173471|54586351|FG001|Overall Study|Reason given as Other|0|||
27930084|NCT01173471|54586352|FG002|Overall Study|Reason given as Other|1|||
27930085|NCT01173471|54586353|FG003|Overall Study|Reason given as Other|0|||
27930086|NCT01172847|54586363|FG000|Overall Study|Withdrawal by Subject|3|||
27930087|NCT00966355|54586376|FG000|Overall Study|non-variceal bleeding on endoscopy|68|||
27930088|NCT00966355|54586377|FG001|Overall Study|non-variceal bleeding on endoscopy|70|||
27930089|NCT00966355|54586378|FG002|Overall Study|non-variceal bleeding on endoscopy|71|||
27930090|NCT00966355|54586376|FG000|Overall Study|newly diagnosed advanced HCC|11|||
27930091|NCT00966355|54586377|FG001|Overall Study|newly diagnosed advanced HCC|12|||
27930092|NCT00966355|54586378|FG002|Overall Study|newly diagnosed advanced HCC|10|||
27930093|NCT00966355|54586376|FG000|Overall Study|Lost to Follow-up|5|||
27930094|NCT00966355|54586377|FG001|Overall Study|Lost to Follow-up|4|||
27930095|NCT00966355|54586378|FG002|Overall Study|Lost to Follow-up|3|||
27930096|NCT01172535|54586386|FG000|Overall Study|Death|3|||
27930097|NCT01172535|54586386|FG000|Overall Study|Withdrawal by Subject|2|||
27930098|NCT01172535|54586386|FG000|Overall Study|Lost to Follow-up|1|||
27930099|NCT01172535|54586386|FG000|Overall Study|Ineligible at study entry|1|||
27930100|NCT01172535|54586386|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
27930101|NCT00966277|54586395|FG000|Overall Study|Withdrawal by Subject|3|||
27930102|NCT00966277|54586396|FG001|Overall Study|Withdrawal by Subject|0|||
27930103|NCT00966277|54586395|FG000|Overall Study|Ineligible|1|||
27930104|NCT00966277|54586396|FG001|Overall Study|Ineligible|3|||
27930105|NCT00966277|54586395|FG000|Overall Study|Treatment Plan Changed|0|||
27930106|NCT00966277|54586396|FG001|Overall Study|Treatment Plan Changed|1|||
27930107|NCT01298141|54586402|FG000|Overall Study|Adverse Event|3|||
27930108|NCT01298141|54586402|FG000|Overall Study|Refusal of Required Study Procedures|1|||
27930109|NCT01298141|54586402|FG000|Overall Study|Withdrawal by Subject|6|||
27930110|NCT01298141|54586402|FG000|Overall Study|Termination of Study by the Investigator|5|||
27930111|NCT01298141|54586402|FG000|Overall Study|Other|5|||
27930112|NCT01298141|54586402|FG000|Overall Study|Lost to Follow-up|1|||
27930113|NCT01298141|54586402|FG000|Overall Study|Death|6|||
27930114|NCT01298141|54586402|FG000|Overall Study|Not treated|4|||
27930115|NCT01171989|54586409|FG000|Overall Study|Lost to Follow-up|0|||
27930116|NCT01171989|54586410|FG001|Overall Study|Lost to Follow-up|0|||
27930117|NCT01171989|54586411|FG002|Overall Study|Lost to Follow-up|1|||
27930118|NCT01297517|54586422|FG000|Overall Study|Adverse Event|21|||
27930119|NCT01297517|54586423|FG001|Overall Study|Adverse Event|7|||
27930120|NCT01297517|54586424|FG002|Overall Study|Adverse Event|16|||
27930121|NCT01297517|54586422|FG000|Overall Study|Lost to Follow-up|1|||
27930122|NCT01297517|54586423|FG001|Overall Study|Lost to Follow-up|0|||
27930123|NCT01297517|54586424|FG002|Overall Study|Lost to Follow-up|1|||
27930124|NCT01297517|54586422|FG000|Overall Study|Patient Decision Unrelated to AE|2|||
27930125|NCT01297517|54586423|FG001|Overall Study|Patient Decision Unrelated to AE|3|||
27930126|NCT01297517|54586424|FG002|Overall Study|Patient Decision Unrelated to AE|7|||
27930127|NCT01297517|54586422|FG000|Overall Study|Noncompliance|1|||
27930128|NCT01297517|54586423|FG001|Overall Study|Noncompliance|0|||
27930129|NCT01297517|54586424|FG002|Overall Study|Noncompliance|0|||
27930130|NCT01297517|54586422|FG000|Overall Study|Protocol Violation|1|||
27930131|NCT01297517|54586423|FG001|Overall Study|Protocol Violation|1|||
27930132|NCT01297517|54586424|FG002|Overall Study|Protocol Violation|1|||
27930133|NCT01297517|54586422|FG000|Overall Study|Inadequate Control of IOP|1|||
27930134|NCT01297517|54586423|FG001|Overall Study|Inadequate Control of IOP|1|||
27930135|NCT01297517|54586424|FG002|Overall Study|Inadequate Control of IOP|2|||
27930136|NCT01171677|54586434|FG000|Overall Study|Withdrawal by Subject|0|||
27930137|NCT01171677|54586435|FG001|Overall Study|Withdrawal by Subject|3|||
27930138|NCT01171677|54586434|FG000|Overall Study|Adverse Event|1|||
27930139|NCT01171677|54586435|FG001|Overall Study|Adverse Event|0|||
27930140|NCT01171677|54586434|FG000|Overall Study|completed <70% IntenSati classes|5|||
27930141|NCT01171677|54586435|FG001|Overall Study|completed <70% IntenSati classes|0|||
27786585|NCT02260934|54241082|FG000|Overall Study|Participant Relocated|1|||
27786586|NCT02260934|54241083|FG001|Overall Study|Participant Relocated|0|||
27786587|NCT02260934|54241082|FG000|Overall Study|Site error|0|||
27786588|NCT02260934|54241083|FG001|Overall Study|Site error|1|||
27786589|NCT02260388|54241100|FG000|Overall Study|Lost to Follow-up|2|||
27786590|NCT02260388|54241101|FG001|Overall Study|Lost to Follow-up|8|||
27786591|NCT02260388|54241102|FG002|Overall Study|Lost to Follow-up|3|||
27786592|NCT02260388|54241103|FG003|Overall Study|Lost to Follow-up|4|||
27786593|NCT02260154|54241113|FG000|Overall Study|Screening failure|2|||
27786594|NCT02284178|54241120|FG000|Overall Study|Met exclusion criteria|49|||
27786595|NCT02284178|54241121|FG001|Overall Study|Met exclusion criteria|54|||
27786596|NCT01643408|54241127|FG000|Overall Study|Adverse Event|12|||
27786597|NCT01643408|54241127|FG000|Overall Study|Other|2|||
27786598|NCT02283788|54241135|FG000|Overall Study|Adverse Event|1|||
27786599|NCT02283788|54241136|FG001|Overall Study|Adverse Event|3|||
27786600|NCT02283788|54241137|FG002|Overall Study|Adverse Event|5|||
27786601|NCT02283788|54241138|FG003|Overall Study|Adverse Event|1|||
27786602|NCT02283788|54241135|FG000|Overall Study|Withdrawal by Subject|0|||
27786603|NCT02283788|54241136|FG001|Overall Study|Withdrawal by Subject|1|||
27786604|NCT02283788|54241137|FG002|Overall Study|Withdrawal by Subject|0|||
27786605|NCT02283788|54241138|FG003|Overall Study|Withdrawal by Subject|1|||
27786606|NCT01739764|54241151|FG000|Overall Study|Adverse Event|0|||
27841558|NCT01559090|54329437|FG000|Stage I|Withdrawal by Subject|2|||
27841559|NCT01559090|54329438|FG001|Stage I|Withdrawal by Subject|2|||
27841560|NCT01559090|54329439|FG002|Stage I|Withdrawal by Subject|3|||
27841561|NCT01559090|54329437|FG000|Stage II|Withdrawal by Subject|1|||
27841562|NCT01559090|54329438|FG001|Stage II|Withdrawal by Subject|0|||
27841563|NCT01559090|54329439|FG002|Stage II|Withdrawal by Subject|0|||
27841564|NCT01683266|54329449|FG000|Overall Study|Adverse Event|5|||
27841565|NCT01683266|54329450|FG001|Overall Study|Adverse Event|4|||
27841566|NCT01683266|54329449|FG000|Overall Study|Lack of Efficacy|5|||
27841567|NCT01683266|54329450|FG001|Overall Study|Lack of Efficacy|2|||
27841568|NCT01683266|54329449|FG000|Overall Study|Protocol Violation|13|||
27841569|NCT01683266|54329450|FG001|Overall Study|Protocol Violation|6|||
27841570|NCT01683266|54329449|FG000|Overall Study|Personal Reason|17|||
27841571|NCT01683266|54329450|FG001|Overall Study|Personal Reason|25|||
27841572|NCT01683266|54329449|FG000|Overall Study|Selection Criterion / Protocol Violation|7|||
27841573|NCT01683266|54329450|FG001|Overall Study|Selection Criterion / Protocol Violation|5|||
27841574|NCT01683266|54329449|FG000|Overall Study|Lost to Follow-up|5|||
27930142|NCT01171521|54586441|FG000|Overall Study|Lost to Follow-up|5|||
27930143|NCT01171521|54586441|FG000|Overall Study|screen failure|1|||
27930144|NCT01296347|54586447|FG000|Allocation|Withdrawal by Subject|1|||
27930145|NCT01296347|54586448|FG001|Allocation|Withdrawal by Subject|2|||
27930146|NCT01296347|54586447|FG000|Allocation|Lack of Efficacy|1|||
27930147|NCT01296347|54586448|FG001|Allocation|Lack of Efficacy|2|||
27930148|NCT01296347|54586447|FG000|Allocation|not received infusion|1|||
27930149|NCT01296347|54586448|FG001|Allocation|not received infusion|0|||
27930150|NCT01296347|54586447|FG000|6 Week Follow up|Death|0|||
27786607|NCT01739764|54241152|FG001|Overall Study|Adverse Event|3|||
27786608|NCT01739764|54241153|FG002|Overall Study|Adverse Event|4|||
27786609|NCT01739764|54241151|FG000|Overall Study|Death|4|||
27786610|NCT01739764|54241152|FG001|Overall Study|Death|6|||
27786611|NCT01739764|54241153|FG002|Overall Study|Death|38|||
27786612|NCT01739764|54241151|FG000|Overall Study|Lost to Follow-up|0|||
27786613|NCT01739764|54241152|FG001|Overall Study|Lost to Follow-up|0|||
27786614|NCT01739764|54241153|FG002|Overall Study|Lost to Follow-up|5|||
27786615|NCT01739764|54241151|FG000|Overall Study|Non-Compliance|0|||
27786616|NCT01739764|54241152|FG001|Overall Study|Non-Compliance|0|||
27786617|NCT01739764|54241153|FG002|Overall Study|Non-Compliance|1|||
27786618|NCT01739764|54241151|FG000|Overall Study|Multiple Reasons|3|||
27786619|NCT01739764|54241152|FG001|Overall Study|Multiple Reasons|2|||
27786620|NCT01739764|54241153|FG002|Overall Study|Multiple Reasons|3|||
27786621|NCT01739764|54241151|FG000|Overall Study|Physician Decision|2|||
27786622|NCT01739764|54241152|FG001|Overall Study|Physician Decision|2|||
27786623|NCT01739764|54241153|FG002|Overall Study|Physician Decision|4|||
27786624|NCT01739764|54241151|FG000|Overall Study|Progressive Disease|3|||
27786625|NCT01739764|54241152|FG001|Overall Study|Progressive Disease|5|||
27786626|NCT01739764|54241153|FG002|Overall Study|Progressive Disease|16|||
27786627|NCT01739764|54241151|FG000|Overall Study|Protocol Violation|0|||
27786628|NCT01739764|54241152|FG001|Overall Study|Protocol Violation|0|||
27786629|NCT01739764|54241153|FG002|Overall Study|Protocol Violation|2|||
27786630|NCT01739764|54241151|FG000|Overall Study|Study Terminated by Sponsor|8|||
27786631|NCT01739764|54241152|FG001|Overall Study|Study Terminated by Sponsor|13|||
27786632|NCT01739764|54241153|FG002|Overall Study|Study Terminated by Sponsor|26|||
27786633|NCT01739764|54241151|FG000|Overall Study|Withdrawal by Subject|6|||
27786634|NCT01739764|54241152|FG001|Overall Study|Withdrawal by Subject|5|||
27786635|NCT01739764|54241153|FG002|Overall Study|Withdrawal by Subject|27|||
27786636|NCT01700530|54241164|FG000|Overall Study|Withdrawal by Subject|0|||
27786637|NCT01700530|54241165|FG001|Overall Study|Withdrawal by Subject|3|||
27786638|NCT01700530|54241166|FG002|Overall Study|Withdrawal by Subject|1|||
27786639|NCT01700140|54241177|FG000|Overall Study|Use of rescue drugs|3|||
27786640|NCT01700140|54241178|FG001|Overall Study|Use of rescue drugs|3|||
27786641|NCT01700140|54241179|FG002|Overall Study|Use of rescue drugs|1|||
27786642|NCT01700140|54241177|FG000|Overall Study|Discontinuation of radiotherapy|1|||
27786643|NCT01700140|54241178|FG001|Overall Study|Discontinuation of radiotherapy|0|||
27930151|NCT01296347|54586448|FG001|6 Week Follow up|Death|1|||
27930152|NCT01296347|54586447|FG000|3 Month Follow up|Death|1|||
27930153|NCT01296347|54586448|FG001|3 Month Follow up|Death|0|||
27930154|NCT01296347|54586447|FG000|3 Month Follow up|Lost to Follow-up|0|||
27930155|NCT01296347|54586448|FG001|3 Month Follow up|Lost to Follow-up|1|||
27930156|NCT01296347|54586447|FG000|6 Month Follow up|Death|2|||
27930157|NCT01296347|54586448|FG001|6 Month Follow up|Death|1|||
27930158|NCT01296347|54586447|FG000|6 Month Follow up|Lost to Follow-up|0|||
27930159|NCT01296347|54586448|FG001|6 Month Follow up|Lost to Follow-up|1|||
27930160|NCT01296347|54586447|FG000|12 Month Follow up|Lost to Follow-up|3|||
27930161|NCT01296347|54586448|FG001|12 Month Follow up|Lost to Follow-up|1|||
27930162|NCT01296347|54586447|FG000|12 Month Follow up|Death|1|||
27930163|NCT01296347|54586448|FG001|12 Month Follow up|Death|1|||
27930164|NCT01296347|54586447|FG000|12 Month Follow up|Withdrawal by Subject|0|||
27930165|NCT01296347|54586448|FG001|12 Month Follow up|Withdrawal by Subject|1|||
27930166|NCT01296035|54586457|FG000|Overall Study|Withdrawal by Subject|1|||
27930167|NCT01294787|54586461|FG000|Period 1|Adverse Event|0|||
27930168|NCT01294787|54586462|FG001|Period 1|Adverse Event|0|||
27930169|NCT01294787|54586463|FG002|Period 1|Adverse Event|0|||
27930170|NCT01294787|54586464|FG003|Period 1|Adverse Event|0|||
27930171|NCT01294787|54586465|FG004|Period 1|Adverse Event|1|||
27930172|NCT01294787|54586466|FG005|Period 1|Adverse Event|0|||
27930173|NCT01294787|54586461|FG000|Period 1|Withdrawal by Subject|0|||
27786644|NCT01700140|54241179|FG002|Overall Study|Discontinuation of radiotherapy|0|||
27786645|NCT01700140|54241177|FG000|Overall Study|Use of chemotherapy or surgical therapy|0|||
27786646|NCT01700140|54241178|FG001|Overall Study|Use of chemotherapy or surgical therapy|1|||
27786647|NCT01700140|54241179|FG002|Overall Study|Use of chemotherapy or surgical therapy|0|||
27786648|NCT01700140|54241177|FG000|Overall Study|Aggravation of symptoms|1|||
27786649|NCT01700140|54241178|FG001|Overall Study|Aggravation of symptoms|0|||
27786650|NCT01700140|54241179|FG002|Overall Study|Aggravation of symptoms|0|||
27786651|NCT01700140|54241177|FG000|Overall Study|Adverse Event|0|||
27786652|NCT01700140|54241178|FG001|Overall Study|Adverse Event|1|||
27786653|NCT01700140|54241179|FG002|Overall Study|Adverse Event|0|||
27786654|NCT01700140|54241177|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
27930174|NCT01294787|54586462|FG001|Period 1|Withdrawal by Subject|0|||
27930175|NCT01294787|54586463|FG002|Period 1|Withdrawal by Subject|0|||
27930176|NCT01294787|54586464|FG003|Period 1|Withdrawal by Subject|1|||
27930177|NCT01294787|54586465|FG004|Period 1|Withdrawal by Subject|1|||
27930178|NCT01294787|54586466|FG005|Period 1|Withdrawal by Subject|1|||
27930179|NCT01294787|54586461|FG000|Period 1|Administrative problem|0|||
27930180|NCT01294787|54586462|FG001|Period 1|Administrative problem|0|||
27930181|NCT01294787|54586463|FG002|Period 1|Administrative problem|1|||
27930182|NCT01294787|54586464|FG003|Period 1|Administrative problem|0|||
27930183|NCT01294787|54586465|FG004|Period 1|Administrative problem|0|||
27930184|NCT01294787|54586466|FG005|Period 1|Administrative problem|1|||
27930185|NCT01294787|54586461|FG000|Period 2|Adverse Event|0|||
27930186|NCT01294787|54586462|FG001|Period 2|Adverse Event|3|||
27930187|NCT01294787|54586463|FG002|Period 2|Adverse Event|0|||
27930188|NCT01294787|54586464|FG003|Period 2|Adverse Event|1|||
27930189|NCT01294787|54586465|FG004|Period 2|Adverse Event|0|||
27930190|NCT01294787|54586466|FG005|Period 2|Adverse Event|0|||
27930191|NCT01294787|54586461|FG000|Period 2|No longer needs study drug|0|||
27930192|NCT01294787|54586462|FG001|Period 2|No longer needs study drug|0|||
27930193|NCT01294787|54586463|FG002|Period 2|No longer needs study drug|0|||
27930194|NCT01294787|54586464|FG003|Period 2|No longer needs study drug|1|||
27930195|NCT01294787|54586465|FG004|Period 2|No longer needs study drug|0|||
27930196|NCT01294787|54586466|FG005|Period 2|No longer needs study drug|0|||
27930197|NCT01294787|54586461|FG000|Period 3|Adverse Event|0|||
27930198|NCT01294787|54586462|FG001|Period 3|Adverse Event|0|||
27930199|NCT01294787|54586463|FG002|Period 3|Adverse Event|0|||
27930200|NCT01294787|54586464|FG003|Period 3|Adverse Event|0|||
27930201|NCT01294787|54586465|FG004|Period 3|Adverse Event|1|||
27930202|NCT01294787|54586466|FG005|Period 3|Adverse Event|0|||
27930203|NCT01294553|54586477|FG000|Overall Study|Duplicated Participants|1|||
27930204|NCT01294553|54586477|FG000|Overall Study|Protocol Violation|268|||
27930205|NCT01294397|54586482|FG000|Overall Study|Withdrawal by Subject|1|||
27930206|NCT01294397|54586482|FG000|Overall Study|Administrative Decision|1|||
27930207|NCT01293695|54586490|FG000|Overall Study|Withdrawal by Subject|7|||
27930208|NCT01293695|54586491|FG001|Overall Study|Withdrawal by Subject|1|||
27930209|NCT01293695|54586490|FG000|Overall Study|Lost to Follow-up|8|||
27930210|NCT01293695|54586491|FG001|Overall Study|Lost to Follow-up|6|||
27930211|NCT01293539|54586500|FG000|Overall Study|Physician Decision|1|||
27930212|NCT01292837|54586504|FG000|Overall Study|Adverse Event|1|||
27930213|NCT01292837|54586504|FG000|Overall Study|Further treatment determined|1|||
27930214|NCT00965731|54586510|FG000|Overall Study|Death|0|||
27930215|NCT00965731|54586511|FG001|Overall Study|Death|4|||
27930216|NCT00965731|54586510|FG000|Overall Study|Withdrawal by Subject|0|||
27930217|NCT00965731|54586511|FG001|Overall Study|Withdrawal by Subject|1|||
27930218|NCT00965731|54586510|FG000|Overall Study|Other|7|||
27930219|NCT00965731|54586511|FG001|Overall Study|Other|15|||
27930220|NCT00965575|54586524|FG000|Overall Study|subject unwillingness to swallow study c|1|||
27930221|NCT00965575|54586525|FG001|Overall Study|subject unwillingness to swallow study c|0|||
27930222|NCT00965497|54586533|FG000|Overall Study|Physician Decision|1|||
27930223|NCT00963937|54586540|FG000|Overall Study|Protocol Violation|1|||
27930224|NCT00963937|54586541|FG001|Overall Study|Protocol Violation|1|||
27930225|NCT00963937|54586542|FG002|Overall Study|Protocol Violation|0|||
27930226|NCT00963937|54586540|FG000|Overall Study|Physician Decision|18|||
27930227|NCT00963937|54586541|FG001|Overall Study|Physician Decision|10|||
27930228|NCT00963937|54586542|FG002|Overall Study|Physician Decision|4|||
27930229|NCT01170663|54586555|FG000|Overall Study|Lost to Follow-up|3|||
27930230|NCT01170663|54586556|FG001|Overall Study|Lost to Follow-up|9|||
27930231|NCT01170663|54586555|FG000|Overall Study|Withdrawal of consent without follow-up|11|||
27930232|NCT01170663|54586556|FG001|Overall Study|Withdrawal of consent without follow-up|11|||
27930233|NCT01170273|54586564|FG000|Overall Study|Lost to Follow-up|6|||
27930234|NCT01170273|54586565|FG001|Overall Study|Lost to Follow-up|8|||
27930235|NCT01170273|54586564|FG000|Overall Study|Protocol Violation|1|||
27930236|NCT01170273|54586565|FG001|Overall Study|Protocol Violation|0|||
27930237|NCT01170273|54586564|FG000|Overall Study|Death|1|||
27930238|NCT01170273|54586565|FG001|Overall Study|Death|0|||
27930239|NCT01170273|54586564|FG000|Overall Study|Adverse Event|0|||
27930240|NCT01170273|54586565|FG001|Overall Study|Adverse Event|1|||
27930241|NCT01170039|54586573|FG000|Overall Study|Withdrawal by Subject|5|||
27930242|NCT01170039|54586574|FG001|Overall Study|Withdrawal by Subject|3|||
27930243|NCT01170039|54586573|FG000|Overall Study|Lack of funding, drug not available|3|||
27930244|NCT01170039|54586574|FG001|Overall Study|Lack of funding, drug not available|3|||
27930245|NCT01169649|54586580|FG000|Overall Study|Patient Not Treated|3|||
27930246|NCT01169493|54586590|FG000|Period 1 (6 Months)|Withdrawal by Subject|0|||
27930247|NCT01169493|54586591|FG001|Period 1 (6 Months)|Withdrawal by Subject|1|||
27930248|NCT01169493|54586592|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
27930249|NCT01169493|54586593|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
27930250|NCT01169493|54586594|FG004|Period 1 (6 Months)|Withdrawal by Subject|0|||
27930251|NCT01169493|54586595|FG005|Period 1 (6 Months)|Withdrawal by Subject|3|||
27930252|NCT01169493|54586590|FG000|Period 3 (6 Months)|Adverse Event|0|||
27930253|NCT01169493|54586591|FG001|Period 3 (6 Months)|Adverse Event|1|||
27930254|NCT01169493|54586592|FG002|Period 3 (6 Months)|Adverse Event|0|||
27930255|NCT01169493|54586593|FG003|Period 3 (6 Months)|Adverse Event|0|||
27930256|NCT01169493|54586594|FG004|Period 3 (6 Months)|Adverse Event|0|||
27930257|NCT01169493|54586595|FG005|Period 3 (6 Months)|Adverse Event|0|||
27930258|NCT01169493|54586590|FG000|Period 3 (6 Months)|Physician Decision|0|||
27930259|NCT01169493|54586591|FG001|Period 3 (6 Months)|Physician Decision|1|||
27930260|NCT01169493|54586592|FG002|Period 3 (6 Months)|Physician Decision|1|||
27930261|NCT01169493|54586593|FG003|Period 3 (6 Months)|Physician Decision|0|||
27930262|NCT01169493|54586594|FG004|Period 3 (6 Months)|Physician Decision|0|||
27930263|NCT01169493|54586595|FG005|Period 3 (6 Months)|Physician Decision|0|||
27930264|NCT01287104|54586607|FG000|Overall Study|Patient developed progressive disease|1|||
27930265|NCT01287104|54586608|FG001|Overall Study|Patient developed progressive disease|1|||
27930266|NCT01287104|54586609|FG002|Overall Study|Patient developed progressive disease|3|||
27930267|NCT01287104|54586610|FG003|Overall Study|Patient developed progressive disease|2|||
27930268|NCT01287104|54586607|FG000|Overall Study|Donor anaphylaxis|0|||
27930269|NCT01287104|54586608|FG001|Overall Study|Donor anaphylaxis|1|||
27930270|NCT01287104|54586609|FG002|Overall Study|Donor anaphylaxis|0|||
27930271|NCT01287104|54586610|FG003|Overall Study|Donor anaphylaxis|1|||
28015989|NCT00357877|54675139|FG001|Overall Study|Withdrawal by Subject|3|||
28015990|NCT00357877|54675138|FG000|Overall Study|Administrative withdrawal|1|||
28015991|NCT00357877|54675139|FG001|Overall Study|Administrative withdrawal|1|||
28015992|NCT00357877|54675138|FG000|Overall Study|Other|0|||
28015993|NCT00357877|54675139|FG001|Overall Study|Other|2|||
28015994|NCT00335959|54675147|FG000|Overall Study|Adverse Event|2|||
28015995|NCT00335959|54675147|FG000|Overall Study|Ineligible|1|||
28015996|NCT00670488|54675162|FG000|Overall Study|Adverse Event|0|||
28015997|NCT00670488|54675163|FG001|Overall Study|Adverse Event|7|||
28015998|NCT00670488|54675164|FG002|Overall Study|Adverse Event|0|||
28015999|NCT00670488|54675165|FG003|Overall Study|Adverse Event|3|||
28016000|NCT00670488|54675166|FG004|Overall Study|Adverse Event|1|||
28016001|NCT00670488|54675167|FG005|Overall Study|Adverse Event|1|||
28016002|NCT00670488|54675168|FG006|Overall Study|Adverse Event|5|||
27930272|NCT01287104|54586607|FG000|Overall Study|Developed GVHD or complications of BMT|0|||
27930273|NCT01287104|54586608|FG001|Overall Study|Developed GVHD or complications of BMT|1|||
28016003|NCT00670488|54675169|FG007|Overall Study|Adverse Event|1|||
28016004|NCT00670488|54675170|FG008|Overall Study|Adverse Event|0|||
28016005|NCT00670488|54675171|FG009|Overall Study|Adverse Event|1|||
28016006|NCT00670488|54675162|FG000|Overall Study|Physician Decision|1|||
28016007|NCT00670488|54675163|FG001|Overall Study|Physician Decision|9|||
27930274|NCT01287104|54586609|FG002|Overall Study|Developed GVHD or complications of BMT|4|||
27930275|NCT01287104|54586610|FG003|Overall Study|Developed GVHD or complications of BMT|0|||
28016008|NCT00670488|54675164|FG002|Overall Study|Physician Decision|0|||
28016009|NCT00670488|54675165|FG003|Overall Study|Physician Decision|1|||
28016010|NCT00670488|54675166|FG004|Overall Study|Physician Decision|0|||
28016011|NCT00670488|54675167|FG005|Overall Study|Physician Decision|0|||
28016012|NCT00670488|54675168|FG006|Overall Study|Physician Decision|0|||
28016013|NCT00670488|54675169|FG007|Overall Study|Physician Decision|0|||
28016014|NCT00670488|54675170|FG008|Overall Study|Physician Decision|0|||
28016015|NCT00670488|54675171|FG009|Overall Study|Physician Decision|0|||
28016016|NCT00670488|54675162|FG000|Overall Study|Progressive Disease|2|||
28016017|NCT00670488|54675163|FG001|Overall Study|Progressive Disease|41|||
28016018|NCT00670488|54675164|FG002|Overall Study|Progressive Disease|3|||
28016019|NCT00670488|54675165|FG003|Overall Study|Progressive Disease|2|||
28016020|NCT00670488|54675166|FG004|Overall Study|Progressive Disease|2|||
28016021|NCT00670488|54675167|FG005|Overall Study|Progressive Disease|4|||
28016022|NCT00670488|54675168|FG006|Overall Study|Progressive Disease|11|||
28016023|NCT00670488|54675169|FG007|Overall Study|Progressive Disease|2|||
28016024|NCT00670488|54675170|FG008|Overall Study|Progressive Disease|2|||
28105559|NCT04553913|54763003|FG000|Overall Study|patient's block resolved prior to PACU|1|||
27930276|NCT01287104|54586607|FG000|Overall Study|Low donor chimerism|0|||
27930277|NCT01287104|54586608|FG001|Overall Study|Low donor chimerism|1|||
27930278|NCT01287104|54586609|FG002|Overall Study|Low donor chimerism|0|||
27930279|NCT01287104|54586610|FG003|Overall Study|Low donor chimerism|0|||
27930280|NCT01287104|54586607|FG000|Overall Study|NK cells did not meet release criteria|0|||
27930281|NCT01287104|54586608|FG001|Overall Study|NK cells did not meet release criteria|1|||
27930282|NCT01287104|54586609|FG002|Overall Study|NK cells did not meet release criteria|0|||
27930283|NCT01287104|54586610|FG003|Overall Study|NK cells did not meet release criteria|0|||
27930284|NCT01286558|54586629|FG000|Overall Study|Adverse Event|1|||
27930285|NCT01286558|54586630|FG001|Overall Study|Adverse Event|1|||
27930286|NCT01286558|54586629|FG000|Overall Study|Withdrawal by Subject|0|||
27930287|NCT01286558|54586630|FG001|Overall Study|Withdrawal by Subject|1|||
27930288|NCT01169103|54586638|FG000|Overall Study|Lost to Follow-up|3|||
27930289|NCT01169103|54586639|FG001|Overall Study|Lost to Follow-up|3|||
27930290|NCT01169103|54586638|FG000|Overall Study|Withdrawal by Subject|3|||
27930291|NCT01169103|54586639|FG001|Overall Study|Withdrawal by Subject|1|||
27930292|NCT01286480|54586647|FG000|Overall Study|Withdrawal by Subject|5|||
27930293|NCT01286480|54586648|FG001|Overall Study|Withdrawal by Subject|3|||
27930294|NCT01286168|54586654|FG000|Overall Study|Withdrawal by Subject|1|||
27930295|NCT01286168|54586654|FG000|Overall Study|Surgical Drains Fell Out at Home|2|||
27930296|NCT01286012|54586661|FG000|Overall Study|Adverse Event|3|||
27930297|NCT01286012|54586662|FG001|Overall Study|Adverse Event|3|||
27930298|NCT01286012|54586661|FG000|Overall Study|Death|2|||
27930299|NCT01286012|54586662|FG001|Overall Study|Death|3|||
27930300|NCT01286012|54586661|FG000|Overall Study|Protocol Violation|1|||
27930301|NCT01286012|54586662|FG001|Overall Study|Protocol Violation|1|||
27930302|NCT01286012|54586661|FG000|Overall Study|Withdrawal by Subject|4|||
27930303|NCT01286012|54586662|FG001|Overall Study|Withdrawal by Subject|4|||
27930304|NCT01286012|54586661|FG000|Overall Study|Physician Decision|2|||
27930305|NCT01286012|54586662|FG001|Overall Study|Physician Decision|0|||
27930306|NCT01286012|54586661|FG000|Overall Study|peritoneal dialysis, randomized in error|1|||
27930307|NCT01286012|54586662|FG001|Overall Study|peritoneal dialysis, randomized in error|3|||
27930308|NCT00963547|54586673|FG000|Overall Study|Adverse Event|0|||
27930309|NCT00963547|54586674|FG001|Overall Study|Adverse Event|1|||
27930310|NCT00963547|54586675|FG002|Overall Study|Adverse Event|0|||
27930311|NCT00963547|54586676|FG003|Overall Study|Adverse Event|1|||
27930312|NCT00963547|54586677|FG004|Overall Study|Adverse Event|0|||
27930313|NCT00963547|54586678|FG005|Overall Study|Adverse Event|0|||
27930314|NCT00963547|54586679|FG006|Overall Study|Adverse Event|0|||
27930315|NCT00963547|54586673|FG000|Overall Study|Physician Decision|1|||
27930316|NCT00963547|54586674|FG001|Overall Study|Physician Decision|1|||
27930317|NCT00963547|54586675|FG002|Overall Study|Physician Decision|0|||
27930318|NCT00963547|54586676|FG003|Overall Study|Physician Decision|0|||
27930319|NCT00963547|54586677|FG004|Overall Study|Physician Decision|0|||
27930320|NCT00963547|54586678|FG005|Overall Study|Physician Decision|0|||
27930321|NCT00963547|54586679|FG006|Overall Study|Physician Decision|0|||
27930322|NCT00963547|54586673|FG000|Overall Study|Progressive Disease|3|||
27930323|NCT00963547|54586674|FG001|Overall Study|Progressive Disease|8|||
27930324|NCT00963547|54586675|FG002|Overall Study|Progressive Disease|9|||
27930325|NCT00963547|54586676|FG003|Overall Study|Progressive Disease|5|||
27930326|NCT00963547|54586677|FG004|Overall Study|Progressive Disease|0|||
27930327|NCT00963547|54586678|FG005|Overall Study|Progressive Disease|0|||
27930328|NCT00963547|54586679|FG006|Overall Study|Progressive Disease|0|||
27930329|NCT00963547|54586673|FG000|Overall Study|Withdrawal by Subject|0|||
27930330|NCT00963547|54586674|FG001|Overall Study|Withdrawal by Subject|0|||
27930331|NCT00963547|54586675|FG002|Overall Study|Withdrawal by Subject|3|||
27930332|NCT00963547|54586676|FG003|Overall Study|Withdrawal by Subject|0|||
27930333|NCT00963547|54586677|FG004|Overall Study|Withdrawal by Subject|0|||
28016025|NCT00670488|54675171|FG009|Overall Study|Progressive Disease|1|||
28016026|NCT00670488|54675162|FG000|Overall Study|Withdrawal by Subject|0|||
28016027|NCT00670488|54675163|FG001|Overall Study|Withdrawal by Subject|1|||
28016028|NCT00670488|54675164|FG002|Overall Study|Withdrawal by Subject|0|||
27930334|NCT00963547|54586678|FG005|Overall Study|Withdrawal by Subject|0|||
27930335|NCT00963547|54586679|FG006|Overall Study|Withdrawal by Subject|0|||
27930336|NCT00963547|54586673|FG000|Overall Study|Reason Unknown|0|||
27930337|NCT00963547|54586674|FG001|Overall Study|Reason Unknown|1|||
27930338|NCT00963547|54586675|FG002|Overall Study|Reason Unknown|0|||
27930339|NCT00963547|54586676|FG003|Overall Study|Reason Unknown|0|||
27930340|NCT00963547|54586677|FG004|Overall Study|Reason Unknown|0|||
27930341|NCT00963547|54586678|FG005|Overall Study|Reason Unknown|0|||
27930342|NCT00963547|54586679|FG006|Overall Study|Reason Unknown|0|||
28016029|NCT00670488|54675165|FG003|Overall Study|Withdrawal by Subject|1|||
28016030|NCT00670488|54675166|FG004|Overall Study|Withdrawal by Subject|0|||
28016031|NCT00670488|54675167|FG005|Overall Study|Withdrawal by Subject|0|||
28016032|NCT00670488|54675168|FG006|Overall Study|Withdrawal by Subject|1|||
28016033|NCT00670488|54675169|FG007|Overall Study|Withdrawal by Subject|0|||
28016034|NCT00670488|54675170|FG008|Overall Study|Withdrawal by Subject|1|||
28016035|NCT00670488|54675171|FG009|Overall Study|Withdrawal by Subject|0|||
28016036|NCT00671658|54675193|FG000|Overall Study|Physician Decision|5|||
28016037|NCT00542386|54675203|FG000|Overall Study|Adverse Event|1|||
28016038|NCT00542386|54675204|FG001|Overall Study|Adverse Event|7|||
28016039|NCT00542386|54675205|FG002|Overall Study|Adverse Event|7|||
28016040|NCT00542386|54675206|FG003|Overall Study|Adverse Event|8|||
28016041|NCT00542386|54675207|FG004|Overall Study|Adverse Event|13|||
28016042|NCT00542386|54675208|FG005|Overall Study|Adverse Event|4|||
28016043|NCT00542386|54675203|FG000|Overall Study|Death|0|||
28016044|NCT00542386|54675204|FG001|Overall Study|Death|0|||
28016045|NCT00542386|54675205|FG002|Overall Study|Death|1|||
28016046|NCT00542386|54675206|FG003|Overall Study|Death|2|||
28016047|NCT00542386|54675207|FG004|Overall Study|Death|1|||
28016048|NCT00542386|54675208|FG005|Overall Study|Death|2|||
28016049|NCT00542386|54675203|FG000|Overall Study|Lack of Efficacy|32|||
28016050|NCT00542386|54675204|FG001|Overall Study|Lack of Efficacy|12|||
28016051|NCT00542386|54675205|FG002|Overall Study|Lack of Efficacy|10|||
28016052|NCT00542386|54675206|FG003|Overall Study|Lack of Efficacy|13|||
28016053|NCT00542386|54675207|FG004|Overall Study|Lack of Efficacy|7|||
28016054|NCT00542386|54675208|FG005|Overall Study|Lack of Efficacy|31|||
28016055|NCT00542386|54675203|FG000|Overall Study|Physician Decision|1|||
28016056|NCT00542386|54675204|FG001|Overall Study|Physician Decision|0|||
28016057|NCT00542386|54675205|FG002|Overall Study|Physician Decision|0|||
28016058|NCT00542386|54675206|FG003|Overall Study|Physician Decision|1|||
28016059|NCT00542386|54675207|FG004|Overall Study|Physician Decision|0|||
28016060|NCT00542386|54675208|FG005|Overall Study|Physician Decision|0|||
28016061|NCT00542386|54675203|FG000|Overall Study|Protocol Violation|0|||
28016062|NCT00542386|54675204|FG001|Overall Study|Protocol Violation|0|||
28016063|NCT00542386|54675205|FG002|Overall Study|Protocol Violation|1|||
28016064|NCT00542386|54675206|FG003|Overall Study|Protocol Violation|0|||
28016065|NCT00542386|54675207|FG004|Overall Study|Protocol Violation|0|||
28016066|NCT00542386|54675208|FG005|Overall Study|Protocol Violation|4|||
28016067|NCT00542386|54675203|FG000|Overall Study|Withdrawal by Subject|5|||
28016068|NCT00542386|54675204|FG001|Overall Study|Withdrawal by Subject|8|||
28016069|NCT00542386|54675205|FG002|Overall Study|Withdrawal by Subject|10|||
28016070|NCT00542386|54675206|FG003|Overall Study|Withdrawal by Subject|11|||
28016071|NCT00542386|54675207|FG004|Overall Study|Withdrawal by Subject|15|||
28016072|NCT00542386|54675208|FG005|Overall Study|Withdrawal by Subject|7|||
28016073|NCT00542386|54675203|FG000|Overall Study|Other Reasons|4|||
28016074|NCT00542386|54675204|FG001|Overall Study|Other Reasons|1|||
28016075|NCT00542386|54675205|FG002|Overall Study|Other Reasons|4|||
28016076|NCT00542386|54675206|FG003|Overall Study|Other Reasons|3|||
28016077|NCT00542386|54675207|FG004|Overall Study|Other Reasons|4|||
28016078|NCT00542386|54675208|FG005|Overall Study|Other Reasons|2|||
28016079|NCT00604383|54675224|FG000|Overall Study|Withdrawal by Subject|33|||
28016080|NCT00604383|54675225|FG001|Overall Study|Withdrawal by Subject|31|||
28016081|NCT00604383|54675224|FG000|Overall Study|Lost to Follow-up|24|||
27930343|NCT01285310|54586695|FG000|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3|||
27930344|NCT01285310|54586696|FG001|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4|||
27930345|NCT01285310|54586697|FG002|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6|||
28016082|NCT00604383|54675225|FG001|Overall Study|Lost to Follow-up|19|||
28016083|NCT00604383|54675224|FG000|Overall Study|Death|14|||
28016084|NCT00604383|54675225|FG001|Overall Study|Death|22|||
28016085|NCT00604383|54675224|FG000|Overall Study|Adverse Event|16|||
28016086|NCT00604383|54675225|FG001|Overall Study|Adverse Event|9|||
28016087|NCT00604383|54675224|FG000|Overall Study|Physician Decision|0|||
28016088|NCT00604383|54675225|FG001|Overall Study|Physician Decision|3|||
28016089|NCT00333775|54675234|FG000|Overall Study|Death|144|||
28016090|NCT00333775|54675235|FG001|Overall Study|Death|149|||
28016091|NCT00333775|54675236|FG002|Overall Study|Death|143|||
28016092|NCT00333775|54675234|FG000|Overall Study|In Follow-up When Study Stopped|87|||
28016093|NCT00333775|54675235|FG001|Overall Study|In Follow-up When Study Stopped|92|||
28016094|NCT00333775|54675236|FG002|Overall Study|In Follow-up When Study Stopped|96|||
28016095|NCT00333775|54675234|FG000|Overall Study|Lost to Follow-up|10|||
28016096|NCT00333775|54675235|FG001|Overall Study|Lost to Follow-up|7|||
28016097|NCT00333775|54675236|FG002|Overall Study|Lost to Follow-up|8|||
28016098|NCT00605475|54675254|FG000|Overall Study|Abnormal Laboratory Values|0|||
28016099|NCT00605475|54675255|FG001|Overall Study|Abnormal Laboratory Values|0|||
28016100|NCT00605475|54675256|FG002|Overall Study|Abnormal Laboratory Values|0|||
28016101|NCT00605475|54675257|FG003|Overall Study|Abnormal Laboratory Values|0|||
28016102|NCT00605475|54675258|FG004|Overall Study|Abnormal Laboratory Values|0|||
28016103|NCT00605475|54675259|FG005|Overall Study|Abnormal Laboratory Values|0|||
28016104|NCT00605475|54675260|FG006|Overall Study|Abnormal Laboratory Values|0|||
28016105|NCT00605475|54675261|FG007|Overall Study|Abnormal Laboratory Values|0|||
27930346|NCT01285310|54586698|FG003|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
27930347|NCT01285310|54586699|FG004|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
27930348|NCT01285310|54586695|FG000|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1|||
27930349|NCT01285310|54586696|FG001|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7|||
27930350|NCT01285310|54586697|FG002|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3|||
27930351|NCT01285310|54586698|FG003|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
27930352|NCT01285310|54586699|FG004|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
27930353|NCT01285310|54586695|FG000|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1|||
27930354|NCT01285310|54586696|FG001|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
28016106|NCT00605475|54675262|FG008|Overall Study|Abnormal Laboratory Values|1|||
28016107|NCT00605475|54675263|FG009|Overall Study|Abnormal Laboratory Values|0|||
28016108|NCT00605475|54675254|FG000|Overall Study|Administrative problems|0|||
28016109|NCT00605475|54675255|FG001|Overall Study|Administrative problems|0|||
28016110|NCT00605475|54675256|FG002|Overall Study|Administrative problems|0|||
28016111|NCT00605475|54675257|FG003|Overall Study|Administrative problems|0|||
28016112|NCT00605475|54675258|FG004|Overall Study|Administrative problems|0|||
28016113|NCT00605475|54675259|FG005|Overall Study|Administrative problems|0|||
28016114|NCT00605475|54675260|FG006|Overall Study|Administrative problems|1|||
28016115|NCT00605475|54675261|FG007|Overall Study|Administrative problems|0|||
28016116|NCT00605475|54675262|FG008|Overall Study|Administrative problems|0|||
28016117|NCT00605475|54675263|FG009|Overall Study|Administrative problems|0|||
28016118|NCT00605475|54675254|FG000|Overall Study|Lost to Follow-up|0|||
28016119|NCT00605475|54675255|FG001|Overall Study|Lost to Follow-up|0|||
28016120|NCT00605475|54675256|FG002|Overall Study|Lost to Follow-up|0|||
28016121|NCT00605475|54675257|FG003|Overall Study|Lost to Follow-up|0|||
28016122|NCT00605475|54675258|FG004|Overall Study|Lost to Follow-up|0|||
28016123|NCT00605475|54675259|FG005|Overall Study|Lost to Follow-up|0|||
28016124|NCT00605475|54675260|FG006|Overall Study|Lost to Follow-up|0|||
28016125|NCT00605475|54675261|FG007|Overall Study|Lost to Follow-up|0|||
28016126|NCT00605475|54675262|FG008|Overall Study|Lost to Follow-up|1|||
28016127|NCT00605475|54675263|FG009|Overall Study|Lost to Follow-up|1|||
28016128|NCT00605475|54675254|FG000|Overall Study|Protocol Violation|0|||
28016129|NCT00605475|54675255|FG001|Overall Study|Protocol Violation|0|||
28016130|NCT00605475|54675256|FG002|Overall Study|Protocol Violation|0|||
28016131|NCT00605475|54675257|FG003|Overall Study|Protocol Violation|0|||
28016132|NCT00605475|54675258|FG004|Overall Study|Protocol Violation|1|||
28016133|NCT00605475|54675259|FG005|Overall Study|Protocol Violation|0|||
28016134|NCT00605475|54675260|FG006|Overall Study|Protocol Violation|0|||
28016135|NCT00605475|54675261|FG007|Overall Study|Protocol Violation|0|||
28016136|NCT00605475|54675262|FG008|Overall Study|Protocol Violation|0|||
28016137|NCT00605475|54675263|FG009|Overall Study|Protocol Violation|0|||
28016138|NCT00605475|54675254|FG000|Overall Study|Withdrawal by Subject|0|||
28016139|NCT00605475|54675255|FG001|Overall Study|Withdrawal by Subject|0|||
28016140|NCT00605475|54675256|FG002|Overall Study|Withdrawal by Subject|0|||
28016141|NCT00605475|54675257|FG003|Overall Study|Withdrawal by Subject|0|||
28016142|NCT00605475|54675258|FG004|Overall Study|Withdrawal by Subject|0|||
28016143|NCT00605475|54675259|FG005|Overall Study|Withdrawal by Subject|2|||
28016144|NCT00605475|54675260|FG006|Overall Study|Withdrawal by Subject|0|||
28016145|NCT00605475|54675261|FG007|Overall Study|Withdrawal by Subject|0|||
28016146|NCT00605475|54675262|FG008|Overall Study|Withdrawal by Subject|0|||
28016147|NCT00605475|54675263|FG009|Overall Study|Withdrawal by Subject|1|||
28016148|NCT00333619|54675308|FG000|Overall Study|Death|12|||
28016149|NCT00333619|54675309|FG001|Overall Study|Death|6|||
27930355|NCT01285310|54586697|FG002|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2|||
28016150|NCT00333619|54675308|FG000|Overall Study|Withdrawal by Subject|6|||
28016151|NCT00333619|54675309|FG001|Overall Study|Withdrawal by Subject|1|||
28016152|NCT00333619|54675308|FG000|Overall Study|Lost to Follow-up|3|||
28016153|NCT00333619|54675309|FG001|Overall Study|Lost to Follow-up|3|||
28016154|NCT00605319|54675317|FG000|Overall Study|Adverse Event|6|||
28016155|NCT00333229|54675329|FG000|Overall Study|Lack of Efficacy|0|||
28016156|NCT00333229|54675330|FG001|Overall Study|Lack of Efficacy|1|||
28016157|NCT00332839|54675338|FG000|Core (Months 0 - 12)|Administrative problems|1|||
28016158|NCT00332839|54675339|FG001|Core (Months 0 - 12)|Administrative problems|1|||
28016159|NCT00332839|54675338|FG000|Core (Months 0 - 12)|Withdrawal by Subject|3|||
28016160|NCT00332839|54675339|FG001|Core (Months 0 - 12)|Withdrawal by Subject|1|||
28016161|NCT00332839|54675338|FG000|Core (Months 0 - 12)|Protocol deviation|1|||
27930356|NCT01285310|54586698|FG003|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
27930357|NCT01285310|54586699|FG004|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
27930358|NCT01285310|54586695|FG000|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
27930359|NCT01285310|54586696|FG001|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
27930360|NCT01285310|54586697|FG002|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2|||
27930361|NCT01285310|54586698|FG003|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
27930362|NCT01285310|54586699|FG004|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
27930363|NCT01285310|54586695|FG000|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
27930364|NCT01285310|54586696|FG001|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
27930365|NCT01285310|54586697|FG002|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
27930366|NCT01285310|54586698|FG003|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
27930367|NCT01285310|54586699|FG004|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
28016162|NCT00332839|54675339|FG001|Core (Months 0 - 12)|Protocol deviation|1|||
28016163|NCT00332839|54675338|FG000|Core (Months 0 - 12)|Adverse Event|5|||
28016164|NCT00332839|54675339|FG001|Core (Months 0 - 12)|Adverse Event|15|||
27786655|NCT01700140|54241178|FG001|Overall Study|Inclusion/exclusion criteria deviation|4|||
27786656|NCT01700140|54241179|FG002|Overall Study|Inclusion/exclusion criteria deviation|0|||
27786657|NCT01717456|54241192|FG000|End of Treatment|Physician Decision|0|||
27786658|NCT01717456|54241193|FG001|End of Treatment|Physician Decision|1|||
27786659|NCT01717456|54241192|FG000|End of Treatment|Lost to Follow-up|0|||
27786660|NCT01717456|54241193|FG001|End of Treatment|Lost to Follow-up|1|||
27786661|NCT01717456|54241192|FG000|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
27786662|NCT01717456|54241193|FG001|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
27786663|NCT01699750|54241202|FG000|Overall Study|Withdrew Consent|0|||
27786664|NCT01699750|54241203|FG001|Overall Study|Withdrew Consent|1|||
27786665|NCT01699750|54241202|FG000|Overall Study|Other|0|||
27786666|NCT01699750|54241203|FG001|Overall Study|Other|2|||
27786667|NCT01716754|54241217|FG000|Overall Study|Death|0|||
27786668|NCT01716754|54241218|FG001|Overall Study|Death|0|||
27786669|NCT01716754|54241219|FG002|Overall Study|Death|0|||
27786670|NCT01716754|54241220|FG003|Overall Study|Death|1|||
27786671|NCT01716754|54241217|FG000|Overall Study|Protocol deviation|0|||
27786672|NCT01716754|54241218|FG001|Overall Study|Protocol deviation|2|||
27786673|NCT01716754|54241219|FG002|Overall Study|Protocol deviation|7|||
27786674|NCT01716754|54241220|FG003|Overall Study|Protocol deviation|2|||
27786675|NCT01716754|54241217|FG000|Overall Study|Non-compliance with study treatment|0|||
27786676|NCT01716754|54241218|FG001|Overall Study|Non-compliance with study treatment|0|||
27786677|NCT01716754|54241219|FG002|Overall Study|Non-compliance with study treatment|1|||
27786678|NCT01716754|54241220|FG003|Overall Study|Non-compliance with study treatment|0|||
27786679|NCT01716754|54241217|FG000|Overall Study|Physician Decision|1|||
27786680|NCT01716754|54241218|FG001|Overall Study|Physician Decision|0|||
27786681|NCT01716754|54241219|FG002|Overall Study|Physician Decision|0|||
27786682|NCT01716754|54241220|FG003|Overall Study|Physician Decision|0|||
27786683|NCT01716754|54241217|FG000|Overall Study|Lost to Follow-up|1|||
27930368|NCT01285310|54586695|FG000|Placebo Controlled Phase: Weeks 0-24|Other|1|||
27930369|NCT01285310|54586696|FG001|Placebo Controlled Phase: Weeks 0-24|Other|0|||
28016165|NCT00332839|54675338|FG000|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
28016166|NCT00332839|54675339|FG001|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
28016167|NCT00332839|54675338|FG000|Follow-up (Months 12 - 60)|Lost to Follow-up|2|||
28016168|NCT00332839|54675339|FG001|Follow-up (Months 12 - 60)|Lost to Follow-up|1|||
28016169|NCT00332839|54675338|FG000|Follow-up (Months 12 - 60)|Death|1|||
28016170|NCT00332839|54675339|FG001|Follow-up (Months 12 - 60)|Death|1|||
27930370|NCT01285310|54586697|FG002|Placebo Controlled Phase: Weeks 0-24|Other|1|||
27930371|NCT01285310|54586698|FG003|Placebo Controlled Phase: Weeks 0-24|Other|0|||
27930372|NCT01285310|54586699|FG004|Placebo Controlled Phase: Weeks 0-24|Other|0|||
27930373|NCT01285310|54586695|FG000|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
27930374|NCT01285310|54586696|FG001|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
27930375|NCT01285310|54586697|FG002|Active Treatment Phase: Weeks 25-52|Adverse Event|3|||
27930376|NCT01285310|54586698|FG003|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
28016171|NCT00357097|54675347|FG000|Overall Study|Did not meet inclusion criteria|5|||
28016172|NCT00357097|54675348|FG001|Overall Study|Did not meet inclusion criteria|3|||
28016173|NCT00357097|54675347|FG000|Overall Study|Adverse Event|34|||
27786684|NCT01716754|54241218|FG001|Overall Study|Lost to Follow-up|0|||
27786685|NCT01716754|54241219|FG002|Overall Study|Lost to Follow-up|0|||
27786686|NCT01716754|54241220|FG003|Overall Study|Lost to Follow-up|1|||
27786687|NCT01716754|54241217|FG000|Overall Study|Adverse Event|4|||
27930377|NCT01285310|54586699|FG004|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
28016174|NCT00357097|54675348|FG001|Overall Study|Adverse Event|6|||
28016175|NCT00357097|54675347|FG000|Overall Study|Withdrawal by Subject|8|||
27786688|NCT01716754|54241218|FG001|Overall Study|Adverse Event|2|||
27786689|NCT01716754|54241219|FG002|Overall Study|Adverse Event|2|||
27786690|NCT01716754|54241220|FG003|Overall Study|Adverse Event|1|||
27786691|NCT01716754|54241217|FG000|Overall Study|Withdrawal by Subject|5|||
28016176|NCT00357097|54675348|FG001|Overall Study|Withdrawal by Subject|7|||
28016177|NCT00357097|54675347|FG000|Overall Study|Non-compliance|1|||
28016178|NCT00357097|54675348|FG001|Overall Study|Non-compliance|2|||
28016179|NCT00357097|54675347|FG000|Overall Study|Lack of Efficacy|2|||
28016180|NCT00357097|54675348|FG001|Overall Study|Lack of Efficacy|8|||
28016181|NCT00357097|54675347|FG000|Overall Study|Met Exclusion Criteria|3|||
28016182|NCT00357097|54675348|FG001|Overall Study|Met Exclusion Criteria|1|||
28016183|NCT00357097|54675347|FG000|Overall Study|Other|1|||
28016184|NCT00357097|54675348|FG001|Overall Study|Other|1|||
28016185|NCT00357097|54675347|FG000|Overall Study|Increase of RLS Symptoms|0|||
28016186|NCT00357097|54675348|FG001|Overall Study|Increase of RLS Symptoms|1|||
28016187|NCT00356863|54675356|FG000|Overall Study|Death|16|||
28016188|NCT00356863|54675357|FG001|Overall Study|Death|32|||
28016189|NCT00356863|54675356|FG000|Overall Study|Lost to Follow-up|76|||
28016190|NCT00356863|54675357|FG001|Overall Study|Lost to Follow-up|43|||
28016191|NCT00355615|54675380|FG000|Randomized Double Blind Period|Adverse Event|1|||
28016192|NCT00355615|54675381|FG001|Randomized Double Blind Period|Adverse Event|0|||
28016193|NCT00355615|54675382|FG002|Randomized Double Blind Period|Adverse Event|0|||
28016194|NCT00355615|54675383|FG003|Randomized Double Blind Period|Adverse Event|0|||
28016195|NCT00355615|54675384|FG004|Randomized Double Blind Period|Adverse Event|0|||
28016196|NCT00355615|54675380|FG000|Randomized Double Blind Period|Protocol Violation|0|||
28016197|NCT00355615|54675381|FG001|Randomized Double Blind Period|Protocol Violation|0|||
28016198|NCT00355615|54675382|FG002|Randomized Double Blind Period|Protocol Violation|1|||
28016199|NCT00355615|54675383|FG003|Randomized Double Blind Period|Protocol Violation|1|||
28016200|NCT00355615|54675384|FG004|Randomized Double Blind Period|Protocol Violation|0|||
28016201|NCT00355615|54675380|FG000|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
28016202|NCT00355615|54675381|FG001|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
28016203|NCT00355615|54675382|FG002|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
28016204|NCT00355615|54675383|FG003|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
28016205|NCT00355615|54675384|FG004|40-week Rosuvastatin Open Label Period|Adverse Event|4|||
28016206|NCT00355615|54675380|FG000|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
28016207|NCT00355615|54675381|FG001|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
28016208|NCT00355615|54675382|FG002|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
28016209|NCT00355615|54675383|FG003|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
28016210|NCT00355615|54675384|FG004|40-week Rosuvastatin Open Label Period|Protocol Violation|1|||
28016211|NCT00355615|54675380|FG000|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
28016212|NCT00355615|54675381|FG001|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
28016213|NCT00355615|54675382|FG002|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
28016214|NCT00355615|54675383|FG003|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
28016215|NCT00355615|54675384|FG004|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3|||
28016216|NCT00355615|54675380|FG000|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
28016217|NCT00355615|54675381|FG001|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
28016218|NCT00355615|54675382|FG002|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
28016219|NCT00355615|54675383|FG003|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
28016220|NCT00355615|54675384|FG004|40-week Rosuvastatin Open Label Period|investigational site closed|1|||
28016221|NCT00347269|54675397|FG000|Overall Study|Lost to Follow-up|74|||
28016222|NCT00347269|54675398|FG001|Overall Study|Lost to Follow-up|65|||
28016223|NCT00347269|54675397|FG000|Overall Study|Withdrawal by Subject|18|||
28016224|NCT00347269|54675398|FG001|Overall Study|Withdrawal by Subject|38|||
28016225|NCT00347269|54675397|FG000|Overall Study|Death|2|||
28016226|NCT00347269|54675398|FG001|Overall Study|Death|3|||
28016227|NCT00544648|54675406|FG000|Overall Study|Withdrawal by Subject|1|||
28016228|NCT00544648|54675407|FG001|Overall Study|Withdrawal by Subject|0|||
28016229|NCT00544648|54675406|FG000|Overall Study|Adverse Event|1|||
28016230|NCT00544648|54675407|FG001|Overall Study|Adverse Event|1|||
28016231|NCT00544648|54675406|FG000|Overall Study|progression of disease|1|||
28016232|NCT00544648|54675407|FG001|Overall Study|progression of disease|0|||
28016233|NCT00346333|54675417|FG000|Overall Study|Death|1|||
28016234|NCT00346333|54675418|FG001|Overall Study|Death|0|||
28016235|NCT00346333|54675417|FG000|Overall Study|unwilling or unable to continue|4|||
28016236|NCT00346333|54675418|FG001|Overall Study|unwilling or unable to continue|8|||
28016237|NCT00330967|54675428|FG000|Overall Study|Withdrawal by Subject|0|||
28016238|NCT00330967|54675429|FG001|Overall Study|Withdrawal by Subject|5|||
28016239|NCT00330967|54675428|FG000|Overall Study|Physician Decision|0|||
28016240|NCT00330967|54675429|FG001|Overall Study|Physician Decision|9|||
28016241|NCT00330343|54675435|FG000|Overall Study|Lost to Follow-up|5|||
28016242|NCT00330187|54675443|FG000|Overall Study|Lost to Follow-up|12|||
28016243|NCT00330187|54675444|FG001|Overall Study|Lost to Follow-up|13|||
28016244|NCT00330187|54675445|FG002|Overall Study|Lost to Follow-up|14|||
28016245|NCT00330187|54675446|FG003|Overall Study|Lost to Follow-up|10|||
28016246|NCT00330187|54675443|FG000|Overall Study|Withdrawal by Subject|8|||
28016247|NCT00330187|54675444|FG001|Overall Study|Withdrawal by Subject|5|||
28016248|NCT00330187|54675445|FG002|Overall Study|Withdrawal by Subject|4|||
28016249|NCT00330187|54675446|FG003|Overall Study|Withdrawal by Subject|4|||
28016250|NCT03914950|54675456|FG000|Overall Study|Physician Decision|54|||
28016251|NCT00329797|54675468|FG000|Overall Study|Protocol Violation|1|||
28016252|NCT00329797|54675469|FG001|Overall Study|Protocol Violation|0|||
28016253|NCT00329797|54675468|FG000|Overall Study|Withdrawal by Subject|6|||
28016254|NCT00329797|54675469|FG001|Overall Study|Withdrawal by Subject|6|||
28016255|NCT00541450|54675477|FG000|Phase A|Adverse Event|3|||
28016256|NCT00541450|54675478|FG001|Phase A|Adverse Event|0|||
28016257|NCT00541450|54675477|FG000|Phase A|Creatinine/CrCl -Increase in creatinine|0|||
28016258|NCT00541450|54675478|FG001|Phase A|Creatinine/CrCl -Increase in creatinine|2|||
28016259|NCT00541450|54675477|FG000|Phase A|Hyperglycemia|0|||
28016260|NCT00541450|54675478|FG001|Phase A|Hyperglycemia|1|||
28016261|NCT00541450|54675477|FG000|Phase A|Lost to Follow-up|6|||
28016262|NCT00541450|54675478|FG001|Phase A|Lost to Follow-up|4|||
28016263|NCT00541450|54675477|FG000|Phase A|Physician Decision|2|||
28016264|NCT00541450|54675478|FG001|Phase A|Physician Decision|0|||
28016265|NCT00541450|54675477|FG000|Phase A|Protocol Violation|2|||
27930378|NCT01285310|54586695|FG000|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
27930379|NCT01285310|54586696|FG001|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4|||
27930380|NCT01285310|54586697|FG002|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3|||
27930381|NCT01285310|54586698|FG003|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1|||
27930382|NCT01285310|54586699|FG004|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
27930383|NCT01285310|54586695|FG000|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
27930384|NCT01285310|54586696|FG001|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3|||
27930385|NCT01285310|54586697|FG002|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
27930386|NCT01285310|54586698|FG003|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
27930387|NCT01285310|54586699|FG004|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
27930388|NCT01285310|54586695|FG000|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0|||
27930389|NCT01285310|54586696|FG001|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21|||
28016266|NCT00541450|54675478|FG001|Phase A|Protocol Violation|3|||
28016267|NCT00541450|54675477|FG000|Phase A|Withdrawal by Subject|7|||
28016268|NCT00541450|54675478|FG001|Phase A|Withdrawal by Subject|7|||
28016269|NCT00541450|54675477|FG000|Phase B|Adverse Event|6|||
28016270|NCT00541450|54675478|FG001|Phase B|Adverse Event|6|||
28016271|NCT00541450|54675477|FG000|Phase B|Hyperglycemia|10|||
28016272|NCT00541450|54675478|FG001|Phase B|Hyperglycemia|9|||
27841575|NCT01683266|54329450|FG001|Overall Study|Lost to Follow-up|0|||
27841576|NCT01683266|54329449|FG000|Overall Study|Site Closure / Site Withdrawal|1|||
27841577|NCT01683266|54329450|FG001|Overall Study|Site Closure / Site Withdrawal|3|||
27841578|NCT01683266|54329449|FG000|Overall Study|Nonserious Hypoglycemia|0|||
27841579|NCT01683266|54329450|FG001|Overall Study|Nonserious Hypoglycemia|3|||
27841580|NCT01683266|54329449|FG000|Overall Study|Perceived Lack of Efficacy|1|||
27841581|NCT01683266|54329450|FG001|Overall Study|Perceived Lack of Efficacy|1|||
27841582|NCT01683266|54329449|FG000|Overall Study|Possibly Hypoglycemia|1|||
27841583|NCT01683266|54329450|FG001|Overall Study|Possibly Hypoglycemia|0|||
27841584|NCT01683266|54329449|FG000|Overall Study|Serious Adverse Event of Hypoglycemia|0|||
27841585|NCT01683266|54329450|FG001|Overall Study|Serious Adverse Event of Hypoglycemia|1|||
27841586|NCT01467661|54329456|FG000|Overall Study|Adverse Event|16|||
27841587|NCT01467661|54329456|FG000|Overall Study|Withdrawal by Subject|1|||
27841588|NCT01467661|54329456|FG000|Overall Study|Lack of Efficacy|3|||
27841589|NCT01467661|54329456|FG000|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1|||
27841590|NCT01577186|54329462|FG000|Overall Study|Adverse Event|23|||
27841591|NCT01577186|54329462|FG000|Overall Study|Death|1|||
27841592|NCT01577186|54329462|FG000|Overall Study|Lost to Follow-up|28|||
27841593|NCT01577186|54329462|FG000|Overall Study|Withdrawal by Subject|35|||
27841594|NCT01577186|54329462|FG000|Overall Study|Insufficient Response|18|||
27841595|NCT01577186|54329462|FG000|Overall Study|Ineligible to Continue|15|||
27841596|NCT01577186|54329462|FG000|Overall Study|Non-Compliant|8|||
27841597|NCT01577186|54329462|FG000|Overall Study|Other|2|||
27841598|NCT01559012|54329468|FG000|Overall Study|Withdrawal by Subject|0|||
27841599|NCT01559012|54329469|FG001|Overall Study|Withdrawal by Subject|1|||
27841600|NCT01451827|54329494|FG000|Overall Study|Adverse Event|2|||
27841601|NCT01451827|54329495|FG001|Overall Study|Adverse Event|0|||
27841602|NCT01451827|54329496|FG002|Overall Study|Adverse Event|1|||
27841603|NCT01451827|54329497|FG003|Overall Study|Adverse Event|1|||
27841604|NCT01451827|54329494|FG000|Overall Study|Protocol deviation|1|||
27841605|NCT01451827|54329495|FG001|Overall Study|Protocol deviation|0|||
27841606|NCT01451827|54329496|FG002|Overall Study|Protocol deviation|0|||
28016273|NCT00541450|54675477|FG000|Phase B|Lost to Follow-up|6|||
27841607|NCT01451827|54329497|FG003|Overall Study|Protocol deviation|0|||
27841608|NCT01451827|54329494|FG000|Overall Study|Lost to Follow-up|0|||
27841609|NCT01451827|54329495|FG001|Overall Study|Lost to Follow-up|3|||
27841610|NCT01451827|54329496|FG002|Overall Study|Lost to Follow-up|0|||
27841611|NCT01451827|54329497|FG003|Overall Study|Lost to Follow-up|2|||
27841612|NCT01451827|54329494|FG000|Overall Study|Participant met withdrawal criteria|0|||
27841613|NCT01451827|54329495|FG001|Overall Study|Participant met withdrawal criteria|2|||
28016274|NCT00541450|54675478|FG001|Phase B|Lost to Follow-up|4|||
28016275|NCT00541450|54675477|FG000|Phase B|Physician Decision|4|||
28016276|NCT00541450|54675478|FG001|Phase B|Physician Decision|2|||
28016277|NCT00541450|54675477|FG000|Phase B|Pregnancy|0|||
28016278|NCT00541450|54675478|FG001|Phase B|Pregnancy|1|||
28016279|NCT00541450|54675477|FG000|Phase B|Protocol Violation|3|||
28016280|NCT00541450|54675478|FG001|Phase B|Protocol Violation|3|||
28016281|NCT00541450|54675477|FG000|Phase B|Withdrawal by Subject|8|||
28016282|NCT00541450|54675478|FG001|Phase B|Withdrawal by Subject|6|||
28016283|NCT00355147|54675490|FG000|Overall Study|Lost to Follow-up|10|||
28016284|NCT00355147|54675491|FG001|Overall Study|Lost to Follow-up|8|||
28016285|NCT00355147|54675490|FG000|Overall Study|Withdrawal by Subject|8|||
28016286|NCT00355147|54675491|FG001|Overall Study|Withdrawal by Subject|12|||
28016287|NCT00540124|54675504|FG000|Overall Study|Adverse Event|0|||
28016288|NCT00540124|54675505|FG001|Overall Study|Adverse Event|2|||
28016289|NCT00540124|54675506|FG002|Overall Study|Adverse Event|1|||
28016290|NCT00540124|54675504|FG000|Overall Study|Entry Criteria Not Met|2|||
28016291|NCT00540124|54675505|FG001|Overall Study|Entry Criteria Not Met|0|||
28016292|NCT00540124|54675506|FG002|Overall Study|Entry Criteria Not Met|0|||
28016293|NCT00540124|54675504|FG000|Overall Study|Lack of Efficacy|1|||
28016294|NCT00540124|54675505|FG001|Overall Study|Lack of Efficacy|0|||
28016295|NCT00540124|54675506|FG002|Overall Study|Lack of Efficacy|0|||
28016296|NCT00540124|54675504|FG000|Overall Study|Withdrawal by Subject|1|||
28016297|NCT00540124|54675505|FG001|Overall Study|Withdrawal by Subject|1|||
28016298|NCT00540124|54675506|FG002|Overall Study|Withdrawal by Subject|0|||
28016299|NCT00540046|54675516|FG000|Overall Study|Lost to Follow-up|33|||
28016300|NCT00540046|54675517|FG001|Overall Study|Lost to Follow-up|23|||
28016301|NCT00689936|54675528|FG000|Active Treatment Phase|Adverse Event|68|||
28016302|NCT00689936|54675529|FG001|Active Treatment Phase|Adverse Event|71|||
28016303|NCT00689936|54675530|FG002|Active Treatment Phase|Adverse Event|76|||
28016304|NCT00689936|54675528|FG000|Active Treatment Phase|Disease Progression|273|||
27930390|NCT01285310|54586697|FG002|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19|||
27930391|NCT01285310|54586698|FG003|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6|||
27930392|NCT01285310|54586699|FG004|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15|||
28016305|NCT00689936|54675529|FG001|Active Treatment Phase|Disease Progression|362|||
27930393|NCT01285310|54586695|FG000|Active Treatment Phase: Weeks 25-52|Other|0|||
27930394|NCT01285310|54586696|FG001|Active Treatment Phase: Weeks 25-52|Other|1|||
27930395|NCT01285310|54586697|FG002|Active Treatment Phase: Weeks 25-52|Other|0|||
27930396|NCT01285310|54586698|FG003|Active Treatment Phase: Weeks 25-52|Other|0|||
27930397|NCT01285310|54586699|FG004|Active Treatment Phase: Weeks 25-52|Other|0|||
27930398|NCT01285310|54586695|FG000|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
27930399|NCT01285310|54586696|FG001|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
27930400|NCT01285310|54586697|FG002|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
27930401|NCT01285310|54586698|FG003|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
28016306|NCT00689936|54675530|FG002|Active Treatment Phase|Disease Progression|339|||
28016307|NCT00689936|54675528|FG000|Active Treatment Phase|Withdrawal by Subject|16|||
28016308|NCT00689936|54675529|FG001|Active Treatment Phase|Withdrawal by Subject|16|||
28016309|NCT00689936|54675530|FG002|Active Treatment Phase|Withdrawal by Subject|21|||
28016310|NCT00689936|54675528|FG000|Active Treatment Phase|Death|60|||
28016311|NCT00689936|54675529|FG001|Active Treatment Phase|Death|28|||
28016312|NCT00689936|54675530|FG002|Active Treatment Phase|Death|37|||
28016313|NCT00689936|54675528|FG000|Active Treatment Phase|Lost to Follow-up|0|||
27930402|NCT01285310|54586699|FG004|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
28016314|NCT00689936|54675529|FG001|Active Treatment Phase|Lost to Follow-up|2|||
28016315|NCT00689936|54675530|FG002|Active Treatment Phase|Lost to Follow-up|2|||
28016316|NCT00689936|54675528|FG000|Active Treatment Phase|Protocol Violation|2|||
28016317|NCT00689936|54675529|FG001|Active Treatment Phase|Protocol Violation|2|||
28016318|NCT00689936|54675530|FG002|Active Treatment Phase|Protocol Violation|4|||
28016319|NCT00689936|54675528|FG000|Active Treatment Phase|Study Close Out|64|||
28016320|NCT00689936|54675529|FG001|Active Treatment Phase|Study Close Out|26|||
28016321|NCT00689936|54675530|FG002|Active Treatment Phase|Study Close Out|21|||
28016322|NCT00689936|54675528|FG000|Active Treatment Phase|Miscellaneous|52|||
28016323|NCT00689936|54675529|FG001|Active Treatment Phase|Miscellaneous|34|||
28016324|NCT00689936|54675530|FG002|Active Treatment Phase|Miscellaneous|47|||
28016325|NCT00689936|54675528|FG000|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127|||
28016326|NCT00689936|54675529|FG001|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188|||
28016327|NCT00689936|54675530|FG002|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144|||
28016328|NCT00671034|54675541|FG000|Overall Study|Adverse Event|5|||
28016329|NCT00671034|54675542|FG001|Overall Study|Adverse Event|7|||
28016330|NCT00671034|54675543|FG002|Overall Study|Adverse Event|1|||
28016331|NCT00671034|54675541|FG000|Overall Study|Death|3|||
28016332|NCT00671034|54675542|FG001|Overall Study|Death|2|||
28016333|NCT00671034|54675543|FG002|Overall Study|Death|1|||
28016334|NCT00671034|54675541|FG000|Overall Study|Physician Decision|12|||
28016335|NCT00671034|54675542|FG001|Overall Study|Physician Decision|4|||
28016336|NCT00671034|54675543|FG002|Overall Study|Physician Decision|5|||
28016337|NCT00671034|54675541|FG000|Overall Study|VHR ALL feature|8|||
28016338|NCT00671034|54675542|FG001|Overall Study|VHR ALL feature|3|||
28016339|NCT00671034|54675543|FG002|Overall Study|VHR ALL feature|5|||
28016340|NCT00671034|54675541|FG000|Overall Study|Refusal|5|||
28016341|NCT00671034|54675542|FG001|Overall Study|Refusal|3|||
28016342|NCT00671034|54675543|FG002|Overall Study|Refusal|5|||
28016343|NCT00671034|54675541|FG000|Overall Study|includes Alternative therapy, etc.|6|||
28016344|NCT00671034|54675542|FG001|Overall Study|includes Alternative therapy, etc.|1|||
28016345|NCT00671034|54675543|FG002|Overall Study|includes Alternative therapy, etc.|7|||
28016346|NCT04404478|54675554|FG000|Overall Study|Withdrawal by Subject|1|||
28016347|NCT04404478|54675555|FG001|Overall Study|Withdrawal by Subject|3|||
28016348|NCT00539734|54675563|FG000|Overall Study|Protocol Violation|1|||
28016349|NCT03907072|54675570|FG000|Overall Study|Study Terminated by Sponsor|2|||
28016350|NCT03907072|54675571|FG001|Overall Study|Study Terminated by Sponsor|2|||
28016351|NCT03907072|54675572|FG002|Overall Study|Study Terminated by Sponsor|2|||
28016352|NCT00329719|54675597|FG000|Overall Study|Lost to Follow-up|0|||
28016353|NCT00329719|54675598|FG001|Overall Study|Lost to Follow-up|0|||
27786692|NCT01716754|54241218|FG001|Overall Study|Withdrawal by Subject|0|||
28016354|NCT00329719|54675599|FG002|Overall Study|Lost to Follow-up|0|||
28016355|NCT00329719|54675600|FG003|Overall Study|Lost to Follow-up|1|||
28016356|NCT00329641|54675610|FG000|Overall Study|Did not start treatment|1|||
28016357|NCT00329641|54675610|FG000|Overall Study|Not eligible|1|||
28016358|NCT00329641|54675610|FG000|Overall Study|Adverse Event|3|||
27930403|NCT01254630|54586741|FG000|Overall Study|Adverse Event|36|||
27930404|NCT01254630|54586742|FG001|Overall Study|Adverse Event|15|||
28016359|NCT00329641|54675610|FG000|Overall Study|Other reason, not protocol specified|1|||
28016360|NCT00329407|54675624|FG000|Overall Study|Withdrawal by Subject|1|||
28105560|NCT04553913|54763003|FG000|Overall Study|did not use the device properly|5|||
27930405|NCT01254630|54586743|FG002|Overall Study|Adverse Event|40|||
27930406|NCT01254630|54586744|FG003|Overall Study|Adverse Event|8|||
27930407|NCT01254630|54586741|FG000|Overall Study|Death|461|||
27930408|NCT01254630|54586742|FG001|Overall Study|Death|151|||
27930409|NCT01254630|54586743|FG002|Overall Study|Death|478|||
27930410|NCT01254630|54586744|FG003|Overall Study|Death|139|||
27930411|NCT01254630|54586741|FG000|Overall Study|Lost to Follow-up|80|||
27930412|NCT01254630|54586742|FG001|Overall Study|Lost to Follow-up|26|||
27930413|NCT01254630|54586743|FG002|Overall Study|Lost to Follow-up|89|||
27930414|NCT01254630|54586744|FG003|Overall Study|Lost to Follow-up|32|||
27930415|NCT01254630|54586741|FG000|Overall Study|Physician Decision|24|||
27930416|NCT01254630|54586742|FG001|Overall Study|Physician Decision|8|||
27930417|NCT01254630|54586743|FG002|Overall Study|Physician Decision|16|||
27930418|NCT01254630|54586744|FG003|Overall Study|Physician Decision|7|||
27930419|NCT01254630|54586741|FG000|Overall Study|Withdrawal by Subject|201|||
27930420|NCT01254630|54586742|FG001|Overall Study|Withdrawal by Subject|94|||
27930421|NCT01254630|54586743|FG002|Overall Study|Withdrawal by Subject|188|||
27930422|NCT01254630|54586744|FG003|Overall Study|Withdrawal by Subject|89|||
27930423|NCT01254630|54586741|FG000|Overall Study|Study terminated by sponsor|0|||
27930424|NCT01254630|54586742|FG001|Overall Study|Study terminated by sponsor|994|||
27930425|NCT01254630|54586743|FG002|Overall Study|Study terminated by sponsor|0|||
27930426|NCT01254630|54586744|FG003|Overall Study|Study terminated by sponsor|1010|||
27930427|NCT01254630|54586741|FG000|Overall Study|Status not recorded|0|||
27930428|NCT01254630|54586742|FG001|Overall Study|Status not recorded|0|||
27930429|NCT01254630|54586743|FG002|Overall Study|Status not recorded|1|||
28016361|NCT00328783|54675628|FG000|Overall Study|Could not tolerate ABC|21|||
28016362|NCT00328783|54675628|FG000|Overall Study|No heart in RT field|4|||
28016363|NCT00328783|54675628|FG000|Overall Study|Withdrawal by Subject|1|||
28016364|NCT00567489|54675636|FG000|Overall Study|Adverse Event|6|||
27786693|NCT01716754|54241219|FG002|Overall Study|Withdrawal by Subject|4|||
27786694|NCT01716754|54241220|FG003|Overall Study|Withdrawal by Subject|3|||
27786695|NCT01698814|54241231|FG000|Overall Study|Adverse Event|0|||
27786696|NCT01698814|54241232|FG001|Overall Study|Adverse Event|2|||
27786697|NCT01698814|54241231|FG000|Overall Study|Lost to Follow-up|0|||
27786698|NCT01698814|54241232|FG001|Overall Study|Lost to Follow-up|1|||
27786699|NCT01698814|54241231|FG000|Overall Study|Pregnancy|1|||
27786700|NCT01698814|54241232|FG001|Overall Study|Pregnancy|0|||
27786701|NCT01698814|54241231|FG000|Overall Study|Randomized in error|1|||
27786702|NCT01698814|54241232|FG001|Overall Study|Randomized in error|0|||
27786703|NCT01738984|54241240|FG000|Overall Study|Pregnancy|4|||
27786704|NCT01738984|54241241|FG001|Overall Study|Pregnancy|0|||
27786705|NCT01738984|54241240|FG000|Overall Study|Withdrawal by Subject|1|||
27786706|NCT01738984|54241241|FG001|Overall Study|Withdrawal by Subject|0|||
27786707|NCT01738984|54241240|FG000|Overall Study|Lost to Follow-up|59|||
27786708|NCT01738984|54241241|FG001|Overall Study|Lost to Follow-up|39|||
27786709|NCT01738594|54241250|FG000|Registration and Treatment Start|Adverse Event|0|||
27786710|NCT01738594|54241251|FG001|Registration and Treatment Start|Adverse Event|1|||
27786711|NCT01738594|54241252|FG002|Registration and Treatment Start|Adverse Event|0|||
27786712|NCT01738594|54241253|FG003|Registration and Treatment Start|Adverse Event|0|||
27786713|NCT01738594|54241254|FG004|Registration and Treatment Start|Adverse Event|0|||
27786714|NCT01738594|54241255|FG005|Registration and Treatment Start|Adverse Event|0|||
27786715|NCT01738594|54241256|FG006|Registration and Treatment Start|Adverse Event|0|||
27786716|NCT01738594|54241257|FG007|Registration and Treatment Start|Adverse Event|0|||
27786717|NCT01738594|54241250|FG000|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
27786718|NCT01738594|54241251|FG001|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
27786719|NCT01738594|54241252|FG002|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
27786720|NCT01738594|54241253|FG003|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
27786721|NCT01738594|54241254|FG004|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
27786722|NCT01738594|54241255|FG005|Completed 2 Cycles/Reached 1st Response|Physician Decision|1|||
27786723|NCT01738594|54241256|FG006|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
27786724|NCT01738594|54241257|FG007|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
27786725|NCT01738594|54241250|FG000|Completed 4 Cycles of Treatment|Progressive disease|0|||
27786726|NCT01738594|54241251|FG001|Completed 4 Cycles of Treatment|Progressive disease|2|||
27786727|NCT01738594|54241252|FG002|Completed 4 Cycles of Treatment|Progressive disease|0|||
27786728|NCT01738594|54241253|FG003|Completed 4 Cycles of Treatment|Progressive disease|0|||
27786729|NCT01738594|54241254|FG004|Completed 4 Cycles of Treatment|Progressive disease|0|||
27786730|NCT01738594|54241255|FG005|Completed 4 Cycles of Treatment|Progressive disease|0|||
27786731|NCT01738594|54241256|FG006|Completed 4 Cycles of Treatment|Progressive disease|0|||
27786732|NCT01738594|54241257|FG007|Completed 4 Cycles of Treatment|Progressive disease|0|||
27786733|NCT01738594|54241250|FG000|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
27786734|NCT01738594|54241251|FG001|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
27786735|NCT01738594|54241252|FG002|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
27786736|NCT01738594|54241253|FG003|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
27786737|NCT01738594|54241254|FG004|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
27786738|NCT01738594|54241255|FG005|Completed 4 Cycles of Treatment|No response/patient benefit|1|||
27786739|NCT01738594|54241256|FG006|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
27786740|NCT01738594|54241257|FG007|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
27786741|NCT01738594|54241250|FG000|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
27786742|NCT01738594|54241251|FG001|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
27786743|NCT01738594|54241252|FG002|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
27786744|NCT01738594|54241253|FG003|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
27786745|NCT01738594|54241254|FG004|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
27786746|NCT01738594|54241255|FG005|Went on to Continue Treatment Cycle 5|Progressive Disease|1|||
27786747|NCT01738594|54241256|FG006|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
27786748|NCT01738594|54241257|FG007|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
27786749|NCT01738594|54241250|FG000|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
27786750|NCT01738594|54241251|FG001|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
27786751|NCT01738594|54241252|FG002|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
27786752|NCT01738594|54241253|FG003|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
27786753|NCT01738594|54241254|FG004|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1|||
27786754|NCT01738594|54241255|FG005|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
27786755|NCT01738594|54241256|FG006|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
27786756|NCT01738594|54241257|FG007|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
27786757|NCT01738594|54241250|FG000|Follow up for 1 Year|Death|0|||
27786758|NCT01738594|54241251|FG001|Follow up for 1 Year|Death|0|||
27786759|NCT01738594|54241252|FG002|Follow up for 1 Year|Death|0|||
27786760|NCT01738594|54241253|FG003|Follow up for 1 Year|Death|0|||
27930430|NCT01254630|54586744|FG003|Overall Study|Status not recorded|0|||
27930431|NCT01284140|54586754|FG000|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
27930432|NCT01284140|54586755|FG001|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
27930433|NCT01284140|54586754|FG000|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0|||
27930434|NCT01284140|54586755|FG001|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1|||
27930435|NCT01254318|54586761|FG000|Overall Study|Lost to Follow-up|5|||
27930436|NCT01254318|54586761|FG000|Overall Study|Death|47|||
27930437|NCT01284062|54586769|FG000|Overall Study|Adverse Event|4|||
27930438|NCT01284062|54586770|FG001|Overall Study|Adverse Event|5|||
27930439|NCT01284062|54586771|FG002|Overall Study|Adverse Event|0|||
27930440|NCT01284062|54586772|FG003|Overall Study|Adverse Event|5|||
27930441|NCT01284062|54586769|FG000|Overall Study|Lack of Efficacy|3|||
27930442|NCT01284062|54586770|FG001|Overall Study|Lack of Efficacy|2|||
27930443|NCT01284062|54586771|FG002|Overall Study|Lack of Efficacy|2|||
27930444|NCT01284062|54586772|FG003|Overall Study|Lack of Efficacy|1|||
27930445|NCT01284062|54586769|FG000|Overall Study|Medication error without adverse event|0|||
27930446|NCT01284062|54586770|FG001|Overall Study|Medication error without adverse event|0|||
27930447|NCT01284062|54586771|FG002|Overall Study|Medication error without adverse event|1|||
27930448|NCT01284062|54586772|FG003|Overall Study|Medication error without adverse event|0|||
27930449|NCT01284062|54586769|FG000|Overall Study|Protocol Violation|1|||
27930450|NCT01284062|54586770|FG001|Overall Study|Protocol Violation|0|||
27930451|NCT01284062|54586771|FG002|Overall Study|Protocol Violation|0|||
27930452|NCT01284062|54586772|FG003|Overall Study|Protocol Violation|2|||
27930453|NCT01284062|54586769|FG000|Overall Study|Withdrawal by Subject|3|||
27930454|NCT01284062|54586770|FG001|Overall Study|Withdrawal by Subject|1|||
27930455|NCT01284062|54586771|FG002|Overall Study|Withdrawal by Subject|2|||
27930456|NCT01284062|54586772|FG003|Overall Study|Withdrawal by Subject|5|||
27930457|NCT01284062|54586769|FG000|Overall Study|Other|0|||
27930458|NCT01284062|54586770|FG001|Overall Study|Other|0|||
28105561|NCT04490499|54763008|FG000|Overall Study|Withdrawal by Subject|2|||
28105562|NCT01332994|54763012|FG000|Overall Study|Adverse Event|34|||
28105563|NCT01332994|54763012|FG000|Overall Study|Death|1|||
27930459|NCT01284062|54586771|FG002|Overall Study|Other|0|||
27930460|NCT01284062|54586772|FG003|Overall Study|Other|1|||
27930461|NCT01284062|54586769|FG000|Overall Study|Site Closed|0|||
27930462|NCT01284062|54586770|FG001|Overall Study|Site Closed|0|||
27930463|NCT01284062|54586771|FG002|Overall Study|Site Closed|1|||
27930464|NCT01284062|54586772|FG003|Overall Study|Site Closed|0|||
27930465|NCT01253304|54586789|FG000|Overall Study|Adverse Event|0|||
27930466|NCT01253304|54586790|FG001|Overall Study|Adverse Event|0|||
27930467|NCT01253304|54586791|FG002|Overall Study|Adverse Event|0|||
27930468|NCT01253304|54586792|FG003|Overall Study|Adverse Event|1|||
27930469|NCT01253226|54586807|FG000|Overall Study|Adverse Event|0|||
27930470|NCT01253226|54586808|FG001|Overall Study|Adverse Event|0|||
27930471|NCT01253226|54586809|FG002|Overall Study|Adverse Event|1|||
27930472|NCT01253226|54586810|FG003|Overall Study|Adverse Event|0|||
27930473|NCT01253226|54586811|FG004|Overall Study|Adverse Event|0|||
27930474|NCT01253226|54586807|FG000|Overall Study|Death|0|||
27930475|NCT01253226|54586808|FG001|Overall Study|Death|1|||
27930476|NCT01253226|54586809|FG002|Overall Study|Death|0|||
27930477|NCT01253226|54586810|FG003|Overall Study|Death|0|||
27930478|NCT01253226|54586811|FG004|Overall Study|Death|0|||
27930479|NCT01253226|54586807|FG000|Overall Study|Physician Decision|0|||
27930480|NCT01253226|54586808|FG001|Overall Study|Physician Decision|0|||
27930481|NCT01253226|54586809|FG002|Overall Study|Physician Decision|0|||
27930482|NCT01253226|54586810|FG003|Overall Study|Physician Decision|0|||
27930483|NCT01253226|54586811|FG004|Overall Study|Physician Decision|2|||
27930484|NCT01253226|54586807|FG000|Overall Study|Withdrawal by Subject|0|||
27930485|NCT01253226|54586808|FG001|Overall Study|Withdrawal by Subject|0|||
27930486|NCT01253226|54586809|FG002|Overall Study|Withdrawal by Subject|0|||
27930487|NCT01253226|54586810|FG003|Overall Study|Withdrawal by Subject|1|||
27930488|NCT01253226|54586811|FG004|Overall Study|Withdrawal by Subject|0|||
27930489|NCT01252290|54586823|FG000|Overall Study|Withdrawal by Subject|1|||
27930490|NCT01252134|54586827|FG000|Period 1, 8 Hours|Personal Reasons|0|||
27930491|NCT01252134|54586828|FG001|Period 1, 8 Hours|Personal Reasons|1|||
27930492|NCT01252134|54586829|FG002|Period 1, 8 Hours|Personal Reasons|1|||
27930493|NCT01252134|54586830|FG003|Period 1, 8 Hours|Personal Reasons|0|||
27930494|NCT01252134|54586831|FG004|Period 1, 8 Hours|Personal Reasons|0|||
27930495|NCT01252134|54586832|FG005|Period 1, 8 Hours|Personal Reasons|0|||
27930496|NCT01251744|54586842|FG000|Overall Study|Lost to Follow-up|1|||
27930497|NCT01251744|54586843|FG001|Overall Study|Lost to Follow-up|0|||
27930498|NCT01251354|54586856|FG000|Overall Study|Adverse Event|1|||
27930499|NCT01251354|54586856|FG000|Overall Study|Investigator's Decision|1|||
27930500|NCT01251354|54586856|FG000|Overall Study|Disease Progression|4|||
27930501|NCT01251276|54586862|FG000|Overall Study|Protocol Violation|1|||
27930502|NCT01251276|54586863|FG001|Overall Study|Protocol Violation|0|||
27930503|NCT01251276|54586862|FG000|Overall Study|Lost to Follow-up|0|||
27930504|NCT01251276|54586863|FG001|Overall Study|Lost to Follow-up|1|||
27930505|NCT01251120|54586871|FG000|Overall Study|Lack of Efficacy|0|||
27930506|NCT01251120|54586872|FG001|Overall Study|Lack of Efficacy|1|||
27930507|NCT01250418|54586880|FG000|Overall Study|monitor data failure|1|||
27930508|NCT01250418|54586881|FG001|Overall Study|monitor data failure|1|||
27930509|NCT01292603|54586892|FG000|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
27930510|NCT01292603|54586893|FG001|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
27930511|NCT01292603|54586894|FG002|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
27930512|NCT01292603|54586895|FG003|Part 1: Pilot Dose Selection Period|Adverse Event|4|||
27930513|NCT01292603|54586896|FG004|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
27930514|NCT01292603|54586897|FG005|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
27930515|NCT01292603|54586892|FG000|Part 1: Pilot Dose Selection Period|Death|0|||
27930516|NCT01292603|54586893|FG001|Part 1: Pilot Dose Selection Period|Death|0|||
27930517|NCT01292603|54586894|FG002|Part 1: Pilot Dose Selection Period|Death|0|||
27930518|NCT01292603|54586895|FG003|Part 1: Pilot Dose Selection Period|Death|1|||
27930519|NCT01292603|54586896|FG004|Part 1: Pilot Dose Selection Period|Death|0|||
27786761|NCT01738594|54241254|FG004|Follow up for 1 Year|Death|0|||
27930520|NCT01292603|54586897|FG005|Part 1: Pilot Dose Selection Period|Death|0|||
27930521|NCT01292603|54586892|FG000|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
27930522|NCT01292603|54586893|FG001|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
27930523|NCT01292603|54586894|FG002|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
27930524|NCT01292603|54586895|FG003|Part 1: Pilot Dose Selection Period|Protocol Violation|2|||
27930525|NCT01292603|54586896|FG004|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
27930526|NCT01292603|54586897|FG005|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
27930527|NCT01292603|54586892|FG000|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
27930528|NCT01292603|54586893|FG001|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
27786762|NCT01738594|54241255|FG005|Follow up for 1 Year|Death|1|||
27930529|NCT01292603|54586894|FG002|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
27930530|NCT01292603|54586895|FG003|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1|||
27786763|NCT01738594|54241256|FG006|Follow up for 1 Year|Death|0|||
27930531|NCT01292603|54586896|FG004|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
27930532|NCT01292603|54586897|FG005|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
27930533|NCT01292603|54586892|FG000|Part 1: Regular Follow-Up Period|Death|3|||
27930534|NCT01292603|54586893|FG001|Part 1: Regular Follow-Up Period|Death|1|||
27930535|NCT01292603|54586894|FG002|Part 1: Regular Follow-Up Period|Death|3|||
27930536|NCT01292603|54586895|FG003|Part 1: Regular Follow-Up Period|Death|1|||
27930537|NCT01292603|54586896|FG004|Part 1: Regular Follow-Up Period|Death|0|||
27930538|NCT01292603|54586897|FG005|Part 1: Regular Follow-Up Period|Death|0|||
27930539|NCT01292603|54586892|FG000|Part 1: Regular Follow-Up Period|Disease Progression|3|||
27930540|NCT01292603|54586893|FG001|Part 1: Regular Follow-Up Period|Disease Progression|6|||
27930541|NCT01292603|54586894|FG002|Part 1: Regular Follow-Up Period|Disease Progression|3|||
27930542|NCT01292603|54586895|FG003|Part 1: Regular Follow-Up Period|Disease Progression|0|||
27930543|NCT01292603|54586896|FG004|Part 1: Regular Follow-Up Period|Disease Progression|0|||
27930544|NCT01292603|54586897|FG005|Part 1: Regular Follow-Up Period|Disease Progression|0|||
27930545|NCT01292603|54586892|FG000|Part 2: Dose Confirmation Period|Death|0|||
27930546|NCT01292603|54586893|FG001|Part 2: Dose Confirmation Period|Death|0|||
27930547|NCT01292603|54586894|FG002|Part 2: Dose Confirmation Period|Death|0|||
27930548|NCT01292603|54586895|FG003|Part 2: Dose Confirmation Period|Death|0|||
27930549|NCT01292603|54586896|FG004|Part 2: Dose Confirmation Period|Death|1|||
27930550|NCT01292603|54586897|FG005|Part 2: Dose Confirmation Period|Death|0|||
27930551|NCT01292603|54586892|FG000|Part 2: Dose Confirmation Period|Physician Decision|0|||
27930552|NCT01292603|54586893|FG001|Part 2: Dose Confirmation Period|Physician Decision|0|||
27930553|NCT01292603|54586894|FG002|Part 2: Dose Confirmation Period|Physician Decision|0|||
27930554|NCT01292603|54586895|FG003|Part 2: Dose Confirmation Period|Physician Decision|0|||
27930555|NCT01292603|54586896|FG004|Part 2: Dose Confirmation Period|Physician Decision|2|||
27930556|NCT01292603|54586897|FG005|Part 2: Dose Confirmation Period|Physician Decision|0|||
27786764|NCT01738594|54241257|FG007|Follow up for 1 Year|Death|0|||
27786765|NCT01738594|54241250|FG000|Follow up for 1 Year|Other|0|||
27786766|NCT01738594|54241251|FG001|Follow up for 1 Year|Other|0|||
27786767|NCT01738594|54241252|FG002|Follow up for 1 Year|Other|0|||
27786768|NCT01738594|54241253|FG003|Follow up for 1 Year|Other|0|||
27786769|NCT01738594|54241254|FG004|Follow up for 1 Year|Other|0|||
27786770|NCT01738594|54241255|FG005|Follow up for 1 Year|Other|2|||
27786771|NCT01738594|54241256|FG006|Follow up for 1 Year|Other|0|||
27786772|NCT01738594|54241257|FG007|Follow up for 1 Year|Other|0|||
27786773|NCT01738438|54241267|FG000|Overall Study|Disease Progression|32|||
27786774|NCT01738438|54241267|FG000|Overall Study|Adverse Event|3|||
27841614|NCT01451827|54329496|FG002|Overall Study|Participant met withdrawal criteria|0|||
27786775|NCT01716520|54241271|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
27786776|NCT01716520|54241272|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
27786777|NCT01716520|54241273|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
27786778|NCT01716520|54241274|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
27786779|NCT01716520|54241275|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
27786780|NCT01716520|54241276|FG005|Treatment Period 1 (14 Days)|Adverse Event|0|||
27786781|NCT01716520|54241271|FG000|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
27786782|NCT01716520|54241272|FG001|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
27786783|NCT01716520|54241273|FG002|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2|||
27786784|NCT01716520|54241274|FG003|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
27786785|NCT01716520|54241275|FG004|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
27786786|NCT01716520|54241276|FG005|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
27786787|NCT01716520|54241271|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
27786788|NCT01716520|54241272|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
27786789|NCT01716520|54241273|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
27786790|NCT01716520|54241274|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
27786791|NCT01716520|54241275|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
27786792|NCT01716520|54241276|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
27786793|NCT01716520|54241271|FG000|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
27786794|NCT01716520|54241272|FG001|Washout Period 1 (10 to 14 Days)|Adverse Event|1|||
27786795|NCT01716520|54241273|FG002|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
27786796|NCT01716520|54241274|FG003|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
27841615|NCT01451827|54329497|FG003|Overall Study|Participant met withdrawal criteria|0|||
27841616|NCT01451827|54329494|FG000|Overall Study|Withdrawal by Subject|0|||
27841617|NCT01451827|54329495|FG001|Overall Study|Withdrawal by Subject|0|||
27841618|NCT01451827|54329496|FG002|Overall Study|Withdrawal by Subject|1|||
27841619|NCT01451827|54329497|FG003|Overall Study|Withdrawal by Subject|1|||
27841620|NCT01557920|54329507|FG000|Overall Study|Withdrawal by Subject|2|||
27841621|NCT01557920|54329508|FG001|Overall Study|Withdrawal by Subject|3|||
27841622|NCT01557920|54329507|FG000|Overall Study|Lack of Efficacy|1|||
27841623|NCT01557920|54329508|FG001|Overall Study|Lack of Efficacy|0|||
27930557|NCT01292603|54586892|FG000|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
27930558|NCT01292603|54586893|FG001|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
27841624|NCT01467583|54329544|FG000|Overall Study|Death|1|||
27930559|NCT01292603|54586894|FG002|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
27841625|NCT01467583|54329545|FG001|Overall Study|Death|1|||
27841626|NCT01467583|54329546|FG002|Overall Study|Death|0|||
27841627|NCT01467583|54329544|FG000|Overall Study|Withdrawal by Subject|1|||
27841628|NCT01467583|54329545|FG001|Overall Study|Withdrawal by Subject|0|||
27841629|NCT01467583|54329546|FG002|Overall Study|Withdrawal by Subject|0|||
27841630|NCT01467583|54329544|FG000|Overall Study|Protocol Violation|0|||
27841631|NCT01467583|54329545|FG001|Overall Study|Protocol Violation|0|||
27841632|NCT01467583|54329546|FG002|Overall Study|Protocol Violation|2|||
27841633|NCT01576718|54329563|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49|||
27841634|NCT01576718|54329564|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
27841635|NCT01576718|54329565|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
27930560|NCT01292603|54586895|FG003|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
27930561|NCT01292603|54586896|FG004|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
27930562|NCT01292603|54586897|FG005|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
27930563|NCT01292603|54586892|FG000|Part 2: Dose Confirmation Period|Adverse Event|0|||
27930564|NCT01292603|54586893|FG001|Part 2: Dose Confirmation Period|Adverse Event|0|||
27930565|NCT01292603|54586894|FG002|Part 2: Dose Confirmation Period|Adverse Event|0|||
27930566|NCT01292603|54586895|FG003|Part 2: Dose Confirmation Period|Adverse Event|0|||
27930567|NCT01292603|54586896|FG004|Part 2: Dose Confirmation Period|Adverse Event|7|||
27930568|NCT01292603|54586897|FG005|Part 2: Dose Confirmation Period|Adverse Event|9|||
27930569|NCT01292603|54586892|FG000|Part 2: Dose Confirmation Period|Protocol Violation|0|||
27930570|NCT01292603|54586893|FG001|Part 2: Dose Confirmation Period|Protocol Violation|0|||
27930571|NCT01292603|54586894|FG002|Part 2: Dose Confirmation Period|Protocol Violation|0|||
27930572|NCT01292603|54586895|FG003|Part 2: Dose Confirmation Period|Protocol Violation|0|||
27930573|NCT01292603|54586896|FG004|Part 2: Dose Confirmation Period|Protocol Violation|5|||
27930574|NCT01292603|54586897|FG005|Part 2: Dose Confirmation Period|Protocol Violation|3|||
27930575|NCT01292603|54586892|FG000|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
27930576|NCT01292603|54586893|FG001|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
27930577|NCT01292603|54586894|FG002|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
27930578|NCT01292603|54586895|FG003|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
27930579|NCT01292603|54586896|FG004|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
27930580|NCT01292603|54586897|FG005|Part 2: Dose Confirmation Period|Withdrawal by Subject|2|||
27930581|NCT01292603|54586892|FG000|Part 2: Regular Follow-Up|Death|0|||
27930582|NCT01292603|54586893|FG001|Part 2: Regular Follow-Up|Death|0|||
27930583|NCT01292603|54586894|FG002|Part 2: Regular Follow-Up|Death|0|||
27930584|NCT01292603|54586895|FG003|Part 2: Regular Follow-Up|Death|0|||
27930585|NCT01292603|54586896|FG004|Part 2: Regular Follow-Up|Death|6|||
27930586|NCT01292603|54586897|FG005|Part 2: Regular Follow-Up|Death|3|||
27930587|NCT01292603|54586892|FG000|Part 2: Regular Follow-Up|Disease Progression|0|||
27930588|NCT01292603|54586893|FG001|Part 2: Regular Follow-Up|Disease Progression|0|||
27930589|NCT01292603|54586894|FG002|Part 2: Regular Follow-Up|Disease Progression|0|||
27930590|NCT01292603|54586895|FG003|Part 2: Regular Follow-Up|Disease Progression|0|||
27930591|NCT01292603|54586896|FG004|Part 2: Regular Follow-Up|Disease Progression|5|||
27930592|NCT01292603|54586897|FG005|Part 2: Regular Follow-Up|Disease Progression|5|||
27930593|NCT01292603|54586892|FG000|Part 2: Regular Follow-Up|Noncompliance|0|||
27930594|NCT01292603|54586893|FG001|Part 2: Regular Follow-Up|Noncompliance|0|||
27930595|NCT01292603|54586894|FG002|Part 2: Regular Follow-Up|Noncompliance|0|||
27930596|NCT01292603|54586895|FG003|Part 2: Regular Follow-Up|Noncompliance|0|||
28105564|NCT01332994|54763012|FG000|Overall Study|Lack of Efficacy|1|||
28105565|NCT01332994|54763012|FG000|Overall Study|Lost to Follow-up|4|||
28105566|NCT01332994|54763012|FG000|Overall Study|Protocol Violation|6|||
28105567|NCT01332994|54763012|FG000|Overall Study|Withdrawal by Subject|15|||
28105568|NCT01332994|54763012|FG000|Overall Study|Administrative Problem|2|||
28105569|NCT01332994|54763012|FG000|Overall Study|Other|8|||
28105570|NCT03698331|54763018|FG000|Overall Study|Adverse Event|2|||
28105571|NCT03698331|54763019|FG001|Overall Study|Adverse Event|3|||
28105572|NCT03698331|54763018|FG000|Overall Study|Withdrawal by Subject|1|||
28105573|NCT03698331|54763019|FG001|Overall Study|Withdrawal by Subject|1|||
28105574|NCT03698331|54763018|FG000|Overall Study|Lost to Follow-up|0|||
28105575|NCT03698331|54763019|FG001|Overall Study|Lost to Follow-up|2|||
27841636|NCT01576718|54329566|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
27930597|NCT01292603|54586896|FG004|Part 2: Regular Follow-Up|Noncompliance|1|||
27930598|NCT01292603|54586897|FG005|Part 2: Regular Follow-Up|Noncompliance|0|||
27930599|NCT01292603|54586892|FG000|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
28016365|NCT00567489|54675637|FG001|Overall Study|Adverse Event|14|||
28016366|NCT00567489|54675636|FG000|Overall Study|Physician Decision|0|||
28016367|NCT00567489|54675637|FG001|Overall Study|Physician Decision|4|||
28016368|NCT00567489|54675636|FG000|Overall Study|Withdrawal by Subject|0|||
28016369|NCT00567489|54675637|FG001|Overall Study|Withdrawal by Subject|2|||
28016370|NCT00567489|54675636|FG000|Overall Study|Renal Transplantation|0|||
28016371|NCT00567489|54675637|FG001|Overall Study|Renal Transplantation|3|||
28016372|NCT00567489|54675636|FG000|Overall Study|Other|1|||
28105576|NCT03698331|54763018|FG000|Overall Study|Non-compliance with study drug|1|||
28105577|NCT03698331|54763019|FG001|Overall Study|Non-compliance with study drug|0|||
28105578|NCT04889625|54763025|FG000|Period 1|Subject did not meet eligibility criteria and was enrolled by error|2|||
28105579|NCT04889625|54763026|FG001|Period 1|Subject did not meet eligibility criteria and was enrolled by error|1|||
28105580|NCT04889625|54763025|FG000|Period 1|Subject out of window|0|||
28105581|NCT04889625|54763026|FG001|Period 1|Subject out of window|1|||
28105582|NCT04889625|54763025|FG000|Period 1|Wrong add power dispensed|0|||
28105583|NCT04889625|54763026|FG001|Period 1|Wrong add power dispensed|1|||
28105584|NCT04889625|54763025|FG000|Period 1|Discontinued due to fitting guide error|1|||
28105585|NCT04889625|54763026|FG001|Period 1|Discontinued due to fitting guide error|1|||
28016373|NCT00567489|54675637|FG001|Overall Study|Other|0|||
28016374|NCT00669942|54675655|FG000|Parts 2 and 3|Adverse Event|0|||
28016375|NCT00669942|54675656|FG001|Parts 2 and 3|Adverse Event|0|||
28016376|NCT00669942|54675657|FG002|Parts 2 and 3|Adverse Event|0|||
28016377|NCT00669942|54675658|FG003|Parts 2 and 3|Adverse Event|0|||
28016378|NCT00669942|54675659|FG004|Parts 2 and 3|Adverse Event|0|||
27786797|NCT01716520|54241275|FG004|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
27786798|NCT01716520|54241276|FG005|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
27786799|NCT01716520|54241271|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
27786800|NCT01716520|54241272|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
27786801|NCT01716520|54241273|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
27786802|NCT01716520|54241274|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
27786803|NCT01716520|54241275|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
27786804|NCT01716520|54241276|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
27786805|NCT01716520|54241271|FG000|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
27786806|NCT01716520|54241272|FG001|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
27786807|NCT01716520|54241273|FG002|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
27786808|NCT01716520|54241274|FG003|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
27786809|NCT01716520|54241275|FG004|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
27786810|NCT01716520|54241276|FG005|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
27786811|NCT01716520|54241271|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
27786812|NCT01716520|54241272|FG001|Treatment Period 2 (14 Days)|Adverse Event|0|||
27786813|NCT01716520|54241273|FG002|Treatment Period 2 (14 Days)|Adverse Event|0|||
27786814|NCT01716520|54241274|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
27786815|NCT01716520|54241275|FG004|Treatment Period 2 (14 Days)|Adverse Event|1|||
27786816|NCT01716520|54241276|FG005|Treatment Period 2 (14 Days)|Adverse Event|0|||
27786817|NCT01716520|54241271|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
27786818|NCT01716520|54241272|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
27930600|NCT01292603|54586893|FG001|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
28016379|NCT00669942|54675660|FG005|Parts 2 and 3|Adverse Event|0|||
28016380|NCT00669942|54675661|FG006|Parts 2 and 3|Adverse Event|0|||
28016381|NCT00669942|54675662|FG007|Parts 2 and 3|Adverse Event|2|||
28016382|NCT00669942|54675663|FG008|Parts 2 and 3|Adverse Event|1|||
27786819|NCT01716520|54241273|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
27786820|NCT01716520|54241274|FG003|Treatment Period 2 (14 Days)|Protocol Violation|0|||
27930601|NCT01292603|54586894|FG002|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
27930602|NCT01292603|54586895|FG003|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
27930603|NCT01292603|54586896|FG004|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
27930604|NCT01292603|54586897|FG005|Part 2: Regular Follow-Up|Withdrawal by Subject|1|||
27930605|NCT01292603|54586892|FG000|Part 2: Regular Follow-Up|Protocol Violation|0|||
27930606|NCT01292603|54586893|FG001|Part 2: Regular Follow-Up|Protocol Violation|0|||
27930607|NCT01292603|54586894|FG002|Part 2: Regular Follow-Up|Protocol Violation|0|||
27930608|NCT01292603|54586895|FG003|Part 2: Regular Follow-Up|Protocol Violation|0|||
27930609|NCT01292603|54586896|FG004|Part 2: Regular Follow-Up|Protocol Violation|2|||
27930610|NCT01292603|54586897|FG005|Part 2: Regular Follow-Up|Protocol Violation|0|||
27930611|NCT01292603|54586892|FG000|Part 2: Regular Follow-Up|Physician Decision|0|||
27930612|NCT01292603|54586893|FG001|Part 2: Regular Follow-Up|Physician Decision|0|||
28016383|NCT00669942|54675664|FG009|Parts 2 and 3|Adverse Event|0|||
28016384|NCT00669942|54675665|FG010|Parts 2 and 3|Adverse Event|0|||
28016385|NCT00669942|54675666|FG011|Parts 2 and 3|Adverse Event|0|||
28016386|NCT00669942|54675655|FG000|Parts 2 and 3|Withdrawal by Subject|0|||
28016387|NCT00669942|54675656|FG001|Parts 2 and 3|Withdrawal by Subject|0|||
28016388|NCT00669942|54675657|FG002|Parts 2 and 3|Withdrawal by Subject|0|||
28016389|NCT00669942|54675658|FG003|Parts 2 and 3|Withdrawal by Subject|0|||
28016390|NCT00669942|54675659|FG004|Parts 2 and 3|Withdrawal by Subject|0|||
28016391|NCT00669942|54675660|FG005|Parts 2 and 3|Withdrawal by Subject|1|||
28105586|NCT04889625|54763025|FG000|Period 2|Test article no longer available|1|||
28016392|NCT00669942|54675661|FG006|Parts 2 and 3|Withdrawal by Subject|0|||
28016393|NCT00669942|54675662|FG007|Parts 2 and 3|Withdrawal by Subject|0|||
28016394|NCT00669942|54675663|FG008|Parts 2 and 3|Withdrawal by Subject|2|||
28016395|NCT00669942|54675664|FG009|Parts 2 and 3|Withdrawal by Subject|0|||
28016396|NCT00669942|54675665|FG010|Parts 2 and 3|Withdrawal by Subject|0|||
28016397|NCT00669942|54675666|FG011|Parts 2 and 3|Withdrawal by Subject|0|||
27930613|NCT01292603|54586894|FG002|Part 2: Regular Follow-Up|Physician Decision|0|||
27930614|NCT01292603|54586895|FG003|Part 2: Regular Follow-Up|Physician Decision|0|||
27930615|NCT01292603|54586896|FG004|Part 2: Regular Follow-Up|Physician Decision|2|||
27930616|NCT01292603|54586897|FG005|Part 2: Regular Follow-Up|Physician Decision|0|||
27930617|NCT01292603|54586892|FG000|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
27930618|NCT01292603|54586893|FG001|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
27930619|NCT01292603|54586894|FG002|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
27930620|NCT01292603|54586895|FG003|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
27930621|NCT01292603|54586896|FG004|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
27930622|NCT01292603|54586897|FG005|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
27930623|NCT01292603|54586892|FG000|Part 2: Regular Follow-Up|Adverse Event|0|||
27930624|NCT01292603|54586893|FG001|Part 2: Regular Follow-Up|Adverse Event|0|||
27930625|NCT01292603|54586894|FG002|Part 2: Regular Follow-Up|Adverse Event|0|||
27930626|NCT01292603|54586895|FG003|Part 2: Regular Follow-Up|Adverse Event|0|||
27930627|NCT01292603|54586896|FG004|Part 2: Regular Follow-Up|Adverse Event|2|||
27930628|NCT01292603|54586897|FG005|Part 2: Regular Follow-Up|Adverse Event|2|||
27930629|NCT01292603|54586892|FG000|Overall Survival Status|Death|3|||
27930630|NCT01292603|54586893|FG001|Overall Survival Status|Death|1|||
27930631|NCT01292603|54586894|FG002|Overall Survival Status|Death|3|||
28016398|NCT00669942|54675655|FG000|Parts 2 and 3|Protocol Violation|0|||
28016399|NCT00669942|54675656|FG001|Parts 2 and 3|Protocol Violation|0|||
28016400|NCT00669942|54675657|FG002|Parts 2 and 3|Protocol Violation|0|||
28016401|NCT00669942|54675658|FG003|Parts 2 and 3|Protocol Violation|0|||
28016402|NCT00669942|54675659|FG004|Parts 2 and 3|Protocol Violation|0|||
28016403|NCT00669942|54675660|FG005|Parts 2 and 3|Protocol Violation|1|||
28016404|NCT00669942|54675661|FG006|Parts 2 and 3|Protocol Violation|0|||
28016405|NCT00669942|54675662|FG007|Parts 2 and 3|Protocol Violation|0|||
28016406|NCT00669942|54675663|FG008|Parts 2 and 3|Protocol Violation|0|||
28016407|NCT00669942|54675664|FG009|Parts 2 and 3|Protocol Violation|0|||
28016408|NCT00669942|54675665|FG010|Parts 2 and 3|Protocol Violation|0|||
28016409|NCT00669942|54675666|FG011|Parts 2 and 3|Protocol Violation|0|||
28016410|NCT00669864|54675689|FG000|Overall Study|Lost to Follow-up|2|||
28016411|NCT00669864|54675689|FG000|Overall Study|Protocol Violation|2|||
28016412|NCT00669864|54675689|FG000|Overall Study|Withdrawal by Subject|3|||
28016413|NCT00669864|54675689|FG000|Overall Study|Other|2|||
28016414|NCT00668148|54675693|FG000|Overall Study|Adverse Event|5|||
28016415|NCT00668148|54675693|FG000|Overall Study|Subject Non-compliance|1|||
28016416|NCT00668148|54675693|FG000|Overall Study|Progressive Disease Before Treatment|2|||
28016417|NCT00668148|54675693|FG000|Overall Study|Withdrawal of Consent|2|||
28016418|NCT00667992|54675710|FG000|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
28016419|NCT00667992|54675711|FG001|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
28016420|NCT00667992|54675710|FG000|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2|||
28016421|NCT00667992|54675711|FG001|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
28016422|NCT00667992|54675710|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
28016423|NCT00667992|54675711|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
28016424|NCT00667992|54675710|FG000|First Intervention 100 Mcg Twice Daily|Pregnancy|1|||
28016425|NCT00667992|54675711|FG001|First Intervention 100 Mcg Twice Daily|Pregnancy|0|||
28016426|NCT00667992|54675710|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
28016427|NCT00667992|54675711|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
28016428|NCT00667992|54675710|FG000|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1|||
28016429|NCT00667992|54675711|FG001|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0|||
28016430|NCT00667992|54675710|FG000|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
28016431|NCT00667992|54675711|FG001|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
28016432|NCT00667992|54675710|FG000|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0|||
28016433|NCT00667992|54675711|FG001|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1|||
28016434|NCT00667992|54675710|FG000|Wash-out|Not within one doubling dilution|4|||
28016435|NCT00667992|54675711|FG001|Wash-out|Not within one doubling dilution|3|||
28016436|NCT00667992|54675710|FG000|Wash-out|Failure to wash-out|2|||
28016437|NCT00667992|54675711|FG001|Wash-out|Failure to wash-out|2|||
28016438|NCT00667992|54675710|FG000|Wash-out|Withdrawal by Subject|1|||
27930632|NCT01292603|54586895|FG003|Overall Survival Status|Death|1|||
27930633|NCT01292603|54586896|FG004|Overall Survival Status|Death|16|||
27930634|NCT01292603|54586897|FG005|Overall Survival Status|Death|10|||
28016439|NCT00667992|54675711|FG001|Wash-out|Withdrawal by Subject|0|||
28016440|NCT00667992|54675710|FG000|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1|||
27930635|NCT01292057|54586920|FG000|Overall Study|Protocol Violation|1|||
28016441|NCT00667992|54675711|FG001|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
28016442|NCT00667992|54675710|FG000|Third Intervention 100 Mcg Twice Daily|Adverse Event|0|||
28016443|NCT00667992|54675711|FG001|Third Intervention 100 Mcg Twice Daily|Adverse Event|1|||
28016444|NCT00669396|54675729|FG000|Overall Study|Lost to Follow-up|10|||
28016445|NCT00669396|54675730|FG001|Overall Study|Lost to Follow-up|12|||
28016446|NCT00669318|54675736|FG000|Overall Study|Withdrawal by Subject|2|||
28016447|NCT00669240|54675740|FG000|Overall Study|Lack of Efficacy|33|||
28016448|NCT00669240|54675740|FG000|Overall Study|Withdrawal by Subject|42|||
28016449|NCT00669240|54675740|FG000|Overall Study|Lost to Follow-up|34|||
28016450|NCT00669240|54675740|FG000|Overall Study|Adverse Event|21|||
28016451|NCT00669240|54675740|FG000|Overall Study|Other|19|||
28016452|NCT00669240|54675740|FG000|Overall Study|Enrolled but not treated|15|||
28016453|NCT00669240|54675740|FG000|Overall Study|Enrolled but no dosing record|1|||
28016454|NCT00669162|54675744|FG000|Overall Study|Withdrawal by Subject|1|||
28016455|NCT00400946|54675753|FG000|Overall Study|Ineligible|0|||
28016456|NCT00400946|54675754|FG001|Overall Study|Ineligible|0|||
28016457|NCT00400946|54675755|FG002|Overall Study|Ineligible|0|||
28016458|NCT00400946|54675756|FG003|Overall Study|Ineligible|5|||
28016459|NCT00400946|54675757|FG004|Overall Study|Ineligible|1|||
28016460|NCT00400946|54675753|FG000|Overall Study|Induction Failure|0|||
28016461|NCT00400946|54675754|FG001|Overall Study|Induction Failure|0|||
28016462|NCT00400946|54675755|FG002|Overall Study|Induction Failure|0|||
28016463|NCT00400946|54675756|FG003|Overall Study|Induction Failure|11|||
28016464|NCT00400946|54675757|FG004|Overall Study|Induction Failure|8|||
28016465|NCT00400946|54675753|FG000|Overall Study|Induction Death|0|||
28016466|NCT00400946|54675754|FG001|Overall Study|Induction Death|0|||
28016467|NCT00400946|54675755|FG002|Overall Study|Induction Death|0|||
28016468|NCT00400946|54675756|FG003|Overall Study|Induction Death|13|||
28016469|NCT00400946|54675757|FG004|Overall Study|Induction Death|3|||
28016470|NCT00400946|54675753|FG000|Overall Study|Lost to Follow-up|1|||
28016471|NCT00400946|54675754|FG001|Overall Study|Lost to Follow-up|1|||
28016472|NCT00400946|54675755|FG002|Overall Study|Lost to Follow-up|0|||
28016473|NCT00400946|54675756|FG003|Overall Study|Lost to Follow-up|0|||
28016474|NCT00400946|54675757|FG004|Overall Study|Lost to Follow-up|1|||
28016475|NCT00400946|54675753|FG000|Overall Study|Remission Death|1|||
28016476|NCT00400946|54675754|FG001|Overall Study|Remission Death|1|||
28016477|NCT00400946|54675755|FG002|Overall Study|Remission Death|0|||
28016478|NCT00400946|54675756|FG003|Overall Study|Remission Death|0|||
28016479|NCT00400946|54675757|FG004|Overall Study|Remission Death|1|||
28016480|NCT00400946|54675753|FG000|Overall Study|Relapse|9|||
28016481|NCT00400946|54675754|FG001|Overall Study|Relapse|2|||
28016482|NCT00400946|54675755|FG002|Overall Study|Relapse|1|||
28016483|NCT00400946|54675756|FG003|Overall Study|Relapse|1|||
28016484|NCT00400946|54675757|FG004|Overall Study|Relapse|5|||
28016485|NCT00400946|54675753|FG000|Overall Study|Transplant in CR1|0|||
28016486|NCT00400946|54675754|FG001|Overall Study|Transplant in CR1|0|||
28016487|NCT00400946|54675755|FG002|Overall Study|Transplant in CR1|0|||
28016488|NCT00400946|54675756|FG003|Overall Study|Transplant in CR1|10|||
28016489|NCT00400946|54675757|FG004|Overall Study|Transplant in CR1|1|||
28016490|NCT00400946|54675753|FG000|Overall Study|Withdrawal by Subject|2|||
28016491|NCT00400946|54675754|FG001|Overall Study|Withdrawal by Subject|5|||
28016492|NCT00400946|54675755|FG002|Overall Study|Withdrawal by Subject|1|||
28016493|NCT00400946|54675756|FG003|Overall Study|Withdrawal by Subject|5|||
28016494|NCT00400946|54675757|FG004|Overall Study|Withdrawal by Subject|8|||
28016495|NCT00400946|54675753|FG000|Overall Study|Clinical|1|||
28016496|NCT00400946|54675754|FG001|Overall Study|Clinical|2|||
28016497|NCT00400946|54675755|FG002|Overall Study|Clinical|0|||
28016498|NCT00400946|54675756|FG003|Overall Study|Clinical|2|||
28016499|NCT00400946|54675757|FG004|Overall Study|Clinical|9|||
28016500|NCT00400946|54675753|FG000|Overall Study|Other|0|||
28016501|NCT00400946|54675754|FG001|Overall Study|Other|0|||
28016502|NCT00400946|54675755|FG002|Overall Study|Other|0|||
28016503|NCT00400946|54675756|FG003|Overall Study|Other|0|||
28016504|NCT00400946|54675757|FG004|Overall Study|Other|1|||
28016505|NCT00666588|54675788|FG000|Overall Study|ineligible|2|||
28016506|NCT00666588|54675789|FG001|Overall Study|ineligible|0|||
28016507|NCT00666588|54675790|FG002|Overall Study|ineligible|0|||
28016508|NCT00666588|54675791|FG003|Overall Study|ineligible|2|||
28016509|NCT00666588|54675788|FG000|Overall Study|inevaluable|2|||
28016510|NCT00666588|54675789|FG001|Overall Study|inevaluable|0|||
28016511|NCT00666588|54675790|FG002|Overall Study|inevaluable|0|||
28016512|NCT00666588|54675791|FG003|Overall Study|inevaluable|0|||
28016513|NCT00689390|54675803|FG000|Overall Study|Adverse Event|19|||
28016514|NCT00689390|54675804|FG001|Overall Study|Adverse Event|0|||
28016515|NCT00689390|54675803|FG000|Overall Study|Lost to Follow-up|179|||
28016516|NCT00689390|54675804|FG001|Overall Study|Lost to Follow-up|7|||
28016517|NCT00689390|54675803|FG000|Overall Study|Withdrawal by Subject|117|||
28016518|NCT00689390|54675804|FG001|Overall Study|Withdrawal by Subject|3|||
28016519|NCT00689390|54675803|FG000|Overall Study|Withdrew Consent-Retreatment Opportunity|52|||
28016520|NCT00689390|54675804|FG001|Overall Study|Withdrew Consent-Retreatment Opportunity|0|||
28016521|NCT00689390|54675803|FG000|Overall Study|Non-Compliance With Protocol|21|||
28016522|NCT00689390|54675804|FG001|Overall Study|Non-Compliance With Protocol|0|||
28016523|NCT00689390|54675803|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
28016524|NCT00689390|54675804|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
28016525|NCT00689390|54675803|FG000|Overall Study|Administrative|37|||
28016526|NCT00689390|54675804|FG001|Overall Study|Administrative|0|||
28016527|NCT00567879|54675821|FG000|Overall Study|Adverse Event|2|||
28016528|NCT00567879|54675822|FG001|Overall Study|Adverse Event|0|||
28016529|NCT00567879|54675823|FG002|Overall Study|Adverse Event|1|||
28016530|NCT00567879|54675824|FG003|Overall Study|Adverse Event|0|||
28016531|NCT00567879|54675825|FG004|Overall Study|Adverse Event|1|||
28016532|NCT00567879|54675826|FG005|Overall Study|Adverse Event|0|||
27930636|NCT01292057|54586921|FG001|Overall Study|Protocol Violation|1|||
27930637|NCT01292057|54586920|FG000|Overall Study|Lost to Follow-up|1|||
27930638|NCT01292057|54586921|FG001|Overall Study|Lost to Follow-up|1|||
27930639|NCT01291277|54586929|FG000|Overall Study|Death|2|||
27930640|NCT01291277|54586930|FG001|Overall Study|Death|2|||
27930641|NCT01291277|54586929|FG000|Overall Study|Lost to Follow-up|3|||
28016533|NCT00567879|54675821|FG000|Overall Study|Abnormal test procedure(s)|0|||
28016534|NCT00567879|54675822|FG001|Overall Study|Abnormal test procedure(s)|0|||
28016535|NCT00567879|54675823|FG002|Overall Study|Abnormal test procedure(s)|1|||
28016536|NCT00567879|54675824|FG003|Overall Study|Abnormal test procedure(s)|0|||
28016537|NCT00567879|54675825|FG004|Overall Study|Abnormal test procedure(s)|0|||
28016538|NCT00567879|54675826|FG005|Overall Study|Abnormal test procedure(s)|0|||
28016539|NCT00567879|54675821|FG000|Overall Study|Withdrawal by Subject|0|||
28016540|NCT00567879|54675822|FG001|Overall Study|Withdrawal by Subject|0|||
27930642|NCT01291277|54586930|FG001|Overall Study|Lost to Follow-up|1|||
27930643|NCT01290887|54586938|FG000|Overall Study|Adverse Event|6|||
27930644|NCT01290887|54586939|FG001|Overall Study|Adverse Event|11|||
27930645|NCT01290887|54586938|FG000|Overall Study|Lack of Efficacy|4|||
28016541|NCT00567879|54675823|FG002|Overall Study|Withdrawal by Subject|3|||
28016542|NCT00567879|54675824|FG003|Overall Study|Withdrawal by Subject|1|||
27786821|NCT01716520|54241275|FG004|Treatment Period 2 (14 Days)|Protocol Violation|1|||
27786822|NCT01716520|54241276|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
27786823|NCT01716520|54241271|FG000|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
27786824|NCT01716520|54241272|FG001|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
27786825|NCT01716520|54241273|FG002|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
27786826|NCT01716520|54241274|FG003|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1|||
27786827|NCT01716520|54241275|FG004|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
27786828|NCT01716520|54241276|FG005|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
27786829|NCT01716520|54241271|FG000|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
27786830|NCT01716520|54241272|FG001|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
27786831|NCT01716520|54241273|FG002|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
27786832|NCT01716520|54241274|FG003|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
27786833|NCT01716520|54241275|FG004|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
27786834|NCT01716520|54241276|FG005|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
27786835|NCT01716520|54241271|FG000|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1|||
27786836|NCT01716520|54241272|FG001|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
27786837|NCT01716520|54241273|FG002|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
27786838|NCT01716520|54241274|FG003|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
27841637|NCT01576718|54329567|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
27841638|NCT01576718|54329568|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
27841639|NCT01576718|54329569|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
27841640|NCT01576718|54329563|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17|||
27841641|NCT01576718|54329564|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
27841642|NCT01576718|54329565|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
27841643|NCT01576718|54329566|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
27841644|NCT01576718|54329567|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
27841645|NCT01576718|54329568|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
27841646|NCT01576718|54329569|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
27841647|NCT01576718|54329563|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166|||
27841648|NCT01576718|54329564|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
27841649|NCT01576718|54329565|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
27841650|NCT01576718|54329566|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
27841651|NCT01576718|54329567|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
27841652|NCT01576718|54329568|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
27930646|NCT01290887|54586939|FG001|Overall Study|Lack of Efficacy|5|||
27930647|NCT01290887|54586938|FG000|Overall Study|Withdrawal by Subject|26|||
28016543|NCT00567879|54675825|FG004|Overall Study|Withdrawal by Subject|0|||
28016544|NCT00567879|54675826|FG005|Overall Study|Withdrawal by Subject|0|||
27930648|NCT01290887|54586939|FG001|Overall Study|Withdrawal by Subject|32|||
27930649|NCT01290887|54586938|FG000|Overall Study|Protocol Violation|2|||
27930650|NCT01290887|54586939|FG001|Overall Study|Protocol Violation|1|||
27930651|NCT01290887|54586938|FG000|Overall Study|Lost to Follow-up|4|||
27930652|NCT01290887|54586939|FG001|Overall Study|Lost to Follow-up|4|||
27930653|NCT01290887|54586938|FG000|Overall Study|Non-compliance to study procedures|0|||
27930654|NCT01290887|54586939|FG001|Overall Study|Non-compliance to study procedures|1|||
27930655|NCT01290887|54586938|FG000|Overall Study|Non-compliance to study medications|1|||
27930656|NCT01290887|54586939|FG001|Overall Study|Non-compliance to study medications|0|||
27930657|NCT01290887|54586938|FG000|Overall Study|Sponsor closure of study|420|||
27930658|NCT01290887|54586939|FG001|Overall Study|Sponsor closure of study|476|||
27930659|NCT01290887|54586938|FG000|Overall Study|Other|3|||
27930660|NCT01290887|54586939|FG001|Overall Study|Other|6|||
27930661|NCT01290731|54586945|FG000|Overall Study|Withdrawal by Subject|1|||
28016545|NCT00567879|54675821|FG000|Overall Study|New cancer therapy|0|||
28016546|NCT00567879|54675822|FG001|Overall Study|New cancer therapy|0|||
28016547|NCT00567879|54675823|FG002|Overall Study|New cancer therapy|1|||
28016548|NCT00567879|54675824|FG003|Overall Study|New cancer therapy|0|||
28016549|NCT00567879|54675825|FG004|Overall Study|New cancer therapy|0|||
28016550|NCT00567879|54675826|FG005|Overall Study|New cancer therapy|0|||
28016551|NCT00567879|54675821|FG000|Overall Study|Disease progression|5|||
28016552|NCT00567879|54675822|FG001|Overall Study|Disease progression|7|||
28016553|NCT00567879|54675823|FG002|Overall Study|Disease progression|15|||
28016554|NCT00567879|54675824|FG003|Overall Study|Disease progression|5|||
28016555|NCT00567879|54675825|FG004|Overall Study|Disease progression|11|||
28016556|NCT00567879|54675826|FG005|Overall Study|Disease progression|3|||
28016557|NCT00603915|54675844|FG000|Overall Study|Physician Decision|1|||
28016558|NCT00603837|54675850|FG000|Overall Study|Physician Decision|3|||
27930662|NCT01290341|54586951|FG000|Overall Study|Protocol Violation|7|||
27930663|NCT01290341|54586952|FG001|Overall Study|Protocol Violation|3|||
27930664|NCT01290341|54586951|FG000|Overall Study|Adverse Event|1|||
27930665|NCT01290341|54586952|FG001|Overall Study|Adverse Event|0|||
27930666|NCT01290341|54586951|FG000|Overall Study|Lost to Follow-up|21|||
27930667|NCT01290341|54586952|FG001|Overall Study|Lost to Follow-up|10|||
27930668|NCT01290341|54586951|FG000|Overall Study|Withdrawal by Subject|19|||
27930669|NCT01290341|54586952|FG001|Overall Study|Withdrawal by Subject|5|||
27930670|NCT01290341|54586951|FG000|Overall Study|Negative baseline culture and others|44|||
27930671|NCT01290341|54586952|FG001|Overall Study|Negative baseline culture and others|11|||
27930672|NCT01290263|54586960|FG000|Overall Study|Adverse Event|0|||
27930673|NCT01290263|54586961|FG001|Overall Study|Adverse Event|0|||
27930674|NCT01290263|54586962|FG002|Overall Study|Adverse Event|0|||
27930675|NCT01290263|54586963|FG003|Overall Study|Adverse Event|1|||
27930676|NCT01290263|54586964|FG004|Overall Study|Adverse Event|1|||
27930677|NCT01290263|54586960|FG000|Overall Study|Lack of Efficacy|8|||
27930678|NCT01290263|54586961|FG001|Overall Study|Lack of Efficacy|2|||
27930679|NCT01290263|54586962|FG002|Overall Study|Lack of Efficacy|7|||
27930680|NCT01290263|54586963|FG003|Overall Study|Lack of Efficacy|24|||
27930681|NCT01290263|54586964|FG004|Overall Study|Lack of Efficacy|33|||
27930682|NCT01290263|54586960|FG000|Overall Study|Withdrawal by Subject|3|||
27930683|NCT01290263|54586961|FG001|Overall Study|Withdrawal by Subject|1|||
27930684|NCT01290263|54586962|FG002|Overall Study|Withdrawal by Subject|0|||
27930685|NCT01290263|54586963|FG003|Overall Study|Withdrawal by Subject|1|||
27930686|NCT01290263|54586964|FG004|Overall Study|Withdrawal by Subject|2|||
27930687|NCT01290263|54586960|FG000|Overall Study|Participant Non-Compliance|0|||
27930688|NCT01290263|54586961|FG001|Overall Study|Participant Non-Compliance|0|||
27930689|NCT01290263|54586962|FG002|Overall Study|Participant Non-Compliance|0|||
27930690|NCT01290263|54586963|FG003|Overall Study|Participant Non-Compliance|1|||
27930691|NCT01290263|54586964|FG004|Overall Study|Participant Non-Compliance|1|||
28016559|NCT00603837|54675851|FG001|Overall Study|Physician Decision|0|||
28016560|NCT00667602|54675860|FG000|Overall Study|Withdrawal by Subject|4|||
28016561|NCT00667602|54675861|FG001|Overall Study|Withdrawal by Subject|9|||
28016562|NCT00667602|54675862|FG002|Overall Study|Withdrawal by Subject|10|||
28016563|NCT00667602|54675860|FG000|Overall Study|Lost to Follow-up|4|||
28016564|NCT00667602|54675861|FG001|Overall Study|Lost to Follow-up|5|||
28016565|NCT00667602|54675862|FG002|Overall Study|Lost to Follow-up|6|||
28016566|NCT00667602|54675860|FG000|Overall Study|Administrative reason|0|||
28016567|NCT00667602|54675861|FG001|Overall Study|Administrative reason|0|||
28016568|NCT00667602|54675862|FG002|Overall Study|Administrative reason|2|||
27930692|NCT01290029|54586972|FG000|Overall Study|Other|2|||
28016569|NCT00667602|54675860|FG000|Overall Study|Protocol Violation|0|||
28016570|NCT00667602|54675861|FG001|Overall Study|Protocol Violation|1|||
28016571|NCT00667602|54675862|FG002|Overall Study|Protocol Violation|0|||
28016572|NCT00691028|54675878|FG000|Open-label Period|Adverse Event|0|||
28016573|NCT00691028|54675879|FG001|Open-label Period|Adverse Event|0|||
28016574|NCT00691028|54675880|FG002|Open-label Period|Adverse Event|0|||
28016575|NCT00691028|54675881|FG003|Open-label Period|Adverse Event|16|||
27930693|NCT01289639|54586979|FG000|Overall Study|Lost to Follow-up|1|||
28016576|NCT00691028|54675878|FG000|Open-label Period|Withdrawal by Subject|0|||
27930694|NCT01289639|54586980|FG001|Overall Study|Lost to Follow-up|0|||
27930695|NCT01289639|54586981|FG002|Overall Study|Lost to Follow-up|0|||
27930696|NCT01289015|54586991|FG000|Overall Study|Protocol Violation|12|||
27930697|NCT01289015|54586992|FG001|Overall Study|Protocol Violation|9|||
27930698|NCT01289015|54586991|FG000|Overall Study|Adverse Event|3|||
27930699|NCT01289015|54586992|FG001|Overall Study|Adverse Event|0|||
27930700|NCT01289015|54586991|FG000|Overall Study|Lost to Follow-up|33|||
27930701|NCT01289015|54586992|FG001|Overall Study|Lost to Follow-up|17|||
27930702|NCT01289015|54586991|FG000|Overall Study|Withdrawal by Subject|17|||
27930703|NCT01289015|54586992|FG001|Overall Study|Withdrawal by Subject|8|||
27930704|NCT01289015|54586991|FG000|Overall Study|Disease progression|1|||
27930705|NCT01289015|54586992|FG001|Overall Study|Disease progression|0|||
27930706|NCT01289015|54586991|FG000|Overall Study|Negative baseline culture and others|33|||
27930707|NCT01289015|54586992|FG001|Overall Study|Negative baseline culture and others|20|||
27930708|NCT01288937|54587000|FG000|Overall Study|Adverse Event|1|||
27930709|NCT01288937|54587001|FG001|Overall Study|Adverse Event|0|||
27930710|NCT01288469|54587010|FG000|Overall Study|Adverse Event|4|||
27930711|NCT01288469|54587011|FG001|Overall Study|Adverse Event|1|||
27930712|NCT01288469|54587012|FG002|Overall Study|Adverse Event|1|||
27930713|NCT01288469|54587010|FG000|Overall Study|Poor compliance to protocol|0|||
27930714|NCT01288469|54587011|FG001|Overall Study|Poor compliance to protocol|1|||
27930715|NCT01288469|54587012|FG002|Overall Study|Poor compliance to protocol|0|||
27786839|NCT01716520|54241275|FG004|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
27786840|NCT01716520|54241276|FG005|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
27786841|NCT01716520|54241271|FG000|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
27786842|NCT01716520|54241272|FG001|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
27786843|NCT01716520|54241273|FG002|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
27786844|NCT01716520|54241274|FG003|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
27786845|NCT01716520|54241275|FG004|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
27786846|NCT01716520|54241276|FG005|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1|||
27786847|NCT01716520|54241271|FG000|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
27786848|NCT01716520|54241272|FG001|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1|||
27786849|NCT01716520|54241273|FG002|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
27930716|NCT01288469|54587010|FG000|Overall Study|Participant Moved|1|||
27930717|NCT01288469|54587011|FG001|Overall Study|Participant Moved|0|||
27930718|NCT01288469|54587012|FG002|Overall Study|Participant Moved|0|||
27930719|NCT01288469|54587010|FG000|Overall Study|Consent withdrawn by subject|1|||
27930720|NCT01288469|54587011|FG001|Overall Study|Consent withdrawn by subject|1|||
27930721|NCT01288469|54587012|FG002|Overall Study|Consent withdrawn by subject|1|||
27930722|NCT01288469|54587010|FG000|Overall Study|Exclusion criteria finally met|1|||
27930723|NCT01288469|54587011|FG001|Overall Study|Exclusion criteria finally met|0|||
27930724|NCT01288469|54587012|FG002|Overall Study|Exclusion criteria finally met|0|||
27930725|NCT01288079|54587024|FG000|Overall Study|Withdrawal by Subject|2|||
27930726|NCT01288079|54587025|FG001|Overall Study|Withdrawal by Subject|4|||
27930727|NCT01288079|54587026|FG002|Overall Study|Withdrawal by Subject|1|||
27930728|NCT01288079|54587027|FG003|Overall Study|Withdrawal by Subject|0|||
27930729|NCT01288079|54587024|FG000|Overall Study|Adverse Event|2|||
27930730|NCT01288079|54587025|FG001|Overall Study|Adverse Event|1|||
27930731|NCT01288079|54587026|FG002|Overall Study|Adverse Event|2|||
27930732|NCT01288079|54587027|FG003|Overall Study|Adverse Event|3|||
27930733|NCT01288079|54587024|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
27930734|NCT01288079|54587025|FG001|Overall Study|Severe Non-Compliance to Protocol|3|||
27930735|NCT01288079|54587026|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
27930736|NCT01288079|54587027|FG003|Overall Study|Severe Non-Compliance to Protocol|3|||
27930737|NCT01288079|54587024|FG000|Overall Study|Condition under Investigation Worsened|0|||
27930738|NCT01288079|54587025|FG001|Overall Study|Condition under Investigation Worsened|0|||
27930739|NCT01288079|54587026|FG002|Overall Study|Condition under Investigation Worsened|0|||
27930740|NCT01288079|54587027|FG003|Overall Study|Condition under Investigation Worsened|1|||
27930741|NCT01288079|54587024|FG000|Overall Study|Lack of Efficacy|2|||
27930742|NCT01288079|54587025|FG001|Overall Study|Lack of Efficacy|2|||
27930743|NCT01288079|54587026|FG002|Overall Study|Lack of Efficacy|0|||
27930744|NCT01288079|54587027|FG003|Overall Study|Lack of Efficacy|2|||
27930745|NCT01288079|54587024|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
27930746|NCT01288079|54587025|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
27930747|NCT01288079|54587026|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
27930748|NCT01288079|54587027|FG003|Overall Study|Study-Specific Withdrawal Criteria|0|||
27930749|NCT01288079|54587024|FG000|Overall Study|Lost to Follow-up|1|||
27930750|NCT01288079|54587025|FG001|Overall Study|Lost to Follow-up|1|||
27930751|NCT01288079|54587026|FG002|Overall Study|Lost to Follow-up|1|||
27930752|NCT01288079|54587027|FG003|Overall Study|Lost to Follow-up|0|||
27930753|NCT01288079|54587024|FG000|Overall Study|Other or Study Termination|11|||
27930754|NCT01288079|54587025|FG001|Overall Study|Other or Study Termination|15|||
27930755|NCT01288079|54587026|FG002|Overall Study|Other or Study Termination|14|||
28016577|NCT00691028|54675879|FG001|Open-label Period|Withdrawal by Subject|0|||
28016578|NCT00691028|54675880|FG002|Open-label Period|Withdrawal by Subject|0|||
28016579|NCT00691028|54675881|FG003|Open-label Period|Withdrawal by Subject|3|||
28016580|NCT00691028|54675878|FG000|Open-label Period|not come to a hospital|0|||
28016581|NCT00691028|54675879|FG001|Open-label Period|not come to a hospital|0|||
28016582|NCT00691028|54675880|FG002|Open-label Period|not come to a hospital|0|||
28016583|NCT00691028|54675881|FG003|Open-label Period|not come to a hospital|1|||
28016584|NCT00691028|54675878|FG000|Double-blind Period|Adverse Event|8|||
28016585|NCT00691028|54675879|FG001|Double-blind Period|Adverse Event|9|||
28016586|NCT00691028|54675880|FG002|Double-blind Period|Adverse Event|6|||
28016587|NCT00691028|54675881|FG003|Double-blind Period|Adverse Event|0|||
28016588|NCT00691028|54675878|FG000|Double-blind Period|Lack of Efficacy|4|||
28016589|NCT00691028|54675879|FG001|Double-blind Period|Lack of Efficacy|3|||
28016590|NCT00691028|54675880|FG002|Double-blind Period|Lack of Efficacy|2|||
28016591|NCT00691028|54675881|FG003|Double-blind Period|Lack of Efficacy|0|||
28016592|NCT00691028|54675878|FG000|Double-blind Period|Withdrawal by Subject|1|||
28016593|NCT00691028|54675879|FG001|Double-blind Period|Withdrawal by Subject|0|||
28016594|NCT00691028|54675880|FG002|Double-blind Period|Withdrawal by Subject|1|||
28016595|NCT00691028|54675881|FG003|Double-blind Period|Withdrawal by Subject|0|||
28016596|NCT00691028|54675878|FG000|Double-blind Period|not come to a hospital.|0|||
28016597|NCT00691028|54675879|FG001|Double-blind Period|not come to a hospital.|1|||
28016598|NCT00691028|54675880|FG002|Double-blind Period|not come to a hospital.|0|||
28016599|NCT00691028|54675881|FG003|Double-blind Period|not come to a hospital.|0|||
28105587|NCT04889625|54763026|FG001|Period 2|Test article no longer available|0|||
27786850|NCT01716520|54241274|FG003|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
27786851|NCT01716520|54241275|FG004|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
27786852|NCT01716520|54241276|FG005|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
27930756|NCT01288079|54587027|FG003|Overall Study|Other or Study Termination|8|||
27930757|NCT01287221|54587039|FG000|Overall Study|Lack of Perceived Benefit|1|||
27930758|NCT01287221|54587040|FG001|Overall Study|Lack of Perceived Benefit|1|||
27930759|NCT01287221|54587039|FG000|Overall Study|Adverse Event|3|||
27930760|NCT01287221|54587040|FG001|Overall Study|Adverse Event|3|||
27930761|NCT01287221|54587039|FG000|Overall Study|Withdrawal by Subject|0|||
27930762|NCT01287221|54587040|FG001|Overall Study|Withdrawal by Subject|1|||
28105588|NCT04889625|54763025|FG000|Period 2|Incorrect lens dispensed|1|||
27786853|NCT01716520|54241271|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
27786854|NCT01716520|54241272|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
27786855|NCT01716520|54241273|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
27786856|NCT01716520|54241274|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
27786857|NCT01716520|54241275|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
27786858|NCT01716520|54241276|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
27786859|NCT01716520|54241271|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
27786860|NCT01716520|54241272|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
27786861|NCT01716520|54241273|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
27841653|NCT01576718|54329569|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
27841654|NCT01576718|54329563|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2|||
27841655|NCT01576718|54329564|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
27841656|NCT01576718|54329565|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
27841657|NCT01576718|54329566|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
27841658|NCT01576718|54329567|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
27841659|NCT01576718|54329568|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
27841660|NCT01576718|54329569|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
27841661|NCT01576718|54329563|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
27841662|NCT01576718|54329564|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
27841663|NCT01576718|54329565|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
27841664|NCT01576718|54329566|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
27841665|NCT01576718|54329567|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
27841666|NCT01576718|54329568|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
27841667|NCT01576718|54329569|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
27841668|NCT01576718|54329563|FG000|Treatment Period|Adverse Event|0|||
27841669|NCT01576718|54329564|FG001|Treatment Period|Adverse Event|1|||
27841670|NCT01576718|54329565|FG002|Treatment Period|Adverse Event|1|||
27841671|NCT01576718|54329566|FG003|Treatment Period|Adverse Event|1|||
27841672|NCT01576718|54329567|FG004|Treatment Period|Adverse Event|1|||
27841673|NCT01576718|54329568|FG005|Treatment Period|Adverse Event|1|||
27841674|NCT01576718|54329569|FG006|Treatment Period|Adverse Event|0|||
27841675|NCT01576718|54329563|FG000|Treatment Period|Withdrawal by Subject|0|||
27841676|NCT01576718|54329564|FG001|Treatment Period|Withdrawal by Subject|1|||
27841677|NCT01576718|54329565|FG002|Treatment Period|Withdrawal by Subject|1|||
27841678|NCT01576718|54329566|FG003|Treatment Period|Withdrawal by Subject|0|||
28016600|NCT00690794|54675895|FG000|Overall Study|Adverse Event|12|||
28016601|NCT00690794|54675896|FG001|Overall Study|Adverse Event|10|||
28016602|NCT00690794|54675895|FG000|Overall Study|Lost to Follow-up|1|||
27786862|NCT01716520|54241274|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
27786863|NCT01716520|54241275|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
27786864|NCT01716520|54241276|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
27786865|NCT01698268|54241286|FG000|Overall Study|Physician Decision|2|||
27786866|NCT01698268|54241287|FG001|Overall Study|Physician Decision|1|||
27786867|NCT01697956|54241295|FG000|Overall Study|Protocol Violation|1|||
27786868|NCT01697956|54241296|FG001|Overall Study|Protocol Violation|1|||
27786869|NCT01697800|54241310|FG000|Overall Study|Death|0|||
27786870|NCT01697800|54241311|FG001|Overall Study|Death|1|||
27786871|NCT01644500|54241320|FG000|Overall Study|Adverse Event|6|||
27786872|NCT01644500|54241321|FG001|Overall Study|Adverse Event|1|||
27786873|NCT01644500|54241322|FG002|Overall Study|Adverse Event|2|||
27786874|NCT01644500|54241320|FG000|Overall Study|Death|0|||
27786875|NCT01644500|54241321|FG001|Overall Study|Death|1|||
27786876|NCT01644500|54241322|FG002|Overall Study|Death|0|||
27786877|NCT01644500|54241320|FG000|Overall Study|Lost to Follow-up|3|||
27786878|NCT01644500|54241321|FG001|Overall Study|Lost to Follow-up|8|||
27786879|NCT01644500|54241322|FG002|Overall Study|Lost to Follow-up|0|||
27786880|NCT01644500|54241320|FG000|Overall Study|Protocol Violation|1|||
27786881|NCT01644500|54241321|FG001|Overall Study|Protocol Violation|1|||
27786882|NCT01644500|54241322|FG002|Overall Study|Protocol Violation|0|||
27786883|NCT01644500|54241320|FG000|Overall Study|Withdrawal by Subject|11|||
27786884|NCT01644500|54241321|FG001|Overall Study|Withdrawal by Subject|12|||
27786885|NCT01644500|54241322|FG002|Overall Study|Withdrawal by Subject|12|||
27786886|NCT01644500|54241320|FG000|Overall Study|Physician Decision|1|||
27786887|NCT01644500|54241321|FG001|Overall Study|Physician Decision|1|||
27786888|NCT01644500|54241322|FG002|Overall Study|Physician Decision|1|||
27786889|NCT01604824|54241334|FG000|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
27786890|NCT01604824|54241335|FG001|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
27786891|NCT01604824|54241336|FG002|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
27786892|NCT01604824|54241337|FG003|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
27786893|NCT01604824|54241338|FG004|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2|||
27786894|NCT01604824|54241339|FG005|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
27786895|NCT01604824|54241334|FG000|Open-label Extension (OLE) Period|Refused to come into office|0|||
27786896|NCT01604824|54241335|FG001|Open-label Extension (OLE) Period|Refused to come into office|0|||
27786897|NCT01604824|54241336|FG002|Open-label Extension (OLE) Period|Refused to come into office|0|||
27930763|NCT01168401|54587057|FG000|Overall Study|Lost to Follow-up|1|||
27930764|NCT01168401|54587058|FG001|Overall Study|Lost to Follow-up|1|||
27930765|NCT01168401|54587059|FG002|Overall Study|Lost to Follow-up|2|||
27930766|NCT01168401|54587060|FG003|Overall Study|Lost to Follow-up|1|||
27930767|NCT01168401|54587061|FG004|Overall Study|Lost to Follow-up|0|||
27930768|NCT01168401|54587062|FG005|Overall Study|Lost to Follow-up|0|||
27930769|NCT01168401|54587063|FG006|Overall Study|Lost to Follow-up|0|||
27930770|NCT01168401|54587064|FG007|Overall Study|Lost to Follow-up|0|||
27930771|NCT01168401|54587065|FG008|Overall Study|Lost to Follow-up|0|||
27930772|NCT01168401|54587066|FG009|Overall Study|Lost to Follow-up|0|||
27930773|NCT01168401|54587067|FG010|Overall Study|Lost to Follow-up|0|||
27930774|NCT01168401|54587057|FG000|Overall Study|Withdrawal by Subject|0|||
27930775|NCT01168401|54587058|FG001|Overall Study|Withdrawal by Subject|0|||
27930776|NCT01168401|54587059|FG002|Overall Study|Withdrawal by Subject|0|||
27930777|NCT01168401|54587060|FG003|Overall Study|Withdrawal by Subject|1|||
27930778|NCT01168401|54587061|FG004|Overall Study|Withdrawal by Subject|0|||
27930779|NCT01168401|54587062|FG005|Overall Study|Withdrawal by Subject|0|||
27930780|NCT01168401|54587063|FG006|Overall Study|Withdrawal by Subject|0|||
27930781|NCT01168401|54587064|FG007|Overall Study|Withdrawal by Subject|0|||
27930782|NCT01168401|54587065|FG008|Overall Study|Withdrawal by Subject|0|||
27930783|NCT01168401|54587066|FG009|Overall Study|Withdrawal by Subject|0|||
27930784|NCT01168401|54587067|FG010|Overall Study|Withdrawal by Subject|0|||
27930785|NCT01287065|54587091|FG000|Treatment Period 1|Adverse Event|0|||
27930786|NCT01287065|54587092|FG001|Treatment Period 1|Adverse Event|0|||
27930787|NCT01287065|54587093|FG002|Treatment Period 1|Adverse Event|0|||
27930788|NCT01287065|54587094|FG003|Treatment Period 1|Adverse Event|0|||
27930789|NCT01287065|54587095|FG004|Treatment Period 1|Adverse Event|1|||
27786898|NCT01604824|54241337|FG003|Open-label Extension (OLE) Period|Refused to come into office|0|||
27786899|NCT01604824|54241338|FG004|Open-label Extension (OLE) Period|Refused to come into office|1|||
27786900|NCT01604824|54241339|FG005|Open-label Extension (OLE) Period|Refused to come into office|0|||
27786901|NCT01716052|54241353|FG000|Overall Study|Withdrawal of funding|1|||
27930790|NCT01287065|54587096|FG005|Treatment Period 1|Adverse Event|0|||
27930791|NCT01287065|54587091|FG000|Treatment Period 1|Withdrawal by Subject|0|||
27930792|NCT01287065|54587092|FG001|Treatment Period 1|Withdrawal by Subject|0|||
27930793|NCT01287065|54587093|FG002|Treatment Period 1|Withdrawal by Subject|0|||
27930794|NCT01287065|54587094|FG003|Treatment Period 1|Withdrawal by Subject|0|||
27786902|NCT01716052|54241354|FG001|Overall Study|Withdrawal of funding|1|||
27786903|NCT01641692|54241360|FG000|Treatment Period 1|Adverse Event|1|||
27786904|NCT01641692|54241361|FG001|Treatment Period 1|Adverse Event|0|||
27930795|NCT01287065|54587095|FG004|Treatment Period 1|Withdrawal by Subject|0|||
27930796|NCT01287065|54587096|FG005|Treatment Period 1|Withdrawal by Subject|1|||
27930797|NCT01167153|54587106|FG000|Overall Study|Non-effective therapy|1|||
27930798|NCT01167153|54587107|FG001|Overall Study|Non-effective therapy|4|||
27930799|NCT01167153|54587106|FG000|Overall Study|AE including clinical laboratory AE|2|||
27930800|NCT01167153|54587107|FG001|Overall Study|AE including clinical laboratory AE|8|||
27930801|NCT01167153|54587106|FG000|Overall Study|Hypotension|1|||
27930802|NCT01167153|54587107|FG001|Overall Study|Hypotension|0|||
27930803|NCT01167153|54587106|FG000|Overall Study|Lost to Follow-up|7|||
27930804|NCT01167153|54587107|FG001|Overall Study|Lost to Follow-up|9|||
27930805|NCT01167153|54587106|FG000|Overall Study|Non-compliance to concomitant medication|0|||
27930806|NCT01167153|54587107|FG001|Overall Study|Non-compliance to concomitant medication|2|||
27930807|NCT01167153|54587106|FG000|Overall Study|Investigator initiation withdrawal,Other|1|||
27930808|NCT01167153|54587107|FG001|Overall Study|Investigator initiation withdrawal,Other|1|||
27930809|NCT01167153|54587106|FG000|Overall Study|Withdrawal consent|1|||
27930810|NCT01167153|54587107|FG001|Overall Study|Withdrawal consent|1|||
27930811|NCT01167153|54587106|FG000|Overall Study|Subject initiation withdrawal, Other|5|||
27930812|NCT01167153|54587107|FG001|Overall Study|Subject initiation withdrawal, Other|8|||
27930813|NCT01166763|54587113|FG000|Overall Study|Withdrawal by Subject|3|||
27930814|NCT01166373|54587121|FG000|Overall Study|Lost to Follow-up|3|||
27930815|NCT01166373|54587122|FG001|Overall Study|Lost to Follow-up|2|||
27930816|NCT01166373|54587123|FG002|Overall Study|Lost to Follow-up|2|||
27930817|NCT01166373|54587124|FG003|Overall Study|Lost to Follow-up|2|||
27930818|NCT01166373|54587121|FG000|Overall Study|Withdrawal by Subject|1|||
27930819|NCT01166373|54587122|FG001|Overall Study|Withdrawal by Subject|2|||
27930820|NCT01166373|54587123|FG002|Overall Study|Withdrawal by Subject|2|||
27930821|NCT01166373|54587124|FG003|Overall Study|Withdrawal by Subject|3|||
27930822|NCT01166373|54587121|FG000|Overall Study|Physician Decision|1|||
27930823|NCT01166373|54587122|FG001|Overall Study|Physician Decision|0|||
27930824|NCT01166373|54587123|FG002|Overall Study|Physician Decision|0|||
27930825|NCT01166373|54587124|FG003|Overall Study|Physician Decision|0|||
27930826|NCT00963235|54587136|FG000|Overall Study|Withdrawal by Subject|22|||
27930827|NCT00963235|54587136|FG000|Overall Study|Lost to Follow-up|14|||
27930828|NCT00963235|54587136|FG000|Overall Study|Failed to return|9|||
27930829|NCT00963235|54587136|FG000|Overall Study|Protocol Violation|7|||
27930830|NCT00963235|54587136|FG000|Overall Study|Adverse Event|5|||
27930831|NCT00963235|54587136|FG000|Overall Study|Physician Decision|2|||
27930832|NCT00963235|54587136|FG000|Overall Study|Other|1|||
27930833|NCT01165281|54587145|FG000|Overall Study|Adverse Event|12|||
27930834|NCT01165281|54587146|FG001|Overall Study|Adverse Event|14|||
27930835|NCT01165281|54587145|FG000|Overall Study|Death|3|||
27930836|NCT01165281|54587146|FG001|Overall Study|Death|4|||
27930837|NCT01165281|54587145|FG000|Overall Study|Lack of Efficacy|4|||
27930838|NCT01165281|54587146|FG001|Overall Study|Lack of Efficacy|1|||
27930839|NCT01165281|54587145|FG000|Overall Study|Lost to Follow-up|0|||
27930840|NCT01165281|54587146|FG001|Overall Study|Lost to Follow-up|1|||
27930841|NCT01165281|54587145|FG000|Overall Study|Physician Decision|8|||
27930842|NCT01165281|54587146|FG001|Overall Study|Physician Decision|1|||
27930843|NCT01165281|54587145|FG000|Overall Study|Protocol Violation|6|||
27930844|NCT01165281|54587146|FG001|Overall Study|Protocol Violation|5|||
27930845|NCT01165281|54587145|FG000|Overall Study|Withdrawal by Subject|8|||
27930846|NCT01165281|54587146|FG001|Overall Study|Withdrawal by Subject|7|||
27930847|NCT01165281|54587145|FG000|Overall Study|Noncompliance with Study Drug|1|||
27930848|NCT01165281|54587146|FG001|Overall Study|Noncompliance with Study Drug|4|||
27930849|NCT01165281|54587145|FG000|Overall Study|Progressive Disease|10|||
27930850|NCT01165281|54587146|FG001|Overall Study|Progressive Disease|14|||
27930851|NCT01165281|54587145|FG000|Overall Study|Other|6|||
27930852|NCT01165281|54587146|FG001|Overall Study|Other|0|||
27930853|NCT01165203|54587154|FG000|Active Phase|Serious Adverse Event|1|||
27930854|NCT01165203|54587155|FG001|Active Phase|Serious Adverse Event|0|||
27930855|NCT01165203|54587154|FG000|Active Phase|Withdrawal by Subject|2|||
27930856|NCT01165203|54587155|FG001|Active Phase|Withdrawal by Subject|1|||
27930857|NCT01165203|54587154|FG000|Active Phase|Migrated/moved from study area|0|||
27930858|NCT01165203|54587155|FG001|Active Phase|Migrated/moved from study area|1|||
27930859|NCT01165203|54587154|FG000|Active Phase|Lost to Follow-up|2|||
27930860|NCT01165203|54587155|FG001|Active Phase|Lost to Follow-up|0|||
27930861|NCT01165203|54587154|FG000|Extended Safety Follow-up Phase|Serious Adverse Event|1|||
27930862|NCT01165203|54587155|FG001|Extended Safety Follow-up Phase|Serious Adverse Event|0|||
27930863|NCT01165203|54587154|FG000|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
27930864|NCT01165203|54587155|FG001|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
27930865|NCT01165203|54587154|FG000|Extended Safety Follow-up Phase|Migrated/moved from study area|2|||
27930866|NCT01165203|54587155|FG001|Extended Safety Follow-up Phase|Migrated/moved from study area|1|||
27930867|NCT01165203|54587154|FG000|Extended Safety Follow-up Phase|Lost to Follow-up|2|||
27930868|NCT01165203|54587155|FG001|Extended Safety Follow-up Phase|Lost to Follow-up|0|||
27930869|NCT01165203|54587154|FG000|Extended Safety Follow-up Phase|Other-subjects business reasons|0|||
27930870|NCT01165203|54587155|FG001|Extended Safety Follow-up Phase|Other-subjects business reasons|1|||
28016603|NCT00690794|54675896|FG001|Overall Study|Lost to Follow-up|4|||
28016604|NCT00690794|54675895|FG000|Overall Study|Withdrawal by Subject|0|||
28016605|NCT00690794|54675896|FG001|Overall Study|Withdrawal by Subject|9|||
28016606|NCT00690794|54675895|FG000|Overall Study|Protocol Violation|6|||
28016607|NCT00690794|54675896|FG001|Overall Study|Protocol Violation|7|||
28016608|NCT00690794|54675895|FG000|Overall Study|Noncompliance|1|||
28016609|NCT00690794|54675896|FG001|Overall Study|Noncompliance|2|||
28016610|NCT00690794|54675895|FG000|Overall Study|Other not specified|1|||
28016611|NCT00690794|54675896|FG001|Overall Study|Other not specified|3|||
28016612|NCT00666276|54675902|FG000|Overall Study|Protocol Violation|34|||
28016613|NCT00567255|54675927|FG000|Overall Study|Adverse Event|241|||
28016614|NCT00567255|54675928|FG001|Overall Study|Adverse Event|68|||
28016615|NCT00567255|54675927|FG000|Overall Study|Lost to Follow-up|77|||
28016616|NCT00567255|54675928|FG001|Overall Study|Lost to Follow-up|48|||
28016617|NCT00567255|54675927|FG000|Overall Study|Withdrawal by Subject|75|||
28016618|NCT00567255|54675928|FG001|Overall Study|Withdrawal by Subject|56|||
28016619|NCT00567255|54675927|FG000|Overall Study|Lack of Efficacy|19|||
28016620|NCT00567255|54675928|FG001|Overall Study|Lack of Efficacy|33|||
28016621|NCT00567255|54675927|FG000|Overall Study|Protocol Violation|20|||
28016622|NCT00567255|54675928|FG001|Overall Study|Protocol Violation|8|||
28016623|NCT00567255|54675927|FG000|Overall Study|Pregnancy|6|||
28016624|NCT00567255|54675928|FG001|Overall Study|Pregnancy|0|||
28016625|NCT00567255|54675927|FG000|Overall Study|Drug noncompliance,moved,other|25|||
28016626|NCT00567255|54675928|FG001|Overall Study|Drug noncompliance,moved,other|15|||
27930871|NCT00960661|54587170|FG000|Basal Insulin Optimization Phase (BIO)|Adverse Event|6|||
27930872|NCT00960661|54587171|FG001|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
28016627|NCT00667446|54675936|FG000|Treatment Period (36 Months)|Ready to enter puberty based on age|13|||
28016628|NCT00667446|54675937|FG001|Treatment Period (36 Months)|Ready to enter puberty based on age|15|||
28016629|NCT00667446|54675936|FG000|Treatment Period (36 Months)|Other|2|||
28016630|NCT00667446|54675937|FG001|Treatment Period (36 Months)|Other|2|||
28016631|NCT00667446|54675936|FG000|Treatment Period (36 Months)|Personal reasons|2|||
28016632|NCT00667446|54675937|FG001|Treatment Period (36 Months)|Personal reasons|2|||
28016633|NCT00667446|54675936|FG000|Treatment Period (36 Months)|Withdrawal by Subject|0|||
27786905|NCT01641692|54241362|FG002|Treatment Period 1|Adverse Event|0|||
27786906|NCT01641692|54241363|FG003|Treatment Period 1|Adverse Event|0|||
27786907|NCT01641692|54241364|FG004|Treatment Period 1|Adverse Event|0|||
27786908|NCT01641692|54241365|FG005|Treatment Period 1|Adverse Event|0|||
27786909|NCT01641692|54241366|FG006|Treatment Period 1|Adverse Event|0|||
28016634|NCT00667446|54675937|FG001|Treatment Period (36 Months)|Withdrawal by Subject|4|||
28016635|NCT00667446|54675936|FG000|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3|||
28016636|NCT00667446|54675937|FG001|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0|||
28016637|NCT00667446|54675936|FG000|Treatment Period (36 Months)|Lost to Follow-up|1|||
28016638|NCT00667446|54675937|FG001|Treatment Period (36 Months)|Lost to Follow-up|0|||
28016639|NCT00667446|54675936|FG000|Treatment Period (36 Months)|Protocol Violation|1|||
28016640|NCT00667446|54675937|FG001|Treatment Period (36 Months)|Protocol Violation|1|||
28016641|NCT00667446|54675936|FG000|Treatment Period (36 Months)|Therapeutic Failure|1|||
28016642|NCT00667446|54675937|FG001|Treatment Period (36 Months)|Therapeutic Failure|1|||
28016643|NCT00667446|54675936|FG000|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0|||
28016644|NCT00667446|54675937|FG001|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1|||
28016645|NCT00688844|54675943|FG000|Overall Study|Lost to Follow-up|10|||
28016646|NCT00667368|54675949|FG000|Overall Study|Lost to Follow-up|176|||
28016647|NCT00667368|54675950|FG001|Overall Study|Lost to Follow-up|155|||
28016648|NCT00667368|54675949|FG000|Overall Study|Discontinued early|24|||
28016649|NCT00667368|54675950|FG001|Overall Study|Discontinued early|17|||
28016650|NCT00567567|54675959|FG000|Overall Study|Adverse Event|0|||
28016651|NCT00567567|54675960|FG001|Overall Study|Adverse Event|2|||
28016652|NCT00567567|54675961|FG002|Overall Study|Adverse Event|5|||
28016653|NCT00567567|54675959|FG000|Overall Study|Death|8|||
28016654|NCT00567567|54675960|FG001|Overall Study|Death|1|||
28016655|NCT00567567|54675961|FG002|Overall Study|Death|5|||
28016656|NCT00567567|54675959|FG000|Overall Study|Lack of Efficacy|16|||
28016657|NCT00567567|54675960|FG001|Overall Study|Lack of Efficacy|17|||
28016658|NCT00567567|54675961|FG002|Overall Study|Lack of Efficacy|48|||
28016659|NCT00567567|54675959|FG000|Overall Study|Lost to Follow-up|0|||
28016660|NCT00567567|54675960|FG001|Overall Study|Lost to Follow-up|0|||
28016661|NCT00567567|54675961|FG002|Overall Study|Lost to Follow-up|1|||
28016662|NCT00567567|54675959|FG000|Overall Study|Physician Decision|16|||
28016663|NCT00567567|54675960|FG001|Overall Study|Physician Decision|18|||
28016664|NCT00567567|54675961|FG002|Overall Study|Physician Decision|84|||
28016665|NCT00567567|54675959|FG000|Overall Study|Withdrawal by Subject|0|||
28016666|NCT00567567|54675960|FG001|Overall Study|Withdrawal by Subject|0|||
28016667|NCT00567567|54675961|FG002|Overall Study|Withdrawal by Subject|2|||
28016668|NCT00567567|54675959|FG000|Overall Study|Ineligible|4|||
28016669|NCT00567567|54675960|FG001|Overall Study|Ineligible|0|||
28016670|NCT00567567|54675961|FG002|Overall Study|Ineligible|9|||
28016671|NCT00567567|54675959|FG000|Overall Study|Refusal by patient/parent/guardian|9|||
28016672|NCT00567567|54675960|FG001|Overall Study|Refusal by patient/parent/guardian|16|||
28016673|NCT00567567|54675961|FG002|Overall Study|Refusal by patient/parent/guardian|122|||
28016674|NCT00567567|54675959|FG000|Overall Study|Enrolled another COG therapeutic study|99|||
28016675|NCT00567567|54675960|FG001|Overall Study|Enrolled another COG therapeutic study|80|||
28016676|NCT00567567|54675961|FG002|Overall Study|Enrolled another COG therapeutic study|0|||
28016677|NCT00567567|54675959|FG000|Overall Study|Unable adequate stem cell for transplant|0|||
28016678|NCT00567567|54675960|FG001|Overall Study|Unable adequate stem cell for transplant|0|||
28016679|NCT00567567|54675961|FG002|Overall Study|Unable adequate stem cell for transplant|2|||
28016680|NCT00666198|54675971|FG000|Overall Study|Protocol Violation|10|||
28016681|NCT00666198|54675971|FG000|Overall Study|No Visit After First Day of Treatment|13|||
27786910|NCT01641692|54241367|FG007|Treatment Period 1|Adverse Event|0|||
27786911|NCT01641692|54241360|FG000|Treatment Period 1|Lack of Efficacy|0|||
27786912|NCT01641692|54241361|FG001|Treatment Period 1|Lack of Efficacy|0|||
27786913|NCT01641692|54241362|FG002|Treatment Period 1|Lack of Efficacy|0|||
27786914|NCT01641692|54241363|FG003|Treatment Period 1|Lack of Efficacy|0|||
27786915|NCT01641692|54241364|FG004|Treatment Period 1|Lack of Efficacy|0|||
27786916|NCT01641692|54241365|FG005|Treatment Period 1|Lack of Efficacy|0|||
27786917|NCT01641692|54241366|FG006|Treatment Period 1|Lack of Efficacy|0|||
27786918|NCT01641692|54241367|FG007|Treatment Period 1|Lack of Efficacy|1|||
27786919|NCT01641692|54241360|FG000|Treatment Period 1|Protocol Violation|1|||
28016682|NCT00666198|54675971|FG000|Overall Study|Safety Not Assessable|6|||
28016683|NCT00666198|54675971|FG000|Overall Study|No Drug Administration|4|||
28016684|NCT00664560|54675978|FG000|Overall Study|Adverse Event|19|||
28016685|NCT00664560|54675979|FG001|Overall Study|Adverse Event|16|||
28016686|NCT00664560|54675980|FG002|Overall Study|Adverse Event|7|||
28016687|NCT00664560|54675978|FG000|Overall Study|Withdrawal by Subject|9|||
28016688|NCT00664560|54675979|FG001|Overall Study|Withdrawal by Subject|13|||
28016689|NCT00664560|54675980|FG002|Overall Study|Withdrawal by Subject|7|||
28016690|NCT00664560|54675978|FG000|Overall Study|Lost to Follow-up|0|||
28016691|NCT00664560|54675979|FG001|Overall Study|Lost to Follow-up|2|||
28016692|NCT00664560|54675980|FG002|Overall Study|Lost to Follow-up|0|||
28016693|NCT00664560|54675978|FG000|Overall Study|Other|11|||
28016694|NCT00664560|54675979|FG001|Overall Study|Other|4|||
28016695|NCT00664560|54675980|FG002|Overall Study|Other|5|||
28016696|NCT00566709|54675990|FG000|Overall Study|Protocol Violation|5|||
28016697|NCT00566709|54675991|FG001|Overall Study|Protocol Violation|0|||
28016698|NCT00688688|54676000|FG000|Overall Study|Eligibility criterion not met|7|||
28016699|NCT00688688|54676001|FG001|Overall Study|Eligibility criterion not met|7|||
28016700|NCT00688688|54676002|FG002|Overall Study|Eligibility criterion not met|10|||
28016701|NCT00688688|54676000|FG000|Overall Study|Adverse Event|52|||
28016702|NCT00688688|54676001|FG001|Overall Study|Adverse Event|51|||
28016703|NCT00688688|54676002|FG002|Overall Study|Adverse Event|50|||
28016704|NCT00688688|54676000|FG000|Overall Study|Lack of Efficacy|34|||
28016705|NCT00688688|54676001|FG001|Overall Study|Lack of Efficacy|25|||
28016706|NCT00688688|54676002|FG002|Overall Study|Lack of Efficacy|45|||
28016707|NCT00688688|54676000|FG000|Overall Study|Withdrawal by Subject|66|||
28016708|NCT00688688|54676001|FG001|Overall Study|Withdrawal by Subject|75|||
28016709|NCT00688688|54676002|FG002|Overall Study|Withdrawal by Subject|65|||
28016710|NCT00688688|54676000|FG000|Overall Study|Lost to Follow-up|14|||
27786920|NCT01641692|54241361|FG001|Treatment Period 1|Protocol Violation|0|||
27786921|NCT01641692|54241362|FG002|Treatment Period 1|Protocol Violation|0|||
27786922|NCT01641692|54241363|FG003|Treatment Period 1|Protocol Violation|0|||
27786923|NCT01641692|54241364|FG004|Treatment Period 1|Protocol Violation|2|||
27786924|NCT01641692|54241365|FG005|Treatment Period 1|Protocol Violation|0|||
27786925|NCT01641692|54241366|FG006|Treatment Period 1|Protocol Violation|0|||
27786926|NCT01641692|54241367|FG007|Treatment Period 1|Protocol Violation|0|||
27786927|NCT01641692|54241360|FG000|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
27786928|NCT01641692|54241361|FG001|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
27786929|NCT01641692|54241362|FG002|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
27786930|NCT01641692|54241363|FG003|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
27786931|NCT01641692|54241364|FG004|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
27786932|NCT01641692|54241365|FG005|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
27786933|NCT01641692|54241366|FG006|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
27786934|NCT01641692|54241367|FG007|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
27786935|NCT01641692|54241360|FG000|Treatment Period 1|Lost to Follow-up|0|||
27786936|NCT01641692|54241361|FG001|Treatment Period 1|Lost to Follow-up|0|||
27786937|NCT01641692|54241362|FG002|Treatment Period 1|Lost to Follow-up|1|||
27786938|NCT01641692|54241363|FG003|Treatment Period 1|Lost to Follow-up|0|||
27786939|NCT01641692|54241364|FG004|Treatment Period 1|Lost to Follow-up|0|||
27786940|NCT01641692|54241365|FG005|Treatment Period 1|Lost to Follow-up|0|||
27786941|NCT01641692|54241366|FG006|Treatment Period 1|Lost to Follow-up|0|||
27930873|NCT00960661|54587172|FG002|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
27930874|NCT00960661|54587170|FG000|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4|||
27930875|NCT00960661|54587171|FG001|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
27930876|NCT00960661|54587172|FG002|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
27930877|NCT00960661|54587170|FG000|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331|||
27930878|NCT00960661|54587171|FG001|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
27930879|NCT00960661|54587172|FG002|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
27930880|NCT00960661|54587170|FG000|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47|||
27930881|NCT00960661|54587171|FG001|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
27930882|NCT00960661|54587172|FG002|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
27930883|NCT00960661|54587170|FG000|Basal Insulin Optimization Phase (BIO)|Physician Decision|8|||
27930884|NCT00960661|54587171|FG001|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
27930885|NCT00960661|54587172|FG002|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
27930886|NCT00960661|54587170|FG000|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3|||
27930887|NCT00960661|54587171|FG001|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
27930888|NCT00960661|54587172|FG002|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
27930889|NCT00960661|54587170|FG000|Interventional Phase|Adverse Event|0|||
27930890|NCT00960661|54587171|FG001|Interventional Phase|Adverse Event|17|||
28016711|NCT00688688|54676001|FG001|Overall Study|Lost to Follow-up|7|||
27786942|NCT01641692|54241367|FG007|Treatment Period 1|Lost to Follow-up|0|||
27786943|NCT01641692|54241360|FG000|Treatment Period 1|Physician Decision|0|||
27786944|NCT01641692|54241361|FG001|Treatment Period 1|Physician Decision|0|||
28016712|NCT00688688|54676002|FG002|Overall Study|Lost to Follow-up|7|||
28016713|NCT00688688|54676000|FG000|Overall Study|Protocol Violation|6|||
28016714|NCT00688688|54676001|FG001|Overall Study|Protocol Violation|9|||
28016715|NCT00688688|54676002|FG002|Overall Study|Protocol Violation|11|||
28016716|NCT00688688|54676000|FG000|Overall Study|Randomized but never received study drug|1|||
27786945|NCT01641692|54241362|FG002|Treatment Period 1|Physician Decision|0|||
27786946|NCT01641692|54241363|FG003|Treatment Period 1|Physician Decision|0|||
27786947|NCT01641692|54241364|FG004|Treatment Period 1|Physician Decision|1|||
28016717|NCT00688688|54676001|FG001|Overall Study|Randomized but never received study drug|0|||
28016718|NCT00688688|54676002|FG002|Overall Study|Randomized but never received study drug|0|||
28016719|NCT00688688|54676000|FG000|Overall Study|Non-compliance with study procedures|5|||
28016720|NCT00688688|54676001|FG001|Overall Study|Non-compliance with study procedures|3|||
28016721|NCT00688688|54676002|FG002|Overall Study|Non-compliance with study procedures|4|||
28016722|NCT00688688|54676000|FG000|Overall Study|Taking exclusionary medications|1|||
28016723|NCT00688688|54676001|FG001|Overall Study|Taking exclusionary medications|0|||
28016724|NCT00688688|54676002|FG002|Overall Study|Taking exclusionary medications|0|||
28016725|NCT00688688|54676000|FG000|Overall Study|Site closure|0|||
28016726|NCT00688688|54676001|FG001|Overall Study|Site closure|1|||
28016727|NCT00688688|54676002|FG002|Overall Study|Site closure|0|||
28016728|NCT00688688|54676000|FG000|Overall Study|Violation of exclusion criterion|0|||
28016729|NCT00688688|54676001|FG001|Overall Study|Violation of exclusion criterion|1|||
28016730|NCT00688688|54676002|FG002|Overall Study|Violation of exclusion criterion|0|||
28016731|NCT00664326|54676010|FG000|Overall Study|Adverse Event|14|||
28016732|NCT00664326|54676010|FG000|Overall Study|Noncompliance with study medication|3|||
28016733|NCT00664326|54676010|FG000|Overall Study|Withdrawal by Subject|1|||
28016734|NCT00664326|54676010|FG000|Overall Study|Physician Decision|1|||
28016735|NCT00664326|54676010|FG000|Overall Study|Other Reasons|3|||
28016736|NCT00664326|54676010|FG000|Overall Study|Death|2|||
28016737|NCT00664326|54676010|FG000|Overall Study|Disease Progression/Recurrence/Relapse|24|||
28016738|NCT00686972|54676014|FG000|Overall Study|P.I, Left institution. Study terminated|51|||
27930891|NCT00960661|54587172|FG002|Interventional Phase|Adverse Event|8|||
27930892|NCT00960661|54587170|FG000|Interventional Phase|Death|0|||
27930893|NCT00960661|54587171|FG001|Interventional Phase|Death|1|||
27930894|NCT00960661|54587172|FG002|Interventional Phase|Death|0|||
27930895|NCT00960661|54587170|FG000|Interventional Phase|Lost to Follow-up|0|||
27930896|NCT00960661|54587171|FG001|Interventional Phase|Lost to Follow-up|0|||
27930897|NCT00960661|54587172|FG002|Interventional Phase|Lost to Follow-up|2|||
27930898|NCT00960661|54587170|FG000|Interventional Phase|entry criteria not met|0|||
27930899|NCT00960661|54587171|FG001|Interventional Phase|entry criteria not met|3|||
27930900|NCT00960661|54587172|FG002|Interventional Phase|entry criteria not met|0|||
27930901|NCT00960661|54587170|FG000|Interventional Phase|Protocol Violation|0|||
27930902|NCT00960661|54587171|FG001|Interventional Phase|Protocol Violation|7|||
27930903|NCT00960661|54587172|FG002|Interventional Phase|Protocol Violation|2|||
27930904|NCT00960661|54587170|FG000|Interventional Phase|Withdrawal by Subject|0|||
27930905|NCT00960661|54587171|FG001|Interventional Phase|Withdrawal by Subject|18|||
27930906|NCT00960661|54587172|FG002|Interventional Phase|Withdrawal by Subject|29|||
27930907|NCT00960661|54587170|FG000|Interventional Phase|Physician Decision|0|||
27930908|NCT00960661|54587171|FG001|Interventional Phase|Physician Decision|3|||
27930909|NCT00960661|54587172|FG002|Interventional Phase|Physician Decision|5|||
27930910|NCT00960661|54587170|FG000|Interventional Phase|sponsor decision|0|||
27930911|NCT00960661|54587171|FG001|Interventional Phase|sponsor decision|1|||
27930912|NCT00960661|54587172|FG002|Interventional Phase|sponsor decision|0|||
27930913|NCT00960661|54587170|FG000|Interventional Phase|Lack of Efficacy|0|||
28016739|NCT00665652|54676018|FG000|Overall Study|Adverse Event|4|||
28016740|NCT00665652|54676018|FG000|Overall Study|Death|1|||
27841679|NCT01576718|54329567|FG004|Treatment Period|Withdrawal by Subject|2|||
27841680|NCT01576718|54329568|FG005|Treatment Period|Withdrawal by Subject|4|||
27841681|NCT01576718|54329569|FG006|Treatment Period|Withdrawal by Subject|2|||
27841682|NCT01576718|54329563|FG000|Treatment Period|Physician Decision|0|||
27841683|NCT01576718|54329564|FG001|Treatment Period|Physician Decision|1|||
27841684|NCT01576718|54329565|FG002|Treatment Period|Physician Decision|1|||
27841685|NCT01576718|54329566|FG003|Treatment Period|Physician Decision|1|||
27841686|NCT01576718|54329567|FG004|Treatment Period|Physician Decision|1|||
27841687|NCT01576718|54329568|FG005|Treatment Period|Physician Decision|0|||
27841688|NCT01576718|54329569|FG006|Treatment Period|Physician Decision|0|||
27841689|NCT01576718|54329563|FG000|Treatment Period|Protocol Violation|0|||
27841690|NCT01576718|54329564|FG001|Treatment Period|Protocol Violation|5|||
27841691|NCT01576718|54329565|FG002|Treatment Period|Protocol Violation|4|||
27841692|NCT01576718|54329566|FG003|Treatment Period|Protocol Violation|10|||
27841693|NCT01576718|54329567|FG004|Treatment Period|Protocol Violation|6|||
27841694|NCT01576718|54329568|FG005|Treatment Period|Protocol Violation|8|||
27841695|NCT01576718|54329569|FG006|Treatment Period|Protocol Violation|12|||
27841696|NCT01576718|54329563|FG000|Treatment Period|Sponsor request|0|||
27841697|NCT01576718|54329564|FG001|Treatment Period|Sponsor request|1|||
27841698|NCT01576718|54329565|FG002|Treatment Period|Sponsor request|0|||
27841699|NCT01576718|54329566|FG003|Treatment Period|Sponsor request|0|||
27841700|NCT01576718|54329567|FG004|Treatment Period|Sponsor request|0|||
27841701|NCT01576718|54329568|FG005|Treatment Period|Sponsor request|1|||
27930914|NCT00960661|54587171|FG001|Interventional Phase|Lack of Efficacy|2|||
27930915|NCT00960661|54587172|FG002|Interventional Phase|Lack of Efficacy|0|||
27930916|NCT00960193|54587178|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
28016741|NCT00665652|54676018|FG000|Overall Study|No longer met inclusion criteria.|1|||
28105589|NCT04889625|54763026|FG001|Period 2|Incorrect lens dispensed|0|||
27930917|NCT00960115|54587187|FG000|Overall Study|Ongoing treatment at data cut-off date|19|||
27930918|NCT00960115|54587188|FG001|Overall Study|Ongoing treatment at data cut-off date|15|||
28016742|NCT00566631|54676022|FG000|Part 1: Core Treatment Phase|Lack of Efficacy|18|||
28016743|NCT00566631|54676022|FG000|Part 1: Core Treatment Phase|Physician Decision|1|||
28016744|NCT00566631|54676022|FG000|Part 1: Core Treatment Phase|Adverse Event|9|||
28016745|NCT00566631|54676022|FG000|Part 1: Core Treatment Phase|Lost to Follow-up|4|||
28016746|NCT00566631|54676022|FG000|Part 1: Core Treatment Phase|Withdrawal by Subject|26|||
28016747|NCT00566631|54676022|FG000|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1|||
28016748|NCT00566631|54676022|FG000|Part 1: Core Treatment Phase|Met exclusion criteria|1|||
28016749|NCT00566631|54676022|FG000|Between Treatment and Extension Phase|Participants not willing to participate|95|||
28016750|NCT00566631|54676022|FG000|Part 2: Extension Phase|Lack of Efficacy|25|||
28016751|NCT00566631|54676022|FG000|Part 2: Extension Phase|Withdrawal by Subject|34|||
28016752|NCT00566631|54676022|FG000|Part 2: Extension Phase|Adverse Event|11|||
28016753|NCT00566631|54676022|FG000|Part 2: Extension Phase|Lost to Follow-up|6|||
28016754|NCT00566631|54676022|FG000|Part 2: Extension Phase|Death|1|||
28016755|NCT00566631|54676022|FG000|Part 2: Extension Phase|Other|5|||
28016756|NCT00661830|54676028|FG000|Overall Study|Death|37|||
28016757|NCT00661830|54676029|FG001|Overall Study|Death|33|||
28016758|NCT00661830|54676028|FG000|Overall Study|Lost to Follow-up|1|||
28016759|NCT00661830|54676029|FG001|Overall Study|Lost to Follow-up|3|||
28016760|NCT00661830|54676028|FG000|Overall Study|Withdrawal by Subject|1|||
28016761|NCT00661830|54676029|FG001|Overall Study|Withdrawal by Subject|1|||
28016762|NCT00661830|54676028|FG000|Overall Study|Other reason|1|||
28016763|NCT00661830|54676029|FG001|Overall Study|Other reason|5|||
28016764|NCT00540592|54676045|FG000|Overall Study|Adverse Event|0|||
28016765|NCT00540592|54676046|FG001|Overall Study|Adverse Event|1|||
28016766|NCT00540592|54676047|FG002|Overall Study|Adverse Event|0|||
28016767|NCT00540592|54676048|FG003|Overall Study|Adverse Event|0|||
28016768|NCT00540592|54676049|FG004|Overall Study|Adverse Event|1|||
28016769|NCT00540592|54676050|FG005|Overall Study|Adverse Event|0|||
28016770|NCT00540592|54676051|FG006|Overall Study|Adverse Event|0|||
28016771|NCT00540592|54676052|FG007|Overall Study|Adverse Event|1|||
28016772|NCT00540592|54676053|FG008|Overall Study|Adverse Event|1|||
28016773|NCT00540592|54676054|FG009|Overall Study|Adverse Event|2|||
28016774|NCT00540592|54676045|FG000|Overall Study|Lost to Follow-up|2|||
28016775|NCT00540592|54676046|FG001|Overall Study|Lost to Follow-up|0|||
28016776|NCT00540592|54676047|FG002|Overall Study|Lost to Follow-up|0|||
27930919|NCT00959647|54587194|FG000|Overall Study|Adverse Event|2|||
27930920|NCT00959647|54587194|FG000|Overall Study|Progressive disease|6|||
27930921|NCT00959647|54587194|FG000|Overall Study|Study terminated by sponsor|4|||
27930922|NCT00959647|54587194|FG000|Overall Study|Withdrawal by Subject|7|||
27930923|NCT00957931|54587198|FG000|Overall Study|Death|4|||
27930924|NCT00957853|54587205|FG000|Overall Study|Withdrawal by Subject|1|||
28016777|NCT00540592|54676048|FG003|Overall Study|Lost to Follow-up|0|||
28016778|NCT00540592|54676049|FG004|Overall Study|Lost to Follow-up|0|||
28016779|NCT00540592|54676050|FG005|Overall Study|Lost to Follow-up|0|||
28016780|NCT00540592|54676051|FG006|Overall Study|Lost to Follow-up|0|||
28016781|NCT00540592|54676052|FG007|Overall Study|Lost to Follow-up|0|||
28016782|NCT00540592|54676053|FG008|Overall Study|Lost to Follow-up|0|||
28016783|NCT00540592|54676054|FG009|Overall Study|Lost to Follow-up|0|||
28016784|NCT00540592|54676045|FG000|Overall Study|Withdrawal by Subject|0|||
28016785|NCT00540592|54676046|FG001|Overall Study|Withdrawal by Subject|0|||
28016786|NCT00540592|54676047|FG002|Overall Study|Withdrawal by Subject|1|||
28016787|NCT00540592|54676048|FG003|Overall Study|Withdrawal by Subject|1|||
28016788|NCT00540592|54676049|FG004|Overall Study|Withdrawal by Subject|0|||
28016789|NCT00540592|54676050|FG005|Overall Study|Withdrawal by Subject|0|||
28016790|NCT00540592|54676051|FG006|Overall Study|Withdrawal by Subject|0|||
28016791|NCT00540592|54676052|FG007|Overall Study|Withdrawal by Subject|0|||
28016792|NCT00540592|54676053|FG008|Overall Study|Withdrawal by Subject|0|||
28016793|NCT00540592|54676054|FG009|Overall Study|Withdrawal by Subject|0|||
28016794|NCT03970395|54676078|FG000|Overall Study|Withdrawal by Subject|3|||
28016795|NCT03970395|54676079|FG001|Overall Study|Withdrawal by Subject|4|||
28016796|NCT03970395|54676078|FG000|Overall Study|Lost to Follow-up|4|||
28016797|NCT03970395|54676079|FG001|Overall Study|Lost to Follow-up|8|||
28016798|NCT00565773|54676089|FG000|Overall Study|Withdrawal by Subject|1|||
28016799|NCT00565773|54676089|FG000|Overall Study|Physician Decision|1|||
28016800|NCT00570492|54676095|FG000|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98|||
28016801|NCT00570492|54676096|FG001|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
28016802|NCT00570492|54676097|FG002|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
28016803|NCT00570492|54676095|FG000|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263|||
28016804|NCT00570492|54676096|FG001|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
27930925|NCT00957853|54587206|FG001|Overall Study|Withdrawal by Subject|0|||
28016805|NCT00570492|54676097|FG002|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
28016806|NCT00570492|54676095|FG000|16-week Single-blind Baseline Period|Withdrawal by Subject|56|||
28016807|NCT00570492|54676096|FG001|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
28016808|NCT00570492|54676097|FG002|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
28016809|NCT00570492|54676095|FG000|16-week Single-blind Baseline Period|Protocol Violation|15|||
28016810|NCT00570492|54676096|FG001|16-week Single-blind Baseline Period|Protocol Violation|0|||
28016811|NCT00570492|54676097|FG002|16-week Single-blind Baseline Period|Protocol Violation|0|||
28016812|NCT00570492|54676095|FG000|16-week Single-blind Baseline Period|Lost to Follow-up|2|||
28016813|NCT00570492|54676096|FG001|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
28016814|NCT00570492|54676097|FG002|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
28016815|NCT00570492|54676095|FG000|16-week Single-blind Baseline Period|Adverse Event|1|||
28016816|NCT00570492|54676096|FG001|16-week Single-blind Baseline Period|Adverse Event|0|||
28016817|NCT00570492|54676097|FG002|16-week Single-blind Baseline Period|Adverse Event|0|||
28016818|NCT00570492|54676095|FG000|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1|||
28016819|NCT00570492|54676096|FG001|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
28016820|NCT00570492|54676097|FG002|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
28016821|NCT00570492|54676095|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
28016822|NCT00570492|54676096|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
28016823|NCT00570492|54676097|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
28016824|NCT00570492|54676095|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
28016825|NCT00570492|54676096|FG001|52-week Double-blind Treatment Period|Protocol Violation|12|||
28016826|NCT00570492|54676097|FG002|52-week Double-blind Treatment Period|Protocol Violation|15|||
28016827|NCT00570492|54676095|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
28016828|NCT00570492|54676096|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|5|||
28016829|NCT00570492|54676097|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|7|||
28016830|NCT00570492|54676095|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
28016831|NCT00570492|54676096|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
28016832|NCT00570492|54676097|FG002|52-week Double-blind Treatment Period|Adverse Event|5|||
28016833|NCT00570492|54676095|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
28016834|NCT00570492|54676096|FG001|52-week Double-blind Treatment Period|Physician Decision|2|||
28016835|NCT00570492|54676097|FG002|52-week Double-blind Treatment Period|Physician Decision|4|||
28016836|NCT00570492|54676095|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
28016837|NCT00570492|54676096|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|3|||
28016838|NCT00570492|54676097|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
28016839|NCT00570492|54676095|FG000|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
28016840|NCT00570492|54676096|FG001|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3|||
28016841|NCT00570492|54676097|FG002|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
28016842|NCT00571922|54676105|FG000|Overall Study|Completion unknown|36|||
28016843|NCT00571922|54676106|FG001|Overall Study|Completion unknown|36|||
28016844|NCT00686894|54676112|FG000|Overall Study|Relapse|2|||
28016845|NCT00686894|54676112|FG000|Overall Study|Protocol Violation|4|||
28016846|NCT00328627|54676128|FG000|Overall Study|Hyperglycemic Rescue|41|||
28016847|NCT00328627|54676129|FG001|Overall Study|Hyperglycemic Rescue|18|||
28016848|NCT00328627|54676130|FG002|Overall Study|Hyperglycemic Rescue|16|||
28016849|NCT00328627|54676131|FG003|Overall Study|Hyperglycemic Rescue|13|||
28016850|NCT00328627|54676132|FG004|Overall Study|Hyperglycemic Rescue|6|||
28016851|NCT00328627|54676133|FG005|Overall Study|Hyperglycemic Rescue|5|||
28016852|NCT00328627|54676134|FG006|Overall Study|Hyperglycemic Rescue|19|||
28016853|NCT00328627|54676135|FG007|Overall Study|Hyperglycemic Rescue|6|||
28016854|NCT00328627|54676136|FG008|Overall Study|Hyperglycemic Rescue|6|||
28016855|NCT00328627|54676137|FG009|Overall Study|Hyperglycemic Rescue|11|||
28016856|NCT00328627|54676138|FG010|Overall Study|Hyperglycemic Rescue|3|||
28016857|NCT00328627|54676139|FG011|Overall Study|Hyperglycemic Rescue|2|||
28016858|NCT00328627|54676128|FG000|Overall Study|Adverse Event|3|||
28016859|NCT00328627|54676129|FG001|Overall Study|Adverse Event|1|||
28016860|NCT00328627|54676130|FG002|Overall Study|Adverse Event|2|||
28016861|NCT00328627|54676131|FG003|Overall Study|Adverse Event|3|||
28016862|NCT00328627|54676132|FG004|Overall Study|Adverse Event|1|||
28016863|NCT00328627|54676133|FG005|Overall Study|Adverse Event|2|||
28016864|NCT00328627|54676134|FG006|Overall Study|Adverse Event|1|||
28016865|NCT00328627|54676135|FG007|Overall Study|Adverse Event|2|||
28016866|NCT00328627|54676136|FG008|Overall Study|Adverse Event|0|||
28016867|NCT00328627|54676137|FG009|Overall Study|Adverse Event|7|||
28016868|NCT00328627|54676138|FG010|Overall Study|Adverse Event|5|||
28016869|NCT00328627|54676139|FG011|Overall Study|Adverse Event|4|||
27841702|NCT01576718|54329569|FG006|Treatment Period|Sponsor request|0|||
28016870|NCT00328627|54676128|FG000|Overall Study|Protocol Violation|2|||
28016871|NCT00328627|54676129|FG001|Overall Study|Protocol Violation|2|||
28016872|NCT00328627|54676130|FG002|Overall Study|Protocol Violation|2|||
28016873|NCT00328627|54676131|FG003|Overall Study|Protocol Violation|8|||
28016874|NCT00328627|54676132|FG004|Overall Study|Protocol Violation|5|||
28016875|NCT00328627|54676133|FG005|Overall Study|Protocol Violation|5|||
28016876|NCT00328627|54676134|FG006|Overall Study|Protocol Violation|6|||
28016877|NCT00328627|54676135|FG007|Overall Study|Protocol Violation|2|||
28016878|NCT00328627|54676136|FG008|Overall Study|Protocol Violation|1|||
28016879|NCT00328627|54676137|FG009|Overall Study|Protocol Violation|4|||
27930926|NCT00957853|54587207|FG002|Overall Study|Withdrawal by Subject|0|||
27930927|NCT00957229|54587217|FG000|Study Start|Adverse Event|0|||
27930928|NCT00957229|54587218|FG001|Study Start|Adverse Event|3|||
27930929|NCT00957229|54587217|FG000|Study Start|Disease Progression|1|||
27930930|NCT00957229|54587218|FG001|Study Start|Disease Progression|0|||
27930931|NCT00957229|54587217|FG000|Reallocated to or Continued Vismodegib|Death|1|||
27930932|NCT00957229|54587218|FG001|Reallocated to or Continued Vismodegib|Death|1|||
27930933|NCT00957229|54587217|FG000|Reallocated to or Continued Vismodegib|Adverse Event|2|||
27930934|NCT00957229|54587218|FG001|Reallocated to or Continued Vismodegib|Adverse Event|1|||
27930935|NCT02604511|54587224|FG000|Overall Study|Adverse Event|3|||
27930936|NCT02604511|54587224|FG000|Overall Study|Disease Progression|4|||
27930937|NCT02604511|54587224|FG000|Overall Study|Withdrawal by Subject|3|||
27930938|NCT02604511|54587224|FG000|Overall Study|Participant ineligible|1|||
27930939|NCT02604511|54587224|FG000|Overall Study|Intercurrent illness|1|||
27930940|NCT00956839|54587232|FG000|Overall Study|Lost to Follow-up|3|||
27930941|NCT00956839|54587233|FG001|Overall Study|Lost to Follow-up|0|||
27930942|NCT00956839|54587234|FG002|Overall Study|Lost to Follow-up|3|||
27930943|NCT00956293|54587244|FG000|Main Period (Pre-randomization)|Not specified (data missing)|0|||
27930944|NCT00956293|54587245|FG001|Main Period (Pre-randomization)|Not specified (data missing)|0|||
27930945|NCT00956293|54587246|FG002|Main Period (Pre-randomization)|Not specified (data missing)|1|||
27930946|NCT00956293|54587244|FG000|Main Period (Pre-randomization)|Death|0|||
27930947|NCT00956293|54587245|FG001|Main Period (Pre-randomization)|Death|0|||
27930948|NCT00956293|54587246|FG002|Main Period (Pre-randomization)|Death|1|||
27930949|NCT00956293|54587244|FG000|Main Period (Pre-randomization)|Protocol Violation|0|||
27930950|NCT00956293|54587245|FG001|Main Period (Pre-randomization)|Protocol Violation|0|||
27930951|NCT00956293|54587246|FG002|Main Period (Pre-randomization)|Protocol Violation|1|||
27930952|NCT00956293|54587244|FG000|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
27930953|NCT00956293|54587245|FG001|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
27930954|NCT00956293|54587246|FG002|Main Period (Pre-randomization)|Abnormal test procedure result|2|||
27930955|NCT00956293|54587244|FG000|Main Period (Pre-randomization)|Administrative problems|0|||
27930956|NCT00956293|54587245|FG001|Main Period (Pre-randomization)|Administrative problems|0|||
27930957|NCT00956293|54587246|FG002|Main Period (Pre-randomization)|Administrative problems|6|||
27930958|NCT00956293|54587244|FG000|Main Period (Pre-randomization)|Graft loss|0|||
27930959|NCT00956293|54587245|FG001|Main Period (Pre-randomization)|Graft loss|0|||
27930960|NCT00956293|54587246|FG002|Main Period (Pre-randomization)|Graft loss|7|||
27930961|NCT00956293|54587244|FG000|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
27930962|NCT00956293|54587245|FG001|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
27930963|NCT00956293|54587246|FG002|Main Period (Pre-randomization)|Withdrawal by Subject|12|||
27930964|NCT00956293|54587244|FG000|Main Period (Pre-randomization)|Lack of Efficacy|0|||
27930965|NCT00956293|54587245|FG001|Main Period (Pre-randomization)|Lack of Efficacy|0|||
27930966|NCT00956293|54587246|FG002|Main Period (Pre-randomization)|Lack of Efficacy|20|||
27930967|NCT00956293|54587244|FG000|Main Period (Pre-randomization)|Adverse Event|0|||
27930968|NCT00956293|54587245|FG001|Main Period (Pre-randomization)|Adverse Event|0|||
27930969|NCT00956293|54587246|FG002|Main Period (Pre-randomization)|Adverse Event|36|||
27930970|NCT00956293|54587244|FG000|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
27930971|NCT00956293|54587245|FG001|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
28016880|NCT00328627|54676138|FG010|Overall Study|Protocol Violation|6|||
28016881|NCT00328627|54676139|FG011|Overall Study|Protocol Violation|2|||
28016882|NCT00328627|54676128|FG000|Overall Study|Lost to Follow-up|4|||
27930972|NCT00956293|54587246|FG002|Main Period (Pre-randomization)|Abnormal laboratory value|44|||
27930973|NCT00956293|54587244|FG000|Main Period (Randomization)|Abnormal laboratory value|0|||
27930974|NCT00956293|54587245|FG001|Main Period (Randomization)|Abnormal laboratory value|2|||
27930975|NCT00956293|54587246|FG002|Main Period (Randomization)|Abnormal laboratory value|0|||
27930976|NCT00956293|54587244|FG000|Main Period (Randomization)|Lack of Efficacy|1|||
28016883|NCT00328627|54676129|FG001|Overall Study|Lost to Follow-up|2|||
28016884|NCT00328627|54676130|FG002|Overall Study|Lost to Follow-up|2|||
28016885|NCT00328627|54676131|FG003|Overall Study|Lost to Follow-up|4|||
27786948|NCT01641692|54241365|FG005|Treatment Period 1|Physician Decision|0|||
27786949|NCT01641692|54241366|FG006|Treatment Period 1|Physician Decision|0|||
27786950|NCT01641692|54241367|FG007|Treatment Period 1|Physician Decision|0|||
27786951|NCT01641692|54241360|FG000|Treatment Period 1|Withdrawal by Subject|0|||
27786952|NCT01641692|54241361|FG001|Treatment Period 1|Withdrawal by Subject|0|||
27786953|NCT01641692|54241362|FG002|Treatment Period 1|Withdrawal by Subject|0|||
27786954|NCT01641692|54241363|FG003|Treatment Period 1|Withdrawal by Subject|0|||
27786955|NCT01641692|54241364|FG004|Treatment Period 1|Withdrawal by Subject|0|||
27786956|NCT01641692|54241365|FG005|Treatment Period 1|Withdrawal by Subject|2|||
27786957|NCT01641692|54241366|FG006|Treatment Period 1|Withdrawal by Subject|0|||
27786958|NCT01641692|54241367|FG007|Treatment Period 1|Withdrawal by Subject|1|||
27786959|NCT01641692|54241360|FG000|Washout Period 1 (12-14 Days)|Adverse Event|2|||
27786960|NCT01641692|54241361|FG001|Washout Period 1 (12-14 Days)|Adverse Event|0|||
27786961|NCT01641692|54241362|FG002|Washout Period 1 (12-14 Days)|Adverse Event|0|||
27786962|NCT01641692|54241363|FG003|Washout Period 1 (12-14 Days)|Adverse Event|0|||
27786963|NCT01641692|54241364|FG004|Washout Period 1 (12-14 Days)|Adverse Event|0|||
27786964|NCT01641692|54241365|FG005|Washout Period 1 (12-14 Days)|Adverse Event|0|||
27786965|NCT01641692|54241366|FG006|Washout Period 1 (12-14 Days)|Adverse Event|0|||
27786966|NCT01641692|54241367|FG007|Washout Period 1 (12-14 Days)|Adverse Event|0|||
27786967|NCT01641692|54241360|FG000|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
27786968|NCT01641692|54241361|FG001|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
27786969|NCT01641692|54241362|FG002|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
27786970|NCT01641692|54241363|FG003|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
27786971|NCT01641692|54241364|FG004|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
27786972|NCT01641692|54241365|FG005|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
27786973|NCT01641692|54241366|FG006|Washout Period 1 (12-14 Days)|Protocol Violation|1|||
27786974|NCT01641692|54241367|FG007|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
27786975|NCT01641692|54241360|FG000|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
27786976|NCT01641692|54241361|FG001|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
27786977|NCT01641692|54241362|FG002|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
27786978|NCT01641692|54241363|FG003|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
27786979|NCT01641692|54241364|FG004|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
27786980|NCT01641692|54241365|FG005|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
27786981|NCT01641692|54241366|FG006|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
27786982|NCT01641692|54241367|FG007|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
27786983|NCT01641692|54241360|FG000|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
27786984|NCT01641692|54241361|FG001|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
27786985|NCT01641692|54241362|FG002|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
27786986|NCT01641692|54241363|FG003|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
27786987|NCT01641692|54241364|FG004|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
27786988|NCT01641692|54241365|FG005|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
27786989|NCT01641692|54241366|FG006|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
27786990|NCT01641692|54241367|FG007|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
27786991|NCT01641692|54241360|FG000|Treatment Period 2|Lack of Efficacy|1|||
27786992|NCT01641692|54241361|FG001|Treatment Period 2|Lack of Efficacy|0|||
27786993|NCT01641692|54241362|FG002|Treatment Period 2|Lack of Efficacy|0|||
27786994|NCT01641692|54241363|FG003|Treatment Period 2|Lack of Efficacy|0|||
27786995|NCT01641692|54241364|FG004|Treatment Period 2|Lack of Efficacy|0|||
27786996|NCT01641692|54241365|FG005|Treatment Period 2|Lack of Efficacy|0|||
27786997|NCT01641692|54241366|FG006|Treatment Period 2|Lack of Efficacy|0|||
27786998|NCT01641692|54241367|FG007|Treatment Period 2|Lack of Efficacy|0|||
27786999|NCT01641692|54241360|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
27787000|NCT01641692|54241361|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
27787001|NCT01641692|54241362|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
27787002|NCT01641692|54241363|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
27787003|NCT01641692|54241364|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
27787004|NCT01641692|54241365|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
27787005|NCT01641692|54241366|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
27787006|NCT01641692|54241367|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
27787007|NCT01641692|54241360|FG000|Treatment Period 2|Lost to Follow-up|0|||
27787008|NCT01641692|54241361|FG001|Treatment Period 2|Lost to Follow-up|0|||
27787009|NCT01641692|54241362|FG002|Treatment Period 2|Lost to Follow-up|0|||
27787010|NCT01641692|54241363|FG003|Treatment Period 2|Lost to Follow-up|0|||
27787011|NCT01641692|54241364|FG004|Treatment Period 2|Lost to Follow-up|0|||
27787012|NCT01641692|54241365|FG005|Treatment Period 2|Lost to Follow-up|1|||
27787013|NCT01641692|54241366|FG006|Treatment Period 2|Lost to Follow-up|0|||
27787014|NCT01641692|54241367|FG007|Treatment Period 2|Lost to Follow-up|0|||
27787015|NCT01641692|54241360|FG000|Treatment Period 2|Withdrawal by Subject|1|||
27787016|NCT01641692|54241361|FG001|Treatment Period 2|Withdrawal by Subject|0|||
27787017|NCT01641692|54241362|FG002|Treatment Period 2|Withdrawal by Subject|0|||
27787018|NCT01641692|54241363|FG003|Treatment Period 2|Withdrawal by Subject|0|||
27787019|NCT01641692|54241364|FG004|Treatment Period 2|Withdrawal by Subject|0|||
27787020|NCT01641692|54241365|FG005|Treatment Period 2|Withdrawal by Subject|1|||
27787021|NCT01641692|54241366|FG006|Treatment Period 2|Withdrawal by Subject|0|||
27787022|NCT01641692|54241367|FG007|Treatment Period 2|Withdrawal by Subject|1|||
27787023|NCT01641692|54241360|FG000|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
27787024|NCT01641692|54241361|FG001|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
27787025|NCT01641692|54241362|FG002|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
27787026|NCT01641692|54241363|FG003|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
27787027|NCT01641692|54241364|FG004|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
27787028|NCT01641692|54241365|FG005|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
27787029|NCT01641692|54241366|FG006|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
27787030|NCT01641692|54241367|FG007|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
27787031|NCT01641692|54241360|FG000|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
27787032|NCT01641692|54241361|FG001|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
27787033|NCT01641692|54241362|FG002|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
27787034|NCT01641692|54241363|FG003|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
27787035|NCT01641692|54241364|FG004|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
27787036|NCT01641692|54241365|FG005|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
27787037|NCT01641692|54241366|FG006|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
27787038|NCT01641692|54241367|FG007|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
27787039|NCT01641692|54241360|FG000|Treatment Period 3|Adverse Event|0|||
27787040|NCT01641692|54241361|FG001|Treatment Period 3|Adverse Event|0|||
27787041|NCT01641692|54241362|FG002|Treatment Period 3|Adverse Event|0|||
27787042|NCT01641692|54241363|FG003|Treatment Period 3|Adverse Event|0|||
27787043|NCT01641692|54241364|FG004|Treatment Period 3|Adverse Event|0|||
27787044|NCT01641692|54241365|FG005|Treatment Period 3|Adverse Event|0|||
27787045|NCT01641692|54241366|FG006|Treatment Period 3|Adverse Event|1|||
27787046|NCT01641692|54241367|FG007|Treatment Period 3|Adverse Event|0|||
27787047|NCT01641692|54241360|FG000|Treatment Period 3|Protocol Violation|0|||
27787048|NCT01641692|54241361|FG001|Treatment Period 3|Protocol Violation|0|||
27787049|NCT01641692|54241362|FG002|Treatment Period 3|Protocol Violation|1|||
27787050|NCT01641692|54241363|FG003|Treatment Period 3|Protocol Violation|0|||
27787051|NCT01641692|54241364|FG004|Treatment Period 3|Protocol Violation|0|||
27787052|NCT01641692|54241365|FG005|Treatment Period 3|Protocol Violation|0|||
27787053|NCT01641692|54241366|FG006|Treatment Period 3|Protocol Violation|0|||
27787054|NCT01641692|54241367|FG007|Treatment Period 3|Protocol Violation|0|||
27787055|NCT01641692|54241360|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
27787056|NCT01641692|54241361|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
27787057|NCT01641692|54241362|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
27787058|NCT01641692|54241363|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
27787059|NCT01641692|54241364|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
27787060|NCT01641692|54241365|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
27787061|NCT01641692|54241366|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
27787062|NCT01641692|54241367|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
27787063|NCT01641692|54241360|FG000|Treatment Period 3|Lost to Follow-up|0|||
27787064|NCT01641692|54241361|FG001|Treatment Period 3|Lost to Follow-up|1|||
27787065|NCT01641692|54241362|FG002|Treatment Period 3|Lost to Follow-up|0|||
27787066|NCT01641692|54241363|FG003|Treatment Period 3|Lost to Follow-up|0|||
27787067|NCT01641692|54241364|FG004|Treatment Period 3|Lost to Follow-up|0|||
27787068|NCT01641692|54241365|FG005|Treatment Period 3|Lost to Follow-up|0|||
27787069|NCT01641692|54241366|FG006|Treatment Period 3|Lost to Follow-up|0|||
27787070|NCT01641692|54241367|FG007|Treatment Period 3|Lost to Follow-up|0|||
27787071|NCT01641692|54241360|FG000|Washout Period 3 or Follow-up|Protocol Violation|0|||
27787072|NCT01641692|54241361|FG001|Washout Period 3 or Follow-up|Protocol Violation|0|||
27787073|NCT01641692|54241362|FG002|Washout Period 3 or Follow-up|Protocol Violation|0|||
27787074|NCT01641692|54241363|FG003|Washout Period 3 or Follow-up|Protocol Violation|0|||
27787075|NCT01641692|54241364|FG004|Washout Period 3 or Follow-up|Protocol Violation|0|||
27787076|NCT01641692|54241365|FG005|Washout Period 3 or Follow-up|Protocol Violation|1|||
27787077|NCT01641692|54241366|FG006|Washout Period 3 or Follow-up|Protocol Violation|0|||
27787078|NCT01641692|54241367|FG007|Washout Period 3 or Follow-up|Protocol Violation|0|||
27841703|NCT01576718|54329563|FG000|Treatment Period|Met stopping criteria|0|||
27787079|NCT01641692|54241360|FG000|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
27787080|NCT01641692|54241361|FG001|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
27787081|NCT01641692|54241362|FG002|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
27787082|NCT01641692|54241363|FG003|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
27787083|NCT01641692|54241364|FG004|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
27787084|NCT01641692|54241365|FG005|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
27787085|NCT01641692|54241366|FG006|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
27787086|NCT01641692|54241367|FG007|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
27787087|NCT01682512|54241389|FG000|Overall Study|Adverse Event|6|||
27787088|NCT01682512|54241390|FG001|Overall Study|Adverse Event|5|||
27787089|NCT01682512|54241391|FG002|Overall Study|Adverse Event|2|||
27787090|NCT01682512|54241389|FG000|Overall Study|Withdrawal by Subject|2|||
27787091|NCT01682512|54241390|FG001|Overall Study|Withdrawal by Subject|6|||
27787092|NCT01682512|54241391|FG002|Overall Study|Withdrawal by Subject|3|||
27787093|NCT01682512|54241389|FG000|Overall Study|Physician Decision|0|||
27787094|NCT01682512|54241390|FG001|Overall Study|Physician Decision|2|||
27787095|NCT01682512|54241391|FG002|Overall Study|Physician Decision|0|||
27787096|NCT01682512|54241389|FG000|Overall Study|Study terminated by sponsor|46|||
27787097|NCT01682512|54241390|FG001|Overall Study|Study terminated by sponsor|43|||
27787098|NCT01682512|54241391|FG002|Overall Study|Study terminated by sponsor|0|||
27787099|NCT01682512|54241389|FG000|Overall Study|Lost to Follow-up|3|||
27787100|NCT01682512|54241390|FG001|Overall Study|Lost to Follow-up|0|||
27787101|NCT01682512|54241391|FG002|Overall Study|Lost to Follow-up|2|||
27787102|NCT01682512|54241389|FG000|Overall Study|Protocol Violation|2|||
27787103|NCT01682512|54241390|FG001|Overall Study|Protocol Violation|3|||
27787104|NCT01682512|54241391|FG002|Overall Study|Protocol Violation|2|||
27787105|NCT01682512|54241389|FG000|Overall Study|Primary lack of efficacy|10|||
27787106|NCT01682512|54241390|FG001|Overall Study|Primary lack of efficacy|7|||
27787107|NCT01682512|54241391|FG002|Overall Study|Primary lack of efficacy|7|||
27787108|NCT01682512|54241389|FG000|Overall Study|Secondary lack of efficacy|1|||
27787109|NCT01682512|54241390|FG001|Overall Study|Secondary lack of efficacy|1|||
27787110|NCT01682512|54241391|FG002|Overall Study|Secondary lack of efficacy|0|||
27787111|NCT01682512|54241389|FG000|Overall Study|Other than stated above|2|||
27787112|NCT01682512|54241390|FG001|Overall Study|Other than stated above|4|||
27787113|NCT01682512|54241391|FG002|Overall Study|Other than stated above|2|||
27787114|NCT02256488|54241403|FG000|Overall Study|Lost to Follow-up|6|||
27787115|NCT02256488|54241404|FG001|Overall Study|Lost to Follow-up|6|||
27930977|NCT00956293|54587245|FG001|Main Period (Randomization)|Lack of Efficacy|10|||
27930978|NCT00956293|54587246|FG002|Main Period (Randomization)|Lack of Efficacy|0|||
27930979|NCT00956293|54587244|FG000|Main Period (Randomization)|Adverse Event|0|||
27930980|NCT00956293|54587245|FG001|Main Period (Randomization)|Adverse Event|15|||
27930981|NCT00956293|54587246|FG002|Main Period (Randomization)|Adverse Event|0|||
27930982|NCT00956293|54587244|FG000|Follow-up Period|Follow-up period was terminated.|20|||
27930983|NCT00956293|54587245|FG001|Follow-up Period|Follow-up period was terminated.|32|||
27930984|NCT00956293|54587246|FG002|Follow-up Period|Follow-up period was terminated.|0|||
27930985|NCT00955825|54587254|FG000|Overall Study|Adverse Event|15|||
27930986|NCT00955825|54587255|FG001|Overall Study|Adverse Event|2|||
27930987|NCT00955825|54587254|FG000|Overall Study|Withdrawal by Subject|4|||
27930988|NCT00955825|54587255|FG001|Overall Study|Withdrawal by Subject|6|||
27930989|NCT00955825|54587254|FG000|Overall Study|Any other reason not above-mentioned|7|||
27930990|NCT00955825|54587255|FG001|Overall Study|Any other reason not above-mentioned|9|||
27930991|NCT01164579|54587264|FG000|Overall Study|Lack of Efficacy|0|||
27930992|NCT01164579|54587265|FG001|Overall Study|Lack of Efficacy|0|||
27930993|NCT01164579|54587266|FG002|Overall Study|Lack of Efficacy|6|||
27930994|NCT01164579|54587264|FG000|Overall Study|Lost to Follow-up|1|||
27930995|NCT01164579|54587265|FG001|Overall Study|Lost to Follow-up|1|||
27930996|NCT01164579|54587266|FG002|Overall Study|Lost to Follow-up|0|||
27930997|NCT01164579|54587264|FG000|Overall Study|Withdrawal by Subject|2|||
27930998|NCT01164579|54587265|FG001|Overall Study|Withdrawal by Subject|5|||
27930999|NCT01164579|54587266|FG002|Overall Study|Withdrawal by Subject|3|||
27931000|NCT01164579|54587264|FG000|Overall Study|Protocol Violation|0|||
27931001|NCT01164579|54587265|FG001|Overall Study|Protocol Violation|1|||
27931002|NCT01164579|54587266|FG002|Overall Study|Protocol Violation|2|||
27931003|NCT01164579|54587264|FG000|Overall Study|Adverse Event|4|||
27931004|NCT01164579|54587265|FG001|Overall Study|Adverse Event|2|||
27931005|NCT01164579|54587266|FG002|Overall Study|Adverse Event|5|||
27931006|NCT01164579|54587264|FG000|Overall Study|Reason not specified|1|||
27931007|NCT01164579|54587265|FG001|Overall Study|Reason not specified|0|||
27787116|NCT02256488|54241405|FG002|Overall Study|Lost to Follow-up|9|||
27787117|NCT02256488|54241406|FG003|Overall Study|Lost to Follow-up|3|||
27787118|NCT02256488|54241403|FG000|Overall Study|OTHER|1|||
27787119|NCT02256488|54241404|FG001|Overall Study|OTHER|0|||
27931008|NCT01164579|54587266|FG002|Overall Study|Reason not specified|0|||
27931009|NCT00958789|54587275|FG000|Overall Study|Death|5|||
27787120|NCT02256488|54241405|FG002|Overall Study|OTHER|1|||
27787121|NCT02256488|54241406|FG003|Overall Study|OTHER|1|||
27787122|NCT02256488|54241403|FG000|Overall Study|Withdrawal by Subject|1|||
27787123|NCT02256488|54241404|FG001|Overall Study|Withdrawal by Subject|0|||
27931010|NCT00958789|54587275|FG000|Overall Study|Lost to Follow-up|14|||
27931011|NCT00958789|54587275|FG000|Overall Study|Withdrawal by Subject|17|||
27931012|NCT00958789|54587275|FG000|Overall Study|No 2 yr. Knee Society Score data|4|||
27787124|NCT02256488|54241405|FG002|Overall Study|Withdrawal by Subject|0|||
27787125|NCT02256488|54241406|FG003|Overall Study|Withdrawal by Subject|2|||
27787126|NCT01715896|54241419|FG000|Overall Study|Lost to Follow-up|0|||
27787127|NCT01715896|54241420|FG001|Overall Study|Lost to Follow-up|2|||
27787128|NCT01715896|54241419|FG000|Overall Study|Withdrawal by Subject|1|||
27787129|NCT01715896|54241420|FG001|Overall Study|Withdrawal by Subject|4|||
27787130|NCT01715896|54241419|FG000|Overall Study|Other|2|||
27787131|NCT01715896|54241420|FG001|Overall Study|Other|5|||
27787132|NCT02255552|54241429|FG000|Overall Study|Participants enrolled into another study|0|||
27787133|NCT02255552|54241430|FG001|Overall Study|Participants enrolled into another study|11|||
27787134|NCT02255552|54241429|FG000|Overall Study|Withdrawal by Subject|1|||
27787135|NCT02255552|54241430|FG001|Overall Study|Withdrawal by Subject|4|||
27787136|NCT01714726|54241438|FG000|Double-Blinded Induction Period|Subject not in open label period|3|||
27787137|NCT01714726|54241439|FG001|Double-Blinded Induction Period|Subject not in open label period|1|||
27787138|NCT01714726|54241440|FG002|Double-Blinded Induction Period|Subject not in open label period|0|||
27787139|NCT01714726|54241441|FG003|Double-Blinded Induction Period|Subject not in open label period|0|||
27787140|NCT01714726|54241438|FG000|Double-Blinded Induction Period|Adverse Event|0|||
27787141|NCT01714726|54241439|FG001|Double-Blinded Induction Period|Adverse Event|1|||
27787142|NCT01714726|54241440|FG002|Double-Blinded Induction Period|Adverse Event|0|||
27787143|NCT01714726|54241441|FG003|Double-Blinded Induction Period|Adverse Event|0|||
27787144|NCT01714726|54241438|FG000|Double-Blinded Induction Period|Withdrawal by Subject|5|||
27787145|NCT01714726|54241439|FG001|Double-Blinded Induction Period|Withdrawal by Subject|3|||
27787146|NCT01714726|54241440|FG002|Double-Blinded Induction Period|Withdrawal by Subject|0|||
27787147|NCT01714726|54241441|FG003|Double-Blinded Induction Period|Withdrawal by Subject|0|||
27787148|NCT01714726|54241438|FG000|Double-Blinded Induction Period|Lost to Follow-up|0|||
27787149|NCT01714726|54241439|FG001|Double-Blinded Induction Period|Lost to Follow-up|2|||
27787150|NCT01714726|54241440|FG002|Double-Blinded Induction Period|Lost to Follow-up|0|||
27787151|NCT01714726|54241441|FG003|Double-Blinded Induction Period|Lost to Follow-up|0|||
27787152|NCT01714726|54241438|FG000|Open-Label Period|Other|0|||
27787153|NCT01714726|54241439|FG001|Open-Label Period|Other|0|||
27787154|NCT01714726|54241440|FG002|Open-Label Period|Other|1|||
27787155|NCT01714726|54241441|FG003|Open-Label Period|Other|3|||
27787156|NCT01714726|54241438|FG000|Open-Label Period|Adverse Event|0|||
27787157|NCT01714726|54241439|FG001|Open-Label Period|Adverse Event|0|||
27787158|NCT01714726|54241440|FG002|Open-Label Period|Adverse Event|1|||
27787159|NCT01714726|54241441|FG003|Open-Label Period|Adverse Event|0|||
27787160|NCT01714726|54241438|FG000|Open-Label Period|Withdrawal by Subject|0|||
27787161|NCT01714726|54241439|FG001|Open-Label Period|Withdrawal by Subject|0|||
27931013|NCT00958789|54587275|FG000|Overall Study|2 yr. Knee Society Score not calculable|1|||
27931014|NCT00958789|54587275|FG000|Overall Study|Subject terminated|2|||
27931015|NCT00958789|54587275|FG000|Overall Study|Revision|7|||
28016886|NCT00328627|54676132|FG004|Overall Study|Lost to Follow-up|0|||
28016887|NCT00328627|54676133|FG005|Overall Study|Lost to Follow-up|2|||
28016888|NCT00328627|54676134|FG006|Overall Study|Lost to Follow-up|3|||
28016889|NCT00328627|54676135|FG007|Overall Study|Lost to Follow-up|0|||
28016890|NCT00328627|54676136|FG008|Overall Study|Lost to Follow-up|3|||
28016891|NCT00328627|54676137|FG009|Overall Study|Lost to Follow-up|2|||
28016892|NCT00328627|54676138|FG010|Overall Study|Lost to Follow-up|0|||
28016893|NCT00328627|54676139|FG011|Overall Study|Lost to Follow-up|1|||
28016894|NCT00328627|54676128|FG000|Overall Study|Withdrawal by Subject|5|||
27931016|NCT02445391|54587286|FG000|Overall Study|No active protocol treatment|3|||
27931017|NCT02445391|54587287|FG001|Overall Study|No active protocol treatment|0|||
27931018|NCT02445391|54587288|FG002|Overall Study|No active protocol treatment|0|||
27931019|NCT02445391|54587286|FG000|Overall Study|Adverse Event|0|||
27931020|NCT02445391|54587287|FG001|Overall Study|Adverse Event|21|||
27931021|NCT02445391|54587288|FG002|Overall Study|Adverse Event|12|||
27931022|NCT02445391|54587286|FG000|Overall Study|Alternative therapy|0|||
28016895|NCT00328627|54676129|FG001|Overall Study|Withdrawal by Subject|4|||
28016896|NCT00328627|54676130|FG002|Overall Study|Withdrawal by Subject|5|||
28016897|NCT00328627|54676131|FG003|Overall Study|Withdrawal by Subject|6|||
28016898|NCT00328627|54676132|FG004|Overall Study|Withdrawal by Subject|2|||
28016899|NCT00328627|54676133|FG005|Overall Study|Withdrawal by Subject|5|||
28016900|NCT00328627|54676134|FG006|Overall Study|Withdrawal by Subject|4|||
28016901|NCT00328627|54676135|FG007|Overall Study|Withdrawal by Subject|4|||
28016902|NCT00328627|54676136|FG008|Overall Study|Withdrawal by Subject|4|||
28016903|NCT00328627|54676137|FG009|Overall Study|Withdrawal by Subject|5|||
28016904|NCT00328627|54676138|FG010|Overall Study|Withdrawal by Subject|2|||
27787162|NCT01714726|54241440|FG002|Open-Label Period|Withdrawal by Subject|9|||
27787163|NCT01714726|54241441|FG003|Open-Label Period|Withdrawal by Subject|19|||
27931023|NCT02445391|54587287|FG001|Overall Study|Alternative therapy|0|||
27931024|NCT02445391|54587288|FG002|Overall Study|Alternative therapy|1|||
28016905|NCT00328627|54676139|FG011|Overall Study|Withdrawal by Subject|7|||
28016906|NCT00328627|54676128|FG000|Overall Study|Pregnancy|0|||
27787164|NCT01714726|54241438|FG000|Open-Label Period|Developed specific withdrawal criteria|0|||
27931025|NCT02445391|54587286|FG000|Overall Study|Disease progression|0|||
27931026|NCT02445391|54587287|FG001|Overall Study|Disease progression|7|||
28016907|NCT00328627|54676129|FG001|Overall Study|Pregnancy|1|||
28016908|NCT00328627|54676130|FG002|Overall Study|Pregnancy|0|||
28016909|NCT00328627|54676131|FG003|Overall Study|Pregnancy|0|||
28016910|NCT00328627|54676132|FG004|Overall Study|Pregnancy|0|||
28016911|NCT00328627|54676133|FG005|Overall Study|Pregnancy|0|||
28016912|NCT00328627|54676134|FG006|Overall Study|Pregnancy|0|||
28016913|NCT00328627|54676135|FG007|Overall Study|Pregnancy|0|||
28016914|NCT00328627|54676136|FG008|Overall Study|Pregnancy|0|||
28016915|NCT00328627|54676137|FG009|Overall Study|Pregnancy|0|||
27787165|NCT01714726|54241439|FG001|Open-Label Period|Developed specific withdrawal criteria|0|||
27787166|NCT01714726|54241440|FG002|Open-Label Period|Developed specific withdrawal criteria|5|||
27787167|NCT01714726|54241441|FG003|Open-Label Period|Developed specific withdrawal criteria|2|||
27787168|NCT01714726|54241438|FG000|Open-Label Period|Lost to Follow-up|0|||
27787169|NCT01714726|54241439|FG001|Open-Label Period|Lost to Follow-up|0|||
27787170|NCT01714726|54241440|FG002|Open-Label Period|Lost to Follow-up|3|||
27787171|NCT01714726|54241441|FG003|Open-Label Period|Lost to Follow-up|4|||
27787172|NCT02255474|54241454|FG000|Overall Study|Lost to Follow-up|1|||
27787173|NCT02255474|54241455|FG001|Overall Study|Lost to Follow-up|1|||
27787174|NCT02255474|54241456|FG002|Overall Study|Lost to Follow-up|3|||
27787175|NCT02255474|54241454|FG000|Overall Study|Withdrawal by Subject|1|||
27787176|NCT02255474|54241455|FG001|Overall Study|Withdrawal by Subject|1|||
27787177|NCT02255474|54241456|FG002|Overall Study|Withdrawal by Subject|0|||
27787178|NCT02254772|54241465|FG000|Overall Study|Ineligible|1|||
27787179|NCT02254772|54241465|FG000|Overall Study|Withdrawal by Subject|1|||
27787180|NCT02254460|54241469|FG000|Overall Study|Adverse Event|1|||
27787181|NCT02254460|54241470|FG001|Overall Study|Adverse Event|0|||
27787182|NCT01682044|54241476|FG000|Overall Study|Death|1|||
27787183|NCT01682044|54241476|FG000|Overall Study|Progression|3|||
27787184|NCT01696942|54241482|FG000|Overall Study|Withdrawal by Subject|1|||
27787185|NCT01696942|54241483|FG001|Overall Study|Withdrawal by Subject|0|||
27787186|NCT01696942|54241482|FG000|Overall Study|Protocol Violation|1|||
27787187|NCT01696942|54241483|FG001|Overall Study|Protocol Violation|2|||
27787188|NCT01696942|54241482|FG000|Overall Study|screen failure|0|||
27787189|NCT01696942|54241483|FG001|Overall Study|screen failure|1|||
27787190|NCT01640366|54241489|FG000|Overall Study|Withdrawal by Subject|1|||
27787191|NCT01640366|54241489|FG000|Overall Study|Protocol Violation|16|||
27787192|NCT01640366|54241489|FG000|Overall Study|Lost to Follow-up|5|||
27787193|NCT01640288|54241497|FG000|Overall Study|Equipment Failure or Poor Image Quality|4|||
27787194|NCT01640288|54241498|FG001|Overall Study|Equipment Failure or Poor Image Quality|5|||
27787195|NCT01640288|54241497|FG000|Overall Study|Screen Failure|20|||
27787196|NCT01640288|54241498|FG001|Overall Study|Screen Failure|18|||
27787197|NCT01640288|54241497|FG000|Overall Study|Withdrawn by PI|5|||
27787198|NCT01640288|54241498|FG001|Overall Study|Withdrawn by PI|0|||
27787199|NCT01640288|54241497|FG000|Overall Study|Withdrawal by Subject|1|||
27787200|NCT01640288|54241498|FG001|Overall Study|Withdrawal by Subject|0|||
27787201|NCT01639040|54241507|FG000|Overall Study|Adverse Event|1|||
27787202|NCT01639040|54241508|FG001|Overall Study|Adverse Event|0|||
27787203|NCT01640054|54241517|FG000|Overall Study|Study-specific disc criteria|1|||
27787204|NCT01640054|54241517|FG000|Overall Study|Lack of Efficacy|3|||
27787205|NCT01640054|54241517|FG000|Overall Study|Adverse Event|2|||
27787206|NCT01600586|54241523|FG000|Overall Study|Physician Decision|3|||
27787207|NCT01600586|54241524|FG001|Overall Study|Physician Decision|3|||
27787208|NCT01639742|54241537|FG000|Overall Study|Study Ongoing|17|||
27787209|NCT01639742|54241537|FG000|Overall Study|Lost to Follow-up|1|||
27787210|NCT02164513|54241544|FG000|Overall Study|Adverse Event|162|||
27787211|NCT02164513|54241545|FG001|Overall Study|Adverse Event|180|||
27931027|NCT02445391|54587288|FG002|Overall Study|Disease progression|22|||
27931028|NCT02445391|54587286|FG000|Overall Study|Complicating disease|0|||
27931029|NCT02445391|54587287|FG001|Overall Study|Complicating disease|2|||
27931030|NCT02445391|54587288|FG002|Overall Study|Complicating disease|1|||
27931031|NCT02445391|54587286|FG000|Overall Study|Withdrawal by Subject|0|||
27931032|NCT02445391|54587287|FG001|Overall Study|Withdrawal by Subject|4|||
27931033|NCT02445391|54587288|FG002|Overall Study|Withdrawal by Subject|9|||
27931034|NCT02445391|54587286|FG000|Overall Study|Financial issue|0|||
27931035|NCT02445391|54587287|FG001|Overall Study|Financial issue|0|||
27931036|NCT02445391|54587288|FG002|Overall Study|Financial issue|2|||
27931037|NCT02445391|54587286|FG000|Overall Study|Still on treatment|0|||
27931038|NCT02445391|54587287|FG001|Overall Study|Still on treatment|7|||
27931039|NCT02445391|54587288|FG002|Overall Study|Still on treatment|16|||
27931040|NCT02445391|54587286|FG000|Overall Study|Not start protocol therapy|0|||
28016916|NCT00328627|54676138|FG010|Overall Study|Pregnancy|0|||
28016917|NCT00328627|54676139|FG011|Overall Study|Pregnancy|0|||
28016918|NCT00328627|54676128|FG000|Overall Study|Physician Decision|4|||
27787212|NCT02164513|54241546|FG002|Overall Study|Adverse Event|111|||
27787213|NCT02164513|54241544|FG000|Overall Study|Other: Study Closed or terminated|5|||
27787214|NCT02164513|54241545|FG001|Overall Study|Other: Study Closed or terminated|2|||
27787215|NCT02164513|54241546|FG002|Overall Study|Other: Study Closed or terminated|4|||
28016919|NCT00328627|54676129|FG001|Overall Study|Physician Decision|3|||
28016920|NCT00328627|54676130|FG002|Overall Study|Physician Decision|1|||
27787216|NCT02164513|54241544|FG000|Overall Study|Lost to Follow-up|30|||
27787217|NCT02164513|54241545|FG001|Overall Study|Lost to Follow-up|36|||
27787218|NCT02164513|54241546|FG002|Overall Study|Lost to Follow-up|22|||
27787219|NCT02164513|54241544|FG000|Overall Study|Physician Decision|47|||
27787220|NCT02164513|54241545|FG001|Overall Study|Physician Decision|57|||
27787221|NCT02164513|54241546|FG002|Overall Study|Physician Decision|28|||
27787222|NCT02164513|54241544|FG000|Overall Study|Withdrawal by Subject|192|||
27787223|NCT02164513|54241545|FG001|Overall Study|Withdrawal by Subject|261|||
27787224|NCT02164513|54241546|FG002|Overall Study|Withdrawal by Subject|130|||
27787225|NCT02164513|54241544|FG000|Overall Study|Other: Reason not provided by site|1|||
27787226|NCT02164513|54241545|FG001|Overall Study|Other: Reason not provided by site|0|||
27787227|NCT02164513|54241546|FG002|Overall Study|Other: Reason not provided by site|0|||
27787228|NCT02218489|54241566|FG000|Overall Study|Withdrawal by Subject|4|||
27787229|NCT02218489|54241567|FG001|Overall Study|Withdrawal by Subject|3|||
27787230|NCT02218489|54241566|FG000|Overall Study|Lost to Follow-up|1|||
27787231|NCT02218489|54241567|FG001|Overall Study|Lost to Follow-up|0|||
27787232|NCT02192905|54241574|FG000|Overall Study|Lost to Follow-up|1|||
27787233|NCT01713946|54241582|FG000|Overall Study|Death|0|||
27787234|NCT01713946|54241583|FG001|Overall Study|Death|2|||
27787235|NCT01713946|54241584|FG002|Overall Study|Death|2|||
27787236|NCT01713946|54241582|FG000|Overall Study|Adverse Event|19|||
27787237|NCT01713946|54241583|FG001|Overall Study|Adverse Event|14|||
27787238|NCT01713946|54241584|FG002|Overall Study|Adverse Event|13|||
27787239|NCT01713946|54241582|FG000|Overall Study|Withdrawal by Subject|12|||
27787240|NCT01713946|54241583|FG001|Overall Study|Withdrawal by Subject|12|||
27787241|NCT01713946|54241584|FG002|Overall Study|Withdrawal by Subject|8|||
27787242|NCT01713946|54241582|FG000|Overall Study|Lack of Efficacy|8|||
27787243|NCT01713946|54241583|FG001|Overall Study|Lack of Efficacy|8|||
27787244|NCT01713946|54241584|FG002|Overall Study|Lack of Efficacy|14|||
27787245|NCT01713946|54241582|FG000|Overall Study|Protocol Violation|2|||
27787246|NCT01713946|54241583|FG001|Overall Study|Protocol Violation|4|||
27787247|NCT01713946|54241584|FG002|Overall Study|Protocol Violation|1|||
27787248|NCT01713946|54241582|FG000|Overall Study|Lost to Follow-up|0|||
27787249|NCT01713946|54241583|FG001|Overall Study|Lost to Follow-up|0|||
27787250|NCT01713946|54241584|FG002|Overall Study|Lost to Follow-up|1|||
27787251|NCT01713946|54241582|FG000|Overall Study|Administrative problems|1|||
27787252|NCT01713946|54241583|FG001|Overall Study|Administrative problems|0|||
27787253|NCT01713946|54241584|FG002|Overall Study|Administrative problems|0|||
27787254|NCT01713946|54241582|FG000|Overall Study|Did not continue in Ext|0|||
27787255|NCT01713946|54241583|FG001|Overall Study|Did not continue in Ext|3|||
27787256|NCT01713946|54241584|FG002|Overall Study|Did not continue in Ext|0|||
27787257|NCT01713946|54241582|FG000|Overall Study|Did not continue in Post-Ext. Phase|1|||
27787258|NCT01713946|54241583|FG001|Overall Study|Did not continue in Post-Ext. Phase|2|||
27787259|NCT01713946|54241584|FG002|Overall Study|Did not continue in Post-Ext. Phase|0|||
27787260|NCT01713946|54241582|FG000|Overall Study|Patients never switched to everolimus|0|||
27931041|NCT02445391|54587287|FG001|Overall Study|Not start protocol therapy|12|||
27931042|NCT02445391|54587288|FG002|Overall Study|Not start protocol therapy|9|||
27931043|NCT01246986|54587304|FG000|Overall Study|Lost to Follow-up|0|||
27931044|NCT01246986|54587305|FG001|Overall Study|Lost to Follow-up|1|||
27931045|NCT01246986|54587306|FG002|Overall Study|Lost to Follow-up|3|||
27931046|NCT01246986|54587307|FG003|Overall Study|Lost to Follow-up|0|||
27931047|NCT01246986|54587308|FG004|Overall Study|Lost to Follow-up|0|||
27931048|NCT01246986|54587309|FG005|Overall Study|Lost to Follow-up|1|||
27931049|NCT01246986|54587310|FG006|Overall Study|Lost to Follow-up|0|||
27931050|NCT01246986|54587304|FG000|Overall Study|Withdrawal by Subject|3|||
27931051|NCT01246986|54587305|FG001|Overall Study|Withdrawal by Subject|4|||
27931052|NCT01246986|54587306|FG002|Overall Study|Withdrawal by Subject|3|||
27931053|NCT01246986|54587307|FG003|Overall Study|Withdrawal by Subject|0|||
27931054|NCT01246986|54587308|FG004|Overall Study|Withdrawal by Subject|4|||
27931055|NCT01246986|54587309|FG005|Overall Study|Withdrawal by Subject|0|||
27931056|NCT01246986|54587310|FG006|Overall Study|Withdrawal by Subject|0|||
27931057|NCT01164501|54587344|FG000|Overall Study|Not treated|2|||
27931058|NCT01164501|54587345|FG001|Overall Study|Not treated|0|||
27931059|NCT01164501|54587346|FG002|Overall Study|Not treated|1|||
27787261|NCT01713946|54241583|FG001|Overall Study|Patients never switched to everolimus|0|||
27787262|NCT01713946|54241584|FG002|Overall Study|Patients never switched to everolimus|5|||
27787263|NCT02163499|54241610|FG000|Acute Phase: ZS 10 g TID|Participant's Compliance|1|||
27787264|NCT02163499|54241610|FG000|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1|||
27787265|NCT02163499|54241610|FG000|Acute Phase: ZS 10 g TID|Protocol Violation|1|||
27931060|NCT01164501|54587344|FG000|Overall Study|Adverse Event|18|||
27931061|NCT01164501|54587345|FG001|Overall Study|Adverse Event|4|||
27931062|NCT01164501|54587346|FG002|Overall Study|Adverse Event|21|||
27931063|NCT01164501|54587344|FG000|Overall Study|Lack of Efficacy|0|||
27931064|NCT01164501|54587345|FG001|Overall Study|Lack of Efficacy|0|||
27931065|NCT01164501|54587346|FG002|Overall Study|Lack of Efficacy|1|||
27787266|NCT02163499|54241610|FG000|Acute Phase: ZS 10 g TID|Physician Decision|1|||
27787267|NCT02163499|54241610|FG000|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1|||
27787268|NCT02163499|54241610|FG000|Extended Dosing Phase: ZS|Adverse Event|51|||
27787269|NCT02163499|54241610|FG000|Extended Dosing Phase: ZS|Expected Progression of CKD|40|||
27787270|NCT02163499|54241610|FG000|Extended Dosing Phase: ZS|Hypokalemia|9|||
27787271|NCT02163499|54241610|FG000|Extended Dosing Phase: ZS|Sponsor's Decision|5|||
27787272|NCT02163499|54241610|FG000|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7|||
27787273|NCT02163499|54241610|FG000|Extended Dosing Phase: ZS|Withdrawal by Subject|81|||
27787274|NCT02163499|54241610|FG000|Extended Dosing Phase: ZS|Physician Decision|8|||
27787275|NCT02163499|54241610|FG000|Extended Dosing Phase: ZS|Lost to Follow-up|31|||
27787276|NCT02163499|54241610|FG000|Extended Dosing Phase: ZS|Protocol Violation|2|||
27787277|NCT02163499|54241610|FG000|Extended Dosing Phase: ZS|Death|8|||
27787278|NCT02163499|54241610|FG000|Extended Dosing Phase: ZS|Subject Compliance|17|||
27787279|NCT02163499|54241610|FG000|Extended Dosing Phase: ZS|Hyperkalemia|5|||
27787280|NCT02163499|54241610|FG000|Extended Dosing Phase: ZS|Various reasons|16|||
27787281|NCT02163187|54241620|FG000|Overall Study|Device removed|1|||
27787282|NCT02163187|54241621|FG001|Overall Study|Device removed|0|||
27787283|NCT02163187|54241620|FG000|Overall Study|Progressive disease|1|||
27787284|NCT02163187|54241621|FG001|Overall Study|Progressive disease|0|||
27787285|NCT02191579|54241629|FG000|Treatment 1|Multiple Reasons Specified|27|||
27787286|NCT02191579|54241630|FG001|Treatment 1|Multiple Reasons Specified|58|||
27787287|NCT02191579|54241629|FG000|Treatment 2|Multiple Reasons Specified|0|||
27787288|NCT02191579|54241630|FG001|Treatment 2|Multiple Reasons Specified|25|||
27787289|NCT01363700|54241639|FG000|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
27787290|NCT01363700|54241640|FG001|Epinastine vs Placebo Period1|Withdrawal by Subject|1|||
27787291|NCT01363700|54241641|FG002|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
27787292|NCT01363700|54241642|FG003|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
27787293|NCT01363700|54241643|FG004|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
27787294|NCT01637402|54241654|FG000|Standard Dose Regimen|Lack of Efficacy|2|||
27787295|NCT01637402|54241655|FG001|Standard Dose Regimen|Lack of Efficacy|0|||
27787296|NCT01637402|54241654|FG000|Standard Dose Regimen|Adverse Event|1|||
27787297|NCT01637402|54241655|FG001|Standard Dose Regimen|Adverse Event|0|||
27787298|NCT01637402|54241654|FG000|Week 12 Evaluation|Lack of Efficacy|6|||
27787299|NCT01637402|54241655|FG001|Week 12 Evaluation|Lack of Efficacy|0|||
27787300|NCT01637402|54241654|FG000|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0|||
27787301|NCT01637402|54241655|FG001|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4|||
27787302|NCT01637402|54241654|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|4|||
27787303|NCT01637402|54241655|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
27787304|NCT01637402|54241654|FG000|Treatment Regiments Post Week 12|Progression after escalation arm closed|5|||
27787305|NCT01637402|54241655|FG001|Treatment Regiments Post Week 12|Progression after escalation arm closed|0|||
27787306|NCT02217475|54241683|FG000|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
27787307|NCT02217475|54241684|FG001|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1|||
27787308|NCT02217475|54241685|FG002|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
27787309|NCT02217475|54241683|FG000|Treatment Period 1 (Year 1)|Adverse Event|4|||
27787310|NCT02217475|54241684|FG001|Treatment Period 1 (Year 1)|Adverse Event|5|||
27787311|NCT02217475|54241685|FG002|Treatment Period 1 (Year 1)|Adverse Event|9|||
27787312|NCT02217475|54241683|FG000|Treatment Period 1 (Year 1)|Lost to Follow-up|1|||
27787313|NCT02217475|54241684|FG001|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
27787314|NCT02217475|54241685|FG002|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
27787315|NCT02217475|54241683|FG000|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5|||
27787316|NCT02217475|54241684|FG001|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2|||
27787317|NCT02217475|54241685|FG002|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11|||
27787318|NCT02217475|54241683|FG000|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
27787319|NCT02217475|54241684|FG001|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
27787320|NCT02217475|54241685|FG002|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1|||
27787321|NCT02217475|54241683|FG000|Discontinued After Period 1|Adverse Event|1|||
27787322|NCT02217475|54241684|FG001|Discontinued After Period 1|Adverse Event|2|||
28016921|NCT00328627|54676131|FG003|Overall Study|Physician Decision|2|||
28016922|NCT00328627|54676132|FG004|Overall Study|Physician Decision|1|||
28016923|NCT00328627|54676133|FG005|Overall Study|Physician Decision|1|||
28016924|NCT00328627|54676134|FG006|Overall Study|Physician Decision|1|||
28016925|NCT00328627|54676135|FG007|Overall Study|Physician Decision|0|||
28016926|NCT00328627|54676136|FG008|Overall Study|Physician Decision|3|||
27787323|NCT02217475|54241685|FG002|Discontinued After Period 1|Adverse Event|0|||
27787324|NCT02217475|54241683|FG000|Discontinued After Period 1|Participant Withdrew Consent|1|||
27787325|NCT02217475|54241684|FG001|Discontinued After Period 1|Participant Withdrew Consent|1|||
28016927|NCT00328627|54676137|FG009|Overall Study|Physician Decision|2|||
28016928|NCT00328627|54676138|FG010|Overall Study|Physician Decision|1|||
28016929|NCT00328627|54676139|FG011|Overall Study|Physician Decision|0|||
28016930|NCT00328627|54676128|FG000|Overall Study|Other|0|||
27787326|NCT02217475|54241685|FG002|Discontinued After Period 1|Participant Withdrew Consent|2|||
27787327|NCT02217475|54241683|FG000|Discontinued After Period 1|Physician Decision|0|||
27787328|NCT02217475|54241684|FG001|Discontinued After Period 1|Physician Decision|0|||
27787329|NCT02217475|54241685|FG002|Discontinued After Period 1|Physician Decision|1|||
27787330|NCT02217475|54241683|FG000|Treatment Period 2 (Year 2)|Adverse Event|0|||
27787331|NCT02217475|54241684|FG001|Treatment Period 2 (Year 2)|Adverse Event|1|||
27787332|NCT02217475|54241685|FG002|Treatment Period 2 (Year 2)|Adverse Event|5|||
27787333|NCT02217475|54241683|FG000|Treatment Period 2 (Year 2)|Lost to Follow-up|0|||
27787334|NCT02217475|54241684|FG001|Treatment Period 2 (Year 2)|Lost to Follow-up|1|||
27787335|NCT02217475|54241685|FG002|Treatment Period 2 (Year 2)|Lost to Follow-up|2|||
27787336|NCT02217475|54241683|FG000|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
27787337|NCT02217475|54241684|FG001|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0|||
27787338|NCT02217475|54241685|FG002|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
27787339|NCT02217475|54241683|FG000|Treatment Period 2 (Year 2)|Physician Decision|0|||
27787340|NCT02217475|54241684|FG001|Treatment Period 2 (Year 2)|Physician Decision|0|||
27787341|NCT02217475|54241685|FG002|Treatment Period 2 (Year 2)|Physician Decision|2|||
27787342|NCT02217475|54241683|FG000|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
27787343|NCT02217475|54241684|FG001|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
27787344|NCT02217475|54241685|FG002|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1|||
27787345|NCT02191267|54241705|FG000|Overall Study|Withdrawal by Subject|1|||
27787346|NCT02191267|54241706|FG001|Overall Study|Withdrawal by Subject|0|||
27787347|NCT02191267|54241707|FG002|Overall Study|Withdrawal by Subject|0|||
27787348|NCT02189941|54241715|FG000|Overall Study|Non-compliance|0|||
27787349|NCT02189941|54241716|FG001|Overall Study|Non-compliance|0|||
27787350|NCT02189941|54241717|FG002|Overall Study|Non-compliance|1|||
27787351|NCT02216773|54241727|FG000|Overall Study|Disease progression|4|||
27787352|NCT02216773|54241728|FG001|Overall Study|Disease progression|2|||
27787353|NCT02216773|54241727|FG000|Overall Study|Insufficient FLRV|4|||
27787354|NCT02216773|54241728|FG001|Overall Study|Insufficient FLRV|0|||
27787355|NCT02216773|54241727|FG000|Overall Study|Abandoned|4|||
27787356|NCT02216773|54241728|FG001|Overall Study|Abandoned|3|||
27787357|NCT01601132|54241734|FG000|Overall Study|Patient withdrew consent|1|||
27787358|NCT01601132|54241734|FG000|Overall Study|Protocol deviation|1|||
27787359|NCT02162719|54241743|FG000|Overall Study|Death|41|||
27787360|NCT02162719|54241744|FG001|Overall Study|Death|46|||
27787361|NCT02162719|54241743|FG000|Overall Study|Lost to Follow-up|1|||
27787362|NCT02162719|54241744|FG001|Overall Study|Lost to Follow-up|3|||
27787363|NCT02162719|54241743|FG000|Overall Study|Disease Progression|2|||
27787364|NCT02162719|54241744|FG001|Overall Study|Disease Progression|1|||
27787365|NCT02162719|54241743|FG000|Overall Study|Withdrawal by Subject|8|||
27787366|NCT02162719|54241744|FG001|Overall Study|Withdrawal by Subject|2|||
27787367|NCT02162719|54241743|FG000|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
27787368|NCT02162719|54241744|FG001|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
27787369|NCT02161549|54241752|FG000|Overall Study|Physician Decision|6|||
27787370|NCT02161549|54241753|FG001|Overall Study|Physician Decision|2|||
27787371|NCT02189863|54241759|FG000|First 2 Weeks|Motion Sickness|4|||
27787372|NCT02189863|54241760|FG001|First 2 Weeks|Motion Sickness|2|||
27787373|NCT02189473|54241771|FG000|Overall Study|Death|22|||
27787374|NCT02189473|54241772|FG001|Overall Study|Death|23|||
27787375|NCT02189473|54241771|FG000|Overall Study|Lost to Follow-up|1|||
27787376|NCT02189473|54241772|FG001|Overall Study|Lost to Follow-up|2|||
27787377|NCT02188849|54241780|FG000|Overall Study|Lost to Follow-up|3|||
27787378|NCT02188849|54241781|FG001|Overall Study|Lost to Follow-up|8|||
27787379|NCT01636076|54241789|FG000|Overall Study|Terminated by sponsor|1|||
27787380|NCT01636076|54241790|FG001|Overall Study|Terminated by sponsor|1|||
27787381|NCT01636076|54241789|FG000|Overall Study|Lack of Efficacy|0|||
27787382|NCT01636076|54241790|FG001|Overall Study|Lack of Efficacy|1|||
27787383|NCT01636076|54241789|FG000|Overall Study|Lost to Follow-up|1|||
27787384|NCT01636076|54241790|FG001|Overall Study|Lost to Follow-up|0|||
27931066|NCT01164501|54587344|FG000|Overall Study|Non compliant with protocol|1|||
27931067|NCT01164501|54587345|FG001|Overall Study|Non compliant with protocol|1|||
27931068|NCT01164501|54587346|FG002|Overall Study|Non compliant with protocol|4|||
27931069|NCT01164501|54587344|FG000|Overall Study|Lost to Follow-up|3|||
27931070|NCT01164501|54587345|FG001|Overall Study|Lost to Follow-up|0|||
27931071|NCT01164501|54587346|FG002|Overall Study|Lost to Follow-up|3|||
27931072|NCT01164501|54587344|FG000|Overall Study|Patient refusal to continue,not due toAE|10|||
27931073|NCT01164501|54587345|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
27787385|NCT01636076|54241789|FG000|Overall Study|Physician Decision|1|||
27787386|NCT01636076|54241790|FG001|Overall Study|Physician Decision|1|||
27787387|NCT01636076|54241789|FG000|Overall Study|Non-compliance with study treatment|1|||
27787388|NCT01636076|54241790|FG001|Overall Study|Non-compliance with study treatment|1|||
27787389|NCT01636076|54241789|FG000|Overall Study|Adverse Event|6|||
27787390|NCT01636076|54241790|FG001|Overall Study|Adverse Event|11|||
27787391|NCT01636076|54241789|FG000|Overall Study|Withdrawal by Subject|7|||
27787392|NCT01636076|54241790|FG001|Overall Study|Withdrawal by Subject|10|||
27931074|NCT01164501|54587346|FG002|Overall Study|Patient refusal to continue,not due toAE|8|||
27841704|NCT01576718|54329564|FG001|Treatment Period|Met stopping criteria|16|||
27841705|NCT01576718|54329565|FG002|Treatment Period|Met stopping criteria|13|||
27787393|NCT01635998|54241805|FG000|Overall Study|Death|1|||
27787394|NCT01635998|54241806|FG001|Overall Study|Death|1|||
27787395|NCT01635998|54241805|FG000|Overall Study|Lost to Follow-up|2|||
27787396|NCT01635998|54241806|FG001|Overall Study|Lost to Follow-up|1|||
27787397|NCT01635998|54241805|FG000|Overall Study|Withdrawal by Subject|1|||
27787398|NCT01635998|54241806|FG001|Overall Study|Withdrawal by Subject|5|||
27787399|NCT01635920|54241814|FG000|Overall Study|Adverse Event|1|||
27787400|NCT01635920|54241815|FG001|Overall Study|Adverse Event|0|||
27787401|NCT01635920|54241814|FG000|Overall Study|Lost to Follow-up|0|||
27787402|NCT01635920|54241815|FG001|Overall Study|Lost to Follow-up|1|||
27787403|NCT01635920|54241814|FG000|Overall Study|Subject decision|2|||
27787404|NCT01635920|54241815|FG001|Overall Study|Subject decision|0|||
27787405|NCT02160145|54241832|FG000|Prerandomization Single-blind Period|Placebo run-in failure|23|||
27787406|NCT02160145|54241833|FG001|Prerandomization Single-blind Period|Placebo run-in failure|0|||
27787407|NCT02160145|54241834|FG002|Prerandomization Single-blind Period|Placebo run-in failure|0|||
27787408|NCT02160145|54241832|FG000|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126|||
27787409|NCT02160145|54241833|FG001|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
27787410|NCT02160145|54241834|FG002|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
27787411|NCT02160145|54241832|FG000|Randomized Double-blind Period|Subject decision|0|||
27787412|NCT02160145|54241833|FG001|Randomized Double-blind Period|Subject decision|21|||
27787413|NCT02160145|54241834|FG002|Randomized Double-blind Period|Subject decision|20|||
27787414|NCT02160145|54241832|FG000|Randomized Double-blind Period|Lost to Follow-up|0|||
27787415|NCT02160145|54241833|FG001|Randomized Double-blind Period|Lost to Follow-up|1|||
27787416|NCT02160145|54241834|FG002|Randomized Double-blind Period|Lost to Follow-up|3|||
27787417|NCT02160145|54241832|FG000|Randomized Double-blind Period|Physician Decision|0|||
27787418|NCT02160145|54241833|FG001|Randomized Double-blind Period|Physician Decision|7|||
27787419|NCT02160145|54241834|FG002|Randomized Double-blind Period|Physician Decision|5|||
27787420|NCT01696396|54241845|FG000|Overall Study|Withdrawal by Subject|19|||
27787421|NCT01696396|54241846|FG001|Overall Study|Withdrawal by Subject|5|||
27787422|NCT01696396|54241847|FG002|Overall Study|Withdrawal by Subject|19|||
27787423|NCT01696396|54241848|FG003|Overall Study|Withdrawal by Subject|11|||
27787424|NCT01696396|54241845|FG000|Overall Study|Decision by Sponsor|3|||
27787425|NCT01696396|54241846|FG001|Overall Study|Decision by Sponsor|1|||
27787426|NCT01696396|54241847|FG002|Overall Study|Decision by Sponsor|2|||
27787427|NCT01696396|54241848|FG003|Overall Study|Decision by Sponsor|2|||
27787428|NCT01696396|54241845|FG000|Overall Study|Lost to Follow-up|9|||
27787429|NCT01696396|54241846|FG001|Overall Study|Lost to Follow-up|1|||
27787430|NCT01696396|54241847|FG002|Overall Study|Lost to Follow-up|4|||
27787431|NCT01696396|54241848|FG003|Overall Study|Lost to Follow-up|1|||
27787432|NCT01696396|54241845|FG000|Overall Study|Death|0|||
27841706|NCT01576718|54329566|FG003|Treatment Period|Met stopping criteria|19|||
27841707|NCT01576718|54329567|FG004|Treatment Period|Met stopping criteria|16|||
27841708|NCT01576718|54329568|FG005|Treatment Period|Met stopping criteria|33|||
27841709|NCT01576718|54329569|FG006|Treatment Period|Met stopping criteria|15|||
27841710|NCT01576718|54329563|FG000|Treatment Period|Lost to Follow-up|0|||
27841711|NCT01576718|54329564|FG001|Treatment Period|Lost to Follow-up|0|||
27841712|NCT01576718|54329565|FG002|Treatment Period|Lost to Follow-up|0|||
27841713|NCT01576718|54329566|FG003|Treatment Period|Lost to Follow-up|0|||
27787433|NCT01696396|54241846|FG001|Overall Study|Death|0|||
27787434|NCT01696396|54241847|FG002|Overall Study|Death|1|||
27787435|NCT01696396|54241848|FG003|Overall Study|Death|0|||
27787436|NCT02216071|54241864|FG000|Overall Study|Withdrawal by Subject|7|||
27787437|NCT02216071|54241865|FG001|Overall Study|Withdrawal by Subject|2|||
27787438|NCT02216071|54241864|FG000|Overall Study|Lost to Follow-up|3|||
27787439|NCT02216071|54241865|FG001|Overall Study|Lost to Follow-up|3|||
27787440|NCT02216071|54241864|FG000|Overall Study|Protocol Violation|3|||
27787441|NCT02216071|54241865|FG001|Overall Study|Protocol Violation|5|||
27787442|NCT02216071|54241864|FG000|Overall Study|Other|2|||
27787443|NCT02216071|54241865|FG001|Overall Study|Other|2|||
27787444|NCT01681576|54241873|FG000|Period 1|Adverse Event|1|||
27787445|NCT01681576|54241874|FG001|Period 1|Adverse Event|0|||
27787446|NCT01681576|54241873|FG000|Period 1|Protocol Deviation|1|||
27787447|NCT01681576|54241874|FG001|Period 1|Protocol Deviation|0|||
27787448|NCT01681576|54241873|FG000|Period 2|subject/guardian decision|3|||
27841714|NCT01576718|54329567|FG004|Treatment Period|Lost to Follow-up|1|||
27841715|NCT01576718|54329568|FG005|Treatment Period|Lost to Follow-up|0|||
27787449|NCT01681576|54241874|FG001|Period 2|subject/guardian decision|1|||
27787450|NCT01681576|54241873|FG000|Period 2|Non-compliance with study treatment|1|||
27787451|NCT01681576|54241874|FG001|Period 2|Non-compliance with study treatment|0|||
27787452|NCT02188459|54241884|FG000|Overall Study|Lost to Follow-up|3|||
27787453|NCT02188459|54241885|FG001|Overall Study|Lost to Follow-up|4|||
27787454|NCT02188459|54241884|FG000|Overall Study|Early Termination|0|||
27787455|NCT02188459|54241885|FG001|Overall Study|Early Termination|3|||
27841716|NCT01576718|54329569|FG006|Treatment Period|Lost to Follow-up|0|||
27787456|NCT02214121|54241907|FG000|Part A|Patient decision|2|||
27787457|NCT02214121|54241908|FG001|Part A|Patient decision|0|||
27787458|NCT02214121|54241909|FG002|Part A|Patient decision|0|||
27787459|NCT02214121|54241907|FG000|Part A|Dev. of study-specific withdrawal crit.|4|||
27787460|NCT02214121|54241908|FG001|Part A|Dev. of study-specific withdrawal crit.|0|||
27787461|NCT02214121|54241909|FG002|Part A|Dev. of study-specific withdrawal crit.|0|||
27787462|NCT02214121|54241907|FG000|Part A|Other|1|||
27787463|NCT02214121|54241908|FG001|Part A|Other|0|||
27787464|NCT02214121|54241909|FG002|Part A|Other|0|||
27787465|NCT02214121|54241907|FG000|Part B|Patient decision|0|||
27787466|NCT02214121|54241908|FG001|Part B|Patient decision|1|||
27787467|NCT02214121|54241909|FG002|Part B|Patient decision|0|||
27787468|NCT02214121|54241907|FG000|Part B|Dev. of study-specific withdrawal crit.|0|||
27787469|NCT02214121|54241908|FG001|Part B|Dev. of study-specific withdrawal crit.|2|||
27787470|NCT02214121|54241909|FG002|Part B|Dev. of study-specific withdrawal crit.|0|||
27787471|NCT02214121|54241907|FG000|Part B|Lost to Follow-up|0|||
27787472|NCT02214121|54241908|FG001|Part B|Lost to Follow-up|0|||
27787473|NCT02214121|54241909|FG002|Part B|Lost to Follow-up|1|||
27787474|NCT01681186|54241937|FG000|Washout Period From Second Intervention|Adverse Event|0|||
27787475|NCT01681186|54241938|FG001|Washout Period From Second Intervention|Adverse Event|0|||
27787476|NCT01681186|54241939|FG002|Washout Period From Second Intervention|Adverse Event|0|||
27787477|NCT01681186|54241940|FG003|Washout Period From Second Intervention|Adverse Event|0|||
27787478|NCT01681186|54241941|FG004|Washout Period From Second Intervention|Adverse Event|0|||
27787479|NCT01681186|54241942|FG005|Washout Period From Second Intervention|Adverse Event|0|||
27787480|NCT01681186|54241943|FG006|Washout Period From Second Intervention|Adverse Event|1|||
27787481|NCT01681186|54241944|FG007|Washout Period From Second Intervention|Adverse Event|0|||
27787482|NCT01681186|54241937|FG000|Washout Period From Second Intervention|Protocol Violation|0|||
27841717|NCT01576718|54329563|FG000|Treatment Period|Noncompliance to study medication|0|||
27841718|NCT01576718|54329564|FG001|Treatment Period|Noncompliance to study medication|0|||
27841719|NCT01576718|54329565|FG002|Treatment Period|Noncompliance to study medication|0|||
27841720|NCT01576718|54329566|FG003|Treatment Period|Noncompliance to study medication|0|||
27841721|NCT01576718|54329567|FG004|Treatment Period|Noncompliance to study medication|0|||
27841722|NCT01576718|54329568|FG005|Treatment Period|Noncompliance to study medication|1|||
27841723|NCT01576718|54329569|FG006|Treatment Period|Noncompliance to study medication|1|||
27931075|NCT01164501|54587344|FG000|Overall Study|Other reason not defined above|9|||
27931076|NCT01164501|54587345|FG001|Overall Study|Other reason not defined above|1|||
27931077|NCT01164501|54587346|FG002|Overall Study|Other reason not defined above|4|||
27931078|NCT00958711|54587358|FG000|Overall Study|Withdrawal by Subject|0|||
27931079|NCT00958711|54587359|FG001|Overall Study|Withdrawal by Subject|4|||
27931080|NCT00958711|54587358|FG000|Overall Study|Physician Decision|5|||
27931081|NCT00958711|54587359|FG001|Overall Study|Physician Decision|7|||
27931082|NCT00958711|54587358|FG000|Overall Study|Lost to Follow-up|4|||
27931083|NCT00958711|54587359|FG001|Overall Study|Lost to Follow-up|1|||
27931084|NCT00958711|54587358|FG000|Overall Study|Other|2|||
27931085|NCT00958711|54587359|FG001|Overall Study|Other|5|||
27931086|NCT00958711|54587358|FG000|Overall Study|Death|1|||
27931087|NCT00958711|54587359|FG001|Overall Study|Death|2|||
27931088|NCT00958711|54587358|FG000|Overall Study|Adverse Event|1|||
27931089|NCT00958711|54587359|FG001|Overall Study|Adverse Event|2|||
27931090|NCT01163721|54587367|FG000|Overall Study|Adverse Event|5|||
27931091|NCT01163721|54587368|FG001|Overall Study|Adverse Event|6|||
27931092|NCT01163721|54587367|FG000|Overall Study|Withdrawal by Subject|3|||
27931093|NCT01163721|54587368|FG001|Overall Study|Withdrawal by Subject|4|||
27931094|NCT01163721|54587367|FG000|Overall Study|Lost to Follow-up|0|||
27931095|NCT01163721|54587368|FG001|Overall Study|Lost to Follow-up|1|||
27931096|NCT01163721|54587367|FG000|Overall Study|Physician Decision|0|||
27931097|NCT01163721|54587368|FG001|Overall Study|Physician Decision|1|||
27931098|NCT00958243|54587380|FG000|Overall Study|Withdrawal by Subject|0|||
27931099|NCT00958243|54587381|FG001|Overall Study|Withdrawal by Subject|1|||
28016931|NCT00328627|54676129|FG001|Overall Study|Other|0|||
27787483|NCT01681186|54241938|FG001|Washout Period From Second Intervention|Protocol Violation|0|||
27787484|NCT01681186|54241939|FG002|Washout Period From Second Intervention|Protocol Violation|0|||
27787485|NCT01681186|54241940|FG003|Washout Period From Second Intervention|Protocol Violation|0|||
27787486|NCT01681186|54241941|FG004|Washout Period From Second Intervention|Protocol Violation|0|||
27787487|NCT01681186|54241942|FG005|Washout Period From Second Intervention|Protocol Violation|0|||
27787488|NCT01681186|54241943|FG006|Washout Period From Second Intervention|Protocol Violation|0|||
27841724|NCT01493557|54329586|FG000|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
27931100|NCT00958243|54587382|FG002|Overall Study|Withdrawal by Subject|3|||
27931101|NCT00958243|54587383|FG003|Overall Study|Withdrawal by Subject|1|||
27931102|NCT00958243|54587384|FG004|Overall Study|Withdrawal by Subject|1|||
27931103|NCT00958243|54587385|FG005|Overall Study|Withdrawal by Subject|5|||
27931104|NCT00958243|54587380|FG000|Overall Study|Lost to Follow-up|2|||
27931105|NCT00958243|54587381|FG001|Overall Study|Lost to Follow-up|5|||
27841725|NCT01493557|54329587|FG001|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
27841726|NCT01493557|54329588|FG002|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1|||
27841727|NCT01493557|54329586|FG000|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
27841728|NCT01493557|54329587|FG001|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
27841729|NCT01493557|54329588|FG002|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9|||
27841730|NCT01493557|54329586|FG000|Not Randomized to Management Strategies|Other adverse event|0|||
27841731|NCT01493557|54329587|FG001|Not Randomized to Management Strategies|Other adverse event|0|||
27841732|NCT01493557|54329588|FG002|Not Randomized to Management Strategies|Other adverse event|54|||
27787489|NCT01681186|54241944|FG007|Washout Period From Second Intervention|Protocol Violation|1|||
27787490|NCT01681186|54241937|FG000|Washout Period From Third Intervention|Lost to Follow-up|0|||
27787491|NCT01681186|54241938|FG001|Washout Period From Third Intervention|Lost to Follow-up|0|||
27787492|NCT01681186|54241939|FG002|Washout Period From Third Intervention|Lost to Follow-up|0|||
27787493|NCT01681186|54241940|FG003|Washout Period From Third Intervention|Lost to Follow-up|0|||
27787494|NCT01681186|54241941|FG004|Washout Period From Third Intervention|Lost to Follow-up|0|||
27787495|NCT01681186|54241942|FG005|Washout Period From Third Intervention|Lost to Follow-up|0|||
27787496|NCT01681186|54241943|FG006|Washout Period From Third Intervention|Lost to Follow-up|1|||
27787497|NCT01681186|54241944|FG007|Washout Period From Third Intervention|Lost to Follow-up|0|||
27787498|NCT01681186|54241937|FG000|Fourth Intervention|Protocol Violation|0|||
27787499|NCT01681186|54241938|FG001|Fourth Intervention|Protocol Violation|0|||
27787500|NCT01681186|54241939|FG002|Fourth Intervention|Protocol Violation|0|||
27787501|NCT01681186|54241940|FG003|Fourth Intervention|Protocol Violation|0|||
27787502|NCT01681186|54241941|FG004|Fourth Intervention|Protocol Violation|0|||
27841733|NCT01493557|54329586|FG000|Not Randomized to Management Strategies|Protocol Violation|0|||
27841734|NCT01493557|54329587|FG001|Not Randomized to Management Strategies|Protocol Violation|0|||
27841735|NCT01493557|54329588|FG002|Not Randomized to Management Strategies|Protocol Violation|1|||
27841736|NCT01493557|54329586|FG000|Not Randomized to Management Strategies|Lost to Follow-up|0|||
27841737|NCT01493557|54329587|FG001|Not Randomized to Management Strategies|Lost to Follow-up|0|||
27841738|NCT01493557|54329588|FG002|Not Randomized to Management Strategies|Lost to Follow-up|4|||
27841739|NCT01493557|54329586|FG000|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
27841740|NCT01493557|54329587|FG001|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
27841741|NCT01493557|54329588|FG002|Not Randomized to Management Strategies|Withdrawal by Subject|10|||
27841742|NCT01493557|54329586|FG000|Not Randomized to Management Strategies|Early termination|0|||
27841743|NCT01493557|54329587|FG001|Not Randomized to Management Strategies|Early termination|0|||
27841744|NCT01493557|54329588|FG002|Not Randomized to Management Strategies|Early termination|34|||
27841745|NCT01493557|54329586|FG000|Not Randomized to Management Strategies|Other than stated above|0|||
27841746|NCT01493557|54329587|FG001|Not Randomized to Management Strategies|Other than stated above|0|||
27841747|NCT01493557|54329588|FG002|Not Randomized to Management Strategies|Other than stated above|21|||
27931106|NCT00958243|54587382|FG002|Overall Study|Lost to Follow-up|11|||
27931107|NCT00958243|54587383|FG003|Overall Study|Lost to Follow-up|2|||
27931108|NCT00958243|54587384|FG004|Overall Study|Lost to Follow-up|8|||
27931109|NCT00958243|54587385|FG005|Overall Study|Lost to Follow-up|5|||
27931110|NCT01241760|54587407|FG000|Overall Study|Adverse Event|1|||
27931111|NCT01241760|54587408|FG001|Overall Study|Adverse Event|0|||
27931112|NCT01241760|54587407|FG000|Overall Study|Lost to Follow-up|18|||
27931113|NCT01241760|54587408|FG001|Overall Study|Lost to Follow-up|22|||
27931114|NCT01241760|54587407|FG000|Overall Study|Withdrawal by Subject|13|||
27931115|NCT01241760|54587408|FG001|Overall Study|Withdrawal by Subject|13|||
27931116|NCT01241760|54587407|FG000|Overall Study|Switch To Commercially Available Medicat|1|||
27931117|NCT01241760|54587408|FG001|Overall Study|Switch To Commercially Available Medicat|4|||
27931118|NCT01241760|54587407|FG000|Overall Study|Other|1|||
27931119|NCT01241760|54587408|FG001|Overall Study|Other|1|||
27931120|NCT00958165|54587415|FG000|Overall Study|Lost to Follow-up|5|||
27931121|NCT00958165|54587415|FG000|Overall Study|Not eligible|9|||
27931122|NCT00958009|54587419|FG000|Overall Study|Adverse Event|1|||
27931123|NCT00958009|54587419|FG000|Overall Study|Subject found device difficult to use|1|||
27931124|NCT00953407|54587428|FG000|Overall Study|Failed inclusion criteria|1|||
27931125|NCT00953407|54587429|FG001|Overall Study|Failed inclusion criteria|1|||
27931126|NCT00953407|54587430|FG002|Overall Study|Failed inclusion criteria|1|||
27787503|NCT01681186|54241942|FG005|Fourth Intervention|Protocol Violation|0|||
27787504|NCT01681186|54241943|FG006|Fourth Intervention|Protocol Violation|0|||
27931127|NCT00953407|54587431|FG003|Overall Study|Failed inclusion criteria|1|||
27787505|NCT01681186|54241944|FG007|Fourth Intervention|Protocol Violation|1|||
27787506|NCT03597464|54241976|FG000|Overall Study|Withdrawal by Subject|4|||
27787507|NCT03597464|54241977|FG001|Overall Study|Withdrawal by Subject|5|||
27787508|NCT03597464|54241976|FG000|Overall Study|Lost to Follow-up|3|||
27787509|NCT03597464|54241977|FG001|Overall Study|Lost to Follow-up|1|||
27787510|NCT03597464|54241976|FG000|Overall Study|Pregnancy|3|||
27787511|NCT03597464|54241977|FG001|Overall Study|Pregnancy|1|||
27787512|NCT03597464|54241976|FG000|Overall Study|Lack of Efficacy|2|||
27787513|NCT03597464|54241977|FG001|Overall Study|Lack of Efficacy|0|||
27787514|NCT03597464|54241976|FG000|Overall Study|Physician Decision|2|||
27787515|NCT03597464|54241977|FG001|Overall Study|Physician Decision|2|||
27787516|NCT03597464|54241976|FG000|Overall Study|Protocol Violation|1|||
27787517|NCT03597464|54241977|FG001|Overall Study|Protocol Violation|1|||
27787518|NCT03597464|54241976|FG000|Overall Study|Adverse Event|0|||
27787519|NCT03597464|54241977|FG001|Overall Study|Adverse Event|2|||
27787520|NCT03597464|54241976|FG000|Overall Study|Death|0|||
27787521|NCT03597464|54241977|FG001|Overall Study|Death|3|||
27787522|NCT01695772|54241985|FG000|Overall Study|Withdrawal by Subject|18|||
27787523|NCT01695772|54241985|FG000|Overall Study|Progressive Disease|8|||
27787524|NCT01695772|54241985|FG000|Overall Study|Investigator Decision|5|||
27787525|NCT01695772|54241985|FG000|Overall Study|Lost to Follow-up|4|||
27787526|NCT01695772|54241985|FG000|Overall Study|Protocol Violation|2|||
27787527|NCT01695772|54241985|FG000|Overall Study|Unspecified Reason|1|||
27787528|NCT02159521|54241989|FG000|Overall Study|Enrolled but not treated|3|||
27787529|NCT02159521|54241989|FG000|Overall Study|Withdrawal by Subject|7|||
27787530|NCT02159521|54241989|FG000|Overall Study|Lost to Follow-up|6|||
27787531|NCT02159521|54241989|FG000|Overall Study|Death|1|||
27787532|NCT02159521|54241989|FG000|Overall Study|Other than specified|1|||
27787533|NCT01636934|54241995|FG000|Overall Study|Withdrawal by Subject|3|||
27787534|NCT01636934|54241996|FG001|Overall Study|Withdrawal by Subject|2|||
27787535|NCT01636934|54241995|FG000|Overall Study|Chemo cancel|1|||
27787536|NCT01636934|54241996|FG001|Overall Study|Chemo cancel|0|||
27787537|NCT01636934|54241995|FG000|Overall Study|Too ill to continue|1|||
27787538|NCT01636934|54241996|FG001|Overall Study|Too ill to continue|0|||
27787539|NCT01636934|54241995|FG000|Overall Study|Never started study medication|1|||
27787540|NCT01636934|54241996|FG001|Overall Study|Never started study medication|1|||
27787541|NCT01712854|54242002|FG000|Overall Study|Physician Decision|1|||
27787542|NCT01693120|54242006|FG000|Enrollment|Lost to Follow-up|1|||
27787543|NCT01693120|54242006|FG000|Enrollment|Withdrawal by Subject|10|||
27787544|NCT01693120|54242006|FG000|Enrollment|Protocol Violation|46|||
27787545|NCT01693120|54242006|FG000|Enrollment|Physician Decision|3|||
27787546|NCT01693120|54242006|FG000|Enrollment|Adverse Event|1|||
27787547|NCT01693120|54242006|FG000|Enrollment|Study closed|8|||
27787548|NCT01693120|54242006|FG000|Enrollment|Other|1|||
27787549|NCT01693120|54242006|FG000|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1|||
27787550|NCT01693120|54242006|FG000|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5|||
27787551|NCT01693120|54242006|FG000|Phased RF Study Procedure and Follow-up|Physician Decision|3|||
27787552|NCT01693120|54242006|FG000|Phased RF Study Procedure and Follow-up|Protocol Violation|1|||
27787553|NCT01693120|54242006|FG000|Phased RF Study Procedure and Follow-up|Other reasons|7|||
27787554|NCT02159365|54242010|FG000|Overall Study|Disease Progression|23|||
27787555|NCT02159365|54242010|FG000|Overall Study|Other reasons|11|||
27787556|NCT02159365|54242010|FG000|Overall Study|Administrative reason by Sponsor|9|||
27787557|NCT02159365|54242010|FG000|Overall Study|Adverse Event unrelated to study drug|9|||
27787558|NCT02159365|54242010|FG000|Overall Study|Study drug toxicity|7|||
27787559|NCT02159365|54242010|FG000|Overall Study|Maximum clinical benefit|3|||
27787560|NCT02159365|54242010|FG000|Overall Study|Subject request to discontinue treatment|3|||
27787561|NCT02159365|54242010|FG000|Overall Study|Subject withdrew consent|3|||
27787562|NCT02159365|54242010|FG000|Overall Study|Death|1|||
27787563|NCT02159365|54242010|FG000|Overall Study|Lost to Follow-up|1|||
27787564|NCT01712074|54242017|FG000|Placebo Run-in Period|Adverse Event|2|||
27787565|NCT01712074|54242018|FG001|Placebo Run-in Period|Adverse Event|0|||
27787566|NCT01712074|54242019|FG002|Placebo Run-in Period|Adverse Event|0|||
27787567|NCT01712074|54242017|FG000|Placebo Run-in Period|Lost to Follow-up|1|||
27787568|NCT01712074|54242018|FG001|Placebo Run-in Period|Lost to Follow-up|0|||
27787569|NCT01712074|54242019|FG002|Placebo Run-in Period|Lost to Follow-up|0|||
27787570|NCT01712074|54242017|FG000|Placebo Run-in Period|No longer meets eligibility criteria|5|||
27787571|NCT01712074|54242018|FG001|Placebo Run-in Period|No longer meets eligibility criteria|0|||
27787572|NCT01712074|54242019|FG002|Placebo Run-in Period|No longer meets eligibility criteria|0|||
27787573|NCT01712074|54242017|FG000|Placebo Run-in Period|Other|1|||
27787574|NCT01712074|54242018|FG001|Placebo Run-in Period|Other|0|||
27787575|NCT01712074|54242019|FG002|Placebo Run-in Period|Other|0|||
27787576|NCT01712074|54242017|FG000|Placebo Run-in Period|No longer willing to participate|1|||
27787577|NCT01712074|54242018|FG001|Placebo Run-in Period|No longer willing to participate|0|||
27787578|NCT01712074|54242019|FG002|Placebo Run-in Period|No longer willing to participate|0|||
28105590|NCT04889625|54763025|FG000|Period 2|Wrong add power dispensed|0|||
27787579|NCT01712074|54242017|FG000|Double Blind Period|Adverse Event|0|||
27787580|NCT01712074|54242018|FG001|Double Blind Period|Adverse Event|2|||
27841748|NCT01493557|54329586|FG000|Randomized to Management Strategies|Worsening of events associate with GIS|3|||
27841749|NCT01493557|54329587|FG001|Randomized to Management Strategies|Worsening of events associate with GIS|2|||
27841750|NCT01493557|54329588|FG002|Randomized to Management Strategies|Worsening of events associate with GIS|0|||
27841751|NCT01493557|54329586|FG000|Randomized to Management Strategies|Other adverse event|8|||
27841752|NCT01493557|54329587|FG001|Randomized to Management Strategies|Other adverse event|5|||
27841753|NCT01493557|54329588|FG002|Randomized to Management Strategies|Other adverse event|0|||
27841754|NCT01493557|54329586|FG000|Randomized to Management Strategies|Protocol Violation|3|||
27841755|NCT01493557|54329587|FG001|Randomized to Management Strategies|Protocol Violation|0|||
27841756|NCT01493557|54329588|FG002|Randomized to Management Strategies|Protocol Violation|0|||
27841757|NCT01493557|54329586|FG000|Randomized to Management Strategies|Withdrawal by Subject|0|||
27841758|NCT01493557|54329587|FG001|Randomized to Management Strategies|Withdrawal by Subject|1|||
27841759|NCT01493557|54329588|FG002|Randomized to Management Strategies|Withdrawal by Subject|0|||
27841760|NCT01493557|54329586|FG000|Randomized to Management Strategies|Other than stated above|1|||
27841761|NCT01493557|54329587|FG001|Randomized to Management Strategies|Other than stated above|3|||
27841762|NCT01493557|54329588|FG002|Randomized to Management Strategies|Other than stated above|0|||
27841763|NCT01493557|54329586|FG000|Adding the Second Strategy|Worsening of events associate with GIS|1|||
27841764|NCT01493557|54329587|FG001|Adding the Second Strategy|Worsening of events associate with GIS|1|||
27841765|NCT01493557|54329588|FG002|Adding the Second Strategy|Worsening of events associate with GIS|0|||
27841766|NCT01493557|54329586|FG000|Adding the Second Strategy|Other adverse event|1|||
27841767|NCT01493557|54329587|FG001|Adding the Second Strategy|Other adverse event|2|||
27787581|NCT01712074|54242019|FG002|Double Blind Period|Adverse Event|1|||
27787582|NCT01712074|54242017|FG000|Double Blind Period|No longer willing to participate|0|||
27787583|NCT01712074|54242018|FG001|Double Blind Period|No longer willing to participate|2|||
27787584|NCT01712074|54242019|FG002|Double Blind Period|No longer willing to participate|4|||
27787585|NCT01712074|54242017|FG000|Double Blind Period|Death|0|||
27787586|NCT01712074|54242018|FG001|Double Blind Period|Death|1|||
27787587|NCT01712074|54242019|FG002|Double Blind Period|Death|0|||
27787588|NCT01712074|54242017|FG000|Double Blind Period|Lost to Follow-up|0|||
27787589|NCT01712074|54242018|FG001|Double Blind Period|Lost to Follow-up|2|||
27787590|NCT01712074|54242019|FG002|Double Blind Period|Lost to Follow-up|1|||
27787591|NCT01712074|54242017|FG000|Double Blind Period|Other|0|||
27787592|NCT01712074|54242018|FG001|Double Blind Period|Other|4|||
27787593|NCT01712074|54242019|FG002|Double Blind Period|Other|1|||
27787594|NCT01712074|54242017|FG000|Double Blind Period|Protocol Violation|0|||
27787595|NCT01712074|54242018|FG001|Double Blind Period|Protocol Violation|0|||
27787596|NCT01712074|54242019|FG002|Double Blind Period|Protocol Violation|1|||
27787597|NCT01712074|54242017|FG000|Double Blind Period|No longer met eligibility criteria|0|||
27787598|NCT01712074|54242018|FG001|Double Blind Period|No longer met eligibility criteria|3|||
27787599|NCT01712074|54242019|FG002|Double Blind Period|No longer met eligibility criteria|0|||
27787600|NCT01711216|54242034|FG000|Overall Study|Adverse Event|4|||
27787601|NCT01711216|54242034|FG000|Overall Study|Pregnancy|56|||
27787602|NCT01711216|54242034|FG000|Overall Study|Withdrawal by Subject|6|||
27787603|NCT01711216|54242034|FG000|Overall Study|Lost to Follow-up|46|||
27787604|NCT01711216|54242034|FG000|Overall Study|variety of other minor reasons|83|||
27787605|NCT01711216|54242034|FG000|Overall Study|no reason specified|22|||
27787606|NCT01692730|54242044|FG000|Overall Study|Lost to Follow-up|225|||
27787607|NCT01692730|54242045|FG001|Overall Study|Lost to Follow-up|227|||
27787608|NCT01691794|54242054|FG000|Overall Study|Poor/Non-Compliance|1|||
27841768|NCT01493557|54329588|FG002|Adding the Second Strategy|Other adverse event|0|||
27841769|NCT01493557|54329586|FG000|Adding the Second Strategy|Withdrawal by Subject|0|||
27841770|NCT01493557|54329587|FG001|Adding the Second Strategy|Withdrawal by Subject|1|||
27841771|NCT01493557|54329588|FG002|Adding the Second Strategy|Withdrawal by Subject|0|||
27841772|NCT01451749|54329597|FG000|Overall Study|Protocol Violation|14|||
27787609|NCT01691794|54242055|FG001|Overall Study|Poor/Non-Compliance|4|||
27787610|NCT01691794|54242056|FG002|Overall Study|Poor/Non-Compliance|1|||
27787611|NCT01691794|54242054|FG000|Overall Study|Death|0|||
27787612|NCT01691794|54242055|FG001|Overall Study|Death|0|||
27787613|NCT01691794|54242056|FG002|Overall Study|Death|1|||
27787614|NCT01691794|54242054|FG000|Overall Study|Lack of Efficacy|0|||
27787615|NCT01691794|54242055|FG001|Overall Study|Lack of Efficacy|7|||
27787616|NCT01691794|54242056|FG002|Overall Study|Lack of Efficacy|1|||
27787617|NCT01691794|54242054|FG000|Overall Study|Participant request to discontinue|0|||
27787618|NCT01691794|54242055|FG001|Overall Study|Participant request to discontinue|1|||
27787619|NCT01691794|54242056|FG002|Overall Study|Participant request to discontinue|0|||
28016932|NCT00328627|54676130|FG002|Overall Study|Other|0|||
27787620|NCT01691794|54242054|FG000|Overall Study|Adverse Event|0|||
27787621|NCT01691794|54242055|FG001|Overall Study|Adverse Event|1|||
27787622|NCT01691794|54242056|FG002|Overall Study|Adverse Event|1|||
27787623|NCT01691794|54242054|FG000|Overall Study|Completed Only first 24 weeks of study|0|||
27787624|NCT01691794|54242055|FG001|Overall Study|Completed Only first 24 weeks of study|2|||
27787625|NCT01691794|54242056|FG002|Overall Study|Completed Only first 24 weeks of study|3|||
27787626|NCT01691794|54242054|FG000|Overall Study|Did not complete first 24 weeks of study|0|||
27841773|NCT01451749|54329598|FG001|Overall Study|Protocol Violation|7|||
27841774|NCT01451749|54329597|FG000|Overall Study|Lost to Follow-up|15|||
27841775|NCT01451749|54329598|FG001|Overall Study|Lost to Follow-up|5|||
27841776|NCT01451749|54329597|FG000|Overall Study|Meet the exclusion criteria,and|1|||
27841777|NCT01451749|54329598|FG001|Overall Study|Meet the exclusion criteria,and|1|||
27841778|NCT01451749|54329597|FG000|Overall Study|Adverse Event|2|||
27841779|NCT01451749|54329598|FG001|Overall Study|Adverse Event|0|||
27841780|NCT01451749|54329597|FG000|Overall Study|Withdrawal by Subject|0|||
27841781|NCT01451749|54329598|FG001|Overall Study|Withdrawal by Subject|1|||
27841782|NCT01576484|54329608|FG000|Overall Study|Adverse Event|1|||
27841783|NCT01576484|54329609|FG001|Overall Study|Adverse Event|1|||
27841784|NCT01576484|54329608|FG000|Overall Study|Protocol Violation|0|||
27841785|NCT01576484|54329609|FG001|Overall Study|Protocol Violation|2|||
27841786|NCT01576484|54329608|FG000|Overall Study|Sponsor Decision|2|||
27841787|NCT01576484|54329609|FG001|Overall Study|Sponsor Decision|8|||
27841788|NCT01576484|54329608|FG000|Overall Study|Withdrawal by Subject|0|||
27841789|NCT01576484|54329609|FG001|Overall Study|Withdrawal by Subject|3|||
27841790|NCT01576484|54329608|FG000|Overall Study|Other|2|||
27841791|NCT01576484|54329609|FG001|Overall Study|Other|5|||
27841792|NCT01467505|54329619|FG000|Overall Study|Adverse Event|1|||
27841793|NCT01467505|54329620|FG001|Overall Study|Adverse Event|0|||
27841794|NCT01467505|54329619|FG000|Overall Study|Withdrawal by Subject|4|||
27841795|NCT01467505|54329620|FG001|Overall Study|Withdrawal by Subject|0|||
27841796|NCT01467505|54329619|FG000|Overall Study|Study Terminated by Sponsor|28|||
27841797|NCT01467505|54329620|FG001|Overall Study|Study Terminated by Sponsor|3|||
27841798|NCT01467271|54329626|FG000|Overall Study|Death|84|||
27841799|NCT01467271|54329626|FG000|Overall Study|Lost to Follow-up|83|||
27841800|NCT01467271|54329626|FG000|Overall Study|Retraction of patient's consent|21|||
27841801|NCT01467271|54329626|FG000|Overall Study|Other reason|14|||
27841802|NCT01449929|54329632|FG000|Randomization Phase 96 Week|Adverse Event|5|||
27841803|NCT01449929|54329633|FG001|Randomization Phase 96 Week|Adverse Event|13|||
27841804|NCT01449929|54329634|FG002|Randomization Phase 96 Week|Adverse Event|0|||
27841805|NCT01449929|54329632|FG000|Randomization Phase 96 Week|Lack of Efficacy|3|||
27841806|NCT01449929|54329633|FG001|Randomization Phase 96 Week|Lack of Efficacy|4|||
27841807|NCT01449929|54329634|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
27787627|NCT01691794|54242055|FG001|Overall Study|Did not complete first 24 weeks of study|3|||
27787628|NCT01691794|54242056|FG002|Overall Study|Did not complete first 24 weeks of study|3|||
27787629|NCT01710514|54242066|FG000|Overall Study|Adverse Event|6|||
27787630|NCT01710514|54242067|FG001|Overall Study|Adverse Event|7|||
27787631|NCT01710514|54242066|FG000|Overall Study|Withdrawal by Subject|1|||
27787632|NCT01710514|54242067|FG001|Overall Study|Withdrawal by Subject|0|||
27787633|NCT01592344|54242078|FG000|Overall Study|Adverse Event|1|||
27787634|NCT01592344|54242079|FG001|Overall Study|Adverse Event|1|||
27787635|NCT01592344|54242078|FG000|Overall Study|Lack of Efficacy|1|||
27787636|NCT01592344|54242079|FG001|Overall Study|Lack of Efficacy|0|||
27787637|NCT01592344|54242078|FG000|Overall Study|not available at primary outcome visit|2|||
27787638|NCT01592344|54242079|FG001|Overall Study|not available at primary outcome visit|4|||
27787639|NCT01636778|54242085|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3|||
27787640|NCT01636778|54242086|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
27787641|NCT01636778|54242087|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
27787642|NCT01636778|54242085|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1|||
27787643|NCT01636778|54242086|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
27787644|NCT01636778|54242087|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
27787645|NCT01636778|54242085|FG000|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
27787646|NCT01636778|54242086|FG001|Antiviral Treatment Period (Part 2)|Adverse Event|7|||
27787647|NCT01636778|54242087|FG002|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
27787648|NCT01636778|54242085|FG000|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
27787649|NCT01636778|54242086|FG001|Antiviral Treatment Period (Part 2)|Protocol Violation|1|||
27787650|NCT01636778|54242087|FG002|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
27787651|NCT01636778|54242085|FG000|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
27787652|NCT01636778|54242086|FG001|Antiviral Treatment Period (Part 2)|Physician Decision|2|||
27841808|NCT01449929|54329632|FG000|Randomization Phase 96 Week|Protocol Violation|5|||
27841809|NCT01449929|54329633|FG001|Randomization Phase 96 Week|Protocol Violation|6|||
27841810|NCT01449929|54329634|FG002|Randomization Phase 96 Week|Protocol Violation|0|||
27841811|NCT01449929|54329632|FG000|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1|||
27841812|NCT01449929|54329633|FG001|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
27841813|NCT01449929|54329634|FG002|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
27841814|NCT01449929|54329632|FG000|Randomization Phase 96 Week|Lost to Follow-up|15|||
27841815|NCT01449929|54329633|FG001|Randomization Phase 96 Week|Lost to Follow-up|18|||
27787653|NCT01636778|54242087|FG002|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
27787654|NCT01636778|54242085|FG000|Follow-up Period After Part 2|Other|0|||
27787655|NCT01636778|54242086|FG001|Follow-up Period After Part 2|Other|0|||
27787656|NCT01636778|54242087|FG002|Follow-up Period After Part 2|Other|1|||
27787657|NCT01636778|54242085|FG000|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
27787658|NCT01636778|54242086|FG001|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
27841816|NCT01449929|54329634|FG002|Randomization Phase 96 Week|Lost to Follow-up|0|||
27841817|NCT01449929|54329632|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
27841818|NCT01449929|54329633|FG001|Randomization Phase 96 Week|Withdrawal by Subject|8|||
27841819|NCT01449929|54329634|FG002|Randomization Phase 96 Week|Withdrawal by Subject|0|||
27841820|NCT01449929|54329632|FG000|Randomization Phase 96 Week|Physician Decision|2|||
27841821|NCT01449929|54329633|FG001|Randomization Phase 96 Week|Physician Decision|3|||
28016933|NCT00328627|54676131|FG003|Overall Study|Other|1|||
28016934|NCT00328627|54676132|FG004|Overall Study|Other|0|||
27841822|NCT01449929|54329634|FG002|Randomization Phase 96 Week|Physician Decision|0|||
27841823|NCT01449929|54329632|FG000|Randomization Phase 96 Week|Other: study closed/terminated|0|||
27841824|NCT01449929|54329633|FG001|Randomization Phase 96 Week|Other: study closed/terminated|1|||
27841825|NCT01449929|54329634|FG002|Randomization Phase 96 Week|Other: study closed/terminated|0|||
27841826|NCT01449929|54329632|FG000|Extension Phase Approximately 3 Years|Adverse Event|0|||
27841827|NCT01449929|54329633|FG001|Extension Phase Approximately 3 Years|Adverse Event|0|||
27841828|NCT01449929|54329634|FG002|Extension Phase Approximately 3 Years|Adverse Event|2|||
27841829|NCT01449929|54329632|FG000|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
27841830|NCT01449929|54329633|FG001|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
28016935|NCT00328627|54676133|FG005|Overall Study|Other|0|||
28016936|NCT00328627|54676134|FG006|Overall Study|Other|1|||
27787659|NCT01636778|54242087|FG002|Follow-up Period After Part 2|Not entered FU period after withdrawal|1|||
27841831|NCT01449929|54329634|FG002|Extension Phase Approximately 3 Years|Lack of Efficacy|2|||
27841832|NCT01449929|54329632|FG000|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
27841833|NCT01449929|54329633|FG001|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
27841834|NCT01449929|54329634|FG002|Extension Phase Approximately 3 Years|Lost to Follow-up|4|||
27841835|NCT01449539|54329644|FG000|Overall Study|Withdrawal by Subject|3|||
27841836|NCT01449539|54329644|FG000|Overall Study|Toxicity not study related|1|||
27841837|NCT01451515|54329651|FG000|Overall Study|Death|0|||
27841838|NCT01451515|54329652|FG001|Overall Study|Death|1|||
27841839|NCT01451515|54329653|FG002|Overall Study|Death|0|||
27841840|NCT01451515|54329651|FG000|Overall Study|Withdrawal by Subject|0|||
27841841|NCT01451515|54329652|FG001|Overall Study|Withdrawal by Subject|1|||
27841842|NCT01451515|54329653|FG002|Overall Study|Withdrawal by Subject|0|||
27841843|NCT01451515|54329651|FG000|Overall Study|Development of unacceptable toxicity during treatment|0|||
27841844|NCT01451515|54329652|FG001|Overall Study|Development of unacceptable toxicity during treatment|0|||
27841845|NCT01451515|54329653|FG002|Overall Study|Development of unacceptable toxicity during treatment|1|||
27841846|NCT01451515|54329651|FG000|Overall Study|Relapse (except CNS)|1|||
27841847|NCT01451515|54329652|FG001|Overall Study|Relapse (except CNS)|1|||
27841848|NCT01451515|54329653|FG002|Overall Study|Relapse (except CNS)|0|||
27841849|NCT01466881|54329664|FG000|Overall Study|Ineligible|5|||
27841850|NCT01466881|54329664|FG000|Overall Study|Adverse Event|6|||
27841851|NCT01466881|54329664|FG000|Overall Study|Progression/relapse|20|||
27787660|NCT01636778|54242085|FG000|Follow-up Period After Part 2|Withdrawal by Subject|0|||
27787661|NCT01636778|54242086|FG001|Follow-up Period After Part 2|Withdrawal by Subject|0|||
27787662|NCT01636778|54242087|FG002|Follow-up Period After Part 2|Withdrawal by Subject|2|||
27787663|NCT02159053|54242098|FG000|Overall Study|Death|2|||
27787664|NCT02159053|54242099|FG001|Overall Study|Death|0|||
27787665|NCT02159053|54242100|FG002|Overall Study|Death|1|||
27787666|NCT02159053|54242098|FG000|Overall Study|Physician Decision|0|||
27787667|NCT02159053|54242099|FG001|Overall Study|Physician Decision|1|||
27787668|NCT02159053|54242100|FG002|Overall Study|Physician Decision|1|||
27787669|NCT02159053|54242098|FG000|Overall Study|Lack of Efficacy|3|||
27787670|NCT02159053|54242099|FG001|Overall Study|Lack of Efficacy|4|||
27787671|NCT02159053|54242100|FG002|Overall Study|Lack of Efficacy|7|||
27787672|NCT02159053|54242098|FG000|Overall Study|Adverse Event|7|||
27787673|NCT02159053|54242099|FG001|Overall Study|Adverse Event|6|||
27787674|NCT02159053|54242100|FG002|Overall Study|Adverse Event|5|||
27787675|NCT02159053|54242098|FG000|Overall Study|Participants/guardian decision|8|||
27787676|NCT02159053|54242099|FG001|Overall Study|Participants/guardian decision|10|||
27841852|NCT01466881|54329664|FG000|Overall Study|Death|4|||
27841853|NCT01466881|54329664|FG000|Overall Study|Other reason not protocol specified|5|||
27787677|NCT02159053|54242100|FG002|Overall Study|Participants/guardian decision|6|||
27787678|NCT02158975|54242110|FG000|Overall Study|Did not complete 1 cycle nor > 1dose|1|||
27841854|NCT01576406|54329676|FG000|Overall Study|Lost to Follow-up|1|||
27841855|NCT01576406|54329677|FG001|Overall Study|Lost to Follow-up|2|||
27841856|NCT01576406|54329678|FG002|Overall Study|Lost to Follow-up|0|||
27841857|NCT01576406|54329679|FG003|Overall Study|Lost to Follow-up|0|||
27841858|NCT01576406|54329680|FG004|Overall Study|Lost to Follow-up|0|||
28016937|NCT00328627|54676135|FG007|Overall Study|Other|0|||
27787679|NCT02158663|54242117|FG000|Overall Study|Withdrawal by Subject|5|||
27787680|NCT02158663|54242118|FG001|Overall Study|Withdrawal by Subject|4|||
27841859|NCT01576406|54329681|FG005|Overall Study|Lost to Follow-up|0|||
27841860|NCT01576406|54329676|FG000|Overall Study|Death|3|||
27841861|NCT01576406|54329677|FG001|Overall Study|Death|4|||
27841862|NCT01576406|54329678|FG002|Overall Study|Death|8|||
27841863|NCT01576406|54329679|FG003|Overall Study|Death|5|||
27841864|NCT01576406|54329680|FG004|Overall Study|Death|7|||
27841865|NCT01576406|54329681|FG005|Overall Study|Death|9|||
27841866|NCT01576406|54329676|FG000|Overall Study|Non-clinical trial supply of Crizotinib|0|||
27841867|NCT01576406|54329677|FG001|Overall Study|Non-clinical trial supply of Crizotinib|0|||
27841868|NCT01576406|54329678|FG002|Overall Study|Non-clinical trial supply of Crizotinib|1|||
27841869|NCT01576406|54329679|FG003|Overall Study|Non-clinical trial supply of Crizotinib|1|||
27841870|NCT01576406|54329680|FG004|Overall Study|Non-clinical trial supply of Crizotinib|0|||
27841871|NCT01576406|54329681|FG005|Overall Study|Non-clinical trial supply of Crizotinib|0|||
27841872|NCT01576406|54329676|FG000|Overall Study|Withdrawal the consent|2|||
27841873|NCT01576406|54329677|FG001|Overall Study|Withdrawal the consent|2|||
27841874|NCT01576406|54329678|FG002|Overall Study|Withdrawal the consent|5|||
27841875|NCT01576406|54329679|FG003|Overall Study|Withdrawal the consent|1|||
27787681|NCT02158039|54242126|FG000|Overall Study|Withdrawal by Subject|1|||
27787682|NCT02158039|54242126|FG000|Overall Study|Screen Failure|9|||
27787683|NCT01635764|54242144|FG000|Overall Study|Adverse Event|46|||
27787684|NCT01635764|54242144|FG000|Overall Study|Lack of Efficacy|76|||
27787685|NCT01635764|54242144|FG000|Overall Study|Exceed Protocol-specified Interventions|2|||
27787686|NCT01635764|54242144|FG000|Overall Study|Protocol Deviation|1|||
27841876|NCT01576406|54329680|FG004|Overall Study|Withdrawal the consent|1|||
27841877|NCT01576406|54329681|FG005|Overall Study|Withdrawal the consent|3|||
27841878|NCT01576406|54329676|FG000|Overall Study|Other|0|||
27841879|NCT01576406|54329677|FG001|Overall Study|Other|0|||
27841880|NCT01576406|54329678|FG002|Overall Study|Other|2|||
27841881|NCT01576406|54329679|FG003|Overall Study|Other|2|||
27841882|NCT01576406|54329680|FG004|Overall Study|Other|0|||
27841883|NCT01576406|54329681|FG005|Overall Study|Other|0|||
27841884|NCT01576172|54329697|FG000|Overall Study|Ineligible|2|||
27841885|NCT01576172|54329698|FG001|Overall Study|Ineligible|1|||
27841886|NCT01576172|54329697|FG000|Overall Study|Withdrawal by Subject|2|||
27841887|NCT01576172|54329698|FG001|Overall Study|Withdrawal by Subject|0|||
27841888|NCT01576172|54329697|FG000|Overall Study|Insurance issue|1|||
27841889|NCT01576172|54329698|FG001|Overall Study|Insurance issue|0|||
27841890|NCT01542788|54329708|FG000|Overall Study|Randomized but Not Treated|2|||
27841891|NCT01542788|54329709|FG001|Overall Study|Randomized but Not Treated|0|||
27841892|NCT01542788|54329708|FG000|Overall Study|Lack of Efficacy|41|||
27841893|NCT01542788|54329709|FG001|Overall Study|Lack of Efficacy|71|||
27841894|NCT01542788|54329708|FG000|Overall Study|Lost to Follow-up|5|||
27841895|NCT01542788|54329709|FG001|Overall Study|Lost to Follow-up|0|||
27841896|NCT01542788|54329708|FG000|Overall Study|Death|3|||
27841897|NCT01542788|54329709|FG001|Overall Study|Death|0|||
27787687|NCT01635764|54242144|FG000|Overall Study|Withdrew Consent|67|||
27787688|NCT01635764|54242144|FG000|Overall Study|Lost to Follow-up|53|||
27787689|NCT01635764|54242144|FG000|Overall Study|Other|28|||
27787690|NCT03432260|54242160|FG000|Overall Study|Lost to Follow-up|1|||
27787691|NCT03432260|54242161|FG001|Overall Study|Lost to Follow-up|1|||
27787692|NCT03432260|54242162|FG002|Overall Study|Lost to Follow-up|0|||
27787693|NCT03432260|54242163|FG003|Overall Study|Lost to Follow-up|0|||
27787694|NCT03432260|54242164|FG004|Overall Study|Lost to Follow-up|1|||
27787695|NCT01634360|54242178|FG000|Overall Study|Adverse Event|10|||
27787696|NCT01634360|54242179|FG001|Overall Study|Adverse Event|34|||
27787697|NCT01634360|54242178|FG000|Overall Study|subject withdrew consent|13|||
27787698|NCT01634360|54242179|FG001|Overall Study|subject withdrew consent|23|||
27787699|NCT01634360|54242178|FG000|Overall Study|Protocol Violation|1|||
27787700|NCT01634360|54242179|FG001|Overall Study|Protocol Violation|1|||
27787701|NCT01634360|54242178|FG000|Overall Study|Lack of Efficacy|4|||
27787702|NCT01634360|54242179|FG001|Overall Study|Lack of Efficacy|14|||
27787703|NCT01634360|54242178|FG000|Overall Study|Other|3|||
27787704|NCT01634360|54242179|FG001|Overall Study|Other|20|||
27787705|NCT01634360|54242178|FG000|Overall Study|Study termination by sponsor|18|||
27787706|NCT01634360|54242179|FG001|Overall Study|Study termination by sponsor|44|||
27787707|NCT01635218|54242196|FG000|Overall Study|Lost to Follow-up|3|||
27787708|NCT01635218|54242197|FG001|Overall Study|Lost to Follow-up|7|||
27841898|NCT01542788|54329708|FG000|Overall Study|Protocol Violation|2|||
27841899|NCT01542788|54329709|FG001|Overall Study|Protocol Violation|0|||
27841900|NCT01542788|54329708|FG000|Overall Study|Physician Decision|1|||
27841901|NCT01542788|54329709|FG001|Overall Study|Physician Decision|0|||
27841902|NCT01542788|54329708|FG000|Overall Study|Withdrawal by Subject|1|||
27787709|NCT01635218|54242198|FG002|Overall Study|Lost to Follow-up|6|||
27787710|NCT02049866|54242206|FG000|Overall Study|Withdrawal by Subject|1|||
27787711|NCT04274894|54242210|FG000|Overall Study|Adverse Event|7|||
27841903|NCT01542788|54329709|FG001|Overall Study|Withdrawal by Subject|0|||
27841904|NCT01542632|54329721|FG000|Overall Study|Withdrawal of Consent|0|||
27841905|NCT01542632|54329722|FG001|Overall Study|Withdrawal of Consent|0|||
27841906|NCT01542632|54329723|FG002|Overall Study|Withdrawal of Consent|0|||
27787712|NCT04274894|54242210|FG000|Overall Study|Withdrew consent|5|||
27787713|NCT04274894|54242210|FG000|Overall Study|Lost to Follow-up|9|||
27787714|NCT04274894|54242210|FG000|Overall Study|COVID-19 infection|1|||
27787715|NCT04274894|54242210|FG000|Overall Study|Other, not specified|20|||
27787716|NCT02213263|54242216|FG000|Overall Study|Insufficient clinical response|4|||
27841907|NCT01542632|54329724|FG003|Overall Study|Withdrawal of Consent|2|||
27841908|NCT01542632|54329725|FG004|Overall Study|Withdrawal of Consent|3|||
27931128|NCT00953407|54587432|FG004|Overall Study|Failed inclusion criteria|1|||
27931129|NCT00953407|54587428|FG000|Overall Study|Lost to Follow-up|0|||
27931130|NCT00953407|54587429|FG001|Overall Study|Lost to Follow-up|0|||
27931131|NCT00953407|54587430|FG002|Overall Study|Lost to Follow-up|0|||
27931132|NCT00953407|54587431|FG003|Overall Study|Lost to Follow-up|1|||
27931133|NCT00953407|54587432|FG004|Overall Study|Lost to Follow-up|0|||
27931134|NCT00953329|54587444|FG000|Overall Study|Lack of Efficacy|1|||
27931135|NCT00953017|54587452|FG000|Overall Study|DId not show up for colonoscopy|4|||
27931136|NCT00953017|54587453|FG001|Overall Study|DId not show up for colonoscopy|4|||
27931137|NCT00953017|54587454|FG002|Overall Study|DId not show up for colonoscopy|5|||
27931138|NCT00953017|54587455|FG003|Overall Study|DId not show up for colonoscopy|4|||
27931139|NCT00953017|54587452|FG000|Overall Study|Incomplete data|1|||
27931140|NCT00953017|54587453|FG001|Overall Study|Incomplete data|1|||
27931141|NCT00953017|54587454|FG002|Overall Study|Incomplete data|0|||
27931142|NCT00953017|54587455|FG003|Overall Study|Incomplete data|0|||
27931143|NCT00953017|54587452|FG000|Overall Study|Procedure incomplete due to pain/looping|0|||
27931144|NCT00953017|54587453|FG001|Overall Study|Procedure incomplete due to pain/looping|1|||
27931145|NCT00953017|54587454|FG002|Overall Study|Procedure incomplete due to pain/looping|0|||
27931146|NCT00953017|54587455|FG003|Overall Study|Procedure incomplete due to pain/looping|1|||
27931147|NCT00953017|54587452|FG000|Overall Study|Brown stool prior to procedure|0|||
27931148|NCT00953017|54587453|FG001|Overall Study|Brown stool prior to procedure|0|||
27931149|NCT00953017|54587454|FG002|Overall Study|Brown stool prior to procedure|1|||
27931150|NCT00953017|54587455|FG003|Overall Study|Brown stool prior to procedure|0|||
27931151|NCT00952705|54587468|FG000|Overall Study|Lost to Follow-up|24|||
27931152|NCT00952705|54587469|FG001|Overall Study|Lost to Follow-up|8|||
27931153|NCT00952705|54587470|FG002|Overall Study|Lost to Follow-up|9|||
27931154|NCT00952705|54587468|FG000|Overall Study|Withdrawal by Subject|2|||
27931155|NCT00952705|54587469|FG001|Overall Study|Withdrawal by Subject|1|||
27931156|NCT00952705|54587470|FG002|Overall Study|Withdrawal by Subject|1|||
27931157|NCT00952705|54587468|FG000|Overall Study|Death|2|||
27931158|NCT00952705|54587469|FG001|Overall Study|Death|0|||
27931159|NCT00952705|54587470|FG002|Overall Study|Death|0|||
27931160|NCT00952705|54587468|FG000|Overall Study|Incarcerated post dose|5|||
27931161|NCT00952705|54587469|FG001|Overall Study|Incarcerated post dose|0|||
27931162|NCT00952705|54587470|FG002|Overall Study|Incarcerated post dose|0|||
27931163|NCT00952705|54587468|FG000|Overall Study|Exclusion criteria not met pre dose|0|||
27931164|NCT00952705|54587469|FG001|Overall Study|Exclusion criteria not met pre dose|1|||
27931165|NCT00952705|54587470|FG002|Overall Study|Exclusion criteria not met pre dose|0|||
27931166|NCT00955357|54587484|FG000|Titration Phase|Adverse Event|9|||
27931167|NCT00955357|54587485|FG001|Titration Phase|Adverse Event|46|||
27931168|NCT00955357|54587484|FG000|Titration Phase|Lack of Efficacy|0|||
27931169|NCT00955357|54587485|FG001|Titration Phase|Lack of Efficacy|2|||
27931170|NCT00955357|54587484|FG000|Titration Phase|Protocol Violation|3|||
27931171|NCT00955357|54587485|FG001|Titration Phase|Protocol Violation|7|||
27787717|NCT02213263|54242217|FG001|Overall Study|Insufficient clinical response|3|||
27787718|NCT02213263|54242216|FG000|Overall Study|Lost to Follow-up|0|||
27787719|NCT02213263|54242217|FG001|Overall Study|Lost to Follow-up|1|||
27787720|NCT02213263|54242216|FG000|Overall Study|No longer willing to participate|3|||
27787721|NCT02213263|54242217|FG001|Overall Study|No longer willing to participate|4|||
27841909|NCT01542632|54329726|FG005|Overall Study|Withdrawal of Consent|0|||
27841910|NCT01542632|54329721|FG000|Overall Study|Adverse Event|0|||
27841911|NCT01542632|54329722|FG001|Overall Study|Adverse Event|0|||
27841912|NCT01542632|54329723|FG002|Overall Study|Adverse Event|1|||
27841913|NCT01542632|54329724|FG003|Overall Study|Adverse Event|0|||
27841914|NCT01542632|54329725|FG004|Overall Study|Adverse Event|0|||
27931172|NCT00955357|54587484|FG000|Titration Phase|Lost to Follow-up|1|||
27931173|NCT00955357|54587485|FG001|Titration Phase|Lost to Follow-up|3|||
27787722|NCT02213263|54242216|FG000|Overall Study|Progressive disease|20|||
27787723|NCT02213263|54242217|FG001|Overall Study|Progressive disease|14|||
27787724|NCT02213263|54242216|FG000|Overall Study|Protocol Violation|0|||
27787725|NCT02213263|54242217|FG001|Overall Study|Protocol Violation|1|||
27931174|NCT00955357|54587484|FG000|Titration Phase|Withdrawal by Subject|3|||
27787726|NCT02213263|54242216|FG000|Overall Study|Adverse Event|1|||
27931175|NCT00955357|54587485|FG001|Titration Phase|Withdrawal by Subject|5|||
27931176|NCT00955357|54587484|FG000|Titration Phase|Prohibited Antiepileptic Drug change|0|||
27787727|NCT02213263|54242217|FG001|Overall Study|Adverse Event|3|||
27841915|NCT01542632|54329726|FG005|Overall Study|Adverse Event|0|||
27841916|NCT01542632|54329721|FG000|Overall Study|Lost to Follow-up|0|||
27841917|NCT01542632|54329722|FG001|Overall Study|Lost to Follow-up|1|||
27841918|NCT01542632|54329723|FG002|Overall Study|Lost to Follow-up|0|||
27931177|NCT00955357|54587485|FG001|Titration Phase|Prohibited Antiepileptic Drug change|1|||
27931178|NCT00955357|54587484|FG000|Titration Phase|Study medication not tolerated|0|||
27931179|NCT00955357|54587485|FG001|Titration Phase|Study medication not tolerated|1|||
27931180|NCT00955357|54587484|FG000|Titration Phase|Non compliance to study procedures|0|||
27931181|NCT00955357|54587485|FG001|Titration Phase|Non compliance to study procedures|1|||
27931182|NCT00955357|54587484|FG000|Maintenance Phase|Adverse Event|3|||
27931183|NCT00955357|54587485|FG001|Maintenance Phase|Adverse Event|23|||
27931184|NCT00955357|54587484|FG000|Maintenance Phase|Lack of Efficacy|0|||
27931185|NCT00955357|54587485|FG001|Maintenance Phase|Lack of Efficacy|4|||
27931186|NCT00955357|54587484|FG000|Maintenance Phase|Protocol Violation|2|||
27931187|NCT00955357|54587485|FG001|Maintenance Phase|Protocol Violation|6|||
27931188|NCT00955357|54587484|FG000|Maintenance Phase|Lost to Follow-up|2|||
27931189|NCT00955357|54587485|FG001|Maintenance Phase|Lost to Follow-up|7|||
27931190|NCT00955357|54587484|FG000|Maintenance Phase|Withdrawal by Subject|4|||
27931191|NCT00955357|54587485|FG001|Maintenance Phase|Withdrawal by Subject|4|||
27931192|NCT00955357|54587484|FG000|Maintenance Phase|Patient moving out of area|0|||
27931193|NCT00955357|54587485|FG001|Maintenance Phase|Patient moving out of area|1|||
27931194|NCT00955357|54587484|FG000|Maintenance Phase|Non compliance to study procedures|1|||
27931195|NCT00955357|54587485|FG001|Maintenance Phase|Non compliance to study procedures|0|||
27931196|NCT00955279|54587494|FG000|Overall Study|Other|0|||
27841919|NCT01542632|54329724|FG003|Overall Study|Lost to Follow-up|0|||
27841920|NCT01542632|54329725|FG004|Overall Study|Lost to Follow-up|0|||
27841921|NCT01542632|54329726|FG005|Overall Study|Lost to Follow-up|0|||
27841922|NCT01542632|54329721|FG000|Overall Study|Sponsor/Investigator Decision|0|||
27841923|NCT01542632|54329722|FG001|Overall Study|Sponsor/Investigator Decision|0|||
27841924|NCT01542632|54329723|FG002|Overall Study|Sponsor/Investigator Decision|0|||
27841925|NCT01542632|54329724|FG003|Overall Study|Sponsor/Investigator Decision|0|||
27841926|NCT01542632|54329725|FG004|Overall Study|Sponsor/Investigator Decision|1|||
27841927|NCT01542632|54329726|FG005|Overall Study|Sponsor/Investigator Decision|0|||
27841928|NCT01557842|54329747|FG000|Overall Study|Lost to Follow-up|0|||
27841929|NCT01557842|54329748|FG001|Overall Study|Lost to Follow-up|1|||
27841930|NCT01557842|54329747|FG000|Overall Study|Death|1|||
27841931|NCT01557842|54329748|FG001|Overall Study|Death|0|||
27841932|NCT01557842|54329747|FG000|Overall Study|Lack of Efficacy|0|||
27841933|NCT01557842|54329748|FG001|Overall Study|Lack of Efficacy|1|||
27841934|NCT01557842|54329747|FG000|Overall Study|Not Meet Inclusion/Exclusion Criteria|3|||
27841935|NCT01557842|54329748|FG001|Overall Study|Not Meet Inclusion/Exclusion Criteria|0|||
27841936|NCT01557842|54329747|FG000|Overall Study|Study Terminated by Sponsor|3|||
27841937|NCT01557842|54329748|FG001|Overall Study|Study Terminated by Sponsor|4|||
27841938|NCT01557842|54329747|FG000|Overall Study|Not Ablated|2|||
27841939|NCT01557842|54329748|FG001|Overall Study|Not Ablated|0|||
27841940|NCT01541930|54329754|FG000|Overall Study|Withdrawal by Subject|1|||
27841941|NCT01576016|54329771|FG000|Lead Safety|Death|132|||
27841942|NCT01576016|54329772|FG001|Lead Safety|Death|0|||
27841943|NCT01576016|54329771|FG000|Lead Safety|Withdrawal by Subject|81|||
27841944|NCT01576016|54329772|FG001|Lead Safety|Withdrawal by Subject|0|||
27841945|NCT01576016|54329771|FG000|Lead Safety|System Explanted without Replacement|24|||
27841946|NCT01576016|54329772|FG001|Lead Safety|System Explanted without Replacement|0|||
27841947|NCT01576016|54329771|FG000|Lead Safety|Physician Decision|14|||
27841948|NCT01576016|54329772|FG001|Lead Safety|Physician Decision|0|||
27841949|NCT01576016|54329771|FG000|Lead Safety|Lost to Follow-up|13|||
27841950|NCT01576016|54329772|FG001|Lead Safety|Lost to Follow-up|0|||
27841951|NCT01576016|54329771|FG000|Lead Safety|Unsuccessful implant|2|||
27841952|NCT01576016|54329772|FG001|Lead Safety|Unsuccessful implant|0|||
27841953|NCT01576016|54329771|FG000|Lead Safety|Sponsor request|1|||
27841954|NCT01576016|54329772|FG001|Lead Safety|Sponsor request|0|||
27841955|NCT01576016|54329771|FG000|Lead Safety|Device replaced with CRT-D|1|||
27931197|NCT00955279|54587495|FG001|Overall Study|Other|0|||
27931198|NCT00955279|54587496|FG002|Overall Study|Other|3|||
27931199|NCT00955279|54587494|FG000|Overall Study|Death|1|||
27931200|NCT00955279|54587495|FG001|Overall Study|Death|1|||
27931201|NCT00955279|54587496|FG002|Overall Study|Death|1|||
27931202|NCT00955279|54587494|FG000|Overall Study|Lost to Follow-up|0|||
27931203|NCT00955279|54587495|FG001|Overall Study|Lost to Follow-up|3|||
27931204|NCT00955279|54587496|FG002|Overall Study|Lost to Follow-up|1|||
27841956|NCT01576016|54329772|FG001|Lead Safety|Device replaced with CRT-D|0|||
27841957|NCT01576016|54329771|FG000|Lead Safety|Patient on Palliative Care|1|||
27841958|NCT01576016|54329772|FG001|Lead Safety|Patient on Palliative Care|0|||
27841959|NCT01576016|54329771|FG000|Lead Safety|Patient noncompliance|1|||
27841960|NCT01576016|54329772|FG001|Lead Safety|Patient noncompliance|0|||
27841961|NCT01576016|54329771|FG000|Lead Safety|Too far from study site|1|||
27841962|NCT01576016|54329772|FG001|Lead Safety|Too far from study site|0|||
27841963|NCT01576016|54329771|FG000|Lead Safety|System deactivated|1|||
27931205|NCT00955279|54587494|FG000|Overall Study|Withdrawal by Subject|2|||
27931206|NCT00955279|54587495|FG001|Overall Study|Withdrawal by Subject|0|||
27931207|NCT00955279|54587496|FG002|Overall Study|Withdrawal by Subject|3|||
27931208|NCT00954733|54587504|FG000|Overall Study|blood gas machine did not work|1|||
27931209|NCT00954421|54587508|FG000|Screening|screen failures|3|||
27931210|NCT00954421|54587508|FG000|6 Months of DBS|Withdrawal by Subject|1|||
27931211|NCT00954421|54587508|FG000|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1|||
27931212|NCT01241448|54587518|FG000|Overall Study|Adverse Event|1|||
27931213|NCT01241448|54587519|FG001|Overall Study|Adverse Event|0|||
27931214|NCT01241448|54587520|FG002|Overall Study|Adverse Event|2|||
27931215|NCT01241448|54587521|FG003|Overall Study|Adverse Event|2|||
27931216|NCT01241448|54587518|FG000|Overall Study|Lost to Follow-up|2|||
27931217|NCT01241448|54587519|FG001|Overall Study|Lost to Follow-up|1|||
27931218|NCT01241448|54587520|FG002|Overall Study|Lost to Follow-up|1|||
27931219|NCT01241448|54587521|FG003|Overall Study|Lost to Follow-up|1|||
27931220|NCT01241448|54587518|FG000|Overall Study|Physician Decision|0|||
27931221|NCT01241448|54587519|FG001|Overall Study|Physician Decision|2|||
27931222|NCT01241448|54587520|FG002|Overall Study|Physician Decision|0|||
27931223|NCT01241448|54587521|FG003|Overall Study|Physician Decision|0|||
27931224|NCT01241448|54587518|FG000|Overall Study|Protocol Violation|10|||
27931225|NCT01241448|54587519|FG001|Overall Study|Protocol Violation|5|||
27931226|NCT01241448|54587520|FG002|Overall Study|Protocol Violation|3|||
27931227|NCT01241448|54587521|FG003|Overall Study|Protocol Violation|6|||
27931228|NCT01241448|54587518|FG000|Overall Study|Sponsor Decision|17|||
27931229|NCT01241448|54587519|FG001|Overall Study|Sponsor Decision|14|||
27931230|NCT01241448|54587520|FG002|Overall Study|Sponsor Decision|12|||
27931231|NCT01241448|54587521|FG003|Overall Study|Sponsor Decision|6|||
27931232|NCT01241448|54587518|FG000|Overall Study|Withdrawal by Subject|4|||
27931233|NCT01241448|54587519|FG001|Overall Study|Withdrawal by Subject|5|||
27931234|NCT01241448|54587520|FG002|Overall Study|Withdrawal by Subject|3|||
27931235|NCT01241448|54587521|FG003|Overall Study|Withdrawal by Subject|6|||
27931236|NCT01241448|54587518|FG000|Overall Study|Excluded due to data integrity issues|3|||
27931237|NCT01241448|54587519|FG001|Overall Study|Excluded due to data integrity issues|2|||
27931238|NCT01241448|54587520|FG002|Overall Study|Excluded due to data integrity issues|2|||
27931239|NCT01241448|54587521|FG003|Overall Study|Excluded due to data integrity issues|2|||
27931240|NCT01240356|54587534|FG000|Overall Study|Withdrawal by Subject|2|||
27931241|NCT01240356|54587535|FG001|Overall Study|Withdrawal by Subject|0|||
27931242|NCT01240356|54587534|FG000|Overall Study|MRI contraindication|1|||
27931243|NCT01240356|54587535|FG001|Overall Study|MRI contraindication|0|||
27931244|NCT01239732|54587544|FG000|Overall Study|Termination of study per protocol|667|||
27931245|NCT01239732|54587544|FG000|Overall Study|Death|226|||
27931246|NCT01239732|54587544|FG000|Overall Study|Withdrawal by Subject|87|||
27931247|NCT01239732|54587544|FG000|Overall Study|Adverse Event|6|||
27931248|NCT01239732|54587544|FG000|Overall Study|Protocol Violation|3|||
27931249|NCT01239732|54587544|FG000|Overall Study|Participant non compliance|5|||
27931250|NCT01239732|54587544|FG000|Overall Study|Study termination by sponsor|2|||
27931251|NCT01239732|54587544|FG000|Overall Study|Investigator's decision|4|||
27931252|NCT01239732|54587544|FG000|Overall Study|Treatment failure|2|||
27931253|NCT01239732|54587544|FG000|Overall Study|Other|19|||
27931254|NCT02227147|54587550|FG000|Controlled Treatment Period|Adverse Event|4|||
27787728|NCT02211313|54242225|FG000|Overall Study|Treatment Failure|5|||
27787729|NCT02211313|54242226|FG001|Overall Study|Treatment Failure|2|||
27787730|NCT02211313|54242225|FG000|Overall Study|No Follow up Questionnaires|1|||
27787731|NCT02211313|54242226|FG001|Overall Study|No Follow up Questionnaires|1|||
27787732|NCT02210689|54242235|FG000|Overall Study|Withdrawal by Subject|7|||
27787733|NCT02210689|54242236|FG001|Overall Study|Withdrawal by Subject|4|||
27787734|NCT02210689|54242237|FG002|Overall Study|Withdrawal by Subject|2|||
27787735|NCT02210689|54242235|FG000|Overall Study|Adverse Event|0|||
27841964|NCT01576016|54329772|FG001|Lead Safety|System deactivated|0|||
27841965|NCT01576016|54329771|FG000|Lead Safety|Patient no longer followed by study PI|1|||
27841966|NCT01576016|54329772|FG001|Lead Safety|Patient no longer followed by study PI|0|||
27841967|NCT01576016|54329771|FG000|MRI Safety|Withdrawal by Subject|0|||
27841968|NCT01576016|54329772|FG001|MRI Safety|Withdrawal by Subject|10|||
27841969|NCT01576016|54329771|FG000|MRI Safety|Non-MRI Compatible Device or Material|0|||
27841970|NCT01576016|54329772|FG001|MRI Safety|Non-MRI Compatible Device or Material|5|||
27841971|NCT01576016|54329771|FG000|MRI Safety|Has not yet completed MRI scan|0|||
27841972|NCT01576016|54329772|FG001|MRI Safety|Has not yet completed MRI scan|56|||
27787736|NCT02210689|54242236|FG001|Overall Study|Adverse Event|1|||
27787737|NCT02210689|54242237|FG002|Overall Study|Adverse Event|0|||
27841973|NCT01576016|54329771|FG000|MRI Safety|MRI scan not performed at MRI visit|0|||
27787738|NCT02210689|54242235|FG000|Overall Study|Protocol Violation|1|||
27787739|NCT02210689|54242236|FG001|Overall Study|Protocol Violation|0|||
27841974|NCT01576016|54329772|FG001|MRI Safety|MRI scan not performed at MRI visit|3|||
27931255|NCT02227147|54587551|FG001|Controlled Treatment Period|Adverse Event|3|||
27931256|NCT02227147|54587550|FG000|Controlled Treatment Period|Other|2|||
27931257|NCT02227147|54587551|FG001|Controlled Treatment Period|Other|0|||
27931258|NCT02227147|54587550|FG000|Follow-up Period|Other|3|||
27931259|NCT02227147|54587551|FG001|Follow-up Period|Other|5|||
27931260|NCT00948025|54587563|FG000|Phase 1 (Pilot Phase)|Adverse Event|1|||
27931261|NCT00948025|54587564|FG001|Phase 1 (Pilot Phase)|Adverse Event|1|||
27931262|NCT00948025|54587563|FG000|Phase 1 (Pilot Phase)|Lost to Follow-up|7|||
27931263|NCT00948025|54587564|FG001|Phase 1 (Pilot Phase)|Lost to Follow-up|1|||
27931264|NCT00948025|54587563|FG000|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
27931265|NCT00948025|54587564|FG001|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
27931266|NCT00947011|54587571|FG000|Overall Study|Study was terminated,PI left institution|12|||
27931267|NCT01239342|54587579|FG000|Overall Study|Adverse Event|1|||
27931268|NCT01239342|54587580|FG001|Overall Study|Adverse Event|0|||
27931269|NCT01239342|54587579|FG000|Overall Study|Withdrawal by Subject|1|||
27931270|NCT01239342|54587580|FG001|Overall Study|Withdrawal by Subject|5|||
27931271|NCT01239342|54587579|FG000|Overall Study|Reason Unknown|1|||
27931272|NCT01239342|54587580|FG001|Overall Study|Reason Unknown|1|||
27931273|NCT00946309|54587588|FG000|Overall Study|Protocol Violation|1|||
27931274|NCT00946309|54587589|FG001|Overall Study|Protocol Violation|0|||
27931275|NCT00946309|54587588|FG000|Overall Study|Lost to Follow-up|0|||
27931276|NCT00946309|54587589|FG001|Overall Study|Lost to Follow-up|1|||
27931277|NCT00946309|54587588|FG000|Overall Study|Procedure cancelled/discontinued|0|||
27931278|NCT00946309|54587589|FG001|Overall Study|Procedure cancelled/discontinued|3|||
27931279|NCT01236534|54587598|FG000|Overall Study|Adverse Event|3|||
27931280|NCT01236534|54587599|FG001|Overall Study|Adverse Event|0|||
27931281|NCT01235598|54587607|FG000|Overall Study|Adverse Event|0|||
27931282|NCT01235598|54587608|FG001|Overall Study|Adverse Event|3|||
27931283|NCT01235598|54587607|FG000|Overall Study|Lack of Efficacy|0|||
27931284|NCT01235598|54587608|FG001|Overall Study|Lack of Efficacy|1|||
27931285|NCT01235598|54587607|FG000|Overall Study|Withdrawal by Subject|1|||
27931286|NCT01235598|54587608|FG001|Overall Study|Withdrawal by Subject|0|||
27931287|NCT01235442|54587617|FG000|Overall Study|Lost to Follow-up|12|||
27931288|NCT01235442|54587618|FG001|Overall Study|Lost to Follow-up|10|||
27931289|NCT01235442|54587617|FG000|Overall Study|Death|0|||
27931290|NCT01235442|54587618|FG001|Overall Study|Death|2|||
27931291|NCT01235442|54587617|FG000|Overall Study|Pregnancy|1|||
27931292|NCT01235442|54587618|FG001|Overall Study|Pregnancy|1|||
27931293|NCT01235442|54587617|FG000|Overall Study|Ineligibility determined|5|||
27931294|NCT01235442|54587618|FG001|Overall Study|Ineligibility determined|4|||
27931295|NCT01235442|54587617|FG000|Overall Study|Protocol Violation|3|||
27931296|NCT01235442|54587618|FG001|Overall Study|Protocol Violation|3|||
27931297|NCT01235442|54587617|FG000|Overall Study|Adverse Event|4|||
27931298|NCT01235442|54587618|FG001|Overall Study|Adverse Event|6|||
27931299|NCT01235442|54587617|FG000|Overall Study|Withdrawal by Subject|15|||
27931300|NCT01235442|54587618|FG001|Overall Study|Withdrawal by Subject|9|||
27931301|NCT01235442|54587617|FG000|Overall Study|Lack of Efficacy|1|||
27931302|NCT01235442|54587618|FG001|Overall Study|Lack of Efficacy|3|||
27931303|NCT01235442|54587617|FG000|Overall Study|Noncompliance|1|||
27931304|NCT01235442|54587618|FG001|Overall Study|Noncompliance|2|||
27931305|NCT01235442|54587617|FG000|Overall Study|Administrative decision|1|||
27931306|NCT01235442|54587618|FG001|Overall Study|Administrative decision|2|||
27931307|NCT01235442|54587617|FG000|Overall Study|Other unspecified|1|||
27931308|NCT01235442|54587618|FG001|Overall Study|Other unspecified|2|||
27931309|NCT01163253|54587626|FG000|Overall Study|Withdrawn Due to Pregnancy|12|||
27931310|NCT01163253|54587627|FG001|Overall Study|Withdrawn Due to Pregnancy|2|||
27931311|NCT01163253|54587626|FG000|Overall Study|Study Terminated by Sponsor|978|||
27931312|NCT01163253|54587627|FG001|Overall Study|Study Terminated by Sponsor|349|||
27931313|NCT01163253|54587626|FG000|Overall Study|Protocol Violation|43|||
27931314|NCT01163253|54587627|FG001|Overall Study|Protocol Violation|12|||
27931315|NCT01163253|54587626|FG000|Overall Study|Withdrawal by Subject|199|||
27931316|NCT01163253|54587627|FG001|Overall Study|Withdrawal by Subject|50|||
27931317|NCT01163253|54587626|FG000|Overall Study|Medication Error|1|||
27931318|NCT01163253|54587627|FG001|Overall Study|Medication Error|0|||
27931319|NCT01163253|54587626|FG000|Overall Study|Lost to Follow-up|125|||
27931320|NCT01163253|54587627|FG001|Overall Study|Lost to Follow-up|23|||
27931321|NCT01163253|54587626|FG000|Overall Study|Insufficient Clinical Response|423|||
27931322|NCT01163253|54587627|FG001|Overall Study|Insufficient Clinical Response|29|||
27931323|NCT01163253|54587626|FG000|Overall Study|Adverse Event|300|||
27931324|NCT01163253|54587627|FG001|Overall Study|Adverse Event|78|||
27931325|NCT01163253|54587626|FG000|Overall Study|Death|17|||
27931326|NCT01163253|54587627|FG001|Overall Study|Death|5|||
27931327|NCT01163253|54587626|FG000|Overall Study|Ongoing|13|||
27931328|NCT01163253|54587627|FG001|Overall Study|Ongoing|4|||
27931329|NCT01163253|54587626|FG000|Overall Study|Other Unspecified|170|||
27931330|NCT01163253|54587627|FG001|Overall Study|Other Unspecified|34|||
27931331|NCT01162863|54587636|FG000|Overall Study|Lack of Efficacy|1|||
27931332|NCT01162863|54587637|FG001|Overall Study|Lack of Efficacy|0|||
28016938|NCT00328627|54676136|FG008|Overall Study|Other|0|||
27931333|NCT01162863|54587638|FG002|Overall Study|Lack of Efficacy|0|||
27931334|NCT01162863|54587636|FG000|Overall Study|Adverse Event|0|||
27931335|NCT01162863|54587637|FG001|Overall Study|Adverse Event|1|||
27931336|NCT01162863|54587638|FG002|Overall Study|Adverse Event|0|||
27931337|NCT01162473|54587648|FG000|Overall Study|Adverse Event|2|||
27931338|NCT01162473|54587649|FG001|Overall Study|Adverse Event|1|||
27931339|NCT01162473|54587648|FG000|Overall Study|Withdrawal by Subject|0|||
27931340|NCT01162473|54587649|FG001|Overall Study|Withdrawal by Subject|4|||
27931341|NCT01162239|54587659|FG000|Treatment Phase|Withdrawal by Subject|1|||
27931342|NCT01162239|54587660|FG001|Treatment Phase|Withdrawal by Subject|3|||
27931343|NCT01162239|54587661|FG002|Treatment Phase|Withdrawal by Subject|2|||
27931344|NCT01162239|54587662|FG003|Treatment Phase|Withdrawal by Subject|3|||
27931345|NCT01162239|54587659|FG000|Treatment Phase|Death|0|||
27931346|NCT01162239|54587660|FG001|Treatment Phase|Death|0|||
27931347|NCT01162239|54587661|FG002|Treatment Phase|Death|0|||
27931348|NCT01162239|54587662|FG003|Treatment Phase|Death|1|||
27931349|NCT01162239|54587659|FG000|Treatment Phase|Lost to Follow-up|5|||
27931350|NCT01162239|54587660|FG001|Treatment Phase|Lost to Follow-up|4|||
27931351|NCT01162239|54587661|FG002|Treatment Phase|Lost to Follow-up|2|||
27931352|NCT01162239|54587662|FG003|Treatment Phase|Lost to Follow-up|1|||
27931353|NCT01162239|54587659|FG000|Extended Follow-up|Lost to Follow-up|8|||
27931354|NCT01162239|54587660|FG001|Extended Follow-up|Lost to Follow-up|13|||
27931355|NCT01162239|54587661|FG002|Extended Follow-up|Lost to Follow-up|8|||
27787740|NCT02210689|54242237|FG002|Overall Study|Protocol Violation|0|||
27787741|NCT02210689|54242235|FG000|Overall Study|Lost to Follow-up|11|||
27787742|NCT02210689|54242236|FG001|Overall Study|Lost to Follow-up|9|||
27787743|NCT02210689|54242237|FG002|Overall Study|Lost to Follow-up|5|||
27787744|NCT02210689|54242235|FG000|Overall Study|Pregnancy|0|||
27787745|NCT02210689|54242236|FG001|Overall Study|Pregnancy|1|||
27787746|NCT02210689|54242237|FG002|Overall Study|Pregnancy|0|||
27931356|NCT01162239|54587662|FG003|Extended Follow-up|Lost to Follow-up|6|||
27931357|NCT01161537|54587673|FG000|Part B|Withdrawal by Subject|2|||
27931358|NCT01234350|54587684|FG000|Overall Study|Adverse Event|277|||
27931359|NCT01234350|54587685|FG001|Overall Study|Adverse Event|92|||
27931360|NCT01234350|54587684|FG000|Overall Study|Withdrawal by Subject|61|||
27931361|NCT01234350|54587685|FG001|Overall Study|Withdrawal by Subject|36|||
27931362|NCT01234350|54587684|FG000|Overall Study|Lost to Follow-up|115|||
27931363|NCT01234350|54587685|FG001|Overall Study|Lost to Follow-up|47|||
27931364|NCT01234350|54587684|FG000|Overall Study|Covers a diverse set of reasons|234|||
27787747|NCT02210689|54242235|FG000|Overall Study|Lack of Efficacy|0|||
27787748|NCT02210689|54242236|FG001|Overall Study|Lack of Efficacy|1|||
27787749|NCT02210689|54242237|FG002|Overall Study|Lack of Efficacy|5|||
27787750|NCT02210689|54242235|FG000|Overall Study|Prohibited medication|2|||
27841975|NCT01540838|54329782|FG000|Overall Study|Open nasogastric tube|9|||
27841976|NCT01540838|54329783|FG001|Overall Study|Open nasogastric tube|7|||
27841977|NCT01540838|54329782|FG000|Overall Study|Treatment doses missing|8|||
27841978|NCT01540838|54329783|FG001|Overall Study|Treatment doses missing|12|||
27841979|NCT01540838|54329782|FG000|Overall Study|Additional antibiotic treatment|1|||
27841980|NCT01540838|54329783|FG001|Overall Study|Additional antibiotic treatment|2|||
27841981|NCT01540838|54329782|FG000|Overall Study|Died before treatment initiation|1|||
27841982|NCT01540838|54329783|FG001|Overall Study|Died before treatment initiation|1|||
27841983|NCT01540838|54329782|FG000|Overall Study|Not BM. Other treatment|3|||
27841984|NCT01540838|54329783|FG001|Overall Study|Not BM. Other treatment|1|||
27841985|NCT01451437|54329798|FG000|Overall Study|Adverse Event|0|||
27841986|NCT01451437|54329799|FG001|Overall Study|Adverse Event|0|||
27841987|NCT01451437|54329800|FG002|Overall Study|Adverse Event|0|||
27841988|NCT01451437|54329801|FG003|Overall Study|Adverse Event|0|||
27841989|NCT01451437|54329802|FG004|Overall Study|Adverse Event|0|||
27841990|NCT01451437|54329803|FG005|Overall Study|Adverse Event|1|||
27841991|NCT01451437|54329804|FG006|Overall Study|Adverse Event|1|||
27841992|NCT01451437|54329805|FG007|Overall Study|Adverse Event|2|||
27841993|NCT01451437|54329806|FG008|Overall Study|Adverse Event|1|||
27841994|NCT01451437|54329798|FG000|Overall Study|Physician Decision|1|||
27841995|NCT01451437|54329799|FG001|Overall Study|Physician Decision|1|||
27841996|NCT01451437|54329800|FG002|Overall Study|Physician Decision|2|||
27841997|NCT01451437|54329801|FG003|Overall Study|Physician Decision|0|||
27841998|NCT01451437|54329802|FG004|Overall Study|Physician Decision|0|||
27841999|NCT01451437|54329803|FG005|Overall Study|Physician Decision|0|||
27842000|NCT01451437|54329804|FG006|Overall Study|Physician Decision|0|||
27842001|NCT01451437|54329805|FG007|Overall Study|Physician Decision|0|||
27842002|NCT01451437|54329806|FG008|Overall Study|Physician Decision|0|||
27842003|NCT01451437|54329798|FG000|Overall Study|Disease Progression|0|||
27842004|NCT01451437|54329799|FG001|Overall Study|Disease Progression|0|||
27842005|NCT01451437|54329800|FG002|Overall Study|Disease Progression|1|||
27842006|NCT01451437|54329801|FG003|Overall Study|Disease Progression|1|||
27787751|NCT02210689|54242236|FG001|Overall Study|Prohibited medication|8|||
27842007|NCT01451437|54329802|FG004|Overall Study|Disease Progression|3|||
27842008|NCT01451437|54329803|FG005|Overall Study|Disease Progression|2|||
27842009|NCT01451437|54329804|FG006|Overall Study|Disease Progression|3|||
27842010|NCT01451437|54329805|FG007|Overall Study|Disease Progression|1|||
27842011|NCT01451437|54329806|FG008|Overall Study|Disease Progression|3|||
27842012|NCT01451437|54329798|FG000|Overall Study|Protocol Violation|0|||
27842013|NCT01451437|54329799|FG001|Overall Study|Protocol Violation|0|||
27842014|NCT01451437|54329800|FG002|Overall Study|Protocol Violation|0|||
27842015|NCT01451437|54329801|FG003|Overall Study|Protocol Violation|0|||
27842016|NCT01451437|54329802|FG004|Overall Study|Protocol Violation|0|||
27842017|NCT01451437|54329803|FG005|Overall Study|Protocol Violation|0|||
27842018|NCT01451437|54329804|FG006|Overall Study|Protocol Violation|1|||
27931365|NCT01234350|54587685|FG001|Overall Study|Covers a diverse set of reasons|92|||
27931366|NCT01233258|54587696|FG000|First Intervention (6 Months)|Withdrawal by Subject|0|||
27931367|NCT01233258|54587697|FG001|First Intervention (6 Months)|Withdrawal by Subject|0|||
27931368|NCT01233258|54587698|FG002|First Intervention (6 Months)|Withdrawal by Subject|0|||
27931369|NCT01233258|54587699|FG003|First Intervention (6 Months)|Withdrawal by Subject|1|||
27931370|NCT01233258|54587700|FG004|First Intervention (6 Months)|Withdrawal by Subject|0|||
27931371|NCT01233258|54587701|FG005|First Intervention (6 Months)|Withdrawal by Subject|1|||
27931372|NCT01233258|54587696|FG000|First Intervention (6 Months)|Protocol Violation|0|||
27787752|NCT02210689|54242237|FG002|Overall Study|Prohibited medication|1|||
27787753|NCT02210689|54242235|FG000|Overall Study|Negative Nugent score at baseline|6|||
27787754|NCT02210689|54242236|FG001|Overall Study|Negative Nugent score at baseline|2|||
27787755|NCT02210689|54242237|FG002|Overall Study|Negative Nugent score at baseline|2|||
27787756|NCT02210689|54242235|FG000|Overall Study|Other|25|||
27787757|NCT02210689|54242236|FG001|Overall Study|Other|21|||
27787758|NCT02210689|54242237|FG002|Overall Study|Other|8|||
27787759|NCT02209597|54242245|FG000|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2|||
27787760|NCT02209597|54242245|FG000|Phase 1 Current Tx (Non-randomized)|Adverse Event|1|||
27787761|NCT02209597|54242245|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3|||
27787762|NCT02209597|54242245|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1|||
27787763|NCT02188303|54242274|FG000|Overall Study|Adverse Event|0|||
27787764|NCT02188303|54242275|FG001|Overall Study|Adverse Event|0|||
27787765|NCT02188303|54242276|FG002|Overall Study|Adverse Event|0|||
27787766|NCT02188303|54242277|FG003|Overall Study|Adverse Event|0|||
27787767|NCT02188303|54242278|FG004|Overall Study|Adverse Event|0|||
27787768|NCT02188303|54242279|FG005|Overall Study|Adverse Event|2|||
27787769|NCT02188303|54242280|FG006|Overall Study|Adverse Event|0|||
27787770|NCT02188303|54242281|FG007|Overall Study|Adverse Event|2|||
27787771|NCT02188303|54242274|FG000|Overall Study|Dose Termination Criteria Met|0|||
27787772|NCT02188303|54242275|FG001|Overall Study|Dose Termination Criteria Met|0|||
27787773|NCT02188303|54242276|FG002|Overall Study|Dose Termination Criteria Met|0|||
27787774|NCT02188303|54242277|FG003|Overall Study|Dose Termination Criteria Met|0|||
27787775|NCT02188303|54242278|FG004|Overall Study|Dose Termination Criteria Met|0|||
27787776|NCT02188303|54242279|FG005|Overall Study|Dose Termination Criteria Met|0|||
27787777|NCT02188303|54242280|FG006|Overall Study|Dose Termination Criteria Met|2|||
27787778|NCT02188303|54242281|FG007|Overall Study|Dose Termination Criteria Met|4|||
27787779|NCT04867382|54242317|FG000|Overall Study|Did not complete the survey|2|||
27787780|NCT04867382|54242318|FG001|Overall Study|Did not complete the survey|1|||
27787781|NCT02187055|54242327|FG000|Overall Study|Lack of Efficacy|10|||
27787782|NCT02187055|54242328|FG001|Overall Study|Lack of Efficacy|3|||
27787783|NCT02187055|54242329|FG002|Overall Study|Lack of Efficacy|7|||
27787784|NCT02187055|54242327|FG000|Overall Study|Lost to Follow-up|2|||
27787785|NCT02187055|54242328|FG001|Overall Study|Lost to Follow-up|7|||
27787786|NCT02187055|54242329|FG002|Overall Study|Lost to Follow-up|3|||
27787787|NCT02187055|54242327|FG000|Overall Study|No longer meets eligibility criteria|0|||
27787788|NCT02187055|54242328|FG001|Overall Study|No longer meets eligibility criteria|2|||
27787789|NCT02187055|54242329|FG002|Overall Study|No longer meets eligibility criteria|0|||
27787790|NCT02187055|54242327|FG000|Overall Study|No longer willing to participate|6|||
27787791|NCT02187055|54242328|FG001|Overall Study|No longer willing to participate|8|||
27787792|NCT02187055|54242329|FG002|Overall Study|No longer willing to participate|10|||
27787793|NCT02187055|54242327|FG000|Overall Study|Other|5|||
27787794|NCT02187055|54242328|FG001|Overall Study|Other|6|||
27787795|NCT02187055|54242329|FG002|Overall Study|Other|3|||
27787796|NCT02187055|54242327|FG000|Overall Study|Protocol Violation|9|||
27787797|NCT02187055|54242328|FG001|Overall Study|Protocol Violation|9|||
27787798|NCT02187055|54242329|FG002|Overall Study|Protocol Violation|4|||
27842019|NCT01451437|54329805|FG007|Overall Study|Protocol Violation|0|||
27842020|NCT01451437|54329806|FG008|Overall Study|Protocol Violation|0|||
27842021|NCT01451437|54329798|FG000|Overall Study|Withdrawal by Subject|0|||
27842022|NCT01451437|54329799|FG001|Overall Study|Withdrawal by Subject|0|||
27842023|NCT01451437|54329800|FG002|Overall Study|Withdrawal by Subject|0|||
27787799|NCT02187055|54242327|FG000|Overall Study|Pregnancy|3|||
27787800|NCT02187055|54242328|FG001|Overall Study|Pregnancy|1|||
27787801|NCT02187055|54242329|FG002|Overall Study|Pregnancy|0|||
27787802|NCT02187055|54242327|FG000|Overall Study|Withdrawal by Subject|11|||
27787803|NCT02187055|54242328|FG001|Overall Study|Withdrawal by Subject|11|||
27787804|NCT02187055|54242329|FG002|Overall Study|Withdrawal by Subject|11|||
27787805|NCT02187055|54242327|FG000|Overall Study|Adverse Event|21|||
27842024|NCT01451437|54329801|FG003|Overall Study|Withdrawal by Subject|0|||
27842025|NCT01451437|54329802|FG004|Overall Study|Withdrawal by Subject|1|||
27842026|NCT01451437|54329803|FG005|Overall Study|Withdrawal by Subject|0|||
27842027|NCT01451437|54329804|FG006|Overall Study|Withdrawal by Subject|1|||
27787806|NCT02187055|54242328|FG001|Overall Study|Adverse Event|26|||
27787807|NCT02187055|54242329|FG002|Overall Study|Adverse Event|36|||
27787808|NCT02187055|54242327|FG000|Overall Study|Death|2|||
27787809|NCT02187055|54242328|FG001|Overall Study|Death|0|||
27787810|NCT02187055|54242329|FG002|Overall Study|Death|0|||
27787811|NCT02246660|54242369|FG000|Overall Study|Withdrawal by Subject|0|||
27787812|NCT02246660|54242370|FG001|Overall Study|Withdrawal by Subject|1|||
27787813|NCT02246660|54242371|FG002|Overall Study|Withdrawal by Subject|0|||
27787814|NCT02246660|54242369|FG000|Overall Study|Death|0|||
27787815|NCT02246660|54242370|FG001|Overall Study|Death|0|||
27787816|NCT02246660|54242371|FG002|Overall Study|Death|1|||
27787817|NCT02246582|54242379|FG000|Overall Study|Withdrawal by Subject|3|||
27787818|NCT02246582|54242380|FG001|Overall Study|Withdrawal by Subject|4|||
27787819|NCT02137369|54242386|FG000|Overall Study|Withdrawal by Subject|3|||
27787820|NCT02137369|54242387|FG001|Overall Study|Withdrawal by Subject|2|||
27787821|NCT02137369|54242386|FG000|Overall Study|Adverse Event|2|||
27787822|NCT02137369|54242387|FG001|Overall Study|Adverse Event|0|||
27787823|NCT02137369|54242386|FG000|Overall Study|Lost to Follow-up|1|||
27787824|NCT02137369|54242387|FG001|Overall Study|Lost to Follow-up|0|||
27787825|NCT02137369|54242386|FG000|Overall Study|Moved away|2|||
27787826|NCT02137369|54242387|FG001|Overall Study|Moved away|0|||
27787827|NCT02155309|54242396|FG000|Overall Study|Protocol Violation|0|||
27787828|NCT02155309|54242397|FG001|Overall Study|Protocol Violation|0|||
27787829|NCT02155309|54242398|FG002|Overall Study|Protocol Violation|1|||
27787830|NCT02186821|54242405|FG000|Overall Study|Adverse Event|9|||
27787831|NCT02186821|54242405|FG000|Overall Study|Death|2|||
27787832|NCT02186821|54242405|FG000|Overall Study|Disease progression|32|||
27787833|NCT02186821|54242405|FG000|Overall Study|Protocol Violation|1|||
27787834|NCT02186821|54242405|FG000|Overall Study|Physician Decision|1|||
27787835|NCT02186821|54242405|FG000|Overall Study|Study terminated by sponsor|2|||
27787836|NCT01710358|54242412|FG000|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15|||
27787837|NCT01710358|54242413|FG001|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18|||
27787838|NCT01710358|54242414|FG002|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7|||
27787839|NCT01710358|54242412|FG000|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
27787840|NCT01710358|54242413|FG001|Treatment Period Part A (Weeks 0 to 24)|Death|2|||
27787841|NCT01710358|54242414|FG002|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
27787842|NCT01710358|54242412|FG000|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0|||
27787843|NCT01710358|54242413|FG001|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
27787844|NCT01710358|54242414|FG002|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
27787845|NCT01710358|54242412|FG000|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15|||
27787846|NCT01710358|54242413|FG001|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1|||
27787847|NCT01710358|54242414|FG002|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3|||
27787848|NCT01710358|54242412|FG000|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
27787849|NCT01710358|54242413|FG001|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1|||
27787850|NCT01710358|54242414|FG002|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
27787851|NCT01710358|54242412|FG000|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1|||
27787852|NCT01710358|54242413|FG001|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
27787853|NCT01710358|54242414|FG002|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
27787854|NCT01710358|54242412|FG000|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4|||
27787855|NCT01710358|54242413|FG001|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
27787856|NCT01710358|54242414|FG002|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
27787857|NCT01710358|54242412|FG000|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15|||
27787858|NCT01710358|54242413|FG001|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5|||
27787859|NCT01710358|54242414|FG002|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12|||
27787860|NCT01710358|54242412|FG000|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
27787861|NCT01710358|54242413|FG001|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
27787862|NCT01710358|54242414|FG002|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0|||
27787863|NCT01710358|54242412|FG000|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10|||
27787864|NCT01710358|54242413|FG001|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16|||
27787865|NCT01710358|54242414|FG002|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5|||
27787866|NCT01710358|54242412|FG000|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
27787867|NCT01710358|54242413|FG001|Treatment Period Part B (Weeks 24 to 52)|Death|0|||
27787868|NCT01710358|54242414|FG002|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
27787869|NCT01710358|54242412|FG000|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
27787870|NCT01710358|54242413|FG001|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
27787871|NCT01710358|54242414|FG002|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1|||
27787872|NCT01710358|54242412|FG000|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
27787873|NCT01710358|54242413|FG001|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
27787874|NCT01710358|54242414|FG002|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1|||
27787875|NCT01710358|54242412|FG000|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
27842028|NCT01451437|54329805|FG007|Overall Study|Withdrawal by Subject|0|||
27842029|NCT01451437|54329806|FG008|Overall Study|Withdrawal by Subject|0|||
27787876|NCT01710358|54242413|FG001|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1|||
27787877|NCT01710358|54242414|FG002|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
27787878|NCT01710358|54242412|FG000|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1|||
27787879|NCT01710358|54242413|FG001|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2|||
27787880|NCT01710358|54242414|FG002|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0|||
27787881|NCT01710358|54242412|FG000|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4|||
27787882|NCT01710358|54242413|FG001|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3|||
27787883|NCT01710358|54242414|FG002|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7|||
27787884|NCT01710358|54242412|FG000|Rescue Period|Adverse Event|0|||
27787885|NCT01710358|54242413|FG001|Rescue Period|Adverse Event|15|||
27787886|NCT01710358|54242414|FG002|Rescue Period|Adverse Event|0|||
27787887|NCT01710358|54242412|FG000|Rescue Period|Death|0|||
27787888|NCT01710358|54242413|FG001|Rescue Period|Death|1|||
27787889|NCT01710358|54242414|FG002|Rescue Period|Death|0|||
27787890|NCT01710358|54242412|FG000|Rescue Period|Lack of Efficacy|0|||
27787891|NCT01710358|54242413|FG001|Rescue Period|Lack of Efficacy|7|||
27787892|NCT01710358|54242414|FG002|Rescue Period|Lack of Efficacy|0|||
27931373|NCT01233258|54587697|FG001|First Intervention (6 Months)|Protocol Violation|0|||
27931374|NCT01233258|54587698|FG002|First Intervention (6 Months)|Protocol Violation|1|||
27931375|NCT01233258|54587699|FG003|First Intervention (6 Months)|Protocol Violation|0|||
27931376|NCT01233258|54587700|FG004|First Intervention (6 Months)|Protocol Violation|0|||
27931377|NCT01233258|54587701|FG005|First Intervention (6 Months)|Protocol Violation|0|||
27931378|NCT01233258|54587696|FG000|First Intervention (6 Months)|Non-compliance with study medication|1|||
27931379|NCT01233258|54587697|FG001|First Intervention (6 Months)|Non-compliance with study medication|0|||
27931380|NCT01233258|54587698|FG002|First Intervention (6 Months)|Non-compliance with study medication|0|||
27931381|NCT01233258|54587699|FG003|First Intervention (6 Months)|Non-compliance with study medication|0|||
27931382|NCT01233258|54587700|FG004|First Intervention (6 Months)|Non-compliance with study medication|0|||
27931383|NCT01233258|54587701|FG005|First Intervention (6 Months)|Non-compliance with study medication|0|||
27931384|NCT01232868|54587718|FG000|Overall Study|Lost to Follow-up|2|||
27931385|NCT01232868|54587719|FG001|Overall Study|Lost to Follow-up|4|||
27931386|NCT01232790|54587725|FG000|Randomization|Withdrawal by Subject|2|||
27931387|NCT01232790|54587726|FG001|Randomization|Withdrawal by Subject|0|||
27931388|NCT01232790|54587725|FG000|Randomization|Protocol Violation|0|||
27931389|NCT01232790|54587726|FG001|Randomization|Protocol Violation|1|||
27931390|NCT01232790|54587725|FG000|Randomization|Physician Decision|0|||
27931391|NCT01232790|54587726|FG001|Randomization|Physician Decision|1|||
27931392|NCT01232790|54587725|FG000|Initial Assessment|Withdrawal by Subject|0|||
27931393|NCT01232790|54587726|FG001|Initial Assessment|Withdrawal by Subject|1|||
27842030|NCT01451203|54329837|FG000|Double-blind Treatment Period|Did not receive treatment|1|||
27842031|NCT01451203|54329838|FG001|Double-blind Treatment Period|Did not receive treatment|2|||
27842032|NCT01451203|54329837|FG000|Double-blind Treatment Period|Consent Withdrawn|3|||
27842033|NCT01451203|54329838|FG001|Double-blind Treatment Period|Consent Withdrawn|2|||
27842034|NCT01451203|54329837|FG000|Double-blind Treatment Period|Lack of Efficacy|71|||
27842035|NCT01451203|54329838|FG001|Double-blind Treatment Period|Lack of Efficacy|36|||
27842036|NCT01451203|54329837|FG000|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0|||
27842037|NCT01451203|54329838|FG001|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1|||
27842038|NCT01451203|54329837|FG000|Double-blind Treatment Period|Adverse Event|6|||
27842039|NCT01451203|54329838|FG001|Double-blind Treatment Period|Adverse Event|9|||
27842040|NCT01451203|54329837|FG000|Double-blind Treatment Period|Missing study medication ≥6 times|1|||
27931394|NCT01232790|54587725|FG000|First Crossover|Withdrawal by Subject|1|||
27931395|NCT01232790|54587726|FG001|First Crossover|Withdrawal by Subject|0|||
27931396|NCT01232790|54587725|FG000|Second Crossover|Withdrawal by Subject|1|||
27931397|NCT01232790|54587726|FG001|Second Crossover|Withdrawal by Subject|2|||
27931398|NCT01232556|54587744|FG000|Overall Study|Withdrawal by Subject|21|||
27931399|NCT01232556|54587745|FG001|Overall Study|Withdrawal by Subject|17|||
27931400|NCT01232556|54587744|FG000|Overall Study|Death|97|||
27931401|NCT01232556|54587745|FG001|Overall Study|Death|97|||
27931402|NCT01232556|54587744|FG000|Overall Study|Lost to Follow-up|0|||
27931403|NCT01232556|54587745|FG001|Overall Study|Lost to Follow-up|2|||
27931404|NCT01232556|54587744|FG000|Overall Study|Terminated by Sponsor|35|||
27931405|NCT01232556|54587745|FG001|Overall Study|Terminated by Sponsor|51|||
27931406|NCT01232556|54587744|FG000|Overall Study|Other|6|||
27931407|NCT01232556|54587745|FG001|Overall Study|Other|4|||
27787893|NCT01710358|54242412|FG000|Rescue Period|Withdrawal by Subject|0|||
27931408|NCT00946153|54587756|FG000|Phase 2|Adverse Event|0|||
27931409|NCT00946153|54587757|FG001|Phase 2|Adverse Event|0|||
27931410|NCT00946153|54587758|FG002|Phase 2|Adverse Event|0|||
27931411|NCT00946153|54587759|FG003|Phase 2|Adverse Event|0|||
27931412|NCT00946153|54587760|FG004|Phase 2|Adverse Event|6|||
27931413|NCT00946153|54587756|FG000|Phase 2|Need more reduction of dose|0|||
27787894|NCT01710358|54242413|FG001|Rescue Period|Withdrawal by Subject|8|||
27787895|NCT01710358|54242414|FG002|Rescue Period|Withdrawal by Subject|0|||
27787896|NCT01633112|54242438|FG000|Overall Study|Lack of Efficacy|1|||
27931414|NCT00946153|54587757|FG001|Phase 2|Need more reduction of dose|0|||
27931415|NCT00946153|54587758|FG002|Phase 2|Need more reduction of dose|0|||
27931416|NCT00946153|54587759|FG003|Phase 2|Need more reduction of dose|0|||
27787897|NCT01633112|54242439|FG001|Overall Study|Lack of Efficacy|6|||
27787898|NCT01633112|54242440|FG002|Overall Study|Lack of Efficacy|13|||
27787899|NCT01633112|54242438|FG000|Overall Study|Abnormal laboratory value(s)|3|||
27787900|NCT01633112|54242439|FG001|Overall Study|Abnormal laboratory value(s)|1|||
27787901|NCT01633112|54242440|FG002|Overall Study|Abnormal laboratory value(s)|0|||
27787902|NCT01633112|54242438|FG000|Overall Study|Abnormal test procedure result(s)|0|||
27787903|NCT01633112|54242439|FG001|Overall Study|Abnormal test procedure result(s)|1|||
27842041|NCT01451203|54329838|FG001|Double-blind Treatment Period|Missing study medication ≥6 times|0|||
27842042|NCT01451203|54329837|FG000|Double-blind Treatment Period|Violation of eligibility criteria|1|||
27842043|NCT01451203|54329838|FG001|Double-blind Treatment Period|Violation of eligibility criteria|0|||
27842044|NCT01451203|54329837|FG000|Double-blind Treatment Period|Investigator decision|2|||
27842045|NCT01451203|54329838|FG001|Double-blind Treatment Period|Investigator decision|0|||
27842046|NCT01451203|54329837|FG000|Post-treatment Period|Consent withdrawn|2|||
27842047|NCT01451203|54329838|FG001|Post-treatment Period|Consent withdrawn|4|||
27842048|NCT01451203|54329837|FG000|Post-treatment Period|Lack of Efficacy|12|||
27842049|NCT01451203|54329838|FG001|Post-treatment Period|Lack of Efficacy|28|||
27842050|NCT01451203|54329837|FG000|Post-treatment Period|Adverse Event|0|||
27842051|NCT01451203|54329838|FG001|Post-treatment Period|Adverse Event|1|||
27842052|NCT01451203|54329837|FG000|Post-treatment Period|Investigator decision|0|||
27842053|NCT01451203|54329838|FG001|Post-treatment Period|Investigator decision|1|||
27842054|NCT01556438|54329846|FG000|Overall Study|Adverse Event|4|||
27842055|NCT01556438|54329847|FG001|Overall Study|Adverse Event|2|||
27842056|NCT01556438|54329846|FG000|Overall Study|Sponsor Decision|0|||
27842057|NCT01556438|54329847|FG001|Overall Study|Sponsor Decision|2|||
27842058|NCT01556438|54329846|FG000|Overall Study|Progressive Disease|0|||
27842059|NCT01556438|54329847|FG001|Overall Study|Progressive Disease|6|||
27842060|NCT01556438|54329846|FG000|Overall Study|Death|0|||
27842061|NCT01556438|54329847|FG001|Overall Study|Death|1|||
27842062|NCT01554176|54329873|FG000|Treatment Phase|Protocol Violation|1|||
27842063|NCT01554176|54329874|FG001|Treatment Phase|Protocol Violation|2|||
27842064|NCT01554176|54329875|FG002|Treatment Phase|Protocol Violation|0|||
27842065|NCT01554176|54329876|FG003|Treatment Phase|Protocol Violation|0|||
27842066|NCT01554176|54329877|FG004|Treatment Phase|Protocol Violation|0|||
27842067|NCT01554176|54329873|FG000|Treatment Phase|Physician Decision|1|||
27842068|NCT01554176|54329874|FG001|Treatment Phase|Physician Decision|1|||
27842069|NCT01554176|54329875|FG002|Treatment Phase|Physician Decision|0|||
27842070|NCT01554176|54329876|FG003|Treatment Phase|Physician Decision|0|||
27842071|NCT01554176|54329877|FG004|Treatment Phase|Physician Decision|0|||
27842072|NCT01554176|54329873|FG000|Treatment Phase|Lack of Efficacy|0|||
27842073|NCT01554176|54329874|FG001|Treatment Phase|Lack of Efficacy|1|||
27842074|NCT01554176|54329875|FG002|Treatment Phase|Lack of Efficacy|0|||
27842075|NCT01554176|54329876|FG003|Treatment Phase|Lack of Efficacy|0|||
27842076|NCT01554176|54329877|FG004|Treatment Phase|Lack of Efficacy|0|||
27842077|NCT01554176|54329873|FG000|Treatment Phase|Adverse event, non-fatal|1|||
27842078|NCT01554176|54329874|FG001|Treatment Phase|Adverse event, non-fatal|1|||
27842079|NCT01554176|54329875|FG002|Treatment Phase|Adverse event, non-fatal|0|||
27842080|NCT01554176|54329876|FG003|Treatment Phase|Adverse event, non-fatal|0|||
27842081|NCT01554176|54329877|FG004|Treatment Phase|Adverse event, non-fatal|0|||
27842082|NCT01554176|54329873|FG000|Treatment Phase|Non-compliance with study drug|1|||
27842083|NCT01554176|54329874|FG001|Treatment Phase|Non-compliance with study drug|0|||
27842084|NCT01554176|54329875|FG002|Treatment Phase|Non-compliance with study drug|0|||
27842085|NCT01554176|54329876|FG003|Treatment Phase|Non-compliance with study drug|0|||
27842086|NCT01554176|54329877|FG004|Treatment Phase|Non-compliance with study drug|0|||
27842087|NCT01554176|54329873|FG000|Treatment Phase|Withdrawal by Subject|1|||
27842088|NCT01554176|54329874|FG001|Treatment Phase|Withdrawal by Subject|0|||
27842089|NCT01554176|54329875|FG002|Treatment Phase|Withdrawal by Subject|0|||
27842090|NCT01554176|54329876|FG003|Treatment Phase|Withdrawal by Subject|0|||
27842091|NCT01554176|54329877|FG004|Treatment Phase|Withdrawal by Subject|0|||
27842092|NCT01554176|54329873|FG000|Treatment Phase|Lost to Follow-up|3|||
27842093|NCT01554176|54329874|FG001|Treatment Phase|Lost to Follow-up|0|||
27842094|NCT01554176|54329875|FG002|Treatment Phase|Lost to Follow-up|0|||
27842095|NCT01554176|54329876|FG003|Treatment Phase|Lost to Follow-up|0|||
27842096|NCT01554176|54329877|FG004|Treatment Phase|Lost to Follow-up|0|||
27842097|NCT01554176|54329873|FG000|Run-out Phase|Protocol Violation|0|||
27842098|NCT01554176|54329874|FG001|Run-out Phase|Protocol Violation|0|||
27842099|NCT01554176|54329875|FG002|Run-out Phase|Protocol Violation|0|||
27842100|NCT01554176|54329876|FG003|Run-out Phase|Protocol Violation|1|||
27842101|NCT01554176|54329877|FG004|Run-out Phase|Protocol Violation|0|||
27842102|NCT01466491|54329893|FG000|Overall Study|Protocol Violation|0|||
27842103|NCT01466491|54329894|FG001|Overall Study|Protocol Violation|3|||
27787904|NCT01633112|54242440|FG002|Overall Study|Abnormal test procedure result(s)|0|||
27787905|NCT01633112|54242438|FG000|Overall Study|Administrative problems|1|||
27931417|NCT00946153|54587760|FG004|Phase 2|Need more reduction of dose|2|||
27931418|NCT00946153|54587756|FG000|Phase 2|Physician Decision|0|||
27842104|NCT01466491|54329895|FG002|Overall Study|Protocol Violation|2|||
27842105|NCT01466491|54329896|FG003|Overall Study|Protocol Violation|0|||
27842106|NCT01466491|54329893|FG000|Overall Study|Missing Data|0|||
27842107|NCT01466491|54329894|FG001|Overall Study|Missing Data|0|||
27842108|NCT01466491|54329895|FG002|Overall Study|Missing Data|1|||
27842109|NCT01466491|54329896|FG003|Overall Study|Missing Data|0|||
27842110|NCT01466179|54329906|FG000|Overall Study|Ongoing in core study|2|||
27842111|NCT01466179|54329906|FG000|Overall Study|Physician Decision|46|||
27842112|NCT01466179|54329906|FG000|Overall Study|Progressive disease|43|||
27842113|NCT01466179|54329906|FG000|Overall Study|Adverse Event|32|||
27842114|NCT01466179|54329906|FG000|Overall Study|Disease relapse|23|||
27842115|NCT01466179|54329906|FG000|Overall Study|Lack of Efficacy|14|||
27842116|NCT01466179|54329906|FG000|Overall Study|Death|7|||
27842117|NCT01466179|54329906|FG000|Overall Study|Withdrawal by Subject|7|||
27842118|NCT01466179|54329906|FG000|Overall Study|Protocol Violation|2|||
27842119|NCT01466179|54329906|FG000|Overall Study|Other|3|||
27842120|NCT01493089|54329915|FG000|Overall Study|Protocol Violation|2|||
27842121|NCT01493089|54329916|FG001|Overall Study|Protocol Violation|2|||
27842122|NCT01493089|54329915|FG000|Overall Study|Withdrawal by Subject|1|||
27842123|NCT01493089|54329916|FG001|Overall Study|Withdrawal by Subject|0|||
27842124|NCT01493089|54329915|FG000|Overall Study|Physician Decision|0|||
27842125|NCT01493089|54329916|FG001|Overall Study|Physician Decision|1|||
27842126|NCT01450813|54329928|FG000|Overall Study|Physician Decision|1|||
27931419|NCT00946153|54587757|FG001|Phase 2|Physician Decision|0|||
27931420|NCT00946153|54587758|FG002|Phase 2|Physician Decision|0|||
27931421|NCT00946153|54587759|FG003|Phase 2|Physician Decision|0|||
27787906|NCT01633112|54242439|FG001|Overall Study|Administrative problems|2|||
27787907|NCT01633112|54242440|FG002|Overall Study|Administrative problems|5|||
27787908|NCT01633112|54242438|FG000|Overall Study|Adverse Event|16|||
27787909|NCT01633112|54242439|FG001|Overall Study|Adverse Event|18|||
27787910|NCT01633112|54242440|FG002|Overall Study|Adverse Event|20|||
27787911|NCT01633112|54242438|FG000|Overall Study|Lost to Follow-up|7|||
27787912|NCT01633112|54242439|FG001|Overall Study|Lost to Follow-up|19|||
27787913|NCT01633112|54242440|FG002|Overall Study|Lost to Follow-up|6|||
27787914|NCT01633112|54242438|FG000|Overall Study|Protocol Violation|4|||
27787915|NCT01633112|54242439|FG001|Overall Study|Protocol Violation|0|||
27787916|NCT01633112|54242440|FG002|Overall Study|Protocol Violation|2|||
27787917|NCT01633112|54242438|FG000|Overall Study|Subject no longer requires study drug|0|||
27787918|NCT01633112|54242439|FG001|Overall Study|Subject no longer requires study drug|0|||
27787919|NCT01633112|54242440|FG002|Overall Study|Subject no longer requires study drug|1|||
27787920|NCT01633112|54242438|FG000|Overall Study|Withdrawal by Subject|20|||
27787921|NCT01633112|54242439|FG001|Overall Study|Withdrawal by Subject|12|||
27787922|NCT01633112|54242440|FG002|Overall Study|Withdrawal by Subject|41|||
27787923|NCT01633112|54242438|FG000|Overall Study|missing Study Completion CRF|1|||
27787924|NCT01633112|54242439|FG001|Overall Study|missing Study Completion CRF|1|||
27787925|NCT01633112|54242440|FG002|Overall Study|missing Study Completion CRF|4|||
27787926|NCT01691482|54242449|FG000|Treatment Period 2|Adverse Event|0|||
27787927|NCT01691482|54242450|FG001|Treatment Period 2|Adverse Event|1|||
27787928|NCT01691482|54242449|FG000|Treatment Period 2|Protocol Violation|1|||
27787929|NCT01691482|54242450|FG001|Treatment Period 2|Protocol Violation|1|||
27787930|NCT02246114|54242459|FG000|Overall Study|miscarriage|1|||
27787931|NCT02246114|54242460|FG001|Overall Study|miscarriage|0|||
27787932|NCT01710046|54242468|FG000|Overall Study|Lost to Follow-up|1|||
27787933|NCT01710046|54242469|FG001|Overall Study|Lost to Follow-up|0|||
27787934|NCT02154529|54242479|FG000|Overall Study|Death|1|||
27787935|NCT02154529|54242480|FG001|Overall Study|Death|1|||
27787936|NCT02154529|54242481|FG002|Overall Study|Death|5|||
27787937|NCT02154529|54242482|FG003|Overall Study|Death|1|||
27787938|NCT02154529|54242479|FG000|Overall Study|Termination of study by sponsor|2|||
27787939|NCT02154529|54242480|FG001|Overall Study|Termination of study by sponsor|2|||
27787940|NCT02154529|54242481|FG002|Overall Study|Termination of study by sponsor|3|||
27787941|NCT02154529|54242482|FG003|Overall Study|Termination of study by sponsor|1|||
27787942|NCT02154529|54242479|FG000|Overall Study|Lost to Follow-up|1|||
27787943|NCT02154529|54242480|FG001|Overall Study|Lost to Follow-up|0|||
27787944|NCT02154529|54242481|FG002|Overall Study|Lost to Follow-up|0|||
27787945|NCT02154529|54242482|FG003|Overall Study|Lost to Follow-up|0|||
27787946|NCT01954017|54242497|FG000|Overall Study|Adverse Event|0|||
27842127|NCT01450813|54329929|FG001|Overall Study|Physician Decision|1|||
27842128|NCT01450813|54329930|FG002|Overall Study|Physician Decision|0|||
27787947|NCT01954017|54242498|FG001|Overall Study|Adverse Event|0|||
27787948|NCT01954017|54242499|FG002|Overall Study|Adverse Event|1|||
27787949|NCT01954017|54242497|FG000|Overall Study|Death|2|||
27842129|NCT01450813|54329931|FG003|Overall Study|Physician Decision|3|||
27787950|NCT01954017|54242498|FG001|Overall Study|Death|1|||
27787951|NCT01954017|54242499|FG002|Overall Study|Death|1|||
27787952|NCT01954017|54242497|FG000|Overall Study|Withdrawal by Subject|0|||
27842130|NCT01539512|54329945|FG000|Overall Study|Adverse Event|9|||
27931422|NCT00946153|54587760|FG004|Phase 2|Physician Decision|1|||
27931423|NCT00946153|54587756|FG000|Phase 2|14 days washout for recovery due to AE|0|||
27931424|NCT00946153|54587757|FG001|Phase 2|14 days washout for recovery due to AE|0|||
27931425|NCT00946153|54587758|FG002|Phase 2|14 days washout for recovery due to AE|0|||
27931426|NCT00946153|54587759|FG003|Phase 2|14 days washout for recovery due to AE|0|||
27931427|NCT00946153|54587760|FG004|Phase 2|14 days washout for recovery due to AE|4|||
27931428|NCT01160289|54587782|FG000|Screening, Washout, and Lead-In Period|Adverse Event|8|||
27931429|NCT01160289|54587783|FG001|Screening, Washout, and Lead-In Period|Adverse Event|0|||
27931430|NCT01160289|54587784|FG002|Screening, Washout, and Lead-In Period|Adverse Event|0|||
27787953|NCT01954017|54242498|FG001|Overall Study|Withdrawal by Subject|1|||
27787954|NCT01954017|54242499|FG002|Overall Study|Withdrawal by Subject|0|||
27787955|NCT01954017|54242497|FG000|Overall Study|Protocol Violation|0|||
27787956|NCT01954017|54242498|FG001|Overall Study|Protocol Violation|3|||
27787957|NCT01954017|54242499|FG002|Overall Study|Protocol Violation|2|||
27787958|NCT01954017|54242497|FG000|Overall Study|Necrotizing enterocolitis|1|||
27787959|NCT01954017|54242498|FG001|Overall Study|Necrotizing enterocolitis|0|||
27787960|NCT01954017|54242499|FG002|Overall Study|Necrotizing enterocolitis|1|||
27787961|NCT01954017|54242497|FG000|Overall Study|Enteral intake stopped >7 days|0|||
27787962|NCT01954017|54242498|FG001|Overall Study|Enteral intake stopped >7 days|1|||
27787963|NCT01954017|54242499|FG002|Overall Study|Enteral intake stopped >7 days|1|||
27787964|NCT01954017|54242497|FG000|Overall Study|All other reasons|2|||
27787965|NCT01954017|54242498|FG001|Overall Study|All other reasons|2|||
27787966|NCT01954017|54242499|FG002|Overall Study|All other reasons|7|||
27787967|NCT02154139|54242533|FG000|Overall Study|Injection not administered|2|||
27787968|NCT02154139|54242533|FG000|Overall Study|Other|2|||
27787969|NCT02154139|54242533|FG000|Overall Study|Investigator transferred|3|||
27787970|NCT02245568|54242537|FG000|Overall Study|Study terminated by Sponsor|346|||
27787971|NCT02245568|54242537|FG000|Overall Study|Adverse Event|144|||
27787972|NCT02245568|54242537|FG000|Overall Study|Lack of Efficacy|98|||
27787973|NCT02245568|54242537|FG000|Overall Study|Withdrawal by Caregiver|85|||
27787974|NCT02245568|54242537|FG000|Overall Study|Withdrawal by Subject|77|||
27787975|NCT02245568|54242537|FG000|Overall Study|Withdrawal by Legal Representative|31|||
27787976|NCT02245568|54242537|FG000|Overall Study|Missing (Site closure)|16|||
27787977|NCT02245568|54242537|FG000|Overall Study|Physician Decision|14|||
27787978|NCT02245568|54242537|FG000|Overall Study|Non-compliance with study drug|11|||
27787979|NCT02245568|54242537|FG000|Overall Study|Death|9|||
27787980|NCT02245568|54242537|FG000|Overall Study|Blue staining|6|||
27787981|NCT02245568|54242537|FG000|Overall Study|Worsening dementia/caregiver withdrawal|6|||
27787982|NCT02245568|54242537|FG000|Overall Study|Intolerance/dosing issues/interruption|5|||
27787983|NCT02245568|54242537|FG000|Overall Study|Lost to Follow-up|5|||
27787984|NCT02154061|54242543|FG000|Overall Study|Pregnancy|1|||
27787985|NCT02154061|54242544|FG001|Overall Study|Pregnancy|0|||
27787986|NCT02154061|54242543|FG000|Overall Study|enrolled but not vaccinated|1|||
27787987|NCT02154061|54242544|FG001|Overall Study|enrolled but not vaccinated|0|||
27787988|NCT01907217|54242552|FG000|Overall Study|Withdrawal by Subject|0|||
27787989|NCT01907217|54242553|FG001|Overall Study|Withdrawal by Subject|2|||
27787990|NCT01953783|54242561|FG000|Overall Study|Progressive disease|2|||
27787991|NCT02134015|54242567|FG000|Overall Study|Protocol Violation|0|||
27787992|NCT02134015|54242568|FG001|Overall Study|Protocol Violation|1|||
27787993|NCT02134015|54242567|FG000|Overall Study|Death|2|||
27787994|NCT02134015|54242568|FG001|Overall Study|Death|1|||
27787995|NCT02134015|54242567|FG000|Overall Study|Reason not provided|1|||
27787996|NCT02134015|54242568|FG001|Overall Study|Reason not provided|2|||
27787997|NCT02134015|54242567|FG000|Overall Study|Clinical progression|14|||
27787998|NCT02134015|54242568|FG001|Overall Study|Clinical progression|7|||
27787999|NCT02134015|54242567|FG000|Overall Study|Progressive disease (per RECIST 1.1)|40|||
27842131|NCT01539512|54329946|FG001|Overall Study|Adverse Event|7|||
27842132|NCT01539512|54329945|FG000|Overall Study|Physician Decision|1|||
27842133|NCT01539512|54329946|FG001|Overall Study|Physician Decision|1|||
27842134|NCT01539512|54329945|FG000|Overall Study|Withdrawal by Subject|12|||
27842135|NCT01539512|54329946|FG001|Overall Study|Withdrawal by Subject|5|||
27842136|NCT01539512|54329945|FG000|Overall Study|Richter's Transformation|1|||
27842137|NCT01539512|54329946|FG001|Overall Study|Richter's Transformation|0|||
27842138|NCT01449955|54329954|FG000|Overall Study|Withdrawal by Subject|1|||
27842139|NCT01449955|54329955|FG001|Overall Study|Withdrawal by Subject|2|||
27842140|NCT01574612|54329968|FG000|Overall Study|Adverse Event|3|||
27842141|NCT01574612|54329968|FG000|Overall Study|non compliant with drug|2|||
27842142|NCT01574612|54329968|FG000|Overall Study|Withdrawal by Subject|1|||
27842143|NCT01574612|54329968|FG000|Overall Study|Lost to Follow-up|2|||
27842144|NCT01573910|54329974|FG000|Overall Study|Adverse Event|4|||
27842145|NCT01573910|54329975|FG001|Overall Study|Adverse Event|4|||
27842146|NCT01573910|54329974|FG000|Overall Study|Lost to Follow-up|2|||
27842147|NCT01573910|54329975|FG001|Overall Study|Lost to Follow-up|1|||
27842148|NCT01573910|54329974|FG000|Overall Study|Withdrawal by Subject|0|||
27842149|NCT01573910|54329975|FG001|Overall Study|Withdrawal by Subject|1|||
27842150|NCT01573910|54329974|FG000|Overall Study|Protocol Violation|3|||
27788000|NCT02134015|54242568|FG001|Overall Study|Progressive disease (per RECIST 1.1)|43|||
27788001|NCT02134015|54242567|FG000|Overall Study|Study terminated by sponsor|2|||
27788002|NCT02134015|54242568|FG001|Overall Study|Study terminated by sponsor|3|||
27788003|NCT02134015|54242567|FG000|Overall Study|Adverse Event|9|||
27788004|NCT02134015|54242568|FG001|Overall Study|Adverse Event|10|||
27788005|NCT02134015|54242567|FG000|Overall Study|Withdrawal by Subject|3|||
27788006|NCT02134015|54242568|FG001|Overall Study|Withdrawal by Subject|7|||
27788007|NCT01924845|54242574|FG000|Overall Study|Adverse Event|3|||
27788008|NCT01924845|54242574|FG000|Overall Study|Withdrawal by Subject|2|||
27788009|NCT01924845|54242574|FG000|Overall Study|Protocol Violation|1|||
27788010|NCT01630135|54242580|FG000|Overall Study|Protocol-defined Stopping Criteria Met|0|||
27788011|NCT01630135|54242581|FG001|Overall Study|Protocol-defined Stopping Criteria Met|2|||
27931431|NCT01160289|54587785|FG003|Screening, Washout, and Lead-In Period|Adverse Event|0|||
27931432|NCT01160289|54587786|FG004|Screening, Washout, and Lead-In Period|Adverse Event|0|||
27931433|NCT01160289|54587787|FG005|Screening, Washout, and Lead-In Period|Adverse Event|0|||
27931434|NCT01160289|54587782|FG000|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308|||
27931435|NCT01160289|54587783|FG001|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
27931436|NCT01160289|54587784|FG002|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
27931437|NCT01160289|54587785|FG003|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
27931438|NCT01160289|54587786|FG004|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
27931439|NCT01160289|54587787|FG005|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
27931440|NCT01160289|54587782|FG000|Screening, Washout, and Lead-In Period|Lack of Efficacy|1|||
27931441|NCT01160289|54587783|FG001|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
27931442|NCT01160289|54587784|FG002|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
27931443|NCT01160289|54587785|FG003|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
27931444|NCT01160289|54587786|FG004|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
27931445|NCT01160289|54587787|FG005|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
27931446|NCT01160289|54587782|FG000|Screening, Washout, and Lead-In Period|Lost to Follow-up|9|||
27931447|NCT01160289|54587783|FG001|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
27931448|NCT01160289|54587784|FG002|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
27931449|NCT01160289|54587785|FG003|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
27931450|NCT01160289|54587786|FG004|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
27931451|NCT01160289|54587787|FG005|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
27931452|NCT01160289|54587782|FG000|Screening, Washout, and Lead-In Period|Physician Decision|26|||
27931453|NCT01160289|54587783|FG001|Screening, Washout, and Lead-In Period|Physician Decision|0|||
27931454|NCT01160289|54587784|FG002|Screening, Washout, and Lead-In Period|Physician Decision|0|||
27931455|NCT01160289|54587785|FG003|Screening, Washout, and Lead-In Period|Physician Decision|0|||
27931456|NCT01160289|54587786|FG004|Screening, Washout, and Lead-In Period|Physician Decision|0|||
27931457|NCT01160289|54587787|FG005|Screening, Washout, and Lead-In Period|Physician Decision|0|||
27931458|NCT01160289|54587782|FG000|Screening, Washout, and Lead-In Period|Protocol Violation|1|||
27931459|NCT01160289|54587783|FG001|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
27931460|NCT01160289|54587784|FG002|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
27931461|NCT01160289|54587785|FG003|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
27931462|NCT01160289|54587786|FG004|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
27931463|NCT01160289|54587787|FG005|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
27931464|NCT01160289|54587782|FG000|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67|||
27931465|NCT01160289|54587783|FG001|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
27931466|NCT01160289|54587784|FG002|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
27931467|NCT01160289|54587785|FG003|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
27931468|NCT01160289|54587786|FG004|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
27931469|NCT01160289|54587787|FG005|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
27931470|NCT01160289|54587782|FG000|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64|||
27931471|NCT01160289|54587783|FG001|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
27931472|NCT01160289|54587784|FG002|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
27931473|NCT01160289|54587785|FG003|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
27931474|NCT01160289|54587786|FG004|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
27931475|NCT01160289|54587787|FG005|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
27931476|NCT01160289|54587782|FG000|Post-Randomization Period|Adverse Event|0|||
27931477|NCT01160289|54587783|FG001|Post-Randomization Period|Adverse Event|4|||
27931478|NCT01160289|54587784|FG002|Post-Randomization Period|Adverse Event|4|||
27931479|NCT01160289|54587785|FG003|Post-Randomization Period|Adverse Event|2|||
27931480|NCT01160289|54587786|FG004|Post-Randomization Period|Adverse Event|0|||
27931481|NCT01160289|54587787|FG005|Post-Randomization Period|Adverse Event|0|||
27931482|NCT01160289|54587782|FG000|Post-Randomization Period|Death|0|||
27788012|NCT01691248|54242589|FG000|Overall Study|Protocol Violation|43|||
27788013|NCT01691248|54242590|FG001|Overall Study|Protocol Violation|27|||
27788014|NCT01691248|54242589|FG000|Overall Study|Adverse Event|24|||
27931483|NCT01160289|54587783|FG001|Post-Randomization Period|Death|0|||
27931484|NCT01160289|54587784|FG002|Post-Randomization Period|Death|0|||
27931485|NCT01160289|54587785|FG003|Post-Randomization Period|Death|1|||
27931486|NCT01160289|54587786|FG004|Post-Randomization Period|Death|0|||
27931487|NCT01160289|54587787|FG005|Post-Randomization Period|Death|0|||
27931488|NCT01160289|54587782|FG000|Post-Randomization Period|Lack of Efficacy|0|||
27931489|NCT01160289|54587783|FG001|Post-Randomization Period|Lack of Efficacy|1|||
27931490|NCT01160289|54587784|FG002|Post-Randomization Period|Lack of Efficacy|0|||
27931491|NCT01160289|54587785|FG003|Post-Randomization Period|Lack of Efficacy|3|||
27931492|NCT01160289|54587786|FG004|Post-Randomization Period|Lack of Efficacy|0|||
27931493|NCT01160289|54587787|FG005|Post-Randomization Period|Lack of Efficacy|0|||
27931494|NCT01160289|54587782|FG000|Post-Randomization Period|Lost to Follow-up|0|||
27931495|NCT01160289|54587783|FG001|Post-Randomization Period|Lost to Follow-up|3|||
27931496|NCT01160289|54587784|FG002|Post-Randomization Period|Lost to Follow-up|2|||
27931497|NCT01160289|54587785|FG003|Post-Randomization Period|Lost to Follow-up|5|||
27931498|NCT01160289|54587786|FG004|Post-Randomization Period|Lost to Follow-up|3|||
27931499|NCT01160289|54587787|FG005|Post-Randomization Period|Lost to Follow-up|4|||
27931500|NCT01160289|54587782|FG000|Post-Randomization Period|Physician Decision|0|||
27931501|NCT01160289|54587783|FG001|Post-Randomization Period|Physician Decision|0|||
27842151|NCT01573910|54329975|FG001|Overall Study|Protocol Violation|0|||
27842152|NCT01573910|54329974|FG000|Overall Study|Patient decision unrelated to Advs Event|11|||
27842153|NCT01573910|54329975|FG001|Overall Study|Patient decision unrelated to Advs Event|11|||
27842154|NCT01491919|54329984|FG000|Overall Study|Insufficient PK sampling|1|||
27842155|NCT01491919|54329985|FG001|Overall Study|Insufficient PK sampling|2|||
27842156|NCT01491919|54329986|FG002|Overall Study|Insufficient PK sampling|1|||
27842157|NCT01573442|54329998|FG000|Overall Study|Cancels|9|||
27842158|NCT01573442|54329999|FG001|Overall Study|Cancels|10|||
27842159|NCT01491841|54330068|FG000|Overall Study|Screen Failure|10|||
27842160|NCT01491841|54330068|FG000|Overall Study|Withdrawal by Subject|1|||
27842161|NCT01553318|54330087|FG000|Overall Study|Protocol Violation|3|||
27931502|NCT01160289|54587784|FG002|Post-Randomization Period|Physician Decision|1|||
27931503|NCT01160289|54587785|FG003|Post-Randomization Period|Physician Decision|0|||
27931504|NCT01160289|54587786|FG004|Post-Randomization Period|Physician Decision|0|||
27931505|NCT01160289|54587787|FG005|Post-Randomization Period|Physician Decision|0|||
27931506|NCT01160289|54587782|FG000|Post-Randomization Period|Protocol Violation|0|||
27931507|NCT01160289|54587783|FG001|Post-Randomization Period|Protocol Violation|4|||
27931508|NCT01160289|54587784|FG002|Post-Randomization Period|Protocol Violation|2|||
27842162|NCT01553318|54330088|FG001|Overall Study|Protocol Violation|2|||
27842163|NCT01572740|54330107|FG000|Overall Study|Adverse Event|1|||
27842164|NCT01572740|54330108|FG001|Overall Study|Adverse Event|1|||
27842165|NCT01572740|54330107|FG000|Overall Study|Withdrawal by Subject|1|||
27842166|NCT01572740|54330108|FG001|Overall Study|Withdrawal by Subject|1|||
27842167|NCT01572740|54330107|FG000|Overall Study|unclassified|4|||
27842168|NCT01572740|54330108|FG001|Overall Study|unclassified|3|||
27842169|NCT01491607|54330118|FG000|Overall Study|Lost to Follow-up|7|||
27842170|NCT01491607|54330118|FG000|Overall Study|Withdrawal by Subject|3|||
27842171|NCT01449721|54330201|FG000|Overall Study|Physician Decision|0|||
27842172|NCT01449721|54330202|FG001|Overall Study|Physician Decision|1|||
27842173|NCT01449721|54330201|FG000|Overall Study|Physician Decision|0|||
27842174|NCT01449721|54330202|FG001|Overall Study|Physician Decision|1|||
27842175|NCT01553084|54330211|FG000|Overall Study|Withdrawal by Subject|15|||
27842176|NCT01553084|54330212|FG001|Overall Study|Withdrawal by Subject|13|||
27842177|NCT01553084|54330213|FG002|Overall Study|Withdrawal by Subject|35|||
27842178|NCT01536860|54330223|FG000|Washout Period (3 Days)|Lost to Follow-up|1|||
27842179|NCT01536860|54330224|FG001|Washout Period (3 Days)|Lost to Follow-up|0|||
27842180|NCT01536860|54330225|FG002|Washout Period (3 Days)|Lost to Follow-up|0|||
27842181|NCT01552928|54330237|FG000|Period 3|Adverse Event|0|||
27842182|NCT01552928|54330238|FG001|Period 3|Adverse Event|0|||
27842183|NCT01552928|54330239|FG002|Period 3|Adverse Event|1|||
27842184|NCT01552928|54330240|FG003|Period 3|Adverse Event|0|||
27842185|NCT01448707|54330259|FG000|Overall Study|Adverse Event|3|||
27842186|NCT01448707|54330260|FG001|Overall Study|Adverse Event|1|||
27842187|NCT01448707|54330259|FG000|Overall Study|Lost to Follow-up|2|||
27842188|NCT01448707|54330260|FG001|Overall Study|Lost to Follow-up|6|||
27842189|NCT01448707|54330259|FG000|Overall Study|Withdrawal by Subject|6|||
27842190|NCT01448707|54330260|FG001|Overall Study|Withdrawal by Subject|7|||
27842191|NCT01448707|54330259|FG000|Overall Study|Other|7|||
27842192|NCT01448707|54330260|FG001|Overall Study|Other|4|||
27842193|NCT01536704|54330266|FG000|Washout Period 1|Withdrawal by Subject|1|||
27931509|NCT01160289|54587785|FG003|Post-Randomization Period|Protocol Violation|0|||
27931510|NCT01160289|54587786|FG004|Post-Randomization Period|Protocol Violation|1|||
27931511|NCT01160289|54587787|FG005|Post-Randomization Period|Protocol Violation|3|||
27931512|NCT01160289|54587782|FG000|Post-Randomization Period|Withdrawal by Subject|0|||
27842194|NCT01536704|54330267|FG001|Washout Period 1|Withdrawal by Subject|2|||
27842195|NCT01536704|54330268|FG002|Washout Period 1|Withdrawal by Subject|0|||
27842196|NCT01536704|54330269|FG003|Washout Period 1|Withdrawal by Subject|0|||
27931513|NCT01160289|54587783|FG001|Post-Randomization Period|Withdrawal by Subject|5|||
27931514|NCT01160289|54587784|FG002|Post-Randomization Period|Withdrawal by Subject|13|||
27931515|NCT01160289|54587785|FG003|Post-Randomization Period|Withdrawal by Subject|8|||
27931516|NCT01160289|54587786|FG004|Post-Randomization Period|Withdrawal by Subject|5|||
27931517|NCT01160289|54587787|FG005|Post-Randomization Period|Withdrawal by Subject|7|||
27931518|NCT01160289|54587782|FG000|Post-Randomization Period|Entry Criteria Not Met|0|||
27931519|NCT01160289|54587783|FG001|Post-Randomization Period|Entry Criteria Not Met|2|||
27931520|NCT01160289|54587784|FG002|Post-Randomization Period|Entry Criteria Not Met|2|||
27931521|NCT01160289|54587785|FG003|Post-Randomization Period|Entry Criteria Not Met|2|||
27931522|NCT01160289|54587786|FG004|Post-Randomization Period|Entry Criteria Not Met|0|||
27931523|NCT01160289|54587787|FG005|Post-Randomization Period|Entry Criteria Not Met|0|||
27931524|NCT01160289|54587782|FG000|Post-Randomization Period|Sponsor Decision|0|||
27931525|NCT01160289|54587783|FG001|Post-Randomization Period|Sponsor Decision|1|||
27931526|NCT01160289|54587784|FG002|Post-Randomization Period|Sponsor Decision|0|||
27931527|NCT01160289|54587785|FG003|Post-Randomization Period|Sponsor Decision|0|||
27931528|NCT01160289|54587786|FG004|Post-Randomization Period|Sponsor Decision|0|||
27931529|NCT01160289|54587787|FG005|Post-Randomization Period|Sponsor Decision|0|||
27788015|NCT01691248|54242590|FG001|Overall Study|Adverse Event|22|||
27931530|NCT01159665|54587806|FG000|Overall Study|Withdrawal by Subject|0|||
27931531|NCT01159665|54587807|FG001|Overall Study|Withdrawal by Subject|1|||
27931532|NCT01159665|54587808|FG002|Overall Study|Withdrawal by Subject|0|||
27931533|NCT01159665|54587809|FG003|Overall Study|Withdrawal by Subject|0|||
27788016|NCT01691248|54242589|FG000|Overall Study|Withdrawal by Subject|20|||
27788017|NCT01691248|54242590|FG001|Overall Study|Withdrawal by Subject|18|||
27788018|NCT01691248|54242589|FG000|Overall Study|Confirmed CDAD|14|||
27788019|NCT01691248|54242590|FG001|Overall Study|Confirmed CDAD|31|||
27788020|NCT01691248|54242589|FG000|Overall Study|Lost to Follow-up|2|||
27788021|NCT01691248|54242590|FG001|Overall Study|Lost to Follow-up|5|||
27788022|NCT01691248|54242589|FG000|Overall Study|Reason not provided|4|||
27788023|NCT01691248|54242590|FG001|Overall Study|Reason not provided|4|||
27788024|NCT01691248|54242589|FG000|Overall Study|Not Treated|4|||
27788025|NCT01691248|54242590|FG001|Overall Study|Not Treated|7|||
27788026|NCT01924767|54242601|FG000|Overall Study|Adverse Event|1|||
27788027|NCT01924767|54242602|FG001|Overall Study|Adverse Event|0|||
27788028|NCT01924767|54242603|FG002|Overall Study|Adverse Event|1|||
27788029|NCT01924767|54242604|FG003|Overall Study|Adverse Event|0|||
27788030|NCT01924767|54242605|FG004|Overall Study|Adverse Event|0|||
27788031|NCT01691092|54242622|FG000|Overall Study|Lost to Follow-up|10|||
27788032|NCT01691092|54242622|FG000|Overall Study|Physician Decision|4|||
27842197|NCT01536704|54330266|FG000|Washout Period 2|Adverse Event|1|||
27842198|NCT01536704|54330267|FG001|Washout Period 2|Adverse Event|0|||
27842199|NCT01536704|54330268|FG002|Washout Period 2|Adverse Event|0|||
27842200|NCT01536704|54330269|FG003|Washout Period 2|Adverse Event|0|||
27842201|NCT01536704|54330266|FG000|Washout Period 2|Withdrawal by Subject|0|||
27842202|NCT01536704|54330267|FG001|Washout Period 2|Withdrawal by Subject|0|||
27842203|NCT01536704|54330268|FG002|Washout Period 2|Withdrawal by Subject|0|||
27842204|NCT01536704|54330269|FG003|Washout Period 2|Withdrawal by Subject|1|||
27842205|NCT01536704|54330266|FG000|Period 3|Adverse Event|0|||
27842206|NCT01536704|54330267|FG001|Period 3|Adverse Event|0|||
27842207|NCT01536704|54330268|FG002|Period 3|Adverse Event|0|||
27842208|NCT01536704|54330269|FG003|Period 3|Adverse Event|1|||
27842209|NCT01536704|54330266|FG000|Washout Period 3|Adverse Event|0|||
27842210|NCT01536704|54330267|FG001|Washout Period 3|Adverse Event|0|||
27842211|NCT01536704|54330268|FG002|Washout Period 3|Adverse Event|1|||
27842212|NCT01536704|54330269|FG003|Washout Period 3|Adverse Event|0|||
27842213|NCT01552772|54330283|FG000|Overall Study|Lost to Follow-up|2|||
27842214|NCT01552772|54330283|FG000|Overall Study|Adverse Event|1|||
27842215|NCT01552772|54330283|FG000|Overall Study|Protocol Deviation|1|||
27842216|NCT01552694|54330290|FG000|Overall Study|Lost to Follow-up|0|||
27842217|NCT01552694|54330291|FG001|Overall Study|Lost to Follow-up|1|||
27842218|NCT01552694|54330290|FG000|Overall Study|Protocol Violation|0|||
27842219|NCT01552694|54330291|FG001|Overall Study|Protocol Violation|1|||
27842220|NCT01464931|54330299|FG000|Overall Study|Withdrawal by Subject|1|||
27931534|NCT01159665|54587810|FG004|Overall Study|Withdrawal by Subject|0|||
27931535|NCT01159665|54587811|FG005|Overall Study|Withdrawal by Subject|0|||
27931536|NCT01159431|54587827|FG000|Overall Study|Adverse Event|1|||
27931537|NCT01159431|54587828|FG001|Overall Study|Adverse Event|2|||
27931538|NCT01159431|54587827|FG000|Overall Study|non-compliance|1|||
27788033|NCT01691092|54242622|FG000|Overall Study|Withdrawal by Subject|3|||
27842221|NCT01464931|54330300|FG001|Overall Study|Withdrawal by Subject|0|||
27842222|NCT01536392|54330325|FG000|Overall Study|Adverse Event|2|||
27842223|NCT01536392|54330326|FG001|Overall Study|Adverse Event|2|||
27842224|NCT01536392|54330325|FG000|Overall Study|Physician Decision|2|||
27788034|NCT01691092|54242622|FG000|Overall Study|non-compliance|3|||
27788035|NCT01691092|54242622|FG000|Overall Study|used for different study|2|||
27788036|NCT01691092|54242622|FG000|Overall Study|screen fail|19|||
27788037|NCT02133001|54242628|FG000|Double Blind (Day 1-25)|Adverse Event|1|||
27842225|NCT01536392|54330326|FG001|Overall Study|Physician Decision|3|||
27788038|NCT02133001|54242629|FG001|Double Blind (Day 1-25)|Adverse Event|5|||
27788039|NCT02133001|54242628|FG000|Double Blind (Day 1-25)|Lack of Efficacy|4|||
27788040|NCT02133001|54242629|FG001|Double Blind (Day 1-25)|Lack of Efficacy|1|||
27788041|NCT02133001|54242628|FG000|Double Blind (Day 1-25)|Lost to Follow-up|2|||
27788042|NCT02133001|54242629|FG001|Double Blind (Day 1-25)|Lost to Follow-up|0|||
27788043|NCT02133001|54242628|FG000|Double Blind (Day 1-25)|Other|2|||
27788044|NCT02133001|54242629|FG001|Double Blind (Day 1-25)|Other|2|||
27788045|NCT02133001|54242628|FG000|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
27788046|NCT02133001|54242629|FG001|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
27842226|NCT01536392|54330325|FG000|Overall Study|Withdrawal by Subject|3|||
27842227|NCT01536392|54330326|FG001|Overall Study|Withdrawal by Subject|6|||
27842228|NCT01536392|54330325|FG000|Overall Study|Non Compliance|3|||
27842229|NCT01536392|54330326|FG001|Overall Study|Non Compliance|4|||
27788047|NCT02133001|54242628|FG000|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
27788048|NCT02133001|54242629|FG001|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
27842230|NCT01536392|54330325|FG000|Overall Study|Completed therapy early|3|||
27842231|NCT01536392|54330326|FG001|Overall Study|Completed therapy early|0|||
27842232|NCT01464619|54330334|FG000|Overall Study|Lost to Follow-up|3|||
27842233|NCT01464619|54330335|FG001|Overall Study|Lost to Follow-up|4|||
27842234|NCT01490125|54330401|FG000|Period I|Adverse Event|4|||
27842235|NCT01490125|54330402|FG001|Period I|Adverse Event|1|||
27842236|NCT01490125|54330403|FG002|Period I|Adverse Event|1|||
27842237|NCT01490125|54330404|FG003|Period I|Adverse Event|3|||
27842238|NCT01490125|54330405|FG004|Period I|Adverse Event|2|||
27842239|NCT01490125|54330406|FG005|Period I|Adverse Event|4|||
27842240|NCT01490125|54330401|FG000|Period I|Protocol Violation|1|||
27842241|NCT01490125|54330402|FG001|Period I|Protocol Violation|1|||
27842242|NCT01490125|54330403|FG002|Period I|Protocol Violation|1|||
27842243|NCT01490125|54330404|FG003|Period I|Protocol Violation|1|||
27842244|NCT01490125|54330405|FG004|Period I|Protocol Violation|0|||
27842245|NCT01490125|54330406|FG005|Period I|Protocol Violation|0|||
27842246|NCT01490125|54330401|FG000|Period I|Withdrawal by Subject|1|||
27842247|NCT01490125|54330402|FG001|Period I|Withdrawal by Subject|3|||
27842248|NCT01490125|54330403|FG002|Period I|Withdrawal by Subject|2|||
27842249|NCT01490125|54330404|FG003|Period I|Withdrawal by Subject|1|||
27842250|NCT01490125|54330405|FG004|Period I|Withdrawal by Subject|2|||
27842251|NCT01490125|54330406|FG005|Period I|Withdrawal by Subject|1|||
27842252|NCT01490125|54330401|FG000|Period II|Adverse Event|2|||
27842253|NCT01490125|54330402|FG001|Period II|Adverse Event|3|||
27842254|NCT01490125|54330403|FG002|Period II|Adverse Event|2|||
27842255|NCT01490125|54330404|FG003|Period II|Adverse Event|2|||
27842256|NCT01490125|54330405|FG004|Period II|Adverse Event|4|||
27842257|NCT01490125|54330406|FG005|Period II|Adverse Event|2|||
27842258|NCT01490125|54330401|FG000|Period II|Protocol Violation|0|||
27842259|NCT01490125|54330402|FG001|Period II|Protocol Violation|0|||
27842260|NCT01490125|54330403|FG002|Period II|Protocol Violation|1|||
27842261|NCT01490125|54330404|FG003|Period II|Protocol Violation|1|||
27842262|NCT01490125|54330405|FG004|Period II|Protocol Violation|0|||
27842263|NCT01490125|54330406|FG005|Period II|Protocol Violation|0|||
27842264|NCT01490125|54330401|FG000|Period II|Lost to Follow-up|0|||
27842265|NCT01490125|54330402|FG001|Period II|Lost to Follow-up|1|||
27842266|NCT01490125|54330403|FG002|Period II|Lost to Follow-up|0|||
27842267|NCT01490125|54330404|FG003|Period II|Lost to Follow-up|0|||
27842268|NCT01490125|54330405|FG004|Period II|Lost to Follow-up|0|||
27842269|NCT01490125|54330406|FG005|Period II|Lost to Follow-up|0|||
27842270|NCT01490125|54330401|FG000|Period II|Withdrawal by Subject|1|||
27842271|NCT01490125|54330402|FG001|Period II|Withdrawal by Subject|0|||
27842272|NCT01490125|54330403|FG002|Period II|Withdrawal by Subject|0|||
27842273|NCT01490125|54330404|FG003|Period II|Withdrawal by Subject|0|||
27842274|NCT01490125|54330405|FG004|Period II|Withdrawal by Subject|0|||
27842275|NCT01490125|54330406|FG005|Period II|Withdrawal by Subject|0|||
27842276|NCT01490125|54330401|FG000|Period III|Adverse Event|3|||
27842277|NCT01490125|54330402|FG001|Period III|Adverse Event|1|||
27842278|NCT01490125|54330403|FG002|Period III|Adverse Event|0|||
27842279|NCT01490125|54330404|FG003|Period III|Adverse Event|1|||
27842280|NCT01490125|54330405|FG004|Period III|Adverse Event|0|||
27788049|NCT02133001|54242628|FG000|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
27842281|NCT01490125|54330406|FG005|Period III|Adverse Event|0|||
27788050|NCT02133001|54242629|FG001|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
27842282|NCT01490125|54330401|FG000|Period III|Death|0|||
27842283|NCT01490125|54330402|FG001|Period III|Death|0|||
27842284|NCT01490125|54330403|FG002|Period III|Death|0|||
27842285|NCT01490125|54330404|FG003|Period III|Death|1|||
27842286|NCT01490125|54330405|FG004|Period III|Death|0|||
27842287|NCT01490125|54330406|FG005|Period III|Death|0|||
27842288|NCT01490125|54330401|FG000|Period III|Lack of Efficacy|0|||
27788051|NCT02133001|54242628|FG000|Follow-Up Phase (Day 26-81)|Other|0|||
27842289|NCT01490125|54330402|FG001|Period III|Lack of Efficacy|0|||
27842290|NCT01490125|54330403|FG002|Period III|Lack of Efficacy|0|||
27842291|NCT01490125|54330404|FG003|Period III|Lack of Efficacy|0|||
27842292|NCT01490125|54330405|FG004|Period III|Lack of Efficacy|1|||
27842293|NCT01490125|54330406|FG005|Period III|Lack of Efficacy|0|||
27842294|NCT01446913|54330417|FG000|Overall Study|Significant illness|1|||
27842295|NCT01446913|54330418|FG001|Overall Study|Significant illness|1|||
27842296|NCT01446913|54330419|FG002|Overall Study|Significant illness|1|||
27842297|NCT01446913|54330417|FG000|Overall Study|Withdrawal by Subject|5|||
27842298|NCT01446913|54330418|FG001|Overall Study|Withdrawal by Subject|3|||
27842299|NCT01446913|54330419|FG002|Overall Study|Withdrawal by Subject|5|||
27842300|NCT01446913|54330417|FG000|Overall Study|Physician Decision|0|||
27842301|NCT01446913|54330418|FG001|Overall Study|Physician Decision|0|||
27842302|NCT01446913|54330419|FG002|Overall Study|Physician Decision|2|||
27842303|NCT01446913|54330417|FG000|Overall Study|Lost to Follow-up|3|||
27842304|NCT01446913|54330418|FG001|Overall Study|Lost to Follow-up|5|||
27842305|NCT01446913|54330419|FG002|Overall Study|Lost to Follow-up|3|||
27842306|NCT01420549|54330450|FG000|Overall Study|Adverse Event|1|||
27842307|NCT01420549|54330451|FG001|Overall Study|Adverse Event|1|||
27842308|NCT01420549|54330450|FG000|Overall Study|Lost to Follow-up|2|||
27842309|NCT01420549|54330451|FG001|Overall Study|Lost to Follow-up|2|||
27842310|NCT01420549|54330450|FG000|Overall Study|Protocol Violation|0|||
27842311|NCT01420549|54330451|FG001|Overall Study|Protocol Violation|1|||
27842312|NCT01420549|54330450|FG000|Overall Study|Non-adherence to medication|4|||
27842313|NCT01420549|54330451|FG001|Overall Study|Non-adherence to medication|1|||
27842314|NCT01440595|54330472|FG000|Overall Study|Lost to Follow-up|0|||
27931539|NCT01159431|54587828|FG001|Overall Study|non-compliance|1|||
27931540|NCT01159431|54587827|FG000|Overall Study|Lack of Efficacy|0|||
27931541|NCT01159431|54587828|FG001|Overall Study|Lack of Efficacy|3|||
27931542|NCT01158261|54587841|FG000|Overall Study|Lost to Follow-up|9|||
27931543|NCT01158261|54587841|FG000|Overall Study|Death|7|||
27931544|NCT01158261|54587841|FG000|Overall Study|Withdrawal by Subject|1|||
27931545|NCT01157169|54587847|FG000|First Intervention|Emesis Within 4 hrs of Administration|4|||
27931546|NCT01157169|54587848|FG001|First Intervention|Emesis Within 4 hrs of Administration|2|||
27931547|NCT01157169|54587847|FG000|Second Intervention|Emesis Within 4 hrs of Administration|0|||
27931548|NCT01157169|54587848|FG001|Second Intervention|Emesis Within 4 hrs of Administration|1|||
27931549|NCT01231620|54587857|FG000|Overall Study|Physician Decision|3|||
27931550|NCT01231620|54587858|FG001|Overall Study|Physician Decision|5|||
27931551|NCT01231620|54587859|FG002|Overall Study|Physician Decision|10|||
27931552|NCT01231620|54587857|FG000|Overall Study|Death|12|||
27931553|NCT01231620|54587858|FG001|Overall Study|Death|14|||
27931554|NCT01231620|54587859|FG002|Overall Study|Death|11|||
27931555|NCT01231620|54587857|FG000|Overall Study|Adverse Event|2|||
27931556|NCT01231620|54587858|FG001|Overall Study|Adverse Event|2|||
27931557|NCT01231620|54587859|FG002|Overall Study|Adverse Event|1|||
27931558|NCT01231620|54587857|FG000|Overall Study|Withdrawal by Subject|6|||
27931559|NCT01231620|54587858|FG001|Overall Study|Withdrawal by Subject|6|||
27931560|NCT01231620|54587859|FG002|Overall Study|Withdrawal by Subject|8|||
27931561|NCT01231620|54587857|FG000|Overall Study|Lost to Follow-up|3|||
27931562|NCT01231620|54587858|FG001|Overall Study|Lost to Follow-up|4|||
27931563|NCT01231620|54587859|FG002|Overall Study|Lost to Follow-up|9|||
27931564|NCT01231464|54587869|FG000|Overall Study|Adverse Event|0|||
27931565|NCT01231464|54587870|FG001|Overall Study|Adverse Event|1|||
27931566|NCT01231464|54587869|FG000|Overall Study|Protocol Violation|1|||
27931567|NCT01231464|54587870|FG001|Overall Study|Protocol Violation|2|||
27931568|NCT01231464|54587869|FG000|Overall Study|Lost to Follow-up|1|||
27931569|NCT01231464|54587870|FG001|Overall Study|Lost to Follow-up|2|||
27931570|NCT01231464|54587869|FG000|Overall Study|Withdrawal by Subject|3|||
27931571|NCT01231464|54587870|FG001|Overall Study|Withdrawal by Subject|2|||
27931572|NCT01156311|54587880|FG000|2-Month Monotherapy Period|Withdrawal by Subject|1|||
27931573|NCT01156311|54587881|FG001|2-Month Monotherapy Period|Withdrawal by Subject|1|||
27931574|NCT01156311|54587882|FG002|2-Month Monotherapy Period|Withdrawal by Subject|0|||
27931575|NCT01156311|54587883|FG003|2-Month Monotherapy Period|Withdrawal by Subject|0|||
27931576|NCT01156311|54587880|FG000|2-Month Monotherapy Period|Physician Decision|0|||
27931577|NCT01156311|54587881|FG001|2-Month Monotherapy Period|Physician Decision|1|||
27931578|NCT01156311|54587882|FG002|2-Month Monotherapy Period|Physician Decision|0|||
27931579|NCT01156311|54587883|FG003|2-Month Monotherapy Period|Physician Decision|0|||
27931580|NCT01156311|54587880|FG000|2-Month Monotherapy Period|Other|1|||
27931581|NCT01156311|54587881|FG001|2-Month Monotherapy Period|Other|0|||
27931582|NCT01156311|54587882|FG002|2-Month Monotherapy Period|Other|0|||
27931583|NCT01156311|54587883|FG003|2-Month Monotherapy Period|Other|0|||
27931584|NCT01156311|54587880|FG000|6-month Add-on Therapy Period|Adverse Event|0|||
27842315|NCT01440595|54330473|FG001|Overall Study|Lost to Follow-up|1|||
27842316|NCT01440595|54330474|FG002|Overall Study|Lost to Follow-up|0|||
27842317|NCT01440595|54330472|FG000|Overall Study|Study terminated by sponsor.|1|||
27931585|NCT01156311|54587881|FG001|6-month Add-on Therapy Period|Adverse Event|0|||
27931586|NCT01156311|54587882|FG002|6-month Add-on Therapy Period|Adverse Event|7|||
27931587|NCT01156311|54587883|FG003|6-month Add-on Therapy Period|Adverse Event|6|||
27842318|NCT01440595|54330473|FG001|Overall Study|Study terminated by sponsor.|2|||
27931588|NCT01156311|54587880|FG000|6-month Add-on Therapy Period|Lost to Follow-up|0|||
27931589|NCT01156311|54587881|FG001|6-month Add-on Therapy Period|Lost to Follow-up|0|||
27931590|NCT01156311|54587882|FG002|6-month Add-on Therapy Period|Lost to Follow-up|2|||
27931591|NCT01156311|54587883|FG003|6-month Add-on Therapy Period|Lost to Follow-up|0|||
27931592|NCT01156311|54587880|FG000|6-month Add-on Therapy Period|Disease Activity|0|||
27931593|NCT01156311|54587881|FG001|6-month Add-on Therapy Period|Disease Activity|0|||
27931594|NCT01156311|54587882|FG002|6-month Add-on Therapy Period|Disease Activity|1|||
27931595|NCT01156311|54587883|FG003|6-month Add-on Therapy Period|Disease Activity|2|||
27931596|NCT01156311|54587880|FG000|6-month Add-on Therapy Period|Physician Decision|0|||
27931597|NCT01156311|54587881|FG001|6-month Add-on Therapy Period|Physician Decision|0|||
27931598|NCT01156311|54587882|FG002|6-month Add-on Therapy Period|Physician Decision|1|||
27931599|NCT01156311|54587883|FG003|6-month Add-on Therapy Period|Physician Decision|0|||
27931600|NCT01156311|54587880|FG000|6-month Add-on Therapy Period|Other|0|||
27931601|NCT01156311|54587881|FG001|6-month Add-on Therapy Period|Other|0|||
27931602|NCT01156311|54587882|FG002|6-month Add-on Therapy Period|Other|1|||
27931603|NCT01156311|54587883|FG003|6-month Add-on Therapy Period|Other|2|||
27931604|NCT01230060|54587894|FG000|Overall Study|Withdrawal by Subject|1|||
27931605|NCT01155531|54587902|FG000|Overall Study|Adverse Event|0|||
27931606|NCT01155531|54587903|FG001|Overall Study|Adverse Event|0|||
27931607|NCT01155531|54587904|FG002|Overall Study|Adverse Event|1|||
27931608|NCT01155531|54587905|FG003|Overall Study|Adverse Event|0|||
27931609|NCT01155531|54587902|FG000|Overall Study|Lost to Follow-up|0|||
27931610|NCT01155531|54587903|FG001|Overall Study|Lost to Follow-up|0|||
27931611|NCT01155531|54587904|FG002|Overall Study|Lost to Follow-up|0|||
27931612|NCT01155531|54587905|FG003|Overall Study|Lost to Follow-up|1|||
27931613|NCT01155531|54587902|FG000|Overall Study|Withdrawal by Subject|1|||
27931614|NCT01155531|54587903|FG001|Overall Study|Withdrawal by Subject|0|||
27931615|NCT01155531|54587904|FG002|Overall Study|Withdrawal by Subject|1|||
27931616|NCT01155531|54587905|FG003|Overall Study|Withdrawal by Subject|0|||
27931617|NCT01155219|54587917|FG000|Overall Study|Adverse Event|3|||
27931618|NCT01155219|54587918|FG001|Overall Study|Adverse Event|1|||
27931619|NCT01155219|54587917|FG000|Overall Study|non-medical reason|1|||
27931620|NCT01155219|54587918|FG001|Overall Study|non-medical reason|2|||
27931621|NCT01229436|54587924|FG000|Overall Study|Withdrawal by Subject|2|||
28016939|NCT00328627|54676137|FG009|Overall Study|Other|1|||
28016940|NCT00328627|54676138|FG010|Overall Study|Other|1|||
27931622|NCT01229436|54587924|FG000|Overall Study|Lost to Follow-up|3|||
27931623|NCT01155141|54587928|FG000|Overall Study|Withdrawal by Subject|1|||
27931624|NCT01155141|54587928|FG000|Overall Study|Screen Failure|1|||
27931625|NCT01155063|54587932|FG000|Overall Study|Adverse Event|1|||
27931626|NCT01155063|54587932|FG000|Overall Study|Withdrawal by Subject|1|||
27931627|NCT01155063|54587932|FG000|Overall Study|Study terminated by sponsor|87|||
27931628|NCT01154673|54587938|FG000|Overall Study|Lost to Follow-up|1|||
27931629|NCT01154673|54587939|FG001|Overall Study|Lost to Follow-up|0|||
27931630|NCT01154673|54587938|FG000|Overall Study|moved out of province|1|||
27931631|NCT01154673|54587939|FG001|Overall Study|moved out of province|0|||
27931632|NCT01154283|54587947|FG000|0-6 Weeks|Withdrawal by Subject|7|||
27931633|NCT01154283|54587948|FG001|0-6 Weeks|Withdrawal by Subject|2|||
27931634|NCT01154283|54587947|FG000|0-6 Weeks|Death|0|||
27931635|NCT01154283|54587948|FG001|0-6 Weeks|Death|1|||
27931636|NCT01154283|54587947|FG000|7-12 Weeks|Death|1|||
27931637|NCT01154283|54587948|FG001|7-12 Weeks|Death|0|||
27931638|NCT01154283|54587947|FG000|7-12 Weeks|Withdrawal by Subject|0|||
27931639|NCT01154283|54587948|FG001|7-12 Weeks|Withdrawal by Subject|1|||
27931640|NCT00944125|54587954|FG000|3 to 6 Months|Withdrawal by Subject|0|||
27931641|NCT00944125|54587955|FG001|3 to 6 Months|Withdrawal by Subject|2|||
27931642|NCT00944125|54587954|FG000|6 Months to Study Completion|Withdrawal by Subject|0|||
27931643|NCT00944125|54587955|FG001|6 Months to Study Completion|Withdrawal by Subject|2|||
27931644|NCT00912223|54587961|FG000|Overall Study|Withdrawal by Subject|1|||
27931645|NCT00912223|54587961|FG000|Overall Study|Not transplanted|1|||
27931646|NCT00912223|54587961|FG000|Overall Study|Transformed disease|1|||
27931647|NCT01154127|54587967|FG000|Period 1 (21 Days)|Adverse Event|3|||
27931648|NCT01154127|54587968|FG001|Period 1 (21 Days)|Adverse Event|4|||
27931649|NCT01154127|54587967|FG000|Period 1 (21 Days)|Withdrawal by Subject|0|||
27931650|NCT01154127|54587968|FG001|Period 1 (21 Days)|Withdrawal by Subject|2|||
27788052|NCT02133001|54242629|FG001|Follow-Up Phase (Day 26-81)|Other|1|||
27931651|NCT01154127|54587967|FG000|Washout (14 - 28 Days)|Adverse Event|2|||
27931652|NCT01154127|54587968|FG001|Washout (14 - 28 Days)|Adverse Event|0|||
27931653|NCT01154127|54587967|FG000|Washout (14 - 28 Days)|Abnormal Test Procedure|1|||
27931654|NCT01154127|54587968|FG001|Washout (14 - 28 Days)|Abnormal Test Procedure|0|||
27931655|NCT01154127|54587967|FG000|Period 2 (21 Days)|Protocol Deviation|0|||
27931656|NCT01154127|54587968|FG001|Period 2 (21 Days)|Protocol Deviation|1|||
27931657|NCT01228734|54587976|FG000|Overall Study|Randomized, but not treated|0|||
27931658|NCT01228734|54587977|FG001|Overall Study|Randomized, but not treated|4|||
27931659|NCT01227954|54587983|FG000|Overall Study|Protocol Violation|6|||
27931660|NCT01227954|54587983|FG000|Overall Study|No protocol treatment|7|||
27931661|NCT01153971|54587987|FG000|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2|||
28016941|NCT00328627|54676139|FG011|Overall Study|Other|0|||
27931662|NCT01153971|54587987|FG000|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1|||
27931663|NCT01153971|54587987|FG000|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2|||
27931664|NCT01153971|54587987|FG000|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1|||
27931665|NCT01153971|54587987|FG000|Follow-up (Months 17-40 of Study)|Adverse Event|1|||
27931666|NCT01153971|54587987|FG000|Follow-up (Months 17-40 of Study)|Protocol Violation|1|||
27931667|NCT01153971|54587987|FG000|Follow-up (Months 17-40 of Study)|Disease progression|2|||
27931668|NCT01153893|54587993|FG000|Overall Study|Adverse Event|1|||
27931669|NCT01153893|54587994|FG001|Overall Study|Adverse Event|0|||
27931670|NCT00951379|54588002|FG000|Overall Study|Adverse Event|4|||
27931671|NCT00951379|54588003|FG001|Overall Study|Adverse Event|1|||
27931672|NCT00951379|54588002|FG000|Overall Study|Withdrawal by Subject|1|||
27931673|NCT00951379|54588003|FG001|Overall Study|Withdrawal by Subject|0|||
27931674|NCT00951379|54588002|FG000|Overall Study|Noncompliance|1|||
27931675|NCT00951379|54588003|FG001|Overall Study|Noncompliance|0|||
27931676|NCT00951379|54588002|FG000|Overall Study|Disease Progression|0|||
27931677|NCT00951379|54588003|FG001|Overall Study|Disease Progression|1|||
27931678|NCT01153815|54588019|FG000|Overall Study|Adverse Event|3|||
27931679|NCT01153815|54588020|FG001|Overall Study|Adverse Event|1|||
27931680|NCT01153815|54588019|FG000|Overall Study|Withdrawal by Subject|6|||
27931681|NCT01153815|54588020|FG001|Overall Study|Withdrawal by Subject|4|||
27931682|NCT01153425|54588028|FG000|Overall Study|Withdrawal by Subject|3|||
27931683|NCT01153425|54588029|FG001|Overall Study|Withdrawal by Subject|3|||
27931684|NCT01153347|54588040|FG000|Overall Study|Withdrawal by Subject|7|||
27842319|NCT01440595|54330474|FG002|Overall Study|Study terminated by sponsor.|1|||
27842320|NCT01440517|54330480|FG000|Overall Study|Subject withdrawn prior to dosing|1|||
27842321|NCT01440283|54330484|FG000|Overall Study|Death|3|||
27842322|NCT01440283|54330484|FG000|Overall Study|Withdrawal by Subject|4|||
27842323|NCT01440283|54330484|FG000|Overall Study|Physician Decision|3|||
27842324|NCT01440049|54330494|FG000|Overall Study|Adverse Event|5|||
27842325|NCT01439971|54330555|FG000|Overall Study|Required number in cohort dosed|0|||
27842326|NCT01439971|54330556|FG001|Overall Study|Required number in cohort dosed|1|||
27842327|NCT01439971|54330557|FG002|Overall Study|Required number in cohort dosed|2|||
27842328|NCT01439971|54330558|FG003|Overall Study|Required number in cohort dosed|0|||
27842329|NCT01439971|54330559|FG004|Overall Study|Required number in cohort dosed|1|||
27842330|NCT01447927|54330622|FG000|Overall Study|Adverse Event|4|||
27842331|NCT01447927|54330623|FG001|Overall Study|Adverse Event|3|||
27842332|NCT01447927|54330622|FG000|Overall Study|Withdrawal by Subject|1|||
27842333|NCT01447927|54330623|FG001|Overall Study|Withdrawal by Subject|0|||
27842334|NCT01551758|54330645|FG000|Overall Study|Adverse Event|29|||
27842335|NCT01551758|54330646|FG001|Overall Study|Adverse Event|43|||
27842336|NCT01551758|54330645|FG000|Overall Study|Lack of Efficacy|0|||
27842337|NCT01551758|54330646|FG001|Overall Study|Lack of Efficacy|1|||
27842338|NCT01551758|54330645|FG000|Overall Study|Protocol Violation|5|||
27842339|NCT01551758|54330646|FG001|Overall Study|Protocol Violation|6|||
27842340|NCT01551758|54330645|FG000|Overall Study|Met Protocol-defined stopping criteria|8|||
27842341|NCT01551758|54330646|FG001|Overall Study|Met Protocol-defined stopping criteria|10|||
27842342|NCT01551758|54330645|FG000|Overall Study|Lost to Follow-up|29|||
27842343|NCT01551758|54330646|FG001|Overall Study|Lost to Follow-up|25|||
27842344|NCT01551758|54330645|FG000|Overall Study|Physician Decision|9|||
27842345|NCT01551758|54330646|FG001|Overall Study|Physician Decision|3|||
27842346|NCT01551758|54330645|FG000|Overall Study|Withdrawal by Subject|14|||
27931685|NCT01153347|54588041|FG001|Overall Study|Withdrawal by Subject|7|||
27931686|NCT01153347|54588042|FG002|Overall Study|Withdrawal by Subject|7|||
27931687|NCT01153347|54588043|FG003|Overall Study|Withdrawal by Subject|7|||
27931688|NCT01153347|54588040|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
27931689|NCT01153347|54588041|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
27931690|NCT01153347|54588042|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
27931691|NCT01153347|54588043|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
27931692|NCT01153347|54588040|FG000|Overall Study|Adverse Event|3|||
27931693|NCT01153347|54588041|FG001|Overall Study|Adverse Event|9|||
27931694|NCT01153347|54588042|FG002|Overall Study|Adverse Event|21|||
27931695|NCT01153347|54588043|FG003|Overall Study|Adverse Event|7|||
27931696|NCT01153347|54588040|FG000|Overall Study|Severe non-compliance to protocol|6|||
27931697|NCT01153347|54588041|FG001|Overall Study|Severe non-compliance to protocol|7|||
27931698|NCT01153347|54588042|FG002|Overall Study|Severe non-compliance to protocol|4|||
27842347|NCT01551758|54330646|FG001|Overall Study|Withdrawal by Subject|17|||
27842348|NCT01449461|54330849|FG000|Overall Study|Adverse Event|0|||
27842349|NCT01449461|54330850|FG001|Overall Study|Adverse Event|3|||
27842350|NCT01449461|54330851|FG002|Overall Study|Adverse Event|2|||
27842351|NCT01449461|54330852|FG003|Overall Study|Adverse Event|3|||
27931699|NCT01153347|54588043|FG003|Overall Study|Severe non-compliance to protocol|3|||
27931700|NCT01153347|54588040|FG000|Overall Study|Condition under investigation worsened|1|||
27931701|NCT01153347|54588041|FG001|Overall Study|Condition under investigation worsened|1|||
27931702|NCT01153347|54588042|FG002|Overall Study|Condition under investigation worsened|0|||
27931703|NCT01153347|54588043|FG003|Overall Study|Condition under investigation worsened|0|||
27931704|NCT01153347|54588040|FG000|Overall Study|Lack of Efficacy|2|||
27931705|NCT01153347|54588041|FG001|Overall Study|Lack of Efficacy|2|||
27931706|NCT01153347|54588042|FG002|Overall Study|Lack of Efficacy|0|||
27931707|NCT01153347|54588043|FG003|Overall Study|Lack of Efficacy|4|||
27931708|NCT01153347|54588040|FG000|Overall Study|Study-specific withdrawal criteria|4|||
27931709|NCT01153347|54588041|FG001|Overall Study|Study-specific withdrawal criteria|3|||
27931710|NCT01153347|54588042|FG002|Overall Study|Study-specific withdrawal criteria|1|||
27931711|NCT01153347|54588043|FG003|Overall Study|Study-specific withdrawal criteria|2|||
27931712|NCT01153347|54588040|FG000|Overall Study|Lost to Follow-up|4|||
27931713|NCT01153347|54588041|FG001|Overall Study|Lost to Follow-up|9|||
27931714|NCT01153347|54588042|FG002|Overall Study|Lost to Follow-up|11|||
27931715|NCT01153347|54588043|FG003|Overall Study|Lost to Follow-up|8|||
27931716|NCT01153347|54588040|FG000|Overall Study|Other|5|||
27931717|NCT01153347|54588041|FG001|Overall Study|Other|5|||
27931718|NCT01153347|54588042|FG002|Overall Study|Other|4|||
27931719|NCT01153347|54588043|FG003|Overall Study|Other|0|||
27931720|NCT01153347|54588040|FG000|Overall Study|Death|1|||
27931721|NCT01153347|54588041|FG001|Overall Study|Death|0|||
27931722|NCT01153347|54588042|FG002|Overall Study|Death|0|||
27931723|NCT01153347|54588043|FG003|Overall Study|Death|0|||
27931724|NCT01153269|54588053|FG000|Overall Study|Withdrawal by Subject|1|||
27931725|NCT01153269|54588053|FG000|Overall Study|Antiretroviral therapy break|1|||
27931726|NCT01152021|54588062|FG000|Overall Study|Adverse Event|4|||
27931727|NCT01152021|54588063|FG001|Overall Study|Adverse Event|4|||
27931728|NCT01152021|54588062|FG000|Overall Study|Study drug had expired|1|||
27931729|NCT01152021|54588063|FG001|Overall Study|Study drug had expired|0|||
27931730|NCT01152021|54588062|FG000|Overall Study|Physician Decision|1|||
27931731|NCT01152021|54588063|FG001|Overall Study|Physician Decision|1|||
27931732|NCT01152021|54588062|FG000|Overall Study|No access to study drug in Pharmacy|0|||
27931733|NCT01152021|54588063|FG001|Overall Study|No access to study drug in Pharmacy|1|||
27788053|NCT01709578|54242640|FG000|Overall Study|Rescued and entered in long term safety|63|||
27788054|NCT01709578|54242641|FG001|Overall Study|Rescued and entered in long term safety|25|||
27788055|NCT01709578|54242642|FG002|Overall Study|Rescued and entered in long term safety|26|||
27788056|NCT01709578|54242640|FG000|Overall Study|Adverse Event|9|||
27788057|NCT01709578|54242641|FG001|Overall Study|Adverse Event|18|||
27788058|NCT01709578|54242642|FG002|Overall Study|Adverse Event|17|||
27788059|NCT01709578|54242640|FG000|Overall Study|Lack of Efficacy|5|||
27788060|NCT01709578|54242641|FG001|Overall Study|Lack of Efficacy|4|||
27788061|NCT01709578|54242642|FG002|Overall Study|Lack of Efficacy|2|||
27788062|NCT01709578|54242640|FG000|Overall Study|Poor compliance to protocol|1|||
27788063|NCT01709578|54242641|FG001|Overall Study|Poor compliance to protocol|2|||
27788064|NCT01709578|54242642|FG002|Overall Study|Poor compliance to protocol|1|||
27788065|NCT01709578|54242640|FG000|Overall Study|Other, not related to safety or efficacy|2|||
27788066|NCT01709578|54242641|FG001|Overall Study|Other, not related to safety or efficacy|7|||
27788067|NCT01709578|54242642|FG002|Overall Study|Other, not related to safety or efficacy|5|||
27788068|NCT02132767|54242652|FG000|Overall Study|Death|3|||
27788069|NCT02132767|54242653|FG001|Overall Study|Death|2|||
27788070|NCT02132767|54242652|FG000|Overall Study|Withdrawal by Subject|10|||
27788071|NCT02132767|54242653|FG001|Overall Study|Withdrawal by Subject|9|||
27788072|NCT02132767|54242652|FG000|Overall Study|Lost to Follow-up|4|||
27788073|NCT02132767|54242653|FG001|Overall Study|Lost to Follow-up|4|||
27788074|NCT02153905|54242661|FG000|Overall Study|Death|1|||
27788075|NCT02153905|54242662|FG001|Overall Study|Death|0|||
27788076|NCT02153827|54242670|FG000|Overall Study|Lost to Follow-up|3|||
27788077|NCT02153827|54242671|FG001|Overall Study|Lost to Follow-up|9|||
27788078|NCT02153359|54242677|FG000|Intervention 2 (1 Month)|Lost to Follow-up|0|||
27788079|NCT02153359|54242678|FG001|Intervention 2 (1 Month)|Lost to Follow-up|2|||
27788080|NCT01691014|54242691|FG000|Overall Study|Premature Termination|1|||
27788081|NCT01691014|54242692|FG001|Overall Study|Premature Termination|6|||
27788082|NCT01691014|54242693|FG002|Overall Study|Premature Termination|0|||
27788083|NCT01691014|54242694|FG003|Overall Study|Premature Termination|3|||
27788084|NCT01691014|54242691|FG000|Overall Study|Other|0|||
27931734|NCT01151085|54588071|FG000|Overall Study|Lost to Follow-up|31|||
27788085|NCT01691014|54242692|FG001|Overall Study|Other|0|||
27788086|NCT01691014|54242693|FG002|Overall Study|Other|2|||
27788087|NCT01691014|54242694|FG003|Overall Study|Other|0|||
27788088|NCT01691014|54242691|FG000|Overall Study|Withdrawal by Subject|0|||
27931735|NCT01151085|54588071|FG000|Overall Study|Protocol Violation|25|||
27931736|NCT01149681|54588082|FG000|Overall Study|Withdrawal by Subject|7|||
27931737|NCT01149681|54588082|FG000|Overall Study|Progressive disease|1|||
27931738|NCT01149681|54588082|FG000|Overall Study|Physician Decision|2|||
27931739|NCT01149681|54588082|FG000|Overall Study|adverse events nonrelated study drug|2|||
27931740|NCT01149369|54588089|FG000|Overall Study|Adverse Event|6|||
27931741|NCT01149369|54588090|FG001|Overall Study|Adverse Event|3|||
27788089|NCT01691014|54242692|FG001|Overall Study|Withdrawal by Subject|1|||
27788090|NCT01691014|54242693|FG002|Overall Study|Withdrawal by Subject|1|||
27788091|NCT01691014|54242694|FG003|Overall Study|Withdrawal by Subject|1|||
27788092|NCT01691014|54242691|FG000|Overall Study|Adverse Event|0|||
27788093|NCT01691014|54242692|FG001|Overall Study|Adverse Event|5|||
27788094|NCT01691014|54242693|FG002|Overall Study|Adverse Event|1|||
27788095|NCT01691014|54242694|FG003|Overall Study|Adverse Event|1|||
27788096|NCT01691014|54242691|FG000|Overall Study|Lack of Efficacy|2|||
27788097|NCT01691014|54242692|FG001|Overall Study|Lack of Efficacy|3|||
27788098|NCT01691014|54242693|FG002|Overall Study|Lack of Efficacy|7|||
27788099|NCT01691014|54242694|FG003|Overall Study|Lack of Efficacy|0|||
27788100|NCT02245412|54242707|FG000|Treatment Period|Death|1|||
27788101|NCT02245412|54242708|FG001|Treatment Period|Death|1|||
27931742|NCT01740427|54588098|FG000|Overall Study|Ongoing|45|||
27931743|NCT01740427|54588099|FG001|Overall Study|Ongoing|5|||
27931744|NCT01740427|54588098|FG000|Overall Study|Objective Progression or Relapse|281|||
27931745|NCT01740427|54588099|FG001|Overall Study|Objective Progression or Relapse|171|||
27931746|NCT01740427|54588098|FG000|Overall Study|Adverse Event|31|||
27931747|NCT01740427|54588099|FG001|Overall Study|Adverse Event|9|||
27931748|NCT01740427|54588098|FG000|Overall Study|Global Deterioration of Health Status|28|||
27931749|NCT01740427|54588099|FG001|Overall Study|Global Deterioration of Health Status|12|||
27931750|NCT01740427|54588098|FG000|Overall Study|Participant Refused Continued Treatment|26|||
27931751|NCT01740427|54588099|FG001|Overall Study|Participant Refused Continued Treatment|15|||
27931752|NCT01740427|54588098|FG000|Overall Study|Unspecified reasons|15|||
27931753|NCT01740427|54588099|FG001|Overall Study|Unspecified reasons|4|||
27931754|NCT01740427|54588098|FG000|Overall Study|Death|10|||
27931755|NCT01740427|54588099|FG001|Overall Study|Death|3|||
27931756|NCT01740427|54588098|FG000|Overall Study|Protocol Violation|5|||
27931757|NCT01740427|54588099|FG001|Overall Study|Protocol Violation|3|||
27931758|NCT01740427|54588098|FG000|Overall Study|Lost to Follow-up|2|||
27931759|NCT01740427|54588099|FG001|Overall Study|Lost to Follow-up|0|||
27931760|NCT01740427|54588098|FG000|Overall Study|Site Terminated by Sponsor|1|||
27931761|NCT01740427|54588099|FG001|Overall Study|Site Terminated by Sponsor|0|||
27931762|NCT01149057|54588105|FG000|Overall Study|Lack of Efficacy|16|||
27931763|NCT01149057|54588105|FG000|Overall Study|Adverse Event|13|||
27931764|NCT01149057|54588105|FG000|Overall Study|Withdrawal by Subject|9|||
27931765|NCT01149057|54588105|FG000|Overall Study|Positive Hepatitis B Core Antibody|5|||
27931766|NCT01149057|54588105|FG000|Overall Study|B Cell Depletion|4|||
27931767|NCT01149057|54588105|FG000|Overall Study|Participant Non-Compliance|2|||
27931768|NCT01149057|54588105|FG000|Overall Study|Lost to Follow-up|1|||
27931769|NCT01149057|54588105|FG000|Overall Study|High Parathyroid Hormone Value|1|||
27931770|NCT01149057|54588105|FG000|Overall Study|Other|6|||
27931771|NCT01227564|54588112|FG000|Overall Study|No Longer Willing to Participate|4|||
27931772|NCT01227564|54588113|FG001|Overall Study|No Longer Willing to Participate|2|||
27931773|NCT01227564|54588114|FG002|Overall Study|No Longer Willing to Participate|5|||
27931774|NCT01227564|54588112|FG000|Overall Study|Participant moved to another town|0|||
27931775|NCT01227564|54588113|FG001|Overall Study|Participant moved to another town|0|||
27931776|NCT01227564|54588114|FG002|Overall Study|Participant moved to another town|1|||
27931777|NCT01148979|54588130|FG000|Overall Study|Lost to Follow-up|0|||
27931778|NCT01148979|54588131|FG001|Overall Study|Lost to Follow-up|1|||
27931779|NCT01148511|54588139|FG000|Exposed to Study Drug|Protocol Violation|2|||
27931780|NCT01148511|54588140|FG001|Exposed to Study Drug|Protocol Violation|0|||
27931781|NCT01148511|54588141|FG002|Exposed to Study Drug|Protocol Violation|0|||
27931782|NCT01148511|54588139|FG000|Exposed to Study Drug|Lost to Follow-up|4|||
27931783|NCT01148511|54588140|FG001|Exposed to Study Drug|Lost to Follow-up|0|||
27931784|NCT01148511|54588141|FG002|Exposed to Study Drug|Lost to Follow-up|0|||
27931785|NCT01148511|54588139|FG000|Randomized|Adverse Event|0|||
27931786|NCT01148511|54588140|FG001|Randomized|Adverse Event|1|||
27788102|NCT02245412|54242709|FG002|Treatment Period|Death|0|||
27788103|NCT02245412|54242707|FG000|Treatment Period|Physician Decision|1|||
27842352|NCT01449461|54330853|FG004|Overall Study|Adverse Event|4|||
27842353|NCT01449461|54330854|FG005|Overall Study|Adverse Event|4|||
27842354|NCT01449461|54330849|FG000|Overall Study|Death|0|||
27842355|NCT01449461|54330850|FG001|Overall Study|Death|2|||
27842356|NCT01449461|54330851|FG002|Overall Study|Death|0|||
27842357|NCT01449461|54330852|FG003|Overall Study|Death|0|||
27931787|NCT01148511|54588141|FG002|Randomized|Adverse Event|0|||
27931788|NCT01148511|54588139|FG000|Randomized|Protocol Violation|0|||
27931789|NCT01148511|54588140|FG001|Randomized|Protocol Violation|2|||
27931790|NCT01148511|54588141|FG002|Randomized|Protocol Violation|1|||
27842358|NCT01449461|54330853|FG004|Overall Study|Death|7|||
27931791|NCT01148511|54588139|FG000|Randomized|Lost to Follow-up|0|||
27931792|NCT01148511|54588140|FG001|Randomized|Lost to Follow-up|1|||
27931793|NCT01148511|54588141|FG002|Randomized|Lost to Follow-up|1|||
27931794|NCT01148511|54588139|FG000|Randomized|Consent withdrawal|0|||
27931795|NCT01148511|54588140|FG001|Randomized|Consent withdrawal|5|||
27788104|NCT02245412|54242708|FG001|Treatment Period|Physician Decision|1|||
27788105|NCT02245412|54242709|FG002|Treatment Period|Physician Decision|0|||
27842359|NCT01449461|54330854|FG005|Overall Study|Death|1|||
27842360|NCT01449461|54330849|FG000|Overall Study|Physician Decision|0|||
27842361|NCT01449461|54330850|FG001|Overall Study|Physician Decision|1|||
27842362|NCT01449461|54330851|FG002|Overall Study|Physician Decision|0|||
27931796|NCT01148511|54588141|FG002|Randomized|Consent withdrawal|3|||
27931797|NCT01148511|54588139|FG000|Randomized|Other|0|||
27931798|NCT01148511|54588140|FG001|Randomized|Other|1|||
27931799|NCT01148511|54588141|FG002|Randomized|Other|1|||
27842363|NCT01449461|54330852|FG003|Overall Study|Physician Decision|4|||
27842364|NCT01449461|54330853|FG004|Overall Study|Physician Decision|1|||
27842365|NCT01449461|54330854|FG005|Overall Study|Physician Decision|0|||
27931800|NCT00547339|54588152|FG000|Overall Study|Physician Decision|0|||
27931801|NCT00547339|54588153|FG001|Overall Study|Physician Decision|0|||
27931802|NCT00547339|54588154|FG002|Overall Study|Physician Decision|1|||
27931803|NCT00547339|54588155|FG003|Overall Study|Physician Decision|0|||
27931804|NCT01227252|54588178|FG000|Overall Study|Sponsor Decision|0|||
27931805|NCT01227252|54588179|FG001|Overall Study|Sponsor Decision|1|||
27931806|NCT01227252|54588180|FG002|Overall Study|Sponsor Decision|0|||
27931807|NCT01227252|54588181|FG003|Overall Study|Sponsor Decision|0|||
27931808|NCT01227252|54588178|FG000|Overall Study|Lost to Follow-up|0|||
27931809|NCT01227252|54588179|FG001|Overall Study|Lost to Follow-up|1|||
27931810|NCT01227252|54588180|FG002|Overall Study|Lost to Follow-up|0|||
27931811|NCT01227252|54588181|FG003|Overall Study|Lost to Follow-up|0|||
27931812|NCT01227252|54588178|FG000|Overall Study|Withdrawal by Subject|0|||
27931813|NCT01227252|54588179|FG001|Overall Study|Withdrawal by Subject|1|||
27931814|NCT01227252|54588180|FG002|Overall Study|Withdrawal by Subject|0|||
27931815|NCT01227252|54588181|FG003|Overall Study|Withdrawal by Subject|0|||
27931816|NCT01227018|54588194|FG000|Overall Study|Disease progression|9|||
27931817|NCT01227018|54588194|FG000|Overall Study|Toxicity|2|||
27931818|NCT01227018|54588194|FG000|Overall Study|Withdrew after beginning treatment|4|||
27931819|NCT01226472|54588208|FG000|Overall Study|Progressive Disease|1|||
27931820|NCT01225146|54588214|FG000|Overall Study|Sponsor discontinued making 2mg drug|0|||
27931821|NCT01225146|54588215|FG001|Overall Study|Sponsor discontinued making 2mg drug|2|||
27931822|NCT01223196|54588225|FG000|Overall Study|Lost to Follow-up|2|||
27931823|NCT01223196|54588226|FG001|Overall Study|Lost to Follow-up|0|||
27931824|NCT01223196|54588225|FG000|Overall Study|Physician Decision|1|||
27931825|NCT01223196|54588226|FG001|Overall Study|Physician Decision|0|||
27931826|NCT01223196|54588225|FG000|Overall Study|Withdrawal by Subject|1|||
27931827|NCT01223196|54588226|FG001|Overall Study|Withdrawal by Subject|0|||
27931828|NCT01222416|54588236|FG000|Overall Study|ineligible;metastasis|3|||
27931829|NCT01222416|54588237|FG001|Overall Study|ineligible;metastasis|0|||
27931830|NCT01222416|54588236|FG000|Overall Study|Adverse Event|4|||
27931831|NCT01222416|54588237|FG001|Overall Study|Adverse Event|0|||
27931832|NCT01222416|54588236|FG000|Overall Study|Withdrawal by Subject|5|||
27931833|NCT01222416|54588237|FG001|Overall Study|Withdrawal by Subject|0|||
27931834|NCT01222416|54588236|FG000|Overall Study|scheduling|6|||
27931835|NCT01222416|54588237|FG001|Overall Study|scheduling|0|||
27931836|NCT01222416|54588236|FG000|Overall Study|missed view/scan|1|||
27931837|NCT01222416|54588237|FG001|Overall Study|missed view/scan|0|||
27931838|NCT01222416|54588236|FG000|Overall Study|Death|1|||
27931839|NCT01222416|54588237|FG001|Overall Study|Death|0|||
27931840|NCT01222104|54588243|FG000|Overall Study|Lost to Follow-up|37|||
27931841|NCT01222104|54588243|FG000|Overall Study|Death|10|||
27931842|NCT01221948|54588253|FG000|Overall Study|Physician Decision|5|||
27931843|NCT01221948|54588253|FG000|Overall Study|Withdrawal by Subject|2|||
27931844|NCT01221948|54588253|FG000|Overall Study|not disclosed|2|||
27931845|NCT01221948|54588253|FG000|Overall Study|Death|1|||
27931846|NCT01221948|54588253|FG000|Overall Study|Protocol Violation|4|||
27931847|NCT01221090|54588261|FG000|Overall Study|Non-Compliant or Unable to Contact|15|||
28105591|NCT04889625|54763026|FG001|Period 2|Wrong add power dispensed|1|||
27842366|NCT01449461|54330849|FG000|Overall Study|Documented Progressive Disease|4|||
27842367|NCT01449461|54330850|FG001|Overall Study|Documented Progressive Disease|7|||
27842368|NCT01449461|54330851|FG002|Overall Study|Documented Progressive Disease|14|||
27842369|NCT01449461|54330852|FG003|Overall Study|Documented Progressive Disease|15|||
27842370|NCT01449461|54330853|FG004|Overall Study|Documented Progressive Disease|24|||
27931848|NCT01221090|54588262|FG001|Overall Study|Non-Compliant or Unable to Contact|12|||
27842371|NCT01449461|54330854|FG005|Overall Study|Documented Progressive Disease|5|||
27842372|NCT01449461|54330849|FG000|Overall Study|Clinical Progressive Disease|2|||
27931849|NCT01221090|54588263|FG002|Overall Study|Non-Compliant or Unable to Contact|15|||
27931850|NCT01221090|54588264|FG003|Overall Study|Non-Compliant or Unable to Contact|20|||
27931851|NCT01221090|54588261|FG000|Overall Study|Withdrawal by Subject|0|||
27931852|NCT01221090|54588262|FG001|Overall Study|Withdrawal by Subject|22|||
27931853|NCT01221090|54588263|FG002|Overall Study|Withdrawal by Subject|27|||
28105592|NCT04883541|54763034|FG000|Overall Study|Not attending regular yoga class|16|||
27931854|NCT01221090|54588264|FG003|Overall Study|Withdrawal by Subject|2|||
27931855|NCT00950911|54588276|FG000|Overall Study|Adverse Event|0|||
27931856|NCT00950911|54588277|FG001|Overall Study|Adverse Event|2|||
27931857|NCT00950911|54588276|FG000|Overall Study|Death|4|||
27931858|NCT00950911|54588277|FG001|Overall Study|Death|6|||
27788106|NCT02245412|54242707|FG000|Treatment Period|Withdrawal by Subject|2|||
27788107|NCT02245412|54242708|FG001|Treatment Period|Withdrawal by Subject|1|||
27788108|NCT02245412|54242709|FG002|Treatment Period|Withdrawal by Subject|0|||
27788109|NCT02245412|54242707|FG000|Treatment Period|Biopsy did not confirm GI GVHD|1|||
27788110|NCT02245412|54242708|FG001|Treatment Period|Biopsy did not confirm GI GVHD|0|||
27788111|NCT02245412|54242709|FG002|Treatment Period|Biopsy did not confirm GI GVHD|0|||
27788112|NCT02245412|54242707|FG000|Follow-Up Period|Death|4|||
27788113|NCT02245412|54242708|FG001|Follow-Up Period|Death|2|||
27788114|NCT02245412|54242709|FG002|Follow-Up Period|Death|1|||
27788115|NCT02245412|54242707|FG000|Follow-Up Period|Physician Decision|1|||
27788116|NCT02245412|54242708|FG001|Follow-Up Period|Physician Decision|0|||
27788117|NCT02245412|54242709|FG002|Follow-Up Period|Physician Decision|0|||
27788118|NCT02245412|54242707|FG000|Follow-Up Period|Other - Terminated by Sponsor|0|||
27788119|NCT02245412|54242708|FG001|Follow-Up Period|Other - Terminated by Sponsor|0|||
27788120|NCT02245412|54242709|FG002|Follow-Up Period|Other - Terminated by Sponsor|1|||
27788121|NCT02244944|54242717|FG000|Overall Study|Withdrawal by Subject|1|||
27788122|NCT02244944|54242717|FG000|Overall Study|Study Terminated|1|||
27788123|NCT01689532|54242723|FG000|Overall Study|Adverse Event|9|||
27788124|NCT01689532|54242724|FG001|Overall Study|Adverse Event|5|||
27788125|NCT01689532|54242723|FG000|Overall Study|Lack of Efficacy|2|||
27788126|NCT01689532|54242724|FG001|Overall Study|Lack of Efficacy|2|||
27788127|NCT01689532|54242723|FG000|Overall Study|Withdrawal by Subject|1|||
27788128|NCT01689532|54242724|FG001|Overall Study|Withdrawal by Subject|2|||
27788129|NCT01689532|54242723|FG000|Overall Study|Physician Decision|2|||
27788130|NCT01689532|54242724|FG001|Overall Study|Physician Decision|0|||
27788131|NCT01924689|54242736|FG000|Overall Study|Death|0|||
27788132|NCT01924689|54242737|FG001|Overall Study|Death|1|||
27788133|NCT01924689|54242738|FG002|Overall Study|Death|0|||
27788134|NCT01924689|54242739|FG003|Overall Study|Death|1|||
27788135|NCT01924689|54242740|FG004|Overall Study|Death|0|||
27788136|NCT01924689|54242741|FG005|Overall Study|Death|0|||
27788137|NCT01924689|54242736|FG000|Overall Study|Disease progression|0|||
27788138|NCT01924689|54242737|FG001|Overall Study|Disease progression|0|||
27788139|NCT01924689|54242738|FG002|Overall Study|Disease progression|2|||
27788140|NCT01924689|54242739|FG003|Overall Study|Disease progression|0|||
27788141|NCT01924689|54242740|FG004|Overall Study|Disease progression|3|||
27788142|NCT01924689|54242741|FG005|Overall Study|Disease progression|2|||
27788143|NCT01924689|54242736|FG000|Overall Study|New therapy or study|3|||
27788144|NCT01924689|54242737|FG001|Overall Study|New therapy or study|2|||
27788145|NCT01924689|54242738|FG002|Overall Study|New therapy or study|1|||
27788146|NCT01924689|54242739|FG003|Overall Study|New therapy or study|4|||
27788147|NCT01924689|54242740|FG004|Overall Study|New therapy or study|2|||
27788148|NCT01924689|54242741|FG005|Overall Study|New therapy or study|0|||
27788149|NCT01924689|54242736|FG000|Overall Study|Withdrawal of consent|0|||
27788150|NCT01924689|54242737|FG001|Overall Study|Withdrawal of consent|0|||
27788151|NCT01924689|54242738|FG002|Overall Study|Withdrawal of consent|1|||
27788152|NCT01924689|54242739|FG003|Overall Study|Withdrawal of consent|1|||
27788153|NCT01924689|54242740|FG004|Overall Study|Withdrawal of consent|0|||
27788154|NCT01924689|54242741|FG005|Overall Study|Withdrawal of consent|0|||
27788155|NCT01924689|54242736|FG000|Overall Study|Other|0|||
27788156|NCT01924689|54242737|FG001|Overall Study|Other|0|||
27788157|NCT01924689|54242738|FG002|Overall Study|Other|0|||
27788158|NCT01924689|54242739|FG003|Overall Study|Other|0|||
27788159|NCT01924689|54242740|FG004|Overall Study|Other|1|||
27788160|NCT01924689|54242741|FG005|Overall Study|Other|0|||
27788161|NCT01591330|54242759|FG000|Period 1|Adverse Event|1|||
27788162|NCT01591330|54242760|FG001|Period 1|Adverse Event|0|||
27788163|NCT01591330|54242761|FG002|Period 1|Adverse Event|0|||
27842373|NCT01449461|54330850|FG001|Overall Study|Clinical Progressive Disease|2|||
27842374|NCT01449461|54330851|FG002|Overall Study|Clinical Progressive Disease|0|||
27842375|NCT01449461|54330852|FG003|Overall Study|Clinical Progressive Disease|3|||
27842376|NCT01449461|54330853|FG004|Overall Study|Clinical Progressive Disease|4|||
27842377|NCT01449461|54330854|FG005|Overall Study|Clinical Progressive Disease|2|||
27842378|NCT01449461|54330849|FG000|Overall Study|Protocol Violation|0|||
27842379|NCT01449461|54330850|FG001|Overall Study|Protocol Violation|0|||
27842380|NCT01449461|54330851|FG002|Overall Study|Protocol Violation|0|||
27842381|NCT01449461|54330852|FG003|Overall Study|Protocol Violation|1|||
27842382|NCT01449461|54330853|FG004|Overall Study|Protocol Violation|0|||
27788164|NCT01591330|54242762|FG003|Period 1|Adverse Event|0|||
27788165|NCT01591330|54242759|FG000|Washout of at Least 3 Days|Withdrawal by Subject|1|||
27788166|NCT01591330|54242760|FG001|Washout of at Least 3 Days|Withdrawal by Subject|0|||
27931859|NCT00950911|54588276|FG000|Overall Study|Disease progression|2|||
27788167|NCT01591330|54242761|FG002|Washout of at Least 3 Days|Withdrawal by Subject|0|||
27788168|NCT01591330|54242762|FG003|Washout of at Least 3 Days|Withdrawal by Subject|0|||
27931860|NCT00950911|54588277|FG001|Overall Study|Disease progression|2|||
28016942|NCT03977727|54676175|FG000|Second Treatment|Lost to Follow-up|0|||
28016943|NCT03977727|54676176|FG001|Second Treatment|Lost to Follow-up|3|||
28016944|NCT00663858|54676185|FG000|Overall Study|Adverse Event|9|||
28016945|NCT00663858|54676186|FG001|Overall Study|Adverse Event|1|||
28016946|NCT00663858|54676187|FG002|Overall Study|Adverse Event|6|||
28016947|NCT00663858|54676185|FG000|Overall Study|Lack of Efficacy|5|||
28016948|NCT00663858|54676186|FG001|Overall Study|Lack of Efficacy|1|||
27931861|NCT00950911|54588276|FG000|Overall Study|Consent withdrawn|1|||
27931862|NCT00950911|54588277|FG001|Overall Study|Consent withdrawn|3|||
27931863|NCT00950911|54588276|FG000|Overall Study|Administrative decision|3|||
27931864|NCT00950911|54588277|FG001|Overall Study|Administrative decision|1|||
27931865|NCT00950911|54588276|FG000|Overall Study|Ineligibility determined|1|||
27931866|NCT00950911|54588277|FG001|Overall Study|Ineligibility determined|0|||
27931867|NCT00950911|54588276|FG000|Overall Study|Noncompliance|1|||
27931868|NCT00950911|54588277|FG001|Overall Study|Noncompliance|0|||
27931869|NCT00950911|54588276|FG000|Overall Study|Poor performance status|0|||
27931870|NCT00950911|54588277|FG001|Overall Study|Poor performance status|1|||
27931871|NCT01220856|54588285|FG000|Overall Study|graft loss|3|||
27931872|NCT01220856|54588286|FG001|Overall Study|graft loss|3|||
27931873|NCT01220856|54588285|FG000|Overall Study|Lost to Follow-up|1|||
27931874|NCT01220856|54588286|FG001|Overall Study|Lost to Follow-up|0|||
27931875|NCT01218594|54588295|FG000|Overall Study|Death|1|||
27931876|NCT01218594|54588295|FG000|Overall Study|Withdrawal by Subject|3|||
27931877|NCT01218594|54588295|FG000|Overall Study|Adverse Event|2|||
27931878|NCT01218594|54588295|FG000|Overall Study|Physician Decision|6|||
27931879|NCT01610557|54588303|FG000|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
27931880|NCT01610557|54588304|FG001|36-Week Randomized Crossover Phase|Withdrawal by Subject|1|||
27931881|NCT01610557|54588305|FG002|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
27931882|NCT01610557|54588306|FG003|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
27931883|NCT01610557|54588307|FG004|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
27931884|NCT01610557|54588303|FG000|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
27931885|NCT01610557|54588304|FG001|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
27931886|NCT01610557|54588305|FG002|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
27931887|NCT01610557|54588306|FG003|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
27931888|NCT01610557|54588307|FG004|Post-36-Week Extension Phase|Withdrawal by Subject|3|||
27931889|NCT00943735|54588318|FG000|Overall Study|Adverse Event|12|||
27931890|NCT00943735|54588318|FG000|Overall Study|Withdrawal by Subject|8|||
27931891|NCT00943735|54588318|FG000|Overall Study|Death|1|||
27931892|NCT00943735|54588318|FG000|Overall Study|Other|8|||
27931893|NCT00943735|54588318|FG000|Overall Study|Other|3|||
27931894|NCT00943579|54588324|FG000|Overall Study|Adverse Event|4|||
27931895|NCT00943579|54588325|FG001|Overall Study|Adverse Event|3|||
27931896|NCT00943579|54588324|FG000|Overall Study|Lack of Efficacy|2|||
27931897|NCT00943579|54588325|FG001|Overall Study|Lack of Efficacy|2|||
27931898|NCT01147809|54588340|FG000|Phase I (168 Days)|Adverse Event|0|||
27931899|NCT01147809|54588341|FG001|Phase I (168 Days)|Adverse Event|0|||
27931900|NCT01147809|54588342|FG002|Phase I (168 Days)|Adverse Event|0|||
27931901|NCT01147809|54588343|FG003|Phase I (168 Days)|Adverse Event|1|||
27931902|NCT01147809|54588344|FG004|Phase I (168 Days)|Adverse Event|0|||
27931903|NCT01147809|54588345|FG005|Phase I (168 Days)|Adverse Event|0|||
27931904|NCT01147809|54588340|FG000|Phase I (168 Days)|Lost to Follow-up|1|||
27931905|NCT01147809|54588341|FG001|Phase I (168 Days)|Lost to Follow-up|0|||
27931906|NCT01147809|54588342|FG002|Phase I (168 Days)|Lost to Follow-up|0|||
27931907|NCT01147809|54588343|FG003|Phase I (168 Days)|Lost to Follow-up|1|||
27931908|NCT01147809|54588344|FG004|Phase I (168 Days)|Lost to Follow-up|0|||
27931909|NCT01147809|54588345|FG005|Phase I (168 Days)|Lost to Follow-up|0|||
27931910|NCT01147809|54588340|FG000|Phase I (168 Days)|Physician Decision|0|||
27931911|NCT01147809|54588341|FG001|Phase I (168 Days)|Physician Decision|1|||
27931912|NCT01147809|54588342|FG002|Phase I (168 Days)|Physician Decision|2|||
27931913|NCT01147809|54588343|FG003|Phase I (168 Days)|Physician Decision|0|||
27931914|NCT01147809|54588344|FG004|Phase I (168 Days)|Physician Decision|0|||
27931915|NCT01147809|54588345|FG005|Phase I (168 Days)|Physician Decision|0|||
27931916|NCT01147809|54588340|FG000|Phase I (168 Days)|Withdrawal by Subject|0|||
27931917|NCT01147809|54588341|FG001|Phase I (168 Days)|Withdrawal by Subject|0|||
27931918|NCT01147809|54588342|FG002|Phase I (168 Days)|Withdrawal by Subject|0|||
27931919|NCT01147809|54588343|FG003|Phase I (168 Days)|Withdrawal by Subject|3|||
27931920|NCT01147809|54588344|FG004|Phase I (168 Days)|Withdrawal by Subject|0|||
27931921|NCT01147809|54588345|FG005|Phase I (168 Days)|Withdrawal by Subject|0|||
27931922|NCT01147809|54588340|FG000|Phase II (168 Days)|Adverse Event|0|||
27931923|NCT01147809|54588341|FG001|Phase II (168 Days)|Adverse Event|0|||
27931924|NCT01147809|54588342|FG002|Phase II (168 Days)|Adverse Event|0|||
27931925|NCT01147809|54588343|FG003|Phase II (168 Days)|Adverse Event|0|||
27931926|NCT01147809|54588344|FG004|Phase II (168 Days)|Adverse Event|3|||
27931927|NCT01147809|54588345|FG005|Phase II (168 Days)|Adverse Event|6|||
28016949|NCT00663858|54676187|FG002|Overall Study|Lack of Efficacy|3|||
28016950|NCT00663858|54676185|FG000|Overall Study|Withdrawal by Subject|7|||
27931928|NCT01147809|54588340|FG000|Phase II (168 Days)|Protocol Violation|0|||
27931929|NCT01147809|54588341|FG001|Phase II (168 Days)|Protocol Violation|0|||
27931930|NCT01147809|54588342|FG002|Phase II (168 Days)|Protocol Violation|0|||
27931931|NCT01147809|54588343|FG003|Phase II (168 Days)|Protocol Violation|0|||
27931932|NCT01147809|54588344|FG004|Phase II (168 Days)|Protocol Violation|0|||
27931933|NCT01147809|54588345|FG005|Phase II (168 Days)|Protocol Violation|1|||
27931934|NCT01147809|54588340|FG000|Phase II (168 Days)|Physician Decision|0|||
27931935|NCT01147809|54588341|FG001|Phase II (168 Days)|Physician Decision|0|||
27931936|NCT01147809|54588342|FG002|Phase II (168 Days)|Physician Decision|0|||
27931937|NCT01147809|54588343|FG003|Phase II (168 Days)|Physician Decision|0|||
27931938|NCT01147809|54588344|FG004|Phase II (168 Days)|Physician Decision|5|||
27931939|NCT01147809|54588345|FG005|Phase II (168 Days)|Physician Decision|11|||
27931940|NCT01147809|54588340|FG000|Phase II (168 Days)|Withdrawal by Subject|0|||
27931941|NCT01147809|54588341|FG001|Phase II (168 Days)|Withdrawal by Subject|0|||
27931942|NCT01147809|54588342|FG002|Phase II (168 Days)|Withdrawal by Subject|0|||
27931943|NCT01147809|54588343|FG003|Phase II (168 Days)|Withdrawal by Subject|0|||
27931944|NCT01147809|54588344|FG004|Phase II (168 Days)|Withdrawal by Subject|7|||
27931945|NCT01147809|54588345|FG005|Phase II (168 Days)|Withdrawal by Subject|15|||
27931946|NCT01147809|54588340|FG000|Phase II (168 Days)|Ongoing|0|||
27931947|NCT01147809|54588341|FG001|Phase II (168 Days)|Ongoing|0|||
27931948|NCT01147809|54588342|FG002|Phase II (168 Days)|Ongoing|0|||
27931949|NCT01147809|54588343|FG003|Phase II (168 Days)|Ongoing|0|||
27931950|NCT01147809|54588344|FG004|Phase II (168 Days)|Ongoing|1|||
27931951|NCT01147809|54588345|FG005|Phase II (168 Days)|Ongoing|0|||
27931952|NCT00943111|54588362|FG000|52-Weeks Primary Analysis Period|Adverse Event|2|||
27931953|NCT00943111|54588363|FG001|52-Weeks Primary Analysis Period|Adverse Event|1|||
27931954|NCT00943111|54588364|FG002|52-Weeks Primary Analysis Period|Adverse Event|0|||
27931955|NCT00943111|54588362|FG000|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
27931956|NCT00943111|54588363|FG001|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1|||
27931957|NCT00943111|54588364|FG002|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
27931958|NCT00943111|54588362|FG000|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
27931959|NCT00943111|54588363|FG001|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
27931960|NCT00943111|54588364|FG002|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51|||
27931961|NCT00943111|54588362|FG000|5 Years Long-term Treatment Period|Adverse Event|0|||
27931962|NCT00943111|54588363|FG001|5 Years Long-term Treatment Period|Adverse Event|0|||
27931963|NCT00943111|54588364|FG002|5 Years Long-term Treatment Period|Adverse Event|9|||
27931964|NCT00943111|54588362|FG000|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
27931965|NCT00943111|54588363|FG001|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
27931966|NCT00943111|54588364|FG002|5 Years Long-term Treatment Period|Withdrawal by Subject|8|||
27931967|NCT00943111|54588362|FG000|5 Years Long-term Treatment Period|Pregnancy|0|||
27931968|NCT00943111|54588363|FG001|5 Years Long-term Treatment Period|Pregnancy|0|||
27931969|NCT00943111|54588364|FG002|5 Years Long-term Treatment Period|Pregnancy|4|||
27931970|NCT00943111|54588362|FG000|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
27931971|NCT00943111|54588363|FG001|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
27931972|NCT00943111|54588364|FG002|5 Years Long-term Treatment Period|Lost to Follow-up|1|||
27931973|NCT00943111|54588362|FG000|5 Years Long-term Treatment Period|Other than specified above|0|||
27931974|NCT00943111|54588363|FG001|5 Years Long-term Treatment Period|Other than specified above|0|||
27931975|NCT00943111|54588364|FG002|5 Years Long-term Treatment Period|Other than specified above|2|||
27931976|NCT01147497|54588373|FG000|Overall Study|failed insertion|2|||
27931977|NCT01147497|54588374|FG001|Overall Study|failed insertion|0|||
27931978|NCT01147341|54588382|FG000|Double Blind Period|Lack of Efficacy|1|||
27931979|NCT01147341|54588383|FG001|Double Blind Period|Lack of Efficacy|1|||
27931980|NCT01147341|54588382|FG000|Double Blind Period|Withdrawal by Subject|0|||
27931981|NCT01147341|54588383|FG001|Double Blind Period|Withdrawal by Subject|1|||
27931982|NCT01147341|54588382|FG000|Open Label Period|Lack of Efficacy|3|||
27931983|NCT01147341|54588383|FG001|Open Label Period|Lack of Efficacy|0|||
27931984|NCT01147341|54588382|FG000|Open Label Period|Subject moved|1|||
27931985|NCT01147341|54588383|FG001|Open Label Period|Subject moved|0|||
27931986|NCT00950755|54588389|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
27931987|NCT00950755|54588389|FG000|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1|||
27931988|NCT00950755|54588389|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|27|||
27931989|NCT00950755|54588389|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
27931990|NCT00950755|54588389|FG000|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1|||
27931991|NCT00950755|54588389|FG000|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1|||
27931992|NCT00950755|54588389|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6|||
27931993|NCT00950755|54588389|FG000|Dosimetric and Therapeutic Treatment|Investigator Discretion|1|||
27931994|NCT00950755|54588389|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
27931995|NCT00950755|54588389|FG000|Long-Term Follow-Up|Death|8|||
27931996|NCT01147107|54588395|FG000|Overall Study|Lack of Efficacy|5|||
27931997|NCT01147107|54588396|FG001|Overall Study|Lack of Efficacy|0|||
27931998|NCT01147107|54588395|FG000|Overall Study|Withdrawal by Subject|1|||
27931999|NCT01147107|54588396|FG001|Overall Study|Withdrawal by Subject|1|||
27932000|NCT00942409|54588402|FG000|Overall Study|Lack of Efficacy|1|||
27932001|NCT00942409|54588402|FG000|Overall Study|study drug unavailable|2|||
27932002|NCT01146951|54588408|FG000|Overall Study|Adverse Event|4|||
27932003|NCT01146951|54588409|FG001|Overall Study|Adverse Event|1|||
27932004|NCT01146873|54588417|FG000|Overall Study|Transfer out|0|||
27932005|NCT01146873|54588418|FG001|Overall Study|Transfer out|6|||
27932006|NCT01146795|54588424|FG000|Overall Study|Withdrawal by Subject|4|||
27932007|NCT01146795|54588424|FG000|Overall Study|Adverse Event|6|||
27932008|NCT01146795|54588424|FG000|Overall Study|Still in treatment at study closure|10|||
27932009|NCT01146561|54588428|FG000|Overall Study|Withdrawal by Subject|1|||
27932010|NCT01146561|54588428|FG000|Overall Study|Lost to Follow-up|1|||
27932011|NCT00942175|54588436|FG000|Overall Study|Adverse Event|2|||
27932012|NCT00942175|54588437|FG001|Overall Study|Adverse Event|1|||
27932013|NCT00942175|54588438|FG002|Overall Study|Adverse Event|0|||
27932014|NCT00942175|54588439|FG003|Overall Study|Adverse Event|0|||
27932015|NCT00942175|54588436|FG000|Overall Study|Protocol Violation|0|||
27932016|NCT00942175|54588437|FG001|Overall Study|Protocol Violation|1|||
27932017|NCT00942175|54588438|FG002|Overall Study|Protocol Violation|2|||
27932018|NCT00942175|54588439|FG003|Overall Study|Protocol Violation|0|||
27932019|NCT00942175|54588436|FG000|Overall Study|Pregnancy|0|||
27932020|NCT00942175|54588437|FG001|Overall Study|Pregnancy|0|||
27932021|NCT00942175|54588438|FG002|Overall Study|Pregnancy|0|||
27932022|NCT00942175|54588439|FG003|Overall Study|Pregnancy|1|||
27932023|NCT00942175|54588436|FG000|Overall Study|Elevated Alanine Amino Transferase|0|||
27932024|NCT00942175|54588437|FG001|Overall Study|Elevated Alanine Amino Transferase|0|||
27932025|NCT00942175|54588438|FG002|Overall Study|Elevated Alanine Amino Transferase|0|||
27932026|NCT00942175|54588439|FG003|Overall Study|Elevated Alanine Amino Transferase|1|||
28016951|NCT00663858|54676186|FG001|Overall Study|Withdrawal by Subject|3|||
27788169|NCT01591330|54242759|FG000|Period 2|Adverse Event|1|||
27788170|NCT01591330|54242760|FG001|Period 2|Adverse Event|0|||
27788171|NCT01591330|54242761|FG002|Period 2|Adverse Event|0|||
27788172|NCT01591330|54242762|FG003|Period 2|Adverse Event|0|||
27788173|NCT01591096|54242772|FG000|Overall Study|Adverse Event|1|||
27788174|NCT01953003|54242778|FG000|Overall Study|Not treated|0|||
27788175|NCT01953003|54242779|FG001|Overall Study|Not treated|1|||
27788176|NCT01953003|54242778|FG000|Overall Study|Progressive disease|35|||
27788177|NCT01953003|54242779|FG001|Overall Study|Progressive disease|45|||
27788178|NCT01953003|54242778|FG000|Overall Study|Related Adverse events|7|||
27788179|NCT01953003|54242779|FG001|Overall Study|Related Adverse events|2|||
27788180|NCT01953003|54242778|FG000|Overall Study|Non-related adverse events|0|||
27788181|NCT01953003|54242779|FG001|Overall Study|Non-related adverse events|2|||
27788182|NCT01953003|54242778|FG000|Overall Study|Protocol Violation|0|||
27788183|NCT01953003|54242779|FG001|Overall Study|Protocol Violation|1|||
27788184|NCT01953003|54242778|FG000|Overall Study|Withdrawal by Subject|14|||
27788185|NCT01953003|54242779|FG001|Overall Study|Withdrawal by Subject|4|||
27788186|NCT01952691|54242785|FG000|Overall Study|Lost to Follow-up|2|||
27788187|NCT01709500|54242791|FG000|Overall Study|Randomized but not treated|0|||
27788188|NCT01709500|54242792|FG001|Overall Study|Randomized but not treated|1|||
27788189|NCT01709500|54242791|FG000|Overall Study|Adverse Event|5|||
27788190|NCT01709500|54242792|FG001|Overall Study|Adverse Event|1|||
27788191|NCT01709500|54242791|FG000|Overall Study|Poor compliance to protocol|2|||
27788192|NCT01709500|54242792|FG001|Overall Study|Poor compliance to protocol|1|||
27788193|NCT01709500|54242791|FG000|Overall Study|Other|3|||
27788194|NCT01709500|54242792|FG001|Overall Study|Other|1|||
27788195|NCT01709500|54242791|FG000|Overall Study|Related to IMP administration|1|||
27788196|NCT01709500|54242792|FG001|Overall Study|Related to IMP administration|0|||
27788197|NCT01709500|54242791|FG000|Overall Study|Treatment ongoing|156|||
27788198|NCT01709500|54242792|FG001|Overall Study|Treatment ongoing|78|||
27788199|NCT01599806|54242800|FG000|Overall Study|Lost to Follow-up|20|||
27842383|NCT01449461|54330854|FG005|Overall Study|Protocol Violation|0|||
27842384|NCT01449461|54330849|FG000|Overall Study|Site Terminated by Sponsor|0|||
27842385|NCT01449461|54330850|FG001|Overall Study|Site Terminated by Sponsor|1|||
27842386|NCT01449461|54330851|FG002|Overall Study|Site Terminated by Sponsor|2|||
27842387|NCT01449461|54330852|FG003|Overall Study|Site Terminated by Sponsor|3|||
27842388|NCT01449461|54330853|FG004|Overall Study|Site Terminated by Sponsor|4|||
27842389|NCT01449461|54330854|FG005|Overall Study|Site Terminated by Sponsor|1|||
27842390|NCT01449461|54330849|FG000|Overall Study|Withdrawal by Subject|0|||
27842391|NCT01449461|54330850|FG001|Overall Study|Withdrawal by Subject|1|||
27932027|NCT00942175|54588436|FG000|Overall Study|Low Platelet Count|0|||
27788200|NCT01599806|54242801|FG001|Overall Study|Lost to Follow-up|20|||
27788201|NCT01599806|54242800|FG000|Overall Study|Withdrawal by Subject|12|||
27932028|NCT00942175|54588437|FG001|Overall Study|Low Platelet Count|2|||
27932029|NCT00942175|54588438|FG002|Overall Study|Low Platelet Count|0|||
27932030|NCT00942175|54588439|FG003|Overall Study|Low Platelet Count|0|||
27932031|NCT01145625|54588459|FG000|Overall Study|Lost to Follow-up|8|||
27788202|NCT01599806|54242801|FG001|Overall Study|Withdrawal by Subject|12|||
27788203|NCT01599806|54242800|FG000|Overall Study|Other Eligibility criteria|11|||
27788204|NCT01599806|54242801|FG001|Overall Study|Other Eligibility criteria|9|||
28016952|NCT00663858|54676187|FG002|Overall Study|Withdrawal by Subject|3|||
28016953|NCT00663858|54676185|FG000|Overall Study|Protocol Violation|5|||
28016954|NCT00663858|54676186|FG001|Overall Study|Protocol Violation|3|||
28016955|NCT00663858|54676187|FG002|Overall Study|Protocol Violation|4|||
28016956|NCT00663858|54676185|FG000|Overall Study|Other|8|||
28016957|NCT00663858|54676186|FG001|Overall Study|Other|2|||
28016958|NCT00663858|54676187|FG002|Overall Study|Other|4|||
27932032|NCT01145625|54588460|FG001|Overall Study|Lost to Follow-up|9|||
27932033|NCT01145625|54588459|FG000|Overall Study|Adverse Event|6|||
27932034|NCT01145625|54588460|FG001|Overall Study|Adverse Event|4|||
27932035|NCT01145625|54588459|FG000|Overall Study|Protocol Violation|3|||
27932036|NCT01145625|54588460|FG001|Overall Study|Protocol Violation|1|||
27932037|NCT01145625|54588459|FG000|Overall Study|Withdrawal by Subject|7|||
27932038|NCT01145625|54588460|FG001|Overall Study|Withdrawal by Subject|16|||
27932039|NCT01145625|54588459|FG000|Overall Study|Pregnancy|0|||
27932040|NCT01145625|54588460|FG001|Overall Study|Pregnancy|1|||
27932041|NCT01144377|54588471|FG000|52 Week Treatment Period|Adverse Event|0|||
27932042|NCT01144377|54588472|FG001|52 Week Treatment Period|Adverse Event|0|||
27932043|NCT01144377|54588473|FG002|52 Week Treatment Period|Adverse Event|3|||
27932044|NCT01144377|54588474|FG003|52 Week Treatment Period|Adverse Event|2|||
27932045|NCT01144377|54588475|FG004|52 Week Treatment Period|Adverse Event|1|||
27932046|NCT01144377|54588471|FG000|52 Week Treatment Period|Entry Criteria Not Met|0|||
27932047|NCT01144377|54588472|FG001|52 Week Treatment Period|Entry Criteria Not Met|0|||
27932048|NCT01144377|54588473|FG002|52 Week Treatment Period|Entry Criteria Not Met|1|||
27932049|NCT01144377|54588474|FG003|52 Week Treatment Period|Entry Criteria Not Met|1|||
27932050|NCT01144377|54588475|FG004|52 Week Treatment Period|Entry Criteria Not Met|0|||
27932051|NCT01144377|54588471|FG000|52 Week Treatment Period|Protocol Violation|0|||
27932052|NCT01144377|54588472|FG001|52 Week Treatment Period|Protocol Violation|0|||
27932053|NCT01144377|54588473|FG002|52 Week Treatment Period|Protocol Violation|0|||
27932054|NCT01144377|54588474|FG003|52 Week Treatment Period|Protocol Violation|0|||
27932055|NCT01144377|54588475|FG004|52 Week Treatment Period|Protocol Violation|1|||
27932056|NCT01144377|54588471|FG000|52 Week Treatment Period|Lost to Follow-up|1|||
27932057|NCT01144377|54588472|FG001|52 Week Treatment Period|Lost to Follow-up|0|||
27932058|NCT01144377|54588473|FG002|52 Week Treatment Period|Lost to Follow-up|0|||
27932059|NCT01144377|54588474|FG003|52 Week Treatment Period|Lost to Follow-up|0|||
27932060|NCT01144377|54588475|FG004|52 Week Treatment Period|Lost to Follow-up|0|||
27932061|NCT01144377|54588471|FG000|52 Week Treatment Period|Withdrawal by Subject|4|||
27932062|NCT01144377|54588472|FG001|52 Week Treatment Period|Withdrawal by Subject|1|||
27932063|NCT01144377|54588473|FG002|52 Week Treatment Period|Withdrawal by Subject|1|||
27932064|NCT01144377|54588474|FG003|52 Week Treatment Period|Withdrawal by Subject|1|||
27932065|NCT01144377|54588475|FG004|52 Week Treatment Period|Withdrawal by Subject|0|||
27932066|NCT01144377|54588471|FG000|52 Week Treatment Period|Sponsor Decision|0|||
27932067|NCT01144377|54588472|FG001|52 Week Treatment Period|Sponsor Decision|0|||
27932068|NCT01144377|54588473|FG002|52 Week Treatment Period|Sponsor Decision|0|||
27932069|NCT01144377|54588474|FG003|52 Week Treatment Period|Sponsor Decision|0|||
27932070|NCT01144377|54588475|FG004|52 Week Treatment Period|Sponsor Decision|1|||
27932071|NCT01144377|54588471|FG000|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
27932072|NCT01144377|54588472|FG001|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
27932073|NCT01144377|54588473|FG002|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
27932074|NCT01144377|54588474|FG003|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
27932075|NCT01144377|54588475|FG004|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
27932076|NCT01144377|54588471|FG000|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
27932077|NCT01144377|54588472|FG001|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
27932078|NCT01144377|54588473|FG002|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
27932079|NCT01144377|54588474|FG003|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
27932080|NCT01144377|54588475|FG004|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1|||
27932081|NCT01144377|54588471|FG000|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1|||
27932082|NCT01144377|54588472|FG001|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
27932083|NCT01144377|54588473|FG002|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
27932084|NCT01144377|54588474|FG003|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
28016959|NCT00659880|54676195|FG000|Overall Study|Lost to Follow-up|5|||
27842392|NCT01449461|54330851|FG002|Overall Study|Withdrawal by Subject|0|||
27842393|NCT01449461|54330852|FG003|Overall Study|Withdrawal by Subject|0|||
27842394|NCT01449461|54330853|FG004|Overall Study|Withdrawal by Subject|2|||
27842395|NCT01449461|54330854|FG005|Overall Study|Withdrawal by Subject|1|||
27842396|NCT01449461|54330849|FG000|Overall Study|Reason not Specified|0|||
27842397|NCT01449461|54330850|FG001|Overall Study|Reason not Specified|1|||
27842398|NCT01449461|54330851|FG002|Overall Study|Reason not Specified|0|||
27842399|NCT01449461|54330852|FG003|Overall Study|Reason not Specified|3|||
27932085|NCT01144377|54588475|FG004|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
27932086|NCT00950599|54588497|FG000|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
27932087|NCT00950599|54588498|FG001|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
27932088|NCT00950599|54588499|FG002|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
27932089|NCT00950599|54588500|FG003|Double-Blind Treatment Period|Administrative reason by sponsor|1|||
27932090|NCT00950599|54588501|FG004|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
27932091|NCT00950599|54588502|FG005|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
27932092|NCT00950599|54588503|FG006|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
27932093|NCT00950599|54588504|FG007|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
27932094|NCT00950599|54588505|FG008|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
27932095|NCT00950599|54588506|FG009|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
27932096|NCT00950599|54588497|FG000|Double-Blind Treatment Period|Adverse Event|0|||
27932097|NCT00950599|54588498|FG001|Double-Blind Treatment Period|Adverse Event|1|||
27932098|NCT00950599|54588499|FG002|Double-Blind Treatment Period|Adverse Event|1|||
27932099|NCT00950599|54588500|FG003|Double-Blind Treatment Period|Adverse Event|1|||
27932100|NCT00950599|54588501|FG004|Double-Blind Treatment Period|Adverse Event|1|||
27932101|NCT00950599|54588502|FG005|Double-Blind Treatment Period|Adverse Event|1|||
27932102|NCT00950599|54588503|FG006|Double-Blind Treatment Period|Adverse Event|0|||
27932103|NCT00950599|54588504|FG007|Double-Blind Treatment Period|Adverse Event|0|||
27932104|NCT00950599|54588505|FG008|Double-Blind Treatment Period|Adverse Event|0|||
27932105|NCT00950599|54588506|FG009|Double-Blind Treatment Period|Adverse Event|0|||
27932106|NCT00950599|54588497|FG000|Double-Blind Treatment Period|Lack of Efficacy|2|||
27932107|NCT00950599|54588498|FG001|Double-Blind Treatment Period|Lack of Efficacy|5|||
27932108|NCT00950599|54588499|FG002|Double-Blind Treatment Period|Lack of Efficacy|5|||
27932109|NCT00950599|54588500|FG003|Double-Blind Treatment Period|Lack of Efficacy|7|||
27932110|NCT00950599|54588501|FG004|Double-Blind Treatment Period|Lack of Efficacy|3|||
27932111|NCT00950599|54588502|FG005|Double-Blind Treatment Period|Lack of Efficacy|6|||
28016960|NCT00683774|54676202|FG000|Overall Study|Withdrawal by Subject|0|||
27788205|NCT01599325|54242807|FG000|Primary Parent Phase|Adverse Event|5|||
27788206|NCT01599325|54242807|FG000|Primary Parent Phase|Disease Progression|7|||
27788207|NCT01599325|54242807|FG000|Primary Parent Phase|Withdrawal by Subject|20|||
27788208|NCT01599325|54242807|FG000|Primary Parent Phase|Death|13|||
27788209|NCT01599325|54242807|FG000|Primary Parent Phase|Protocol Violation|1|||
27788210|NCT01599325|54242807|FG000|Primary Parent Phase|Lack of Therapeutic Effect|9|||
27788211|NCT01599325|54242807|FG000|Primary Parent Phase|Other|2|||
27788212|NCT01599325|54242807|FG000|Extension Phase|Study Closure|1|||
27788213|NCT01599325|54242807|FG000|Extension Phase|Stopped to Receive Stem Cell Transplant|1|||
27788214|NCT01599325|54242807|FG000|Extension Phase|Lack of Therapeutic Effect|4|||
27788215|NCT01599325|54242807|FG000|Extension Phase|Disease Progression|1|||
27788216|NCT01599325|54242807|FG000|Extension Phase|Withdrawal by Subject|8|||
27788217|NCT01924299|54242814|FG000|Period 2|Withdrawal by Subject|1|||
27788218|NCT01924299|54242815|FG001|Period 2|Withdrawal by Subject|0|||
27788219|NCT01924299|54242814|FG000|Period 2|Adverse Event|0|||
27932112|NCT00950599|54588503|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
27932113|NCT00950599|54588504|FG007|Double-Blind Treatment Period|Lack of Efficacy|1|||
27932114|NCT00950599|54588505|FG008|Double-Blind Treatment Period|Lack of Efficacy|0|||
27932115|NCT00950599|54588506|FG009|Double-Blind Treatment Period|Lack of Efficacy|0|||
27932116|NCT00950599|54588497|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
27932117|NCT00950599|54588498|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
27932118|NCT00950599|54588499|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
27932119|NCT00950599|54588500|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
27932120|NCT00950599|54588501|FG004|Double-Blind Treatment Period|Lost to Follow-up|1|||
27932121|NCT00950599|54588502|FG005|Double-Blind Treatment Period|Lost to Follow-up|2|||
27932122|NCT00950599|54588503|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
27932123|NCT00950599|54588504|FG007|Double-Blind Treatment Period|Lost to Follow-up|1|||
27932124|NCT00950599|54588505|FG008|Double-Blind Treatment Period|Lost to Follow-up|0|||
27932125|NCT00950599|54588506|FG009|Double-Blind Treatment Period|Lost to Follow-up|0|||
27932126|NCT00950599|54588497|FG000|Double-Blind Treatment Period|Poor/Noncompliance|1|||
27932127|NCT00950599|54588498|FG001|Double-Blind Treatment Period|Poor/Noncompliance|1|||
27932128|NCT00950599|54588499|FG002|Double-Blind Treatment Period|Poor/Noncompliance|0|||
27932129|NCT00950599|54588500|FG003|Double-Blind Treatment Period|Poor/Noncompliance|0|||
27932130|NCT00950599|54588501|FG004|Double-Blind Treatment Period|Poor/Noncompliance|0|||
27932131|NCT00950599|54588502|FG005|Double-Blind Treatment Period|Poor/Noncompliance|0|||
27932132|NCT00950599|54588503|FG006|Double-Blind Treatment Period|Poor/Noncompliance|0|||
27932133|NCT00950599|54588504|FG007|Double-Blind Treatment Period|Poor/Noncompliance|1|||
28016961|NCT00683774|54676203|FG001|Overall Study|Withdrawal by Subject|1|||
27788220|NCT01924299|54242815|FG001|Period 2|Adverse Event|1|||
27788221|NCT02182999|54242829|FG000|Overall Study|Adverse Event|4|||
27788222|NCT02182999|54242830|FG001|Overall Study|Adverse Event|3|||
27788223|NCT02182999|54242829|FG000|Overall Study|Physician Decision|1|||
27932134|NCT00950599|54588505|FG008|Double-Blind Treatment Period|Poor/Noncompliance|0|||
27932135|NCT00950599|54588506|FG009|Double-Blind Treatment Period|Poor/Noncompliance|0|||
27932136|NCT00950599|54588497|FG000|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
27932137|NCT00950599|54588498|FG001|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
27932138|NCT00950599|54588499|FG002|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
27932139|NCT00950599|54588500|FG003|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
27932140|NCT00950599|54588501|FG004|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
27932141|NCT00950599|54588502|FG005|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
27932142|NCT00950599|54588503|FG006|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
27932143|NCT00950599|54588504|FG007|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
27932144|NCT00950599|54588505|FG008|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
27932145|NCT00950599|54588506|FG009|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
27932146|NCT00950599|54588497|FG000|Double-Blind Treatment Period|Subject Withdrew consent|4|||
27932147|NCT00950599|54588498|FG001|Double-Blind Treatment Period|Subject Withdrew consent|3|||
27932148|NCT00950599|54588499|FG002|Double-Blind Treatment Period|Subject Withdrew consent|3|||
27932149|NCT00950599|54588500|FG003|Double-Blind Treatment Period|Subject Withdrew consent|1|||
27932150|NCT00950599|54588501|FG004|Double-Blind Treatment Period|Subject Withdrew consent|1|||
27932151|NCT00950599|54588502|FG005|Double-Blind Treatment Period|Subject Withdrew consent|2|||
27932152|NCT00950599|54588503|FG006|Double-Blind Treatment Period|Subject Withdrew consent|0|||
27932153|NCT00950599|54588504|FG007|Double-Blind Treatment Period|Subject Withdrew consent|3|||
27932154|NCT00950599|54588505|FG008|Double-Blind Treatment Period|Subject Withdrew consent|0|||
27932155|NCT00950599|54588506|FG009|Double-Blind Treatment Period|Subject Withdrew consent|0|||
27932156|NCT00950599|54588497|FG000|Follow-Up Period|Adverse Event|0|||
27932157|NCT00950599|54588498|FG001|Follow-Up Period|Adverse Event|0|||
27932158|NCT00950599|54588499|FG002|Follow-Up Period|Adverse Event|0|||
27932159|NCT00950599|54588500|FG003|Follow-Up Period|Adverse Event|0|||
27932160|NCT00950599|54588501|FG004|Follow-Up Period|Adverse Event|0|||
27932161|NCT00950599|54588502|FG005|Follow-Up Period|Adverse Event|0|||
27932162|NCT00950599|54588503|FG006|Follow-Up Period|Adverse Event|0|||
27932163|NCT00950599|54588504|FG007|Follow-Up Period|Adverse Event|0|||
27932164|NCT00950599|54588505|FG008|Follow-Up Period|Adverse Event|1|||
27932165|NCT00950599|54588506|FG009|Follow-Up Period|Adverse Event|0|||
27932166|NCT00950599|54588497|FG000|Follow-Up Period|Lack of Efficacy|0|||
27932167|NCT00950599|54588498|FG001|Follow-Up Period|Lack of Efficacy|0|||
27932168|NCT00950599|54588499|FG002|Follow-Up Period|Lack of Efficacy|0|||
27788224|NCT02182999|54242830|FG001|Overall Study|Physician Decision|0|||
27788225|NCT02243696|54242836|FG000|Overall Study|Death|282|||
27788226|NCT02243696|54242836|FG000|Overall Study|Withdrawal by Subject|79|||
27788227|NCT02243696|54242836|FG000|Overall Study|Lost to Follow-up|57|||
27788228|NCT02243696|54242836|FG000|Overall Study|Subject No Longer has Study System|42|||
27788229|NCT02243696|54242836|FG000|Overall Study|Subject Withdrawn by Investigator|273|||
27788230|NCT02243696|54242836|FG000|Overall Study|Study Terminated for EP PASSION|961|||
27788231|NCT01598311|54242842|FG000|Overall Study|Physician Decision|4|||
27788232|NCT01598311|54242843|FG001|Overall Study|Physician Decision|5|||
27788233|NCT01598311|54242842|FG000|Overall Study|Adverse Event|9|||
27788234|NCT01598311|54242843|FG001|Overall Study|Adverse Event|13|||
27788235|NCT01598311|54242842|FG000|Overall Study|Lost to Follow-up|7|||
27788236|NCT01598311|54242843|FG001|Overall Study|Lost to Follow-up|12|||
27788237|NCT01598311|54242842|FG000|Overall Study|Withdrawal by Subject|9|||
27788238|NCT01598311|54242843|FG001|Overall Study|Withdrawal by Subject|13|||
27788239|NCT01598311|54242842|FG000|Overall Study|No reason provided.|0|||
27788240|NCT01598311|54242843|FG001|Overall Study|No reason provided.|5|||
27788241|NCT01598311|54242842|FG000|Overall Study|Randomized but never treated|8|||
27788242|NCT01598311|54242843|FG001|Overall Study|Randomized but never treated|5|||
27788243|NCT01598311|54242842|FG000|Overall Study|Treated but no confirmed CDAD|9|||
27788244|NCT01598311|54242843|FG001|Overall Study|Treated but no confirmed CDAD|8|||
27788245|NCT01598311|54242842|FG000|Overall Study|Assigned to CB but received vancomycin|1|||
27788246|NCT01598311|54242843|FG001|Overall Study|Assigned to CB but received vancomycin|0|||
27788247|NCT02182843|54242849|FG000|Overall Study|Withdrawal by Subject|7|||
27788248|NCT02182843|54242849|FG000|Overall Study|Lost to Follow-up|2|||
27788249|NCT02182843|54242849|FG000|Overall Study|Adverse Event|1|||
27788250|NCT02208050|54242855|FG000|Washout Period 1: 2 Weeks|Withdrawal by Subject|1|||
27788251|NCT02208050|54242856|FG001|Washout Period 1: 2 Weeks|Withdrawal by Subject|0|||
27788252|NCT02978222|54242878|FG000|Overall Study|Withdrawal by Subject|2|||
27932169|NCT00950599|54588500|FG003|Follow-Up Period|Lack of Efficacy|0|||
27932170|NCT00950599|54588501|FG004|Follow-Up Period|Lack of Efficacy|0|||
27788253|NCT02978222|54242879|FG001|Overall Study|Withdrawal by Subject|2|||
27788254|NCT02978222|54242878|FG000|Overall Study|Physician Decision|2|||
27788255|NCT02978222|54242879|FG001|Overall Study|Physician Decision|0|||
27788256|NCT02978222|54242878|FG000|Overall Study|Adverse Event|0|||
27788257|NCT02978222|54242879|FG001|Overall Study|Adverse Event|1|||
27788258|NCT02978222|54242878|FG000|Overall Study|Death|1|||
27788259|NCT02978222|54242879|FG001|Overall Study|Death|0|||
27788260|NCT02978222|54242878|FG000|Overall Study|Disease Progression|32|||
27788261|NCT02978222|54242879|FG001|Overall Study|Disease Progression|32|||
27788262|NCT02978222|54242878|FG000|Overall Study|Early Study Termination|24|||
27788263|NCT02978222|54242879|FG001|Overall Study|Early Study Termination|21|||
27788264|NCT02181673|54242887|FG000|Up to Week 24|Adverse Event|2|||
27932171|NCT00950599|54588502|FG005|Follow-Up Period|Lack of Efficacy|0|||
27932172|NCT00950599|54588503|FG006|Follow-Up Period|Lack of Efficacy|0|||
27932173|NCT00950599|54588504|FG007|Follow-Up Period|Lack of Efficacy|0|||
27932174|NCT00950599|54588505|FG008|Follow-Up Period|Lack of Efficacy|3|||
27932175|NCT00950599|54588506|FG009|Follow-Up Period|Lack of Efficacy|0|||
27932176|NCT00950599|54588497|FG000|Follow-Up Period|Lost to Follow-up|0|||
27932177|NCT00950599|54588498|FG001|Follow-Up Period|Lost to Follow-up|0|||
27932178|NCT00950599|54588499|FG002|Follow-Up Period|Lost to Follow-up|0|||
27932179|NCT00950599|54588500|FG003|Follow-Up Period|Lost to Follow-up|0|||
27932180|NCT00950599|54588501|FG004|Follow-Up Period|Lost to Follow-up|0|||
27932181|NCT00950599|54588502|FG005|Follow-Up Period|Lost to Follow-up|0|||
27932182|NCT00950599|54588503|FG006|Follow-Up Period|Lost to Follow-up|0|||
27932183|NCT00950599|54588504|FG007|Follow-Up Period|Lost to Follow-up|0|||
27932184|NCT00950599|54588505|FG008|Follow-Up Period|Lost to Follow-up|5|||
27932185|NCT00950599|54588506|FG009|Follow-Up Period|Lost to Follow-up|1|||
27932186|NCT00950599|54588497|FG000|Follow-Up Period|Physician Decision|0|||
27932187|NCT00950599|54588498|FG001|Follow-Up Period|Physician Decision|0|||
27932188|NCT00950599|54588499|FG002|Follow-Up Period|Physician Decision|0|||
27932189|NCT00950599|54588500|FG003|Follow-Up Period|Physician Decision|0|||
27932190|NCT00950599|54588501|FG004|Follow-Up Period|Physician Decision|0|||
27932191|NCT00950599|54588502|FG005|Follow-Up Period|Physician Decision|0|||
27932192|NCT00950599|54588503|FG006|Follow-Up Period|Physician Decision|0|||
27932193|NCT00950599|54588504|FG007|Follow-Up Period|Physician Decision|0|||
27932194|NCT00950599|54588505|FG008|Follow-Up Period|Physician Decision|1|||
27932195|NCT00950599|54588506|FG009|Follow-Up Period|Physician Decision|0|||
27932196|NCT00950599|54588497|FG000|Follow-Up Period|Poor/Noncompliance|0|||
27932197|NCT00950599|54588498|FG001|Follow-Up Period|Poor/Noncompliance|0|||
27932198|NCT00950599|54588499|FG002|Follow-Up Period|Poor/Noncompliance|0|||
27932199|NCT00950599|54588500|FG003|Follow-Up Period|Poor/Noncompliance|0|||
27932200|NCT00950599|54588501|FG004|Follow-Up Period|Poor/Noncompliance|0|||
27932201|NCT00950599|54588502|FG005|Follow-Up Period|Poor/Noncompliance|0|||
27932202|NCT00950599|54588503|FG006|Follow-Up Period|Poor/Noncompliance|0|||
27932203|NCT00950599|54588504|FG007|Follow-Up Period|Poor/Noncompliance|0|||
27932204|NCT00950599|54588505|FG008|Follow-Up Period|Poor/Noncompliance|1|||
27932205|NCT00950599|54588506|FG009|Follow-Up Period|Poor/Noncompliance|0|||
27788265|NCT02181673|54242888|FG001|Up to Week 24|Adverse Event|0|||
27788266|NCT02181673|54242889|FG002|Up to Week 24|Adverse Event|3|||
27788267|NCT02181673|54242887|FG000|Up to Week 24|Death|1|||
27788268|NCT02181673|54242888|FG001|Up to Week 24|Death|0|||
27788269|NCT02181673|54242889|FG002|Up to Week 24|Death|0|||
27788270|NCT02181673|54242887|FG000|Up to Week 24|Lack of Efficacy|1|||
27788271|NCT02181673|54242888|FG001|Up to Week 24|Lack of Efficacy|0|||
27788272|NCT02181673|54242889|FG002|Up to Week 24|Lack of Efficacy|0|||
27788273|NCT02181673|54242887|FG000|Up to Week 24|Lost to Follow-up|1|||
27788274|NCT02181673|54242888|FG001|Up to Week 24|Lost to Follow-up|0|||
27788275|NCT02181673|54242889|FG002|Up to Week 24|Lost to Follow-up|0|||
27788276|NCT02181673|54242887|FG000|Up to Week 24|Physician Decision|0|||
27788277|NCT02181673|54242888|FG001|Up to Week 24|Physician Decision|0|||
27788278|NCT02181673|54242889|FG002|Up to Week 24|Physician Decision|3|||
27788279|NCT02181673|54242887|FG000|Up to Week 24|Withdrawal by Subject|10|||
27788280|NCT02181673|54242888|FG001|Up to Week 24|Withdrawal by Subject|0|||
27788281|NCT02181673|54242889|FG002|Up to Week 24|Withdrawal by Subject|1|||
27788282|NCT02181673|54242887|FG000|Up to Week 24|Other|2|||
27788283|NCT02181673|54242888|FG001|Up to Week 24|Other|0|||
27788284|NCT02181673|54242889|FG002|Up to Week 24|Other|3|||
27788285|NCT02181673|54242887|FG000|Up to Week 24|Randomized not Treated|0|||
27788286|NCT02181673|54242888|FG001|Up to Week 24|Randomized not Treated|0|||
27932206|NCT00950599|54588497|FG000|Follow-Up Period|Subject withdrew Consent|0|||
27932207|NCT00950599|54588498|FG001|Follow-Up Period|Subject withdrew Consent|0|||
27932208|NCT00950599|54588499|FG002|Follow-Up Period|Subject withdrew Consent|0|||
27932209|NCT00950599|54588500|FG003|Follow-Up Period|Subject withdrew Consent|0|||
27932210|NCT00950599|54588501|FG004|Follow-Up Period|Subject withdrew Consent|0|||
27788287|NCT02181673|54242889|FG002|Up to Week 24|Randomized not Treated|1|||
27788288|NCT02181673|54242887|FG000|Week 24-Week 60|Adverse Event|0|||
27788289|NCT02181673|54242888|FG001|Week 24-Week 60|Adverse Event|4|||
27788290|NCT02181673|54242889|FG002|Week 24-Week 60|Adverse Event|10|||
27788291|NCT02181673|54242887|FG000|Week 24-Week 60|Other|0|||
27788292|NCT02181673|54242888|FG001|Week 24-Week 60|Other|2|||
27788293|NCT02181673|54242889|FG002|Week 24-Week 60|Other|1|||
27788294|NCT02181673|54242887|FG000|Week 24-Week 60|Withdrawal by Subject|0|||
27788295|NCT02181673|54242888|FG001|Week 24-Week 60|Withdrawal by Subject|2|||
27788296|NCT02181673|54242889|FG002|Week 24-Week 60|Withdrawal by Subject|2|||
27788297|NCT02181673|54242887|FG000|Week 24-Week 60|Pregnancy|0|||
27788298|NCT02181673|54242888|FG001|Week 24-Week 60|Pregnancy|0|||
27788299|NCT02181673|54242889|FG002|Week 24-Week 60|Pregnancy|1|||
27788300|NCT02181673|54242887|FG000|Week 24-Week 60|Lack of Efficacy|0|||
27788301|NCT02181673|54242888|FG001|Week 24-Week 60|Lack of Efficacy|0|||
27932211|NCT00950599|54588502|FG005|Follow-Up Period|Subject withdrew Consent|0|||
27932212|NCT00950599|54588503|FG006|Follow-Up Period|Subject withdrew Consent|0|||
27932213|NCT00950599|54588504|FG007|Follow-Up Period|Subject withdrew Consent|0|||
27932214|NCT00950599|54588505|FG008|Follow-Up Period|Subject withdrew Consent|2|||
27932215|NCT00950599|54588506|FG009|Follow-Up Period|Subject withdrew Consent|1|||
27932216|NCT01144299|54588531|FG000|Overall Study|Lost to Follow-up|1|||
27932217|NCT01144299|54588532|FG001|Overall Study|Lost to Follow-up|0|||
27932218|NCT01144299|54588531|FG000|Overall Study|Withdrawal by Subject|1|||
27932219|NCT01144299|54588532|FG001|Overall Study|Withdrawal by Subject|0|||
27932220|NCT01143207|54588538|FG000|Overall Study|Lost to Follow-up|2|||
27932221|NCT01143051|54588548|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
27932222|NCT01143051|54588549|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
27932223|NCT01143051|54588550|FG002|3-14 Day Washout|Withdrawal by Subject|1|||
27932224|NCT01143051|54588551|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
27932225|NCT01143051|54588552|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
27932226|NCT01143051|54588553|FG005|3-14 Day Washout|Withdrawal by Subject|0|||
27932227|NCT01143051|54588548|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
27932228|NCT01143051|54588549|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
27932229|NCT01143051|54588550|FG002|3-14 Day Washout|Withdrawal by Subject|0|||
27932230|NCT01143051|54588551|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
27932231|NCT01143051|54588552|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
27932232|NCT01143051|54588553|FG005|3-14 Day Washout|Withdrawal by Subject|1|||
27932233|NCT01142661|54588563|FG000|Overall Study|Adverse Event|2|||
27932234|NCT01142661|54588563|FG000|Overall Study|Withdrawal by Subject|1|||
27932235|NCT01142661|54588563|FG000|Overall Study|Physician Decision|1|||
27932236|NCT01142193|54588569|FG000|Overall Study|Adverse Event|12|||
27932237|NCT01142193|54588570|FG001|Overall Study|Adverse Event|4|||
27932238|NCT01142193|54588569|FG000|Overall Study|Lack of Efficacy|2|||
27932239|NCT01142193|54588570|FG001|Overall Study|Lack of Efficacy|1|||
27932240|NCT01142193|54588569|FG000|Overall Study|Physician Decision|1|||
27932241|NCT01142193|54588570|FG001|Overall Study|Physician Decision|1|||
27932242|NCT01142193|54588569|FG000|Overall Study|Withdrawal by Subject|4|||
27932243|NCT01142193|54588570|FG001|Overall Study|Withdrawal by Subject|3|||
27932244|NCT01142193|54588569|FG000|Overall Study|Protocol Discontinuation Criterion Met|1|||
27932245|NCT01142193|54588570|FG001|Overall Study|Protocol Discontinuation Criterion Met|0|||
27932246|NCT01142193|54588569|FG000|Overall Study|Other|1|||
27932247|NCT01142193|54588570|FG001|Overall Study|Other|2|||
27932248|NCT01142115|54588576|FG000|First Intervention|Lack of Efficacy|1|||
27932249|NCT01142115|54588577|FG001|First Intervention|Lack of Efficacy|1|||
27932250|NCT01142115|54588576|FG000|First Intervention|Adverse Event|1|||
27932251|NCT01142115|54588577|FG001|First Intervention|Adverse Event|0|||
27932252|NCT01140477|54588584|FG000|Overall Study|Lost to Follow-up|4|||
27932253|NCT01140477|54588585|FG001|Overall Study|Lost to Follow-up|0|||
27932254|NCT01140477|54588584|FG000|Overall Study|Withdrawal by Subject|1|||
27932255|NCT01140477|54588585|FG001|Overall Study|Withdrawal by Subject|4|||
27932256|NCT01140477|54588584|FG000|Overall Study|Surgical complication preventing implant|2|||
27932257|NCT01140477|54588585|FG001|Overall Study|Surgical complication preventing implant|0|||
27932258|NCT01140477|54588584|FG000|Overall Study|Death|1|||
27932259|NCT01140477|54588585|FG001|Overall Study|Death|1|||
27932260|NCT01140477|54588584|FG000|Overall Study|Subject explanted|0|||
27932261|NCT01140477|54588585|FG001|Overall Study|Subject explanted|1|||
27932262|NCT01139775|54588594|FG000|Overall Study|Adverse Event|0|||
27932263|NCT01139775|54588595|FG001|Overall Study|Adverse Event|6|||
27932264|NCT01139775|54588596|FG002|Overall Study|Adverse Event|2|||
27932265|NCT01139775|54588594|FG000|Overall Study|Protocol Violation|0|||
27932266|NCT01139775|54588595|FG001|Overall Study|Protocol Violation|5|||
27932267|NCT01139775|54588596|FG002|Overall Study|Protocol Violation|0|||
27932268|NCT01139775|54588594|FG000|Overall Study|Withdrawal by Subject|1|||
27932269|NCT01139775|54588595|FG001|Overall Study|Withdrawal by Subject|0|||
27932270|NCT01139775|54588596|FG002|Overall Study|Withdrawal by Subject|2|||
27932271|NCT01139775|54588594|FG000|Overall Study|Physician Decision|0|||
27788302|NCT02181673|54242889|FG002|Week 24-Week 60|Lack of Efficacy|1|||
27932272|NCT01139775|54588595|FG001|Overall Study|Physician Decision|2|||
27932273|NCT01139775|54588596|FG002|Overall Study|Physician Decision|2|||
27932274|NCT01283516|54588615|FG000|Overall Study|Adverse Event|0|||
27932275|NCT01283516|54588616|FG001|Overall Study|Adverse Event|0|||
27932276|NCT01283516|54588617|FG002|Overall Study|Adverse Event|0|||
27932277|NCT01283516|54588618|FG003|Overall Study|Adverse Event|0|||
27932278|NCT01283516|54588619|FG004|Overall Study|Adverse Event|0|||
27932279|NCT01283516|54588620|FG005|Overall Study|Adverse Event|0|||
27932280|NCT01283516|54588621|FG006|Overall Study|Adverse Event|2|||
27788303|NCT02181673|54242887|FG000|Week 24-Week 60|Lost to Follow-up|0|||
27932281|NCT01283516|54588622|FG007|Overall Study|Adverse Event|0|||
27932282|NCT01283516|54588623|FG008|Overall Study|Adverse Event|28|||
27932283|NCT01283516|54588615|FG000|Overall Study|Death|0|||
27932284|NCT01283516|54588616|FG001|Overall Study|Death|0|||
27932285|NCT01283516|54588617|FG002|Overall Study|Death|0|||
27932286|NCT01283516|54588618|FG003|Overall Study|Death|0|||
27932287|NCT01283516|54588619|FG004|Overall Study|Death|0|||
27932288|NCT01283516|54588620|FG005|Overall Study|Death|1|||
27932289|NCT01283516|54588621|FG006|Overall Study|Death|0|||
27932290|NCT01283516|54588622|FG007|Overall Study|Death|1|||
27932291|NCT01283516|54588623|FG008|Overall Study|Death|12|||
27932292|NCT01283516|54588615|FG000|Overall Study|Disease Progression|2|||
27932293|NCT01283516|54588616|FG001|Overall Study|Disease Progression|2|||
27932294|NCT01283516|54588617|FG002|Overall Study|Disease Progression|3|||
27932295|NCT01283516|54588618|FG003|Overall Study|Disease Progression|3|||
27932296|NCT01283516|54588619|FG004|Overall Study|Disease Progression|13|||
27932297|NCT01283516|54588620|FG005|Overall Study|Disease Progression|8|||
27932298|NCT01283516|54588621|FG006|Overall Study|Disease Progression|6|||
27932299|NCT01283516|54588622|FG007|Overall Study|Disease Progression|3|||
27932300|NCT01283516|54588623|FG008|Overall Study|Disease Progression|139|||
27932301|NCT01283516|54588615|FG000|Overall Study|Withdrawal by Subject|0|||
28016962|NCT00683774|54676202|FG000|Overall Study|Physician Decision|3|||
28016963|NCT00683774|54676203|FG001|Overall Study|Physician Decision|0|||
28016964|NCT00354679|54676209|FG000|Overall Study|Patient Not Treated|1|||
28016965|NCT00683696|54676215|FG000|Overall Study|Withdrawn due to study closure|337|||
28016966|NCT00683696|54676216|FG001|Overall Study|Withdrawn due to study closure|338|||
28016967|NCT00683696|54676215|FG000|Overall Study|Withdrawn prior to study closure|13|||
28016968|NCT00683696|54676216|FG001|Overall Study|Withdrawn prior to study closure|28|||
28016969|NCT00683696|54676215|FG000|Overall Study|Lost to Follow-up|5|||
27788304|NCT02181673|54242888|FG001|Week 24-Week 60|Lost to Follow-up|0|||
27788305|NCT02181673|54242889|FG002|Week 24-Week 60|Lost to Follow-up|1|||
27788306|NCT02181673|54242887|FG000|Week 24-Week 60|Physician Decision|0|||
27788307|NCT02181673|54242888|FG001|Week 24-Week 60|Physician Decision|0|||
27788308|NCT02181673|54242889|FG002|Week 24-Week 60|Physician Decision|1|||
27788309|NCT02131129|54242898|FG000|Overall Study|Withdrawal by Subject|1|||
27788310|NCT02131129|54242899|FG001|Overall Study|Withdrawal by Subject|0|||
27788311|NCT02152345|54242907|FG000|Overall Study|Case Cancellations|2|||
27788312|NCT02152345|54242908|FG001|Overall Study|Case Cancellations|4|||
27788313|NCT02152345|54242907|FG000|Overall Study|Withdrawal by Subject|2|||
27788314|NCT02152345|54242908|FG001|Overall Study|Withdrawal by Subject|1|||
27788315|NCT02180659|54242916|FG000|Overall Study|Adverse Event|1|||
27788316|NCT02180659|54242917|FG001|Overall Study|Adverse Event|0|||
27788317|NCT02180659|54242916|FG000|Overall Study|Lost to Follow-up|4|||
27788318|NCT02180659|54242917|FG001|Overall Study|Lost to Follow-up|2|||
27788319|NCT02180659|54242916|FG000|Overall Study|Subject incarcerated during conduct|1|||
27788320|NCT02180659|54242917|FG001|Overall Study|Subject incarcerated during conduct|0|||
27788321|NCT02180659|54242916|FG000|Overall Study|Withdrawal by Subject|0|||
27788322|NCT02180659|54242917|FG001|Overall Study|Withdrawal by Subject|2|||
27788323|NCT02180659|54242916|FG000|Overall Study|AT REQUEST OF THE SPONSOR|0|||
27788324|NCT02180659|54242917|FG001|Overall Study|AT REQUEST OF THE SPONSOR|1|||
27788325|NCT02130427|54242923|FG000|Overall Study|Imaging results not interpretable|30|||
27788326|NCT02207816|54242930|FG000|Overall Study|Serious Adverse Event|0|||
27788327|NCT02207816|54242931|FG001|Overall Study|Serious Adverse Event|5|||
27788328|NCT02207816|54242932|FG002|Overall Study|Serious Adverse Event|2|||
27788329|NCT02207816|54242930|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
27788330|NCT02207816|54242931|FG001|Overall Study|Eligibility Criteria Not Fulfilled|1|||
27788331|NCT02207816|54242932|FG002|Overall Study|Eligibility Criteria Not Fulfilled|2|||
28016970|NCT00683696|54676216|FG001|Overall Study|Lost to Follow-up|6|||
28016971|NCT00683696|54676215|FG000|Overall Study|Vital status follow-up only|3|||
28016972|NCT00683696|54676216|FG001|Overall Study|Vital status follow-up only|3|||
28016973|NCT00683696|54676215|FG000|Overall Study|Death|46|||
28016974|NCT00683696|54676216|FG001|Overall Study|Death|30|||
28016975|NCT00345631|54676226|FG000|Overall Study|Withdrawal by Subject|1|||
28016976|NCT00345631|54676227|FG001|Overall Study|Withdrawal by Subject|0|||
27788332|NCT02207816|54242930|FG000|Overall Study|Withdrawal by Subject|4|||
27788333|NCT02207816|54242931|FG001|Overall Study|Withdrawal by Subject|9|||
27788334|NCT02207816|54242932|FG002|Overall Study|Withdrawal by Subject|7|||
27788335|NCT02207816|54242930|FG000|Overall Study|Migrated/Moved From Study Area|41|||
27932302|NCT01283516|54588616|FG001|Overall Study|Withdrawal by Subject|0|||
28016977|NCT00345631|54676228|FG002|Overall Study|Withdrawal by Subject|1|||
27788336|NCT02207816|54242931|FG001|Overall Study|Migrated/Moved From Study Area|60|||
28016978|NCT00345631|54676226|FG000|Overall Study|Adverse Event|0|||
27788337|NCT02207816|54242932|FG002|Overall Study|Migrated/Moved From Study Area|51|||
27932303|NCT01283516|54588617|FG002|Overall Study|Withdrawal by Subject|0|||
27932304|NCT01283516|54588618|FG003|Overall Study|Withdrawal by Subject|0|||
27932305|NCT01283516|54588619|FG004|Overall Study|Withdrawal by Subject|1|||
28016979|NCT00345631|54676227|FG001|Overall Study|Adverse Event|1|||
28016980|NCT00345631|54676228|FG002|Overall Study|Adverse Event|0|||
28016981|NCT00345631|54676226|FG000|Overall Study|Lost to Follow-up|3|||
28016982|NCT00345631|54676227|FG001|Overall Study|Lost to Follow-up|7|||
27842400|NCT01449461|54330853|FG004|Overall Study|Reason not Specified|2|||
27932306|NCT01283516|54588620|FG005|Overall Study|Withdrawal by Subject|0|||
27932307|NCT01283516|54588621|FG006|Overall Study|Withdrawal by Subject|1|||
27932308|NCT01283516|54588622|FG007|Overall Study|Withdrawal by Subject|0|||
27932309|NCT01283516|54588623|FG008|Overall Study|Withdrawal by Subject|36|||
27932310|NCT01283516|54588615|FG000|Overall Study|Administrative problems|0|||
27932311|NCT01283516|54588616|FG001|Overall Study|Administrative problems|0|||
27932312|NCT01283516|54588617|FG002|Overall Study|Administrative problems|0|||
27932313|NCT01283516|54588618|FG003|Overall Study|Administrative problems|0|||
27932314|NCT01283516|54588619|FG004|Overall Study|Administrative problems|0|||
27932315|NCT01283516|54588620|FG005|Overall Study|Administrative problems|1|||
27932316|NCT01283516|54588621|FG006|Overall Study|Administrative problems|1|||
27932317|NCT01283516|54588622|FG007|Overall Study|Administrative problems|1|||
27932318|NCT01283516|54588623|FG008|Overall Study|Administrative problems|39|||
27932319|NCT01283516|54588615|FG000|Overall Study|Lost to Follow-up|0|||
27932320|NCT01283516|54588616|FG001|Overall Study|Lost to Follow-up|0|||
27932321|NCT01283516|54588617|FG002|Overall Study|Lost to Follow-up|0|||
27932322|NCT01283516|54588618|FG003|Overall Study|Lost to Follow-up|0|||
27932323|NCT01283516|54588619|FG004|Overall Study|Lost to Follow-up|0|||
27932324|NCT01283516|54588620|FG005|Overall Study|Lost to Follow-up|0|||
27932325|NCT01283516|54588621|FG006|Overall Study|Lost to Follow-up|0|||
27932326|NCT01283516|54588622|FG007|Overall Study|Lost to Follow-up|0|||
27932327|NCT01283516|54588623|FG008|Overall Study|Lost to Follow-up|1|||
27932328|NCT01137435|54588651|FG000|Overall Study|Lost to Follow-up|24|||
27932329|NCT01137435|54588651|FG000|Overall Study|Off label usage|4|||
27932330|NCT01283282|54588655|FG000|First Intervention (6 Weeks)|Physician Decision|0|||
27932331|NCT01283282|54588656|FG001|First Intervention (6 Weeks)|Physician Decision|1|||
27932332|NCT01283282|54588655|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|2|||
27932333|NCT01283282|54588656|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|3|||
27932334|NCT01283282|54588655|FG000|First Intervention (6 Weeks)|Lost to Follow-up|1|||
27932335|NCT01283282|54588656|FG001|First Intervention (6 Weeks)|Lost to Follow-up|0|||
27932336|NCT01282814|54588665|FG000|First Intervention|Emesis During Dosing Interval|0|||
27932337|NCT01282814|54588666|FG001|First Intervention|Emesis During Dosing Interval|3|||
27932338|NCT01282814|54588665|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
27932339|NCT01282814|54588666|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
27932340|NCT00941863|54588677|FG000|Until Primary Completion Date (PCD)|Adverse Event|1|||
27932341|NCT00941863|54588678|FG001|Until Primary Completion Date (PCD)|Adverse Event|2|||
27932342|NCT00941863|54588679|FG002|Until Primary Completion Date (PCD)|Adverse Event|2|||
27932343|NCT00941863|54588680|FG003|Until Primary Completion Date (PCD)|Adverse Event|1|||
27932344|NCT00941863|54588681|FG004|Until Primary Completion Date (PCD)|Adverse Event|5|||
27932345|NCT00941863|54588677|FG000|Until Primary Completion Date (PCD)|Physician Decision|0|||
27932346|NCT00941863|54588678|FG001|Until Primary Completion Date (PCD)|Physician Decision|0|||
27932347|NCT00941863|54588679|FG002|Until Primary Completion Date (PCD)|Physician Decision|0|||
27932348|NCT00941863|54588680|FG003|Until Primary Completion Date (PCD)|Physician Decision|0|||
27932349|NCT00941863|54588681|FG004|Until Primary Completion Date (PCD)|Physician Decision|1|||
27932350|NCT00941863|54588677|FG000|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
27932351|NCT00941863|54588678|FG001|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
27932352|NCT00941863|54588679|FG002|Until Primary Completion Date (PCD)|Withdrawal by Subject|1|||
27932353|NCT00941863|54588680|FG003|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
27932354|NCT00941863|54588681|FG004|Until Primary Completion Date (PCD)|Withdrawal by Subject|8|||
27932355|NCT00941863|54588677|FG000|Until Primary Completion Date (PCD)|Death|0|||
27932356|NCT00941863|54588678|FG001|Until Primary Completion Date (PCD)|Death|0|||
27932357|NCT00941863|54588679|FG002|Until Primary Completion Date (PCD)|Death|1|||
27932358|NCT00941863|54588680|FG003|Until Primary Completion Date (PCD)|Death|2|||
27932359|NCT00941863|54588681|FG004|Until Primary Completion Date (PCD)|Death|7|||
27932360|NCT00941863|54588677|FG000|Until Primary Completion Date (PCD)|Disease progression|6|||
27932361|NCT00941863|54588678|FG001|Until Primary Completion Date (PCD)|Disease progression|1|||
27932362|NCT00941863|54588679|FG002|Until Primary Completion Date (PCD)|Disease progression|8|||
27842401|NCT01449461|54330854|FG005|Overall Study|Reason not Specified|1|||
27842402|NCT01572038|54330890|FG000|Overall Study|Death|648|||
27842403|NCT01572038|54330890|FG000|Overall Study|Withdrawal by Subject|204|||
27842404|NCT01572038|54330890|FG000|Overall Study|Lost to Follow-up|81|||
27842405|NCT01572038|54330890|FG000|Overall Study|Physician Decision|20|||
27842406|NCT01572038|54330890|FG000|Overall Study|Patient Decision|14|||
27842407|NCT01572038|54330890|FG000|Overall Study|Progressive Disease|8|||
27842408|NCT01572038|54330890|FG000|Overall Study|Site Closed Before Completing Form|6|||
27842409|NCT01572038|54330890|FG000|Overall Study|Enrolled into Another Trial|3|||
27842410|NCT01572038|54330890|FG000|Overall Study|Participated in Another Trial|3|||
27842411|NCT01572038|54330890|FG000|Overall Study|Termination by Sponsor|2|||
27842412|NCT01572038|54330890|FG000|Overall Study|Patient Deterioration|1|||
27842413|NCT01572038|54330890|FG000|Overall Study|Sponsor Decision|1|||
27932363|NCT00941863|54588680|FG003|Until Primary Completion Date (PCD)|Disease progression|14|||
27932364|NCT00941863|54588681|FG004|Until Primary Completion Date (PCD)|Disease progression|73|||
27932365|NCT00941863|54588677|FG000|Continued After PCD|Withdrawal by Subject|0|||
27932366|NCT00941863|54588678|FG001|Continued After PCD|Withdrawal by Subject|0|||
27932367|NCT00941863|54588679|FG002|Continued After PCD|Withdrawal by Subject|0|||
27932368|NCT00941863|54588680|FG003|Continued After PCD|Withdrawal by Subject|0|||
27932369|NCT00941863|54588681|FG004|Continued After PCD|Withdrawal by Subject|1|||
27932370|NCT00941863|54588677|FG000|Continued After PCD|Disease progression, recurrence, relapse|0|||
27932371|NCT00941863|54588678|FG001|Continued After PCD|Disease progression, recurrence, relapse|0|||
27932372|NCT00941863|54588679|FG002|Continued After PCD|Disease progression, recurrence, relapse|0|||
27932373|NCT00941863|54588680|FG003|Continued After PCD|Disease progression, recurrence, relapse|0|||
27932374|NCT00941863|54588681|FG004|Continued After PCD|Disease progression, recurrence, relapse|18|||
27932375|NCT01282424|54588697|FG000|Treatment Period (TP) (81 Months)|Adverse Event|30|||
27932376|NCT01282424|54588697|FG000|Treatment Period (TP) (81 Months)|Withdrew Consent|6|||
27932377|NCT01282424|54588697|FG000|Treatment Period (TP) (81 Months)|Investigator Request|7|||
27932378|NCT01282424|54588697|FG000|Treatment Period (TP) (81 Months)|Other (Unknown)|3|||
27932379|NCT01282424|54588697|FG000|Long-term Follow-up Period (5 Years)|Withdrew Consent|2|||
27932380|NCT01282424|54588697|FG000|Long-term Follow-up Period (5 Years)|Death|40|||
27932381|NCT01282424|54588697|FG000|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1|||
27932382|NCT01282424|54588697|FG000|Long-term Follow-up Period (5 Years)|Other (Unknown)|21|||
27932383|NCT01281956|54588701|FG000|2nd Intervention (3 Months)|Withdrawal by Subject|1|||
27932384|NCT01281956|54588702|FG001|2nd Intervention (3 Months)|Withdrawal by Subject|0|||
27932385|NCT01279850|54588711|FG000|Overall Study|Protocol Violation|50|||
27932386|NCT01279850|54588711|FG000|Overall Study|No Drug Administration Information|7|||
27932387|NCT01279850|54588711|FG000|Overall Study|No Visit After Treatment|34|||
27932388|NCT00949975|54588719|FG000|Overall Study|Voluntary discontinuation|6|||
27932389|NCT00949975|54588720|FG001|Overall Study|Voluntary discontinuation|5|||
27932390|NCT00949975|54588721|FG002|Overall Study|Voluntary discontinuation|3|||
27932391|NCT00949975|54588722|FG003|Overall Study|Voluntary discontinuation|6|||
27932392|NCT00949975|54588719|FG000|Overall Study|Adverse Event|11|||
27932393|NCT00949975|54588720|FG001|Overall Study|Adverse Event|11|||
27932394|NCT00949975|54588721|FG002|Overall Study|Adverse Event|10|||
27932395|NCT00949975|54588722|FG003|Overall Study|Adverse Event|10|||
27932396|NCT00949975|54588719|FG000|Overall Study|Safety reason|0|||
27932397|NCT00949975|54588720|FG001|Overall Study|Safety reason|1|||
27932398|NCT00949975|54588721|FG002|Overall Study|Safety reason|0|||
27932399|NCT00949975|54588722|FG003|Overall Study|Safety reason|0|||
27932400|NCT00949975|54588719|FG000|Overall Study|Study-specific criteria|0|||
27932401|NCT00949975|54588720|FG001|Overall Study|Study-specific criteria|1|||
27932402|NCT00949975|54588721|FG002|Overall Study|Study-specific criteria|1|||
27932403|NCT00949975|54588722|FG003|Overall Study|Study-specific criteria|0|||
27932404|NCT00949975|54588719|FG000|Overall Study|Incorrect enrolment|5|||
27932405|NCT00949975|54588720|FG001|Overall Study|Incorrect enrolment|10|||
27932406|NCT00949975|54588721|FG002|Overall Study|Incorrect enrolment|4|||
27932407|NCT00949975|54588722|FG003|Overall Study|Incorrect enrolment|7|||
27932408|NCT00949975|54588719|FG000|Overall Study|Severe non-compliance|3|||
27932409|NCT00949975|54588720|FG001|Overall Study|Severe non-compliance|1|||
27932410|NCT00949975|54588721|FG002|Overall Study|Severe non-compliance|0|||
27932411|NCT00949975|54588722|FG003|Overall Study|Severe non-compliance|2|||
27932412|NCT00949975|54588719|FG000|Overall Study|Lost to Follow-up|1|||
27932413|NCT00949975|54588720|FG001|Overall Study|Lost to Follow-up|0|||
27932414|NCT00949975|54588721|FG002|Overall Study|Lost to Follow-up|1|||
27932415|NCT00949975|54588722|FG003|Overall Study|Lost to Follow-up|3|||
27932416|NCT00949975|54588719|FG000|Overall Study|Other|1|||
27932417|NCT00949975|54588720|FG001|Overall Study|Other|0|||
27932418|NCT00949975|54588721|FG002|Overall Study|Other|0|||
27932419|NCT00949975|54588722|FG003|Overall Study|Other|0|||
27932420|NCT00939055|54588734|FG000|Overall Study|Discontinuation prior to procedure|4|||
27932421|NCT00939055|54588735|FG001|Overall Study|Discontinuation prior to procedure|0|||
27932422|NCT01136967|54588744|FG000|Overall Study|Adverse Event|9|||
27932423|NCT01136967|54588745|FG001|Overall Study|Adverse Event|12|||
27932424|NCT01136967|54588744|FG000|Overall Study|Participant Choice|8|||
27932425|NCT01136967|54588745|FG001|Overall Study|Participant Choice|3|||
27932426|NCT01136967|54588744|FG000|Overall Study|Lost to Follow-up|0|||
27932427|NCT01136967|54588745|FG001|Overall Study|Lost to Follow-up|1|||
27932428|NCT01136967|54588744|FG000|Overall Study|Withdrawal by Subject|1|||
27932429|NCT01136967|54588745|FG001|Overall Study|Withdrawal by Subject|2|||
27932430|NCT01136967|54588744|FG000|Overall Study|Clinical Progression|3|||
27932431|NCT01136967|54588745|FG001|Overall Study|Clinical Progression|5|||
27932432|NCT01136967|54588744|FG000|Overall Study|Radiation|1|||
27932433|NCT01136967|54588745|FG001|Overall Study|Radiation|0|||
27932434|NCT01136967|54588744|FG000|Overall Study|Non-compliance|1|||
27932435|NCT01136967|54588745|FG001|Overall Study|Non-compliance|0|||
27932436|NCT01136967|54588744|FG000|Overall Study|Investigator's Choice|1|||
27932437|NCT01136967|54588745|FG001|Overall Study|Investigator's Choice|1|||
27932438|NCT01136967|54588744|FG000|Overall Study|Increase in Lesion Size|0|||
27932439|NCT01136967|54588745|FG001|Overall Study|Increase in Lesion Size|2|||
27788338|NCT02207816|54242930|FG000|Overall Study|Lost to Follow-up|3|||
27788339|NCT02207816|54242931|FG001|Overall Study|Lost to Follow-up|9|||
27788340|NCT02207816|54242932|FG002|Overall Study|Lost to Follow-up|1|||
27788341|NCT02207816|54242930|FG000|Overall Study|Other|1|||
27788342|NCT02207816|54242931|FG001|Overall Study|Other|2|||
27788343|NCT02207816|54242932|FG002|Overall Study|Other|4|||
27788344|NCT02241512|54242945|FG000|Overall Study|Pump malfunction, drug not delivered|1|||
27788345|NCT02241512|54242946|FG001|Overall Study|Pump malfunction, drug not delivered|0|||
27788346|NCT02205476|54242954|FG000|Overall Study|Study termination by Sponsor|7|||
27788347|NCT02205476|54242955|FG001|Overall Study|Study termination by Sponsor|3|||
27788348|NCT01709110|54242969|FG000|Overall Study|Adverse Event|56|||
27788349|NCT01709110|54242970|FG001|Overall Study|Adverse Event|48|||
27788350|NCT01709110|54242969|FG000|Overall Study|Death|14|||
27788351|NCT01709110|54242970|FG001|Overall Study|Death|6|||
27788352|NCT01709110|54242969|FG000|Overall Study|Lost to Follow-up|7|||
27788353|NCT01709110|54242970|FG001|Overall Study|Lost to Follow-up|5|||
27788354|NCT01709110|54242969|FG000|Overall Study|Protocol Violation|4|||
27788355|NCT01709110|54242970|FG001|Overall Study|Protocol Violation|6|||
27788356|NCT01709110|54242969|FG000|Overall Study|Withdrawal by Subject|96|||
27788357|NCT01709110|54242970|FG001|Overall Study|Withdrawal by Subject|89|||
27788358|NCT01709110|54242969|FG000|Overall Study|Physician Decision|4|||
27788359|NCT01709110|54242970|FG001|Overall Study|Physician Decision|10|||
27788360|NCT01709110|54242969|FG000|Overall Study|Sponsor Decision|2|||
27788361|NCT01709110|54242970|FG001|Overall Study|Sponsor Decision|2|||
27788362|NCT01709110|54242969|FG000|Overall Study|Lack of Efficacy|1|||
27788363|NCT01709110|54242970|FG001|Overall Study|Lack of Efficacy|1|||
27788364|NCT01709110|54242969|FG000|Overall Study|Caregiver Decision|1|||
27788365|NCT01709110|54242970|FG001|Overall Study|Caregiver Decision|1|||
27788366|NCT02240108|54242978|FG000|Overall Study|Other than specified|8|||
27788367|NCT02240108|54242979|FG001|Overall Study|Other than specified|6|||
27788368|NCT02240108|54242978|FG000|Overall Study|Adverse Event|1|||
27788369|NCT02240108|54242979|FG001|Overall Study|Adverse Event|9|||
27788370|NCT02240108|54242978|FG000|Overall Study|Pregnancy|1|||
27788371|NCT02240108|54242979|FG001|Overall Study|Pregnancy|0|||
27788372|NCT02240108|54242978|FG000|Overall Study|Withdrawal by Subject|4|||
27788373|NCT02240108|54242979|FG001|Overall Study|Withdrawal by Subject|9|||
27788374|NCT02240108|54242978|FG000|Overall Study|StudyTerminated by Sponsor|0|||
27788375|NCT02240108|54242979|FG001|Overall Study|StudyTerminated by Sponsor|1|||
27788376|NCT02239640|54242985|FG000|Overall Study|Withdrawal by Subject|3|||
27788377|NCT02239640|54242985|FG000|Overall Study|Lost to Follow-up|72|||
27788378|NCT02239640|54242985|FG000|Overall Study|Death|142|||
27788379|NCT01590628|54242997|FG000|Overall Study|Death|2|||
27788380|NCT01590628|54242998|FG001|Overall Study|Death|0|||
27788381|NCT02130193|54243010|FG000|Part B: 52-week Double-blind Period|Adverse Event|0|||
27788382|NCT02130193|54243011|FG001|Part B: 52-week Double-blind Period|Adverse Event|5|||
27788383|NCT02130193|54243012|FG002|Part B: 52-week Double-blind Period|Adverse Event|3|||
27788384|NCT02130193|54243010|FG000|Part B: 52-week Double-blind Period|Protocol Violation|0|||
27788385|NCT02130193|54243011|FG001|Part B: 52-week Double-blind Period|Protocol Violation|2|||
27788386|NCT02130193|54243012|FG002|Part B: 52-week Double-blind Period|Protocol Violation|1|||
27788387|NCT02130193|54243010|FG000|Part B: 52-week Double-blind Period|Physician Decision|0|||
27788388|NCT02130193|54243011|FG001|Part B: 52-week Double-blind Period|Physician Decision|0|||
27788389|NCT02130193|54243012|FG002|Part B: 52-week Double-blind Period|Physician Decision|1|||
27788390|NCT02130193|54243010|FG000|Part B: 52-week Double-blind Period|Withdrawal by Subject|0|||
27788391|NCT02130193|54243011|FG001|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
27788392|NCT02130193|54243012|FG002|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
27788393|NCT01590082|54243023|FG000|Overall Study|Withdrawal by Subject|1|||
27788394|NCT01590082|54243024|FG001|Overall Study|Withdrawal by Subject|0|||
27788395|NCT01590082|54243023|FG000|Overall Study|Ineligible|1|||
27788396|NCT01590082|54243024|FG001|Overall Study|Ineligible|0|||
27788397|NCT01631474|54243035|FG000|Overall Study|Lost to Follow-up|8|||
27788398|NCT01631474|54243036|FG001|Overall Study|Lost to Follow-up|5|||
27788399|NCT01631474|54243037|FG002|Overall Study|Lost to Follow-up|7|||
27788400|NCT01631474|54243038|FG003|Overall Study|Lost to Follow-up|5|||
27788401|NCT01631474|54243039|FG004|Overall Study|Lost to Follow-up|5|||
27788402|NCT01631474|54243035|FG000|Overall Study|Withdrawal by Subject|4|||
27788403|NCT01631474|54243036|FG001|Overall Study|Withdrawal by Subject|4|||
27788404|NCT01631474|54243037|FG002|Overall Study|Withdrawal by Subject|2|||
27788405|NCT01631474|54243038|FG003|Overall Study|Withdrawal by Subject|6|||
27788406|NCT01631474|54243039|FG004|Overall Study|Withdrawal by Subject|5|||
27788407|NCT01631474|54243035|FG000|Overall Study|Lack of Efficacy|2|||
27788408|NCT01631474|54243036|FG001|Overall Study|Lack of Efficacy|2|||
27788409|NCT01631474|54243037|FG002|Overall Study|Lack of Efficacy|0|||
27788410|NCT01631474|54243038|FG003|Overall Study|Lack of Efficacy|0|||
27788411|NCT01631474|54243039|FG004|Overall Study|Lack of Efficacy|2|||
27788412|NCT01631474|54243035|FG000|Overall Study|Noncompliance with Study Drug|0|||
27932440|NCT01136967|54588744|FG000|Overall Study|Diagnosis of Second Primary Cancer|0|||
27932441|NCT01136967|54588745|FG001|Overall Study|Diagnosis of Second Primary Cancer|1|||
27932442|NCT01218516|54588753|FG000|Combination Therapy (up to 4.5 Months)|Death|2|||
27788413|NCT01631474|54243036|FG001|Overall Study|Noncompliance with Study Drug|0|||
27788414|NCT01631474|54243037|FG002|Overall Study|Noncompliance with Study Drug|0|||
27788415|NCT01631474|54243038|FG003|Overall Study|Noncompliance with Study Drug|0|||
27788416|NCT01631474|54243039|FG004|Overall Study|Noncompliance with Study Drug|1|||
27788417|NCT01631474|54243035|FG000|Overall Study|Adverse Event|0|||
27788418|NCT01631474|54243036|FG001|Overall Study|Adverse Event|1|||
27932443|NCT01218516|54588754|FG001|Combination Therapy (up to 4.5 Months)|Death|1|||
27932444|NCT01218516|54588755|FG002|Combination Therapy (up to 4.5 Months)|Death|0|||
27932445|NCT01218516|54588756|FG003|Combination Therapy (up to 4.5 Months)|Death|0|||
27932446|NCT01218516|54588753|FG000|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
27932447|NCT01218516|54588754|FG001|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3|||
27932448|NCT01218516|54588755|FG002|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
27932449|NCT01218516|54588756|FG003|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
27932450|NCT01218516|54588753|FG000|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
27932451|NCT01218516|54588754|FG001|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
27932452|NCT01218516|54588755|FG002|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
27932453|NCT01218516|54588756|FG003|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
27932454|NCT01218516|54588753|FG000|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2|||
27932455|NCT01218516|54588754|FG001|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
27932456|NCT01218516|54588755|FG002|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
27932457|NCT01218516|54588756|FG003|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
27932458|NCT01218516|54588753|FG000|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17|||
27932459|NCT01218516|54588754|FG001|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15|||
27932460|NCT01218516|54588755|FG002|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
27932461|NCT01218516|54588756|FG003|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
27932462|NCT01218516|54588753|FG000|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
27932463|NCT01218516|54588754|FG001|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1|||
27932464|NCT01218516|54588755|FG002|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
27932465|NCT01218516|54588756|FG003|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
27932466|NCT01218516|54588753|FG000|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
27932467|NCT01218516|54588754|FG001|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1|||
27932468|NCT01218516|54588755|FG002|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
27932469|NCT01218516|54588756|FG003|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
27932470|NCT01218516|54588753|FG000|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
27932471|NCT01218516|54588754|FG001|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3|||
27932472|NCT01218516|54588755|FG002|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
27932473|NCT01218516|54588756|FG003|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
27932474|NCT01218516|54588753|FG000|Combination Therapy (up to 4.5 Months)|Other|3|||
27932475|NCT01218516|54588754|FG001|Combination Therapy (up to 4.5 Months)|Other|4|||
27932476|NCT01218516|54588755|FG002|Combination Therapy (up to 4.5 Months)|Other|0|||
27932477|NCT01218516|54588756|FG003|Combination Therapy (up to 4.5 Months)|Other|0|||
27932478|NCT01218516|54588753|FG000|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
27932479|NCT01218516|54588754|FG001|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1|||
27932480|NCT01218516|54588755|FG002|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
27932481|NCT01218516|54588756|FG003|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
27932482|NCT01218516|54588753|FG000|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2|||
27788419|NCT01631474|54243037|FG002|Overall Study|Adverse Event|0|||
27788420|NCT01631474|54243038|FG003|Overall Study|Adverse Event|0|||
27842414|NCT01448213|54330918|FG000|Overall Study|Lost to Follow-up|12|||
27842415|NCT01448213|54330919|FG001|Overall Study|Lost to Follow-up|10|||
27842416|NCT01448213|54330918|FG000|Overall Study|Adverse Event|4|||
27842417|NCT01448213|54330919|FG001|Overall Study|Adverse Event|10|||
27842418|NCT01448213|54330918|FG000|Overall Study|Protocol Violation|1|||
27842419|NCT01448213|54330919|FG001|Overall Study|Protocol Violation|2|||
27842420|NCT01448057|54330936|FG000|Overall Study|Protocol Violation|3|||
27842421|NCT01448057|54330937|FG001|Overall Study|Protocol Violation|2|||
27842422|NCT01448057|54330936|FG000|Overall Study|Lost to Follow-up|3|||
27842423|NCT01448057|54330937|FG001|Overall Study|Lost to Follow-up|0|||
27842424|NCT01448057|54330936|FG000|Overall Study|Adverse Event|0|||
27788421|NCT01631474|54243039|FG004|Overall Study|Adverse Event|0|||
27788422|NCT02203916|54243054|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
27842425|NCT01448057|54330937|FG001|Overall Study|Adverse Event|2|||
27842426|NCT01448057|54330936|FG000|Overall Study|Withdrawal by Subject|2|||
27842427|NCT01448057|54330937|FG001|Overall Study|Withdrawal by Subject|0|||
27932483|NCT01218516|54588754|FG001|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3|||
27932484|NCT01218516|54588755|FG002|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
27932485|NCT01218516|54588756|FG003|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
27932486|NCT01218516|54588753|FG000|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
27932487|NCT01218516|54588754|FG001|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
27932488|NCT01218516|54588755|FG002|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
27932489|NCT01218516|54588756|FG003|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
27932490|NCT00938431|54588769|FG000|Overall Study|Adverse Event|5|||
27932491|NCT00938431|54588770|FG001|Overall Study|Adverse Event|8|||
27932492|NCT00938431|54588771|FG002|Overall Study|Adverse Event|6|||
27932493|NCT00938431|54588769|FG000|Overall Study|Lack of Efficacy|0|||
27932494|NCT00938431|54588770|FG001|Overall Study|Lack of Efficacy|1|||
27932495|NCT00938431|54588771|FG002|Overall Study|Lack of Efficacy|0|||
27932496|NCT00938431|54588769|FG000|Overall Study|Did not up titrate to 12 mg kg/day|1|||
27932497|NCT00938431|54588770|FG001|Overall Study|Did not up titrate to 12 mg kg/day|0|||
27932498|NCT00938431|54588771|FG002|Overall Study|Did not up titrate to 12 mg kg/day|0|||
27932499|NCT00938431|54588769|FG000|Overall Study|Dosing compliance issue|0|||
27932500|NCT00938431|54588770|FG001|Overall Study|Dosing compliance issue|0|||
27932501|NCT00938431|54588771|FG002|Overall Study|Dosing compliance issue|1|||
27932502|NCT00938431|54588769|FG000|Overall Study|Reached maximum dose early|0|||
27932503|NCT00938431|54588770|FG001|Overall Study|Reached maximum dose early|0|||
27932504|NCT00938431|54588771|FG002|Overall Study|Reached maximum dose early|1|||
27932505|NCT01136811|54588783|FG000|Overall Study|Physician Decision|11|||
27932506|NCT00949117|54588789|FG000|Overall Study|Lack of Efficacy|2|||
27932507|NCT00949117|54588790|FG001|Overall Study|Lack of Efficacy|3|||
27932508|NCT00949117|54588789|FG000|Overall Study|Protocol Violation|1|||
27932509|NCT00949117|54588790|FG001|Overall Study|Protocol Violation|1|||
27932510|NCT00949117|54588789|FG000|Overall Study|Adverse Event|0|||
27932511|NCT00949117|54588790|FG001|Overall Study|Adverse Event|1|||
27932512|NCT00938041|54588798|FG000|Overall Study|Lost to Follow-up|6|||
27932513|NCT00938041|54588798|FG000|Overall Study|Received Alternative Therapy|1|||
27932514|NCT00938041|54588798|FG000|Overall Study|Progressive Disease|5|||
27932515|NCT00938041|54588798|FG000|Overall Study|Death|12|||
27932516|NCT00938041|54588798|FG000|Overall Study|Adrenal Insufficiency|3|||
27932517|NCT01218438|54588802|FG000|Epoch 1|Physician Decision|2|||
27932518|NCT01218438|54588802|FG000|Epoch 1|Adverse Event|1|||
27932519|NCT01218438|54588802|FG000|Epoch 3|Withdrawal by Subject|3|||
27932520|NCT01218438|54588802|FG000|Epoch 3|Adverse Event|1|||
27932521|NCT01218438|54588802|FG000|Epoch 4|Physician Decision|1|||
27932522|NCT01218438|54588802|FG000|Epoch 4|Withdrawal by Subject|2|||
27932523|NCT00935701|54588876|FG000|Overall Study|Failure to Transition to Acupuncture|1|||
27932524|NCT01277510|54588883|FG000|Double-blind Phase|Non-compliance|0|||
27932525|NCT01277510|54588884|FG001|Double-blind Phase|Non-compliance|1|||
27932526|NCT01277510|54588883|FG000|Double-blind Phase|Adverse Event|1|||
27932527|NCT01277510|54588884|FG001|Double-blind Phase|Adverse Event|0|||
27932528|NCT01277510|54588883|FG000|Double-blind Phase|Withdrawal by Subject|2|||
27932529|NCT01277510|54588884|FG001|Double-blind Phase|Withdrawal by Subject|0|||
27932530|NCT01277510|54588883|FG000|Double-blind Phase|Administrative decision|7|||
27932531|NCT01277510|54588884|FG001|Double-blind Phase|Administrative decision|9|||
27932532|NCT01277510|54588883|FG000|Double-blind Phase|Death|0|||
27932533|NCT01277510|54588884|FG001|Double-blind Phase|Death|1|||
27932534|NCT01277510|54588883|FG000|Double-blind Phase|Protocol-specified criteria|2|||
27932535|NCT01277510|54588884|FG001|Double-blind Phase|Protocol-specified criteria|6|||
27932536|NCT01277510|54588883|FG000|Double-blind Phase|Other|1|||
27932537|NCT01277510|54588884|FG001|Double-blind Phase|Other|1|||
27932538|NCT01277510|54588883|FG000|Open-label Phase|Administrative decision|4|||
27932539|NCT01277510|54588884|FG001|Open-label Phase|Administrative decision|3|||
27932540|NCT01277510|54588883|FG000|Open-label Phase|Protocol-specified criteria|1|||
27932541|NCT01277510|54588884|FG001|Open-label Phase|Protocol-specified criteria|0|||
27932542|NCT01277510|54588883|FG000|Open-label Phase|Never received investigational product|2|||
27932543|NCT01277510|54588884|FG001|Open-label Phase|Never received investigational product|0|||
27932544|NCT00937495|54588892|FG000|Overall Study|Protocol Violation|2|||
27932545|NCT01268306|54588896|FG000|Overall Study|Lost to Follow-up|1|||
27932546|NCT00936715|54588900|FG000|Overall Study|Investigators Discretion|1|||
27932547|NCT00936715|54588900|FG000|Overall Study|Protocol Violation|1|||
27932548|NCT00936715|54588900|FG000|Overall Study|Safety or Tolerability Reasons|4|||
27932549|NCT01267994|54588904|FG000|Overall Study|Adverse Event|2|||
27932550|NCT00934843|54588911|FG000|Overall Study|Protocol Violation|0|||
27932551|NCT00934843|54588912|FG001|Overall Study|Protocol Violation|1|||
27932552|NCT01266902|54588920|FG000|Period 1 (Main Study)|Investigator's decision/Participant's decision|2|||
27932553|NCT01266902|54588921|FG001|Period 1 (Main Study)|Investigator's decision/Participant's decision|3|||
27932554|NCT01266902|54588922|FG002|Period 1 (Main Study)|Investigator's decision/Participant's decision|0|||
27932555|NCT01266902|54588920|FG000|Period 1 (Main Study)|Lost to Follow-up|5|||
27932556|NCT01266902|54588921|FG001|Period 1 (Main Study)|Lost to Follow-up|12|||
27932557|NCT01266902|54588922|FG002|Period 1 (Main Study)|Lost to Follow-up|0|||
27932558|NCT01266902|54588920|FG000|Period 1 (Main Study)|Lack of Efficacy|4|||
27932559|NCT01266902|54588921|FG001|Period 1 (Main Study)|Lack of Efficacy|2|||
27932560|NCT01266902|54588922|FG002|Period 1 (Main Study)|Lack of Efficacy|0|||
27932561|NCT01266902|54588920|FG000|Period 1 (Main Study)|Adverse Event|3|||
27932562|NCT01266902|54588921|FG001|Period 1 (Main Study)|Adverse Event|11|||
27932563|NCT01266902|54588922|FG002|Period 1 (Main Study)|Adverse Event|0|||
27932564|NCT01266902|54588920|FG000|Period 1 (Main Study)|Withdrawal by Subject|2|||
27932565|NCT01266902|54588921|FG001|Period 1 (Main Study)|Withdrawal by Subject|12|||
27932566|NCT01266902|54588922|FG002|Period 1 (Main Study)|Withdrawal by Subject|0|||
27932567|NCT01266902|54588920|FG000|Period 1 (Main Study)|Subject non-compliant|3|||
27932568|NCT01266902|54588921|FG001|Period 1 (Main Study)|Subject non-compliant|7|||
27932569|NCT01266902|54588922|FG002|Period 1 (Main Study)|Subject non-compliant|0|||
27932570|NCT01266902|54588920|FG000|Period 1 (Main Study)|Continued RPV treatment|11|||
27932571|NCT01266902|54588921|FG001|Period 1 (Main Study)|Continued RPV treatment|34|||
27932572|NCT01266902|54588922|FG002|Period 1 (Main Study)|Continued RPV treatment|0|||
27932573|NCT01266902|54588920|FG000|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
27932574|NCT01266902|54588921|FG001|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
27932575|NCT01266902|54588922|FG002|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|1|||
27932576|NCT01266902|54588920|FG000|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
27932577|NCT01266902|54588921|FG001|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
27932578|NCT01266902|54588922|FG002|Period 2 (After Protocol Amendment 3)|Adverse Event|1|||
27932579|NCT01266902|54588920|FG000|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
27932580|NCT01266902|54588921|FG001|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
27932581|NCT01266902|54588922|FG002|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|6|||
27932582|NCT01266824|54588932|FG000|Overall Study|Study terminated prior to completion|2|||
27932583|NCT01266824|54588933|FG001|Overall Study|Study terminated prior to completion|3|||
27932584|NCT01266590|54588939|FG000|Overall Study|Adverse Event|3|||
27932585|NCT01266590|54588939|FG000|Overall Study|Lost to Follow-up|1|||
27932586|NCT01266590|54588939|FG000|Overall Study|Withdrawal by Subject|1|||
27932587|NCT01266590|54588939|FG000|Overall Study|Physician Decision|1|||
27932588|NCT01266122|54588948|FG000|Overall Study|Lost to Follow-up|6|||
27932589|NCT01266122|54588949|FG001|Overall Study|Lost to Follow-up|6|||
27932590|NCT01265498|54588957|FG000|Overall Study|Protocol modified to eliminate wk72 bx|31|||
27932591|NCT01265498|54588958|FG001|Overall Study|Protocol modified to eliminate wk72 bx|33|||
27932592|NCT01265420|54588964|FG000|Overall Study|Lost to Follow-up|1|||
27932593|NCT01264718|54588970|FG000|Overall Study|Lost to Follow-up|3|||
27932594|NCT01264718|54588971|FG001|Overall Study|Lost to Follow-up|2|||
27932595|NCT01264718|54588970|FG000|Overall Study|Withdrawal by Subject|9|||
27932596|NCT01264718|54588971|FG001|Overall Study|Withdrawal by Subject|15|||
27932597|NCT01264718|54588970|FG000|Overall Study|Loss of Medicaid/CHIP eligibility|37|||
27932598|NCT01264718|54588971|FG001|Overall Study|Loss of Medicaid/CHIP eligibility|26|||
27932599|NCT01264016|54588977|FG000|Overall Study|Withdrawal by Subject|1|||
27932600|NCT01264016|54588977|FG000|Overall Study|Felt faint at sight of blood|1|||
27932601|NCT01263782|54588986|FG000|Overall Study|Death|0|||
27932602|NCT01263782|54588987|FG001|Overall Study|Death|0|||
27932603|NCT01263782|54588988|FG002|Overall Study|Death|1|||
27932604|NCT01263782|54588989|FG003|Overall Study|Death|0|||
27932605|NCT01263782|54588986|FG000|Overall Study|Progressive disease|0|||
27932606|NCT01263782|54588987|FG001|Overall Study|Progressive disease|0|||
27932607|NCT01263782|54588988|FG002|Overall Study|Progressive disease|0|||
27932608|NCT01263782|54588989|FG003|Overall Study|Progressive disease|1|||
27932609|NCT01263782|54588986|FG000|Overall Study|Too early|0|||
27932610|NCT01263782|54588987|FG001|Overall Study|Too early|0|||
27932611|NCT01263782|54588988|FG002|Overall Study|Too early|1|||
27932612|NCT01263782|54588989|FG003|Overall Study|Too early|0|||
27932613|NCT01263782|54588986|FG000|Overall Study|Inevaluable|0|||
27932614|NCT01263782|54588987|FG001|Overall Study|Inevaluable|0|||
27932615|NCT01263782|54588988|FG002|Overall Study|Inevaluable|1|||
27932616|NCT01263782|54588989|FG003|Overall Study|Inevaluable|0|||
27932617|NCT01263704|54588999|FG000|Overall Study|Progressive disease|18|||
27932618|NCT01263704|54588999|FG000|Overall Study|Adverse Event|3|||
27932619|NCT01263704|54588999|FG000|Overall Study|Death|2|||
27932620|NCT01263704|54588999|FG000|Overall Study|Patient withdrew consent|2|||
27932621|NCT01263704|54588999|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
27932622|NCT01263704|54588999|FG000|Overall Study|Lost to Follow-up|1|||
27932623|NCT01263704|54588999|FG000|Overall Study|Colon metastases|1|||
27932624|NCT01263704|54588999|FG000|Overall Study|Principal Investigator (PI) decision|1|||
27932625|NCT01263470|54589009|FG000|Overall Study|Adverse Event|2|||
27932626|NCT01263470|54589010|FG001|Overall Study|Adverse Event|2|||
27932627|NCT01263470|54589011|FG002|Overall Study|Adverse Event|1|||
27932628|NCT01263470|54589012|FG003|Overall Study|Adverse Event|1|||
27932629|NCT01263470|54589013|FG004|Overall Study|Adverse Event|2|||
27932630|NCT01263470|54589014|FG005|Overall Study|Adverse Event|2|||
27932631|NCT01263470|54589009|FG000|Overall Study|Protocol Violation|0|||
28016983|NCT00345631|54676228|FG002|Overall Study|Lost to Follow-up|4|||
27932632|NCT01263470|54589010|FG001|Overall Study|Protocol Violation|1|||
27932633|NCT01263470|54589011|FG002|Overall Study|Protocol Violation|0|||
27932634|NCT01263470|54589012|FG003|Overall Study|Protocol Violation|0|||
27932635|NCT01263470|54589013|FG004|Overall Study|Protocol Violation|0|||
27932636|NCT01263470|54589014|FG005|Overall Study|Protocol Violation|1|||
27932637|NCT01263470|54589009|FG000|Overall Study|Withdrawal by Subject|0|||
27932638|NCT01263470|54589010|FG001|Overall Study|Withdrawal by Subject|1|||
27932639|NCT01263470|54589011|FG002|Overall Study|Withdrawal by Subject|1|||
27932640|NCT01263470|54589012|FG003|Overall Study|Withdrawal by Subject|2|||
27932641|NCT01263470|54589013|FG004|Overall Study|Withdrawal by Subject|0|||
27932642|NCT01263470|54589014|FG005|Overall Study|Withdrawal by Subject|2|||
27932643|NCT01263470|54589009|FG000|Overall Study|Lack of Efficacy|0|||
27932644|NCT01263470|54589010|FG001|Overall Study|Lack of Efficacy|0|||
27932645|NCT01263470|54589011|FG002|Overall Study|Lack of Efficacy|2|||
27932646|NCT01263470|54589012|FG003|Overall Study|Lack of Efficacy|0|||
27788423|NCT02203916|54243055|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
27788424|NCT02203916|54243056|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
27788425|NCT02203916|54243054|FG000|Overall Study|Major Protocol Deviation|1|||
27788426|NCT02203916|54243055|FG001|Overall Study|Major Protocol Deviation|1|||
27788427|NCT02203916|54243056|FG002|Overall Study|Major Protocol Deviation|0|||
27788428|NCT02203916|54243054|FG000|Overall Study|Lost to Follow-up|0|||
27788429|NCT02203916|54243055|FG001|Overall Study|Lost to Follow-up|1|||
27788430|NCT02203916|54243056|FG002|Overall Study|Lost to Follow-up|0|||
27788431|NCT02203916|54243054|FG000|Overall Study|Voluntary Withdrawal|3|||
27788432|NCT02203916|54243055|FG001|Overall Study|Voluntary Withdrawal|3|||
27788433|NCT02203916|54243056|FG002|Overall Study|Voluntary Withdrawal|8|||
27788434|NCT02203916|54243054|FG000|Overall Study|Lack of Efficacy|3|||
27788435|NCT02203916|54243055|FG001|Overall Study|Lack of Efficacy|0|||
27788436|NCT02203916|54243056|FG002|Overall Study|Lack of Efficacy|0|||
27788437|NCT02203916|54243054|FG000|Overall Study|Reason Not Specified|0|||
27788438|NCT02203916|54243055|FG001|Overall Study|Reason Not Specified|2|||
27788439|NCT02203916|54243056|FG002|Overall Study|Reason Not Specified|1|||
27788440|NCT02179177|54243080|FG000|Overall Study|Lost to Follow-up|1|||
27788441|NCT02179177|54243081|FG001|Overall Study|Lost to Follow-up|1|||
27788442|NCT02179177|54243080|FG000|Overall Study|Withdrawal by Subject|1|||
27788443|NCT02179177|54243081|FG001|Overall Study|Withdrawal by Subject|1|||
27788444|NCT02239328|54243087|FG000|Overall Study|Benign disease noted at time of surgery|6|||
27788445|NCT02239328|54243087|FG000|Overall Study|Equipment or website malfunction|2|||
27788446|NCT02129803|54243093|FG000|Overall Study|Protocol Violation|4|||
27788447|NCT02129803|54243094|FG001|Overall Study|Protocol Violation|0|||
27788448|NCT02129803|54243093|FG000|Overall Study|Physician Decision|0|||
27788449|NCT02129803|54243094|FG001|Overall Study|Physician Decision|1|||
27788450|NCT02129803|54243093|FG000|Overall Study|Difficulty sleeping|1|||
27788451|NCT02129803|54243094|FG001|Overall Study|Difficulty sleeping|0|||
27788452|NCT02129803|54243093|FG000|Overall Study|Morning headache|0|||
27788453|NCT02129803|54243094|FG001|Overall Study|Morning headache|1|||
27788454|NCT02129803|54243093|FG000|Overall Study|Withdrawal by Subject|1|||
27788455|NCT02129803|54243094|FG001|Overall Study|Withdrawal by Subject|1|||
27788456|NCT02239094|54243100|FG000|Overall Study|Withdrawal by Subject|1|||
27788457|NCT02239094|54243100|FG000|Overall Study|Remitted before started|1|||
27788458|NCT02129647|54243104|FG000|Overall Study|Adverse Event|2|||
27788459|NCT02129647|54243104|FG000|Overall Study|surgical intervention for clinically progressive disease|1|||
27788460|NCT02238626|54243112|FG000|Overall Study|Adverse Event|3|||
27788461|NCT02238626|54243113|FG001|Overall Study|Adverse Event|5|||
27788462|NCT02238626|54243114|FG002|Overall Study|Adverse Event|0|||
27788463|NCT02238626|54243115|FG003|Overall Study|Adverse Event|3|||
27788464|NCT02238626|54243112|FG000|Overall Study|Lost to Follow-up|2|||
27788465|NCT02238626|54243113|FG001|Overall Study|Lost to Follow-up|4|||
27932647|NCT01263470|54589013|FG004|Overall Study|Lack of Efficacy|0|||
27932648|NCT01263470|54589014|FG005|Overall Study|Lack of Efficacy|0|||
27932649|NCT01263470|54589009|FG000|Overall Study|Participant Unavailability|0|||
27932650|NCT01263470|54589010|FG001|Overall Study|Participant Unavailability|1|||
27932651|NCT01263470|54589011|FG002|Overall Study|Participant Unavailability|0|||
27932652|NCT01263470|54589012|FG003|Overall Study|Participant Unavailability|0|||
27932653|NCT01263470|54589013|FG004|Overall Study|Participant Unavailability|0|||
27932654|NCT01263470|54589014|FG005|Overall Study|Participant Unavailability|0|||
27788466|NCT02238626|54243114|FG002|Overall Study|Lost to Follow-up|2|||
27788467|NCT02238626|54243115|FG003|Overall Study|Lost to Follow-up|2|||
27788468|NCT02238626|54243112|FG000|Overall Study|Withdrawal by Subject|0|||
27788469|NCT02238626|54243113|FG001|Overall Study|Withdrawal by Subject|3|||
27788470|NCT02238626|54243114|FG002|Overall Study|Withdrawal by Subject|0|||
27788471|NCT02238626|54243115|FG003|Overall Study|Withdrawal by Subject|1|||
27932655|NCT01263470|54589009|FG000|Overall Study|Study Drug Non-compliance|0|||
27932656|NCT01263470|54589010|FG001|Overall Study|Study Drug Non-compliance|0|||
27932657|NCT01263470|54589011|FG002|Overall Study|Study Drug Non-compliance|0|||
27788472|NCT02238626|54243112|FG000|Overall Study|Death|0|||
27932658|NCT01263470|54589012|FG003|Overall Study|Study Drug Non-compliance|0|||
27788473|NCT02238626|54243113|FG001|Overall Study|Death|0|||
28016984|NCT00345631|54676226|FG000|Overall Study|Other reasons|0|||
28016985|NCT00345631|54676227|FG001|Overall Study|Other reasons|0|||
28016986|NCT00345631|54676228|FG002|Overall Study|Other reasons|1|||
28016987|NCT00540514|54676240|FG000|Overall Study|Still on treatment|3|||
28016988|NCT00540514|54676241|FG001|Overall Study|Still on treatment|0|||
27932659|NCT01263470|54589013|FG004|Overall Study|Study Drug Non-compliance|1|||
27932660|NCT01263470|54589014|FG005|Overall Study|Study Drug Non-compliance|0|||
27932661|NCT01262456|54589031|FG000|3-Month Double-Blind Period|Withdrawal by Subject|6|||
27932662|NCT01262456|54589032|FG001|3-Month Double-Blind Period|Withdrawal by Subject|8|||
27932663|NCT01262456|54589033|FG002|3-Month Double-Blind Period|Withdrawal by Subject|9|||
27932664|NCT01262456|54589031|FG000|3-Month Double-Blind Period|Lost to Follow-up|4|||
27932665|NCT01262456|54589032|FG001|3-Month Double-Blind Period|Lost to Follow-up|5|||
27932666|NCT01262456|54589033|FG002|3-Month Double-Blind Period|Lost to Follow-up|3|||
27932667|NCT01262456|54589031|FG000|3-Month Double-Blind Period|Adverse Event|6|||
27932668|NCT01262456|54589032|FG001|3-Month Double-Blind Period|Adverse Event|4|||
27932669|NCT01262456|54589033|FG002|3-Month Double-Blind Period|Adverse Event|8|||
27932670|NCT01262456|54589031|FG000|3-Month Double-Blind Period|Protocol Violation|3|||
27932671|NCT01262456|54589032|FG001|3-Month Double-Blind Period|Protocol Violation|6|||
27932672|NCT01262456|54589033|FG002|3-Month Double-Blind Period|Protocol Violation|6|||
27932673|NCT01262456|54589031|FG000|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
27932674|NCT01262456|54589032|FG001|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
27932675|NCT01262456|54589033|FG002|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
27932676|NCT01262456|54589031|FG000|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
27932677|NCT01262456|54589032|FG001|1-Month Open-Label Extension Period|Lost to Follow-up|1|||
27932678|NCT01262456|54589033|FG002|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
27932679|NCT01262456|54589031|FG000|1-Month Open-Label Extension Period|Adverse Event|2|||
27932680|NCT01262456|54589032|FG001|1-Month Open-Label Extension Period|Adverse Event|0|||
27932681|NCT01262456|54589033|FG002|1-Month Open-Label Extension Period|Adverse Event|2|||
27932682|NCT01262456|54589031|FG000|1-Month Open-Label Extension Period|Protocol Violation|1|||
27932683|NCT01262456|54589032|FG001|1-Month Open-Label Extension Period|Protocol Violation|0|||
27932684|NCT01262456|54589033|FG002|1-Month Open-Label Extension Period|Protocol Violation|2|||
27932685|NCT01262456|54589031|FG000|1-Month Open-Label Extension Period|Other Reason|0|||
27932686|NCT01262456|54589032|FG001|1-Month Open-Label Extension Period|Other Reason|1|||
27932687|NCT01262456|54589033|FG002|1-Month Open-Label Extension Period|Other Reason|0|||
27932688|NCT00932893|54589051|FG000|Overall Study|Death|115|||
27932689|NCT00932893|54589052|FG001|Overall Study|Death|24|||
27932690|NCT00932893|54589051|FG000|Overall Study|Lost to Follow-up|8|||
27932691|NCT00932893|54589052|FG001|Overall Study|Lost to Follow-up|0|||
27932692|NCT00932893|54589051|FG000|Overall Study|Withdrawal by Subject|5|||
27932693|NCT00932893|54589052|FG001|Overall Study|Withdrawal by Subject|2|||
27932694|NCT00932893|54589051|FG000|Overall Study|Other|5|||
27932695|NCT00932893|54589052|FG001|Overall Study|Other|144|||
27932696|NCT01260896|54589061|FG000|First Intervention|Withdrawn Due to Emesis|2|||
28016989|NCT00540514|54676240|FG000|Overall Study|Unacceptable Toxicity|61|||
28016990|NCT00540514|54676241|FG001|Overall Study|Unacceptable Toxicity|62|||
28016991|NCT00540514|54676240|FG000|Overall Study|Adverse Event|20|||
28016992|NCT00540514|54676241|FG001|Overall Study|Adverse Event|24|||
28016993|NCT00540514|54676240|FG000|Overall Study|Physician Decision|86|||
28016994|NCT00540514|54676241|FG001|Overall Study|Physician Decision|99|||
28016995|NCT00540514|54676240|FG000|Overall Study|Protocol Deviation|3|||
28016996|NCT00540514|54676241|FG001|Overall Study|Protocol Deviation|4|||
28016997|NCT00540514|54676240|FG000|Overall Study|Lost to Follow-up|1|||
27788474|NCT02238626|54243114|FG002|Overall Study|Death|1|||
27788475|NCT02238626|54243115|FG003|Overall Study|Death|1|||
27788476|NCT02238626|54243112|FG000|Overall Study|Other|0|||
27788477|NCT02238626|54243113|FG001|Overall Study|Other|2|||
27788478|NCT02238626|54243114|FG002|Overall Study|Other|0|||
27932697|NCT01260896|54589062|FG001|First Intervention|Withdrawn Due to Emesis|0|||
27932698|NCT00932737|54589070|FG000|Overall Study|Not treated in second episode|1|||
27932699|NCT00932737|54589071|FG001|Overall Study|Not treated in second episode|0|||
27932700|NCT00932737|54589070|FG000|Overall Study|Adverse Event|0|||
27932701|NCT00932737|54589071|FG001|Overall Study|Adverse Event|1|||
27932702|NCT00939523|54589077|FG000|Overall Study|Lack of Efficacy|1|||
27932703|NCT00939523|54589077|FG000|Overall Study|Physician Decision|2|||
27932704|NCT01260584|54589085|FG000|Period 1|Protocol Violation|0|||
27932705|NCT01260584|54589086|FG001|Period 1|Protocol Violation|0|||
27932706|NCT01260584|54589087|FG002|Period 1|Protocol Violation|1|||
28016998|NCT00540514|54676241|FG001|Overall Study|Lost to Follow-up|1|||
28016999|NCT00540514|54676240|FG000|Overall Study|Withdrawal by Subject|65|||
28017000|NCT00540514|54676241|FG001|Overall Study|Withdrawal by Subject|67|||
27788479|NCT02238626|54243115|FG003|Overall Study|Other|0|||
27788480|NCT02151643|54243141|FG000|Overall Study|Adverse Event|2|||
28017001|NCT00540514|54676240|FG000|Overall Study|Excluded prior to treatment|7|||
27788481|NCT02151643|54243142|FG001|Overall Study|Adverse Event|0|||
27788482|NCT02151643|54243143|FG002|Overall Study|Adverse Event|1|||
27932707|NCT01260584|54589088|FG003|Period 1|Protocol Violation|1|||
27932708|NCT01260584|54589085|FG000|Period 1|Adverse Event|0|||
27932709|NCT01260584|54589086|FG001|Period 1|Adverse Event|0|||
27932710|NCT01260584|54589087|FG002|Period 1|Adverse Event|1|||
27932711|NCT01260584|54589088|FG003|Period 1|Adverse Event|0|||
27932712|NCT01260584|54589085|FG000|Period 2|Protocol Violation|0|||
27932713|NCT01260584|54589086|FG001|Period 2|Protocol Violation|2|||
27932714|NCT01260584|54589087|FG002|Period 2|Protocol Violation|3|||
27932715|NCT01260584|54589088|FG003|Period 2|Protocol Violation|1|||
27932716|NCT01260584|54589085|FG000|Period 2|Adverse Event|1|||
27932717|NCT01260584|54589086|FG001|Period 2|Adverse Event|0|||
27932718|NCT01260584|54589087|FG002|Period 2|Adverse Event|2|||
27932719|NCT01260584|54589088|FG003|Period 2|Adverse Event|0|||
27932720|NCT01260584|54589085|FG000|Period 2|Withdrawal by Subject|0|||
27932721|NCT01260584|54589086|FG001|Period 2|Withdrawal by Subject|1|||
27932722|NCT01260584|54589087|FG002|Period 2|Withdrawal by Subject|0|||
27932723|NCT01260584|54589088|FG003|Period 2|Withdrawal by Subject|0|||
27932724|NCT00927589|54589098|FG000|Overall Study|Death|1|||
27932725|NCT00927589|54589098|FG000|Overall Study|Physician Decision|1|||
27932726|NCT00927589|54589098|FG000|Overall Study|Withdrawal by Subject|3|||
27932727|NCT00927589|54589098|FG000|Overall Study|Adverse Event|2|||
27932728|NCT00927589|54589098|FG000|Overall Study|Disease Progression|8|||
27932729|NCT00927589|54589098|FG000|Overall Study|Non-compliance|1|||
27932730|NCT00932425|54589104|FG000|Overall Study|Lost to Follow-up|0|||
27932731|NCT00932425|54589105|FG001|Overall Study|Lost to Follow-up|1|||
27932732|NCT00932425|54589104|FG000|Overall Study|Withdrawal by Subject|0|||
27932733|NCT00932425|54589105|FG001|Overall Study|Withdrawal by Subject|1|||
27932734|NCT05867342|54589111|FG000|Overall Study|Investigator Decision|3|||
27932735|NCT05867342|54589112|FG001|Overall Study|Investigator Decision|3|||
27932736|NCT04340362|54589147|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
27932737|NCT04024462|54589169|FG000|Overall Study|Withdrawal by Subject|6|||
27932738|NCT04024462|54589170|FG001|Overall Study|Withdrawal by Subject|7|||
27932739|NCT04024462|54589169|FG000|Overall Study|Progressive Disease|0|||
27932740|NCT04024462|54589170|FG001|Overall Study|Progressive Disease|1|||
27932741|NCT04024462|54589169|FG000|Overall Study|Adverse Event|0|||
27932742|NCT04024462|54589170|FG001|Overall Study|Adverse Event|1|||
27932743|NCT04024462|54589169|FG000|Overall Study|Death|0|||
27932744|NCT04024462|54589170|FG001|Overall Study|Death|1|||
27932745|NCT04024462|54589169|FG000|Overall Study|Lost to Follow-up|1|||
27932746|NCT04024462|54589170|FG001|Overall Study|Lost to Follow-up|0|||
27932747|NCT04024462|54589169|FG000|Overall Study|Ongoing in the Study|94|||
27932748|NCT04024462|54589170|FG001|Overall Study|Ongoing in the Study|89|||
27932749|NCT03980808|54589178|FG000|Overall Study|Lost to Follow-up|2|||
27932750|NCT03980808|54589179|FG001|Overall Study|Lost to Follow-up|2|||
27932751|NCT03943953|54589196|FG000|Trial of ITG 1|Lost to Follow-up|19|||
27932752|NCT03943953|54589197|FG001|Trial of ITG 1|Lost to Follow-up|1|||
27932753|NCT03943953|54589196|FG000|Trial of ITG 2|Lost to Follow-up|8|||
27932754|NCT03943953|54589197|FG001|Trial of ITG 2|Lost to Follow-up|0|||
27932755|NCT03943953|54589196|FG000|Trial of ITG 3|Lost to Follow-up|2|||
27932756|NCT03943953|54589197|FG001|Trial of ITG 3|Lost to Follow-up|0|||
27932757|NCT03943953|54589196|FG000|Trial of ITG 4|Lost to Follow-up|2|||
27932758|NCT03943953|54589197|FG001|Trial of ITG 4|Lost to Follow-up|0|||
27932759|NCT03670628|54589207|FG000|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|8|||
27932760|NCT03670628|54589208|FG001|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|3|||
27932761|NCT03670628|54589207|FG000|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|4|||
27932762|NCT03670628|54589208|FG001|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|6|||
27932763|NCT03637764|54589218|FG000|Overall Study|Adverse Event|2|||
27932764|NCT03637764|54589219|FG001|Overall Study|Adverse Event|0|||
27932765|NCT03637764|54589220|FG002|Overall Study|Adverse Event|0|||
27932766|NCT03637764|54589221|FG003|Overall Study|Adverse Event|1|||
27932767|NCT03637764|54589218|FG000|Overall Study|Progressive Disease|23|||
27932768|NCT03637764|54589219|FG001|Overall Study|Progressive Disease|23|||
27932769|NCT03637764|54589220|FG002|Overall Study|Progressive Disease|18|||
27932770|NCT03637764|54589221|FG003|Overall Study|Progressive Disease|31|||
27932771|NCT03637764|54589218|FG000|Overall Study|Withdrawal by Subject|1|||
27932772|NCT03637764|54589219|FG001|Overall Study|Withdrawal by Subject|3|||
27932773|NCT03637764|54589220|FG002|Overall Study|Withdrawal by Subject|0|||
27932774|NCT03637764|54589221|FG003|Overall Study|Withdrawal by Subject|1|||
27932775|NCT03483116|54589251|FG000|Overall Study|Adverse Event|0|||
27932776|NCT03483116|54589252|FG001|Overall Study|Adverse Event|1|||
27932777|NCT03483116|54589253|FG002|Overall Study|Adverse Event|0|||
27932778|NCT03483116|54589254|FG003|Overall Study|Adverse Event|1|||
27932779|NCT03483116|54589251|FG000|Overall Study|Protocol Violation|1|||
27788483|NCT02151643|54243144|FG003|Overall Study|Adverse Event|4|||
27932780|NCT03483116|54589252|FG001|Overall Study|Protocol Violation|0|||
27932781|NCT03483116|54589253|FG002|Overall Study|Protocol Violation|0|||
27932782|NCT03483116|54589254|FG003|Overall Study|Protocol Violation|7|||
27932783|NCT03483116|54589251|FG000|Overall Study|Lost to Follow-up|9|||
27932784|NCT03483116|54589252|FG001|Overall Study|Lost to Follow-up|4|||
27932785|NCT03483116|54589253|FG002|Overall Study|Lost to Follow-up|9|||
27932786|NCT03483116|54589254|FG003|Overall Study|Lost to Follow-up|5|||
27932787|NCT03483116|54589251|FG000|Overall Study|Death|1|||
27932788|NCT03483116|54589252|FG001|Overall Study|Death|0|||
27932789|NCT03483116|54589253|FG002|Overall Study|Death|2|||
27932790|NCT03483116|54589254|FG003|Overall Study|Death|1|||
27932791|NCT03483116|54589251|FG000|Overall Study|Withdrawal by Subject|14|||
27932792|NCT03483116|54589252|FG001|Overall Study|Withdrawal by Subject|16|||
27932793|NCT03483116|54589253|FG002|Overall Study|Withdrawal by Subject|14|||
27932794|NCT03483116|54589254|FG003|Overall Study|Withdrawal by Subject|16|||
27932795|NCT03483116|54589251|FG000|Overall Study|Unknown other reason|3|||
27932796|NCT03483116|54589252|FG001|Overall Study|Unknown other reason|2|||
27932797|NCT03483116|54589253|FG002|Overall Study|Unknown other reason|1|||
27932798|NCT03483116|54589254|FG003|Overall Study|Unknown other reason|1|||
27932799|NCT03215706|54589284|FG000|Randomization|Adverse Event unrelated to study drug|1|||
27932800|NCT03215706|54589285|FG001|Randomization|Adverse Event unrelated to study drug|0|||
27932801|NCT03215706|54589284|FG000|Randomization|participant withdrew consent|1|||
27932802|NCT03215706|54589285|FG001|Randomization|participant withdrew consent|3|||
27788484|NCT02151643|54243145|FG004|Overall Study|Adverse Event|0|||
27788485|NCT02151643|54243141|FG000|Overall Study|Withdrawal by Subject|0|||
27788486|NCT02151643|54243142|FG001|Overall Study|Withdrawal by Subject|1|||
27788487|NCT02151643|54243143|FG002|Overall Study|Withdrawal by Subject|1|||
27788488|NCT02151643|54243144|FG003|Overall Study|Withdrawal by Subject|1|||
27788489|NCT02151643|54243145|FG004|Overall Study|Withdrawal by Subject|1|||
27788490|NCT02151643|54243141|FG000|Overall Study|Hyperphosphataemia|1|||
27788491|NCT02151643|54243142|FG001|Overall Study|Hyperphosphataemia|0|||
27788492|NCT02151643|54243143|FG002|Overall Study|Hyperphosphataemia|0|||
27788493|NCT02151643|54243144|FG003|Overall Study|Hyperphosphataemia|0|||
27788494|NCT02151643|54243145|FG004|Overall Study|Hyperphosphataemia|1|||
27788495|NCT02151643|54243141|FG000|Overall Study|High Ferritin levels|3|||
27932803|NCT03215706|54589284|FG000|Randomization|no longer meets study criteria|1|||
27932804|NCT03215706|54589285|FG001|Randomization|no longer meets study criteria|4|||
27932805|NCT03215706|54589284|FG000|Randomization|other reasons|0|||
27932806|NCT03215706|54589285|FG001|Randomization|other reasons|2|||
27932807|NCT03215706|54589284|FG000|Treatment Period|Disease Progression|150|||
27932808|NCT03215706|54589285|FG001|Treatment Period|Disease Progression|142|||
27932809|NCT03215706|54589284|FG000|Treatment Period|Study Drug Toxicity|53|||
27932810|NCT03215706|54589285|FG001|Treatment Period|Study Drug Toxicity|21|||
27932811|NCT03215706|54589284|FG000|Treatment Period|Death|2|||
27932812|NCT03215706|54589285|FG001|Treatment Period|Death|1|||
27932813|NCT03215706|54589284|FG000|Treatment Period|Adverse event unrelated to study drug|24|||
27932814|NCT03215706|54589285|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
27932815|NCT03215706|54589284|FG000|Treatment Period|Request to D/C treatment|1|||
27932816|NCT03215706|54589285|FG001|Treatment Period|Request to D/C treatment|6|||
27932817|NCT03215706|54589284|FG000|Treatment Period|Participant withdrew consent|3|||
27932818|NCT03215706|54589285|FG001|Treatment Period|Participant withdrew consent|4|||
27932819|NCT03215706|54589284|FG000|Treatment Period|Lost to Follow-up|0|||
27932820|NCT03215706|54589285|FG001|Treatment Period|Lost to Follow-up|1|||
27932821|NCT03215706|54589284|FG000|Treatment Period|Other Reasons|4|||
27932822|NCT03215706|54589285|FG001|Treatment Period|Other Reasons|5|||
27932823|NCT03215706|54589284|FG000|Treatment Period|Ongoing in the treatment period|105|||
27932824|NCT03215706|54589285|FG001|Treatment Period|Ongoing in the treatment period|43|||
27932825|NCT03141177|54589303|FG000|Overall Study|Death|62|||
27932826|NCT03141177|54589304|FG001|Overall Study|Death|13|||
27932827|NCT03141177|54589305|FG002|Overall Study|Death|84|||
27932828|NCT03141177|54589303|FG000|Overall Study|Participant withdrew consent|9|||
27932829|NCT03141177|54589304|FG001|Overall Study|Participant withdrew consent|2|||
27932830|NCT03141177|54589305|FG002|Overall Study|Participant withdrew consent|13|||
27932831|NCT03141177|54589303|FG000|Overall Study|Not reported|1|||
27932832|NCT03141177|54589304|FG001|Overall Study|Not reported|0|||
27932833|NCT03141177|54589305|FG002|Overall Study|Not reported|1|||
27932834|NCT03141177|54589303|FG000|Overall Study|Lost to Follow-up|2|||
27932835|NCT03141177|54589304|FG001|Overall Study|Lost to Follow-up|1|||
27932836|NCT03141177|54589305|FG002|Overall Study|Lost to Follow-up|1|||
27788496|NCT02151643|54243142|FG001|Overall Study|High Ferritin levels|3|||
27788497|NCT02151643|54243143|FG002|Overall Study|High Ferritin levels|2|||
27788498|NCT02151643|54243144|FG003|Overall Study|High Ferritin levels|2|||
27788499|NCT02151643|54243145|FG004|Overall Study|High Ferritin levels|1|||
27788500|NCT02203838|54243161|FG000|Overall Study|Lack of Efficacy|7|||
27788501|NCT02203838|54243162|FG001|Overall Study|Lack of Efficacy|0|||
27932837|NCT03141177|54589303|FG000|Overall Study|Other reasons|4|||
27932838|NCT03141177|54589304|FG001|Overall Study|Other reasons|0|||
27932839|NCT03141177|54589305|FG002|Overall Study|Other reasons|11|||
27932840|NCT03141177|54589303|FG000|Overall Study|Participants did not start treatment period|3|||
27932841|NCT03141177|54589304|FG001|Overall Study|Participants did not start treatment period|0|||
27932842|NCT03141177|54589305|FG002|Overall Study|Participants did not start treatment period|8|||
27932843|NCT02985957|54589321|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
27932844|NCT02985957|54589322|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
27932845|NCT02985957|54589323|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
27932846|NCT02985957|54589324|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
27932847|NCT02985957|54589325|FG004|Pre-Treatment Period|Participant no longer meets study criteria|1|||
27932848|NCT02985957|54589326|FG005|Pre-Treatment Period|Participant no longer meets study criteria|0|||
27932849|NCT02985957|54589327|FG006|Pre-Treatment Period|Participant no longer meets study criteria|0|||
27932850|NCT02985957|54589321|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
27932851|NCT02985957|54589322|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
27932852|NCT02985957|54589323|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
27932853|NCT02985957|54589324|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
27932854|NCT02985957|54589325|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
27932855|NCT02985957|54589326|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
27932856|NCT02985957|54589327|FG006|Pre-Treatment Period|Participant withdrew consent|1|||
27932857|NCT02985957|54589321|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
27932858|NCT02985957|54589322|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
27932859|NCT02985957|54589323|FG002|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
27932860|NCT02985957|54589324|FG003|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
27932861|NCT02985957|54589325|FG004|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
27932862|NCT02985957|54589326|FG005|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
27932863|NCT02985957|54589327|FG006|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
27932864|NCT02985957|54589321|FG000|Treatment Period|Death|0|||
27932865|NCT02985957|54589322|FG001|Treatment Period|Death|0|||
27932866|NCT02985957|54589323|FG002|Treatment Period|Death|0|||
27932867|NCT02985957|54589324|FG003|Treatment Period|Death|0|||
27932868|NCT02985957|54589325|FG004|Treatment Period|Death|1|||
27932869|NCT02985957|54589326|FG005|Treatment Period|Death|0|||
27932870|NCT02985957|54589327|FG006|Treatment Period|Death|0|||
27932871|NCT02985957|54589321|FG000|Treatment Period|Participant withdrew consent|0|||
27932872|NCT02985957|54589322|FG001|Treatment Period|Participant withdrew consent|0|||
27932873|NCT02985957|54589323|FG002|Treatment Period|Participant withdrew consent|0|||
27932874|NCT02985957|54589324|FG003|Treatment Period|Participant withdrew consent|1|||
27932875|NCT02985957|54589325|FG004|Treatment Period|Participant withdrew consent|3|||
27932876|NCT02985957|54589326|FG005|Treatment Period|Participant withdrew consent|0|||
27932877|NCT02985957|54589327|FG006|Treatment Period|Participant withdrew consent|1|||
27932878|NCT02985957|54589321|FG000|Treatment Period|Lost to Follow-up|0|||
27932879|NCT02985957|54589322|FG001|Treatment Period|Lost to Follow-up|0|||
27932880|NCT02985957|54589323|FG002|Treatment Period|Lost to Follow-up|0|||
27932881|NCT02985957|54589324|FG003|Treatment Period|Lost to Follow-up|0|||
27932882|NCT02985957|54589325|FG004|Treatment Period|Lost to Follow-up|1|||
27932883|NCT02985957|54589326|FG005|Treatment Period|Lost to Follow-up|0|||
27932884|NCT02985957|54589327|FG006|Treatment Period|Lost to Follow-up|0|||
27932885|NCT02985957|54589321|FG000|Treatment Period|Other reasons|0|||
27932886|NCT02985957|54589322|FG001|Treatment Period|Other reasons|0|||
27932887|NCT02985957|54589323|FG002|Treatment Period|Other reasons|1|||
27932888|NCT02985957|54589324|FG003|Treatment Period|Other reasons|3|||
27932889|NCT02985957|54589325|FG004|Treatment Period|Other reasons|6|||
27932890|NCT02985957|54589326|FG005|Treatment Period|Other reasons|0|||
27932891|NCT02985957|54589327|FG006|Treatment Period|Other reasons|1|||
27932892|NCT02985957|54589321|FG000|Treatment Period|Not reported|0|||
27932893|NCT02985957|54589322|FG001|Treatment Period|Not reported|1|||
27932894|NCT02985957|54589323|FG002|Treatment Period|Not reported|2|||
27932895|NCT02985957|54589324|FG003|Treatment Period|Not reported|5|||
27932896|NCT02985957|54589325|FG004|Treatment Period|Not reported|0|||
27932897|NCT02985957|54589326|FG005|Treatment Period|Not reported|0|||
27932898|NCT02985957|54589327|FG006|Treatment Period|Not reported|0|||
27932899|NCT02985957|54589321|FG000|Treatment Period|Maximum clinical benefit|0|||
27842428|NCT01447433|54330945|FG000|Overall Study|Lost to Follow-up|0|||
27842429|NCT01447433|54330946|FG001|Overall Study|Lost to Follow-up|2|||
27842430|NCT01447433|54330945|FG000|Overall Study|Withdrawal by Subject|3|||
27842431|NCT01447433|54330946|FG001|Overall Study|Withdrawal by Subject|3|||
27842432|NCT01447433|54330945|FG000|Overall Study|Protocol Violation|1|||
27842433|NCT01447433|54330946|FG001|Overall Study|Protocol Violation|1|||
27842434|NCT01446965|54330954|FG000|Randominization|One site was dismissed due to IRB irregularity|30|||
27842435|NCT01446965|54330955|FG001|Randominization|One site was dismissed due to IRB irregularity|16|||
27842436|NCT01446965|54330954|FG000|Participants Followed and Analyzed|Lost to Follow-up|10|||
27932900|NCT02985957|54589322|FG001|Treatment Period|Maximum clinical benefit|0|||
27932901|NCT02985957|54589323|FG002|Treatment Period|Maximum clinical benefit|1|||
27932902|NCT02985957|54589324|FG003|Treatment Period|Maximum clinical benefit|1|||
27932903|NCT02985957|54589325|FG004|Treatment Period|Maximum clinical benefit|0|||
27932904|NCT02985957|54589326|FG005|Treatment Period|Maximum clinical benefit|0|||
27932905|NCT02985957|54589327|FG006|Treatment Period|Maximum clinical benefit|2|||
27788502|NCT02203838|54243163|FG002|Overall Study|Lack of Efficacy|1|||
27788503|NCT02203838|54243164|FG003|Overall Study|Lack of Efficacy|1|||
27788504|NCT02203838|54243161|FG000|Overall Study|Adverse Event|46|||
27788505|NCT02203838|54243162|FG001|Overall Study|Adverse Event|6|||
27788506|NCT02203838|54243163|FG002|Overall Study|Adverse Event|3|||
27788507|NCT02203838|54243164|FG003|Overall Study|Adverse Event|2|||
27788508|NCT02203838|54243161|FG000|Overall Study|Lost to Follow-up|39|||
27788509|NCT02203838|54243162|FG001|Overall Study|Lost to Follow-up|3|||
27788510|NCT02203838|54243163|FG002|Overall Study|Lost to Follow-up|2|||
27788511|NCT02203838|54243164|FG003|Overall Study|Lost to Follow-up|1|||
27788512|NCT02203838|54243161|FG000|Overall Study|Protocol Violation|7|||
27788513|NCT02203838|54243162|FG001|Overall Study|Protocol Violation|3|||
27788514|NCT02203838|54243163|FG002|Overall Study|Protocol Violation|0|||
27788515|NCT02203838|54243164|FG003|Overall Study|Protocol Violation|0|||
27788516|NCT02203838|54243161|FG000|Overall Study|Withdrawal by Subject|83|||
27788517|NCT02203838|54243162|FG001|Overall Study|Withdrawal by Subject|10|||
27788518|NCT02203838|54243163|FG002|Overall Study|Withdrawal by Subject|8|||
27788519|NCT02203838|54243164|FG003|Overall Study|Withdrawal by Subject|11|||
27788520|NCT02203838|54243161|FG000|Overall Study|Physician Decision|27|||
27788521|NCT02203838|54243162|FG001|Overall Study|Physician Decision|0|||
27788522|NCT02203838|54243163|FG002|Overall Study|Physician Decision|2|||
27788523|NCT02203838|54243164|FG003|Overall Study|Physician Decision|3|||
27788524|NCT02203838|54243161|FG000|Overall Study|Other|1|||
27788525|NCT02203838|54243162|FG001|Overall Study|Other|0|||
27788526|NCT02203838|54243163|FG002|Overall Study|Other|0|||
27788527|NCT02203838|54243164|FG003|Overall Study|Other|0|||
27788528|NCT02178787|54243176|FG000|Overall Study|Lost to Follow-up|1|||
27788529|NCT02178787|54243177|FG001|Overall Study|Lost to Follow-up|0|||
27788530|NCT02178787|54243176|FG000|Overall Study|Withdrawal by Subject|0|||
27788531|NCT02178787|54243177|FG001|Overall Study|Withdrawal by Subject|2|||
27788532|NCT02178787|54243176|FG000|Overall Study|No TCD window|3|||
27788533|NCT02178787|54243177|FG001|Overall Study|No TCD window|7|||
27788534|NCT02178787|54243176|FG000|Overall Study|Physician Decision|1|||
27788535|NCT02178787|54243177|FG001|Overall Study|Physician Decision|0|||
27788536|NCT02178709|54243185|FG000|Overall Study|Adverse Event|5|||
27788537|NCT02178709|54243185|FG000|Overall Study|Death|2|||
27788538|NCT02178709|54243185|FG000|Overall Study|Withdrawal by Subject|2|||
27788539|NCT02178709|54243185|FG000|Overall Study|Physician Decision|2|||
27788540|NCT02178709|54243185|FG000|Overall Study|Disease Progression|5|||
27788541|NCT02238080|54243189|FG000|Overall Study|Death|13|||
27788542|NCT02238080|54243189|FG000|Overall Study|Treatment interrupted|6|||
27788543|NCT02238080|54243189|FG000|Overall Study|Withdrawal by Subject|2|||
27788544|NCT02238080|54243189|FG000|Overall Study|Other|4|||
27788545|NCT02150863|54243196|FG000|Overall Study|Lost to Follow-up|0|||
27788546|NCT02150863|54243197|FG001|Overall Study|Lost to Follow-up|1|||
27788547|NCT02150863|54243198|FG002|Overall Study|Lost to Follow-up|0|||
27788548|NCT02178553|54243208|FG000|Overall Study|Did not proceed to open thoracotomy|7|||
27788549|NCT02178553|54243209|FG001|Overall Study|Did not proceed to open thoracotomy|3|||
27788550|NCT02178553|54243208|FG000|Overall Study|Physician Decision|0|||
27788551|NCT02178553|54243209|FG001|Overall Study|Physician Decision|4|||
27788552|NCT02178553|54243208|FG000|Overall Study|Technical problem with injection|1|||
27788553|NCT02178553|54243209|FG001|Overall Study|Technical problem with injection|3|||
27788554|NCT01627327|54243217|FG000|Overall Study|Adverse Event|6|||
27788555|NCT01627327|54243218|FG001|Overall Study|Adverse Event|12|||
27788556|NCT01627327|54243217|FG000|Overall Study|Lack of Efficacy-No Sub-Reason|0|||
27788557|NCT01627327|54243218|FG001|Overall Study|Lack of Efficacy-No Sub-Reason|2|||
27788558|NCT01627327|54243217|FG000|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4|||
27788559|NCT01627327|54243218|FG001|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9|||
27788560|NCT01627327|54243217|FG000|Overall Study|Protocol Violation|4|||
27788561|NCT01627327|54243218|FG001|Overall Study|Protocol Violation|10|||
27788562|NCT01627327|54243217|FG000|Overall Study|Lost to Follow-up|1|||
27788563|NCT01627327|54243218|FG001|Overall Study|Lost to Follow-up|3|||
27788564|NCT01627327|54243217|FG000|Overall Study|Physician Decision|1|||
27788565|NCT01627327|54243218|FG001|Overall Study|Physician Decision|0|||
27788566|NCT01627327|54243217|FG000|Overall Study|Withdrawal by Subject|3|||
27788567|NCT01627327|54243218|FG001|Overall Study|Withdrawal by Subject|3|||
27788568|NCT01627249|54243227|FG000|Overall Study|Death|3|||
27932906|NCT02985957|54589321|FG000|Treatment Period|Adverse event unrelated to study drug|1|||
27788569|NCT01627249|54243228|FG001|Overall Study|Death|5|||
27932907|NCT02985957|54589322|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
27788570|NCT01627249|54243229|FG002|Overall Study|Death|3|||
27788571|NCT01627249|54243227|FG000|Overall Study|Withdrawal by Subject|12|||
27788572|NCT01627249|54243228|FG001|Overall Study|Withdrawal by Subject|6|||
27788573|NCT01627249|54243229|FG002|Overall Study|Withdrawal by Subject|9|||
27788574|NCT01627249|54243227|FG000|Overall Study|Missed Visit|1|||
27788575|NCT01627249|54243228|FG001|Overall Study|Missed Visit|1|||
27788576|NCT01627249|54243229|FG002|Overall Study|Missed Visit|0|||
27788577|NCT01688830|54243258|FG000|Overall Study|Lost to Follow-up|0|||
27788578|NCT01688830|54243259|FG001|Overall Study|Lost to Follow-up|0|||
27788579|NCT01688830|54243260|FG002|Overall Study|Lost to Follow-up|0|||
27788580|NCT01688830|54243261|FG003|Overall Study|Lost to Follow-up|0|||
27788581|NCT01688830|54243262|FG004|Overall Study|Lost to Follow-up|0|||
27932908|NCT02985957|54589323|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
27932909|NCT02985957|54589324|FG003|Treatment Period|Adverse event unrelated to study drug|3|||
27932910|NCT02985957|54589325|FG004|Treatment Period|Adverse event unrelated to study drug|7|||
27932911|NCT02985957|54589326|FG005|Treatment Period|Adverse event unrelated to study drug|2|||
27932912|NCT02985957|54589327|FG006|Treatment Period|Adverse event unrelated to study drug|7|||
27932913|NCT02985957|54589321|FG000|Treatment Period|Study drug toxicity|1|||
27932914|NCT02985957|54589322|FG001|Treatment Period|Study drug toxicity|23|||
27932915|NCT02985957|54589323|FG002|Treatment Period|Study drug toxicity|20|||
27788582|NCT01688830|54243263|FG005|Overall Study|Lost to Follow-up|0|||
27788583|NCT01688830|54243264|FG006|Overall Study|Lost to Follow-up|0|||
27788584|NCT01688830|54243265|FG007|Overall Study|Lost to Follow-up|0|||
27788585|NCT01688830|54243266|FG008|Overall Study|Lost to Follow-up|0|||
27788586|NCT01688830|54243267|FG009|Overall Study|Lost to Follow-up|0|||
27788587|NCT01688830|54243268|FG010|Overall Study|Lost to Follow-up|1|||
27788588|NCT01688830|54243269|FG011|Overall Study|Lost to Follow-up|0|||
27788589|NCT01688830|54243270|FG012|Overall Study|Lost to Follow-up|0|||
27788590|NCT01688830|54243271|FG013|Overall Study|Lost to Follow-up|0|||
27788591|NCT01688830|54243272|FG014|Overall Study|Lost to Follow-up|0|||
27788592|NCT01688830|54243273|FG015|Overall Study|Lost to Follow-up|0|||
27788593|NCT01688830|54243274|FG016|Overall Study|Lost to Follow-up|0|||
27788594|NCT01688830|54243275|FG017|Overall Study|Lost to Follow-up|0|||
27788595|NCT01688830|54243276|FG018|Overall Study|Lost to Follow-up|0|||
27788596|NCT01688830|54243277|FG019|Overall Study|Lost to Follow-up|0|||
27788597|NCT01688830|54243278|FG020|Overall Study|Lost to Follow-up|0|||
27788598|NCT02178475|54243362|FG000|Overall Study|Withdrawal by Subject|7|||
27788599|NCT02178475|54243362|FG000|Overall Study|Lost to Follow-up|10|||
27788600|NCT02178475|54243362|FG000|Overall Study|Death|13|||
27788601|NCT02178475|54243362|FG000|Overall Study|Protocol-specified Criteria|99|||
27788602|NCT01569022|54243366|FG000|First Intervention|Lost to Follow-up|2|||
27788603|NCT01569022|54243367|FG001|First Intervention|Lost to Follow-up|1|||
27788604|NCT01569022|54243366|FG000|Second Intervention|Lost to Follow-up|2|||
27788605|NCT01569022|54243367|FG001|Second Intervention|Lost to Follow-up|2|||
27788606|NCT01629823|54243378|FG000|Trial Period|Missed visit|11|||
27788607|NCT01629823|54243379|FG001|Trial Period|Missed visit|9|||
27788608|NCT01629823|54243380|FG002|Trial Period|Missed visit|8|||
27788609|NCT01629823|54243378|FG000|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
27788610|NCT01629823|54243379|FG001|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
27788611|NCT01629823|54243380|FG002|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
27788612|NCT01629823|54243378|FG000|Trial Period|Pregnancy|1|||
27788613|NCT01629823|54243379|FG001|Trial Period|Pregnancy|0|||
27788614|NCT01629823|54243380|FG002|Trial Period|Pregnancy|0|||
27788615|NCT01629823|54243378|FG000|Trial Period|Adverse Event|0|||
27788616|NCT01629823|54243379|FG001|Trial Period|Adverse Event|1|||
27788617|NCT01629823|54243380|FG002|Trial Period|Adverse Event|0|||
27788618|NCT01629823|54243378|FG000|Trial Period|Out-of-window visit|0|||
27788619|NCT01629823|54243379|FG001|Trial Period|Out-of-window visit|2|||
27932916|NCT02985957|54589324|FG003|Treatment Period|Study drug toxicity|11|||
27932917|NCT02985957|54589325|FG004|Treatment Period|Study drug toxicity|19|||
27932918|NCT02985957|54589326|FG005|Treatment Period|Study drug toxicity|3|||
27932919|NCT02985957|54589327|FG006|Treatment Period|Study drug toxicity|5|||
27932920|NCT02985957|54589321|FG000|Treatment Period|Disease progression|0|||
27932921|NCT02985957|54589322|FG001|Treatment Period|Disease progression|16|||
27932922|NCT02985957|54589323|FG002|Treatment Period|Disease progression|20|||
27932923|NCT02985957|54589324|FG003|Treatment Period|Disease progression|39|||
27932924|NCT02985957|54589325|FG004|Treatment Period|Disease progression|29|||
27932925|NCT02985957|54589326|FG005|Treatment Period|Disease progression|11|||
27932926|NCT02985957|54589327|FG006|Treatment Period|Disease progression|28|||
27932927|NCT02985957|54589321|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
27932928|NCT02985957|54589322|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
27932929|NCT02985957|54589323|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
27932930|NCT02985957|54589324|FG003|Treatment Period|Participant request to discontinue study treatment|4|||
27932931|NCT02985957|54589325|FG004|Treatment Period|Participant request to discontinue study treatment|2|||
27932932|NCT02985957|54589326|FG005|Treatment Period|Participant request to discontinue study treatment|2|||
27932933|NCT02985957|54589327|FG006|Treatment Period|Participant request to discontinue study treatment|3|||
27788620|NCT01629823|54243380|FG002|Trial Period|Out-of-window visit|0|||
27788621|NCT01629823|54243378|FG000|Trial Period|Failed to hold medication|0|||
27788622|NCT01629823|54243379|FG001|Trial Period|Failed to hold medication|0|||
27788623|NCT01629823|54243380|FG002|Trial Period|Failed to hold medication|1|||
27788624|NCT01629823|54243378|FG000|Washout Period|Safety|2|||
27788625|NCT01629823|54243379|FG001|Washout Period|Safety|5|||
27788626|NCT01629823|54243380|FG002|Washout Period|Safety|0|||
27788627|NCT01629823|54243378|FG000|Washout Period|Pregnancy|1|||
27788628|NCT01629823|54243379|FG001|Washout Period|Pregnancy|0|||
27932934|NCT02985957|54589321|FG000|Treatment Period|Poor/Non-Compliance|0|||
27932935|NCT02985957|54589322|FG001|Treatment Period|Poor/Non-Compliance|0|||
27932936|NCT02985957|54589323|FG002|Treatment Period|Poor/Non-Compliance|0|||
27932937|NCT02985957|54589324|FG003|Treatment Period|Poor/Non-Compliance|0|||
27932938|NCT02985957|54589325|FG004|Treatment Period|Poor/Non-Compliance|1|||
27788629|NCT01629823|54243380|FG002|Washout Period|Pregnancy|0|||
27788630|NCT01629823|54243378|FG000|Washout Period|Protocol Violation|0|||
27788631|NCT01629823|54243379|FG001|Washout Period|Protocol Violation|1|||
27788632|NCT01629823|54243380|FG002|Washout Period|Protocol Violation|0|||
27788633|NCT01688050|54243388|FG000|Overall Study|Death|7|||
27788634|NCT01688050|54243388|FG000|Overall Study|Conversion to open repair|1|||
27788635|NCT01688050|54243388|FG000|Overall Study|Lost to Follow-up|13|||
27788636|NCT01688050|54243388|FG000|Overall Study|Withdrawal by Subject|10|||
27788637|NCT01604278|54243394|FG000|Overall Study|Lack of Efficacy|0|||
27788638|NCT01604278|54243395|FG001|Overall Study|Lack of Efficacy|1|||
27788639|NCT01604278|54243394|FG000|Overall Study|Lost to Follow-up|1|||
27788640|NCT01604278|54243395|FG001|Overall Study|Lost to Follow-up|0|||
27788641|NCT01604278|54243394|FG000|Overall Study|Administrative problems|2|||
27788642|NCT01604278|54243395|FG001|Overall Study|Administrative problems|1|||
27788643|NCT01604278|54243394|FG000|Overall Study|Withdrawal by Subject|3|||
27788644|NCT01604278|54243395|FG001|Overall Study|Withdrawal by Subject|3|||
27788645|NCT01604278|54243394|FG000|Overall Study|Adverse Event|3|||
27788646|NCT01604278|54243395|FG001|Overall Study|Adverse Event|5|||
27788647|NCT01604278|54243394|FG000|Overall Study|Protocol Deviation|5|||
27788648|NCT01604278|54243395|FG001|Overall Study|Protocol Deviation|3|||
27788649|NCT01687270|54243401|FG000|Overall Study|Lack of Efficacy|11|||
27788650|NCT01687270|54243401|FG000|Overall Study|Lost to Follow-up|1|||
27788651|NCT01589770|54243407|FG000|Overall Study|EGFR <60ml/min|6|||
27788652|NCT01589770|54243408|FG001|Overall Study|EGFR <60ml/min|4|||
27788653|NCT01589770|54243407|FG000|Overall Study|claustrophobic when entering cardiac MRI|2|||
27788654|NCT01589770|54243408|FG001|Overall Study|claustrophobic when entering cardiac MRI|1|||
27788655|NCT01588990|54243414|FG000|Phase A|Withdrawal by Subject|5|||
27788656|NCT01588990|54243414|FG000|Phase A|Physician Decision|11|||
27788657|NCT01588990|54243414|FG000|Phase A|Other|14|||
27788658|NCT01588990|54243414|FG000|Phase A|Lost to Follow-up|1|||
27788659|NCT01588990|54243414|FG000|Phase A|Death|5|||
27788660|NCT01588990|54243414|FG000|Phase A|Adverse Event|28|||
27788661|NCT01588990|54243414|FG000|Phase A|Still on therapy at end of study|6|||
27788662|NCT01588990|54243414|FG000|Phase B|Adverse Event|2|||
27788663|NCT01588990|54243414|FG000|Phase B|Still on therapy at end of study|5|||
27788664|NCT01588990|54243414|FG000|Phase B|Withdrawal by Subject|3|||
27788665|NCT01588990|54243414|FG000|Phase B|Physician Decision|4|||
27788666|NCT01588990|54243414|FG000|Phase B|Other|2|||
27788667|NCT02176525|54243430|FG000|Overall Study|Adverse Event|0|||
27788668|NCT02176525|54243431|FG001|Overall Study|Adverse Event|0|||
27788669|NCT02176525|54243432|FG002|Overall Study|Adverse Event|0|||
27788670|NCT02176525|54243433|FG003|Overall Study|Adverse Event|1|||
27788671|NCT02176525|54243434|FG004|Overall Study|Adverse Event|1|||
27788672|NCT02176525|54243435|FG005|Overall Study|Adverse Event|0|||
27788673|NCT02176525|54243436|FG006|Overall Study|Adverse Event|1|||
27788674|NCT02176525|54243437|FG007|Overall Study|Adverse Event|0|||
27788675|NCT02176525|54243430|FG000|Overall Study|not treated|1|||
27788676|NCT02176525|54243431|FG001|Overall Study|not treated|0|||
27788677|NCT02176525|54243432|FG002|Overall Study|not treated|0|||
27788678|NCT02176525|54243433|FG003|Overall Study|not treated|0|||
27788679|NCT02176525|54243434|FG004|Overall Study|not treated|0|||
27788680|NCT02176525|54243435|FG005|Overall Study|not treated|1|||
27788681|NCT02176525|54243436|FG006|Overall Study|not treated|0|||
27788682|NCT02176525|54243437|FG007|Overall Study|not treated|0|||
27788683|NCT02127931|54243463|FG000|Overall Study|Glitch in Game|1|||
27788684|NCT02127307|54243468|FG000|Overall Study|Protocol Violation|36|||
27788685|NCT02127307|54243468|FG000|Overall Study|Lost to Follow-up|2|||
27788686|NCT02127307|54243468|FG000|Overall Study|Death|101|||
27788687|NCT02127307|54243468|FG000|Overall Study|Other than specified above|169|||
27788688|NCT02126839|54243474|FG000|Overall Study|Adverse Event|0|||
27788689|NCT02126839|54243475|FG001|Overall Study|Adverse Event|1|||
27788690|NCT02126839|54243474|FG000|Overall Study|Withdrawal by Subject|1|||
27788691|NCT02126839|54243475|FG001|Overall Study|Withdrawal by Subject|0|||
27788692|NCT02126839|54243474|FG000|Overall Study|Withdrawal by parent/guardian|1|||
27788693|NCT02126839|54243475|FG001|Overall Study|Withdrawal by parent/guardian|0|||
27788694|NCT02126839|54243474|FG000|Overall Study|Protocol Violation|2|||
27788695|NCT02126839|54243475|FG001|Overall Study|Protocol Violation|3|||
27788696|NCT02126839|54243474|FG000|Overall Study|Sponsor request|0|||
27788697|NCT02126839|54243475|FG001|Overall Study|Sponsor request|1|||
27788698|NCT02126839|54243474|FG000|Overall Study|Lost to Follow-up|1|||
27788699|NCT02126839|54243475|FG001|Overall Study|Lost to Follow-up|4|||
27932939|NCT02985957|54589326|FG005|Treatment Period|Poor/Non-Compliance|1|||
27788700|NCT02126839|54243474|FG000|Overall Study|Other|5|||
27788701|NCT02126839|54243475|FG001|Overall Study|Other|5|||
27788702|NCT02125279|54243481|FG000|Overall Study|Lack of Efficacy|2|||
27788703|NCT02125279|54243481|FG000|Overall Study|Withdrawal by Subject|6|||
27788704|NCT02125279|54243481|FG000|Overall Study|Protocol Violation|1|||
27932940|NCT02985957|54589327|FG006|Treatment Period|Poor/Non-Compliance|0|||
27932941|NCT02985957|54589321|FG000|Treatment Period|Continuing in Treatment Period|0|||
27932942|NCT02985957|54589322|FG001|Treatment Period|Continuing in Treatment Period|1|||
27932943|NCT02985957|54589323|FG002|Treatment Period|Continuing in Treatment Period|0|||
27932944|NCT02985957|54589324|FG003|Treatment Period|Continuing in Treatment Period|4|||
27932945|NCT02985957|54589325|FG004|Treatment Period|Continuing in Treatment Period|4|||
27788705|NCT02125279|54243481|FG000|Overall Study|Lost to Follow-up|4|||
27788706|NCT02124811|54243489|FG000|Overall Study|Early termination|2|||
27788707|NCT02124811|54243490|FG001|Overall Study|Early termination|2|||
27788708|NCT02124811|54243489|FG000|Overall Study|Withdrawal by Subject|1|||
27788709|NCT02124811|54243490|FG001|Overall Study|Withdrawal by Subject|0|||
27788710|NCT02148445|54243498|FG000|Overall Study|Death|1|||
27788711|NCT02148445|54243499|FG001|Overall Study|Death|3|||
27788712|NCT02148211|54243507|FG000|Overall Study|Lost to Follow-up|352|||
27788713|NCT02147587|54243513|FG000|Overall Study|Adverse Event|9|||
27788714|NCT02147587|54243514|FG001|Overall Study|Adverse Event|4|||
27788715|NCT02147587|54243513|FG000|Overall Study|Lack of Efficacy|2|||
27788716|NCT02147587|54243514|FG001|Overall Study|Lack of Efficacy|1|||
27788717|NCT02147353|54243522|FG000|Overall Study|Lost to Follow-up|2|||
27788718|NCT02147353|54243523|FG001|Overall Study|Lost to Follow-up|0|||
27788719|NCT02147353|54243522|FG000|Overall Study|unable to make visits|4|||
27788720|NCT02147353|54243523|FG001|Overall Study|unable to make visits|0|||
27788721|NCT02147353|54243522|FG000|Overall Study|medication noncompliance|3|||
27788722|NCT02147353|54243523|FG001|Overall Study|medication noncompliance|0|||
27788723|NCT02147197|54243532|FG000|Overall Study|Adverse Event|1|||
27788724|NCT02147197|54243533|FG001|Overall Study|Adverse Event|0|||
27788725|NCT02147197|54243534|FG002|Overall Study|Adverse Event|0|||
27788726|NCT02147197|54243532|FG000|Overall Study|Withdrawal of Consent|4|||
27788727|NCT02147197|54243533|FG001|Overall Study|Withdrawal of Consent|3|||
27788728|NCT02147197|54243534|FG002|Overall Study|Withdrawal of Consent|2|||
27788729|NCT02147197|54243532|FG000|Overall Study|Lost to Follow-up|2|||
27788730|NCT02147197|54243533|FG001|Overall Study|Lost to Follow-up|3|||
27788731|NCT02147197|54243534|FG002|Overall Study|Lost to Follow-up|1|||
27788732|NCT02147197|54243532|FG000|Overall Study|Protocol Violation|1|||
27788733|NCT02147197|54243533|FG001|Overall Study|Protocol Violation|0|||
27788734|NCT02147197|54243534|FG002|Overall Study|Protocol Violation|3|||
27788735|NCT02147197|54243532|FG000|Overall Study|Other Miscellaneous Reasons|1|||
27788736|NCT02147197|54243533|FG001|Overall Study|Other Miscellaneous Reasons|0|||
27788737|NCT02147197|54243534|FG002|Overall Study|Other Miscellaneous Reasons|3|||
27788738|NCT02176291|54243544|FG000|Overall Study|Death|1|||
27788739|NCT02176291|54243545|FG001|Overall Study|Death|0|||
27788740|NCT02176291|54243544|FG000|Overall Study|non compliance with protocol|2|||
27788741|NCT02176291|54243545|FG001|Overall Study|non compliance with protocol|0|||
27788742|NCT02176291|54243544|FG000|Overall Study|Withdrawal by Subject|2|||
27788743|NCT02176291|54243545|FG001|Overall Study|Withdrawal by Subject|0|||
27788744|NCT02175745|54243551|FG000|Overall Study|Not Eligible|1|||
27788745|NCT02175277|54243555|FG000|Overall Study|Protocol-specified Criteria|1|||
27788746|NCT02124265|54243559|FG000|Overall Study|Adverse Event|1|||
27788747|NCT02146105|54243563|FG000|Overall Study|Adverse Event|1|||
27788748|NCT02146105|54243563|FG000|Overall Study|Withdrawal by Subject|5|||
27788749|NCT02175199|54243569|FG000|Overall Study|Withdrawal by Subject|1|||
27788750|NCT02175199|54243570|FG001|Overall Study|Withdrawal by Subject|5|||
27788751|NCT02175199|54243569|FG000|Overall Study|Randomized in Error|1|||
27788752|NCT02175199|54243570|FG001|Overall Study|Randomized in Error|0|||
27788753|NCT02175199|54243569|FG000|Overall Study|Sponsor Decision|1|||
27788754|NCT02175199|54243570|FG001|Overall Study|Sponsor Decision|0|||
27788755|NCT02123797|54243579|FG000|Baseline Intervention|Death|9|||
27788756|NCT02123797|54243580|FG001|Baseline Intervention|Death|16|||
27788757|NCT02123797|54243581|FG002|Baseline Intervention|Death|0|||
27788758|NCT02123797|54243582|FG003|Baseline Intervention|Death|0|||
27788759|NCT02123797|54243583|FG004|Baseline Intervention|Death|0|||
27788760|NCT02123797|54243579|FG000|Baseline Intervention|Withdrawal by Subject|2|||
27788761|NCT02123797|54243580|FG001|Baseline Intervention|Withdrawal by Subject|8|||
27788762|NCT02123797|54243581|FG002|Baseline Intervention|Withdrawal by Subject|0|||
27932946|NCT02985957|54589326|FG005|Treatment Period|Continuing in Treatment Period|0|||
27932947|NCT02985957|54589327|FG006|Treatment Period|Continuing in Treatment Period|0|||
27788763|NCT02123797|54243582|FG003|Baseline Intervention|Withdrawal by Subject|0|||
27788764|NCT02123797|54243583|FG004|Baseline Intervention|Withdrawal by Subject|0|||
27788765|NCT02123797|54243579|FG000|Baseline Intervention|Relocation|2|||
27788766|NCT02123797|54243580|FG001|Baseline Intervention|Relocation|0|||
27788767|NCT02123797|54243581|FG002|Baseline Intervention|Relocation|0|||
27788768|NCT02123797|54243582|FG003|Baseline Intervention|Relocation|0|||
27788769|NCT02123797|54243583|FG004|Baseline Intervention|Relocation|0|||
27788770|NCT02123797|54243579|FG000|Baseline Intervention|Out of window for initial survey|6|||
27788771|NCT02123797|54243580|FG001|Baseline Intervention|Out of window for initial survey|13|||
27788772|NCT02123797|54243581|FG002|Baseline Intervention|Out of window for initial survey|0|||
27788773|NCT02123797|54243582|FG003|Baseline Intervention|Out of window for initial survey|0|||
27932948|NCT02811861|54589357|FG000|Overall Study|Radiological Disease Progression|123|||
27932949|NCT02811861|54589358|FG001|Overall Study|Radiological Disease Progression|97|||
27932950|NCT02811861|54589359|FG002|Overall Study|Radiological Disease Progression|174|||
27932951|NCT02811861|54589357|FG000|Overall Study|Clinical Disease Progression|20|||
27932952|NCT02811861|54589358|FG001|Overall Study|Clinical Disease Progression|19|||
27932953|NCT02811861|54589359|FG002|Overall Study|Clinical Disease Progression|22|||
27932954|NCT02811861|54589357|FG000|Overall Study|Adverse Event|63|||
27932955|NCT02811861|54589358|FG001|Overall Study|Adverse Event|60|||
27932956|NCT02811861|54589359|FG002|Overall Study|Adverse Event|41|||
27932957|NCT02811861|54589357|FG000|Overall Study|Lost to Follow-up|0|||
27932958|NCT02811861|54589358|FG001|Overall Study|Lost to Follow-up|0|||
27932959|NCT02811861|54589359|FG002|Overall Study|Lost to Follow-up|1|||
27932960|NCT02811861|54589357|FG000|Overall Study|Subject Choice|29|||
27932961|NCT02811861|54589358|FG001|Overall Study|Subject Choice|17|||
27932962|NCT02811861|54589359|FG002|Overall Study|Subject Choice|23|||
27932963|NCT02811861|54589357|FG000|Overall Study|Withdrawal by Subject|4|||
27932964|NCT02811861|54589358|FG001|Overall Study|Withdrawal by Subject|4|||
27932965|NCT02811861|54589359|FG002|Overall Study|Withdrawal by Subject|9|||
27932966|NCT02811861|54589357|FG000|Overall Study|Other|4|||
27932967|NCT02811861|54589358|FG001|Overall Study|Other|13|||
27932968|NCT02811861|54589359|FG002|Overall Study|Other|3|||
27932969|NCT02811861|54589357|FG000|Overall Study|Treatment Ongoing at Cutoff Date|112|||
27788774|NCT02123797|54243583|FG004|Baseline Intervention|Out of window for initial survey|0|||
27788775|NCT02123797|54243579|FG000|Baseline Intervention|Lost to Follow-up|0|||
27788776|NCT02123797|54243580|FG001|Baseline Intervention|Lost to Follow-up|5|||
27788777|NCT02123797|54243581|FG002|Baseline Intervention|Lost to Follow-up|0|||
27788778|NCT02123797|54243582|FG003|Baseline Intervention|Lost to Follow-up|0|||
27788779|NCT02123797|54243583|FG004|Baseline Intervention|Lost to Follow-up|0|||
27788780|NCT02123797|54243579|FG000|Baseline Intervention|Other Disease|3|||
27788781|NCT02123797|54243580|FG001|Baseline Intervention|Other Disease|0|||
27788782|NCT02123797|54243581|FG002|Baseline Intervention|Other Disease|0|||
27788783|NCT02123797|54243582|FG003|Baseline Intervention|Other Disease|0|||
27788784|NCT02123797|54243583|FG004|Baseline Intervention|Other Disease|0|||
27788785|NCT02123797|54243579|FG000|3-month Follow up (Cumulative Counts)|Death|33|||
27788786|NCT02123797|54243580|FG001|3-month Follow up (Cumulative Counts)|Death|57|||
27788787|NCT02123797|54243581|FG002|3-month Follow up (Cumulative Counts)|Death|0|||
27788788|NCT02123797|54243582|FG003|3-month Follow up (Cumulative Counts)|Death|0|||
27788789|NCT02123797|54243583|FG004|3-month Follow up (Cumulative Counts)|Death|0|||
27788790|NCT02123797|54243579|FG000|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2|||
27788791|NCT02123797|54243580|FG001|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7|||
27788792|NCT02123797|54243581|FG002|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50|||
27788793|NCT02123797|54243582|FG003|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82|||
27788794|NCT02123797|54243583|FG004|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
27788795|NCT02123797|54243579|FG000|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6|||
27788796|NCT02123797|54243580|FG001|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16|||
27788797|NCT02123797|54243581|FG002|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
27788798|NCT02123797|54243582|FG003|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
27788799|NCT02123797|54243583|FG004|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
27788800|NCT02123797|54243579|FG000|3-month Follow up (Cumulative Counts)|Relocation|0|||
27788801|NCT02123797|54243580|FG001|3-month Follow up (Cumulative Counts)|Relocation|1|||
27788802|NCT02123797|54243581|FG002|3-month Follow up (Cumulative Counts)|Relocation|0|||
27788803|NCT02123797|54243582|FG003|3-month Follow up (Cumulative Counts)|Relocation|0|||
27788804|NCT02123797|54243583|FG004|3-month Follow up (Cumulative Counts)|Relocation|0|||
27788805|NCT02123797|54243579|FG000|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16|||
27788806|NCT02123797|54243580|FG001|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36|||
27788807|NCT02123797|54243581|FG002|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
27788808|NCT02123797|54243582|FG003|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
27788809|NCT02123797|54243583|FG004|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
27788810|NCT02123797|54243579|FG000|6-month Follow up (Cumulative Counts)|Death|51|||
27788811|NCT02123797|54243580|FG001|6-month Follow up (Cumulative Counts)|Death|97|||
27788812|NCT02123797|54243581|FG002|6-month Follow up (Cumulative Counts)|Death|0|||
27788813|NCT02123797|54243582|FG003|6-month Follow up (Cumulative Counts)|Death|0|||
27788814|NCT02123797|54243583|FG004|6-month Follow up (Cumulative Counts)|Death|0|||
27788815|NCT02123797|54243579|FG000|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
27932970|NCT02811861|54589358|FG001|Overall Study|Treatment Ongoing at Cutoff Date|142|||
27932971|NCT02811861|54589359|FG002|Overall Study|Treatment Ongoing at Cutoff Date|67|||
27932972|NCT02811861|54589357|FG000|Overall Study|Randomized but not treated|2|||
27932973|NCT02811861|54589358|FG001|Overall Study|Randomized but not treated|3|||
27932974|NCT02811861|54589359|FG002|Overall Study|Randomized but not treated|17|||
27932975|NCT02744612|54589369|FG000|Overall Study|Withdrawal by Subject|0|||
27932976|NCT02744612|54589370|FG001|Overall Study|Withdrawal by Subject|2|||
27932977|NCT02700451|54589379|FG000|Overall Study|Protocol Violation|2|||
27932978|NCT02700451|54589380|FG001|Overall Study|Protocol Violation|2|||
27932979|NCT02700451|54589381|FG002|Overall Study|Protocol Violation|3|||
27932980|NCT02700451|54589379|FG000|Overall Study|Discontinued intervention|14|||
27932981|NCT02700451|54589380|FG001|Overall Study|Discontinued intervention|15|||
27932982|NCT02700451|54589381|FG002|Overall Study|Discontinued intervention|14|||
27932983|NCT02623426|54589392|FG000|Overall Study|Lost to Follow-up|0|||
27932984|NCT02623426|54589393|FG001|Overall Study|Lost to Follow-up|0|||
27932985|NCT02623426|54589394|FG002|Overall Study|Lost to Follow-up|1|||
27932986|NCT02623426|54589392|FG000|Overall Study|Withdrawal by Subject|1|||
27932987|NCT02623426|54589393|FG001|Overall Study|Withdrawal by Subject|2|||
27932988|NCT02623426|54589394|FG002|Overall Study|Withdrawal by Subject|2|||
27932989|NCT02580058|54589405|FG000|Overall Study|Adverse Event|16|||
27932990|NCT02580058|54589406|FG001|Overall Study|Adverse Event|30|||
27932991|NCT02580058|54589407|FG002|Overall Study|Adverse Event|20|||
27932992|NCT02580058|54589405|FG000|Overall Study|Death|4|||
27932993|NCT02580058|54589406|FG001|Overall Study|Death|4|||
27932994|NCT02580058|54589407|FG002|Overall Study|Death|5|||
27932995|NCT02580058|54589405|FG000|Overall Study|Physician Decision|1|||
27932996|NCT02580058|54589406|FG001|Overall Study|Physician Decision|3|||
27932997|NCT02580058|54589407|FG002|Overall Study|Physician Decision|11|||
27932998|NCT02580058|54589405|FG000|Overall Study|Other|5|||
27932999|NCT02580058|54589406|FG001|Overall Study|Other|1|||
27933000|NCT02580058|54589407|FG002|Overall Study|Other|3|||
27933001|NCT02580058|54589405|FG000|Overall Study|Withdrawal by Subject|4|||
27933002|NCT02580058|54589406|FG001|Overall Study|Withdrawal by Subject|7|||
27933003|NCT02580058|54589407|FG002|Overall Study|Withdrawal by Subject|31|||
27933004|NCT02580058|54589405|FG000|Overall Study|Global Deterioration of Health Status|19|||
27933005|NCT02580058|54589406|FG001|Overall Study|Global Deterioration of Health Status|18|||
27933006|NCT02580058|54589407|FG002|Overall Study|Global Deterioration of Health Status|24|||
27933007|NCT02580058|54589405|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
27933008|NCT02580058|54589406|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
27933009|NCT02580058|54589407|FG002|Overall Study|No Longer Meets Eligibility Criteria|2|||
27933010|NCT02580058|54589405|FG000|Overall Study|Progressive Disease|137|||
27933011|NCT02580058|54589406|FG001|Overall Study|Progressive Disease|125|||
27933012|NCT02580058|54589407|FG002|Overall Study|Progressive Disease|94|||
27933013|NCT02580058|54589405|FG000|Overall Study|Non-Compliance With Study Drug|1|||
27933014|NCT02580058|54589406|FG001|Overall Study|Non-Compliance With Study Drug|0|||
27933015|NCT02580058|54589407|FG002|Overall Study|Non-Compliance With Study Drug|0|||
27933016|NCT02539394|54589419|FG000|Overall Study|Protocol Violation|1|||
27933017|NCT02539394|54589420|FG001|Overall Study|Protocol Violation|3|||
27933018|NCT02539394|54589419|FG000|Overall Study|Lost to Follow-up|1|||
27933019|NCT02539394|54589420|FG001|Overall Study|Lost to Follow-up|2|||
27933020|NCT02539394|54589419|FG000|Overall Study|Incomplete dataset|6|||
27933021|NCT02539394|54589420|FG001|Overall Study|Incomplete dataset|6|||
27933022|NCT02412670|54589434|FG000|Overall Study|Adverse Event|4|||
27933023|NCT02412670|54589435|FG001|Overall Study|Adverse Event|1|||
27933024|NCT02412670|54589434|FG000|Overall Study|Physician Decision|1|||
27933025|NCT02412670|54589435|FG001|Overall Study|Physician Decision|0|||
27933026|NCT02412670|54589434|FG000|Overall Study|Withdrawal by Subject|1|||
27933027|NCT02412670|54589435|FG001|Overall Study|Withdrawal by Subject|0|||
27933028|NCT02412670|54589434|FG000|Overall Study|Ineligible|1|||
27933029|NCT02412670|54589435|FG001|Overall Study|Ineligible|0|||
27933030|NCT01358877|54589443|FG000|Overall Study|Death|80|||
27933031|NCT01358877|54589444|FG001|Overall Study|Death|89|||
27933032|NCT01358877|54589443|FG000|Overall Study|Ongoing follow-up for post-recurrence|87|||
27933033|NCT01358877|54589444|FG001|Overall Study|Ongoing follow-up for post-recurrence|108|||
27933034|NCT01358877|54589443|FG000|Overall Study|Ongoing follow-up for IDFS event|2084|||
27933035|NCT01358877|54589444|FG001|Overall Study|Ongoing follow-up for IDFS event|2073|||
27933036|NCT01358877|54589443|FG000|Overall Study|Ongoing follow-up for overall survival|7|||
27933037|NCT01358877|54589444|FG001|Overall Study|Ongoing follow-up for overall survival|5|||
27933038|NCT01358877|54589443|FG000|Overall Study|Other|142|||
27933039|NCT01358877|54589444|FG001|Overall Study|Other|129|||
27933040|NCT01084252|54589471|FG000|Phase 1 (120 Weeks)|Adverse Event|0|||
27933041|NCT01084252|54589472|FG001|Phase 1 (120 Weeks)|Adverse Event|0|||
27933042|NCT01084252|54589473|FG002|Phase 1 (120 Weeks)|Adverse Event|1|||
28017002|NCT00540514|54676241|FG001|Overall Study|Excluded prior to treatment|7|||
27933043|NCT01084252|54589474|FG003|Phase 1 (120 Weeks)|Adverse Event|1|||
27933044|NCT01084252|54589475|FG004|Phase 1 (120 Weeks)|Adverse Event|1|||
27933045|NCT01084252|54589476|FG005|Phase 1 (120 Weeks)|Adverse Event|0|||
27933046|NCT01084252|54589477|FG006|Phase 1 (120 Weeks)|Adverse Event|1|||
27933047|NCT01084252|54589478|FG007|Phase 1 (120 Weeks)|Adverse Event|0|||
27933048|NCT01084252|54589479|FG008|Phase 1 (120 Weeks)|Adverse Event|0|||
27933049|NCT01084252|54589480|FG009|Phase 1 (120 Weeks)|Adverse Event|0|||
27933050|NCT01084252|54589481|FG010|Phase 1 (120 Weeks)|Adverse Event|0|||
27933051|NCT01084252|54589482|FG011|Phase 1 (120 Weeks)|Adverse Event|0|||
27933052|NCT01084252|54589483|FG012|Phase 1 (120 Weeks)|Adverse Event|0|||
27933053|NCT01084252|54589484|FG013|Phase 1 (120 Weeks)|Adverse Event|0|||
27933054|NCT01084252|54589471|FG000|Phase 1 (120 Weeks)|Progressive disease|15|||
27933055|NCT01084252|54589472|FG001|Phase 1 (120 Weeks)|Progressive disease|5|||
27933056|NCT01084252|54589473|FG002|Phase 1 (120 Weeks)|Progressive disease|2|||
27933057|NCT01084252|54589474|FG003|Phase 1 (120 Weeks)|Progressive disease|22|||
27933058|NCT01084252|54589475|FG004|Phase 1 (120 Weeks)|Progressive disease|16|||
27933059|NCT01084252|54589476|FG005|Phase 1 (120 Weeks)|Progressive disease|6|||
27933060|NCT01084252|54589477|FG006|Phase 1 (120 Weeks)|Progressive disease|5|||
27933061|NCT01084252|54589478|FG007|Phase 1 (120 Weeks)|Progressive disease|6|||
27933062|NCT01084252|54589479|FG008|Phase 1 (120 Weeks)|Progressive disease|0|||
27933063|NCT01084252|54589480|FG009|Phase 1 (120 Weeks)|Progressive disease|0|||
27933064|NCT01084252|54589481|FG010|Phase 1 (120 Weeks)|Progressive disease|0|||
27933065|NCT01084252|54589482|FG011|Phase 1 (120 Weeks)|Progressive disease|0|||
27933066|NCT01084252|54589483|FG012|Phase 1 (120 Weeks)|Progressive disease|0|||
27933067|NCT01084252|54589484|FG013|Phase 1 (120 Weeks)|Progressive disease|0|||
27933068|NCT01084252|54589471|FG000|Phase 1 (120 Weeks)|Other than specified above|1|||
27933069|NCT01084252|54589472|FG001|Phase 1 (120 Weeks)|Other than specified above|1|||
27933070|NCT01084252|54589473|FG002|Phase 1 (120 Weeks)|Other than specified above|0|||
27933071|NCT01084252|54589474|FG003|Phase 1 (120 Weeks)|Other than specified above|3|||
27933072|NCT01084252|54589475|FG004|Phase 1 (120 Weeks)|Other than specified above|1|||
27788816|NCT02123797|54243580|FG001|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20|||
27788817|NCT02123797|54243581|FG002|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66|||
27788818|NCT02123797|54243582|FG003|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113|||
27788819|NCT02123797|54243583|FG004|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
27788820|NCT02123797|54243579|FG000|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1|||
27788821|NCT02123797|54243580|FG001|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9|||
27788822|NCT02123797|54243581|FG002|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
27788823|NCT02123797|54243582|FG003|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
27788824|NCT02123797|54243583|FG004|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
27788825|NCT02123797|54243579|FG000|6-month Follow up (Cumulative Counts)|Relocation|0|||
27788826|NCT02123797|54243580|FG001|6-month Follow up (Cumulative Counts)|Relocation|2|||
27788827|NCT02123797|54243581|FG002|6-month Follow up (Cumulative Counts)|Relocation|0|||
27788828|NCT02123797|54243582|FG003|6-month Follow up (Cumulative Counts)|Relocation|0|||
27788829|NCT02123797|54243583|FG004|6-month Follow up (Cumulative Counts)|Relocation|0|||
27788830|NCT02175121|54243608|FG000|Overall Study|Lack of Efficacy|1|||
27788831|NCT02175121|54243609|FG001|Overall Study|Lack of Efficacy|0|||
27788832|NCT02175121|54243610|FG002|Overall Study|Lack of Efficacy|0|||
27788833|NCT02175121|54243611|FG003|Overall Study|Lack of Efficacy|0|||
27788834|NCT02175121|54243612|FG004|Overall Study|Lack of Efficacy|0|||
27788835|NCT02175121|54243608|FG000|Overall Study|Lost to Follow-up|0|||
27788836|NCT02175121|54243609|FG001|Overall Study|Lost to Follow-up|1|||
27788837|NCT02175121|54243610|FG002|Overall Study|Lost to Follow-up|0|||
27788838|NCT02175121|54243611|FG003|Overall Study|Lost to Follow-up|1|||
27788839|NCT02175121|54243612|FG004|Overall Study|Lost to Follow-up|0|||
27788840|NCT02175121|54243608|FG000|Overall Study|Personal emergency|0|||
27788841|NCT02175121|54243609|FG001|Overall Study|Personal emergency|0|||
27788842|NCT02175121|54243610|FG002|Overall Study|Personal emergency|0|||
27788843|NCT02175121|54243611|FG003|Overall Study|Personal emergency|0|||
27788844|NCT02175121|54243612|FG004|Overall Study|Personal emergency|1|||
27788845|NCT02175121|54243608|FG000|Overall Study|Schedule conflict|0|||
27788846|NCT02175121|54243609|FG001|Overall Study|Schedule conflict|0|||
27788847|NCT02175121|54243610|FG002|Overall Study|Schedule conflict|1|||
27788848|NCT02175121|54243611|FG003|Overall Study|Schedule conflict|0|||
27788849|NCT02175121|54243612|FG004|Overall Study|Schedule conflict|0|||
27788850|NCT02175121|54243608|FG000|Overall Study|Time issues|0|||
27788851|NCT02175121|54243609|FG001|Overall Study|Time issues|0|||
27788852|NCT02175121|54243610|FG002|Overall Study|Time issues|1|||
27788853|NCT02175121|54243611|FG003|Overall Study|Time issues|0|||
27788854|NCT02175121|54243612|FG004|Overall Study|Time issues|0|||
27788855|NCT01568866|54243630|FG000|Overall Study|Disease Progression|208|||
27788856|NCT01568866|54243631|FG001|Overall Study|Disease Progression|183|||
27788857|NCT01568866|54243630|FG000|Overall Study|Adverse Event|94|||
27788858|NCT01568866|54243631|FG001|Overall Study|Adverse Event|96|||
27933073|NCT01084252|54589476|FG005|Phase 1 (120 Weeks)|Other than specified above|0|||
27788859|NCT01568866|54243630|FG000|Overall Study|Patient Request|55|||
27788860|NCT01568866|54243631|FG001|Overall Study|Patient Request|71|||
27788861|NCT01568866|54243630|FG000|Overall Study|Physician Decision|40|||
27788862|NCT01568866|54243631|FG001|Overall Study|Physician Decision|32|||
27933074|NCT01084252|54589477|FG006|Phase 1 (120 Weeks)|Other than specified above|1|||
27933075|NCT01084252|54589478|FG007|Phase 1 (120 Weeks)|Other than specified above|1|||
27788863|NCT01568866|54243630|FG000|Overall Study|Withdrawal by Subject|19|||
27933076|NCT01084252|54589479|FG008|Phase 1 (120 Weeks)|Other than specified above|0|||
27933077|NCT01084252|54589480|FG009|Phase 1 (120 Weeks)|Other than specified above|0|||
27788864|NCT01568866|54243631|FG001|Overall Study|Withdrawal by Subject|11|||
27788865|NCT01568866|54243630|FG000|Overall Study|Death|10|||
27933078|NCT01084252|54589481|FG010|Phase 1 (120 Weeks)|Other than specified above|0|||
27933079|NCT01084252|54589482|FG011|Phase 1 (120 Weeks)|Other than specified above|0|||
27933080|NCT01084252|54589483|FG012|Phase 1 (120 Weeks)|Other than specified above|0|||
27933081|NCT01084252|54589484|FG013|Phase 1 (120 Weeks)|Other than specified above|0|||
27933082|NCT01084252|54589471|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
27933083|NCT01084252|54589472|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
27933084|NCT01084252|54589473|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
27788866|NCT01568866|54243631|FG001|Overall Study|Death|18|||
27788867|NCT01568866|54243630|FG000|Overall Study|Protocol Non-compliance|2|||
27788868|NCT01568866|54243631|FG001|Overall Study|Protocol Non-compliance|4|||
27788869|NCT01568866|54243630|FG000|Overall Study|Lost to Follow-up|1|||
27788870|NCT01568866|54243631|FG001|Overall Study|Lost to Follow-up|0|||
27788871|NCT01568866|54243630|FG000|Overall Study|Randomized but Not Dosed|9|||
27788872|NCT01568866|54243631|FG001|Overall Study|Randomized but Not Dosed|1|||
27788873|NCT01568320|54243637|FG000|Overall Study|Death|20|||
27788874|NCT01568320|54243637|FG000|Overall Study|Lost to Follow-up|9|||
27788875|NCT01568320|54243637|FG000|Overall Study|Withdrawal by Subject|10|||
27788876|NCT01568320|54243637|FG000|Overall Study|Conversion to open repair|1|||
27788877|NCT01568320|54243637|FG000|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1|||
27788878|NCT01567852|54243643|FG000|Overall Study|Withdrawal by Subject|3|||
27788879|NCT01567852|54243644|FG001|Overall Study|Withdrawal by Subject|6|||
27788880|NCT01567852|54243643|FG000|Overall Study|ECT discontinued|1|||
27788881|NCT01567852|54243644|FG001|Overall Study|ECT discontinued|1|||
27788882|NCT01588366|54243655|FG000|Overall Study|Adverse Event|0|||
27788883|NCT01588366|54243656|FG001|Overall Study|Adverse Event|1|||
27788884|NCT01588366|54243657|FG002|Overall Study|Adverse Event|0|||
27788885|NCT01588366|54243658|FG003|Overall Study|Adverse Event|1|||
27788886|NCT01588366|54243659|FG004|Overall Study|Adverse Event|0|||
27788887|NCT01588366|54243660|FG005|Overall Study|Adverse Event|2|||
27842437|NCT01446965|54330955|FG001|Participants Followed and Analyzed|Lost to Follow-up|12|||
27842438|NCT01446809|54330963|FG000|Overall Study|Adverse Event|0|||
27842439|NCT01446809|54330964|FG001|Overall Study|Adverse Event|0|||
27842440|NCT01446809|54330965|FG002|Overall Study|Adverse Event|1|||
27842441|NCT01446809|54330963|FG000|Overall Study|Failure to complete study procedures|0|||
27842442|NCT01446809|54330964|FG001|Overall Study|Failure to complete study procedures|0|||
27842443|NCT01446809|54330965|FG002|Overall Study|Failure to complete study procedures|1|||
27842444|NCT01446419|54330976|FG000|Overall Study|Death|1|||
27842445|NCT01446419|54330977|FG001|Overall Study|Death|0|||
27842446|NCT01446419|54330976|FG000|Overall Study|Withdrawal by Subject|1|||
27842447|NCT01446419|54330977|FG001|Overall Study|Withdrawal by Subject|1|||
27842448|NCT01446419|54330976|FG000|Overall Study|Terminated per protocol|3|||
27842449|NCT01446419|54330977|FG001|Overall Study|Terminated per protocol|0|||
27842450|NCT01445951|54330986|FG000|Overall Study|Adverse Event|16|||
27842451|NCT01445951|54330987|FG001|Overall Study|Adverse Event|9|||
27842452|NCT01445951|54330988|FG002|Overall Study|Adverse Event|0|||
27842453|NCT01445951|54330986|FG000|Overall Study|Protocol Violation|2|||
27842454|NCT01445951|54330987|FG001|Overall Study|Protocol Violation|2|||
27842455|NCT01445951|54330988|FG002|Overall Study|Protocol Violation|2|||
27842456|NCT01445951|54330986|FG000|Overall Study|Withdrawal by Subject|21|||
27842457|NCT01445951|54330987|FG001|Overall Study|Withdrawal by Subject|16|||
27842458|NCT01445951|54330988|FG002|Overall Study|Withdrawal by Subject|8|||
27842459|NCT01445951|54330986|FG000|Overall Study|Physician Decision|3|||
27842460|NCT01445951|54330987|FG001|Overall Study|Physician Decision|1|||
27842461|NCT01445951|54330988|FG002|Overall Study|Physician Decision|0|||
27842462|NCT01445951|54330986|FG000|Overall Study|Lost to Follow-up|1|||
27933085|NCT01084252|54589474|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
27933086|NCT01084252|54589475|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
27933087|NCT01084252|54589476|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
27933088|NCT01084252|54589477|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
27933089|NCT01084252|54589478|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
27933090|NCT01084252|54589479|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
27933091|NCT01084252|54589480|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|2|||
27933092|NCT01084252|54589481|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|2|||
27933093|NCT01084252|54589482|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|1|||
27933094|NCT01084252|54589483|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
27933095|NCT01084252|54589484|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
27933096|NCT01084252|54589471|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
27933097|NCT01084252|54589472|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
27933098|NCT01084252|54589473|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
27933099|NCT01084252|54589474|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
27933100|NCT01084252|54589475|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
27933101|NCT01084252|54589476|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
27933102|NCT01084252|54589477|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
27933103|NCT01084252|54589478|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
27933104|NCT01084252|54589479|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|20|||
27933105|NCT01084252|54589480|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|18|||
27933106|NCT01084252|54589481|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|17|||
27933107|NCT01084252|54589482|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|19|||
27933108|NCT01084252|54589483|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
27933109|NCT01084252|54589484|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
27933110|NCT01084252|54589471|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
27933111|NCT01084252|54589472|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
27933112|NCT01084252|54589473|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
27933113|NCT01084252|54589474|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
27933114|NCT01084252|54589475|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
27933115|NCT01084252|54589476|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
27933116|NCT01084252|54589477|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
27933117|NCT01084252|54589478|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
27933118|NCT01084252|54589479|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|2|||
27933119|NCT01084252|54589480|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
27933120|NCT01084252|54589481|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|4|||
27933121|NCT01084252|54589482|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|3|||
27933122|NCT01084252|54589483|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
27933123|NCT01084252|54589484|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
27933124|NCT01084252|54589471|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
27933125|NCT01084252|54589472|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
27933126|NCT01084252|54589473|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
27933127|NCT01084252|54589474|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
27933128|NCT01084252|54589475|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
27933129|NCT01084252|54589476|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
27933130|NCT01084252|54589477|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
27933131|NCT01084252|54589478|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
27933132|NCT01084252|54589479|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|1|||
27933133|NCT01084252|54589480|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|4|||
27933134|NCT01084252|54589481|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|2|||
27933135|NCT01084252|54589482|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|2|||
27933136|NCT01084252|54589483|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
27933137|NCT01084252|54589484|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
27933138|NCT01084252|54589471|FG000|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
27933139|NCT01084252|54589472|FG001|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
27933140|NCT01084252|54589473|FG002|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
27933141|NCT01084252|54589474|FG003|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
27933142|NCT01084252|54589475|FG004|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
27933143|NCT01084252|54589476|FG005|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
27933144|NCT01084252|54589477|FG006|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
27933145|NCT01084252|54589478|FG007|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
27933146|NCT01084252|54589479|FG008|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
27933147|NCT01084252|54589480|FG009|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
27933148|NCT01084252|54589481|FG010|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
27933149|NCT01084252|54589482|FG011|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
27933150|NCT01084252|54589483|FG012|Phase 2 Stage 2 (97 Weeks)|Adverse Event|13|||
27933151|NCT01084252|54589484|FG013|Phase 2 Stage 2 (97 Weeks)|Adverse Event|5|||
27788888|NCT01686958|54243676|FG000|Overall Study|Withdrawal by Subject|1|||
27788889|NCT01686568|54243683|FG000|Main Study|Withdrawal by Subject|1|||
27788890|NCT01686568|54243684|FG001|Main Study|Withdrawal by Subject|3|||
27788891|NCT01686568|54243683|FG000|Main Study|Noncompliance with protocol|0|||
27788892|NCT01686568|54243684|FG001|Main Study|Noncompliance with protocol|1|||
27788893|NCT01686568|54243683|FG000|Main Study|Liver enzymes above range of exclusion|1|||
27788894|NCT01686568|54243684|FG001|Main Study|Liver enzymes above range of exclusion|0|||
27788895|NCT01686568|54243683|FG000|Sub-Study|Not consented for sub-study|2|||
27788896|NCT01686568|54243684|FG001|Sub-Study|Not consented for sub-study|2|||
27788897|NCT01567462|54243692|FG000|Overall Study|Withdrawal by Subject|4|||
27788898|NCT01567462|54243693|FG001|Overall Study|Withdrawal by Subject|7|||
27788899|NCT01587898|54243703|FG000|Overall Study|Adverse Event|1|||
27788900|NCT01587898|54243704|FG001|Overall Study|Adverse Event|1|||
27788901|NCT01587898|54243705|FG002|Overall Study|Adverse Event|0|||
27788902|NCT01587898|54243706|FG003|Overall Study|Adverse Event|0|||
27788903|NCT01587898|54243703|FG000|Overall Study|Protocol Violation|0|||
27788904|NCT01587898|54243704|FG001|Overall Study|Protocol Violation|2|||
27788905|NCT01587898|54243705|FG002|Overall Study|Protocol Violation|1|||
27788906|NCT01587898|54243706|FG003|Overall Study|Protocol Violation|1|||
27788907|NCT01587898|54243703|FG000|Overall Study|Lost to Follow-up|0|||
27788908|NCT01587898|54243704|FG001|Overall Study|Lost to Follow-up|0|||
27788909|NCT01587898|54243705|FG002|Overall Study|Lost to Follow-up|0|||
27788910|NCT01587898|54243706|FG003|Overall Study|Lost to Follow-up|1|||
27788911|NCT01587898|54243703|FG000|Overall Study|Withdrawal by Subject|2|||
27788912|NCT01587898|54243704|FG001|Overall Study|Withdrawal by Subject|1|||
27788913|NCT01587898|54243705|FG002|Overall Study|Withdrawal by Subject|0|||
27788914|NCT01587898|54243706|FG003|Overall Study|Withdrawal by Subject|0|||
27788915|NCT01587898|54243703|FG000|Overall Study|Met haemoglobin stopping criteria|1|||
27788916|NCT01587898|54243704|FG001|Overall Study|Met haemoglobin stopping criteria|1|||
27788917|NCT01587898|54243705|FG002|Overall Study|Met haemoglobin stopping criteria|1|||
27788918|NCT01587898|54243706|FG003|Overall Study|Met haemoglobin stopping criteria|0|||
27788919|NCT01567306|54243725|FG000|Overall Study|Protocol Violation|2|||
27788920|NCT01567306|54243726|FG001|Overall Study|Protocol Violation|2|||
27788921|NCT01567306|54243727|FG002|Overall Study|Protocol Violation|0|||
27788922|NCT01567306|54243728|FG003|Overall Study|Protocol Violation|3|||
27788923|NCT01567306|54243729|FG004|Overall Study|Protocol Violation|1|||
27788924|NCT01567306|54243730|FG005|Overall Study|Protocol Violation|1|||
27788925|NCT01567306|54243725|FG000|Overall Study|Change site living|1|||
27788926|NCT01567306|54243726|FG001|Overall Study|Change site living|0|||
27788927|NCT01567306|54243727|FG002|Overall Study|Change site living|0|||
27788928|NCT01567306|54243728|FG003|Overall Study|Change site living|0|||
27788929|NCT01567306|54243729|FG004|Overall Study|Change site living|0|||
27788930|NCT01567306|54243730|FG005|Overall Study|Change site living|0|||
27788931|NCT01567306|54243725|FG000|Overall Study|Adverse Event|0|||
27788932|NCT01567306|54243726|FG001|Overall Study|Adverse Event|0|||
27788933|NCT01567306|54243727|FG002|Overall Study|Adverse Event|0|||
27788934|NCT01567306|54243728|FG003|Overall Study|Adverse Event|2|||
27788935|NCT01567306|54243729|FG004|Overall Study|Adverse Event|4|||
27788936|NCT01567306|54243730|FG005|Overall Study|Adverse Event|1|||
27788937|NCT01567306|54243725|FG000|Overall Study|Lost to Follow-up|0|||
27788938|NCT01567306|54243726|FG001|Overall Study|Lost to Follow-up|0|||
27788939|NCT01567306|54243727|FG002|Overall Study|Lost to Follow-up|0|||
27933152|NCT01084252|54589471|FG000|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
27933153|NCT01084252|54589472|FG001|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
27933154|NCT01084252|54589473|FG002|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
27933155|NCT01084252|54589474|FG003|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
27933156|NCT01084252|54589475|FG004|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
27933157|NCT01084252|54589476|FG005|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
27933158|NCT01084252|54589477|FG006|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
27933159|NCT01084252|54589478|FG007|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
27933160|NCT01084252|54589479|FG008|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
27933161|NCT01084252|54589480|FG009|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
27933162|NCT01084252|54589481|FG010|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
27933163|NCT01084252|54589482|FG011|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
27933164|NCT01084252|54589483|FG012|Phase 2 Stage 2 (97 Weeks)|Progressive disease|70|||
28017003|NCT00540514|54676240|FG000|Overall Study|Paclitaxel not available|0|||
27788940|NCT01567306|54243728|FG003|Overall Study|Lost to Follow-up|0|||
27788941|NCT01567306|54243729|FG004|Overall Study|Lost to Follow-up|2|||
27788942|NCT01567306|54243730|FG005|Overall Study|Lost to Follow-up|0|||
27788943|NCT01567306|54243725|FG000|Overall Study|Withdrawal by Subject|0|||
27788944|NCT01567306|54243726|FG001|Overall Study|Withdrawal by Subject|0|||
27788945|NCT01567306|54243727|FG002|Overall Study|Withdrawal by Subject|0|||
27788946|NCT01567306|54243728|FG003|Overall Study|Withdrawal by Subject|0|||
27933165|NCT01084252|54589484|FG013|Phase 2 Stage 2 (97 Weeks)|Progressive disease|33|||
27933166|NCT01084252|54589471|FG000|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
27933167|NCT01084252|54589472|FG001|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
27933168|NCT01084252|54589473|FG002|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
27933169|NCT01084252|54589474|FG003|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
27933170|NCT01084252|54589475|FG004|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
27933171|NCT01084252|54589476|FG005|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
27933172|NCT01084252|54589477|FG006|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
27933173|NCT01084252|54589478|FG007|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
27933174|NCT01084252|54589479|FG008|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
27933175|NCT01084252|54589480|FG009|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
27933176|NCT01084252|54589481|FG010|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
27933177|NCT01084252|54589482|FG011|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
27933178|NCT01084252|54589483|FG012|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|1|||
27933179|NCT01084252|54589484|FG013|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
27933180|NCT01084252|54589471|FG000|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
27933181|NCT01084252|54589472|FG001|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
27933182|NCT01084252|54589473|FG002|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
27933183|NCT01084252|54589474|FG003|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
27933184|NCT01084252|54589475|FG004|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
27933185|NCT01084252|54589476|FG005|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
27933186|NCT01084252|54589477|FG006|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
27933187|NCT01084252|54589478|FG007|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
27933188|NCT01084252|54589479|FG008|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
27933189|NCT01084252|54589480|FG009|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
27933190|NCT01084252|54589481|FG010|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
27933191|NCT01084252|54589482|FG011|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
27933192|NCT01084252|54589483|FG012|Phase 2 Stage 2 (97 Weeks)|Other than specified above|12|||
27933193|NCT01084252|54589484|FG013|Phase 2 Stage 2 (97 Weeks)|Other than specified above|2|||
27933194|NCT01084252|54589471|FG000|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
27933195|NCT01084252|54589472|FG001|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
27933196|NCT01084252|54589473|FG002|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
27933197|NCT01084252|54589474|FG003|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
27933198|NCT01084252|54589475|FG004|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
27933199|NCT01084252|54589476|FG005|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
27933200|NCT01084252|54589477|FG006|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
27933201|NCT01084252|54589478|FG007|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
27933202|NCT01084252|54589479|FG008|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
27933203|NCT01084252|54589480|FG009|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
27933204|NCT01084252|54589481|FG010|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
27933205|NCT01084252|54589482|FG011|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
27933206|NCT01084252|54589483|FG012|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|13|||
27933207|NCT01084252|54589484|FG013|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|15|||
27933208|NCT01084252|54589471|FG000|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
27933209|NCT01084252|54589472|FG001|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
27933210|NCT01084252|54589473|FG002|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
27933211|NCT01084252|54589474|FG003|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
27933212|NCT01084252|54589475|FG004|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
27933213|NCT01084252|54589476|FG005|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
27933214|NCT01084252|54589477|FG006|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
27933215|NCT01084252|54589478|FG007|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
27933216|NCT01084252|54589479|FG008|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
27933217|NCT01084252|54589480|FG009|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
27933218|NCT01084252|54589481|FG010|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
27933219|NCT01084252|54589482|FG011|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
27933220|NCT01084252|54589483|FG012|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|1|||
27933221|NCT01084252|54589484|FG013|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
27933222|NCT05111145|54589555|FG000|Overall Study|Commercial drug is available for participant|76|||
27933223|NCT05111145|54589555|FG000|Overall Study|Participant enrolled in another qualified Vertex study|10|||
27933224|NCT04823130|54589574|FG000|Overall Study|Withdrawal by Subject|2|||
27933225|NCT04823130|54589575|FG001|Overall Study|Withdrawal by Subject|3|||
27933226|NCT04823130|54589574|FG000|Overall Study|Failure to meet inclusion criteria|6|||
27933227|NCT04823130|54589575|FG001|Overall Study|Failure to meet inclusion criteria|4|||
27933228|NCT04823130|54589574|FG000|Overall Study|Other-unspecified|1|||
27933229|NCT04823130|54589575|FG001|Overall Study|Other-unspecified|0|||
27933230|NCT04402385|54589634|FG000|Overall Study|Withdrawal by Subject|4|||
27933231|NCT04402385|54589635|FG001|Overall Study|Withdrawal by Subject|4|||
27933232|NCT04402385|54589634|FG000|Overall Study|Lost to Follow-up|1|||
27933233|NCT04402385|54589635|FG001|Overall Study|Lost to Follow-up|1|||
27933234|NCT04402385|54589634|FG000|Overall Study|Physician Decision|0|||
27933235|NCT04402385|54589635|FG001|Overall Study|Physician Decision|1|||
27933236|NCT04060680|54589643|FG000|Overall Study|Unsuccessful implant|17|||
27933237|NCT04060680|54589643|FG000|Overall Study|Adverse Event|3|||
27933238|NCT04060680|54589643|FG000|Overall Study|Death|2|||
27933239|NCT04060680|54589643|FG000|Overall Study|Study product no longer in use|1|||
27933240|NCT04060680|54589643|FG000|Overall Study|Withdrawal by Subject|1|||
27933241|NCT03785210|54589650|FG000|Overall Study|Principal investigator decision - clinical progression|1|||
27933242|NCT03785210|54589651|FG001|Overall Study|Principal investigator decision - clinical progression|6|||
27933243|NCT03750968|54589659|FG000|Overall Study|Adverse Event|2|||
27933244|NCT03750968|54589660|FG001|Overall Study|Adverse Event|0|||
27933245|NCT03750968|54589659|FG000|Overall Study|Lost to Follow-up|1|||
27933246|NCT03750968|54589660|FG001|Overall Study|Lost to Follow-up|3|||
27933247|NCT03690388|54589672|FG000|Overall Study|Adverse Event|8|||
27933248|NCT03690388|54589673|FG001|Overall Study|Adverse Event|1|||
27933249|NCT03690388|54589672|FG000|Overall Study|Radiographic Progression|14|||
27933250|NCT03690388|54589673|FG001|Overall Study|Radiographic Progression|29|||
27933251|NCT03690388|54589672|FG000|Overall Study|Clinical deterioration|10|||
27933252|NCT03690388|54589673|FG001|Overall Study|Clinical deterioration|6|||
27933253|NCT03690388|54589672|FG000|Overall Study|Withdrawal by Subject|2|||
27933254|NCT03690388|54589673|FG001|Overall Study|Withdrawal by Subject|0|||
27933255|NCT03690388|54589672|FG000|Overall Study|Lack of Efficacy|1|||
27933256|NCT03690388|54589673|FG001|Overall Study|Lack of Efficacy|0|||
27933257|NCT03690388|54589672|FG000|Overall Study|Lost to Follow-up|1|||
27933258|NCT03690388|54589673|FG001|Overall Study|Lost to Follow-up|0|||
27933259|NCT03619213|54589685|FG000|Overall Study|Lost to Follow-up|2|||
27933260|NCT03619213|54589686|FG001|Overall Study|Lost to Follow-up|1|||
27933261|NCT03619213|54589685|FG000|Overall Study|Withdrawal by Subject|8|||
27933262|NCT03619213|54589686|FG001|Overall Study|Withdrawal by Subject|10|||
27933263|NCT03342690|54589692|FG000|Overall Study|Missing Information|9|||
27933264|NCT03342690|54589692|FG000|Overall Study|Protocol Violation|16|||
27933265|NCT03257267|54589711|FG000|Overall Study|Adverse Event|9|||
27933266|NCT03257267|54589712|FG001|Overall Study|Adverse Event|7|||
27933267|NCT03257267|54589711|FG000|Overall Study|Death|92|||
27933268|NCT03257267|54589712|FG001|Overall Study|Death|95|||
27933269|NCT03257267|54589711|FG000|Overall Study|Lost to Follow-up|2|||
27933270|NCT03257267|54589712|FG001|Overall Study|Lost to Follow-up|2|||
27933271|NCT03257267|54589711|FG000|Overall Study|Non-compliance with Study Drug|0|||
27933272|NCT03257267|54589712|FG001|Overall Study|Non-compliance with Study Drug|1|||
27933273|NCT03257267|54589711|FG000|Overall Study|Participant Decision|34|||
27933274|NCT03257267|54589712|FG001|Overall Study|Participant Decision|42|||
27933275|NCT03257267|54589711|FG000|Overall Study|Physician Decision|1|||
27933276|NCT03257267|54589712|FG001|Overall Study|Physician Decision|3|||
27933277|NCT03257267|54589711|FG000|Overall Study|Disease Progression|98|||
27933278|NCT03257267|54589712|FG001|Overall Study|Disease Progression|117|||
27933279|NCT03257267|54589711|FG000|Overall Study|Withdrawal of Consent|8|||
27933280|NCT03257267|54589712|FG001|Overall Study|Withdrawal of Consent|26|||
27933281|NCT03257267|54589711|FG000|Overall Study|Study Ongoing|53|||
27933282|NCT03257267|54589712|FG001|Overall Study|Study Ongoing|11|||
27933283|NCT03201458|54589720|FG000|Overall Study|No longer eligible|2|||
27933284|NCT03201458|54589721|FG001|Overall Study|No longer eligible|5|||
27933285|NCT03201458|54589720|FG000|Overall Study|Health event before starting|1|||
27933286|NCT03201458|54589721|FG001|Overall Study|Health event before starting|0|||
27933287|NCT03201458|54589720|FG000|Overall Study|Physician Decision|1|||
27933288|NCT03201458|54589721|FG001|Overall Study|Physician Decision|0|||
27933289|NCT03064035|54589738|FG000|Overall Study|Did not receive allocated intervention|4|||
27933290|NCT03064035|54589739|FG001|Overall Study|Did not receive allocated intervention|2|||
27933291|NCT03064035|54589738|FG000|Overall Study|Lost to Follow-up|1|||
27933292|NCT03064035|54589739|FG001|Overall Study|Lost to Follow-up|1|||
27933293|NCT02991456|54589747|FG000|Overall Study|Adverse Event|2|||
27933294|NCT02991456|54589748|FG001|Overall Study|Adverse Event|0|||
27933295|NCT02991456|54589747|FG000|Overall Study|Lost to Follow-up|0|||
27933296|NCT02991456|54589748|FG001|Overall Study|Lost to Follow-up|2|||
27933297|NCT02991456|54589747|FG000|Overall Study|Withdrawal by Subject|1|||
27933298|NCT02991456|54589748|FG001|Overall Study|Withdrawal by Subject|0|||
27933299|NCT02921256|54589761|FG000|Arm 1a v. Arm II|Adverse Event|6|||
27933300|NCT02921256|54589762|FG001|Arm 1a v. Arm II|Adverse Event|15|||
27933301|NCT02921256|54589763|FG002|Arm 1a v. Arm II|Adverse Event|0|||
27933302|NCT02921256|54589761|FG000|Arm 1a v. Arm II|Death|0|||
27933303|NCT02921256|54589762|FG001|Arm 1a v. Arm II|Death|2|||
27933304|NCT02921256|54589763|FG002|Arm 1a v. Arm II|Death|0|||
27933305|NCT02921256|54589761|FG000|Arm 1a v. Arm II|Lack of Efficacy|2|||
27933306|NCT02921256|54589762|FG001|Arm 1a v. Arm II|Lack of Efficacy|0|||
27933307|NCT02921256|54589763|FG002|Arm 1a v. Arm II|Lack of Efficacy|0|||
27933308|NCT02921256|54589761|FG000|Arm 1a v. Arm II|Lost to Follow-up|2|||
27933309|NCT02921256|54589762|FG001|Arm 1a v. Arm II|Lost to Follow-up|9|||
27933310|NCT02921256|54589763|FG002|Arm 1a v. Arm II|Lost to Follow-up|0|||
27933311|NCT02921256|54589761|FG000|Arm 1a v. Arm II|Physician Decision|1|||
27933312|NCT02921256|54589762|FG001|Arm 1a v. Arm II|Physician Decision|1|||
27933313|NCT02921256|54589763|FG002|Arm 1a v. Arm II|Physician Decision|0|||
27933314|NCT02921256|54589761|FG000|Arm 1a v. Arm II|Withdrawal by Subject|5|||
27933315|NCT02921256|54589762|FG001|Arm 1a v. Arm II|Withdrawal by Subject|6|||
27933316|NCT02921256|54589763|FG002|Arm 1a v. Arm II|Withdrawal by Subject|0|||
27933317|NCT02921256|54589761|FG000|Arm Ib v Arm III|Adverse Event|9|||
27933318|NCT02921256|54589762|FG001|Arm Ib v Arm III|Adverse Event|0|||
27933319|NCT02921256|54589763|FG002|Arm Ib v Arm III|Adverse Event|4|||
27933320|NCT02921256|54589761|FG000|Arm Ib v Arm III|Death|1|||
27933321|NCT02921256|54589762|FG001|Arm Ib v Arm III|Death|0|||
27933322|NCT02921256|54589763|FG002|Arm Ib v Arm III|Death|1|||
27933323|NCT02921256|54589761|FG000|Arm Ib v Arm III|Lack of Efficacy|2|||
27933324|NCT02921256|54589762|FG001|Arm Ib v Arm III|Lack of Efficacy|0|||
27933325|NCT02921256|54589763|FG002|Arm Ib v Arm III|Lack of Efficacy|2|||
27933326|NCT02921256|54589761|FG000|Arm Ib v Arm III|Lost to Follow-up|1|||
27933327|NCT02921256|54589762|FG001|Arm Ib v Arm III|Lost to Follow-up|0|||
27933328|NCT02921256|54589763|FG002|Arm Ib v Arm III|Lost to Follow-up|3|||
27933329|NCT02921256|54589761|FG000|Arm Ib v Arm III|Physician Decision|4|||
27933330|NCT02921256|54589762|FG001|Arm Ib v Arm III|Physician Decision|0|||
27933331|NCT02921256|54589763|FG002|Arm Ib v Arm III|Physician Decision|1|||
27933332|NCT02921256|54589761|FG000|Arm Ib v Arm III|Withdrawal by Subject|7|||
27933333|NCT02921256|54589762|FG001|Arm Ib v Arm III|Withdrawal by Subject|0|||
27933334|NCT02921256|54589763|FG002|Arm Ib v Arm III|Withdrawal by Subject|4|||
27933335|NCT02842827|54589785|FG000|Overall Study|Adverse Event|0|||
27933336|NCT02842827|54589786|FG001|Overall Study|Adverse Event|1|||
27933337|NCT02842827|54589787|FG002|Overall Study|Adverse Event|0|||
27933338|NCT02842827|54589788|FG003|Overall Study|Adverse Event|1|||
27933339|NCT02842827|54589789|FG004|Overall Study|Adverse Event|0|||
27933340|NCT02842827|54589790|FG005|Overall Study|Adverse Event|1|||
27933341|NCT02842827|54589791|FG006|Overall Study|Adverse Event|0|||
27933342|NCT02842827|54589792|FG007|Overall Study|Adverse Event|0|||
27933343|NCT02842827|54589785|FG000|Overall Study|Death|1|||
27933344|NCT02842827|54589786|FG001|Overall Study|Death|0|||
27933345|NCT02842827|54589787|FG002|Overall Study|Death|2|||
27933346|NCT02842827|54589788|FG003|Overall Study|Death|3|||
27933347|NCT02842827|54589789|FG004|Overall Study|Death|2|||
27933348|NCT02842827|54589790|FG005|Overall Study|Death|1|||
27933349|NCT02842827|54589791|FG006|Overall Study|Death|0|||
27933350|NCT02842827|54589792|FG007|Overall Study|Death|4|||
27933351|NCT02842827|54589785|FG000|Overall Study|Physician Decision|1|||
27933352|NCT02842827|54589786|FG001|Overall Study|Physician Decision|3|||
27933353|NCT02842827|54589787|FG002|Overall Study|Physician Decision|0|||
27933354|NCT02842827|54589788|FG003|Overall Study|Physician Decision|0|||
27933355|NCT02842827|54589789|FG004|Overall Study|Physician Decision|1|||
27933356|NCT02842827|54589790|FG005|Overall Study|Physician Decision|4|||
27933357|NCT02842827|54589791|FG006|Overall Study|Physician Decision|2|||
27933358|NCT02842827|54589792|FG007|Overall Study|Physician Decision|1|||
27933359|NCT02842827|54589785|FG000|Overall Study|Protocol Defined Disease Progression|0|||
27933360|NCT02842827|54589786|FG001|Overall Study|Protocol Defined Disease Progression|0|||
27933361|NCT02842827|54589787|FG002|Overall Study|Protocol Defined Disease Progression|0|||
27933362|NCT02842827|54589788|FG003|Overall Study|Protocol Defined Disease Progression|0|||
27933363|NCT02842827|54589789|FG004|Overall Study|Protocol Defined Disease Progression|0|||
27933364|NCT02842827|54589790|FG005|Overall Study|Protocol Defined Disease Progression|1|||
27933365|NCT02842827|54589791|FG006|Overall Study|Protocol Defined Disease Progression|0|||
27933366|NCT02842827|54589792|FG007|Overall Study|Protocol Defined Disease Progression|0|||
27933367|NCT02842827|54589785|FG000|Overall Study|Participant Withdrawal of Consent|1|||
27933368|NCT02842827|54589786|FG001|Overall Study|Participant Withdrawal of Consent|2|||
27933369|NCT02842827|54589787|FG002|Overall Study|Participant Withdrawal of Consent|2|||
27933370|NCT02842827|54589788|FG003|Overall Study|Participant Withdrawal of Consent|2|||
27933371|NCT02842827|54589789|FG004|Overall Study|Participant Withdrawal of Consent|2|||
27933372|NCT02842827|54589790|FG005|Overall Study|Participant Withdrawal of Consent|1|||
28017004|NCT00540514|54676241|FG001|Overall Study|Paclitaxel not available|2|||
27933373|NCT02842827|54589791|FG006|Overall Study|Participant Withdrawal of Consent|2|||
27933374|NCT02842827|54589792|FG007|Overall Study|Participant Withdrawal of Consent|1|||
27933375|NCT02432274|54589818|FG000|Overall Study|Death|2|||
27933376|NCT02432274|54589819|FG001|Overall Study|Death|6|||
27933377|NCT02432274|54589820|FG002|Overall Study|Death|7|||
27933378|NCT02432274|54589821|FG003|Overall Study|Death|0|||
27933379|NCT02432274|54589822|FG004|Overall Study|Death|27|||
27933380|NCT02432274|54589823|FG005|Overall Study|Death|7|||
27933381|NCT02432274|54589824|FG006|Overall Study|Death|9|||
27933382|NCT02432274|54589825|FG007|Overall Study|Death|14|||
27933383|NCT02432274|54589818|FG000|Overall Study|Withdrawal of Consent|0|||
28017005|NCT00663702|54676250|FG000|Overall Study|Adverse Event|8|||
27933384|NCT02432274|54589819|FG001|Overall Study|Withdrawal of Consent|0|||
27933385|NCT02432274|54589820|FG002|Overall Study|Withdrawal of Consent|0|||
27933386|NCT02432274|54589821|FG003|Overall Study|Withdrawal of Consent|0|||
27933387|NCT02432274|54589822|FG004|Overall Study|Withdrawal of Consent|2|||
27933388|NCT02432274|54589823|FG005|Overall Study|Withdrawal of Consent|0|||
27933389|NCT02432274|54589824|FG006|Overall Study|Withdrawal of Consent|1|||
27933390|NCT02432274|54589825|FG007|Overall Study|Withdrawal of Consent|2|||
27933391|NCT02393859|54589861|FG000|Overall Study|Decision by Sponsor|2|||
27933392|NCT02393859|54589862|FG001|Overall Study|Decision by Sponsor|4|||
27933393|NCT02393859|54589861|FG000|Overall Study|Withdrawal by Subject|11|||
27933394|NCT02393859|54589862|FG001|Overall Study|Withdrawal by Subject|6|||
27933395|NCT02393859|54589861|FG000|Overall Study|Death|27|||
27933396|NCT02393859|54589862|FG001|Overall Study|Death|10|||
27933397|NCT02393859|54589861|FG000|Overall Study|Lost to Follow-up|1|||
27933398|NCT02393859|54589862|FG001|Overall Study|Lost to Follow-up|1|||
27933399|NCT02231749|54589871|FG000|Overall Study|Disease progression|229|||
27933400|NCT02231749|54589872|FG001|Overall Study|Disease progression|297|||
27933401|NCT02231749|54589871|FG000|Overall Study|Study Drug Toxicity|134|||
27933402|NCT02231749|54589872|FG001|Overall Study|Study Drug Toxicity|63|||
27933403|NCT02231749|54589871|FG000|Overall Study|Death|1|||
27933404|NCT02231749|54589872|FG001|Overall Study|Death|1|||
27933405|NCT02231749|54589871|FG000|Overall Study|AE unrelated to Study drug|32|||
27933406|NCT02231749|54589872|FG001|Overall Study|AE unrelated to Study drug|31|||
27933407|NCT02231749|54589871|FG000|Overall Study|Participant's request to discontinue|10|||
27933408|NCT02231749|54589872|FG001|Overall Study|Participant's request to discontinue|21|||
27933409|NCT02231749|54589871|FG000|Overall Study|Participant withdrew Consent|8|||
27933410|NCT02231749|54589872|FG001|Overall Study|Participant withdrew Consent|15|||
27933411|NCT02231749|54589871|FG000|Overall Study|Lost to Follow-up|1|||
27933412|NCT02231749|54589872|FG001|Overall Study|Lost to Follow-up|2|||
27933413|NCT02231749|54589871|FG000|Overall Study|Maximum Clinical Benefit|5|||
27933414|NCT02231749|54589872|FG001|Overall Study|Maximum Clinical Benefit|8|||
27933415|NCT02231749|54589871|FG000|Overall Study|Poor/Non-Compliance|0|||
27933416|NCT02231749|54589872|FG001|Overall Study|Poor/Non-Compliance|3|||
27933417|NCT02231749|54589871|FG000|Overall Study|Pregnancy|1|||
27933418|NCT02231749|54589872|FG001|Overall Study|Pregnancy|0|||
27933419|NCT02231749|54589871|FG000|Overall Study|other|0|||
27933420|NCT02231749|54589872|FG001|Overall Study|other|8|||
27933421|NCT02231749|54589871|FG000|Overall Study|No longer meets Study Criteria|1|||
27933422|NCT02231749|54589872|FG001|Overall Study|No longer meets Study Criteria|0|||
27933423|NCT02197234|54589878|FG000|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1|||
27933424|NCT02197234|54589878|FG000|Part A: Day 3-30 (AZD9291 Alone)|Adverse Event|1|||
27933425|NCT02197234|54589878|FG000|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1|||
27933426|NCT02197234|54589878|FG000|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1|||
27933427|NCT02197234|54589878|FG000|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1|||
27933428|NCT02197234|54589878|FG000|Part B: Day 33 to End Part B (AZD9291)|Death|6|||
27933429|NCT02197234|54589878|FG000|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22|||
27933430|NCT02096588|54589887|FG000|Overall Study|Lack of Efficacy|2|||
27933431|NCT02096588|54589888|FG001|Overall Study|Lack of Efficacy|0|||
27933432|NCT02096588|54589887|FG000|Overall Study|Withdrawal by Subject|0|||
27933433|NCT02096588|54589888|FG001|Overall Study|Withdrawal by Subject|1|||
27933434|NCT01359592|54589894|FG000|Initial Registration|Adverse Event|1|||
27933435|NCT01359592|54589895|FG001|Initial Registration|Adverse Event|0|||
27933436|NCT01359592|54589896|FG002|Initial Registration|Adverse Event|0|||
27933437|NCT01359592|54589897|FG003|Initial Registration|Adverse Event|0|||
27933438|NCT01359592|54589894|FG000|Initial Registration|Death|1|||
27933439|NCT01359592|54589895|FG001|Initial Registration|Death|0|||
27933440|NCT01359592|54589896|FG002|Initial Registration|Death|0|||
27933441|NCT01359592|54589897|FG003|Initial Registration|Death|0|||
27933442|NCT01359592|54589894|FG000|Initial Registration|Other reason not protocol specified|1|||
27933443|NCT01359592|54589895|FG001|Initial Registration|Other reason not protocol specified|0|||
27933444|NCT01359592|54589896|FG002|Initial Registration|Other reason not protocol specified|0|||
27933445|NCT01359592|54589897|FG003|Initial Registration|Other reason not protocol specified|0|||
27933446|NCT01359592|54589894|FG000|Initial Registration|Ineligible|26|||
27933447|NCT01359592|54589895|FG001|Initial Registration|Ineligible|0|||
27933448|NCT01359592|54589896|FG002|Initial Registration|Ineligible|0|||
27933449|NCT01359592|54589897|FG003|Initial Registration|Ineligible|0|||
27933450|NCT01359592|54589894|FG000|PET-Directed Therapy|Adverse Event|0|||
27933451|NCT01359592|54589895|FG001|PET-Directed Therapy|Adverse Event|0|||
27933452|NCT01359592|54589896|FG002|PET-Directed Therapy|Adverse Event|1|||
27933453|NCT01359592|54589897|FG003|PET-Directed Therapy|Adverse Event|0|||
27933454|NCT01359592|54589894|FG000|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
27933455|NCT01359592|54589895|FG001|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
27933456|NCT01359592|54589896|FG002|PET-Directed Therapy|Refusal unrelated to adverse event|1|||
27933457|NCT01359592|54589897|FG003|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
27933458|NCT01359592|54589894|FG000|PET-Directed Therapy|Ineligible|0|||
27933459|NCT01359592|54589895|FG001|PET-Directed Therapy|Ineligible|0|||
27933460|NCT01359592|54589896|FG002|PET-Directed Therapy|Ineligible|24|||
27933461|NCT01359592|54589897|FG003|PET-Directed Therapy|Ineligible|0|||
27933462|NCT00699816|54589914|FG000|Overall Study|Protocol Violation|1|||
27933463|NCT00699816|54589915|FG001|Overall Study|Protocol Violation|3|||
27933464|NCT00697073|54589921|FG000|Overall Study|Withdrawal by Subject|2|||
27933465|NCT00697073|54589921|FG000|Overall Study|Pregnancy|1|||
27933466|NCT00697073|54589921|FG000|Overall Study|non compliance and other|6|||
27933467|NCT00653432|54589927|FG000|Overall Study|Adverse Event|4|||
27933468|NCT00653432|54589928|FG001|Overall Study|Adverse Event|1|||
27933469|NCT00653432|54589927|FG000|Overall Study|Withdrawal by Subject|4|||
27933470|NCT00653432|54589928|FG001|Overall Study|Withdrawal by Subject|5|||
27933471|NCT00653432|54589927|FG000|Overall Study|Lost to Follow-up|7|||
27933472|NCT00653432|54589928|FG001|Overall Study|Lost to Follow-up|6|||
27933473|NCT00653432|54589927|FG000|Overall Study|Use/Need of Con Therapy|2|||
27933474|NCT00653432|54589928|FG001|Overall Study|Use/Need of Con Therapy|1|||
27933475|NCT00653432|54589927|FG000|Overall Study|Other - Reason Not Provided|5|||
27933476|NCT00653432|54589928|FG001|Overall Study|Other - Reason Not Provided|3|||
27933477|NCT00446043|54589947|FG000|Overall Study|Adverse Event|9|||
27933478|NCT00446043|54589947|FG000|Overall Study|Withdrawal by Subject|70|||
27933479|NCT00446043|54589947|FG000|Overall Study|Protocol Violation|2|||
27933480|NCT00446043|54589947|FG000|Overall Study|Lost to Follow-up|42|||
27933481|NCT00446043|54589947|FG000|Overall Study|Pregnancy|2|||
27933482|NCT00400725|54589954|FG000|Initial Phase (up to 4 Weeks)|Adverse Event|1|||
27933483|NCT00400725|54589955|FG001|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
27933484|NCT00400725|54589956|FG002|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
27933485|NCT00400725|54589954|FG000|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|14|||
27933486|NCT00400725|54589955|FG001|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
27933487|NCT00400725|54589956|FG002|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
27933488|NCT00400725|54589954|FG000|Initial Phase (up to 4 Weeks)|Lost to Follow-up|1|||
27933489|NCT00400725|54589955|FG001|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
27933490|NCT00400725|54589956|FG002|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
27933491|NCT00400725|54589954|FG000|Initial Phase (up to 4 Weeks)|Other|1|||
27933492|NCT00400725|54589955|FG001|Initial Phase (up to 4 Weeks)|Other|0|||
27933493|NCT00400725|54589956|FG002|Initial Phase (up to 4 Weeks)|Other|0|||
27933494|NCT00400725|54589954|FG000|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
27933495|NCT00400725|54589955|FG001|Maintenance Phase (up to 6 Months)|Lack of Efficacy|1|||
27933496|NCT00400725|54589956|FG002|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
27933497|NCT00400725|54589954|FG000|Maintenance Phase (up to 6 Months)|Adverse Event|0|||
27933498|NCT00400725|54589955|FG001|Maintenance Phase (up to 6 Months)|Adverse Event|2|||
27933499|NCT00400725|54589956|FG002|Maintenance Phase (up to 6 Months)|Adverse Event|4|||
27933500|NCT00400725|54589954|FG000|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|0|||
27933501|NCT00400725|54589955|FG001|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|11|||
27933502|NCT00400725|54589956|FG002|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|21|||
27933503|NCT00400725|54589954|FG000|Maintenance Phase (up to 6 Months)|Lost to Follow-up|0|||
27933504|NCT00400725|54589955|FG001|Maintenance Phase (up to 6 Months)|Lost to Follow-up|1|||
27933505|NCT00400725|54589956|FG002|Maintenance Phase (up to 6 Months)|Lost to Follow-up|2|||
27933506|NCT00400725|54589954|FG000|Maintenance Phase (up to 6 Months)|Other|0|||
27933507|NCT00400725|54589955|FG001|Maintenance Phase (up to 6 Months)|Other|1|||
27933508|NCT00400725|54589956|FG002|Maintenance Phase (up to 6 Months)|Other|2|||
27933509|NCT00099437|54589972|FG000|Overall Study|Lost to Follow-up|30|||
27933510|NCT00099437|54589973|FG001|Overall Study|Lost to Follow-up|33|||
27933511|NCT00099437|54589972|FG000|Overall Study|Death|293|||
27933512|NCT00099437|54589973|FG001|Overall Study|Death|261|||
27933513|NCT00099437|54589972|FG000|Overall Study|Withdrawal by Subject|6|||
27933514|NCT00099437|54589973|FG001|Overall Study|Withdrawal by Subject|10|||
27933515|NCT00099437|54589972|FG000|Overall Study|Ongoing in FU but not on treatment|37|||
27933516|NCT00099437|54589973|FG001|Overall Study|Ongoing in FU but not on treatment|45|||
27933517|NCT00932113|54589981|FG000|Overall Study|Lost to Follow-up|1|||
27933518|NCT00932113|54589982|FG001|Overall Study|Lost to Follow-up|0|||
27933519|NCT00931801|54589991|FG000|Overall Study|Adverse Event|0|||
27933520|NCT00931801|54589992|FG001|Overall Study|Adverse Event|0|||
27933521|NCT00931801|54589993|FG002|Overall Study|Adverse Event|1|||
27933522|NCT00931801|54589991|FG000|Overall Study|Lost to Follow-up|0|||
27933523|NCT00931801|54589992|FG001|Overall Study|Lost to Follow-up|1|||
27933524|NCT00931801|54589993|FG002|Overall Study|Lost to Follow-up|0|||
27933525|NCT00931801|54589991|FG000|Overall Study|Withdrawal by Subject|1|||
27933526|NCT00931801|54589992|FG001|Overall Study|Withdrawal by Subject|0|||
27933527|NCT00931801|54589993|FG002|Overall Study|Withdrawal by Subject|0|||
27933528|NCT00931801|54589991|FG000|Overall Study|Confirmed Virologic Failure|0|||
27933529|NCT00931801|54589992|FG001|Overall Study|Confirmed Virologic Failure|0|||
27933530|NCT00931801|54589993|FG002|Overall Study|Confirmed Virologic Failure|3|||
27933531|NCT00931723|54590007|FG000|Overall Study|Withdrawal by Subject|11|||
27933532|NCT00931723|54590008|FG001|Overall Study|Withdrawal by Subject|13|||
27933533|NCT00931723|54590007|FG000|Overall Study|Adverse Event|6|||
27933534|NCT00931723|54590008|FG001|Overall Study|Adverse Event|13|||
27933535|NCT00931723|54590007|FG000|Overall Study|Lithium found in blood|0|||
27933536|NCT00931723|54590008|FG001|Overall Study|Lithium found in blood|1|||
27933537|NCT00931723|54590007|FG000|Overall Study|Condition under investigation worsened|1|||
27933538|NCT00931723|54590008|FG001|Overall Study|Condition under investigation worsened|2|||
27933539|NCT00931723|54590007|FG000|Overall Study|Lost to Follow-up|1|||
27933540|NCT00931723|54590008|FG001|Overall Study|Lost to Follow-up|2|||
27933541|NCT00931723|54590007|FG000|Overall Study|Study-specific discontinuation criteria|1|||
27933542|NCT00931723|54590008|FG001|Overall Study|Study-specific discontinuation criteria|1|||
27933543|NCT00931723|54590007|FG000|Overall Study|Severe non-compliance to protocol|2|||
27933544|NCT00931723|54590008|FG001|Overall Study|Severe non-compliance to protocol|0|||
27933545|NCT00931723|54590007|FG000|Overall Study|Safety reasons|0|||
27933546|NCT00931723|54590008|FG001|Overall Study|Safety reasons|1|||
27933547|NCT00931723|54590007|FG000|Overall Study|Took prohibited concomitant medication|0|||
27933548|NCT00931723|54590008|FG001|Overall Study|Took prohibited concomitant medication|1|||
27933549|NCT00931723|54590007|FG000|Overall Study|Lack or insufficient theraputic response|2|||
27933550|NCT00931723|54590008|FG001|Overall Study|Lack or insufficient theraputic response|5|||
27933551|NCT00931723|54590007|FG000|Overall Study|Sponsor decision|1|||
27933552|NCT00931723|54590008|FG001|Overall Study|Sponsor decision|0|||
27933553|NCT00931723|54590007|FG000|Overall Study|Late hospital discharge|1|||
27933554|NCT00931723|54590008|FG001|Overall Study|Late hospital discharge|0|||
27933555|NCT00931411|54590016|FG000|First Intervention - 42 Days|Adverse Event|2|||
27933556|NCT00931411|54590017|FG001|First Intervention - 42 Days|Adverse Event|3|||
27933557|NCT00931411|54590016|FG000|First Intervention - 42 Days|Lost to Follow-up|2|||
27933558|NCT00931411|54590017|FG001|First Intervention - 42 Days|Lost to Follow-up|0|||
27933559|NCT00931411|54590016|FG000|After Crossover - 14 Days (up to Day 56)|Adverse Event|0|||
27933560|NCT00931411|54590017|FG001|After Crossover - 14 Days (up to Day 56)|Adverse Event|1|||
27933561|NCT00931255|54590029|FG000|Overall Study|Follow up biopsy not done|2|||
27933562|NCT00931255|54590030|FG001|Overall Study|Follow up biopsy not done|3|||
27933563|NCT00930553|54590036|FG000|Overall Study|Adverse Event|1|||
27933564|NCT00930553|54590036|FG000|Overall Study|Lack of Efficacy|7|||
27933565|NCT00930553|54590036|FG000|Overall Study|Physician Decision|39|||
27933566|NCT00930553|54590036|FG000|Overall Study|Protocol Violation|1|||
27933567|NCT00930553|54590036|FG000|Overall Study|Pregnancy|1|||
27933568|NCT00930553|54590036|FG000|Overall Study|Withdrawal by Subject|88|||
27933569|NCT00930553|54590036|FG000|Overall Study|Lost to Follow-up|25|||
27933570|NCT00930553|54590036|FG000|Overall Study|Death|9|||
27933571|NCT00930553|54590036|FG000|Overall Study|Study terminated by sponsor|24|||
27933572|NCT00930553|54590036|FG000|Overall Study|Other than specified above|28|||
27933573|NCT00929695|54590060|FG000|Overall Study|Death|2|||
27933574|NCT00929695|54590061|FG001|Overall Study|Death|1|||
27788947|NCT01567306|54243729|FG004|Overall Study|Withdrawal by Subject|0|||
27788948|NCT01567306|54243730|FG005|Overall Study|Withdrawal by Subject|1|||
27788949|NCT01587274|54243747|FG000|Overall Study|Lost to Follow-up|4|||
27788950|NCT01587274|54243748|FG001|Overall Study|Lost to Follow-up|5|||
27788951|NCT01587274|54243749|FG002|Overall Study|Lost to Follow-up|3|||
27788952|NCT01587118|54243757|FG000|Overall Study|Adverse Event|3|||
27788953|NCT01587118|54243757|FG000|Overall Study|Lost to Follow-up|2|||
27933575|NCT00929695|54590060|FG000|Overall Study|Withdrawal by Subject|0|||
27933576|NCT00929695|54590061|FG001|Overall Study|Withdrawal by Subject|2|||
27933577|NCT00929695|54590060|FG000|Overall Study|discharge home|4|||
27933578|NCT00929695|54590061|FG001|Overall Study|discharge home|3|||
27933579|NCT00929695|54590060|FG000|Overall Study|incorrect stratification|2|||
27933580|NCT00929695|54590061|FG001|Overall Study|incorrect stratification|0|||
27933581|NCT00927355|54590074|FG000|Overall Study|Adverse Event|1|||
27933582|NCT00927355|54590075|FG001|Overall Study|Adverse Event|1|||
27933583|NCT00923845|54590095|FG000|Induction Therapy|Poor performance status|0|||
27933584|NCT00923845|54590096|FG001|Induction Therapy|Poor performance status|2|||
27933585|NCT00922987|54590103|FG000|Overall Study|Insufficient clinical response|1|||
27933586|NCT00922987|54590103|FG000|Overall Study|Protocol Violation|2|||
27933587|NCT00922987|54590103|FG000|Overall Study|Adverse Event|1|||
27933588|NCT00928135|54590109|FG000|Overall Study|Withdrawal by Subject|1|||
27933589|NCT00928135|54590110|FG001|Overall Study|Withdrawal by Subject|0|||
27933590|NCT00928057|54590118|FG000|Overall Study|Adverse Event|1|||
27933591|NCT00928057|54590119|FG001|Overall Study|Adverse Event|2|||
27933592|NCT00928057|54590118|FG000|Overall Study|Withdrawal by Subject|1|||
27933593|NCT00928057|54590119|FG001|Overall Study|Withdrawal by Subject|0|||
27933594|NCT00928057|54590118|FG000|Overall Study|Lost to Follow-up|0|||
27933595|NCT00928057|54590119|FG001|Overall Study|Lost to Follow-up|1|||
27933596|NCT00928057|54590118|FG000|Overall Study|Protocol Violation|0|||
27933597|NCT00928057|54590119|FG001|Overall Study|Protocol Violation|1|||
27933598|NCT00927901|54590135|FG000|Treatment Period 1|Subject withdrew consent|0|||
28105593|NCT04883541|54763035|FG001|Overall Study|Not attending regular yoga class|0|||
27788954|NCT01587118|54243757|FG000|Overall Study|Relocation|1|||
27933599|NCT00927901|54590136|FG001|Treatment Period 1|Subject withdrew consent|0|||
27933600|NCT00927901|54590137|FG002|Treatment Period 1|Subject withdrew consent|1|||
27933601|NCT00927901|54590138|FG003|Treatment Period 1|Subject withdrew consent|0|||
27933602|NCT00927901|54590135|FG000|Treatment Period 4|Adverse Event|0|||
27933603|NCT00927901|54590136|FG001|Treatment Period 4|Adverse Event|0|||
27933604|NCT00927901|54590137|FG002|Treatment Period 4|Adverse Event|0|||
27933605|NCT00927901|54590138|FG003|Treatment Period 4|Adverse Event|1|||
27933606|NCT00927901|54590135|FG000|Treatment Period 4|Subject withdrew consent|0|||
27933607|NCT00927901|54590136|FG001|Treatment Period 4|Subject withdrew consent|0|||
27933608|NCT00927901|54590137|FG002|Treatment Period 4|Subject withdrew consent|1|||
27933609|NCT00927901|54590138|FG003|Treatment Period 4|Subject withdrew consent|0|||
27933610|NCT01218204|54590153|FG000|Part B Washout|Adverse Event|0|||
27933611|NCT01218204|54590154|FG001|Part B Washout|Adverse Event|1|||
27933612|NCT01218204|54590155|FG002|Part B Washout|Adverse Event|0|||
27933613|NCT01218204|54590156|FG003|Part B Washout|Adverse Event|0|||
27933614|NCT01218204|54590153|FG000|Part B Washout|Lost to Follow-up|0|||
27933615|NCT01218204|54590154|FG001|Part B Washout|Lost to Follow-up|2|||
27933616|NCT01218204|54590155|FG002|Part B Washout|Lost to Follow-up|0|||
27933617|NCT01218204|54590156|FG003|Part B Washout|Lost to Follow-up|0|||
27933618|NCT01218204|54590153|FG000|Part B Washout|Physician Decision|0|||
27933619|NCT01218204|54590154|FG001|Part B Washout|Physician Decision|14|||
27933620|NCT01218204|54590155|FG002|Part B Washout|Physician Decision|0|||
27933621|NCT01218204|54590156|FG003|Part B Washout|Physician Decision|0|||
27933622|NCT01218204|54590153|FG000|Part B Washout|Withdrawal by Subject|0|||
27933623|NCT01218204|54590154|FG001|Part B Washout|Withdrawal by Subject|14|||
27933624|NCT01218204|54590155|FG002|Part B Washout|Withdrawal by Subject|0|||
27788955|NCT01587118|54243757|FG000|Overall Study|nonresponse|1|||
27788956|NCT01905657|54243764|FG000|Overall Study|Adverse Event|23|||
27788957|NCT01905657|54243765|FG001|Overall Study|Adverse Event|17|||
27788958|NCT01905657|54243766|FG002|Overall Study|Adverse Event|18|||
27788959|NCT01905657|54243764|FG000|Overall Study|Clinical Progression|103|||
27788960|NCT01905657|54243765|FG001|Overall Study|Clinical Progression|78|||
27788961|NCT01905657|54243766|FG002|Overall Study|Clinical Progression|59|||
27788962|NCT01905657|54243764|FG000|Overall Study|Death|40|||
27788963|NCT01905657|54243765|FG001|Overall Study|Death|43|||
27788964|NCT01905657|54243766|FG002|Overall Study|Death|47|||
27788965|NCT01905657|54243764|FG000|Overall Study|Excluded Medication|13|||
27788966|NCT01905657|54243765|FG001|Overall Study|Excluded Medication|16|||
27788967|NCT01905657|54243766|FG002|Overall Study|Excluded Medication|9|||
27788968|NCT01905657|54243764|FG000|Overall Study|Lost to Follow-up|1|||
27788969|NCT01905657|54243765|FG001|Overall Study|Lost to Follow-up|2|||
27788970|NCT01905657|54243766|FG002|Overall Study|Lost to Follow-up|1|||
27788971|NCT01905657|54243764|FG000|Overall Study|Physician Decision|5|||
27788972|NCT01905657|54243765|FG001|Overall Study|Physician Decision|8|||
27788973|NCT01905657|54243766|FG002|Overall Study|Physician Decision|12|||
27788974|NCT01905657|54243764|FG000|Overall Study|Protocol Violation|2|||
27788975|NCT01905657|54243765|FG001|Overall Study|Protocol Violation|1|||
27788976|NCT01905657|54243766|FG002|Overall Study|Protocol Violation|1|||
27788977|NCT01905657|54243764|FG000|Overall Study|Screen Failure|0|||
27788978|NCT01905657|54243765|FG001|Overall Study|Screen Failure|1|||
27788979|NCT01905657|54243766|FG002|Overall Study|Screen Failure|0|||
27788980|NCT01905657|54243764|FG000|Overall Study|Withdrawal by Subject|15|||
27788981|NCT01905657|54243765|FG001|Overall Study|Withdrawal by Subject|21|||
27788982|NCT01905657|54243766|FG002|Overall Study|Withdrawal by Subject|53|||
27788983|NCT01905657|54243764|FG000|Overall Study|Sponsor Decision|1|||
27788984|NCT01905657|54243765|FG001|Overall Study|Sponsor Decision|0|||
27788985|NCT01905657|54243766|FG002|Overall Study|Sponsor Decision|0|||
27788986|NCT02202980|54243791|FG000|Overall Study|Lack of Efficacy|1|||
27788987|NCT02202980|54243792|FG001|Overall Study|Lack of Efficacy|0|||
27788988|NCT02202980|54243793|FG002|Overall Study|Lack of Efficacy|7|||
27788989|NCT02202980|54243794|FG003|Overall Study|Lack of Efficacy|0|||
27788990|NCT02202980|54243795|FG004|Overall Study|Lack of Efficacy|3|||
27788991|NCT02202980|54243796|FG005|Overall Study|Lack of Efficacy|1|||
27788992|NCT02202980|54243797|FG006|Overall Study|Lack of Efficacy|11|||
27788993|NCT02202980|54243798|FG007|Overall Study|Lack of Efficacy|2|||
27788994|NCT02202980|54243799|FG008|Overall Study|Lack of Efficacy|2|||
27788995|NCT02202980|54243800|FG009|Overall Study|Lack of Efficacy|0|||
27788996|NCT02202980|54243801|FG010|Overall Study|Lack of Efficacy|0|||
27933625|NCT01218204|54590156|FG003|Part B Washout|Withdrawal by Subject|0|||
27788997|NCT02202980|54243802|FG011|Overall Study|Lack of Efficacy|3|||
27842463|NCT01445951|54330987|FG001|Overall Study|Lost to Follow-up|2|||
27933626|NCT01218204|54590153|FG000|Part B Washout|Reached defined stopping criteria|0|||
27933627|NCT01218204|54590154|FG001|Part B Washout|Reached defined stopping criteria|2|||
27933628|NCT01218204|54590155|FG002|Part B Washout|Reached defined stopping criteria|0|||
27933629|NCT01218204|54590156|FG003|Part B Washout|Reached defined stopping criteria|0|||
27788998|NCT02202980|54243803|FG012|Overall Study|Lack of Efficacy|10|||
27788999|NCT02202980|54243804|FG013|Overall Study|Lack of Efficacy|0|||
27789000|NCT02202980|54243791|FG000|Overall Study|Protocol Violation|0|||
27789001|NCT02202980|54243792|FG001|Overall Study|Protocol Violation|0|||
27933630|NCT01218204|54590153|FG000|Part B Washout|Did not meet continuation criteria|0|||
27933631|NCT01218204|54590154|FG001|Part B Washout|Did not meet continuation criteria|112|||
27933632|NCT01218204|54590155|FG002|Part B Washout|Did not meet continuation criteria|0|||
27933633|NCT01218204|54590156|FG003|Part B Washout|Did not meet continuation criteria|0|||
27933634|NCT01218204|54590153|FG000|Part B Run-in|Adverse Event|0|||
27933635|NCT01218204|54590154|FG001|Part B Run-in|Adverse Event|0|||
27933636|NCT01218204|54590155|FG002|Part B Run-in|Adverse Event|1|||
27933637|NCT01218204|54590156|FG003|Part B Run-in|Adverse Event|0|||
27933638|NCT01218204|54590153|FG000|Part B Run-in|Protocol Violation|0|||
27933639|NCT01218204|54590154|FG001|Part B Run-in|Protocol Violation|0|||
27933640|NCT01218204|54590155|FG002|Part B Run-in|Protocol Violation|2|||
27933641|NCT01218204|54590156|FG003|Part B Run-in|Protocol Violation|0|||
27933642|NCT01218204|54590153|FG000|Part B Run-in|Withdrawal by Subject|0|||
27933643|NCT01218204|54590154|FG001|Part B Run-in|Withdrawal by Subject|0|||
27933644|NCT01218204|54590155|FG002|Part B Run-in|Withdrawal by Subject|3|||
27933645|NCT01218204|54590156|FG003|Part B Run-in|Withdrawal by Subject|0|||
27933646|NCT01218204|54590153|FG000|Part B Pooled Treatment Arm|Adverse Event|0|||
27933647|NCT01218204|54590154|FG001|Part B Pooled Treatment Arm|Adverse Event|0|||
27933648|NCT01218204|54590155|FG002|Part B Pooled Treatment Arm|Adverse Event|0|||
27933649|NCT01218204|54590156|FG003|Part B Pooled Treatment Arm|Adverse Event|2|||
27933650|NCT01218204|54590153|FG000|Part B Pooled Treatment Arm|Protocol Violation|0|||
27933651|NCT01218204|54590154|FG001|Part B Pooled Treatment Arm|Protocol Violation|0|||
27933652|NCT01218204|54590155|FG002|Part B Pooled Treatment Arm|Protocol Violation|0|||
27933653|NCT01218204|54590156|FG003|Part B Pooled Treatment Arm|Protocol Violation|1|||
27933654|NCT00926575|54590205|FG000|Overall Study|Adverse Event|1|||
27933655|NCT00926575|54590206|FG001|Overall Study|Adverse Event|1|||
27933656|NCT00926575|54590205|FG000|Overall Study|Death|4|||
27933657|NCT00926575|54590206|FG001|Overall Study|Death|4|||
27933658|NCT00926575|54590205|FG000|Overall Study|Lost to Follow-up|1|||
27933659|NCT00926575|54590206|FG001|Overall Study|Lost to Follow-up|1|||
27933660|NCT00926575|54590205|FG000|Overall Study|Physician Decision|1|||
27933661|NCT00926575|54590206|FG001|Overall Study|Physician Decision|2|||
27933662|NCT00926575|54590205|FG000|Overall Study|Protocol Violation|1|||
27933663|NCT00926575|54590206|FG001|Overall Study|Protocol Violation|0|||
27933664|NCT00926575|54590205|FG000|Overall Study|Withdrawal by Subject|8|||
27933665|NCT00926575|54590206|FG001|Overall Study|Withdrawal by Subject|9|||
27933666|NCT01218126|54590216|FG000|Overall Study|Adverse Event|8|||
27933667|NCT01218126|54590217|FG001|Overall Study|Adverse Event|10|||
27933668|NCT01218126|54590218|FG002|Overall Study|Adverse Event|12|||
27933669|NCT01218126|54590219|FG003|Overall Study|Adverse Event|16|||
27933670|NCT01218126|54590216|FG000|Overall Study|Lack of Efficacy|7|||
27933671|NCT01218126|54590217|FG001|Overall Study|Lack of Efficacy|2|||
27933672|NCT01218126|54590218|FG002|Overall Study|Lack of Efficacy|2|||
27933673|NCT01218126|54590219|FG003|Overall Study|Lack of Efficacy|6|||
27933674|NCT01218126|54590216|FG000|Overall Study|Protocol Violation|5|||
27933675|NCT01218126|54590217|FG001|Overall Study|Protocol Violation|2|||
27933676|NCT01218126|54590218|FG002|Overall Study|Protocol Violation|2|||
27933677|NCT01218126|54590219|FG003|Overall Study|Protocol Violation|3|||
27933678|NCT01218126|54590216|FG000|Overall Study|Protocol-defined stopping criteria|1|||
27933679|NCT01218126|54590217|FG001|Overall Study|Protocol-defined stopping criteria|1|||
27933680|NCT01218126|54590218|FG002|Overall Study|Protocol-defined stopping criteria|0|||
27933681|NCT01218126|54590219|FG003|Overall Study|Protocol-defined stopping criteria|0|||
27933682|NCT01218126|54590216|FG000|Overall Study|Lost to Follow-up|0|||
27933683|NCT01218126|54590217|FG001|Overall Study|Lost to Follow-up|0|||
27933684|NCT01218126|54590218|FG002|Overall Study|Lost to Follow-up|0|||
27933685|NCT01218126|54590219|FG003|Overall Study|Lost to Follow-up|2|||
27933686|NCT01218126|54590216|FG000|Overall Study|Physician Decision|1|||
27933687|NCT01218126|54590217|FG001|Overall Study|Physician Decision|2|||
27933688|NCT01218126|54590218|FG002|Overall Study|Physician Decision|4|||
27933689|NCT01218126|54590219|FG003|Overall Study|Physician Decision|2|||
27933690|NCT01218126|54590216|FG000|Overall Study|Withdrawal by Subject|2|||
27933691|NCT01218126|54590217|FG001|Overall Study|Withdrawal by Subject|5|||
27933692|NCT01218126|54590218|FG002|Overall Study|Withdrawal by Subject|4|||
27933693|NCT01218126|54590219|FG003|Overall Study|Withdrawal by Subject|6|||
27933694|NCT01217892|54590233|FG000|Overall Study|Adverse Event|1|||
27933695|NCT01217892|54590234|FG001|Overall Study|Adverse Event|1|||
27933696|NCT01217892|54590235|FG002|Overall Study|Adverse Event|1|||
27933697|NCT01217892|54590236|FG003|Overall Study|Adverse Event|0|||
27933698|NCT01217892|54590233|FG000|Overall Study|Withdrawal by Subject|0|||
27933699|NCT01217892|54590234|FG001|Overall Study|Withdrawal by Subject|2|||
27933700|NCT01217892|54590235|FG002|Overall Study|Withdrawal by Subject|1|||
27933701|NCT01217892|54590236|FG003|Overall Study|Withdrawal by Subject|0|||
27933702|NCT01217892|54590233|FG000|Overall Study|Lab value|1|||
27933703|NCT01217892|54590234|FG001|Overall Study|Lab value|0|||
27933704|NCT01217892|54590235|FG002|Overall Study|Lab value|1|||
27933705|NCT01217892|54590236|FG003|Overall Study|Lab value|0|||
27933706|NCT01217892|54590233|FG000|Overall Study|Subject no longer meets study criteria|5|||
27933707|NCT01217892|54590234|FG001|Overall Study|Subject no longer meets study criteria|2|||
27933708|NCT01217892|54590235|FG002|Overall Study|Subject no longer meets study criteria|4|||
27933709|NCT01217892|54590236|FG003|Overall Study|Subject no longer meets study criteria|8|||
27789002|NCT02202980|54243793|FG002|Overall Study|Protocol Violation|0|||
27789003|NCT02202980|54243794|FG003|Overall Study|Protocol Violation|3|||
27789004|NCT02202980|54243795|FG004|Overall Study|Protocol Violation|3|||
27789005|NCT02202980|54243796|FG005|Overall Study|Protocol Violation|0|||
27789006|NCT02202980|54243797|FG006|Overall Study|Protocol Violation|0|||
27789007|NCT02202980|54243798|FG007|Overall Study|Protocol Violation|0|||
27789008|NCT02202980|54243799|FG008|Overall Study|Protocol Violation|0|||
27933710|NCT01217892|54590233|FG000|Overall Study|Incorrect enrollment|0|||
27933711|NCT01217892|54590234|FG001|Overall Study|Incorrect enrollment|1|||
27933712|NCT01217892|54590235|FG002|Overall Study|Incorrect enrollment|1|||
27933713|NCT01217892|54590236|FG003|Overall Study|Incorrect enrollment|0|||
27933714|NCT01217892|54590233|FG000|Overall Study|Poor/Non-Compliance|0|||
27933715|NCT01217892|54590234|FG001|Overall Study|Poor/Non-Compliance|0|||
27933716|NCT01217892|54590235|FG002|Overall Study|Poor/Non-Compliance|1|||
27933717|NCT01217892|54590236|FG003|Overall Study|Poor/Non-Compliance|0|||
27933718|NCT01217814|54590249|FG000|Overall Study|Adverse Event|1|||
27933719|NCT01217814|54590250|FG001|Overall Study|Adverse Event|1|||
27933720|NCT01217814|54590251|FG002|Overall Study|Adverse Event|0|||
27933721|NCT01217814|54590249|FG000|Overall Study|Lack of Efficacy|0|||
27933722|NCT01217814|54590250|FG001|Overall Study|Lack of Efficacy|0|||
27933723|NCT01217814|54590251|FG002|Overall Study|Lack of Efficacy|1|||
27933724|NCT01217190|54590262|FG000|Second Dosing|Withdrawal by Subject|0|||
27933725|NCT01217190|54590263|FG001|Second Dosing|Withdrawal by Subject|2|||
27933726|NCT01136733|54590279|FG000|Phase 1b|Adverse Event|0|||
27933727|NCT01136733|54590280|FG001|Phase 1b|Adverse Event|3|||
27933728|NCT01136733|54590281|FG002|Phase 1b|Adverse Event|1|||
27933729|NCT01136733|54590282|FG003|Phase 1b|Adverse Event|0|||
27933730|NCT01136733|54590283|FG004|Phase 1b|Adverse Event|0|||
27933731|NCT01136733|54590284|FG005|Phase 1b|Adverse Event|0|||
27933732|NCT01136733|54590285|FG006|Phase 1b|Adverse Event|0|||
27933733|NCT01136733|54590279|FG000|Phase 1b|Participant Choice|0|||
27933734|NCT01136733|54590280|FG001|Phase 1b|Participant Choice|0|||
27933735|NCT01136733|54590281|FG002|Phase 1b|Participant Choice|1|||
27933736|NCT01136733|54590282|FG003|Phase 1b|Participant Choice|0|||
27933737|NCT01136733|54590283|FG004|Phase 1b|Participant Choice|0|||
27933738|NCT01136733|54590284|FG005|Phase 1b|Participant Choice|0|||
27933739|NCT01136733|54590285|FG006|Phase 1b|Participant Choice|0|||
27933740|NCT01136733|54590279|FG000|Phase 1b|Administrative-Withdrew Consent|0|||
27789009|NCT02202980|54243800|FG009|Overall Study|Protocol Violation|0|||
27933741|NCT01136733|54590280|FG001|Phase 1b|Administrative-Withdrew Consent|1|||
27933742|NCT01136733|54590281|FG002|Phase 1b|Administrative-Withdrew Consent|0|||
27789010|NCT02202980|54243801|FG010|Overall Study|Protocol Violation|0|||
27789011|NCT02202980|54243802|FG011|Overall Study|Protocol Violation|0|||
27933743|NCT01136733|54590282|FG003|Phase 1b|Administrative-Withdrew Consent|0|||
27933744|NCT01136733|54590283|FG004|Phase 1b|Administrative-Withdrew Consent|0|||
27933745|NCT01136733|54590284|FG005|Phase 1b|Administrative-Withdrew Consent|0|||
27933746|NCT01136733|54590285|FG006|Phase 1b|Administrative-Withdrew Consent|0|||
27933747|NCT01136733|54590279|FG000|Phase 1b|Clinical Progression|1|||
27933748|NCT01136733|54590280|FG001|Phase 1b|Clinical Progression|1|||
27789012|NCT02202980|54243803|FG012|Overall Study|Protocol Violation|0|||
27789013|NCT02202980|54243804|FG013|Overall Study|Protocol Violation|0|||
27789014|NCT02202980|54243791|FG000|Overall Study|Lost to Follow-up|0|||
27789015|NCT02202980|54243792|FG001|Overall Study|Lost to Follow-up|1|||
27789016|NCT02202980|54243793|FG002|Overall Study|Lost to Follow-up|1|||
27789017|NCT02202980|54243794|FG003|Overall Study|Lost to Follow-up|1|||
27789018|NCT02202980|54243795|FG004|Overall Study|Lost to Follow-up|0|||
27789019|NCT02202980|54243796|FG005|Overall Study|Lost to Follow-up|0|||
27789020|NCT02202980|54243797|FG006|Overall Study|Lost to Follow-up|0|||
27789021|NCT02202980|54243798|FG007|Overall Study|Lost to Follow-up|1|||
27789022|NCT02202980|54243799|FG008|Overall Study|Lost to Follow-up|1|||
27789023|NCT02202980|54243800|FG009|Overall Study|Lost to Follow-up|0|||
27789024|NCT02202980|54243801|FG010|Overall Study|Lost to Follow-up|0|||
27789025|NCT02202980|54243802|FG011|Overall Study|Lost to Follow-up|0|||
27789026|NCT02202980|54243803|FG012|Overall Study|Lost to Follow-up|1|||
27789027|NCT02202980|54243804|FG013|Overall Study|Lost to Follow-up|0|||
27789028|NCT02202980|54243791|FG000|Overall Study|Withdrew Consent|0|||
27789029|NCT02202980|54243792|FG001|Overall Study|Withdrew Consent|1|||
27789030|NCT02202980|54243793|FG002|Overall Study|Withdrew Consent|2|||
27789031|NCT02202980|54243794|FG003|Overall Study|Withdrew Consent|0|||
27789032|NCT02202980|54243795|FG004|Overall Study|Withdrew Consent|0|||
27789033|NCT02202980|54243796|FG005|Overall Study|Withdrew Consent|0|||
27789034|NCT02202980|54243797|FG006|Overall Study|Withdrew Consent|0|||
27789035|NCT02202980|54243798|FG007|Overall Study|Withdrew Consent|0|||
27789036|NCT02202980|54243799|FG008|Overall Study|Withdrew Consent|1|||
27789037|NCT02202980|54243800|FG009|Overall Study|Withdrew Consent|0|||
27789038|NCT02202980|54243801|FG010|Overall Study|Withdrew Consent|0|||
27789039|NCT02202980|54243802|FG011|Overall Study|Withdrew Consent|0|||
27789040|NCT02202980|54243803|FG012|Overall Study|Withdrew Consent|0|||
27789041|NCT02202980|54243804|FG013|Overall Study|Withdrew Consent|0|||
27789042|NCT01952145|54243836|FG000|Overall Study|Protocol Violation|2|||
27789043|NCT01952145|54243837|FG001|Overall Study|Protocol Violation|1|||
27789044|NCT01952145|54243836|FG000|Overall Study|Death|0|||
27789045|NCT01952145|54243837|FG001|Overall Study|Death|1|||
27789046|NCT01952145|54243836|FG000|Overall Study|Adverse Event|9|||
27789047|NCT01952145|54243837|FG001|Overall Study|Adverse Event|0|||
27789048|NCT01952145|54243836|FG000|Overall Study|Withdrawal Criteria|16|||
27789049|NCT01952145|54243837|FG001|Overall Study|Withdrawal Criteria|11|||
28017006|NCT00663702|54676251|FG001|Overall Study|Adverse Event|4|||
28017007|NCT00663702|54676250|FG000|Overall Study|Withdrawal by Subject|3|||
28017008|NCT00663702|54676251|FG001|Overall Study|Withdrawal by Subject|1|||
28017009|NCT00663702|54676250|FG000|Overall Study|Pregnancy|0|||
28017010|NCT00663702|54676251|FG001|Overall Study|Pregnancy|1|||
28017011|NCT00663702|54676250|FG000|Overall Study|Lost to Follow-up|3|||
28017012|NCT00663702|54676251|FG001|Overall Study|Lost to Follow-up|0|||
27789050|NCT01952145|54243836|FG000|Overall Study|Unclassified|1|||
27789051|NCT01952145|54243837|FG001|Overall Study|Unclassified|1|||
27789052|NCT01923363|54243843|FG000|Overall Study|Protocol Violation|1|||
27789053|NCT01905267|54243849|FG000|Overall Study|Physician Decision|2|||
27789054|NCT01905267|54243850|FG001|Overall Study|Physician Decision|2|||
27789055|NCT01923285|54243858|FG000|Overall Study|Withdrawal by Subject|7|||
27789056|NCT01923285|54243859|FG001|Overall Study|Withdrawal by Subject|6|||
27789057|NCT01904721|54243872|FG000|Overall Study|Other Reasons|0|||
27789058|NCT01904721|54243873|FG001|Overall Study|Other Reasons|0|||
27789059|NCT01904721|54243874|FG002|Overall Study|Other Reasons|1|||
27789060|NCT01904721|54243875|FG003|Overall Study|Other Reasons|1|||
27842464|NCT01445951|54330988|FG002|Overall Study|Lost to Follow-up|4|||
27842465|NCT01445951|54330986|FG000|Overall Study|Pregnancy|0|||
27842466|NCT01445951|54330987|FG001|Overall Study|Pregnancy|1|||
28017013|NCT00663702|54676250|FG000|Overall Study|Death|1|||
28105594|NCT04883541|54763034|FG000|Overall Study|Not attending the pregnancy school|0|||
27789061|NCT01904721|54243876|FG004|Overall Study|Other Reasons|2|||
27789062|NCT01904721|54243877|FG005|Overall Study|Other Reasons|2|||
27789063|NCT01904721|54243878|FG006|Overall Study|Other Reasons|2|||
27789064|NCT01904721|54243872|FG000|Overall Study|Personal Reasons|0|||
27789065|NCT01904721|54243873|FG001|Overall Study|Personal Reasons|0|||
27789066|NCT01904721|54243874|FG002|Overall Study|Personal Reasons|0|||
27789067|NCT01904721|54243875|FG003|Overall Study|Personal Reasons|0|||
27789068|NCT01904721|54243876|FG004|Overall Study|Personal Reasons|2|||
27789069|NCT01904721|54243877|FG005|Overall Study|Personal Reasons|3|||
27789070|NCT01904721|54243878|FG006|Overall Study|Personal Reasons|3|||
27789071|NCT01904721|54243872|FG000|Overall Study|Lost to Follow-up|0|||
27789072|NCT01904721|54243873|FG001|Overall Study|Lost to Follow-up|0|||
27789073|NCT01904721|54243874|FG002|Overall Study|Lost to Follow-up|0|||
27789074|NCT01904721|54243875|FG003|Overall Study|Lost to Follow-up|0|||
27789075|NCT01904721|54243876|FG004|Overall Study|Lost to Follow-up|1|||
27789076|NCT01904721|54243877|FG005|Overall Study|Lost to Follow-up|3|||
27789077|NCT01904721|54243878|FG006|Overall Study|Lost to Follow-up|1|||
27789078|NCT01904721|54243872|FG000|Overall Study|Lack of Efficacy|0|||
27789079|NCT01904721|54243873|FG001|Overall Study|Lack of Efficacy|0|||
28017014|NCT00663702|54676251|FG001|Overall Study|Death|1|||
27789080|NCT01904721|54243874|FG002|Overall Study|Lack of Efficacy|0|||
27789081|NCT01904721|54243875|FG003|Overall Study|Lack of Efficacy|0|||
27789082|NCT01904721|54243876|FG004|Overall Study|Lack of Efficacy|0|||
27789083|NCT01904721|54243877|FG005|Overall Study|Lack of Efficacy|0|||
27789084|NCT01904721|54243878|FG006|Overall Study|Lack of Efficacy|1|||
27789085|NCT01904721|54243872|FG000|Overall Study|Adverse Event|0|||
27789086|NCT01904721|54243873|FG001|Overall Study|Adverse Event|0|||
27789087|NCT01904721|54243874|FG002|Overall Study|Adverse Event|0|||
27789088|NCT01904721|54243875|FG003|Overall Study|Adverse Event|0|||
27789089|NCT01904721|54243876|FG004|Overall Study|Adverse Event|3|||
27789090|NCT01904721|54243877|FG005|Overall Study|Adverse Event|1|||
27789091|NCT01904721|54243878|FG006|Overall Study|Adverse Event|0|||
27789092|NCT01904019|54243890|FG000|1 Year Follow-up|Withdrawal by Subject|4|||
27789093|NCT01904019|54243890|FG000|1 Year Follow-up|Impossibility to contact patient|5|||
27789094|NCT01904019|54243890|FG000|3 Year Follow-up|Withdrawal by Subject|1|||
27789095|NCT01904019|54243890|FG000|3 Year Follow-up|Impossibility to contact patient|14|||
27789096|NCT01904019|54243890|FG000|5 Year Follow-up|Withdrawal by Subject|2|||
27789097|NCT01904019|54243890|FG000|5 Year Follow-up|Impossibility to contact patient|4|||
27789098|NCT01922895|54243896|FG000|Overall Study|Death|0|||
27789099|NCT01922895|54243897|FG001|Overall Study|Death|1|||
27789100|NCT01922895|54243896|FG000|Overall Study|Withdrawal by Subject|1|||
27789101|NCT01922895|54243897|FG001|Overall Study|Withdrawal by Subject|2|||
27789102|NCT01922895|54243896|FG000|Overall Study|Lost to Follow-up|5|||
27789103|NCT01922895|54243897|FG001|Overall Study|Lost to Follow-up|11|||
27789104|NCT01922739|54243905|FG000|Titration/Adjustment Period|Adverse Event|3|||
27789105|NCT01922739|54243905|FG000|Titration/Adjustment Period|Withdrawal by Subject|5|||
27789106|NCT01922739|54243905|FG000|Titration/Adjustment Period|Lost to Follow-up|1|||
27789107|NCT01922739|54243905|FG000|Titration/Adjustment Period|Lack of Efficacy|3|||
27789108|NCT01922739|54243905|FG000|Open-label Treatment Period|Adverse Event|6|||
27789109|NCT01922739|54243905|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
27789110|NCT01922739|54243905|FG000|Open-label Treatment Period|Noncompliance to study medication|3|||
27789111|NCT01922739|54243905|FG000|Open-label Treatment Period|Protocol Violation|5|||
27789112|NCT01922739|54243905|FG000|Open-label Treatment Period|Pregnancy|1|||
27789113|NCT01922739|54243905|FG000|Open-label Treatment Period|Noncompliance to study procedures|1|||
27789114|NCT01922739|54243905|FG000|Open-label Treatment Period|Lost to Follow-up|2|||
27789115|NCT01922739|54243905|FG000|Open-label Treatment Period|Physician Decision|1|||
27789116|NCT01922739|54243905|FG000|Open-label Treatment Period|Sponsor request - investigator leaving|1|||
27789117|NCT02236988|54243925|FG000|Overall Study|Lost to Follow-up|0|||
27789118|NCT02236988|54243926|FG001|Overall Study|Lost to Follow-up|0|||
27789119|NCT02236988|54243927|FG002|Overall Study|Lost to Follow-up|0|||
27789120|NCT02236988|54243928|FG003|Overall Study|Lost to Follow-up|1|||
27789121|NCT02236988|54243925|FG000|Overall Study|Unable to Comply with Study Visits|0|||
27789122|NCT02236988|54243926|FG001|Overall Study|Unable to Comply with Study Visits|0|||
27789123|NCT02236988|54243927|FG002|Overall Study|Unable to Comply with Study Visits|0|||
27789124|NCT02236988|54243928|FG003|Overall Study|Unable to Comply with Study Visits|2|||
27789125|NCT02236598|54243981|FG000|Overall Study|Adverse Event|0|||
27789126|NCT02236598|54243982|FG001|Overall Study|Adverse Event|1|||
27789127|NCT02236598|54243981|FG000|Overall Study|Withdrawal by Subject|0|||
27789128|NCT02236598|54243982|FG001|Overall Study|Withdrawal by Subject|1|||
27789129|NCT01922349|54243992|FG000|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
27789130|NCT01922349|54243993|FG001|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
27789131|NCT01922349|54243994|FG002|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
27789132|NCT01922349|54243995|FG003|Multiple Rising Dose (MRD) Period|Adverse Event|1|||
27789133|NCT02236520|54244033|FG000|Overall Study|Physician Decision|0|||
27789134|NCT02236520|54244034|FG001|Overall Study|Physician Decision|5|||
27789135|NCT02236520|54244035|FG002|Overall Study|Physician Decision|0|||
27789136|NCT02236520|54244036|FG003|Overall Study|Physician Decision|0|||
27789137|NCT02236520|54244033|FG000|Overall Study|Withdrawal by Subject|1|||
27789138|NCT02236520|54244034|FG001|Overall Study|Withdrawal by Subject|0|||
27789139|NCT02236520|54244035|FG002|Overall Study|Withdrawal by Subject|0|||
27789140|NCT02236520|54244036|FG003|Overall Study|Withdrawal by Subject|1|||
27789141|NCT02236520|54244033|FG000|Overall Study|Pregnancy|1|||
27789142|NCT02236520|54244034|FG001|Overall Study|Pregnancy|0|||
27789143|NCT02236520|54244035|FG002|Overall Study|Pregnancy|0|||
27789144|NCT02236520|54244036|FG003|Overall Study|Pregnancy|0|||
27789145|NCT01922271|54244048|FG000|WASHOUT Period|Withdrawal by Subject|1|||
27789146|NCT01922271|54244049|FG001|WASHOUT Period|Withdrawal by Subject|0|||
27933749|NCT01136733|54590281|FG002|Phase 1b|Clinical Progression|0|||
27933750|NCT01136733|54590282|FG003|Phase 1b|Clinical Progression|0|||
27933751|NCT01136733|54590283|FG004|Phase 1b|Clinical Progression|0|||
27789147|NCT02236130|54244057|FG000|Overall Study|Lost to Follow-up|7|||
27789148|NCT02236130|54244058|FG001|Overall Study|Lost to Follow-up|12|||
27789149|NCT02233946|54244066|FG000|Baseline|Withdrawal by Subject|2|||
27789150|NCT02233946|54244067|FG001|Baseline|Withdrawal by Subject|0|||
27789151|NCT02233946|54244066|FG000|3-months Follow-up|Lost to Follow-up|53|||
27789152|NCT02233946|54244067|FG001|3-months Follow-up|Lost to Follow-up|29|||
27789153|NCT02233946|54244066|FG000|6-months Follow-up|Lost to Follow-up|21|||
27789154|NCT02233946|54244067|FG001|6-months Follow-up|Lost to Follow-up|2|||
27789155|NCT02233946|54244066|FG000|9-month Follow-up|Lost to Follow-up|20|||
27789156|NCT02233946|54244067|FG001|9-month Follow-up|Lost to Follow-up|11|||
27789157|NCT02233946|54244066|FG000|12-month Follow-up|Lost to Follow-up|28|||
27789158|NCT02233946|54244067|FG001|12-month Follow-up|Lost to Follow-up|11|||
27789159|NCT02232698|54244075|FG000|Overall Study|Pregnancy|1|||
27789160|NCT02232698|54244076|FG001|Overall Study|Pregnancy|1|||
27789161|NCT02232698|54244075|FG000|Overall Study|Met exclusion criteria|1|||
27789162|NCT02232698|54244076|FG001|Overall Study|Met exclusion criteria|1|||
27789163|NCT02232698|54244075|FG000|Overall Study|Had device-associated symptoms|7|||
27789164|NCT02232698|54244076|FG001|Overall Study|Had device-associated symptoms|0|||
27789165|NCT02232698|54244075|FG000|Overall Study|Non-compliance with study device|1|||
27789166|NCT02232698|54244076|FG001|Overall Study|Non-compliance with study device|4|||
27789167|NCT02232698|54244075|FG000|Overall Study|Allocated to control group|0|||
27789168|NCT02232698|54244076|FG001|Overall Study|Allocated to control group|3|||
27789169|NCT02232698|54244075|FG000|Overall Study|Withdrawal by Subject|0|||
27789170|NCT02232698|54244076|FG001|Overall Study|Withdrawal by Subject|11|||
27789171|NCT01632878|54244084|FG000|Screening|Physician Decision|268|||
27789172|NCT01632878|54244084|FG000|Treatment|Lost to Follow-up|41|||
27789173|NCT01632878|54244084|FG000|Treatment|Withdrawal by Subject|36|||
27789174|NCT01632878|54244084|FG000|Treatment|Physician Decision|34|||
27789175|NCT01632878|54244084|FG000|Treatment|missing information|4|||
27789176|NCT01632878|54244084|FG000|Treatment|no information on study completion|43|||
27789177|NCT01632800|54244088|FG000|Overall Study|Subject did not fit in apparatus|1|||
27789178|NCT01641809|54244096|FG000|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
27789179|NCT01641809|54244097|FG001|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
27789180|NCT01641809|54244098|FG002|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0|||
27789181|NCT01641809|54244099|FG003|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
27789182|NCT01641809|54244096|FG000|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
27789183|NCT01641809|54244097|FG001|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
27789184|NCT01641809|54244098|FG002|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
27789185|NCT01641809|54244099|FG003|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
27789186|NCT01641809|54244096|FG000|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1|||
27789187|NCT01641809|54244097|FG001|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2|||
27789188|NCT01641809|54244098|FG002|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0|||
27789189|NCT01641809|54244099|FG003|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3|||
27789190|NCT01641809|54244096|FG000|Induction Phase (Day 1 to Week 24)|Protocol Violation|2|||
27789191|NCT01641809|54244097|FG001|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
27789192|NCT01641809|54244098|FG002|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
27789193|NCT01641809|54244099|FG003|Induction Phase (Day 1 to Week 24)|Protocol Violation|0|||
27789194|NCT01641809|54244096|FG000|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4|||
27789195|NCT01641809|54244097|FG001|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1|||
27789196|NCT01641809|54244098|FG002|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2|||
27789197|NCT01641809|54244099|FG003|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3|||
27789198|NCT01641809|54244096|FG000|Induction Phase (Day 1 to Week 24)|Adverse Event|0|||
27789199|NCT01641809|54244097|FG001|Induction Phase (Day 1 to Week 24)|Adverse Event|1|||
27789200|NCT01641809|54244098|FG002|Induction Phase (Day 1 to Week 24)|Adverse Event|3|||
27789201|NCT01641809|54244099|FG003|Induction Phase (Day 1 to Week 24)|Adverse Event|7|||
27789202|NCT01641809|54244096|FG000|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2|||
27789203|NCT01641809|54244097|FG001|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3|||
27789204|NCT01641809|54244098|FG002|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1|||
27789205|NCT01641809|54244099|FG003|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0|||
27789206|NCT01641809|54244096|FG000|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
27789207|NCT01641809|54244097|FG001|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1|||
27789208|NCT01641809|54244098|FG002|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
27789209|NCT01641809|54244099|FG003|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
27789210|NCT01641809|54244096|FG000|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
27789211|NCT01641809|54244097|FG001|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0|||
27789212|NCT01641809|54244098|FG002|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1|||
27933752|NCT01136733|54590284|FG005|Phase 1b|Clinical Progression|0|||
27933753|NCT01136733|54590285|FG006|Phase 1b|Clinical Progression|0|||
27933754|NCT01136733|54590279|FG000|Phase 2|Disease Progression|0|||
27789213|NCT01641809|54244099|FG003|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
27933755|NCT01136733|54590280|FG001|Phase 2|Disease Progression|0|||
27789214|NCT01641809|54244096|FG000|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
27789215|NCT01641809|54244097|FG001|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
27842467|NCT01445951|54330988|FG002|Overall Study|Pregnancy|4|||
27933756|NCT01136733|54590281|FG002|Phase 2|Disease Progression|0|||
28105595|NCT04883541|54763035|FG001|Overall Study|Not attending the pregnancy school|9|||
27933757|NCT01136733|54590282|FG003|Phase 2|Disease Progression|0|||
27933758|NCT01136733|54590283|FG004|Phase 2|Disease Progression|30|||
27933759|NCT01136733|54590284|FG005|Phase 2|Disease Progression|32|||
27933760|NCT01136733|54590285|FG006|Phase 2|Disease Progression|38|||
27933761|NCT01136733|54590279|FG000|Phase 2|Adverse Event|0|||
27933762|NCT01136733|54590280|FG001|Phase 2|Adverse Event|0|||
27933763|NCT01136733|54590281|FG002|Phase 2|Adverse Event|0|||
27933764|NCT01136733|54590282|FG003|Phase 2|Adverse Event|0|||
27933765|NCT01136733|54590283|FG004|Phase 2|Adverse Event|11|||
27933766|NCT01136733|54590284|FG005|Phase 2|Adverse Event|13|||
27933767|NCT01136733|54590285|FG006|Phase 2|Adverse Event|5|||
27933768|NCT01136733|54590279|FG000|Phase 2|Participant Choice|0|||
27933769|NCT01136733|54590280|FG001|Phase 2|Participant Choice|0|||
27933770|NCT01136733|54590281|FG002|Phase 2|Participant Choice|0|||
27933771|NCT01136733|54590282|FG003|Phase 2|Participant Choice|0|||
27933772|NCT01136733|54590283|FG004|Phase 2|Participant Choice|3|||
27933773|NCT01136733|54590284|FG005|Phase 2|Participant Choice|0|||
27933774|NCT01136733|54590285|FG006|Phase 2|Participant Choice|1|||
27933775|NCT01136733|54590279|FG000|Phase 2|Administrative-Withdrew Consent|0|||
27933776|NCT01136733|54590280|FG001|Phase 2|Administrative-Withdrew Consent|0|||
27933777|NCT01136733|54590281|FG002|Phase 2|Administrative-Withdrew Consent|0|||
27933778|NCT01136733|54590282|FG003|Phase 2|Administrative-Withdrew Consent|0|||
27933779|NCT01136733|54590283|FG004|Phase 2|Administrative-Withdrew Consent|1|||
27933780|NCT01136733|54590284|FG005|Phase 2|Administrative-Withdrew Consent|0|||
27933781|NCT01136733|54590285|FG006|Phase 2|Administrative-Withdrew Consent|0|||
27933782|NCT01136733|54590279|FG000|Phase 2|Other|0|||
27933783|NCT01136733|54590280|FG001|Phase 2|Other|0|||
27933784|NCT01136733|54590281|FG002|Phase 2|Other|0|||
27933785|NCT01136733|54590282|FG003|Phase 2|Other|0|||
27933786|NCT01136733|54590283|FG004|Phase 2|Other|6|||
27933787|NCT01136733|54590284|FG005|Phase 2|Other|7|||
27933788|NCT01136733|54590285|FG006|Phase 2|Other|6|||
27933789|NCT01136655|54590315|FG000|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1|||
27933790|NCT01136655|54590315|FG000|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1|||
27933791|NCT01136655|54590315|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1|||
27933792|NCT01136655|54590315|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1|||
27933793|NCT01135017|54590330|FG000|Overall Study|Adverse Event|3|||
27933794|NCT01135017|54590331|FG001|Overall Study|Adverse Event|8|||
27933795|NCT01135017|54590330|FG000|Overall Study|Other than above|3|||
27933796|NCT01135017|54590331|FG001|Overall Study|Other than above|4|||
27933797|NCT01134939|54590345|FG000|Overall Study|Adverse Event|9|||
27933798|NCT01134939|54590346|FG001|Overall Study|Adverse Event|3|||
27933799|NCT01134939|54590347|FG002|Overall Study|Adverse Event|4|||
27933800|NCT01134939|54590348|FG003|Overall Study|Adverse Event|5|||
27933801|NCT01134939|54590349|FG004|Overall Study|Adverse Event|5|||
27933802|NCT01134939|54590350|FG005|Overall Study|Adverse Event|5|||
27933803|NCT01134939|54590351|FG006|Overall Study|Adverse Event|1|||
27933804|NCT01134939|54590352|FG007|Overall Study|Adverse Event|0|||
27933805|NCT01134939|54590345|FG000|Overall Study|Lack of Efficacy|2|||
27933806|NCT01134939|54590346|FG001|Overall Study|Lack of Efficacy|5|||
27933807|NCT01134939|54590347|FG002|Overall Study|Lack of Efficacy|1|||
27933808|NCT01134939|54590348|FG003|Overall Study|Lack of Efficacy|0|||
27933809|NCT01134939|54590349|FG004|Overall Study|Lack of Efficacy|3|||
27933810|NCT01134939|54590350|FG005|Overall Study|Lack of Efficacy|0|||
27933811|NCT01134939|54590351|FG006|Overall Study|Lack of Efficacy|1|||
27933812|NCT01134939|54590352|FG007|Overall Study|Lack of Efficacy|0|||
27933813|NCT01134939|54590345|FG000|Overall Study|Lost to Follow-up|2|||
27933814|NCT01134939|54590346|FG001|Overall Study|Lost to Follow-up|3|||
27933815|NCT01134939|54590347|FG002|Overall Study|Lost to Follow-up|0|||
27933816|NCT01134939|54590348|FG003|Overall Study|Lost to Follow-up|1|||
27933817|NCT01134939|54590349|FG004|Overall Study|Lost to Follow-up|2|||
27933818|NCT01134939|54590350|FG005|Overall Study|Lost to Follow-up|1|||
27933819|NCT01134939|54590351|FG006|Overall Study|Lost to Follow-up|0|||
27933820|NCT01134939|54590352|FG007|Overall Study|Lost to Follow-up|0|||
27933821|NCT01134939|54590345|FG000|Overall Study|Death|0|||
27933822|NCT01134939|54590346|FG001|Overall Study|Death|1|||
27933823|NCT01134939|54590347|FG002|Overall Study|Death|0|||
27933824|NCT01134939|54590348|FG003|Overall Study|Death|0|||
27933825|NCT01134939|54590349|FG004|Overall Study|Death|0|||
27933826|NCT01134939|54590350|FG005|Overall Study|Death|0|||
27933827|NCT01134939|54590351|FG006|Overall Study|Death|0|||
27933828|NCT01134939|54590352|FG007|Overall Study|Death|0|||
27933829|NCT01134939|54590345|FG000|Overall Study|Termination page not available|4|||
27933830|NCT01134939|54590346|FG001|Overall Study|Termination page not available|6|||
27933831|NCT01134939|54590347|FG002|Overall Study|Termination page not available|5|||
27933832|NCT01134939|54590348|FG003|Overall Study|Termination page not available|8|||
27933833|NCT01134939|54590349|FG004|Overall Study|Termination page not available|0|||
27933834|NCT01134939|54590350|FG005|Overall Study|Termination page not available|3|||
27933835|NCT01134939|54590351|FG006|Overall Study|Termination page not available|7|||
27933836|NCT01134939|54590352|FG007|Overall Study|Termination page not available|0|||
27933837|NCT01134783|54590368|FG000|Overall Study|Pregnancy|16|||
27933838|NCT01134783|54590369|FG001|Overall Study|Pregnancy|8|||
27933839|NCT01134783|54590368|FG000|Overall Study|Withdrawal by Subject|15|||
27933840|NCT01134783|54590369|FG001|Overall Study|Withdrawal by Subject|9|||
27933841|NCT01134783|54590368|FG000|Overall Study|Lost to Follow-up|5|||
27933842|NCT01134783|54590369|FG001|Overall Study|Lost to Follow-up|20|||
27933843|NCT01134705|54590381|FG000|Overall Study|Adverse Event|1|||
27933844|NCT01134705|54590382|FG001|Overall Study|Adverse Event|7|||
27933845|NCT01134705|54590381|FG000|Overall Study|Withdrawal by Subject|6|||
27933846|NCT01134705|54590382|FG001|Overall Study|Withdrawal by Subject|6|||
27933847|NCT01134705|54590381|FG000|Overall Study|Pregnancy|1|||
27933848|NCT01134705|54590382|FG001|Overall Study|Pregnancy|0|||
27933849|NCT01134705|54590381|FG000|Overall Study|Lost to Follow-up|5|||
27933850|NCT01134705|54590382|FG001|Overall Study|Lost to Follow-up|2|||
27933851|NCT01134705|54590381|FG000|Overall Study|Protocol Violation|1|||
27933852|NCT01134705|54590382|FG001|Overall Study|Protocol Violation|1|||
27933853|NCT01134705|54590381|FG000|Overall Study|Other|1|||
27933854|NCT01134705|54590382|FG001|Overall Study|Other|6|||
27933855|NCT00927823|54590388|FG000|Continuous Dosing Period|Death|0|||
27933856|NCT00927823|54590389|FG001|Continuous Dosing Period|Death|0|||
27933857|NCT00927823|54590390|FG002|Continuous Dosing Period|Death|6|||
27933858|NCT00927823|54590391|FG003|Continuous Dosing Period|Death|0|||
27933859|NCT00927823|54590388|FG000|Continuous Dosing Period|Lost to Follow-up|1|||
27933860|NCT00927823|54590389|FG001|Continuous Dosing Period|Lost to Follow-up|1|||
27933861|NCT00927823|54590390|FG002|Continuous Dosing Period|Lost to Follow-up|9|||
27933862|NCT00927823|54590391|FG003|Continuous Dosing Period|Lost to Follow-up|0|||
27933863|NCT00927823|54590388|FG000|Continuous Dosing Period|Withdrawal by Subject|1|||
27933864|NCT00927823|54590389|FG001|Continuous Dosing Period|Withdrawal by Subject|0|||
27933865|NCT00927823|54590390|FG002|Continuous Dosing Period|Withdrawal by Subject|2|||
27933866|NCT00927823|54590391|FG003|Continuous Dosing Period|Withdrawal by Subject|2|||
27933867|NCT00927823|54590388|FG000|Continuous Dosing Period|Other|1|||
27933868|NCT00927823|54590389|FG001|Continuous Dosing Period|Other|2|||
27933869|NCT00927823|54590390|FG002|Continuous Dosing Period|Other|9|||
27933870|NCT00927823|54590391|FG003|Continuous Dosing Period|Other|3|||
27933871|NCT01134627|54590410|FG000|Overall Study|Adverse Event|47|||
27933872|NCT01134627|54590411|FG001|Overall Study|Adverse Event|31|||
27933873|NCT01134627|54590410|FG000|Overall Study|Lost to Follow-up|1|||
27933874|NCT01134627|54590411|FG001|Overall Study|Lost to Follow-up|2|||
27933875|NCT01134627|54590410|FG000|Overall Study|Protocol Violation|3|||
27842468|NCT01445951|54330986|FG000|Overall Study|Death|0|||
27933876|NCT01134627|54590411|FG001|Overall Study|Protocol Violation|5|||
27933877|NCT01134627|54590410|FG000|Overall Study|Lack of Efficacy|2|||
27933878|NCT01134627|54590411|FG001|Overall Study|Lack of Efficacy|12|||
27933879|NCT01134627|54590410|FG000|Overall Study|Withdrawal by Subject|4|||
27933880|NCT01134627|54590411|FG001|Overall Study|Withdrawal by Subject|3|||
27933881|NCT01134627|54590410|FG000|Overall Study|Planning to become pregnant/pregnancy|1|||
27933882|NCT01134627|54590411|FG001|Overall Study|Planning to become pregnant/pregnancy|0|||
27933883|NCT01134627|54590410|FG000|Overall Study|Other|11|||
27933884|NCT01134627|54590411|FG001|Overall Study|Other|14|||
27933885|NCT01134393|54590417|FG000|Overall Study|Adverse Event|18|||
27933886|NCT01134393|54590417|FG000|Overall Study|Lack of Efficacy|2|||
27933887|NCT01134393|54590417|FG000|Overall Study|Protocol Violation|12|||
27933888|NCT01134393|54590417|FG000|Overall Study|Lost to Follow-up|3|||
27933889|NCT01134393|54590417|FG000|Overall Study|Withdrawal by Subject|11|||
27933890|NCT01134393|54590417|FG000|Overall Study|Other|6|||
27933891|NCT00922441|54590425|FG000|Overall Study|Protocol Violation|0|||
27933892|NCT00922441|54590426|FG001|Overall Study|Protocol Violation|0|||
27933893|NCT00922441|54590427|FG002|Overall Study|Protocol Violation|2|||
27933894|NCT00922441|54590425|FG000|Overall Study|Withdrawal by Subject|0|||
27933895|NCT00922441|54590426|FG001|Overall Study|Withdrawal by Subject|0|||
27789216|NCT01641809|54244098|FG002|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0|||
27789217|NCT01641809|54244099|FG003|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2|||
27789218|NCT01641809|54244096|FG000|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
27789219|NCT01641809|54244097|FG001|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0|||
27789220|NCT01641809|54244098|FG002|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
27789221|NCT01641809|54244099|FG003|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2|||
27789222|NCT01641809|54244096|FG000|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2|||
27789223|NCT01641809|54244097|FG001|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3|||
27789224|NCT01641809|54244098|FG002|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1|||
27789225|NCT01641809|54244099|FG003|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0|||
27789226|NCT01641809|54244096|FG000|Open-label (Week 96 to Week 324)|Physician Decision|0|||
27789227|NCT01641809|54244097|FG001|Open-label (Week 96 to Week 324)|Physician Decision|1|||
27789228|NCT01641809|54244098|FG002|Open-label (Week 96 to Week 324)|Physician Decision|1|||
27789229|NCT01641809|54244099|FG003|Open-label (Week 96 to Week 324)|Physician Decision|0|||
27789230|NCT01641809|54244096|FG000|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
27789231|NCT01641809|54244097|FG001|Open-label (Week 96 to Week 324)|Lost to Follow-up|4|||
27789232|NCT01641809|54244098|FG002|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
27789233|NCT01641809|54244099|FG003|Open-label (Week 96 to Week 324)|Lost to Follow-up|0|||
27789234|NCT01641809|54244096|FG000|Open-label (Week 96 to Week 324)|Site closed|1|||
27933896|NCT00922441|54590427|FG002|Overall Study|Withdrawal by Subject|1|||
27933897|NCT01217112|54590440|FG000|Overall Study|Adverse Event|0|||
27933898|NCT01217112|54590441|FG001|Overall Study|Adverse Event|2|||
27933899|NCT01217112|54590442|FG002|Overall Study|Adverse Event|0|||
27933900|NCT01217112|54590443|FG003|Overall Study|Adverse Event|2|||
27933901|NCT01217112|54590444|FG004|Overall Study|Adverse Event|0|||
27933902|NCT01217112|54590440|FG000|Overall Study|Withdrawal by Subject|0|||
27933903|NCT01217112|54590441|FG001|Overall Study|Withdrawal by Subject|0|||
27933904|NCT01217112|54590442|FG002|Overall Study|Withdrawal by Subject|1|||
27933905|NCT01217112|54590443|FG003|Overall Study|Withdrawal by Subject|0|||
27933906|NCT01217112|54590444|FG004|Overall Study|Withdrawal by Subject|0|||
27933907|NCT01217112|54590440|FG000|Overall Study|Physician Decision|0|||
27933908|NCT01217112|54590441|FG001|Overall Study|Physician Decision|0|||
27933909|NCT01217112|54590442|FG002|Overall Study|Physician Decision|0|||
27933910|NCT01217112|54590443|FG003|Overall Study|Physician Decision|0|||
27933911|NCT01217112|54590444|FG004|Overall Study|Physician Decision|1|||
27933912|NCT01216332|54590458|FG000|Overall Study|Withdrawal by Subject|4|||
27933913|NCT01216332|54590459|FG001|Overall Study|Withdrawal by Subject|0|||
27933914|NCT00922207|54590468|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
27933915|NCT00922207|54590469|FG001|Overall Study|Adverse Event/Intercurrent Illness|0|||
27933916|NCT00922207|54590470|FG002|Overall Study|Adverse Event/Intercurrent Illness|0|||
27933917|NCT00922207|54590468|FG000|Overall Study|Insufficient Therapeutic Response|0|||
27933918|NCT00922207|54590469|FG001|Overall Study|Insufficient Therapeutic Response|0|||
27933919|NCT00922207|54590470|FG002|Overall Study|Insufficient Therapeutic Response|1|||
27933920|NCT00922207|54590468|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
27789235|NCT01641809|54244097|FG001|Open-label (Week 96 to Week 324)|Site closed|0|||
27789236|NCT01641809|54244098|FG002|Open-label (Week 96 to Week 324)|Site closed|0|||
27933921|NCT00922207|54590469|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
27933922|NCT00922207|54590470|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
27933923|NCT00922207|54590468|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
27933924|NCT00922207|54590469|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
27933925|NCT00922207|54590470|FG002|Overall Study|Refused Treatment/Did Not Cooperate|0|||
27933926|NCT00922207|54590468|FG000|Overall Study|Withdrew Consent|2|||
27933927|NCT00922207|54590469|FG001|Overall Study|Withdrew Consent|5|||
27933928|NCT00922207|54590470|FG002|Overall Study|Withdrew Consent|2|||
27933929|NCT00922207|54590468|FG000|Overall Study|Abnormality of Laboratory Test|0|||
27933930|NCT00922207|54590469|FG001|Overall Study|Abnormality of Laboratory Test|1|||
27933931|NCT00922207|54590470|FG002|Overall Study|Abnormality of Laboratory Test|1|||
27933932|NCT01134315|54590480|FG000|Overall Study|Adverse Event|1|||
27933933|NCT01134315|54590481|FG001|Overall Study|Adverse Event|2|||
27933934|NCT01134315|54590480|FG000|Overall Study|Other Reason|8|||
27933935|NCT01134315|54590481|FG001|Overall Study|Other Reason|17|||
27933936|NCT01216176|54590490|FG000|Overall Study|Adverse Event|0|||
27933937|NCT01216176|54590491|FG001|Overall Study|Adverse Event|8|||
27933938|NCT01216176|54590492|FG002|Overall Study|Adverse Event|0|||
27933939|NCT01216176|54590490|FG000|Overall Study|Physician Decision|0|||
27933940|NCT01216176|54590491|FG001|Overall Study|Physician Decision|0|||
27933941|NCT01216176|54590492|FG002|Overall Study|Physician Decision|1|||
27933942|NCT01133847|54590504|FG000|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5|||
27933943|NCT01133847|54590505|FG001|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1|||
27933944|NCT01133847|54590506|FG002|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3|||
27933945|NCT01133847|54590504|FG000|Follow-Up Phase|Lost to Follow-up|1|||
27933946|NCT01133847|54590505|FG001|Follow-Up Phase|Lost to Follow-up|3|||
27933947|NCT01133847|54590506|FG002|Follow-Up Phase|Lost to Follow-up|7|||
27933948|NCT01133379|54590518|FG000|Overall Study|Withdrawal by Subject|0|||
27933949|NCT01133379|54590519|FG001|Overall Study|Withdrawal by Subject|1|||
27933950|NCT01133379|54590520|FG002|Overall Study|Withdrawal by Subject|1|||
27933951|NCT01133379|54590518|FG000|Overall Study|Lost to Follow-up|1|||
27933952|NCT01133379|54590519|FG001|Overall Study|Lost to Follow-up|1|||
27933953|NCT01133379|54590520|FG002|Overall Study|Lost to Follow-up|1|||
27933954|NCT01133067|54590528|FG000|Overall Study|Death|136|||
27933955|NCT01133067|54590528|FG000|Overall Study|Lost to Follow-up|3|||
27933956|NCT01132755|54590532|FG000|Overall Study|Procedure not done due to medical reason|23|||
27933957|NCT01132755|54590532|FG000|Overall Study|Protocol Violation|15|||
27933958|NCT01132755|54590532|FG000|Overall Study|Withdrawal by Subject|4|||
27933959|NCT00919711|54590538|FG000|Overall Study|Withdrawal by Subject|15|||
27933960|NCT00919711|54590539|FG001|Overall Study|Withdrawal by Subject|7|||
27933961|NCT00919711|54590538|FG000|Overall Study|Adverse Event|13|||
27933962|NCT00919711|54590539|FG001|Overall Study|Adverse Event|3|||
27933963|NCT00919711|54590538|FG000|Overall Study|Other|1|||
27933964|NCT00919711|54590539|FG001|Overall Study|Other|2|||
27933965|NCT00919711|54590538|FG000|Overall Study|Administrative Decision|0|||
27933966|NCT00919711|54590539|FG001|Overall Study|Administrative Decision|1|||
27933967|NCT00919711|54590538|FG000|Overall Study|Lost to Follow-up|2|||
27933968|NCT00919711|54590539|FG001|Overall Study|Lost to Follow-up|0|||
27933969|NCT00919711|54590538|FG000|Overall Study|Death|1|||
27933970|NCT00919711|54590539|FG001|Overall Study|Death|0|||
27933971|NCT00919711|54590538|FG000|Overall Study|Noncompliance|1|||
27933972|NCT00919711|54590539|FG001|Overall Study|Noncompliance|0|||
27933973|NCT01131585|54590547|FG000|Overall Study|Adverse Event|0|||
27933974|NCT01131585|54590548|FG001|Overall Study|Adverse Event|2|||
27933975|NCT01131585|54590547|FG000|Overall Study|Abnormal laboratory value|1|||
27933976|NCT01131585|54590548|FG001|Overall Study|Abnormal laboratory value|0|||
27933977|NCT01131585|54590547|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
27933978|NCT01131585|54590548|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
27933979|NCT01131585|54590547|FG000|Overall Study|Protocol Violation|2|||
27933980|NCT01131585|54590548|FG001|Overall Study|Protocol Violation|1|||
27933981|NCT01131585|54590547|FG000|Overall Study|Withdrawal by Subject|3|||
27933982|NCT01131585|54590548|FG001|Overall Study|Withdrawal by Subject|3|||
27933983|NCT01131585|54590547|FG000|Overall Study|Lost to Follow-up|0|||
27933984|NCT01131585|54590548|FG001|Overall Study|Lost to Follow-up|1|||
27933985|NCT01131585|54590547|FG000|Overall Study|Administrative problems|1|||
27933986|NCT01131585|54590548|FG001|Overall Study|Administrative problems|1|||
27933987|NCT01131585|54590547|FG000|Overall Study|Study termination|78|||
27933988|NCT01131585|54590548|FG001|Overall Study|Study termination|32|||
27933989|NCT01131507|54590554|FG000|Overall Study|Adverse Event|1|||
27933990|NCT01131507|54590554|FG000|Overall Study|Lost to Follow-up|1|||
27933991|NCT01131507|54590554|FG000|Overall Study|Withdrawal by Subject|1|||
27933992|NCT01131351|54590560|FG000|Overall Study|Adverse Event|0|||
27933993|NCT01131351|54590561|FG001|Overall Study|Adverse Event|2|||
27933994|NCT01131351|54590560|FG000|Overall Study|Protocol Deviation|0|||
27933995|NCT01131351|54590561|FG001|Overall Study|Protocol Deviation|1|||
27933996|NCT00919633|54590571|FG000|Overall Study|Adverse Event|1|||
27933997|NCT00919633|54590572|FG001|Overall Study|Adverse Event|9|||
27933998|NCT00919633|54590573|FG002|Overall Study|Adverse Event|12|||
27933999|NCT00919633|54590574|FG003|Overall Study|Adverse Event|10|||
27934000|NCT00919633|54590571|FG000|Overall Study|Death|0|||
27842469|NCT01445951|54330987|FG001|Overall Study|Death|0|||
27934001|NCT00919633|54590572|FG001|Overall Study|Death|0|||
27934002|NCT00919633|54590573|FG002|Overall Study|Death|2|||
27934003|NCT00919633|54590574|FG003|Overall Study|Death|0|||
27934004|NCT00919633|54590571|FG000|Overall Study|Lack of Efficacy|17|||
27934005|NCT00919633|54590572|FG001|Overall Study|Lack of Efficacy|3|||
27934006|NCT00919633|54590573|FG002|Overall Study|Lack of Efficacy|2|||
27934007|NCT00919633|54590574|FG003|Overall Study|Lack of Efficacy|3|||
27934008|NCT00919633|54590571|FG000|Overall Study|Withdrawal by Subject|1|||
27934009|NCT00919633|54590572|FG001|Overall Study|Withdrawal by Subject|2|||
27934010|NCT00919633|54590573|FG002|Overall Study|Withdrawal by Subject|4|||
27934011|NCT00919633|54590574|FG003|Overall Study|Withdrawal by Subject|3|||
27934012|NCT00919633|54590571|FG000|Overall Study|Lost to Follow-up|3|||
27934013|NCT00919633|54590572|FG001|Overall Study|Lost to Follow-up|1|||
27934014|NCT00919633|54590573|FG002|Overall Study|Lost to Follow-up|0|||
27934015|NCT00919633|54590574|FG003|Overall Study|Lost to Follow-up|2|||
27934016|NCT00919633|54590571|FG000|Overall Study|Withdraw consent post transition to SOC|0|||
27934017|NCT00919633|54590572|FG001|Overall Study|Withdraw consent post transition to SOC|0|||
27934018|NCT00919633|54590573|FG002|Overall Study|Withdraw consent post transition to SOC|1|||
27934019|NCT00919633|54590574|FG003|Overall Study|Withdraw consent post transition to SOC|1|||
27934020|NCT00919633|54590571|FG000|Overall Study|Protocol Violation|0|||
27934021|NCT00919633|54590572|FG001|Overall Study|Protocol Violation|0|||
27934022|NCT00919633|54590573|FG002|Overall Study|Protocol Violation|0|||
27934023|NCT00919633|54590574|FG003|Overall Study|Protocol Violation|1|||
27934024|NCT00919633|54590571|FG000|Overall Study|Physician Decision|0|||
27934025|NCT00919633|54590572|FG001|Overall Study|Physician Decision|0|||
27934026|NCT00919633|54590573|FG002|Overall Study|Physician Decision|0|||
27934027|NCT00919633|54590574|FG003|Overall Study|Physician Decision|1|||
27934028|NCT00919633|54590571|FG000|Overall Study|Request of withdrawal w/o future contact|0|||
27934029|NCT00919633|54590572|FG001|Overall Study|Request of withdrawal w/o future contact|0|||
27934030|NCT00919633|54590573|FG002|Overall Study|Request of withdrawal w/o future contact|1|||
27934031|NCT00919633|54590574|FG003|Overall Study|Request of withdrawal w/o future contact|0|||
27934032|NCT00919633|54590571|FG000|Overall Study|Viral rebound outside protocol timepoint|0|||
27934033|NCT00919633|54590572|FG001|Overall Study|Viral rebound outside protocol timepoint|0|||
27934034|NCT00919633|54590573|FG002|Overall Study|Viral rebound outside protocol timepoint|1|||
27934035|NCT00919633|54590574|FG003|Overall Study|Viral rebound outside protocol timepoint|0|||
27934036|NCT01130883|54590584|FG000|Overall Study|Patient Noncompliance|6|||
27934037|NCT01130883|54590584|FG000|Overall Study|Reason Unknown|1|||
27934038|NCT01130883|54590584|FG000|Overall Study|Adverse Event|3|||
27934039|NCT00926029|54590591|FG000|Overall Study|Lost to Follow-up|2|||
27934040|NCT00926029|54590592|FG001|Overall Study|Lost to Follow-up|1|||
27934041|NCT00926029|54590593|FG002|Overall Study|Lost to Follow-up|1|||
27934042|NCT01130493|54590603|FG000|Open-label Dose Conversion to IPX066|Adverse Event|1|||
27934043|NCT01130493|54590604|FG001|Open-label Dose Conversion to IPX066|Adverse Event|0|||
27934044|NCT01130493|54590605|FG002|Open-label Dose Conversion to IPX066|Adverse Event|0|||
27934045|NCT01130493|54590603|FG000|Open-label Dose Conversion to IPX066|Protocol Violation|3|||
27934046|NCT01130493|54590604|FG001|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
27934047|NCT01130493|54590605|FG002|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
27934048|NCT01130493|54590603|FG000|Open-label Dose Conversion to IPX066|Lack of Efficacy|7|||
27934049|NCT01130493|54590604|FG001|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
27934050|NCT01130493|54590605|FG002|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
27934051|NCT01130493|54590603|FG000|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7|||
27934052|NCT01130493|54590604|FG001|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
27934053|NCT01130493|54590605|FG002|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
27934054|NCT01130493|54590603|FG000|Open-label Dose Conversion to IPX066|Diary imcomplete|1|||
27934055|NCT01130493|54590604|FG001|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
27934056|NCT01130493|54590605|FG002|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
27934057|NCT01130493|54590603|FG000|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
27934058|NCT01130493|54590604|FG001|Part 1: Double-blind Treatment Period 1|Protocol Violation|1|||
27934059|NCT01130493|54590605|FG002|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
27934060|NCT01130493|54590603|FG000|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
27934061|NCT01130493|54590604|FG001|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1|||
27934062|NCT01130493|54590605|FG002|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
27934063|NCT01130493|54590603|FG000|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
27934064|NCT01130493|54590604|FG001|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1|||
27934065|NCT01130493|54590605|FG002|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
27934066|NCT01130493|54590603|FG000|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
27934067|NCT01130493|54590604|FG001|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
27934068|NCT01130493|54590605|FG002|Part 1: Open-Label IPX066 Washout|Adverse Event|1|||
28017015|NCT00663702|54676250|FG000|Overall Study|Lack of Efficacy|3|||
28017016|NCT00663702|54676251|FG001|Overall Study|Lack of Efficacy|3|||
27934069|NCT01130493|54590603|FG000|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
27934070|NCT01130493|54590604|FG001|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
27934071|NCT01130493|54590605|FG002|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1|||
27934072|NCT01130493|54590603|FG000|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
27934073|NCT01130493|54590604|FG001|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
27934074|NCT01130493|54590605|FG002|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1|||
27934075|NCT01130493|54590603|FG000|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
27934076|NCT01130493|54590604|FG001|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
27934077|NCT01130493|54590605|FG002|Part 1: Double-blind Treatment Period 2|Noncompliance|1|||
27934078|NCT01130493|54590603|FG000|Part 2: OLE|Adverse Event|0|||
27934079|NCT01130493|54590604|FG001|Part 2: OLE|Adverse Event|2|||
27934080|NCT01130493|54590605|FG002|Part 2: OLE|Adverse Event|1|||
27934081|NCT01130493|54590603|FG000|Part 2: OLE|Withdrawal by Subject|0|||
27934082|NCT01130493|54590604|FG001|Part 2: OLE|Withdrawal by Subject|1|||
27934083|NCT01130493|54590605|FG002|Part 2: OLE|Withdrawal by Subject|4|||
27934084|NCT01130337|54590616|FG000|Overall Study|Withdrawal by Subject|3|||
27934085|NCT01130337|54590616|FG000|Overall Study|Principal investigator decision|1|||
27934086|NCT01130337|54590616|FG000|Overall Study|Death|1|||
27934087|NCT01130337|54590616|FG000|Overall Study|Disease progression|1|||
27934088|NCT01130337|54590616|FG000|Overall Study|Toxicity, AE/intercurrent disease|7|||
27934089|NCT01130337|54590616|FG000|Overall Study|Surgical resection (R2)|1|||
27934090|NCT01130103|54590622|FG000|Randomized Treatment|Adverse Event|1|||
27934091|NCT01130103|54590623|FG001|Randomized Treatment|Adverse Event|1|||
27934092|NCT01130103|54590622|FG000|Randomized Treatment|Lost to Follow-up|1|||
27934093|NCT01130103|54590623|FG001|Randomized Treatment|Lost to Follow-up|0|||
27934094|NCT01130103|54590622|FG000|Randomized Treatment|Protocol Violation|3|||
27934095|NCT01130103|54590623|FG001|Randomized Treatment|Protocol Violation|2|||
27934096|NCT01130103|54590622|FG000|Randomized Treatment|Withdrawal by Subject|1|||
27934097|NCT01130103|54590623|FG001|Randomized Treatment|Withdrawal by Subject|2|||
27934098|NCT01130103|54590622|FG000|Maintenance Treatment|Lack of Efficacy|0|||
27934099|NCT01130103|54590623|FG001|Maintenance Treatment|Lack of Efficacy|1|||
27934100|NCT01130103|54590622|FG000|Maintenance Treatment|Lost to Follow-up|1|||
27934101|NCT01130103|54590623|FG001|Maintenance Treatment|Lost to Follow-up|1|||
27934102|NCT01130103|54590622|FG000|Maintenance Treatment|Withdrawal by Subject|1|||
27934103|NCT01130103|54590623|FG001|Maintenance Treatment|Withdrawal by Subject|0|||
27934104|NCT01129557|54590632|FG000|Overall Study|Adverse Event|1|||
27934105|NCT01129557|54590633|FG001|Overall Study|Adverse Event|2|||
27934106|NCT01129557|54590634|FG002|Overall Study|Adverse Event|2|||
27934107|NCT01129557|54590632|FG000|Overall Study|Novartis terminated study early|3|||
27934108|NCT01129557|54590633|FG001|Overall Study|Novartis terminated study early|3|||
27934109|NCT01129557|54590634|FG002|Overall Study|Novartis terminated study early|2|||
27934110|NCT01129011|54590655|FG000|Overall Study|Adverse Event|20|||
27934111|NCT01129011|54590656|FG001|Overall Study|Adverse Event|30|||
27934112|NCT01129011|54590655|FG000|Overall Study|Withdrawal by Subject|24|||
28017017|NCT00683618|54676260|FG000|Randomised Treatment Period|Withdrawal by Subject|4|||
28017018|NCT00683618|54676261|FG001|Randomised Treatment Period|Withdrawal by Subject|1|||
28017019|NCT00683618|54676262|FG002|Randomised Treatment Period|Withdrawal by Subject|2|||
28017020|NCT00683618|54676260|FG000|Randomised Treatment Period|Protocol Violation|0|||
27789237|NCT01641809|54244099|FG003|Open-label (Week 96 to Week 324)|Site closed|0|||
27789238|NCT01641809|54244096|FG000|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
27789239|NCT01641809|54244097|FG001|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
27789240|NCT01641809|54244098|FG002|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
27789241|NCT01641809|54244099|FG003|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
27789242|NCT01641809|54244096|FG000|Open-label (Week 96 to Week 324)|Lack of Efficacy|4|||
27789243|NCT01641809|54244097|FG001|Open-label (Week 96 to Week 324)|Lack of Efficacy|1|||
27789244|NCT01641809|54244098|FG002|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
27789245|NCT01641809|54244099|FG003|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
27789246|NCT01641809|54244096|FG000|Open-label (Week 96 to Week 324)|Adverse Event|3|||
27789247|NCT01641809|54244097|FG001|Open-label (Week 96 to Week 324)|Adverse Event|2|||
27789248|NCT01641809|54244098|FG002|Open-label (Week 96 to Week 324)|Adverse Event|1|||
27789249|NCT01641809|54244099|FG003|Open-label (Week 96 to Week 324)|Adverse Event|0|||
27789250|NCT01632566|54244122|FG000|Overall Study|Withdrawal by Subject|0|||
27789251|NCT01632566|54244123|FG001|Overall Study|Withdrawal by Subject|1|||
27789252|NCT01632566|54244124|FG002|Overall Study|Withdrawal by Subject|0|||
27789253|NCT01632566|54244125|FG003|Overall Study|Withdrawal by Subject|0|||
27789254|NCT01632566|54244126|FG004|Overall Study|Withdrawal by Subject|0|||
27934113|NCT01129011|54590656|FG001|Overall Study|Withdrawal by Subject|8|||
27934114|NCT01129011|54590655|FG000|Overall Study|Lost to Follow-up|6|||
27934115|NCT01129011|54590656|FG001|Overall Study|Lost to Follow-up|7|||
27934116|NCT01129011|54590655|FG000|Overall Study|Duodenal Ulcer|2|||
27934117|NCT01129011|54590656|FG001|Overall Study|Duodenal Ulcer|8|||
28017021|NCT00683618|54676261|FG001|Randomised Treatment Period|Protocol Violation|1|||
27789255|NCT01632566|54244122|FG000|Overall Study|Sponsor Decision|0|||
27789256|NCT01632566|54244123|FG001|Overall Study|Sponsor Decision|2|||
27934118|NCT01129011|54590655|FG000|Overall Study|misc|7|||
27934119|NCT01129011|54590656|FG001|Overall Study|misc|4|||
27934120|NCT00919867|54590668|FG000|First Intervention|Withdrawal by Subject|0|||
27934121|NCT00919867|54590669|FG001|First Intervention|Withdrawal by Subject|0|||
27934122|NCT00919867|54590670|FG002|First Intervention|Withdrawal by Subject|1|||
27934123|NCT00919867|54590671|FG003|First Intervention|Withdrawal by Subject|0|||
27934124|NCT00919867|54590672|FG004|First Intervention|Withdrawal by Subject|0|||
27934125|NCT00919867|54590673|FG005|First Intervention|Withdrawal by Subject|0|||
27934126|NCT00919867|54590668|FG000|First Intervention|Physician Decision|0|||
27934127|NCT00919867|54590669|FG001|First Intervention|Physician Decision|0|||
27934128|NCT00919867|54590670|FG002|First Intervention|Physician Decision|0|||
27934129|NCT00919867|54590671|FG003|First Intervention|Physician Decision|0|||
27934130|NCT00919867|54590672|FG004|First Intervention|Physician Decision|0|||
27934131|NCT00919867|54590673|FG005|First Intervention|Physician Decision|1|||
27934132|NCT01215942|54590683|FG000|Treatment Period|Adverse Event|15|||
27934133|NCT01215942|54590684|FG001|Treatment Period|Adverse Event|26|||
27934134|NCT01215942|54590683|FG000|Treatment Period|Death|2|||
27934135|NCT01215942|54590684|FG001|Treatment Period|Death|4|||
27934136|NCT01215942|54590683|FG000|Treatment Period|Lack of Efficacy|23|||
27934137|NCT01215942|54590684|FG001|Treatment Period|Lack of Efficacy|62|||
27934138|NCT01215942|54590683|FG000|Treatment Period|Lost to Follow-up|3|||
27934139|NCT01215942|54590684|FG001|Treatment Period|Lost to Follow-up|4|||
27934140|NCT01215942|54590683|FG000|Treatment Period|Withdrawal by Subject|17|||
27934141|NCT01215942|54590684|FG001|Treatment Period|Withdrawal by Subject|40|||
27934142|NCT01215942|54590683|FG000|Treatment Period|Physician Decision|5|||
27934143|NCT01215942|54590684|FG001|Treatment Period|Physician Decision|5|||
27934144|NCT01215942|54590683|FG000|Treatment Period|Protocol Violation|0|||
27934145|NCT01215942|54590684|FG001|Treatment Period|Protocol Violation|1|||
27934146|NCT01215942|54590683|FG000|Treatment Period|Sponsor Decision|349|||
27934147|NCT01215942|54590684|FG001|Treatment Period|Sponsor Decision|530|||
27934148|NCT01215942|54590683|FG000|Post-Treatment Follow-Up Period|Death|0|||
27934149|NCT01215942|54590684|FG001|Post-Treatment Follow-Up Period|Death|1|||
27934150|NCT01215942|54590683|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
27934151|NCT01215942|54590684|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
27934152|NCT01215942|54590683|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|43|||
27934153|NCT01215942|54590684|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|69|||
27934154|NCT01215942|54590683|FG000|Post-Treatment Follow-Up Period|Physician Decision|1|||
27934155|NCT01215942|54590684|FG001|Post-Treatment Follow-Up Period|Physician Decision|2|||
27934156|NCT01215942|54590683|FG000|Post-Treatment Follow-Up Period|Sponsor Decision|28|||
27934157|NCT01215942|54590684|FG001|Post-Treatment Follow-Up Period|Sponsor Decision|61|||
27934158|NCT01128621|54590703|FG000|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0|||
27934159|NCT01128621|54590704|FG001|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2|||
27934160|NCT00918463|54590726|FG000|Overall Study|Death|1|||
27934161|NCT00918463|54590726|FG000|Overall Study|Lack of Efficacy|1|||
27934162|NCT01128543|54590730|FG000|Overall Study|Withdrawal by Subject|3|||
27934163|NCT01128543|54590730|FG000|Overall Study|Protocol Violation|1|||
27934164|NCT01128387|54590736|FG000|Overall Study|Physician Decision|0|||
27934165|NCT01128387|54590737|FG001|Overall Study|Physician Decision|1|||
27934166|NCT01214850|54590746|FG000|Overall Study|Withdrawal by Subject|38|||
27934167|NCT01214850|54590747|FG001|Overall Study|Withdrawal by Subject|31|||
27934168|NCT01214850|54590748|FG002|Overall Study|Withdrawal by Subject|28|||
27934169|NCT01214850|54590746|FG000|Overall Study|Lost to Follow-up|124|||
27934170|NCT01214850|54590747|FG001|Overall Study|Lost to Follow-up|98|||
27934171|NCT01214850|54590748|FG002|Overall Study|Lost to Follow-up|123|||
27934172|NCT01214850|54590746|FG000|Overall Study|Protocol Violation|5|||
27934173|NCT01214850|54590747|FG001|Overall Study|Protocol Violation|5|||
27934174|NCT01214850|54590748|FG002|Overall Study|Protocol Violation|6|||
27934175|NCT01214850|54590746|FG000|Overall Study|Adverse event or death|11|||
27934176|NCT01214850|54590747|FG001|Overall Study|Adverse event or death|8|||
27934177|NCT01214850|54590748|FG002|Overall Study|Adverse event or death|3|||
27934178|NCT01214850|54590746|FG000|Overall Study|Inappropriate enrollment|2|||
27934179|NCT01214850|54590747|FG001|Overall Study|Inappropriate enrollment|1|||
27934180|NCT01214850|54590748|FG002|Overall Study|Inappropriate enrollment|0|||
27934181|NCT01214850|54590746|FG000|Overall Study|Administrative reason|1|||
27934182|NCT01214850|54590747|FG001|Overall Study|Administrative reason|0|||
27934183|NCT01214850|54590748|FG002|Overall Study|Administrative reason|0|||
27934184|NCT01214850|54590746|FG000|Overall Study|Unable to classify|2|||
27934185|NCT01214850|54590747|FG001|Overall Study|Unable to classify|1|||
27934186|NCT01214850|54590748|FG002|Overall Study|Unable to classify|1|||
27934187|NCT01128153|54590761|FG000|Overall Study|Adverse Event|1|||
27789257|NCT01632566|54244124|FG002|Overall Study|Sponsor Decision|9|||
27934188|NCT01128153|54590762|FG001|Overall Study|Adverse Event|3|||
27934189|NCT01128153|54590761|FG000|Overall Study|Condition under investigation worsened|8|||
27934190|NCT01128153|54590762|FG001|Overall Study|Condition under investigation worsened|7|||
27934191|NCT01128153|54590761|FG000|Overall Study|Withdrawal by Subject|2|||
27934192|NCT01128153|54590762|FG001|Overall Study|Withdrawal by Subject|3|||
27789258|NCT01632566|54244125|FG003|Overall Study|Sponsor Decision|2|||
27934193|NCT01128153|54590761|FG000|Overall Study|Incorrect enrolment to study|2|||
27934194|NCT01128153|54590762|FG001|Overall Study|Incorrect enrolment to study|1|||
27934195|NCT01128153|54590761|FG000|Overall Study|Protocol Violation|2|||
27934196|NCT01128153|54590762|FG001|Overall Study|Protocol Violation|0|||
27934197|NCT01128153|54590761|FG000|Overall Study|Developed discontinuation criteria|1|||
27934198|NCT01128153|54590762|FG001|Overall Study|Developed discontinuation criteria|1|||
27934199|NCT00925015|54590771|FG000|Overall Study|Adverse Event|1|||
27934200|NCT00925015|54590772|FG001|Overall Study|Adverse Event|2|||
27934201|NCT00925015|54590773|FG002|Overall Study|Adverse Event|1|||
27934202|NCT00925015|54590771|FG000|Overall Study|Physician Decision|0|||
27934203|NCT00925015|54590772|FG001|Overall Study|Physician Decision|1|||
27934204|NCT00925015|54590773|FG002|Overall Study|Physician Decision|0|||
27934205|NCT00925015|54590771|FG000|Overall Study|Progressive Disease|7|||
27934206|NCT00925015|54590772|FG001|Overall Study|Progressive Disease|3|||
27934207|NCT00925015|54590773|FG002|Overall Study|Progressive Disease|4|||
27934208|NCT00925015|54590771|FG000|Overall Study|Withdrawal by Subject|0|||
27934209|NCT00925015|54590772|FG001|Overall Study|Withdrawal by Subject|0|||
27934210|NCT00925015|54590773|FG002|Overall Study|Withdrawal by Subject|1|||
27934211|NCT01127763|54590785|FG000|Overall Study|Adverse Event|2|||
27934212|NCT01127763|54590785|FG000|Overall Study|Withdrawal by Subject|1|||
27934213|NCT01127763|54590785|FG000|Overall Study|Physician Decision|2|||
27934214|NCT01127607|54590795|FG000|Phase II (Between Subjects)|Lost to Follow-up|0|||
27934215|NCT01127607|54590796|FG001|Phase II (Between Subjects)|Lost to Follow-up|2|||
27934216|NCT01127607|54590795|FG000|Phase II (Between Subjects)|Withdrawal by Subject|1|||
27934217|NCT01127607|54590796|FG001|Phase II (Between Subjects)|Withdrawal by Subject|0|||
27934218|NCT00924781|54590823|FG000|Overall Study|Study terminated by sponsor|12|||
27934219|NCT00924781|54590824|FG001|Overall Study|Study terminated by sponsor|10|||
27934220|NCT01127451|54590842|FG000|Overall Study|Other|2|||
27934221|NCT01127451|54590843|FG001|Overall Study|Other|1|||
27934222|NCT01127451|54590842|FG000|Overall Study|Completed 1 Year Follow-up after last dose of study drug|14|||
27934223|NCT01127451|54590843|FG001|Overall Study|Completed 1 Year Follow-up after last dose of study drug|12|||
27934224|NCT01127451|54590842|FG000|Overall Study|Death|22|||
27934225|NCT01127451|54590843|FG001|Overall Study|Death|17|||
27934226|NCT01127451|54590842|FG000|Overall Study|Lost to Follow-up|3|||
27934227|NCT01127451|54590843|FG001|Overall Study|Lost to Follow-up|0|||
27934228|NCT01127451|54590842|FG000|Overall Study|Administrative Reason by Sponsor|2|||
27934229|NCT01127451|54590843|FG001|Overall Study|Administrative Reason by Sponsor|2|||
27934230|NCT01127373|54590849|FG000|Overall Study|Not Treated|3|||
27934231|NCT01127373|54590849|FG000|Overall Study|Lost to Follow-up|7|||
27934232|NCT01127373|54590849|FG000|Overall Study|Withdrawal by Subject|1|||
27934233|NCT01127373|54590849|FG000|Overall Study|Disease progression|1|||
27934234|NCT01127139|54590853|FG000|Overall Study|Adverse Event|40|||
27934235|NCT01127139|54590853|FG000|Overall Study|Incompliance|12|||
27934236|NCT01127139|54590853|FG000|Overall Study|Lack of Efficacy|4|||
27934237|NCT01127139|54590853|FG000|Overall Study|Reason not specified|1|||
27934238|NCT01214616|54590864|FG000|Overall Study|Progressive disease|2|||
27934239|NCT01214616|54590865|FG001|Overall Study|Progressive disease|2|||
27934240|NCT01214616|54590866|FG002|Overall Study|Progressive disease|2|||
27934241|NCT01214616|54590867|FG003|Overall Study|Progressive disease|4|||
27934242|NCT01214616|54590864|FG000|Overall Study|Dose limiting toxicity|0|||
27789259|NCT01632566|54244126|FG004|Overall Study|Sponsor Decision|2|||
27789260|NCT02254304|54244144|FG000|Overall Study|Adverse Event|2|||
27789261|NCT02254304|54244145|FG001|Overall Study|Adverse Event|1|||
27789262|NCT02254304|54244144|FG000|Overall Study|Lost to Follow-up|2|||
27789263|NCT02254304|54244145|FG001|Overall Study|Lost to Follow-up|2|||
27789264|NCT02254304|54244144|FG000|Overall Study|Protocol Violation|1|||
27789265|NCT02254304|54244145|FG001|Overall Study|Protocol Violation|0|||
27789266|NCT02254304|54244144|FG000|Overall Study|Withdrawal by Subject|3|||
27789267|NCT02254304|54244145|FG001|Overall Study|Withdrawal by Subject|0|||
27789268|NCT02254304|54244144|FG000|Overall Study|Injection site pain and Injection fear|1|||
27789269|NCT02254304|54244145|FG001|Overall Study|Injection site pain and Injection fear|0|||
27789270|NCT02254304|54244144|FG000|Overall Study|Personal causes|4|||
27789271|NCT02254304|54244145|FG001|Overall Study|Personal causes|1|||
27934243|NCT01214616|54590865|FG001|Overall Study|Dose limiting toxicity|2|||
27934244|NCT01214616|54590866|FG002|Overall Study|Dose limiting toxicity|0|||
27934245|NCT01214616|54590867|FG003|Overall Study|Dose limiting toxicity|0|||
27789272|NCT02254304|54244144|FG000|Overall Study|Personal decision|1|||
27789273|NCT02254304|54244145|FG001|Overall Study|Personal decision|0|||
27934246|NCT01214616|54590864|FG000|Overall Study|Other adverse events|0|||
27934247|NCT01214616|54590865|FG001|Overall Study|Other adverse events|1|||
27934248|NCT01214616|54590866|FG002|Overall Study|Other adverse events|1|||
27934249|NCT01214616|54590867|FG003|Overall Study|Other adverse events|1|||
27934250|NCT01214616|54590864|FG000|Overall Study|Withdrawal by Subject|1|||
27934251|NCT01214616|54590865|FG001|Overall Study|Withdrawal by Subject|0|||
27842470|NCT01445951|54330988|FG002|Overall Study|Death|1|||
27934252|NCT01214616|54590866|FG002|Overall Study|Withdrawal by Subject|0|||
27934253|NCT01214616|54590867|FG003|Overall Study|Withdrawal by Subject|1|||
27934254|NCT01213836|54590887|FG000|Period 1, First Intervention|Adverse Event|2|||
27934255|NCT01213836|54590888|FG001|Period 1, First Intervention|Adverse Event|1|||
27934256|NCT01213836|54590887|FG000|Period 1, First Intervention|Protocol Violation|0|||
27934257|NCT01213836|54590888|FG001|Period 1, First Intervention|Protocol Violation|1|||
27934258|NCT01213836|54590887|FG000|Period 1, First Intervention|Withdrawal by Subject|1|||
27934259|NCT01213836|54590888|FG001|Period 1, First Intervention|Withdrawal by Subject|1|||
27934260|NCT01127061|54590899|FG000|Overall Study|Lost to Follow-up|7|||
27934261|NCT01127061|54590900|FG001|Overall Study|Lost to Follow-up|10|||
27934262|NCT01127061|54590899|FG000|Overall Study|Physician Decision|3|||
27934263|NCT01127061|54590900|FG001|Overall Study|Physician Decision|3|||
27934264|NCT00924703|54590906|FG000|Overall Study|Withdrawal by Subject|11|||
27934265|NCT00924703|54590906|FG000|Overall Study|Physician Decision|5|||
27934266|NCT00924703|54590906|FG000|Overall Study|Lost to Follow-up|3|||
27934267|NCT00924703|54590906|FG000|Overall Study|Adverse Event|2|||
27934268|NCT00924703|54590906|FG000|Overall Study|Withdrawal by Sponsor|1|||
27934269|NCT01213524|54590912|FG000|Baseline|Withdrawal by Subject|5|||
27934270|NCT01213524|54590912|FG000|Baseline|high breath alcohol levels|1|||
27934271|NCT01213524|54590912|FG000|Baseline|Physician Decision|1|||
27934272|NCT01213524|54590912|FG000|Session 2|Withdrawal by Subject|5|||
27934273|NCT01213524|54590912|FG000|Session 3|Withdrawal by Subject|4|||
27934274|NCT01213524|54590912|FG000|Session 4|Physician Decision|1|||
27934275|NCT01213524|54590912|FG000|Session 4|Withdrawal by Subject|2|||
27934276|NCT01212744|54590923|FG000|Overall Study|Withdrawal by Subject|1|||
27934277|NCT01212588|54590931|FG000|Overall Study|Physician Decision|0|||
27934278|NCT01212588|54590932|FG001|Overall Study|Physician Decision|1|||
27934279|NCT01212588|54590931|FG000|Overall Study|Protocol Violation|1|||
27934280|NCT01212588|54590932|FG001|Overall Study|Protocol Violation|1|||
27934281|NCT00918385|54590940|FG000|Monotherapy|Adverse Event|1|||
27934282|NCT00918385|54590941|FG001|Monotherapy|Adverse Event|6|||
27934283|NCT00918385|54590940|FG000|Monotherapy|Complicating illness|1|||
27934284|NCT00918385|54590941|FG001|Monotherapy|Complicating illness|0|||
27934285|NCT00918385|54590940|FG000|Combination Nilutamide and Dasatinib|Adverse Event|1|||
27934286|NCT00918385|54590941|FG001|Combination Nilutamide and Dasatinib|Adverse Event|1|||
27934287|NCT00918385|54590940|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
27934288|NCT00918385|54590941|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0|||
27934289|NCT00918385|54590940|FG000|Combination Nilutamide and Dasatinib|Complicating illness|1|||
27934290|NCT00918385|54590941|FG001|Combination Nilutamide and Dasatinib|Complicating illness|0|||
27934291|NCT00918385|54590940|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
27934292|NCT00918385|54590941|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7|||
27934293|NCT01211262|54590951|FG000|Overall Study|Progressive Disease|18|||
27934294|NCT01211262|54590952|FG001|Overall Study|Progressive Disease|9|||
27934295|NCT01211262|54590951|FG000|Overall Study|Adverse Event|4|||
27934296|NCT01211262|54590952|FG001|Overall Study|Adverse Event|0|||
27934297|NCT01211262|54590951|FG000|Overall Study|Withdrawal of Consent|1|||
27934298|NCT01211262|54590952|FG001|Overall Study|Withdrawal of Consent|0|||
27934299|NCT01211262|54590951|FG000|Overall Study|Other|0|||
27934300|NCT01211262|54590952|FG001|Overall Study|Other|1|||
27934301|NCT01211184|54590964|FG000|Overall Study|Withdrawal by Subject|0|||
27934302|NCT01211184|54590965|FG001|Overall Study|Withdrawal by Subject|2|||
27934303|NCT01211184|54590966|FG002|Overall Study|Withdrawal by Subject|1|||
27934304|NCT00924469|54590979|FG000|Overall Study|Adverse Event|2|||
27934305|NCT00924469|54590980|FG001|Overall Study|Adverse Event|0|||
27934306|NCT00924469|54590979|FG000|Overall Study|Withdrawal by Subject|0|||
27934307|NCT00924469|54590980|FG001|Overall Study|Withdrawal by Subject|1|||
27934308|NCT00924469|54590979|FG000|Overall Study|Lost to Follow-up|0|||
27934309|NCT00924469|54590980|FG001|Overall Study|Lost to Follow-up|1|||
27934310|NCT00924313|54590986|FG000|Overall Study|not imaged due to failed tracer imaging|1|||
27934311|NCT01209780|54590994|FG000|Overall Study|Adverse Event|0|||
27934312|NCT01209780|54590995|FG001|Overall Study|Adverse Event|1|||
27934313|NCT01209780|54590996|FG002|Overall Study|Adverse Event|0|||
27934314|NCT01209780|54590997|FG003|Overall Study|Adverse Event|0|||
27934315|NCT01209780|54590998|FG004|Overall Study|Adverse Event|0|||
27789274|NCT02174731|54244155|FG000|Overall Study|Participant decision|67|||
27934316|NCT01209780|54590994|FG000|Overall Study|Withdrawal by Subject|9|||
27934317|NCT01209780|54590995|FG001|Overall Study|Withdrawal by Subject|2|||
27789275|NCT02174731|54244156|FG001|Overall Study|Participant decision|64|||
27934318|NCT01209780|54590996|FG002|Overall Study|Withdrawal by Subject|1|||
27934319|NCT01209780|54590997|FG003|Overall Study|Withdrawal by Subject|1|||
27934320|NCT01209780|54590998|FG004|Overall Study|Withdrawal by Subject|0|||
27934321|NCT01209780|54590994|FG000|Overall Study|Lost to Follow-up|17|||
27934322|NCT01209780|54590995|FG001|Overall Study|Lost to Follow-up|12|||
27934323|NCT01209780|54590996|FG002|Overall Study|Lost to Follow-up|3|||
27934324|NCT01209780|54590997|FG003|Overall Study|Lost to Follow-up|9|||
27934325|NCT01209780|54590998|FG004|Overall Study|Lost to Follow-up|4|||
27934326|NCT01209780|54590994|FG000|Overall Study|Protocol Violation|0|||
27934327|NCT01209780|54590995|FG001|Overall Study|Protocol Violation|1|||
27934328|NCT01209780|54590996|FG002|Overall Study|Protocol Violation|0|||
27934329|NCT01209780|54590997|FG003|Overall Study|Protocol Violation|0|||
27934330|NCT01209780|54590998|FG004|Overall Study|Protocol Violation|0|||
27934331|NCT01209780|54590994|FG000|Overall Study|Inappropriate enrollment|0|||
27934332|NCT01209780|54590995|FG001|Overall Study|Inappropriate enrollment|2|||
27934333|NCT01209780|54590996|FG002|Overall Study|Inappropriate enrollment|0|||
27934334|NCT01209780|54590997|FG003|Overall Study|Inappropriate enrollment|0|||
27934335|NCT01209780|54590998|FG004|Overall Study|Inappropriate enrollment|1|||
27934336|NCT00916357|54591011|FG000|Period 1|Withdrawal by Subject|1|||
27934337|NCT00916357|54591012|FG001|Period 1|Withdrawal by Subject|0|||
27934338|NCT00916357|54591013|FG002|Period 1|Withdrawal by Subject|0|||
27934339|NCT00916357|54591014|FG003|Period 1|Withdrawal by Subject|0|||
27934340|NCT00916357|54591015|FG004|Period 1|Withdrawal by Subject|0|||
27934341|NCT00916357|54591016|FG005|Period 1|Withdrawal by Subject|0|||
27934342|NCT00916357|54591011|FG000|Period 2|Weight loss > 3 kilograms (kg)|0|||
27934343|NCT00916357|54591012|FG001|Period 2|Weight loss > 3 kilograms (kg)|0|||
27934344|NCT00916357|54591013|FG002|Period 2|Weight loss > 3 kilograms (kg)|0|||
27934345|NCT00916357|54591014|FG003|Period 2|Weight loss > 3 kilograms (kg)|1|||
27934346|NCT00916357|54591015|FG004|Period 2|Weight loss > 3 kilograms (kg)|0|||
27789276|NCT02174731|54244155|FG000|Overall Study|Incorrect enrolment before randomization|0|||
27934347|NCT00916357|54591016|FG005|Period 2|Weight loss > 3 kilograms (kg)|0|||
27934348|NCT01209624|54591025|FG000|Overall Study|Death|2|||
27934349|NCT01209624|54591025|FG000|Overall Study|Adverse Event|13|||
27934350|NCT01209624|54591025|FG000|Overall Study|Lack of Efficacy|17|||
27934351|NCT01209624|54591025|FG000|Overall Study|Lost to Follow-up|290|||
27934352|NCT01209624|54591025|FG000|Overall Study|Other|4|||
27934353|NCT00916279|54591029|FG000|Overall Study|Death|2|||
27934354|NCT00916279|54591029|FG000|Overall Study|Lost to Follow-up|2|||
27934355|NCT01209078|54591038|FG000|Overall Study|Adverse Event|5|||
27934356|NCT01209078|54591039|FG001|Overall Study|Adverse Event|0|||
27934357|NCT01209078|54591038|FG000|Overall Study|Lost to Follow-up|4|||
27934358|NCT01209078|54591039|FG001|Overall Study|Lost to Follow-up|0|||
27934359|NCT01209078|54591038|FG000|Overall Study|Physician Decision|5|||
27934360|NCT01209078|54591039|FG001|Overall Study|Physician Decision|2|||
27934361|NCT01209078|54591038|FG000|Overall Study|Withdrawal by Subject|2|||
27934362|NCT01209078|54591039|FG001|Overall Study|Withdrawal by Subject|1|||
27789277|NCT02174731|54244156|FG001|Overall Study|Incorrect enrolment before randomization|1|||
27789278|NCT02174731|54244155|FG000|Overall Study|Missing|2|||
27789279|NCT02174731|54244156|FG001|Overall Study|Missing|0|||
27789280|NCT01922037|54244164|FG000|Overall Study|Withdrawal by Subject|2|||
27789281|NCT01922037|54244165|FG001|Overall Study|Withdrawal by Subject|44|||
27789282|NCT01922037|54244164|FG000|Overall Study|Adverse Event|1|||
27789283|NCT01922037|54244165|FG001|Overall Study|Adverse Event|7|||
27789284|NCT01922037|54244164|FG000|Overall Study|Death|0|||
27789285|NCT01922037|54244165|FG001|Overall Study|Death|5|||
27789286|NCT01922037|54244164|FG000|Overall Study|Pregnancy|0|||
27789287|NCT01922037|54244165|FG001|Overall Study|Pregnancy|2|||
27789288|NCT01922037|54244164|FG000|Overall Study|Participant non-compliance|4|||
27789289|NCT01922037|54244165|FG001|Overall Study|Participant non-compliance|46|||
27789290|NCT01922037|54244164|FG000|Overall Study|Investigator/Sponsor decision|1|||
27789291|NCT01922037|54244165|FG001|Overall Study|Investigator/Sponsor decision|4|||
27789292|NCT01922037|54244164|FG000|Overall Study|Other unspecified|2|||
27789293|NCT01922037|54244165|FG001|Overall Study|Other unspecified|66|||
27789294|NCT02282813|54244176|FG000|Overall Study|Withdrawal by Subject|4|||
27789295|NCT02282813|54244177|FG001|Overall Study|Withdrawal by Subject|5|||
27789296|NCT02282813|54244178|FG002|Overall Study|Withdrawal by Subject|0|||
27934363|NCT01207596|54591047|FG000|Overall Study|Physician Decision|4|||
27934364|NCT01207596|54591047|FG000|Overall Study|Lack of Efficacy|1|||
27934365|NCT01207596|54591047|FG000|Overall Study|Adverse Event|3|||
27934366|NCT01207596|54591047|FG000|Overall Study|Withdrawal by Subject|1|||
27934367|NCT00915343|54591051|FG000|Part B - Open Label Period|Treatment switch|0|||
27934368|NCT00915343|54591052|FG001|Part B - Open Label Period|Treatment switch|0|||
27934369|NCT00915343|54591053|FG002|Part B - Open Label Period|Treatment switch|1|||
27934370|NCT00915343|54591051|FG000|Part B - Open Label Period|Did not attend the last visit|0|||
27934371|NCT00915343|54591052|FG001|Part B - Open Label Period|Did not attend the last visit|0|||
27934372|NCT00915343|54591053|FG002|Part B - Open Label Period|Did not attend the last visit|1|||
27934373|NCT00911989|54591065|FG000|Overall Study|Adverse Event|1|||
27789297|NCT02282813|54244176|FG000|Overall Study|Adverse Event|3|||
27934374|NCT00910273|54591071|FG000|Overall Study|Lack of Efficacy|6|||
27934375|NCT00910273|54591072|FG001|Overall Study|Lack of Efficacy|9|||
27934376|NCT00910273|54591071|FG000|Overall Study|Adverse Event|1|||
27789298|NCT02282813|54244177|FG001|Overall Study|Adverse Event|10|||
27789299|NCT02282813|54244178|FG002|Overall Study|Adverse Event|1|||
27789300|NCT02282813|54244176|FG000|Overall Study|Subject non-compliance|1|||
27789301|NCT02282813|54244177|FG001|Overall Study|Subject non-compliance|4|||
27934377|NCT00910273|54591072|FG001|Overall Study|Adverse Event|1|||
27934378|NCT00910273|54591071|FG000|Overall Study|Withdrawal by Subject|1|||
27934379|NCT00910273|54591072|FG001|Overall Study|Withdrawal by Subject|0|||
27934380|NCT00910273|54591071|FG000|Overall Study|Discontinuation of study by sponsor|8|||
27934381|NCT00910273|54591072|FG001|Overall Study|Discontinuation of study by sponsor|2|||
27934382|NCT00910273|54591071|FG000|Overall Study|Protocol Violation|1|||
27934383|NCT00910273|54591072|FG001|Overall Study|Protocol Violation|0|||
27934384|NCT00910273|54591071|FG000|Overall Study|Lost to Follow-up|1|||
27934385|NCT00910273|54591072|FG001|Overall Study|Lost to Follow-up|1|||
27934386|NCT00910039|54591078|FG000|Overall Study|Physician Decision|1|||
27934387|NCT00909181|54591086|FG000|Overall Study|Lost to Follow-up|39|||
27934388|NCT00909181|54591087|FG001|Overall Study|Lost to Follow-up|18|||
27934389|NCT00909181|54591088|FG002|Overall Study|Lost to Follow-up|33|||
27934390|NCT01286987|54591111|FG000|Part 1: Dose Escalation|Clinical Progression|1|||
27934391|NCT01286987|54591112|FG001|Part 1: Dose Escalation|Clinical Progression|1|||
27934392|NCT01286987|54591113|FG002|Part 1: Dose Escalation|Clinical Progression|0|||
27934393|NCT01286987|54591114|FG003|Part 1: Dose Escalation|Clinical Progression|1|||
27934394|NCT01286987|54591115|FG004|Part 1: Dose Escalation|Clinical Progression|1|||
27934395|NCT01286987|54591116|FG005|Part 1: Dose Escalation|Clinical Progression|1|||
27934396|NCT01286987|54591117|FG006|Part 1: Dose Escalation|Clinical Progression|0|||
27934397|NCT01286987|54591118|FG007|Part 1: Dose Escalation|Clinical Progression|2|||
27934398|NCT01286987|54591119|FG008|Part 1: Dose Escalation|Clinical Progression|1|||
27934399|NCT01286987|54591120|FG009|Part 1: Dose Escalation|Clinical Progression|0|||
27934400|NCT01286987|54591121|FG010|Part 1: Dose Escalation|Clinical Progression|0|||
27934401|NCT01286987|54591122|FG011|Part 1: Dose Escalation|Clinical Progression|0|||
27934402|NCT01286987|54591123|FG012|Part 1: Dose Escalation|Clinical Progression|0|||
27934403|NCT01286987|54591124|FG013|Part 1: Dose Escalation|Clinical Progression|0|||
27934404|NCT01286987|54591125|FG014|Part 1: Dose Escalation|Clinical Progression|0|||
27934405|NCT01286987|54591111|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
27934406|NCT01286987|54591112|FG001|Part 1: Dose Escalation|Progressive Disease|2|||
27934407|NCT01286987|54591113|FG002|Part 1: Dose Escalation|Progressive Disease|3|||
27934408|NCT01286987|54591114|FG003|Part 1: Dose Escalation|Progressive Disease|2|||
27934409|NCT01286987|54591115|FG004|Part 1: Dose Escalation|Progressive Disease|1|||
27934410|NCT01286987|54591116|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
27934411|NCT01286987|54591117|FG006|Part 1: Dose Escalation|Progressive Disease|5|||
27934412|NCT01286987|54591118|FG007|Part 1: Dose Escalation|Progressive Disease|3|||
27934413|NCT01286987|54591119|FG008|Part 1: Dose Escalation|Progressive Disease|5|||
27934414|NCT01286987|54591120|FG009|Part 1: Dose Escalation|Progressive Disease|0|||
27934415|NCT01286987|54591121|FG010|Part 1: Dose Escalation|Progressive Disease|0|||
27934416|NCT01286987|54591122|FG011|Part 1: Dose Escalation|Progressive Disease|0|||
27934417|NCT01286987|54591123|FG012|Part 1: Dose Escalation|Progressive Disease|0|||
27934418|NCT01286987|54591124|FG013|Part 1: Dose Escalation|Progressive Disease|0|||
27934419|NCT01286987|54591125|FG014|Part 1: Dose Escalation|Progressive Disease|0|||
27934420|NCT01286987|54591111|FG000|Part 1: Dose Escalation|Physician Decision|0|||
27934421|NCT01286987|54591112|FG001|Part 1: Dose Escalation|Physician Decision|0|||
27934422|NCT01286987|54591113|FG002|Part 1: Dose Escalation|Physician Decision|0|||
27934423|NCT01286987|54591114|FG003|Part 1: Dose Escalation|Physician Decision|0|||
27934424|NCT01286987|54591115|FG004|Part 1: Dose Escalation|Physician Decision|1|||
27934425|NCT01286987|54591116|FG005|Part 1: Dose Escalation|Physician Decision|0|||
27934426|NCT01286987|54591117|FG006|Part 1: Dose Escalation|Physician Decision|0|||
27934427|NCT01286987|54591118|FG007|Part 1: Dose Escalation|Physician Decision|0|||
27789302|NCT02282813|54244178|FG002|Overall Study|Subject non-compliance|0|||
27934428|NCT01286987|54591119|FG008|Part 1: Dose Escalation|Physician Decision|0|||
27934429|NCT01286987|54591120|FG009|Part 1: Dose Escalation|Physician Decision|0|||
27934430|NCT01286987|54591121|FG010|Part 1: Dose Escalation|Physician Decision|0|||
27934431|NCT01286987|54591122|FG011|Part 1: Dose Escalation|Physician Decision|0|||
27934432|NCT01286987|54591123|FG012|Part 1: Dose Escalation|Physician Decision|0|||
27934433|NCT01286987|54591124|FG013|Part 1: Dose Escalation|Physician Decision|0|||
27789303|NCT02282813|54244176|FG000|Overall Study|Physician Decision|0|||
27789304|NCT02282813|54244177|FG001|Overall Study|Physician Decision|3|||
27789305|NCT02282813|54244178|FG002|Overall Study|Physician Decision|1|||
27789306|NCT02282813|54244176|FG000|Overall Study|Lost to Follow-up|2|||
27789307|NCT02282813|54244177|FG001|Overall Study|Lost to Follow-up|0|||
27789308|NCT02282813|54244178|FG002|Overall Study|Lost to Follow-up|1|||
27789309|NCT02282813|54244176|FG000|Overall Study|Serum Ca >/=11.0mg/dL|1|||
27789310|NCT02282813|54244177|FG001|Overall Study|Serum Ca >/=11.0mg/dL|0|||
27789311|NCT02282813|54244178|FG002|Overall Study|Serum Ca >/=11.0mg/dL|0|||
27934434|NCT01286987|54591125|FG014|Part 1: Dose Escalation|Physician Decision|0|||
27934435|NCT01286987|54591111|FG000|Part 2: Dose Expansion|Death|0|||
27934436|NCT01286987|54591112|FG001|Part 2: Dose Expansion|Death|0|||
27934437|NCT01286987|54591113|FG002|Part 2: Dose Expansion|Death|0|||
27789312|NCT02282813|54244176|FG000|Overall Study|Lack of Efficacy|1|||
27934438|NCT01286987|54591114|FG003|Part 2: Dose Expansion|Death|0|||
27789313|NCT02282813|54244177|FG001|Overall Study|Lack of Efficacy|0|||
27789314|NCT02282813|54244178|FG002|Overall Study|Lack of Efficacy|0|||
27789315|NCT02282813|54244176|FG000|Overall Study|Administrative reasons|0|||
27789316|NCT02282813|54244177|FG001|Overall Study|Administrative reasons|1|||
27789317|NCT02282813|54244178|FG002|Overall Study|Administrative reasons|0|||
27789318|NCT01903863|54244190|FG000|Overall Study|Physician Decision|2|||
27789319|NCT01903863|54244191|FG001|Overall Study|Physician Decision|0|||
27934439|NCT01286987|54591115|FG004|Part 2: Dose Expansion|Death|0|||
27934440|NCT01286987|54591116|FG005|Part 2: Dose Expansion|Death|0|||
27934441|NCT01286987|54591117|FG006|Part 2: Dose Expansion|Death|0|||
27934442|NCT01286987|54591118|FG007|Part 2: Dose Expansion|Death|0|||
27934443|NCT01286987|54591119|FG008|Part 2: Dose Expansion|Death|0|||
27934444|NCT01286987|54591120|FG009|Part 2: Dose Expansion|Death|0|||
27934445|NCT01286987|54591121|FG010|Part 2: Dose Expansion|Death|0|||
27934446|NCT01286987|54591122|FG011|Part 2: Dose Expansion|Death|0|||
27934447|NCT01286987|54591123|FG012|Part 2: Dose Expansion|Death|1|||
27934448|NCT01286987|54591124|FG013|Part 2: Dose Expansion|Death|1|||
27934449|NCT01286987|54591125|FG014|Part 2: Dose Expansion|Death|0|||
27934450|NCT01286987|54591111|FG000|Part 2: Dose Expansion|Physician Decision|0|||
27934451|NCT01286987|54591112|FG001|Part 2: Dose Expansion|Physician Decision|0|||
27934452|NCT01286987|54591113|FG002|Part 2: Dose Expansion|Physician Decision|0|||
27934453|NCT01286987|54591114|FG003|Part 2: Dose Expansion|Physician Decision|0|||
27934454|NCT01286987|54591115|FG004|Part 2: Dose Expansion|Physician Decision|0|||
27934455|NCT01286987|54591116|FG005|Part 2: Dose Expansion|Physician Decision|0|||
27934456|NCT01286987|54591117|FG006|Part 2: Dose Expansion|Physician Decision|0|||
27934457|NCT01286987|54591118|FG007|Part 2: Dose Expansion|Physician Decision|0|||
27934458|NCT01286987|54591119|FG008|Part 2: Dose Expansion|Physician Decision|0|||
27934459|NCT01286987|54591120|FG009|Part 2: Dose Expansion|Physician Decision|0|||
27934460|NCT01286987|54591121|FG010|Part 2: Dose Expansion|Physician Decision|1|||
27934461|NCT01286987|54591122|FG011|Part 2: Dose Expansion|Physician Decision|1|||
27934462|NCT01286987|54591123|FG012|Part 2: Dose Expansion|Physician Decision|0|||
27934463|NCT01286987|54591124|FG013|Part 2: Dose Expansion|Physician Decision|1|||
27934464|NCT01286987|54591125|FG014|Part 2: Dose Expansion|Physician Decision|0|||
27789320|NCT02123251|54244199|FG000|Overall Study|Death|1|||
27789321|NCT02123251|54244200|FG001|Overall Study|Death|1|||
27789322|NCT02123251|54244199|FG000|Overall Study|Withdrawal by Subject|0|||
27789323|NCT02123251|54244200|FG001|Overall Study|Withdrawal by Subject|3|||
27789324|NCT02123251|54244199|FG000|Overall Study|Lost Medicaid eligibility|29|||
27934465|NCT01286987|54591111|FG000|Part 2: Dose Expansion|Other|0|||
27934466|NCT01286987|54591112|FG001|Part 2: Dose Expansion|Other|0|||
27934467|NCT01286987|54591113|FG002|Part 2: Dose Expansion|Other|0|||
27934468|NCT01286987|54591114|FG003|Part 2: Dose Expansion|Other|0|||
27934469|NCT01286987|54591115|FG004|Part 2: Dose Expansion|Other|0|||
27934470|NCT01286987|54591116|FG005|Part 2: Dose Expansion|Other|0|||
27934471|NCT01286987|54591117|FG006|Part 2: Dose Expansion|Other|0|||
27934472|NCT01286987|54591118|FG007|Part 2: Dose Expansion|Other|0|||
27934473|NCT01286987|54591119|FG008|Part 2: Dose Expansion|Other|0|||
27934474|NCT01286987|54591120|FG009|Part 2: Dose Expansion|Other|0|||
27934475|NCT01286987|54591121|FG010|Part 2: Dose Expansion|Other|0|||
27934476|NCT01286987|54591122|FG011|Part 2: Dose Expansion|Other|0|||
27934477|NCT01286987|54591123|FG012|Part 2: Dose Expansion|Other|0|||
27934478|NCT01286987|54591124|FG013|Part 2: Dose Expansion|Other|1|||
27934479|NCT01286987|54591125|FG014|Part 2: Dose Expansion|Other|0|||
27934480|NCT01286987|54591111|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
27934481|NCT01286987|54591112|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
27934482|NCT01286987|54591113|FG002|Part 2: Dose Expansion|Progressive Disease|0|||
27842471|NCT01445951|54330986|FG000|Overall Study|Non-compliance with study drug|1|||
27842472|NCT01445951|54330987|FG001|Overall Study|Non-compliance with study drug|2|||
27842473|NCT01445951|54330988|FG002|Overall Study|Non-compliance with study drug|0|||
27842474|NCT01445951|54330986|FG000|Overall Study|Non-compliance with protocol|0|||
27842475|NCT01445951|54330987|FG001|Overall Study|Non-compliance with protocol|1|||
27842476|NCT01445951|54330988|FG002|Overall Study|Non-compliance with protocol|0|||
27842477|NCT01445951|54330986|FG000|Overall Study|Sponsor decision - subject travel|0|||
27842478|NCT01445951|54330987|FG001|Overall Study|Sponsor decision - subject travel|1|||
27842479|NCT01445951|54330988|FG002|Overall Study|Sponsor decision - subject travel|0|||
27934483|NCT01286987|54591114|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
27934484|NCT01286987|54591115|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
27934485|NCT01286987|54591116|FG005|Part 2: Dose Expansion|Progressive Disease|0|||
27842480|NCT01445951|54330986|FG000|Overall Study|Cough|0|||
27842481|NCT01445951|54330987|FG001|Overall Study|Cough|1|||
27934486|NCT01286987|54591117|FG006|Part 2: Dose Expansion|Progressive Disease|0|||
27934487|NCT01286987|54591118|FG007|Part 2: Dose Expansion|Progressive Disease|0|||
27934488|NCT01286987|54591119|FG008|Part 2: Dose Expansion|Progressive Disease|0|||
27934489|NCT01286987|54591120|FG009|Part 2: Dose Expansion|Progressive Disease|11|||
27842482|NCT01445951|54330988|FG002|Overall Study|Cough|0|||
27789325|NCT02123251|54244200|FG001|Overall Study|Lost Medicaid eligibility|22|||
27789326|NCT02123251|54244199|FG000|Overall Study|Switched Managed Care Organization (MCO)|4|||
27934490|NCT01286987|54591121|FG010|Part 2: Dose Expansion|Progressive Disease|6|||
27934491|NCT01286987|54591122|FG011|Part 2: Dose Expansion|Progressive Disease|7|||
27934492|NCT01286987|54591123|FG012|Part 2: Dose Expansion|Progressive Disease|11|||
27934493|NCT01286987|54591124|FG013|Part 2: Dose Expansion|Progressive Disease|19|||
27934494|NCT01286987|54591125|FG014|Part 2: Dose Expansion|Progressive Disease|2|||
27934495|NCT01286987|54591111|FG000|Part 2: Dose Expansion|Clinical Progression|0|||
27934496|NCT01286987|54591112|FG001|Part 2: Dose Expansion|Clinical Progression|0|||
27934497|NCT01286987|54591113|FG002|Part 2: Dose Expansion|Clinical Progression|0|||
27934498|NCT01286987|54591114|FG003|Part 2: Dose Expansion|Clinical Progression|0|||
27934499|NCT01286987|54591115|FG004|Part 2: Dose Expansion|Clinical Progression|0|||
27934500|NCT01286987|54591116|FG005|Part 2: Dose Expansion|Clinical Progression|0|||
27934501|NCT01286987|54591117|FG006|Part 2: Dose Expansion|Clinical Progression|0|||
27934502|NCT01286987|54591118|FG007|Part 2: Dose Expansion|Clinical Progression|0|||
27934503|NCT01286987|54591119|FG008|Part 2: Dose Expansion|Clinical Progression|0|||
27934504|NCT01286987|54591120|FG009|Part 2: Dose Expansion|Clinical Progression|0|||
27934505|NCT01286987|54591121|FG010|Part 2: Dose Expansion|Clinical Progression|2|||
27934506|NCT01286987|54591122|FG011|Part 2: Dose Expansion|Clinical Progression|2|||
27934507|NCT01286987|54591123|FG012|Part 2: Dose Expansion|Clinical Progression|0|||
27934508|NCT01286987|54591124|FG013|Part 2: Dose Expansion|Clinical Progression|2|||
27934509|NCT01286987|54591125|FG014|Part 2: Dose Expansion|Clinical Progression|0|||
27934510|NCT01286987|54591111|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
27934511|NCT01286987|54591112|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
27934512|NCT01286987|54591113|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
27934513|NCT01286987|54591114|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
27934514|NCT01286987|54591115|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
27934515|NCT01286987|54591116|FG005|Part 2: Dose Expansion|Withdrawal by Subject|0|||
27934516|NCT01286987|54591117|FG006|Part 2: Dose Expansion|Withdrawal by Subject|0|||
27934517|NCT01286987|54591118|FG007|Part 2: Dose Expansion|Withdrawal by Subject|0|||
27934518|NCT01286987|54591119|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
27934519|NCT01286987|54591120|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
27934520|NCT01286987|54591121|FG010|Part 2: Dose Expansion|Withdrawal by Subject|1|||
27934521|NCT01286987|54591122|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
27934522|NCT01286987|54591123|FG012|Part 2: Dose Expansion|Withdrawal by Subject|0|||
27934523|NCT01286987|54591124|FG013|Part 2: Dose Expansion|Withdrawal by Subject|0|||
27934524|NCT01286987|54591125|FG014|Part 2: Dose Expansion|Withdrawal by Subject|0|||
27934525|NCT01286753|54591168|FG000|Overall Study|Adverse Event|7|||
27934526|NCT01286753|54591169|FG001|Overall Study|Adverse Event|6|||
27934527|NCT01286753|54591168|FG000|Overall Study|Progression|11|||
27934528|NCT01286753|54591169|FG001|Overall Study|Progression|13|||
27934529|NCT01286753|54591168|FG000|Overall Study|Refused Treatment|1|||
27934530|NCT01286753|54591169|FG001|Overall Study|Refused Treatment|0|||
27934531|NCT01286753|54591168|FG000|Overall Study|Withdrawal of Consent|0|||
27934532|NCT01286753|54591169|FG001|Overall Study|Withdrawal of Consent|2|||
27934533|NCT01286753|54591168|FG000|Overall Study|Discontinued to Join Extension Study|6|||
27934534|NCT01286753|54591169|FG001|Overall Study|Discontinued to Join Extension Study|4|||
27934535|NCT01286753|54591168|FG000|Overall Study|Participant to Receive Radiotherapy|1|||
27934536|NCT01286753|54591169|FG001|Overall Study|Participant to Receive Radiotherapy|0|||
27934537|NCT01286129|54591178|FG000|Overall Study|Withdrawal by Subject|4|||
27934538|NCT01286129|54591179|FG001|Overall Study|Withdrawal by Subject|1|||
27934539|NCT01286129|54591178|FG000|Overall Study|Could not comply with study requirements|4|||
27789327|NCT02123251|54244200|FG001|Overall Study|Switched Managed Care Organization (MCO)|4|||
27789328|NCT01902303|54244209|FG000|Overall Study|Adverse Event|0|||
27789329|NCT01902303|54244210|FG001|Overall Study|Adverse Event|1|||
27789330|NCT01902303|54244209|FG000|Overall Study|Lost to Follow-up|0|||
27789331|NCT01902303|54244210|FG001|Overall Study|Lost to Follow-up|1|||
27789332|NCT01902303|54244209|FG000|Overall Study|Protocol Violation|2|||
27789333|NCT01902303|54244210|FG001|Overall Study|Protocol Violation|2|||
27789334|NCT01902303|54244209|FG000|Overall Study|subject lost investigational product|0|||
27789335|NCT01902303|54244210|FG001|Overall Study|subject lost investigational product|1|||
27789336|NCT01902303|54244209|FG000|Overall Study|Did not develop a cold sore|21|||
27789337|NCT01902303|54244210|FG001|Overall Study|Did not develop a cold sore|19|||
27789338|NCT02122783|54244220|FG000|Overall Study|Adverse Event|0|||
27934540|NCT01286129|54591179|FG001|Overall Study|Could not comply with study requirements|4|||
27934541|NCT01285349|54591190|FG000|Overall Study|Lost to Follow-up|27|||
27934542|NCT01285349|54591191|FG001|Overall Study|Lost to Follow-up|20|||
27934543|NCT01285349|54591192|FG002|Overall Study|Lost to Follow-up|27|||
28017022|NCT00683618|54676262|FG002|Randomised Treatment Period|Protocol Violation|0|||
28017023|NCT00683618|54676260|FG000|Randomised Treatment Period|Adverse Event|2|||
28017024|NCT00683618|54676261|FG001|Randomised Treatment Period|Adverse Event|0|||
27789339|NCT02122783|54244221|FG001|Overall Study|Adverse Event|1|||
27842483|NCT01445171|54331000|FG000|Overall Study|Lost to Follow-up|11|||
27789340|NCT01921257|54244230|FG000|Overall Study|Adverse Event|1|||
27789341|NCT01921257|54244230|FG000|Overall Study|Protocol Violation|1|||
27789342|NCT01921257|54244230|FG000|Overall Study|Withdrawal by Subject|1|||
27789343|NCT02121847|54244235|FG000|Overall Study|Administrative Reasons|1|||
27789344|NCT02121847|54244235|FG000|Overall Study|Adverse Event|2|||
27789345|NCT01921179|54244241|FG000|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
27789346|NCT01921179|54244242|FG001|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
27789347|NCT01921179|54244241|FG000|Long Term Follow-up After GOALS Training|Lost to Follow-up|2|||
27789348|NCT01921179|54244242|FG001|Long Term Follow-up After GOALS Training|Lost to Follow-up|0|||
27789349|NCT01587040|54244253|FG000|Overall Study|Protocol Violation|0|||
27789350|NCT01587040|54244254|FG001|Overall Study|Protocol Violation|0|||
27789351|NCT01587040|54244255|FG002|Overall Study|Protocol Violation|1|||
27789352|NCT01587040|54244256|FG003|Overall Study|Protocol Violation|0|||
27789353|NCT01587040|54244253|FG000|Overall Study|Adverse Event|0|||
27789354|NCT01587040|54244254|FG001|Overall Study|Adverse Event|1|||
27789355|NCT01587040|54244255|FG002|Overall Study|Adverse Event|10|||
27789356|NCT01587040|54244256|FG003|Overall Study|Adverse Event|0|||
27789357|NCT01587040|54244253|FG000|Overall Study|Disease progression|12|||
27789358|NCT01587040|54244254|FG001|Overall Study|Disease progression|1|||
27789359|NCT01587040|54244255|FG002|Overall Study|Disease progression|15|||
27789360|NCT01587040|54244256|FG003|Overall Study|Disease progression|3|||
27789361|NCT01587040|54244253|FG000|Overall Study|Other than specified|5|||
27789362|NCT01587040|54244254|FG001|Overall Study|Other than specified|1|||
27789363|NCT01587040|54244255|FG002|Overall Study|Other than specified|11|||
27789364|NCT01587040|54244256|FG003|Overall Study|Other than specified|1|||
27789365|NCT02144701|54244268|FG000|Overall Study|development of relapse, GVHD or death|9|||
27789366|NCT02144701|54244269|FG001|Overall Study|development of relapse, GVHD or death|3|||
27789367|NCT01921101|54244277|FG000|Overall Study|Death|16|||
27789368|NCT01921101|54244278|FG001|Overall Study|Death|6|||
27789369|NCT01586806|54244287|FG000|Overall Study|Protocol Violation|0|||
27789370|NCT01586806|54244288|FG001|Overall Study|Protocol Violation|1|||
27789371|NCT01586806|54244289|FG002|Overall Study|Protocol Violation|0|||
27789372|NCT01586806|54244287|FG000|Overall Study|Withdrawal by Subject|1|||
27789373|NCT01586806|54244288|FG001|Overall Study|Withdrawal by Subject|0|||
27789374|NCT01586806|54244289|FG002|Overall Study|Withdrawal by Subject|0|||
27789375|NCT01586806|54244287|FG000|Overall Study|Lost to Follow-up|2|||
27789376|NCT01586806|54244288|FG001|Overall Study|Lost to Follow-up|3|||
27789377|NCT01586806|54244289|FG002|Overall Study|Lost to Follow-up|2|||
27789378|NCT02144077|54244299|FG000|Overall Study|Withdrawal by Subject|3|||
27789379|NCT02144077|54244300|FG001|Overall Study|Withdrawal by Subject|3|||
27789380|NCT02144077|54244299|FG000|Overall Study|Adverse Event|2|||
27789381|NCT02144077|54244300|FG001|Overall Study|Adverse Event|3|||
27789382|NCT02144077|54244299|FG000|Overall Study|Lost to Follow-up|2|||
27789383|NCT02144077|54244300|FG001|Overall Study|Lost to Follow-up|2|||
27789384|NCT02144077|54244299|FG000|Overall Study|Protocol Violation|1|||
27789385|NCT02144077|54244300|FG001|Overall Study|Protocol Violation|2|||
27789386|NCT02144077|54244299|FG000|Overall Study|Death|0|||
27789387|NCT02144077|54244300|FG001|Overall Study|Death|1|||
27789388|NCT02144077|54244299|FG000|Overall Study|no visits 7 & 8/no visits after visit 4|2|||
27789389|NCT02144077|54244300|FG001|Overall Study|no visits 7 & 8/no visits after visit 4|0|||
27789390|NCT02172625|54244308|FG000|Overall Study|Adverse Event|0|||
27789391|NCT02172625|54244309|FG001|Overall Study|Adverse Event|1|||
27789392|NCT02172625|54244308|FG000|Overall Study|Pregnancy|0|||
27789393|NCT02172625|54244309|FG001|Overall Study|Pregnancy|1|||
27789394|NCT02172625|54244308|FG000|Overall Study|car accident|0|||
27789395|NCT02172625|54244309|FG001|Overall Study|car accident|1|||
27789396|NCT02143843|54244319|FG000|Overall Study|Adverse Event|8|||
27789397|NCT02143843|54244319|FG000|Overall Study|Lack of Efficacy|2|||
27934544|NCT01284959|54591204|FG000|Overall Study|Withdrawal by Subject|1|||
27934545|NCT01284959|54591205|FG001|Overall Study|Withdrawal by Subject|0|||
27934546|NCT01284959|54591206|FG002|Overall Study|Withdrawal by Subject|0|||
27934547|NCT01284959|54591204|FG000|Overall Study|Adverse Event|0|||
27934548|NCT01284959|54591205|FG001|Overall Study|Adverse Event|0|||
27934549|NCT01284959|54591206|FG002|Overall Study|Adverse Event|1|||
27934550|NCT01284491|54591214|FG000|Overall Study|Study termination|13|||
27934551|NCT01283009|54591222|FG000|Overall Study|Death|83|||
27934552|NCT01283009|54591223|FG001|Overall Study|Death|78|||
27789398|NCT02143843|54244319|FG000|Overall Study|Withdrawal by Subject|2|||
27789399|NCT02121535|54244325|FG000|Period 1 (8 Trial Days)|Withdrawal by Subject|0|||
27789400|NCT02121535|54244326|FG001|Period 1 (8 Trial Days)|Withdrawal by Subject|1|||
27789401|NCT02121535|54244325|FG000|Period 3 (8 Trial Days)|Withdrawal by Subject|1|||
27789402|NCT02121535|54244326|FG001|Period 3 (8 Trial Days)|Withdrawal by Subject|0|||
27789403|NCT01586338|54244333|FG000|Overall Study|Adverse Event|3|||
27789404|NCT01586338|54244333|FG000|Overall Study|Lost to Follow-up|1|||
27789405|NCT01586338|54244333|FG000|Overall Study|Withdrawal by participant|3|||
27934553|NCT01283009|54591222|FG000|Overall Study|Study ended early|23|||
27789406|NCT01586338|54244333|FG000|Overall Study|Other|1|||
27789407|NCT02143141|54244339|FG000|Overall Study|pain scores at 24 hours not collected|1|||
27789408|NCT02143141|54244340|FG001|Overall Study|pain scores at 24 hours not collected|0|||
27789409|NCT02171065|54244349|FG000|Overall Study|Withdrawal by Subject|1|||
27934554|NCT01283009|54591223|FG001|Overall Study|Study ended early|26|||
27934555|NCT01283009|54591222|FG000|Overall Study|Withdrawal by Subject|10|||
27934556|NCT01283009|54591223|FG001|Overall Study|Withdrawal by Subject|8|||
27934557|NCT01283009|54591222|FG000|Overall Study|Physician Decision|1|||
27934558|NCT01283009|54591223|FG001|Overall Study|Physician Decision|1|||
27934559|NCT01283009|54591222|FG000|Overall Study|Lost to Follow-up|1|||
27934560|NCT01283009|54591223|FG001|Overall Study|Lost to Follow-up|0|||
27934561|NCT01283009|54591222|FG000|Overall Study|Patient Withdrawn by LAR/DPOA|0|||
27934562|NCT01283009|54591223|FG001|Overall Study|Patient Withdrawn by LAR/DPOA|4|||
27934563|NCT01282463|54591232|FG000|Overall Study|Lost to Follow-up|1|||
27934564|NCT01282463|54591233|FG001|Overall Study|Lost to Follow-up|0|||
27934565|NCT01282463|54591234|FG002|Overall Study|Lost to Follow-up|0|||
27934566|NCT01282463|54591232|FG000|Overall Study|Withdrawal by Subject|6|||
27934567|NCT01282463|54591233|FG001|Overall Study|Withdrawal by Subject|2|||
27934568|NCT01282463|54591234|FG002|Overall Study|Withdrawal by Subject|3|||
27934569|NCT01282463|54591232|FG000|Overall Study|"Never Treated Death"|0|||
27934570|NCT01282463|54591233|FG001|Overall Study|"Never Treated Death"|1|||
27934571|NCT01282463|54591234|FG002|Overall Study|"Never Treated Death"|0|||
27934572|NCT01282463|54591232|FG000|Overall Study|"Never Treated PD"|0|||
27934573|NCT01282463|54591233|FG001|Overall Study|"Never Treated PD"|1|||
27934574|NCT01282463|54591234|FG002|Overall Study|"Never Treated PD"|0|||
27934575|NCT01282463|54591232|FG000|Overall Study|Protocol Violation|0|||
27934576|NCT01282463|54591233|FG001|Overall Study|Protocol Violation|0|||
27934577|NCT01282463|54591234|FG002|Overall Study|Protocol Violation|1|||
27934578|NCT01282463|54591232|FG000|Overall Study|Physician Decision|1|||
27934579|NCT01282463|54591233|FG001|Overall Study|Physician Decision|0|||
27789410|NCT02171065|54244350|FG001|Overall Study|Withdrawal by Subject|0|||
27789411|NCT02171065|54244351|FG002|Overall Study|Withdrawal by Subject|0|||
27789412|NCT02171065|54244349|FG000|Overall Study|Lost to Follow-up|0|||
27789413|NCT02171065|54244350|FG001|Overall Study|Lost to Follow-up|0|||
27789414|NCT02171065|54244351|FG002|Overall Study|Lost to Follow-up|1|||
27789415|NCT01566604|54244363|FG000|Overall Study|Patient's inability to use the device|1|||
27789416|NCT01566604|54244364|FG001|Overall Study|Patient's inability to use the device|0|||
27789417|NCT01566604|54244363|FG000|Overall Study|Administrative problems|1|||
27789418|NCT01566604|54244364|FG001|Overall Study|Administrative problems|0|||
27789419|NCT01566604|54244363|FG000|Overall Study|Lack of Efficacy|1|||
27789420|NCT01566604|54244364|FG001|Overall Study|Lack of Efficacy|2|||
27789421|NCT01566604|54244363|FG000|Overall Study|Protocol deviation|2|||
27789422|NCT01566604|54244364|FG001|Overall Study|Protocol deviation|0|||
27789423|NCT01566604|54244363|FG000|Overall Study|Abnormal laboratory value|2|||
27789424|NCT01566604|54244364|FG001|Overall Study|Abnormal laboratory value|0|||
27789425|NCT01566604|54244363|FG000|Overall Study|Death|4|||
27789426|NCT01566604|54244364|FG001|Overall Study|Death|1|||
27789427|NCT01566604|54244363|FG000|Overall Study|Adverse Event|4|||
27789428|NCT01566604|54244364|FG001|Overall Study|Adverse Event|2|||
27789429|NCT01566604|54244363|FG000|Overall Study|Withdrawal by Subject|9|||
27789430|NCT01566604|54244364|FG001|Overall Study|Withdrawal by Subject|6|||
27789431|NCT01684930|54244372|FG000|Overall Study|Withdrawal by Subject|3|||
27789432|NCT01684930|54244373|FG001|Overall Study|Withdrawal by Subject|1|||
27789433|NCT01566214|54244381|FG000|Overall Study|Lost to Follow-up|3|||
27789434|NCT01566214|54244382|FG001|Overall Study|Lost to Follow-up|0|||
27789435|NCT02253992|54244391|FG000|Overall Study|Study drug toxicity|1|||
27789436|NCT02253992|54244392|FG001|Overall Study|Study drug toxicity|0|||
27789437|NCT02253992|54244393|FG002|Overall Study|Study drug toxicity|10|||
27789438|NCT02253992|54244391|FG000|Overall Study|Disease progression|4|||
27789439|NCT02253992|54244392|FG001|Overall Study|Disease progression|3|||
27789440|NCT02253992|54244393|FG002|Overall Study|Disease progression|98|||
27789441|NCT02253992|54244391|FG000|Overall Study|Withdrawal by Subject|0|||
27789442|NCT02253992|54244392|FG001|Overall Study|Withdrawal by Subject|0|||
27789443|NCT02253992|54244393|FG002|Overall Study|Withdrawal by Subject|3|||
27789444|NCT02253992|54244391|FG000|Overall Study|Adverse Event|0|||
27789445|NCT02253992|54244392|FG001|Overall Study|Adverse Event|0|||
27789446|NCT02253992|54244393|FG002|Overall Study|Adverse Event|8|||
27934580|NCT01282463|54591234|FG002|Overall Study|Physician Decision|0|||
27934581|NCT01282229|54591250|FG000|Overall Study|Protocol Violation|2|||
27789447|NCT02253992|54244391|FG000|Overall Study|Death|0|||
27789448|NCT02253992|54244392|FG001|Overall Study|Death|0|||
27789449|NCT02253992|54244393|FG002|Overall Study|Death|1|||
27789450|NCT02253992|54244391|FG000|Overall Study|Subject discontinued study drug|1|||
27789451|NCT02253992|54244392|FG001|Overall Study|Subject discontinued study drug|0|||
27789452|NCT02253992|54244393|FG002|Overall Study|Subject discontinued study drug|1|||
27789453|NCT02253992|54244391|FG000|Overall Study|Completed treatment as per protocol|0|||
27789454|NCT02253992|54244392|FG001|Overall Study|Completed treatment as per protocol|1|||
27789455|NCT02253992|54244393|FG002|Overall Study|Completed treatment as per protocol|22|||
27934582|NCT01281917|54591268|FG000|Overall Study|Withdrawal by Subject|1|||
27934583|NCT01281839|54591274|FG000|Overall Study|Lost to Follow-up|6|||
27934584|NCT01281839|54591275|FG001|Overall Study|Lost to Follow-up|3|||
27934585|NCT01281839|54591274|FG000|Overall Study|Withdrawal by Subject|4|||
27934586|NCT01281839|54591275|FG001|Overall Study|Withdrawal by Subject|10|||
27934587|NCT01281839|54591274|FG000|Overall Study|Reason not specified|0|||
27934588|NCT01281839|54591275|FG001|Overall Study|Reason not specified|1|||
27934589|NCT01281137|54591283|FG000|Baseline Population|No samples assayed (excluded from all analyses)|0|||
27934590|NCT01281137|54591284|FG001|Baseline Population|No samples assayed (excluded from all analyses)|1|||
27934591|NCT01281137|54591283|FG000|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|4|||
27934592|NCT01281137|54591284|FG001|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|9|||
27934593|NCT01281137|54591283|FG000|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|0|||
27934594|NCT01281137|54591284|FG001|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|5|||
27934595|NCT01281137|54591283|FG000|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|1|||
27934596|NCT01281137|54591284|FG001|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|0|||
27934597|NCT01281137|54591283|FG000|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|1|||
27934598|NCT01281137|54591284|FG001|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|2|||
27934599|NCT01280981|54591308|FG000|Overall Study|Withdrawal by Subject|11|||
27934600|NCT01280981|54591308|FG000|Overall Study|Protocol Violation|2|||
27934601|NCT01280981|54591308|FG000|Overall Study|Lack of Efficacy|13|||
27934602|NCT01280981|54591308|FG000|Overall Study|Lost to Follow-up|3|||
27934603|NCT01280981|54591308|FG000|Overall Study|Adverse Event|6|||
27934604|NCT01280981|54591308|FG000|Overall Study|Irregular or discontinued menses|3|||
27934605|NCT01280981|54591308|FG000|Overall Study|Failed to return|45|||
27934606|NCT01280981|54591308|FG000|Overall Study|Non-compliance with protocol|3|||
27934607|NCT01280981|54591308|FG000|Overall Study|Withdrawal of consent|3|||
27934608|NCT01280981|54591308|FG000|Overall Study|Elective surgery|2|||
27934609|NCT01280981|54591308|FG000|Overall Study|Study site closure|1|||
27934610|NCT01280903|54591314|FG000|Overall Study|Lost to Follow-up|23|||
27934611|NCT01280903|54591315|FG001|Overall Study|Lost to Follow-up|16|||
27934612|NCT01280591|54591325|FG000|Overall Study|Withdrawal by Subject|0|||
27934613|NCT01280591|54591326|FG001|Overall Study|Withdrawal by Subject|0|||
27934614|NCT01280591|54591327|FG002|Overall Study|Withdrawal by Subject|0|||
27934615|NCT01280591|54591328|FG003|Overall Study|Withdrawal by Subject|2|||
27934616|NCT01280591|54591325|FG000|Overall Study|Does not meet exclusion #27 criteria|0|||
27934617|NCT01280591|54591326|FG001|Overall Study|Does not meet exclusion #27 criteria|0|||
27934618|NCT01280591|54591327|FG002|Overall Study|Does not meet exclusion #27 criteria|0|||
27934619|NCT01280591|54591328|FG003|Overall Study|Does not meet exclusion #27 criteria|1|||
27934620|NCT01280357|54591338|FG000|Overall Study|Excluded no internal monitoring|14|||
27934621|NCT01280357|54591338|FG000|Overall Study|IInsufficient data/No data supplied|12|||
27934622|NCT01274351|54591345|FG000|Overall Study|Lost to Follow-up|1|||
27934623|NCT01274351|54591345|FG000|Overall Study|patient not compliant with the protocol|1|||
27934624|NCT01274351|54591345|FG000|Overall Study|Pregnancy|1|||
27934625|NCT01274351|54591345|FG000|Overall Study|Death|2|||
27934626|NCT01274351|54591345|FG000|Overall Study|Withdrawal by Subject|3|||
27934627|NCT01274351|54591345|FG000|Overall Study|Adverse Event|8|||
27934628|NCT01274351|54591345|FG000|Overall Study|progression of disease|3|||
27934629|NCT01274351|54591345|FG000|Overall Study|hospitalization|1|||
27934630|NCT01271933|54591349|FG000|Single-Blind Phase|Lack of Efficacy|37|||
27934631|NCT01271933|54591350|FG001|Single-Blind Phase|Lack of Efficacy|0|||
27934632|NCT01271933|54591351|FG002|Single-Blind Phase|Lack of Efficacy|0|||
27934633|NCT01271933|54591349|FG000|Single-Blind Phase|Lost to Follow-up|10|||
27934634|NCT01271933|54591350|FG001|Single-Blind Phase|Lost to Follow-up|0|||
27934635|NCT01271933|54591351|FG002|Single-Blind Phase|Lost to Follow-up|0|||
27934636|NCT01271933|54591349|FG000|Single-Blind Phase|Withdrawal by Subject|15|||
27934637|NCT01271933|54591350|FG001|Single-Blind Phase|Withdrawal by Subject|0|||
27934638|NCT01271933|54591351|FG002|Single-Blind Phase|Withdrawal by Subject|0|||
27934639|NCT01271933|54591349|FG000|Single-Blind Phase|Protocol Violation|3|||
27934640|NCT01271933|54591350|FG001|Single-Blind Phase|Protocol Violation|0|||
27934641|NCT01271933|54591351|FG002|Single-Blind Phase|Protocol Violation|0|||
27934642|NCT01271933|54591349|FG000|Single-Blind Phase|Adverse Event|52|||
27934643|NCT01271933|54591350|FG001|Single-Blind Phase|Adverse Event|0|||
27934644|NCT01271933|54591351|FG002|Single-Blind Phase|Adverse Event|0|||
27934645|NCT01271933|54591349|FG000|Single-Blind Phase|(Failed to meet dosing requirement)|1|||
27934646|NCT01271933|54591350|FG001|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
27934647|NCT01271933|54591351|FG002|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
27934648|NCT01271933|54591349|FG000|Single-Blind Phase|(Protocol non-compliance)|2|||
27934649|NCT01271933|54591350|FG001|Single-Blind Phase|(Protocol non-compliance)|0|||
27934650|NCT01271933|54591351|FG002|Single-Blind Phase|(Protocol non-compliance)|0|||
27934651|NCT01271933|54591349|FG000|Single-Blind Phase|(Participant request-personal reason)|1|||
27934652|NCT01271933|54591350|FG001|Single-Blind Phase|(Participant request-personal reason)|0|||
28017025|NCT00683618|54676262|FG002|Randomised Treatment Period|Adverse Event|2|||
27934653|NCT01271933|54591351|FG002|Single-Blind Phase|(Participant request-personal reason)|0|||
27934654|NCT01271933|54591349|FG000|Double-Blind Phase|Randomized but not treated|0|||
27934655|NCT01271933|54591350|FG001|Double-Blind Phase|Randomized but not treated|0|||
27934656|NCT01271933|54591351|FG002|Double-Blind Phase|Randomized but not treated|1|||
27934657|NCT01271933|54591349|FG000|Double-Blind Phase|Lack of Efficacy|0|||
27934658|NCT01271933|54591350|FG001|Double-Blind Phase|Lack of Efficacy|6|||
27934659|NCT01271933|54591351|FG002|Double-Blind Phase|Lack of Efficacy|9|||
27934660|NCT01271933|54591349|FG000|Double-Blind Phase|Lost to Follow-up|0|||
27934661|NCT01271933|54591350|FG001|Double-Blind Phase|Lost to Follow-up|1|||
27934662|NCT01271933|54591351|FG002|Double-Blind Phase|Lost to Follow-up|1|||
27789456|NCT02253992|54244391|FG000|Overall Study|Other|0|||
27789457|NCT02253992|54244392|FG001|Overall Study|Other|0|||
27789458|NCT02253992|54244393|FG002|Overall Study|Other|1|||
27789459|NCT02252588|54244417|FG000|Overall Study|Withdrawal by Subject|4|||
27789460|NCT02252588|54244418|FG001|Overall Study|Withdrawal by Subject|0|||
27789461|NCT01585558|54244427|FG000|Overall Study|Withdrawal by Subject|4|||
27789462|NCT01585558|54244428|FG001|Overall Study|Withdrawal by Subject|5|||
27789463|NCT01585558|54244429|FG002|Overall Study|Withdrawal by Subject|8|||
27789464|NCT01585558|54244427|FG000|Overall Study|Lost to Follow-up|2|||
27789465|NCT01585558|54244428|FG001|Overall Study|Lost to Follow-up|0|||
27789466|NCT01585558|54244429|FG002|Overall Study|Lost to Follow-up|3|||
27789467|NCT01585558|54244427|FG000|Overall Study|Adverse Event|3|||
27789468|NCT01585558|54244428|FG001|Overall Study|Adverse Event|4|||
27789469|NCT01585558|54244429|FG002|Overall Study|Adverse Event|1|||
27789470|NCT01585558|54244427|FG000|Overall Study|Protocol Violation|4|||
27789471|NCT01585558|54244428|FG001|Overall Study|Protocol Violation|3|||
27934663|NCT01271933|54591349|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
27934664|NCT01271933|54591350|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
27934665|NCT01271933|54591351|FG002|Double-Blind Phase|Withdrawal by Subject|1|||
27934666|NCT01271933|54591349|FG000|Double-Blind Phase|Adverse Event|0|||
27934667|NCT01271933|54591350|FG001|Double-Blind Phase|Adverse Event|3|||
27934668|NCT01271933|54591351|FG002|Double-Blind Phase|Adverse Event|0|||
27934669|NCT01271933|54591349|FG000|Double-Blind Phase|Participant request-personal reason|0|||
27934670|NCT01271933|54591350|FG001|Double-Blind Phase|Participant request-personal reason|1|||
27934671|NCT01271933|54591351|FG002|Double-Blind Phase|Participant request-personal reason|0|||
27934672|NCT01269125|54591364|FG000|Overall Study|Adverse Event|3|||
27934673|NCT01269125|54591365|FG001|Overall Study|Adverse Event|5|||
27934674|NCT01269125|54591366|FG002|Overall Study|Adverse Event|0|||
27934675|NCT01269125|54591364|FG000|Overall Study|Lost to Follow-up|4|||
27934676|NCT01269125|54591365|FG001|Overall Study|Lost to Follow-up|0|||
27934677|NCT01269125|54591366|FG002|Overall Study|Lost to Follow-up|0|||
27934678|NCT01268891|54591376|FG000|Overall Study|Adverse Event|3|||
27934679|NCT01268891|54591377|FG001|Overall Study|Adverse Event|7|||
27934680|NCT01268891|54591376|FG000|Overall Study|Lack of Efficacy|1|||
27934681|NCT01268891|54591377|FG001|Overall Study|Lack of Efficacy|0|||
27934682|NCT01268891|54591376|FG000|Overall Study|Withdrawal of Consent|3|||
27934683|NCT01268891|54591377|FG001|Overall Study|Withdrawal of Consent|1|||
27934684|NCT01268891|54591376|FG000|Overall Study|Administrative or other reason(s)|1|||
27934685|NCT01268891|54591377|FG001|Overall Study|Administrative or other reason(s)|0|||
27934686|NCT01268501|54591383|FG000|Overall Study|Lost to Follow-up|1|||
27934687|NCT01268501|54591383|FG000|Overall Study|Withdrawal by Subject|3|||
27934688|NCT01268501|54591383|FG000|Overall Study|Unacceptable Subjective Vision|3|||
27934689|NCT01268501|54591383|FG000|Overall Study|Handling Difficulties|2|||
27934690|NCT01268267|54591387|FG000|Overall Study|Protocol Violation|1|||
27934691|NCT01267253|54591392|FG000|Overall Study|Ineligible - required test not done|1|||
27934692|NCT01267253|54591392|FG000|Overall Study|Inevaluable-never received study treatme|2|||
27934693|NCT01266317|54591396|FG000|Overall Study|Withdrawal by Subject|2|||
27934694|NCT01266161|54591402|FG000|Overall Study|Ineligible|1|||
27934695|NCT01266161|54591403|FG001|Overall Study|Ineligible|0|||
27934696|NCT01266161|54591402|FG000|Overall Study|Lack of Efficacy|0|||
27934697|NCT01266161|54591403|FG001|Overall Study|Lack of Efficacy|1|||
27789472|NCT01585558|54244429|FG002|Overall Study|Protocol Violation|2|||
27789473|NCT01585558|54244427|FG000|Overall Study|Lack of Efficacy|0|||
27789474|NCT01585558|54244428|FG001|Overall Study|Lack of Efficacy|0|||
27789475|NCT01585558|54244429|FG002|Overall Study|Lack of Efficacy|1|||
27789476|NCT01565980|54244439|FG000|Overall Study|Death|1|||
27934698|NCT01266161|54591402|FG000|Overall Study|Vomited within 4 hours of dosing|3|||
27934699|NCT01266161|54591403|FG001|Overall Study|Vomited within 4 hours of dosing|0|||
27934700|NCT01265849|54591412|FG000|Overall Study|Randomized//Treatment not initiated|1|||
27934701|NCT01265849|54591413|FG001|Overall Study|Randomized//Treatment not initiated|4|||
27934702|NCT01265849|54591414|FG002|Overall Study|Randomized//Treatment not initiated|0|||
27934703|NCT01265849|54591412|FG000|Overall Study|Physician Decision|1|||
27934704|NCT01265849|54591413|FG001|Overall Study|Physician Decision|2|||
27789477|NCT01565980|54244440|FG001|Overall Study|Death|0|||
27789478|NCT01565980|54244439|FG000|Overall Study|Lost to Follow-up|1|||
27934705|NCT01265849|54591414|FG002|Overall Study|Physician Decision|0|||
28105596|NCT04882995|54763043|FG000|Overall Study|Withdrawal by Subject|1|||
27934706|NCT01265849|54591412|FG000|Overall Study|Lost to Follow-up|18|||
27934707|NCT01265849|54591413|FG001|Overall Study|Lost to Follow-up|15|||
27934708|NCT01265849|54591414|FG002|Overall Study|Lost to Follow-up|5|||
27934709|NCT01265849|54591412|FG000|Overall Study|Not otherwise specified|1|||
27934710|NCT01265849|54591413|FG001|Overall Study|Not otherwise specified|6|||
27934711|NCT01265849|54591414|FG002|Overall Study|Not otherwise specified|1|||
27934712|NCT01265849|54591412|FG000|Overall Study|Withdrawal by Subject|25|||
27934713|NCT01265849|54591413|FG001|Overall Study|Withdrawal by Subject|34|||
27934714|NCT01265849|54591414|FG002|Overall Study|Withdrawal by Subject|13|||
27934715|NCT01265615|54591430|FG000|Overall Study|Protocol Violation|2|||
27934716|NCT01265615|54591431|FG001|Overall Study|Protocol Violation|2|||
27934717|NCT01265615|54591432|FG002|Overall Study|Protocol Violation|4|||
27934718|NCT01265615|54591433|FG003|Overall Study|Protocol Violation|3|||
27934719|NCT01264835|54591443|FG000|Overall Study|Lost to Follow-up|1|||
27934720|NCT01264679|54591447|FG000|Overall Study|Participation in Another Clinical Trial|1|||
27934721|NCT01264679|54591447|FG000|Overall Study|Physician Decision|1|||
27934722|NCT01264679|54591447|FG000|Overall Study|Sponsor's Suspension of Dosing|2|||
27934723|NCT01264679|54591447|FG000|Overall Study|Withdrawal by Subject|1|||
27934724|NCT01263665|54591452|FG000|Overall Study|Withdrew Consent|1|||
27934725|NCT01263665|54591452|FG000|Overall Study|Lost to Follow-up|3|||
27934726|NCT01263665|54591452|FG000|Overall Study|Death|2|||
27934727|NCT01263665|54591452|FG000|Overall Study|Amputation above the ankle|1|||
27934728|NCT01263665|54591452|FG000|Overall Study|Surgical Bypass|2|||
27934729|NCT01263509|54591458|FG000|Entered - Long-Term Extension Study|Adverse Event|5|||
27934730|NCT01263509|54591459|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
27934731|NCT01263509|54591460|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
27934732|NCT01263509|54591461|FG003|Entered - Long-Term Extension Study|Adverse Event|1|||
27934733|NCT01263509|54591458|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
27934734|NCT01263509|54591459|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
27934735|NCT01263509|54591460|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
27934736|NCT01263509|54591461|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
27934737|NCT01263509|54591458|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
27934738|NCT01263509|54591459|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
27934739|NCT01263509|54591460|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
27934740|NCT01263509|54591461|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
27934741|NCT01263509|54591458|FG000|Entered - Long-Term Extension Study|Participant Unavailability|1|||
27934742|NCT01263509|54591459|FG001|Entered - Long-Term Extension Study|Participant Unavailability|1|||
27934743|NCT01263509|54591460|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
27934744|NCT01263509|54591461|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
27934745|NCT01263509|54591458|FG000|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
27934746|NCT01263509|54591459|FG001|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
27934747|NCT01263509|54591460|FG002|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
27934748|NCT01263509|54591461|FG003|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1|||
27934749|NCT01263197|54591469|FG000|First Intervention (Period 1)|Adverse Event|0|||
27789479|NCT01565980|54244440|FG001|Overall Study|Lost to Follow-up|0|||
27789480|NCT01565980|54244439|FG000|Overall Study|health complications|1|||
27789481|NCT01565980|54244440|FG001|Overall Study|health complications|1|||
27789482|NCT01565980|54244439|FG000|Overall Study|stopped medical treatment|1|||
27789483|NCT01565980|54244440|FG001|Overall Study|stopped medical treatment|0|||
27789484|NCT01565980|54244439|FG000|Overall Study|Withdrawal by Subject|0|||
27789485|NCT01565980|54244440|FG001|Overall Study|Withdrawal by Subject|3|||
27789486|NCT01585246|54244455|FG000|Overall Study|Lost to Follow-up|0|||
27789487|NCT01585246|54244456|FG001|Overall Study|Lost to Follow-up|0|||
27789488|NCT01585246|54244457|FG002|Overall Study|Lost to Follow-up|2|||
27789489|NCT01585246|54244458|FG003|Overall Study|Lost to Follow-up|1|||
27934750|NCT01263197|54591470|FG001|First Intervention (Period 1)|Adverse Event|0|||
27934751|NCT01263197|54591471|FG002|First Intervention (Period 1)|Adverse Event|0|||
27934752|NCT01263197|54591472|FG003|First Intervention (Period 1)|Adverse Event|0|||
27934753|NCT01263197|54591473|FG004|First Intervention (Period 1)|Adverse Event|0|||
27934754|NCT01263197|54591474|FG005|First Intervention (Period 1)|Adverse Event|1|||
27934755|NCT01263197|54591469|FG000|Washout Period 1|Protocol Violation|0|||
27934756|NCT01263197|54591470|FG001|Washout Period 1|Protocol Violation|0|||
27934757|NCT01263197|54591471|FG002|Washout Period 1|Protocol Violation|0|||
27934758|NCT01263197|54591472|FG003|Washout Period 1|Protocol Violation|0|||
27934759|NCT01263197|54591473|FG004|Washout Period 1|Protocol Violation|1|||
27789490|NCT01585246|54244459|FG004|Overall Study|Lost to Follow-up|0|||
27789491|NCT01585246|54244455|FG000|Overall Study|Protocol Violation|0|||
27789492|NCT01585246|54244456|FG001|Overall Study|Protocol Violation|0|||
27934760|NCT01263197|54591474|FG005|Washout Period 1|Protocol Violation|0|||
27934761|NCT01263197|54591469|FG000|Washout Period 2|Physician Decision|0|||
27934762|NCT01263197|54591470|FG001|Washout Period 2|Physician Decision|0|||
27789493|NCT01585246|54244457|FG002|Overall Study|Protocol Violation|0|||
27934763|NCT01263197|54591471|FG002|Washout Period 2|Physician Decision|0|||
27934764|NCT01263197|54591472|FG003|Washout Period 2|Physician Decision|0|||
27934765|NCT01263197|54591473|FG004|Washout Period 2|Physician Decision|0|||
27934766|NCT01263197|54591474|FG005|Washout Period 2|Physician Decision|1|||
27934767|NCT01263197|54591469|FG000|Washout Period 2|Protocol Violation|0|||
27934768|NCT01263197|54591470|FG001|Washout Period 2|Protocol Violation|0|||
27934769|NCT01263197|54591471|FG002|Washout Period 2|Protocol Violation|0|||
27934770|NCT01263197|54591472|FG003|Washout Period 2|Protocol Violation|1|||
27934771|NCT01263197|54591473|FG004|Washout Period 2|Protocol Violation|0|||
27934772|NCT01263197|54591474|FG005|Washout Period 2|Protocol Violation|0|||
27934773|NCT01263197|54591469|FG000|Third Intervention (Period 3)|Adverse Event|0|||
27934774|NCT01263197|54591470|FG001|Third Intervention (Period 3)|Adverse Event|1|||
27934775|NCT01263197|54591471|FG002|Third Intervention (Period 3)|Adverse Event|0|||
27934776|NCT01263197|54591472|FG003|Third Intervention (Period 3)|Adverse Event|0|||
27934777|NCT01263197|54591473|FG004|Third Intervention (Period 3)|Adverse Event|0|||
27934778|NCT01263197|54591474|FG005|Third Intervention (Period 3)|Adverse Event|0|||
27934779|NCT01263119|54591488|FG000|Period 1|Protocol Violation|2|||
27934780|NCT01263119|54591488|FG000|Period 2|Adverse Event|2|||
27934781|NCT01262651|54591498|FG000|Overall Study|Adverse Event|40|||
27934782|NCT01262651|54591499|FG001|Overall Study|Adverse Event|35|||
27934783|NCT01262651|54591498|FG000|Overall Study|Withdrawal by Subject|15|||
27934784|NCT01262651|54591499|FG001|Overall Study|Withdrawal by Subject|11|||
27934785|NCT01262651|54591498|FG000|Overall Study|Withdrawal by Investigator|2|||
27934786|NCT01262651|54591499|FG001|Overall Study|Withdrawal by Investigator|2|||
27934787|NCT01262651|54591498|FG000|Overall Study|Met Withdrawal Criteria|1|||
27934788|NCT01262651|54591499|FG001|Overall Study|Met Withdrawal Criteria|0|||
27934789|NCT01262573|54591507|FG000|Overall Study|Withdrawal by Subject|0|||
27934790|NCT01262573|54591508|FG001|Overall Study|Withdrawal by Subject|1|||
27934791|NCT01262027|54591514|FG000|Overall Study|Adverse Event|1|||
27934792|NCT01262027|54591514|FG000|Overall Study|Withdrawal by Subject|3|||
27934793|NCT01262027|54591514|FG000|Overall Study|Protocol Violation|1|||
27934794|NCT01261793|54591521|FG000|Overall Study|Lack of Efficacy|44|||
27934795|NCT01261793|54591522|FG001|Overall Study|Lack of Efficacy|37|||
27934796|NCT01261793|54591523|FG002|Overall Study|Lack of Efficacy|32|||
27934797|NCT01261793|54591521|FG000|Overall Study|Protocol Violation|3|||
27934798|NCT01261793|54591522|FG001|Overall Study|Protocol Violation|5|||
27934799|NCT01261793|54591523|FG002|Overall Study|Protocol Violation|6|||
27934800|NCT01261793|54591521|FG000|Overall Study|Lost to Follow-up|10|||
27934801|NCT01261793|54591522|FG001|Overall Study|Lost to Follow-up|3|||
27934802|NCT01261793|54591523|FG002|Overall Study|Lost to Follow-up|7|||
27789494|NCT01585246|54244458|FG003|Overall Study|Protocol Violation|0|||
27789495|NCT01585246|54244459|FG004|Overall Study|Protocol Violation|1|||
27789496|NCT01585246|54244455|FG000|Overall Study|Withdrawal by Subject|0|||
27789497|NCT01585246|54244456|FG001|Overall Study|Withdrawal by Subject|0|||
27789498|NCT01585246|54244457|FG002|Overall Study|Withdrawal by Subject|1|||
27789499|NCT01585246|54244458|FG003|Overall Study|Withdrawal by Subject|2|||
27789500|NCT01585246|54244459|FG004|Overall Study|Withdrawal by Subject|1|||
27789501|NCT01585246|54244455|FG000|Overall Study|Other|0|||
27789502|NCT01585246|54244456|FG001|Overall Study|Other|1|||
27789503|NCT01585246|54244457|FG002|Overall Study|Other|1|||
27789504|NCT01585246|54244458|FG003|Overall Study|Other|1|||
27789505|NCT01585246|54244459|FG004|Overall Study|Other|0|||
27934803|NCT01261793|54591521|FG000|Overall Study|Withdrawal by Subject|12|||
27934804|NCT01261793|54591522|FG001|Overall Study|Withdrawal by Subject|14|||
27934805|NCT01261793|54591523|FG002|Overall Study|Withdrawal by Subject|14|||
27934806|NCT01261793|54591521|FG000|Overall Study|Death|3|||
27934807|NCT01261793|54591522|FG001|Overall Study|Death|1|||
27934808|NCT01261793|54591523|FG002|Overall Study|Death|0|||
27934809|NCT01261793|54591521|FG000|Overall Study|Adverse Event|9|||
27934810|NCT01261793|54591522|FG001|Overall Study|Adverse Event|24|||
27934811|NCT01261793|54591523|FG002|Overall Study|Adverse Event|19|||
27934812|NCT01261793|54591521|FG000|Overall Study|Patient non-availability|1|||
27789506|NCT01585168|54244476|FG000|Overall Study|Lost to Follow-up|3|||
27789507|NCT01585168|54244477|FG001|Overall Study|Lost to Follow-up|1|||
27789508|NCT01585168|54244478|FG002|Overall Study|Lost to Follow-up|1|||
27934813|NCT01261793|54591522|FG001|Overall Study|Patient non-availability|1|||
27934814|NCT01261793|54591523|FG002|Overall Study|Patient non-availability|1|||
27789509|NCT01585168|54244479|FG003|Overall Study|Lost to Follow-up|1|||
27934815|NCT01261793|54591521|FG000|Overall Study|Suspected pregnancy|1|||
27934816|NCT01261793|54591522|FG001|Overall Study|Suspected pregnancy|1|||
28105597|NCT04882995|54763044|FG001|Overall Study|Withdrawal by Subject|2|||
27934817|NCT01261793|54591523|FG002|Overall Study|Suspected pregnancy|0|||
27934818|NCT01261793|54591521|FG000|Overall Study|Patient non-compliance|1|||
27934819|NCT01261793|54591522|FG001|Overall Study|Patient non-compliance|0|||
27934820|NCT01261793|54591523|FG002|Overall Study|Patient non-compliance|1|||
27934821|NCT01261793|54591521|FG000|Overall Study|Patient pregnant|1|||
27934822|NCT01261793|54591522|FG001|Overall Study|Patient pregnant|0|||
27934823|NCT01261793|54591523|FG002|Overall Study|Patient pregnant|0|||
27934824|NCT01261793|54591521|FG000|Overall Study|Outside the study area|0|||
27934825|NCT01261793|54591522|FG001|Overall Study|Outside the study area|2|||
27934826|NCT01261793|54591523|FG002|Overall Study|Outside the study area|1|||
27934827|NCT01261793|54591521|FG000|Overall Study|Lack of efficacy & patient not available|0|||
27934828|NCT01261793|54591522|FG001|Overall Study|Lack of efficacy & patient not available|1|||
27934829|NCT01261793|54591523|FG002|Overall Study|Lack of efficacy & patient not available|0|||
27934830|NCT01261793|54591521|FG000|Overall Study|Patient withdrew after cardiology visit|0|||
27934831|NCT01261793|54591522|FG001|Overall Study|Patient withdrew after cardiology visit|1|||
27934832|NCT01261793|54591523|FG002|Overall Study|Patient withdrew after cardiology visit|0|||
27934833|NCT01261793|54591521|FG000|Overall Study|Randomization error|0|||
27934834|NCT01261793|54591522|FG001|Overall Study|Randomization error|1|||
27934835|NCT01261793|54591523|FG002|Overall Study|Randomization error|0|||
27934836|NCT01261793|54591521|FG000|Overall Study|Patient unable to start IV line|0|||
27934837|NCT01261793|54591522|FG001|Overall Study|Patient unable to start IV line|0|||
27934838|NCT01261793|54591523|FG002|Overall Study|Patient unable to start IV line|1|||
27934839|NCT01261325|54591534|FG000|Overall Study|Lack of Efficacy|1|||
27934840|NCT01261325|54591535|FG001|Overall Study|Lack of Efficacy|1|||
27934841|NCT01261325|54591536|FG002|Overall Study|Lack of Efficacy|0|||
27934842|NCT01261325|54591534|FG000|Overall Study|Withdrawal by Subject|2|||
27934843|NCT01261325|54591535|FG001|Overall Study|Withdrawal by Subject|2|||
27934844|NCT01261325|54591536|FG002|Overall Study|Withdrawal by Subject|4|||
27934845|NCT01261325|54591534|FG000|Overall Study|SAE, non-fatal|1|||
27934846|NCT01261325|54591535|FG001|Overall Study|SAE, non-fatal|5|||
27934847|NCT01261325|54591536|FG002|Overall Study|SAE, non-fatal|1|||
27934848|NCT01261325|54591534|FG000|Overall Study|AE, non-serious non-fatal|9|||
27934849|NCT01261325|54591535|FG001|Overall Study|AE, non-serious non-fatal|15|||
27934850|NCT01261325|54591536|FG002|Overall Study|AE, non-serious non-fatal|13|||
27934851|NCT01261325|54591534|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
27934852|NCT01261325|54591535|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
27934853|NCT01261325|54591536|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
27934854|NCT01261325|54591534|FG000|Overall Study|Non Compliance|2|||
27934855|NCT01261325|54591535|FG001|Overall Study|Non Compliance|0|||
27934856|NCT01261325|54591536|FG002|Overall Study|Non Compliance|0|||
27934857|NCT01261325|54591534|FG000|Overall Study|Patient Randomized by Mistake|0|||
27934858|NCT01261325|54591535|FG001|Overall Study|Patient Randomized by Mistake|1|||
27934859|NCT01261325|54591536|FG002|Overall Study|Patient Randomized by Mistake|0|||
27934860|NCT01261325|54591534|FG000|Overall Study|Erroneously Randomized|1|||
27934861|NCT01261325|54591535|FG001|Overall Study|Erroneously Randomized|0|||
27934862|NCT01261325|54591536|FG002|Overall Study|Erroneously Randomized|0|||
27934863|NCT01261325|54591534|FG000|Overall Study|Screen Failure|1|||
27934864|NCT01261325|54591535|FG001|Overall Study|Screen Failure|0|||
27934865|NCT01261325|54591536|FG002|Overall Study|Screen Failure|0|||
27934866|NCT01261325|54591534|FG000|Overall Study|Randomized in Error|0|||
27934867|NCT01261325|54591535|FG001|Overall Study|Randomized in Error|0|||
27934868|NCT01261325|54591536|FG002|Overall Study|Randomized in Error|1|||
27934869|NCT01261325|54591534|FG000|Overall Study|Protocol Violation|0|||
27934870|NCT01261325|54591535|FG001|Overall Study|Protocol Violation|3|||
27934871|NCT01261325|54591536|FG002|Overall Study|Protocol Violation|1|||
27934872|NCT01261325|54591534|FG000|Overall Study|Lost to Follow-up|0|||
27934873|NCT01261325|54591535|FG001|Overall Study|Lost to Follow-up|1|||
27934874|NCT01261325|54591536|FG002|Overall Study|Lost to Follow-up|3|||
27934875|NCT01261325|54591534|FG000|Overall Study|AE, serious fatal|0|||
27934876|NCT01261325|54591535|FG001|Overall Study|AE, serious fatal|0|||
27934877|NCT01261325|54591536|FG002|Overall Study|AE, serious fatal|2|||
27943475|NCT00929110|54600375|FG002|Overall Study|Abnormal test procedure result(s)|1|||
27943476|NCT00929110|54600373|FG000|Overall Study|Patient inability to use the device|0|||
27934878|NCT01260701|54591547|FG000|Overall Study|Adverse Event|9|||
27934879|NCT01260701|54591547|FG000|Overall Study|Withdrawal by Subject|2|||
27934880|NCT01260701|54591547|FG000|Overall Study|Progression|53|||
27934881|NCT01260701|54591547|FG000|Overall Study|Death|2|||
27934882|NCT01260701|54591547|FG000|Overall Study|Not protocol specified|3|||
27934883|NCT01260701|54591547|FG000|Overall Study|Under review|1|||
27934884|NCT01260701|54591547|FG000|Overall Study|Ineligible|4|||
27934885|NCT01260701|54591547|FG000|Overall Study|Did not begin protocol therapy|1|||
27934886|NCT01260467|54591551|FG000|Overall Study|Withdrawal by Subject|2|||
27934887|NCT01260311|54591557|FG000|Overall Study|Adverse Event|11|||
27934888|NCT01260311|54591557|FG000|Overall Study|Lack of Efficacy|4|||
27934889|NCT01260311|54591557|FG000|Overall Study|Lost to Follow-up|25|||
27934890|NCT01260311|54591557|FG000|Overall Study|Withdrawal by Subject|6|||
27934891|NCT01260311|54591557|FG000|Overall Study|Financial Constraints|77|||
27934892|NCT01260311|54591557|FG000|Overall Study|Gone to Province|2|||
27934893|NCT01260311|54591557|FG000|Overall Study|Medication Stopped|1|||
27934894|NCT01260311|54591557|FG000|Overall Study|Fesoterodine Started Before Enrollment|1|||
27934895|NCT01259375|54591561|FG000|Overall Study|Adverse Event|1|||
27934896|NCT01940471|54591578|FG000|Double-Blind Phase|Randomized but Never Treated|1|||
27934897|NCT01940471|54591579|FG001|Double-Blind Phase|Randomized but Never Treated|1|||
27934898|NCT01940471|54591578|FG000|Double-Blind Phase|Withdrew Consent|13|||
27934899|NCT01940471|54591579|FG001|Double-Blind Phase|Withdrew Consent|7|||
27934900|NCT01940471|54591578|FG000|Double-Blind Phase|Adverse Event|1|||
27934901|NCT01940471|54591579|FG001|Double-Blind Phase|Adverse Event|2|||
27934902|NCT01940471|54591578|FG000|Double-Blind Phase|Lost to Follow-up|3|||
27934903|NCT01940471|54591579|FG001|Double-Blind Phase|Lost to Follow-up|2|||
27934904|NCT01940471|54591578|FG000|Double-Blind Phase|Pregnancy|2|||
27934905|NCT01940471|54591579|FG001|Double-Blind Phase|Pregnancy|1|||
27934906|NCT01940471|54591578|FG000|Double-Blind Phase|Investigator's Discretion|5|||
27934907|NCT01940471|54591579|FG001|Double-Blind Phase|Investigator's Discretion|0|||
27934908|NCT01940471|54591578|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
27934909|NCT01940471|54591579|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
27934910|NCT01940471|54591578|FG000|Double-Blind Phase|Protocol-Specified Criteria|1|||
27934911|NCT01940471|54591579|FG001|Double-Blind Phase|Protocol-Specified Criteria|0|||
27934912|NCT01940471|54591578|FG000|Double-Blind Phase|Death|1|||
27934913|NCT01940471|54591579|FG001|Double-Blind Phase|Death|0|||
27934914|NCT01940471|54591578|FG000|Double-Blind Phase|Lack of Efficacy|1|||
27934915|NCT01940471|54591579|FG001|Double-Blind Phase|Lack of Efficacy|0|||
27934916|NCT01940471|54591578|FG000|Double-Blind Phase|Protocol Violation|0|||
27934917|NCT01940471|54591579|FG001|Double-Blind Phase|Protocol Violation|1|||
27934918|NCT01940471|54591578|FG000|Double-Blind Phase|Still in Double-Blind Phase|539|||
27934919|NCT01940471|54591579|FG001|Double-Blind Phase|Still in Double-Blind Phase|270|||
27934920|NCT01940471|54591578|FG000|Open-Label Extension|Still in Open-Label Extension Phase|14|||
27934921|NCT01940471|54591579|FG001|Open-Label Extension|Still in Open-Label Extension Phase|8|||
27934922|NCT01321073|54591586|FG000|Overall Study|Did not attempt implant|4|||
27934923|NCT01321073|54591586|FG000|Overall Study|Death|3|||
27934924|NCT01259297|54591598|FG000|Double Blind Randomized Period|Death|1|||
27789510|NCT02232074|54244489|FG000|Overall Study|Withdrawal by Subject|5|||
27789511|NCT02232074|54244490|FG001|Overall Study|Withdrawal by Subject|3|||
27789512|NCT02232074|54244489|FG000|Overall Study|No legal concerns at baseline|36|||
27789513|NCT02232074|54244490|FG001|Overall Study|No legal concerns at baseline|41|||
27789514|NCT02232074|54244489|FG000|Overall Study|deemed ineligible|0|||
27934925|NCT01259297|54591599|FG001|Double Blind Randomized Period|Death|1|||
27934926|NCT01259297|54591600|FG002|Double Blind Randomized Period|Death|1|||
27934927|NCT01259297|54591601|FG003|Double Blind Randomized Period|Death|2|||
27934928|NCT01259297|54591602|FG004|Double Blind Randomized Period|Death|1|||
27934929|NCT01259297|54591603|FG005|Double Blind Randomized Period|Death|5|||
27934930|NCT01259297|54591604|FG006|Double Blind Randomized Period|Death|2|||
27934931|NCT01259297|54591605|FG007|Double Blind Randomized Period|Death|1|||
27934932|NCT01259297|54591598|FG000|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
27934933|NCT01259297|54591599|FG001|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
27934934|NCT01259297|54591600|FG002|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0|||
27934935|NCT01259297|54591601|FG003|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
27934936|NCT01259297|54591602|FG004|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
27934937|NCT01259297|54591603|FG005|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
27934938|NCT01259297|54591604|FG006|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
27934939|NCT01259297|54591605|FG007|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
27934940|NCT01259297|54591598|FG000|Double Blind Randomized Period|Other reasons|0|||
27934941|NCT01259297|54591599|FG001|Double Blind Randomized Period|Other reasons|1|||
27934942|NCT01259297|54591600|FG002|Double Blind Randomized Period|Other reasons|0|||
27934943|NCT01259297|54591601|FG003|Double Blind Randomized Period|Other reasons|0|||
27934944|NCT01259297|54591602|FG004|Double Blind Randomized Period|Other reasons|1|||
27934945|NCT01259297|54591603|FG005|Double Blind Randomized Period|Other reasons|2|||
27934946|NCT01259297|54591604|FG006|Double Blind Randomized Period|Other reasons|3|||
27934947|NCT01259297|54591605|FG007|Double Blind Randomized Period|Other reasons|1|||
27934948|NCT01126437|54591625|FG000|Overall Study|Not treated|11|||
27934949|NCT01126437|54591626|FG001|Overall Study|Not treated|18|||
27934950|NCT01126437|54591627|FG002|Overall Study|Not treated|19|||
27934951|NCT01126437|54591625|FG000|Overall Study|Sites with data irregularities/fraud|6|||
27934952|NCT01126437|54591626|FG001|Overall Study|Sites with data irregularities/fraud|6|||
27934953|NCT01126437|54591627|FG002|Overall Study|Sites with data irregularities/fraud|7|||
27934954|NCT01126437|54591625|FG000|Overall Study|Adverse Event|602|||
27934955|NCT01126437|54591626|FG001|Overall Study|Adverse Event|606|||
27934956|NCT01126437|54591627|FG002|Overall Study|Adverse Event|635|||
27934957|NCT01126437|54591625|FG000|Overall Study|Lack of Efficacy|65|||
27934958|NCT01126437|54591626|FG001|Overall Study|Lack of Efficacy|60|||
27934959|NCT01126437|54591627|FG002|Overall Study|Lack of Efficacy|59|||
27934960|NCT01126437|54591625|FG000|Overall Study|Protocol Violation|64|||
27934961|NCT01126437|54591626|FG001|Overall Study|Protocol Violation|66|||
27934962|NCT01126437|54591627|FG002|Overall Study|Protocol Violation|41|||
27934963|NCT01126437|54591625|FG000|Overall Study|Lost to Follow-up|52|||
27934964|NCT01126437|54591626|FG001|Overall Study|Lost to Follow-up|63|||
27934965|NCT01126437|54591627|FG002|Overall Study|Lost to Follow-up|55|||
27934966|NCT01126437|54591625|FG000|Overall Study|Withdrawal by Subject|331|||
27934967|NCT01126437|54591626|FG001|Overall Study|Withdrawal by Subject|335|||
27934968|NCT01126437|54591627|FG002|Overall Study|Withdrawal by Subject|319|||
27934969|NCT01126437|54591625|FG000|Overall Study|Other reason not specified|210|||
27934970|NCT01126437|54591626|FG001|Overall Study|Other reason not specified|176|||
27934971|NCT01126437|54591627|FG002|Overall Study|Other reason not specified|178|||
27934972|NCT01258595|54591637|FG000|Overall Study|Lost to Follow-up|1|||
27934973|NCT01258595|54591638|FG001|Overall Study|Lost to Follow-up|0|||
27934974|NCT01258595|54591637|FG000|Overall Study|Withdrawal by Subject|0|||
27934975|NCT01258595|54591638|FG001|Overall Study|Withdrawal by Subject|1|||
27934976|NCT01257737|54591646|FG000|Overall Study|Lost to Follow-up|1|||
27934977|NCT01257737|54591647|FG001|Overall Study|Lost to Follow-up|2|||
27934978|NCT01257737|54591646|FG000|Overall Study|Liver transplant|1|||
27934979|NCT01257737|54591647|FG001|Overall Study|Liver transplant|0|||
27934980|NCT01257737|54591646|FG000|Overall Study|Relocation out of the country|0|||
27934981|NCT01257737|54591647|FG001|Overall Study|Relocation out of the country|1|||
27934982|NCT01257737|54591646|FG000|Overall Study|Withdrew from study|0|||
27789515|NCT02232074|54244490|FG001|Overall Study|deemed ineligible|1|||
27789516|NCT02142283|54244504|FG000|Overall Study|Death|20|||
27789517|NCT02142283|54244505|FG001|Overall Study|Death|18|||
27789518|NCT02142283|54244504|FG000|Overall Study|Withdrawal by Subject|1|||
27789519|NCT02142283|54244505|FG001|Overall Study|Withdrawal by Subject|3|||
27789520|NCT02231918|54244514|FG000|Overall Study|Withdrawal by Subject|0|||
27789521|NCT02231918|54244515|FG001|Overall Study|Withdrawal by Subject|1|||
27789522|NCT02231918|54244516|FG002|Overall Study|Withdrawal by Subject|0|||
27789523|NCT02231918|54244514|FG000|Overall Study|Adverse Event|0|||
27789524|NCT02231918|54244515|FG001|Overall Study|Adverse Event|0|||
27789525|NCT02231918|54244516|FG002|Overall Study|Adverse Event|1|||
27789526|NCT02199314|54244524|FG000|Overall Study|Withdrawal by Subject|6|||
27789527|NCT02199314|54244524|FG000|Overall Study|Physician Decision|10|||
27789528|NCT02199080|54244528|FG000|Overall Study|Protocol Violation|12|||
27789529|NCT02251652|54244534|FG000|Overall Study|Withdrawal by Subject|1|||
27789530|NCT02197520|54244540|FG000|Period 1|Withdrawal by Subject|1|||
27934983|NCT01257737|54591647|FG001|Overall Study|Withdrew from study|1|||
27789531|NCT02197520|54244541|FG001|Period 1|Withdrawal by Subject|0|||
27789532|NCT02197520|54244540|FG000|Period 2|Adverse Event|0|||
27789533|NCT02197520|54244541|FG001|Period 2|Adverse Event|2|||
27789534|NCT02197520|54244540|FG000|Period 2|Withdrawal by Subject|1|||
27789535|NCT02197520|54244541|FG001|Period 2|Withdrawal by Subject|0|||
27789536|NCT02230904|54244551|FG000|Overall Study|Safety follow up could not take place|0|||
27789537|NCT02230904|54244552|FG001|Overall Study|Safety follow up could not take place|1|||
27789538|NCT02230670|54244562|FG000|Overall Study|Adverse Event|1|||
27789539|NCT02230670|54244563|FG001|Overall Study|Adverse Event|2|||
27789540|NCT02230670|54244562|FG000|Overall Study|Withdrawal by Subject|2|||
27789541|NCT02230670|54244563|FG001|Overall Study|Withdrawal by Subject|2|||
27934984|NCT01126359|54591654|FG000|First Intervention (20-minutes)|Physician Decision|0|||
27789542|NCT02230670|54244562|FG000|Overall Study|Physician Decision|0|||
27934985|NCT01126359|54591655|FG001|First Intervention (20-minutes)|Physician Decision|1|||
27934986|NCT01125813|54591665|FG000|Overall Study|Death|1|||
27934987|NCT01125813|54591665|FG000|Overall Study|Withdrawal by Subject|1|||
27934988|NCT01125813|54591665|FG000|Overall Study|Screen Failures|4|||
27934989|NCT00996892|54591669|FG000|Dose-Escalation Stage 1|Adverse Event|0|||
27789543|NCT02230670|54244563|FG001|Overall Study|Physician Decision|1|||
27789544|NCT02230670|54244562|FG000|Overall Study|Protocol Violation|0|||
27789545|NCT02230670|54244563|FG001|Overall Study|Protocol Violation|1|||
27934990|NCT00996892|54591670|FG001|Dose-Escalation Stage 1|Adverse Event|0|||
27934991|NCT00996892|54591671|FG002|Dose-Escalation Stage 1|Adverse Event|0|||
27934992|NCT00996892|54591672|FG003|Dose-Escalation Stage 1|Adverse Event|2|||
27789546|NCT02230670|54244562|FG000|Overall Study|Progression to Child-Pugh C|1|||
27789547|NCT02230670|54244563|FG001|Overall Study|Progression to Child-Pugh C|2|||
27789548|NCT02197130|54244572|FG000|Overall Study|Adverse Event|13|||
27789549|NCT02197130|54244573|FG001|Overall Study|Adverse Event|4|||
27789550|NCT02197130|54244574|FG002|Overall Study|Adverse Event|23|||
27789551|NCT02197130|54244572|FG000|Overall Study|Death|0|||
27789552|NCT02197130|54244573|FG001|Overall Study|Death|1|||
27789553|NCT02197130|54244574|FG002|Overall Study|Death|0|||
27789554|NCT02197130|54244572|FG000|Overall Study|Lost to Follow-up|2|||
27789555|NCT02197130|54244573|FG001|Overall Study|Lost to Follow-up|0|||
27789556|NCT02197130|54244574|FG002|Overall Study|Lost to Follow-up|1|||
27789557|NCT02197130|54244572|FG000|Overall Study|Does not meet entrance criteria|0|||
27789558|NCT02197130|54244573|FG001|Overall Study|Does not meet entrance criteria|0|||
27789559|NCT02197130|54244574|FG002|Overall Study|Does not meet entrance criteria|1|||
27789560|NCT02197130|54244572|FG000|Overall Study|Withdrawal by Subject|0|||
27789561|NCT02197130|54244573|FG001|Overall Study|Withdrawal by Subject|3|||
27789562|NCT02197130|54244574|FG002|Overall Study|Withdrawal by Subject|4|||
27789563|NCT02197130|54244572|FG000|Overall Study|Other|1|||
27789564|NCT02197130|54244573|FG001|Overall Study|Other|0|||
27789565|NCT02197130|54244574|FG002|Overall Study|Other|3|||
27789566|NCT02196506|54244584|FG000|Phase A|Participant Met Withdrawal Criteria|34|||
27789567|NCT02196506|54244585|FG001|Phase A|Participant Met Withdrawal Criteria|0|||
27789568|NCT02196506|54244586|FG002|Phase A|Participant Met Withdrawal Criteria|0|||
27789569|NCT02196506|54244587|FG003|Phase A|Participant Met Withdrawal Criteria|0|||
27789570|NCT02196506|54244584|FG000|Phase A|Withdrawal by Subject|34|||
27789571|NCT02196506|54244585|FG001|Phase A|Withdrawal by Subject|0|||
27789572|NCT02196506|54244586|FG002|Phase A|Withdrawal by Subject|0|||
27789573|NCT02196506|54244587|FG003|Phase A|Withdrawal by Subject|0|||
27789574|NCT02196506|54244584|FG000|Phase A|Adverse Event|22|||
27789575|NCT02196506|54244585|FG001|Phase A|Adverse Event|0|||
27789576|NCT02196506|54244586|FG002|Phase A|Adverse Event|0|||
27789577|NCT02196506|54244587|FG003|Phase A|Adverse Event|0|||
27789578|NCT02196506|54244584|FG000|Phase A|Lost to Follow-up|9|||
27789579|NCT02196506|54244585|FG001|Phase A|Lost to Follow-up|0|||
27789580|NCT02196506|54244586|FG002|Phase A|Lost to Follow-up|0|||
27789581|NCT02196506|54244587|FG003|Phase A|Lost to Follow-up|0|||
27789582|NCT02196506|54244584|FG000|Phase A|Protocol deviation|12|||
27789583|NCT02196506|54244585|FG001|Phase A|Protocol deviation|0|||
27789584|NCT02196506|54244586|FG002|Phase A|Protocol deviation|0|||
27789585|NCT02196506|54244587|FG003|Phase A|Protocol deviation|0|||
27789586|NCT02196506|54244584|FG000|Phase A|Participant withdrawn by investigator|10|||
27789587|NCT02196506|54244585|FG001|Phase A|Participant withdrawn by investigator|0|||
27789588|NCT02196506|54244586|FG002|Phase A|Participant withdrawn by investigator|0|||
27789589|NCT02196506|54244587|FG003|Phase A|Participant withdrawn by investigator|0|||
27789590|NCT02196506|54244584|FG000|Phase B|Participant Met Withdrawal Criteria|0|||
27934993|NCT00996892|54591673|FG004|Dose-Escalation Stage 1|Adverse Event|0|||
27934994|NCT00996892|54591674|FG005|Dose-Escalation Stage 1|Adverse Event|0|||
27934995|NCT00996892|54591675|FG006|Dose-Escalation Stage 1|Adverse Event|1|||
27934996|NCT00996892|54591676|FG007|Dose-Escalation Stage 1|Adverse Event|0|||
27934997|NCT00996892|54591677|FG008|Dose-Escalation Stage 1|Adverse Event|0|||
27934998|NCT00996892|54591678|FG009|Dose-Escalation Stage 1|Adverse Event|0|||
27934999|NCT00996892|54591679|FG010|Dose-Escalation Stage 1|Adverse Event|0|||
27935000|NCT00996892|54591680|FG011|Dose-Escalation Stage 1|Adverse Event|0|||
27935001|NCT00996892|54591681|FG012|Dose-Escalation Stage 1|Adverse Event|0|||
27935002|NCT00996892|54591682|FG013|Dose-Escalation Stage 1|Adverse Event|0|||
27935003|NCT00996892|54591683|FG014|Dose-Escalation Stage 1|Adverse Event|0|||
27935004|NCT00996892|54591684|FG015|Dose-Escalation Stage 1|Adverse Event|0|||
27935005|NCT00996892|54591685|FG016|Dose-Escalation Stage 1|Adverse Event|0|||
27935006|NCT00996892|54591686|FG017|Dose-Escalation Stage 1|Adverse Event|0|||
27935007|NCT00996892|54591687|FG018|Dose-Escalation Stage 1|Adverse Event|0|||
27789591|NCT02196506|54244585|FG001|Phase B|Participant Met Withdrawal Criteria|0|||
27789592|NCT02196506|54244586|FG002|Phase B|Participant Met Withdrawal Criteria|1|||
27842484|NCT01445171|54331000|FG000|Overall Study|Withdrawal by Subject|16|||
27842485|NCT01445171|54331000|FG000|Overall Study|Death|51|||
27789593|NCT02196506|54244587|FG003|Phase B|Participant Met Withdrawal Criteria|0|||
27789594|NCT02196506|54244584|FG000|Phase B|Lack of Efficacy|0|||
27789595|NCT02196506|54244585|FG001|Phase B|Lack of Efficacy|1|||
27789596|NCT02196506|54244586|FG002|Phase B|Lack of Efficacy|2|||
27789597|NCT02196506|54244587|FG003|Phase B|Lack of Efficacy|0|||
27789598|NCT02196506|54244584|FG000|Phase B|Withdrawal by Participant|0|||
27789599|NCT02196506|54244585|FG001|Phase B|Withdrawal by Participant|8|||
27789600|NCT02196506|54244586|FG002|Phase B|Withdrawal by Participant|1|||
27789601|NCT02196506|54244587|FG003|Phase B|Withdrawal by Participant|0|||
27935008|NCT00996892|54591688|FG019|Dose-Escalation Stage 1|Adverse Event|0|||
27935009|NCT00996892|54591669|FG000|Dose-Escalation Stage 1|Death|1|||
27935010|NCT00996892|54591670|FG001|Dose-Escalation Stage 1|Death|0|||
27935011|NCT00996892|54591671|FG002|Dose-Escalation Stage 1|Death|0|||
27935012|NCT00996892|54591672|FG003|Dose-Escalation Stage 1|Death|0|||
27935013|NCT00996892|54591673|FG004|Dose-Escalation Stage 1|Death|0|||
27935014|NCT00996892|54591674|FG005|Dose-Escalation Stage 1|Death|1|||
27935015|NCT00996892|54591675|FG006|Dose-Escalation Stage 1|Death|0|||
27935016|NCT00996892|54591676|FG007|Dose-Escalation Stage 1|Death|0|||
27935017|NCT00996892|54591677|FG008|Dose-Escalation Stage 1|Death|0|||
27935018|NCT00996892|54591678|FG009|Dose-Escalation Stage 1|Death|0|||
27935019|NCT00996892|54591679|FG010|Dose-Escalation Stage 1|Death|0|||
27935020|NCT00996892|54591680|FG011|Dose-Escalation Stage 1|Death|0|||
27935021|NCT00996892|54591681|FG012|Dose-Escalation Stage 1|Death|0|||
27935022|NCT00996892|54591682|FG013|Dose-Escalation Stage 1|Death|0|||
27935023|NCT00996892|54591683|FG014|Dose-Escalation Stage 1|Death|0|||
27935024|NCT00996892|54591684|FG015|Dose-Escalation Stage 1|Death|0|||
27789602|NCT02196506|54244584|FG000|Phase B|Adverse Event|0|||
27789603|NCT02196506|54244585|FG001|Phase B|Adverse Event|4|||
27789604|NCT02196506|54244586|FG002|Phase B|Adverse Event|1|||
27789605|NCT02196506|54244587|FG003|Phase B|Adverse Event|0|||
27789606|NCT02196506|54244584|FG000|Phase B|Lost to Follow-up|0|||
27789607|NCT02196506|54244585|FG001|Phase B|Lost to Follow-up|2|||
27789608|NCT02196506|54244586|FG002|Phase B|Lost to Follow-up|1|||
27789609|NCT02196506|54244587|FG003|Phase B|Lost to Follow-up|0|||
27789610|NCT02196506|54244584|FG000|Phase A+|Participant Met Withdrawal Criteria|0|||
27789611|NCT02196506|54244585|FG001|Phase A+|Participant Met Withdrawal Criteria|0|||
27789612|NCT02196506|54244586|FG002|Phase A+|Participant Met Withdrawal Criteria|0|||
27789613|NCT02196506|54244587|FG003|Phase A+|Participant Met Withdrawal Criteria|1|||
27789614|NCT02196506|54244584|FG000|Phase A+|Withdrawal by Participant|0|||
27789615|NCT02196506|54244585|FG001|Phase A+|Withdrawal by Participant|0|||
27789616|NCT02196506|54244586|FG002|Phase A+|Withdrawal by Participant|0|||
27789617|NCT02196506|54244587|FG003|Phase A+|Withdrawal by Participant|5|||
27789618|NCT02196506|54244584|FG000|Phase A+|Adverse Event|0|||
27789619|NCT02196506|54244585|FG001|Phase A+|Adverse Event|0|||
27789620|NCT02196506|54244586|FG002|Phase A+|Adverse Event|0|||
27789621|NCT02196506|54244587|FG003|Phase A+|Adverse Event|1|||
27789622|NCT02196506|54244584|FG000|Phase A+|Lost to Follow-up|0|||
27789623|NCT02196506|54244585|FG001|Phase A+|Lost to Follow-up|0|||
27789624|NCT02196506|54244586|FG002|Phase A+|Lost to Follow-up|0|||
27789625|NCT02196506|54244587|FG003|Phase A+|Lost to Follow-up|6|||
27789626|NCT02196506|54244584|FG000|Phase A+|Participant withdrawn by investigator|0|||
27789627|NCT02196506|54244585|FG001|Phase A+|Participant withdrawn by investigator|0|||
27789628|NCT02196506|54244586|FG002|Phase A+|Participant withdrawn by investigator|0|||
27789629|NCT02196506|54244587|FG003|Phase A+|Participant withdrawn by investigator|1|||
27789630|NCT02228720|54244593|FG000|Open Label - Day 30|Lost to Follow-up|1|||
27789631|NCT02228564|54244597|FG000|Overall Study|Withdrawal by Subject|10|||
27789632|NCT02228564|54244597|FG000|Overall Study|Death|11|||
27789633|NCT02228564|54244597|FG000|Overall Study|Physician Decision|5|||
27789634|NCT02228564|54244597|FG000|Overall Study|Lost to Follow-up|17|||
27789635|NCT02228564|54244597|FG000|Overall Study|Other|6|||
27789636|NCT01640951|54244609|FG000|Overall Study|Adverse Event|8|||
27789637|NCT01640951|54244610|FG001|Overall Study|Adverse Event|3|||
27789638|NCT01640951|54244611|FG002|Overall Study|Adverse Event|10|||
27789639|NCT01640951|54244612|FG003|Overall Study|Adverse Event|6|||
27935025|NCT00996892|54591685|FG016|Dose-Escalation Stage 1|Death|0|||
27935026|NCT00996892|54591686|FG017|Dose-Escalation Stage 1|Death|0|||
27935027|NCT00996892|54591687|FG018|Dose-Escalation Stage 1|Death|0|||
27935028|NCT00996892|54591688|FG019|Dose-Escalation Stage 1|Death|0|||
27935029|NCT00996892|54591669|FG000|Dose-Escalation Stage 1|Physician Decision|1|||
27935030|NCT00996892|54591670|FG001|Dose-Escalation Stage 1|Physician Decision|0|||
27935031|NCT00996892|54591671|FG002|Dose-Escalation Stage 1|Physician Decision|0|||
27935032|NCT00996892|54591672|FG003|Dose-Escalation Stage 1|Physician Decision|1|||
27935033|NCT00996892|54591673|FG004|Dose-Escalation Stage 1|Physician Decision|0|||
27935034|NCT00996892|54591674|FG005|Dose-Escalation Stage 1|Physician Decision|1|||
27935035|NCT00996892|54591675|FG006|Dose-Escalation Stage 1|Physician Decision|2|||
27935036|NCT00996892|54591676|FG007|Dose-Escalation Stage 1|Physician Decision|0|||
27935037|NCT00996892|54591677|FG008|Dose-Escalation Stage 1|Physician Decision|0|||
27935038|NCT00996892|54591678|FG009|Dose-Escalation Stage 1|Physician Decision|0|||
27935039|NCT00996892|54591679|FG010|Dose-Escalation Stage 1|Physician Decision|0|||
27789640|NCT01640951|54244613|FG004|Overall Study|Adverse Event|1|||
27789641|NCT01640951|54244614|FG005|Overall Study|Adverse Event|11|||
27789642|NCT01640951|54244615|FG006|Overall Study|Adverse Event|1|||
27935040|NCT00996892|54591680|FG011|Dose-Escalation Stage 1|Physician Decision|0|||
28017026|NCT00683618|54676260|FG000|Randomised Treatment Period|Reason not provided|0|||
28105598|NCT04882995|54763043|FG000|Overall Study|Protocol Violation|4|||
27789643|NCT01640951|54244616|FG007|Overall Study|Adverse Event|3|||
27789644|NCT01640951|54244609|FG000|Overall Study|Lack of Efficacy|20|||
27935041|NCT00996892|54591681|FG012|Dose-Escalation Stage 1|Physician Decision|0|||
27789645|NCT01640951|54244610|FG001|Overall Study|Lack of Efficacy|1|||
27935042|NCT00996892|54591682|FG013|Dose-Escalation Stage 1|Physician Decision|0|||
27789646|NCT01640951|54244611|FG002|Overall Study|Lack of Efficacy|7|||
27935043|NCT00996892|54591683|FG014|Dose-Escalation Stage 1|Physician Decision|0|||
27935044|NCT00996892|54591684|FG015|Dose-Escalation Stage 1|Physician Decision|0|||
27935045|NCT00996892|54591685|FG016|Dose-Escalation Stage 1|Physician Decision|0|||
27935046|NCT00996892|54591686|FG017|Dose-Escalation Stage 1|Physician Decision|0|||
27935047|NCT00996892|54591687|FG018|Dose-Escalation Stage 1|Physician Decision|0|||
27935048|NCT00996892|54591688|FG019|Dose-Escalation Stage 1|Physician Decision|0|||
27935049|NCT00996892|54591669|FG000|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
27935050|NCT00996892|54591670|FG001|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
27935051|NCT00996892|54591671|FG002|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
27935052|NCT00996892|54591672|FG003|Dose-Escalation Stage 1|Withdrawal by Subject|2|||
27935053|NCT00996892|54591673|FG004|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
27789647|NCT01640951|54244612|FG003|Overall Study|Lack of Efficacy|14|||
27789648|NCT01640951|54244613|FG004|Overall Study|Lack of Efficacy|0|||
27789649|NCT01640951|54244614|FG005|Overall Study|Lack of Efficacy|6|||
27789650|NCT01640951|54244615|FG006|Overall Study|Lack of Efficacy|5|||
27789651|NCT01640951|54244616|FG007|Overall Study|Lack of Efficacy|6|||
27789652|NCT01640951|54244609|FG000|Overall Study|Lost to Follow-up|1|||
27789653|NCT01640951|54244610|FG001|Overall Study|Lost to Follow-up|0|||
27789654|NCT01640951|54244611|FG002|Overall Study|Lost to Follow-up|6|||
27789655|NCT01640951|54244612|FG003|Overall Study|Lost to Follow-up|2|||
27789656|NCT01640951|54244613|FG004|Overall Study|Lost to Follow-up|2|||
27789657|NCT01640951|54244614|FG005|Overall Study|Lost to Follow-up|3|||
27789658|NCT01640951|54244615|FG006|Overall Study|Lost to Follow-up|1|||
27789659|NCT01640951|54244616|FG007|Overall Study|Lost to Follow-up|1|||
27789660|NCT01640951|54244609|FG000|Overall Study|Non-compliance with study treatment|0|||
27789661|NCT01640951|54244610|FG001|Overall Study|Non-compliance with study treatment|0|||
27789662|NCT01640951|54244611|FG002|Overall Study|Non-compliance with study treatment|1|||
27789663|NCT01640951|54244612|FG003|Overall Study|Non-compliance with study treatment|1|||
27789664|NCT01640951|54244613|FG004|Overall Study|Non-compliance with study treatment|1|||
27789665|NCT01640951|54244614|FG005|Overall Study|Non-compliance with study treatment|4|||
27789666|NCT01640951|54244615|FG006|Overall Study|Non-compliance with study treatment|1|||
27789667|NCT01640951|54244616|FG007|Overall Study|Non-compliance with study treatment|0|||
27789668|NCT01640951|54244609|FG000|Overall Study|Physician Decision|2|||
27789669|NCT01640951|54244610|FG001|Overall Study|Physician Decision|5|||
27789670|NCT01640951|54244611|FG002|Overall Study|Physician Decision|2|||
27789671|NCT01640951|54244612|FG003|Overall Study|Physician Decision|2|||
27789672|NCT01640951|54244613|FG004|Overall Study|Physician Decision|2|||
27789673|NCT01640951|54244614|FG005|Overall Study|Physician Decision|3|||
27789674|NCT01640951|54244615|FG006|Overall Study|Physician Decision|3|||
27789675|NCT01640951|54244616|FG007|Overall Study|Physician Decision|0|||
27789676|NCT01640951|54244609|FG000|Overall Study|Pregnancy|3|||
27789677|NCT01640951|54244610|FG001|Overall Study|Pregnancy|0|||
27789678|NCT01640951|54244611|FG002|Overall Study|Pregnancy|0|||
27789679|NCT01640951|54244612|FG003|Overall Study|Pregnancy|4|||
27789680|NCT01640951|54244613|FG004|Overall Study|Pregnancy|0|||
27789681|NCT01640951|54244614|FG005|Overall Study|Pregnancy|0|||
27789682|NCT01640951|54244615|FG006|Overall Study|Pregnancy|2|||
27789683|NCT01640951|54244616|FG007|Overall Study|Pregnancy|0|||
27789684|NCT01640951|54244609|FG000|Overall Study|Protocol Deviation|0|||
27789685|NCT01640951|54244610|FG001|Overall Study|Protocol Deviation|1|||
27789686|NCT01640951|54244611|FG002|Overall Study|Protocol Deviation|2|||
27935054|NCT00996892|54591674|FG005|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
27935055|NCT00996892|54591675|FG006|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
27935056|NCT00996892|54591676|FG007|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
27935057|NCT00996892|54591677|FG008|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
27935058|NCT00996892|54591678|FG009|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
27935059|NCT00996892|54591679|FG010|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
27935060|NCT00996892|54591680|FG011|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
27935061|NCT00996892|54591681|FG012|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
27935062|NCT00996892|54591682|FG013|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
27935063|NCT00996892|54591683|FG014|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
27935064|NCT00996892|54591684|FG015|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
27935065|NCT00996892|54591685|FG016|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
27935066|NCT00996892|54591686|FG017|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
27789687|NCT01640951|54244612|FG003|Overall Study|Protocol Deviation|1|||
27789688|NCT01640951|54244613|FG004|Overall Study|Protocol Deviation|0|||
27789689|NCT01640951|54244614|FG005|Overall Study|Protocol Deviation|1|||
27789690|NCT01640951|54244615|FG006|Overall Study|Protocol Deviation|0|||
27789691|NCT01640951|54244616|FG007|Overall Study|Protocol Deviation|0|||
27789692|NCT01640951|54244609|FG000|Overall Study|Subject/Guardian decision|12|||
27935067|NCT00996892|54591687|FG018|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
27789693|NCT01640951|54244610|FG001|Overall Study|Subject/Guardian decision|4|||
27935068|NCT00996892|54591688|FG019|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
27789694|NCT01640951|54244611|FG002|Overall Study|Subject/Guardian decision|13|||
27789695|NCT01640951|54244612|FG003|Overall Study|Subject/Guardian decision|15|||
27789696|NCT01640951|54244613|FG004|Overall Study|Subject/Guardian decision|7|||
27789697|NCT01640951|54244614|FG005|Overall Study|Subject/Guardian decision|19|||
27789698|NCT01640951|54244615|FG006|Overall Study|Subject/Guardian decision|5|||
27789699|NCT01640951|54244616|FG007|Overall Study|Subject/Guardian decision|4|||
27789700|NCT01640951|54244609|FG000|Overall Study|Death|0|||
27789701|NCT01640951|54244610|FG001|Overall Study|Death|1|||
27789702|NCT01640951|54244611|FG002|Overall Study|Death|1|||
27789703|NCT01640951|54244612|FG003|Overall Study|Death|0|||
27789704|NCT01640951|54244613|FG004|Overall Study|Death|0|||
27789705|NCT01640951|54244614|FG005|Overall Study|Death|0|||
27789706|NCT01640951|54244615|FG006|Overall Study|Death|0|||
27789707|NCT01640951|54244616|FG007|Overall Study|Death|2|||
27789708|NCT02228096|54244638|FG000|Overall Study|Study terminated by Sponsor|24|||
27789709|NCT02228096|54244638|FG000|Overall Study|Lack of Efficacy|18|||
27789710|NCT02228096|54244638|FG000|Overall Study|Death|12|||
27789711|NCT02228096|54244638|FG000|Overall Study|Physician Decision|3|||
27789712|NCT02228096|54244638|FG000|Overall Study|Subject/guardian decision|2|||
27789713|NCT02228096|54244638|FG000|Overall Study|New therapy for study indication|1|||
27789714|NCT02228096|54244638|FG000|Overall Study|Enrolled, not infused|11|||
27789715|NCT01640873|54244658|FG000|Overall Study|Protocol Violation|2|||
27789716|NCT01640873|54244659|FG001|Overall Study|Protocol Violation|1|||
27789717|NCT01683994|54244670|FG000|Overall Study|Withdrawal by Subject|1|||
27789718|NCT01683994|54244671|FG001|Overall Study|Withdrawal by Subject|0|||
27789719|NCT01683994|54244672|FG002|Overall Study|Withdrawal by Subject|0|||
27789720|NCT01683994|54244673|FG003|Overall Study|Withdrawal by Subject|1|||
27789721|NCT01683994|54244674|FG004|Overall Study|Withdrawal by Subject|0|||
27789722|NCT01683994|54244670|FG000|Overall Study|Intercurrent illness|0|||
27789723|NCT01683994|54244671|FG001|Overall Study|Intercurrent illness|0|||
27789724|NCT01683994|54244672|FG002|Overall Study|Intercurrent illness|0|||
27789725|NCT01683994|54244673|FG003|Overall Study|Intercurrent illness|2|||
27789726|NCT01683994|54244674|FG004|Overall Study|Intercurrent illness|1|||
27789727|NCT02247440|54244692|FG000|Overall Study|Withdrawal by Subject|1|||
27789728|NCT02247440|54244692|FG000|Overall Study|Lack of Efficacy|3|||
27789729|NCT01683838|54244698|FG000|Overall Study|Adverse Event|12|||
27789730|NCT01683838|54244699|FG001|Overall Study|Adverse Event|2|||
27789731|NCT01683838|54244698|FG000|Overall Study|Protocol Violation|3|||
27789732|NCT01683838|54244699|FG001|Overall Study|Protocol Violation|1|||
27789733|NCT01683838|54244698|FG000|Overall Study|Withdrawal by Subject|6|||
27789734|NCT01683838|54244699|FG001|Overall Study|Withdrawal by Subject|5|||
27789735|NCT01683838|54244698|FG000|Overall Study|Lost to Follow-up|1|||
27789736|NCT01683838|54244699|FG001|Overall Study|Lost to Follow-up|1|||
27789737|NCT01683838|54244698|FG000|Overall Study|Other|4|||
27789738|NCT01683838|54244699|FG001|Overall Study|Other|3|||
27789739|NCT01683604|54244705|FG000|Overall Study|Adverse Event|2|||
27789740|NCT01683604|54244705|FG000|Overall Study|Lack of Efficacy|1|||
27789741|NCT01683604|54244705|FG000|Overall Study|Other|2|||
27789742|NCT02196038|54244716|FG000|Overall Study|Death|16|||
27789743|NCT02196038|54244717|FG001|Overall Study|Death|21|||
27789744|NCT02196038|54244716|FG000|Overall Study|Withdrawal by Subject|0|||
27789745|NCT02196038|54244717|FG001|Overall Study|Withdrawal by Subject|1|||
27789746|NCT02196038|54244716|FG000|Overall Study|Lost to Follow-up|1|||
27789747|NCT02196038|54244717|FG001|Overall Study|Lost to Follow-up|0|||
27789748|NCT02141659|54244729|FG000|Overall Study|Major Protocol Deviation|0|||
27789749|NCT02141659|54244730|FG001|Overall Study|Major Protocol Deviation|1|||
27789750|NCT02141659|54244731|FG002|Overall Study|Major Protocol Deviation|0|||
27935069|NCT00996892|54591669|FG000|Dose-Escalation Stage 1|Disease Progression|2|||
27935070|NCT00996892|54591670|FG001|Dose-Escalation Stage 1|Disease Progression|2|||
27935071|NCT00996892|54591671|FG002|Dose-Escalation Stage 1|Disease Progression|3|||
27935072|NCT00996892|54591672|FG003|Dose-Escalation Stage 1|Disease Progression|4|||
27935073|NCT00996892|54591673|FG004|Dose-Escalation Stage 1|Disease Progression|10|||
27935074|NCT00996892|54591674|FG005|Dose-Escalation Stage 1|Disease Progression|7|||
27935075|NCT00996892|54591675|FG006|Dose-Escalation Stage 1|Disease Progression|0|||
27935076|NCT00996892|54591676|FG007|Dose-Escalation Stage 1|Disease Progression|0|||
27935077|NCT00996892|54591677|FG008|Dose-Escalation Stage 1|Disease Progression|0|||
27935078|NCT00996892|54591678|FG009|Dose-Escalation Stage 1|Disease Progression|0|||
27935079|NCT00996892|54591679|FG010|Dose-Escalation Stage 1|Disease Progression|0|||
27935080|NCT00996892|54591680|FG011|Dose-Escalation Stage 1|Disease Progression|0|||
27789751|NCT02141659|54244732|FG003|Overall Study|Major Protocol Deviation|0|||
27789752|NCT02141659|54244733|FG004|Overall Study|Major Protocol Deviation|0|||
27789753|NCT02141659|54244734|FG005|Overall Study|Major Protocol Deviation|0|||
27789754|NCT02141659|54244729|FG000|Overall Study|Lack of Efficacy|0|||
27789755|NCT02141659|54244730|FG001|Overall Study|Lack of Efficacy|0|||
27789756|NCT02141659|54244731|FG002|Overall Study|Lack of Efficacy|0|||
27789757|NCT02141659|54244732|FG003|Overall Study|Lack of Efficacy|0|||
27789758|NCT02141659|54244733|FG004|Overall Study|Lack of Efficacy|0|||
27789759|NCT02141659|54244734|FG005|Overall Study|Lack of Efficacy|1|||
27789760|NCT02141659|54244729|FG000|Overall Study|Pretreatment Event/ Adverse Event|0|||
27789761|NCT02141659|54244730|FG001|Overall Study|Pretreatment Event/ Adverse Event|0|||
27935081|NCT00996892|54591681|FG012|Dose-Escalation Stage 1|Disease Progression|0|||
27789762|NCT02141659|54244731|FG002|Overall Study|Pretreatment Event/ Adverse Event|0|||
27789763|NCT02141659|54244732|FG003|Overall Study|Pretreatment Event/ Adverse Event|0|||
27789764|NCT02141659|54244733|FG004|Overall Study|Pretreatment Event/ Adverse Event|2|||
27789765|NCT02141659|54244734|FG005|Overall Study|Pretreatment Event/ Adverse Event|1|||
27789766|NCT01640249|54244755|FG000|Period 1|Withdrawal by Subject|1|||
27789767|NCT01640249|54244756|FG001|Period 1|Withdrawal by Subject|0|||
27789768|NCT01640249|54244757|FG002|Period 1|Withdrawal by Subject|0|||
27789769|NCT01640249|54244758|FG003|Period 1|Withdrawal by Subject|0|||
27789770|NCT01640249|54244759|FG004|Period 1|Withdrawal by Subject|0|||
27789771|NCT01640249|54244760|FG005|Period 1|Withdrawal by Subject|1|||
27789772|NCT01640249|54244761|FG006|Period 1|Withdrawal by Subject|0|||
27789773|NCT02121301|54244783|FG000|Overall Study|Protocol Violation|1|||
27789774|NCT02121301|54244784|FG001|Overall Study|Protocol Violation|4|||
27789775|NCT02121301|54244785|FG002|Overall Study|Protocol Violation|1|||
27789776|NCT02227862|54244795|FG000|Overall Study|Protocol Violation|7|||
27789777|NCT02227862|54244796|FG001|Overall Study|Protocol Violation|9|||
27789778|NCT02227862|54244795|FG000|Overall Study|Other|0|||
27789779|NCT02227862|54244796|FG001|Overall Study|Other|2|||
27789780|NCT02227862|54244795|FG000|Overall Study|Adverse Event|4|||
27789781|NCT02227862|54244796|FG001|Overall Study|Adverse Event|3|||
27789782|NCT02227862|54244795|FG000|Overall Study|Withdrawal by Subject|7|||
27789783|NCT02227862|54244796|FG001|Overall Study|Withdrawal by Subject|6|||
27789784|NCT02227862|54244795|FG000|Overall Study|Lost to Follow-up|1|||
27789785|NCT02227862|54244796|FG001|Overall Study|Lost to Follow-up|2|||
27789786|NCT02120833|54244804|FG000|Overall Study|Adverse Event|1|||
27789787|NCT02120833|54244805|FG001|Overall Study|Adverse Event|0|||
27789788|NCT02120833|54244804|FG000|Overall Study|Withdrawal by Subject|2|||
27789789|NCT02120833|54244805|FG001|Overall Study|Withdrawal by Subject|0|||
27789790|NCT02120833|54244804|FG000|Overall Study|Lost to Follow-up|1|||
27789791|NCT02120833|54244805|FG001|Overall Study|Lost to Follow-up|1|||
27789792|NCT02170207|54244811|FG000|Overall Study|Case report forms unavailable|5|||
27789793|NCT02227784|54244819|FG000|Double-Blind Phase|Adverse Event|3|||
27789794|NCT02227784|54244820|FG001|Double-Blind Phase|Adverse Event|2|||
27789795|NCT02227784|54244821|FG002|Double-Blind Phase|Adverse Event|1|||
27789796|NCT02227784|54244822|FG003|Double-Blind Phase|Adverse Event|3|||
27789797|NCT02227784|54244823|FG004|Double-Blind Phase|Adverse Event|0|||
27789798|NCT02227784|54244819|FG000|Double-Blind Phase|Physician Decision|1|||
27789799|NCT02227784|54244820|FG001|Double-Blind Phase|Physician Decision|0|||
27789800|NCT02227784|54244821|FG002|Double-Blind Phase|Physician Decision|0|||
27789801|NCT02227784|54244822|FG003|Double-Blind Phase|Physician Decision|1|||
27789802|NCT02227784|54244823|FG004|Double-Blind Phase|Physician Decision|0|||
27789803|NCT02227784|54244819|FG000|Double-Blind Phase|Protocol Violation|0|||
27789804|NCT02227784|54244820|FG001|Double-Blind Phase|Protocol Violation|0|||
27789805|NCT02227784|54244821|FG002|Double-Blind Phase|Protocol Violation|1|||
27789806|NCT02227784|54244822|FG003|Double-Blind Phase|Protocol Violation|1|||
27935082|NCT00996892|54591682|FG013|Dose-Escalation Stage 1|Disease Progression|0|||
27935083|NCT00996892|54591683|FG014|Dose-Escalation Stage 1|Disease Progression|0|||
27935084|NCT00996892|54591684|FG015|Dose-Escalation Stage 1|Disease Progression|0|||
27935085|NCT00996892|54591685|FG016|Dose-Escalation Stage 1|Disease Progression|0|||
27935086|NCT00996892|54591686|FG017|Dose-Escalation Stage 1|Disease Progression|0|||
27935087|NCT00996892|54591687|FG018|Dose-Escalation Stage 1|Disease Progression|0|||
27935088|NCT00996892|54591688|FG019|Dose-Escalation Stage 1|Disease Progression|0|||
27935089|NCT00996892|54591669|FG000|Dose-Escalation Stage 1A|Adverse Event|0|||
27935090|NCT00996892|54591670|FG001|Dose-Escalation Stage 1A|Adverse Event|0|||
27935091|NCT00996892|54591671|FG002|Dose-Escalation Stage 1A|Adverse Event|0|||
27935092|NCT00996892|54591672|FG003|Dose-Escalation Stage 1A|Adverse Event|0|||
27935093|NCT00996892|54591673|FG004|Dose-Escalation Stage 1A|Adverse Event|0|||
27935094|NCT00996892|54591674|FG005|Dose-Escalation Stage 1A|Adverse Event|0|||
27935095|NCT00996892|54591675|FG006|Dose-Escalation Stage 1A|Adverse Event|0|||
27935096|NCT00996892|54591676|FG007|Dose-Escalation Stage 1A|Adverse Event|0|||
27935097|NCT00996892|54591677|FG008|Dose-Escalation Stage 1A|Adverse Event|0|||
27935098|NCT00996892|54591678|FG009|Dose-Escalation Stage 1A|Adverse Event|0|||
27935099|NCT00996892|54591679|FG010|Dose-Escalation Stage 1A|Adverse Event|1|||
27935100|NCT00996892|54591680|FG011|Dose-Escalation Stage 1A|Adverse Event|0|||
27789807|NCT02227784|54244823|FG004|Double-Blind Phase|Protocol Violation|0|||
27789808|NCT02227784|54244819|FG000|Double-Blind Phase|Sponsor Decision|34|||
27789809|NCT02227784|54244820|FG001|Double-Blind Phase|Sponsor Decision|15|||
27789810|NCT02227784|54244821|FG002|Double-Blind Phase|Sponsor Decision|14|||
27789811|NCT02227784|54244822|FG003|Double-Blind Phase|Sponsor Decision|32|||
27789812|NCT02227784|54244823|FG004|Double-Blind Phase|Sponsor Decision|0|||
27789813|NCT02227784|54244819|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
27789814|NCT02227784|54244820|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
27789815|NCT02227784|54244821|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
27935101|NCT00996892|54591681|FG012|Dose-Escalation Stage 1A|Adverse Event|0|||
27789816|NCT02227784|54244822|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
27789817|NCT02227784|54244823|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
27935102|NCT00996892|54591682|FG013|Dose-Escalation Stage 1A|Adverse Event|1|||
27935103|NCT00996892|54591683|FG014|Dose-Escalation Stage 1A|Adverse Event|0|||
27935104|NCT00996892|54591684|FG015|Dose-Escalation Stage 1A|Adverse Event|0|||
27935105|NCT00996892|54591685|FG016|Dose-Escalation Stage 1A|Adverse Event|0|||
27935106|NCT00996892|54591686|FG017|Dose-Escalation Stage 1A|Adverse Event|0|||
27935107|NCT00996892|54591687|FG018|Dose-Escalation Stage 1A|Adverse Event|0|||
27935108|NCT00996892|54591688|FG019|Dose-Escalation Stage 1A|Adverse Event|0|||
27789818|NCT02227784|54244819|FG000|Open-Label Extension Phase (OLE)|Adverse Event|0|||
27789819|NCT02227784|54244820|FG001|Open-Label Extension Phase (OLE)|Adverse Event|0|||
27789820|NCT02227784|54244821|FG002|Open-Label Extension Phase (OLE)|Adverse Event|0|||
27789821|NCT02227784|54244822|FG003|Open-Label Extension Phase (OLE)|Adverse Event|0|||
27789822|NCT02227784|54244823|FG004|Open-Label Extension Phase (OLE)|Adverse Event|1|||
27789823|NCT02227784|54244819|FG000|Open-Label Extension Phase (OLE)|Death|0|||
27789824|NCT02227784|54244820|FG001|Open-Label Extension Phase (OLE)|Death|0|||
27789825|NCT02227784|54244821|FG002|Open-Label Extension Phase (OLE)|Death|0|||
27789826|NCT02227784|54244822|FG003|Open-Label Extension Phase (OLE)|Death|0|||
27789827|NCT02227784|54244823|FG004|Open-Label Extension Phase (OLE)|Death|1|||
27789828|NCT02227784|54244819|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
27789829|NCT02227784|54244820|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
27789830|NCT02227784|54244821|FG002|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
27789831|NCT02227784|54244822|FG003|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
27789832|NCT02227784|54244823|FG004|Open-Label Extension Phase (OLE)|Sponsor Decision|243|||
27789833|NCT02227784|54244819|FG000|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
27789834|NCT02227784|54244820|FG001|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
27789835|NCT02227784|54244821|FG002|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
27789836|NCT02227784|54244822|FG003|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
27789837|NCT02227784|54244823|FG004|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3|||
27789838|NCT01565668|54244838|FG000|Overall Study|Death|2|||
27789839|NCT01565668|54244839|FG001|Overall Study|Death|1|||
27789840|NCT01565668|54244838|FG000|Overall Study|Lack of Efficacy|4|||
27789841|NCT01565668|54244839|FG001|Overall Study|Lack of Efficacy|2|||
27789842|NCT01565668|54244838|FG000|Overall Study|Participant went on Hospice Care|1|||
27789843|NCT01565668|54244839|FG001|Overall Study|Participant went on Hospice Care|0|||
27789844|NCT01565668|54244838|FG000|Overall Study|Adverse Event|6|||
27789845|NCT01565668|54244839|FG001|Overall Study|Adverse Event|1|||
27789846|NCT01565668|54244838|FG000|Overall Study|Randomized, but never received drug|0|||
27789847|NCT01565668|54244839|FG001|Overall Study|Randomized, but never received drug|2|||
27789848|NCT01565668|54244838|FG000|Overall Study|Progressive disease|13|||
27789849|NCT01565668|54244839|FG001|Overall Study|Progressive disease|14|||
27789850|NCT01565668|54244838|FG000|Overall Study|Withdrawal by Subject|1|||
27789851|NCT01565668|54244839|FG001|Overall Study|Withdrawal by Subject|3|||
27789852|NCT01565668|54244838|FG000|Overall Study|HSCT Transplant|11|||
27789853|NCT01565668|54244839|FG001|Overall Study|HSCT Transplant|15|||
27789854|NCT01683058|54244845|FG000|Overall Study|Lost to Follow-up|9|||
27789855|NCT01683058|54244845|FG000|Overall Study|Adverse Event|6|||
27789856|NCT01683058|54244845|FG000|Overall Study|Subject Met Withdrawal Criteria|5|||
27935109|NCT00996892|54591669|FG000|Dose-Escalation Stage 1A|Death|0|||
27935110|NCT00996892|54591670|FG001|Dose-Escalation Stage 1A|Death|0|||
27935111|NCT00996892|54591671|FG002|Dose-Escalation Stage 1A|Death|0|||
27935112|NCT00996892|54591672|FG003|Dose-Escalation Stage 1A|Death|0|||
27935113|NCT00996892|54591673|FG004|Dose-Escalation Stage 1A|Death|0|||
27935114|NCT00996892|54591674|FG005|Dose-Escalation Stage 1A|Death|0|||
27935115|NCT00996892|54591675|FG006|Dose-Escalation Stage 1A|Death|0|||
27935116|NCT00996892|54591676|FG007|Dose-Escalation Stage 1A|Death|0|||
27935117|NCT00996892|54591677|FG008|Dose-Escalation Stage 1A|Death|0|||
27935118|NCT00996892|54591678|FG009|Dose-Escalation Stage 1A|Death|2|||
27935119|NCT00996892|54591679|FG010|Dose-Escalation Stage 1A|Death|0|||
27935120|NCT00996892|54591680|FG011|Dose-Escalation Stage 1A|Death|1|||
27935121|NCT00996892|54591681|FG012|Dose-Escalation Stage 1A|Death|1|||
27935122|NCT00996892|54591682|FG013|Dose-Escalation Stage 1A|Death|0|||
27935123|NCT00996892|54591683|FG014|Dose-Escalation Stage 1A|Death|0|||
27935124|NCT00996892|54591684|FG015|Dose-Escalation Stage 1A|Death|0|||
27789857|NCT01683058|54244845|FG000|Overall Study|Withdrawal by Subject|7|||
27789858|NCT01683058|54244845|FG000|Overall Study|Lack of Efficacy|2|||
27789859|NCT01626859|54244853|FG000|Overall Study|Adverse Event|1|||
27789860|NCT01626859|54244854|FG001|Overall Study|Adverse Event|3|||
27789861|NCT01626859|54244855|FG002|Overall Study|Adverse Event|2|||
27789862|NCT01626859|54244853|FG000|Overall Study|Physician Decision|0|||
27789863|NCT01626859|54244854|FG001|Overall Study|Physician Decision|1|||
27935125|NCT00996892|54591685|FG016|Dose-Escalation Stage 1A|Death|0|||
27935126|NCT00996892|54591686|FG017|Dose-Escalation Stage 1A|Death|0|||
27935127|NCT00996892|54591687|FG018|Dose-Escalation Stage 1A|Death|0|||
27935128|NCT00996892|54591688|FG019|Dose-Escalation Stage 1A|Death|0|||
27935129|NCT00996892|54591669|FG000|Dose-Escalation Stage 1A|Physician Decision|0|||
27935130|NCT00996892|54591670|FG001|Dose-Escalation Stage 1A|Physician Decision|0|||
27935131|NCT00996892|54591671|FG002|Dose-Escalation Stage 1A|Physician Decision|0|||
27935132|NCT00996892|54591672|FG003|Dose-Escalation Stage 1A|Physician Decision|0|||
27935133|NCT00996892|54591673|FG004|Dose-Escalation Stage 1A|Physician Decision|0|||
27935134|NCT00996892|54591674|FG005|Dose-Escalation Stage 1A|Physician Decision|0|||
27935135|NCT00996892|54591675|FG006|Dose-Escalation Stage 1A|Physician Decision|0|||
27935136|NCT00996892|54591676|FG007|Dose-Escalation Stage 1A|Physician Decision|1|||
27935137|NCT00996892|54591677|FG008|Dose-Escalation Stage 1A|Physician Decision|0|||
27935138|NCT00996892|54591678|FG009|Dose-Escalation Stage 1A|Physician Decision|0|||
27935139|NCT00996892|54591679|FG010|Dose-Escalation Stage 1A|Physician Decision|0|||
27935140|NCT00996892|54591680|FG011|Dose-Escalation Stage 1A|Physician Decision|0|||
27935141|NCT00996892|54591681|FG012|Dose-Escalation Stage 1A|Physician Decision|0|||
27935142|NCT00996892|54591682|FG013|Dose-Escalation Stage 1A|Physician Decision|0|||
27935143|NCT00996892|54591683|FG014|Dose-Escalation Stage 1A|Physician Decision|0|||
27935144|NCT00996892|54591684|FG015|Dose-Escalation Stage 1A|Physician Decision|0|||
27935145|NCT00996892|54591685|FG016|Dose-Escalation Stage 1A|Physician Decision|0|||
27935146|NCT00996892|54591686|FG017|Dose-Escalation Stage 1A|Physician Decision|0|||
27789864|NCT01626859|54244855|FG002|Overall Study|Physician Decision|0|||
27789865|NCT01626859|54244853|FG000|Overall Study|Withdrawal by Subject|1|||
27789866|NCT01626859|54244854|FG001|Overall Study|Withdrawal by Subject|4|||
27789867|NCT01626859|54244855|FG002|Overall Study|Withdrawal by Subject|2|||
27789868|NCT02193776|54244867|FG000|Overall Study|Consent withdrawn|1|||
27789869|NCT02193776|54244868|FG001|Overall Study|Consent withdrawn|0|||
27789870|NCT02193776|54244869|FG002|Overall Study|Consent withdrawn|0|||
27789871|NCT02193776|54244870|FG003|Overall Study|Consent withdrawn|0|||
27789872|NCT02193776|54244867|FG000|Overall Study|Failure to comply with protocol|0|||
27789873|NCT02193776|54244868|FG001|Overall Study|Failure to comply with protocol|1|||
27789874|NCT02193776|54244869|FG002|Overall Study|Failure to comply with protocol|0|||
27789875|NCT02193776|54244870|FG003|Overall Study|Failure to comply with protocol|0|||
27789876|NCT02193776|54244867|FG000|Overall Study|Investigator/Sponsor decision|1|||
27789877|NCT02193776|54244868|FG001|Overall Study|Investigator/Sponsor decision|1|||
27789878|NCT02193776|54244869|FG002|Overall Study|Investigator/Sponsor decision|0|||
27789879|NCT02193776|54244870|FG003|Overall Study|Investigator/Sponsor decision|0|||
27789880|NCT02193776|54244867|FG000|Overall Study|Death|1|||
27789881|NCT02193776|54244868|FG001|Overall Study|Death|0|||
27789882|NCT02193776|54244869|FG002|Overall Study|Death|0|||
27789883|NCT02193776|54244870|FG003|Overall Study|Death|0|||
27789884|NCT02193776|54244867|FG000|Overall Study|Adverse event/Specific toxicity|5|||
27789885|NCT02193776|54244868|FG001|Overall Study|Adverse event/Specific toxicity|5|||
27789886|NCT02193776|54244869|FG002|Overall Study|Adverse event/Specific toxicity|2|||
27789887|NCT02193776|54244870|FG003|Overall Study|Adverse event/Specific toxicity|2|||
27789888|NCT02170064|54244883|FG000|Overall Study|Withdrawal by Subject|5|||
27789889|NCT02170064|54244884|FG001|Overall Study|Withdrawal by Subject|1|||
27789890|NCT02170064|54244885|FG002|Overall Study|Withdrawal by Subject|1|||
27789891|NCT02170064|54244883|FG000|Overall Study|Physician Decision|1|||
27789892|NCT02170064|54244884|FG001|Overall Study|Physician Decision|1|||
27789893|NCT02170064|54244885|FG002|Overall Study|Physician Decision|0|||
27935147|NCT00996892|54591687|FG018|Dose-Escalation Stage 1A|Physician Decision|0|||
27935148|NCT00996892|54591688|FG019|Dose-Escalation Stage 1A|Physician Decision|0|||
27935149|NCT00996892|54591669|FG000|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
27935150|NCT00996892|54591670|FG001|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
27935151|NCT00996892|54591671|FG002|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
27935152|NCT00996892|54591672|FG003|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
27935153|NCT00996892|54591673|FG004|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
27935154|NCT00996892|54591674|FG005|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
27935155|NCT00996892|54591675|FG006|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
27935156|NCT00996892|54591676|FG007|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
27935157|NCT00996892|54591677|FG008|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
27935158|NCT00996892|54591678|FG009|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
27935159|NCT00996892|54591679|FG010|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
27935160|NCT00996892|54591680|FG011|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
27935161|NCT00996892|54591681|FG012|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
27935162|NCT00996892|54591682|FG013|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
27935163|NCT00996892|54591683|FG014|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
27935164|NCT00996892|54591684|FG015|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
27935165|NCT00996892|54591685|FG016|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
28105599|NCT04882995|54763044|FG001|Overall Study|Protocol Violation|4|||
27789894|NCT02169830|54244896|FG000|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
27789895|NCT02169830|54244897|FG001|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
27789896|NCT02169830|54244898|FG002|Diet Intervention (4 Weeks)|Lost to Follow-up|1|||
27789897|NCT02169830|54244896|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
27789898|NCT02169830|54244897|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
27935166|NCT00996892|54591686|FG017|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
27935167|NCT00996892|54591687|FG018|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
27935168|NCT00996892|54591688|FG019|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
27935169|NCT00996892|54591669|FG000|Dose-Escalation Stage 1A|Disease Progression|0|||
27935170|NCT00996892|54591670|FG001|Dose-Escalation Stage 1A|Disease Progression|0|||
27935171|NCT00996892|54591671|FG002|Dose-Escalation Stage 1A|Disease Progression|0|||
27935172|NCT00996892|54591672|FG003|Dose-Escalation Stage 1A|Disease Progression|0|||
27935173|NCT00996892|54591673|FG004|Dose-Escalation Stage 1A|Disease Progression|0|||
27935174|NCT00996892|54591674|FG005|Dose-Escalation Stage 1A|Disease Progression|0|||
27935175|NCT00996892|54591675|FG006|Dose-Escalation Stage 1A|Disease Progression|0|||
27935176|NCT00996892|54591676|FG007|Dose-Escalation Stage 1A|Disease Progression|2|||
27935177|NCT00996892|54591677|FG008|Dose-Escalation Stage 1A|Disease Progression|3|||
27935178|NCT00996892|54591678|FG009|Dose-Escalation Stage 1A|Disease Progression|1|||
27935179|NCT00996892|54591679|FG010|Dose-Escalation Stage 1A|Disease Progression|5|||
27935180|NCT00996892|54591680|FG011|Dose-Escalation Stage 1A|Disease Progression|7|||
27935181|NCT00996892|54591681|FG012|Dose-Escalation Stage 1A|Disease Progression|6|||
27935182|NCT00996892|54591682|FG013|Dose-Escalation Stage 1A|Disease Progression|4|||
27935183|NCT00996892|54591683|FG014|Dose-Escalation Stage 1A|Disease Progression|0|||
27935184|NCT00996892|54591684|FG015|Dose-Escalation Stage 1A|Disease Progression|0|||
27935185|NCT00996892|54591685|FG016|Dose-Escalation Stage 1A|Disease Progression|0|||
27935186|NCT00996892|54591686|FG017|Dose-Escalation Stage 1A|Disease Progression|0|||
27935187|NCT00996892|54591687|FG018|Dose-Escalation Stage 1A|Disease Progression|0|||
27935188|NCT00996892|54591688|FG019|Dose-Escalation Stage 1A|Disease Progression|0|||
27935189|NCT00996892|54591669|FG000|Dose-Escalation Stage 1B|Physician Decision|0|||
27935190|NCT00996892|54591670|FG001|Dose-Escalation Stage 1B|Physician Decision|0|||
27935191|NCT00996892|54591671|FG002|Dose-Escalation Stage 1B|Physician Decision|0|||
27935192|NCT00996892|54591672|FG003|Dose-Escalation Stage 1B|Physician Decision|0|||
27935193|NCT00996892|54591673|FG004|Dose-Escalation Stage 1B|Physician Decision|0|||
27935194|NCT00996892|54591674|FG005|Dose-Escalation Stage 1B|Physician Decision|0|||
27935195|NCT00996892|54591675|FG006|Dose-Escalation Stage 1B|Physician Decision|0|||
27935196|NCT00996892|54591676|FG007|Dose-Escalation Stage 1B|Physician Decision|0|||
27935197|NCT00996892|54591677|FG008|Dose-Escalation Stage 1B|Physician Decision|0|||
27935198|NCT00996892|54591678|FG009|Dose-Escalation Stage 1B|Physician Decision|0|||
27935199|NCT00996892|54591679|FG010|Dose-Escalation Stage 1B|Physician Decision|0|||
27935200|NCT00996892|54591680|FG011|Dose-Escalation Stage 1B|Physician Decision|0|||
27935201|NCT00996892|54591681|FG012|Dose-Escalation Stage 1B|Physician Decision|0|||
27935202|NCT00996892|54591682|FG013|Dose-Escalation Stage 1B|Physician Decision|0|||
27935203|NCT00996892|54591683|FG014|Dose-Escalation Stage 1B|Physician Decision|0|||
27935204|NCT00996892|54591684|FG015|Dose-Escalation Stage 1B|Physician Decision|0|||
27935205|NCT00996892|54591685|FG016|Dose-Escalation Stage 1B|Physician Decision|0|||
27935206|NCT00996892|54591686|FG017|Dose-Escalation Stage 1B|Physician Decision|2|||
27935207|NCT00996892|54591687|FG018|Dose-Escalation Stage 1B|Physician Decision|0|||
27935208|NCT00996892|54591688|FG019|Dose-Escalation Stage 1B|Physician Decision|0|||
27935209|NCT00996892|54591669|FG000|Dose-Escalation Stage 1B|Disease Progression|0|||
27935210|NCT00996892|54591670|FG001|Dose-Escalation Stage 1B|Disease Progression|0|||
27935211|NCT00996892|54591671|FG002|Dose-Escalation Stage 1B|Disease Progression|0|||
27935212|NCT00996892|54591672|FG003|Dose-Escalation Stage 1B|Disease Progression|0|||
27935213|NCT00996892|54591673|FG004|Dose-Escalation Stage 1B|Disease Progression|0|||
27935214|NCT00996892|54591674|FG005|Dose-Escalation Stage 1B|Disease Progression|0|||
27935215|NCT00996892|54591675|FG006|Dose-Escalation Stage 1B|Disease Progression|0|||
27935216|NCT00996892|54591676|FG007|Dose-Escalation Stage 1B|Disease Progression|0|||
27935217|NCT00996892|54591677|FG008|Dose-Escalation Stage 1B|Disease Progression|0|||
27935218|NCT00996892|54591678|FG009|Dose-Escalation Stage 1B|Disease Progression|0|||
27935219|NCT00996892|54591679|FG010|Dose-Escalation Stage 1B|Disease Progression|0|||
27935220|NCT00996892|54591680|FG011|Dose-Escalation Stage 1B|Disease Progression|0|||
27935221|NCT00996892|54591681|FG012|Dose-Escalation Stage 1B|Disease Progression|0|||
27935222|NCT00996892|54591682|FG013|Dose-Escalation Stage 1B|Disease Progression|0|||
27935223|NCT00996892|54591683|FG014|Dose-Escalation Stage 1B|Disease Progression|4|||
27935224|NCT00996892|54591684|FG015|Dose-Escalation Stage 1B|Disease Progression|3|||
27935225|NCT00996892|54591685|FG016|Dose-Escalation Stage 1B|Disease Progression|3|||
27935226|NCT00996892|54591686|FG017|Dose-Escalation Stage 1B|Disease Progression|3|||
27935227|NCT00996892|54591687|FG018|Dose-Escalation Stage 1B|Disease Progression|0|||
27935228|NCT00996892|54591688|FG019|Dose-Escalation Stage 1B|Disease Progression|0|||
27935229|NCT00996892|54591669|FG000|Expansion Stage 2|Adverse Event|0|||
27935230|NCT00996892|54591670|FG001|Expansion Stage 2|Adverse Event|0|||
27935231|NCT00996892|54591671|FG002|Expansion Stage 2|Adverse Event|0|||
27935232|NCT00996892|54591672|FG003|Expansion Stage 2|Adverse Event|0|||
27935233|NCT00996892|54591673|FG004|Expansion Stage 2|Adverse Event|0|||
27935234|NCT00996892|54591674|FG005|Expansion Stage 2|Adverse Event|0|||
27935235|NCT00996892|54591675|FG006|Expansion Stage 2|Adverse Event|0|||
27935236|NCT00996892|54591676|FG007|Expansion Stage 2|Adverse Event|0|||
27935237|NCT00996892|54591677|FG008|Expansion Stage 2|Adverse Event|0|||
27935238|NCT00996892|54591678|FG009|Expansion Stage 2|Adverse Event|0|||
27935239|NCT00996892|54591679|FG010|Expansion Stage 2|Adverse Event|0|||
27935240|NCT00996892|54591680|FG011|Expansion Stage 2|Adverse Event|0|||
27935241|NCT00996892|54591681|FG012|Expansion Stage 2|Adverse Event|0|||
27935242|NCT00996892|54591682|FG013|Expansion Stage 2|Adverse Event|0|||
27935243|NCT00996892|54591683|FG014|Expansion Stage 2|Adverse Event|0|||
27935244|NCT00996892|54591684|FG015|Expansion Stage 2|Adverse Event|0|||
27935245|NCT00996892|54591685|FG016|Expansion Stage 2|Adverse Event|0|||
27935246|NCT00996892|54591686|FG017|Expansion Stage 2|Adverse Event|0|||
27935247|NCT00996892|54591687|FG018|Expansion Stage 2|Adverse Event|3|||
27935248|NCT00996892|54591688|FG019|Expansion Stage 2|Adverse Event|0|||
27935249|NCT00996892|54591669|FG000|Expansion Stage 2|Death|0|||
27935250|NCT00996892|54591670|FG001|Expansion Stage 2|Death|0|||
27935251|NCT00996892|54591671|FG002|Expansion Stage 2|Death|0|||
27935252|NCT00996892|54591672|FG003|Expansion Stage 2|Death|0|||
27935253|NCT00996892|54591673|FG004|Expansion Stage 2|Death|0|||
27935254|NCT00996892|54591674|FG005|Expansion Stage 2|Death|0|||
27935255|NCT00996892|54591675|FG006|Expansion Stage 2|Death|0|||
27935256|NCT00996892|54591676|FG007|Expansion Stage 2|Death|0|||
27935257|NCT00996892|54591677|FG008|Expansion Stage 2|Death|0|||
27935258|NCT00996892|54591678|FG009|Expansion Stage 2|Death|0|||
27789899|NCT02169830|54244898|FG002|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
27789900|NCT02169830|54244896|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
27789901|NCT02169830|54244897|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|5|||
27789902|NCT02169830|54244898|FG002|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
27789903|NCT02169830|54244896|FG000|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
27789904|NCT02169830|54244897|FG001|Third Intervention (8 Weeks)|Lost to Follow-up|1|||
27789905|NCT02169830|54244898|FG002|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
27789906|NCT02169830|54244896|FG000|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
27789907|NCT02169830|54244897|FG001|Third Intervention (8 Weeks)|Withdrawal by Subject|1|||
27789908|NCT02169830|54244898|FG002|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
27789909|NCT02169674|54244908|FG000|Overall Study|Withdrawal by Subject|2|||
27789910|NCT02169674|54244909|FG001|Overall Study|Withdrawal by Subject|1|||
27789911|NCT02169674|54244908|FG000|Overall Study|Seroprotected|30|||
27789912|NCT02169674|54244909|FG001|Overall Study|Seroprotected|76|||
27789913|NCT02169674|54244908|FG000|Overall Study|Lost to Follow-up|0|||
27789914|NCT02169674|54244909|FG001|Overall Study|Lost to Follow-up|1|||
27789915|NCT02169284|54244917|FG000|Overall Study|Physician Decision|0|||
27789916|NCT02169284|54244918|FG001|Overall Study|Physician Decision|1|||
27789917|NCT02119819|54244932|FG000|Overall Study|Adverse Event|3|||
27789918|NCT02119819|54244933|FG001|Overall Study|Adverse Event|1|||
27789919|NCT02119819|54244934|FG002|Overall Study|Adverse Event|2|||
27935259|NCT00996892|54591679|FG010|Expansion Stage 2|Death|0|||
27935260|NCT00996892|54591680|FG011|Expansion Stage 2|Death|0|||
27935261|NCT00996892|54591681|FG012|Expansion Stage 2|Death|0|||
27935262|NCT00996892|54591682|FG013|Expansion Stage 2|Death|0|||
27935263|NCT00996892|54591683|FG014|Expansion Stage 2|Death|0|||
27935264|NCT00996892|54591684|FG015|Expansion Stage 2|Death|0|||
27935265|NCT00996892|54591685|FG016|Expansion Stage 2|Death|0|||
27935266|NCT00996892|54591686|FG017|Expansion Stage 2|Death|0|||
27935267|NCT00996892|54591687|FG018|Expansion Stage 2|Death|2|||
27789920|NCT02119819|54244935|FG003|Overall Study|Adverse Event|3|||
27789921|NCT02119819|54244936|FG004|Overall Study|Adverse Event|0|||
27789922|NCT02119819|54244937|FG005|Overall Study|Adverse Event|1|||
27789923|NCT02119819|54244932|FG000|Overall Study|Lack of Efficacy|0|||
27789924|NCT02119819|54244933|FG001|Overall Study|Lack of Efficacy|0|||
27789925|NCT02119819|54244934|FG002|Overall Study|Lack of Efficacy|0|||
27789926|NCT02119819|54244935|FG003|Overall Study|Lack of Efficacy|0|||
27789927|NCT02119819|54244936|FG004|Overall Study|Lack of Efficacy|0|||
27789928|NCT02119819|54244937|FG005|Overall Study|Lack of Efficacy|1|||
27789929|NCT02119819|54244932|FG000|Overall Study|Lost to Follow-up|0|||
27789930|NCT02119819|54244933|FG001|Overall Study|Lost to Follow-up|0|||
27935268|NCT00996892|54591688|FG019|Expansion Stage 2|Death|0|||
27789931|NCT02119819|54244934|FG002|Overall Study|Lost to Follow-up|1|||
27789932|NCT02119819|54244935|FG003|Overall Study|Lost to Follow-up|2|||
27935269|NCT00996892|54591669|FG000|Expansion Stage 2|Physician Decision|0|||
27935270|NCT00996892|54591670|FG001|Expansion Stage 2|Physician Decision|0|||
27935271|NCT00996892|54591671|FG002|Expansion Stage 2|Physician Decision|0|||
27789933|NCT02119819|54244936|FG004|Overall Study|Lost to Follow-up|1|||
27789934|NCT02119819|54244937|FG005|Overall Study|Lost to Follow-up|2|||
27789935|NCT02119819|54244932|FG000|Overall Study|Physician Decision|1|||
27789936|NCT02119819|54244933|FG001|Overall Study|Physician Decision|1|||
27789937|NCT02119819|54244934|FG002|Overall Study|Physician Decision|0|||
27935272|NCT00996892|54591672|FG003|Expansion Stage 2|Physician Decision|0|||
27935273|NCT00996892|54591673|FG004|Expansion Stage 2|Physician Decision|0|||
27935274|NCT00996892|54591674|FG005|Expansion Stage 2|Physician Decision|0|||
27935275|NCT00996892|54591675|FG006|Expansion Stage 2|Physician Decision|0|||
27935276|NCT00996892|54591676|FG007|Expansion Stage 2|Physician Decision|0|||
27935277|NCT00996892|54591677|FG008|Expansion Stage 2|Physician Decision|0|||
27789938|NCT02119819|54244935|FG003|Overall Study|Physician Decision|0|||
27789939|NCT02119819|54244936|FG004|Overall Study|Physician Decision|0|||
27789940|NCT02119819|54244937|FG005|Overall Study|Physician Decision|1|||
27789941|NCT02119819|54244932|FG000|Overall Study|Withdrawal by Subject|5|||
27789942|NCT02119819|54244933|FG001|Overall Study|Withdrawal by Subject|3|||
27789943|NCT02119819|54244934|FG002|Overall Study|Withdrawal by Subject|0|||
27789944|NCT02119819|54244935|FG003|Overall Study|Withdrawal by Subject|0|||
27789945|NCT02119819|54244936|FG004|Overall Study|Withdrawal by Subject|6|||
27789946|NCT02119819|54244937|FG005|Overall Study|Withdrawal by Subject|10|||
27789947|NCT02119819|54244932|FG000|Overall Study|Jury Duty|0|||
27789948|NCT02119819|54244933|FG001|Overall Study|Jury Duty|0|||
27789949|NCT02119819|54244934|FG002|Overall Study|Jury Duty|1|||
27789950|NCT02119819|54244935|FG003|Overall Study|Jury Duty|0|||
27789951|NCT02119819|54244936|FG004|Overall Study|Jury Duty|0|||
27789952|NCT02119819|54244937|FG005|Overall Study|Jury Duty|0|||
27789953|NCT02119819|54244932|FG000|Overall Study|Protocol Violation|0|||
27789954|NCT02119819|54244933|FG001|Overall Study|Protocol Violation|0|||
27789955|NCT02119819|54244934|FG002|Overall Study|Protocol Violation|0|||
27789956|NCT02119819|54244935|FG003|Overall Study|Protocol Violation|1|||
27789957|NCT02119819|54244936|FG004|Overall Study|Protocol Violation|0|||
27789958|NCT02119819|54244937|FG005|Overall Study|Protocol Violation|0|||
27789959|NCT02119819|54244932|FG000|Overall Study|Left the city to get a job|0|||
27789960|NCT02119819|54244933|FG001|Overall Study|Left the city to get a job|0|||
27789961|NCT02119819|54244934|FG002|Overall Study|Left the city to get a job|0|||
27789962|NCT02119819|54244935|FG003|Overall Study|Left the city to get a job|1|||
27789963|NCT02119819|54244936|FG004|Overall Study|Left the city to get a job|0|||
27789964|NCT02119819|54244937|FG005|Overall Study|Left the city to get a job|0|||
27789965|NCT02168816|54244953|FG000|Overall Study|Lost to Follow-up|2|||
27789966|NCT02168816|54244954|FG001|Overall Study|Lost to Follow-up|2|||
27789967|NCT01584232|54244962|FG000|Overall Study|Adverse Event|3|||
27789968|NCT01584232|54244963|FG001|Overall Study|Adverse Event|1|||
27789969|NCT01584232|54244962|FG000|Overall Study|Withdrawal by Subject|2|||
27789970|NCT01584232|54244963|FG001|Overall Study|Withdrawal by Subject|1|||
27789971|NCT01584232|54244962|FG000|Overall Study|Physician Decision|2|||
27789972|NCT01584232|54244963|FG001|Overall Study|Physician Decision|1|||
27789973|NCT01584232|54244962|FG000|Overall Study|Lost to Follow-up|1|||
27789974|NCT01584232|54244963|FG001|Overall Study|Lost to Follow-up|0|||
27789975|NCT01639703|54244969|FG000|Overall Study|Withdrawal by Subject|5|||
27789976|NCT01639703|54244969|FG000|Overall Study|Other reason|7|||
27935278|NCT00996892|54591678|FG009|Expansion Stage 2|Physician Decision|0|||
27935279|NCT00996892|54591679|FG010|Expansion Stage 2|Physician Decision|0|||
27935280|NCT00996892|54591680|FG011|Expansion Stage 2|Physician Decision|0|||
27935281|NCT00996892|54591681|FG012|Expansion Stage 2|Physician Decision|0|||
27935282|NCT00996892|54591682|FG013|Expansion Stage 2|Physician Decision|0|||
27935283|NCT00996892|54591683|FG014|Expansion Stage 2|Physician Decision|0|||
27935284|NCT00996892|54591684|FG015|Expansion Stage 2|Physician Decision|0|||
27935285|NCT00996892|54591685|FG016|Expansion Stage 2|Physician Decision|0|||
27935286|NCT00996892|54591686|FG017|Expansion Stage 2|Physician Decision|0|||
27935287|NCT00996892|54591687|FG018|Expansion Stage 2|Physician Decision|1|||
27935288|NCT00996892|54591688|FG019|Expansion Stage 2|Physician Decision|0|||
27935289|NCT00996892|54591669|FG000|Expansion Stage 2|Withdrawal by Subject|0|||
27935290|NCT00996892|54591670|FG001|Expansion Stage 2|Withdrawal by Subject|0|||
27935291|NCT00996892|54591671|FG002|Expansion Stage 2|Withdrawal by Subject|0|||
27935292|NCT00996892|54591672|FG003|Expansion Stage 2|Withdrawal by Subject|0|||
27935293|NCT00996892|54591673|FG004|Expansion Stage 2|Withdrawal by Subject|0|||
27935294|NCT00996892|54591674|FG005|Expansion Stage 2|Withdrawal by Subject|0|||
27935295|NCT00996892|54591675|FG006|Expansion Stage 2|Withdrawal by Subject|0|||
27935296|NCT00996892|54591676|FG007|Expansion Stage 2|Withdrawal by Subject|0|||
27935297|NCT00996892|54591677|FG008|Expansion Stage 2|Withdrawal by Subject|0|||
27935298|NCT00996892|54591678|FG009|Expansion Stage 2|Withdrawal by Subject|0|||
27935299|NCT00996892|54591679|FG010|Expansion Stage 2|Withdrawal by Subject|0|||
27935300|NCT00996892|54591680|FG011|Expansion Stage 2|Withdrawal by Subject|0|||
27789977|NCT02119663|54244987|FG000|Overall Study|Disease progression|26|||
27789978|NCT02119663|54244988|FG001|Overall Study|Disease progression|27|||
27789979|NCT02119663|54244987|FG000|Overall Study|Adverse Event|5|||
27789980|NCT02119663|54244988|FG001|Overall Study|Adverse Event|5|||
27789981|NCT02119663|54244987|FG000|Overall Study|Death|3|||
27789982|NCT02119663|54244988|FG001|Overall Study|Death|2|||
27935301|NCT00996892|54591681|FG012|Expansion Stage 2|Withdrawal by Subject|0|||
27935302|NCT00996892|54591682|FG013|Expansion Stage 2|Withdrawal by Subject|0|||
27935303|NCT00996892|54591683|FG014|Expansion Stage 2|Withdrawal by Subject|0|||
27789983|NCT02119663|54244987|FG000|Overall Study|Physician Decision|1|||
27789984|NCT02119663|54244988|FG001|Overall Study|Physician Decision|2|||
27789985|NCT02119663|54244987|FG000|Overall Study|Other unspecified|2|||
27789986|NCT02119663|54244988|FG001|Overall Study|Other unspecified|0|||
27789987|NCT02119663|54244987|FG000|Overall Study|Subject decision|0|||
27789988|NCT02119663|54244988|FG001|Overall Study|Subject decision|1|||
27789989|NCT02119663|54244987|FG000|Overall Study|Study Terminated by the Sponsor|3|||
27935304|NCT00996892|54591684|FG015|Expansion Stage 2|Withdrawal by Subject|0|||
27935305|NCT00996892|54591685|FG016|Expansion Stage 2|Withdrawal by Subject|0|||
27935306|NCT00996892|54591686|FG017|Expansion Stage 2|Withdrawal by Subject|0|||
27935307|NCT00996892|54591687|FG018|Expansion Stage 2|Withdrawal by Subject|1|||
27935308|NCT00996892|54591688|FG019|Expansion Stage 2|Withdrawal by Subject|0|||
27935309|NCT00996892|54591669|FG000|Expansion Stage 2|Disease Progression|0|||
27935310|NCT00996892|54591670|FG001|Expansion Stage 2|Disease Progression|0|||
27935311|NCT00996892|54591671|FG002|Expansion Stage 2|Disease Progression|0|||
27935312|NCT00996892|54591672|FG003|Expansion Stage 2|Disease Progression|0|||
27935313|NCT00996892|54591673|FG004|Expansion Stage 2|Disease Progression|0|||
27935314|NCT00996892|54591674|FG005|Expansion Stage 2|Disease Progression|0|||
27935315|NCT00996892|54591675|FG006|Expansion Stage 2|Disease Progression|0|||
27935316|NCT00996892|54591676|FG007|Expansion Stage 2|Disease Progression|0|||
27935317|NCT00996892|54591677|FG008|Expansion Stage 2|Disease Progression|0|||
27935318|NCT00996892|54591678|FG009|Expansion Stage 2|Disease Progression|0|||
27935319|NCT00996892|54591679|FG010|Expansion Stage 2|Disease Progression|0|||
27935320|NCT00996892|54591680|FG011|Expansion Stage 2|Disease Progression|0|||
27935321|NCT00996892|54591681|FG012|Expansion Stage 2|Disease Progression|0|||
27935322|NCT00996892|54591682|FG013|Expansion Stage 2|Disease Progression|0|||
27935323|NCT00996892|54591683|FG014|Expansion Stage 2|Disease Progression|0|||
27935324|NCT00996892|54591684|FG015|Expansion Stage 2|Disease Progression|0|||
27935325|NCT00996892|54591685|FG016|Expansion Stage 2|Disease Progression|0|||
27935326|NCT00996892|54591686|FG017|Expansion Stage 2|Disease Progression|0|||
27935327|NCT00996892|54591687|FG018|Expansion Stage 2|Disease Progression|28|||
27935328|NCT00996892|54591688|FG019|Expansion Stage 2|Disease Progression|0|||
27935329|NCT00996892|54591669|FG000|Expansion Stage 2A|Adverse Event|0|||
27935330|NCT00996892|54591670|FG001|Expansion Stage 2A|Adverse Event|0|||
27935331|NCT00996892|54591671|FG002|Expansion Stage 2A|Adverse Event|0|||
27935332|NCT00996892|54591672|FG003|Expansion Stage 2A|Adverse Event|0|||
27935333|NCT00996892|54591673|FG004|Expansion Stage 2A|Adverse Event|0|||
27935334|NCT00996892|54591674|FG005|Expansion Stage 2A|Adverse Event|0|||
27935335|NCT00996892|54591675|FG006|Expansion Stage 2A|Adverse Event|0|||
27935336|NCT00996892|54591676|FG007|Expansion Stage 2A|Adverse Event|0|||
27935337|NCT00996892|54591677|FG008|Expansion Stage 2A|Adverse Event|0|||
27935338|NCT00996892|54591678|FG009|Expansion Stage 2A|Adverse Event|0|||
27935339|NCT00996892|54591679|FG010|Expansion Stage 2A|Adverse Event|0|||
27935340|NCT00996892|54591680|FG011|Expansion Stage 2A|Adverse Event|0|||
27935341|NCT00996892|54591681|FG012|Expansion Stage 2A|Adverse Event|0|||
27935342|NCT00996892|54591682|FG013|Expansion Stage 2A|Adverse Event|0|||
27935343|NCT00996892|54591683|FG014|Expansion Stage 2A|Adverse Event|0|||
27935344|NCT00996892|54591684|FG015|Expansion Stage 2A|Adverse Event|0|||
27935345|NCT00996892|54591685|FG016|Expansion Stage 2A|Adverse Event|0|||
27935346|NCT00996892|54591686|FG017|Expansion Stage 2A|Adverse Event|0|||
27935347|NCT00996892|54591687|FG018|Expansion Stage 2A|Adverse Event|0|||
27935348|NCT00996892|54591688|FG019|Expansion Stage 2A|Adverse Event|8|||
27935349|NCT00996892|54591669|FG000|Expansion Stage 2A|Physician Decision|0|||
27935350|NCT00996892|54591670|FG001|Expansion Stage 2A|Physician Decision|0|||
27935351|NCT00996892|54591671|FG002|Expansion Stage 2A|Physician Decision|0|||
27935352|NCT00996892|54591672|FG003|Expansion Stage 2A|Physician Decision|0|||
27935353|NCT00996892|54591673|FG004|Expansion Stage 2A|Physician Decision|0|||
27935354|NCT00996892|54591674|FG005|Expansion Stage 2A|Physician Decision|0|||
27935355|NCT00996892|54591675|FG006|Expansion Stage 2A|Physician Decision|0|||
27935356|NCT00996892|54591676|FG007|Expansion Stage 2A|Physician Decision|0|||
27935357|NCT00996892|54591677|FG008|Expansion Stage 2A|Physician Decision|0|||
28017027|NCT00683618|54676261|FG001|Randomised Treatment Period|Reason not provided|0|||
28017028|NCT00683618|54676262|FG002|Randomised Treatment Period|Reason not provided|2|||
28017029|NCT00683618|54676260|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
28017030|NCT00683618|54676261|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
28017031|NCT00683618|54676262|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
28017032|NCT00683618|54676260|FG000|Extension Treatment Period|Adverse Event|1|||
28017033|NCT00683618|54676261|FG001|Extension Treatment Period|Adverse Event|0|||
28017034|NCT00683618|54676262|FG002|Extension Treatment Period|Adverse Event|0|||
28017035|NCT00683618|54676260|FG000|Extension Treatment Period|Protocol Violation|1|||
28017036|NCT00683618|54676261|FG001|Extension Treatment Period|Protocol Violation|0|||
28017037|NCT00683618|54676262|FG002|Extension Treatment Period|Protocol Violation|0|||
28017038|NCT00688064|54676274|FG000|Overall Study|Protocol Violation|0|||
27935358|NCT00996892|54591678|FG009|Expansion Stage 2A|Physician Decision|0|||
27935359|NCT00996892|54591679|FG010|Expansion Stage 2A|Physician Decision|0|||
27935360|NCT00996892|54591680|FG011|Expansion Stage 2A|Physician Decision|0|||
27842486|NCT01445171|54331000|FG000|Overall Study|Subjects declined to return for followup|9|||
27842487|NCT01445171|54331000|FG000|Overall Study|Consented but did not receive device|8|||
27935361|NCT00996892|54591681|FG012|Expansion Stage 2A|Physician Decision|0|||
27935362|NCT00996892|54591682|FG013|Expansion Stage 2A|Physician Decision|0|||
27935363|NCT00996892|54591683|FG014|Expansion Stage 2A|Physician Decision|0|||
27935364|NCT00996892|54591684|FG015|Expansion Stage 2A|Physician Decision|0|||
27935365|NCT00996892|54591685|FG016|Expansion Stage 2A|Physician Decision|0|||
27935366|NCT00996892|54591686|FG017|Expansion Stage 2A|Physician Decision|0|||
27935367|NCT00996892|54591687|FG018|Expansion Stage 2A|Physician Decision|0|||
27935368|NCT00996892|54591688|FG019|Expansion Stage 2A|Physician Decision|2|||
27935369|NCT00996892|54591669|FG000|Expansion Stage 2A|Withdrawal by Subject|0|||
27935370|NCT00996892|54591670|FG001|Expansion Stage 2A|Withdrawal by Subject|0|||
27935371|NCT00996892|54591671|FG002|Expansion Stage 2A|Withdrawal by Subject|0|||
27935372|NCT00996892|54591672|FG003|Expansion Stage 2A|Withdrawal by Subject|0|||
27935373|NCT00996892|54591673|FG004|Expansion Stage 2A|Withdrawal by Subject|0|||
27935374|NCT00996892|54591674|FG005|Expansion Stage 2A|Withdrawal by Subject|0|||
27935375|NCT00996892|54591675|FG006|Expansion Stage 2A|Withdrawal by Subject|0|||
27935376|NCT00996892|54591676|FG007|Expansion Stage 2A|Withdrawal by Subject|0|||
27935377|NCT00996892|54591677|FG008|Expansion Stage 2A|Withdrawal by Subject|0|||
27935378|NCT00996892|54591678|FG009|Expansion Stage 2A|Withdrawal by Subject|0|||
27935379|NCT00996892|54591679|FG010|Expansion Stage 2A|Withdrawal by Subject|0|||
27935380|NCT00996892|54591680|FG011|Expansion Stage 2A|Withdrawal by Subject|0|||
27789990|NCT02119663|54244988|FG001|Overall Study|Study Terminated by the Sponsor|4|||
27789991|NCT01639469|54244996|FG000|Overall Study|Death|4|||
27789992|NCT01639469|54244997|FG001|Overall Study|Death|2|||
27789993|NCT01639469|54244996|FG000|Overall Study|Lost to Follow-up|1|||
27789994|NCT01639469|54244997|FG001|Overall Study|Lost to Follow-up|1|||
27789995|NCT02193074|54245005|FG000|Overall Study|Withdrawal by Subject|1|||
27789996|NCT02193074|54245006|FG001|Overall Study|Withdrawal by Subject|2|||
27789997|NCT02193074|54245005|FG000|Overall Study|Adverse Event|16|||
27789998|NCT02193074|54245006|FG001|Overall Study|Adverse Event|13|||
27789999|NCT02192606|54245014|FG000|Overall Study|surgery type was changed|1|||
27790000|NCT02192606|54245015|FG001|Overall Study|surgery type was changed|1|||
27790001|NCT02192606|54245014|FG000|Overall Study|Physician Decision|1|||
27790002|NCT02192606|54245015|FG001|Overall Study|Physician Decision|2|||
27790003|NCT02192606|54245014|FG000|Overall Study|3D equipment rep unable to join|0|||
27790004|NCT02192606|54245015|FG001|Overall Study|3D equipment rep unable to join|1|||
27790005|NCT01628107|54245021|FG000|Overall Study|Withdrawal by Subject|17|||
27790006|NCT01628107|54245021|FG000|Overall Study|Lost to Follow-up|4|||
27790007|NCT01628107|54245021|FG000|Overall Study|Adverse Event|33|||
27790008|NCT01628107|54245021|FG000|Overall Study|Physician Decision|2|||
27790009|NCT01628107|54245021|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|1|||
27790010|NCT01628107|54245021|FG000|Overall Study|Non-compliant with Study Procedures|10|||
27790011|NCT01628107|54245021|FG000|Overall Study|Not Treated|8|||
27790012|NCT01628107|54245021|FG000|Overall Study|Sponsor Decision|11|||
27790013|NCT01628107|54245021|FG000|Overall Study|Missed Study Drug More than 2 Weeks|7|||
27790014|NCT01628107|54245021|FG000|Overall Study|Relocated|8|||
27790015|NCT01628107|54245021|FG000|Overall Study|Kidney Transplant|9|||
27790016|NCT01628107|54245021|FG000|Overall Study|Use of Standard of Care|9|||
27935381|NCT00996892|54591681|FG012|Expansion Stage 2A|Withdrawal by Subject|0|||
27935382|NCT00996892|54591682|FG013|Expansion Stage 2A|Withdrawal by Subject|0|||
27935383|NCT00996892|54591683|FG014|Expansion Stage 2A|Withdrawal by Subject|0|||
27935384|NCT00996892|54591684|FG015|Expansion Stage 2A|Withdrawal by Subject|0|||
27935385|NCT00996892|54591685|FG016|Expansion Stage 2A|Withdrawal by Subject|0|||
27935386|NCT00996892|54591686|FG017|Expansion Stage 2A|Withdrawal by Subject|0|||
27935387|NCT00996892|54591687|FG018|Expansion Stage 2A|Withdrawal by Subject|0|||
27935388|NCT00996892|54591688|FG019|Expansion Stage 2A|Withdrawal by Subject|4|||
27935389|NCT00996892|54591669|FG000|Expansion Stage 2A|Disease Progression|0|||
27935390|NCT00996892|54591670|FG001|Expansion Stage 2A|Disease Progression|0|||
27935391|NCT00996892|54591671|FG002|Expansion Stage 2A|Disease Progression|0|||
27935392|NCT00996892|54591672|FG003|Expansion Stage 2A|Disease Progression|0|||
27935393|NCT00996892|54591673|FG004|Expansion Stage 2A|Disease Progression|0|||
27935394|NCT00996892|54591674|FG005|Expansion Stage 2A|Disease Progression|0|||
27935395|NCT00996892|54591675|FG006|Expansion Stage 2A|Disease Progression|0|||
27935396|NCT00996892|54591676|FG007|Expansion Stage 2A|Disease Progression|0|||
27935397|NCT00996892|54591677|FG008|Expansion Stage 2A|Disease Progression|0|||
27935398|NCT00996892|54591678|FG009|Expansion Stage 2A|Disease Progression|0|||
27935399|NCT00996892|54591679|FG010|Expansion Stage 2A|Disease Progression|0|||
28017039|NCT00688064|54676275|FG001|Overall Study|Protocol Violation|1|||
27790017|NCT01583530|54245031|FG000|Overall Study|Adverse Event|0|||
27790018|NCT01583530|54245032|FG001|Overall Study|Adverse Event|0|||
27790019|NCT01583530|54245033|FG002|Overall Study|Adverse Event|0|||
27935400|NCT00996892|54591680|FG011|Expansion Stage 2A|Disease Progression|0|||
27935401|NCT00996892|54591681|FG012|Expansion Stage 2A|Disease Progression|0|||
27790020|NCT01583530|54245034|FG003|Overall Study|Adverse Event|0|||
27790021|NCT01583530|54245035|FG004|Overall Study|Adverse Event|0|||
27790022|NCT01583530|54245036|FG005|Overall Study|Adverse Event|1|||
27790023|NCT01583530|54245031|FG000|Overall Study|Withdrawal by Subject|0|||
27790024|NCT01583530|54245032|FG001|Overall Study|Withdrawal by Subject|3|||
27935402|NCT00996892|54591682|FG013|Expansion Stage 2A|Disease Progression|0|||
27935403|NCT00996892|54591683|FG014|Expansion Stage 2A|Disease Progression|0|||
27935404|NCT00996892|54591684|FG015|Expansion Stage 2A|Disease Progression|0|||
27790025|NCT01583530|54245033|FG002|Overall Study|Withdrawal by Subject|0|||
27935405|NCT00996892|54591685|FG016|Expansion Stage 2A|Disease Progression|0|||
27935406|NCT00996892|54591686|FG017|Expansion Stage 2A|Disease Progression|0|||
27935407|NCT00996892|54591687|FG018|Expansion Stage 2A|Disease Progression|0|||
27935408|NCT00996892|54591688|FG019|Expansion Stage 2A|Disease Progression|31|||
27935409|NCT01257581|54591752|FG000|Overall Study|Early Termination|3|||
27935410|NCT01257581|54591753|FG001|Overall Study|Early Termination|1|||
27935411|NCT01257581|54591754|FG002|Overall Study|Early Termination|2|||
27935412|NCT01257581|54591752|FG000|Overall Study|Death|2|||
27935413|NCT01257581|54591753|FG001|Overall Study|Death|2|||
27935414|NCT01257581|54591754|FG002|Overall Study|Death|4|||
27935415|NCT01257503|54591764|FG000|Overall Study|Lost to Follow-up|7|||
27935416|NCT01257503|54591765|FG001|Overall Study|Lost to Follow-up|10|||
27935417|NCT01257503|54591764|FG000|Overall Study|Over 5 years old at enrollment|0|||
27935418|NCT01257503|54591765|FG001|Overall Study|Over 5 years old at enrollment|1|||
27935419|NCT01257503|54591764|FG000|Overall Study|strep culture positive at enrollment|1|||
27935420|NCT01257503|54591765|FG001|Overall Study|strep culture positive at enrollment|0|||
27935421|NCT00995566|54591771|FG000|Overall Study|Adverse Event|2|||
27935422|NCT00995566|54591771|FG000|Overall Study|Early study termination|52|||
27935423|NCT01257425|54591777|FG000|Overall Study|Lack of Efficacy|3|||
27935424|NCT01257425|54591778|FG001|Overall Study|Lack of Efficacy|3|||
27935425|NCT01257425|54591777|FG000|Overall Study|Adverse Event|1|||
27935426|NCT01257425|54591778|FG001|Overall Study|Adverse Event|1|||
27935427|NCT01257425|54591777|FG000|Overall Study|Protocol Violation|1|||
27935428|NCT01257425|54591778|FG001|Overall Study|Protocol Violation|1|||
27935429|NCT01257425|54591777|FG000|Overall Study|Withdrawal by Subject|0|||
27935430|NCT01257425|54591778|FG001|Overall Study|Withdrawal by Subject|1|||
27935431|NCT01257425|54591777|FG000|Overall Study|Death|1|||
27935432|NCT01257425|54591778|FG001|Overall Study|Death|0|||
27935433|NCT00995488|54591784|FG000|Overall Study|Withdrawal by Subject|1|||
27935434|NCT01256879|54591788|FG000|Overall Study|Withdrawal by Subject|1|||
27935435|NCT01125189|54591801|FG000|Treatment Period|Lack of Efficacy|15|||
27935436|NCT01125189|54591802|FG001|Treatment Period|Lack of Efficacy|18|||
27935437|NCT01125189|54591803|FG002|Treatment Period|Lack of Efficacy|25|||
27935438|NCT01125189|54591801|FG000|Treatment Period|Adverse Event|7|||
27935439|NCT01125189|54591802|FG001|Treatment Period|Adverse Event|8|||
27935440|NCT01125189|54591803|FG002|Treatment Period|Adverse Event|8|||
27935441|NCT01125189|54591801|FG000|Treatment Period|Withdrawal by Subject|3|||
27935442|NCT01125189|54591802|FG001|Treatment Period|Withdrawal by Subject|1|||
27935443|NCT01125189|54591803|FG002|Treatment Period|Withdrawal by Subject|1|||
27935444|NCT01125189|54591801|FG000|Treatment Period|Death|1|||
27935445|NCT01125189|54591802|FG001|Treatment Period|Death|0|||
27935446|NCT01125189|54591803|FG002|Treatment Period|Death|0|||
27935447|NCT01125189|54591801|FG000|Treatment Period|Lost to Follow-up|1|||
27935448|NCT01125189|54591802|FG001|Treatment Period|Lost to Follow-up|2|||
27935449|NCT01125189|54591803|FG002|Treatment Period|Lost to Follow-up|1|||
27935450|NCT01125189|54591801|FG000|Treatment Period|Poor compliance/noncompliance|0|||
27935451|NCT01125189|54591802|FG001|Treatment Period|Poor compliance/noncompliance|1|||
27935452|NCT01125189|54591803|FG002|Treatment Period|Poor compliance/noncompliance|0|||
27935453|NCT01125189|54591801|FG000|Treatment Period|Participants requested to discontinue|1|||
27935454|NCT01125189|54591802|FG001|Treatment Period|Participants requested to discontinue|3|||
27935455|NCT01125189|54591803|FG002|Treatment Period|Participants requested to discontinue|4|||
27935456|NCT01125189|54591801|FG000|Treatment Period|Other reasons|1|||
27935457|NCT01125189|54591802|FG001|Treatment Period|Other reasons|1|||
27935458|NCT01125189|54591803|FG002|Treatment Period|Other reasons|0|||
27935459|NCT01125189|54591801|FG000|Treatment Period|Completed 24 week treatment period only|2|||
27935460|NCT01125189|54591802|FG001|Treatment Period|Completed 24 week treatment period only|1|||
27935461|NCT01125189|54591803|FG002|Treatment Period|Completed 24 week treatment period only|2|||
27935462|NCT01125189|54591801|FG000|Follow up Period|Withdrawal by Subject|3|||
27935463|NCT01125189|54591802|FG001|Follow up Period|Withdrawal by Subject|2|||
27935464|NCT01125189|54591803|FG002|Follow up Period|Withdrawal by Subject|5|||
27935465|NCT01125189|54591801|FG000|Follow up Period|Death|1|||
27935466|NCT01125189|54591802|FG001|Follow up Period|Death|0|||
27935467|NCT01125189|54591803|FG002|Follow up Period|Death|0|||
27935468|NCT01125189|54591801|FG000|Follow up Period|Lost to Follow-up|12|||
27935469|NCT01125189|54591802|FG001|Follow up Period|Lost to Follow-up|9|||
27935470|NCT01125189|54591803|FG002|Follow up Period|Lost to Follow-up|6|||
27935471|NCT01125189|54591801|FG000|Follow up Period|Other reasons|4|||
27935472|NCT01125189|54591802|FG001|Follow up Period|Other reasons|4|||
27935473|NCT01125189|54591803|FG002|Follow up Period|Other reasons|5|||
27935474|NCT01256567|54591814|FG000|Overall Study|Withdrawal by Subject|1|||
27935475|NCT00996736|54591821|FG000|Overall Study|Death|1|||
27935476|NCT00996736|54591822|FG001|Overall Study|Death|1|||
27935477|NCT00996736|54591821|FG000|Overall Study|Lost to Follow-up|15|||
27935478|NCT00996736|54591822|FG001|Overall Study|Lost to Follow-up|14|||
27935479|NCT00996736|54591821|FG000|Overall Study|Visit not within 3-month window|5|||
27935480|NCT00996736|54591822|FG001|Overall Study|Visit not within 3-month window|3|||
27935481|NCT00996658|54591830|FG000|Overall Study|Adverse Event|2|||
27790026|NCT01583530|54245034|FG003|Overall Study|Withdrawal by Subject|1|||
27790027|NCT01583530|54245035|FG004|Overall Study|Withdrawal by Subject|1|||
27790028|NCT01583530|54245036|FG005|Overall Study|Withdrawal by Subject|2|||
27790029|NCT01583530|54245031|FG000|Overall Study|Lost to Follow-up|0|||
27790030|NCT01583530|54245032|FG001|Overall Study|Lost to Follow-up|0|||
27790031|NCT01583530|54245033|FG002|Overall Study|Lost to Follow-up|0|||
27790032|NCT01583530|54245034|FG003|Overall Study|Lost to Follow-up|0|||
27790033|NCT01583530|54245035|FG004|Overall Study|Lost to Follow-up|3|||
27790034|NCT01583530|54245036|FG005|Overall Study|Lost to Follow-up|0|||
27790035|NCT01583530|54245031|FG000|Overall Study|Lack of compliance|0|||
27790036|NCT01583530|54245032|FG001|Overall Study|Lack of compliance|0|||
27790037|NCT01583530|54245033|FG002|Overall Study|Lack of compliance|0|||
27790038|NCT01583530|54245034|FG003|Overall Study|Lack of compliance|0|||
27790039|NCT01583530|54245035|FG004|Overall Study|Lack of compliance|1|||
27790040|NCT01583530|54245036|FG005|Overall Study|Lack of compliance|0|||
27790041|NCT01639001|54245055|FG000|Overall Study|Refused further follow-up|9|||
27790042|NCT01639001|54245056|FG001|Overall Study|Refused further follow-up|12|||
27790043|NCT01639001|54245055|FG000|Overall Study|Lost to Follow-up|3|||
27790044|NCT01639001|54245056|FG001|Overall Study|Lost to Follow-up|0|||
27790045|NCT01639001|54245055|FG000|Overall Study|Death|62|||
27790046|NCT01639001|54245056|FG001|Overall Study|Death|61|||
27790047|NCT01639001|54245055|FG000|Overall Study|Randomized but not treated|0|||
27790048|NCT01639001|54245056|FG001|Overall Study|Randomized but not treated|2|||
27790049|NCT01639001|54245055|FG000|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1|||
27790050|NCT01639001|54245056|FG001|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2|||
27790051|NCT02224664|54245064|FG000|Lead-in Period (3 Days)|Does not meet entrance criteria|5|||
27790052|NCT02224664|54245065|FG001|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
27790053|NCT02224664|54245066|FG002|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
27790054|NCT02224664|54245067|FG003|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
27790055|NCT02224664|54245068|FG004|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
27790056|NCT02224664|54245064|FG000|Dose Escalation Period (21 Days)|Adverse Event|0|||
27790057|NCT02224664|54245065|FG001|Dose Escalation Period (21 Days)|Adverse Event|0|||
27790058|NCT02224664|54245066|FG002|Dose Escalation Period (21 Days)|Adverse Event|2|||
27790059|NCT02224664|54245067|FG003|Dose Escalation Period (21 Days)|Adverse Event|2|||
27790060|NCT02224664|54245068|FG004|Dose Escalation Period (21 Days)|Adverse Event|7|||
27790061|NCT02224664|54245064|FG000|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
27790062|NCT02224664|54245065|FG001|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
27790063|NCT02224664|54245066|FG002|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
27790064|NCT02224664|54245067|FG003|Dose Escalation Period (21 Days)|Withdrawal by Subject|1|||
27790065|NCT02224664|54245068|FG004|Dose Escalation Period (21 Days)|Withdrawal by Subject|4|||
27790066|NCT02168270|54245084|FG000|Overall Study|Lack of Efficacy|4|||
27790067|NCT02167256|54245090|FG000|Overall Study|Adverse Event|13|||
27790068|NCT02167256|54245091|FG001|Overall Study|Adverse Event|6|||
27790069|NCT02167256|54245090|FG000|Overall Study|Withdrawal by Subject|4|||
27790070|NCT02167256|54245091|FG001|Overall Study|Withdrawal by Subject|4|||
27790071|NCT02167256|54245090|FG000|Overall Study|non-compliance|3|||
27790072|NCT02167256|54245091|FG001|Overall Study|non-compliance|0|||
27790073|NCT02167256|54245090|FG000|Overall Study|Study partner unable to participate|1|||
27790074|NCT02167256|54245091|FG001|Overall Study|Study partner unable to participate|0|||
27790075|NCT02191046|54245099|FG000|Overall Study|low compliance|5|||
27790076|NCT02191046|54245100|FG001|Overall Study|low compliance|1|||
27790077|NCT02166476|54245108|FG000|Overall Study|Withdrawal by Subject|5|||
27790078|NCT02166476|54245109|FG001|Overall Study|Withdrawal by Subject|7|||
27790079|NCT02166476|54245108|FG000|Overall Study|Adverse Event|3|||
27790080|NCT02166476|54245109|FG001|Overall Study|Adverse Event|3|||
27790081|NCT02166476|54245108|FG000|Overall Study|Lost to Follow-up|5|||
27790082|NCT02166476|54245109|FG001|Overall Study|Lost to Follow-up|10|||
27790083|NCT02166476|54245108|FG000|Overall Study|Physician Decision|1|||
27790084|NCT02166476|54245109|FG001|Overall Study|Physician Decision|0|||
27790085|NCT02166476|54245108|FG000|Overall Study|Unable to Come for Visit|0|||
27790086|NCT02166476|54245109|FG001|Overall Study|Unable to Come for Visit|3|||
27790087|NCT02224274|54245120|FG000|Overall Study|Death|1|||
27790088|NCT02224274|54245121|FG001|Overall Study|Death|0|||
27790089|NCT02189252|54245135|FG000|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
27790090|NCT02189252|54245136|FG001|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1|||
27790091|NCT02189252|54245137|FG002|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
27790092|NCT02189252|54245138|FG003|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
27790093|NCT02189252|54245135|FG000|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
27790094|NCT02189252|54245136|FG001|Period 1 (Visit 4b, Week 4)|Adverse Event|1|||
27790095|NCT02189252|54245137|FG002|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
27790096|NCT02189252|54245138|FG003|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
27790097|NCT01583374|54245152|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|6|||
27790098|NCT01583374|54245153|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|7|||
27790099|NCT01583374|54245154|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|12|||
27790100|NCT01583374|54245155|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
27790101|NCT01583374|54245156|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
27790102|NCT01583374|54245157|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
27790103|NCT01583374|54245158|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
27790104|NCT01583374|54245159|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
27790105|NCT01583374|54245160|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
27790106|NCT01583374|54245152|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3|||
27790107|NCT01583374|54245153|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2|||
27790108|NCT01583374|54245154|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
27790109|NCT01583374|54245155|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
27790110|NCT01583374|54245156|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
27790111|NCT01583374|54245157|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
27790112|NCT01583374|54245158|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
27790113|NCT01583374|54245159|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
27790114|NCT01583374|54245160|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
27790115|NCT01583374|54245152|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
27790116|NCT01583374|54245153|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
27790117|NCT01583374|54245154|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
27790118|NCT01583374|54245155|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
27790119|NCT01583374|54245156|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
27790120|NCT01583374|54245157|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
28017040|NCT00688064|54676274|FG000|Overall Study|Adverse Event|2|||
27790121|NCT01583374|54245158|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
27790122|NCT01583374|54245159|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
28017041|NCT00688064|54676275|FG001|Overall Study|Adverse Event|4|||
28017042|NCT00688064|54676274|FG000|Overall Study|Withdrawal by Subject|7|||
28017043|NCT00688064|54676275|FG001|Overall Study|Withdrawal by Subject|7|||
28017044|NCT00688064|54676274|FG000|Overall Study|Lost to Follow-up|10|||
28017045|NCT00688064|54676275|FG001|Overall Study|Lost to Follow-up|10|||
28017046|NCT00688064|54676274|FG000|Overall Study|Lack of Efficacy|0|||
28017047|NCT00688064|54676275|FG001|Overall Study|Lack of Efficacy|1|||
28017048|NCT00688064|54676274|FG000|Overall Study|Pregnancy|1|||
28017049|NCT00688064|54676275|FG001|Overall Study|Pregnancy|0|||
27935482|NCT00996658|54591831|FG001|Overall Study|Adverse Event|5|||
27935483|NCT00996658|54591830|FG000|Overall Study|Protocol Violation|0|||
27935484|NCT00996658|54591831|FG001|Overall Study|Protocol Violation|1|||
27935485|NCT00996658|54591830|FG000|Overall Study|Lost to Follow-up|2|||
27935486|NCT00996658|54591831|FG001|Overall Study|Lost to Follow-up|5|||
27935487|NCT00996658|54591830|FG000|Overall Study|Non-compliance issues|3|||
27935488|NCT00996658|54591831|FG001|Overall Study|Non-compliance issues|3|||
27935489|NCT00996658|54591830|FG000|Overall Study|Other|9|||
27935490|NCT00996658|54591831|FG001|Overall Study|Other|7|||
27935491|NCT01124643|54591837|FG000|Overall Study|Death|1|||
27935492|NCT01256411|54591845|FG000|Extension by Maximum Treatment|Protocol deviation|0|||
27935493|NCT01256411|54591846|FG001|Extension by Maximum Treatment|Protocol deviation|0|||
27935494|NCT01256411|54591847|FG002|Extension by Maximum Treatment|Protocol deviation|1|||
28017050|NCT00688064|54676274|FG000|Overall Study|Any other reasons|1|||
28017051|NCT00688064|54676275|FG001|Overall Study|Any other reasons|3|||
28017052|NCT00663234|54676281|FG000|Overall Study|Not willing to adhere to requirements|1|||
27790123|NCT01583374|54245160|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
27790124|NCT01583374|54245152|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8|||
27790125|NCT01583374|54245153|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
27790126|NCT01583374|54245154|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
27790127|NCT01583374|54245155|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
27790128|NCT01583374|54245156|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
27790129|NCT01583374|54245157|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
27790130|NCT01583374|54245158|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
27842488|NCT01444781|54331009|FG000|Overall Study|Lost to Follow-up|0|||
27935495|NCT01256411|54591848|FG003|Extension by Maximum Treatment|Protocol deviation|0|||
27935496|NCT01256411|54591849|FG004|Extension by Maximum Treatment|Protocol deviation|0|||
27935497|NCT01256411|54591850|FG005|Extension by Maximum Treatment|Protocol deviation|0|||
27935498|NCT01256411|54591845|FG000|Extension by Maximum Treatment|Lost to Follow-up|1|||
27935499|NCT01256411|54591846|FG001|Extension by Maximum Treatment|Lost to Follow-up|2|||
28017053|NCT00683384|54676289|FG000|Overall Study|Death|1|||
28017054|NCT00683384|54676289|FG000|Overall Study|Adverse Event|1|||
27790131|NCT01583374|54245159|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
27790132|NCT01583374|54245160|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
27790133|NCT01583374|54245152|FG000|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1|||
27790134|NCT01583374|54245153|FG001|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2|||
27790135|NCT01583374|54245154|FG002|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
27790136|NCT01583374|54245155|FG003|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
27790137|NCT01583374|54245156|FG004|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
27790138|NCT01583374|54245157|FG005|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
27790139|NCT01583374|54245158|FG006|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
27790140|NCT01583374|54245159|FG007|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
27790141|NCT01583374|54245160|FG008|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
27790142|NCT01583374|54245152|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
27790143|NCT01583374|54245153|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
27790144|NCT01583374|54245154|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3|||
27790145|NCT01583374|54245155|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
27790146|NCT01583374|54245156|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
27790147|NCT01583374|54245157|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
27790148|NCT01583374|54245158|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
27790149|NCT01583374|54245159|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
27790150|NCT01583374|54245160|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
27790151|NCT01583374|54245152|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
27790152|NCT01583374|54245153|FG001|Placebo-controlled Phase (Week 0-24)|Other|1|||
27790153|NCT01583374|54245154|FG002|Placebo-controlled Phase (Week 0-24)|Other|0|||
27790154|NCT01583374|54245155|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
27790155|NCT01583374|54245156|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
27790156|NCT01583374|54245157|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
27790157|NCT01583374|54245158|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
27790158|NCT01583374|54245159|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
27790159|NCT01583374|54245160|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
27790160|NCT01583374|54245152|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
27790161|NCT01583374|54245153|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
27790162|NCT01583374|54245154|FG002|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
27790163|NCT01583374|54245155|FG003|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
27935500|NCT01256411|54591847|FG002|Extension by Maximum Treatment|Lost to Follow-up|0|||
27935501|NCT01256411|54591848|FG003|Extension by Maximum Treatment|Lost to Follow-up|0|||
27842489|NCT01444781|54331010|FG001|Overall Study|Lost to Follow-up|3|||
27842490|NCT01444781|54331011|FG002|Overall Study|Lost to Follow-up|1|||
27842491|NCT01444781|54331009|FG000|Overall Study|Withdrawal by Subject|3|||
27842492|NCT01444781|54331010|FG001|Overall Study|Withdrawal by Subject|1|||
27842493|NCT01444781|54331011|FG002|Overall Study|Withdrawal by Subject|2|||
27842494|NCT01444391|54331026|FG000|Overall Study|Death|1|||
27842495|NCT01443923|54331032|FG000|Overall Study|Adverse Event|1|||
27842496|NCT01443923|54331033|FG001|Overall Study|Adverse Event|0|||
27842497|NCT01551212|54331045|FG000|Overall Study|Graft loss/Retransplantation|0|||
27842498|NCT01551212|54331046|FG001|Overall Study|Graft loss/Retransplantation|1|||
27842499|NCT01551212|54331045|FG000|Overall Study|Administrative problems|1|||
27842500|NCT01551212|54331046|FG001|Overall Study|Administrative problems|2|||
27842501|NCT01551212|54331045|FG000|Overall Study|Lost to Follow-up|0|||
27790164|NCT01583374|54245156|FG004|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
27790165|NCT01583374|54245157|FG005|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
27790166|NCT01583374|54245158|FG006|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
27790167|NCT01583374|54245159|FG007|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
27790168|NCT01583374|54245160|FG008|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
27790169|NCT01583374|54245152|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
27790170|NCT01583374|54245153|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
27790171|NCT01583374|54245154|FG002|Extension Phase (Weeks 24 to 52)|Adverse Event|2|||
27790172|NCT01583374|54245155|FG003|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
27790173|NCT01583374|54245156|FG004|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
27790174|NCT01583374|54245157|FG005|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
27790175|NCT01583374|54245158|FG006|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
27790176|NCT01583374|54245159|FG007|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
27790177|NCT01583374|54245160|FG008|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
27790178|NCT01583374|54245152|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
27790179|NCT01583374|54245153|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
27842502|NCT01551212|54331046|FG001|Overall Study|Lost to Follow-up|1|||
27842503|NCT01551212|54331045|FG000|Overall Study|Protocol Violation|0|||
27842504|NCT01551212|54331046|FG001|Overall Study|Protocol Violation|1|||
27842505|NCT01551212|54331045|FG000|Overall Study|Withdrawal by Subject|0|||
27842506|NCT01551212|54331046|FG001|Overall Study|Withdrawal by Subject|7|||
27790180|NCT01583374|54245154|FG002|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
27790181|NCT01583374|54245155|FG003|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6|||
27790182|NCT01583374|54245156|FG004|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3|||
27790183|NCT01583374|54245157|FG005|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
27790184|NCT01583374|54245158|FG006|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5|||
27790185|NCT01583374|54245159|FG007|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
27790186|NCT01583374|54245160|FG008|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
27790187|NCT01583374|54245152|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
27790188|NCT01583374|54245153|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2|||
27790189|NCT01583374|54245154|FG002|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
27790190|NCT01583374|54245155|FG003|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
27790191|NCT01583374|54245156|FG004|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
27790192|NCT01583374|54245157|FG005|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
27790193|NCT01583374|54245158|FG006|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
27790194|NCT01583374|54245159|FG007|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
27790195|NCT01583374|54245160|FG008|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
27790196|NCT01583374|54245152|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
27790197|NCT01583374|54245153|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
27790198|NCT01583374|54245154|FG002|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
27790199|NCT01583374|54245155|FG003|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
27790200|NCT01583374|54245156|FG004|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
27790201|NCT01583374|54245157|FG005|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2|||
27790202|NCT01583374|54245158|FG006|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
27790203|NCT01583374|54245159|FG007|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
27790204|NCT01583374|54245160|FG008|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
27790205|NCT01583374|54245152|FG000|Long-Term Extension Phase Weeks 52-260|Adverse Event|0|||
27842507|NCT01551212|54331045|FG000|Overall Study|Death|2|||
27842508|NCT01551212|54331046|FG001|Overall Study|Death|4|||
27842509|NCT01551212|54331045|FG000|Overall Study|Never Received Study Treatment|2|||
27842510|NCT01551212|54331046|FG001|Overall Study|Never Received Study Treatment|4|||
27842511|NCT01550744|54331106|FG000|Open-Label|Lost to Follow-up|7|||
27842512|NCT01550744|54331107|FG001|Open-Label|Lost to Follow-up|0|||
27842513|NCT01550744|54331108|FG002|Open-Label|Lost to Follow-up|0|||
27842514|NCT01550744|54331106|FG000|Open-Label|Withdrawal by Subject|13|||
27842515|NCT01550744|54331107|FG001|Open-Label|Withdrawal by Subject|0|||
27842516|NCT01550744|54331108|FG002|Open-Label|Withdrawal by Subject|0|||
27790206|NCT01583374|54245153|FG001|Long-Term Extension Phase Weeks 52-260|Adverse Event|5|||
27790207|NCT01583374|54245154|FG002|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
27790208|NCT01583374|54245155|FG003|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
27790209|NCT01583374|54245156|FG004|Long-Term Extension Phase Weeks 52-260|Adverse Event|6|||
27790210|NCT01583374|54245157|FG005|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
27790211|NCT01583374|54245158|FG006|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
27842517|NCT01550744|54331106|FG000|Open-Label|Adverse Event|11|||
27842518|NCT01550744|54331107|FG001|Open-Label|Adverse Event|0|||
27842519|NCT01550744|54331108|FG002|Open-Label|Adverse Event|0|||
27842520|NCT01550744|54331106|FG000|Open-Label|Lack of Efficacy|4|||
27842521|NCT01550744|54331107|FG001|Open-Label|Lack of Efficacy|0|||
28017055|NCT00326911|54676295|FG000|Overall Study|Hospitalization prior to treatment|0|||
28017056|NCT00326911|54676296|FG001|Overall Study|Hospitalization prior to treatment|1|||
28017057|NCT00326911|54676295|FG000|Overall Study|Physician decision prior to treatment|1|||
28017058|NCT00326911|54676296|FG001|Overall Study|Physician decision prior to treatment|0|||
28017059|NCT00326911|54676295|FG000|Overall Study|Withdrawal by subject prior to treatment|0|||
28017060|NCT00326911|54676296|FG001|Overall Study|Withdrawal by subject prior to treatment|1|||
28017061|NCT00540436|54676302|FG000|First 12-Week Treatment Period|Adverse Event|1|||
28017062|NCT00540436|54676302|FG000|First 12-Week Treatment Period|Withdrawal by Subject|1|||
28017063|NCT00540436|54676302|FG000|First 12-Week Treatment Period|Initiation of prohibited medication|1|||
28017064|NCT00540436|54676302|FG000|Second 12-Week Treatment Period|Adverse Event|1|||
28017065|NCT00687440|54676306|FG000|Overall Study|Adverse Event|3|||
28017066|NCT00687440|54676306|FG000|Overall Study|Lost to Follow-up|3|||
27842522|NCT01550744|54331108|FG002|Open-Label|Lack of Efficacy|0|||
28017067|NCT00687440|54676306|FG000|Overall Study|Lack of Efficacy|2|||
28017068|NCT00687440|54676306|FG000|Overall Study|Death|2|||
28017069|NCT00687440|54676306|FG000|Overall Study|Other|1|||
28017070|NCT00687440|54676306|FG000|Overall Study|Missing|1|||
28017071|NCT00659490|54676313|FG000|Overall Study|Lost to Follow-up|2|||
28017072|NCT00659490|54676314|FG001|Overall Study|Lost to Follow-up|0|||
28017073|NCT00659490|54676315|FG002|Overall Study|Lost to Follow-up|1|||
28017074|NCT00539500|54676323|FG000|Overall Study|Disease Progression|1|||
27842523|NCT01550744|54331106|FG000|Open-Label|Protocol Violation|4|||
28017075|NCT00539500|54676323|FG000|Overall Study|Lost to Follow-up|2|||
28017076|NCT00662532|54676329|FG000|Overall Study|Adverse Event|0|||
28017077|NCT00662532|54676330|FG001|Overall Study|Adverse Event|1|||
28017078|NCT00662532|54676329|FG000|Overall Study|Lost to Follow-up|0|||
28017079|NCT00662532|54676330|FG001|Overall Study|Lost to Follow-up|1|||
28017080|NCT00686036|54676338|FG000|Overall Study|Adverse Event|3|||
28017081|NCT00686036|54676339|FG001|Overall Study|Adverse Event|0|||
28017082|NCT00686036|54676338|FG000|Overall Study|Withdrawal by Subject|3|||
28017083|NCT00686036|54676339|FG001|Overall Study|Withdrawal by Subject|1|||
28017084|NCT00686036|54676338|FG000|Overall Study|Study terminated by AstraZeneca|2|||
27790212|NCT01583374|54245159|FG007|Long-Term Extension Phase Weeks 52-260|Adverse Event|3|||
27790213|NCT01583374|54245160|FG008|Long-Term Extension Phase Weeks 52-260|Adverse Event|1|||
27790214|NCT01583374|54245152|FG000|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0|||
27790215|NCT01583374|54245153|FG001|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
27790216|NCT01583374|54245154|FG002|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6|||
27790217|NCT01583374|54245155|FG003|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
27790218|NCT01583374|54245156|FG004|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10|||
27790219|NCT01583374|54245157|FG005|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
27790220|NCT01583374|54245158|FG006|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
27790221|NCT01583374|54245159|FG007|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2|||
27790222|NCT01583374|54245160|FG008|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
27790223|NCT01583374|54245152|FG000|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
27790224|NCT01583374|54245153|FG001|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
27790225|NCT01583374|54245154|FG002|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
27790226|NCT01583374|54245155|FG003|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
27790227|NCT01583374|54245156|FG004|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
27790228|NCT01583374|54245157|FG005|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
27790229|NCT01583374|54245158|FG006|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
27790230|NCT01583374|54245159|FG007|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
27790231|NCT01583374|54245160|FG008|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
27790232|NCT01583374|54245152|FG000|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0|||
27790233|NCT01583374|54245153|FG001|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
27790234|NCT01583374|54245154|FG002|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
27790235|NCT01583374|54245155|FG003|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1|||
27790236|NCT01583374|54245156|FG004|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12|||
27935502|NCT01256411|54591849|FG004|Extension by Maximum Treatment|Lost to Follow-up|0|||
27935503|NCT01256411|54591850|FG005|Extension by Maximum Treatment|Lost to Follow-up|0|||
27935504|NCT01256411|54591845|FG000|Extension by Maximum Treatment|Withdrawal by Subject|1|||
27935505|NCT01256411|54591846|FG001|Extension by Maximum Treatment|Withdrawal by Subject|6|||
27935506|NCT01256411|54591847|FG002|Extension by Maximum Treatment|Withdrawal by Subject|1|||
27935507|NCT01256411|54591848|FG003|Extension by Maximum Treatment|Withdrawal by Subject|0|||
27935508|NCT01256411|54591849|FG004|Extension by Maximum Treatment|Withdrawal by Subject|0|||
27935509|NCT01256411|54591850|FG005|Extension by Maximum Treatment|Withdrawal by Subject|0|||
27935510|NCT01256411|54591845|FG000|Extension by Maximum Treatment|Lack of Efficacy|1|||
27935511|NCT01256411|54591846|FG001|Extension by Maximum Treatment|Lack of Efficacy|0|||
27935512|NCT01256411|54591847|FG002|Extension by Maximum Treatment|Lack of Efficacy|1|||
27935513|NCT01256411|54591848|FG003|Extension by Maximum Treatment|Lack of Efficacy|0|||
27935514|NCT01256411|54591849|FG004|Extension by Maximum Treatment|Lack of Efficacy|0|||
27935515|NCT01256411|54591850|FG005|Extension by Maximum Treatment|Lack of Efficacy|0|||
27935516|NCT01256411|54591845|FG000|Extension by Maximum Treatment|Adverse Event|4|||
27935517|NCT01256411|54591846|FG001|Extension by Maximum Treatment|Adverse Event|2|||
27935518|NCT01256411|54591847|FG002|Extension by Maximum Treatment|Adverse Event|1|||
27935519|NCT01256411|54591848|FG003|Extension by Maximum Treatment|Adverse Event|0|||
27935520|NCT01256411|54591849|FG004|Extension by Maximum Treatment|Adverse Event|0|||
27935521|NCT01256411|54591850|FG005|Extension by Maximum Treatment|Adverse Event|0|||
27935522|NCT01256411|54591845|FG000|Extension by Mono or Combination Therapy|Adverse Event|0|||
27935523|NCT01256411|54591846|FG001|Extension by Mono or Combination Therapy|Adverse Event|0|||
27935524|NCT01256411|54591847|FG002|Extension by Mono or Combination Therapy|Adverse Event|0|||
27935525|NCT01256411|54591848|FG003|Extension by Mono or Combination Therapy|Adverse Event|0|||
27935526|NCT01256411|54591849|FG004|Extension by Mono or Combination Therapy|Adverse Event|6|||
28017085|NCT00686036|54676339|FG001|Overall Study|Study terminated by AstraZeneca|1|||
28017086|NCT00686036|54676338|FG000|Overall Study|PSA ≥ 10ng/mL|1|||
28017087|NCT00686036|54676339|FG001|Overall Study|PSA ≥ 10ng/mL|0|||
28017088|NCT00686036|54676338|FG000|Overall Study|Other reasons not identified|0|||
28017089|NCT00686036|54676339|FG001|Overall Study|Other reasons not identified|4|||
28017090|NCT00682448|54676347|FG000|Overall Study|Adverse Event|1|||
28017091|NCT00682448|54676348|FG001|Overall Study|Adverse Event|2|||
28017092|NCT00682448|54676347|FG000|Overall Study|Lack of Efficacy|1|||
28017093|NCT00682448|54676348|FG001|Overall Study|Lack of Efficacy|0|||
28017094|NCT00682448|54676347|FG000|Overall Study|Lost to Follow-up|1|||
27935527|NCT01256411|54591850|FG005|Extension by Mono or Combination Therapy|Adverse Event|1|||
27935528|NCT01256411|54591845|FG000|Extension by Mono or Combination Therapy|Protocol deviation|0|||
27935529|NCT01256411|54591846|FG001|Extension by Mono or Combination Therapy|Protocol deviation|0|||
27935530|NCT01256411|54591847|FG002|Extension by Mono or Combination Therapy|Protocol deviation|0|||
27935531|NCT01256411|54591848|FG003|Extension by Mono or Combination Therapy|Protocol deviation|0|||
27935532|NCT01256411|54591849|FG004|Extension by Mono or Combination Therapy|Protocol deviation|0|||
27935533|NCT01256411|54591850|FG005|Extension by Mono or Combination Therapy|Protocol deviation|1|||
28105600|NCT04882995|54763043|FG000|Overall Study|Surgery postponed due to COVID|1|||
28105601|NCT04882995|54763044|FG001|Overall Study|Surgery postponed due to COVID|1|||
28105602|NCT04483011|54763052|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
28105603|NCT04483011|54763053|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
28105604|NCT04545567|54763063|FG000|Overall Study|tested positive for SARS-co-V2|1|||
28105605|NCT04545567|54763064|FG001|Overall Study|tested positive for SARS-co-V2|1|||
28105606|NCT04545567|54763063|FG000|Overall Study|Withdrawal by Subject|0|||
28105607|NCT04545567|54763064|FG001|Overall Study|Withdrawal by Subject|1|||
28105608|NCT04534491|54763070|FG000|Overall Study|Not completed end-of-study interview|24|||
28105609|NCT04534491|54763070|FG000|Overall Study|Non-users|70|||
28105610|NCT04534491|54763070|FG000|Overall Study|Non-verifiable users|58|||
28105611|NCT03694821|54763077|FG000|Overall Study|Study terminated|4|||
28105612|NCT03694821|54763078|FG001|Overall Study|Study terminated|8|||
28105613|NCT03694821|54763079|FG002|Overall Study|Study terminated|4|||
28105614|NCT04531527|54763087|FG000|Overall Study|Found to be Ineligible|3|||
28105615|NCT04474197|54763095|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
28105616|NCT04474197|54763096|FG001|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
27790237|NCT01583374|54245157|FG005|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7|||
27790238|NCT01583374|54245158|FG006|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5|||
27935534|NCT01256411|54591845|FG000|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
27935535|NCT01256411|54591846|FG001|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
27935536|NCT01256411|54591847|FG002|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
27935537|NCT01256411|54591848|FG003|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
27935538|NCT01256411|54591849|FG004|Extension by Mono or Combination Therapy|Lost to Follow-up|3|||
27935539|NCT01256411|54591850|FG005|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
27935540|NCT01256411|54591845|FG000|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
27935541|NCT01256411|54591846|FG001|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
27935542|NCT01256411|54591847|FG002|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
27935543|NCT01256411|54591848|FG003|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
27935544|NCT01256411|54591849|FG004|Extension by Mono or Combination Therapy|Withdrawal by Subject|7|||
27935545|NCT01256411|54591850|FG005|Extension by Mono or Combination Therapy|Withdrawal by Subject|1|||
27935546|NCT01256411|54591845|FG000|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
27935547|NCT01256411|54591846|FG001|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
27935548|NCT01256411|54591847|FG002|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
27935549|NCT01256411|54591848|FG003|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
27935550|NCT01256411|54591849|FG004|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
27935551|NCT01256411|54591850|FG005|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
27935552|NCT00996580|54591864|FG000|Overall Study|Adverse Event|466|||
27935553|NCT00996580|54591864|FG000|Overall Study|Lost to Follow-up|480|||
27790239|NCT01583374|54245159|FG007|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
27790240|NCT01583374|54245160|FG008|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
27790241|NCT01583374|54245152|FG000|Long-Term Extension Phase Weeks 52-260|Death|0|||
27790242|NCT01583374|54245153|FG001|Long-Term Extension Phase Weeks 52-260|Death|0|||
27790243|NCT01583374|54245154|FG002|Long-Term Extension Phase Weeks 52-260|Death|0|||
27790244|NCT01583374|54245155|FG003|Long-Term Extension Phase Weeks 52-260|Death|0|||
27790245|NCT01583374|54245156|FG004|Long-Term Extension Phase Weeks 52-260|Death|1|||
27790246|NCT01583374|54245157|FG005|Long-Term Extension Phase Weeks 52-260|Death|0|||
27790247|NCT01583374|54245158|FG006|Long-Term Extension Phase Weeks 52-260|Death|1|||
27790248|NCT01583374|54245159|FG007|Long-Term Extension Phase Weeks 52-260|Death|0|||
27935554|NCT00996580|54591864|FG000|Overall Study|Noncompliance with the protocol|137|||
27935555|NCT00996580|54591864|FG000|Overall Study|Physician Decision|5|||
27935556|NCT00996580|54591864|FG000|Overall Study|Pregnancy|68|||
27935557|NCT00996580|54591864|FG000|Overall Study|Protocol Violation|16|||
27935558|NCT00996580|54591864|FG000|Overall Study|Sponsor requested participant withdrawal|35|||
27935559|NCT00996580|54591864|FG000|Overall Study|Withdrawal by Subject|217|||
27935560|NCT00996580|54591864|FG000|Overall Study|Other|29|||
27935561|NCT01124175|54591873|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
27935562|NCT01124175|54591874|FG001|Washout of 7 Days|Withdrawal by Subject|2|||
27935563|NCT01256177|54591882|FG000|Overall Study|Withdrawal by Subject|23|||
28017095|NCT00682448|54676348|FG001|Overall Study|Lost to Follow-up|3|||
28017096|NCT00682448|54676347|FG000|Overall Study|Pregnancy|0|||
28017097|NCT00682448|54676348|FG001|Overall Study|Pregnancy|1|||
27935564|NCT01256177|54591883|FG001|Overall Study|Withdrawal by Subject|22|||
27935565|NCT01256177|54591882|FG000|Overall Study|Lost to Follow-up|2|||
27935566|NCT01256177|54591883|FG001|Overall Study|Lost to Follow-up|2|||
27935567|NCT01256177|54591882|FG000|Overall Study|Adverse Event|8|||
27790249|NCT01583374|54245160|FG008|Long-Term Extension Phase Weeks 52-260|Death|0|||
27790250|NCT01583374|54245152|FG000|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
27790251|NCT01583374|54245153|FG001|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
27790252|NCT01583374|54245154|FG002|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
27790253|NCT01583374|54245155|FG003|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
27790254|NCT01583374|54245156|FG004|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
27790255|NCT01583374|54245157|FG005|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
27790256|NCT01583374|54245158|FG006|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
27790257|NCT01583374|54245159|FG007|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
27790258|NCT01583374|54245160|FG008|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
27790259|NCT01583374|54245152|FG000|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
27790260|NCT01583374|54245153|FG001|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
27790261|NCT01583374|54245154|FG002|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
27790262|NCT01583374|54245155|FG003|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2|||
27790263|NCT01583374|54245156|FG004|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
27790264|NCT01583374|54245157|FG005|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
27790265|NCT01583374|54245158|FG006|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
27790266|NCT01583374|54245159|FG007|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
27790267|NCT01583374|54245160|FG008|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
27790268|NCT01583296|54245181|FG000|Overall Study|Withdrawal by Subject|11|||
27790269|NCT01583296|54245182|FG001|Overall Study|Withdrawal by Subject|10|||
27790270|NCT02222714|54245193|FG000|Overall Study|Death|0|||
27790271|NCT02222714|54245194|FG001|Overall Study|Death|2|||
27790272|NCT02222714|54245195|FG002|Overall Study|Death|3|||
27790273|NCT02222714|54245196|FG003|Overall Study|Death|4|||
27790274|NCT02222714|54245197|FG004|Overall Study|Death|6|||
27790275|NCT02222714|54245193|FG000|Overall Study|Withdrawal by Subject|0|||
27790276|NCT02222714|54245194|FG001|Overall Study|Withdrawal by Subject|0|||
27935568|NCT01256177|54591883|FG001|Overall Study|Adverse Event|9|||
27935569|NCT01256177|54591882|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
27935570|NCT01256177|54591883|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
27935571|NCT01256177|54591882|FG000|Overall Study|Condition under Investigation Worsened|1|||
27935572|NCT01256177|54591883|FG001|Overall Study|Condition under Investigation Worsened|0|||
27935573|NCT01256177|54591882|FG000|Overall Study|Lack of Efficacy|11|||
27935574|NCT01256177|54591883|FG001|Overall Study|Lack of Efficacy|2|||
27935575|NCT01256177|54591882|FG000|Overall Study|TG=593mg/dL, not fit to participate.|1|||
27935576|NCT01256177|54591883|FG001|Overall Study|TG=593mg/dL, not fit to participate.|0|||
27935577|NCT00999544|54591889|FG000|Overall Study|Withdrawal by Subject|1|||
27935578|NCT01124097|54591926|FG000|Overall Study|Withdrawal by Subject|4|||
27935579|NCT01124097|54591927|FG001|Overall Study|Withdrawal by Subject|3|||
27935580|NCT01124097|54591928|FG002|Overall Study|Withdrawal by Subject|2|||
27935581|NCT01124097|54591929|FG003|Overall Study|Withdrawal by Subject|3|||
27935582|NCT01124097|54591926|FG000|Overall Study|Lack of Efficacy|2|||
27935583|NCT01124097|54591927|FG001|Overall Study|Lack of Efficacy|3|||
27935584|NCT01124097|54591928|FG002|Overall Study|Lack of Efficacy|1|||
27935585|NCT01124097|54591929|FG003|Overall Study|Lack of Efficacy|3|||
27935586|NCT01124097|54591926|FG000|Overall Study|Adverse Event|24|||
27935587|NCT01124097|54591927|FG001|Overall Study|Adverse Event|15|||
27935588|NCT01124097|54591928|FG002|Overall Study|Adverse Event|15|||
27935589|NCT01124097|54591929|FG003|Overall Study|Adverse Event|7|||
27935590|NCT01124097|54591926|FG000|Overall Study|Protocol Violation|2|||
27935591|NCT01124097|54591927|FG001|Overall Study|Protocol Violation|0|||
27935592|NCT01124097|54591928|FG002|Overall Study|Protocol Violation|2|||
27935593|NCT01124097|54591929|FG003|Overall Study|Protocol Violation|1|||
27935594|NCT01124097|54591926|FG000|Overall Study|Physician Decision|2|||
27935595|NCT01124097|54591927|FG001|Overall Study|Physician Decision|1|||
27935596|NCT01124097|54591928|FG002|Overall Study|Physician Decision|0|||
27790277|NCT02222714|54245195|FG002|Overall Study|Withdrawal by Subject|1|||
27790278|NCT02222714|54245196|FG003|Overall Study|Withdrawal by Subject|0|||
27790279|NCT02222714|54245197|FG004|Overall Study|Withdrawal by Subject|1|||
27935597|NCT01124097|54591929|FG003|Overall Study|Physician Decision|0|||
27790280|NCT02164916|54245214|FG000|Overall Study|Adverse Event|3|||
27790281|NCT02164916|54245215|FG001|Overall Study|Adverse Event|8|||
27790282|NCT02164916|54245214|FG000|Overall Study|Death|1|||
27790283|NCT02164916|54245215|FG001|Overall Study|Death|1|||
27790284|NCT02164916|54245214|FG000|Overall Study|Refusal unrelated to adverse event|3|||
27935598|NCT01123941|54591941|FG000|Overall Study|Lost to Follow-up|2|||
27935599|NCT01123941|54591942|FG001|Overall Study|Lost to Follow-up|1|||
27935600|NCT01123395|54591948|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
27935601|NCT01123395|54591949|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
27935602|NCT01255787|54591959|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
27935603|NCT01255787|54591960|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|2|||
27935604|NCT01255787|54591961|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
27935605|NCT01255787|54591962|FG003|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
27935606|NCT01255787|54591959|FG000|Overall Study|Major Protocol Deviation|1|||
27935607|NCT01255787|54591960|FG001|Overall Study|Major Protocol Deviation|1|||
27935608|NCT01255787|54591961|FG002|Overall Study|Major Protocol Deviation|0|||
27935609|NCT01255787|54591962|FG003|Overall Study|Major Protocol Deviation|4|||
27935610|NCT01255787|54591959|FG000|Overall Study|Lost to Follow-up|1|||
27935611|NCT01255787|54591960|FG001|Overall Study|Lost to Follow-up|2|||
27935612|NCT01255787|54591961|FG002|Overall Study|Lost to Follow-up|4|||
27935613|NCT01255787|54591962|FG003|Overall Study|Lost to Follow-up|2|||
27935614|NCT01255787|54591959|FG000|Overall Study|Withdrawal of Consent|3|||
27935615|NCT01255787|54591960|FG001|Overall Study|Withdrawal of Consent|9|||
27935616|NCT01255787|54591961|FG002|Overall Study|Withdrawal of Consent|3|||
27935617|NCT01255787|54591962|FG003|Overall Study|Withdrawal of Consent|4|||
27935618|NCT01255787|54591959|FG000|Overall Study|Pregnancy|0|||
27935619|NCT01255787|54591960|FG001|Overall Study|Pregnancy|0|||
27935620|NCT01255787|54591961|FG002|Overall Study|Pregnancy|0|||
27935621|NCT01255787|54591962|FG003|Overall Study|Pregnancy|1|||
27935622|NCT01255787|54591959|FG000|Overall Study|Lack of Efficacy|2|||
27935623|NCT01255787|54591960|FG001|Overall Study|Lack of Efficacy|2|||
27935624|NCT01255787|54591961|FG002|Overall Study|Lack of Efficacy|2|||
27935625|NCT01255787|54591962|FG003|Overall Study|Lack of Efficacy|2|||
27935626|NCT01255787|54591959|FG000|Overall Study|Noncompliance with Study Drug|3|||
27935627|NCT01255787|54591960|FG001|Overall Study|Noncompliance with Study Drug|1|||
27935628|NCT01255787|54591961|FG002|Overall Study|Noncompliance with Study Drug|0|||
27935629|NCT01255787|54591962|FG003|Overall Study|Noncompliance with Study Drug|0|||
27935630|NCT01123161|54591974|FG000|Overall Study|Lost to Follow-up|1|||
27935631|NCT01123161|54591975|FG001|Overall Study|Lost to Follow-up|0|||
27935632|NCT01123161|54591974|FG000|Overall Study|Withdrawal by Subject|1|||
27935633|NCT01123161|54591975|FG001|Overall Study|Withdrawal by Subject|0|||
27935634|NCT01255631|54591986|FG000|Overall Study|poor enrollment, no data analyzed|9|||
27935635|NCT01255631|54591987|FG001|Overall Study|poor enrollment, no data analyzed|6|||
27935636|NCT00999466|54591996|FG000|Main Part|Withdrawal by Subject|0|||
27935637|NCT00999466|54591997|FG001|Main Part|Withdrawal by Subject|0|||
27935638|NCT00999466|54591998|FG002|Main Part|Withdrawal by Subject|2|||
27935639|NCT00999466|54591996|FG000|Main Part|Adverse Event|0|||
27935640|NCT00999466|54591997|FG001|Main Part|Adverse Event|4|||
27935641|NCT00999466|54591998|FG002|Main Part|Adverse Event|2|||
27935642|NCT01255163|54592008|FG000|Overall Study|Withdrawal by Subject|1|||
27935643|NCT01255163|54592009|FG001|Overall Study|Withdrawal by Subject|0|||
27935644|NCT01255163|54592008|FG000|Overall Study|Lost to Follow-up|2|||
28017098|NCT00682448|54676347|FG000|Overall Study|Withdrawal by Subject|2|||
28017099|NCT00682448|54676348|FG001|Overall Study|Withdrawal by Subject|0|||
28017100|NCT00681824|54676357|FG000|Overall Study|withdrawn by investigator|0|||
28017101|NCT00681824|54676358|FG001|Overall Study|withdrawn by investigator|0|||
28017102|NCT00681824|54676359|FG002|Overall Study|withdrawn by investigator|1|||
28017103|NCT00681824|54676357|FG000|Overall Study|scheduling conflict|1|||
28017104|NCT00681824|54676358|FG001|Overall Study|scheduling conflict|0|||
27790285|NCT02164916|54245215|FG001|Overall Study|Refusal unrelated to adverse event|7|||
27790286|NCT02164916|54245214|FG000|Overall Study|Progression|37|||
27790287|NCT02164916|54245215|FG001|Overall Study|Progression|26|||
27790288|NCT02164916|54245214|FG000|Overall Study|Not protocol specified|5|||
27790289|NCT02164916|54245215|FG001|Overall Study|Not protocol specified|1|||
27790290|NCT02164916|54245214|FG000|Overall Study|Reason under review|1|||
27790291|NCT02164916|54245215|FG001|Overall Study|Reason under review|6|||
27790292|NCT02164916|54245214|FG000|Overall Study|Not eligible|2|||
27790293|NCT02164916|54245215|FG001|Overall Study|Not eligible|5|||
27790294|NCT02222558|54245226|FG000|Period 1: Single Dose|Withdrawal by Subject|4|||
27935645|NCT01255163|54592009|FG001|Overall Study|Lost to Follow-up|0|||
27935646|NCT01255163|54592008|FG000|Overall Study|Adverse Event|0|||
27935647|NCT01255163|54592009|FG001|Overall Study|Adverse Event|2|||
27935648|NCT01255163|54592008|FG000|Overall Study|AstraZeneca stopped support of the study|1|||
28017105|NCT00681824|54676359|FG002|Overall Study|scheduling conflict|0|||
28017106|NCT00681824|54676357|FG000|Overall Study|Death|0|||
28017107|NCT00681824|54676358|FG001|Overall Study|Death|1|||
27790295|NCT02222558|54245227|FG001|Period 1: Single Dose|Withdrawal by Subject|0|||
27790296|NCT02222558|54245228|FG002|Period 1: Single Dose|Withdrawal by Subject|0|||
27935649|NCT01255163|54592009|FG001|Overall Study|AstraZeneca stopped support of the study|3|||
27935650|NCT01123083|54592019|FG000|Overall Study|Investigator recommendation|1|||
27935651|NCT01123083|54592020|FG001|Overall Study|Investigator recommendation|1|||
27935652|NCT01123083|54592019|FG000|Overall Study|Administrative reasons|0|||
27935653|NCT01123083|54592020|FG001|Overall Study|Administrative reasons|4|||
27935654|NCT01123083|54592019|FG000|Overall Study|Lost to Follow-up|2|||
27935655|NCT01123083|54592020|FG001|Overall Study|Lost to Follow-up|6|||
27790297|NCT02222558|54245229|FG003|Period 1: Single Dose|Withdrawal by Subject|0|||
27790298|NCT02222558|54245230|FG004|Period 1: Single Dose|Withdrawal by Subject|0|||
27790299|NCT02222558|54245231|FG005|Period 1: Single Dose|Withdrawal by Subject|0|||
27790300|NCT02222558|54245226|FG000|Period 3|Withdrawal by Subject|0|||
27790301|NCT02222558|54245227|FG001|Period 3|Withdrawal by Subject|0|||
27790302|NCT02222558|54245228|FG002|Period 3|Withdrawal by Subject|0|||
27790303|NCT02222558|54245229|FG003|Period 3|Withdrawal by Subject|0|||
27790304|NCT02222558|54245230|FG004|Period 3|Withdrawal by Subject|0|||
27790305|NCT02222558|54245231|FG005|Period 3|Withdrawal by Subject|1|||
27790306|NCT02188784|54245247|FG000|Overall Study|Death|3|||
27790307|NCT02188784|54245248|FG001|Overall Study|Death|1|||
27790308|NCT02188784|54245247|FG000|Overall Study|Lost to Follow-up|1|||
27790309|NCT02188784|54245248|FG001|Overall Study|Lost to Follow-up|0|||
27790310|NCT02188784|54245247|FG000|Overall Study|Withdrawal by Subject|3|||
27790311|NCT02188784|54245248|FG001|Overall Study|Withdrawal by Subject|9|||
27790312|NCT02188784|54245247|FG000|Overall Study|Physician Decision|2|||
27790313|NCT02188784|54245248|FG001|Overall Study|Physician Decision|3|||
27790314|NCT02222246|54245271|FG000|Overall Study|No Emergency Department Visits|27|||
27790315|NCT02222246|54245272|FG001|Overall Study|No Emergency Department Visits|26|||
27790316|NCT02222246|54245271|FG000|Overall Study|Physician Decision|0|||
27790317|NCT02222246|54245272|FG001|Overall Study|Physician Decision|1|||
27790318|NCT02188160|54245282|FG000|Overall Study|Adverse Event|1|||
27790319|NCT02188160|54245283|FG001|Overall Study|Adverse Event|0|||
27790320|NCT02188160|54245282|FG000|Overall Study|Use of an excluded medication|0|||
27790321|NCT02188160|54245283|FG001|Overall Study|Use of an excluded medication|1|||
27790322|NCT02220998|54245291|FG000|Overall Study|Randomized but Never Treated|1|||
27790323|NCT02220998|54245292|FG001|Overall Study|Randomized but Never Treated|2|||
27790324|NCT02220998|54245291|FG000|Overall Study|Death|2|||
27790325|NCT02220998|54245292|FG001|Overall Study|Death|0|||
27790326|NCT02220998|54245291|FG000|Overall Study|Lack of Efficacy|0|||
27790327|NCT02220998|54245292|FG001|Overall Study|Lack of Efficacy|5|||
27790328|NCT02220998|54245291|FG000|Overall Study|Lost to Follow-up|4|||
27790329|NCT02220998|54245292|FG001|Overall Study|Lost to Follow-up|4|||
27790330|NCT02220920|54245300|FG000|Overall Study|Adverse Event|1|||
27790331|NCT02220920|54245301|FG001|Overall Study|Adverse Event|0|||
27790332|NCT02220920|54245300|FG000|Overall Study|Lack of Efficacy|0|||
27790333|NCT02220920|54245301|FG001|Overall Study|Lack of Efficacy|1|||
27790334|NCT02220920|54245300|FG000|Overall Study|Withdrawal by Subject|1|||
27790335|NCT02220920|54245301|FG001|Overall Study|Withdrawal by Subject|0|||
27790336|NCT02220920|54245300|FG000|Overall Study|Conflict with the stopping criteria|1|||
27790337|NCT02220920|54245301|FG001|Overall Study|Conflict with the stopping criteria|2|||
27790338|NCT03966053|54245307|FG000|Overall Study|Withdrawal by subject prior to starting study drug.|1|||
27790339|NCT01583218|54245322|FG000|Overall Study|Withdrawal by Subject|43|||
27790340|NCT01583218|54245323|FG001|Overall Study|Withdrawal by Subject|29|||
27790341|NCT01583218|54245322|FG000|Overall Study|Death|206|||
27790342|NCT01583218|54245323|FG001|Overall Study|Death|211|||
27790343|NCT01583218|54245322|FG000|Overall Study|Lost to Follow-up|11|||
27790344|NCT01583218|54245323|FG001|Overall Study|Lost to Follow-up|17|||
27790345|NCT01583218|54245322|FG000|Overall Study|Adverse event or serious adverse event|3|||
27790346|NCT01583218|54245323|FG001|Overall Study|Adverse event or serious adverse event|3|||
27790347|NCT01583218|54245322|FG000|Overall Study|Patient /Family decision|3|||
27790348|NCT01583218|54245323|FG001|Overall Study|Patient /Family decision|0|||
27790349|NCT01583218|54245322|FG000|Overall Study|Cannot contact patient directly|1|||
27790350|NCT01583218|54245323|FG001|Overall Study|Cannot contact patient directly|2|||
27790351|NCT01583218|54245322|FG000|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0|||
27790352|NCT01583218|54245323|FG001|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2|||
27790353|NCT01583218|54245322|FG000|Overall Study|Patient did not wish to attend visits|0|||
27790354|NCT01583218|54245323|FG001|Overall Study|Patient did not wish to attend visits|1|||
27790355|NCT01583218|54245322|FG000|Overall Study|Patient randomized but not dosed|17|||
27790356|NCT01583218|54245323|FG001|Overall Study|Patient randomized but not dosed|16|||
27790357|NCT01583218|54245322|FG000|Overall Study|Patient was assessed via phone in person|1|||
27790358|NCT01583218|54245323|FG001|Overall Study|Patient was assessed via phone in person|0|||
27790359|NCT01583218|54245322|FG000|Overall Study|Patient deemed ineligible after random|2|||
27790360|NCT01583218|54245323|FG001|Overall Study|Patient deemed ineligible after random|0|||
27790361|NCT01583218|54245322|FG000|Overall Study|Patient was early terminated from study|0|||
27790362|NCT01583218|54245323|FG001|Overall Study|Patient was early terminated from study|1|||
27790363|NCT01583218|54245322|FG000|Overall Study|Patient was randomized due to mistake|1|||
27790364|NCT01583218|54245323|FG001|Overall Study|Patient was randomized due to mistake|0|||
27790365|NCT01583218|54245322|FG000|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0|||
27790366|NCT01583218|54245323|FG001|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1|||
27790367|NCT01583218|54245322|FG000|Overall Study|Withdraw of consent on day of random|1|||
27790368|NCT01583218|54245323|FG001|Overall Study|Withdraw of consent on day of random|0|||
27790369|NCT01634555|54245329|FG000|Overall Study|Adverse Event|3|||
27790370|NCT01634555|54245329|FG000|Overall Study|Physician Decision|1|||
27790371|NCT01634243|54245336|FG000|Overall Study|Adverse Event|5|||
27790372|NCT01634243|54245337|FG001|Overall Study|Adverse Event|5|||
27790373|NCT01634243|54245336|FG000|Overall Study|Lack of Efficacy|1|||
27790374|NCT01634243|54245337|FG001|Overall Study|Lack of Efficacy|0|||
27790375|NCT01542034|54245354|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|20|||
27790376|NCT01542034|54245355|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|12|||
27790377|NCT01542034|54245354|FG000|Overall Study|Administrative decision|0|||
27790378|NCT01542034|54245355|FG001|Overall Study|Administrative decision|3|||
27790379|NCT01542034|54245354|FG000|Overall Study|Subject Noncompliance|1|||
27790380|NCT01542034|54245355|FG001|Overall Study|Subject Noncompliance|0|||
27790381|NCT01542034|54245354|FG000|Overall Study|Adverse Event|2|||
27790382|NCT01542034|54245355|FG001|Overall Study|Adverse Event|2|||
27790383|NCT01542034|54245354|FG000|Overall Study|Lost to Follow-up|7|||
27790384|NCT01542034|54245355|FG001|Overall Study|Lost to Follow-up|6|||
27790385|NCT01564732|54245363|FG000|Overall Study|Early termination by the study sponsor|6|||
27790386|NCT01564732|54245364|FG001|Overall Study|Early termination by the study sponsor|5|||
27790387|NCT01541644|54245370|FG000|Overall Study|Withdrawal by Subject|3|||
27790388|NCT01582282|54245377|FG000|Overall Study|Adverse Event|1|||
27790389|NCT01582282|54245378|FG001|Overall Study|Adverse Event|1|||
27790390|NCT01582282|54245379|FG002|Overall Study|Adverse Event|0|||
27790391|NCT01582282|54245377|FG000|Overall Study|Lost to Follow-up|1|||
27790392|NCT01582282|54245378|FG001|Overall Study|Lost to Follow-up|0|||
27790393|NCT01582282|54245379|FG002|Overall Study|Lost to Follow-up|0|||
27790394|NCT01582282|54245377|FG000|Overall Study|fasting blood glucose outside Protocol|0|||
27790395|NCT01582282|54245378|FG001|Overall Study|fasting blood glucose outside Protocol|1|||
27790396|NCT01582282|54245379|FG002|Overall Study|fasting blood glucose outside Protocol|0|||
27790397|NCT01599650|54245390|FG000|Overall Study|Administrative issue|1|||
27790398|NCT01599650|54245391|FG001|Overall Study|Administrative issue|0|||
27790399|NCT01599650|54245392|FG002|Overall Study|Administrative issue|1|||
27790400|NCT01599650|54245390|FG000|Overall Study|Physician Decision|2|||
27790401|NCT01599650|54245391|FG001|Overall Study|Physician Decision|0|||
27790402|NCT01599650|54245392|FG002|Overall Study|Physician Decision|7|||
27790403|NCT01599650|54245390|FG000|Overall Study|Protocol Violation|0|||
27790404|NCT01599650|54245391|FG001|Overall Study|Protocol Violation|3|||
27790405|NCT01599650|54245392|FG002|Overall Study|Protocol Violation|0|||
27790406|NCT01599650|54245390|FG000|Overall Study|Death|2|||
27790407|NCT01599650|54245391|FG001|Overall Study|Death|1|||
27790408|NCT01599650|54245392|FG002|Overall Study|Death|2|||
27790409|NCT01599650|54245390|FG000|Overall Study|Lost to Follow-up|3|||
27935656|NCT01123083|54592019|FG000|Overall Study|Adverse Event|1|||
27935657|NCT01123083|54592020|FG001|Overall Study|Adverse Event|0|||
27935658|NCT01123083|54592019|FG000|Overall Study|Withdrew for another reason not covered|0|||
27935659|NCT01123083|54592020|FG001|Overall Study|Withdrew for another reason not covered|1|||
27935660|NCT01123083|54592019|FG000|Overall Study|Participant/legal representative request|7|||
27935661|NCT01123083|54592020|FG001|Overall Study|Participant/legal representative request|3|||
27935662|NCT01254305|54592029|FG000|Overall Study|Adverse Event|6|||
27935663|NCT01254305|54592030|FG001|Overall Study|Adverse Event|3|||
27935664|NCT01254305|54592031|FG002|Overall Study|Adverse Event|2|||
27935665|NCT01254305|54592029|FG000|Overall Study|Lack of Efficacy|1|||
27935666|NCT01254305|54592030|FG001|Overall Study|Lack of Efficacy|0|||
27935667|NCT01254305|54592031|FG002|Overall Study|Lack of Efficacy|1|||
27935668|NCT01254305|54592029|FG000|Overall Study|Protocol Violation|1|||
27935669|NCT01254305|54592030|FG001|Overall Study|Protocol Violation|7|||
27935670|NCT01254305|54592031|FG002|Overall Study|Protocol Violation|3|||
27935671|NCT01254305|54592029|FG000|Overall Study|Withdrawal by Subject|4|||
27935672|NCT01254305|54592030|FG001|Overall Study|Withdrawal by Subject|2|||
27935673|NCT01254305|54592031|FG002|Overall Study|Withdrawal by Subject|4|||
27935674|NCT01254305|54592029|FG000|Overall Study|Lost to Follow-up|10|||
27935675|NCT01254305|54592030|FG001|Overall Study|Lost to Follow-up|6|||
27935676|NCT01254305|54592031|FG002|Overall Study|Lost to Follow-up|5|||
27935677|NCT01254305|54592029|FG000|Overall Study|Other Reasons|0|||
27790410|NCT01599650|54245391|FG001|Overall Study|Lost to Follow-up|3|||
27790411|NCT01599650|54245392|FG002|Overall Study|Lost to Follow-up|3|||
27790412|NCT01599650|54245390|FG000|Overall Study|Withdrawal by Subject|11|||
27790413|NCT01599650|54245391|FG001|Overall Study|Withdrawal by Subject|11|||
27790414|NCT01599650|54245392|FG002|Overall Study|Withdrawal by Subject|10|||
27790415|NCT01599650|54245390|FG000|Overall Study|Adverse Event|3|||
27790416|NCT01599650|54245391|FG001|Overall Study|Adverse Event|8|||
27790417|NCT01599650|54245392|FG002|Overall Study|Adverse Event|4|||
27790418|NCT01541254|54245402|FG000|Overall Study|Withdrawal by Subject|1|||
27790419|NCT01541254|54245402|FG000|Overall Study|excluded - metal allergy|1|||
27790420|NCT01541254|54245402|FG000|Overall Study|enrolled after study closed|1|||
27935678|NCT01254305|54592030|FG001|Overall Study|Other Reasons|0|||
27935679|NCT01254305|54592031|FG002|Overall Study|Other Reasons|2|||
27935680|NCT01122927|54592042|FG000|Period 1 - Conversion Phase|Adverse Event|3|||
27935681|NCT01122927|54592043|FG001|Period 1 - Conversion Phase|Adverse Event|0|||
27935682|NCT01122927|54592042|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
27935683|NCT01122927|54592043|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
27790421|NCT01541254|54245402|FG000|Overall Study|GI bleed prior to procedure|1|||
27790422|NCT01541254|54245402|FG000|Overall Study|stent not required|1|||
27790423|NCT01541254|54245402|FG000|Overall Study|alternate stent used|1|||
27790424|NCT02163902|54245408|FG000|Overall Study|Subject's Request|3|||
27790425|NCT02163902|54245409|FG001|Overall Study|Subject's Request|4|||
27790426|NCT02163902|54245408|FG000|Overall Study|Lost to Follow-up|6|||
27790427|NCT02163902|54245409|FG001|Overall Study|Lost to Follow-up|7|||
27790428|NCT02163902|54245408|FG000|Overall Study|Administrative Decision|2|||
27790429|NCT02163902|54245409|FG001|Overall Study|Administrative Decision|2|||
27790430|NCT01630616|54245421|FG000|Overall Study|Adverse Event|0|||
27790431|NCT01630616|54245422|FG001|Overall Study|Adverse Event|0|||
27790432|NCT01630616|54245423|FG002|Overall Study|Adverse Event|0|||
27790433|NCT01630616|54245424|FG003|Overall Study|Adverse Event|1|||
27790434|NCT01630616|54245425|FG004|Overall Study|Adverse Event|0|||
27790435|NCT01630616|54245426|FG005|Overall Study|Adverse Event|0|||
27790436|NCT01630616|54245421|FG000|Overall Study|Withdrawal by Subject|0|||
27790437|NCT01630616|54245422|FG001|Overall Study|Withdrawal by Subject|0|||
27790438|NCT01630616|54245423|FG002|Overall Study|Withdrawal by Subject|0|||
27790439|NCT01630616|54245424|FG003|Overall Study|Withdrawal by Subject|2|||
27790440|NCT01630616|54245425|FG004|Overall Study|Withdrawal by Subject|0|||
27790441|NCT01630616|54245426|FG005|Overall Study|Withdrawal by Subject|0|||
27790442|NCT03774875|54245445|FG000|Placebo-controlled Period (Week 1-16)|Adverse Event|8|||
27790443|NCT03774875|54245446|FG001|Placebo-controlled Period (Week 1-16)|Adverse Event|16|||
27790444|NCT03774875|54245445|FG000|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|2|||
27790445|NCT03774875|54245446|FG001|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|4|||
27790446|NCT03774875|54245445|FG000|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|12|||
27790447|NCT03774875|54245446|FG001|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|10|||
27790448|NCT03774875|54245445|FG000|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|0|||
27790449|NCT03774875|54245446|FG001|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|2|||
27935684|NCT01122927|54592042|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
27935685|NCT01122927|54592043|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
27935686|NCT01122927|54592042|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
27935687|NCT01122927|54592043|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
27935688|NCT01122927|54592042|FG000|Period 1 - Conversion Phase|Protocol Deviation|1|||
27935689|NCT01122927|54592043|FG001|Period 1 - Conversion Phase|Protocol Deviation|0|||
27935690|NCT01122927|54592042|FG000|Period 2- Open-label Treatment Phase|Lost to Follow-up|0|||
27935691|NCT01122927|54592043|FG001|Period 2- Open-label Treatment Phase|Lost to Follow-up|21|||
27935692|NCT01122927|54592042|FG000|Period 2- Open-label Treatment Phase|Adverse Event|0|||
27935693|NCT01122927|54592043|FG001|Period 2- Open-label Treatment Phase|Adverse Event|33|||
27935694|NCT01122927|54592042|FG000|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0|||
27935695|NCT01122927|54592043|FG001|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165|||
27935696|NCT01122927|54592042|FG000|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0|||
27935697|NCT01122927|54592043|FG001|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9|||
27935698|NCT01122927|54592042|FG000|Period 2- Open-label Treatment Phase|Physician Decision|0|||
27935699|NCT01122927|54592043|FG001|Period 2- Open-label Treatment Phase|Physician Decision|12|||
27935700|NCT01122927|54592042|FG000|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0|||
27935701|NCT01122927|54592043|FG001|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65|||
27935702|NCT01122927|54592042|FG000|Period 2- Open-label Treatment Phase|Lack of Efficacy|0|||
27935703|NCT01122927|54592043|FG001|Period 2- Open-label Treatment Phase|Lack of Efficacy|7|||
27935704|NCT01254227|54592053|FG000|Overall Study|Withdrawal by Subject|6|||
27935705|NCT01254227|54592053|FG000|Overall Study|Lost to Follow-up|6|||
27935706|NCT01254227|54592053|FG000|Overall Study|Adverse Event|5|||
27935707|NCT01254227|54592053|FG000|Overall Study|Abnormal test procedure result|5|||
27935708|NCT01254227|54592053|FG000|Overall Study|Administrative problems|2|||
27935709|NCT01254227|54592053|FG000|Overall Study|Death|1|||
27935710|NCT01254227|54592053|FG000|Overall Study|Protocol deviation|1|||
27935711|NCT00995410|54592057|FG000|Overall Study|Adverse Event|51|||
27935712|NCT00995410|54592057|FG000|Overall Study|Withdrawal by Subject|7|||
27935713|NCT00995410|54592057|FG000|Overall Study|Lost to Follow-up|2|||
27935714|NCT00995410|54592057|FG000|Overall Study|Misc|28|||
27790450|NCT03774875|54245445|FG000|Placebo-controlled Period (Week 1-16)|Protocol Deviation|0|||
27790451|NCT03774875|54245446|FG001|Placebo-controlled Period (Week 1-16)|Protocol Deviation|1|||
27790452|NCT03774875|54245445|FG000|Placebo-controlled Period (Week 1-16)|Reason Unknown|1|||
27935715|NCT00995020|54592063|FG000|Overall Study|margin analysis not performed|2|||
27935716|NCT00995020|54592064|FG001|Overall Study|margin analysis not performed|5|||
27790453|NCT03774875|54245446|FG001|Placebo-controlled Period (Week 1-16)|Reason Unknown|0|||
27790454|NCT03774875|54245445|FG000|Apremilast Extension Period (Week 16-52)|Adverse Event|6|||
27790455|NCT03774875|54245446|FG001|Apremilast Extension Period (Week 16-52)|Adverse Event|9|||
27935717|NCT00995020|54592063|FG000|Overall Study|specimen fragmentation, thermal damage|1|||
27935718|NCT00995020|54592064|FG001|Overall Study|specimen fragmentation, thermal damage|2|||
27935719|NCT01122381|54592074|FG000|Overall Study|study terminated early|0|||
27935720|NCT01122381|54592075|FG001|Overall Study|study terminated early|1|||
27935721|NCT00996034|54592081|FG000|Overall Study|Lost to Follow-up|2|||
27935722|NCT00996034|54592081|FG000|Overall Study|withdrawn by PI|1|||
27935723|NCT01253447|54592085|FG000|Overall Study|Adverse Event|2|||
27935724|NCT01121991|54592090|FG000|Overall Study|Lack of Ovarian Response|2|||
27935725|NCT01121991|54592090|FG000|Overall Study|No Oocytes Retrieved|3|||
27935726|NCT01121991|54592090|FG000|Overall Study|No Fertilization|1|||
27935727|NCT00994240|54592096|FG000|Overall Study|Lost to Follow-up|3|||
27935728|NCT00994240|54592097|FG001|Overall Study|Lost to Follow-up|2|||
27935729|NCT00994240|54592096|FG000|Overall Study|Withdrawal by Subject|1|||
27935730|NCT00994240|54592097|FG001|Overall Study|Withdrawal by Subject|0|||
27935731|NCT00994240|54592096|FG000|Overall Study|study termination|2|||
27935732|NCT00994240|54592097|FG001|Overall Study|study termination|3|||
27935733|NCT01253369|54592103|FG000|Overall Study|Adverse Event|4|||
27935734|NCT01253369|54592103|FG000|Overall Study|Withdrawal by Subject|2|||
27935735|NCT01253369|54592103|FG000|Overall Study|Death|1|||
27935736|NCT01253369|54592103|FG000|Overall Study|Progressive disease|23|||
27935737|NCT01253369|54592103|FG000|Overall Study|Not Evaluable|3|||
27935738|NCT01121913|54592107|FG000|First Intervention Period|Adverse Event|0|||
27935739|NCT01121913|54592108|FG001|First Intervention Period|Adverse Event|0|||
27935740|NCT01121913|54592109|FG002|First Intervention Period|Adverse Event|1|||
27935741|NCT01121913|54592110|FG003|First Intervention Period|Adverse Event|0|||
27790456|NCT03774875|54245445|FG000|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|2|||
27790457|NCT03774875|54245446|FG001|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|11|||
27790458|NCT03774875|54245445|FG000|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|7|||
27790459|NCT03774875|54245446|FG001|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|20|||
27790460|NCT03774875|54245445|FG000|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|0|||
27790461|NCT03774875|54245446|FG001|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|2|||
27790462|NCT03774875|54245445|FG000|Apremilast Extension Period (Week 16-52)|Other|1|||
27790463|NCT03774875|54245446|FG001|Apremilast Extension Period (Week 16-52)|Other|1|||
27790464|NCT03774875|54245445|FG000|Apremilast Extension Period (Week 16-52)|Protocol Deviation|0|||
27790465|NCT03774875|54245446|FG001|Apremilast Extension Period (Week 16-52)|Protocol Deviation|1|||
27790466|NCT03774875|54245445|FG000|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|0|||
27790467|NCT03774875|54245446|FG001|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|3|||
27790468|NCT02220764|54245459|FG000|Overall Study|Lost to Follow-up|3|||
27790469|NCT02220764|54245460|FG001|Overall Study|Lost to Follow-up|1|||
27790470|NCT02220764|54245459|FG000|Overall Study|Death|1|||
27790471|NCT02220764|54245460|FG001|Overall Study|Death|0|||
27790472|NCT01563172|54245466|FG000|Overall Study|Adverse Event|5|||
27790473|NCT01563172|54245466|FG000|Overall Study|Lost to Follow-up|2|||
27790474|NCT01563172|54245466|FG000|Overall Study|Other (Protocol deviation)|5|||
27790475|NCT01563172|54245466|FG000|Overall Study|Other (Not specified)|1|||
27790476|NCT02161718|54245483|FG000|Open-Label ALKS 3831 Period|Protocol Violation|2|||
27790477|NCT02161718|54245484|FG001|Open-Label ALKS 3831 Period|Protocol Violation|0|||
27790478|NCT02161718|54245485|FG002|Open-Label ALKS 3831 Period|Protocol Violation|0|||
27790479|NCT02161718|54245483|FG000|Open-Label ALKS 3831 Period|Physician Decision|1|||
27790480|NCT02161718|54245484|FG001|Open-Label ALKS 3831 Period|Physician Decision|0|||
27790481|NCT02161718|54245485|FG002|Open-Label ALKS 3831 Period|Physician Decision|0|||
27790482|NCT02161718|54245483|FG000|Open-Label ALKS 3831 Period|Non-compliance with study drug|1|||
27790483|NCT02161718|54245484|FG001|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
27790484|NCT02161718|54245485|FG002|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
27790485|NCT02161718|54245483|FG000|Open-Label ALKS 3831 Period|Lack of Efficacy|1|||
27790486|NCT02161718|54245484|FG001|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
27790487|NCT02161718|54245485|FG002|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
27790488|NCT02161718|54245483|FG000|Open-Label ALKS 3831 Period|Adverse Event|3|||
27790489|NCT02161718|54245484|FG001|Open-Label ALKS 3831 Period|Adverse Event|0|||
27790490|NCT02161718|54245485|FG002|Open-Label ALKS 3831 Period|Adverse Event|0|||
27790491|NCT02161718|54245483|FG000|Open-Label ALKS 3831 Period|Withdrawal by Subject|4|||
27790492|NCT02161718|54245484|FG001|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
27790493|NCT02161718|54245485|FG002|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
27790494|NCT02161718|54245483|FG000|Open-Label ALKS 3831 Period|Lost to Follow-up|3|||
27790495|NCT02161718|54245484|FG001|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
27790496|NCT02161718|54245485|FG002|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
27790497|NCT02161718|54245483|FG000|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|6|||
27790498|NCT02161718|54245484|FG001|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
27790499|NCT02161718|54245485|FG002|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
27935742|NCT01121913|54592107|FG000|First Washout Period|Withdrawal by Subject|1|||
27935743|NCT01121913|54592108|FG001|First Washout Period|Withdrawal by Subject|0|||
27935744|NCT01121913|54592109|FG002|First Washout Period|Withdrawal by Subject|0|||
27935745|NCT01121913|54592110|FG003|First Washout Period|Withdrawal by Subject|0|||
27935746|NCT01121913|54592107|FG000|Second Intervention Period|Adverse Event|0|||
27790500|NCT02161718|54245483|FG000|Post- Randomization Period|Withdrawal by Subject|0|||
27790501|NCT02161718|54245484|FG001|Post- Randomization Period|Withdrawal by Subject|23|||
27790502|NCT02161718|54245485|FG002|Post- Randomization Period|Withdrawal by Subject|18|||
27790503|NCT02161718|54245483|FG000|Post- Randomization Period|Lost to Follow-up|0|||
27790504|NCT02161718|54245484|FG001|Post- Randomization Period|Lost to Follow-up|9|||
27790505|NCT02161718|54245485|FG002|Post- Randomization Period|Lost to Follow-up|15|||
27790506|NCT02161718|54245483|FG000|Post- Randomization Period|Adverse Event|0|||
27790507|NCT02161718|54245484|FG001|Post- Randomization Period|Adverse Event|9|||
27790508|NCT02161718|54245485|FG002|Post- Randomization Period|Adverse Event|10|||
27790509|NCT02161718|54245483|FG000|Post- Randomization Period|Non- compliance with study drug|0|||
27790510|NCT02161718|54245484|FG001|Post- Randomization Period|Non- compliance with study drug|8|||
27790511|NCT02161718|54245485|FG002|Post- Randomization Period|Non- compliance with study drug|2|||
27790512|NCT02161718|54245483|FG000|Post- Randomization Period|Physician Decision|0|||
27790513|NCT02161718|54245484|FG001|Post- Randomization Period|Physician Decision|2|||
27790514|NCT02161718|54245485|FG002|Post- Randomization Period|Physician Decision|4|||
27790515|NCT02161718|54245483|FG000|Post- Randomization Period|Protocol Violation|0|||
27790516|NCT02161718|54245484|FG001|Post- Randomization Period|Protocol Violation|2|||
27790517|NCT02161718|54245485|FG002|Post- Randomization Period|Protocol Violation|3|||
27790518|NCT02161718|54245483|FG000|Post- Randomization Period|Lack of Efficacy|0|||
27790519|NCT02161718|54245484|FG001|Post- Randomization Period|Lack of Efficacy|0|||
27790520|NCT02161718|54245485|FG002|Post- Randomization Period|Lack of Efficacy|1|||
27790521|NCT02161718|54245483|FG000|Post- Randomization Period|Non-compliance with study procedures|0|||
27790522|NCT02161718|54245484|FG001|Post- Randomization Period|Non-compliance with study procedures|2|||
27790523|NCT02161718|54245485|FG002|Post- Randomization Period|Non-compliance with study procedures|4|||
27790524|NCT02161718|54245483|FG000|Post- Randomization Period|Received prohibitive treatment|0|||
27790525|NCT02161718|54245484|FG001|Post- Randomization Period|Received prohibitive treatment|1|||
27790526|NCT02161718|54245485|FG002|Post- Randomization Period|Received prohibitive treatment|2|||
27790527|NCT02161718|54245483|FG000|Post- Randomization Period|Relocation|0|||
27935747|NCT01121913|54592108|FG001|Second Intervention Period|Adverse Event|0|||
27935748|NCT01121913|54592109|FG002|Second Intervention Period|Adverse Event|1|||
27790528|NCT02161718|54245484|FG001|Post- Randomization Period|Relocation|3|||
27790529|NCT02161718|54245485|FG002|Post- Randomization Period|Relocation|0|||
27790530|NCT02219048|54245494|FG000|Overall Study|Adverse Event|2|||
27790531|NCT02219048|54245495|FG001|Overall Study|Adverse Event|5|||
27790532|NCT02219048|54245494|FG000|Overall Study|No longer meets eligibility criteria|1|||
27790533|NCT02219048|54245495|FG001|Overall Study|No longer meets eligibility criteria|0|||
27790534|NCT02219048|54245494|FG000|Overall Study|Study terminated by sponsor|16|||
27790535|NCT02219048|54245495|FG001|Overall Study|Study terminated by sponsor|15|||
27935749|NCT01121913|54592110|FG003|Second Intervention Period|Adverse Event|0|||
27935750|NCT01121913|54592107|FG000|Second Washout Period|Withdrawal by Subject|0|||
27935751|NCT01121913|54592108|FG001|Second Washout Period|Withdrawal by Subject|0|||
27935752|NCT01121913|54592109|FG002|Second Washout Period|Withdrawal by Subject|1|||
27935753|NCT01121913|54592110|FG003|Second Washout Period|Withdrawal by Subject|0|||
27935754|NCT01121913|54592107|FG000|Third Washout Period|Adverse Event|1|||
27935755|NCT01121913|54592108|FG001|Third Washout Period|Adverse Event|0|||
27935756|NCT01121913|54592109|FG002|Third Washout Period|Adverse Event|0|||
27935757|NCT01121913|54592110|FG003|Third Washout Period|Adverse Event|0|||
27935758|NCT00994162|54592122|FG000|Overall Study|Withdrawal by Subject|1|||
27935759|NCT00994162|54592122|FG000|Overall Study|Lost to Follow-up|2|||
27935760|NCT00994162|54592122|FG000|Overall Study|Product Complaint|1|||
27935761|NCT00994162|54592122|FG000|Overall Study|Poor Compliance|5|||
27935762|NCT00994162|54592122|FG000|Overall Study|Lack of Response|3|||
27935763|NCT00994162|54592122|FG000|Overall Study|Discharged from Hospital|4|||
27935764|NCT00994162|54592122|FG000|Overall Study|Death|2|||
27935765|NCT00994162|54592122|FG000|Overall Study|Care Transferred to Another Physician|2|||
27935766|NCT00994162|54592122|FG000|Overall Study|Discontinued and Changed to Iodoflex|1|||
27935767|NCT00994162|54592122|FG000|Overall Study|Physician Decision|2|||
27935768|NCT00994162|54592122|FG000|Overall Study|Surrounding Wound Erythematous|1|||
27935769|NCT00994162|54592122|FG000|Overall Study|Machine Losing Vaccum|1|||
27935770|NCT00994162|54592122|FG000|Overall Study|Patient Lived Too Far Away|1|||
27935771|NCT00994162|54592122|FG000|Overall Study|Above Knee Amputation|1|||
27935772|NCT00994162|54592122|FG000|Overall Study|Reason Not Reported By Site|1|||
27935773|NCT00993928|54592129|FG000|Overall Study|Withdrawal by Subject|4|||
27935774|NCT00993928|54592130|FG001|Overall Study|Withdrawal by Subject|7|||
27790536|NCT02219048|54245494|FG000|Overall Study|Withdrawal by Subject|2|||
27935775|NCT00993928|54592129|FG000|Overall Study|ineligible|1|||
27935776|NCT00993928|54592130|FG001|Overall Study|ineligible|0|||
27935777|NCT01253291|54592145|FG000|Overall Study|Withdrawal by Subject|1|||
27935778|NCT01253291|54592146|FG001|Overall Study|Withdrawal by Subject|1|||
27935779|NCT01253291|54592147|FG002|Overall Study|Withdrawal by Subject|0|||
27935780|NCT01253291|54592148|FG003|Overall Study|Withdrawal by Subject|0|||
27935781|NCT01253291|54592149|FG004|Overall Study|Withdrawal by Subject|0|||
27935782|NCT01253291|54592145|FG000|Overall Study|Adverse Event|0|||
27935783|NCT01253291|54592146|FG001|Overall Study|Adverse Event|1|||
27935784|NCT01253291|54592147|FG002|Overall Study|Adverse Event|0|||
27935785|NCT01253291|54592148|FG003|Overall Study|Adverse Event|0|||
27935786|NCT01253291|54592149|FG004|Overall Study|Adverse Event|0|||
27935787|NCT01253291|54592145|FG000|Overall Study|Lack of Efficacy|1|||
27935788|NCT01253291|54592146|FG001|Overall Study|Lack of Efficacy|0|||
27935789|NCT01253291|54592147|FG002|Overall Study|Lack of Efficacy|0|||
27935790|NCT01253291|54592148|FG003|Overall Study|Lack of Efficacy|0|||
27935791|NCT01253291|54592149|FG004|Overall Study|Lack of Efficacy|0|||
27935792|NCT01253291|54592145|FG000|Overall Study|Physician Decision|2|||
27935793|NCT01253291|54592146|FG001|Overall Study|Physician Decision|0|||
27935794|NCT01253291|54592147|FG002|Overall Study|Physician Decision|0|||
27935795|NCT01253291|54592148|FG003|Overall Study|Physician Decision|0|||
27935796|NCT01253291|54592149|FG004|Overall Study|Physician Decision|2|||
27935797|NCT01121757|54592164|FG000|First Drug|Death|1|||
27935798|NCT01121757|54592165|FG001|First Drug|Death|0|||
27935799|NCT01121757|54592164|FG000|First Drug|Disease Progression|0|||
27935800|NCT01121757|54592165|FG001|First Drug|Disease Progression|2|||
27935801|NCT01121757|54592164|FG000|Combination|Physician Decision|0|||
27935802|NCT01121757|54592165|FG001|Combination|Physician Decision|1|||
27935803|NCT01121757|54592164|FG000|Combination|Disease Progression|2|||
27935804|NCT01121757|54592165|FG001|Combination|Disease Progression|0|||
27935805|NCT01253135|54592173|FG000|Original Protocol|Protocol Amendment|15|||
27935806|NCT01253135|54592173|FG000|Amended Protocol|Non-compliance|1|||
27935807|NCT00993616|54592181|FG000|Overall Study|No tumor at entry|1|||
27935808|NCT00993616|54592181|FG000|Overall Study|Never treated|1|||
27935809|NCT01120899|54592191|FG000|Overall Study|Withdrawal by Subject|3|||
27935810|NCT01120275|54592195|FG000|Overall Study|Adverse Event|3|||
27935811|NCT01120275|54592195|FG000|Overall Study|Progression|27|||
27935812|NCT01120275|54592195|FG000|Overall Study|Ineligible|3|||
27935813|NCT01120275|54592195|FG000|Overall Study|Withdrawal by Subject|1|||
27935814|NCT01120275|54592195|FG000|Overall Study|Refusal|1|||
27935815|NCT01120275|54592195|FG000|Overall Study|Not specific|1|||
27935816|NCT00991510|54592202|FG000|Period I (Days 1-14)|Adverse Event|1|||
27935817|NCT00991510|54592203|FG001|Period I (Days 1-14)|Adverse Event|0|||
27935818|NCT00991510|54592202|FG000|Period III (Days 29-112)|Adverse Event|1|||
27935819|NCT00991510|54592203|FG001|Period III (Days 29-112)|Adverse Event|1|||
27935820|NCT01119963|54592215|FG000|Overall Study|Lost to Follow-up|1|||
27935821|NCT01119963|54592216|FG001|Overall Study|Lost to Follow-up|1|||
27790537|NCT02219048|54245495|FG001|Overall Study|Withdrawal by Subject|0|||
27790538|NCT02219048|54245494|FG000|Overall Study|Other|0|||
27790539|NCT02219048|54245495|FG001|Overall Study|Other|1|||
27790540|NCT02218736|54245503|FG000|Overall Study|Withdrawal by Subject|10|||
27790541|NCT02218736|54245504|FG001|Overall Study|Withdrawal by Subject|9|||
27790542|NCT02218736|54245503|FG000|Overall Study|Protocol Violation|2|||
27790543|NCT02218736|54245504|FG001|Overall Study|Protocol Violation|0|||
27935822|NCT01252667|54592230|FG000|Overall Study|Transplant aborted post-conditioning|0|||
27935823|NCT01252667|54592231|FG001|Overall Study|Transplant aborted post-conditioning|0|||
27935824|NCT01252667|54592232|FG002|Overall Study|Transplant aborted post-conditioning|0|||
27935825|NCT01252667|54592233|FG003|Overall Study|Transplant aborted post-conditioning|0|||
27935826|NCT01252667|54592234|FG004|Overall Study|Transplant aborted post-conditioning|0|||
27935827|NCT01252667|54592235|FG005|Overall Study|Transplant aborted post-conditioning|1|||
27935828|NCT01119105|54592252|FG000|Overall Study|Withdrawal by Subject|1|||
27935829|NCT01119105|54592253|FG001|Overall Study|Withdrawal by Subject|1|||
27935830|NCT01119105|54592254|FG002|Overall Study|Withdrawal by Subject|1|||
27935831|NCT01119105|54592252|FG000|Overall Study|Lost to Follow-up|0|||
27935832|NCT01119105|54592253|FG001|Overall Study|Lost to Follow-up|2|||
27935833|NCT01119105|54592254|FG002|Overall Study|Lost to Follow-up|5|||
27935834|NCT01119105|54592252|FG000|Overall Study|Adverse Event|1|||
27935835|NCT01119105|54592253|FG001|Overall Study|Adverse Event|0|||
27935836|NCT01119105|54592254|FG002|Overall Study|Adverse Event|1|||
27935837|NCT01119105|54592252|FG000|Overall Study|study drug missed on 2 consecutive days|1|||
27935838|NCT01119105|54592253|FG001|Overall Study|study drug missed on 2 consecutive days|2|||
27935839|NCT01119105|54592254|FG002|Overall Study|study drug missed on 2 consecutive days|1|||
28017108|NCT00681824|54676359|FG002|Overall Study|Death|0|||
27790544|NCT01540474|54245514|FG000|Vaccination Period|Lost to Follow-up|0|||
27935840|NCT01119105|54592252|FG000|Overall Study|Other|1|||
27935841|NCT01119105|54592253|FG001|Overall Study|Other|1|||
27935842|NCT01119105|54592254|FG002|Overall Study|Other|0|||
27935843|NCT01118949|54592262|FG000|Overall Study|Adverse Event|5|||
27935844|NCT01118949|54592262|FG000|Overall Study|Withdrawal by Subject|4|||
27935845|NCT01252355|54592269|FG000|Overall Study|Adverse Event|9|||
27935846|NCT01252355|54592270|FG001|Overall Study|Adverse Event|17|||
27935847|NCT01252355|54592271|FG002|Overall Study|Adverse Event|22|||
27935848|NCT01252355|54592269|FG000|Overall Study|Lack of Efficacy|6|||
27790545|NCT01540474|54245515|FG001|Vaccination Period|Lost to Follow-up|1|||
27790546|NCT01540474|54245516|FG002|Vaccination Period|Lost to Follow-up|0|||
27935849|NCT01252355|54592270|FG001|Overall Study|Lack of Efficacy|4|||
27935850|NCT01252355|54592271|FG002|Overall Study|Lack of Efficacy|2|||
27935851|NCT01252355|54592269|FG000|Overall Study|Lost to Follow-up|0|||
27935852|NCT01252355|54592270|FG001|Overall Study|Lost to Follow-up|0|||
27935853|NCT01252355|54592271|FG002|Overall Study|Lost to Follow-up|1|||
27935854|NCT01252355|54592269|FG000|Overall Study|Poor Compliance to Protocol|1|||
27935855|NCT01252355|54592270|FG001|Overall Study|Poor Compliance to Protocol|1|||
27935856|NCT01252355|54592271|FG002|Overall Study|Poor Compliance to Protocol|1|||
27935857|NCT01252355|54592269|FG000|Overall Study|Progressive Disease|2|||
27935858|NCT01252355|54592270|FG001|Overall Study|Progressive Disease|0|||
27935859|NCT01252355|54592271|FG002|Overall Study|Progressive Disease|0|||
27935860|NCT01252355|54592269|FG000|Overall Study|Sponsor Early Termination of Study|149|||
27935861|NCT01252355|54592270|FG001|Overall Study|Sponsor Early Termination of Study|149|||
27935862|NCT01252355|54592271|FG002|Overall Study|Sponsor Early Termination of Study|146|||
27935863|NCT01252355|54592269|FG000|Overall Study|Randomized but not Treated|2|||
27935864|NCT01252355|54592270|FG001|Overall Study|Randomized but not Treated|0|||
27935865|NCT01252355|54592271|FG002|Overall Study|Randomized but not Treated|0|||
27935866|NCT01252355|54592269|FG000|Overall Study|Other Than Above|8|||
27935867|NCT01252355|54592270|FG001|Overall Study|Other Than Above|7|||
27935868|NCT01252355|54592271|FG002|Overall Study|Other Than Above|7|||
27935869|NCT01118325|54592282|FG000|Overall Study|Adverse Event|1|||
27935870|NCT01118325|54592283|FG001|Overall Study|Adverse Event|0|||
27935871|NCT01118325|54592284|FG002|Overall Study|Adverse Event|1|||
27935872|NCT01117857|54592305|FG000|Overall Study|Lost to Follow-up|4|||
27935873|NCT01117857|54592305|FG000|Overall Study|Withdrawal by Subject|4|||
27935874|NCT01117857|54592305|FG000|Overall Study|Physician Decision|1|||
27935875|NCT01251887|54592312|FG000|Overall Study|Scheduling conflict|1|||
27935876|NCT01251887|54592313|FG001|Overall Study|Scheduling conflict|2|||
27935877|NCT01251887|54592314|FG002|Overall Study|Scheduling conflict|2|||
27935878|NCT01251887|54592312|FG000|Overall Study|Physician Decision|0|||
27935879|NCT01251887|54592313|FG001|Overall Study|Physician Decision|1|||
27935880|NCT01251887|54592314|FG002|Overall Study|Physician Decision|0|||
27935881|NCT00991276|54592328|FG000|First Intervention Period|Adverse Event|0|||
27935882|NCT00991276|54592329|FG001|First Intervention Period|Adverse Event|1|||
27935883|NCT00991276|54592330|FG002|First Intervention Period|Adverse Event|0|||
27935884|NCT00991276|54592331|FG003|First Intervention Period|Adverse Event|1|||
27935885|NCT00991276|54592332|FG004|First Intervention Period|Adverse Event|0|||
27935886|NCT00991276|54592333|FG005|First Intervention Period|Adverse Event|0|||
27935887|NCT00991276|54592328|FG000|First Intervention Period|Protocol Violation|0|||
27935888|NCT00991276|54592329|FG001|First Intervention Period|Protocol Violation|0|||
27935889|NCT00991276|54592330|FG002|First Intervention Period|Protocol Violation|0|||
27935890|NCT00991276|54592331|FG003|First Intervention Period|Protocol Violation|0|||
27935891|NCT00991276|54592332|FG004|First Intervention Period|Protocol Violation|2|||
27935892|NCT00991276|54592333|FG005|First Intervention Period|Protocol Violation|0|||
27935893|NCT00991276|54592328|FG000|First Intervention Period|Insufficient clinical response|0|||
27935894|NCT00991276|54592329|FG001|First Intervention Period|Insufficient clinical response|0|||
27935895|NCT00991276|54592330|FG002|First Intervention Period|Insufficient clinical response|0|||
27935896|NCT00991276|54592331|FG003|First Intervention Period|Insufficient clinical response|0|||
27935897|NCT00991276|54592332|FG004|First Intervention Period|Insufficient clinical response|1|||
27935898|NCT00991276|54592333|FG005|First Intervention Period|Insufficient clinical response|0|||
27935899|NCT00991276|54592328|FG000|First Intervention Period|Other|0|||
27935900|NCT00991276|54592329|FG001|First Intervention Period|Other|0|||
27790547|NCT01540474|54245517|FG003|Vaccination Period|Lost to Follow-up|0|||
27790548|NCT01580488|54245528|FG000|Overall Study|Withdrawal by Subject|1|||
27790549|NCT01580020|54245544|FG000|Overall Study|Lack of Efficacy|0|||
27790550|NCT01580020|54245545|FG001|Overall Study|Lack of Efficacy|5|||
27790551|NCT01580020|54245546|FG002|Overall Study|Lack of Efficacy|0|||
27790552|NCT01580020|54245547|FG003|Overall Study|Lack of Efficacy|1|||
27790553|NCT01580020|54245544|FG000|Overall Study|Withdrawal by Subject|0|||
27790554|NCT01580020|54245545|FG001|Overall Study|Withdrawal by Subject|1|||
27935901|NCT00991276|54592330|FG002|First Intervention Period|Other|0|||
27935902|NCT00991276|54592331|FG003|First Intervention Period|Other|1|||
27935903|NCT00991276|54592332|FG004|First Intervention Period|Other|1|||
27935904|NCT00991276|54592333|FG005|First Intervention Period|Other|0|||
27935905|NCT00991276|54592328|FG000|First Intervention Period|Withdrawal by Subject|0|||
27935906|NCT00991276|54592329|FG001|First Intervention Period|Withdrawal by Subject|1|||
27935907|NCT00991276|54592330|FG002|First Intervention Period|Withdrawal by Subject|0|||
27935908|NCT00991276|54592331|FG003|First Intervention Period|Withdrawal by Subject|1|||
27935909|NCT00991276|54592332|FG004|First Intervention Period|Withdrawal by Subject|0|||
27935910|NCT00991276|54592333|FG005|First Intervention Period|Withdrawal by Subject|1|||
27935911|NCT00991276|54592328|FG000|First Intervention Period|Lost to Follow-up|0|||
27935912|NCT00991276|54592329|FG001|First Intervention Period|Lost to Follow-up|1|||
27935913|NCT00991276|54592330|FG002|First Intervention Period|Lost to Follow-up|0|||
27790555|NCT01580020|54245546|FG002|Overall Study|Withdrawal by Subject|1|||
27790556|NCT01580020|54245547|FG003|Overall Study|Withdrawal by Subject|0|||
27790557|NCT01580020|54245544|FG000|Overall Study|Adverse Event|1|||
27790558|NCT01580020|54245545|FG001|Overall Study|Adverse Event|1|||
27790559|NCT01580020|54245546|FG002|Overall Study|Adverse Event|1|||
27790560|NCT01580020|54245547|FG003|Overall Study|Adverse Event|1|||
27790561|NCT01580020|54245544|FG000|Overall Study|Administrative Problems|0|||
27790562|NCT01580020|54245545|FG001|Overall Study|Administrative Problems|0|||
27790563|NCT01580020|54245546|FG002|Overall Study|Administrative Problems|1|||
27790564|NCT01580020|54245547|FG003|Overall Study|Administrative Problems|0|||
27790565|NCT01580020|54245544|FG000|Overall Study|Lost to Follow-up|0|||
27790566|NCT01580020|54245545|FG001|Overall Study|Lost to Follow-up|0|||
27790567|NCT01580020|54245546|FG002|Overall Study|Lost to Follow-up|1|||
27790568|NCT01580020|54245547|FG003|Overall Study|Lost to Follow-up|0|||
27935914|NCT00991276|54592331|FG003|First Intervention Period|Lost to Follow-up|1|||
27935915|NCT00991276|54592332|FG004|First Intervention Period|Lost to Follow-up|0|||
27935916|NCT00991276|54592333|FG005|First Intervention Period|Lost to Follow-up|0|||
27935917|NCT00991276|54592328|FG000|Second Intervention Period|Adverse Event|0|||
27935918|NCT00991276|54592329|FG001|Second Intervention Period|Adverse Event|2|||
27935919|NCT00991276|54592330|FG002|Second Intervention Period|Adverse Event|0|||
27935920|NCT00991276|54592331|FG003|Second Intervention Period|Adverse Event|1|||
27935921|NCT00991276|54592332|FG004|Second Intervention Period|Adverse Event|1|||
27935922|NCT00991276|54592333|FG005|Second Intervention Period|Adverse Event|0|||
27935923|NCT00991276|54592328|FG000|Second Intervention Period|Protocol Violation|1|||
27935924|NCT00991276|54592329|FG001|Second Intervention Period|Protocol Violation|0|||
27935925|NCT00991276|54592330|FG002|Second Intervention Period|Protocol Violation|0|||
27935926|NCT00991276|54592331|FG003|Second Intervention Period|Protocol Violation|0|||
27790569|NCT01579474|54245563|FG000|Overall Study|Adverse Event|1|||
27790570|NCT01579474|54245564|FG001|Overall Study|Adverse Event|13|||
27790571|NCT01579474|54245565|FG002|Overall Study|Adverse Event|2|||
27790572|NCT01579474|54245566|FG003|Overall Study|Adverse Event|0|||
27790573|NCT01579474|54245567|FG004|Overall Study|Adverse Event|0|||
27790574|NCT01579474|54245568|FG005|Overall Study|Adverse Event|1|||
27790575|NCT01579474|54245563|FG000|Overall Study|Lack of Efficacy|1|||
27790576|NCT01579474|54245564|FG001|Overall Study|Lack of Efficacy|0|||
27790577|NCT01579474|54245565|FG002|Overall Study|Lack of Efficacy|0|||
27790578|NCT01579474|54245566|FG003|Overall Study|Lack of Efficacy|0|||
27790579|NCT01579474|54245567|FG004|Overall Study|Lack of Efficacy|1|||
27790580|NCT01579474|54245568|FG005|Overall Study|Lack of Efficacy|0|||
27790581|NCT01579474|54245563|FG000|Overall Study|Withdrawal by Subject|1|||
27790582|NCT01579474|54245564|FG001|Overall Study|Withdrawal by Subject|0|||
27790583|NCT01579474|54245565|FG002|Overall Study|Withdrawal by Subject|0|||
27790584|NCT01579474|54245566|FG003|Overall Study|Withdrawal by Subject|0|||
27790585|NCT01579474|54245567|FG004|Overall Study|Withdrawal by Subject|0|||
27790586|NCT01579474|54245568|FG005|Overall Study|Withdrawal by Subject|0|||
27790587|NCT01579318|54245581|FG000|Overall Study|Disease Progression|1|||
27790588|NCT01562782|54245587|FG000|Overall Study|Withdrawal by Subject|3|||
27790589|NCT01562782|54245588|FG001|Overall Study|Withdrawal by Subject|3|||
27790590|NCT01562782|54245587|FG000|Overall Study|screen failure|1|||
27790591|NCT01562782|54245588|FG001|Overall Study|screen failure|2|||
27790592|NCT01579006|54245594|FG000|Overall Study|Lack of Efficacy|10|||
27790593|NCT01579006|54245594|FG000|Overall Study|Adverse Event|13|||
27790594|NCT01579006|54245594|FG000|Overall Study|Withdrawal by Subject|5|||
27790595|NCT01579006|54245594|FG000|Overall Study|Non-compliance|3|||
27790596|NCT01579006|54245594|FG000|Overall Study|Due to participant's health fund|1|||
27790597|NCT01579006|54245594|FG000|Overall Study|Scheduled surgery|1|||
27790598|NCT01578850|54245600|FG000|Period 1|Insufficient Clinical Response|1|||
27790599|NCT01578850|54245601|FG001|Period 1|Insufficient Clinical Response|0|||
27790600|NCT01578850|54245602|FG002|Period 1|Insufficient Clinical Response|0|||
27790601|NCT01578850|54245600|FG000|Period 1|Adverse Event|11|||
27790602|NCT01578850|54245601|FG001|Period 1|Adverse Event|0|||
27935927|NCT00991276|54592332|FG004|Second Intervention Period|Protocol Violation|0|||
27935928|NCT00991276|54592333|FG005|Second Intervention Period|Protocol Violation|0|||
27935929|NCT00991276|54592328|FG000|Second Intervention Period|Other|0|||
27935930|NCT00991276|54592329|FG001|Second Intervention Period|Other|0|||
27935931|NCT00991276|54592330|FG002|Second Intervention Period|Other|0|||
27935932|NCT00991276|54592331|FG003|Second Intervention Period|Other|1|||
27935933|NCT00991276|54592332|FG004|Second Intervention Period|Other|0|||
27790603|NCT01578850|54245602|FG002|Period 1|Adverse Event|0|||
27790604|NCT01578850|54245600|FG000|Period 1|Death|1|||
27790605|NCT01578850|54245601|FG001|Period 1|Death|0|||
27790606|NCT01578850|54245602|FG002|Period 1|Death|0|||
27790607|NCT01578850|54245600|FG000|Period 1|Does Not Meet Entrance Criteria|12|||
27790608|NCT01578850|54245601|FG001|Period 1|Does Not Meet Entrance Criteria|0|||
27790609|NCT01578850|54245602|FG002|Period 1|Does Not Meet Entrance Criteria|0|||
27790610|NCT01578850|54245600|FG000|Period 1|Withdrawal by Subject|9|||
27790611|NCT01578850|54245601|FG001|Period 1|Withdrawal by Subject|0|||
27790612|NCT01578850|54245602|FG002|Period 1|Withdrawal by Subject|0|||
27790613|NCT01578850|54245600|FG000|Period 1|Study Terminated by Sponsor|3|||
27790614|NCT01578850|54245601|FG001|Period 1|Study Terminated by Sponsor|0|||
27790615|NCT01578850|54245602|FG002|Period 1|Study Terminated by Sponsor|0|||
27790616|NCT01578850|54245600|FG000|Period 2|Insufficient Clinical Response|0|||
27790617|NCT01578850|54245601|FG001|Period 2|Insufficient Clinical Response|1|||
27790618|NCT01578850|54245602|FG002|Period 2|Insufficient Clinical Response|0|||
27790619|NCT01578850|54245600|FG000|Period 2|Adverse Event|0|||
27790620|NCT01578850|54245601|FG001|Period 2|Adverse Event|3|||
27790621|NCT01578850|54245602|FG002|Period 2|Adverse Event|6|||
27790622|NCT01578850|54245600|FG000|Period 2|Lost to Follow-up|0|||
27790623|NCT01578850|54245601|FG001|Period 2|Lost to Follow-up|1|||
27790624|NCT01578850|54245602|FG002|Period 2|Lost to Follow-up|2|||
27790625|NCT01578850|54245600|FG000|Period 2|Withdrawal by Subject|0|||
27790626|NCT01578850|54245601|FG001|Period 2|Withdrawal by Subject|2|||
27790627|NCT01578850|54245602|FG002|Period 2|Withdrawal by Subject|2|||
27790628|NCT01578850|54245600|FG000|Period 2|Study Terminated by Sponsor|0|||
27790629|NCT01578850|54245601|FG001|Period 2|Study Terminated by Sponsor|5|||
27790630|NCT01578850|54245602|FG002|Period 2|Study Terminated by Sponsor|4|||
27790631|NCT01578850|54245600|FG000|Period 2|Unspecified Reasons|0|||
27790632|NCT01578850|54245601|FG001|Period 2|Unspecified Reasons|1|||
27790633|NCT01578850|54245602|FG002|Period 2|Unspecified Reasons|0|||
27790634|NCT01539538|54245612|FG000|Overall Study|Adverse Event|13|||
27790635|NCT01539538|54245613|FG001|Overall Study|Adverse Event|18|||
27790636|NCT01539538|54245612|FG000|Overall Study|Lack of Efficacy|13|||
27790637|NCT01539538|54245613|FG001|Overall Study|Lack of Efficacy|16|||
27790638|NCT01539538|54245612|FG000|Overall Study|Withdrawal by Subject|2|||
27935934|NCT00991276|54592333|FG005|Second Intervention Period|Other|1|||
27935935|NCT00991276|54592328|FG000|Third Intervention Period|Protocol Violation|1|||
27935936|NCT00991276|54592329|FG001|Third Intervention Period|Protocol Violation|0|||
27935937|NCT00991276|54592330|FG002|Third Intervention Period|Protocol Violation|0|||
27935938|NCT00991276|54592331|FG003|Third Intervention Period|Protocol Violation|0|||
27935939|NCT00991276|54592332|FG004|Third Intervention Period|Protocol Violation|0|||
27935940|NCT00991276|54592333|FG005|Third Intervention Period|Protocol Violation|0|||
27935941|NCT00991276|54592328|FG000|Third Intervention Period|Other|0|||
27935942|NCT00991276|54592329|FG001|Third Intervention Period|Other|0|||
27935943|NCT00991276|54592330|FG002|Third Intervention Period|Other|0|||
27935944|NCT00991276|54592331|FG003|Third Intervention Period|Other|0|||
27935945|NCT00991276|54592332|FG004|Third Intervention Period|Other|0|||
27935946|NCT00991276|54592333|FG005|Third Intervention Period|Other|1|||
27935947|NCT00991276|54592328|FG000|Third Intervention Period|Adverse Event|0|||
27935948|NCT00991276|54592329|FG001|Third Intervention Period|Adverse Event|0|||
27935949|NCT00991276|54592330|FG002|Third Intervention Period|Adverse Event|1|||
27935950|NCT00991276|54592331|FG003|Third Intervention Period|Adverse Event|0|||
27935951|NCT00991276|54592332|FG004|Third Intervention Period|Adverse Event|0|||
27935952|NCT00991276|54592333|FG005|Third Intervention Period|Adverse Event|0|||
27935953|NCT00991276|54592328|FG000|Third Intervention Period|Withdrawal by Subject|0|||
27935954|NCT00991276|54592329|FG001|Third Intervention Period|Withdrawal by Subject|0|||
27935955|NCT00991276|54592330|FG002|Third Intervention Period|Withdrawal by Subject|0|||
27935956|NCT00991276|54592331|FG003|Third Intervention Period|Withdrawal by Subject|1|||
27935957|NCT00991276|54592332|FG004|Third Intervention Period|Withdrawal by Subject|0|||
27935958|NCT00991276|54592333|FG005|Third Intervention Period|Withdrawal by Subject|0|||
27935959|NCT00990652|54592342|FG000|Pre-surgical Bortezomib|Adverse Event|1|||
27935960|NCT00990652|54592342|FG000|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1|||
27935961|NCT00990340|54592349|FG000|First 14-day Treatment|Not Compliant|2|||
27935962|NCT00990340|54592350|FG001|First 14-day Treatment|Not Compliant|1|||
27935963|NCT00990340|54592349|FG000|First 14-day Treatment|Lost to Follow-up|2|||
27935964|NCT00990340|54592350|FG001|First 14-day Treatment|Lost to Follow-up|1|||
27935965|NCT00990340|54592349|FG000|First 14-day Treatment|Protocol Violation|2|||
27935966|NCT00990340|54592350|FG001|First 14-day Treatment|Protocol Violation|2|||
27935967|NCT01207440|54592365|FG000|Overall Study|Adverse Event|46|||
27935968|NCT01207440|54592366|FG001|Overall Study|Adverse Event|11|||
27935969|NCT01207440|54592367|FG002|Overall Study|Adverse Event|7|||
27935970|NCT01207440|54592368|FG003|Overall Study|Adverse Event|2|||
27935971|NCT01207440|54592369|FG004|Overall Study|Adverse Event|6|||
27935972|NCT01207440|54592370|FG005|Overall Study|Adverse Event|6|||
27935973|NCT01207440|54592371|FG006|Overall Study|Adverse Event|2|||
27935974|NCT01207440|54592365|FG000|Overall Study|Death|6|||
27935975|NCT01207440|54592366|FG001|Overall Study|Death|3|||
27935976|NCT01207440|54592367|FG002|Overall Study|Death|2|||
27935977|NCT01207440|54592368|FG003|Overall Study|Death|2|||
27935978|NCT01207440|54592369|FG004|Overall Study|Death|7|||
27935979|NCT01207440|54592370|FG005|Overall Study|Death|5|||
27935980|NCT01207440|54592371|FG006|Overall Study|Death|1|||
27935981|NCT01207440|54592365|FG000|Overall Study|Lack of Efficacy|13|||
27790639|NCT01539538|54245613|FG001|Overall Study|Withdrawal by Subject|3|||
27790640|NCT01539538|54245612|FG000|Overall Study|PCA no longer required or PCA problem|3|||
27790641|NCT01539538|54245613|FG001|Overall Study|PCA no longer required or PCA problem|7|||
27790642|NCT01562548|54245623|FG000|Overall Study|Lost to Follow-up|0|||
27790643|NCT01562548|54245624|FG001|Overall Study|Lost to Follow-up|0|||
27935982|NCT01207440|54592366|FG001|Overall Study|Lack of Efficacy|2|||
27935983|NCT01207440|54592367|FG002|Overall Study|Lack of Efficacy|5|||
27935984|NCT01207440|54592368|FG003|Overall Study|Lack of Efficacy|1|||
27935985|NCT01207440|54592369|FG004|Overall Study|Lack of Efficacy|2|||
27935986|NCT01207440|54592370|FG005|Overall Study|Lack of Efficacy|3|||
27935987|NCT01207440|54592371|FG006|Overall Study|Lack of Efficacy|0|||
27935988|NCT01207440|54592365|FG000|Overall Study|Lost to Follow-up|0|||
27935989|NCT01207440|54592366|FG001|Overall Study|Lost to Follow-up|0|||
27935990|NCT01207440|54592367|FG002|Overall Study|Lost to Follow-up|2|||
27935991|NCT01207440|54592368|FG003|Overall Study|Lost to Follow-up|1|||
27935992|NCT01207440|54592369|FG004|Overall Study|Lost to Follow-up|0|||
27935993|NCT01207440|54592370|FG005|Overall Study|Lost to Follow-up|0|||
27935994|NCT01207440|54592371|FG006|Overall Study|Lost to Follow-up|0|||
27935995|NCT01207440|54592365|FG000|Overall Study|Non-compliance with Study Drug|3|||
27935996|NCT01207440|54592366|FG001|Overall Study|Non-compliance with Study Drug|0|||
27935997|NCT01207440|54592367|FG002|Overall Study|Non-compliance with Study Drug|1|||
27935998|NCT01207440|54592368|FG003|Overall Study|Non-compliance with Study Drug|0|||
27935999|NCT01207440|54592369|FG004|Overall Study|Non-compliance with Study Drug|0|||
27936000|NCT01207440|54592370|FG005|Overall Study|Non-compliance with Study Drug|0|||
27936001|NCT01207440|54592371|FG006|Overall Study|Non-compliance with Study Drug|0|||
27936002|NCT01207440|54592365|FG000|Overall Study|Physician Decision|6|||
27936003|NCT01207440|54592366|FG001|Overall Study|Physician Decision|5|||
27936004|NCT01207440|54592367|FG002|Overall Study|Physician Decision|5|||
27936005|NCT01207440|54592368|FG003|Overall Study|Physician Decision|0|||
27936006|NCT01207440|54592369|FG004|Overall Study|Physician Decision|1|||
27936007|NCT01207440|54592370|FG005|Overall Study|Physician Decision|0|||
27936008|NCT01207440|54592371|FG006|Overall Study|Physician Decision|0|||
27936009|NCT01207440|54592365|FG000|Overall Study|Progressive Disease|19|||
27936010|NCT01207440|54592366|FG001|Overall Study|Progressive Disease|10|||
27936011|NCT01207440|54592367|FG002|Overall Study|Progressive Disease|19|||
27936012|NCT01207440|54592368|FG003|Overall Study|Progressive Disease|7|||
27936013|NCT01207440|54592369|FG004|Overall Study|Progressive Disease|23|||
27936014|NCT01207440|54592370|FG005|Overall Study|Progressive Disease|27|||
27936015|NCT01207440|54592371|FG006|Overall Study|Progressive Disease|0|||
27936016|NCT01207440|54592365|FG000|Overall Study|Protocol Violation|2|||
27936017|NCT01207440|54592366|FG001|Overall Study|Protocol Violation|0|||
27936018|NCT01207440|54592367|FG002|Overall Study|Protocol Violation|0|||
27936019|NCT01207440|54592368|FG003|Overall Study|Protocol Violation|0|||
27936020|NCT01207440|54592369|FG004|Overall Study|Protocol Violation|0|||
27790644|NCT01562548|54245625|FG002|Overall Study|Lost to Follow-up|1|||
27790645|NCT01562548|54245626|FG003|Overall Study|Lost to Follow-up|0|||
27790646|NCT01562314|54245640|FG000|Overall Study|Adverse Event|10|||
27790647|NCT01562314|54245641|FG001|Overall Study|Adverse Event|5|||
27790648|NCT01562314|54245640|FG000|Overall Study|Met Withdrawal Criteria|3|||
27790649|NCT01562314|54245641|FG001|Overall Study|Met Withdrawal Criteria|2|||
27790650|NCT01562314|54245640|FG000|Overall Study|Withdrawal by Subject|0|||
27790651|NCT01562314|54245641|FG001|Overall Study|Withdrawal by Subject|1|||
27790652|NCT01539226|54245649|FG000|Overall Study|Withdrawal by Subject|24|||
27790653|NCT01539226|54245650|FG001|Overall Study|Withdrawal by Subject|54|||
27790654|NCT01539226|54245649|FG000|Overall Study|Lost to Follow-up|20|||
27790655|NCT01539226|54245650|FG001|Overall Study|Lost to Follow-up|54|||
27790656|NCT01539226|54245649|FG000|Overall Study|Death|1|||
27790657|NCT01539226|54245650|FG001|Overall Study|Death|2|||
27790658|NCT01539226|54245649|FG000|Overall Study|Adverse Event|2|||
27790659|NCT01539226|54245650|FG001|Overall Study|Adverse Event|0|||
27790660|NCT01539226|54245649|FG000|Overall Study|Pregnancy|13|||
27790661|NCT01539226|54245650|FG001|Overall Study|Pregnancy|29|||
27790662|NCT01539226|54245649|FG000|Overall Study|inappropriate enrollment|0|||
27790663|NCT01539226|54245650|FG001|Overall Study|inappropriate enrollment|1|||
27790664|NCT01539226|54245649|FG000|Overall Study|Multiple Reasons|3|||
27790665|NCT01539226|54245650|FG001|Overall Study|Multiple Reasons|1|||
27790666|NCT01539226|54245649|FG000|Overall Study|not HIV seroconversion-related|93|||
27790667|NCT01539226|54245650|FG001|Overall Study|not HIV seroconversion-related|176|||
27790668|NCT01539226|54245649|FG000|Overall Study|HIV seroconversion-related|55|||
27936021|NCT01207440|54592370|FG005|Overall Study|Protocol Violation|0|||
27936022|NCT01207440|54592371|FG006|Overall Study|Protocol Violation|0|||
27936023|NCT01207440|54592365|FG000|Overall Study|Site Terminated by Sponsor|69|||
27936024|NCT01207440|54592366|FG001|Overall Study|Site Terminated by Sponsor|19|||
27936025|NCT01207440|54592367|FG002|Overall Study|Site Terminated by Sponsor|12|||
27936026|NCT01207440|54592368|FG003|Overall Study|Site Terminated by Sponsor|2|||
28017109|NCT00681668|54676367|FG000|Overall Study|Protocol Violation|1|||
27936027|NCT01207440|54592369|FG004|Overall Study|Site Terminated by Sponsor|3|||
27936028|NCT01207440|54592370|FG005|Overall Study|Site Terminated by Sponsor|0|||
27936029|NCT01207440|54592371|FG006|Overall Study|Site Terminated by Sponsor|2|||
27936030|NCT01207440|54592365|FG000|Overall Study|Withdrawal by Subject|29|||
27936031|NCT01207440|54592366|FG001|Overall Study|Withdrawal by Subject|4|||
27790669|NCT01539226|54245650|FG001|Overall Study|HIV seroconversion-related|80|||
27790670|NCT01539226|54245649|FG000|Overall Study|Non-compliance|6|||
27790671|NCT01539226|54245650|FG001|Overall Study|Non-compliance|8|||
27790672|NCT01577758|54245656|FG000|Dose Escalation Phase|Adverse Event|0|||
27790673|NCT01577758|54245657|FG001|Dose Escalation Phase|Adverse Event|0|||
27790674|NCT01577758|54245658|FG002|Dose Escalation Phase|Adverse Event|0|||
27790675|NCT01577758|54245659|FG003|Dose Escalation Phase|Adverse Event|0|||
27790676|NCT01577758|54245660|FG004|Dose Escalation Phase|Adverse Event|0|||
27790677|NCT01577758|54245661|FG005|Dose Escalation Phase|Adverse Event|2|||
27790678|NCT01577758|54245662|FG006|Dose Escalation Phase|Adverse Event|1|||
27790679|NCT01577758|54245663|FG007|Dose Escalation Phase|Adverse Event|0|||
27790680|NCT01577758|54245656|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
27790681|NCT01577758|54245657|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
27790682|NCT01577758|54245658|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
27936032|NCT01207440|54592367|FG002|Overall Study|Withdrawal by Subject|5|||
27936033|NCT01207440|54592368|FG003|Overall Study|Withdrawal by Subject|3|||
27936034|NCT01207440|54592369|FG004|Overall Study|Withdrawal by Subject|2|||
27936035|NCT01207440|54592370|FG005|Overall Study|Withdrawal by Subject|2|||
27936036|NCT01207440|54592371|FG006|Overall Study|Withdrawal by Subject|0|||
27936037|NCT01207440|54592365|FG000|Overall Study|Reason Not Specified|10|||
27936038|NCT01207440|54592366|FG001|Overall Study|Reason Not Specified|10|||
27936039|NCT01207440|54592367|FG002|Overall Study|Reason Not Specified|7|||
27936040|NCT01207440|54592368|FG003|Overall Study|Reason Not Specified|0|||
27936041|NCT01207440|54592369|FG004|Overall Study|Reason Not Specified|4|||
27936042|NCT01207440|54592370|FG005|Overall Study|Reason Not Specified|3|||
27936043|NCT01207440|54592371|FG006|Overall Study|Reason Not Specified|0|||
27936044|NCT00990184|54592393|FG000|Overall Study|Physician Decision|1|||
27936045|NCT00986830|54592399|FG000|Overall Study|Death|1|||
27936046|NCT00986830|54592399|FG000|Overall Study|Lost to Follow-up|1|||
27936047|NCT00986830|54592399|FG000|Overall Study|Lack of Efficacy|1|||
27936048|NCT00986830|54592399|FG000|Overall Study|Unable to access sinus with device|5|||
27936049|NCT00990106|54592405|FG000|Overall Study|"too busy to continue"|1|||
27936050|NCT00990106|54592406|FG001|Overall Study|"too busy to continue"|2|||
27936051|NCT00990106|54592405|FG000|Overall Study|Lost to Follow-up|1|||
27936052|NCT00990106|54592406|FG001|Overall Study|Lost to Follow-up|3|||
27936053|NCT00990106|54592405|FG000|Overall Study|Withdrawal by Subject|2|||
27936054|NCT00990106|54592406|FG001|Overall Study|Withdrawal by Subject|1|||
27936055|NCT00990106|54592405|FG000|Overall Study|opted for open label prazosin|1|||
27936056|NCT00990106|54592406|FG001|Overall Study|opted for open label prazosin|1|||
27936057|NCT00990106|54592405|FG000|Overall Study|relocation/deployment|4|||
27936058|NCT00990106|54592406|FG001|Overall Study|relocation/deployment|1|||
27936059|NCT00990106|54592405|FG000|Overall Study|started exclusionary medication|0|||
27936060|NCT00990106|54592406|FG001|Overall Study|started exclusionary medication|1|||
27936061|NCT00990106|54592405|FG000|Overall Study|planned major surgery|0|||
27936062|NCT00990106|54592406|FG001|Overall Study|planned major surgery|1|||
27936063|NCT00990106|54592405|FG000|Overall Study|scheduling conflicts|0|||
27936064|NCT00990106|54592406|FG001|Overall Study|scheduling conflicts|2|||
27936065|NCT00983476|54592415|FG000|Overall Study|Did not receive intervention|17|||
27936066|NCT00983476|54592416|FG001|Overall Study|Did not receive intervention|22|||
27936067|NCT00983476|54592417|FG002|Overall Study|Did not receive intervention|0|||
27936068|NCT00982228|54592461|FG000|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12|||
27936069|NCT00982228|54592462|FG001|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2|||
27936070|NCT00982228|54592461|FG000|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2|||
27936071|NCT00982228|54592462|FG001|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0|||
27936072|NCT00982228|54592461|FG000|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11|||
27936073|NCT00982228|54592462|FG001|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2|||
27936074|NCT00982228|54592461|FG000|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15|||
27936075|NCT00982228|54592462|FG001|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3|||
27936076|NCT00982228|54592461|FG000|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28|||
27936077|NCT00982228|54592462|FG001|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13|||
27936078|NCT00982228|54592461|FG000|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3|||
27936079|NCT00982228|54592462|FG001|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2|||
27936080|NCT00982228|54592461|FG000|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1|||
27936081|NCT00982228|54592462|FG001|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0|||
27936082|NCT00982228|54592461|FG000|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1|||
27790683|NCT01577758|54245659|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
27790684|NCT01577758|54245660|FG004|Dose Escalation Phase|Symptomatic Deterioration|1|||
27790685|NCT01577758|54245661|FG005|Dose Escalation Phase|Symptomatic Deterioration|1|||
27936083|NCT00982228|54592462|FG001|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2|||
27936084|NCT00982228|54592461|FG000|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5|||
27936085|NCT00982228|54592462|FG001|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0|||
27936086|NCT00982228|54592461|FG000|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11|||
27936087|NCT00982228|54592462|FG001|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1|||
27936088|NCT01260350|54592488|FG000|Overall Study|Lack of Efficacy|0|||
27936089|NCT01260350|54592489|FG001|Overall Study|Lack of Efficacy|0|||
27936090|NCT01260350|54592490|FG002|Overall Study|Lack of Efficacy|0|||
27936091|NCT01260350|54592491|FG003|Overall Study|Lack of Efficacy|0|||
27936092|NCT01260350|54592492|FG004|Overall Study|Lack of Efficacy|0|||
27936093|NCT01260350|54592493|FG005|Overall Study|Lack of Efficacy|0|||
27936094|NCT01260350|54592494|FG006|Overall Study|Lack of Efficacy|0|||
27936095|NCT01260350|54592495|FG007|Overall Study|Lack of Efficacy|0|||
27936096|NCT01260350|54592496|FG008|Overall Study|Lack of Efficacy|0|||
27936097|NCT01260350|54592497|FG009|Overall Study|Lack of Efficacy|0|||
27936098|NCT01260350|54592498|FG010|Overall Study|Lack of Efficacy|0|||
27936099|NCT01260350|54592499|FG011|Overall Study|Lack of Efficacy|0|||
27936100|NCT01260350|54592500|FG012|Overall Study|Lack of Efficacy|0|||
27936101|NCT01260350|54592501|FG013|Overall Study|Lack of Efficacy|0|||
27936102|NCT01260350|54592502|FG014|Overall Study|Lack of Efficacy|0|||
27936103|NCT01260350|54592503|FG015|Overall Study|Lack of Efficacy|0|||
27936104|NCT01260350|54592504|FG016|Overall Study|Lack of Efficacy|0|||
27936105|NCT01260350|54592505|FG017|Overall Study|Lack of Efficacy|1|||
27936106|NCT01260350|54592506|FG018|Overall Study|Lack of Efficacy|0|||
27936107|NCT01260350|54592507|FG019|Overall Study|Lack of Efficacy|0|||
27790686|NCT01577758|54245662|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
27790687|NCT01577758|54245663|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
27790688|NCT01577758|54245656|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
27790689|NCT01577758|54245657|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
27790690|NCT01577758|54245658|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
27790691|NCT01577758|54245659|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
27790692|NCT01577758|54245660|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
27790693|NCT01577758|54245661|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
27790694|NCT01577758|54245662|FG006|Dose Escalation Phase|Withdrawal by Subject|0|||
27790695|NCT01577758|54245663|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
27790696|NCT01577758|54245656|FG000|Dose Escalation Phase|Progression Disease|2|||
27790697|NCT01577758|54245657|FG001|Dose Escalation Phase|Progression Disease|2|||
27790698|NCT01577758|54245658|FG002|Dose Escalation Phase|Progression Disease|1|||
27790699|NCT01577758|54245659|FG003|Dose Escalation Phase|Progression Disease|2|||
27790700|NCT01577758|54245660|FG004|Dose Escalation Phase|Progression Disease|5|||
27790701|NCT01577758|54245661|FG005|Dose Escalation Phase|Progression Disease|0|||
27790702|NCT01577758|54245662|FG006|Dose Escalation Phase|Progression Disease|0|||
27790703|NCT01577758|54245663|FG007|Dose Escalation Phase|Progression Disease|0|||
27790704|NCT01577758|54245656|FG000|mCRC Expansion Phase|Symptomatic Deterioration|0|||
27790705|NCT01577758|54245657|FG001|mCRC Expansion Phase|Symptomatic Deterioration|0|||
27790706|NCT01577758|54245658|FG002|mCRC Expansion Phase|Symptomatic Deterioration|0|||
27790707|NCT01577758|54245659|FG003|mCRC Expansion Phase|Symptomatic Deterioration|0|||
27790708|NCT01577758|54245660|FG004|mCRC Expansion Phase|Symptomatic Deterioration|0|||
27790709|NCT01577758|54245661|FG005|mCRC Expansion Phase|Symptomatic Deterioration|0|||
27790710|NCT01577758|54245662|FG006|mCRC Expansion Phase|Symptomatic Deterioration|0|||
27790711|NCT01577758|54245663|FG007|mCRC Expansion Phase|Symptomatic Deterioration|4|||
27790712|NCT01577758|54245656|FG000|mCRC Expansion Phase|Withdrawal by Subject|0|||
27790713|NCT01577758|54245657|FG001|mCRC Expansion Phase|Withdrawal by Subject|0|||
27790714|NCT01577758|54245658|FG002|mCRC Expansion Phase|Withdrawal by Subject|0|||
27790715|NCT01577758|54245659|FG003|mCRC Expansion Phase|Withdrawal by Subject|0|||
27790716|NCT01577758|54245660|FG004|mCRC Expansion Phase|Withdrawal by Subject|0|||
27790717|NCT01577758|54245661|FG005|mCRC Expansion Phase|Withdrawal by Subject|0|||
27790718|NCT01577758|54245662|FG006|mCRC Expansion Phase|Withdrawal by Subject|0|||
27790719|NCT01577758|54245663|FG007|mCRC Expansion Phase|Withdrawal by Subject|2|||
27790720|NCT01577758|54245656|FG000|mCRC Expansion Phase|Progression Disease|0|||
27790721|NCT01577758|54245657|FG001|mCRC Expansion Phase|Progression Disease|0|||
27790722|NCT01577758|54245658|FG002|mCRC Expansion Phase|Progression Disease|0|||
27790723|NCT01577758|54245659|FG003|mCRC Expansion Phase|Progression Disease|0|||
27790724|NCT01577758|54245660|FG004|mCRC Expansion Phase|Progression Disease|0|||
27790725|NCT01577758|54245661|FG005|mCRC Expansion Phase|Progression Disease|0|||
27790726|NCT01577758|54245662|FG006|mCRC Expansion Phase|Progression Disease|0|||
27790727|NCT01577758|54245663|FG007|mCRC Expansion Phase|Progression Disease|19|||
27790728|NCT01537432|54245685|FG000|Overall Study|Lost to Follow-up|3|||
27790729|NCT01537432|54245686|FG001|Overall Study|Lost to Follow-up|1|||
27936108|NCT01260350|54592508|FG020|Overall Study|Lack of Efficacy|3|||
27790730|NCT01537432|54245685|FG000|Overall Study|Withdrawal by Subject|0|||
27790731|NCT01537432|54245686|FG001|Overall Study|Withdrawal by Subject|1|||
27790732|NCT01537432|54245685|FG000|Overall Study|Administrative problems|1|||
27790733|NCT01537432|54245686|FG001|Overall Study|Administrative problems|0|||
27790734|NCT01537432|54245685|FG000|Overall Study|Adverse Event|1|||
27790735|NCT01537432|54245686|FG001|Overall Study|Adverse Event|0|||
27790736|NCT01537432|54245685|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
27936109|NCT01260350|54592509|FG021|Overall Study|Lack of Efficacy|0|||
27790737|NCT01537432|54245686|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
27790738|NCT01537198|54245692|FG000|Overall Study|RSV infection|2|||
27936110|NCT01260350|54592488|FG000|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
27790739|NCT01537198|54245692|FG000|Overall Study|Adverse Event|4|||
27790740|NCT01537198|54245692|FG000|Overall Study|No Further Visits to the Clinic|37|||
27790741|NCT01537198|54245692|FG000|Overall Study|Other|111|||
27790742|NCT01537120|54245696|FG000|8 Weeks Washout|Inclusion/exclusion criteria not met|1|||
27790743|NCT01537120|54245696|FG000|3 Weeks Placebo|Withdrawal by Subject|1|||
27790744|NCT01537042|54245704|FG000|Overall Study|Adverse Event|0|||
27790745|NCT01537042|54245705|FG001|Overall Study|Adverse Event|2|||
27790746|NCT01537042|54245704|FG000|Overall Study|Lack of Efficacy|0|||
27790747|NCT01537042|54245705|FG001|Overall Study|Lack of Efficacy|1|||
27790748|NCT01537042|54245704|FG000|Overall Study|Protocol Violation|0|||
27790749|NCT01537042|54245705|FG001|Overall Study|Protocol Violation|1|||
27790750|NCT01537042|54245704|FG000|Overall Study|Other|0|||
27790751|NCT01537042|54245705|FG001|Overall Study|Other|1|||
27790752|NCT01536574|54245726|FG000|Overall Study|Adverse Event|4|||
27790753|NCT01536574|54245727|FG001|Overall Study|Adverse Event|5|||
27790754|NCT01536574|54245726|FG000|Overall Study|Withdrawal by Subject|1|||
27790755|NCT01536574|54245727|FG001|Overall Study|Withdrawal by Subject|2|||
27790756|NCT01536574|54245726|FG000|Overall Study|Lack of Efficacy|1|||
27790757|NCT01536574|54245727|FG001|Overall Study|Lack of Efficacy|0|||
27790758|NCT01536418|54245735|FG000|Overall Study|Protocol Violation|2|||
27790759|NCT01536418|54245736|FG001|Overall Study|Protocol Violation|3|||
27790760|NCT01536418|54245735|FG000|Overall Study|Physician Decision|1|||
27790761|NCT01536418|54245736|FG001|Overall Study|Physician Decision|3|||
27790762|NCT01536418|54245735|FG000|Overall Study|Study closed/terminated|41|||
27790763|NCT01536418|54245736|FG001|Overall Study|Study closed/terminated|37|||
27790764|NCT01536418|54245735|FG000|Overall Study|Lack of Efficacy|10|||
27790765|NCT01536418|54245736|FG001|Overall Study|Lack of Efficacy|16|||
27790766|NCT01536418|54245735|FG000|Overall Study|Adverse Event|9|||
27936111|NCT01260350|54592489|FG001|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
27936112|NCT01260350|54592490|FG002|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
27936113|NCT01260350|54592491|FG003|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
27936114|NCT01260350|54592492|FG004|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
27936115|NCT01260350|54592493|FG005|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
27936116|NCT01260350|54592494|FG006|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
27936117|NCT01260350|54592495|FG007|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
27936118|NCT01260350|54592496|FG008|Overall Study|Did Not Complete Follow-up 12 Visit|1|||
27936119|NCT01260350|54592497|FG009|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
27936120|NCT01260350|54592498|FG010|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
27936121|NCT01260350|54592499|FG011|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
27936122|NCT01260350|54592500|FG012|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
27790767|NCT01536418|54245736|FG001|Overall Study|Adverse Event|4|||
27790768|NCT01536418|54245735|FG000|Overall Study|Met Liver Chemistry Stopping criteria|1|||
27790769|NCT01536418|54245736|FG001|Overall Study|Met Liver Chemistry Stopping criteria|0|||
27790770|NCT01536418|54245735|FG000|Overall Study|Withdrawal by Subject|5|||
27936123|NCT01260350|54592501|FG013|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
27936124|NCT01260350|54592502|FG014|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
27936125|NCT01260350|54592503|FG015|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
27936126|NCT01260350|54592504|FG016|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
27936127|NCT01260350|54592505|FG017|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
27936128|NCT01260350|54592506|FG018|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
27936129|NCT01260350|54592507|FG019|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
27936130|NCT01260350|54592508|FG020|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
27790771|NCT01536418|54245736|FG001|Overall Study|Withdrawal by Subject|3|||
27790772|NCT01576042|54245745|FG000|Overall Study|Physician Decision|2|||
27790773|NCT01576042|54245746|FG001|Overall Study|Physician Decision|0|||
27790774|NCT01561300|54245752|FG000|Run in on Placebo|Adverse Event|1|||
27790775|NCT01561300|54245753|FG001|Run in on Placebo|Adverse Event|0|||
27790776|NCT01536262|54245763|FG000|Overall Study|Adverse Event|6|||
27790777|NCT01536262|54245764|FG001|Overall Study|Adverse Event|1|||
27790778|NCT01536262|54245765|FG002|Overall Study|Adverse Event|2|||
27790779|NCT01536262|54245763|FG000|Overall Study|Withdrawal by Subject|1|||
27790780|NCT01536262|54245764|FG001|Overall Study|Withdrawal by Subject|1|||
27790781|NCT01536262|54245765|FG002|Overall Study|Withdrawal by Subject|0|||
27842524|NCT01550744|54331107|FG001|Open-Label|Protocol Violation|0|||
27936131|NCT01260350|54592509|FG021|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
27790782|NCT01536262|54245763|FG000|Overall Study|Other than stated above|1|||
27790783|NCT01536262|54245764|FG001|Overall Study|Other than stated above|0|||
27790784|NCT01536262|54245765|FG002|Overall Study|Other than stated above|0|||
27790785|NCT01560988|54245774|FG000|First Intervention (Six Weeks)|Lost to Follow-up|7|||
27936132|NCT01260194|54592563|FG000|Overall Study|Withdrawal of Consent|1|||
27936133|NCT01259726|54592571|FG000|Overall Study|Death|1|||
27936134|NCT01259726|54592572|FG001|Overall Study|Death|0|||
27936135|NCT01259726|54592573|FG002|Overall Study|Death|0|||
27790786|NCT01560988|54245775|FG001|First Intervention (Six Weeks)|Lost to Follow-up|4|||
27790787|NCT01560988|54245774|FG000|First Intervention (Six Weeks)|Withdrawal by Subject|3|||
27842525|NCT01550744|54331108|FG002|Open-Label|Protocol Violation|0|||
27790788|NCT01560988|54245775|FG001|First Intervention (Six Weeks)|Withdrawal by Subject|0|||
27790789|NCT01560988|54245774|FG000|Washout (Six Weeks)|Lost to Follow-up|2|||
27790790|NCT01560988|54245775|FG001|Washout (Six Weeks)|Lost to Follow-up|2|||
27790791|NCT01535638|54245786|FG000|Treatment 1 (Single Dose)|Protocol Violation|0|||
27790792|NCT01535638|54245787|FG001|Treatment 1 (Single Dose)|Protocol Violation|0|||
27790793|NCT01535638|54245788|FG002|Treatment 1 (Single Dose)|Protocol Violation|0|||
27790794|NCT01535638|54245789|FG003|Treatment 1 (Single Dose)|Protocol Violation|0|||
27790795|NCT01535638|54245790|FG004|Treatment 1 (Single Dose)|Protocol Violation|0|||
27790796|NCT01535638|54245791|FG005|Treatment 1 (Single Dose)|Protocol Violation|1|||
27790797|NCT01535638|54245786|FG000|Treatment 3 (Single Dose)|Protocol Violation|0|||
27790798|NCT01535638|54245787|FG001|Treatment 3 (Single Dose)|Protocol Violation|0|||
27790799|NCT01535638|54245788|FG002|Treatment 3 (Single Dose)|Protocol Violation|0|||
27790800|NCT01535638|54245789|FG003|Treatment 3 (Single Dose)|Protocol Violation|1|||
27790801|NCT01535638|54245790|FG004|Treatment 3 (Single Dose)|Protocol Violation|0|||
27790802|NCT01535638|54245791|FG005|Treatment 3 (Single Dose)|Protocol Violation|0|||
27790803|NCT01535560|54245802|FG000|Overall Study|Adverse Event|12|||
27790804|NCT01535560|54245803|FG001|Overall Study|Adverse Event|7|||
27790805|NCT01535560|54245802|FG000|Overall Study|Lost to Follow-up|1|||
27790806|NCT01535560|54245803|FG001|Overall Study|Lost to Follow-up|3|||
27790807|NCT01535560|54245802|FG000|Overall Study|Subj Decision Unrel to an Adverse Event|3|||
27790808|NCT01535560|54245803|FG001|Overall Study|Subj Decision Unrel to an Adverse Event|1|||
27790809|NCT01535560|54245802|FG000|Overall Study|Treatment Failure|21|||
27790810|NCT01535560|54245803|FG001|Overall Study|Treatment Failure|83|||
27790811|NCT01535560|54245802|FG000|Overall Study|Other|0|||
27790812|NCT01535560|54245803|FG001|Overall Study|Other|1|||
27790813|NCT01535560|54245802|FG000|Overall Study|Randomized in Error|0|||
27790814|NCT01535560|54245803|FG001|Overall Study|Randomized in Error|1|||
27936136|NCT01259726|54592574|FG003|Overall Study|Death|0|||
27936137|NCT01259726|54592571|FG000|Overall Study|Physician Decision|2|||
27936138|NCT01259726|54592572|FG001|Overall Study|Physician Decision|0|||
27936139|NCT01259726|54592573|FG002|Overall Study|Physician Decision|1|||
27936140|NCT01259726|54592574|FG003|Overall Study|Physician Decision|1|||
27936141|NCT01259726|54592571|FG000|Overall Study|Withdrawal by Subject|1|||
27936142|NCT01259726|54592572|FG001|Overall Study|Withdrawal by Subject|3|||
27936143|NCT01259726|54592573|FG002|Overall Study|Withdrawal by Subject|2|||
27936144|NCT01259726|54592574|FG003|Overall Study|Withdrawal by Subject|1|||
27936145|NCT01259726|54592571|FG000|Overall Study|Lost to Follow-up|1|||
27790815|NCT01575028|54245811|FG000|Overall Study|Physician Decision|0|||
27790816|NCT01575028|54245812|FG001|Overall Study|Physician Decision|1|||
27790817|NCT03576131|54245826|FG000|Overall Study|Investigator decision|0|||
27790818|NCT03576131|54245827|FG001|Overall Study|Investigator decision|0|||
27790819|NCT03576131|54245828|FG002|Overall Study|Investigator decision|0|||
27790820|NCT03576131|54245829|FG003|Overall Study|Investigator decision|1|||
27790821|NCT03576131|54245830|FG004|Overall Study|Investigator decision|0|||
27790822|NCT03576131|54245831|FG005|Overall Study|Investigator decision|1|||
27790823|NCT03576131|54245832|FG006|Overall Study|Investigator decision|0|||
27790824|NCT03576131|54245833|FG007|Overall Study|Investigator decision|0|||
27790825|NCT03576131|54245826|FG000|Overall Study|Withdrawal by Subject|1|||
27790826|NCT03576131|54245827|FG001|Overall Study|Withdrawal by Subject|1|||
27790827|NCT03576131|54245828|FG002|Overall Study|Withdrawal by Subject|0|||
27790828|NCT03576131|54245829|FG003|Overall Study|Withdrawal by Subject|1|||
27790829|NCT03576131|54245830|FG004|Overall Study|Withdrawal by Subject|2|||
27790830|NCT03576131|54245831|FG005|Overall Study|Withdrawal by Subject|3|||
27790831|NCT03576131|54245832|FG006|Overall Study|Withdrawal by Subject|1|||
27790832|NCT03576131|54245833|FG007|Overall Study|Withdrawal by Subject|0|||
27790833|NCT03576131|54245826|FG000|Overall Study|Death|3|||
27790834|NCT03576131|54245827|FG001|Overall Study|Death|3|||
27790835|NCT03576131|54245828|FG002|Overall Study|Death|1|||
27790836|NCT03576131|54245829|FG003|Overall Study|Death|5|||
27790837|NCT03576131|54245830|FG004|Overall Study|Death|4|||
27790838|NCT03576131|54245831|FG005|Overall Study|Death|1|||
27936146|NCT01259726|54592572|FG001|Overall Study|Lost to Follow-up|1|||
27790839|NCT03576131|54245832|FG006|Overall Study|Death|0|||
27936147|NCT01259726|54592573|FG002|Overall Study|Lost to Follow-up|1|||
27790840|NCT03576131|54245833|FG007|Overall Study|Death|1|||
27790841|NCT03576131|54245826|FG000|Overall Study|New anti-cancer treatment|5|||
27790842|NCT03576131|54245827|FG001|Overall Study|New anti-cancer treatment|1|||
27790843|NCT03576131|54245828|FG002|Overall Study|New anti-cancer treatment|2|||
27936148|NCT01259726|54592574|FG003|Overall Study|Lost to Follow-up|3|||
27936149|NCT01259492|54592588|FG000|Period 1 (9 Weeks)|Adverse Event|13|||
28017110|NCT00681668|54676367|FG000|Overall Study|Withdrawal by Subject|1|||
27790844|NCT03576131|54245829|FG003|Overall Study|New anti-cancer treatment|3|||
27790845|NCT03576131|54245830|FG004|Overall Study|New anti-cancer treatment|0|||
27790846|NCT03576131|54245831|FG005|Overall Study|New anti-cancer treatment|0|||
27790847|NCT03576131|54245832|FG006|Overall Study|New anti-cancer treatment|0|||
27790848|NCT03576131|54245833|FG007|Overall Study|New anti-cancer treatment|0|||
27790849|NCT03576131|54245826|FG000|Overall Study|Unspecified reason|0|||
27790850|NCT03576131|54245827|FG001|Overall Study|Unspecified reason|0|||
27790851|NCT03576131|54245828|FG002|Overall Study|Unspecified reason|1|||
27790852|NCT03576131|54245829|FG003|Overall Study|Unspecified reason|1|||
27790853|NCT03576131|54245830|FG004|Overall Study|Unspecified reason|1|||
27790854|NCT03576131|54245831|FG005|Overall Study|Unspecified reason|1|||
27790855|NCT03576131|54245832|FG006|Overall Study|Unspecified reason|0|||
27790856|NCT03576131|54245833|FG007|Overall Study|Unspecified reason|0|||
27790857|NCT03576131|54245826|FG000|Overall Study|Subject non-compliance|0|||
27790858|NCT03576131|54245827|FG001|Overall Study|Subject non-compliance|0|||
27790859|NCT03576131|54245828|FG002|Overall Study|Subject non-compliance|0|||
27790860|NCT03576131|54245829|FG003|Overall Study|Subject non-compliance|0|||
27936150|NCT01259492|54592589|FG001|Period 1 (9 Weeks)|Adverse Event|18|||
27936151|NCT01259492|54592590|FG002|Period 1 (9 Weeks)|Adverse Event|26|||
27936152|NCT01259492|54592591|FG003|Period 1 (9 Weeks)|Adverse Event|3|||
27936153|NCT01259492|54592588|FG000|Period 1 (9 Weeks)|Lack of Efficacy|2|||
27936154|NCT01259492|54592589|FG001|Period 1 (9 Weeks)|Lack of Efficacy|2|||
27936155|NCT01259492|54592590|FG002|Period 1 (9 Weeks)|Lack of Efficacy|4|||
27936156|NCT01259492|54592591|FG003|Period 1 (9 Weeks)|Lack of Efficacy|11|||
27936157|NCT01259492|54592588|FG000|Period 1 (9 Weeks)|Withdrawal by Subject|5|||
27936158|NCT01259492|54592589|FG001|Period 1 (9 Weeks)|Withdrawal by Subject|8|||
27936159|NCT01259492|54592590|FG002|Period 1 (9 Weeks)|Withdrawal by Subject|6|||
27936160|NCT01259492|54592591|FG003|Period 1 (9 Weeks)|Withdrawal by Subject|7|||
27936161|NCT01259492|54592588|FG000|Period 1 (9 Weeks)|Lost to Follow-up|4|||
27936162|NCT01259492|54592589|FG001|Period 1 (9 Weeks)|Lost to Follow-up|6|||
27936163|NCT01259492|54592590|FG002|Period 1 (9 Weeks)|Lost to Follow-up|3|||
27936164|NCT01259492|54592591|FG003|Period 1 (9 Weeks)|Lost to Follow-up|4|||
27936165|NCT01259492|54592588|FG000|Period 1 (9 Weeks)|Administrative Problems|0|||
27790861|NCT03576131|54245830|FG004|Overall Study|Subject non-compliance|0|||
27790862|NCT03576131|54245831|FG005|Overall Study|Subject non-compliance|1|||
27790863|NCT03576131|54245832|FG006|Overall Study|Subject non-compliance|0|||
27790864|NCT03576131|54245833|FG007|Overall Study|Subject non-compliance|0|||
27790865|NCT01574716|54245865|FG000|Part 1|Death|3|||
27790866|NCT01574716|54245866|FG001|Part 1|Death|1|||
27790867|NCT01574716|54245867|FG002|Part 1|Death|8|||
27790868|NCT01574716|54245868|FG003|Part 1|Death|0|||
27790869|NCT01574716|54245869|FG004|Part 1|Death|0|||
27790870|NCT01574716|54245865|FG000|Part 1|Discontinuation of study by sponsor|0|||
27790871|NCT01574716|54245866|FG001|Part 1|Discontinuation of study by sponsor|0|||
27790872|NCT01574716|54245867|FG002|Part 1|Discontinuation of study by sponsor|1|||
27790873|NCT01574716|54245868|FG003|Part 1|Discontinuation of study by sponsor|0|||
27790874|NCT01574716|54245869|FG004|Part 1|Discontinuation of study by sponsor|0|||
27790875|NCT01574716|54245865|FG000|Part 1|Withdrawal by Subject|0|||
27790876|NCT01574716|54245866|FG001|Part 1|Withdrawal by Subject|2|||
27790877|NCT01574716|54245867|FG002|Part 1|Withdrawal by Subject|0|||
27936166|NCT01259492|54592589|FG001|Period 1 (9 Weeks)|Administrative Problems|1|||
27936167|NCT01259492|54592590|FG002|Period 1 (9 Weeks)|Administrative Problems|1|||
27936168|NCT01259492|54592591|FG003|Period 1 (9 Weeks)|Administrative Problems|2|||
27936169|NCT01259492|54592588|FG000|Period 1 (9 Weeks)|Protocol Violation|5|||
27936170|NCT01259492|54592589|FG001|Period 1 (9 Weeks)|Protocol Violation|6|||
27936171|NCT01259492|54592590|FG002|Period 1 (9 Weeks)|Protocol Violation|3|||
27936172|NCT01259492|54592591|FG003|Period 1 (9 Weeks)|Protocol Violation|1|||
27936173|NCT01259492|54592588|FG000|Period 2 (Week 10 to Week 14)|Adverse Event|3|||
27936174|NCT01259492|54592589|FG001|Period 2 (Week 10 to Week 14)|Adverse Event|4|||
27936175|NCT01259492|54592590|FG002|Period 2 (Week 10 to Week 14)|Adverse Event|7|||
27936176|NCT01259492|54592591|FG003|Period 2 (Week 10 to Week 14)|Adverse Event|8|||
27936177|NCT01259492|54592588|FG000|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
27936178|NCT01259492|54592589|FG001|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
27936179|NCT01259492|54592590|FG002|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
27936180|NCT01259492|54592591|FG003|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
27790878|NCT01574716|54245868|FG003|Part 1|Withdrawal by Subject|0|||
27790879|NCT01574716|54245869|FG004|Part 1|Withdrawal by Subject|0|||
27790880|NCT01574716|54245865|FG000|Part 1|Lost to Follow-up|0|||
27936181|NCT01259492|54592588|FG000|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6|||
27936182|NCT01259492|54592589|FG001|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2|||
27936183|NCT01259492|54592590|FG002|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8|||
27936184|NCT01259492|54592591|FG003|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4|||
27936185|NCT01259492|54592588|FG000|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
27790881|NCT01574716|54245866|FG001|Part 1|Lost to Follow-up|1|||
27790882|NCT01574716|54245867|FG002|Part 1|Lost to Follow-up|0|||
27790883|NCT01574716|54245868|FG003|Part 1|Lost to Follow-up|0|||
27790884|NCT01574716|54245869|FG004|Part 1|Lost to Follow-up|0|||
27790885|NCT01574716|54245865|FG000|Part 2|Progressive disease|0|||
27790886|NCT01574716|54245866|FG001|Part 2|Progressive disease|0|||
27790887|NCT01574716|54245867|FG002|Part 2|Progressive disease|0|||
27790888|NCT01574716|54245868|FG003|Part 2|Progressive disease|1|||
27790889|NCT01574716|54245869|FG004|Part 2|Progressive disease|0|||
27790890|NCT01574716|54245865|FG000|Part 2|Death|0|||
27790891|NCT01574716|54245866|FG001|Part 2|Death|0|||
27790892|NCT01574716|54245867|FG002|Part 2|Death|0|||
27936186|NCT01259492|54592589|FG001|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
27936187|NCT01259492|54592590|FG002|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1|||
27936188|NCT01259492|54592591|FG003|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
27936189|NCT01259492|54592588|FG000|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
27936190|NCT01259492|54592589|FG001|Period 2 (Week 10 to Week 14)|Protocol Violation|2|||
27936191|NCT01259492|54592590|FG002|Period 2 (Week 10 to Week 14)|Protocol Violation|1|||
27936192|NCT01259492|54592591|FG003|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
27936193|NCT01259492|54592588|FG000|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
27936194|NCT01259492|54592589|FG001|Period 3 (Week 15 to End of Week 40)|Adverse Event|11|||
27936195|NCT01259492|54592590|FG002|Period 3 (Week 15 to End of Week 40)|Adverse Event|6|||
27936196|NCT01259492|54592591|FG003|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
27936197|NCT01259492|54592588|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
27936198|NCT01259492|54592589|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
27936199|NCT01259492|54592590|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
27936200|NCT01259492|54592591|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1|||
27790893|NCT01574716|54245868|FG003|Part 2|Death|76|||
27790894|NCT01574716|54245869|FG004|Part 2|Death|35|||
27790895|NCT01574716|54245865|FG000|Part 2|Discontinuation of study by sponsor|0|||
27936201|NCT01259492|54592588|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
27936202|NCT01259492|54592589|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
27936203|NCT01259492|54592590|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1|||
27936204|NCT01259492|54592591|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
27936205|NCT01259492|54592588|FG000|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28|||
27936206|NCT01259492|54592589|FG001|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42|||
27936207|NCT01259492|54592590|FG002|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29|||
27936208|NCT01259492|54592591|FG003|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62|||
27936209|NCT01259492|54592588|FG000|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1|||
27936210|NCT01259492|54592589|FG001|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
27936211|NCT01259492|54592590|FG002|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
27936212|NCT01259492|54592591|FG003|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
27936213|NCT01259492|54592588|FG000|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12|||
27936214|NCT01259492|54592589|FG001|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6|||
27936215|NCT01259492|54592590|FG002|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4|||
27936216|NCT01259492|54592591|FG003|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3|||
27936217|NCT01259492|54592588|FG000|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
27936218|NCT01259492|54592589|FG001|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4|||
27936219|NCT01259492|54592590|FG002|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6|||
27936220|NCT01259492|54592591|FG003|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
27936221|NCT01259492|54592588|FG000|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
27936222|NCT01259492|54592589|FG001|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
27936223|NCT01259492|54592590|FG002|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1|||
27936224|NCT01259492|54592591|FG003|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
27936225|NCT01259492|54592588|FG000|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5|||
27790896|NCT01574716|54245866|FG001|Part 2|Discontinuation of study by sponsor|0|||
27790897|NCT01574716|54245867|FG002|Part 2|Discontinuation of study by sponsor|0|||
27790898|NCT01574716|54245868|FG003|Part 2|Discontinuation of study by sponsor|51|||
27790899|NCT01574716|54245869|FG004|Part 2|Discontinuation of study by sponsor|31|||
27790900|NCT01574716|54245865|FG000|Part 2|Withdrawal by Subject|0|||
27790901|NCT01574716|54245866|FG001|Part 2|Withdrawal by Subject|0|||
27790902|NCT01574716|54245867|FG002|Part 2|Withdrawal by Subject|0|||
27790903|NCT01574716|54245868|FG003|Part 2|Withdrawal by Subject|5|||
27790904|NCT01574716|54245869|FG004|Part 2|Withdrawal by Subject|4|||
27790905|NCT01574716|54245865|FG000|Part 2|Brain metastases|0|||
27790906|NCT01574716|54245866|FG001|Part 2|Brain metastases|0|||
27790907|NCT01574716|54245867|FG002|Part 2|Brain metastases|0|||
27936226|NCT01259492|54592589|FG001|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6|||
27936227|NCT01259492|54592590|FG002|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3|||
27936228|NCT01259492|54592591|FG003|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7|||
27936229|NCT01117623|54592608|FG000|Overall Study|Adverse Event|0|||
27790908|NCT01574716|54245868|FG003|Part 2|Brain metastases|1|||
27790909|NCT01574716|54245869|FG004|Part 2|Brain metastases|0|||
27790910|NCT01574716|54245865|FG000|Part 2|Lost to Follow-up|0|||
27790911|NCT01574716|54245866|FG001|Part 2|Lost to Follow-up|0|||
27790912|NCT01574716|54245867|FG002|Part 2|Lost to Follow-up|0|||
27790913|NCT01574716|54245868|FG003|Part 2|Lost to Follow-up|3|||
27790914|NCT01574716|54245869|FG004|Part 2|Lost to Follow-up|0|||
27790915|NCT02161562|54245880|FG000|Overall Study|Withdrawal by Subject|5|||
27790916|NCT02161562|54245881|FG001|Overall Study|Withdrawal by Subject|8|||
27790917|NCT02161562|54245880|FG000|Overall Study|Protocol Violation|9|||
27790918|NCT02161562|54245881|FG001|Overall Study|Protocol Violation|4|||
27790919|NCT02161562|54245880|FG000|Overall Study|Pregnancy|1|||
27790920|NCT02161562|54245881|FG001|Overall Study|Pregnancy|2|||
27790921|NCT02161562|54245880|FG000|Overall Study|Lost to Follow-up|3|||
27790922|NCT02161562|54245881|FG001|Overall Study|Lost to Follow-up|1|||
27790923|NCT02161562|54245880|FG000|Overall Study|Lack of Efficacy|4|||
27790924|NCT02161562|54245881|FG001|Overall Study|Lack of Efficacy|1|||
27790925|NCT02161562|54245880|FG000|Overall Study|Adverse Event|1|||
27790926|NCT02161562|54245881|FG001|Overall Study|Adverse Event|1|||
27790927|NCT02161562|54245880|FG000|Overall Study|Participant moved back to home country|1|||
27790928|NCT02161562|54245881|FG001|Overall Study|Participant moved back to home country|0|||
27790929|NCT02161562|54245880|FG000|Overall Study|Withdrew due to being out of the country|1|||
27790930|NCT02161562|54245881|FG001|Overall Study|Withdrew due to being out of the country|0|||
27790931|NCT02161562|54245880|FG000|Overall Study|Participant moved out of province|1|||
27790932|NCT02161562|54245881|FG001|Overall Study|Participant moved out of province|0|||
27790933|NCT01559116|54245900|FG000|Overall Study|Adverse Event|10|||
27790934|NCT01559116|54245900|FG000|Overall Study|Lack of Efficacy|1|||
27936230|NCT01117623|54592609|FG001|Overall Study|Adverse Event|2|||
27936231|NCT01117623|54592610|FG002|Overall Study|Adverse Event|4|||
27936232|NCT01117623|54592611|FG003|Overall Study|Adverse Event|0|||
27936233|NCT01117623|54592612|FG004|Overall Study|Adverse Event|2|||
27936234|NCT01117623|54592613|FG005|Overall Study|Adverse Event|0|||
27936235|NCT01117623|54592614|FG006|Overall Study|Adverse Event|0|||
27936236|NCT01117623|54592615|FG007|Overall Study|Adverse Event|2|||
27936237|NCT01117623|54592608|FG000|Overall Study|Disease progression, recurrence, relapse|3|||
27936238|NCT01117623|54592609|FG001|Overall Study|Disease progression, recurrence, relapse|6|||
27936239|NCT01117623|54592610|FG002|Overall Study|Disease progression, recurrence, relapse|5|||
27936240|NCT01117623|54592611|FG003|Overall Study|Disease progression, recurrence, relapse|6|||
27936241|NCT01117623|54592612|FG004|Overall Study|Disease progression, recurrence, relapse|8|||
27936242|NCT01117623|54592613|FG005|Overall Study|Disease progression, recurrence, relapse|14|||
27936243|NCT01117623|54592614|FG006|Overall Study|Disease progression, recurrence, relapse|5|||
27936244|NCT01117623|54592615|FG007|Overall Study|Disease progression, recurrence, relapse|22|||
27936245|NCT01117623|54592608|FG000|Overall Study|Withdrawal by Subject|0|||
27936246|NCT01117623|54592609|FG001|Overall Study|Withdrawal by Subject|0|||
27936247|NCT01117623|54592610|FG002|Overall Study|Withdrawal by Subject|2|||
27936248|NCT01117623|54592611|FG003|Overall Study|Withdrawal by Subject|0|||
27936249|NCT01117623|54592612|FG004|Overall Study|Withdrawal by Subject|0|||
27936250|NCT01117623|54592613|FG005|Overall Study|Withdrawal by Subject|1|||
27936251|NCT01117623|54592614|FG006|Overall Study|Withdrawal by Subject|1|||
27936252|NCT01117623|54592615|FG007|Overall Study|Withdrawal by Subject|1|||
27936253|NCT01117623|54592608|FG000|Overall Study|Non-compliance with study medication|0|||
27936254|NCT01117623|54592609|FG001|Overall Study|Non-compliance with study medication|0|||
27936255|NCT01117623|54592610|FG002|Overall Study|Non-compliance with study medication|0|||
27936256|NCT01117623|54592611|FG003|Overall Study|Non-compliance with study medication|0|||
27936257|NCT01117623|54592612|FG004|Overall Study|Non-compliance with study medication|0|||
27936258|NCT01117623|54592613|FG005|Overall Study|Non-compliance with study medication|0|||
27936259|NCT01117623|54592614|FG006|Overall Study|Non-compliance with study medication|0|||
27790935|NCT01559116|54245900|FG000|Overall Study|Lost to Follow-up|1|||
27790936|NCT01559116|54245900|FG000|Overall Study|Protocol Violation|1|||
27790937|NCT01559116|54245900|FG000|Overall Study|Withdrawal by Subject|4|||
27790938|NCT01559116|54245900|FG000|Overall Study|other than stated above|9|||
27790939|NCT01574326|54245919|FG000|Overall Study|Randomized but not treated|0|||
27790940|NCT01574326|54245920|FG001|Overall Study|Randomized but not treated|1|||
27936260|NCT01117623|54592615|FG007|Overall Study|Non-compliance with study medication|1|||
27936261|NCT01117623|54592608|FG000|Overall Study|Invest. text: completed all planned txs|0|||
27936262|NCT01117623|54592609|FG001|Overall Study|Invest. text: completed all planned txs|0|||
27936263|NCT01117623|54592610|FG002|Overall Study|Invest. text: completed all planned txs|0|||
27936264|NCT01117623|54592611|FG003|Overall Study|Invest. text: completed all planned txs|0|||
27936265|NCT01117623|54592612|FG004|Overall Study|Invest. text: completed all planned txs|0|||
27936266|NCT01117623|54592613|FG005|Overall Study|Invest. text: completed all planned txs|1|||
27936267|NCT01117623|54592614|FG006|Overall Study|Invest. text: completed all planned txs|0|||
27936268|NCT01117623|54592615|FG007|Overall Study|Invest. text: completed all planned txs|0|||
27936269|NCT01116687|54592635|FG000|Overall Study|Withdrawal by Subject|4|||
27936270|NCT01114737|54592641|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
27936271|NCT01114737|54592642|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
27936272|NCT01114737|54592641|FG000|Randomized Treatment Period|Lost to Follow-up|1|||
27936273|NCT01114737|54592642|FG001|Randomized Treatment Period|Lost to Follow-up|1|||
27936274|NCT01114737|54592641|FG000|Randomized Treatment Period|Pregnancy|1|||
27936275|NCT01114737|54592642|FG001|Randomized Treatment Period|Pregnancy|0|||
27936276|NCT01114737|54592641|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
27936277|NCT01114737|54592642|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
27936278|NCT01114737|54592641|FG000|Open-Label Treatment Period|Lost to Follow-up|3|||
27936279|NCT01114737|54592642|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
27936280|NCT01114737|54592641|FG000|Open-Label Treatment Period|Difficult Personal Events|1|||
27936281|NCT01114737|54592642|FG001|Open-Label Treatment Period|Difficult Personal Events|0|||
27936282|NCT01113879|54592665|FG000|Period 1: Block 1|Withdrawal by Subject|2|||
27936283|NCT01113879|54592666|FG001|Period 1: Block 1|Withdrawal by Subject|0|||
27936284|NCT00979576|54592677|FG000|Combination Treatment Phase|Progressive disease|3|||
27936285|NCT00979576|54592678|FG001|Combination Treatment Phase|Progressive disease|1|||
27936286|NCT00979576|54592679|FG002|Combination Treatment Phase|Progressive disease|5|||
27936287|NCT00979576|54592677|FG000|Combination Treatment Phase|Dose limiting toxicity|0|||
27936288|NCT00979576|54592678|FG001|Combination Treatment Phase|Dose limiting toxicity|3|||
27936289|NCT00979576|54592679|FG002|Combination Treatment Phase|Dose limiting toxicity|2|||
27936290|NCT00979576|54592677|FG000|Combination Treatment Phase|Adverse Event|0|||
27936291|NCT00979576|54592678|FG001|Combination Treatment Phase|Adverse Event|2|||
27936292|NCT00979576|54592679|FG002|Combination Treatment Phase|Adverse Event|2|||
27936293|NCT00979576|54592677|FG000|Combination Followed by Monotherapy|Progressive Disease|0|||
27936294|NCT00979576|54592678|FG001|Combination Followed by Monotherapy|Progressive Disease|2|||
27936295|NCT00979576|54592679|FG002|Combination Followed by Monotherapy|Progressive Disease|1|||
27936296|NCT00979420|54592692|FG000|Overall Study|Adverse Event|1|||
27936297|NCT00979420|54592693|FG001|Overall Study|Adverse Event|0|||
27936298|NCT00979420|54592694|FG002|Overall Study|Adverse Event|0|||
27936299|NCT00979420|54592695|FG003|Overall Study|Adverse Event|0|||
27936300|NCT00979420|54592692|FG000|Overall Study|Lack of Efficacy|3|||
27936301|NCT00979420|54592693|FG001|Overall Study|Lack of Efficacy|0|||
27936302|NCT00979420|54592694|FG002|Overall Study|Lack of Efficacy|1|||
27936303|NCT00979420|54592695|FG003|Overall Study|Lack of Efficacy|1|||
27936304|NCT00979420|54592692|FG000|Overall Study|Other reasons not related to Viramune|3|||
27936305|NCT00979420|54592693|FG001|Overall Study|Other reasons not related to Viramune|0|||
27936306|NCT00979420|54592694|FG002|Overall Study|Other reasons not related to Viramune|0|||
27936307|NCT00979420|54592695|FG003|Overall Study|Other reasons not related to Viramune|1|||
27936308|NCT02702180|54592706|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
27936309|NCT02702180|54592707|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
27936310|NCT02702180|54592708|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
27936311|NCT02702180|54592706|FG000|Double-blind Treatment Period|Adverse Event|0|||
27790941|NCT01574326|54245919|FG000|Overall Study|Withdrawal by Participant|2|||
27790942|NCT01574326|54245920|FG001|Overall Study|Withdrawal by Participant|4|||
27790943|NCT01574326|54245919|FG000|Overall Study|Physician Decision|5|||
27842526|NCT01550744|54331106|FG000|Open-Label|Not all 3 study drug injections received|2|||
27936312|NCT02702180|54592707|FG001|Double-blind Treatment Period|Adverse Event|0|||
27936313|NCT02702180|54592708|FG002|Double-blind Treatment Period|Adverse Event|1|||
27936314|NCT02702180|54592706|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
27936315|NCT02702180|54592707|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
27936316|NCT02702180|54592708|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
27936317|NCT02702180|54592706|FG000|Double-blind Treatment Period|Protocol Violation|0|||
27936318|NCT02702180|54592707|FG001|Double-blind Treatment Period|Protocol Violation|0|||
27936319|NCT02702180|54592708|FG002|Double-blind Treatment Period|Protocol Violation|2|||
27936320|NCT02702180|54592706|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
27936321|NCT02702180|54592707|FG001|Open-label Treatment Period|Withdrawal by Subject|1|||
27936322|NCT02702180|54592708|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
27936323|NCT02702180|54592706|FG000|Open-label Treatment Period|Withdrawn in error|0|||
27936324|NCT02702180|54592707|FG001|Open-label Treatment Period|Withdrawn in error|0|||
27936325|NCT02702180|54592708|FG002|Open-label Treatment Period|Withdrawn in error|1|||
27936326|NCT00980980|54592720|FG000|Overall Study|Withdrawal by Hospital|0|||
27936327|NCT00980980|54592721|FG001|Overall Study|Withdrawal by Hospital|1|||
27936328|NCT00980980|54592722|FG002|Overall Study|Withdrawal by Hospital|0|||
27936329|NCT00980200|54592733|FG000|7-day Treatment Period 1|Withdrawal by Subject|0|||
27936330|NCT00980200|54592734|FG001|7-day Treatment Period 1|Withdrawal by Subject|1|||
27936331|NCT00980200|54592735|FG002|7-day Treatment Period 1|Withdrawal by Subject|0|||
27936332|NCT00980200|54592736|FG003|7-day Treatment Period 1|Withdrawal by Subject|0|||
27936333|NCT00980200|54592737|FG004|7-day Treatment Period 1|Withdrawal by Subject|0|||
27936334|NCT00980200|54592733|FG000|7-day Treatment Period 3|Lack of Efficacy|0|||
27936335|NCT00980200|54592734|FG001|7-day Treatment Period 3|Lack of Efficacy|1|||
27936336|NCT00980200|54592735|FG002|7-day Treatment Period 3|Lack of Efficacy|0|||
27936337|NCT00980200|54592736|FG003|7-day Treatment Period 3|Lack of Efficacy|0|||
27936338|NCT00980200|54592737|FG004|7-day Treatment Period 3|Lack of Efficacy|1|||
27936339|NCT00979654|54592749|FG000|Overall Study|Lost to Follow-up|1|||
27936340|NCT00979654|54592749|FG000|Overall Study|Withdrawal by Subject|22|||
27936341|NCT00979654|54592749|FG000|Overall Study|Death|1|||
27936342|NCT00979654|54592749|FG000|Overall Study|Lack of Efficacy|6|||
27936343|NCT00979654|54592749|FG000|Overall Study|Adverse Event|1|||
27936344|NCT00979654|54592749|FG000|Overall Study|Adverse Event of Diverticulitis|1|||
27936345|NCT00979654|54592749|FG000|Overall Study|Per Principal Investigator's Discretion|1|||
27936346|NCT00979654|54592749|FG000|Overall Study|Patient Wanted to Pursue Other Treatment|1|||
27936347|NCT00979654|54592749|FG000|Overall Study|Serious Adverse Event|1|||
27936348|NCT00979654|54592749|FG000|Overall Study|Unfavorable Risk-Benefit Analysis|1|||
27936349|NCT00978562|54592753|FG000|Overall Study|Withdrawal by participant before receiving study drug/imaging|2|||
27936350|NCT02865460|54592761|FG000|Overall Study|Adverse Event|1|||
27936351|NCT02865460|54592762|FG001|Overall Study|Adverse Event|0|||
27936352|NCT02865460|54592761|FG000|Overall Study|Withdrawal by Subject|1|||
27936353|NCT02865460|54592762|FG001|Overall Study|Withdrawal by Subject|1|||
27936354|NCT02865460|54592761|FG000|Overall Study|Lost to Follow-up|7|||
27936355|NCT02865460|54592762|FG001|Overall Study|Lost to Follow-up|4|||
27936356|NCT02865460|54592761|FG000|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
27936357|NCT02865460|54592762|FG001|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
27936358|NCT01206816|54592775|FG000|Overall Study|Protocol Violation|0|||
27936359|NCT01206816|54592776|FG001|Overall Study|Protocol Violation|0|||
27936360|NCT01206816|54592777|FG002|Overall Study|Protocol Violation|1|||
27936361|NCT01206816|54592778|FG003|Overall Study|Protocol Violation|0|||
27936362|NCT01206816|54592779|FG004|Overall Study|Protocol Violation|0|||
27936363|NCT01206816|54592780|FG005|Overall Study|Protocol Violation|0|||
27936364|NCT01206816|54592781|FG006|Overall Study|Protocol Violation|0|||
27936365|NCT01206816|54592775|FG000|Overall Study|Withdrawal by Subject|0|||
27936366|NCT01206816|54592776|FG001|Overall Study|Withdrawal by Subject|0|||
27936367|NCT01206816|54592777|FG002|Overall Study|Withdrawal by Subject|1|||
27936368|NCT01206816|54592778|FG003|Overall Study|Withdrawal by Subject|0|||
27936369|NCT01206816|54592779|FG004|Overall Study|Withdrawal by Subject|0|||
27936370|NCT01206816|54592780|FG005|Overall Study|Withdrawal by Subject|0|||
27936371|NCT01206816|54592781|FG006|Overall Study|Withdrawal by Subject|0|||
27936372|NCT01206816|54592775|FG000|Overall Study|Progressive disease|3|||
27936373|NCT01206816|54592776|FG001|Overall Study|Progressive disease|3|||
27936374|NCT01206816|54592777|FG002|Overall Study|Progressive disease|13|||
27936375|NCT01206816|54592778|FG003|Overall Study|Progressive disease|3|||
27936376|NCT01206816|54592779|FG004|Overall Study|Progressive disease|3|||
27936377|NCT01206816|54592780|FG005|Overall Study|Progressive disease|16|||
27936378|NCT01206816|54592781|FG006|Overall Study|Progressive disease|3|||
27936379|NCT01206816|54592775|FG000|Overall Study|Other AE|0|||
27936380|NCT01206816|54592776|FG001|Overall Study|Other AE|0|||
27936381|NCT01206816|54592777|FG002|Overall Study|Other AE|4|||
27936382|NCT01206816|54592778|FG003|Overall Study|Other AE|0|||
27936383|NCT01206816|54592779|FG004|Overall Study|Other AE|0|||
27936384|NCT01206816|54592780|FG005|Overall Study|Other AE|3|||
27936385|NCT01206816|54592781|FG006|Overall Study|Other AE|2|||
27936386|NCT01206816|54592775|FG000|Overall Study|other than stated above|0|||
27936387|NCT01206816|54592776|FG001|Overall Study|other than stated above|0|||
27936388|NCT01206816|54592777|FG002|Overall Study|other than stated above|1|||
27936389|NCT01206816|54592778|FG003|Overall Study|other than stated above|0|||
27936390|NCT01206816|54592779|FG004|Overall Study|other than stated above|0|||
27936391|NCT01206816|54592780|FG005|Overall Study|other than stated above|0|||
27936392|NCT01206816|54592781|FG006|Overall Study|other than stated above|1|||
27936393|NCT01206582|54592803|FG000|Overall Study|Withdrew prior to study|1|||
27936394|NCT01206582|54592804|FG001|Overall Study|Withdrew prior to study|0|||
27936395|NCT01206582|54592803|FG000|Overall Study|Discontinued intervention before week 8|1|||
27936396|NCT01206582|54592804|FG001|Overall Study|Discontinued intervention before week 8|2|||
27936397|NCT01259102|54592815|FG000|Overall Study|Adverse Event|1|||
27936398|NCT01259102|54592816|FG001|Overall Study|Adverse Event|0|||
27936399|NCT01259102|54592817|FG002|Overall Study|Adverse Event|1|||
27936400|NCT01259102|54592818|FG003|Overall Study|Adverse Event|1|||
27936401|NCT01259102|54592819|FG004|Overall Study|Adverse Event|0|||
27936402|NCT01259102|54592815|FG000|Overall Study|Other|0|||
27936403|NCT01259102|54592816|FG001|Overall Study|Other|0|||
27936404|NCT01259102|54592817|FG002|Overall Study|Other|1|||
27936405|NCT01259102|54592818|FG003|Overall Study|Other|1|||
27936406|NCT01259102|54592819|FG004|Overall Study|Other|1|||
27936407|NCT00978250|54592835|FG000|Overall Study|Late determination of ineligibility|0|||
27936408|NCT00978250|54592836|FG001|Overall Study|Late determination of ineligibility|1|||
27936409|NCT00978250|54592837|FG002|Overall Study|Late determination of ineligibility|0|||
27936410|NCT00978250|54592838|FG003|Overall Study|Late determination of ineligibility|1|||
27936411|NCT01259024|54592850|FG000|Overall Study|Physician Decision|1|||
27936412|NCT01257698|54592856|FG000|Overall Study|Protocol Violation|4|||
27936413|NCT01257698|54592857|FG001|Overall Study|Protocol Violation|0|||
27936414|NCT01257542|54592865|FG000|Overall Study|Protocol Violation|3|||
27936415|NCT01257542|54592866|FG001|Overall Study|Protocol Violation|5|||
27936416|NCT01257542|54592865|FG000|Overall Study|Withdrawal by Subject|0|||
27936417|NCT01257542|54592866|FG001|Overall Study|Withdrawal by Subject|2|||
27936418|NCT01257230|54592875|FG000|Overall Study|Not Treated|0|||
27936419|NCT01257230|54592876|FG001|Overall Study|Not Treated|0|||
27936420|NCT01257230|54592877|FG002|Overall Study|Not Treated|1|||
27936421|NCT01257230|54592875|FG000|Overall Study|Adverse Event|2|||
27936422|NCT01257230|54592876|FG001|Overall Study|Adverse Event|0|||
27936423|NCT01257230|54592877|FG002|Overall Study|Adverse Event|0|||
27936424|NCT01257230|54592875|FG000|Overall Study|Lack of Efficacy|0|||
27936425|NCT01257230|54592876|FG001|Overall Study|Lack of Efficacy|1|||
27936426|NCT01257230|54592877|FG002|Overall Study|Lack of Efficacy|0|||
27936427|NCT01257230|54592875|FG000|Overall Study|Protocol Violation|3|||
27936428|NCT01257230|54592876|FG001|Overall Study|Protocol Violation|0|||
27790944|NCT01574326|54245920|FG001|Overall Study|Physician Decision|3|||
27790945|NCT01574326|54245919|FG000|Overall Study|Adverse Event|1|||
27790946|NCT01574326|54245920|FG001|Overall Study|Adverse Event|3|||
27790947|NCT01574326|54245919|FG000|Overall Study|Other: Mainly kidney transplant|8|||
27790948|NCT01574326|54245920|FG001|Overall Study|Other: Mainly kidney transplant|8|||
27790949|NCT01574248|54245933|FG000|Overall Study|Withdrawal by Subject|2|||
27790950|NCT01574248|54245934|FG001|Overall Study|Withdrawal by Subject|0|||
27790951|NCT01574248|54245933|FG000|Overall Study|Missing primary endpoint data|1|||
27790952|NCT01574248|54245934|FG001|Overall Study|Missing primary endpoint data|0|||
27790953|NCT01573624|54245940|FG000|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
27790954|NCT01573624|54245941|FG001|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
27790955|NCT01573624|54245942|FG002|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
27790956|NCT01573624|54245943|FG003|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
27790957|NCT01573624|54245944|FG004|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
27790958|NCT01573624|54245945|FG005|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
27790959|NCT01573624|54245946|FG006|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
27790960|NCT01573624|54245940|FG000|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4|||
27790961|NCT01573624|54245941|FG001|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3|||
27790962|NCT01573624|54245942|FG002|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6|||
27790963|NCT01573624|54245943|FG003|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
27790964|NCT01573624|54245944|FG004|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2|||
27790965|NCT01573624|54245945|FG005|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
27790966|NCT01573624|54245946|FG006|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
27790967|NCT01573624|54245940|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1|||
27790968|NCT01573624|54245941|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
27790969|NCT01573624|54245942|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
27790970|NCT01573624|54245943|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
27790971|NCT01573624|54245944|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
27790972|NCT01573624|54245945|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
27790973|NCT01573624|54245946|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
27790974|NCT01573624|54245940|FG000|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
27790975|NCT01573624|54245941|FG001|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
27790976|NCT01573624|54245942|FG002|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
27790977|NCT01573624|54245943|FG003|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
27790978|NCT01573624|54245944|FG004|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
27790979|NCT01573624|54245945|FG005|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
27790980|NCT01573624|54245946|FG006|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
27790981|NCT01573624|54245940|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
27936429|NCT01257230|54592877|FG002|Overall Study|Protocol Violation|1|||
27936430|NCT01257230|54592875|FG000|Overall Study|Withdrawal by Subject|0|||
27936431|NCT01257230|54592876|FG001|Overall Study|Withdrawal by Subject|4|||
27936432|NCT01257230|54592877|FG002|Overall Study|Withdrawal by Subject|1|||
27936433|NCT01257230|54592875|FG000|Overall Study|Other reason not defined above|1|||
27936434|NCT01257230|54592876|FG001|Overall Study|Other reason not defined above|5|||
28017111|NCT00539188|54676373|FG000|Overall Study|Withdrawal by Subject|1|||
27790982|NCT01573624|54245941|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
27790983|NCT01573624|54245942|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
27790984|NCT01573624|54245943|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
27790985|NCT01573624|54245944|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
27790986|NCT01573624|54245945|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
27790987|NCT01573624|54245946|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
27790988|NCT01573624|54245940|FG000|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
27790989|NCT01573624|54245941|FG001|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
27790990|NCT01573624|54245942|FG002|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
27790991|NCT01573624|54245943|FG003|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
27790992|NCT01573624|54245944|FG004|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
27790993|NCT01573624|54245945|FG005|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1|||
27790994|NCT01573624|54245946|FG006|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
27790995|NCT01573624|54245940|FG000|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
27790996|NCT01573624|54245941|FG001|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
27790997|NCT01573624|54245942|FG002|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
27790998|NCT01573624|54245943|FG003|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
27790999|NCT01573624|54245944|FG004|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
27791000|NCT01573624|54245945|FG005|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
27791001|NCT01573624|54245946|FG006|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
27791002|NCT01573624|54245940|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
27791003|NCT01573624|54245941|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
27791004|NCT01573624|54245942|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2|||
27791005|NCT01573624|54245943|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
27791006|NCT01573624|54245944|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
27936435|NCT01257230|54592877|FG002|Overall Study|Other reason not defined above|3|||
27791007|NCT01573624|54245945|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
27791008|NCT01573624|54245946|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
27791009|NCT01573624|54245940|FG000|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
27791010|NCT01573624|54245941|FG001|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
27791011|NCT01573624|54245942|FG002|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
27791012|NCT01573624|54245943|FG003|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
27791013|NCT01573624|54245944|FG004|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
27791014|NCT01573624|54245945|FG005|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1|||
27791015|NCT01573624|54245946|FG006|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
27791016|NCT01573624|54245940|FG000|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
27791017|NCT01573624|54245941|FG001|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
27791018|NCT01573624|54245942|FG002|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
27791019|NCT01573624|54245943|FG003|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2|||
27791020|NCT01573624|54245944|FG004|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
27791021|NCT01573624|54245945|FG005|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
27791022|NCT01573624|54245946|FG006|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
27791023|NCT01573624|54245940|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
27791024|NCT01573624|54245941|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
27791025|NCT01573624|54245942|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
27791026|NCT01573624|54245943|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
27791027|NCT01573624|54245944|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
27791028|NCT01573624|54245945|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
27791029|NCT01573624|54245946|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
27791030|NCT01573624|54245940|FG000|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5|||
27791031|NCT01573624|54245941|FG001|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4|||
27791032|NCT01573624|54245942|FG002|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
27791033|NCT01573624|54245943|FG003|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1|||
27791034|NCT01573624|54245944|FG004|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3|||
27791035|NCT01573624|54245945|FG005|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
27791036|NCT01573624|54245946|FG006|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0|||
27791037|NCT01573624|54245940|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
27791038|NCT01573624|54245941|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1|||
27791039|NCT01573624|54245942|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
27791040|NCT01573624|54245943|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
27791041|NCT01573624|54245944|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
27936436|NCT01113801|54592890|FG000|Overall Study|Adverse Event|4|||
27936437|NCT01113801|54592891|FG001|Overall Study|Adverse Event|0|||
27936438|NCT01113801|54592892|FG002|Overall Study|Adverse Event|2|||
27936439|NCT01113801|54592893|FG003|Overall Study|Adverse Event|6|||
27936440|NCT01113801|54592890|FG000|Overall Study|Death|4|||
27936441|NCT01113801|54592891|FG001|Overall Study|Death|5|||
27936442|NCT01113801|54592892|FG002|Overall Study|Death|3|||
27936443|NCT01113801|54592893|FG003|Overall Study|Death|4|||
27936444|NCT01113801|54592890|FG000|Overall Study|Protocol Violation|0|||
27936445|NCT01113801|54592891|FG001|Overall Study|Protocol Violation|1|||
27936446|NCT01113801|54592892|FG002|Overall Study|Protocol Violation|0|||
27936447|NCT01113801|54592893|FG003|Overall Study|Protocol Violation|0|||
27936448|NCT01113801|54592890|FG000|Overall Study|Withdrawal by Subject|9|||
27936449|NCT01113801|54592891|FG001|Overall Study|Withdrawal by Subject|7|||
27936450|NCT01113801|54592892|FG002|Overall Study|Withdrawal by Subject|7|||
27791042|NCT01573624|54245945|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2|||
27791043|NCT01573624|54245946|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
27791044|NCT01573624|54245940|FG000|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1|||
27791045|NCT01573624|54245941|FG001|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
27791046|NCT01573624|54245942|FG002|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
27791047|NCT01573624|54245943|FG003|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
27791048|NCT01573624|54245944|FG004|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
27791049|NCT01573624|54245945|FG005|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
27791050|NCT01573624|54245946|FG006|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
27791051|NCT01573624|54245940|FG000|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
27791052|NCT01573624|54245941|FG001|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
27791053|NCT01573624|54245942|FG002|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
27791054|NCT01573624|54245943|FG003|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
27791055|NCT01573624|54245944|FG004|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
27791056|NCT01573624|54245945|FG005|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
27791057|NCT01573624|54245946|FG006|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
27791058|NCT01573624|54245940|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1|||
27791059|NCT01573624|54245941|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
27791060|NCT01573624|54245942|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
27791061|NCT01573624|54245943|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
27791062|NCT01573624|54245944|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
27791063|NCT01573624|54245945|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
27791064|NCT01573624|54245946|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
27791065|NCT01573624|54245940|FG000|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
27791066|NCT01573624|54245941|FG001|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
27791067|NCT01573624|54245942|FG002|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
27791068|NCT01573624|54245943|FG003|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
27791069|NCT01573624|54245944|FG004|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
27791070|NCT01573624|54245945|FG005|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
27791071|NCT01573624|54245946|FG006|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
27791072|NCT01573624|54245940|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
27791073|NCT01573624|54245941|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
27791074|NCT01573624|54245942|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
27791075|NCT01573624|54245943|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
27791076|NCT01573624|54245944|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
27791077|NCT01573624|54245945|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
27791078|NCT01573624|54245946|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
27791079|NCT01573624|54245940|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
27791080|NCT01573624|54245941|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1|||
27791081|NCT01573624|54245942|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
27791082|NCT01573624|54245943|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
27791083|NCT01573624|54245944|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
27791084|NCT01573624|54245945|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
27791085|NCT01573624|54245946|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
27791086|NCT01573624|54245940|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
27791087|NCT01573624|54245941|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1|||
27936451|NCT01113801|54592893|FG003|Overall Study|Withdrawal by Subject|8|||
27936452|NCT01113801|54592890|FG000|Overall Study|Physician Decision|2|||
27936453|NCT01113801|54592891|FG001|Overall Study|Physician Decision|2|||
27936454|NCT01113801|54592892|FG002|Overall Study|Physician Decision|3|||
27936455|NCT01113801|54592893|FG003|Overall Study|Physician Decision|3|||
27791088|NCT01573624|54245942|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
27791089|NCT01573624|54245943|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
27791090|NCT01573624|54245944|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
27791091|NCT01573624|54245945|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
27791092|NCT01573624|54245946|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
27791093|NCT01573624|54245940|FG000|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
27791094|NCT01573624|54245941|FG001|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
27791095|NCT01573624|54245942|FG002|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
27791096|NCT01573624|54245943|FG003|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
27791097|NCT01573624|54245944|FG004|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
27791098|NCT01573624|54245945|FG005|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
27791099|NCT01573624|54245946|FG006|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
27791100|NCT01573624|54245940|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
27791101|NCT01573624|54245941|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
27791102|NCT01573624|54245942|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
27791103|NCT01573624|54245943|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
27791104|NCT01573624|54245944|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
27791105|NCT01573624|54245945|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
27791106|NCT01573624|54245946|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
27791107|NCT01573624|54245940|FG000|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
27791108|NCT01573624|54245941|FG001|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
27791109|NCT01573624|54245942|FG002|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
27791110|NCT01573624|54245943|FG003|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
27791111|NCT01573624|54245944|FG004|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
27791112|NCT01573624|54245945|FG005|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
27791113|NCT01573624|54245946|FG006|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4|||
27791114|NCT01573624|54245940|FG000|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
27791115|NCT01573624|54245941|FG001|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
27791116|NCT01573624|54245942|FG002|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
27791117|NCT01573624|54245943|FG003|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
27791118|NCT01573624|54245944|FG004|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
27791119|NCT01573624|54245945|FG005|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
27791120|NCT01573624|54245946|FG006|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
27791121|NCT01573624|54245940|FG000|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1|||
27791122|NCT01573624|54245941|FG001|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
27791123|NCT01573624|54245942|FG002|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
27791124|NCT01573624|54245943|FG003|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
27791125|NCT01573624|54245944|FG004|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
27791126|NCT01573624|54245945|FG005|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
27791127|NCT01573624|54245946|FG006|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
27791128|NCT01573624|54245940|FG000|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
27791129|NCT01573624|54245941|FG001|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
27791130|NCT01573624|54245942|FG002|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
27791131|NCT01573624|54245943|FG003|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
27791132|NCT01573624|54245944|FG004|Period 6 : Follow-up Period (7 Days)|Adverse Event|2|||
27791133|NCT01573624|54245945|FG005|Period 6 : Follow-up Period (7 Days)|Adverse Event|1|||
27791134|NCT01573624|54245946|FG006|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
27791135|NCT01573624|54245940|FG000|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1|||
27791136|NCT01573624|54245941|FG001|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
27791137|NCT01573624|54245942|FG002|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
27791138|NCT01573624|54245943|FG003|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
27791139|NCT01573624|54245944|FG004|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
27791140|NCT01573624|54245945|FG005|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
27791141|NCT01573624|54245946|FG006|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
27791142|NCT01557946|54245970|FG000|Overall Study|Adverse Event|3|||
27791143|NCT01557946|54245971|FG001|Overall Study|Adverse Event|0|||
27791144|NCT01534078|54245976|FG000|Overall Study|Death|1|||
27791145|NCT01534078|54245976|FG000|Overall Study|Withdrawal by Subject|1|||
27791146|NCT02185040|54245985|FG000|Part 1 Treatment Phase|Miscellaneous|0|||
27791147|NCT02185040|54245986|FG001|Part 1 Treatment Phase|Miscellaneous|0|||
27791148|NCT02185040|54245987|FG002|Part 1 Treatment Phase|Miscellaneous|1|||
27791149|NCT02185040|54245988|FG003|Part 1 Treatment Phase|Miscellaneous|0|||
27791150|NCT02185040|54245989|FG004|Part 1 Treatment Phase|Miscellaneous|0|||
27791151|NCT02185040|54245990|FG005|Part 1 Treatment Phase|Miscellaneous|0|||
27936456|NCT01113801|54592890|FG000|Overall Study|Sponsor Decision|15|||
27791152|NCT02185040|54245991|FG006|Part 1 Treatment Phase|Miscellaneous|0|||
27791153|NCT02185040|54245985|FG000|Part 1 Treatment Phase|Adverse Event|1|||
27791154|NCT02185040|54245986|FG001|Part 1 Treatment Phase|Adverse Event|0|||
27791155|NCT02185040|54245987|FG002|Part 1 Treatment Phase|Adverse Event|0|||
27791156|NCT02185040|54245988|FG003|Part 1 Treatment Phase|Adverse Event|2|||
27791157|NCT02185040|54245989|FG004|Part 1 Treatment Phase|Adverse Event|3|||
27791158|NCT02185040|54245990|FG005|Part 1 Treatment Phase|Adverse Event|0|||
27791159|NCT02185040|54245991|FG006|Part 1 Treatment Phase|Adverse Event|0|||
27791160|NCT02185040|54245985|FG000|Part 1 Treatment Phase|Withdrawal by Subject|0|||
27791161|NCT02185040|54245986|FG001|Part 1 Treatment Phase|Withdrawal by Subject|1|||
27791162|NCT02185040|54245987|FG002|Part 1 Treatment Phase|Withdrawal by Subject|0|||
27791163|NCT02185040|54245988|FG003|Part 1 Treatment Phase|Withdrawal by Subject|0|||
27791164|NCT02185040|54245989|FG004|Part 1 Treatment Phase|Withdrawal by Subject|0|||
27791165|NCT02185040|54245990|FG005|Part 1 Treatment Phase|Withdrawal by Subject|0|||
27791166|NCT02185040|54245991|FG006|Part 1 Treatment Phase|Withdrawal by Subject|0|||
27791167|NCT02185040|54245985|FG000|Part 1 Treatment Phase|Lost to Follow-up|0|||
27791168|NCT02185040|54245986|FG001|Part 1 Treatment Phase|Lost to Follow-up|1|||
27791169|NCT02185040|54245987|FG002|Part 1 Treatment Phase|Lost to Follow-up|0|||
27791170|NCT02185040|54245988|FG003|Part 1 Treatment Phase|Lost to Follow-up|0|||
27936457|NCT01113801|54592891|FG001|Overall Study|Sponsor Decision|21|||
27936458|NCT01113801|54592892|FG002|Overall Study|Sponsor Decision|20|||
27936459|NCT01113801|54592893|FG003|Overall Study|Sponsor Decision|15|||
27936460|NCT01113801|54592890|FG000|Overall Study|Clinical Endpoint (ESRD)|7|||
27936461|NCT01113801|54592891|FG001|Overall Study|Clinical Endpoint (ESRD)|4|||
27936462|NCT01113801|54592892|FG002|Overall Study|Clinical Endpoint (ESRD)|2|||
27936463|NCT01113801|54592893|FG003|Overall Study|Clinical Endpoint (ESRD)|5|||
27936464|NCT01256684|54592906|FG000|Overall Study|Adverse Event|1|||
27936465|NCT01256684|54592907|FG001|Overall Study|Adverse Event|4|||
27936466|NCT01256684|54592908|FG002|Overall Study|Adverse Event|2|||
27936467|NCT01256684|54592906|FG000|Overall Study|Withdrawal by Subject|4|||
27936468|NCT01256684|54592907|FG001|Overall Study|Withdrawal by Subject|0|||
27936469|NCT01256684|54592908|FG002|Overall Study|Withdrawal by Subject|2|||
27936470|NCT01256684|54592906|FG000|Overall Study|Physician Decision|0|||
27791171|NCT02185040|54245989|FG004|Part 1 Treatment Phase|Lost to Follow-up|0|||
27791172|NCT02185040|54245990|FG005|Part 1 Treatment Phase|Lost to Follow-up|0|||
27791173|NCT02185040|54245991|FG006|Part 1 Treatment Phase|Lost to Follow-up|0|||
27791174|NCT02185040|54245985|FG000|Active Treatment Extension Phase|Miscellaneous|0|||
27791175|NCT02185040|54245986|FG001|Active Treatment Extension Phase|Miscellaneous|0|||
27791176|NCT02185040|54245987|FG002|Active Treatment Extension Phase|Miscellaneous|0|||
27791177|NCT02185040|54245988|FG003|Active Treatment Extension Phase|Miscellaneous|0|||
27791178|NCT02185040|54245989|FG004|Active Treatment Extension Phase|Miscellaneous|0|||
27791179|NCT02185040|54245990|FG005|Active Treatment Extension Phase|Miscellaneous|1|||
27791180|NCT02185040|54245991|FG006|Active Treatment Extension Phase|Miscellaneous|0|||
27791181|NCT02185040|54245985|FG000|Active Treatment Extension Phase|Adverse Event|0|||
27791182|NCT02185040|54245986|FG001|Active Treatment Extension Phase|Adverse Event|0|||
27791183|NCT02185040|54245987|FG002|Active Treatment Extension Phase|Adverse Event|0|||
27791184|NCT02185040|54245988|FG003|Active Treatment Extension Phase|Adverse Event|0|||
27791185|NCT02185040|54245989|FG004|Active Treatment Extension Phase|Adverse Event|0|||
27791186|NCT02185040|54245990|FG005|Active Treatment Extension Phase|Adverse Event|1|||
27791187|NCT02185040|54245991|FG006|Active Treatment Extension Phase|Adverse Event|4|||
27791188|NCT02185040|54245985|FG000|Active Treatment Extension Phase|Withdrawal by Subject|0|||
27791189|NCT02185040|54245986|FG001|Active Treatment Extension Phase|Withdrawal by Subject|0|||
27791190|NCT02185040|54245987|FG002|Active Treatment Extension Phase|Withdrawal by Subject|0|||
27791191|NCT02185040|54245988|FG003|Active Treatment Extension Phase|Withdrawal by Subject|0|||
27791192|NCT02185040|54245989|FG004|Active Treatment Extension Phase|Withdrawal by Subject|0|||
27791193|NCT02185040|54245990|FG005|Active Treatment Extension Phase|Withdrawal by Subject|1|||
27791194|NCT02185040|54245991|FG006|Active Treatment Extension Phase|Withdrawal by Subject|1|||
27791195|NCT02185040|54245985|FG000|Active Treatment Extension Phase|Lost to Follow-up|0|||
27791196|NCT02185040|54245986|FG001|Active Treatment Extension Phase|Lost to Follow-up|0|||
27791197|NCT02185040|54245987|FG002|Active Treatment Extension Phase|Lost to Follow-up|0|||
27791198|NCT02185040|54245988|FG003|Active Treatment Extension Phase|Lost to Follow-up|0|||
27791199|NCT02185040|54245989|FG004|Active Treatment Extension Phase|Lost to Follow-up|0|||
27791200|NCT02185040|54245990|FG005|Active Treatment Extension Phase|Lost to Follow-up|0|||
27791201|NCT02185040|54245991|FG006|Active Treatment Extension Phase|Lost to Follow-up|2|||
27791202|NCT02161406|54246013|FG000|Overall Study|Death|2|||
27791203|NCT02161406|54246014|FG001|Overall Study|Death|1|||
27791204|NCT02161406|54246013|FG000|Overall Study|Lost to Follow-up|2|||
27936471|NCT01256684|54592907|FG001|Overall Study|Physician Decision|1|||
27936472|NCT01256684|54592908|FG002|Overall Study|Physician Decision|0|||
27936473|NCT01256684|54592906|FG000|Overall Study|Lack of Efficacy|0|||
27936474|NCT01256684|54592907|FG001|Overall Study|Lack of Efficacy|1|||
27936475|NCT01256684|54592908|FG002|Overall Study|Lack of Efficacy|1|||
27936476|NCT01256684|54592906|FG000|Overall Study|Entry criteria not met/non-compliance|4|||
27936477|NCT01256684|54592907|FG001|Overall Study|Entry criteria not met/non-compliance|7|||
27936478|NCT01256684|54592908|FG002|Overall Study|Entry criteria not met/non-compliance|6|||
27936479|NCT01204710|54592918|FG000|Randomization Treatment|Lost to Follow-up|1|||
27936480|NCT01204710|54592919|FG001|Randomization Treatment|Lost to Follow-up|0|||
27936481|NCT01204710|54592918|FG000|Randomization Treatment|Withdrawal by Subject|6|||
27936482|NCT01204710|54592919|FG001|Randomization Treatment|Withdrawal by Subject|5|||
27936483|NCT01204710|54592918|FG000|Randomization Treatment|Physician Decision|3|||
27936484|NCT01204710|54592919|FG001|Randomization Treatment|Physician Decision|2|||
27936485|NCT01204710|54592918|FG000|Randomization Treatment|Entry criteria not met|0|||
27936486|NCT01204710|54592919|FG001|Randomization Treatment|Entry criteria not met|1|||
27936487|NCT01204710|54592918|FG000|Randomization Treatment|Adverse Event|4|||
27936488|NCT01204710|54592919|FG001|Randomization Treatment|Adverse Event|2|||
27936489|NCT01204710|54592918|FG000|Randomization Treatment|Sponsor Decision|0|||
27936490|NCT01204710|54592919|FG001|Randomization Treatment|Sponsor Decision|1|||
27936491|NCT01204710|54592918|FG000|Randomization Treatment|Worsening of General condition|0|||
27936492|NCT01204710|54592919|FG001|Randomization Treatment|Worsening of General condition|1|||
27936493|NCT01204710|54592918|FG000|Randomization Treatment|Moved and Followed for Survival|0|||
27936494|NCT01204710|54592919|FG001|Randomization Treatment|Moved and Followed for Survival|1|||
27936495|NCT01204710|54592918|FG000|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0|||
27936496|NCT01204710|54592919|FG001|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1|||
27936497|NCT01204710|54592918|FG000|Optional Olaratumab Monotherapy|Physician Decision|0|||
27936498|NCT01204710|54592919|FG001|Optional Olaratumab Monotherapy|Physician Decision|1|||
27936499|NCT01204710|54592918|FG000|Optional Olaratumab Monotherapy|Withdrawal by Subject|0|||
27936500|NCT01204710|54592919|FG001|Optional Olaratumab Monotherapy|Withdrawal by Subject|1|||
27936501|NCT01256450|54592934|FG000|Open-label Titration|Adverse Event|39|||
27936502|NCT01256450|54592935|FG001|Open-label Titration|Adverse Event|0|||
27936503|NCT01256450|54592936|FG002|Open-label Titration|Adverse Event|0|||
27936504|NCT01256450|54592934|FG000|Open-label Titration|Lost to Follow-up|7|||
28017112|NCT00539188|54676374|FG001|Overall Study|Withdrawal by Subject|0|||
28017113|NCT00539188|54676373|FG000|Overall Study|Lost to Follow-up|2|||
28017114|NCT00539188|54676374|FG001|Overall Study|Lost to Follow-up|1|||
28017115|NCT00681590|54676382|FG000|Overall Study|Withdrawal by Subject|2|||
27791205|NCT02161406|54246014|FG001|Overall Study|Lost to Follow-up|1|||
27791206|NCT02161406|54246013|FG000|Overall Study|Withdrawal by Subject|2|||
27791207|NCT02161406|54246014|FG001|Overall Study|Withdrawal by Subject|4|||
27791208|NCT02161406|54246013|FG000|Overall Study|investigator withdrew subject|3|||
27791209|NCT02161406|54246014|FG001|Overall Study|investigator withdrew subject|1|||
27791210|NCT02161406|54246013|FG000|Overall Study|Lack of Efficacy|1|||
27791211|NCT02161406|54246014|FG001|Overall Study|Lack of Efficacy|1|||
27791212|NCT02161406|54246013|FG000|Overall Study|relocation|0|||
27791213|NCT02161406|54246014|FG001|Overall Study|relocation|1|||
27791214|NCT02161016|54246020|FG000|Overall Study|withdrawn by IRB|1|||
27791215|NCT01573000|54246026|FG000|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27|||
27791216|NCT01573000|54246027|FG001|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32|||
27791217|NCT01573000|54246026|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4|||
27791218|NCT01573000|54246027|FG001|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
27791219|NCT01573000|54246026|FG000|Dosimetric and Therapeutic Treatment|Death|0|||
27791220|NCT01573000|54246027|FG001|Dosimetric and Therapeutic Treatment|Death|1|||
27791221|NCT01573000|54246026|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2|||
27791222|NCT01573000|54246027|FG001|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0|||
27791223|NCT01573000|54246026|FG000|Dosimetric and Therapeutic Treatment|Received Other Treatment|2|||
27791224|NCT01573000|54246027|FG001|Dosimetric and Therapeutic Treatment|Received Other Treatment|0|||
27791225|NCT01573000|54246026|FG000|Crossover Phase|Lack of Efficacy|0|||
28017116|NCT00681590|54676383|FG001|Overall Study|Withdrawal by Subject|12|||
28017117|NCT04980456|54676391|FG000|Period 1 (Approximately 30 Days)|Adverse Event|2|||
28017118|NCT04980456|54676392|FG001|Period 1 (Approximately 30 Days)|Adverse Event|0|||
28017119|NCT04980456|54676391|FG000|Period 1 (Approximately 30 Days)|Lost to Follow-up|0|||
28017120|NCT04980456|54676392|FG001|Period 1 (Approximately 30 Days)|Lost to Follow-up|1|||
27791226|NCT01573000|54246027|FG001|Crossover Phase|Lack of Efficacy|13|||
27791227|NCT01573000|54246026|FG000|Crossover Phase|Lost to Follow-up|0|||
27791228|NCT01573000|54246027|FG001|Crossover Phase|Lost to Follow-up|2|||
27791229|NCT01573000|54246026|FG000|Crossover Phase|Death|0|||
27791230|NCT01573000|54246027|FG001|Crossover Phase|Death|3|||
27791231|NCT01573000|54246026|FG000|Long-Term Follow-Up|Death|3|||
28017121|NCT04980456|54676391|FG000|Period 1 (Approximately 30 Days)|Withdrawal by Subject|1|||
27791232|NCT01573000|54246027|FG001|Long-Term Follow-Up|Death|0|||
27936505|NCT01256450|54592935|FG001|Open-label Titration|Lost to Follow-up|0|||
27936506|NCT01256450|54592936|FG002|Open-label Titration|Lost to Follow-up|0|||
27936507|NCT01256450|54592934|FG000|Open-label Titration|Lack of analgesic effect|30|||
27936508|NCT01256450|54592935|FG001|Open-label Titration|Lack of analgesic effect|0|||
27936509|NCT01256450|54592936|FG002|Open-label Titration|Lack of analgesic effect|0|||
28017122|NCT04980456|54676392|FG001|Period 1 (Approximately 30 Days)|Withdrawal by Subject|2|||
27791233|NCT01573000|54246026|FG000|Long-Term Follow-Up|Lost to Follow-up|0|||
27791234|NCT01573000|54246027|FG001|Long-Term Follow-Up|Lost to Follow-up|1|||
27791235|NCT01572922|54246037|FG000|Overall Study|Adverse Event|1|||
27791236|NCT01572922|54246037|FG000|Overall Study|Protocol Violation|1|||
27791237|NCT01572922|54246037|FG000|Overall Study|Death|1|||
27791238|NCT01572844|54246046|FG000|Overall Study|Physician Decision|1|||
27791239|NCT01572844|54246047|FG001|Overall Study|Physician Decision|1|||
27791240|NCT01557400|54246056|FG000|Overall Study|Transitioned to Commercial Drug Product|40|||
27791241|NCT01557400|54246056|FG000|Overall Study|Adverse Event|3|||
27791242|NCT01557400|54246056|FG000|Overall Study|Lost to Follow-up|5|||
27791243|NCT01557400|54246056|FG000|Overall Study|Withdrawal by Subject|9|||
27791244|NCT01533922|54246060|FG000|Overall Study|Adverse Event|5|||
27791245|NCT01533922|54246061|FG001|Overall Study|Adverse Event|8|||
27791246|NCT01533922|54246062|FG002|Overall Study|Adverse Event|6|||
27791247|NCT01533922|54246063|FG003|Overall Study|Adverse Event|3|||
27791248|NCT01533922|54246064|FG004|Overall Study|Adverse Event|4|||
27936510|NCT01256450|54592934|FG000|Open-label Titration|Non-compliance|9|||
27936511|NCT01256450|54592935|FG001|Open-label Titration|Non-compliance|0|||
27936512|NCT01256450|54592936|FG002|Open-label Titration|Non-compliance|0|||
27936513|NCT01256450|54592934|FG000|Open-label Titration|Screen failure|1|||
27936514|NCT01256450|54592935|FG001|Open-label Titration|Screen failure|0|||
27936515|NCT01256450|54592936|FG002|Open-label Titration|Screen failure|0|||
27936516|NCT01256450|54592934|FG000|Open-label Titration|Other|13|||
27936517|NCT01256450|54592935|FG001|Open-label Titration|Other|0|||
27936518|NCT01256450|54592936|FG002|Open-label Titration|Other|0|||
27936519|NCT01256450|54592934|FG000|Double-blind Treatment|Adverse Event|0|||
27936520|NCT01256450|54592935|FG001|Double-blind Treatment|Adverse Event|8|||
27936521|NCT01256450|54592936|FG002|Double-blind Treatment|Adverse Event|6|||
28017123|NCT04980456|54676391|FG000|Period 2 (Approximately 30 Days)|Adverse Event|0|||
28017124|NCT04980456|54676392|FG001|Period 2 (Approximately 30 Days)|Adverse Event|1|||
28017125|NCT00326599|54676405|FG000|Overall Study|Withdrawal by Subject|1|||
27791249|NCT01533922|54246060|FG000|Overall Study|Lack of Efficacy|0|||
27791250|NCT01533922|54246061|FG001|Overall Study|Lack of Efficacy|0|||
27791251|NCT01533922|54246062|FG002|Overall Study|Lack of Efficacy|1|||
27791252|NCT01533922|54246063|FG003|Overall Study|Lack of Efficacy|0|||
27791253|NCT01533922|54246064|FG004|Overall Study|Lack of Efficacy|0|||
27791254|NCT01533922|54246060|FG000|Overall Study|Protocol Violation|0|||
27791255|NCT01533922|54246061|FG001|Overall Study|Protocol Violation|3|||
27791256|NCT01533922|54246062|FG002|Overall Study|Protocol Violation|0|||
27791257|NCT01533922|54246063|FG003|Overall Study|Protocol Violation|0|||
27791258|NCT01533922|54246064|FG004|Overall Study|Protocol Violation|1|||
27791259|NCT01533922|54246060|FG000|Overall Study|Withdrawal by Subject|3|||
27791260|NCT01533922|54246061|FG001|Overall Study|Withdrawal by Subject|1|||
27791261|NCT01533922|54246062|FG002|Overall Study|Withdrawal by Subject|2|||
27791262|NCT01533922|54246063|FG003|Overall Study|Withdrawal by Subject|2|||
27791263|NCT01533922|54246064|FG004|Overall Study|Withdrawal by Subject|1|||
27791264|NCT01533922|54246060|FG000|Overall Study|Other reason not defined above|2|||
27791265|NCT01533922|54246061|FG001|Overall Study|Other reason not defined above|0|||
27791266|NCT01533922|54246062|FG002|Overall Study|Other reason not defined above|1|||
27791267|NCT01533922|54246063|FG003|Overall Study|Other reason not defined above|0|||
27791268|NCT01533922|54246064|FG004|Overall Study|Other reason not defined above|0|||
27791269|NCT01533688|54246079|FG000|Overall Study|Withdrawal by Subject|5|||
27791270|NCT01533688|54246080|FG001|Overall Study|Withdrawal by Subject|4|||
27791271|NCT01533688|54246081|FG002|Overall Study|Withdrawal by Subject|3|||
27791272|NCT01533688|54246079|FG000|Overall Study|Medically unstable|1|||
27791273|NCT01533688|54246080|FG001|Overall Study|Medically unstable|3|||
27791274|NCT01533688|54246081|FG002|Overall Study|Medically unstable|3|||
27791275|NCT01533688|54246079|FG000|Overall Study|Had colonoscopy at outside hospital|2|||
27791276|NCT01533688|54246080|FG001|Overall Study|Had colonoscopy at outside hospital|3|||
27791277|NCT01533688|54246081|FG002|Overall Study|Had colonoscopy at outside hospital|2|||
27791278|NCT01532986|54246093|FG000|Overall Study|Death|9|||
27791279|NCT01532986|54246094|FG001|Overall Study|Death|9|||
27791280|NCT01532986|54246093|FG000|Overall Study|Withdrawal by Subject|7|||
27791281|NCT01532986|54246094|FG001|Overall Study|Withdrawal by Subject|10|||
27791282|NCT01532986|54246093|FG000|Overall Study|Physician Decision|7|||
28017126|NCT00326599|54676406|FG001|Overall Study|Withdrawal by Subject|0|||
27791283|NCT01532986|54246094|FG001|Overall Study|Physician Decision|5|||
27791284|NCT01532908|54246103|FG000|Overall Study|Not Transplanted|1|||
27936522|NCT01256450|54592934|FG000|Double-blind Treatment|Lost to Follow-up|0|||
27791285|NCT01532908|54246104|FG001|Overall Study|Not Transplanted|0|||
27791286|NCT02160782|54246110|FG000|Open-label Period: Maralixibat|Adverse Event|2|||
27791287|NCT02160782|54246111|FG001|Open-label Period: Maralixibat|Adverse Event|0|||
27791288|NCT02160782|54246112|FG002|Open-label Period: Maralixibat|Adverse Event|0|||
27936523|NCT01256450|54592935|FG001|Double-blind Treatment|Lost to Follow-up|1|||
28017127|NCT00326599|54676407|FG002|Overall Study|Withdrawal by Subject|5|||
27791289|NCT02160782|54246113|FG003|Open-label Period: Maralixibat|Adverse Event|0|||
27791290|NCT02160782|54246114|FG004|Open-label Period: Maralixibat|Adverse Event|0|||
27791291|NCT02160782|54246110|FG000|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
27791292|NCT02160782|54246111|FG001|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
27791293|NCT02160782|54246112|FG002|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
27791294|NCT02160782|54246113|FG003|After Randomized Withdrawal: Maralixibat|Adverse Event|1|||
27791295|NCT02160782|54246114|FG004|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
27791296|NCT02160782|54246110|FG000|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
27791297|NCT02160782|54246111|FG001|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
27791298|NCT02160782|54246112|FG002|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
27791299|NCT02160782|54246113|FG003|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|5|||
27791300|NCT02160782|54246114|FG004|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
27791301|NCT02160782|54246110|FG000|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
27791302|NCT02160782|54246111|FG001|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
27791303|NCT02160782|54246112|FG002|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
27936524|NCT01256450|54592936|FG002|Double-blind Treatment|Lost to Follow-up|7|||
27936525|NCT01256450|54592934|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
27936526|NCT01256450|54592935|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
27936527|NCT01256450|54592936|FG002|Double-blind Treatment|Withdrawal by Subject|1|||
27936528|NCT01256450|54592934|FG000|Double-blind Treatment|Lack of analgesic effect|0|||
27936529|NCT01256450|54592935|FG001|Double-blind Treatment|Lack of analgesic effect|5|||
27936530|NCT01256450|54592936|FG002|Double-blind Treatment|Lack of analgesic effect|6|||
27936531|NCT01256450|54592934|FG000|Double-blind Treatment|Non-compliance|0|||
27936532|NCT01256450|54592935|FG001|Double-blind Treatment|Non-compliance|5|||
27936533|NCT01256450|54592936|FG002|Double-blind Treatment|Non-compliance|4|||
27936534|NCT01256450|54592934|FG000|Double-blind Treatment|Opioid withdrawal symptoms|0|||
27936535|NCT01256450|54592935|FG001|Double-blind Treatment|Opioid withdrawal symptoms|0|||
27936536|NCT01256450|54592936|FG002|Double-blind Treatment|Opioid withdrawal symptoms|1|||
27936537|NCT01256450|54592934|FG000|Double-blind Treatment|Other|0|||
27936538|NCT01256450|54592935|FG001|Double-blind Treatment|Other|9|||
27936539|NCT01256450|54592936|FG002|Double-blind Treatment|Other|12|||
27936540|NCT01204398|54592943|FG000|Overall Study|Adverse Event|1|||
27936541|NCT01111851|54592949|FG000|Overall Study|All planned PET scans were not obtained.|2|||
27936542|NCT01111851|54592950|FG001|Overall Study|All planned PET scans were not obtained.|0|||
27936543|NCT01256294|54592956|FG000|Overall Study|Adverse Event|1|||
27936544|NCT01256294|54592957|FG001|Overall Study|Adverse Event|0|||
27936545|NCT01256294|54592956|FG000|Overall Study|Withdrawal by Subject|1|||
27936546|NCT01256294|54592957|FG001|Overall Study|Withdrawal by Subject|1|||
27936547|NCT01256294|54592956|FG000|Overall Study|Protocol deviation|2|||
27936548|NCT01256294|54592957|FG001|Overall Study|Protocol deviation|1|||
27936549|NCT01256060|54592963|FG000|Overall Study|Lost to Follow-up|0|||
27936550|NCT01256060|54592964|FG001|Overall Study|Lost to Follow-up|1|||
27936551|NCT01256060|54592965|FG002|Overall Study|Lost to Follow-up|0|||
27936552|NCT01256060|54592966|FG003|Overall Study|Lost to Follow-up|0|||
27936553|NCT01255904|54592974|FG000|Overall Study|Physician Decision|1|||
27936554|NCT01255904|54592975|FG001|Overall Study|Physician Decision|4|||
27936555|NCT01255670|54592983|FG000|Overall Study|Adverse Event|10|||
27936556|NCT01255670|54592984|FG001|Overall Study|Adverse Event|10|||
27936557|NCT01255670|54592983|FG000|Overall Study|Lost to Follow-up|16|||
27936558|NCT01255670|54592984|FG001|Overall Study|Lost to Follow-up|10|||
27936559|NCT01255592|54592992|FG000|Overall Study|Adverse Event|5|||
27936560|NCT01255592|54592993|FG001|Overall Study|Adverse Event|0|||
27936561|NCT01255592|54592992|FG000|Overall Study|Withdrawal by Subject|1|||
27936562|NCT01255592|54592993|FG001|Overall Study|Withdrawal by Subject|0|||
27936563|NCT01255592|54592992|FG000|Overall Study|Other|0|||
27936564|NCT01255592|54592993|FG001|Overall Study|Other|1|||
27936565|NCT01255436|54593002|FG000|Overall Study|Lost to Follow-up|178|||
27936566|NCT01255436|54593003|FG001|Overall Study|Lost to Follow-up|191|||
27936567|NCT01255436|54593002|FG000|Overall Study|Death, stroke, or MI|4|||
27936568|NCT01255436|54593003|FG001|Overall Study|Death, stroke, or MI|3|||
27936569|NCT01203930|54593011|FG000|Overall Study|Disease Progression|0|||
27936570|NCT01203930|54593012|FG001|Overall Study|Disease Progression|4|||
27936571|NCT01203930|54593011|FG000|Overall Study|Death|3|||
27936572|NCT01203930|54593012|FG001|Overall Study|Death|1|||
27936573|NCT01203930|54593011|FG000|Overall Study|Withdrew Consent|1|||
27936574|NCT01203930|54593012|FG001|Overall Study|Withdrew Consent|10|||
27936575|NCT01203930|54593011|FG000|Overall Study|Investigator Request|0|||
27936576|NCT01203930|54593012|FG001|Overall Study|Investigator Request|8|||
27936577|NCT01203930|54593011|FG000|Overall Study|Study Terminated by Sponsor|0|||
27936578|NCT01203930|54593012|FG001|Overall Study|Study Terminated by Sponsor|12|||
27936579|NCT01203930|54593011|FG000|Overall Study|Poor tolerance of study drug|0|||
27936580|NCT01203930|54593012|FG001|Overall Study|Poor tolerance of study drug|1|||
28017128|NCT00326599|54676408|FG003|Overall Study|Withdrawal by Subject|2|||
28017129|NCT00326599|54676405|FG000|Overall Study|Adverse Event|1|||
27936581|NCT01203930|54593011|FG000|Overall Study|Adverse Event|17|||
27936582|NCT01203930|54593012|FG001|Overall Study|Adverse Event|5|||
27936583|NCT01254890|54593022|FG000|Overall Study|Ineligible|0|||
27936584|NCT01254890|54593023|FG001|Overall Study|Ineligible|3|||
27936585|NCT01254890|54593022|FG000|Overall Study|Withdrawal by Subject|1|||
27936586|NCT01254890|54593023|FG001|Overall Study|Withdrawal by Subject|2|||
27936587|NCT01254890|54593022|FG000|Overall Study|Disease Progression|0|||
27936588|NCT01254890|54593023|FG001|Overall Study|Disease Progression|5|||
27936589|NCT01203852|54593028|FG000|Metoprolol 8 Weeks|Physician Decision|470|||
27936590|NCT01203852|54593028|FG000|Washout 2 Weeks|Physician Decision|46|||
27936591|NCT01105533|54593035|FG000|Overall Study|Death|0|||
27936592|NCT01105533|54593036|FG001|Overall Study|Death|0|||
27936593|NCT01105533|54593037|FG002|Overall Study|Death|0|||
27936594|NCT01105533|54593038|FG003|Overall Study|Death|0|||
27936595|NCT01105533|54593039|FG004|Overall Study|Death|1|||
27936596|NCT01105533|54593040|FG005|Overall Study|Death|0|||
27936597|NCT01105533|54593041|FG006|Overall Study|Death|0|||
27936598|NCT01105533|54593042|FG007|Overall Study|Death|0|||
27936599|NCT01105533|54593043|FG008|Overall Study|Death|0|||
27936600|NCT01105533|54593035|FG000|Overall Study|Lack of Efficacy|1|||
27936601|NCT01105533|54593036|FG001|Overall Study|Lack of Efficacy|1|||
27936602|NCT01105533|54593037|FG002|Overall Study|Lack of Efficacy|3|||
27936603|NCT01105533|54593038|FG003|Overall Study|Lack of Efficacy|3|||
27936604|NCT01105533|54593039|FG004|Overall Study|Lack of Efficacy|4|||
27936605|NCT01105533|54593040|FG005|Overall Study|Lack of Efficacy|5|||
27936606|NCT01105533|54593041|FG006|Overall Study|Lack of Efficacy|3|||
27936607|NCT01105533|54593042|FG007|Overall Study|Lack of Efficacy|2|||
27936608|NCT01105533|54593043|FG008|Overall Study|Lack of Efficacy|9|||
27936609|NCT01105533|54593035|FG000|Overall Study|Adverse Event|0|||
27936610|NCT01105533|54593036|FG001|Overall Study|Adverse Event|0|||
27936611|NCT01105533|54593037|FG002|Overall Study|Adverse Event|0|||
28017130|NCT00326599|54676406|FG001|Overall Study|Adverse Event|0|||
28017131|NCT00326599|54676407|FG002|Overall Study|Adverse Event|32|||
28017132|NCT00326599|54676408|FG003|Overall Study|Adverse Event|3|||
28017133|NCT00326599|54676405|FG000|Overall Study|Disease Progression|3|||
28017134|NCT00326599|54676406|FG001|Overall Study|Disease Progression|1|||
28017135|NCT00326599|54676407|FG002|Overall Study|Disease Progression|13|||
28017136|NCT00326599|54676408|FG003|Overall Study|Disease Progression|11|||
28017137|NCT00326599|54676405|FG000|Overall Study|Alternate Treatment|1|||
28017138|NCT00326599|54676406|FG001|Overall Study|Alternate Treatment|0|||
28017139|NCT00326599|54676407|FG002|Overall Study|Alternate Treatment|0|||
28017140|NCT00326599|54676408|FG003|Overall Study|Alternate Treatment|0|||
28017141|NCT00326599|54676405|FG000|Overall Study|Death|0|||
28017142|NCT00326599|54676406|FG001|Overall Study|Death|0|||
28017143|NCT00326599|54676407|FG002|Overall Study|Death|1|||
28017144|NCT00326599|54676408|FG003|Overall Study|Death|2|||
28017145|NCT00326599|54676405|FG000|Overall Study|Other Unspecified Reason|0|||
28017146|NCT00326599|54676406|FG001|Overall Study|Other Unspecified Reason|0|||
28017147|NCT00326599|54676407|FG002|Overall Study|Other Unspecified Reason|2|||
27936612|NCT01105533|54593038|FG003|Overall Study|Adverse Event|0|||
27936613|NCT01105533|54593039|FG004|Overall Study|Adverse Event|1|||
27936614|NCT01105533|54593040|FG005|Overall Study|Adverse Event|2|||
28017148|NCT00326599|54676408|FG003|Overall Study|Other Unspecified Reason|1|||
28017149|NCT00539032|54676419|FG000|Overall Study|Withdrawal by Subject|2|||
28017150|NCT00539032|54676420|FG001|Overall Study|Withdrawal by Subject|1|||
27791304|NCT02160782|54246113|FG003|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
27791305|NCT02160782|54246114|FG004|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|4|||
27791306|NCT02160782|54246110|FG000|Long-term Extension Period: Maralixibat|Physician Decision|0|||
27791307|NCT02160782|54246111|FG001|Long-term Extension Period: Maralixibat|Physician Decision|0|||
27791308|NCT02160782|54246112|FG002|Long-term Extension Period: Maralixibat|Physician Decision|0|||
27791309|NCT02160782|54246113|FG003|Long-term Extension Period: Maralixibat|Physician Decision|0|||
28017151|NCT00685802|54676426|FG000|Washout Period of 7 Days|Protocol Violation|2|||
28017152|NCT00685802|54676427|FG001|Washout Period of 7 Days|Protocol Violation|0|||
28017153|NCT00685802|54676426|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
28017154|NCT00685802|54676427|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
27791310|NCT02160782|54246114|FG004|Long-term Extension Period: Maralixibat|Physician Decision|1|||
27791311|NCT02160782|54246110|FG000|Long-term Extension Period: Maralixibat|Adverse Event|0|||
27791312|NCT02160782|54246111|FG001|Long-term Extension Period: Maralixibat|Adverse Event|0|||
27936615|NCT01105533|54593041|FG006|Overall Study|Adverse Event|2|||
27936616|NCT01105533|54593042|FG007|Overall Study|Adverse Event|0|||
27936617|NCT01105533|54593043|FG008|Overall Study|Adverse Event|1|||
27936618|NCT01105533|54593035|FG000|Overall Study|Other|0|||
27936619|NCT01105533|54593036|FG001|Overall Study|Other|0|||
27936620|NCT01105533|54593037|FG002|Overall Study|Other|0|||
27936621|NCT01105533|54593038|FG003|Overall Study|Other|0|||
28017155|NCT00354601|54676433|FG000|Overall Study|Protocol Violation|1|||
27936622|NCT01105533|54593039|FG004|Overall Study|Other|1|||
27936623|NCT01105533|54593040|FG005|Overall Study|Other|0|||
27936624|NCT01105533|54593041|FG006|Overall Study|Other|3|||
27936625|NCT01105533|54593042|FG007|Overall Study|Other|1|||
27936626|NCT01105533|54593043|FG008|Overall Study|Other|2|||
27936627|NCT01105533|54593035|FG000|Overall Study|Physician Decision|0|||
27936628|NCT01105533|54593036|FG001|Overall Study|Physician Decision|0|||
27936629|NCT01105533|54593037|FG002|Overall Study|Physician Decision|0|||
27936630|NCT01105533|54593038|FG003|Overall Study|Physician Decision|0|||
27936631|NCT01105533|54593039|FG004|Overall Study|Physician Decision|0|||
27936632|NCT01105533|54593040|FG005|Overall Study|Physician Decision|0|||
27936633|NCT01105533|54593041|FG006|Overall Study|Physician Decision|0|||
27936634|NCT01105533|54593042|FG007|Overall Study|Physician Decision|1|||
27936635|NCT01105533|54593043|FG008|Overall Study|Physician Decision|0|||
27936636|NCT01203072|54593061|FG000|Overall Study|Adverse Event|5|||
27936637|NCT01203072|54593062|FG001|Overall Study|Adverse Event|3|||
27936638|NCT01203072|54593063|FG002|Overall Study|Adverse Event|2|||
27936639|NCT01203072|54593064|FG003|Overall Study|Adverse Event|4|||
27936640|NCT01203072|54593065|FG004|Overall Study|Adverse Event|2|||
27936641|NCT01203072|54593061|FG000|Overall Study|Lack of Efficacy|1|||
27936642|NCT01203072|54593062|FG001|Overall Study|Lack of Efficacy|0|||
27936643|NCT01203072|54593063|FG002|Overall Study|Lack of Efficacy|0|||
27936644|NCT01203072|54593064|FG003|Overall Study|Lack of Efficacy|0|||
27936645|NCT01203072|54593065|FG004|Overall Study|Lack of Efficacy|0|||
27936646|NCT01203072|54593061|FG000|Overall Study|Lost to Follow-up|0|||
27936647|NCT01203072|54593062|FG001|Overall Study|Lost to Follow-up|1|||
27936648|NCT01203072|54593063|FG002|Overall Study|Lost to Follow-up|0|||
27936649|NCT01203072|54593064|FG003|Overall Study|Lost to Follow-up|0|||
27936650|NCT01203072|54593065|FG004|Overall Study|Lost to Follow-up|0|||
27936651|NCT01203072|54593061|FG000|Overall Study|Protocol Violation|2|||
27936652|NCT01203072|54593062|FG001|Overall Study|Protocol Violation|0|||
27936653|NCT01203072|54593063|FG002|Overall Study|Protocol Violation|0|||
27936654|NCT01203072|54593064|FG003|Overall Study|Protocol Violation|0|||
27936655|NCT01203072|54593065|FG004|Overall Study|Protocol Violation|1|||
27936656|NCT01203072|54593061|FG000|Overall Study|Withdrawal by Subject|2|||
27936657|NCT01203072|54593062|FG001|Overall Study|Withdrawal by Subject|2|||
27936658|NCT01203072|54593063|FG002|Overall Study|Withdrawal by Subject|1|||
27936659|NCT01203072|54593064|FG003|Overall Study|Withdrawal by Subject|2|||
27936660|NCT01203072|54593065|FG004|Overall Study|Withdrawal by Subject|3|||
27936661|NCT01105377|54593079|FG000|Overall Study|Withdrawal by Subject|0|||
27936662|NCT01105377|54593080|FG001|Overall Study|Withdrawal by Subject|1|||
27936663|NCT01105065|54593086|FG000|Overall Study|Adverse Event|5|||
27936664|NCT01105065|54593086|FG000|Overall Study|Technical Problems|1|||
27936665|NCT01111539|54593092|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|6|||
27936666|NCT01111539|54593093|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
27936667|NCT01111539|54593094|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
27936668|NCT01111539|54593095|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
27936669|NCT01111539|54593096|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
27936670|NCT01111539|54593092|FG000|Phase B (Day 1 to Week 8)|Adverse Event|5|||
27936671|NCT01111539|54593093|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
27936672|NCT01111539|54593094|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
27936673|NCT01111539|54593095|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
27936674|NCT01111539|54593096|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
27936675|NCT01111539|54593092|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|60|||
27936676|NCT01111539|54593093|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
27936677|NCT01111539|54593094|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
27936678|NCT01111539|54593095|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
27936679|NCT01111539|54593096|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
27936680|NCT01111539|54593092|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|1|||
27936681|NCT01111539|54593093|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
27936682|NCT01111539|54593094|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
27936683|NCT01111539|54593095|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
27936684|NCT01111539|54593096|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
27936685|NCT01111539|54593092|FG000|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|7|||
27936686|NCT01111539|54593093|FG001|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
27936687|NCT01111539|54593094|FG002|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
27936688|NCT01111539|54593095|FG003|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
27936689|NCT01111539|54593096|FG004|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
27936690|NCT01111539|54593092|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|2|||
27936691|NCT01111539|54593093|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
27936692|NCT01111539|54593094|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
27936693|NCT01111539|54593095|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
27936694|NCT01111539|54593096|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
27936695|NCT01111539|54593092|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|1|||
27936696|NCT01111539|54593093|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
27936697|NCT01111539|54593094|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
27936698|NCT01111539|54593095|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
27936699|NCT01111539|54593096|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
27936700|NCT01111539|54593092|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
27936701|NCT01111539|54593093|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
27936702|NCT01111539|54593094|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
27936703|NCT01111539|54593095|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
27936704|NCT01111539|54593096|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
27936705|NCT01111539|54593092|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
27936706|NCT01111539|54593093|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
27936707|NCT01111539|54593094|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
27936708|NCT01111539|54593095|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
27936709|NCT01111539|54593096|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|2|||
27936710|NCT01111539|54593092|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
27936711|NCT01111539|54593093|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
27936712|NCT01111539|54593094|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
27936713|NCT01111539|54593095|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
27936714|NCT01111539|54593096|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
27936715|NCT01111539|54593092|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
27936716|NCT01111539|54593093|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
27936717|NCT01111539|54593094|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
27936718|NCT01111539|54593095|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
27936719|NCT01111539|54593096|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|1|||
27936720|NCT01111539|54593092|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
27936721|NCT01111539|54593093|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
27936722|NCT01111539|54593094|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
27936723|NCT01111539|54593095|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|1|||
27936724|NCT01111539|54593096|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
27936725|NCT01111539|54593092|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
27936726|NCT01111539|54593093|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
27936727|NCT01111539|54593094|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
27936728|NCT01111539|54593095|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|2|||
27936729|NCT01111539|54593096|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
27936730|NCT01111539|54593092|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
27936731|NCT01111539|54593093|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
27936732|NCT01111539|54593094|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
27936733|NCT01111539|54593095|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
27936734|NCT01111539|54593096|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
27936735|NCT01111149|54593109|FG000|Overall Study|Protocol Violation|1|||
27936736|NCT01111149|54593110|FG001|Overall Study|Protocol Violation|1|||
27936737|NCT01111149|54593111|FG002|Overall Study|Protocol Violation|2|||
27936738|NCT01111149|54593109|FG000|Overall Study|Withdrawal by Subject|1|||
27936739|NCT01111149|54593110|FG001|Overall Study|Withdrawal by Subject|0|||
27936740|NCT01111149|54593111|FG002|Overall Study|Withdrawal by Subject|2|||
27936741|NCT01254656|54593122|FG000|Overall Study|Discontinued due to termination of study|40|||
27936742|NCT01254656|54593123|FG001|Overall Study|Discontinued due to termination of study|39|||
27936743|NCT01254656|54593124|FG002|Overall Study|Discontinued due to termination of study|13|||
27936744|NCT01254656|54593122|FG000|Overall Study|Lack of Efficacy|3|||
27936745|NCT01254656|54593123|FG001|Overall Study|Lack of Efficacy|0|||
27936746|NCT01254656|54593124|FG002|Overall Study|Lack of Efficacy|0|||
28017156|NCT00354601|54676433|FG000|Overall Study|progression|1|||
27791313|NCT02160782|54246112|FG002|Long-term Extension Period: Maralixibat|Adverse Event|0|||
27791314|NCT02160782|54246113|FG003|Long-term Extension Period: Maralixibat|Adverse Event|0|||
27791315|NCT02160782|54246114|FG004|Long-term Extension Period: Maralixibat|Adverse Event|3|||
27791316|NCT02160782|54246110|FG000|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
27791317|NCT02160782|54246111|FG001|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
27791318|NCT02160782|54246112|FG002|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
27791319|NCT02160782|54246113|FG003|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
27791320|NCT02160782|54246114|FG004|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|1|||
27791321|NCT02160626|54246141|FG000|Overall Study|Adverse Event|1|||
27791322|NCT02160626|54246142|FG001|Overall Study|Adverse Event|0|||
27791323|NCT02160626|54246143|FG002|Overall Study|Adverse Event|0|||
27791324|NCT02160626|54246141|FG000|Overall Study|Schedule not conducive to study visits|0|||
27791325|NCT02160626|54246142|FG001|Overall Study|Schedule not conducive to study visits|0|||
27791326|NCT02160626|54246143|FG002|Overall Study|Schedule not conducive to study visits|1|||
27791327|NCT02160626|54246141|FG000|Overall Study|Withdrawal by Subject|0|||
27791328|NCT02160626|54246142|FG001|Overall Study|Withdrawal by Subject|1|||
27791329|NCT02160626|54246143|FG002|Overall Study|Withdrawal by Subject|0|||
27791330|NCT02160314|54246155|FG000|Overall Study|Adverse Event|0|||
27791331|NCT02160314|54246156|FG001|Overall Study|Adverse Event|6|||
27791332|NCT02160314|54246155|FG000|Overall Study|Protocol Violation|0|||
27791333|NCT02160314|54246156|FG001|Overall Study|Protocol Violation|4|||
27791334|NCT02160314|54246155|FG000|Overall Study|Withdrawal by Subject|1|||
27791335|NCT02160314|54246156|FG001|Overall Study|Withdrawal by Subject|2|||
27791336|NCT02160314|54246155|FG000|Overall Study|Lost to Follow-up|0|||
27791337|NCT02160314|54246156|FG001|Overall Study|Lost to Follow-up|1|||
27791338|NCT02160002|54246164|FG000|Overall Study|Withdrawal by Subject|2|||
27791339|NCT02160002|54246165|FG001|Overall Study|Withdrawal by Subject|1|||
27791340|NCT02218268|54246171|FG000|24 Hour Washout|Physician Decision|11|||
27791341|NCT02218268|54246172|FG001|24 Hour Washout|Physician Decision|9|||
27791342|NCT02217878|54246180|FG000|Overall Study|required morphine due to chest pain|1|||
27936747|NCT01254656|54593122|FG000|Overall Study|Lost to Follow-up|1|||
27936748|NCT01254656|54593123|FG001|Overall Study|Lost to Follow-up|0|||
27791343|NCT02217878|54246181|FG001|Overall Study|required morphine due to chest pain|2|||
27791344|NCT02217878|54246180|FG000|Overall Study|initial diagnosis of STEMI not confirmed|1|||
27791345|NCT02217878|54246181|FG001|Overall Study|initial diagnosis of STEMI not confirmed|0|||
27791346|NCT02217566|54246187|FG000|Overall Study|Lost to Follow-up|2|||
27791347|NCT02217566|54246187|FG000|Overall Study|Death|3|||
27791348|NCT02217566|54246187|FG000|Overall Study|Early study termination|6|||
27791349|NCT02217410|54246194|FG000|Overall Study|Graft Loss|0|||
27791350|NCT02217410|54246195|FG001|Overall Study|Graft Loss|0|||
27791351|NCT02217410|54246196|FG002|Overall Study|Graft Loss|2|||
27791352|NCT02217410|54246194|FG000|Overall Study|Withdrawal by Subject|0|||
27791353|NCT02217410|54246195|FG001|Overall Study|Withdrawal by Subject|0|||
27791354|NCT02217410|54246196|FG002|Overall Study|Withdrawal by Subject|2|||
27791355|NCT02217410|54246194|FG000|Overall Study|Lost to Follow-up|0|||
27791356|NCT02217410|54246195|FG001|Overall Study|Lost to Follow-up|0|||
27791357|NCT02217410|54246196|FG002|Overall Study|Lost to Follow-up|1|||
27791358|NCT02217410|54246194|FG000|Overall Study|Lack of Efficacy|0|||
27791359|NCT02217410|54246195|FG001|Overall Study|Lack of Efficacy|1|||
27791360|NCT02217410|54246196|FG002|Overall Study|Lack of Efficacy|0|||
27791361|NCT02217410|54246194|FG000|Overall Study|Physician Decision|1|||
27791362|NCT02217410|54246195|FG001|Overall Study|Physician Decision|3|||
27791363|NCT02217410|54246196|FG002|Overall Study|Physician Decision|0|||
27791364|NCT02217332|54246209|FG000|Overall Study|Adverse Event|3|||
27791365|NCT02217332|54246209|FG000|Overall Study|Dose interruption >1 month|1|||
27791366|NCT02217332|54246209|FG000|Overall Study|Protocol Violation (eligibility)|1|||
27791367|NCT02217332|54246209|FG000|Overall Study|Withdrawal by Subject|1|||
27791368|NCT02217332|54246209|FG000|Overall Study|Lost to Follow-up|1|||
27791369|NCT02184572|54246215|FG000|Overall Study|Lost to Follow-up|29|||
27791370|NCT02184572|54246216|FG001|Overall Study|Lost to Follow-up|21|||
27791371|NCT02184572|54246215|FG000|Overall Study|Family Out Of Country Until 9/29/2015|1|||
27791372|NCT02184572|54246216|FG001|Overall Study|Family Out Of Country Until 9/29/2015|0|||
27791373|NCT02184572|54246215|FG000|Overall Study|Loss Of Kaiser Insurance|1|||
27791374|NCT02184572|54246216|FG001|Overall Study|Loss Of Kaiser Insurance|0|||
27791375|NCT02184572|54246215|FG000|Overall Study|2nd blooddraw & diary card incomplete|1|||
27791376|NCT02184572|54246216|FG001|Overall Study|2nd blooddraw & diary card incomplete|0|||
27791377|NCT02184572|54246215|FG000|Overall Study|Traveling Outside The Country|1|||
27791378|NCT02184572|54246216|FG001|Overall Study|Traveling Outside The Country|0|||
27791379|NCT02184572|54246215|FG000|Overall Study|Withdrawal by Subject|14|||
27791380|NCT02184572|54246216|FG001|Overall Study|Withdrawal by Subject|9|||
27791381|NCT02181842|54246224|FG000|Overall Study|Case Report Forms Uncollected|2|||
27791382|NCT01632020|54246230|FG000|Overall Study|Withdrawal by Subject|1|||
27791383|NCT01632020|54246231|FG001|Overall Study|Withdrawal by Subject|0|||
27791384|NCT01632020|54246230|FG000|Overall Study|Adverse Event|1|||
27791385|NCT01632020|54246231|FG001|Overall Study|Adverse Event|0|||
27936749|NCT01254656|54593124|FG002|Overall Study|Lost to Follow-up|2|||
27791386|NCT02181296|54246239|FG000|Overall Study|Lost to Follow-up|7|||
27791387|NCT02181296|54246240|FG001|Overall Study|Lost to Follow-up|6|||
27791388|NCT02215616|54246250|FG000|Overall Study|Sponsor requested to stop study drug|0|||
27791389|NCT02215616|54246251|FG001|Overall Study|Sponsor requested to stop study drug|0|||
27791390|NCT02215616|54246252|FG002|Overall Study|Sponsor requested to stop study drug|1|||
27791391|NCT02215616|54246253|FG003|Overall Study|Sponsor requested to stop study drug|4|||
27791392|NCT02215616|54246250|FG000|Overall Study|Death|1|||
27791393|NCT02215616|54246251|FG001|Overall Study|Death|0|||
27791394|NCT02215616|54246252|FG002|Overall Study|Death|0|||
27791395|NCT02215616|54246253|FG003|Overall Study|Death|0|||
27791396|NCT02215616|54246250|FG000|Overall Study|Adverse Event|7|||
27791397|NCT02215616|54246251|FG001|Overall Study|Adverse Event|4|||
27791398|NCT02215616|54246252|FG002|Overall Study|Adverse Event|9|||
27936750|NCT01254656|54593122|FG000|Overall Study|Withdrawal by Subject|2|||
27791399|NCT02215616|54246253|FG003|Overall Study|Adverse Event|2|||
27936751|NCT01254656|54593123|FG001|Overall Study|Withdrawal by Subject|2|||
27791400|NCT02215616|54246250|FG000|Overall Study|Withdrawal by Subject|1|||
27791401|NCT02215616|54246251|FG001|Overall Study|Withdrawal by Subject|8|||
27791402|NCT02215616|54246252|FG002|Overall Study|Withdrawal by Subject|2|||
27936752|NCT01254656|54593124|FG002|Overall Study|Withdrawal by Subject|1|||
27936753|NCT01254656|54593122|FG000|Overall Study|Pregnancy|0|||
27936754|NCT01254656|54593123|FG001|Overall Study|Pregnancy|0|||
27936755|NCT01254656|54593124|FG002|Overall Study|Pregnancy|2|||
27936756|NCT01254656|54593122|FG000|Overall Study|Adverse Event|1|||
27936757|NCT01254656|54593123|FG001|Overall Study|Adverse Event|1|||
27936758|NCT01254656|54593124|FG002|Overall Study|Adverse Event|0|||
27936759|NCT01254656|54593122|FG000|Overall Study|Death|0|||
27936760|NCT01254656|54593123|FG001|Overall Study|Death|1|||
27936761|NCT01254656|54593124|FG002|Overall Study|Death|0|||
27936762|NCT01110915|54593134|FG000|Overall Study|Death|2|||
27791403|NCT02215616|54246253|FG003|Overall Study|Withdrawal by Subject|5|||
27791404|NCT02215616|54246250|FG000|Overall Study|Non-compliance|0|||
27791405|NCT02215616|54246251|FG001|Overall Study|Non-compliance|2|||
27791406|NCT02215616|54246252|FG002|Overall Study|Non-compliance|1|||
27791407|NCT02215616|54246253|FG003|Overall Study|Non-compliance|0|||
27791408|NCT02215616|54246250|FG000|Overall Study|Protocol Violation|0|||
27791409|NCT02215616|54246251|FG001|Overall Study|Protocol Violation|2|||
27791410|NCT02215616|54246252|FG002|Overall Study|Protocol Violation|0|||
27791411|NCT02215616|54246253|FG003|Overall Study|Protocol Violation|0|||
27791412|NCT02215616|54246250|FG000|Overall Study|Lost to Follow-up|1|||
27791413|NCT02215616|54246251|FG001|Overall Study|Lost to Follow-up|1|||
27791414|NCT02215616|54246252|FG002|Overall Study|Lost to Follow-up|0|||
27791415|NCT02215616|54246253|FG003|Overall Study|Lost to Follow-up|1|||
27791416|NCT02215616|54246250|FG000|Overall Study|Other than specified|1|||
27791417|NCT02215616|54246251|FG001|Overall Study|Other than specified|0|||
27791418|NCT02215616|54246252|FG002|Overall Study|Other than specified|1|||
27791419|NCT02215616|54246253|FG003|Overall Study|Other than specified|1|||
27791420|NCT02213666|54246263|FG000|Overall Study|Withdrawal by Subject|1|||
28017157|NCT03827473|54676439|FG000|Overall Study|Withdrawal by Subject|1|||
28017158|NCT03827473|54676440|FG001|Overall Study|Withdrawal by Subject|0|||
28017159|NCT00345397|54676446|FG000|Overall Study|Death|1|||
28017160|NCT00326209|54676451|FG000|Overall Study|Adverse Event|28|||
28017161|NCT00326209|54676451|FG000|Overall Study|Withdrawal by Subject|22|||
28017162|NCT00326209|54676451|FG000|Overall Study|Lack of Efficacy|31|||
28017163|NCT00326209|54676451|FG000|Overall Study|Lost to Follow-up|18|||
28017164|NCT00326209|54676451|FG000|Overall Study|Participant non-compliant|6|||
28017165|NCT00326209|54676451|FG000|Overall Study|Sponsor closed study|173|||
28017166|NCT00326209|54676451|FG000|Overall Study|Prohibited medication use|1|||
28017167|NCT00326209|54676451|FG000|Overall Study|Violation of entry criteria|1|||
28017168|NCT00326209|54676451|FG000|Overall Study|Withdrawn in error|1|||
28017169|NCT00326209|54676451|FG000|Overall Study|Pregnancy|1|||
28017170|NCT00537940|54676457|FG000|Overall Study|Adverse Event|20|||
28017171|NCT00537940|54676458|FG001|Overall Study|Adverse Event|19|||
28017172|NCT00537940|54676457|FG000|Overall Study|Lack of Efficacy|8|||
28017173|NCT00537940|54676458|FG001|Overall Study|Lack of Efficacy|16|||
28017174|NCT00537940|54676457|FG000|Overall Study|Lost to Follow-up|23|||
28017175|NCT00537940|54676458|FG001|Overall Study|Lost to Follow-up|29|||
28017176|NCT00537940|54676457|FG000|Overall Study|Withdrawal by Subject|113|||
28017177|NCT00537940|54676458|FG001|Overall Study|Withdrawal by Subject|95|||
28017178|NCT00537940|54676457|FG000|Overall Study|Protocol Violation|6|||
28017179|NCT00537940|54676458|FG001|Overall Study|Protocol Violation|4|||
28017180|NCT00537940|54676457|FG000|Overall Study|Pregnancy|1|||
28017181|NCT00537940|54676458|FG001|Overall Study|Pregnancy|1|||
28017182|NCT00537940|54676457|FG000|Overall Study|Study terminated by sponsor|2|||
28017183|NCT00537940|54676458|FG001|Overall Study|Study terminated by sponsor|3|||
28017184|NCT00537940|54676457|FG000|Overall Study|Other|10|||
28017185|NCT00537940|54676458|FG001|Overall Study|Other|12|||
27791421|NCT02213510|54246269|FG000|Overall Study|Death|0|||
27791422|NCT02213510|54246270|FG001|Overall Study|Death|1|||
27791423|NCT02213510|54246269|FG000|Overall Study|Lost to Follow-up|1|||
27791424|NCT02213510|54246270|FG001|Overall Study|Lost to Follow-up|0|||
27791425|NCT02158442|54246278|FG000|Overall Study|Withdrawal by Subject|1|||
27791426|NCT02158442|54246279|FG001|Overall Study|Withdrawal by Subject|0|||
27842527|NCT01550744|54331107|FG001|Open-Label|Not all 3 study drug injections received|0|||
27936763|NCT01110915|54593135|FG001|Overall Study|Death|1|||
28017186|NCT00661362|54676466|FG000|Overall Study|Adverse Event|5|||
28017187|NCT00661362|54676467|FG001|Overall Study|Adverse Event|4|||
28017188|NCT00661362|54676466|FG000|Overall Study|Incorrect enrollment|2|||
28017189|NCT00661362|54676467|FG001|Overall Study|Incorrect enrollment|0|||
28017190|NCT00661362|54676466|FG000|Overall Study|Study specific discontinuation criteria|4|||
28017191|NCT00661362|54676467|FG001|Overall Study|Study specific discontinuation criteria|11|||
28017192|NCT00661362|54676466|FG000|Overall Study|Withdrawal by Subject|13|||
27936764|NCT01110915|54593134|FG000|Overall Study|Lost to Follow-up|1|||
27936765|NCT01110915|54593135|FG001|Overall Study|Lost to Follow-up|0|||
27936766|NCT01110915|54593134|FG000|Overall Study|Withdrawal by Subject|7|||
27936767|NCT01110915|54593135|FG001|Overall Study|Withdrawal by Subject|1|||
27936768|NCT01254344|54593144|FG000|Overall Study|Adverse Event|2|||
27936769|NCT01254344|54593145|FG001|Overall Study|Adverse Event|5|||
27936770|NCT01254344|54593144|FG000|Overall Study|Physician Decision|7|||
27936771|NCT01254344|54593145|FG001|Overall Study|Physician Decision|4|||
27936772|NCT01254344|54593144|FG000|Overall Study|Protocol Violation|1|||
27936773|NCT01254344|54593145|FG001|Overall Study|Protocol Violation|4|||
27936774|NCT01254344|54593144|FG000|Overall Study|Withdrawal by Subject|3|||
27936775|NCT01254344|54593145|FG001|Overall Study|Withdrawal by Subject|6|||
27936776|NCT01102803|54593153|FG000|Baseline to Post-Treatment|Lost to Follow-up|3|||
27936777|NCT01102803|54593154|FG001|Baseline to Post-Treatment|Lost to Follow-up|0|||
27936778|NCT01102803|54593153|FG000|Post to Follow-Up|Lost to Follow-up|1|||
27936779|NCT01102803|54593154|FG001|Post to Follow-Up|Lost to Follow-up|3|||
27936780|NCT01254188|54593162|FG000|Overall Study|Disease Progression|6|||
27936781|NCT01254188|54593162|FG000|Overall Study|Protocol Violation|6|||
27936782|NCT01254188|54593162|FG000|Overall Study|Pregnancy|2|||
27791427|NCT02158442|54246278|FG000|Overall Study|Perfusion staff not available|1|||
27791428|NCT02158442|54246279|FG001|Overall Study|Perfusion staff not available|0|||
27791429|NCT02158364|54246285|FG000|Overall Study|Case report forms uncollected|10|||
27791430|NCT02158364|54246285|FG000|Overall Study|Protocol Deviation|50|||
27791431|NCT02180672|54246291|FG000|Overall Study|Lost to Follow-up|5|||
27791432|NCT02180672|54246292|FG001|Overall Study|Lost to Follow-up|7|||
27791433|NCT02213198|54246300|FG000|Baseline|No show for intake|7|||
27791434|NCT02213198|54246301|FG001|Baseline|No show for intake|9|||
27791435|NCT02213198|54246300|FG000|Baseline|Withdrawal by Subject|34|||
27791436|NCT02213198|54246301|FG001|Baseline|Withdrawal by Subject|11|||
27791437|NCT02213198|54246300|FG000|Baseline|transferred out of clinic|7|||
27791438|NCT02213198|54246301|FG001|Baseline|transferred out of clinic|9|||
27791439|NCT02213198|54246300|FG000|Baseline|Lost to Follow-up|40|||
27791440|NCT02213198|54246301|FG001|Baseline|Lost to Follow-up|21|||
27936783|NCT01254188|54593162|FG000|Overall Study|Death|4|||
27936784|NCT01254188|54593162|FG000|Overall Study|Lost to Follow-up|5|||
27936785|NCT01254188|54593162|FG000|Overall Study|Withdrawal by Subject|7|||
27936786|NCT01254188|54593162|FG000|Overall Study|Adverse Event|43|||
27936787|NCT01254188|54593162|FG000|Overall Study|per investigator discretion|20|||
27936788|NCT01109979|54593168|FG000|Overall Study|Physician Decision|2|||
27936789|NCT01109979|54593169|FG001|Overall Study|Physician Decision|0|||
27936790|NCT01109979|54593168|FG000|Overall Study|Withdrawal by Subject|0|||
27936791|NCT01109979|54593169|FG001|Overall Study|Withdrawal by Subject|1|||
27936792|NCT01102491|54593177|FG000|Overall Study|Protocol Violation|11|||
27936793|NCT01102491|54593178|FG001|Overall Study|Protocol Violation|12|||
27936794|NCT01102257|54593186|FG000|Overall Study|Adverse Event|1|||
27936795|NCT01102257|54593187|FG001|Overall Study|Adverse Event|0|||
27936796|NCT01102257|54593186|FG000|Overall Study|Adverse Event|1|||
27936797|NCT01102257|54593187|FG001|Overall Study|Adverse Event|0|||
27936798|NCT01253564|54593193|FG000|Overall Study|Disease Progression|22|||
27936799|NCT01253564|54593193|FG000|Overall Study|Withdrawal by Subject|1|||
27936800|NCT01253564|54593193|FG000|Overall Study|Serious Adverse Event|1|||
27936801|NCT01108809|54593197|FG000|Overall Study|Adverse Event|3|||
27936802|NCT01108809|54593197|FG000|Overall Study|Lost to Follow-up|1|||
27936803|NCT01253408|54593205|FG000|Overall Study|Adverse Event|0|||
27936804|NCT01253408|54593206|FG001|Overall Study|Adverse Event|1|||
27936805|NCT01253408|54593207|FG002|Overall Study|Adverse Event|0|||
27936806|NCT01253174|54593215|FG000|Period 1|Randomized but not treated|0|||
27936807|NCT01253174|54593216|FG001|Period 1|Randomized but not treated|1|||
27936808|NCT01253174|54593217|FG002|Period 1|Randomized but not treated|1|||
27936809|NCT01253174|54593218|FG003|Period 1|Randomized but not treated|0|||
27936810|NCT01253174|54593219|FG004|Period 1|Randomized but not treated|1|||
27936811|NCT01253174|54593220|FG005|Period 1|Randomized but not treated|0|||
27936812|NCT01253174|54593215|FG000|Period 2|Adverse Event|0|||
27936813|NCT01253174|54593216|FG001|Period 2|Adverse Event|0|||
28017193|NCT00661362|54676467|FG001|Overall Study|Withdrawal by Subject|23|||
27791441|NCT02213198|54246300|FG000|Baseline|incarcerated,violent|0|||
27791442|NCT02213198|54246301|FG001|Baseline|incarcerated,violent|1|||
27791443|NCT02213198|54246300|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
27791444|NCT02213198|54246301|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
27936814|NCT01253174|54593217|FG002|Period 2|Adverse Event|1|||
27936815|NCT01253174|54593218|FG003|Period 2|Adverse Event|0|||
27936816|NCT01253174|54593219|FG004|Period 2|Adverse Event|0|||
27936817|NCT01253174|54593220|FG005|Period 2|Adverse Event|0|||
27936818|NCT01253174|54593215|FG000|Period 3|Withdrawal by Subject|0|||
27936819|NCT01253174|54593216|FG001|Period 3|Withdrawal by Subject|1|||
28105617|NCT04474197|54763097|FG002|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
27936820|NCT01253174|54593217|FG002|Period 3|Withdrawal by Subject|0|||
27936821|NCT01253174|54593218|FG003|Period 3|Withdrawal by Subject|0|||
27936822|NCT01253174|54593219|FG004|Period 3|Withdrawal by Subject|1|||
27936823|NCT01253174|54593220|FG005|Period 3|Withdrawal by Subject|0|||
27936824|NCT01253174|54593215|FG000|Period 3|Pregnancy|0|||
27936825|NCT01253174|54593216|FG001|Period 3|Pregnancy|0|||
27936826|NCT01253174|54593217|FG002|Period 3|Pregnancy|1|||
27936827|NCT01253174|54593218|FG003|Period 3|Pregnancy|0|||
27791445|NCT02213198|54246300|FG000|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3|||
27791446|NCT02213198|54246301|FG001|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2|||
27791447|NCT02213198|54246300|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Death|1|||
27791448|NCT02213198|54246301|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Death|0|||
27791449|NCT02213198|54246300|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68|||
27791450|NCT02213198|54246301|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25|||
27791451|NCT02213198|54246300|FG000|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17|||
27791452|NCT02213198|54246301|FG001|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10|||
27791453|NCT02213198|54246300|FG000|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23|||
27791454|NCT02213198|54246301|FG001|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7|||
27791455|NCT02157506|54246312|FG000|Overall Study|Adverse Event|0|||
27791456|NCT02157506|54246313|FG001|Overall Study|Adverse Event|1|||
27791457|NCT02157506|54246314|FG002|Overall Study|Adverse Event|0|||
27791458|NCT02157506|54246315|FG003|Overall Study|Adverse Event|0|||
27791459|NCT02157506|54246316|FG004|Overall Study|Adverse Event|0|||
27791460|NCT02157506|54246312|FG000|Overall Study|Lost to Follow-up|0|||
27791461|NCT02157506|54246313|FG001|Overall Study|Lost to Follow-up|0|||
27791462|NCT02157506|54246314|FG002|Overall Study|Lost to Follow-up|1|||
27791463|NCT02157506|54246315|FG003|Overall Study|Lost to Follow-up|0|||
27791464|NCT02157506|54246316|FG004|Overall Study|Lost to Follow-up|0|||
27791465|NCT01920711|54246330|FG000|Overall Study|Death|347|||
27791466|NCT01920711|54246331|FG001|Overall Study|Death|356|||
27791467|NCT01920711|54246330|FG000|Overall Study|Lost to Follow-up|13|||
27791468|NCT01920711|54246331|FG001|Overall Study|Lost to Follow-up|14|||
27791469|NCT01920711|54246330|FG000|Overall Study|Withdrawal by Subject|4|||
27791470|NCT01920711|54246331|FG001|Overall Study|Withdrawal by Subject|3|||
27791471|NCT02180438|54246338|FG000|Overall Study|Lost to Follow-up|1|||
27791472|NCT02179190|54246342|FG000|Enrollment|Exit Prior to Device Attempt|11|||
27791473|NCT02179190|54246342|FG000|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7|||
27791474|NCT02179190|54246342|FG000|Follow-Up Post Barrel VRD Implanted|Death|3|||
27791475|NCT02179190|54246342|FG000|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3|||
27791476|NCT02179190|54246342|FG000|Follow-Up Post Barrel VRD Implanted|Physician Decision|2|||
27791477|NCT02179190|54246342|FG000|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1|||
27791478|NCT02157116|54246346|FG000|Overall Study|Withdrawal by Subject|4|||
27791479|NCT02157116|54246346|FG000|Overall Study|Physician Decision|3|||
27791480|NCT02157116|54246346|FG000|Overall Study|Failed Screening|2|||
27791481|NCT01920555|54246355|FG000|Overall Study|Physician Decision|1|||
27791482|NCT01920555|54246356|FG001|Overall Study|Physician Decision|2|||
27791483|NCT01920555|54246357|FG002|Overall Study|Physician Decision|1|||
27791484|NCT01920555|54246358|FG003|Overall Study|Physician Decision|2|||
27791485|NCT01920555|54246359|FG004|Overall Study|Physician Decision|0|||
27791486|NCT01920555|54246355|FG000|Overall Study|Lack of Efficacy|2|||
27791487|NCT01920555|54246356|FG001|Overall Study|Lack of Efficacy|0|||
27791488|NCT01920555|54246357|FG002|Overall Study|Lack of Efficacy|0|||
27791489|NCT01920555|54246358|FG003|Overall Study|Lack of Efficacy|0|||
27791490|NCT01920555|54246359|FG004|Overall Study|Lack of Efficacy|0|||
27791491|NCT01920555|54246355|FG000|Overall Study|Travel Difficulties|1|||
27791492|NCT01920555|54246356|FG001|Overall Study|Travel Difficulties|1|||
27791493|NCT01920555|54246357|FG002|Overall Study|Travel Difficulties|0|||
27791494|NCT01920555|54246358|FG003|Overall Study|Travel Difficulties|0|||
27791495|NCT01920555|54246359|FG004|Overall Study|Travel Difficulties|1|||
27791496|NCT01920555|54246355|FG000|Overall Study|Lost to Follow-up|0|||
27791497|NCT01920555|54246356|FG001|Overall Study|Lost to Follow-up|1|||
27791498|NCT01920555|54246357|FG002|Overall Study|Lost to Follow-up|0|||
27791499|NCT01920555|54246358|FG003|Overall Study|Lost to Follow-up|1|||
27791500|NCT01920555|54246359|FG004|Overall Study|Lost to Follow-up|0|||
27791501|NCT02156804|54246371|FG000|Overall Study|Withdrawal by Subject|1|||
27791502|NCT02156492|54246378|FG000|Period 1|No Reason Given|0|||
27791503|NCT02156492|54246379|FG001|Period 1|No Reason Given|1|||
27791504|NCT02156492|54246380|FG002|Period 1|No Reason Given|0|||
27791505|NCT02156492|54246378|FG000|Period 3|Adverse Event|0|||
27791506|NCT02156492|54246379|FG001|Period 3|Adverse Event|1|||
27791507|NCT02156492|54246380|FG002|Period 3|Adverse Event|0|||
27791508|NCT01920477|54246400|FG000|Overall Study|Adverse Event|0|||
27791509|NCT01920477|54246401|FG001|Overall Study|Adverse Event|1|||
27791510|NCT01920477|54246400|FG000|Overall Study|Lack of Efficacy|1|||
27936828|NCT01253174|54593219|FG004|Period 3|Pregnancy|0|||
27791511|NCT01920477|54246401|FG001|Overall Study|Lack of Efficacy|0|||
27791512|NCT01920477|54246400|FG000|Overall Study|Study closed/terminated|14|||
27791513|NCT01920477|54246401|FG001|Overall Study|Study closed/terminated|15|||
27791514|NCT01920477|54246400|FG000|Overall Study|Withdrawal by Subject|0|||
27791515|NCT01920477|54246401|FG001|Overall Study|Withdrawal by Subject|1|||
27791516|NCT02213042|54246410|FG000|Overall Study|Disease progression (incl. death due to disease progression)|14|||
27936829|NCT01253174|54593220|FG005|Period 3|Pregnancy|0|||
27791517|NCT02213042|54246411|FG001|Overall Study|Disease progression (incl. death due to disease progression)|13|||
27791518|NCT02213042|54246412|FG002|Overall Study|Disease progression (incl. death due to disease progression)|8|||
27791519|NCT02213042|54246410|FG000|Overall Study|Adverse Event|2|||
27791520|NCT02213042|54246411|FG001|Overall Study|Adverse Event|1|||
27791521|NCT02213042|54246412|FG002|Overall Study|Adverse Event|0|||
27791522|NCT02213042|54246410|FG000|Overall Study|Withdrawal by Subject|0|||
27791523|NCT02213042|54246411|FG001|Overall Study|Withdrawal by Subject|1|||
27791524|NCT02213042|54246412|FG002|Overall Study|Withdrawal by Subject|1|||
27791525|NCT02213042|54246410|FG000|Overall Study|Protocol Violation|1|||
27791526|NCT02213042|54246411|FG001|Overall Study|Protocol Violation|0|||
27791527|NCT02213042|54246412|FG002|Overall Study|Protocol Violation|0|||
27791528|NCT02213042|54246410|FG000|Overall Study|Investigator discretion|0|||
27791529|NCT02213042|54246411|FG001|Overall Study|Investigator discretion|0|||
27791530|NCT02213042|54246412|FG002|Overall Study|Investigator discretion|1|||
27791531|NCT02212730|54246424|FG000|Overall Study|Tumor not of the required cell histology|1|||
27791532|NCT02212730|54246425|FG001|Overall Study|Tumor not of the required cell histology|0|||
27791533|NCT02212730|54246424|FG000|Overall Study|Withdrawal by Subject|1|||
27842528|NCT01550744|54331108|FG002|Open-Label|Not all 3 study drug injections received|0|||
27842529|NCT01550744|54331106|FG000|Open-Label|Static PGA-cleared/minimal not achieved|58|||
27842530|NCT01550744|54331107|FG001|Open-Label|Static PGA-cleared/minimal not achieved|0|||
27842531|NCT01550744|54331108|FG002|Open-Label|Static PGA-cleared/minimal not achieved|0|||
27842532|NCT01550744|54331106|FG000|Open-Label|Other|1|||
27842533|NCT01550744|54331107|FG001|Open-Label|Other|0|||
27842534|NCT01550744|54331108|FG002|Open-Label|Other|0|||
27791534|NCT02212730|54246425|FG001|Overall Study|Withdrawal by Subject|0|||
27791535|NCT02212730|54246424|FG000|Overall Study|Disease progression prior to RCC surgery|0|||
27791536|NCT02212730|54246425|FG001|Overall Study|Disease progression prior to RCC surgery|1|||
27791537|NCT02178956|54246435|FG000|Overall Study|Lost to Follow-up|4|||
27791538|NCT02178956|54246436|FG001|Overall Study|Lost to Follow-up|4|||
27791539|NCT02178956|54246435|FG000|Overall Study|Sponsor terminated study|49|||
27791540|NCT02178956|54246436|FG001|Overall Study|Sponsor terminated study|58|||
27791541|NCT02178956|54246435|FG000|Overall Study|Withdrawal by Subject|15|||
27791542|NCT02178956|54246436|FG001|Overall Study|Withdrawal by Subject|11|||
27791543|NCT02178956|54246435|FG000|Overall Study|Various Reasons|3|||
27791544|NCT02178956|54246436|FG001|Overall Study|Various Reasons|5|||
27791545|NCT02211638|54246446|FG000|Overall Study|Case Report Forms Uncollected|291|||
27791546|NCT02211638|54246446|FG000|Overall Study|Protocol Violation|692|||
27791547|NCT02178566|54246452|FG000|Overall Study|patient did not complete due to noncompliance|0|||
27791548|NCT02178566|54246453|FG001|Overall Study|patient did not complete due to noncompliance|1|||
27791549|NCT02211014|54246461|FG000|Overall Study|Adverse Event|0|||
27791550|NCT02211014|54246462|FG001|Overall Study|Adverse Event|2|||
27791551|NCT02211014|54246461|FG000|Overall Study|Physician Decision|1|||
27791552|NCT02211014|54246462|FG001|Overall Study|Physician Decision|2|||
27791553|NCT02211014|54246461|FG000|Overall Study|Started another cancer therapy|1|||
27791554|NCT02211014|54246462|FG001|Overall Study|Started another cancer therapy|0|||
27791555|NCT02211014|54246461|FG000|Overall Study|Withdrawal by Subject|0|||
27791556|NCT02211014|54246462|FG001|Overall Study|Withdrawal by Subject|1|||
27791557|NCT02211014|54246461|FG000|Overall Study|In agreement with patient, no benefit|0|||
27791558|NCT02211014|54246462|FG001|Overall Study|In agreement with patient, no benefit|1|||
27791559|NCT01631864|54246486|FG000|Overall Study|Withdrawal by Subject|0|||
27791560|NCT01631864|54246487|FG001|Overall Study|Withdrawal by Subject|1|||
27791561|NCT01631864|54246486|FG000|Overall Study|Adverse Event|2|||
27791562|NCT01631864|54246487|FG001|Overall Study|Adverse Event|3|||
27791563|NCT02210780|54246495|FG000|Overall Study|Adverse Event|0|||
27791564|NCT02210780|54246496|FG001|Overall Study|Adverse Event|5|||
27791565|NCT02210780|54246495|FG000|Overall Study|Lost to Follow-up|2|||
27791566|NCT02210780|54246496|FG001|Overall Study|Lost to Follow-up|1|||
27791567|NCT02210780|54246495|FG000|Overall Study|Withdrawal by Subject|1|||
27791568|NCT02210780|54246496|FG001|Overall Study|Withdrawal by Subject|1|||
27791569|NCT02210780|54246495|FG000|Overall Study|Physician Decision|1|||
27791570|NCT02210780|54246496|FG001|Overall Study|Physician Decision|0|||
27791571|NCT02210780|54246495|FG000|Overall Study|Protocol Violation|1|||
27791572|NCT02210780|54246496|FG001|Overall Study|Protocol Violation|0|||
27791573|NCT02210780|54246495|FG000|Overall Study|Other than specified above|0|||
27791574|NCT02210780|54246496|FG001|Overall Study|Other than specified above|1|||
27791575|NCT01557244|54246507|FG000|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
27791576|NCT01557244|54246508|FG001|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
27791577|NCT01557244|54246509|FG002|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
27791578|NCT01557244|54246510|FG003|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
27842535|NCT01550744|54331106|FG000|Double-Blind|Lost to Follow-up|0|||
27842536|NCT01550744|54331107|FG001|Double-Blind|Lost to Follow-up|6|||
27936830|NCT01108731|54593231|FG000|Overall Study|Withdrawal by Subject|1|||
27936831|NCT01108731|54593232|FG001|Overall Study|Withdrawal by Subject|1|||
27936832|NCT01108731|54593231|FG000|Overall Study|Adverse Event|3|||
27791579|NCT01557244|54246511|FG004|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
27791580|NCT01557244|54246512|FG005|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
27936833|NCT01108731|54593232|FG001|Overall Study|Adverse Event|3|||
27936834|NCT01253018|54593240|FG000|Overall Study|Lost to Follow-up|1|||
27936835|NCT01253018|54593241|FG001|Overall Study|Lost to Follow-up|1|||
27936836|NCT01253018|54593240|FG000|Overall Study|Robot Repair Issues|2|||
27936837|NCT01253018|54593241|FG001|Overall Study|Robot Repair Issues|0|||
27936838|NCT01253018|54593240|FG000|Overall Study|Withdrawal by Subject|1|||
27791581|NCT01557244|54246513|FG006|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
27791582|NCT01557244|54246507|FG000|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2|||
27791583|NCT01557244|54246508|FG001|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
27791584|NCT01557244|54246509|FG002|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1|||
27791585|NCT01557244|54246510|FG003|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
27791586|NCT01557244|54246511|FG004|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
27791587|NCT01557244|54246512|FG005|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
27791588|NCT01557244|54246513|FG006|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
27791589|NCT01557244|54246507|FG000|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1|||
27791590|NCT01557244|54246508|FG001|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
27791591|NCT01557244|54246509|FG002|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
27791592|NCT01557244|54246510|FG003|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
27791593|NCT01557244|54246511|FG004|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
27791594|NCT01557244|54246512|FG005|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
27791595|NCT01557244|54246513|FG006|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
27791596|NCT01557244|54246507|FG000|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2|||
27791597|NCT01557244|54246508|FG001|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
27791598|NCT01557244|54246509|FG002|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
27791599|NCT01557244|54246510|FG003|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
27791600|NCT01557244|54246511|FG004|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
27791601|NCT01557244|54246512|FG005|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3|||
27791602|NCT01557244|54246513|FG006|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
27791603|NCT01557244|54246507|FG000|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
27791604|NCT01557244|54246508|FG001|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1|||
27791605|NCT01557244|54246509|FG002|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
27791606|NCT01557244|54246510|FG003|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
27791607|NCT01557244|54246511|FG004|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
27791608|NCT01557244|54246512|FG005|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
27791609|NCT01557244|54246513|FG006|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
27791610|NCT01557244|54246507|FG000|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
27791611|NCT01557244|54246508|FG001|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
27791612|NCT01557244|54246509|FG002|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
27791613|NCT01557244|54246510|FG003|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
27791614|NCT01557244|54246511|FG004|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
27791615|NCT01557244|54246512|FG005|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
27791616|NCT01557244|54246513|FG006|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
27791617|NCT01557244|54246507|FG000|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
27791618|NCT01557244|54246508|FG001|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
27791619|NCT01557244|54246509|FG002|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
27791620|NCT01557244|54246510|FG003|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
27791621|NCT01557244|54246511|FG004|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
27791622|NCT01557244|54246512|FG005|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
27791623|NCT01557244|54246513|FG006|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
27791624|NCT01557244|54246507|FG000|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
27791625|NCT01557244|54246508|FG001|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
27791626|NCT01557244|54246509|FG002|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
27791627|NCT01557244|54246510|FG003|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
27791628|NCT01557244|54246511|FG004|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
27791629|NCT01557244|54246512|FG005|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
27791630|NCT01557244|54246513|FG006|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
27791631|NCT01557244|54246507|FG000|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
27936839|NCT01253018|54593241|FG001|Overall Study|Withdrawal by Subject|1|||
27936840|NCT01108341|54593248|FG000|Overall Study|Death|2|||
27936841|NCT01108341|54593248|FG000|Overall Study|Withdrawal by Subject|1|||
27791632|NCT01557244|54246508|FG001|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
27791633|NCT01557244|54246509|FG002|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
27791634|NCT01557244|54246510|FG003|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
27791635|NCT01557244|54246511|FG004|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
27791636|NCT01557244|54246512|FG005|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
27791637|NCT01557244|54246513|FG006|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
27791638|NCT01557244|54246507|FG000|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
27791639|NCT01557244|54246508|FG001|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
27791640|NCT01557244|54246509|FG002|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
27791641|NCT01557244|54246510|FG003|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
27791642|NCT01557244|54246511|FG004|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
27791643|NCT01557244|54246512|FG005|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
27791644|NCT01557244|54246513|FG006|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
27791645|NCT01557244|54246507|FG000|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
27791646|NCT01557244|54246508|FG001|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
27791647|NCT01557244|54246509|FG002|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
27791648|NCT01557244|54246510|FG003|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1|||
27791649|NCT01557244|54246511|FG004|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
27791650|NCT01557244|54246512|FG005|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
27791651|NCT01557244|54246513|FG006|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
27791652|NCT01557244|54246507|FG000|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1|||
27791653|NCT01557244|54246508|FG001|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2|||
27791654|NCT01557244|54246509|FG002|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
27791655|NCT01557244|54246510|FG003|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
27791656|NCT01557244|54246511|FG004|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
27791657|NCT01557244|54246512|FG005|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
27791658|NCT01557244|54246513|FG006|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
27791659|NCT02155712|54246543|FG000|Primary Objective|Death|3|||
27791660|NCT02155712|54246544|FG001|Primary Objective|Death|0|||
27791661|NCT02155712|54246543|FG000|Primary Objective|Lost to Follow-up|22|||
27791662|NCT02155712|54246544|FG001|Primary Objective|Lost to Follow-up|0|||
27791663|NCT02155712|54246543|FG000|Primary Objective|No 2-Year Forms but not Terminated|13|||
27791664|NCT02155712|54246544|FG001|Primary Objective|No 2-Year Forms but not Terminated|0|||
27791665|NCT02155712|54246543|FG000|Primary Objective|Revision/Removal of Tibial Baseplate|1|||
27791666|NCT02155712|54246544|FG001|Primary Objective|Revision/Removal of Tibial Baseplate|0|||
27791667|NCT02155712|54246543|FG000|Primary Objective|Withdrawal by Subject|21|||
27791668|NCT02155712|54246544|FG001|Primary Objective|Withdrawal by Subject|0|||
27791669|NCT02177942|54246552|FG000|Overall Study|Adverse Event|1|||
27791670|NCT02177942|54246553|FG001|Overall Study|Adverse Event|0|||
27791671|NCT02177942|54246552|FG000|Overall Study|Lost to Follow-up|1|||
27791672|NCT02177942|54246553|FG001|Overall Study|Lost to Follow-up|1|||
27791673|NCT02177942|54246552|FG000|Overall Study|Protocol Violation|4|||
27791674|NCT02177942|54246553|FG001|Overall Study|Protocol Violation|6|||
27791675|NCT02177942|54246552|FG000|Overall Study|Withdrawal by Subject|71|||
27791676|NCT02177942|54246553|FG001|Overall Study|Withdrawal by Subject|81|||
27791677|NCT02155322|54246563|FG000|Overall Study|Adverse Event|1|||
27791678|NCT02155322|54246563|FG000|Overall Study|Physician Decision|1|||
27791679|NCT02155322|54246563|FG000|Overall Study|Relapse/Recurrence|8|||
27791680|NCT02155322|54246563|FG000|Overall Study|Withdrawal by Subject|4|||
27791681|NCT02210000|54246569|FG000|Overall Study|Study Terminated|11|||
27791682|NCT02210000|54246570|FG001|Overall Study|Study Terminated|12|||
27791683|NCT02210000|54246569|FG000|Overall Study|Withdrawal by Subject|7|||
27791684|NCT02210000|54246570|FG001|Overall Study|Withdrawal by Subject|1|||
27791685|NCT02210000|54246569|FG000|Overall Study|Adverse Event|1|||
27791686|NCT02210000|54246570|FG001|Overall Study|Adverse Event|5|||
27791687|NCT02210000|54246569|FG000|Overall Study|Lost to Follow-up|0|||
27791688|NCT02210000|54246570|FG001|Overall Study|Lost to Follow-up|2|||
27791689|NCT02210000|54246569|FG000|Overall Study|Physician Decision|0|||
27791690|NCT02210000|54246570|FG001|Overall Study|Physician Decision|1|||
27791691|NCT01531894|54246576|FG000|Overall Study|Physician Decision|8|||
27791692|NCT01531894|54246576|FG000|Overall Study|Death|1|||
27791693|NCT02209766|54246584|FG000|Overall Study|Withdrawal by Subject|0|||
27791694|NCT02209766|54246585|FG001|Overall Study|Withdrawal by Subject|0|||
27791695|NCT02209766|54246586|FG002|Overall Study|Withdrawal by Subject|0|||
27791696|NCT02209766|54246587|FG003|Overall Study|Withdrawal by Subject|1|||
27791697|NCT02209766|54246588|FG004|Overall Study|Withdrawal by Subject|0|||
27791698|NCT02209454|54246598|FG000|Second Period|Adverse Event|1|||
27791699|NCT02209454|54246599|FG001|Second Period|Adverse Event|0|||
27842537|NCT01550744|54331108|FG002|Double-Blind|Lost to Follow-up|12|||
27791700|NCT01571596|54246608|FG000|Overall Study|Adverse Event|2|||
27791701|NCT01571596|54246609|FG001|Overall Study|Adverse Event|0|||
27791702|NCT01571596|54246610|FG002|Overall Study|Adverse Event|0|||
27791703|NCT01571596|54246608|FG000|Overall Study|Study Terminated by the Sponsor|0|||
27791704|NCT01571596|54246609|FG001|Overall Study|Study Terminated by the Sponsor|1|||
27791705|NCT01571596|54246610|FG002|Overall Study|Study Terminated by the Sponsor|1|||
27791706|NCT01557166|54246622|FG000|Overall Study|Adverse Event|20|||
27791707|NCT01557166|54246623|FG001|Overall Study|Adverse Event|6|||
27791708|NCT01557166|54246622|FG000|Overall Study|Lack of Efficacy|2|||
27791709|NCT01557166|54246623|FG001|Overall Study|Lack of Efficacy|1|||
27791710|NCT01557166|54246622|FG000|Overall Study|Protocol Violation|8|||
27791711|NCT01557166|54246623|FG001|Overall Study|Protocol Violation|5|||
27791712|NCT01557166|54246622|FG000|Overall Study|Withdrawn consent|12|||
27791713|NCT01557166|54246623|FG001|Overall Study|Withdrawn consent|20|||
27791714|NCT01557166|54246622|FG000|Overall Study|Target dose not tolerated|1|||
27791715|NCT01557166|54246623|FG001|Overall Study|Target dose not tolerated|0|||
27791716|NCT01557166|54246622|FG000|Overall Study|Psychiatric disorder|1|||
27791717|NCT01557166|54246623|FG001|Overall Study|Psychiatric disorder|0|||
27791718|NCT01557166|54246622|FG000|Overall Study|Unclassified|2|||
27791719|NCT01557166|54246623|FG001|Overall Study|Unclassified|5|||
27791720|NCT01556932|54246629|FG000|Time Point 60 Minutes|Withdrawal by Subject|1|||
27791721|NCT01556932|54246630|FG001|Time Point 60 Minutes|Withdrawal by Subject|1|||
27791722|NCT02177786|54246639|FG000|Overall Study|Withdrew Consent|2|||
27791723|NCT02177786|54246640|FG001|Overall Study|Withdrew Consent|6|||
27791724|NCT02177786|54246641|FG002|Overall Study|Withdrew Consent|9|||
27791725|NCT02177786|54246642|FG003|Overall Study|Withdrew Consent|5|||
27791726|NCT02177786|54246639|FG000|Overall Study|Progression to End Stage Renal Disease|2|||
27791727|NCT02177786|54246640|FG001|Overall Study|Progression to End Stage Renal Disease|3|||
27791728|NCT02177786|54246641|FG002|Overall Study|Progression to End Stage Renal Disease|2|||
27791729|NCT02177786|54246642|FG003|Overall Study|Progression to End Stage Renal Disease|1|||
27791730|NCT02177786|54246639|FG000|Overall Study|Adverse Event|1|||
27791731|NCT02177786|54246640|FG001|Overall Study|Adverse Event|1|||
27791732|NCT02177786|54246641|FG002|Overall Study|Adverse Event|2|||
27791733|NCT02177786|54246642|FG003|Overall Study|Adverse Event|3|||
27791734|NCT02177786|54246639|FG000|Overall Study|Death|1|||
27791735|NCT02177786|54246640|FG001|Overall Study|Death|1|||
27791736|NCT02177786|54246641|FG002|Overall Study|Death|1|||
27791737|NCT02177786|54246642|FG003|Overall Study|Death|1|||
27791738|NCT02177786|54246639|FG000|Overall Study|Lost to Follow-up|0|||
27791739|NCT02177786|54246640|FG001|Overall Study|Lost to Follow-up|0|||
27791740|NCT02177786|54246641|FG002|Overall Study|Lost to Follow-up|2|||
27791741|NCT02177786|54246642|FG003|Overall Study|Lost to Follow-up|2|||
27791742|NCT02177786|54246639|FG000|Overall Study|Non-Compliance with Study Drug|0|||
27791743|NCT02177786|54246640|FG001|Overall Study|Non-Compliance with Study Drug|1|||
27791744|NCT02177786|54246641|FG002|Overall Study|Non-Compliance with Study Drug|0|||
27791745|NCT02177786|54246642|FG003|Overall Study|Non-Compliance with Study Drug|1|||
27791746|NCT02177786|54246639|FG000|Overall Study|Protocol Violation|0|||
27791747|NCT02177786|54246640|FG001|Overall Study|Protocol Violation|0|||
27791748|NCT02177786|54246641|FG002|Overall Study|Protocol Violation|2|||
27791749|NCT02177786|54246642|FG003|Overall Study|Protocol Violation|0|||
27791750|NCT02177786|54246639|FG000|Overall Study|Progressive Disease|0|||
27791751|NCT02177786|54246640|FG001|Overall Study|Progressive Disease|1|||
27791752|NCT02177786|54246641|FG002|Overall Study|Progressive Disease|0|||
27791753|NCT02177786|54246642|FG003|Overall Study|Progressive Disease|0|||
27791754|NCT02177786|54246639|FG000|Overall Study|Missing study completion status|0|||
27791755|NCT02177786|54246640|FG001|Overall Study|Missing study completion status|1|||
27791756|NCT02177786|54246641|FG002|Overall Study|Missing study completion status|0|||
27791757|NCT02177786|54246642|FG003|Overall Study|Missing study completion status|0|||
27791758|NCT01555762|54246652|FG000|Overall Study|No information on Bevacizumab intake|11|||
27791759|NCT01555762|54246652|FG000|Overall Study|Missing start date of infusion|8|||
27791760|NCT01555762|54246652|FG000|Overall Study|75 years old or more ticked No|1|||
27791761|NCT01555762|54246652|FG000|Overall Study|Treatment with Bevacizumab ticked No|24|||
27791762|NCT01555762|54246652|FG000|Overall Study|Death linked to progression of disease|165|||
27791763|NCT01555762|54246652|FG000|Overall Study|Lost follow-up/moved house/changed team|35|||
27791764|NCT01555762|54246652|FG000|Overall Study|Investigator's decision|10|||
27791765|NCT01555762|54246652|FG000|Overall Study|Participant not wishing to continue|5|||
27791766|NCT01555762|54246652|FG000|Overall Study|Missing data|1|||
27791767|NCT01555762|54246652|FG000|Overall Study|Death linked to an adverse event|14|||
27842538|NCT01550744|54331106|FG000|Double-Blind|Withdrawal by Subject|0|||
28105618|NCT04474197|54763098|FG003|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
27791768|NCT02153918|54246656|FG000|Overall Study|Refused further treatment|1|||
27791769|NCT02176928|54246662|FG000|Overall Study|Lost to Follow-up|2|||
27791770|NCT02176928|54246663|FG001|Overall Study|Lost to Follow-up|4|||
27791771|NCT01628510|54246671|FG000|Overall Study|Withdrawal by Subject|0|||
27791772|NCT01628510|54246672|FG001|Overall Study|Withdrawal by Subject|4|||
27791773|NCT01628510|54246671|FG000|Overall Study|Death|3|||
27791774|NCT01628510|54246672|FG001|Overall Study|Death|1|||
27791775|NCT01571362|54246680|FG000|Open-Label Conversion + Titration Period|Withdrawal by Subject|11|||
27791776|NCT01571362|54246681|FG001|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
27791777|NCT01571362|54246682|FG002|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
27791778|NCT01571362|54246680|FG000|Open-Label Conversion + Titration Period|Protocol Violation|7|||
27791779|NCT01571362|54246681|FG001|Open-Label Conversion + Titration Period|Protocol Violation|0|||
27791780|NCT01571362|54246682|FG002|Open-Label Conversion + Titration Period|Protocol Violation|0|||
27791781|NCT01571362|54246680|FG000|Open-Label Conversion + Titration Period|Adverse Event|57|||
27791782|NCT01571362|54246681|FG001|Open-Label Conversion + Titration Period|Adverse Event|0|||
27791783|NCT01571362|54246682|FG002|Open-Label Conversion + Titration Period|Adverse Event|0|||
27791784|NCT01571362|54246680|FG000|Open-Label Conversion + Titration Period|Lost to Follow-up|10|||
27791785|NCT01571362|54246681|FG001|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
27791786|NCT01571362|54246682|FG002|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
27791787|NCT01571362|54246680|FG000|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41|||
27791788|NCT01571362|54246681|FG001|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
27791789|NCT01571362|54246682|FG002|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
27791790|NCT01571362|54246680|FG000|Open-Label Conversion + Titration Period|Other - unspecified|3|||
27791791|NCT01571362|54246681|FG001|Open-Label Conversion + Titration Period|Other - unspecified|0|||
27791792|NCT01571362|54246682|FG002|Open-Label Conversion + Titration Period|Other - unspecified|0|||
27791793|NCT01571362|54246680|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
27791794|NCT01571362|54246681|FG001|Double-Blind Treatment Period|Withdrawal by Subject|11|||
27791795|NCT01571362|54246682|FG002|Double-Blind Treatment Period|Withdrawal by Subject|5|||
27791796|NCT01571362|54246680|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
27791797|NCT01571362|54246681|FG001|Double-Blind Treatment Period|Protocol Violation|8|||
27791798|NCT01571362|54246682|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
27791799|NCT01571362|54246680|FG000|Double-Blind Treatment Period|Adverse Event|0|||
27791800|NCT01571362|54246681|FG001|Double-Blind Treatment Period|Adverse Event|9|||
27791801|NCT01571362|54246682|FG002|Double-Blind Treatment Period|Adverse Event|14|||
27791802|NCT01571362|54246680|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
27791803|NCT01571362|54246681|FG001|Double-Blind Treatment Period|Lost to Follow-up|3|||
27791804|NCT01571362|54246682|FG002|Double-Blind Treatment Period|Lost to Follow-up|6|||
27791805|NCT01571362|54246680|FG000|Double-Blind Treatment Period|Insufficient clinical response|0|||
27791806|NCT01571362|54246681|FG001|Double-Blind Treatment Period|Insufficient clinical response|16|||
27791807|NCT01571362|54246682|FG002|Double-Blind Treatment Period|Insufficient clinical response|4|||
27791808|NCT01571362|54246680|FG000|Double-Blind Treatment Period|Other - unspecified|0|||
27791809|NCT01571362|54246681|FG001|Double-Blind Treatment Period|Other - unspecified|6|||
27791810|NCT01571362|54246682|FG002|Double-Blind Treatment Period|Other - unspecified|1|||
27791811|NCT01571284|54246690|FG000|Overall Study|Participant's decision|84|||
27791812|NCT01571284|54246690|FG000|Overall Study|Lost to Follow-up|3|||
27791813|NCT01571284|54246690|FG000|Overall Study|Enrolled but not treated|2|||
27791814|NCT01571284|54246690|FG000|Overall Study|Other than specified above|80|||
27791815|NCT02137772|54246696|FG000|Overall Study|Adverse Event|6|||
27936842|NCT01108341|54593248|FG000|Overall Study|Lost to Follow-up|1|||
27936843|NCT01108341|54593248|FG000|Overall Study|Other|1|||
27936844|NCT01108263|54593254|FG000|Overall Study|Adverse Event|0|||
27936845|NCT01108263|54593255|FG001|Overall Study|Adverse Event|1|||
27791816|NCT02137772|54246697|FG001|Overall Study|Adverse Event|3|||
27791817|NCT02137772|54246696|FG000|Overall Study|Death|71|||
27791818|NCT02137772|54246697|FG001|Overall Study|Death|44|||
27791819|NCT02137772|54246696|FG000|Overall Study|Lost to Follow-up|8|||
27791820|NCT02137772|54246697|FG001|Overall Study|Lost to Follow-up|4|||
27791821|NCT02137772|54246696|FG000|Overall Study|Physician Decision|15|||
27791822|NCT02137772|54246697|FG001|Overall Study|Physician Decision|5|||
27936846|NCT01108185|54593261|FG000|Overall Study|Non-compliance|15|||
27936847|NCT01108185|54593261|FG000|Overall Study|Lost to Follow-up|12|||
27936848|NCT01252940|54593267|FG000|Main Study Phase|Randomized but not treated|4|||
27936849|NCT01252940|54593268|FG001|Main Study Phase|Randomized but not treated|2|||
27936850|NCT01252940|54593267|FG000|Main Study Phase|Adverse Event|3|||
27936851|NCT01252940|54593268|FG001|Main Study Phase|Adverse Event|1|||
27936852|NCT01252940|54593267|FG000|Main Study Phase|Lack of Efficacy|1|||
27936853|NCT01252940|54593268|FG001|Main Study Phase|Lack of Efficacy|0|||
27936854|NCT01252940|54593267|FG000|Main Study Phase|Lost to Follow-up|6|||
27936855|NCT01252940|54593268|FG001|Main Study Phase|Lost to Follow-up|1|||
28017194|NCT00661362|54676466|FG000|Overall Study|Lost to Follow-up|3|||
27791823|NCT02137772|54246696|FG000|Overall Study|Withdrawal by Subject|28|||
27936856|NCT01252940|54593267|FG000|Main Study Phase|Physician Decision|1|||
27936857|NCT01252940|54593268|FG001|Main Study Phase|Physician Decision|0|||
27936858|NCT01252940|54593267|FG000|Main Study Phase|Protocol Violation|4|||
27936859|NCT01252940|54593268|FG001|Main Study Phase|Protocol Violation|2|||
27791824|NCT02137772|54246697|FG001|Overall Study|Withdrawal by Subject|17|||
27791825|NCT02137772|54246696|FG000|Overall Study|Non-compliance with study drug|1|||
27791826|NCT02137772|54246697|FG001|Overall Study|Non-compliance with study drug|0|||
27936860|NCT01252940|54593267|FG000|Main Study Phase|Withdrawal by Subject|6|||
27936861|NCT01252940|54593268|FG001|Main Study Phase|Withdrawal by Subject|5|||
27936862|NCT01252940|54593267|FG000|Main Study Phase|Subject Non-compliance|1|||
27936863|NCT01252940|54593268|FG001|Main Study Phase|Subject Non-compliance|1|||
27936864|NCT01252940|54593267|FG000|Extension Phase|Adverse Event|2|||
27936865|NCT01252940|54593268|FG001|Extension Phase|Adverse Event|1|||
27936866|NCT01252940|54593267|FG000|Extension Phase|Lack of Efficacy|1|||
27936867|NCT01252940|54593268|FG001|Extension Phase|Lack of Efficacy|0|||
27936868|NCT01252940|54593267|FG000|Extension Phase|Lost to Follow-up|5|||
27936869|NCT01252940|54593268|FG001|Extension Phase|Lost to Follow-up|0|||
27791827|NCT02137772|54246696|FG000|Overall Study|Not treated|3|||
27791828|NCT02137772|54246697|FG001|Overall Study|Not treated|2|||
27791829|NCT01555138|54246705|FG000|Overall Study|Death|0|||
27791830|NCT01555138|54246706|FG001|Overall Study|Death|1|||
27791831|NCT01555138|54246705|FG000|Overall Study|Lost to Follow-up|1|||
27791832|NCT01555138|54246706|FG001|Overall Study|Lost to Follow-up|0|||
27791833|NCT01555138|54246705|FG000|Overall Study|Abnormal Lab reults|1|||
27791834|NCT01555138|54246706|FG001|Overall Study|Abnormal Lab reults|3|||
27791835|NCT01555138|54246705|FG000|Overall Study|Lack of Efficacy|2|||
27791836|NCT01555138|54246706|FG001|Overall Study|Lack of Efficacy|2|||
27791837|NCT01555138|54246705|FG000|Overall Study|Protocol Violation|5|||
27791838|NCT01555138|54246706|FG001|Overall Study|Protocol Violation|3|||
27791839|NCT01555138|54246705|FG000|Overall Study|Administrative problems|8|||
27791840|NCT01555138|54246706|FG001|Overall Study|Administrative problems|0|||
27791841|NCT01555138|54246705|FG000|Overall Study|Withdrawal by Subject|16|||
27791842|NCT01555138|54246706|FG001|Overall Study|Withdrawal by Subject|15|||
27791843|NCT01555138|54246705|FG000|Overall Study|Adverse Event|14|||
27791844|NCT01555138|54246706|FG001|Overall Study|Adverse Event|14|||
27791845|NCT02137226|54246714|FG000|Period 1 (Initial Randomization)|Adverse Event|3|||
27791846|NCT02137226|54246715|FG001|Period 1 (Initial Randomization)|Adverse Event|3|||
27791847|NCT02137226|54246716|FG002|Period 1 (Initial Randomization)|Adverse Event|0|||
27791848|NCT02137226|54246717|FG003|Period 1 (Initial Randomization)|Adverse Event|0|||
27791849|NCT02137226|54246718|FG004|Period 1 (Initial Randomization)|Adverse Event|0|||
27791850|NCT02137226|54246714|FG000|Period 1 (Initial Randomization)|Withdrawal by Subject|11|||
27791851|NCT02137226|54246715|FG001|Period 1 (Initial Randomization)|Withdrawal by Subject|5|||
27791852|NCT02137226|54246716|FG002|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
27791853|NCT02137226|54246717|FG003|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
27791854|NCT02137226|54246718|FG004|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
27791855|NCT02137226|54246714|FG000|Period 1 (Initial Randomization)|Physician Decision|1|||
27791856|NCT02137226|54246715|FG001|Period 1 (Initial Randomization)|Physician Decision|3|||
27791857|NCT02137226|54246716|FG002|Period 1 (Initial Randomization)|Physician Decision|0|||
27791858|NCT02137226|54246717|FG003|Period 1 (Initial Randomization)|Physician Decision|0|||
27791859|NCT02137226|54246718|FG004|Period 1 (Initial Randomization)|Physician Decision|0|||
27936870|NCT01252940|54593267|FG000|Extension Phase|Physician Decision|0|||
27936871|NCT01252940|54593268|FG001|Extension Phase|Physician Decision|1|||
27936872|NCT01252940|54593267|FG000|Extension Phase|Subject Non-compliance|1|||
27936873|NCT01252940|54593268|FG001|Extension Phase|Subject Non-compliance|0|||
27936874|NCT01252940|54593267|FG000|Extension Phase|Withdrawal by Subject|1|||
27936875|NCT01252940|54593268|FG001|Extension Phase|Withdrawal by Subject|1|||
27936876|NCT01252238|54593278|FG000|Overall Study|Sponsor terminated study|4|||
27936877|NCT01252238|54593279|FG001|Overall Study|Sponsor terminated study|4|||
27936878|NCT01252238|54593280|FG002|Overall Study|Sponsor terminated study|4|||
27936879|NCT01101477|54593294|FG000|Overall Study|Protocol Violation|5|||
27936880|NCT01101477|54593295|FG001|Overall Study|Protocol Violation|3|||
27936881|NCT01101477|54593296|FG002|Overall Study|Protocol Violation|1|||
27936882|NCT01251770|54593306|FG000|Overall Study|Protocol Violation|13|||
27936883|NCT01251770|54593307|FG001|Overall Study|Protocol Violation|7|||
27936884|NCT01101321|54593313|FG000|Period 1|Withdrawal by Subject|1|||
27936885|NCT01101321|54593314|FG001|Period 1|Withdrawal by Subject|1|||
27936886|NCT01101321|54593313|FG000|Period 1|Adverse Event|3|||
27936887|NCT01101321|54593314|FG001|Period 1|Adverse Event|3|||
27936888|NCT01101165|54593320|FG000|Period 1|Adverse Event|1|||
27936889|NCT01101165|54593321|FG001|Period 1|Adverse Event|2|||
27936890|NCT01101165|54593320|FG000|Period 1|Withdrawal by Subject|0|||
27936891|NCT01101165|54593321|FG001|Period 1|Withdrawal by Subject|2|||
27936892|NCT01101165|54593320|FG000|Period 1|Positive Drug Screen|0|||
27936893|NCT01101165|54593321|FG001|Period 1|Positive Drug Screen|1|||
27936894|NCT01101165|54593320|FG000|Period 1|Lost to Follow-up|1|||
27936895|NCT01101165|54593321|FG001|Period 1|Lost to Follow-up|0|||
27936896|NCT01101165|54593320|FG000|Period 2|Withdrawal by Subject|3|||
27936897|NCT01101165|54593321|FG001|Period 2|Withdrawal by Subject|1|||
27936898|NCT01101165|54593320|FG000|Period 2|Adverse Event|1|||
27936899|NCT01101165|54593321|FG001|Period 2|Adverse Event|0|||
27791860|NCT02137226|54246714|FG000|Period 1 (Initial Randomization)|Lost to Follow-up|3|||
27791861|NCT02137226|54246715|FG001|Period 1 (Initial Randomization)|Lost to Follow-up|2|||
27791862|NCT02137226|54246716|FG002|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
27936900|NCT01100853|54593329|FG000|Overall Study|Lost to Follow-up|11|||
27936901|NCT01100853|54593330|FG001|Overall Study|Lost to Follow-up|6|||
27936902|NCT01100853|54593329|FG000|Overall Study|Received <4 study injections|10|||
27936903|NCT01100853|54593330|FG001|Overall Study|Received <4 study injections|13|||
27936904|NCT01100853|54593329|FG000|Overall Study|Withdrawal by Subject|6|||
27936905|NCT01100853|54593330|FG001|Overall Study|Withdrawal by Subject|4|||
27936906|NCT01100307|54593338|FG000|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
27936907|NCT01100307|54593339|FG001|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
27936908|NCT01100307|54593338|FG000|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0|||
27936909|NCT01100307|54593339|FG001|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1|||
27791863|NCT02137226|54246717|FG003|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
27791864|NCT02137226|54246718|FG004|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
27791865|NCT02137226|54246714|FG000|Period 1 (Initial Randomization)|Lack of Efficacy|1|||
27791866|NCT02137226|54246715|FG001|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
27791867|NCT02137226|54246716|FG002|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
27791868|NCT02137226|54246717|FG003|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
27791869|NCT02137226|54246718|FG004|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
27791870|NCT02137226|54246714|FG000|Period 1 (Initial Randomization)|Other Reason|1|||
27791871|NCT02137226|54246715|FG001|Period 1 (Initial Randomization)|Other Reason|3|||
27791872|NCT02137226|54246716|FG002|Period 1 (Initial Randomization)|Other Reason|0|||
27791873|NCT02137226|54246717|FG003|Period 1 (Initial Randomization)|Other Reason|0|||
27791874|NCT02137226|54246718|FG004|Period 1 (Initial Randomization)|Other Reason|0|||
27791875|NCT02137226|54246714|FG000|Period 2 (Re - Randomization)|Adverse Event|0|||
27791876|NCT02137226|54246715|FG001|Period 2 (Re - Randomization)|Adverse Event|0|||
27791877|NCT02137226|54246716|FG002|Period 2 (Re - Randomization)|Adverse Event|3|||
27791878|NCT02137226|54246717|FG003|Period 2 (Re - Randomization)|Adverse Event|1|||
27791879|NCT02137226|54246718|FG004|Period 2 (Re - Randomization)|Adverse Event|4|||
27791880|NCT02137226|54246714|FG000|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
27791881|NCT02137226|54246715|FG001|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
27791882|NCT02137226|54246716|FG002|Period 2 (Re - Randomization)|Withdrawal by Subject|8|||
27791883|NCT02137226|54246717|FG003|Period 2 (Re - Randomization)|Withdrawal by Subject|5|||
27791884|NCT02137226|54246718|FG004|Period 2 (Re - Randomization)|Withdrawal by Subject|4|||
27791885|NCT02137226|54246714|FG000|Period 2 (Re - Randomization)|Physician Decision|0|||
27791886|NCT02137226|54246715|FG001|Period 2 (Re - Randomization)|Physician Decision|0|||
27791887|NCT02137226|54246716|FG002|Period 2 (Re - Randomization)|Physician Decision|0|||
27791888|NCT02137226|54246717|FG003|Period 2 (Re - Randomization)|Physician Decision|1|||
27791889|NCT02137226|54246718|FG004|Period 2 (Re - Randomization)|Physician Decision|0|||
27791890|NCT02137226|54246714|FG000|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
27791891|NCT02137226|54246715|FG001|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
27791892|NCT02137226|54246716|FG002|Period 2 (Re - Randomization)|Lost to Follow-up|3|||
27791893|NCT02137226|54246717|FG003|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
27791894|NCT02137226|54246718|FG004|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
27791895|NCT02137226|54246714|FG000|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
27791896|NCT02137226|54246715|FG001|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
27791897|NCT02137226|54246716|FG002|Period 2 (Re - Randomization)|Lack of Efficacy|2|||
27791898|NCT02137226|54246717|FG003|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
27791899|NCT02137226|54246718|FG004|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
27791900|NCT02137226|54246714|FG000|Period 2 (Re - Randomization)|Other Reason|0|||
27791901|NCT02137226|54246715|FG001|Period 2 (Re - Randomization)|Other Reason|0|||
27791902|NCT02137226|54246716|FG002|Period 2 (Re - Randomization)|Other Reason|1|||
27791903|NCT02137226|54246717|FG003|Period 2 (Re - Randomization)|Other Reason|1|||
27791904|NCT02137226|54246718|FG004|Period 2 (Re - Randomization)|Other Reason|1|||
27791905|NCT01530334|54246726|FG000|Overall Study|Adverse Event|3|||
27791906|NCT01530334|54246726|FG000|Overall Study|unknown reason|1|||
27791907|NCT01530334|54246726|FG000|Overall Study|Progressive disease|47|||
27791908|NCT01570192|54246732|FG000|Overall Study|no qualifying organism|6|||
27791909|NCT01570192|54246733|FG001|Overall Study|no qualifying organism|12|||
27791910|NCT01570192|54246732|FG000|Overall Study|changed to palliative care|1|||
27791911|NCT01570192|54246733|FG001|Overall Study|changed to palliative care|0|||
27791912|NCT01570192|54246732|FG000|Overall Study|Physician Decision|0|||
27791913|NCT01570192|54246733|FG001|Overall Study|Physician Decision|1|||
27791914|NCT02136914|54246746|FG000|Overall Study|Sponsor's Decision to Stop the Study|7|||
27791915|NCT02136914|54246747|FG001|Overall Study|Sponsor's Decision to Stop the Study|7|||
27791916|NCT02136914|54246746|FG000|Overall Study|Withdrawal by Subject|3|||
27791917|NCT02136914|54246747|FG001|Overall Study|Withdrawal by Subject|10|||
27791918|NCT02136914|54246746|FG000|Overall Study|Subject Unwilling to Proceed|7|||
27936910|NCT01100307|54593338|FG000|Double Masked Phase (Up to Week 24)|Adverse Event|5|||
27936911|NCT01100307|54593339|FG001|Double Masked Phase (Up to Week 24)|Adverse Event|2|||
27936912|NCT01100307|54593338|FG000|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1|||
28017195|NCT00661362|54676467|FG001|Overall Study|Lost to Follow-up|1|||
27791919|NCT02136914|54246747|FG001|Overall Study|Subject Unwilling to Proceed|2|||
27791920|NCT02136914|54246746|FG000|Overall Study|Lost to Follow-up|1|||
27791921|NCT02136914|54246747|FG001|Overall Study|Lost to Follow-up|1|||
27791922|NCT02136914|54246746|FG000|Overall Study|Did Not Receive Study Drug|2|||
27791923|NCT02136914|54246747|FG001|Overall Study|Did Not Receive Study Drug|0|||
27791924|NCT02136914|54246746|FG000|Overall Study|Lack of Efficacy|1|||
27791925|NCT02136914|54246747|FG001|Overall Study|Lack of Efficacy|0|||
27791926|NCT02136914|54246746|FG000|Overall Study|Death|0|||
27791927|NCT02136914|54246747|FG001|Overall Study|Death|1|||
27791928|NCT01530256|54246753|FG000|Overall Study|Death|2|||
27791929|NCT01554904|54246757|FG000|Overall Study|Withdrawal by Subject|3|||
27791930|NCT01554904|54246757|FG000|Overall Study|Had sleep apnea on Home Study 1|1|||
27791931|NCT01529632|54246763|FG000|Overall Study|Administrative problem|2|||
27791932|NCT01529632|54246764|FG001|Overall Study|Administrative problem|1|||
27791933|NCT01529632|54246763|FG000|Overall Study|Protocol Violation|0|||
27791934|NCT01529632|54246764|FG001|Overall Study|Protocol Violation|1|||
27791935|NCT01529632|54246763|FG000|Overall Study|Adverse Event|1|||
27791936|NCT01529632|54246764|FG001|Overall Study|Adverse Event|1|||
27791937|NCT01554514|54246770|FG000|Overall Study|1 patient ineligible with congenital TTP|1|||
27791938|NCT01554514|54246770|FG000|Overall Study|Physician Decision|1|||
27791939|NCT01553188|54246778|FG000|Overall Study|Patient choice|1|||
27791940|NCT01553188|54246779|FG001|Overall Study|Patient choice|0|||
27791941|NCT01553188|54246780|FG002|Overall Study|Patient choice|0|||
27791942|NCT01553188|54246781|FG003|Overall Study|Patient choice|0|||
27791943|NCT01553188|54246778|FG000|Overall Study|Intercurrent illness and adverse event|0|||
27791944|NCT01553188|54246779|FG001|Overall Study|Intercurrent illness and adverse event|1|||
27791945|NCT01553188|54246780|FG002|Overall Study|Intercurrent illness and adverse event|2|||
27791946|NCT01553188|54246781|FG003|Overall Study|Intercurrent illness and adverse event|0|||
27791947|NCT02175758|54246800|FG000|Treatment Phase|Lost to Follow-up|0|||
27791948|NCT02175758|54246801|FG001|Treatment Phase|Lost to Follow-up|1|||
27791949|NCT02175758|54246802|FG002|Treatment Phase|Lost to Follow-up|0|||
27791950|NCT02175758|54246803|FG003|Treatment Phase|Lost to Follow-up|0|||
27791951|NCT02175758|54246804|FG004|Treatment Phase|Lost to Follow-up|0|||
27791952|NCT02175758|54246805|FG005|Treatment Phase|Lost to Follow-up|0|||
27791953|NCT02175758|54246800|FG000|Treatment Phase|Adverse Event|0|||
27791954|NCT02175758|54246801|FG001|Treatment Phase|Adverse Event|0|||
27791955|NCT02175758|54246802|FG002|Treatment Phase|Adverse Event|0|||
27791956|NCT02175758|54246803|FG003|Treatment Phase|Adverse Event|0|||
27936913|NCT01100307|54593339|FG001|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2|||
27936914|NCT01100307|54593338|FG000|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2|||
27936915|NCT01100307|54593339|FG001|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3|||
27936916|NCT01100307|54593338|FG000|Open Phase (Week 24 up to Week 54)|Adverse Event|3|||
27936917|NCT01100307|54593339|FG001|Open Phase (Week 24 up to Week 54)|Adverse Event|8|||
27936918|NCT01100073|54593347|FG000|Overall Study|Lack of Efficacy|4|||
27936919|NCT01100073|54593347|FG000|Overall Study|Insufficient Tolerability|21|||
27936920|NCT01100073|54593347|FG000|Overall Study|Withdrawal by Subject|13|||
27936921|NCT01100073|54593347|FG000|Overall Study|Lost to Follow-up|39|||
27936922|NCT01100073|54593347|FG000|Overall Study|Lack of effect + patient's wish|2|||
27936923|NCT01100073|54593347|FG000|Overall Study|Insufficient tolerability +patients wish|8|||
27936924|NCT01100073|54593347|FG000|Overall Study|Other|8|||
27936925|NCT01100073|54593347|FG000|Overall Study|Missing|5|||
27936926|NCT01099917|54593351|FG000|Overall Study|Adverse Event|3|||
27936927|NCT01099917|54593351|FG000|Overall Study|Not Treated|24|||
27936928|NCT01099215|54593357|FG000|Overall Study|Withdrawal by Subject|1|||
27936929|NCT01099215|54593358|FG001|Overall Study|Withdrawal by Subject|0|||
27936930|NCT01099215|54593357|FG000|Overall Study|Adverse Event|0|||
27936931|NCT01099215|54593358|FG001|Overall Study|Adverse Event|1|||
27936932|NCT01097655|54593364|FG000|Overall Study|Withdrawal by Subject|1|||
27936933|NCT01097655|54593364|FG000|Overall Study|Subject Documented Twice|1|||
27936934|NCT01097655|54593364|FG000|Overall Study|Did Not Meet Inclusion Criteria|8|||
27936935|NCT01107405|54593373|FG000|Overall Study|Adverse Event|1|||
27936936|NCT01107405|54593374|FG001|Overall Study|Adverse Event|1|||
27936937|NCT01107405|54593375|FG002|Overall Study|Adverse Event|0|||
27791957|NCT02175758|54246804|FG004|Treatment Phase|Adverse Event|1|||
27791958|NCT02175758|54246805|FG005|Treatment Phase|Adverse Event|0|||
27791959|NCT01529008|54246847|FG000|Bone Marrow Harvesting|Physician Decision|1|||
27936938|NCT01107405|54593376|FG003|Overall Study|Adverse Event|0|||
27936939|NCT01107405|54593377|FG004|Overall Study|Adverse Event|2|||
27936940|NCT01107405|54593373|FG000|Overall Study|Withdrawal by Subject|1|||
27936941|NCT01107405|54593374|FG001|Overall Study|Withdrawal by Subject|0|||
27936942|NCT01107405|54593375|FG002|Overall Study|Withdrawal by Subject|1|||
27936943|NCT01107405|54593376|FG003|Overall Study|Withdrawal by Subject|2|||
27936944|NCT01107405|54593377|FG004|Overall Study|Withdrawal by Subject|1|||
27791960|NCT01529008|54246848|FG001|Bone Marrow Harvesting|Physician Decision|1|||
27791961|NCT01529008|54246847|FG000|Bone Marrow Harvesting|Withdrawal by Subject|0|||
27791962|NCT01529008|54246848|FG001|Bone Marrow Harvesting|Withdrawal by Subject|2|||
27791963|NCT01529008|54246847|FG000|Treatment|Adverse Event|6|||
27791964|NCT01529008|54246848|FG001|Treatment|Adverse Event|0|||
27791965|NCT01529008|54246847|FG000|Treatment|Other|3|||
27791966|NCT01529008|54246848|FG001|Treatment|Other|1|||
27936945|NCT01107405|54593373|FG000|Overall Study|Protocol Violation|0|||
27936946|NCT01107405|54593374|FG001|Overall Study|Protocol Violation|0|||
27936947|NCT01107405|54593375|FG002|Overall Study|Protocol Violation|1|||
27936948|NCT01107405|54593376|FG003|Overall Study|Protocol Violation|1|||
27936949|NCT01107405|54593377|FG004|Overall Study|Protocol Violation|0|||
27936950|NCT01097577|54593391|FG000|Overall Study|Adverse Event|0|||
27936951|NCT01097577|54593392|FG001|Overall Study|Adverse Event|1|||
27936952|NCT01097421|54593398|FG000|Overall Study|Adverse Event|8|||
27936953|NCT01097421|54593398|FG000|Overall Study|Protocol Violation|2|||
27791967|NCT01529008|54246847|FG000|Efficacy Analysis|Protocol Violation|2|||
27791968|NCT01529008|54246848|FG001|Efficacy Analysis|Protocol Violation|0|||
27791969|NCT01529008|54246847|FG000|Efficacy Analysis|Physician Decision|0|||
27791970|NCT01529008|54246848|FG001|Efficacy Analysis|Physician Decision|1|||
27791971|NCT01529008|54246847|FG000|Efficacy Analysis|Withdrawal by Subject|0|||
27791972|NCT01529008|54246848|FG001|Efficacy Analysis|Withdrawal by Subject|2|||
27791973|NCT01599104|54246857|FG000|Overall Study|Withdrawal by Subject|1|||
27791974|NCT01599104|54246858|FG001|Overall Study|Withdrawal by Subject|1|||
27791975|NCT01599104|54246859|FG002|Overall Study|Withdrawal by Subject|2|||
27791976|NCT01599104|54246857|FG000|Overall Study|Technical Problems|1|||
27791977|NCT01599104|54246858|FG001|Overall Study|Technical Problems|0|||
27791978|NCT01599104|54246859|FG002|Overall Study|Technical Problems|0|||
27791979|NCT01599104|54246857|FG000|Overall Study|Physician Decision|3|||
27791980|NCT01599104|54246858|FG001|Overall Study|Physician Decision|2|||
27791981|NCT01599104|54246859|FG002|Overall Study|Physician Decision|2|||
27791982|NCT01599104|54246857|FG000|Overall Study|Non-compliance with study treatment|0|||
27791983|NCT01599104|54246858|FG001|Overall Study|Non-compliance with study treatment|1|||
27791984|NCT01599104|54246859|FG002|Overall Study|Non-compliance with study treatment|0|||
27791985|NCT01599104|54246857|FG000|Overall Study|Lack of Efficacy|4|||
27791986|NCT01599104|54246858|FG001|Overall Study|Lack of Efficacy|4|||
27791987|NCT01599104|54246859|FG002|Overall Study|Lack of Efficacy|10|||
27791988|NCT01599104|54246857|FG000|Overall Study|Adverse Event|7|||
27791989|NCT01599104|54246858|FG001|Overall Study|Adverse Event|6|||
27791990|NCT01599104|54246859|FG002|Overall Study|Adverse Event|12|||
27791991|NCT01569568|54246869|FG000|Overall Study|Physician Decision|0|||
27791992|NCT01569568|54246870|FG001|Overall Study|Physician Decision|2|||
27791993|NCT02136680|54246878|FG000|Overall Study|No Longer Interested|1|||
27791994|NCT02136680|54246879|FG001|Overall Study|No Longer Interested|1|||
27791995|NCT02136680|54246878|FG000|Overall Study|No longer receiving care at clinic|3|||
27791996|NCT02136680|54246879|FG001|Overall Study|No longer receiving care at clinic|5|||
27791997|NCT02136680|54246878|FG000|Overall Study|Moved away|5|||
27791998|NCT02136680|54246879|FG001|Overall Study|Moved away|4|||
27791999|NCT02136680|54246878|FG000|Overall Study|Unable to schedule|17|||
27792000|NCT02136680|54246879|FG001|Overall Study|Unable to schedule|16|||
27792001|NCT02136680|54246878|FG000|Overall Study|Study ended before interview due|6|||
27792002|NCT02136680|54246879|FG001|Overall Study|Study ended before interview due|3|||
27792003|NCT01552954|54246887|FG000|Overall Study|Adverse Event|1|||
27792004|NCT01552954|54246888|FG001|Overall Study|Adverse Event|2|||
27792005|NCT01552954|54246887|FG000|Overall Study|Lost to Follow-up|1|||
27792006|NCT01552954|54246888|FG001|Overall Study|Lost to Follow-up|1|||
27792007|NCT01552954|54246887|FG000|Overall Study|Withdrawal by Subject|1|||
27792008|NCT01552954|54246888|FG001|Overall Study|Withdrawal by Subject|1|||
27792009|NCT01552954|54246887|FG000|Overall Study|Protocol Violation|1|||
27792010|NCT01552954|54246888|FG001|Overall Study|Protocol Violation|2|||
27792011|NCT01552954|54246887|FG000|Overall Study|diagnosed DM|1|||
27792012|NCT01552954|54246888|FG001|Overall Study|diagnosed DM|0|||
27792013|NCT02175368|54246894|FG000|Overall Study|Lost to Follow-up|1|||
27792014|NCT01518244|54246898|FG000|Overall Study|Adverse Event|3|||
27792015|NCT01552408|54246904|FG000|Overall Study|Lost to Follow-up|2|||
27792016|NCT01552408|54246905|FG001|Overall Study|Lost to Follow-up|0|||
27792017|NCT01552408|54246904|FG000|Overall Study|Relocation|0|||
27792018|NCT01552408|54246905|FG001|Overall Study|Relocation|1|||
27792019|NCT01552408|54246904|FG000|Overall Study|Withdrawal by Subject|2|||
27792020|NCT01552408|54246905|FG001|Overall Study|Withdrawal by Subject|1|||
27792021|NCT01528696|54246914|FG000|Overall Study|See detailed description|18|||
27792022|NCT01528696|54246915|FG001|Overall Study|See detailed description|19|||
27792023|NCT02174276|54246925|FG000|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1|||
27792024|NCT02174276|54246926|FG001|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
27792025|NCT02174276|54246927|FG002|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
27792026|NCT02174276|54246928|FG003|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
27792027|NCT02174276|54246925|FG000|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
27792028|NCT02174276|54246926|FG001|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
27792029|NCT02174276|54246927|FG002|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1|||
27792030|NCT02174276|54246928|FG003|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
27792031|NCT02174276|54246925|FG000|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
27792032|NCT02174276|54246926|FG001|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1|||
27936954|NCT01097421|54593398|FG000|Overall Study|Lost to Follow-up|1|||
27936955|NCT01097421|54593398|FG000|Overall Study|Withdrawal by Subject|3|||
27792033|NCT02174276|54246927|FG002|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2|||
27792034|NCT02174276|54246928|FG003|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
27792035|NCT02174276|54246925|FG000|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
27792036|NCT02174276|54246926|FG001|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
27792037|NCT02174276|54246927|FG002|OTEP (Weeks 48 to 144)|Lost to Follow-up|1|||
27792038|NCT02174276|54246928|FG003|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
27792039|NCT02174276|54246925|FG000|OTEP (Weeks 48 to 144)|Pregnancy|0|||
27792040|NCT02174276|54246926|FG001|OTEP (Weeks 48 to 144)|Pregnancy|0|||
27792041|NCT02174276|54246927|FG002|OTEP (Weeks 48 to 144)|Pregnancy|1|||
27792042|NCT02174276|54246928|FG003|OTEP (Weeks 48 to 144)|Pregnancy|0|||
27792043|NCT02174276|54246925|FG000|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
27792044|NCT02174276|54246926|FG001|OTEP (Weeks 48 to 144)|Withdrew Consent|0|||
27792045|NCT02174276|54246927|FG002|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
27792046|NCT02174276|54246928|FG003|OTEP (Weeks 48 to 144)|Withdrew Consent|2|||
27792047|NCT01528072|54246938|FG000|Overall Study|Withdrawal by Subject|5|||
27792048|NCT01528072|54246938|FG000|Overall Study|Physician Decision|1|||
27792049|NCT01528072|54246938|FG000|Overall Study|Determined not eligible by AEAC|1|||
27792050|NCT01528072|54246938|FG000|Overall Study|Missed Visit|2|||
27792051|NCT01528072|54246938|FG000|Overall Study|Lost to Follow-up|5|||
27936956|NCT01251614|54593405|FG000|Overall Study|Adverse Event|1|||
27936957|NCT01251614|54593406|FG001|Overall Study|Adverse Event|0|||
27936958|NCT01251614|54593407|FG002|Overall Study|Adverse Event|1|||
27936959|NCT01251614|54593405|FG000|Overall Study|Lack of Efficacy|1|||
27936960|NCT01251614|54593406|FG001|Overall Study|Lack of Efficacy|9|||
27936961|NCT01251614|54593407|FG002|Overall Study|Lack of Efficacy|4|||
27936962|NCT01251614|54593405|FG000|Overall Study|Clearing of Psoriatic Lesions|1|||
27936963|NCT01251614|54593406|FG001|Overall Study|Clearing of Psoriatic Lesions|0|||
27936964|NCT01251614|54593407|FG002|Overall Study|Clearing of Psoriatic Lesions|0|||
27936965|NCT01251614|54593405|FG000|Overall Study|Pregnancy|0|||
27936966|NCT01251614|54593406|FG001|Overall Study|Pregnancy|0|||
27936967|NCT01251614|54593407|FG002|Overall Study|Pregnancy|2|||
27936968|NCT01251614|54593405|FG000|Overall Study|Loss of Disease Control|0|||
27936969|NCT01251614|54593406|FG001|Overall Study|Loss of Disease Control|1|||
27936970|NCT01251614|54593407|FG002|Overall Study|Loss of Disease Control|0|||
27936971|NCT01251614|54593405|FG000|Overall Study|Withdrawal by Subject|0|||
27936972|NCT01251614|54593406|FG001|Overall Study|Withdrawal by Subject|2|||
27936973|NCT01251614|54593407|FG002|Overall Study|Withdrawal by Subject|1|||
28017196|NCT00661362|54676466|FG000|Overall Study|Severe non-compliance to protocol|0|||
28017197|NCT00661362|54676467|FG001|Overall Study|Severe non-compliance to protocol|1|||
27936974|NCT01251614|54593405|FG000|Overall Study|Lost to Follow-up|0|||
27936975|NCT01251614|54593406|FG001|Overall Study|Lost to Follow-up|1|||
27936976|NCT01251614|54593407|FG002|Overall Study|Lost to Follow-up|0|||
27936977|NCT01106625|54593428|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
27936978|NCT01106625|54593429|FG001|Core Period: Baseline to Week 26|Adverse Event|8|||
27936979|NCT01106625|54593430|FG002|Core Period: Baseline to Week 26|Adverse Event|8|||
27936980|NCT01106625|54593428|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
27936981|NCT01106625|54593429|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
27936982|NCT01106625|54593430|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|4|||
27936983|NCT01106625|54593428|FG000|Core Period: Baseline to Week 26|Physician Decision|1|||
27936984|NCT01106625|54593429|FG001|Core Period: Baseline to Week 26|Physician Decision|0|||
27936985|NCT01106625|54593430|FG002|Core Period: Baseline to Week 26|Physician Decision|0|||
27936986|NCT01106625|54593428|FG000|Core Period: Baseline to Week 26|Protocol Violation|2|||
27936987|NCT01106625|54593429|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
27936988|NCT01106625|54593430|FG002|Core Period: Baseline to Week 26|Protocol Violation|3|||
27936989|NCT01106625|54593428|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
27936990|NCT01106625|54593429|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
27936991|NCT01106625|54593430|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|7|||
27936992|NCT01106625|54593428|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|4|||
27936993|NCT01106625|54593429|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
27936994|NCT01106625|54593430|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
27936995|NCT01106625|54593428|FG000|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0|||
27936996|NCT01106625|54593429|FG001|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
27936997|NCT01106625|54593430|FG002|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
27936998|NCT01106625|54593428|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
27936999|NCT01106625|54593429|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
27937000|NCT01106625|54593430|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
27792052|NCT01528072|54246938|FG000|Overall Study|Explanted|2|||
27792053|NCT01528072|54246938|FG000|Overall Study|Site Closure|4|||
27792054|NCT01528072|54246938|FG000|Overall Study|Death|2|||
27792055|NCT01528072|54246938|FG000|Overall Study|Early Termination of Study|52|||
27792056|NCT01527682|54246942|FG000|Overall Study|Protocol Violation|8|||
27792057|NCT01527370|54246946|FG000|Overall Study|Withdrawal by Subject|4|||
27937001|NCT01106625|54593428|FG000|Core Period: Baseline to Week 26|Other|8|||
27937002|NCT01106625|54593429|FG001|Core Period: Baseline to Week 26|Other|7|||
27937003|NCT01106625|54593430|FG002|Core Period: Baseline to Week 26|Other|4|||
27937004|NCT01106625|54593428|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
27937005|NCT01106625|54593429|FG001|Extension Period: Week 26 to Week 52|Adverse Event|2|||
27937006|NCT01106625|54593430|FG002|Extension Period: Week 26 to Week 52|Adverse Event|3|||
27937007|NCT01106625|54593428|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
27937008|NCT01106625|54593429|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|3|||
27937009|NCT01106625|54593430|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
27937010|NCT01106625|54593428|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
27792058|NCT01527370|54246946|FG000|Overall Study|Physician Decision|1|||
27792059|NCT01527370|54246946|FG000|Overall Study|Death|1|||
27792060|NCT01527292|54246952|FG000|Overall Study|Physician Decision|0|||
27792061|NCT01527292|54246953|FG001|Overall Study|Physician Decision|3|||
27792062|NCT01516216|54246961|FG000|Overall Study|Adverse Event|2|||
27792063|NCT01516216|54246962|FG001|Overall Study|Adverse Event|4|||
27792064|NCT01516216|54246961|FG000|Overall Study|Disease Progression|38|||
27792065|NCT01516216|54246962|FG001|Overall Study|Disease Progression|34|||
27792066|NCT01516216|54246961|FG000|Overall Study|Withdrawal by Subject|9|||
27792067|NCT01516216|54246962|FG001|Overall Study|Withdrawal by Subject|11|||
27792068|NCT01516216|54246961|FG000|Overall Study|Potentially Curative Resection|6|||
27792069|NCT01516216|54246962|FG001|Overall Study|Potentially Curative Resection|12|||
27792070|NCT01516216|54246961|FG000|Overall Study|Nonadherence|2|||
27792071|NCT01516216|54246962|FG001|Overall Study|Nonadherence|3|||
27792072|NCT01516216|54246961|FG000|Overall Study|Physician Decision|6|||
27792073|NCT01516216|54246962|FG001|Overall Study|Physician Decision|3|||
27792074|NCT01516216|54246961|FG000|Overall Study|Prolonged Treatment Delay|5|||
27792075|NCT01516216|54246962|FG001|Overall Study|Prolonged Treatment Delay|1|||
27792076|NCT01516216|54246961|FG000|Overall Study|Intercurrent Illness|1|||
27792077|NCT01516216|54246962|FG001|Overall Study|Intercurrent Illness|0|||
27792078|NCT01516216|54246961|FG000|Overall Study|Death|1|||
27792079|NCT01516216|54246962|FG001|Overall Study|Death|1|||
27792080|NCT01950819|54246972|FG000|Overall Study|Graft Loss|35|||
27792081|NCT01950819|54246973|FG001|Overall Study|Graft Loss|30|||
27792082|NCT01950819|54246972|FG000|Overall Study|Death|29|||
27792083|NCT01950819|54246973|FG001|Overall Study|Death|34|||
27792084|NCT01950819|54246972|FG000|Overall Study|Subject / Gardian decision|54|||
27792085|NCT01950819|54246973|FG001|Overall Study|Subject / Gardian decision|51|||
27792086|NCT01950819|54246972|FG000|Overall Study|technical problems|2|||
27792087|NCT01950819|54246973|FG001|Overall Study|technical problems|0|||
27792088|NCT01950819|54246972|FG000|Overall Study|Pregnancy|0|||
27792089|NCT01950819|54246973|FG001|Overall Study|Pregnancy|2|||
27792090|NCT01950819|54246972|FG000|Overall Study|Lost to Follow-up|9|||
27937011|NCT01106625|54593429|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
27937012|NCT01106625|54593430|FG002|Extension Period: Week 26 to Week 52|Physician Decision|1|||
27937013|NCT01106625|54593428|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
27937014|NCT01106625|54593429|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
27937015|NCT01106625|54593430|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
27937016|NCT01106625|54593428|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4|||
27937017|NCT01106625|54593429|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
27937018|NCT01106625|54593430|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
27937019|NCT01106625|54593428|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14|||
27937020|NCT01106625|54593429|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5|||
27937021|NCT01106625|54593430|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4|||
27937022|NCT01106625|54593428|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
27937023|NCT01106625|54593429|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
27937024|NCT01106625|54593430|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
27937025|NCT01106625|54593428|FG000|Extension Period: Week 26 to Week 52|Other|5|||
27937026|NCT01106625|54593429|FG001|Extension Period: Week 26 to Week 52|Other|5|||
27937027|NCT01106625|54593430|FG002|Extension Period: Week 26 to Week 52|Other|4|||
28017198|NCT00661362|54676466|FG000|Overall Study|Safety reasons|1|||
27792091|NCT01950819|54246973|FG001|Overall Study|Lost to Follow-up|17|||
27792092|NCT01514422|54246979|FG000|Overall Study|Lost to Follow-up|1|||
27937028|NCT01251380|54593441|FG000|Overall Study|Other (Not otherwise specified)|12|||
27937029|NCT01251380|54593441|FG000|Overall Study|Withdrawal by Subject|6|||
27792093|NCT01513330|54246983|FG000|SenSura Mio First,|Adverse Event|2|||
27937030|NCT01251380|54593441|FG000|Overall Study|Lack of Efficacy|1|||
27937031|NCT01251380|54593441|FG000|Overall Study|Adverse Event|1|||
27937032|NCT01251380|54593441|FG000|Overall Study|Lost to Follow-up|2|||
28017199|NCT00661362|54676467|FG001|Overall Study|Safety reasons|0|||
27792094|NCT01513330|54246984|FG001|SenSura Mio First,|Adverse Event|0|||
27792095|NCT01513330|54246983|FG000|SenSura Mio First,|Lack of Efficacy|0|||
27792096|NCT01513330|54246984|FG001|SenSura Mio First,|Lack of Efficacy|1|||
27937033|NCT01251146|54593452|FG000|Overall Study|Lost to Follow-up|3|||
27937034|NCT01251146|54593453|FG001|Overall Study|Lost to Follow-up|10|||
27937035|NCT01096017|54593459|FG000|Treatment Period 2|Eligibility criteria not fulfilled|1|||
27937036|NCT01096017|54593460|FG001|Treatment Period 2|Eligibility criteria not fulfilled|1|||
27937037|NCT01106157|54593468|FG000|Overall Study|Withdrawal by Subject|1|||
27937038|NCT01106157|54593469|FG001|Overall Study|Withdrawal by Subject|0|||
27937039|NCT01094301|54593475|FG000|Trial Stage|Withdrawal by Subject|1|||
27937040|NCT01094301|54593475|FG000|Implant Stage|Adverse Event|1|||
27792097|NCT01513330|54246983|FG000|SenSura Mio First,|Withdrawal by Subject|1|||
27792098|NCT01513330|54246984|FG001|SenSura Mio First,|Withdrawal by Subject|1|||
27792099|NCT01513330|54246983|FG000|SenSura Mio First,|Other|1|||
27792100|NCT01513330|54246984|FG001|SenSura Mio First,|Other|0|||
27792101|NCT01513330|54246983|FG000|Standard Care First,|Lack of Efficacy|2|||
27792102|NCT01513330|54246984|FG001|Standard Care First,|Lack of Efficacy|2|||
27792103|NCT01513330|54246983|FG000|Standard Care First,|Withdrawal by Subject|1|||
27792104|NCT01513330|54246984|FG001|Standard Care First,|Withdrawal by Subject|2|||
27792105|NCT01513330|54246983|FG000|Standard Care First,|Other|1|||
27792106|NCT01513330|54246984|FG001|Standard Care First,|Other|0|||
27792107|NCT01524796|54246990|FG000|Overall Study|Adverse Event|13|||
27792108|NCT01524796|54246990|FG000|Overall Study|Lack of Efficacy|3|||
27792109|NCT01524796|54246990|FG000|Overall Study|Lost to Follow-up|1|||
27792110|NCT01524796|54246990|FG000|Overall Study|The price|1|||
27792111|NCT01524796|54246990|FG000|Overall Study|Withdrawal by Subject|4|||
27792112|NCT01524796|54246990|FG000|Overall Study|Move|1|||
27792113|NCT01524796|54246990|FG000|Overall Study|Deterioration of pains|1|||
27792114|NCT01524796|54246990|FG000|Overall Study|Gall stone surgery|1|||
27792115|NCT01524796|54246990|FG000|Overall Study|Nervous about confidentiality|1|||
27792116|NCT01524796|54246990|FG000|Overall Study|Switch to carbamazapine|1|||
27792117|NCT01524796|54246990|FG000|Overall Study|Adverse Event and Lack of Efficacy|1|||
27792118|NCT01547728|54246994|FG000|Overall Study|Change in procedure and equipment|1|||
27792119|NCT01547728|54246994|FG000|Overall Study|Drug not ready for subject|1|||
27792120|NCT01547728|54246994|FG000|Overall Study|Screen failure|39|||
27792121|NCT01523392|54247000|FG000|Treatment Period 1|Withdrawal by Subject|2|||
27792122|NCT01523392|54247001|FG001|Treatment Period 1|Withdrawal by Subject|0|||
27792123|NCT01523392|54247000|FG000|Treatment Period 1|Did not complete 7-9 days of treatment.|1|||
27792124|NCT01523392|54247001|FG001|Treatment Period 1|Did not complete 7-9 days of treatment.|0|||
27792125|NCT01523392|54247000|FG000|Washout Period - 10 to 14 Days|Adverse Event|1|||
27792126|NCT01523392|54247001|FG001|Washout Period - 10 to 14 Days|Adverse Event|0|||
27792127|NCT01512160|54247013|FG000|Overall Study|Lost to Follow-up|1|||
27792128|NCT01512160|54247014|FG001|Overall Study|Lost to Follow-up|0|||
27792129|NCT01512160|54247015|FG002|Overall Study|Lost to Follow-up|0|||
27792130|NCT01512160|54247016|FG003|Overall Study|Lost to Follow-up|0|||
27792131|NCT01512160|54247013|FG000|Overall Study|Withdrawal by Subject|1|||
27792132|NCT01512160|54247014|FG001|Overall Study|Withdrawal by Subject|0|||
27792133|NCT01512160|54247015|FG002|Overall Study|Withdrawal by Subject|0|||
27792134|NCT01512160|54247016|FG003|Overall Study|Withdrawal by Subject|1|||
27792135|NCT01546168|54247029|FG000|Overall Study|Lost to Follow-up|1|||
27792136|NCT01546168|54247030|FG001|Overall Study|Lost to Follow-up|0|||
27792137|NCT01546168|54247029|FG000|Overall Study|Withdrawal by Subject|1|||
27792138|NCT01546168|54247030|FG001|Overall Study|Withdrawal by Subject|0|||
27792139|NCT01546168|54247029|FG000|Overall Study|ineligible after signing consent|2|||
27792140|NCT01546168|54247030|FG001|Overall Study|ineligible after signing consent|0|||
27937041|NCT01094301|54593475|FG000|Implant Stage|Protocol Violation|1|||
27937042|NCT01094301|54593475|FG000|Implant Stage|Withdrawal by Subject|2|||
27937043|NCT01094301|54593475|FG000|Implant Stage|No return of pain|4|||
27937044|NCT01093755|54593483|FG000|Overall Study|Withdrawal by Subject|3|||
27937045|NCT01093755|54593484|FG001|Overall Study|Withdrawal by Subject|4|||
27937046|NCT01093599|54593492|FG000|Overall Study|Lost to Follow-up|32|||
27937047|NCT01093599|54593493|FG001|Overall Study|Lost to Follow-up|46|||
27937048|NCT01092663|54593501|FG000|Overall Study|Withdrawal by Subject|3|||
27937049|NCT01092663|54593502|FG001|Overall Study|Withdrawal by Subject|2|||
27937050|NCT01092663|54593501|FG000|Overall Study|Glucose >300mg/dL|1|||
27792141|NCT01901289|54247036|FG000|Overall Study|Death|32|||
27792142|NCT01901289|54247036|FG000|Overall Study|Lost to Follow-up|16|||
27937051|NCT01092663|54593502|FG001|Overall Study|Glucose >300mg/dL|0|||
27937052|NCT01092663|54593501|FG000|Overall Study|High fasting triglyceride|2|||
27792143|NCT01901289|54247036|FG000|Overall Study|Withdrawal by Subject|35|||
27792144|NCT01901289|54247036|FG000|Overall Study|Other type of endpoint met|2|||
27792145|NCT01950741|54247040|FG000|Overall Study|Lost to Follow-up|1|||
27792146|NCT01950741|54247040|FG000|Overall Study|Death|1|||
27792147|NCT01950741|54247040|FG000|Overall Study|Withdrawal by Subject|1|||
28105619|NCT02079766|54763115|FG000|Overall Study|Physician Decision|1|||
28105620|NCT02079766|54763116|FG001|Overall Study|Physician Decision|0|||
27792148|NCT01950273|54247046|FG000|Overall Study|Protocol Violation|1|||
27792149|NCT01950273|54247047|FG001|Overall Study|Protocol Violation|0|||
27792150|NCT01950273|54247046|FG000|Overall Study|Withdrawal by Subject|2|||
27937053|NCT01092663|54593502|FG001|Overall Study|High fasting triglyceride|0|||
27937054|NCT01092663|54593501|FG000|Overall Study|Adverse Event|1|||
27937055|NCT01092663|54593502|FG001|Overall Study|Adverse Event|1|||
27937056|NCT01092663|54593501|FG000|Overall Study|Protocol Violation|0|||
27937057|NCT01092663|54593502|FG001|Overall Study|Protocol Violation|1|||
27937058|NCT01078623|54593513|FG000|Treatment Period 1|Adverse Event|1|||
27937059|NCT01078623|54593514|FG001|Treatment Period 1|Adverse Event|1|||
27792151|NCT01950273|54247047|FG001|Overall Study|Withdrawal by Subject|0|||
27792152|NCT01950273|54247046|FG000|Overall Study|Other not defined above|1|||
27792153|NCT01950273|54247047|FG001|Overall Study|Other not defined above|0|||
27792154|NCT01919307|54247053|FG000|Overall Study|Withdrawal by Subject|9|||
27792155|NCT01919229|54247060|FG000|Overall Study|Subject/guardian decision|0|||
27792156|NCT01919229|54247061|FG001|Overall Study|Subject/guardian decision|0|||
27792157|NCT01919229|54247062|FG002|Overall Study|Subject/guardian decision|1|||
27792158|NCT01901055|54247072|FG000|Randomization But Not Titrated|Did not come to titration study|1|||
27792159|NCT01901055|54247073|FG001|Randomization But Not Titrated|Did not come to titration study|1|||
27792160|NCT01901055|54247072|FG000|Randomization But Not Titrated|Physician Decision|0|||
27792161|NCT01901055|54247073|FG001|Randomization But Not Titrated|Physician Decision|1|||
27792162|NCT01901055|54247072|FG000|Started Protocol to Week 6|Physician Decision|2|||
27792163|NCT01901055|54247073|FG001|Started Protocol to Week 6|Physician Decision|1|||
27792164|NCT01901055|54247072|FG000|Started Protocol to Week 6|complains of difficulty with wearing mask|0|||
27792165|NCT01901055|54247073|FG001|Started Protocol to Week 6|complains of difficulty with wearing mask|2|||
27792166|NCT01901055|54247072|FG000|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|1|||
27792167|NCT01901055|54247073|FG001|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|0|||
27792168|NCT01901055|54247072|FG000|Started Protocol to Week 6|Withdrawal by Subject|0|||
27792169|NCT01901055|54247073|FG001|Started Protocol to Week 6|Withdrawal by Subject|1|||
27792170|NCT01901055|54247072|FG000|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|1|||
27792171|NCT01901055|54247073|FG001|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|0|||
27792172|NCT01901055|54247072|FG000|Week 12 Assessment|Withdrawal by Subject|0|||
27792173|NCT01901055|54247073|FG001|Week 12 Assessment|Withdrawal by Subject|4|||
27792174|NCT01901055|54247072|FG000|Week 24|Withdrawal by Subject|13|||
27792175|NCT01901055|54247073|FG001|Week 24|Withdrawal by Subject|19|||
27792176|NCT01901055|54247072|FG000|Week 24|Physician Decision|1|||
27792177|NCT01901055|54247073|FG001|Week 24|Physician Decision|0|||
27792178|NCT01901055|54247072|FG000|Week 36|Withdrawal by Subject|0|||
27792179|NCT01901055|54247073|FG001|Week 36|Withdrawal by Subject|5|||
27792180|NCT01511536|54247085|FG000|Phase 1|Other|0|||
27792181|NCT01511536|54247086|FG001|Phase 1|Other|1|||
27792182|NCT01511536|54247087|FG002|Phase 1|Other|0|||
27792183|NCT01511536|54247085|FG000|Phase 2|Other|0|||
27792184|NCT01511536|54247086|FG001|Phase 2|Other|0|||
27792185|NCT01511536|54247087|FG002|Phase 2|Other|9|||
27792186|NCT01890759|54247097|FG000|Overall Study|Protocol Violation|0|||
27792187|NCT01890759|54247098|FG001|Overall Study|Protocol Violation|2|||
27792188|NCT01890759|54247097|FG000|Overall Study|Lost to Follow-up|0|||
27792189|NCT01890759|54247098|FG001|Overall Study|Lost to Follow-up|2|||
27792190|NCT01890759|54247097|FG000|Overall Study|Withdrawal by Subject|2|||
27792191|NCT01890759|54247098|FG001|Overall Study|Withdrawal by Subject|8|||
27792192|NCT01900899|54247106|FG000|Overall Study|Withdrawal by Subject|7|||
27792193|NCT01900899|54247107|FG001|Overall Study|Withdrawal by Subject|1|||
27792194|NCT01900899|54247106|FG000|Overall Study|Migrated from study area|2|||
27792195|NCT01900899|54247107|FG001|Overall Study|Migrated from study area|0|||
27792196|NCT01510912|54247113|FG000|Overall Study|Adverse Event|99|||
27792197|NCT01510912|54247113|FG000|Overall Study|Lack of Efficacy|12|||
27792198|NCT01510912|54247113|FG000|Overall Study|Non-compliance with trial drug|23|||
27792199|NCT01510912|54247113|FG000|Overall Study|Withdrawal by Subject|49|||
27792200|NCT01510912|54247113|FG000|Overall Study|Physician Decision|1|||
27792201|NCT01510912|54247113|FG000|Overall Study|Protocol Violation|27|||
27792202|NCT01510912|54247113|FG000|Overall Study|Lost to Follow-up|26|||
27792203|NCT01510912|54247113|FG000|Overall Study|Other, including joint replacement|5|||
27792204|NCT01510756|54247117|FG000|Overall Study|Death|1|||
27792205|NCT01510756|54247117|FG000|Overall Study|Lack of Efficacy|2|||
27937060|NCT01078623|54593515|FG002|Treatment Period 1|Adverse Event|1|||
27792206|NCT01510756|54247117|FG000|Overall Study|Physician Decision|1|||
27792207|NCT01522456|54247121|FG000|Overall Study|Adverse Event|2|||
27792208|NCT01522456|54247121|FG000|Overall Study|Lost to Follow-up|2|||
27792209|NCT01522456|54247121|FG000|Overall Study|Withdrawal by Subject|2|||
27937061|NCT01078623|54593516|FG003|Treatment Period 1|Adverse Event|0|||
27937062|NCT01078623|54593517|FG004|Treatment Period 1|Adverse Event|0|||
27937063|NCT01078623|54593518|FG005|Treatment Period 1|Adverse Event|0|||
27792210|NCT01522456|54247121|FG000|Overall Study|Pregnancy|1|||
27792211|NCT01522456|54247121|FG000|Overall Study|Tolerability Assessment|1|||
27792212|NCT01545934|54247134|FG000|Overall Study|Withdrawal by Subject|4|||
27792213|NCT01545934|54247135|FG001|Overall Study|Withdrawal by Subject|3|||
27792214|NCT01545934|54247134|FG000|Overall Study|Lost to Follow-up|1|||
27937064|NCT01078623|54593519|FG006|Treatment Period 1|Adverse Event|1|||
27937065|NCT01078623|54593520|FG007|Treatment Period 1|Adverse Event|0|||
27792215|NCT01545934|54247135|FG001|Overall Study|Lost to Follow-up|0|||
27792216|NCT01521364|54247142|FG000|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1|||
27792217|NCT01521364|54247142|FG000|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1|||
27792218|NCT01545388|54247156|FG000|Overall Study|Adverse Event|2|||
27792219|NCT01545388|54247157|FG001|Overall Study|Adverse Event|4|||
27792220|NCT01545388|54247158|FG002|Overall Study|Adverse Event|1|||
27792221|NCT01545388|54247156|FG000|Overall Study|Lack of Efficacy|3|||
27792222|NCT01545388|54247157|FG001|Overall Study|Lack of Efficacy|2|||
27792223|NCT01545388|54247158|FG002|Overall Study|Lack of Efficacy|5|||
27792224|NCT01545388|54247156|FG000|Overall Study|Participant moved or relocated|1|||
27792225|NCT01545388|54247157|FG001|Overall Study|Participant moved or relocated|0|||
27792226|NCT01545388|54247158|FG002|Overall Study|Participant moved or relocated|0|||
27792227|NCT01545388|54247156|FG000|Overall Study|Withdrawal by Subject|1|||
27792228|NCT01545388|54247157|FG001|Overall Study|Withdrawal by Subject|4|||
27792229|NCT01545388|54247158|FG002|Overall Study|Withdrawal by Subject|2|||
27792230|NCT01545388|54247156|FG000|Overall Study|Other|1|||
27792231|NCT01545388|54247157|FG001|Overall Study|Other|1|||
27792232|NCT01545388|54247158|FG002|Overall Study|Other|0|||
27792233|NCT01545076|54247166|FG000|IgPro10 Restabilization Period|Adverse Event|4|||
27792234|NCT01545076|54247167|FG001|IgPro10 Restabilization Period|Adverse Event|0|||
27792235|NCT01545076|54247168|FG002|IgPro10 Restabilization Period|Adverse Event|0|||
27792236|NCT01545076|54247169|FG003|IgPro10 Restabilization Period|Adverse Event|0|||
27792237|NCT01545076|54247170|FG004|IgPro10 Restabilization Period|Adverse Event|0|||
27792238|NCT01545076|54247166|FG000|IgPro10 Restabilization Period|Physician Decision|2|||
27792239|NCT01545076|54247167|FG001|IgPro10 Restabilization Period|Physician Decision|0|||
27792240|NCT01545076|54247168|FG002|IgPro10 Restabilization Period|Physician Decision|0|||
27792241|NCT01545076|54247169|FG003|IgPro10 Restabilization Period|Physician Decision|0|||
27792242|NCT01545076|54247170|FG004|IgPro10 Restabilization Period|Physician Decision|0|||
27792243|NCT01545076|54247166|FG000|IgPro10 Restabilization Period|Protocol Violation|1|||
27792244|NCT01545076|54247167|FG001|IgPro10 Restabilization Period|Protocol Violation|0|||
27792245|NCT01545076|54247168|FG002|IgPro10 Restabilization Period|Protocol Violation|0|||
27792246|NCT01545076|54247169|FG003|IgPro10 Restabilization Period|Protocol Violation|0|||
27792247|NCT01545076|54247170|FG004|IgPro10 Restabilization Period|Protocol Violation|0|||
27792248|NCT01545076|54247166|FG000|IgPro10 Restabilization Period|Failure to meet randomization criteria|22|||
27792249|NCT01545076|54247167|FG001|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
27792250|NCT01545076|54247168|FG002|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
27792251|NCT01545076|54247169|FG003|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
27792252|NCT01545076|54247170|FG004|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
27792253|NCT01545076|54247166|FG000|IgPro10 Restabilization Period|Withdrawal by Subject|7|||
27792254|NCT01545076|54247167|FG001|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
27792255|NCT01545076|54247168|FG002|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
27792256|NCT01545076|54247169|FG003|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
27792257|NCT01545076|54247170|FG004|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
27792258|NCT01545076|54247166|FG000|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
27792259|NCT01545076|54247167|FG001|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
27792260|NCT01545076|54247168|FG002|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
27792261|NCT01545076|54247169|FG003|IgPro20 Subcutaneous Treatment Period|Physician Decision|1|||
27792262|NCT01545076|54247170|FG004|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
27792263|NCT01545076|54247166|FG000|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
27792264|NCT01545076|54247167|FG001|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10|||
27792265|NCT01545076|54247168|FG002|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18|||
27792266|NCT01545076|54247169|FG003|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32|||
27792267|NCT01545076|54247170|FG004|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
27792268|NCT01545076|54247166|FG000|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
27792269|NCT01545076|54247167|FG001|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
27792270|NCT01545076|54247168|FG002|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
27792271|NCT01545076|54247169|FG003|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
27792272|NCT01545076|54247170|FG004|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
27792273|NCT01545076|54247166|FG000|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
27792274|NCT01545076|54247167|FG001|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8|||
27792275|NCT01545076|54247168|FG002|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2|||
27792276|NCT01545076|54247169|FG003|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3|||
27792277|NCT01545076|54247170|FG004|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
27792278|NCT01544920|54247185|FG000|Overall Study|Adverse Event|0|||
27937066|NCT01078623|54593521|FG008|Treatment Period 1|Adverse Event|1|||
27937067|NCT01078623|54593522|FG009|Treatment Period 1|Adverse Event|1|||
27792279|NCT01544920|54247186|FG001|Overall Study|Adverse Event|3|||
27937068|NCT01078623|54593523|FG010|Treatment Period 1|Adverse Event|0|||
27792280|NCT01544920|54247185|FG000|Overall Study|Death|0|||
27792281|NCT01544920|54247186|FG001|Overall Study|Death|1|||
27792282|NCT01544920|54247185|FG000|Overall Study|Lost to Follow-up|11|||
27792283|NCT01544920|54247186|FG001|Overall Study|Lost to Follow-up|12|||
27792284|NCT01544920|54247185|FG000|Overall Study|Protocol Violation|0|||
27792285|NCT01544920|54247186|FG001|Overall Study|Protocol Violation|2|||
27792286|NCT01544920|54247185|FG000|Overall Study|Physician Decision|4|||
27792287|NCT01544920|54247186|FG001|Overall Study|Physician Decision|1|||
27792288|NCT01544920|54247185|FG000|Overall Study|Withdrawal by Subject|4|||
27792289|NCT01544920|54247186|FG001|Overall Study|Withdrawal by Subject|4|||
27792290|NCT01509664|54247196|FG000|Overall Study|Lost to Follow-up|15|||
27792291|NCT01509664|54247197|FG001|Overall Study|Lost to Follow-up|21|||
27792292|NCT01543828|54247205|FG000|Treatment 2|Lost to Follow-up|1|||
27792293|NCT01543828|54247206|FG001|Treatment 2|Lost to Follow-up|0|||
27792294|NCT01520506|54247214|FG000|Overall Study|Missed Visit|4|||
27792295|NCT01520506|54247214|FG000|Overall Study|Lost to Follow-up|1|||
27792296|NCT01520506|54247214|FG000|Overall Study|Withdrawal by Subject|1|||
27792297|NCT01519960|54247221|FG000|Overall Study|Withdrawal from the study|26|||
27792298|NCT01519960|54247222|FG001|Overall Study|Withdrawal from the study|22|||
27792299|NCT01519960|54247223|FG002|Overall Study|Withdrawal from the study|5|||
27792300|NCT01543204|54247239|FG000|Overall Study|Non-compliance|1|||
27792301|NCT01543204|54247239|FG000|Overall Study|Adverse Event|1|||
27792302|NCT01543204|54247239|FG000|Overall Study|Withdrawal by Subject|4|||
27792303|NCT01543204|54247239|FG000|Overall Study|Requirement for Alternative Therapy|1|||
27792304|NCT01543204|54247239|FG000|Overall Study|Lost to Follow-up|1|||
27792305|NCT01488994|54247249|FG000|Overall Study|Withdrawal by Subject|0|||
27792306|NCT01488994|54247250|FG001|Overall Study|Withdrawal by Subject|1|||
27792307|NCT01508650|54247263|FG000|Overall Study|Lost to Follow-up|0|||
27792308|NCT01508650|54247264|FG001|Overall Study|Lost to Follow-up|3|||
27792309|NCT01488448|54247272|FG000|Overall Study|Withdrawal by Subject|3|||
27792310|NCT01488448|54247273|FG001|Overall Study|Withdrawal by Subject|1|||
27792311|NCT01488448|54247272|FG000|Overall Study|Adverse Event|9|||
27792312|NCT01488448|54247273|FG001|Overall Study|Adverse Event|4|||
27792313|NCT01488448|54247272|FG000|Overall Study|Physician Decision|4|||
27792314|NCT01488448|54247273|FG001|Overall Study|Physician Decision|9|||
27792315|NCT01488448|54247272|FG000|Overall Study|Protocol Violation|4|||
27792316|NCT01488448|54247273|FG001|Overall Study|Protocol Violation|3|||
27792317|NCT01518946|54247283|FG000|Open-label Phase|Other|4|||
27792318|NCT01518946|54247284|FG001|Open-label Phase|Other|0|||
27792319|NCT01518946|54247285|FG002|Open-label Phase|Other|0|||
27792320|NCT01518946|54247283|FG000|Randomized Phase (First Intervention)|Other|0|||
27792321|NCT01518946|54247284|FG001|Randomized Phase (First Intervention)|Other|1|||
27792322|NCT01518946|54247285|FG002|Randomized Phase (First Intervention)|Other|0|||
27792323|NCT01488370|54247295|FG000|Overall Study|Protocol Violation|0|||
27792324|NCT01488370|54247296|FG001|Overall Study|Protocol Violation|1|||
27792325|NCT01488370|54247297|FG002|Overall Study|Protocol Violation|1|||
27792326|NCT01518322|54247305|FG000|Overall Study|FeNO measurement was missing|13|||
27792327|NCT01507246|54247316|FG000|Overall Study|Required different surgical procedures|2|||
27792328|NCT01507246|54247317|FG001|Overall Study|Required different surgical procedures|1|||
27792329|NCT01507090|54247326|FG000|Overall Study|incomplete dataset|18|||
27792330|NCT01464346|54247340|FG000|Overall Study|Withdrawal by Subject|0|||
27792331|NCT01464346|54247341|FG001|Overall Study|Withdrawal by Subject|0|||
27792332|NCT01464346|54247342|FG002|Overall Study|Withdrawal by Subject|1|||
27792333|NCT01487200|54247369|FG000|Overall Study|Withdrawal by Subject|0|||
27792334|NCT01487200|54247370|FG001|Overall Study|Withdrawal by Subject|1|||
27792335|NCT01487200|54247371|FG002|Overall Study|Withdrawal by Subject|0|||
27792336|NCT01487200|54247372|FG003|Overall Study|Withdrawal by Subject|0|||
27792337|NCT01463878|54247385|FG000|Overall Study|no longer met criteria for tube feed|2|||
27792338|NCT01463878|54247386|FG001|Overall Study|no longer met criteria for tube feed|2|||
27792339|NCT01505608|54247394|FG000|Phase I|Lack of Efficacy|0|||
27792340|NCT01505608|54247395|FG001|Phase I|Lack of Efficacy|4|||
27792341|NCT01505608|54247394|FG000|Phase I|Adverse Event|0|||
27792342|NCT01505608|54247395|FG001|Phase I|Adverse Event|1|||
27937069|NCT01078623|54593524|FG011|Treatment Period 1|Adverse Event|0|||
27937070|NCT01078623|54593525|FG012|Treatment Period 1|Adverse Event|0|||
27937071|NCT01078623|54593526|FG013|Treatment Period 1|Adverse Event|0|||
27937072|NCT01078623|54593527|FG014|Treatment Period 1|Adverse Event|0|||
27792343|NCT01505608|54247394|FG000|Phase I|Withdrawal by Subject|0|||
27792344|NCT01505608|54247395|FG001|Phase I|Withdrawal by Subject|1|||
27792345|NCT01505608|54247394|FG000|Phase II|Lack of Efficacy|2|||
27792346|NCT01505608|54247395|FG001|Phase II|Lack of Efficacy|1|||
27792347|NCT01505608|54247394|FG000|Phase II|Protocol Violation|0|||
27792348|NCT01505608|54247395|FG001|Phase II|Protocol Violation|1|||
27792349|NCT01486966|54247406|FG000|Overall Study|Adverse Event|0|||
27792350|NCT01486966|54247407|FG001|Overall Study|Adverse Event|1|||
27792351|NCT01486966|54247406|FG000|Overall Study|Withdrawal by Subject|0|||
27937073|NCT01078623|54593528|FG015|Treatment Period 1|Adverse Event|0|||
27792352|NCT01486966|54247407|FG001|Overall Study|Withdrawal by Subject|1|||
27792353|NCT01900665|54247415|FG000|Placebo Controlled Period|Death|9|||
27937074|NCT01078623|54593529|FG016|Treatment Period 1|Adverse Event|0|||
27937075|NCT01078623|54593530|FG017|Treatment Period 1|Adverse Event|0|||
27937076|NCT01078623|54593531|FG018|Treatment Period 1|Adverse Event|0|||
27937077|NCT01078623|54593532|FG019|Treatment Period 1|Adverse Event|0|||
27937078|NCT01078623|54593513|FG000|Treatment Period 1|Withdrawal by Subject|0|||
27937079|NCT01078623|54593514|FG001|Treatment Period 1|Withdrawal by Subject|0|||
27937080|NCT01078623|54593515|FG002|Treatment Period 1|Withdrawal by Subject|0|||
27937081|NCT01078623|54593516|FG003|Treatment Period 1|Withdrawal by Subject|0|||
27937082|NCT01078623|54593517|FG004|Treatment Period 1|Withdrawal by Subject|0|||
27937083|NCT01078623|54593518|FG005|Treatment Period 1|Withdrawal by Subject|0|||
27792354|NCT01900665|54247416|FG001|Placebo Controlled Period|Death|16|||
27792355|NCT01900665|54247415|FG000|Placebo Controlled Period|Adverse Event|48|||
27792356|NCT01900665|54247416|FG001|Placebo Controlled Period|Adverse Event|39|||
27792357|NCT01900665|54247415|FG000|Placebo Controlled Period|Protocol Violation|1|||
27792358|NCT01900665|54247416|FG001|Placebo Controlled Period|Protocol Violation|7|||
27792359|NCT01900665|54247415|FG000|Placebo Controlled Period|Withdrawal by Subject|33|||
27792360|NCT01900665|54247416|FG001|Placebo Controlled Period|Withdrawal by Subject|45|||
27937084|NCT01078623|54593519|FG006|Treatment Period 1|Withdrawal by Subject|0|||
27937085|NCT01078623|54593520|FG007|Treatment Period 1|Withdrawal by Subject|1|||
27937086|NCT01078623|54593521|FG008|Treatment Period 1|Withdrawal by Subject|0|||
27937087|NCT01078623|54593522|FG009|Treatment Period 1|Withdrawal by Subject|0|||
27937088|NCT01078623|54593523|FG010|Treatment Period 1|Withdrawal by Subject|1|||
27937089|NCT01078623|54593524|FG011|Treatment Period 1|Withdrawal by Subject|0|||
27937090|NCT01078623|54593525|FG012|Treatment Period 1|Withdrawal by Subject|0|||
27937091|NCT01078623|54593526|FG013|Treatment Period 1|Withdrawal by Subject|0|||
27937092|NCT01078623|54593527|FG014|Treatment Period 1|Withdrawal by Subject|0|||
27937093|NCT01078623|54593528|FG015|Treatment Period 1|Withdrawal by Subject|0|||
27937094|NCT01078623|54593529|FG016|Treatment Period 1|Withdrawal by Subject|0|||
27937095|NCT01078623|54593530|FG017|Treatment Period 1|Withdrawal by Subject|0|||
27937096|NCT01078623|54593531|FG018|Treatment Period 1|Withdrawal by Subject|0|||
27937097|NCT01078623|54593532|FG019|Treatment Period 1|Withdrawal by Subject|0|||
27937098|NCT01078623|54593513|FG000|Treatment Period 1|Protocol Violation|0|||
27937099|NCT01078623|54593514|FG001|Treatment Period 1|Protocol Violation|0|||
27937100|NCT01078623|54593515|FG002|Treatment Period 1|Protocol Violation|0|||
27937101|NCT01078623|54593516|FG003|Treatment Period 1|Protocol Violation|0|||
27937102|NCT01078623|54593517|FG004|Treatment Period 1|Protocol Violation|0|||
27937103|NCT01078623|54593518|FG005|Treatment Period 1|Protocol Violation|1|||
27937104|NCT01078623|54593519|FG006|Treatment Period 1|Protocol Violation|0|||
27937105|NCT01078623|54593520|FG007|Treatment Period 1|Protocol Violation|0|||
27937106|NCT01078623|54593521|FG008|Treatment Period 1|Protocol Violation|0|||
27937107|NCT01078623|54593522|FG009|Treatment Period 1|Protocol Violation|0|||
27937108|NCT01078623|54593523|FG010|Treatment Period 1|Protocol Violation|0|||
27937109|NCT01078623|54593524|FG011|Treatment Period 1|Protocol Violation|0|||
27937110|NCT01078623|54593525|FG012|Treatment Period 1|Protocol Violation|0|||
27937111|NCT01078623|54593526|FG013|Treatment Period 1|Protocol Violation|0|||
27937112|NCT01078623|54593527|FG014|Treatment Period 1|Protocol Violation|0|||
27937113|NCT01078623|54593528|FG015|Treatment Period 1|Protocol Violation|0|||
27937114|NCT01078623|54593529|FG016|Treatment Period 1|Protocol Violation|0|||
27937115|NCT01078623|54593530|FG017|Treatment Period 1|Protocol Violation|0|||
27937116|NCT01078623|54593531|FG018|Treatment Period 1|Protocol Violation|0|||
27937117|NCT01078623|54593532|FG019|Treatment Period 1|Protocol Violation|0|||
27937118|NCT01078623|54593513|FG000|Treatment Period 2|Adverse Event|0|||
27937119|NCT01078623|54593514|FG001|Treatment Period 2|Adverse Event|0|||
27937120|NCT01078623|54593515|FG002|Treatment Period 2|Adverse Event|0|||
27937121|NCT01078623|54593516|FG003|Treatment Period 2|Adverse Event|0|||
27937122|NCT01078623|54593517|FG004|Treatment Period 2|Adverse Event|0|||
27937123|NCT01078623|54593518|FG005|Treatment Period 2|Adverse Event|0|||
27937124|NCT01078623|54593519|FG006|Treatment Period 2|Adverse Event|1|||
27937125|NCT01078623|54593520|FG007|Treatment Period 2|Adverse Event|0|||
27937126|NCT01078623|54593521|FG008|Treatment Period 2|Adverse Event|0|||
27937127|NCT01078623|54593522|FG009|Treatment Period 2|Adverse Event|0|||
27937128|NCT01078623|54593523|FG010|Treatment Period 2|Adverse Event|0|||
27937129|NCT01078623|54593524|FG011|Treatment Period 2|Adverse Event|0|||
27937130|NCT01078623|54593525|FG012|Treatment Period 2|Adverse Event|0|||
27937131|NCT01078623|54593526|FG013|Treatment Period 2|Adverse Event|0|||
27937132|NCT01078623|54593527|FG014|Treatment Period 2|Adverse Event|0|||
27937133|NCT01078623|54593528|FG015|Treatment Period 2|Adverse Event|0|||
27937134|NCT01078623|54593529|FG016|Treatment Period 2|Adverse Event|0|||
27937135|NCT01078623|54593530|FG017|Treatment Period 2|Adverse Event|0|||
27937136|NCT01078623|54593531|FG018|Treatment Period 2|Adverse Event|1|||
27937137|NCT01078623|54593532|FG019|Treatment Period 2|Adverse Event|0|||
27937138|NCT01078623|54593513|FG000|Treatment Period 2|Withdrawal by Subject|0|||
27937139|NCT01078623|54593514|FG001|Treatment Period 2|Withdrawal by Subject|0|||
27937140|NCT01078623|54593515|FG002|Treatment Period 2|Withdrawal by Subject|0|||
27792361|NCT01900665|54247415|FG000|Placebo Controlled Period|Physician Decision|11|||
27792362|NCT01900665|54247416|FG001|Placebo Controlled Period|Physician Decision|7|||
27937141|NCT01078623|54593516|FG003|Treatment Period 2|Withdrawal by Subject|0|||
27937142|NCT01078623|54593517|FG004|Treatment Period 2|Withdrawal by Subject|0|||
27937143|NCT01078623|54593518|FG005|Treatment Period 2|Withdrawal by Subject|1|||
27937144|NCT01078623|54593519|FG006|Treatment Period 2|Withdrawal by Subject|0|||
27937145|NCT01078623|54593520|FG007|Treatment Period 2|Withdrawal by Subject|0|||
27937146|NCT01078623|54593521|FG008|Treatment Period 2|Withdrawal by Subject|0|||
27937147|NCT01078623|54593522|FG009|Treatment Period 2|Withdrawal by Subject|0|||
27792363|NCT01900665|54247415|FG000|Placebo Controlled Period|Lost to Follow-up|3|||
27792364|NCT01900665|54247416|FG001|Placebo Controlled Period|Lost to Follow-up|0|||
27792365|NCT01900665|54247415|FG000|Placebo Controlled Period|Caregiver Decision|33|||
27792366|NCT01900665|54247416|FG001|Placebo Controlled Period|Caregiver Decision|41|||
27792367|NCT01900665|54247415|FG000|Placebo Controlled Period|Entry Criteria Not Met|5|||
27792368|NCT01900665|54247416|FG001|Placebo Controlled Period|Entry Criteria Not Met|9|||
27792369|NCT01900665|54247415|FG000|Open Label Period|Adverse Event|16|||
27792370|NCT01900665|54247416|FG001|Open Label Period|Adverse Event|20|||
27792371|NCT01900665|54247415|FG000|Open Label Period|Death|5|||
27792372|NCT01900665|54247416|FG001|Open Label Period|Death|6|||
27792373|NCT01900665|54247415|FG000|Open Label Period|Lost to Follow-up|1|||
27792374|NCT01900665|54247416|FG001|Open Label Period|Lost to Follow-up|1|||
27792375|NCT01900665|54247415|FG000|Open Label Period|Parent/Caregiver Decision|33|||
27792376|NCT01900665|54247416|FG001|Open Label Period|Parent/Caregiver Decision|34|||
27792377|NCT01900665|54247415|FG000|Open Label Period|Physician Decision|4|||
27792378|NCT01900665|54247416|FG001|Open Label Period|Physician Decision|4|||
27792379|NCT01900665|54247415|FG000|Open Label Period|Protocol Violation|0|||
27792380|NCT01900665|54247416|FG001|Open Label Period|Protocol Violation|1|||
27792381|NCT01900665|54247415|FG000|Open Label Period|Sponsor Decision|802|||
27792382|NCT01900665|54247416|FG001|Open Label Period|Sponsor Decision|765|||
27792383|NCT01900665|54247415|FG000|Open Label Period|Withdrawal by Subject|20|||
27792384|NCT01900665|54247416|FG001|Open Label Period|Withdrawal by Subject|28|||
27792385|NCT01900431|54247427|FG000|Principal Treatment Period (Part A)|Adverse Event|1|||
27792386|NCT01900431|54247428|FG001|Principal Treatment Period (Part A)|Adverse Event|3|||
27792387|NCT01900431|54247429|FG002|Principal Treatment Period (Part A)|Adverse Event|0|||
27792388|NCT01900431|54247427|FG000|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
27792389|NCT01900431|54247428|FG001|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
27792390|NCT01900431|54247429|FG002|Principal Treatment Period (Part A)|Lack of Efficacy|0|||
27792391|NCT01900431|54247427|FG000|Principal Treatment Period (Part A)|Other than specified above|0|||
27792392|NCT01900431|54247428|FG001|Principal Treatment Period (Part A)|Other than specified above|1|||
27792393|NCT01900431|54247429|FG002|Principal Treatment Period (Part A)|Other than specified above|0|||
27792394|NCT01900431|54247427|FG000|Extended Treatment Period (Part B)|Adverse Event|0|||
27792395|NCT01900431|54247428|FG001|Extended Treatment Period (Part B)|Adverse Event|2|||
27792396|NCT01900431|54247429|FG002|Extended Treatment Period (Part B)|Adverse Event|0|||
27792397|NCT01900431|54247427|FG000|Extended Treatment Period (Part B)|Lack of Efficacy|1|||
27792398|NCT01900431|54247428|FG001|Extended Treatment Period (Part B)|Lack of Efficacy|7|||
27792399|NCT01900431|54247429|FG002|Extended Treatment Period (Part B)|Lack of Efficacy|0|||
27792400|NCT01900431|54247427|FG000|Extended Treatment Period (Part B)|Other than specified above|0|||
27792401|NCT01900431|54247428|FG001|Extended Treatment Period (Part B)|Other than specified above|1|||
27792402|NCT01900431|54247429|FG002|Extended Treatment Period (Part B)|Other than specified above|0|||
27792403|NCT01900431|54247427|FG000|Open-Label Treatment Period (Part C)|Adverse Event|0|||
27792404|NCT01900431|54247428|FG001|Open-Label Treatment Period (Part C)|Adverse Event|0|||
27792405|NCT01900431|54247429|FG002|Open-Label Treatment Period (Part C)|Adverse Event|2|||
27792406|NCT01900431|54247427|FG000|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
27792407|NCT01900431|54247428|FG001|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
27792408|NCT01900431|54247429|FG002|Open-Label Treatment Period (Part C)|Lack of Efficacy|3|||
27792409|NCT01900431|54247427|FG000|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
27792410|NCT01900431|54247428|FG001|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
27792411|NCT01900431|54247429|FG002|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3|||
27792412|NCT01948791|54247437|FG000|Overall Study|Adverse Event|12|||
27792413|NCT01948791|54247437|FG000|Overall Study|Lack of Efficacy|3|||
27792414|NCT01948791|54247437|FG000|Overall Study|Protocol Violation|2|||
27792415|NCT01948791|54247437|FG000|Overall Study|Withdrawal by Subject|5|||
27792416|NCT01948791|54247437|FG000|Overall Study|Lost to Follow-up|6|||
27792417|NCT01948791|54247437|FG000|Overall Study|Management issues|1|||
27792418|NCT01948791|54247437|FG000|Overall Study|Others|7|||
27792419|NCT01948791|54247437|FG000|Overall Study|Screening failure|35|||
27792420|NCT01899729|54247446|FG000|Overall Study|Adverse Event|1|||
27792421|NCT01899729|54247447|FG001|Overall Study|Adverse Event|0|||
27792422|NCT01899729|54247448|FG002|Overall Study|Adverse Event|0|||
27792423|NCT01899729|54247449|FG003|Overall Study|Adverse Event|0|||
27792424|NCT01899729|54247450|FG004|Overall Study|Adverse Event|1|||
27937148|NCT01078623|54593523|FG010|Treatment Period 2|Withdrawal by Subject|0|||
27792425|NCT01899729|54247446|FG000|Overall Study|Withdrawal by Subject|1|||
27937149|NCT01078623|54593524|FG011|Treatment Period 2|Withdrawal by Subject|0|||
27937150|NCT01078623|54593525|FG012|Treatment Period 2|Withdrawal by Subject|0|||
27792426|NCT01899729|54247447|FG001|Overall Study|Withdrawal by Subject|2|||
27792427|NCT01899729|54247448|FG002|Overall Study|Withdrawal by Subject|0|||
27792428|NCT01899729|54247449|FG003|Overall Study|Withdrawal by Subject|0|||
27792429|NCT01899729|54247450|FG004|Overall Study|Withdrawal by Subject|0|||
27792430|NCT01899729|54247446|FG000|Overall Study|Lack of Efficacy|0|||
27792431|NCT01899729|54247447|FG001|Overall Study|Lack of Efficacy|0|||
27792432|NCT01899729|54247448|FG002|Overall Study|Lack of Efficacy|2|||
27792433|NCT01899729|54247449|FG003|Overall Study|Lack of Efficacy|0|||
27792434|NCT01899729|54247450|FG004|Overall Study|Lack of Efficacy|1|||
27792435|NCT01898091|54247464|FG000|Overall Study|Lost to Follow-up|1|||
27792436|NCT01898091|54247465|FG001|Overall Study|Lost to Follow-up|1|||
27792437|NCT01898091|54247464|FG000|Overall Study|Withdrawal by Subject|1|||
27792438|NCT01898091|54247465|FG001|Overall Study|Withdrawal by Subject|5|||
27937151|NCT01078623|54593526|FG013|Treatment Period 2|Withdrawal by Subject|0|||
27937152|NCT01078623|54593527|FG014|Treatment Period 2|Withdrawal by Subject|0|||
27937153|NCT01078623|54593528|FG015|Treatment Period 2|Withdrawal by Subject|0|||
27937154|NCT01078623|54593529|FG016|Treatment Period 2|Withdrawal by Subject|0|||
27937155|NCT01078623|54593530|FG017|Treatment Period 2|Withdrawal by Subject|0|||
27937156|NCT01078623|54593531|FG018|Treatment Period 2|Withdrawal by Subject|0|||
27937157|NCT01078623|54593532|FG019|Treatment Period 2|Withdrawal by Subject|0|||
27937158|NCT01078623|54593513|FG000|Treatment Period 3|Adverse Event|0|||
27937159|NCT01078623|54593514|FG001|Treatment Period 3|Adverse Event|0|||
27937160|NCT01078623|54593515|FG002|Treatment Period 3|Adverse Event|0|||
27937161|NCT01078623|54593516|FG003|Treatment Period 3|Adverse Event|0|||
27937162|NCT01078623|54593517|FG004|Treatment Period 3|Adverse Event|1|||
27937163|NCT01078623|54593518|FG005|Treatment Period 3|Adverse Event|0|||
27937164|NCT01078623|54593519|FG006|Treatment Period 3|Adverse Event|0|||
27937165|NCT01078623|54593520|FG007|Treatment Period 3|Adverse Event|0|||
27937166|NCT01078623|54593521|FG008|Treatment Period 3|Adverse Event|0|||
27937167|NCT01078623|54593522|FG009|Treatment Period 3|Adverse Event|0|||
27937168|NCT01078623|54593523|FG010|Treatment Period 3|Adverse Event|0|||
27937169|NCT01078623|54593524|FG011|Treatment Period 3|Adverse Event|0|||
27937170|NCT01078623|54593525|FG012|Treatment Period 3|Adverse Event|0|||
27937171|NCT01078623|54593526|FG013|Treatment Period 3|Adverse Event|1|||
27937172|NCT01078623|54593527|FG014|Treatment Period 3|Adverse Event|0|||
27937173|NCT01078623|54593528|FG015|Treatment Period 3|Adverse Event|0|||
27937174|NCT01078623|54593529|FG016|Treatment Period 3|Adverse Event|0|||
27937175|NCT01078623|54593530|FG017|Treatment Period 3|Adverse Event|0|||
27937176|NCT01078623|54593531|FG018|Treatment Period 3|Adverse Event|0|||
27937177|NCT01078623|54593532|FG019|Treatment Period 3|Adverse Event|0|||
27937178|NCT01078623|54593513|FG000|Treatment Period 4|Adverse Event|0|||
27937179|NCT01078623|54593514|FG001|Treatment Period 4|Adverse Event|0|||
27937180|NCT01078623|54593515|FG002|Treatment Period 4|Adverse Event|1|||
27937181|NCT01078623|54593516|FG003|Treatment Period 4|Adverse Event|0|||
27937182|NCT01078623|54593517|FG004|Treatment Period 4|Adverse Event|0|||
27937183|NCT01078623|54593518|FG005|Treatment Period 4|Adverse Event|0|||
27937184|NCT01078623|54593519|FG006|Treatment Period 4|Adverse Event|0|||
27937185|NCT01078623|54593520|FG007|Treatment Period 4|Adverse Event|0|||
27937186|NCT01078623|54593521|FG008|Treatment Period 4|Adverse Event|0|||
27937187|NCT01078623|54593522|FG009|Treatment Period 4|Adverse Event|0|||
27937188|NCT01078623|54593523|FG010|Treatment Period 4|Adverse Event|0|||
27937189|NCT01078623|54593524|FG011|Treatment Period 4|Adverse Event|0|||
27937190|NCT01078623|54593525|FG012|Treatment Period 4|Adverse Event|0|||
27937191|NCT01078623|54593526|FG013|Treatment Period 4|Adverse Event|0|||
27937192|NCT01078623|54593527|FG014|Treatment Period 4|Adverse Event|0|||
27937193|NCT01078623|54593528|FG015|Treatment Period 4|Adverse Event|0|||
27792439|NCT01947855|54247474|FG000|Overall Study|Withdrawal by Subject|1|||
27792440|NCT01947855|54247475|FG001|Overall Study|Withdrawal by Subject|0|||
27792441|NCT01947855|54247476|FG002|Overall Study|Withdrawal by Subject|0|||
27792442|NCT01888965|54247484|FG000|Overall Study|Adverse Event|5|||
27792443|NCT01888965|54247484|FG000|Overall Study|Lack of Efficacy|4|||
27792444|NCT01888497|54247488|FG000|Washout Period 1|Withdrawal by Subject|0|||
27792445|NCT01888497|54247489|FG001|Washout Period 1|Withdrawal by Subject|0|||
27792446|NCT01888497|54247490|FG002|Washout Period 1|Withdrawal by Subject|1|||
27792447|NCT01888497|54247491|FG003|Washout Period 1|Withdrawal by Subject|1|||
27792448|NCT01888497|54247488|FG000|Washout Period 2|Adverse Event|0|||
27937194|NCT01078623|54593529|FG016|Treatment Period 4|Adverse Event|0|||
27937195|NCT01078623|54593530|FG017|Treatment Period 4|Adverse Event|0|||
27937196|NCT01078623|54593531|FG018|Treatment Period 4|Adverse Event|0|||
27792449|NCT01888497|54247489|FG001|Washout Period 2|Adverse Event|0|||
27792450|NCT01888497|54247490|FG002|Washout Period 2|Adverse Event|0|||
27792451|NCT01888497|54247491|FG003|Washout Period 2|Adverse Event|1|||
27937197|NCT01078623|54593532|FG019|Treatment Period 4|Adverse Event|0|||
27937198|NCT01078623|54593513|FG000|Treatment Period 4|Withdrawal by Subject|0|||
27937199|NCT01078623|54593514|FG001|Treatment Period 4|Withdrawal by Subject|0|||
27937200|NCT01078623|54593515|FG002|Treatment Period 4|Withdrawal by Subject|0|||
27937201|NCT01078623|54593516|FG003|Treatment Period 4|Withdrawal by Subject|0|||
27937202|NCT01078623|54593517|FG004|Treatment Period 4|Withdrawal by Subject|0|||
27792452|NCT01888497|54247488|FG000|Washout Period 2|Withdrawal by Subject|0|||
27792453|NCT01888497|54247489|FG001|Washout Period 2|Withdrawal by Subject|0|||
27792454|NCT01888497|54247490|FG002|Washout Period 2|Withdrawal by Subject|0|||
27792455|NCT01888497|54247491|FG003|Washout Period 2|Withdrawal by Subject|1|||
27792456|NCT01505530|54247504|FG000|Overall Study|Progressive Disease|19|||
27792457|NCT01505530|54247505|FG001|Overall Study|Progressive Disease|17|||
27792458|NCT01505530|54247506|FG002|Overall Study|Progressive Disease|18|||
27792459|NCT01505530|54247504|FG000|Overall Study|Adverse Event|1|||
27792460|NCT01505530|54247505|FG001|Overall Study|Adverse Event|1|||
27792461|NCT01505530|54247506|FG002|Overall Study|Adverse Event|0|||
27792462|NCT01505530|54247504|FG000|Overall Study|Withdrawal by Subject|7|||
27792463|NCT01505530|54247505|FG001|Overall Study|Withdrawal by Subject|8|||
27792464|NCT01505530|54247506|FG002|Overall Study|Withdrawal by Subject|6|||
27792465|NCT01505530|54247504|FG000|Overall Study|Physician Decision|6|||
27792466|NCT01505530|54247505|FG001|Overall Study|Physician Decision|2|||
27792467|NCT01505530|54247506|FG002|Overall Study|Physician Decision|5|||
27792468|NCT01505530|54247504|FG000|Overall Study|Sponsor Decision|1|||
27792469|NCT01505530|54247505|FG001|Overall Study|Sponsor Decision|8|||
27792470|NCT01505530|54247506|FG002|Overall Study|Sponsor Decision|7|||
27792471|NCT01505530|54247504|FG000|Overall Study|Death|7|||
27792472|NCT01505530|54247505|FG001|Overall Study|Death|6|||
27792473|NCT01505530|54247506|FG002|Overall Study|Death|5|||
27792474|NCT01505530|54247504|FG000|Overall Study|entry criteria not met|0|||
27792475|NCT01505530|54247505|FG001|Overall Study|entry criteria not met|1|||
27792476|NCT01505530|54247506|FG002|Overall Study|entry criteria not met|0|||
27792477|NCT01485796|54247514|FG000|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1|||
27792478|NCT01485796|54247514|FG000|Period 2: Epoch 2|Withdrawal by Subject|6|||
27792479|NCT01485796|54247514|FG000|Period 2: Epoch 2|Adverse Event|3|||
27792480|NCT01485796|54247514|FG000|Period 2: Epoch 2|Switch to safety follow-up|26|||
27792481|NCT01485796|54247514|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1|||
27792482|NCT01485796|54247514|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6|||
27792483|NCT01485796|54247514|FG000|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3|||
27792484|NCT01485796|54247514|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2|||
27792485|NCT01505374|54247522|FG000|Overall Study|Lost to Follow-up|1|||
27792486|NCT01505374|54247523|FG001|Overall Study|Lost to Follow-up|0|||
27792487|NCT01897233|54247530|FG000|Part B (24 Weeks)|Adverse Event|1|||
27792488|NCT01897233|54247530|FG000|Part B (24 Weeks)|Withdrawal by Subject|2|||
27792489|NCT01897233|54247530|FG000|Part B (24 Weeks)|Physician Decision|1|||
27792490|NCT01887717|54247540|FG000|Overall Study|Withdrawal by Subject|1|||
27792491|NCT01887717|54247541|FG001|Overall Study|Withdrawal by Subject|7|||
27937203|NCT01078623|54593518|FG005|Treatment Period 4|Withdrawal by Subject|0|||
27937204|NCT01078623|54593519|FG006|Treatment Period 4|Withdrawal by Subject|0|||
27937205|NCT01078623|54593520|FG007|Treatment Period 4|Withdrawal by Subject|0|||
27937206|NCT01078623|54593521|FG008|Treatment Period 4|Withdrawal by Subject|0|||
27937207|NCT01078623|54593522|FG009|Treatment Period 4|Withdrawal by Subject|0|||
27937208|NCT01078623|54593523|FG010|Treatment Period 4|Withdrawal by Subject|0|||
27937209|NCT01078623|54593524|FG011|Treatment Period 4|Withdrawal by Subject|0|||
27937210|NCT01078623|54593525|FG012|Treatment Period 4|Withdrawal by Subject|0|||
27937211|NCT01078623|54593526|FG013|Treatment Period 4|Withdrawal by Subject|0|||
27937212|NCT01078623|54593527|FG014|Treatment Period 4|Withdrawal by Subject|0|||
27937213|NCT01078623|54593528|FG015|Treatment Period 4|Withdrawal by Subject|1|||
27937214|NCT01078623|54593529|FG016|Treatment Period 4|Withdrawal by Subject|0|||
27937215|NCT01078623|54593530|FG017|Treatment Period 4|Withdrawal by Subject|0|||
27937216|NCT01078623|54593531|FG018|Treatment Period 4|Withdrawal by Subject|0|||
27937217|NCT01078623|54593532|FG019|Treatment Period 4|Withdrawal by Subject|0|||
27937218|NCT01092507|54593546|FG000|Overall Study|Withdrawal by Subject|2|||
27937219|NCT01092507|54593547|FG001|Overall Study|Withdrawal by Subject|0|||
27937220|NCT01078545|54593553|FG000|Overall Study|Lost to Follow-up|13|||
27937221|NCT01078545|54593553|FG000|Overall Study|Physician Decision|6|||
27937222|NCT01078545|54593553|FG000|Overall Study|Withdrawal by Subject|3|||
27937223|NCT01078545|54593553|FG000|Overall Study|Death|3|||
27937224|NCT01078545|54593553|FG000|Overall Study|Participant moved to another physician|1|||
27937225|NCT01202760|54593560|FG000|Overall Study|Entry Criteria Not Met|0|||
27937226|NCT01202760|54593561|FG001|Overall Study|Entry Criteria Not Met|3|||
27937227|NCT01202760|54593562|FG002|Overall Study|Entry Criteria Not Met|1|||
27937228|NCT01202760|54593560|FG000|Overall Study|Adverse Event|11|||
27937229|NCT01202760|54593561|FG001|Overall Study|Adverse Event|9|||
27792492|NCT01887717|54247540|FG000|Overall Study|Physician Decision|0|||
27792493|NCT01887717|54247541|FG001|Overall Study|Physician Decision|2|||
27792494|NCT01887717|54247540|FG000|Overall Study|Administrative reasons|5|||
27792495|NCT01887717|54247541|FG001|Overall Study|Administrative reasons|2|||
27792496|NCT01886781|54247549|FG000|Overall Study|Protocol Violation|5|||
27792497|NCT01886781|54247550|FG001|Overall Study|Protocol Violation|0|||
27792498|NCT01886781|54247549|FG000|Overall Study|Adverse Event|1|||
27792499|NCT01886781|54247550|FG001|Overall Study|Adverse Event|0|||
27792500|NCT01886781|54247549|FG000|Overall Study|Lost to Follow-up|5|||
27792501|NCT01886781|54247550|FG001|Overall Study|Lost to Follow-up|0|||
27937230|NCT01202760|54593562|FG002|Overall Study|Adverse Event|10|||
27937231|NCT01202760|54593560|FG000|Overall Study|Death|2|||
27937232|NCT01202760|54593561|FG001|Overall Study|Death|1|||
27937233|NCT01202760|54593562|FG002|Overall Study|Death|0|||
27937234|NCT01202760|54593560|FG000|Overall Study|Lack of Efficacy|6|||
27937235|NCT01202760|54593561|FG001|Overall Study|Lack of Efficacy|8|||
27792502|NCT01886781|54247549|FG000|Overall Study|Withdrawal by Subject|2|||
27792503|NCT01886781|54247550|FG001|Overall Study|Withdrawal by Subject|1|||
27792504|NCT01886781|54247549|FG000|Overall Study|Worsening of symptoms|1|||
27792505|NCT01886781|54247550|FG001|Overall Study|Worsening of symptoms|1|||
27792506|NCT01946529|54247559|FG000|End of Window Therapy (2 Courses)|Physician Decision|0|||
27792507|NCT01946529|54247560|FG001|End of Window Therapy (2 Courses)|Physician Decision|1|||
27792508|NCT01946529|54247561|FG002|End of Window Therapy (2 Courses)|Physician Decision|0|||
27792509|NCT01946529|54247559|FG000|Completion of All Therapy|Some pts. still receiving study therapy|1|||
27792510|NCT01946529|54247560|FG001|Completion of All Therapy|Some pts. still receiving study therapy|16|||
27792511|NCT01946529|54247561|FG002|Completion of All Therapy|Some pts. still receiving study therapy|6|||
27792512|NCT01463098|54247582|FG000|Part A (11 Days)|Participant Choice|2|||
27792513|NCT01463098|54247583|FG001|Part A (11 Days)|Participant Choice|0|||
27792514|NCT01463098|54247584|FG002|Part A (11 Days)|Participant Choice|0|||
27792515|NCT01463098|54247585|FG003|Part A (11 Days)|Participant Choice|0|||
27792516|NCT01463098|54247586|FG004|Part A (11 Days)|Participant Choice|0|||
27792517|NCT01463098|54247587|FG005|Part A (11 Days)|Participant Choice|0|||
27792518|NCT01463098|54247588|FG006|Part A (11 Days)|Participant Choice|0|||
27792519|NCT01463098|54247589|FG007|Part A (11 Days)|Participant Choice|0|||
27792520|NCT01463098|54247590|FG008|Part A (11 Days)|Participant Choice|1|||
27792521|NCT01463098|54247591|FG009|Part A (11 Days)|Participant Choice|0|||
27792522|NCT01463098|54247592|FG010|Part A (11 Days)|Participant Choice|0|||
27792523|NCT01463098|54247593|FG011|Part A (11 Days)|Participant Choice|0|||
27792524|NCT01463098|54247594|FG012|Part A (11 Days)|Participant Choice|0|||
27792525|NCT01463098|54247595|FG013|Part A (11 Days)|Participant Choice|0|||
27792526|NCT01463098|54247582|FG000|Part A (11 Days)|Lost to Follow-up|0|||
27792527|NCT01463098|54247583|FG001|Part A (11 Days)|Lost to Follow-up|0|||
27792528|NCT01463098|54247584|FG002|Part A (11 Days)|Lost to Follow-up|0|||
27792529|NCT01463098|54247585|FG003|Part A (11 Days)|Lost to Follow-up|0|||
27792530|NCT01463098|54247586|FG004|Part A (11 Days)|Lost to Follow-up|1|||
27792531|NCT01463098|54247587|FG005|Part A (11 Days)|Lost to Follow-up|0|||
27792532|NCT01463098|54247588|FG006|Part A (11 Days)|Lost to Follow-up|0|||
27792533|NCT01463098|54247589|FG007|Part A (11 Days)|Lost to Follow-up|0|||
27792534|NCT01463098|54247590|FG008|Part A (11 Days)|Lost to Follow-up|0|||
27792535|NCT01463098|54247591|FG009|Part A (11 Days)|Lost to Follow-up|0|||
27792536|NCT01463098|54247592|FG010|Part A (11 Days)|Lost to Follow-up|0|||
27792537|NCT01463098|54247593|FG011|Part A (11 Days)|Lost to Follow-up|0|||
27792538|NCT01463098|54247594|FG012|Part A (11 Days)|Lost to Follow-up|0|||
27792539|NCT01463098|54247595|FG013|Part A (11 Days)|Lost to Follow-up|0|||
27792540|NCT01463098|54247582|FG000|Part B (11 Days)|Participant Choice|0|||
27792541|NCT01463098|54247583|FG001|Part B (11 Days)|Participant Choice|0|||
27792542|NCT01463098|54247584|FG002|Part B (11 Days)|Participant Choice|0|||
27792543|NCT01463098|54247585|FG003|Part B (11 Days)|Participant Choice|0|||
27792544|NCT01463098|54247586|FG004|Part B (11 Days)|Participant Choice|0|||
27792545|NCT01463098|54247587|FG005|Part B (11 Days)|Participant Choice|0|||
27792546|NCT01463098|54247588|FG006|Part B (11 Days)|Participant Choice|0|||
27792547|NCT01463098|54247589|FG007|Part B (11 Days)|Participant Choice|0|||
27792548|NCT01463098|54247590|FG008|Part B (11 Days)|Participant Choice|0|||
27792549|NCT01463098|54247591|FG009|Part B (11 Days)|Participant Choice|0|||
27792550|NCT01463098|54247592|FG010|Part B (11 Days)|Participant Choice|0|||
27792551|NCT01463098|54247593|FG011|Part B (11 Days)|Participant Choice|1|||
27792552|NCT01463098|54247594|FG012|Part B (11 Days)|Participant Choice|0|||
27792553|NCT01463098|54247595|FG013|Part B (11 Days)|Participant Choice|0|||
27792554|NCT01626079|54247647|FG000|Overall Study|Death|117|||
27792555|NCT01626079|54247648|FG001|Overall Study|Death|153|||
27792556|NCT01626079|54247649|FG002|Overall Study|Death|39|||
27792557|NCT01626079|54247647|FG000|Overall Study|Withdrawal by Subject|15|||
27937236|NCT01202760|54593562|FG002|Overall Study|Lack of Efficacy|7|||
27937237|NCT01202760|54593560|FG000|Overall Study|Lost to Follow-up|0|||
27937238|NCT01202760|54593561|FG001|Overall Study|Lost to Follow-up|2|||
27937239|NCT01202760|54593562|FG002|Overall Study|Lost to Follow-up|1|||
27937240|NCT01202760|54593560|FG000|Overall Study|Parent / Caregiver Decision|0|||
27937241|NCT01202760|54593561|FG001|Overall Study|Parent / Caregiver Decision|1|||
27937242|NCT01202760|54593562|FG002|Overall Study|Parent / Caregiver Decision|0|||
27792558|NCT01626079|54247648|FG001|Overall Study|Withdrawal by Subject|39|||
27792559|NCT01626079|54247649|FG002|Overall Study|Withdrawal by Subject|5|||
27792560|NCT01626079|54247647|FG000|Overall Study|Lost to Follow-up|5|||
27792561|NCT01626079|54247648|FG001|Overall Study|Lost to Follow-up|4|||
27792562|NCT01626079|54247649|FG002|Overall Study|Lost to Follow-up|2|||
27792563|NCT01626079|54247647|FG000|Overall Study|Missed Visits|13|||
27792564|NCT01626079|54247648|FG001|Overall Study|Missed Visits|5|||
27842539|NCT01550744|54331107|FG001|Double-Blind|Withdrawal by Subject|2|||
27842540|NCT01550744|54331108|FG002|Double-Blind|Withdrawal by Subject|15|||
27842541|NCT01550744|54331106|FG000|Double-Blind|Adverse Event|0|||
27842542|NCT01550744|54331107|FG001|Double-Blind|Adverse Event|4|||
27842543|NCT01550744|54331108|FG002|Double-Blind|Adverse Event|15|||
27842544|NCT01550744|54331106|FG000|Double-Blind|Death|0|||
27842545|NCT01550744|54331107|FG001|Double-Blind|Death|1|||
27842546|NCT01550744|54331108|FG002|Double-Blind|Death|0|||
27842547|NCT01550744|54331106|FG000|Double-Blind|Lack of Efficacy|0|||
27842548|NCT01550744|54331107|FG001|Double-Blind|Lack of Efficacy|2|||
27842549|NCT01550744|54331108|FG002|Double-Blind|Lack of Efficacy|8|||
27792565|NCT01626079|54247649|FG002|Overall Study|Missed Visits|6|||
27792566|NCT01462942|54247665|FG000|Overall Study|Adverse Event|7|||
27792567|NCT01462942|54247666|FG001|Overall Study|Adverse Event|12|||
27792568|NCT01462942|54247667|FG002|Overall Study|Adverse Event|10|||
27792569|NCT01462942|54247668|FG003|Overall Study|Adverse Event|11|||
27792570|NCT01462942|54247669|FG004|Overall Study|Adverse Event|11|||
27792571|NCT01462942|54247665|FG000|Overall Study|Other, including COPD exacerbation|3|||
27792572|NCT01462942|54247666|FG001|Overall Study|Other, including COPD exacerbation|5|||
27792573|NCT01462942|54247667|FG002|Overall Study|Other, including COPD exacerbation|2|||
27792574|NCT01462942|54247668|FG003|Overall Study|Other, including COPD exacerbation|8|||
27792575|NCT01462942|54247669|FG004|Overall Study|Other, including COPD exacerbation|5|||
27792576|NCT01462942|54247665|FG000|Overall Study|Withdrawal by Subject|14|||
27792577|NCT01462942|54247666|FG001|Overall Study|Withdrawal by Subject|10|||
27792578|NCT01462942|54247667|FG002|Overall Study|Withdrawal by Subject|14|||
27792579|NCT01462942|54247668|FG003|Overall Study|Withdrawal by Subject|16|||
27792580|NCT01462942|54247669|FG004|Overall Study|Withdrawal by Subject|19|||
27792581|NCT01462942|54247665|FG000|Overall Study|Lack of Efficacy|6|||
27792582|NCT01462942|54247666|FG001|Overall Study|Lack of Efficacy|0|||
27792583|NCT01462942|54247667|FG002|Overall Study|Lack of Efficacy|4|||
27792584|NCT01462942|54247668|FG003|Overall Study|Lack of Efficacy|5|||
27792585|NCT01462942|54247669|FG004|Overall Study|Lack of Efficacy|3|||
27792586|NCT01462942|54247665|FG000|Overall Study|Lost to Follow-up|0|||
27792587|NCT01462942|54247666|FG001|Overall Study|Lost to Follow-up|1|||
27792588|NCT01462942|54247667|FG002|Overall Study|Lost to Follow-up|1|||
27792589|NCT01462942|54247668|FG003|Overall Study|Lost to Follow-up|1|||
27792590|NCT01462942|54247669|FG004|Overall Study|Lost to Follow-up|1|||
27792591|NCT01462942|54247665|FG000|Overall Study|Protocol Violation|4|||
27792592|NCT01462942|54247666|FG001|Overall Study|Protocol Violation|6|||
27792593|NCT01462942|54247667|FG002|Overall Study|Protocol Violation|9|||
27792594|NCT01462942|54247668|FG003|Overall Study|Protocol Violation|9|||
27792595|NCT01462942|54247669|FG004|Overall Study|Protocol Violation|6|||
27792596|NCT01462630|54247681|FG000|Overall Study|Did not initiate therapy|3|||
27792597|NCT01462630|54247681|FG000|Overall Study|Death|1|||
27792598|NCT01462630|54247681|FG000|Overall Study|Protocol Violation|2|||
27792599|NCT01462630|54247681|FG000|Overall Study|Adverse Event|1|||
27792600|NCT01504204|54247687|FG000|Overall Study|Lost to Follow-up|1|||
27792601|NCT01504204|54247688|FG001|Overall Study|Lost to Follow-up|1|||
27792602|NCT01485640|54247694|FG000|Overall Study|Adverse Event|10|||
27792603|NCT01485640|54247694|FG000|Overall Study|Lack of Efficacy|2|||
27792604|NCT01485640|54247694|FG000|Overall Study|Protocol Violation|1|||
27792605|NCT01485640|54247694|FG000|Overall Study|Withdrawal by Subject|14|||
27792606|NCT01485640|54247694|FG000|Overall Study|Terminated by Sponsor|95|||
27792607|NCT02118961|54247700|FG000|Overall Study|Withdrawal by Subject|1|||
27792608|NCT02118961|54247701|FG001|Overall Study|Withdrawal by Subject|0|||
27792609|NCT02140645|54247713|FG000|Overall Study|Not linked|5489|||
27792610|NCT02140645|54247714|FG001|Overall Study|Not linked|61654|||
27792611|NCT02140645|54247715|FG002|Overall Study|Not linked|4236|||
27842550|NCT01550744|54331106|FG000|Double-Blind|Protocol Violation|0|||
27842551|NCT01550744|54331107|FG001|Double-Blind|Protocol Violation|0|||
27842552|NCT01550744|54331108|FG002|Double-Blind|Protocol Violation|4|||
27842553|NCT01550744|54331106|FG000|Double-Blind|Pregnancy|0|||
27842554|NCT01550744|54331107|FG001|Double-Blind|Pregnancy|0|||
27792612|NCT02140645|54247716|FG003|Overall Study|Not linked|13833|||
27792613|NCT02140645|54247717|FG004|Overall Study|Not linked|3286|||
27792614|NCT02140645|54247718|FG005|Overall Study|Not linked|70896|||
27792615|NCT02140567|54247727|FG000|Overall Study|Problems with recording equipment|6|||
27792616|NCT02140411|54247732|FG000|Overall Study|Adverse Event|1|||
27792617|NCT02139943|54247739|FG000|Overall Study|Adverse Event|0|||
27792618|NCT02139943|54247740|FG001|Overall Study|Adverse Event|1|||
27792619|NCT02139943|54247741|FG002|Overall Study|Adverse Event|2|||
27792620|NCT02139943|54247739|FG000|Overall Study|Lost to Follow-up|3|||
27792621|NCT02139943|54247740|FG001|Overall Study|Lost to Follow-up|2|||
27792622|NCT02139943|54247741|FG002|Overall Study|Lost to Follow-up|2|||
27792623|NCT02139943|54247739|FG000|Overall Study|Withdrawal by Subject|4|||
27792624|NCT02139943|54247740|FG001|Overall Study|Withdrawal by Subject|3|||
27792625|NCT02139943|54247741|FG002|Overall Study|Withdrawal by Subject|0|||
27842555|NCT01550744|54331108|FG002|Double-Blind|Pregnancy|3|||
27792626|NCT02139943|54247739|FG000|Overall Study|Other|0|||
27842556|NCT01550744|54331106|FG000|Double-Blind|Other|0|||
27792627|NCT02139943|54247740|FG001|Overall Study|Other|0|||
27792628|NCT02139943|54247741|FG002|Overall Study|Other|1|||
27792629|NCT02139943|54247739|FG000|Overall Study|Participant wishes to discontinue|2|||
27792630|NCT02139943|54247740|FG001|Overall Study|Participant wishes to discontinue|0|||
27792631|NCT02139943|54247741|FG002|Overall Study|Participant wishes to discontinue|0|||
27792632|NCT02139943|54247739|FG000|Overall Study|Participant in Poor Compliance|1|||
27792633|NCT02139943|54247740|FG001|Overall Study|Participant in Poor Compliance|0|||
27792634|NCT02139943|54247741|FG002|Overall Study|Participant in Poor Compliance|1|||
27792635|NCT02139943|54247739|FG000|Overall Study|eGFR Withdrawal Criteria|0|||
27792636|NCT02139943|54247740|FG001|Overall Study|eGFR Withdrawal Criteria|0|||
27792637|NCT02139943|54247741|FG002|Overall Study|eGFR Withdrawal Criteria|1|||
27792638|NCT01485172|54247755|FG000|Overall Study|Adverse Event|2|||
27792639|NCT01485172|54247756|FG001|Overall Study|Adverse Event|1|||
28017200|NCT00661362|54676466|FG000|Overall Study|Metformin dose haven't decreasd to 2.5 g|1|||
28017201|NCT00661362|54676467|FG001|Overall Study|Metformin dose haven't decreasd to 2.5 g|0|||
28017202|NCT00325897|54676475|FG000|Overall Study|Lost to Follow-up|12|||
28017203|NCT00325897|54676476|FG001|Overall Study|Lost to Follow-up|13|||
28017204|NCT00344773|54676485|FG000|Overall Study|Adverse Event|2|||
28017205|NCT00344773|54676485|FG000|Overall Study|Objective Disease Progression|16|||
27792640|NCT01485172|54247757|FG002|Overall Study|Adverse Event|2|||
27792641|NCT01485172|54247758|FG003|Overall Study|Adverse Event|2|||
27792642|NCT01485172|54247759|FG004|Overall Study|Adverse Event|1|||
27792643|NCT01485172|54247760|FG005|Overall Study|Adverse Event|2|||
27937243|NCT01202760|54593560|FG000|Overall Study|Withdrawal by Subject|17|||
27937244|NCT01202760|54593561|FG001|Overall Study|Withdrawal by Subject|18|||
27937245|NCT01202760|54593562|FG002|Overall Study|Withdrawal by Subject|14|||
27937246|NCT01202760|54593560|FG000|Overall Study|Physician Decision|0|||
27937247|NCT01202760|54593561|FG001|Overall Study|Physician Decision|1|||
27937248|NCT01202760|54593562|FG002|Overall Study|Physician Decision|0|||
27937249|NCT01202760|54593560|FG000|Overall Study|Protocol Violation|7|||
27937250|NCT01202760|54593561|FG001|Overall Study|Protocol Violation|5|||
27937251|NCT01202760|54593562|FG002|Overall Study|Protocol Violation|2|||
27792644|NCT01485172|54247755|FG000|Overall Study|Lack of Efficacy|2|||
27792645|NCT01485172|54247756|FG001|Overall Study|Lack of Efficacy|0|||
27792646|NCT01485172|54247757|FG002|Overall Study|Lack of Efficacy|0|||
27792647|NCT01485172|54247758|FG003|Overall Study|Lack of Efficacy|0|||
27792648|NCT01485172|54247759|FG004|Overall Study|Lack of Efficacy|0|||
27792649|NCT01485172|54247760|FG005|Overall Study|Lack of Efficacy|0|||
27792650|NCT01485172|54247755|FG000|Overall Study|Protocol Violation|0|||
27792651|NCT01485172|54247756|FG001|Overall Study|Protocol Violation|0|||
27792652|NCT01485172|54247757|FG002|Overall Study|Protocol Violation|4|||
27792653|NCT01485172|54247758|FG003|Overall Study|Protocol Violation|5|||
27792654|NCT01485172|54247759|FG004|Overall Study|Protocol Violation|1|||
27792655|NCT01485172|54247760|FG005|Overall Study|Protocol Violation|0|||
27792656|NCT01485172|54247755|FG000|Overall Study|Protocol defined stopping criteria|1|||
27792657|NCT01485172|54247756|FG001|Overall Study|Protocol defined stopping criteria|0|||
27792658|NCT01485172|54247757|FG002|Overall Study|Protocol defined stopping criteria|0|||
27792659|NCT01485172|54247758|FG003|Overall Study|Protocol defined stopping criteria|0|||
27792660|NCT01485172|54247759|FG004|Overall Study|Protocol defined stopping criteria|1|||
27792661|NCT01485172|54247760|FG005|Overall Study|Protocol defined stopping criteria|0|||
27792662|NCT01485172|54247755|FG000|Overall Study|Lost to Follow-up|0|||
27792663|NCT01485172|54247756|FG001|Overall Study|Lost to Follow-up|0|||
27792664|NCT01485172|54247757|FG002|Overall Study|Lost to Follow-up|1|||
27792665|NCT01485172|54247758|FG003|Overall Study|Lost to Follow-up|0|||
27792666|NCT01485172|54247759|FG004|Overall Study|Lost to Follow-up|0|||
27792667|NCT01485172|54247760|FG005|Overall Study|Lost to Follow-up|1|||
27792668|NCT01485172|54247755|FG000|Overall Study|Physician Decision|0|||
27792669|NCT01485172|54247756|FG001|Overall Study|Physician Decision|0|||
27792670|NCT01485172|54247757|FG002|Overall Study|Physician Decision|0|||
27937252|NCT01202760|54593560|FG000|Overall Study|Sponsor Decision|4|||
27937253|NCT01202760|54593561|FG001|Overall Study|Sponsor Decision|4|||
27937254|NCT01202760|54593562|FG002|Overall Study|Sponsor Decision|0|||
27937255|NCT01091259|54593582|FG000|Overall Study|Adverse Event|3|||
27937256|NCT01091259|54593582|FG000|Overall Study|Lack of Efficacy|2|||
27792671|NCT01485172|54247758|FG003|Overall Study|Physician Decision|0|||
27792672|NCT01485172|54247759|FG004|Overall Study|Physician Decision|1|||
27792673|NCT01485172|54247760|FG005|Overall Study|Physician Decision|0|||
27792674|NCT01485172|54247755|FG000|Overall Study|Withdrawal by Subject|2|||
27792675|NCT01485172|54247756|FG001|Overall Study|Withdrawal by Subject|0|||
27792676|NCT01485172|54247757|FG002|Overall Study|Withdrawal by Subject|0|||
27792677|NCT01485172|54247758|FG003|Overall Study|Withdrawal by Subject|1|||
27792678|NCT01485172|54247759|FG004|Overall Study|Withdrawal by Subject|1|||
27792679|NCT01485172|54247760|FG005|Overall Study|Withdrawal by Subject|1|||
27792680|NCT02105701|54247778|FG000|Overall Study|Lost to Follow-up|1|||
27792681|NCT02105701|54247779|FG001|Overall Study|Lost to Follow-up|0|||
27792682|NCT02105701|54247780|FG002|Overall Study|Lost to Follow-up|2|||
27792683|NCT02105701|54247781|FG003|Overall Study|Lost to Follow-up|1|||
27937257|NCT01091103|54593586|FG000|Overall Study|Adverse Event|1|||
27937258|NCT01091103|54593586|FG000|Overall Study|Progressive Disease|3|||
27792684|NCT02105701|54247778|FG000|Overall Study|Protocol Violation|0|||
27792685|NCT02105701|54247779|FG001|Overall Study|Protocol Violation|0|||
27792686|NCT02105701|54247780|FG002|Overall Study|Protocol Violation|1|||
27792687|NCT02105701|54247781|FG003|Overall Study|Protocol Violation|0|||
27792688|NCT02105701|54247778|FG000|Overall Study|Withdrawal by Subject|2|||
27792689|NCT02105701|54247779|FG001|Overall Study|Withdrawal by Subject|1|||
27792690|NCT02105701|54247780|FG002|Overall Study|Withdrawal by Subject|0|||
27792691|NCT02105701|54247781|FG003|Overall Study|Withdrawal by Subject|1|||
27792692|NCT02105701|54247778|FG000|Overall Study|Death|1|||
27792693|NCT02105701|54247779|FG001|Overall Study|Death|0|||
27792694|NCT02105701|54247780|FG002|Overall Study|Death|0|||
27792695|NCT02105701|54247781|FG003|Overall Study|Death|0|||
27792696|NCT01502956|54247793|FG000|Overall Study|Death|0|||
27792697|NCT01502956|54247794|FG001|Overall Study|Death|2|||
27792698|NCT01502956|54247793|FG000|Overall Study|Lost to Follow-up|14|||
27792699|NCT01502956|54247794|FG001|Overall Study|Lost to Follow-up|11|||
27792700|NCT01502956|54247793|FG000|Overall Study|Physician Decision|2|||
27792701|NCT01502956|54247794|FG001|Overall Study|Physician Decision|3|||
27792702|NCT01502956|54247793|FG000|Overall Study|Withdrawal by Subject|8|||
27792703|NCT01502956|54247794|FG001|Overall Study|Withdrawal by Subject|10|||
27792704|NCT01502644|54247803|FG000|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1|||
27792705|NCT01502644|54247804|FG001|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
27792706|NCT01502644|54247805|FG002|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
27792707|NCT01502644|54247806|FG003|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
27792708|NCT01502644|54247803|FG000|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2|||
27792709|NCT01502644|54247804|FG001|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
27792710|NCT01502644|54247805|FG002|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
27792711|NCT01502644|54247806|FG003|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
27792712|NCT01502644|54247803|FG000|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6|||
27792713|NCT01502644|54247804|FG001|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
27792714|NCT01502644|54247805|FG002|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
27792715|NCT01502644|54247806|FG003|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
27792716|NCT01502644|54247803|FG000|Assigned to NA Groups|Drop Out due to Side Effects|0|||
27792717|NCT01502644|54247804|FG001|Assigned to NA Groups|Drop Out due to Side Effects|6|||
27792718|NCT01502644|54247805|FG002|Assigned to NA Groups|Drop Out due to Side Effects|2|||
27792719|NCT01502644|54247806|FG003|Assigned to NA Groups|Drop Out due to Side Effects|7|||
27792720|NCT01502644|54247803|FG000|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
27792721|NCT01502644|54247804|FG001|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
27792722|NCT01502644|54247805|FG002|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
27792723|NCT01502644|54247806|FG003|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
27792724|NCT01462318|54247816|FG000|Main Study / TP-DI Study|Other|2|||
27792725|NCT01462318|54247817|FG001|Main Study / TP-DI Study|Other|0|||
27792726|NCT01462318|54247818|FG002|Main Study / TP-DI Study|Other|0|||
27792727|NCT01462318|54247816|FG000|Main Study / TP-DI Study|Withdrawal by Subject|2|||
27792728|NCT01462318|54247817|FG001|Main Study / TP-DI Study|Withdrawal by Subject|0|||
27792729|NCT01462318|54247818|FG002|Main Study / TP-DI Study|Withdrawal by Subject|0|||
27792730|NCT01462318|54247816|FG000|Main Study / TP-DI Study|Adverse Event|4|||
27792731|NCT01462318|54247817|FG001|Main Study / TP-DI Study|Adverse Event|0|||
27792732|NCT01462318|54247818|FG002|Main Study / TP-DI Study|Adverse Event|0|||
27792733|NCT01462318|54247816|FG000|Extension Phase|Lost to Follow-up|0|||
27792734|NCT01462318|54247817|FG001|Extension Phase|Lost to Follow-up|0|||
27792735|NCT01462318|54247818|FG002|Extension Phase|Lost to Follow-up|1|||
27792736|NCT01462318|54247816|FG000|Extension Phase|Other|0|||
27792737|NCT01462318|54247817|FG001|Extension Phase|Other|0|||
27792738|NCT01462318|54247818|FG002|Extension Phase|Other|1|||
27792739|NCT01462318|54247816|FG000|Extension Phase|Disease Progression|0|||
27792740|NCT01462318|54247817|FG001|Extension Phase|Disease Progression|0|||
27792741|NCT01462318|54247818|FG002|Extension Phase|Disease Progression|1|||
27792742|NCT01462318|54247816|FG000|Extension Phase|Withdrawal by Subject|0|||
27937259|NCT01078389|54593594|FG000|Overall Study|Adverse Event|10|||
27937260|NCT01078389|54593595|FG001|Overall Study|Adverse Event|6|||
27937261|NCT01078389|54593594|FG000|Overall Study|Major Protocol Deviation|2|||
27792743|NCT01462318|54247817|FG001|Extension Phase|Withdrawal by Subject|0|||
27792744|NCT01462318|54247818|FG002|Extension Phase|Withdrawal by Subject|15|||
27792745|NCT01462318|54247816|FG000|Extension Phase|Investigator Decision|0|||
27792746|NCT01462318|54247817|FG001|Extension Phase|Investigator Decision|0|||
27792747|NCT01462318|54247818|FG002|Extension Phase|Investigator Decision|5|||
27792748|NCT01462318|54247816|FG000|Extension Phase|Adverse Event|0|||
27792749|NCT01462318|54247817|FG001|Extension Phase|Adverse Event|0|||
27792750|NCT01462318|54247818|FG002|Extension Phase|Adverse Event|22|||
27792751|NCT01485094|54247826|FG000|Overall Study|Adverse Event|1|||
27792752|NCT01485094|54247827|FG001|Overall Study|Adverse Event|1|||
27792753|NCT01485094|54247828|FG002|Overall Study|Adverse Event|1|||
27792754|NCT01485094|54247826|FG000|Overall Study|Lost to Follow-up|1|||
27792755|NCT01485094|54247827|FG001|Overall Study|Lost to Follow-up|0|||
27792756|NCT01485094|54247828|FG002|Overall Study|Lost to Follow-up|0|||
27792757|NCT01485094|54247826|FG000|Overall Study|Withdrawal by Subject|1|||
27792758|NCT01485094|54247827|FG001|Overall Study|Withdrawal by Subject|1|||
27792759|NCT01485094|54247828|FG002|Overall Study|Withdrawal by Subject|0|||
27792760|NCT01484938|54247836|FG000|Overall Study|Adverse Event|2|||
27792761|NCT01484938|54247836|FG000|Overall Study|Lost to Follow-up|1|||
27792762|NCT01484938|54247836|FG000|Overall Study|Noncompliance|1|||
27792763|NCT01502410|54247844|FG000|Overall Study|Adverse Event|1|||
27792764|NCT01502410|54247845|FG001|Overall Study|Adverse Event|2|||
27792765|NCT01502410|54247846|FG002|Overall Study|Adverse Event|0|||
27792766|NCT01502410|54247847|FG003|Overall Study|Adverse Event|0|||
27792767|NCT01502410|54247844|FG000|Overall Study|Lack of Efficacy|7|||
27792768|NCT01502410|54247845|FG001|Overall Study|Lack of Efficacy|7|||
27792769|NCT01502410|54247846|FG002|Overall Study|Lack of Efficacy|0|||
27792770|NCT01502410|54247847|FG003|Overall Study|Lack of Efficacy|0|||
27792771|NCT01502410|54247844|FG000|Overall Study|Physician Decision|0|||
27792772|NCT01502410|54247845|FG001|Overall Study|Physician Decision|1|||
27792773|NCT01502410|54247846|FG002|Overall Study|Physician Decision|0|||
27792774|NCT01502410|54247847|FG003|Overall Study|Physician Decision|0|||
27792775|NCT01502410|54247844|FG000|Overall Study|Withdrawal by Subject|2|||
27792776|NCT01502410|54247845|FG001|Overall Study|Withdrawal by Subject|0|||
27792777|NCT01502410|54247846|FG002|Overall Study|Withdrawal by Subject|0|||
27792778|NCT01502410|54247847|FG003|Overall Study|Withdrawal by Subject|0|||
27792779|NCT01462162|54247856|FG000|Overall Study|Adverse Event|5|||
27792780|NCT01462162|54247856|FG000|Overall Study|Lack of Efficacy|4|||
27792781|NCT01462162|54247856|FG000|Overall Study|Abnormal laboratory parameters|1|||
27792782|NCT01462162|54247856|FG000|Overall Study|Other|2|||
27792783|NCT01483924|54247866|FG000|Overall Study|Withdrawal by Subject|2|||
27792784|NCT01483924|54247867|FG001|Overall Study|Withdrawal by Subject|0|||
27792785|NCT01483924|54247868|FG002|Overall Study|Withdrawal by Subject|0|||
27792786|NCT01483924|54247869|FG003|Overall Study|Withdrawal by Subject|1|||
27792787|NCT01483924|54247870|FG004|Overall Study|Withdrawal by Subject|1|||
27792788|NCT01483924|54247866|FG000|Overall Study|Adverse Event|0|||
27792789|NCT01483924|54247867|FG001|Overall Study|Adverse Event|0|||
27792790|NCT01483924|54247868|FG002|Overall Study|Adverse Event|1|||
27792791|NCT01483924|54247869|FG003|Overall Study|Adverse Event|1|||
27792792|NCT01483924|54247870|FG004|Overall Study|Adverse Event|0|||
27792793|NCT01483924|54247866|FG000|Overall Study|Non-compliance|0|||
27792794|NCT01483924|54247867|FG001|Overall Study|Non-compliance|0|||
27792795|NCT01483924|54247868|FG002|Overall Study|Non-compliance|0|||
27792796|NCT01483924|54247869|FG003|Overall Study|Non-compliance|1|||
27792797|NCT01483924|54247870|FG004|Overall Study|Non-compliance|1|||
27792798|NCT01483924|54247866|FG000|Overall Study|Sponsor concern over ECG result|0|||
27792799|NCT01483924|54247867|FG001|Overall Study|Sponsor concern over ECG result|0|||
27792800|NCT01483924|54247868|FG002|Overall Study|Sponsor concern over ECG result|0|||
27792801|NCT01483924|54247869|FG003|Overall Study|Sponsor concern over ECG result|1|||
27792802|NCT01483924|54247870|FG004|Overall Study|Sponsor concern over ECG result|0|||
27792803|NCT01462084|54247891|FG000|Overall Study|Withdrawal by Subject|1|||
27792804|NCT01462084|54247892|FG001|Overall Study|Withdrawal by Subject|0|||
27792805|NCT01462084|54247891|FG000|Overall Study|Protocol Violation|1|||
27792806|NCT01462084|54247892|FG001|Overall Study|Protocol Violation|1|||
27792807|NCT02134028|54247907|FG000|Overall Study|Lack of Efficacy|1|||
27792808|NCT02134028|54247908|FG001|Overall Study|Lack of Efficacy|0|||
27792809|NCT02134028|54247909|FG002|Overall Study|Lack of Efficacy|3|||
27792810|NCT02134028|54247910|FG003|Overall Study|Lack of Efficacy|2|||
27792811|NCT02134028|54247911|FG004|Overall Study|Lack of Efficacy|1|||
27792812|NCT02134028|54247912|FG005|Overall Study|Lack of Efficacy|2|||
27792813|NCT02134028|54247913|FG006|Overall Study|Lack of Efficacy|1|||
27792814|NCT02134028|54247914|FG007|Overall Study|Lack of Efficacy|0|||
27792815|NCT02134028|54247907|FG000|Overall Study|Poor compliance to protocol|1|||
27792816|NCT02134028|54247908|FG001|Overall Study|Poor compliance to protocol|1|||
27792817|NCT02134028|54247909|FG002|Overall Study|Poor compliance to protocol|3|||
27792818|NCT02134028|54247910|FG003|Overall Study|Poor compliance to protocol|7|||
27792819|NCT02134028|54247911|FG004|Overall Study|Poor compliance to protocol|1|||
27792820|NCT02134028|54247912|FG005|Overall Study|Poor compliance to protocol|1|||
27792821|NCT02134028|54247913|FG006|Overall Study|Poor compliance to protocol|0|||
27792822|NCT02134028|54247914|FG007|Overall Study|Poor compliance to protocol|0|||
27792823|NCT02134028|54247907|FG000|Overall Study|Other unspecified|4|||
27792824|NCT02134028|54247908|FG001|Overall Study|Other unspecified|22|||
27792825|NCT02134028|54247909|FG002|Overall Study|Other unspecified|33|||
27792826|NCT02134028|54247910|FG003|Overall Study|Other unspecified|64|||
27792827|NCT02134028|54247911|FG004|Overall Study|Other unspecified|8|||
27792828|NCT02134028|54247912|FG005|Overall Study|Other unspecified|6|||
27792829|NCT02134028|54247913|FG006|Overall Study|Other unspecified|2|||
27792830|NCT02134028|54247914|FG007|Overall Study|Other unspecified|1|||
27792831|NCT02134028|54247907|FG000|Overall Study|Adverse Event|3|||
27792832|NCT02134028|54247908|FG001|Overall Study|Adverse Event|19|||
27792833|NCT02134028|54247909|FG002|Overall Study|Adverse Event|13|||
27792834|NCT02134028|54247910|FG003|Overall Study|Adverse Event|32|||
27792835|NCT02134028|54247911|FG004|Overall Study|Adverse Event|4|||
27792836|NCT02134028|54247912|FG005|Overall Study|Adverse Event|5|||
27792837|NCT02134028|54247913|FG006|Overall Study|Adverse Event|1|||
27792838|NCT02134028|54247914|FG007|Overall Study|Adverse Event|2|||
27792839|NCT02172950|54247936|FG000|Overall Study|Physician Decision|3|||
27792840|NCT02172950|54247937|FG001|Overall Study|Physician Decision|3|||
27792841|NCT02172950|54247936|FG000|Overall Study|Lack of Efficacy|1|||
27792842|NCT02172950|54247937|FG001|Overall Study|Lack of Efficacy|0|||
27792843|NCT02172950|54247936|FG000|Overall Study|Adverse Event|4|||
27792844|NCT02172950|54247937|FG001|Overall Study|Adverse Event|1|||
27792845|NCT02172950|54247936|FG000|Overall Study|Withdrawal by Subject|10|||
27792846|NCT02172950|54247937|FG001|Overall Study|Withdrawal by Subject|0|||
27792847|NCT02172950|54247936|FG000|Overall Study|Protocol Violation|1|||
27792848|NCT02172950|54247937|FG001|Overall Study|Protocol Violation|0|||
27792849|NCT02172950|54247936|FG000|Overall Study|Lost to Follow-up|1|||
27792850|NCT02172950|54247937|FG001|Overall Study|Lost to Follow-up|0|||
27792851|NCT02172950|54247936|FG000|Overall Study|Death|1|||
27792852|NCT02172950|54247937|FG001|Overall Study|Death|0|||
27792853|NCT02172950|54247936|FG000|Overall Study|Patient traveling|1|||
27792854|NCT02172950|54247937|FG001|Overall Study|Patient traveling|0|||
27792855|NCT02172950|54247936|FG000|Overall Study|Patient went to other country|1|||
27792856|NCT02172950|54247937|FG001|Overall Study|Patient went to other country|0|||
27792857|NCT02172950|54247936|FG000|Overall Study|Patient relocated overseas|1|||
27792858|NCT02172950|54247937|FG001|Overall Study|Patient relocated overseas|1|||
27792859|NCT02172950|54247936|FG000|Overall Study|Patient moving|1|||
27792860|NCT02172950|54247937|FG001|Overall Study|Patient moving|0|||
27937262|NCT01078389|54593595|FG001|Overall Study|Major Protocol Deviation|0|||
27937263|NCT01078389|54593594|FG000|Overall Study|Lost to Follow-up|23|||
27937264|NCT01078389|54593595|FG001|Overall Study|Lost to Follow-up|23|||
27937265|NCT01078389|54593594|FG000|Overall Study|Voluntary Withdrawal|20|||
27937266|NCT01078389|54593595|FG001|Overall Study|Voluntary Withdrawal|36|||
27937267|NCT01078389|54593594|FG000|Overall Study|Other|9|||
27937268|NCT01078389|54593595|FG001|Overall Study|Other|2|||
27937269|NCT01090323|54593603|FG000|Overall Study|Adverse Event|12|||
27937270|NCT01090323|54593604|FG001|Overall Study|Adverse Event|2|||
27937271|NCT01090323|54593603|FG000|Overall Study|Abnormal Lab Values|3|||
27937272|NCT01090323|54593604|FG001|Overall Study|Abnormal Lab Values|1|||
27937273|NCT01090323|54593603|FG000|Overall Study|Abnormal Test Procedure Results|2|||
27937274|NCT01090323|54593604|FG001|Overall Study|Abnormal Test Procedure Results|0|||
27937275|NCT01090323|54593603|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
27937276|NCT01090323|54593604|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
27937277|NCT01090323|54593603|FG000|Overall Study|Condition no longer requires drug|5|||
27937278|NCT01090323|54593604|FG001|Overall Study|Condition no longer requires drug|4|||
27937279|NCT01090323|54593603|FG000|Overall Study|Protocol Violation|2|||
27937280|NCT01090323|54593604|FG001|Overall Study|Protocol Violation|1|||
27937281|NCT01090323|54593603|FG000|Overall Study|Withdrew consent|33|||
27937282|NCT01090323|54593604|FG001|Overall Study|Withdrew consent|11|||
27937283|NCT01090323|54593603|FG000|Overall Study|Lost to Follow-up|11|||
27937284|NCT01090323|54593604|FG001|Overall Study|Lost to Follow-up|6|||
27937285|NCT01090323|54593603|FG000|Overall Study|Administrative problems|6|||
27937286|NCT01090323|54593604|FG001|Overall Study|Administrative problems|4|||
27937287|NCT01090323|54593603|FG000|Overall Study|Death|1|||
27937288|NCT01090323|54593604|FG001|Overall Study|Death|2|||
27937289|NCT01090323|54593603|FG000|Overall Study|Stopped end of core|7|||
27937290|NCT01090323|54593604|FG001|Overall Study|Stopped end of core|0|||
27937291|NCT01090323|54593603|FG000|Overall Study|Stopped end of extension 1#|3|||
27937292|NCT01090323|54593604|FG001|Overall Study|Stopped end of extension 1#|1|||
27937293|NCT01078155|54593610|FG000|Overall Study|Adverse Event|7|||
27937294|NCT01078155|54593610|FG000|Overall Study|Lack of Efficacy|16|||
27937295|NCT01078155|54593610|FG000|Overall Study|Participant's Decision|6|||
27937296|NCT01078155|54593610|FG000|Overall Study|Lost to Follow-up|15|||
27937297|NCT01201356|54593614|FG000|Overall Study|Adverse Event|170|||
27937298|NCT01201356|54593614|FG000|Overall Study|Abnormal laboratory value(s)|51|||
27937299|NCT01201356|54593614|FG000|Overall Study|Abnormal test procedure result(s)|3|||
27937300|NCT01201356|54593614|FG000|Overall Study|Unsatisfactory therapeutic effect|112|||
27937301|NCT01201356|54593614|FG000|Overall Study|Condition no longer requires study drug|12|||
28017206|NCT00344773|54676485|FG000|Overall Study|Withdrawal by Subject|1|||
27792861|NCT02151266|54247947|FG000|Overall Study|Lost to Follow-up|1|||
27792862|NCT02151266|54247948|FG001|Overall Study|Lost to Follow-up|4|||
27792863|NCT02151266|54247949|FG002|Overall Study|Lost to Follow-up|1|||
27792864|NCT02151266|54247947|FG000|Overall Study|Did NOT receive intervention|3|||
27792865|NCT02151266|54247948|FG001|Overall Study|Did NOT receive intervention|6|||
27937302|NCT01201356|54593614|FG000|Overall Study|Withdrawal by Subject|144|||
27937303|NCT01201356|54593614|FG000|Overall Study|Lost to Follow-up|50|||
27937304|NCT01201356|54593614|FG000|Overall Study|administrative problems|74|||
27792866|NCT02151266|54247949|FG002|Overall Study|Did NOT receive intervention|2|||
27792867|NCT02151266|54247947|FG000|Overall Study|Not able to exercise|4|||
27792868|NCT02151266|54247948|FG001|Overall Study|Not able to exercise|5|||
27792869|NCT02151266|54247949|FG002|Overall Study|Not able to exercise|4|||
27792870|NCT02151110|54247965|FG000|Overall Study|Withdrawal by Subject|0|||
27792871|NCT02151110|54247966|FG001|Overall Study|Withdrawal by Subject|0|||
27792872|NCT02151110|54247967|FG002|Overall Study|Withdrawal by Subject|0|||
27792873|NCT02151110|54247968|FG003|Overall Study|Withdrawal by Subject|0|||
27792874|NCT02151110|54247969|FG004|Overall Study|Withdrawal by Subject|0|||
27792875|NCT02151110|54247970|FG005|Overall Study|Withdrawal by Subject|0|||
27792876|NCT02151110|54247971|FG006|Overall Study|Withdrawal by Subject|0|||
27792877|NCT02151110|54247972|FG007|Overall Study|Withdrawal by Subject|1|||
27792878|NCT02151110|54247965|FG000|Overall Study|Lost to Follow-up|0|||
27792879|NCT02151110|54247966|FG001|Overall Study|Lost to Follow-up|0|||
27792880|NCT02151110|54247967|FG002|Overall Study|Lost to Follow-up|0|||
27792881|NCT02151110|54247968|FG003|Overall Study|Lost to Follow-up|0|||
27792882|NCT02151110|54247969|FG004|Overall Study|Lost to Follow-up|0|||
27792883|NCT02151110|54247970|FG005|Overall Study|Lost to Follow-up|0|||
27792884|NCT02151110|54247971|FG006|Overall Study|Lost to Follow-up|0|||
27792885|NCT02151110|54247972|FG007|Overall Study|Lost to Follow-up|2|||
27792886|NCT02132312|54247999|FG000|Overall Study|Adverse Event|2|||
27792887|NCT02132312|54248000|FG001|Overall Study|Adverse Event|0|||
27792888|NCT02132312|54247999|FG000|Overall Study|Physician Decision|1|||
27792889|NCT02132312|54248000|FG001|Overall Study|Physician Decision|1|||
27792890|NCT02132312|54247999|FG000|Overall Study|Protocol Violation|0|||
27792891|NCT02132312|54248000|FG001|Overall Study|Protocol Violation|1|||
27792892|NCT02132312|54247999|FG000|Overall Study|Withdrawal by Subject|1|||
27792893|NCT02132312|54248000|FG001|Overall Study|Withdrawal by Subject|0|||
27792894|NCT02132312|54247999|FG000|Overall Study|Lost to Follow-up|2|||
27792895|NCT02132312|54248000|FG001|Overall Study|Lost to Follow-up|1|||
27792896|NCT02131766|54248006|FG000|Overall Study|Withdrawal by Subject|4|||
27792897|NCT02150954|54248015|FG000|Overall Study|Protocol Violation|1|||
27792898|NCT02150954|54248016|FG001|Overall Study|Protocol Violation|0|||
27792899|NCT02131532|54248022|FG000|Overall Study|Withdrawal by Subject|1|||
27792900|NCT02131532|54248022|FG000|Overall Study|Physician Decision|1|||
27792901|NCT02131532|54248022|FG000|Overall Study|Other health conditions|2|||
27792902|NCT02170688|54248036|FG000|Overall Study|Exclusion Criteria: Fatty Liver|4|||
27792903|NCT02170688|54248037|FG001|Overall Study|Exclusion Criteria: Fatty Liver|2|||
27792904|NCT02170688|54248038|FG002|Overall Study|Exclusion Criteria: Fatty Liver|3|||
27792905|NCT02170688|54248039|FG003|Overall Study|Exclusion Criteria: Fatty Liver|2|||
27792906|NCT02170688|54248040|FG004|Overall Study|Exclusion Criteria: Fatty Liver|0|||
27792907|NCT02170688|54248036|FG000|Overall Study|Full dose not received|0|||
27792908|NCT02170688|54248037|FG001|Overall Study|Full dose not received|1|||
27792909|NCT02170688|54248038|FG002|Overall Study|Full dose not received|0|||
27792910|NCT02170688|54248039|FG003|Overall Study|Full dose not received|0|||
27792911|NCT02170688|54248040|FG004|Overall Study|Full dose not received|0|||
27792912|NCT02170688|54248036|FG000|Overall Study|Physician Decision|0|||
27792913|NCT02170688|54248037|FG001|Overall Study|Physician Decision|0|||
27937305|NCT01201356|54593614|FG000|Overall Study|Death|16|||
27937306|NCT01201356|54593614|FG000|Overall Study|Protocol Violation|12|||
27937307|NCT01200810|54593620|FG000|Overall Study|Physician Decision|1|||
27937308|NCT01200810|54593621|FG001|Overall Study|Physician Decision|0|||
27937309|NCT01200810|54593620|FG000|Overall Study|Withdrawal by Subject|1|||
27937310|NCT01200810|54593621|FG001|Overall Study|Withdrawal by Subject|2|||
27937311|NCT01200810|54593620|FG000|Overall Study|Sponsor stopped making study drug|3|||
27937312|NCT01200810|54593621|FG001|Overall Study|Sponsor stopped making study drug|3|||
27937313|NCT01200342|54593627|FG000|Overall Study|Disease Progression|1|||
27937314|NCT01199016|54593631|FG000|Overall Study|No longer meets eligibility criteria|4|||
27937315|NCT01199016|54593631|FG000|Overall Study|Entrance criteria|5|||
27792914|NCT02170688|54248038|FG002|Overall Study|Physician Decision|1|||
27792915|NCT02170688|54248039|FG003|Overall Study|Physician Decision|0|||
27792916|NCT02170688|54248040|FG004|Overall Study|Physician Decision|0|||
27792917|NCT02170298|54248054|FG000|Overall Study|Withdrawal by Subject|0|||
27792918|NCT02170298|54248055|FG001|Overall Study|Withdrawal by Subject|1|||
27937316|NCT01199016|54593631|FG000|Overall Study|Protocol Violation|9|||
27937317|NCT01199016|54593631|FG000|Overall Study|Other|13|||
27937318|NCT01199016|54593631|FG000|Overall Study|Withdrawal by Subject|21|||
27937319|NCT01199016|54593631|FG000|Overall Study|Lost to Follow-up|25|||
27792919|NCT02170298|54248054|FG000|Overall Study|unblinded, rerandomized to intervention|1|||
27792920|NCT02170298|54248055|FG001|Overall Study|unblinded, rerandomized to intervention|0|||
27792921|NCT02131064|54248063|FG000|Overall Study|Death|5|||
27792922|NCT02131064|54248064|FG001|Overall Study|Death|6|||
27792923|NCT02131064|54248063|FG000|Overall Study|Lost to Follow-up|4|||
27792924|NCT02131064|54248064|FG001|Overall Study|Lost to Follow-up|8|||
27937320|NCT01198548|54593635|FG000|Overall Study|Disease Progression|9|||
27937321|NCT01198548|54593635|FG000|Overall Study|Administrative Decision|1|||
27937322|NCT01198470|54593639|FG000|Overall Study|Adverse Event|2|||
27792925|NCT02131064|54248063|FG000|Overall Study|Withdrawal by Subject|14|||
27792926|NCT02131064|54248064|FG001|Overall Study|Withdrawal by Subject|18|||
27792927|NCT02131064|54248063|FG000|Overall Study|Other|2|||
27792928|NCT02131064|54248064|FG001|Overall Study|Other|2|||
27792929|NCT02130986|54248073|FG000|Overall Study|Withdrawal by Subject|4|||
27792930|NCT02130986|54248074|FG001|Overall Study|Withdrawal by Subject|4|||
27792931|NCT02130986|54248073|FG000|Overall Study|Lost to Follow-up|151|||
27792932|NCT02130986|54248074|FG001|Overall Study|Lost to Follow-up|160|||
27792933|NCT02130284|54248082|FG000|Overall Study|Withdrawal by Subject|3|||
27792934|NCT02130284|54248082|FG000|Overall Study|Subject Withdrew Consent|1|||
27792935|NCT02130284|54248082|FG000|Overall Study|Subject's sensor failed at Visit 2, Day|1|||
27792936|NCT02130284|54248082|FG000|Overall Study|Subject was screened as backup for study|3|||
27937323|NCT00977938|54593647|FG000|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132|||
27792937|NCT02130284|54248082|FG000|Overall Study|Screen Failure|1|||
27792938|NCT02147288|54248088|FG000|Overall Study|post-operative hematoma|1|||
27792939|NCT02147288|54248089|FG001|Overall Study|post-operative hematoma|1|||
27792940|NCT02147288|54248090|FG002|Overall Study|post-operative hematoma|0|||
27792941|NCT02147288|54248091|FG003|Overall Study|post-operative hematoma|0|||
27792942|NCT02147288|54248092|FG004|Overall Study|post-operative hematoma|0|||
27792943|NCT02147288|54248093|FG005|Overall Study|post-operative hematoma|0|||
27792944|NCT02147288|54248094|FG006|Overall Study|post-operative hematoma|0|||
27937324|NCT00977938|54593648|FG001|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116|||
27937325|NCT00977938|54593649|FG002|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13|||
27937326|NCT00977938|54593650|FG003|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20|||
27937327|NCT00977938|54593647|FG000|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88|||
27937328|NCT00977938|54593648|FG001|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91|||
27937329|NCT00977938|54593649|FG002|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30|||
27937330|NCT00977938|54593650|FG003|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37|||
27937331|NCT00977938|54593647|FG000|Treatment (12-30 mo. Post Procedure)|Other|17|||
27937332|NCT00977938|54593648|FG001|Treatment (12-30 mo. Post Procedure)|Other|18|||
27937333|NCT00977938|54593649|FG002|Treatment (12-30 mo. Post Procedure)|Other|3|||
27937334|NCT00977938|54593650|FG003|Treatment (12-30 mo. Post Procedure)|Other|4|||
27937335|NCT00977938|54593647|FG000|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9|||
27937336|NCT00977938|54593648|FG001|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12|||
27792945|NCT02147288|54248095|FG007|Overall Study|post-operative hematoma|0|||
27792946|NCT02147288|54248096|FG008|Overall Study|post-operative hematoma|0|||
27792947|NCT02147288|54248097|FG009|Overall Study|post-operative hematoma|0|||
27792948|NCT02147288|54248088|FG000|Overall Study|complications from concurrent hernia rep|0|||
27792949|NCT02147288|54248089|FG001|Overall Study|complications from concurrent hernia rep|1|||
27792950|NCT02147288|54248090|FG002|Overall Study|complications from concurrent hernia rep|0|||
27792951|NCT02147288|54248091|FG003|Overall Study|complications from concurrent hernia rep|0|||
27792952|NCT02147288|54248092|FG004|Overall Study|complications from concurrent hernia rep|0|||
27792953|NCT02147288|54248093|FG005|Overall Study|complications from concurrent hernia rep|0|||
27792954|NCT02147288|54248094|FG006|Overall Study|complications from concurrent hernia rep|0|||
27792955|NCT02147288|54248095|FG007|Overall Study|complications from concurrent hernia rep|0|||
27792956|NCT02147288|54248096|FG008|Overall Study|complications from concurrent hernia rep|0|||
27792957|NCT02147288|54248097|FG009|Overall Study|complications from concurrent hernia rep|0|||
27792958|NCT02147132|54248103|FG000|Overall Study|Lost to Follow-up|1|||
27792959|NCT02147132|54248104|FG001|Overall Study|Lost to Follow-up|0|||
27792960|NCT02147132|54248105|FG002|Overall Study|Lost to Follow-up|0|||
27792961|NCT02147132|54248106|FG003|Overall Study|Lost to Follow-up|0|||
27792962|NCT02146430|54248120|FG000|Overall Study|Protocol Violation|5|||
27792963|NCT02146430|54248121|FG001|Overall Study|Protocol Violation|4|||
27792964|NCT02146430|54248122|FG002|Overall Study|Protocol Violation|8|||
27792965|NCT02146430|54248123|FG003|Overall Study|Protocol Violation|6|||
27792966|NCT02146430|54248120|FG000|Overall Study|Lack of Efficacy|13|||
27792967|NCT02146430|54248121|FG001|Overall Study|Lack of Efficacy|11|||
27792968|NCT02146430|54248122|FG002|Overall Study|Lack of Efficacy|8|||
27792969|NCT02146430|54248123|FG003|Overall Study|Lack of Efficacy|5|||
27792970|NCT02146430|54248120|FG000|Overall Study|Adverse Event|20|||
27792971|NCT02146430|54248121|FG001|Overall Study|Adverse Event|40|||
27792972|NCT02146430|54248122|FG002|Overall Study|Adverse Event|32|||
27792973|NCT02146430|54248123|FG003|Overall Study|Adverse Event|49|||
27792974|NCT02146430|54248120|FG000|Overall Study|Reason missing or not reported|2|||
27792975|NCT02146430|54248121|FG001|Overall Study|Reason missing or not reported|3|||
27792976|NCT02146430|54248122|FG002|Overall Study|Reason missing or not reported|4|||
27792977|NCT02146430|54248123|FG003|Overall Study|Reason missing or not reported|5|||
27792978|NCT02146430|54248120|FG000|Overall Study|Withdrawal by Subject|27|||
27792979|NCT02146430|54248121|FG001|Overall Study|Withdrawal by Subject|29|||
27792980|NCT02146430|54248122|FG002|Overall Study|Withdrawal by Subject|30|||
27792981|NCT02146430|54248123|FG003|Overall Study|Withdrawal by Subject|34|||
27792982|NCT02129192|54248139|FG000|Period 1 Including Washout Period|Withdrawal by Subject|0|||
27792983|NCT02129192|54248140|FG001|Period 1 Including Washout Period|Withdrawal by Subject|1|||
27792984|NCT02105948|54248153|FG000|Overall Study|Adverse Event|10|||
27792985|NCT02105948|54248154|FG001|Overall Study|Adverse Event|7|||
27792986|NCT02105948|54248155|FG002|Overall Study|Adverse Event|11|||
27792987|NCT02105948|54248156|FG003|Overall Study|Adverse Event|11|||
27792988|NCT02105948|54248153|FG000|Overall Study|Lack of Efficacy|0|||
27792989|NCT02105948|54248154|FG001|Overall Study|Lack of Efficacy|1|||
27792990|NCT02105948|54248155|FG002|Overall Study|Lack of Efficacy|3|||
27792991|NCT02105948|54248156|FG003|Overall Study|Lack of Efficacy|2|||
27792992|NCT02105948|54248153|FG000|Overall Study|Lost to Follow-up|0|||
27792993|NCT02105948|54248154|FG001|Overall Study|Lost to Follow-up|0|||
27792994|NCT02105948|54248155|FG002|Overall Study|Lost to Follow-up|2|||
27792995|NCT02105948|54248156|FG003|Overall Study|Lost to Follow-up|1|||
27792996|NCT02105948|54248153|FG000|Overall Study|Physician Decision|2|||
27792997|NCT02105948|54248154|FG001|Overall Study|Physician Decision|2|||
27792998|NCT02105948|54248155|FG002|Overall Study|Physician Decision|2|||
27792999|NCT02105948|54248156|FG003|Overall Study|Physician Decision|2|||
27793000|NCT02105948|54248153|FG000|Overall Study|Withdrawal by Subject|15|||
27793001|NCT02105948|54248154|FG001|Overall Study|Withdrawal by Subject|10|||
27793002|NCT02105948|54248155|FG002|Overall Study|Withdrawal by Subject|10|||
27793003|NCT02105948|54248156|FG003|Overall Study|Withdrawal by Subject|11|||
27793004|NCT02128724|54248171|FG000|Overall Study|Death|1|||
27793005|NCT02128724|54248172|FG001|Overall Study|Death|0|||
27793006|NCT02128724|54248173|FG002|Overall Study|Death|0|||
27793007|NCT02128724|54248174|FG003|Overall Study|Death|0|||
27793008|NCT02128724|54248171|FG000|Overall Study|Adverse Event|0|||
27793009|NCT02128724|54248172|FG001|Overall Study|Adverse Event|1|||
27793010|NCT02128724|54248173|FG002|Overall Study|Adverse Event|0|||
27793011|NCT02128724|54248174|FG003|Overall Study|Adverse Event|0|||
27793012|NCT02128724|54248171|FG000|Overall Study|Physician Decision|0|||
27793013|NCT02128724|54248172|FG001|Overall Study|Physician Decision|0|||
27793014|NCT02128724|54248173|FG002|Overall Study|Physician Decision|0|||
27793015|NCT02128724|54248174|FG003|Overall Study|Physician Decision|2|||
27793016|NCT02128724|54248171|FG000|Overall Study|Withdrawal by Subject|0|||
27793017|NCT02128724|54248172|FG001|Overall Study|Withdrawal by Subject|0|||
27793018|NCT02128724|54248173|FG002|Overall Study|Withdrawal by Subject|0|||
27793019|NCT02128724|54248174|FG003|Overall Study|Withdrawal by Subject|1|||
27793020|NCT02128490|54248188|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
27793021|NCT02128490|54248189|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
27842557|NCT01550744|54331107|FG001|Double-Blind|Other|2|||
27793022|NCT02128490|54248190|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
27793023|NCT02128490|54248191|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
27793024|NCT02128490|54248192|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
27793025|NCT02128490|54248188|FG000|Overall Study|Major Protocol Deviation|1|||
27793026|NCT02128490|54248189|FG001|Overall Study|Major Protocol Deviation|2|||
27793027|NCT02128490|54248190|FG002|Overall Study|Major Protocol Deviation|0|||
27793028|NCT02128490|54248191|FG003|Overall Study|Major Protocol Deviation|2|||
27793029|NCT02128490|54248192|FG004|Overall Study|Major Protocol Deviation|2|||
27793030|NCT02128490|54248188|FG000|Overall Study|Lost to Follow-up|0|||
27793031|NCT02128490|54248189|FG001|Overall Study|Lost to Follow-up|0|||
27793032|NCT02128490|54248190|FG002|Overall Study|Lost to Follow-up|1|||
27793033|NCT02128490|54248191|FG003|Overall Study|Lost to Follow-up|1|||
27793034|NCT02128490|54248192|FG004|Overall Study|Lost to Follow-up|1|||
27793035|NCT02128490|54248188|FG000|Overall Study|Voluntary Withdrawal|3|||
27793036|NCT02128490|54248189|FG001|Overall Study|Voluntary Withdrawal|3|||
27793037|NCT02128490|54248190|FG002|Overall Study|Voluntary Withdrawal|1|||
27793038|NCT02128490|54248191|FG003|Overall Study|Voluntary Withdrawal|1|||
27793039|NCT02128490|54248192|FG004|Overall Study|Voluntary Withdrawal|2|||
27793040|NCT02128490|54248188|FG000|Overall Study|Lack of Efficacy|0|||
27793041|NCT02128490|54248189|FG001|Overall Study|Lack of Efficacy|1|||
27793042|NCT02128490|54248190|FG002|Overall Study|Lack of Efficacy|0|||
27793043|NCT02128490|54248191|FG003|Overall Study|Lack of Efficacy|0|||
27793044|NCT02128490|54248192|FG004|Overall Study|Lack of Efficacy|0|||
27793045|NCT02128490|54248188|FG000|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
27793046|NCT02128490|54248189|FG001|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
27793047|NCT02128490|54248190|FG002|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
27793048|NCT02128490|54248191|FG003|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
27793049|NCT02128490|54248192|FG004|Overall Study|Withdraw from Study Drug, Gout Flare|1|||
27793050|NCT02128490|54248188|FG000|Overall Study|Other Miscellaneous Reasons|0|||
27793051|NCT02128490|54248189|FG001|Overall Study|Other Miscellaneous Reasons|0|||
27793052|NCT02128490|54248190|FG002|Overall Study|Other Miscellaneous Reasons|2|||
27793053|NCT02128490|54248191|FG003|Overall Study|Other Miscellaneous Reasons|1|||
27793054|NCT02128490|54248192|FG004|Overall Study|Other Miscellaneous Reasons|1|||
27793055|NCT02146352|54248204|FG000|Overall Study|Death|1|||
27793056|NCT02146352|54248204|FG000|Overall Study|Patient entered hospice care|1|||
27793057|NCT02146274|54248208|FG000|Overall Study|Protocol Violation|73|||
27793058|NCT02105636|54248217|FG000|Pre-Treatment|Disease Progression|1|||
27793059|NCT02105636|54248218|FG001|Pre-Treatment|Disease Progression|0|||
27793060|NCT02105636|54248217|FG000|Pre-Treatment|Participant request to discontinue study treatment|1|||
27793061|NCT02105636|54248218|FG001|Pre-Treatment|Participant request to discontinue study treatment|2|||
27793062|NCT02105636|54248217|FG000|Pre-Treatment|Participant withdrew consent|0|||
27793063|NCT02105636|54248218|FG001|Pre-Treatment|Participant withdrew consent|6|||
27793064|NCT02105636|54248217|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
27793065|NCT02105636|54248218|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
27793066|NCT02105636|54248217|FG000|Treatment|Study Drug Toxicity|14|||
27793067|NCT02105636|54248218|FG001|Treatment|Study Drug Toxicity|10|||
27793068|NCT02105636|54248217|FG000|Treatment|Adverse event unrelated to study drug|19|||
27793069|NCT02105636|54248218|FG001|Treatment|Adverse event unrelated to study drug|3|||
27793070|NCT02105636|54248217|FG000|Treatment|Participant request to discontinue study treatment|8|||
27793071|NCT02105636|54248218|FG001|Treatment|Participant request to discontinue study treatment|6|||
27793072|NCT02105636|54248217|FG000|Treatment|Participant withdrew consent|5|||
27937337|NCT00977938|54593649|FG002|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2|||
27937338|NCT00977938|54593650|FG003|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0|||
27937339|NCT00977938|54593647|FG000|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34|||
27937340|NCT00977938|54593648|FG001|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42|||
27937341|NCT00977938|54593649|FG002|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10|||
27937342|NCT00977938|54593650|FG003|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3|||
27937343|NCT00977938|54593647|FG000|Observation (30-33 mo. Post Procedure)|Other|8|||
27793073|NCT02105636|54248218|FG001|Treatment|Participant withdrew consent|1|||
27793074|NCT02105636|54248217|FG000|Treatment|Lost to Follow-up|1|||
27793075|NCT02105636|54248218|FG001|Treatment|Lost to Follow-up|0|||
27793076|NCT02105636|54248217|FG000|Treatment|Maximum Clinical Benefit|1|||
27793077|NCT02105636|54248218|FG001|Treatment|Maximum Clinical Benefit|3|||
27937344|NCT00977938|54593648|FG001|Observation (30-33 mo. Post Procedure)|Other|4|||
28017207|NCT00344773|54676485|FG000|Overall Study|Not Eligible for the study|2|||
27793078|NCT02105636|54248217|FG000|Treatment|Poor/Non-compliance|0|||
27793079|NCT02105636|54248218|FG001|Treatment|Poor/Non-compliance|1|||
27793080|NCT02105636|54248217|FG000|Treatment|Participant no longer meets study criteria|1|||
27793081|NCT02105636|54248218|FG001|Treatment|Participant no longer meets study criteria|0|||
27793082|NCT02105636|54248217|FG000|Treatment|Other reasons|1|||
27793083|NCT02105636|54248218|FG001|Treatment|Other reasons|0|||
27793084|NCT02105636|54248217|FG000|Treatment|Disease Progression|185|||
27793085|NCT02105636|54248218|FG001|Treatment|Disease Progression|87|||
27793086|NCT01626872|54248227|FG000|Overall Study|Physician Decision|13|||
27793087|NCT01626872|54248228|FG001|Overall Study|Physician Decision|9|||
27793088|NCT01626872|54248229|FG002|Overall Study|Physician Decision|6|||
27793089|NCT01626872|54248227|FG000|Overall Study|Withdrawal by Subject|19|||
27793090|NCT01626872|54248228|FG001|Overall Study|Withdrawal by Subject|27|||
27793091|NCT01626872|54248229|FG002|Overall Study|Withdrawal by Subject|8|||
27793092|NCT01626872|54248227|FG000|Overall Study|Adverse Event (including Death)|20|||
27793093|NCT01626872|54248228|FG001|Overall Study|Adverse Event (including Death)|28|||
27793094|NCT01626872|54248229|FG002|Overall Study|Adverse Event (including Death)|8|||
27793095|NCT01626872|54248227|FG000|Overall Study|Protocol Violation (including Pregnancy)|0|||
27793096|NCT01626872|54248228|FG001|Overall Study|Protocol Violation (including Pregnancy)|2|||
27793097|NCT01626872|54248229|FG002|Overall Study|Protocol Violation (including Pregnancy)|2|||
27793098|NCT01598090|54248240|FG000|Treatment Period|Poor/non-compliance|0|||
27793099|NCT01598090|54248241|FG001|Treatment Period|Poor/non-compliance|2|||
27793100|NCT01598090|54248242|FG002|Treatment Period|Poor/non-compliance|0|||
27793101|NCT01598090|54248240|FG000|Treatment Period|No longer meet study criteria|0|||
27793102|NCT01598090|54248241|FG001|Treatment Period|No longer meet study criteria|1|||
27793103|NCT01598090|54248242|FG002|Treatment Period|No longer meet study criteria|0|||
27793104|NCT01598090|54248240|FG000|Treatment Period|Lack of Efficacy|5|||
27793105|NCT01598090|54248241|FG001|Treatment Period|Lack of Efficacy|14|||
27793106|NCT01598090|54248242|FG002|Treatment Period|Lack of Efficacy|6|||
27793107|NCT01598090|54248240|FG000|Treatment Period|Adverse Event|2|||
27793108|NCT01598090|54248241|FG001|Treatment Period|Adverse Event|33|||
27793109|NCT01598090|54248242|FG002|Treatment Period|Adverse Event|17|||
27793110|NCT01598090|54248240|FG000|Treatment Period|Other reasons|0|||
27793111|NCT01598090|54248241|FG001|Treatment Period|Other reasons|4|||
27793112|NCT01598090|54248242|FG002|Treatment Period|Other reasons|1|||
27793113|NCT01598090|54248240|FG000|Treatment Period|Withdrawal by Subject|3|||
27793114|NCT01598090|54248241|FG001|Treatment Period|Withdrawal by Subject|13|||
27793115|NCT01598090|54248242|FG002|Treatment Period|Withdrawal by Subject|10|||
27937345|NCT00977938|54593649|FG002|Observation (30-33 mo. Post Procedure)|Other|0|||
27937346|NCT00977938|54593650|FG003|Observation (30-33 mo. Post Procedure)|Other|0|||
27937347|NCT02716675|54593665|FG000|Overall Study|Death|2|||
27937348|NCT02716675|54593666|FG001|Overall Study|Death|3|||
27937349|NCT02716675|54593667|FG002|Overall Study|Death|0|||
27937350|NCT02716675|54593665|FG000|Overall Study|Physician Decision|2|||
27937351|NCT02716675|54593666|FG001|Overall Study|Physician Decision|1|||
27937352|NCT02716675|54593667|FG002|Overall Study|Physician Decision|1|||
27937353|NCT02716675|54593665|FG000|Overall Study|Lost to Follow-up|100|||
27937354|NCT02716675|54593666|FG001|Overall Study|Lost to Follow-up|87|||
27937355|NCT02716675|54593667|FG002|Overall Study|Lost to Follow-up|99|||
27937356|NCT02716675|54593665|FG000|Overall Study|Withdrawal by Subject|22|||
27937357|NCT02716675|54593666|FG001|Overall Study|Withdrawal by Subject|25|||
27937358|NCT02716675|54593667|FG002|Overall Study|Withdrawal by Subject|20|||
27937359|NCT02716675|54593665|FG000|Overall Study|Protocol Violation|0|||
27937360|NCT02716675|54593666|FG001|Overall Study|Protocol Violation|3|||
27937361|NCT02716675|54593667|FG002|Overall Study|Protocol Violation|1|||
27937362|NCT02716675|54593665|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|36|||
27937363|NCT02716675|54593666|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|31|||
27937364|NCT02716675|54593667|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|42|||
27937365|NCT02716675|54593665|FG000|Overall Study|Other|38|||
27937366|NCT02716675|54593666|FG001|Overall Study|Other|47|||
27937367|NCT02716675|54593667|FG002|Overall Study|Other|48|||
27937368|NCT00977548|54593680|FG000|Overall Study|Ineligible|4|||
27937369|NCT00977548|54593680|FG000|Overall Study|Adverse Event|8|||
27937370|NCT00977548|54593680|FG000|Overall Study|Withdrawal by Subject|1|||
27937371|NCT01090011|54593684|FG000|Overall Study|Progressive disease|128|||
27937372|NCT01090011|54593684|FG000|Overall Study|Adverse Event|32|||
27937373|NCT01090011|54593684|FG000|Overall Study|Protocol Violation|1|||
27937374|NCT01090011|54593684|FG000|Overall Study|Refusal to start/continue medication|5|||
27793116|NCT01598090|54248240|FG000|Treatment Period|Lost to Follow-up|1|||
27793117|NCT01598090|54248241|FG001|Treatment Period|Lost to Follow-up|5|||
27793118|NCT01598090|54248242|FG002|Treatment Period|Lost to Follow-up|1|||
27793119|NCT01598090|54248240|FG000|Follow-up Period|Death|0|||
27937375|NCT01090011|54593684|FG000|Overall Study|Other reason not defined above|5|||
27842558|NCT01550744|54331108|FG002|Double-Blind|Other|10|||
27842559|NCT01549964|54331169|FG000|24-Week Treatment Period|Study Terminated by Sponsor|50|||
27937376|NCT01251653|54593705|FG000|Overall Study|Progressive Disease|1|||
27793120|NCT01598090|54248241|FG001|Follow-up Period|Death|1|||
27793121|NCT01598090|54248242|FG002|Follow-up Period|Death|0|||
27842560|NCT01549964|54331170|FG001|24-Week Treatment Period|Study Terminated by Sponsor|104|||
27937377|NCT01251653|54593706|FG001|Overall Study|Progressive Disease|7|||
27937378|NCT01251653|54593707|FG002|Overall Study|Progressive Disease|16|||
27937379|NCT01251653|54593708|FG003|Overall Study|Progressive Disease|4|||
27937380|NCT01251653|54593709|FG004|Overall Study|Progressive Disease|0|||
27937381|NCT01251653|54593710|FG005|Overall Study|Progressive Disease|17|||
28105621|NCT02079766|54763115|FG000|Overall Study|Withdrawal by Subject|1|||
27793122|NCT01598090|54248240|FG000|Follow-up Period|No longer required per protocol|1|||
27793123|NCT01598090|54248241|FG001|Follow-up Period|No longer required per protocol|3|||
27793124|NCT01598090|54248242|FG002|Follow-up Period|No longer required per protocol|2|||
27793125|NCT01598090|54248240|FG000|Follow-up Period|Not reported|0|||
27793126|NCT01598090|54248241|FG001|Follow-up Period|Not reported|10|||
27793127|NCT01598090|54248242|FG002|Follow-up Period|Not reported|4|||
27937382|NCT01251653|54593711|FG006|Overall Study|Progressive Disease|14|||
27937383|NCT01251653|54593712|FG007|Overall Study|Progressive Disease|7|||
27937384|NCT01251653|54593713|FG008|Overall Study|Progressive Disease|5|||
27937385|NCT01251653|54593705|FG000|Overall Study|Dose-limiting toxicity|0|||
27937386|NCT01251653|54593706|FG001|Overall Study|Dose-limiting toxicity|1|||
27937387|NCT01251653|54593707|FG002|Overall Study|Dose-limiting toxicity|1|||
27937388|NCT01251653|54593708|FG003|Overall Study|Dose-limiting toxicity|1|||
27937389|NCT01251653|54593709|FG004|Overall Study|Dose-limiting toxicity|0|||
27937390|NCT01251653|54593710|FG005|Overall Study|Dose-limiting toxicity|0|||
27937391|NCT01251653|54593711|FG006|Overall Study|Dose-limiting toxicity|2|||
27937392|NCT01251653|54593712|FG007|Overall Study|Dose-limiting toxicity|0|||
27937393|NCT01251653|54593713|FG008|Overall Study|Dose-limiting toxicity|0|||
27937394|NCT01251653|54593705|FG000|Overall Study|Adverse Event|1|||
27937395|NCT01251653|54593706|FG001|Overall Study|Adverse Event|0|||
27937396|NCT01251653|54593707|FG002|Overall Study|Adverse Event|2|||
27937397|NCT01251653|54593708|FG003|Overall Study|Adverse Event|1|||
27937398|NCT01251653|54593709|FG004|Overall Study|Adverse Event|1|||
27937399|NCT01251653|54593710|FG005|Overall Study|Adverse Event|0|||
27937400|NCT01251653|54593711|FG006|Overall Study|Adverse Event|2|||
27937401|NCT01251653|54593712|FG007|Overall Study|Adverse Event|2|||
27937402|NCT01251653|54593713|FG008|Overall Study|Adverse Event|1|||
27937403|NCT01251653|54593705|FG000|Overall Study|Withdrawal by Subject|1|||
27937404|NCT01251653|54593706|FG001|Overall Study|Withdrawal by Subject|0|||
27937405|NCT01251653|54593707|FG002|Overall Study|Withdrawal by Subject|1|||
27937406|NCT01251653|54593708|FG003|Overall Study|Withdrawal by Subject|0|||
27937407|NCT01251653|54593709|FG004|Overall Study|Withdrawal by Subject|1|||
27937408|NCT01251653|54593710|FG005|Overall Study|Withdrawal by Subject|1|||
27937409|NCT01251653|54593711|FG006|Overall Study|Withdrawal by Subject|0|||
27937410|NCT01251653|54593712|FG007|Overall Study|Withdrawal by Subject|1|||
27937411|NCT01251653|54593713|FG008|Overall Study|Withdrawal by Subject|0|||
27937412|NCT01251653|54593705|FG000|Overall Study|Other reason not mentioned above|0|||
27937413|NCT01251653|54593706|FG001|Overall Study|Other reason not mentioned above|0|||
27937414|NCT01251653|54593707|FG002|Overall Study|Other reason not mentioned above|0|||
27937415|NCT01251653|54593708|FG003|Overall Study|Other reason not mentioned above|0|||
27937416|NCT01251653|54593709|FG004|Overall Study|Other reason not mentioned above|0|||
27937417|NCT01251653|54593710|FG005|Overall Study|Other reason not mentioned above|0|||
27937418|NCT01251653|54593711|FG006|Overall Study|Other reason not mentioned above|0|||
27937419|NCT01251653|54593712|FG007|Overall Study|Other reason not mentioned above|2|||
27937420|NCT01251653|54593713|FG008|Overall Study|Other reason not mentioned above|0|||
27937421|NCT00910663|54593751|FG000|Period 1|Withdrawal by Subject|0|||
27937422|NCT00910663|54593752|FG001|Period 1|Withdrawal by Subject|1|||
27937423|NCT01077375|54593760|FG000|Overall Study|Adverse Event|2|||
27937424|NCT01077375|54593761|FG001|Overall Study|Adverse Event|15|||
27937425|NCT01077375|54593760|FG000|Overall Study|Lack of Efficacy|6|||
27937426|NCT01077375|54593761|FG001|Overall Study|Lack of Efficacy|8|||
27937427|NCT01077375|54593760|FG000|Overall Study|Withdrawal by Subject|0|||
27937428|NCT01077375|54593761|FG001|Overall Study|Withdrawal by Subject|6|||
27937429|NCT01077375|54593760|FG000|Overall Study|Lost to Follow-up|2|||
27937430|NCT01077375|54593761|FG001|Overall Study|Lost to Follow-up|5|||
27937431|NCT01077375|54593760|FG000|Overall Study|Other Reason|0|||
27937432|NCT01077375|54593761|FG001|Overall Study|Other Reason|1|||
27793128|NCT01598090|54248240|FG000|Follow-up Period|Withdrawal by Subject|0|||
27793129|NCT01598090|54248241|FG001|Follow-up Period|Withdrawal by Subject|3|||
27793130|NCT01598090|54248242|FG002|Follow-up Period|Withdrawal by Subject|2|||
27793131|NCT01598090|54248240|FG000|Follow-up Period|Other reasons|2|||
27793132|NCT01598090|54248241|FG001|Follow-up Period|Other reasons|8|||
27793133|NCT01598090|54248242|FG002|Follow-up Period|Other reasons|8|||
27793134|NCT01598090|54248240|FG000|Follow-up Period|Lost to Follow-up|2|||
27793135|NCT01598090|54248241|FG001|Follow-up Period|Lost to Follow-up|10|||
27937433|NCT01250873|54593769|FG000|Period 1: LY2216684 (Days 1-3)|Adverse Event|2|||
27937434|NCT01250873|54593769|FG000|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1|||
27937435|NCT01250171|54593778|FG000|Overall Study|Administrative reasons|1|||
27937436|NCT01250171|54593779|FG001|Overall Study|Administrative reasons|0|||
27937437|NCT01250171|54593780|FG002|Overall Study|Administrative reasons|0|||
27793136|NCT01598090|54248242|FG002|Follow-up Period|Lost to Follow-up|12|||
27937438|NCT01077063|54593790|FG000|Overall Study|Adverse Event|3|||
27937439|NCT01077063|54593791|FG001|Overall Study|Adverse Event|0|||
27937440|NCT01077063|54593790|FG000|Overall Study|Death|1|||
27937441|NCT01077063|54593791|FG001|Overall Study|Death|1|||
27937442|NCT01077063|54593790|FG000|Overall Study|Withdrawal by Subject|0|||
27793137|NCT02105012|54248253|FG000|Overall Study|Withdrawal by Subject|11|||
27793138|NCT02105012|54248253|FG000|Overall Study|Protocol Specified Criteria|9|||
27793139|NCT02105012|54248253|FG000|Overall Study|Lost to Follow-up|4|||
27793140|NCT02105012|54248253|FG000|Overall Study|Protocol Violation|4|||
27793141|NCT02105012|54248253|FG000|Overall Study|Physician Decision|3|||
27793142|NCT02105012|54248253|FG000|Overall Study|Adverse Event|1|||
27793143|NCT02105012|54248253|FG000|Overall Study|Lack of Efficacy|1|||
27793144|NCT02145182|54248267|FG000|Overall Study|Adverse Event|4|||
27793145|NCT02145182|54248268|FG001|Overall Study|Adverse Event|1|||
27793146|NCT02145182|54248267|FG000|Overall Study|Death|7|||
27793147|NCT02145182|54248268|FG001|Overall Study|Death|7|||
27793148|NCT02145182|54248267|FG000|Overall Study|Lost to Follow-up|2|||
27793149|NCT02145182|54248268|FG001|Overall Study|Lost to Follow-up|2|||
27793150|NCT02145182|54248267|FG000|Overall Study|Pre-transplant Withdrawal|0|||
27793151|NCT02145182|54248268|FG001|Overall Study|Pre-transplant Withdrawal|2|||
27793152|NCT02145182|54248267|FG000|Overall Study|Withdrawal by Subject|5|||
27793153|NCT02145182|54248268|FG001|Overall Study|Withdrawal by Subject|4|||
27793154|NCT02145026|54248274|FG000|Overall Study|Adverse Event|2|||
27793155|NCT02145026|54248274|FG000|Overall Study|Death|4|||
27793156|NCT02145026|54248274|FG000|Overall Study|Withdrawal by Subject|2|||
27793157|NCT02145026|54248274|FG000|Overall Study|Physician Decision|4|||
27793158|NCT02144012|54248280|FG000|Overall Study|Adverse Event|1|||
27793159|NCT02144012|54248281|FG001|Overall Study|Adverse Event|0|||
27793160|NCT02144012|54248280|FG000|Overall Study|Death|1|||
27793161|NCT02144012|54248281|FG001|Overall Study|Death|0|||
27793162|NCT02144012|54248280|FG000|Overall Study|Withdrawal by Subject|11|||
27793163|NCT02144012|54248281|FG001|Overall Study|Withdrawal by Subject|3|||
27793164|NCT02144012|54248280|FG000|Overall Study|Study Terminated by Sponsor|18|||
27793165|NCT02144012|54248281|FG001|Overall Study|Study Terminated by Sponsor|12|||
27793166|NCT02144012|54248280|FG000|Overall Study|Other|3|||
27793167|NCT02144012|54248281|FG001|Overall Study|Other|0|||
27793168|NCT02103062|54248289|FG000|Overall Study|Adverse Event|1|||
27793169|NCT02103062|54248290|FG001|Overall Study|Adverse Event|2|||
27793170|NCT02103062|54248289|FG000|Overall Study|Progressive Disease|17|||
27793171|NCT02103062|54248290|FG001|Overall Study|Progressive Disease|20|||
27793172|NCT02103062|54248289|FG000|Overall Study|Death|0|||
27793173|NCT02103062|54248290|FG001|Overall Study|Death|1|||
27793174|NCT02141984|54248298|FG000|Overall Study|Lack of Efficacy|2|||
27793175|NCT02141672|54248305|FG000|Overall Study|Adverse Event|0|||
27793176|NCT02141672|54248306|FG001|Overall Study|Adverse Event|1|||
27793177|NCT02141672|54248307|FG002|Overall Study|Adverse Event|0|||
27793178|NCT02141672|54248305|FG000|Overall Study|Death|10|||
27793179|NCT02141672|54248306|FG001|Overall Study|Death|2|||
27793180|NCT02141672|54248307|FG002|Overall Study|Death|1|||
27793181|NCT02141672|54248305|FG000|Overall Study|Lack of Efficacy|0|||
27793182|NCT02141672|54248306|FG001|Overall Study|Lack of Efficacy|0|||
27793183|NCT02141672|54248307|FG002|Overall Study|Lack of Efficacy|2|||
27793184|NCT02141672|54248305|FG000|Overall Study|Lost to Follow-up|1|||
27793185|NCT02141672|54248306|FG001|Overall Study|Lost to Follow-up|1|||
27793186|NCT02141672|54248307|FG002|Overall Study|Lost to Follow-up|3|||
27793187|NCT02141672|54248305|FG000|Overall Study|Physician Decision|1|||
27793188|NCT02141672|54248306|FG001|Overall Study|Physician Decision|2|||
27793189|NCT02141672|54248307|FG002|Overall Study|Physician Decision|5|||
27793190|NCT02141672|54248305|FG000|Overall Study|Protocol Violation|0|||
27793191|NCT02141672|54248306|FG001|Overall Study|Protocol Violation|0|||
27793192|NCT02141672|54248307|FG002|Overall Study|Protocol Violation|1|||
27793193|NCT02141672|54248305|FG000|Overall Study|Withdrawal by Subject|3|||
27793194|NCT02141672|54248306|FG001|Overall Study|Withdrawal by Subject|2|||
27793195|NCT02141672|54248307|FG002|Overall Study|Withdrawal by Subject|5|||
27793196|NCT02141672|54248305|FG000|Overall Study|refused to follow-up|1|||
27793197|NCT02141672|54248306|FG001|Overall Study|refused to follow-up|0|||
27793198|NCT02141672|54248307|FG002|Overall Study|refused to follow-up|1|||
27793199|NCT02141516|54248318|FG000|Overall Study|Adverse Event|0|||
27793200|NCT02141516|54248319|FG001|Overall Study|Adverse Event|1|||
27793201|NCT02141516|54248320|FG002|Overall Study|Adverse Event|0|||
27842561|NCT01549964|54331171|FG002|24-Week Treatment Period|Study Terminated by Sponsor|104|||
27793202|NCT02141516|54248318|FG000|Overall Study|Lost to Follow-up|0|||
27793203|NCT02141516|54248319|FG001|Overall Study|Lost to Follow-up|1|||
27937443|NCT01077063|54593791|FG001|Overall Study|Withdrawal by Subject|2|||
27793204|NCT02141516|54248320|FG002|Overall Study|Lost to Follow-up|0|||
27793205|NCT02141516|54248318|FG000|Overall Study|Other|0|||
27793206|NCT02141516|54248319|FG001|Overall Study|Other|3|||
27793207|NCT02141516|54248320|FG002|Overall Study|Other|0|||
27793208|NCT02141360|54248334|FG000|Overall Study|Withdrawal by Subject|6|||
27793209|NCT02141360|54248335|FG001|Overall Study|Withdrawal by Subject|0|||
27793210|NCT02141360|54248336|FG002|Overall Study|Withdrawal by Subject|0|||
27793211|NCT02141360|54248334|FG000|Overall Study|Study Terminated before Visit|1|||
27793212|NCT02141360|54248335|FG001|Overall Study|Study Terminated before Visit|0|||
27793213|NCT02141360|54248336|FG002|Overall Study|Study Terminated before Visit|0|||
27793214|NCT01628198|54248344|FG000|Overall Study|Lost to Follow-up|7|||
27793215|NCT01628198|54248344|FG000|Overall Study|Withdrawal by Subject|10|||
27793216|NCT01628198|54248344|FG000|Overall Study|Screen failure|1|||
27793217|NCT01628120|54248348|FG000|Overall Study|Withdrawal by Subject|7|||
27793218|NCT01628120|54248348|FG000|Overall Study|Adverse Event|12|||
27793219|NCT01628120|54248348|FG000|Overall Study|Lost to Follow-up|1|||
27793220|NCT01628120|54248348|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|2|||
27793221|NCT01628120|54248348|FG000|Overall Study|Non-compliant with Study Procedures|1|||
27793222|NCT01628120|54248348|FG000|Overall Study|Not Treated|3|||
27793223|NCT01628120|54248348|FG000|Overall Study|Sponsor Decision|5|||
27842562|NCT01549964|54331172|FG003|24-Week Treatment Period|Study Terminated by Sponsor|105|||
27937444|NCT01248065|54593799|FG000|Overall Study|Lost to Follow-up|3|||
27937445|NCT01248065|54593800|FG001|Overall Study|Lost to Follow-up|5|||
27937446|NCT01248065|54593799|FG000|Overall Study|Withdrawal by Subject|14|||
27937447|NCT01248065|54593800|FG001|Overall Study|Withdrawal by Subject|11|||
27937448|NCT01248065|54593799|FG000|Overall Study|Adverse Event|3|||
27937449|NCT01248065|54593800|FG001|Overall Study|Adverse Event|0|||
27937450|NCT01248065|54593799|FG000|Overall Study|Third treatment failure event|3|||
27937451|NCT01248065|54593800|FG001|Overall Study|Third treatment failure event|1|||
27937452|NCT01248065|54593799|FG000|Overall Study|Other|3|||
27937453|NCT01248065|54593800|FG001|Overall Study|Other|5|||
27937454|NCT01250756|54593808|FG000|Infant Series|Withdrawal by Subject|4|||
27937455|NCT01250756|54593809|FG001|Infant Series|Withdrawal by Subject|5|||
27937456|NCT01250756|54593808|FG000|Infant Series|Randomized, Not Vaccinated|2|||
27937457|NCT01250756|54593809|FG001|Infant Series|Randomized, Not Vaccinated|2|||
27937458|NCT01250756|54593808|FG000|Infant Series|Other|22|||
27937459|NCT01250756|54593809|FG001|Infant Series|Other|0|||
27937460|NCT01250756|54593808|FG000|After Infant Series|Adverse Event|5|||
27937461|NCT01250756|54593809|FG001|After Infant Series|Adverse Event|2|||
27937462|NCT01250756|54593808|FG000|After Infant Series|Withdrawal by Subject|4|||
27937463|NCT01250756|54593809|FG001|After Infant Series|Withdrawal by Subject|1|||
27937464|NCT01250756|54593808|FG000|After Infant Series|Other|2|||
27937465|NCT01250756|54593809|FG001|After Infant Series|Other|1|||
27937466|NCT01250756|54593808|FG000|Toddler Dose|Adverse Event|0|||
27937467|NCT01250756|54593809|FG001|Toddler Dose|Adverse Event|1|||
27937468|NCT01250756|54593808|FG000|After Toddler Dose|Adverse Event|0|||
27937469|NCT01250756|54593809|FG001|After Toddler Dose|Adverse Event|1|||
27937470|NCT01250054|54593821|FG000|Period 2, One Week of Wear|Unacceptable subjective vision|1|||
27937471|NCT01250054|54593822|FG001|Period 2, One Week of Wear|Unacceptable subjective vision|0|||
27937472|NCT00977470|54593830|FG000|Overall Study|Lack of Efficacy|32|||
27937473|NCT00977470|54593831|FG001|Overall Study|Lack of Efficacy|30|||
27937474|NCT00977470|54593830|FG000|Overall Study|Physician Decision|2|||
27937475|NCT00977470|54593831|FG001|Overall Study|Physician Decision|0|||
27937476|NCT00977470|54593830|FG000|Overall Study|Adverse Event|1|||
27937477|NCT00977470|54593831|FG001|Overall Study|Adverse Event|2|||
27937478|NCT00977470|54593830|FG000|Overall Study|Protocol Violation|1|||
27937479|NCT00977470|54593831|FG001|Overall Study|Protocol Violation|0|||
27937480|NCT00977470|54593830|FG000|Overall Study|Withdrawal by Subject|0|||
27937481|NCT00977470|54593831|FG001|Overall Study|Withdrawal by Subject|2|||
27937482|NCT00977470|54593830|FG000|Overall Study|Death|0|||
27937483|NCT00977470|54593831|FG001|Overall Study|Death|2|||
27937484|NCT00977470|54593830|FG000|Overall Study|clinical decline|0|||
27937485|NCT00977470|54593831|FG001|Overall Study|clinical decline|1|||
27937486|NCT00977470|54593830|FG000|Overall Study|prolonged recovery post-surgery|0|||
27937487|NCT00977470|54593831|FG001|Overall Study|prolonged recovery post-surgery|1|||
27937488|NCT00977470|54593830|FG000|Overall Study|Still on-study|2|||
27937489|NCT00977470|54593831|FG001|Overall Study|Still on-study|0|||
27937490|NCT01245374|54593837|FG000|Overall Study|Protocol Violation|1|||
27937491|NCT01245374|54593837|FG000|Overall Study|Withdrawal by Subject|3|||
27937492|NCT00977314|54593844|FG000|Overall Study|Withdrawal by Subject|1|||
27937493|NCT00977314|54593845|FG001|Overall Study|Withdrawal by Subject|0|||
27937494|NCT00977314|54593844|FG000|Overall Study|Physician Decision|1|||
27937495|NCT00977314|54593845|FG001|Overall Study|Physician Decision|0|||
27937496|NCT01087203|54593853|FG000|Overall Study|Lost to Follow-up|2|||
27937497|NCT01087203|54593854|FG001|Overall Study|Lost to Follow-up|0|||
27937498|NCT01087203|54593853|FG000|Overall Study|Withdrawal by Subject|2|||
27937499|NCT01087203|54593854|FG001|Overall Study|Withdrawal by Subject|6|||
27937500|NCT01087203|54593853|FG000|Overall Study|Lack of Efficacy|1|||
27937501|NCT01087203|54593854|FG001|Overall Study|Lack of Efficacy|2|||
27937502|NCT01087203|54593853|FG000|Overall Study|Study terminated by sponsor|27|||
28105622|NCT02079766|54763116|FG001|Overall Study|Withdrawal by Subject|0|||
28105623|NCT04841577|54763124|FG000|Overall Study|Adverse Event|5|||
27793224|NCT01628120|54248348|FG000|Overall Study|Switched Dialysis Method|2|||
27793225|NCT01628120|54248348|FG000|Overall Study|Missed Study Drug More than 2 Weeks|3|||
27793226|NCT01628120|54248348|FG000|Overall Study|Moved or Relocated|5|||
27793227|NCT01628120|54248348|FG000|Overall Study|Kidney Transplant|2|||
27937503|NCT01087203|54593854|FG001|Overall Study|Study terminated by sponsor|27|||
27937504|NCT01246583|54593865|FG000|Overall Study|Lost to Follow-up|0|||
27937505|NCT01246583|54593866|FG001|Overall Study|Lost to Follow-up|0|||
27937506|NCT01246583|54593867|FG002|Overall Study|Lost to Follow-up|0|||
27937507|NCT01246583|54593868|FG003|Overall Study|Lost to Follow-up|1|||
27937508|NCT01246583|54593865|FG000|Overall Study|Protocol Violation|0|||
27937509|NCT01246583|54593866|FG001|Overall Study|Protocol Violation|0|||
27937510|NCT01246583|54593867|FG002|Overall Study|Protocol Violation|1|||
27937511|NCT01246583|54593868|FG003|Overall Study|Protocol Violation|0|||
27937512|NCT01246583|54593865|FG000|Overall Study|Withdrawal by Subject|1|||
27937513|NCT01246583|54593866|FG001|Overall Study|Withdrawal by Subject|0|||
27937514|NCT01246583|54593867|FG002|Overall Study|Withdrawal by Subject|0|||
27937515|NCT01246583|54593868|FG003|Overall Study|Withdrawal by Subject|0|||
27937516|NCT01084239|54593881|FG000|28-Day Follow-up|Lost to Follow-up|4|||
27937517|NCT01084239|54593882|FG001|28-Day Follow-up|Lost to Follow-up|9|||
27937518|NCT01244906|54593890|FG000|Overall Study|Death|2|||
27937519|NCT01244906|54593890|FG000|Overall Study|Progression of disease post treatment|6|||
27937520|NCT01080807|54593896|FG000|Overall Study|Adverse Event|9|||
27937521|NCT01080807|54593897|FG001|Overall Study|Adverse Event|1|||
27937522|NCT01080807|54593896|FG000|Overall Study|Lack of Efficacy|0|||
27937523|NCT01080807|54593897|FG001|Overall Study|Lack of Efficacy|1|||
27937524|NCT01080807|54593896|FG000|Overall Study|Withdrawal by Subject|7|||
27937525|NCT01080807|54593897|FG001|Overall Study|Withdrawal by Subject|2|||
27937526|NCT01080807|54593896|FG000|Overall Study|Protocol Violation|7|||
27937527|NCT01080807|54593897|FG001|Overall Study|Protocol Violation|6|||
27937528|NCT01080807|54593896|FG000|Overall Study|Lost to Follow-up|6|||
27937529|NCT01080807|54593897|FG001|Overall Study|Lost to Follow-up|4|||
27937530|NCT01080807|54593896|FG000|Overall Study|Noncompliance with drug administration|1|||
27937531|NCT01080807|54593897|FG001|Overall Study|Noncompliance with drug administration|1|||
27937532|NCT01080807|54593896|FG000|Overall Study|Noncompliance to study procedures|1|||
27937533|NCT01080807|54593897|FG001|Overall Study|Noncompliance to study procedures|1|||
27937534|NCT01080807|54593896|FG000|Overall Study|Began working day shift|0|||
27937535|NCT01080807|54593897|FG001|Overall Study|Began working day shift|2|||
27937536|NCT01080807|54593896|FG000|Overall Study|Laid off or terminated from job|1|||
27937537|NCT01080807|54593897|FG001|Overall Study|Laid off or terminated from job|2|||
27937538|NCT01080807|54593896|FG000|Overall Study|Stopped working consistent night shifts|0|||
27937539|NCT01080807|54593897|FG001|Overall Study|Stopped working consistent night shifts|1|||
27937540|NCT01080807|54593896|FG000|Overall Study|Work schedule changing|1|||
27937541|NCT01080807|54593897|FG001|Overall Study|Work schedule changing|1|||
27937542|NCT01080807|54593896|FG000|Overall Study|Work schedule and travel|0|||
27937543|NCT01080807|54593897|FG001|Overall Study|Work schedule and travel|1|||
27937544|NCT01080807|54593896|FG000|Overall Study|Switched to first shift|1|||
27937545|NCT01080807|54593897|FG001|Overall Study|Switched to first shift|0|||
27937546|NCT01080807|54593896|FG000|Overall Study|Moved away without notifying center|1|||
27937547|NCT01080807|54593897|FG001|Overall Study|Moved away without notifying center|0|||
27937548|NCT01076361|54593903|FG000|Overall Study|22 leads were excluded from analysis|21|||
27937549|NCT01079949|54593909|FG000|Overall Study|Withdrawal before r-hCG administration|2|||
27937550|NCT01079949|54593910|FG001|Overall Study|Withdrawal before r-hCG administration|3|||
27937551|NCT01079949|54593909|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4|||
27937552|NCT01079949|54593910|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8|||
27937553|NCT01079949|54593909|FG000|Overall Study|Withdrawal between OPU - embryo transfer|8|||
27937554|NCT01079949|54593910|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
27937555|NCT01079949|54593909|FG000|Overall Study|Randomized but not treated|1|||
27937556|NCT01079949|54593910|FG001|Overall Study|Randomized but not treated|0|||
27937557|NCT00910429|54593918|FG000|Overall Study|Death|18|||
27937558|NCT00910429|54593919|FG001|Overall Study|Death|12|||
27937559|NCT00910429|54593918|FG000|Overall Study|Withdrawal by Subject|3|||
27937560|NCT00910429|54593919|FG001|Overall Study|Withdrawal by Subject|2|||
27937561|NCT00910429|54593918|FG000|Overall Study|Protocol Violation|1|||
27937562|NCT00910429|54593919|FG001|Overall Study|Protocol Violation|0|||
27937563|NCT00910429|54593918|FG000|Overall Study|Lost to Follow-up|2|||
27937564|NCT00910429|54593919|FG001|Overall Study|Lost to Follow-up|1|||
27937565|NCT00910429|54593918|FG000|Overall Study|Adverse Event|10|||
27937566|NCT00910429|54593919|FG001|Overall Study|Adverse Event|5|||
27937567|NCT00910429|54593918|FG000|Overall Study|Drug non-compliance|1|||
27937568|NCT00910429|54593919|FG001|Overall Study|Drug non-compliance|0|||
27937569|NCT00910429|54593918|FG000|Overall Study|Lack of Efficacy|4|||
27937570|NCT00910429|54593919|FG001|Overall Study|Lack of Efficacy|1|||
27937571|NCT00909727|54593927|FG000|Overall Study|Adverse Event|1|||
27937572|NCT00909727|54593928|FG001|Overall Study|Adverse Event|0|||
27937573|NCT00909727|54593927|FG000|Overall Study|Wrong Genotype|1|||
27937574|NCT00909727|54593928|FG001|Overall Study|Wrong Genotype|0|||
27937575|NCT00909727|54593927|FG000|Overall Study|Withdrawal of Consent|1|||
27937576|NCT00909727|54593928|FG001|Overall Study|Withdrawal of Consent|0|||
27937577|NCT00909727|54593927|FG000|Overall Study|Prohibited Medication|1|||
27937578|NCT00909727|54593928|FG001|Overall Study|Prohibited Medication|0|||
27937579|NCT00977080|54593938|FG000|Overall Study|Adverse Event|2|||
28105624|NCT04841577|54763125|FG001|Overall Study|Adverse Event|10|||
27937580|NCT00977080|54593939|FG001|Overall Study|Adverse Event|7|||
27937581|NCT00977080|54593940|FG002|Overall Study|Adverse Event|7|||
27937582|NCT00977080|54593941|FG003|Overall Study|Adverse Event|7|||
27937583|NCT00977080|54593938|FG000|Overall Study|Withdrawal by Subject|1|||
27937584|NCT00977080|54593939|FG001|Overall Study|Withdrawal by Subject|5|||
27937585|NCT00977080|54593940|FG002|Overall Study|Withdrawal by Subject|1|||
27937586|NCT00977080|54593941|FG003|Overall Study|Withdrawal by Subject|5|||
27937587|NCT00977080|54593938|FG000|Overall Study|Protocol Violation|7|||
27937588|NCT00977080|54593939|FG001|Overall Study|Protocol Violation|3|||
27937589|NCT00977080|54593940|FG002|Overall Study|Protocol Violation|4|||
27937590|NCT00977080|54593941|FG003|Overall Study|Protocol Violation|3|||
27937591|NCT00977080|54593938|FG000|Overall Study|Noncompliance|0|||
27937592|NCT00977080|54593939|FG001|Overall Study|Noncompliance|2|||
27937593|NCT00977080|54593940|FG002|Overall Study|Noncompliance|1|||
27937594|NCT00977080|54593941|FG003|Overall Study|Noncompliance|0|||
27937595|NCT00977080|54593938|FG000|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
27937596|NCT00977080|54593939|FG001|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
27937597|NCT00977080|54593940|FG002|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
27937598|NCT00977080|54593941|FG003|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1|||
27937599|NCT00977080|54593938|FG000|Overall Study|Required kidney transplantation|1|||
27937600|NCT00977080|54593939|FG001|Overall Study|Required kidney transplantation|3|||
27937601|NCT00977080|54593940|FG002|Overall Study|Required kidney transplantation|3|||
27937602|NCT00977080|54593941|FG003|Overall Study|Required kidney transplantation|1|||
27793228|NCT01628120|54248348|FG000|Overall Study|Use of Standard of Care|1|||
27793229|NCT01627340|54248354|FG000|Overall Study|Adverse Event|1|||
27793230|NCT01627340|54248355|FG001|Overall Study|Adverse Event|0|||
27793231|NCT01627340|54248354|FG000|Overall Study|Lost to Follow-up|8|||
27793232|NCT01627340|54248355|FG001|Overall Study|Lost to Follow-up|4|||
27793233|NCT01627340|54248354|FG000|Overall Study|Pregnancy|1|||
27793234|NCT01627340|54248355|FG001|Overall Study|Pregnancy|0|||
27793235|NCT01627340|54248354|FG000|Overall Study|Withdrawal by Subject|2|||
27793236|NCT01627340|54248355|FG001|Overall Study|Withdrawal by Subject|0|||
27793237|NCT02125838|54248365|FG000|Overall Study|Lost to Follow-up|4|||
27793238|NCT02125838|54248366|FG001|Overall Study|Lost to Follow-up|4|||
27793239|NCT02125604|54248372|FG000|Overall Study|Other|4|||
27793240|NCT02125604|54248372|FG000|Overall Study|Investigator Decision|1|||
27793241|NCT02125604|54248372|FG000|Overall Study|Lost to Follow-up|2|||
27793242|NCT02125604|54248372|FG000|Overall Study|Consent Withdrawn|4|||
27793243|NCT02125604|54248372|FG000|Overall Study|Adverse Event|20|||
27793244|NCT02124746|54248379|FG000|Overall Study|Adverse Event|2|||
27793245|NCT02124746|54248380|FG001|Overall Study|Adverse Event|1|||
27793246|NCT02124746|54248381|FG002|Overall Study|Adverse Event|2|||
27793247|NCT02124746|54248379|FG000|Overall Study|Death|2|||
27842563|NCT01549964|54331169|FG000|24-Week Treatment Period|Voluntary Withdrawal|6|||
27842564|NCT01549964|54331170|FG001|24-Week Treatment Period|Voluntary Withdrawal|3|||
27842565|NCT01549964|54331171|FG002|24-Week Treatment Period|Voluntary Withdrawal|3|||
27842566|NCT01549964|54331172|FG003|24-Week Treatment Period|Voluntary Withdrawal|8|||
27842567|NCT01549964|54331169|FG000|24-Week Treatment Period|Pretreatment Event/Adverse Event|1|||
27842568|NCT01549964|54331170|FG001|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
27842569|NCT01549964|54331171|FG002|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
27842570|NCT01549964|54331172|FG003|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
27842571|NCT01549964|54331169|FG000|24-Week Treatment Period|Lost to Follow-up|1|||
27842572|NCT01549964|54331170|FG001|24-Week Treatment Period|Lost to Follow-up|0|||
27842573|NCT01549964|54331171|FG002|24-Week Treatment Period|Lost to Follow-up|1|||
27842574|NCT01549964|54331172|FG003|24-Week Treatment Period|Lost to Follow-up|2|||
27842575|NCT01549964|54331169|FG000|24-Week Treatment Period|Lack of Efficacy|1|||
27842576|NCT01549964|54331170|FG001|24-Week Treatment Period|Lack of Efficacy|0|||
27842577|NCT01549964|54331171|FG002|24-Week Treatment Period|Lack of Efficacy|1|||
27793248|NCT02124746|54248380|FG001|Overall Study|Death|1|||
27793249|NCT02124746|54248381|FG002|Overall Study|Death|3|||
27793250|NCT02124746|54248379|FG000|Overall Study|Lack of Efficacy|3|||
27793251|NCT02124746|54248380|FG001|Overall Study|Lack of Efficacy|2|||
27793252|NCT02124746|54248381|FG002|Overall Study|Lack of Efficacy|2|||
27793253|NCT02124746|54248379|FG000|Overall Study|Physician Decision|6|||
27937603|NCT00977080|54593938|FG000|Overall Study|Travel for family reasons|1|||
27937604|NCT00977080|54593939|FG001|Overall Study|Travel for family reasons|0|||
27937605|NCT00977080|54593940|FG002|Overall Study|Travel for family reasons|0|||
27793254|NCT02124746|54248380|FG001|Overall Study|Physician Decision|4|||
27793255|NCT02124746|54248381|FG002|Overall Study|Physician Decision|5|||
27937606|NCT00977080|54593941|FG003|Overall Study|Travel for family reasons|0|||
27937607|NCT00975676|54593953|FG000|Overall Study|Baseline samples only, no sample analyzed or only single sample available|6|||
27793256|NCT02124746|54248379|FG000|Overall Study|Non-Compliance with Study Drug|0|||
28105625|NCT04841577|54763124|FG000|Overall Study|Lost to Follow-up|8|||
27793257|NCT02124746|54248380|FG001|Overall Study|Non-Compliance with Study Drug|1|||
27793258|NCT02124746|54248381|FG002|Overall Study|Non-Compliance with Study Drug|0|||
27793259|NCT02124746|54248379|FG000|Overall Study|Withdrawal by Subject|3|||
27793260|NCT02124746|54248380|FG001|Overall Study|Withdrawal by Subject|3|||
27793261|NCT02124746|54248381|FG002|Overall Study|Withdrawal by Subject|0|||
27793262|NCT02124746|54248379|FG000|Overall Study|Study Terminated by Sponsor|0|||
27793263|NCT02124746|54248380|FG001|Overall Study|Study Terminated by Sponsor|0|||
27793264|NCT02124746|54248381|FG002|Overall Study|Study Terminated by Sponsor|6|||
27793265|NCT02124746|54248379|FG000|Overall Study|Disease Progression|3|||
27793266|NCT02124746|54248380|FG001|Overall Study|Disease Progression|6|||
27793267|NCT02124746|54248381|FG002|Overall Study|Disease Progression|4|||
27793268|NCT02123966|54248389|FG000|Overall Study|Intercurrent Illness|1|||
27793269|NCT02123576|54248395|FG000|Overall Study|Adverse Event|1|||
27793270|NCT02123576|54248396|FG001|Overall Study|Adverse Event|0|||
27793271|NCT01177397|54248414|FG000|Overall Study|Protocol Violation|0|||
27793272|NCT01177397|54248415|FG001|Overall Study|Protocol Violation|0|||
27793273|NCT01177397|54248416|FG002|Overall Study|Protocol Violation|0|||
27793274|NCT01177397|54248417|FG003|Overall Study|Protocol Violation|0|||
27793275|NCT01177397|54248418|FG004|Overall Study|Protocol Violation|0|||
27793276|NCT01177397|54248419|FG005|Overall Study|Protocol Violation|1|||
27793277|NCT01177397|54248420|FG006|Overall Study|Protocol Violation|0|||
27793278|NCT01177397|54248421|FG007|Overall Study|Protocol Violation|0|||
27793279|NCT01177397|54248422|FG008|Overall Study|Protocol Violation|0|||
27793280|NCT01177397|54248423|FG009|Overall Study|Protocol Violation|0|||
27793281|NCT01177397|54248424|FG010|Overall Study|Protocol Violation|0|||
27793282|NCT01177397|54248425|FG011|Overall Study|Protocol Violation|0|||
27793283|NCT01177397|54248414|FG000|Overall Study|Lost to Follow-up|0|||
27793284|NCT01177397|54248415|FG001|Overall Study|Lost to Follow-up|0|||
27793285|NCT01177397|54248416|FG002|Overall Study|Lost to Follow-up|0|||
27793286|NCT01177397|54248417|FG003|Overall Study|Lost to Follow-up|0|||
27793287|NCT01177397|54248418|FG004|Overall Study|Lost to Follow-up|1|||
27793288|NCT01177397|54248419|FG005|Overall Study|Lost to Follow-up|0|||
27793289|NCT01177397|54248420|FG006|Overall Study|Lost to Follow-up|0|||
27793290|NCT01177397|54248421|FG007|Overall Study|Lost to Follow-up|2|||
27793291|NCT01177397|54248422|FG008|Overall Study|Lost to Follow-up|0|||
27793292|NCT01177397|54248423|FG009|Overall Study|Lost to Follow-up|0|||
27793293|NCT01177397|54248424|FG010|Overall Study|Lost to Follow-up|0|||
27793294|NCT01177397|54248425|FG011|Overall Study|Lost to Follow-up|0|||
27793295|NCT01177397|54248414|FG000|Overall Study|Death|0|||
27793296|NCT01177397|54248415|FG001|Overall Study|Death|0|||
27793297|NCT01177397|54248416|FG002|Overall Study|Death|1|||
27793298|NCT01177397|54248417|FG003|Overall Study|Death|1|||
27793299|NCT01177397|54248418|FG004|Overall Study|Death|0|||
27793300|NCT01177397|54248419|FG005|Overall Study|Death|0|||
27793301|NCT01177397|54248420|FG006|Overall Study|Death|0|||
27793302|NCT01177397|54248421|FG007|Overall Study|Death|5|||
27793303|NCT01177397|54248422|FG008|Overall Study|Death|2|||
27793304|NCT01177397|54248423|FG009|Overall Study|Death|1|||
27793305|NCT01177397|54248424|FG010|Overall Study|Death|0|||
27793306|NCT01177397|54248425|FG011|Overall Study|Death|0|||
27793307|NCT01177397|54248414|FG000|Overall Study|Withdrawal by Subject|0|||
27793308|NCT01177397|54248415|FG001|Overall Study|Withdrawal by Subject|0|||
27793309|NCT01177397|54248416|FG002|Overall Study|Withdrawal by Subject|1|||
27793310|NCT01177397|54248417|FG003|Overall Study|Withdrawal by Subject|1|||
27793311|NCT01177397|54248418|FG004|Overall Study|Withdrawal by Subject|1|||
27793312|NCT01177397|54248419|FG005|Overall Study|Withdrawal by Subject|2|||
27793313|NCT01177397|54248420|FG006|Overall Study|Withdrawal by Subject|0|||
27793314|NCT01177397|54248421|FG007|Overall Study|Withdrawal by Subject|5|||
27793315|NCT01177397|54248422|FG008|Overall Study|Withdrawal by Subject|9|||
27793316|NCT01177397|54248423|FG009|Overall Study|Withdrawal by Subject|1|||
27793317|NCT01177397|54248424|FG010|Overall Study|Withdrawal by Subject|1|||
27793318|NCT01177397|54248425|FG011|Overall Study|Withdrawal by Subject|0|||
27793319|NCT01177397|54248414|FG000|Overall Study|Adverse Event|0|||
27793320|NCT01177397|54248415|FG001|Overall Study|Adverse Event|0|||
27793321|NCT01177397|54248416|FG002|Overall Study|Adverse Event|1|||
27793322|NCT01177397|54248417|FG003|Overall Study|Adverse Event|2|||
27793323|NCT01177397|54248418|FG004|Overall Study|Adverse Event|0|||
27793324|NCT01177397|54248419|FG005|Overall Study|Adverse Event|12|||
27793325|NCT01177397|54248420|FG006|Overall Study|Adverse Event|1|||
27793326|NCT01177397|54248421|FG007|Overall Study|Adverse Event|14|||
27793327|NCT01177397|54248422|FG008|Overall Study|Adverse Event|8|||
27793328|NCT01177397|54248423|FG009|Overall Study|Adverse Event|6|||
27793329|NCT01177397|54248424|FG010|Overall Study|Adverse Event|3|||
27793330|NCT01177397|54248425|FG011|Overall Study|Adverse Event|7|||
27793331|NCT01177397|54248414|FG000|Overall Study|Disease progression|1|||
27937608|NCT00975676|54593954|FG001|Overall Study|Baseline samples only, no sample analyzed or only single sample available|8|||
27793332|NCT01177397|54248415|FG001|Overall Study|Disease progression|2|||
27793333|NCT01177397|54248416|FG002|Overall Study|Disease progression|5|||
27793334|NCT01177397|54248417|FG003|Overall Study|Disease progression|5|||
27793335|NCT01177397|54248418|FG004|Overall Study|Disease progression|4|||
27793336|NCT01177397|54248419|FG005|Overall Study|Disease progression|10|||
27793337|NCT01177397|54248420|FG006|Overall Study|Disease progression|10|||
27793338|NCT01177397|54248421|FG007|Overall Study|Disease progression|21|||
27793339|NCT01177397|54248422|FG008|Overall Study|Disease progression|18|||
27793340|NCT01177397|54248423|FG009|Overall Study|Disease progression|12|||
27793341|NCT01177397|54248424|FG010|Overall Study|Disease progression|10|||
27793342|NCT01177397|54248425|FG011|Overall Study|Disease progression|8|||
27793343|NCT01177397|54248414|FG000|Overall Study|Other reasons|0|||
27793344|NCT01177397|54248415|FG001|Overall Study|Other reasons|0|||
27793345|NCT01177397|54248416|FG002|Overall Study|Other reasons|1|||
27793346|NCT01177397|54248417|FG003|Overall Study|Other reasons|0|||
27793347|NCT01177397|54248418|FG004|Overall Study|Other reasons|1|||
27793348|NCT01177397|54248419|FG005|Overall Study|Other reasons|1|||
27793349|NCT01177397|54248420|FG006|Overall Study|Other reasons|2|||
27842578|NCT01549964|54331172|FG003|24-Week Treatment Period|Lack of Efficacy|1|||
27842579|NCT01549964|54331169|FG000|24-Week Treatment Period|Other|1|||
27842580|NCT01549964|54331170|FG001|24-Week Treatment Period|Other|0|||
27842581|NCT01549964|54331171|FG002|24-Week Treatment Period|Other|1|||
27842582|NCT01549964|54331172|FG003|24-Week Treatment Period|Other|0|||
27842583|NCT01549964|54331169|FG000|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
28105626|NCT04841577|54763125|FG001|Overall Study|Lost to Follow-up|7|||
27793350|NCT01177397|54248421|FG007|Overall Study|Other reasons|6|||
27793351|NCT01177397|54248422|FG008|Overall Study|Other reasons|10|||
27793352|NCT01177397|54248423|FG009|Overall Study|Other reasons|8|||
27793353|NCT01177397|54248424|FG010|Overall Study|Other reasons|0|||
27793354|NCT01177397|54248425|FG011|Overall Study|Other reasons|2|||
27793355|NCT00864227|54248466|FG000|Overall Study|Withdrawal by Subject|1|||
27793356|NCT00864227|54248466|FG000|Overall Study|Disease Relapse/Progression|3|||
27793357|NCT02102204|54248470|FG000|Overall Study|Withdrawal by Subject|137|||
27793358|NCT02102204|54248470|FG000|Overall Study|Death|92|||
27793359|NCT02102204|54248470|FG000|Overall Study|Lost to Follow-up|65|||
27793360|NCT02102204|54248470|FG000|Overall Study|Sponsor Decision|5|||
27793361|NCT02102204|54248470|FG000|Overall Study|Ongoing|5|||
27793362|NCT02141204|54248476|FG000|Overall Study|Lost to Follow-up|2|||
27793363|NCT02141204|54248477|FG001|Overall Study|Lost to Follow-up|1|||
27793364|NCT02141204|54248476|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1|||
27793365|NCT02141204|54248477|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2|||
27793366|NCT02141204|54248476|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
27793367|NCT02141204|54248477|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5|||
27793368|NCT02141204|54248476|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9|||
27793369|NCT02141204|54248477|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7|||
27793370|NCT02140970|54248485|FG000|Overall Study|Lost to Follow-up|1|||
27793371|NCT02140970|54248486|FG001|Overall Study|Lost to Follow-up|2|||
27793372|NCT02140970|54248485|FG000|Overall Study|Misplaced consent, subject withdrawn|1|||
27793373|NCT02140970|54248486|FG001|Overall Study|Misplaced consent, subject withdrawn|0|||
27793374|NCT02140970|54248485|FG000|Overall Study|Did not meet inclusion criteria|0|||
27793375|NCT02140970|54248486|FG001|Overall Study|Did not meet inclusion criteria|1|||
27793376|NCT02101112|54248492|FG000|Overall Study|Adverse Event|0|||
27793377|NCT02101112|54248493|FG001|Overall Study|Adverse Event|0|||
27793378|NCT02101112|54248494|FG002|Overall Study|Adverse Event|1|||
27793379|NCT02101112|54248495|FG003|Overall Study|Adverse Event|0|||
27793380|NCT02101112|54248496|FG004|Overall Study|Adverse Event|0|||
27793381|NCT02101112|54248497|FG005|Overall Study|Adverse Event|0|||
27793382|NCT02101112|54248492|FG000|Overall Study|Withdrawal by Subject|0|||
27793383|NCT02101112|54248493|FG001|Overall Study|Withdrawal by Subject|0|||
27793384|NCT02101112|54248494|FG002|Overall Study|Withdrawal by Subject|0|||
27793385|NCT02101112|54248495|FG003|Overall Study|Withdrawal by Subject|0|||
27793386|NCT02101112|54248496|FG004|Overall Study|Withdrawal by Subject|1|||
27793387|NCT02101112|54248497|FG005|Overall Study|Withdrawal by Subject|0|||
27793388|NCT02139644|54248512|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|70|||
27793389|NCT02139644|54248513|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
27793390|NCT02139644|54248514|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
27793391|NCT02139644|54248515|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
27793392|NCT02139644|54248516|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
27793393|NCT02139644|54248517|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
27793394|NCT02139644|54248512|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|30|||
27793395|NCT02139644|54248513|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
27793396|NCT02139644|54248514|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
27793397|NCT02139644|54248515|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
27793398|NCT02139644|54248516|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
27793399|NCT02139644|54248517|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
27793400|NCT02139644|54248512|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|12|||
27793401|NCT02139644|54248513|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
27793402|NCT02139644|54248514|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
27793403|NCT02139644|54248515|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
27793404|NCT02139644|54248516|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
27842584|NCT01549964|54331170|FG001|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
27793405|NCT02139644|54248517|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
27793406|NCT02139644|54248512|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|11|||
27793407|NCT02139644|54248513|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
27793408|NCT02139644|54248514|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
27793409|NCT02139644|54248515|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
27793410|NCT02139644|54248516|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
27793411|NCT02139644|54248517|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
27793412|NCT02139644|54248512|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|8|||
27793413|NCT02139644|54248513|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
27793414|NCT02139644|54248514|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
27793415|NCT02139644|54248515|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
27793416|NCT02139644|54248516|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
27793417|NCT02139644|54248517|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
27793418|NCT02139644|54248512|FG000|Run-In Period (Pre-assignment)|Adverse Event|3|||
27793419|NCT02139644|54248513|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
27793420|NCT02139644|54248514|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
27793421|NCT02139644|54248515|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
27793422|NCT02139644|54248516|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
27793423|NCT02139644|54248517|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
27793424|NCT02139644|54248512|FG000|Run-In Period (Pre-assignment)|Other|6|||
27793425|NCT02139644|54248513|FG001|Run-In Period (Pre-assignment)|Other|0|||
27793426|NCT02139644|54248514|FG002|Run-In Period (Pre-assignment)|Other|0|||
27793427|NCT02139644|54248515|FG003|Run-In Period (Pre-assignment)|Other|0|||
27793428|NCT02139644|54248516|FG004|Run-In Period (Pre-assignment)|Other|0|||
27793429|NCT02139644|54248517|FG005|Run-In Period (Pre-assignment)|Other|0|||
27793430|NCT02139644|54248512|FG000|Treatment Period|Adverse Event|0|||
27793431|NCT02139644|54248513|FG001|Treatment Period|Adverse Event|0|||
27793432|NCT02139644|54248514|FG002|Treatment Period|Adverse Event|3|||
27793433|NCT02139644|54248515|FG003|Treatment Period|Adverse Event|2|||
27793434|NCT02139644|54248516|FG004|Treatment Period|Adverse Event|1|||
27793435|NCT02139644|54248517|FG005|Treatment Period|Adverse Event|6|||
27793436|NCT02139644|54248512|FG000|Treatment Period|Withdrawal by Subject|0|||
27793437|NCT02139644|54248513|FG001|Treatment Period|Withdrawal by Subject|0|||
27793438|NCT02139644|54248514|FG002|Treatment Period|Withdrawal by Subject|2|||
27793439|NCT02139644|54248515|FG003|Treatment Period|Withdrawal by Subject|2|||
27793440|NCT02139644|54248516|FG004|Treatment Period|Withdrawal by Subject|3|||
27793441|NCT02139644|54248517|FG005|Treatment Period|Withdrawal by Subject|2|||
27793442|NCT02139644|54248512|FG000|Treatment Period|Non-compliance|0|||
27793443|NCT02139644|54248513|FG001|Treatment Period|Non-compliance|0|||
27793444|NCT02139644|54248514|FG002|Treatment Period|Non-compliance|0|||
27793445|NCT02139644|54248515|FG003|Treatment Period|Non-compliance|1|||
27793446|NCT02139644|54248516|FG004|Treatment Period|Non-compliance|0|||
27793447|NCT02139644|54248517|FG005|Treatment Period|Non-compliance|0|||
27793448|NCT02139644|54248512|FG000|Treatment Period|Protocol Violation|0|||
27793449|NCT02139644|54248513|FG001|Treatment Period|Protocol Violation|0|||
27793450|NCT02139644|54248514|FG002|Treatment Period|Protocol Violation|0|||
27793451|NCT02139644|54248515|FG003|Treatment Period|Protocol Violation|1|||
27793452|NCT02139644|54248516|FG004|Treatment Period|Protocol Violation|1|||
27793453|NCT02139644|54248517|FG005|Treatment Period|Protocol Violation|1|||
27793454|NCT02139644|54248512|FG000|Treatment Period|Disease progression|0|||
27793455|NCT02139644|54248513|FG001|Treatment Period|Disease progression|0|||
27793456|NCT02139644|54248514|FG002|Treatment Period|Disease progression|0|||
27793457|NCT02139644|54248515|FG003|Treatment Period|Disease progression|1|||
27793458|NCT02139644|54248516|FG004|Treatment Period|Disease progression|1|||
27793459|NCT02139644|54248517|FG005|Treatment Period|Disease progression|2|||
27793460|NCT02139644|54248512|FG000|Treatment Period|Lost to Follow-up|0|||
27793461|NCT02139644|54248513|FG001|Treatment Period|Lost to Follow-up|0|||
27793462|NCT02139644|54248514|FG002|Treatment Period|Lost to Follow-up|1|||
27793463|NCT02139644|54248515|FG003|Treatment Period|Lost to Follow-up|1|||
27793464|NCT02139644|54248516|FG004|Treatment Period|Lost to Follow-up|1|||
27793465|NCT02139644|54248517|FG005|Treatment Period|Lost to Follow-up|1|||
27793466|NCT02139644|54248512|FG000|Treatment Period|Lack of Efficacy|0|||
27793467|NCT02139644|54248513|FG001|Treatment Period|Lack of Efficacy|0|||
27793468|NCT02139644|54248514|FG002|Treatment Period|Lack of Efficacy|1|||
27793469|NCT02139644|54248515|FG003|Treatment Period|Lack of Efficacy|0|||
27937609|NCT00975286|54593967|FG000|Overall Study|Adverse Event|9|||
27937610|NCT00975286|54593968|FG001|Overall Study|Adverse Event|19|||
27793470|NCT02139644|54248516|FG004|Treatment Period|Lack of Efficacy|1|||
27793471|NCT02139644|54248517|FG005|Treatment Period|Lack of Efficacy|4|||
27793472|NCT02139644|54248512|FG000|Treatment Period|Other|0|||
27793473|NCT02139644|54248513|FG001|Treatment Period|Other|3|||
27793474|NCT02139644|54248514|FG002|Treatment Period|Other|1|||
27793475|NCT02139644|54248515|FG003|Treatment Period|Other|1|||
27793476|NCT02139644|54248516|FG004|Treatment Period|Other|0|||
27793477|NCT02139644|54248517|FG005|Treatment Period|Other|1|||
27937611|NCT00975286|54593967|FG000|Overall Study|Protocol Violation|1|||
27793478|NCT02100644|54248529|FG000|LTG Escalation Phase|Adverse Event|9|||
27793479|NCT02100644|54248530|FG001|LTG Escalation Phase|Adverse Event|0|||
27793480|NCT02100644|54248531|FG002|LTG Escalation Phase|Adverse Event|0|||
27793481|NCT02100644|54248529|FG000|LTG Escalation Phase|Protocol-defined Stopping Criteria|1|||
27793482|NCT02100644|54248530|FG001|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
27793483|NCT02100644|54248531|FG002|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
27793484|NCT02100644|54248529|FG000|LTG Escalation Phase|Withdrawal by Subject|3|||
27793485|NCT02100644|54248530|FG001|LTG Escalation Phase|Withdrawal by Subject|0|||
27793486|NCT02100644|54248531|FG002|LTG Escalation Phase|Withdrawal by Subject|0|||
27793487|NCT02074982|54248537|FG000|Overall Study|Adverse Event|15|||
27793488|NCT02074982|54248538|FG001|Overall Study|Adverse Event|7|||
27793489|NCT02074982|54248537|FG000|Overall Study|Lack of Efficacy|6|||
27793490|NCT02074982|54248538|FG001|Overall Study|Lack of Efficacy|1|||
27793491|NCT02074982|54248537|FG000|Overall Study|Lost to Follow-up|9|||
27793492|NCT02074982|54248538|FG001|Overall Study|Lost to Follow-up|10|||
27793493|NCT02074982|54248537|FG000|Overall Study|Non-compliance with study treatment|0|||
27793494|NCT02074982|54248538|FG001|Overall Study|Non-compliance with study treatment|2|||
27793495|NCT02074982|54248537|FG000|Overall Study|Physician Decision|1|||
27793496|NCT02074982|54248538|FG001|Overall Study|Physician Decision|1|||
27793497|NCT02074982|54248537|FG000|Overall Study|Pregnancy|1|||
27793498|NCT02074982|54248538|FG001|Overall Study|Pregnancy|2|||
27793499|NCT02074982|54248537|FG000|Overall Study|Protocol deviation|4|||
27793500|NCT02074982|54248538|FG001|Overall Study|Protocol deviation|3|||
27793501|NCT02074982|54248537|FG000|Overall Study|Technical problems|0|||
27793502|NCT02074982|54248538|FG001|Overall Study|Technical problems|2|||
27793503|NCT02074982|54248537|FG000|Overall Study|Subject/guardian decision|15|||
27793504|NCT02074982|54248538|FG001|Overall Study|Subject/guardian decision|24|||
27793505|NCT02074982|54248537|FG000|Overall Study|Death|0|||
27793506|NCT02074982|54248538|FG001|Overall Study|Death|2|||
27793507|NCT02074514|54248548|FG000|Overall Study|Lack of Efficacy|3|||
27793508|NCT02074514|54248549|FG001|Overall Study|Lack of Efficacy|2|||
27793509|NCT02074514|54248548|FG000|Overall Study|Lost to Follow-up|0|||
27793510|NCT02074514|54248549|FG001|Overall Study|Lost to Follow-up|1|||
27793511|NCT02074514|54248548|FG000|Overall Study|Withdrew Consent|0|||
27793512|NCT02074514|54248549|FG001|Overall Study|Withdrew Consent|1|||
27793513|NCT02099708|54248559|FG000|Overall Study|Data Not Available|30|||
27793514|NCT02099708|54248559|FG000|Overall Study|Lost to Follow-up|141|||
27793515|NCT02099708|54248559|FG000|Overall Study|Other|29|||
27793516|NCT02073656|54248563|FG000|Primary Study|Lost to Follow-up|6|||
27793517|NCT02073656|54248563|FG000|Primary Study|Death|1|||
27793518|NCT02073656|54248563|FG000|Primary Study|Withdrew Consent|1|||
27937612|NCT00975286|54593968|FG001|Overall Study|Protocol Violation|2|||
27937613|NCT00975286|54593967|FG000|Overall Study|Withdrawal by Subject|0|||
27937614|NCT00975286|54593968|FG001|Overall Study|Withdrawal by Subject|2|||
27937615|NCT00975286|54593967|FG000|Overall Study|Familial and Personal Reasons|2|||
27937616|NCT00975286|54593968|FG001|Overall Study|Familial and Personal Reasons|2|||
27937617|NCT00975286|54593967|FG000|Overall Study|Poor Compliance to Protocol|0|||
27937618|NCT00975286|54593968|FG001|Overall Study|Poor Compliance to Protocol|2|||
27937619|NCT00975286|54593967|FG000|Overall Study|Sponsor Decision|0|||
27937620|NCT00975286|54593968|FG001|Overall Study|Sponsor Decision|2|||
27937621|NCT00907777|54593976|FG000|Overall Study|Withdrawal by Subject|0|||
27937622|NCT00907777|54593977|FG001|Overall Study|Withdrawal by Subject|1|||
27937623|NCT00908011|54593985|FG000|Overall Study|Withdrawal by Subject|2|||
27937624|NCT00908011|54593986|FG001|Overall Study|Withdrawal by Subject|2|||
27937625|NCT00976456|54593994|FG000|Overall Study|Adverse Event|17|||
27937626|NCT00976456|54593995|FG001|Overall Study|Adverse Event|22|||
27937627|NCT00976456|54593994|FG000|Overall Study|Death|7|||
27937628|NCT00976456|54593995|FG001|Overall Study|Death|9|||
27937629|NCT00976456|54593994|FG000|Overall Study|Lack of Efficacy|5|||
27793519|NCT02242643|54248571|FG000|Overall Study|Protocol Violation|1|||
27793520|NCT02242643|54248572|FG001|Overall Study|Protocol Violation|2|||
27793521|NCT02242643|54248571|FG000|Overall Study|Withdrawal by Subject|15|||
27793522|NCT02242643|54248572|FG001|Overall Study|Withdrawal by Subject|10|||
27842585|NCT01549964|54331171|FG002|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1|||
27937630|NCT00976456|54593995|FG001|Overall Study|Lack of Efficacy|2|||
27937631|NCT00976456|54593994|FG000|Overall Study|Withdrawal by Subject|3|||
27793523|NCT02242643|54248571|FG000|Overall Study|Migrated/moved from study area|1|||
27793524|NCT02242643|54248572|FG001|Overall Study|Migrated/moved from study area|3|||
27793525|NCT02242643|54248571|FG000|Overall Study|Lost to Follow-up|54|||
27842586|NCT01549964|54331172|FG003|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
27937632|NCT00976456|54593995|FG001|Overall Study|Withdrawal by Subject|1|||
27937633|NCT00976456|54593994|FG000|Overall Study|screening failure, unknown|11|||
27937634|NCT00976456|54593995|FG001|Overall Study|screening failure, unknown|4|||
27793526|NCT02242643|54248572|FG001|Overall Study|Lost to Follow-up|61|||
27793527|NCT02242643|54248571|FG000|Overall Study|Child placed in foster care by family|0|||
27793528|NCT02242643|54248572|FG001|Overall Study|Child placed in foster care by family|1|||
27793529|NCT02242643|54248571|FG000|Overall Study|Non-compliance|1|||
27793530|NCT02242643|54248572|FG001|Overall Study|Non-compliance|0|||
27793531|NCT02242643|54248571|FG000|Overall Study|Consent withdrawal by parent|1|||
27793532|NCT02242643|54248572|FG001|Overall Study|Consent withdrawal by parent|0|||
27793533|NCT02242643|54248571|FG000|Overall Study|Protocol requirements not followed|1|||
27793534|NCT02242643|54248572|FG001|Overall Study|Protocol requirements not followed|0|||
27793535|NCT02242643|54248571|FG000|Overall Study|Language barrier|1|||
27793536|NCT02242643|54248572|FG001|Overall Study|Language barrier|0|||
27793537|NCT02242643|54248571|FG000|Overall Study|Withdrawal by subject at Visit 2|0|||
27793538|NCT02242643|54248572|FG001|Overall Study|Withdrawal by subject at Visit 2|1|||
27793539|NCT02097290|54248580|FG000|Overall Study|Death|6|||
27793540|NCT02097290|54248580|FG000|Overall Study|Total Withdrawals|3|||
27793541|NCT02097290|54248580|FG000|Overall Study|Attempt|8|||
27793542|NCT02072174|54248586|FG000|Overall Study|Did Not Meet In-/Exclusion Criteria|14|||
27793543|NCT02072174|54248587|FG001|Overall Study|Did Not Meet In-/Exclusion Criteria|15|||
27793544|NCT02072174|54248586|FG000|Overall Study|Protocol Violation|16|||
27793545|NCT02072174|54248587|FG001|Overall Study|Protocol Violation|23|||
27793546|NCT02072174|54248586|FG000|Overall Study|Physician Decision|0|||
27793547|NCT02072174|54248587|FG001|Overall Study|Physician Decision|1|||
27793548|NCT02072174|54248586|FG000|Overall Study|Non-compliance with protocol requirement|2|||
27793549|NCT02072174|54248587|FG001|Overall Study|Non-compliance with protocol requirement|0|||
27793550|NCT02209181|54248599|FG000|Overall Study|Adverse Event|1|||
27793551|NCT02209181|54248600|FG001|Overall Study|Adverse Event|0|||
27793552|NCT02209181|54248601|FG002|Overall Study|Adverse Event|1|||
27793553|NCT02209181|54248602|FG003|Overall Study|Adverse Event|0|||
27793554|NCT02209181|54248599|FG000|Overall Study|Withdrawal by Subject|0|||
27793555|NCT02209181|54248600|FG001|Overall Study|Withdrawal by Subject|1|||
27793556|NCT02209181|54248601|FG002|Overall Study|Withdrawal by Subject|0|||
27793557|NCT02209181|54248602|FG003|Overall Study|Withdrawal by Subject|0|||
27793558|NCT02208089|54248614|FG000|Overall Study|Withdrawal by Subject|1|||
27793559|NCT02208089|54248615|FG001|Overall Study|Withdrawal by Subject|0|||
27793560|NCT02208089|54248614|FG000|Overall Study|Lost to Follow-up|6|||
27793561|NCT02208089|54248615|FG001|Overall Study|Lost to Follow-up|0|||
27793562|NCT02242487|54248624|FG000|Overall Study|Adverse Event|13|||
27793563|NCT02242487|54248625|FG001|Overall Study|Adverse Event|15|||
27793564|NCT02242487|54248624|FG000|Overall Study|Lack of Efficacy|4|||
27793565|NCT02242487|54248625|FG001|Overall Study|Lack of Efficacy|6|||
27793566|NCT02242487|54248624|FG000|Overall Study|Protocol Violation|2|||
27793567|NCT02242487|54248625|FG001|Overall Study|Protocol Violation|0|||
27793568|NCT02242487|54248624|FG000|Overall Study|Lost to Follow-up|2|||
27793569|NCT02242487|54248625|FG001|Overall Study|Lost to Follow-up|1|||
27793570|NCT02242487|54248624|FG000|Overall Study|Other - Miscellaneous|4|||
27793571|NCT02242487|54248625|FG001|Overall Study|Other - Miscellaneous|6|||
27793572|NCT02242487|54248624|FG000|Overall Study|Withdrawal by Subject|37|||
27793573|NCT02242487|54248625|FG001|Overall Study|Withdrawal by Subject|19|||
27793574|NCT02241785|54248633|FG000|Overall Study|Sponsor Termination|43|||
27793575|NCT02241785|54248633|FG000|Overall Study|Withdrawal by Subject|1|||
27793576|NCT02241785|54248633|FG000|Overall Study|Lost to Follow-up|2|||
27793577|NCT02241785|54248633|FG000|Overall Study|Adverse Event|1|||
27793578|NCT02241551|54248639|FG000|Overall Study|Adverse Event|1|||
27793579|NCT02241551|54248640|FG001|Overall Study|Adverse Event|0|||
27793580|NCT02207621|54248651|FG000|Overall Study|Adverse Event|71|||
27793581|NCT02207621|54248652|FG001|Overall Study|Adverse Event|15|||
27793582|NCT02207621|54248653|FG002|Overall Study|Adverse Event|132|||
27793583|NCT02207621|54248651|FG000|Overall Study|Withdrawal by Subject|9|||
27793584|NCT02207621|54248652|FG001|Overall Study|Withdrawal by Subject|9|||
27793585|NCT02207621|54248653|FG002|Overall Study|Withdrawal by Subject|13|||
27793586|NCT02207621|54248651|FG000|Overall Study|Non-Compliant|3|||
27793587|NCT02207621|54248652|FG001|Overall Study|Non-Compliant|3|||
27793588|NCT02207621|54248653|FG002|Overall Study|Non-Compliant|1|||
27793589|NCT02207621|54248651|FG000|Overall Study|Lost to Follow-up|1|||
27793590|NCT02207621|54248652|FG001|Overall Study|Lost to Follow-up|0|||
27793591|NCT02207621|54248653|FG002|Overall Study|Lost to Follow-up|3|||
27793592|NCT02207621|54248651|FG000|Overall Study|Lack of Efficacy|10|||
27793593|NCT02207621|54248652|FG001|Overall Study|Lack of Efficacy|2|||
27793594|NCT02207621|54248653|FG002|Overall Study|Lack of Efficacy|4|||
27793595|NCT02207621|54248651|FG000|Overall Study|Disallowed Concurrent Medication|2|||
27793596|NCT02207621|54248652|FG001|Overall Study|Disallowed Concurrent Medication|5|||
27793597|NCT02207621|54248653|FG002|Overall Study|Disallowed Concurrent Medication|2|||
27793598|NCT02207621|54248651|FG000|Overall Study|Physician Decision|1|||
27793599|NCT02207621|54248652|FG001|Overall Study|Physician Decision|2|||
27793600|NCT02207621|54248653|FG002|Overall Study|Physician Decision|2|||
27793601|NCT02207621|54248651|FG000|Overall Study|Protocol Violation|4|||
27793602|NCT02207621|54248652|FG001|Overall Study|Protocol Violation|10|||
27793603|NCT02207621|54248653|FG002|Overall Study|Protocol Violation|6|||
27793604|NCT02207621|54248651|FG000|Overall Study|Death|2|||
27793605|NCT02207621|54248652|FG001|Overall Study|Death|0|||
27793606|NCT02207621|54248653|FG002|Overall Study|Death|0|||
27793607|NCT02207621|54248651|FG000|Overall Study|Other(Site,Sponsor and Subject request)|2|||
27793608|NCT02207621|54248652|FG001|Overall Study|Other(Site,Sponsor and Subject request)|1|||
27793609|NCT02207621|54248653|FG002|Overall Study|Other(Site,Sponsor and Subject request)|5|||
27793610|NCT02240693|54248667|FG000|Overall Study|Adverse Event|0|||
27793611|NCT02240693|54248668|FG001|Overall Study|Adverse Event|0|||
27793612|NCT02240693|54248669|FG002|Overall Study|Adverse Event|0|||
27793613|NCT02240693|54248670|FG003|Overall Study|Adverse Event|0|||
27793614|NCT02240693|54248671|FG004|Overall Study|Adverse Event|1|||
27793615|NCT02240693|54248667|FG000|Overall Study|Withdrawal by Subject|0|||
27793616|NCT02240693|54248668|FG001|Overall Study|Withdrawal by Subject|0|||
27793617|NCT02240693|54248669|FG002|Overall Study|Withdrawal by Subject|2|||
27793618|NCT02240693|54248670|FG003|Overall Study|Withdrawal by Subject|1|||
27793619|NCT02240693|54248671|FG004|Overall Study|Withdrawal by Subject|0|||
27793620|NCT02240693|54248667|FG000|Overall Study|Other than specified|0|||
27793621|NCT02240693|54248668|FG001|Overall Study|Other than specified|0|||
27793622|NCT02240693|54248669|FG002|Overall Study|Other than specified|2|||
27793623|NCT02240693|54248670|FG003|Overall Study|Other than specified|0|||
27793624|NCT02240693|54248671|FG004|Overall Study|Other than specified|0|||
27793625|NCT02239679|54248688|FG000|Overall Study|Lost to Follow-up|1|||
27793626|NCT02239679|54248689|FG001|Overall Study|Lost to Follow-up|0|||
27793627|NCT02239679|54248690|FG002|Overall Study|Lost to Follow-up|0|||
27793628|NCT02239679|54248688|FG000|Overall Study|Withdrawal by Subject|2|||
27793629|NCT02239679|54248689|FG001|Overall Study|Withdrawal by Subject|3|||
27793630|NCT02239679|54248690|FG002|Overall Study|Withdrawal by Subject|1|||
27793631|NCT02072096|54248700|FG000|Overall Study|Lack of Efficacy|18|||
27793632|NCT02072096|54248701|FG001|Overall Study|Lack of Efficacy|29|||
27793633|NCT02072096|54248700|FG000|Overall Study|Protocol Violation|7|||
27793634|NCT02072096|54248701|FG001|Overall Study|Protocol Violation|7|||
27793635|NCT02072096|54248700|FG000|Overall Study|Withdrawal by Subject|5|||
27793636|NCT02072096|54248701|FG001|Overall Study|Withdrawal by Subject|7|||
27793637|NCT02072096|54248700|FG000|Overall Study|Adverse Event|5|||
27793638|NCT02072096|54248701|FG001|Overall Study|Adverse Event|2|||
27793639|NCT02072096|54248700|FG000|Overall Study|No Reason Provided|4|||
27793640|NCT02072096|54248701|FG001|Overall Study|No Reason Provided|2|||
27793641|NCT02072096|54248700|FG000|Overall Study|Death|2|||
27793642|NCT02072096|54248701|FG001|Overall Study|Death|0|||
27793643|NCT02072096|54248700|FG000|Overall Study|Physician Decision|0|||
27793644|NCT02072096|54248701|FG001|Overall Study|Physician Decision|1|||
27793645|NCT02072096|54248700|FG000|Overall Study|Study Terminated by Sponsor|43|||
27793646|NCT02072096|54248701|FG001|Overall Study|Study Terminated by Sponsor|30|||
27793647|NCT02072096|54248700|FG000|Overall Study|Lost to Follow-up|1|||
27793648|NCT02072096|54248701|FG001|Overall Study|Lost to Follow-up|0|||
27793649|NCT02071706|54248708|FG000|Overall Study|Adverse Event|1|||
27793650|NCT02071706|54248708|FG000|Overall Study|Withdrawal by Subject|2|||
27793651|NCT01631825|54248712|FG000|Overall Study|Adverse Event|42|||
27793652|NCT01631825|54248712|FG000|Overall Study|Lack of Efficacy|7|||
27793653|NCT01631825|54248712|FG000|Overall Study|Withdrawal by Subject|9|||
27793654|NCT01631825|54248712|FG000|Overall Study|Protocol Violation|4|||
27793655|NCT01631825|54248712|FG000|Overall Study|Discontinuation criteria|1|||
27793656|NCT01631825|54248712|FG000|Overall Study|Physician Decision|2|||
27793657|NCT02071082|54248718|FG000|Overall Study|Enrolled and Never Treated|1|||
27793658|NCT02071082|54248719|FG001|Overall Study|Enrolled and Never Treated|1|||
27793659|NCT02071082|54248718|FG000|Overall Study|Adverse Event|0|||
27793660|NCT02071082|54248719|FG001|Overall Study|Adverse Event|1|||
27793661|NCT02071082|54248718|FG000|Overall Study|Withdrew Consent|0|||
27793662|NCT02071082|54248719|FG001|Overall Study|Withdrew Consent|4|||
27793663|NCT02071082|54248718|FG000|Overall Study|Lost to Follow-up|1|||
27793664|NCT02071082|54248719|FG001|Overall Study|Lost to Follow-up|1|||
27793665|NCT02123108|54248727|FG000|Overall Study|Death|2|||
27793666|NCT02123108|54248728|FG001|Overall Study|Death|3|||
27793667|NCT02121392|54248736|FG000|Prior to Intervention|Protocol Violation|40|||
27793668|NCT02121392|54248737|FG001|Prior to Intervention|Protocol Violation|35|||
27793669|NCT02121392|54248736|FG000|Prior to Intervention|Withdrawal by Subject|8|||
27793670|NCT02121392|54248737|FG001|Prior to Intervention|Withdrawal by Subject|6|||
27793671|NCT02121392|54248736|FG000|After Placement of AC Block vs Sham|Protocol Violation|3|||
27793672|NCT02121392|54248737|FG001|After Placement of AC Block vs Sham|Protocol Violation|2|||
27793673|NCT02121392|54248736|FG000|After Placement of AC Block vs Sham|Lost to Follow-up|0|||
27793674|NCT02121392|54248737|FG001|After Placement of AC Block vs Sham|Lost to Follow-up|1|||
27793675|NCT02097056|54248743|FG000|Overall Study|Protocol Violation|2|||
27793676|NCT02097056|54248743|FG000|Overall Study|Withdrawal by Subject|15|||
27793677|NCT02097056|54248743|FG000|Overall Study|Lost to Follow-up|2|||
27793678|NCT02097056|54248743|FG000|Overall Study|Adverse Event|37|||
27793679|NCT02097056|54248743|FG000|Overall Study|Other|2|||
27793680|NCT02121002|54248750|FG000|Overall Study|Physician Decision|2|||
27793681|NCT02121002|54248751|FG001|Overall Study|Physician Decision|0|||
27793682|NCT02121002|54248752|FG002|Overall Study|Physician Decision|0|||
27793683|NCT02121002|54248750|FG000|Overall Study|Withdrawal by Subject|3|||
27793684|NCT02121002|54248751|FG001|Overall Study|Withdrawal by Subject|1|||
27793685|NCT02121002|54248752|FG002|Overall Study|Withdrawal by Subject|4|||
27793686|NCT02121002|54248750|FG000|Overall Study|Protocol Violation|1|||
27793687|NCT02121002|54248751|FG001|Overall Study|Protocol Violation|2|||
27937635|NCT01243151|54594006|FG000|Overall Study|Adverse Event|0|||
27937636|NCT01243151|54594007|FG001|Overall Study|Adverse Event|1|||
28105627|NCT04841577|54763124|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
27793688|NCT02121002|54248752|FG002|Overall Study|Protocol Violation|4|||
27793689|NCT02121002|54248750|FG000|Overall Study|Concomitant therapy|0|||
27793690|NCT02121002|54248751|FG001|Overall Study|Concomitant therapy|1|||
27793691|NCT02121002|54248752|FG002|Overall Study|Concomitant therapy|1|||
27793692|NCT02121002|54248750|FG000|Overall Study|Others|1|||
27793693|NCT02121002|54248751|FG001|Overall Study|Others|0|||
27793694|NCT02121002|54248752|FG002|Overall Study|Others|1|||
27793695|NCT02096900|54248762|FG000|Overall Study|Did not receive medication|3|||
27793696|NCT02096900|54248763|FG001|Overall Study|Did not receive medication|1|||
27793697|NCT02096900|54248762|FG000|Overall Study|Surgery cancelled- medication received|1|||
27793698|NCT02096900|54248763|FG001|Overall Study|Surgery cancelled- medication received|1|||
27793699|NCT02120924|54248772|FG000|Overall Study|Lack of Efficacy|1|||
27793700|NCT02120924|54248773|FG001|Overall Study|Lack of Efficacy|2|||
27793701|NCT02120924|54248774|FG002|Overall Study|Lack of Efficacy|3|||
27793702|NCT02120924|54248772|FG000|Overall Study|Adverse Event|0|||
27793703|NCT02120924|54248773|FG001|Overall Study|Adverse Event|1|||
27793704|NCT02120924|54248774|FG002|Overall Study|Adverse Event|3|||
27793705|NCT02120924|54248772|FG000|Overall Study|Withdrawal by Subject|16|||
27793706|NCT02120924|54248773|FG001|Overall Study|Withdrawal by Subject|20|||
27793707|NCT02120924|54248774|FG002|Overall Study|Withdrawal by Subject|8|||
27793708|NCT02120924|54248772|FG000|Overall Study|Lost to Follow-up|14|||
27793709|NCT02120924|54248773|FG001|Overall Study|Lost to Follow-up|14|||
27793710|NCT02120924|54248774|FG002|Overall Study|Lost to Follow-up|11|||
27793711|NCT02120924|54248772|FG000|Overall Study|Pregnancy|2|||
27793712|NCT02120924|54248773|FG001|Overall Study|Pregnancy|0|||
27793713|NCT02120924|54248774|FG002|Overall Study|Pregnancy|0|||
27793714|NCT02120924|54248772|FG000|Overall Study|Protocol Violation|3|||
27793715|NCT02120924|54248773|FG001|Overall Study|Protocol Violation|7|||
27793716|NCT02120924|54248774|FG002|Overall Study|Protocol Violation|2|||
27793717|NCT02120924|54248772|FG000|Overall Study|Physician Decision|0|||
27793718|NCT02120924|54248773|FG001|Overall Study|Physician Decision|1|||
27793719|NCT02120924|54248774|FG002|Overall Study|Physician Decision|1|||
27793720|NCT02120924|54248772|FG000|Overall Study|Death|1|||
27793721|NCT02120924|54248773|FG001|Overall Study|Death|0|||
27793722|NCT02120924|54248774|FG002|Overall Study|Death|0|||
27793723|NCT02120924|54248772|FG000|Overall Study|Compliance with IP|5|||
27793724|NCT02120924|54248773|FG001|Overall Study|Compliance with IP|1|||
27793725|NCT02120924|54248774|FG002|Overall Study|Compliance with IP|1|||
27793726|NCT02096744|54248783|FG000|Treatment Period 1(7 Days)|Accidental early removal of the patch|0|||
27793727|NCT02096744|54248784|FG001|Treatment Period 1(7 Days)|Accidental early removal of the patch|1|||
27793728|NCT02096744|54248783|FG000|Treatment Period 1(7 Days)|Non compliance with the site rule|1|||
27793729|NCT02096744|54248784|FG001|Treatment Period 1(7 Days)|Non compliance with the site rule|0|||
27793730|NCT02096744|54248783|FG000|Treatment Period 3 (7 Days)|Withdrawal by Subject|0|||
27793731|NCT02096744|54248784|FG001|Treatment Period 3 (7 Days)|Withdrawal by Subject|1|||
27793732|NCT02096042|54248792|FG000|Overall Study|Disease Progression|1|||
27793733|NCT02096042|54248793|FG001|Overall Study|Disease Progression|0|||
27793734|NCT02096042|54248794|FG002|Overall Study|Disease Progression|0|||
27793735|NCT02120456|54248810|FG000|Part 2 Double-blind Phase|Lost to Follow-up|0|||
27793736|NCT02120456|54248811|FG001|Part 2 Double-blind Phase|Lost to Follow-up|0|||
27793737|NCT02120456|54248812|FG002|Part 2 Double-blind Phase|Lost to Follow-up|0|||
27793738|NCT02120456|54248813|FG003|Part 2 Double-blind Phase|Lost to Follow-up|0|||
27793739|NCT02120456|54248814|FG004|Part 2 Double-blind Phase|Lost to Follow-up|0|||
27793740|NCT02120456|54248815|FG005|Part 2 Double-blind Phase|Lost to Follow-up|0|||
27793741|NCT02120456|54248816|FG006|Part 2 Double-blind Phase|Lost to Follow-up|1|||
27793742|NCT02120456|54248817|FG007|Part 2 Double-blind Phase|Lost to Follow-up|0|||
27793743|NCT02120456|54248818|FG008|Part 2 Double-blind Phase|Lost to Follow-up|0|||
27793744|NCT02120456|54248810|FG000|Part 2 Double-blind Phase|Withdrawal of consent|0|||
27793745|NCT02120456|54248811|FG001|Part 2 Double-blind Phase|Withdrawal of consent|0|||
27793746|NCT02120456|54248812|FG002|Part 2 Double-blind Phase|Withdrawal of consent|0|||
27793747|NCT02120456|54248813|FG003|Part 2 Double-blind Phase|Withdrawal of consent|0|||
27793748|NCT02120456|54248814|FG004|Part 2 Double-blind Phase|Withdrawal of consent|0|||
27793749|NCT02120456|54248815|FG005|Part 2 Double-blind Phase|Withdrawal of consent|0|||
27793750|NCT02120456|54248816|FG006|Part 2 Double-blind Phase|Withdrawal of consent|1|||
27793751|NCT02120456|54248817|FG007|Part 2 Double-blind Phase|Withdrawal of consent|0|||
27793752|NCT02120456|54248818|FG008|Part 2 Double-blind Phase|Withdrawal of consent|0|||
27793753|NCT02120456|54248810|FG000|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
27793754|NCT02120456|54248811|FG001|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
27793755|NCT02120456|54248812|FG002|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
27937637|NCT01243151|54594008|FG002|Overall Study|Adverse Event|0|||
27793756|NCT02120456|54248813|FG003|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
27793757|NCT02120456|54248814|FG004|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
27793758|NCT02120456|54248815|FG005|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
27793759|NCT02120456|54248816|FG006|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
27793760|NCT02120456|54248817|FG007|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
27793761|NCT02120456|54248818|FG008|Part 2 Double-blind Phase|Unable to attend visit due to work|1|||
27793762|NCT02120300|54248842|FG000|Overall Study|Enrolled but Never Treated|2|||
27793763|NCT02120300|54248843|FG001|Overall Study|Enrolled but Never Treated|0|||
27793764|NCT02120300|54248844|FG002|Overall Study|Enrolled but Never Treated|0|||
27793765|NCT02120300|54248845|FG003|Overall Study|Enrolled but Never Treated|0|||
27793766|NCT02120300|54248842|FG000|Overall Study|Lack of Efficacy|0|||
27793767|NCT02120300|54248843|FG001|Overall Study|Lack of Efficacy|0|||
27793768|NCT02120300|54248844|FG002|Overall Study|Lack of Efficacy|0|||
27793769|NCT02120300|54248845|FG003|Overall Study|Lack of Efficacy|1|||
27793770|NCT02120300|54248842|FG000|Overall Study|Lost to Follow-up|1|||
27793771|NCT02120300|54248843|FG001|Overall Study|Lost to Follow-up|0|||
27793772|NCT02120300|54248844|FG002|Overall Study|Lost to Follow-up|0|||
27793773|NCT02120300|54248845|FG003|Overall Study|Lost to Follow-up|0|||
27793774|NCT02070380|54248861|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|0|||
27793775|NCT02070380|54248862|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|5|||
27793776|NCT02070380|54248863|FG002|Washout (no Second Injection/MRI)|Withdrawal by Subject|2|||
27793777|NCT02070380|54248864|FG003|Washout (no Second Injection/MRI)|Withdrawal by Subject|3|||
27793778|NCT02070380|54248861|FG000|Second Injection|Image sets missing or technically inadeq|0|||
27793779|NCT02070380|54248862|FG001|Second Injection|Image sets missing or technically inadeq|1|||
27793780|NCT02070380|54248863|FG002|Second Injection|Image sets missing or technically inadeq|0|||
27793781|NCT02070380|54248864|FG003|Second Injection|Image sets missing or technically inadeq|0|||
27793782|NCT02070380|54248861|FG000|Second Injection|Protocol Violation|0|||
27793783|NCT02070380|54248862|FG001|Second Injection|Protocol Violation|1|||
27793784|NCT02070380|54248863|FG002|Second Injection|Protocol Violation|1|||
27793785|NCT02070380|54248864|FG003|Second Injection|Protocol Violation|5|||
27793786|NCT02069366|54248882|FG000|Overall Study|Lost to Follow-up|0|||
27793787|NCT02069366|54248883|FG001|Overall Study|Lost to Follow-up|0|||
27793788|NCT02069366|54248884|FG002|Overall Study|Lost to Follow-up|1|||
27793789|NCT02069366|54248885|FG003|Overall Study|Lost to Follow-up|0|||
27793790|NCT02069366|54248886|FG004|Overall Study|Lost to Follow-up|0|||
27793791|NCT02069366|54248887|FG005|Overall Study|Lost to Follow-up|2|||
27793792|NCT02069366|54248882|FG000|Overall Study|Protocol Violation|0|||
27793793|NCT02069366|54248883|FG001|Overall Study|Protocol Violation|0|||
27793794|NCT02069366|54248884|FG002|Overall Study|Protocol Violation|1|||
27793795|NCT02069366|54248885|FG003|Overall Study|Protocol Violation|0|||
27793796|NCT02069366|54248886|FG004|Overall Study|Protocol Violation|0|||
27793797|NCT02069366|54248887|FG005|Overall Study|Protocol Violation|0|||
27793798|NCT02069366|54248882|FG000|Overall Study|Withdrawal by Subject|1|||
27793799|NCT02069366|54248883|FG001|Overall Study|Withdrawal by Subject|0|||
27793800|NCT02069366|54248884|FG002|Overall Study|Withdrawal by Subject|1|||
27793801|NCT02069366|54248885|FG003|Overall Study|Withdrawal by Subject|2|||
27793802|NCT02069366|54248886|FG004|Overall Study|Withdrawal by Subject|0|||
27793803|NCT02069366|54248887|FG005|Overall Study|Withdrawal by Subject|0|||
27793804|NCT02068508|54248902|FG000|Overall Study|Case report forms uncollected|27|||
27793805|NCT02068508|54248902|FG000|Overall Study|Patient did not visit the study site|1|||
27793806|NCT02068508|54248902|FG000|Overall Study|Protocol Violation|4|||
27793807|NCT02068352|54248909|FG000|Overall Study|Lost to Follow-up|0|||
27793808|NCT02068352|54248910|FG001|Overall Study|Lost to Follow-up|2|||
27793809|NCT02068352|54248911|FG002|Overall Study|Lost to Follow-up|0|||
27793810|NCT02068352|54248909|FG000|Overall Study|Adverse Event|4|||
27793811|NCT02068352|54248910|FG001|Overall Study|Adverse Event|2|||
27793812|NCT02068352|54248911|FG002|Overall Study|Adverse Event|7|||
27793813|NCT02068352|54248909|FG000|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
27793814|NCT02068352|54248910|FG001|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|1|||
27793815|NCT02068352|54248911|FG002|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
27793816|NCT02068352|54248909|FG000|Overall Study|Participant Withdrew Consent to Participate|6|||
27793817|NCT02068352|54248910|FG001|Overall Study|Participant Withdrew Consent to Participate|3|||
27793818|NCT02068352|54248911|FG002|Overall Study|Participant Withdrew Consent to Participate|1|||
27793819|NCT02068352|54248909|FG000|Overall Study|Protocol Deviation|0|||
27793820|NCT02068352|54248910|FG001|Overall Study|Protocol Deviation|0|||
27793821|NCT02068352|54248911|FG002|Overall Study|Protocol Deviation|1|||
27793822|NCT02207231|54248922|FG000|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
27793823|NCT02207231|54248923|FG001|Placebo Controlled Period: Week 0 - 16|Adverse Event|4|||
27793824|NCT02207231|54248924|FG002|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
27793825|NCT02207231|54248925|FG003|Placebo Controlled Period: Week 0 - 16|Adverse Event|0|||
27793826|NCT02207231|54248922|FG000|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2|||
27937638|NCT01243151|54594009|FG003|Overall Study|Adverse Event|0|||
27793827|NCT02207231|54248923|FG001|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
27793828|NCT02207231|54248924|FG002|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1|||
27793829|NCT02207231|54248925|FG003|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
27793830|NCT02207231|54248922|FG000|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
27793831|NCT02207231|54248923|FG001|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
27793832|NCT02207231|54248924|FG002|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
27793833|NCT02207231|54248925|FG003|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0|||
27842587|NCT01549964|54331169|FG000|24-Week Treatment Period|Randomized but Not Treated|0|||
27842588|NCT01549964|54331170|FG001|24-Week Treatment Period|Randomized but Not Treated|0|||
27842589|NCT01549964|54331171|FG002|24-Week Treatment Period|Randomized but Not Treated|0|||
27842590|NCT01549964|54331172|FG003|24-Week Treatment Period|Randomized but Not Treated|1|||
27842591|NCT01549964|54331169|FG000|24-Week Treatment Period|Completion Status Unknown|1|||
27842592|NCT01549964|54331170|FG001|24-Week Treatment Period|Completion Status Unknown|0|||
27842593|NCT01549964|54331171|FG002|24-Week Treatment Period|Completion Status Unknown|1|||
27842594|NCT01549964|54331172|FG003|24-Week Treatment Period|Completion Status Unknown|0|||
27842595|NCT01549964|54331169|FG000|80-Week Extension Period|Pregnancy|0|||
27842596|NCT01549964|54331170|FG001|80-Week Extension Period|Pregnancy|0|||
27842597|NCT01549964|54331171|FG002|80-Week Extension Period|Pregnancy|1|||
27842598|NCT01549964|54331172|FG003|80-Week Extension Period|Pregnancy|0|||
27842599|NCT01549964|54331169|FG000|80-Week Extension Period|Study Terminated by Sponsor|65|||
27842600|NCT01549964|54331170|FG001|80-Week Extension Period|Study Terminated by Sponsor|137|||
27793834|NCT02207231|54248922|FG000|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2|||
27793835|NCT02207231|54248923|FG001|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
27793836|NCT02207231|54248924|FG002|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4|||
27793837|NCT02207231|54248925|FG003|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
27793838|NCT02207231|54248922|FG000|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
27793839|NCT02207231|54248923|FG001|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
27793840|NCT02207231|54248924|FG002|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1|||
27793841|NCT02207231|54248925|FG003|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
27793842|NCT02207231|54248922|FG000|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
27793843|NCT02207231|54248923|FG001|Placebo Controlled Period: Week 0 - 16|Noncompliance|2|||
27793844|NCT02207231|54248924|FG002|Placebo Controlled Period: Week 0 - 16|Noncompliance|1|||
27793845|NCT02207231|54248925|FG003|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
27793846|NCT02207231|54248922|FG000|Active Controlled Period: Week 16 - 48|Adverse Event|1|||
27793847|NCT02207231|54248923|FG001|Active Controlled Period: Week 16 - 48|Adverse Event|6|||
27793848|NCT02207231|54248924|FG002|Active Controlled Period: Week 16 - 48|Adverse Event|10|||
27793849|NCT02207231|54248925|FG003|Active Controlled Period: Week 16 - 48|Adverse Event|0|||
27793850|NCT02207231|54248922|FG000|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
27793851|NCT02207231|54248923|FG001|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
27793852|NCT02207231|54248924|FG002|Active Controlled Period: Week 16 - 48|Pregnancy|1|||
27793853|NCT02207231|54248925|FG003|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
27793854|NCT02207231|54248922|FG000|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
27793855|NCT02207231|54248923|FG001|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3|||
27793856|NCT02207231|54248924|FG002|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11|||
27793857|NCT02207231|54248925|FG003|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
27793858|NCT02207231|54248922|FG000|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1|||
27793859|NCT02207231|54248923|FG001|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2|||
27793860|NCT02207231|54248924|FG002|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5|||
27793861|NCT02207231|54248925|FG003|Active Controlled Period: Week 16 - 48|Lost to Follow-up|0|||
27793862|NCT02207231|54248922|FG000|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1|||
27793863|NCT02207231|54248923|FG001|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4|||
27793864|NCT02207231|54248924|FG002|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10|||
27793865|NCT02207231|54248925|FG003|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|0|||
27793866|NCT02207231|54248922|FG000|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
27793867|NCT02207231|54248923|FG001|Active Controlled Period: Week 16 - 48|Protocol Violation|1|||
27793868|NCT02207231|54248924|FG002|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
27793869|NCT02207231|54248925|FG003|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
27793870|NCT02207231|54248922|FG000|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
27793871|NCT02207231|54248923|FG001|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
27793872|NCT02207231|54248924|FG002|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
27793873|NCT02207231|54248925|FG003|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
27793874|NCT02207231|54248922|FG000|Active Controlled Period: Week 16 - 48|Other|0|||
27793875|NCT02207231|54248923|FG001|Active Controlled Period: Week 16 - 48|Other|2|||
27793876|NCT02207231|54248924|FG002|Active Controlled Period: Week 16 - 48|Other|3|||
27793877|NCT02207231|54248925|FG003|Active Controlled Period: Week 16 - 48|Other|0|||
27793878|NCT02207231|54248922|FG000|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
27793879|NCT02207231|54248923|FG001|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
27793880|NCT02207231|54248924|FG002|Open-label Guselkumab: Week 48 - 264|Adverse Event|12|||
27793881|NCT02207231|54248925|FG003|Open-label Guselkumab: Week 48 - 264|Adverse Event|19|||
27793882|NCT02207231|54248922|FG000|Open-label Guselkumab: Week 48 - 264|Death|0|||
27793883|NCT02207231|54248923|FG001|Open-label Guselkumab: Week 48 - 264|Death|0|||
27793884|NCT02207231|54248924|FG002|Open-label Guselkumab: Week 48 - 264|Death|1|||
27793885|NCT02207231|54248925|FG003|Open-label Guselkumab: Week 48 - 264|Death|3|||
27793886|NCT02207231|54248922|FG000|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
27793887|NCT02207231|54248923|FG001|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
27793888|NCT02207231|54248924|FG002|Open-label Guselkumab: Week 48 - 264|Pregnancy|3|||
27793889|NCT02207231|54248925|FG003|Open-label Guselkumab: Week 48 - 264|Pregnancy|7|||
27793890|NCT02207231|54248922|FG000|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
27793891|NCT02207231|54248923|FG001|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
27793892|NCT02207231|54248924|FG002|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|2|||
27793893|NCT02207231|54248925|FG003|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|4|||
27793894|NCT02207231|54248922|FG000|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
27793895|NCT02207231|54248923|FG001|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
27793896|NCT02207231|54248924|FG002|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|6|||
27793897|NCT02207231|54248925|FG003|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|11|||
27793898|NCT02207231|54248922|FG000|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
27793899|NCT02207231|54248923|FG001|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
27793900|NCT02207231|54248924|FG002|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|10|||
27793901|NCT02207231|54248925|FG003|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|28|||
27793902|NCT02207231|54248922|FG000|Open-label Guselkumab: Week 48 - 264|Other|0|||
27793903|NCT02207231|54248923|FG001|Open-label Guselkumab: Week 48 - 264|Other|0|||
27793904|NCT02207231|54248924|FG002|Open-label Guselkumab: Week 48 - 264|Other|4|||
27793905|NCT02207231|54248925|FG003|Open-label Guselkumab: Week 48 - 264|Other|11|||
27793906|NCT02239601|54248945|FG000|Overall Study|Withdrawal by Subject|3|||
27793907|NCT02239601|54248946|FG001|Overall Study|Withdrawal by Subject|4|||
27793908|NCT02239601|54248945|FG000|Overall Study|Protocol Violation|4|||
27793909|NCT02239601|54248946|FG001|Overall Study|Protocol Violation|2|||
27793910|NCT02236559|54248959|FG000|Overall Study|Met Exclusion|3|||
27793911|NCT02236559|54248960|FG001|Overall Study|Met Exclusion|6|||
27793912|NCT02236559|54248959|FG000|Overall Study|Did not Meet Inclusion|3|||
27842601|NCT01549964|54331171|FG002|80-Week Extension Period|Study Terminated by Sponsor|132|||
27842602|NCT01549964|54331172|FG003|80-Week Extension Period|Study Terminated by Sponsor|132|||
27842603|NCT01549964|54331169|FG000|80-Week Extension Period|Voluntary Withdrawal|0|||
27842604|NCT01549964|54331170|FG001|80-Week Extension Period|Voluntary Withdrawal|1|||
27842605|NCT01549964|54331171|FG002|80-Week Extension Period|Voluntary Withdrawal|4|||
27842606|NCT01549964|54331172|FG003|80-Week Extension Period|Voluntary Withdrawal|2|||
27842607|NCT01549964|54331169|FG000|80-Week Extension Period|Lost to Follow-up|1|||
27842608|NCT01549964|54331170|FG001|80-Week Extension Period|Lost to Follow-up|0|||
27842609|NCT01549964|54331171|FG002|80-Week Extension Period|Lost to Follow-up|2|||
27842610|NCT01549964|54331172|FG003|80-Week Extension Period|Lost to Follow-up|1|||
27842611|NCT01549964|54331169|FG000|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
27842612|NCT01549964|54331170|FG001|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
27793913|NCT02236559|54248960|FG001|Overall Study|Did not Meet Inclusion|3|||
27793914|NCT02236559|54248959|FG000|Overall Study|Subject Did Not Consent|4|||
27793915|NCT02236559|54248960|FG001|Overall Study|Subject Did Not Consent|2|||
27793916|NCT02236559|54248959|FG000|Overall Study|Physician Decision|1|||
27793917|NCT02236559|54248960|FG001|Overall Study|Physician Decision|1|||
27793918|NCT02236559|54248959|FG000|Overall Study|Withdrawal by Subject|1|||
27793919|NCT02236559|54248960|FG001|Overall Study|Withdrawal by Subject|0|||
27842613|NCT01549964|54331171|FG002|80-Week Extension Period|Pretreatment Event/Adverse Event|1|||
27842614|NCT01549964|54331172|FG003|80-Week Extension Period|Pretreatment Event/Adverse Event|2|||
27842615|NCT01570244|54331254|FG000|Microgynon+Faldaprevir|Adverse Event|1|||
27842616|NCT01535222|54331289|FG000|Overall Study|Inclusion/exclusion|0|||
27793920|NCT02206685|54248968|FG000|Overall Study|Surgery cancelled/changed|2|||
27793921|NCT02206685|54248969|FG001|Overall Study|Surgery cancelled/changed|3|||
27793922|NCT02206685|54248968|FG000|Overall Study|Withdrawal by Subject|1|||
27793923|NCT02206685|54248969|FG001|Overall Study|Withdrawal by Subject|2|||
27793924|NCT02206685|54248968|FG000|Overall Study|Protocol Violation|2|||
27793925|NCT02206685|54248969|FG001|Overall Study|Protocol Violation|2|||
27793926|NCT02206607|54248975|FG000|Open-Label Run-In|Withdrawal by Subject|3|||
27793927|NCT02206607|54248976|FG001|Open-Label Run-In|Withdrawal by Subject|0|||
27793928|NCT02206607|54248977|FG002|Open-Label Run-In|Withdrawal by Subject|0|||
27793929|NCT02206607|54248978|FG003|Open-Label Run-In|Withdrawal by Subject|0|||
27793930|NCT02206607|54248979|FG004|Open-Label Run-In|Withdrawal by Subject|0|||
27793931|NCT02206607|54248975|FG000|Second Intervention Period|Insufficient Clinical Response|0|||
27793932|NCT02206607|54248976|FG001|Second Intervention Period|Insufficient Clinical Response|0|||
27793933|NCT02206607|54248977|FG002|Second Intervention Period|Insufficient Clinical Response|0|||
27793934|NCT02206607|54248978|FG003|Second Intervention Period|Insufficient Clinical Response|1|||
27793935|NCT02206607|54248979|FG004|Second Intervention Period|Insufficient Clinical Response|0|||
27793936|NCT02119676|54248999|FG000|Overall Study|Adverse Event|9|||
27793937|NCT02119676|54249000|FG001|Overall Study|Adverse Event|17|||
27793938|NCT02119676|54249001|FG002|Overall Study|Adverse Event|10|||
27793939|NCT02119676|54249002|FG003|Overall Study|Adverse Event|10|||
27793940|NCT02119676|54248999|FG000|Overall Study|Disease progression|53|||
27793941|NCT02119676|54249000|FG001|Overall Study|Disease progression|55|||
27793942|NCT02119676|54249001|FG002|Overall Study|Disease progression|68|||
27793943|NCT02119676|54249002|FG003|Overall Study|Disease progression|73|||
27793944|NCT02119676|54248999|FG000|Overall Study|Patient decision, inc. consent withdrawn|4|||
27793945|NCT02119676|54249000|FG001|Overall Study|Patient decision, inc. consent withdrawn|5|||
27793946|NCT02119676|54249001|FG002|Overall Study|Patient decision, inc. consent withdrawn|5|||
27793947|NCT02119676|54249002|FG003|Overall Study|Patient decision, inc. consent withdrawn|6|||
27793948|NCT02119676|54248999|FG000|Overall Study|Physician Decision|4|||
27793949|NCT02119676|54249000|FG001|Overall Study|Physician Decision|2|||
27793950|NCT02119676|54249001|FG002|Overall Study|Physician Decision|3|||
27793951|NCT02119676|54249002|FG003|Overall Study|Physician Decision|2|||
27793952|NCT02119676|54248999|FG000|Overall Study|Death|9|||
27793953|NCT02119676|54249000|FG001|Overall Study|Death|3|||
27793954|NCT02119676|54249001|FG002|Overall Study|Death|2|||
27793955|NCT02119676|54249002|FG003|Overall Study|Death|1|||
27793956|NCT02119676|54248999|FG000|Overall Study|Noncompliance|0|||
27793957|NCT02119676|54249000|FG001|Overall Study|Noncompliance|1|||
27793958|NCT02119676|54249001|FG002|Overall Study|Noncompliance|0|||
27793959|NCT02119676|54249002|FG003|Overall Study|Noncompliance|0|||
27793960|NCT02119676|54248999|FG000|Overall Study|Lost to Follow-up|0|||
27793961|NCT02119676|54249000|FG001|Overall Study|Lost to Follow-up|0|||
27793962|NCT02119676|54249001|FG002|Overall Study|Lost to Follow-up|1|||
27793963|NCT02119676|54249002|FG003|Overall Study|Lost to Follow-up|0|||
27793964|NCT02119676|54248999|FG000|Overall Study|Protocol deviation|0|||
27793965|NCT02119676|54249000|FG001|Overall Study|Protocol deviation|0|||
27793966|NCT02119676|54249001|FG002|Overall Study|Protocol deviation|1|||
27793967|NCT02119676|54249002|FG003|Overall Study|Protocol deviation|0|||
27793968|NCT02119676|54248999|FG000|Overall Study|Other, unspecified|2|||
27793969|NCT02119676|54249000|FG001|Overall Study|Other, unspecified|1|||
27793970|NCT02119676|54249001|FG002|Overall Study|Other, unspecified|3|||
27793971|NCT02119676|54249002|FG003|Overall Study|Other, unspecified|4|||
27793972|NCT02119676|54248999|FG000|Overall Study|Did not receive study med|2|||
27793973|NCT02119676|54249000|FG001|Overall Study|Did not receive study med|2|||
27793974|NCT02119676|54249001|FG002|Overall Study|Did not receive study med|4|||
27793975|NCT02119676|54249002|FG003|Overall Study|Did not receive study med|5|||
27793976|NCT02206061|54249015|FG000|Overall Study|Withdrawal by Subject|4|||
27793977|NCT02206061|54249016|FG001|Overall Study|Withdrawal by Subject|7|||
27793978|NCT02206061|54249017|FG002|Overall Study|Withdrawal by Subject|1|||
27793979|NCT02206061|54249015|FG000|Overall Study|Lost to Follow-up|14|||
27793980|NCT02206061|54249016|FG001|Overall Study|Lost to Follow-up|7|||
27793981|NCT02206061|54249017|FG002|Overall Study|Lost to Follow-up|20|||
27793982|NCT02095106|54249027|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
27793983|NCT02095106|54249028|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
27793984|NCT01631747|54249040|FG000|Randomization Through End of Pregnancy|Lost to Follow-up|1|||
27793985|NCT01631747|54249041|FG001|Randomization Through End of Pregnancy|Lost to Follow-up|0|||
27793986|NCT01631747|54249040|FG000|Live Birth|Pregnancy Termination|1|||
27793987|NCT01631747|54249041|FG001|Live Birth|Pregnancy Termination|0|||
27793988|NCT01631747|54249040|FG000|Live Birth|MIscarriage|2|||
27793989|NCT01631747|54249041|FG001|Live Birth|MIscarriage|0|||
27793990|NCT01631747|54249040|FG000|Live Birth|Stillbirth|1|||
27793991|NCT01631747|54249041|FG001|Live Birth|Stillbirth|1|||
27793992|NCT01631747|54249040|FG000|One Year Infant Outcomes|Patient Refused|13|||
27793993|NCT01631747|54249041|FG001|One Year Infant Outcomes|Patient Refused|9|||
27793994|NCT02068118|54249050|FG000|18-month Comparative Study Period|Death|90|||
27793995|NCT02068118|54249051|FG001|18-month Comparative Study Period|Death|97|||
28105628|NCT04841577|54763125|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|8|||
27793996|NCT02068118|54249050|FG000|18-month Comparative Study Period|Withdrawal by Subject|23|||
27793997|NCT02068118|54249051|FG001|18-month Comparative Study Period|Withdrawal by Subject|52|||
27793998|NCT02068118|54249050|FG000|18-month Comparative Study Period|Lost to Follow-up|6|||
27793999|NCT02068118|54249051|FG001|18-month Comparative Study Period|Lost to Follow-up|7|||
27794000|NCT02068118|54249050|FG000|18-month Comparative Study Period|Heart transplant|9|||
27794001|NCT02068118|54249051|FG001|18-month Comparative Study Period|Heart transplant|15|||
27794002|NCT02068118|54249050|FG000|18-month Comparative Study Period|Inclusion in another protocol|0|||
27794003|NCT02068118|54249051|FG001|18-month Comparative Study Period|Inclusion in another protocol|2|||
27794004|NCT02068118|54249050|FG000|18-month Comparative Study Period|Hemiplegia|0|||
27794005|NCT02068118|54249051|FG001|18-month Comparative Study Period|Hemiplegia|1|||
27794006|NCT02068118|54249050|FG000|18-month Comparative Study Period|Alzheimer's disease|0|||
27794007|NCT02068118|54249051|FG001|18-month Comparative Study Period|Alzheimer's disease|1|||
27794008|NCT02068118|54249050|FG000|18-month Comparative Study Period|Move|0|||
27794009|NCT02068118|54249051|FG001|18-month Comparative Study Period|Move|1|||
27794010|NCT02068118|54249050|FG000|18-month Comparative Study Period|Hearing loss|0|||
27794011|NCT02068118|54249051|FG001|18-month Comparative Study Period|Hearing loss|1|||
28017208|NCT00325819|54676491|FG000|Overall Study|Study product lost in mail|2|||
28017209|NCT00325819|54676492|FG001|Overall Study|Study product lost in mail|1|||
28017210|NCT00325819|54676491|FG000|Overall Study|Did not take a dose of study product|4|||
28017211|NCT00325819|54676492|FG001|Overall Study|Did not take a dose of study product|9|||
28017212|NCT00325819|54676491|FG000|Overall Study|Lost to Follow-up|3|||
28017213|NCT00325819|54676492|FG001|Overall Study|Lost to Follow-up|3|||
27794012|NCT02068118|54249050|FG000|Extension Period|Death|0|||
27794013|NCT02068118|54249051|FG001|Extension Period|Death|2|||
27794014|NCT02068118|54249050|FG000|Extension Period|Withdrawal by Subject|1|||
27794015|NCT02068118|54249051|FG001|Extension Period|Withdrawal by Subject|0|||
27794016|NCT02068118|54249050|FG000|Extension Period|Heart transplant|1|||
27794017|NCT02068118|54249051|FG001|Extension Period|Heart transplant|0|||
27794018|NCT02068118|54249050|FG000|Extension Period|Wrong device use|0|||
27794019|NCT02068118|54249051|FG001|Extension Period|Wrong device use|1|||
27794020|NCT01623830|54249061|FG000|Overall Study|Withdrawal by Subject|6|||
27794021|NCT01623830|54249062|FG001|Overall Study|Withdrawal by Subject|7|||
27794022|NCT01623830|54249061|FG000|Overall Study|Exclusion from Study|1|||
27794023|NCT01623830|54249062|FG001|Overall Study|Exclusion from Study|2|||
27794024|NCT01634165|54249068|FG000|Period 2|Adverse Event|0|||
27794025|NCT01634165|54249069|FG001|Period 2|Adverse Event|1|||
27794026|NCT01634165|54249070|FG002|Period 2|Adverse Event|0|||
27794027|NCT01634165|54249071|FG003|Period 2|Adverse Event|0|||
27794028|NCT03575897|54249083|FG000|Overall Study|Lost to Follow-up|12|||
27794029|NCT03575897|54249084|FG001|Overall Study|Lost to Follow-up|13|||
27794030|NCT02235311|54249092|FG000|Overall Study|Lost to Follow-up|0|||
27794031|NCT02235311|54249093|FG001|Overall Study|Lost to Follow-up|1|||
27794032|NCT02235311|54249092|FG000|Overall Study|Protocol Violation|0|||
27794033|NCT02235311|54249093|FG001|Overall Study|Protocol Violation|1|||
27794034|NCT02204579|54249099|FG000|Overall Study|Screen failures|2|||
27794035|NCT02235077|54249110|FG000|Overall Study|Death|5|||
27794036|NCT02235077|54249111|FG001|Overall Study|Death|7|||
27794037|NCT02235077|54249110|FG000|Overall Study|Lost to Follow-up|5|||
27794038|NCT02235077|54249111|FG001|Overall Study|Lost to Follow-up|6|||
27794039|NCT02235077|54249110|FG000|Overall Study|Withdrawal by Subject|8|||
27794040|NCT02235077|54249111|FG001|Overall Study|Withdrawal by Subject|5|||
27794041|NCT02235077|54249110|FG000|Overall Study|Physician Decision|0|||
27794042|NCT02235077|54249111|FG001|Overall Study|Physician Decision|1|||
27794043|NCT02234141|54249121|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
27794044|NCT02234141|54249122|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
27794045|NCT02234141|54249123|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
27794046|NCT02234141|54249124|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
27794047|NCT02234141|54249125|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
27794048|NCT02234141|54249126|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
27794049|NCT02234141|54249127|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
27794050|NCT02234141|54249121|FG000|Treatment Period (24 Weeks)|Investigator's discretion|0|||
27794051|NCT02234141|54249122|FG001|Treatment Period (24 Weeks)|Investigator's discretion|2|||
27842617|NCT01535222|54331290|FG001|Overall Study|Inclusion/exclusion|0|||
27842618|NCT01535222|54331291|FG002|Overall Study|Inclusion/exclusion|1|||
27842619|NCT01535222|54331292|FG003|Overall Study|Inclusion/exclusion|0|||
27937639|NCT01243151|54594010|FG004|Overall Study|Adverse Event|0|||
27937640|NCT01243151|54594006|FG000|Overall Study|Protocol Violation|0|||
27937641|NCT01243151|54594007|FG001|Overall Study|Protocol Violation|0|||
27937642|NCT01243151|54594008|FG002|Overall Study|Protocol Violation|1|||
27937643|NCT01243151|54594009|FG003|Overall Study|Protocol Violation|0|||
27937644|NCT01243151|54594010|FG004|Overall Study|Protocol Violation|0|||
27937645|NCT01243151|54594006|FG000|Overall Study|Other|0|||
27937646|NCT01243151|54594007|FG001|Overall Study|Other|0|||
28017214|NCT00687362|54676500|FG000|Overall Study|Protocol Violation|2|||
28017215|NCT00687362|54676500|FG000|Overall Study|Withdrawal by Subject|1|||
28017216|NCT00325195|54676507|FG000|Randomized|Not dosed|5|||
27794052|NCT02234141|54249123|FG002|Treatment Period (24 Weeks)|Investigator's discretion|0|||
27794053|NCT02234141|54249124|FG003|Treatment Period (24 Weeks)|Investigator's discretion|0|||
27794054|NCT02234141|54249125|FG004|Treatment Period (24 Weeks)|Investigator's discretion|0|||
27794055|NCT02234141|54249126|FG005|Treatment Period (24 Weeks)|Investigator's discretion|0|||
27794056|NCT02234141|54249127|FG006|Treatment Period (24 Weeks)|Investigator's discretion|0|||
27794057|NCT02234141|54249121|FG000|Treatment Period (24 Weeks)|Death|1|||
27794058|NCT02234141|54249122|FG001|Treatment Period (24 Weeks)|Death|2|||
27794059|NCT02234141|54249123|FG002|Treatment Period (24 Weeks)|Death|0|||
27794060|NCT02234141|54249124|FG003|Treatment Period (24 Weeks)|Death|1|||
27794061|NCT02234141|54249125|FG004|Treatment Period (24 Weeks)|Death|0|||
27794062|NCT02234141|54249126|FG005|Treatment Period (24 Weeks)|Death|0|||
27794063|NCT02234141|54249127|FG006|Treatment Period (24 Weeks)|Death|0|||
27794064|NCT02234141|54249121|FG000|Treatment Period (24 Weeks)|Adverse Event|3|||
27794065|NCT02234141|54249122|FG001|Treatment Period (24 Weeks)|Adverse Event|1|||
27794066|NCT02234141|54249123|FG002|Treatment Period (24 Weeks)|Adverse Event|2|||
27794067|NCT02234141|54249124|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
27794068|NCT02234141|54249125|FG004|Treatment Period (24 Weeks)|Adverse Event|0|||
27794069|NCT02234141|54249126|FG005|Treatment Period (24 Weeks)|Adverse Event|0|||
27794070|NCT02234141|54249127|FG006|Treatment Period (24 Weeks)|Adverse Event|0|||
27794071|NCT02234141|54249121|FG000|Treatment Period (24 Weeks)|Randomized but not treated|0|||
27794072|NCT02234141|54249122|FG001|Treatment Period (24 Weeks)|Randomized but not treated|1|||
27794073|NCT02234141|54249123|FG002|Treatment Period (24 Weeks)|Randomized but not treated|0|||
27794074|NCT02234141|54249124|FG003|Treatment Period (24 Weeks)|Randomized but not treated|0|||
27794075|NCT02234141|54249125|FG004|Treatment Period (24 Weeks)|Randomized but not treated|0|||
27794076|NCT02234141|54249126|FG005|Treatment Period (24 Weeks)|Randomized but not treated|0|||
27794077|NCT02234141|54249127|FG006|Treatment Period (24 Weeks)|Randomized but not treated|0|||
27794078|NCT02234141|54249121|FG000|Long-Term Treatment Period|Death|0|||
27794079|NCT02234141|54249122|FG001|Long-Term Treatment Period|Death|0|||
27794080|NCT02234141|54249123|FG002|Long-Term Treatment Period|Death|0|||
27794081|NCT02234141|54249124|FG003|Long-Term Treatment Period|Death|0|||
27794082|NCT02234141|54249125|FG004|Long-Term Treatment Period|Death|0|||
27794083|NCT02234141|54249126|FG005|Long-Term Treatment Period|Death|1|||
27794084|NCT02234141|54249127|FG006|Long-Term Treatment Period|Death|0|||
27794085|NCT02234141|54249121|FG000|Long-Term Treatment Period|Investigator's discretion|1|||
27794086|NCT02234141|54249122|FG001|Long-Term Treatment Period|Investigator's discretion|3|||
27794087|NCT02234141|54249123|FG002|Long-Term Treatment Period|Investigator's discretion|2|||
27794088|NCT02234141|54249124|FG003|Long-Term Treatment Period|Investigator's discretion|0|||
27794089|NCT02234141|54249125|FG004|Long-Term Treatment Period|Investigator's discretion|0|||
27794090|NCT02234141|54249126|FG005|Long-Term Treatment Period|Investigator's discretion|0|||
27794091|NCT02234141|54249127|FG006|Long-Term Treatment Period|Investigator's discretion|1|||
27794092|NCT02234141|54249121|FG000|Long-Term Treatment Period|Adverse Event|4|||
27794093|NCT02234141|54249122|FG001|Long-Term Treatment Period|Adverse Event|0|||
27794094|NCT02234141|54249123|FG002|Long-Term Treatment Period|Adverse Event|5|||
27794095|NCT02234141|54249124|FG003|Long-Term Treatment Period|Adverse Event|0|||
27794096|NCT02234141|54249125|FG004|Long-Term Treatment Period|Adverse Event|1|||
27794097|NCT02234141|54249126|FG005|Long-Term Treatment Period|Adverse Event|1|||
27794098|NCT02234141|54249127|FG006|Long-Term Treatment Period|Adverse Event|1|||
27794099|NCT02234141|54249121|FG000|Long-Term Treatment Period|Withdrew Consent|0|||
27794100|NCT02234141|54249122|FG001|Long-Term Treatment Period|Withdrew Consent|1|||
27794101|NCT02234141|54249123|FG002|Long-Term Treatment Period|Withdrew Consent|1|||
27794102|NCT02234141|54249124|FG003|Long-Term Treatment Period|Withdrew Consent|0|||
27794103|NCT02234141|54249125|FG004|Long-Term Treatment Period|Withdrew Consent|0|||
27794104|NCT02234141|54249126|FG005|Long-Term Treatment Period|Withdrew Consent|0|||
27794105|NCT02234141|54249127|FG006|Long-Term Treatment Period|Withdrew Consent|0|||
27794106|NCT02234141|54249121|FG000|Long-Term Treatment Period|Study Discontinued by Sponsor|28|||
27794107|NCT02234141|54249122|FG001|Long-Term Treatment Period|Study Discontinued by Sponsor|27|||
27794108|NCT02234141|54249123|FG002|Long-Term Treatment Period|Study Discontinued by Sponsor|25|||
27794109|NCT02234141|54249124|FG003|Long-Term Treatment Period|Study Discontinued by Sponsor|0|||
27794110|NCT02234141|54249125|FG004|Long-Term Treatment Period|Study Discontinued by Sponsor|9|||
27842620|NCT01535222|54331293|FG004|Overall Study|Inclusion/exclusion|0|||
27937647|NCT01243151|54594008|FG002|Overall Study|Other|0|||
27937648|NCT01243151|54594009|FG003|Overall Study|Other|1|||
27937649|NCT01243151|54594010|FG004|Overall Study|Other|0|||
27937650|NCT01243151|54594006|FG000|Overall Study|Randomized but not treated|0|||
27937651|NCT01243151|54594007|FG001|Overall Study|Randomized but not treated|0|||
27937652|NCT01243151|54594008|FG002|Overall Study|Randomized but not treated|0|||
27937653|NCT01243151|54594009|FG003|Overall Study|Randomized but not treated|1|||
27937654|NCT01243151|54594010|FG004|Overall Study|Randomized but not treated|0|||
27937655|NCT00993148|54594026|FG000|Overall Study|Lost to Follow-up|2|||
27937656|NCT00993148|54594026|FG000|Overall Study|never initiated treatment|1|||
27937657|NCT00907621|54594032|FG000|Overall Study|Lost to Follow-up|6|||
27937658|NCT00907621|54594033|FG001|Overall Study|Lost to Follow-up|3|||
27937659|NCT00907621|54594032|FG000|Overall Study|intercurrent febrile illness|1|||
27794111|NCT02234141|54249126|FG005|Long-Term Treatment Period|Study Discontinued by Sponsor|10|||
27794112|NCT02234141|54249127|FG006|Long-Term Treatment Period|Study Discontinued by Sponsor|8|||
27794113|NCT02234063|54249140|FG000|Overall Study|Lost to Follow-up|235|||
27794114|NCT02234063|54249141|FG001|Overall Study|Lost to Follow-up|42|||
27794115|NCT02234063|54249140|FG000|Overall Study|Withdrawal by Subject|20|||
27794116|NCT02234063|54249141|FG001|Overall Study|Withdrawal by Subject|1|||
27794117|NCT02232893|54249154|FG000|Overall Study|Withdrawal by Subject|4|||
27794118|NCT02232893|54249155|FG001|Overall Study|Withdrawal by Subject|1|||
27794119|NCT02232893|54249154|FG000|Overall Study|Adverse Event|0|||
27794120|NCT02232893|54249155|FG001|Overall Study|Adverse Event|1|||
27794121|NCT02232893|54249154|FG000|Overall Study|Sponsor request early termination|0|||
27794122|NCT02232893|54249155|FG001|Overall Study|Sponsor request early termination|1|||
27794123|NCT02232893|54249154|FG000|Overall Study|Developed exclusion criteria|0|||
27794124|NCT02232893|54249155|FG001|Overall Study|Developed exclusion criteria|1|||
27794125|NCT02232893|54249154|FG000|Overall Study|Other|0|||
27794126|NCT02232893|54249155|FG001|Overall Study|Other|3|||
27794127|NCT02203721|54249163|FG000|Overall Study|Lost to Follow-up|1|||
27794128|NCT02203721|54249164|FG001|Overall Study|Lost to Follow-up|0|||
27794129|NCT02203721|54249163|FG000|Overall Study|Death|0|||
27794130|NCT02203721|54249164|FG001|Overall Study|Death|2|||
27794131|NCT02203721|54249163|FG000|Overall Study|Illness|0|||
27794132|NCT02203721|54249164|FG001|Overall Study|Illness|1|||
27794133|NCT01618695|54249174|FG000|Core Phase|Adverse Event|4|||
27794134|NCT01618695|54249175|FG001|Core Phase|Adverse Event|5|||
27794135|NCT01618695|54249176|FG002|Core Phase|Adverse Event|15|||
27794136|NCT01618695|54249177|FG003|Core Phase|Adverse Event|20|||
27937660|NCT00907621|54594033|FG001|Overall Study|intercurrent febrile illness|1|||
27937661|NCT00907153|54594052|FG000|Overall Study|Lost to Follow-up|1|||
27937662|NCT00907153|54594053|FG001|Overall Study|Lost to Follow-up|1|||
27937663|NCT00907153|54594052|FG000|Overall Study|Withdrawal by Subject|1|||
27937664|NCT00907153|54594053|FG001|Overall Study|Withdrawal by Subject|3|||
27937665|NCT00904033|54594063|FG000|Overall Study|Withdrawal by Subject|1|||
28017217|NCT00325195|54676508|FG001|Randomized|Not dosed|5|||
28017218|NCT00325195|54676509|FG002|Randomized|Not dosed|3|||
28017219|NCT00325195|54676507|FG000|Received Intervention: ITT Population|Adverse Event|15|||
28017220|NCT00325195|54676508|FG001|Received Intervention: ITT Population|Adverse Event|17|||
28017221|NCT00325195|54676509|FG002|Received Intervention: ITT Population|Adverse Event|1|||
28017222|NCT00325195|54676507|FG000|Received Intervention: ITT Population|Death|3|||
28017223|NCT00325195|54676508|FG001|Received Intervention: ITT Population|Death|1|||
28017224|NCT00325195|54676509|FG002|Received Intervention: ITT Population|Death|0|||
28017225|NCT00325195|54676507|FG000|Received Intervention: ITT Population|Withdrawal by Subject|7|||
28017226|NCT00325195|54676508|FG001|Received Intervention: ITT Population|Withdrawal by Subject|6|||
27794137|NCT01618695|54249174|FG000|Core Phase|Lost to Follow-up|0|||
27794138|NCT01618695|54249175|FG001|Core Phase|Lost to Follow-up|0|||
27794139|NCT01618695|54249176|FG002|Core Phase|Lost to Follow-up|1|||
27794140|NCT01618695|54249177|FG003|Core Phase|Lost to Follow-up|0|||
27794141|NCT01618695|54249174|FG000|Core Phase|Withdrawal by Subject|16|||
27842621|NCT01535222|54331294|FG005|Overall Study|Inclusion/exclusion|0|||
27842622|NCT01549886|54331310|FG000|Overall Study|Sponsor's decision|2|||
27842623|NCT01549886|54331311|FG001|Overall Study|Sponsor's decision|3|||
27842624|NCT01443845|54331340|FG000|Overall Study|Protocol Violation|43|||
27842625|NCT01443845|54331341|FG001|Overall Study|Protocol Violation|45|||
27842626|NCT01443845|54331340|FG000|Overall Study|Other reasons, such as COPD exacerbation|44|||
27842627|NCT01443845|54331341|FG001|Overall Study|Other reasons, such as COPD exacerbation|44|||
27937666|NCT00904033|54594064|FG001|Overall Study|Withdrawal by Subject|1|||
27794142|NCT01618695|54249175|FG001|Core Phase|Withdrawal by Subject|11|||
28017227|NCT00325195|54676509|FG002|Received Intervention: ITT Population|Withdrawal by Subject|1|||
27794143|NCT01618695|54249176|FG002|Core Phase|Withdrawal by Subject|9|||
27794144|NCT01618695|54249177|FG003|Core Phase|Withdrawal by Subject|13|||
27794145|NCT01618695|54249174|FG000|Core Phase|Pregnancy|2|||
27842628|NCT01443845|54331340|FG000|Overall Study|Deterioration in pulmonary function|1|||
27842629|NCT01443845|54331341|FG001|Overall Study|Deterioration in pulmonary function|4|||
27842630|NCT01443845|54331340|FG000|Overall Study|Lack of Efficacy|10|||
28017228|NCT00325195|54676507|FG000|Received Intervention: ITT Population|Lost to Follow-up|0|||
28017229|NCT00325195|54676508|FG001|Received Intervention: ITT Population|Lost to Follow-up|0|||
28017230|NCT00325195|54676509|FG002|Received Intervention: ITT Population|Lost to Follow-up|2|||
27794146|NCT01618695|54249175|FG001|Core Phase|Pregnancy|0|||
27794147|NCT01618695|54249176|FG002|Core Phase|Pregnancy|0|||
27794148|NCT01618695|54249177|FG003|Core Phase|Pregnancy|0|||
27794149|NCT01618695|54249174|FG000|Core Phase|Lack of Efficacy|1|||
27794150|NCT01618695|54249175|FG001|Core Phase|Lack of Efficacy|2|||
27794151|NCT01618695|54249176|FG002|Core Phase|Lack of Efficacy|1|||
27842631|NCT01443845|54331341|FG001|Overall Study|Lack of Efficacy|5|||
27794152|NCT01618695|54249177|FG003|Core Phase|Lack of Efficacy|1|||
27937667|NCT00904033|54594065|FG002|Overall Study|Withdrawal by Subject|0|||
27937668|NCT00904033|54594066|FG003|Overall Study|Withdrawal by Subject|0|||
27794153|NCT01618695|54249174|FG000|Core Phase|Other than specified|1|||
27794154|NCT01618695|54249175|FG001|Core Phase|Other than specified|2|||
27794155|NCT01618695|54249176|FG002|Core Phase|Other than specified|2|||
27794156|NCT01618695|54249177|FG003|Core Phase|Other than specified|2|||
27794157|NCT01618695|54249174|FG000|Core Phase|Not treated|1|||
27794158|NCT01618695|54249175|FG001|Core Phase|Not treated|0|||
27794159|NCT01618695|54249176|FG002|Core Phase|Not treated|2|||
27794160|NCT01618695|54249177|FG003|Core Phase|Not treated|0|||
27794161|NCT01618695|54249174|FG000|Extension Phase|Lack of Efficacy|17|||
27794162|NCT01618695|54249175|FG001|Extension Phase|Lack of Efficacy|33|||
27794163|NCT01618695|54249176|FG002|Extension Phase|Lack of Efficacy|26|||
27794164|NCT01618695|54249177|FG003|Extension Phase|Lack of Efficacy|24|||
27794165|NCT01618695|54249174|FG000|Extension Phase|Pregnancy|2|||
27794166|NCT01618695|54249175|FG001|Extension Phase|Pregnancy|0|||
27794167|NCT01618695|54249176|FG002|Extension Phase|Pregnancy|1|||
27794168|NCT01618695|54249177|FG003|Extension Phase|Pregnancy|1|||
27794169|NCT01618695|54249174|FG000|Extension Phase|Withdrawal by Subject|43|||
27794170|NCT01618695|54249175|FG001|Extension Phase|Withdrawal by Subject|48|||
27794171|NCT01618695|54249176|FG002|Extension Phase|Withdrawal by Subject|42|||
27794172|NCT01618695|54249177|FG003|Extension Phase|Withdrawal by Subject|33|||
27794173|NCT01618695|54249174|FG000|Extension Phase|Adverse Event|18|||
27794174|NCT01618695|54249175|FG001|Extension Phase|Adverse Event|16|||
27794175|NCT01618695|54249176|FG002|Extension Phase|Adverse Event|9|||
27794176|NCT01618695|54249177|FG003|Extension Phase|Adverse Event|20|||
27794177|NCT01618695|54249174|FG000|Extension Phase|Lost to Follow-up|2|||
27794178|NCT01618695|54249175|FG001|Extension Phase|Lost to Follow-up|1|||
27794179|NCT01618695|54249176|FG002|Extension Phase|Lost to Follow-up|1|||
27794180|NCT01618695|54249177|FG003|Extension Phase|Lost to Follow-up|1|||
27794181|NCT01618695|54249174|FG000|Extension Phase|Other than specified|13|||
27794182|NCT01618695|54249175|FG001|Extension Phase|Other than specified|18|||
27794183|NCT01618695|54249176|FG002|Extension Phase|Other than specified|13|||
27794184|NCT01618695|54249177|FG003|Extension Phase|Other than specified|18|||
27794185|NCT01896531|54249190|FG000|Overall Study|Death|57|||
27794186|NCT01896531|54249191|FG001|Overall Study|Death|59|||
27794187|NCT01896531|54249190|FG000|Overall Study|Lost to Follow-up|3|||
27794188|NCT01896531|54249191|FG001|Overall Study|Lost to Follow-up|0|||
27794189|NCT01896531|54249190|FG000|Overall Study|Non-compliance|0|||
27794190|NCT01896531|54249191|FG001|Overall Study|Non-compliance|1|||
27794191|NCT01896531|54249190|FG000|Overall Study|Study Ended by Sponsor|7|||
27794192|NCT01896531|54249191|FG001|Overall Study|Study Ended by Sponsor|20|||
27794193|NCT01896531|54249190|FG000|Overall Study|Withdrawal by Subject|3|||
27794194|NCT01896531|54249191|FG001|Overall Study|Withdrawal by Subject|2|||
27794195|NCT01896531|54249190|FG000|Overall Study|Death Prior to Treatment|1|||
27794196|NCT01896531|54249191|FG001|Overall Study|Death Prior to Treatment|0|||
27794197|NCT01618305|54249199|FG000|Overall Study|Death|0|||
27794198|NCT01618305|54249200|FG001|Overall Study|Death|1|||
27794199|NCT01618305|54249199|FG000|Overall Study|Lost to Follow-up|11|||
27794200|NCT01618305|54249200|FG001|Overall Study|Lost to Follow-up|7|||
27794201|NCT01618305|54249199|FG000|Overall Study|Protocol Violation|1|||
27794202|NCT01618305|54249200|FG001|Overall Study|Protocol Violation|0|||
27794203|NCT01618305|54249199|FG000|Overall Study|Withdrawal by Subject|3|||
27794204|NCT01618305|54249200|FG001|Overall Study|Withdrawal by Subject|2|||
27794205|NCT01886313|54249212|FG000|Overall Study|Adverse Event|1|||
27794206|NCT01886313|54249213|FG001|Overall Study|Adverse Event|1|||
27794207|NCT01896297|54249219|FG000|Overall Study|Died in post treatment phase|1|||
27794208|NCT01884675|54249225|FG000|Overall Study|Study closed/terminated|3|||
27794209|NCT01884675|54249226|FG001|Overall Study|Study closed/terminated|2|||
27794210|NCT01884597|54249237|FG000|Overall Study|Adverse Event|0|||
27794211|NCT01884597|54249238|FG001|Overall Study|Adverse Event|0|||
27794212|NCT01884597|54249239|FG002|Overall Study|Adverse Event|1|||
27794213|NCT01884597|54249237|FG000|Overall Study|Lack of Efficacy|1|||
27794214|NCT01884597|54249238|FG001|Overall Study|Lack of Efficacy|0|||
27794215|NCT01884597|54249239|FG002|Overall Study|Lack of Efficacy|0|||
27794216|NCT01884597|54249237|FG000|Overall Study|Death|0|||
27794217|NCT01884597|54249238|FG001|Overall Study|Death|1|||
27794218|NCT01884597|54249239|FG002|Overall Study|Death|0|||
27794219|NCT01895361|54249256|FG000|Overall Study|Adverse Event|1|||
27794220|NCT01895361|54249257|FG001|Overall Study|Adverse Event|1|||
27794221|NCT01895361|54249258|FG002|Overall Study|Adverse Event|3|||
27794222|NCT01895361|54249256|FG000|Overall Study|Death|2|||
27794223|NCT01895361|54249257|FG001|Overall Study|Death|1|||
27794224|NCT01895361|54249258|FG002|Overall Study|Death|2|||
27794225|NCT01895361|54249256|FG000|Overall Study|Lost to Follow-up|4|||
27794226|NCT01895361|54249257|FG001|Overall Study|Lost to Follow-up|4|||
27794227|NCT01895361|54249258|FG002|Overall Study|Lost to Follow-up|6|||
27794228|NCT01895361|54249256|FG000|Overall Study|Non-compliance with study|1|||
27794229|NCT01895361|54249257|FG001|Overall Study|Non-compliance with study|3|||
27794230|NCT01895361|54249258|FG002|Overall Study|Non-compliance with study|1|||
27794231|NCT01895361|54249256|FG000|Overall Study|Physician Decision|2|||
27794232|NCT01895361|54249257|FG001|Overall Study|Physician Decision|2|||
27794233|NCT01895361|54249258|FG002|Overall Study|Physician Decision|2|||
27794234|NCT01895361|54249256|FG000|Overall Study|Withdrawal by Subject|7|||
27794235|NCT01895361|54249257|FG001|Overall Study|Withdrawal by Subject|6|||
27794236|NCT01895361|54249258|FG002|Overall Study|Withdrawal by Subject|6|||
27794237|NCT01895361|54249256|FG000|Overall Study|Lack of Efficacy|0|||
27794238|NCT01895361|54249257|FG001|Overall Study|Lack of Efficacy|1|||
27794239|NCT01895361|54249258|FG002|Overall Study|Lack of Efficacy|0|||
27794240|NCT01895361|54249256|FG000|Overall Study|Reasons different from categories above|7|||
27794241|NCT01895361|54249257|FG001|Overall Study|Reasons different from categories above|3|||
27794242|NCT01895361|54249258|FG002|Overall Study|Reasons different from categories above|4|||
27794243|NCT01883895|54249266|FG000|Overall Study|Lost to Follow-up|2|||
27794244|NCT01864005|54249272|FG000|Overall Study|Protocol Violation|0|||
27794245|NCT01864005|54249273|FG001|Overall Study|Protocol Violation|1|||
27794246|NCT01864005|54249272|FG000|Overall Study|Withdrawal by Subject|0|||
27794247|NCT01864005|54249273|FG001|Overall Study|Withdrawal by Subject|1|||
27794248|NCT01864005|54249272|FG000|Overall Study|Incorrect enrolment|1|||
27794249|NCT01864005|54249273|FG001|Overall Study|Incorrect enrolment|0|||
27794250|NCT01864005|54249272|FG000|Overall Study|Disease need|1|||
27794251|NCT01864005|54249273|FG001|Overall Study|Disease need|1|||
27794252|NCT01864005|54249272|FG000|Overall Study|Need GP IIb/IIIa|1|||
27794253|NCT01864005|54249273|FG001|Overall Study|Need GP IIb/IIIa|3|||
27794254|NCT01863849|54249281|FG000|Overall Study|Lost to Follow-up|1|||
27794255|NCT01863849|54249282|FG001|Overall Study|Lost to Follow-up|0|||
27794256|NCT01863771|54249289|FG000|Induction Phase|Adverse Event|9|||
27794257|NCT01863771|54249290|FG001|Induction Phase|Adverse Event|0|||
27794258|NCT01863771|54249291|FG002|Induction Phase|Adverse Event|0|||
27794259|NCT01863771|54249292|FG003|Induction Phase|Adverse Event|0|||
27794260|NCT01863771|54249289|FG000|Induction Phase|Lack of Efficacy|10|||
27794261|NCT01863771|54249290|FG001|Induction Phase|Lack of Efficacy|0|||
27794262|NCT01863771|54249291|FG002|Induction Phase|Lack of Efficacy|0|||
27794263|NCT01863771|54249292|FG003|Induction Phase|Lack of Efficacy|0|||
27794264|NCT01863771|54249289|FG000|Induction Phase|Withdrawal by Subject|2|||
27794265|NCT01863771|54249290|FG001|Induction Phase|Withdrawal by Subject|0|||
27794266|NCT01863771|54249291|FG002|Induction Phase|Withdrawal by Subject|0|||
27794267|NCT01863771|54249292|FG003|Induction Phase|Withdrawal by Subject|0|||
27794268|NCT01863771|54249289|FG000|Maintenance Phase|Adverse Event|0|||
27794269|NCT01863771|54249290|FG001|Maintenance Phase|Adverse Event|0|||
27794270|NCT01863771|54249291|FG002|Maintenance Phase|Adverse Event|1|||
27794271|NCT01863771|54249292|FG003|Maintenance Phase|Adverse Event|1|||
27794272|NCT01863771|54249289|FG000|Maintenance Phase|Lack of Efficacy|0|||
27794273|NCT01863771|54249290|FG001|Maintenance Phase|Lack of Efficacy|3|||
27794274|NCT01863771|54249291|FG002|Maintenance Phase|Lack of Efficacy|7|||
27794275|NCT01863771|54249292|FG003|Maintenance Phase|Lack of Efficacy|38|||
27794276|NCT01863771|54249289|FG000|Maintenance Phase|Physician Decision|0|||
27794277|NCT01863771|54249290|FG001|Maintenance Phase|Physician Decision|0|||
27794278|NCT01863771|54249291|FG002|Maintenance Phase|Physician Decision|2|||
27794279|NCT01863771|54249292|FG003|Maintenance Phase|Physician Decision|1|||
27794280|NCT01863771|54249289|FG000|Maintenance Phase|Pregnancy|0|||
27794281|NCT01863771|54249290|FG001|Maintenance Phase|Pregnancy|1|||
27794282|NCT01863771|54249291|FG002|Maintenance Phase|Pregnancy|0|||
27794283|NCT01863771|54249292|FG003|Maintenance Phase|Pregnancy|0|||
27794284|NCT01863771|54249289|FG000|Maintenance Phase|Withdrawal by Subject|0|||
27794285|NCT01863771|54249290|FG001|Maintenance Phase|Withdrawal by Subject|1|||
27794286|NCT01863771|54249291|FG002|Maintenance Phase|Withdrawal by Subject|2|||
27794287|NCT01863771|54249292|FG003|Maintenance Phase|Withdrawal by Subject|3|||
27794288|NCT01894581|54249302|FG000|Overall Study|Withdrawal by Subject|2|||
27794289|NCT01894581|54249303|FG001|Overall Study|Withdrawal by Subject|3|||
27794290|NCT01894581|54249302|FG000|Overall Study|Screen Failure|3|||
27794291|NCT01894581|54249303|FG001|Overall Study|Screen Failure|4|||
27794292|NCT02203331|54249315|FG000|Overall Study|Pregnancy|1|||
27794293|NCT02203331|54249316|FG001|Overall Study|Pregnancy|0|||
27794294|NCT02203331|54249317|FG002|Overall Study|Pregnancy|0|||
27794295|NCT02203331|54249318|FG003|Overall Study|Pregnancy|0|||
27794296|NCT02203331|54249319|FG004|Overall Study|Pregnancy|2|||
27794297|NCT02203331|54249320|FG005|Overall Study|Pregnancy|0|||
27794298|NCT02203331|54249315|FG000|Overall Study|Withdrawal by Subject|1|||
27794299|NCT02203331|54249316|FG001|Overall Study|Withdrawal by Subject|0|||
27794300|NCT02203331|54249317|FG002|Overall Study|Withdrawal by Subject|1|||
27794301|NCT02203331|54249318|FG003|Overall Study|Withdrawal by Subject|0|||
27794302|NCT02203331|54249319|FG004|Overall Study|Withdrawal by Subject|0|||
27794303|NCT02203331|54249320|FG005|Overall Study|Withdrawal by Subject|3|||
27794304|NCT02203331|54249315|FG000|Overall Study|Adverse Event|4|||
27794305|NCT02203331|54249316|FG001|Overall Study|Adverse Event|8|||
27794306|NCT02203331|54249317|FG002|Overall Study|Adverse Event|3|||
27794307|NCT02203331|54249318|FG003|Overall Study|Adverse Event|4|||
27794308|NCT02203331|54249319|FG004|Overall Study|Adverse Event|3|||
27794309|NCT02203331|54249320|FG005|Overall Study|Adverse Event|3|||
27794310|NCT02203331|54249315|FG000|Overall Study|Other Reasons|1|||
27794311|NCT02203331|54249316|FG001|Overall Study|Other Reasons|2|||
27794312|NCT02203331|54249317|FG002|Overall Study|Other Reasons|0|||
27794313|NCT02203331|54249318|FG003|Overall Study|Other Reasons|2|||
27794314|NCT02203331|54249319|FG004|Overall Study|Other Reasons|0|||
27794315|NCT02203331|54249320|FG005|Overall Study|Other Reasons|0|||
27794316|NCT02203331|54249315|FG000|Overall Study|Lack of Efficacy|0|||
27794317|NCT02203331|54249316|FG001|Overall Study|Lack of Efficacy|2|||
27794318|NCT02203331|54249317|FG002|Overall Study|Lack of Efficacy|1|||
27794319|NCT02203331|54249318|FG003|Overall Study|Lack of Efficacy|0|||
27794320|NCT02203331|54249319|FG004|Overall Study|Lack of Efficacy|0|||
27794321|NCT02203331|54249320|FG005|Overall Study|Lack of Efficacy|1|||
27794322|NCT02203331|54249315|FG000|Overall Study|Protocol Violation|0|||
27794323|NCT02203331|54249316|FG001|Overall Study|Protocol Violation|2|||
27794324|NCT02203331|54249317|FG002|Overall Study|Protocol Violation|0|||
27794325|NCT02203331|54249318|FG003|Overall Study|Protocol Violation|1|||
27794326|NCT02203331|54249319|FG004|Overall Study|Protocol Violation|1|||
27794327|NCT02203331|54249320|FG005|Overall Study|Protocol Violation|0|||
27794328|NCT02203331|54249315|FG000|Overall Study|Lost to Follow-up|0|||
27794329|NCT02203331|54249316|FG001|Overall Study|Lost to Follow-up|0|||
27794330|NCT02203331|54249317|FG002|Overall Study|Lost to Follow-up|0|||
27794331|NCT02203331|54249318|FG003|Overall Study|Lost to Follow-up|0|||
27794332|NCT02203331|54249319|FG004|Overall Study|Lost to Follow-up|1|||
27794333|NCT02203331|54249320|FG005|Overall Study|Lost to Follow-up|0|||
27794334|NCT01893411|54249337|FG000|Overall Study|Protocol Violation|1|||
27794335|NCT01893411|54249338|FG001|Overall Study|Protocol Violation|0|||
27794336|NCT01893411|54249339|FG002|Overall Study|Protocol Violation|0|||
27794337|NCT01893411|54249337|FG000|Overall Study|Physician Decision|1|||
27794338|NCT01893411|54249338|FG001|Overall Study|Physician Decision|1|||
27794339|NCT01893411|54249339|FG002|Overall Study|Physician Decision|2|||
27794340|NCT01893411|54249337|FG000|Overall Study|Lack of Efficacy|2|||
27794341|NCT01893411|54249338|FG001|Overall Study|Lack of Efficacy|1|||
27794342|NCT01893411|54249339|FG002|Overall Study|Lack of Efficacy|0|||
27794343|NCT01893411|54249337|FG000|Overall Study|Other|3|||
27794344|NCT01893411|54249338|FG001|Overall Study|Other|1|||
27794345|NCT01893411|54249339|FG002|Overall Study|Other|3|||
27794346|NCT01893411|54249337|FG000|Overall Study|Adverse Event|1|||
27794347|NCT01893411|54249338|FG001|Overall Study|Adverse Event|0|||
27794348|NCT01893411|54249339|FG002|Overall Study|Adverse Event|0|||
27794349|NCT01893411|54249337|FG000|Overall Study|Withdrawal by Subject|7|||
27794350|NCT01893411|54249338|FG001|Overall Study|Withdrawal by Subject|4|||
27794351|NCT01893411|54249339|FG002|Overall Study|Withdrawal by Subject|3|||
27794352|NCT01893411|54249337|FG000|Overall Study|Lost to Follow-up|2|||
27794353|NCT01893411|54249338|FG001|Overall Study|Lost to Follow-up|0|||
27794354|NCT01893411|54249339|FG002|Overall Study|Lost to Follow-up|1|||
27794355|NCT02232425|54249349|FG000|Overall Study|Lost to Follow-up|6|||
27794356|NCT02232425|54249350|FG001|Overall Study|Lost to Follow-up|2|||
27794357|NCT02232425|54249349|FG000|Overall Study|Adverse Event|2|||
27794358|NCT02232425|54249350|FG001|Overall Study|Adverse Event|0|||
27794359|NCT02232425|54249349|FG000|Overall Study|Withdrawal by Subject|5|||
27794360|NCT02232425|54249350|FG001|Overall Study|Withdrawal by Subject|6|||
27794361|NCT02232425|54249349|FG000|Overall Study|Lack of Efficacy|1|||
27794362|NCT02232425|54249350|FG001|Overall Study|Lack of Efficacy|0|||
27794363|NCT01631435|54249356|FG000|Overall Study|Adverse Event|2|||
27794364|NCT01631435|54249356|FG000|Overall Study|Withdrawal by Subject|2|||
27794365|NCT01631435|54249356|FG000|Overall Study|incomplete study procedure|5|||
27794366|NCT02230085|54249361|FG000|Overall Study|Physician Decision|1|||
27794367|NCT02230085|54249361|FG000|Overall Study|Withdrawal by Subject|3|||
27794368|NCT01882803|54249365|FG000|Overall Study|Disease Progression|53|||
27794369|NCT01882803|54249365|FG000|Overall Study|Adverse Event|22|||
27794370|NCT01882803|54249365|FG000|Overall Study|Death|7|||
27794371|NCT01882803|54249365|FG000|Overall Study|Physician Decision|7|||
27794372|NCT01882803|54249365|FG000|Overall Study|Protocol Violation|1|||
27794373|NCT01882803|54249365|FG000|Overall Study|Withdrawal by Subject|4|||
27794374|NCT02202785|54249373|FG000|Overall Study|Study Terminated by Sponsor|1|||
27794375|NCT02202785|54249374|FG001|Overall Study|Study Terminated by Sponsor|6|||
27794376|NCT02202785|54249375|FG002|Overall Study|Study Terminated by Sponsor|4|||
27794377|NCT02202785|54249373|FG000|Overall Study|Withdrawal by Subject|0|||
27794378|NCT02202785|54249374|FG001|Overall Study|Withdrawal by Subject|1|||
27794379|NCT02202785|54249375|FG002|Overall Study|Withdrawal by Subject|0|||
27794380|NCT02202785|54249373|FG000|Overall Study|Lost to Follow-up|0|||
27794381|NCT02202785|54249374|FG001|Overall Study|Lost to Follow-up|1|||
27794382|NCT02202785|54249375|FG002|Overall Study|Lost to Follow-up|0|||
27794383|NCT02202785|54249373|FG000|Overall Study|Reason not Specified|10|||
27794384|NCT02202785|54249374|FG001|Overall Study|Reason not Specified|7|||
27794385|NCT02202785|54249375|FG002|Overall Study|Reason not Specified|13|||
27794386|NCT01882647|54249385|FG000|Overall Study|Lost to Follow-up|2|||
27794387|NCT01882647|54249386|FG001|Overall Study|Lost to Follow-up|2|||
27794388|NCT01882647|54249385|FG000|Overall Study|Withdrawal by Subject|0|||
27794389|NCT01882647|54249386|FG001|Overall Study|Withdrawal by Subject|4|||
27794390|NCT01882257|54249395|FG000|Study Origination to Beginning Therapy|Withdrawal by Subject|0|||
27794391|NCT01882257|54249396|FG001|Study Origination to Beginning Therapy|Withdrawal by Subject|2|||
27794392|NCT01882257|54249397|FG002|Study Origination to Beginning Therapy|Withdrawal by Subject|1|||
27794393|NCT01882257|54249395|FG000|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0|||
27794394|NCT01882257|54249396|FG001|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11|||
27794395|NCT01882257|54249397|FG002|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4|||
27794396|NCT01862991|54249407|FG000|Overall Study|Lost to Follow-up|2|||
27794397|NCT01862991|54249408|FG001|Overall Study|Lost to Follow-up|1|||
27794398|NCT01862991|54249409|FG002|Overall Study|Lost to Follow-up|1|||
27794399|NCT01862991|54249407|FG000|Overall Study|Protocol Violation|1|||
27794400|NCT01862991|54249408|FG001|Overall Study|Protocol Violation|0|||
27794401|NCT01862991|54249409|FG002|Overall Study|Protocol Violation|0|||
27794402|NCT02202551|54249421|FG000|Overall Study|Adverse Event|8|||
27794403|NCT02202551|54249422|FG001|Overall Study|Adverse Event|19|||
27794404|NCT02202551|54249423|FG002|Overall Study|Adverse Event|5|||
27794405|NCT02202551|54249424|FG003|Overall Study|Adverse Event|9|||
27794406|NCT02202551|54249421|FG000|Overall Study|Death|3|||
27794407|NCT02202551|54249422|FG001|Overall Study|Death|2|||
27794408|NCT02202551|54249423|FG002|Overall Study|Death|1|||
27937669|NCT00904033|54594063|FG000|Overall Study|Physician Decision|0|||
27937670|NCT00904033|54594064|FG001|Overall Study|Physician Decision|0|||
27937671|NCT00904033|54594065|FG002|Overall Study|Physician Decision|1|||
27937672|NCT00904033|54594066|FG003|Overall Study|Physician Decision|0|||
27937673|NCT00904033|54594063|FG000|Overall Study|Unable to obtain final blood draw|0|||
27937674|NCT00904033|54594064|FG001|Overall Study|Unable to obtain final blood draw|0|||
27937675|NCT00904033|54594065|FG002|Overall Study|Unable to obtain final blood draw|0|||
27937676|NCT00904033|54594066|FG003|Overall Study|Unable to obtain final blood draw|2|||
27937677|NCT00903877|54594077|FG000|Overall Study|Did not meet study criteria|33|||
27937678|NCT00903877|54594077|FG000|Overall Study|Withdrawal by Subject|3|||
27937679|NCT00903877|54594077|FG000|Overall Study|Adverse Event|2|||
27937680|NCT00903877|54594077|FG000|Overall Study|Lost to Follow-up|1|||
27937681|NCT00903877|54594077|FG000|Overall Study|Participation put on hold|4|||
27937682|NCT01241591|54594085|FG000|Overall Study|Lack of Efficacy|5|||
27937683|NCT01241591|54594086|FG001|Overall Study|Lack of Efficacy|2|||
27937684|NCT01241591|54594087|FG002|Overall Study|Lack of Efficacy|2|||
27937685|NCT01241591|54594088|FG003|Overall Study|Lack of Efficacy|3|||
27937686|NCT01241591|54594085|FG000|Overall Study|Protocol Violation|5|||
27937687|NCT01241591|54594086|FG001|Overall Study|Protocol Violation|2|||
27937688|NCT01241591|54594087|FG002|Overall Study|Protocol Violation|3|||
27937689|NCT01241591|54594088|FG003|Overall Study|Protocol Violation|0|||
27937690|NCT01241591|54594085|FG000|Overall Study|Lost to Follow-up|1|||
27937691|NCT01241591|54594086|FG001|Overall Study|Lost to Follow-up|2|||
27937692|NCT01241591|54594087|FG002|Overall Study|Lost to Follow-up|2|||
27937693|NCT01241591|54594088|FG003|Overall Study|Lost to Follow-up|2|||
27937694|NCT01241591|54594085|FG000|Overall Study|Screen Failure|3|||
28105629|NCT04841577|54763124|FG000|Overall Study|Other|0|||
27794409|NCT02202551|54249424|FG003|Overall Study|Death|1|||
27937695|NCT01241591|54594086|FG001|Overall Study|Screen Failure|2|||
27937696|NCT01241591|54594087|FG002|Overall Study|Screen Failure|1|||
27937697|NCT01241591|54594088|FG003|Overall Study|Screen Failure|0|||
27794410|NCT02202551|54249421|FG000|Overall Study|Lost to Follow-up|0|||
27794411|NCT02202551|54249422|FG001|Overall Study|Lost to Follow-up|1|||
27794412|NCT02202551|54249423|FG002|Overall Study|Lost to Follow-up|0|||
27794413|NCT02202551|54249424|FG003|Overall Study|Lost to Follow-up|1|||
27794414|NCT02202551|54249421|FG000|Overall Study|Needed to take excluded medication|0|||
27794415|NCT02202551|54249422|FG001|Overall Study|Needed to take excluded medication|2|||
27794416|NCT02202551|54249423|FG002|Overall Study|Needed to take excluded medication|0|||
27794417|NCT02202551|54249424|FG003|Overall Study|Needed to take excluded medication|1|||
27794418|NCT02202551|54249421|FG000|Overall Study|Subject moved away|0|||
27794419|NCT02202551|54249422|FG001|Overall Study|Subject moved away|1|||
27794420|NCT02202551|54249423|FG002|Overall Study|Subject moved away|0|||
27794421|NCT02202551|54249424|FG003|Overall Study|Subject moved away|0|||
27937698|NCT01241591|54594085|FG000|Overall Study|Withdrawal by Subject|6|||
27937699|NCT01241591|54594086|FG001|Overall Study|Withdrawal by Subject|4|||
27937700|NCT01241591|54594087|FG002|Overall Study|Withdrawal by Subject|2|||
27794422|NCT02202551|54249421|FG000|Overall Study|DBS surgery|3|||
27794423|NCT02202551|54249422|FG001|Overall Study|DBS surgery|0|||
27794424|NCT02202551|54249423|FG002|Overall Study|DBS surgery|0|||
27794425|NCT02202551|54249424|FG003|Overall Study|DBS surgery|0|||
27794426|NCT02202551|54249421|FG000|Overall Study|Dyskinesia upon taper|1|||
27794427|NCT02202551|54249422|FG001|Overall Study|Dyskinesia upon taper|0|||
27794428|NCT02202551|54249423|FG002|Overall Study|Dyskinesia upon taper|0|||
27794429|NCT02202551|54249424|FG003|Overall Study|Dyskinesia upon taper|0|||
27794430|NCT02202551|54249421|FG000|Overall Study|Lack of Efficacy|0|||
27794431|NCT02202551|54249422|FG001|Overall Study|Lack of Efficacy|1|||
27794432|NCT02202551|54249423|FG002|Overall Study|Lack of Efficacy|0|||
27794433|NCT02202551|54249424|FG003|Overall Study|Lack of Efficacy|0|||
27794434|NCT02202551|54249421|FG000|Overall Study|Physician Decision|1|||
27842632|NCT01443845|54331340|FG000|Overall Study|Adverse Event|64|||
27842633|NCT01443845|54331341|FG001|Overall Study|Adverse Event|138|||
27842634|NCT01443845|54331340|FG000|Overall Study|Withdrawal by Subject|63|||
27842635|NCT01443845|54331341|FG001|Overall Study|Withdrawal by Subject|67|||
27842636|NCT01443845|54331340|FG000|Overall Study|Military Conflict - Site Terminated|20|||
27794435|NCT02202551|54249422|FG001|Overall Study|Physician Decision|0|||
27794436|NCT02202551|54249423|FG002|Overall Study|Physician Decision|0|||
27794437|NCT02202551|54249424|FG003|Overall Study|Physician Decision|0|||
27794438|NCT02202551|54249421|FG000|Overall Study|Site closure|3|||
27794439|NCT02202551|54249422|FG001|Overall Study|Site closure|0|||
27794440|NCT02202551|54249423|FG002|Overall Study|Site closure|0|||
27794441|NCT02202551|54249424|FG003|Overall Study|Site closure|1|||
27794442|NCT02202551|54249421|FG000|Overall Study|Unable to complete visits per protocol|1|||
27794443|NCT02202551|54249422|FG001|Overall Study|Unable to complete visits per protocol|0|||
27794444|NCT02202551|54249423|FG002|Overall Study|Unable to complete visits per protocol|0|||
27794445|NCT02202551|54249424|FG003|Overall Study|Unable to complete visits per protocol|0|||
27794446|NCT02202551|54249421|FG000|Overall Study|Worsening Dyskinesia|0|||
27794447|NCT02202551|54249422|FG001|Overall Study|Worsening Dyskinesia|0|||
27794448|NCT02202551|54249423|FG002|Overall Study|Worsening Dyskinesia|0|||
27794449|NCT02202551|54249424|FG003|Overall Study|Worsening Dyskinesia|1|||
27794450|NCT02202551|54249421|FG000|Overall Study|Protocol Violation|0|||
27794451|NCT02202551|54249422|FG001|Overall Study|Protocol Violation|1|||
27794452|NCT02202551|54249423|FG002|Overall Study|Protocol Violation|0|||
27794453|NCT02202551|54249424|FG003|Overall Study|Protocol Violation|0|||
27794454|NCT02202551|54249421|FG000|Overall Study|Sponsor's decision|2|||
27794455|NCT02202551|54249422|FG001|Overall Study|Sponsor's decision|0|||
27794456|NCT02202551|54249423|FG002|Overall Study|Sponsor's decision|0|||
27794457|NCT02202551|54249424|FG003|Overall Study|Sponsor's decision|0|||
27794458|NCT02202551|54249421|FG000|Overall Study|Subject unwilling to proceed|1|||
27794459|NCT02202551|54249422|FG001|Overall Study|Subject unwilling to proceed|5|||
27794460|NCT02202551|54249423|FG002|Overall Study|Subject unwilling to proceed|3|||
27794461|NCT02202551|54249424|FG003|Overall Study|Subject unwilling to proceed|5|||
27794462|NCT02202551|54249421|FG000|Overall Study|Subject consent withdrawn|0|||
27794463|NCT02202551|54249422|FG001|Overall Study|Subject consent withdrawn|3|||
27794464|NCT02202551|54249423|FG002|Overall Study|Subject consent withdrawn|1|||
27794465|NCT02202551|54249424|FG003|Overall Study|Subject consent withdrawn|2|||
27794466|NCT02202551|54249421|FG000|Overall Study|eGFR<50mL/min/m2|2|||
27794467|NCT02202551|54249422|FG001|Overall Study|eGFR<50mL/min/m2|2|||
27794468|NCT02202551|54249423|FG002|Overall Study|eGFR<50mL/min/m2|0|||
27794469|NCT02202551|54249424|FG003|Overall Study|eGFR<50mL/min/m2|1|||
27794470|NCT02202317|54249438|FG000|Overall Study|Lost to Follow-up|1|||
27794471|NCT02118337|54249451|FG000|Overall Study|Other|1|||
27794472|NCT02118337|54249452|FG001|Overall Study|Other|0|||
27794473|NCT02118337|54249453|FG002|Overall Study|Other|0|||
27794474|NCT02118337|54249454|FG003|Overall Study|Other|0|||
27794475|NCT02118337|54249455|FG004|Overall Study|Other|2|||
27794476|NCT02118337|54249456|FG005|Overall Study|Other|3|||
27794477|NCT02118337|54249457|FG006|Overall Study|Other|1|||
27794478|NCT02118337|54249458|FG007|Overall Study|Other|28|||
27794479|NCT02118337|54249459|FG008|Overall Study|Other|15|||
27794480|NCT02118337|54249451|FG000|Overall Study|Lost to Follow-up|0|||
27794481|NCT02118337|54249452|FG001|Overall Study|Lost to Follow-up|0|||
27794482|NCT02118337|54249453|FG002|Overall Study|Lost to Follow-up|0|||
27794483|NCT02118337|54249454|FG003|Overall Study|Lost to Follow-up|0|||
27842637|NCT01443845|54331341|FG001|Overall Study|Military Conflict - Site Terminated|21|||
27794484|NCT02118337|54249455|FG004|Overall Study|Lost to Follow-up|0|||
27794485|NCT02118337|54249456|FG005|Overall Study|Lost to Follow-up|0|||
27794486|NCT02118337|54249457|FG006|Overall Study|Lost to Follow-up|0|||
27794487|NCT02118337|54249458|FG007|Overall Study|Lost to Follow-up|1|||
27794488|NCT02118337|54249459|FG008|Overall Study|Lost to Follow-up|0|||
27794489|NCT02118337|54249451|FG000|Overall Study|Withdrawal by Subject|1|||
27794490|NCT02118337|54249452|FG001|Overall Study|Withdrawal by Subject|3|||
27794491|NCT02118337|54249453|FG002|Overall Study|Withdrawal by Subject|2|||
27842638|NCT01443845|54331340|FG000|Overall Study|Lost to Follow-up|9|||
27794492|NCT02118337|54249454|FG003|Overall Study|Withdrawal by Subject|1|||
27794493|NCT02118337|54249455|FG004|Overall Study|Withdrawal by Subject|2|||
27794494|NCT02118337|54249456|FG005|Overall Study|Withdrawal by Subject|2|||
27794495|NCT02118337|54249457|FG006|Overall Study|Withdrawal by Subject|1|||
27794496|NCT02118337|54249458|FG007|Overall Study|Withdrawal by Subject|4|||
27794497|NCT02118337|54249459|FG008|Overall Study|Withdrawal by Subject|2|||
27794498|NCT02118337|54249451|FG000|Overall Study|Death|2|||
27794499|NCT02118337|54249452|FG001|Overall Study|Death|2|||
27794500|NCT02118337|54249453|FG002|Overall Study|Death|1|||
27794501|NCT02118337|54249454|FG003|Overall Study|Death|2|||
27794502|NCT02118337|54249455|FG004|Overall Study|Death|5|||
27794503|NCT02118337|54249456|FG005|Overall Study|Death|1|||
27794504|NCT02118337|54249457|FG006|Overall Study|Death|2|||
27794505|NCT02118337|54249458|FG007|Overall Study|Death|9|||
27794506|NCT02118337|54249459|FG008|Overall Study|Death|4|||
27794507|NCT02117713|54249483|FG000|Week 48|Adverse Event|4|||
27794508|NCT02117713|54249483|FG000|Week 48|Withdrawal by caregiver|2|||
27794509|NCT02117713|54249483|FG000|Week 48|Did not consent to Protocol Amendment 4|2|||
27794510|NCT02117713|54249483|FG000|Long Term Follow-up Treatment|Adverse Event|3|||
27794511|NCT02117713|54249483|FG000|Long Term Follow-up Treatment|Progressive Disease|2|||
27794512|NCT02117713|54249483|FG000|Long Term Follow-up Treatment|Non-Compliance with study drug|1|||
27794513|NCT02105467|54249497|FG000|Period 1|Lost to Follow-up|1|||
27794514|NCT02105467|54249498|FG001|Period 1|Lost to Follow-up|0|||
27794515|NCT02105467|54249497|FG000|Period 1|Death|1|||
27794516|NCT02105467|54249498|FG001|Period 1|Death|0|||
27794517|NCT02105467|54249497|FG000|Period 2|Lost to Follow-up|1|||
27794518|NCT02105467|54249498|FG001|Period 2|Lost to Follow-up|0|||
27794519|NCT02105467|54249497|FG000|Period 2|Death|1|||
27794520|NCT02105467|54249498|FG001|Period 2|Death|0|||
27794521|NCT02105467|54249497|FG000|Period 2|Withdrawal by Subject|0|||
27794522|NCT02105467|54249498|FG001|Period 2|Withdrawal by Subject|2|||
27794523|NCT02105467|54249497|FG000|Period 3|Lost to Follow-up|0|||
27794524|NCT02105467|54249498|FG001|Period 3|Lost to Follow-up|1|||
27794525|NCT02202161|54249513|FG000|Overall Study|Adverse Event|1|||
27794526|NCT02202161|54249514|FG001|Overall Study|Adverse Event|1|||
27794527|NCT02202161|54249515|FG002|Overall Study|Adverse Event|0|||
27794528|NCT02202161|54249516|FG003|Overall Study|Adverse Event|0|||
27794529|NCT02202161|54249517|FG004|Overall Study|Adverse Event|0|||
27794530|NCT02202161|54249518|FG005|Overall Study|Adverse Event|1|||
27794531|NCT02202161|54249519|FG006|Overall Study|Adverse Event|0|||
27794532|NCT02202161|54249520|FG007|Overall Study|Adverse Event|0|||
27794533|NCT02202161|54249513|FG000|Overall Study|Did not meet continuation criteria|0|||
27794534|NCT02202161|54249514|FG001|Overall Study|Did not meet continuation criteria|0|||
27794535|NCT02202161|54249515|FG002|Overall Study|Did not meet continuation criteria|0|||
27794536|NCT02202161|54249516|FG003|Overall Study|Did not meet continuation criteria|0|||
27794537|NCT02202161|54249517|FG004|Overall Study|Did not meet continuation criteria|0|||
27794538|NCT02202161|54249518|FG005|Overall Study|Did not meet continuation criteria|0|||
27794539|NCT02202161|54249519|FG006|Overall Study|Did not meet continuation criteria|0|||
27794540|NCT02202161|54249520|FG007|Overall Study|Did not meet continuation criteria|3|||
27794541|NCT02202161|54249513|FG000|Overall Study|Physician Decision|0|||
27794542|NCT02202161|54249514|FG001|Overall Study|Physician Decision|0|||
27794543|NCT02202161|54249515|FG002|Overall Study|Physician Decision|0|||
27794544|NCT02202161|54249516|FG003|Overall Study|Physician Decision|0|||
27794545|NCT02202161|54249517|FG004|Overall Study|Physician Decision|0|||
27794546|NCT02202161|54249518|FG005|Overall Study|Physician Decision|0|||
27794547|NCT02202161|54249519|FG006|Overall Study|Physician Decision|0|||
27794548|NCT02202161|54249520|FG007|Overall Study|Physician Decision|3|||
27794549|NCT02202161|54249513|FG000|Overall Study|Withdrawal by Subject|0|||
27794550|NCT02202161|54249514|FG001|Overall Study|Withdrawal by Subject|0|||
27794551|NCT02202161|54249515|FG002|Overall Study|Withdrawal by Subject|0|||
27794552|NCT02202161|54249516|FG003|Overall Study|Withdrawal by Subject|0|||
27794553|NCT02202161|54249517|FG004|Overall Study|Withdrawal by Subject|1|||
27794554|NCT02202161|54249518|FG005|Overall Study|Withdrawal by Subject|0|||
27842639|NCT01443845|54331341|FG001|Overall Study|Lost to Follow-up|13|||
27842640|NCT01549652|54331350|FG000|Overall Study|Did Not Receive Allocated Intervention|0|||
27842641|NCT01549652|54331351|FG001|Overall Study|Did Not Receive Allocated Intervention|0|||
27794555|NCT02202161|54249519|FG006|Overall Study|Withdrawal by Subject|0|||
27842642|NCT01549652|54331352|FG002|Overall Study|Did Not Receive Allocated Intervention|2|||
27794556|NCT02202161|54249520|FG007|Overall Study|Withdrawal by Subject|0|||
27794557|NCT01461928|54249539|FG000|Induction (up to 8 Months)|Adverse Event|76|||
27794558|NCT01461928|54249540|FG001|Induction (up to 8 Months)|Adverse Event|0|||
27794559|NCT01461928|54249541|FG002|Induction (up to 8 Months)|Adverse Event|0|||
27794560|NCT01461928|54249539|FG000|Induction (up to 8 Months)|Death|3|||
27794561|NCT01461928|54249540|FG001|Induction (up to 8 Months)|Death|0|||
27794562|NCT01461928|54249541|FG002|Induction (up to 8 Months)|Death|0|||
27794563|NCT01461928|54249539|FG000|Induction (up to 8 Months)|Lost to Follow-up|5|||
27794564|NCT01461928|54249540|FG001|Induction (up to 8 Months)|Lost to Follow-up|0|||
27794565|NCT01461928|54249541|FG002|Induction (up to 8 Months)|Lost to Follow-up|0|||
27794566|NCT01461928|54249539|FG000|Induction (up to 8 Months)|Physician Decision|9|||
27794567|NCT01461928|54249540|FG001|Induction (up to 8 Months)|Physician Decision|0|||
27794568|NCT01461928|54249541|FG002|Induction (up to 8 Months)|Physician Decision|0|||
27794569|NCT01461928|54249539|FG000|Induction (up to 8 Months)|Withdrawal by Subject|18|||
27794570|NCT01461928|54249540|FG001|Induction (up to 8 Months)|Withdrawal by Subject|0|||
27794571|NCT01461928|54249541|FG002|Induction (up to 8 Months)|Withdrawal by Subject|0|||
27794572|NCT01461928|54249539|FG000|Induction (up to 8 Months)|Disease progression|45|||
27794573|NCT01461928|54249540|FG001|Induction (up to 8 Months)|Disease progression|0|||
27794574|NCT01461928|54249541|FG002|Induction (up to 8 Months)|Disease progression|0|||
27794575|NCT01461928|54249539|FG000|Induction (up to 8 Months)|Eligibility criteria deviation|10|||
27794576|NCT01461928|54249540|FG001|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
27794577|NCT01461928|54249541|FG002|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
27794578|NCT01461928|54249539|FG000|Induction (up to 8 Months)|Completed Induction, no Maint I received|11|||
27794579|NCT01461928|54249540|FG001|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
27794580|NCT01461928|54249541|FG002|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
27794581|NCT01461928|54249539|FG000|Induction (up to 8 Months)|Not responding to treatment|11|||
27794582|NCT01461928|54249540|FG001|Induction (up to 8 Months)|Not responding to treatment|0|||
27794583|NCT01461928|54249541|FG002|Induction (up to 8 Months)|Not responding to treatment|0|||
27794584|NCT01461928|54249539|FG000|Induction (up to 8 Months)|Termination of study in Switzerland|1|||
27794585|NCT01461928|54249540|FG001|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
27794586|NCT01461928|54249541|FG002|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
27794587|NCT01461928|54249539|FG000|Induction (up to 8 Months)|Treated before eligibility was confirmed|1|||
27794588|NCT01461928|54249540|FG001|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
27794589|NCT01461928|54249541|FG002|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
27794590|NCT01461928|54249539|FG000|Induction (up to 8 Months)|Sponsor decision|1|||
27794591|NCT01461928|54249540|FG001|Induction (up to 8 Months)|Sponsor decision|0|||
27794592|NCT01461928|54249541|FG002|Induction (up to 8 Months)|Sponsor decision|0|||
27794593|NCT01461928|54249539|FG000|Induction (up to 8 Months)|Protocol deviation|2|||
27794594|NCT01461928|54249540|FG001|Induction (up to 8 Months)|Protocol deviation|0|||
27794595|NCT01461928|54249541|FG002|Induction (up to 8 Months)|Protocol deviation|0|||
27794596|NCT01461928|54249539|FG000|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1|||
27794597|NCT01461928|54249540|FG001|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
27794598|NCT01461928|54249541|FG002|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
27794599|NCT01461928|54249539|FG000|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1|||
27794600|NCT01461928|54249540|FG001|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
27794601|NCT01461928|54249541|FG002|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
27794602|NCT01461928|54249539|FG000|Induction (up to 8 Months)|Promotor request|1|||
27794603|NCT01461928|54249540|FG001|Induction (up to 8 Months)|Promotor request|0|||
27794604|NCT01461928|54249541|FG002|Induction (up to 8 Months)|Promotor request|0|||
27794605|NCT01461928|54249539|FG000|Induction (up to 8 Months)|Exceeded time limit for next cycle|1|||
27794606|NCT01461928|54249540|FG001|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
27794607|NCT01461928|54249541|FG002|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
27794608|NCT01461928|54249539|FG000|Induction (up to 8 Months)|Medical advisor request|1|||
27794609|NCT01461928|54249540|FG001|Induction (up to 8 Months)|Medical advisor request|0|||
27794610|NCT01461928|54249541|FG002|Induction (up to 8 Months)|Medical advisor request|0|||
27794611|NCT01461928|54249539|FG000|Maintenance I (24 Months)|Death|3|||
27794612|NCT01461928|54249540|FG001|Maintenance I (24 Months)|Death|0|||
27794613|NCT01461928|54249541|FG002|Maintenance I (24 Months)|Death|0|||
27794614|NCT01461928|54249539|FG000|Maintenance I (24 Months)|Withdrawal by Subject|32|||
27794615|NCT01461928|54249540|FG001|Maintenance I (24 Months)|Withdrawal by Subject|0|||
27794616|NCT01461928|54249541|FG002|Maintenance I (24 Months)|Withdrawal by Subject|0|||
27794617|NCT01461928|54249539|FG000|Maintenance I (24 Months)|Lost to Follow-up|2|||
27794618|NCT01461928|54249540|FG001|Maintenance I (24 Months)|Lost to Follow-up|0|||
27794619|NCT01461928|54249541|FG002|Maintenance I (24 Months)|Lost to Follow-up|0|||
27794620|NCT01461928|54249539|FG000|Maintenance I (24 Months)|Diseases progression|91|||
27794621|NCT01461928|54249540|FG001|Maintenance I (24 Months)|Diseases progression|0|||
27794622|NCT01461928|54249541|FG002|Maintenance I (24 Months)|Diseases progression|0|||
27937701|NCT01241591|54594088|FG003|Overall Study|Withdrawal by Subject|2|||
27937702|NCT01241591|54594085|FG000|Overall Study|Other|0|||
27937703|NCT01241591|54594086|FG001|Overall Study|Other|1|||
27937704|NCT01241591|54594087|FG002|Overall Study|Other|0|||
27794623|NCT01461928|54249539|FG000|Maintenance I (24 Months)|Adverse Event|70|||
27794624|NCT01461928|54249540|FG001|Maintenance I (24 Months)|Adverse Event|0|||
27794625|NCT01461928|54249541|FG002|Maintenance I (24 Months)|Adverse Event|0|||
27794626|NCT01461928|54249539|FG000|Maintenance I (24 Months)|Physician Decision|9|||
27937705|NCT01241591|54594088|FG003|Overall Study|Other|1|||
27937706|NCT01241591|54594085|FG000|Overall Study|Adverse Event|3|||
27937707|NCT01241591|54594086|FG001|Overall Study|Adverse Event|11|||
27937708|NCT01241591|54594087|FG002|Overall Study|Adverse Event|12|||
27937709|NCT01241591|54594088|FG003|Overall Study|Adverse Event|4|||
27937710|NCT00906373|54594100|FG000|Overall Study|Withdrawal by Subject|0|||
27937711|NCT00906373|54594101|FG001|Overall Study|Withdrawal by Subject|5|||
27937712|NCT00906373|54594100|FG000|Overall Study|Other|0|||
27937713|NCT00906373|54594101|FG001|Overall Study|Other|1|||
27937714|NCT00906373|54594100|FG000|Overall Study|Still on treatment at cutoff date|0|||
27937715|NCT00906373|54594101|FG001|Overall Study|Still on treatment at cutoff date|2|||
27937716|NCT00905437|54594110|FG000|Overall Study|Adverse Event|3|||
27937717|NCT00905437|54594111|FG001|Overall Study|Adverse Event|2|||
27937718|NCT00905437|54594110|FG000|Overall Study|Lost to Follow-up|0|||
27937719|NCT00905437|54594111|FG001|Overall Study|Lost to Follow-up|1|||
27937720|NCT00905437|54594110|FG000|Overall Study|Withdrawal by Subject|0|||
27937721|NCT00905437|54594111|FG001|Overall Study|Withdrawal by Subject|1|||
27937722|NCT00905437|54594110|FG000|Overall Study|Other|5|||
27937723|NCT00905437|54594111|FG001|Overall Study|Other|6|||
27937724|NCT01238861|54594123|FG000|Overall Study|Lost to Follow-up|4|||
27937725|NCT01238861|54594124|FG001|Overall Study|Lost to Follow-up|2|||
27937726|NCT01238861|54594125|FG002|Overall Study|Lost to Follow-up|3|||
27937727|NCT01238861|54594126|FG003|Overall Study|Lost to Follow-up|1|||
27937728|NCT01238861|54594127|FG004|Overall Study|Lost to Follow-up|1|||
27937729|NCT01238861|54594128|FG005|Overall Study|Lost to Follow-up|2|||
27937730|NCT01238861|54594123|FG000|Overall Study|Unplanned surgery|1|||
27937731|NCT01238861|54594124|FG001|Overall Study|Unplanned surgery|0|||
27937732|NCT01238861|54594125|FG002|Overall Study|Unplanned surgery|0|||
27937733|NCT01238861|54594126|FG003|Overall Study|Unplanned surgery|0|||
27937734|NCT01238861|54594127|FG004|Overall Study|Unplanned surgery|0|||
27937735|NCT01238861|54594128|FG005|Overall Study|Unplanned surgery|0|||
27937736|NCT01238861|54594123|FG000|Overall Study|Did not meet entry ACQ-6 criteria|0|||
27937737|NCT01238861|54594124|FG001|Overall Study|Did not meet entry ACQ-6 criteria|0|||
27937738|NCT01238861|54594125|FG002|Overall Study|Did not meet entry ACQ-6 criteria|1|||
27937739|NCT01238861|54594126|FG003|Overall Study|Did not meet entry ACQ-6 criteria|0|||
27937740|NCT01238861|54594127|FG004|Overall Study|Did not meet entry ACQ-6 criteria|1|||
27937741|NCT01238861|54594128|FG005|Overall Study|Did not meet entry ACQ-6 criteria|1|||
27937742|NCT01238861|54594123|FG000|Overall Study|Incorrect enrollment/randomization|0|||
27937743|NCT01238861|54594124|FG001|Overall Study|Incorrect enrollment/randomization|0|||
27937744|NCT01238861|54594125|FG002|Overall Study|Incorrect enrollment/randomization|1|||
27937745|NCT01238861|54594126|FG003|Overall Study|Incorrect enrollment/randomization|0|||
27937746|NCT01238861|54594127|FG004|Overall Study|Incorrect enrollment/randomization|1|||
27937747|NCT01238861|54594128|FG005|Overall Study|Incorrect enrollment/randomization|0|||
27937748|NCT01238861|54594123|FG000|Overall Study|Subject traveled to Argentina by 1 year|0|||
27937749|NCT01238861|54594124|FG001|Overall Study|Subject traveled to Argentina by 1 year|0|||
27937750|NCT01238861|54594125|FG002|Overall Study|Subject traveled to Argentina by 1 year|1|||
27937751|NCT01238861|54594126|FG003|Overall Study|Subject traveled to Argentina by 1 year|0|||
27937752|NCT01238861|54594127|FG004|Overall Study|Subject traveled to Argentina by 1 year|0|||
27937753|NCT01238861|54594128|FG005|Overall Study|Subject traveled to Argentina by 1 year|0|||
27937754|NCT01238861|54594123|FG000|Overall Study|Subject moved out of state/area|0|||
27794627|NCT01461928|54249540|FG001|Maintenance I (24 Months)|Physician Decision|0|||
27794628|NCT01461928|54249541|FG002|Maintenance I (24 Months)|Physician Decision|0|||
27794629|NCT01461928|54249539|FG000|Maintenance I (24 Months)|Did not meet randomization criteria|2|||
27794630|NCT01461928|54249540|FG001|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
27794631|NCT01461928|54249541|FG002|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
27794632|NCT01461928|54249539|FG000|Maintenance I (24 Months)|Did not perform scheduled assessment|2|||
27794633|NCT01461928|54249540|FG001|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
27794634|NCT01461928|54249541|FG002|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
27937755|NCT01238861|54594124|FG001|Overall Study|Subject moved out of state/area|0|||
27937756|NCT01238861|54594125|FG002|Overall Study|Subject moved out of state/area|1|||
27937757|NCT01238861|54594126|FG003|Overall Study|Subject moved out of state/area|1|||
27937758|NCT01238861|54594127|FG004|Overall Study|Subject moved out of state/area|0|||
27937759|NCT01238861|54594128|FG005|Overall Study|Subject moved out of state/area|0|||
27937760|NCT01238861|54594123|FG000|Overall Study|Strongyloides stercoralis antibodies +|0|||
27937761|NCT01238861|54594124|FG001|Overall Study|Strongyloides stercoralis antibodies +|0|||
28105630|NCT04841577|54763125|FG001|Overall Study|Other|1|||
27794635|NCT01461928|54249539|FG000|Maintenance I (24 Months)|Delay in rituximab administration|1|||
27794636|NCT01461928|54249540|FG001|Maintenance I (24 Months)|Delay in rituximab administration|0|||
27794637|NCT01461928|54249541|FG002|Maintenance I (24 Months)|Delay in rituximab administration|0|||
27794638|NCT01461928|54249539|FG000|Maintenance I (24 Months)|Not compliant|1|||
27937762|NCT01238861|54594125|FG002|Overall Study|Strongyloides stercoralis antibodies +|0|||
27937763|NCT01238861|54594126|FG003|Overall Study|Strongyloides stercoralis antibodies +|1|||
27937764|NCT01238861|54594127|FG004|Overall Study|Strongyloides stercoralis antibodies +|0|||
27937765|NCT01238861|54594128|FG005|Overall Study|Strongyloides stercoralis antibodies +|0|||
27937766|NCT01238861|54594123|FG000|Overall Study|Personal problems|0|||
27937767|NCT01238861|54594124|FG001|Overall Study|Personal problems|0|||
27937768|NCT01238861|54594125|FG002|Overall Study|Personal problems|0|||
27937769|NCT01238861|54594126|FG003|Overall Study|Personal problems|1|||
27937770|NCT01238861|54594127|FG004|Overall Study|Personal problems|0|||
27937771|NCT01238861|54594128|FG005|Overall Study|Personal problems|0|||
27937772|NCT01238861|54594123|FG000|Overall Study|Unable to continue visits|0|||
27937773|NCT01238861|54594124|FG001|Overall Study|Unable to continue visits|0|||
27937774|NCT01238861|54594125|FG002|Overall Study|Unable to continue visits|0|||
27937775|NCT01238861|54594126|FG003|Overall Study|Unable to continue visits|1|||
27937776|NCT01238861|54594127|FG004|Overall Study|Unable to continue visits|0|||
27937777|NCT01238861|54594128|FG005|Overall Study|Unable to continue visits|1|||
27937778|NCT01238861|54594123|FG000|Overall Study|Serious adverse event|0|||
27937779|NCT01238861|54594124|FG001|Overall Study|Serious adverse event|0|||
27937780|NCT01238861|54594125|FG002|Overall Study|Serious adverse event|0|||
27937781|NCT01238861|54594126|FG003|Overall Study|Serious adverse event|0|||
27937782|NCT01238861|54594127|FG004|Overall Study|Serious adverse event|0|||
27937783|NCT01238861|54594128|FG005|Overall Study|Serious adverse event|1|||
27937784|NCT01238861|54594123|FG000|Overall Study|Lack of compliance|0|||
27937785|NCT01238861|54594124|FG001|Overall Study|Lack of compliance|0|||
27937786|NCT01238861|54594125|FG002|Overall Study|Lack of compliance|0|||
27937787|NCT01238861|54594126|FG003|Overall Study|Lack of compliance|0|||
27937788|NCT01238861|54594127|FG004|Overall Study|Lack of compliance|0|||
27937789|NCT01238861|54594128|FG005|Overall Study|Lack of compliance|1|||
27937790|NCT01238861|54594123|FG000|Overall Study|Adverse Event|0|||
27937791|NCT01238861|54594124|FG001|Overall Study|Adverse Event|1|||
27937792|NCT01238861|54594125|FG002|Overall Study|Adverse Event|0|||
27937793|NCT01238861|54594126|FG003|Overall Study|Adverse Event|0|||
27937794|NCT01238861|54594127|FG004|Overall Study|Adverse Event|0|||
27937795|NCT01238861|54594128|FG005|Overall Study|Adverse Event|0|||
27937796|NCT01238861|54594123|FG000|Overall Study|Withdrawal by Subject|6|||
27937797|NCT01238861|54594124|FG001|Overall Study|Withdrawal by Subject|5|||
27937798|NCT01238861|54594125|FG002|Overall Study|Withdrawal by Subject|4|||
27937799|NCT01238861|54594126|FG003|Overall Study|Withdrawal by Subject|8|||
27937800|NCT01238861|54594127|FG004|Overall Study|Withdrawal by Subject|10|||
27937801|NCT01238861|54594128|FG005|Overall Study|Withdrawal by Subject|9|||
27937802|NCT00903409|54594151|FG000|Overall Study|Adverse Event|11|||
27937803|NCT00903409|54594152|FG001|Overall Study|Adverse Event|9|||
27937804|NCT00903409|54594151|FG000|Overall Study|Non-compliance with Protocol|1|||
27937805|NCT00903409|54594152|FG001|Overall Study|Non-compliance with Protocol|1|||
27937806|NCT00903409|54594151|FG000|Overall Study|Laboratory Abnormality|2|||
27937807|NCT00903409|54594152|FG001|Overall Study|Laboratory Abnormality|0|||
27937808|NCT00903409|54594151|FG000|Overall Study|Withdrawal by Subject|8|||
27937809|NCT00903409|54594152|FG001|Overall Study|Withdrawal by Subject|8|||
27842643|NCT01549652|54331353|FG003|Overall Study|Did Not Receive Allocated Intervention|0|||
27842644|NCT01549652|54331350|FG000|Overall Study|Study Drug Titration Failure|5|||
27937810|NCT00903409|54594151|FG000|Overall Study|Other|2|||
27937811|NCT00903409|54594152|FG001|Overall Study|Other|3|||
27937812|NCT00903409|54594151|FG000|Overall Study|Lost to Follow-up|2|||
27937813|NCT00903409|54594152|FG001|Overall Study|Lost to Follow-up|6|||
27937814|NCT01237223|54594166|FG000|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29|||
27937815|NCT01237223|54594167|FG001|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
27937816|NCT01237223|54594168|FG002|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
27937817|NCT01237223|54594169|FG003|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
27937818|NCT01237223|54594170|FG004|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
27937819|NCT01237223|54594171|FG005|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
27937820|NCT01237223|54594166|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25|||
27794639|NCT01461928|54249540|FG001|Maintenance I (24 Months)|Not compliant|0|||
27794640|NCT01461928|54249541|FG002|Maintenance I (24 Months)|Not compliant|0|||
27794641|NCT01461928|54249539|FG000|Maintenance I (24 Months)|Did not meet criteria|5|||
27794642|NCT01461928|54249540|FG001|Maintenance I (24 Months)|Did not meet criteria|0|||
27794643|NCT01461928|54249541|FG002|Maintenance I (24 Months)|Did not meet criteria|0|||
27794644|NCT01461928|54249539|FG000|Maintenance II (15 Months)|Adverse Event|0|||
27794645|NCT01461928|54249540|FG001|Maintenance II (15 Months)|Adverse Event|2|||
27794646|NCT01461928|54249541|FG002|Maintenance II (15 Months)|Adverse Event|0|||
27794647|NCT01461928|54249539|FG000|Maintenance II (15 Months)|Death|0|||
27794648|NCT01461928|54249540|FG001|Maintenance II (15 Months)|Death|10|||
28017231|NCT00325195|54676507|FG000|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
28017232|NCT00325195|54676508|FG001|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
28017233|NCT00325195|54676509|FG002|Received Intervention: ITT Population|Protocol violation/non-compliance|0|||
28017234|NCT03976401|54676523|FG000|Overall Study|Adverse Event|2|||
28017235|NCT03976401|54676524|FG001|Overall Study|Adverse Event|0|||
28017236|NCT03976401|54676525|FG002|Overall Study|Adverse Event|4|||
28017237|NCT03976401|54676526|FG003|Overall Study|Adverse Event|1|||
28017238|NCT03976401|54676527|FG004|Overall Study|Adverse Event|1|||
28017239|NCT03976401|54676528|FG005|Overall Study|Adverse Event|0|||
28017240|NCT03976401|54676523|FG000|Overall Study|Withdrawal by Subject|0|||
28017241|NCT03976401|54676524|FG001|Overall Study|Withdrawal by Subject|1|||
28017242|NCT03976401|54676525|FG002|Overall Study|Withdrawal by Subject|0|||
28017243|NCT03976401|54676526|FG003|Overall Study|Withdrawal by Subject|0|||
28017244|NCT03976401|54676527|FG004|Overall Study|Withdrawal by Subject|0|||
27794649|NCT01461928|54249541|FG002|Maintenance II (15 Months)|Death|8|||
27794650|NCT01461928|54249539|FG000|Maintenance II (15 Months)|Physician Decision|0|||
27794651|NCT01461928|54249540|FG001|Maintenance II (15 Months)|Physician Decision|0|||
27794652|NCT01461928|54249541|FG002|Maintenance II (15 Months)|Physician Decision|4|||
27937821|NCT01237223|54594167|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
27937822|NCT01237223|54594168|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
27937823|NCT01237223|54594169|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
27937824|NCT01237223|54594170|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
27937825|NCT01237223|54594171|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
27937826|NCT01237223|54594166|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308|||
27937827|NCT01237223|54594167|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
27937828|NCT01237223|54594168|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
27937829|NCT01237223|54594169|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
27937830|NCT01237223|54594170|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
27937831|NCT01237223|54594171|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
27937832|NCT01237223|54594166|FG000|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28|||
27937833|NCT01237223|54594167|FG001|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
27937834|NCT01237223|54594168|FG002|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
27937835|NCT01237223|54594169|FG003|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
27937836|NCT01237223|54594170|FG004|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
28017245|NCT03976401|54676528|FG005|Overall Study|Withdrawal by Subject|1|||
27794653|NCT01461928|54249539|FG000|Maintenance II (15 Months)|Lost to Follow-up|0|||
27794654|NCT01461928|54249540|FG001|Maintenance II (15 Months)|Lost to Follow-up|1|||
27794655|NCT01461928|54249541|FG002|Maintenance II (15 Months)|Lost to Follow-up|0|||
27794656|NCT01461928|54249539|FG000|Maintenance II (15 Months)|Moved to another town|0|||
28017246|NCT03976401|54676523|FG000|Overall Study|Physician Decision|0|||
27794657|NCT01461928|54249540|FG001|Maintenance II (15 Months)|Moved to another town|1|||
27794658|NCT01461928|54249541|FG002|Maintenance II (15 Months)|Moved to another town|0|||
27794659|NCT01461928|54249539|FG000|Maintenance II (15 Months)|Disease progression|0|||
27794660|NCT01461928|54249540|FG001|Maintenance II (15 Months)|Disease progression|0|||
27794661|NCT01461928|54249541|FG002|Maintenance II (15 Months)|Disease progression|3|||
27794662|NCT01461928|54249539|FG000|Maintenance II (15 Months)|Withdrawal by Subject|0|||
27794663|NCT01461928|54249540|FG001|Maintenance II (15 Months)|Withdrawal by Subject|9|||
27794664|NCT01461928|54249541|FG002|Maintenance II (15 Months)|Withdrawal by Subject|8|||
27794665|NCT01461928|54249539|FG000|Maintenance II (15 Months)|Changed physician in another hospital|0|||
27794666|NCT01461928|54249540|FG001|Maintenance II (15 Months)|Changed physician in another hospital|0|||
27794667|NCT01461928|54249541|FG002|Maintenance II (15 Months)|Changed physician in another hospital|1|||
27794668|NCT01461928|54249539|FG000|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
27794669|NCT01461928|54249540|FG001|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
27794670|NCT01461928|54249541|FG002|Maintenance II (15 Months)|Squamous lung carcinoma|1|||
27794671|NCT01461928|54249539|FG000|Maintenance II (15 Months)|Withdrew informed consent|0|||
27794672|NCT01461928|54249540|FG001|Maintenance II (15 Months)|Withdrew informed consent|0|||
27794673|NCT01461928|54249541|FG002|Maintenance II (15 Months)|Withdrew informed consent|1|||
27794674|NCT01461928|54249539|FG000|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
27937837|NCT01237223|54594171|FG005|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
27937838|NCT01237223|54594166|FG000|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8|||
27937839|NCT01237223|54594167|FG001|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
27937840|NCT01237223|54594168|FG002|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
27937841|NCT01237223|54594169|FG003|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
27937842|NCT01237223|54594170|FG004|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
27937843|NCT01237223|54594171|FG005|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
27937844|NCT01237223|54594166|FG000|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12|||
27937845|NCT01237223|54594167|FG001|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4|||
27937846|NCT01237223|54594168|FG002|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3|||
27937847|NCT01237223|54594169|FG003|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
27937848|NCT01237223|54594170|FG004|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
27937849|NCT01237223|54594171|FG005|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1|||
27937850|NCT01237223|54594166|FG000|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20|||
27937851|NCT01237223|54594167|FG001|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6|||
27937852|NCT01237223|54594168|FG002|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7|||
27937853|NCT01237223|54594169|FG003|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
27937854|NCT01237223|54594170|FG004|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0|||
27937855|NCT01237223|54594171|FG005|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
27937856|NCT01237223|54594166|FG000|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
27937857|NCT01237223|54594167|FG001|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
27937858|NCT01237223|54594168|FG002|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
27937859|NCT01237223|54594169|FG003|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0|||
27937860|NCT01237223|54594170|FG004|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
27937861|NCT01237223|54594171|FG005|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
27937862|NCT01237223|54594166|FG000|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
28017247|NCT03976401|54676524|FG001|Overall Study|Physician Decision|0|||
28017248|NCT03976401|54676525|FG002|Overall Study|Physician Decision|1|||
28017249|NCT03976401|54676526|FG003|Overall Study|Physician Decision|0|||
28017250|NCT03976401|54676527|FG004|Overall Study|Physician Decision|0|||
28017251|NCT03976401|54676528|FG005|Overall Study|Physician Decision|0|||
28017252|NCT03976401|54676523|FG000|Overall Study|Lost to Follow-up|1|||
28017253|NCT03976401|54676524|FG001|Overall Study|Lost to Follow-up|2|||
28017254|NCT03976401|54676525|FG002|Overall Study|Lost to Follow-up|0|||
28017255|NCT03976401|54676526|FG003|Overall Study|Lost to Follow-up|0|||
28017256|NCT03976401|54676527|FG004|Overall Study|Lost to Follow-up|0|||
28017257|NCT03976401|54676528|FG005|Overall Study|Lost to Follow-up|0|||
28017258|NCT03976401|54676523|FG000|Overall Study|Protocol Violation|0|||
28017259|NCT03976401|54676524|FG001|Overall Study|Protocol Violation|1|||
28017260|NCT03976401|54676525|FG002|Overall Study|Protocol Violation|0|||
28017261|NCT03976401|54676526|FG003|Overall Study|Protocol Violation|0|||
28017262|NCT03976401|54676527|FG004|Overall Study|Protocol Violation|0|||
27794675|NCT01461928|54249540|FG001|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
27794676|NCT01461928|54249541|FG002|Maintenance II (15 Months)|Refused to be transferred to other site|1|||
27794677|NCT03097991|54249554|FG000|Overall Study|Didn't meet study criteria|8|||
27794678|NCT03097991|54249555|FG001|Overall Study|Didn't meet study criteria|0|||
27794679|NCT03097991|54249554|FG000|Overall Study|Withdrawal by Subject|12|||
27794680|NCT03097991|54249555|FG001|Overall Study|Withdrawal by Subject|6|||
27794681|NCT03097991|54249554|FG000|Overall Study|Death of Baby|3|||
27794682|NCT03097991|54249555|FG001|Overall Study|Death of Baby|1|||
27794683|NCT03097991|54249554|FG000|Overall Study|Lost to Follow-up|24|||
27794684|NCT03097991|54249555|FG001|Overall Study|Lost to Follow-up|38|||
27794685|NCT03097991|54249554|FG000|Overall Study|Adverse Event|3|||
27794686|NCT03097991|54249555|FG001|Overall Study|Adverse Event|5|||
27794687|NCT02623205|54249567|FG000|Overall Study|Lost to Follow-Up or Discontinued Intervention|4|||
27794688|NCT02623205|54249568|FG001|Overall Study|Lost to Follow-Up or Discontinued Intervention|3|||
27794689|NCT01500694|54249577|FG000|Overall Study|Adverse Event|4|||
27794690|NCT01500694|54249578|FG001|Overall Study|Adverse Event|3|||
27794691|NCT01500694|54249577|FG000|Overall Study|Protocol Violation|0|||
27794692|NCT01500694|54249578|FG001|Overall Study|Protocol Violation|1|||
27794693|NCT01500694|54249577|FG000|Overall Study|Withdrawal by Subject|23|||
27794694|NCT01500694|54249578|FG001|Overall Study|Withdrawal by Subject|14|||
27794695|NCT01500694|54249577|FG000|Overall Study|Lost to Follow-up|2|||
27794696|NCT01500694|54249578|FG001|Overall Study|Lost to Follow-up|3|||
27794697|NCT01500694|54249577|FG000|Overall Study|Lack of Efficacy|14|||
28017263|NCT03976401|54676528|FG005|Overall Study|Protocol Violation|0|||
28017264|NCT03976401|54676523|FG000|Overall Study|Withdrew Consent|0|||
27794698|NCT01500694|54249578|FG001|Overall Study|Lack of Efficacy|5|||
27794699|NCT01500694|54249577|FG000|Overall Study|Other|9|||
27794700|NCT01500694|54249578|FG001|Overall Study|Other|3|||
27794701|NCT01500382|54249588|FG000|Washout Period|Study site went out of business|0|||
27794702|NCT01500382|54249589|FG001|Washout Period|Study site went out of business|0|||
27794703|NCT01500382|54249590|FG002|Washout Period|Study site went out of business|1|||
27794704|NCT01500382|54249591|FG003|Washout Period|Study site went out of business|0|||
27794705|NCT02137837|54249604|FG000|Overall Study|Adverse Event|0|||
27794706|NCT02137837|54249605|FG001|Overall Study|Adverse Event|2|||
27794707|NCT02137837|54249606|FG002|Overall Study|Adverse Event|1|||
28017265|NCT03976401|54676524|FG001|Overall Study|Withdrew Consent|0|||
28017266|NCT03976401|54676525|FG002|Overall Study|Withdrew Consent|0|||
28017267|NCT03976401|54676526|FG003|Overall Study|Withdrew Consent|1|||
28017268|NCT03976401|54676527|FG004|Overall Study|Withdrew Consent|0|||
28017269|NCT03976401|54676528|FG005|Overall Study|Withdrew Consent|0|||
28017270|NCT00685334|54676544|FG000|Overall Study|Withdrawal by Subject|5|||
28017271|NCT00685334|54676545|FG001|Overall Study|Withdrawal by Subject|6|||
27794708|NCT02137837|54249604|FG000|Overall Study|Refusal unrelated to adverse event|2|||
27794709|NCT02137837|54249605|FG001|Overall Study|Refusal unrelated to adverse event|2|||
27794710|NCT02137837|54249606|FG002|Overall Study|Refusal unrelated to adverse event|1|||
27794711|NCT02137837|54249604|FG000|Overall Study|Progression/relapse|9|||
27794712|NCT02137837|54249605|FG001|Overall Study|Progression/relapse|7|||
27794713|NCT02137837|54249606|FG002|Overall Study|Progression/relapse|7|||
27794714|NCT02137837|54249604|FG000|Overall Study|Not protocol specified|2|||
27794715|NCT02137837|54249605|FG001|Overall Study|Not protocol specified|1|||
27794716|NCT02137837|54249606|FG002|Overall Study|Not protocol specified|3|||
27794717|NCT01483690|54249621|FG000|Overall Study|Adverse Event|1|||
27794718|NCT01483690|54249622|FG001|Overall Study|Adverse Event|2|||
27794719|NCT01483690|54249621|FG000|Overall Study|clinical deterioration|1|||
27794720|NCT01483690|54249622|FG001|Overall Study|clinical deterioration|0|||
27794721|NCT01483690|54249621|FG000|Overall Study|Physician Decision|0|||
27794722|NCT01483690|54249622|FG001|Overall Study|Physician Decision|2|||
27794723|NCT01483690|54249621|FG000|Overall Study|exclusionary procedure|0|||
27794724|NCT01483690|54249622|FG001|Overall Study|exclusionary procedure|1|||
27794725|NCT02104765|54249635|FG000|Overall Study|Lost to Follow-up|0|||
27794726|NCT02104765|54249636|FG001|Overall Study|Lost to Follow-up|0|||
27794727|NCT02104765|54249637|FG002|Overall Study|Lost to Follow-up|1|||
27937863|NCT01237223|54594167|FG001|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
27937864|NCT01237223|54594168|FG002|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
27937865|NCT01237223|54594169|FG003|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
27937866|NCT01237223|54594170|FG004|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
27937867|NCT01237223|54594171|FG005|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1|||
27937868|NCT01237223|54594166|FG000|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0|||
27937869|NCT01237223|54594167|FG001|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
27937870|NCT01237223|54594168|FG002|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
27937871|NCT01237223|54594169|FG003|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2|||
27937872|NCT01237223|54594170|FG004|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
27937873|NCT01237223|54594171|FG005|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
27937874|NCT01236755|54594187|FG000|Spectacles Wearing Phase|Withdrawal by Subject|8|||
27937875|NCT01236755|54594187|FG000|Spectacles Wearing Phase|Lost to Follow-up|9|||
27794728|NCT02104765|54249638|FG003|Overall Study|Lost to Follow-up|0|||
27794729|NCT02104765|54249639|FG004|Overall Study|Lost to Follow-up|0|||
27794730|NCT02104765|54249640|FG005|Overall Study|Lost to Follow-up|0|||
27794731|NCT02104765|54249641|FG006|Overall Study|Lost to Follow-up|0|||
27794732|NCT02104765|54249635|FG000|Overall Study|Withdrawal by Subject|0|||
27794733|NCT02104765|54249636|FG001|Overall Study|Withdrawal by Subject|0|||
27794734|NCT02104765|54249637|FG002|Overall Study|Withdrawal by Subject|0|||
27794735|NCT02104765|54249638|FG003|Overall Study|Withdrawal by Subject|1|||
27794736|NCT02104765|54249639|FG004|Overall Study|Withdrawal by Subject|1|||
27794737|NCT02104765|54249640|FG005|Overall Study|Withdrawal by Subject|0|||
27794738|NCT02104765|54249641|FG006|Overall Study|Withdrawal by Subject|1|||
27794739|NCT01483144|54249666|FG000|Overall Study|Adverse Event|9|||
27794740|NCT01483144|54249667|FG001|Overall Study|Adverse Event|4|||
27794741|NCT01483144|54249668|FG002|Overall Study|Adverse Event|6|||
27794742|NCT01483144|54249666|FG000|Overall Study|Withdrawal by Subject|0|||
27794743|NCT01483144|54249667|FG001|Overall Study|Withdrawal by Subject|2|||
27794744|NCT01483144|54249668|FG002|Overall Study|Withdrawal by Subject|5|||
27794745|NCT01483144|54249666|FG000|Overall Study|Physician Decision|1|||
27794746|NCT01483144|54249667|FG001|Overall Study|Physician Decision|0|||
27794747|NCT01483144|54249668|FG002|Overall Study|Physician Decision|0|||
27937876|NCT01236755|54594187|FG000|Orthokeratology Wearing Phase|Withdrawal by Subject|5|||
27937877|NCT01236755|54594187|FG000|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3|||
27794748|NCT01483144|54249666|FG000|Overall Study|Lost to Follow-up|2|||
27794749|NCT01483144|54249667|FG001|Overall Study|Lost to Follow-up|4|||
28017272|NCT00685334|54676544|FG000|Overall Study|Lost to Follow-up|4|||
28017273|NCT00685334|54676545|FG001|Overall Study|Lost to Follow-up|0|||
27794750|NCT01483144|54249668|FG002|Overall Study|Lost to Follow-up|1|||
27794751|NCT01483144|54249666|FG000|Overall Study|Protocol Violation|3|||
27794752|NCT01483144|54249667|FG001|Overall Study|Protocol Violation|3|||
27794753|NCT01483144|54249668|FG002|Overall Study|Protocol Violation|3|||
27794754|NCT01881789|54249682|FG000|Overall Study|Withdrawal by Subject|0|||
27794755|NCT01881789|54249683|FG001|Overall Study|Withdrawal by Subject|2|||
27794756|NCT01881789|54249684|FG002|Overall Study|Withdrawal by Subject|1|||
27794757|NCT01881789|54249685|FG003|Overall Study|Withdrawal by Subject|0|||
27794758|NCT01881789|54249686|FG004|Overall Study|Withdrawal by Subject|1|||
27794759|NCT01881789|54249687|FG005|Overall Study|Withdrawal by Subject|1|||
27794760|NCT01881789|54249682|FG000|Overall Study|Study Terminated by Sponsor|0|||
27794761|NCT01881789|54249683|FG001|Overall Study|Study Terminated by Sponsor|0|||
27794762|NCT01881789|54249684|FG002|Overall Study|Study Terminated by Sponsor|0|||
27794763|NCT01881789|54249685|FG003|Overall Study|Study Terminated by Sponsor|0|||
27794764|NCT01881789|54249686|FG004|Overall Study|Study Terminated by Sponsor|0|||
27794765|NCT01881789|54249687|FG005|Overall Study|Study Terminated by Sponsor|1|||
27794766|NCT01881789|54249682|FG000|Overall Study|Other|3|||
27794767|NCT01881789|54249683|FG001|Overall Study|Other|5|||
27794768|NCT01881789|54249684|FG002|Overall Study|Other|2|||
27794769|NCT01881789|54249685|FG003|Overall Study|Other|3|||
27794770|NCT01881789|54249686|FG004|Overall Study|Other|1|||
27794771|NCT01881789|54249687|FG005|Overall Study|Other|1|||
27794772|NCT02075203|54249705|FG000|Overall Study|Withdrawal by Subject|1|||
27794773|NCT02075203|54249706|FG001|Overall Study|Withdrawal by Subject|0|||
27937878|NCT01236365|54594194|FG000|Overall Study|Lost to Follow-up|0|||
27937879|NCT01236365|54594195|FG001|Overall Study|Lost to Follow-up|2|||
27794774|NCT02075203|54249707|FG002|Overall Study|Withdrawal by Subject|1|||
27794775|NCT02075203|54249705|FG000|Overall Study|Adverse Event|1|||
27794776|NCT02075203|54249706|FG001|Overall Study|Adverse Event|0|||
27794777|NCT02075203|54249707|FG002|Overall Study|Adverse Event|0|||
27794778|NCT02075203|54249705|FG000|Overall Study|participant refused to use contraception|1|||
27794779|NCT02075203|54249706|FG001|Overall Study|participant refused to use contraception|0|||
27794780|NCT02075203|54249707|FG002|Overall Study|participant refused to use contraception|0|||
27794781|NCT01892163|54249717|FG000|Overall Study|Death|1|||
27794782|NCT01892163|54249718|FG001|Overall Study|Death|1|||
27794783|NCT01892163|54249717|FG000|Overall Study|Lost to Follow-up|1|||
27794784|NCT01892163|54249718|FG001|Overall Study|Lost to Follow-up|0|||
27794785|NCT01881009|54249726|FG000|Summer Camp Session (6 Days)|Unable to wear device|0|||
27794786|NCT01881009|54249727|FG001|Summer Camp Session (6 Days)|Unable to wear device|1|||
27794787|NCT01500226|54249736|FG000|Overall Study|Adverse Event|31|||
27794788|NCT01500226|54249737|FG001|Overall Study|Adverse Event|38|||
27794789|NCT01500226|54249736|FG000|Overall Study|Chemo Completed or Change in Therapy|235|||
27794790|NCT01500226|54249737|FG001|Overall Study|Chemo Completed or Change in Therapy|237|||
27794791|NCT01500226|54249736|FG000|Overall Study|Withdrawal by Subject|93|||
27794792|NCT01500226|54249737|FG001|Overall Study|Withdrawal by Subject|96|||
27794793|NCT01500226|54249736|FG000|Overall Study|Death|12|||
27794794|NCT01500226|54249737|FG001|Overall Study|Death|4|||
27794795|NCT01500226|54249736|FG000|Overall Study|Disease Progression|16|||
27794796|NCT01500226|54249737|FG001|Overall Study|Disease Progression|14|||
27794797|NCT01500226|54249736|FG000|Overall Study|Protocol Violation|53|||
27937880|NCT01236365|54594194|FG000|Overall Study|Moved Out of State|1|||
27937881|NCT01236365|54594195|FG001|Overall Study|Moved Out of State|0|||
27937882|NCT01236365|54594194|FG000|Overall Study|Dropped at Randomization due to high LFT|1|||
27937883|NCT01236365|54594195|FG001|Overall Study|Dropped at Randomization due to high LFT|0|||
27794798|NCT01500226|54249737|FG001|Overall Study|Protocol Violation|39|||
27794799|NCT01500226|54249736|FG000|Overall Study|Physician Decision|17|||
27794800|NCT01500226|54249737|FG001|Overall Study|Physician Decision|15|||
27794801|NCT01500226|54249736|FG000|Overall Study|Lack of Efficacy|14|||
27794802|NCT01500226|54249737|FG001|Overall Study|Lack of Efficacy|30|||
27794803|NCT01500226|54249736|FG000|Overall Study|Lost to Follow-up|9|||
27794804|NCT01500226|54249737|FG001|Overall Study|Lost to Follow-up|5|||
27794805|NCT01500226|54249736|FG000|Overall Study|Other Reasons|19|||
27794806|NCT01500226|54249737|FG001|Overall Study|Other Reasons|16|||
27794807|NCT02075047|54249745|FG000|Treatment Phase (4 Weeks)|Adverse Event|14|||
27794808|NCT02075047|54249746|FG001|Treatment Phase (4 Weeks)|Adverse Event|4|||
27794809|NCT02075047|54249745|FG000|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
27794810|NCT02075047|54249746|FG001|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
27937884|NCT01235975|54594215|FG000|Overall Study|Serious Adverse Event|0|||
27794811|NCT02075047|54249745|FG000|Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
27794812|NCT02075047|54249746|FG001|Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
27794813|NCT02075047|54249745|FG000|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|1|||
27937885|NCT01235975|54594216|FG001|Overall Study|Serious Adverse Event|1|||
27794814|NCT02075047|54249746|FG001|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|0|||
27794815|NCT02075047|54249745|FG000|Treatment Phase (4 Weeks)|Screen Failure|1|||
27794816|NCT02075047|54249746|FG001|Treatment Phase (4 Weeks)|Screen Failure|0|||
27794817|NCT02075047|54249745|FG000|Treatment Phase (4 Weeks)|Other|1|||
27794818|NCT02075047|54249746|FG001|Treatment Phase (4 Weeks)|Other|1|||
27794819|NCT02075047|54249745|FG000|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|4|||
27794820|NCT02075047|54249746|FG001|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|2|||
27794821|NCT02075047|54249745|FG000|Follow up Phase (5 Weeks)|Adverse Event|14|||
27794822|NCT02075047|54249746|FG001|Follow up Phase (5 Weeks)|Adverse Event|4|||
27794823|NCT02075047|54249745|FG000|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
27794824|NCT02075047|54249746|FG001|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
27794825|NCT02075047|54249745|FG000|Follow up Phase (5 Weeks)|Lost to Follow-up|0|||
27794826|NCT02075047|54249746|FG001|Follow up Phase (5 Weeks)|Lost to Follow-up|1|||
27794827|NCT02075047|54249745|FG000|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|1|||
27794828|NCT02075047|54249746|FG001|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|0|||
27794829|NCT02075047|54249745|FG000|Follow up Phase (5 Weeks)|Screen Failure|1|||
27794830|NCT02075047|54249746|FG001|Follow up Phase (5 Weeks)|Screen Failure|0|||
27937886|NCT01235975|54594215|FG000|Overall Study|Withdrawal by Subject|8|||
27937887|NCT01235975|54594216|FG001|Overall Study|Withdrawal by Subject|2|||
27937888|NCT01235975|54594215|FG000|Overall Study|Migrated/moved from study area|2|||
27937889|NCT01235975|54594216|FG001|Overall Study|Migrated/moved from study area|1|||
27937890|NCT01235975|54594215|FG000|Overall Study|Lost to Follow-up|7|||
27937891|NCT01235975|54594216|FG001|Overall Study|Lost to Follow-up|3|||
27937892|NCT00903331|54594224|FG000|Overall Study|Death|4|||
27937893|NCT00903331|54594225|FG001|Overall Study|Death|8|||
27937894|NCT00903331|54594224|FG000|Overall Study|Withdrawal of consent|1|||
27937895|NCT00903331|54594225|FG001|Overall Study|Withdrawal of consent|8|||
27937896|NCT00903331|54594224|FG000|Overall Study|Lung transplant|0|||
27937897|NCT00903331|54594225|FG001|Overall Study|Lung transplant|2|||
27937898|NCT01235741|54594234|FG000|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9|||
27937899|NCT01235741|54594235|FG001|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
27937900|NCT01235741|54594236|FG002|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
27937901|NCT01235741|54594234|FG000|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121|||
27937902|NCT01235741|54594235|FG001|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
27937903|NCT01235741|54594236|FG002|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
27937904|NCT01235741|54594234|FG000|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1|||
27937905|NCT01235741|54594235|FG001|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
27937906|NCT01235741|54594236|FG002|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
27937907|NCT01235741|54594234|FG000|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1|||
27937908|NCT01235741|54594235|FG001|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
27937909|NCT01235741|54594236|FG002|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
27937910|NCT01235741|54594234|FG000|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5|||
27937911|NCT01235741|54594235|FG001|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
27937912|NCT01235741|54594236|FG002|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
27937913|NCT01235741|54594234|FG000|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4|||
27937914|NCT01235741|54594235|FG001|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
27937915|NCT01235741|54594236|FG002|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
27937916|NCT01235741|54594234|FG000|Randomized to Treatment|Withdrawal by Subject|0|||
27937917|NCT01235741|54594235|FG001|Randomized to Treatment|Withdrawal by Subject|0|||
27794831|NCT02075047|54249745|FG000|Follow up Phase (5 Weeks)|Other|1|||
27794832|NCT02075047|54249746|FG001|Follow up Phase (5 Weeks)|Other|2|||
27794833|NCT02075047|54249745|FG000|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|7|||
27794834|NCT02075047|54249746|FG001|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|4|||
27794835|NCT01859949|54249754|FG000|Overall Study|Family Matters|0|||
27794836|NCT01859949|54249755|FG001|Overall Study|Family Matters|1|||
27794837|NCT01859949|54249754|FG000|Overall Study|Physician Decision|2|||
27794838|NCT01859949|54249755|FG001|Overall Study|Physician Decision|4|||
27794839|NCT01859949|54249754|FG000|Overall Study|Withdrawal by Subject|11|||
27794840|NCT01859949|54249755|FG001|Overall Study|Withdrawal by Subject|10|||
27794841|NCT01859949|54249754|FG000|Overall Study|Protocol Violation|1|||
27794842|NCT01859949|54249755|FG001|Overall Study|Protocol Violation|1|||
27794843|NCT01859949|54249754|FG000|Overall Study|Adverse Event|0|||
27794844|NCT01859949|54249755|FG001|Overall Study|Adverse Event|1|||
27794845|NCT01859793|54249763|FG000|First Intervention (8 Weeks)|Protocol Violation|2|||
27794846|NCT01859793|54249764|FG001|First Intervention (8 Weeks)|Protocol Violation|0|||
27794847|NCT01859793|54249763|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
27794848|NCT01859793|54249764|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
27937918|NCT01235741|54594236|FG002|Randomized to Treatment|Withdrawal by Subject|1|||
27937919|NCT01235741|54594234|FG000|Randomized to Treatment|Adverse Event|0|||
27937920|NCT01235741|54594235|FG001|Randomized to Treatment|Adverse Event|1|||
27937921|NCT01235741|54594236|FG002|Randomized to Treatment|Adverse Event|1|||
27937922|NCT01235741|54594234|FG000|Randomized to Treatment|Sponsor terminated study|0|||
27937923|NCT01235741|54594235|FG001|Randomized to Treatment|Sponsor terminated study|35|||
27937924|NCT01235741|54594236|FG002|Randomized to Treatment|Sponsor terminated study|34|||
27794849|NCT01859793|54249763|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
27794850|NCT01859793|54249764|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
27794851|NCT01859793|54249763|FG000|Washout Period (4 Weeks)|Lost to Follow-up|1|||
27794852|NCT01859793|54249764|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
27794853|NCT01859715|54249773|FG000|Overall Study|No 2nd VAS|16|||
27794854|NCT01859715|54249774|FG001|Overall Study|No 2nd VAS|8|||
27794855|NCT01859715|54249775|FG002|Overall Study|No 2nd VAS|23|||
27794856|NCT01890915|54249787|FG000|Overall Study|Adverse Event|1|||
27794857|NCT01890915|54249788|FG001|Overall Study|Adverse Event|0|||
27794858|NCT01890915|54249787|FG000|Overall Study|Protocol Violation|2|||
27794859|NCT01890915|54249788|FG001|Overall Study|Protocol Violation|0|||
27794860|NCT01890915|54249787|FG000|Overall Study|Equipment Malfunction|0|||
27794861|NCT01890915|54249788|FG001|Overall Study|Equipment Malfunction|1|||
27794862|NCT01615263|54249796|FG000|Overall Study|Post-randomization exclusion|0|||
27794863|NCT01615263|54249797|FG001|Overall Study|Post-randomization exclusion|2|||
27794864|NCT01859403|54249814|FG000|Primary Endpoint Measure|Lost to Follow-up|0|||
27794865|NCT01859403|54249815|FG001|Primary Endpoint Measure|Lost to Follow-up|2|||
27794866|NCT01859403|54249814|FG000|Primary Endpoint Measure|Withdrawal by Subject|1|||
27794867|NCT01859403|54249815|FG001|Primary Endpoint Measure|Withdrawal by Subject|1|||
27794868|NCT01859403|54249814|FG000|Primary Endpoint Measure|Physician Decision|0|||
27794869|NCT01859403|54249815|FG001|Primary Endpoint Measure|Physician Decision|1|||
27794870|NCT01859403|54249814|FG000|Secondary Endpoint Measure|Withdrawal by Subject|6|||
27794871|NCT01859403|54249815|FG001|Secondary Endpoint Measure|Withdrawal by Subject|8|||
27794872|NCT01858701|54249821|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
27794873|NCT01858701|54249822|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
27794874|NCT01858701|54249821|FG000|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1|||
27794875|NCT01858701|54249822|FG001|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0|||
27794876|NCT01858701|54249821|FG000|Washout Period, 1-13 Days|Withdrawal by Subject|1|||
27794877|NCT01858701|54249822|FG001|Washout Period, 1-13 Days|Withdrawal by Subject|2|||
27794878|NCT01858701|54249821|FG000|Period 2, Second 30 Days of Wear|Comfort|0|||
27794879|NCT01858701|54249822|FG001|Period 2, Second 30 Days of Wear|Comfort|1|||
27794880|NCT01461538|54249831|FG000|Overall Study|Death|15|||
27794881|NCT01461538|54249832|FG001|Overall Study|Death|6|||
27794882|NCT01461538|54249833|FG002|Overall Study|Death|2|||
27794883|NCT01461538|54249831|FG000|Overall Study|Study Stopped by Sponsor|2|||
27794884|NCT01461538|54249832|FG001|Overall Study|Study Stopped by Sponsor|1|||
27794885|NCT01461538|54249833|FG002|Overall Study|Study Stopped by Sponsor|0|||
27794886|NCT01461538|54249831|FG000|Overall Study|Withdrawal by Subject|1|||
27794887|NCT01461538|54249832|FG001|Overall Study|Withdrawal by Subject|1|||
27794888|NCT01461538|54249833|FG002|Overall Study|Withdrawal by Subject|0|||
27937925|NCT01235741|54594234|FG000|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0|||
27937926|NCT01235741|54594235|FG001|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3|||
27937927|NCT01235741|54594236|FG002|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6|||
27937928|NCT01235741|54594234|FG000|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0|||
27937929|NCT01235741|54594235|FG001|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5|||
27937930|NCT01235741|54594236|FG002|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1|||
27937931|NCT01235741|54594234|FG000|Follow-Up Post Treatment up to Month 6|Other|0|||
27937932|NCT01235741|54594235|FG001|Follow-Up Post Treatment up to Month 6|Other|1|||
27937933|NCT01235741|54594236|FG002|Follow-Up Post Treatment up to Month 6|Other|0|||
27794889|NCT02117479|54249845|FG000|Overall Study|Death|13|||
27794890|NCT02117479|54249846|FG001|Overall Study|Death|8|||
27794891|NCT02117479|54249845|FG000|Overall Study|Adverse Event|8|||
27794892|NCT02117479|54249846|FG001|Overall Study|Adverse Event|16|||
27794893|NCT02117479|54249845|FG000|Overall Study|Subject decision|8|||
27794894|NCT02117479|54249846|FG001|Overall Study|Subject decision|9|||
27794895|NCT02117479|54249845|FG000|Overall Study|Disease progression|104|||
27794896|NCT02117479|54249846|FG001|Overall Study|Disease progression|108|||
27794897|NCT02117479|54249845|FG000|Overall Study|Noncompliance with study treatment|1|||
27794898|NCT02117479|54249846|FG001|Overall Study|Noncompliance with study treatment|0|||
27794899|NCT02117479|54249845|FG000|Overall Study|Study terminated by the sponsor|4|||
27794900|NCT02117479|54249846|FG001|Overall Study|Study terminated by the sponsor|6|||
27794901|NCT02117479|54249845|FG000|Overall Study|Physician Decision|7|||
27794902|NCT02117479|54249846|FG001|Overall Study|Physician Decision|2|||
27794903|NCT02117479|54249845|FG000|Overall Study|Other unspecified|11|||
27794904|NCT02117479|54249846|FG001|Overall Study|Other unspecified|7|||
27794905|NCT02229851|54249855|FG000|Main Phase (Double-blind Phase)|Unclassified|1|||
27937934|NCT01235507|54594248|FG000|Overall Study|Adverse Event|1|||
27937935|NCT01235507|54594248|FG000|Overall Study|Withdrawal by Subject|1|||
27937936|NCT01235351|54594254|FG000|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10|||
27794906|NCT02229851|54249856|FG001|Main Phase (Double-blind Phase)|Unclassified|2|||
27794907|NCT02229851|54249857|FG002|Main Phase (Double-blind Phase)|Unclassified|0|||
27794908|NCT02229851|54249858|FG003|Main Phase (Double-blind Phase)|Unclassified|0|||
27794909|NCT02229851|54249859|FG004|Main Phase (Double-blind Phase)|Unclassified|0|||
27794910|NCT02229851|54249860|FG005|Main Phase (Double-blind Phase)|Unclassified|0|||
27794911|NCT02229851|54249861|FG006|Main Phase (Double-blind Phase)|Unclassified|0|||
27794912|NCT02229851|54249855|FG000|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
27794913|NCT02229851|54249856|FG001|Main Phase (Double-blind Phase)|Lost to Follow-up|1|||
27794914|NCT02229851|54249857|FG002|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
27794915|NCT02229851|54249858|FG003|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
27794916|NCT02229851|54249859|FG004|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
27794917|NCT02229851|54249860|FG005|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
27794918|NCT02229851|54249861|FG006|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
27794919|NCT02229851|54249855|FG000|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
27794920|NCT02229851|54249856|FG001|Main Phase (Double-blind Phase)|Withdrawal by Subject|12|||
27794921|NCT02229851|54249857|FG002|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
27794922|NCT02229851|54249858|FG003|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
27794923|NCT02229851|54249859|FG004|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
27794924|NCT02229851|54249860|FG005|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
27794925|NCT02229851|54249861|FG006|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
27794926|NCT02229851|54249855|FG000|Main Phase (Double-blind Phase)|Protocol Violation|0|||
27794927|NCT02229851|54249856|FG001|Main Phase (Double-blind Phase)|Protocol Violation|0|||
27794928|NCT02229851|54249857|FG002|Main Phase (Double-blind Phase)|Protocol Violation|2|||
27794929|NCT02229851|54249858|FG003|Main Phase (Double-blind Phase)|Protocol Violation|0|||
27794930|NCT02229851|54249859|FG004|Main Phase (Double-blind Phase)|Protocol Violation|0|||
27794931|NCT02229851|54249860|FG005|Main Phase (Double-blind Phase)|Protocol Violation|0|||
27794932|NCT02229851|54249861|FG006|Main Phase (Double-blind Phase)|Protocol Violation|0|||
27794933|NCT02229851|54249855|FG000|Main Phase (Double-blind Phase)|Death|1|||
27794934|NCT02229851|54249856|FG001|Main Phase (Double-blind Phase)|Death|1|||
27794935|NCT02229851|54249857|FG002|Main Phase (Double-blind Phase)|Death|0|||
27794936|NCT02229851|54249858|FG003|Main Phase (Double-blind Phase)|Death|0|||
27794937|NCT02229851|54249859|FG004|Main Phase (Double-blind Phase)|Death|0|||
27794938|NCT02229851|54249860|FG005|Main Phase (Double-blind Phase)|Death|0|||
27794939|NCT02229851|54249861|FG006|Main Phase (Double-blind Phase)|Death|0|||
27794940|NCT02229851|54249855|FG000|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
27794941|NCT02229851|54249856|FG001|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
27794942|NCT02229851|54249857|FG002|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
27794943|NCT02229851|54249858|FG003|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
27794944|NCT02229851|54249859|FG004|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
27794945|NCT02229851|54249860|FG005|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
27794946|NCT02229851|54249861|FG006|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
27794947|NCT02229851|54249855|FG000|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
27794948|NCT02229851|54249856|FG001|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
27794949|NCT02229851|54249857|FG002|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
27794950|NCT02229851|54249858|FG003|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
27794951|NCT02229851|54249859|FG004|Extension Phase (Open-label Phase)|Withdrawal by Subject|4|||
27794952|NCT02229851|54249860|FG005|Extension Phase (Open-label Phase)|Withdrawal by Subject|3|||
27794953|NCT02229851|54249861|FG006|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
27794954|NCT02229851|54249855|FG000|Extension Phase (Open-label Phase)|Death|0|||
27794955|NCT02229851|54249856|FG001|Extension Phase (Open-label Phase)|Death|0|||
27794956|NCT02229851|54249857|FG002|Extension Phase (Open-label Phase)|Death|0|||
27794957|NCT02229851|54249858|FG003|Extension Phase (Open-label Phase)|Death|1|||
27794958|NCT02229851|54249859|FG004|Extension Phase (Open-label Phase)|Death|0|||
27794959|NCT02229851|54249860|FG005|Extension Phase (Open-label Phase)|Death|1|||
27794960|NCT02229851|54249861|FG006|Extension Phase (Open-label Phase)|Death|1|||
27937937|NCT01235351|54594255|FG001|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4|||
27937938|NCT01076205|54594265|FG000|Overall Study|Adverse Drug Reaction|299|||
27937939|NCT01076205|54594265|FG000|Overall Study|Lack of Effectiveness|1423|||
27937940|NCT01076205|54594265|FG000|Overall Study|Other Reason|1075|||
27937941|NCT01076205|54594265|FG000|Overall Study|Unknown Reason|71|||
27937942|NCT01076205|54594265|FG000|Overall Study|Lost to Follow-up|3151|||
27937943|NCT01234883|54594287|FG000|Overall Study|Early treatment release|8|||
27794961|NCT01482910|54249878|FG000|Overall Study|Adverse Event|6|||
27794962|NCT01482910|54249879|FG001|Overall Study|Adverse Event|5|||
27794963|NCT01482910|54249878|FG000|Overall Study|Lost to Follow-up|0|||
27794964|NCT01482910|54249879|FG001|Overall Study|Lost to Follow-up|1|||
27794965|NCT01482910|54249878|FG000|Overall Study|Protocol Violation|1|||
27794966|NCT01482910|54249879|FG001|Overall Study|Protocol Violation|1|||
27794967|NCT01482910|54249878|FG000|Overall Study|Withdrawal by Subject|7|||
27794968|NCT01482910|54249879|FG001|Overall Study|Withdrawal by Subject|2|||
27794969|NCT01482910|54249878|FG000|Overall Study|Death|1|||
27794970|NCT01482910|54249879|FG001|Overall Study|Death|0|||
27794971|NCT01626391|54249889|FG000|Overall Study|Physician Decision|1|||
27794972|NCT01626391|54249890|FG001|Overall Study|Physician Decision|0|||
27937944|NCT01234883|54594288|FG001|Overall Study|Early treatment release|10|||
27937945|NCT01234883|54594287|FG000|Overall Study|Parent/guardian withdrew consent|1|||
27794973|NCT01626391|54249889|FG000|Overall Study|Withdrawal by Subject|1|||
27794974|NCT01626391|54249890|FG001|Overall Study|Withdrawal by Subject|0|||
27794975|NCT02103439|54249898|FG000|Overall Study|Adverse Event|0|||
27794976|NCT02103439|54249899|FG001|Overall Study|Adverse Event|2|||
27794977|NCT02103439|54249898|FG000|Overall Study|Withdrawal by Subject|3|||
27794978|NCT02103439|54249899|FG001|Overall Study|Withdrawal by Subject|1|||
27794979|NCT02229539|54249912|FG000|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
27794980|NCT02229539|54249913|FG001|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1|||
27794981|NCT02229539|54249914|FG002|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
27794982|NCT02229539|54249912|FG000|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
27794983|NCT02229539|54249913|FG001|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
27794984|NCT02229539|54249914|FG002|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1|||
27794985|NCT02229539|54249912|FG000|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
27794986|NCT02229539|54249913|FG001|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
27794987|NCT02229539|54249914|FG002|Cycle 1 (Treatment Per Protocol)|Medical Problems|1|||
27794988|NCT02229539|54249912|FG000|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|3|||
27794989|NCT02229539|54249913|FG001|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|4|||
27794990|NCT02229539|54249914|FG002|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|1|||
27794991|NCT02229539|54249912|FG000|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
27794992|NCT02229539|54249913|FG001|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
27794993|NCT02229539|54249914|FG002|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6|||
27794994|NCT02229539|54249912|FG000|Cycle 2 (Optional Continuation Phase)|Adverse Event|2|||
27794995|NCT02229539|54249913|FG001|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
27794996|NCT02229539|54249914|FG002|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
27794997|NCT02229539|54249912|FG000|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0|||
27794998|NCT02229539|54249913|FG001|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
27794999|NCT02229539|54249914|FG002|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
27795000|NCT02229539|54249912|FG000|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0|||
27795001|NCT02229539|54249913|FG001|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0|||
27795002|NCT02229539|54249914|FG002|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|3|||
27795003|NCT02229539|54249912|FG000|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|2|||
27795004|NCT02229539|54249913|FG001|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|1|||
27795005|NCT02229539|54249914|FG002|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|0|||
27795006|NCT01835223|54249924|FG000|Overall Study|Adverse Event|1|||
27795007|NCT01835223|54249925|FG001|Overall Study|Adverse Event|0|||
27795008|NCT01835223|54249924|FG000|Overall Study|Withdrawal by Subject|2|||
27795009|NCT01835223|54249925|FG001|Overall Study|Withdrawal by Subject|0|||
27795010|NCT01835223|54249924|FG000|Overall Study|Disease progression|2|||
27795011|NCT01835223|54249925|FG001|Overall Study|Disease progression|1|||
27795012|NCT01835223|54249924|FG000|Overall Study|Became Inelligible|4|||
27795013|NCT01835223|54249925|FG001|Overall Study|Became Inelligible|0|||
27795014|NCT01482598|54249935|FG000|Overall Study|Death|7|||
27795015|NCT01482598|54249936|FG001|Overall Study|Death|10|||
27795016|NCT01482598|54249935|FG000|Overall Study|Physician Decision|0|||
27795017|NCT01482598|54249936|FG001|Overall Study|Physician Decision|3|||
27795018|NCT01482598|54249935|FG000|Overall Study|Withdrawal by Subject|4|||
27795019|NCT01482598|54249936|FG001|Overall Study|Withdrawal by Subject|5|||
27795020|NCT01482598|54249935|FG000|Overall Study|Lost to Follow-up|5|||
27795021|NCT01482598|54249936|FG001|Overall Study|Lost to Follow-up|4|||
27795022|NCT01460446|54249944|FG000|Overall Study|Non-compliance|2|||
27795023|NCT01460446|54249945|FG001|Overall Study|Non-compliance|9|||
27795024|NCT01460446|54249944|FG000|Overall Study|Consent Withdrawn|0|||
27795025|NCT01460446|54249945|FG001|Overall Study|Consent Withdrawn|4|||
27795026|NCT01460446|54249944|FG000|Overall Study|Non-compliance & Consent Withdrawn|1|||
27795027|NCT01460446|54249945|FG001|Overall Study|Non-compliance & Consent Withdrawn|3|||
27795028|NCT01460446|54249944|FG000|Overall Study|Surgery/Illness|1|||
27795029|NCT01460446|54249945|FG001|Overall Study|Surgery/Illness|1|||
27795030|NCT01460446|54249944|FG000|Overall Study|Pregnancy|1|||
27795031|NCT01460446|54249945|FG001|Overall Study|Pregnancy|0|||
27795032|NCT01460446|54249944|FG000|Overall Study|Other Reasons Incl. Lost for Follow-Up|0|||
27795033|NCT01460446|54249945|FG001|Overall Study|Other Reasons Incl. Lost for Follow-Up|3|||
27937946|NCT01234883|54594288|FG001|Overall Study|Parent/guardian withdrew consent|2|||
27795034|NCT02229383|54249954|FG000|Overall Study|Adverse Event|7|||
27795035|NCT02229383|54249955|FG001|Overall Study|Adverse Event|4|||
27795036|NCT02229383|54249954|FG000|Overall Study|Death|0|||
27795037|NCT02229383|54249955|FG001|Overall Study|Death|1|||
27795038|NCT02229383|54249954|FG000|Overall Study|Lost to Follow-up|5|||
27795039|NCT02229383|54249955|FG001|Overall Study|Lost to Follow-up|3|||
27937947|NCT01234883|54594287|FG000|Overall Study|Technical difficulties with IV infusion|0|||
27795040|NCT02229383|54249954|FG000|Overall Study|Withdrawal by Subject|4|||
27795041|NCT02229383|54249955|FG001|Overall Study|Withdrawal by Subject|6|||
27937948|NCT01234883|54594288|FG001|Overall Study|Technical difficulties with IV infusion|1|||
27795042|NCT02229383|54249954|FG000|Overall Study|Did not receive treatment|1|||
27795043|NCT02229383|54249955|FG001|Overall Study|Did not receive treatment|0|||
27795044|NCT02229383|54249954|FG000|Overall Study|Other|3|||
27795045|NCT02229383|54249955|FG001|Overall Study|Other|8|||
27795046|NCT01499368|54249964|FG000|Overall Study|Did not meet I/E criteria|8|||
27795047|NCT01499368|54249965|FG001|Overall Study|Did not meet I/E criteria|4|||
27795048|NCT01499368|54249966|FG002|Overall Study|Did not meet I/E criteria|4|||
27795049|NCT01499368|54249964|FG000|Overall Study|Prohibited Concomitant medication|1|||
27795050|NCT01499368|54249965|FG001|Overall Study|Prohibited Concomitant medication|1|||
27795051|NCT01499368|54249966|FG002|Overall Study|Prohibited Concomitant medication|0|||
27795052|NCT01499368|54249964|FG000|Overall Study|Withdrawal by Subject|11|||
27795053|NCT01499368|54249965|FG001|Overall Study|Withdrawal by Subject|10|||
27795054|NCT01499368|54249966|FG002|Overall Study|Withdrawal by Subject|8|||
27795055|NCT01499368|54249964|FG000|Overall Study|Lost to Follow-up|3|||
27795056|NCT01499368|54249965|FG001|Overall Study|Lost to Follow-up|2|||
27795057|NCT01499368|54249966|FG002|Overall Study|Lost to Follow-up|5|||
27795058|NCT01499368|54249964|FG000|Overall Study|Adverse Event|4|||
27795059|NCT01499368|54249965|FG001|Overall Study|Adverse Event|0|||
27795060|NCT01499368|54249966|FG002|Overall Study|Adverse Event|2|||
27795061|NCT01499368|54249964|FG000|Overall Study|Physician Decision|0|||
27842645|NCT01549652|54331351|FG001|Overall Study|Study Drug Titration Failure|6|||
27842646|NCT01549652|54331352|FG002|Overall Study|Study Drug Titration Failure|0|||
27937949|NCT01234883|54594287|FG000|Overall Study|Inclusion/exclusion failure|1|||
27842647|NCT01549652|54331353|FG003|Overall Study|Study Drug Titration Failure|0|||
27842648|NCT01549652|54331350|FG000|Overall Study|Withdrawal Effect|0|||
27842649|NCT01549652|54331351|FG001|Overall Study|Withdrawal Effect|2|||
27842650|NCT01549652|54331352|FG002|Overall Study|Withdrawal Effect|0|||
27842651|NCT01549652|54331353|FG003|Overall Study|Withdrawal Effect|0|||
27937950|NCT01234883|54594288|FG001|Overall Study|Inclusion/exclusion failure|0|||
27937951|NCT01234649|54594296|FG000|Overall Study|Withdrawal by Subject|32|||
27795062|NCT01499368|54249965|FG001|Overall Study|Physician Decision|1|||
27795063|NCT01499368|54249966|FG002|Overall Study|Physician Decision|0|||
27795064|NCT01499368|54249964|FG000|Overall Study|Deviation from visit window|0|||
27795065|NCT01499368|54249965|FG001|Overall Study|Deviation from visit window|0|||
27842652|NCT01549652|54331350|FG000|Overall Study|Did Not Return Due to Withdrawal Effect|5|||
27937952|NCT01234649|54594297|FG001|Overall Study|Withdrawal by Subject|26|||
27937953|NCT01234649|54594296|FG000|Overall Study|Pregnancy|6|||
27795066|NCT01499368|54249966|FG002|Overall Study|Deviation from visit window|1|||
27795067|NCT01499368|54249964|FG000|Overall Study|Error of Prescriptions|0|||
27795068|NCT01499368|54249965|FG001|Overall Study|Error of Prescriptions|0|||
27795069|NCT01499368|54249966|FG002|Overall Study|Error of Prescriptions|1|||
27795070|NCT01835145|54249976|FG000|Overall Study|Ineligible prior to treatment|1|||
27795071|NCT01835145|54249977|FG001|Overall Study|Ineligible prior to treatment|0|||
27795072|NCT02229227|54249987|FG000|Overall Study|Adverse Event|14|||
27795073|NCT02229227|54249988|FG001|Overall Study|Adverse Event|9|||
27795074|NCT02229227|54249987|FG000|Overall Study|Lack of Efficacy|3|||
27795075|NCT02229227|54249988|FG001|Overall Study|Lack of Efficacy|3|||
27795076|NCT02229227|54249987|FG000|Overall Study|Protocol Violation|6|||
27795077|NCT02229227|54249988|FG001|Overall Study|Protocol Violation|8|||
27795078|NCT02229227|54249987|FG000|Overall Study|Protocol defined stopping criteria|1|||
27795079|NCT02229227|54249988|FG001|Overall Study|Protocol defined stopping criteria|3|||
27795080|NCT02229227|54249987|FG000|Overall Study|Lost to Follow-up|3|||
27795081|NCT02229227|54249988|FG001|Overall Study|Lost to Follow-up|3|||
27795082|NCT02229227|54249987|FG000|Overall Study|Study terminated by sponsor|11|||
27795083|NCT02229227|54249988|FG001|Overall Study|Study terminated by sponsor|11|||
27795084|NCT02229227|54249987|FG000|Overall Study|Withdrawal by Subject|8|||
27795085|NCT02229227|54249988|FG001|Overall Study|Withdrawal by Subject|12|||
27795086|NCT02229227|54249987|FG000|Overall Study|Other|0|||
27795087|NCT02229227|54249988|FG001|Overall Study|Other|1|||
27795088|NCT02229227|54249987|FG000|Overall Study|Physician Decision|5|||
27795089|NCT02229227|54249988|FG001|Overall Study|Physician Decision|12|||
27795090|NCT01499290|54249996|FG000|Overall Study|Withdrawal by Subject|22|||
27795091|NCT01499290|54249997|FG001|Overall Study|Withdrawal by Subject|15|||
27795092|NCT01499290|54249996|FG000|Overall Study|Not specified in study report|11|||
27937954|NCT01234649|54594297|FG001|Overall Study|Pregnancy|6|||
27937955|NCT01234649|54594296|FG000|Overall Study|intolerant to side effects|4|||
27937956|NCT01234649|54594297|FG001|Overall Study|intolerant to side effects|3|||
27937957|NCT01234649|54594296|FG000|Overall Study|Allergic reaction|1|||
27937958|NCT01234649|54594297|FG001|Overall Study|Allergic reaction|0|||
27937959|NCT01234649|54594296|FG000|Overall Study|Lack of Efficacy|0|||
27937960|NCT01234649|54594297|FG001|Overall Study|Lack of Efficacy|3|||
27937961|NCT01075815|54594305|FG000|Overall Study|Withdrawal before r-hCG administration|6|||
27937962|NCT01075815|54594306|FG001|Overall Study|Withdrawal before r-hCG administration|1|||
27937963|NCT01075815|54594305|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
27937964|NCT01075815|54594306|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
27937965|NCT01075815|54594305|FG000|Overall Study|Withdrawal between OPU - embryo transfer|3|||
27937966|NCT01075815|54594306|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
27937967|NCT01075191|54594312|FG000|Overall Study|Death|1|||
28017274|NCT00685334|54676544|FG000|Overall Study|Chose to enter hospital|1|||
28017275|NCT00685334|54676545|FG001|Overall Study|Chose to enter hospital|1|||
28017276|NCT00325039|54676553|FG000|Overall Study|Lost to Follow-up|18|||
28017277|NCT00325039|54676554|FG001|Overall Study|Lost to Follow-up|14|||
28017278|NCT00344461|54676560|FG000|Overall Study|Adverse Event|6|||
28017279|NCT00344461|54676560|FG000|Overall Study|Death|1|||
28017280|NCT00344461|54676560|FG000|Overall Study|Lack of Efficacy|2|||
28017281|NCT00344461|54676560|FG000|Overall Study|Lost to Follow-up|2|||
28017282|NCT00344461|54676560|FG000|Overall Study|Physician Decision|2|||
28017283|NCT00344461|54676560|FG000|Overall Study|Protocol Violation|6|||
28017284|NCT00344461|54676560|FG000|Overall Study|Withdrawal by Subject|2|||
27795093|NCT01499290|54249997|FG001|Overall Study|Not specified in study report|5|||
27795094|NCT01499290|54249996|FG000|Overall Study|Condition improved/subject recovered|1|||
27795095|NCT01499290|54249997|FG001|Overall Study|Condition improved/subject recovered|0|||
27795096|NCT01499290|54249996|FG000|Overall Study|Lack of Efficacy|7|||
27795097|NCT01499290|54249997|FG001|Overall Study|Lack of Efficacy|8|||
27795098|NCT01499290|54249996|FG000|Overall Study|Adverse Event|14|||
27795099|NCT01499290|54249997|FG001|Overall Study|Adverse Event|7|||
27937968|NCT01075191|54594312|FG000|Overall Study|Intensification|3|||
27937969|NCT01075191|54594312|FG000|Overall Study|Co-morbidities|1|||
27937970|NCT01075191|54594312|FG000|Overall Study|Adverse Event|4|||
27937971|NCT01075191|54594312|FG000|Overall Study|Noncompliance|3|||
28017285|NCT00685178|54676569|FG000|Overall Study|Adverse Event|1|||
27795100|NCT01833897|54250022|FG000|Overall Study|Lack of Efficacy|1|||
27795101|NCT01481896|54250026|FG000|Overall Study|Lost to Follow-up|12|||
27795102|NCT02226653|54250042|FG000|Treatment Period 2 Fasted State|Lost to Follow-up|1|||
27795103|NCT02226653|54250043|FG001|Treatment Period 2 Fasted State|Lost to Follow-up|0|||
27795104|NCT02226653|54250042|FG000|Treatment Period 5 Fed State|Adverse Event|0|||
27795105|NCT02226653|54250043|FG001|Treatment Period 5 Fed State|Adverse Event|1|||
27795106|NCT02201771|54250059|FG000|Overall Study|Death|3|||
27795107|NCT02201771|54250060|FG001|Overall Study|Death|2|||
27795108|NCT02201771|54250061|FG002|Overall Study|Death|0|||
27795109|NCT02201771|54250059|FG000|Overall Study|Protocol Violation|10|||
27937972|NCT01075191|54594312|FG000|Overall Study|Therapy Break|3|||
28017286|NCT00685178|54676570|FG001|Overall Study|Adverse Event|5|||
27795110|NCT02201771|54250060|FG001|Overall Study|Protocol Violation|8|||
27795111|NCT02201771|54250061|FG002|Overall Study|Protocol Violation|10|||
27795112|NCT01460368|54250071|FG000|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
27795113|NCT01460368|54250072|FG001|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
27795114|NCT01460368|54250073|FG002|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
27795115|NCT01460368|54250074|FG003|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
27795116|NCT01460368|54250075|FG004|Part B: First Intervention (Period 1)|Lost to Follow-up|1|||
27795117|NCT01460368|54250076|FG005|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
27795118|NCT01460368|54250077|FG006|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
27795119|NCT01460368|54250071|FG000|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
27795120|NCT01460368|54250072|FG001|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
27795121|NCT01460368|54250073|FG002|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
27795122|NCT01460368|54250074|FG003|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
27795123|NCT01460368|54250075|FG004|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
27795124|NCT01460368|54250076|FG005|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
27795125|NCT01460368|54250077|FG006|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
27795126|NCT01460368|54250071|FG000|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
27795127|NCT01460368|54250072|FG001|Part B: Second Intervention (Period 2)|Lost to Follow-up|1|||
27795128|NCT01460368|54250073|FG002|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
27795129|NCT01460368|54250074|FG003|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
27795130|NCT01460368|54250075|FG004|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
27795131|NCT01460368|54250076|FG005|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
27795132|NCT01460368|54250077|FG006|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
27795133|NCT01460368|54250071|FG000|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
27795134|NCT01460368|54250072|FG001|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
27795135|NCT01460368|54250073|FG002|Part B: Washout (up to 15 Days)|Protocol Violation|1|||
27795136|NCT01460368|54250074|FG003|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
27795137|NCT01460368|54250075|FG004|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
27795138|NCT01460368|54250076|FG005|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
27795139|NCT01460368|54250077|FG006|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
27795140|NCT01460368|54250071|FG000|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
27795141|NCT01460368|54250072|FG001|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
27795142|NCT01460368|54250073|FG002|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
27795143|NCT01460368|54250074|FG003|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
27795144|NCT01460368|54250075|FG004|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
27795145|NCT01460368|54250076|FG005|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
27795146|NCT01460368|54250077|FG006|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
27795147|NCT01460290|54250086|FG000|Overall Study|Adverse Event|3|||
27795148|NCT01460290|54250086|FG000|Overall Study|Elevated liver function|1|||
27795149|NCT02200211|54250095|FG000|Overall Study|Lost to Follow-up|7|||
27795150|NCT02200211|54250096|FG001|Overall Study|Lost to Follow-up|7|||
27795151|NCT02200211|54250097|FG002|Overall Study|Lost to Follow-up|1|||
27795152|NCT02200211|54250098|FG003|Overall Study|Lost to Follow-up|2|||
27795153|NCT02200211|54250095|FG000|Overall Study|Withdrawal by Subject|1|||
27795154|NCT02200211|54250096|FG001|Overall Study|Withdrawal by Subject|0|||
27795155|NCT02200211|54250097|FG002|Overall Study|Withdrawal by Subject|0|||
27795156|NCT02200211|54250098|FG003|Overall Study|Withdrawal by Subject|0|||
27795157|NCT01459666|54250118|FG000|Overall Study|PI left institution|5|||
27795158|NCT01459666|54250119|FG001|Overall Study|PI left institution|4|||
27795159|NCT01858389|54250127|FG000|Overall Study|Death|1|||
27795160|NCT01858389|54250128|FG001|Overall Study|Death|3|||
27795161|NCT01858389|54250127|FG000|Overall Study|Study terminated by sponsor|0|||
27795162|NCT01858389|54250128|FG001|Overall Study|Study terminated by sponsor|2|||
27795163|NCT01858389|54250127|FG000|Overall Study|Withdrawal by Subject|0|||
27795164|NCT01858389|54250128|FG001|Overall Study|Withdrawal by Subject|1|||
27795165|NCT01858389|54250127|FG000|Overall Study|Progressive disease|10|||
27795166|NCT01858389|54250128|FG001|Overall Study|Progressive disease|11|||
27795167|NCT01858389|54250127|FG000|Overall Study|Other|2|||
27795168|NCT01858389|54250128|FG001|Overall Study|Other|4|||
27795169|NCT01858389|54250127|FG000|Overall Study|Adverse Event|3|||
27795170|NCT01858389|54250128|FG001|Overall Study|Adverse Event|1|||
27795171|NCT01858389|54250127|FG000|Overall Study|Did not receive treatment|0|||
27795172|NCT01858389|54250128|FG001|Overall Study|Did not receive treatment|3|||
27795173|NCT02199509|54250136|FG000|Overall Study|Suicidal Ideation|0|||
27795174|NCT02199509|54250137|FG001|Overall Study|Suicidal Ideation|1|||
27795175|NCT02199509|54250136|FG000|Overall Study|Misunderstood titration schedule|1|||
27795176|NCT02199509|54250137|FG001|Overall Study|Misunderstood titration schedule|0|||
27937973|NCT01075191|54594312|FG000|Overall Study|Patient's Wish|2|||
27937974|NCT01075191|54594312|FG000|Overall Study|Unknown Reasons|1|||
27937975|NCT00905359|54594318|FG000|Overall Study|Lost to Follow-up|17|||
27842653|NCT01549652|54331351|FG001|Overall Study|Did Not Return Due to Withdrawal Effect|1|||
27842654|NCT01549652|54331352|FG002|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
27842655|NCT01549652|54331353|FG003|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
27842656|NCT01549652|54331350|FG000|Overall Study|Problem with Infusion|1|||
27842657|NCT01549652|54331351|FG001|Overall Study|Problem with Infusion|0|||
27842658|NCT01549652|54331352|FG002|Overall Study|Problem with Infusion|0|||
27842659|NCT01549652|54331353|FG003|Overall Study|Problem with Infusion|0|||
27842660|NCT01549652|54331350|FG000|Overall Study|Titration Non-Compliance|1|||
27937976|NCT00905359|54594319|FG001|Overall Study|Lost to Follow-up|10|||
27937977|NCT00905359|54594318|FG000|Overall Study|Death|2|||
27937978|NCT00905359|54594319|FG001|Overall Study|Death|0|||
27937979|NCT00905359|54594318|FG000|Overall Study|Withdrawal consent|5|||
27937980|NCT00905359|54594319|FG001|Overall Study|Withdrawal consent|6|||
27937981|NCT01072149|54594325|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
27937982|NCT01072149|54594326|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
27937983|NCT01072149|54594327|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
27937984|NCT01072149|54594328|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
27937985|NCT01072149|54594329|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
27937986|NCT01072149|54594330|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
27937987|NCT01072149|54594331|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
27937988|NCT01072149|54594332|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
27937989|NCT01072149|54594333|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
27937990|NCT01072149|54594334|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
27937991|NCT01072149|54594335|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
27937992|NCT01072149|54594336|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
27937993|NCT01072149|54594337|FG012|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
27937994|NCT01072149|54594338|FG013|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
27937995|NCT01072149|54594339|FG014|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
27795177|NCT01458574|54250150|FG000|Overall Study|Adverse Event|5|||
27795178|NCT01458574|54250151|FG001|Overall Study|Adverse Event|9|||
27795179|NCT01458574|54250152|FG002|Overall Study|Adverse Event|7|||
27795180|NCT01458574|54250150|FG000|Overall Study|Lack of Efficacy|70|||
27795181|NCT01458574|54250151|FG001|Overall Study|Lack of Efficacy|53|||
27795182|NCT01458574|54250152|FG002|Overall Study|Lack of Efficacy|132|||
27795183|NCT01458574|54250150|FG000|Overall Study|Lost to Follow-up|3|||
27795184|NCT01458574|54250151|FG001|Overall Study|Lost to Follow-up|2|||
27795185|NCT01458574|54250152|FG002|Overall Study|Lost to Follow-up|1|||
27795186|NCT01458574|54250150|FG000|Overall Study|Pregnancy|1|||
27795187|NCT01458574|54250151|FG001|Overall Study|Pregnancy|1|||
27795188|NCT01458574|54250152|FG002|Overall Study|Pregnancy|0|||
27795189|NCT01458574|54250150|FG000|Overall Study|Protocol Violation|0|||
27795190|NCT01458574|54250151|FG001|Overall Study|Protocol Violation|1|||
27795191|NCT01458574|54250152|FG002|Overall Study|Protocol Violation|0|||
27795192|NCT01458574|54250150|FG000|Overall Study|Withdrawal by Subject|6|||
27795193|NCT01458574|54250151|FG001|Overall Study|Withdrawal by Subject|3|||
27795194|NCT01458574|54250152|FG002|Overall Study|Withdrawal by Subject|5|||
27795195|NCT01458574|54250150|FG000|Overall Study|Other|2|||
27795196|NCT01458574|54250151|FG001|Overall Study|Other|1|||
27795197|NCT01458574|54250152|FG002|Overall Study|Other|0|||
27795198|NCT01458574|54250150|FG000|Overall Study|Randomized but not treated|0|||
27795199|NCT01458574|54250151|FG001|Overall Study|Randomized but not treated|1|||
27795200|NCT01458574|54250152|FG002|Overall Study|Randomized but not treated|0|||
27795201|NCT02224703|54250163|FG000|Overall Study|Adverse Event|0|||
27795202|NCT02224703|54250164|FG001|Overall Study|Adverse Event|5|||
27795203|NCT02224703|54250165|FG002|Overall Study|Adverse Event|0|||
27795204|NCT02224703|54250163|FG000|Overall Study|Withdrawn by investigator|1|||
27795205|NCT02224703|54250164|FG001|Overall Study|Withdrawn by investigator|0|||
27795206|NCT02224703|54250165|FG002|Overall Study|Withdrawn by investigator|0|||
27937996|NCT01072149|54594340|FG015|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
27937997|NCT01072149|54594341|FG016|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
27937998|NCT01072149|54594342|FG017|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
27795207|NCT02224703|54250163|FG000|Overall Study|Advised by medical monitor|1|||
27937999|NCT01072149|54594325|FG000|Treatment Period 1 (28 Days)|Protocol Violation|0|||
27795208|NCT02224703|54250164|FG001|Overall Study|Advised by medical monitor|0|||
27795209|NCT02224703|54250165|FG002|Overall Study|Advised by medical monitor|0|||
27795210|NCT02224703|54250163|FG000|Overall Study|Withdrawn by parent/guardian|0|||
27795211|NCT02224703|54250164|FG001|Overall Study|Withdrawn by parent/guardian|1|||
27795212|NCT02224703|54250165|FG002|Overall Study|Withdrawn by parent/guardian|0|||
27795213|NCT02224703|54250163|FG000|Overall Study|Lack of Efficacy|1|||
27795214|NCT02224703|54250164|FG001|Overall Study|Lack of Efficacy|0|||
27795215|NCT02224703|54250165|FG002|Overall Study|Lack of Efficacy|0|||
27795216|NCT02198963|54250174|FG000|Overall Study|Adverse Event|1|||
27795217|NCT02198963|54250174|FG000|Overall Study|Withdrawal by Subject|6|||
27795218|NCT01458106|54250198|FG000|Overall Study|Withdrawal by Subject|2|||
27795219|NCT01458106|54250199|FG001|Overall Study|Withdrawal by Subject|0|||
27795220|NCT01458106|54250198|FG000|Overall Study|Pre-rFVIIIFc Adverse Event|1|||
27795221|NCT01458106|54250199|FG001|Overall Study|Pre-rFVIIIFc Adverse Event|0|||
27795222|NCT01458106|54250198|FG000|Overall Study|Withdrawn Per Protocol|0|||
27795223|NCT01458106|54250199|FG001|Overall Study|Withdrawn Per Protocol|1|||
27795224|NCT01457950|54250210|FG000|Double-Blind Phase|Continuation Criteria Not Met|1|||
27795225|NCT01457950|54250211|FG001|Double-Blind Phase|Continuation Criteria Not Met|0|||
27795226|NCT01457950|54250212|FG002|Double-Blind Phase|Continuation Criteria Not Met|0|||
27795227|NCT01457950|54250213|FG003|Double-Blind Phase|Continuation Criteria Not Met|0|||
27795228|NCT01457950|54250210|FG000|Double-Blind Phase|Protocol Violation|2|||
27795229|NCT01457950|54250211|FG001|Double-Blind Phase|Protocol Violation|1|||
27795230|NCT01457950|54250212|FG002|Double-Blind Phase|Protocol Violation|0|||
27795231|NCT01457950|54250213|FG003|Double-Blind Phase|Protocol Violation|0|||
27795232|NCT01457950|54250210|FG000|Double-Blind Phase|Withdrawal by Subject|6|||
27938000|NCT01072149|54594326|FG001|Treatment Period 1 (28 Days)|Protocol Violation|0|||
27938001|NCT01072149|54594327|FG002|Treatment Period 1 (28 Days)|Protocol Violation|0|||
28017287|NCT00685178|54676571|FG002|Overall Study|Adverse Event|2|||
28017288|NCT00685178|54676572|FG003|Overall Study|Adverse Event|4|||
28017289|NCT00685178|54676569|FG000|Overall Study|missed 3 consecutive methadone clin days|7|||
28017290|NCT00685178|54676570|FG001|Overall Study|missed 3 consecutive methadone clin days|5|||
28017291|NCT00685178|54676571|FG002|Overall Study|missed 3 consecutive methadone clin days|2|||
28017292|NCT00685178|54676572|FG003|Overall Study|missed 3 consecutive methadone clin days|6|||
28017293|NCT00685178|54676569|FG000|Overall Study|voluntary study discharge|4|||
28017294|NCT00685178|54676570|FG001|Overall Study|voluntary study discharge|5|||
28017295|NCT00685178|54676571|FG002|Overall Study|voluntary study discharge|1|||
28017296|NCT00685178|54676572|FG003|Overall Study|voluntary study discharge|1|||
28017297|NCT00685178|54676569|FG000|Overall Study|incarcerated|1|||
28017298|NCT00685178|54676570|FG001|Overall Study|incarcerated|3|||
28017299|NCT00685178|54676571|FG002|Overall Study|incarcerated|7|||
28017300|NCT00685178|54676572|FG003|Overall Study|incarcerated|0|||
28017301|NCT00685178|54676569|FG000|Overall Study|administrative (disciplinary) discharge|0|||
28017302|NCT00685178|54676570|FG001|Overall Study|administrative (disciplinary) discharge|1|||
28017303|NCT00685178|54676571|FG002|Overall Study|administrative (disciplinary) discharge|0|||
28017304|NCT00685178|54676572|FG003|Overall Study|administrative (disciplinary) discharge|2|||
27795233|NCT01457950|54250211|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
27795234|NCT01457950|54250212|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
27795235|NCT01457950|54250213|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
27795236|NCT01457950|54250210|FG000|Open-Label Phase|Adverse Event|0|||
27795237|NCT01457950|54250211|FG001|Open-Label Phase|Adverse Event|0|||
27795238|NCT01457950|54250212|FG002|Open-Label Phase|Adverse Event|0|||
27795239|NCT01457950|54250213|FG003|Open-Label Phase|Adverse Event|1|||
27795240|NCT01457950|54250210|FG000|Open-Label Phase|Protocol Violation|0|||
27938002|NCT01072149|54594328|FG003|Treatment Period 1 (28 Days)|Protocol Violation|0|||
27938003|NCT01072149|54594329|FG004|Treatment Period 1 (28 Days)|Protocol Violation|0|||
27938004|NCT01072149|54594330|FG005|Treatment Period 1 (28 Days)|Protocol Violation|0|||
28017305|NCT00685178|54676569|FG000|Overall Study|Pregnancy|0|||
28017306|NCT00685178|54676570|FG001|Overall Study|Pregnancy|0|||
28017307|NCT00685178|54676571|FG002|Overall Study|Pregnancy|0|||
28017308|NCT00685178|54676572|FG003|Overall Study|Pregnancy|1|||
28017309|NCT00537394|54676585|FG000|First Year of Follow-up|Death|7|||
28017310|NCT00537394|54676586|FG001|First Year of Follow-up|Death|0|||
27795241|NCT01457950|54250211|FG001|Open-Label Phase|Protocol Violation|0|||
27938005|NCT01072149|54594331|FG006|Treatment Period 1 (28 Days)|Protocol Violation|0|||
27938006|NCT01072149|54594332|FG007|Treatment Period 1 (28 Days)|Protocol Violation|0|||
27938007|NCT01072149|54594333|FG008|Treatment Period 1 (28 Days)|Protocol Violation|0|||
27938008|NCT01072149|54594334|FG009|Treatment Period 1 (28 Days)|Protocol Violation|0|||
28017311|NCT00537394|54676587|FG002|First Year of Follow-up|Death|0|||
27795242|NCT01457950|54250212|FG002|Open-Label Phase|Protocol Violation|0|||
27938009|NCT01072149|54594335|FG010|Treatment Period 1 (28 Days)|Protocol Violation|0|||
28017312|NCT00537394|54676585|FG000|First Year of Follow-up|Severe debilitation|1|||
27795243|NCT01457950|54250213|FG003|Open-Label Phase|Protocol Violation|1|||
27795244|NCT01457950|54250210|FG000|Open-Label Phase|Withdrawal by Subject|0|||
27795245|NCT01457950|54250211|FG001|Open-Label Phase|Withdrawal by Subject|0|||
28017313|NCT00537394|54676586|FG001|First Year of Follow-up|Severe debilitation|0|||
28017314|NCT00537394|54676587|FG002|First Year of Follow-up|Severe debilitation|1|||
28017315|NCT00537394|54676585|FG000|First Year of Follow-up|Withdrawal by Subject|3|||
28017316|NCT00537394|54676586|FG001|First Year of Follow-up|Withdrawal by Subject|6|||
28017317|NCT00537394|54676587|FG002|First Year of Follow-up|Withdrawal by Subject|1|||
28017318|NCT00537394|54676585|FG000|First Year of Follow-up|Lost to Follow-up|1|||
28017319|NCT00537394|54676586|FG001|First Year of Follow-up|Lost to Follow-up|5|||
28017320|NCT00537394|54676587|FG002|First Year of Follow-up|Lost to Follow-up|1|||
28017321|NCT00537394|54676585|FG000|2nd Year of Follow-up|Death|4|||
28017322|NCT00537394|54676586|FG001|2nd Year of Follow-up|Death|1|||
28017323|NCT00537394|54676587|FG002|2nd Year of Follow-up|Death|2|||
28017324|NCT00537394|54676585|FG000|2nd Year of Follow-up|Withdrawal by Subject|0|||
28017325|NCT00537394|54676586|FG001|2nd Year of Follow-up|Withdrawal by Subject|1|||
28017326|NCT00537394|54676587|FG002|2nd Year of Follow-up|Withdrawal by Subject|2|||
28017327|NCT00537394|54676585|FG000|2nd Year of Follow-up|Lost to Follow-up|6|||
28017328|NCT00537394|54676586|FG001|2nd Year of Follow-up|Lost to Follow-up|7|||
28017329|NCT00537394|54676587|FG002|2nd Year of Follow-up|Lost to Follow-up|2|||
28017330|NCT00537394|54676585|FG000|2nd Year of Follow-up|Clinic site closure|1|||
28017331|NCT00537394|54676586|FG001|2nd Year of Follow-up|Clinic site closure|0|||
28017332|NCT00537394|54676587|FG002|2nd Year of Follow-up|Clinic site closure|0|||
28017333|NCT00352885|54676595|FG000|Overall Study|Withdrawal by Subject|0|||
28017334|NCT00352885|54676596|FG001|Overall Study|Withdrawal by Subject|3|||
28017335|NCT00352885|54676595|FG000|Overall Study|Development of major depression|0|||
28017336|NCT00352885|54676596|FG001|Overall Study|Development of major depression|1|||
28017337|NCT00352885|54676595|FG000|Overall Study|Progression of metastatic melanoma|5|||
28017338|NCT00352885|54676596|FG001|Overall Study|Progression of metastatic melanoma|3|||
28017339|NCT00352885|54676595|FG000|Overall Study|Side effects of IL-2 administration|1|||
28017340|NCT00352885|54676596|FG001|Overall Study|Side effects of IL-2 administration|0|||
28017341|NCT00660660|54676604|FG000|Overall Study|Adverse Event|1|||
28017342|NCT00660660|54676605|FG001|Overall Study|Adverse Event|0|||
28017343|NCT00660660|54676604|FG000|Overall Study|Lost to Follow-up|0|||
28017344|NCT00660660|54676605|FG001|Overall Study|Lost to Follow-up|6|||
28017345|NCT00660660|54676604|FG000|Overall Study|Lack of Efficacy|0|||
28017346|NCT00660660|54676605|FG001|Overall Study|Lack of Efficacy|2|||
28017347|NCT00660660|54676604|FG000|Overall Study|Withdrawal by Subject|3|||
28017348|NCT00660660|54676605|FG001|Overall Study|Withdrawal by Subject|0|||
28017349|NCT00660660|54676604|FG000|Overall Study|Incorrect enrollment and other|0|||
28017350|NCT00660660|54676605|FG001|Overall Study|Incorrect enrollment and other|1|||
27795246|NCT01457950|54250212|FG002|Open-Label Phase|Withdrawal by Subject|2|||
27795247|NCT01457950|54250213|FG003|Open-Label Phase|Withdrawal by Subject|0|||
27795248|NCT01499134|54250226|FG000|Overall Study|Withdrawal by Subject|0|||
27795249|NCT01499134|54250227|FG001|Overall Study|Withdrawal by Subject|1|||
27795250|NCT02198651|54250233|FG000|Lead-in Period|Withdrew consent|13|||
27795251|NCT02198651|54250234|FG001|Lead-in Period|Withdrew consent|0|||
27795252|NCT02198651|54250235|FG002|Lead-in Period|Withdrew consent|0|||
27795253|NCT02198651|54250236|FG003|Lead-in Period|Withdrew consent|0|||
27795254|NCT02198651|54250237|FG004|Lead-in Period|Withdrew consent|0|||
27795255|NCT02198651|54250233|FG000|Lead-in Period|Adverse Event|2|||
27795256|NCT02198651|54250234|FG001|Lead-in Period|Adverse Event|0|||
27795257|NCT02198651|54250235|FG002|Lead-in Period|Adverse Event|0|||
28017351|NCT00660660|54676604|FG000|Overall Study|New medication after randomization|1|||
28017352|NCT00660660|54676605|FG001|Overall Study|New medication after randomization|0|||
28017353|NCT00344305|54676613|FG000|Overall Study|Lost to Follow-up|2|||
28017354|NCT00344305|54676614|FG001|Overall Study|Lost to Follow-up|0|||
28017355|NCT00344305|54676613|FG000|Overall Study|Participant was not contacted in window|0|||
27795258|NCT02198651|54250236|FG003|Lead-in Period|Adverse Event|0|||
27795259|NCT02198651|54250237|FG004|Lead-in Period|Adverse Event|0|||
27795260|NCT02198651|54250233|FG000|Lead-in Period|Other, not specified|22|||
27795261|NCT02198651|54250234|FG001|Lead-in Period|Other, not specified|0|||
27795262|NCT02198651|54250235|FG002|Lead-in Period|Other, not specified|0|||
27795263|NCT02198651|54250236|FG003|Lead-in Period|Other, not specified|0|||
27795264|NCT02198651|54250237|FG004|Lead-in Period|Other, not specified|0|||
27795265|NCT02198651|54250233|FG000|Double-blind Period|Withdrew consent|0|||
27795266|NCT02198651|54250234|FG001|Double-blind Period|Withdrew consent|4|||
28017356|NCT00344305|54676614|FG001|Overall Study|Participant was not contacted in window|1|||
27795267|NCT02198651|54250235|FG002|Double-blind Period|Withdrew consent|0|||
27795268|NCT02198651|54250236|FG003|Double-blind Period|Withdrew consent|0|||
27795269|NCT02198651|54250237|FG004|Double-blind Period|Withdrew consent|0|||
28017357|NCT00660816|54676623|FG000|Overall Study|Adverse Event|1|||
28017358|NCT00660816|54676624|FG001|Overall Study|Adverse Event|2|||
28017359|NCT00660816|54676623|FG000|Overall Study|Withdrawal by Subject|1|||
28017360|NCT00660816|54676624|FG001|Overall Study|Withdrawal by Subject|0|||
28017361|NCT00660816|54676623|FG000|Overall Study|Death|0|||
28017362|NCT00660816|54676624|FG001|Overall Study|Death|2|||
28017363|NCT00660816|54676623|FG000|Overall Study|Lack of Efficacy|1|||
28017364|NCT00660816|54676624|FG001|Overall Study|Lack of Efficacy|0|||
27795270|NCT02198651|54250233|FG000|Double-blind Period|Adverse Event|0|||
27795271|NCT02198651|54250234|FG001|Double-blind Period|Adverse Event|1|||
27795272|NCT02198651|54250235|FG002|Double-blind Period|Adverse Event|0|||
27795273|NCT02198651|54250236|FG003|Double-blind Period|Adverse Event|0|||
27795274|NCT02198651|54250237|FG004|Double-blind Period|Adverse Event|0|||
27795275|NCT02198651|54250233|FG000|Double-blind Period|Other, not specified|0|||
27795276|NCT02198651|54250234|FG001|Double-blind Period|Other, not specified|4|||
27795277|NCT02198651|54250235|FG002|Double-blind Period|Other, not specified|1|||
27795278|NCT02198651|54250236|FG003|Double-blind Period|Other, not specified|0|||
27795279|NCT02198651|54250237|FG004|Double-blind Period|Other, not specified|0|||
27795280|NCT02198651|54250233|FG000|Open-label Rescue Period|Withdrew consent|0|||
27795281|NCT02198651|54250234|FG001|Open-label Rescue Period|Withdrew consent|0|||
27795282|NCT02198651|54250235|FG002|Open-label Rescue Period|Withdrew consent|0|||
27795283|NCT02198651|54250236|FG003|Open-label Rescue Period|Withdrew consent|2|||
27795284|NCT02198651|54250237|FG004|Open-label Rescue Period|Withdrew consent|0|||
27795285|NCT02198651|54250233|FG000|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
27795286|NCT02198651|54250234|FG001|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
27795287|NCT02198651|54250235|FG002|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
27795288|NCT02198651|54250236|FG003|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1|||
28017365|NCT00660816|54676623|FG000|Overall Study|Physician Decision|0|||
28017366|NCT00660816|54676624|FG001|Overall Study|Physician Decision|2|||
28017367|NCT00660816|54676623|FG000|Overall Study|Protocol Violation|1|||
28017368|NCT00660816|54676624|FG001|Overall Study|Protocol Violation|0|||
28017369|NCT00660816|54676623|FG000|Overall Study|Disease Progression|16|||
28017370|NCT00660816|54676624|FG001|Overall Study|Disease Progression|12|||
28017371|NCT00660816|54676623|FG000|Overall Study|Complicating Disease|0|||
28017372|NCT00660816|54676624|FG001|Overall Study|Complicating Disease|1|||
28017373|NCT00576056|54676630|FG000|Overall Study|Adverse Event|1|||
28017374|NCT00576056|54676630|FG000|Overall Study|Death|1|||
28017375|NCT00576056|54676630|FG000|Overall Study|Lack of Efficacy|1|||
28017376|NCT00576056|54676630|FG000|Overall Study|Withdrawal by Subject|2|||
28017377|NCT00576056|54676630|FG000|Overall Study|did not meet eligibility criteria|8|||
28017378|NCT00576056|54676630|FG000|Overall Study|Physician Decision|1|||
28017379|NCT00575510|54676637|FG000|Overall Study|Lost to Follow-up|4|||
28017380|NCT00575510|54676638|FG001|Overall Study|Lost to Follow-up|6|||
28017381|NCT00575510|54676639|FG002|Overall Study|Lost to Follow-up|9|||
28017382|NCT00575510|54676637|FG000|Overall Study|Withdrawal by Subject|1|||
27795289|NCT02198651|54250237|FG004|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
27795290|NCT01498822|54250252|FG000|Overall Study|Protocol Violation|8|||
27795291|NCT01498822|54250253|FG001|Overall Study|Protocol Violation|4|||
27795292|NCT01498822|54250252|FG000|Overall Study|Other Reason|5|||
27795293|NCT01498822|54250253|FG001|Overall Study|Other Reason|2|||
27795294|NCT01498822|54250252|FG000|Overall Study|Lack of Efficacy|7|||
27795295|NCT01498822|54250253|FG001|Overall Study|Lack of Efficacy|2|||
27795296|NCT01498822|54250252|FG000|Overall Study|AE, non-serious non-fatal|8|||
27795297|NCT01498822|54250253|FG001|Overall Study|AE, non-serious non-fatal|17|||
27795298|NCT01498822|54250252|FG000|Overall Study|SAE, non-fatal|2|||
27795299|NCT01498822|54250253|FG001|Overall Study|SAE, non-fatal|2|||
27795300|NCT01498822|54250252|FG000|Overall Study|Adverse Event, serious fatal|1|||
27795301|NCT01498822|54250253|FG001|Overall Study|Adverse Event, serious fatal|1|||
27795302|NCT01498822|54250252|FG000|Overall Study|Withdrawal by Subject|15|||
27795303|NCT01498822|54250253|FG001|Overall Study|Withdrawal by Subject|25|||
27795304|NCT01498822|54250252|FG000|Overall Study|Lost to Follow-up|8|||
27795305|NCT01498822|54250253|FG001|Overall Study|Lost to Follow-up|3|||
27795306|NCT01498120|54250261|FG000|Overall Study|Lost to Follow-up|1|||
27795307|NCT01498120|54250261|FG000|Overall Study|Withdrawal by Subject|5|||
27795308|NCT01498120|54250261|FG000|Overall Study|AE, non-serious non-fatal|3|||
27795309|NCT01498120|54250261|FG000|Overall Study|Other|4|||
27795310|NCT01497262|54250265|FG000|Overall Study|Abnormal Lab Values|4|||
27795311|NCT01497262|54250265|FG000|Overall Study|Abnormal Test Procedure Result|1|||
27795312|NCT01497262|54250265|FG000|Overall Study|Physician Decision|1|||
27842661|NCT01549652|54331351|FG001|Overall Study|Titration Non-Compliance|3|||
27795313|NCT01497262|54250265|FG000|Overall Study|Withdrawal by Subject|2|||
27795314|NCT01497262|54250265|FG000|Overall Study|Adverse Event|2|||
27795315|NCT01497262|54250265|FG000|Overall Study|Protocol Violation|1|||
27795316|NCT02224625|54250269|FG000|Irritation|Adverse Event|6|||
27795317|NCT02224625|54250269|FG000|Sensitization|Adverse Event|55|||
27795318|NCT02197247|54250281|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2|||
27842662|NCT01549652|54331352|FG002|Overall Study|Titration Non-Compliance|4|||
28017383|NCT00575510|54676638|FG001|Overall Study|Withdrawal by Subject|0|||
28017384|NCT00575510|54676639|FG002|Overall Study|Withdrawal by Subject|0|||
28017385|NCT00575510|54676637|FG000|Overall Study|Clinic Called Patient|7|||
27795319|NCT02197247|54250281|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2|||
27842663|NCT01549652|54331353|FG003|Overall Study|Titration Non-Compliance|5|||
28017386|NCT00575510|54676638|FG001|Overall Study|Clinic Called Patient|7|||
28017387|NCT00575510|54676639|FG002|Overall Study|Clinic Called Patient|7|||
27795320|NCT02197247|54250281|FG000|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5|||
27795321|NCT02197247|54250281|FG000|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2|||
27795322|NCT02197247|54250281|FG000|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2|||
27795323|NCT02197247|54250281|FG000|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1|||
27795324|NCT02197247|54250281|FG000|Part B: Day 78 to End Part B (AZD9291)|Death|1|||
27795325|NCT02197247|54250281|FG000|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9|||
27795326|NCT02224157|54250293|FG000|Overall Study|Severe non-compliance to protocol|2|||
27795327|NCT02224157|54250294|FG001|Overall Study|Severe non-compliance to protocol|2|||
27795328|NCT02224157|54250293|FG000|Overall Study|Other|13|||
27795329|NCT02224157|54250294|FG001|Overall Study|Other|10|||
27795330|NCT02224157|54250293|FG000|Overall Study|Subject decision|58|||
27795331|NCT02224157|54250294|FG001|Overall Study|Subject decision|50|||
27795332|NCT02224157|54250293|FG000|Overall Study|Prematurely closed site|4|||
27795333|NCT02224157|54250294|FG001|Overall Study|Prematurely closed site|2|||
27795334|NCT02224157|54250293|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
27795335|NCT02224157|54250294|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
27795336|NCT02224157|54250293|FG000|Overall Study|Lost to Follow-up|27|||
27795337|NCT02224157|54250294|FG001|Overall Study|Lost to Follow-up|35|||
27795338|NCT02224157|54250293|FG000|Overall Study|Death|1|||
27795339|NCT02224157|54250294|FG001|Overall Study|Death|1|||
27795340|NCT02224157|54250293|FG000|Overall Study|Adverse Event|1|||
27795341|NCT02224157|54250294|FG001|Overall Study|Adverse Event|3|||
27795342|NCT02196701|54250302|FG000|Overall Study|Adverse Event|1|||
27795343|NCT02196701|54250302|FG000|Overall Study|Lost to Follow-up|1|||
27795344|NCT02196701|54250302|FG000|Overall Study|Non-adherence to Protocol|1|||
27795345|NCT01481116|54250312|FG000|Overall Study|Adverse Event|26|||
27795346|NCT01481116|54250313|FG001|Overall Study|Adverse Event|26|||
27795347|NCT01481116|54250314|FG002|Overall Study|Adverse Event|42|||
27795348|NCT01481116|54250312|FG000|Overall Study|Major Protocol Deviation|3|||
27842664|NCT01549652|54331350|FG000|Overall Study|Titration Side Effects|0|||
27842665|NCT01549652|54331351|FG001|Overall Study|Titration Side Effects|0|||
27842666|NCT01549652|54331352|FG002|Overall Study|Titration Side Effects|6|||
27842667|NCT01549652|54331353|FG003|Overall Study|Titration Side Effects|3|||
27842668|NCT01549652|54331350|FG000|Overall Study|Withdrawal by Subject|0|||
27842669|NCT01549652|54331351|FG001|Overall Study|Withdrawal by Subject|0|||
27842670|NCT01549652|54331352|FG002|Overall Study|Withdrawal by Subject|5|||
27842671|NCT01549652|54331353|FG003|Overall Study|Withdrawal by Subject|3|||
27795349|NCT01481116|54250313|FG001|Overall Study|Major Protocol Deviation|7|||
27795350|NCT01481116|54250314|FG002|Overall Study|Major Protocol Deviation|1|||
27795351|NCT01481116|54250312|FG000|Overall Study|Lost to Follow-up|8|||
27795352|NCT01481116|54250313|FG001|Overall Study|Lost to Follow-up|12|||
27795353|NCT01481116|54250314|FG002|Overall Study|Lost to Follow-up|11|||
27795354|NCT01481116|54250312|FG000|Overall Study|Withdrawal by Subject|37|||
27795355|NCT01481116|54250313|FG001|Overall Study|Withdrawal by Subject|33|||
27795356|NCT01481116|54250314|FG002|Overall Study|Withdrawal by Subject|37|||
27795357|NCT01481116|54250312|FG000|Overall Study|Study Termination|730|||
27795358|NCT01481116|54250313|FG001|Overall Study|Study Termination|729|||
27795359|NCT01481116|54250314|FG002|Overall Study|Study Termination|713|||
27795360|NCT01481116|54250312|FG000|Overall Study|Pregnancy|0|||
27795361|NCT01481116|54250313|FG001|Overall Study|Pregnancy|0|||
27795362|NCT01481116|54250314|FG002|Overall Study|Pregnancy|1|||
27795363|NCT01481116|54250312|FG000|Overall Study|Lack of Efficacy|3|||
27795364|NCT01481116|54250313|FG001|Overall Study|Lack of Efficacy|3|||
27842672|NCT01569464|54331361|FG000|Overall Study|Adverse Event|4|||
27842673|NCT01569464|54331362|FG001|Overall Study|Adverse Event|0|||
27842674|NCT01569464|54331361|FG000|Overall Study|Lack of Efficacy|1|||
27795365|NCT01481116|54250314|FG002|Overall Study|Lack of Efficacy|1|||
27795366|NCT01481116|54250312|FG000|Overall Study|Contraindications|1|||
27795367|NCT01481116|54250313|FG001|Overall Study|Contraindications|1|||
27795368|NCT01481116|54250314|FG002|Overall Study|Contraindications|0|||
27795369|NCT01481116|54250312|FG000|Overall Study|Other|1|||
27842675|NCT01569464|54331362|FG001|Overall Study|Lack of Efficacy|0|||
27842676|NCT01569464|54331361|FG000|Overall Study|Protocol Violation|1|||
27842677|NCT01569464|54331362|FG001|Overall Study|Protocol Violation|0|||
27842678|NCT01569464|54331361|FG000|Overall Study|Lost to Follow-up|2|||
27795370|NCT01481116|54250313|FG001|Overall Study|Other|1|||
27795371|NCT01481116|54250314|FG002|Overall Study|Other|0|||
27795372|NCT01481116|54250312|FG000|Overall Study|Participant Started Taking Glipizide|1|||
27795373|NCT01481116|54250313|FG001|Overall Study|Participant Started Taking Glipizide|0|||
27795374|NCT01481116|54250314|FG002|Overall Study|Participant Started Taking Glipizide|0|||
27795375|NCT01481116|54250312|FG000|Overall Study|Participant Moved Out of Area|2|||
27795376|NCT01481116|54250313|FG001|Overall Study|Participant Moved Out of Area|0|||
27795377|NCT01481116|54250314|FG002|Overall Study|Participant Moved Out of Area|1|||
27795378|NCT01481116|54250312|FG000|Overall Study|Participant Moved Out of Country|1|||
27795379|NCT01481116|54250313|FG001|Overall Study|Participant Moved Out of Country|0|||
27795380|NCT01481116|54250314|FG002|Overall Study|Participant Moved Out of Country|1|||
27795381|NCT01481116|54250312|FG000|Overall Study|Investigator Decision|3|||
27795382|NCT01481116|54250313|FG001|Overall Study|Investigator Decision|2|||
27795383|NCT01481116|54250314|FG002|Overall Study|Investigator Decision|1|||
27795384|NCT01481116|54250312|FG000|Overall Study|Sponsor Decision|0|||
27795385|NCT01481116|54250313|FG001|Overall Study|Sponsor Decision|1|||
27842679|NCT01569464|54331362|FG001|Overall Study|Lost to Follow-up|3|||
27842680|NCT01569464|54331361|FG000|Overall Study|Withdrawal by Subject|1|||
27842681|NCT01569464|54331362|FG001|Overall Study|Withdrawal by Subject|1|||
27842682|NCT01569464|54331361|FG000|Overall Study|Other|1|||
27842683|NCT01569464|54331362|FG001|Overall Study|Other|1|||
27842684|NCT01534676|54331372|FG000|Overall Study|Study closed due to poor enrollment|2|||
27842685|NCT01534676|54331373|FG001|Overall Study|Study closed due to poor enrollment|1|||
27842686|NCT01442675|54331379|FG000|Overall Study|Protocol Violation|6|||
27842687|NCT01442675|54331379|FG000|Overall Study|Lost to Follow-up|2|||
27842688|NCT01442675|54331379|FG000|Overall Study|Withdrawal by Subject|4|||
27842689|NCT01534520|54331386|FG000|Overall Study|Adverse Event|0|||
27842690|NCT01534520|54331387|FG001|Overall Study|Adverse Event|1|||
27842691|NCT01534208|54331417|FG000|Overall Study|Lost to Follow-up|19|||
27842692|NCT01534208|54331418|FG001|Overall Study|Lost to Follow-up|14|||
27842693|NCT01534208|54331417|FG000|Overall Study|Withdrawal by Subject|6|||
27842694|NCT01534208|54331418|FG001|Overall Study|Withdrawal by Subject|20|||
27842695|NCT01534208|54331417|FG000|Overall Study|Adverse Event|15|||
27842696|NCT01534208|54331418|FG001|Overall Study|Adverse Event|8|||
27842697|NCT01534208|54331417|FG000|Overall Study|Physician Decision|2|||
27842698|NCT01534208|54331418|FG001|Overall Study|Physician Decision|0|||
27795386|NCT01481116|54250314|FG002|Overall Study|Sponsor Decision|3|||
27795387|NCT01481116|54250312|FG000|Overall Study|Non-Compliant With Study Drug|0|||
27795388|NCT01481116|54250313|FG001|Overall Study|Non-Compliant With Study Drug|1|||
27795389|NCT01481116|54250314|FG002|Overall Study|Non-Compliant With Study Drug|1|||
27795390|NCT01481116|54250312|FG000|Overall Study|Investigator's Discretion|2|||
27795391|NCT01481116|54250313|FG001|Overall Study|Investigator's Discretion|0|||
27795392|NCT01481116|54250314|FG002|Overall Study|Investigator's Discretion|0|||
27795393|NCT01481116|54250312|FG000|Overall Study|Death|2|||
27795394|NCT01481116|54250313|FG001|Overall Study|Death|1|||
27795395|NCT01481116|54250314|FG002|Overall Study|Death|0|||
27795396|NCT01481116|54250312|FG000|Overall Study|Hypoglycemic Event|4|||
27795397|NCT01481116|54250313|FG001|Overall Study|Hypoglycemic Event|0|||
27795398|NCT01481116|54250314|FG002|Overall Study|Hypoglycemic Event|0|||
27795399|NCT02222207|54250322|FG000|Overall Study|Death|1|||
27795400|NCT02222207|54250322|FG000|Overall Study|Other reasons|2|||
27795401|NCT02222207|54250322|FG000|Overall Study|Adverse Event|1|||
27795402|NCT01457014|54250326|FG000|First Night|Didn't meet inclusion/exclusion criteria|37|||
27795403|NCT01457014|54250327|FG001|First Night|Didn't meet inclusion/exclusion criteria|0|||
27795404|NCT01457014|54250328|FG002|First Night|Didn't meet inclusion/exclusion criteria|0|||
27795405|NCT01457014|54250329|FG003|First Night|Didn't meet inclusion/exclusion criteria|0|||
27795406|NCT01457014|54250326|FG000|First Night|Withdrawal by Subject|3|||
27795407|NCT01457014|54250327|FG001|First Night|Withdrawal by Subject|0|||
27795408|NCT01457014|54250328|FG002|First Night|Withdrawal by Subject|0|||
27795409|NCT01457014|54250329|FG003|First Night|Withdrawal by Subject|0|||
27842699|NCT01534208|54331417|FG000|Overall Study|Lack of Efficacy|0|||
27842700|NCT01534208|54331418|FG001|Overall Study|Lack of Efficacy|3|||
27795410|NCT02254421|54250339|FG000|Overall Study|Randomized but Not Treated|1|||
27842701|NCT01534208|54331417|FG000|Overall Study|Protocol Violation|2|||
27795411|NCT02254421|54250340|FG001|Overall Study|Randomized but Not Treated|0|||
27795412|NCT02254421|54250339|FG000|Overall Study|Death|0|||
27795413|NCT02254421|54250340|FG001|Overall Study|Death|2|||
27795414|NCT02254421|54250339|FG000|Overall Study|Withdrew Consent|1|||
27795415|NCT02254421|54250340|FG001|Overall Study|Withdrew Consent|1|||
27795416|NCT02252939|54250346|FG000|Overall Study|Lost to Follow-up|3|||
27795417|NCT02196077|54250355|FG000|Overall Study|Adverse Event|4|||
27795418|NCT02196077|54250355|FG000|Overall Study|Lack of Efficacy|1|||
27842702|NCT01534208|54331418|FG001|Overall Study|Protocol Violation|2|||
27842703|NCT01534208|54331417|FG000|Overall Study|Sponsor decision|4|||
27842704|NCT01534208|54331418|FG001|Overall Study|Sponsor decision|1|||
27842705|NCT01534208|54331417|FG000|Overall Study|Subject relocation|2|||
27842706|NCT01534208|54331418|FG001|Overall Study|Subject relocation|0|||
27842707|NCT01534208|54331417|FG000|Overall Study|Lab assessment|2|||
27795419|NCT02196077|54250355|FG000|Overall Study|Withdrawal by Subject|14|||
27795420|NCT02196077|54250355|FG000|Overall Study|Physician Decision|1|||
27795421|NCT02196077|54250355|FG000|Overall Study|Lost to Follow-up|3|||
27795422|NCT02196077|54250355|FG000|Overall Study|Protocol Violation|24|||
27795423|NCT02195687|54250369|FG000|Overall Study|Personal Reasons|1|||
27795424|NCT02195687|54250370|FG001|Overall Study|Personal Reasons|1|||
27795425|NCT02195687|54250369|FG000|Overall Study|Lost to Follow-up|4|||
27795426|NCT02195687|54250370|FG001|Overall Study|Lost to Follow-up|1|||
27795427|NCT02195531|54250379|FG000|Overall Study|Withdrawal by Subject|1|||
27795428|NCT02195531|54250380|FG001|Overall Study|Withdrawal by Subject|1|||
27795429|NCT02195531|54250381|FG002|Overall Study|Withdrawal by Subject|1|||
27795430|NCT02252081|54250391|FG000|Overall Study|Withdrawal by Subject|2|||
27795431|NCT02252081|54250392|FG001|Overall Study|Withdrawal by Subject|1|||
27795432|NCT02252081|54250391|FG000|Overall Study|Adverse Event|4|||
27795433|NCT02252081|54250392|FG001|Overall Study|Adverse Event|1|||
27795434|NCT02252081|54250391|FG000|Overall Study|non compliance & others|0|||
27795435|NCT02252081|54250392|FG001|Overall Study|non compliance & others|2|||
27795436|NCT01623752|54250406|FG000|Phase 1 (78 Weeks)|No Data|249|||
27795437|NCT01623752|54250407|FG001|Phase 1 (78 Weeks)|No Data|66|||
27795438|NCT01623752|54250408|FG002|Phase 1 (78 Weeks)|No Data|2|||
27795439|NCT01623752|54250406|FG000|Phase 1 (78 Weeks)|Other|33|||
27795440|NCT01623752|54250407|FG001|Phase 1 (78 Weeks)|Other|20|||
27795441|NCT01623752|54250408|FG002|Phase 1 (78 Weeks)|Other|0|||
27795442|NCT01623752|54250406|FG000|Phase 1 (78 Weeks)|Adverse Event|122|||
27795443|NCT01623752|54250407|FG001|Phase 1 (78 Weeks)|Adverse Event|39|||
27795444|NCT01623752|54250408|FG002|Phase 1 (78 Weeks)|Adverse Event|0|||
27795445|NCT01623752|54250406|FG000|Phase 1 (78 Weeks)|Lack of Efficacy|227|||
27795446|NCT01623752|54250407|FG001|Phase 1 (78 Weeks)|Lack of Efficacy|82|||
27795447|NCT01623752|54250408|FG002|Phase 1 (78 Weeks)|Lack of Efficacy|0|||
27795448|NCT01623752|54250406|FG000|Phase 2 (78 Weeks)|Lack of Efficacy|14|||
27795449|NCT01623752|54250407|FG001|Phase 2 (78 Weeks)|Lack of Efficacy|2|||
27795450|NCT01623752|54250408|FG002|Phase 2 (78 Weeks)|Lack of Efficacy|0|||
27795451|NCT01623752|54250406|FG000|Phase 2 (78 Weeks)|Other|5|||
27795452|NCT01623752|54250407|FG001|Phase 2 (78 Weeks)|Other|1|||
27795453|NCT01623752|54250408|FG002|Phase 2 (78 Weeks)|Other|0|||
27795454|NCT01623752|54250406|FG000|Phase 2 (78 Weeks)|No Data|43|||
27795455|NCT01623752|54250407|FG001|Phase 2 (78 Weeks)|No Data|11|||
27795456|NCT01623752|54250408|FG002|Phase 2 (78 Weeks)|No Data|0|||
27795457|NCT01623752|54250406|FG000|Phase 2 (78 Weeks)|Adverse Event|4|||
27795458|NCT01623752|54250407|FG001|Phase 2 (78 Weeks)|Adverse Event|4|||
27795459|NCT01623752|54250408|FG002|Phase 2 (78 Weeks)|Adverse Event|0|||
27795460|NCT01623596|54250419|FG000|Overall Study|Abnormal laboratory values|2|||
27842708|NCT01534208|54331418|FG001|Overall Study|Lab assessment|1|||
27842709|NCT01534208|54331417|FG000|Overall Study|Eligibility error|3|||
27795461|NCT01623596|54250420|FG001|Overall Study|Abnormal laboratory values|0|||
27795462|NCT01623596|54250419|FG000|Overall Study|Administrative problems|9|||
27795463|NCT01623596|54250420|FG001|Overall Study|Administrative problems|13|||
27795464|NCT01623596|54250419|FG000|Overall Study|Adverse Event|20|||
27795465|NCT01623596|54250420|FG001|Overall Study|Adverse Event|29|||
27795466|NCT01623596|54250419|FG000|Overall Study|Death|0|||
27795467|NCT01623596|54250420|FG001|Overall Study|Death|2|||
27795468|NCT01623596|54250419|FG000|Overall Study|Lost to Follow-up|12|||
27795469|NCT01623596|54250420|FG001|Overall Study|Lost to Follow-up|16|||
27795470|NCT01623596|54250419|FG000|Overall Study|Withdrawal by Subject|13|||
27795471|NCT01623596|54250420|FG001|Overall Study|Withdrawal by Subject|31|||
27795472|NCT01623596|54250419|FG000|Overall Study|Patient no longer requires study drug|1|||
27795473|NCT01623596|54250420|FG001|Overall Study|Patient no longer requires study drug|0|||
27795474|NCT01623596|54250419|FG000|Overall Study|Protocol Violation|0|||
27795475|NCT01623596|54250420|FG001|Overall Study|Protocol Violation|6|||
27795476|NCT01623596|54250419|FG000|Overall Study|Lack of Efficacy|5|||
27795477|NCT01623596|54250420|FG001|Overall Study|Lack of Efficacy|3|||
27831241|NCT01790633|54307627|FG000|Overall Study|RT failure and no follow-up ELISA|0|||
27831242|NCT01790633|54307628|FG001|Overall Study|RT failure and no follow-up ELISA|3|||
27842710|NCT01534208|54331418|FG001|Overall Study|Eligibility error|0|||
27831243|NCT01788215|54307637|FG000|Overall Study|Withdrawal by Subject|0|||
27831244|NCT01788215|54307638|FG001|Overall Study|Withdrawal by Subject|1|||
27831245|NCT01788215|54307637|FG000|Overall Study|Lost to Follow-up|2|||
27831246|NCT01788215|54307638|FG001|Overall Study|Lost to Follow-up|0|||
27831247|NCT01787825|54307644|FG000|Overall Study|Subject Did Not Ingest Capsules|1|||
27831248|NCT01787825|54307645|FG001|Overall Study|Subject Did Not Ingest Capsules|0|||
27831249|NCT01787825|54307644|FG000|Overall Study|Data Not Analyzable|5|||
27831250|NCT01787825|54307645|FG001|Overall Study|Data Not Analyzable|1|||
27831251|NCT01813019|54307654|FG000|Overall Study|Adverse Event|0|||
27831252|NCT01813019|54307655|FG001|Overall Study|Adverse Event|3|||
27831253|NCT01813019|54307654|FG000|Overall Study|Withdrawal by Subject|3|||
27842711|NCT01534208|54331417|FG000|Overall Study|PCP decision|1|||
27831254|NCT01813019|54307655|FG001|Overall Study|Withdrawal by Subject|2|||
27831255|NCT01813019|54307654|FG000|Overall Study|administrative problems|2|||
27842712|NCT01534208|54331418|FG001|Overall Study|PCP decision|0|||
27842713|NCT01534208|54331417|FG000|Overall Study|Needed prohibited meds|1|||
27842714|NCT01534208|54331418|FG001|Overall Study|Needed prohibited meds|0|||
27842715|NCT01548638|54331424|FG000|Overall Study|Protocol Violation|3|||
27842716|NCT01548638|54331424|FG000|Overall Study|Withdrawal by Subject|1|||
27842717|NCT01533428|54331448|FG000|Overall Study|Adverse Event|0|||
27842718|NCT01533428|54331449|FG001|Overall Study|Adverse Event|1|||
27842719|NCT01533428|54331448|FG000|Overall Study|Lost to Follow-up|2|||
27842720|NCT01533428|54331449|FG001|Overall Study|Lost to Follow-up|1|||
27842721|NCT01533428|54331448|FG000|Overall Study|Withdrawal by Subject|7|||
27842722|NCT01533428|54331449|FG001|Overall Study|Withdrawal by Subject|6|||
28017388|NCT00575510|54676637|FG000|Overall Study|Pregnancy|0|||
28017389|NCT00575510|54676638|FG001|Overall Study|Pregnancy|0|||
28017390|NCT00575510|54676639|FG002|Overall Study|Pregnancy|1|||
27842723|NCT01517984|54331458|FG000|Overall Study|Lost to Follow-up|0|||
27842724|NCT01517984|54331459|FG001|Overall Study|Lost to Follow-up|1|||
27842725|NCT01517984|54331460|FG002|Overall Study|Lost to Follow-up|0|||
27842726|NCT01517984|54331461|FG003|Overall Study|Lost to Follow-up|0|||
27842727|NCT01517984|54331458|FG000|Overall Study|Withdrawal by Subject|1|||
28017391|NCT02636439|54676650|FG000|Overall Study|Adverse Event|2|||
28017392|NCT02636439|54676651|FG001|Overall Study|Adverse Event|2|||
28017393|NCT02636439|54676650|FG000|Overall Study|Lost to Follow-up|1|||
28017394|NCT02636439|54676651|FG001|Overall Study|Lost to Follow-up|0|||
28017395|NCT02636439|54676650|FG000|Overall Study|Non-compliance|1|||
28017396|NCT02636439|54676651|FG001|Overall Study|Non-compliance|1|||
28017397|NCT02636439|54676650|FG000|Overall Study|Personal reasons|2|||
28017398|NCT02636439|54676651|FG001|Overall Study|Personal reasons|0|||
28017399|NCT00343915|54676659|FG000|Primary Study|Withdrawal by Subject|1|||
28017400|NCT00343915|54676660|FG001|Primary Study|Withdrawal by Subject|0|||
28017401|NCT00343915|54676659|FG000|Primary Study|Lost to Follow-up|2|||
28017402|NCT00343915|54676660|FG001|Primary Study|Lost to Follow-up|3|||
28017403|NCT00343915|54676659|FG000|Primary Study|Other|1|||
28017404|NCT00343915|54676660|FG001|Primary Study|Other|0|||
28017405|NCT00575666|54676671|FG000|Overall Study|Withdrawal by Subject|3|||
28017406|NCT00575666|54676672|FG001|Overall Study|Withdrawal by Subject|2|||
28017407|NCT00575666|54676671|FG000|Overall Study|Physician Decision|1|||
27795478|NCT02219477|54250431|FG000|Overall Study|Adverse Event|0|||
27795479|NCT02219477|54250432|FG001|Overall Study|Adverse Event|1|||
27795480|NCT02219477|54250433|FG002|Overall Study|Adverse Event|1|||
27795481|NCT02219477|54250431|FG000|Overall Study|Withdrawal by Subject|0|||
27795482|NCT02219477|54250432|FG001|Overall Study|Withdrawal by Subject|1|||
27795483|NCT02219477|54250433|FG002|Overall Study|Withdrawal by Subject|0|||
27795484|NCT02119286|54250445|FG000|Overall Study|Adverse Event|9|||
27795485|NCT02119286|54250446|FG001|Overall Study|Adverse Event|7|||
27795486|NCT02119286|54250447|FG002|Overall Study|Adverse Event|2|||
27795487|NCT02119286|54250445|FG000|Overall Study|Lack of Efficacy|11|||
27795488|NCT02119286|54250446|FG001|Overall Study|Lack of Efficacy|3|||
27795489|NCT02119286|54250447|FG002|Overall Study|Lack of Efficacy|4|||
27795490|NCT02119286|54250445|FG000|Overall Study|Lost to Follow-up|2|||
27795491|NCT02119286|54250446|FG001|Overall Study|Lost to Follow-up|0|||
27795492|NCT02119286|54250447|FG002|Overall Study|Lost to Follow-up|1|||
27795493|NCT02119286|54250445|FG000|Overall Study|Withdrawal by Subject|4|||
27795494|NCT02119286|54250446|FG001|Overall Study|Withdrawal by Subject|1|||
27795495|NCT02119286|54250447|FG002|Overall Study|Withdrawal by Subject|0|||
27795496|NCT02250443|54250455|FG000|Overall Study|Administrative problems|7|||
27795497|NCT02250443|54250455|FG000|Overall Study|Adverse Event|3|||
27795498|NCT02093390|54250461|FG000|Overall Study|Withdrawal by Subject|0|||
27795499|NCT02093390|54250462|FG001|Overall Study|Withdrawal by Subject|1|||
27795500|NCT02194985|54250469|FG000|Overall Study|Adverse Event|1|||
27795501|NCT02194985|54250469|FG000|Overall Study|Met Protocol Defined Stopping Criteria|3|||
27795502|NCT02194985|54250469|FG000|Overall Study|Physician Decision|4|||
27795503|NCT02194985|54250469|FG000|Overall Study|Lost to Follow-up|1|||
27795504|NCT02194985|54250469|FG000|Overall Study|Withdrawal by Subject|2|||
27795505|NCT02219087|54250475|FG000|Overall Study|Randomization envelope pulled out of seq|0|||
27795506|NCT02219087|54250476|FG001|Overall Study|Randomization envelope pulled out of seq|1|||
27842728|NCT01517984|54331459|FG001|Overall Study|Withdrawal by Subject|8|||
27842729|NCT01517984|54331460|FG002|Overall Study|Withdrawal by Subject|4|||
27842730|NCT01517984|54331461|FG003|Overall Study|Withdrawal by Subject|1|||
27842731|NCT01517984|54331458|FG000|Overall Study|Screen Failure|4|||
27842732|NCT01517984|54331459|FG001|Overall Study|Screen Failure|0|||
28017408|NCT00575666|54676672|FG001|Overall Study|Physician Decision|1|||
28017409|NCT00658632|54676680|FG000|Overall Study|Adverse Event|13|||
28017410|NCT00658632|54676681|FG001|Overall Study|Adverse Event|11|||
28017411|NCT00658632|54676680|FG000|Overall Study|Lost to Follow-up|25|||
27795507|NCT02248961|54250484|FG000|Overall Study|Adverse Event|1|||
27795508|NCT02248961|54250485|FG001|Overall Study|Adverse Event|0|||
27795509|NCT02248961|54250484|FG000|Overall Study|Withdrawal by Subject|1|||
27795510|NCT02248961|54250485|FG001|Overall Study|Withdrawal by Subject|2|||
27795511|NCT02248961|54250484|FG000|Overall Study|Unmet inclusion/exclusion criteria|1|||
27795512|NCT02248961|54250485|FG001|Overall Study|Unmet inclusion/exclusion criteria|0|||
27795513|NCT02219009|54250493|FG000|Overall Study|Withdrawal by Subject|5|||
27795514|NCT02219009|54250494|FG001|Overall Study|Withdrawal by Subject|1|||
27795515|NCT02219009|54250493|FG000|Overall Study|Adverse Event|2|||
27795516|NCT02219009|54250494|FG001|Overall Study|Adverse Event|4|||
27795517|NCT02219009|54250493|FG000|Overall Study|Lost to Follow-up|2|||
27795518|NCT02219009|54250494|FG001|Overall Study|Lost to Follow-up|2|||
27795519|NCT02219009|54250493|FG000|Overall Study|Protocol deviation|1|||
27795520|NCT02219009|54250494|FG001|Overall Study|Protocol deviation|0|||
27795521|NCT02219009|54250493|FG000|Overall Study|Physician Decision|0|||
27795522|NCT02219009|54250494|FG001|Overall Study|Physician Decision|1|||
27795523|NCT02248649|54250502|FG000|Overall Study|Death|7|||
27795524|NCT02248649|54250503|FG001|Overall Study|Death|11|||
27795525|NCT02248649|54250502|FG000|Overall Study|Lost to Follow-up|14|||
27795526|NCT02248649|54250503|FG001|Overall Study|Lost to Follow-up|10|||
27795527|NCT02218541|54250511|FG000|Overall Study|Lost to Follow-up|2|||
27795528|NCT02218541|54250512|FG001|Overall Study|Lost to Follow-up|1|||
27795529|NCT02218541|54250511|FG000|Overall Study|Implant Failure|4|||
27795530|NCT02218541|54250512|FG001|Overall Study|Implant Failure|1|||
27795531|NCT02217527|54250521|FG000|Drug Condition 1: First Study Phase|Withdrawal by Subject|1|||
27795532|NCT02217527|54250522|FG001|Drug Condition 1: First Study Phase|Withdrawal by Subject|3|||
27795533|NCT02217527|54250521|FG000|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0|||
27795534|NCT02217527|54250522|FG001|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1|||
27795535|NCT01456936|54250532|FG000|Overall Study|Other reason|41|||
27795536|NCT01456936|54250533|FG001|Overall Study|Other reason|30|||
27795537|NCT01456936|54250534|FG002|Overall Study|Other reason|36|||
27795538|NCT01456936|54250535|FG003|Overall Study|Other reason|33|||
27795539|NCT01456936|54250532|FG000|Overall Study|No longer meets eligibility criteria|4|||
27795540|NCT01456936|54250533|FG001|Overall Study|No longer meets eligibility criteria|8|||
27795541|NCT01456936|54250534|FG002|Overall Study|No longer meets eligibility criteria|6|||
27795542|NCT01456936|54250535|FG003|Overall Study|No longer meets eligibility criteria|5|||
27795543|NCT01456936|54250532|FG000|Overall Study|Protocol Violation|4|||
27795544|NCT01456936|54250533|FG001|Overall Study|Protocol Violation|2|||
27795545|NCT01456936|54250534|FG002|Overall Study|Protocol Violation|5|||
27795546|NCT01456936|54250535|FG003|Overall Study|Protocol Violation|5|||
27795547|NCT01456936|54250532|FG000|Overall Study|Pregnancy|1|||
27795548|NCT01456936|54250533|FG001|Overall Study|Pregnancy|0|||
27795549|NCT01456936|54250534|FG002|Overall Study|Pregnancy|0|||
27795550|NCT01456936|54250535|FG003|Overall Study|Pregnancy|1|||
27795551|NCT01456936|54250532|FG000|Overall Study|Insufficient clinical response|4|||
27795552|NCT01456936|54250533|FG001|Overall Study|Insufficient clinical response|4|||
27795553|NCT01456936|54250534|FG002|Overall Study|Insufficient clinical response|14|||
27795554|NCT01456936|54250535|FG003|Overall Study|Insufficient clinical response|13|||
27795555|NCT01456936|54250532|FG000|Overall Study|No longer willing to participate|195|||
27795556|NCT01456936|54250533|FG001|Overall Study|No longer willing to participate|218|||
27795557|NCT01456936|54250534|FG002|Overall Study|No longer willing to participate|224|||
27795558|NCT01456936|54250535|FG003|Overall Study|No longer willing to participate|248|||
27795559|NCT01456936|54250532|FG000|Overall Study|Lost to Follow-up|135|||
27795560|NCT01456936|54250533|FG001|Overall Study|Lost to Follow-up|126|||
27795561|NCT01456936|54250534|FG002|Overall Study|Lost to Follow-up|144|||
27795562|NCT01456936|54250535|FG003|Overall Study|Lost to Follow-up|127|||
27795563|NCT01456936|54250532|FG000|Overall Study|Medication error|0|||
27795564|NCT01456936|54250533|FG001|Overall Study|Medication error|1|||
27795565|NCT01456936|54250534|FG002|Overall Study|Medication error|0|||
27795566|NCT01456936|54250535|FG003|Overall Study|Medication error|1|||
27795567|NCT01456936|54250532|FG000|Overall Study|Adverse event (study drug)|25|||
27795568|NCT01456936|54250533|FG001|Overall Study|Adverse event (study drug)|21|||
27795569|NCT01456936|54250534|FG002|Overall Study|Adverse event (study drug)|26|||
27795570|NCT01456936|54250535|FG003|Overall Study|Adverse event (study drug)|17|||
27795571|NCT01456936|54250532|FG000|Overall Study|Adverse event (study drug unrelated)|9|||
27795572|NCT01456936|54250533|FG001|Overall Study|Adverse event (study drug unrelated)|7|||
27795573|NCT01456936|54250534|FG002|Overall Study|Adverse event (study drug unrelated)|9|||
27795574|NCT01456936|54250535|FG003|Overall Study|Adverse event (study drug unrelated)|9|||
27795575|NCT01456936|54250532|FG000|Overall Study|Death|0|||
27795576|NCT01456936|54250533|FG001|Overall Study|Death|3|||
27795577|NCT01456936|54250534|FG002|Overall Study|Death|1|||
27795578|NCT01456936|54250535|FG003|Overall Study|Death|3|||
27795579|NCT01456936|54250532|FG000|Overall Study|Randomized but not treated|21|||
27795580|NCT01456936|54250533|FG001|Overall Study|Randomized but not treated|28|||
27795581|NCT01456936|54250534|FG002|Overall Study|Randomized but not treated|16|||
27795582|NCT01456936|54250535|FG003|Overall Study|Randomized but not treated|21|||
27795583|NCT01456780|54250548|FG000|Overall Study|Lost to Follow-up|3|||
27795584|NCT01456780|54250549|FG001|Overall Study|Lost to Follow-up|3|||
27795585|NCT01456780|54250550|FG002|Overall Study|Lost to Follow-up|0|||
27795586|NCT01480258|54250560|FG000|Infant Series|Protocol Violation|2|||
27795587|NCT01480258|54250561|FG001|Infant Series|Protocol Violation|0|||
27795588|NCT01480258|54250560|FG000|Infant Series|Physician Decision|0|||
27795589|NCT01480258|54250561|FG001|Infant Series|Physician Decision|1|||
27795590|NCT01480258|54250560|FG000|Infant Series|Not Vaccinated|3|||
27795591|NCT01480258|54250561|FG001|Infant Series|Not Vaccinated|0|||
27795592|NCT01480258|54250560|FG000|Infant Series|Adverse Event|1|||
27795593|NCT01480258|54250561|FG001|Infant Series|Adverse Event|1|||
27795594|NCT01480258|54250560|FG000|Infant Series|Withdrawal by Subject|1|||
27795595|NCT01480258|54250561|FG001|Infant Series|Withdrawal by Subject|6|||
27795596|NCT01480258|54250560|FG000|Interim Period|Lost to Follow-up|0|||
27795597|NCT01480258|54250561|FG001|Interim Period|Lost to Follow-up|2|||
27795598|NCT01480258|54250560|FG000|Interim Period|Physician Decision|1|||
28017412|NCT00658632|54676681|FG001|Overall Study|Lost to Follow-up|23|||
28017413|NCT00658632|54676680|FG000|Overall Study|Withdrawal by Subject|10|||
28017414|NCT00658632|54676681|FG001|Overall Study|Withdrawal by Subject|7|||
28017415|NCT00658632|54676680|FG000|Overall Study|Lack of Efficacy|0|||
28017416|NCT00658632|54676681|FG001|Overall Study|Lack of Efficacy|1|||
28017417|NCT00658632|54676680|FG000|Overall Study|Withdrawal of consent|8|||
28017418|NCT00658632|54676681|FG001|Overall Study|Withdrawal of consent|14|||
28017419|NCT00658632|54676680|FG000|Overall Study|Pregnancy|1|||
28017420|NCT00658632|54676681|FG001|Overall Study|Pregnancy|1|||
28017421|NCT00658632|54676680|FG000|Overall Study|Other|7|||
28017422|NCT00658632|54676681|FG001|Overall Study|Other|8|||
28017423|NCT00677534|54676687|FG000|Washout (Weeks 1-4)|did not qualify after signing consent|1|||
28017424|NCT00677534|54676687|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
28017425|NCT00677534|54676687|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
28017426|NCT00660348|54676693|FG000|Overall Study|Withdrawal by Subject|1|||
27795599|NCT01480258|54250561|FG001|Interim Period|Physician Decision|0|||
27795600|NCT01480258|54250560|FG000|Interim Period|Protocol Violation|0|||
28017427|NCT00660348|54676694|FG001|Overall Study|Withdrawal by Subject|0|||
28017428|NCT00660192|54676702|FG000|Overall Study|Lost to Follow-up|2|||
28017429|NCT00660192|54676703|FG001|Overall Study|Lost to Follow-up|3|||
28017430|NCT00571688|54676711|FG000|Overall Study|Lost to Follow-up|3|||
28017431|NCT00571688|54676712|FG001|Overall Study|Lost to Follow-up|6|||
28017432|NCT00571688|54676711|FG000|Overall Study|subject did not tolerate Consta|1|||
28017433|NCT00571688|54676712|FG001|Overall Study|subject did not tolerate Consta|0|||
28017434|NCT00571688|54676711|FG000|Overall Study|subject moved out of the area|1|||
28017435|NCT00571688|54676712|FG001|Overall Study|subject moved out of the area|0|||
28017436|NCT00343291|54676720|FG000|Overall Study|Adverse Event|13|||
28017437|NCT00343291|54676721|FG001|Overall Study|Adverse Event|13|||
28017438|NCT00343291|54676720|FG000|Overall Study|Death|3|||
28017439|NCT00343291|54676721|FG001|Overall Study|Death|2|||
28017440|NCT00343291|54676720|FG000|Overall Study|Progressive disease|33|||
28017441|NCT00343291|54676721|FG001|Overall Study|Progressive disease|34|||
28017442|NCT00343291|54676720|FG000|Overall Study|Withdrawal by Subject|0|||
28017443|NCT00343291|54676721|FG001|Overall Study|Withdrawal by Subject|2|||
28017444|NCT00343291|54676720|FG000|Overall Study|Other|8|||
28017445|NCT00343291|54676721|FG001|Overall Study|Other|5|||
28017446|NCT00658788|54676727|FG000|Overall Study|Adverse Event|11|||
28017447|NCT00658788|54676727|FG000|Overall Study|Withdrawal by Subject|13|||
28017448|NCT00658788|54676727|FG000|Overall Study|Lost to Follow-up|18|||
28017449|NCT00658788|54676727|FG000|Overall Study|Treatment Discontinuation|32|||
28017450|NCT04829214|54676742|FG000|Follow-up and Efficacy Analysis|Withdrawal by Subject|5|||
27795601|NCT01480258|54250561|FG001|Interim Period|Protocol Violation|1|||
27795602|NCT01480258|54250560|FG000|Interim Period|Withdrawal by Subject|9|||
27795603|NCT01480258|54250561|FG001|Interim Period|Withdrawal by Subject|6|||
27795604|NCT01479868|54250567|FG000|Overall Study|Adverse Event|1|||
27795605|NCT01479868|54250567|FG000|Overall Study|Lost to Follow-up|4|||
28017451|NCT04829214|54676743|FG001|Follow-up and Efficacy Analysis|Withdrawal by Subject|3|||
28017452|NCT04829214|54676742|FG000|Follow-up and Efficacy Analysis|Lost to Follow-up|2|||
28017453|NCT04829214|54676743|FG001|Follow-up and Efficacy Analysis|Lost to Follow-up|1|||
28017454|NCT00562965|54676753|FG000|Overall Study|Withdrawal by Subject|0|||
28017455|NCT00562965|54676754|FG001|Overall Study|Withdrawal by Subject|1|||
28017456|NCT00562965|54676753|FG000|Overall Study|Death|2|||
28017457|NCT00562965|54676754|FG001|Overall Study|Death|4|||
28017458|NCT00562965|54676753|FG000|Overall Study|Lost to Follow-up|1|||
28017459|NCT00562965|54676754|FG001|Overall Study|Lost to Follow-up|0|||
28017460|NCT00562965|54676753|FG000|Overall Study|Other|0|||
28017461|NCT00562965|54676754|FG001|Overall Study|Other|1|||
28017462|NCT00537082|54676763|FG000|Overall Study|Adverse Event|6|||
28017463|NCT00537082|54676764|FG001|Overall Study|Adverse Event|6|||
28017464|NCT00537082|54676765|FG002|Overall Study|Adverse Event|3|||
28017465|NCT00537082|54676763|FG000|Overall Study|Protocol Violation|0|||
28017466|NCT00537082|54676764|FG001|Overall Study|Protocol Violation|2|||
28017467|NCT00537082|54676765|FG002|Overall Study|Protocol Violation|1|||
28017468|NCT00537082|54676763|FG000|Overall Study|Lack of Efficacy|0|||
28017469|NCT00537082|54676764|FG001|Overall Study|Lack of Efficacy|0|||
28017470|NCT00537082|54676765|FG002|Overall Study|Lack of Efficacy|2|||
28017471|NCT00537082|54676763|FG000|Overall Study|Withdrawal by Subject|0|||
28017472|NCT00537082|54676764|FG001|Overall Study|Withdrawal by Subject|1|||
28017473|NCT00537082|54676765|FG002|Overall Study|Withdrawal by Subject|0|||
28017474|NCT00537082|54676763|FG000|Overall Study|Discontinued before initiating treatment|3|||
28017475|NCT00537082|54676764|FG001|Overall Study|Discontinued before initiating treatment|0|||
28017476|NCT00537082|54676765|FG002|Overall Study|Discontinued before initiating treatment|0|||
28017477|NCT03828487|54676773|FG000|Overall Study|Physician Decision|1|||
28017478|NCT00324961|54676777|FG000|Overall Study|Adverse Event|5|||
28017479|NCT00324961|54676777|FG000|Overall Study|Consent Withdrawn|11|||
28017480|NCT00324961|54676777|FG000|Overall Study|Lost to Follow-up|22|||
28017481|NCT00324961|54676777|FG000|Overall Study|Protocol Violation|3|||
28017482|NCT00324961|54676777|FG000|Overall Study|Other|2|||
28017483|NCT00324649|54676785|FG000|Overall Study|Adverse Event|1|||
28017484|NCT00324649|54676786|FG001|Overall Study|Adverse Event|4|||
28017485|NCT00324649|54676785|FG000|Overall Study|Withdrawal by Subject|0|||
27795606|NCT01479868|54250567|FG000|Overall Study|Protocol Violation|1|||
27795607|NCT01479868|54250567|FG000|Overall Study|Withdrawal by Subject|1|||
27795608|NCT01479868|54250567|FG000|Overall Study|Sponsor's Decision|1|||
27795609|NCT01479868|54250567|FG000|Overall Study|Initiation of new HCV Therapy|1|||
27795610|NCT01478620|54250571|FG000|Overall Study|Lost to Follow-up|6|||
27795611|NCT01455220|54250575|FG000|Overall Study|screen fail|30|||
27795612|NCT01454830|54250584|FG000|Overall Study|Withdrawal by Subject|4|||
27795613|NCT01454830|54250585|FG001|Overall Study|Withdrawal by Subject|4|||
27795614|NCT01454830|54250584|FG000|Overall Study|Post-allocation Exclude- AHI<10|18|||
27795615|NCT01454830|54250585|FG001|Overall Study|Post-allocation Exclude- AHI<10|12|||
27938010|NCT01072149|54594336|FG011|Treatment Period 1 (28 Days)|Protocol Violation|0|||
27938011|NCT01072149|54594337|FG012|Treatment Period 1 (28 Days)|Protocol Violation|0|||
27938012|NCT01072149|54594338|FG013|Treatment Period 1 (28 Days)|Protocol Violation|0|||
27938013|NCT01072149|54594339|FG014|Treatment Period 1 (28 Days)|Protocol Violation|0|||
27938014|NCT01072149|54594340|FG015|Treatment Period 1 (28 Days)|Protocol Violation|0|||
27938015|NCT01072149|54594341|FG016|Treatment Period 1 (28 Days)|Protocol Violation|0|||
27938016|NCT01072149|54594342|FG017|Treatment Period 1 (28 Days)|Protocol Violation|1|||
27938017|NCT01072149|54594325|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
27938018|NCT01072149|54594326|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
27938019|NCT01072149|54594327|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
27938020|NCT01072149|54594328|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
27938021|NCT01072149|54594329|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
27938022|NCT01072149|54594330|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
27938023|NCT01072149|54594331|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
27938024|NCT01072149|54594332|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
27938025|NCT01072149|54594333|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
27938026|NCT01072149|54594334|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
27938027|NCT01072149|54594335|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
27938028|NCT01072149|54594336|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
27938029|NCT01072149|54594337|FG012|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
27938030|NCT01072149|54594338|FG013|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
28017486|NCT00324649|54676786|FG001|Overall Study|Withdrawal by Subject|1|||
28017487|NCT00324649|54676785|FG000|Overall Study|Noncompliance|1|||
28017488|NCT00324649|54676786|FG001|Overall Study|Noncompliance|0|||
28017489|NCT00656370|54676792|FG000|Overall Study|Screen Failures|7|||
28017490|NCT00656370|54676792|FG000|Overall Study|Alternates|3|||
28017491|NCT00680186|54676800|FG000|Overall Study|Adverse Event|47|||
28017492|NCT00680186|54676801|FG001|Overall Study|Adverse Event|44|||
28017493|NCT00680186|54676800|FG000|Overall Study|Protocol Violation|31|||
28017494|NCT00680186|54676801|FG001|Overall Study|Protocol Violation|26|||
27795616|NCT01454830|54250584|FG000|Overall Study|Post-allocation Exclude-refused PAP|0|||
27795617|NCT01454830|54250585|FG001|Overall Study|Post-allocation Exclude-refused PAP|2|||
27938031|NCT01072149|54594339|FG014|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
28017495|NCT00680186|54676800|FG000|Overall Study|Lost to Follow-up|11|||
28017496|NCT00680186|54676801|FG001|Overall Study|Lost to Follow-up|6|||
28017497|NCT00680186|54676800|FG000|Overall Study|Withdrawal by Subject|32|||
28017498|NCT00680186|54676801|FG001|Overall Study|Withdrawal by Subject|39|||
28017499|NCT00680186|54676800|FG000|Overall Study|Other|4|||
28017500|NCT00680186|54676801|FG001|Overall Study|Other|1|||
28017501|NCT00656292|54676809|FG000|Overall Study|Withdrawal by Subject|2|||
28017502|NCT00656292|54676810|FG001|Overall Study|Withdrawal by Subject|3|||
28017503|NCT00656292|54676809|FG000|Overall Study|Screen failure|1|||
28017504|NCT00656292|54676810|FG001|Overall Study|Screen failure|2|||
28017505|NCT00352417|54676818|FG000|Overall Study|Adverse Event|1|||
28017506|NCT00352417|54676819|FG001|Overall Study|Adverse Event|0|||
28017507|NCT00352417|54676818|FG000|Overall Study|Protocol Violation|0|||
28017508|NCT00352417|54676819|FG001|Overall Study|Protocol Violation|2|||
28017509|NCT00352417|54676818|FG000|Overall Study|Withdrawal by Subject|1|||
28017510|NCT00352417|54676819|FG001|Overall Study|Withdrawal by Subject|2|||
28017511|NCT00352417|54676818|FG000|Overall Study|Lost to Follow-up|1|||
28017512|NCT00352417|54676819|FG001|Overall Study|Lost to Follow-up|0|||
28017513|NCT00352417|54676818|FG000|Overall Study|Schedule Change|2|||
28017514|NCT00352417|54676819|FG001|Overall Study|Schedule Change|1|||
28017515|NCT00323869|54676825|FG000|Overall Study|Death|1|||
28017516|NCT00323557|54676831|FG000|Overall Study|Physician Decision|1|||
28017517|NCT00323557|54676832|FG001|Overall Study|Physician Decision|0|||
28017518|NCT00558363|54676841|FG000|Overall Study|Physician Decision|18|||
28017519|NCT00558363|54676842|FG001|Overall Study|Physician Decision|4|||
28017520|NCT00558363|54676841|FG000|Overall Study|Withdrawal by Subject|11|||
28017521|NCT00558363|54676842|FG001|Overall Study|Withdrawal by Subject|4|||
28017522|NCT00558363|54676841|FG000|Overall Study|Adverse Event|5|||
28017523|NCT00558363|54676842|FG001|Overall Study|Adverse Event|5|||
28017524|NCT00558363|54676841|FG000|Overall Study|Lack of Efficacy|2|||
28017525|NCT00558363|54676842|FG001|Overall Study|Lack of Efficacy|2|||
28017526|NCT00558363|54676841|FG000|Overall Study|Protocol Violation|2|||
28017527|NCT00558363|54676842|FG001|Overall Study|Protocol Violation|1|||
28017528|NCT00558363|54676841|FG000|Overall Study|Lost to Follow-up|0|||
28017529|NCT00558363|54676842|FG001|Overall Study|Lost to Follow-up|1|||
27795618|NCT01454830|54250584|FG000|Overall Study|Post-allocation Exclude-other treatment|6|||
27795619|NCT01454830|54250585|FG001|Overall Study|Post-allocation Exclude-other treatment|7|||
27795620|NCT01454830|54250584|FG000|Overall Study|Withdrawal - no polysomnography|3|||
27795621|NCT01454830|54250585|FG001|Overall Study|Withdrawal - no polysomnography|2|||
27795622|NCT01454596|54250603|FG000|Overall Study|Death|0|||
27795623|NCT01454596|54250604|FG001|Overall Study|Death|0|||
27795624|NCT01454596|54250605|FG002|Overall Study|Death|0|||
27795625|NCT01454596|54250606|FG003|Overall Study|Death|0|||
27795626|NCT01454596|54250607|FG004|Overall Study|Death|0|||
27795627|NCT01454596|54250608|FG005|Overall Study|Death|0|||
27795628|NCT01454596|54250609|FG006|Overall Study|Death|0|||
27795629|NCT01454596|54250610|FG007|Overall Study|Death|0|||
27795630|NCT01454596|54250611|FG008|Overall Study|Death|0|||
27795631|NCT01454596|54250612|FG009|Overall Study|Death|1|||
27795632|NCT01454596|54250613|FG010|Overall Study|Death|1|||
27795633|NCT01454596|54250614|FG011|Overall Study|Death|0|||
27795634|NCT02247479|54250643|FG000|Overall Study|Adverse Event|8|||
27795635|NCT02247479|54250644|FG001|Overall Study|Adverse Event|9|||
27938032|NCT01072149|54594340|FG015|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
27938033|NCT01072149|54594341|FG016|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
27938034|NCT01072149|54594342|FG017|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
27938035|NCT01072149|54594325|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
27938036|NCT01072149|54594326|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|1|||
27938037|NCT01072149|54594327|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
27938038|NCT01072149|54594328|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
27938039|NCT01072149|54594329|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
27938040|NCT01072149|54594330|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
27938041|NCT01072149|54594331|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
27938042|NCT01072149|54594332|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
28017530|NCT00558363|54676841|FG000|Overall Study|Met Protocol-defined Stopping Criteria|32|||
27938043|NCT01072149|54594333|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
27938044|NCT01072149|54594334|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
28017531|NCT00558363|54676842|FG001|Overall Study|Met Protocol-defined Stopping Criteria|16|||
28017532|NCT00558363|54676841|FG000|Overall Study|Randomized in Error|1|||
28017533|NCT00558363|54676842|FG001|Overall Study|Randomized in Error|2|||
28017534|NCT00558363|54676841|FG000|Overall Study|Hospitalized; Unable to Continue|0|||
28017535|NCT00558363|54676842|FG001|Overall Study|Hospitalized; Unable to Continue|1|||
28017536|NCT00323479|54676848|FG000|Overall Study|Adverse Event|2|||
28017537|NCT00323479|54676848|FG000|Overall Study|Withdrawal by Subject|2|||
27795636|NCT02247479|54250645|FG002|Overall Study|Adverse Event|8|||
27795637|NCT02247479|54250643|FG000|Overall Study|Death|5|||
27795638|NCT02247479|54250644|FG001|Overall Study|Death|4|||
27795639|NCT02247479|54250645|FG002|Overall Study|Death|6|||
28017538|NCT00323479|54676848|FG000|Overall Study|Protocol Violation|3|||
28017539|NCT00323479|54676848|FG000|Overall Study|house moving|1|||
28017540|NCT00352105|54676852|FG000|Overall Study|Death|5|||
28017541|NCT00352105|54676852|FG000|Overall Study|Withdrawal by Subject|5|||
28017542|NCT00352105|54676852|FG000|Overall Study|Lack of Efficacy|9|||
28017543|NCT00352105|54676852|FG000|Overall Study|Adverse Event|19|||
28017544|NCT00352105|54676852|FG000|Overall Study|Protocol Violation|2|||
28017545|NCT00350779|54676858|FG000|Overall Study|Adverse Event|4|||
28017546|NCT00350779|54676859|FG001|Overall Study|Adverse Event|2|||
28017547|NCT00350779|54676858|FG000|Overall Study|Lack of Efficacy|0|||
28017548|NCT00350779|54676859|FG001|Overall Study|Lack of Efficacy|4|||
28017549|NCT00350779|54676858|FG000|Overall Study|Lost to Follow-up|2|||
28017550|NCT00350779|54676859|FG001|Overall Study|Lost to Follow-up|0|||
28017551|NCT00350779|54676858|FG000|Overall Study|Physician Decision|2|||
28017552|NCT00350779|54676859|FG001|Overall Study|Physician Decision|4|||
28017553|NCT00350779|54676858|FG000|Overall Study|Protocol Violation|3|||
28017554|NCT00350779|54676859|FG001|Overall Study|Protocol Violation|1|||
28017555|NCT00350779|54676858|FG000|Overall Study|Withdrawal by Subject|9|||
28017556|NCT00350779|54676859|FG001|Overall Study|Withdrawal by Subject|8|||
28017557|NCT00350779|54676858|FG000|Overall Study|Patient Moved|2|||
28017558|NCT00350779|54676859|FG001|Overall Study|Patient Moved|1|||
28017559|NCT00350779|54676858|FG000|Overall Study|Non-compliance with study procedures|0|||
28017560|NCT00350779|54676859|FG001|Overall Study|Non-compliance with study procedures|1|||
28017561|NCT00350623|54676870|FG000|Overall Study|Lost to Follow-up|8|||
28017562|NCT00350623|54676871|FG001|Overall Study|Lost to Follow-up|3|||
28017563|NCT00350623|54676872|FG002|Overall Study|Lost to Follow-up|4|||
28017564|NCT00350623|54676870|FG000|Overall Study|Withdrawal by Subject|0|||
28017565|NCT00350623|54676871|FG001|Overall Study|Withdrawal by Subject|1|||
28017566|NCT00350623|54676872|FG002|Overall Study|Withdrawal by Subject|1|||
28017567|NCT00350623|54676870|FG000|Overall Study|patient traveling outside the country|0|||
28017568|NCT00350623|54676871|FG001|Overall Study|patient traveling outside the country|0|||
28017569|NCT00350623|54676872|FG002|Overall Study|patient traveling outside the country|1|||
28017570|NCT00656136|54676882|FG000|Overall Study|Progressive disease|177|||
28017571|NCT00656136|54676883|FG001|Overall Study|Progressive disease|322|||
28017572|NCT00656136|54676882|FG000|Overall Study|Other Adverse Event|5|||
28017573|NCT00656136|54676883|FG001|Overall Study|Other Adverse Event|51|||
28017574|NCT00656136|54676882|FG000|Overall Study|Protocol Violation|2|||
28017575|NCT00656136|54676883|FG001|Overall Study|Protocol Violation|3|||
28017576|NCT00656136|54676882|FG000|Overall Study|Patient refused to take study medication|7|||
28017577|NCT00656136|54676883|FG001|Overall Study|Patient refused to take study medication|10|||
28017578|NCT00656136|54676882|FG000|Overall Study|Unknown and others|4|||
28017579|NCT00656136|54676883|FG001|Overall Study|Unknown and others|4|||
28017580|NCT00676520|54676889|FG000|Overall Study|Withdrawal by Subject|163|||
28017581|NCT00676520|54676889|FG000|Overall Study|Lost to Follow-up|162|||
28017582|NCT00676520|54676889|FG000|Overall Study|Death|159|||
28017583|NCT00676520|54676889|FG000|Overall Study|Physician Decision|20|||
28017584|NCT00676520|54676889|FG000|Overall Study|Ineligible for Randomization to DAPT|209|||
28017585|NCT00676520|54676889|FG000|Overall Study|Other Reason|18|||
27795640|NCT02247479|54250643|FG000|Overall Study|Lost to Follow-up|3|||
27795641|NCT02247479|54250644|FG001|Overall Study|Lost to Follow-up|3|||
27795642|NCT02247479|54250645|FG002|Overall Study|Lost to Follow-up|1|||
27795643|NCT02247479|54250643|FG000|Overall Study|Non-compliance|0|||
27795644|NCT02247479|54250644|FG001|Overall Study|Non-compliance|0|||
27795645|NCT02247479|54250645|FG002|Overall Study|Non-compliance|1|||
27795646|NCT02247479|54250643|FG000|Overall Study|Withdrawal by Subject|25|||
27795647|NCT02247479|54250644|FG001|Overall Study|Withdrawal by Subject|29|||
27795648|NCT02247479|54250645|FG002|Overall Study|Withdrawal by Subject|24|||
27795649|NCT02247479|54250643|FG000|Overall Study|Study Terminated by Sponsor|98|||
27795650|NCT02247479|54250644|FG001|Overall Study|Study Terminated by Sponsor|88|||
28017586|NCT00652938|54676901|FG000|Overall Study|Adverse Event|1|||
28017587|NCT00652938|54676902|FG001|Overall Study|Adverse Event|0|||
28017588|NCT00652938|54676903|FG002|Overall Study|Adverse Event|2|||
28017589|NCT00652938|54676901|FG000|Overall Study|Withdrawal by Subject|0|||
28017590|NCT00652938|54676902|FG001|Overall Study|Withdrawal by Subject|6|||
28017591|NCT00652938|54676903|FG002|Overall Study|Withdrawal by Subject|1|||
28017592|NCT00652938|54676901|FG000|Overall Study|Lost to Follow-up|0|||
28017593|NCT00652938|54676902|FG001|Overall Study|Lost to Follow-up|0|||
28017594|NCT00652938|54676903|FG002|Overall Study|Lost to Follow-up|2|||
28017595|NCT00652938|54676901|FG000|Overall Study|fear of blood sampling|0|||
28017596|NCT00652938|54676902|FG001|Overall Study|fear of blood sampling|1|||
28017597|NCT00652938|54676903|FG002|Overall Study|fear of blood sampling|0|||
28017598|NCT00322621|54676911|FG000|Period II - Acute Therapy Phase|Adverse Event|20|||
28017599|NCT00322621|54676912|FG001|Period II - Acute Therapy Phase|Adverse Event|0|||
28017600|NCT00322621|54676913|FG002|Period II - Acute Therapy Phase|Adverse Event|0|||
28017601|NCT00322621|54676911|FG000|Period II - Acute Therapy Phase|Lack of Efficacy|1|||
27795651|NCT02247479|54250645|FG002|Overall Study|Study Terminated by Sponsor|94|||
27795652|NCT02247479|54250643|FG000|Overall Study|Physician Decision|1|||
28017602|NCT00322621|54676912|FG001|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
28017603|NCT00322621|54676913|FG002|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
28017604|NCT00322621|54676911|FG000|Period II - Acute Therapy Phase|Withdrawal by Subject|8|||
28017605|NCT00322621|54676912|FG001|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
28017606|NCT00322621|54676913|FG002|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
28017607|NCT00322621|54676911|FG000|Period II - Acute Therapy Phase|Protocol Violation|2|||
28017608|NCT00322621|54676912|FG001|Period II - Acute Therapy Phase|Protocol Violation|0|||
28017609|NCT00322621|54676913|FG002|Period II - Acute Therapy Phase|Protocol Violation|0|||
28017610|NCT00322621|54676911|FG000|Period II - Acute Therapy Phase|Physician Decision|1|||
28017611|NCT00322621|54676912|FG001|Period II - Acute Therapy Phase|Physician Decision|0|||
28017612|NCT00322621|54676913|FG002|Period II - Acute Therapy Phase|Physician Decision|0|||
28017613|NCT00322621|54676911|FG000|Period III - Maintenance / Rescue Phase|Adverse Event|0|||
28017614|NCT00322621|54676912|FG001|Period III - Maintenance / Rescue Phase|Adverse Event|14|||
28017615|NCT00322621|54676913|FG002|Period III - Maintenance / Rescue Phase|Adverse Event|5|||
28017616|NCT00322621|54676911|FG000|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0|||
28017617|NCT00322621|54676912|FG001|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4|||
28017618|NCT00322621|54676913|FG002|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24|||
28017619|NCT00322621|54676911|FG000|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0|||
28017620|NCT00322621|54676912|FG001|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7|||
28017621|NCT00322621|54676913|FG002|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1|||
28017622|NCT00322621|54676911|FG000|Period III - Maintenance / Rescue Phase|Protocol Violation|0|||
28017623|NCT00322621|54676912|FG001|Period III - Maintenance / Rescue Phase|Protocol Violation|2|||
28017624|NCT00322621|54676913|FG002|Period III - Maintenance / Rescue Phase|Protocol Violation|5|||
28017625|NCT00322621|54676911|FG000|Period III - Maintenance / Rescue Phase|Death|0|||
28017626|NCT00322621|54676912|FG001|Period III - Maintenance / Rescue Phase|Death|1|||
28017627|NCT00322621|54676913|FG002|Period III - Maintenance / Rescue Phase|Death|0|||
28017628|NCT00322621|54676911|FG000|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0|||
28017629|NCT00322621|54676912|FG001|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
28017630|NCT00322621|54676913|FG002|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
28017631|NCT00575042|54676926|FG000|Overall Study|Adverse Event|2|||
28017632|NCT00575042|54676926|FG000|Overall Study|Lost to Follow-up|1|||
28017633|NCT00676208|54676933|FG000|Overall Study|Lost to Follow-up|0|||
28017634|NCT00676208|54676934|FG001|Overall Study|Lost to Follow-up|2|||
28017635|NCT00676208|54676933|FG000|Overall Study|Incomplete data|2|||
28017636|NCT00676208|54676934|FG001|Overall Study|Incomplete data|4|||
28017637|NCT00656058|54676942|FG000|Overall Study|Withdrawal by Subject|2|||
28017638|NCT00656058|54676942|FG000|Overall Study|Withdrawal by Subject|4|||
28017639|NCT00537316|54676952|FG000|Part 1|Adverse Event|7|||
28017640|NCT00537316|54676953|FG001|Part 1|Adverse Event|11|||
28017641|NCT00537316|54676954|FG002|Part 1|Adverse Event|8|||
28017642|NCT00537316|54676955|FG003|Part 1|Adverse Event|0|||
27795653|NCT02247479|54250644|FG001|Overall Study|Physician Decision|0|||
27795654|NCT02247479|54250645|FG002|Overall Study|Physician Decision|2|||
27795655|NCT02247479|54250643|FG000|Overall Study|Unspecified Reason|2|||
27795656|NCT02247479|54250644|FG001|Overall Study|Unspecified Reason|5|||
27795657|NCT02247479|54250645|FG002|Overall Study|Unspecified Reason|2|||
28017643|NCT00537316|54676956|FG004|Part 1|Adverse Event|0|||
28017644|NCT00537316|54676957|FG005|Part 1|Adverse Event|0|||
28017645|NCT00537316|54676958|FG006|Part 1|Adverse Event|0|||
28017646|NCT00537316|54676952|FG000|Part 1|Protocol defined clinical event|1|||
28017647|NCT00537316|54676953|FG001|Part 1|Protocol defined clinical event|0|||
28017648|NCT00537316|54676954|FG002|Part 1|Protocol defined clinical event|0|||
28017649|NCT00537316|54676955|FG003|Part 1|Protocol defined clinical event|0|||
28017650|NCT00537316|54676956|FG004|Part 1|Protocol defined clinical event|0|||
28017651|NCT00537316|54676957|FG005|Part 1|Protocol defined clinical event|0|||
27795658|NCT01454284|54250655|FG000|Overall Study|Adverse Event|20|||
27795659|NCT01454284|54250656|FG001|Overall Study|Adverse Event|7|||
27795660|NCT01454284|54250655|FG000|Overall Study|Death|0|||
27795661|NCT01454284|54250656|FG001|Overall Study|Death|3|||
27795662|NCT01454284|54250655|FG000|Overall Study|Lost to Follow-up|13|||
27795663|NCT01454284|54250656|FG001|Overall Study|Lost to Follow-up|8|||
27795664|NCT01454284|54250655|FG000|Overall Study|Protocol Violation|9|||
27795665|NCT01454284|54250656|FG001|Overall Study|Protocol Violation|6|||
28017652|NCT00537316|54676958|FG006|Part 1|Protocol defined clinical event|0|||
27795666|NCT01454284|54250655|FG000|Overall Study|Withdrawal by Subject|58|||
28017653|NCT00537316|54676952|FG000|Part 1|Lost to Follow-up|1|||
28017654|NCT00537316|54676953|FG001|Part 1|Lost to Follow-up|0|||
28017655|NCT00537316|54676954|FG002|Part 1|Lost to Follow-up|0|||
28017656|NCT00537316|54676955|FG003|Part 1|Lost to Follow-up|0|||
27795667|NCT01454284|54250656|FG001|Overall Study|Withdrawal by Subject|36|||
27842733|NCT01517984|54331460|FG002|Overall Study|Screen Failure|0|||
27795668|NCT01454284|54250655|FG000|Overall Study|Physician Decision|16|||
27842734|NCT01517984|54331461|FG003|Overall Study|Screen Failure|0|||
28017657|NCT00537316|54676956|FG004|Part 1|Lost to Follow-up|0|||
28017658|NCT00537316|54676957|FG005|Part 1|Lost to Follow-up|0|||
28017659|NCT00537316|54676958|FG006|Part 1|Lost to Follow-up|0|||
28017660|NCT00537316|54676952|FG000|Part 1|Withdrawal by Subject|3|||
28017661|NCT00537316|54676953|FG001|Part 1|Withdrawal by Subject|8|||
28017662|NCT00537316|54676954|FG002|Part 1|Withdrawal by Subject|4|||
28017663|NCT00537316|54676955|FG003|Part 1|Withdrawal by Subject|0|||
28017664|NCT00537316|54676956|FG004|Part 1|Withdrawal by Subject|0|||
28017665|NCT00537316|54676957|FG005|Part 1|Withdrawal by Subject|0|||
28017666|NCT00537316|54676958|FG006|Part 1|Withdrawal by Subject|0|||
28017667|NCT00537316|54676952|FG000|Part 1|Protocol Violation|1|||
27795669|NCT01454284|54250656|FG001|Overall Study|Physician Decision|11|||
27795670|NCT01454284|54250655|FG000|Overall Study|Sponsor Decision|0|||
27795671|NCT01454284|54250656|FG001|Overall Study|Sponsor Decision|2|||
27795672|NCT02247401|54250665|FG000|Overall Study|Adverse Event|1|||
27795673|NCT02247401|54250666|FG001|Overall Study|Adverse Event|0|||
27795674|NCT02247401|54250667|FG002|Overall Study|Adverse Event|0|||
27795675|NCT02247401|54250665|FG000|Overall Study|Withdrawal by Subject|4|||
27795676|NCT02247401|54250666|FG001|Overall Study|Withdrawal by Subject|1|||
27795677|NCT02247401|54250667|FG002|Overall Study|Withdrawal by Subject|1|||
27795678|NCT02247401|54250665|FG000|Overall Study|Lost to Follow-up|1|||
27795679|NCT02247401|54250666|FG001|Overall Study|Lost to Follow-up|1|||
27795680|NCT02247401|54250667|FG002|Overall Study|Lost to Follow-up|1|||
27795681|NCT02247011|54250678|FG000|Overall Study|Poor quality of radiological results|125|||
27795682|NCT02246777|54250685|FG000|Overall Study|Adverse Event|2|||
27795683|NCT02246777|54250685|FG000|Overall Study|Change of residence|1|||
27795684|NCT01495702|54250696|FG000|Randomized Phase|Randomized But Not Treated|1|||
27795685|NCT01495702|54250697|FG001|Randomized Phase|Randomized But Not Treated|4|||
27795686|NCT01495702|54250696|FG000|Randomized Phase|Adverse Event|2|||
27795687|NCT01495702|54250697|FG001|Randomized Phase|Adverse Event|2|||
27795688|NCT01495702|54250696|FG000|Randomized Phase|Death|1|||
27795689|NCT01495702|54250697|FG001|Randomized Phase|Death|0|||
27795690|NCT01495702|54250696|FG000|Randomized Phase|Lack of Efficacy|2|||
27795691|NCT01495702|54250697|FG001|Randomized Phase|Lack of Efficacy|0|||
27795692|NCT01495702|54250696|FG000|Randomized Phase|Investigators Discretion|2|||
27795693|NCT01495702|54250697|FG001|Randomized Phase|Investigators Discretion|0|||
27795694|NCT01495702|54250696|FG000|Randomized Phase|Withdrew Consent|10|||
27795695|NCT01495702|54250697|FG001|Randomized Phase|Withdrew Consent|18|||
27795696|NCT01495702|54250696|FG000|Randomized Phase|Lost to Follow-up|4|||
27795697|NCT01495702|54250697|FG001|Randomized Phase|Lost to Follow-up|3|||
27795698|NCT01495702|54250696|FG000|Randomized Phase|Participant Noncompliance|1|||
27795699|NCT01495702|54250697|FG001|Randomized Phase|Participant Noncompliance|0|||
27795700|NCT01495702|54250696|FG000|Randomized Phase|Protocol Violation|3|||
27795701|NCT01495702|54250697|FG001|Randomized Phase|Protocol Violation|1|||
27795702|NCT01630889|54250704|FG000|Overall Study|Death|2|||
27795703|NCT01630889|54250704|FG000|Overall Study|Withdrawal by Subject|1|||
27795704|NCT01630889|54250704|FG000|Overall Study|Other than Specified|2|||
27795705|NCT01630889|54250704|FG000|Overall Study|Lost to Follow-up|4|||
27795706|NCT01630889|54250704|FG000|Overall Study|Other|1|||
27795707|NCT01495000|54250710|FG000|Overall Study|Lost to Follow-up|2|||
27795708|NCT01495000|54250711|FG001|Overall Study|Lost to Follow-up|2|||
27795709|NCT01495000|54250710|FG000|Overall Study|Protocol Violation|1|||
27795710|NCT01495000|54250711|FG001|Overall Study|Protocol Violation|0|||
27795711|NCT01495000|54250710|FG000|Overall Study|Withdrawal by Subject|10|||
27795712|NCT01495000|54250711|FG001|Overall Study|Withdrawal by Subject|10|||
27795713|NCT01494922|54250717|FG000|Overall Study|Adverse Event|1|||
27795714|NCT02192099|54250721|FG000|Overall Study|Adverse Event|1|||
27795715|NCT02192099|54250721|FG000|Overall Study|Lost to Follow-up|2|||
27795716|NCT02192099|54250721|FG000|Overall Study|Physician Decision|1|||
27795717|NCT02192099|54250721|FG000|Overall Study|Pregnancy|1|||
27795718|NCT02192099|54250721|FG000|Overall Study|Protocol Violation|8|||
27795719|NCT02192099|54250721|FG000|Overall Study|Study Terminated by Sponsor|32|||
28017668|NCT00537316|54676953|FG001|Part 1|Protocol Violation|5|||
28017669|NCT00537316|54676954|FG002|Part 1|Protocol Violation|1|||
27795720|NCT02192099|54250721|FG000|Overall Study|Withdrawal by Subject|11|||
27795721|NCT02192099|54250721|FG000|Overall Study|Miscellaneous Reasons|5|||
27795722|NCT01494610|54250725|FG000|Period 1|Withdrawal by Subject|1|||
27795723|NCT01494610|54250726|FG001|Period 1|Withdrawal by Subject|1|||
27795724|NCT01494610|54250725|FG000|Period 3|Adverse Event|1|||
27795725|NCT01494610|54250726|FG001|Period 3|Adverse Event|0|||
27795726|NCT01494610|54250725|FG000|Period 3|Withdrawal by Subject|1|||
27795727|NCT01494610|54250726|FG001|Period 3|Withdrawal by Subject|0|||
27842735|NCT01517984|54331458|FG000|Overall Study|Ineligible for randomization|0|||
28017670|NCT00537316|54676955|FG003|Part 1|Protocol Violation|0|||
27795728|NCT01494610|54250725|FG000|Period 4|Protocol Violation|1|||
27795729|NCT01494610|54250726|FG001|Period 4|Protocol Violation|0|||
27795730|NCT02116777|54250745|FG000|Overall Study|Adverse Event|0|||
27795731|NCT02116777|54250746|FG001|Overall Study|Adverse Event|0|||
28017671|NCT00537316|54676956|FG004|Part 1|Protocol Violation|0|||
28017672|NCT00537316|54676957|FG005|Part 1|Protocol Violation|0|||
27795732|NCT02116777|54250747|FG002|Overall Study|Adverse Event|0|||
27795733|NCT02116777|54250748|FG003|Overall Study|Adverse Event|0|||
27795734|NCT02116777|54250749|FG004|Overall Study|Adverse Event|2|||
27795735|NCT02116777|54250750|FG005|Overall Study|Adverse Event|2|||
27795736|NCT02116777|54250751|FG006|Overall Study|Adverse Event|0|||
27795737|NCT02116777|54250745|FG000|Overall Study|Death|0|||
27795738|NCT02116777|54250746|FG001|Overall Study|Death|0|||
27795739|NCT02116777|54250747|FG002|Overall Study|Death|0|||
27795740|NCT02116777|54250748|FG003|Overall Study|Death|1|||
27795741|NCT02116777|54250749|FG004|Overall Study|Death|0|||
27795742|NCT02116777|54250750|FG005|Overall Study|Death|0|||
27795743|NCT02116777|54250751|FG006|Overall Study|Death|0|||
27795744|NCT02116777|54250745|FG000|Overall Study|Lack of Efficacy|3|||
27795745|NCT02116777|54250746|FG001|Overall Study|Lack of Efficacy|3|||
27795746|NCT02116777|54250747|FG002|Overall Study|Lack of Efficacy|3|||
27795747|NCT02116777|54250748|FG003|Overall Study|Lack of Efficacy|8|||
27795748|NCT02116777|54250749|FG004|Overall Study|Lack of Efficacy|4|||
27795749|NCT02116777|54250750|FG005|Overall Study|Lack of Efficacy|1|||
27795750|NCT02116777|54250751|FG006|Overall Study|Lack of Efficacy|9|||
27795751|NCT02116777|54250745|FG000|Overall Study|Physician Decision|0|||
27795752|NCT02116777|54250746|FG001|Overall Study|Physician Decision|0|||
27795753|NCT02116777|54250747|FG002|Overall Study|Physician Decision|0|||
27795754|NCT02116777|54250748|FG003|Overall Study|Physician Decision|2|||
27795755|NCT02116777|54250749|FG004|Overall Study|Physician Decision|0|||
27795756|NCT02116777|54250750|FG005|Overall Study|Physician Decision|0|||
28017673|NCT00537316|54676958|FG006|Part 1|Protocol Violation|0|||
28017674|NCT00537316|54676952|FG000|Part 1|Did not meet protocol eligibility|1|||
28017675|NCT00537316|54676953|FG001|Part 1|Did not meet protocol eligibility|3|||
28017676|NCT00537316|54676954|FG002|Part 1|Did not meet protocol eligibility|2|||
27795757|NCT02116777|54250751|FG006|Overall Study|Physician Decision|0|||
27795758|NCT02116777|54250745|FG000|Overall Study|Protocol Violation|0|||
27795759|NCT02116777|54250746|FG001|Overall Study|Protocol Violation|0|||
27795760|NCT02116777|54250747|FG002|Overall Study|Protocol Violation|0|||
27795761|NCT02116777|54250748|FG003|Overall Study|Protocol Violation|1|||
27795762|NCT02116777|54250749|FG004|Overall Study|Protocol Violation|0|||
27795763|NCT02116777|54250750|FG005|Overall Study|Protocol Violation|0|||
27795764|NCT02116777|54250751|FG006|Overall Study|Protocol Violation|0|||
27795765|NCT02116777|54250745|FG000|Overall Study|Withdrawal by Subject|0|||
27795766|NCT02116777|54250746|FG001|Overall Study|Withdrawal by Subject|0|||
27795767|NCT02116777|54250747|FG002|Overall Study|Withdrawal by Subject|0|||
27795768|NCT02116777|54250748|FG003|Overall Study|Withdrawal by Subject|1|||
27795769|NCT02116777|54250749|FG004|Overall Study|Withdrawal by Subject|0|||
27795770|NCT02116777|54250750|FG005|Overall Study|Withdrawal by Subject|0|||
27795771|NCT02116777|54250751|FG006|Overall Study|Withdrawal by Subject|0|||
27795772|NCT01494532|54250776|FG000|Overall Study|Adverse Event|4|||
27795773|NCT01494532|54250777|FG001|Overall Study|Adverse Event|1|||
27795774|NCT01494532|54250778|FG002|Overall Study|Adverse Event|8|||
27795775|NCT01494532|54250779|FG003|Overall Study|Adverse Event|6|||
27795776|NCT01494532|54250780|FG004|Overall Study|Adverse Event|5|||
27795777|NCT01494532|54250781|FG005|Overall Study|Adverse Event|0|||
27795778|NCT01494532|54250776|FG000|Overall Study|Lack of Efficacy|0|||
27795779|NCT01494532|54250777|FG001|Overall Study|Lack of Efficacy|0|||
27795780|NCT01494532|54250778|FG002|Overall Study|Lack of Efficacy|0|||
27795781|NCT01494532|54250779|FG003|Overall Study|Lack of Efficacy|0|||
27795782|NCT01494532|54250780|FG004|Overall Study|Lack of Efficacy|2|||
27795783|NCT01494532|54250781|FG005|Overall Study|Lack of Efficacy|0|||
27795784|NCT01494532|54250776|FG000|Overall Study|Protocol deviation|2|||
27795785|NCT01494532|54250777|FG001|Overall Study|Protocol deviation|1|||
27938045|NCT01072149|54594335|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
27938046|NCT01072149|54594336|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
27938047|NCT01072149|54594337|FG012|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
27938048|NCT01072149|54594338|FG013|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
27938049|NCT01072149|54594339|FG014|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
27938050|NCT01072149|54594340|FG015|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
27938051|NCT01072149|54594341|FG016|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
27938052|NCT01072149|54594342|FG017|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
27795786|NCT01494532|54250778|FG002|Overall Study|Protocol deviation|3|||
27795787|NCT01494532|54250779|FG003|Overall Study|Protocol deviation|2|||
27795788|NCT01494532|54250780|FG004|Overall Study|Protocol deviation|3|||
27795789|NCT01494532|54250781|FG005|Overall Study|Protocol deviation|0|||
27795790|NCT01494532|54250776|FG000|Overall Study|Protocol-defined stopping criteria|0|||
27795791|NCT01494532|54250777|FG001|Overall Study|Protocol-defined stopping criteria|0|||
27795792|NCT01494532|54250778|FG002|Overall Study|Protocol-defined stopping criteria|1|||
27795793|NCT01494532|54250779|FG003|Overall Study|Protocol-defined stopping criteria|0|||
27795794|NCT01494532|54250780|FG004|Overall Study|Protocol-defined stopping criteria|0|||
27795795|NCT01494532|54250781|FG005|Overall Study|Protocol-defined stopping criteria|0|||
27795796|NCT01494532|54250776|FG000|Overall Study|Lost to Follow-up|1|||
27795797|NCT01494532|54250777|FG001|Overall Study|Lost to Follow-up|0|||
27795798|NCT01494532|54250778|FG002|Overall Study|Lost to Follow-up|0|||
27795799|NCT01494532|54250779|FG003|Overall Study|Lost to Follow-up|2|||
27795800|NCT01494532|54250780|FG004|Overall Study|Lost to Follow-up|0|||
27795801|NCT01494532|54250781|FG005|Overall Study|Lost to Follow-up|0|||
27795802|NCT01494532|54250776|FG000|Overall Study|Physician Decision|0|||
27795803|NCT01494532|54250777|FG001|Overall Study|Physician Decision|1|||
27795804|NCT01494532|54250778|FG002|Overall Study|Physician Decision|1|||
27795805|NCT01494532|54250779|FG003|Overall Study|Physician Decision|2|||
27795806|NCT01494532|54250780|FG004|Overall Study|Physician Decision|0|||
27795807|NCT01494532|54250781|FG005|Overall Study|Physician Decision|0|||
27795808|NCT01494532|54250776|FG000|Overall Study|Withdrawal by Subject|3|||
27795809|NCT01494532|54250777|FG001|Overall Study|Withdrawal by Subject|1|||
27795810|NCT01494532|54250778|FG002|Overall Study|Withdrawal by Subject|4|||
27795811|NCT01494532|54250779|FG003|Overall Study|Withdrawal by Subject|3|||
27795812|NCT01494532|54250780|FG004|Overall Study|Withdrawal by Subject|2|||
27795813|NCT01494532|54250781|FG005|Overall Study|Withdrawal by Subject|0|||
27795814|NCT02191397|54250798|FG000|Overall Study|Adverse Event|28|||
27795815|NCT02191397|54250799|FG001|Overall Study|Adverse Event|17|||
27795816|NCT02191397|54250798|FG000|Overall Study|Lack of Efficacy|10|||
27795817|NCT02191397|54250799|FG001|Overall Study|Lack of Efficacy|5|||
27795818|NCT02191397|54250798|FG000|Overall Study|Protocol Violation|0|||
27795819|NCT02191397|54250799|FG001|Overall Study|Protocol Violation|3|||
27795820|NCT02191397|54250798|FG000|Overall Study|Met protocol-defined stopping criteria|5|||
27795821|NCT02191397|54250799|FG001|Overall Study|Met protocol-defined stopping criteria|4|||
27795822|NCT02191397|54250798|FG000|Overall Study|Lost to Follow-up|10|||
27795823|NCT02191397|54250799|FG001|Overall Study|Lost to Follow-up|11|||
27795824|NCT02191397|54250798|FG000|Overall Study|Physician Decision|8|||
27795825|NCT02191397|54250799|FG001|Overall Study|Physician Decision|3|||
27795826|NCT02191397|54250798|FG000|Overall Study|Withdrawal by Subject|22|||
27795827|NCT02191397|54250799|FG001|Overall Study|Withdrawal by Subject|27|||
27795828|NCT01630811|54250805|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
27795829|NCT01630811|54250806|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
27795830|NCT01494298|54250816|FG000|Overall Study|Protocol Violation|2|||
27795831|NCT01494298|54250817|FG001|Overall Study|Protocol Violation|8|||
27795832|NCT02170025|54250827|FG000|Overall Study|Adverse Event|2|||
27795833|NCT02170025|54250828|FG001|Overall Study|Adverse Event|0|||
27795834|NCT02169791|54250834|FG000|Overall Study|Death|6|||
27795835|NCT02169791|54250834|FG000|Overall Study|patient withdrew consent|1|||
27795836|NCT02216591|54250840|FG000|Overall Study|Lost to Follow-up|0|||
27795837|NCT02216591|54250841|FG001|Overall Study|Lost to Follow-up|1|||
27795838|NCT02216357|54250849|FG000|Overall Study|Inclusion or exclusion criteria not met|2|||
27795839|NCT02216357|54250850|FG001|Overall Study|Inclusion or exclusion criteria not met|1|||
27795840|NCT01492426|54250858|FG000|Treatment|Death|0|||
27795841|NCT01492426|54250859|FG001|Treatment|Death|1|||
27795842|NCT01492426|54250858|FG000|Treatment|Other|1|||
27795843|NCT01492426|54250859|FG001|Treatment|Other|0|||
27795844|NCT01492426|54250858|FG000|Treatment|Adverse Event|25|||
27795845|NCT01492426|54250859|FG001|Treatment|Adverse Event|25|||
27795846|NCT01492426|54250858|FG000|Treatment|Lack of Efficacy|38|||
27795847|NCT01492426|54250859|FG001|Treatment|Lack of Efficacy|5|||
27795848|NCT01492426|54250858|FG000|Treatment|Participant withdrew consent|1|||
27795849|NCT01492426|54250859|FG001|Treatment|Participant withdrew consent|2|||
27795850|NCT01492426|54250858|FG000|Treatment|Poor compliance/noncompliance|1|||
27795851|NCT01492426|54250859|FG001|Treatment|Poor compliance/noncompliance|0|||
27795852|NCT01492426|54250858|FG000|Treatment|Subject requested discontinue study drug|7|||
27795853|NCT01492426|54250859|FG001|Treatment|Subject requested discontinue study drug|3|||
27795854|NCT01492426|54250858|FG000|Treatment|Lost to Follow-up|9|||
27795855|NCT01492426|54250859|FG001|Treatment|Lost to Follow-up|4|||
27795856|NCT01492426|54250858|FG000|Treatment|Participant does not meet study criteria|1|||
27795857|NCT01492426|54250859|FG001|Treatment|Participant does not meet study criteria|0|||
27842736|NCT01517984|54331459|FG001|Overall Study|Ineligible for randomization|14|||
27842737|NCT01517984|54331460|FG002|Overall Study|Ineligible for randomization|0|||
27842738|NCT01517984|54331461|FG003|Overall Study|Ineligible for randomization|0|||
27842739|NCT01517750|54331489|FG000|Overall Study|Lost to Follow-up|1|||
28017677|NCT00537316|54676955|FG003|Part 1|Did not meet protocol eligibility|0|||
28017678|NCT00537316|54676956|FG004|Part 1|Did not meet protocol eligibility|0|||
27795858|NCT01492426|54250858|FG000|Follow-Up|Protocol Requires no Follow-Up|2|||
27795859|NCT01492426|54250859|FG001|Follow-Up|Protocol Requires no Follow-Up|1|||
27795860|NCT01492426|54250858|FG000|Follow-Up|Death|1|||
27795861|NCT01492426|54250859|FG001|Follow-Up|Death|0|||
27795862|NCT01492426|54250858|FG000|Follow-Up|Other|4|||
27795863|NCT01492426|54250859|FG001|Follow-Up|Other|2|||
27795864|NCT01492426|54250858|FG000|Follow-Up|Participant Withdrew Consent|6|||
27795865|NCT01492426|54250859|FG001|Follow-Up|Participant Withdrew Consent|1|||
27795866|NCT01492426|54250858|FG000|Follow-Up|Lost to Follow-up|12|||
27795867|NCT01492426|54250859|FG001|Follow-Up|Lost to Follow-up|6|||
27795868|NCT01453348|54250872|FG000|Overall Study|Death|0|||
27795869|NCT01453348|54250873|FG001|Overall Study|Death|0|||
27795870|NCT01453348|54250874|FG002|Overall Study|Death|1|||
27795871|NCT01453348|54250872|FG000|Overall Study|Withdrawal by Subject|0|||
27795872|NCT01453348|54250873|FG001|Overall Study|Withdrawal by Subject|1|||
27795873|NCT01453348|54250874|FG002|Overall Study|Withdrawal by Subject|0|||
27795874|NCT01453348|54250872|FG000|Overall Study|Protocol Violation|1|||
27795875|NCT01453348|54250873|FG001|Overall Study|Protocol Violation|0|||
27795876|NCT01453348|54250874|FG002|Overall Study|Protocol Violation|0|||
27795877|NCT01453036|54250888|FG000|Overall Study|Lost to Follow-up|26|||
27795878|NCT01453036|54250889|FG001|Overall Study|Lost to Follow-up|115|||
27795879|NCT01453036|54250890|FG002|Overall Study|Lost to Follow-up|31|||
27795880|NCT01475734|54250900|FG000|Overall Study|Withdrawal by Subject|1|||
27795881|NCT01475734|54250901|FG001|Overall Study|Withdrawal by Subject|0|||
27795882|NCT01475734|54250900|FG000|Overall Study|Protocol Violation|1|||
27795883|NCT01475734|54250901|FG001|Overall Study|Protocol Violation|0|||
27795884|NCT01475734|54250900|FG000|Overall Study|Physician Decision|0|||
27795885|NCT01475734|54250901|FG001|Overall Study|Physician Decision|1|||
27795886|NCT01452412|54250909|FG000|Overall Study|Withdrawal by Subject|15|||
27795887|NCT01452412|54250910|FG001|Overall Study|Withdrawal by Subject|11|||
27795888|NCT01452412|54250909|FG000|Overall Study|Adverse Event|4|||
27795889|NCT01452412|54250910|FG001|Overall Study|Adverse Event|3|||
27795890|NCT01452412|54250909|FG000|Overall Study|Lost to Follow-up|5|||
27795891|NCT01452412|54250910|FG001|Overall Study|Lost to Follow-up|3|||
27795892|NCT01452412|54250909|FG000|Overall Study|Death|1|||
27795893|NCT01452412|54250910|FG001|Overall Study|Death|0|||
27795894|NCT01452412|54250909|FG000|Overall Study|Initiated dialysis|1|||
27795895|NCT01452412|54250910|FG001|Overall Study|Initiated dialysis|0|||
27795896|NCT01452412|54250909|FG000|Overall Study|Other|2|||
27795897|NCT01452412|54250910|FG001|Overall Study|Other|0|||
27795898|NCT01474876|54250919|FG000|Overall Study|Adverse Event|11|||
27795899|NCT01474876|54250920|FG001|Overall Study|Adverse Event|5|||
27795900|NCT01474876|54250921|FG002|Overall Study|Adverse Event|0|||
27795901|NCT01474876|54250919|FG000|Overall Study|Serious Adverse Event|2|||
27795902|NCT01474876|54250920|FG001|Overall Study|Serious Adverse Event|3|||
27795903|NCT01474876|54250921|FG002|Overall Study|Serious Adverse Event|0|||
27795904|NCT01474876|54250919|FG000|Overall Study|Lost to Follow-up|5|||
27795905|NCT01474876|54250920|FG001|Overall Study|Lost to Follow-up|4|||
27795906|NCT01474876|54250921|FG002|Overall Study|Lost to Follow-up|0|||
27795907|NCT01474876|54250919|FG000|Overall Study|Investigator's decision|28|||
27795908|NCT01474876|54250920|FG001|Overall Study|Investigator's decision|6|||
27795909|NCT01474876|54250921|FG002|Overall Study|Investigator's decision|0|||
27795910|NCT01474876|54250919|FG000|Overall Study|Patient's request|19|||
27795911|NCT01474876|54250920|FG001|Overall Study|Patient's request|5|||
27795912|NCT01474876|54250921|FG002|Overall Study|Patient's request|0|||
27795913|NCT01474876|54250919|FG000|Overall Study|Investigator's decision and pt request|1|||
27795914|NCT01474876|54250920|FG001|Overall Study|Investigator's decision and pt request|0|||
27795915|NCT01474876|54250921|FG002|Overall Study|Investigator's decision and pt request|0|||
27795916|NCT01491802|54250927|FG000|Overall Study|Adverse Event|1|||
27795917|NCT01491802|54250928|FG001|Overall Study|Adverse Event|1|||
27795918|NCT01491802|54250927|FG000|Overall Study|Withdrawal by Subject|0|||
27795919|NCT01491802|54250928|FG001|Overall Study|Withdrawal by Subject|1|||
27795920|NCT02168777|54250938|FG000|Overall Study|Withdrawal by Subject|1|||
27795921|NCT02168777|54250939|FG001|Overall Study|Withdrawal by Subject|0|||
27795922|NCT02168777|54250940|FG002|Overall Study|Withdrawal by Subject|2|||
27795923|NCT02168777|54250938|FG000|Overall Study|Adverse Event|1|||
27795924|NCT02168777|54250939|FG001|Overall Study|Adverse Event|0|||
27795925|NCT02168777|54250940|FG002|Overall Study|Adverse Event|1|||
27795926|NCT02168777|54250938|FG000|Overall Study|Disease recurrence|0|||
27795927|NCT02168777|54250939|FG001|Overall Study|Disease recurrence|0|||
27795928|NCT02168777|54250940|FG002|Overall Study|Disease recurrence|1|||
27842740|NCT01517750|54331490|FG001|Overall Study|Lost to Follow-up|2|||
27842741|NCT01517750|54331491|FG002|Overall Study|Lost to Follow-up|4|||
27842742|NCT01517750|54331492|FG003|Overall Study|Lost to Follow-up|1|||
27842743|NCT01548404|54331517|FG000|Overall Study|Adverse Event|3|||
27795929|NCT02168777|54250938|FG000|Overall Study|Radiological disease progression|0|||
27795930|NCT02168777|54250939|FG001|Overall Study|Radiological disease progression|5|||
27795931|NCT02168777|54250940|FG002|Overall Study|Radiological disease progression|5|||
27795932|NCT02168777|54250938|FG000|Overall Study|Clinical disease progression|0|||
27795933|NCT02168777|54250939|FG001|Overall Study|Clinical disease progression|1|||
27795934|NCT02168777|54250940|FG002|Overall Study|Clinical disease progression|2|||
27795935|NCT02168777|54250938|FG000|Overall Study|Other reason|0|||
27795936|NCT02168777|54250939|FG001|Overall Study|Other reason|1|||
27795937|NCT02168777|54250940|FG002|Overall Study|Other reason|0|||
27795938|NCT01491178|54250951|FG000|Overall Study|Adverse Event|1016|||
27795939|NCT01491178|54250951|FG000|Overall Study|Improvement of NVAF|210|||
27795940|NCT01491178|54250951|FG000|Overall Study|To conduct invasive treatment|59|||
27795941|NCT01491178|54250951|FG000|Overall Study|Lost to follow-up (unknown reason)|287|||
27795942|NCT01491178|54250951|FG000|Overall Study|Lost to follow-up (changing hospital)|545|||
27842744|NCT01548404|54331518|FG001|Overall Study|Adverse Event|1|||
28017679|NCT00537316|54676957|FG005|Part 1|Did not meet protocol eligibility|0|||
28017680|NCT00537316|54676958|FG006|Part 1|Did not meet protocol eligibility|0|||
28017681|NCT00537316|54676952|FG000|Part 1|Administrative|0|||
28017682|NCT00537316|54676953|FG001|Part 1|Administrative|0|||
28017683|NCT00537316|54676954|FG002|Part 1|Administrative|2|||
28017684|NCT00537316|54676955|FG003|Part 1|Administrative|0|||
28017685|NCT00537316|54676956|FG004|Part 1|Administrative|0|||
28017686|NCT00537316|54676957|FG005|Part 1|Administrative|0|||
28017687|NCT00537316|54676958|FG006|Part 1|Administrative|0|||
28017688|NCT00537316|54676952|FG000|Part 2|Never entered follow-up|0|||
27795943|NCT01491178|54250951|FG000|Overall Study|To take a contraindication|20|||
27795944|NCT01491178|54250951|FG000|Overall Study|Other than specified above|657|||
27795945|NCT02189837|54250959|FG000|Overall Study|Withdrawal by Subject|2|||
27795946|NCT02189837|54250960|FG001|Overall Study|Withdrawal by Subject|1|||
27795947|NCT02189837|54250961|FG002|Overall Study|Withdrawal by Subject|3|||
27795948|NCT02189837|54250962|FG003|Overall Study|Withdrawal by Subject|1|||
27795949|NCT02189837|54250959|FG000|Overall Study|Sponsor Decision|0|||
27795950|NCT02189837|54250960|FG001|Overall Study|Sponsor Decision|0|||
27795951|NCT02189837|54250961|FG002|Overall Study|Sponsor Decision|0|||
27795952|NCT02189837|54250962|FG003|Overall Study|Sponsor Decision|1|||
27795953|NCT02216123|54250974|FG000|Overall Study|Lost to Follow-up|4|||
27795954|NCT02216123|54250975|FG001|Overall Study|Lost to Follow-up|2|||
27795955|NCT02216123|54250974|FG000|Overall Study|Withdrawal by Subject|2|||
27795956|NCT02216123|54250975|FG001|Overall Study|Withdrawal by Subject|0|||
27795957|NCT02189759|54250989|FG000|Overall Study|Lost to Follow-up|0|||
27795958|NCT02189759|54250990|FG001|Overall Study|Lost to Follow-up|0|||
27795959|NCT02189759|54250991|FG002|Overall Study|Lost to Follow-up|2|||
27795960|NCT02189759|54250992|FG003|Overall Study|Lost to Follow-up|5|||
27795961|NCT01490866|54251004|FG000|FOLFOX/Bevacizumab Treatment|Disease Progression|6|||
27795962|NCT01490866|54251004|FG000|FOLFOX/Bevacizumab Treatment|Adverse Event|6|||
27795963|NCT01490866|54251004|FG000|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5|||
27795964|NCT01490866|54251004|FG000|FOLFOX/Bevacizumab Treatment|Protocol Violation|1|||
27795965|NCT01490866|54251004|FG000|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1|||
27795966|NCT01490866|54251004|FG000|FOLFOX/Bevacizumab Treatment|Physician Decision|2|||
27795967|NCT01490866|54251004|FG000|Axitinib Maintenance Therapy|Disease Progression|30|||
27795968|NCT01490866|54251004|FG000|Axitinib Maintenance Therapy|Adverse Event|12|||
27795969|NCT01490866|54251004|FG000|Axitinib Maintenance Therapy|Withdrawal by Subject|3|||
27795970|NCT01490866|54251004|FG000|Axitinib Maintenance Therapy|Protocol Violation|2|||
27795971|NCT01490866|54251004|FG000|Axitinib Maintenance Therapy|Intercurrent illness|2|||
28017689|NCT00537316|54676953|FG001|Part 2|Never entered follow-up|0|||
28017690|NCT00537316|54676954|FG002|Part 2|Never entered follow-up|0|||
28017691|NCT00537316|54676955|FG003|Part 2|Never entered follow-up|0|||
28017692|NCT00537316|54676956|FG004|Part 2|Never entered follow-up|0|||
28017693|NCT00537316|54676957|FG005|Part 2|Never entered follow-up|0|||
28017694|NCT00537316|54676958|FG006|Part 2|Never entered follow-up|1|||
28017695|NCT00537316|54676952|FG000|Part 2|Adverse Event|4|||
28017696|NCT00537316|54676953|FG001|Part 2|Adverse Event|0|||
28017697|NCT00537316|54676954|FG002|Part 2|Adverse Event|2|||
28017698|NCT00537316|54676955|FG003|Part 2|Adverse Event|0|||
28017699|NCT00537316|54676956|FG004|Part 2|Adverse Event|0|||
28017700|NCT00537316|54676957|FG005|Part 2|Adverse Event|0|||
28017701|NCT00537316|54676958|FG006|Part 2|Adverse Event|0|||
28017702|NCT00537316|54676952|FG000|Part 2|Lost to Follow-up|1|||
28017703|NCT00537316|54676953|FG001|Part 2|Lost to Follow-up|0|||
28017704|NCT00537316|54676954|FG002|Part 2|Lost to Follow-up|2|||
28017705|NCT00537316|54676955|FG003|Part 2|Lost to Follow-up|0|||
28017706|NCT00537316|54676956|FG004|Part 2|Lost to Follow-up|0|||
28017707|NCT00537316|54676957|FG005|Part 2|Lost to Follow-up|0|||
28017708|NCT00537316|54676958|FG006|Part 2|Lost to Follow-up|0|||
28017709|NCT00537316|54676952|FG000|Part 2|Withdrawal by Subject|5|||
28017710|NCT00537316|54676953|FG001|Part 2|Withdrawal by Subject|1|||
28017711|NCT00537316|54676954|FG002|Part 2|Withdrawal by Subject|4|||
28017712|NCT00537316|54676955|FG003|Part 2|Withdrawal by Subject|0|||
28017713|NCT00537316|54676956|FG004|Part 2|Withdrawal by Subject|0|||
28017714|NCT00537316|54676957|FG005|Part 2|Withdrawal by Subject|0|||
28017715|NCT00537316|54676958|FG006|Part 2|Withdrawal by Subject|0|||
28017716|NCT00537316|54676952|FG000|Part 2|Administrative|16|||
28017717|NCT00537316|54676953|FG001|Part 2|Administrative|8|||
28017718|NCT00537316|54676954|FG002|Part 2|Administrative|24|||
27795972|NCT02215967|54251015|FG000|Overall Study|Patient became ineligible for treatment|0|||
27795973|NCT02215967|54251016|FG001|Overall Study|Patient became ineligible for treatment|0|||
27795974|NCT02215967|54251017|FG002|Overall Study|Patient became ineligible for treatment|0|||
28017719|NCT00537316|54676955|FG003|Part 2|Administrative|3|||
28017720|NCT00537316|54676956|FG004|Part 2|Administrative|1|||
27795975|NCT02215967|54251018|FG003|Overall Study|Patient became ineligible for treatment|3|||
28017721|NCT00537316|54676957|FG005|Part 2|Administrative|4|||
28017722|NCT00537316|54676958|FG006|Part 2|Administrative|1|||
28017723|NCT03827395|54676979|FG000|Overall Study|Lost to Follow-up|1|||
28017724|NCT03827395|54676980|FG001|Overall Study|Lost to Follow-up|0|||
28017725|NCT03827395|54676979|FG000|Overall Study|Protocol Violation|1|||
28017726|NCT03827395|54676980|FG001|Overall Study|Protocol Violation|0|||
28017727|NCT03827395|54676979|FG000|Overall Study|Became ineligible after enrollment|1|||
28017728|NCT03827395|54676980|FG001|Overall Study|Became ineligible after enrollment|2|||
28017729|NCT00655980|54676989|FG000|Overall Study|surgery canceled; or subject or anesthes|26|||
28017730|NCT00655980|54676990|FG001|Overall Study|surgery canceled; or subject or anesthes|31|||
28017731|NCT00655980|54676991|FG002|Overall Study|surgery canceled; or subject or anesthes|5|||
28017732|NCT00679172|54677007|FG000|Overall Study|Non-compliance|1|||
28017733|NCT00679172|54677008|FG001|Overall Study|Non-compliance|1|||
28017734|NCT00679172|54677009|FG002|Overall Study|Non-compliance|0|||
28017735|NCT00679172|54677010|FG003|Overall Study|Non-compliance|1|||
28017736|NCT00679172|54677011|FG004|Overall Study|Non-compliance|0|||
28017737|NCT00679172|54677007|FG000|Overall Study|Other not specified|0|||
28017738|NCT00679172|54677008|FG001|Overall Study|Other not specified|0|||
28017739|NCT00679172|54677009|FG002|Overall Study|Other not specified|1|||
28017740|NCT00679172|54677010|FG003|Overall Study|Other not specified|0|||
28017741|NCT00679172|54677011|FG004|Overall Study|Other not specified|0|||
28017742|NCT00676130|54677028|FG000|Overall Study|Lost to Follow-up|0|||
28017743|NCT00676130|54677029|FG001|Overall Study|Lost to Follow-up|1|||
28017744|NCT00676130|54677028|FG000|Overall Study|Found ineligible|3|||
28017745|NCT00676130|54677029|FG001|Overall Study|Found ineligible|2|||
28017746|NCT00676130|54677028|FG000|Overall Study|Withdrawal by Subject|0|||
28017747|NCT00676130|54677029|FG001|Overall Study|Withdrawal by Subject|1|||
28017748|NCT00676052|54677041|FG000|Overall Study|Adverse Event|0|||
28017749|NCT00676052|54677042|FG001|Overall Study|Adverse Event|1|||
28017750|NCT00676052|54677043|FG002|Overall Study|Adverse Event|1|||
28017751|NCT00676052|54677044|FG003|Overall Study|Adverse Event|2|||
28017752|NCT00676052|54677045|FG004|Overall Study|Adverse Event|2|||
27938053|NCT01072149|54594325|FG000|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
27938054|NCT01072149|54594326|FG001|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
27938055|NCT01072149|54594327|FG002|Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
27938056|NCT01072149|54594328|FG003|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
27938057|NCT01072149|54594329|FG004|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
27938058|NCT01072149|54594330|FG005|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
27938059|NCT01072149|54594331|FG006|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
27938060|NCT01072149|54594332|FG007|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
27938061|NCT01072149|54594333|FG008|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
27938062|NCT01072149|54594334|FG009|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
27938063|NCT01072149|54594335|FG010|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
27938064|NCT01072149|54594336|FG011|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
27938065|NCT01072149|54594337|FG012|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
27938066|NCT01072149|54594338|FG013|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
27938067|NCT01072149|54594339|FG014|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
27938068|NCT01072149|54594340|FG015|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
27938069|NCT01072149|54594341|FG016|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
27938070|NCT01072149|54594342|FG017|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
27938071|NCT01072149|54594325|FG000|Treatment Period 2 (28 Days)|Physician Decision|0|||
27938072|NCT01072149|54594326|FG001|Treatment Period 2 (28 Days)|Physician Decision|0|||
27938073|NCT01072149|54594327|FG002|Treatment Period 2 (28 Days)|Physician Decision|0|||
27938074|NCT01072149|54594328|FG003|Treatment Period 2 (28 Days)|Physician Decision|0|||
27938075|NCT01072149|54594329|FG004|Treatment Period 2 (28 Days)|Physician Decision|0|||
27938076|NCT01072149|54594330|FG005|Treatment Period 2 (28 Days)|Physician Decision|0|||
27938077|NCT01072149|54594331|FG006|Treatment Period 2 (28 Days)|Physician Decision|0|||
28017753|NCT00676052|54677046|FG005|Overall Study|Adverse Event|2|||
28017754|NCT00676052|54677041|FG000|Overall Study|Lack of Efficacy|2|||
28017755|NCT00676052|54677042|FG001|Overall Study|Lack of Efficacy|2|||
27795976|NCT02215967|54251015|FG000|Overall Study|Patient did not get CAR T-Cells|0|||
28017756|NCT00676052|54677043|FG002|Overall Study|Lack of Efficacy|1|||
28017757|NCT00676052|54677044|FG003|Overall Study|Lack of Efficacy|1|||
28017758|NCT00676052|54677045|FG004|Overall Study|Lack of Efficacy|2|||
28017759|NCT00676052|54677046|FG005|Overall Study|Lack of Efficacy|1|||
28017760|NCT00676052|54677041|FG000|Overall Study|Protocol Violation|5|||
28017761|NCT00676052|54677042|FG001|Overall Study|Protocol Violation|3|||
28017762|NCT00676052|54677043|FG002|Overall Study|Protocol Violation|2|||
28017763|NCT00676052|54677044|FG003|Overall Study|Protocol Violation|2|||
28017764|NCT00676052|54677045|FG004|Overall Study|Protocol Violation|1|||
28017765|NCT00676052|54677046|FG005|Overall Study|Protocol Violation|2|||
28017766|NCT00676052|54677041|FG000|Overall Study|Lost to Follow-up|0|||
28017767|NCT00676052|54677042|FG001|Overall Study|Lost to Follow-up|0|||
28017768|NCT00676052|54677043|FG002|Overall Study|Lost to Follow-up|0|||
28017769|NCT00676052|54677044|FG003|Overall Study|Lost to Follow-up|0|||
28017770|NCT00676052|54677045|FG004|Overall Study|Lost to Follow-up|1|||
28017771|NCT00676052|54677046|FG005|Overall Study|Lost to Follow-up|0|||
28017772|NCT00676052|54677041|FG000|Overall Study|Physician Decision|1|||
28017773|NCT00676052|54677042|FG001|Overall Study|Physician Decision|1|||
28017774|NCT00676052|54677043|FG002|Overall Study|Physician Decision|1|||
28017775|NCT00676052|54677044|FG003|Overall Study|Physician Decision|0|||
28017776|NCT00676052|54677045|FG004|Overall Study|Physician Decision|0|||
28017777|NCT00676052|54677046|FG005|Overall Study|Physician Decision|1|||
28017778|NCT00676052|54677041|FG000|Overall Study|Withdrawal by Subject|1|||
28017779|NCT00676052|54677042|FG001|Overall Study|Withdrawal by Subject|0|||
28017780|NCT00676052|54677043|FG002|Overall Study|Withdrawal by Subject|1|||
28017781|NCT00676052|54677044|FG003|Overall Study|Withdrawal by Subject|0|||
28017782|NCT00676052|54677045|FG004|Overall Study|Withdrawal by Subject|0|||
28017783|NCT00676052|54677046|FG005|Overall Study|Withdrawal by Subject|0|||
28017784|NCT00535288|54677065|FG000|Overall Study|Adverse Event|20|||
28017785|NCT00535288|54677066|FG001|Overall Study|Adverse Event|19|||
28017786|NCT00535288|54677067|FG002|Overall Study|Adverse Event|25|||
28017787|NCT00535288|54677068|FG003|Overall Study|Adverse Event|20|||
28017788|NCT00535288|54677069|FG004|Overall Study|Adverse Event|30|||
28017789|NCT00535288|54677065|FG000|Overall Study|Lost to Follow-up|0|||
28017790|NCT00535288|54677066|FG001|Overall Study|Lost to Follow-up|3|||
28017791|NCT00535288|54677067|FG002|Overall Study|Lost to Follow-up|0|||
28017792|NCT00535288|54677068|FG003|Overall Study|Lost to Follow-up|0|||
28017793|NCT00535288|54677069|FG004|Overall Study|Lost to Follow-up|0|||
27795977|NCT02215967|54251016|FG001|Overall Study|Patient did not get CAR T-Cells|0|||
27795978|NCT02215967|54251017|FG002|Overall Study|Patient did not get CAR T-Cells|1|||
27795979|NCT02215967|54251018|FG003|Overall Study|Patient did not get CAR T-Cells|0|||
27795980|NCT02168387|54251030|FG000|Overall Study|Planned exubation|6|||
27795981|NCT02168387|54251031|FG001|Overall Study|Planned exubation|3|||
27795982|NCT02168387|54251030|FG000|Overall Study|Death|1|||
28017794|NCT00535288|54677065|FG000|Overall Study|Lack of Efficacy|26|||
28017795|NCT00535288|54677066|FG001|Overall Study|Lack of Efficacy|3|||
28017796|NCT00535288|54677067|FG002|Overall Study|Lack of Efficacy|4|||
28017797|NCT00535288|54677068|FG003|Overall Study|Lack of Efficacy|4|||
28017798|NCT00535288|54677069|FG004|Overall Study|Lack of Efficacy|7|||
28017799|NCT00535288|54677065|FG000|Overall Study|Unwilling to cooperate|6|||
28017800|NCT00535288|54677066|FG001|Overall Study|Unwilling to cooperate|6|||
28017801|NCT00535288|54677067|FG002|Overall Study|Unwilling to cooperate|3|||
27795983|NCT02168387|54251031|FG001|Overall Study|Death|0|||
27795984|NCT02188589|54251037|FG000|Overall Study|Withdrawal by Subject|5|||
27938078|NCT01072149|54594332|FG007|Treatment Period 2 (28 Days)|Physician Decision|1|||
28017802|NCT00535288|54677068|FG003|Overall Study|Unwilling to cooperate|3|||
28017803|NCT00535288|54677069|FG004|Overall Study|Unwilling to cooperate|4|||
28017804|NCT00535288|54677065|FG000|Overall Study|Other|2|||
27795985|NCT02167451|54251042|FG000|Overall Study|Withdrawal by Subject|1|||
27795986|NCT02167139|54251048|FG000|Randomised, Double-blind|Withdrawal by Subject|11|||
27795987|NCT02167139|54251049|FG001|Randomised, Double-blind|Withdrawal by Subject|8|||
27938079|NCT01072149|54594333|FG008|Treatment Period 2 (28 Days)|Physician Decision|0|||
27938080|NCT01072149|54594334|FG009|Treatment Period 2 (28 Days)|Physician Decision|0|||
27938081|NCT01072149|54594335|FG010|Treatment Period 2 (28 Days)|Physician Decision|0|||
27938082|NCT01072149|54594336|FG011|Treatment Period 2 (28 Days)|Physician Decision|0|||
27938083|NCT01072149|54594337|FG012|Treatment Period 2 (28 Days)|Physician Decision|0|||
27938084|NCT01072149|54594338|FG013|Treatment Period 2 (28 Days)|Physician Decision|0|||
27938085|NCT01072149|54594339|FG014|Treatment Period 2 (28 Days)|Physician Decision|0|||
27938086|NCT01072149|54594340|FG015|Treatment Period 2 (28 Days)|Physician Decision|0|||
27938087|NCT01072149|54594341|FG016|Treatment Period 2 (28 Days)|Physician Decision|0|||
27938088|NCT01072149|54594342|FG017|Treatment Period 2 (28 Days)|Physician Decision|0|||
28017805|NCT00535288|54677066|FG001|Overall Study|Other|1|||
28017806|NCT00535288|54677067|FG002|Overall Study|Other|1|||
28017807|NCT00535288|54677068|FG003|Overall Study|Other|2|||
28017808|NCT00535288|54677069|FG004|Overall Study|Other|1|||
28017809|NCT03904420|54677088|FG000|Overall Study|Study terminated|2|||
28017810|NCT03904420|54677089|FG001|Overall Study|Study terminated|2|||
28017811|NCT00675506|54677097|FG000|Overall Study|Lost to Follow-up|1|||
28017812|NCT00675506|54677098|FG001|Overall Study|Lost to Follow-up|5|||
28017813|NCT00675506|54677097|FG000|Overall Study|Lost interest|3|||
28017814|NCT00675506|54677098|FG001|Overall Study|Lost interest|5|||
28017815|NCT00675506|54677097|FG000|Overall Study|Elevated fasting glucose|2|||
28017816|NCT00675506|54677098|FG001|Overall Study|Elevated fasting glucose|1|||
28017817|NCT00675506|54677097|FG000|Overall Study|Elevated IGF-1 prior to treatment|1|||
28017818|NCT00675506|54677098|FG001|Overall Study|Elevated IGF-1 prior to treatment|0|||
28017819|NCT00675506|54677097|FG000|Overall Study|Elevated IGF-1|2|||
28017820|NCT00675506|54677098|FG001|Overall Study|Elevated IGF-1|0|||
27795988|NCT02167139|54251050|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
27795989|NCT02167139|54251051|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
27795990|NCT02167139|54251048|FG000|Randomised, Double-blind|Adverse Event|2|||
27795991|NCT02167139|54251049|FG001|Randomised, Double-blind|Adverse Event|9|||
27795992|NCT02167139|54251050|FG002|Randomised, Double-blind|Adverse Event|0|||
27795993|NCT02167139|54251051|FG003|Randomised, Double-blind|Adverse Event|0|||
27795994|NCT02167139|54251048|FG000|Randomised, Double-blind|Lack of Efficacy|1|||
27795995|NCT02167139|54251049|FG001|Randomised, Double-blind|Lack of Efficacy|2|||
27795996|NCT02167139|54251050|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
27795997|NCT02167139|54251051|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
27795998|NCT02167139|54251048|FG000|Randomised, Double-blind|Other|3|||
27795999|NCT02167139|54251049|FG001|Randomised, Double-blind|Other|0|||
27796000|NCT02167139|54251050|FG002|Randomised, Double-blind|Other|0|||
27796001|NCT02167139|54251051|FG003|Randomised, Double-blind|Other|0|||
27796002|NCT02167139|54251048|FG000|Transition-extension|Adverse Event|2|||
27796003|NCT02167139|54251049|FG001|Transition-extension|Adverse Event|0|||
27796004|NCT02167139|54251050|FG002|Transition-extension|Adverse Event|2|||
27796005|NCT02167139|54251051|FG003|Transition-extension|Adverse Event|3|||
27796006|NCT02167139|54251048|FG000|Transition-extension|Withdrawal by Subject|2|||
27796007|NCT02167139|54251049|FG001|Transition-extension|Withdrawal by Subject|0|||
27796008|NCT02167139|54251050|FG002|Transition-extension|Withdrawal by Subject|4|||
27796009|NCT02167139|54251051|FG003|Transition-extension|Withdrawal by Subject|1|||
27796010|NCT02167139|54251048|FG000|Transition-extension|Lack of Efficacy|0|||
27938089|NCT01072149|54594325|FG000|Washout Period 2 (14 Days)|Physician Decision|1|||
27938090|NCT01072149|54594326|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
27938091|NCT01072149|54594327|FG002|Washout Period 2 (14 Days)|Physician Decision|0|||
27938092|NCT01072149|54594328|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
27938093|NCT01072149|54594329|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
27938094|NCT01072149|54594330|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
28017821|NCT00675506|54677097|FG000|Overall Study|Hypersensitivity Reaction|1|||
28017822|NCT00675506|54677098|FG001|Overall Study|Hypersensitivity Reaction|0|||
28017823|NCT00675506|54677097|FG000|Overall Study|Disclosed history of cancer|1|||
28017824|NCT00675506|54677098|FG001|Overall Study|Disclosed history of cancer|0|||
28017825|NCT00675506|54677097|FG000|Overall Study|Declined participation|1|||
28017826|NCT00675506|54677098|FG001|Overall Study|Declined participation|0|||
28017827|NCT00675506|54677097|FG000|Overall Study|Schedule conflict|0|||
28017828|NCT00675506|54677098|FG001|Overall Study|Schedule conflict|1|||
28017829|NCT03895840|54677105|FG000|Overall Study|Withdrawal by Subject|21|||
28017830|NCT00310375|54677111|FG000|Primary Reporting Phase|Adverse Event|28|||
28017831|NCT00310375|54677112|FG001|Primary Reporting Phase|Adverse Event|22|||
28017832|NCT00310375|54677113|FG002|Primary Reporting Phase|Adverse Event|0|||
28017833|NCT00310375|54677111|FG000|Primary Reporting Phase|Lack of Efficacy|24|||
28017834|NCT00310375|54677112|FG001|Primary Reporting Phase|Lack of Efficacy|19|||
28017835|NCT00310375|54677113|FG002|Primary Reporting Phase|Lack of Efficacy|0|||
28017836|NCT00310375|54677111|FG000|Primary Reporting Phase|Pregnancy|2|||
28017837|NCT00310375|54677112|FG001|Primary Reporting Phase|Pregnancy|2|||
28017838|NCT00310375|54677113|FG002|Primary Reporting Phase|Pregnancy|0|||
28017839|NCT00310375|54677111|FG000|Primary Reporting Phase|Withdrawal by Subject|10|||
27938095|NCT01072149|54594331|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
27938096|NCT01072149|54594332|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
28017840|NCT00310375|54677112|FG001|Primary Reporting Phase|Withdrawal by Subject|7|||
28017841|NCT00310375|54677113|FG002|Primary Reporting Phase|Withdrawal by Subject|0|||
28017842|NCT00310375|54677111|FG000|Primary Reporting Phase|Protocol Violation|8|||
28017843|NCT00310375|54677112|FG001|Primary Reporting Phase|Protocol Violation|5|||
28017844|NCT00310375|54677113|FG002|Primary Reporting Phase|Protocol Violation|0|||
28017845|NCT00310375|54677111|FG000|Primary Reporting Phase|Change in Par medical condition|2|||
27796011|NCT02167139|54251049|FG001|Transition-extension|Lack of Efficacy|0|||
27796012|NCT02167139|54251050|FG002|Transition-extension|Lack of Efficacy|1|||
27796013|NCT02167139|54251051|FG003|Transition-extension|Lack of Efficacy|1|||
27796014|NCT02167139|54251048|FG000|Transition-extension|Other|1|||
27796015|NCT02167139|54251049|FG001|Transition-extension|Other|0|||
27796016|NCT02167139|54251050|FG002|Transition-extension|Other|1|||
27796017|NCT02167139|54251051|FG003|Transition-extension|Other|0|||
27796018|NCT02167139|54251048|FG000|Transition-extension|Lost to Follow-up|1|||
27796019|NCT02167139|54251049|FG001|Transition-extension|Lost to Follow-up|0|||
27796020|NCT02167139|54251050|FG002|Transition-extension|Lost to Follow-up|0|||
27796021|NCT02167139|54251051|FG003|Transition-extension|Lost to Follow-up|0|||
27796022|NCT02116621|54251067|FG000|Baseline|Withdrawal by Subject|0|||
27796023|NCT02116621|54251068|FG001|Baseline|Withdrawal by Subject|4|||
27796024|NCT02116621|54251067|FG000|Three Month Follow-up|Death|1|||
27796025|NCT02116621|54251068|FG001|Three Month Follow-up|Death|1|||
27796026|NCT02116621|54251067|FG000|Three Month Follow-up|Withdrawal by Subject|4|||
27796027|NCT02116621|54251068|FG001|Three Month Follow-up|Withdrawal by Subject|1|||
27796028|NCT02116621|54251067|FG000|Three Month Follow-up|Lost to Follow-up|0|||
27796029|NCT02116621|54251068|FG001|Three Month Follow-up|Lost to Follow-up|1|||
27796030|NCT02116621|54251067|FG000|Three Month Follow-up|Did not complete follow-up survey|14|||
27796031|NCT02116621|54251068|FG001|Three Month Follow-up|Did not complete follow-up survey|4|||
27796032|NCT02116621|54251067|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
27796033|NCT02116621|54251068|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
27796034|NCT02116621|54251067|FG000|Six Month Follow-up|Lost to Follow-up|2|||
27796035|NCT02116621|54251068|FG001|Six Month Follow-up|Lost to Follow-up|1|||
27796036|NCT02116621|54251067|FG000|Six Month Follow-up|Did not complete follow-up survey|1|||
27796037|NCT02116621|54251068|FG001|Six Month Follow-up|Did not complete follow-up survey|1|||
27796038|NCT02116621|54251067|FG000|Twelve Month Follow-up|Withdrawal by Subject|1|||
27796039|NCT02116621|54251068|FG001|Twelve Month Follow-up|Withdrawal by Subject|0|||
27796040|NCT02116621|54251067|FG000|Twelve Month Follow-up|Lost to Follow-up|0|||
27796041|NCT02116621|54251068|FG001|Twelve Month Follow-up|Lost to Follow-up|1|||
27796042|NCT02116621|54251067|FG000|Twelve Month Follow-up|Did not complete follow-up survey|1|||
27796043|NCT02116621|54251068|FG001|Twelve Month Follow-up|Did not complete follow-up survey|3|||
27796044|NCT02116621|54251067|FG000|Twelve Month Follow-up|Enrolled within 12 months of study end|14|||
27796045|NCT02116621|54251068|FG001|Twelve Month Follow-up|Enrolled within 12 months of study end|8|||
27796046|NCT02116309|54251076|FG000|Overall Study|Lost to Follow-up|0|||
27796047|NCT02116309|54251077|FG001|Overall Study|Lost to Follow-up|1|||
27796048|NCT02115607|54251083|FG000|Overall Study|Withdrawal by Subject|1|||
27796049|NCT01490632|54251092|FG000|Part A: Initial Treatment Period|Adverse Event|0|||
27796050|NCT01490632|54251093|FG001|Part A: Initial Treatment Period|Adverse Event|0|||
27796051|NCT01490632|54251094|FG002|Part A: Initial Treatment Period|Adverse Event|2|||
27796052|NCT01490632|54251095|FG003|Part A: Initial Treatment Period|Adverse Event|4|||
27796053|NCT01490632|54251096|FG004|Part A: Initial Treatment Period|Adverse Event|4|||
27796054|NCT01490632|54251097|FG005|Part A: Initial Treatment Period|Adverse Event|0|||
27796055|NCT01490632|54251098|FG006|Part A: Initial Treatment Period|Adverse Event|0|||
27796056|NCT01490632|54251099|FG007|Part A: Initial Treatment Period|Adverse Event|0|||
27796057|NCT01490632|54251100|FG008|Part A: Initial Treatment Period|Adverse Event|0|||
27796058|NCT01490632|54251101|FG009|Part A: Initial Treatment Period|Adverse Event|0|||
27796059|NCT01490632|54251102|FG010|Part A: Initial Treatment Period|Adverse Event|0|||
27796060|NCT01490632|54251103|FG011|Part A: Initial Treatment Period|Adverse Event|0|||
27796061|NCT01490632|54251104|FG012|Part A: Initial Treatment Period|Adverse Event|0|||
27796062|NCT01490632|54251105|FG013|Part A: Initial Treatment Period|Adverse Event|0|||
27796063|NCT01490632|54251106|FG014|Part A: Initial Treatment Period|Adverse Event|0|||
27796064|NCT01490632|54251107|FG015|Part A: Initial Treatment Period|Adverse Event|0|||
27796065|NCT01490632|54251108|FG016|Part A: Initial Treatment Period|Adverse Event|0|||
27796066|NCT01490632|54251109|FG017|Part A: Initial Treatment Period|Adverse Event|0|||
27796067|NCT01490632|54251110|FG018|Part A: Initial Treatment Period|Adverse Event|0|||
27796068|NCT01490632|54251111|FG019|Part A: Initial Treatment Period|Adverse Event|0|||
27796069|NCT01490632|54251092|FG000|Part A: Initial Treatment Period|Lack of Efficacy|3|||
27796070|NCT01490632|54251093|FG001|Part A: Initial Treatment Period|Lack of Efficacy|1|||
27796071|NCT01490632|54251094|FG002|Part A: Initial Treatment Period|Lack of Efficacy|2|||
27796072|NCT01490632|54251095|FG003|Part A: Initial Treatment Period|Lack of Efficacy|2|||
27796073|NCT01490632|54251096|FG004|Part A: Initial Treatment Period|Lack of Efficacy|0|||
27796074|NCT01490632|54251097|FG005|Part A: Initial Treatment Period|Lack of Efficacy|0|||
27796075|NCT01490632|54251098|FG006|Part A: Initial Treatment Period|Lack of Efficacy|0|||
27796076|NCT01490632|54251099|FG007|Part A: Initial Treatment Period|Lack of Efficacy|0|||
27796077|NCT01490632|54251100|FG008|Part A: Initial Treatment Period|Lack of Efficacy|0|||
27796078|NCT01490632|54251101|FG009|Part A: Initial Treatment Period|Lack of Efficacy|0|||
27796079|NCT01490632|54251102|FG010|Part A: Initial Treatment Period|Lack of Efficacy|0|||
27796080|NCT01490632|54251103|FG011|Part A: Initial Treatment Period|Lack of Efficacy|0|||
27796081|NCT01490632|54251104|FG012|Part A: Initial Treatment Period|Lack of Efficacy|0|||
27796082|NCT01490632|54251105|FG013|Part A: Initial Treatment Period|Lack of Efficacy|0|||
28017846|NCT00310375|54677112|FG001|Primary Reporting Phase|Change in Par medical condition|0|||
28017847|NCT00310375|54677113|FG002|Primary Reporting Phase|Change in Par medical condition|0|||
28017848|NCT00310375|54677111|FG000|Primary Reporting Phase|Transaminase >5 upper limit of normal|2|||
28017849|NCT00310375|54677112|FG001|Primary Reporting Phase|Transaminase >5 upper limit of normal|1|||
28017850|NCT00310375|54677113|FG002|Primary Reporting Phase|Transaminase >5 upper limit of normal|0|||
28017851|NCT00310375|54677111|FG000|Primary Reporting Phase|Physician Decision|5|||
28017852|NCT00310375|54677112|FG001|Primary Reporting Phase|Physician Decision|3|||
28017853|NCT00310375|54677113|FG002|Primary Reporting Phase|Physician Decision|0|||
28017854|NCT00310375|54677111|FG000|Primary Reporting Phase|Request of the sponsor|2|||
28017855|NCT00310375|54677112|FG001|Primary Reporting Phase|Request of the sponsor|2|||
28017856|NCT00310375|54677113|FG002|Primary Reporting Phase|Request of the sponsor|0|||
28017857|NCT00310375|54677111|FG000|Primary Reporting Phase|Failed to return|1|||
28017858|NCT00310375|54677112|FG001|Primary Reporting Phase|Failed to return|3|||
28017859|NCT00310375|54677113|FG002|Primary Reporting Phase|Failed to return|0|||
28017860|NCT00310375|54677111|FG000|Primary Reporting Phase|Participant request unrelated to study|1|||
28017861|NCT00310375|54677112|FG001|Primary Reporting Phase|Participant request unrelated to study|2|||
28017862|NCT00310375|54677113|FG002|Primary Reporting Phase|Participant request unrelated to study|0|||
28017863|NCT00310375|54677111|FG000|Primary Reporting Phase|Going for temporal lobectomy|1|||
28017864|NCT00310375|54677112|FG001|Primary Reporting Phase|Going for temporal lobectomy|0|||
28017865|NCT00310375|54677113|FG002|Primary Reporting Phase|Going for temporal lobectomy|0|||
28017866|NCT00310375|54677111|FG000|Primary Reporting Phase|Missed study drug >5 days|1|||
28017867|NCT00310375|54677112|FG001|Primary Reporting Phase|Missed study drug >5 days|0|||
27796083|NCT01490632|54251106|FG014|Part A: Initial Treatment Period|Lack of Efficacy|0|||
27796084|NCT01490632|54251107|FG015|Part A: Initial Treatment Period|Lack of Efficacy|0|||
27796085|NCT01490632|54251108|FG016|Part A: Initial Treatment Period|Lack of Efficacy|0|||
27796086|NCT01490632|54251109|FG017|Part A: Initial Treatment Period|Lack of Efficacy|0|||
27796087|NCT01490632|54251110|FG018|Part A: Initial Treatment Period|Lack of Efficacy|0|||
27796088|NCT01490632|54251111|FG019|Part A: Initial Treatment Period|Lack of Efficacy|0|||
27796089|NCT01490632|54251092|FG000|Part A: Initial Treatment Period|Lost to Follow-up|0|||
27796090|NCT01490632|54251093|FG001|Part A: Initial Treatment Period|Lost to Follow-up|0|||
27796091|NCT01490632|54251094|FG002|Part A: Initial Treatment Period|Lost to Follow-up|1|||
27796092|NCT01490632|54251095|FG003|Part A: Initial Treatment Period|Lost to Follow-up|1|||
27796093|NCT01490632|54251096|FG004|Part A: Initial Treatment Period|Lost to Follow-up|2|||
27796094|NCT01490632|54251097|FG005|Part A: Initial Treatment Period|Lost to Follow-up|0|||
27796095|NCT01490632|54251098|FG006|Part A: Initial Treatment Period|Lost to Follow-up|0|||
27796096|NCT01490632|54251099|FG007|Part A: Initial Treatment Period|Lost to Follow-up|0|||
27796097|NCT01490632|54251100|FG008|Part A: Initial Treatment Period|Lost to Follow-up|0|||
27796098|NCT01490632|54251101|FG009|Part A: Initial Treatment Period|Lost to Follow-up|0|||
27796099|NCT01490632|54251102|FG010|Part A: Initial Treatment Period|Lost to Follow-up|0|||
27796100|NCT01490632|54251103|FG011|Part A: Initial Treatment Period|Lost to Follow-up|0|||
27796101|NCT01490632|54251104|FG012|Part A: Initial Treatment Period|Lost to Follow-up|0|||
27796102|NCT01490632|54251105|FG013|Part A: Initial Treatment Period|Lost to Follow-up|0|||
27796103|NCT01490632|54251106|FG014|Part A: Initial Treatment Period|Lost to Follow-up|0|||
27796104|NCT01490632|54251107|FG015|Part A: Initial Treatment Period|Lost to Follow-up|0|||
27796105|NCT01490632|54251108|FG016|Part A: Initial Treatment Period|Lost to Follow-up|0|||
27796106|NCT01490632|54251109|FG017|Part A: Initial Treatment Period|Lost to Follow-up|0|||
27796107|NCT01490632|54251110|FG018|Part A: Initial Treatment Period|Lost to Follow-up|0|||
27796108|NCT01490632|54251111|FG019|Part A: Initial Treatment Period|Lost to Follow-up|0|||
27796109|NCT01490632|54251092|FG000|Part A: Initial Treatment Period|Physician Decision|0|||
27796110|NCT01490632|54251093|FG001|Part A: Initial Treatment Period|Physician Decision|1|||
27796111|NCT01490632|54251094|FG002|Part A: Initial Treatment Period|Physician Decision|0|||
27796112|NCT01490632|54251095|FG003|Part A: Initial Treatment Period|Physician Decision|1|||
27796113|NCT01490632|54251096|FG004|Part A: Initial Treatment Period|Physician Decision|0|||
27796114|NCT01490632|54251097|FG005|Part A: Initial Treatment Period|Physician Decision|0|||
27796115|NCT01490632|54251098|FG006|Part A: Initial Treatment Period|Physician Decision|0|||
27796116|NCT01490632|54251099|FG007|Part A: Initial Treatment Period|Physician Decision|0|||
27796117|NCT01490632|54251100|FG008|Part A: Initial Treatment Period|Physician Decision|0|||
27796118|NCT01490632|54251101|FG009|Part A: Initial Treatment Period|Physician Decision|0|||
27796119|NCT01490632|54251102|FG010|Part A: Initial Treatment Period|Physician Decision|0|||
27796120|NCT01490632|54251103|FG011|Part A: Initial Treatment Period|Physician Decision|0|||
27796121|NCT01490632|54251104|FG012|Part A: Initial Treatment Period|Physician Decision|0|||
27796122|NCT01490632|54251105|FG013|Part A: Initial Treatment Period|Physician Decision|0|||
27796123|NCT01490632|54251106|FG014|Part A: Initial Treatment Period|Physician Decision|0|||
27796124|NCT01490632|54251107|FG015|Part A: Initial Treatment Period|Physician Decision|0|||
27796125|NCT01490632|54251108|FG016|Part A: Initial Treatment Period|Physician Decision|0|||
27796126|NCT01490632|54251109|FG017|Part A: Initial Treatment Period|Physician Decision|0|||
27796127|NCT01490632|54251110|FG018|Part A: Initial Treatment Period|Physician Decision|0|||
27796128|NCT01490632|54251111|FG019|Part A: Initial Treatment Period|Physician Decision|0|||
27796129|NCT01490632|54251092|FG000|Part A: Initial Treatment Period|Sponsor Decision|2|||
27796130|NCT01490632|54251093|FG001|Part A: Initial Treatment Period|Sponsor Decision|0|||
27796131|NCT01490632|54251094|FG002|Part A: Initial Treatment Period|Sponsor Decision|0|||
27796132|NCT01490632|54251095|FG003|Part A: Initial Treatment Period|Sponsor Decision|0|||
27796133|NCT01490632|54251096|FG004|Part A: Initial Treatment Period|Sponsor Decision|0|||
27796134|NCT01490632|54251097|FG005|Part A: Initial Treatment Period|Sponsor Decision|0|||
27796135|NCT01490632|54251098|FG006|Part A: Initial Treatment Period|Sponsor Decision|0|||
27796136|NCT01490632|54251099|FG007|Part A: Initial Treatment Period|Sponsor Decision|0|||
27796137|NCT01490632|54251100|FG008|Part A: Initial Treatment Period|Sponsor Decision|0|||
27796138|NCT01490632|54251101|FG009|Part A: Initial Treatment Period|Sponsor Decision|0|||
27796139|NCT01490632|54251102|FG010|Part A: Initial Treatment Period|Sponsor Decision|0|||
27796140|NCT01490632|54251103|FG011|Part A: Initial Treatment Period|Sponsor Decision|0|||
27796141|NCT01490632|54251104|FG012|Part A: Initial Treatment Period|Sponsor Decision|0|||
27796142|NCT01490632|54251105|FG013|Part A: Initial Treatment Period|Sponsor Decision|0|||
27796143|NCT01490632|54251106|FG014|Part A: Initial Treatment Period|Sponsor Decision|0|||
27796144|NCT01490632|54251107|FG015|Part A: Initial Treatment Period|Sponsor Decision|0|||
27796145|NCT01490632|54251108|FG016|Part A: Initial Treatment Period|Sponsor Decision|0|||
27796146|NCT01490632|54251109|FG017|Part A: Initial Treatment Period|Sponsor Decision|0|||
27796147|NCT01490632|54251110|FG018|Part A: Initial Treatment Period|Sponsor Decision|0|||
27796148|NCT01490632|54251111|FG019|Part A: Initial Treatment Period|Sponsor Decision|0|||
27796149|NCT01490632|54251092|FG000|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
27796150|NCT01490632|54251093|FG001|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
27796151|NCT01490632|54251094|FG002|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
27796152|NCT01490632|54251095|FG003|Part A: Initial Treatment Period|Withdrawal by Subject|1|||
27796153|NCT01490632|54251096|FG004|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
27796154|NCT01490632|54251097|FG005|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
27796155|NCT01490632|54251098|FG006|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
27796156|NCT01490632|54251099|FG007|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
27796157|NCT01490632|54251100|FG008|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
27796158|NCT01490632|54251101|FG009|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
27796159|NCT01490632|54251102|FG010|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
27796160|NCT01490632|54251103|FG011|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
27796161|NCT01490632|54251104|FG012|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
27796162|NCT01490632|54251105|FG013|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
27796163|NCT01490632|54251106|FG014|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
27796164|NCT01490632|54251107|FG015|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
27796165|NCT01490632|54251108|FG016|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
27796166|NCT01490632|54251109|FG017|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
27796167|NCT01490632|54251110|FG018|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
27796168|NCT01490632|54251111|FG019|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
27796169|NCT01490632|54251092|FG000|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
27796170|NCT01490632|54251093|FG001|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
27796171|NCT01490632|54251094|FG002|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
27796172|NCT01490632|54251095|FG003|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
27796173|NCT01490632|54251096|FG004|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9|||
27796174|NCT01490632|54251097|FG005|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
27796175|NCT01490632|54251098|FG006|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
27796176|NCT01490632|54251099|FG007|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
27796177|NCT01490632|54251100|FG008|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
27796178|NCT01490632|54251101|FG009|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
27796179|NCT01490632|54251102|FG010|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
27796180|NCT01490632|54251103|FG011|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
27796181|NCT01490632|54251104|FG012|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
27796182|NCT01490632|54251105|FG013|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
27796183|NCT01490632|54251106|FG014|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
27796184|NCT01490632|54251107|FG015|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
27796185|NCT01490632|54251108|FG016|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
27796186|NCT01490632|54251109|FG017|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
27796187|NCT01490632|54251110|FG018|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
27796188|NCT01490632|54251111|FG019|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
27796189|NCT01490632|54251092|FG000|Part B: Extension or Step-Up Period|Adverse Event|0|||
27796190|NCT01490632|54251093|FG001|Part B: Extension or Step-Up Period|Adverse Event|0|||
27796191|NCT01490632|54251094|FG002|Part B: Extension or Step-Up Period|Adverse Event|0|||
27796192|NCT01490632|54251095|FG003|Part B: Extension or Step-Up Period|Adverse Event|0|||
27796193|NCT01490632|54251096|FG004|Part B: Extension or Step-Up Period|Adverse Event|0|||
27796194|NCT01490632|54251097|FG005|Part B: Extension or Step-Up Period|Adverse Event|2|||
27796195|NCT01490632|54251098|FG006|Part B: Extension or Step-Up Period|Adverse Event|2|||
27796196|NCT01490632|54251099|FG007|Part B: Extension or Step-Up Period|Adverse Event|0|||
27796197|NCT01490632|54251100|FG008|Part B: Extension or Step-Up Period|Adverse Event|0|||
27796198|NCT01490632|54251101|FG009|Part B: Extension or Step-Up Period|Adverse Event|2|||
28017868|NCT00310375|54677113|FG002|Primary Reporting Phase|Missed study drug >5 days|0|||
28017869|NCT00310375|54677111|FG000|Primary Reporting Phase|Site closure|3|||
28017870|NCT00310375|54677112|FG001|Primary Reporting Phase|Site closure|0|||
28017871|NCT00310375|54677113|FG002|Primary Reporting Phase|Site closure|0|||
28017872|NCT00310375|54677111|FG000|Primary Reporting Phase|Missed study drug for 2 months|1|||
28017873|NCT00310375|54677112|FG001|Primary Reporting Phase|Missed study drug for 2 months|0|||
28017874|NCT00310375|54677113|FG002|Primary Reporting Phase|Missed study drug for 2 months|0|||
28017875|NCT00310375|54677111|FG000|Primary Reporting Phase|Par. switched to commercial product|0|||
28017876|NCT00310375|54677112|FG001|Primary Reporting Phase|Par. switched to commercial product|1|||
28017877|NCT00310375|54677113|FG002|Primary Reporting Phase|Par. switched to commercial product|0|||
28017878|NCT00310375|54677111|FG000|Primary Reporting Phase|Request of Ethics Committee|0|||
28017879|NCT00310375|54677112|FG001|Primary Reporting Phase|Request of Ethics Committee|1|||
28017880|NCT00310375|54677113|FG002|Primary Reporting Phase|Request of Ethics Committee|0|||
28017881|NCT00310375|54677111|FG000|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
27796199|NCT01490632|54251102|FG010|Part B: Extension or Step-Up Period|Adverse Event|3|||
27796200|NCT01490632|54251103|FG011|Part B: Extension or Step-Up Period|Adverse Event|1|||
27796201|NCT01490632|54251104|FG012|Part B: Extension or Step-Up Period|Adverse Event|0|||
27796202|NCT01490632|54251105|FG013|Part B: Extension or Step-Up Period|Adverse Event|0|||
27796203|NCT01490632|54251106|FG014|Part B: Extension or Step-Up Period|Adverse Event|0|||
27796204|NCT01490632|54251107|FG015|Part B: Extension or Step-Up Period|Adverse Event|0|||
27796205|NCT01490632|54251108|FG016|Part B: Extension or Step-Up Period|Adverse Event|0|||
27796206|NCT01490632|54251109|FG017|Part B: Extension or Step-Up Period|Adverse Event|0|||
27796207|NCT01490632|54251110|FG018|Part B: Extension or Step-Up Period|Adverse Event|0|||
27796208|NCT01490632|54251111|FG019|Part B: Extension or Step-Up Period|Adverse Event|0|||
27796209|NCT01490632|54251092|FG000|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
27796210|NCT01490632|54251093|FG001|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
27796211|NCT01490632|54251094|FG002|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
27796212|NCT01490632|54251095|FG003|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
27796213|NCT01490632|54251096|FG004|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
27796214|NCT01490632|54251097|FG005|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
27796215|NCT01490632|54251098|FG006|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
27796216|NCT01490632|54251099|FG007|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
27796217|NCT01490632|54251100|FG008|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
27796218|NCT01490632|54251101|FG009|Part B: Extension or Step-Up Period|Lack of Efficacy|3|||
27796219|NCT01490632|54251102|FG010|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
27796220|NCT01490632|54251103|FG011|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
27796221|NCT01490632|54251104|FG012|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
27796222|NCT01490632|54251105|FG013|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
27796223|NCT01490632|54251106|FG014|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
27796224|NCT01490632|54251107|FG015|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
27796225|NCT01490632|54251108|FG016|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
27796226|NCT01490632|54251109|FG017|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
27796227|NCT01490632|54251110|FG018|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
27796228|NCT01490632|54251111|FG019|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
27796229|NCT01490632|54251092|FG000|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
27796230|NCT01490632|54251093|FG001|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
27796231|NCT01490632|54251094|FG002|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
27796232|NCT01490632|54251095|FG003|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
27796233|NCT01490632|54251096|FG004|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
27796234|NCT01490632|54251097|FG005|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
27796235|NCT01490632|54251098|FG006|Part B: Extension or Step-Up Period|Lost to Follow-up|2|||
27796236|NCT01490632|54251099|FG007|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
27842745|NCT01548404|54331517|FG000|Overall Study|Physician Decision|2|||
27842746|NCT01548404|54331518|FG001|Overall Study|Physician Decision|1|||
28017882|NCT00310375|54677112|FG001|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
28017883|NCT00310375|54677113|FG002|Safety Follow-up Continuation Phase|Lost to Follow-up|1|||
27796237|NCT01490632|54251100|FG008|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
27796238|NCT01490632|54251101|FG009|Part B: Extension or Step-Up Period|Lost to Follow-up|1|||
27796239|NCT01490632|54251102|FG010|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
27796240|NCT01490632|54251103|FG011|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
27796241|NCT01490632|54251104|FG012|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
27796242|NCT01490632|54251105|FG013|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
27796243|NCT01490632|54251106|FG014|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
27796244|NCT01490632|54251107|FG015|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
27796245|NCT01490632|54251108|FG016|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
27796246|NCT01490632|54251109|FG017|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
27796247|NCT01490632|54251110|FG018|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
27796248|NCT01490632|54251111|FG019|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
27796249|NCT01490632|54251092|FG000|Part B: Extension or Step-Up Period|Physician Decision|0|||
27796250|NCT01490632|54251093|FG001|Part B: Extension or Step-Up Period|Physician Decision|0|||
27796251|NCT01490632|54251094|FG002|Part B: Extension or Step-Up Period|Physician Decision|0|||
27796252|NCT01490632|54251095|FG003|Part B: Extension or Step-Up Period|Physician Decision|0|||
27796253|NCT01490632|54251096|FG004|Part B: Extension or Step-Up Period|Physician Decision|0|||
27796254|NCT01490632|54251097|FG005|Part B: Extension or Step-Up Period|Physician Decision|0|||
27796255|NCT01490632|54251098|FG006|Part B: Extension or Step-Up Period|Physician Decision|1|||
27796256|NCT01490632|54251099|FG007|Part B: Extension or Step-Up Period|Physician Decision|0|||
27796257|NCT01490632|54251100|FG008|Part B: Extension or Step-Up Period|Physician Decision|0|||
27796258|NCT01490632|54251101|FG009|Part B: Extension or Step-Up Period|Physician Decision|0|||
27796259|NCT01490632|54251102|FG010|Part B: Extension or Step-Up Period|Physician Decision|0|||
27796260|NCT01490632|54251103|FG011|Part B: Extension or Step-Up Period|Physician Decision|0|||
27796261|NCT01490632|54251104|FG012|Part B: Extension or Step-Up Period|Physician Decision|0|||
27796262|NCT01490632|54251105|FG013|Part B: Extension or Step-Up Period|Physician Decision|0|||
27796263|NCT01490632|54251106|FG014|Part B: Extension or Step-Up Period|Physician Decision|0|||
27796264|NCT01490632|54251107|FG015|Part B: Extension or Step-Up Period|Physician Decision|0|||
27796265|NCT01490632|54251108|FG016|Part B: Extension or Step-Up Period|Physician Decision|0|||
27796266|NCT01490632|54251109|FG017|Part B: Extension or Step-Up Period|Physician Decision|0|||
27796267|NCT01490632|54251110|FG018|Part B: Extension or Step-Up Period|Physician Decision|0|||
27796268|NCT01490632|54251111|FG019|Part B: Extension or Step-Up Period|Physician Decision|0|||
27796269|NCT01490632|54251092|FG000|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
27796270|NCT01490632|54251093|FG001|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
27796271|NCT01490632|54251094|FG002|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
27796272|NCT01490632|54251095|FG003|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
27796273|NCT01490632|54251096|FG004|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
27796274|NCT01490632|54251097|FG005|Part B: Extension or Step-Up Period|Sponsor Decision|1|||
27796275|NCT01490632|54251098|FG006|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
27796276|NCT01490632|54251099|FG007|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
27796277|NCT01490632|54251100|FG008|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
27796278|NCT01490632|54251101|FG009|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
27796279|NCT01490632|54251102|FG010|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
27796280|NCT01490632|54251103|FG011|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
27796281|NCT01490632|54251104|FG012|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
27796282|NCT01490632|54251105|FG013|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
27796283|NCT01490632|54251106|FG014|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
27796284|NCT01490632|54251107|FG015|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
27796285|NCT01490632|54251108|FG016|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
27796286|NCT01490632|54251109|FG017|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
27796287|NCT01490632|54251110|FG018|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
27796288|NCT01490632|54251111|FG019|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
27796289|NCT01490632|54251092|FG000|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
27796290|NCT01490632|54251093|FG001|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
27796291|NCT01490632|54251094|FG002|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
27796292|NCT01490632|54251095|FG003|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
27796293|NCT01490632|54251096|FG004|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
27796294|NCT01490632|54251097|FG005|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
27796295|NCT01490632|54251098|FG006|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
27796296|NCT01490632|54251099|FG007|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
27796297|NCT01490632|54251100|FG008|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
27796298|NCT01490632|54251101|FG009|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
27796299|NCT01490632|54251102|FG010|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
27796300|NCT01490632|54251103|FG011|Part B: Extension or Step-Up Period|Withdrawal by Subject|2|||
27796301|NCT01490632|54251104|FG012|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
28017884|NCT00309907|54677122|FG000|Overall Study|Death|4|||
27796302|NCT01490632|54251105|FG013|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
27796303|NCT01490632|54251106|FG014|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
27796304|NCT01490632|54251107|FG015|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
27796305|NCT01490632|54251108|FG016|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
27796306|NCT01490632|54251109|FG017|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
27796307|NCT01490632|54251110|FG018|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
27796308|NCT01490632|54251111|FG019|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
27796309|NCT01490632|54251092|FG000|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
27796310|NCT01490632|54251093|FG001|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
27796311|NCT01490632|54251094|FG002|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
27796312|NCT01490632|54251095|FG003|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
27796313|NCT01490632|54251096|FG004|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
27796314|NCT01490632|54251097|FG005|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1|||
27796315|NCT01490632|54251098|FG006|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
27796316|NCT01490632|54251099|FG007|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
27796317|NCT01490632|54251100|FG008|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8|||
27796318|NCT01490632|54251101|FG009|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19|||
27796319|NCT01490632|54251102|FG010|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16|||
27796320|NCT01490632|54251103|FG011|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5|||
27796321|NCT01490632|54251104|FG012|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
27796322|NCT01490632|54251105|FG013|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
27796323|NCT01490632|54251106|FG014|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
27796324|NCT01490632|54251107|FG015|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
27796325|NCT01490632|54251108|FG016|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
27796326|NCT01490632|54251109|FG017|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
27796327|NCT01490632|54251110|FG018|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
27796328|NCT01490632|54251111|FG019|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
27796329|NCT01490632|54251092|FG000|Part C: Washout or Step-Down Period|Adverse Event|0|||
27796330|NCT01490632|54251093|FG001|Part C: Washout or Step-Down Period|Adverse Event|0|||
27796331|NCT01490632|54251094|FG002|Part C: Washout or Step-Down Period|Adverse Event|0|||
27796332|NCT01490632|54251095|FG003|Part C: Washout or Step-Down Period|Adverse Event|0|||
27796333|NCT01490632|54251096|FG004|Part C: Washout or Step-Down Period|Adverse Event|0|||
27796334|NCT01490632|54251097|FG005|Part C: Washout or Step-Down Period|Adverse Event|0|||
27796335|NCT01490632|54251098|FG006|Part C: Washout or Step-Down Period|Adverse Event|0|||
27796336|NCT01490632|54251099|FG007|Part C: Washout or Step-Down Period|Adverse Event|0|||
27796337|NCT01490632|54251100|FG008|Part C: Washout or Step-Down Period|Adverse Event|0|||
27796338|NCT01490632|54251101|FG009|Part C: Washout or Step-Down Period|Adverse Event|0|||
27796339|NCT01490632|54251102|FG010|Part C: Washout or Step-Down Period|Adverse Event|0|||
27796340|NCT01490632|54251103|FG011|Part C: Washout or Step-Down Period|Adverse Event|0|||
27796341|NCT01490632|54251104|FG012|Part C: Washout or Step-Down Period|Adverse Event|0|||
27796342|NCT01490632|54251105|FG013|Part C: Washout or Step-Down Period|Adverse Event|0|||
27796343|NCT01490632|54251106|FG014|Part C: Washout or Step-Down Period|Adverse Event|2|||
27796344|NCT01490632|54251107|FG015|Part C: Washout or Step-Down Period|Adverse Event|2|||
27796345|NCT01490632|54251108|FG016|Part C: Washout or Step-Down Period|Adverse Event|0|||
27796346|NCT01490632|54251109|FG017|Part C: Washout or Step-Down Period|Adverse Event|0|||
27796347|NCT01490632|54251110|FG018|Part C: Washout or Step-Down Period|Adverse Event|0|||
27796348|NCT01490632|54251111|FG019|Part C: Washout or Step-Down Period|Adverse Event|0|||
27796349|NCT01490632|54251092|FG000|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
27796350|NCT01490632|54251093|FG001|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
27796351|NCT01490632|54251094|FG002|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
27796352|NCT01490632|54251095|FG003|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
27796353|NCT01490632|54251096|FG004|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
27796354|NCT01490632|54251097|FG005|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
27796355|NCT01490632|54251098|FG006|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
27796356|NCT01490632|54251099|FG007|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
27796357|NCT01490632|54251100|FG008|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
27796358|NCT01490632|54251101|FG009|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
27796359|NCT01490632|54251102|FG010|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
27796360|NCT01490632|54251103|FG011|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
27796361|NCT01490632|54251104|FG012|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
27796362|NCT01490632|54251105|FG013|Part C: Washout or Step-Down Period|Lost to Follow-up|1|||
27796363|NCT01490632|54251106|FG014|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
27796364|NCT01490632|54251107|FG015|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
27796365|NCT01490632|54251108|FG016|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
27796366|NCT01490632|54251109|FG017|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
27796367|NCT01490632|54251110|FG018|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
27796368|NCT01490632|54251111|FG019|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
27796369|NCT01490632|54251092|FG000|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
27796370|NCT01490632|54251093|FG001|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
27796371|NCT01490632|54251094|FG002|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
27796372|NCT01490632|54251095|FG003|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
27796373|NCT01490632|54251096|FG004|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
27796374|NCT01490632|54251097|FG005|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
27796375|NCT01490632|54251098|FG006|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
27796376|NCT01490632|54251099|FG007|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
27796377|NCT01490632|54251100|FG008|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
27796378|NCT01490632|54251101|FG009|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
27796379|NCT01490632|54251102|FG010|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
27796380|NCT01490632|54251103|FG011|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
27796381|NCT01490632|54251104|FG012|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
27796382|NCT01490632|54251105|FG013|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
27796383|NCT01490632|54251106|FG014|Part C: Washout or Step-Down Period|Withdrawal by Subject|2|||
27796384|NCT01490632|54251107|FG015|Part C: Washout or Step-Down Period|Withdrawal by Subject|1|||
27796385|NCT01490632|54251108|FG016|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
27796386|NCT01490632|54251109|FG017|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
27796387|NCT01490632|54251110|FG018|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
27796388|NCT01490632|54251111|FG019|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
27796389|NCT01490632|54251092|FG000|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
27796390|NCT01490632|54251093|FG001|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
27796391|NCT01490632|54251094|FG002|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
27796392|NCT01490632|54251095|FG003|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
27796393|NCT01490632|54251096|FG004|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
27796394|NCT01490632|54251097|FG005|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
27796395|NCT01490632|54251098|FG006|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
27796396|NCT01490632|54251099|FG007|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
27796397|NCT01490632|54251100|FG008|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
27796398|NCT01490632|54251101|FG009|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
27796399|NCT01490632|54251102|FG010|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
27796400|NCT01490632|54251103|FG011|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
27796401|NCT01490632|54251104|FG012|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5|||
27796402|NCT01490632|54251105|FG013|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9|||
27796403|NCT01490632|54251106|FG014|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14|||
27796404|NCT01490632|54251107|FG015|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34|||
27796405|NCT01490632|54251108|FG016|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
27796406|NCT01490632|54251109|FG017|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
27796407|NCT01490632|54251110|FG018|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
27796408|NCT01490632|54251111|FG019|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
27796409|NCT01490632|54251092|FG000|Part D: Re-Treatment Period|Adverse Event|0|||
27796410|NCT01490632|54251093|FG001|Part D: Re-Treatment Period|Adverse Event|0|||
27796411|NCT01490632|54251094|FG002|Part D: Re-Treatment Period|Adverse Event|0|||
27796412|NCT01490632|54251095|FG003|Part D: Re-Treatment Period|Adverse Event|0|||
27796413|NCT01490632|54251096|FG004|Part D: Re-Treatment Period|Adverse Event|0|||
27796414|NCT01490632|54251097|FG005|Part D: Re-Treatment Period|Adverse Event|0|||
27796415|NCT01490632|54251098|FG006|Part D: Re-Treatment Period|Adverse Event|0|||
28017885|NCT00309907|54677122|FG000|Overall Study|Physician Decision|1|||
28017886|NCT00309907|54677122|FG000|Overall Study|Ineligible|11|||
28017887|NCT00309907|54677122|FG000|Overall Study|Major infectious event|4|||
28017888|NCT00655824|54677127|FG000|Overall Study|Adverse Event|3|||
28017889|NCT00655824|54677127|FG000|Overall Study|Early Termination of Study by Sponsor|74|||
28017890|NCT00655824|54677127|FG000|Overall Study|Protocol Violation|1|||
28017891|NCT00655824|54677127|FG000|Overall Study|Withdrawal by Subject|4|||
28017892|NCT00655824|54677127|FG000|Overall Study|Deterioration of Trial Disease|2|||
28017893|NCT00575588|54677133|FG000|Overall Study|Adverse Event|11|||
28017894|NCT00575588|54677134|FG001|Overall Study|Adverse Event|13|||
28017895|NCT00575588|54677133|FG000|Overall Study|Withdrawal by Subject|27|||
28017896|NCT00575588|54677134|FG001|Overall Study|Withdrawal by Subject|31|||
28017897|NCT00575588|54677133|FG000|Overall Study|Lost to Follow-up|1|||
28017898|NCT00575588|54677134|FG001|Overall Study|Lost to Follow-up|3|||
27796416|NCT01490632|54251099|FG007|Part D: Re-Treatment Period|Adverse Event|0|||
27796417|NCT01490632|54251100|FG008|Part D: Re-Treatment Period|Adverse Event|0|||
27796418|NCT01490632|54251101|FG009|Part D: Re-Treatment Period|Adverse Event|0|||
27796419|NCT01490632|54251102|FG010|Part D: Re-Treatment Period|Adverse Event|0|||
27796420|NCT01490632|54251103|FG011|Part D: Re-Treatment Period|Adverse Event|0|||
27796421|NCT01490632|54251104|FG012|Part D: Re-Treatment Period|Adverse Event|0|||
27796422|NCT01490632|54251105|FG013|Part D: Re-Treatment Period|Adverse Event|0|||
27796423|NCT01490632|54251106|FG014|Part D: Re-Treatment Period|Adverse Event|0|||
27796424|NCT01490632|54251107|FG015|Part D: Re-Treatment Period|Adverse Event|0|||
27796425|NCT01490632|54251108|FG016|Part D: Re-Treatment Period|Adverse Event|0|||
27796426|NCT01490632|54251109|FG017|Part D: Re-Treatment Period|Adverse Event|1|||
27796427|NCT01490632|54251110|FG018|Part D: Re-Treatment Period|Adverse Event|1|||
27796428|NCT01490632|54251111|FG019|Part D: Re-Treatment Period|Adverse Event|3|||
27796429|NCT01490632|54251092|FG000|Part D: Re-Treatment Period|Death|0|||
27796430|NCT01490632|54251093|FG001|Part D: Re-Treatment Period|Death|0|||
27796431|NCT01490632|54251094|FG002|Part D: Re-Treatment Period|Death|0|||
27796432|NCT01490632|54251095|FG003|Part D: Re-Treatment Period|Death|0|||
27796433|NCT01490632|54251096|FG004|Part D: Re-Treatment Period|Death|0|||
27796434|NCT01490632|54251097|FG005|Part D: Re-Treatment Period|Death|0|||
27796435|NCT01490632|54251098|FG006|Part D: Re-Treatment Period|Death|0|||
27796436|NCT01490632|54251099|FG007|Part D: Re-Treatment Period|Death|0|||
27796437|NCT01490632|54251100|FG008|Part D: Re-Treatment Period|Death|0|||
27796438|NCT01490632|54251101|FG009|Part D: Re-Treatment Period|Death|0|||
27796439|NCT01490632|54251102|FG010|Part D: Re-Treatment Period|Death|0|||
27796440|NCT01490632|54251103|FG011|Part D: Re-Treatment Period|Death|0|||
27796441|NCT01490632|54251104|FG012|Part D: Re-Treatment Period|Death|0|||
27796442|NCT01490632|54251105|FG013|Part D: Re-Treatment Period|Death|0|||
27796443|NCT01490632|54251106|FG014|Part D: Re-Treatment Period|Death|0|||
27796444|NCT01490632|54251107|FG015|Part D: Re-Treatment Period|Death|0|||
27796445|NCT01490632|54251108|FG016|Part D: Re-Treatment Period|Death|0|||
27796446|NCT01490632|54251109|FG017|Part D: Re-Treatment Period|Death|0|||
27796447|NCT01490632|54251110|FG018|Part D: Re-Treatment Period|Death|1|||
27796448|NCT01490632|54251111|FG019|Part D: Re-Treatment Period|Death|0|||
27796449|NCT01490632|54251092|FG000|Part D: Re-Treatment Period|Lack of Efficacy|0|||
27796450|NCT01490632|54251093|FG001|Part D: Re-Treatment Period|Lack of Efficacy|0|||
27796451|NCT01490632|54251094|FG002|Part D: Re-Treatment Period|Lack of Efficacy|0|||
27796452|NCT01490632|54251095|FG003|Part D: Re-Treatment Period|Lack of Efficacy|0|||
27796453|NCT01490632|54251096|FG004|Part D: Re-Treatment Period|Lack of Efficacy|0|||
27796454|NCT01490632|54251097|FG005|Part D: Re-Treatment Period|Lack of Efficacy|0|||
27796455|NCT01490632|54251098|FG006|Part D: Re-Treatment Period|Lack of Efficacy|0|||
27796456|NCT01490632|54251099|FG007|Part D: Re-Treatment Period|Lack of Efficacy|0|||
27796457|NCT01490632|54251100|FG008|Part D: Re-Treatment Period|Lack of Efficacy|0|||
27796458|NCT01490632|54251101|FG009|Part D: Re-Treatment Period|Lack of Efficacy|0|||
27796459|NCT01490632|54251102|FG010|Part D: Re-Treatment Period|Lack of Efficacy|0|||
27796460|NCT01490632|54251103|FG011|Part D: Re-Treatment Period|Lack of Efficacy|0|||
27796461|NCT01490632|54251104|FG012|Part D: Re-Treatment Period|Lack of Efficacy|0|||
27796462|NCT01490632|54251105|FG013|Part D: Re-Treatment Period|Lack of Efficacy|0|||
27796463|NCT01490632|54251106|FG014|Part D: Re-Treatment Period|Lack of Efficacy|0|||
27796464|NCT01490632|54251107|FG015|Part D: Re-Treatment Period|Lack of Efficacy|0|||
27796465|NCT01490632|54251108|FG016|Part D: Re-Treatment Period|Lack of Efficacy|0|||
27796466|NCT01490632|54251109|FG017|Part D: Re-Treatment Period|Lack of Efficacy|3|||
27796467|NCT01490632|54251110|FG018|Part D: Re-Treatment Period|Lack of Efficacy|1|||
27796468|NCT01490632|54251111|FG019|Part D: Re-Treatment Period|Lack of Efficacy|2|||
27796469|NCT01490632|54251092|FG000|Part D: Re-Treatment Period|Lost to Follow-up|0|||
27796470|NCT01490632|54251093|FG001|Part D: Re-Treatment Period|Lost to Follow-up|0|||
27796471|NCT01490632|54251094|FG002|Part D: Re-Treatment Period|Lost to Follow-up|0|||
27796472|NCT01490632|54251095|FG003|Part D: Re-Treatment Period|Lost to Follow-up|0|||
27796473|NCT01490632|54251096|FG004|Part D: Re-Treatment Period|Lost to Follow-up|0|||
27796474|NCT01490632|54251097|FG005|Part D: Re-Treatment Period|Lost to Follow-up|0|||
27796475|NCT01490632|54251098|FG006|Part D: Re-Treatment Period|Lost to Follow-up|0|||
27796476|NCT01490632|54251099|FG007|Part D: Re-Treatment Period|Lost to Follow-up|0|||
27796477|NCT01490632|54251100|FG008|Part D: Re-Treatment Period|Lost to Follow-up|0|||
27796478|NCT01490632|54251101|FG009|Part D: Re-Treatment Period|Lost to Follow-up|0|||
27796479|NCT01490632|54251102|FG010|Part D: Re-Treatment Period|Lost to Follow-up|0|||
27796480|NCT01490632|54251103|FG011|Part D: Re-Treatment Period|Lost to Follow-up|0|||
27796481|NCT01490632|54251104|FG012|Part D: Re-Treatment Period|Lost to Follow-up|0|||
27796482|NCT01490632|54251105|FG013|Part D: Re-Treatment Period|Lost to Follow-up|0|||
27796483|NCT01490632|54251106|FG014|Part D: Re-Treatment Period|Lost to Follow-up|0|||
27796484|NCT01490632|54251107|FG015|Part D: Re-Treatment Period|Lost to Follow-up|0|||
27796485|NCT01490632|54251108|FG016|Part D: Re-Treatment Period|Lost to Follow-up|0|||
27796486|NCT01490632|54251109|FG017|Part D: Re-Treatment Period|Lost to Follow-up|0|||
27796487|NCT01490632|54251110|FG018|Part D: Re-Treatment Period|Lost to Follow-up|1|||
28017899|NCT00575588|54677133|FG000|Overall Study|Death|4|||
27796488|NCT01490632|54251111|FG019|Part D: Re-Treatment Period|Lost to Follow-up|0|||
27796489|NCT01490632|54251092|FG000|Part D: Re-Treatment Period|Physician Decision|0|||
27796490|NCT01490632|54251093|FG001|Part D: Re-Treatment Period|Physician Decision|0|||
27796491|NCT01490632|54251094|FG002|Part D: Re-Treatment Period|Physician Decision|0|||
27796492|NCT01490632|54251095|FG003|Part D: Re-Treatment Period|Physician Decision|0|||
27796493|NCT01490632|54251096|FG004|Part D: Re-Treatment Period|Physician Decision|0|||
27796494|NCT01490632|54251097|FG005|Part D: Re-Treatment Period|Physician Decision|0|||
27796495|NCT01490632|54251098|FG006|Part D: Re-Treatment Period|Physician Decision|0|||
27796496|NCT01490632|54251099|FG007|Part D: Re-Treatment Period|Physician Decision|0|||
27796497|NCT01490632|54251100|FG008|Part D: Re-Treatment Period|Physician Decision|0|||
27796498|NCT01490632|54251101|FG009|Part D: Re-Treatment Period|Physician Decision|0|||
27796499|NCT01490632|54251102|FG010|Part D: Re-Treatment Period|Physician Decision|0|||
27796500|NCT01490632|54251103|FG011|Part D: Re-Treatment Period|Physician Decision|0|||
27796501|NCT01490632|54251104|FG012|Part D: Re-Treatment Period|Physician Decision|0|||
27796502|NCT01490632|54251105|FG013|Part D: Re-Treatment Period|Physician Decision|0|||
27796503|NCT01490632|54251106|FG014|Part D: Re-Treatment Period|Physician Decision|0|||
27796504|NCT01490632|54251107|FG015|Part D: Re-Treatment Period|Physician Decision|0|||
27796505|NCT01490632|54251108|FG016|Part D: Re-Treatment Period|Physician Decision|0|||
27796506|NCT01490632|54251109|FG017|Part D: Re-Treatment Period|Physician Decision|0|||
27796507|NCT01490632|54251110|FG018|Part D: Re-Treatment Period|Physician Decision|1|||
27796508|NCT01490632|54251111|FG019|Part D: Re-Treatment Period|Physician Decision|1|||
27796509|NCT01490632|54251092|FG000|Part D: Re-Treatment Period|Protocol Violation|0|||
27796510|NCT01490632|54251093|FG001|Part D: Re-Treatment Period|Protocol Violation|0|||
27796511|NCT01490632|54251094|FG002|Part D: Re-Treatment Period|Protocol Violation|0|||
27796512|NCT01490632|54251095|FG003|Part D: Re-Treatment Period|Protocol Violation|0|||
27796513|NCT01490632|54251096|FG004|Part D: Re-Treatment Period|Protocol Violation|0|||
27796514|NCT01490632|54251097|FG005|Part D: Re-Treatment Period|Protocol Violation|0|||
28017900|NCT00575588|54677134|FG001|Overall Study|Death|2|||
27796515|NCT01490632|54251098|FG006|Part D: Re-Treatment Period|Protocol Violation|0|||
27796516|NCT01490632|54251099|FG007|Part D: Re-Treatment Period|Protocol Violation|0|||
27796517|NCT01490632|54251100|FG008|Part D: Re-Treatment Period|Protocol Violation|0|||
27796518|NCT01490632|54251101|FG009|Part D: Re-Treatment Period|Protocol Violation|0|||
28017901|NCT00575588|54677133|FG000|Overall Study|Incorrect enrollment|8|||
28017902|NCT00575588|54677134|FG001|Overall Study|Incorrect enrollment|4|||
28017903|NCT00575588|54677133|FG000|Overall Study|Study specific discontinuation criteria|203|||
28017904|NCT00575588|54677134|FG001|Overall Study|Study specific discontinuation criteria|218|||
28017905|NCT00575588|54677133|FG000|Overall Study|Severe non-compliance to protocol|5|||
28017906|NCT00575588|54677134|FG001|Overall Study|Severe non-compliance to protocol|7|||
28017907|NCT00575588|54677133|FG000|Overall Study|Safety reasons|2|||
28017908|NCT00575588|54677134|FG001|Overall Study|Safety reasons|1|||
28017909|NCT00575588|54677133|FG000|Overall Study|Elevated triglyceride|1|||
28017910|NCT00575588|54677134|FG001|Overall Study|Elevated triglyceride|0|||
28017911|NCT00575588|54677133|FG000|Overall Study|Patient moved|1|||
28017912|NCT00575588|54677134|FG001|Overall Study|Patient moved|3|||
28017913|NCT00575588|54677133|FG000|Overall Study|Impossible to determine HbA1c|0|||
28017914|NCT00575588|54677134|FG001|Overall Study|Impossible to determine HbA1c|1|||
28017915|NCT00675428|54677142|FG000|Overall Study|Disease Progression|2|||
28017916|NCT00675428|54677143|FG001|Overall Study|Disease Progression|2|||
28017917|NCT00675428|54677142|FG000|Overall Study|No Disease Response After Cycle 6|0|||
28017918|NCT00675428|54677143|FG001|Overall Study|No Disease Response After Cycle 6|1|||
28017919|NCT00675428|54677142|FG000|Overall Study|Physician Decision|1|||
28017920|NCT00675428|54677143|FG001|Overall Study|Physician Decision|0|||
28017921|NCT00557505|54677167|FG000|Overall Study|Death|0|||
28017922|NCT00557505|54677168|FG001|Overall Study|Death|0|||
28017923|NCT00557505|54677169|FG002|Overall Study|Death|0|||
27796519|NCT01490632|54251102|FG010|Part D: Re-Treatment Period|Protocol Violation|0|||
27796520|NCT01490632|54251103|FG011|Part D: Re-Treatment Period|Protocol Violation|0|||
27938097|NCT01072149|54594333|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
27938098|NCT01072149|54594334|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
27938099|NCT01072149|54594335|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
27938100|NCT01072149|54594336|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
27938101|NCT01072149|54594337|FG012|Washout Period 2 (14 Days)|Physician Decision|0|||
27938102|NCT01072149|54594338|FG013|Washout Period 2 (14 Days)|Physician Decision|0|||
27938103|NCT01072149|54594339|FG014|Washout Period 2 (14 Days)|Physician Decision|0|||
27938104|NCT01072149|54594340|FG015|Washout Period 2 (14 Days)|Physician Decision|0|||
27938105|NCT01072149|54594341|FG016|Washout Period 2 (14 Days)|Physician Decision|0|||
27938106|NCT01072149|54594342|FG017|Washout Period 2 (14 Days)|Physician Decision|0|||
28017924|NCT00557505|54677170|FG003|Overall Study|Death|0|||
28017925|NCT00557505|54677171|FG004|Overall Study|Death|0|||
28017926|NCT00557505|54677172|FG005|Overall Study|Death|0|||
28017927|NCT00557505|54677173|FG006|Overall Study|Death|0|||
28017928|NCT00557505|54677174|FG007|Overall Study|Death|0|||
28017929|NCT00557505|54677175|FG008|Overall Study|Death|1|||
28017930|NCT00557505|54677167|FG000|Overall Study|Adverse Event|0|||
28017931|NCT00557505|54677168|FG001|Overall Study|Adverse Event|0|||
28017932|NCT00557505|54677169|FG002|Overall Study|Adverse Event|1|||
28017933|NCT00557505|54677170|FG003|Overall Study|Adverse Event|0|||
28017934|NCT00557505|54677171|FG004|Overall Study|Adverse Event|0|||
28017935|NCT00557505|54677172|FG005|Overall Study|Adverse Event|0|||
28017936|NCT00557505|54677173|FG006|Overall Study|Adverse Event|1|||
28017937|NCT00557505|54677174|FG007|Overall Study|Adverse Event|0|||
28017938|NCT00557505|54677175|FG008|Overall Study|Adverse Event|0|||
28017939|NCT00557505|54677167|FG000|Overall Study|Global deterioration of health|1|||
28017940|NCT00557505|54677168|FG001|Overall Study|Global deterioration of health|0|||
27796521|NCT01490632|54251104|FG012|Part D: Re-Treatment Period|Protocol Violation|0|||
27796522|NCT01490632|54251105|FG013|Part D: Re-Treatment Period|Protocol Violation|0|||
27796523|NCT01490632|54251106|FG014|Part D: Re-Treatment Period|Protocol Violation|0|||
27796524|NCT01490632|54251107|FG015|Part D: Re-Treatment Period|Protocol Violation|0|||
27796525|NCT01490632|54251108|FG016|Part D: Re-Treatment Period|Protocol Violation|0|||
27796526|NCT01490632|54251109|FG017|Part D: Re-Treatment Period|Protocol Violation|0|||
27796527|NCT01490632|54251110|FG018|Part D: Re-Treatment Period|Protocol Violation|1|||
27796528|NCT01490632|54251111|FG019|Part D: Re-Treatment Period|Protocol Violation|0|||
27796529|NCT01490632|54251092|FG000|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
27796530|NCT01490632|54251093|FG001|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
27796531|NCT01490632|54251094|FG002|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
27796532|NCT01490632|54251095|FG003|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
27796533|NCT01490632|54251096|FG004|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
27796534|NCT01490632|54251097|FG005|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
27796535|NCT01490632|54251098|FG006|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
27796536|NCT01490632|54251099|FG007|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
27796537|NCT01490632|54251100|FG008|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
27796538|NCT01490632|54251101|FG009|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
27796539|NCT01490632|54251102|FG010|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
27796540|NCT01490632|54251103|FG011|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
27796541|NCT01490632|54251104|FG012|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
27796542|NCT01490632|54251105|FG013|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
27796543|NCT01490632|54251106|FG014|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
27796544|NCT01490632|54251107|FG015|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
28017941|NCT00557505|54677169|FG002|Overall Study|Global deterioration of health|0|||
28017942|NCT00557505|54677170|FG003|Overall Study|Global deterioration of health|0|||
28017943|NCT00557505|54677171|FG004|Overall Study|Global deterioration of health|0|||
28017944|NCT00557505|54677172|FG005|Overall Study|Global deterioration of health|0|||
28017945|NCT00557505|54677173|FG006|Overall Study|Global deterioration of health|0|||
28017946|NCT00557505|54677174|FG007|Overall Study|Global deterioration of health|0|||
28017947|NCT00557505|54677175|FG008|Overall Study|Global deterioration of health|0|||
28017948|NCT00557505|54677167|FG000|Overall Study|Objective progression or relapse|2|||
28017949|NCT00557505|54677168|FG001|Overall Study|Objective progression or relapse|3|||
28017950|NCT00557505|54677169|FG002|Overall Study|Objective progression or relapse|3|||
28017951|NCT00557505|54677170|FG003|Overall Study|Objective progression or relapse|2|||
28017952|NCT00557505|54677171|FG004|Overall Study|Objective progression or relapse|2|||
28017953|NCT00557505|54677172|FG005|Overall Study|Objective progression or relapse|3|||
28017954|NCT00557505|54677173|FG006|Overall Study|Objective progression or relapse|2|||
28017955|NCT00557505|54677174|FG007|Overall Study|Objective progression or relapse|5|||
28017956|NCT00557505|54677175|FG008|Overall Study|Objective progression or relapse|15|||
28017957|NCT00557505|54677167|FG000|Overall Study|Withdrawal by Subject|0|||
28017958|NCT00557505|54677168|FG001|Overall Study|Withdrawal by Subject|0|||
27796545|NCT01490632|54251108|FG016|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
27796546|NCT01490632|54251109|FG017|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
27842747|NCT01548404|54331517|FG000|Overall Study|Inadequate response to study treatment|23|||
27842748|NCT01548404|54331518|FG001|Overall Study|Inadequate response to study treatment|7|||
28017959|NCT00557505|54677169|FG002|Overall Study|Withdrawal by Subject|0|||
28017960|NCT00557505|54677170|FG003|Overall Study|Withdrawal by Subject|1|||
28017961|NCT00557505|54677171|FG004|Overall Study|Withdrawal by Subject|0|||
28017962|NCT00557505|54677172|FG005|Overall Study|Withdrawal by Subject|0|||
28017963|NCT00557505|54677173|FG006|Overall Study|Withdrawal by Subject|0|||
28017964|NCT00557505|54677174|FG007|Overall Study|Withdrawal by Subject|0|||
28017965|NCT00557505|54677175|FG008|Overall Study|Withdrawal by Subject|1|||
28017966|NCT00674570|54677201|FG000|Overall Study|Withdrawal by Subject|0|||
28017967|NCT00674570|54677202|FG001|Overall Study|Withdrawal by Subject|2|||
28017968|NCT00674570|54677203|FG002|Overall Study|Withdrawal by Subject|0|||
28017969|NCT00561951|54677214|FG000|Overall Study|Adverse Event|11|||
28017970|NCT00561951|54677215|FG001|Overall Study|Adverse Event|14|||
28017971|NCT00561951|54677216|FG002|Overall Study|Adverse Event|14|||
28017972|NCT00561951|54677214|FG000|Overall Study|Lack of Efficacy|5|||
27796547|NCT01490632|54251110|FG018|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
27796548|NCT01490632|54251111|FG019|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
27796549|NCT02073643|54251154|FG000|Overall Study|Lost to Follow-up|24|||
28017973|NCT00561951|54677215|FG001|Overall Study|Lack of Efficacy|3|||
28017974|NCT00561951|54677216|FG002|Overall Study|Lack of Efficacy|2|||
28017975|NCT00561951|54677214|FG000|Overall Study|Lost to Follow-up|1|||
28017976|NCT00561951|54677215|FG001|Overall Study|Lost to Follow-up|1|||
28017977|NCT00561951|54677216|FG002|Overall Study|Lost to Follow-up|0|||
28017978|NCT00561951|54677214|FG000|Overall Study|Withdrawal by Subject|10|||
28017979|NCT00561951|54677215|FG001|Overall Study|Withdrawal by Subject|9|||
28017980|NCT00561951|54677216|FG002|Overall Study|Withdrawal by Subject|10|||
28017981|NCT00561951|54677214|FG000|Overall Study|Protocol Violation|4|||
28017982|NCT00561951|54677215|FG001|Overall Study|Protocol Violation|3|||
28017983|NCT00561951|54677216|FG002|Overall Study|Protocol Violation|4|||
28017984|NCT00561951|54677214|FG000|Overall Study|Physician Decision|1|||
28017985|NCT00561951|54677215|FG001|Overall Study|Physician Decision|0|||
28017986|NCT00561951|54677216|FG002|Overall Study|Physician Decision|0|||
27796550|NCT01451554|54251160|FG000|Overall Study|Withdrawal by Subject|14|||
27796551|NCT01451554|54251161|FG001|Overall Study|Withdrawal by Subject|9|||
27796552|NCT01474486|54251167|FG000|Overall Study|Death|2|||
27796553|NCT01474486|54251167|FG000|Overall Study|Withdrawal by Subject|4|||
27796554|NCT01474486|54251167|FG000|Overall Study|Withdrawn by the PI: One didn't understand what he consented for and one required surgery.|2|||
27796555|NCT01451398|54251177|FG000|Overall Study|Adverse Event|7|||
27796556|NCT01451398|54251178|FG001|Overall Study|Adverse Event|9|||
27796557|NCT01451398|54251177|FG000|Overall Study|Protocol Violation|1|||
27796558|NCT01451398|54251178|FG001|Overall Study|Protocol Violation|2|||
27796559|NCT01451398|54251177|FG000|Overall Study|Physician Decision|1|||
27796560|NCT01451398|54251178|FG001|Overall Study|Physician Decision|1|||
27796561|NCT01451398|54251177|FG000|Overall Study|Withdrawal by Subject|10|||
27796562|NCT01451398|54251178|FG001|Overall Study|Withdrawal by Subject|14|||
27796563|NCT01451398|54251177|FG000|Overall Study|Lost to Follow-up|6|||
27796564|NCT01451398|54251178|FG001|Overall Study|Lost to Follow-up|4|||
27796565|NCT01451398|54251177|FG000|Overall Study|Non-compliance with study drug|1|||
27796566|NCT01451398|54251178|FG001|Overall Study|Non-compliance with study drug|3|||
27796567|NCT01451398|54251177|FG000|Overall Study|Non-compliance with protocol|1|||
27796568|NCT01451398|54251178|FG001|Overall Study|Non-compliance with protocol|1|||
27796569|NCT01451398|54251177|FG000|Overall Study|Moved out of country|0|||
27796570|NCT01451398|54251178|FG001|Overall Study|Moved out of country|1|||
27796571|NCT01451398|54251177|FG000|Overall Study|Adverse Event + Elevated Fasting Glucose|0|||
27796572|NCT01451398|54251178|FG001|Overall Study|Adverse Event + Elevated Fasting Glucose|1|||
27796573|NCT01451398|54251177|FG000|Overall Study|Lack of Efficacy|0|||
27796574|NCT01451398|54251178|FG001|Overall Study|Lack of Efficacy|1|||
27796575|NCT02073565|54251186|FG000|Cohort A|Withdrawal by Subject|1|||
27796576|NCT02073565|54251187|FG001|Cohort A|Withdrawal by Subject|0|||
27796577|NCT02073565|54251186|FG000|Cohort B|Withdrawal by Subject|1|||
27796578|NCT02073565|54251187|FG001|Cohort B|Withdrawal by Subject|2|||
27796579|NCT02073565|54251186|FG000|Cohort C|Withdrawal by Subject|0|||
27796580|NCT02073565|54251187|FG001|Cohort C|Withdrawal by Subject|2|||
27796581|NCT02073565|54251186|FG000|Cohort C|Lost to Follow-up|0|||
27796582|NCT02073565|54251187|FG001|Cohort C|Lost to Follow-up|2|||
27796583|NCT02072941|54251195|FG000|Overall Study|Withdrawal by Subject|29|||
27796584|NCT02072941|54251196|FG001|Overall Study|Withdrawal by Subject|21|||
27796585|NCT02072941|54251195|FG000|Overall Study|Lost to Follow-up|4|||
27796586|NCT02072941|54251196|FG001|Overall Study|Lost to Follow-up|4|||
27796587|NCT02072941|54251195|FG000|Overall Study|Death|3|||
27796588|NCT02072941|54251196|FG001|Overall Study|Death|2|||
27796589|NCT02072941|54251195|FG000|Overall Study|Removed by Study Staff|2|||
27796590|NCT02072941|54251196|FG001|Overall Study|Removed by Study Staff|2|||
27796591|NCT02100631|54251205|FG000|Overall Study|Withdrawal by Subject|1|||
27796592|NCT02100631|54251206|FG001|Overall Study|Withdrawal by Subject|0|||
27796593|NCT02100631|54251207|FG002|Overall Study|Withdrawal by Subject|0|||
27796594|NCT02100631|54251205|FG000|Overall Study|Lost to Follow-up|3|||
27796595|NCT02100631|54251206|FG001|Overall Study|Lost to Follow-up|4|||
27796596|NCT02100631|54251207|FG002|Overall Study|Lost to Follow-up|0|||
28017987|NCT00561951|54677214|FG000|Overall Study|Pregnancy|0|||
28017988|NCT00561951|54677215|FG001|Overall Study|Pregnancy|1|||
27796597|NCT02100631|54251205|FG000|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|3|||
27796598|NCT02100631|54251206|FG001|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
27796599|NCT02100631|54251207|FG002|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
27796600|NCT01451164|54251219|FG000|Overall Study|Adverse Event|19|||
27796601|NCT01451164|54251220|FG001|Overall Study|Adverse Event|12|||
27796602|NCT01451164|54251221|FG002|Overall Study|Adverse Event|18|||
27796603|NCT01451164|54251222|FG003|Overall Study|Adverse Event|21|||
27796604|NCT01451164|54251219|FG000|Overall Study|Withdrawal Criteria|1|||
28017989|NCT00561951|54677216|FG002|Overall Study|Pregnancy|0|||
28017990|NCT00561951|54677214|FG000|Overall Study|Meet Withdrawal Criterion|0|||
28017991|NCT00561951|54677215|FG001|Overall Study|Meet Withdrawal Criterion|1|||
27796605|NCT01451164|54251220|FG001|Overall Study|Withdrawal Criteria|1|||
28017992|NCT00561951|54677216|FG002|Overall Study|Meet Withdrawal Criterion|1|||
27796606|NCT01451164|54251221|FG002|Overall Study|Withdrawal Criteria|1|||
27796607|NCT01451164|54251222|FG003|Overall Study|Withdrawal Criteria|1|||
27796608|NCT01451164|54251219|FG000|Overall Study|Physician Decision|2|||
27796609|NCT01451164|54251220|FG001|Overall Study|Physician Decision|0|||
27796610|NCT01451164|54251221|FG002|Overall Study|Physician Decision|1|||
27796611|NCT01451164|54251222|FG003|Overall Study|Physician Decision|0|||
27796612|NCT01451164|54251219|FG000|Overall Study|Withdrawal by Subject|14|||
27796613|NCT01451164|54251220|FG001|Overall Study|Withdrawal by Subject|11|||
27796614|NCT01451164|54251221|FG002|Overall Study|Withdrawal by Subject|16|||
27796615|NCT01451164|54251222|FG003|Overall Study|Withdrawal by Subject|17|||
27796616|NCT01451164|54251219|FG000|Overall Study|Protocol Violation|0|||
27796617|NCT01451164|54251220|FG001|Overall Study|Protocol Violation|1|||
27796618|NCT01451164|54251221|FG002|Overall Study|Protocol Violation|0|||
27796619|NCT01451164|54251222|FG003|Overall Study|Protocol Violation|0|||
27796620|NCT01451164|54251219|FG000|Overall Study|Lack of Efficacy|7|||
27796621|NCT01451164|54251220|FG001|Overall Study|Lack of Efficacy|9|||
27796622|NCT01451164|54251221|FG002|Overall Study|Lack of Efficacy|9|||
27796623|NCT01451164|54251222|FG003|Overall Study|Lack of Efficacy|7|||
27796624|NCT02071849|54251232|FG000|6-month Primary Endpoint|Did not receive device|4|||
27796625|NCT02071849|54251232|FG000|6-month Primary Endpoint|Adverse Event|1|||
27796626|NCT02071849|54251232|FG000|2-year Extended Follow-up|Adverse Event|1|||
27796627|NCT02071771|54251236|FG000|Period 1: First 10 Days|Unacceptable lens fit|1|||
27796628|NCT02071771|54251237|FG001|Period 1: First 10 Days|Unacceptable lens fit|0|||
27796629|NCT02071771|54251236|FG000|Period 1: First 10 Days|Unavailable lens power|1|||
27796630|NCT02071771|54251237|FG001|Period 1: First 10 Days|Unavailable lens power|0|||
27796631|NCT02071225|54251243|FG000|Overall Study|Withdrawal of Consent|2|||
27796632|NCT02071225|54251243|FG000|Overall Study|Protocol Deviation|1|||
27796633|NCT02071225|54251243|FG000|Overall Study|Lost to Follow-up|2|||
27796634|NCT02071225|54251243|FG000|Overall Study|Death|25|||
27796635|NCT01450696|54251249|FG000|Overall Study|Never Treated|1|||
27796636|NCT01450696|54251250|FG001|Overall Study|Never Treated|1|||
27796637|NCT01450696|54251249|FG000|Overall Study|Death|77|||
27796638|NCT01450696|54251250|FG001|Overall Study|Death|84|||
27796639|NCT01450696|54251249|FG000|Overall Study|Lost to Follow-up|3|||
27796640|NCT01450696|54251250|FG001|Overall Study|Lost to Follow-up|3|||
27796641|NCT01450696|54251249|FG000|Overall Study|Non-Compliance|1|||
27796642|NCT01450696|54251250|FG001|Overall Study|Non-Compliance|0|||
27796643|NCT01450696|54251249|FG000|Overall Study|Withdrawal by Subject|13|||
27796644|NCT01450696|54251250|FG001|Overall Study|Withdrawal by Subject|2|||
27796645|NCT01450696|54251249|FG000|Overall Study|Study Terminated by Sponsor|53|||
27796646|NCT01450696|54251250|FG001|Overall Study|Study Terminated by Sponsor|58|||
27796647|NCT02070991|54251258|FG000|Overall Study|Death|2|||
27796648|NCT02070991|54251259|FG001|Overall Study|Death|0|||
28017993|NCT00561951|54677214|FG000|Overall Study|Adverse Event Occured Before Treatment|1|||
28017994|NCT00561951|54677215|FG001|Overall Study|Adverse Event Occured Before Treatment|2|||
28017995|NCT00561951|54677216|FG002|Overall Study|Adverse Event Occured Before Treatment|1|||
28017996|NCT00322387|54677226|FG000|Treatment Period|Adverse Event|0|||
28017997|NCT00322387|54677227|FG001|Treatment Period|Adverse Event|1|||
28017998|NCT00322387|54677226|FG000|Follow-up Period|Final assessment not done|1|||
28017999|NCT00322387|54677227|FG001|Follow-up Period|Final assessment not done|3|||
28018000|NCT00322387|54677226|FG000|Follow-up Period|Death|1|||
28018001|NCT00322387|54677227|FG001|Follow-up Period|Death|0|||
28018002|NCT00561015|54677250|FG000|Overall Study|Adverse Event|0|||
28018003|NCT00561015|54677251|FG001|Overall Study|Adverse Event|0|||
28018004|NCT00561015|54677252|FG002|Overall Study|Adverse Event|0|||
28018005|NCT00561015|54677253|FG003|Overall Study|Adverse Event|0|||
28018006|NCT00561015|54677254|FG004|Overall Study|Adverse Event|1|||
28018007|NCT00561015|54677255|FG005|Overall Study|Adverse Event|0|||
28018008|NCT00561015|54677250|FG000|Overall Study|Lost to Follow-up|2|||
28018009|NCT00561015|54677251|FG001|Overall Study|Lost to Follow-up|0|||
28018010|NCT00561015|54677252|FG002|Overall Study|Lost to Follow-up|0|||
28018011|NCT00561015|54677253|FG003|Overall Study|Lost to Follow-up|1|||
28018012|NCT00561015|54677254|FG004|Overall Study|Lost to Follow-up|0|||
28018013|NCT00561015|54677255|FG005|Overall Study|Lost to Follow-up|3|||
27796649|NCT02070991|54251258|FG000|Overall Study|Withdrawal by Subject|1|||
27796650|NCT02070991|54251259|FG001|Overall Study|Withdrawal by Subject|0|||
27796651|NCT02114515|54251267|FG000|Overall Study|Lost to Follow-up|52|||
27796652|NCT02114515|54251268|FG001|Overall Study|Lost to Follow-up|55|||
27796653|NCT02114515|54251267|FG000|Overall Study|Death|12|||
27796654|NCT02114515|54251268|FG001|Overall Study|Death|12|||
27796655|NCT02114515|54251267|FG000|Overall Study|Withdrawal by Subject|4|||
27796656|NCT02114515|54251268|FG001|Overall Study|Withdrawal by Subject|22|||
27796657|NCT02114515|54251267|FG000|Overall Study|Other|65|||
28018014|NCT00561015|54677250|FG000|Overall Study|Participant non-compliance|2|||
28018015|NCT00561015|54677251|FG001|Overall Study|Participant non-compliance|0|||
28018016|NCT00561015|54677252|FG002|Overall Study|Participant non-compliance|0|||
28018017|NCT00561015|54677253|FG003|Overall Study|Participant non-compliance|0|||
27796658|NCT02114515|54251268|FG001|Overall Study|Other|61|||
27796659|NCT01490086|54251279|FG000|Overall Study|Consent withdrawn|4|||
27796660|NCT01490086|54251280|FG001|Overall Study|Consent withdrawn|4|||
27796661|NCT01490086|54251281|FG002|Overall Study|Consent withdrawn|3|||
27796662|NCT01490086|54251282|FG003|Overall Study|Consent withdrawn|0|||
27796663|NCT01490086|54251283|FG004|Overall Study|Consent withdrawn|1|||
27796664|NCT01490086|54251279|FG000|Overall Study|Non-compliance|0|||
27796665|NCT01490086|54251280|FG001|Overall Study|Non-compliance|1|||
27796666|NCT01490086|54251281|FG002|Overall Study|Non-compliance|0|||
27796667|NCT01490086|54251282|FG003|Overall Study|Non-compliance|0|||
27796668|NCT01490086|54251283|FG004|Overall Study|Non-compliance|0|||
27796669|NCT01490086|54251279|FG000|Overall Study|Abnormal laboratory findings|1|||
27796670|NCT01490086|54251280|FG001|Overall Study|Abnormal laboratory findings|0|||
27796671|NCT01490086|54251281|FG002|Overall Study|Abnormal laboratory findings|0|||
27796672|NCT01490086|54251282|FG003|Overall Study|Abnormal laboratory findings|0|||
27796673|NCT01490086|54251283|FG004|Overall Study|Abnormal laboratory findings|0|||
27796674|NCT01490086|54251279|FG000|Overall Study|Lost to Follow-up|0|||
27796675|NCT01490086|54251280|FG001|Overall Study|Lost to Follow-up|0|||
27796676|NCT01490086|54251281|FG002|Overall Study|Lost to Follow-up|0|||
27796677|NCT01490086|54251282|FG003|Overall Study|Lost to Follow-up|0|||
27796678|NCT01490086|54251283|FG004|Overall Study|Lost to Follow-up|1|||
27796679|NCT01490086|54251279|FG000|Overall Study|Physician Decision|3|||
27796680|NCT01490086|54251280|FG001|Overall Study|Physician Decision|4|||
27796681|NCT01490086|54251281|FG002|Overall Study|Physician Decision|2|||
27796682|NCT01490086|54251282|FG003|Overall Study|Physician Decision|3|||
27796683|NCT01490086|54251283|FG004|Overall Study|Physician Decision|1|||
27796684|NCT01490086|54251279|FG000|Overall Study|Adverse Event|0|||
27796685|NCT01490086|54251280|FG001|Overall Study|Adverse Event|0|||
27796686|NCT01490086|54251281|FG002|Overall Study|Adverse Event|1|||
27796687|NCT01490086|54251282|FG003|Overall Study|Adverse Event|2|||
27796688|NCT01490086|54251283|FG004|Overall Study|Adverse Event|0|||
27796689|NCT01490086|54251279|FG000|Overall Study|Lack of Efficacy|0|||
27796690|NCT01490086|54251280|FG001|Overall Study|Lack of Efficacy|3|||
27796691|NCT01490086|54251281|FG002|Overall Study|Lack of Efficacy|1|||
27796692|NCT01490086|54251282|FG003|Overall Study|Lack of Efficacy|0|||
27796693|NCT01490086|54251283|FG004|Overall Study|Lack of Efficacy|8|||
27796694|NCT01490086|54251279|FG000|Overall Study|Worsening of symptoms|0|||
27796695|NCT01490086|54251280|FG001|Overall Study|Worsening of symptoms|1|||
27796696|NCT01490086|54251281|FG002|Overall Study|Worsening of symptoms|0|||
27796697|NCT01490086|54251282|FG003|Overall Study|Worsening of symptoms|1|||
27796698|NCT01490086|54251283|FG004|Overall Study|Worsening of symptoms|0|||
27796699|NCT01490086|54251279|FG000|Overall Study|Subject uncontrollable and abusive|0|||
27796700|NCT01490086|54251280|FG001|Overall Study|Subject uncontrollable and abusive|1|||
27796701|NCT01490086|54251281|FG002|Overall Study|Subject uncontrollable and abusive|0|||
27796702|NCT01490086|54251282|FG003|Overall Study|Subject uncontrollable and abusive|0|||
27796703|NCT01490086|54251283|FG004|Overall Study|Subject uncontrollable and abusive|0|||
27796704|NCT01490086|54251279|FG000|Overall Study|Subject left hospital|0|||
27796705|NCT01490086|54251280|FG001|Overall Study|Subject left hospital|1|||
27796706|NCT01490086|54251281|FG002|Overall Study|Subject left hospital|0|||
27796707|NCT01490086|54251282|FG003|Overall Study|Subject left hospital|1|||
27796708|NCT01490086|54251283|FG004|Overall Study|Subject left hospital|0|||
27796709|NCT02114203|54251298|FG000|Overall Study|Adverse Event|0|||
27796710|NCT02114203|54251299|FG001|Overall Study|Adverse Event|1|||
27796711|NCT02114203|54251300|FG002|Overall Study|Adverse Event|0|||
27796712|NCT02114203|54251298|FG000|Overall Study|Withdrawal by Subject|0|||
27796713|NCT02114203|54251299|FG001|Overall Study|Withdrawal by Subject|1|||
27796714|NCT02114203|54251300|FG002|Overall Study|Withdrawal by Subject|0|||
27796715|NCT02113579|54251310|FG000|Overall Study|Adverse Event|1|||
27796716|NCT02113579|54251311|FG001|Overall Study|Adverse Event|0|||
27796717|NCT02113579|54251310|FG000|Overall Study|Withdrawal by Subject|3|||
27796718|NCT02113579|54251311|FG001|Overall Study|Withdrawal by Subject|2|||
27796719|NCT02113579|54251310|FG000|Overall Study|Lost to Follow-up|6|||
28018018|NCT00561015|54677254|FG004|Overall Study|Participant non-compliance|0|||
28018019|NCT00561015|54677255|FG005|Overall Study|Participant non-compliance|0|||
27796720|NCT02113579|54251311|FG001|Overall Study|Lost to Follow-up|2|||
27796721|NCT01474018|54251319|FG000|Overall Study|Lost to Follow-up|0|||
27796722|NCT01474018|54251320|FG001|Overall Study|Lost to Follow-up|1|||
27796723|NCT01474018|54251319|FG000|Overall Study|Withdrawal by Subject|0|||
27796724|NCT01474018|54251320|FG001|Overall Study|Withdrawal by Subject|2|||
27796725|NCT02100475|54251328|FG000|Overall Study|Unclassified|1|||
27796726|NCT02100475|54251329|FG001|Overall Study|Unclassified|2|||
28018020|NCT00560937|54677275|FG000|Overall Study|Withdrawal by Subject|0|||
27796727|NCT02100475|54251328|FG000|Overall Study|Withdrawal criteria|1|||
27796728|NCT02100475|54251329|FG001|Overall Study|Withdrawal criteria|0|||
27796729|NCT02113189|54251338|FG000|Overall Study|Lost to follow up|2|||
27796730|NCT02113189|54251339|FG001|Overall Study|Lost to follow up|1|||
27796731|NCT02113189|54251340|FG002|Overall Study|Lost to follow up|3|||
27796732|NCT01440946|54251353|FG000|Overall Study|Lost to Follow-up|1|||
27796733|NCT01440946|54251354|FG001|Overall Study|Lost to Follow-up|1|||
27796734|NCT01440946|54251353|FG000|Overall Study|Physician Decision|1|||
27796735|NCT01440946|54251354|FG001|Overall Study|Physician Decision|0|||
27796736|NCT01450540|54251363|FG000|Overall Study|Withdrawal by Subject|19|||
27796737|NCT01450540|54251364|FG001|Overall Study|Withdrawal by Subject|13|||
27796738|NCT01450540|54251363|FG000|Overall Study|protocol deviation|3|||
27796739|NCT01450540|54251364|FG001|Overall Study|protocol deviation|23|||
27796740|NCT02070757|54251374|FG000|Overall Study|Adverse Event|107|||
27796741|NCT02070757|54251375|FG001|Overall Study|Adverse Event|99|||
27796742|NCT02070757|54251374|FG000|Overall Study|Lost to Follow-up|7|||
27796743|NCT02070757|54251375|FG001|Overall Study|Lost to Follow-up|4|||
27796744|NCT02070757|54251374|FG000|Overall Study|Protocol Violation|0|||
27796745|NCT02070757|54251375|FG001|Overall Study|Protocol Violation|4|||
27796746|NCT02070757|54251374|FG000|Overall Study|Withdrawal by Subject|1|||
27796747|NCT02070757|54251375|FG001|Overall Study|Withdrawal by Subject|3|||
27796748|NCT02070757|54251374|FG000|Overall Study|Investigator Decision|0|||
27796749|NCT02070757|54251375|FG001|Overall Study|Investigator Decision|2|||
27796750|NCT02070757|54251374|FG000|Overall Study|Discharged from Study Hospital|2|||
27796751|NCT02070757|54251375|FG001|Overall Study|Discharged from Study Hospital|2|||
27796752|NCT02100319|54251381|FG000|Overall Study|Case Report Forms Uncollected|11|||
27796753|NCT02100319|54251381|FG000|Overall Study|Protocol Deviation|5|||
27796754|NCT01625845|54251387|FG000|Overall Study|Adverse Event|1|||
27796755|NCT01625845|54251388|FG001|Overall Study|Adverse Event|2|||
27938107|NCT01072149|54594325|FG000|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
27938108|NCT01072149|54594326|FG001|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
28018021|NCT00560937|54677276|FG001|Overall Study|Withdrawal by Subject|1|||
28018022|NCT00560937|54677275|FG000|Overall Study|Physician Decision|1|||
28018023|NCT00560937|54677276|FG001|Overall Study|Physician Decision|1|||
28018024|NCT00561795|54677284|FG000|Overall Study|Adverse Event|3|||
28018025|NCT00561795|54677285|FG001|Overall Study|Adverse Event|3|||
28018026|NCT00561795|54677286|FG002|Overall Study|Adverse Event|0|||
28018027|NCT00561795|54677287|FG003|Overall Study|Adverse Event|0|||
28018028|NCT00561795|54677284|FG000|Overall Study|Study Closed/Terminated|0|||
28018029|NCT00561795|54677285|FG001|Overall Study|Study Closed/Terminated|3|||
28018030|NCT00561795|54677286|FG002|Overall Study|Study Closed/Terminated|0|||
28018031|NCT00561795|54677287|FG003|Overall Study|Study Closed/Terminated|0|||
28018032|NCT00561795|54677284|FG000|Overall Study|Physician Decision|1|||
28018033|NCT00561795|54677285|FG001|Overall Study|Physician Decision|0|||
28018034|NCT00561795|54677286|FG002|Overall Study|Physician Decision|0|||
28018035|NCT00561795|54677287|FG003|Overall Study|Physician Decision|0|||
28018036|NCT00652626|54677302|FG000|Initial Treatment Phase|Adverse Event|0|||
28018037|NCT00652626|54677303|FG001|Initial Treatment Phase|Adverse Event|0|||
28018038|NCT00652626|54677304|FG002|Initial Treatment Phase|Adverse Event|0|||
28018039|NCT00652626|54677305|FG003|Initial Treatment Phase|Adverse Event|0|||
28018040|NCT00652626|54677306|FG004|Initial Treatment Phase|Adverse Event|1|||
27796756|NCT01625845|54251387|FG000|Overall Study|Lost to Follow-up|2|||
27796757|NCT01625845|54251388|FG001|Overall Study|Lost to Follow-up|1|||
27796758|NCT01625845|54251387|FG000|Overall Study|Withdrawal by Subject|2|||
27796759|NCT01625845|54251388|FG001|Overall Study|Withdrawal by Subject|0|||
27796760|NCT01473940|54251398|FG000|Induction Therapy|Death|0|||
27938109|NCT01072149|54594327|FG002|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
27938110|NCT01072149|54594328|FG003|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
27938111|NCT01072149|54594329|FG004|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
27938112|NCT01072149|54594330|FG005|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
27938113|NCT01072149|54594331|FG006|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
27938114|NCT01072149|54594332|FG007|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
27938115|NCT01072149|54594333|FG008|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
27938116|NCT01072149|54594334|FG009|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
27938117|NCT01072149|54594335|FG010|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
27938118|NCT01072149|54594336|FG011|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
27938119|NCT01072149|54594337|FG012|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
27938120|NCT01072149|54594338|FG013|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
27938121|NCT01072149|54594339|FG014|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
28018041|NCT00652626|54677307|FG005|Initial Treatment Phase|Adverse Event|0|||
28018042|NCT00652626|54677308|FG006|Initial Treatment Phase|Adverse Event|0|||
28018043|NCT00652626|54677302|FG000|Initial Treatment Phase|Protocol Violation|0|||
28018044|NCT00652626|54677303|FG001|Initial Treatment Phase|Protocol Violation|0|||
28018045|NCT00652626|54677304|FG002|Initial Treatment Phase|Protocol Violation|0|||
28018046|NCT00652626|54677305|FG003|Initial Treatment Phase|Protocol Violation|1|||
28018047|NCT00652626|54677306|FG004|Initial Treatment Phase|Protocol Violation|0|||
28018048|NCT00652626|54677307|FG005|Initial Treatment Phase|Protocol Violation|0|||
28018049|NCT00652626|54677308|FG006|Initial Treatment Phase|Protocol Violation|0|||
28018050|NCT00652626|54677302|FG000|Initial Treatment Phase|Physician Decision|0|||
27796761|NCT01473940|54251399|FG001|Induction Therapy|Death|0|||
27796762|NCT01473940|54251400|FG002|Induction Therapy|Death|1|||
27796763|NCT01473940|54251401|FG003|Induction Therapy|Death|1|||
27796764|NCT01473940|54251398|FG000|Induction Therapy|Progressive Disease|0|||
27796765|NCT01473940|54251399|FG001|Induction Therapy|Progressive Disease|1|||
27796766|NCT01473940|54251400|FG002|Induction Therapy|Progressive Disease|1|||
27796767|NCT01473940|54251401|FG003|Induction Therapy|Progressive Disease|0|||
27796768|NCT01473940|54251398|FG000|Maintenance Therapy|Progressive Disease|1|||
27796769|NCT01473940|54251399|FG001|Maintenance Therapy|Progressive Disease|2|||
27796770|NCT01473940|54251400|FG002|Maintenance Therapy|Progressive Disease|1|||
27796771|NCT01473940|54251401|FG003|Maintenance Therapy|Progressive Disease|4|||
27796772|NCT01832727|54251423|FG000|Overall Study|Adverse Event|4|||
27796773|NCT01832727|54251424|FG001|Overall Study|Adverse Event|6|||
27796774|NCT01832727|54251425|FG002|Overall Study|Adverse Event|1|||
27796775|NCT01832727|54251426|FG003|Overall Study|Adverse Event|0|||
27796776|NCT01832727|54251427|FG004|Overall Study|Adverse Event|1|||
27796777|NCT01832727|54251428|FG005|Overall Study|Adverse Event|1|||
27796778|NCT01832727|54251429|FG006|Overall Study|Adverse Event|2|||
27796779|NCT01832727|54251430|FG007|Overall Study|Adverse Event|1|||
27796780|NCT01832727|54251431|FG008|Overall Study|Adverse Event|9|||
27796781|NCT01832727|54251423|FG000|Overall Study|Disease progression|3|||
27796782|NCT01832727|54251424|FG001|Overall Study|Disease progression|0|||
27796783|NCT01832727|54251425|FG002|Overall Study|Disease progression|2|||
27796784|NCT01832727|54251426|FG003|Overall Study|Disease progression|1|||
27796785|NCT01832727|54251427|FG004|Overall Study|Disease progression|3|||
27796786|NCT01832727|54251428|FG005|Overall Study|Disease progression|3|||
27796787|NCT01832727|54251429|FG006|Overall Study|Disease progression|6|||
27796788|NCT01832727|54251430|FG007|Overall Study|Disease progression|2|||
27796789|NCT01832727|54251431|FG008|Overall Study|Disease progression|7|||
27796790|NCT01832727|54251423|FG000|Overall Study|Lost to Follow-up|0|||
27796791|NCT01832727|54251424|FG001|Overall Study|Lost to Follow-up|0|||
27796792|NCT01832727|54251425|FG002|Overall Study|Lost to Follow-up|0|||
27796793|NCT01832727|54251426|FG003|Overall Study|Lost to Follow-up|1|||
27796794|NCT01832727|54251427|FG004|Overall Study|Lost to Follow-up|0|||
27796795|NCT01832727|54251428|FG005|Overall Study|Lost to Follow-up|0|||
27796796|NCT01832727|54251429|FG006|Overall Study|Lost to Follow-up|0|||
27796797|NCT01832727|54251430|FG007|Overall Study|Lost to Follow-up|0|||
27796798|NCT01832727|54251431|FG008|Overall Study|Lost to Follow-up|0|||
27796799|NCT01832727|54251423|FG000|Overall Study|Physician Decision|1|||
27796800|NCT01832727|54251424|FG001|Overall Study|Physician Decision|0|||
27796801|NCT01832727|54251425|FG002|Overall Study|Physician Decision|0|||
27796802|NCT01832727|54251426|FG003|Overall Study|Physician Decision|1|||
27796803|NCT01832727|54251427|FG004|Overall Study|Physician Decision|0|||
27796804|NCT01832727|54251428|FG005|Overall Study|Physician Decision|1|||
27796805|NCT01832727|54251429|FG006|Overall Study|Physician Decision|0|||
27796806|NCT01832727|54251430|FG007|Overall Study|Physician Decision|0|||
27796807|NCT01832727|54251431|FG008|Overall Study|Physician Decision|0|||
27796808|NCT01832727|54251423|FG000|Overall Study|Withdrawal by Subject|1|||
27796809|NCT01832727|54251424|FG001|Overall Study|Withdrawal by Subject|1|||
27796810|NCT01832727|54251425|FG002|Overall Study|Withdrawal by Subject|0|||
27796811|NCT01832727|54251426|FG003|Overall Study|Withdrawal by Subject|1|||
27796812|NCT01832727|54251427|FG004|Overall Study|Withdrawal by Subject|0|||
27796813|NCT01832727|54251428|FG005|Overall Study|Withdrawal by Subject|1|||
27796814|NCT01832727|54251429|FG006|Overall Study|Withdrawal by Subject|0|||
27796815|NCT01832727|54251430|FG007|Overall Study|Withdrawal by Subject|2|||
27796816|NCT01832727|54251431|FG008|Overall Study|Withdrawal by Subject|1|||
27796817|NCT01832727|54251423|FG000|Overall Study|Study terminated by sponsor|0|||
27796818|NCT01832727|54251424|FG001|Overall Study|Study terminated by sponsor|0|||
27796819|NCT01832727|54251425|FG002|Overall Study|Study terminated by sponsor|0|||
27796820|NCT01832727|54251426|FG003|Overall Study|Study terminated by sponsor|0|||
27796821|NCT01832727|54251427|FG004|Overall Study|Study terminated by sponsor|0|||
27796822|NCT01832727|54251428|FG005|Overall Study|Study terminated by sponsor|0|||
27796823|NCT01832727|54251429|FG006|Overall Study|Study terminated by sponsor|0|||
27796824|NCT01832727|54251430|FG007|Overall Study|Study terminated by sponsor|1|||
27796825|NCT01832727|54251431|FG008|Overall Study|Study terminated by sponsor|1|||
27796826|NCT01473394|54251462|FG000|Overall Study|Adverse Event|13|||
27796827|NCT01473394|54251463|FG001|Overall Study|Adverse Event|16|||
27796828|NCT01473394|54251462|FG000|Overall Study|Insufficient Therapeutic Response|4|||
27796829|NCT01473394|54251463|FG001|Overall Study|Insufficient Therapeutic Response|1|||
27796830|NCT01473394|54251462|FG000|Overall Study|Protocol Violation|7|||
27796831|NCT01473394|54251463|FG001|Overall Study|Protocol Violation|5|||
27796832|NCT01473394|54251462|FG000|Overall Study|Withdrew Consent|12|||
27796833|NCT01473394|54251463|FG001|Overall Study|Withdrew Consent|10|||
27796834|NCT01473394|54251462|FG000|Overall Study|Lost to Follow-up|9|||
27796835|NCT01473394|54251463|FG001|Overall Study|Lost to Follow-up|11|||
27938122|NCT01072149|54594340|FG015|Washout Period 2 (14 Days)|Withdrawal by Subject|1|||
27938123|NCT01072149|54594341|FG016|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
27796836|NCT01449682|54251471|FG000|Overall Study|Death|0|||
27796837|NCT01449682|54251472|FG001|Overall Study|Death|1|||
27796838|NCT01449682|54251471|FG000|Overall Study|Adverse Event|1|||
27796839|NCT01449682|54251472|FG001|Overall Study|Adverse Event|0|||
27796840|NCT01449526|54251480|FG000|Overall Study|Lost to Follow-up|1|||
27796841|NCT01449526|54251481|FG001|Overall Study|Lost to Follow-up|2|||
27796842|NCT01449526|54251480|FG000|Overall Study|Withdrawal by Subject|1|||
27796843|NCT01449526|54251481|FG001|Overall Study|Withdrawal by Subject|1|||
27796844|NCT01449526|54251480|FG000|Overall Study|Symptoms/complaints|0|||
27796845|NCT01449526|54251481|FG001|Overall Study|Symptoms/complaints|1|||
27796846|NCT01449526|54251480|FG000|Overall Study|Lack of Motivation|0|||
27796847|NCT01449526|54251481|FG001|Overall Study|Lack of Motivation|1|||
27796848|NCT01449526|54251480|FG000|Overall Study|Cannot maintain visits|0|||
27796849|NCT01449526|54251481|FG001|Overall Study|Cannot maintain visits|1|||
27796850|NCT01440322|54251489|FG000|Overall Study|Discomfort|2|||
27796851|NCT01440322|54251490|FG001|Overall Study|Discomfort|0|||
27796852|NCT01440322|54251489|FG000|Overall Study|Biomicroscopy|1|||
27796853|NCT01440322|54251490|FG001|Overall Study|Biomicroscopy|0|||
27796854|NCT01440322|54251489|FG000|Overall Study|Symptoms and Problems|1|||
27796855|NCT01440322|54251490|FG001|Overall Study|Symptoms and Problems|0|||
27796856|NCT01440322|54251489|FG000|Overall Study|Unacceptable Subjective Vision|1|||
27796857|NCT01440322|54251490|FG001|Overall Study|Unacceptable Subjective Vision|0|||
27796858|NCT01440322|54251489|FG000|Overall Study|Other Product Related|1|||
27796859|NCT01440322|54251490|FG001|Overall Study|Other Product Related|0|||
27796860|NCT01440322|54251489|FG000|Overall Study|Unrelated Medical Problem|0|||
27796861|NCT01440322|54251490|FG001|Overall Study|Unrelated Medical Problem|1|||
27796862|NCT01440322|54251489|FG000|Overall Study|Other Non-Product Related|1|||
27796863|NCT01440322|54251490|FG001|Overall Study|Other Non-Product Related|0|||
27796864|NCT01832493|54251496|FG000|Overall Study|Physician Decision|2|||
27796865|NCT01832493|54251496|FG000|Overall Study|Protocol Violation|4|||
27796866|NCT01832493|54251496|FG000|Overall Study|Unable to place LV lead|2|||
27796867|NCT01831791|54251500|FG000|Overall Study|Withdrawal by Subject|10|||
27796868|NCT01857531|54251504|FG000|Overall Study|Withdrawal by Subject|4|||
27796869|NCT02166047|54251520|FG000|Overall Study|Withdrawal by Participant|0|||
27796870|NCT02166047|54251521|FG001|Overall Study|Withdrawal by Participant|1|||
27796871|NCT02166047|54251522|FG002|Overall Study|Withdrawal by Participant|2|||
27796872|NCT02166047|54251523|FG003|Overall Study|Withdrawal by Participant|0|||
27796873|NCT02166047|54251524|FG004|Overall Study|Withdrawal by Participant|0|||
27796874|NCT02166047|54251525|FG005|Overall Study|Withdrawal by Participant|0|||
27796875|NCT02166047|54251526|FG006|Overall Study|Withdrawal by Participant|1|||
27796876|NCT02166047|54251527|FG007|Overall Study|Withdrawal by Participant|0|||
27796877|NCT02166047|54251528|FG008|Overall Study|Withdrawal by Participant|0|||
27796878|NCT02166047|54251529|FG009|Overall Study|Withdrawal by Participant|0|||
27796879|NCT02166047|54251530|FG010|Overall Study|Withdrawal by Participant|0|||
27796880|NCT02166047|54251531|FG011|Overall Study|Withdrawal by Participant|0|||
27796881|NCT02166047|54251520|FG000|Overall Study|Adverse Event|0|||
27796882|NCT02166047|54251521|FG001|Overall Study|Adverse Event|0|||
27796883|NCT02166047|54251522|FG002|Overall Study|Adverse Event|0|||
27796884|NCT02166047|54251523|FG003|Overall Study|Adverse Event|0|||
27796885|NCT02166047|54251524|FG004|Overall Study|Adverse Event|1|||
27796886|NCT02166047|54251525|FG005|Overall Study|Adverse Event|0|||
27796887|NCT02166047|54251526|FG006|Overall Study|Adverse Event|1|||
27796888|NCT02166047|54251527|FG007|Overall Study|Adverse Event|0|||
27796889|NCT02166047|54251528|FG008|Overall Study|Adverse Event|0|||
27796890|NCT02166047|54251529|FG009|Overall Study|Adverse Event|0|||
27796891|NCT02166047|54251530|FG010|Overall Study|Adverse Event|2|||
27796892|NCT02166047|54251531|FG011|Overall Study|Adverse Event|0|||
27796893|NCT01493284|54251557|FG000|Overall Study|Death|29|||
27796894|NCT01493284|54251557|FG000|Overall Study|Withdrawal by Subject|32|||
27796895|NCT02165735|54251563|FG000|Overall Study|Lost to Follow-up|12|||
27796896|NCT02165735|54251564|FG001|Overall Study|Lost to Follow-up|10|||
27796897|NCT02165735|54251563|FG000|Overall Study|Withdrawal by Subject|3|||
27796898|NCT02165735|54251564|FG001|Overall Study|Withdrawal by Subject|0|||
27796899|NCT02165735|54251563|FG000|Overall Study|Participant indicated lack of time|1|||
27796900|NCT02165735|54251564|FG001|Overall Study|Participant indicated lack of time|3|||
27796901|NCT02165735|54251563|FG000|Overall Study|Protocol Violation|0|||
27796902|NCT02165735|54251564|FG001|Overall Study|Protocol Violation|1|||
27796903|NCT02069899|54251573|FG000|Overall Study|Adverse Event|6|||
27796904|NCT02069899|54251574|FG001|Overall Study|Adverse Event|0|||
27796905|NCT02069899|54251575|FG002|Overall Study|Adverse Event|1|||
27796906|NCT02069899|54251573|FG000|Overall Study|Withdrawal by Participant|2|||
27796907|NCT02069899|54251574|FG001|Overall Study|Withdrawal by Participant|0|||
27796908|NCT02069899|54251575|FG002|Overall Study|Withdrawal by Participant|0|||
27796909|NCT02069899|54251573|FG000|Overall Study|Lost to Follow-up|1|||
27796910|NCT02069899|54251574|FG001|Overall Study|Lost to Follow-up|0|||
27796911|NCT02069899|54251575|FG002|Overall Study|Lost to Follow-up|1|||
27796912|NCT02069899|54251573|FG000|Overall Study|Other|4|||
27796913|NCT02069899|54251574|FG001|Overall Study|Other|0|||
27796914|NCT02069899|54251575|FG002|Overall Study|Other|0|||
27796915|NCT02069899|54251573|FG000|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
27796916|NCT02069899|54251574|FG001|Overall Study|Participant could not travel to the study site due to Covid restrictions|1|||
27796917|NCT02069899|54251575|FG002|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
27796918|NCT02069899|54251573|FG000|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
27796919|NCT02069899|54251574|FG001|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
27796920|NCT02069899|54251575|FG002|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|1|||
27796921|NCT01831089|54251590|FG000|Cohort I: Dose Level 1|Progressive disease|3|||
27796922|NCT01831089|54251591|FG001|Cohort I: Dose Level 1|Progressive disease|0|||
27796923|NCT01831089|54251592|FG002|Cohort I: Dose Level 1|Progressive disease|0|||
27796924|NCT01831089|54251593|FG003|Cohort I: Dose Level 1|Progressive disease|0|||
27796925|NCT01831089|54251594|FG004|Cohort I: Dose Level 1|Progressive disease|0|||
27796926|NCT01831089|54251595|FG005|Cohort I: Dose Level 1|Progressive disease|0|||
27796927|NCT01831089|54251590|FG000|Cohort II: Dose Level 2|Progressive disease|0|||
27796928|NCT01831089|54251591|FG001|Cohort II: Dose Level 2|Progressive disease|2|||
27796929|NCT01831089|54251592|FG002|Cohort II: Dose Level 2|Progressive disease|0|||
27796930|NCT01831089|54251593|FG003|Cohort II: Dose Level 2|Progressive disease|0|||
27796931|NCT01831089|54251594|FG004|Cohort II: Dose Level 2|Progressive disease|0|||
27796932|NCT01831089|54251595|FG005|Cohort II: Dose Level 2|Progressive disease|0|||
27796933|NCT01831089|54251590|FG000|Cohort II: Dose Level 2|Clinical progressive disease|0|||
27796934|NCT01831089|54251591|FG001|Cohort II: Dose Level 2|Clinical progressive disease|1|||
27796935|NCT01831089|54251592|FG002|Cohort II: Dose Level 2|Clinical progressive disease|0|||
27796936|NCT01831089|54251593|FG003|Cohort II: Dose Level 2|Clinical progressive disease|0|||
27796937|NCT01831089|54251594|FG004|Cohort II: Dose Level 2|Clinical progressive disease|0|||
27796938|NCT01831089|54251595|FG005|Cohort II: Dose Level 2|Clinical progressive disease|0|||
27796939|NCT01831089|54251590|FG000|Cohort III: Dose Level 3|Progressive disease|0|||
27796940|NCT01831089|54251591|FG001|Cohort III: Dose Level 3|Progressive disease|0|||
27796941|NCT01831089|54251592|FG002|Cohort III: Dose Level 3|Progressive disease|3|||
27796942|NCT01831089|54251593|FG003|Cohort III: Dose Level 3|Progressive disease|0|||
27796943|NCT01831089|54251594|FG004|Cohort III: Dose Level 3|Progressive disease|0|||
27796944|NCT01831089|54251595|FG005|Cohort III: Dose Level 3|Progressive disease|0|||
27796945|NCT01831089|54251590|FG000|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
27796946|NCT01831089|54251591|FG001|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
27796947|NCT01831089|54251592|FG002|Cohort III: Dose Level 3|Withdrawal by Subject|1|||
27796948|NCT01831089|54251593|FG003|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
27796949|NCT01831089|54251594|FG004|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
27796950|NCT01831089|54251595|FG005|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
27796951|NCT01831089|54251590|FG000|Cohort III: Dose Level 3|Adverse Event|0|||
27796952|NCT01831089|54251591|FG001|Cohort III: Dose Level 3|Adverse Event|0|||
27796953|NCT01831089|54251592|FG002|Cohort III: Dose Level 3|Adverse Event|1|||
27796954|NCT01831089|54251593|FG003|Cohort III: Dose Level 3|Adverse Event|0|||
27796955|NCT01831089|54251594|FG004|Cohort III: Dose Level 3|Adverse Event|0|||
27796956|NCT01831089|54251595|FG005|Cohort III: Dose Level 3|Adverse Event|0|||
27796957|NCT01831089|54251590|FG000|Cohort III: Dose Level 3|Global end of study|0|||
27796958|NCT01831089|54251591|FG001|Cohort III: Dose Level 3|Global end of study|0|||
27796959|NCT01831089|54251592|FG002|Cohort III: Dose Level 3|Global end of study|1|||
27796960|NCT01831089|54251593|FG003|Cohort III: Dose Level 3|Global end of study|0|||
27796961|NCT01831089|54251594|FG004|Cohort III: Dose Level 3|Global end of study|0|||
27796962|NCT01831089|54251595|FG005|Cohort III: Dose Level 3|Global end of study|0|||
27796963|NCT01831089|54251590|FG000|Cohort IV: Dose Level 4|Progressive disease|0|||
27796964|NCT01831089|54251591|FG001|Cohort IV: Dose Level 4|Progressive disease|0|||
27796965|NCT01831089|54251592|FG002|Cohort IV: Dose Level 4|Progressive disease|0|||
27796966|NCT01831089|54251593|FG003|Cohort IV: Dose Level 4|Progressive disease|6|||
27796967|NCT01831089|54251594|FG004|Cohort IV: Dose Level 4|Progressive disease|0|||
27796968|NCT01831089|54251595|FG005|Cohort IV: Dose Level 4|Progressive disease|0|||
27796969|NCT01831089|54251590|FG000|Cohort V: Dose Level 5|Progressive disease|0|||
27796970|NCT01831089|54251591|FG001|Cohort V: Dose Level 5|Progressive disease|0|||
27796971|NCT01831089|54251592|FG002|Cohort V: Dose Level 5|Progressive disease|0|||
27796972|NCT01831089|54251593|FG003|Cohort V: Dose Level 5|Progressive disease|0|||
27796973|NCT01831089|54251594|FG004|Cohort V: Dose Level 5|Progressive disease|30|||
27796974|NCT01831089|54251595|FG005|Cohort V: Dose Level 5|Progressive disease|0|||
27796975|NCT01831089|54251590|FG000|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
27796976|NCT01831089|54251591|FG001|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
27796977|NCT01831089|54251592|FG002|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
27796978|NCT01831089|54251593|FG003|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
27796979|NCT01831089|54251594|FG004|Cohort V: Dose Level 5|Withdrawal by Subject|3|||
27796980|NCT01831089|54251595|FG005|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
27796981|NCT01831089|54251590|FG000|Cohort V: Dose Level 5|Death|0|||
27796982|NCT01831089|54251591|FG001|Cohort V: Dose Level 5|Death|0|||
27796983|NCT01831089|54251592|FG002|Cohort V: Dose Level 5|Death|0|||
27796984|NCT01831089|54251593|FG003|Cohort V: Dose Level 5|Death|0|||
27796985|NCT01831089|54251594|FG004|Cohort V: Dose Level 5|Death|1|||
27796986|NCT01831089|54251595|FG005|Cohort V: Dose Level 5|Death|0|||
27796987|NCT01831089|54251590|FG000|Cohort V: Dose Level 5|Global end of study|0|||
27796988|NCT01831089|54251591|FG001|Cohort V: Dose Level 5|Global end of study|0|||
27796989|NCT01831089|54251592|FG002|Cohort V: Dose Level 5|Global end of study|0|||
27796990|NCT01831089|54251593|FG003|Cohort V: Dose Level 5|Global end of study|0|||
27796991|NCT01831089|54251594|FG004|Cohort V: Dose Level 5|Global end of study|2|||
27796992|NCT01831089|54251595|FG005|Cohort V: Dose Level 5|Global end of study|0|||
27796993|NCT01831089|54251590|FG000|Cohort V: Dose Level 5|Lost to Follow-up|0|||
27796994|NCT01831089|54251591|FG001|Cohort V: Dose Level 5|Lost to Follow-up|0|||
27796995|NCT01831089|54251592|FG002|Cohort V: Dose Level 5|Lost to Follow-up|0|||
27796996|NCT01831089|54251593|FG003|Cohort V: Dose Level 5|Lost to Follow-up|0|||
27796997|NCT01831089|54251594|FG004|Cohort V: Dose Level 5|Lost to Follow-up|1|||
27796998|NCT01831089|54251595|FG005|Cohort V: Dose Level 5|Lost to Follow-up|0|||
27796999|NCT01831089|54251590|FG000|Cohort B: Arm B|Progressive disease|0|||
27797000|NCT01831089|54251591|FG001|Cohort B: Arm B|Progressive disease|0|||
27797001|NCT01831089|54251592|FG002|Cohort B: Arm B|Progressive disease|0|||
27797002|NCT01831089|54251593|FG003|Cohort B: Arm B|Progressive disease|0|||
27797003|NCT01831089|54251594|FG004|Cohort B: Arm B|Progressive disease|0|||
27797004|NCT01831089|54251595|FG005|Cohort B: Arm B|Progressive disease|8|||
27797005|NCT01831089|54251590|FG000|Cohort B: Arm B|Physician Decision|0|||
27797006|NCT01831089|54251591|FG001|Cohort B: Arm B|Physician Decision|0|||
27797007|NCT01831089|54251592|FG002|Cohort B: Arm B|Physician Decision|0|||
27797008|NCT01831089|54251593|FG003|Cohort B: Arm B|Physician Decision|0|||
27797009|NCT01831089|54251594|FG004|Cohort B: Arm B|Physician Decision|0|||
27797010|NCT01831089|54251595|FG005|Cohort B: Arm B|Physician Decision|2|||
27797011|NCT01831089|54251590|FG000|Cohort B: Arm B|Never treated|0|||
27797012|NCT01831089|54251591|FG001|Cohort B: Arm B|Never treated|0|||
27797013|NCT01831089|54251592|FG002|Cohort B: Arm B|Never treated|0|||
27938124|NCT01072149|54594342|FG017|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
27938125|NCT01072149|54594325|FG000|Washout Period 2 (14 Days)|Adverse Event|0|||
27938126|NCT01072149|54594326|FG001|Washout Period 2 (14 Days)|Adverse Event|0|||
27938127|NCT01072149|54594327|FG002|Washout Period 2 (14 Days)|Adverse Event|0|||
27938128|NCT01072149|54594328|FG003|Washout Period 2 (14 Days)|Adverse Event|0|||
27938129|NCT01072149|54594329|FG004|Washout Period 2 (14 Days)|Adverse Event|0|||
27938130|NCT01072149|54594330|FG005|Washout Period 2 (14 Days)|Adverse Event|0|||
27938131|NCT01072149|54594331|FG006|Washout Period 2 (14 Days)|Adverse Event|0|||
27938132|NCT01072149|54594332|FG007|Washout Period 2 (14 Days)|Adverse Event|0|||
27938133|NCT01072149|54594333|FG008|Washout Period 2 (14 Days)|Adverse Event|0|||
27938134|NCT01072149|54594334|FG009|Washout Period 2 (14 Days)|Adverse Event|0|||
27797014|NCT01831089|54251593|FG003|Cohort B: Arm B|Never treated|0|||
27797015|NCT01831089|54251594|FG004|Cohort B: Arm B|Never treated|0|||
27797016|NCT01831089|54251595|FG005|Cohort B: Arm B|Never treated|2|||
27797017|NCT01831089|54251590|FG000|Cohort B: Arm B|Adverse Event|0|||
27797018|NCT01831089|54251591|FG001|Cohort B: Arm B|Adverse Event|0|||
27797019|NCT01831089|54251592|FG002|Cohort B: Arm B|Adverse Event|0|||
27797020|NCT01831089|54251593|FG003|Cohort B: Arm B|Adverse Event|0|||
27797021|NCT01831089|54251594|FG004|Cohort B: Arm B|Adverse Event|0|||
27797022|NCT01831089|54251595|FG005|Cohort B: Arm B|Adverse Event|1|||
27797023|NCT01831089|54251590|FG000|Cohort B: Arm B|Global end of study|0|||
28018051|NCT00652626|54677303|FG001|Initial Treatment Phase|Physician Decision|0|||
27797024|NCT01831089|54251591|FG001|Cohort B: Arm B|Global end of study|0|||
27797025|NCT01831089|54251592|FG002|Cohort B: Arm B|Global end of study|0|||
27797026|NCT01831089|54251593|FG003|Cohort B: Arm B|Global end of study|0|||
27797027|NCT01831089|54251594|FG004|Cohort B: Arm B|Global end of study|0|||
27797028|NCT01831089|54251595|FG005|Cohort B: Arm B|Global end of study|1|||
27797029|NCT02112877|54251612|FG000|Overall Study|Withdrawal by Subject|1|||
27797030|NCT02112877|54251613|FG001|Overall Study|Withdrawal by Subject|7|||
27797031|NCT02112877|54251612|FG000|Overall Study|Visit Missed|1|||
27797032|NCT02112877|54251613|FG001|Overall Study|Visit Missed|6|||
27797033|NCT02098369|54251624|FG000|Overall Study|Withdrawal by Subject|1|||
27797034|NCT02098369|54251625|FG001|Overall Study|Withdrawal by Subject|5|||
27797035|NCT02098369|54251626|FG002|Overall Study|Withdrawal by Subject|0|||
27797036|NCT02098369|54251624|FG000|Overall Study|Lost to Follow-up|5|||
27797037|NCT02098369|54251625|FG001|Overall Study|Lost to Follow-up|1|||
27797038|NCT02098369|54251626|FG002|Overall Study|Lost to Follow-up|3|||
27797039|NCT02098369|54251624|FG000|Overall Study|Death|1|||
27797040|NCT02098369|54251625|FG001|Overall Study|Death|1|||
27797041|NCT02098369|54251626|FG002|Overall Study|Death|1|||
27797042|NCT02098369|54251624|FG000|Overall Study|Other|0|||
27797043|NCT02098369|54251625|FG001|Overall Study|Other|2|||
27797044|NCT02098369|54251626|FG002|Overall Study|Other|1|||
27797045|NCT02111785|54251638|FG000|Overall Study|Death|0|||
27797046|NCT02111785|54251639|FG001|Overall Study|Death|1|||
27797047|NCT02111785|54251640|FG002|Overall Study|Death|0|||
27797048|NCT02111785|54251641|FG003|Overall Study|Death|0|||
27797049|NCT02068885|54251658|FG000|Overall Study|Withdrew|3|||
27797050|NCT02068885|54251659|FG001|Overall Study|Withdrew|5|||
27797051|NCT02068885|54251660|FG002|Overall Study|Withdrew|8|||
27797052|NCT02068495|54251669|FG000|Overall Study|Case Report Forms Uncollected|60|||
27797053|NCT02068495|54251669|FG000|Overall Study|Protocol Deviation|49|||
27797054|NCT02097823|54251675|FG000|Overall Study|Withdrawal by Subject|1|||
27797055|NCT02097823|54251676|FG001|Overall Study|Withdrawal by Subject|1|||
27797056|NCT01830855|54251687|FG000|Overall Study|Other|7|||
27797057|NCT01830855|54251688|FG001|Overall Study|Other|1|||
27797058|NCT01830855|54251689|FG002|Overall Study|Other|4|||
27797059|NCT01830855|54251690|FG003|Overall Study|Other|4|||
27797060|NCT01830855|54251687|FG000|Overall Study|Medication error without associated AE|1|||
27797061|NCT01830855|54251688|FG001|Overall Study|Medication error without associated AE|0|||
27797062|NCT01830855|54251689|FG002|Overall Study|Medication error without associated AE|0|||
27797063|NCT01830855|54251690|FG003|Overall Study|Medication error without associated AE|1|||
27797064|NCT01830855|54251687|FG000|Overall Study|Pregnancy|3|||
27797065|NCT01830855|54251688|FG001|Overall Study|Pregnancy|1|||
27797066|NCT01830855|54251689|FG002|Overall Study|Pregnancy|2|||
27797067|NCT01830855|54251690|FG003|Overall Study|Pregnancy|1|||
27797068|NCT01830855|54251687|FG000|Overall Study|No longer meets eligibility criteria|11|||
27797069|NCT01830855|54251688|FG001|Overall Study|No longer meets eligibility criteria|2|||
27797070|NCT01830855|54251689|FG002|Overall Study|No longer meets eligibility criteria|3|||
27797071|NCT01830855|54251690|FG003|Overall Study|No longer meets eligibility criteria|5|||
27797072|NCT01830855|54251687|FG000|Overall Study|Adverse Event|11|||
27797073|NCT01830855|54251688|FG001|Overall Study|Adverse Event|5|||
27797074|NCT01830855|54251689|FG002|Overall Study|Adverse Event|6|||
27938135|NCT01072149|54594335|FG010|Washout Period 2 (14 Days)|Adverse Event|0|||
27938136|NCT01072149|54594336|FG011|Washout Period 2 (14 Days)|Adverse Event|0|||
27938137|NCT01072149|54594337|FG012|Washout Period 2 (14 Days)|Adverse Event|0|||
27938138|NCT01072149|54594338|FG013|Washout Period 2 (14 Days)|Adverse Event|0|||
27938139|NCT01072149|54594339|FG014|Washout Period 2 (14 Days)|Adverse Event|0|||
27938140|NCT01072149|54594340|FG015|Washout Period 2 (14 Days)|Adverse Event|1|||
27938141|NCT01072149|54594341|FG016|Washout Period 2 (14 Days)|Adverse Event|0|||
27938142|NCT01072149|54594342|FG017|Washout Period 2 (14 Days)|Adverse Event|0|||
27938143|NCT01072149|54594325|FG000|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
27797075|NCT01830855|54251690|FG003|Overall Study|Adverse Event|3|||
27938144|NCT01072149|54594326|FG001|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
27797076|NCT01830855|54251687|FG000|Overall Study|Protocol deviation|10|||
27797077|NCT01830855|54251688|FG001|Overall Study|Protocol deviation|5|||
27797078|NCT01830855|54251689|FG002|Overall Study|Protocol deviation|6|||
27797079|NCT01830855|54251690|FG003|Overall Study|Protocol deviation|6|||
27797080|NCT01830855|54251687|FG000|Overall Study|Withdrawal by Subject|33|||
27797081|NCT01830855|54251688|FG001|Overall Study|Withdrawal by Subject|14|||
27797082|NCT01830855|54251689|FG002|Overall Study|Withdrawal by Subject|10|||
27797083|NCT01830855|54251690|FG003|Overall Study|Withdrawal by Subject|12|||
27797084|NCT01830855|54251687|FG000|Overall Study|No longer willing to participate|32|||
27797085|NCT01830855|54251688|FG001|Overall Study|No longer willing to participate|13|||
27797086|NCT01830855|54251689|FG002|Overall Study|No longer willing to participate|12|||
27797087|NCT01830855|54251690|FG003|Overall Study|No longer willing to participate|17|||
27797088|NCT01830855|54251687|FG000|Overall Study|Lost to Follow-up|47|||
27797089|NCT01830855|54251688|FG001|Overall Study|Lost to Follow-up|20|||
27797090|NCT01830855|54251689|FG002|Overall Study|Lost to Follow-up|23|||
27797091|NCT01830855|54251690|FG003|Overall Study|Lost to Follow-up|33|||
27797092|NCT01857063|54251707|FG000|Period 1 (7 Days)|Adverse Event|0|||
27797093|NCT01857063|54251708|FG001|Period 1 (7 Days)|Adverse Event|1|||
27797094|NCT01857063|54251707|FG000|Period 1 (7 Days)|Physician Decision|1|||
27797095|NCT01857063|54251708|FG001|Period 1 (7 Days)|Physician Decision|0|||
27797096|NCT01857063|54251707|FG000|Period 1 (7 Days)|Withdrawal by Subject|1|||
27797097|NCT01857063|54251708|FG001|Period 1 (7 Days)|Withdrawal by Subject|3|||
27797098|NCT01857063|54251707|FG000|Period 2 (7 Days)|Adverse Event|2|||
27797099|NCT01857063|54251708|FG001|Period 2 (7 Days)|Adverse Event|1|||
27797100|NCT01857063|54251707|FG000|Period 2 (7 Days)|Physician Decision|1|||
27797101|NCT01857063|54251708|FG001|Period 2 (7 Days)|Physician Decision|1|||
27797102|NCT01857063|54251707|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
27797103|NCT01857063|54251708|FG001|Period 2 (7 Days)|Withdrawal by Subject|0|||
27797104|NCT01856907|54251717|FG000|Overall Study|Pregnancy|0|||
27797105|NCT01856907|54251718|FG001|Overall Study|Pregnancy|1|||
27797106|NCT01856907|54251719|FG002|Overall Study|Pregnancy|0|||
27797107|NCT01856907|54251717|FG000|Overall Study|Pregnancy|0|||
27797108|NCT01856907|54251718|FG001|Overall Study|Pregnancy|1|||
27797109|NCT01856907|54251719|FG002|Overall Study|Pregnancy|0|||
27797110|NCT01856907|54251717|FG000|Overall Study|Withdrawal by Subject|0|||
27797111|NCT01856907|54251718|FG001|Overall Study|Withdrawal by Subject|1|||
27797112|NCT01856907|54251719|FG002|Overall Study|Withdrawal by Subject|0|||
27797113|NCT02212457|54251736|FG000|Overall Study|Adverse Event|1|||
27797114|NCT02212457|54251737|FG001|Overall Study|Adverse Event|2|||
27797115|NCT02212457|54251738|FG002|Overall Study|Adverse Event|2|||
27797116|NCT02212457|54251739|FG003|Overall Study|Adverse Event|2|||
27797117|NCT02212457|54251740|FG004|Overall Study|Adverse Event|0|||
27797118|NCT02212457|54251741|FG005|Overall Study|Adverse Event|1|||
27797119|NCT02212457|54251736|FG000|Overall Study|Withdrawal by Subject|8|||
27797120|NCT02212457|54251737|FG001|Overall Study|Withdrawal by Subject|10|||
27797121|NCT02212457|54251738|FG002|Overall Study|Withdrawal by Subject|8|||
27797122|NCT02212457|54251739|FG003|Overall Study|Withdrawal by Subject|6|||
27797123|NCT02212457|54251740|FG004|Overall Study|Withdrawal by Subject|5|||
27797124|NCT02212457|54251741|FG005|Overall Study|Withdrawal by Subject|4|||
27797125|NCT02212457|54251736|FG000|Overall Study|Lost to Follow-up|6|||
27797126|NCT02212457|54251737|FG001|Overall Study|Lost to Follow-up|7|||
27797127|NCT02212457|54251738|FG002|Overall Study|Lost to Follow-up|4|||
27797128|NCT02212457|54251739|FG003|Overall Study|Lost to Follow-up|1|||
27797129|NCT02212457|54251740|FG004|Overall Study|Lost to Follow-up|8|||
27797130|NCT02212457|54251741|FG005|Overall Study|Lost to Follow-up|4|||
27797131|NCT02212457|54251736|FG000|Overall Study|Protocol Violation|2|||
27797132|NCT02212457|54251737|FG001|Overall Study|Protocol Violation|1|||
27797133|NCT02212457|54251738|FG002|Overall Study|Protocol Violation|0|||
27797134|NCT02212457|54251739|FG003|Overall Study|Protocol Violation|1|||
27797135|NCT02212457|54251740|FG004|Overall Study|Protocol Violation|2|||
27797136|NCT02212457|54251741|FG005|Overall Study|Protocol Violation|3|||
27797137|NCT02212457|54251736|FG000|Overall Study|Other|2|||
27797138|NCT02212457|54251737|FG001|Overall Study|Other|1|||
27797139|NCT02212457|54251738|FG002|Overall Study|Other|2|||
27797140|NCT02212457|54251739|FG003|Overall Study|Other|1|||
27797141|NCT02212457|54251740|FG004|Overall Study|Other|0|||
27797142|NCT02212457|54251741|FG005|Overall Study|Other|1|||
27797143|NCT02097745|54251762|FG000|Overall Study|Adverse Event|25|||
27797144|NCT02097745|54251762|FG000|Overall Study|Death|16|||
27797145|NCT02097745|54251762|FG000|Overall Study|Failure to Return|14|||
27797146|NCT02097745|54251762|FG000|Overall Study|Administrative/Other|27|||
27797147|NCT02097745|54251762|FG000|Overall Study|Reason Not Specified|96|||
27797148|NCT02111083|54251771|FG000|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
27797149|NCT02111083|54251772|FG001|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
27797150|NCT01629563|54251780|FG000|Overall Study|Adverse Event|16|||
27797151|NCT01629563|54251781|FG001|Overall Study|Adverse Event|16|||
27797152|NCT01629563|54251780|FG000|Overall Study|Death|2|||
27797153|NCT01629563|54251781|FG001|Overall Study|Death|0|||
27797154|NCT01629563|54251780|FG000|Overall Study|Lack of Efficacy|2|||
27797155|NCT01629563|54251781|FG001|Overall Study|Lack of Efficacy|3|||
27797156|NCT01629563|54251780|FG000|Overall Study|Lost to Follow-up|1|||
27797157|NCT01629563|54251781|FG001|Overall Study|Lost to Follow-up|0|||
27797158|NCT01629563|54251780|FG000|Overall Study|Pregnancy|1|||
27797159|NCT01629563|54251781|FG001|Overall Study|Pregnancy|2|||
27797160|NCT01629563|54251780|FG000|Overall Study|Protocol Violation|0|||
27797161|NCT01629563|54251781|FG001|Overall Study|Protocol Violation|1|||
27797162|NCT01629563|54251780|FG000|Overall Study|Withdrawal by Subject|27|||
27797163|NCT01629563|54251781|FG001|Overall Study|Withdrawal by Subject|20|||
27797164|NCT01629563|54251780|FG000|Overall Study|surgery|0|||
27797165|NCT01629563|54251781|FG001|Overall Study|surgery|3|||
27797166|NCT01629563|54251780|FG000|Overall Study|Lack of return of menses|12|||
27797167|NCT01629563|54251781|FG001|Overall Study|Lack of return of menses|7|||
27797168|NCT01629563|54251780|FG000|Overall Study|Protocol Violation|0|||
27797169|NCT01629563|54251781|FG001|Overall Study|Protocol Violation|1|||
27797170|NCT02097277|54251792|FG000|Overall Study|Subject no longer meets study criteria|0|||
27797171|NCT02097277|54251793|FG001|Overall Study|Subject no longer meets study criteria|1|||
27797172|NCT02097277|54251794|FG002|Overall Study|Subject no longer meets study criteria|0|||
27797173|NCT02097277|54251795|FG003|Overall Study|Subject no longer meets study criteria|1|||
27797174|NCT02097277|54251796|FG004|Overall Study|Subject no longer meets study criteria|0|||
27797175|NCT02097277|54251792|FG000|Overall Study|Subject request to discontinue treatment|0|||
27797176|NCT02097277|54251793|FG001|Overall Study|Subject request to discontinue treatment|0|||
27797177|NCT02097277|54251794|FG002|Overall Study|Subject request to discontinue treatment|0|||
27797178|NCT02097277|54251795|FG003|Overall Study|Subject request to discontinue treatment|0|||
27797179|NCT02097277|54251796|FG004|Overall Study|Subject request to discontinue treatment|1|||
27797180|NCT02097277|54251792|FG000|Overall Study|Lost to Follow-up|0|||
27797181|NCT02097277|54251793|FG001|Overall Study|Lost to Follow-up|1|||
27797182|NCT02097277|54251794|FG002|Overall Study|Lost to Follow-up|1|||
27797183|NCT02097277|54251795|FG003|Overall Study|Lost to Follow-up|0|||
27797184|NCT02097277|54251796|FG004|Overall Study|Lost to Follow-up|0|||
27797185|NCT02097277|54251792|FG000|Overall Study|Withdrawal by Subject|2|||
27797186|NCT02097277|54251793|FG001|Overall Study|Withdrawal by Subject|1|||
27797187|NCT02097277|54251794|FG002|Overall Study|Withdrawal by Subject|0|||
27797188|NCT02097277|54251795|FG003|Overall Study|Withdrawal by Subject|1|||
27797189|NCT02097277|54251796|FG004|Overall Study|Withdrawal by Subject|0|||
27797190|NCT02097277|54251792|FG000|Overall Study|Adverse Event|0|||
27797191|NCT02097277|54251793|FG001|Overall Study|Adverse Event|0|||
27797192|NCT02097277|54251794|FG002|Overall Study|Adverse Event|1|||
27797193|NCT02097277|54251795|FG003|Overall Study|Adverse Event|2|||
27797194|NCT02097277|54251796|FG004|Overall Study|Adverse Event|0|||
27797195|NCT02212379|54251812|FG000|From Baseline to Week 48|Lack of Efficacy|1|||
27797196|NCT02212379|54251812|FG000|From Baseline to Week 48|Adverse Event|7|||
27797197|NCT02212379|54251812|FG000|From Baseline to Week 48|Withdrawal by Subject|1|||
27797198|NCT02212379|54251812|FG000|From Week 48 to Week 96|Lack of Efficacy|1|||
27797199|NCT02212379|54251812|FG000|From Week 48 to Week 96|Adverse Event|1|||
27797200|NCT02212379|54251812|FG000|From Week 48 to Week 96|Withdrawal by Subject|2|||
27797201|NCT02110693|54251819|FG000|Overall Study|Withdrawal by Subject|6|||
27797202|NCT02110693|54251820|FG001|Overall Study|Withdrawal by Subject|7|||
27797203|NCT02110693|54251819|FG000|Overall Study|skipped assessment|15|||
27797204|NCT02110693|54251820|FG001|Overall Study|skipped assessment|18|||
27797205|NCT02110693|54251819|FG000|Overall Study|technical difficulties|6|||
27797206|NCT02110693|54251820|FG001|Overall Study|technical difficulties|4|||
27797207|NCT02110693|54251819|FG000|Overall Study|Other|1|||
27797208|NCT02110693|54251820|FG001|Overall Study|Other|0|||
27797209|NCT02212301|54251840|FG000|Period 1|Lost to Follow-up|0|||
27797210|NCT02212301|54251841|FG001|Period 1|Lost to Follow-up|1|||
27797211|NCT02211209|54251850|FG000|Overall Study|Investigator judgment|0|||
27797212|NCT02211209|54251851|FG001|Overall Study|Investigator judgment|1|||
27797213|NCT02211209|54251850|FG000|Overall Study|Voluntary withdrawal|1|||
27797214|NCT02211209|54251851|FG001|Overall Study|Voluntary withdrawal|4|||
27797215|NCT02211209|54251850|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
27797216|NCT02211209|54251851|FG001|Overall Study|Adverse Event or Serious Adverse Event|9|||
27797217|NCT02211209|54251850|FG000|Overall Study|Reason Not Specified|1|||
27797218|NCT02211209|54251851|FG001|Overall Study|Reason Not Specified|0|||
27797219|NCT02187809|54251857|FG000|Overall Study|The study was terminated|3|||
27797220|NCT02110225|54251864|FG000|Overall Study|Lost to Follow-up|0|||
27797221|NCT02110225|54251865|FG001|Overall Study|Lost to Follow-up|1|||
27797222|NCT02110225|54251866|FG002|Overall Study|Lost to Follow-up|0|||
27797223|NCT02187029|54251879|FG000|Overall Study|Adverse Event|0|||
27797224|NCT02187029|54251880|FG001|Overall Study|Adverse Event|1|||
27797225|NCT02187029|54251881|FG002|Overall Study|Adverse Event|1|||
27797226|NCT02187029|54251882|FG003|Overall Study|Adverse Event|0|||
27797227|NCT02187029|54251879|FG000|Overall Study|Study Terminated by Sponsor|0|||
27797228|NCT02187029|54251880|FG001|Overall Study|Study Terminated by Sponsor|0|||
27797229|NCT02187029|54251881|FG002|Overall Study|Study Terminated by Sponsor|10|||
27797230|NCT02187029|54251882|FG003|Overall Study|Study Terminated by Sponsor|3|||
27797231|NCT02187029|54251879|FG000|Overall Study|Withdrawal by Subject|1|||
27797232|NCT02187029|54251880|FG001|Overall Study|Withdrawal by Subject|0|||
27938145|NCT01072149|54594327|FG002|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
27938146|NCT01072149|54594328|FG003|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
27938147|NCT01072149|54594329|FG004|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
27938148|NCT01072149|54594330|FG005|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
27938149|NCT01072149|54594331|FG006|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
27938150|NCT01072149|54594332|FG007|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
27797233|NCT02187029|54251881|FG002|Overall Study|Withdrawal by Subject|0|||
27797234|NCT02187029|54251882|FG003|Overall Study|Withdrawal by Subject|0|||
27797235|NCT02163395|54251892|FG000|Overall Study|Withdrawal by Subject|1|||
27797236|NCT02163395|54251892|FG000|Overall Study|Lost to Follow-up|3|||
27797237|NCT02163395|54251892|FG000|Overall Study|Adverse Event|1|||
27797238|NCT02162771|54251898|FG000|Core Study Period (Part 2)|Progressive Disease|2|||
27797239|NCT02162771|54251899|FG001|Core Study Period (Part 2)|Progressive Disease|3|||
27797240|NCT02162771|54251898|FG000|Core Study Period (Part 2)|Adverse Event|4|||
27797241|NCT02162771|54251899|FG001|Core Study Period (Part 2)|Adverse Event|1|||
27797242|NCT02162771|54251898|FG000|Core Study Period (Part 2)|Withdrawal by Subject|1|||
27797243|NCT02162771|54251899|FG001|Core Study Period (Part 2)|Withdrawal by Subject|2|||
27797244|NCT02162771|54251898|FG000|Core Study Period (Part 2)|Physician Decision|0|||
27797245|NCT02162771|54251899|FG001|Core Study Period (Part 2)|Physician Decision|2|||
27797246|NCT02162771|54251898|FG000|Core Study Period (Part 2)|Death|1|||
27797247|NCT02162771|54251899|FG001|Core Study Period (Part 2)|Death|0|||
27797248|NCT02162771|54251898|FG000|Maintenance Study Period (Part 2)|Progressive Disease|11|||
27797249|NCT02162771|54251899|FG001|Maintenance Study Period (Part 2)|Progressive Disease|13|||
27797250|NCT02162771|54251898|FG000|Maintenance Study Period (Part 2)|Adverse Event|3|||
27797251|NCT02162771|54251899|FG001|Maintenance Study Period (Part 2)|Adverse Event|3|||
27797252|NCT02162771|54251898|FG000|Maintenance Study Period (Part 2)|Death|2|||
27797253|NCT02162771|54251899|FG001|Maintenance Study Period (Part 2)|Death|1|||
27797254|NCT02162771|54251898|FG000|Maintenance Study Period (Part 2)|Withdrawal by Subject|0|||
27797255|NCT02162771|54251899|FG001|Maintenance Study Period (Part 2)|Withdrawal by Subject|3|||
27797256|NCT02162771|54251898|FG000|Maintenance Study Period (Part 2)|Protocol Violation|0|||
27797257|NCT02162771|54251899|FG001|Maintenance Study Period (Part 2)|Protocol Violation|1|||
27797258|NCT02162771|54251898|FG000|Maintenance Study Period (Part 2)|Stable Disease|0|||
27797259|NCT02162771|54251899|FG001|Maintenance Study Period (Part 2)|Stable Disease|1|||
27797260|NCT02161757|54251908|FG000|Randomised Through Start Treatment|Did not receive treatment|3|||
27797261|NCT02161757|54251909|FG001|Randomised Through Start Treatment|Did not receive treatment|2|||
27797262|NCT02161757|54251910|FG002|Randomised Through Start Treatment|Did not receive treatment|0|||
27797263|NCT02161757|54251908|FG000|Treatment Through Study Completion|Adverse Event|1|||
27797264|NCT02161757|54251909|FG001|Treatment Through Study Completion|Adverse Event|1|||
27797265|NCT02161757|54251910|FG002|Treatment Through Study Completion|Adverse Event|0|||
27797266|NCT02161757|54251908|FG000|Treatment Through Study Completion|Protocol Violation|0|||
27797267|NCT02161757|54251909|FG001|Treatment Through Study Completion|Protocol Violation|1|||
27797268|NCT02161757|54251910|FG002|Treatment Through Study Completion|Protocol Violation|2|||
27797269|NCT02161757|54251908|FG000|Treatment Through Study Completion|Withdrawal by Subject|27|||
27797270|NCT02161757|54251909|FG001|Treatment Through Study Completion|Withdrawal by Subject|19|||
27797271|NCT02161757|54251910|FG002|Treatment Through Study Completion|Withdrawal by Subject|20|||
27797272|NCT02161757|54251908|FG000|Treatment Through Study Completion|Lost to Follow-up|7|||
27797273|NCT02161757|54251909|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
27797274|NCT02161757|54251910|FG002|Treatment Through Study Completion|Lost to Follow-up|4|||
27797275|NCT02161757|54251908|FG000|Treatment Through Study Completion|Other|20|||
27797276|NCT02161757|54251909|FG001|Treatment Through Study Completion|Other|19|||
27797277|NCT02161757|54251910|FG002|Treatment Through Study Completion|Other|12|||
27797278|NCT02161757|54251908|FG000|Treatment Through Study Completion|Death|2|||
27797279|NCT02161757|54251909|FG001|Treatment Through Study Completion|Death|1|||
27797280|NCT02161757|54251910|FG002|Treatment Through Study Completion|Death|1|||
27797281|NCT02160977|54251920|FG000|Six Weeks After Surgery|Lost to Follow-up|1|||
27797282|NCT02160977|54251921|FG001|Six Weeks After Surgery|Lost to Follow-up|0|||
27797283|NCT02160977|54251920|FG000|Three Months After Surgery|Lost to Follow-up|0|||
27797284|NCT02160977|54251921|FG001|Three Months After Surgery|Lost to Follow-up|2|||
27797285|NCT02160977|54251920|FG000|Six Months After Surgery|Lost to Follow-up|2|||
27797286|NCT02160977|54251921|FG001|Six Months After Surgery|Lost to Follow-up|1|||
27797287|NCT02160899|54251933|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
27797288|NCT02160899|54251934|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
27797289|NCT02160899|54251935|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
27797290|NCT02160899|54251936|FG003|Overall Study|Adverse Event or Serious Adverse Event|1|||
27797291|NCT02160899|54251937|FG004|Overall Study|Adverse Event or Serious Adverse Event|2|||
27797292|NCT02160899|54251938|FG005|Overall Study|Adverse Event or Serious Adverse Event|0|||
27797293|NCT02160041|54251952|FG000|Overall Study|Adverse Event|11|||
27797294|NCT02160041|54251952|FG000|Overall Study|Death|2|||
27797295|NCT02160041|54251952|FG000|Overall Study|disease progression|57|||
27797296|NCT02160041|54251952|FG000|Overall Study|Protocol Violation|1|||
27797297|NCT02160041|54251952|FG000|Overall Study|non-compliance with study|1|||
27797298|NCT02160041|54251952|FG000|Overall Study|Physician Decision|3|||
27797299|NCT02160041|54251952|FG000|Overall Study|Withdrawal by Subject|8|||
27938151|NCT01072149|54594333|FG008|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
27938152|NCT01072149|54594334|FG009|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
27797300|NCT02160041|54251952|FG000|Overall Study|study terminated by by sponsor|1|||
27797301|NCT02186873|54251958|FG000|Overall Study|Adverse Event|1|||
27797302|NCT02186873|54251959|FG001|Overall Study|Adverse Event|3|||
27797303|NCT02186873|54251958|FG000|Overall Study|Lack of Efficacy|0|||
27797304|NCT02186873|54251959|FG001|Overall Study|Lack of Efficacy|1|||
27797305|NCT02186873|54251958|FG000|Overall Study|Lost to Follow-up|1|||
27797306|NCT02186873|54251959|FG001|Overall Study|Lost to Follow-up|2|||
27797307|NCT02186873|54251958|FG000|Overall Study|Withdrawal by Subject|7|||
27797308|NCT02186873|54251959|FG001|Overall Study|Withdrawal by Subject|2|||
27797309|NCT02096263|54251969|FG000|Overall Study|Adverse Event|1|||
27797310|NCT02096263|54251970|FG001|Overall Study|Adverse Event|0|||
27797311|NCT02096263|54251971|FG002|Overall Study|Adverse Event|1|||
27797312|NCT02096263|54251969|FG000|Overall Study|Lost to Follow-up|14|||
27797313|NCT02096263|54251970|FG001|Overall Study|Lost to Follow-up|18|||
27797314|NCT02096263|54251971|FG002|Overall Study|Lost to Follow-up|15|||
27797315|NCT02096263|54251969|FG000|Overall Study|Other|7|||
27797316|NCT02096263|54251970|FG001|Overall Study|Other|9|||
27797317|NCT02096263|54251971|FG002|Overall Study|Other|6|||
27797318|NCT02096263|54251969|FG000|Overall Study|Sponsor study termination|0|||
27797319|NCT02096263|54251970|FG001|Overall Study|Sponsor study termination|0|||
27797320|NCT02096263|54251971|FG002|Overall Study|Sponsor study termination|1|||
27797321|NCT02096263|54251969|FG000|Overall Study|Protocol Violation|7|||
27797322|NCT02096263|54251970|FG001|Overall Study|Protocol Violation|2|||
27797323|NCT02096263|54251971|FG002|Overall Study|Protocol Violation|8|||
27797324|NCT02096263|54251969|FG000|Overall Study|Withdrawal by Subject|5|||
28018052|NCT00652626|54677304|FG002|Initial Treatment Phase|Physician Decision|0|||
28018053|NCT00652626|54677305|FG003|Initial Treatment Phase|Physician Decision|0|||
28018054|NCT00652626|54677306|FG004|Initial Treatment Phase|Physician Decision|1|||
28018055|NCT00652626|54677307|FG005|Initial Treatment Phase|Physician Decision|0|||
28018056|NCT00652626|54677308|FG006|Initial Treatment Phase|Physician Decision|0|||
28018057|NCT00652626|54677302|FG000|Initial Treatment Phase|Sponsor Request|0|||
28018058|NCT00652626|54677303|FG001|Initial Treatment Phase|Sponsor Request|0|||
28018059|NCT00652626|54677304|FG002|Initial Treatment Phase|Sponsor Request|1|||
28018060|NCT00652626|54677305|FG003|Initial Treatment Phase|Sponsor Request|0|||
28018061|NCT00652626|54677306|FG004|Initial Treatment Phase|Sponsor Request|0|||
28018062|NCT00652626|54677307|FG005|Initial Treatment Phase|Sponsor Request|0|||
28018063|NCT00652626|54677308|FG006|Initial Treatment Phase|Sponsor Request|0|||
28018064|NCT00652626|54677302|FG000|Initial Treatment Phase|Lost to Follow-up|0|||
28018065|NCT00652626|54677303|FG001|Initial Treatment Phase|Lost to Follow-up|0|||
27797325|NCT02096263|54251970|FG001|Overall Study|Withdrawal by Subject|7|||
27797326|NCT02096263|54251971|FG002|Overall Study|Withdrawal by Subject|8|||
27797327|NCT01830543|54251982|FG000|Overall Study|Subject Decision|19|||
27797328|NCT01830543|54251983|FG001|Overall Study|Subject Decision|21|||
27938153|NCT01072149|54594335|FG010|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
27938154|NCT01072149|54594336|FG011|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
27938155|NCT01072149|54594337|FG012|Washout Period 2 (14 Days)|Lack of Efficacy|1|||
27938156|NCT01072149|54594338|FG013|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
27938157|NCT01072149|54594339|FG014|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
27938158|NCT01072149|54594340|FG015|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
27938159|NCT01072149|54594341|FG016|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
27938160|NCT01072149|54594342|FG017|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
27938161|NCT01072149|54594325|FG000|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
27938162|NCT01072149|54594326|FG001|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
27938163|NCT01072149|54594327|FG002|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
27938164|NCT01072149|54594328|FG003|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
27938165|NCT01072149|54594329|FG004|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
27938166|NCT01072149|54594330|FG005|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
27938167|NCT01072149|54594331|FG006|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
27938168|NCT01072149|54594332|FG007|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
27938169|NCT01072149|54594333|FG008|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
27938170|NCT01072149|54594334|FG009|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
27938171|NCT01072149|54594335|FG010|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
27938172|NCT01072149|54594336|FG011|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
27938173|NCT01072149|54594337|FG012|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
27938174|NCT01072149|54594338|FG013|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
27938175|NCT01072149|54594339|FG014|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
27938176|NCT01072149|54594340|FG015|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
27938177|NCT01072149|54594341|FG016|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
27938178|NCT01072149|54594342|FG017|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
28018066|NCT00652626|54677304|FG002|Initial Treatment Phase|Lost to Follow-up|0|||
28018067|NCT00652626|54677305|FG003|Initial Treatment Phase|Lost to Follow-up|0|||
27797329|NCT01830543|54251984|FG002|Overall Study|Subject Decision|57|||
27797330|NCT01830543|54251982|FG000|Overall Study|Adverse Event|91|||
27797331|NCT01830543|54251983|FG001|Overall Study|Adverse Event|77|||
27797332|NCT01830543|54251984|FG002|Overall Study|Adverse Event|76|||
27797333|NCT01830543|54251982|FG000|Overall Study|Death|20|||
27797334|NCT01830543|54251983|FG001|Overall Study|Death|22|||
27797335|NCT01830543|54251984|FG002|Overall Study|Death|22|||
27797336|NCT01830543|54251982|FG000|Overall Study|Protocol Violation|3|||
27797337|NCT01830543|54251983|FG001|Overall Study|Protocol Violation|7|||
27797338|NCT01830543|54251984|FG002|Overall Study|Protocol Violation|7|||
27797339|NCT01830543|54251982|FG000|Overall Study|Physician Decision|11|||
27797340|NCT01830543|54251983|FG001|Overall Study|Physician Decision|5|||
27797341|NCT01830543|54251984|FG002|Overall Study|Physician Decision|12|||
27797342|NCT01830543|54251982|FG000|Overall Study|Withdrawal by consent|3|||
27797343|NCT01830543|54251983|FG001|Overall Study|Withdrawal by consent|3|||
27797344|NCT01830543|54251984|FG002|Overall Study|Withdrawal by consent|3|||
27797345|NCT01830543|54251982|FG000|Overall Study|Other|12|||
27797346|NCT01830543|54251983|FG001|Overall Study|Other|17|||
27797347|NCT01830543|54251984|FG002|Overall Study|Other|37|||
27797348|NCT02109445|54251992|FG000|Overall Study|Symptomatic deterioration|2|||
27797349|NCT02109445|54251992|FG000|Overall Study|Adverse Event|1|||
27797350|NCT02109133|54251998|FG000|Overall Study|Lost to Follow-up|1|||
27797351|NCT02109133|54251999|FG001|Overall Study|Lost to Follow-up|0|||
27797352|NCT01623271|54252007|FG000|Overall Study|Withdrawal by Subject|2|||
27797353|NCT01856673|54252014|FG000|Overall Study|Withdrawal by Subject|44|||
27797354|NCT01856673|54252015|FG001|Overall Study|Withdrawal by Subject|50|||
27797355|NCT01856673|54252016|FG002|Overall Study|Withdrawal by Subject|33|||
27797356|NCT01856673|54252014|FG000|Overall Study|Lost to Follow-up|31|||
27797357|NCT01856673|54252015|FG001|Overall Study|Lost to Follow-up|34|||
27797358|NCT01856673|54252016|FG002|Overall Study|Lost to Follow-up|0|||
27797359|NCT01856673|54252014|FG000|Overall Study|Unknown reasons|9|||
27797360|NCT01856673|54252015|FG001|Overall Study|Unknown reasons|0|||
27797361|NCT01856673|54252016|FG002|Overall Study|Unknown reasons|0|||
27797362|NCT01856673|54252014|FG000|Overall Study|Psychologist decision|1|||
27797363|NCT01856673|54252015|FG001|Overall Study|Psychologist decision|0|||
27797364|NCT01856673|54252016|FG002|Overall Study|Psychologist decision|0|||
27797365|NCT01856673|54252014|FG000|Overall Study|Paperwork errors|8|||
27797366|NCT01856673|54252015|FG001|Overall Study|Paperwork errors|0|||
27797367|NCT01856673|54252016|FG002|Overall Study|Paperwork errors|0|||
27797368|NCT01856673|54252014|FG000|Overall Study|Death|1|||
27797369|NCT01856673|54252015|FG001|Overall Study|Death|1|||
27797370|NCT01856673|54252016|FG002|Overall Study|Death|0|||
27797371|NCT01856673|54252014|FG000|Overall Study|Protocol Violation|1|||
27797372|NCT01856673|54252015|FG001|Overall Study|Protocol Violation|0|||
27797373|NCT01856673|54252016|FG002|Overall Study|Protocol Violation|1|||
27797374|NCT02095951|54252026|FG000|Overall Study|NO POSITIVE BLOOD CULTURE|9|||
27797375|NCT02095951|54252027|FG001|Overall Study|NO POSITIVE BLOOD CULTURE|6|||
27797376|NCT02095873|54252039|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
27797377|NCT02095873|54252040|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
27797378|NCT02095873|54252039|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
27797379|NCT02095873|54252040|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
27797380|NCT02095873|54252039|FG000|Second Intervention (8 Weeks)|Protocol Violation|1|||
27797381|NCT02095873|54252040|FG001|Second Intervention (8 Weeks)|Protocol Violation|0|||
27797382|NCT02094937|54252048|FG000|8 Weeks in Period 1|Adverse Event|9|||
27797383|NCT02094937|54252049|FG001|8 Weeks in Period 1|Adverse Event|0|||
27797384|NCT02094937|54252050|FG002|8 Weeks in Period 1|Adverse Event|0|||
27797385|NCT02094937|54252051|FG003|8 Weeks in Period 1|Adverse Event|0|||
27797386|NCT02094937|54252048|FG000|8 Weeks in Period 1|Lack of Efficacy|3|||
27797387|NCT02094937|54252049|FG001|8 Weeks in Period 1|Lack of Efficacy|0|||
27797388|NCT02094937|54252050|FG002|8 Weeks in Period 1|Lack of Efficacy|0|||
27938179|NCT01071915|54594352|FG000|Overall Study|Adverse Event|3|||
27938180|NCT01071915|54594352|FG000|Overall Study|Physician Decision|2|||
27938181|NCT01071915|54594352|FG000|Overall Study|Withdrawal by Subject|2|||
27938182|NCT01071915|54594352|FG000|Overall Study|Miscellaneous Reasons|2|||
27938183|NCT00904969|54594356|FG000|Overall Study|Lost to Follow-up|4|||
27938184|NCT00904969|54594356|FG000|Overall Study|Withdrawal by Subject|3|||
27938185|NCT00904969|54594356|FG000|Overall Study|Additional Treatments|11|||
27938186|NCT00904969|54594356|FG000|Overall Study|Case Aborted; Subject Exited|1|||
27938187|NCT01070979|54594378|FG000|Overall Study|Adverse Event|2|||
27938188|NCT01070979|54594379|FG001|Overall Study|Adverse Event|3|||
27938189|NCT01070979|54594380|FG002|Overall Study|Adverse Event|3|||
27797389|NCT02094937|54252051|FG003|8 Weeks in Period 1|Lack of Efficacy|0|||
27797390|NCT02094937|54252048|FG000|8 Weeks in Period 1|Protocol Violation|2|||
27797391|NCT02094937|54252049|FG001|8 Weeks in Period 1|Protocol Violation|0|||
27797392|NCT02094937|54252050|FG002|8 Weeks in Period 1|Protocol Violation|0|||
27797393|NCT02094937|54252051|FG003|8 Weeks in Period 1|Protocol Violation|0|||
27938190|NCT01070979|54594378|FG000|Overall Study|Lost to Follow-up|2|||
27938191|NCT01070979|54594379|FG001|Overall Study|Lost to Follow-up|1|||
27938192|NCT01070979|54594380|FG002|Overall Study|Lost to Follow-up|1|||
27797394|NCT02094937|54252048|FG000|8 Weeks in Period 1|Protocol defined stopping criteria|41|||
27797395|NCT02094937|54252049|FG001|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
27797396|NCT02094937|54252050|FG002|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
27797397|NCT02094937|54252051|FG003|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
27797398|NCT02094937|54252048|FG000|8 Weeks in Period 1|Physician Decision|1|||
27797399|NCT02094937|54252049|FG001|8 Weeks in Period 1|Physician Decision|0|||
27797400|NCT02094937|54252050|FG002|8 Weeks in Period 1|Physician Decision|0|||
27797401|NCT02094937|54252051|FG003|8 Weeks in Period 1|Physician Decision|0|||
27797402|NCT02094937|54252048|FG000|8 Weeks in Period 1|Withdrawal by Subject|4|||
27797403|NCT02094937|54252049|FG001|8 Weeks in Period 1|Withdrawal by Subject|0|||
27797404|NCT02094937|54252050|FG002|8 Weeks in Period 1|Withdrawal by Subject|0|||
27797405|NCT02094937|54252051|FG003|8 Weeks in Period 1|Withdrawal by Subject|0|||
27797406|NCT02094937|54252048|FG000|12 Weeks in Period 2|Adverse Event|0|||
27797407|NCT02094937|54252049|FG001|12 Weeks in Period 2|Adverse Event|2|||
27797408|NCT02094937|54252050|FG002|12 Weeks in Period 2|Adverse Event|4|||
27797409|NCT02094937|54252051|FG003|12 Weeks in Period 2|Adverse Event|1|||
27797410|NCT02094937|54252048|FG000|12 Weeks in Period 2|Lack of Efficacy|0|||
27797411|NCT02094937|54252049|FG001|12 Weeks in Period 2|Lack of Efficacy|1|||
27797412|NCT02094937|54252050|FG002|12 Weeks in Period 2|Lack of Efficacy|0|||
27797413|NCT02094937|54252051|FG003|12 Weeks in Period 2|Lack of Efficacy|0|||
27797414|NCT02094937|54252048|FG000|12 Weeks in Period 2|Protocol defined stopping criteria|0|||
27797415|NCT02094937|54252049|FG001|12 Weeks in Period 2|Protocol defined stopping criteria|5|||
27797416|NCT02094937|54252050|FG002|12 Weeks in Period 2|Protocol defined stopping criteria|6|||
27797417|NCT02094937|54252051|FG003|12 Weeks in Period 2|Protocol defined stopping criteria|11|||
27797418|NCT02094937|54252048|FG000|12 Weeks in Period 2|Withdrawal by Subject|0|||
27797419|NCT02094937|54252049|FG001|12 Weeks in Period 2|Withdrawal by Subject|2|||
27797420|NCT02094937|54252050|FG002|12 Weeks in Period 2|Withdrawal by Subject|2|||
27797421|NCT02094937|54252051|FG003|12 Weeks in Period 2|Withdrawal by Subject|0|||
27797422|NCT02094937|54252048|FG000|12 Weeks in Period 2|Randomized incorrectly|0|||
27797423|NCT02094937|54252049|FG001|12 Weeks in Period 2|Randomized incorrectly|1|||
27797424|NCT02094937|54252050|FG002|12 Weeks in Period 2|Randomized incorrectly|0|||
27797425|NCT02094937|54252051|FG003|12 Weeks in Period 2|Randomized incorrectly|0|||
27797426|NCT02093923|54252065|FG000|Overall Study|Lost to Follow-up|0|||
27797427|NCT02093923|54252066|FG001|Overall Study|Lost to Follow-up|0|||
27797428|NCT02093923|54252067|FG002|Overall Study|Lost to Follow-up|0|||
27797429|NCT02093923|54252068|FG003|Overall Study|Lost to Follow-up|1|||
27797430|NCT02093923|54252069|FG004|Overall Study|Lost to Follow-up|0|||
27797431|NCT02093923|54252065|FG000|Overall Study|Screen failure after randomization|0|||
27797432|NCT02093923|54252066|FG001|Overall Study|Screen failure after randomization|0|||
27797433|NCT02093923|54252067|FG002|Overall Study|Screen failure after randomization|0|||
27797434|NCT02093923|54252068|FG003|Overall Study|Screen failure after randomization|1|||
27797435|NCT02093923|54252069|FG004|Overall Study|Screen failure after randomization|0|||
27797436|NCT02186561|54252085|FG000|Enrollment|Did Not Meet Inclusion Criteria|46|||
27797437|NCT02186561|54252085|FG000|Enrollment|Enrollment Cap Reached|5|||
27797438|NCT02186561|54252085|FG000|Enrollment|Insurance Denial|2|||
27797439|NCT02186561|54252085|FG000|Enrollment|Withdrawal by Subject|2|||
27797440|NCT02186561|54252085|FG000|Enrollment|Investigator Withdrew Consent|1|||
27797441|NCT02186561|54252085|FG000|30-Day Post Index Procedure Visit|Death|1|||
27797442|NCT02186561|54252085|FG000|1- Year Post Index Procedure Visit|Death|1|||
27797443|NCT02186561|54252085|FG000|1- Year Post Index Procedure Visit|Missed|1|||
27797444|NCT02066467|54252091|FG000|Overall Study|Did not undergo implant procedure|24|||
27797445|NCT02066467|54252091|FG000|Overall Study|Attempted to implant withoput success|43|||
27797446|NCT02066467|54252091|FG000|Overall Study|Consent ineligible|1|||
27797447|NCT02066467|54252091|FG000|Overall Study|Death|54|||
27797448|NCT02066467|54252091|FG000|Overall Study|Lost to Follow-up|51|||
27797449|NCT02066467|54252091|FG000|Overall Study|Adverse Event|20|||
27797450|NCT02066467|54252091|FG000|Overall Study|Withdrawal by Subject|16|||
27938193|NCT01070979|54594378|FG000|Overall Study|Protocol Violation|0|||
27938194|NCT01070979|54594379|FG001|Overall Study|Protocol Violation|2|||
27938195|NCT01070979|54594380|FG002|Overall Study|Protocol Violation|6|||
27938196|NCT01070979|54594378|FG000|Overall Study|Surgery, moving, personal, abn. labs|4|||
27938197|NCT01070979|54594379|FG001|Overall Study|Surgery, moving, personal, abn. labs|4|||
27938198|NCT01070979|54594380|FG002|Overall Study|Surgery, moving, personal, abn. labs|2|||
27938199|NCT01070979|54594378|FG000|Overall Study|Withdrawal by Subject|3|||
27938200|NCT01070979|54594379|FG001|Overall Study|Withdrawal by Subject|1|||
27938201|NCT01070979|54594380|FG002|Overall Study|Withdrawal by Subject|1|||
27938202|NCT01070979|54594378|FG000|Overall Study|No study drug taken|0|||
27938203|NCT01070979|54594379|FG001|Overall Study|No study drug taken|1|||
27938204|NCT01070979|54594380|FG002|Overall Study|No study drug taken|0|||
27938205|NCT01234337|54594390|FG000|Overall Study|Adverse Event|58|||
28018068|NCT00652626|54677306|FG004|Initial Treatment Phase|Lost to Follow-up|1|||
27797451|NCT02066467|54252091|FG000|Overall Study|Physician Decision|2|||
27797452|NCT02066467|54252091|FG000|Overall Study|Not defined|4|||
27938206|NCT01234337|54594391|FG001|Overall Study|Adverse Event|21|||
27938207|NCT01234337|54594390|FG000|Overall Study|Disease progression/recurrence/relapse|181|||
27938208|NCT01234337|54594391|FG001|Overall Study|Disease progression/recurrence/relapse|223|||
27797453|NCT02186171|54252097|FG000|Overall Study|Withdrawal by Subject|1|||
28018069|NCT00652626|54677307|FG005|Initial Treatment Phase|Lost to Follow-up|0|||
28018070|NCT00652626|54677308|FG006|Initial Treatment Phase|Lost to Follow-up|0|||
28018071|NCT00652626|54677302|FG000|Extension Phase|Withdrawal by Subject|0|||
28018072|NCT00652626|54677303|FG001|Extension Phase|Withdrawal by Subject|0|||
28018073|NCT00652626|54677304|FG002|Extension Phase|Withdrawal by Subject|0|||
28018074|NCT00652626|54677305|FG003|Extension Phase|Withdrawal by Subject|0|||
28018075|NCT00652626|54677306|FG004|Extension Phase|Withdrawal by Subject|0|||
28018076|NCT00652626|54677307|FG005|Extension Phase|Withdrawal by Subject|2|||
28018077|NCT00652626|54677308|FG006|Extension Phase|Withdrawal by Subject|0|||
28018078|NCT00652626|54677302|FG000|Extension Phase|Adverse Event|0|||
28018079|NCT00652626|54677303|FG001|Extension Phase|Adverse Event|0|||
28018080|NCT00652626|54677304|FG002|Extension Phase|Adverse Event|0|||
28018081|NCT00652626|54677305|FG003|Extension Phase|Adverse Event|0|||
28018082|NCT00652626|54677306|FG004|Extension Phase|Adverse Event|0|||
27797454|NCT02186171|54252098|FG001|Overall Study|Withdrawal by Subject|9|||
27797455|NCT02186171|54252097|FG000|Overall Study|Lost to Follow-up|2|||
27797456|NCT02186171|54252098|FG001|Overall Study|Lost to Follow-up|2|||
27797457|NCT02186171|54252097|FG000|Overall Study|Death|1|||
27797458|NCT02186171|54252098|FG001|Overall Study|Death|2|||
27797459|NCT02186171|54252097|FG000|Overall Study|Protocol-specified Criteria|0|||
27797460|NCT02186171|54252098|FG001|Overall Study|Protocol-specified Criteria|2|||
28018083|NCT00652626|54677307|FG005|Extension Phase|Adverse Event|2|||
28018084|NCT00652626|54677308|FG006|Extension Phase|Adverse Event|1|||
28018085|NCT00652626|54677302|FG000|Extension Phase|No Longer Receiving Clinical Benefit|0|||
28018086|NCT00652626|54677303|FG001|Extension Phase|No Longer Receiving Clinical Benefit|0|||
28018087|NCT00652626|54677304|FG002|Extension Phase|No Longer Receiving Clinical Benefit|0|||
28018088|NCT00652626|54677305|FG003|Extension Phase|No Longer Receiving Clinical Benefit|0|||
28018089|NCT00652626|54677306|FG004|Extension Phase|No Longer Receiving Clinical Benefit|0|||
28018090|NCT00652626|54677307|FG005|Extension Phase|No Longer Receiving Clinical Benefit|6|||
28018091|NCT00652626|54677308|FG006|Extension Phase|No Longer Receiving Clinical Benefit|0|||
28018092|NCT00652626|54677302|FG000|Extension Phase|Physician Decision|0|||
28018093|NCT00652626|54677303|FG001|Extension Phase|Physician Decision|0|||
28018094|NCT00652626|54677304|FG002|Extension Phase|Physician Decision|0|||
28018095|NCT00652626|54677305|FG003|Extension Phase|Physician Decision|0|||
28018096|NCT00652626|54677306|FG004|Extension Phase|Physician Decision|0|||
28018097|NCT00652626|54677307|FG005|Extension Phase|Physician Decision|1|||
28018098|NCT00652626|54677308|FG006|Extension Phase|Physician Decision|1|||
28018099|NCT00652626|54677302|FG000|Extension Phase|Death|0|||
28018100|NCT00652626|54677303|FG001|Extension Phase|Death|0|||
28018101|NCT00652626|54677304|FG002|Extension Phase|Death|0|||
28018102|NCT00652626|54677305|FG003|Extension Phase|Death|0|||
28018103|NCT00652626|54677306|FG004|Extension Phase|Death|0|||
28018104|NCT00652626|54677307|FG005|Extension Phase|Death|1|||
28018105|NCT00652626|54677308|FG006|Extension Phase|Death|1|||
28018106|NCT00560703|54677328|FG000|Overall Study|Adverse Event|0|||
28018107|NCT00560703|54677329|FG001|Overall Study|Adverse Event|2|||
27938209|NCT01234337|54594390|FG000|Overall Study|Investi. decision not protocol driven|5|||
27938210|NCT01234337|54594391|FG001|Overall Study|Investi. decision not protocol driven|6|||
28018108|NCT00560703|54677328|FG000|Overall Study|Protocol Violation|0|||
28018109|NCT00560703|54677329|FG001|Overall Study|Protocol Violation|2|||
28018110|NCT00560703|54677328|FG000|Overall Study|Withdrawal by Subject|0|||
28018111|NCT00560703|54677329|FG001|Overall Study|Withdrawal by Subject|1|||
28018112|NCT00560703|54677328|FG000|Overall Study|non-compliance|0|||
28018113|NCT00560703|54677329|FG001|Overall Study|non-compliance|1|||
28018114|NCT00308737|54677338|FG000|Overall Study|Adverse Event|104|||
28018115|NCT00308737|54677339|FG001|Overall Study|Adverse Event|9|||
27797461|NCT02186015|54252106|FG000|Overall Study|Physician Decision|1|||
27938211|NCT01234337|54594390|FG000|Overall Study|Non-compliant with study medication|3|||
27938212|NCT01234337|54594391|FG001|Overall Study|Non-compliant with study medication|2|||
27938213|NCT01234337|54594390|FG000|Overall Study|Randomized but not treated|6|||
27938214|NCT01234337|54594391|FG001|Overall Study|Randomized but not treated|4|||
27938215|NCT01234337|54594390|FG000|Overall Study|Lost to Follow-up|0|||
27938216|NCT01234337|54594391|FG001|Overall Study|Lost to Follow-up|1|||
27938217|NCT01234337|54594390|FG000|Overall Study|Protocol Violation|2|||
27938218|NCT01234337|54594391|FG001|Overall Study|Protocol Violation|3|||
28018116|NCT00308737|54677340|FG002|Overall Study|Adverse Event|0|||
28018117|NCT00308737|54677338|FG000|Overall Study|Death|4|||
28018118|NCT00308737|54677339|FG001|Overall Study|Death|3|||
27797462|NCT02186015|54252107|FG001|Overall Study|Physician Decision|0|||
27797463|NCT02066389|54252120|FG000|Overall Study|Adverse Event|1|||
27797464|NCT02066389|54252121|FG001|Overall Study|Adverse Event|1|||
27797465|NCT02066389|54252122|FG002|Overall Study|Adverse Event|1|||
27797466|NCT02066389|54252123|FG003|Overall Study|Adverse Event|1|||
27797467|NCT02066389|54252124|FG004|Overall Study|Adverse Event|5|||
27797468|NCT02066389|54252125|FG005|Overall Study|Adverse Event|1|||
27797469|NCT02066389|54252120|FG000|Overall Study|Withdrawal by Subject|4|||
27797470|NCT02066389|54252121|FG001|Overall Study|Withdrawal by Subject|0|||
28018119|NCT00308737|54677340|FG002|Overall Study|Death|0|||
27797471|NCT02066389|54252122|FG002|Overall Study|Withdrawal by Subject|5|||
27797472|NCT02066389|54252123|FG003|Overall Study|Withdrawal by Subject|1|||
27797473|NCT02066389|54252124|FG004|Overall Study|Withdrawal by Subject|1|||
27797474|NCT02066389|54252125|FG005|Overall Study|Withdrawal by Subject|2|||
27797475|NCT02066389|54252120|FG000|Overall Study|Lost to Follow-up|0|||
27797476|NCT02066389|54252121|FG001|Overall Study|Lost to Follow-up|0|||
27797477|NCT02066389|54252122|FG002|Overall Study|Lost to Follow-up|0|||
27797478|NCT02066389|54252123|FG003|Overall Study|Lost to Follow-up|1|||
27797479|NCT02066389|54252124|FG004|Overall Study|Lost to Follow-up|1|||
27797480|NCT02066389|54252125|FG005|Overall Study|Lost to Follow-up|1|||
27797481|NCT02066389|54252120|FG000|Overall Study|Randomized in Error|0|||
27797482|NCT02066389|54252121|FG001|Overall Study|Randomized in Error|0|||
27797483|NCT02066389|54252122|FG002|Overall Study|Randomized in Error|0|||
27797484|NCT02066389|54252123|FG003|Overall Study|Randomized in Error|0|||
27797485|NCT02066389|54252124|FG004|Overall Study|Randomized in Error|0|||
27797486|NCT02066389|54252125|FG005|Overall Study|Randomized in Error|1|||
27797487|NCT02106403|54252139|FG000|Follow-Up Visit 3|Other Reason|0|||
27797488|NCT02106403|54252140|FG001|Follow-Up Visit 3|Other Reason|0|||
27797489|NCT02106403|54252141|FG002|Follow-Up Visit 3|Other Reason|0|||
27797490|NCT02106403|54252142|FG003|Follow-Up Visit 3|Other Reason|0|||
27797491|NCT02106403|54252143|FG004|Follow-Up Visit 3|Other Reason|0|||
27797492|NCT02106403|54252144|FG005|Follow-Up Visit 3|Other Reason|1|||
27797493|NCT02133131|54252161|FG000|Overall Study|Adverse Event|0|||
27797494|NCT02133131|54252162|FG001|Overall Study|Adverse Event|0|||
27797495|NCT02133131|54252163|FG002|Overall Study|Adverse Event|0|||
27797496|NCT02133131|54252164|FG003|Overall Study|Adverse Event|1|||
27797497|NCT02133131|54252165|FG004|Overall Study|Adverse Event|0|||
27797498|NCT02133131|54252166|FG005|Overall Study|Adverse Event|0|||
27797499|NCT02133131|54252167|FG006|Overall Study|Adverse Event|0|||
27797500|NCT02133131|54252161|FG000|Overall Study|Lost to Follow-up|1|||
27797501|NCT02133131|54252162|FG001|Overall Study|Lost to Follow-up|0|||
27797502|NCT02133131|54252163|FG002|Overall Study|Lost to Follow-up|0|||
27797503|NCT02133131|54252164|FG003|Overall Study|Lost to Follow-up|1|||
27797504|NCT02133131|54252165|FG004|Overall Study|Lost to Follow-up|0|||
27797505|NCT02133131|54252166|FG005|Overall Study|Lost to Follow-up|0|||
27797506|NCT02133131|54252167|FG006|Overall Study|Lost to Follow-up|0|||
27797507|NCT02133131|54252161|FG000|Overall Study|Status not recorded|4|||
27797508|NCT02133131|54252162|FG001|Overall Study|Status not recorded|5|||
27797509|NCT02133131|54252163|FG002|Overall Study|Status not recorded|1|||
27797510|NCT02133131|54252164|FG003|Overall Study|Status not recorded|4|||
27797511|NCT02133131|54252165|FG004|Overall Study|Status not recorded|0|||
27797512|NCT02133131|54252166|FG005|Overall Study|Status not recorded|0|||
27797513|NCT02133131|54252167|FG006|Overall Study|Status not recorded|0|||
27797514|NCT02133131|54252161|FG000|Overall Study|Ongoing in study|0|||
27938219|NCT01234337|54594390|FG000|Overall Study|Withdrawal by Subject|11|||
27938220|NCT01234337|54594391|FG001|Overall Study|Withdrawal by Subject|9|||
27938221|NCT01234337|54594390|FG000|Overall Study|Death|0|||
27938222|NCT01234337|54594391|FG001|Overall Study|Death|1|||
27938223|NCT01234337|54594390|FG000|Overall Study|Switch to commercial drug|0|||
27938224|NCT01234337|54594391|FG001|Overall Study|Switch to commercial drug|1|||
27938225|NCT01070043|54594399|FG000|Run-In Phase|Did not Meet Inclusion Criteria|18|||
27938226|NCT01070043|54594400|FG001|Run-In Phase|Did not Meet Inclusion Criteria|0|||
27938227|NCT01070043|54594401|FG002|Run-In Phase|Did not Meet Inclusion Criteria|0|||
27938228|NCT01070043|54594399|FG000|Double-Blind Treatment|Adverse Event|0|||
27797515|NCT02133131|54252162|FG001|Overall Study|Ongoing in study|0|||
27797516|NCT02133131|54252163|FG002|Overall Study|Ongoing in study|0|||
27797517|NCT02133131|54252164|FG003|Overall Study|Ongoing in study|0|||
27797518|NCT02133131|54252165|FG004|Overall Study|Ongoing in study|15|||
27797519|NCT02133131|54252166|FG005|Overall Study|Ongoing in study|14|||
27797520|NCT02133131|54252167|FG006|Overall Study|Ongoing in study|11|||
27797521|NCT02133131|54252161|FG000|Overall Study|Protocol Violation|0|||
27797522|NCT02133131|54252162|FG001|Overall Study|Protocol Violation|0|||
27797523|NCT02133131|54252163|FG002|Overall Study|Protocol Violation|0|||
27938229|NCT01070043|54594400|FG001|Double-Blind Treatment|Adverse Event|0|||
27938230|NCT01070043|54594401|FG002|Double-Blind Treatment|Adverse Event|2|||
27938231|NCT01074255|54594407|FG000|Overall Study|Did not receive EMEND|2|||
27938232|NCT01073943|54594413|FG000|Overall Study|Withdrawal by Subject|8|||
27938233|NCT01073943|54594414|FG001|Overall Study|Withdrawal by Subject|2|||
27797524|NCT02133131|54252164|FG003|Overall Study|Protocol Violation|0|||
27797525|NCT02133131|54252165|FG004|Overall Study|Protocol Violation|0|||
27797526|NCT02133131|54252166|FG005|Overall Study|Protocol Violation|0|||
27797527|NCT02133131|54252167|FG006|Overall Study|Protocol Violation|1|||
27797528|NCT02106325|54252185|FG000|Phase 1|Lost to Follow-up|2|||
27797529|NCT02106325|54252186|FG001|Phase 1|Lost to Follow-up|2|||
27797530|NCT02106325|54252185|FG000|Phase 2|Lost to Follow-up|2|||
27797531|NCT02106325|54252186|FG001|Phase 2|Lost to Follow-up|3|||
27797532|NCT02106325|54252185|FG000|Phase 3|Lost to Follow-up|2|||
27797533|NCT02106325|54252186|FG001|Phase 3|Lost to Follow-up|1|||
27797534|NCT01625689|54252194|FG000|Overall Study|Migration|2|||
27797535|NCT01625689|54252195|FG001|Overall Study|Migration|1|||
27797536|NCT02184611|54252203|FG000|Overall Study|Lack of Efficacy|11|||
28018120|NCT00308737|54677338|FG000|Overall Study|Lost to Follow-up|56|||
28018121|NCT00308737|54677339|FG001|Overall Study|Lost to Follow-up|80|||
28018122|NCT00308737|54677340|FG002|Overall Study|Lost to Follow-up|5|||
28018123|NCT00308737|54677338|FG000|Overall Study|Physician Decision|15|||
28018124|NCT00308737|54677339|FG001|Overall Study|Physician Decision|2|||
28018125|NCT00308737|54677340|FG002|Overall Study|Physician Decision|1|||
28018126|NCT00308737|54677338|FG000|Overall Study|Protocol Violation|34|||
28018127|NCT00308737|54677339|FG001|Overall Study|Protocol Violation|9|||
28018128|NCT00308737|54677340|FG002|Overall Study|Protocol Violation|5|||
28018129|NCT00308737|54677338|FG000|Overall Study|Withdrawal by Subject|218|||
28018130|NCT00308737|54677339|FG001|Overall Study|Withdrawal by Subject|166|||
28018131|NCT00308737|54677340|FG002|Overall Study|Withdrawal by Subject|18|||
28018132|NCT00308737|54677338|FG000|Overall Study|Various|32|||
28018133|NCT00308737|54677339|FG001|Overall Study|Various|20|||
28018134|NCT00308737|54677340|FG002|Overall Study|Various|8|||
28018135|NCT00655746|54677348|FG000|Overall Study|Withdrawal by Subject|1|||
28018136|NCT00338455|54677358|FG000|Overall Study|Death|2|||
28018137|NCT00338455|54677359|FG001|Overall Study|Death|1|||
28018138|NCT00338455|54677358|FG000|Overall Study|Physician Decision|1|||
28018139|NCT00338455|54677359|FG001|Overall Study|Physician Decision|0|||
28018140|NCT00651924|54677367|FG000|Overall Study|Withdrawal by PI|0|||
28018141|NCT00651924|54677368|FG001|Overall Study|Withdrawal by PI|2|||
28018142|NCT00651924|54677367|FG000|Overall Study|Withdrawal by Subject|0|||
28018143|NCT00651924|54677368|FG001|Overall Study|Withdrawal by Subject|5|||
28018144|NCT00678392|54677376|FG000|Overall Study|Adverse Event|0|||
28018145|NCT00678392|54677377|FG001|Overall Study|Adverse Event|6|||
27938234|NCT01073943|54594413|FG000|Overall Study|Protocol Violation|2|||
27938235|NCT01073943|54594414|FG001|Overall Study|Protocol Violation|1|||
27938236|NCT01073943|54594413|FG000|Overall Study|Adverse Event|1|||
27938237|NCT01073943|54594414|FG001|Overall Study|Adverse Event|1|||
27938238|NCT01073943|54594413|FG000|Overall Study|Lost to Follow-up|0|||
27938239|NCT01073943|54594414|FG001|Overall Study|Lost to Follow-up|2|||
27938240|NCT01073943|54594413|FG000|Overall Study|Power outage; colonoscopy not done|1|||
27938241|NCT01073943|54594414|FG001|Overall Study|Power outage; colonoscopy not done|0|||
27938242|NCT01073943|54594413|FG000|Overall Study|Subject forgot|0|||
27938243|NCT01073943|54594414|FG001|Overall Study|Subject forgot|1|||
27938244|NCT01073943|54594413|FG000|Overall Study|Unable to return for follow-up|0|||
27938245|NCT01073943|54594414|FG001|Overall Study|Unable to return for follow-up|1|||
27938246|NCT01073943|54594413|FG000|Overall Study|Could not tolerate prep|1|||
27938247|NCT01073943|54594414|FG001|Overall Study|Could not tolerate prep|0|||
27938248|NCT01073865|54594422|FG000|Overall Study|Reasons other than below|19|||
27938249|NCT01073865|54594423|FG001|Overall Study|Reasons other than below|31|||
27938250|NCT01073865|54594422|FG000|Overall Study|Lost to Follow-up|1|||
27938251|NCT01073865|54594423|FG001|Overall Study|Lost to Follow-up|1|||
27938252|NCT01073865|54594422|FG000|Overall Study|Death|3|||
27938253|NCT01073865|54594423|FG001|Overall Study|Death|2|||
27938254|NCT01073865|54594422|FG000|Overall Study|Withdrawal by Subject|5|||
27938255|NCT01073865|54594423|FG001|Overall Study|Withdrawal by Subject|5|||
27938256|NCT04862065|54594432|FG000|Screening|Protocol Violation|54|||
27938257|NCT04862065|54594433|FG001|Screening|Protocol Violation|0|||
28018146|NCT00678392|54677376|FG000|Overall Study|Death|280|||
28018147|NCT00678392|54677377|FG001|Overall Study|Death|269|||
28018148|NCT00678392|54677376|FG000|Overall Study|Lost to Follow-up|15|||
28018149|NCT00678392|54677377|FG001|Overall Study|Lost to Follow-up|13|||
28018150|NCT00678392|54677376|FG000|Overall Study|Objective Progression or Relapse|3|||
28018151|NCT00678392|54677377|FG001|Overall Study|Objective Progression or Relapse|8|||
28018152|NCT00678392|54677376|FG000|Overall Study|Sponsor's Decision|1|||
27938258|NCT04862065|54594434|FG002|Screening|Protocol Violation|0|||
27938259|NCT04862065|54594432|FG000|Screening|Insufficient Sample|1|||
27938260|NCT04862065|54594433|FG001|Screening|Insufficient Sample|0|||
27938261|NCT04862065|54594434|FG002|Screening|Insufficient Sample|0|||
28018153|NCT00678392|54677377|FG001|Overall Study|Sponsor's Decision|2|||
28018154|NCT00678392|54677376|FG000|Overall Study|Withdrawal by Subject|4|||
28018155|NCT00678392|54677377|FG001|Overall Study|Withdrawal by Subject|4|||
28018156|NCT00678392|54677376|FG000|Overall Study|Randomized But Not Treated|2|||
27797537|NCT02184611|54252204|FG001|Overall Study|Lack of Efficacy|15|||
27797538|NCT02184611|54252203|FG000|Overall Study|Withdrawal by Subject|5|||
28018157|NCT00678392|54677377|FG001|Overall Study|Randomized But Not Treated|7|||
28018158|NCT00678392|54677376|FG000|Overall Study|Other|56|||
28018159|NCT00678392|54677377|FG001|Overall Study|Other|53|||
28018160|NCT00308581|54677383|FG000|Induction Phase|Adverse Event|0|||
28018161|NCT00308581|54677384|FG001|Induction Phase|Adverse Event|0|||
28018162|NCT00308581|54677385|FG002|Induction Phase|Adverse Event|37|||
28018163|NCT00308581|54677383|FG000|Induction Phase|Lack of Efficacy|0|||
27797539|NCT02184611|54252204|FG001|Overall Study|Withdrawal by Subject|6|||
27797540|NCT02184611|54252203|FG000|Overall Study|Adverse Event|4|||
27797541|NCT02184611|54252204|FG001|Overall Study|Adverse Event|5|||
27938262|NCT04862065|54594432|FG000|Follow-Up|Lost to Follow-up|3|||
27938263|NCT04862065|54594433|FG001|Follow-Up|Lost to Follow-up|0|||
27938264|NCT04862065|54594434|FG002|Follow-Up|Lost to Follow-up|0|||
27938265|NCT01073631|54594440|FG000|Overall Study|Death|82|||
27938266|NCT01073631|54594440|FG000|Overall Study|Adverse Event|24|||
27938267|NCT01073631|54594440|FG000|Overall Study|Other|63|||
27938268|NCT01073163|54594444|FG000|Overall Study|Adverse Event|1|||
27938269|NCT01073163|54594444|FG000|Overall Study|Disease Progression|1|||
27938270|NCT01073163|54594444|FG000|Overall Study|Early termination|1|||
27938271|NCT01072929|54594455|FG000|Overall Study|Adverse Event|8|||
27938272|NCT01072929|54594456|FG001|Overall Study|Adverse Event|11|||
27938273|NCT01072929|54594457|FG002|Overall Study|Adverse Event|2|||
27938274|NCT01072929|54594455|FG000|Overall Study|Lack of Efficacy|7|||
27797542|NCT02184611|54252203|FG000|Overall Study|Protocol Violation|1|||
27797543|NCT02184611|54252204|FG001|Overall Study|Protocol Violation|1|||
27797544|NCT02184611|54252203|FG000|Overall Study|Protocol defined stopping criteria|0|||
27797545|NCT02184611|54252204|FG001|Overall Study|Protocol defined stopping criteria|1|||
27797546|NCT02066311|54252210|FG000|Overall Study|Adverse Event|4|||
27797547|NCT02066311|54252210|FG000|Overall Study|Withdrawal by Subject|1|||
27797548|NCT02184455|54252214|FG000|Overall Study|Lost to Follow-up|1|||
27797549|NCT02184143|54252220|FG000|Overall Study|Withdrawal by Subject|4|||
27797550|NCT02184143|54252221|FG001|Overall Study|Withdrawal by Subject|4|||
27797551|NCT02184143|54252220|FG000|Overall Study|Lost to Follow-up|5|||
27797552|NCT02184143|54252221|FG001|Overall Study|Lost to Follow-up|3|||
27797553|NCT02184143|54252220|FG000|Overall Study|Death|1|||
27797554|NCT02184143|54252221|FG001|Overall Study|Death|0|||
27797555|NCT01625611|54252231|FG000|Overall Study|No adlib drinks Lab 1|3|||
27797556|NCT01625611|54252232|FG001|Overall Study|No adlib drinks Lab 1|0|||
27797557|NCT01625611|54252231|FG000|Overall Study|Technical issues with PET|1|||
27797558|NCT01625611|54252232|FG001|Overall Study|Technical issues with PET|0|||
27797559|NCT01625611|54252231|FG000|Overall Study|Unable to complete study procedures|1|||
27797560|NCT01625611|54252232|FG001|Overall Study|Unable to complete study procedures|0|||
27797561|NCT01625611|54252231|FG000|Overall Study|Withdrawal by Subject|3|||
27797562|NCT01625611|54252232|FG001|Overall Study|Withdrawal by Subject|0|||
27797563|NCT02159807|54252242|FG000|Overall Study|Adverse Event|0|||
27797564|NCT02159807|54252243|FG001|Overall Study|Adverse Event|0|||
27797565|NCT02159807|54252244|FG002|Overall Study|Adverse Event|1|||
27797566|NCT02159807|54252242|FG000|Overall Study|No CSF|1|||
27797567|NCT02159807|54252243|FG001|Overall Study|No CSF|1|||
27797568|NCT02159807|54252244|FG002|Overall Study|No CSF|1|||
27797569|NCT02159807|54252242|FG000|Overall Study|elevated blood pressure|0|||
27797570|NCT02159807|54252243|FG001|Overall Study|elevated blood pressure|0|||
27797571|NCT02159807|54252244|FG002|Overall Study|elevated blood pressure|1|||
27797572|NCT02066233|54252254|FG000|EG Scan II (Day 1)|difficulty intubating subject|6|||
27797573|NCT02066233|54252255|FG001|EG Scan II (Day 1)|difficulty intubating subject|6|||
27797574|NCT02159729|54252263|FG000|Overall Study|Adverse Event|0|||
27797575|NCT02159729|54252264|FG001|Overall Study|Adverse Event|1|||
27797576|NCT02159729|54252263|FG000|Overall Study|Subject's Request|13|||
27797577|NCT02159729|54252264|FG001|Overall Study|Subject's Request|10|||
27797578|NCT02159729|54252263|FG000|Overall Study|Lost to Follow-up|24|||
27797579|NCT02159729|54252264|FG001|Overall Study|Lost to Follow-up|9|||
27797580|NCT02159729|54252263|FG000|Overall Study|Non compliance|2|||
27797581|NCT02159729|54252264|FG001|Overall Study|Non compliance|0|||
27797582|NCT02159729|54252263|FG000|Overall Study|Other Unspecified|3|||
27797583|NCT02159729|54252264|FG001|Overall Study|Other Unspecified|1|||
27797584|NCT02159183|54252272|FG000|Analysis After the 36 Months Follow-up|Protocol Violation|2|||
27797585|NCT02159183|54252273|FG001|Analysis After the 36 Months Follow-up|Protocol Violation|1|||
27797586|NCT02159183|54252272|FG000|Analysis After the 36 Months Follow-up|Adverse Event|1|||
27797587|NCT02159183|54252273|FG001|Analysis After the 36 Months Follow-up|Adverse Event|0|||
27938275|NCT01072929|54594456|FG001|Overall Study|Lack of Efficacy|4|||
27938276|NCT01072929|54594457|FG002|Overall Study|Lack of Efficacy|0|||
27938277|NCT01072929|54594455|FG000|Overall Study|Withdrawal by Subject|7|||
27938278|NCT01072929|54594456|FG001|Overall Study|Withdrawal by Subject|15|||
27938279|NCT01072929|54594457|FG002|Overall Study|Withdrawal by Subject|3|||
28018164|NCT00308581|54677384|FG001|Induction Phase|Lack of Efficacy|0|||
28018165|NCT00308581|54677385|FG002|Induction Phase|Lack of Efficacy|121|||
28018166|NCT00308581|54677383|FG000|Induction Phase|Withdrawal by Subject|0|||
28018167|NCT00308581|54677384|FG001|Induction Phase|Withdrawal by Subject|0|||
27797588|NCT02159183|54252272|FG000|Analysis After the 36 Months Follow-up|Death|0|||
27797589|NCT02159183|54252273|FG001|Analysis After the 36 Months Follow-up|Death|1|||
27797590|NCT02159183|54252272|FG000|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1|||
27797591|NCT02159183|54252273|FG001|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0|||
27797592|NCT02159183|54252272|FG000|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2|||
27797593|NCT02159183|54252273|FG001|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1|||
27797594|NCT02183675|54252285|FG000|Treatment Period 2 (10 Days)|Adverse Event|0|||
27797595|NCT02183675|54252286|FG001|Treatment Period 2 (10 Days)|Adverse Event|0|||
27797596|NCT02183675|54252287|FG002|Treatment Period 2 (10 Days)|Adverse Event|0|||
27797597|NCT02183675|54252288|FG003|Treatment Period 2 (10 Days)|Adverse Event|0|||
27797598|NCT02183675|54252289|FG004|Treatment Period 2 (10 Days)|Adverse Event|0|||
27797599|NCT02183675|54252290|FG005|Treatment Period 2 (10 Days)|Adverse Event|2|||
27797600|NCT02183519|54252302|FG000|Overall Study|computer error|3|||
27797601|NCT02183519|54252303|FG001|Overall Study|computer error|0|||
27797602|NCT02183519|54252302|FG000|Overall Study|Did not respond to cough inducter|0|||
27797603|NCT02183519|54252303|FG001|Overall Study|Did not respond to cough inducter|3|||
27797604|NCT02132195|54252312|FG000|Initial Assignment|Relapsed|14|||
27797605|NCT02132195|54252313|FG001|Initial Assignment|Relapsed|0|||
27797606|NCT02132195|54252314|FG002|Initial Assignment|Relapsed|0|||
27797607|NCT02132195|54252312|FG000|Rescue Therapy|Relapsed|0|||
27797608|NCT02132195|54252313|FG001|Rescue Therapy|Relapsed|0|||
27797609|NCT02132195|54252314|FG002|Rescue Therapy|Relapsed|7|||
27797610|NCT02132195|54252312|FG000|Rescue Therapy|Physician Decision|0|||
27797611|NCT02132195|54252313|FG001|Rescue Therapy|Physician Decision|0|||
27797612|NCT02132195|54252314|FG002|Rescue Therapy|Physician Decision|1|||
27797613|NCT02132195|54252312|FG000|Rescue Therapy|Withdrawal by Subject|0|||
27797614|NCT02132195|54252313|FG001|Rescue Therapy|Withdrawal by Subject|0|||
27797615|NCT02132195|54252314|FG002|Rescue Therapy|Withdrawal by Subject|1|||
27797616|NCT02132195|54252312|FG000|Rescue Therapy|Adverse Event|0|||
27797617|NCT02132195|54252313|FG001|Rescue Therapy|Adverse Event|0|||
27797618|NCT02132195|54252314|FG002|Rescue Therapy|Adverse Event|2|||
27797619|NCT02182973|54252324|FG000|Overall Study|Withdrawal by Subject|3|||
27797620|NCT02182973|54252325|FG001|Overall Study|Withdrawal by Subject|0|||
27797621|NCT02182895|54252334|FG000|Overall Study|Discharged from hospital within 24 hours|2|||
27797622|NCT02182895|54252335|FG001|Overall Study|Discharged from hospital within 24 hours|4|||
27797623|NCT01625377|54252343|FG000|Overall Study|Death|1|||
27797624|NCT01625377|54252344|FG001|Overall Study|Death|1|||
27797625|NCT01625377|54252343|FG000|Overall Study|Administrative Problem|1|||
27797626|NCT01625377|54252344|FG001|Overall Study|Administrative Problem|1|||
27797627|NCT01625377|54252343|FG000|Overall Study|Protocol Violation|0|||
27797628|NCT01625377|54252344|FG001|Overall Study|Protocol Violation|3|||
27797629|NCT01625377|54252343|FG000|Overall Study|Adverse Event|3|||
27797630|NCT01625377|54252344|FG001|Overall Study|Adverse Event|16|||
27797631|NCT01625377|54252343|FG000|Overall Study|Graft loss|1|||
27797632|NCT01625377|54252344|FG001|Overall Study|Graft loss|0|||
27797633|NCT01625377|54252343|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
27797634|NCT01625377|54252344|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
27797635|NCT01625377|54252343|FG000|Overall Study|Abnormal laboratory values|1|||
27797636|NCT01625377|54252344|FG001|Overall Study|Abnormal laboratory values|0|||
27797637|NCT02158949|54252352|FG000|Overall Study|Withdrawal by Subject|1|||
27797638|NCT02158949|54252353|FG001|Overall Study|Withdrawal by Subject|0|||
27797639|NCT02158949|54252352|FG000|Overall Study|Lost to Follow-up|5|||
27797640|NCT02158949|54252353|FG001|Overall Study|Lost to Follow-up|11|||
27797641|NCT02132117|54252361|FG000|Overall Study|Adverse Event|6|||
27797642|NCT02132117|54252362|FG001|Overall Study|Adverse Event|1|||
27797643|NCT02132117|54252361|FG000|Overall Study|Lost to Follow-up|2|||
27797644|NCT02132117|54252362|FG001|Overall Study|Lost to Follow-up|2|||
27797645|NCT02132117|54252361|FG000|Overall Study|Personal Reasons|1|||
27797646|NCT02132117|54252362|FG001|Overall Study|Personal Reasons|2|||
27797647|NCT02132117|54252361|FG000|Overall Study|Other Miscellaneous Reasons|2|||
27797648|NCT02132117|54252362|FG001|Overall Study|Other Miscellaneous Reasons|0|||
27797649|NCT02093689|54252371|FG000|Overall Study|Physician Decision|4|||
27797650|NCT02093689|54252372|FG001|Overall Study|Physician Decision|0|||
27797651|NCT02093689|54252373|FG002|Overall Study|Physician Decision|0|||
27797652|NCT02047045|54252381|FG000|Baseline|Withdrawal by Subject|3|||
27797653|NCT02047045|54252382|FG001|Baseline|Withdrawal by Subject|2|||
27797654|NCT02047045|54252381|FG000|Treatment Period (8 Weeks )|Adverse Event|3|||
27797655|NCT02047045|54252382|FG001|Treatment Period (8 Weeks )|Adverse Event|1|||
27797656|NCT02047045|54252381|FG000|Treatment Period (8 Weeks )|Lost to Follow-up|1|||
27797657|NCT02047045|54252382|FG001|Treatment Period (8 Weeks )|Lost to Follow-up|3|||
27797658|NCT02047045|54252381|FG000|Treatment Period (8 Weeks )|Withdrawal by Subject|3|||
27797659|NCT02047045|54252382|FG001|Treatment Period (8 Weeks )|Withdrawal by Subject|5|||
27797660|NCT02047045|54252381|FG000|Treatment Period (8 Weeks )|moved far away out of work|3|||
27797661|NCT02047045|54252382|FG001|Treatment Period (8 Weeks )|moved far away out of work|0|||
27797662|NCT02047045|54252381|FG000|Treatment Period (8 Weeks )|no reason was given|1|||
27797663|NCT02047045|54252382|FG001|Treatment Period (8 Weeks )|no reason was given|0|||
27797664|NCT02047045|54252381|FG000|Treatment Period (8 Weeks )|refused to take drugs|0|||
27797665|NCT02047045|54252382|FG001|Treatment Period (8 Weeks )|refused to take drugs|5|||
27797666|NCT02047045|54252381|FG000|Treatment Period (8 Weeks )|for safety considerations|0|||
27797667|NCT02047045|54252382|FG001|Treatment Period (8 Weeks )|for safety considerations|1|||
27797668|NCT02047045|54252381|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
27797669|NCT02047045|54252382|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
27797670|NCT02131259|54252388|FG000|Overall Study|Progressive disease|751|||
27797671|NCT02131259|54252388|FG000|Overall Study|Adverse Event|341|||
27797672|NCT02131259|54252388|FG000|Overall Study|Lost to Follow-up|7|||
27797673|NCT02131259|54252388|FG000|Overall Study|Relocation|32|||
27797674|NCT02131259|54252388|FG000|Overall Study|Other|63|||
27797675|NCT02131259|54252388|FG000|Overall Study|Progressive disease/Adverse Event (AE)|22|||
27797676|NCT02131259|54252388|FG000|Overall Study|Progressive disease/relocation|1|||
27797677|NCT02131259|54252388|FG000|Overall Study|Progressive disease/other|2|||
27797678|NCT02131259|54252388|FG000|Overall Study|AE/lost to follow-up|1|||
27797679|NCT02131259|54252388|FG000|Overall Study|AE/other|1|||
27797680|NCT02131259|54252388|FG000|Overall Study|Progressive disease/AE/other|1|||
27797681|NCT02131259|54252388|FG000|Overall Study|Missing|3|||
27797682|NCT01856595|54252401|FG000|Overall Study|Withdrawal by Subject|0|||
27797683|NCT01856595|54252402|FG001|Overall Study|Withdrawal by Subject|1|||
27797684|NCT01856595|54252403|FG002|Overall Study|Withdrawal by Subject|0|||
27797685|NCT01856595|54252404|FG003|Overall Study|Withdrawal by Subject|0|||
27797686|NCT01856595|54252405|FG004|Overall Study|Withdrawal by Subject|0|||
27797687|NCT01856595|54252406|FG005|Overall Study|Withdrawal by Subject|0|||
27797688|NCT01856595|54252407|FG006|Overall Study|Withdrawal by Subject|1|||
27797689|NCT01856595|54252408|FG007|Overall Study|Withdrawal by Subject|0|||
27797690|NCT01856595|54252409|FG008|Overall Study|Withdrawal by Subject|0|||
27797691|NCT02158247|54252446|FG000|Overall Study|Invisible vocal cords|5|||
27797692|NCT01829295|54252468|FG000|6-12 Months|Did not want to switch antimetabolites|0|||
27797693|NCT01829295|54252469|FG001|6-12 Months|Did not want to switch antimetabolites|0|||
27797694|NCT01829295|54252470|FG002|6-12 Months|Did not want to switch antimetabolites|9|||
27797695|NCT01829295|54252471|FG003|6-12 Months|Did not want to switch antimetabolites|11|||
27797696|NCT01829295|54252468|FG000|6-12 Months|Adverse Event|0|||
27797697|NCT01829295|54252469|FG001|6-12 Months|Adverse Event|0|||
27797698|NCT01829295|54252470|FG002|6-12 Months|Adverse Event|3|||
27797699|NCT01829295|54252471|FG003|6-12 Months|Adverse Event|2|||
27797700|NCT01829295|54252468|FG000|6-12 Months|Lost to Follow-up|2|||
27797701|NCT01829295|54252469|FG001|6-12 Months|Lost to Follow-up|0|||
27797702|NCT01829295|54252470|FG002|6-12 Months|Lost to Follow-up|0|||
27797703|NCT01829295|54252471|FG003|6-12 Months|Lost to Follow-up|0|||
27797704|NCT01829295|54252468|FG000|6-12 Months|Withdrawal by Subject|2|||
27797705|NCT01829295|54252469|FG001|6-12 Months|Withdrawal by Subject|2|||
27797706|NCT01829295|54252470|FG002|6-12 Months|Withdrawal by Subject|0|||
27797707|NCT01829295|54252471|FG003|6-12 Months|Withdrawal by Subject|0|||
27797708|NCT02157935|54252483|FG000|Overall Study|Withdrawal by Subject|25|||
27797709|NCT02157935|54252484|FG001|Overall Study|Withdrawal by Subject|39|||
27797710|NCT02157935|54252483|FG000|Overall Study|Screen failure|1|||
27797711|NCT02157935|54252484|FG001|Overall Study|Screen failure|2|||
27797712|NCT02157935|54252483|FG000|Overall Study|Protocol Violation|1|||
27797713|NCT02157935|54252484|FG001|Overall Study|Protocol Violation|0|||
27797714|NCT02157935|54252483|FG000|Overall Study|Progressive disease|0|||
27797715|NCT02157935|54252484|FG001|Overall Study|Progressive disease|2|||
27797716|NCT02157935|54252483|FG000|Overall Study|Other|5|||
27797717|NCT02157935|54252484|FG001|Overall Study|Other|12|||
27797718|NCT02157935|54252483|FG000|Overall Study|Lack of Efficacy|0|||
27797719|NCT02157935|54252484|FG001|Overall Study|Lack of Efficacy|1|||
27797720|NCT02157935|54252483|FG000|Overall Study|Death|4|||
27797721|NCT02157935|54252484|FG001|Overall Study|Death|4|||
27797722|NCT02157935|54252483|FG000|Overall Study|Adverse Event|3|||
27797723|NCT02157935|54252484|FG001|Overall Study|Adverse Event|5|||
27797724|NCT02157779|54252492|FG000|Overall Study|Logistical|9|||
27797725|NCT02157779|54252493|FG001|Overall Study|Logistical|3|||
27797726|NCT02157779|54252492|FG000|Overall Study|Stopped attending, reason unknown|11|||
27797727|NCT02157779|54252493|FG001|Overall Study|Stopped attending, reason unknown|7|||
28018168|NCT00308581|54677385|FG002|Induction Phase|Withdrawal by Subject|5|||
27797728|NCT02157779|54252492|FG000|Overall Study|No response to outreach after Baseline|1|||
27797729|NCT02157779|54252493|FG001|Overall Study|No response to outreach after Baseline|1|||
27797730|NCT02157779|54252492|FG000|Overall Study|Moved|1|||
27797731|NCT02157779|54252493|FG001|Overall Study|Moved|0|||
27797732|NCT02157779|54252492|FG000|Overall Study|Medical|1|||
27797733|NCT02157779|54252493|FG001|Overall Study|Medical|0|||
27797734|NCT02157779|54252492|FG000|Overall Study|Legal issue|1|||
27797735|NCT02157779|54252493|FG001|Overall Study|Legal issue|0|||
27797736|NCT02093221|54252507|FG000|Overall Study|Adverse Event|1|||
27797737|NCT02093221|54252508|FG001|Overall Study|Adverse Event|0|||
27797738|NCT02093221|54252509|FG002|Overall Study|Adverse Event|0|||
27797739|NCT02093221|54252510|FG003|Overall Study|Adverse Event|0|||
27797740|NCT02093221|54252511|FG004|Overall Study|Adverse Event|0|||
27842749|NCT01548404|54331517|FG000|Overall Study|Lost to Follow-up|2|||
27842750|NCT01548404|54331518|FG001|Overall Study|Lost to Follow-up|0|||
27842751|NCT01548404|54331517|FG000|Overall Study|Withdrawal by Subject|0|||
27797741|NCT02093221|54252507|FG000|Overall Study|Withdrawal by Subject|1|||
27797742|NCT02093221|54252508|FG001|Overall Study|Withdrawal by Subject|1|||
27797743|NCT02093221|54252509|FG002|Overall Study|Withdrawal by Subject|4|||
27797744|NCT02093221|54252510|FG003|Overall Study|Withdrawal by Subject|1|||
27797745|NCT02093221|54252511|FG004|Overall Study|Withdrawal by Subject|1|||
27797746|NCT02093221|54252507|FG000|Overall Study|Lost to Follow-up|2|||
27797747|NCT02093221|54252508|FG001|Overall Study|Lost to Follow-up|0|||
27797748|NCT02093221|54252509|FG002|Overall Study|Lost to Follow-up|1|||
27797749|NCT02093221|54252510|FG003|Overall Study|Lost to Follow-up|1|||
27797750|NCT02093221|54252511|FG004|Overall Study|Lost to Follow-up|0|||
27797751|NCT02093221|54252507|FG000|Overall Study|Death|0|||
27797752|NCT02093221|54252508|FG001|Overall Study|Death|1|||
27797753|NCT02093221|54252509|FG002|Overall Study|Death|0|||
27797754|NCT02093221|54252510|FG003|Overall Study|Death|0|||
27797755|NCT02093221|54252511|FG004|Overall Study|Death|0|||
27797756|NCT02093221|54252507|FG000|Overall Study|Protocol Violation|0|||
27797757|NCT02093221|54252508|FG001|Overall Study|Protocol Violation|1|||
27797758|NCT02093221|54252509|FG002|Overall Study|Protocol Violation|0|||
27797759|NCT02093221|54252510|FG003|Overall Study|Protocol Violation|0|||
27797760|NCT02093221|54252511|FG004|Overall Study|Protocol Violation|0|||
27797761|NCT02093221|54252507|FG000|Overall Study|Study termination|6|||
27797762|NCT02093221|54252508|FG001|Overall Study|Study termination|5|||
27797763|NCT02093221|54252509|FG002|Overall Study|Study termination|4|||
27797764|NCT02093221|54252510|FG003|Overall Study|Study termination|6|||
27797765|NCT02093221|54252511|FG004|Overall Study|Study termination|7|||
27797766|NCT02092909|54252527|FG000|Overall Study|Adverse Event|0|||
27797767|NCT02092909|54252528|FG001|Overall Study|Adverse Event|0|||
27797768|NCT02092909|54252529|FG002|Overall Study|Adverse Event|4|||
27797769|NCT02092909|54252530|FG003|Overall Study|Adverse Event|2|||
27797770|NCT02092909|54252527|FG000|Overall Study|Lack of Efficacy|0|||
27797771|NCT02092909|54252528|FG001|Overall Study|Lack of Efficacy|2|||
27797772|NCT02092909|54252529|FG002|Overall Study|Lack of Efficacy|1|||
27797773|NCT02092909|54252530|FG003|Overall Study|Lack of Efficacy|0|||
27797774|NCT02092909|54252527|FG000|Overall Study|Withdrawal by Subject|0|||
27797775|NCT02092909|54252528|FG001|Overall Study|Withdrawal by Subject|0|||
27797776|NCT02092909|54252529|FG002|Overall Study|Withdrawal by Subject|2|||
27797777|NCT02092909|54252530|FG003|Overall Study|Withdrawal by Subject|1|||
27797778|NCT02092909|54252527|FG000|Overall Study|Study terminated by Sponsor|0|||
27797779|NCT02092909|54252528|FG001|Overall Study|Study terminated by Sponsor|0|||
27797780|NCT02092909|54252529|FG002|Overall Study|Study terminated by Sponsor|0|||
27797781|NCT02092909|54252530|FG003|Overall Study|Study terminated by Sponsor|2|||
27797782|NCT02092909|54252527|FG000|Overall Study|Miscellaneous|1|||
27797783|NCT02092909|54252528|FG001|Overall Study|Miscellaneous|1|||
27797784|NCT02092909|54252529|FG002|Overall Study|Miscellaneous|2|||
27797785|NCT02092909|54252530|FG003|Overall Study|Miscellaneous|1|||
27797786|NCT01623115|54252542|FG000|Overall Study|Randomized but not treated|0|||
27797787|NCT01623115|54252543|FG001|Overall Study|Randomized but not treated|1|||
27797788|NCT01623115|54252542|FG000|Overall Study|Physician Decision|1|||
27797789|NCT01623115|54252543|FG001|Overall Study|Physician Decision|0|||
27797790|NCT01623115|54252542|FG000|Overall Study|Participants moved|1|||
27797791|NCT01623115|54252543|FG001|Overall Study|Participants moved|5|||
27797792|NCT01623115|54252542|FG000|Overall Study|Adverse Event|10|||
27797793|NCT01623115|54252543|FG001|Overall Study|Adverse Event|13|||
27797794|NCT01623115|54252542|FG000|Overall Study|Poor compliance to protocol|4|||
28018169|NCT00308581|54677383|FG000|Induction Phase|Unknown reason|0|||
27938280|NCT01072929|54594455|FG000|Overall Study|Protocol Violation|13|||
27938281|NCT01072929|54594456|FG001|Overall Study|Protocol Violation|11|||
27938282|NCT01072929|54594457|FG002|Overall Study|Protocol Violation|2|||
27938283|NCT01072929|54594455|FG000|Overall Study|Lost to Follow-up|8|||
27938284|NCT01072929|54594456|FG001|Overall Study|Lost to Follow-up|4|||
27938285|NCT01072929|54594457|FG002|Overall Study|Lost to Follow-up|1|||
27938286|NCT01072929|54594455|FG000|Overall Study|Noncompliance with study medication|0|||
27938287|NCT01072929|54594456|FG001|Overall Study|Noncompliance with study medication|3|||
27938288|NCT01072929|54594457|FG002|Overall Study|Noncompliance with study medication|0|||
27797795|NCT01623115|54252543|FG001|Overall Study|Poor compliance to protocol|10|||
28018170|NCT00308581|54677384|FG001|Induction Phase|Unknown reason|0|||
28018171|NCT00308581|54677385|FG002|Induction Phase|Unknown reason|3|||
27797796|NCT01623115|54252542|FG000|Overall Study|Consent withdrawn by participant|2|||
27797797|NCT01623115|54252543|FG001|Overall Study|Consent withdrawn by participant|6|||
27797798|NCT01623115|54252542|FG000|Overall Study|Related to study drug administration|0|||
27797799|NCT01623115|54252543|FG001|Overall Study|Related to study drug administration|2|||
27797800|NCT01623115|54252542|FG000|Overall Study|Last visit outside protocol visit window|14|||
27797801|NCT01623115|54252543|FG001|Overall Study|Last visit outside protocol visit window|26|||
27797802|NCT01623115|54252542|FG000|Overall Study|Site closure|1|||
27797803|NCT01623115|54252543|FG001|Overall Study|Site closure|7|||
27797804|NCT01623115|54252542|FG000|Overall Study|Death|0|||
27797805|NCT01623115|54252543|FG001|Overall Study|Death|4|||
27797806|NCT01623115|54252542|FG000|Overall Study|Other than specified above|0|||
28018172|NCT00308581|54677383|FG000|Randomized Maintenance Phase|Adverse Event|10|||
28018173|NCT00308581|54677384|FG001|Randomized Maintenance Phase|Adverse Event|17|||
28018174|NCT00308581|54677385|FG002|Randomized Maintenance Phase|Adverse Event|0|||
28018175|NCT00308581|54677383|FG000|Randomized Maintenance Phase|Lack of Efficacy|9|||
28018176|NCT00308581|54677384|FG001|Randomized Maintenance Phase|Lack of Efficacy|21|||
28018177|NCT00308581|54677385|FG002|Randomized Maintenance Phase|Lack of Efficacy|0|||
28018178|NCT00308581|54677383|FG000|Randomized Maintenance Phase|Lost to Follow-up|0|||
27797807|NCT01623115|54252543|FG001|Overall Study|Other than specified above|3|||
27797808|NCT02092285|54252549|FG000|Induction Phase|Adverse Event|7|||
27797809|NCT02092285|54252549|FG000|Induction Phase|Physician Decision|4|||
27797810|NCT02092285|54252549|FG000|Induction Phase|Pregnancy|1|||
27797811|NCT02092285|54252549|FG000|Induction Phase|Relapse/Recurrence|7|||
27797812|NCT02092285|54252549|FG000|Induction Phase|Withdrawal by Subject|2|||
27797813|NCT02092285|54252549|FG000|Induction Phase|Lack of Efficacy|14|||
27797814|NCT02092285|54252549|FG000|Maintenance Phase & Follow-up|Adverse Event|22|||
27797815|NCT02092285|54252549|FG000|Maintenance Phase & Follow-up|Lost to Follow-up|1|||
27797816|NCT02092285|54252549|FG000|Maintenance Phase & Follow-up|Non-compliance with study drug|2|||
27797817|NCT02092285|54252549|FG000|Maintenance Phase & Follow-up|Physician Decision|10|||
27797818|NCT02092285|54252549|FG000|Maintenance Phase & Follow-up|Pregnancy|1|||
27797819|NCT02092285|54252549|FG000|Maintenance Phase & Follow-up|Protocol Violation|11|||
27797820|NCT02092285|54252549|FG000|Maintenance Phase & Follow-up|Relapse/recurrence|29|||
27797821|NCT02092285|54252549|FG000|Maintenance Phase & Follow-up|Withdrawal by Subject|11|||
27797822|NCT02092285|54252549|FG000|Maintenance Phase & Follow-up|Lack of Efficacy|23|||
27797823|NCT02091739|54252556|FG000|MP: 16 Weeks|Adverse Event|1|||
27797824|NCT02091739|54252557|FG001|MP: 16 Weeks|Adverse Event|1|||
28018179|NCT00308581|54677384|FG001|Randomized Maintenance Phase|Lost to Follow-up|2|||
28018180|NCT00308581|54677385|FG002|Randomized Maintenance Phase|Lost to Follow-up|0|||
28018181|NCT00308581|54677383|FG000|Randomized Maintenance Phase|Withdrawal by Subject|1|||
28018182|NCT00308581|54677384|FG001|Randomized Maintenance Phase|Withdrawal by Subject|4|||
28018183|NCT00308581|54677385|FG002|Randomized Maintenance Phase|Withdrawal by Subject|0|||
28018184|NCT00308581|54677383|FG000|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82|||
28018185|NCT00308581|54677384|FG001|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59|||
28018186|NCT00308581|54677385|FG002|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0|||
28018187|NCT00308581|54677383|FG000|Randomized Maintenance Phase|Unknown reason|3|||
28018188|NCT00308581|54677384|FG001|Randomized Maintenance Phase|Unknown reason|0|||
28018189|NCT00308581|54677385|FG002|Randomized Maintenance Phase|Unknown reason|0|||
28018190|NCT00678080|54677395|FG000|Overall Study|Physician Decision|2|||
28018191|NCT00678080|54677396|FG001|Overall Study|Physician Decision|0|||
28018192|NCT00678080|54677395|FG000|Overall Study|Lost to Follow-up|1|||
28018193|NCT00678080|54677396|FG001|Overall Study|Lost to Follow-up|0|||
28018194|NCT00678080|54677395|FG000|Overall Study|Withdrawal by Subject|0|||
28018195|NCT00678080|54677396|FG001|Overall Study|Withdrawal by Subject|1|||
28018196|NCT00658320|54677404|FG000|Core Study: 12 Months|Subject withdrew consent|5|||
28018197|NCT00658320|54677405|FG001|Core Study: 12 Months|Subject withdrew consent|3|||
28018198|NCT00658320|54677404|FG000|Extension Study: Month 12 to Month 24|Subject withdrew consent|3|||
28018199|NCT00658320|54677405|FG001|Extension Study: Month 12 to Month 24|Subject withdrew consent|0|||
28018200|NCT00658320|54677404|FG000|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3|||
28018201|NCT00658320|54677405|FG001|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7|||
28018202|NCT00658320|54677404|FG000|Extension Study: After Month 24|Subject withdrew consent|2|||
28018203|NCT00658320|54677405|FG001|Extension Study: After Month 24|Subject withdrew consent|0|||
28018204|NCT00322153|54677415|FG000|Overall Study|Adverse Event|21|||
28018205|NCT00322153|54677416|FG001|Overall Study|Adverse Event|34|||
28018206|NCT00322153|54677415|FG000|Overall Study|Protocol Violation|6|||
28018207|NCT00322153|54677416|FG001|Overall Study|Protocol Violation|14|||
28018208|NCT00322153|54677415|FG000|Overall Study|Withdrawal by Subject|18|||
28018209|NCT00322153|54677416|FG001|Overall Study|Withdrawal by Subject|10|||
27797825|NCT02091739|54252558|FG002|MP: 16 Weeks|Adverse Event|1|||
28018210|NCT00322153|54677415|FG000|Overall Study|Lack of Efficacy|8|||
28018211|NCT00322153|54677416|FG001|Overall Study|Lack of Efficacy|3|||
28018212|NCT00322153|54677415|FG000|Overall Study|Lost to Follow-up|5|||
28018213|NCT00322153|54677416|FG001|Overall Study|Lost to Follow-up|4|||
28018214|NCT00322153|54677415|FG000|Overall Study|Withdrawn for other reasons|5|||
28018215|NCT00322153|54677416|FG001|Overall Study|Withdrawn for other reasons|4|||
28018216|NCT00657618|54677422|FG000|Overall Study|Adverse Event|32|||
28018217|NCT00657618|54677422|FG000|Overall Study|Withdrawal by Subject|8|||
28018218|NCT00657618|54677422|FG000|Overall Study|negative for leishmaniasis|2|||
28018219|NCT00657618|54677422|FG000|Overall Study|didn't start due to schedule conflicts|1|||
28018220|NCT00657540|54677428|FG000|Overall Study|Lost to Follow-up|1|||
27797826|NCT02091739|54252559|FG003|MP: 16 Weeks|Adverse Event|0|||
27797827|NCT02091739|54252560|FG004|MP: 16 Weeks|Adverse Event|0|||
27797828|NCT02091739|54252556|FG000|MP: 16 Weeks|Withdrawal by Subject|3|||
27797829|NCT02091739|54252557|FG001|MP: 16 Weeks|Withdrawal by Subject|4|||
28018221|NCT00657540|54677429|FG001|Overall Study|Lost to Follow-up|4|||
28018222|NCT00672620|54677439|FG000|Overall Study|Adverse Event|7|||
28018223|NCT00672620|54677440|FG001|Overall Study|Adverse Event|7|||
28018224|NCT00672620|54677441|FG002|Overall Study|Adverse Event|12|||
28018225|NCT00672620|54677442|FG003|Overall Study|Adverse Event|17|||
28018226|NCT00672620|54677439|FG000|Overall Study|Lack of Efficacy|1|||
28018227|NCT00672620|54677440|FG001|Overall Study|Lack of Efficacy|2|||
27797830|NCT02091739|54252558|FG002|MP: 16 Weeks|Withdrawal by Subject|0|||
27797831|NCT02091739|54252559|FG003|MP: 16 Weeks|Withdrawal by Subject|0|||
28018228|NCT00672620|54677441|FG002|Overall Study|Lack of Efficacy|2|||
27797832|NCT02091739|54252560|FG004|MP: 16 Weeks|Withdrawal by Subject|0|||
27797833|NCT02091739|54252556|FG000|MP: 16 Weeks|Lost to Follow-up|0|||
27797834|NCT02091739|54252557|FG001|MP: 16 Weeks|Lost to Follow-up|0|||
27797835|NCT02091739|54252558|FG002|MP: 16 Weeks|Lost to Follow-up|1|||
27797836|NCT02091739|54252559|FG003|MP: 16 Weeks|Lost to Follow-up|0|||
27797837|NCT02091739|54252560|FG004|MP: 16 Weeks|Lost to Follow-up|0|||
27797838|NCT02091739|54252556|FG000|EP: 48 Weeks|Other|0|||
27797839|NCT02091739|54252557|FG001|EP: 48 Weeks|Other|0|||
27797840|NCT02091739|54252558|FG002|EP: 48 Weeks|Other|0|||
27797841|NCT02091739|54252559|FG003|EP: 48 Weeks|Other|1|||
27797842|NCT02091739|54252560|FG004|EP: 48 Weeks|Other|0|||
27797843|NCT02091739|54252556|FG000|EP: 48 Weeks|Death|0|||
27797844|NCT02091739|54252557|FG001|EP: 48 Weeks|Death|0|||
27797845|NCT02091739|54252558|FG002|EP: 48 Weeks|Death|0|||
27797846|NCT02091739|54252559|FG003|EP: 48 Weeks|Death|3|||
27797847|NCT02091739|54252560|FG004|EP: 48 Weeks|Death|2|||
27797848|NCT02091739|54252556|FG000|EP: 48 Weeks|Adverse Event|0|||
27797849|NCT02091739|54252557|FG001|EP: 48 Weeks|Adverse Event|0|||
27797850|NCT02091739|54252558|FG002|EP: 48 Weeks|Adverse Event|0|||
27797851|NCT02091739|54252559|FG003|EP: 48 Weeks|Adverse Event|2|||
27797852|NCT02091739|54252560|FG004|EP: 48 Weeks|Adverse Event|6|||
27797853|NCT02091739|54252556|FG000|EP: 48 Weeks|Withdrawal by Subject|0|||
27797854|NCT02091739|54252557|FG001|EP: 48 Weeks|Withdrawal by Subject|0|||
27797855|NCT02091739|54252558|FG002|EP: 48 Weeks|Withdrawal by Subject|0|||
27797856|NCT02091739|54252559|FG003|EP: 48 Weeks|Withdrawal by Subject|2|||
27797857|NCT02091739|54252560|FG004|EP: 48 Weeks|Withdrawal by Subject|6|||
27797858|NCT02045875|54252572|FG000|Overall Study|Lost to Follow-up|3|||
27797859|NCT02045875|54252573|FG001|Overall Study|Lost to Follow-up|0|||
27797860|NCT02045875|54252572|FG000|Overall Study|Withdrawal by Subject|4|||
27797861|NCT02045875|54252573|FG001|Overall Study|Withdrawal by Subject|3|||
27797862|NCT01597635|54252582|FG000|Part A|Adverse Event|3|||
27797863|NCT01597635|54252583|FG001|Part A|Adverse Event|0|||
27797864|NCT01597635|54252584|FG002|Part A|Adverse Event|0|||
27797865|NCT01597635|54252582|FG000|Part B|Adverse Event|0|||
27797866|NCT01597635|54252583|FG001|Part B|Adverse Event|0|||
27797867|NCT01597635|54252584|FG002|Part B|Adverse Event|1|||
27797868|NCT01597635|54252582|FG000|Part B|Protocol Violation|0|||
27797869|NCT01597635|54252583|FG001|Part B|Protocol Violation|1|||
27797870|NCT01597635|54252584|FG002|Part B|Protocol Violation|0|||
27797871|NCT01597635|54252582|FG000|Part B|Protocol-defined stopping criteria|0|||
27797872|NCT01597635|54252583|FG001|Part B|Protocol-defined stopping criteria|4|||
27797873|NCT01597635|54252584|FG002|Part B|Protocol-defined stopping criteria|3|||
27797874|NCT01597635|54252582|FG000|Part B|Withdrawal by Subject|0|||
27797875|NCT01597635|54252583|FG001|Part B|Withdrawal by Subject|1|||
27797876|NCT01597635|54252584|FG002|Part B|Withdrawal by Subject|0|||
27938289|NCT01072929|54594455|FG000|Overall Study|Noncompliance with study procedures|1|||
27938290|NCT01072929|54594456|FG001|Overall Study|Noncompliance with study procedures|0|||
27938291|NCT01072929|54594457|FG002|Overall Study|Noncompliance with study procedures|1|||
27938292|NCT01072929|54594455|FG000|Overall Study|Other|0|||
27938293|NCT01072929|54594456|FG001|Overall Study|Other|3|||
27938294|NCT01072929|54594457|FG002|Overall Study|Other|0|||
27938295|NCT01231607|54594471|FG000|Overall Study|Adverse Event|0|||
27938296|NCT01231607|54594472|FG001|Overall Study|Adverse Event|8|||
27938297|NCT01231607|54594473|FG002|Overall Study|Adverse Event|4|||
27938298|NCT01231607|54594474|FG003|Overall Study|Adverse Event|4|||
27938299|NCT01231607|54594475|FG004|Overall Study|Adverse Event|5|||
27938300|NCT01231607|54594471|FG000|Overall Study|Lost to Follow-up|13|||
27938301|NCT01231607|54594472|FG001|Overall Study|Lost to Follow-up|11|||
27938302|NCT01231607|54594473|FG002|Overall Study|Lost to Follow-up|10|||
28018229|NCT00672620|54677442|FG003|Overall Study|Lack of Efficacy|0|||
28018230|NCT00672620|54677439|FG000|Overall Study|Noncompliance with Study Drug|3|||
28018231|NCT00672620|54677440|FG001|Overall Study|Noncompliance with Study Drug|4|||
28018232|NCT00672620|54677441|FG002|Overall Study|Noncompliance with Study Drug|0|||
28018233|NCT00672620|54677442|FG003|Overall Study|Noncompliance with Study Drug|2|||
27797877|NCT01828281|54252595|FG000|Overall Study|Withdrawal by Subject|1|||
27797878|NCT01828281|54252596|FG001|Overall Study|Withdrawal by Subject|0|||
27797879|NCT01827267|54252605|FG000|Overall Study|Did not receive study drug|1|||
27797880|NCT01827267|54252606|FG001|Overall Study|Did not receive study drug|1|||
27797881|NCT01827267|54252605|FG000|Overall Study|Physician Decision|1|||
27797882|NCT01827267|54252606|FG001|Overall Study|Physician Decision|0|||
27797883|NCT01827267|54252605|FG000|Overall Study|Disease Progression|1|||
27797884|NCT01827267|54252606|FG001|Overall Study|Disease Progression|1|||
27797885|NCT01827267|54252605|FG000|Overall Study|Sponsor Discontinued Study|2|||
27797886|NCT01827267|54252606|FG001|Overall Study|Sponsor Discontinued Study|8|||
27797887|NCT01827267|54252605|FG000|Overall Study|Still on study|0|||
27797888|NCT01827267|54252606|FG001|Overall Study|Still on study|2|||
27797889|NCT01855425|54252613|FG000|Overall Study|Physician Decision|20|||
28018234|NCT00672620|54677439|FG000|Overall Study|Protocol Deviations|5|||
28018235|NCT00672620|54677440|FG001|Overall Study|Protocol Deviations|7|||
28018236|NCT00672620|54677441|FG002|Overall Study|Protocol Deviations|2|||
28018237|NCT00672620|54677442|FG003|Overall Study|Protocol Deviations|5|||
28018238|NCT00672620|54677439|FG000|Overall Study|Withdrawal of Consent|6|||
28018239|NCT00672620|54677440|FG001|Overall Study|Withdrawal of Consent|12|||
28018240|NCT00672620|54677441|FG002|Overall Study|Withdrawal of Consent|5|||
28018241|NCT00672620|54677442|FG003|Overall Study|Withdrawal of Consent|6|||
28018242|NCT00672620|54677439|FG000|Overall Study|Lost to Follow-up|8|||
28018243|NCT00672620|54677440|FG001|Overall Study|Lost to Follow-up|19|||
28018244|NCT00672620|54677441|FG002|Overall Study|Lost to Follow-up|8|||
28018245|NCT00672620|54677442|FG003|Overall Study|Lost to Follow-up|11|||
28018246|NCT00672620|54677439|FG000|Overall Study|Reason not Specified|3|||
28018247|NCT00672620|54677440|FG001|Overall Study|Reason not Specified|3|||
28018248|NCT00672620|54677441|FG002|Overall Study|Reason not Specified|2|||
28018249|NCT00672620|54677442|FG003|Overall Study|Reason not Specified|1|||
28018250|NCT00673790|54677455|FG000|Overall Study|Adverse Event|23|||
28018251|NCT00673790|54677456|FG001|Overall Study|Adverse Event|14|||
28018252|NCT00673790|54677457|FG002|Overall Study|Adverse Event|2|||
28018253|NCT00673790|54677455|FG000|Overall Study|Lack of Efficacy|2|||
28018254|NCT00673790|54677456|FG001|Overall Study|Lack of Efficacy|2|||
28018255|NCT00673790|54677457|FG002|Overall Study|Lack of Efficacy|2|||
28018256|NCT00673790|54677455|FG000|Overall Study|Protocol Violation|6|||
28018257|NCT00673790|54677456|FG001|Overall Study|Protocol Violation|9|||
28018258|NCT00673790|54677457|FG002|Overall Study|Protocol Violation|1|||
28018259|NCT00673790|54677455|FG000|Overall Study|Withdrawal by Subject|7|||
28018260|NCT00673790|54677456|FG001|Overall Study|Withdrawal by Subject|4|||
28018261|NCT00673790|54677457|FG002|Overall Study|Withdrawal by Subject|1|||
28018262|NCT00673790|54677455|FG000|Overall Study|Lost to Follow-up|6|||
28018263|NCT00673790|54677456|FG001|Overall Study|Lost to Follow-up|6|||
28018264|NCT00673790|54677457|FG002|Overall Study|Lost to Follow-up|5|||
28018265|NCT00673790|54677455|FG000|Overall Study|Sponsor Terminated due to PI oversight|0|||
28018266|NCT00673790|54677456|FG001|Overall Study|Sponsor Terminated due to PI oversight|1|||
28018267|NCT00673790|54677457|FG002|Overall Study|Sponsor Terminated due to PI oversight|0|||
28018268|NCT00673790|54677455|FG000|Overall Study|Poor compliance|1|||
28018269|NCT00673790|54677456|FG001|Overall Study|Poor compliance|0|||
28018270|NCT00673790|54677457|FG002|Overall Study|Poor compliance|0|||
28018271|NCT00673790|54677455|FG000|Overall Study|Participated in two Nebivolol studies|0|||
28018272|NCT00673790|54677456|FG001|Overall Study|Participated in two Nebivolol studies|0|||
28018273|NCT00673790|54677457|FG002|Overall Study|Participated in two Nebivolol studies|1|||
28018274|NCT00673790|54677455|FG000|Overall Study|Unconfirmed pregnancy|0|||
28018275|NCT00673790|54677456|FG001|Overall Study|Unconfirmed pregnancy|1|||
28018276|NCT00673790|54677457|FG002|Overall Study|Unconfirmed pregnancy|0|||
28018277|NCT00673790|54677455|FG000|Overall Study|Randomization criteria not met|0|||
28018278|NCT00673790|54677456|FG001|Overall Study|Randomization criteria not met|1|||
28018279|NCT00673790|54677457|FG002|Overall Study|Randomization criteria not met|0|||
28018280|NCT00657150|54677468|FG000|Overall Study|Adverse Event|19|||
28018281|NCT00657150|54677469|FG001|Overall Study|Adverse Event|10|||
28018282|NCT00657150|54677468|FG000|Overall Study|Non-compliant with protocol|5|||
28018283|NCT00657150|54677469|FG001|Overall Study|Non-compliant with protocol|9|||
28018284|NCT00657150|54677468|FG000|Overall Study|Lost to Follow-up|2|||
28018285|NCT00657150|54677469|FG001|Overall Study|Lost to Follow-up|0|||
28018286|NCT00657150|54677468|FG000|Overall Study|Withdrawal by Subject|51|||
28018287|NCT00657150|54677469|FG001|Overall Study|Withdrawal by Subject|36|||
28018288|NCT00657150|54677468|FG000|Overall Study|Other|38|||
28018289|NCT00657150|54677469|FG001|Overall Study|Other|38|||
28018290|NCT00657150|54677468|FG000|Treatment|Adverse Event|60|||
27797890|NCT01854879|54252617|FG000|Overall Study|Could not complete testing within the scheduled time.|1|||
27797891|NCT01854879|54252617|FG000|Overall Study|screen fail|3|||
27797892|NCT01854879|54252617|FG000|Overall Study|incomplete data set|1|||
27797893|NCT01827111|54252621|FG000|Overall Study|Disease Progression|1|||
28018291|NCT00657150|54677469|FG001|Treatment|Adverse Event|53|||
28018292|NCT00657150|54677468|FG000|Treatment|Non-compliant with protocol|10|||
28018293|NCT00657150|54677469|FG001|Treatment|Non-compliant with protocol|9|||
28018294|NCT00657150|54677468|FG000|Treatment|Lost to Follow-up|1|||
28018295|NCT00657150|54677469|FG001|Treatment|Lost to Follow-up|0|||
28018296|NCT00657150|54677468|FG000|Treatment|Withdrawal by Subject|23|||
28018297|NCT00657150|54677469|FG001|Treatment|Withdrawal by Subject|20|||
28018298|NCT00657150|54677468|FG000|Treatment|Other|13|||
28018299|NCT00657150|54677469|FG001|Treatment|Other|15|||
27797894|NCT02045095|54252625|FG000|Overall Study|Other|0|||
27797895|NCT02045095|54252626|FG001|Overall Study|Other|0|||
27797896|NCT02045095|54252627|FG002|Overall Study|Other|1|||
27797897|NCT02045095|54252628|FG003|Overall Study|Other|0|||
27797898|NCT02045095|54252629|FG004|Overall Study|Other|0|||
27797899|NCT02045095|54252630|FG005|Overall Study|Other|2|||
27797900|NCT02045095|54252631|FG006|Overall Study|Other|0|||
27797901|NCT02045095|54252625|FG000|Overall Study|Progressive Disease|3|||
27797902|NCT02045095|54252626|FG001|Overall Study|Progressive Disease|3|||
27797903|NCT02045095|54252627|FG002|Overall Study|Progressive Disease|2|||
27797904|NCT02045095|54252628|FG003|Overall Study|Progressive Disease|4|||
27797905|NCT02045095|54252629|FG004|Overall Study|Progressive Disease|2|||
27797906|NCT02045095|54252630|FG005|Overall Study|Progressive Disease|4|||
27797907|NCT02045095|54252631|FG006|Overall Study|Progressive Disease|1|||
27797908|NCT02045095|54252625|FG000|Overall Study|Withdrawal by Subject|0|||
27797909|NCT02045095|54252626|FG001|Overall Study|Withdrawal by Subject|0|||
27797910|NCT02045095|54252627|FG002|Overall Study|Withdrawal by Subject|0|||
27797911|NCT02045095|54252628|FG003|Overall Study|Withdrawal by Subject|0|||
27797912|NCT02045095|54252629|FG004|Overall Study|Withdrawal by Subject|3|||
27797913|NCT02045095|54252630|FG005|Overall Study|Withdrawal by Subject|0|||
27797914|NCT02045095|54252631|FG006|Overall Study|Withdrawal by Subject|0|||
27797915|NCT02045095|54252625|FG000|Overall Study|Adverse Event|0|||
27797916|NCT02045095|54252626|FG001|Overall Study|Adverse Event|1|||
27938303|NCT01231607|54594474|FG003|Overall Study|Lost to Follow-up|10|||
27938304|NCT01231607|54594475|FG004|Overall Study|Lost to Follow-up|4|||
27938305|NCT01231607|54594471|FG000|Overall Study|Physician Decision|4|||
27938306|NCT01231607|54594472|FG001|Overall Study|Physician Decision|4|||
27938307|NCT01231607|54594473|FG002|Overall Study|Physician Decision|3|||
27938308|NCT01231607|54594474|FG003|Overall Study|Physician Decision|5|||
27938309|NCT01231607|54594475|FG004|Overall Study|Physician Decision|4|||
28018300|NCT00670748|54677479|FG000|Overall Study|Death during treatment|1|||
28018301|NCT00670748|54677480|FG001|Overall Study|Death during treatment|1|||
28018302|NCT00670748|54677481|FG002|Overall Study|Death during treatment|1|||
28018303|NCT00670748|54677482|FG003|Overall Study|Death during treatment|0|||
28018304|NCT00670748|54677479|FG000|Overall Study|Not off study|2|||
28018305|NCT00670748|54677480|FG001|Overall Study|Not off study|1|||
28018306|NCT00670748|54677481|FG002|Overall Study|Not off study|1|||
28018307|NCT00670748|54677482|FG003|Overall Study|Not off study|1|||
28018308|NCT00646776|54677494|FG000|Overall Study|Adverse Event|1|||
28018309|NCT00646776|54677495|FG001|Overall Study|Adverse Event|9|||
28018310|NCT00646776|54677494|FG000|Overall Study|Investigator discretion|0|||
28018311|NCT00646776|54677495|FG001|Overall Study|Investigator discretion|4|||
28018312|NCT00655668|54677504|FG000|Overall Study|Adverse Event|6|||
28018313|NCT00655668|54677504|FG000|Overall Study|Death|5|||
28018314|NCT00655668|54677504|FG000|Overall Study|Disease Progression|27|||
28018315|NCT00655668|54677504|FG000|Overall Study|Study Terminated|9|||
28018316|NCT00655668|54677504|FG000|Overall Study|Other|1|||
28018317|NCT00655668|54677504|FG000|Overall Study|New Lymphoma Treatment Started|4|||
28018318|NCT00655668|54677504|FG000|Overall Study|Withdrawal by Subject|2|||
28018319|NCT00569166|54677511|FG000|Overall Study|Withdrawal by Subject|7|||
28018320|NCT00569166|54677512|FG001|Overall Study|Withdrawal by Subject|5|||
28018321|NCT00569166|54677513|FG002|Overall Study|Withdrawal by Subject|3|||
28018322|NCT00569166|54677511|FG000|Overall Study|Lost to Follow-up|2|||
28018323|NCT00569166|54677512|FG001|Overall Study|Lost to Follow-up|1|||
28018324|NCT00569166|54677513|FG002|Overall Study|Lost to Follow-up|1|||
27938310|NCT01231607|54594471|FG000|Overall Study|Protocol Violation|3|||
27938311|NCT01231607|54594472|FG001|Overall Study|Protocol Violation|2|||
27938312|NCT01231607|54594473|FG002|Overall Study|Protocol Violation|0|||
27938313|NCT01231607|54594474|FG003|Overall Study|Protocol Violation|2|||
27938314|NCT01231607|54594475|FG004|Overall Study|Protocol Violation|2|||
27938315|NCT01231607|54594471|FG000|Overall Study|Withdrawal by Subject|9|||
27938316|NCT01231607|54594472|FG001|Overall Study|Withdrawal by Subject|9|||
27938317|NCT01231607|54594473|FG002|Overall Study|Withdrawal by Subject|14|||
28018325|NCT00655356|54677523|FG000|Overall Study|Withdrawal by Subject|3|||
28018326|NCT00655356|54677524|FG001|Overall Study|Withdrawal by Subject|4|||
27797917|NCT02045095|54252627|FG002|Overall Study|Adverse Event|1|||
27797918|NCT02045095|54252628|FG003|Overall Study|Adverse Event|0|||
27797919|NCT02045095|54252629|FG004|Overall Study|Adverse Event|0|||
27797920|NCT02045095|54252630|FG005|Overall Study|Adverse Event|2|||
27797921|NCT02045095|54252631|FG006|Overall Study|Adverse Event|0|||
27797922|NCT02181803|54252656|FG000|Overall Study|Withdrawal by Subject|0|||
27797923|NCT02181803|54252657|FG001|Overall Study|Withdrawal by Subject|2|||
27938318|NCT01231607|54594474|FG003|Overall Study|Withdrawal by Subject|17|||
27938319|NCT01231607|54594475|FG004|Overall Study|Withdrawal by Subject|9|||
28018327|NCT00655356|54677523|FG000|Overall Study|Sponsor Request|10|||
27797924|NCT02181803|54252658|FG002|Overall Study|Withdrawal by Subject|0|||
27797925|NCT02181803|54252659|FG003|Overall Study|Withdrawal by Subject|0|||
27797926|NCT02181803|54252660|FG004|Overall Study|Withdrawal by Subject|0|||
28018328|NCT00655356|54677524|FG001|Overall Study|Sponsor Request|4|||
28018329|NCT00655356|54677523|FG000|Overall Study|Adverse Event|1|||
27797927|NCT02181803|54252661|FG005|Overall Study|Withdrawal by Subject|0|||
27797928|NCT02181803|54252662|FG006|Overall Study|Withdrawal by Subject|0|||
27797929|NCT02181803|54252663|FG007|Overall Study|Withdrawal by Subject|0|||
27797930|NCT02181803|54252664|FG008|Overall Study|Withdrawal by Subject|0|||
27797931|NCT02181803|54252656|FG000|Overall Study|Physician Decision|0|||
27797932|NCT02181803|54252657|FG001|Overall Study|Physician Decision|0|||
27797933|NCT02181803|54252658|FG002|Overall Study|Physician Decision|0|||
27797934|NCT02181803|54252659|FG003|Overall Study|Physician Decision|1|||
27797935|NCT02181803|54252660|FG004|Overall Study|Physician Decision|0|||
27797936|NCT02181803|54252661|FG005|Overall Study|Physician Decision|0|||
27797937|NCT02181803|54252662|FG006|Overall Study|Physician Decision|0|||
27797938|NCT02181803|54252663|FG007|Overall Study|Physician Decision|1|||
27797939|NCT02181803|54252664|FG008|Overall Study|Physician Decision|0|||
27797940|NCT02181803|54252656|FG000|Overall Study|Adverse Event|0|||
27797941|NCT02181803|54252657|FG001|Overall Study|Adverse Event|2|||
27797942|NCT02181803|54252658|FG002|Overall Study|Adverse Event|0|||
27797943|NCT02181803|54252659|FG003|Overall Study|Adverse Event|1|||
27797944|NCT02181803|54252660|FG004|Overall Study|Adverse Event|0|||
27797945|NCT02181803|54252661|FG005|Overall Study|Adverse Event|0|||
27797946|NCT02181803|54252662|FG006|Overall Study|Adverse Event|1|||
27797947|NCT02181803|54252663|FG007|Overall Study|Adverse Event|0|||
27797948|NCT02181803|54252664|FG008|Overall Study|Adverse Event|0|||
27797949|NCT01826487|54252711|FG000|Overall Study|Adverse Event|1|||
27797950|NCT01826487|54252712|FG001|Overall Study|Adverse Event|1|||
27797951|NCT01826487|54252711|FG000|Overall Study|Lost to Follow-up|1|||
27797952|NCT01826487|54252712|FG001|Overall Study|Lost to Follow-up|0|||
27797953|NCT01826487|54252711|FG000|Overall Study|Withdrawal by Subject|1|||
27797954|NCT01826487|54252712|FG001|Overall Study|Withdrawal by Subject|3|||
27797955|NCT01826487|54252711|FG000|Overall Study|Protocol Violation|1|||
27797956|NCT01826487|54252712|FG001|Overall Study|Protocol Violation|1|||
27797957|NCT02064439|54252722|FG000|Overall Study|Adverse Event|51|||
27797958|NCT02064439|54252723|FG001|Overall Study|Adverse Event|47|||
27797959|NCT02064439|54252724|FG002|Overall Study|Adverse Event|46|||
27797960|NCT02064439|54252722|FG000|Overall Study|Death|0|||
27797961|NCT02064439|54252723|FG001|Overall Study|Death|2|||
27797962|NCT02064439|54252724|FG002|Overall Study|Death|3|||
27797963|NCT02064439|54252722|FG000|Overall Study|Withdrawal by Subject|29|||
27797964|NCT02064439|54252723|FG001|Overall Study|Withdrawal by Subject|18|||
27797965|NCT02064439|54252724|FG002|Overall Study|Withdrawal by Subject|26|||
27797966|NCT02064439|54252722|FG000|Overall Study|Protocol Violation|3|||
27797967|NCT02064439|54252723|FG001|Overall Study|Protocol Violation|5|||
27797968|NCT02064439|54252724|FG002|Overall Study|Protocol Violation|3|||
27797969|NCT02064439|54252722|FG000|Overall Study|Lost to Follow-up|1|||
27797970|NCT02064439|54252723|FG001|Overall Study|Lost to Follow-up|3|||
27797971|NCT02064439|54252724|FG002|Overall Study|Lost to Follow-up|4|||
27797972|NCT02064439|54252722|FG000|Overall Study|Non-compliance with study medication|21|||
27797973|NCT02064439|54252723|FG001|Overall Study|Non-compliance with study medication|19|||
27797974|NCT02064439|54252724|FG002|Overall Study|Non-compliance with study medication|23|||
27797975|NCT02064439|54252722|FG000|Overall Study|Physician Decision|0|||
27797976|NCT02064439|54252723|FG001|Overall Study|Physician Decision|1|||
27797977|NCT02064439|54252724|FG002|Overall Study|Physician Decision|1|||
27797978|NCT02064439|54252722|FG000|Overall Study|Logistical difficulties|6|||
27797979|NCT02064439|54252723|FG001|Overall Study|Logistical difficulties|5|||
27797980|NCT02064439|54252724|FG002|Overall Study|Logistical difficulties|2|||
27797981|NCT02064439|54252722|FG000|Overall Study|Efficacy outcome reached|18|||
27797982|NCT02064439|54252723|FG001|Overall Study|Efficacy outcome reached|16|||
27797983|NCT02064439|54252724|FG002|Overall Study|Efficacy outcome reached|57|||
27797984|NCT02064439|54252722|FG000|Overall Study|Safety outcome reached|12|||
27797985|NCT02064439|54252723|FG001|Overall Study|Safety outcome reached|20|||
27797986|NCT02064439|54252724|FG002|Overall Study|Safety outcome reached|10|||
27797987|NCT02064439|54252722|FG000|Overall Study|Other|2|||
27797988|NCT02064439|54252723|FG001|Overall Study|Other|2|||
27797989|NCT02064439|54252724|FG002|Overall Study|Other|7|||
27797990|NCT02130557|54252734|FG000|Overall Study|Withdrawal by Subject|12|||
27797991|NCT02130557|54252735|FG001|Overall Study|Withdrawal by Subject|12|||
27797992|NCT02130557|54252734|FG000|Overall Study|Investigator Request|0|||
27797993|NCT02130557|54252735|FG001|Overall Study|Investigator Request|2|||
27938320|NCT01231373|54594494|FG000|Overall Study|Withdrew consent prior to randomization|2|||
27938321|NCT01231373|54594495|FG001|Overall Study|Withdrew consent prior to randomization|1|||
27938322|NCT01231373|54594496|FG002|Overall Study|Withdrew consent prior to randomization|0|||
27797994|NCT02130557|54252734|FG000|Overall Study|Deceased|14|||
27797995|NCT02130557|54252735|FG001|Overall Study|Deceased|14|||
27797996|NCT02130557|54252734|FG000|Overall Study|Lost to Follow-up|6|||
27797997|NCT02130557|54252735|FG001|Overall Study|Lost to Follow-up|7|||
27797998|NCT02130557|54252734|FG000|Overall Study|Other|2|||
27938323|NCT01231373|54594497|FG003|Overall Study|Withdrew consent prior to randomization|0|||
27938324|NCT01231373|54594494|FG000|Overall Study|Lost to Follow-up|0|||
27938325|NCT01231373|54594495|FG001|Overall Study|Lost to Follow-up|0|||
27797999|NCT02130557|54252735|FG001|Overall Study|Other|1|||
27798000|NCT02130557|54252734|FG000|Overall Study|Missing|2|||
27798001|NCT02130557|54252735|FG001|Overall Study|Missing|1|||
27798002|NCT01854645|54252746|FG000|Overall Study|Protocol-Specified Criteria|13|||
27798003|NCT01854645|54252747|FG001|Overall Study|Protocol-Specified Criteria|10|||
27798004|NCT01854645|54252748|FG002|Overall Study|Protocol-Specified Criteria|8|||
27798005|NCT01854645|54252749|FG003|Overall Study|Protocol-Specified Criteria|5|||
27798006|NCT01854645|54252750|FG004|Overall Study|Protocol-Specified Criteria|7|||
27798007|NCT01854645|54252746|FG000|Overall Study|Administrative Reasons / Missing|0|||
28018330|NCT00655356|54677524|FG001|Overall Study|Adverse Event|1|||
28018331|NCT00655356|54677523|FG000|Overall Study|Protocol Violation|2|||
28018332|NCT00655356|54677524|FG001|Overall Study|Protocol Violation|1|||
28018333|NCT00655356|54677523|FG000|Overall Study|Other Reason|1|||
28018334|NCT00655356|54677524|FG001|Overall Study|Other Reason|0|||
28018335|NCT00571064|54677530|FG000|Overall Study|Adverse Event|13|||
28018336|NCT00571064|54677530|FG000|Overall Study|Protocol Violation|4|||
28018337|NCT00571064|54677530|FG000|Overall Study|Withdrawal by Subject|2|||
28018338|NCT00571064|54677530|FG000|Overall Study|Other|2|||
28018339|NCT03895372|54677543|FG000|Investigational Treatment Period|Adverse Event|1|||
28018340|NCT03895372|54677544|FG001|Investigational Treatment Period|Adverse Event|0|||
28018341|NCT03895372|54677545|FG002|Investigational Treatment Period|Adverse Event|0|||
28018342|NCT03895372|54677546|FG003|Investigational Treatment Period|Adverse Event|0|||
28018343|NCT03895372|54677547|FG004|Investigational Treatment Period|Adverse Event|0|||
28018344|NCT03895372|54677548|FG005|Investigational Treatment Period|Adverse Event|0|||
28018345|NCT03895372|54677549|FG006|Investigational Treatment Period|Adverse Event|4|||
28018346|NCT03895372|54677550|FG007|Investigational Treatment Period|Adverse Event|3|||
28018347|NCT03895372|54677543|FG000|Investigational Treatment Period|Lack of Efficacy|1|||
28018348|NCT03895372|54677544|FG001|Investigational Treatment Period|Lack of Efficacy|0|||
28018349|NCT03895372|54677545|FG002|Investigational Treatment Period|Lack of Efficacy|0|||
28018350|NCT03895372|54677546|FG003|Investigational Treatment Period|Lack of Efficacy|0|||
28018351|NCT03895372|54677547|FG004|Investigational Treatment Period|Lack of Efficacy|0|||
28018352|NCT03895372|54677548|FG005|Investigational Treatment Period|Lack of Efficacy|0|||
28018353|NCT03895372|54677549|FG006|Investigational Treatment Period|Lack of Efficacy|0|||
28018354|NCT03895372|54677550|FG007|Investigational Treatment Period|Lack of Efficacy|0|||
28018355|NCT03895372|54677543|FG000|Investigational Treatment Period|Lost to Follow-up|0|||
28018356|NCT03895372|54677544|FG001|Investigational Treatment Period|Lost to Follow-up|0|||
28018357|NCT03895372|54677545|FG002|Investigational Treatment Period|Lost to Follow-up|0|||
28018358|NCT03895372|54677546|FG003|Investigational Treatment Period|Lost to Follow-up|0|||
28018359|NCT03895372|54677547|FG004|Investigational Treatment Period|Lost to Follow-up|0|||
28018360|NCT03895372|54677548|FG005|Investigational Treatment Period|Lost to Follow-up|0|||
28018361|NCT03895372|54677549|FG006|Investigational Treatment Period|Lost to Follow-up|1|||
28018362|NCT03895372|54677550|FG007|Investigational Treatment Period|Lost to Follow-up|0|||
28018363|NCT03895372|54677543|FG000|Investigational Treatment Period|Other|0|||
28018364|NCT03895372|54677544|FG001|Investigational Treatment Period|Other|0|||
28018365|NCT03895372|54677545|FG002|Investigational Treatment Period|Other|0|||
28018366|NCT03895372|54677546|FG003|Investigational Treatment Period|Other|0|||
28018367|NCT03895372|54677547|FG004|Investigational Treatment Period|Other|0|||
28018368|NCT03895372|54677548|FG005|Investigational Treatment Period|Other|1|||
28018369|NCT03895372|54677549|FG006|Investigational Treatment Period|Other|0|||
28018370|NCT03895372|54677550|FG007|Investigational Treatment Period|Other|2|||
28018371|NCT03895372|54677543|FG000|Investigational Treatment Period|Protocol Violation|0|||
28018372|NCT03895372|54677544|FG001|Investigational Treatment Period|Protocol Violation|0|||
28018373|NCT03895372|54677545|FG002|Investigational Treatment Period|Protocol Violation|0|||
27798008|NCT01854645|54252747|FG001|Overall Study|Administrative Reasons / Missing|0|||
27798009|NCT01854645|54252748|FG002|Overall Study|Administrative Reasons / Missing|0|||
27798010|NCT01854645|54252749|FG003|Overall Study|Administrative Reasons / Missing|1|||
27938326|NCT01231373|54594496|FG002|Overall Study|Lost to Follow-up|0|||
27938327|NCT01231373|54594497|FG003|Overall Study|Lost to Follow-up|1|||
27938328|NCT01231373|54594494|FG000|Overall Study|Withdrew Consent|1|||
27938329|NCT01231373|54594495|FG001|Overall Study|Withdrew Consent|0|||
27938330|NCT01231373|54594496|FG002|Overall Study|Withdrew Consent|0|||
27938331|NCT01231373|54594497|FG003|Overall Study|Withdrew Consent|0|||
27938332|NCT00975130|54594509|FG000|Study Part 1|Adverse Event|150|||
27938333|NCT00975130|54594510|FG001|Study Part 1|Adverse Event|0|||
27938334|NCT00975130|54594511|FG002|Study Part 1|Adverse Event|0|||
27938335|NCT00975130|54594509|FG000|Study Part 1|Lost to Follow-up|19|||
27938336|NCT00975130|54594510|FG001|Study Part 1|Lost to Follow-up|0|||
27938337|NCT00975130|54594511|FG002|Study Part 1|Lost to Follow-up|0|||
28018374|NCT03895372|54677546|FG003|Investigational Treatment Period|Protocol Violation|1|||
28018375|NCT03895372|54677547|FG004|Investigational Treatment Period|Protocol Violation|0|||
28018376|NCT03895372|54677548|FG005|Investigational Treatment Period|Protocol Violation|0|||
28018377|NCT03895372|54677549|FG006|Investigational Treatment Period|Protocol Violation|0|||
28018378|NCT03895372|54677550|FG007|Investigational Treatment Period|Protocol Violation|0|||
27798011|NCT01854645|54252750|FG004|Overall Study|Administrative Reasons / Missing|1|||
27798012|NCT01854645|54252746|FG000|Overall Study|Protocol Violation|3|||
27798013|NCT01854645|54252747|FG001|Overall Study|Protocol Violation|0|||
27798014|NCT01854645|54252748|FG002|Overall Study|Protocol Violation|5|||
27798015|NCT01854645|54252749|FG003|Overall Study|Protocol Violation|4|||
27798016|NCT01854645|54252750|FG004|Overall Study|Protocol Violation|1|||
27798017|NCT01854645|54252746|FG000|Overall Study|Lost to Follow-up|10|||
27798018|NCT01854645|54252747|FG001|Overall Study|Lost to Follow-up|7|||
27798019|NCT01854645|54252748|FG002|Overall Study|Lost to Follow-up|8|||
27798020|NCT01854645|54252749|FG003|Overall Study|Lost to Follow-up|5|||
27798021|NCT01854645|54252750|FG004|Overall Study|Lost to Follow-up|0|||
27798022|NCT01854645|54252746|FG000|Overall Study|Physician Decision|1|||
27798023|NCT01854645|54252747|FG001|Overall Study|Physician Decision|5|||
27798024|NCT01854645|54252748|FG002|Overall Study|Physician Decision|3|||
27798025|NCT01854645|54252749|FG003|Overall Study|Physician Decision|3|||
27798026|NCT01854645|54252750|FG004|Overall Study|Physician Decision|7|||
27798027|NCT01854645|54252746|FG000|Overall Study|Withdrawal by Subject|31|||
27798028|NCT01854645|54252747|FG001|Overall Study|Withdrawal by Subject|41|||
27798029|NCT01854645|54252748|FG002|Overall Study|Withdrawal by Subject|30|||
27798030|NCT01854645|54252749|FG003|Overall Study|Withdrawal by Subject|21|||
27798031|NCT01854645|54252750|FG004|Overall Study|Withdrawal by Subject|24|||
27798032|NCT01854645|54252746|FG000|Overall Study|Lack of Efficacy|7|||
27798033|NCT01854645|54252747|FG001|Overall Study|Lack of Efficacy|12|||
27798034|NCT01854645|54252748|FG002|Overall Study|Lack of Efficacy|9|||
27798035|NCT01854645|54252749|FG003|Overall Study|Lack of Efficacy|3|||
27798036|NCT01854645|54252750|FG004|Overall Study|Lack of Efficacy|9|||
27798037|NCT01854645|54252746|FG000|Overall Study|Adverse Event|33|||
27798038|NCT01854645|54252747|FG001|Overall Study|Adverse Event|31|||
27798039|NCT01854645|54252748|FG002|Overall Study|Adverse Event|19|||
27798040|NCT01854645|54252749|FG003|Overall Study|Adverse Event|20|||
27798041|NCT01854645|54252750|FG004|Overall Study|Adverse Event|11|||
27798042|NCT01825941|54252764|FG000|Overall Study|Lost to Follow-up|4|||
27798043|NCT01825941|54252765|FG001|Overall Study|Lost to Follow-up|1|||
27798044|NCT02064205|54252771|FG000|Overall Study|Withdrawal by Subject|1|||
27798045|NCT02090959|54252787|FG000|Overall Study|Withdrawal by Subject|10|||
27798046|NCT02090959|54252787|FG000|Overall Study|Adverse Event|1|||
27798047|NCT02090959|54252787|FG000|Overall Study|Investigator decision|2|||
27798048|NCT02090959|54252787|FG000|Overall Study|Study termination|6|||
27798049|NCT02090959|54252787|FG000|Overall Study|Enrolled but not treated|1|||
27798050|NCT02090959|54252787|FG000|Overall Study|Transfer for compassionate use medicine|4|||
27798051|NCT02090959|54252787|FG000|Overall Study|Move to medical need program|3|||
27798052|NCT02090959|54252787|FG000|Overall Study|Entered in to other study|34|||
27798053|NCT02090959|54252787|FG000|Overall Study|Switched to commercial supply|88|||
27798054|NCT02090959|54252787|FG000|Overall Study|Other than specified|2|||
27938338|NCT00975130|54594509|FG000|Study Part 1|Withdrawal by Subject|61|||
27938339|NCT00975130|54594510|FG001|Study Part 1|Withdrawal by Subject|0|||
27938340|NCT00975130|54594511|FG002|Study Part 1|Withdrawal by Subject|0|||
27938341|NCT00975130|54594509|FG000|Study Part 1|Protocol Violation|13|||
27938342|NCT00975130|54594510|FG001|Study Part 1|Protocol Violation|0|||
27938343|NCT00975130|54594511|FG002|Study Part 1|Protocol Violation|0|||
27938344|NCT00975130|54594509|FG000|Study Part 1|Did Not Meet Protocol Eligibility|9|||
27938345|NCT00975130|54594510|FG001|Study Part 1|Did Not Meet Protocol Eligibility|0|||
27938346|NCT00975130|54594511|FG002|Study Part 1|Did Not Meet Protocol Eligibility|0|||
27938347|NCT00975130|54594509|FG000|Study Part 1|Administrative|4|||
27938348|NCT00975130|54594510|FG001|Study Part 1|Administrative|0|||
27938349|NCT00975130|54594511|FG002|Study Part 1|Administrative|0|||
27938350|NCT00975130|54594509|FG000|Study Part 1|Withdrew Consent|24|||
27938351|NCT00975130|54594510|FG001|Study Part 1|Withdrew Consent|0|||
27938352|NCT00975130|54594511|FG002|Study Part 1|Withdrew Consent|0|||
27938353|NCT00975130|54594509|FG000|Study Part 2|Adverse Event|0|||
27798055|NCT02044159|54252793|FG000|Overall Study|Consent declined (deferred consent)|2|||
27798056|NCT02044159|54252794|FG001|Overall Study|Consent declined (deferred consent)|4|||
27798057|NCT02044159|54252793|FG000|Overall Study|No longer eligible, drug not given|1|||
27798058|NCT02044159|54252794|FG001|Overall Study|No longer eligible, drug not given|0|||
27798059|NCT02044159|54252793|FG000|Overall Study|Nurse declined to give study drug|1|||
27798060|NCT02044159|54252794|FG001|Overall Study|Nurse declined to give study drug|0|||
27798061|NCT02090725|54252803|FG000|Overall Study|Withdrawal by Subject|1|||
27798062|NCT02090725|54252803|FG000|Overall Study|participants moved from area|3|||
27798063|NCT02180165|54252811|FG000|Overall Study|Not Treated|0|||
27798064|NCT02180165|54252812|FG001|Overall Study|Not Treated|0|||
27798065|NCT02180165|54252813|FG002|Overall Study|Not Treated|1|||
27938354|NCT00975130|54594510|FG001|Study Part 2|Adverse Event|14|||
27938355|NCT00975130|54594511|FG002|Study Part 2|Adverse Event|7|||
27938356|NCT00975130|54594509|FG000|Study Part 2|Lost to Follow-up|0|||
27938357|NCT00975130|54594510|FG001|Study Part 2|Lost to Follow-up|0|||
27798066|NCT02180165|54252814|FG003|Overall Study|Not Treated|0|||
27798067|NCT02180165|54252811|FG000|Overall Study|Adverse Event|7|||
27938358|NCT00975130|54594511|FG002|Study Part 2|Lost to Follow-up|1|||
27798068|NCT02180165|54252812|FG001|Overall Study|Adverse Event|0|||
27798069|NCT02180165|54252813|FG002|Overall Study|Adverse Event|18|||
27798070|NCT02180165|54252814|FG003|Overall Study|Adverse Event|3|||
27798071|NCT02180165|54252811|FG000|Overall Study|Lack of Efficacy|0|||
27798072|NCT02180165|54252812|FG001|Overall Study|Lack of Efficacy|1|||
27798073|NCT02180165|54252813|FG002|Overall Study|Lack of Efficacy|3|||
27798074|NCT02180165|54252814|FG003|Overall Study|Lack of Efficacy|2|||
27798075|NCT02180165|54252811|FG000|Overall Study|Physician Decision|1|||
27798076|NCT02180165|54252812|FG001|Overall Study|Physician Decision|0|||
27798077|NCT02180165|54252813|FG002|Overall Study|Physician Decision|5|||
27798078|NCT02180165|54252814|FG003|Overall Study|Physician Decision|0|||
27798079|NCT02180165|54252811|FG000|Overall Study|Withdrawal by Subject|3|||
27798080|NCT02180165|54252812|FG001|Overall Study|Withdrawal by Subject|0|||
27798081|NCT02180165|54252813|FG002|Overall Study|Withdrawal by Subject|2|||
27798082|NCT02180165|54252814|FG003|Overall Study|Withdrawal by Subject|1|||
27798083|NCT02155985|54252829|FG000|Overall Study|Withdrawal by Subject|0|||
27798084|NCT02155985|54252830|FG001|Overall Study|Withdrawal by Subject|0|||
27798085|NCT02155985|54252831|FG002|Overall Study|Withdrawal by Subject|1|||
27798086|NCT02155985|54252829|FG000|Overall Study|Lost to Follow-up|1|||
27798087|NCT02155985|54252830|FG001|Overall Study|Lost to Follow-up|0|||
27798088|NCT02155985|54252831|FG002|Overall Study|Lost to Follow-up|0|||
27798089|NCT02155829|54252841|FG000|Overall Study|Adverse Event|1|||
27798090|NCT02155829|54252842|FG001|Overall Study|Adverse Event|0|||
27798091|NCT02155829|54252841|FG000|Overall Study|Withdrawal by Subject|3|||
27798092|NCT02155829|54252842|FG001|Overall Study|Withdrawal by Subject|3|||
27798093|NCT02155829|54252841|FG000|Overall Study|Protocol Violation|2|||
27798094|NCT02155829|54252842|FG001|Overall Study|Protocol Violation|0|||
27798095|NCT02129777|54252854|FG000|Double-Blind Period|Adverse Event|0|||
27798096|NCT02129777|54252855|FG001|Double-Blind Period|Adverse Event|0|||
27798097|NCT02129777|54252856|FG002|Double-Blind Period|Adverse Event|0|||
27798098|NCT02129777|54252857|FG003|Double-Blind Period|Adverse Event|0|||
27798099|NCT02129777|54252858|FG004|Double-Blind Period|Adverse Event|1|||
27798100|NCT02129777|54252859|FG005|Double-Blind Period|Adverse Event|0|||
27798101|NCT02129777|54252860|FG006|Double-Blind Period|Adverse Event|0|||
27798102|NCT02129777|54252854|FG000|Double-Blind Period|Lost to Follow-up|1|||
27798103|NCT02129777|54252855|FG001|Double-Blind Period|Lost to Follow-up|1|||
27798104|NCT02129777|54252856|FG002|Double-Blind Period|Lost to Follow-up|1|||
27798105|NCT02129777|54252857|FG003|Double-Blind Period|Lost to Follow-up|2|||
27798106|NCT02129777|54252858|FG004|Double-Blind Period|Lost to Follow-up|0|||
27798107|NCT02129777|54252859|FG005|Double-Blind Period|Lost to Follow-up|0|||
27798108|NCT02129777|54252860|FG006|Double-Blind Period|Lost to Follow-up|0|||
27798109|NCT02129777|54252854|FG000|Double-Blind Period|Withdrawal by Subject|2|||
27798110|NCT02129777|54252855|FG001|Double-Blind Period|Withdrawal by Subject|4|||
27798111|NCT02129777|54252856|FG002|Double-Blind Period|Withdrawal by Subject|3|||
27798112|NCT02129777|54252857|FG003|Double-Blind Period|Withdrawal by Subject|2|||
27798113|NCT02129777|54252858|FG004|Double-Blind Period|Withdrawal by Subject|3|||
27798114|NCT02129777|54252859|FG005|Double-Blind Period|Withdrawal by Subject|0|||
27798115|NCT02129777|54252860|FG006|Double-Blind Period|Withdrawal by Subject|0|||
27798116|NCT02129777|54252854|FG000|Double-Blind Period|Pregnancy|0|||
27798117|NCT02129777|54252855|FG001|Double-Blind Period|Pregnancy|0|||
27798118|NCT02129777|54252856|FG002|Double-Blind Period|Pregnancy|0|||
27798119|NCT02129777|54252857|FG003|Double-Blind Period|Pregnancy|0|||
27798120|NCT02129777|54252858|FG004|Double-Blind Period|Pregnancy|1|||
27798121|NCT02129777|54252859|FG005|Double-Blind Period|Pregnancy|0|||
27798122|NCT02129777|54252860|FG006|Double-Blind Period|Pregnancy|0|||
27798123|NCT02129777|54252854|FG000|Double-Blind Period|Lack of Efficacy|3|||
27798124|NCT02129777|54252855|FG001|Double-Blind Period|Lack of Efficacy|1|||
27798125|NCT02129777|54252856|FG002|Double-Blind Period|Lack of Efficacy|0|||
27798126|NCT02129777|54252857|FG003|Double-Blind Period|Lack of Efficacy|3|||
27798127|NCT02129777|54252858|FG004|Double-Blind Period|Lack of Efficacy|2|||
27798128|NCT02129777|54252859|FG005|Double-Blind Period|Lack of Efficacy|0|||
27798129|NCT02129777|54252860|FG006|Double-Blind Period|Lack of Efficacy|0|||
27798130|NCT02129777|54252854|FG000|Double-Blind Period|Other|1|||
27798131|NCT02129777|54252855|FG001|Double-Blind Period|Other|2|||
27798132|NCT02129777|54252856|FG002|Double-Blind Period|Other|0|||
27798133|NCT02129777|54252857|FG003|Double-Blind Period|Other|0|||
27798134|NCT02129777|54252858|FG004|Double-Blind Period|Other|0|||
27798135|NCT02129777|54252859|FG005|Double-Blind Period|Other|0|||
27798136|NCT02129777|54252860|FG006|Double-Blind Period|Other|0|||
27798137|NCT02129777|54252854|FG000|Open-Label Period|Lack of Efficacy|0|||
27798138|NCT02129777|54252855|FG001|Open-Label Period|Lack of Efficacy|0|||
27798139|NCT02129777|54252856|FG002|Open-Label Period|Lack of Efficacy|0|||
27798140|NCT02129777|54252857|FG003|Open-Label Period|Lack of Efficacy|0|||
27798141|NCT02129777|54252858|FG004|Open-Label Period|Lack of Efficacy|0|||
27798142|NCT02129777|54252859|FG005|Open-Label Period|Lack of Efficacy|0|||
27798143|NCT02129777|54252860|FG006|Open-Label Period|Lack of Efficacy|5|||
27798144|NCT02129777|54252854|FG000|Open-Label Period|Lost to Follow-up|0|||
27798145|NCT02129777|54252855|FG001|Open-Label Period|Lost to Follow-up|0|||
27798146|NCT02129777|54252856|FG002|Open-Label Period|Lost to Follow-up|0|||
27798147|NCT02129777|54252857|FG003|Open-Label Period|Lost to Follow-up|0|||
27798148|NCT02129777|54252858|FG004|Open-Label Period|Lost to Follow-up|0|||
27798149|NCT02129777|54252859|FG005|Open-Label Period|Lost to Follow-up|1|||
27798150|NCT02129777|54252860|FG006|Open-Label Period|Lost to Follow-up|1|||
27798151|NCT02129777|54252854|FG000|Open-Label Period|Withdrawal by Subject|0|||
27798152|NCT02129777|54252855|FG001|Open-Label Period|Withdrawal by Subject|0|||
27798153|NCT02129777|54252856|FG002|Open-Label Period|Withdrawal by Subject|0|||
27798154|NCT02129777|54252857|FG003|Open-Label Period|Withdrawal by Subject|0|||
27798155|NCT02129777|54252858|FG004|Open-Label Period|Withdrawal by Subject|0|||
27798156|NCT02129777|54252859|FG005|Open-Label Period|Withdrawal by Subject|1|||
27798157|NCT02129777|54252860|FG006|Open-Label Period|Withdrawal by Subject|3|||
27798158|NCT02129777|54252854|FG000|Open-Label Period|Study Termination|0|||
27798159|NCT02129777|54252855|FG001|Open-Label Period|Study Termination|0|||
27798160|NCT02129777|54252856|FG002|Open-Label Period|Study Termination|0|||
27798161|NCT02129777|54252857|FG003|Open-Label Period|Study Termination|0|||
27798162|NCT02129777|54252858|FG004|Open-Label Period|Study Termination|0|||
27798163|NCT02129777|54252859|FG005|Open-Label Period|Study Termination|10|||
27798164|NCT02129777|54252860|FG006|Open-Label Period|Study Termination|39|||
27798165|NCT02178995|54252881|FG000|Double Blind|Adverse Event|0|||
27798166|NCT02178995|54252882|FG001|Double Blind|Adverse Event|0|||
27798167|NCT02178995|54252883|FG002|Double Blind|Adverse Event|0|||
27798168|NCT02178995|54252884|FG003|Double Blind|Adverse Event|0|||
27798169|NCT02178995|54252885|FG004|Double Blind|Adverse Event|0|||
27798170|NCT02178995|54252886|FG005|Double Blind|Adverse Event|1|||
27798171|NCT02178995|54252887|FG006|Double Blind|Adverse Event|0|||
27798172|NCT02178995|54252888|FG007|Double Blind|Adverse Event|1|||
27798173|NCT02178995|54252889|FG008|Double Blind|Adverse Event|1|||
27798174|NCT02178995|54252881|FG000|Double Blind|Lost to Follow-up|0|||
27798175|NCT02178995|54252882|FG001|Double Blind|Lost to Follow-up|1|||
27798176|NCT02178995|54252883|FG002|Double Blind|Lost to Follow-up|0|||
27798177|NCT02178995|54252884|FG003|Double Blind|Lost to Follow-up|0|||
27798178|NCT02178995|54252885|FG004|Double Blind|Lost to Follow-up|0|||
27798179|NCT02178995|54252886|FG005|Double Blind|Lost to Follow-up|0|||
27798180|NCT02178995|54252887|FG006|Double Blind|Lost to Follow-up|0|||
27798181|NCT02178995|54252888|FG007|Double Blind|Lost to Follow-up|1|||
27798182|NCT02178995|54252889|FG008|Double Blind|Lost to Follow-up|0|||
27798183|NCT02178995|54252881|FG000|Open Label|Adverse Event|2|||
27798184|NCT02178995|54252882|FG001|Open Label|Adverse Event|0|||
27798185|NCT02178995|54252883|FG002|Open Label|Adverse Event|0|||
27798186|NCT02178995|54252884|FG003|Open Label|Adverse Event|0|||
27798187|NCT02178995|54252885|FG004|Open Label|Adverse Event|0|||
27798188|NCT02178995|54252886|FG005|Open Label|Adverse Event|0|||
27798189|NCT02178995|54252887|FG006|Open Label|Adverse Event|0|||
27798190|NCT02178995|54252888|FG007|Open Label|Adverse Event|0|||
27798191|NCT02178995|54252889|FG008|Open Label|Adverse Event|0|||
27798192|NCT02128997|54252915|FG000|Overall Study|Lost to Follow-up|6|||
27798193|NCT02128997|54252916|FG001|Overall Study|Lost to Follow-up|11|||
27798194|NCT02155283|54252922|FG000|Overall Study|Lost to Follow-up|3|||
28018379|NCT03895372|54677543|FG000|Investigational Treatment Period|Withdrawal by Subject|2|||
28018380|NCT03895372|54677544|FG001|Investigational Treatment Period|Withdrawal by Subject|3|||
28018381|NCT03895372|54677545|FG002|Investigational Treatment Period|Withdrawal by Subject|1|||
28018382|NCT03895372|54677546|FG003|Investigational Treatment Period|Withdrawal by Subject|1|||
28018383|NCT03895372|54677547|FG004|Investigational Treatment Period|Withdrawal by Subject|0|||
27798195|NCT02155283|54252922|FG000|Overall Study|Withdrawal by Subject|1|||
27798196|NCT02155283|54252922|FG000|Overall Study|Protocol Violation|3|||
28018384|NCT03895372|54677548|FG005|Investigational Treatment Period|Withdrawal by Subject|1|||
28018385|NCT03895372|54677549|FG006|Investigational Treatment Period|Withdrawal by Subject|3|||
28018386|NCT03895372|54677550|FG007|Investigational Treatment Period|Withdrawal by Subject|0|||
28018387|NCT03895372|54677543|FG000|Extension Treatment Period|Adverse Event|0|||
28018388|NCT03895372|54677544|FG001|Extension Treatment Period|Adverse Event|1|||
28018389|NCT03895372|54677545|FG002|Extension Treatment Period|Adverse Event|0|||
28018390|NCT03895372|54677546|FG003|Extension Treatment Period|Adverse Event|1|||
27798197|NCT02154581|54252928|FG000|Overall Study|Lost to Follow-up|7|||
27798198|NCT02154581|54252929|FG001|Overall Study|Lost to Follow-up|8|||
27798199|NCT02154425|54252937|FG000|Screening Period|Adverse Event|1|||
27798200|NCT02154347|54252947|FG000|Double-blind Period|Adverse Event|1|||
27798201|NCT02154347|54252948|FG001|Double-blind Period|Adverse Event|2|||
27798202|NCT02154347|54252947|FG000|Double-blind Period|Lack of Efficacy|1|||
27798203|NCT02154347|54252948|FG001|Double-blind Period|Lack of Efficacy|0|||
27798204|NCT02154347|54252947|FG000|Double-blind Period|Physician Decision|0|||
27798205|NCT02154347|54252948|FG001|Double-blind Period|Physician Decision|1|||
28018391|NCT03895372|54677547|FG004|Extension Treatment Period|Adverse Event|0|||
27798206|NCT02154347|54252947|FG000|Double-blind Period|Withdrawal by Subject|1|||
27798207|NCT02154347|54252948|FG001|Double-blind Period|Withdrawal by Subject|1|||
27798208|NCT02154347|54252947|FG000|Open-label Period|Adverse Event|3|||
27798209|NCT02154347|54252948|FG001|Open-label Period|Adverse Event|4|||
27798210|NCT02154347|54252947|FG000|Open-label Period|Lack of Efficacy|4|||
28018392|NCT03895372|54677548|FG005|Extension Treatment Period|Adverse Event|0|||
28018393|NCT03895372|54677549|FG006|Extension Treatment Period|Adverse Event|3|||
27798211|NCT02154347|54252948|FG001|Open-label Period|Lack of Efficacy|19|||
27798212|NCT02154347|54252947|FG000|Open-label Period|Protocol Violation|0|||
27798213|NCT02154347|54252948|FG001|Open-label Period|Protocol Violation|1|||
27798214|NCT02154347|54252947|FG000|Open-label Period|Withdrawal by Subject|0|||
27798215|NCT02154347|54252948|FG001|Open-label Period|Withdrawal by Subject|1|||
27798216|NCT01627067|54252955|FG000|Overall Study|Screen Failure|1|||
27798217|NCT02178059|54252961|FG000|Washout|Physician Decision|1|||
27798218|NCT02178059|54252962|FG001|Washout|Physician Decision|0|||
27798219|NCT01626989|54252968|FG000|Screening Period|Screen Failure|15|||
27798220|NCT01626989|54252969|FG001|Screening Period|Screen Failure|0|||
27798221|NCT01626989|54252970|FG002|Screening Period|Screen Failure|0|||
27798222|NCT01626989|54252968|FG000|Screening Period|Withdrawal by Subject|2|||
27798223|NCT01626989|54252969|FG001|Screening Period|Withdrawal by Subject|0|||
27798224|NCT01626989|54252970|FG002|Screening Period|Withdrawal by Subject|0|||
27798225|NCT02128217|54252981|FG000|Overall Study|Lost to Follow-up|0|||
27798226|NCT02128217|54252982|FG001|Overall Study|Lost to Follow-up|1|||
27798227|NCT01629953|54252995|FG000|Overall Study|Death|3|||
27798228|NCT01629953|54252996|FG001|Overall Study|Death|1|||
27798229|NCT01629953|54252995|FG000|Overall Study|Lost to Follow-up|10|||
27798230|NCT01629953|54252996|FG001|Overall Study|Lost to Follow-up|14|||
27798231|NCT02127281|54253004|FG000|Overall Study|Lost to Follow-up|1|||
27798232|NCT02127281|54253005|FG001|Overall Study|Lost to Follow-up|0|||
27798233|NCT01628549|54253015|FG000|Overall Study|Adverse Event|1|||
27798234|NCT01628549|54253016|FG001|Overall Study|Adverse Event|1|||
27798235|NCT01628549|54253017|FG002|Overall Study|Adverse Event|0|||
27798236|NCT01628549|54253018|FG003|Overall Study|Adverse Event|4|||
27798237|NCT01628549|54253015|FG000|Overall Study|Lost to Follow-up|3|||
27798238|NCT01628549|54253016|FG001|Overall Study|Lost to Follow-up|4|||
27938359|NCT00975130|54594509|FG000|Study Part 2|Withdrawal by Subject|0|||
28018394|NCT03895372|54677550|FG007|Extension Treatment Period|Adverse Event|3|||
28018395|NCT03895372|54677543|FG000|Extension Treatment Period|Other|1|||
28018396|NCT03895372|54677544|FG001|Extension Treatment Period|Other|3|||
27938360|NCT00975130|54594510|FG001|Study Part 2|Withdrawal by Subject|13|||
27938361|NCT00975130|54594511|FG002|Study Part 2|Withdrawal by Subject|5|||
27938362|NCT00975130|54594509|FG000|Study Part 2|Withdrew Consent|0|||
27938363|NCT00975130|54594510|FG001|Study Part 2|Withdrew Consent|6|||
27938364|NCT00975130|54594511|FG002|Study Part 2|Withdrew Consent|2|||
27938365|NCT00975130|54594509|FG000|Study Part 2|Did Not Meet Protocol Eligibility|0|||
27938366|NCT00975130|54594510|FG001|Study Part 2|Did Not Meet Protocol Eligibility|4|||
27938367|NCT00975130|54594511|FG002|Study Part 2|Did Not Meet Protocol Eligibility|1|||
27938368|NCT00975130|54594509|FG000|Study Part 2|Administrative|0|||
27938369|NCT00975130|54594510|FG001|Study Part 2|Administrative|1|||
27938370|NCT00975130|54594511|FG002|Study Part 2|Administrative|0|||
27938371|NCT00975130|54594509|FG000|Study Part 2|Protocol Violation|0|||
27938372|NCT00975130|54594510|FG001|Study Part 2|Protocol Violation|0|||
27938373|NCT00975130|54594511|FG002|Study Part 2|Protocol Violation|1|||
27938374|NCT01230827|54594528|FG000|Overall Study|Lost to Follow-up|0|||
27938375|NCT01230827|54594529|FG001|Overall Study|Lost to Follow-up|0|||
27938376|NCT01230827|54594530|FG002|Overall Study|Lost to Follow-up|1|||
27938377|NCT01230827|54594531|FG003|Overall Study|Lost to Follow-up|3|||
27938378|NCT01230827|54594528|FG000|Overall Study|Withdrawal by Subject|1|||
27938379|NCT01230827|54594529|FG001|Overall Study|Withdrawal by Subject|0|||
27938380|NCT01230827|54594530|FG002|Overall Study|Withdrawal by Subject|3|||
27938381|NCT01230827|54594531|FG003|Overall Study|Withdrawal by Subject|2|||
27938382|NCT01230827|54594528|FG000|Overall Study|Lack of Efficacy|14|||
27938383|NCT01230827|54594529|FG001|Overall Study|Lack of Efficacy|1|||
27938384|NCT01230827|54594530|FG002|Overall Study|Lack of Efficacy|2|||
27938385|NCT01230827|54594531|FG003|Overall Study|Lack of Efficacy|3|||
27938386|NCT01230827|54594528|FG000|Overall Study|Adverse Event|4|||
27938387|NCT01230827|54594529|FG001|Overall Study|Adverse Event|2|||
27938388|NCT01230827|54594530|FG002|Overall Study|Adverse Event|3|||
27938389|NCT01230827|54594531|FG003|Overall Study|Adverse Event|7|||
27938390|NCT01230827|54594528|FG000|Overall Study|Recovery|0|||
27938391|NCT01230827|54594529|FG001|Overall Study|Recovery|6|||
27938392|NCT01230827|54594530|FG002|Overall Study|Recovery|0|||
28018397|NCT03895372|54677545|FG002|Extension Treatment Period|Other|0|||
28018398|NCT03895372|54677546|FG003|Extension Treatment Period|Other|0|||
27798239|NCT01628549|54253017|FG002|Overall Study|Lost to Follow-up|3|||
27798240|NCT01628549|54253018|FG003|Overall Study|Lost to Follow-up|3|||
27798241|NCT01628549|54253015|FG000|Overall Study|Withdrawal by Subject|3|||
27798242|NCT01628549|54253016|FG001|Overall Study|Withdrawal by Subject|4|||
27798243|NCT01628549|54253017|FG002|Overall Study|Withdrawal by Subject|4|||
27798244|NCT01628549|54253018|FG003|Overall Study|Withdrawal by Subject|1|||
27798245|NCT01628549|54253015|FG000|Overall Study|Protocol Violation|2|||
27938393|NCT01230827|54594531|FG003|Overall Study|Recovery|0|||
27938394|NCT01230827|54594528|FG000|Overall Study|Study terminated by Sponsor|0|||
27938395|NCT01230827|54594529|FG001|Overall Study|Study terminated by Sponsor|2|||
28018399|NCT03895372|54677547|FG004|Extension Treatment Period|Other|1|||
27798246|NCT01628549|54253016|FG001|Overall Study|Protocol Violation|1|||
27798247|NCT01628549|54253017|FG002|Overall Study|Protocol Violation|1|||
28018400|NCT03895372|54677548|FG005|Extension Treatment Period|Other|0|||
28018401|NCT03895372|54677549|FG006|Extension Treatment Period|Other|0|||
28018402|NCT03895372|54677550|FG007|Extension Treatment Period|Other|2|||
28018403|NCT03895372|54677543|FG000|Extension Treatment Period|Pregnancy|0|||
28018404|NCT03895372|54677544|FG001|Extension Treatment Period|Pregnancy|0|||
28018405|NCT03895372|54677545|FG002|Extension Treatment Period|Pregnancy|0|||
28018406|NCT03895372|54677546|FG003|Extension Treatment Period|Pregnancy|0|||
28018407|NCT03895372|54677547|FG004|Extension Treatment Period|Pregnancy|1|||
28018408|NCT03895372|54677548|FG005|Extension Treatment Period|Pregnancy|0|||
28018409|NCT03895372|54677549|FG006|Extension Treatment Period|Pregnancy|0|||
28018410|NCT03895372|54677550|FG007|Extension Treatment Period|Pregnancy|0|||
28018411|NCT03895372|54677543|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
28018412|NCT03895372|54677544|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
28018413|NCT03895372|54677545|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
28018414|NCT03895372|54677546|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
28018415|NCT03895372|54677547|FG004|Extension Treatment Period|Withdrawal by Subject|1|||
28018416|NCT03895372|54677548|FG005|Extension Treatment Period|Withdrawal by Subject|1|||
28018417|NCT03895372|54677549|FG006|Extension Treatment Period|Withdrawal by Subject|1|||
28018418|NCT03895372|54677550|FG007|Extension Treatment Period|Withdrawal by Subject|1|||
28018419|NCT00669110|54677575|FG000|Overall Study|Adverse Event|4|||
27798248|NCT01628549|54253018|FG003|Overall Study|Protocol Violation|0|||
27798249|NCT01628549|54253015|FG000|Overall Study|withdrawn for noncompliance|0|||
27798250|NCT01628549|54253016|FG001|Overall Study|withdrawn for noncompliance|2|||
27798251|NCT01628549|54253017|FG002|Overall Study|withdrawn for noncompliance|1|||
27798252|NCT01628549|54253018|FG003|Overall Study|withdrawn for noncompliance|0|||
27798253|NCT01628549|54253015|FG000|Overall Study|abnormal laboratory test results|0|||
27798254|NCT01628549|54253016|FG001|Overall Study|abnormal laboratory test results|0|||
27798255|NCT01628549|54253017|FG002|Overall Study|abnormal laboratory test results|1|||
27798256|NCT01628549|54253018|FG003|Overall Study|abnormal laboratory test results|0|||
27798257|NCT01628549|54253015|FG000|Overall Study|positive pregnancy test|0|||
27938396|NCT01230827|54594530|FG002|Overall Study|Study terminated by Sponsor|56|||
27938397|NCT01230827|54594531|FG003|Overall Study|Study terminated by Sponsor|63|||
27938398|NCT01230749|54594543|FG000|Overall Study|Adverse Event|0|||
27938399|NCT01230749|54594544|FG001|Overall Study|Adverse Event|0|||
27938400|NCT01230749|54594545|FG002|Overall Study|Adverse Event|0|||
27938401|NCT01230749|54594546|FG003|Overall Study|Adverse Event|1|||
27938402|NCT01230749|54594543|FG000|Overall Study|Physician Decision|0|||
27938403|NCT01230749|54594544|FG001|Overall Study|Physician Decision|0|||
27938404|NCT01230749|54594545|FG002|Overall Study|Physician Decision|1|||
27938405|NCT01230749|54594546|FG003|Overall Study|Physician Decision|0|||
27938406|NCT01230749|54594543|FG000|Overall Study|Withdrawal by Subject|0|||
27938407|NCT01230749|54594544|FG001|Overall Study|Withdrawal by Subject|1|||
27938408|NCT01230749|54594545|FG002|Overall Study|Withdrawal by Subject|0|||
27938409|NCT01230749|54594546|FG003|Overall Study|Withdrawal by Subject|0|||
27938410|NCT01230749|54594543|FG000|Overall Study|Fasting glucose more than 270 mg/dL|0|||
27938411|NCT01230749|54594544|FG001|Overall Study|Fasting glucose more than 270 mg/dL|1|||
27938412|NCT01230749|54594545|FG002|Overall Study|Fasting glucose more than 270 mg/dL|1|||
27938413|NCT01230749|54594546|FG003|Overall Study|Fasting glucose more than 270 mg/dL|1|||
27938414|NCT00903175|54594561|FG000|Period 1 - First Line|Adverse Event|36|||
27938415|NCT00903175|54594562|FG001|Period 1 - First Line|Adverse Event|50|||
27938416|NCT00903175|54594561|FG000|Period 1 - First Line|Abnormal lab value(s)|0|||
27938417|NCT00903175|54594562|FG001|Period 1 - First Line|Abnormal lab value(s)|1|||
27938418|NCT00903175|54594561|FG000|Period 1 - First Line|Abnormal test procedure result(s)|1|||
27938419|NCT00903175|54594562|FG001|Period 1 - First Line|Abnormal test procedure result(s)|0|||
27938420|NCT00903175|54594561|FG000|Period 1 - First Line|Protocol Violation|3|||
27938421|NCT00903175|54594562|FG001|Period 1 - First Line|Protocol Violation|3|||
27938422|NCT00903175|54594561|FG000|Period 1 - First Line|Withdrawal by Subject|8|||
27938423|NCT00903175|54594562|FG001|Period 1 - First Line|Withdrawal by Subject|12|||
27938424|NCT00903175|54594561|FG000|Period 1 - First Line|Administrative problems|12|||
27938425|NCT00903175|54594562|FG001|Period 1 - First Line|Administrative problems|13|||
27938426|NCT00903175|54594561|FG000|Period 1 - First Line|Death|17|||
27938427|NCT00903175|54594562|FG001|Period 1 - First Line|Death|10|||
27938428|NCT00903175|54594561|FG000|Period 2 - Second Line|Missing|1|||
27938429|NCT00903175|54594562|FG001|Period 2 - Second Line|Missing|0|||
27938430|NCT00903175|54594561|FG000|Period 2 - Second Line|Adverse Event|16|||
27938431|NCT00903175|54594562|FG001|Period 2 - Second Line|Adverse Event|20|||
27938432|NCT00903175|54594561|FG000|Period 2 - Second Line|Withdrawal by Subject|7|||
28018420|NCT00669110|54677576|FG001|Overall Study|Adverse Event|3|||
28018421|NCT00669110|54677575|FG000|Overall Study|Caregiver request|3|||
28018422|NCT00669110|54677576|FG001|Overall Study|Caregiver request|2|||
27798258|NCT01628549|54253016|FG001|Overall Study|positive pregnancy test|0|||
27938433|NCT00903175|54594562|FG001|Period 2 - Second Line|Withdrawal by Subject|5|||
27798259|NCT01628549|54253017|FG002|Overall Study|positive pregnancy test|0|||
27798260|NCT01628549|54253018|FG003|Overall Study|positive pregnancy test|1|||
27798261|NCT02127125|54253037|FG000|Overall Study|Lost to Follow-up|0|||
27798262|NCT02127125|54253038|FG001|Overall Study|Lost to Follow-up|0|||
27798263|NCT02127125|54253039|FG002|Overall Study|Lost to Follow-up|0|||
27798264|NCT02127125|54253040|FG003|Overall Study|Lost to Follow-up|0|||
27798265|NCT02127125|54253041|FG004|Overall Study|Lost to Follow-up|2|||
28018423|NCT00669110|54677575|FG000|Overall Study|Physician Decision|0|||
28018424|NCT00669110|54677576|FG001|Overall Study|Physician Decision|1|||
28018425|NCT00669110|54677575|FG000|Overall Study|Lost to Follow-up|1|||
28018426|NCT00669110|54677576|FG001|Overall Study|Lost to Follow-up|0|||
28018427|NCT00669110|54677575|FG000|Overall Study|Protocol Violation|0|||
28018428|NCT00669110|54677576|FG001|Overall Study|Protocol Violation|5|||
28018429|NCT00669110|54677575|FG000|Overall Study|Withdrawal by Subject|0|||
28018430|NCT00669110|54677576|FG001|Overall Study|Withdrawal by Subject|2|||
28018431|NCT00654732|54677584|FG000|Overall Study|Adverse Event|4|||
27798266|NCT02127125|54253042|FG005|Overall Study|Lost to Follow-up|1|||
27798267|NCT02127125|54253043|FG006|Overall Study|Lost to Follow-up|0|||
27798268|NCT02127125|54253044|FG007|Overall Study|Lost to Follow-up|0|||
27798269|NCT02127125|54253045|FG008|Overall Study|Lost to Follow-up|0|||
27798270|NCT02127125|54253037|FG000|Overall Study|Withdrawal by Subject|0|||
27798271|NCT02127125|54253038|FG001|Overall Study|Withdrawal by Subject|0|||
27798272|NCT02127125|54253039|FG002|Overall Study|Withdrawal by Subject|0|||
27798273|NCT02127125|54253040|FG003|Overall Study|Withdrawal by Subject|1|||
27798274|NCT02127125|54253041|FG004|Overall Study|Withdrawal by Subject|0|||
27798275|NCT02127125|54253042|FG005|Overall Study|Withdrawal by Subject|0|||
27798276|NCT02127125|54253043|FG006|Overall Study|Withdrawal by Subject|0|||
27798277|NCT02127125|54253044|FG007|Overall Study|Withdrawal by Subject|0|||
27798278|NCT02127125|54253045|FG008|Overall Study|Withdrawal by Subject|0|||
27798279|NCT02127125|54253037|FG000|Overall Study|Physician Decision|0|||
27798280|NCT02127125|54253038|FG001|Overall Study|Physician Decision|0|||
27798281|NCT02127125|54253039|FG002|Overall Study|Physician Decision|1|||
27798282|NCT02127125|54253040|FG003|Overall Study|Physician Decision|0|||
27798283|NCT02127125|54253041|FG004|Overall Study|Physician Decision|1|||
27798284|NCT02127125|54253042|FG005|Overall Study|Physician Decision|2|||
27798285|NCT02127125|54253043|FG006|Overall Study|Physician Decision|0|||
27798286|NCT02127125|54253044|FG007|Overall Study|Physician Decision|0|||
27798287|NCT02127125|54253045|FG008|Overall Study|Physician Decision|0|||
27798288|NCT02090413|54253068|FG000|Overall Study|Adverse Event|11|||
27798289|NCT02090413|54253069|FG001|Overall Study|Adverse Event|15|||
27798290|NCT02090413|54253070|FG002|Overall Study|Adverse Event|20|||
27798291|NCT02090413|54253068|FG000|Overall Study|Flushing event|2|||
27798292|NCT02090413|54253069|FG001|Overall Study|Flushing event|0|||
27798293|NCT02090413|54253070|FG002|Overall Study|Flushing event|1|||
27798294|NCT02090413|54253068|FG000|Overall Study|Withdrawal by Subject|2|||
27798295|NCT02090413|54253069|FG001|Overall Study|Withdrawal by Subject|2|||
27798296|NCT02090413|54253070|FG002|Overall Study|Withdrawal by Subject|2|||
27798297|NCT02090413|54253068|FG000|Overall Study|Investigator Decision|1|||
27798298|NCT02090413|54253069|FG001|Overall Study|Investigator Decision|1|||
27798299|NCT02090413|54253070|FG002|Overall Study|Investigator Decision|0|||
27798300|NCT02090413|54253068|FG000|Overall Study|Other|2|||
27798301|NCT02090413|54253069|FG001|Overall Study|Other|1|||
27798302|NCT02090413|54253070|FG002|Overall Study|Other|0|||
27798303|NCT02090413|54253068|FG000|Overall Study|Lost to Follow-up|1|||
27798304|NCT02090413|54253069|FG001|Overall Study|Lost to Follow-up|1|||
27798305|NCT02090413|54253070|FG002|Overall Study|Lost to Follow-up|0|||
27798306|NCT02063737|54253081|FG000|Overall Study|Lost to Follow-up|11|||
27798307|NCT02063737|54253082|FG001|Overall Study|Lost to Follow-up|4|||
27798308|NCT02125877|54253090|FG000|Overall Study|Physician Decision|1|||
27798309|NCT02125877|54253091|FG001|Overall Study|Physician Decision|0|||
27798310|NCT02125877|54253090|FG000|Overall Study|Death|0|||
27798311|NCT02125877|54253091|FG001|Overall Study|Death|1|||
27798312|NCT02125877|54253090|FG000|Overall Study|Administrative problems|0|||
27798313|NCT02125877|54253091|FG001|Overall Study|Administrative problems|1|||
27798314|NCT02125877|54253090|FG000|Overall Study|Participant/guardian decision|0|||
27798315|NCT02125877|54253091|FG001|Overall Study|Participant/guardian decision|2|||
27798316|NCT02125877|54253090|FG000|Overall Study|Withdrawal by Subject|2|||
27798317|NCT02125877|54253091|FG001|Overall Study|Withdrawal by Subject|1|||
27798318|NCT02125877|54253090|FG000|Overall Study|Protocol deviation|4|||
28018432|NCT00654732|54677585|FG001|Overall Study|Adverse Event|6|||
28018433|NCT00649428|54677593|FG000|Overall Study|Adverse Event|2|||
28018434|NCT00649428|54677594|FG001|Overall Study|Adverse Event|2|||
27798319|NCT02125877|54253091|FG001|Overall Study|Protocol deviation|1|||
27798320|NCT02125877|54253090|FG000|Overall Study|Adverse Event|6|||
27798321|NCT02125877|54253091|FG001|Overall Study|Adverse Event|4|||
27798322|NCT01598987|54253097|FG000|Baseline to Month 12|Administrative problems|2|||
27798323|NCT01598987|54253097|FG000|Baseline to Month 12|Withdrawal by Subject|4|||
27798324|NCT01598987|54253097|FG000|Baseline to 24 Month|Withdrawal by Subject|5|||
27798325|NCT01598987|54253097|FG000|Baseline to 24 Month|Administrative problems|2|||
27798326|NCT01598987|54253097|FG000|Baseline to 24 Month|Lost to Follow-up|1|||
28018435|NCT00649428|54677593|FG000|Overall Study|Withdrawal by Subject|6|||
28018436|NCT00649428|54677594|FG001|Overall Study|Withdrawal by Subject|6|||
28018437|NCT00649428|54677593|FG000|Overall Study|Lost to Follow-up|1|||
28018438|NCT00649428|54677594|FG001|Overall Study|Lost to Follow-up|3|||
28018439|NCT00649428|54677593|FG000|Overall Study|Insufficient manufacturing yield|5|||
28018440|NCT00649428|54677594|FG001|Overall Study|Insufficient manufacturing yield|1|||
28018441|NCT00649428|54677593|FG000|Overall Study|Protocol Violation|6|||
28018442|NCT00649428|54677594|FG001|Overall Study|Protocol Violation|2|||
28018443|NCT00649428|54677593|FG000|Overall Study|Physician Decision|0|||
28018444|NCT00649428|54677594|FG001|Overall Study|Physician Decision|1|||
28018445|NCT00669032|54677603|FG000|Overall Study|Lost to Follow-up|6|||
28018446|NCT00669032|54677604|FG001|Overall Study|Lost to Follow-up|5|||
28018447|NCT00669032|54677603|FG000|Overall Study|Lack of Efficacy|8|||
28018448|NCT00669032|54677604|FG001|Overall Study|Lack of Efficacy|19|||
28018449|NCT00669032|54677603|FG000|Overall Study|Withdrawal by Subject|12|||
28018450|NCT00669032|54677604|FG001|Overall Study|Withdrawal by Subject|13|||
28018451|NCT00669032|54677603|FG000|Overall Study|Adverse Event|12|||
28018452|NCT00669032|54677604|FG001|Overall Study|Adverse Event|16|||
28018453|NCT00669032|54677603|FG000|Overall Study|Physician Decision|1|||
28018454|NCT00669032|54677604|FG001|Overall Study|Physician Decision|1|||
28018455|NCT00669032|54677603|FG000|Overall Study|No fulfilment of the selection criteria|5|||
28018456|NCT00669032|54677604|FG001|Overall Study|No fulfilment of the selection criteria|5|||
28018457|NCT00654498|54677612|FG000|Overall Study|Not Treated|1|||
28018458|NCT00654498|54677613|FG001|Overall Study|Not Treated|0|||
28018459|NCT00654498|54677612|FG000|Overall Study|Adverse Event|6|||
28018460|NCT00654498|54677613|FG001|Overall Study|Adverse Event|1|||
28018461|NCT00654498|54677612|FG000|Overall Study|Protocol Violation|1|||
28018462|NCT00654498|54677613|FG001|Overall Study|Protocol Violation|1|||
28018463|NCT00654498|54677612|FG000|Overall Study|Lost to Follow-up|1|||
28018464|NCT00654498|54677613|FG001|Overall Study|Lost to Follow-up|5|||
28018465|NCT00654498|54677612|FG000|Overall Study|Withdrawal by Subject|1|||
28018466|NCT00654498|54677613|FG001|Overall Study|Withdrawal by Subject|0|||
28018467|NCT00654498|54677612|FG000|Overall Study|Other reason not defined above|4|||
28018468|NCT00654498|54677613|FG001|Overall Study|Other reason not defined above|5|||
28018469|NCT00670046|54677621|FG000|Overall Study|Lost to Follow-up|1|||
28018470|NCT00670046|54677622|FG001|Overall Study|Lost to Follow-up|1|||
28018471|NCT00670046|54677621|FG000|Overall Study|Withdrawal by Subject|0|||
28018472|NCT00670046|54677622|FG001|Overall Study|Withdrawal by Subject|1|||
28018473|NCT00560391|54677633|FG000|Overall Study|Still on treatment|0|||
28018474|NCT00560391|54677634|FG001|Overall Study|Still on treatment|0|||
28018475|NCT00560391|54677635|FG002|Overall Study|Still on treatment|0|||
28018476|NCT00560391|54677636|FG003|Overall Study|Still on treatment|1|||
28018477|NCT00560391|54677637|FG004|Overall Study|Still on treatment|2|||
28018478|NCT00537238|54677652|FG000|Overall Study|Death|1|||
28018479|NCT00537238|54677653|FG001|Overall Study|Death|2|||
28018480|NCT00537238|54677652|FG000|Overall Study|Adverse Event|31|||
28018481|NCT00537238|54677653|FG001|Overall Study|Adverse Event|22|||
27798327|NCT02063659|54253111|FG000|Double-Blind Treatment Period|Adverse Event|1|||
27798328|NCT02063659|54253112|FG001|Double-Blind Treatment Period|Adverse Event|2|||
27798329|NCT02063659|54253113|FG002|Double-Blind Treatment Period|Adverse Event|0|||
27798330|NCT02063659|54253114|FG003|Double-Blind Treatment Period|Adverse Event|0|||
27798331|NCT02063659|54253111|FG000|Double-Blind Treatment Period|Physician Decision|1|||
27798332|NCT02063659|54253112|FG001|Double-Blind Treatment Period|Physician Decision|0|||
27798333|NCT02063659|54253113|FG002|Double-Blind Treatment Period|Physician Decision|0|||
27938434|NCT00903175|54594561|FG000|Period 2 - Second Line|Lost to Follow-up|1|||
28018482|NCT00537238|54677652|FG000|Overall Study|Lack of Efficacy|20|||
28018483|NCT00537238|54677653|FG001|Overall Study|Lack of Efficacy|21|||
27938435|NCT00903175|54594562|FG001|Period 2 - Second Line|Lost to Follow-up|0|||
27938436|NCT00903175|54594561|FG000|Period 2 - Second Line|Administrative problems|19|||
27938437|NCT00903175|54594562|FG001|Period 2 - Second Line|Administrative problems|9|||
27938438|NCT00903175|54594561|FG000|Period 2 - Second Line|Death|5|||
27938439|NCT00903175|54594562|FG001|Period 2 - Second Line|Death|2|||
27938440|NCT01229735|54594570|FG000|Overall Study|Lack of Efficacy|8|||
27938441|NCT01229735|54594571|FG001|Overall Study|Lack of Efficacy|8|||
28018484|NCT00537238|54677652|FG000|Overall Study|Lost to Follow-up|12|||
28018485|NCT00537238|54677653|FG001|Overall Study|Lost to Follow-up|8|||
28018486|NCT00537238|54677652|FG000|Overall Study|Withdrawal by Subject|51|||
28018487|NCT00537238|54677653|FG001|Overall Study|Withdrawal by Subject|47|||
28018488|NCT00537238|54677652|FG000|Overall Study|Protocol Violation|15|||
28018489|NCT00537238|54677653|FG001|Overall Study|Protocol Violation|19|||
28018490|NCT00537238|54677652|FG000|Overall Study|Does not meet entrance criteria|0|||
28018491|NCT00537238|54677653|FG001|Overall Study|Does not meet entrance criteria|2|||
28018492|NCT00537238|54677652|FG000|Overall Study|Other|44|||
28018493|NCT00537238|54677653|FG001|Overall Study|Other|52|||
28018494|NCT03966885|54677661|FG000|Overall Study|Death|1|||
28018495|NCT03966885|54677662|FG001|Overall Study|Death|0|||
28018496|NCT03966885|54677661|FG000|Overall Study|Lost to Follow-up|1|||
27798334|NCT02063659|54253114|FG003|Double-Blind Treatment Period|Physician Decision|0|||
27798335|NCT02063659|54253111|FG000|Double-Blind Treatment Period|Withdrawal of consent|0|||
27798336|NCT02063659|54253112|FG001|Double-Blind Treatment Period|Withdrawal of consent|1|||
27798337|NCT02063659|54253113|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
27798338|NCT02063659|54253114|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
27798339|NCT02063659|54253111|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
27798340|NCT02063659|54253112|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
27798341|NCT02063659|54253113|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
27798342|NCT02063659|54253114|FG003|Open-Label Extension Period (OLE)|Physician Decision|1|||
27798343|NCT02063659|54253111|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
27798344|NCT02063659|54253112|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
27798345|NCT02063659|54253113|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
27798346|NCT02063659|54253114|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
27798347|NCT02063659|54253111|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
27798348|NCT02063659|54253112|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
27798349|NCT02063659|54253113|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
27798350|NCT02063659|54253114|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|1|||
27798351|NCT02063659|54253111|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
27798352|NCT02063659|54253112|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
27798353|NCT02063659|54253113|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
27798354|NCT02063659|54253114|FG003|Open-Label Extension Period (OLE)|Adverse Event|7|||
27798355|NCT02063659|54253111|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
27798356|NCT02063659|54253112|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
28018497|NCT03966885|54677662|FG001|Overall Study|Lost to Follow-up|2|||
28018498|NCT03966885|54677661|FG000|Overall Study|Not post-assessed. Study ended early due to COVID-19|20|||
28018499|NCT03966885|54677662|FG001|Overall Study|Not post-assessed. Study ended early due to COVID-19|16|||
28018500|NCT03966885|54677661|FG000|Overall Study|Moved from study area.|0|||
28018501|NCT03966885|54677662|FG001|Overall Study|Moved from study area.|2|||
28018502|NCT03965403|54677669|FG000|Overall Study|Subject not meeting eligibility criteria|1|||
28018503|NCT00552669|54677675|FG000|Overall Study|Death|3|||
28018504|NCT00552669|54677676|FG001|Overall Study|Death|7|||
28018505|NCT00552513|54677684|FG000|Overall Study|Lost to Follow-up|5|||
28018506|NCT00552513|54677685|FG001|Overall Study|Lost to Follow-up|1|||
28018507|NCT00560313|54677693|FG000|Overall Study|Adverse Events or Death|2|||
28018508|NCT00560313|54677693|FG000|Overall Study|Withdrawal by Subject|2|||
28018509|NCT00560313|54677693|FG000|Overall Study|Lost to Follow-up|1|||
28018510|NCT00560313|54677693|FG000|Overall Study|Protocol Violation|1|||
28018511|NCT00667862|54677712|FG000|Overall Study|Adverse Event|9|||
28018512|NCT00667862|54677712|FG000|Overall Study|Death|1|||
28018513|NCT00667862|54677712|FG000|Overall Study|Disease Progression|22|||
28018514|NCT00667862|54677712|FG000|Overall Study|Withdrawal by Subject|3|||
28018515|NCT00535132|54677718|FG000|Safety Analysis Set|Did Not Receive Study Medication|2|||
28018516|NCT00535132|54677719|FG001|Safety Analysis Set|Did Not Receive Study Medication|2|||
28018517|NCT00535132|54677718|FG000|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
28018518|NCT00535132|54677719|FG001|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
28018519|NCT00570908|54677727|FG000|Overall Study|Adverse Event|5|||
28018520|NCT00570908|54677727|FG000|Overall Study|Withdrawal by Subject|2|||
28018521|NCT00321919|54677733|FG000|Overall Study|Adverse Event|17|||
28018522|NCT00321919|54677734|FG001|Overall Study|Adverse Event|10|||
28018523|NCT00321919|54677733|FG000|Overall Study|Death|21|||
28018524|NCT00321919|54677734|FG001|Overall Study|Death|17|||
28018525|NCT00321919|54677733|FG000|Overall Study|Insufficient Therapeutic Response|1|||
28018526|NCT00321919|54677734|FG001|Overall Study|Insufficient Therapeutic Response|0|||
28018527|NCT00321919|54677733|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
28018528|NCT00321919|54677734|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
28018529|NCT00321919|54677733|FG000|Overall Study|Refused Treatment|23|||
28018530|NCT00321919|54677734|FG001|Overall Study|Refused Treatment|14|||
28018531|NCT00321919|54677733|FG000|Overall Study|Other Protocol Violation|2|||
28018532|NCT00321919|54677734|FG001|Overall Study|Other Protocol Violation|3|||
28018533|NCT00321919|54677733|FG000|Overall Study|Failure to Return|3|||
28018534|NCT00321919|54677734|FG001|Overall Study|Failure to Return|1|||
28018535|NCT00321919|54677733|FG000|Overall Study|Other withdrawal reason|7|||
27798357|NCT02063659|54253113|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
27798358|NCT02063659|54253114|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
28018536|NCT00321919|54677734|FG001|Overall Study|Other withdrawal reason|6|||
28018537|NCT00781391|54677744|FG000|Overall Study|never received study drug|24|||
27798359|NCT02062879|54253130|FG000|Overall Study|Withdrawal by Subject|4|||
28018538|NCT00781391|54677745|FG001|Overall Study|never received study drug|23|||
28018539|NCT00781391|54677746|FG002|Overall Study|never received study drug|32|||
28018540|NCT00781391|54677744|FG000|Overall Study|Protocol Violation|19|||
28018541|NCT00781391|54677745|FG001|Overall Study|Protocol Violation|17|||
28018542|NCT00781391|54677746|FG002|Overall Study|Protocol Violation|20|||
27798360|NCT02062879|54253131|FG001|Overall Study|Withdrawal by Subject|1|||
27798361|NCT02062645|54253137|FG000|Overall Study|Adverse Event|2|||
27798362|NCT02062645|54253137|FG000|Overall Study|Protocol Violation|8|||
27798363|NCT02062645|54253137|FG000|Overall Study|Lost to Follow-up|5|||
27798364|NCT02088697|54253143|FG000|Period I|Physician Decision|1|||
27798365|NCT02088697|54253144|FG001|Period I|Physician Decision|4|||
27798366|NCT02088697|54253143|FG000|Wash-out Period (at Least 10 Days)|Adverse Event|1|||
27798367|NCT02088697|54253144|FG001|Wash-out Period (at Least 10 Days)|Adverse Event|0|||
27798368|NCT01825785|54253157|FG000|Overall Study|Adverse Event|0|||
27798369|NCT01825785|54253158|FG001|Overall Study|Adverse Event|0|||
27798370|NCT01825785|54253159|FG002|Overall Study|Adverse Event|0|||
27798371|NCT01825785|54253160|FG003|Overall Study|Adverse Event|0|||
27798372|NCT01825785|54253161|FG004|Overall Study|Adverse Event|1|||
27798373|NCT01825785|54253162|FG005|Overall Study|Adverse Event|0|||
27798374|NCT01825785|54253163|FG006|Overall Study|Adverse Event|0|||
27798375|NCT01825785|54253157|FG000|Overall Study|Withdrawal by Subject|0|||
27798376|NCT01825785|54253158|FG001|Overall Study|Withdrawal by Subject|0|||
27798377|NCT01825785|54253159|FG002|Overall Study|Withdrawal by Subject|0|||
27798378|NCT01825785|54253160|FG003|Overall Study|Withdrawal by Subject|0|||
27798379|NCT01825785|54253161|FG004|Overall Study|Withdrawal by Subject|1|||
28018543|NCT00781391|54677744|FG000|Overall Study|Death|789|||
28018544|NCT00781391|54677745|FG001|Overall Study|Death|730|||
28018545|NCT00781391|54677746|FG002|Overall Study|Death|706|||
28018546|NCT00781391|54677744|FG000|Overall Study|Withdrawal by Subject|47|||
28018547|NCT00781391|54677745|FG001|Overall Study|Withdrawal by Subject|37|||
28018548|NCT00781391|54677746|FG002|Overall Study|Withdrawal by Subject|25|||
28018549|NCT00781391|54677744|FG000|Overall Study|Lost to Follow-up|0|||
28018550|NCT00781391|54677745|FG001|Overall Study|Lost to Follow-up|0|||
28018551|NCT00781391|54677746|FG002|Overall Study|Lost to Follow-up|1|||
28018552|NCT00534976|54677756|FG000|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0|||
28018553|NCT00534976|54677757|FG001|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1|||
28018554|NCT00534976|54677756|FG000|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1|||
28018555|NCT00534976|54677757|FG001|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0|||
28018556|NCT00534976|54677756|FG000|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1|||
28018557|NCT00534976|54677757|FG001|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0|||
28018558|NCT00321763|54677767|FG000|Overall Study|Adverse Event|1|||
28018559|NCT00321763|54677768|FG001|Overall Study|Adverse Event|1|||
28018560|NCT00321763|54677769|FG002|Overall Study|Adverse Event|0|||
28018561|NCT00321763|54677770|FG003|Overall Study|Adverse Event|1|||
28018562|NCT00321763|54677767|FG000|Overall Study|Withdrawal by Subject|2|||
28018563|NCT00321763|54677768|FG001|Overall Study|Withdrawal by Subject|0|||
28018564|NCT00321763|54677769|FG002|Overall Study|Withdrawal by Subject|1|||
28018565|NCT00321763|54677770|FG003|Overall Study|Withdrawal by Subject|0|||
28018566|NCT00321763|54677767|FG000|Overall Study|Lost to Follow-up|3|||
28018567|NCT00321763|54677768|FG001|Overall Study|Lost to Follow-up|1|||
28018568|NCT00321763|54677769|FG002|Overall Study|Lost to Follow-up|5|||
28018569|NCT00321763|54677770|FG003|Overall Study|Lost to Follow-up|4|||
28018570|NCT00308113|54677786|FG000|Overall Study|Protocol closure|0|||
28018571|NCT00308113|54677787|FG001|Overall Study|Protocol closure|0|||
28018572|NCT00308113|54677788|FG002|Overall Study|Protocol closure|0|||
28018573|NCT00308113|54677789|FG003|Overall Study|Protocol closure|1|||
28018574|NCT00307801|54677805|FG000|Overall Study|Adverse Event|12|||
28018575|NCT00307801|54677806|FG001|Overall Study|Adverse Event|4|||
28018576|NCT00307801|54677805|FG000|Overall Study|Withdrawal by Subject|9|||
28018577|NCT00307801|54677806|FG001|Overall Study|Withdrawal by Subject|4|||
28018578|NCT00307801|54677805|FG000|Overall Study|Non-compliance, not taken all tablets|1|||
28018579|NCT00307801|54677806|FG001|Overall Study|Non-compliance, not taken all tablets|2|||
28018580|NCT00307801|54677805|FG000|Overall Study|Adverse event (AE)/Withdrawal of consent|2|||
28018581|NCT00307801|54677806|FG001|Overall Study|Adverse event (AE)/Withdrawal of consent|0|||
28018582|NCT00307801|54677805|FG000|Overall Study|Decreased Libido (AE at discontinuation)|0|||
28018583|NCT00307801|54677806|FG001|Overall Study|Decreased Libido (AE at discontinuation)|1|||
28018584|NCT00307801|54677805|FG000|Overall Study|Wrong Randomization|1|||
27798380|NCT01825785|54253162|FG005|Overall Study|Withdrawal by Subject|1|||
27798381|NCT01825785|54253163|FG006|Overall Study|Withdrawal by Subject|0|||
28018585|NCT00307801|54677806|FG001|Overall Study|Wrong Randomization|0|||
28018586|NCT00307801|54677805|FG000|Overall Study|Lack of Efficacy|0|||
28018587|NCT00307801|54677806|FG001|Overall Study|Lack of Efficacy|2|||
27798382|NCT02043301|54253188|FG000|Overall Study|Discontinued|0|||
27798383|NCT02043301|54253189|FG001|Overall Study|Discontinued|1|||
27798384|NCT02043301|54253190|FG002|Overall Study|Discontinued|0|||
27798385|NCT01598753|54253202|FG000|Overall Study|Adverse Event|1|||
27798386|NCT01598753|54253203|FG001|Overall Study|Adverse Event|9|||
28018588|NCT00307801|54677805|FG000|Overall Study|Lost to Follow-up, moved abroad|1|||
28018589|NCT00307801|54677806|FG001|Overall Study|Lost to Follow-up, moved abroad|1|||
28018590|NCT00307801|54677805|FG000|Overall Study|Frustration with e-diary|1|||
28018591|NCT00307801|54677806|FG001|Overall Study|Frustration with e-diary|0|||
27798387|NCT01598753|54253204|FG002|Overall Study|Adverse Event|1|||
27798388|NCT01598753|54253205|FG003|Overall Study|Adverse Event|7|||
27798389|NCT01598753|54253202|FG000|Overall Study|Lost to Follow-up|4|||
27798390|NCT01598753|54253203|FG001|Overall Study|Lost to Follow-up|3|||
27798391|NCT01598753|54253204|FG002|Overall Study|Lost to Follow-up|7|||
27798392|NCT01598753|54253205|FG003|Overall Study|Lost to Follow-up|5|||
27798393|NCT01598753|54253202|FG000|Overall Study|Physician Decision|0|||
27798394|NCT01598753|54253203|FG001|Overall Study|Physician Decision|1|||
27798395|NCT01598753|54253204|FG002|Overall Study|Physician Decision|0|||
27798396|NCT01598753|54253205|FG003|Overall Study|Physician Decision|2|||
27798397|NCT01598753|54253202|FG000|Overall Study|Withdrawal by Subject|7|||
27798398|NCT01598753|54253203|FG001|Overall Study|Withdrawal by Subject|2|||
27798399|NCT01598753|54253204|FG002|Overall Study|Withdrawal by Subject|0|||
27798400|NCT01598753|54253205|FG003|Overall Study|Withdrawal by Subject|1|||
27798401|NCT02177123|54253215|FG000|Overall Study|Lost to Follow-up|6|||
27798402|NCT02177123|54253215|FG000|Overall Study|Withdrawal by Subject|4|||
27798403|NCT02177123|54253215|FG000|Overall Study|Adverse Event|4|||
27798404|NCT02177123|54253215|FG000|Overall Study|Physician Decision|3|||
27798405|NCT02177123|54253215|FG000|Overall Study|Excluded by Sponsor - other reason|2|||
27798406|NCT02177123|54253215|FG000|Overall Study|Excluded for medical reasons|2|||
27798407|NCT02177123|54253215|FG000|Overall Study|Death|1|||
27798408|NCT02177123|54253215|FG000|Overall Study|Other|1|||
27798409|NCT02177123|54253215|FG000|Overall Study|Excl. #31 Ocular pathology or medical condition which would place subject at increased risk|1|||
27798410|NCT01824693|54253225|FG000|Overall Study|Death|0|||
27798411|NCT01824693|54253226|FG001|Overall Study|Death|1|||
27798412|NCT01824693|54253227|FG002|Overall Study|Death|0|||
27798413|NCT01824693|54253225|FG000|Overall Study|Physician Decision|1|||
27938442|NCT01229735|54594570|FG000|Overall Study|Protocol Violation|13|||
27938443|NCT01229735|54594571|FG001|Overall Study|Protocol Violation|8|||
28018592|NCT00307801|54677805|FG000|Overall Study|Protocol Violation|3|||
28018593|NCT00307801|54677806|FG001|Overall Study|Protocol Violation|2|||
28018594|NCT00307801|54677805|FG000|Overall Study|No reason specified|2|||
28018595|NCT00307801|54677806|FG001|Overall Study|No reason specified|0|||
28018596|NCT00307801|54677805|FG000|Overall Study|Pregnancy|0|||
28018597|NCT00307801|54677806|FG001|Overall Study|Pregnancy|1|||
28018598|NCT00671060|54677815|FG000|Overall Study|Protocol Violation|1|||
28018599|NCT00671060|54677816|FG001|Overall Study|Protocol Violation|0|||
28018600|NCT00671060|54677815|FG000|Overall Study|Physician Decision|0|||
28018601|NCT00671060|54677816|FG001|Overall Study|Physician Decision|1|||
28018602|NCT00654420|54677826|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
28018603|NCT00654420|54677827|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
28018604|NCT00654420|54677828|FG002|Phase I (Dose Escalation)|Adverse Event|0|||
28018605|NCT00654420|54677829|FG003|Phase I (Dose Escalation)|Adverse Event|0|||
28018606|NCT00654420|54677826|FG000|Phase I (Dose Escalation)|Progressive Disease|4|||
28018607|NCT00654420|54677827|FG001|Phase I (Dose Escalation)|Progressive Disease|15|||
28018608|NCT00654420|54677828|FG002|Phase I (Dose Escalation)|Progressive Disease|0|||
28018609|NCT00654420|54677829|FG003|Phase I (Dose Escalation)|Progressive Disease|0|||
28018610|NCT00654420|54677826|FG000|Phase II|Adverse Event|0|||
28018611|NCT00654420|54677827|FG001|Phase II|Adverse Event|0|||
28018612|NCT00654420|54677828|FG002|Phase II|Adverse Event|3|||
28018613|NCT00654420|54677829|FG003|Phase II|Adverse Event|3|||
28018614|NCT00654420|54677826|FG000|Phase II|Lost to Follow-up|0|||
28018615|NCT00654420|54677827|FG001|Phase II|Lost to Follow-up|0|||
28018616|NCT00654420|54677828|FG002|Phase II|Lost to Follow-up|0|||
27798414|NCT01824693|54253226|FG001|Overall Study|Physician Decision|1|||
27798415|NCT01824693|54253227|FG002|Overall Study|Physician Decision|1|||
27798416|NCT01824693|54253225|FG000|Overall Study|Withdrawal by Subject|0|||
27798417|NCT01824693|54253226|FG001|Overall Study|Withdrawal by Subject|0|||
27798418|NCT01824693|54253227|FG002|Overall Study|Withdrawal by Subject|1|||
27798419|NCT01824693|54253225|FG000|Overall Study|Progressive Disease|0|||
27798420|NCT01824693|54253226|FG001|Overall Study|Progressive Disease|5|||
27798421|NCT01824693|54253227|FG002|Overall Study|Progressive Disease|0|||
27938444|NCT01229735|54594570|FG000|Overall Study|Lost to Follow-up|0|||
27938445|NCT01229735|54594571|FG001|Overall Study|Lost to Follow-up|2|||
27938446|NCT01229735|54594570|FG000|Overall Study|Withdrawal by Subject|18|||
27938447|NCT01229735|54594571|FG001|Overall Study|Withdrawal by Subject|17|||
27938448|NCT01229735|54594570|FG000|Overall Study|Other Reason|13|||
27938449|NCT01229735|54594571|FG001|Overall Study|Other Reason|10|||
27938450|NCT01229735|54594570|FG000|Overall Study|SAE, non-fatal|0|||
27938451|NCT01229735|54594571|FG001|Overall Study|SAE, non-fatal|4|||
27938452|NCT01229735|54594570|FG000|Overall Study|AE, non-serious non-fatal|13|||
27938453|NCT01229735|54594571|FG001|Overall Study|AE, non-serious non-fatal|17|||
27938454|NCT01229735|54594570|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
27938455|NCT01229735|54594571|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
28018617|NCT00654420|54677829|FG003|Phase II|Lost to Follow-up|1|||
28018618|NCT00654420|54677826|FG000|Phase II|Physician Decision|0|||
28018619|NCT00654420|54677827|FG001|Phase II|Physician Decision|0|||
28018620|NCT00654420|54677828|FG002|Phase II|Physician Decision|0|||
28018621|NCT00654420|54677829|FG003|Phase II|Physician Decision|4|||
27798422|NCT01824693|54253225|FG000|Overall Study|Ineligible|0|||
27798423|NCT01824693|54253226|FG001|Overall Study|Ineligible|0|||
27798424|NCT01824693|54253227|FG002|Overall Study|Ineligible|3|||
27798425|NCT01824693|54253225|FG000|Overall Study|No Transplant Planned|0|||
27798426|NCT01824693|54253226|FG001|Overall Study|No Transplant Planned|0|||
27798427|NCT01824693|54253227|FG002|Overall Study|No Transplant Planned|10|||
27798428|NCT02176655|54253234|FG000|Overall Study|Subjects did not treat|6|||
27798429|NCT02125331|54253241|FG000|Overall Study|Protocol Violation|1|||
27798430|NCT02125331|54253242|FG001|Overall Study|Protocol Violation|0|||
27798431|NCT02125331|54253241|FG000|Overall Study|technical problem|2|||
27798432|NCT02125331|54253242|FG001|Overall Study|technical problem|0|||
27798433|NCT02125331|54253241|FG000|Overall Study|screen failure|2|||
27798434|NCT02125331|54253242|FG001|Overall Study|screen failure|0|||
27798435|NCT01622569|54253252|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4|||
27798436|NCT01622569|54253253|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
27798437|NCT01622569|54253254|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3|||
27798438|NCT01622569|54253255|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
28018622|NCT00654420|54677826|FG000|Phase II|Progressive Disease|0|||
28018623|NCT00654420|54677827|FG001|Phase II|Progressive Disease|0|||
28018624|NCT00654420|54677828|FG002|Phase II|Progressive Disease|29|||
28018625|NCT00654420|54677829|FG003|Phase II|Progressive Disease|29|||
28018626|NCT00654420|54677826|FG000|Phase II|Withdrawal by Subject|0|||
28018627|NCT00654420|54677827|FG001|Phase II|Withdrawal by Subject|0|||
28018628|NCT00654420|54677828|FG002|Phase II|Withdrawal by Subject|4|||
28018629|NCT00654420|54677829|FG003|Phase II|Withdrawal by Subject|1|||
28018630|NCT00654420|54677826|FG000|Phase II|Missing Disposition Record|0|||
28018631|NCT00654420|54677827|FG001|Phase II|Missing Disposition Record|0|||
28018632|NCT00654420|54677828|FG002|Phase II|Missing Disposition Record|1|||
28018633|NCT00654420|54677829|FG003|Phase II|Missing Disposition Record|0|||
28018634|NCT00307489|54677841|FG000|Baseline Through Week 48|Lost to Follow-up|0|||
28018635|NCT00307489|54677842|FG001|Baseline Through Week 48|Lost to Follow-up|1|||
28018636|NCT00307489|54677841|FG000|Baseline Through Week 48|Physician Decision|1|||
28018637|NCT00307489|54677842|FG001|Baseline Through Week 48|Physician Decision|0|||
28018638|NCT00307489|54677841|FG000|Baseline Through Week 48|Withdrawal by Subject|0|||
28018639|NCT00307489|54677842|FG001|Baseline Through Week 48|Withdrawal by Subject|1|||
28018640|NCT00307489|54677841|FG000|Week 48 Through Week 168|Adverse Event|1|||
28018641|NCT00307489|54677842|FG001|Week 48 Through Week 168|Adverse Event|0|||
28018642|NCT00307489|54677841|FG000|Week 48 Through Week 168|Physician Decision|1|||
28018643|NCT00307489|54677842|FG001|Week 48 Through Week 168|Physician Decision|0|||
28018644|NCT00307489|54677841|FG000|Week 48 Through Week 168|Withdrawal by Subject|1|||
28018645|NCT00307489|54677842|FG001|Week 48 Through Week 168|Withdrawal by Subject|2|||
28018646|NCT00307489|54677841|FG000|Week 48 Through Week 168|Lack of Efficacy|2|||
28018647|NCT00307489|54677842|FG001|Week 48 Through Week 168|Lack of Efficacy|2|||
28018648|NCT00307489|54677841|FG000|Week 48 Through Week 168|Death|0|||
28018649|NCT00307489|54677842|FG001|Week 48 Through Week 168|Death|1|||
28018650|NCT00307489|54677841|FG000|Week 48 Through Week 168|Lost to Follow-up|0|||
28018651|NCT00307489|54677842|FG001|Week 48 Through Week 168|Lost to Follow-up|1|||
28018652|NCT00307489|54677841|FG000|Week 48 Through Week 168|Seroconversion|1|||
28018653|NCT00307489|54677842|FG001|Week 48 Through Week 168|Seroconversion|0|||
28018654|NCT00645840|54677848|FG000|Overall Study|Protocol Violation|3|||
28018655|NCT00307333|54677854|FG000|Overall Study|Lost to Follow-up|11|||
28018656|NCT00307333|54677855|FG001|Overall Study|Lost to Follow-up|3|||
28018657|NCT00762359|54677863|FG000|Overall Study|Adverse Event|20|||
28018658|NCT00762359|54677864|FG001|Overall Study|Adverse Event|23|||
28018659|NCT00762359|54677863|FG000|Overall Study|Protocol Violation|21|||
28018660|NCT00762359|54677864|FG001|Overall Study|Protocol Violation|13|||
28018661|NCT00762359|54677863|FG000|Overall Study|Withdrawal by Subject|13|||
28018662|NCT00762359|54677864|FG001|Overall Study|Withdrawal by Subject|10|||
28018663|NCT00762359|54677863|FG000|Overall Study|Lack of Efficacy|0|||
28018664|NCT00762359|54677864|FG001|Overall Study|Lack of Efficacy|4|||
28018665|NCT00762359|54677863|FG000|Overall Study|Institution closed|2|||
28018666|NCT00762359|54677864|FG001|Overall Study|Institution closed|3|||
28018667|NCT00762359|54677863|FG000|Overall Study|Physician Decision|2|||
28018668|NCT00762359|54677864|FG001|Overall Study|Physician Decision|3|||
28018669|NCT00762359|54677863|FG000|Overall Study|Removal|0|||
28018670|NCT00762359|54677864|FG001|Overall Study|Removal|1|||
27798439|NCT01622569|54253252|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
27798440|NCT01622569|54253253|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
27798441|NCT01622569|54253254|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1|||
27798442|NCT01622569|54253255|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
28018671|NCT00762359|54677863|FG000|Overall Study|Withdrew consent|1|||
28018672|NCT00762359|54677864|FG001|Overall Study|Withdrew consent|0|||
28018673|NCT00654186|54677870|FG000|Overall Study|Withdrawal by Subject|5|||
28018674|NCT00761969|54677876|FG000|Overall Study|Death|112|||
28018675|NCT00761969|54677877|FG001|Overall Study|Death|47|||
28018676|NCT00761969|54677876|FG000|Overall Study|Lost to Follow-up|88|||
28018677|NCT00761969|54677877|FG001|Overall Study|Lost to Follow-up|93|||
28018678|NCT00761891|54677888|FG000|Overall Study|Withdrawal by Subject|10|||
27798443|NCT01622569|54253252|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6|||
27798444|NCT01622569|54253253|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
27798445|NCT01622569|54253254|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3|||
27798446|NCT01622569|54253255|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2|||
27798447|NCT01622569|54253252|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
27798448|NCT01622569|54253253|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2|||
27798449|NCT01622569|54253254|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
27798450|NCT01622569|54253255|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
27798451|NCT01622569|54253252|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
27798452|NCT01622569|54253253|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
27798453|NCT01622569|54253254|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
27798454|NCT01622569|54253255|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
27798455|NCT01622569|54253252|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
27798456|NCT01622569|54253253|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2|||
27798457|NCT01622569|54253254|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
27798458|NCT01622569|54253255|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
27798459|NCT01622569|54253252|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
27798460|NCT01622569|54253253|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
27798461|NCT01622569|54253254|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2|||
27798462|NCT01622569|54253255|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
27798463|NCT01622569|54253252|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
27798464|NCT01622569|54253253|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
27798465|NCT01622569|54253254|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
27798466|NCT01622569|54253255|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
27798467|NCT01824303|54253277|FG000|Randomized Study|Withdrawal by Subject|1|||
27798468|NCT01824303|54253278|FG001|Randomized Study|Withdrawal by Subject|1|||
27798469|NCT01824303|54253277|FG000|Randomized Study|Other Miscellaneous Reasons|1|||
27798470|NCT01824303|54253278|FG001|Randomized Study|Other Miscellaneous Reasons|0|||
27798471|NCT01853397|54253290|FG000|Overall Study|Withdrawal by Subject|0|||
27798472|NCT01853397|54253291|FG001|Overall Study|Withdrawal by Subject|0|||
27798473|NCT01853397|54253292|FG002|Overall Study|Withdrawal by Subject|0|||
27798474|NCT01853397|54253293|FG003|Overall Study|Withdrawal by Subject|1|||
27798475|NCT01853397|54253290|FG000|Overall Study|Subject Noncompliance|0|||
27798476|NCT01853397|54253291|FG001|Overall Study|Subject Noncompliance|0|||
27798477|NCT01853397|54253292|FG002|Overall Study|Subject Noncompliance|0|||
27798478|NCT01853397|54253293|FG003|Overall Study|Subject Noncompliance|1|||
28018679|NCT00321685|54677893|FG000|Overall Study|Adverse Event|18|||
28018680|NCT00321685|54677893|FG000|Overall Study|Death|2|||
28018681|NCT00321685|54677893|FG000|Overall Study|Withdrawal by Subject|8|||
28018682|NCT00321685|54677893|FG000|Overall Study|Alternative therapy|1|||
28018683|NCT00321685|54677893|FG000|Overall Study|Complicating disese|1|||
28018684|NCT00321685|54677893|FG000|Overall Study|Other|5|||
28018685|NCT00321685|54677893|FG000|Overall Study|Not start protocol therapy|2|||
28018686|NCT00321685|54677893|FG000|Overall Study|Ineligible|2|||
28018687|NCT03902392|54677899|FG000|Overall Study|Lost to Follow-up|7|||
28018688|NCT03902392|54677900|FG001|Overall Study|Lost to Follow-up|7|||
28018689|NCT00306787|54677908|FG000|Overall Study|Discontinued without taking study drug|208|||
27798479|NCT02088073|54253308|FG000|Acute Phase|Withdrawal by Subject|5|||
27798480|NCT02088073|54253309|FG001|Acute Phase|Withdrawal by Subject|0|||
27798481|NCT02088073|54253310|FG002|Acute Phase|Withdrawal by Subject|0|||
27798482|NCT02088073|54253311|FG003|Acute Phase|Withdrawal by Subject|0|||
27798483|NCT02088073|54253312|FG004|Acute Phase|Withdrawal by Subject|0|||
27798484|NCT02088073|54253308|FG000|Acute Phase|Hyperkalemia|2|||
27798485|NCT02088073|54253309|FG001|Acute Phase|Hyperkalemia|0|||
27798486|NCT02088073|54253310|FG002|Acute Phase|Hyperkalemia|0|||
27798487|NCT02088073|54253311|FG003|Acute Phase|Hyperkalemia|0|||
27798488|NCT02088073|54253312|FG004|Acute Phase|Hyperkalemia|0|||
27938456|NCT00974974|54594590|FG000|IR CD-LD Dose Adjustment|Adverse Event|0|||
27938457|NCT00974974|54594591|FG001|IR CD-LD Dose Adjustment|Adverse Event|3|||
27938458|NCT00974974|54594590|FG000|IR CD-LD Dose Adjustment|Protocol Violation|0|||
27938459|NCT00974974|54594591|FG001|IR CD-LD Dose Adjustment|Protocol Violation|1|||
27938460|NCT00974974|54594590|FG000|IR CD-LD Dose Adjustment|Noncompliance with study drug|0|||
27938461|NCT00974974|54594591|FG001|IR CD-LD Dose Adjustment|Noncompliance with study drug|1|||
27938462|NCT00974974|54594590|FG000|IR CD-LD Dose Adjustment|Withdrawal by Subject|0|||
27938463|NCT00974974|54594591|FG001|IR CD-LD Dose Adjustment|Withdrawal by Subject|7|||
27938464|NCT00974974|54594590|FG000|IR CD-LD Dose Adjustment|Various|0|||
27938465|NCT00974974|54594591|FG001|IR CD-LD Dose Adjustment|Various|9|||
27938466|NCT00974974|54594590|FG000|IPX066 Dose Conversion|Adverse Event|23|||
28018690|NCT00306787|54677909|FG001|Overall Study|Discontinued without taking study drug|215|||
28018691|NCT00306787|54677908|FG000|Overall Study|Adverse Event|1|||
28018692|NCT00306787|54677909|FG001|Overall Study|Adverse Event|1|||
27798489|NCT02088073|54253308|FG000|Maintanance Phase|Withdrawal by Subject|0|||
27798490|NCT02088073|54253309|FG001|Maintanance Phase|Withdrawal by Subject|2|||
27798491|NCT02088073|54253310|FG002|Maintanance Phase|Withdrawal by Subject|0|||
27798492|NCT02088073|54253311|FG003|Maintanance Phase|Withdrawal by Subject|0|||
27798493|NCT02088073|54253312|FG004|Maintanance Phase|Withdrawal by Subject|0|||
27798494|NCT02088073|54253308|FG000|Maintanance Phase|Adverse Event|0|||
27798495|NCT02088073|54253309|FG001|Maintanance Phase|Adverse Event|0|||
27798496|NCT02088073|54253310|FG002|Maintanance Phase|Adverse Event|3|||
27798497|NCT02088073|54253311|FG003|Maintanance Phase|Adverse Event|0|||
27798498|NCT02088073|54253312|FG004|Maintanance Phase|Adverse Event|1|||
27798499|NCT02088073|54253308|FG000|Maintanance Phase|Physician Decision|0|||
27798500|NCT02088073|54253309|FG001|Maintanance Phase|Physician Decision|0|||
27938467|NCT00974974|54594591|FG001|IPX066 Dose Conversion|Adverse Event|0|||
27938468|NCT00974974|54594590|FG000|IPX066 Dose Conversion|Death|2|||
27938469|NCT00974974|54594591|FG001|IPX066 Dose Conversion|Death|0|||
27938470|NCT00974974|54594590|FG000|IPX066 Dose Conversion|Lack of Efficacy|13|||
27938471|NCT00974974|54594591|FG001|IPX066 Dose Conversion|Lack of Efficacy|0|||
27938472|NCT00974974|54594590|FG000|IPX066 Dose Conversion|Withdrawal by Subject|12|||
27938473|NCT00974974|54594591|FG001|IPX066 Dose Conversion|Withdrawal by Subject|0|||
27938474|NCT00974974|54594590|FG000|IPX066 Dose Conversion|Various|3|||
27938475|NCT00974974|54594591|FG001|IPX066 Dose Conversion|Various|0|||
27938476|NCT00974974|54594590|FG000|IPX066 Dose Conversion|Protocol Violation|4|||
28018693|NCT00306787|54677908|FG000|Overall Study|Lack of Efficacy|1|||
28018694|NCT00306787|54677909|FG001|Overall Study|Lack of Efficacy|0|||
28018695|NCT00306787|54677908|FG000|Overall Study|Protocol Violation|8|||
28018696|NCT00306787|54677909|FG001|Overall Study|Protocol Violation|10|||
28018697|NCT00306787|54677908|FG000|Overall Study|Withdrawal by Subject|2|||
28018698|NCT00306787|54677909|FG001|Overall Study|Withdrawal by Subject|9|||
28018699|NCT00306787|54677908|FG000|Overall Study|Lost to Follow-up|9|||
28018700|NCT00306787|54677909|FG001|Overall Study|Lost to Follow-up|6|||
28018701|NCT00306787|54677908|FG000|Overall Study|Administrative problems|4|||
28018702|NCT00306787|54677909|FG001|Overall Study|Administrative problems|0|||
28018703|NCT00306787|54677908|FG000|Overall Study|Abnormal laboratory value(s)|1|||
28018704|NCT00306787|54677909|FG001|Overall Study|Abnormal laboratory value(s)|0|||
28018705|NCT00769067|54677917|FG000|Overall Study|Death|89|||
28018706|NCT00769067|54677918|FG001|Overall Study|Death|86|||
28018707|NCT00769067|54677917|FG000|Overall Study|Lost to Follow-up|3|||
28018708|NCT00769067|54677918|FG001|Overall Study|Lost to Follow-up|1|||
28018709|NCT00769067|54677917|FG000|Overall Study|Study terminated by sponsor|1|||
28018710|NCT00769067|54677918|FG001|Overall Study|Study terminated by sponsor|3|||
28018711|NCT00769067|54677917|FG000|Overall Study|Other|1|||
28018712|NCT00769067|54677918|FG001|Overall Study|Other|3|||
28018713|NCT00769067|54677917|FG000|Overall Study|Withdrawal by Subject|0|||
28018714|NCT00769067|54677918|FG001|Overall Study|Withdrawal by Subject|1|||
28018715|NCT00321373|54677928|FG000|Overall Study|Adverse Event|0|||
28018716|NCT00321373|54677929|FG001|Overall Study|Adverse Event|0|||
28018717|NCT00321373|54677930|FG002|Overall Study|Adverse Event|1|||
28018718|NCT00321373|54677928|FG000|Overall Study|Lost to Follow-up|1|||
28018719|NCT00321373|54677929|FG001|Overall Study|Lost to Follow-up|0|||
28018720|NCT00321373|54677930|FG002|Overall Study|Lost to Follow-up|1|||
28018721|NCT00321373|54677928|FG000|Overall Study|Withdrawal by Subject|1|||
28018722|NCT00321373|54677929|FG001|Overall Study|Withdrawal by Subject|0|||
28018723|NCT00321373|54677930|FG002|Overall Study|Withdrawal by Subject|0|||
28018724|NCT00321373|54677928|FG000|Overall Study|Other|0|||
27798501|NCT02088073|54253310|FG002|Maintanance Phase|Physician Decision|0|||
27938477|NCT00974974|54594591|FG001|IPX066 Dose Conversion|Protocol Violation|0|||
27938478|NCT00974974|54594590|FG000|Maintenance - Double Blind Treatment|Adverse Event|3|||
27938479|NCT00974974|54594591|FG001|Maintenance - Double Blind Treatment|Adverse Event|3|||
27938480|NCT00974974|54594590|FG000|Maintenance - Double Blind Treatment|Protocol Violation|1|||
27938481|NCT00974974|54594591|FG001|Maintenance - Double Blind Treatment|Protocol Violation|1|||
27938482|NCT00974974|54594590|FG000|Maintenance - Double Blind Treatment|Noncompliance with study drug|0|||
27938483|NCT00974974|54594591|FG001|Maintenance - Double Blind Treatment|Noncompliance with study drug|1|||
27938484|NCT00974974|54594590|FG000|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
27938485|NCT00974974|54594591|FG001|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
27938486|NCT00974974|54594590|FG000|Maintenance - Double Blind Treatment|Lost to Follow-up|0|||
27938487|NCT00974974|54594591|FG001|Maintenance - Double Blind Treatment|Lost to Follow-up|1|||
28018725|NCT00321373|54677929|FG001|Overall Study|Other|0|||
27798502|NCT02088073|54253311|FG003|Maintanance Phase|Physician Decision|0|||
28018726|NCT00321373|54677930|FG002|Overall Study|Other|1|||
28018727|NCT00667394|54677940|FG000|Overall Study|Adverse Event|3|||
28018728|NCT00667394|54677941|FG001|Overall Study|Adverse Event|0|||
28018729|NCT00667394|54677940|FG000|Overall Study|Progressive disease|1|||
28018730|NCT00667394|54677941|FG001|Overall Study|Progressive disease|0|||
28018731|NCT00761735|54677947|FG000|Overall Study|Lost to Follow-up|6|||
28018732|NCT00761735|54677947|FG000|Overall Study|Withdrawal by Subject|6|||
28018733|NCT00761735|54677947|FG000|Overall Study|Non-compliance with protocol|1|||
28018734|NCT00761735|54677947|FG000|Overall Study|Administrative|1|||
28018735|NCT00569946|54677955|FG000|Overall Study|Adverse Event|16|||
28018736|NCT00569946|54677955|FG000|Overall Study|Objective Progression or Relapse|42|||
28018737|NCT00569946|54677955|FG000|Overall Study|Global Deterioration of Health Status|1|||
28018738|NCT00645528|54677959|FG000|Overall Study|Did not show up for Visit 2|7|||
28018739|NCT00295633|54677966|FG000|Overall Study|Lack of Efficacy|19|||
28018740|NCT00295633|54677967|FG001|Overall Study|Lack of Efficacy|7|||
28018741|NCT00295633|54677968|FG002|Overall Study|Lack of Efficacy|16|||
28018742|NCT00295633|54677966|FG000|Overall Study|Withdrawal of consent by subject|16|||
28018743|NCT00295633|54677967|FG001|Overall Study|Withdrawal of consent by subject|16|||
28018744|NCT00295633|54677968|FG002|Overall Study|Withdrawal of consent by subject|26|||
28018745|NCT00295633|54677966|FG000|Overall Study|Adverse Event|9|||
28018746|NCT00295633|54677967|FG001|Overall Study|Adverse Event|17|||
28018747|NCT00295633|54677968|FG002|Overall Study|Adverse Event|9|||
28018748|NCT00295633|54677966|FG000|Overall Study|Lost to Follow-up|6|||
28018749|NCT00295633|54677967|FG001|Overall Study|Lost to Follow-up|11|||
28018750|NCT00295633|54677968|FG002|Overall Study|Lost to Follow-up|7|||
28018751|NCT00295633|54677966|FG000|Overall Study|Physician Decision|9|||
28018752|NCT00295633|54677967|FG001|Overall Study|Physician Decision|10|||
27938488|NCT00974974|54594590|FG000|Maintenance - Double Blind Treatment|Withdrawal by Subject|5|||
27938489|NCT00974974|54594591|FG001|Maintenance - Double Blind Treatment|Withdrawal by Subject|2|||
27938490|NCT00974974|54594590|FG000|Maintenance - Double Blind Treatment|Various|4|||
27938491|NCT00974974|54594591|FG001|Maintenance - Double Blind Treatment|Various|0|||
27938492|NCT01233869|54594601|FG000|Initial Treatment Period (24 Months)|Death|1|||
27938493|NCT01233869|54594602|FG001|Initial Treatment Period (24 Months)|Death|0|||
27938494|NCT01233869|54594603|FG002|Initial Treatment Period (24 Months)|Death|0|||
27938495|NCT01233869|54594604|FG003|Initial Treatment Period (24 Months)|Death|0|||
27938496|NCT01233869|54594601|FG000|Initial Treatment Period (24 Months)|Adverse Event|9|||
27938497|NCT01233869|54594602|FG001|Initial Treatment Period (24 Months)|Adverse Event|17|||
27938498|NCT01233869|54594603|FG002|Initial Treatment Period (24 Months)|Adverse Event|0|||
27938499|NCT01233869|54594604|FG003|Initial Treatment Period (24 Months)|Adverse Event|3|||
27938500|NCT01233869|54594601|FG000|Initial Treatment Period (24 Months)|Not Related to Study Drug|14|||
27938501|NCT01233869|54594602|FG001|Initial Treatment Period (24 Months)|Not Related to Study Drug|11|||
27938502|NCT01233869|54594603|FG002|Initial Treatment Period (24 Months)|Not Related to Study Drug|2|||
27938503|NCT01233869|54594604|FG003|Initial Treatment Period (24 Months)|Not Related to Study Drug|19|||
27938504|NCT01233869|54594601|FG000|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
28018753|NCT00295633|54677968|FG002|Overall Study|Physician Decision|8|||
28018754|NCT00295633|54677966|FG000|Overall Study|Poor/Noncompliance|2|||
27798503|NCT02088073|54253312|FG004|Maintanance Phase|Physician Decision|1|||
27798504|NCT02088073|54253308|FG000|Maintanance Phase|Sponsor's decision|0|||
27798505|NCT02088073|54253309|FG001|Maintanance Phase|Sponsor's decision|2|||
27798506|NCT02088073|54253310|FG002|Maintanance Phase|Sponsor's decision|0|||
27798507|NCT02088073|54253311|FG003|Maintanance Phase|Sponsor's decision|2|||
27798508|NCT02088073|54253312|FG004|Maintanance Phase|Sponsor's decision|1|||
27798509|NCT02088073|54253308|FG000|Maintanance Phase|Hypo- or hyperkalemia|0|||
27798510|NCT02088073|54253309|FG001|Maintanance Phase|Hypo- or hyperkalemia|3|||
27798511|NCT02088073|54253310|FG002|Maintanance Phase|Hypo- or hyperkalemia|0|||
27798512|NCT02088073|54253311|FG003|Maintanance Phase|Hypo- or hyperkalemia|3|||
27798513|NCT02088073|54253312|FG004|Maintanance Phase|Hypo- or hyperkalemia|1|||
27798514|NCT02088073|54253308|FG000|Maintanance Phase|Miscellaneous|0|||
27798515|NCT02088073|54253309|FG001|Maintanance Phase|Miscellaneous|2|||
27798516|NCT02088073|54253310|FG002|Maintanance Phase|Miscellaneous|1|||
27798517|NCT02088073|54253311|FG003|Maintanance Phase|Miscellaneous|2|||
27798518|NCT02088073|54253312|FG004|Maintanance Phase|Miscellaneous|1|||
27798519|NCT02088073|54253308|FG000|Maintanance Phase|Met ECG withdrawal criteria|0|||
27798520|NCT02088073|54253309|FG001|Maintanance Phase|Met ECG withdrawal criteria|0|||
27798521|NCT02088073|54253310|FG002|Maintanance Phase|Met ECG withdrawal criteria|1|||
27798522|NCT02088073|54253311|FG003|Maintanance Phase|Met ECG withdrawal criteria|0|||
27798523|NCT02088073|54253312|FG004|Maintanance Phase|Met ECG withdrawal criteria|2|||
27798524|NCT02088073|54253308|FG000|Maintanance Phase|Subject compliance|0|||
27798525|NCT02088073|54253309|FG001|Maintanance Phase|Subject compliance|1|||
27798526|NCT02088073|54253310|FG002|Maintanance Phase|Subject compliance|0|||
27798527|NCT02088073|54253311|FG003|Maintanance Phase|Subject compliance|0|||
27798528|NCT02088073|54253312|FG004|Maintanance Phase|Subject compliance|0|||
27798529|NCT01823991|54253327|FG000|Overall Study|Withdrawal by Subject|8|||
27798530|NCT01823991|54253328|FG001|Overall Study|Withdrawal by Subject|5|||
27798531|NCT02087059|54253338|FG000|Overall Study|Disease Progression|1|||
27798532|NCT02087059|54253338|FG000|Overall Study|Adverse Event|5|||
27798533|NCT02087059|54253338|FG000|Overall Study|Lost to Follow-up|1|||
27798534|NCT02152631|54253344|FG000|Overall Study|Adverse Event|32|||
27798535|NCT02152631|54253345|FG001|Overall Study|Adverse Event|4|||
28018755|NCT00295633|54677967|FG001|Overall Study|Poor/Noncompliance|2|||
28018756|NCT00295633|54677968|FG002|Overall Study|Poor/Noncompliance|6|||
28018757|NCT00295633|54677966|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
27798536|NCT02152631|54253344|FG000|Overall Study|Withdrawal by Subject|13|||
27798537|NCT02152631|54253345|FG001|Overall Study|Withdrawal by Subject|16|||
27798538|NCT02152631|54253344|FG000|Overall Study|Noncompliance with study drug|1|||
27798539|NCT02152631|54253345|FG001|Overall Study|Noncompliance with study drug|0|||
27798540|NCT02152631|54253344|FG000|Overall Study|Physician Decision|1|||
27798541|NCT02152631|54253345|FG001|Overall Study|Physician Decision|2|||
27798542|NCT02152631|54253344|FG000|Overall Study|Lost to Follow-up|0|||
27798543|NCT02152631|54253345|FG001|Overall Study|Lost to Follow-up|1|||
27798544|NCT02152631|54253344|FG000|Overall Study|On Treatment|19|||
27798545|NCT02152631|54253345|FG001|Overall Study|On Treatment|3|||
27798546|NCT02152163|54253353|FG000|Overall Study|Physician Decision|12|||
27798547|NCT02152163|54253354|FG001|Overall Study|Physician Decision|13|||
27798548|NCT02152007|54253360|FG000|Overall Study|Withdrawal by Subject|1|||
27798549|NCT02151851|54253367|FG000|Overall Study|Lack of Efficacy|67|||
27798550|NCT02151851|54253368|FG001|Overall Study|Lack of Efficacy|94|||
27798551|NCT02151851|54253367|FG000|Overall Study|Protocol Violation|0|||
27798552|NCT02151851|54253368|FG001|Overall Study|Protocol Violation|1|||
27798553|NCT02151851|54253367|FG000|Overall Study|Withdrawal by Subject|2|||
27798554|NCT02151851|54253368|FG001|Overall Study|Withdrawal by Subject|5|||
27798555|NCT02151851|54253367|FG000|Overall Study|Medical impairment|1|||
27798556|NCT02151851|54253368|FG001|Overall Study|Medical impairment|0|||
27798557|NCT02151851|54253367|FG000|Overall Study|Low compliance to study visits|0|||
27798558|NCT02151851|54253368|FG001|Overall Study|Low compliance to study visits|1|||
27798559|NCT02151851|54253367|FG000|Overall Study|Subject entered into study in error|0|||
27798560|NCT02151851|54253368|FG001|Overall Study|Subject entered into study in error|1|||
27798561|NCT02151851|54253367|FG000|Overall Study|Adverse Event|6|||
27798562|NCT02151851|54253368|FG001|Overall Study|Adverse Event|28|||
27798563|NCT02176421|54253374|FG000|Overall Study|Lost to Follow-up|4|||
27798564|NCT02176421|54253374|FG000|Overall Study|Adverse Event|1|||
27798565|NCT02042443|54253380|FG000|Overall Study|Adverse Event|2|||
27798566|NCT02042443|54253381|FG001|Overall Study|Adverse Event|1|||
27798567|NCT02042443|54253380|FG000|Overall Study|Withdrawal by Subject|0|||
27798568|NCT02042443|54253381|FG001|Overall Study|Withdrawal by Subject|1|||
27798569|NCT02042443|54253380|FG000|Overall Study|Progression|21|||
27798570|NCT02042443|54253381|FG001|Overall Study|Progression|17|||
27798571|NCT02042443|54253380|FG000|Overall Study|not protocol specified|1|||
27798572|NCT02042443|54253381|FG001|Overall Study|not protocol specified|1|||
27798573|NCT02042443|54253380|FG000|Overall Study|Not eligible/not analyzable|3|||
27798574|NCT02042443|54253381|FG001|Overall Study|Not eligible/not analyzable|6|||
27798575|NCT02118896|54253398|FG000|Overall Study|Death|4|||
27798576|NCT02118896|54253399|FG001|Overall Study|Death|0|||
27798577|NCT02118896|54253400|FG002|Overall Study|Death|4|||
27798578|NCT02118896|54253401|FG003|Overall Study|Death|6|||
27798579|NCT02118896|54253402|FG004|Overall Study|Death|3|||
27798580|NCT02118896|54253403|FG005|Overall Study|Death|1|||
27798581|NCT02118896|54253404|FG006|Overall Study|Death|0|||
27798582|NCT02118896|54253405|FG007|Overall Study|Death|0|||
27798583|NCT02118896|54253406|FG008|Overall Study|Death|0|||
27798584|NCT02118896|54253407|FG009|Overall Study|Death|0|||
27798585|NCT02118896|54253398|FG000|Overall Study|Adverse Event|5|||
27798586|NCT02118896|54253399|FG001|Overall Study|Adverse Event|4|||
27798587|NCT02118896|54253400|FG002|Overall Study|Adverse Event|4|||
27798588|NCT02118896|54253401|FG003|Overall Study|Adverse Event|5|||
27798589|NCT02118896|54253402|FG004|Overall Study|Adverse Event|5|||
27798590|NCT02118896|54253403|FG005|Overall Study|Adverse Event|9|||
27798591|NCT02118896|54253404|FG006|Overall Study|Adverse Event|1|||
27798592|NCT02118896|54253405|FG007|Overall Study|Adverse Event|1|||
27798593|NCT02118896|54253406|FG008|Overall Study|Adverse Event|4|||
27798594|NCT02118896|54253407|FG009|Overall Study|Adverse Event|0|||
27798595|NCT02118896|54253398|FG000|Overall Study|Consent withdrawn|2|||
27798596|NCT02118896|54253399|FG001|Overall Study|Consent withdrawn|0|||
28018758|NCT00295633|54677967|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
27798597|NCT02118896|54253400|FG002|Overall Study|Consent withdrawn|3|||
27798598|NCT02118896|54253401|FG003|Overall Study|Consent withdrawn|4|||
28018759|NCT00295633|54677968|FG002|Overall Study|Subject No Longer Meets Study Criteria|3|||
28018760|NCT00295633|54677966|FG000|Overall Study|Death|1|||
28018761|NCT00295633|54677967|FG001|Overall Study|Death|1|||
27798599|NCT02118896|54253402|FG004|Overall Study|Consent withdrawn|1|||
27798600|NCT02118896|54253403|FG005|Overall Study|Consent withdrawn|4|||
27798601|NCT02118896|54253404|FG006|Overall Study|Consent withdrawn|0|||
27798602|NCT02118896|54253405|FG007|Overall Study|Consent withdrawn|0|||
27798603|NCT02118896|54253406|FG008|Overall Study|Consent withdrawn|0|||
27798604|NCT02118896|54253407|FG009|Overall Study|Consent withdrawn|0|||
27798605|NCT02118896|54253398|FG000|Overall Study|Non-compliance|2|||
27798606|NCT02118896|54253399|FG001|Overall Study|Non-compliance|1|||
27798607|NCT02118896|54253400|FG002|Overall Study|Non-compliance|1|||
27798608|NCT02118896|54253401|FG003|Overall Study|Non-compliance|5|||
27798609|NCT02118896|54253402|FG004|Overall Study|Non-compliance|0|||
27798610|NCT02118896|54253403|FG005|Overall Study|Non-compliance|1|||
27798611|NCT02118896|54253404|FG006|Overall Study|Non-compliance|0|||
27798612|NCT02118896|54253405|FG007|Overall Study|Non-compliance|1|||
28018762|NCT00295633|54677968|FG002|Overall Study|Death|0|||
28018763|NCT00295633|54677966|FG000|Overall Study|Administrative reason by sponsor|0|||
28018764|NCT00295633|54677967|FG001|Overall Study|Administrative reason by sponsor|0|||
28018765|NCT00295633|54677968|FG002|Overall Study|Administrative reason by sponsor|1|||
28018766|NCT00570674|54677976|FG000|Overall Study|Withdrawal by Subject|0|||
28018767|NCT00570674|54677977|FG001|Overall Study|Withdrawal by Subject|0|||
27798613|NCT02118896|54253406|FG008|Overall Study|Non-compliance|0|||
27798614|NCT02118896|54253407|FG009|Overall Study|Non-compliance|0|||
27798615|NCT02118896|54253398|FG000|Overall Study|Pregnancy|1|||
27798616|NCT02118896|54253399|FG001|Overall Study|Pregnancy|1|||
27798617|NCT02118896|54253400|FG002|Overall Study|Pregnancy|0|||
27798618|NCT02118896|54253401|FG003|Overall Study|Pregnancy|0|||
27798619|NCT02118896|54253402|FG004|Overall Study|Pregnancy|1|||
27798620|NCT02118896|54253403|FG005|Overall Study|Pregnancy|3|||
27798621|NCT02118896|54253404|FG006|Overall Study|Pregnancy|1|||
27798622|NCT02118896|54253405|FG007|Overall Study|Pregnancy|0|||
27798623|NCT02118896|54253406|FG008|Overall Study|Pregnancy|0|||
27798624|NCT02118896|54253407|FG009|Overall Study|Pregnancy|0|||
27798625|NCT02118896|54253398|FG000|Overall Study|Lost to Follow-up|1|||
27798626|NCT02118896|54253399|FG001|Overall Study|Lost to Follow-up|2|||
27798627|NCT02118896|54253400|FG002|Overall Study|Lost to Follow-up|1|||
27798628|NCT02118896|54253401|FG003|Overall Study|Lost to Follow-up|0|||
27798629|NCT02118896|54253402|FG004|Overall Study|Lost to Follow-up|2|||
27798630|NCT02118896|54253403|FG005|Overall Study|Lost to Follow-up|1|||
27798631|NCT02118896|54253404|FG006|Overall Study|Lost to Follow-up|0|||
27798632|NCT02118896|54253405|FG007|Overall Study|Lost to Follow-up|0|||
27798633|NCT02118896|54253406|FG008|Overall Study|Lost to Follow-up|0|||
27798634|NCT02118896|54253407|FG009|Overall Study|Lost to Follow-up|0|||
27798635|NCT02118896|54253398|FG000|Overall Study|Immunosuppressive regimen (not MR4)|1|||
27798636|NCT02118896|54253399|FG001|Overall Study|Immunosuppressive regimen (not MR4)|5|||
27798637|NCT02118896|54253400|FG002|Overall Study|Immunosuppressive regimen (not MR4)|1|||
27798638|NCT02118896|54253401|FG003|Overall Study|Immunosuppressive regimen (not MR4)|2|||
27798639|NCT02118896|54253402|FG004|Overall Study|Immunosuppressive regimen (not MR4)|4|||
27798640|NCT02118896|54253403|FG005|Overall Study|Immunosuppressive regimen (not MR4)|2|||
27798641|NCT02118896|54253404|FG006|Overall Study|Immunosuppressive regimen (not MR4)|0|||
27798642|NCT02118896|54253405|FG007|Overall Study|Immunosuppressive regimen (not MR4)|0|||
27798643|NCT02118896|54253406|FG008|Overall Study|Immunosuppressive regimen (not MR4)|0|||
27798644|NCT02118896|54253407|FG009|Overall Study|Immunosuppressive regimen (not MR4)|2|||
27798645|NCT02118896|54253398|FG000|Overall Study|Prohibited medication|0|||
27798646|NCT02118896|54253399|FG001|Overall Study|Prohibited medication|0|||
27798647|NCT02118896|54253400|FG002|Overall Study|Prohibited medication|0|||
27798648|NCT02118896|54253401|FG003|Overall Study|Prohibited medication|0|||
27798649|NCT02118896|54253402|FG004|Overall Study|Prohibited medication|1|||
27798650|NCT02118896|54253403|FG005|Overall Study|Prohibited medication|3|||
27798651|NCT02118896|54253404|FG006|Overall Study|Prohibited medication|0|||
27798652|NCT02118896|54253405|FG007|Overall Study|Prohibited medication|0|||
27798653|NCT02118896|54253406|FG008|Overall Study|Prohibited medication|0|||
27798654|NCT02118896|54253407|FG009|Overall Study|Prohibited medication|0|||
27798655|NCT02118896|54253398|FG000|Overall Study|Miscellaneous|1|||
27798656|NCT02118896|54253399|FG001|Overall Study|Miscellaneous|2|||
27798657|NCT02118896|54253400|FG002|Overall Study|Miscellaneous|0|||
27798658|NCT02118896|54253401|FG003|Overall Study|Miscellaneous|2|||
27798659|NCT02118896|54253402|FG004|Overall Study|Miscellaneous|0|||
27798660|NCT02118896|54253403|FG005|Overall Study|Miscellaneous|4|||
27798661|NCT02118896|54253404|FG006|Overall Study|Miscellaneous|0|||
27798662|NCT02118896|54253405|FG007|Overall Study|Miscellaneous|0|||
27798663|NCT02118896|54253406|FG008|Overall Study|Miscellaneous|0|||
27798664|NCT02118896|54253407|FG009|Overall Study|Miscellaneous|0|||
27798665|NCT02124707|54253430|FG000|Overall Study|Adverse Event|5|||
28018768|NCT00570674|54677978|FG002|Overall Study|Withdrawal by Subject|1|||
28018769|NCT00570674|54677979|FG003|Overall Study|Withdrawal by Subject|0|||
28018770|NCT00570674|54677980|FG004|Overall Study|Withdrawal by Subject|0|||
28018771|NCT00570674|54677981|FG005|Overall Study|Withdrawal by Subject|0|||
28018772|NCT00570674|54677982|FG006|Overall Study|Withdrawal by Subject|0|||
28018773|NCT00768989|54677995|FG000|Prior to Week 24|Withdrawal by Subject|1|||
27798666|NCT02124707|54253430|FG000|Overall Study|Physician Decision|1|||
27798667|NCT02124707|54253430|FG000|Overall Study|Death|1|||
27798668|NCT02067728|54253437|FG000|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7|||
27798669|NCT02067728|54253438|FG001|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28|||
27798670|NCT02067728|54253437|FG000|6 Month Follow up Survey|Lost to Follow-up|48|||
27798671|NCT02067728|54253438|FG001|6 Month Follow up Survey|Lost to Follow-up|60|||
28018774|NCT00768989|54677996|FG001|Prior to Week 24|Withdrawal by Subject|0|||
27798672|NCT02067728|54253437|FG000|6 Month Measurements|Unable to attend|114|||
27798673|NCT02067728|54253438|FG001|6 Month Measurements|Unable to attend|97|||
27798674|NCT02118428|54253446|FG000|Overall Study|Physician Decision|0|||
28018775|NCT00768989|54677995|FG000|Prior to Week 24|Adverse Event|3|||
28018776|NCT00768989|54677996|FG001|Prior to Week 24|Adverse Event|0|||
28018777|NCT00768989|54677995|FG000|Prior to Week 24|Lost to Follow-up|0|||
28018778|NCT00768989|54677996|FG001|Prior to Week 24|Lost to Follow-up|1|||
28018779|NCT00768989|54677995|FG000|Prior to Week 24|Protocol Violation|0|||
28018780|NCT00768989|54677996|FG001|Prior to Week 24|Protocol Violation|2|||
28018781|NCT00768989|54677995|FG000|Week 24 to Prior to Week 36|Adverse Event|1|||
28018782|NCT00768989|54677996|FG001|Week 24 to Prior to Week 36|Adverse Event|0|||
28018783|NCT00768989|54677995|FG000|Week 24 to Prior to Week 36|Lack of Efficacy|6|||
28018784|NCT00768989|54677996|FG001|Week 24 to Prior to Week 36|Lack of Efficacy|0|||
28018785|NCT00768989|54677995|FG000|Week 24 to Prior to Week 36|Withdrawal by Subject|1|||
28018786|NCT00768989|54677996|FG001|Week 24 to Prior to Week 36|Withdrawal by Subject|0|||
28018787|NCT00768989|54677995|FG000|On or After Week 36|Lack of Efficacy|1|||
28018788|NCT00768989|54677996|FG001|On or After Week 36|Lack of Efficacy|0|||
28018789|NCT00768989|54677995|FG000|On or After Week 36|Adverse Event|0|||
28018790|NCT00768989|54677996|FG001|On or After Week 36|Adverse Event|1|||
28018791|NCT00768989|54677995|FG000|On or After Week 36|Lost to Follow-up|1|||
28018792|NCT00768989|54677996|FG001|On or After Week 36|Lost to Follow-up|0|||
28018793|NCT00768989|54677995|FG000|On or After Week 36|Poor Compliance|1|||
28018794|NCT00768989|54677996|FG001|On or After Week 36|Poor Compliance|0|||
28018795|NCT00768989|54677995|FG000|On or After Week 36|Protocol Violation|1|||
28018796|NCT00768989|54677996|FG001|On or After Week 36|Protocol Violation|0|||
28018797|NCT00768989|54677995|FG000|On or After Week 36|Did not attend termination visit|2|||
28018798|NCT00768989|54677996|FG001|On or After Week 36|Did not attend termination visit|0|||
28018799|NCT00768989|54677995|FG000|On or After Week 36|Sponsor Termination|45|||
28018800|NCT00768989|54677996|FG001|On or After Week 36|Sponsor Termination|26|||
28018801|NCT00305773|54678006|FG000|Overall Study|Death|3|||
28018802|NCT00305773|54678007|FG001|Overall Study|Death|2|||
28018803|NCT00305773|54678006|FG000|Overall Study|Adverse Event|1|||
28018804|NCT00305773|54678007|FG001|Overall Study|Adverse Event|2|||
28018805|NCT00305773|54678006|FG000|Overall Study|Alternative Treatment|4|||
28018806|NCT00305773|54678007|FG001|Overall Study|Alternative Treatment|4|||
28018807|NCT00305773|54678006|FG000|Overall Study|Physician Decision|1|||
28018808|NCT00305773|54678007|FG001|Overall Study|Physician Decision|1|||
28018809|NCT00305773|54678006|FG000|Overall Study|Withdrawal by Subject|1|||
28018810|NCT00305773|54678007|FG001|Overall Study|Withdrawal by Subject|4|||
28018811|NCT00305773|54678006|FG000|Overall Study|Disease Progression|1|||
28018812|NCT00305773|54678007|FG001|Overall Study|Disease Progression|3|||
28018813|NCT00305773|54678006|FG000|Overall Study|All other reasons|3|||
28018814|NCT00305773|54678007|FG001|Overall Study|All other reasons|2|||
28018815|NCT00305695|54678015|FG000|Overall Study|Withdrawal by subject prior to 18 month|40|||
28018816|NCT00305695|54678016|FG001|Overall Study|Withdrawal by subject prior to 18 month|26|||
28018817|NCT00305695|54678015|FG000|Overall Study|Did not have baseline scan|1|||
28018818|NCT00305695|54678016|FG001|Overall Study|Did not have baseline scan|1|||
27798675|NCT02118428|54253447|FG001|Overall Study|Physician Decision|1|||
27798676|NCT02118428|54253448|FG002|Overall Study|Physician Decision|0|||
27798677|NCT02118428|54253446|FG000|Overall Study|Withdrawal by Subject|2|||
27798678|NCT02118428|54253447|FG001|Overall Study|Withdrawal by Subject|2|||
27798679|NCT02118428|54253448|FG002|Overall Study|Withdrawal by Subject|0|||
27798680|NCT02118428|54253446|FG000|Overall Study|Death|7|||
27798681|NCT02118428|54253447|FG001|Overall Study|Death|5|||
27798682|NCT02118428|54253448|FG002|Overall Study|Death|0|||
27798683|NCT02118428|54253446|FG000|Overall Study|Lost to Follow-up|3|||
27798684|NCT02118428|54253447|FG001|Overall Study|Lost to Follow-up|1|||
27798685|NCT02118428|54253448|FG002|Overall Study|Lost to Follow-up|0|||
27798686|NCT02118428|54253446|FG000|Overall Study|Screen Failure or Became Inelegible|1|||
27798687|NCT02118428|54253447|FG001|Overall Study|Screen Failure or Became Inelegible|0|||
27938505|NCT01233869|54594602|FG001|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
27938506|NCT01233869|54594603|FG002|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
27938507|NCT01233869|54594604|FG003|Extended Treatment Period (46 Months)|Lost to Follow-up|1|||
27938508|NCT01233869|54594601|FG000|Extended Treatment Period (46 Months)|Withdrawal by Subject|10|||
27938509|NCT01233869|54594602|FG001|Extended Treatment Period (46 Months)|Withdrawal by Subject|3|||
27938510|NCT01233869|54594603|FG002|Extended Treatment Period (46 Months)|Withdrawal by Subject|5|||
27938511|NCT01233869|54594604|FG003|Extended Treatment Period (46 Months)|Withdrawal by Subject|11|||
27938512|NCT01233869|54594601|FG000|Extended Treatment Period (46 Months)|Other|3|||
27938513|NCT01233869|54594602|FG001|Extended Treatment Period (46 Months)|Other|0|||
27938514|NCT01233869|54594603|FG002|Extended Treatment Period (46 Months)|Other|0|||
27938515|NCT01233869|54594604|FG003|Extended Treatment Period (46 Months)|Other|3|||
27938516|NCT01233869|54594601|FG000|Extended Treatment Period (46 Months)|Adverse Event|1|||
27938517|NCT01233869|54594602|FG001|Extended Treatment Period (46 Months)|Adverse Event|0|||
28018819|NCT00647556|54678024|FG000|Overall Study|Adverse Event|0|||
28018820|NCT00647556|54678025|FG001|Overall Study|Adverse Event|1|||
28018821|NCT00647556|54678024|FG000|Overall Study|Lost to Follow-up|1|||
28018822|NCT00647556|54678025|FG001|Overall Study|Lost to Follow-up|0|||
28018823|NCT00647556|54678024|FG000|Overall Study|Protocol Violation|0|||
28018824|NCT00647556|54678025|FG001|Overall Study|Protocol Violation|1|||
28018825|NCT00647556|54678024|FG000|Overall Study|Withdrawal by Subject|1|||
28018826|NCT00647556|54678025|FG001|Overall Study|Withdrawal by Subject|0|||
28018827|NCT00647556|54678024|FG000|Overall Study|Surgery for pre-existing neck pain|1|||
28018828|NCT00647556|54678025|FG001|Overall Study|Surgery for pre-existing neck pain|0|||
28076955|NCT00094458|54731724|FG002|Main Study: Through Week 30|Withdrawal by Subject|7|||
28076956|NCT00094458|54731725|FG003|Main Study: Through Week 30|Withdrawal by Subject|0|||
28076957|NCT00094458|54731726|FG004|Main Study: Through Week 30|Withdrawal by Subject|0|||
28076958|NCT00094458|54731727|FG005|Main Study: Through Week 30|Withdrawal by Subject|0|||
28076959|NCT00094458|54731722|FG000|Main Study: Through Week 30|Adverse Event|38|||
28076960|NCT00094458|54731723|FG001|Main Study: Through Week 30|Adverse Event|20|||
28076961|NCT00094458|54731724|FG002|Main Study: Through Week 30|Adverse Event|28|||
28076962|NCT00094458|54731725|FG003|Main Study: Through Week 30|Adverse Event|0|||
28076963|NCT00094458|54731726|FG004|Main Study: Through Week 30|Adverse Event|0|||
28076964|NCT00094458|54731727|FG005|Main Study: Through Week 30|Adverse Event|0|||
28076965|NCT00094458|54731722|FG000|Main Study: Through Week 30|Death|1|||
28076966|NCT00094458|54731723|FG001|Main Study: Through Week 30|Death|0|||
28076967|NCT00094458|54731724|FG002|Main Study: Through Week 30|Death|0|||
28076968|NCT00094458|54731725|FG003|Main Study: Through Week 30|Death|0|||
28076969|NCT00094458|54731726|FG004|Main Study: Through Week 30|Death|0|||
28076970|NCT00094458|54731727|FG005|Main Study: Through Week 30|Death|0|||
28076971|NCT00094458|54731722|FG000|Main Study: Through Week 30|Other|19|||
28076972|NCT00094458|54731723|FG001|Main Study: Through Week 30|Other|16|||
28076973|NCT00094458|54731724|FG002|Main Study: Through Week 30|Other|9|||
28076974|NCT00094458|54731725|FG003|Main Study: Through Week 30|Other|0|||
28076975|NCT00094458|54731726|FG004|Main Study: Through Week 30|Other|0|||
28076976|NCT00094458|54731727|FG005|Main Study: Through Week 30|Other|0|||
28076977|NCT00094458|54731722|FG000|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2|||
28076978|NCT00094458|54731723|FG001|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1|||
28076979|NCT00094458|54731724|FG002|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4|||
28076980|NCT00094458|54731725|FG003|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
28076981|NCT00094458|54731726|FG004|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
28076982|NCT00094458|54731727|FG005|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
28076983|NCT00094458|54731722|FG000|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2|||
28076984|NCT00094458|54731723|FG001|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
28076985|NCT00094458|54731724|FG002|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4|||
28076986|NCT00094458|54731725|FG003|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
28076987|NCT00094458|54731726|FG004|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
27798688|NCT02118428|54253448|FG002|Overall Study|Screen Failure or Became Inelegible|1|||
27798689|NCT02067104|54253456|FG000|Overall Study|Study termination due to low accrual|4|||
27798690|NCT02067104|54253457|FG001|Overall Study|Study termination due to low accrual|5|||
27798691|NCT02092220|54253463|FG000|Period 1|Unrelated Illness|0|||
27798692|NCT02092220|54253464|FG001|Period 1|Unrelated Illness|2|||
27798693|NCT02092220|54253463|FG000|Period 2|Severe Hypoglycaemia|1|||
27798694|NCT02092220|54253464|FG001|Period 2|Severe Hypoglycaemia|0|||
27798695|NCT02092220|54253463|FG000|Period 2|Nausea, Anxiety, Inconvenience|0|||
27798696|NCT02092220|54253464|FG001|Period 2|Nausea, Anxiety, Inconvenience|1|||
27798697|NCT02066402|54253474|FG000|Overall Study|Adverse Event|1|||
27798698|NCT02066402|54253475|FG001|Overall Study|Adverse Event|2|||
27798699|NCT02066402|54253474|FG000|Overall Study|Lost to Follow-up|11|||
27798700|NCT02066402|54253475|FG001|Overall Study|Lost to Follow-up|8|||
27798701|NCT02066402|54253474|FG000|Overall Study|Withdrawal by Subject|14|||
27798702|NCT02066402|54253475|FG001|Overall Study|Withdrawal by Subject|11|||
27798703|NCT02066402|54253474|FG000|Overall Study|Progressive disease-clinical progression|0|||
27798704|NCT02066402|54253475|FG001|Overall Study|Progressive disease-clinical progression|1|||
27798705|NCT02066402|54253474|FG000|Overall Study|Protocol driven decision point|0|||
27798706|NCT02066402|54253475|FG001|Overall Study|Protocol driven decision point|1|||
27798707|NCT02060383|54253486|FG000|Core Phase|Unsatisfactory therapeutic effect|1|||
27798708|NCT02060383|54253487|FG001|Core Phase|Unsatisfactory therapeutic effect|5|||
27798709|NCT02060383|54253488|FG002|Core Phase|Unsatisfactory therapeutic effect|0|||
27798710|NCT02060383|54253489|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
27798711|NCT02060383|54253490|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
27798712|NCT02060383|54253486|FG000|Core Phase|Adverse Event|2|||
27798713|NCT02060383|54253487|FG001|Core Phase|Adverse Event|0|||
27798714|NCT02060383|54253488|FG002|Core Phase|Adverse Event|0|||
28076988|NCT00094458|54731727|FG005|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
28076989|NCT00094458|54731722|FG000|Study Extension: Week 30 Through Week 50|Adverse Event|3|||
28076990|NCT00094458|54731723|FG001|Study Extension: Week 30 Through Week 50|Adverse Event|9|||
28076991|NCT00094458|54731724|FG002|Study Extension: Week 30 Through Week 50|Adverse Event|7|||
28076992|NCT00094458|54731725|FG003|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
27798715|NCT02060383|54253489|FG003|Core Phase|Adverse Event|2|||
27798716|NCT02060383|54253490|FG004|Core Phase|Adverse Event|6|||
28018829|NCT00320593|54678033|FG000|Overall Study|Lost to Follow-up|3|||
28018830|NCT00320593|54678034|FG001|Overall Study|Lost to Follow-up|0|||
28018831|NCT00320593|54678033|FG000|Overall Study|Moved to another state|1|||
28018832|NCT00320593|54678034|FG001|Overall Study|Moved to another state|0|||
28018833|NCT00320593|54678033|FG000|Overall Study|Withdrawal by Subject|2|||
28018834|NCT00320593|54678034|FG001|Overall Study|Withdrawal by Subject|1|||
28018835|NCT00320593|54678033|FG000|Overall Study|Withdrawal by clinical center|1|||
28018836|NCT00320593|54678034|FG001|Overall Study|Withdrawal by clinical center|0|||
28018837|NCT00320515|54678040|FG000|Overall Study|Death|33|||
28018838|NCT00320515|54678040|FG000|Overall Study|Lost to Follow-up|6|||
28018839|NCT00320515|54678040|FG000|Overall Study|Physician Decision|2|||
28018840|NCT00320515|54678040|FG000|Overall Study|Withdrawal by Subject|8|||
28018841|NCT00662012|54678044|FG000|Overall Study|Lost to Follow-up|85|||
28018842|NCT00662012|54678044|FG000|Overall Study|Death|1|||
28018843|NCT00662012|54678044|FG000|Overall Study|Withdrawal by Subject|1|||
28018844|NCT00661778|54678048|FG000|Overall Study|Disease Progression|23|||
28018845|NCT00661778|54678048|FG000|Overall Study|Adverse Event|18|||
28018846|NCT00661778|54678048|FG000|Overall Study|Reason not Specified|6|||
27798717|NCT02060383|54253486|FG000|Core Phase|Administrative problems|0|||
27798718|NCT02060383|54253487|FG001|Core Phase|Administrative problems|1|||
27798719|NCT02060383|54253488|FG002|Core Phase|Administrative problems|0|||
27798720|NCT02060383|54253489|FG003|Core Phase|Administrative problems|0|||
27798721|NCT02060383|54253490|FG004|Core Phase|Administrative problems|0|||
27798722|NCT02060383|54253486|FG000|Core Phase|Protocol Violation|0|||
27798723|NCT02060383|54253487|FG001|Core Phase|Protocol Violation|0|||
27798724|NCT02060383|54253488|FG002|Core Phase|Protocol Violation|0|||
27798725|NCT02060383|54253489|FG003|Core Phase|Protocol Violation|1|||
27798726|NCT02060383|54253490|FG004|Core Phase|Protocol Violation|0|||
27798727|NCT02060383|54253486|FG000|Core Phase|Withdrawal by Subject|0|||
27798728|NCT02060383|54253487|FG001|Core Phase|Withdrawal by Subject|0|||
27798729|NCT02060383|54253488|FG002|Core Phase|Withdrawal by Subject|0|||
27798730|NCT02060383|54253489|FG003|Core Phase|Withdrawal by Subject|4|||
27798731|NCT02060383|54253490|FG004|Core Phase|Withdrawal by Subject|2|||
27798732|NCT02060383|54253486|FG000|Extension Phase|Unsatisfactory therapeutic effect|1|||
27798733|NCT02060383|54253487|FG001|Extension Phase|Unsatisfactory therapeutic effect|1|||
27798734|NCT02060383|54253488|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
27798735|NCT02060383|54253489|FG003|Extension Phase|Unsatisfactory therapeutic effect|2|||
27798736|NCT02060383|54253490|FG004|Extension Phase|Unsatisfactory therapeutic effect|2|||
27798737|NCT02060383|54253486|FG000|Extension Phase|Adverse Event|1|||
27798738|NCT02060383|54253487|FG001|Extension Phase|Adverse Event|1|||
27798739|NCT02060383|54253488|FG002|Extension Phase|Adverse Event|2|||
27798740|NCT02060383|54253489|FG003|Extension Phase|Adverse Event|0|||
27798741|NCT02060383|54253490|FG004|Extension Phase|Adverse Event|1|||
27798742|NCT02060383|54253486|FG000|Extension Phase|Withdrawal by Subject|0|||
27798743|NCT02060383|54253487|FG001|Extension Phase|Withdrawal by Subject|1|||
27798744|NCT02060383|54253488|FG002|Extension Phase|Withdrawal by Subject|0|||
27798745|NCT02060383|54253489|FG003|Extension Phase|Withdrawal by Subject|0|||
27798746|NCT02060383|54253490|FG004|Extension Phase|Withdrawal by Subject|2|||
27798747|NCT02060383|54253486|FG000|Extension Phase|Administrative problems|1|||
27798748|NCT02060383|54253487|FG001|Extension Phase|Administrative problems|0|||
27798749|NCT02060383|54253488|FG002|Extension Phase|Administrative problems|0|||
27798750|NCT02060383|54253489|FG003|Extension Phase|Administrative problems|0|||
27798751|NCT02060383|54253490|FG004|Extension Phase|Administrative problems|0|||
27798752|NCT02060383|54253486|FG000|Extension Phase|Death|0|||
27798753|NCT02060383|54253487|FG001|Extension Phase|Death|0|||
27798754|NCT02060383|54253488|FG002|Extension Phase|Death|1|||
27798755|NCT02060383|54253489|FG003|Extension Phase|Death|0|||
27798756|NCT02060383|54253490|FG004|Extension Phase|Death|1|||
27798757|NCT02060383|54253486|FG000|Extension Phase|Protocol Violation|0|||
27798758|NCT02060383|54253487|FG001|Extension Phase|Protocol Violation|0|||
27938518|NCT01233869|54594603|FG002|Extended Treatment Period (46 Months)|Adverse Event|0|||
27938519|NCT01233869|54594604|FG003|Extended Treatment Period (46 Months)|Adverse Event|1|||
27938520|NCT00992992|54594614|FG000|Overall Study|Lost to Follow-up|3|||
27938521|NCT00992992|54594614|FG000|Overall Study|Death|16|||
27938522|NCT00992992|54594614|FG000|Overall Study|GlaxoSmithKline Closed the Study|2|||
27938523|NCT00992992|54594614|FG000|Overall Study|Sponsor Closed the Study|4|||
27938524|NCT00992836|54594618|FG000|Overall Study|Lost to Follow-up|1|||
27938525|NCT00992836|54594618|FG000|Overall Study|Withdrawal by Subject|2|||
27938526|NCT00992836|54594618|FG000|Overall Study|Protocol Violation|2|||
28018847|NCT00661778|54678048|FG000|Overall Study|Protocol Violation|2|||
27798759|NCT02060383|54253488|FG002|Extension Phase|Protocol Violation|0|||
27798760|NCT02060383|54253489|FG003|Extension Phase|Protocol Violation|0|||
27798761|NCT02060383|54253490|FG004|Extension Phase|Protocol Violation|1|||
27798762|NCT02086591|54253502|FG000|Overall Study|Adverse Event|1|||
27798763|NCT02086591|54253502|FG000|Overall Study|Withdrawal by Subject|1|||
28018848|NCT00661778|54678048|FG000|Overall Study|Withdrawal of Consent|1|||
28018849|NCT00319735|54678052|FG000|Overall Study|Death|2|||
28018850|NCT00653328|54678057|FG000|Overall Study|Withdrawal by Subject|1|||
27798764|NCT02086591|54253502|FG000|Overall Study|protocol terminated|3|||
27798765|NCT02065622|54253508|FG000|Induction Study|Adverse Event|13|||
27798766|NCT02065622|54253509|FG001|Induction Study|Adverse Event|19|||
28018851|NCT00653328|54678057|FG000|Overall Study|Adverse Event|2|||
28018852|NCT00653328|54678057|FG000|Overall Study|Disease progression|10|||
28018853|NCT00653328|54678057|FG000|Overall Study|Drug manufacturer no longing making drug|2|||
28018854|NCT00642642|54678070|FG000|Treatment & Follow Up|Adverse Event|2|||
28018855|NCT00642642|54678070|FG000|Treatment & Follow Up|Withdrawal by Subject|5|||
28018856|NCT00642642|54678070|FG000|Treatment & Follow Up|Lost to Follow-up|10|||
28018857|NCT00534352|54678080|FG000|Treatment A: TMC125 + TDF/FTC|Physician Decision|1|||
28018858|NCT00534352|54678080|FG000|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1|||
28018859|NCT00534352|54678080|FG000|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1|||
28018860|NCT00534352|54678080|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1|||
28018861|NCT00534352|54678080|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2|||
28018862|NCT00534352|54678080|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1|||
28018863|NCT00642174|54678095|FG000|Period 1 - Initial Drug|Entry Criteria Not Met|0|||
28018864|NCT00642174|54678096|FG001|Period 1 - Initial Drug|Entry Criteria Not Met|1|||
28018865|NCT00665366|54678104|FG000|Overall Study|Lack of Efficacy|11|||
28018866|NCT00665366|54678105|FG001|Overall Study|Lack of Efficacy|10|||
28018867|NCT00665366|54678104|FG000|Overall Study|Adverse Event|25|||
28018868|NCT00665366|54678105|FG001|Overall Study|Adverse Event|23|||
28018869|NCT00665366|54678104|FG000|Overall Study|Withdrawal by Subject|11|||
28018870|NCT00665366|54678105|FG001|Overall Study|Withdrawal by Subject|14|||
28018871|NCT00665366|54678104|FG000|Overall Study|Lost to Follow-up|3|||
28018872|NCT00665366|54678105|FG001|Overall Study|Lost to Follow-up|5|||
28018873|NCT00665366|54678104|FG000|Overall Study|Poor compliance/noncompliance|3|||
27798767|NCT02065622|54253510|FG002|Induction Study|Adverse Event|0|||
27798768|NCT02065622|54253511|FG003|Induction Study|Adverse Event|0|||
27798769|NCT02065622|54253512|FG004|Induction Study|Adverse Event|0|||
27798770|NCT02065622|54253508|FG000|Induction Study|Withdrawal by Subject|3|||
27798771|NCT02065622|54253509|FG001|Induction Study|Withdrawal by Subject|5|||
27798772|NCT02065622|54253510|FG002|Induction Study|Withdrawal by Subject|0|||
27798773|NCT02065622|54253511|FG003|Induction Study|Withdrawal by Subject|0|||
27798774|NCT02065622|54253512|FG004|Induction Study|Withdrawal by Subject|0|||
27798775|NCT02065622|54253508|FG000|Induction Study|Lost to Follow-up|1|||
27798776|NCT02065622|54253509|FG001|Induction Study|Lost to Follow-up|0|||
27798777|NCT02065622|54253510|FG002|Induction Study|Lost to Follow-up|0|||
27798778|NCT02065622|54253511|FG003|Induction Study|Lost to Follow-up|0|||
27798779|NCT02065622|54253512|FG004|Induction Study|Lost to Follow-up|0|||
27798780|NCT02065622|54253508|FG000|Induction Study|Lack of Efficacy|22|||
27798781|NCT02065622|54253509|FG001|Induction Study|Lack of Efficacy|27|||
27798782|NCT02065622|54253510|FG002|Induction Study|Lack of Efficacy|0|||
27798783|NCT02065622|54253511|FG003|Induction Study|Lack of Efficacy|0|||
27798784|NCT02065622|54253512|FG004|Induction Study|Lack of Efficacy|0|||
27798785|NCT02065622|54253508|FG000|Induction Study|Requires Alternative/Prohibited Therapy|4|||
27798786|NCT02065622|54253509|FG001|Induction Study|Requires Alternative/Prohibited Therapy|5|||
27798787|NCT02065622|54253510|FG002|Induction Study|Requires Alternative/Prohibited Therapy|0|||
27798788|NCT02065622|54253511|FG003|Induction Study|Requires Alternative/Prohibited Therapy|0|||
28018874|NCT00665366|54678105|FG001|Overall Study|Poor compliance/noncompliance|5|||
28018875|NCT00665366|54678104|FG000|Overall Study|Pregnancy|1|||
28018876|NCT00665366|54678105|FG001|Overall Study|Pregnancy|0|||
27798789|NCT02065622|54253512|FG004|Induction Study|Requires Alternative/Prohibited Therapy|0|||
27798790|NCT02065622|54253508|FG000|Induction Study|Subject Noncompliance|1|||
27798791|NCT02065622|54253509|FG001|Induction Study|Subject Noncompliance|1|||
27798792|NCT02065622|54253510|FG002|Induction Study|Subject Noncompliance|0|||
27798793|NCT02065622|54253511|FG003|Induction Study|Subject Noncompliance|0|||
27798794|NCT02065622|54253512|FG004|Induction Study|Subject Noncompliance|0|||
27798795|NCT02065622|54253508|FG000|Induction Study|Other, Not Specified|3|||
27798796|NCT02065622|54253509|FG001|Induction Study|Other, Not Specified|2|||
27798797|NCT02065622|54253510|FG002|Induction Study|Other, Not Specified|0|||
27798798|NCT02065622|54253511|FG003|Induction Study|Other, Not Specified|0|||
27798799|NCT02065622|54253512|FG004|Induction Study|Other, Not Specified|0|||
27798800|NCT02065622|54253508|FG000|Maintenance Study|Adverse Event|0|||
27798801|NCT02065622|54253509|FG001|Maintenance Study|Adverse Event|0|||
27798802|NCT02065622|54253510|FG002|Maintenance Study|Adverse Event|25|||
27798803|NCT02065622|54253511|FG003|Maintenance Study|Adverse Event|22|||
27798804|NCT02065622|54253512|FG004|Maintenance Study|Adverse Event|11|||
27798805|NCT02065622|54253508|FG000|Maintenance Study|Withdrawal by Subject|0|||
27798806|NCT02065622|54253509|FG001|Maintenance Study|Withdrawal by Subject|0|||
27798807|NCT02065622|54253510|FG002|Maintenance Study|Withdrawal by Subject|11|||
27798808|NCT02065622|54253511|FG003|Maintenance Study|Withdrawal by Subject|5|||
27798809|NCT02065622|54253512|FG004|Maintenance Study|Withdrawal by Subject|7|||
27798810|NCT02065622|54253508|FG000|Maintenance Study|Lost to Follow-up|0|||
27798811|NCT02065622|54253509|FG001|Maintenance Study|Lost to Follow-up|0|||
27798812|NCT02065622|54253510|FG002|Maintenance Study|Lost to Follow-up|4|||
27798813|NCT02065622|54253511|FG003|Maintenance Study|Lost to Follow-up|1|||
27798814|NCT02065622|54253512|FG004|Maintenance Study|Lost to Follow-up|1|||
27798815|NCT02065622|54253508|FG000|Maintenance Study|Lack of Efficacy|0|||
27798816|NCT02065622|54253509|FG001|Maintenance Study|Lack of Efficacy|0|||
27798817|NCT02065622|54253510|FG002|Maintenance Study|Lack of Efficacy|70|||
27798818|NCT02065622|54253511|FG003|Maintenance Study|Lack of Efficacy|55|||
27798819|NCT02065622|54253512|FG004|Maintenance Study|Lack of Efficacy|19|||
27798820|NCT02065622|54253508|FG000|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
27798821|NCT02065622|54253509|FG001|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
27798822|NCT02065622|54253510|FG002|Maintenance Study|Requires Alternative/Prohibited Therapy|7|||
27798823|NCT02065622|54253511|FG003|Maintenance Study|Requires Alternative/Prohibited Therapy|3|||
27798824|NCT02065622|54253512|FG004|Maintenance Study|Requires Alternative/Prohibited Therapy|4|||
27798825|NCT02065622|54253508|FG000|Maintenance Study|Subject Non-Compliance|0|||
27798826|NCT02065622|54253509|FG001|Maintenance Study|Subject Non-Compliance|0|||
27798827|NCT02065622|54253510|FG002|Maintenance Study|Subject Non-Compliance|1|||
27798828|NCT02065622|54253511|FG003|Maintenance Study|Subject Non-Compliance|3|||
27798829|NCT02065622|54253512|FG004|Maintenance Study|Subject Non-Compliance|2|||
27798830|NCT02065622|54253508|FG000|Maintenance Study|Other, Not Specified|0|||
27798831|NCT02065622|54253509|FG001|Maintenance Study|Other, Not Specified|0|||
27798832|NCT02065622|54253510|FG002|Maintenance Study|Other, Not Specified|6|||
27798833|NCT02065622|54253511|FG003|Maintenance Study|Other, Not Specified|14|||
27798834|NCT02065622|54253512|FG004|Maintenance Study|Other, Not Specified|2|||
27798835|NCT02065622|54253508|FG000|Maintenance Study|Unknown Reason|0|||
27798836|NCT02065622|54253509|FG001|Maintenance Study|Unknown Reason|0|||
28018877|NCT00665366|54678104|FG000|Overall Study|No longer meets study criteria|0|||
28018878|NCT00665366|54678105|FG001|Overall Study|No longer meets study criteria|1|||
28018879|NCT00665366|54678104|FG000|Overall Study|Other reasons|4|||
28018880|NCT00665366|54678105|FG001|Overall Study|Other reasons|1|||
28018881|NCT00642018|54678135|FG000|Overall Study|Adverse Event|11|||
28018882|NCT00642018|54678136|FG001|Overall Study|Adverse Event|36|||
28018883|NCT00642018|54678135|FG000|Overall Study|Withdrawal by Subject|4|||
28018884|NCT00642018|54678136|FG001|Overall Study|Withdrawal by Subject|10|||
28018885|NCT00642018|54678135|FG000|Overall Study|Progressive Disease|13|||
28018886|NCT00642018|54678136|FG001|Overall Study|Progressive Disease|18|||
28018887|NCT00642018|54678135|FG000|Overall Study|Physician Decision|0|||
28018888|NCT00642018|54678136|FG001|Overall Study|Physician Decision|10|||
28018889|NCT00642018|54678135|FG000|Overall Study|Protocol Violation|0|||
27798837|NCT02065622|54253510|FG002|Maintenance Study|Unknown Reason|0|||
27798838|NCT02065622|54253511|FG003|Maintenance Study|Unknown Reason|1|||
27798839|NCT02065622|54253512|FG004|Maintenance Study|Unknown Reason|0|||
27798840|NCT02117648|54253527|FG000|Abemaciclib Alone Period 1|Withdrawal by Subject|1|||
27798841|NCT02117648|54253527|FG000|Abemaciclib Alone Period 1|Adverse Event|1|||
27798842|NCT02117648|54253527|FG000|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1|||
27798843|NCT02117648|54253527|FG000|Abemaciclib + Clarithromycin Period 2|Death|1|||
27798844|NCT02117648|54253527|FG000|Abemaciclib + Clarithromycin Period 2|Adverse Event|1|||
27798845|NCT02117648|54253527|FG000|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1|||
27798846|NCT02117648|54253527|FG000|Abemaciclib Safety-Extension Phase|Progressive Disease|12|||
28018890|NCT00642018|54678136|FG001|Overall Study|Protocol Violation|1|||
28018891|NCT00642018|54678135|FG000|Overall Study|Death|0|||
28018892|NCT00642018|54678136|FG001|Overall Study|Death|3|||
28018893|NCT00642018|54678135|FG000|Overall Study|Entry Criteria Not Met|0|||
27798847|NCT02117648|54253527|FG000|Abemaciclib Safety-Extension Phase|Physician Decision|1|||
27798848|NCT02117648|54253527|FG000|Abemaciclib Safety-Extension Phase|Death|3|||
27798849|NCT02117648|54253527|FG000|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2|||
27798850|NCT02117648|54253527|FG000|Abemaciclib Safety-Extension Phase|Adverse Event|2|||
27798851|NCT02124161|54253537|FG000|Overall Study|Other unspecified|0|||
27798852|NCT02124161|54253538|FG001|Overall Study|Other unspecified|1|||
27798853|NCT02124161|54253537|FG000|Overall Study|Death|1|||
27798854|NCT02124161|54253538|FG001|Overall Study|Death|0|||
27798855|NCT02124161|54253537|FG000|Overall Study|Protocol Violation|2|||
27798856|NCT02124161|54253538|FG001|Overall Study|Protocol Violation|1|||
27798857|NCT02124161|54253537|FG000|Overall Study|Withdrawal by Subject|1|||
27798858|NCT02124161|54253538|FG001|Overall Study|Withdrawal by Subject|2|||
27798859|NCT02124161|54253537|FG000|Overall Study|Adverse Event|2|||
27798860|NCT02124161|54253538|FG001|Overall Study|Adverse Event|0|||
27798861|NCT02124161|54253537|FG000|Overall Study|Does not meet entrance criteria|2|||
27798862|NCT02124161|54253538|FG001|Overall Study|Does not meet entrance criteria|3|||
27798863|NCT02124161|54253537|FG000|Overall Study|No longer meets eligibility criteria|5|||
27798864|NCT02124161|54253538|FG001|Overall Study|No longer meets eligibility criteria|4|||
27798865|NCT02124161|54253537|FG000|Overall Study|Lost to Follow-up|3|||
27798866|NCT02124161|54253538|FG001|Overall Study|Lost to Follow-up|4|||
27798867|NCT02175641|54253553|FG000|Overall Study|Death|3|||
27798868|NCT02175641|54253554|FG001|Overall Study|Death|4|||
27798869|NCT02175641|54253553|FG000|Overall Study|Lost to Follow-up|4|||
27798870|NCT02175641|54253554|FG001|Overall Study|Lost to Follow-up|4|||
27798871|NCT02175641|54253553|FG000|Overall Study|Withdrawal by Subject|7|||
27798872|NCT02175641|54253554|FG001|Overall Study|Withdrawal by Subject|4|||
27798873|NCT02175641|54253553|FG000|Overall Study|Discharged from Supportive Housing Agenc|13|||
27798874|NCT02175641|54253554|FG001|Overall Study|Discharged from Supportive Housing Agenc|15|||
27798875|NCT02175641|54253553|FG000|Overall Study|Developed Contraindicated Condition|8|||
27798876|NCT02175641|54253554|FG001|Overall Study|Developed Contraindicated Condition|0|||
27798877|NCT02117570|54253563|FG000|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0|||
27798878|NCT02117570|54253564|FG001|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2|||
27798879|NCT02117570|54253565|FG002|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1|||
27798880|NCT02117570|54253563|FG000|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
27798881|NCT02117570|54253564|FG001|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
27798882|NCT02117570|54253565|FG002|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0|||
27798883|NCT02117570|54253563|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
27798884|NCT02117570|54253564|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
27798885|NCT02117570|54253565|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2|||
27798886|NCT02117570|54253563|FG000|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
27798887|NCT02117570|54253564|FG001|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
27798888|NCT02117570|54253565|FG002|Stage 2 Participants Aged 65 to 85 Years|Death|1|||
27798889|NCT02117570|54253563|FG000|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
27798890|NCT02117570|54253564|FG001|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
27798891|NCT02117570|54253565|FG002|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1|||
27798892|NCT02117570|54253563|FG000|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1|||
27798893|NCT02117570|54253564|FG001|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
27798894|NCT02117570|54253565|FG002|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
27798895|NCT02117570|54253563|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
27798896|NCT02117570|54253564|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1|||
27798897|NCT02117570|54253565|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
27798898|NCT02123459|54253576|FG000|Washout Period (1 Day)|Adverse Event|1|||
27798899|NCT02123459|54253577|FG001|Washout Period (1 Day)|Adverse Event|0|||
27798900|NCT01853475|54253586|FG000|Overall Study|Withdrawal by Subject|0|||
27798901|NCT01853475|54253587|FG001|Overall Study|Withdrawal by Subject|1|||
27798902|NCT01853475|54253588|FG002|Overall Study|Withdrawal by Subject|0|||
27798903|NCT02151773|54253596|FG000|Overall Study|Protocol Deviation|64|||
27798904|NCT02151461|54253604|FG000|Overall Study|Adverse Event|5|||
27798905|NCT02151461|54253605|FG001|Overall Study|Adverse Event|1|||
27798906|NCT02151461|54253606|FG002|Overall Study|Adverse Event|0|||
28018894|NCT00642018|54678136|FG001|Overall Study|Entry Criteria Not Met|1|||
28018895|NCT00532948|54678146|FG000|Overall Study|Protocol Violation|1|||
28018896|NCT00532948|54678147|FG001|Overall Study|Protocol Violation|0|||
28018897|NCT00532948|54678148|FG002|Overall Study|Protocol Violation|0|||
28018898|NCT00532948|54678146|FG000|Overall Study|Death|3|||
27798907|NCT02151461|54253607|FG003|Overall Study|Adverse Event|2|||
28018899|NCT00532948|54678147|FG001|Overall Study|Death|3|||
28018900|NCT00532948|54678148|FG002|Overall Study|Death|4|||
27798908|NCT02151461|54253604|FG000|Overall Study|Lost to Follow-up|0|||
27798909|NCT02151461|54253605|FG001|Overall Study|Lost to Follow-up|0|||
27798910|NCT02151461|54253606|FG002|Overall Study|Lost to Follow-up|1|||
27798911|NCT02151461|54253607|FG003|Overall Study|Lost to Follow-up|1|||
28018901|NCT00532948|54678146|FG000|Overall Study|Violation of selection criteria at entry|0|||
28018902|NCT00532948|54678147|FG001|Overall Study|Violation of selection criteria at entry|1|||
28018903|NCT00532948|54678148|FG002|Overall Study|Violation of selection criteria at entry|0|||
28018904|NCT00532948|54678146|FG000|Overall Study|Failure to return|0|||
28018905|NCT00532948|54678147|FG001|Overall Study|Failure to return|1|||
28018906|NCT00532948|54678148|FG002|Overall Study|Failure to return|0|||
28018907|NCT00641706|54678162|FG000|Overall Study|Adverse Event|2|||
28018908|NCT00641706|54678163|FG001|Overall Study|Adverse Event|1|||
28018909|NCT00641706|54678162|FG000|Overall Study|Withdrawal by Subject|6|||
28018910|NCT00641706|54678163|FG001|Overall Study|Withdrawal by Subject|1|||
28018911|NCT00641706|54678162|FG000|Overall Study|Clinical Decline|1|||
28018912|NCT00641706|54678163|FG001|Overall Study|Clinical Decline|0|||
28018913|NCT00641706|54678162|FG000|Overall Study|Lead Investigator Decision|0|||
28018914|NCT00641706|54678163|FG001|Overall Study|Lead Investigator Decision|1|||
28018915|NCT00644358|54678169|FG000|Overall Study|Adverse Event|124|||
28018916|NCT00644358|54678169|FG000|Overall Study|Lost to Follow-up|105|||
27798912|NCT02151461|54253604|FG000|Overall Study|Withdrawal by Subject|1|||
27798913|NCT02151461|54253605|FG001|Overall Study|Withdrawal by Subject|0|||
27798914|NCT02151461|54253606|FG002|Overall Study|Withdrawal by Subject|1|||
27798915|NCT02151461|54253607|FG003|Overall Study|Withdrawal by Subject|1|||
27798916|NCT02151461|54253604|FG000|Overall Study|Treatment discontinuation|0|||
27798917|NCT02151461|54253605|FG001|Overall Study|Treatment discontinuation|0|||
27798918|NCT02151461|54253606|FG002|Overall Study|Treatment discontinuation|1|||
27798919|NCT02151461|54253607|FG003|Overall Study|Treatment discontinuation|0|||
27798920|NCT02117414|54253619|FG000|Overall Study|Death|5|||
27798921|NCT02117414|54253620|FG001|Overall Study|Death|2|||
27798922|NCT02117414|54253619|FG000|Overall Study|Withdrawal by Subject|10|||
27798923|NCT02117414|54253620|FG001|Overall Study|Withdrawal by Subject|4|||
27798924|NCT02091986|54253631|FG000|Overall Study|7 rand in error 1 patient decision|2|||
27798925|NCT02091986|54253632|FG001|Overall Study|7 rand in error 1 patient decision|3|||
27798926|NCT02091986|54253633|FG002|Overall Study|7 rand in error 1 patient decision|3|||
27798927|NCT02091986|54253631|FG000|Overall Study|Lost to Follow-up|1|||
27798928|NCT02091986|54253632|FG001|Overall Study|Lost to Follow-up|0|||
27798929|NCT02091986|54253633|FG002|Overall Study|Lost to Follow-up|0|||
27798930|NCT02091986|54253631|FG000|Overall Study|Withdrawal by Subject|4|||
27798931|NCT02091986|54253632|FG001|Overall Study|Withdrawal by Subject|8|||
27798932|NCT02091986|54253633|FG002|Overall Study|Withdrawal by Subject|3|||
27798933|NCT02091986|54253631|FG000|Overall Study|Adverse Event|0|||
27798934|NCT02091986|54253632|FG001|Overall Study|Adverse Event|0|||
27798935|NCT02091986|54253633|FG002|Overall Study|Adverse Event|2|||
27798936|NCT02091752|54253641|FG000|Overall Study|Study terminated by Sponsor|2|||
27798937|NCT02091752|54253641|FG000|Overall Study|Adverse Event|1|||
27798938|NCT02117024|54253647|FG000|Overall Study|Progressive Disease|26|||
27798939|NCT02117024|54253648|FG001|Overall Study|Progressive Disease|9|||
27798940|NCT02117024|54253647|FG000|Overall Study|Significant Clinical Progression|7|||
27798941|NCT02117024|54253648|FG001|Overall Study|Significant Clinical Progression|4|||
27798942|NCT02117024|54253647|FG000|Overall Study|Death|5|||
27798943|NCT02117024|54253648|FG001|Overall Study|Death|0|||
27798944|NCT02117024|54253647|FG000|Overall Study|Withdrawal by Subject|3|||
27798945|NCT02117024|54253648|FG001|Overall Study|Withdrawal by Subject|1|||
27798946|NCT02117024|54253647|FG000|Overall Study|Protocol Violation|1|||
27798947|NCT02117024|54253648|FG001|Overall Study|Protocol Violation|0|||
27798948|NCT02117024|54253647|FG000|Overall Study|Adverse Event|1|||
27798949|NCT02117024|54253648|FG001|Overall Study|Adverse Event|2|||
27798950|NCT02117024|54253647|FG000|Overall Study|Randomized in Error|1|||
27798951|NCT02117024|54253648|FG001|Overall Study|Randomized in Error|0|||
27798952|NCT02117024|54253647|FG000|Overall Study|Patient returned to primary oncologist|0|||
27798953|NCT02117024|54253648|FG001|Overall Study|Patient returned to primary oncologist|1|||
27798954|NCT02117024|54253647|FG000|Overall Study|Patient took treatment break|0|||
27798955|NCT02117024|54253648|FG001|Overall Study|Patient took treatment break|1|||
27798956|NCT02117024|54253647|FG000|Overall Study|Physician Decision|0|||
28018917|NCT00644358|54678169|FG000|Overall Study|Consent Withdrawal|64|||
28018918|NCT00644358|54678169|FG000|Overall Study|Lack of Effectiveness|39|||
28018919|NCT00644358|54678169|FG000|Overall Study|Protocol Violation|5|||
27798957|NCT02117024|54253648|FG001|Overall Study|Physician Decision|2|||
27798958|NCT02091440|54253654|FG000|Overall Study|Death|2|||
27798959|NCT02064920|54253660|FG000|Overall Study|Adverse Event|0|||
27798960|NCT02064920|54253661|FG001|Overall Study|Adverse Event|4|||
27798961|NCT02064920|54253660|FG000|Overall Study|Physician Decision|0|||
27798962|NCT02064920|54253661|FG001|Overall Study|Physician Decision|1|||
27798963|NCT02064920|54253660|FG000|Overall Study|Technical Problems|0|||
27798964|NCT02064920|54253661|FG001|Overall Study|Technical Problems|1|||
27798965|NCT02064920|54253660|FG000|Overall Study|Withdrawal by Subject|1|||
27798966|NCT02064920|54253661|FG001|Overall Study|Withdrawal by Subject|3|||
27798967|NCT02151149|54253669|FG000|Treatment Period|Death|2|||
27798968|NCT02151149|54253670|FG001|Treatment Period|Death|3|||
27798969|NCT02151149|54253669|FG000|Treatment Period|Adverse Event|17|||
28018920|NCT00644358|54678169|FG000|Overall Study|Noncompliance|14|||
28018921|NCT00644358|54678169|FG000|Overall Study|Other Unspecified|11|||
28018922|NCT00640926|54678176|FG000|Overall Study|Adverse Event|2|||
28018923|NCT00640926|54678177|FG001|Overall Study|Adverse Event|3|||
28018924|NCT00640926|54678178|FG002|Overall Study|Adverse Event|2|||
28018925|NCT00640926|54678176|FG000|Overall Study|Lack of Efficacy|0|||
28018926|NCT00640926|54678177|FG001|Overall Study|Lack of Efficacy|2|||
28018927|NCT00640926|54678178|FG002|Overall Study|Lack of Efficacy|1|||
28018928|NCT00640926|54678176|FG000|Overall Study|Protocol Violation|2|||
28018929|NCT00640926|54678177|FG001|Overall Study|Protocol Violation|0|||
28018930|NCT00640926|54678178|FG002|Overall Study|Protocol Violation|2|||
28018931|NCT00640926|54678176|FG000|Overall Study|Lost to Follow-up|3|||
28018932|NCT00640926|54678177|FG001|Overall Study|Lost to Follow-up|1|||
28018933|NCT00640926|54678178|FG002|Overall Study|Lost to Follow-up|2|||
28018934|NCT00640926|54678176|FG000|Overall Study|Withdrawal by Subject|1|||
28018935|NCT00640926|54678177|FG001|Overall Study|Withdrawal by Subject|0|||
28018936|NCT00640926|54678178|FG002|Overall Study|Withdrawal by Subject|1|||
28018937|NCT03892564|54678186|FG000|Overall Study|Withdrawal by Subject|2|||
28018938|NCT03891862|54678193|FG000|Open-label Period|Adverse Event|2|||
28018939|NCT03891862|54678194|FG001|Open-label Period|Adverse Event|0|||
28018940|NCT03891862|54678195|FG002|Open-label Period|Adverse Event|0|||
28018941|NCT03891862|54678193|FG000|Open-label Period|Protocol Violation|5|||
28018942|NCT03891862|54678194|FG001|Open-label Period|Protocol Violation|0|||
28018943|NCT03891862|54678195|FG002|Open-label Period|Protocol Violation|0|||
28018944|NCT03891862|54678193|FG000|Open-label Period|Withdrawal by Subject|6|||
28018945|NCT03891862|54678194|FG001|Open-label Period|Withdrawal by Subject|0|||
28018946|NCT03891862|54678195|FG002|Open-label Period|Withdrawal by Subject|0|||
28018947|NCT03891862|54678193|FG000|Open-label Period|Death|1|||
28018948|NCT03891862|54678194|FG001|Open-label Period|Death|0|||
28018949|NCT03891862|54678195|FG002|Open-label Period|Death|0|||
28018950|NCT03891862|54678193|FG000|Open-label Period|Lost to Follow-up|2|||
28018951|NCT03891862|54678194|FG001|Open-label Period|Lost to Follow-up|0|||
28018952|NCT03891862|54678195|FG002|Open-label Period|Lost to Follow-up|0|||
28018953|NCT03891862|54678193|FG000|Placebo-controlled Period and Follow-up|Adverse Event|0|||
28018954|NCT03891862|54678194|FG001|Placebo-controlled Period and Follow-up|Adverse Event|1|||
28018955|NCT03891862|54678195|FG002|Placebo-controlled Period and Follow-up|Adverse Event|1|||
28018956|NCT03891862|54678193|FG000|Placebo-controlled Period and Follow-up|Protocol Violation|0|||
28018957|NCT03891862|54678194|FG001|Placebo-controlled Period and Follow-up|Protocol Violation|2|||
27798970|NCT02151149|54253670|FG001|Treatment Period|Adverse Event|14|||
28018958|NCT03891862|54678195|FG002|Placebo-controlled Period and Follow-up|Protocol Violation|1|||
28018959|NCT03891862|54678193|FG000|Placebo-controlled Period and Follow-up|Withdrawal by Subject|0|||
28018960|NCT03891862|54678194|FG001|Placebo-controlled Period and Follow-up|Withdrawal by Subject|1|||
28018961|NCT03891862|54678195|FG002|Placebo-controlled Period and Follow-up|Withdrawal by Subject|2|||
28018962|NCT03891862|54678193|FG000|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
28018963|NCT03891862|54678194|FG001|Placebo-controlled Period and Follow-up|Lost to Follow-up|2|||
28018964|NCT03891862|54678195|FG002|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
28018965|NCT00640614|54678204|FG000|Overall Study|Lost to Follow-up|1|||
27798971|NCT02151149|54253669|FG000|Treatment Period|Progressive Disease|25|||
27798972|NCT02151149|54253670|FG001|Treatment Period|Progressive Disease|24|||
27798973|NCT02151149|54253669|FG000|Treatment Period|Symptomatic Deterioration|2|||
27798974|NCT02151149|54253670|FG001|Treatment Period|Symptomatic Deterioration|10|||
27798975|NCT02151149|54253669|FG000|Treatment Period|Withdrawal by Subject|13|||
27798976|NCT02151149|54253670|FG001|Treatment Period|Withdrawal by Subject|11|||
27798977|NCT02151149|54253669|FG000|Treatment Period|Miscellaneous|8|||
27798978|NCT02151149|54253670|FG001|Treatment Period|Miscellaneous|7|||
27798979|NCT02151149|54253669|FG000|Treatment Period|Participants randomized but not treated|3|||
27798980|NCT02151149|54253670|FG001|Treatment Period|Participants randomized but not treated|2|||
28018966|NCT00640614|54678205|FG001|Overall Study|Lost to Follow-up|0|||
28018967|NCT00761657|54678243|FG000|Part 1 (up to Day 57)|Adverse Event|0|||
28018968|NCT00761657|54678244|FG001|Part 1 (up to Day 57)|Adverse Event|0|||
28018969|NCT00761657|54678245|FG002|Part 1 (up to Day 57)|Adverse Event|0|||
28018970|NCT00761657|54678246|FG003|Part 1 (up to Day 57)|Adverse Event|1|||
28018971|NCT00761657|54678247|FG004|Part 1 (up to Day 57)|Adverse Event|0|||
28018972|NCT00761657|54678248|FG005|Part 1 (up to Day 57)|Adverse Event|0|||
28018973|NCT00761657|54678249|FG006|Part 1 (up to Day 57)|Adverse Event|0|||
28018974|NCT00761657|54678250|FG007|Part 1 (up to Day 57)|Adverse Event|0|||
28018975|NCT00761657|54678251|FG008|Part 1 (up to Day 57)|Adverse Event|0|||
28018976|NCT00761657|54678243|FG000|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
28018977|NCT00761657|54678244|FG001|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
28018978|NCT00761657|54678245|FG002|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
27798981|NCT02151149|54253669|FG000|Follow-Up Period|Lost to Follow-up|2|||
27798982|NCT02151149|54253670|FG001|Follow-Up Period|Lost to Follow-up|3|||
28018979|NCT00761657|54678246|FG003|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
27798983|NCT02151149|54253669|FG000|Follow-Up Period|Death|37|||
27798984|NCT02151149|54253670|FG001|Follow-Up Period|Death|34|||
27798985|NCT02150213|54253676|FG000|Overall Study|Lost to Follow-up|1|||
27798986|NCT02150213|54253676|FG000|Overall Study|Withdrawal by Subject|1|||
27798987|NCT02091362|54253682|FG000|Period 1|Protocol Violation|1|||
27798988|NCT02091362|54253683|FG001|Period 1|Protocol Violation|0|||
27798989|NCT02091362|54253682|FG000|Period 1|Withdrawal by Subject|2|||
27798990|NCT02091362|54253683|FG001|Period 1|Withdrawal by Subject|3|||
27798991|NCT02091362|54253682|FG000|Period 1|Lost to Follow-up|0|||
27798992|NCT02091362|54253683|FG001|Period 1|Lost to Follow-up|1|||
27798993|NCT02091362|54253682|FG000|Period 1|Adverse Event|2|||
27798994|NCT02091362|54253683|FG001|Period 1|Adverse Event|0|||
27798995|NCT02091362|54253682|FG000|Wash-out|Lost to Follow-up|1|||
27798996|NCT02091362|54253683|FG001|Wash-out|Lost to Follow-up|1|||
27798997|NCT02091362|54253682|FG000|Wash-out|Withdrawal by Subject|0|||
27798998|NCT02091362|54253683|FG001|Wash-out|Withdrawal by Subject|2|||
27798999|NCT02091362|54253682|FG000|Period 2|Adverse Event|1|||
27799000|NCT02091362|54253683|FG001|Period 2|Adverse Event|0|||
27799001|NCT02091362|54253682|FG000|Period 2|Lost to Follow-up|0|||
27799002|NCT02091362|54253683|FG001|Period 2|Lost to Follow-up|1|||
27799003|NCT02091362|54253682|FG000|Period 2|Withdrawal by Subject|1|||
27799004|NCT02091362|54253683|FG001|Period 2|Withdrawal by Subject|1|||
27799005|NCT02150057|54253695|FG000|Overall Study|Lost to Follow-up|6|||
27799006|NCT02150057|54253696|FG001|Overall Study|Lost to Follow-up|4|||
27799007|NCT02064296|54253705|FG000|Eligibility to Baseline Data Collection|Withdrawal by Subject|1|||
27799008|NCT02064296|54253706|FG001|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
27799009|NCT02064296|54253707|FG002|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
27799010|NCT02064296|54253705|FG000|Intervention|Withdrawal by Subject|0|||
27799011|NCT02064296|54253706|FG001|Intervention|Withdrawal by Subject|1|||
27799012|NCT02064296|54253707|FG002|Intervention|Withdrawal by Subject|2|||
27799013|NCT02063984|54253719|FG000|Overall Study|Lost to Follow-up|6|||
27799014|NCT02063984|54253720|FG001|Overall Study|Lost to Follow-up|5|||
27799015|NCT02091284|54253732|FG000|Overall Study|Withdrawal by Subject|2|||
27799016|NCT02091284|54253733|FG001|Overall Study|Withdrawal by Subject|1|||
27799017|NCT02091284|54253732|FG000|Overall Study|unreliable data|1|||
27799018|NCT02091284|54253733|FG001|Overall Study|unreliable data|0|||
27799019|NCT02115386|54253741|FG000|Overall Study|Protocol Violation|1|||
27799020|NCT02115386|54253741|FG000|Overall Study|Administrative - trial was terminated|6|||
27799021|NCT02091206|54253749|FG000|Treatment Period|Adverse Event|0|||
27799022|NCT02091206|54253750|FG001|Treatment Period|Adverse Event|1|||
27799023|NCT02091206|54253751|FG002|Treatment Period|Adverse Event|0|||
27799024|NCT02091206|54253752|FG003|Treatment Period|Adverse Event|0|||
27799025|NCT02091206|54253749|FG000|Treatment Period|Met withdrawal criteria|0|||
27799026|NCT02091206|54253750|FG001|Treatment Period|Met withdrawal criteria|0|||
27799027|NCT02091206|54253751|FG002|Treatment Period|Met withdrawal criteria|1|||
27799028|NCT02091206|54253752|FG003|Treatment Period|Met withdrawal criteria|0|||
27799029|NCT02091206|54253749|FG000|Taper Period|Participant refused study drug|1|||
27799030|NCT02091206|54253750|FG001|Taper Period|Participant refused study drug|0|||
27799031|NCT02091206|54253751|FG002|Taper Period|Participant refused study drug|0|||
27799032|NCT02091206|54253752|FG003|Taper Period|Participant refused study drug|1|||
27799033|NCT02091206|54253749|FG000|Taper Period|Lost to Follow-up|0|||
27799034|NCT02091206|54253750|FG001|Taper Period|Lost to Follow-up|0|||
27799035|NCT02091206|54253751|FG002|Taper Period|Lost to Follow-up|0|||
27799036|NCT02091206|54253752|FG003|Taper Period|Lost to Follow-up|1|||
27799037|NCT02090426|54253764|FG000|Overall Study|Lost to Follow-up|12|||
27799038|NCT02090426|54253765|FG001|Overall Study|Lost to Follow-up|6|||
27799039|NCT02063828|54253774|FG000|Overall Study|Withdrawal by Subject|4|||
27799040|NCT02063828|54253775|FG001|Overall Study|Withdrawal by Subject|6|||
27799041|NCT02063828|54253776|FG002|Overall Study|Withdrawal by Subject|3|||
27799042|NCT02063828|54253774|FG000|Overall Study|Death|0|||
27799043|NCT02063828|54253775|FG001|Overall Study|Death|0|||
27799044|NCT02063828|54253776|FG002|Overall Study|Death|1|||
27799045|NCT02063672|54253786|FG000|Overall Study|Ongoing Follow-up|27|||
27799046|NCT02063672|54253787|FG001|Overall Study|Ongoing Follow-up|14|||
27799047|NCT02063672|54253786|FG000|Overall Study|Death|5|||
27799048|NCT02063672|54253787|FG001|Overall Study|Death|3|||
27799049|NCT02063672|54253786|FG000|Overall Study|Lost to Follow-up|1|||
27799050|NCT02063672|54253787|FG001|Overall Study|Lost to Follow-up|3|||
27799051|NCT02063672|54253786|FG000|Overall Study|Withdrawal by Subject|2|||
27799052|NCT02063672|54253787|FG001|Overall Study|Withdrawal by Subject|2|||
27799053|NCT02062658|54253793|FG000|Overall Study|Withdrawal by Subject|1|||
27799054|NCT02062658|54253793|FG000|Overall Study|Lack of Efficacy|1|||
27799055|NCT02115308|54253799|FG000|Overall Study|Safety Screening|2|||
27799056|NCT02115308|54253800|FG001|Overall Study|Safety Screening|2|||
28018980|NCT00761657|54678247|FG004|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
28018981|NCT00761657|54678248|FG005|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
27799057|NCT02114684|54253812|FG000|Overall Study|Death|6|||
27799058|NCT02114684|54253813|FG001|Overall Study|Death|4|||
27799059|NCT02114684|54253812|FG000|Overall Study|Lost to Follow-up|1|||
28018982|NCT00761657|54678249|FG006|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
28018983|NCT00761657|54678250|FG007|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
28018984|NCT00761657|54678251|FG008|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
28018985|NCT00761657|54678243|FG000|Part 1 (up to Day 57)|Sponsor Decision|0|||
28018986|NCT00761657|54678244|FG001|Part 1 (up to Day 57)|Sponsor Decision|0|||
28018987|NCT00761657|54678245|FG002|Part 1 (up to Day 57)|Sponsor Decision|3|||
28018988|NCT00761657|54678246|FG003|Part 1 (up to Day 57)|Sponsor Decision|4|||
28018989|NCT00761657|54678247|FG004|Part 1 (up to Day 57)|Sponsor Decision|0|||
28018990|NCT00761657|54678248|FG005|Part 1 (up to Day 57)|Sponsor Decision|0|||
28018991|NCT00761657|54678249|FG006|Part 1 (up to Day 57)|Sponsor Decision|1|||
28018992|NCT00761657|54678250|FG007|Part 1 (up to Day 57)|Sponsor Decision|1|||
28018993|NCT00761657|54678251|FG008|Part 1 (up to Day 57)|Sponsor Decision|1|||
28018994|NCT00761657|54678243|FG000|Part 2 (up to Day 114)|Adverse Event|0|||
28018995|NCT00761657|54678244|FG001|Part 2 (up to Day 114)|Adverse Event|0|||
28018996|NCT00761657|54678245|FG002|Part 2 (up to Day 114)|Adverse Event|0|||
28018997|NCT00761657|54678246|FG003|Part 2 (up to Day 114)|Adverse Event|0|||
28018998|NCT00761657|54678247|FG004|Part 2 (up to Day 114)|Adverse Event|0|||
28018999|NCT00761657|54678248|FG005|Part 2 (up to Day 114)|Adverse Event|0|||
28019000|NCT00761657|54678249|FG006|Part 2 (up to Day 114)|Adverse Event|0|||
28019001|NCT00761657|54678250|FG007|Part 2 (up to Day 114)|Adverse Event|0|||
28019002|NCT00761657|54678251|FG008|Part 2 (up to Day 114)|Adverse Event|1|||
28019003|NCT00319501|54678283|FG000|Double-blind Period|Withdrawal by Subject|0|||
28019004|NCT00319501|54678284|FG001|Double-blind Period|Withdrawal by Subject|3|||
27799060|NCT02114684|54253813|FG001|Overall Study|Lost to Follow-up|2|||
27799061|NCT02114684|54253812|FG000|Overall Study|Withdrawal by Subject|1|||
27799062|NCT02114684|54253813|FG001|Overall Study|Withdrawal by Subject|2|||
27799063|NCT02114684|54253812|FG000|Overall Study|Relocation|3|||
27799064|NCT02114684|54253813|FG001|Overall Study|Relocation|1|||
27799065|NCT02114684|54253812|FG000|Overall Study|Rifampicin resistant on culture|0|||
27799066|NCT02114684|54253813|FG001|Overall Study|Rifampicin resistant on culture|1|||
27799067|NCT02114684|54253812|FG000|Overall Study|Patient Incarcerated|1|||
27799068|NCT02114684|54253813|FG001|Overall Study|Patient Incarcerated|0|||
27799069|NCT02090114|54253827|FG000|Overall Study|Withdrawal by Subject|3|||
27799070|NCT02090114|54253828|FG001|Overall Study|Withdrawal by Subject|6|||
27799071|NCT02090114|54253829|FG002|Overall Study|Withdrawal by Subject|2|||
27799072|NCT02090114|54253830|FG003|Overall Study|Withdrawal by Subject|1|||
27799073|NCT02090114|54253827|FG000|Overall Study|Physician Decision|5|||
27799074|NCT02090114|54253828|FG001|Overall Study|Physician Decision|0|||
27799075|NCT02090114|54253829|FG002|Overall Study|Physician Decision|1|||
27799076|NCT02090114|54253830|FG003|Overall Study|Physician Decision|1|||
27799077|NCT02090114|54253827|FG000|Overall Study|Adverse Event|1|||
27799078|NCT02090114|54253828|FG001|Overall Study|Adverse Event|2|||
27799079|NCT02090114|54253829|FG002|Overall Study|Adverse Event|2|||
27799080|NCT02090114|54253830|FG003|Overall Study|Adverse Event|0|||
27799081|NCT02090114|54253827|FG000|Overall Study|Progressive Disease|20|||
27799082|NCT02090114|54253828|FG001|Overall Study|Progressive Disease|21|||
27799083|NCT02090114|54253829|FG002|Overall Study|Progressive Disease|23|||
27799084|NCT02090114|54253830|FG003|Overall Study|Progressive Disease|6|||
27799085|NCT02090114|54253827|FG000|Overall Study|Death|1|||
27799086|NCT02090114|54253828|FG001|Overall Study|Death|0|||
27799087|NCT02090114|54253829|FG002|Overall Study|Death|1|||
27799088|NCT02090114|54253830|FG003|Overall Study|Death|0|||
27799089|NCT01623050|54253840|FG000|Overall Study|Lost to Follow-up|9|||
27799090|NCT02089334|54253848|FG000|Overall Study|Withdrawal by Subject|0|||
27799091|NCT02089334|54253849|FG001|Overall Study|Withdrawal by Subject|0|||
27799092|NCT02089334|54253850|FG002|Overall Study|Withdrawal by Subject|0|||
27799093|NCT02089334|54253851|FG003|Overall Study|Withdrawal by Subject|2|||
27799094|NCT02089334|54253848|FG000|Overall Study|Adverse Event|0|||
27799095|NCT02089334|54253849|FG001|Overall Study|Adverse Event|0|||
27799096|NCT02089334|54253850|FG002|Overall Study|Adverse Event|0|||
27799097|NCT02089334|54253851|FG003|Overall Study|Adverse Event|2|||
27799098|NCT02089334|54253848|FG000|Overall Study|Progressive disease|0|||
27799099|NCT02089334|54253849|FG001|Overall Study|Progressive disease|0|||
27799100|NCT02089334|54253850|FG002|Overall Study|Progressive disease|0|||
28019005|NCT00319501|54678283|FG000|Double-blind Period|Sponsor Request|1|||
27799101|NCT02089334|54253851|FG003|Overall Study|Progressive disease|2|||
27799102|NCT02089334|54253848|FG000|Overall Study|Physician Decision|0|||
27799103|NCT02089334|54253849|FG001|Overall Study|Physician Decision|0|||
27799104|NCT02089334|54253850|FG002|Overall Study|Physician Decision|1|||
27799105|NCT02089334|54253851|FG003|Overall Study|Physician Decision|1|||
27799106|NCT02114606|54253864|FG000|Overall Study|Unable to swallow Cytosponge|6|||
27799107|NCT02113436|54253870|FG000|Period 1: 8 Weeks|Adverse Event|1|||
28019006|NCT00319501|54678284|FG001|Double-blind Period|Sponsor Request|0|||
28019007|NCT00319501|54678283|FG000|Double-blind Period|Did not receive treatment|42|||
28019008|NCT00319501|54678284|FG001|Double-blind Period|Did not receive treatment|29|||
27799108|NCT02113436|54253871|FG001|Period 1: 8 Weeks|Adverse Event|0|||
27799109|NCT02113436|54253872|FG002|Period 1: 8 Weeks|Adverse Event|0|||
28019009|NCT00319501|54678283|FG000|Open-label Period|Adverse Event|5|||
28019010|NCT00319501|54678284|FG001|Open-label Period|Adverse Event|0|||
27799110|NCT02113436|54253873|FG003|Period 1: 8 Weeks|Adverse Event|0|||
27799111|NCT02113436|54253870|FG000|Period 1: 8 Weeks|Protocol Violation|1|||
27799112|NCT02113436|54253871|FG001|Period 1: 8 Weeks|Protocol Violation|0|||
27799113|NCT02113436|54253872|FG002|Period 1: 8 Weeks|Protocol Violation|0|||
27799114|NCT02113436|54253873|FG003|Period 1: 8 Weeks|Protocol Violation|0|||
27799115|NCT02113436|54253870|FG000|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5|||
27799116|NCT02113436|54253871|FG001|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2|||
27799117|NCT02113436|54253872|FG002|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
27799118|NCT02113436|54253873|FG003|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
27799119|NCT02113436|54253870|FG000|Period 1: 8 Weeks|Withdrawal by Subject|1|||
27799120|NCT02113436|54253871|FG001|Period 1: 8 Weeks|Withdrawal by Subject|0|||
27799121|NCT02113436|54253872|FG002|Period 1: 8 Weeks|Withdrawal by Subject|0|||
27799122|NCT02113436|54253873|FG003|Period 1: 8 Weeks|Withdrawal by Subject|0|||
27799123|NCT02113436|54253870|FG000|Period 2: 16 Weeks|Adverse Event|0|||
27799124|NCT02113436|54253871|FG001|Period 2: 16 Weeks|Adverse Event|0|||
27799125|NCT02113436|54253872|FG002|Period 2: 16 Weeks|Adverse Event|4|||
27799126|NCT02113436|54253873|FG003|Period 2: 16 Weeks|Adverse Event|5|||
27799127|NCT02113436|54253870|FG000|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
27799128|NCT02113436|54253871|FG001|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
27799129|NCT02113436|54253872|FG002|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2|||
27799130|NCT02113436|54253873|FG003|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5|||
27799131|NCT02113436|54253870|FG000|Period 2: 16 Weeks|Physician Decision|0|||
27799132|NCT02113436|54253871|FG001|Period 2: 16 Weeks|Physician Decision|0|||
28019011|NCT00319501|54678283|FG000|Open-label Period|Protocol Violation|6|||
28019012|NCT00319501|54678284|FG001|Open-label Period|Protocol Violation|0|||
28019013|NCT00319501|54678283|FG000|Open-label Period|Withdrawal by Subject|38|||
28019014|NCT00319501|54678284|FG001|Open-label Period|Withdrawal by Subject|0|||
28019015|NCT00319501|54678283|FG000|Open-label Period|Principal Investigator decision|6|||
28019016|NCT00319501|54678284|FG001|Open-label Period|Principal Investigator decision|0|||
28019017|NCT00319501|54678283|FG000|Open-label Period|Sponsor request|12|||
28019018|NCT00319501|54678284|FG001|Open-label Period|Sponsor request|0|||
28019019|NCT00319501|54678283|FG000|Open-label Period|Lost to Follow-up|5|||
28019020|NCT00319501|54678284|FG001|Open-label Period|Lost to Follow-up|0|||
28019021|NCT00319501|54678283|FG000|Open-label Period|Did not receive treatment|33|||
28019022|NCT00319501|54678284|FG001|Open-label Period|Did not receive treatment|0|||
28019023|NCT00319501|54678283|FG000|Open-label Period|Other|11|||
28019024|NCT00319501|54678284|FG001|Open-label Period|Other|0|||
28019025|NCT00319501|54678283|FG000|Open-label Extension Period|Adverse Event|2|||
28019026|NCT00319501|54678284|FG001|Open-label Extension Period|Adverse Event|0|||
28019027|NCT00319501|54678283|FG000|Open-label Extension Period|Did not receive treatment|18|||
28019028|NCT00319501|54678284|FG001|Open-label Extension Period|Did not receive treatment|0|||
28019029|NCT00319501|54678283|FG000|Open-label Extension Period|Other|1|||
28019030|NCT00319501|54678284|FG001|Open-label Extension Period|Other|0|||
28019031|NCT00319501|54678283|FG000|Open-label Extension Period|Principal investigator decision|2|||
28019032|NCT00319501|54678284|FG001|Open-label Extension Period|Principal investigator decision|0|||
28019033|NCT00319501|54678283|FG000|Open-label Extension Period|Sponsor request|26|||
28019034|NCT00319501|54678284|FG001|Open-label Extension Period|Sponsor request|0|||
28019035|NCT00319501|54678283|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
28019036|NCT00319501|54678284|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
28019037|NCT00761579|54678295|FG000|Overall Study|Adverse Event|10|||
28019038|NCT00761579|54678295|FG000|Overall Study|Death|2|||
28019039|NCT00761579|54678295|FG000|Overall Study|Lack of Efficacy|21|||
28019040|NCT00761579|54678295|FG000|Overall Study|Lost to Follow-up|16|||
28019041|NCT00761579|54678295|FG000|Overall Study|Pregnancy|1|||
27799133|NCT02113436|54253872|FG002|Period 2: 16 Weeks|Physician Decision|2|||
27799134|NCT02113436|54253873|FG003|Period 2: 16 Weeks|Physician Decision|0|||
27799135|NCT02113436|54253870|FG000|Period 2: 16 Weeks|Withdrawal by Subject|0|||
27799136|NCT02113436|54253871|FG001|Period 2: 16 Weeks|Withdrawal by Subject|0|||
27799137|NCT02113436|54253872|FG002|Period 2: 16 Weeks|Withdrawal by Subject|1|||
27799138|NCT02113436|54253873|FG003|Period 2: 16 Weeks|Withdrawal by Subject|1|||
27799139|NCT02113124|54253884|FG000|Overall Study|Unable to retrieve blood sample|1|||
27799140|NCT02113124|54253885|FG001|Overall Study|Unable to retrieve blood sample|1|||
27799141|NCT02087774|54253893|FG000|Overall Study|Were absent day of data collection|8|||
27799142|NCT02087774|54253894|FG001|Overall Study|Were absent day of data collection|20|||
27799143|NCT02111564|54253902|FG000|Overall Study|Death|109|||
27799144|NCT02111564|54253903|FG001|Overall Study|Death|120|||
27799145|NCT02111564|54253902|FG000|Overall Study|Lost to Follow-up|2|||
28019042|NCT00761579|54678295|FG000|Overall Study|Withdrawal by Subject|34|||
28019043|NCT00761579|54678295|FG000|Overall Study|Lack of compliance|2|||
28019044|NCT00761579|54678295|FG000|Overall Study|Protocol deviation|1|||
28019045|NCT00761579|54678295|FG000|Overall Study|Drug overdose|1|||
28019046|NCT00761579|54678295|FG000|Overall Study|Aggravation of depression|1|||
27799146|NCT02111564|54253903|FG001|Overall Study|Lost to Follow-up|3|||
27799147|NCT02111564|54253902|FG000|Overall Study|Withdrawal by Subject|20|||
27799148|NCT02111564|54253903|FG001|Overall Study|Withdrawal by Subject|20|||
27799149|NCT02087150|54253912|FG000|Overall Study|Death|0|||
27799150|NCT02087150|54253913|FG001|Overall Study|Death|1|||
27799151|NCT02087150|54253914|FG002|Overall Study|Death|0|||
27799152|NCT02087150|54253912|FG000|Overall Study|Lost to Follow-up|6|||
27799153|NCT02087150|54253913|FG001|Overall Study|Lost to Follow-up|13|||
27799154|NCT02087150|54253914|FG002|Overall Study|Lost to Follow-up|7|||
27799155|NCT02087150|54253912|FG000|Overall Study|Withdrawal by Subject|2|||
27799156|NCT02087150|54253913|FG001|Overall Study|Withdrawal by Subject|5|||
27799157|NCT02087150|54253914|FG002|Overall Study|Withdrawal by Subject|3|||
27799158|NCT02087150|54253912|FG000|Overall Study|Physician Decision|0|||
27799159|NCT02087150|54253913|FG001|Overall Study|Physician Decision|1|||
27799160|NCT02087150|54253914|FG002|Overall Study|Physician Decision|0|||
27799161|NCT02087150|54253912|FG000|Overall Study|Procedure not done|1|||
27799162|NCT02087150|54253913|FG001|Overall Study|Procedure not done|13|||
27799163|NCT02087150|54253914|FG002|Overall Study|Procedure not done|0|||
27799164|NCT02087150|54253912|FG000|Overall Study|F/U not completed w/in study window|0|||
27799165|NCT02087150|54253913|FG001|Overall Study|F/U not completed w/in study window|0|||
27799166|NCT02087150|54253914|FG002|Overall Study|F/U not completed w/in study window|1|||
27799167|NCT02087150|54253912|FG000|Overall Study|Other|1|||
27799168|NCT02087150|54253913|FG001|Overall Study|Other|0|||
27799169|NCT02087150|54253914|FG002|Overall Study|Other|0|||
27799170|NCT02087150|54253912|FG000|Overall Study|Pt moved out of town|0|||
27799171|NCT02087150|54253913|FG001|Overall Study|Pt moved out of town|1|||
27799172|NCT02087150|54253914|FG002|Overall Study|Pt moved out of town|0|||
27799173|NCT02111174|54253925|FG000|Treatment and Primary Outcome|Ineligible (not used in analysis)|1|||
27799174|NCT02111174|54253926|FG001|Treatment and Primary Outcome|Ineligible (not used in analysis)|0|||
27799175|NCT02111174|54253925|FG000|Treatment and Primary Outcome|Withdrawal by Subject|2|||
27799176|NCT02111174|54253926|FG001|Treatment and Primary Outcome|Withdrawal by Subject|2|||
27799177|NCT02111174|54253925|FG000|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8|||
27799178|NCT02111174|54253926|FG001|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6|||
27799179|NCT02111174|54253925|FG000|Secondary Outcomes (2 and 3 Month f/u)|Death|0|||
27799180|NCT02111174|54253926|FG001|Secondary Outcomes (2 and 3 Month f/u)|Death|1|||
27799181|NCT02111096|54253935|FG000|Overall Study|Adverse Event|4|||
27799182|NCT02111096|54253936|FG001|Overall Study|Adverse Event|1|||
27799183|NCT02111096|54253937|FG002|Overall Study|Adverse Event|2|||
27799184|NCT02111096|54253935|FG000|Overall Study|Non-Compliance with Study Drug|1|||
27799185|NCT02111096|54253936|FG001|Overall Study|Non-Compliance with Study Drug|1|||
27799186|NCT02111096|54253937|FG002|Overall Study|Non-Compliance with Study Drug|0|||
27799187|NCT02111096|54253935|FG000|Overall Study|Lost to Follow Up|1|||
27799188|NCT02111096|54253936|FG001|Overall Study|Lost to Follow Up|1|||
28019047|NCT00761579|54678295|FG000|Overall Study|Aggravation of symptoms by changing drug|1|||
28019048|NCT00761579|54678295|FG000|Overall Study|Lost survey form|1|||
28019049|NCT00761579|54678295|FG000|Overall Study|Intake of prohibited concomitant drug|1|||
28019050|NCT00627042|54678301|FG000|Overall Study|Withdrawal by Subject|2|||
28019051|NCT00319111|54678305|FG000|Overall Study|Adverse Event|20|||
28019052|NCT00319111|54678305|FG000|Overall Study|Withdrawal of consent|11|||
28019053|NCT00319111|54678305|FG000|Overall Study|Death|9|||
28019054|NCT00319111|54678305|FG000|Overall Study|Lack of clinical improvement|4|||
28019055|NCT00319111|54678305|FG000|Overall Study|Administrative|2|||
28019056|NCT00319111|54678305|FG000|Overall Study|Treatment failure|1|||
28019057|NCT00640224|54678313|FG000|Overall Study|Lost to Follow-up|5|||
28019058|NCT00640224|54678314|FG001|Overall Study|Lost to Follow-up|2|||
28019059|NCT00640224|54678315|FG002|Overall Study|Lost to Follow-up|0|||
28019060|NCT00640224|54678316|FG003|Overall Study|Lost to Follow-up|0|||
28019061|NCT00640224|54678313|FG000|Overall Study|Withdrawal by Subject|1|||
28019062|NCT00640224|54678314|FG001|Overall Study|Withdrawal by Subject|0|||
28019063|NCT00640224|54678315|FG002|Overall Study|Withdrawal by Subject|0|||
28019064|NCT00640224|54678316|FG003|Overall Study|Withdrawal by Subject|0|||
28019065|NCT00640224|54678313|FG000|Overall Study|Headaches|0|||
28019066|NCT00640224|54678314|FG001|Overall Study|Headaches|1|||
28019067|NCT00640224|54678315|FG002|Overall Study|Headaches|0|||
27799189|NCT02111096|54253937|FG002|Overall Study|Lost to Follow Up|1|||
28019068|NCT00640224|54678316|FG003|Overall Study|Headaches|0|||
28019069|NCT00318643|54678331|FG000|Overall Study|Adverse Event|0|||
28019070|NCT00318643|54678332|FG001|Overall Study|Adverse Event|0|||
27799190|NCT02111096|54253935|FG000|Overall Study|Physician Decision|0|||
27799191|NCT02111096|54253936|FG001|Overall Study|Physician Decision|1|||
27799192|NCT02111096|54253937|FG002|Overall Study|Physician Decision|0|||
28019071|NCT00318643|54678333|FG002|Overall Study|Adverse Event|0|||
28019072|NCT00318643|54678334|FG003|Overall Study|Adverse Event|0|||
28019073|NCT00318643|54678335|FG004|Overall Study|Adverse Event|1|||
28019074|NCT00318643|54678331|FG000|Overall Study|Participant's Decision|0|||
28019075|NCT00318643|54678332|FG001|Overall Study|Participant's Decision|0|||
28019076|NCT00318643|54678333|FG002|Overall Study|Participant's Decision|0|||
28019077|NCT00318643|54678334|FG003|Overall Study|Participant's Decision|0|||
28019078|NCT00318643|54678335|FG004|Overall Study|Participant's Decision|1|||
28019079|NCT00318643|54678331|FG000|Overall Study|Investigator's Decision|0|||
28019080|NCT00318643|54678332|FG001|Overall Study|Investigator's Decision|0|||
28019081|NCT00318643|54678333|FG002|Overall Study|Investigator's Decision|0|||
28019082|NCT00318643|54678334|FG003|Overall Study|Investigator's Decision|0|||
28019083|NCT00318643|54678335|FG004|Overall Study|Investigator's Decision|1|||
28019084|NCT00318565|54678348|FG000|Overall Study|Excluded per protocol|24|||
28019085|NCT00304915|54678354|FG000|Overall Study|Lost to Follow-up|11|||
28019086|NCT00304915|54678355|FG001|Overall Study|Lost to Follow-up|11|||
28019087|NCT00304915|54678354|FG000|Overall Study|Death|4|||
28019088|NCT00304915|54678355|FG001|Overall Study|Death|5|||
28019089|NCT00304915|54678354|FG000|Overall Study|Withdrawal by Subject|3|||
28019090|NCT00304915|54678355|FG001|Overall Study|Withdrawal by Subject|0|||
28019091|NCT03687970|54678363|FG000|Overall Study|visit scheduling conflicts|2|||
28019092|NCT03687970|54678364|FG001|Overall Study|visit scheduling conflicts|0|||
28019093|NCT00530920|54678375|FG000|Overall Study|Randomized but not treated|0|||
28019094|NCT00530920|54678376|FG001|Overall Study|Randomized but not treated|2|||
28019095|NCT00530920|54678377|FG002|Overall Study|Randomized but not treated|0|||
28019096|NCT00530920|54678375|FG000|Overall Study|Adverse Event|0|||
28019097|NCT00530920|54678376|FG001|Overall Study|Adverse Event|0|||
28019098|NCT00530920|54678377|FG002|Overall Study|Adverse Event|3|||
28019099|NCT00530920|54678375|FG000|Overall Study|Withdrawal by Subject|0|||
28019100|NCT00530920|54678376|FG001|Overall Study|Withdrawal by Subject|0|||
28019101|NCT00530920|54678377|FG002|Overall Study|Withdrawal by Subject|1|||
28019102|NCT03878758|54678386|FG000|Overall Study|Withdrawal by Subject|1|||
28019103|NCT03878758|54678386|FG000|Overall Study|Protocol defined|2|||
28019104|NCT03878758|54678386|FG000|Overall Study|Improper consent documentation|1|||
28019105|NCT03878602|54678401|FG000|Overall Study|cord blood donation|7|||
28019106|NCT03878602|54678402|FG001|Overall Study|cord blood donation|1|||
28019107|NCT03878602|54678401|FG000|Overall Study|incomplete data collection|2|||
27799193|NCT02111096|54253935|FG000|Overall Study|Protocol Violation|1|||
27799194|NCT02111096|54253936|FG001|Overall Study|Protocol Violation|0|||
27799195|NCT02111096|54253937|FG002|Overall Study|Protocol Violation|1|||
27799196|NCT02111096|54253935|FG000|Overall Study|Terminated by Sponsor|53|||
27799197|NCT02111096|54253936|FG001|Overall Study|Terminated by Sponsor|35|||
27799198|NCT02111096|54253937|FG002|Overall Study|Terminated by Sponsor|54|||
27799199|NCT02111096|54253935|FG000|Overall Study|Withdrawal by Subject|4|||
27799200|NCT02111096|54253936|FG001|Overall Study|Withdrawal by Subject|2|||
27799201|NCT02111096|54253937|FG002|Overall Study|Withdrawal by Subject|8|||
27799202|NCT02110706|54253950|FG000|Overall Study|Adverse Event|2|||
27799203|NCT02110706|54253951|FG001|Overall Study|Adverse Event|3|||
27799204|NCT02110706|54253950|FG000|Overall Study|Patients who didn't receive 2nd infusion|3|||
27799205|NCT02110706|54253951|FG001|Overall Study|Patients who didn't receive 2nd infusion|1|||
27799206|NCT02110238|54253961|FG000|12 Week Pivotal Phase|Adverse Event|3|||
27799207|NCT02110238|54253962|FG001|12 Week Pivotal Phase|Adverse Event|0|||
27799208|NCT02110238|54253961|FG000|12 Week Pivotal Phase|Lack of Efficacy|2|||
27799209|NCT02110238|54253962|FG001|12 Week Pivotal Phase|Lack of Efficacy|3|||
27799210|NCT02110238|54253961|FG000|12 Week Pivotal Phase|Lost to Follow-up|2|||
27799211|NCT02110238|54253962|FG001|12 Week Pivotal Phase|Lost to Follow-up|0|||
27799212|NCT02110238|54253961|FG000|12 Week Pivotal Phase|Physician Decision|0|||
27799213|NCT02110238|54253962|FG001|12 Week Pivotal Phase|Physician Decision|2|||
27799214|NCT02110238|54253961|FG000|12 Week Pivotal Phase|Protocol Violation|0|||
27799215|NCT02110238|54253962|FG001|12 Week Pivotal Phase|Protocol Violation|1|||
27799216|NCT02110238|54253961|FG000|12 Week Pivotal Phase|Withdrawal by Subject|3|||
27799217|NCT02110238|54253962|FG001|12 Week Pivotal Phase|Withdrawal by Subject|3|||
27799218|NCT02110238|54253961|FG000|14 Week Blinded Extension Phase|Adverse Event|1|||
27799219|NCT02110238|54253962|FG001|14 Week Blinded Extension Phase|Adverse Event|1|||
27799220|NCT02110238|54253961|FG000|14 Week Blinded Extension Phase|Lack of Efficacy|2|||
28019108|NCT03878602|54678402|FG001|Overall Study|incomplete data collection|0|||
28019109|NCT00768755|54678414|FG000|Phase 1|Death|6|||
28019110|NCT00768755|54678415|FG001|Phase 1|Death|0|||
28019111|NCT00768755|54678416|FG002|Phase 1|Death|0|||
28019112|NCT00768755|54678417|FG003|Phase 1|Death|0|||
28019113|NCT00768755|54678414|FG000|Phase 1|Other|4|||
28019114|NCT00768755|54678415|FG001|Phase 1|Other|0|||
28019115|NCT00768755|54678416|FG002|Phase 1|Other|0|||
28019116|NCT00768755|54678417|FG003|Phase 1|Other|0|||
27799221|NCT02110238|54253962|FG001|14 Week Blinded Extension Phase|Lack of Efficacy|4|||
28019117|NCT00768755|54678414|FG000|Phase 2|Death|0|||
28019118|NCT00768755|54678415|FG001|Phase 2|Death|37|||
27799222|NCT02110238|54253961|FG000|14 Week Blinded Extension Phase|Lost to Follow-up|3|||
27799223|NCT02110238|54253962|FG001|14 Week Blinded Extension Phase|Lost to Follow-up|1|||
27799224|NCT02110238|54253961|FG000|14 Week Blinded Extension Phase|Protocol Violation|2|||
28019119|NCT00768755|54678416|FG002|Phase 2|Death|48|||
28019120|NCT00768755|54678417|FG003|Phase 2|Death|31|||
28019121|NCT00768755|54678414|FG000|Phase 2|Protocol Violation|0|||
27799225|NCT02110238|54253962|FG001|14 Week Blinded Extension Phase|Protocol Violation|3|||
27799226|NCT02110238|54253961|FG000|14 Week Blinded Extension Phase|Withdrawal by Subject|4|||
27799227|NCT02110238|54253962|FG001|14 Week Blinded Extension Phase|Withdrawal by Subject|3|||
27799228|NCT02108912|54253970|FG000|Overall Study|Lost to Follow-up|1|||
27799229|NCT02108912|54253971|FG001|Overall Study|Lost to Follow-up|1|||
27799230|NCT02108912|54253970|FG000|Overall Study|lack of transportation|1|||
27799231|NCT02108912|54253971|FG001|Overall Study|lack of transportation|0|||
27799232|NCT02108912|54253970|FG000|Overall Study|high blood pressure|1|||
27799233|NCT02108912|54253971|FG001|Overall Study|high blood pressure|0|||
27799234|NCT02108600|54253979|FG000|Overall Study|Withdrawal by Subject|2|||
27799235|NCT02108600|54253980|FG001|Overall Study|Withdrawal by Subject|0|||
27799236|NCT02108600|54253979|FG000|Overall Study|Lost to Follow-up|1|||
27799237|NCT02108600|54253980|FG001|Overall Study|Lost to Follow-up|1|||
27799238|NCT02107898|54253988|FG000|Overall Study|Adverse Event|4|||
27799239|NCT02107898|54253989|FG001|Overall Study|Adverse Event|7|||
27799240|NCT02107898|54253988|FG000|Overall Study|Poor compliance to protocol|0|||
27799241|NCT02107898|54253989|FG001|Overall Study|Poor compliance to protocol|1|||
27799242|NCT02107898|54253988|FG000|Overall Study|Participant moved|0|||
27799243|NCT02107898|54253989|FG001|Overall Study|Participant moved|2|||
27799244|NCT02107898|54253988|FG000|Overall Study|Consent withdrawn by participant|2|||
27799245|NCT02107898|54253989|FG001|Overall Study|Consent withdrawn by participant|1|||
27799246|NCT02107898|54253988|FG000|Overall Study|Randomized but not treated|0|||
27799247|NCT02107898|54253989|FG001|Overall Study|Randomized but not treated|1|||
27799248|NCT02059148|54253995|FG000|Treatment 1|Protocol Violation|0|||
27799249|NCT02059148|54253996|FG001|Treatment 1|Protocol Violation|0|||
27799250|NCT02059148|54253997|FG002|Treatment 1|Protocol Violation|0|||
27799251|NCT02059148|54253998|FG003|Treatment 1|Protocol Violation|0|||
27799252|NCT02059148|54253999|FG004|Treatment 1|Protocol Violation|0|||
27799253|NCT02059148|54254000|FG005|Treatment 1|Protocol Violation|1|||
27799254|NCT02058992|54254011|FG000|Overall Study|Lost to Follow-up|4|||
27799255|NCT02058992|54254011|FG000|Overall Study|Protocol Violation|92|||
27799256|NCT02058992|54254011|FG000|Overall Study|CRF Uncollected|20|||
27799257|NCT02058836|54254017|FG000|Overall Study|Withdrawal by Subject|1|||
27799258|NCT02058836|54254018|FG001|Overall Study|Withdrawal by Subject|1|||
27799259|NCT02107274|54254026|FG000|Treatment vs. Placebo|Adverse Event|3|||
27799260|NCT02107274|54254027|FG001|Treatment vs. Placebo|Adverse Event|0|||
27799261|NCT02107274|54254026|FG000|Treatment vs. Placebo|Lost to Follow-up|0|||
27799262|NCT02107274|54254027|FG001|Treatment vs. Placebo|Lost to Follow-up|2|||
27799263|NCT02107274|54254026|FG000|Control Phase|Lost to Follow-up|1|||
27799264|NCT02107274|54254027|FG001|Control Phase|Lost to Follow-up|1|||
27799265|NCT02107274|54254026|FG000|Control Phase|Death|2|||
27799266|NCT02107274|54254027|FG001|Control Phase|Death|0|||
27799267|NCT02107274|54254026|FG000|Control Phase|Adverse Event|0|||
27799268|NCT02107274|54254027|FG001|Control Phase|Adverse Event|1|||
27799269|NCT02174627|54254035|FG000|Overall Study|Missing|0|||
27799270|NCT02174627|54254036|FG001|Overall Study|Missing|1|||
27799271|NCT02174627|54254035|FG000|Overall Study|Incorrect enrolment before randomization|0|||
27799272|NCT02174627|54254036|FG001|Overall Study|Incorrect enrolment before randomization|1|||
27799273|NCT02174627|54254035|FG000|Overall Study|Participant decision|84|||
27799274|NCT02174627|54254036|FG001|Overall Study|Participant decision|128|||
27799275|NCT02173769|54254042|FG000|Overall Study|Protocol Violation|4|||
27799276|NCT02121509|54254049|FG000|Washout Period (35 Days)|Adverse Event|1|||
28019122|NCT00768755|54678415|FG001|Phase 2|Protocol Violation|2|||
28019123|NCT00768755|54678416|FG002|Phase 2|Protocol Violation|0|||
28019124|NCT00768755|54678417|FG003|Phase 2|Protocol Violation|1|||
28019125|NCT00768755|54678414|FG000|Phase 2|Lost to Follow-up|0|||
27799277|NCT02121509|54254050|FG001|Washout Period (35 Days)|Adverse Event|1|||
27799278|NCT02121509|54254051|FG002|Washout Period (35 Days)|Adverse Event|0|||
27799279|NCT02121509|54254052|FG003|Washout Period (35 Days)|Adverse Event|0|||
28019126|NCT00768755|54678415|FG001|Phase 2|Lost to Follow-up|1|||
28019127|NCT00768755|54678416|FG002|Phase 2|Lost to Follow-up|1|||
28019128|NCT00768755|54678417|FG003|Phase 2|Lost to Follow-up|4|||
28019129|NCT00768755|54678414|FG000|Phase 2|Withdrawal by Subject|0|||
28019130|NCT00768755|54678415|FG001|Phase 2|Withdrawal by Subject|1|||
27799280|NCT02121509|54254049|FG000|Washout Period (35 Days)|Withdrawal by Subject|0|||
27799281|NCT02121509|54254050|FG001|Washout Period (35 Days)|Withdrawal by Subject|3|||
27799282|NCT02121509|54254051|FG002|Washout Period (35 Days)|Withdrawal by Subject|0|||
27799283|NCT02121509|54254052|FG003|Washout Period (35 Days)|Withdrawal by Subject|0|||
27799284|NCT02121509|54254049|FG000|Washout Period (35 Days)|elevated AST and ALT levels|1|||
27799285|NCT02121509|54254050|FG001|Washout Period (35 Days)|elevated AST and ALT levels|0|||
27799286|NCT02121509|54254051|FG002|Washout Period (35 Days)|elevated AST and ALT levels|0|||
27799287|NCT02121509|54254052|FG003|Washout Period (35 Days)|elevated AST and ALT levels|0|||
27799288|NCT02149199|54254065|FG000|Overall Study|Study specific withdrawal criteria|4|||
27799289|NCT02149199|54254066|FG001|Overall Study|Study specific withdrawal criteria|21|||
27799290|NCT02149199|54254067|FG002|Overall Study|Study specific withdrawal criteria|6|||
28019131|NCT00768755|54678416|FG002|Phase 2|Withdrawal by Subject|0|||
28019132|NCT00768755|54678417|FG003|Phase 2|Withdrawal by Subject|1|||
28019133|NCT00768755|54678414|FG000|Phase 2|Other|0|||
28019134|NCT00768755|54678415|FG001|Phase 2|Other|1|||
28019135|NCT00768755|54678416|FG002|Phase 2|Other|2|||
28019136|NCT00768755|54678417|FG003|Phase 2|Other|4|||
28019137|NCT00768755|54678414|FG000|Phase 2|Study Terminated by Sponsor|0|||
28019138|NCT00768755|54678415|FG001|Phase 2|Study Terminated by Sponsor|13|||
28019139|NCT00768755|54678416|FG002|Phase 2|Study Terminated by Sponsor|7|||
28019140|NCT00768755|54678417|FG003|Phase 2|Study Terminated by Sponsor|14|||
28019141|NCT00768755|54678414|FG000|Phase 2|Randomized but not treated|0|||
28019142|NCT00768755|54678415|FG001|Phase 2|Randomized but not treated|0|||
28019143|NCT00768755|54678416|FG002|Phase 2|Randomized but not treated|0|||
28019144|NCT00768755|54678417|FG003|Phase 2|Randomized but not treated|2|||
28019145|NCT00530842|54678428|FG000|Overall Study|Adverse Event|10|||
28019146|NCT00530842|54678429|FG001|Overall Study|Adverse Event|6|||
28019147|NCT00530842|54678428|FG000|Overall Study|Lack of Efficacy|2|||
28019148|NCT00530842|54678429|FG001|Overall Study|Lack of Efficacy|1|||
28019149|NCT00530842|54678428|FG000|Overall Study|Lost to Follow-up|0|||
28019150|NCT00530842|54678429|FG001|Overall Study|Lost to Follow-up|4|||
28019151|NCT00530842|54678428|FG000|Overall Study|Protocol Violation|3|||
28019152|NCT00530842|54678429|FG001|Overall Study|Protocol Violation|2|||
28019153|NCT00530842|54678428|FG000|Overall Study|Withdrawal by Subject|4|||
28019154|NCT00530842|54678429|FG001|Overall Study|Withdrawal by Subject|5|||
28019155|NCT00530842|54678428|FG000|Overall Study|Individual different reasons|4|||
28019156|NCT00530842|54678429|FG001|Overall Study|Individual different reasons|3|||
28019157|NCT00530842|54678428|FG000|Period 1|Adverse Event|7|||
28019158|NCT00530842|54678429|FG001|Period 1|Adverse Event|3|||
28019159|NCT00530842|54678428|FG000|Period 1|Lack of Efficacy|1|||
28019160|NCT00530842|54678429|FG001|Period 1|Lack of Efficacy|1|||
28019161|NCT00530842|54678428|FG000|Period 1|Protocol Violation|2|||
28019162|NCT00530842|54678429|FG001|Period 1|Protocol Violation|1|||
28019163|NCT00530842|54678428|FG000|Period 1|Withdrawal by Subject|2|||
27799291|NCT02149199|54254065|FG000|Overall Study|Other|20|||
27799292|NCT02149199|54254066|FG001|Overall Study|Other|25|||
27799293|NCT02149199|54254067|FG002|Overall Study|Other|20|||
27799294|NCT02149199|54254065|FG000|Overall Study|Eligibility criteria not fulfilled|9|||
27799295|NCT02149199|54254066|FG001|Overall Study|Eligibility criteria not fulfilled|14|||
27799296|NCT02149199|54254067|FG002|Overall Study|Eligibility criteria not fulfilled|8|||
27799297|NCT02149199|54254065|FG000|Overall Study|Withdrawal by Subject|75|||
27799298|NCT02149199|54254066|FG001|Overall Study|Withdrawal by Subject|93|||
27799299|NCT02149199|54254067|FG002|Overall Study|Withdrawal by Subject|77|||
27799300|NCT02149199|54254065|FG000|Overall Study|Protocol Violation|16|||
27799301|NCT02149199|54254066|FG001|Overall Study|Protocol Violation|13|||
27799302|NCT02149199|54254067|FG002|Overall Study|Protocol Violation|15|||
27799303|NCT02149199|54254065|FG000|Overall Study|Lost to Follow-up|3|||
27799304|NCT02149199|54254066|FG001|Overall Study|Lost to Follow-up|12|||
27799305|NCT02149199|54254067|FG002|Overall Study|Lost to Follow-up|11|||
27799306|NCT02149199|54254065|FG000|Overall Study|Death|0|||
27799307|NCT02149199|54254066|FG001|Overall Study|Death|0|||
27799308|NCT02149199|54254067|FG002|Overall Study|Death|1|||
27799309|NCT02149199|54254065|FG000|Overall Study|Adverse Event|6|||
27799310|NCT02149199|54254066|FG001|Overall Study|Adverse Event|15|||
27799311|NCT02149199|54254067|FG002|Overall Study|Adverse Event|9|||
27799312|NCT02120417|54254077|FG000|Overall Study|Death|5|||
27799313|NCT02120417|54254078|FG001|Overall Study|Death|1|||
27799314|NCT02120417|54254077|FG000|Overall Study|Adverse Event|3|||
27799315|NCT02120417|54254078|FG001|Overall Study|Adverse Event|9|||
27799316|NCT02120417|54254077|FG000|Overall Study|Participant decision|4|||
28019164|NCT00530842|54678429|FG001|Period 1|Withdrawal by Subject|3|||
28019165|NCT00530842|54678428|FG000|Period 1|Individual different reasons|2|||
28019166|NCT00530842|54678429|FG001|Period 1|Individual different reasons|3|||
28019167|NCT00530842|54678428|FG000|Period 2|Adverse Event|3|||
28019168|NCT00530842|54678429|FG001|Period 2|Adverse Event|3|||
28019169|NCT00530842|54678428|FG000|Period 2|Lack of Efficacy|1|||
27799317|NCT02120417|54254078|FG001|Overall Study|Participant decision|4|||
27799318|NCT02120417|54254077|FG000|Overall Study|Disease progression|41|||
28019170|NCT00530842|54678429|FG001|Period 2|Lack of Efficacy|0|||
28019171|NCT00530842|54678428|FG000|Period 2|Lost to Follow-up|0|||
28019172|NCT00530842|54678429|FG001|Period 2|Lost to Follow-up|4|||
27799319|NCT02120417|54254078|FG001|Overall Study|Disease progression|45|||
27799320|NCT02120417|54254077|FG000|Overall Study|Noncompliance with study treatment|0|||
27799321|NCT02120417|54254078|FG001|Overall Study|Noncompliance with study treatment|2|||
27799322|NCT02120417|54254077|FG000|Overall Study|Physician Decision|2|||
27799323|NCT02120417|54254078|FG001|Overall Study|Physician Decision|3|||
28019173|NCT00530842|54678428|FG000|Period 2|Protocol Violation|1|||
28019174|NCT00530842|54678429|FG001|Period 2|Protocol Violation|0|||
28019175|NCT00530842|54678428|FG000|Period 2|Withdrawal by Subject|1|||
28019176|NCT00530842|54678429|FG001|Period 2|Withdrawal by Subject|2|||
28019177|NCT00530842|54678428|FG000|Period 2|Individual different reasons|2|||
28019178|NCT00530842|54678429|FG001|Period 2|Individual different reasons|0|||
28019179|NCT03882424|54678440|FG000|Overall Study|Lost to Follow-up|3|||
28019180|NCT03882424|54678441|FG001|Overall Study|Lost to Follow-up|0|||
28019181|NCT03882424|54678442|FG002|Overall Study|Lost to Follow-up|0|||
28019182|NCT03882424|54678440|FG000|Overall Study|schedule conflict|1|||
28019183|NCT03882424|54678441|FG001|Overall Study|schedule conflict|0|||
28019184|NCT03882424|54678442|FG002|Overall Study|schedule conflict|0|||
27799324|NCT02120417|54254077|FG000|Overall Study|Other unspecified|5|||
27799325|NCT02120417|54254078|FG001|Overall Study|Other unspecified|4|||
27799326|NCT02148263|54254086|FG000|Overall Study|Withdrawal by Subject|3|||
27799327|NCT02148263|54254087|FG001|Overall Study|Withdrawal by Subject|2|||
27799328|NCT02147561|54254093|FG000|Overall Study|Lost to Follow-up|3|||
27799329|NCT02147561|54254093|FG000|Overall Study|Subjects who didn't receive BOTOX|1|||
27799330|NCT02058368|54254099|FG000|Overall Study|Adverse Event|15|||
27799331|NCT02058368|54254100|FG001|Overall Study|Adverse Event|20|||
27799332|NCT02058368|54254099|FG000|Overall Study|Lack of Efficacy|0|||
27799333|NCT02058368|54254100|FG001|Overall Study|Lack of Efficacy|1|||
27799334|NCT02058368|54254099|FG000|Overall Study|Protocol Violation|0|||
27799335|NCT02058368|54254100|FG001|Overall Study|Protocol Violation|4|||
27799336|NCT02058368|54254099|FG000|Overall Study|Lost to Follow-up|2|||
27799337|NCT02058368|54254100|FG001|Overall Study|Lost to Follow-up|0|||
27799338|NCT02058368|54254099|FG000|Overall Study|Physician Decision|2|||
27799339|NCT02058368|54254100|FG001|Overall Study|Physician Decision|3|||
27799340|NCT02058368|54254099|FG000|Overall Study|Withdrawal by Subject|22|||
27799341|NCT02058368|54254100|FG001|Overall Study|Withdrawal by Subject|26|||
27799342|NCT02107196|54254108|FG000|12-week Treatment Period|Adverse Event|6|||
27799343|NCT02107196|54254109|FG001|12-week Treatment Period|Adverse Event|3|||
28019185|NCT03879772|54678455|FG000|Overall Study|Adverse Event|2|||
28019186|NCT03879772|54678456|FG001|Overall Study|Adverse Event|2|||
28019187|NCT03879772|54678457|FG002|Overall Study|Adverse Event|3|||
28019188|NCT03879772|54678458|FG003|Overall Study|Adverse Event|4|||
28019189|NCT03879772|54678459|FG004|Overall Study|Adverse Event|3|||
28019190|NCT03879772|54678455|FG000|Overall Study|Treatment Failure|1|||
28019191|NCT03879772|54678456|FG001|Overall Study|Treatment Failure|0|||
28019192|NCT03879772|54678457|FG002|Overall Study|Treatment Failure|0|||
28019193|NCT03879772|54678458|FG003|Overall Study|Treatment Failure|2|||
28019194|NCT03879772|54678459|FG004|Overall Study|Treatment Failure|1|||
28019195|NCT03879772|54678455|FG000|Overall Study|Lost to Follow-up|0|||
28019196|NCT03879772|54678456|FG001|Overall Study|Lost to Follow-up|0|||
28019197|NCT03879772|54678457|FG002|Overall Study|Lost to Follow-up|0|||
28019198|NCT03879772|54678458|FG003|Overall Study|Lost to Follow-up|0|||
28019199|NCT03879772|54678459|FG004|Overall Study|Lost to Follow-up|1|||
28019200|NCT03879772|54678455|FG000|Overall Study|Withdrawal by Subject|0|||
28019201|NCT03879772|54678456|FG001|Overall Study|Withdrawal by Subject|1|||
28019202|NCT03879772|54678457|FG002|Overall Study|Withdrawal by Subject|3|||
28019203|NCT03879772|54678458|FG003|Overall Study|Withdrawal by Subject|1|||
28019204|NCT03879772|54678459|FG004|Overall Study|Withdrawal by Subject|1|||
28019205|NCT03879772|54678455|FG000|Overall Study|Protocol Violation|0|||
28019206|NCT03879772|54678456|FG001|Overall Study|Protocol Violation|0|||
28019207|NCT03879772|54678457|FG002|Overall Study|Protocol Violation|3|||
28019208|NCT03879772|54678458|FG003|Overall Study|Protocol Violation|1|||
28019209|NCT03879772|54678459|FG004|Overall Study|Protocol Violation|2|||
28019210|NCT03879772|54678455|FG000|Overall Study|Did Not Meet Entry Requirements|1|||
28019211|NCT03879772|54678456|FG001|Overall Study|Did Not Meet Entry Requirements|0|||
28019212|NCT03879772|54678457|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
28019213|NCT03879772|54678458|FG003|Overall Study|Did Not Meet Entry Requirements|0|||
28019214|NCT03879772|54678459|FG004|Overall Study|Did Not Meet Entry Requirements|0|||
28019215|NCT00642954|54678476|FG000|Overall Study|Progressive Disease|3|||
28019216|NCT00642954|54678477|FG001|Overall Study|Progressive Disease|3|||
28019217|NCT00642954|54678478|FG002|Overall Study|Progressive Disease|3|||
28019218|NCT00642954|54678479|FG003|Overall Study|Progressive Disease|3|||
28019219|NCT00642954|54678480|FG004|Overall Study|Progressive Disease|9|||
27799344|NCT02107196|54254108|FG000|12-week Treatment Period|Lack of Efficacy|2|||
27799345|NCT02107196|54254109|FG001|12-week Treatment Period|Lack of Efficacy|1|||
27799346|NCT02107196|54254108|FG000|12-week Treatment Period|Lost to Follow-up|3|||
27799347|NCT02107196|54254109|FG001|12-week Treatment Period|Lost to Follow-up|6|||
27799348|NCT02107196|54254108|FG000|12-week Treatment Period|Physician Decision|0|||
27799349|NCT02107196|54254109|FG001|12-week Treatment Period|Physician Decision|1|||
27799350|NCT02107196|54254108|FG000|12-week Treatment Period|Withdrawal by Subject|15|||
27799351|NCT02107196|54254109|FG001|12-week Treatment Period|Withdrawal by Subject|12|||
27938527|NCT00992446|54594628|FG000|Overall Study|Disease Progression|1|||
27938528|NCT00992446|54594628|FG000|Overall Study|Withdrawal by Subject|2|||
27938529|NCT00992446|54594628|FG000|Overall Study|Maintenance Therapy Screen Fail|5|||
27938530|NCT00970294|54594632|FG000|Overall Study|Physician Decision|4|||
27938531|NCT00970294|54594632|FG000|Overall Study|Withdrawal by Subject|1|||
27938532|NCT00969436|54594639|FG000|Overall Study|Protocol Violation|1|||
27938533|NCT00969436|54594640|FG001|Overall Study|Protocol Violation|3|||
27938534|NCT00969436|54594641|FG002|Overall Study|Protocol Violation|0|||
27938535|NCT00969436|54594639|FG000|Overall Study|Migrated/moved from study area|12|||
28019220|NCT00642954|54678476|FG000|Overall Study|Withdrawal by Subject|0|||
27799352|NCT02107196|54254108|FG000|12-week Treatment Period|Protocol Violation|7|||
27799353|NCT02107196|54254109|FG001|12-week Treatment Period|Protocol Violation|8|||
27799354|NCT02107196|54254108|FG000|12-week Treatment Period|Reason Missing|11|||
27799355|NCT02107196|54254109|FG001|12-week Treatment Period|Reason Missing|8|||
27799356|NCT02107196|54254108|FG000|4-week Randomized Withdrawal (RW) Period|Adverse Event|2|||
27799357|NCT02107196|54254109|FG001|4-week Randomized Withdrawal (RW) Period|Adverse Event|0|||
27799358|NCT02107196|54254108|FG000|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
27799359|NCT02107196|54254109|FG001|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
27799360|NCT02107196|54254108|FG000|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2|||
27799361|NCT02107196|54254109|FG001|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0|||
27799362|NCT02107196|54254108|FG000|4-week Randomized Withdrawal (RW) Period|Reason Missing|18|||
27799363|NCT02107196|54254109|FG001|4-week Randomized Withdrawal (RW) Period|Reason Missing|5|||
27799364|NCT02058290|54254117|FG000|Overall Study|Protocol Violation|2|||
27799365|NCT02058290|54254118|FG001|Overall Study|Protocol Violation|1|||
27799366|NCT02058290|54254117|FG000|Overall Study|Physician Decision|1|||
27799367|NCT02058290|54254118|FG001|Overall Study|Physician Decision|0|||
27799368|NCT02058290|54254117|FG000|Overall Study|Didn't meet intraoperative criteria|8|||
27799369|NCT02058290|54254118|FG001|Overall Study|Didn't meet intraoperative criteria|7|||
27799370|NCT02058290|54254117|FG000|Overall Study|Withdrawal by Subject|0|||
27799371|NCT02058290|54254118|FG001|Overall Study|Withdrawal by Subject|1|||
28019221|NCT00642954|54678477|FG001|Overall Study|Withdrawal by Subject|0|||
28019222|NCT00642954|54678478|FG002|Overall Study|Withdrawal by Subject|0|||
28019223|NCT00642954|54678479|FG003|Overall Study|Withdrawal by Subject|0|||
28019224|NCT00642954|54678480|FG004|Overall Study|Withdrawal by Subject|1|||
28019225|NCT00642954|54678476|FG000|Overall Study|Adverse Event|1|||
28019226|NCT00642954|54678477|FG001|Overall Study|Adverse Event|1|||
28019227|NCT00642954|54678478|FG002|Overall Study|Adverse Event|0|||
28019228|NCT00642954|54678479|FG003|Overall Study|Adverse Event|0|||
28019229|NCT00642954|54678480|FG004|Overall Study|Adverse Event|6|||
28019230|NCT00640146|54678494|FG000|Overall Study|Adverse Event|2|||
28019231|NCT00640146|54678495|FG001|Overall Study|Adverse Event|0|||
28019232|NCT00640146|54678494|FG000|Overall Study|Lost to Follow-up|0|||
28019233|NCT00640146|54678495|FG001|Overall Study|Lost to Follow-up|1|||
28019234|NCT00640146|54678494|FG000|Overall Study|Lack of Efficacy|0|||
28019235|NCT00640146|54678495|FG001|Overall Study|Lack of Efficacy|1|||
28019236|NCT00640146|54678494|FG000|Overall Study|Withdrawal by Subject|1|||
28019237|NCT00640146|54678495|FG001|Overall Study|Withdrawal by Subject|1|||
28019238|NCT00640146|54678494|FG000|Overall Study|Randomized but not treated|1|||
28019239|NCT00640146|54678495|FG001|Overall Study|Randomized but not treated|3|||
28019240|NCT00317473|54678507|FG000|Overall Study|Withdrawal by Subject|2|||
28019241|NCT00317473|54678508|FG001|Overall Study|Withdrawal by Subject|1|||
28019242|NCT00317473|54678509|FG002|Overall Study|Withdrawal by Subject|2|||
28019243|NCT00317473|54678510|FG003|Overall Study|Withdrawal by Subject|1|||
28019244|NCT00317473|54678511|FG004|Overall Study|Withdrawal by Subject|3|||
28019245|NCT00317473|54678512|FG005|Overall Study|Withdrawal by Subject|1|||
28019246|NCT00317473|54678507|FG000|Overall Study|Relocation|1|||
28019247|NCT00317473|54678508|FG001|Overall Study|Relocation|0|||
27799372|NCT02082158|54254130|FG000|Overall Study|Withdrawal by Subject|0|||
27799373|NCT02082158|54254131|FG001|Overall Study|Withdrawal by Subject|0|||
27799374|NCT02082158|54254132|FG002|Overall Study|Withdrawal by Subject|0|||
27799375|NCT02082158|54254133|FG003|Overall Study|Withdrawal by Subject|0|||
27799376|NCT02082158|54254134|FG004|Overall Study|Withdrawal by Subject|1|||
27799377|NCT02082158|54254135|FG005|Overall Study|Withdrawal by Subject|0|||
27799378|NCT02082158|54254130|FG000|Overall Study|Failed Fit-testing|8|||
27799379|NCT02082158|54254131|FG001|Overall Study|Failed Fit-testing|8|||
27799380|NCT02082158|54254132|FG002|Overall Study|Failed Fit-testing|14|||
27799381|NCT02082158|54254133|FG003|Overall Study|Failed Fit-testing|4|||
27799382|NCT02082158|54254134|FG004|Overall Study|Failed Fit-testing|3|||
27799383|NCT02082158|54254135|FG005|Overall Study|Failed Fit-testing|7|||
27799384|NCT02106884|54254157|FG000|Overall Study|Change of diagnosis/exclusion|0|||
27799385|NCT02106884|54254158|FG001|Overall Study|Change of diagnosis/exclusion|1|||
27799386|NCT02081846|54254169|FG000|Overall Study|Withdrawal by Subject|1|||
27799387|NCT02081846|54254170|FG001|Overall Study|Withdrawal by Subject|0|||
27799388|NCT02081846|54254169|FG000|Overall Study|invalid consent|1|||
27799389|NCT02081846|54254170|FG001|Overall Study|invalid consent|0|||
27799390|NCT02081690|54254176|FG000|Overall Study|Death|3|||
27799391|NCT02081690|54254176|FG000|Overall Study|Physician Decision|3|||
27799392|NCT02081690|54254176|FG000|Overall Study|Withdrawal by Subject|1|||
28019248|NCT00317473|54678509|FG002|Overall Study|Relocation|1|||
28019249|NCT00317473|54678510|FG003|Overall Study|Relocation|1|||
28019250|NCT00317473|54678511|FG004|Overall Study|Relocation|5|||
28019251|NCT00317473|54678512|FG005|Overall Study|Relocation|2|||
28019252|NCT00317473|54678507|FG000|Overall Study|Death|1|||
28019253|NCT00317473|54678508|FG001|Overall Study|Death|0|||
28019254|NCT00317473|54678509|FG002|Overall Study|Death|0|||
28019255|NCT00317473|54678510|FG003|Overall Study|Death|0|||
28019256|NCT00317473|54678511|FG004|Overall Study|Death|0|||
28019257|NCT00317473|54678512|FG005|Overall Study|Death|0|||
28019258|NCT00317473|54678507|FG000|Overall Study|Other|0|||
28019259|NCT00317473|54678508|FG001|Overall Study|Other|2|||
28019260|NCT00317473|54678509|FG002|Overall Study|Other|0|||
28019261|NCT00317473|54678510|FG003|Overall Study|Other|0|||
28019262|NCT00317473|54678511|FG004|Overall Study|Other|0|||
28019263|NCT00317473|54678512|FG005|Overall Study|Other|0|||
28019264|NCT00530218|54678536|FG000|Overall Study|CMV Not Detected|13|||
28019265|NCT00530218|54678536|FG000|Overall Study|Death|12|||
28019266|NCT00761267|54678546|FG000|Overall Study|Death|1|||
28019267|NCT00761267|54678547|FG001|Overall Study|Death|2|||
28019268|NCT00761267|54678548|FG002|Overall Study|Death|5|||
28019269|NCT00761267|54678546|FG000|Overall Study|Lost to Follow-up|0|||
28019270|NCT00761267|54678547|FG001|Overall Study|Lost to Follow-up|0|||
28019271|NCT00761267|54678548|FG002|Overall Study|Lost to Follow-up|1|||
28019272|NCT00761267|54678546|FG000|Overall Study|Randomized but not treated|1|||
28019273|NCT00761267|54678547|FG001|Overall Study|Randomized but not treated|1|||
28019274|NCT00761267|54678548|FG002|Overall Study|Randomized but not treated|0|||
28019275|NCT00761267|54678546|FG000|Overall Study|Withdrawal by Subject|0|||
28019276|NCT00761267|54678547|FG001|Overall Study|Withdrawal by Subject|1|||
28019277|NCT00761267|54678548|FG002|Overall Study|Withdrawal by Subject|0|||
28019278|NCT00303667|54678569|FG000|Overall Study|Death|0|||
28019279|NCT00303667|54678570|FG001|Overall Study|Death|4|||
28019280|NCT00761189|54678576|FG000|Overall Study|Adverse Event|42|||
28019281|NCT00761189|54678576|FG000|Overall Study|Lack of Efficacy|45|||
28019282|NCT00761189|54678576|FG000|Overall Study|Lost to Follow-up|36|||
28019283|NCT00761189|54678576|FG000|Overall Study|Withdrawal by Subject|49|||
28019284|NCT00761189|54678576|FG000|Overall Study|Other|13|||
28019285|NCT00529516|54678583|FG000|Overall Study|Adverse Event|2|||
27799393|NCT02057666|54254182|FG000|Double Blind Treatment Period|Withdrawal by Subject|8|||
28019286|NCT00529516|54678584|FG001|Overall Study|Adverse Event|1|||
28019287|NCT00529516|54678585|FG002|Overall Study|Adverse Event|0|||
28019288|NCT00529516|54678583|FG000|Overall Study|Withdrawal by Subject|1|||
28019289|NCT00529516|54678584|FG001|Overall Study|Withdrawal by Subject|1|||
28019290|NCT00529516|54678585|FG002|Overall Study|Withdrawal by Subject|0|||
28019291|NCT00529516|54678583|FG000|Overall Study|Lost to Follow-up|0|||
28019292|NCT00529516|54678584|FG001|Overall Study|Lost to Follow-up|0|||
28019293|NCT00529516|54678585|FG002|Overall Study|Lost to Follow-up|1|||
28019294|NCT00316693|54678595|FG000|Overall Study|Adverse Event|6|||
28019295|NCT00316693|54678596|FG001|Overall Study|Adverse Event|1|||
28019296|NCT00316693|54678595|FG000|Overall Study|Protocol Violation|1|||
28019297|NCT00316693|54678596|FG001|Overall Study|Protocol Violation|0|||
28019298|NCT00316693|54678595|FG000|Overall Study|Withdrawal by Subject|6|||
28019299|NCT00316693|54678596|FG001|Overall Study|Withdrawal by Subject|6|||
28019300|NCT00316693|54678595|FG000|Overall Study|Lost to Follow-up|26|||
28019301|NCT00316693|54678596|FG001|Overall Study|Lost to Follow-up|34|||
28019302|NCT00316693|54678595|FG000|Overall Study|Other|38|||
28019303|NCT00316693|54678596|FG001|Overall Study|Other|44|||
27799394|NCT02057666|54254183|FG001|Double Blind Treatment Period|Withdrawal by Subject|5|||
27799395|NCT02057666|54254182|FG000|Double Blind Treatment Period|Poor tolerability|7|||
27799396|NCT02057666|54254183|FG001|Double Blind Treatment Period|Poor tolerability|2|||
27799397|NCT02057666|54254182|FG000|Double Blind Treatment Period|Symptomatic disease progression|8|||
27799398|NCT02057666|54254183|FG001|Double Blind Treatment Period|Symptomatic disease progression|3|||
27799399|NCT02057666|54254182|FG000|Double Blind Treatment Period|Physician Decision|1|||
27799400|NCT02057666|54254183|FG001|Double Blind Treatment Period|Physician Decision|0|||
27799401|NCT02057666|54254182|FG000|Double Blind Treatment Period|Progressive disease for bone lesion|1|||
27799402|NCT02057666|54254183|FG001|Double Blind Treatment Period|Progressive disease for bone lesion|0|||
27799403|NCT02057666|54254182|FG000|Double Blind Treatment Period|Subject planning to withdraw|1|||
27799404|NCT02057666|54254183|FG001|Double Blind Treatment Period|Subject planning to withdraw|0|||
27799405|NCT02057666|54254182|FG000|Double Blind Treatment Period|Sponsor's request|70|||
27799406|NCT02057666|54254183|FG001|Double Blind Treatment Period|Sponsor's request|34|||
28019304|NCT00316303|54678604|FG000|Overall Study|Lost to Follow-up|11|||
28019305|NCT00316303|54678605|FG001|Overall Study|Lost to Follow-up|16|||
28019306|NCT00760877|54678616|FG000|Overall Study|Protocol Violation|1|||
28019307|NCT00760877|54678617|FG001|Overall Study|Protocol Violation|0|||
28019308|NCT00760877|54678616|FG000|Overall Study|Non-compliance with protocol treatment|2|||
28019309|NCT00760877|54678617|FG001|Overall Study|Non-compliance with protocol treatment|1|||
28019310|NCT00760877|54678616|FG000|Overall Study|Pregnancy|1|||
28019311|NCT00760877|54678617|FG001|Overall Study|Pregnancy|4|||
28019312|NCT00760877|54678616|FG000|Overall Study|Death|2|||
28019313|NCT00760877|54678617|FG001|Overall Study|Death|1|||
28019314|NCT00760877|54678616|FG000|Overall Study|Withdrawal by Subject|7|||
28019315|NCT00760877|54678617|FG001|Overall Study|Withdrawal by Subject|3|||
28019316|NCT00760877|54678616|FG000|Overall Study|Adverse Event|19|||
28019317|NCT00760877|54678617|FG001|Overall Study|Adverse Event|12|||
28019318|NCT00760877|54678616|FG000|Overall Study|Participant diagnosed with AML|0|||
27799407|NCT02057666|54254182|FG000|Open-Label Treatment Period|Poor tolerability|0|||
27799408|NCT02057666|54254183|FG001|Open-Label Treatment Period|Poor tolerability|1|||
27799409|NCT02057666|54254182|FG000|Open-Label Treatment Period|Symptomatic disease progression|0|||
27799410|NCT02057666|54254183|FG001|Open-Label Treatment Period|Symptomatic disease progression|1|||
27799411|NCT02057666|54254182|FG000|Open-Label Treatment Period|Sponsor's request|0|||
27799412|NCT02057666|54254183|FG001|Open-Label Treatment Period|Sponsor's request|4|||
27799413|NCT01625000|54254194|FG000|Overall Study|Physician Decision|15|||
27799414|NCT01625000|54254195|FG001|Overall Study|Physician Decision|7|||
28019319|NCT00760877|54678617|FG001|Overall Study|Participant diagnosed with AML|1|||
28019320|NCT00760877|54678616|FG000|Overall Study|Participant not eligible to cross-over|0|||
28019321|NCT00760877|54678617|FG001|Overall Study|Participant not eligible to cross-over|1|||
28019322|NCT00760877|54678616|FG000|Overall Study|Physician Decision|1|||
28019323|NCT00760877|54678617|FG001|Overall Study|Physician Decision|2|||
28019324|NCT00760877|54678616|FG000|Overall Study|Participants transferred to AMN107A2408|11|||
28019325|NCT00760877|54678617|FG001|Overall Study|Participants transferred to AMN107A2408|1|||
28019326|NCT00760877|54678616|FG000|Overall Study|Treatment failure|1|||
28019327|NCT00760877|54678617|FG001|Overall Study|Treatment failure|0|||
28019328|NCT00302731|54678628|FG000|Overall Study|Lost to Follow-up|1|||
27799415|NCT01625000|54254196|FG002|Overall Study|Physician Decision|7|||
27799416|NCT01625000|54254197|FG003|Overall Study|Physician Decision|2|||
27799417|NCT01625000|54254198|FG004|Overall Study|Physician Decision|15|||
27799418|NCT01625000|54254194|FG000|Overall Study|Protocol Violation|3|||
27799419|NCT01625000|54254195|FG001|Overall Study|Protocol Violation|10|||
27799420|NCT01625000|54254196|FG002|Overall Study|Protocol Violation|4|||
27799421|NCT01625000|54254197|FG003|Overall Study|Protocol Violation|1|||
27799422|NCT01625000|54254198|FG004|Overall Study|Protocol Violation|2|||
28019329|NCT00302731|54678629|FG001|Overall Study|Lost to Follow-up|2|||
28019330|NCT00302731|54678630|FG002|Overall Study|Lost to Follow-up|0|||
28019331|NCT00302731|54678631|FG003|Overall Study|Lost to Follow-up|0|||
28019332|NCT00302731|54678628|FG000|Overall Study|Adverse Event|0|||
28019333|NCT00302731|54678629|FG001|Overall Study|Adverse Event|2|||
28019334|NCT00302731|54678630|FG002|Overall Study|Adverse Event|2|||
28019335|NCT00302731|54678631|FG003|Overall Study|Adverse Event|0|||
28019336|NCT00302731|54678628|FG000|Overall Study|Withdrawal by Subject|1|||
28019337|NCT00302731|54678629|FG001|Overall Study|Withdrawal by Subject|1|||
28019338|NCT00302731|54678630|FG002|Overall Study|Withdrawal by Subject|0|||
28019339|NCT00302731|54678631|FG003|Overall Study|Withdrawal by Subject|0|||
28019340|NCT00302731|54678628|FG000|Overall Study|Protocol Violation|1|||
28019341|NCT00302731|54678629|FG001|Overall Study|Protocol Violation|0|||
28019342|NCT00302731|54678630|FG002|Overall Study|Protocol Violation|0|||
28019343|NCT00302731|54678631|FG003|Overall Study|Protocol Violation|0|||
28019344|NCT00302731|54678628|FG000|Overall Study|cancer unrelated to study discovered|1|||
28019345|NCT00302731|54678629|FG001|Overall Study|cancer unrelated to study discovered|0|||
28019346|NCT00302731|54678630|FG002|Overall Study|cancer unrelated to study discovered|1|||
28019347|NCT00302731|54678631|FG003|Overall Study|cancer unrelated to study discovered|0|||
28019348|NCT00780143|54678641|FG000|Overall Study|Progressive disease|1|||
28019349|NCT00780143|54678641|FG000|Overall Study|Toxicity|1|||
28019350|NCT00780143|54678641|FG000|Overall Study|Adverse Event|1|||
28019351|NCT00779909|54678649|FG000|Overall Study|Lost to Follow-up|1|||
28019352|NCT00779909|54678650|FG001|Overall Study|Lost to Follow-up|0|||
28019353|NCT00779909|54678651|FG002|Overall Study|Lost to Follow-up|0|||
28019354|NCT00779909|54678652|FG003|Overall Study|Lost to Follow-up|1|||
27799423|NCT01625000|54254194|FG000|Overall Study|Withdrawal by Subject|19|||
27799424|NCT01625000|54254195|FG001|Overall Study|Withdrawal by Subject|16|||
27799425|NCT01625000|54254196|FG002|Overall Study|Withdrawal by Subject|11|||
27799426|NCT01625000|54254197|FG003|Overall Study|Withdrawal by Subject|9|||
27799427|NCT01625000|54254198|FG004|Overall Study|Withdrawal by Subject|17|||
27799428|NCT01625000|54254194|FG000|Overall Study|Adverse Event (including Death)|15|||
27799429|NCT01625000|54254195|FG001|Overall Study|Adverse Event (including Death)|19|||
27799430|NCT01625000|54254196|FG002|Overall Study|Adverse Event (including Death)|11|||
27799431|NCT01625000|54254197|FG003|Overall Study|Adverse Event (including Death)|7|||
27799432|NCT01625000|54254198|FG004|Overall Study|Adverse Event (including Death)|21|||
28019355|NCT00779909|54678649|FG000|Overall Study|Withdrawal by Subject|0|||
28019356|NCT00779909|54678650|FG001|Overall Study|Withdrawal by Subject|1|||
28019357|NCT00779909|54678651|FG002|Overall Study|Withdrawal by Subject|0|||
28019358|NCT00779909|54678652|FG003|Overall Study|Withdrawal by Subject|0|||
28019359|NCT00302107|54678671|FG000|Overall Study|Lost to Follow-up|6|||
28019360|NCT00302107|54678672|FG001|Overall Study|Lost to Follow-up|5|||
28019361|NCT00302107|54678671|FG000|Overall Study|Protocol Violation|1|||
28019362|NCT00302107|54678672|FG001|Overall Study|Protocol Violation|0|||
27799433|NCT02081534|54254217|FG000|Overall Study|Adverse Event|5|||
28019363|NCT00302107|54678671|FG000|Overall Study|Relocation|0|||
27799434|NCT02081534|54254218|FG001|Overall Study|Adverse Event|4|||
28019364|NCT00302107|54678672|FG001|Overall Study|Relocation|1|||
28019365|NCT00302107|54678671|FG000|Overall Study|Withdrawal by Subject|0|||
28019366|NCT00302107|54678672|FG001|Overall Study|Withdrawal by Subject|3|||
28019367|NCT00302107|54678671|FG000|Overall Study|Adverse Event|1|||
28019368|NCT00302107|54678672|FG001|Overall Study|Adverse Event|0|||
28019369|NCT00760487|54678678|FG000|Overall Study|Unilateral implantation|3|||
28019370|NCT00316225|54678682|FG000|Overall Study|Adverse Event|2|||
28019371|NCT00316225|54678682|FG000|Overall Study|Physician Decision|3|||
28019372|NCT00316225|54678682|FG000|Overall Study|Progressive Disease|15|||
28019373|NCT00316225|54678682|FG000|Overall Study|Withdrawal by Subject|3|||
28019374|NCT00316225|54678682|FG000|Overall Study|Death|2|||
28019375|NCT00586703|54678686|FG000|Overall Study|Death|12|||
28019376|NCT00586625|54678692|FG000|Overall Study|Adverse Event|6|||
28019377|NCT00586625|54678693|FG001|Overall Study|Adverse Event|6|||
28019378|NCT00586625|54678692|FG000|Overall Study|Protocol Violation|3|||
28019379|NCT00586625|54678693|FG001|Overall Study|Protocol Violation|0|||
28019380|NCT00586625|54678692|FG000|Overall Study|Withdrawal by Subject|32|||
28019381|NCT00586625|54678693|FG001|Overall Study|Withdrawal by Subject|10|||
28019382|NCT00586625|54678692|FG000|Overall Study|Subject non-compliance|0|||
28019383|NCT00586625|54678693|FG001|Overall Study|Subject non-compliance|1|||
28019384|NCT00586625|54678692|FG000|Overall Study|Subject unable to return for visit|2|||
28019385|NCT00586625|54678693|FG001|Overall Study|Subject unable to return for visit|0|||
28019386|NCT00636168|54678701|FG000|Randomized to Study Drug|Withdrawal by Subject|2|||
28019387|NCT00636168|54678702|FG001|Randomized to Study Drug|Withdrawal by Subject|2|||
27799435|NCT02081534|54254219|FG002|Overall Study|Adverse Event|3|||
27799436|NCT02081534|54254220|FG003|Overall Study|Adverse Event|10|||
27799437|NCT02081534|54254221|FG004|Overall Study|Adverse Event|2|||
27799438|NCT02081534|54254222|FG005|Overall Study|Adverse Event|8|||
27799439|NCT02081534|54254223|FG006|Overall Study|Adverse Event|2|||
27799440|NCT02081534|54254217|FG000|Overall Study|Withdrawal by Subject|0|||
27799441|NCT02081534|54254218|FG001|Overall Study|Withdrawal by Subject|1|||
27799442|NCT02081534|54254219|FG002|Overall Study|Withdrawal by Subject|1|||
27799443|NCT02081534|54254220|FG003|Overall Study|Withdrawal by Subject|1|||
27799444|NCT02081534|54254221|FG004|Overall Study|Withdrawal by Subject|1|||
27799445|NCT02081534|54254222|FG005|Overall Study|Withdrawal by Subject|0|||
27799446|NCT02081534|54254223|FG006|Overall Study|Withdrawal by Subject|1|||
27799447|NCT02081534|54254217|FG000|Overall Study|Protocol Violation|0|||
27799448|NCT02081534|54254218|FG001|Overall Study|Protocol Violation|3|||
27799449|NCT02081534|54254219|FG002|Overall Study|Protocol Violation|0|||
27799450|NCT02081534|54254220|FG003|Overall Study|Protocol Violation|0|||
27799451|NCT02081534|54254221|FG004|Overall Study|Protocol Violation|0|||
27799452|NCT02081534|54254222|FG005|Overall Study|Protocol Violation|0|||
27799453|NCT02081534|54254223|FG006|Overall Study|Protocol Violation|1|||
28019388|NCT00636168|54678701|FG000|Randomized to Study Drug|Adverse Event|1|||
28019389|NCT00636168|54678702|FG001|Randomized to Study Drug|Adverse Event|0|||
28019390|NCT00636168|54678701|FG000|Randomized to Study Drug|No longer meets study criteria|1|||
28019391|NCT00636168|54678702|FG001|Randomized to Study Drug|No longer meets study criteria|0|||
28019392|NCT00636168|54678701|FG000|Treated With Study Drug|Recurrence of disease|135|||
28019393|NCT00636168|54678702|FG001|Treated With Study Drug|Recurrence of disease|282|||
28019394|NCT00636168|54678701|FG000|Treated With Study Drug|Adverse Event|250|||
28019395|NCT00636168|54678702|FG001|Treated With Study Drug|Adverse Event|22|||
28019396|NCT00636168|54678701|FG000|Treated With Study Drug|Participant withdrew consent|16|||
28019397|NCT00636168|54678702|FG001|Treated With Study Drug|Participant withdrew consent|21|||
28019398|NCT00636168|54678701|FG000|Treated With Study Drug|Poor/non-compliance|1|||
28019399|NCT00636168|54678702|FG001|Treated With Study Drug|Poor/non-compliance|3|||
28019400|NCT00636168|54678701|FG000|Treated With Study Drug|Death|3|||
28019401|NCT00636168|54678702|FG001|Treated With Study Drug|Death|0|||
28019402|NCT00636168|54678701|FG000|Treated With Study Drug|Pregnancy|1|||
28019403|NCT00636168|54678702|FG001|Treated With Study Drug|Pregnancy|0|||
28019404|NCT00636168|54678701|FG000|Treated With Study Drug|No longer meets study criteria|1|||
28019405|NCT00636168|54678702|FG001|Treated With Study Drug|No longer meets study criteria|0|||
28019406|NCT00636168|54678701|FG000|Treated With Study Drug|Other reason|1|||
28019407|NCT00636168|54678702|FG001|Treated With Study Drug|Other reason|3|||
27799454|NCT02081534|54254217|FG000|Overall Study|Lost to Follow-up|0|||
28019408|NCT00636168|54678701|FG000|Long Term Follow-Up|Lost to Follow-up|3|||
27799455|NCT02081534|54254218|FG001|Overall Study|Lost to Follow-up|0|||
28019409|NCT00636168|54678702|FG001|Long Term Follow-Up|Lost to Follow-up|3|||
28019410|NCT00636168|54678701|FG000|Long Term Follow-Up|Participant withdrew consent|0|||
28019411|NCT00636168|54678702|FG001|Long Term Follow-Up|Participant withdrew consent|2|||
27799456|NCT02081534|54254219|FG002|Overall Study|Lost to Follow-up|0|||
28019412|NCT00636168|54678701|FG000|Long Term Follow-Up|Death|8|||
27799457|NCT02081534|54254220|FG003|Overall Study|Lost to Follow-up|2|||
28019413|NCT00636168|54678702|FG001|Long Term Follow-Up|Death|9|||
28019414|NCT00759941|54678710|FG000|Overall Study|Use of medication|1|||
28019415|NCT00759941|54678711|FG001|Overall Study|Use of medication|0|||
28019416|NCT00759941|54678710|FG000|Overall Study|Adverse Event|1|||
28019417|NCT00759941|54678711|FG001|Overall Study|Adverse Event|0|||
28019418|NCT00759941|54678710|FG000|Overall Study|Exited in error by site|1|||
28019419|NCT00759941|54678711|FG001|Overall Study|Exited in error by site|1|||
28019420|NCT00528424|54678717|FG000|Overall Study|Lost to Follow-up|13|||
28019421|NCT00528424|54678717|FG000|Overall Study|Withdrew consent|2|||
28019422|NCT00528424|54678717|FG000|Overall Study|Administrative reason|2|||
28019423|NCT00528424|54678717|FG000|Overall Study|Other|12|||
28019424|NCT00315445|54678724|FG000|Overall Study|Adverse Event|7|||
28019425|NCT00315445|54678725|FG001|Overall Study|Adverse Event|12|||
28019426|NCT00315445|54678726|FG002|Overall Study|Adverse Event|15|||
28019427|NCT00315445|54678724|FG000|Overall Study|Lack of Efficacy|16|||
28019428|NCT00315445|54678725|FG001|Overall Study|Lack of Efficacy|1|||
28019429|NCT00315445|54678726|FG002|Overall Study|Lack of Efficacy|7|||
28019430|NCT00315445|54678724|FG000|Overall Study|Lost to Follow-up|1|||
28019431|NCT00315445|54678725|FG001|Overall Study|Lost to Follow-up|0|||
28019432|NCT00315445|54678726|FG002|Overall Study|Lost to Follow-up|1|||
28019433|NCT00315445|54678724|FG000|Overall Study|Protocol Violation|2|||
28019434|NCT00315445|54678725|FG001|Overall Study|Protocol Violation|0|||
27799458|NCT02081534|54254221|FG004|Overall Study|Lost to Follow-up|1|||
27799459|NCT02081534|54254222|FG005|Overall Study|Lost to Follow-up|1|||
27799460|NCT02081534|54254223|FG006|Overall Study|Lost to Follow-up|0|||
27799461|NCT02057198|54254242|FG000|Overall Study|Death|0|||
27799462|NCT02057198|54254243|FG001|Overall Study|Death|0|||
27799463|NCT02057198|54254244|FG002|Overall Study|Death|1|||
27799464|NCT02057198|54254242|FG000|Overall Study|Discharged early; lost to followup|0|||
27799465|NCT02057198|54254243|FG001|Overall Study|Discharged early; lost to followup|1|||
27799466|NCT02057198|54254244|FG002|Overall Study|Discharged early; lost to followup|0|||
27799467|NCT02056652|54254254|FG000|Overall Study|Withdrawal by Subject|1|||
27799468|NCT02056652|54254255|FG001|Overall Study|Withdrawal by Subject|0|||
27799469|NCT02056652|54254254|FG000|Overall Study|Lost to Follow-up|0|||
27799470|NCT02056652|54254255|FG001|Overall Study|Lost to Follow-up|3|||
27799471|NCT02056340|54254263|FG000|Overall Study|Lost to Follow-up|5|||
27799472|NCT02056340|54254264|FG001|Overall Study|Lost to Follow-up|5|||
27799473|NCT02056340|54254263|FG000|Overall Study|Withdrawal by Subject|2|||
27799474|NCT02056340|54254264|FG001|Overall Study|Withdrawal by Subject|6|||
27799475|NCT02046122|54254270|FG000|Overall Study|Physician Decision|8|||
27799476|NCT02046122|54254270|FG000|Overall Study|Withdrawal by Subject|1|||
27799477|NCT02080832|54254277|FG000|Overall Study|Excluded from analysis by MRI|9|||
27799478|NCT02080832|54254278|FG001|Overall Study|Excluded from analysis by MRI|10|||
28019435|NCT00315445|54678726|FG002|Overall Study|Protocol Violation|1|||
28019436|NCT00315445|54678724|FG000|Overall Study|Other|1|||
28019437|NCT00315445|54678725|FG001|Overall Study|Other|3|||
28019438|NCT00315445|54678726|FG002|Overall Study|Other|0|||
28019439|NCT03687736|54678734|FG000|Overall Study|Lost to Follow-up|7|||
28019440|NCT03687736|54678734|FG000|Overall Study|Withdrawal by Subject|3|||
28019441|NCT00779675|54678740|FG000|Treatment Period|Adverse Event|87|||
28019442|NCT00779675|54678740|FG000|Treatment Period|Treatment Failure|80|||
28019443|NCT00779675|54678740|FG000|Treatment Period|Transferred to Another Study|38|||
28019444|NCT00779675|54678740|FG000|Treatment Period|Lost to Follow-up|23|||
28019445|NCT00779675|54678740|FG000|Treatment Period|Withdrawal by Subject|46|||
28019446|NCT00779675|54678740|FG000|Treatment Period|Protocol Violation|54|||
28019447|NCT00779675|54678740|FG000|Treatment Period|Did Not Meet Protocol Eligibility|1|||
28019448|NCT00779675|54678740|FG000|Treatment Period|Administrative|3|||
28019449|NCT00779675|54678740|FG000|Extended Treatment Period|Reasons unrelated to study treatment|9|||
28019450|NCT00779675|54678740|FG000|Extended Treatment Period|Protocol Violation|13|||
28019451|NCT00779675|54678740|FG000|Extended Treatment Period|Adverse Event|6|||
28019452|NCT00779675|54678740|FG000|Extended Treatment Period|Treatment Failure|11|||
28019453|NCT00779675|54678740|FG000|Extended Treatment Period|Protocol defined clinical event|1|||
28019454|NCT00779675|54678740|FG000|Extended Treatment Period|Lost to Follow-up|6|||
27799479|NCT02080832|54254279|FG002|Overall Study|Excluded from analysis by MRI|14|||
27799480|NCT02080832|54254277|FG000|Overall Study|Lost to Follow-up|0|||
28019455|NCT00759863|54678750|FG000|Overall Study|Death, moved, or lost contact|20|||
28019456|NCT00759863|54678751|FG001|Overall Study|Death, moved, or lost contact|18|||
28019457|NCT00759785|54678759|FG000|Overall Study|Participant sample not evaluable|11|||
28019458|NCT00759785|54678760|FG001|Overall Study|Participant sample not evaluable|2|||
27799481|NCT02080832|54254278|FG001|Overall Study|Lost to Follow-up|2|||
28019459|NCT00759785|54678759|FG000|Overall Study|Participant sample lost|0|||
28019460|NCT00759785|54678760|FG001|Overall Study|Participant sample lost|1|||
28019461|NCT00759785|54678759|FG000|Overall Study|Protocol Violation|1|||
28019462|NCT00759785|54678760|FG001|Overall Study|Protocol Violation|0|||
28019463|NCT00759785|54678759|FG000|Overall Study|Physician Decision|0|||
27799482|NCT02080832|54254279|FG002|Overall Study|Lost to Follow-up|2|||
27799483|NCT02080364|54254293|FG000|Baseline Period|Protocol Violation|2|||
28019464|NCT00759785|54678760|FG001|Overall Study|Physician Decision|1|||
28019465|NCT00759785|54678759|FG000|Overall Study|Withdrawal by Subject|0|||
28019466|NCT00759785|54678760|FG001|Overall Study|Withdrawal by Subject|1|||
28019467|NCT00300781|54678768|FG000|Overall Study|Disease Progression|55|||
28019468|NCT00300781|54678769|FG001|Overall Study|Disease Progression|52|||
28019469|NCT00300781|54678768|FG000|Overall Study|Adverse Event|5|||
28019470|NCT00300781|54678769|FG001|Overall Study|Adverse Event|6|||
28019471|NCT00300781|54678768|FG000|Overall Study|Withdrawal by Subject|1|||
28019472|NCT00300781|54678769|FG001|Overall Study|Withdrawal by Subject|2|||
28019473|NCT00300781|54678768|FG000|Overall Study|Physician Decision|1|||
28019474|NCT00300781|54678769|FG001|Overall Study|Physician Decision|0|||
28019475|NCT00300781|54678768|FG000|Overall Study|Not Recorded|0|||
28019476|NCT00300781|54678769|FG001|Overall Study|Not Recorded|1|||
28019477|NCT00300781|54678768|FG000|Overall Study|Symptomatic Deterioration|1|||
28019478|NCT00300781|54678769|FG001|Overall Study|Symptomatic Deterioration|0|||
28019479|NCT00300781|54678768|FG000|Overall Study|Lost to Follow-up|0|||
28019480|NCT00300781|54678769|FG001|Overall Study|Lost to Follow-up|1|||
28019481|NCT00315055|54678777|FG000|Overall Study|Protocol Violation|2|||
27799484|NCT02080364|54254294|FG001|Baseline Period|Protocol Violation|1|||
28019482|NCT00315055|54678778|FG001|Overall Study|Protocol Violation|4|||
28019483|NCT00315055|54678777|FG000|Overall Study|Lost to Follow-up|1|||
28019484|NCT00315055|54678778|FG001|Overall Study|Lost to Follow-up|1|||
28019485|NCT00528970|54678790|FG000|Overall Study|Adverse Event|6|||
28019486|NCT00528970|54678791|FG001|Overall Study|Adverse Event|8|||
28019487|NCT00528970|54678792|FG002|Overall Study|Adverse Event|5|||
28019488|NCT00528970|54678790|FG000|Overall Study|Lost to Follow-up|0|||
28019489|NCT00528970|54678791|FG001|Overall Study|Lost to Follow-up|0|||
28019490|NCT00528970|54678792|FG002|Overall Study|Lost to Follow-up|1|||
28019491|NCT00528970|54678790|FG000|Overall Study|Other than specified|2|||
28019492|NCT00528970|54678791|FG001|Overall Study|Other than specified|3|||
28019493|NCT00528970|54678792|FG002|Overall Study|Other than specified|3|||
28019494|NCT00528970|54678790|FG000|Overall Study|Protocol Violation|2|||
28019495|NCT00528970|54678791|FG001|Overall Study|Protocol Violation|1|||
28019496|NCT00528970|54678792|FG002|Overall Study|Protocol Violation|4|||
28019497|NCT00528970|54678790|FG000|Overall Study|Lack of Efficacy|0|||
28019498|NCT00528970|54678791|FG001|Overall Study|Lack of Efficacy|0|||
28019499|NCT00528970|54678792|FG002|Overall Study|Lack of Efficacy|1|||
28019500|NCT00528970|54678790|FG000|Overall Study|Withdrawal by Subject|4|||
28019501|NCT00528970|54678791|FG001|Overall Study|Withdrawal by Subject|3|||
28019502|NCT00528970|54678792|FG002|Overall Study|Withdrawal by Subject|5|||
28019503|NCT00528970|54678790|FG000|Overall Study|Randomized but not treated|0|||
28019504|NCT00528970|54678791|FG001|Overall Study|Randomized but not treated|0|||
28019505|NCT00528970|54678792|FG002|Overall Study|Randomized but not treated|1|||
28019506|NCT00759395|54678802|FG000|Overall Study|Adverse Event|1|||
28019507|NCT00759395|54678803|FG001|Overall Study|Adverse Event|0|||
28019508|NCT00759395|54678802|FG000|Overall Study|Withdrawal by Subject|1|||
27799485|NCT02080364|54254295|FG002|Baseline Period|Protocol Violation|0|||
27799486|NCT02080364|54254296|FG003|Baseline Period|Protocol Violation|0|||
27799487|NCT02080364|54254293|FG000|Baseline Period|Other|0|||
27799488|NCT02080364|54254294|FG001|Baseline Period|Other|1|||
27799489|NCT02080364|54254295|FG002|Baseline Period|Other|1|||
27799490|NCT02080364|54254296|FG003|Baseline Period|Other|0|||
27799491|NCT02080364|54254293|FG000|Treatment Period|Adverse Event|10|||
27799492|NCT02080364|54254294|FG001|Treatment Period|Adverse Event|15|||
27799493|NCT02080364|54254295|FG002|Treatment Period|Adverse Event|11|||
27799494|NCT02080364|54254296|FG003|Treatment Period|Adverse Event|14|||
28019509|NCT00759395|54678803|FG001|Overall Study|Withdrawal by Subject|0|||
27799495|NCT02080364|54254293|FG000|Treatment Period|Lost to Follow-up|2|||
27799496|NCT02080364|54254294|FG001|Treatment Period|Lost to Follow-up|3|||
27799497|NCT02080364|54254295|FG002|Treatment Period|Lost to Follow-up|5|||
28019510|NCT00759395|54678802|FG000|Overall Study|Lack of Efficacy|0|||
28019511|NCT00759395|54678803|FG001|Overall Study|Lack of Efficacy|2|||
28019512|NCT00293293|54678811|FG000|Overall Study|Withdrawal by Subject|1|||
28019513|NCT00293293|54678812|FG001|Overall Study|Withdrawal by Subject|1|||
28019514|NCT00293293|54678811|FG000|Overall Study|"Patient too anxious to complete trial"|1|||
28019515|NCT00293293|54678812|FG001|Overall Study|"Patient too anxious to complete trial"|0|||
28019516|NCT00293293|54678811|FG000|Overall Study|Patient discontinued chemotherapy|0|||
28019517|NCT00293293|54678812|FG001|Overall Study|Patient discontinued chemotherapy|1|||
28019518|NCT04864639|54678819|FG000|Overall Study|Death|1|||
28019519|NCT04864639|54678819|FG000|Overall Study|Lost to Follow-up|1|||
28019520|NCT04245449|54678845|FG000|Overall Study|COVID shutdown|7|||
28019521|NCT03887221|54678855|FG000|Overall Study|Protocol Violation|1|||
27842752|NCT01548404|54331518|FG001|Overall Study|Withdrawal by Subject|3|||
28019522|NCT03887221|54678856|FG001|Overall Study|Protocol Violation|0|||
28019523|NCT02782741|54678876|FG000|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
28019524|NCT02782741|54678877|FG001|Blinded Treatment Period: up to Week 49|Adverse Event|4|||
27799498|NCT02080364|54254296|FG003|Treatment Period|Lost to Follow-up|0|||
28019525|NCT02782741|54678876|FG000|Blinded Treatment Period: up to Week 49|Other|0|||
27799499|NCT02080364|54254293|FG000|Treatment Period|Protocol Violation|5|||
27799500|NCT02080364|54254294|FG001|Treatment Period|Protocol Violation|3|||
27799501|NCT02080364|54254295|FG002|Treatment Period|Protocol Violation|5|||
27799502|NCT02080364|54254296|FG003|Treatment Period|Protocol Violation|1|||
27799503|NCT02080364|54254293|FG000|Treatment Period|Withdrawal by Subject|16|||
27799504|NCT02080364|54254294|FG001|Treatment Period|Withdrawal by Subject|16|||
27799505|NCT02080364|54254295|FG002|Treatment Period|Withdrawal by Subject|15|||
27799506|NCT02080364|54254296|FG003|Treatment Period|Withdrawal by Subject|10|||
27799507|NCT02080364|54254293|FG000|Treatment Period|Study Terminated by Sponsor|0|||
27799508|NCT02080364|54254294|FG001|Treatment Period|Study Terminated by Sponsor|0|||
27799509|NCT02080364|54254295|FG002|Treatment Period|Study Terminated by Sponsor|180|||
27799510|NCT02080364|54254296|FG003|Treatment Period|Study Terminated by Sponsor|183|||
27799511|NCT02080364|54254293|FG000|Treatment Period|Other|14|||
27799512|NCT02080364|54254294|FG001|Treatment Period|Other|12|||
27799513|NCT02080364|54254295|FG002|Treatment Period|Other|21|||
27799514|NCT02080364|54254296|FG003|Treatment Period|Other|16|||
27799515|NCT02079038|54254308|FG000|Modified Intent to Treat Population|Withdrawal by Subject|6|||
27799516|NCT02079038|54254309|FG001|Modified Intent to Treat Population|Withdrawal by Subject|5|||
27799517|NCT02079038|54254308|FG000|Modified Intent to Treat Population|Death|1|||
27799518|NCT02079038|54254309|FG001|Modified Intent to Treat Population|Death|0|||
27799519|NCT02079038|54254308|FG000|Completed 6 Months|Lost to Follow-up|2|||
27799520|NCT02079038|54254309|FG001|Completed 6 Months|Lost to Follow-up|1|||
27799521|NCT02045732|54254317|FG000|Overall Study|At the discretion of the investigator|1|||
27799522|NCT02045732|54254318|FG001|Overall Study|At the discretion of the investigator|1|||
27799523|NCT02044874|54254327|FG000|Overall Study|Adverse Event|5|||
27799524|NCT02044874|54254328|FG001|Overall Study|Adverse Event|6|||
27799525|NCT02044874|54254329|FG002|Overall Study|Adverse Event|6|||
27799526|NCT02044874|54254327|FG000|Overall Study|Withdrawal by Subject|8|||
27799527|NCT02044874|54254328|FG001|Overall Study|Withdrawal by Subject|16|||
27799528|NCT02044874|54254329|FG002|Overall Study|Withdrawal by Subject|23|||
27799529|NCT02044874|54254327|FG000|Overall Study|Physician Decision|0|||
27799530|NCT02044874|54254328|FG001|Overall Study|Physician Decision|2|||
27799531|NCT02044874|54254329|FG002|Overall Study|Physician Decision|1|||
27799532|NCT02044874|54254327|FG000|Overall Study|Lost to Follow-up|10|||
28019526|NCT02782741|54678877|FG001|Blinded Treatment Period: up to Week 49|Other|1|||
28019527|NCT02782741|54678876|FG000|Open-label Long-term: Week 50 to 145|Adverse Event|2|||
28019528|NCT02782741|54678877|FG001|Open-label Long-term: Week 50 to 145|Adverse Event|1|||
28019529|NCT02782741|54678876|FG000|Open-label Long-term: Week 50 to 145|Other|1|||
28019530|NCT02782741|54678877|FG001|Open-label Long-term: Week 50 to 145|Other|0|||
28019531|NCT02782741|54678876|FG000|Open-label Long-term: Week 50 to 145|Ongoing|48|||
28019532|NCT02782741|54678877|FG001|Open-label Long-term: Week 50 to 145|Ongoing|43|||
28019533|NCT02771626|54678893|FG000|Overall Study|Adverse Event|1|||
28019534|NCT02771626|54678894|FG001|Overall Study|Adverse Event|5|||
28019535|NCT02771626|54678895|FG002|Overall Study|Adverse Event|3|||
28019536|NCT02771626|54678896|FG003|Overall Study|Adverse Event|0|||
28019537|NCT02771626|54678897|FG004|Overall Study|Adverse Event|1|||
28019538|NCT02771626|54678898|FG005|Overall Study|Adverse Event|1|||
28019539|NCT02771626|54678893|FG000|Overall Study|Radiologic Disease Progression|6|||
28019540|NCT02771626|54678894|FG001|Overall Study|Radiologic Disease Progression|13|||
28019541|NCT02771626|54678895|FG002|Overall Study|Radiologic Disease Progression|10|||
28019542|NCT02771626|54678896|FG003|Overall Study|Radiologic Disease Progression|7|||
28019543|NCT02771626|54678897|FG004|Overall Study|Radiologic Disease Progression|28|||
28019544|NCT02771626|54678898|FG005|Overall Study|Radiologic Disease Progression|15|||
27799533|NCT02044874|54254328|FG001|Overall Study|Lost to Follow-up|27|||
27799534|NCT02044874|54254329|FG002|Overall Study|Lost to Follow-up|21|||
27799535|NCT02044874|54254327|FG000|Overall Study|Sponsor Decision|0|||
27799536|NCT02044874|54254328|FG001|Overall Study|Sponsor Decision|1|||
27799537|NCT02044874|54254329|FG002|Overall Study|Sponsor Decision|1|||
27799538|NCT02044874|54254327|FG000|Overall Study|Other|7|||
27799539|NCT02044874|54254328|FG001|Overall Study|Other|3|||
27799540|NCT02044874|54254329|FG002|Overall Study|Other|8|||
27799541|NCT02078960|54254342|FG000|Treatment Period|Other|0|||
27799542|NCT02078960|54254343|FG001|Treatment Period|Other|0|||
28019545|NCT02771626|54678893|FG000|Overall Study|Symptomatic Deterioration|0|||
28019546|NCT02771626|54678894|FG001|Overall Study|Symptomatic Deterioration|4|||
28019547|NCT02771626|54678895|FG002|Overall Study|Symptomatic Deterioration|2|||
28019548|NCT02771626|54678896|FG003|Overall Study|Symptomatic Deterioration|0|||
28019549|NCT02771626|54678897|FG004|Overall Study|Symptomatic Deterioration|5|||
28019550|NCT02771626|54678898|FG005|Overall Study|Symptomatic Deterioration|2|||
28019551|NCT02771626|54678893|FG000|Overall Study|Participant Request|0|||
28019552|NCT02771626|54678894|FG001|Overall Study|Participant Request|1|||
28019553|NCT02771626|54678895|FG002|Overall Study|Participant Request|0|||
28019554|NCT02771626|54678896|FG003|Overall Study|Participant Request|2|||
27799543|NCT02078960|54254344|FG002|Treatment Period|Other|1|||
27799544|NCT02078960|54254342|FG000|Treatment Period|Lack of Efficacy|0|||
27799545|NCT02078960|54254343|FG001|Treatment Period|Lack of Efficacy|1|||
27799546|NCT02078960|54254344|FG002|Treatment Period|Lack of Efficacy|0|||
27799547|NCT02078960|54254342|FG000|Treatment Period|Disease progression - accelerated phase|0|||
27799548|NCT02078960|54254343|FG001|Treatment Period|Disease progression - accelerated phase|1|||
27799549|NCT02078960|54254344|FG002|Treatment Period|Disease progression - accelerated phase|0|||
27799550|NCT02078960|54254342|FG000|Treatment Period|Disease progression - blast phase|1|||
27799551|NCT02078960|54254343|FG001|Treatment Period|Disease progression - blast phase|0|||
27799552|NCT02078960|54254344|FG002|Treatment Period|Disease progression - blast phase|0|||
27799553|NCT02078960|54254342|FG000|Treatment Period|Withdrawal by Subject|0|||
27799554|NCT02078960|54254343|FG001|Treatment Period|Withdrawal by Subject|1|||
27799555|NCT02078960|54254344|FG002|Treatment Period|Withdrawal by Subject|1|||
28019555|NCT02771626|54678897|FG004|Overall Study|Participant Request|0|||
28019556|NCT02771626|54678898|FG005|Overall Study|Participant Request|1|||
28019557|NCT02771626|54678893|FG000|Overall Study|Investigator Decision|0|||
28019558|NCT02771626|54678894|FG001|Overall Study|Investigator Decision|1|||
28019559|NCT02771626|54678895|FG002|Overall Study|Investigator Decision|0|||
28019560|NCT02771626|54678896|FG003|Overall Study|Investigator Decision|0|||
28019561|NCT02771626|54678897|FG004|Overall Study|Investigator Decision|1|||
28019562|NCT02771626|54678898|FG005|Overall Study|Investigator Decision|0|||
28019563|NCT02771626|54678893|FG000|Overall Study|Study Termination by Sponsor|0|||
28019564|NCT02771626|54678894|FG001|Overall Study|Study Termination by Sponsor|2|||
28019565|NCT02771626|54678895|FG002|Overall Study|Study Termination by Sponsor|1|||
28019566|NCT02771626|54678896|FG003|Overall Study|Study Termination by Sponsor|0|||
28019567|NCT02771626|54678897|FG004|Overall Study|Study Termination by Sponsor|1|||
28019568|NCT02771626|54678898|FG005|Overall Study|Study Termination by Sponsor|0|||
28019569|NCT02771626|54678893|FG000|Overall Study|Informed Consent Withdrawn|0|||
28019570|NCT02771626|54678894|FG001|Overall Study|Informed Consent Withdrawn|0|||
28019571|NCT02771626|54678895|FG002|Overall Study|Informed Consent Withdrawn|1|||
28019572|NCT02771626|54678896|FG003|Overall Study|Informed Consent Withdrawn|0|||
28019573|NCT02771626|54678897|FG004|Overall Study|Informed Consent Withdrawn|1|||
28019574|NCT02771626|54678898|FG005|Overall Study|Informed Consent Withdrawn|1|||
28019575|NCT02771626|54678893|FG000|Overall Study|Other, Not Specified|1|||
28019576|NCT02771626|54678894|FG001|Overall Study|Other, Not Specified|0|||
28019577|NCT02771626|54678895|FG002|Overall Study|Other, Not Specified|0|||
28019578|NCT02771626|54678896|FG003|Overall Study|Other, Not Specified|0|||
28019579|NCT02771626|54678897|FG004|Overall Study|Other, Not Specified|0|||
28019580|NCT02771626|54678898|FG005|Overall Study|Other, Not Specified|1|||
28019581|NCT02272790|54678918|FG000|Overall Study|Physician Decision|0|||
28019582|NCT02272790|54678919|FG001|Overall Study|Physician Decision|1|||
28019583|NCT02272790|54678920|FG002|Overall Study|Physician Decision|0|||
28019584|NCT02272790|54678921|FG003|Overall Study|Physician Decision|0|||
28019585|NCT02272790|54678922|FG004|Overall Study|Physician Decision|0|||
28019586|NCT02272790|54678923|FG005|Overall Study|Physician Decision|0|||
27799556|NCT02078960|54254342|FG000|Treatment Period|Adverse Event|1|||
27799557|NCT02078960|54254343|FG001|Treatment Period|Adverse Event|0|||
27799558|NCT02078960|54254344|FG002|Treatment Period|Adverse Event|0|||
27799559|NCT02078960|54254342|FG000|Treatment Period|Death|0|||
27799560|NCT02078960|54254343|FG001|Treatment Period|Death|0|||
27799561|NCT02078960|54254344|FG002|Treatment Period|Death|1|||
27799562|NCT02078960|54254342|FG000|Follow-up Period|Death|2|||
27799563|NCT02078960|54254343|FG001|Follow-up Period|Death|0|||
27799564|NCT02078960|54254344|FG002|Follow-up Period|Death|0|||
27799565|NCT02078960|54254342|FG000|Follow-up Period|Lost to Follow-up|0|||
27799566|NCT02078960|54254343|FG001|Follow-up Period|Lost to Follow-up|1|||
27799567|NCT02078960|54254344|FG002|Follow-up Period|Lost to Follow-up|0|||
27799568|NCT02078102|54254356|FG000|Overall Study|Adverse Event|1|||
27799569|NCT02078102|54254357|FG001|Overall Study|Adverse Event|0|||
27799570|NCT02078102|54254356|FG000|Overall Study|Withdrawal by Subject|1|||
27799571|NCT02078102|54254357|FG001|Overall Study|Withdrawal by Subject|0|||
27799572|NCT02078102|54254356|FG000|Overall Study|Physician Decision|0|||
27799573|NCT02078102|54254357|FG001|Overall Study|Physician Decision|1|||
28019587|NCT01464164|54678950|FG000|Overall Study|Screen failure|0|||
27799574|NCT02054702|54254366|FG000|Overall Study|Lost to Follow-up|3|||
27799575|NCT02054702|54254367|FG001|Overall Study|Lost to Follow-up|5|||
27799576|NCT02054702|54254366|FG000|Overall Study|Adverse Event|3|||
27799577|NCT02054702|54254367|FG001|Overall Study|Adverse Event|1|||
28019588|NCT01464164|54678951|FG001|Overall Study|Screen failure|1|||
28019589|NCT01464164|54678952|FG002|Overall Study|Screen failure|2|||
28019590|NCT01464164|54678953|FG003|Overall Study|Screen failure|0|||
28019591|NCT01464164|54678954|FG004|Overall Study|Screen failure|0|||
28019592|NCT01464164|54678955|FG005|Overall Study|Screen failure|0|||
28019593|NCT01464164|54678956|FG006|Overall Study|Screen failure|0|||
28019594|NCT01464164|54678950|FG000|Overall Study|Physician Decision|0|||
28019595|NCT01464164|54678951|FG001|Overall Study|Physician Decision|1|||
28019596|NCT01464164|54678952|FG002|Overall Study|Physician Decision|0|||
27799578|NCT02054702|54254366|FG000|Overall Study|Met Withdrawal Criteria|4|||
27799579|NCT02054702|54254367|FG001|Overall Study|Met Withdrawal Criteria|1|||
28019597|NCT01464164|54678953|FG003|Overall Study|Physician Decision|0|||
27799580|NCT02054702|54254366|FG000|Overall Study|Physician Decision|0|||
27799581|NCT02054702|54254367|FG001|Overall Study|Physician Decision|1|||
27799582|NCT02054702|54254366|FG000|Overall Study|Withdrawal by Subject|14|||
27799583|NCT02054702|54254367|FG001|Overall Study|Withdrawal by Subject|4|||
27799584|NCT02044094|54254373|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3|||
27799585|NCT02044094|54254373|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3|||
27799586|NCT02044094|54254373|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3|||
27799587|NCT02044094|54254373|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4|||
27799588|NCT02044094|54254373|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5|||
27799589|NCT02044094|54254373|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2|||
27799590|NCT02044094|54254373|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1|||
27799591|NCT02044094|54254373|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1|||
27799592|NCT02043938|54254388|FG000|Overall Study|Withdrawal by Subject|7|||
27799593|NCT02043938|54254388|FG000|Overall Study|Unable to place EEG sensors on patient|1|||
27799594|NCT02043938|54254388|FG000|Overall Study|No show by subject|1|||
27799595|NCT02043938|54254388|FG000|Overall Study|Investigator decision|1|||
27799596|NCT02053610|54254397|FG000|Overall Study|Adverse Event/Intercurrent Illness|25|||
27799597|NCT02053610|54254398|FG001|Overall Study|Adverse Event/Intercurrent Illness|43|||
27799598|NCT02053610|54254397|FG000|Overall Study|Withdrew Consent|2|||
27799599|NCT02053610|54254398|FG001|Overall Study|Withdrew Consent|9|||
27799600|NCT02053610|54254397|FG000|Overall Study|Death|5|||
27799601|NCT02053610|54254398|FG001|Overall Study|Death|5|||
27799602|NCT02053610|54254397|FG000|Overall Study|Administrative/Other|1|||
27799603|NCT02053610|54254398|FG001|Overall Study|Administrative/Other|1|||
27799604|NCT02053610|54254397|FG000|Overall Study|Disease Progression|2|||
27799605|NCT02053610|54254398|FG001|Overall Study|Disease Progression|3|||
27799606|NCT02053610|54254397|FG000|Overall Study|Refused treatment/Did not cooperate|1|||
27799607|NCT02053610|54254398|FG001|Overall Study|Refused treatment/Did not cooperate|3|||
27799608|NCT02053610|54254397|FG000|Overall Study|Did not Receive Treatment|4|||
27799609|NCT02053610|54254398|FG001|Overall Study|Did not Receive Treatment|2|||
27799610|NCT02053610|54254397|FG000|Overall Study|Insufficient Therapeutic Response|1|||
27799611|NCT02053610|54254398|FG001|Overall Study|Insufficient Therapeutic Response|1|||
27799612|NCT02053610|54254397|FG000|Overall Study|Violation of Selection Criteria|1|||
27799613|NCT02053610|54254398|FG001|Overall Study|Violation of Selection Criteria|0|||
27799614|NCT02075606|54254404|FG000|Overall Study|Adverse Event|5|||
27799615|NCT02075606|54254404|FG000|Overall Study|Withdrawal by Subject|1|||
27799616|NCT02075606|54254404|FG000|Overall Study|Death|1|||
27799617|NCT02075606|54254404|FG000|Overall Study|Investigator's decision|1|||
27799618|NCT02075606|54254404|FG000|Overall Study|Symptom management|1|||
27799619|NCT02075606|54254404|FG000|Overall Study|Increasing Symptoms|1|||
27799620|NCT02043782|54254413|FG000|Period 1|Adverse Event|0|||
27799621|NCT02043782|54254414|FG001|Period 1|Adverse Event|0|||
27799622|NCT02043782|54254415|FG002|Period 1|Adverse Event|1|||
27799623|NCT02043782|54254416|FG003|Period 1|Adverse Event|0|||
27799624|NCT02043782|54254417|FG004|Period 1|Adverse Event|0|||
27799625|NCT02043782|54254418|FG005|Period 1|Adverse Event|0|||
27799626|NCT02052596|54254428|FG000|Active Phase|Adverse Event|3|||
27799627|NCT02052596|54254429|FG001|Active Phase|Adverse Event|2|||
27799628|NCT02052596|54254428|FG000|Active Phase|Lost to Follow-up|8|||
27799629|NCT02052596|54254429|FG001|Active Phase|Lost to Follow-up|11|||
27799630|NCT02052596|54254428|FG000|Active Phase|Protocol Violation|1|||
27799631|NCT02052596|54254429|FG001|Active Phase|Protocol Violation|2|||
27799632|NCT02052596|54254428|FG000|Active Phase|Withdrawal by Subject|3|||
27799633|NCT02052596|54254429|FG001|Active Phase|Withdrawal by Subject|4|||
27799634|NCT02052596|54254428|FG000|Active Phase|Enrolled in error|1|||
27799635|NCT02052596|54254429|FG001|Active Phase|Enrolled in error|0|||
27799636|NCT02052596|54254428|FG000|Active Phase|Lost due to Crohn's disease|0|||
28019598|NCT01464164|54678954|FG004|Overall Study|Physician Decision|0|||
28019599|NCT01464164|54678955|FG005|Overall Study|Physician Decision|0|||
28019600|NCT01464164|54678956|FG006|Overall Study|Physician Decision|2|||
28019601|NCT01377389|54678972|FG000|Overall Study|Withdrawal by Subject|1|||
28019602|NCT01377389|54678972|FG000|Overall Study|Screen failure|2|||
28019603|NCT01194271|54678976|FG000|Overall Study|Withdrawal by Subject|1|||
28019604|NCT01194271|54678976|FG000|Overall Study|Ineligible, Screen Failure|1|||
28019605|NCT01194271|54678976|FG000|Overall Study|Death|1|||
28019606|NCT01119508|54678980|FG000|Overall Study|Adverse Event|56|||
27799637|NCT02052596|54254429|FG001|Active Phase|Lost due to Crohn's disease|1|||
28019607|NCT01119508|54678980|FG000|Overall Study|Withdrawal by Subject|2|||
28019608|NCT01119508|54678980|FG000|Overall Study|Died before tumor response evaluation|1|||
28019609|NCT00568776|54679011|FG000|Overall Study|Adverse Event|8|||
28019610|NCT00568776|54679012|FG001|Overall Study|Adverse Event|8|||
27799638|NCT02052596|54254428|FG000|Safety Phase|Adverse Event|6|||
27799639|NCT02052596|54254429|FG001|Safety Phase|Adverse Event|3|||
27799640|NCT02052596|54254428|FG000|Safety Phase|Lost to Follow-up|11|||
27799641|NCT02052596|54254429|FG001|Safety Phase|Lost to Follow-up|18|||
27799642|NCT02052596|54254428|FG000|Safety Phase|Protocol Violation|1|||
28019611|NCT00568776|54679013|FG002|Overall Study|Adverse Event|10|||
28019612|NCT00568776|54679014|FG003|Overall Study|Adverse Event|8|||
28019613|NCT00568776|54679011|FG000|Overall Study|Death|0|||
28019614|NCT00568776|54679012|FG001|Overall Study|Death|1|||
28019615|NCT00568776|54679013|FG002|Overall Study|Death|4|||
28019616|NCT00568776|54679014|FG003|Overall Study|Death|3|||
28019617|NCT00568776|54679011|FG000|Overall Study|Physician Decision|0|||
28019618|NCT00568776|54679012|FG001|Overall Study|Physician Decision|2|||
28019619|NCT00568776|54679013|FG002|Overall Study|Physician Decision|0|||
28019620|NCT00568776|54679014|FG003|Overall Study|Physician Decision|0|||
28019621|NCT00568776|54679011|FG000|Overall Study|Lack of Efficacy|2|||
28019622|NCT00568776|54679012|FG001|Overall Study|Lack of Efficacy|2|||
28019623|NCT00568776|54679013|FG002|Overall Study|Lack of Efficacy|2|||
28019624|NCT00568776|54679014|FG003|Overall Study|Lack of Efficacy|4|||
28019625|NCT00568776|54679011|FG000|Overall Study|Lost to Follow-up|1|||
28019626|NCT00568776|54679012|FG001|Overall Study|Lost to Follow-up|1|||
28019627|NCT00568776|54679013|FG002|Overall Study|Lost to Follow-up|1|||
28019628|NCT00568776|54679014|FG003|Overall Study|Lost to Follow-up|1|||
28019629|NCT00568776|54679011|FG000|Overall Study|Protocol Violation|1|||
28019630|NCT00568776|54679012|FG001|Overall Study|Protocol Violation|0|||
28019631|NCT00568776|54679013|FG002|Overall Study|Protocol Violation|1|||
28019632|NCT00568776|54679014|FG003|Overall Study|Protocol Violation|1|||
28019633|NCT00568776|54679011|FG000|Overall Study|Withdrawal by Subject|13|||
28019634|NCT00568776|54679012|FG001|Overall Study|Withdrawal by Subject|15|||
28019635|NCT00568776|54679013|FG002|Overall Study|Withdrawal by Subject|13|||
28019636|NCT00568776|54679014|FG003|Overall Study|Withdrawal by Subject|7|||
28019637|NCT00568776|54679011|FG000|Overall Study|Loss of Caregiver|0|||
28019638|NCT00568776|54679012|FG001|Overall Study|Loss of Caregiver|2|||
28019639|NCT00568776|54679013|FG002|Overall Study|Loss of Caregiver|1|||
28019640|NCT00568776|54679014|FG003|Overall Study|Loss of Caregiver|2|||
28019641|NCT00568776|54679011|FG000|Overall Study|Sponsor Decision|2|||
27799643|NCT02052596|54254429|FG001|Safety Phase|Protocol Violation|2|||
27799644|NCT02052596|54254428|FG000|Safety Phase|Withdrawal by Subject|8|||
27799645|NCT02052596|54254429|FG001|Safety Phase|Withdrawal by Subject|11|||
27799646|NCT02052596|54254428|FG000|Safety Phase|Enrolled in error|1|||
27799647|NCT02052596|54254429|FG001|Safety Phase|Enrolled in error|0|||
27799648|NCT02052596|54254428|FG000|Safety Phase|Lost due to Crohn's disease|0|||
27799649|NCT02052596|54254429|FG001|Safety Phase|Lost due to Crohn's disease|1|||
27799650|NCT02052440|54254437|FG000|Overall Study|Withdrawal by Subject|0|||
27799651|NCT02052440|54254438|FG001|Overall Study|Withdrawal by Subject|1|||
27799652|NCT02049944|54254444|FG000|Overall Study|Protocol Violation|2|||
27799653|NCT02043548|54254450|FG000|Overall Study|Lack of Efficacy|1|||
27799654|NCT02043548|54254451|FG001|Overall Study|Lack of Efficacy|0|||
27799655|NCT02043548|54254450|FG000|Overall Study|Adverse Event|0|||
27799656|NCT02043548|54254451|FG001|Overall Study|Adverse Event|1|||
27799657|NCT01622348|54254460|FG000|Overall Study|Withdrawal by Subject|1|||
27799658|NCT01622348|54254461|FG001|Overall Study|Withdrawal by Subject|0|||
27799659|NCT01622348|54254462|FG002|Overall Study|Withdrawal by Subject|1|||
27799660|NCT01621880|54254472|FG000|Overall Study|Adverse Event|5|||
27799661|NCT01621880|54254473|FG001|Overall Study|Adverse Event|1|||
27799662|NCT01621880|54254472|FG000|Overall Study|Withdrawal by Subject|5|||
27799663|NCT01621880|54254473|FG001|Overall Study|Withdrawal by Subject|4|||
28019642|NCT00568776|54679012|FG001|Overall Study|Sponsor Decision|2|||
28019643|NCT00568776|54679013|FG002|Overall Study|Sponsor Decision|41|||
28019644|NCT00568776|54679014|FG003|Overall Study|Sponsor Decision|42|||
28019645|NCT00568776|54679011|FG000|Overall Study|Miscellaeneous|3|||
28019646|NCT00568776|54679012|FG001|Overall Study|Miscellaeneous|3|||
28019647|NCT00568776|54679013|FG002|Overall Study|Miscellaeneous|1|||
27799664|NCT01621802|54254486|FG000|Overall Study|Protocol Violation|0|||
27799665|NCT01621802|54254487|FG001|Overall Study|Protocol Violation|0|||
27799666|NCT01621802|54254488|FG002|Overall Study|Protocol Violation|0|||
27799667|NCT01621802|54254489|FG003|Overall Study|Protocol Violation|0|||
27799668|NCT01621802|54254490|FG004|Overall Study|Protocol Violation|0|||
28019648|NCT00568776|54679014|FG003|Overall Study|Miscellaeneous|4|||
28019649|NCT00758771|54679026|FG000|Overall Study|Withdrawal by Subject|1|||
27799669|NCT01621802|54254491|FG005|Overall Study|Protocol Violation|1|||
27799670|NCT01621802|54254486|FG000|Overall Study|Withdrawal by Subject|8|||
28019650|NCT00758771|54679027|FG001|Overall Study|Withdrawal by Subject|1|||
28019651|NCT00758771|54679026|FG000|Overall Study|Did not meet eligibility criteria|2|||
28019652|NCT00758771|54679027|FG001|Overall Study|Did not meet eligibility criteria|4|||
28019653|NCT00635154|54679033|FG000|Overall Study|Alternative Treatment|8|||
27799671|NCT01621802|54254487|FG001|Overall Study|Withdrawal by Subject|4|||
27799672|NCT01621802|54254488|FG002|Overall Study|Withdrawal by Subject|4|||
28019654|NCT00635154|54679033|FG000|Overall Study|Other|4|||
28019655|NCT00635154|54679033|FG000|Overall Study|Still on treatment|21|||
28019656|NCT00778895|54679042|FG000|Active Phase|Adverse Event|3|||
28019657|NCT00778895|54679043|FG001|Active Phase|Adverse Event|1|||
28019658|NCT00778895|54679044|FG002|Active Phase|Adverse Event|0|||
28019659|NCT00778895|54679042|FG000|Active Phase|Withdrawal by Subject|1|||
27799673|NCT01621802|54254489|FG003|Overall Study|Withdrawal by Subject|2|||
28019660|NCT00778895|54679043|FG001|Active Phase|Withdrawal by Subject|4|||
28019661|NCT00778895|54679044|FG002|Active Phase|Withdrawal by Subject|0|||
28019662|NCT00778895|54679042|FG000|Active Phase|Lost to Follow-up|1|||
28019663|NCT00778895|54679043|FG001|Active Phase|Lost to Follow-up|1|||
27799674|NCT01621802|54254490|FG004|Overall Study|Withdrawal by Subject|2|||
27799675|NCT01621802|54254491|FG005|Overall Study|Withdrawal by Subject|0|||
27799676|NCT01621802|54254486|FG000|Overall Study|Migrated/moved from study area|0|||
27799677|NCT01621802|54254487|FG001|Overall Study|Migrated/moved from study area|0|||
27799678|NCT01621802|54254488|FG002|Overall Study|Migrated/moved from study area|2|||
27799679|NCT01621802|54254489|FG003|Overall Study|Migrated/moved from study area|0|||
27799680|NCT01621802|54254490|FG004|Overall Study|Migrated/moved from study area|1|||
27799681|NCT01621802|54254491|FG005|Overall Study|Migrated/moved from study area|0|||
27799682|NCT01621802|54254486|FG000|Overall Study|Others|3|||
27799683|NCT01621802|54254487|FG001|Overall Study|Others|3|||
27799684|NCT01621802|54254488|FG002|Overall Study|Others|3|||
27799685|NCT01621802|54254489|FG003|Overall Study|Others|2|||
27799686|NCT01621802|54254490|FG004|Overall Study|Others|1|||
27799687|NCT01621802|54254491|FG005|Overall Study|Others|0|||
27799688|NCT01621802|54254486|FG000|Overall Study|Lost to Follow-up|36|||
27799689|NCT01621802|54254487|FG001|Overall Study|Lost to Follow-up|16|||
27799690|NCT01621802|54254488|FG002|Overall Study|Lost to Follow-up|24|||
27799691|NCT01621802|54254489|FG003|Overall Study|Lost to Follow-up|7|||
27799692|NCT01621802|54254490|FG004|Overall Study|Lost to Follow-up|31|||
27799693|NCT01621802|54254491|FG005|Overall Study|Lost to Follow-up|11|||
27799694|NCT02059291|54254517|FG000|Epoch 2|Lack of Efficacy|0|||
27799695|NCT02059291|54254518|FG001|Epoch 2|Lack of Efficacy|0|||
27799696|NCT02059291|54254519|FG002|Epoch 2|Lack of Efficacy|0|||
27799697|NCT02059291|54254520|FG003|Epoch 2|Lack of Efficacy|1|||
27799698|NCT02059291|54254521|FG004|Epoch 2|Lack of Efficacy|0|||
27799699|NCT02059291|54254522|FG005|Epoch 2|Lack of Efficacy|1|||
27799700|NCT02059291|54254523|FG006|Epoch 2|Lack of Efficacy|0|||
27799701|NCT02059291|54254524|FG007|Epoch 2|Lack of Efficacy|0|||
27799702|NCT02059291|54254525|FG008|Epoch 2|Lack of Efficacy|0|||
27799703|NCT02059291|54254526|FG009|Epoch 2|Lack of Efficacy|0|||
28019664|NCT00778895|54679044|FG002|Active Phase|Lost to Follow-up|0|||
28019665|NCT00778895|54679042|FG000|Active Phase|Other|2|||
28019666|NCT00778895|54679043|FG001|Active Phase|Other|0|||
27799704|NCT02059291|54254527|FG010|Epoch 2|Lack of Efficacy|0|||
27799705|NCT02059291|54254528|FG011|Epoch 2|Lack of Efficacy|0|||
27799706|NCT02059291|54254529|FG012|Epoch 2|Lack of Efficacy|0|||
27799707|NCT02059291|54254530|FG013|Epoch 2|Lack of Efficacy|0|||
28019667|NCT00778895|54679044|FG002|Active Phase|Other|0|||
27799708|NCT02059291|54254531|FG014|Epoch 2|Lack of Efficacy|0|||
27799709|NCT02059291|54254532|FG015|Epoch 2|Lack of Efficacy|0|||
27799710|NCT02059291|54254533|FG016|Epoch 2|Lack of Efficacy|0|||
27799711|NCT02059291|54254534|FG017|Epoch 2|Lack of Efficacy|0|||
27799712|NCT02059291|54254535|FG018|Epoch 2|Lack of Efficacy|0|||
27799713|NCT02059291|54254536|FG019|Epoch 2|Lack of Efficacy|0|||
27799714|NCT02059291|54254537|FG020|Epoch 2|Lack of Efficacy|0|||
27799715|NCT02059291|54254538|FG021|Epoch 2|Lack of Efficacy|0|||
27799716|NCT02059291|54254539|FG022|Epoch 2|Lack of Efficacy|0|||
28019668|NCT00778895|54679042|FG000|ESFU Phase|Adverse Event|2|||
28019669|NCT00778895|54679043|FG001|ESFU Phase|Adverse Event|1|||
28019670|NCT00778895|54679044|FG002|ESFU Phase|Adverse Event|0|||
28019671|NCT00778895|54679042|FG000|ESFU Phase|Withdrawal by Subject|1|||
28019672|NCT00778895|54679043|FG001|ESFU Phase|Withdrawal by Subject|4|||
27799717|NCT02059291|54254540|FG023|Epoch 2|Lack of Efficacy|0|||
27799718|NCT02059291|54254541|FG024|Epoch 2|Lack of Efficacy|0|||
27799719|NCT02059291|54254517|FG000|Epoch 2|Adverse Event|0|||
27799720|NCT02059291|54254518|FG001|Epoch 2|Adverse Event|0|||
28019673|NCT00778895|54679044|FG002|ESFU Phase|Withdrawal by Subject|0|||
28019674|NCT00778895|54679042|FG000|ESFU Phase|Lost to Follow-up|6|||
28019675|NCT00778895|54679043|FG001|ESFU Phase|Lost to Follow-up|7|||
28019676|NCT00778895|54679044|FG002|ESFU Phase|Lost to Follow-up|2|||
28019677|NCT00778895|54679042|FG000|ESFU Phase|Other|2|||
28019678|NCT00778895|54679043|FG001|ESFU Phase|Other|0|||
28019679|NCT00778895|54679044|FG002|ESFU Phase|Other|0|||
28019680|NCT00293215|54679055|FG000|Overall Study|Progressive disease|3|||
28019681|NCT00293215|54679056|FG001|Overall Study|Progressive disease|1|||
28019682|NCT00293215|54679055|FG000|Overall Study|Adverse Event|2|||
28019683|NCT00293215|54679056|FG001|Overall Study|Adverse Event|2|||
28019684|NCT00778817|54679062|FG000|Overall Study|Adverse Event|2|||
28019685|NCT00778817|54679062|FG000|Overall Study|Withdrawal by Subject|2|||
28019686|NCT00293059|54679068|FG000|Overall Study|Adverse Event|12|||
28019687|NCT00293059|54679069|FG001|Overall Study|Adverse Event|4|||
28019688|NCT00293059|54679068|FG000|Overall Study|Lack of Efficacy|2|||
28019689|NCT00293059|54679069|FG001|Overall Study|Lack of Efficacy|0|||
28019690|NCT00293059|54679068|FG000|Overall Study|Lost to Follow-up|2|||
28019691|NCT00293059|54679069|FG001|Overall Study|Lost to Follow-up|3|||
28019692|NCT00293059|54679068|FG000|Overall Study|Pregnancy|1|||
28019693|NCT00293059|54679069|FG001|Overall Study|Pregnancy|1|||
28019694|NCT00293059|54679068|FG000|Overall Study|Protocol Violation|2|||
28019695|NCT00293059|54679069|FG001|Overall Study|Protocol Violation|0|||
28019696|NCT00293059|54679068|FG000|Overall Study|Withdrawal by Subject|11|||
28019697|NCT00293059|54679069|FG001|Overall Study|Withdrawal by Subject|5|||
28019698|NCT00293059|54679068|FG000|Overall Study|Participant moved out of state|1|||
28019699|NCT00293059|54679069|FG001|Overall Study|Participant moved out of state|0|||
28019700|NCT00293059|54679068|FG000|Overall Study|Participant stopped study drug|1|||
28019701|NCT00293059|54679069|FG001|Overall Study|Participant stopped study drug|0|||
28019702|NCT00293059|54679068|FG000|Overall Study|Noncompliant - sanitary pads collection|0|||
27799721|NCT02059291|54254519|FG002|Epoch 2|Adverse Event|1|||
27799722|NCT02059291|54254520|FG003|Epoch 2|Adverse Event|1|||
27799723|NCT02059291|54254521|FG004|Epoch 2|Adverse Event|0|||
27799724|NCT02059291|54254522|FG005|Epoch 2|Adverse Event|0|||
27799725|NCT02059291|54254523|FG006|Epoch 2|Adverse Event|0|||
27799726|NCT02059291|54254524|FG007|Epoch 2|Adverse Event|1|||
28019703|NCT00293059|54679069|FG001|Overall Study|Noncompliant - sanitary pads collection|1|||
28019704|NCT00293059|54679068|FG000|Overall Study|missing|3|||
28019705|NCT00293059|54679069|FG001|Overall Study|missing|5|||
28019706|NCT00756275|54679077|FG000|Overall Study|Lost to Follow-up|25|||
28019707|NCT00756275|54679078|FG001|Overall Study|Lost to Follow-up|21|||
28019708|NCT00756275|54679077|FG000|Overall Study|Withdrawal by Subject|4|||
28019709|NCT00756275|54679078|FG001|Overall Study|Withdrawal by Subject|7|||
28019710|NCT00758459|54679086|FG000|Overall Study|Adverse Event|3|||
28019711|NCT00758459|54679087|FG001|Overall Study|Adverse Event|2|||
27799727|NCT02059291|54254525|FG008|Epoch 2|Adverse Event|1|||
27799728|NCT02059291|54254526|FG009|Epoch 2|Adverse Event|0|||
27799729|NCT02059291|54254527|FG010|Epoch 2|Adverse Event|0|||
27799730|NCT02059291|54254528|FG011|Epoch 2|Adverse Event|0|||
27799731|NCT02059291|54254529|FG012|Epoch 2|Adverse Event|0|||
27799732|NCT02059291|54254530|FG013|Epoch 2|Adverse Event|0|||
27799733|NCT02059291|54254531|FG014|Epoch 2|Adverse Event|0|||
28019712|NCT00758459|54679086|FG000|Overall Study|Protocol Violation|0|||
28019713|NCT00758459|54679087|FG001|Overall Study|Protocol Violation|1|||
28019714|NCT00758459|54679086|FG000|Overall Study|Withdrawal by Subject|0|||
28019715|NCT00758459|54679087|FG001|Overall Study|Withdrawal by Subject|1|||
27799734|NCT02059291|54254532|FG015|Epoch 2|Adverse Event|0|||
27799735|NCT02059291|54254533|FG016|Epoch 2|Adverse Event|0|||
27799736|NCT02059291|54254534|FG017|Epoch 2|Adverse Event|0|||
27799737|NCT02059291|54254535|FG018|Epoch 2|Adverse Event|0|||
27799738|NCT02059291|54254536|FG019|Epoch 2|Adverse Event|0|||
28019716|NCT00298831|54679093|FG000|Overall Study|Adverse Event|1|||
28019717|NCT00298831|54679093|FG000|Overall Study|Lost to Follow-up|3|||
28019718|NCT00298831|54679093|FG000|Overall Study|Withdrawal by Subject|1|||
28019719|NCT00298831|54679093|FG000|Overall Study|Participants did not receive treatment|27|||
28019720|NCT00758069|54679100|FG000|Overall Study|Lack of Efficacy|0|||
28019721|NCT00758069|54679101|FG001|Overall Study|Lack of Efficacy|0|||
28019722|NCT00758069|54679102|FG002|Overall Study|Lack of Efficacy|1|||
28019723|NCT00758069|54679100|FG000|Overall Study|Incorrect Study Drug|1|||
28019724|NCT00758069|54679101|FG001|Overall Study|Incorrect Study Drug|0|||
28019725|NCT00758069|54679102|FG002|Overall Study|Incorrect Study Drug|0|||
28019726|NCT00311623|54679113|FG000|Overall Study|Physician Decision|0|||
27799739|NCT02059291|54254537|FG020|Epoch 2|Adverse Event|0|||
27799740|NCT02059291|54254538|FG021|Epoch 2|Adverse Event|0|||
27799741|NCT02059291|54254539|FG022|Epoch 2|Adverse Event|0|||
28019727|NCT00311623|54679114|FG001|Overall Study|Physician Decision|0|||
28019728|NCT00311623|54679115|FG002|Overall Study|Physician Decision|2|||
28019729|NCT00528112|54679126|FG000|Treatment up to 3 Years|Adverse Event|313|||
28019730|NCT00528112|54679127|FG001|Treatment up to 3 Years|Adverse Event|278|||
28019731|NCT00528112|54679126|FG000|Treatment up to 3 Years|Withdrawal by Subject|26|||
28019732|NCT00528112|54679127|FG001|Treatment up to 3 Years|Withdrawal by Subject|31|||
27799742|NCT02059291|54254540|FG023|Epoch 2|Adverse Event|0|||
27799743|NCT02059291|54254541|FG024|Epoch 2|Adverse Event|0|||
28019733|NCT00528112|54679126|FG000|Treatment up to 3 Years|Protocol Violation|16|||
28019734|NCT00528112|54679127|FG001|Treatment up to 3 Years|Protocol Violation|16|||
28019735|NCT00528112|54679126|FG000|Treatment up to 3 Years|Death|0|||
28019736|NCT00528112|54679127|FG001|Treatment up to 3 Years|Death|1|||
28019737|NCT00528112|54679126|FG000|Treatment up to 3 Years|Lost to Follow-up|63|||
28019738|NCT00528112|54679127|FG001|Treatment up to 3 Years|Lost to Follow-up|61|||
28019739|NCT00528112|54679126|FG000|Treatment up to 3 Years|Pregnancy|9|||
28019740|NCT00528112|54679127|FG001|Treatment up to 3 Years|Pregnancy|10|||
28019741|NCT00528112|54679126|FG000|Treatment up to 3 Years|Other reasons|186|||
28019742|NCT00528112|54679127|FG001|Treatment up to 3 Years|Other reasons|186|||
28019743|NCT00528112|54679126|FG000|Extension Phase|Withdrawal by Subject|0|||
27799744|NCT02059291|54254517|FG000|Epoch 2|Withdrawal by Subject|0|||
28019744|NCT00528112|54679127|FG001|Extension Phase|Withdrawal by Subject|3|||
28019745|NCT00528112|54679126|FG000|Extension Phase|Other reasons|0|||
28019746|NCT00528112|54679127|FG001|Extension Phase|Other reasons|100|||
28019747|NCT00528112|54679126|FG000|Extension Phase|Pregnancy|0|||
28019748|NCT00528112|54679127|FG001|Extension Phase|Pregnancy|3|||
28019749|NCT00528112|54679126|FG000|Extension Phase|Lost to Follow-up|0|||
28019750|NCT00528112|54679127|FG001|Extension Phase|Lost to Follow-up|12|||
28019751|NCT00528112|54679126|FG000|Extension Phase|Death|0|||
28019752|NCT00528112|54679127|FG001|Extension Phase|Death|1|||
28019753|NCT00528112|54679126|FG000|Extension Phase|Adverse Event|0|||
28019754|NCT00528112|54679127|FG001|Extension Phase|Adverse Event|36|||
28019755|NCT00528112|54679126|FG000|Extension Phase|Protocol Violation|0|||
27799745|NCT02059291|54254518|FG001|Epoch 2|Withdrawal by Subject|1|||
27799746|NCT02059291|54254519|FG002|Epoch 2|Withdrawal by Subject|0|||
27799747|NCT02059291|54254520|FG003|Epoch 2|Withdrawal by Subject|0|||
27799748|NCT02059291|54254521|FG004|Epoch 2|Withdrawal by Subject|0|||
27799749|NCT02059291|54254522|FG005|Epoch 2|Withdrawal by Subject|1|||
27799750|NCT02059291|54254523|FG006|Epoch 2|Withdrawal by Subject|0|||
27799751|NCT02059291|54254524|FG007|Epoch 2|Withdrawal by Subject|0|||
27799752|NCT02059291|54254525|FG008|Epoch 2|Withdrawal by Subject|1|||
27799753|NCT02059291|54254526|FG009|Epoch 2|Withdrawal by Subject|0|||
27799754|NCT02059291|54254527|FG010|Epoch 2|Withdrawal by Subject|0|||
27799755|NCT02059291|54254528|FG011|Epoch 2|Withdrawal by Subject|0|||
28019756|NCT00528112|54679127|FG001|Extension Phase|Protocol Violation|2|||
28019757|NCT00633594|54679138|FG000|Overall Study|Adverse Event|0|||
27799756|NCT02059291|54254529|FG012|Epoch 2|Withdrawal by Subject|0|||
27799757|NCT02059291|54254530|FG013|Epoch 2|Withdrawal by Subject|0|||
27799758|NCT02059291|54254531|FG014|Epoch 2|Withdrawal by Subject|0|||
28019758|NCT00633594|54679139|FG001|Overall Study|Adverse Event|4|||
28019759|NCT00633594|54679140|FG002|Overall Study|Adverse Event|7|||
28019760|NCT00633594|54679138|FG000|Overall Study|Death|0|||
28019761|NCT00633594|54679139|FG001|Overall Study|Death|1|||
28019762|NCT00633594|54679140|FG002|Overall Study|Death|2|||
28019763|NCT00633594|54679138|FG000|Overall Study|Disease Progression|0|||
28019764|NCT00633594|54679139|FG001|Overall Study|Disease Progression|0|||
28019765|NCT00633594|54679140|FG002|Overall Study|Disease Progression|1|||
28019766|NCT00755807|54679153|FG000|Acute Phase|Adverse Event|16|||
28019767|NCT00755807|54679154|FG001|Acute Phase|Adverse Event|5|||
28019768|NCT00755807|54679153|FG000|Acute Phase|Protocol Violation|1|||
28019769|NCT00755807|54679154|FG001|Acute Phase|Protocol Violation|3|||
28019770|NCT00755807|54679153|FG000|Acute Phase|Withdrawal by Subject|1|||
27799759|NCT02059291|54254532|FG015|Epoch 2|Withdrawal by Subject|0|||
27799760|NCT02059291|54254533|FG016|Epoch 2|Withdrawal by Subject|0|||
27842753|NCT01548404|54331517|FG000|Overall Study|Other than specified above|0|||
27799761|NCT02059291|54254534|FG017|Epoch 2|Withdrawal by Subject|0|||
27799762|NCT02059291|54254535|FG018|Epoch 2|Withdrawal by Subject|0|||
28019771|NCT00755807|54679154|FG001|Acute Phase|Withdrawal by Subject|2|||
28019772|NCT00755807|54679153|FG000|Acute Phase|Lack of Efficacy|0|||
28019773|NCT00755807|54679154|FG001|Acute Phase|Lack of Efficacy|1|||
28019774|NCT00755807|54679153|FG000|Acute Phase|Physician Decision|0|||
28019775|NCT00755807|54679154|FG001|Acute Phase|Physician Decision|1|||
28019776|NCT00755807|54679153|FG000|Open-label Extension Phase|Adverse Event|7|||
28019777|NCT00755807|54679154|FG001|Open-label Extension Phase|Adverse Event|7|||
28019778|NCT00755807|54679153|FG000|Open-label Extension Phase|Protocol Violation|5|||
28019779|NCT00755807|54679154|FG001|Open-label Extension Phase|Protocol Violation|2|||
28019780|NCT00755807|54679153|FG000|Open-label Extension Phase|Lack of Efficacy|3|||
28019781|NCT00755807|54679154|FG001|Open-label Extension Phase|Lack of Efficacy|3|||
28019782|NCT00755807|54679153|FG000|Open-label Extension Phase|Withdrawal by Subject|1|||
28019783|NCT00755807|54679154|FG001|Open-label Extension Phase|Withdrawal by Subject|3|||
28019784|NCT00755807|54679153|FG000|Open-label Extension Phase|Lost to Follow-up|2|||
28019785|NCT00755807|54679154|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
28019786|NCT00755807|54679153|FG000|Open-label Extension Phase|Sponsor Decision|0|||
28019787|NCT00755807|54679154|FG001|Open-label Extension Phase|Sponsor Decision|1|||
28019788|NCT00631410|54679166|FG000|Overall Study|Adverse Event|1|||
28019789|NCT00631410|54679167|FG001|Overall Study|Adverse Event|3|||
28019790|NCT00631410|54679166|FG000|Overall Study|Objective Progression or Relapse|4|||
28019791|NCT00631410|54679167|FG001|Overall Study|Objective Progression or Relapse|3|||
28019792|NCT00631410|54679166|FG000|Overall Study|Surgery|1|||
28019793|NCT00631410|54679167|FG001|Overall Study|Surgery|0|||
28019794|NCT03686176|54679179|FG000|Overall Study|Procedure cancelled|1|||
28019795|NCT03686176|54679180|FG001|Overall Study|Procedure cancelled|0|||
28019796|NCT03686176|54679181|FG002|Overall Study|Procedure cancelled|0|||
28019797|NCT03686176|54679179|FG000|Overall Study|VR Malfunction|1|||
28019798|NCT03686176|54679180|FG001|Overall Study|VR Malfunction|0|||
28019799|NCT03686176|54679181|FG002|Overall Study|VR Malfunction|0|||
28019800|NCT00755417|54679192|FG000|Overall Study|Adverse Event|28|||
28019801|NCT00755417|54679193|FG001|Overall Study|Adverse Event|20|||
28019802|NCT00755417|54679194|FG002|Overall Study|Adverse Event|7|||
28019803|NCT00755417|54679192|FG000|Overall Study|Lack of Efficacy|8|||
28019804|NCT00755417|54679193|FG001|Overall Study|Lack of Efficacy|4|||
28019805|NCT00755417|54679194|FG002|Overall Study|Lack of Efficacy|9|||
28019806|NCT00755417|54679192|FG000|Overall Study|Protocol Violation|2|||
28019807|NCT00755417|54679193|FG001|Overall Study|Protocol Violation|1|||
28019808|NCT00755417|54679194|FG002|Overall Study|Protocol Violation|1|||
28019809|NCT00755417|54679192|FG000|Overall Study|Lost to Follow-up|3|||
28019810|NCT00755417|54679193|FG001|Overall Study|Lost to Follow-up|0|||
28019811|NCT00755417|54679194|FG002|Overall Study|Lost to Follow-up|1|||
28019812|NCT00755417|54679192|FG000|Overall Study|Withdrawal by Subject|12|||
28019813|NCT00755417|54679193|FG001|Overall Study|Withdrawal by Subject|12|||
28019814|NCT00755417|54679194|FG002|Overall Study|Withdrawal by Subject|12|||
28019815|NCT00755417|54679192|FG000|Overall Study|Not specified or missing data|9|||
28019816|NCT00755417|54679193|FG001|Overall Study|Not specified or missing data|18|||
28019817|NCT00755417|54679194|FG002|Overall Study|Not specified or missing data|12|||
28019818|NCT03685708|54679205|FG000|Overall Study|Withdrawal by Subject|0|||
28019819|NCT03685708|54679206|FG001|Overall Study|Withdrawal by Subject|0|||
28019820|NCT03685708|54679207|FG002|Overall Study|Withdrawal by Subject|1|||
28019821|NCT03685708|54679205|FG000|Overall Study|Screen Fail|0|||
27799763|NCT02059291|54254536|FG019|Epoch 2|Withdrawal by Subject|0|||
27799764|NCT02059291|54254537|FG020|Epoch 2|Withdrawal by Subject|0|||
27799765|NCT02059291|54254538|FG021|Epoch 2|Withdrawal by Subject|0|||
27799766|NCT02059291|54254539|FG022|Epoch 2|Withdrawal by Subject|0|||
27799767|NCT02059291|54254540|FG023|Epoch 2|Withdrawal by Subject|0|||
27799768|NCT02059291|54254541|FG024|Epoch 2|Withdrawal by Subject|0|||
27799769|NCT02059291|54254517|FG000|Epoch 3|Physician Decision|0|||
27799770|NCT02059291|54254518|FG001|Epoch 3|Physician Decision|0|||
27799771|NCT02059291|54254519|FG002|Epoch 3|Physician Decision|0|||
28019822|NCT03685708|54679206|FG001|Overall Study|Screen Fail|1|||
28019823|NCT03685708|54679207|FG002|Overall Study|Screen Fail|1|||
28019824|NCT03685708|54679205|FG000|Overall Study|COVID 19 Pandemic|1|||
28019825|NCT03685708|54679206|FG001|Overall Study|COVID 19 Pandemic|1|||
28019826|NCT03685708|54679207|FG002|Overall Study|COVID 19 Pandemic|6|||
28019827|NCT03685708|54679205|FG000|Overall Study|Disease Progression|0|||
28019828|NCT03685708|54679206|FG001|Overall Study|Disease Progression|0|||
28019829|NCT03685708|54679207|FG002|Overall Study|Disease Progression|1|||
28019830|NCT03684928|54679215|FG000|First Intervention|Lost to Follow-up|0|||
28019831|NCT03684928|54679216|FG001|First Intervention|Lost to Follow-up|1|||
28019832|NCT03684928|54679215|FG000|First Intervention|Withdrawal by Subject|0|||
28019833|NCT03684928|54679216|FG001|First Intervention|Withdrawal by Subject|2|||
28019834|NCT03684928|54679215|FG000|Second Intervention|Soft Tissue Injury|1|||
28019835|NCT03684928|54679216|FG001|Second Intervention|Soft Tissue Injury|0|||
28019836|NCT00777803|54679224|FG000|Overall Study|Lost to Follow-up|12|||
28019837|NCT00777803|54679225|FG001|Overall Study|Lost to Follow-up|5|||
28019838|NCT00777803|54679224|FG000|Overall Study|Adverse Event|1|||
28019839|NCT00777803|54679225|FG001|Overall Study|Adverse Event|0|||
27799772|NCT02059291|54254520|FG003|Epoch 3|Physician Decision|0|||
27799773|NCT02059291|54254521|FG004|Epoch 3|Physician Decision|0|||
28019840|NCT00777803|54679224|FG000|Overall Study|Non-compliance|2|||
28019841|NCT00777803|54679225|FG001|Overall Study|Non-compliance|2|||
27799774|NCT02059291|54254522|FG005|Epoch 3|Physician Decision|0|||
27799775|NCT02059291|54254523|FG006|Epoch 3|Physician Decision|0|||
27799776|NCT02059291|54254524|FG007|Epoch 3|Physician Decision|0|||
27799777|NCT02059291|54254525|FG008|Epoch 3|Physician Decision|0|||
28019842|NCT00527488|54679235|FG000|Overall Study|Withdrawn prior to dosing|0|||
27799778|NCT02059291|54254526|FG009|Epoch 3|Physician Decision|0|||
27799779|NCT02059291|54254527|FG010|Epoch 3|Physician Decision|0|||
27799780|NCT02059291|54254528|FG011|Epoch 3|Physician Decision|0|||
27799781|NCT02059291|54254529|FG012|Epoch 3|Physician Decision|0|||
27799782|NCT02059291|54254530|FG013|Epoch 3|Physician Decision|1|||
27799783|NCT02059291|54254531|FG014|Epoch 3|Physician Decision|0|||
27842754|NCT01548404|54331518|FG001|Overall Study|Other than specified above|2|||
27842755|NCT01547780|54331532|FG000|Baseline PET Scan|Physician Decision|1|||
28019843|NCT00527488|54679236|FG001|Overall Study|Withdrawn prior to dosing|1|||
28019844|NCT00527488|54679237|FG002|Overall Study|Withdrawn prior to dosing|1|||
28019845|NCT00527488|54679238|FG003|Overall Study|Withdrawn prior to dosing|0|||
28019846|NCT00527332|54679250|FG000|Overall Study|Protocol Violation|4|||
28019847|NCT00527332|54679251|FG001|Overall Study|Protocol Violation|8|||
28019848|NCT00527332|54679250|FG000|Overall Study|Withdrew consent|5|||
28019849|NCT00527332|54679251|FG001|Overall Study|Withdrew consent|1|||
28019850|NCT00752609|54679259|FG000|Overall Study|Adverse Event|2|||
28019851|NCT00752609|54679260|FG001|Overall Study|Adverse Event|2|||
28019852|NCT00752609|54679259|FG000|Overall Study|Withdrawal by Subject|3|||
28019853|NCT00752609|54679260|FG001|Overall Study|Withdrawal by Subject|0|||
28019854|NCT00752609|54679259|FG000|Overall Study|Physician Decision|1|||
28019855|NCT00752609|54679260|FG001|Overall Study|Physician Decision|0|||
28019856|NCT00752609|54679259|FG000|Overall Study|Death|1|||
28019857|NCT00752609|54679260|FG001|Overall Study|Death|0|||
28019858|NCT00752609|54679259|FG000|Overall Study|Met exclusion criteria|1|||
27842756|NCT01547780|54331533|FG001|Baseline PET Scan|Physician Decision|0|||
27842757|NCT01547780|54331534|FG002|Baseline PET Scan|Physician Decision|1|||
27842758|NCT01547780|54331535|FG003|Baseline PET Scan|Physician Decision|0|||
27842759|NCT01547780|54331532|FG000|Baseline PET Scan|Withdrawal by Subject|2|||
27842760|NCT01547780|54331533|FG001|Baseline PET Scan|Withdrawal by Subject|0|||
27842761|NCT01547780|54331534|FG002|Baseline PET Scan|Withdrawal by Subject|1|||
27842762|NCT01547780|54331535|FG003|Baseline PET Scan|Withdrawal by Subject|0|||
27842763|NCT01547390|54331557|FG000|Overall Study|Withdrawal by Subject|10|||
27938536|NCT00969436|54594640|FG001|Overall Study|Migrated/moved from study area|10|||
27938537|NCT00969436|54594641|FG002|Overall Study|Migrated/moved from study area|2|||
28019859|NCT00752609|54679260|FG001|Overall Study|Met exclusion criteria|0|||
28019860|NCT00752609|54679259|FG000|Overall Study|Received Aranesp in error|1|||
28019861|NCT00752609|54679260|FG001|Overall Study|Received Aranesp in error|0|||
28019862|NCT03684304|54679271|FG000|Overall Study|Lost to Follow-up|19|||
28019863|NCT03684304|54679272|FG001|Overall Study|Lost to Follow-up|17|||
28019864|NCT00629772|54679280|FG000|Second Intervention Week 14 - Week 26|Adverse Event|1|||
28019865|NCT00629772|54679281|FG001|Second Intervention Week 14 - Week 26|Adverse Event|1|||
28019866|NCT00629772|54679280|FG000|Second Intervention Week 14 - Week 26|Lack of Efficacy|0|||
28019867|NCT00629772|54679281|FG001|Second Intervention Week 14 - Week 26|Lack of Efficacy|1|||
28019868|NCT00526630|54679288|FG000|First Intervention Period - 12 Weeks|Withdrawn|0|||
28019869|NCT00526630|54679289|FG001|First Intervention Period - 12 Weeks|Withdrawn|3|||
28019870|NCT00526630|54679288|FG000|Second Intervention Period - 12 Weeks|Withdrawn|2|||
28019871|NCT00526630|54679289|FG001|Second Intervention Period - 12 Weeks|Withdrawn|1|||
28019872|NCT00755183|54679299|FG000|Overall Study|Adverse Event|5|||
28019873|NCT00755183|54679300|FG001|Overall Study|Adverse Event|2|||
28019874|NCT00755183|54679299|FG000|Overall Study|Protocol Violation|0|||
28019875|NCT00755183|54679300|FG001|Overall Study|Protocol Violation|1|||
28019876|NCT00755183|54679299|FG000|Overall Study|Withdrawal by Subject|0|||
28019877|NCT00755183|54679300|FG001|Overall Study|Withdrawal by Subject|2|||
28019878|NCT00755183|54679299|FG000|Overall Study|Administrative|2|||
28019879|NCT00755183|54679300|FG001|Overall Study|Administrative|1|||
28019880|NCT00755105|54679311|FG000|Overall Study|Withdrawal by Subject|9|||
28019881|NCT00755105|54679312|FG001|Overall Study|Withdrawal by Subject|11|||
28019882|NCT00755105|54679313|FG002|Overall Study|Withdrawal by Subject|4|||
28019883|NCT00526162|54679321|FG000|Overall Study|Device not implanted|3|||
27938538|NCT00969436|54594639|FG000|Overall Study|Father - serious health problem|0|||
27938539|NCT00969436|54594640|FG001|Overall Study|Father - serious health problem|0|||
27938540|NCT00969436|54594641|FG002|Overall Study|Father - serious health problem|1|||
27938541|NCT00969436|54594639|FG000|Overall Study|Parents personal problem|0|||
27938542|NCT00969436|54594640|FG001|Overall Study|Parents personal problem|0|||
28019884|NCT03875482|54679331|FG000|Overall Study|Adverse Event|0|||
28019885|NCT03875482|54679332|FG001|Overall Study|Adverse Event|1|||
27799784|NCT02059291|54254532|FG015|Epoch 3|Physician Decision|1|||
27799785|NCT02059291|54254533|FG016|Epoch 3|Physician Decision|0|||
27799786|NCT02059291|54254534|FG017|Epoch 3|Physician Decision|0|||
27938543|NCT00969436|54594641|FG002|Overall Study|Parents personal problem|1|||
28019886|NCT03875482|54679331|FG000|Overall Study|Withdrew consent|5|||
28019887|NCT03875482|54679332|FG001|Overall Study|Withdrew consent|6|||
28019888|NCT03875482|54679331|FG000|Overall Study|Lost to Follow-up|8|||
28019889|NCT03875482|54679332|FG001|Overall Study|Lost to Follow-up|2|||
28019890|NCT03875482|54679331|FG000|Overall Study|Lack of Efficacy|0|||
28019891|NCT03875482|54679332|FG001|Overall Study|Lack of Efficacy|11|||
28019892|NCT00754793|54679340|FG000|Overall Study|voluntary withdrawn from study|0|||
28019893|NCT00754793|54679341|FG001|Overall Study|voluntary withdrawn from study|1|||
28019894|NCT00586469|54679349|FG000|Overall Study|Adverse Event|0|||
28019895|NCT00586469|54679350|FG001|Overall Study|Adverse Event|1|||
28019896|NCT00626028|54679358|FG000|Overall Study|Adverse Event|1|||
28019897|NCT00626028|54679359|FG001|Overall Study|Adverse Event|1|||
28019898|NCT00626028|54679358|FG000|Overall Study|Device Failure|0|||
28019899|NCT00626028|54679359|FG001|Overall Study|Device Failure|1|||
28019900|NCT00626028|54679358|FG000|Overall Study|Physician Decision|2|||
28019901|NCT00626028|54679359|FG001|Overall Study|Physician Decision|1|||
28019902|NCT00626028|54679358|FG000|Overall Study|Inclusion/Exclusion Criteria|3|||
28019903|NCT00626028|54679359|FG001|Overall Study|Inclusion/Exclusion Criteria|6|||
28019904|NCT00777257|54679368|FG000|Overall Study|Adverse Event|3|||
28019905|NCT00777257|54679369|FG001|Overall Study|Adverse Event|1|||
28019906|NCT00777257|54679370|FG002|Overall Study|Adverse Event|0|||
28019907|NCT00777257|54679368|FG000|Overall Study|Lost to Follow-up|3|||
28019908|NCT00777257|54679369|FG001|Overall Study|Lost to Follow-up|3|||
28019909|NCT00777257|54679370|FG002|Overall Study|Lost to Follow-up|2|||
27799787|NCT02059291|54254535|FG018|Epoch 3|Physician Decision|0|||
27799788|NCT02059291|54254536|FG019|Epoch 3|Physician Decision|0|||
27799789|NCT02059291|54254537|FG020|Epoch 3|Physician Decision|0|||
27799790|NCT02059291|54254538|FG021|Epoch 3|Physician Decision|0|||
27799791|NCT02059291|54254539|FG022|Epoch 3|Physician Decision|0|||
27799792|NCT02059291|54254540|FG023|Epoch 3|Physician Decision|0|||
27799793|NCT02059291|54254541|FG024|Epoch 3|Physician Decision|0|||
27799794|NCT02059291|54254517|FG000|Epoch 3|Adverse Event|0|||
27842764|NCT01547390|54331558|FG001|Overall Study|Withdrawal by Subject|7|||
27842765|NCT01547390|54331557|FG000|Overall Study|termination of pregnancy|0|||
27842766|NCT01547390|54331558|FG001|Overall Study|termination of pregnancy|1|||
27842767|NCT01547390|54331557|FG000|Overall Study|Lost to Follow-up|0|||
27842768|NCT01547390|54331558|FG001|Overall Study|Lost to Follow-up|2|||
28019910|NCT00777257|54679368|FG000|Overall Study|Protocol Violation|2|||
28019911|NCT00777257|54679369|FG001|Overall Study|Protocol Violation|2|||
27842769|NCT01547390|54331557|FG000|Overall Study|Adverse Event|3|||
27842770|NCT01547390|54331558|FG001|Overall Study|Adverse Event|0|||
27842771|NCT01546922|54331564|FG000|First Period of 10 Weeks|Protocol Violation|3|||
27842772|NCT01546922|54331565|FG001|First Period of 10 Weeks|Protocol Violation|1|||
27842773|NCT01546922|54331564|FG000|First Period of 10 Weeks|Withdrawal by Subject|1|||
27842774|NCT01546922|54331565|FG001|First Period of 10 Weeks|Withdrawal by Subject|1|||
27842775|NCT01546922|54331564|FG000|First Period of 10 Weeks|Investigator's judgment|1|||
27842776|NCT01546922|54331565|FG001|First Period of 10 Weeks|Investigator's judgment|0|||
28019912|NCT00777257|54679370|FG002|Overall Study|Protocol Violation|2|||
28019913|NCT00777257|54679368|FG000|Overall Study|Withdrawal by Subject|3|||
28019914|NCT00777257|54679369|FG001|Overall Study|Withdrawal by Subject|6|||
28019915|NCT00777257|54679370|FG002|Overall Study|Withdrawal by Subject|5|||
28019916|NCT00628758|54679380|FG000|Overall Study|Adverse Event|2|||
28019917|NCT00628758|54679381|FG001|Overall Study|Adverse Event|3|||
28019918|NCT00628758|54679380|FG000|Overall Study|Withdrawal by Subject|6|||
28019919|NCT00628758|54679381|FG001|Overall Study|Withdrawal by Subject|3|||
28019920|NCT00628758|54679380|FG000|Overall Study|Death|1|||
28019921|NCT00628758|54679381|FG001|Overall Study|Death|0|||
28019922|NCT00628758|54679380|FG000|Overall Study|Protocol Violation|5|||
28019923|NCT00628758|54679381|FG001|Overall Study|Protocol Violation|1|||
28019924|NCT00628758|54679380|FG000|Overall Study|Lost to Follow-up|25|||
28019925|NCT00628758|54679381|FG001|Overall Study|Lost to Follow-up|31|||
28019926|NCT00628758|54679380|FG000|Overall Study|Pregnancy|2|||
28019927|NCT00628758|54679381|FG001|Overall Study|Pregnancy|2|||
28019928|NCT00628758|54679380|FG000|Overall Study|Investigator Moved|3|||
28019929|NCT00628758|54679381|FG001|Overall Study|Investigator Moved|0|||
28019930|NCT00628758|54679380|FG000|Overall Study|Treatment Failure|0|||
28019931|NCT00628758|54679381|FG001|Overall Study|Treatment Failure|2|||
28019932|NCT04491604|54679389|FG000|Overall Study|Withdrawal by Subject|3|||
28019933|NCT00628446|54679394|FG000|Overall Study|Lost to Follow-up|3|||
28019934|NCT00628446|54679394|FG000|Overall Study|Withdrawal by Subject|1|||
28019935|NCT00628446|54679394|FG000|Overall Study|Protocol Violation|3|||
28019936|NCT00754559|54679399|FG000|Overall Study|Adverse Event|15|||
27799795|NCT02059291|54254518|FG001|Epoch 3|Adverse Event|0|||
27799796|NCT02059291|54254519|FG002|Epoch 3|Adverse Event|0|||
27842777|NCT01546922|54331564|FG000|Second Period of 10 Weeks|Protocol Violation|3|||
28019937|NCT00754559|54679399|FG000|Overall Study|Protocol Violation|11|||
28019938|NCT00754559|54679399|FG000|Overall Study|Lack of Efficacy|10|||
28019939|NCT00754559|54679399|FG000|Overall Study|Lost to Follow-up|2|||
27842778|NCT01546922|54331565|FG001|Second Period of 10 Weeks|Protocol Violation|1|||
28019940|NCT00754559|54679399|FG000|Overall Study|Administrative reason|1|||
28019941|NCT00754559|54679399|FG000|Overall Study|Other|5|||
28019942|NCT00754559|54679399|FG000|Overall Study|Withdrawal by Subject|3|||
28019943|NCT00525148|54679410|FG000|Overall Study|Other Adverse Event|3|||
28019944|NCT00525148|54679411|FG001|Overall Study|Other Adverse Event|5|||
28019945|NCT00525148|54679412|FG002|Overall Study|Other Adverse Event|1|||
28019946|NCT00525148|54679413|FG003|Overall Study|Other Adverse Event|8|||
28019947|NCT00525148|54679410|FG000|Overall Study|Progressive disease|18|||
28019948|NCT00525148|54679411|FG001|Overall Study|Progressive disease|30|||
28019949|NCT00525148|54679412|FG002|Overall Study|Progressive disease|6|||
28019950|NCT00525148|54679413|FG003|Overall Study|Progressive disease|49|||
28019951|NCT00525148|54679410|FG000|Overall Study|Refused continuation of study medication|0|||
28019952|NCT00525148|54679411|FG001|Overall Study|Refused continuation of study medication|2|||
28019953|NCT00525148|54679412|FG002|Overall Study|Refused continuation of study medication|0|||
28019954|NCT00525148|54679413|FG003|Overall Study|Refused continuation of study medication|1|||
28019955|NCT00525148|54679410|FG000|Overall Study|Other than stated|2|||
28019956|NCT00525148|54679411|FG001|Overall Study|Other than stated|1|||
28019957|NCT00525148|54679412|FG002|Overall Study|Other than stated|0|||
28019958|NCT00525148|54679413|FG003|Overall Study|Other than stated|3|||
28019959|NCT00754325|54679425|FG000|Initial Treatment|Continuing Active Treatment|4|||
28019960|NCT00754325|54679426|FG001|Initial Treatment|Continuing Active Treatment|5|||
28019961|NCT00754325|54679425|FG000|Initial Treatment|Adverse Event|7|||
28019962|NCT00754325|54679426|FG001|Initial Treatment|Adverse Event|6|||
28019963|NCT00754325|54679425|FG000|Initial Treatment|Withdrawal by Subject|2|||
28019964|NCT00754325|54679426|FG001|Initial Treatment|Withdrawal by Subject|2|||
28019965|NCT00754325|54679425|FG000|Initial Treatment|Physician Decision|2|||
28019966|NCT00754325|54679426|FG001|Initial Treatment|Physician Decision|0|||
28019967|NCT00754325|54679425|FG000|Initial Treatment|Sponsor Request|0|||
28019968|NCT00754325|54679426|FG001|Initial Treatment|Sponsor Request|1|||
28019969|NCT00754325|54679425|FG000|Initial Treatment|Disease Progression|35|||
28019970|NCT00754325|54679426|FG001|Initial Treatment|Disease Progression|35|||
28019971|NCT00524680|54679437|FG000|Overall Study|progression|0|||
28019972|NCT00524680|54679438|FG001|Overall Study|progression|0|||
28019973|NCT00524680|54679439|FG002|Overall Study|progression|0|||
27799797|NCT02059291|54254520|FG003|Epoch 3|Adverse Event|0|||
27799798|NCT02059291|54254521|FG004|Epoch 3|Adverse Event|0|||
27799799|NCT02059291|54254522|FG005|Epoch 3|Adverse Event|0|||
27799800|NCT02059291|54254523|FG006|Epoch 3|Adverse Event|0|||
27842779|NCT01546922|54331564|FG000|Second Period of 10 Weeks|Withdrawal by Subject|0|||
27842780|NCT01546922|54331565|FG001|Second Period of 10 Weeks|Withdrawal by Subject|2|||
27842781|NCT01532648|54331582|FG000|Overall Study|Lost to Follow-up|3|||
27799801|NCT02059291|54254524|FG007|Epoch 3|Adverse Event|0|||
27799802|NCT02059291|54254525|FG008|Epoch 3|Adverse Event|0|||
27799803|NCT02059291|54254526|FG009|Epoch 3|Adverse Event|0|||
27799804|NCT02059291|54254527|FG010|Epoch 3|Adverse Event|0|||
27799805|NCT02059291|54254528|FG011|Epoch 3|Adverse Event|0|||
27799806|NCT02059291|54254529|FG012|Epoch 3|Adverse Event|0|||
27799807|NCT02059291|54254530|FG013|Epoch 3|Adverse Event|0|||
27799808|NCT02059291|54254531|FG014|Epoch 3|Adverse Event|0|||
27799809|NCT02059291|54254532|FG015|Epoch 3|Adverse Event|1|||
27799810|NCT02059291|54254533|FG016|Epoch 3|Adverse Event|0|||
27799811|NCT02059291|54254534|FG017|Epoch 3|Adverse Event|0|||
27799812|NCT02059291|54254535|FG018|Epoch 3|Adverse Event|0|||
27799813|NCT02059291|54254536|FG019|Epoch 3|Adverse Event|0|||
27799814|NCT02059291|54254537|FG020|Epoch 3|Adverse Event|0|||
27799815|NCT02059291|54254538|FG021|Epoch 3|Adverse Event|0|||
27799816|NCT02059291|54254539|FG022|Epoch 3|Adverse Event|0|||
27799817|NCT02059291|54254540|FG023|Epoch 3|Adverse Event|0|||
27799818|NCT02059291|54254541|FG024|Epoch 3|Adverse Event|0|||
27799819|NCT02059291|54254517|FG000|Epoch 3|Lack of Efficacy|0|||
27799820|NCT02059291|54254518|FG001|Epoch 3|Lack of Efficacy|0|||
27842782|NCT01532648|54331583|FG001|Overall Study|Lost to Follow-up|4|||
28019974|NCT00524680|54679440|FG003|Overall Study|progression|1|||
28019975|NCT00524680|54679437|FG000|Overall Study|Adverse Event|2|||
28019976|NCT00524680|54679438|FG001|Overall Study|Adverse Event|0|||
28019977|NCT00524680|54679439|FG002|Overall Study|Adverse Event|0|||
28019978|NCT00524680|54679440|FG003|Overall Study|Adverse Event|1|||
27799821|NCT02059291|54254519|FG002|Epoch 3|Lack of Efficacy|0|||
27799822|NCT02059291|54254520|FG003|Epoch 3|Lack of Efficacy|0|||
27799823|NCT02059291|54254521|FG004|Epoch 3|Lack of Efficacy|0|||
27799824|NCT02059291|54254522|FG005|Epoch 3|Lack of Efficacy|0|||
27799825|NCT02059291|54254523|FG006|Epoch 3|Lack of Efficacy|0|||
27799826|NCT02059291|54254524|FG007|Epoch 3|Lack of Efficacy|0|||
27799827|NCT02059291|54254525|FG008|Epoch 3|Lack of Efficacy|0|||
27799828|NCT02059291|54254526|FG009|Epoch 3|Lack of Efficacy|0|||
27799829|NCT02059291|54254527|FG010|Epoch 3|Lack of Efficacy|0|||
27799830|NCT02059291|54254528|FG011|Epoch 3|Lack of Efficacy|0|||
27842783|NCT01532648|54331582|FG000|Overall Study|Lack of Efficacy|4|||
28019979|NCT00524680|54679437|FG000|Overall Study|Other|0|||
28019980|NCT00524680|54679438|FG001|Overall Study|Other|1|||
28019981|NCT00524680|54679439|FG002|Overall Study|Other|2|||
28019982|NCT00524680|54679440|FG003|Overall Study|Other|3|||
28019983|NCT00524680|54679437|FG000|Overall Study|Withdrawal by Subject|1|||
28019984|NCT00524680|54679438|FG001|Overall Study|Withdrawal by Subject|0|||
28019985|NCT00524680|54679439|FG002|Overall Study|Withdrawal by Subject|1|||
28019986|NCT00524680|54679440|FG003|Overall Study|Withdrawal by Subject|1|||
28019987|NCT00628212|54679454|FG000|Overall Study|Adverse Event|2|||
28019988|NCT00628212|54679455|FG001|Overall Study|Adverse Event|0|||
28019989|NCT00628212|54679456|FG002|Overall Study|Adverse Event|1|||
28019990|NCT00628212|54679457|FG003|Overall Study|Adverse Event|2|||
28019991|NCT00628212|54679454|FG000|Overall Study|Physician Decision|1|||
28019992|NCT00628212|54679455|FG001|Overall Study|Physician Decision|1|||
28019993|NCT00628212|54679456|FG002|Overall Study|Physician Decision|2|||
28019994|NCT00628212|54679457|FG003|Overall Study|Physician Decision|3|||
28019995|NCT00298363|54679470|FG000|Overall Study|Lost to Follow-up|0|||
28019996|NCT00298363|54679471|FG001|Overall Study|Lost to Follow-up|0|||
28019997|NCT00298363|54679472|FG002|Overall Study|Lost to Follow-up|1|||
28019998|NCT00298363|54679470|FG000|Overall Study|Physician Decision|4|||
28019999|NCT00298363|54679471|FG001|Overall Study|Physician Decision|1|||
28020000|NCT00298363|54679472|FG002|Overall Study|Physician Decision|0|||
28020001|NCT00298363|54679470|FG000|Overall Study|Protocol Violation|1|||
28020002|NCT00298363|54679471|FG001|Overall Study|Protocol Violation|1|||
28020003|NCT00298363|54679472|FG002|Overall Study|Protocol Violation|0|||
28020004|NCT00298363|54679470|FG000|Overall Study|Withdrawal by Subject|5|||
28020005|NCT00298363|54679471|FG001|Overall Study|Withdrawal by Subject|1|||
28020006|NCT00298363|54679472|FG002|Overall Study|Withdrawal by Subject|3|||
28020007|NCT00298363|54679470|FG000|Overall Study|Adverse Event|5|||
28020008|NCT00298363|54679471|FG001|Overall Study|Adverse Event|2|||
28020009|NCT00298363|54679472|FG002|Overall Study|Adverse Event|2|||
28020010|NCT00298363|54679470|FG000|Overall Study|Lack of Efficacy|2|||
28020011|NCT00298363|54679471|FG001|Overall Study|Lack of Efficacy|3|||
28020012|NCT00298363|54679472|FG002|Overall Study|Lack of Efficacy|0|||
28020013|NCT00524368|54679488|FG000|Overall Study|Adverse Event|10|||
28020014|NCT00524368|54679489|FG001|Overall Study|Adverse Event|12|||
27842784|NCT01532648|54331583|FG001|Overall Study|Lack of Efficacy|1|||
27842785|NCT01532648|54331582|FG000|Overall Study|Protocol Violation|1|||
27842786|NCT01532648|54331583|FG001|Overall Study|Protocol Violation|1|||
27842787|NCT01532648|54331582|FG000|Overall Study|Adverse Event|12|||
27842788|NCT01532648|54331583|FG001|Overall Study|Adverse Event|9|||
27842789|NCT01532648|54331582|FG000|Overall Study|Withdrawal by Subject|16|||
27842790|NCT01532648|54331583|FG001|Overall Study|Withdrawal by Subject|2|||
27842791|NCT01532570|54331613|FG000|Overall Study|Lack of Efficacy|1|||
27842792|NCT01532570|54331614|FG001|Overall Study|Lack of Efficacy|0|||
27842793|NCT01532570|54331615|FG002|Overall Study|Lack of Efficacy|0|||
27842794|NCT01532570|54331616|FG003|Overall Study|Lack of Efficacy|0|||
27842795|NCT01532570|54331613|FG000|Overall Study|Withdrawal by Subject|0|||
27842796|NCT01532570|54331614|FG001|Overall Study|Withdrawal by Subject|1|||
27842797|NCT01532570|54331615|FG002|Overall Study|Withdrawal by Subject|0|||
27842798|NCT01532570|54331616|FG003|Overall Study|Withdrawal by Subject|0|||
27842799|NCT01532414|54331662|FG000|Overall Study|Lost to Follow-up|3|||
27842800|NCT01532414|54331663|FG001|Overall Study|Lost to Follow-up|0|||
27842801|NCT01532414|54331664|FG002|Overall Study|Lost to Follow-up|1|||
27842802|NCT01532414|54331662|FG000|Overall Study|Withdrawal by Subject|3|||
28020015|NCT00524368|54679488|FG000|Overall Study|Lost to Follow-up|9|||
28020016|NCT00524368|54679489|FG001|Overall Study|Lost to Follow-up|13|||
27799831|NCT02059291|54254529|FG012|Epoch 3|Lack of Efficacy|0|||
27799832|NCT02059291|54254530|FG013|Epoch 3|Lack of Efficacy|0|||
27799833|NCT02059291|54254531|FG014|Epoch 3|Lack of Efficacy|0|||
27799834|NCT02059291|54254532|FG015|Epoch 3|Lack of Efficacy|3|||
27799835|NCT02059291|54254533|FG016|Epoch 3|Lack of Efficacy|0|||
27799836|NCT02059291|54254534|FG017|Epoch 3|Lack of Efficacy|0|||
27799837|NCT02059291|54254535|FG018|Epoch 3|Lack of Efficacy|0|||
27799838|NCT02059291|54254536|FG019|Epoch 3|Lack of Efficacy|0|||
27799839|NCT02059291|54254537|FG020|Epoch 3|Lack of Efficacy|0|||
27799840|NCT02059291|54254538|FG021|Epoch 3|Lack of Efficacy|0|||
27799841|NCT02059291|54254539|FG022|Epoch 3|Lack of Efficacy|0|||
27799842|NCT02059291|54254540|FG023|Epoch 3|Lack of Efficacy|0|||
27842803|NCT01532414|54331663|FG001|Overall Study|Withdrawal by Subject|0|||
27842804|NCT01532414|54331664|FG002|Overall Study|Withdrawal by Subject|0|||
27842805|NCT01532414|54331662|FG000|Overall Study|No V6 semen sample|0|||
28020017|NCT00524368|54679488|FG000|Overall Study|Withdrawal by Subject|4|||
28020018|NCT00524368|54679489|FG001|Overall Study|Withdrawal by Subject|5|||
28020019|NCT00524368|54679488|FG000|Overall Study|Non-compliant|8|||
28020020|NCT00524368|54679489|FG001|Overall Study|Non-compliant|9|||
27842806|NCT01532414|54331663|FG001|Overall Study|No V6 semen sample|1|||
27842807|NCT01532414|54331664|FG002|Overall Study|No V6 semen sample|0|||
27842808|NCT01532414|54331662|FG000|Overall Study|Adverse Event|0|||
28020021|NCT00524368|54679488|FG000|Overall Study|Reached a Virologic Endpoint|3|||
27799843|NCT02059291|54254541|FG024|Epoch 3|Lack of Efficacy|0|||
27799844|NCT02059291|54254517|FG000|Epoch 3|Withdrawal by Subject|0|||
27799845|NCT02059291|54254518|FG001|Epoch 3|Withdrawal by Subject|0|||
27799846|NCT02059291|54254519|FG002|Epoch 3|Withdrawal by Subject|0|||
28020022|NCT00524368|54679489|FG001|Overall Study|Reached a Virologic Endpoint|2|||
28020023|NCT00524368|54679488|FG000|Overall Study|Sponsor's Decision|2|||
28020024|NCT00524368|54679489|FG001|Overall Study|Sponsor's Decision|0|||
28020025|NCT00524368|54679488|FG000|Overall Study|Ineligible to Continue the study|2|||
28020026|NCT00524368|54679489|FG001|Overall Study|Ineligible to Continue the study|5|||
28020027|NCT00524368|54679488|FG000|Overall Study|Other|3|||
28020028|NCT00524368|54679489|FG001|Overall Study|Other|2|||
28020029|NCT00777101|54679497|FG000|Overall Study|Death|48|||
28020030|NCT00777101|54679498|FG001|Overall Study|Death|43|||
28020031|NCT00777101|54679497|FG000|Overall Study|Withdrawal by Subject|11|||
28020032|NCT00777101|54679498|FG001|Overall Study|Withdrawal by Subject|6|||
28020033|NCT00777101|54679497|FG000|Overall Study|Lost to Follow-up|2|||
28020034|NCT00777101|54679498|FG001|Overall Study|Lost to Follow-up|1|||
28020035|NCT00777101|54679497|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
28020036|NCT00777101|54679498|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
28020037|NCT00777101|54679497|FG000|Overall Study|Failed to Return|0|||
28020038|NCT00777101|54679498|FG001|Overall Study|Failed to Return|1|||
28020039|NCT00297427|54679507|FG000|Phase 1: Initial Intervention|Withdrawal by Subject|8|||
28020040|NCT00297427|54679508|FG001|Phase 1: Initial Intervention|Withdrawal by Subject|5|||
28020041|NCT00297427|54679507|FG000|Phase 1: Initial Intervention|Lost to Follow-up|0|||
28020042|NCT00297427|54679508|FG001|Phase 1: Initial Intervention|Lost to Follow-up|3|||
28020043|NCT00297427|54679507|FG000|Phase 1: Initial Intervention|Death|0|||
28020044|NCT00297427|54679508|FG001|Phase 1: Initial Intervention|Death|1|||
27799847|NCT02059291|54254520|FG003|Epoch 3|Withdrawal by Subject|0|||
27799848|NCT02059291|54254521|FG004|Epoch 3|Withdrawal by Subject|0|||
27799849|NCT02059291|54254522|FG005|Epoch 3|Withdrawal by Subject|0|||
27799850|NCT02059291|54254523|FG006|Epoch 3|Withdrawal by Subject|0|||
27799851|NCT02059291|54254524|FG007|Epoch 3|Withdrawal by Subject|0|||
27799852|NCT02059291|54254525|FG008|Epoch 3|Withdrawal by Subject|0|||
27799853|NCT02059291|54254526|FG009|Epoch 3|Withdrawal by Subject|0|||
27799854|NCT02059291|54254527|FG010|Epoch 3|Withdrawal by Subject|0|||
27799855|NCT02059291|54254528|FG011|Epoch 3|Withdrawal by Subject|0|||
27799856|NCT02059291|54254529|FG012|Epoch 3|Withdrawal by Subject|0|||
27799857|NCT02059291|54254530|FG013|Epoch 3|Withdrawal by Subject|0|||
27799858|NCT02059291|54254531|FG014|Epoch 3|Withdrawal by Subject|0|||
27799859|NCT02059291|54254532|FG015|Epoch 3|Withdrawal by Subject|1|||
27799860|NCT02059291|54254533|FG016|Epoch 3|Withdrawal by Subject|0|||
27799861|NCT02059291|54254534|FG017|Epoch 3|Withdrawal by Subject|0|||
27799862|NCT02059291|54254535|FG018|Epoch 3|Withdrawal by Subject|0|||
27799863|NCT02059291|54254536|FG019|Epoch 3|Withdrawal by Subject|0|||
27799864|NCT02059291|54254537|FG020|Epoch 3|Withdrawal by Subject|0|||
27799865|NCT02059291|54254538|FG021|Epoch 3|Withdrawal by Subject|0|||
27799866|NCT02059291|54254539|FG022|Epoch 3|Withdrawal by Subject|0|||
27799867|NCT02059291|54254540|FG023|Epoch 3|Withdrawal by Subject|0|||
27799868|NCT02059291|54254541|FG024|Epoch 3|Withdrawal by Subject|0|||
27799869|NCT02059291|54254517|FG000|Epoch 4|Adverse Event|0|||
27799870|NCT02059291|54254518|FG001|Epoch 4|Adverse Event|0|||
28020045|NCT00297427|54679507|FG000|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15|||
28020046|NCT00297427|54679508|FG001|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0|||
28020047|NCT00297427|54679507|FG000|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1|||
28020048|NCT00297427|54679508|FG001|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0|||
28020049|NCT00297427|54679507|FG000|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29|||
28020050|NCT00297427|54679508|FG001|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0|||
28020051|NCT00297427|54679507|FG000|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3|||
28020052|NCT00297427|54679508|FG001|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0|||
28020053|NCT00297427|54679507|FG000|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2|||
28020054|NCT00297427|54679508|FG001|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0|||
28020055|NCT00524134|54679522|FG000|Overall Study|Withdrawal by Subject|1|||
28020056|NCT00524134|54679522|FG000|Overall Study|Physician Decision|1|||
28020057|NCT00777023|54679529|FG000|Overall Study|Adverse Event|15|||
28020058|NCT00777023|54679530|FG001|Overall Study|Adverse Event|21|||
28020059|NCT00777023|54679531|FG002|Overall Study|Adverse Event|8|||
28020060|NCT00777023|54679529|FG000|Overall Study|Lack of Efficacy|1|||
27799871|NCT02059291|54254519|FG002|Epoch 4|Adverse Event|0|||
28020061|NCT00777023|54679530|FG001|Overall Study|Lack of Efficacy|0|||
28020062|NCT00777023|54679531|FG002|Overall Study|Lack of Efficacy|14|||
28020063|NCT00777023|54679529|FG000|Overall Study|Protocol Violation|2|||
28020064|NCT00777023|54679530|FG001|Overall Study|Protocol Violation|1|||
28020065|NCT00777023|54679531|FG002|Overall Study|Protocol Violation|1|||
27799872|NCT02059291|54254520|FG003|Epoch 4|Adverse Event|0|||
27799873|NCT02059291|54254521|FG004|Epoch 4|Adverse Event|0|||
27799874|NCT02059291|54254522|FG005|Epoch 4|Adverse Event|0|||
27799875|NCT02059291|54254523|FG006|Epoch 4|Adverse Event|0|||
27799876|NCT02059291|54254524|FG007|Epoch 4|Adverse Event|0|||
27799877|NCT02059291|54254525|FG008|Epoch 4|Adverse Event|0|||
27799878|NCT02059291|54254526|FG009|Epoch 4|Adverse Event|0|||
27799879|NCT02059291|54254527|FG010|Epoch 4|Adverse Event|0|||
28020066|NCT00777023|54679529|FG000|Overall Study|Lost to Follow-up|2|||
28020067|NCT00777023|54679530|FG001|Overall Study|Lost to Follow-up|3|||
28020068|NCT00777023|54679531|FG002|Overall Study|Lost to Follow-up|3|||
28020069|NCT00777023|54679529|FG000|Overall Study|Death|0|||
28020070|NCT00777023|54679530|FG001|Overall Study|Death|1|||
28020071|NCT00777023|54679531|FG002|Overall Study|Death|0|||
28020072|NCT00777023|54679529|FG000|Overall Study|Withdrawal by Subject|7|||
28020073|NCT00777023|54679530|FG001|Overall Study|Withdrawal by Subject|7|||
28020074|NCT00777023|54679531|FG002|Overall Study|Withdrawal by Subject|8|||
28020075|NCT00777023|54679529|FG000|Overall Study|Missing data|1|||
28020076|NCT00777023|54679530|FG001|Overall Study|Missing data|1|||
28020077|NCT00777023|54679531|FG002|Overall Study|Missing data|0|||
28020078|NCT00777023|54679529|FG000|Overall Study|Reasons not specified|4|||
28020079|NCT00777023|54679530|FG001|Overall Study|Reasons not specified|4|||
28020080|NCT00777023|54679531|FG002|Overall Study|Reasons not specified|2|||
28020081|NCT00777023|54679529|FG000|Overall Study|Last dose date unknown|3|||
28020082|NCT00777023|54679530|FG001|Overall Study|Last dose date unknown|3|||
28020083|NCT00777023|54679531|FG002|Overall Study|Last dose date unknown|1|||
28020084|NCT00297037|54679541|FG000|Overall Study|Withdrawal by Subject|2|||
28020085|NCT00297037|54679542|FG001|Overall Study|Withdrawal by Subject|0|||
28020086|NCT00292981|54679550|FG000|Overall Study|Adverse Event|1|||
28020087|NCT00292981|54679550|FG000|Overall Study|Lost to Follow-up|13|||
28020088|NCT00292981|54679550|FG000|Overall Study|Withdrawal by Subject|22|||
28020089|NCT00292981|54679550|FG000|Overall Study|Other|3|||
28020090|NCT00296725|54679554|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1|||
28020091|NCT00296725|54679554|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4|||
28020092|NCT00296725|54679554|FG000|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1|||
28020093|NCT00625872|54679562|FG000|Overall Study|Withdrawal by Subject|1|||
28020094|NCT00625872|54679563|FG001|Overall Study|Withdrawal by Subject|0|||
27799880|NCT02059291|54254528|FG011|Epoch 4|Adverse Event|0|||
27799881|NCT02059291|54254529|FG012|Epoch 4|Adverse Event|0|||
27799882|NCT02059291|54254530|FG013|Epoch 4|Adverse Event|0|||
27799883|NCT02059291|54254531|FG014|Epoch 4|Adverse Event|0|||
27799884|NCT02059291|54254532|FG015|Epoch 4|Adverse Event|0|||
27799885|NCT02059291|54254533|FG016|Epoch 4|Adverse Event|1|||
27799886|NCT02059291|54254534|FG017|Epoch 4|Adverse Event|0|||
27799887|NCT02059291|54254535|FG018|Epoch 4|Adverse Event|0|||
27799888|NCT02059291|54254536|FG019|Epoch 4|Adverse Event|0|||
27799889|NCT02059291|54254537|FG020|Epoch 4|Adverse Event|0|||
27799890|NCT02059291|54254538|FG021|Epoch 4|Adverse Event|0|||
27799891|NCT02059291|54254539|FG022|Epoch 4|Adverse Event|1|||
28020095|NCT00625872|54679562|FG000|Overall Study|Does not meet inclusion criteria|1|||
28020096|NCT00625872|54679563|FG001|Overall Study|Does not meet inclusion criteria|0|||
28020097|NCT00625872|54679562|FG000|Overall Study|Terminated by sponsor|2|||
28020098|NCT00625872|54679563|FG001|Overall Study|Terminated by sponsor|5|||
28020099|NCT00625872|54679562|FG000|Overall Study|Randomized but not treated|0|||
28020100|NCT00625872|54679563|FG001|Overall Study|Randomized but not treated|1|||
28020101|NCT00523978|54679571|FG000|Overall Study|Withdrawal by Subject|3|||
28020102|NCT00523978|54679572|FG001|Overall Study|Withdrawal by Subject|7|||
28020103|NCT00523978|54679571|FG000|Overall Study|Screen Failures|5|||
28020104|NCT00523978|54679572|FG001|Overall Study|Screen Failures|1|||
28020105|NCT00523978|54679571|FG000|Overall Study|Death|1|||
28020106|NCT00523978|54679572|FG001|Overall Study|Death|0|||
28020107|NCT00296647|54679584|FG000|Overall Study|Death|4|||
28020108|NCT00296647|54679585|FG001|Overall Study|Death|1|||
28020109|NCT00296647|54679586|FG002|Overall Study|Death|2|||
28020110|NCT00296647|54679587|FG003|Overall Study|Death|1|||
28020111|NCT00296647|54679588|FG004|Overall Study|Death|1|||
28020112|NCT00296647|54679584|FG000|Overall Study|Withdrawal by Subject|28|||
28020113|NCT00296647|54679585|FG001|Overall Study|Withdrawal by Subject|27|||
28020114|NCT00296647|54679586|FG002|Overall Study|Withdrawal by Subject|32|||
28020115|NCT00296647|54679587|FG003|Overall Study|Withdrawal by Subject|16|||
28020116|NCT00296647|54679588|FG004|Overall Study|Withdrawal by Subject|19|||
28020117|NCT00754013|54679602|FG000|Overall Study|Lost to Follow-up|1|||
28020118|NCT00754013|54679603|FG001|Overall Study|Lost to Follow-up|1|||
28020119|NCT00754013|54679602|FG000|Overall Study|didn't return after study termed|3|||
28020120|NCT00754013|54679603|FG001|Overall Study|didn't return after study termed|4|||
28020121|NCT00523744|54679609|FG000|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2|||
28020122|NCT00523744|54679609|FG000|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1|||
28020123|NCT00523744|54679609|FG000|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2|||
28020124|NCT00523744|54679609|FG000|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1|||
28020125|NCT00523744|54679609|FG000|Phase 2 - Amlodipine+Valsartan|Adverse Event|2|||
28020126|NCT00523744|54679609|FG000|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1|||
27799892|NCT02059291|54254540|FG023|Epoch 4|Adverse Event|0|||
27799893|NCT02059291|54254541|FG024|Epoch 4|Adverse Event|0|||
27799894|NCT02059291|54254517|FG000|Epoch 4|Pregnancy|0|||
28020127|NCT00752219|54679627|FG000|Overall Study|Clinical failure|0|||
28020128|NCT00752219|54679628|FG001|Overall Study|Clinical failure|1|||
28020129|NCT00752219|54679627|FG000|Overall Study|Adverse Event|5|||
28020130|NCT00752219|54679628|FG001|Overall Study|Adverse Event|3|||
28020131|NCT00752219|54679627|FG000|Overall Study|Protocol deviation|1|||
28020132|NCT00752219|54679628|FG001|Overall Study|Protocol deviation|0|||
28020133|NCT00752219|54679627|FG000|Overall Study|Lost to Follow-up|1|||
28020134|NCT00752219|54679628|FG001|Overall Study|Lost to Follow-up|2|||
28020135|NCT00752219|54679627|FG000|Overall Study|Randomized but not treated|1|||
28020136|NCT00752219|54679628|FG001|Overall Study|Randomized but not treated|0|||
28020137|NCT00752219|54679627|FG000|Overall Study|Other|3|||
28020138|NCT00752219|54679628|FG001|Overall Study|Other|0|||
28020139|NCT00622908|54679636|FG000|Overall Study|Protocol Violation|1|||
28020140|NCT00622908|54679637|FG001|Overall Study|Protocol Violation|0|||
28020141|NCT00622908|54679636|FG000|Overall Study|Adverse Event|0|||
28020142|NCT00622908|54679637|FG001|Overall Study|Adverse Event|1|||
28020143|NCT00622908|54679636|FG000|Overall Study|Lack of Efficacy|1|||
28020144|NCT00622908|54679637|FG001|Overall Study|Lack of Efficacy|7|||
28020145|NCT00622908|54679636|FG000|Overall Study|Lost to Follow-up|1|||
28020146|NCT00622908|54679637|FG001|Overall Study|Lost to Follow-up|0|||
28020147|NCT00622908|54679636|FG000|Overall Study|Refusal|0|||
28020148|NCT00622908|54679637|FG001|Overall Study|Refusal|1|||
28020149|NCT00622908|54679636|FG000|Overall Study|Termination by study sponser|0|||
28020150|NCT00622908|54679637|FG001|Overall Study|Termination by study sponser|1|||
28020151|NCT00296491|54679647|FG000|Overall Study|Low Pollen Counts|18|||
28020152|NCT00296491|54679648|FG001|Overall Study|Low Pollen Counts|26|||
28020153|NCT00296491|54679649|FG002|Overall Study|Low Pollen Counts|25|||
28020154|NCT00296491|54679650|FG003|Overall Study|Low Pollen Counts|16|||
27799895|NCT02059291|54254518|FG001|Epoch 4|Pregnancy|0|||
27799896|NCT02059291|54254519|FG002|Epoch 4|Pregnancy|0|||
27799897|NCT02059291|54254520|FG003|Epoch 4|Pregnancy|0|||
27799898|NCT02059291|54254521|FG004|Epoch 4|Pregnancy|0|||
27799899|NCT02059291|54254522|FG005|Epoch 4|Pregnancy|0|||
27799900|NCT02059291|54254523|FG006|Epoch 4|Pregnancy|0|||
27799901|NCT02059291|54254524|FG007|Epoch 4|Pregnancy|0|||
27799902|NCT02059291|54254525|FG008|Epoch 4|Pregnancy|0|||
27799903|NCT02059291|54254526|FG009|Epoch 4|Pregnancy|0|||
27799904|NCT02059291|54254527|FG010|Epoch 4|Pregnancy|0|||
27799905|NCT02059291|54254528|FG011|Epoch 4|Pregnancy|0|||
27799906|NCT02059291|54254529|FG012|Epoch 4|Pregnancy|0|||
27799907|NCT02059291|54254530|FG013|Epoch 4|Pregnancy|0|||
27799908|NCT02059291|54254531|FG014|Epoch 4|Pregnancy|0|||
27799909|NCT02059291|54254532|FG015|Epoch 4|Pregnancy|0|||
28020155|NCT00296491|54679647|FG000|Overall Study|Protocol Violation|4|||
28020156|NCT00296491|54679648|FG001|Overall Study|Protocol Violation|6|||
28020157|NCT00296491|54679649|FG002|Overall Study|Protocol Violation|2|||
28020158|NCT00296491|54679650|FG003|Overall Study|Protocol Violation|3|||
28020159|NCT00296491|54679647|FG000|Overall Study|Adverse Event|1|||
28020160|NCT00296491|54679648|FG001|Overall Study|Adverse Event|3|||
28020161|NCT00296491|54679649|FG002|Overall Study|Adverse Event|1|||
28020162|NCT00296491|54679650|FG003|Overall Study|Adverse Event|4|||
28020163|NCT00296491|54679647|FG000|Overall Study|Withdrawn due to Asthma|0|||
28020164|NCT00296491|54679648|FG001|Overall Study|Withdrawn due to Asthma|0|||
28020165|NCT00296491|54679649|FG002|Overall Study|Withdrawn due to Asthma|0|||
28020166|NCT00296491|54679650|FG003|Overall Study|Withdrawn due to Asthma|4|||
28020167|NCT00296491|54679647|FG000|Overall Study|Withdrawal by Subject|7|||
28020168|NCT00296491|54679648|FG001|Overall Study|Withdrawal by Subject|3|||
28020169|NCT00296491|54679649|FG002|Overall Study|Withdrawal by Subject|3|||
28020170|NCT00296491|54679650|FG003|Overall Study|Withdrawal by Subject|2|||
28020171|NCT00296491|54679647|FG000|Overall Study|Non-Compliance|12|||
28020172|NCT00296491|54679648|FG001|Overall Study|Non-Compliance|13|||
28020173|NCT00296491|54679649|FG002|Overall Study|Non-Compliance|10|||
28020174|NCT00296491|54679650|FG003|Overall Study|Non-Compliance|14|||
28020175|NCT00296491|54679647|FG000|Overall Study|Lost to Follow-up|0|||
28020176|NCT00296491|54679648|FG001|Overall Study|Lost to Follow-up|2|||
28020177|NCT00296491|54679649|FG002|Overall Study|Lost to Follow-up|2|||
28020178|NCT00296491|54679650|FG003|Overall Study|Lost to Follow-up|0|||
28020179|NCT00747617|54679669|FG000|Overall Study|Lost to Follow-up|3|||
28020180|NCT00747617|54679670|FG001|Overall Study|Lost to Follow-up|1|||
28020181|NCT00296335|54679678|FG000|Overall Study|Recurrence|3|||
28020182|NCT00296335|54679679|FG001|Overall Study|Recurrence|51|||
28020183|NCT00296335|54679678|FG000|Overall Study|Adverse Event|17|||
28020184|NCT00296335|54679679|FG001|Overall Study|Adverse Event|27|||
28020185|NCT00296335|54679678|FG000|Overall Study|Lost to Follow-up|7|||
28020186|NCT00296335|54679679|FG001|Overall Study|Lost to Follow-up|33|||
28020187|NCT00296335|54679678|FG000|Overall Study|Physician Decision|3|||
28020188|NCT00296335|54679679|FG001|Overall Study|Physician Decision|11|||
28020189|NCT00747461|54679687|FG000|Overall Study|study terminated by sponsor|5|||
27799910|NCT02059291|54254533|FG016|Epoch 4|Pregnancy|1|||
27799911|NCT02059291|54254534|FG017|Epoch 4|Pregnancy|0|||
27799912|NCT02059291|54254535|FG018|Epoch 4|Pregnancy|0|||
27799913|NCT02059291|54254536|FG019|Epoch 4|Pregnancy|0|||
27799914|NCT02059291|54254537|FG020|Epoch 4|Pregnancy|0|||
27799915|NCT02059291|54254538|FG021|Epoch 4|Pregnancy|0|||
27799916|NCT02059291|54254539|FG022|Epoch 4|Pregnancy|0|||
27799917|NCT02059291|54254540|FG023|Epoch 4|Pregnancy|0|||
28020190|NCT03683758|54679694|FG000|Overall Study|Non-study commitment conflict|1|||
28020191|NCT03683758|54679695|FG001|Overall Study|Non-study commitment conflict|3|||
28020192|NCT03683758|54679694|FG000|Overall Study|Illness preventing participation|1|||
28020193|NCT03683758|54679695|FG001|Overall Study|Illness preventing participation|0|||
28020194|NCT03683758|54679694|FG000|Overall Study|Adverse Event|1|||
28020195|NCT03683758|54679695|FG001|Overall Study|Adverse Event|0|||
28020196|NCT00522418|54679703|FG000|Overall Study|Local IRB Consent Violation|5|||
28020197|NCT00522418|54679704|FG001|Overall Study|Local IRB Consent Violation|5|||
28020198|NCT00522418|54679703|FG000|Overall Study|Early Study Termination|46|||
28020199|NCT00522418|54679704|FG001|Overall Study|Early Study Termination|47|||
28020200|NCT00522418|54679703|FG000|Overall Study|Noncompliance|2|||
28020201|NCT00522418|54679704|FG001|Overall Study|Noncompliance|2|||
28020202|NCT00522418|54679703|FG000|Overall Study|Reason Not Specified|3|||
28020203|NCT00522418|54679704|FG001|Overall Study|Reason Not Specified|1|||
28020204|NCT00522418|54679703|FG000|Overall Study|Consent Withdraw|1|||
28020205|NCT00522418|54679704|FG001|Overall Study|Consent Withdraw|2|||
28020206|NCT00522418|54679703|FG000|Overall Study|Lack of Efficacy|0|||
28020207|NCT00522418|54679704|FG001|Overall Study|Lack of Efficacy|1|||
28020208|NCT00624780|54679718|FG000|Treatment Optimization (Up to Week 12)|Adverse Event|7|||
28020209|NCT00624780|54679719|FG001|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
28020210|NCT00624780|54679720|FG002|Treatment Optimization (Up to Week 12)|Adverse Event|15|||
28020211|NCT00624780|54679721|FG003|Treatment Optimization (Up to Week 12)|Adverse Event|3|||
28020212|NCT00624780|54679722|FG004|Treatment Optimization (Up to Week 12)|Adverse Event|9|||
28020213|NCT00624780|54679723|FG005|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
28020214|NCT00624780|54679718|FG000|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
28020215|NCT00624780|54679719|FG001|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2|||
28020216|NCT00624780|54679720|FG002|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10|||
28020217|NCT00624780|54679721|FG003|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
28020218|NCT00624780|54679722|FG004|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9|||
28020219|NCT00624780|54679723|FG005|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1|||
28020220|NCT00624780|54679718|FG000|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
28020221|NCT00624780|54679719|FG001|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
28020222|NCT00624780|54679720|FG002|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
28020223|NCT00624780|54679721|FG003|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
28020224|NCT00624780|54679722|FG004|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
28020225|NCT00624780|54679723|FG005|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
28020226|NCT00624780|54679718|FG000|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
28020227|NCT00624780|54679719|FG001|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2|||
28020228|NCT00624780|54679720|FG002|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7|||
28020229|NCT00624780|54679721|FG003|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
28020230|NCT00624780|54679722|FG004|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
28020231|NCT00624780|54679723|FG005|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
28020232|NCT00624780|54679718|FG000|Treatment Optimization (Up to Week 12)|Other|10|||
28020233|NCT00624780|54679719|FG001|Treatment Optimization (Up to Week 12)|Other|4|||
28020234|NCT00624780|54679720|FG002|Treatment Optimization (Up to Week 12)|Other|8|||
28020235|NCT00624780|54679721|FG003|Treatment Optimization (Up to Week 12)|Other|2|||
28020236|NCT00624780|54679722|FG004|Treatment Optimization (Up to Week 12)|Other|9|||
28020237|NCT00624780|54679723|FG005|Treatment Optimization (Up to Week 12)|Other|0|||
28020238|NCT00624780|54679718|FG000|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
28020239|NCT00624780|54679719|FG001|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4|||
28020240|NCT00624780|54679720|FG002|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
28020241|NCT00624780|54679721|FG003|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2|||
28020242|NCT00624780|54679722|FG004|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3|||
28020243|NCT00624780|54679723|FG005|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1|||
28020244|NCT00624780|54679718|FG000|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
28020245|NCT00624780|54679719|FG001|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1|||
28020246|NCT00624780|54679720|FG002|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
28020247|NCT00624780|54679721|FG003|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
28020248|NCT00624780|54679722|FG004|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
28020249|NCT00624780|54679723|FG005|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
28020250|NCT00624780|54679718|FG000|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
28020251|NCT00624780|54679719|FG001|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
28020252|NCT00624780|54679720|FG002|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
28020253|NCT00624780|54679721|FG003|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
28020254|NCT00624780|54679722|FG004|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
28020255|NCT00624780|54679723|FG005|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
28020256|NCT00624780|54679718|FG000|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
28020257|NCT00624780|54679719|FG001|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
27842809|NCT01532414|54331663|FG001|Overall Study|Adverse Event|1|||
27799918|NCT02059291|54254541|FG024|Epoch 4|Pregnancy|0|||
27799919|NCT02059291|54254517|FG000|Epoch 4|Withdrawal by Subject|0|||
28020258|NCT00624780|54679720|FG002|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
28020259|NCT00624780|54679721|FG003|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
28020260|NCT00624780|54679722|FG004|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
28020261|NCT00624780|54679723|FG005|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
28020262|NCT00624780|54679718|FG000|Fixed Dosing (Week 13 to Week 24)|Other|5|||
28020263|NCT00624780|54679719|FG001|Fixed Dosing (Week 13 to Week 24)|Other|3|||
28020264|NCT00624780|54679720|FG002|Fixed Dosing (Week 13 to Week 24)|Other|4|||
28020265|NCT00624780|54679721|FG003|Fixed Dosing (Week 13 to Week 24)|Other|1|||
28020266|NCT00624780|54679722|FG004|Fixed Dosing (Week 13 to Week 24)|Other|4|||
28020267|NCT00624780|54679723|FG005|Fixed Dosing (Week 13 to Week 24)|Other|3|||
28020268|NCT00624780|54679718|FG000|Treatment Discontinuation (Week 25)|Adverse Event|1|||
28020269|NCT00624780|54679719|FG001|Treatment Discontinuation (Week 25)|Adverse Event|0|||
28020270|NCT00624780|54679720|FG002|Treatment Discontinuation (Week 25)|Adverse Event|2|||
28020271|NCT00624780|54679721|FG003|Treatment Discontinuation (Week 25)|Adverse Event|1|||
28020272|NCT00624780|54679722|FG004|Treatment Discontinuation (Week 25)|Adverse Event|0|||
28020273|NCT00624780|54679723|FG005|Treatment Discontinuation (Week 25)|Adverse Event|1|||
28020274|NCT00624780|54679718|FG000|Treatment Discontinuation (Week 25)|Lack of Efficacy|1|||
28020275|NCT00624780|54679719|FG001|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
28020276|NCT00624780|54679720|FG002|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
28020277|NCT00624780|54679721|FG003|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
28020278|NCT00624780|54679722|FG004|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
28020279|NCT00624780|54679723|FG005|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
28020280|NCT00624780|54679718|FG000|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
28020281|NCT00624780|54679719|FG001|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
28020282|NCT00624780|54679720|FG002|Treatment Discontinuation (Week 25)|Lost to Follow-up|1|||
28020283|NCT00624780|54679721|FG003|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
28020284|NCT00624780|54679722|FG004|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
28020285|NCT00624780|54679723|FG005|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
28020286|NCT00624780|54679718|FG000|Follow-up (Week 26)|Death|0|||
28020287|NCT00624780|54679719|FG001|Follow-up (Week 26)|Death|0|||
28020288|NCT00624780|54679720|FG002|Follow-up (Week 26)|Death|1|||
28020289|NCT00624780|54679721|FG003|Follow-up (Week 26)|Death|0|||
28020290|NCT00624780|54679722|FG004|Follow-up (Week 26)|Death|0|||
28020291|NCT00624780|54679723|FG005|Follow-up (Week 26)|Death|0|||
28020292|NCT00624780|54679718|FG000|Follow-up (Week 26)|Adverse Event|0|||
28020293|NCT00624780|54679719|FG001|Follow-up (Week 26)|Adverse Event|0|||
28020294|NCT00624780|54679720|FG002|Follow-up (Week 26)|Adverse Event|0|||
28020295|NCT00624780|54679721|FG003|Follow-up (Week 26)|Adverse Event|0|||
28020296|NCT00624780|54679722|FG004|Follow-up (Week 26)|Adverse Event|1|||
28020297|NCT00624780|54679723|FG005|Follow-up (Week 26)|Adverse Event|0|||
28020298|NCT00624780|54679718|FG000|Follow-up (Week 26)|Lost to Follow-up|0|||
27799920|NCT02059291|54254518|FG001|Epoch 4|Withdrawal by Subject|0|||
27799921|NCT02059291|54254519|FG002|Epoch 4|Withdrawal by Subject|0|||
27799922|NCT02059291|54254520|FG003|Epoch 4|Withdrawal by Subject|0|||
27799923|NCT02059291|54254521|FG004|Epoch 4|Withdrawal by Subject|0|||
27799924|NCT02059291|54254522|FG005|Epoch 4|Withdrawal by Subject|0|||
27799925|NCT02059291|54254523|FG006|Epoch 4|Withdrawal by Subject|0|||
27799926|NCT02059291|54254524|FG007|Epoch 4|Withdrawal by Subject|0|||
27799927|NCT02059291|54254525|FG008|Epoch 4|Withdrawal by Subject|0|||
27799928|NCT02059291|54254526|FG009|Epoch 4|Withdrawal by Subject|0|||
27799929|NCT02059291|54254527|FG010|Epoch 4|Withdrawal by Subject|0|||
27799930|NCT02059291|54254528|FG011|Epoch 4|Withdrawal by Subject|0|||
27799931|NCT02059291|54254529|FG012|Epoch 4|Withdrawal by Subject|0|||
27799932|NCT02059291|54254530|FG013|Epoch 4|Withdrawal by Subject|0|||
27799933|NCT02059291|54254531|FG014|Epoch 4|Withdrawal by Subject|0|||
27799934|NCT02059291|54254532|FG015|Epoch 4|Withdrawal by Subject|0|||
27799935|NCT02059291|54254533|FG016|Epoch 4|Withdrawal by Subject|0|||
27799936|NCT02059291|54254534|FG017|Epoch 4|Withdrawal by Subject|0|||
27799937|NCT02059291|54254535|FG018|Epoch 4|Withdrawal by Subject|0|||
27799938|NCT02059291|54254536|FG019|Epoch 4|Withdrawal by Subject|0|||
27799939|NCT02059291|54254537|FG020|Epoch 4|Withdrawal by Subject|1|||
27842810|NCT01532414|54331664|FG002|Overall Study|Adverse Event|1|||
27842811|NCT01532414|54331662|FG000|Overall Study|Unable to complete 24 hour PK|0|||
28020299|NCT00624780|54679719|FG001|Follow-up (Week 26)|Lost to Follow-up|0|||
28020300|NCT00624780|54679720|FG002|Follow-up (Week 26)|Lost to Follow-up|1|||
28020301|NCT00624780|54679721|FG003|Follow-up (Week 26)|Lost to Follow-up|0|||
28020302|NCT00624780|54679722|FG004|Follow-up (Week 26)|Lost to Follow-up|1|||
27799940|NCT02059291|54254538|FG021|Epoch 4|Withdrawal by Subject|0|||
27799941|NCT02059291|54254539|FG022|Epoch 4|Withdrawal by Subject|0|||
27799942|NCT02059291|54254540|FG023|Epoch 4|Withdrawal by Subject|0|||
27799943|NCT02059291|54254541|FG024|Epoch 4|Withdrawal by Subject|0|||
27799944|NCT02059291|54254517|FG000|Epoch 4|Lack of Efficacy|0|||
27799945|NCT02059291|54254518|FG001|Epoch 4|Lack of Efficacy|0|||
27799946|NCT02059291|54254519|FG002|Epoch 4|Lack of Efficacy|0|||
28020303|NCT00624780|54679723|FG005|Follow-up (Week 26)|Lost to Follow-up|0|||
28020304|NCT00624780|54679718|FG000|Follow-up (Week 26)|Withdrawal by Subject|1|||
28020305|NCT00624780|54679719|FG001|Follow-up (Week 26)|Withdrawal by Subject|0|||
28020306|NCT00624780|54679720|FG002|Follow-up (Week 26)|Withdrawal by Subject|0|||
28020307|NCT00624780|54679721|FG003|Follow-up (Week 26)|Withdrawal by Subject|0|||
28020308|NCT00624780|54679722|FG004|Follow-up (Week 26)|Withdrawal by Subject|0|||
28020309|NCT00624780|54679723|FG005|Follow-up (Week 26)|Withdrawal by Subject|0|||
28020310|NCT00624780|54679718|FG000|Follow-up (Week 26)|Other|1|||
28020311|NCT00624780|54679719|FG001|Follow-up (Week 26)|Other|1|||
28020312|NCT00624780|54679720|FG002|Follow-up (Week 26)|Other|0|||
28020313|NCT00624780|54679721|FG003|Follow-up (Week 26)|Other|0|||
28020314|NCT00624780|54679722|FG004|Follow-up (Week 26)|Other|0|||
28020315|NCT00624780|54679723|FG005|Follow-up (Week 26)|Other|0|||
28020316|NCT00750893|54679740|FG000|Overall Study|Adverse Event|5|||
28020317|NCT00750893|54679740|FG000|Overall Study|Withdrawal by Subject|10|||
28020318|NCT00750893|54679740|FG000|Overall Study|Lost to Follow-up|510|||
28020319|NCT00750893|54679740|FG000|Overall Study|Other|17|||
28020320|NCT00753623|54679746|FG000|Phase I (14 Days)|Withdrawal by Subject|1|||
28020321|NCT00753623|54679747|FG001|Phase I (14 Days)|Withdrawal by Subject|1|||
28020322|NCT00753623|54679746|FG000|Phase I (14 Days)|Physician Decision|1|||
28020323|NCT00753623|54679747|FG001|Phase I (14 Days)|Physician Decision|2|||
28020324|NCT00753623|54679746|FG000|Phase I (14 Days)|Adverse Event|0|||
28020325|NCT00753623|54679747|FG001|Phase I (14 Days)|Adverse Event|1|||
28020326|NCT00753623|54679746|FG000|Washout (7 Days)|Physician Decision|1|||
28020327|NCT00753623|54679747|FG001|Washout (7 Days)|Physician Decision|0|||
28020328|NCT00753623|54679746|FG000|Phase II (14 Days)|Physician Decision|0|||
28020329|NCT00753623|54679747|FG001|Phase II (14 Days)|Physician Decision|1|||
28020330|NCT00750737|54679755|FG000|Overall Study|Withdrawal by Subject|3|||
28020331|NCT00750737|54679756|FG001|Overall Study|Withdrawal by Subject|3|||
28020332|NCT00622440|54679764|FG000|Baseline - Week 12 (Treatment)|Received cream but did not return|4|||
28020333|NCT00622440|54679765|FG001|Baseline - Week 12 (Treatment)|Received cream but did not return|1|||
28020334|NCT00622440|54679764|FG000|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3|||
28020335|NCT00622440|54679765|FG001|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5|||
28020336|NCT00622440|54679764|FG000|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0|||
28020337|NCT00622440|54679765|FG001|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1|||
28020338|NCT00622440|54679764|FG000|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0|||
28020339|NCT00622440|54679765|FG001|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1|||
28020340|NCT00744653|54679771|FG000|Overall Study|antineoplastic treatment|11|||
28020341|NCT00744653|54679771|FG000|Overall Study|Death|1|||
28020342|NCT00744653|54679771|FG000|Overall Study|Lost to Follow-up|1|||
28020343|NCT00744653|54679771|FG000|Overall Study|Physician Decision|3|||
28020344|NCT00311311|54679778|FG000|Overall Study|Adverse Event|3|||
28020345|NCT00311311|54679779|FG001|Overall Study|Adverse Event|2|||
28020346|NCT00311311|54679778|FG000|Overall Study|Withdrawal by Subject|1|||
28020347|NCT00311311|54679779|FG001|Overall Study|Withdrawal by Subject|1|||
28020348|NCT00311311|54679778|FG000|Overall Study|Noncompliance|0|||
28020349|NCT00311311|54679779|FG001|Overall Study|Noncompliance|1|||
28020350|NCT00311311|54679778|FG000|Overall Study|Study Termination by Sponsor|3|||
27799947|NCT02059291|54254520|FG003|Epoch 4|Lack of Efficacy|0|||
27799948|NCT02059291|54254521|FG004|Epoch 4|Lack of Efficacy|0|||
27799949|NCT02059291|54254522|FG005|Epoch 4|Lack of Efficacy|0|||
27799950|NCT02059291|54254523|FG006|Epoch 4|Lack of Efficacy|0|||
27799951|NCT02059291|54254524|FG007|Epoch 4|Lack of Efficacy|0|||
27799952|NCT02059291|54254525|FG008|Epoch 4|Lack of Efficacy|0|||
27799953|NCT02059291|54254526|FG009|Epoch 4|Lack of Efficacy|0|||
27799954|NCT02059291|54254527|FG010|Epoch 4|Lack of Efficacy|0|||
27799955|NCT02059291|54254528|FG011|Epoch 4|Lack of Efficacy|0|||
27799956|NCT02059291|54254529|FG012|Epoch 4|Lack of Efficacy|0|||
27799957|NCT02059291|54254530|FG013|Epoch 4|Lack of Efficacy|0|||
27799958|NCT02059291|54254531|FG014|Epoch 4|Lack of Efficacy|0|||
27799959|NCT02059291|54254532|FG015|Epoch 4|Lack of Efficacy|0|||
27799960|NCT02059291|54254533|FG016|Epoch 4|Lack of Efficacy|0|||
28020351|NCT00311311|54679779|FG001|Overall Study|Study Termination by Sponsor|4|||
27799961|NCT02059291|54254534|FG017|Epoch 4|Lack of Efficacy|0|||
27799962|NCT02059291|54254535|FG018|Epoch 4|Lack of Efficacy|0|||
28020352|NCT00311311|54679778|FG000|Overall Study|Death|1|||
28020353|NCT00311311|54679779|FG001|Overall Study|Death|0|||
28020354|NCT00311311|54679778|FG000|Overall Study|Lack of ancillary assistance|0|||
28020355|NCT00311311|54679779|FG001|Overall Study|Lack of ancillary assistance|1|||
28020356|NCT00521404|54679785|FG000|Overall Study|Adverse Event|13|||
28020357|NCT00521404|54679785|FG000|Overall Study|Disease Progression|33|||
28020358|NCT00521404|54679785|FG000|Overall Study|Investigator decision|5|||
28020359|NCT00521404|54679785|FG000|Overall Study|Withdrawal of consent|3|||
27799963|NCT02059291|54254536|FG019|Epoch 4|Lack of Efficacy|0|||
27799964|NCT02059291|54254537|FG020|Epoch 4|Lack of Efficacy|0|||
27799965|NCT02059291|54254538|FG021|Epoch 4|Lack of Efficacy|0|||
27799966|NCT02059291|54254539|FG022|Epoch 4|Lack of Efficacy|0|||
27799967|NCT02059291|54254540|FG023|Epoch 4|Lack of Efficacy|1|||
27799968|NCT02059291|54254541|FG024|Epoch 4|Lack of Efficacy|0|||
27799969|NCT02042924|54254569|FG000|Overall Study|Early Death|1|||
27799970|NCT02041520|54254575|FG000|Overall Study|Adverse Event|2|||
27799971|NCT02041520|54254576|FG001|Overall Study|Adverse Event|1|||
27799972|NCT02041520|54254575|FG000|Overall Study|Withdrawal by Subject|3|||
27799973|NCT02041520|54254576|FG001|Overall Study|Withdrawal by Subject|4|||
27799974|NCT02041520|54254575|FG000|Overall Study|Protocol Violation|1|||
27799975|NCT02041520|54254576|FG001|Overall Study|Protocol Violation|0|||
27799976|NCT02041520|54254575|FG000|Overall Study|Lost to Follow-up|0|||
27799977|NCT02041520|54254576|FG001|Overall Study|Lost to Follow-up|1|||
27799978|NCT02041520|54254575|FG000|Overall Study|Hypothiroidism identified during follow-|0|||
27799979|NCT02041520|54254576|FG001|Overall Study|Hypothiroidism identified during follow-|1|||
27799980|NCT02041429|54254588|FG000|Overall Study|Progressive Disease|2|||
27799981|NCT02041429|54254589|FG001|Overall Study|Progressive Disease|2|||
27799982|NCT02041429|54254590|FG002|Overall Study|Progressive Disease|3|||
27799983|NCT02041429|54254591|FG003|Overall Study|Progressive Disease|2|||
27799984|NCT02041429|54254588|FG000|Overall Study|Toxicity|0|||
27799985|NCT02041429|54254589|FG001|Overall Study|Toxicity|1|||
27799986|NCT02041429|54254590|FG002|Overall Study|Toxicity|4|||
27799987|NCT02041429|54254591|FG003|Overall Study|Toxicity|2|||
27799988|NCT02041429|54254588|FG000|Overall Study|Withdrawal by Subject|0|||
27799989|NCT02041429|54254589|FG001|Overall Study|Withdrawal by Subject|1|||
27799990|NCT02041429|54254590|FG002|Overall Study|Withdrawal by Subject|0|||
27799991|NCT02041429|54254591|FG003|Overall Study|Withdrawal by Subject|0|||
27799992|NCT02041429|54254588|FG000|Overall Study|On Maintenance Therapy|1|||
27799993|NCT02041429|54254589|FG001|Overall Study|On Maintenance Therapy|0|||
27799994|NCT02041429|54254590|FG002|Overall Study|On Maintenance Therapy|0|||
27799995|NCT02041429|54254591|FG003|Overall Study|On Maintenance Therapy|2|||
27799996|NCT02083783|54254608|FG000|Overall Study|Withdrawal by Subject|1|||
27799997|NCT02083783|54254609|FG001|Overall Study|Withdrawal by Subject|0|||
27799998|NCT02083081|54254619|FG000|Overall Study|Lost to Follow-up|31|||
27799999|NCT02083081|54254620|FG001|Overall Study|Lost to Follow-up|9|||
27800000|NCT02040805|54254628|FG000|Overall Study|Lost to Follow-up|14|||
27800001|NCT02040805|54254629|FG001|Overall Study|Lost to Follow-up|9|||
27800002|NCT02040805|54254628|FG000|Overall Study|Withdrawal by Subject|28|||
27800003|NCT02040805|54254629|FG001|Overall Study|Withdrawal by Subject|41|||
27800004|NCT02040259|54254635|FG000|Overall Study|Death|280|||
27800005|NCT02040259|54254635|FG000|Overall Study|Lost to Follow-up|76|||
27800006|NCT02040259|54254635|FG000|Overall Study|Assessment not completed|3|||
28020360|NCT00521404|54679785|FG000|Overall Study|Noncompliance or lack of cooperation|1|||
28020361|NCT00521404|54679785|FG000|Overall Study|Other|7|||
28020362|NCT00311155|54679789|FG000|Overall Study|Adverse Event|21|||
28020363|NCT00311155|54679789|FG000|Overall Study|Withdrawal by Subject|17|||
28020364|NCT00311155|54679789|FG000|Overall Study|Did not meet entry criteria|55|||
28020365|NCT00292045|54679793|FG000|Core Study (Through Week 13)|Adverse Event|1|||
28020366|NCT00292045|54679793|FG000|Core Study (Through Week 13)|Withdrawal by Subject|1|||
28020367|NCT00274651|54679799|FG000|Overall Study|Adverse Event|6|||
28020368|NCT00274651|54679800|FG001|Overall Study|Adverse Event|3|||
28020369|NCT00274651|54679799|FG000|Overall Study|Lack of Efficacy|13|||
28020370|NCT00274651|54679800|FG001|Overall Study|Lack of Efficacy|6|||
28020371|NCT00274651|54679799|FG000|Overall Study|Death|1|||
28020372|NCT00274651|54679800|FG001|Overall Study|Death|3|||
28020373|NCT00274651|54679799|FG000|Overall Study|Withdrawal by Subject|0|||
28020374|NCT00274651|54679800|FG001|Overall Study|Withdrawal by Subject|1|||
28020375|NCT00274651|54679799|FG000|Overall Study|Physician Decision|8|||
28020376|NCT00274651|54679800|FG001|Overall Study|Physician Decision|7|||
28020377|NCT00274261|54679809|FG000|Overall Study|Adverse Event|19|||
28020378|NCT00274261|54679810|FG001|Overall Study|Adverse Event|11|||
28020379|NCT00274261|54679809|FG000|Overall Study|Pregnancy|114|||
28020380|NCT00274261|54679810|FG001|Overall Study|Pregnancy|83|||
28020381|NCT00274261|54679809|FG000|Overall Study|Withdrawal by Subject|179|||
28020382|NCT00274261|54679810|FG001|Overall Study|Withdrawal by Subject|126|||
28020383|NCT00274261|54679809|FG000|Overall Study|Protocol Violation|71|||
28020384|NCT00274261|54679810|FG001|Overall Study|Protocol Violation|42|||
28020385|NCT00274261|54679809|FG000|Overall Study|Lost to Follow-up|106|||
28020386|NCT00274261|54679810|FG001|Overall Study|Lost to Follow-up|75|||
28020387|NCT00624468|54679820|FG000|Double-blind Period|Early Termination Initiated by Sponsor|13|||
28020388|NCT00624468|54679821|FG001|Double-blind Period|Early Termination Initiated by Sponsor|12|||
28020389|NCT00624468|54679822|FG002|Double-blind Period|Early Termination Initiated by Sponsor|0|||
28020390|NCT00624468|54679823|FG003|Double-blind Period|Early Termination Initiated by Sponsor|0|||
27800007|NCT02040259|54254635|FG000|Overall Study|Withdrawal by Subject|4|||
27800008|NCT02059135|54254643|FG000|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3|||
27800009|NCT02059135|54254644|FG001|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2|||
27800010|NCT02059135|54254643|FG000|Maternal Follow-up (ITT Population)|Lost to Follow-up|0|||
27800011|NCT02059135|54254644|FG001|Maternal Follow-up (ITT Population)|Lost to Follow-up|3|||
28020391|NCT00624468|54679820|FG000|Double-blind Period|Withdrew Prematurely|1|||
28020392|NCT00624468|54679821|FG001|Double-blind Period|Withdrew Prematurely|1|||
28020393|NCT00624468|54679822|FG002|Double-blind Period|Withdrew Prematurely|0|||
28020394|NCT00624468|54679823|FG003|Double-blind Period|Withdrew Prematurely|0|||
28020395|NCT00624468|54679820|FG000|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
28020396|NCT00624468|54679821|FG001|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
28020397|NCT00624468|54679822|FG002|Safety Follow-up (SFU) Period|Lost to Follow-up|1|||
28020398|NCT00624468|54679823|FG003|Safety Follow-up (SFU) Period|Lost to Follow-up|2|||
28020399|NCT00624468|54679820|FG000|Safety Follow-up (SFU) Period|Other|0|||
28020400|NCT00624468|54679821|FG001|Safety Follow-up (SFU) Period|Other|0|||
28020401|NCT00624468|54679822|FG002|Safety Follow-up (SFU) Period|Other|1|||
28020402|NCT00624468|54679823|FG003|Safety Follow-up (SFU) Period|Other|1|||
28020403|NCT00521014|54679831|FG000|Overall Study|Inevaluable, not treated|1|||
28020404|NCT00560235|54679838|FG000|Phase 1|Discontinued|8|||
28020405|NCT00560235|54679839|FG001|Phase 1|Discontinued|0|||
28020406|NCT00560235|54679840|FG002|Phase 1|Discontinued|0|||
28020407|NCT00560235|54679838|FG000|Phase 1B|Discontinued|0|||
28020408|NCT00560235|54679839|FG001|Phase 1B|Discontinued|19|||
28020409|NCT00560235|54679840|FG002|Phase 1B|Discontinued|0|||
28020410|NCT00560235|54679838|FG000|Phase 2|Discontinued|0|||
28020411|NCT00560235|54679839|FG001|Phase 2|Discontinued|0|||
28020412|NCT00560235|54679840|FG002|Phase 2|Discontinued|96|||
28020413|NCT00560235|54679838|FG000|Phase 2|Ongoing at Date of Cut-Off|0|||
28020414|NCT00560235|54679839|FG001|Phase 2|Ongoing at Date of Cut-Off|0|||
28020415|NCT00560235|54679840|FG002|Phase 2|Ongoing at Date of Cut-Off|1|||
28020416|NCT00291577|54679858|FG000|Overall Study|Adverse Event|1|||
28020417|NCT00291577|54679858|FG000|Overall Study|Other|4|||
28020418|NCT00291577|54679858|FG000|Overall Study|Withdrawal by Subject|2|||
28020419|NCT00291577|54679858|FG000|Overall Study|Lack of Efficacy|14|||
27800012|NCT02059135|54254643|FG000|Maternal Follow-up (ITT Population)|declined to see site staff|0|||
27800013|NCT02059135|54254644|FG001|Maternal Follow-up (ITT Population)|declined to see site staff|1|||
27800014|NCT02059135|54254643|FG000|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0|||
28020420|NCT00520936|54679870|FG000|Overall Study|Physician Decision|0|||
28020421|NCT00520936|54679871|FG001|Overall Study|Physician Decision|2|||
28020422|NCT00520936|54679872|FG002|Overall Study|Physician Decision|1|||
28020423|NCT00520936|54679873|FG003|Overall Study|Physician Decision|0|||
28020424|NCT00520936|54679874|FG004|Overall Study|Physician Decision|0|||
28020425|NCT00520936|54679875|FG005|Overall Study|Physician Decision|0|||
28020426|NCT00520936|54679876|FG006|Overall Study|Physician Decision|0|||
28020427|NCT00520936|54679877|FG007|Overall Study|Physician Decision|0|||
28020428|NCT00520936|54679870|FG000|Overall Study|Withdrawal by Subject|0|||
28020429|NCT00520936|54679871|FG001|Overall Study|Withdrawal by Subject|0|||
28020430|NCT00520936|54679872|FG002|Overall Study|Withdrawal by Subject|0|||
28020431|NCT00520936|54679873|FG003|Overall Study|Withdrawal by Subject|0|||
28020432|NCT00520936|54679874|FG004|Overall Study|Withdrawal by Subject|0|||
28020433|NCT00520936|54679875|FG005|Overall Study|Withdrawal by Subject|0|||
28020434|NCT00520936|54679876|FG006|Overall Study|Withdrawal by Subject|0|||
28020435|NCT00520936|54679877|FG007|Overall Study|Withdrawal by Subject|1|||
28020436|NCT00520936|54679870|FG000|Overall Study|Toxicity Requiring Removal from Study|0|||
28020437|NCT00520936|54679871|FG001|Overall Study|Toxicity Requiring Removal from Study|1|||
28020438|NCT00520936|54679872|FG002|Overall Study|Toxicity Requiring Removal from Study|0|||
28020439|NCT00520936|54679873|FG003|Overall Study|Toxicity Requiring Removal from Study|0|||
28020440|NCT00520936|54679874|FG004|Overall Study|Toxicity Requiring Removal from Study|0|||
28020441|NCT00520936|54679875|FG005|Overall Study|Toxicity Requiring Removal from Study|0|||
28020442|NCT00520936|54679876|FG006|Overall Study|Toxicity Requiring Removal from Study|2|||
28020443|NCT00520936|54679877|FG007|Overall Study|Toxicity Requiring Removal from Study|0|||
28020444|NCT00520936|54679870|FG000|Overall Study|Death|0|||
28020445|NCT00520936|54679871|FG001|Overall Study|Death|0|||
28020446|NCT00520936|54679872|FG002|Overall Study|Death|0|||
28020447|NCT00520936|54679873|FG003|Overall Study|Death|0|||
28020448|NCT00520936|54679874|FG004|Overall Study|Death|0|||
28020449|NCT00520936|54679875|FG005|Overall Study|Death|0|||
28020450|NCT00520936|54679876|FG006|Overall Study|Death|1|||
28020451|NCT00520936|54679877|FG007|Overall Study|Death|0|||
28020452|NCT00520936|54679870|FG000|Overall Study|Protocol Violation|0|||
28020453|NCT00520936|54679871|FG001|Overall Study|Protocol Violation|1|||
28020454|NCT00520936|54679872|FG002|Overall Study|Protocol Violation|1|||
28020455|NCT00520936|54679873|FG003|Overall Study|Protocol Violation|0|||
28020456|NCT00520936|54679874|FG004|Overall Study|Protocol Violation|1|||
28020457|NCT00520936|54679875|FG005|Overall Study|Protocol Violation|0|||
28020458|NCT00520936|54679876|FG006|Overall Study|Protocol Violation|1|||
28020459|NCT00520936|54679877|FG007|Overall Study|Protocol Violation|0|||
28020460|NCT03867760|54679890|FG000|Overall Study|Lost to Follow-up|2|||
27800015|NCT02059135|54254644|FG001|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1|||
28020461|NCT03867760|54679891|FG001|Overall Study|Lost to Follow-up|3|||
28020462|NCT03867760|54679890|FG000|Overall Study|Withdrawal by Subject|1|||
28020463|NCT03867760|54679891|FG001|Overall Study|Withdrawal by Subject|2|||
28020464|NCT03867760|54679890|FG000|Overall Study|subject could not meet study logistics|3|||
28020465|NCT03867760|54679891|FG001|Overall Study|subject could not meet study logistics|3|||
28020466|NCT03865732|54679901|FG000|Overall Study|Adverse Event|0|||
28020467|NCT03865732|54679902|FG001|Overall Study|Adverse Event|1|||
28020468|NCT00520546|54679909|FG000|Overall Study|Withdrawal by Subject|1|||
28020469|NCT00520546|54679909|FG000|Overall Study|failed radiopharmaceut. synthesis of FEC|5|||
28020470|NCT00555009|54679920|FG000|Overall Study|Withdrawal by Subject|0|||
28020471|NCT00555009|54679921|FG001|Overall Study|Withdrawal by Subject|1|||
28020472|NCT00555009|54679920|FG000|Overall Study|Terminated by Sponsor|2|||
28020473|NCT00555009|54679921|FG001|Overall Study|Terminated by Sponsor|5|||
28020474|NCT00623766|54679929|FG000|Induction Phase (Day 1 to Week 24)|Off treatment|36|||
28020475|NCT00623766|54679930|FG001|Induction Phase (Day 1 to Week 24)|Off treatment|16|||
28020476|NCT00623766|54679929|FG000|Maintenance Phase (Week 24 to Year 2)|Disease progression|4|||
28020477|NCT00623766|54679930|FG001|Maintenance Phase (Week 24 to Year 2)|Disease progression|0|||
28020478|NCT00623766|54679929|FG000|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4|||
28020479|NCT00623766|54679930|FG001|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0|||
28020480|NCT00623766|54679929|FG000|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1|||
28020481|NCT00623766|54679930|FG001|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2|||
28020482|NCT00623766|54679929|FG000|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1|||
28020483|NCT00623766|54679930|FG001|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0|||
28020484|NCT00550407|54679942|FG000|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55|||
28020485|NCT00550407|54679943|FG001|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
28020486|NCT00550407|54679944|FG002|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
28020487|NCT00550407|54679942|FG000|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39|||
28020488|NCT00550407|54679943|FG001|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
28020489|NCT00550407|54679944|FG002|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
28020490|NCT00550407|54679942|FG000|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1|||
28020491|NCT00550407|54679943|FG001|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
28020492|NCT00550407|54679944|FG002|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
28020493|NCT00550407|54679942|FG000|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1|||
28020494|NCT00550407|54679943|FG001|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
28020495|NCT00550407|54679944|FG002|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
28020496|NCT00550407|54679942|FG000|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1|||
28020497|NCT00550407|54679943|FG001|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
28020498|NCT00550407|54679944|FG002|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
28020499|NCT00550407|54679942|FG000|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8|||
28020500|NCT00550407|54679943|FG001|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
28020501|NCT00550407|54679944|FG002|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
28020502|NCT00550407|54679942|FG000|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6|||
28020503|NCT00550407|54679943|FG001|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
28020504|NCT00550407|54679944|FG002|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
28020505|NCT00550407|54679942|FG000|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1|||
28020506|NCT00550407|54679943|FG001|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
28020507|NCT00550407|54679944|FG002|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
28020508|NCT00550407|54679942|FG000|26-Week Randomized Phase|Adverse Event|0|||
28020509|NCT00550407|54679943|FG001|26-Week Randomized Phase|Adverse Event|5|||
28020510|NCT00550407|54679944|FG002|26-Week Randomized Phase|Adverse Event|2|||
28020511|NCT00550407|54679942|FG000|26-Week Randomized Phase|Lack of Efficacy|0|||
28020512|NCT00550407|54679943|FG001|26-Week Randomized Phase|Lack of Efficacy|36|||
28020513|NCT00550407|54679944|FG002|26-Week Randomized Phase|Lack of Efficacy|19|||
28020514|NCT00550407|54679942|FG000|26-Week Randomized Phase|Investigator Discretion|0|||
28020515|NCT00550407|54679943|FG001|26-Week Randomized Phase|Investigator Discretion|1|||
28020516|NCT00550407|54679944|FG002|26-Week Randomized Phase|Investigator Discretion|0|||
28020517|NCT00550407|54679942|FG000|26-Week Randomized Phase|Withdrawal by Subject|0|||
28020518|NCT00550407|54679943|FG001|26-Week Randomized Phase|Withdrawal by Subject|1|||
28020519|NCT00550407|54679944|FG002|26-Week Randomized Phase|Withdrawal by Subject|3|||
28020520|NCT00531934|54679954|FG000|Overall Study|Adverse Event|4|||
27800016|NCT02059135|54254643|FG000|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1|||
27800017|NCT02059135|54254644|FG001|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0|||
27800018|NCT02059135|54254643|FG000|Neonatal Follow-up (Safety Population)|Death|3|||
27800019|NCT02059135|54254644|FG001|Neonatal Follow-up (Safety Population)|Death|2|||
27800020|NCT02059135|54254643|FG000|Neonatal Follow-up (Safety Population)|delivered at another hospital|0|||
27800021|NCT02059135|54254644|FG001|Neonatal Follow-up (Safety Population)|delivered at another hospital|1|||
27800022|NCT02059135|54254643|FG000|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0|||
27800023|NCT02059135|54254644|FG001|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1|||
27800024|NCT02081677|54254656|FG000|Overall Study|Adverse Event|0|||
27800025|NCT02081677|54254657|FG001|Overall Study|Adverse Event|0|||
28020521|NCT00531934|54679955|FG001|Overall Study|Adverse Event|8|||
28020522|NCT00531934|54679954|FG000|Overall Study|Progression|52|||
28020523|NCT00531934|54679955|FG001|Overall Study|Progression|42|||
28020524|NCT00531934|54679954|FG000|Overall Study|Death|7|||
28020525|NCT00531934|54679955|FG001|Overall Study|Death|10|||
28020526|NCT00531934|54679954|FG000|Overall Study|Withdrawal by Subject|1|||
28020527|NCT00531934|54679955|FG001|Overall Study|Withdrawal by Subject|1|||
28020528|NCT00531934|54679954|FG000|Overall Study|Other|2|||
28020529|NCT00531934|54679955|FG001|Overall Study|Other|2|||
28020530|NCT00549939|54679964|FG000|12-week Double Blind Treatment Period|Adverse Event|1|||
28020531|NCT00549939|54679965|FG001|12-week Double Blind Treatment Period|Adverse Event|1|||
28020532|NCT00549939|54679966|FG002|12-week Double Blind Treatment Period|Adverse Event|2|||
28020533|NCT00549939|54679964|FG000|12-week Double Blind Treatment Period|Too many blood draws|0|||
28020534|NCT00549939|54679965|FG001|12-week Double Blind Treatment Period|Too many blood draws|1|||
28020535|NCT00549939|54679966|FG002|12-week Double Blind Treatment Period|Too many blood draws|0|||
28020536|NCT00549939|54679964|FG000|40-week Open Label Treatment Period|Adverse Event|0|||
28020537|NCT00549939|54679965|FG001|40-week Open Label Treatment Period|Adverse Event|2|||
28020538|NCT00549939|54679966|FG002|40-week Open Label Treatment Period|Adverse Event|1|||
28020539|NCT00549939|54679964|FG000|40-week Open Label Treatment Period|Lack of Efficacy|0|||
28020540|NCT00549939|54679965|FG001|40-week Open Label Treatment Period|Lack of Efficacy|1|||
28020541|NCT00549939|54679966|FG002|40-week Open Label Treatment Period|Lack of Efficacy|0|||
28020542|NCT00549939|54679964|FG000|40-week Open Label Treatment Period|Protocol Violation|0|||
28020543|NCT00549939|54679965|FG001|40-week Open Label Treatment Period|Protocol Violation|1|||
28020544|NCT00549939|54679966|FG002|40-week Open Label Treatment Period|Protocol Violation|0|||
28020545|NCT00549939|54679964|FG000|40-week Open Label Treatment Period|Other|0|||
28020546|NCT00549939|54679965|FG001|40-week Open Label Treatment Period|Other|1|||
28020547|NCT00549939|54679966|FG002|40-week Open Label Treatment Period|Other|4|||
28020548|NCT00272779|54679978|FG000|Baseline Through Week 48|Adverse event before Week 48|10|||
28020549|NCT00272779|54679979|FG001|Baseline Through Week 48|Adverse event before Week 48|14|||
28020550|NCT00272779|54679978|FG000|Baseline Through Week 48|Death before Week 48|4|||
28020551|NCT00272779|54679979|FG001|Baseline Through Week 48|Death before Week 48|4|||
28020552|NCT00272779|54679978|FG000|Baseline Through Week 48|Lack of efficacy before Week 48|5|||
28020553|NCT00272779|54679979|FG001|Baseline Through Week 48|Lack of efficacy before Week 48|8|||
28020554|NCT00272779|54679978|FG000|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
28020555|NCT00272779|54679979|FG001|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
28020556|NCT00272779|54679978|FG000|Baseline Through Week 48|Viral load rebound before Week 48|1|||
28020557|NCT00272779|54679979|FG001|Baseline Through Week 48|Viral load rebound before Week 48|0|||
28020558|NCT00272779|54679978|FG000|Baseline Through Week 48|Poor/non compliance before Week 48|6|||
28020559|NCT00272779|54679979|FG001|Baseline Through Week 48|Poor/non compliance before Week 48|9|||
28020560|NCT00272779|54679978|FG000|Baseline Through Week 48|Pregnancy before Week 48|2|||
28020561|NCT00272779|54679979|FG001|Baseline Through Week 48|Pregnancy before Week 48|2|||
28020562|NCT00272779|54679978|FG000|Baseline Through Week 48|No longer meets criteria before Week 48|1|||
28020563|NCT00272779|54679979|FG001|Baseline Through Week 48|No longer meets criteria before Week 48|0|||
28020564|NCT00272779|54679978|FG000|Baseline Through Week 48|Withdrew consent before Week 48|4|||
28020565|NCT00272779|54679979|FG001|Baseline Through Week 48|Withdrew consent before Week 48|13|||
28020566|NCT00272779|54679978|FG000|Baseline Through Week 48|Participant's decision before wk 48|0|||
28020567|NCT00272779|54679979|FG001|Baseline Through Week 48|Participant's decision before wk 48|1|||
28020568|NCT00272779|54679978|FG000|Baseline Through Week 48|Chose different site before wk 48|0|||
28020569|NCT00272779|54679979|FG001|Baseline Through Week 48|Chose different site before wk 48|1|||
28020570|NCT00272779|54679978|FG000|Baseline Through Week 48|Adverse event on/after Week 48|1|||
28020571|NCT00272779|54679979|FG001|Baseline Through Week 48|Adverse event on/after Week 48|1|||
28020572|NCT00272779|54679978|FG000|Baseline Through Week 48|Death on/after Week 48|1|||
28020573|NCT00272779|54679979|FG001|Baseline Through Week 48|Death on/after Week 48|1|||
28020574|NCT00272779|54679978|FG000|Baseline Through Week 48|Lack of efficacy on/after Week 48|7|||
28020575|NCT00272779|54679979|FG001|Baseline Through Week 48|Lack of efficacy on/after Week 48|1|||
28020576|NCT00272779|54679978|FG000|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
28020577|NCT00272779|54679979|FG001|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
28020578|NCT00272779|54679978|FG000|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
28020579|NCT00272779|54679979|FG001|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
28020580|NCT00272779|54679978|FG000|Baseline Through Week 48|Pregnancy on/after Week 48|1|||
28020581|NCT00272779|54679979|FG001|Baseline Through Week 48|Pregnancy on/after Week 48|2|||
28020582|NCT00272779|54679978|FG000|Baseline Through Week 48|Withdrew consent on/after Week 48|0|||
28020583|NCT00272779|54679979|FG001|Baseline Through Week 48|Withdrew consent on/after Week 48|2|||
27800026|NCT02081677|54254658|FG002|Overall Study|Adverse Event|1|||
27800027|NCT02081677|54254659|FG003|Overall Study|Adverse Event|0|||
27800028|NCT02081677|54254656|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
27800029|NCT02081677|54254657|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
28020584|NCT00272779|54679978|FG000|Baseline Through Week 48|Continuing treatment|385|||
28020585|NCT00272779|54679979|FG001|Baseline Through Week 48|Continuing treatment|368|||
28020586|NCT00272779|54679978|FG000|Baseline Through Week 48|Lost to follow-up on/after Week 48|0|||
28020587|NCT00272779|54679979|FG001|Baseline Through Week 48|Lost to follow-up on/after Week 48|3|||
28020588|NCT00272779|54679978|FG000|Baseline Through Week 48|Never treated|2|||
28020589|NCT00272779|54679979|FG001|Baseline Through Week 48|Never treated|3|||
28020590|NCT00272779|54679978|FG000|Baseline Through Week 96|Adverse event before Week 96|13|||
28020591|NCT00272779|54679979|FG001|Baseline Through Week 96|Adverse event before Week 96|22|||
28020592|NCT00272779|54679978|FG000|Baseline Through Week 96|Death before Week 96|6|||
28020593|NCT00272779|54679979|FG001|Baseline Through Week 96|Death before Week 96|5|||
28020594|NCT00272779|54679978|FG000|Baseline Through Week 96|Lack of efficacy before Week 96|16|||
28020595|NCT00272779|54679979|FG001|Baseline Through Week 96|Lack of efficacy before Week 96|10|||
28020596|NCT00272779|54679978|FG000|Baseline Through Week 96|Lost to follow up before Week 96|10|||
28020597|NCT00272779|54679979|FG001|Baseline Through Week 96|Lost to follow up before Week 96|13|||
28020598|NCT00272779|54679978|FG000|Baseline Through Week 96|Participant Imprisoned before Week 96|1|||
28020599|NCT00272779|54679979|FG001|Baseline Through Week 96|Participant Imprisoned before Week 96|0|||
28020600|NCT00272779|54679978|FG000|Baseline Through Week 96|Poor/non compliance before Week 96|12|||
28020601|NCT00272779|54679979|FG001|Baseline Through Week 96|Poor/non compliance before Week 96|16|||
28020602|NCT00272779|54679978|FG000|Baseline Through Week 96|Pregnancy before Week 96|5|||
28020603|NCT00272779|54679979|FG001|Baseline Through Week 96|Pregnancy before Week 96|7|||
28020604|NCT00272779|54679978|FG000|Baseline Through Week 96|No longer meets criteria before Week 96|4|||
28020605|NCT00272779|54679979|FG001|Baseline Through Week 96|No longer meets criteria before Week 96|3|||
28020606|NCT00272779|54679978|FG000|Baseline Through Week 96|Withdrew consent before Week 96|5|||
28020607|NCT00272779|54679979|FG001|Baseline Through Week 96|Withdrew consent before Week 96|18|||
28020608|NCT00272779|54679978|FG000|Baseline Through Week 96|Changed address before Week 96|0|||
28020609|NCT00272779|54679979|FG001|Baseline Through Week 96|Changed address before Week 96|1|||
28020610|NCT00272779|54679978|FG000|Baseline Through Week 96|Lost to follow-up at Week 96|1|||
28020611|NCT00272779|54679979|FG001|Baseline Through Week 96|Lost to follow-up at Week 96|0|||
28020612|NCT00272779|54679978|FG000|Baseline Through Week 96|Poor/non compliance at Week 96]|2|||
28020613|NCT00272779|54679979|FG001|Baseline Through Week 96|Poor/non compliance at Week 96]|0|||
28020614|NCT00272779|54679978|FG000|Baseline Through Week 96|Pregnancy at Week 96|1|||
28020615|NCT00272779|54679979|FG001|Baseline Through Week 96|Pregnancy at Week 96|0|||
28020616|NCT00272779|54679978|FG000|Baseline Through Week 96|Never treated|2|||
28020617|NCT00272779|54679979|FG001|Baseline Through Week 96|Never treated|3|||
28020618|NCT00272779|54679978|FG000|Baseline Through Week 96|Continuing on treatment|61|||
28020619|NCT00272779|54679979|FG001|Baseline Through Week 96|Continuing on treatment|38|||
28020620|NCT00511810|54679988|FG000|Overall Study|Lost to Follow-up|1|||
28020621|NCT00511810|54679989|FG001|Overall Study|Lost to Follow-up|2|||
28020622|NCT00511810|54679988|FG000|Overall Study|Lack of Efficacy|0|||
28020623|NCT00511810|54679989|FG001|Overall Study|Lack of Efficacy|2|||
28020624|NCT00511810|54679988|FG000|Overall Study|Refused second scn|0|||
28020625|NCT00511810|54679989|FG001|Overall Study|Refused second scn|1|||
28020626|NCT00291499|54679997|FG000|Overall Study|Adverse Event|3|||
28020627|NCT00291499|54679998|FG001|Overall Study|Adverse Event|8|||
28020628|NCT00291499|54679997|FG000|Overall Study|Change to other therapy|2|||
28020629|NCT00291499|54679998|FG001|Overall Study|Change to other therapy|1|||
28020630|NCT00291499|54679997|FG000|Overall Study|Intercurrent illness|1|||
28020631|NCT00291499|54679998|FG001|Overall Study|Intercurrent illness|0|||
28020632|NCT00291499|54679997|FG000|Overall Study|Protocol Violation|2|||
28020633|NCT00291499|54679998|FG001|Overall Study|Protocol Violation|2|||
28020634|NCT00291499|54679997|FG000|Overall Study|Other reasons|1|||
28020635|NCT00291499|54679998|FG001|Overall Study|Other reasons|4|||
28020636|NCT00553605|54680006|FG000|Overall Study|Did not meet entrance criteria|1|||
28020637|NCT00553605|54680007|FG001|Overall Study|Did not meet entrance criteria|3|||
28020638|NCT00553605|54680006|FG000|Overall Study|Did not receive full dose|1|||
28020639|NCT00553605|54680007|FG001|Overall Study|Did not receive full dose|0|||
28020640|NCT00553605|54680006|FG000|Overall Study|Randomized but not treated|2|||
28020641|NCT00553605|54680007|FG001|Overall Study|Randomized but not treated|0|||
28020642|NCT00621582|54680013|FG000|Overall Study|Adverse Event|7|||
28020643|NCT00621582|54680013|FG000|Overall Study|Protocol Violation|57|||
28020644|NCT00621582|54680013|FG000|Overall Study|Lost to Follow-up|24|||
28020645|NCT00621582|54680013|FG000|Overall Study|issues not identified by investigators|18|||
28020646|NCT00744497|54680019|FG000|Overall Study|Withdrawal by Subject|21|||
28020647|NCT00744497|54680020|FG001|Overall Study|Withdrawal by Subject|18|||
28020648|NCT00744497|54680019|FG000|Overall Study|Death|11|||
28020649|NCT00744497|54680020|FG001|Overall Study|Death|9|||
28020650|NCT00744497|54680019|FG000|Overall Study|Lost to Follow-up|4|||
28020651|NCT00744497|54680020|FG001|Overall Study|Lost to Follow-up|2|||
28020652|NCT00744497|54680019|FG000|Overall Study|Poor compliance/noncompliance|9|||
28020653|NCT00744497|54680020|FG001|Overall Study|Poor compliance/noncompliance|5|||
28020654|NCT00744497|54680019|FG000|Overall Study|No longer meets study criteria|7|||
28020655|NCT00744497|54680020|FG001|Overall Study|No longer meets study criteria|3|||
28020656|NCT00744497|54680019|FG000|Overall Study|Administrative Reason By Sponsor|25|||
28020657|NCT00744497|54680020|FG001|Overall Study|Administrative Reason By Sponsor|8|||
28020658|NCT00744497|54680019|FG000|Overall Study|Disease progression|312|||
28020659|NCT00744497|54680020|FG001|Overall Study|Disease progression|219|||
28020660|NCT00744497|54680019|FG000|Overall Study|Study drug toxicity|68|||
28020661|NCT00744497|54680020|FG001|Overall Study|Study drug toxicity|141|||
28020662|NCT00744497|54680019|FG000|Overall Study|Adverse event unrelated to study drug|78|||
28020663|NCT00744497|54680020|FG001|Overall Study|Adverse event unrelated to study drug|122|||
28020664|NCT00744497|54680019|FG000|Overall Study|Patient requested to stop study drug|65|||
28020665|NCT00744497|54680020|FG001|Overall Study|Patient requested to stop study drug|80|||
28020666|NCT00744497|54680019|FG000|Overall Study|Maximum clinical benefit|141|||
28020667|NCT00744497|54680020|FG001|Overall Study|Maximum clinical benefit|142|||
28020668|NCT00744497|54680019|FG000|Overall Study|Not defined|19|||
28020669|NCT00744497|54680020|FG001|Overall Study|Not defined|13|||
28020670|NCT00747227|54680028|FG000|Overall Study|Death|3|||
28020671|NCT00747227|54680029|FG001|Overall Study|Death|1|||
28020672|NCT00747227|54680028|FG000|Overall Study|Withdrawal by Subject|1|||
28020673|NCT00747227|54680029|FG001|Overall Study|Withdrawal by Subject|0|||
28020674|NCT00747227|54680028|FG000|Overall Study|Lost to Follow-up|1|||
28020675|NCT00747227|54680029|FG001|Overall Study|Lost to Follow-up|2|||
28020676|NCT00747227|54680028|FG000|Overall Study|Illness|1|||
28020677|NCT00747227|54680029|FG001|Overall Study|Illness|1|||
28020678|NCT00747149|54680037|FG000|Overall Study|Adverse Event|0|||
28020679|NCT00747149|54680038|FG001|Overall Study|Adverse Event|15|||
28020680|NCT00747149|54680037|FG000|Overall Study|Lost to Follow-up|0|||
28020681|NCT00747149|54680038|FG001|Overall Study|Lost to Follow-up|10|||
28020682|NCT00747149|54680037|FG000|Overall Study|Withdrawal by Subject|0|||
28020683|NCT00747149|54680038|FG001|Overall Study|Withdrawal by Subject|6|||
28020684|NCT00747149|54680037|FG000|Overall Study|Did not receive treatment|0|||
28020685|NCT00747149|54680038|FG001|Overall Study|Did not receive treatment|1|||
28020686|NCT00747149|54680037|FG000|Overall Study|Incorrect enrollment|0|||
28020687|NCT00747149|54680038|FG001|Overall Study|Incorrect enrollment|6|||
28020688|NCT00747149|54680037|FG000|Overall Study|Severe non-compliance to protocol|0|||
28020689|NCT00747149|54680038|FG001|Overall Study|Severe non-compliance to protocol|1|||
28020690|NCT00747149|54680037|FG000|Overall Study|Not reported|1|||
28020691|NCT00747149|54680038|FG001|Overall Study|Not reported|4|||
28020692|NCT00271609|54680052|FG000|Overall Study|Adverse Event|11|||
28020693|NCT00271609|54680053|FG001|Overall Study|Adverse Event|3|||
28020694|NCT00271609|54680052|FG000|Overall Study|Withdrawal by Subject|2|||
28020695|NCT00271609|54680053|FG001|Overall Study|Withdrawal by Subject|0|||
28020696|NCT00548847|54680059|FG000|Overall Study|Disease progression|7|||
28020697|NCT00290407|54680063|FG000|Overall Study|Physician Decision|2|||
28020698|NCT00749411|54680069|FG000|Overall Study|Adverse Event|0|||
28020699|NCT00749411|54680070|FG001|Overall Study|Adverse Event|2|||
28020700|NCT00749411|54680069|FG000|Overall Study|Lack of Efficacy|0|||
28020701|NCT00749411|54680070|FG001|Overall Study|Lack of Efficacy|1|||
28020702|NCT00749411|54680069|FG000|Overall Study|Protocol Violation|1|||
28020703|NCT00749411|54680070|FG001|Overall Study|Protocol Violation|1|||
28020704|NCT00749411|54680069|FG000|Overall Study|Protocol-defined stopping criteria|0|||
28020705|NCT00749411|54680070|FG001|Overall Study|Protocol-defined stopping criteria|1|||
28020706|NCT03958149|54680078|FG000|Overall Study|Withdrawal by Subject|0|||
28020707|NCT03958149|54680079|FG001|Overall Study|Withdrawal by Subject|1|||
28020708|NCT00549549|54680093|FG000|Overall Study|Adverse Event|5|||
28020709|NCT00549549|54680094|FG001|Overall Study|Adverse Event|3|||
28020710|NCT00549549|54680095|FG002|Overall Study|Adverse Event|1|||
28020711|NCT00549549|54680096|FG003|Overall Study|Adverse Event|9|||
28020712|NCT00549549|54680093|FG000|Overall Study|Lack of Efficacy|9|||
28020713|NCT00549549|54680094|FG001|Overall Study|Lack of Efficacy|6|||
28020714|NCT00549549|54680095|FG002|Overall Study|Lack of Efficacy|4|||
28020715|NCT00549549|54680096|FG003|Overall Study|Lack of Efficacy|2|||
28020716|NCT00549549|54680093|FG000|Overall Study|Lost to Follow-up|1|||
28020717|NCT00549549|54680094|FG001|Overall Study|Lost to Follow-up|0|||
28020718|NCT00549549|54680095|FG002|Overall Study|Lost to Follow-up|1|||
28020719|NCT00549549|54680096|FG003|Overall Study|Lost to Follow-up|2|||
28020720|NCT00549549|54680093|FG000|Overall Study|Withdrawal by Subject|0|||
28020721|NCT00549549|54680094|FG001|Overall Study|Withdrawal by Subject|4|||
28020722|NCT00549549|54680095|FG002|Overall Study|Withdrawal by Subject|1|||
28020723|NCT00549549|54680096|FG003|Overall Study|Withdrawal by Subject|0|||
28020724|NCT00549549|54680093|FG000|Overall Study|Other|9|||
28020725|NCT00549549|54680094|FG001|Overall Study|Other|9|||
28020726|NCT00549549|54680095|FG002|Overall Study|Other|9|||
28020727|NCT00549549|54680096|FG003|Overall Study|Other|11|||
28020728|NCT00549549|54680093|FG000|Overall Study|Randomized but not treated|0|||
28020729|NCT00549549|54680094|FG001|Overall Study|Randomized but not treated|0|||
28020730|NCT00549549|54680095|FG002|Overall Study|Randomized but not treated|1|||
28020731|NCT00549549|54680096|FG003|Overall Study|Randomized but not treated|1|||
28020732|NCT00270205|54680110|FG000|Overall Study|Lost to Follow-up|1|||
28020733|NCT00270205|54680111|FG001|Overall Study|Lost to Follow-up|0|||
28020734|NCT00270205|54680112|FG002|Overall Study|Lost to Follow-up|0|||
28020735|NCT00270205|54680113|FG003|Overall Study|Lost to Follow-up|1|||
28020736|NCT00622284|54680125|FG000|Overall Study|Lack of Efficacy|45|||
28020737|NCT00622284|54680126|FG001|Overall Study|Lack of Efficacy|15|||
28020738|NCT00622284|54680125|FG000|Overall Study|Adverse Event|61|||
28020739|NCT00622284|54680126|FG001|Overall Study|Adverse Event|90|||
28020740|NCT00622284|54680125|FG000|Overall Study|Protocol Violation|12|||
28020741|NCT00622284|54680126|FG001|Overall Study|Protocol Violation|5|||
28020742|NCT00622284|54680125|FG000|Overall Study|Lost to Follow-up|11|||
28020743|NCT00622284|54680126|FG001|Overall Study|Lost to Follow-up|13|||
28020744|NCT00622284|54680125|FG000|Overall Study|Withdrawal by Subject|27|||
28020745|NCT00622284|54680126|FG001|Overall Study|Withdrawal by Subject|24|||
28020746|NCT00622284|54680125|FG000|Overall Study|Other reason (not specified)|33|||
28020747|NCT00622284|54680126|FG001|Overall Study|Other reason (not specified)|24|||
28020748|NCT00269113|54680134|FG000|Overall Study|Adverse Event|14|||
28020749|NCT00269113|54680135|FG001|Overall Study|Adverse Event|7|||
28020750|NCT00269113|54680134|FG000|Overall Study|Lack of Efficacy|35|||
28020751|NCT00269113|54680135|FG001|Overall Study|Lack of Efficacy|18|||
28020752|NCT00269113|54680134|FG000|Overall Study|Early Improvement|2|||
28020753|NCT00269113|54680135|FG001|Overall Study|Early Improvement|0|||
28020754|NCT00269113|54680134|FG000|Overall Study|Withdrawal by Subject|0|||
28020755|NCT00269113|54680135|FG001|Overall Study|Withdrawal by Subject|2|||
28020756|NCT00269113|54680134|FG000|Overall Study|Death|6|||
28020757|NCT00269113|54680135|FG001|Overall Study|Death|2|||
28020758|NCT00269113|54680134|FG000|Overall Study|Lost to Follow-up|2|||
28020759|NCT00269113|54680135|FG001|Overall Study|Lost to Follow-up|1|||
28020760|NCT00269113|54680134|FG000|Overall Study|Protocol Violation|15|||
28020761|NCT00269113|54680135|FG001|Overall Study|Protocol Violation|5|||
28020762|NCT00269113|54680134|FG000|Overall Study|Other|0|||
28020763|NCT00269113|54680135|FG001|Overall Study|Other|2|||
28020764|NCT00291187|54680145|FG000|Overall Study|Protocol Violation- No Drug Administered|0|||
28020765|NCT00291187|54680146|FG001|Overall Study|Protocol Violation- No Drug Administered|0|||
28020766|NCT00291187|54680147|FG002|Overall Study|Protocol Violation- No Drug Administered|1|||
28020767|NCT00291187|54680148|FG003|Overall Study|Protocol Violation- No Drug Administered|0|||
28020768|NCT00546819|54680164|FG000|Overall Study|Adverse Event|2|||
28020769|NCT00546819|54680165|FG001|Overall Study|Adverse Event|3|||
28020770|NCT00546819|54680164|FG000|Overall Study|Lost to Follow-up|2|||
28020771|NCT00546819|54680165|FG001|Overall Study|Lost to Follow-up|1|||
28020772|NCT00546819|54680164|FG000|Overall Study|Withdrawal by Subject|4|||
28020773|NCT00546819|54680165|FG001|Overall Study|Withdrawal by Subject|2|||
28020774|NCT00621504|54680173|FG000|Overall Study|Adverse Event|1|||
28020775|NCT00621504|54680174|FG001|Overall Study|Adverse Event|3|||
28020776|NCT00621504|54680173|FG000|Overall Study|At the request of sponsor/investigator|1|||
28020777|NCT00621504|54680174|FG001|Overall Study|At the request of sponsor/investigator|0|||
28020778|NCT00621504|54680173|FG000|Overall Study|Withdrew consent|9|||
28020779|NCT00621504|54680174|FG001|Overall Study|Withdrew consent|6|||
28020780|NCT00621504|54680173|FG000|Overall Study|Lost to Follow-up|8|||
28020781|NCT00621504|54680174|FG001|Overall Study|Lost to Follow-up|10|||
28020782|NCT00621504|54680173|FG000|Overall Study|Other|1|||
28020783|NCT00621504|54680174|FG001|Overall Study|Other|0|||
28020784|NCT00621504|54680173|FG000|Overall Study|Death|6|||
28020785|NCT00621504|54680174|FG001|Overall Study|Death|6|||
28020786|NCT00548145|54680182|FG000|Overall Study|Death|0|||
28020787|NCT00548145|54680183|FG001|Overall Study|Death|1|||
28020788|NCT00548145|54680182|FG000|Overall Study|Withdrawal by Subject|0|||
28020789|NCT00548145|54680183|FG001|Overall Study|Withdrawal by Subject|2|||
28020790|NCT00548145|54680182|FG000|Overall Study|Physician Decision|1|||
28020791|NCT00548145|54680183|FG001|Overall Study|Physician Decision|1|||
28020792|NCT00547911|54680193|FG000|Overall Study|Adverse Event|0|||
28020793|NCT00547911|54680194|FG001|Overall Study|Adverse Event|0|||
28020794|NCT00547911|54680195|FG002|Overall Study|Adverse Event|0|||
28020795|NCT00547911|54680196|FG003|Overall Study|Adverse Event|1|||
28020796|NCT00547911|54680197|FG004|Overall Study|Adverse Event|0|||
28020797|NCT00547911|54680198|FG005|Overall Study|Adverse Event|0|||
28020798|NCT00289783|54680213|FG000|Primary Phase|Adverse Event|10|||
28020799|NCT00289783|54680214|FG001|Primary Phase|Adverse Event|1|||
28020800|NCT00289783|54680213|FG000|Primary Phase|Protocol Violation|27|||
28020801|NCT00289783|54680214|FG001|Primary Phase|Protocol Violation|6|||
28020802|NCT00289783|54680213|FG000|Primary Phase|Withdrawal by Subject|93|||
28020803|NCT00289783|54680214|FG001|Primary Phase|Withdrawal by Subject|40|||
28020804|NCT00289783|54680213|FG000|Primary Phase|Lost to Follow-up|60|||
28020805|NCT00289783|54680214|FG001|Primary Phase|Lost to Follow-up|14|||
28020806|NCT00289783|54680213|FG000|Primary Phase|Migration from the study area|26|||
28020807|NCT00289783|54680214|FG001|Primary Phase|Migration from the study area|10|||
28020808|NCT00289783|54680213|FG000|Primary Phase|Other|32|||
28020809|NCT00289783|54680214|FG001|Primary Phase|Other|12|||
28020810|NCT00289783|54680213|FG000|Fourth Dose Phase|Adverse Event|1|||
28020811|NCT00289783|54680214|FG001|Fourth Dose Phase|Adverse Event|0|||
28020812|NCT00289783|54680213|FG000|Fourth Dose Phase|Withdrawal by Subject|10|||
28020813|NCT00289783|54680214|FG001|Fourth Dose Phase|Withdrawal by Subject|1|||
28020814|NCT00289783|54680213|FG000|Fourth Dose Phase|Lost to Follow-up|53|||
28020815|NCT00289783|54680214|FG001|Fourth Dose Phase|Lost to Follow-up|12|||
28020816|NCT00289783|54680213|FG000|Fourth Dose Phase|Migration from the study area|1|||
28020817|NCT00289783|54680214|FG001|Fourth Dose Phase|Migration from the study area|1|||
28020818|NCT00289783|54680213|FG000|Fourth Dose Phase|Other|22|||
28020819|NCT00289783|54680214|FG001|Fourth Dose Phase|Other|10|||
28020820|NCT00574080|54680230|FG000|Overall Study|Death|10|||
28020821|NCT00574080|54680231|FG001|Overall Study|Death|10|||
28020822|NCT00546351|54680237|FG000|Overall Study|Adverse Event|76|||
28020823|NCT00546351|54680237|FG000|Overall Study|Lack of Efficacy|15|||
28020824|NCT00546351|54680237|FG000|Overall Study|Withdrawal by Subject|109|||
28020825|NCT00546351|54680237|FG000|Overall Study|Lost to Follow-up|9|||
28020826|NCT00546351|54680237|FG000|Overall Study|Protocol Deviation|1|||
28020827|NCT00546351|54680237|FG000|Overall Study|Unsatisfactory compliance|9|||
28020828|NCT00546351|54680237|FG000|Overall Study|Other reasons for premature termination|17|||
28020829|NCT00267865|54680241|FG000|Induction Treatment|Died before completing.|2|||
28020830|NCT00267865|54680241|FG000|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1|||
28020831|NCT00546117|54680247|FG000|Overall Study|Withdrawal by Subject|3|||
28020832|NCT00546117|54680248|FG001|Overall Study|Withdrawal by Subject|0|||
28020833|NCT00546117|54680247|FG000|Overall Study|Inability to schedule follow-up visit|1|||
28020834|NCT00546117|54680248|FG001|Overall Study|Inability to schedule follow-up visit|0|||
28020835|NCT00251719|54680259|FG000|Overall Study|Adverse Event|14|||
28020836|NCT00251719|54680260|FG001|Overall Study|Adverse Event|8|||
28020837|NCT00251719|54680261|FG002|Overall Study|Adverse Event|7|||
28020838|NCT00251719|54680259|FG000|Overall Study|Protocol Violation|1|||
28020839|NCT00251719|54680260|FG001|Overall Study|Protocol Violation|1|||
28020840|NCT00251719|54680261|FG002|Overall Study|Protocol Violation|1|||
28020841|NCT00251719|54680259|FG000|Overall Study|Lost to Follow-up|5|||
28020842|NCT00251719|54680260|FG001|Overall Study|Lost to Follow-up|11|||
28020843|NCT00251719|54680261|FG002|Overall Study|Lost to Follow-up|8|||
28020844|NCT00251719|54680259|FG000|Overall Study|Withdrawal by Subject|14|||
28020845|NCT00251719|54680260|FG001|Overall Study|Withdrawal by Subject|12|||
28020846|NCT00251719|54680261|FG002|Overall Study|Withdrawal by Subject|11|||
28020847|NCT00251719|54680259|FG000|Overall Study|Lack of Efficacy|2|||
28020848|NCT00251719|54680260|FG001|Overall Study|Lack of Efficacy|1|||
28020849|NCT00251719|54680261|FG002|Overall Study|Lack of Efficacy|0|||
28020850|NCT00251719|54680259|FG000|Overall Study|Inclusion/exclusion criteria not met|12|||
28020851|NCT00251719|54680260|FG001|Overall Study|Inclusion/exclusion criteria not met|6|||
28020852|NCT00251719|54680261|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
28020853|NCT00251719|54680259|FG000|Overall Study|Investigator decision|1|||
28020854|NCT00251719|54680260|FG001|Overall Study|Investigator decision|1|||
28020855|NCT00251719|54680261|FG002|Overall Study|Investigator decision|0|||
28020856|NCT00251719|54680259|FG000|Overall Study|Noncompliance|2|||
28020857|NCT00251719|54680260|FG001|Overall Study|Noncompliance|3|||
28020858|NCT00251719|54680261|FG002|Overall Study|Noncompliance|1|||
28020859|NCT00251719|54680259|FG000|Overall Study|Barrett's esophagus|2|||
28020860|NCT00251719|54680260|FG001|Overall Study|Barrett's esophagus|2|||
28020861|NCT00251719|54680261|FG002|Overall Study|Barrett's esophagus|0|||
28020862|NCT03952143|54680271|FG000|Lead-In Period|Adverse Event|2|||
28020863|NCT03952143|54680272|FG001|Lead-In Period|Adverse Event|0|||
28020864|NCT03952143|54680273|FG002|Lead-In Period|Adverse Event|0|||
28020865|NCT03952143|54680271|FG000|Lead-In Period|Lack of Efficacy|2|||
28020866|NCT03952143|54680272|FG001|Lead-In Period|Lack of Efficacy|0|||
28020867|NCT03952143|54680273|FG002|Lead-In Period|Lack of Efficacy|0|||
28020868|NCT03952143|54680271|FG000|Lead-In Period|Physician Decision|5|||
28020869|NCT03952143|54680272|FG001|Lead-In Period|Physician Decision|0|||
28020870|NCT03952143|54680273|FG002|Lead-In Period|Physician Decision|0|||
28020871|NCT03952143|54680271|FG000|Lead-In Period|Protocol Violation|5|||
28020872|NCT03952143|54680272|FG001|Lead-In Period|Protocol Violation|0|||
28020873|NCT03952143|54680273|FG002|Lead-In Period|Protocol Violation|0|||
28020874|NCT03952143|54680271|FG000|Lead-In Period|Withdrawal by Subject|19|||
28020875|NCT03952143|54680272|FG001|Lead-In Period|Withdrawal by Subject|0|||
28020876|NCT03952143|54680273|FG002|Lead-In Period|Withdrawal by Subject|0|||
28020877|NCT03952143|54680271|FG000|Treatment Period|Adverse Event|0|||
28020878|NCT03952143|54680272|FG001|Treatment Period|Adverse Event|0|||
28020879|NCT03952143|54680273|FG002|Treatment Period|Adverse Event|1|||
28020880|NCT03952143|54680271|FG000|Treatment Period|Lost to Follow-up|0|||
28020881|NCT03952143|54680272|FG001|Treatment Period|Lost to Follow-up|2|||
28020882|NCT03952143|54680273|FG002|Treatment Period|Lost to Follow-up|0|||
28020883|NCT03952143|54680271|FG000|Treatment Period|Physician Decision|0|||
28020884|NCT03952143|54680272|FG001|Treatment Period|Physician Decision|0|||
28020885|NCT03952143|54680273|FG002|Treatment Period|Physician Decision|2|||
28020886|NCT03952143|54680271|FG000|Treatment Period|Protocol Violation|0|||
28020887|NCT03952143|54680272|FG001|Treatment Period|Protocol Violation|0|||
28020888|NCT03952143|54680273|FG002|Treatment Period|Protocol Violation|1|||
28020889|NCT03952143|54680271|FG000|Treatment Period|Withdrawal by Subject|0|||
28020890|NCT03952143|54680272|FG001|Treatment Period|Withdrawal by Subject|5|||
28020891|NCT03952143|54680273|FG002|Treatment Period|Withdrawal by Subject|26|||
28020892|NCT03952143|54680271|FG000|Treatment Period|Due to COVID 19 restrictions|0|||
28020893|NCT03952143|54680272|FG001|Treatment Period|Due to COVID 19 restrictions|2|||
28020894|NCT03952143|54680273|FG002|Treatment Period|Due to COVID 19 restrictions|5|||
28020895|NCT03952143|54680271|FG000|Treatment Period|Participant had taken prohibited concomitant medication|0|||
28020896|NCT03952143|54680272|FG001|Treatment Period|Participant had taken prohibited concomitant medication|0|||
28020897|NCT03952143|54680273|FG002|Treatment Period|Participant had taken prohibited concomitant medication|1|||
28020898|NCT00267007|54680282|FG000|Overall Study|Withdrawal by Subject|6|||
28020899|NCT00267007|54680283|FG001|Overall Study|Withdrawal by Subject|0|||
28020900|NCT00267007|54680282|FG000|Overall Study|Lost to Follow-up|1|||
28020901|NCT00267007|54680283|FG001|Overall Study|Lost to Follow-up|0|||
28020902|NCT00267007|54680282|FG000|Overall Study|Non-compliance|0|||
28020903|NCT00267007|54680283|FG001|Overall Study|Non-compliance|1|||
28020904|NCT00267007|54680282|FG000|Overall Study|Adverse Event|1|||
28020905|NCT00267007|54680283|FG001|Overall Study|Adverse Event|0|||
28020906|NCT03943095|54680291|FG000|Overall Study|Incorrectly dispensed wrong box kit|0|||
28020907|NCT03943095|54680292|FG001|Overall Study|Incorrectly dispensed wrong box kit|1|||
28020908|NCT03943095|54680291|FG000|Overall Study|Withdrawal by Subject|1|||
28020909|NCT03943095|54680292|FG001|Overall Study|Withdrawal by Subject|0|||
28020910|NCT00251641|54680301|FG000|Overall Study|Adverse Event|80|||
28020911|NCT00251641|54680302|FG001|Overall Study|Adverse Event|8|||
28020912|NCT00251641|54680301|FG000|Overall Study|Lack of Efficacy|2|||
28020913|NCT00251641|54680302|FG001|Overall Study|Lack of Efficacy|1|||
28020914|NCT00251641|54680301|FG000|Overall Study|Progression of Disease|0|||
28020915|NCT00251641|54680302|FG001|Overall Study|Progression of Disease|2|||
28020916|NCT00251641|54680301|FG000|Overall Study|Lost to Follow-up|3|||
28020917|NCT00251641|54680302|FG001|Overall Study|Lost to Follow-up|3|||
28020918|NCT00251641|54680301|FG000|Overall Study|Withdrawal by Subject|6|||
28020919|NCT00251641|54680302|FG001|Overall Study|Withdrawal by Subject|8|||
28020920|NCT00251641|54680301|FG000|Overall Study|Protocol Violation|10|||
28020921|NCT00251641|54680302|FG001|Overall Study|Protocol Violation|2|||
28020922|NCT00251641|54680301|FG000|Overall Study|Did not Meet protocol Eligibility|2|||
28020923|NCT00251641|54680302|FG001|Overall Study|Did not Meet protocol Eligibility|1|||
28020924|NCT00251641|54680301|FG000|Overall Study|Switched Treatment|9|||
28020925|NCT00251641|54680302|FG001|Overall Study|Switched Treatment|63|||
28020926|NCT00250705|54680310|FG000|Overall Study|Lack of Efficacy|2|||
28020927|NCT00266695|54680316|FG000|Overall Study|Adverse Event|1|||
28020928|NCT00266695|54680316|FG000|Overall Study|Death|9|||
28020929|NCT00266695|54680316|FG000|Overall Study|Physician Decision|1|||
28020930|NCT00266695|54680316|FG000|Overall Study|Lost to Follow-up|3|||
28020931|NCT00266695|54680316|FG000|Overall Study|Withdrawal by Subject|15|||
28020932|NCT00620022|54680320|FG000|Treatment Period 1|Adverse Event|4|||
28020933|NCT00620022|54680321|FG001|Treatment Period 1|Adverse Event|6|||
28020934|NCT00620022|54680320|FG000|Treatment Period 1|Subject withdrew consent|1|||
28020935|NCT00620022|54680321|FG001|Treatment Period 1|Subject withdrew consent|0|||
28020936|NCT00620022|54680320|FG000|Treatment Period 2|Adverse Event|2|||
28020937|NCT00620022|54680321|FG001|Treatment Period 2|Adverse Event|2|||
28020938|NCT00547521|54680329|FG000|Short Term Study (4 Months)|Adverse Event|1|||
28020939|NCT00547521|54680330|FG001|Short Term Study (4 Months)|Adverse Event|0|||
28020940|NCT00547521|54680329|FG000|Short Term Study (4 Months)|Lack of Efficacy|0|||
28020941|NCT00547521|54680330|FG001|Short Term Study (4 Months)|Lack of Efficacy|2|||
28020942|NCT00547521|54680329|FG000|Short Term Study (4 Months)|Withdrawal of consent|0|||
28020943|NCT00547521|54680330|FG001|Short Term Study (4 Months)|Withdrawal of consent|1|||
28020944|NCT00547521|54680329|FG000|Short Term Study (4 Months)|primary endpoint evaluation not complete|0|||
28020945|NCT00547521|54680330|FG001|Short Term Study (4 Months)|primary endpoint evaluation not complete|1|||
28020946|NCT00547521|54680329|FG000|Long Term Extension (LTE) Study|Lack of Efficacy|0|||
28020947|NCT00547521|54680330|FG001|Long Term Extension (LTE) Study|Lack of Efficacy|14|||
28020948|NCT00547521|54680329|FG000|Long Term Extension (LTE) Study|Adverse Event|0|||
28020949|NCT00547521|54680330|FG001|Long Term Extension (LTE) Study|Adverse Event|9|||
28020950|NCT00547521|54680329|FG000|Long Term Extension (LTE) Study|Lost to Follow-up|0|||
28020951|NCT00547521|54680330|FG001|Long Term Extension (LTE) Study|Lost to Follow-up|3|||
28020952|NCT00547521|54680329|FG000|Long Term Extension (LTE) Study|Withdrawal by Subject|0|||
28020953|NCT00547521|54680330|FG001|Long Term Extension (LTE) Study|Withdrawal by Subject|2|||
28020954|NCT00547521|54680329|FG000|Long Term Extension (LTE) Study|Other|0|||
28020955|NCT00547521|54680330|FG001|Long Term Extension (LTE) Study|Other|2|||
28020956|NCT00547521|54680329|FG000|Long Term Extension (LTE) Study|Poor/Non-Compliance|0|||
28020957|NCT00547521|54680330|FG001|Long Term Extension (LTE) Study|Poor/Non-Compliance|1|||
28020958|NCT00266227|54680345|FG000|Initial Treatment|Adverse Event|0|||
28020959|NCT00266227|54680346|FG001|Initial Treatment|Adverse Event|0|||
28020960|NCT00266227|54680347|FG002|Initial Treatment|Adverse Event|13|||
28020961|NCT00266227|54680345|FG000|Initial Treatment|Lost to Follow-up|0|||
28020962|NCT00266227|54680346|FG001|Initial Treatment|Lost to Follow-up|0|||
28020963|NCT00266227|54680347|FG002|Initial Treatment|Lost to Follow-up|6|||
28020964|NCT00266227|54680345|FG000|Initial Treatment|Subject/Guardian decision to withdraw|0|||
28020965|NCT00266227|54680346|FG001|Initial Treatment|Subject/Guardian decision to withdraw|0|||
28020966|NCT00266227|54680347|FG002|Initial Treatment|Subject/Guardian decision to withdraw|45|||
28020967|NCT00266227|54680345|FG000|Initial Treatment|Physician decision to withdraw|0|||
28020968|NCT00266227|54680346|FG001|Initial Treatment|Physician decision to withdraw|0|||
28020969|NCT00266227|54680347|FG002|Initial Treatment|Physician decision to withdraw|12|||
28020970|NCT00266227|54680345|FG000|Initial Treatment|Pregnancy|0|||
28020971|NCT00266227|54680346|FG001|Initial Treatment|Pregnancy|0|||
28020972|NCT00266227|54680347|FG002|Initial Treatment|Pregnancy|1|||
28020973|NCT00266227|54680345|FG000|Retreatment: Up to Week 48|Death|1|||
28020974|NCT00266227|54680346|FG001|Retreatment: Up to Week 48|Death|0|||
28020975|NCT00266227|54680347|FG002|Retreatment: Up to Week 48|Death|0|||
28020976|NCT00266227|54680345|FG000|Retreatment: Up to Week 48|Adverse Event|7|||
28020977|NCT00266227|54680346|FG001|Retreatment: Up to Week 48|Adverse Event|7|||
28020978|NCT00266227|54680347|FG002|Retreatment: Up to Week 48|Adverse Event|0|||
28020979|NCT00266227|54680345|FG000|Retreatment: Up to Week 48|Lost to Follow-up|3|||
28020980|NCT00266227|54680346|FG001|Retreatment: Up to Week 48|Lost to Follow-up|0|||
28020981|NCT00266227|54680347|FG002|Retreatment: Up to Week 48|Lost to Follow-up|0|||
28020982|NCT00266227|54680345|FG000|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11|||
28020983|NCT00266227|54680346|FG001|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14|||
28020984|NCT00266227|54680347|FG002|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0|||
28020985|NCT00266227|54680345|FG000|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4|||
28020986|NCT00266227|54680346|FG001|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2|||
28020987|NCT00266227|54680347|FG002|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0|||
28020988|NCT00266227|54680345|FG000|Retreatment: Up to Week 48|Pregnancy|1|||
28020989|NCT00266227|54680346|FG001|Retreatment: Up to Week 48|Pregnancy|0|||
28020990|NCT00266227|54680347|FG002|Retreatment: Up to Week 48|Pregnancy|0|||
28020991|NCT00266227|54680345|FG000|Retreatment: Week 48 to Week 72|Death|1|||
28020992|NCT00266227|54680346|FG001|Retreatment: Week 48 to Week 72|Death|1|||
28020993|NCT00266227|54680347|FG002|Retreatment: Week 48 to Week 72|Death|0|||
28020994|NCT00266227|54680345|FG000|Retreatment: Week 48 to Week 72|Adverse Event|6|||
28020995|NCT00266227|54680346|FG001|Retreatment: Week 48 to Week 72|Adverse Event|2|||
28020996|NCT00266227|54680347|FG002|Retreatment: Week 48 to Week 72|Adverse Event|0|||
28020997|NCT00266227|54680345|FG000|Retreatment: Week 48 to Week 72|Lost to Follow-up|1|||
28020998|NCT00266227|54680346|FG001|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
28020999|NCT00266227|54680347|FG002|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
28021000|NCT00266227|54680345|FG000|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41|||
28021001|NCT00266227|54680346|FG001|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29|||
28021002|NCT00266227|54680347|FG002|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0|||
28021003|NCT00266227|54680345|FG000|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15|||
28021004|NCT00266227|54680346|FG001|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10|||
28021005|NCT00266227|54680347|FG002|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0|||
28021006|NCT00287365|54680356|FG000|Overall Study|sample not acquired|13|||
28021007|NCT00573768|54680364|FG000|Overall Study|Adverse Event|1|||
27800030|NCT02081677|54254658|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
27800031|NCT02081677|54254659|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
27800032|NCT02081677|54254656|FG000|Overall Study|Not comfortable with lens care system|1|||
27800033|NCT02081677|54254657|FG001|Overall Study|Not comfortable with lens care system|0|||
27938544|NCT00969436|54594639|FG000|Overall Study|Subject eliminated (other vaccine)|1|||
27938545|NCT00969436|54594640|FG001|Overall Study|Subject eliminated (other vaccine)|0|||
27938546|NCT00969436|54594641|FG002|Overall Study|Subject eliminated (other vaccine)|0|||
27938547|NCT00969436|54594639|FG000|Overall Study|Withdrawal by Subject|3|||
27938548|NCT00969436|54594640|FG001|Overall Study|Withdrawal by Subject|0|||
27938549|NCT00969436|54594641|FG002|Overall Study|Withdrawal by Subject|2|||
27938550|NCT00969436|54594639|FG000|Overall Study|Lost to Follow-up|8|||
27938551|NCT00969436|54594640|FG001|Overall Study|Lost to Follow-up|8|||
27938552|NCT00969436|54594641|FG002|Overall Study|Lost to Follow-up|5|||
27938553|NCT00900757|54594649|FG000|Overall Study|screen failure|19|||
27938554|NCT00969280|54594655|FG000|Overall Study|Protocol Violation|2|||
27938555|NCT00969280|54594656|FG001|Overall Study|Protocol Violation|1|||
27938556|NCT00969280|54594655|FG000|Overall Study|Withdrawal by Subject|0|||
28021008|NCT00573768|54680365|FG001|Overall Study|Adverse Event|1|||
28021009|NCT00573768|54680366|FG002|Overall Study|Adverse Event|2|||
28021010|NCT00573768|54680364|FG000|Overall Study|Protocol Violation|1|||
28021011|NCT00573768|54680365|FG001|Overall Study|Protocol Violation|0|||
28021012|NCT00573768|54680366|FG002|Overall Study|Protocol Violation|1|||
28021013|NCT00573768|54680364|FG000|Overall Study|Withdrawal by Subject|0|||
28021014|NCT00573768|54680365|FG001|Overall Study|Withdrawal by Subject|1|||
28021015|NCT00573768|54680366|FG002|Overall Study|Withdrawal by Subject|0|||
28021016|NCT00573768|54680364|FG000|Overall Study|Lost to Follow-up|0|||
28021017|NCT00573768|54680365|FG001|Overall Study|Lost to Follow-up|0|||
28021018|NCT00573768|54680366|FG002|Overall Study|Lost to Follow-up|1|||
28021019|NCT00547365|54680374|FG000|Overall Study|Physician Decision|1|||
28021020|NCT00547365|54680374|FG000|Overall Study|Lost to Follow-up|1|||
28021021|NCT00547365|54680374|FG000|Overall Study|Protocol Violation|2|||
28021022|NCT00547365|54680374|FG000|Overall Study|death (not related to study)|4|||
28021023|NCT00619866|54680382|FG000|Weeks 1 - 12|Adverse Event|0|||
28021024|NCT00619866|54680383|FG001|Weeks 1 - 12|Adverse Event|1|||
28021025|NCT00619866|54680384|FG002|Weeks 1 - 12|Adverse Event|2|||
28021026|NCT00619866|54680385|FG003|Weeks 1 - 12|Adverse Event|0|||
28021027|NCT00619866|54680386|FG004|Weeks 1 - 12|Adverse Event|0|||
28021028|NCT00619866|54680382|FG000|Weeks 1 - 12|Non-compliance|0|||
28021029|NCT00619866|54680383|FG001|Weeks 1 - 12|Non-compliance|0|||
28021030|NCT00619866|54680384|FG002|Weeks 1 - 12|Non-compliance|1|||
28021031|NCT00619866|54680385|FG003|Weeks 1 - 12|Non-compliance|0|||
28021032|NCT00619866|54680386|FG004|Weeks 1 - 12|Non-compliance|0|||
28021033|NCT00619866|54680382|FG000|Weeks 1 - 12|Withdrawal by Subject|7|||
28021034|NCT00619866|54680383|FG001|Weeks 1 - 12|Withdrawal by Subject|2|||
28021035|NCT00619866|54680384|FG002|Weeks 1 - 12|Withdrawal by Subject|4|||
28021036|NCT00619866|54680385|FG003|Weeks 1 - 12|Withdrawal by Subject|0|||
28021037|NCT00619866|54680386|FG004|Weeks 1 - 12|Withdrawal by Subject|0|||
28021038|NCT00619866|54680382|FG000|Weeks 1 - 12|Lack of Efficacy|3|||
28021039|NCT00619866|54680383|FG001|Weeks 1 - 12|Lack of Efficacy|2|||
28021040|NCT00619866|54680384|FG002|Weeks 1 - 12|Lack of Efficacy|1|||
28021041|NCT00619866|54680385|FG003|Weeks 1 - 12|Lack of Efficacy|0|||
28021042|NCT00619866|54680386|FG004|Weeks 1 - 12|Lack of Efficacy|0|||
28021043|NCT00619866|54680382|FG000|Weeks 1 - 12|Lost to Follow-up|4|||
28021044|NCT00619866|54680383|FG001|Weeks 1 - 12|Lost to Follow-up|0|||
28021045|NCT00619866|54680384|FG002|Weeks 1 - 12|Lost to Follow-up|2|||
28021046|NCT00619866|54680385|FG003|Weeks 1 - 12|Lost to Follow-up|0|||
28021047|NCT00619866|54680386|FG004|Weeks 1 - 12|Lost to Follow-up|0|||
28021048|NCT00619866|54680382|FG000|Weeks 1 - 12|Sponsor Decision|0|||
28021049|NCT00619866|54680383|FG001|Weeks 1 - 12|Sponsor Decision|1|||
28021050|NCT00619866|54680384|FG002|Weeks 1 - 12|Sponsor Decision|0|||
28021051|NCT00619866|54680385|FG003|Weeks 1 - 12|Sponsor Decision|0|||
28021052|NCT00619866|54680386|FG004|Weeks 1 - 12|Sponsor Decision|0|||
28021053|NCT00619866|54680382|FG000|Weeks 13 - 24|Adverse Event|0|||
28021054|NCT00619866|54680383|FG001|Weeks 13 - 24|Adverse Event|0|||
28021055|NCT00619866|54680384|FG002|Weeks 13 - 24|Adverse Event|2|||
28021056|NCT00619866|54680385|FG003|Weeks 13 - 24|Adverse Event|1|||
28021057|NCT00619866|54680386|FG004|Weeks 13 - 24|Adverse Event|0|||
28021058|NCT00619866|54680382|FG000|Weeks 13 - 24|Protocol Deviation|0|||
28021059|NCT00619866|54680383|FG001|Weeks 13 - 24|Protocol Deviation|0|||
28021060|NCT00619866|54680384|FG002|Weeks 13 - 24|Protocol Deviation|0|||
28021061|NCT00619866|54680385|FG003|Weeks 13 - 24|Protocol Deviation|1|||
28021062|NCT00619866|54680386|FG004|Weeks 13 - 24|Protocol Deviation|0|||
28021063|NCT00619866|54680382|FG000|Weeks 13 - 24|Withdrawal by Subject|0|||
28021064|NCT00619866|54680383|FG001|Weeks 13 - 24|Withdrawal by Subject|3|||
28021065|NCT00619866|54680384|FG002|Weeks 13 - 24|Withdrawal by Subject|2|||
28021066|NCT00619866|54680385|FG003|Weeks 13 - 24|Withdrawal by Subject|2|||
28021067|NCT00619866|54680386|FG004|Weeks 13 - 24|Withdrawal by Subject|2|||
28021068|NCT00619866|54680382|FG000|Weeks 13 - 24|Non-compliance|0|||
28021069|NCT00619866|54680383|FG001|Weeks 13 - 24|Non-compliance|1|||
28021070|NCT00619866|54680384|FG002|Weeks 13 - 24|Non-compliance|1|||
28021071|NCT00619866|54680385|FG003|Weeks 13 - 24|Non-compliance|0|||
28021072|NCT00619866|54680386|FG004|Weeks 13 - 24|Non-compliance|0|||
28021073|NCT00619866|54680382|FG000|Weeks 13 - 24|Lost to Follow-up|0|||
28021074|NCT00619866|54680383|FG001|Weeks 13 - 24|Lost to Follow-up|3|||
28021075|NCT00619866|54680384|FG002|Weeks 13 - 24|Lost to Follow-up|0|||
28021076|NCT00619866|54680385|FG003|Weeks 13 - 24|Lost to Follow-up|0|||
28021077|NCT00619866|54680386|FG004|Weeks 13 - 24|Lost to Follow-up|0|||
27800034|NCT02081677|54254658|FG002|Overall Study|Not comfortable with lens care system|0|||
28021078|NCT03937479|54680414|FG000|Overall Study|Adverse Event|2|||
28021079|NCT03937479|54680415|FG001|Overall Study|Adverse Event|3|||
28021080|NCT03937479|54680416|FG002|Overall Study|Adverse Event|0|||
28021081|NCT03937479|54680417|FG003|Overall Study|Adverse Event|0|||
28021082|NCT03937479|54680418|FG004|Overall Study|Adverse Event|1|||
28021083|NCT03937479|54680414|FG000|Overall Study|Withdrawal by Subject|3|||
28021084|NCT03937479|54680415|FG001|Overall Study|Withdrawal by Subject|5|||
28021085|NCT03937479|54680416|FG002|Overall Study|Withdrawal by Subject|2|||
28021086|NCT03937479|54680417|FG003|Overall Study|Withdrawal by Subject|2|||
28021087|NCT03937479|54680418|FG004|Overall Study|Withdrawal by Subject|1|||
28021088|NCT03937479|54680414|FG000|Overall Study|Protocol Violation|5|||
28021089|NCT03937479|54680415|FG001|Overall Study|Protocol Violation|6|||
28021090|NCT03937479|54680416|FG002|Overall Study|Protocol Violation|4|||
28021091|NCT03937479|54680417|FG003|Overall Study|Protocol Violation|3|||
28021092|NCT03937479|54680418|FG004|Overall Study|Protocol Violation|2|||
28021093|NCT03937479|54680414|FG000|Overall Study|Lost to Follow-up|0|||
28021094|NCT03937479|54680415|FG001|Overall Study|Lost to Follow-up|1|||
28021095|NCT03937479|54680416|FG002|Overall Study|Lost to Follow-up|0|||
28021096|NCT03937479|54680417|FG003|Overall Study|Lost to Follow-up|1|||
28021097|NCT03937479|54680418|FG004|Overall Study|Lost to Follow-up|0|||
28021098|NCT03937479|54680414|FG000|Overall Study|Physician Decision|0|||
28021099|NCT03937479|54680415|FG001|Overall Study|Physician Decision|0|||
28021100|NCT03937479|54680416|FG002|Overall Study|Physician Decision|1|||
28021101|NCT03937479|54680417|FG003|Overall Study|Physician Decision|0|||
28021102|NCT03937479|54680418|FG004|Overall Study|Physician Decision|1|||
28021103|NCT00619476|54680434|FG000|Overall Study|Adverse Event|12|||
28021104|NCT00619476|54680435|FG001|Overall Study|Adverse Event|6|||
28021105|NCT00619476|54680436|FG002|Overall Study|Adverse Event|12|||
28021106|NCT00619476|54680437|FG003|Overall Study|Adverse Event|16|||
28021107|NCT00619476|54680434|FG000|Overall Study|Lack of Efficacy|6|||
28021108|NCT00619476|54680435|FG001|Overall Study|Lack of Efficacy|1|||
28021109|NCT00619476|54680436|FG002|Overall Study|Lack of Efficacy|1|||
28021110|NCT00619476|54680437|FG003|Overall Study|Lack of Efficacy|4|||
28021111|NCT00619476|54680434|FG000|Overall Study|Protocol Violation|5|||
28021112|NCT00619476|54680435|FG001|Overall Study|Protocol Violation|4|||
28021113|NCT00619476|54680436|FG002|Overall Study|Protocol Violation|4|||
28021114|NCT00619476|54680437|FG003|Overall Study|Protocol Violation|9|||
28021115|NCT00619476|54680434|FG000|Overall Study|Lost to Follow-up|1|||
28021116|NCT00619476|54680435|FG001|Overall Study|Lost to Follow-up|2|||
28021117|NCT00619476|54680436|FG002|Overall Study|Lost to Follow-up|0|||
28021118|NCT00619476|54680437|FG003|Overall Study|Lost to Follow-up|1|||
28021119|NCT00619476|54680434|FG000|Overall Study|Investigator Discretion|2|||
28021120|NCT00619476|54680435|FG001|Overall Study|Investigator Discretion|2|||
28021121|NCT00619476|54680436|FG002|Overall Study|Investigator Discretion|2|||
28021122|NCT00619476|54680437|FG003|Overall Study|Investigator Discretion|0|||
28021123|NCT00619476|54680434|FG000|Overall Study|Withdrawal by Subject|5|||
28021124|NCT00619476|54680435|FG001|Overall Study|Withdrawal by Subject|7|||
28021125|NCT00619476|54680436|FG002|Overall Study|Withdrawal by Subject|5|||
28021126|NCT00619476|54680437|FG003|Overall Study|Withdrawal by Subject|4|||
28021127|NCT00618072|54680450|FG000|Overall Study|Lost to Follow-up|2|||
28021128|NCT00618072|54680451|FG001|Overall Study|Lost to Follow-up|0|||
28021129|NCT00618072|54680452|FG002|Overall Study|Lost to Follow-up|3|||
28021130|NCT00618072|54680450|FG000|Overall Study|Physician Decision|0|||
28021131|NCT00618072|54680451|FG001|Overall Study|Physician Decision|1|||
28021132|NCT00618072|54680452|FG002|Overall Study|Physician Decision|1|||
28021133|NCT00666926|54680460|FG000|Overall Study|Adverse Event|0|||
28021134|NCT00666926|54680461|FG001|Overall Study|Adverse Event|0|||
28021135|NCT00666926|54680462|FG002|Overall Study|Adverse Event|0|||
28021136|NCT00666926|54680463|FG003|Overall Study|Adverse Event|0|||
28021137|NCT00666926|54680464|FG004|Overall Study|Adverse Event|0|||
28021138|NCT00666926|54680465|FG005|Overall Study|Adverse Event|0|||
28021139|NCT00666926|54680466|FG006|Overall Study|Adverse Event|0|||
28021140|NCT00666926|54680467|FG007|Overall Study|Adverse Event|0|||
28021141|NCT00666926|54680468|FG008|Overall Study|Adverse Event|0|||
28021142|NCT00666926|54680469|FG009|Overall Study|Adverse Event|2|||
28021143|NCT00666926|54680470|FG010|Overall Study|Adverse Event|2|||
28021144|NCT00666926|54680471|FG011|Overall Study|Adverse Event|2|||
28021145|NCT00666926|54680472|FG012|Overall Study|Adverse Event|0|||
28021146|NCT00666926|54680473|FG013|Overall Study|Adverse Event|1|||
28021147|NCT00666926|54680474|FG014|Overall Study|Adverse Event|0|||
28021148|NCT00666926|54680475|FG015|Overall Study|Adverse Event|0|||
28021149|NCT00666926|54680460|FG000|Overall Study|Laboratory abnormality|0|||
28021150|NCT00666926|54680461|FG001|Overall Study|Laboratory abnormality|0|||
28021151|NCT00666926|54680462|FG002|Overall Study|Laboratory abnormality|0|||
28021152|NCT00666926|54680463|FG003|Overall Study|Laboratory abnormality|0|||
28021153|NCT00666926|54680464|FG004|Overall Study|Laboratory abnormality|0|||
28021154|NCT00666926|54680465|FG005|Overall Study|Laboratory abnormality|0|||
28021155|NCT00666926|54680466|FG006|Overall Study|Laboratory abnormality|0|||
28021156|NCT00666926|54680467|FG007|Overall Study|Laboratory abnormality|0|||
28021157|NCT00666926|54680468|FG008|Overall Study|Laboratory abnormality|0|||
28021158|NCT00666926|54680469|FG009|Overall Study|Laboratory abnormality|0|||
28021159|NCT00666926|54680470|FG010|Overall Study|Laboratory abnormality|1|||
28021160|NCT00666926|54680471|FG011|Overall Study|Laboratory abnormality|0|||
28021161|NCT00666926|54680472|FG012|Overall Study|Laboratory abnormality|0|||
28021162|NCT00666926|54680473|FG013|Overall Study|Laboratory abnormality|0|||
28021163|NCT00666926|54680474|FG014|Overall Study|Laboratory abnormality|0|||
28021164|NCT00666926|54680475|FG015|Overall Study|Laboratory abnormality|1|||
28021165|NCT00666926|54680460|FG000|Overall Study|Lack of Efficacy|0|||
28021166|NCT00666926|54680461|FG001|Overall Study|Lack of Efficacy|0|||
28021167|NCT00666926|54680462|FG002|Overall Study|Lack of Efficacy|0|||
28021168|NCT00666926|54680463|FG003|Overall Study|Lack of Efficacy|0|||
28021169|NCT00666926|54680464|FG004|Overall Study|Lack of Efficacy|0|||
28021170|NCT00666926|54680465|FG005|Overall Study|Lack of Efficacy|1|||
28021171|NCT00666926|54680466|FG006|Overall Study|Lack of Efficacy|0|||
28021172|NCT00666926|54680467|FG007|Overall Study|Lack of Efficacy|0|||
28021173|NCT00666926|54680468|FG008|Overall Study|Lack of Efficacy|0|||
28021174|NCT00666926|54680469|FG009|Overall Study|Lack of Efficacy|0|||
28021175|NCT00666926|54680470|FG010|Overall Study|Lack of Efficacy|0|||
28021176|NCT00666926|54680471|FG011|Overall Study|Lack of Efficacy|1|||
28021177|NCT00666926|54680472|FG012|Overall Study|Lack of Efficacy|0|||
28021178|NCT00666926|54680473|FG013|Overall Study|Lack of Efficacy|0|||
28021179|NCT00666926|54680474|FG014|Overall Study|Lack of Efficacy|0|||
28021180|NCT00666926|54680475|FG015|Overall Study|Lack of Efficacy|0|||
28021181|NCT00666926|54680460|FG000|Overall Study|Lost to Follow-up|0|||
28021182|NCT00666926|54680461|FG001|Overall Study|Lost to Follow-up|0|||
28021183|NCT00666926|54680462|FG002|Overall Study|Lost to Follow-up|0|||
28021184|NCT00666926|54680463|FG003|Overall Study|Lost to Follow-up|1|||
28021185|NCT00666926|54680464|FG004|Overall Study|Lost to Follow-up|0|||
28021186|NCT00666926|54680465|FG005|Overall Study|Lost to Follow-up|0|||
28021187|NCT00666926|54680466|FG006|Overall Study|Lost to Follow-up|0|||
28021188|NCT00666926|54680467|FG007|Overall Study|Lost to Follow-up|0|||
28021189|NCT00666926|54680468|FG008|Overall Study|Lost to Follow-up|0|||
28021190|NCT00666926|54680469|FG009|Overall Study|Lost to Follow-up|0|||
28021191|NCT00666926|54680470|FG010|Overall Study|Lost to Follow-up|0|||
28021192|NCT00666926|54680471|FG011|Overall Study|Lost to Follow-up|0|||
28021193|NCT00666926|54680472|FG012|Overall Study|Lost to Follow-up|0|||
28021194|NCT00666926|54680473|FG013|Overall Study|Lost to Follow-up|0|||
28021195|NCT00666926|54680474|FG014|Overall Study|Lost to Follow-up|0|||
28021196|NCT00666926|54680475|FG015|Overall Study|Lost to Follow-up|0|||
28021197|NCT00666926|54680460|FG000|Overall Study|Other|2|||
28021198|NCT00666926|54680461|FG001|Overall Study|Other|4|||
28021199|NCT00666926|54680462|FG002|Overall Study|Other|3|||
28021200|NCT00666926|54680463|FG003|Overall Study|Other|3|||
28021201|NCT00666926|54680464|FG004|Overall Study|Other|3|||
28021202|NCT00666926|54680465|FG005|Overall Study|Other|3|||
28021203|NCT00666926|54680466|FG006|Overall Study|Other|4|||
28021204|NCT00666926|54680467|FG007|Overall Study|Other|0|||
28021205|NCT00666926|54680468|FG008|Overall Study|Other|3|||
28021206|NCT00666926|54680469|FG009|Overall Study|Other|5|||
28021207|NCT00666926|54680470|FG010|Overall Study|Other|3|||
28021208|NCT00666926|54680471|FG011|Overall Study|Other|26|||
28021209|NCT00666926|54680472|FG012|Overall Study|Other|3|||
28021210|NCT00666926|54680473|FG013|Overall Study|Other|2|||
28021211|NCT00666926|54680474|FG014|Overall Study|Other|4|||
28021212|NCT00666926|54680475|FG015|Overall Study|Other|4|||
28021213|NCT00666926|54680460|FG000|Overall Study|Withdrawal by Subject|0|||
28021214|NCT00666926|54680461|FG001|Overall Study|Withdrawal by Subject|0|||
28021215|NCT00666926|54680462|FG002|Overall Study|Withdrawal by Subject|0|||
28021216|NCT00666926|54680463|FG003|Overall Study|Withdrawal by Subject|0|||
28021217|NCT00666926|54680464|FG004|Overall Study|Withdrawal by Subject|0|||
28021218|NCT00666926|54680465|FG005|Overall Study|Withdrawal by Subject|0|||
28021219|NCT00666926|54680466|FG006|Overall Study|Withdrawal by Subject|0|||
28021220|NCT00666926|54680467|FG007|Overall Study|Withdrawal by Subject|1|||
28021221|NCT00666926|54680468|FG008|Overall Study|Withdrawal by Subject|0|||
28021222|NCT00666926|54680469|FG009|Overall Study|Withdrawal by Subject|3|||
28021223|NCT00666926|54680470|FG010|Overall Study|Withdrawal by Subject|0|||
28021224|NCT00666926|54680471|FG011|Overall Study|Withdrawal by Subject|3|||
28021225|NCT00666926|54680472|FG012|Overall Study|Withdrawal by Subject|0|||
28021226|NCT00666926|54680473|FG013|Overall Study|Withdrawal by Subject|1|||
28021227|NCT00666926|54680474|FG014|Overall Study|Withdrawal by Subject|3|||
28021228|NCT00666926|54680475|FG015|Overall Study|Withdrawal by Subject|3|||
28021229|NCT00666926|54680460|FG000|Overall Study|Death|0|||
28021230|NCT00666926|54680461|FG001|Overall Study|Death|0|||
28021231|NCT00666926|54680462|FG002|Overall Study|Death|0|||
28021232|NCT00666926|54680463|FG003|Overall Study|Death|0|||
28021233|NCT00666926|54680464|FG004|Overall Study|Death|0|||
28021234|NCT00666926|54680465|FG005|Overall Study|Death|0|||
28021235|NCT00666926|54680466|FG006|Overall Study|Death|0|||
28021236|NCT00666926|54680467|FG007|Overall Study|Death|0|||
28021237|NCT00666926|54680468|FG008|Overall Study|Death|0|||
28021238|NCT00666926|54680469|FG009|Overall Study|Death|0|||
28021239|NCT00666926|54680470|FG010|Overall Study|Death|0|||
28021240|NCT00666926|54680471|FG011|Overall Study|Death|1|||
28021241|NCT00666926|54680472|FG012|Overall Study|Death|0|||
28021242|NCT00666926|54680473|FG013|Overall Study|Death|0|||
28021243|NCT00666926|54680474|FG014|Overall Study|Death|0|||
28021244|NCT00666926|54680475|FG015|Overall Study|Death|0|||
28021245|NCT03861052|54680530|FG000|Overall Study|Adverse Event|1|||
28021246|NCT03861052|54680531|FG001|Overall Study|Adverse Event|1|||
28021247|NCT03861052|54680532|FG002|Overall Study|Adverse Event|2|||
28021248|NCT03861052|54680533|FG003|Overall Study|Adverse Event|4|||
28021249|NCT03861052|54680530|FG000|Overall Study|Lost to Follow-up|0|||
28021250|NCT03861052|54680531|FG001|Overall Study|Lost to Follow-up|0|||
28021251|NCT03861052|54680532|FG002|Overall Study|Lost to Follow-up|0|||
28021252|NCT03861052|54680533|FG003|Overall Study|Lost to Follow-up|1|||
28021253|NCT03861052|54680530|FG000|Overall Study|Physician Decision|0|||
28021254|NCT03861052|54680531|FG001|Overall Study|Physician Decision|1|||
28021255|NCT03861052|54680532|FG002|Overall Study|Physician Decision|0|||
28021256|NCT03861052|54680533|FG003|Overall Study|Physician Decision|0|||
28021257|NCT03861052|54680530|FG000|Overall Study|Withdrawal by Subject|2|||
28021258|NCT03861052|54680531|FG001|Overall Study|Withdrawal by Subject|5|||
28021259|NCT03861052|54680532|FG002|Overall Study|Withdrawal by Subject|3|||
28021260|NCT03861052|54680533|FG003|Overall Study|Withdrawal by Subject|0|||
28021261|NCT03861052|54680530|FG000|Overall Study|Relocation to other city|1|||
28021262|NCT03861052|54680531|FG001|Overall Study|Relocation to other city|0|||
28021263|NCT03861052|54680532|FG002|Overall Study|Relocation to other city|0|||
28021264|NCT03861052|54680533|FG003|Overall Study|Relocation to other city|0|||
28021265|NCT00664742|54680548|FG000|Overall Study|Withdrawn due to adverse events|3|||
28021266|NCT00664742|54680548|FG000|Overall Study|Withdrawal by Subject|31|||
28021267|NCT00664742|54680548|FG000|Overall Study|Lost to Follow-up|92|||
28021268|NCT00511342|54680554|FG000|Overall Study|Unacceptable vaginal bleeding|2|||
28021269|NCT00511342|54680555|FG001|Overall Study|Unacceptable vaginal bleeding|1|||
28021270|NCT00511342|54680554|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|8|||
28021271|NCT00511342|54680555|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|12|||
28021272|NCT00511342|54680554|FG000|Overall Study|Pregnancy|0|||
28021273|NCT00511342|54680555|FG001|Overall Study|Pregnancy|1|||
28021274|NCT00511342|54680554|FG000|Overall Study|Pregnancy wish|0|||
28021275|NCT00511342|54680555|FG001|Overall Study|Pregnancy wish|1|||
28021276|NCT00511342|54680554|FG000|Overall Study|Lost to Follow-up|1|||
28021277|NCT00511342|54680555|FG001|Overall Study|Lost to Follow-up|5|||
28021278|NCT00511342|54680554|FG000|Overall Study|Other Reason|2|||
28021279|NCT00511342|54680555|FG001|Overall Study|Other Reason|2|||
28021280|NCT03931785|54680565|FG000|Overall Study|Lost to Follow-up|4|||
28021281|NCT03931785|54680566|FG001|Overall Study|Lost to Follow-up|1|||
28021282|NCT03931785|54680567|FG002|Overall Study|Lost to Follow-up|4|||
28021283|NCT03931785|54680568|FG003|Overall Study|Lost to Follow-up|3|||
28021284|NCT03931785|54680565|FG000|Overall Study|Adverse Event|1|||
28021285|NCT03931785|54680566|FG001|Overall Study|Adverse Event|0|||
28021286|NCT03931785|54680567|FG002|Overall Study|Adverse Event|3|||
28021287|NCT03931785|54680568|FG003|Overall Study|Adverse Event|4|||
28021288|NCT03931785|54680565|FG000|Overall Study|Protocol Violation|0|||
28021289|NCT03931785|54680566|FG001|Overall Study|Protocol Violation|1|||
28021290|NCT03931785|54680567|FG002|Overall Study|Protocol Violation|0|||
28021291|NCT03931785|54680568|FG003|Overall Study|Protocol Violation|0|||
27800035|NCT02081677|54254659|FG003|Overall Study|Not comfortable with lens care system|0|||
27800036|NCT02081677|54254656|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
27800037|NCT02081677|54254657|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
27800038|NCT02081677|54254658|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
27800039|NCT02081677|54254659|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
27800040|NCT02038933|54254671|FG000|Overall Study|Disease progression|104|||
27800041|NCT02038933|54254671|FG000|Overall Study|Study drug toxicity|6|||
27800042|NCT02038933|54254671|FG000|Overall Study|Adverse event unrelated to study drug|6|||
27800043|NCT02038933|54254671|FG000|Overall Study|Participant request to discontinue treatment|2|||
27800044|NCT02038933|54254671|FG000|Overall Study|Lost to Follow-up|1|||
27800045|NCT02038933|54254671|FG000|Overall Study|Other reasons|2|||
27800046|NCT02081599|54254678|FG000|Period 1：Double-blind Period|Adverse Event|3|||
27800047|NCT02081599|54254679|FG001|Period 1：Double-blind Period|Adverse Event|0|||
27800048|NCT02081599|54254678|FG000|Period 1：Double-blind Period|Lack of Efficacy|2|||
27800049|NCT02081599|54254679|FG001|Period 1：Double-blind Period|Lack of Efficacy|1|||
27800050|NCT02081599|54254678|FG000|Period 1：Double-blind Period|Physician Decision|1|||
27800051|NCT02081599|54254679|FG001|Period 1：Double-blind Period|Physician Decision|0|||
27800052|NCT02081599|54254678|FG000|Period 1：Double-blind Period|Protocol Violation|0|||
27800053|NCT02081599|54254679|FG001|Period 1：Double-blind Period|Protocol Violation|1|||
27800054|NCT02081599|54254678|FG000|Period 1：Double-blind Period|Withdrawal by Subject|1|||
27800055|NCT02081599|54254679|FG001|Period 1：Double-blind Period|Withdrawal by Subject|0|||
27800056|NCT02081599|54254678|FG000|Period 1：Double-blind Period|stopping criteria|1|||
28021292|NCT03931785|54680565|FG000|Overall Study|Noncompliance With Study drug|0|||
28021293|NCT03931785|54680566|FG001|Overall Study|Noncompliance With Study drug|1|||
28021294|NCT03931785|54680567|FG002|Overall Study|Noncompliance With Study drug|0|||
28021295|NCT03931785|54680568|FG003|Overall Study|Noncompliance With Study drug|0|||
28021296|NCT03931785|54680565|FG000|Overall Study|Other Not specified|0|||
28021297|NCT03931785|54680566|FG001|Overall Study|Other Not specified|2|||
28021298|NCT03931785|54680567|FG002|Overall Study|Other Not specified|2|||
28021299|NCT03931785|54680568|FG003|Overall Study|Other Not specified|2|||
28021300|NCT03931785|54680565|FG000|Overall Study|Withdrawal by Subject|0|||
28021301|NCT03931785|54680566|FG001|Overall Study|Withdrawal by Subject|2|||
28021302|NCT03931785|54680567|FG002|Overall Study|Withdrawal by Subject|4|||
28021303|NCT03931785|54680568|FG003|Overall Study|Withdrawal by Subject|1|||
28021304|NCT03931785|54680565|FG000|Overall Study|Pregnancy|0|||
28021305|NCT03931785|54680566|FG001|Overall Study|Pregnancy|0|||
28021306|NCT03931785|54680567|FG002|Overall Study|Pregnancy|0|||
28021307|NCT03931785|54680568|FG003|Overall Study|Pregnancy|1|||
28021308|NCT00666536|54680580|FG000|Overall Study|Adverse Event|9|||
28021309|NCT00666536|54680581|FG001|Overall Study|Adverse Event|19|||
28021310|NCT00666536|54680580|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
28021311|NCT00666536|54680581|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
28021312|NCT00666536|54680580|FG000|Overall Study|Protocol deviation(s)|8|||
28021313|NCT00666536|54680581|FG001|Overall Study|Protocol deviation(s)|6|||
28021314|NCT00666536|54680580|FG000|Overall Study|Withdrawal by Subject|10|||
28021315|NCT00666536|54680581|FG001|Overall Study|Withdrawal by Subject|9|||
28021316|NCT00666536|54680580|FG000|Overall Study|Lost to Follow-up|4|||
28021317|NCT00666536|54680581|FG001|Overall Study|Lost to Follow-up|3|||
28021318|NCT00519532|54680587|FG000|Overall Study|Adverse Event|11|||
28021319|NCT00519532|54680587|FG000|Overall Study|Withdrawal by Subject|5|||
28021320|NCT00519532|54680587|FG000|Overall Study|Lost to Follow-up|2|||
28021321|NCT00666458|54680593|FG000|Overall Study|Adverse Event|8|||
28021322|NCT00666458|54680594|FG001|Overall Study|Adverse Event|7|||
28021323|NCT00666458|54680593|FG000|Overall Study|Withdrawal by Subject|5|||
28021324|NCT00666458|54680594|FG001|Overall Study|Withdrawal by Subject|4|||
28021325|NCT00666458|54680593|FG000|Overall Study|Lost to Follow-up|0|||
28021326|NCT00666458|54680594|FG001|Overall Study|Lost to Follow-up|3|||
28021327|NCT00666458|54680593|FG000|Overall Study|Administrative reason by sponsor|1|||
28021328|NCT00666458|54680594|FG001|Overall Study|Administrative reason by sponsor|1|||
28021329|NCT00666458|54680593|FG000|Overall Study|Incorrect enrollment|7|||
28021330|NCT00666458|54680594|FG001|Overall Study|Incorrect enrollment|1|||
28021331|NCT00666458|54680593|FG000|Overall Study|Study specific discontinuation criteria|14|||
28021332|NCT00666458|54680594|FG001|Overall Study|Study specific discontinuation criteria|7|||
28021333|NCT00666458|54680593|FG000|Overall Study|Severe non-compliance to the protocol|1|||
28021334|NCT00666458|54680594|FG001|Overall Study|Severe non-compliance to the protocol|1|||
28021335|NCT00666458|54680593|FG000|Overall Study|Safety reasons|1|||
28021336|NCT00666458|54680594|FG001|Overall Study|Safety reasons|0|||
28021337|NCT00666458|54680593|FG000|Overall Study|Medical history of anemia|1|||
28021338|NCT00666458|54680594|FG001|Overall Study|Medical history of anemia|0|||
28021339|NCT00511108|54680604|FG000|Overall Study|Adverse Event|2|||
28021340|NCT00511108|54680605|FG001|Overall Study|Adverse Event|0|||
28021341|NCT00511108|54680606|FG002|Overall Study|Adverse Event|1|||
28021342|NCT00511108|54680607|FG003|Overall Study|Adverse Event|2|||
28021343|NCT00511108|54680604|FG000|Overall Study|Lost to Follow-up|0|||
28021344|NCT00511108|54680605|FG001|Overall Study|Lost to Follow-up|2|||
28021345|NCT00511108|54680606|FG002|Overall Study|Lost to Follow-up|1|||
27800057|NCT02081599|54254679|FG001|Period 1：Double-blind Period|stopping criteria|0|||
28021346|NCT00511108|54680607|FG003|Overall Study|Lost to Follow-up|0|||
28021347|NCT00511108|54680604|FG000|Overall Study|Physician Decision|0|||
28021348|NCT00511108|54680605|FG001|Overall Study|Physician Decision|0|||
28021349|NCT00511108|54680606|FG002|Overall Study|Physician Decision|0|||
28021350|NCT00511108|54680607|FG003|Overall Study|Physician Decision|1|||
28021351|NCT00511108|54680604|FG000|Overall Study|Withdrawal by Subject|4|||
28021352|NCT00511108|54680605|FG001|Overall Study|Withdrawal by Subject|0|||
28021353|NCT00511108|54680606|FG002|Overall Study|Withdrawal by Subject|3|||
28021354|NCT00511108|54680607|FG003|Overall Study|Withdrawal by Subject|2|||
28021355|NCT00510952|54680619|FG000|Overall Study|Adverse Event|1|||
27800058|NCT02081599|54254678|FG000|Period 2：Open-label Period|Adverse Event|1|||
27800059|NCT02081599|54254679|FG001|Period 2：Open-label Period|Adverse Event|0|||
27800060|NCT02081599|54254678|FG000|Period 2：Open-label Period|Lack of Efficacy|2|||
27800061|NCT02081599|54254679|FG001|Period 2：Open-label Period|Lack of Efficacy|4|||
27800062|NCT02081599|54254678|FG000|Period 2：Open-label Period|Physician Decision|1|||
27800063|NCT02081599|54254679|FG001|Period 2：Open-label Period|Physician Decision|0|||
27800064|NCT02081599|54254678|FG000|Period 2：Open-label Period|Withdrawal by Subject|2|||
27800065|NCT02081599|54254679|FG001|Period 2：Open-label Period|Withdrawal by Subject|0|||
28021356|NCT00510952|54680620|FG001|Overall Study|Adverse Event|0|||
28021357|NCT00510952|54680619|FG000|Overall Study|Entry Criteria Not Met|3|||
28021358|NCT00510952|54680620|FG001|Overall Study|Entry Criteria Not Met|1|||
28021359|NCT00510952|54680619|FG000|Overall Study|Lost to Follow-up|5|||
28021360|NCT00510952|54680620|FG001|Overall Study|Lost to Follow-up|3|||
28021361|NCT00510952|54680619|FG000|Overall Study|Physician Decision|1|||
28021362|NCT00510952|54680620|FG001|Overall Study|Physician Decision|1|||
28021363|NCT00510952|54680619|FG000|Overall Study|Protocol Violation|7|||
28021364|NCT00510952|54680620|FG001|Overall Study|Protocol Violation|4|||
28021365|NCT00510952|54680619|FG000|Overall Study|Sponsor Decision|1|||
28021366|NCT00510952|54680620|FG001|Overall Study|Sponsor Decision|0|||
28021367|NCT00510952|54680619|FG000|Overall Study|Withdrawal by Subject|6|||
28021368|NCT00510952|54680620|FG001|Overall Study|Withdrawal by Subject|7|||
27800066|NCT02038543|54254691|FG000|Overall Study|Screen Failure|0|||
27800067|NCT02038543|54254692|FG001|Overall Study|Screen Failure|0|||
27800068|NCT02038543|54254693|FG002|Overall Study|Screen Failure|0|||
27800069|NCT02038543|54254694|FG003|Overall Study|Screen Failure|1|||
27800070|NCT02038543|54254691|FG000|Overall Study|Withdrawal by Subject|0|||
27800071|NCT02038543|54254692|FG001|Overall Study|Withdrawal by Subject|0|||
27800072|NCT02038543|54254693|FG002|Overall Study|Withdrawal by Subject|0|||
27800073|NCT02038543|54254694|FG003|Overall Study|Withdrawal by Subject|1|||
27800074|NCT02038153|54254704|FG000|Overall Study|Withdrawal by Subject|1|||
27800075|NCT02038075|54254710|FG000|Overall Study|Withdrawal by Subject|3|||
27800076|NCT02038075|54254711|FG001|Overall Study|Withdrawal by Subject|0|||
27800077|NCT02058589|54254719|FG000|Overall Study|Serious Adverse Event|1|||
27800078|NCT02058589|54254720|FG001|Overall Study|Serious Adverse Event|1|||
27800079|NCT02058589|54254719|FG000|Overall Study|Non-Serious Adverse Event|1|||
27800080|NCT02058589|54254720|FG001|Overall Study|Non-Serious Adverse Event|0|||
27800081|NCT02058589|54254719|FG000|Overall Study|Withdrawal by Subject|0|||
27800082|NCT02058589|54254720|FG001|Overall Study|Withdrawal by Subject|1|||
27800083|NCT02079805|54254730|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
27800084|NCT02079805|54254731|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
27800085|NCT02079805|54254730|FG000|Overall Study|Voluntary Withdrawal|0|||
27800086|NCT02079805|54254731|FG001|Overall Study|Voluntary Withdrawal|1|||
27800087|NCT02037295|54254741|FG000|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
27800088|NCT02037295|54254742|FG001|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
27800089|NCT02037295|54254743|FG002|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
27800090|NCT02037295|54254744|FG003|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
27800091|NCT02079649|54254760|FG000|Overall Study|Lost to Follow-up|0|||
27800092|NCT02079649|54254761|FG001|Overall Study|Lost to Follow-up|0|||
27800093|NCT02079649|54254762|FG002|Overall Study|Lost to Follow-up|0|||
27800094|NCT02079649|54254763|FG003|Overall Study|Lost to Follow-up|1|||
27800095|NCT02079649|54254760|FG000|Overall Study|Withdrawal by Subject|0|||
27800096|NCT02079649|54254761|FG001|Overall Study|Withdrawal by Subject|0|||
27800097|NCT02079649|54254762|FG002|Overall Study|Withdrawal by Subject|0|||
27800098|NCT02079649|54254763|FG003|Overall Study|Withdrawal by Subject|1|||
27800099|NCT02079649|54254760|FG000|Overall Study|Randomization error (prior to treatment)|1|||
27800100|NCT02079649|54254761|FG001|Overall Study|Randomization error (prior to treatment)|0|||
27800101|NCT02079649|54254762|FG002|Overall Study|Randomization error (prior to treatment)|1|||
27800102|NCT02079649|54254763|FG003|Overall Study|Randomization error (prior to treatment)|0|||
27800103|NCT02036515|54254777|FG000|Overall Study|Adverse Event|1|||
27800104|NCT02036515|54254778|FG001|Overall Study|Adverse Event|1|||
27800105|NCT02036515|54254779|FG002|Overall Study|Adverse Event|2|||
27800106|NCT02036515|54254777|FG000|Overall Study|Lost to Follow-up|0|||
27800107|NCT02036515|54254778|FG001|Overall Study|Lost to Follow-up|2|||
27800108|NCT02036515|54254779|FG002|Overall Study|Lost to Follow-up|0|||
27800109|NCT02036515|54254777|FG000|Overall Study|Non-compliance with study drug|0|||
27800110|NCT02036515|54254778|FG001|Overall Study|Non-compliance with study drug|0|||
27800111|NCT02036515|54254779|FG002|Overall Study|Non-compliance with study drug|2|||
27800112|NCT02036515|54254777|FG000|Overall Study|Screen failure|0|||
27800113|NCT02036515|54254778|FG001|Overall Study|Screen failure|2|||
27800114|NCT02036515|54254779|FG002|Overall Study|Screen failure|0|||
27800115|NCT02036515|54254777|FG000|Overall Study|Withdrawal by Subject|4|||
27800116|NCT02036515|54254778|FG001|Overall Study|Withdrawal by Subject|7|||
27800117|NCT02036515|54254779|FG002|Overall Study|Withdrawal by Subject|9|||
27800118|NCT02036515|54254777|FG000|Overall Study|Hyperglycemia|0|||
27800119|NCT02036515|54254778|FG001|Overall Study|Hyperglycemia|0|||
27800120|NCT02036515|54254779|FG002|Overall Study|Hyperglycemia|1|||
27800121|NCT02078713|54254791|FG000|Overall Study|Lost to Follow-up|49|||
27800122|NCT02078713|54254792|FG001|Overall Study|Lost to Follow-up|55|||
27800123|NCT02078713|54254793|FG002|Overall Study|Lost to Follow-up|0|||
27800124|NCT02078713|54254794|FG003|Overall Study|Lost to Follow-up|0|||
27800125|NCT02078713|54254791|FG000|Overall Study|Pregnant at baseline|3|||
27800126|NCT02078713|54254792|FG001|Overall Study|Pregnant at baseline|5|||
27800127|NCT02078713|54254793|FG002|Overall Study|Pregnant at baseline|0|||
27800128|NCT02078713|54254794|FG003|Overall Study|Pregnant at baseline|0|||
27800129|NCT02078713|54254791|FG000|Overall Study|Enrolled twice|0|||
28021369|NCT00510952|54680619|FG000|Overall Study|Did Not Receive Study Drug|2|||
28021370|NCT00510952|54680620|FG001|Overall Study|Did Not Receive Study Drug|0|||
28021371|NCT00617604|54680628|FG000|Overall Study|Death|2|||
27800130|NCT02078713|54254792|FG001|Overall Study|Enrolled twice|1|||
27800131|NCT02078713|54254793|FG002|Overall Study|Enrolled twice|0|||
28021372|NCT00617604|54680629|FG001|Overall Study|Death|1|||
28021373|NCT00617604|54680628|FG000|Overall Study|Lost to Follow-up|1|||
28021374|NCT00617604|54680629|FG001|Overall Study|Lost to Follow-up|0|||
27800132|NCT02078713|54254794|FG003|Overall Study|Enrolled twice|0|||
27800133|NCT02035267|54254810|FG000|Overall Study|Withdrawal consent-subject convenience|0|||
27800134|NCT02035267|54254811|FG001|Overall Study|Withdrawal consent-subject convenience|0|||
28021375|NCT00617604|54680628|FG000|Overall Study|Miscellaneous Reasons|8|||
28021376|NCT00617604|54680629|FG001|Overall Study|Miscellaneous Reasons|10|||
28021377|NCT00617604|54680628|FG000|Overall Study|Withdrawal by Subject|4|||
28021378|NCT00617604|54680629|FG001|Overall Study|Withdrawal by Subject|6|||
28021379|NCT00617604|54680628|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
28021380|NCT00617604|54680629|FG001|Overall Study|Randomized but Never Received Study Drug|3|||
28021381|NCT00661622|54680637|FG000|Overall Study|Protocol Violation|1|||
28021382|NCT00661622|54680638|FG001|Overall Study|Protocol Violation|0|||
28021383|NCT04093752|54680649|FG000|Overall Study|Adverse Event|7|||
28021384|NCT04093752|54680650|FG001|Overall Study|Adverse Event|19|||
28021385|NCT04093752|54680651|FG002|Overall Study|Adverse Event|18|||
28021386|NCT04093752|54680652|FG003|Overall Study|Adverse Event|4|||
28021387|NCT04093752|54680649|FG000|Overall Study|Withdrawal by Subject|6|||
28021388|NCT04093752|54680650|FG001|Overall Study|Withdrawal by Subject|6|||
28021389|NCT04093752|54680651|FG002|Overall Study|Withdrawal by Subject|8|||
28021390|NCT04093752|54680652|FG003|Overall Study|Withdrawal by Subject|20|||
28021391|NCT04093752|54680649|FG000|Overall Study|Lost to Follow-up|2|||
28021392|NCT04093752|54680650|FG001|Overall Study|Lost to Follow-up|1|||
27800135|NCT02035267|54254812|FG002|Overall Study|Withdrawal consent-subject convenience|1|||
27800136|NCT02035267|54254813|FG003|Overall Study|Withdrawal consent-subject convenience|0|||
27800137|NCT02035267|54254810|FG000|Overall Study|Adverse Event|0|||
27800138|NCT02035267|54254811|FG001|Overall Study|Adverse Event|0|||
27800139|NCT02035267|54254812|FG002|Overall Study|Adverse Event|1|||
27800140|NCT02035267|54254813|FG003|Overall Study|Adverse Event|0|||
27800141|NCT02035267|54254810|FG000|Overall Study|Lost to Follow-up|0|||
27800142|NCT02035267|54254811|FG001|Overall Study|Lost to Follow-up|0|||
27800143|NCT02035267|54254812|FG002|Overall Study|Lost to Follow-up|0|||
27800144|NCT02035267|54254813|FG003|Overall Study|Lost to Follow-up|1|||
27800145|NCT02035267|54254810|FG000|Overall Study|Other unspecified|0|||
27800146|NCT02035267|54254811|FG001|Overall Study|Other unspecified|1|||
27800147|NCT02035267|54254812|FG002|Overall Study|Other unspecified|0|||
27800148|NCT02035267|54254813|FG003|Overall Study|Other unspecified|0|||
27800149|NCT04373460|54254847|FG000|Overall Study|Did not receive tranfusion|18|||
27800150|NCT04373460|54254848|FG001|Overall Study|Did not receive tranfusion|26|||
27800151|NCT04280081|54254858|FG000|Overall Study|Adverse Event|4|||
27800152|NCT04280081|54254858|FG000|Overall Study|Death|2|||
27800153|NCT04280081|54254858|FG000|Overall Study|Progressive Disease|6|||
27800154|NCT04159805|54254874|FG000|Overall Study|Withdrawal by Subject|0|||
27800155|NCT04159805|54254875|FG001|Overall Study|Withdrawal by Subject|2|||
27800156|NCT04159805|54254876|FG002|Overall Study|Withdrawal by Subject|2|||
27800157|NCT03901456|54254887|FG000|Overall Study|Withdrawal by Subject|0|||
27800158|NCT03901456|54254888|FG001|Overall Study|Withdrawal by Subject|0|||
27800159|NCT03901456|54254889|FG002|Overall Study|Withdrawal by Subject|1|||
27800160|NCT03901456|54254887|FG000|Overall Study|Lost to Follow-up|0|||
27800161|NCT03901456|54254888|FG001|Overall Study|Lost to Follow-up|1|||
27800162|NCT03901456|54254889|FG002|Overall Study|Lost to Follow-up|0|||
28021393|NCT04093752|54680651|FG002|Overall Study|Lost to Follow-up|1|||
27800163|NCT03848845|54254902|FG000|Overall Study|Lost to Follow-up|0|||
27800164|NCT03848845|54254903|FG001|Overall Study|Lost to Follow-up|1|||
28021394|NCT04093752|54680652|FG003|Overall Study|Lost to Follow-up|1|||
28021395|NCT04093752|54680649|FG000|Overall Study|Death|0|||
28021396|NCT04093752|54680650|FG001|Overall Study|Death|0|||
28021397|NCT04093752|54680651|FG002|Overall Study|Death|1|||
28021398|NCT04093752|54680652|FG003|Overall Study|Death|2|||
28021399|NCT04093752|54680649|FG000|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
28021400|NCT04093752|54680650|FG001|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
27800165|NCT03848845|54254904|FG002|Overall Study|Lost to Follow-up|0|||
28021401|NCT04093752|54680651|FG002|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
28021402|NCT04093752|54680652|FG003|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
28021403|NCT04093752|54680649|FG000|Overall Study|Covid 19|0|||
28021404|NCT04093752|54680650|FG001|Overall Study|Covid 19|0|||
28021405|NCT04093752|54680651|FG002|Overall Study|Covid 19|0|||
27800166|NCT03848845|54254902|FG000|Overall Study|Withdrawal by Subject|3|||
27842812|NCT01532414|54331663|FG001|Overall Study|Unable to complete 24 hour PK|0|||
27800167|NCT03848845|54254903|FG001|Overall Study|Withdrawal by Subject|2|||
28021406|NCT04093752|54680652|FG003|Overall Study|Covid 19|1|||
28021407|NCT04093752|54680649|FG000|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
28021408|NCT04093752|54680650|FG001|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
28021409|NCT04093752|54680651|FG002|Overall Study|Participant Thought there were Too Many Adverse Events|1|||
28021410|NCT04093752|54680652|FG003|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
28021411|NCT04093752|54680649|FG000|Overall Study|Participant was Reluctant to Follow-up|1|||
28021412|NCT04093752|54680650|FG001|Overall Study|Participant was Reluctant to Follow-up|0|||
28021413|NCT04093752|54680651|FG002|Overall Study|Participant was Reluctant to Follow-up|0|||
28021414|NCT04093752|54680652|FG003|Overall Study|Participant was Reluctant to Follow-up|0|||
28021415|NCT04093752|54680649|FG000|Overall Study|Participant Did Not Come for the Visit|1|||
28021416|NCT04093752|54680650|FG001|Overall Study|Participant Did Not Come for the Visit|0|||
28021417|NCT04093752|54680651|FG002|Overall Study|Participant Did Not Come for the Visit|0|||
28021418|NCT04093752|54680652|FG003|Overall Study|Participant Did Not Come for the Visit|0|||
28021419|NCT03928821|54680670|FG000|Overall Study|Death|0|||
28021420|NCT03928821|54680671|FG001|Overall Study|Death|1|||
28021421|NCT03928821|54680672|FG002|Overall Study|Death|0|||
28021422|NCT03928821|54680673|FG003|Overall Study|Death|0|||
27800168|NCT03848845|54254904|FG002|Overall Study|Withdrawal by Subject|6|||
28021423|NCT03928821|54680670|FG000|Overall Study|Lost to Follow-up|0|||
28021424|NCT03928821|54680671|FG001|Overall Study|Lost to Follow-up|2|||
28021425|NCT03928821|54680672|FG002|Overall Study|Lost to Follow-up|3|||
28021426|NCT03928821|54680673|FG003|Overall Study|Lost to Follow-up|0|||
28021427|NCT03928821|54680670|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
28021428|NCT03928821|54680671|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
28021429|NCT03928821|54680672|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
28021430|NCT03928821|54680673|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
27800169|NCT03848845|54254902|FG000|Overall Study|In Follow-up|0|||
27800170|NCT03848845|54254903|FG001|Overall Study|In Follow-up|1|||
27800171|NCT03848845|54254904|FG002|Overall Study|In Follow-up|12|||
27800172|NCT03848845|54254902|FG000|Overall Study|On Study Treatment|0|||
27800173|NCT03848845|54254903|FG001|Overall Study|On Study Treatment|0|||
27800174|NCT03848845|54254904|FG002|Overall Study|On Study Treatment|4|||
27800175|NCT03848845|54254902|FG000|Overall Study|Physician Decision|0|||
27800176|NCT03848845|54254903|FG001|Overall Study|Physician Decision|0|||
27800177|NCT03848845|54254904|FG002|Overall Study|Physician Decision|1|||
27800178|NCT03299166|54254955|FG000|Overall Study|Adverse Event|9|||
27800179|NCT03299166|54254956|FG001|Overall Study|Adverse Event|4|||
27800180|NCT03299166|54254955|FG000|Overall Study|Withdrawal by Subject|6|||
27800181|NCT03299166|54254956|FG001|Overall Study|Withdrawal by Subject|5|||
27800182|NCT03299166|54254955|FG000|Overall Study|Physician Decision|1|||
27800183|NCT03299166|54254956|FG001|Overall Study|Physician Decision|1|||
27800184|NCT03299166|54254955|FG000|Overall Study|Sponsor Decision|3|||
27800185|NCT03299166|54254956|FG001|Overall Study|Sponsor Decision|0|||
27800186|NCT03299166|54254955|FG000|Overall Study|Lost to Follow-up|2|||
27800187|NCT03299166|54254956|FG001|Overall Study|Lost to Follow-up|4|||
27800188|NCT03299166|54254955|FG000|Overall Study|Randomization Error|0|||
27800189|NCT03299166|54254956|FG001|Overall Study|Randomization Error|1|||
27800190|NCT03299166|54254955|FG000|Overall Study|Subject unable to return due to COVID|1|||
27800191|NCT03299166|54254956|FG001|Overall Study|Subject unable to return due to COVID|0|||
27800192|NCT03299166|54254955|FG000|Overall Study|Unable to complete Week 12 visit at site|1|||
27800193|NCT03299166|54254956|FG001|Overall Study|Unable to complete Week 12 visit at site|0|||
27800194|NCT03286504|54254964|FG000|Overall Study|Lost to Follow-up|19|||
27800195|NCT03286504|54254965|FG001|Overall Study|Lost to Follow-up|16|||
27800196|NCT03226249|54254971|FG000|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1|||
27800197|NCT03226249|54254971|FG000|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29|||
27800198|NCT03226249|54254971|FG000|Survival Follow-up|Patients still in follow-up.|30|||
27800199|NCT02941926|54254975|FG000|Overall Study|Progressive disease|1109|||
27800200|NCT02941926|54254975|FG000|Overall Study|Adverse Event|504|||
27800201|NCT02941926|54254975|FG000|Overall Study|Subject/guardian decision|127|||
27800202|NCT02941926|54254975|FG000|Overall Study|Physician Decision|112|||
27800203|NCT02941926|54254975|FG000|Overall Study|Death|46|||
28021431|NCT00666224|54680685|FG000|Double-Blind|Adverse Event|15|||
28021432|NCT00666224|54680686|FG001|Double-Blind|Adverse Event|5|||
27800204|NCT02941926|54254975|FG000|Overall Study|Protocol deviation|34|||
27800205|NCT02941926|54254975|FG000|Overall Study|Lost to Follow-up|8|||
27800206|NCT02941926|54254975|FG000|Overall Study|Technical problems|5|||
27800207|NCT02849548|54254983|FG000|Overall Study|Lost to Follow-up|1|||
27800208|NCT02849548|54254984|FG001|Overall Study|Lost to Follow-up|2|||
27800209|NCT02849548|54254983|FG000|Overall Study|Protocol Violation|1|||
27800210|NCT02849548|54254984|FG001|Overall Study|Protocol Violation|0|||
27800211|NCT02411448|54255002|FG000|Overall Study|Withdrawal by Subject|1|||
27800212|NCT02411448|54255003|FG001|Overall Study|Withdrawal by Subject|14|||
27800213|NCT02411448|54255004|FG002|Overall Study|Withdrawal by Subject|9|||
27800214|NCT02411448|54255002|FG000|Overall Study|Other|0|||
27800215|NCT02411448|54255003|FG001|Overall Study|Other|2|||
27800216|NCT02411448|54255004|FG002|Overall Study|Other|0|||
27800217|NCT02411448|54255002|FG000|Overall Study|Did not receive study treatment|0|||
27800218|NCT02411448|54255003|FG001|Overall Study|Did not receive study treatment|3|||
27800219|NCT02411448|54255004|FG002|Overall Study|Did not receive study treatment|0|||
27800220|NCT02411448|54255002|FG000|Overall Study|Alive on study treatment|3|||
27800221|NCT02411448|54255003|FG001|Overall Study|Alive on study treatment|64|||
27800222|NCT02411448|54255004|FG002|Overall Study|Alive on study treatment|43|||
27800223|NCT02321514|54255016|FG000|Overall Study|Death|15|||
27800224|NCT02321514|54255016|FG000|Overall Study|Missed Visit|7|||
27800225|NCT02321514|54255016|FG000|Overall Study|Study Exit|3|||
27800226|NCT02266134|54255024|FG000|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|6|||
27800227|NCT02266134|54255025|FG001|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|3|||
27800228|NCT02266134|54255026|FG002|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
27800229|NCT02266134|54255027|FG003|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
27800230|NCT02266134|54255024|FG000|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|8|||
27800231|NCT02266134|54255025|FG001|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|2|||
27800232|NCT02266134|54255026|FG002|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
27800233|NCT02266134|54255027|FG003|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
27800234|NCT02266134|54255024|FG000|Clinics #7-10: Beginning May 2016|Lost to Follow-up|10|||
27800235|NCT02266134|54255025|FG001|Clinics #7-10: Beginning May 2016|Lost to Follow-up|5|||
28021433|NCT00666224|54680685|FG000|Double-Blind|Lost to Follow-up|2|||
28021434|NCT00666224|54680686|FG001|Double-Blind|Lost to Follow-up|2|||
28021435|NCT00666224|54680685|FG000|Double-Blind|Withdrawal by Subject|18|||
28021436|NCT00666224|54680686|FG001|Double-Blind|Withdrawal by Subject|14|||
28021437|NCT00666224|54680685|FG000|Double-Blind|Physician Decision|0|||
28021438|NCT00666224|54680686|FG001|Double-Blind|Physician Decision|3|||
27800236|NCT02266134|54255026|FG002|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
27800237|NCT02266134|54255027|FG003|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
27800238|NCT02266134|54255024|FG000|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|3|||
27800239|NCT02266134|54255025|FG001|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
27800240|NCT02266134|54255026|FG002|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
27800241|NCT02266134|54255027|FG003|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
27800242|NCT02266134|54255024|FG000|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|6|||
27800243|NCT02266134|54255025|FG001|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|2|||
27800244|NCT02266134|54255026|FG002|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
27800245|NCT02266134|54255027|FG003|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
27800246|NCT02266134|54255024|FG000|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|3|||
27800247|NCT02266134|54255025|FG001|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
27800248|NCT02266134|54255026|FG002|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
27800249|NCT02266134|54255027|FG003|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
27800250|NCT01847274|54255055|FG000|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|22|||
27800251|NCT01847274|54255056|FG001|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|8|||
27800252|NCT01847274|54255057|FG002|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|31|||
27800253|NCT01847274|54255058|FG003|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|13|||
27800254|NCT01847274|54255059|FG004|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
27800255|NCT01847274|54255060|FG005|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
27800256|NCT01847274|54255061|FG006|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
27800257|NCT01847274|54255062|FG007|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
27800258|NCT01847274|54255063|FG008|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
27800259|NCT01847274|54255064|FG009|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
27800260|NCT01847274|54255065|FG010|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
27800261|NCT01847274|54255055|FG000|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|20|||
27800262|NCT01847274|54255056|FG001|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|11|||
27800263|NCT01847274|54255057|FG002|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|29|||
27800264|NCT01847274|54255058|FG003|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|14|||
27800265|NCT01847274|54255059|FG004|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
27800266|NCT01847274|54255060|FG005|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
27800267|NCT01847274|54255061|FG006|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
27800268|NCT01847274|54255062|FG007|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
27800269|NCT01847274|54255063|FG008|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
27800270|NCT01847274|54255064|FG009|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
27800271|NCT01847274|54255065|FG010|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
27800272|NCT01847274|54255055|FG000|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|7|||
27800273|NCT01847274|54255056|FG001|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|2|||
28021439|NCT00666224|54680685|FG000|Double-Blind|Sponsor decision|1|||
27800274|NCT01847274|54255057|FG002|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|5|||
27800275|NCT01847274|54255058|FG003|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|1|||
27800276|NCT01847274|54255059|FG004|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
27800277|NCT01847274|54255060|FG005|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
27800278|NCT01847274|54255061|FG006|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
27800279|NCT01847274|54255062|FG007|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
27800280|NCT01847274|54255063|FG008|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
27800281|NCT01847274|54255064|FG009|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
27800282|NCT01847274|54255065|FG010|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
27800283|NCT01847274|54255055|FG000|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
27800284|NCT01847274|54255056|FG001|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
27800285|NCT01847274|54255057|FG002|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
27800286|NCT01847274|54255058|FG003|Main Study (Upto 7years 7months 6 Days)|Disease progression|2|||
27800287|NCT01847274|54255059|FG004|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
27800288|NCT01847274|54255060|FG005|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
27800289|NCT01847274|54255061|FG006|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
27800290|NCT01847274|54255062|FG007|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
27800291|NCT01847274|54255063|FG008|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
27800292|NCT01847274|54255064|FG009|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
27800293|NCT01847274|54255065|FG010|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
27800294|NCT01847274|54255055|FG000|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
27800295|NCT01847274|54255056|FG001|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
27800296|NCT01847274|54255057|FG002|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|15|||
27800297|NCT01847274|54255058|FG003|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|14|||
27800298|NCT01847274|54255059|FG004|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
27800299|NCT01847274|54255060|FG005|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
27800300|NCT01847274|54255061|FG006|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
28021440|NCT00666224|54680686|FG001|Double-Blind|Sponsor decision|0|||
28021441|NCT00666224|54680685|FG000|Double-Blind|Pregnancy|3|||
28021442|NCT00666224|54680686|FG001|Double-Blind|Pregnancy|2|||
28021443|NCT00666224|54680685|FG000|Double-Blind|Noncompliance|1|||
28021444|NCT00666224|54680686|FG001|Double-Blind|Noncompliance|0|||
28021445|NCT00666224|54680685|FG000|Double-Blind|Death|1|||
28021446|NCT00666224|54680686|FG001|Double-Blind|Death|0|||
28021447|NCT00666224|54680685|FG000|Double-Blind|Undefined/Unknown|4|||
28021448|NCT00666224|54680686|FG001|Double-Blind|Undefined/Unknown|1|||
28021449|NCT00666224|54680685|FG000|Open-Label|Adverse Event|8|||
28021450|NCT00666224|54680686|FG001|Open-Label|Adverse Event|43|||
28021451|NCT00666224|54680685|FG000|Open-Label|Lost to Follow-up|4|||
28021452|NCT00666224|54680686|FG001|Open-Label|Lost to Follow-up|5|||
28021453|NCT00666224|54680685|FG000|Open-Label|Withdrawal by Subject|12|||
28021454|NCT00666224|54680686|FG001|Open-Label|Withdrawal by Subject|25|||
28021455|NCT00666224|54680685|FG000|Open-Label|Physician Decision|7|||
28021456|NCT00666224|54680686|FG001|Open-Label|Physician Decision|5|||
28021457|NCT00666224|54680685|FG000|Open-Label|Pregnancy|1|||
28021458|NCT00666224|54680686|FG001|Open-Label|Pregnancy|5|||
28021459|NCT00666224|54680685|FG000|Open-Label|Noncompliance|2|||
28021460|NCT00666224|54680686|FG001|Open-Label|Noncompliance|1|||
28021461|NCT00666224|54680685|FG000|Open-Label|Undefined/Unknown|1|||
28021462|NCT00666224|54680686|FG001|Open-Label|Undefined/Unknown|1|||
28021463|NCT00663962|54680695|FG000|Overall Study|somnolence|1|||
28021464|NCT00663962|54680696|FG001|Overall Study|somnolence|0|||
28021465|NCT00265759|54680708|FG000|Overall Study|Withdrawal by Subject|0|||
28021466|NCT00265759|54680709|FG001|Overall Study|Withdrawal by Subject|1|||
28021467|NCT00265759|54680710|FG002|Overall Study|Withdrawal by Subject|2|||
28021468|NCT00265759|54680711|FG003|Overall Study|Withdrawal by Subject|2|||
28021469|NCT00265759|54680708|FG000|Overall Study|Cancel|0|||
28021470|NCT00265759|54680709|FG001|Overall Study|Cancel|0|||
28021471|NCT00265759|54680710|FG002|Overall Study|Cancel|0|||
28021472|NCT00265759|54680711|FG003|Overall Study|Cancel|3|||
28021473|NCT00265759|54680708|FG000|Overall Study|Ineligible|0|||
28021474|NCT00265759|54680709|FG001|Overall Study|Ineligible|0|||
28021475|NCT00265759|54680710|FG002|Overall Study|Ineligible|0|||
28021476|NCT00265759|54680711|FG003|Overall Study|Ineligible|1|||
28021477|NCT00265759|54680708|FG000|Overall Study|Bilateral disease|0|||
28021478|NCT00265759|54680709|FG001|Overall Study|Bilateral disease|0|||
28021479|NCT00265759|54680710|FG002|Overall Study|Bilateral disease|0|||
28021480|NCT00265759|54680711|FG003|Overall Study|Bilateral disease|2|||
28021481|NCT00265759|54680708|FG000|Overall Study|Discontinued due to intolerability|0|||
28021482|NCT00265759|54680709|FG001|Overall Study|Discontinued due to intolerability|0|||
28021483|NCT00265759|54680710|FG002|Overall Study|Discontinued due to intolerability|0|||
28021484|NCT00265759|54680711|FG003|Overall Study|Discontinued due to intolerability|1|||
28021485|NCT00744263|54680724|FG000|Overall Study|Death|3006|||
28021486|NCT00744263|54680725|FG001|Overall Study|Death|3005|||
28021487|NCT00744263|54680724|FG000|Overall Study|Lost to Follow-up|2038|||
28021488|NCT00744263|54680725|FG001|Overall Study|Lost to Follow-up|2135|||
28021489|NCT00744263|54680724|FG000|Overall Study|Withdrawal by Subject|166|||
28021490|NCT00744263|54680725|FG001|Overall Study|Withdrawal by Subject|150|||
28021491|NCT00744263|54680724|FG000|Overall Study|Physician Decision|20|||
28021492|NCT00744263|54680725|FG001|Overall Study|Physician Decision|23|||
28021493|NCT00744263|54680724|FG000|Overall Study|Protocol Violation|3|||
28021494|NCT00744263|54680725|FG001|Overall Study|Protocol Violation|5|||
28021495|NCT00744263|54680724|FG000|Overall Study|Adverse Event|1|||
28021496|NCT00744263|54680725|FG001|Overall Study|Adverse Event|0|||
28021497|NCT00744263|54680724|FG000|Overall Study|Other|2|||
28021498|NCT00744263|54680725|FG001|Overall Study|Other|2|||
28021499|NCT00618774|54680735|FG000|Overall Study|Adverse Event|5|||
28021500|NCT00618774|54680736|FG001|Overall Study|Adverse Event|3|||
28021501|NCT00618774|54680735|FG000|Overall Study|Withdrawal by Subject|1|||
28021502|NCT00618774|54680736|FG001|Overall Study|Withdrawal by Subject|0|||
28021503|NCT00545571|54680742|FG000|Overall Study|Administrative Reasons|1|||
28021504|NCT00545571|54680742|FG000|Overall Study|Adverse Event|2|||
28021505|NCT00545571|54680742|FG000|Overall Study|Death|5|||
28021506|NCT00545571|54680742|FG000|Overall Study|Lack of Efficacy|1|||
28021507|NCT00545571|54680742|FG000|Overall Study|Protocol Violation|2|||
28021508|NCT00545571|54680742|FG000|Overall Study|Refused Treatment|1|||
28021509|NCT00545571|54680742|FG000|Overall Study|Screen Failure|16|||
28021510|NCT00545571|54680742|FG000|Overall Study|Transfusion|12|||
28021511|NCT00545571|54680742|FG000|Overall Study|Early Termination of Study|24|||
28021512|NCT00545571|54680742|FG000|Overall Study|Kidney Transplantation|3|||
28021513|NCT00748709|54680746|FG000|Overall Study|Progressive disease|15|||
28021514|NCT00748709|54680746|FG000|Overall Study|Drug reducing Toxity|2|||
28021515|NCT00748709|54680746|FG000|Overall Study|Other Adverse Event|1|||
28021516|NCT00748709|54680746|FG000|Overall Study|Withdrawal by Subject|1|||
28021517|NCT00748709|54680746|FG000|Overall Study|Other Reasons|1|||
28021518|NCT00263887|54680752|FG000|Overall Study|Withdrawal by Subject|1|||
28021519|NCT00263887|54680753|FG001|Overall Study|Withdrawal by Subject|1|||
28021520|NCT00263887|54680752|FG000|Overall Study|Lung transplantation|1|||
28021521|NCT00263887|54680753|FG001|Overall Study|Lung transplantation|2|||
28021522|NCT00263887|54680752|FG000|Overall Study|Too ill to attend visit|1|||
28021523|NCT00263887|54680753|FG001|Overall Study|Too ill to attend visit|0|||
28021524|NCT00263887|54680752|FG000|Overall Study|Adverse Event|0|||
28021525|NCT00263887|54680753|FG001|Overall Study|Adverse Event|2|||
28021526|NCT00263887|54680752|FG000|Overall Study|Disease progression|0|||
28021527|NCT00263887|54680753|FG001|Overall Study|Disease progression|1|||
28021528|NCT00263887|54680752|FG000|Overall Study|Lack of Efficacy|0|||
28021529|NCT00263887|54680753|FG001|Overall Study|Lack of Efficacy|1|||
28021530|NCT00748553|54680761|FG000|Overall Study|Adverse Event|0|||
28021531|NCT00748553|54680762|FG001|Overall Study|Adverse Event|1|||
28021532|NCT00748553|54680761|FG000|Overall Study|disease progression|2|||
28021533|NCT00748553|54680762|FG001|Overall Study|disease progression|0|||
28021534|NCT00748553|54680761|FG000|Overall Study|noncompliance|1|||
28021535|NCT00748553|54680762|FG001|Overall Study|noncompliance|0|||
28021536|NCT00661388|54680767|FG000|Overall Study|Adverse Event|14|||
28021537|NCT00661388|54680767|FG000|Overall Study|Protocol Violation|7|||
28021538|NCT00661388|54680767|FG000|Overall Study|Renal transplantation|1|||
28021539|NCT00661388|54680767|FG000|Overall Study|Dialysis initiation|1|||
28021540|NCT00661388|54680767|FG000|Overall Study|Administrative reasons|1|||
28021541|NCT00743483|54680771|FG000|Baseline Period|Physician Decision|1|||
28021542|NCT00743483|54680771|FG000|Treatment Period|Adverse Event|1|||
28021543|NCT00263575|54680775|FG000|Titration Period|Adverse Event|14|||
28021544|NCT00263575|54680775|FG000|Titration Period|Withdrawal by Subject|10|||
28021545|NCT00263575|54680775|FG000|Titration Period|Protocol Violation|9|||
28021546|NCT00263575|54680775|FG000|Titration Period|Sponsor Decision|2|||
28021547|NCT00263575|54680775|FG000|Titration Period|Other|2|||
28021548|NCT00263575|54680775|FG000|Titration Period|Lack of Efficacy|6|||
28021549|NCT00263575|54680775|FG000|Maintence Period|Adverse Event|23|||
28021550|NCT00263575|54680775|FG000|Maintence Period|Withdrawal by Subject|8|||
27800301|NCT01847274|54255062|FG007|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
28021551|NCT00263575|54680775|FG000|Maintence Period|Protocol Violation|4|||
28021552|NCT00263575|54680775|FG000|Maintence Period|Lack of Efficacy|4|||
28021553|NCT00263575|54680775|FG000|Maintence Period|Physician Decision|6|||
28021554|NCT00263575|54680775|FG000|Maintence Period|Lost to Follow-up|1|||
28021555|NCT00263575|54680775|FG000|Maintence Period|Sponsor Decision|24|||
28021556|NCT00263575|54680775|FG000|Maintence Period|Other|7|||
28021557|NCT00748241|54680781|FG000|Overall Study|Implant failure|1|||
28021558|NCT00748241|54680781|FG000|Overall Study|Lost to Follow-up|5|||
28021559|NCT00748241|54680781|FG000|Overall Study|Death|2|||
28021560|NCT00570128|54680787|FG000|Overall Study|Adverse Event|1|||
28021561|NCT00570128|54680788|FG001|Overall Study|Adverse Event|0|||
28021562|NCT00570128|54680787|FG000|Overall Study|Lost to Follow-up|1|||
28021563|NCT00570128|54680788|FG001|Overall Study|Lost to Follow-up|0|||
28021564|NCT00570128|54680787|FG000|Overall Study|Withdrawal by Subject|2|||
28021565|NCT00570128|54680788|FG001|Overall Study|Withdrawal by Subject|0|||
28021566|NCT00743249|54680796|FG000|Overall Study|Adverse Event|0|||
28021567|NCT00743249|54680797|FG001|Overall Study|Adverse Event|4|||
28021568|NCT00743249|54680796|FG000|Overall Study|Patient Decision Unrelated to Ad Event|0|||
28021569|NCT00743249|54680797|FG001|Overall Study|Patient Decision Unrelated to Ad Event|1|||
28021570|NCT00743249|54680796|FG000|Overall Study|Unsuccessful insertion of stent|2|||
28021571|NCT00743249|54680797|FG001|Overall Study|Unsuccessful insertion of stent|1|||
28021572|NCT00262951|54680803|FG000|Overall Study|Progressive disease/relapse|3|||
28021573|NCT00262951|54680803|FG000|Overall Study|Adverse Event|7|||
28021574|NCT00262951|54680803|FG000|Overall Study|Death|1|||
28021575|NCT00262951|54680803|FG000|Overall Study|Withdrawal by Subject|1|||
28021576|NCT00262951|54680803|FG000|Overall Study|Alternative treatment|3|||
28021577|NCT00262951|54680803|FG000|Overall Study|Off treatment for other disease|1|||
28021578|NCT00262873|54680807|FG000|Overall Study|Adverse Event|3|||
28021579|NCT00262873|54680807|FG000|Overall Study|Withdrawal by Subject|5|||
28021580|NCT00573534|54680811|FG000|Overall Study|oppositional behavior|3|||
28021581|NCT00260533|54680818|FG000|Overall Study|Other|3|||
28021582|NCT00260533|54680819|FG001|Overall Study|Other|3|||
28021583|NCT03945981|54680825|FG000|Overall Study|Lost to Follow-up|12|||
28021584|NCT03945981|54680825|FG000|Overall Study|Physician Decision|4|||
28021585|NCT03945981|54680825|FG000|Overall Study|Withdrawal by Subject|6|||
28021586|NCT03945981|54680825|FG000|Overall Study|Protocol Violation|1|||
28021587|NCT00745901|54680852|FG000|Overall Study|Adverse Event|3|||
28021588|NCT00745901|54680853|FG001|Overall Study|Adverse Event|4|||
28021589|NCT00745901|54680852|FG000|Overall Study|Protocol Violation|0|||
28021590|NCT00745901|54680853|FG001|Overall Study|Protocol Violation|1|||
28021591|NCT00745901|54680852|FG000|Overall Study|Withdrawal by Subject|1|||
28021592|NCT00745901|54680853|FG001|Overall Study|Withdrawal by Subject|0|||
28021593|NCT00745901|54680852|FG000|Overall Study|Lost to Follow-up|7|||
28021594|NCT00745901|54680853|FG001|Overall Study|Lost to Follow-up|4|||
28021595|NCT00745901|54680852|FG000|Overall Study|Pregnancy|2|||
28021596|NCT00745901|54680853|FG001|Overall Study|Pregnancy|4|||
28021597|NCT00745901|54680852|FG000|Overall Study|Lack of compliance|2|||
28021598|NCT00745901|54680853|FG001|Overall Study|Lack of compliance|2|||
27800302|NCT01847274|54255063|FG008|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
27800303|NCT01847274|54255064|FG009|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
27800304|NCT01847274|54255065|FG010|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
27800305|NCT01847274|54255055|FG000|Main Study (Upto 7years 7months 6 Days)|Death|72|||
27800306|NCT01847274|54255056|FG001|Main Study (Upto 7years 7months 6 Days)|Death|29|||
27800307|NCT01847274|54255057|FG002|Main Study (Upto 7years 7months 6 Days)|Death|146|||
27800308|NCT01847274|54255058|FG003|Main Study (Upto 7years 7months 6 Days)|Death|68|||
27800309|NCT01847274|54255059|FG004|Main Study (Upto 7years 7months 6 Days)|Death|0|||
27800310|NCT01847274|54255060|FG005|Main Study (Upto 7years 7months 6 Days)|Death|0|||
27800311|NCT01847274|54255061|FG006|Main Study (Upto 7years 7months 6 Days)|Death|0|||
28021599|NCT00745901|54680852|FG000|Overall Study|Patient's next menses did not start with|1|||
27800312|NCT01847274|54255062|FG007|Main Study (Upto 7years 7months 6 Days)|Death|0|||
28021600|NCT00745901|54680853|FG001|Overall Study|Patient's next menses did not start with|0|||
28021601|NCT00745901|54680852|FG000|Overall Study|Results of Pap smear at Vis 1 malignant|0|||
28021602|NCT00745901|54680853|FG001|Overall Study|Results of Pap smear at Vis 1 malignant|2|||
28021603|NCT00745901|54680852|FG000|Overall Study|Chlamydia test at Visit 1 was positive|1|||
28021604|NCT00745901|54680853|FG001|Overall Study|Chlamydia test at Visit 1 was positive|1|||
28021605|NCT00745901|54680852|FG000|Overall Study|Patient didn't take any study medication|7|||
27800313|NCT01847274|54255063|FG008|Main Study (Upto 7years 7months 6 Days)|Death|0|||
27800314|NCT01847274|54255064|FG009|Main Study (Upto 7years 7months 6 Days)|Death|0|||
27800315|NCT01847274|54255065|FG010|Main Study (Upto 7years 7months 6 Days)|Death|0|||
27800316|NCT01847274|54255055|FG000|Main Study (Upto 7years 7months 6 Days)|Other reasons|5|||
27800317|NCT01847274|54255056|FG001|Main Study (Upto 7years 7months 6 Days)|Other reasons|3|||
27800318|NCT01847274|54255057|FG002|Main Study (Upto 7years 7months 6 Days)|Other reasons|8|||
27800319|NCT01847274|54255058|FG003|Main Study (Upto 7years 7months 6 Days)|Other reasons|4|||
27800320|NCT01847274|54255059|FG004|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
27800321|NCT01847274|54255060|FG005|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
27800322|NCT01847274|54255061|FG006|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
27800323|NCT01847274|54255062|FG007|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
27800324|NCT01847274|54255063|FG008|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
27800325|NCT01847274|54255064|FG009|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
27800326|NCT01847274|54255065|FG010|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
27800327|NCT01847274|54255055|FG000|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
28021606|NCT00745901|54680853|FG001|Overall Study|Patient didn't take any study medication|3|||
28021607|NCT00286429|54680862|FG000|Overall Study|Adverse Event|4|||
28021608|NCT00286429|54680863|FG001|Overall Study|Adverse Event|1|||
28021609|NCT00286429|54680864|FG002|Overall Study|Adverse Event|6|||
28021610|NCT00286429|54680862|FG000|Overall Study|Lack of Efficacy|52|||
28021611|NCT00286429|54680863|FG001|Overall Study|Lack of Efficacy|27|||
28021612|NCT00286429|54680864|FG002|Overall Study|Lack of Efficacy|25|||
28021613|NCT00286429|54680862|FG000|Overall Study|Lost to Follow-up|2|||
28021614|NCT00286429|54680863|FG001|Overall Study|Lost to Follow-up|4|||
28021615|NCT00286429|54680864|FG002|Overall Study|Lost to Follow-up|3|||
28021616|NCT00286429|54680862|FG000|Overall Study|Physician Decision|10|||
28021617|NCT00286429|54680863|FG001|Overall Study|Physician Decision|7|||
28021618|NCT00286429|54680864|FG002|Overall Study|Physician Decision|7|||
28021619|NCT00286429|54680862|FG000|Overall Study|Protocol Violation|3|||
28021620|NCT00286429|54680863|FG001|Overall Study|Protocol Violation|5|||
28021621|NCT00286429|54680864|FG002|Overall Study|Protocol Violation|4|||
28021622|NCT00286429|54680862|FG000|Overall Study|Withdrawal by Subject|3|||
28021623|NCT00286429|54680863|FG001|Overall Study|Withdrawal by Subject|2|||
28021624|NCT00286429|54680864|FG002|Overall Study|Withdrawal by Subject|6|||
28021625|NCT00286429|54680862|FG000|Overall Study|Administrative Error|1|||
28021626|NCT00286429|54680863|FG001|Overall Study|Administrative Error|1|||
28021627|NCT00286429|54680864|FG002|Overall Study|Administrative Error|1|||
28021628|NCT00286429|54680862|FG000|Overall Study|Administrative Decision|0|||
28021629|NCT00286429|54680863|FG001|Overall Study|Administrative Decision|1|||
28021630|NCT00286429|54680864|FG002|Overall Study|Administrative Decision|0|||
28021631|NCT00665444|54680872|FG000|Overall Study|Physician Decision|1|||
28021632|NCT00665444|54680872|FG000|Overall Study|Study Terminated by Study Sponsor|1|||
28021633|NCT03926169|54680879|FG000|Period A|Adverse Event|2|||
28021634|NCT03926169|54680880|FG001|Period A|Adverse Event|2|||
28021635|NCT03926169|54680881|FG002|Period A|Adverse Event|1|||
28021636|NCT03926169|54680879|FG000|Period A|Withdrawal by Subject|2|||
28021637|NCT03926169|54680880|FG001|Period A|Withdrawal by Subject|2|||
28021638|NCT03926169|54680881|FG002|Period A|Withdrawal by Subject|2|||
28021639|NCT03926169|54680879|FG000|Period A|Lost to Follow-up|3|||
28021640|NCT03926169|54680880|FG001|Period A|Lost to Follow-up|1|||
28021641|NCT03926169|54680881|FG002|Period A|Lost to Follow-up|0|||
28021642|NCT03926169|54680879|FG000|Period A|Lack of Efficacy|0|||
28021643|NCT03926169|54680880|FG001|Period A|Lack of Efficacy|2|||
28021644|NCT03926169|54680881|FG002|Period A|Lack of Efficacy|2|||
28021645|NCT03926169|54680879|FG000|Period A|COVID-19 Infection|0|||
28021646|NCT03926169|54680880|FG001|Period A|COVID-19 Infection|1|||
28021647|NCT03926169|54680881|FG002|Period A|COVID-19 Infection|0|||
28021648|NCT03926169|54680879|FG000|Period A|COVID-19 Logistical Restrictions|0|||
28021649|NCT03926169|54680880|FG001|Period A|COVID-19 Logistical Restrictions|2|||
28021650|NCT03926169|54680881|FG002|Period A|COVID-19 Logistical Restrictions|1|||
28021651|NCT03926169|54680879|FG000|Period A|Other, Not Specified|1|||
28021652|NCT03926169|54680880|FG001|Period A|Other, Not Specified|0|||
28021653|NCT03926169|54680881|FG002|Period A|Other, Not Specified|0|||
28021654|NCT03926169|54680879|FG000|Period B|Adverse Event|3|||
28021655|NCT03926169|54680880|FG001|Period B|Adverse Event|1|||
28021656|NCT03926169|54680881|FG002|Period B|Adverse Event|1|||
28021657|NCT03926169|54680879|FG000|Period B|Withdrawal by Subject|1|||
28021658|NCT03926169|54680880|FG001|Period B|Withdrawal by Subject|3|||
28021659|NCT03926169|54680881|FG002|Period B|Withdrawal by Subject|0|||
27800328|NCT01847274|54255056|FG001|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
28021660|NCT03926169|54680879|FG000|Period B|Lack of Efficacy|3|||
28021661|NCT03926169|54680880|FG001|Period B|Lack of Efficacy|1|||
28021662|NCT03926169|54680881|FG002|Period B|Lack of Efficacy|1|||
28021663|NCT03926169|54680879|FG000|Period B|Lost to Follow-up|1|||
28021664|NCT03926169|54680880|FG001|Period B|Lost to Follow-up|1|||
28021665|NCT03926169|54680881|FG002|Period B|Lost to Follow-up|4|||
28021666|NCT03926169|54680879|FG000|Period B|Other, Not Specified|62|||
28021667|NCT03926169|54680880|FG001|Period B|Other, Not Specified|57|||
28021668|NCT03926169|54680881|FG002|Period B|Other, Not Specified|65|||
28021669|NCT00285649|54680895|FG000|Overall Study|Lost to Follow-up|6|||
28021670|NCT00285649|54680896|FG001|Overall Study|Lost to Follow-up|4|||
28021671|NCT00285649|54680897|FG002|Overall Study|Lost to Follow-up|4|||
28021672|NCT00285649|54680895|FG000|Overall Study|Withdrawal by Subject|3|||
28021673|NCT00285649|54680896|FG001|Overall Study|Withdrawal by Subject|2|||
28021674|NCT00285649|54680897|FG002|Overall Study|Withdrawal by Subject|2|||
28021675|NCT00745823|54680907|FG000|Overall Study|Adverse Event|5|||
27800329|NCT01847274|54255057|FG002|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
27800330|NCT01847274|54255058|FG003|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
27800331|NCT01847274|54255059|FG004|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
27800332|NCT01847274|54255060|FG005|FE Sub-study, Period1 (Day1)|Adverse Event|1|||
27800333|NCT01847274|54255061|FG006|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
27800334|NCT01847274|54255062|FG007|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
27800335|NCT01847274|54255063|FG008|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
27800336|NCT01847274|54255064|FG009|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
27800337|NCT01847274|54255065|FG010|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
27800338|NCT01847274|54255055|FG000|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
28021676|NCT00745823|54680908|FG001|Overall Study|Adverse Event|3|||
28021677|NCT00745823|54680907|FG000|Overall Study|Lack of Efficacy|20|||
28021678|NCT00745823|54680908|FG001|Overall Study|Lack of Efficacy|6|||
28021679|NCT00745823|54680907|FG000|Overall Study|Lost to Follow-up|10|||
28021680|NCT00745823|54680908|FG001|Overall Study|Lost to Follow-up|11|||
28021681|NCT00745823|54680907|FG000|Overall Study|Physician Decision|10|||
28021682|NCT00745823|54680908|FG001|Overall Study|Physician Decision|5|||
28021683|NCT00745823|54680907|FG000|Overall Study|Pregnancy|0|||
28021684|NCT00745823|54680908|FG001|Overall Study|Pregnancy|4|||
28021685|NCT00745823|54680907|FG000|Overall Study|Withdrawal by Subject|14|||
28021686|NCT00745823|54680908|FG001|Overall Study|Withdrawal by Subject|8|||
28021687|NCT00745823|54680907|FG000|Overall Study|Study Terminated by Sponsor|326|||
28021688|NCT00745823|54680908|FG001|Overall Study|Study Terminated by Sponsor|349|||
28021689|NCT00663260|54680919|FG000|Overall Study|Lack of Efficacy|2|||
28021690|NCT00663260|54680920|FG001|Overall Study|Lack of Efficacy|0|||
28021691|NCT00663260|54680921|FG002|Overall Study|Lack of Efficacy|0|||
28021692|NCT00663260|54680919|FG000|Overall Study|Adverse Event|12|||
28021693|NCT00663260|54680920|FG001|Overall Study|Adverse Event|7|||
28021694|NCT00663260|54680921|FG002|Overall Study|Adverse Event|6|||
28021695|NCT00663260|54680919|FG000|Overall Study|Withdrawal by Subject|3|||
28021696|NCT00663260|54680920|FG001|Overall Study|Withdrawal by Subject|1|||
28021697|NCT00663260|54680921|FG002|Overall Study|Withdrawal by Subject|6|||
28021698|NCT00663260|54680919|FG000|Overall Study|Death|1|||
28021699|NCT00663260|54680920|FG001|Overall Study|Death|0|||
28021700|NCT00663260|54680921|FG002|Overall Study|Death|1|||
28021701|NCT00663260|54680919|FG000|Overall Study|Lost to Follow-up|0|||
28021702|NCT00663260|54680920|FG001|Overall Study|Lost to Follow-up|1|||
28021703|NCT00663260|54680921|FG002|Overall Study|Lost to Follow-up|0|||
28021704|NCT00663260|54680919|FG000|Overall Study|non-compliance, not met criteria, etc.|3|||
28021705|NCT00663260|54680920|FG001|Overall Study|non-compliance, not met criteria, etc.|2|||
27800339|NCT01847274|54255056|FG001|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
27800340|NCT01847274|54255057|FG002|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
27800341|NCT01847274|54255058|FG003|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
28021706|NCT00663260|54680921|FG002|Overall Study|non-compliance, not met criteria, etc.|3|||
28021707|NCT00740597|54680929|FG000|Overall Study|insurance would not cover treatment|1|||
28021708|NCT00284089|54680937|FG000|Multiple Dose Phase|Adverse Event|1|||
28021709|NCT00284089|54680938|FG001|Multiple Dose Phase|Adverse Event|0|||
28021710|NCT00284089|54680939|FG002|Multiple Dose Phase|Adverse Event|1|||
28021711|NCT00284089|54680940|FG003|Multiple Dose Phase|Adverse Event|1|||
28021712|NCT00284089|54680937|FG000|Multiple Dose Phase|Protocol Violation|0|||
28021713|NCT00284089|54680938|FG001|Multiple Dose Phase|Protocol Violation|0|||
28021714|NCT00284089|54680939|FG002|Multiple Dose Phase|Protocol Violation|1|||
28021715|NCT00284089|54680940|FG003|Multiple Dose Phase|Protocol Violation|0|||
28021716|NCT00284089|54680937|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
28021717|NCT00284089|54680938|FG001|Multiple Dose Phase|Withdrawal by Subject|0|||
28021718|NCT00284089|54680939|FG002|Multiple Dose Phase|Withdrawal by Subject|1|||
28021719|NCT00284089|54680940|FG003|Multiple Dose Phase|Withdrawal by Subject|2|||
28021720|NCT00284089|54680937|FG000|Multiple Dose Phase|Death|0|||
28021721|NCT00284089|54680938|FG001|Multiple Dose Phase|Death|0|||
28021722|NCT00284089|54680939|FG002|Multiple Dose Phase|Death|1|||
28021723|NCT00284089|54680940|FG003|Multiple Dose Phase|Death|1|||
28021724|NCT00284089|54680937|FG000|Extension Phase|Adverse Event|0|||
28021725|NCT00284089|54680938|FG001|Extension Phase|Adverse Event|0|||
28021726|NCT00284089|54680939|FG002|Extension Phase|Adverse Event|2|||
27800342|NCT01847274|54255059|FG004|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|1|||
28021727|NCT00284089|54680940|FG003|Extension Phase|Adverse Event|2|||
28021728|NCT00284089|54680937|FG000|Extension Phase|condition no longer requires study drug|2|||
27800343|NCT01847274|54255060|FG005|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
27800344|NCT01847274|54255061|FG006|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
27800345|NCT01847274|54255062|FG007|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
27800346|NCT01847274|54255063|FG008|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
27800347|NCT01847274|54255064|FG009|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
27800348|NCT01847274|54255065|FG010|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
27800349|NCT01847274|54255055|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
27800350|NCT01847274|54255056|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
27800351|NCT01847274|54255057|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
27800352|NCT01847274|54255058|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
27800353|NCT01847274|54255059|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
27800354|NCT01847274|54255060|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
27800355|NCT01847274|54255061|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|4|||
27800356|NCT01847274|54255062|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
28021729|NCT00284089|54680938|FG001|Extension Phase|condition no longer requires study drug|0|||
28021730|NCT00284089|54680939|FG002|Extension Phase|condition no longer requires study drug|2|||
28021731|NCT00284089|54680940|FG003|Extension Phase|condition no longer requires study drug|7|||
28021732|NCT00284089|54680937|FG000|Extension Phase|Protocol Violation|0|||
28021733|NCT00284089|54680938|FG001|Extension Phase|Protocol Violation|0|||
28021734|NCT00284089|54680939|FG002|Extension Phase|Protocol Violation|1|||
28021735|NCT00284089|54680940|FG003|Extension Phase|Protocol Violation|0|||
28021736|NCT00284089|54680937|FG000|Extension Phase|Withdrawal by Subject|0|||
27800357|NCT01847274|54255063|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
27800358|NCT01847274|54255064|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
28021737|NCT00284089|54680938|FG001|Extension Phase|Withdrawal by Subject|0|||
28021738|NCT00284089|54680939|FG002|Extension Phase|Withdrawal by Subject|1|||
28021739|NCT00284089|54680940|FG003|Extension Phase|Withdrawal by Subject|3|||
28021740|NCT00659984|54680950|FG000|Overall Study|Adverse Event|1|||
28021741|NCT00283387|54680964|FG000|First Intervention|Subject non-compliant|1|||
28021742|NCT00283387|54680965|FG001|First Intervention|Subject non-compliant|1|||
28021743|NCT00283387|54680964|FG000|First Intervention|Withdrawal by Subject|0|||
28021744|NCT00283387|54680965|FG001|First Intervention|Withdrawal by Subject|1|||
28021745|NCT00282919|54680971|FG000|Overall Study|Lack of Efficacy|4|||
28021746|NCT00282919|54680971|FG000|Overall Study|Withdrawal by Subject|1|||
28021747|NCT00282919|54680971|FG000|Overall Study|Asymptomatic Parasitemia|2|||
28021748|NCT00742859|54680979|FG000|Overall Study|Adverse Event|5|||
28021749|NCT00742859|54680980|FG001|Overall Study|Adverse Event|6|||
28021750|NCT00742859|54680981|FG002|Overall Study|Adverse Event|3|||
28021751|NCT00742859|54680982|FG003|Overall Study|Adverse Event|1|||
28021752|NCT00742859|54680979|FG000|Overall Study|Death|1|||
28021753|NCT00742859|54680980|FG001|Overall Study|Death|0|||
28021754|NCT00742859|54680981|FG002|Overall Study|Death|0|||
28021755|NCT00742859|54680982|FG003|Overall Study|Death|1|||
28021756|NCT00742859|54680979|FG000|Overall Study|Physician Decision|1|||
28021757|NCT00742859|54680980|FG001|Overall Study|Physician Decision|2|||
28021758|NCT00742859|54680981|FG002|Overall Study|Physician Decision|0|||
28021759|NCT00742859|54680982|FG003|Overall Study|Physician Decision|0|||
28021760|NCT00742859|54680979|FG000|Overall Study|Withdrawal by Subject|4|||
28021761|NCT00742859|54680980|FG001|Overall Study|Withdrawal by Subject|2|||
28021762|NCT00742859|54680981|FG002|Overall Study|Withdrawal by Subject|4|||
28021763|NCT00742859|54680982|FG003|Overall Study|Withdrawal by Subject|1|||
28021764|NCT00742859|54680979|FG000|Overall Study|Endpoint|0|||
28021765|NCT00742859|54680980|FG001|Overall Study|Endpoint|1|||
28021766|NCT00742859|54680981|FG002|Overall Study|Endpoint|1|||
28021767|NCT00742859|54680982|FG003|Overall Study|Endpoint|2|||
28021768|NCT00742859|54680979|FG000|Overall Study|Amendment 2 patient off study drug >4wks|0|||
28021769|NCT00742859|54680980|FG001|Overall Study|Amendment 2 patient off study drug >4wks|1|||
28021770|NCT00742859|54680981|FG002|Overall Study|Amendment 2 patient off study drug >4wks|1|||
28021771|NCT00742859|54680982|FG003|Overall Study|Amendment 2 patient off study drug >4wks|0|||
28021772|NCT00742859|54680979|FG000|Overall Study|Sponsor req visit schedule noncompliance|0|||
28021773|NCT00742859|54680980|FG001|Overall Study|Sponsor req visit schedule noncompliance|0|||
28021774|NCT00742859|54680981|FG002|Overall Study|Sponsor req visit schedule noncompliance|0|||
28021775|NCT00742859|54680982|FG003|Overall Study|Sponsor req visit schedule noncompliance|1|||
28021776|NCT00742859|54680979|FG000|Overall Study|Sponsor request patient out of town|0|||
28021777|NCT00742859|54680980|FG001|Overall Study|Sponsor request patient out of town|0|||
28021778|NCT00742859|54680981|FG002|Overall Study|Sponsor request patient out of town|1|||
28021779|NCT00742859|54680982|FG003|Overall Study|Sponsor request patient out of town|1|||
28021780|NCT00742859|54680979|FG000|Overall Study|Site error|0|||
28021781|NCT00742859|54680980|FG001|Overall Study|Site error|0|||
28021782|NCT00742859|54680981|FG002|Overall Study|Site error|1|||
28021783|NCT00742859|54680982|FG003|Overall Study|Site error|1|||
28021784|NCT00282295|54680995|FG000|Overall Study|Adverse Event|0|||
28021785|NCT00282295|54680996|FG001|Overall Study|Adverse Event|1|||
28021786|NCT00282295|54680997|FG002|Overall Study|Adverse Event|0|||
28021787|NCT00282295|54680995|FG000|Overall Study|Serious Adverse Events|0|||
28021788|NCT00282295|54680996|FG001|Overall Study|Serious Adverse Events|0|||
28021789|NCT00282295|54680997|FG002|Overall Study|Serious Adverse Events|1|||
28021790|NCT00282295|54680995|FG000|Overall Study|Protocol Violation|0|||
28021791|NCT00282295|54680996|FG001|Overall Study|Protocol Violation|2|||
28021792|NCT00282295|54680997|FG002|Overall Study|Protocol Violation|1|||
28021793|NCT00282295|54680995|FG000|Overall Study|Withdrawal by Subject|2|||
28021794|NCT00282295|54680996|FG001|Overall Study|Withdrawal by Subject|6|||
28021795|NCT00282295|54680997|FG002|Overall Study|Withdrawal by Subject|4|||
28021796|NCT00282295|54680995|FG000|Overall Study|Lost to Follow-up|1|||
28021797|NCT00282295|54680996|FG001|Overall Study|Lost to Follow-up|7|||
27800359|NCT01847274|54255065|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
27800360|NCT01847274|54255055|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
27800361|NCT01847274|54255056|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
27800362|NCT01847274|54255057|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
27800363|NCT01847274|54255058|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
27800364|NCT01847274|54255059|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
27800365|NCT01847274|54255060|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
27800366|NCT01847274|54255061|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|5|||
27800367|NCT01847274|54255062|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
27800368|NCT01847274|54255063|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
27800369|NCT01847274|54255064|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
27800370|NCT01847274|54255065|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
27800371|NCT01847274|54255055|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
27800372|NCT01847274|54255056|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
27800373|NCT01847274|54255057|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
27800374|NCT01847274|54255058|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
27800375|NCT01847274|54255059|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
27800376|NCT01847274|54255060|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
27800377|NCT01847274|54255061|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|17|||
27800378|NCT01847274|54255062|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
27800379|NCT01847274|54255063|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
27800380|NCT01847274|54255064|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
27800381|NCT01847274|54255065|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
27800382|NCT01847274|54255055|FG000|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
27800383|NCT01847274|54255056|FG001|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
27800384|NCT01847274|54255057|FG002|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
27800385|NCT01847274|54255058|FG003|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
27800386|NCT01847274|54255059|FG004|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
27800387|NCT01847274|54255060|FG005|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
27800388|NCT01847274|54255061|FG006|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
27800389|NCT01847274|54255062|FG007|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|15|||
27800390|NCT01847274|54255063|FG008|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|8|||
27800391|NCT01847274|54255064|FG009|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|18|||
27800392|NCT01847274|54255065|FG010|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|12|||
27800393|NCT01847274|54255055|FG000|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
27800394|NCT01847274|54255056|FG001|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
27800395|NCT01847274|54255057|FG002|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
27800396|NCT01847274|54255058|FG003|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
27800397|NCT01847274|54255059|FG004|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
27800398|NCT01847274|54255060|FG005|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
27800399|NCT01847274|54255061|FG006|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
27800400|NCT01847274|54255062|FG007|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|6|||
27800401|NCT01847274|54255063|FG008|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
27800402|NCT01847274|54255064|FG009|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|9|||
27800403|NCT01847274|54255065|FG010|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
27800404|NCT01847274|54255055|FG000|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
28021798|NCT00282295|54680997|FG002|Overall Study|Lost to Follow-up|2|||
28021799|NCT00282295|54680995|FG000|Overall Study|Other|0|||
28021800|NCT00282295|54680996|FG001|Overall Study|Other|1|||
28021801|NCT00282295|54680997|FG002|Overall Study|Other|0|||
28021802|NCT00742781|54681010|FG000|Overall Study|Withdrawal by Subject|3|||
28021803|NCT00663026|54681018|FG000|Overall Study|Lost to Follow-up|1|||
28021804|NCT00663026|54681019|FG001|Overall Study|Lost to Follow-up|0|||
28021805|NCT00663026|54681020|FG002|Overall Study|Lost to Follow-up|0|||
28021806|NCT00663026|54681018|FG000|Overall Study|Other|1|||
28021807|NCT00663026|54681019|FG001|Overall Study|Other|2|||
28021808|NCT00663026|54681020|FG002|Overall Study|Other|0|||
28021809|NCT00663026|54681018|FG000|Overall Study|Adverse Event|0|||
28021810|NCT00663026|54681019|FG001|Overall Study|Adverse Event|2|||
28021811|NCT00663026|54681020|FG002|Overall Study|Adverse Event|3|||
28021812|NCT00663026|54681018|FG000|Overall Study|Caregiver Request|0|||
28021813|NCT00663026|54681019|FG001|Overall Study|Caregiver Request|2|||
28021814|NCT00663026|54681020|FG002|Overall Study|Caregiver Request|0|||
28021815|NCT00663026|54681018|FG000|Overall Study|Withdrawal by Subject|0|||
28021816|NCT00663026|54681019|FG001|Overall Study|Withdrawal by Subject|0|||
28021817|NCT00663026|54681020|FG002|Overall Study|Withdrawal by Subject|1|||
28021818|NCT00280735|54681030|FG000|Overall Study|Adverse Event|5|||
28021819|NCT00280735|54681030|FG000|Overall Study|Lack of Efficacy|3|||
28021820|NCT00280735|54681030|FG000|Overall Study|Withdrawal by Subject|8|||
28021821|NCT00280735|54681030|FG000|Overall Study|Intercurrent Illness|2|||
28021822|NCT00260065|54681038|FG000|Overall Study|Progressive Disease|22|||
28021823|NCT00260065|54681038|FG000|Overall Study|Adverse Event|17|||
28021824|NCT00260065|54681038|FG000|Overall Study|Death|13|||
28021825|NCT00260065|54681038|FG000|Overall Study|Withdrawal by Subject|13|||
28021826|NCT00260065|54681038|FG000|Overall Study|Physician Decision|19|||
28021827|NCT00260065|54681038|FG000|Overall Study|Not otherwise specified|8|||
28021828|NCT00260065|54681038|FG000|Overall Study|Medication Noncompliance|1|||
28021829|NCT00506350|54681051|FG000|Overall Study|Serious Adverse Event|1|||
28021830|NCT00506350|54681052|FG001|Overall Study|Serious Adverse Event|0|||
28021831|NCT00506350|54681053|FG002|Overall Study|Serious Adverse Event|0|||
28021832|NCT00506350|54681054|FG003|Overall Study|Serious Adverse Event|0|||
28021833|NCT00506350|54681055|FG004|Overall Study|Serious Adverse Event|0|||
28021834|NCT00506350|54681056|FG005|Overall Study|Serious Adverse Event|0|||
28021835|NCT00506350|54681057|FG006|Overall Study|Serious Adverse Event|0|||
28021836|NCT00506350|54681058|FG007|Overall Study|Serious Adverse Event|0|||
27800405|NCT01847274|54255056|FG001|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
27800406|NCT01847274|54255057|FG002|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
27800407|NCT01847274|54255058|FG003|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
27800408|NCT01847274|54255059|FG004|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
27800409|NCT01847274|54255060|FG005|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
27800410|NCT01847274|54255061|FG006|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
27800411|NCT01847274|54255062|FG007|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
27800412|NCT01847274|54255063|FG008|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
27800413|NCT01847274|54255064|FG009|Main Study PSU (Up to 8months, 26days)|Other reasons|3|||
27800414|NCT01847274|54255065|FG010|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
27800415|NCT01847274|54255055|FG000|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
27800416|NCT01847274|54255056|FG001|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
27800417|NCT01847274|54255057|FG002|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
27800418|NCT01847274|54255058|FG003|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
27800419|NCT01847274|54255059|FG004|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
27800420|NCT01847274|54255060|FG005|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
27800421|NCT01847274|54255061|FG006|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
27800422|NCT01847274|54255062|FG007|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
27800423|NCT01847274|54255063|FG008|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
27800424|NCT01847274|54255064|FG009|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|1|||
27800425|NCT01847274|54255065|FG010|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
27800426|NCT01566695|54255104|FG000|Overall Study|Lack of Efficacy|18|||
27800427|NCT01566695|54255105|FG001|Overall Study|Lack of Efficacy|45|||
27800428|NCT01566695|54255104|FG000|Overall Study|Adverse Event|28|||
27800429|NCT01566695|54255105|FG001|Overall Study|Adverse Event|27|||
27800430|NCT01566695|54255104|FG000|Overall Study|Death|20|||
27800431|NCT01566695|54255105|FG001|Overall Study|Death|8|||
27800432|NCT01566695|54255104|FG000|Overall Study|Withdrawal by Subject|14|||
27800433|NCT01566695|54255105|FG001|Overall Study|Withdrawal by Subject|7|||
28021837|NCT00506350|54681059|FG008|Overall Study|Serious Adverse Event|0|||
28021838|NCT00506350|54681051|FG000|Overall Study|Adverse Event|0|||
28021839|NCT00506350|54681052|FG001|Overall Study|Adverse Event|0|||
28021840|NCT00506350|54681053|FG002|Overall Study|Adverse Event|0|||
28021841|NCT00506350|54681054|FG003|Overall Study|Adverse Event|0|||
27800434|NCT01566695|54255104|FG000|Overall Study|Progressive Disease|11|||
27800435|NCT01566695|54255105|FG001|Overall Study|Progressive Disease|6|||
27800436|NCT01566695|54255104|FG000|Overall Study|Miscellaneous|4|||
27800437|NCT01566695|54255105|FG001|Overall Study|Miscellaneous|6|||
27800438|NCT01560819|54255113|FG000|Overall Study|Physician Decision|1|||
28021842|NCT00506350|54681055|FG004|Overall Study|Adverse Event|0|||
28021843|NCT00506350|54681056|FG005|Overall Study|Adverse Event|0|||
28021844|NCT00506350|54681057|FG006|Overall Study|Adverse Event|0|||
28021845|NCT00506350|54681058|FG007|Overall Study|Adverse Event|1|||
28021846|NCT00506350|54681059|FG008|Overall Study|Adverse Event|1|||
28021847|NCT00506350|54681051|FG000|Overall Study|Protocol Violation|0|||
28021848|NCT00506350|54681052|FG001|Overall Study|Protocol Violation|0|||
28021849|NCT00506350|54681053|FG002|Overall Study|Protocol Violation|1|||
28021850|NCT00506350|54681054|FG003|Overall Study|Protocol Violation|0|||
28021851|NCT00506350|54681055|FG004|Overall Study|Protocol Violation|0|||
28021852|NCT00506350|54681056|FG005|Overall Study|Protocol Violation|0|||
28021853|NCT00506350|54681057|FG006|Overall Study|Protocol Violation|1|||
28021854|NCT00506350|54681058|FG007|Overall Study|Protocol Violation|0|||
28021855|NCT00506350|54681059|FG008|Overall Study|Protocol Violation|0|||
28021856|NCT00506350|54681051|FG000|Overall Study|Withdrawal by Subject|0|||
28021857|NCT00506350|54681052|FG001|Overall Study|Withdrawal by Subject|1|||
28021858|NCT00506350|54681053|FG002|Overall Study|Withdrawal by Subject|1|||
28021859|NCT00506350|54681054|FG003|Overall Study|Withdrawal by Subject|1|||
28021860|NCT00506350|54681055|FG004|Overall Study|Withdrawal by Subject|4|||
28021861|NCT00506350|54681056|FG005|Overall Study|Withdrawal by Subject|1|||
28021862|NCT00506350|54681057|FG006|Overall Study|Withdrawal by Subject|1|||
28021863|NCT00506350|54681058|FG007|Overall Study|Withdrawal by Subject|2|||
28021864|NCT00506350|54681059|FG008|Overall Study|Withdrawal by Subject|0|||
28021865|NCT00506350|54681051|FG000|Overall Study|Lost to Follow-up|1|||
28021866|NCT00506350|54681052|FG001|Overall Study|Lost to Follow-up|1|||
28021867|NCT00506350|54681053|FG002|Overall Study|Lost to Follow-up|1|||
28021868|NCT00506350|54681054|FG003|Overall Study|Lost to Follow-up|1|||
28021869|NCT00506350|54681055|FG004|Overall Study|Lost to Follow-up|2|||
28021870|NCT00506350|54681056|FG005|Overall Study|Lost to Follow-up|1|||
28021871|NCT00506350|54681057|FG006|Overall Study|Lost to Follow-up|0|||
28021872|NCT00506350|54681058|FG007|Overall Study|Lost to Follow-up|0|||
28021873|NCT00506350|54681059|FG008|Overall Study|Lost to Follow-up|2|||
28021874|NCT00506350|54681051|FG000|Overall Study|Medical Reason|0|||
28021875|NCT00506350|54681052|FG001|Overall Study|Medical Reason|0|||
28021876|NCT00506350|54681053|FG002|Overall Study|Medical Reason|0|||
28021877|NCT00506350|54681054|FG003|Overall Study|Medical Reason|0|||
28021878|NCT00506350|54681055|FG004|Overall Study|Medical Reason|1|||
28021879|NCT00506350|54681056|FG005|Overall Study|Medical Reason|0|||
28021880|NCT00506350|54681057|FG006|Overall Study|Medical Reason|0|||
28021881|NCT00506350|54681058|FG007|Overall Study|Medical Reason|0|||
28021882|NCT00506350|54681059|FG008|Overall Study|Medical Reason|0|||
28021883|NCT00506350|54681051|FG000|Overall Study|Other|1|||
28021884|NCT00506350|54681052|FG001|Overall Study|Other|1|||
28021885|NCT00506350|54681053|FG002|Overall Study|Other|3|||
28021886|NCT00506350|54681054|FG003|Overall Study|Other|0|||
28021887|NCT00506350|54681055|FG004|Overall Study|Other|3|||
28021888|NCT00506350|54681056|FG005|Overall Study|Other|0|||
28021889|NCT00506350|54681057|FG006|Overall Study|Other|0|||
28021890|NCT00506350|54681058|FG007|Overall Study|Other|2|||
28021891|NCT00506350|54681059|FG008|Overall Study|Other|2|||
28021892|NCT00258895|54681088|FG000|Overall Study|Lost to Follow-up|3|||
28021893|NCT00258895|54681089|FG001|Overall Study|Lost to Follow-up|1|||
28021894|NCT00258895|54681088|FG000|Overall Study|Protocol Violation|6|||
28021895|NCT00258895|54681089|FG001|Overall Study|Protocol Violation|2|||
28021896|NCT00258895|54681088|FG000|Overall Study|Withdrawal by Subject|1|||
28021897|NCT00258895|54681089|FG001|Overall Study|Withdrawal by Subject|0|||
28021898|NCT00742625|54681095|FG000|Remission Induction|Progression|6|||
28021899|NCT00742625|54681095|FG000|Remission Induction|Failed induction|8|||
28021900|NCT00742625|54681095|FG000|Remission Induction|Adverse Event|3|||
28021901|NCT00742625|54681095|FG000|Remission Induction|Death|10|||
28021902|NCT00742625|54681095|FG000|Remission Induction|Refusal|5|||
28021903|NCT00742625|54681095|FG000|Remission Induction|Non protocol treatment|17|||
28021904|NCT00742625|54681095|FG000|Remission Induction|Other, not specified|5|||
28021905|NCT00742625|54681095|FG000|Consolidation|Progression|5|||
28021906|NCT00742625|54681095|FG000|Consolidation|Adverse Event|1|||
28021907|NCT00742625|54681095|FG000|Consolidation|Death|1|||
28021908|NCT00742625|54681095|FG000|Consolidation|Refused|1|||
28021909|NCT00742625|54681095|FG000|Consolidation|Non protocol therapy|13|||
28021910|NCT00618618|54681106|FG000|Overall Study|Patient Request|0|||
28021911|NCT00618618|54681107|FG001|Overall Study|Patient Request|0|||
28021912|NCT00618618|54681108|FG002|Overall Study|Patient Request|2|||
28021913|NCT00618618|54681109|FG003|Overall Study|Patient Request|0|||
28021914|NCT00618618|54681106|FG000|Overall Study|Inability to Complete Study Procedures|0|||
28021915|NCT00618618|54681107|FG001|Overall Study|Inability to Complete Study Procedures|1|||
28021916|NCT00618618|54681108|FG002|Overall Study|Inability to Complete Study Procedures|0|||
28021917|NCT00618618|54681109|FG003|Overall Study|Inability to Complete Study Procedures|0|||
28021918|NCT00618618|54681106|FG000|Overall Study|Lost to Follow-up|3|||
28021919|NCT00618618|54681107|FG001|Overall Study|Lost to Follow-up|0|||
28021920|NCT00618618|54681108|FG002|Overall Study|Lost to Follow-up|0|||
27800439|NCT01560819|54255114|FG001|Overall Study|Physician Decision|0|||
28021921|NCT00618618|54681109|FG003|Overall Study|Lost to Follow-up|1|||
28021922|NCT00618618|54681106|FG000|Overall Study|Non-compliance|1|||
28021923|NCT00618618|54681107|FG001|Overall Study|Non-compliance|1|||
28021924|NCT00618618|54681108|FG002|Overall Study|Non-compliance|0|||
28021925|NCT00618618|54681109|FG003|Overall Study|Non-compliance|0|||
28021926|NCT00618618|54681106|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
28021927|NCT00618618|54681107|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
28021928|NCT00618618|54681108|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
28021929|NCT00618618|54681109|FG003|Overall Study|Did Not Meet Entry Criteria|0|||
28021930|NCT00618618|54681106|FG000|Overall Study|Death|0|||
28021931|NCT00618618|54681107|FG001|Overall Study|Death|1|||
28021932|NCT00618618|54681108|FG002|Overall Study|Death|0|||
28021933|NCT00618618|54681109|FG003|Overall Study|Death|0|||
28021934|NCT00246805|54681122|FG000|Phase 1|Lost to Follow-up|1|||
28021935|NCT00246805|54681123|FG001|Phase 1|Lost to Follow-up|0|||
28021936|NCT00519376|54681129|FG000|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
28021937|NCT00519376|54681130|FG001|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
28021938|NCT00519376|54681131|FG002|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
28021939|NCT00519376|54681132|FG003|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
28021940|NCT00519376|54681133|FG004|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
28021941|NCT00519376|54681134|FG005|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
28021942|NCT00519376|54681135|FG006|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
28021943|NCT00519376|54681136|FG007|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
28021944|NCT00519376|54681137|FG008|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
27800440|NCT01425528|54255120|FG000|Overall Study|Withdrawal by Subject|1|||
27800441|NCT01425528|54255121|FG001|Overall Study|Withdrawal by Subject|1|||
27800442|NCT00442104|54255127|FG000|Overall Study|Adverse Event|5|||
27800443|NCT00442104|54255127|FG000|Overall Study|Death|2|||
27800444|NCT00442104|54255127|FG000|Overall Study|Lost to Follow-up|3|||
27800445|NCT00442104|54255127|FG000|Overall Study|Withdrawal by Subject|5|||
27800446|NCT00442104|54255127|FG000|Overall Study|Insufficient Clinical Response|10|||
27800447|NCT00442104|54255127|FG000|Overall Study|Other|21|||
27800448|NCT00442104|54255127|FG000|Overall Study|Discretion of the Investigator/Sponsor|1|||
27800449|NCT00441896|54255141|FG000|Overall Study|Withdrawal by Subject|0|||
27800450|NCT00441896|54255142|FG001|Overall Study|Withdrawal by Subject|0|||
27800451|NCT00441896|54255143|FG002|Overall Study|Withdrawal by Subject|0|||
27800452|NCT00441896|54255144|FG003|Overall Study|Withdrawal by Subject|1|||
27800453|NCT00441896|54255145|FG004|Overall Study|Withdrawal by Subject|0|||
27800454|NCT00441896|54255146|FG005|Overall Study|Withdrawal by Subject|0|||
27800455|NCT00441896|54255147|FG006|Overall Study|Withdrawal by Subject|0|||
27800456|NCT00441896|54255148|FG007|Overall Study|Withdrawal by Subject|0|||
27800457|NCT00441896|54255149|FG008|Overall Study|Withdrawal by Subject|0|||
27800458|NCT00441896|54255150|FG009|Overall Study|Withdrawal by Subject|0|||
27800459|NCT00441896|54255141|FG000|Overall Study|Other|0|||
27800460|NCT00441896|54255142|FG001|Overall Study|Other|0|||
27800461|NCT00441896|54255143|FG002|Overall Study|Other|0|||
27800462|NCT00441896|54255144|FG003|Overall Study|Other|0|||
27800463|NCT00441896|54255145|FG004|Overall Study|Other|1|||
27800464|NCT00441896|54255146|FG005|Overall Study|Other|0|||
27800465|NCT00441896|54255147|FG006|Overall Study|Other|0|||
27800466|NCT00441896|54255148|FG007|Overall Study|Other|0|||
27800467|NCT00441896|54255149|FG008|Overall Study|Other|0|||
27800468|NCT00441896|54255150|FG009|Overall Study|Other|0|||
27800469|NCT02034877|54255178|FG000|Overall Study|Lost to Follow-up|0|||
27800470|NCT02034877|54255179|FG001|Overall Study|Lost to Follow-up|3|||
27800471|NCT02034877|54255178|FG000|Overall Study|No Longer Willing to Participate|0|||
27800472|NCT02034877|54255179|FG001|Overall Study|No Longer Willing to Participate|3|||
27800473|NCT02034799|54255187|FG000|Overall Study|Withdrawal by Subject|0|||
27800474|NCT02034799|54255188|FG001|Overall Study|Withdrawal by Subject|2|||
27800475|NCT02034799|54255187|FG000|Overall Study|Lost to Follow-up|0|||
27800476|NCT02034799|54255188|FG001|Overall Study|Lost to Follow-up|1|||
28021945|NCT00519376|54681138|FG009|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
28021946|NCT00519376|54681139|FG010|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
28021947|NCT00519376|54681140|FG011|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
28021948|NCT00519376|54681141|FG012|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1|||
28021949|NCT00519376|54681142|FG013|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
28021950|NCT00519376|54681143|FG014|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
28021951|NCT00519376|54681144|FG015|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
27800477|NCT02034799|54255187|FG000|Overall Study|Death|2|||
27800478|NCT02034799|54255188|FG001|Overall Study|Death|1|||
27842813|NCT01532414|54331664|FG002|Overall Study|Unable to complete 24 hour PK|1|||
28021952|NCT00519376|54681129|FG000|Treatment Period 4|Lost to Follow-up|0|||
27800479|NCT02057575|54255198|FG000|Overall Study|Adverse Event|0|||
27800480|NCT02057575|54255199|FG001|Overall Study|Adverse Event|2|||
27800481|NCT02057575|54255200|FG002|Overall Study|Adverse Event|0|||
27800482|NCT02057575|54255201|FG003|Overall Study|Adverse Event|1|||
27800483|NCT02057575|54255198|FG000|Overall Study|Withdrawal by Subject|1|||
27800484|NCT02057575|54255199|FG001|Overall Study|Withdrawal by Subject|0|||
27800485|NCT02057575|54255200|FG002|Overall Study|Withdrawal by Subject|0|||
28021953|NCT00519376|54681130|FG001|Treatment Period 4|Lost to Follow-up|0|||
28021954|NCT00519376|54681131|FG002|Treatment Period 4|Lost to Follow-up|1|||
28021955|NCT00519376|54681132|FG003|Treatment Period 4|Lost to Follow-up|0|||
28021956|NCT00519376|54681133|FG004|Treatment Period 4|Lost to Follow-up|0|||
28021957|NCT00519376|54681134|FG005|Treatment Period 4|Lost to Follow-up|0|||
28021958|NCT00519376|54681135|FG006|Treatment Period 4|Lost to Follow-up|0|||
28021959|NCT00519376|54681136|FG007|Treatment Period 4|Lost to Follow-up|0|||
28021960|NCT00519376|54681137|FG008|Treatment Period 4|Lost to Follow-up|0|||
28021961|NCT00519376|54681138|FG009|Treatment Period 4|Lost to Follow-up|0|||
28021962|NCT00519376|54681139|FG010|Treatment Period 4|Lost to Follow-up|0|||
28021963|NCT00519376|54681140|FG011|Treatment Period 4|Lost to Follow-up|0|||
28021964|NCT00519376|54681141|FG012|Treatment Period 4|Lost to Follow-up|0|||
28021965|NCT00519376|54681142|FG013|Treatment Period 4|Lost to Follow-up|0|||
28021966|NCT00519376|54681143|FG014|Treatment Period 4|Lost to Follow-up|0|||
28021967|NCT00519376|54681144|FG015|Treatment Period 4|Lost to Follow-up|0|||
28021968|NCT00745121|54681158|FG000|Overall Study|Death|3|||
28021969|NCT00745121|54681159|FG001|Overall Study|Death|0|||
28021970|NCT00745121|54681158|FG000|Overall Study|Adverse Event|1|||
28021971|NCT00745121|54681159|FG001|Overall Study|Adverse Event|0|||
28021972|NCT00745121|54681158|FG000|Overall Study|Lost to Follow-up|1|||
28021973|NCT00745121|54681159|FG001|Overall Study|Lost to Follow-up|0|||
28021974|NCT00745121|54681158|FG000|Overall Study|Withdrawal by Subject|4|||
28021975|NCT00745121|54681159|FG001|Overall Study|Withdrawal by Subject|2|||
28021976|NCT00740051|54681167|FG000|Overall Study|Lack of Efficacy|2|||
28021977|NCT00740051|54681168|FG001|Overall Study|Lack of Efficacy|5|||
28021978|NCT00740051|54681167|FG000|Overall Study|Adverse Event|1|||
28021979|NCT00740051|54681168|FG001|Overall Study|Adverse Event|4|||
28021980|NCT00740051|54681167|FG000|Overall Study|Protocol Violation|2|||
28021981|NCT00740051|54681168|FG001|Overall Study|Protocol Violation|6|||
28021982|NCT00740051|54681167|FG000|Overall Study|Lost to Follow-up|3|||
28021983|NCT00740051|54681168|FG001|Overall Study|Lost to Follow-up|8|||
28021984|NCT00740051|54681167|FG000|Overall Study|Withdrawal by Subject|6|||
28021985|NCT00740051|54681168|FG001|Overall Study|Withdrawal by Subject|8|||
28021986|NCT00740051|54681167|FG000|Overall Study|Other reason (not specified)|4|||
28021987|NCT00740051|54681168|FG001|Overall Study|Other reason (not specified)|1|||
28021988|NCT00518986|54681177|FG000|Overall Study|Adverse Event|12|||
28021989|NCT00518986|54681178|FG001|Overall Study|Adverse Event|7|||
28021990|NCT00518986|54681177|FG000|Overall Study|Lack of Efficacy|0|||
28021991|NCT00518986|54681178|FG001|Overall Study|Lack of Efficacy|2|||
28021992|NCT00518986|54681177|FG000|Overall Study|Lost to Follow-up|3|||
28021993|NCT00518986|54681178|FG001|Overall Study|Lost to Follow-up|2|||
27800486|NCT02057575|54255201|FG003|Overall Study|Withdrawal by Subject|0|||
27800487|NCT02057575|54255198|FG000|Overall Study|Dissallowed Concurrent Medication|0|||
27800488|NCT02057575|54255199|FG001|Overall Study|Dissallowed Concurrent Medication|1|||
27800489|NCT02057575|54255200|FG002|Overall Study|Dissallowed Concurrent Medication|0|||
27800490|NCT02057575|54255201|FG003|Overall Study|Dissallowed Concurrent Medication|0|||
27800491|NCT02057575|54255198|FG000|Overall Study|Protocol Violation|0|||
27800492|NCT02057575|54255199|FG001|Overall Study|Protocol Violation|1|||
27800493|NCT02057575|54255200|FG002|Overall Study|Protocol Violation|0|||
27800494|NCT02057575|54255201|FG003|Overall Study|Protocol Violation|0|||
27800495|NCT02077465|54255213|FG000|Overall Study|Withdrew Consent|0|||
27800496|NCT02077465|54255214|FG001|Overall Study|Withdrew Consent|1|||
27800497|NCT02077465|54255213|FG000|Overall Study|Lost to Follow-up|1|||
27800498|NCT02077465|54255214|FG001|Overall Study|Lost to Follow-up|0|||
27800499|NCT02034565|54255220|FG000|Overall Study|Adverse Event|1|||
28021994|NCT00518986|54681177|FG000|Overall Study|Physician Decision|0|||
28021995|NCT00518986|54681178|FG001|Overall Study|Physician Decision|3|||
28021996|NCT00518986|54681177|FG000|Overall Study|Protocol Violation|5|||
28021997|NCT00518986|54681178|FG001|Overall Study|Protocol Violation|7|||
28021998|NCT00518986|54681177|FG000|Overall Study|Withdrawal by Subject|4|||
28021999|NCT00518986|54681178|FG001|Overall Study|Withdrawal by Subject|4|||
28022000|NCT00518986|54681177|FG000|Overall Study|Non-Specific|2|||
28022001|NCT00518986|54681178|FG001|Overall Study|Non-Specific|1|||
28022002|NCT00742391|54681186|FG000|Overall Study|Adverse Event|2|||
28022003|NCT00742391|54681187|FG001|Overall Study|Adverse Event|1|||
28022004|NCT00742391|54681186|FG000|Overall Study|Lost to Follow-up|1|||
28022005|NCT00742391|54681187|FG001|Overall Study|Lost to Follow-up|0|||
28022006|NCT00742391|54681186|FG000|Overall Study|Protocol Violation|1|||
27842814|NCT01532414|54331662|FG000|Overall Study|Withdrawn by sponsor|1|||
28022007|NCT00742391|54681187|FG001|Overall Study|Protocol Violation|0|||
28022008|NCT00742235|54681195|FG000|Overall Study|Lost to Follow-up|0|||
28022009|NCT00742235|54681196|FG001|Overall Study|Lost to Follow-up|31|||
28022010|NCT00742079|54681204|FG000|Overall Study|Lost to Follow-up|0|||
28022011|NCT00742079|54681205|FG001|Overall Study|Lost to Follow-up|1|||
28022012|NCT00662792|54681211|FG000|Period 1|Personal Reasons|0|||
28022013|NCT00662792|54681212|FG001|Period 1|Personal Reasons|0|||
27800500|NCT02034565|54255221|FG001|Overall Study|Adverse Event|0|||
27800501|NCT02075515|54255232|FG000|Overall Study|Serious Adverse Event|1|||
28022014|NCT00662792|54681213|FG002|Period 1|Personal Reasons|1|||
28022015|NCT00662792|54681214|FG003|Period 1|Personal Reasons|0|||
28022016|NCT00662792|54681211|FG000|Period 1|Refused continuing medication|0|||
28022017|NCT00662792|54681212|FG001|Period 1|Refused continuing medication|1|||
28022018|NCT00662792|54681213|FG002|Period 1|Refused continuing medication|1|||
28022019|NCT00662792|54681214|FG003|Period 1|Refused continuing medication|0|||
28022020|NCT00662792|54681211|FG000|Period 1|Lost to Follow-up|1|||
28022021|NCT00662792|54681212|FG001|Period 1|Lost to Follow-up|0|||
28022022|NCT00662792|54681213|FG002|Period 1|Lost to Follow-up|0|||
28022023|NCT00662792|54681214|FG003|Period 1|Lost to Follow-up|0|||
28022024|NCT00662792|54681211|FG000|Period 1|Other adverse event (AE)|0|||
28022025|NCT00662792|54681212|FG001|Period 1|Other adverse event (AE)|2|||
28022026|NCT00662792|54681213|FG002|Period 1|Other adverse event (AE)|0|||
28022027|NCT00662792|54681214|FG003|Period 1|Other adverse event (AE)|0|||
28022028|NCT00662792|54681211|FG000|Period 1|Worsening of disease under study (AE)|1|||
28022029|NCT00662792|54681212|FG001|Period 1|Worsening of disease under study (AE)|3|||
28022030|NCT00662792|54681213|FG002|Period 1|Worsening of disease under study (AE)|2|||
28022031|NCT00662792|54681214|FG003|Period 1|Worsening of disease under study (AE)|0|||
28022032|NCT00662792|54681211|FG000|Period 1|Not treated|0|||
28022033|NCT00662792|54681212|FG001|Period 1|Not treated|1|||
28022034|NCT00662792|54681213|FG002|Period 1|Not treated|0|||
28022035|NCT00662792|54681214|FG003|Period 1|Not treated|0|||
28022036|NCT00662792|54681211|FG000|Period 2|Worsening of disease under study|1|||
28022037|NCT00662792|54681212|FG001|Period 2|Worsening of disease under study|0|||
28022038|NCT00662792|54681213|FG002|Period 2|Worsening of disease under study|0|||
28022039|NCT00662792|54681214|FG003|Period 2|Worsening of disease under study|3|||
28022040|NCT00662792|54681211|FG000|Period 3|Refused continuing medication|1|||
28022041|NCT00662792|54681212|FG001|Period 3|Refused continuing medication|0|||
28022042|NCT00662792|54681213|FG002|Period 3|Refused continuing medication|1|||
28022043|NCT00662792|54681214|FG003|Period 3|Refused continuing medication|0|||
28022044|NCT00662792|54681211|FG000|Period 3|Other adverse event (AE)|0|||
28022045|NCT00662792|54681212|FG001|Period 3|Other adverse event (AE)|0|||
28022046|NCT00662792|54681213|FG002|Period 3|Other adverse event (AE)|1|||
28022047|NCT00662792|54681214|FG003|Period 3|Other adverse event (AE)|1|||
28022048|NCT00662792|54681211|FG000|Period 4|Refused continuing medication|0|||
28022049|NCT00662792|54681212|FG001|Period 4|Refused continuing medication|1|||
28022050|NCT00662792|54681213|FG002|Period 4|Refused continuing medication|0|||
28022051|NCT00662792|54681214|FG003|Period 4|Refused continuing medication|0|||
28022052|NCT00662792|54681211|FG000|Period 4|Other adverse event (AE)|1|||
28022053|NCT00662792|54681212|FG001|Period 4|Other adverse event (AE)|0|||
28022054|NCT00662792|54681213|FG002|Period 4|Other adverse event (AE)|0|||
28022055|NCT00662792|54681214|FG003|Period 4|Other adverse event (AE)|0|||
28022056|NCT00662792|54681211|FG000|Period 4|Worsening of disease under study (AE)|0|||
28022057|NCT00662792|54681212|FG001|Period 4|Worsening of disease under study (AE)|0|||
28022058|NCT00662792|54681213|FG002|Period 4|Worsening of disease under study (AE)|0|||
28022059|NCT00662792|54681214|FG003|Period 4|Worsening of disease under study (AE)|1|||
28022060|NCT00742001|54681229|FG000|Overall Study|Withdrawn; health exclusion (flu)|0|||
28022061|NCT00742001|54681230|FG001|Overall Study|Withdrawn; health exclusion (flu)|0|||
28022062|NCT00742001|54681231|FG002|Overall Study|Withdrawn; health exclusion (flu)|1|||
28022063|NCT00616902|54681244|FG000|Overall Study|Termination of study|6|||
28022064|NCT00616902|54681245|FG001|Overall Study|Termination of study|6|||
28022065|NCT00741611|54681254|FG000|Overall Study|Death|0|||
28022066|NCT00741611|54681255|FG001|Overall Study|Death|0|||
28022067|NCT00741611|54681256|FG002|Overall Study|Death|1|||
28022068|NCT00741611|54681254|FG000|Overall Study|Withdrawal by Subject|0|||
28022069|NCT00741611|54681255|FG001|Overall Study|Withdrawal by Subject|2|||
28022070|NCT00741611|54681256|FG002|Overall Study|Withdrawal by Subject|2|||
28022071|NCT00662558|54681267|FG000|Overall Study|Adverse Event|21|||
28022072|NCT00662558|54681268|FG001|Overall Study|Adverse Event|59|||
28022073|NCT00662558|54681267|FG000|Overall Study|Lack of Efficacy|4|||
28022074|NCT00662558|54681268|FG001|Overall Study|Lack of Efficacy|7|||
28022075|NCT00662558|54681267|FG000|Overall Study|Lost to Follow-up|13|||
28022076|NCT00662558|54681268|FG001|Overall Study|Lost to Follow-up|10|||
28022077|NCT00662558|54681267|FG000|Overall Study|Other|9|||
28022078|NCT00662558|54681268|FG001|Overall Study|Other|14|||
28022079|NCT00662558|54681267|FG000|Overall Study|Withdrawal by Subject|7|||
28022080|NCT00662558|54681268|FG001|Overall Study|Withdrawal by Subject|12|||
28022081|NCT00662558|54681267|FG000|Overall Study|Randomized But Did Not Receive Treatment|2|||
28022082|NCT00662558|54681268|FG001|Overall Study|Randomized But Did Not Receive Treatment|8|||
28022083|NCT00739973|54681283|FG000|Single-blind Period (2 to 4 Weeks)|Adverse Event|35|||
28022084|NCT00739973|54681284|FG001|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
28022085|NCT00739973|54681285|FG002|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
28022086|NCT00739973|54681286|FG003|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
28022087|NCT00739973|54681287|FG004|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
28022088|NCT00739973|54681288|FG005|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
28022089|NCT00739973|54681289|FG006|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
28022090|NCT00739973|54681290|FG007|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
28022091|NCT00739973|54681291|FG008|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
28022092|NCT00739973|54681283|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38|||
28022093|NCT00739973|54681284|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
28022094|NCT00739973|54681285|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
28022095|NCT00739973|54681286|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
28022096|NCT00739973|54681287|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
28022097|NCT00739973|54681288|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
28022098|NCT00739973|54681289|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
28022099|NCT00739973|54681290|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
28022100|NCT00739973|54681291|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
28022101|NCT00739973|54681283|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810|||
27800502|NCT02075515|54255233|FG001|Overall Study|Serious Adverse Event|1|||
27800503|NCT02075515|54255234|FG002|Overall Study|Serious Adverse Event|1|||
27800504|NCT02075515|54255232|FG000|Overall Study|Non-Serious Adverse Event|0|||
27800505|NCT02075515|54255233|FG001|Overall Study|Non-Serious Adverse Event|1|||
28022102|NCT00739973|54681284|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
28022103|NCT00739973|54681285|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
28022104|NCT00739973|54681286|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
28022105|NCT00739973|54681287|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
28022106|NCT00739973|54681288|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
28022107|NCT00739973|54681289|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
28022108|NCT00739973|54681290|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
28022109|NCT00739973|54681291|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
28022110|NCT00739973|54681283|FG000|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86|||
28022111|NCT00739973|54681284|FG001|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
28022112|NCT00739973|54681285|FG002|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
28022113|NCT00739973|54681286|FG003|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
28022114|NCT00739973|54681287|FG004|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
28022115|NCT00739973|54681288|FG005|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
28022116|NCT00739973|54681289|FG006|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
28022117|NCT00739973|54681290|FG007|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
28022118|NCT00739973|54681291|FG008|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
28022119|NCT00739973|54681283|FG000|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17|||
28022120|NCT00739973|54681284|FG001|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
28022121|NCT00739973|54681285|FG002|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
28022122|NCT00739973|54681286|FG003|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
28022123|NCT00739973|54681287|FG004|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
28022124|NCT00739973|54681288|FG005|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
28022125|NCT00739973|54681289|FG006|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
28022126|NCT00739973|54681290|FG007|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
28022127|NCT00739973|54681291|FG008|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
28022128|NCT00739973|54681283|FG000|Single-blind Period (2 to 4 Weeks)|Administrative problems|12|||
28022129|NCT00739973|54681284|FG001|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
27800506|NCT02075515|54255234|FG002|Overall Study|Non-Serious Adverse Event|0|||
27800507|NCT02075515|54255232|FG000|Overall Study|Withdrawal by Subject|2|||
27800508|NCT02075515|54255233|FG001|Overall Study|Withdrawal by Subject|0|||
27800509|NCT02075515|54255234|FG002|Overall Study|Withdrawal by Subject|1|||
27800510|NCT02075515|54255232|FG000|Overall Study|Lost to Follow-up|1|||
27800511|NCT02075515|54255233|FG001|Overall Study|Lost to Follow-up|3|||
27800512|NCT02075515|54255234|FG002|Overall Study|Lost to Follow-up|6|||
27800513|NCT02034409|54255245|FG000|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|4|||
27800514|NCT02034409|54255246|FG001|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|0|||
27800515|NCT02034409|54255245|FG000|Sham-Controlled Treatment Period|Adverse Event|1|||
27800516|NCT02034409|54255246|FG001|Sham-Controlled Treatment Period|Adverse Event|1|||
27800517|NCT02034409|54255245|FG000|Sham-Controlled Treatment Period|Lost to Follow-up|0|||
27938557|NCT00969280|54594656|FG001|Overall Study|Withdrawal by Subject|1|||
27938558|NCT00969280|54594655|FG000|Overall Study|infection of influenza A(H1N1)|0|||
27938559|NCT00969280|54594656|FG001|Overall Study|infection of influenza A(H1N1)|1|||
27938560|NCT00969124|54594662|FG000|Overall Study|Protocol Violation|2|||
27938561|NCT00969124|54594662|FG000|Overall Study|Inadequate bowel preparation|15|||
27938562|NCT00969124|54594662|FG000|Overall Study|Inability to reach cecum|9|||
27938563|NCT00969124|54594662|FG000|Overall Study|Previously unrecognized disease|3|||
27938564|NCT00969124|54594662|FG000|Overall Study|Technical error|1|||
27938565|NCT00900601|54594667|FG000|Overall Study|Physician Decision|1|||
27938566|NCT00901927|54594694|FG000|Overall Study|Lack of Efficacy|1|||
28022130|NCT00739973|54681285|FG002|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
28022131|NCT00739973|54681286|FG003|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
28022132|NCT00739973|54681287|FG004|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
28022133|NCT00739973|54681288|FG005|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
28022134|NCT00739973|54681289|FG006|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
28022135|NCT00739973|54681290|FG007|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
28022136|NCT00739973|54681291|FG008|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
28022137|NCT00739973|54681283|FG000|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11|||
28022138|NCT00739973|54681284|FG001|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
28022139|NCT00739973|54681285|FG002|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
28022140|NCT00739973|54681286|FG003|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
28022141|NCT00739973|54681287|FG004|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
28022142|NCT00739973|54681288|FG005|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
28022143|NCT00739973|54681289|FG006|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
28022144|NCT00739973|54681290|FG007|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
28022145|NCT00739973|54681291|FG008|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
28022146|NCT00739973|54681283|FG000|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
28022147|NCT00739973|54681284|FG001|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
28022148|NCT00739973|54681285|FG002|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
28022149|NCT00739973|54681286|FG003|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2|||
28022150|NCT00739973|54681287|FG004|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7|||
28022151|NCT00739973|54681288|FG005|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
28022152|NCT00739973|54681289|FG006|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
28022153|NCT00739973|54681290|FG007|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
28022154|NCT00739973|54681291|FG008|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
28022155|NCT00739973|54681283|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
28022156|NCT00739973|54681284|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
28022157|NCT00739973|54681285|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
28022158|NCT00739973|54681286|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
28022159|NCT00739973|54681287|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
28022160|NCT00739973|54681288|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
28022161|NCT00739973|54681289|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
28022162|NCT00739973|54681290|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
28022163|NCT00739973|54681291|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
28022164|NCT00739973|54681283|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
28022165|NCT00739973|54681284|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
28022166|NCT00739973|54681285|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
28022167|NCT00739973|54681286|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
28022168|NCT00739973|54681287|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
28022169|NCT00739973|54681288|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
28022170|NCT00739973|54681289|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
28022171|NCT00739973|54681290|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
28022172|NCT00739973|54681291|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
28022173|NCT00739973|54681283|FG000|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17|||
28022174|NCT00739973|54681284|FG001|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
28022175|NCT00739973|54681285|FG002|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
28022176|NCT00739973|54681286|FG003|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4|||
28022177|NCT00739973|54681287|FG004|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
28022178|NCT00739973|54681288|FG005|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
28022179|NCT00739973|54681289|FG006|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
28022180|NCT00739973|54681290|FG007|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
28022181|NCT00739973|54681291|FG008|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
28022182|NCT00739973|54681283|FG000|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
28022183|NCT00739973|54681284|FG001|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
28022184|NCT00739973|54681285|FG002|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1|||
28022185|NCT00739973|54681286|FG003|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
28022186|NCT00739973|54681287|FG004|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
28076993|NCT00094458|54731726|FG004|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
27800518|NCT02034409|54255246|FG001|Sham-Controlled Treatment Period|Lost to Follow-up|1|||
28022187|NCT00739973|54681288|FG005|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
28022188|NCT00739973|54681289|FG006|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
28022189|NCT00739973|54681290|FG007|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
28022190|NCT00739973|54681291|FG008|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
28022191|NCT00739973|54681283|FG000|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
28022192|NCT00739973|54681284|FG001|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
28022193|NCT00739973|54681285|FG002|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
28022194|NCT00739973|54681286|FG003|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
28022195|NCT00739973|54681287|FG004|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
28022196|NCT00739973|54681288|FG005|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
28022197|NCT00739973|54681289|FG006|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
28022198|NCT00739973|54681290|FG007|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
28022199|NCT00739973|54681291|FG008|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
28022200|NCT00739973|54681283|FG000|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
28022201|NCT00739973|54681284|FG001|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
27800519|NCT02034409|54255245|FG000|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
27800520|NCT02034409|54255246|FG001|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
28022202|NCT00739973|54681285|FG002|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4|||
28022203|NCT00739973|54681286|FG003|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
28022204|NCT00739973|54681287|FG004|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
28022205|NCT00739973|54681288|FG005|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
28022206|NCT00739973|54681289|FG006|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
28022207|NCT00739973|54681290|FG007|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3|||
28022208|NCT00739973|54681291|FG008|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
28022209|NCT00739973|54681283|FG000|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
28022210|NCT00739973|54681284|FG001|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
28022211|NCT00739973|54681285|FG002|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
28022212|NCT00739973|54681286|FG003|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
28022213|NCT00739973|54681287|FG004|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
28022214|NCT00739973|54681288|FG005|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
28022215|NCT00739973|54681289|FG006|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1|||
28022216|NCT00739973|54681290|FG007|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
28022217|NCT00739973|54681291|FG008|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
28022218|NCT00739973|54681283|FG000|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5|||
28022219|NCT00739973|54681284|FG001|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
28022220|NCT00739973|54681285|FG002|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
28022221|NCT00739973|54681286|FG003|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
28022222|NCT00739973|54681287|FG004|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
28022223|NCT00739973|54681288|FG005|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
28022224|NCT00739973|54681289|FG006|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
28022225|NCT00739973|54681290|FG007|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
28022226|NCT00739973|54681291|FG008|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
28022227|NCT00739973|54681283|FG000|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
28022228|NCT00739973|54681284|FG001|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1|||
28022229|NCT00739973|54681285|FG002|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
28022230|NCT00739973|54681286|FG003|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
28022231|NCT00739973|54681287|FG004|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
28022232|NCT00739973|54681288|FG005|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
27800521|NCT02034409|54255245|FG000|Sham-Controlled Treatment Period|Physician Decision|1|||
27800522|NCT02034409|54255246|FG001|Sham-Controlled Treatment Period|Physician Decision|3|||
27800523|NCT02034409|54255245|FG000|Sham-Controlled Treatment Period|misrandomized|2|||
27800524|NCT02034409|54255246|FG001|Sham-Controlled Treatment Period|misrandomized|2|||
27800525|NCT02021318|54255254|FG000|Overall Study|Adverse Event|2|||
27800526|NCT02021318|54255255|FG001|Overall Study|Adverse Event|1|||
27800527|NCT02021318|54255254|FG000|Overall Study|Death|33|||
27800528|NCT02021318|54255255|FG001|Overall Study|Death|34|||
27800529|NCT02021318|54255254|FG000|Overall Study|Lost to Follow-up|3|||
27800530|NCT02021318|54255255|FG001|Overall Study|Lost to Follow-up|3|||
27800531|NCT02021318|54255254|FG000|Overall Study|Progressive Disease|0|||
27800532|NCT02021318|54255255|FG001|Overall Study|Progressive Disease|1|||
27800533|NCT02021318|54255254|FG000|Overall Study|Withdrawal by Subject|30|||
27800534|NCT02021318|54255255|FG001|Overall Study|Withdrawal by Subject|18|||
27800535|NCT02021318|54255254|FG000|Overall Study|Physician Decision|3|||
27800536|NCT02021318|54255255|FG001|Overall Study|Physician Decision|3|||
27800537|NCT02021318|54255254|FG000|Overall Study|Miscellaneous|2|||
27800538|NCT02021318|54255255|FG001|Overall Study|Miscellaneous|3|||
27800539|NCT02041286|54255262|FG000|Overall Study|Adverse Event|1|||
27800540|NCT02020616|54255275|FG000|Overall Study|Adverse Event|0|||
27800541|NCT02020616|54255276|FG001|Overall Study|Adverse Event|0|||
27800542|NCT02020616|54255277|FG002|Overall Study|Adverse Event|0|||
27800543|NCT02020616|54255278|FG003|Overall Study|Adverse Event|0|||
27800544|NCT02020616|54255279|FG004|Overall Study|Adverse Event|0|||
27800545|NCT02020616|54255280|FG005|Overall Study|Adverse Event|1|||
27800546|NCT02020616|54255281|FG006|Overall Study|Adverse Event|1|||
27800547|NCT02020616|54255275|FG000|Overall Study|Physician Decision|0|||
27800548|NCT02020616|54255276|FG001|Overall Study|Physician Decision|0|||
27800549|NCT02020616|54255277|FG002|Overall Study|Physician Decision|0|||
27800550|NCT02020616|54255278|FG003|Overall Study|Physician Decision|0|||
27800551|NCT02020616|54255279|FG004|Overall Study|Physician Decision|0|||
27800552|NCT02020616|54255280|FG005|Overall Study|Physician Decision|1|||
27800553|NCT02020616|54255281|FG006|Overall Study|Physician Decision|2|||
27800554|NCT02020616|54255275|FG000|Overall Study|Withdrawal by Subject|0|||
27800555|NCT02020616|54255276|FG001|Overall Study|Withdrawal by Subject|0|||
27800556|NCT02020616|54255277|FG002|Overall Study|Withdrawal by Subject|1|||
27800557|NCT02020616|54255278|FG003|Overall Study|Withdrawal by Subject|0|||
27800558|NCT02020616|54255279|FG004|Overall Study|Withdrawal by Subject|0|||
27800559|NCT02020616|54255280|FG005|Overall Study|Withdrawal by Subject|1|||
27800560|NCT02020616|54255281|FG006|Overall Study|Withdrawal by Subject|1|||
27800561|NCT02020616|54255275|FG000|Overall Study|Lost to Follow-up|0|||
27800562|NCT02020616|54255276|FG001|Overall Study|Lost to Follow-up|1|||
27800563|NCT02020616|54255277|FG002|Overall Study|Lost to Follow-up|0|||
27800564|NCT02020616|54255278|FG003|Overall Study|Lost to Follow-up|1|||
27800565|NCT02020616|54255279|FG004|Overall Study|Lost to Follow-up|1|||
27800566|NCT02020616|54255280|FG005|Overall Study|Lost to Follow-up|1|||
27800567|NCT02020616|54255281|FG006|Overall Study|Lost to Follow-up|0|||
27800568|NCT02020616|54255275|FG000|Overall Study|Early Termination Criteria Met|0|||
27800569|NCT02020616|54255276|FG001|Overall Study|Early Termination Criteria Met|0|||
27800570|NCT02020616|54255277|FG002|Overall Study|Early Termination Criteria Met|1|||
27800571|NCT02020616|54255278|FG003|Overall Study|Early Termination Criteria Met|0|||
27800572|NCT02020616|54255279|FG004|Overall Study|Early Termination Criteria Met|0|||
27800573|NCT02020616|54255280|FG005|Overall Study|Early Termination Criteria Met|1|||
27800574|NCT02020616|54255281|FG006|Overall Study|Early Termination Criteria Met|0|||
27800575|NCT02020616|54255275|FG000|Overall Study|Randomized in Error|0|||
27800576|NCT02020616|54255276|FG001|Overall Study|Randomized in Error|0|||
27800577|NCT02020616|54255277|FG002|Overall Study|Randomized in Error|0|||
27800578|NCT02020616|54255278|FG003|Overall Study|Randomized in Error|1|||
27800579|NCT02020616|54255279|FG004|Overall Study|Randomized in Error|0|||
27800580|NCT02020616|54255280|FG005|Overall Study|Randomized in Error|0|||
27800581|NCT02020616|54255281|FG006|Overall Study|Randomized in Error|0|||
27938567|NCT00901927|54594694|FG000|Overall Study|Protocol Violation|3|||
27938568|NCT00901927|54594694|FG000|Overall Study|Withdrawal by Subject|2|||
27938569|NCT00968968|54594700|FG000|Overall Study|Study closed/terminated|10|||
27938570|NCT00968968|54594701|FG001|Overall Study|Study closed/terminated|10|||
27938571|NCT00968968|54594700|FG000|Overall Study|Protocol defined stopping criteria|3|||
27938572|NCT00968968|54594701|FG001|Overall Study|Protocol defined stopping criteria|1|||
27938573|NCT00968968|54594700|FG000|Overall Study|Withdrawal by Subject|2|||
28022233|NCT00739973|54681289|FG006|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2|||
28022234|NCT00739973|54681290|FG007|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
27800582|NCT02020616|54255275|FG000|Overall Study|Lack of Efficacy|0|||
27800583|NCT02020616|54255276|FG001|Overall Study|Lack of Efficacy|0|||
27938574|NCT00968968|54594701|FG001|Overall Study|Withdrawal by Subject|0|||
27800584|NCT02020616|54255277|FG002|Overall Study|Lack of Efficacy|0|||
27800585|NCT02020616|54255278|FG003|Overall Study|Lack of Efficacy|0|||
27938575|NCT00968968|54594700|FG000|Overall Study|Physician Decision|1|||
27800586|NCT02020616|54255279|FG004|Overall Study|Lack of Efficacy|1|||
27800587|NCT02020616|54255280|FG005|Overall Study|Lack of Efficacy|0|||
27800588|NCT02020616|54255281|FG006|Overall Study|Lack of Efficacy|0|||
27800589|NCT02048072|54255311|FG000|Overall Study|Adverse Event|3|||
27800590|NCT02048072|54255311|FG000|Overall Study|Lost to Follow-up|1|||
27800591|NCT02047604|54255321|FG000|Overall Study|Withdrawal by Subject|0|||
27938576|NCT00968968|54594701|FG001|Overall Study|Physician Decision|2|||
27938577|NCT00968968|54594700|FG000|Overall Study|Lost to Follow-up|0|||
27800592|NCT02047604|54255322|FG001|Overall Study|Withdrawal by Subject|0|||
27800593|NCT02047604|54255323|FG002|Overall Study|Withdrawal by Subject|0|||
27800594|NCT02047604|54255324|FG003|Overall Study|Withdrawal by Subject|0|||
27800595|NCT02047604|54255325|FG004|Overall Study|Withdrawal by Subject|1|||
27800596|NCT02047604|54255326|FG005|Overall Study|Withdrawal by Subject|1|||
27800597|NCT01622660|54255340|FG000|Overall Study|Adverse Event|1|||
27800598|NCT02019602|54255346|FG000|Screening Period|Ineligibility|4|||
27800599|NCT02019602|54255347|FG001|Screening Period|Ineligibility|0|||
27800600|NCT02019602|54255346|FG000|Screening Period|Adverse Event|1|||
27800601|NCT02019602|54255347|FG001|Screening Period|Adverse Event|0|||
27800602|NCT01994876|54255354|FG000|Test Period 1|Withdrawal by Subject|0|||
27800603|NCT01994876|54255355|FG001|Test Period 1|Withdrawal by Subject|1|||
27800604|NCT01994876|54255354|FG000|Test Period 1|Adverse Event|0|||
27800605|NCT01994876|54255355|FG001|Test Period 1|Adverse Event|1|||
28022235|NCT00739973|54681291|FG008|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
28022236|NCT00510874|54681326|FG000|Overall Study|Withdrawal by Subject|1|||
28022237|NCT00510874|54681327|FG001|Overall Study|Withdrawal by Subject|1|||
28022238|NCT00510874|54681328|FG002|Overall Study|Withdrawal by Subject|0|||
28022239|NCT00510874|54681329|FG003|Overall Study|Withdrawal by Subject|0|||
28022240|NCT00510874|54681330|FG004|Overall Study|Withdrawal by Subject|3|||
28022241|NCT00510874|54681331|FG005|Overall Study|Withdrawal by Subject|0|||
28022242|NCT00510874|54681332|FG006|Overall Study|Withdrawal by Subject|0|||
28022243|NCT00510874|54681326|FG000|Overall Study|Lost to Follow-up|2|||
28022244|NCT00510874|54681327|FG001|Overall Study|Lost to Follow-up|3|||
28022245|NCT00510874|54681328|FG002|Overall Study|Lost to Follow-up|1|||
28022246|NCT00510874|54681329|FG003|Overall Study|Lost to Follow-up|3|||
28022247|NCT00510874|54681330|FG004|Overall Study|Lost to Follow-up|4|||
28022248|NCT00510874|54681331|FG005|Overall Study|Lost to Follow-up|0|||
28022249|NCT00510874|54681332|FG006|Overall Study|Lost to Follow-up|1|||
28022250|NCT00739661|54681351|FG000|Overall Study|Adverse Event|2|||
28022251|NCT00739661|54681352|FG001|Overall Study|Adverse Event|0|||
28022252|NCT00739661|54681351|FG000|Overall Study|Physician decision to withdraw patient|1|||
28022253|NCT00739661|54681352|FG001|Overall Study|Physician decision to withdraw patient|0|||
28022254|NCT00739661|54681351|FG000|Overall Study|Patient decision to withdraw|9|||
28022255|NCT00739661|54681352|FG001|Overall Study|Patient decision to withdraw|4|||
28022256|NCT00739661|54681351|FG000|Overall Study|Disease progression, radiographic|33|||
28022257|NCT00739661|54681352|FG001|Overall Study|Disease progression, radiographic|37|||
28022258|NCT00739661|54681351|FG000|Overall Study|Reason for discontinuation not available|1|||
28022259|NCT00739661|54681352|FG001|Overall Study|Reason for discontinuation not available|1|||
28022260|NCT00615030|54681358|FG000|Period I|Administrative problem|0|||
28022261|NCT00615030|54681359|FG001|Period I|Administrative problem|0|||
28022262|NCT00615030|54681360|FG002|Period I|Administrative problem|0|||
28022263|NCT00615030|54681361|FG003|Period I|Administrative problem|0|||
28022264|NCT00615030|54681362|FG004|Period I|Administrative problem|1|||
28022265|NCT00615030|54681363|FG005|Period I|Administrative problem|0|||
28022266|NCT00615030|54681364|FG006|Period I|Administrative problem|0|||
28022267|NCT00615030|54681365|FG007|Period I|Administrative problem|0|||
28022268|NCT00615030|54681366|FG008|Period I|Administrative problem|0|||
28022269|NCT00615030|54681367|FG009|Period I|Administrative problem|0|||
28022270|NCT00615030|54681368|FG010|Period I|Administrative problem|0|||
28022271|NCT00615030|54681369|FG011|Period I|Administrative problem|0|||
27800606|NCT01994876|54255354|FG000|Test Period 2|Adverse Event|1|||
27800607|NCT01994876|54255355|FG001|Test Period 2|Adverse Event|0|||
28022272|NCT00615030|54681358|FG000|Period I|Protocol deviation|1|||
28022273|NCT00615030|54681359|FG001|Period I|Protocol deviation|0|||
28022274|NCT00615030|54681360|FG002|Period I|Protocol deviation|0|||
28022275|NCT00615030|54681361|FG003|Period I|Protocol deviation|0|||
28022276|NCT00615030|54681362|FG004|Period I|Protocol deviation|0|||
28022277|NCT00615030|54681363|FG005|Period I|Protocol deviation|0|||
28022278|NCT00615030|54681364|FG006|Period I|Protocol deviation|0|||
28022279|NCT00615030|54681365|FG007|Period I|Protocol deviation|0|||
28022280|NCT00615030|54681366|FG008|Period I|Protocol deviation|0|||
28022281|NCT00615030|54681367|FG009|Period I|Protocol deviation|0|||
28022282|NCT00615030|54681368|FG010|Period I|Protocol deviation|0|||
28022283|NCT00615030|54681369|FG011|Period I|Protocol deviation|0|||
28022284|NCT00615030|54681358|FG000|Period I|Subject withdrew consent|0|||
28022285|NCT00615030|54681359|FG001|Period I|Subject withdrew consent|0|||
28022286|NCT00615030|54681360|FG002|Period I|Subject withdrew consent|0|||
28022287|NCT00615030|54681361|FG003|Period I|Subject withdrew consent|0|||
28022288|NCT00615030|54681362|FG004|Period I|Subject withdrew consent|0|||
28022289|NCT00615030|54681363|FG005|Period I|Subject withdrew consent|0|||
28022290|NCT00615030|54681364|FG006|Period I|Subject withdrew consent|0|||
28022291|NCT00615030|54681365|FG007|Period I|Subject withdrew consent|0|||
28022292|NCT00615030|54681366|FG008|Period I|Subject withdrew consent|1|||
28022293|NCT00615030|54681367|FG009|Period I|Subject withdrew consent|0|||
28022294|NCT00615030|54681368|FG010|Period I|Subject withdrew consent|1|||
28022295|NCT00615030|54681369|FG011|Period I|Subject withdrew consent|1|||
27800608|NCT01994876|54255354|FG000|Test Period 2|Protocol Violation|0|||
27800609|NCT01994876|54255355|FG001|Test Period 2|Protocol Violation|1|||
27800610|NCT02040428|54255365|FG000|Overall Study|Death|4|||
28022296|NCT00615030|54681358|FG000|Period I|Abnormal laboratory value(s)|0|||
28022297|NCT00615030|54681359|FG001|Period I|Abnormal laboratory value(s)|0|||
28022298|NCT00615030|54681360|FG002|Period I|Abnormal laboratory value(s)|0|||
28022299|NCT00615030|54681361|FG003|Period I|Abnormal laboratory value(s)|0|||
28022300|NCT00615030|54681362|FG004|Period I|Abnormal laboratory value(s)|0|||
28022301|NCT00615030|54681363|FG005|Period I|Abnormal laboratory value(s)|1|||
28022302|NCT00615030|54681364|FG006|Period I|Abnormal laboratory value(s)|0|||
28022303|NCT00615030|54681365|FG007|Period I|Abnormal laboratory value(s)|0|||
28022304|NCT00615030|54681366|FG008|Period I|Abnormal laboratory value(s)|0|||
28022305|NCT00615030|54681367|FG009|Period I|Abnormal laboratory value(s)|0|||
28022306|NCT00615030|54681368|FG010|Period I|Abnormal laboratory value(s)|0|||
28022307|NCT00615030|54681369|FG011|Period I|Abnormal laboratory value(s)|0|||
28022308|NCT00615030|54681358|FG000|Period II|Adverse Event|0|||
28022309|NCT00615030|54681359|FG001|Period II|Adverse Event|0|||
28022310|NCT00615030|54681360|FG002|Period II|Adverse Event|1|||
28022311|NCT00615030|54681361|FG003|Period II|Adverse Event|0|||
28022312|NCT00615030|54681362|FG004|Period II|Adverse Event|0|||
28022313|NCT00615030|54681363|FG005|Period II|Adverse Event|0|||
28022314|NCT00615030|54681364|FG006|Period II|Adverse Event|0|||
28022315|NCT00615030|54681365|FG007|Period II|Adverse Event|0|||
28022316|NCT00615030|54681366|FG008|Period II|Adverse Event|1|||
28022317|NCT00615030|54681367|FG009|Period II|Adverse Event|0|||
28022318|NCT00615030|54681368|FG010|Period II|Adverse Event|0|||
28022319|NCT00615030|54681369|FG011|Period II|Adverse Event|0|||
28022320|NCT00615030|54681358|FG000|Period II|Subject withdrew consent|0|||
28022321|NCT00615030|54681359|FG001|Period II|Subject withdrew consent|0|||
28022322|NCT00615030|54681360|FG002|Period II|Subject withdrew consent|0|||
28022323|NCT00615030|54681361|FG003|Period II|Subject withdrew consent|1|||
28022324|NCT00615030|54681362|FG004|Period II|Subject withdrew consent|0|||
28022325|NCT00615030|54681363|FG005|Period II|Subject withdrew consent|0|||
28022326|NCT00615030|54681364|FG006|Period II|Subject withdrew consent|1|||
28022327|NCT00615030|54681365|FG007|Period II|Subject withdrew consent|0|||
28022328|NCT00615030|54681366|FG008|Period II|Subject withdrew consent|0|||
28022329|NCT00615030|54681367|FG009|Period II|Subject withdrew consent|0|||
28022330|NCT00615030|54681368|FG010|Period II|Subject withdrew consent|0|||
28022331|NCT00615030|54681369|FG011|Period II|Subject withdrew consent|0|||
28022332|NCT00615030|54681358|FG000|Period III|Administrative problems|1|||
28022333|NCT00615030|54681359|FG001|Period III|Administrative problems|0|||
28022334|NCT00615030|54681360|FG002|Period III|Administrative problems|0|||
28022335|NCT00615030|54681361|FG003|Period III|Administrative problems|1|||
28022336|NCT00615030|54681362|FG004|Period III|Administrative problems|0|||
28022337|NCT00615030|54681363|FG005|Period III|Administrative problems|0|||
28022338|NCT00615030|54681364|FG006|Period III|Administrative problems|0|||
28022339|NCT00615030|54681365|FG007|Period III|Administrative problems|0|||
28022340|NCT00615030|54681366|FG008|Period III|Administrative problems|0|||
28022341|NCT00615030|54681367|FG009|Period III|Administrative problems|0|||
28022342|NCT00615030|54681368|FG010|Period III|Administrative problems|0|||
28022343|NCT00615030|54681369|FG011|Period III|Administrative problems|0|||
28022344|NCT00518284|54681387|FG000|Overall Study|Adverse Event|0|||
28022345|NCT00518284|54681388|FG001|Overall Study|Adverse Event|1|||
28022346|NCT00518284|54681389|FG002|Overall Study|Adverse Event|0|||
28022347|NCT00518284|54681390|FG003|Overall Study|Adverse Event|0|||
28022348|NCT00518284|54681387|FG000|Overall Study|Study Termination|0|||
28022349|NCT00518284|54681388|FG001|Overall Study|Study Termination|2|||
27800611|NCT02040428|54255366|FG001|Overall Study|Death|3|||
27800612|NCT02040428|54255365|FG000|Overall Study|Withdrawal by Subject|1|||
27800613|NCT02040428|54255366|FG001|Overall Study|Withdrawal by Subject|1|||
27800614|NCT02018822|54255374|FG000|Overall Study|filling replaced by crown|0|||
27800615|NCT02018822|54255375|FG001|Overall Study|filling replaced by crown|1|||
28022350|NCT00518284|54681389|FG002|Overall Study|Study Termination|1|||
28022351|NCT00518284|54681390|FG003|Overall Study|Study Termination|2|||
28022352|NCT00614874|54681400|FG000|Overall Study|Protocol Violation|1|||
28022353|NCT00614874|54681400|FG000|Overall Study|Withdrawal by Subject|1|||
27842815|NCT01532414|54331663|FG001|Overall Study|Withdrawn by sponsor|0|||
27800616|NCT02018822|54255376|FG002|Overall Study|filling replaced by crown|0|||
27800617|NCT02018822|54255374|FG000|Overall Study|Physician Decision|0|||
27800618|NCT02018822|54255375|FG001|Overall Study|Physician Decision|1|||
27800619|NCT02018822|54255376|FG002|Overall Study|Physician Decision|1|||
27800620|NCT02018822|54255374|FG000|Overall Study|Lost to Follow-up|6|||
27842816|NCT01532414|54331664|FG002|Overall Study|Withdrawn by sponsor|0|||
27842817|NCT01441973|54331674|FG000|Overall Study|Disease progression|8|||
27842818|NCT01441973|54331675|FG001|Overall Study|Disease progression|6|||
27842819|NCT01441973|54331674|FG000|Overall Study|Adverse event unrelated to study drug|3|||
28022354|NCT00727415|54681404|FG000|Phase I|Dose Limiting Toxicity|2|||
28022355|NCT00544557|54681408|FG000|Overall Study|Adverse Event|140|||
28022356|NCT00544557|54681408|FG000|Overall Study|Lack of Efficacy|196|||
28022357|NCT00544557|54681408|FG000|Overall Study|Other|98|||
28022358|NCT00727259|54681412|FG000|Overall Study|Not all questionnaires completed|1055|||
28022359|NCT00735371|54681421|FG000|Overall Study|Adverse Event|3|||
28022360|NCT00735371|54681422|FG001|Overall Study|Adverse Event|3|||
28022361|NCT00735371|54681423|FG002|Overall Study|Adverse Event|4|||
27800621|NCT02018822|54255375|FG001|Overall Study|Lost to Follow-up|6|||
27800622|NCT02018822|54255376|FG002|Overall Study|Lost to Follow-up|5|||
28022362|NCT00735371|54681424|FG003|Overall Study|Adverse Event|1|||
28022363|NCT00735371|54681421|FG000|Overall Study|Protocol Violation|2|||
27842820|NCT01441973|54331675|FG001|Overall Study|Adverse event unrelated to study drug|2|||
27842821|NCT01441973|54331674|FG000|Overall Study|Participant request to discontinue|1|||
27842822|NCT01441973|54331675|FG001|Overall Study|Participant request to discontinue|1|||
27842823|NCT01441973|54331674|FG000|Overall Study|Poor compliance/noncompliance|0|||
27842824|NCT01441973|54331675|FG001|Overall Study|Poor compliance/noncompliance|1|||
27842825|NCT01441973|54331674|FG000|Overall Study|Administrative reason by sponsor|3|||
27842826|NCT01441973|54331675|FG001|Overall Study|Administrative reason by sponsor|5|||
27842827|NCT01441973|54331674|FG000|Overall Study|Participant withdrew consent|0|||
27842828|NCT01441973|54331675|FG001|Overall Study|Participant withdrew consent|1|||
27842829|NCT01575899|54331694|FG000|Overall Study|Lost to Follow-up|3|||
27842830|NCT01575899|54331695|FG001|Overall Study|Lost to Follow-up|4|||
27842831|NCT01575899|54331696|FG002|Overall Study|Lost to Follow-up|2|||
27842832|NCT01575899|54331694|FG000|Overall Study|Protocol Violation|2|||
27842833|NCT01575899|54331695|FG001|Overall Study|Protocol Violation|1|||
27842834|NCT01575899|54331696|FG002|Overall Study|Protocol Violation|0|||
28022364|NCT00735371|54681422|FG001|Overall Study|Protocol Violation|2|||
28022365|NCT00735371|54681423|FG002|Overall Study|Protocol Violation|0|||
28022366|NCT00735371|54681424|FG003|Overall Study|Protocol Violation|3|||
27800623|NCT02055157|54255391|FG000|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
27800624|NCT02055157|54255392|FG001|Initial 6 Months|Subject discontinued due to NeedlePhobia|1|||
27800625|NCT02055157|54255393|FG002|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
27800626|NCT02055157|54255394|FG003|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
27800627|NCT02055157|54255391|FG000|Initial 6 Months|Adverse Event|0|||
27800628|NCT02055157|54255392|FG001|Initial 6 Months|Adverse Event|0|||
27800629|NCT02055157|54255393|FG002|Initial 6 Months|Adverse Event|0|||
27800630|NCT02055157|54255394|FG003|Initial 6 Months|Adverse Event|1|||
27800631|NCT02055157|54255391|FG000|Initial 6 Months|Consent withdrawn by subject|1|||
27800632|NCT02055157|54255392|FG001|Initial 6 Months|Consent withdrawn by subject|0|||
27800633|NCT02055157|54255393|FG002|Initial 6 Months|Consent withdrawn by subject|0|||
27800634|NCT02055157|54255394|FG003|Initial 6 Months|Consent withdrawn by subject|0|||
27800635|NCT02055157|54255391|FG000|18-month Extension|Investigator decision|0|||
27800636|NCT02055157|54255392|FG001|18-month Extension|Investigator decision|1|||
27800637|NCT02055157|54255393|FG002|18-month Extension|Investigator decision|0|||
27800638|NCT02055157|54255394|FG003|18-month Extension|Investigator decision|0|||
27800639|NCT02055157|54255391|FG000|18-month Extension|Subject discontinued due to NeedlePhobia|1|||
27800640|NCT02055157|54255392|FG001|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
27800641|NCT02055157|54255393|FG002|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
27800642|NCT02055157|54255394|FG003|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
27800643|NCT02022007|54255418|FG000|Overall Study|Withdrawal by Subject|1|||
27800644|NCT02022007|54255419|FG001|Overall Study|Withdrawal by Subject|1|||
27800645|NCT02022007|54255420|FG002|Overall Study|Withdrawal by Subject|1|||
27800646|NCT02022007|54255418|FG000|Overall Study|Noncompliant|0|||
27800647|NCT02022007|54255419|FG001|Overall Study|Noncompliant|0|||
27800648|NCT02022007|54255420|FG002|Overall Study|Noncompliant|1|||
27800649|NCT02031679|54255430|FG000|Overall Study|Protocol Violation|0|||
27800650|NCT02031679|54255431|FG001|Overall Study|Protocol Violation|1|||
27800651|NCT02031679|54255430|FG000|Overall Study|Lack of Efficacy|0|||
27800652|NCT02031679|54255431|FG001|Overall Study|Lack of Efficacy|1|||
27800653|NCT02053753|54255439|FG000|Overall Study|Withdrawal by Subject|2|||
27800654|NCT02053753|54255440|FG001|Overall Study|Withdrawal by Subject|4|||
28022367|NCT00735371|54681421|FG000|Overall Study|Withdrawal by Subject|0|||
28022368|NCT00735371|54681422|FG001|Overall Study|Withdrawal by Subject|2|||
28022369|NCT00735371|54681423|FG002|Overall Study|Withdrawal by Subject|2|||
27800655|NCT02053753|54255439|FG000|Overall Study|Decision by Sponsor|1|||
27800656|NCT02053753|54255440|FG001|Overall Study|Decision by Sponsor|1|||
27800657|NCT02053753|54255439|FG000|Overall Study|Lost to Follow-up|4|||
27800658|NCT02053753|54255440|FG001|Overall Study|Lost to Follow-up|3|||
27800659|NCT02019979|54255446|FG000|Overall Study|study terminated|14|||
27800660|NCT02019667|54255450|FG000|First Intervention (6 Months)|Adverse Event|0|||
27800661|NCT02019667|54255451|FG001|First Intervention (6 Months)|Adverse Event|1|||
27800662|NCT02019667|54255450|FG000|2nd Intervention (6 Months)|Adverse Event|0|||
28022370|NCT00735371|54681424|FG003|Overall Study|Withdrawal by Subject|0|||
28022371|NCT00735371|54681421|FG000|Overall Study|Lost to Follow-up|1|||
27800663|NCT02019667|54255451|FG001|2nd Intervention (6 Months)|Adverse Event|1|||
28022372|NCT00735371|54681422|FG001|Overall Study|Lost to Follow-up|1|||
28022373|NCT00735371|54681423|FG002|Overall Study|Lost to Follow-up|3|||
27800664|NCT02019667|54255450|FG000|2nd Intervention (6 Months)|Physician Decision|0|||
27800665|NCT02019667|54255451|FG001|2nd Intervention (6 Months)|Physician Decision|1|||
27800666|NCT02030821|54255463|FG000|Overall Study|Physician Decision|2|||
27800667|NCT02030821|54255464|FG001|Overall Study|Physician Decision|2|||
27800668|NCT02030821|54255465|FG002|Overall Study|Physician Decision|5|||
28022374|NCT00735371|54681424|FG003|Overall Study|Lost to Follow-up|1|||
28022375|NCT00735371|54681421|FG000|Overall Study|Lack of Efficacy|4|||
28022376|NCT00735371|54681422|FG001|Overall Study|Lack of Efficacy|2|||
27800669|NCT02030821|54255466|FG003|Overall Study|Physician Decision|2|||
28022377|NCT00735371|54681423|FG002|Overall Study|Lack of Efficacy|0|||
27800670|NCT02052739|54255478|FG000|Overall Study|Withdrew due to Adverse Event|3|||
27800671|NCT02052739|54255479|FG001|Overall Study|Withdrew due to Adverse Event|0|||
27800672|NCT02052739|54255478|FG000|Overall Study|Participant Died|2|||
27800673|NCT02052739|54255479|FG001|Overall Study|Participant Died|1|||
27800674|NCT02019277|54255487|FG000|Overall Study|Withdrawal by Subject|3|||
27800675|NCT02019277|54255487|FG000|Overall Study|Death|7|||
27800676|NCT02019277|54255487|FG000|Overall Study|Did no Cooperate|1|||
27800677|NCT02019277|54255487|FG000|Overall Study|Adverse Event|1|||
27800678|NCT02030119|54255495|FG000|Overall Study|Withdrawal by Subject|3|||
27800679|NCT02030119|54255496|FG001|Overall Study|Withdrawal by Subject|1|||
27800680|NCT02030119|54255497|FG002|Overall Study|Withdrawal by Subject|5|||
27800681|NCT02030119|54255498|FG003|Overall Study|Withdrawal by Subject|3|||
27800682|NCT02030119|54255495|FG000|Overall Study|Ineligible (see Pre-assignment Details)|0|||
27800683|NCT02030119|54255496|FG001|Overall Study|Ineligible (see Pre-assignment Details)|1|||
27800684|NCT02030119|54255497|FG002|Overall Study|Ineligible (see Pre-assignment Details)|1|||
27800685|NCT02030119|54255498|FG003|Overall Study|Ineligible (see Pre-assignment Details)|0|||
27800686|NCT01823835|54255523|FG000|Overall Study|Adverse Event|0|||
27800687|NCT01823835|54255524|FG001|Overall Study|Adverse Event|0|||
27800688|NCT01823835|54255525|FG002|Overall Study|Adverse Event|0|||
27800689|NCT01823835|54255526|FG003|Overall Study|Adverse Event|0|||
27800690|NCT01823835|54255527|FG004|Overall Study|Adverse Event|1|||
27800691|NCT01823835|54255528|FG005|Overall Study|Adverse Event|0|||
27800692|NCT01823835|54255529|FG006|Overall Study|Adverse Event|1|||
27800693|NCT01823835|54255530|FG007|Overall Study|Adverse Event|0|||
27800694|NCT01823835|54255531|FG008|Overall Study|Adverse Event|0|||
27800695|NCT01823835|54255532|FG009|Overall Study|Adverse Event|0|||
27800696|NCT01823835|54255533|FG010|Overall Study|Adverse Event|1|||
27800697|NCT01823835|54255534|FG011|Overall Study|Adverse Event|2|||
27800698|NCT01823835|54255535|FG012|Overall Study|Adverse Event|0|||
27800699|NCT01823835|54255536|FG013|Overall Study|Adverse Event|0|||
27800700|NCT01823835|54255537|FG014|Overall Study|Adverse Event|0|||
27800701|NCT01823835|54255523|FG000|Overall Study|Physician Decision|0|||
27800702|NCT01823835|54255524|FG001|Overall Study|Physician Decision|0|||
27800703|NCT01823835|54255525|FG002|Overall Study|Physician Decision|0|||
27800704|NCT01823835|54255526|FG003|Overall Study|Physician Decision|0|||
27800705|NCT01823835|54255527|FG004|Overall Study|Physician Decision|0|||
27800706|NCT01823835|54255528|FG005|Overall Study|Physician Decision|0|||
28022378|NCT00735371|54681424|FG003|Overall Study|Lack of Efficacy|4|||
28022379|NCT00735371|54681421|FG000|Overall Study|Sponsor Decision|3|||
28022380|NCT00735371|54681422|FG001|Overall Study|Sponsor Decision|1|||
28022381|NCT00735371|54681423|FG002|Overall Study|Sponsor Decision|0|||
28022382|NCT00735371|54681424|FG003|Overall Study|Sponsor Decision|1|||
28022383|NCT00735371|54681421|FG000|Overall Study|Protocol Violation|0|||
28022384|NCT00735371|54681422|FG001|Overall Study|Protocol Violation|1|||
28022385|NCT00735371|54681423|FG002|Overall Study|Protocol Violation|2|||
28022386|NCT00735371|54681424|FG003|Overall Study|Protocol Violation|0|||
28022387|NCT00735371|54681421|FG000|Overall Study|Prior Vyvanse Exposure|1|||
28022388|NCT00735371|54681422|FG001|Overall Study|Prior Vyvanse Exposure|1|||
28022389|NCT00735371|54681423|FG002|Overall Study|Prior Vyvanse Exposure|0|||
28022390|NCT00735371|54681424|FG003|Overall Study|Prior Vyvanse Exposure|0|||
28022391|NCT00735371|54681421|FG000|Overall Study|Exclusion criteria|1|||
28022392|NCT00735371|54681422|FG001|Overall Study|Exclusion criteria|0|||
28022393|NCT00735371|54681423|FG002|Overall Study|Exclusion criteria|0|||
28022394|NCT00735371|54681424|FG003|Overall Study|Exclusion criteria|0|||
28022395|NCT00518206|54681436|FG000|Overall Study|Disease Progression Requiring Therapy|6|||
28022396|NCT00518206|54681437|FG001|Overall Study|Disease Progression Requiring Therapy|6|||
28022397|NCT00518206|54681436|FG000|Overall Study|Withdrawal by Subject|2|||
28022398|NCT00518206|54681437|FG001|Overall Study|Withdrawal by Subject|0|||
28022399|NCT00518206|54681436|FG000|Overall Study|Drug Supply Issue|1|||
28022400|NCT00518206|54681437|FG001|Overall Study|Drug Supply Issue|0|||
28022401|NCT00518206|54681436|FG000|Overall Study|Reason Unknown|1|||
28022402|NCT00518206|54681437|FG001|Overall Study|Reason Unknown|0|||
28022403|NCT00518206|54681436|FG000|Overall Study|Completion Status Unknown|1|||
28022404|NCT00518206|54681437|FG001|Overall Study|Completion Status Unknown|0|||
27800707|NCT01823835|54255529|FG006|Overall Study|Physician Decision|0|||
28022405|NCT00586313|54681443|FG000|Overall Study|Lack of Efficacy|2|||
28022406|NCT00727025|54681447|FG000|Overall Study|Physician Decision|23|||
28022407|NCT00734747|54681455|FG000|SRS Procedure|No staples placed|3|||
27800708|NCT01823835|54255530|FG007|Overall Study|Physician Decision|0|||
27800709|NCT01823835|54255531|FG008|Overall Study|Physician Decision|0|||
27800710|NCT01823835|54255532|FG009|Overall Study|Physician Decision|0|||
27800711|NCT01823835|54255533|FG010|Overall Study|Physician Decision|0|||
27800712|NCT01823835|54255534|FG011|Overall Study|Physician Decision|2|||
27800713|NCT01823835|54255535|FG012|Overall Study|Physician Decision|0|||
28022408|NCT00734747|54681455|FG000|6 Month Follow-up|Did not meet inclusion criteria|3|||
28022409|NCT00726557|54681459|FG000|Overall Study|Screening failure|4|||
28022410|NCT00726557|54681459|FG000|Overall Study|No end of treatment documentation|37|||
28022411|NCT00726557|54681459|FG000|Overall Study|No follow-up documentation available|55|||
28022412|NCT00726557|54681459|FG000|Overall Study|Treatment less than 3 months|17|||
28022413|NCT00726557|54681459|FG000|Overall Study|Inclusion criteria not met|15|||
28022414|NCT00738881|54681466|FG000|Overall Study|Withdrawal by Subject|0|||
28022415|NCT00738881|54681467|FG001|Overall Study|Withdrawal by Subject|2|||
27938578|NCT00968968|54594701|FG001|Overall Study|Lost to Follow-up|1|||
27938579|NCT00973102|54594710|FG000|Overall Study|Protocol Violation|1|||
27938580|NCT00973102|54594711|FG001|Overall Study|Protocol Violation|0|||
27938581|NCT00973102|54594710|FG000|Overall Study|Prisoner|0|||
27938582|NCT00973102|54594711|FG001|Overall Study|Prisoner|1|||
27938583|NCT00901459|54594717|FG000|Overall Study|Withdrawal by Subject|6|||
27938584|NCT00896233|54594728|FG000|Overall Study|Claustrophobia during MRI|1|||
27938585|NCT00899431|54594753|FG000|Overall Study|Physician Decision|1|||
27938586|NCT00899431|54594754|FG001|Overall Study|Physician Decision|0|||
27938587|NCT00899431|54594755|FG002|Overall Study|Physician Decision|0|||
27938588|NCT00899353|54594766|FG000|Overall Study|Adverse Event|2|||
27938589|NCT00899353|54594766|FG000|Overall Study|Lost to Follow-up|1|||
27938590|NCT00899353|54594766|FG000|Overall Study|Withdrawal by Subject|2|||
27938591|NCT00898807|54594789|FG000|Overall Study|Withdrawal by Subject|5|||
27938592|NCT00898807|54594790|FG001|Overall Study|Withdrawal by Subject|3|||
27938593|NCT00898807|54594789|FG000|Overall Study|Family pressure to discontinue|2|||
27938594|NCT00898807|54594790|FG001|Overall Study|Family pressure to discontinue|2|||
27938595|NCT00898807|54594789|FG000|Overall Study|Lost to Follow-up|1|||
27938596|NCT00898807|54594790|FG001|Overall Study|Lost to Follow-up|3|||
27938597|NCT00898807|54594789|FG000|Overall Study|Death|0|||
27938598|NCT00898807|54594790|FG001|Overall Study|Death|1|||
27938599|NCT01229267|54594801|FG000|Overall Study|Adverse Event|4|||
27938600|NCT01229267|54594802|FG001|Overall Study|Adverse Event|6|||
27938601|NCT01229267|54594803|FG002|Overall Study|Adverse Event|3|||
27938602|NCT01229267|54594804|FG003|Overall Study|Adverse Event|2|||
27938603|NCT01229267|54594805|FG004|Overall Study|Adverse Event|10|||
27938604|NCT01229267|54594801|FG000|Overall Study|Death|40|||
27938605|NCT01229267|54594802|FG001|Overall Study|Death|37|||
27938606|NCT01229267|54594803|FG002|Overall Study|Death|35|||
28022416|NCT00657020|54681473|FG000|PERIOD 1|Adverse Event|0|||
28022417|NCT00657020|54681474|FG001|PERIOD 1|Adverse Event|1|||
28022418|NCT03921723|54681486|FG000|Period 2 (4 Days)|Withdrawal by Subject|3|||
28022419|NCT03921723|54681486|FG000|Period 3 (4 Days)|Withdrawal by Subject|1|||
28022420|NCT00544167|54681494|FG000|Overall Study|Adverse Event|21|||
28022421|NCT00544167|54681494|FG000|Overall Study|Physician Decision|8|||
28022422|NCT00659438|54681500|FG000|Overall Study|Withdrawal by Subject|2|||
28022423|NCT00659438|54681501|FG001|Overall Study|Withdrawal by Subject|2|||
28022424|NCT00659438|54681500|FG000|Overall Study|Death|11|||
28022425|NCT00659438|54681501|FG001|Overall Study|Death|6|||
28022426|NCT00659438|54681500|FG000|Overall Study|Lost to Follow-up|1|||
28022427|NCT00659438|54681501|FG001|Overall Study|Lost to Follow-up|0|||
28022428|NCT00543855|54681511|FG000|Overall Study|Adverse Event|3|||
28022429|NCT00543855|54681512|FG001|Overall Study|Adverse Event|1|||
28022430|NCT00543855|54681513|FG002|Overall Study|Adverse Event|3|||
28022431|NCT00543855|54681514|FG003|Overall Study|Adverse Event|4|||
28022432|NCT00543855|54681511|FG000|Overall Study|Lost to Follow-up|0|||
28022433|NCT00543855|54681512|FG001|Overall Study|Lost to Follow-up|0|||
28022434|NCT00543855|54681513|FG002|Overall Study|Lost to Follow-up|1|||
28022435|NCT00543855|54681514|FG003|Overall Study|Lost to Follow-up|0|||
28022436|NCT00543855|54681511|FG000|Overall Study|Withdrawal by Subject|0|||
28022437|NCT00543855|54681512|FG001|Overall Study|Withdrawal by Subject|1|||
28022438|NCT00543855|54681513|FG002|Overall Study|Withdrawal by Subject|2|||
28022439|NCT00543855|54681514|FG003|Overall Study|Withdrawal by Subject|0|||
28022440|NCT00543855|54681511|FG000|Overall Study|Protocol Violation|1|||
28022441|NCT00543855|54681512|FG001|Overall Study|Protocol Violation|0|||
28022442|NCT00543855|54681513|FG002|Overall Study|Protocol Violation|0|||
28022443|NCT00543855|54681514|FG003|Overall Study|Protocol Violation|0|||
28022444|NCT00656474|54681524|FG000|Overall Study|Other Reason|1|||
28022445|NCT00656084|54681529|FG000|Overall Study|Adverse Event|4|||
28022446|NCT00656084|54681529|FG000|Overall Study|Withdrawal by Subject|1|||
28022447|NCT00656084|54681529|FG000|Overall Study|Patient Request|1|||
28022448|NCT00656084|54681529|FG000|Overall Study|Investigator Request|1|||
28022449|NCT00613938|54681537|FG000|Overall Study|Withdrawal by Subject|2|||
28022450|NCT00613938|54681538|FG001|Overall Study|Withdrawal by Subject|4|||
28022451|NCT00613938|54681539|FG002|Overall Study|Withdrawal by Subject|9|||
28022452|NCT00613938|54681540|FG003|Overall Study|Withdrawal by Subject|9|||
28022453|NCT00613938|54681537|FG000|Overall Study|Adverse Event|1|||
28022454|NCT00613938|54681538|FG001|Overall Study|Adverse Event|4|||
28022455|NCT00613938|54681539|FG002|Overall Study|Adverse Event|8|||
28022456|NCT00613938|54681540|FG003|Overall Study|Adverse Event|5|||
28022457|NCT00613938|54681537|FG000|Overall Study|Lack of Efficacy|16|||
28022458|NCT00613938|54681538|FG001|Overall Study|Lack of Efficacy|18|||
28022459|NCT00613938|54681539|FG002|Overall Study|Lack of Efficacy|5|||
28022460|NCT00613938|54681540|FG003|Overall Study|Lack of Efficacy|9|||
28022461|NCT00613938|54681537|FG000|Overall Study|Other|1|||
28022462|NCT00613938|54681538|FG001|Overall Study|Other|2|||
28022463|NCT00613938|54681539|FG002|Overall Study|Other|1|||
28022464|NCT00613938|54681540|FG003|Overall Study|Other|3|||
28022465|NCT00655928|54681552|FG000|Overall Study|Withdrawal by Subject|2|||
28022466|NCT00655928|54681553|FG001|Overall Study|Withdrawal by Subject|1|||
28022467|NCT00655928|54681552|FG000|Overall Study|Physician Decision|1|||
28022468|NCT00655928|54681553|FG001|Overall Study|Physician Decision|1|||
28022469|NCT00655850|54681559|FG000|Overall Study|Death|2|||
28022470|NCT00655850|54681559|FG000|Overall Study|Withdrawal by Subject|1|||
27800714|NCT01823835|54255536|FG013|Overall Study|Physician Decision|0|||
28022471|NCT00726323|54681567|FG000|Overall Study|Withdrawal by Subject|3|||
28022472|NCT00726323|54681568|FG001|Overall Study|Withdrawal by Subject|1|||
28022473|NCT00726323|54681567|FG000|Overall Study|Physician Decision|1|||
28022474|NCT00726323|54681568|FG001|Overall Study|Physician Decision|0|||
28022475|NCT00726323|54681567|FG000|Overall Study|Progressive disease|23|||
28022476|NCT00726323|54681568|FG001|Overall Study|Progressive disease|16|||
28022477|NCT00726323|54681567|FG000|Overall Study|Clinical progression|0|||
28022478|NCT00726323|54681568|FG001|Overall Study|Clinical progression|3|||
28022479|NCT00726323|54681567|FG000|Overall Study|Adverse Event|9|||
28022480|NCT00726323|54681568|FG001|Overall Study|Adverse Event|9|||
28022481|NCT00726323|54681567|FG000|Overall Study|Death|1|||
28022482|NCT00726323|54681568|FG001|Overall Study|Death|0|||
28022483|NCT00726323|54681567|FG000|Overall Study|Participant wished to discontinue|0|||
28022484|NCT00726323|54681568|FG001|Overall Study|Participant wished to discontinue|1|||
28022485|NCT00726323|54681567|FG000|Overall Study|Metastatic lesions inferred cyst|0|||
28022486|NCT00726323|54681568|FG001|Overall Study|Metastatic lesions inferred cyst|1|||
28022487|NCT00246571|54681576|FG000|Overall Study|Adverse Event|7|||
28022488|NCT00246571|54681577|FG001|Overall Study|Adverse Event|0|||
28022489|NCT00246571|54681576|FG000|Overall Study|Protocol Violation|0|||
28022490|NCT00246571|54681577|FG001|Overall Study|Protocol Violation|1|||
28022491|NCT00246571|54681576|FG000|Overall Study|Withdrawal by Subject|2|||
28022492|NCT00246571|54681577|FG001|Overall Study|Withdrawal by Subject|3|||
28022493|NCT00246571|54681576|FG000|Overall Study|Lack of Efficacy|84|||
28022494|NCT00246571|54681577|FG001|Overall Study|Lack of Efficacy|21|||
28022495|NCT00246571|54681576|FG000|Overall Study|Death|17|||
28022496|NCT00246571|54681577|FG001|Overall Study|Death|3|||
28022497|NCT00246571|54681576|FG000|Overall Study|Sponsor|0|||
28022498|NCT00246571|54681577|FG001|Overall Study|Sponsor|1|||
28022499|NCT00246571|54681576|FG000|Overall Study|Did not meet entrance criteria|2|||
28022500|NCT00246571|54681577|FG001|Overall Study|Did not meet entrance criteria|1|||
28022501|NCT00246571|54681576|FG000|Overall Study|Laboratory abnormalities|1|||
28022502|NCT00246571|54681577|FG001|Overall Study|Laboratory abnormalities|0|||
28022503|NCT00246571|54681576|FG000|Overall Study|Crossover participants|0|||
28022504|NCT00246571|54681577|FG001|Overall Study|Crossover participants|74|||
28022505|NCT00734591|54681585|FG000|Screening for Prospective Period|Site did not participate|1604|||
28022506|NCT00734591|54681586|FG001|Screening for Prospective Period|Site did not participate|1488|||
28022507|NCT00734591|54681585|FG000|Screening for Prospective Period|Patient at partic. site not enrolled|913|||
28022508|NCT00734591|54681586|FG001|Screening for Prospective Period|Patient at partic. site not enrolled|803|||
28022509|NCT00734591|54681585|FG000|Prospective Period|Withdrawal by Subject|11|||
28022510|NCT00734591|54681586|FG001|Prospective Period|Withdrawal by Subject|9|||
28022511|NCT00734591|54681585|FG000|Prospective Period|Lost to Follow-up|37|||
28022512|NCT00734591|54681586|FG001|Prospective Period|Lost to Follow-up|33|||
28022513|NCT00734591|54681585|FG000|Prospective Period|Study Terminated|1|||
28022514|NCT00734591|54681586|FG001|Prospective Period|Study Terminated|0|||
28022515|NCT00734591|54681585|FG000|Prospective Period|Other|2|||
28022516|NCT00734591|54681586|FG001|Prospective Period|Other|2|||
28022517|NCT00569270|54681592|FG000|Period: First Intervention|Protocol Violation|0|||
28022518|NCT00569270|54681593|FG001|Period: First Intervention|Protocol Violation|1|||
28022519|NCT00545103|54681612|FG000|Overall Study|Lack of Efficacy|48|||
28022520|NCT00545103|54681613|FG001|Overall Study|Lack of Efficacy|45|||
28022521|NCT00545103|54681614|FG002|Overall Study|Lack of Efficacy|31|||
28022522|NCT00545103|54681615|FG003|Overall Study|Lack of Efficacy|27|||
28022523|NCT00545103|54681612|FG000|Overall Study|Withdrawal by Subject|6|||
28022524|NCT00545103|54681613|FG001|Overall Study|Withdrawal by Subject|10|||
28022525|NCT00545103|54681614|FG002|Overall Study|Withdrawal by Subject|18|||
28022526|NCT00545103|54681615|FG003|Overall Study|Withdrawal by Subject|22|||
28022527|NCT00545103|54681612|FG000|Overall Study|Adverse Event|11|||
28022528|NCT00545103|54681613|FG001|Overall Study|Adverse Event|12|||
28022529|NCT00545103|54681614|FG002|Overall Study|Adverse Event|17|||
28022530|NCT00545103|54681615|FG003|Overall Study|Adverse Event|10|||
28022531|NCT00545103|54681612|FG000|Overall Study|Lost to Follow-up|4|||
28022532|NCT00545103|54681613|FG001|Overall Study|Lost to Follow-up|6|||
28022533|NCT00545103|54681614|FG002|Overall Study|Lost to Follow-up|3|||
28022534|NCT00545103|54681615|FG003|Overall Study|Lost to Follow-up|4|||
28022535|NCT00545103|54681612|FG000|Overall Study|Protocol Violation|1|||
28022536|NCT00545103|54681613|FG001|Overall Study|Protocol Violation|2|||
28022537|NCT00545103|54681614|FG002|Overall Study|Protocol Violation|3|||
28022538|NCT00545103|54681615|FG003|Overall Study|Protocol Violation|0|||
28022539|NCT00545103|54681612|FG000|Overall Study|Suspected recurrence of diverticulitis|1|||
28022540|NCT00545103|54681613|FG001|Overall Study|Suspected recurrence of diverticulitis|0|||
28022541|NCT00545103|54681614|FG002|Overall Study|Suspected recurrence of diverticulitis|0|||
28022542|NCT00545103|54681615|FG003|Overall Study|Suspected recurrence of diverticulitis|3|||
28022543|NCT00545103|54681612|FG000|Overall Study|Difficult to open package|0|||
28022544|NCT00545103|54681613|FG001|Overall Study|Difficult to open package|0|||
28022545|NCT00545103|54681614|FG002|Overall Study|Difficult to open package|0|||
28022546|NCT00545103|54681615|FG003|Overall Study|Difficult to open package|1|||
28022547|NCT00545103|54681612|FG000|Overall Study|Investigational product not taken|1|||
28022548|NCT00545103|54681613|FG001|Overall Study|Investigational product not taken|0|||
28022549|NCT00545103|54681614|FG002|Overall Study|Investigational product not taken|0|||
28022550|NCT00545103|54681615|FG003|Overall Study|Investigational product not taken|1|||
28022551|NCT00545103|54681612|FG000|Overall Study|Wish to start a family|0|||
28022552|NCT00545103|54681613|FG001|Overall Study|Wish to start a family|0|||
28022553|NCT00545103|54681614|FG002|Overall Study|Wish to start a family|0|||
28022554|NCT00545103|54681615|FG003|Overall Study|Wish to start a family|1|||
28022555|NCT00545103|54681612|FG000|Overall Study|Diverticulitis crisis|0|||
28022556|NCT00545103|54681613|FG001|Overall Study|Diverticulitis crisis|0|||
28022557|NCT00545103|54681614|FG002|Overall Study|Diverticulitis crisis|0|||
28022558|NCT00545103|54681615|FG003|Overall Study|Diverticulitis crisis|1|||
28022559|NCT00545103|54681612|FG000|Overall Study|Personal reasons|1|||
28022560|NCT00545103|54681613|FG001|Overall Study|Personal reasons|0|||
28022561|NCT00545103|54681614|FG002|Overall Study|Personal reasons|0|||
28022562|NCT00545103|54681615|FG003|Overall Study|Personal reasons|0|||
28022563|NCT00545103|54681612|FG000|Overall Study|Subject's decision|1|||
28022564|NCT00545103|54681613|FG001|Overall Study|Subject's decision|0|||
28022565|NCT00545103|54681614|FG002|Overall Study|Subject's decision|0|||
28022566|NCT00545103|54681615|FG003|Overall Study|Subject's decision|0|||
28022567|NCT00545103|54681612|FG000|Overall Study|Noncompliance|0|||
28022568|NCT00545103|54681613|FG001|Overall Study|Noncompliance|1|||
28022569|NCT00545103|54681614|FG002|Overall Study|Noncompliance|0|||
28022570|NCT00545103|54681615|FG003|Overall Study|Noncompliance|0|||
28022571|NCT00545103|54681612|FG000|Overall Study|Investigator decision|0|||
28022572|NCT00545103|54681613|FG001|Overall Study|Investigator decision|0|||
28022573|NCT00545103|54681614|FG002|Overall Study|Investigator decision|1|||
28022574|NCT00545103|54681615|FG003|Overall Study|Investigator decision|0|||
28022575|NCT00545103|54681612|FG000|Overall Study|Subject moved|0|||
28022576|NCT00545103|54681613|FG001|Overall Study|Subject moved|1|||
28022577|NCT00545103|54681614|FG002|Overall Study|Subject moved|0|||
28022578|NCT00545103|54681615|FG003|Overall Study|Subject moved|0|||
28022579|NCT00545103|54681612|FG000|Overall Study|Use of prohibited medication|0|||
28022580|NCT00545103|54681613|FG001|Overall Study|Use of prohibited medication|0|||
28022581|NCT00545103|54681614|FG002|Overall Study|Use of prohibited medication|1|||
28022582|NCT00545103|54681615|FG003|Overall Study|Use of prohibited medication|0|||
28022583|NCT00545103|54681612|FG000|Overall Study|Does not want to take study drug anymore|1|||
28022584|NCT00545103|54681613|FG001|Overall Study|Does not want to take study drug anymore|0|||
28022585|NCT00545103|54681614|FG002|Overall Study|Does not want to take study drug anymore|1|||
28022586|NCT00545103|54681615|FG003|Overall Study|Does not want to take study drug anymore|0|||
28022587|NCT00545103|54681612|FG000|Overall Study|Subject met endpoint under protocol v. 1|0|||
28022588|NCT00545103|54681613|FG001|Overall Study|Subject met endpoint under protocol v. 1|0|||
28022589|NCT00545103|54681614|FG002|Overall Study|Subject met endpoint under protocol v. 1|1|||
28022590|NCT00545103|54681615|FG003|Overall Study|Subject met endpoint under protocol v. 1|0|||
28022591|NCT00545103|54681612|FG000|Overall Study|Death|0|||
28022592|NCT00545103|54681613|FG001|Overall Study|Death|1|||
28022593|NCT00545103|54681614|FG002|Overall Study|Death|0|||
28022594|NCT00545103|54681615|FG003|Overall Study|Death|0|||
28022595|NCT00586157|54681625|FG000|First Intervention|Worsening behavior|1|||
28022596|NCT00586157|54681626|FG001|First Intervention|Worsening behavior|0|||
28022597|NCT00586157|54681625|FG000|Second Intervention|Withdrawal by Subject|1|||
28022598|NCT00586157|54681626|FG001|Second Intervention|Withdrawal by Subject|0|||
28022599|NCT00586157|54681625|FG000|Second Intervention|Worsening behavior|1|||
28022600|NCT00586157|54681626|FG001|Second Intervention|Worsening behavior|0|||
28022601|NCT00586157|54681625|FG000|Second Intervention|Adverse Event|0|||
28022602|NCT00586157|54681626|FG001|Second Intervention|Adverse Event|1|||
28022603|NCT00246337|54681641|FG000|Overall Study|Lost to Follow-up|3|||
28022604|NCT00246337|54681642|FG001|Overall Study|Lost to Follow-up|0|||
28022605|NCT00246337|54681643|FG002|Overall Study|Lost to Follow-up|0|||
28022606|NCT00246337|54681644|FG003|Overall Study|Lost to Follow-up|0|||
28022607|NCT00246337|54681645|FG004|Overall Study|Lost to Follow-up|2|||
28022608|NCT00246337|54681646|FG005|Overall Study|Lost to Follow-up|2|||
28022609|NCT00246337|54681647|FG006|Overall Study|Lost to Follow-up|1|||
28022610|NCT00246337|54681648|FG007|Overall Study|Lost to Follow-up|2|||
28022611|NCT00246337|54681649|FG008|Overall Study|Lost to Follow-up|0|||
28022612|NCT00246337|54681641|FG000|Overall Study|Protocol Violation|1|||
28022613|NCT00246337|54681642|FG001|Overall Study|Protocol Violation|0|||
28022614|NCT00246337|54681643|FG002|Overall Study|Protocol Violation|0|||
28022615|NCT00246337|54681644|FG003|Overall Study|Protocol Violation|0|||
28022616|NCT00246337|54681645|FG004|Overall Study|Protocol Violation|1|||
28022617|NCT00246337|54681646|FG005|Overall Study|Protocol Violation|0|||
28022618|NCT00246337|54681647|FG006|Overall Study|Protocol Violation|1|||
28022619|NCT00246337|54681648|FG007|Overall Study|Protocol Violation|1|||
28022620|NCT00246337|54681649|FG008|Overall Study|Protocol Violation|0|||
28022621|NCT00246337|54681641|FG000|Overall Study|Withdrawal by Subject|2|||
28022622|NCT00246337|54681642|FG001|Overall Study|Withdrawal by Subject|0|||
28022623|NCT00246337|54681643|FG002|Overall Study|Withdrawal by Subject|0|||
28022624|NCT00246337|54681644|FG003|Overall Study|Withdrawal by Subject|0|||
28022625|NCT00246337|54681645|FG004|Overall Study|Withdrawal by Subject|0|||
28022626|NCT00246337|54681646|FG005|Overall Study|Withdrawal by Subject|0|||
28022627|NCT00246337|54681647|FG006|Overall Study|Withdrawal by Subject|1|||
28022628|NCT00246337|54681648|FG007|Overall Study|Withdrawal by Subject|1|||
28022629|NCT00246337|54681649|FG008|Overall Study|Withdrawal by Subject|0|||
28022630|NCT00246337|54681641|FG000|Overall Study|Lack of Qualifying Event|8|||
28022631|NCT00246337|54681642|FG001|Overall Study|Lack of Qualifying Event|2|||
28022632|NCT00246337|54681643|FG002|Overall Study|Lack of Qualifying Event|1|||
28022633|NCT00246337|54681644|FG003|Overall Study|Lack of Qualifying Event|1|||
28022634|NCT00246337|54681645|FG004|Overall Study|Lack of Qualifying Event|1|||
28022635|NCT00246337|54681646|FG005|Overall Study|Lack of Qualifying Event|3|||
28022636|NCT00246337|54681647|FG006|Overall Study|Lack of Qualifying Event|3|||
28022637|NCT00246337|54681648|FG007|Overall Study|Lack of Qualifying Event|2|||
28022638|NCT00246337|54681649|FG008|Overall Study|Lack of Qualifying Event|5|||
28022639|NCT00246337|54681641|FG000|Overall Study|Site Terminated|10|||
28022640|NCT00246337|54681642|FG001|Overall Study|Site Terminated|0|||
28022641|NCT00246337|54681643|FG002|Overall Study|Site Terminated|0|||
28022642|NCT00246337|54681644|FG003|Overall Study|Site Terminated|0|||
28022643|NCT00246337|54681645|FG004|Overall Study|Site Terminated|0|||
28022644|NCT00246337|54681646|FG005|Overall Study|Site Terminated|7|||
28022645|NCT00246337|54681647|FG006|Overall Study|Site Terminated|1|||
28022646|NCT00246337|54681648|FG007|Overall Study|Site Terminated|6|||
28022647|NCT00246337|54681649|FG008|Overall Study|Site Terminated|2|||
28022648|NCT00246337|54681641|FG000|Overall Study|Abnormal baseline lab values|7|||
28022649|NCT00246337|54681642|FG001|Overall Study|Abnormal baseline lab values|0|||
28022650|NCT00246337|54681643|FG002|Overall Study|Abnormal baseline lab values|2|||
28022651|NCT00246337|54681644|FG003|Overall Study|Abnormal baseline lab values|0|||
28022652|NCT00246337|54681645|FG004|Overall Study|Abnormal baseline lab values|0|||
28022653|NCT00246337|54681646|FG005|Overall Study|Abnormal baseline lab values|2|||
27800715|NCT01823835|54255537|FG014|Overall Study|Physician Decision|0|||
27800716|NCT01823835|54255523|FG000|Overall Study|Progressive Disease|3|||
27800717|NCT01823835|54255524|FG001|Overall Study|Progressive Disease|4|||
27800718|NCT01823835|54255525|FG002|Overall Study|Progressive Disease|3|||
27800719|NCT01823835|54255526|FG003|Overall Study|Progressive Disease|6|||
27800720|NCT01823835|54255527|FG004|Overall Study|Progressive Disease|4|||
27800721|NCT01823835|54255528|FG005|Overall Study|Progressive Disease|6|||
27800722|NCT01823835|54255529|FG006|Overall Study|Progressive Disease|5|||
27800723|NCT01823835|54255530|FG007|Overall Study|Progressive Disease|3|||
27800724|NCT01823835|54255531|FG008|Overall Study|Progressive Disease|3|||
27800725|NCT01823835|54255532|FG009|Overall Study|Progressive Disease|18|||
27800726|NCT01823835|54255533|FG010|Overall Study|Progressive Disease|8|||
27800727|NCT01823835|54255534|FG011|Overall Study|Progressive Disease|46|||
27800728|NCT01823835|54255535|FG012|Overall Study|Progressive Disease|18|||
27800729|NCT01823835|54255536|FG013|Overall Study|Progressive Disease|4|||
27800730|NCT01823835|54255537|FG014|Overall Study|Progressive Disease|6|||
27938607|NCT01229267|54594804|FG003|Overall Study|Death|13|||
28022654|NCT00246337|54681647|FG006|Overall Study|Abnormal baseline lab values|2|||
28022655|NCT00246337|54681648|FG007|Overall Study|Abnormal baseline lab values|0|||
28022656|NCT00246337|54681649|FG008|Overall Study|Abnormal baseline lab values|4|||
28022657|NCT00246337|54681641|FG000|Overall Study|Overwhelmed|0|||
28022658|NCT00246337|54681642|FG001|Overall Study|Overwhelmed|0|||
28022659|NCT00246337|54681643|FG002|Overall Study|Overwhelmed|0|||
28022660|NCT00246337|54681644|FG003|Overall Study|Overwhelmed|0|||
28022661|NCT00246337|54681645|FG004|Overall Study|Overwhelmed|0|||
28022662|NCT00246337|54681646|FG005|Overall Study|Overwhelmed|1|||
28022663|NCT00246337|54681647|FG006|Overall Study|Overwhelmed|0|||
28022664|NCT00246337|54681648|FG007|Overall Study|Overwhelmed|0|||
28022665|NCT00246337|54681649|FG008|Overall Study|Overwhelmed|0|||
28022666|NCT00246337|54681641|FG000|Overall Study|Protocol Violator|1|||
28022667|NCT00246337|54681642|FG001|Overall Study|Protocol Violator|0|||
28022668|NCT00246337|54681643|FG002|Overall Study|Protocol Violator|0|||
28022669|NCT00246337|54681644|FG003|Overall Study|Protocol Violator|0|||
28022670|NCT00246337|54681645|FG004|Overall Study|Protocol Violator|0|||
28022671|NCT00246337|54681646|FG005|Overall Study|Protocol Violator|0|||
28022672|NCT00246337|54681647|FG006|Overall Study|Protocol Violator|0|||
28022673|NCT00246337|54681648|FG007|Overall Study|Protocol Violator|0|||
28022674|NCT00246337|54681649|FG008|Overall Study|Protocol Violator|0|||
27938608|NCT01229267|54594805|FG004|Overall Study|Death|103|||
27938609|NCT01229267|54594801|FG000|Overall Study|Withdrawal by Subject|23|||
27938610|NCT01229267|54594802|FG001|Overall Study|Withdrawal by Subject|22|||
27938611|NCT01229267|54594803|FG002|Overall Study|Withdrawal by Subject|32|||
27938612|NCT01229267|54594804|FG003|Overall Study|Withdrawal by Subject|14|||
27938613|NCT01229267|54594805|FG004|Overall Study|Withdrawal by Subject|59|||
27938614|NCT01229267|54594801|FG000|Overall Study|Protocol Violation|0|||
27800731|NCT01823835|54255523|FG000|Overall Study|Study Termination|0|||
27800732|NCT01823835|54255524|FG001|Overall Study|Study Termination|0|||
27938615|NCT01229267|54594802|FG001|Overall Study|Protocol Violation|1|||
28022675|NCT00246337|54681641|FG000|Overall Study|Reported as completing trial in error|0|||
28022676|NCT00246337|54681642|FG001|Overall Study|Reported as completing trial in error|0|||
28022677|NCT00246337|54681643|FG002|Overall Study|Reported as completing trial in error|0|||
28022678|NCT00246337|54681644|FG003|Overall Study|Reported as completing trial in error|0|||
28022679|NCT00246337|54681645|FG004|Overall Study|Reported as completing trial in error|0|||
27800733|NCT01823835|54255525|FG002|Overall Study|Study Termination|0|||
27938616|NCT01229267|54594803|FG002|Overall Study|Protocol Violation|0|||
28022680|NCT00246337|54681646|FG005|Overall Study|Reported as completing trial in error|0|||
28022681|NCT00246337|54681647|FG006|Overall Study|Reported as completing trial in error|0|||
28022682|NCT00246337|54681648|FG007|Overall Study|Reported as completing trial in error|1|||
28022683|NCT00246337|54681649|FG008|Overall Study|Reported as completing trial in error|0|||
28022684|NCT00243919|54681672|FG000|Overall Study|Death|3|||
28022685|NCT00243919|54681673|FG001|Overall Study|Death|4|||
28022686|NCT00243919|54681674|FG002|Overall Study|Death|6|||
28022687|NCT00243919|54681672|FG000|Overall Study|Withdrawal by Subject|6|||
28022688|NCT00243919|54681673|FG001|Overall Study|Withdrawal by Subject|6|||
28022689|NCT00243919|54681674|FG002|Overall Study|Withdrawal by Subject|2|||
28022690|NCT00243919|54681672|FG000|Overall Study|Lost to Follow-up|6|||
28022691|NCT00243919|54681673|FG001|Overall Study|Lost to Follow-up|7|||
28022692|NCT00243919|54681674|FG002|Overall Study|Lost to Follow-up|3|||
28022693|NCT00243919|54681672|FG000|Overall Study|Administrative Error|1|||
28022694|NCT00243919|54681673|FG001|Overall Study|Administrative Error|0|||
28022695|NCT00243919|54681674|FG002|Overall Study|Administrative Error|0|||
28022696|NCT00243919|54681672|FG000|Overall Study|Physician Decision|1|||
28022697|NCT00243919|54681673|FG001|Overall Study|Physician Decision|1|||
28022698|NCT00243919|54681674|FG002|Overall Study|Physician Decision|0|||
27800734|NCT01823835|54255526|FG003|Overall Study|Study Termination|0|||
27800735|NCT01823835|54255527|FG004|Overall Study|Study Termination|1|||
27800736|NCT01823835|54255528|FG005|Overall Study|Study Termination|0|||
27800737|NCT01823835|54255529|FG006|Overall Study|Study Termination|0|||
27800738|NCT01823835|54255530|FG007|Overall Study|Study Termination|0|||
27800739|NCT01823835|54255531|FG008|Overall Study|Study Termination|0|||
27800740|NCT01823835|54255532|FG009|Overall Study|Study Termination|0|||
27800741|NCT01823835|54255533|FG010|Overall Study|Study Termination|0|||
27800742|NCT01823835|54255534|FG011|Overall Study|Study Termination|1|||
27800743|NCT01823835|54255535|FG012|Overall Study|Study Termination|0|||
27800744|NCT01823835|54255536|FG013|Overall Study|Study Termination|0|||
27800745|NCT01823835|54255537|FG014|Overall Study|Study Termination|0|||
27800746|NCT01823835|54255523|FG000|Overall Study|Withdrawal by Subject|0|||
27800747|NCT01823835|54255524|FG001|Overall Study|Withdrawal by Subject|0|||
27800748|NCT01823835|54255525|FG002|Overall Study|Withdrawal by Subject|1|||
27800749|NCT01823835|54255526|FG003|Overall Study|Withdrawal by Subject|0|||
27800750|NCT01823835|54255527|FG004|Overall Study|Withdrawal by Subject|0|||
27800751|NCT01823835|54255528|FG005|Overall Study|Withdrawal by Subject|0|||
27800752|NCT01823835|54255529|FG006|Overall Study|Withdrawal by Subject|0|||
27800753|NCT01823835|54255530|FG007|Overall Study|Withdrawal by Subject|0|||
28022699|NCT00725621|54681682|FG000|Overall Study|Adverse Event|25|||
28022700|NCT00725621|54681682|FG000|Overall Study|Lack of Efficacy|46|||
27800754|NCT01823835|54255531|FG008|Overall Study|Withdrawal by Subject|0|||
27800755|NCT01823835|54255532|FG009|Overall Study|Withdrawal by Subject|1|||
28022701|NCT00725621|54681682|FG000|Overall Study|Withdrawal by Subject|57|||
28022702|NCT00725621|54681682|FG000|Overall Study|Physician Decision|19|||
28022703|NCT00725621|54681682|FG000|Overall Study|Lost to Follow-up|52|||
28022704|NCT00725621|54681682|FG000|Overall Study|Non-compliance|8|||
28022705|NCT00725621|54681682|FG000|Overall Study|Continued treatment by other physician|6|||
28022706|NCT00725621|54681682|FG000|Overall Study|Switched to other study|1|||
28022707|NCT00725621|54681682|FG000|Overall Study|Switched to other drug|1|||
28022708|NCT00725621|54681682|FG000|Overall Study|Prepared for elective surgery|1|||
28022709|NCT00725621|54681682|FG000|Overall Study|Reason not specified|55|||
28022710|NCT00613626|54681693|FG000|Overall Study|Ineligible|0|||
28022711|NCT00613626|54681694|FG001|Overall Study|Ineligible|1|||
28022712|NCT00613626|54681695|FG002|Overall Study|Ineligible|0|||
28022713|NCT00725543|54681702|FG000|Overall Study|Adverse Event|10|||
28022714|NCT00725543|54681702|FG000|Overall Study|Lack of Efficacy|3|||
28022715|NCT00725543|54681702|FG000|Overall Study|Withdrawal by Subject|10|||
28022716|NCT00725543|54681702|FG000|Overall Study|Physician Decision|5|||
27800756|NCT01823835|54255533|FG010|Overall Study|Withdrawal by Subject|1|||
28022717|NCT00725543|54681702|FG000|Overall Study|Lost to Follow-up|4|||
28022718|NCT00725543|54681702|FG000|Overall Study|Non-compliance|2|||
28022719|NCT00725543|54681702|FG000|Overall Study|Other|119|||
28022720|NCT00239005|54681708|FG000|Overall Study|Adverse Event|6|||
28022721|NCT00239005|54681709|FG001|Overall Study|Adverse Event|6|||
28022722|NCT00239005|54681708|FG000|Overall Study|Withdrawal by Subject|3|||
27800757|NCT01823835|54255534|FG011|Overall Study|Withdrawal by Subject|2|||
27800758|NCT01823835|54255535|FG012|Overall Study|Withdrawal by Subject|1|||
27800759|NCT01823835|54255536|FG013|Overall Study|Withdrawal by Subject|0|||
28022723|NCT00239005|54681709|FG001|Overall Study|Withdrawal by Subject|4|||
28022724|NCT00239005|54681708|FG000|Overall Study|Unsatisfactory Therapeutic effect|2|||
28022725|NCT00239005|54681709|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
28022726|NCT00239005|54681708|FG000|Overall Study|Protocol Violation|1|||
28022727|NCT00239005|54681709|FG001|Overall Study|Protocol Violation|0|||
28022728|NCT00239005|54681708|FG000|Overall Study|Subj. cond. no longer needs study drug|0|||
28022729|NCT00239005|54681709|FG001|Overall Study|Subj. cond. no longer needs study drug|1|||
28022730|NCT00239005|54681708|FG000|Overall Study|Lost to Follow-up|0|||
27800760|NCT01823835|54255537|FG014|Overall Study|Withdrawal by Subject|0|||
28022731|NCT00239005|54681709|FG001|Overall Study|Lost to Follow-up|1|||
28022732|NCT00616434|54681717|FG000|Overall Study|Adverse Event|5|||
28022733|NCT00616434|54681718|FG001|Overall Study|Adverse Event|2|||
28022734|NCT00616434|54681717|FG000|Overall Study|Physician Decision|0|||
28022735|NCT00616434|54681718|FG001|Overall Study|Physician Decision|4|||
28022736|NCT00616434|54681717|FG000|Overall Study|Withdrawal by Subject|1|||
28022737|NCT00616434|54681718|FG001|Overall Study|Withdrawal by Subject|1|||
28022738|NCT00616434|54681717|FG000|Overall Study|Protocol deviation|0|||
28022739|NCT00616434|54681718|FG001|Overall Study|Protocol deviation|1|||
28022740|NCT00652340|54681726|FG000|Overall Study|Had not progressed.|4|||
28022741|NCT00652340|54681727|FG001|Overall Study|Had not progressed.|3|||
28022742|NCT00613314|54681733|FG000|Overall Study|Adverse Event|5|||
28022743|NCT00613314|54681733|FG000|Overall Study|Protocol Violation|14|||
28022744|NCT00613314|54681733|FG000|Overall Study|Lost to Follow-up|46|||
28022745|NCT00613314|54681733|FG000|Overall Study|Other reason not defined above|90|||
28022746|NCT00257725|54681737|FG000|Overall Study|Adverse Event|3|||
28022747|NCT00544869|54681745|FG000|Overall Study|Rsolution of congenitive symptoms|3|||
28022748|NCT00544869|54681746|FG001|Overall Study|Rsolution of congenitive symptoms|0|||
28022749|NCT00544869|54681747|FG002|Overall Study|Rsolution of congenitive symptoms|0|||
28022750|NCT00544869|54681745|FG000|Overall Study|Adverse Event|6|||
28022751|NCT00544869|54681746|FG001|Overall Study|Adverse Event|1|||
28022752|NCT00544869|54681747|FG002|Overall Study|Adverse Event|0|||
28022753|NCT00544869|54681745|FG000|Overall Study|Lack of Efficacy|1|||
28022754|NCT00544869|54681746|FG001|Overall Study|Lack of Efficacy|1|||
28022755|NCT00544869|54681747|FG002|Overall Study|Lack of Efficacy|0|||
28022756|NCT00544869|54681745|FG000|Overall Study|Physician Decision|2|||
28022757|NCT00544869|54681746|FG001|Overall Study|Physician Decision|0|||
28022758|NCT00544869|54681747|FG002|Overall Study|Physician Decision|0|||
28022759|NCT00725075|54681758|FG000|Overall Study|Use of Excluded Medication|0|||
27800761|NCT02173379|54255579|FG000|Overall Study|Lost to Follow-up|48|||
27800762|NCT02173379|54255580|FG001|Overall Study|Lost to Follow-up|34|||
27800763|NCT02173379|54255579|FG000|Overall Study|Withdrawal by Subject|14|||
27800764|NCT02173379|54255580|FG001|Overall Study|Withdrawal by Subject|17|||
27800765|NCT02173379|54255579|FG000|Overall Study|Physician Decision|7|||
27800766|NCT02173379|54255580|FG001|Overall Study|Physician Decision|4|||
27800767|NCT02173379|54255579|FG000|Overall Study|Death|22|||
27800768|NCT02173379|54255580|FG001|Overall Study|Death|22|||
27800769|NCT01823679|54255587|FG000|Overall Study|Death|1|||
27800770|NCT01823289|54255592|FG000|Overall Study|Lost to Follow-up|5|||
27800771|NCT01823289|54255592|FG000|Overall Study|Adverse Event|5|||
27800772|NCT01823289|54255592|FG000|Overall Study|Lack of Efficacy|1|||
27800773|NCT01823289|54255592|FG000|Overall Study|Physician Decision|9|||
27800774|NCT01823289|54255592|FG000|Overall Study|Administered contraindicated medicine|1|||
27800775|NCT01823289|54255592|FG000|Overall Study|Transaminase increased more than 3 times|1|||
27800776|NCT01823289|54255592|FG000|Overall Study|Drug affected efficacy and safety|1|||
28022760|NCT00725075|54681759|FG001|Overall Study|Use of Excluded Medication|1|||
28022761|NCT00725075|54681760|FG002|Overall Study|Use of Excluded Medication|0|||
28022762|NCT00725075|54681758|FG000|Overall Study|Protocol Violation|0|||
28022763|NCT00725075|54681759|FG001|Overall Study|Protocol Violation|0|||
27800777|NCT01823289|54255592|FG000|Overall Study|Creatinine clearance<30milliliter/minute|1|||
27800778|NCT01822899|54255598|FG000|Overall Study|Adverse Event|6|||
27800779|NCT01822899|54255599|FG001|Overall Study|Adverse Event|5|||
28022764|NCT00725075|54681760|FG002|Overall Study|Protocol Violation|1|||
28022765|NCT00725075|54681758|FG000|Overall Study|Lost to Follow-up|1|||
28022766|NCT00725075|54681759|FG001|Overall Study|Lost to Follow-up|0|||
28022767|NCT00725075|54681760|FG002|Overall Study|Lost to Follow-up|0|||
28022768|NCT00725075|54681758|FG000|Overall Study|Withdrawal by Subject|4|||
28022769|NCT00725075|54681759|FG001|Overall Study|Withdrawal by Subject|5|||
27800780|NCT01822899|54255598|FG000|Overall Study|Lack of Efficacy|6|||
27800781|NCT01822899|54255599|FG001|Overall Study|Lack of Efficacy|3|||
27800782|NCT01822899|54255598|FG000|Overall Study|Protocol Violation|6|||
28022770|NCT00725075|54681760|FG002|Overall Study|Withdrawal by Subject|4|||
28022771|NCT00725075|54681758|FG000|Overall Study|Adverse Event|2|||
28022772|NCT00725075|54681759|FG001|Overall Study|Adverse Event|1|||
28022773|NCT00725075|54681760|FG002|Overall Study|Adverse Event|1|||
28022774|NCT00725075|54681758|FG000|Overall Study|Worsening of Disease|2|||
28022775|NCT00725075|54681759|FG001|Overall Study|Worsening of Disease|1|||
28022776|NCT00725075|54681760|FG002|Overall Study|Worsening of Disease|2|||
28022777|NCT00725075|54681758|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
27800783|NCT01822899|54255599|FG001|Overall Study|Protocol Violation|3|||
27800784|NCT01822899|54255598|FG000|Overall Study|Lost to Follow-up|1|||
28022778|NCT00725075|54681759|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
28022779|NCT00725075|54681760|FG002|Overall Study|Inclusion/Exclusion Criteria|1|||
28022780|NCT00725075|54681758|FG000|Overall Study|Other|1|||
28022781|NCT00725075|54681759|FG001|Overall Study|Other|0|||
28022782|NCT00725075|54681760|FG002|Overall Study|Other|0|||
28022783|NCT00733499|54681770|FG000|Pre-operative|Protocol Violation|0|||
28022784|NCT00733499|54681771|FG001|Pre-operative|Protocol Violation|1|||
28022785|NCT00733499|54681770|FG000|3 Months Follow-up|Death|1|||
28022786|NCT00733499|54681771|FG001|3 Months Follow-up|Death|2|||
28022787|NCT00733499|54681770|FG000|6 Months Follow-up|Death|0|||
28022788|NCT00733499|54681771|FG001|6 Months Follow-up|Death|2|||
28022789|NCT00733499|54681770|FG000|6 Months Follow-up|Adverse Event|0|||
28022790|NCT00733499|54681771|FG001|6 Months Follow-up|Adverse Event|1|||
28022791|NCT00733499|54681770|FG000|12 Months Follow-up|Death|2|||
28022792|NCT00733499|54681771|FG001|12 Months Follow-up|Death|1|||
28022793|NCT00733499|54681770|FG000|24 Months Follow-up|Death|0|||
28022794|NCT00733499|54681771|FG001|24 Months Follow-up|Death|1|||
28022795|NCT00733499|54681770|FG000|5 Year Followup|Adverse Event|2|||
28022796|NCT00733499|54681771|FG001|5 Year Followup|Adverse Event|2|||
28022797|NCT00733499|54681770|FG000|5 Year Followup|Non device related AE|0|||
28022798|NCT00733499|54681771|FG001|5 Year Followup|Non device related AE|1|||
28022799|NCT00733499|54681770|FG000|5 Year Followup|Revision of Study Implant|0|||
28022800|NCT00733499|54681771|FG001|5 Year Followup|Revision of Study Implant|1|||
28022801|NCT00733499|54681770|FG000|5 Year Followup|Lost to Follow-up|2|||
28022802|NCT00733499|54681771|FG001|5 Year Followup|Lost to Follow-up|0|||
28022803|NCT00733499|54681770|FG000|5 Year Followup|Death|13|||
28022804|NCT00733499|54681771|FG001|5 Year Followup|Death|19|||
28022805|NCT00733499|54681770|FG000|5 Year Followup|missing, unable to locate|0|||
28022806|NCT00733499|54681771|FG001|5 Year Followup|missing, unable to locate|1|||
28022807|NCT00733499|54681770|FG000|5 Year Followup|Withdrawal by Subject|4|||
28022808|NCT00733499|54681771|FG001|5 Year Followup|Withdrawal by Subject|1|||
28022809|NCT00733499|54681770|FG000|10 Year Followup|Death|9|||
28022810|NCT00733499|54681771|FG001|10 Year Followup|Death|7|||
28022811|NCT00733499|54681770|FG000|10 Year Followup|Adverse Event|3|||
28022812|NCT00733499|54681771|FG001|10 Year Followup|Adverse Event|3|||
28022813|NCT00733499|54681770|FG000|10 Year Followup|Lost to Follow-up|3|||
28022814|NCT00733499|54681771|FG001|10 Year Followup|Lost to Follow-up|2|||
28022815|NCT00733499|54681770|FG000|10 Year Followup|Withdrawal by Subject|5|||
28022816|NCT00733499|54681771|FG001|10 Year Followup|Withdrawal by Subject|5|||
28022817|NCT00733499|54681770|FG000|10 Year Followup|missing, unable to locate|0|||
28022818|NCT00733499|54681771|FG001|10 Year Followup|missing, unable to locate|2|||
28022819|NCT00652028|54681781|FG000|Overall Study|Adverse Event|1|||
28022820|NCT00652028|54681782|FG001|Overall Study|Adverse Event|0|||
28022821|NCT00652028|54681783|FG002|Overall Study|Adverse Event|0|||
28022822|NCT00652028|54681784|FG003|Overall Study|Adverse Event|0|||
28022823|NCT00652028|54681781|FG000|Overall Study|No Longer Meets Entry Criteria|0|||
28022824|NCT00652028|54681782|FG001|Overall Study|No Longer Meets Entry Criteria|1|||
28022825|NCT00652028|54681783|FG002|Overall Study|No Longer Meets Entry Criteria|0|||
28022826|NCT00652028|54681784|FG003|Overall Study|No Longer Meets Entry Criteria|0|||
28022827|NCT00652028|54681781|FG000|Overall Study|Physician Decision|0|||
28022828|NCT00652028|54681782|FG001|Overall Study|Physician Decision|0|||
28022829|NCT00652028|54681783|FG002|Overall Study|Physician Decision|1|||
28022830|NCT00652028|54681784|FG003|Overall Study|Physician Decision|0|||
28022831|NCT00738101|54681794|FG000|Overall Study|Physician Decision|5|||
28022832|NCT00738101|54681794|FG000|Overall Study|Death|1|||
28022833|NCT00738101|54681794|FG000|Overall Study|Repeat enrollment|1|||
28022834|NCT00733421|54681800|FG000|Overall Study|Withdrawal by Subject|1|||
28022835|NCT00733421|54681801|FG001|Overall Study|Withdrawal by Subject|1|||
28022836|NCT00613080|54681807|FG000|Overall Study|Ineligible / no protocol treatment|11|||
28022837|NCT00732875|54681811|FG000|Overall Study|Adverse Event|16|||
28022838|NCT00732875|54681811|FG000|Overall Study|Withdrawal by Subject|6|||
28022839|NCT00732875|54681811|FG000|Overall Study|Lack of Efficacy|13|||
28022840|NCT00615264|54681821|FG000|Overall Study|Withdrawal by Subject|17|||
28022841|NCT00615264|54681822|FG001|Overall Study|Withdrawal by Subject|19|||
28022842|NCT00615264|54681821|FG000|Overall Study|Lost to Follow-up|6|||
28022843|NCT00615264|54681822|FG001|Overall Study|Lost to Follow-up|13|||
28022844|NCT00615264|54681821|FG000|Overall Study|Adverse Event|8|||
28022845|NCT00615264|54681822|FG001|Overall Study|Adverse Event|5|||
28022846|NCT00615264|54681821|FG000|Overall Study|Death|1|||
28022847|NCT00615264|54681822|FG001|Overall Study|Death|1|||
28022848|NCT00615264|54681821|FG000|Overall Study|Protocol Violation|11|||
28022849|NCT00615264|54681822|FG001|Overall Study|Protocol Violation|7|||
28022850|NCT00615264|54681821|FG000|Overall Study|Not defined|7|||
28022851|NCT00615264|54681822|FG001|Overall Study|Not defined|4|||
28022852|NCT00615264|54681821|FG000|Overall Study|Dermal Hypersensitivity|0|||
28022853|NCT00615264|54681822|FG001|Overall Study|Dermal Hypersensitivity|3|||
28022854|NCT00732641|54681830|FG000|Overall Study|Relapse or Progressive Disease|65|||
28022855|NCT00732641|54681831|FG001|Overall Study|Relapse or Progressive Disease|101|||
28022856|NCT00732641|54681830|FG000|Overall Study|Serious Adverse Events|12|||
28022857|NCT00732641|54681831|FG001|Overall Study|Serious Adverse Events|3|||
28022858|NCT00732641|54681830|FG000|Overall Study|Physician Decision|6|||
28022859|NCT00732641|54681831|FG001|Overall Study|Physician Decision|0|||
28022860|NCT00732641|54681830|FG000|Overall Study|Withdrawal by Subject|4|||
28022861|NCT00732641|54681831|FG001|Overall Study|Withdrawal by Subject|2|||
28022862|NCT00732641|54681830|FG000|Overall Study|Unable to Complete|1|||
28022863|NCT00732641|54681831|FG001|Overall Study|Unable to Complete|1|||
28022864|NCT00732641|54681830|FG000|Overall Study|Other|18|||
28022865|NCT00732641|54681831|FG001|Overall Study|Other|5|||
28022866|NCT00737711|54681837|FG000|Overall Study|Adverse Event|2|||
28022867|NCT00737711|54681837|FG000|Overall Study|Death|8|||
28022868|NCT00737711|54681837|FG000|Overall Study|Failure to return|4|||
28022869|NCT00737711|54681837|FG000|Overall Study|Protocol Violation|1|||
28022870|NCT00737711|54681837|FG000|Overall Study|Withdrawal by Subject|5|||
28022871|NCT00737711|54681837|FG000|Overall Study|Blood transfusion|6|||
28022872|NCT00737711|54681837|FG000|Overall Study|Other|5|||
28022873|NCT00615108|54681841|FG000|Overall Study|Adverse Event|122|||
28022874|NCT00615108|54681841|FG000|Overall Study|Other|370|||
28022875|NCT00615108|54681841|FG000|Overall Study|Lost to Follow-up|15|||
28022876|NCT00238303|54681850|FG000|Overall Study|Withdrawal by Subject|11|||
28022877|NCT00238303|54681851|FG001|Overall Study|Withdrawal by Subject|1|||
27800785|NCT01822899|54255599|FG001|Overall Study|Lost to Follow-up|0|||
27800786|NCT01822899|54255598|FG000|Overall Study|Withdrawal by Subject|5|||
27800787|NCT01822899|54255599|FG001|Overall Study|Withdrawal by Subject|7|||
27800788|NCT01822821|54255607|FG000|Overall Study|Eligible surgery cancelled|1|||
27800789|NCT01822821|54255608|FG001|Overall Study|Eligible surgery cancelled|1|||
27800790|NCT01822821|54255607|FG000|Overall Study|Other reasons|1|||
27800791|NCT01822821|54255608|FG001|Overall Study|Other reasons|0|||
27800792|NCT01822665|54255614|FG000|Overall Study|Adverse Event|3|||
27800793|NCT01822665|54255614|FG000|Overall Study|Other Reason|5|||
27800794|NCT02173301|54255636|FG000|Overall Study|Adverse Event|7|||
27800795|NCT02173301|54255637|FG001|Overall Study|Adverse Event|8|||
27800796|NCT02173301|54255638|FG002|Overall Study|Adverse Event|13|||
27800797|NCT02173301|54255639|FG003|Overall Study|Adverse Event|5|||
27800798|NCT02173301|54255636|FG000|Overall Study|Withdrawal by Subject|8|||
27800799|NCT02173301|54255637|FG001|Overall Study|Withdrawal by Subject|10|||
27800800|NCT02173301|54255638|FG002|Overall Study|Withdrawal by Subject|4|||
27800801|NCT02173301|54255639|FG003|Overall Study|Withdrawal by Subject|8|||
27800802|NCT02173301|54255636|FG000|Overall Study|Lost to Follow-up|4|||
27800803|NCT02173301|54255637|FG001|Overall Study|Lost to Follow-up|4|||
27800804|NCT02173301|54255638|FG002|Overall Study|Lost to Follow-up|2|||
27800805|NCT02173301|54255639|FG003|Overall Study|Lost to Follow-up|2|||
27800806|NCT02173301|54255636|FG000|Overall Study|Protocol Violation|0|||
27800807|NCT02173301|54255637|FG001|Overall Study|Protocol Violation|1|||
27800808|NCT02173301|54255638|FG002|Overall Study|Protocol Violation|0|||
27800809|NCT02173301|54255639|FG003|Overall Study|Protocol Violation|0|||
27800810|NCT02173301|54255636|FG000|Overall Study|Physician Decision|0|||
27800811|NCT02173301|54255637|FG001|Overall Study|Physician Decision|0|||
27800812|NCT02173301|54255638|FG002|Overall Study|Physician Decision|1|||
27800813|NCT02173301|54255639|FG003|Overall Study|Physician Decision|0|||
27800814|NCT02173301|54255636|FG000|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|1|||
27800815|NCT02173301|54255637|FG001|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
27800816|NCT02173301|54255638|FG002|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
27800817|NCT02173301|54255639|FG003|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
27800818|NCT01822587|54255652|FG000|Overall Study|Lost to Follow-up|7|||
27800819|NCT01822587|54255653|FG001|Overall Study|Lost to Follow-up|9|||
27800820|NCT01822587|54255654|FG002|Overall Study|Lost to Follow-up|12|||
27800821|NCT01822587|54255652|FG000|Overall Study|Physician Decision|9|||
27800822|NCT01822587|54255653|FG001|Overall Study|Physician Decision|6|||
27800823|NCT01822587|54255654|FG002|Overall Study|Physician Decision|6|||
27800824|NCT01822353|54255665|FG000|Overall Study|Adverse Event|1|||
28022878|NCT00238303|54681852|FG002|Overall Study|Withdrawal by Subject|2|||
28022879|NCT00238303|54681850|FG000|Overall Study|Death|1|||
28022880|NCT00238303|54681851|FG001|Overall Study|Death|0|||
28022881|NCT00238303|54681852|FG002|Overall Study|Death|1|||
27800825|NCT01822353|54255666|FG001|Overall Study|Adverse Event|3|||
27800826|NCT01822353|54255667|FG002|Overall Study|Adverse Event|1|||
27800827|NCT01822353|54255665|FG000|Overall Study|Pregnancy|0|||
27800828|NCT01822353|54255666|FG001|Overall Study|Pregnancy|1|||
27800829|NCT01822353|54255667|FG002|Overall Study|Pregnancy|0|||
27800830|NCT01822353|54255665|FG000|Overall Study|Withdrawal by Subject|3|||
27800831|NCT01822353|54255666|FG001|Overall Study|Withdrawal by Subject|1|||
27800832|NCT01822353|54255667|FG002|Overall Study|Withdrawal by Subject|0|||
27800833|NCT01821963|54255678|FG000|Overall Study|Adverse Event|1|||
28022882|NCT00238303|54681850|FG000|Overall Study|Other Medical Problems|2|||
28022883|NCT00238303|54681851|FG001|Overall Study|Other Medical Problems|0|||
28022884|NCT00238303|54681852|FG002|Overall Study|Other Medical Problems|2|||
28022885|NCT00238303|54681850|FG000|Overall Study|Poor tolerance of study treatment|1|||
28022886|NCT00238303|54681851|FG001|Overall Study|Poor tolerance of study treatment|0|||
28022887|NCT00238303|54681852|FG002|Overall Study|Poor tolerance of study treatment|1|||
28022888|NCT00238303|54681850|FG000|Overall Study|Adverse Event|0|||
28022889|NCT00238303|54681851|FG001|Overall Study|Adverse Event|1|||
28022890|NCT00238303|54681852|FG002|Overall Study|Adverse Event|3|||
28022891|NCT00737633|54681863|FG000|Overall Study|Study terminated by sponsor|44|||
28022892|NCT00737633|54681864|FG001|Overall Study|Study terminated by sponsor|55|||
28022893|NCT00737633|54681863|FG000|Overall Study|Lost to Follow-up|0|||
28022894|NCT00737633|54681864|FG001|Overall Study|Lost to Follow-up|1|||
28022895|NCT00737633|54681863|FG000|Overall Study|protocol non-compliance|0|||
28022896|NCT00737633|54681864|FG001|Overall Study|protocol non-compliance|1|||
28022897|NCT00732251|54681870|FG000|Overall Study|Lost to Follow-up|3|||
28022898|NCT00732251|54681870|FG000|Overall Study|Withdrawal by Subject|3|||
28022899|NCT00732251|54681870|FG000|Overall Study|Early Term due to Site Closure|1|||
28022900|NCT00737477|54681874|FG000|Overall Study|Adverse Event|9|||
28022901|NCT00737477|54681874|FG000|Overall Study|Death|9|||
28022902|NCT00737477|54681874|FG000|Overall Study|Treatment Refusal|1|||
28022903|NCT00737477|54681874|FG000|Overall Study|Withdrawal by Subject|1|||
28022904|NCT00737477|54681874|FG000|Overall Study|Renal Transplantation|10|||
28022905|NCT00737477|54681874|FG000|Overall Study|Other|4|||
28022906|NCT00256867|54681886|FG000|Overall Study|Adverse Event|0|||
28022907|NCT00256867|54681887|FG001|Overall Study|Adverse Event|1|||
28022908|NCT00256867|54681888|FG002|Overall Study|Adverse Event|1|||
28022909|NCT00256867|54681889|FG003|Overall Study|Adverse Event|1|||
28022910|NCT00256867|54681890|FG004|Overall Study|Adverse Event|2|||
28022911|NCT00256867|54681891|FG005|Overall Study|Adverse Event|2|||
28022912|NCT00256867|54681892|FG006|Overall Study|Adverse Event|1|||
28022913|NCT00256867|54681893|FG007|Overall Study|Adverse Event|4|||
28022914|NCT00256867|54681886|FG000|Overall Study|Lost to Follow-up|2|||
28022915|NCT00256867|54681887|FG001|Overall Study|Lost to Follow-up|2|||
28022916|NCT00256867|54681888|FG002|Overall Study|Lost to Follow-up|2|||
28022917|NCT00256867|54681889|FG003|Overall Study|Lost to Follow-up|3|||
28022918|NCT00256867|54681890|FG004|Overall Study|Lost to Follow-up|2|||
28022919|NCT00256867|54681891|FG005|Overall Study|Lost to Follow-up|0|||
28022920|NCT00256867|54681892|FG006|Overall Study|Lost to Follow-up|1|||
28022921|NCT00256867|54681893|FG007|Overall Study|Lost to Follow-up|2|||
28022922|NCT00256867|54681886|FG000|Overall Study|Protocol Violation|0|||
28022923|NCT00256867|54681887|FG001|Overall Study|Protocol Violation|0|||
28022924|NCT00256867|54681888|FG002|Overall Study|Protocol Violation|0|||
27800834|NCT01821807|54255684|FG000|Overall Study|Lost to Follow-up|3|||
27800835|NCT01821807|54255685|FG001|Overall Study|Lost to Follow-up|1|||
27800836|NCT01821729|54255691|FG000|Overall Study|Withdrawal by Subject|1|||
27800837|NCT01820637|54255695|FG000|Overall Study|Death|2|||
27800838|NCT01820637|54255695|FG000|Overall Study|Withdrawal by Subject|1|||
27800839|NCT02172911|54255701|FG000|Overall Study|Serious Adverse Event|0|||
27800840|NCT02172911|54255702|FG001|Overall Study|Serious Adverse Event|1|||
27800841|NCT02172911|54255701|FG000|Overall Study|Progression of Disease|0|||
27800842|NCT02172911|54255702|FG001|Overall Study|Progression of Disease|1|||
27800843|NCT02172911|54255701|FG000|Overall Study|Loss of insurance coverage|1|||
27800844|NCT02172911|54255702|FG001|Overall Study|Loss of insurance coverage|0|||
27800845|NCT02120027|54255710|FG000|Overall Study|Adverse Event|4|||
27800846|NCT02120027|54255711|FG001|Overall Study|Adverse Event|5|||
27800847|NCT02120027|54255710|FG000|Overall Study|Lack of Efficacy|3|||
27800848|NCT02120027|54255711|FG001|Overall Study|Lack of Efficacy|5|||
27800849|NCT02120027|54255710|FG000|Overall Study|Lost to Follow-up|5|||
27800850|NCT02120027|54255711|FG001|Overall Study|Lost to Follow-up|13|||
27800851|NCT02120027|54255710|FG000|Overall Study|Other|4|||
27800852|NCT02120027|54255711|FG001|Overall Study|Other|0|||
27800853|NCT02120027|54255710|FG000|Overall Study|Physician Decision|4|||
27800854|NCT02120027|54255711|FG001|Overall Study|Physician Decision|3|||
27800855|NCT02120027|54255710|FG000|Overall Study|Protocol Violation|18|||
27800856|NCT02120027|54255711|FG001|Overall Study|Protocol Violation|21|||
27800857|NCT02120027|54255710|FG000|Overall Study|Study terminated by Sponsor|45|||
27800858|NCT02120027|54255711|FG001|Overall Study|Study terminated by Sponsor|47|||
27800859|NCT02120027|54255710|FG000|Overall Study|Withdrawal by Subject|33|||
27800860|NCT02120027|54255711|FG001|Overall Study|Withdrawal by Subject|25|||
27800861|NCT01850823|54255720|FG000|Overall Study|Early Visit Window|0|||
27800862|NCT01850823|54255721|FG001|Overall Study|Early Visit Window|1|||
27800863|NCT01850823|54255722|FG002|Overall Study|Early Visit Window|4|||
27800864|NCT01850823|54255720|FG000|Overall Study|Enrolled in Error|0|||
27800865|NCT01850823|54255721|FG001|Overall Study|Enrolled in Error|1|||
27800866|NCT01850823|54255722|FG002|Overall Study|Enrolled in Error|2|||
27800867|NCT01850823|54255720|FG000|Overall Study|Lack of Efficacy|1|||
27800868|NCT01850823|54255721|FG001|Overall Study|Lack of Efficacy|0|||
27800869|NCT01850823|54255722|FG002|Overall Study|Lack of Efficacy|0|||
27800870|NCT01850823|54255720|FG000|Overall Study|Lost to Follow-up|0|||
27800871|NCT01850823|54255721|FG001|Overall Study|Lost to Follow-up|0|||
27800872|NCT01850823|54255722|FG002|Overall Study|Lost to Follow-up|1|||
27800873|NCT01850823|54255720|FG000|Overall Study|Restricted Medication|0|||
27800874|NCT01850823|54255721|FG001|Overall Study|Restricted Medication|0|||
27800875|NCT01850823|54255722|FG002|Overall Study|Restricted Medication|2|||
27800876|NCT01850823|54255720|FG000|Overall Study|Significant worstening of SAR|0|||
27800877|NCT01850823|54255721|FG001|Overall Study|Significant worstening of SAR|1|||
27800878|NCT01850823|54255722|FG002|Overall Study|Significant worstening of SAR|0|||
27800879|NCT01850823|54255720|FG000|Overall Study|Withdrawal by Subject|2|||
27800880|NCT01850823|54255721|FG001|Overall Study|Withdrawal by Subject|0|||
27800881|NCT01850823|54255722|FG002|Overall Study|Withdrawal by Subject|1|||
27800882|NCT01820559|54255735|FG000|Overall Study|Adverse Event|4|||
27800883|NCT01820559|54255736|FG001|Overall Study|Adverse Event|6|||
27800884|NCT01820559|54255737|FG002|Overall Study|Adverse Event|13|||
27800885|NCT01820559|54255735|FG000|Overall Study|Withdrawal by Subject|1|||
27800886|NCT01820559|54255736|FG001|Overall Study|Withdrawal by Subject|2|||
27800887|NCT01820559|54255737|FG002|Overall Study|Withdrawal by Subject|5|||
27800888|NCT01820559|54255735|FG000|Overall Study|Protocol Violation|2|||
27800889|NCT01820559|54255736|FG001|Overall Study|Protocol Violation|1|||
27800890|NCT01820559|54255737|FG002|Overall Study|Protocol Violation|3|||
27800891|NCT01820559|54255735|FG000|Overall Study|Subject's non-compliance|1|||
27800892|NCT01820559|54255736|FG001|Overall Study|Subject's non-compliance|0|||
27800893|NCT01820559|54255737|FG002|Overall Study|Subject's non-compliance|2|||
27800894|NCT01820559|54255735|FG000|Overall Study|Lost to Follow-up|3|||
27800895|NCT01820559|54255736|FG001|Overall Study|Lost to Follow-up|2|||
27800896|NCT01820559|54255737|FG002|Overall Study|Lost to Follow-up|2|||
27800897|NCT01820559|54255735|FG000|Overall Study|At sponsor request|0|||
28022925|NCT00256867|54681889|FG003|Overall Study|Protocol Violation|1|||
28022926|NCT00256867|54681890|FG004|Overall Study|Protocol Violation|0|||
28022927|NCT00256867|54681891|FG005|Overall Study|Protocol Violation|1|||
27800898|NCT01820559|54255736|FG001|Overall Study|At sponsor request|0|||
28022928|NCT00256867|54681892|FG006|Overall Study|Protocol Violation|0|||
27800899|NCT01820559|54255737|FG002|Overall Study|At sponsor request|1|||
27800900|NCT01820559|54255735|FG000|Overall Study|Lack of Efficacy|3|||
27800901|NCT01820559|54255736|FG001|Overall Study|Lack of Efficacy|2|||
28022929|NCT00256867|54681893|FG007|Overall Study|Protocol Violation|1|||
27800902|NCT01820559|54255737|FG002|Overall Study|Lack of Efficacy|3|||
27800903|NCT01818765|54255745|FG000|Overall Study|Death|2|||
27800904|NCT01850589|54255752|FG000|Overall Study|Withdrawal by Subject|8|||
27800905|NCT01850589|54255753|FG001|Overall Study|Withdrawal by Subject|0|||
27800906|NCT01818531|54255761|FG000|Overall Study|Withdrawn for case delay after block|1|||
28022930|NCT00256867|54681886|FG000|Overall Study|Withdrawal by Subject|0|||
28022931|NCT00256867|54681887|FG001|Overall Study|Withdrawal by Subject|0|||
28022932|NCT00256867|54681888|FG002|Overall Study|Withdrawal by Subject|1|||
28022933|NCT00256867|54681889|FG003|Overall Study|Withdrawal by Subject|1|||
28022934|NCT00256867|54681890|FG004|Overall Study|Withdrawal by Subject|2|||
28022935|NCT00256867|54681891|FG005|Overall Study|Withdrawal by Subject|2|||
28022936|NCT00256867|54681892|FG006|Overall Study|Withdrawal by Subject|3|||
28022937|NCT00256867|54681893|FG007|Overall Study|Withdrawal by Subject|2|||
28022938|NCT00256867|54681886|FG000|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
28022939|NCT00256867|54681887|FG001|Overall Study|Fasting plasma glucose >240 mg/dL|1|||
28022940|NCT00256867|54681888|FG002|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
28022941|NCT00256867|54681889|FG003|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
28022942|NCT00256867|54681890|FG004|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
28022943|NCT00256867|54681891|FG005|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
28022944|NCT00256867|54681892|FG006|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
28022945|NCT00256867|54681893|FG007|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
28022946|NCT00256867|54681886|FG000|Overall Study|Glycemia over 13.3 millimole per litre|0|||
28022947|NCT00256867|54681887|FG001|Overall Study|Glycemia over 13.3 millimole per litre|0|||
28022948|NCT00256867|54681888|FG002|Overall Study|Glycemia over 13.3 millimole per litre|0|||
28022949|NCT00256867|54681889|FG003|Overall Study|Glycemia over 13.3 millimole per litre|0|||
28022950|NCT00256867|54681890|FG004|Overall Study|Glycemia over 13.3 millimole per litre|0|||
28022951|NCT00256867|54681891|FG005|Overall Study|Glycemia over 13.3 millimole per litre|0|||
28022952|NCT00256867|54681892|FG006|Overall Study|Glycemia over 13.3 millimole per litre|0|||
28022953|NCT00256867|54681893|FG007|Overall Study|Glycemia over 13.3 millimole per litre|1|||
27938617|NCT01229267|54594804|FG003|Overall Study|Protocol Violation|0|||
27938618|NCT01229267|54594805|FG004|Overall Study|Protocol Violation|0|||
27938619|NCT01229267|54594801|FG000|Overall Study|Progressive disease|0|||
27938620|NCT01229267|54594802|FG001|Overall Study|Progressive disease|0|||
27938621|NCT01229267|54594803|FG002|Overall Study|Progressive disease|0|||
27938622|NCT01229267|54594804|FG003|Overall Study|Progressive disease|0|||
28022954|NCT00256867|54681886|FG000|Overall Study|Investigator's Decision|0|||
28022955|NCT00256867|54681887|FG001|Overall Study|Investigator's Decision|0|||
28022956|NCT00256867|54681888|FG002|Overall Study|Investigator's Decision|0|||
28022957|NCT00256867|54681889|FG003|Overall Study|Investigator's Decision|0|||
28022958|NCT00256867|54681890|FG004|Overall Study|Investigator's Decision|1|||
28022959|NCT00256867|54681891|FG005|Overall Study|Investigator's Decision|0|||
28022960|NCT00256867|54681892|FG006|Overall Study|Investigator's Decision|0|||
28022961|NCT00256867|54681893|FG007|Overall Study|Investigator's Decision|0|||
28022962|NCT00256867|54681886|FG000|Overall Study|Non-compliance with study medication|0|||
28022963|NCT00256867|54681887|FG001|Overall Study|Non-compliance with study medication|0|||
28022964|NCT00256867|54681888|FG002|Overall Study|Non-compliance with study medication|0|||
28022965|NCT00256867|54681889|FG003|Overall Study|Non-compliance with study medication|0|||
28022966|NCT00256867|54681890|FG004|Overall Study|Non-compliance with study medication|0|||
28022967|NCT00256867|54681891|FG005|Overall Study|Non-compliance with study medication|0|||
28022968|NCT00256867|54681892|FG006|Overall Study|Non-compliance with study medication|0|||
28022969|NCT00256867|54681893|FG007|Overall Study|Non-compliance with study medication|1|||
28022970|NCT00256867|54681886|FG000|Overall Study|Participant travelled Overseas|0|||
28022971|NCT00256867|54681887|FG001|Overall Study|Participant travelled Overseas|1|||
28022972|NCT00256867|54681888|FG002|Overall Study|Participant travelled Overseas|0|||
28022973|NCT00256867|54681889|FG003|Overall Study|Participant travelled Overseas|0|||
27800907|NCT01818531|54255762|FG001|Overall Study|Withdrawn for case delay after block|0|||
27800908|NCT01818531|54255761|FG000|Overall Study|Withdrawn for long-acting opioid patch|0|||
27938623|NCT01229267|54594805|FG004|Overall Study|Progressive disease|1|||
27938624|NCT01229267|54594801|FG000|Overall Study|Physician Decision|8|||
27938625|NCT01229267|54594802|FG001|Overall Study|Physician Decision|11|||
27938626|NCT01229267|54594803|FG002|Overall Study|Physician Decision|8|||
27938627|NCT01229267|54594804|FG003|Overall Study|Physician Decision|3|||
27938628|NCT01229267|54594805|FG004|Overall Study|Physician Decision|25|||
27938629|NCT01229267|54594801|FG000|Overall Study|Lost to Follow-up|6|||
27938630|NCT01229267|54594802|FG001|Overall Study|Lost to Follow-up|5|||
27938631|NCT01229267|54594803|FG002|Overall Study|Lost to Follow-up|8|||
27938632|NCT01229267|54594804|FG003|Overall Study|Lost to Follow-up|3|||
27938633|NCT01229267|54594805|FG004|Overall Study|Lost to Follow-up|22|||
27938634|NCT00897715|54594814|FG000|Overall Study|Lost to Follow-up|0|||
27938635|NCT00897715|54594815|FG001|Overall Study|Lost to Follow-up|1|||
27938636|NCT00897715|54594814|FG000|Overall Study|Physician Decision|1|||
27938637|NCT00897715|54594815|FG001|Overall Study|Physician Decision|0|||
27800909|NCT01818531|54255762|FG001|Overall Study|Withdrawn for long-acting opioid patch|1|||
28022974|NCT00256867|54681890|FG004|Overall Study|Participant travelled Overseas|0|||
28022975|NCT00256867|54681891|FG005|Overall Study|Participant travelled Overseas|0|||
28022976|NCT00256867|54681892|FG006|Overall Study|Participant travelled Overseas|0|||
28022977|NCT00256867|54681893|FG007|Overall Study|Participant travelled Overseas|0|||
28022978|NCT00256867|54681886|FG000|Overall Study|Participant out of assessment window|0|||
28022979|NCT00256867|54681887|FG001|Overall Study|Participant out of assessment window|0|||
28022980|NCT00256867|54681888|FG002|Overall Study|Participant out of assessment window|1|||
28022981|NCT00256867|54681889|FG003|Overall Study|Participant out of assessment window|0|||
28022982|NCT00256867|54681890|FG004|Overall Study|Participant out of assessment window|0|||
28022983|NCT00256867|54681891|FG005|Overall Study|Participant out of assessment window|0|||
28022984|NCT00256867|54681892|FG006|Overall Study|Participant out of assessment window|0|||
28022985|NCT00256867|54681893|FG007|Overall Study|Participant out of assessment window|0|||
28022986|NCT00256867|54681886|FG000|Overall Study|Withdrawal by participant|0|||
28022987|NCT00256867|54681887|FG001|Overall Study|Withdrawal by participant|0|||
28022988|NCT00256867|54681888|FG002|Overall Study|Withdrawal by participant|0|||
28022989|NCT00256867|54681889|FG003|Overall Study|Withdrawal by participant|0|||
28022990|NCT00256867|54681890|FG004|Overall Study|Withdrawal by participant|0|||
28022991|NCT00256867|54681891|FG005|Overall Study|Withdrawal by participant|1|||
28022992|NCT00256867|54681892|FG006|Overall Study|Withdrawal by participant|0|||
28022993|NCT00256867|54681893|FG007|Overall Study|Withdrawal by participant|0|||
28022994|NCT00731939|54681916|FG000|Overall Study|Adverse Event|6|||
28022995|NCT00731939|54681916|FG000|Overall Study|Lost to Follow-up|15|||
28022996|NCT00731939|54681916|FG000|Overall Study|Not implanted with study device|9|||
28022997|NCT00731939|54681916|FG000|Overall Study|Withdrawal by Subject|2|||
28022998|NCT00731939|54681916|FG000|Overall Study|Did not meet enrollment criteria|2|||
28022999|NCT00731783|54681922|FG000|One Month Follow-Up Visit|Lost to Follow-up|14|||
28023000|NCT00731783|54681923|FG001|One Month Follow-Up Visit|Lost to Follow-up|22|||
28023001|NCT00731783|54681922|FG000|Three Month Follow-Up Visit|Lost to Follow-up|7|||
28023002|NCT00731783|54681923|FG001|Three Month Follow-Up Visit|Lost to Follow-up|16|||
28023003|NCT00731783|54681922|FG000|Six Month Follow-Up Visit|Lost to Follow-up|6|||
28023004|NCT00731783|54681923|FG001|Six Month Follow-Up Visit|Lost to Follow-up|3|||
28023005|NCT00731783|54681922|FG000|12 Month Follow-Up Visit|Lost to Follow-up|6|||
28023006|NCT00731783|54681923|FG001|12 Month Follow-Up Visit|Lost to Follow-up|7|||
27800910|NCT01818531|54255761|FG000|Overall Study|Withdrawn for failure to place block|0|||
27800911|NCT01818531|54255762|FG001|Overall Study|Withdrawn for failure to place block|1|||
27800912|NCT02171429|54255771|FG000|Overall Study|Other|0|||
27938638|NCT00897715|54594814|FG000|Overall Study|increased risk of infection|1|||
27938639|NCT00897715|54594815|FG001|Overall Study|increased risk of infection|0|||
27938640|NCT01229111|54594821|FG000|Overall Study|Death|1|||
27938641|NCT00894361|54594827|FG000|Overall Study|deaths and less than 2 years followup|24|||
27938642|NCT00894361|54594828|FG001|Overall Study|deaths and less than 2 years followup|64|||
27800913|NCT02171429|54255772|FG001|Overall Study|Other|1|||
27938643|NCT01228175|54594838|FG000|Overall Study|Lost to Follow-up|64|||
27938644|NCT01228175|54594839|FG001|Overall Study|Lost to Follow-up|50|||
27938645|NCT01228175|54594838|FG000|Overall Study|Withdrawal by Subject|1|||
27938646|NCT01228175|54594839|FG001|Overall Study|Withdrawal by Subject|2|||
27938647|NCT01228175|54594838|FG000|Overall Study|Physician Decision|1|||
27938648|NCT01228175|54594839|FG001|Overall Study|Physician Decision|1|||
27938649|NCT01228019|54594845|FG000|Overall Study|Dose Violation|70|||
27938650|NCT01228019|54594845|FG000|Overall Study|Duplicate enrollment|1|||
27938651|NCT01228019|54594845|FG000|Overall Study|Missing pre-treatment data|72|||
28023007|NCT00724451|54681929|FG000|Overall Study|Excluded - Prior Use of Peginterferon|7|||
28023008|NCT00724451|54681929|FG000|Overall Study|Excluded - Hepatitis C Virus Negative|3|||
28023009|NCT00724451|54681929|FG000|Overall Study|Not Eligible for Treatment|431|||
28023010|NCT00724451|54681929|FG000|Overall Study|Participant Refused Treatment|89|||
28023011|NCT00724451|54681929|FG000|Overall Study|Never Started Treatment|89|||
28023012|NCT00724451|54681929|FG000|Overall Study|Unknown; No Data Sources Available|9|||
28023013|NCT00724451|54681929|FG000|Overall Study|Physician Decision|116|||
28023014|NCT00724451|54681929|FG000|Overall Study|Withdrawal by Subject|45|||
28023015|NCT00724451|54681929|FG000|Overall Study|Investigator + Participant Decision|13|||
28023016|NCT00724373|54681933|FG000|Overall Study|Adverse Event|41|||
28023017|NCT00724373|54681933|FG000|Overall Study|Lack of Efficacy|82|||
28023018|NCT00724373|54681933|FG000|Overall Study|Lost to Follow-up|7|||
28023019|NCT00724373|54681933|FG000|Overall Study|Non-compliance|2|||
28023020|NCT00724373|54681933|FG000|Overall Study|HCV RNA negative after 4 weeks|9|||
28023021|NCT00724373|54681933|FG000|Overall Study|Participant moved away|1|||
28023022|NCT00724373|54681933|FG000|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2|||
28023023|NCT00724373|54681933|FG000|Overall Study|Only to have 24 week regimen|1|||
28023024|NCT00724373|54681933|FG000|Overall Study|Viral Relapse|1|||
28023025|NCT00724373|54681933|FG000|Overall Study|Acute HCV infection|1|||
28023026|NCT00724373|54681933|FG000|Overall Study|Drug Relapse|1|||
28023027|NCT00724373|54681933|FG000|Overall Study|Tolerability|23|||
28023028|NCT00724061|54681937|FG000|Dose Escalation Phase|Adverse Event|2|||
28023029|NCT00724061|54681937|FG000|Dose Escalation Phase|Disease Progression|3|||
28023030|NCT00731549|54681941|FG000|Overall Study|Lost to Follow-up|19|||
28023031|NCT00731549|54681941|FG000|Overall Study|Met withdrawal criteria|24|||
28023032|NCT00731549|54681941|FG000|Overall Study|Physician Decision|16|||
28023033|NCT00731549|54681941|FG000|Overall Study|Withdrawal by Subject|89|||
28023034|NCT00731549|54681941|FG000|Overall Study|Protocol deviation|1|||
28023035|NCT00731549|54681941|FG000|Overall Study|Adverse Event|31|||
28023036|NCT00731549|54681941|FG000|Overall Study|Lack of efficacy with AE|37|||
28023037|NCT00731549|54681941|FG000|Overall Study|Lack of efficacy without AE|6|||
28023038|NCT00730925|54681986|FG000|Overall Study|Progressive Disease|21|||
28023039|NCT00730925|54681986|FG000|Overall Study|Dose reducing Event|2|||
28023040|NCT00730925|54681986|FG000|Overall Study|Other Averse Event|7|||
28023041|NCT00730925|54681986|FG000|Overall Study|Protocol Violation|1|||
28023042|NCT00730925|54681986|FG000|Overall Study|Withdrawal by Subject|1|||
28023043|NCT00730925|54681986|FG000|Overall Study|Switch to combination therapy|8|||
28023044|NCT00730925|54681986|FG000|Overall Study|Other|1|||
28023045|NCT00236899|54681994|FG000|Overall Study|Adverse Event (Study Related)|1|||
28023046|NCT00236899|54681995|FG001|Overall Study|Adverse Event (Study Related)|1|||
28023047|NCT00236899|54681996|FG002|Overall Study|Adverse Event (Study Related)|2|||
28023048|NCT00236899|54681997|FG003|Overall Study|Adverse Event (Study Related)|1|||
28023049|NCT00236899|54681994|FG000|Overall Study|Adverse Event (Not Study Related)|3|||
28023050|NCT00236899|54681995|FG001|Overall Study|Adverse Event (Not Study Related)|3|||
28023051|NCT00236899|54681996|FG002|Overall Study|Adverse Event (Not Study Related)|4|||
28023052|NCT00236899|54681997|FG003|Overall Study|Adverse Event (Not Study Related)|7|||
28023053|NCT00236899|54681994|FG000|Overall Study|Death (Study Disease)|1|||
28023054|NCT00236899|54681995|FG001|Overall Study|Death (Study Disease)|4|||
28023055|NCT00236899|54681996|FG002|Overall Study|Death (Study Disease)|0|||
28023056|NCT00236899|54681997|FG003|Overall Study|Death (Study Disease)|0|||
27938652|NCT01228019|54594845|FG000|Overall Study|Triglyceride Entry Criteria Not Met|152|||
27938653|NCT01228019|54594845|FG000|Overall Study|Violation of Entry Criterion|9|||
27938654|NCT02987959|54594849|FG000|Overall Study|Grantor stopped supply of drugs|6|||
27938655|NCT01227707|54594853|FG000|Overall Study|Adverse Event|10|||
27938656|NCT01227707|54594853|FG000|Overall Study|Progression of disease|3|||
27938657|NCT01227707|54594853|FG000|Overall Study|Withdrawal by Subject|1|||
27938658|NCT01227707|54594853|FG000|Overall Study|Patient non-compliance|3|||
27938659|NCT01227707|54594853|FG000|Overall Study|Medical decision|6|||
27938660|NCT01227707|54594853|FG000|Overall Study|Death|1|||
27938661|NCT00895843|54594859|FG000|Overall Study|Protocol Violation|12|||
27938662|NCT00895843|54594860|FG001|Overall Study|Protocol Violation|12|||
27938663|NCT00895453|54594869|FG000|Overall Study|Lost to Follow-up|25|||
27938664|NCT00895453|54594870|FG001|Overall Study|Lost to Follow-up|25|||
27938665|NCT00895453|54594871|FG002|Overall Study|Lost to Follow-up|23|||
27938666|NCT00893971|54594879|FG000|Overall Study|Physician Decision|3|||
27938667|NCT00893737|54594892|FG000|Overall Study|Adverse Event|4|||
27938668|NCT00893737|54594892|FG000|Overall Study|Withdrawal by Subject|2|||
27938669|NCT00893737|54594892|FG000|Overall Study|Lost to Follow-up|6|||
27938670|NCT00893113|54594898|FG000|Overall Study|Lost to Follow-up|4|||
28023057|NCT00236899|54681994|FG000|Overall Study|Death (Not Study Related)|2|||
28023058|NCT00236899|54681995|FG001|Overall Study|Death (Not Study Related)|0|||
28023059|NCT00236899|54681996|FG002|Overall Study|Death (Not Study Related)|0|||
28023060|NCT00236899|54681997|FG003|Overall Study|Death (Not Study Related)|0|||
27800914|NCT02171429|54255773|FG002|Overall Study|Other|1|||
27938671|NCT00893113|54594899|FG001|Overall Study|Lost to Follow-up|8|||
27938672|NCT00893113|54594898|FG000|Overall Study|Early Termination|1|||
28023061|NCT00236899|54681994|FG000|Overall Study|Death (Study Drug Toxicity)|1|||
28023062|NCT00236899|54681995|FG001|Overall Study|Death (Study Drug Toxicity)|0|||
28023063|NCT00236899|54681996|FG002|Overall Study|Death (Study Drug Toxicity)|0|||
28023064|NCT00236899|54681997|FG003|Overall Study|Death (Study Drug Toxicity)|0|||
28023065|NCT00236899|54681994|FG000|Overall Study|Lost to Follow-up|0|||
28023066|NCT00236899|54681995|FG001|Overall Study|Lost to Follow-up|1|||
28023067|NCT00236899|54681996|FG002|Overall Study|Lost to Follow-up|0|||
28023068|NCT00236899|54681997|FG003|Overall Study|Lost to Follow-up|0|||
28023069|NCT00236899|54681994|FG000|Overall Study|Entry Criteria Exclusion|0|||
28023070|NCT00236899|54681995|FG001|Overall Study|Entry Criteria Exclusion|1|||
28023071|NCT00236899|54681996|FG002|Overall Study|Entry Criteria Exclusion|1|||
28023072|NCT00236899|54681997|FG003|Overall Study|Entry Criteria Exclusion|0|||
28023073|NCT00236899|54681994|FG000|Overall Study|Protocol Violation|1|||
28023074|NCT00236899|54681995|FG001|Overall Study|Protocol Violation|0|||
28023075|NCT00236899|54681996|FG002|Overall Study|Protocol Violation|0|||
28023076|NCT00236899|54681997|FG003|Overall Study|Protocol Violation|0|||
28023077|NCT00236899|54681994|FG000|Overall Study|Withdrawal by Subject|6|||
28023078|NCT00236899|54681995|FG001|Overall Study|Withdrawal by Subject|4|||
28023079|NCT00236899|54681996|FG002|Overall Study|Withdrawal by Subject|5|||
28023080|NCT00236899|54681997|FG003|Overall Study|Withdrawal by Subject|2|||
28023081|NCT00236899|54681994|FG000|Overall Study|Physician Decision|7|||
28023082|NCT00236899|54681995|FG001|Overall Study|Physician Decision|8|||
28023083|NCT00236899|54681996|FG002|Overall Study|Physician Decision|7|||
28023084|NCT00236899|54681997|FG003|Overall Study|Physician Decision|6|||
28023085|NCT00236899|54681994|FG000|Overall Study|Satisfactory Response|2|||
28023086|NCT00236899|54681995|FG001|Overall Study|Satisfactory Response|0|||
28023087|NCT00236899|54681996|FG002|Overall Study|Satisfactory Response|0|||
28023088|NCT00236899|54681997|FG003|Overall Study|Satisfactory Response|1|||
28023089|NCT00236899|54681994|FG000|Overall Study|Lack of Efficacy|18|||
28023090|NCT00236899|54681995|FG001|Overall Study|Lack of Efficacy|18|||
28023091|NCT00236899|54681996|FG002|Overall Study|Lack of Efficacy|25|||
28023092|NCT00236899|54681997|FG003|Overall Study|Lack of Efficacy|23|||
28023093|NCT00611130|54682016|FG000|Overall Study|Lost to Follow-up|25|||
28023094|NCT00611130|54682017|FG001|Overall Study|Lost to Follow-up|29|||
28023095|NCT00611130|54682016|FG000|Overall Study|Protocol noncompliance|7|||
28023096|NCT00611130|54682017|FG001|Overall Study|Protocol noncompliance|6|||
28023097|NCT00611130|54682016|FG000|Overall Study|Withdrawal by Subject|6|||
28023098|NCT00611130|54682017|FG001|Overall Study|Withdrawal by Subject|5|||
28023099|NCT00611130|54682016|FG000|Overall Study|Other|5|||
28023100|NCT00611130|54682017|FG001|Overall Study|Other|4|||
28023101|NCT00611130|54682016|FG000|Overall Study|Incarceration|3|||
28023102|NCT00611130|54682017|FG001|Overall Study|Incarceration|2|||
28023103|NCT00611130|54682016|FG000|Overall Study|Administrative|1|||
28023104|NCT00611130|54682017|FG001|Overall Study|Administrative|1|||
28023105|NCT00611130|54682016|FG000|Overall Study|Adverse Event|1|||
28023106|NCT00611130|54682017|FG001|Overall Study|Adverse Event|0|||
28023107|NCT00611130|54682016|FG000|Overall Study|Death|1|||
28023108|NCT00611130|54682017|FG001|Overall Study|Death|0|||
28023109|NCT00256243|54682024|FG000|Overall Study|Lost to Follow-up|2|||
28023110|NCT00256243|54682024|FG000|Overall Study|Death|7|||
28023111|NCT00256243|54682024|FG000|Overall Study|Not treated|1|||
28023112|NCT00236197|54682031|FG000|Overall Study|Withdrawal by Subject|3|||
28023113|NCT00236197|54682032|FG001|Overall Study|Withdrawal by Subject|2|||
28023114|NCT00236197|54682031|FG000|Overall Study|Lost to Follow-up|1|||
28023115|NCT00236197|54682032|FG001|Overall Study|Lost to Follow-up|5|||
28023116|NCT00236197|54682031|FG000|Overall Study|Protocol Violation|0|||
28023117|NCT00236197|54682032|FG001|Overall Study|Protocol Violation|3|||
28023118|NCT00236197|54682031|FG000|Overall Study|Medication non-compliance|1|||
28023119|NCT00236197|54682032|FG001|Overall Study|Medication non-compliance|2|||
28023120|NCT00236197|54682031|FG000|Overall Study|Other|0|||
27938673|NCT00893113|54594899|FG001|Overall Study|Early Termination|1|||
27938674|NCT00893113|54594898|FG000|Overall Study|Withdrew Consent|8|||
27938675|NCT00893113|54594899|FG001|Overall Study|Withdrew Consent|7|||
27938676|NCT00892957|54594907|FG000|Between Postoperative Day 1 and Day 14|Death|0|||
27938677|NCT00892957|54594908|FG001|Between Postoperative Day 1 and Day 14|Death|2|||
27938678|NCT00892957|54594907|FG000|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0|||
27938679|NCT00892957|54594908|FG001|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2|||
27938680|NCT00968812|54594931|FG000|Overall Study|Adverse Event|30|||
27938681|NCT00968812|54594932|FG001|Overall Study|Adverse Event|46|||
27938682|NCT00968812|54594933|FG002|Overall Study|Adverse Event|33|||
27938683|NCT00968812|54594931|FG000|Overall Study|Death|2|||
28023121|NCT00236197|54682032|FG001|Overall Study|Other|2|||
28023122|NCT00278629|54682038|FG000|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14|||
28023123|NCT00612690|54682045|FG000|Overall Study|Lost to Follow-up|72|||
28023124|NCT00612690|54682046|FG001|Overall Study|Lost to Follow-up|98|||
28023125|NCT00612690|54682045|FG000|Overall Study|Withdrawal by Subject|32|||
27938684|NCT00968812|54594932|FG001|Overall Study|Death|2|||
27938685|NCT00968812|54594933|FG002|Overall Study|Death|1|||
27938686|NCT00968812|54594931|FG000|Overall Study|Lack of Efficacy|9|||
27938687|NCT00968812|54594932|FG001|Overall Study|Lack of Efficacy|7|||
27938688|NCT00968812|54594933|FG002|Overall Study|Lack of Efficacy|16|||
27938689|NCT00968812|54594931|FG000|Overall Study|Lost to Follow-up|17|||
27938690|NCT00968812|54594932|FG001|Overall Study|Lost to Follow-up|12|||
27938691|NCT00968812|54594933|FG002|Overall Study|Lost to Follow-up|11|||
27938692|NCT00968812|54594931|FG000|Overall Study|Physician Decision|8|||
27938693|NCT00968812|54594932|FG001|Overall Study|Physician Decision|5|||
27938694|NCT00968812|54594933|FG002|Overall Study|Physician Decision|9|||
27938695|NCT00968812|54594931|FG000|Overall Study|Protocol Violation|7|||
27938696|NCT00968812|54594932|FG001|Overall Study|Protocol Violation|4|||
27938697|NCT00968812|54594933|FG002|Overall Study|Protocol Violation|3|||
27938698|NCT00968812|54594931|FG000|Overall Study|Withdrawal by Subject|17|||
27938699|NCT00968812|54594932|FG001|Overall Study|Withdrawal by Subject|23|||
27938700|NCT00968812|54594933|FG002|Overall Study|Withdrawal by Subject|25|||
27938701|NCT00968812|54594931|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|9|||
27938702|NCT00968812|54594932|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|13|||
27938703|NCT00968812|54594933|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|7|||
27938704|NCT00968812|54594931|FG000|Overall Study|Noncompliance with study drug|4|||
27938705|NCT00968812|54594932|FG001|Overall Study|Noncompliance with study drug|1|||
27938706|NCT00968812|54594933|FG002|Overall Study|Noncompliance with study drug|6|||
27938707|NCT00968812|54594931|FG000|Overall Study|Unable to take rescue therapy|12|||
27938708|NCT00968812|54594932|FG001|Overall Study|Unable to take rescue therapy|12|||
27938709|NCT00968812|54594933|FG002|Overall Study|Unable to take rescue therapy|17|||
27938710|NCT00968812|54594931|FG000|Overall Study|Other|25|||
27938711|NCT00968812|54594932|FG001|Overall Study|Other|37|||
27938712|NCT00968812|54594933|FG002|Overall Study|Other|40|||
27938713|NCT00992056|54594946|FG000|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1|||
27938714|NCT00992056|54594947|FG001|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2|||
27938715|NCT00992056|54594946|FG000|Washout Period (2 Weeks)|Physician Decision|1|||
27938716|NCT00992056|54594947|FG001|Washout Period (2 Weeks)|Physician Decision|0|||
27938717|NCT00972322|54594955|FG000|Overall Study|Adverse Event|2|||
27938718|NCT00972322|54594956|FG001|Overall Study|Adverse Event|1|||
27938719|NCT00972322|54594955|FG000|Overall Study|Positive drug screen|0|||
27938720|NCT00972322|54594956|FG001|Overall Study|Positive drug screen|1|||
28023126|NCT00612690|54682046|FG001|Overall Study|Withdrawal by Subject|20|||
27800915|NCT02171429|54255771|FG000|Overall Study|Non-Compliance|0|||
28023127|NCT00612690|54682045|FG000|Overall Study|Withdrawal by Site|11|||
28023128|NCT00612690|54682046|FG001|Overall Study|Withdrawal by Site|0|||
28023129|NCT00278473|54682056|FG000|Overall Study|drop out|4|||
28023130|NCT00278473|54682057|FG001|Overall Study|drop out|3|||
28023131|NCT00278395|54682063|FG000|Overall Study|Adverse Event|2|||
28023132|NCT00278395|54682063|FG000|Overall Study|Nonevaluable|1|||
28023133|NCT00612534|54682074|FG000|Overall Study|Adverse Event|0|||
27800916|NCT02171429|54255772|FG001|Overall Study|Non-Compliance|0|||
27800917|NCT02171429|54255773|FG002|Overall Study|Non-Compliance|1|||
27800918|NCT02171429|54255771|FG000|Overall Study|Physician Decision|0|||
27800919|NCT02171429|54255772|FG001|Overall Study|Physician Decision|0|||
27800920|NCT02171429|54255773|FG002|Overall Study|Physician Decision|1|||
27800921|NCT02171429|54255771|FG000|Overall Study|Withdrawal by Subject|1|||
27800922|NCT02171429|54255772|FG001|Overall Study|Withdrawal by Subject|1|||
27800923|NCT02171429|54255773|FG002|Overall Study|Withdrawal by Subject|1|||
27938721|NCT00972322|54594955|FG000|Overall Study|Lost to Follow-up|0|||
27938722|NCT00972322|54594956|FG001|Overall Study|Lost to Follow-up|1|||
27938723|NCT00972322|54594955|FG000|Overall Study|Consistently high glucose values|1|||
27938724|NCT00972322|54594956|FG001|Overall Study|Consistently high glucose values|0|||
27938725|NCT00967798|54594964|FG000|Overall Study|Withdrawal by Subject|5|||
27938726|NCT00967798|54594965|FG001|Overall Study|Withdrawal by Subject|2|||
27938727|NCT00967798|54594964|FG000|Overall Study|Lost to Follow-up|4|||
27938728|NCT00967798|54594965|FG001|Overall Study|Lost to Follow-up|1|||
27938729|NCT00965458|54594973|FG000|Overall Study|Adverse Event|1|||
28023134|NCT00612534|54682075|FG001|Overall Study|Adverse Event|4|||
28023135|NCT00612534|54682076|FG002|Overall Study|Adverse Event|2|||
28023136|NCT00612534|54682077|FG003|Overall Study|Adverse Event|1|||
28023137|NCT00612534|54682074|FG000|Overall Study|Lack of Efficacy|13|||
28023138|NCT00612534|54682075|FG001|Overall Study|Lack of Efficacy|12|||
28023139|NCT00612534|54682076|FG002|Overall Study|Lack of Efficacy|5|||
28023140|NCT00612534|54682077|FG003|Overall Study|Lack of Efficacy|16|||
28023141|NCT00612534|54682074|FG000|Overall Study|Other Reason|0|||
28023142|NCT00612534|54682075|FG001|Overall Study|Other Reason|1|||
28023143|NCT00612534|54682076|FG002|Overall Study|Other Reason|0|||
28023144|NCT00612534|54682077|FG003|Overall Study|Other Reason|0|||
27800924|NCT02171429|54255771|FG000|Overall Study|Lost to Follow-up|0|||
27800925|NCT02171429|54255772|FG001|Overall Study|Lost to Follow-up|1|||
27800926|NCT02171429|54255773|FG002|Overall Study|Lost to Follow-up|0|||
27800927|NCT02171429|54255771|FG000|Overall Study|Death|0|||
27800928|NCT02171429|54255772|FG001|Overall Study|Death|0|||
27800929|NCT02171429|54255773|FG002|Overall Study|Death|1|||
28023145|NCT00736853|54682087|FG000|Open-Label Period|Physician Decision|2|||
28023146|NCT00736853|54682088|FG001|Open-Label Period|Physician Decision|0|||
28023147|NCT00736853|54682089|FG002|Open-Label Period|Physician Decision|0|||
28023148|NCT00736853|54682087|FG000|Open-Label Period|Adverse Event|31|||
28023149|NCT00736853|54682088|FG001|Open-Label Period|Adverse Event|0|||
28023150|NCT00736853|54682089|FG002|Open-Label Period|Adverse Event|0|||
28023151|NCT00736853|54682087|FG000|Open-Label Period|Withdrawal by Subject|16|||
28023152|NCT00736853|54682088|FG001|Open-Label Period|Withdrawal by Subject|0|||
28023153|NCT00736853|54682089|FG002|Open-Label Period|Withdrawal by Subject|0|||
28023154|NCT00736853|54682087|FG000|Open-Label Period|Started but not treated|42|||
28023155|NCT00736853|54682088|FG001|Open-Label Period|Started but not treated|0|||
28023156|NCT00736853|54682089|FG002|Open-Label Period|Started but not treated|0|||
28023157|NCT00736853|54682087|FG000|Open-Label Period|Failed to meet the transfer criteria|40|||
28023158|NCT00736853|54682088|FG001|Open-Label Period|Failed to meet the transfer criteria|0|||
28023159|NCT00736853|54682089|FG002|Open-Label Period|Failed to meet the transfer criteria|0|||
28023160|NCT00736853|54682087|FG000|Open-Label Period|Unable to attend hospital appointments|1|||
27800930|NCT01818297|54255786|FG000|Blinded Phase (Randomization - 3 Months)|Adverse Event|0|||
27800931|NCT01818297|54255787|FG001|Blinded Phase (Randomization - 3 Months)|Adverse Event|1|||
27800932|NCT01818297|54255786|FG000|Open Label Phase (3-12 Months)|Physician Decision|1|||
27800933|NCT01818297|54255787|FG001|Open Label Phase (3-12 Months)|Physician Decision|0|||
27800934|NCT01818297|54255786|FG000|Open Label Phase (3-12 Months)|Early study closure|17|||
27800935|NCT01818297|54255787|FG001|Open Label Phase (3-12 Months)|Early study closure|10|||
27800936|NCT01818141|54255795|FG000|Overall Study|Withdrawal by Subject|2|||
27800937|NCT01818141|54255796|FG001|Overall Study|Withdrawal by Subject|0|||
27800938|NCT01818141|54255795|FG000|Overall Study|No baseline C.diff colonies|1|||
27800939|NCT01818141|54255796|FG001|Overall Study|No baseline C.diff colonies|1|||
27938730|NCT00965458|54594974|FG001|Overall Study|Adverse Event|0|||
28023161|NCT00736853|54682088|FG001|Open-Label Period|Unable to attend hospital appointments|0|||
28023162|NCT00736853|54682089|FG002|Open-Label Period|Unable to attend hospital appointments|0|||
28023163|NCT00736853|54682087|FG000|Double-Blind Period|Lack of Efficacy|0|||
28023164|NCT00736853|54682088|FG001|Double-Blind Period|Lack of Efficacy|19|||
28023165|NCT00736853|54682089|FG002|Double-Blind Period|Lack of Efficacy|42|||
28023166|NCT00736853|54682087|FG000|Double-Blind Period|Adverse Event|0|||
28023167|NCT00736853|54682088|FG001|Double-Blind Period|Adverse Event|3|||
28023168|NCT00736853|54682089|FG002|Double-Blind Period|Adverse Event|2|||
28023169|NCT00736853|54682087|FG000|Double-Blind Period|Withdrawal by Subject|0|||
28023170|NCT00736853|54682088|FG001|Double-Blind Period|Withdrawal by Subject|1|||
28023171|NCT00736853|54682089|FG002|Double-Blind Period|Withdrawal by Subject|4|||
28023172|NCT00736853|54682087|FG000|Double-Blind Period|Ineligible to participate the study|0|||
28023173|NCT00736853|54682088|FG001|Double-Blind Period|Ineligible to participate the study|1|||
28023174|NCT00736853|54682089|FG002|Double-Blind Period|Ineligible to participate the study|0|||
28023175|NCT00730847|54682098|FG000|Overall Study|Adverse Event|1|||
28023176|NCT00730847|54682098|FG000|Overall Study|Protocol Violation|2|||
28023177|NCT00730847|54682098|FG000|Overall Study|Withdrawal by Subject|16|||
28023178|NCT00730847|54682098|FG000|Overall Study|Lost to Follow-up|67|||
28023179|NCT00730847|54682098|FG000|Overall Study|Unknown completion status|21|||
28023180|NCT00730847|54682098|FG000|Overall Study|Other|24|||
28023181|NCT00573066|54682102|FG000|Overall Study|Exclusion criteria|18|||
28023182|NCT00573066|54682102|FG000|Overall Study|IV malfunction|1|||
28023183|NCT00573066|54682102|FG000|Overall Study|Postoperative bleeding|1|||
28023184|NCT00612456|54682109|FG000|Overall Study|Adverse Event|1|||
28023185|NCT00612456|54682110|FG001|Overall Study|Adverse Event|0|||
27938731|NCT00965458|54594973|FG000|Overall Study|Lost to Follow-up|1|||
27938732|NCT00965458|54594974|FG001|Overall Study|Lost to Follow-up|3|||
27938733|NCT00965458|54594973|FG000|Overall Study|Withdrawal by Subject|0|||
27938734|NCT00965458|54594974|FG001|Overall Study|Withdrawal by Subject|1|||
27938735|NCT00972244|54594987|FG000|Overall Study|Incorrect Enrolment|1|||
27938736|NCT00972244|54594988|FG001|Overall Study|Incorrect Enrolment|0|||
27938737|NCT00972244|54594989|FG002|Overall Study|Incorrect Enrolment|0|||
27938738|NCT00972244|54594990|FG003|Overall Study|Incorrect Enrolment|0|||
27938739|NCT00972244|54594991|FG004|Overall Study|Incorrect Enrolment|0|||
27938740|NCT00972244|54594987|FG000|Overall Study|Adverse Event|0|||
28023186|NCT00612456|54682111|FG002|Overall Study|Adverse Event|0|||
28023187|NCT00612456|54682109|FG000|Overall Study|Lack of Efficacy|1|||
28023188|NCT00612456|54682110|FG001|Overall Study|Lack of Efficacy|1|||
28023189|NCT00612456|54682111|FG002|Overall Study|Lack of Efficacy|0|||
28023190|NCT00612456|54682109|FG000|Overall Study|Withdrawal by Subject|0|||
27938741|NCT00972244|54594988|FG001|Overall Study|Adverse Event|1|||
27938742|NCT00972244|54594989|FG002|Overall Study|Adverse Event|1|||
28023191|NCT00612456|54682110|FG001|Overall Study|Withdrawal by Subject|1|||
27800940|NCT01818141|54255795|FG000|Overall Study|Lost to Follow-up|0|||
27800941|NCT01818141|54255796|FG001|Overall Study|Lost to Follow-up|2|||
28023192|NCT00612456|54682111|FG002|Overall Study|Withdrawal by Subject|0|||
28023193|NCT00730691|54682126|FG000|Overall Study|Adverse Event|4|||
28023194|NCT00730691|54682127|FG001|Overall Study|Adverse Event|8|||
28023195|NCT00730691|54682128|FG002|Overall Study|Adverse Event|11|||
28023196|NCT00730691|54682129|FG003|Overall Study|Adverse Event|11|||
28023197|NCT00730691|54682130|FG004|Overall Study|Adverse Event|23|||
28023198|NCT00730691|54682126|FG000|Overall Study|Lack of Efficacy|4|||
28023199|NCT00730691|54682127|FG001|Overall Study|Lack of Efficacy|4|||
28023200|NCT00730691|54682128|FG002|Overall Study|Lack of Efficacy|2|||
28023201|NCT00730691|54682129|FG003|Overall Study|Lack of Efficacy|1|||
28023202|NCT00730691|54682130|FG004|Overall Study|Lack of Efficacy|1|||
28023203|NCT00730691|54682126|FG000|Overall Study|Non-compliance with Study Drug|6|||
28023204|NCT00730691|54682127|FG001|Overall Study|Non-compliance with Study Drug|1|||
28023205|NCT00730691|54682128|FG002|Overall Study|Non-compliance with Study Drug|6|||
28023206|NCT00730691|54682129|FG003|Overall Study|Non-compliance with Study Drug|3|||
28023207|NCT00730691|54682130|FG004|Overall Study|Non-compliance with Study Drug|3|||
28023208|NCT00730691|54682126|FG000|Overall Study|Protocol Deviations|3|||
28023209|NCT00730691|54682127|FG001|Overall Study|Protocol Deviations|5|||
28023210|NCT00730691|54682128|FG002|Overall Study|Protocol Deviations|3|||
28023211|NCT00730691|54682129|FG003|Overall Study|Protocol Deviations|7|||
28023212|NCT00730691|54682130|FG004|Overall Study|Protocol Deviations|5|||
28023213|NCT00730691|54682126|FG000|Overall Study|Withdrawal of Consent|7|||
28023214|NCT00730691|54682127|FG001|Overall Study|Withdrawal of Consent|9|||
28023215|NCT00730691|54682128|FG002|Overall Study|Withdrawal of Consent|3|||
28023216|NCT00730691|54682129|FG003|Overall Study|Withdrawal of Consent|6|||
28023217|NCT00730691|54682130|FG004|Overall Study|Withdrawal of Consent|3|||
28023218|NCT00730691|54682126|FG000|Overall Study|Lost to Follow-up|11|||
28023219|NCT00730691|54682127|FG001|Overall Study|Lost to Follow-up|8|||
28023220|NCT00730691|54682128|FG002|Overall Study|Lost to Follow-up|13|||
28023221|NCT00730691|54682129|FG003|Overall Study|Lost to Follow-up|15|||
28023222|NCT00730691|54682130|FG004|Overall Study|Lost to Follow-up|13|||
28023223|NCT00730691|54682126|FG000|Overall Study|Other|1|||
28023224|NCT00730691|54682127|FG001|Overall Study|Other|1|||
28023225|NCT00730691|54682128|FG002|Overall Study|Other|1|||
28023226|NCT00730691|54682129|FG003|Overall Study|Other|2|||
28023227|NCT00730691|54682130|FG004|Overall Study|Other|2|||
28023228|NCT00235495|54682144|FG000|Overall Study|Death|52|||
28023229|NCT00235495|54682145|FG001|Overall Study|Death|42|||
28023230|NCT00235495|54682144|FG000|Overall Study|Withdrawal by Subject|5|||
28023231|NCT00235495|54682145|FG001|Overall Study|Withdrawal by Subject|3|||
28023232|NCT00235495|54682144|FG000|Overall Study|Lost to Follow-up|11|||
28023233|NCT00235495|54682145|FG001|Overall Study|Lost to Follow-up|13|||
28023234|NCT00235495|54682144|FG000|Overall Study|Visit/assessmen outside window/missing|0|||
28023235|NCT00235495|54682145|FG001|Overall Study|Visit/assessmen outside window/missing|10|||
28023236|NCT00278161|54682151|FG000|Overall Study|Death|11|||
28023237|NCT00255151|54682158|FG000|Overall Study|Adverse Event|10|||
28023238|NCT00255151|54682159|FG001|Overall Study|Adverse Event|6|||
28023239|NCT00255151|54682160|FG002|Overall Study|Adverse Event|9|||
28023240|NCT00255151|54682158|FG000|Overall Study|Lost to Follow-up|4|||
28023241|NCT00255151|54682159|FG001|Overall Study|Lost to Follow-up|3|||
28023242|NCT00255151|54682160|FG002|Overall Study|Lost to Follow-up|4|||
28023243|NCT00255151|54682158|FG000|Overall Study|Withdrawal by Subject|18|||
28023244|NCT00255151|54682159|FG001|Overall Study|Withdrawal by Subject|17|||
28023245|NCT00255151|54682160|FG002|Overall Study|Withdrawal by Subject|8|||
28023246|NCT00255151|54682158|FG000|Overall Study|Noncompliance|0|||
28023247|NCT00255151|54682159|FG001|Overall Study|Noncompliance|1|||
28023248|NCT00255151|54682160|FG002|Overall Study|Noncompliance|2|||
28023249|NCT00255151|54682158|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
28023250|NCT00255151|54682159|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
28023251|NCT00255151|54682160|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
28023252|NCT00255151|54682158|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
28023253|NCT00255151|54682159|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
28023254|NCT00255151|54682160|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
28023255|NCT00255151|54682158|FG000|Overall Study|Possible Barrett's Esophagus|1|||
28023256|NCT00255151|54682159|FG001|Overall Study|Possible Barrett's Esophagus|3|||
28023257|NCT00255151|54682160|FG002|Overall Study|Possible Barrett's Esophagus|8|||
28023258|NCT00255151|54682158|FG000|Overall Study|Esophageal Stricture|0|||
28023259|NCT00255151|54682159|FG001|Overall Study|Esophageal Stricture|0|||
27800942|NCT01849497|54255804|FG000|Overall Study|Withdrawal by Subject|1|||
28023260|NCT00255151|54682160|FG002|Overall Study|Esophageal Stricture|1|||
28023261|NCT00255151|54682158|FG000|Overall Study|Therapeutic Failure|11|||
28023262|NCT00255151|54682159|FG001|Overall Study|Therapeutic Failure|2|||
28023263|NCT00255151|54682160|FG002|Overall Study|Therapeutic Failure|3|||
28023264|NCT00658658|54682173|FG000|Overall Study|Withdrawal by Subject|0|||
28023265|NCT00658658|54682174|FG001|Overall Study|Withdrawal by Subject|1|||
28023266|NCT00658658|54682175|FG002|Overall Study|Withdrawal by Subject|0|||
28023267|NCT00658658|54682176|FG003|Overall Study|Withdrawal by Subject|0|||
28023268|NCT00658658|54682177|FG004|Overall Study|Withdrawal by Subject|0|||
28023269|NCT00658658|54682173|FG000|Overall Study|Death|4|||
28023270|NCT00658658|54682174|FG001|Overall Study|Death|0|||
28023271|NCT00658658|54682175|FG002|Overall Study|Death|0|||
28023272|NCT00658658|54682176|FG003|Overall Study|Death|1|||
28023273|NCT00658658|54682177|FG004|Overall Study|Death|1|||
28023274|NCT00658658|54682173|FG000|Overall Study|Disease Progression|0|||
28023275|NCT00658658|54682174|FG001|Overall Study|Disease Progression|1|||
28023276|NCT00658658|54682175|FG002|Overall Study|Disease Progression|0|||
28023277|NCT00658658|54682176|FG003|Overall Study|Disease Progression|1|||
28023278|NCT00658658|54682177|FG004|Overall Study|Disease Progression|3|||
28023279|NCT00658658|54682173|FG000|Overall Study|Protocol-specified Criteria|1|||
28023280|NCT00658658|54682174|FG001|Overall Study|Protocol-specified Criteria|0|||
28023281|NCT00658658|54682175|FG002|Overall Study|Protocol-specified Criteria|0|||
28023282|NCT00658658|54682176|FG003|Overall Study|Protocol-specified Criteria|0|||
28023283|NCT00658658|54682177|FG004|Overall Study|Protocol-specified Criteria|0|||
28023284|NCT00658658|54682173|FG000|Overall Study|Other|0|||
28023285|NCT00658658|54682174|FG001|Overall Study|Other|0|||
28023286|NCT00658658|54682175|FG002|Overall Study|Other|0|||
28023287|NCT00658658|54682176|FG003|Overall Study|Other|0|||
28023288|NCT00658658|54682177|FG004|Overall Study|Other|1|||
28023289|NCT00723203|54682189|FG000|Overall Study|Withdrawal by Subject|3|||
28023290|NCT00233389|54682195|FG000|Overall Study|Adverse Event|5|||
28023291|NCT00233389|54682196|FG001|Overall Study|Adverse Event|5|||
28023292|NCT00233389|54682195|FG000|Overall Study|Lack of Efficacy|11|||
28023293|NCT00233389|54682196|FG001|Overall Study|Lack of Efficacy|8|||
28023294|NCT00233389|54682195|FG000|Overall Study|Lost to Follow-up|1|||
27800943|NCT01849497|54255805|FG001|Overall Study|Withdrawal by Subject|2|||
27800944|NCT01849497|54255804|FG000|Overall Study|Sponsor Decision|0|||
27800945|NCT01849497|54255805|FG001|Overall Study|Sponsor Decision|1|||
27800946|NCT01849497|54255804|FG000|Overall Study|Lost to Follow-up|0|||
27800947|NCT01849497|54255805|FG001|Overall Study|Lost to Follow-up|1|||
27800948|NCT02147093|54255813|FG000|Period 1|Lost to Follow-up|0|||
27800949|NCT02147093|54255814|FG001|Period 1|Lost to Follow-up|1|||
27800950|NCT02147093|54255813|FG000|Period 2|Protocol Violation|2|||
27800951|NCT02147093|54255814|FG001|Period 2|Protocol Violation|0|||
27800952|NCT02119325|54255820|FG000|Washout Period 1|Adverse Event|0|||
27800953|NCT02119325|54255821|FG001|Washout Period 1|Adverse Event|1|||
27800954|NCT01816893|54255831|FG000|Washout Period|Withdrawal by Subject|2|||
27800955|NCT01816893|54255832|FG001|Washout Period|Withdrawal by Subject|0|||
27800956|NCT01848483|54255840|FG000|Overall Study|Death|2|||
27800957|NCT01848483|54255841|FG001|Overall Study|Death|1|||
27800958|NCT01848483|54255840|FG000|Overall Study|Lost to Follow-up|6|||
27800959|NCT01848483|54255841|FG001|Overall Study|Lost to Follow-up|8|||
27800960|NCT01848483|54255840|FG000|Overall Study|Withdrawal by Subject|1|||
27800961|NCT01848483|54255841|FG001|Overall Study|Withdrawal by Subject|0|||
27800962|NCT01848483|54255840|FG000|Overall Study|Incarceration|2|||
27800963|NCT01848483|54255841|FG001|Overall Study|Incarceration|2|||
27800964|NCT01610271|54255850|FG000|Overall Study|Surgery not complete|0|||
27800965|NCT01610271|54255851|FG001|Overall Study|Surgery not complete|1|||
27800966|NCT01610271|54255850|FG000|Overall Study|Prosthesis not implanted|2|||
28023295|NCT00233389|54682196|FG001|Overall Study|Lost to Follow-up|1|||
28023296|NCT00233389|54682195|FG000|Overall Study|Physician Decision|1|||
28023297|NCT00233389|54682196|FG001|Overall Study|Physician Decision|0|||
27800967|NCT01610271|54255851|FG001|Overall Study|Prosthesis not implanted|3|||
27800968|NCT02170727|54255861|FG000|Overall Study|Lost to Follow-up|1|||
27800969|NCT02170727|54255862|FG001|Overall Study|Lost to Follow-up|0|||
27800970|NCT02170727|54255861|FG000|Overall Study|Withdrawal by Subject|2|||
27800971|NCT02170727|54255862|FG001|Overall Study|Withdrawal by Subject|0|||
27800972|NCT01847313|54255873|FG000|Overall Study|Death|0|||
28023298|NCT00233389|54682195|FG000|Overall Study|Protocol Violation|0|||
28023299|NCT00233389|54682196|FG001|Overall Study|Protocol Violation|1|||
28023300|NCT00233389|54682195|FG000|Overall Study|Withdrawal by Subject|0|||
28023301|NCT00233389|54682196|FG001|Overall Study|Withdrawal by Subject|1|||
28023302|NCT00649220|54682202|FG000|Overall Study|Adverse Event|2|||
28023303|NCT00649220|54682202|FG000|Overall Study|Withdrawal by Subject|1|||
28023304|NCT00654368|54682209|FG000|Overall Study|Ineligibility determined|6|||
28023305|NCT00654368|54682210|FG001|Overall Study|Ineligibility determined|0|||
28023306|NCT00654368|54682211|FG002|Overall Study|Ineligibility determined|0|||
28023307|NCT00654368|54682209|FG000|Overall Study|Protocol deviation|3|||
28023308|NCT00654368|54682210|FG001|Overall Study|Protocol deviation|2|||
28023309|NCT00654368|54682211|FG002|Overall Study|Protocol deviation|1|||
28023310|NCT00654368|54682209|FG000|Overall Study|Non-compliance|2|||
28023311|NCT00654368|54682210|FG001|Overall Study|Non-compliance|1|||
28023312|NCT00654368|54682211|FG002|Overall Study|Non-compliance|2|||
28023313|NCT00654368|54682209|FG000|Overall Study|Withdrawal by Subject|5|||
28023314|NCT00654368|54682210|FG001|Overall Study|Withdrawal by Subject|2|||
28023315|NCT00654368|54682211|FG002|Overall Study|Withdrawal by Subject|2|||
28023316|NCT00654368|54682209|FG000|Overall Study|Disease progression|21|||
28023317|NCT00654368|54682210|FG001|Overall Study|Disease progression|31|||
28023318|NCT00654368|54682211|FG002|Overall Study|Disease progression|13|||
28023319|NCT00654368|54682209|FG000|Overall Study|Requirement for alternative therapy|1|||
28023320|NCT00654368|54682210|FG001|Overall Study|Requirement for alternative therapy|1|||
28023321|NCT00654368|54682211|FG002|Overall Study|Requirement for alternative therapy|1|||
28023322|NCT00654368|54682209|FG000|Overall Study|Physician Decision|0|||
28023323|NCT00654368|54682210|FG001|Overall Study|Physician Decision|0|||
28023324|NCT00654368|54682211|FG002|Overall Study|Physician Decision|2|||
28023325|NCT00654368|54682209|FG000|Overall Study|Death|1|||
28023326|NCT00654368|54682210|FG001|Overall Study|Death|0|||
28023327|NCT00654368|54682211|FG002|Overall Study|Death|0|||
28023328|NCT00654368|54682209|FG000|Overall Study|Pregnancy|0|||
28023329|NCT00654368|54682210|FG001|Overall Study|Pregnancy|0|||
28023330|NCT00654368|54682211|FG002|Overall Study|Pregnancy|2|||
28023331|NCT00654368|54682209|FG000|Overall Study|Other|0|||
28023332|NCT00654368|54682210|FG001|Overall Study|Other|2|||
28023333|NCT00654368|54682211|FG002|Overall Study|Other|3|||
28023334|NCT00654368|54682209|FG000|Overall Study|Adverse Event|14|||
28023335|NCT00654368|54682210|FG001|Overall Study|Adverse Event|9|||
28023336|NCT00654368|54682211|FG002|Overall Study|Adverse Event|6|||
28023337|NCT00647426|54682218|FG000|Overall Study|Withdrawal by Subject|2|||
28023338|NCT00647348|54682225|FG000|Overall Study|Lost to Follow-up|3|||
28023339|NCT00647348|54682226|FG001|Overall Study|Lost to Follow-up|6|||
28023340|NCT00647270|54682235|FG000|Period 1, Placebo-control (12 Weeks)|Adverse Event|2|||
28023341|NCT00647270|54682236|FG001|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
28023342|NCT00647270|54682237|FG002|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
28023343|NCT00647270|54682235|FG000|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0|||
28023344|NCT00647270|54682236|FG001|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
28023345|NCT00647270|54682237|FG002|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
28023346|NCT00647270|54682235|FG000|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2|||
28023347|NCT00647270|54682236|FG001|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1|||
28023348|NCT00647270|54682237|FG002|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7|||
28023349|NCT00647270|54682235|FG000|Period 1, Placebo-control (12 Weeks)|Other|4|||
28023350|NCT00647270|54682236|FG001|Period 1, Placebo-control (12 Weeks)|Other|4|||
28023351|NCT00647270|54682237|FG002|Period 1, Placebo-control (12 Weeks)|Other|8|||
28023352|NCT00647270|54682235|FG000|Period 2, Placebo Switched to Adalimumab|Adverse Event|1|||
28023353|NCT00647270|54682236|FG001|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
28023354|NCT00647270|54682237|FG002|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
28023355|NCT00647270|54682235|FG000|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
28023356|NCT00647270|54682236|FG001|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
28023357|NCT00647270|54682237|FG002|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4|||
28023358|NCT00647270|54682235|FG000|Period 2, Placebo Switched to Adalimumab|Other|2|||
28023359|NCT00647270|54682236|FG001|Period 2, Placebo Switched to Adalimumab|Other|6|||
28023360|NCT00647270|54682237|FG002|Period 2, Placebo Switched to Adalimumab|Other|0|||
28023361|NCT00645944|54682250|FG000|Randomized|Withdrawal by Subject|1|||
28023362|NCT00645944|54682251|FG001|Randomized|Withdrawal by Subject|2|||
28023363|NCT00645944|54682250|FG000|Received Medication|Adverse Event|2|||
28023364|NCT00645944|54682251|FG001|Received Medication|Adverse Event|1|||
28023365|NCT00645944|54682250|FG000|Received Medication|Withdrawal by Subject|1|||
28023366|NCT00645944|54682251|FG001|Received Medication|Withdrawal by Subject|1|||
28023367|NCT00645944|54682250|FG000|Received Medication|Lost to Follow-up|1|||
28023368|NCT00645944|54682251|FG001|Received Medication|Lost to Follow-up|0|||
28023369|NCT00645944|54682250|FG000|Received Medication|Protocol Violation|2|||
28023370|NCT00645944|54682251|FG001|Received Medication|Protocol Violation|1|||
28023371|NCT00646958|54682260|FG000|Overall Study|Lack of Efficacy|1|||
28023372|NCT00646958|54682261|FG001|Overall Study|Lack of Efficacy|0|||
28023373|NCT00646958|54682262|FG002|Overall Study|Lack of Efficacy|0|||
28023374|NCT00646958|54682260|FG000|Overall Study|Adverse Event|4|||
27800973|NCT01847313|54255874|FG001|Overall Study|Death|1|||
27800974|NCT01847313|54255873|FG000|Overall Study|Withdrawal by Subject|0|||
27800975|NCT01847313|54255874|FG001|Overall Study|Withdrawal by Subject|1|||
27800976|NCT02144285|54255890|FG000|Overall Study|Withdrawal by Subject|0|||
27800977|NCT02144285|54255891|FG001|Overall Study|Withdrawal by Subject|0|||
27800978|NCT02144285|54255892|FG002|Overall Study|Withdrawal by Subject|0|||
27800979|NCT02144285|54255893|FG003|Overall Study|Withdrawal by Subject|0|||
28023375|NCT00646958|54682261|FG001|Overall Study|Adverse Event|0|||
28023376|NCT00646958|54682262|FG002|Overall Study|Adverse Event|0|||
28023377|NCT00646958|54682260|FG000|Overall Study|Lost to Follow-up|1|||
28023378|NCT00646958|54682261|FG001|Overall Study|Lost to Follow-up|5|||
28023379|NCT00646958|54682262|FG002|Overall Study|Lost to Follow-up|7|||
28023380|NCT00646958|54682260|FG000|Overall Study|Protocol Violation|1|||
28023381|NCT00646958|54682261|FG001|Overall Study|Protocol Violation|1|||
28023382|NCT00646958|54682262|FG002|Overall Study|Protocol Violation|0|||
28023383|NCT00646958|54682260|FG000|Overall Study|Abnormal screening lab tests|1|||
28023384|NCT00646958|54682261|FG001|Overall Study|Abnormal screening lab tests|1|||
28023385|NCT00646958|54682262|FG002|Overall Study|Abnormal screening lab tests|0|||
28023386|NCT00646958|54682260|FG000|Overall Study|Withdrawal by Subject|1|||
28023387|NCT00646958|54682261|FG001|Overall Study|Withdrawal by Subject|2|||
28023388|NCT00646958|54682262|FG002|Overall Study|Withdrawal by Subject|0|||
28023389|NCT00646958|54682260|FG000|Overall Study|Did not receive study drug|2|||
28023390|NCT00646958|54682261|FG001|Overall Study|Did not receive study drug|0|||
28023391|NCT00646958|54682262|FG002|Overall Study|Did not receive study drug|2|||
28023392|NCT00642746|54682272|FG000|Overall Study|Patient unevaluable|1|||
27938743|NCT00972244|54594990|FG003|Overall Study|Adverse Event|0|||
27938744|NCT00972244|54594991|FG004|Overall Study|Adverse Event|0|||
27938745|NCT00972244|54594987|FG000|Overall Study|Subject No Longer Meets Study Criteria|2|||
28023393|NCT00642746|54682273|FG001|Overall Study|Patient unevaluable|0|||
28023394|NCT00642668|54682279|FG000|Overall Study|Lost to Follow-up|1|||
28023395|NCT00642668|54682279|FG000|Overall Study|Adverse Event|2|||
28023396|NCT00642668|54682279|FG000|Overall Study|Death|2|||
28023397|NCT00642668|54682279|FG000|Overall Study|Insufficient Therapeutic Response|1|||
28023398|NCT00642668|54682279|FG000|Overall Study|Failure to Return|1|||
28023399|NCT00642668|54682279|FG000|Overall Study|Dialysis Initiation|5|||
28023400|NCT00642668|54682279|FG000|Overall Study|Blood Transfusion|2|||
28023401|NCT00729833|54682283|FG000|Overall Study|Death|5|||
28023402|NCT00729833|54682284|FG001|Overall Study|Death|1|||
28023403|NCT00729833|54682285|FG002|Overall Study|Death|3|||
27800980|NCT02144285|54255894|FG004|Overall Study|Withdrawal by Subject|1|||
27800981|NCT02144285|54255895|FG005|Overall Study|Withdrawal by Subject|0|||
27938746|NCT00972244|54594988|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
27938747|NCT00972244|54594989|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
27938748|NCT00972244|54594990|FG003|Overall Study|Subject No Longer Meets Study Criteria|0|||
27938749|NCT00972244|54594991|FG004|Overall Study|Subject No Longer Meets Study Criteria|5|||
27938750|NCT00972244|54594987|FG000|Overall Study|Withdrawal by Subject|1|||
27938751|NCT00972244|54594988|FG001|Overall Study|Withdrawal by Subject|2|||
27938752|NCT00972244|54594989|FG002|Overall Study|Withdrawal by Subject|1|||
27938753|NCT00972244|54594990|FG003|Overall Study|Withdrawal by Subject|0|||
27938754|NCT00972244|54594991|FG004|Overall Study|Withdrawal by Subject|1|||
27938755|NCT00972244|54594987|FG000|Overall Study|Safety|0|||
27938756|NCT00972244|54594988|FG001|Overall Study|Safety|0|||
27938757|NCT00972244|54594989|FG002|Overall Study|Safety|0|||
27938758|NCT00972244|54594990|FG003|Overall Study|Safety|0|||
27938759|NCT00972244|54594991|FG004|Overall Study|Safety|1|||
27938760|NCT00972244|54594987|FG000|Overall Study|Death|1|||
27938761|NCT00972244|54594988|FG001|Overall Study|Death|0|||
27938762|NCT00972244|54594989|FG002|Overall Study|Death|0|||
27938763|NCT00972244|54594990|FG003|Overall Study|Death|0|||
27938764|NCT00972244|54594991|FG004|Overall Study|Death|0|||
27938765|NCT00972244|54594987|FG000|Overall Study|Various|0|||
27938766|NCT00972244|54594988|FG001|Overall Study|Various|0|||
27938767|NCT00972244|54594989|FG002|Overall Study|Various|0|||
27938768|NCT00972244|54594990|FG003|Overall Study|Various|0|||
27938769|NCT00972244|54594991|FG004|Overall Study|Various|2|||
27938770|NCT00892723|54595006|FG000|Overall Study|Lost to Follow-up|1|||
28023404|NCT00729833|54682286|FG003|Overall Study|Death|5|||
28023405|NCT00729833|54682283|FG000|Overall Study|Study Terminated by Sponsor|0|||
28023406|NCT00729833|54682284|FG001|Overall Study|Study Terminated by Sponsor|0|||
28023407|NCT00729833|54682285|FG002|Overall Study|Study Terminated by Sponsor|1|||
28023408|NCT00729833|54682286|FG003|Overall Study|Study Terminated by Sponsor|0|||
28023409|NCT00729833|54682283|FG000|Overall Study|Lost to Follow-up|1|||
28023410|NCT00729833|54682284|FG001|Overall Study|Lost to Follow-up|0|||
28023411|NCT00729833|54682285|FG002|Overall Study|Lost to Follow-up|0|||
28023412|NCT00729833|54682286|FG003|Overall Study|Lost to Follow-up|0|||
28023413|NCT00729833|54682283|FG000|Overall Study|Withdrawal by Subject|3|||
28023414|NCT00729833|54682284|FG001|Overall Study|Withdrawal by Subject|1|||
28023415|NCT00729833|54682285|FG002|Overall Study|Withdrawal by Subject|3|||
28023416|NCT00729833|54682286|FG003|Overall Study|Withdrawal by Subject|0|||
28023417|NCT00729833|54682283|FG000|Overall Study|Unspecified Reasons|11|||
28023418|NCT00729833|54682284|FG001|Overall Study|Unspecified Reasons|5|||
28023419|NCT00729833|54682285|FG002|Overall Study|Unspecified Reasons|5|||
28023420|NCT00729833|54682286|FG003|Overall Study|Unspecified Reasons|1|||
28023421|NCT00645788|54682301|FG000|Overall Study|Did not receive study drug|1|||
28023422|NCT00645788|54682302|FG001|Overall Study|Did not receive study drug|1|||
28023423|NCT00645788|54682303|FG002|Overall Study|Did not receive study drug|0|||
28023424|NCT00645788|54682304|FG003|Overall Study|Did not receive study drug|0|||
28023425|NCT00645788|54682301|FG000|Overall Study|Adverse Event|4|||
28023426|NCT00645788|54682302|FG001|Overall Study|Adverse Event|9|||
28023427|NCT00645788|54682303|FG002|Overall Study|Adverse Event|5|||
28023428|NCT00645788|54682304|FG003|Overall Study|Adverse Event|3|||
28023429|NCT00645788|54682301|FG000|Overall Study|Lost to Follow-up|1|||
28023430|NCT00645788|54682302|FG001|Overall Study|Lost to Follow-up|0|||
28023431|NCT00645788|54682303|FG002|Overall Study|Lost to Follow-up|0|||
28023432|NCT00645788|54682304|FG003|Overall Study|Lost to Follow-up|0|||
28023433|NCT00645788|54682301|FG000|Overall Study|Protocol Violation|1|||
28023434|NCT00645788|54682302|FG001|Overall Study|Protocol Violation|0|||
28023435|NCT00645788|54682303|FG002|Overall Study|Protocol Violation|2|||
28023436|NCT00645788|54682304|FG003|Overall Study|Protocol Violation|0|||
28023437|NCT00645788|54682301|FG000|Overall Study|Withdrawal by Subject|0|||
28023438|NCT00645788|54682302|FG001|Overall Study|Withdrawal by Subject|1|||
28023439|NCT00645788|54682303|FG002|Overall Study|Withdrawal by Subject|0|||
28023440|NCT00645788|54682304|FG003|Overall Study|Withdrawal by Subject|2|||
28023441|NCT00645788|54682301|FG000|Overall Study|Pulmonary exacerbation|13|||
28023442|NCT00645788|54682302|FG001|Overall Study|Pulmonary exacerbation|16|||
28023443|NCT00645788|54682303|FG002|Overall Study|Pulmonary exacerbation|11|||
28023444|NCT00645788|54682304|FG003|Overall Study|Pulmonary exacerbation|9|||
28023445|NCT00642356|54682316|FG000|Overall Study|Adverse Event|1|||
28023446|NCT00642356|54682317|FG001|Overall Study|Adverse Event|0|||
28023447|NCT00642356|54682316|FG000|Overall Study|Protocol Violation|0|||
28023448|NCT00642356|54682317|FG001|Overall Study|Protocol Violation|3|||
28023449|NCT00642356|54682316|FG000|Overall Study|Lack of Efficacy|1|||
28023450|NCT00642356|54682317|FG001|Overall Study|Lack of Efficacy|0|||
28023451|NCT00642278|54682330|FG000|Overall Study|Adverse Event|2|||
28023452|NCT00642278|54682331|FG001|Overall Study|Adverse Event|1|||
27800982|NCT02144285|54255896|FG006|Overall Study|Withdrawal by Subject|0|||
27800983|NCT02144285|54255897|FG007|Overall Study|Withdrawal by Subject|0|||
27800984|NCT02144285|54255898|FG008|Overall Study|Withdrawal by Subject|0|||
27800985|NCT02144285|54255899|FG009|Overall Study|Withdrawal by Subject|0|||
27800986|NCT02117687|54255937|FG000|Overall Study|Lost to Follow-up|0|||
27800987|NCT02117687|54255938|FG001|Overall Study|Lost to Follow-up|1|||
27800988|NCT02117687|54255937|FG000|Overall Study|Adverse Event|0|||
27800989|NCT02117687|54255938|FG001|Overall Study|Adverse Event|2|||
27800990|NCT02117687|54255937|FG000|Overall Study|Other Reasons|1|||
27938771|NCT00892723|54595007|FG001|Overall Study|Lost to Follow-up|3|||
27938772|NCT00892723|54595008|FG002|Overall Study|Lost to Follow-up|1|||
27938773|NCT00892723|54595006|FG000|Overall Study|Withdrawal by Subject|1|||
27938774|NCT00892723|54595007|FG001|Overall Study|Withdrawal by Subject|1|||
27938775|NCT00892723|54595008|FG002|Overall Study|Withdrawal by Subject|1|||
27938776|NCT03811912|54595051|FG000|Overall Study|Withdrew Consent|4|||
27938777|NCT03811912|54595052|FG001|Overall Study|Withdrew Consent|2|||
27938778|NCT00971932|54595058|FG000|Overall Study|Withdrawal by Subject|1|||
27938779|NCT00971932|54595058|FG000|Overall Study|Investigator's decision|2|||
27938780|NCT00971932|54595058|FG000|Overall Study|Ongoing|4|||
27938781|NCT00970684|54595062|FG000|Overall Study|Lack of Efficacy|5|||
27938782|NCT00970684|54595062|FG000|Overall Study|Adverse Event|4|||
27938783|NCT00970684|54595062|FG000|Overall Study|Withdrawal by Subject|1|||
27842835|NCT01440881|54331708|FG000|Overall Study|Death|0|||
28023453|NCT00642278|54682332|FG002|Overall Study|Adverse Event|3|||
28023454|NCT00642278|54682333|FG003|Overall Study|Adverse Event|1|||
28023455|NCT00642278|54682334|FG004|Overall Study|Adverse Event|2|||
28023456|NCT00642278|54682335|FG005|Overall Study|Adverse Event|2|||
28023457|NCT00642278|54682336|FG006|Overall Study|Adverse Event|0|||
28023458|NCT00642278|54682330|FG000|Overall Study|Lack of Efficacy|0|||
27800991|NCT02117687|54255938|FG001|Overall Study|Other Reasons|1|||
27800992|NCT02143583|54255947|FG000|Overall Study|Withdrawal by Subject|1|||
28023459|NCT00642278|54682331|FG001|Overall Study|Lack of Efficacy|1|||
27938784|NCT00967330|54595068|FG000|Overall Study|Protocol Violation|3|||
27938785|NCT00967330|54595069|FG001|Overall Study|Protocol Violation|4|||
28023460|NCT00642278|54682332|FG002|Overall Study|Lack of Efficacy|0|||
28023461|NCT00642278|54682333|FG003|Overall Study|Lack of Efficacy|0|||
28023462|NCT00642278|54682334|FG004|Overall Study|Lack of Efficacy|0|||
28023463|NCT00642278|54682335|FG005|Overall Study|Lack of Efficacy|0|||
28023464|NCT00642278|54682336|FG006|Overall Study|Lack of Efficacy|0|||
28023465|NCT00642278|54682330|FG000|Overall Study|Lost to Follow-up|5|||
27800993|NCT02143583|54255948|FG001|Overall Study|Withdrawal by Subject|0|||
27800994|NCT02143583|54255949|FG002|Overall Study|Withdrawal by Subject|1|||
28023466|NCT00642278|54682331|FG001|Overall Study|Lost to Follow-up|1|||
28023467|NCT00642278|54682332|FG002|Overall Study|Lost to Follow-up|0|||
28023468|NCT00642278|54682333|FG003|Overall Study|Lost to Follow-up|1|||
28023469|NCT00642278|54682334|FG004|Overall Study|Lost to Follow-up|0|||
28023470|NCT00642278|54682335|FG005|Overall Study|Lost to Follow-up|1|||
28023471|NCT00642278|54682336|FG006|Overall Study|Lost to Follow-up|1|||
28023472|NCT00642278|54682330|FG000|Overall Study|Physician Decision|0|||
28023473|NCT00642278|54682331|FG001|Overall Study|Physician Decision|0|||
28023474|NCT00642278|54682332|FG002|Overall Study|Physician Decision|0|||
28023475|NCT00642278|54682333|FG003|Overall Study|Physician Decision|1|||
28023476|NCT00642278|54682334|FG004|Overall Study|Physician Decision|0|||
27800995|NCT02143583|54255947|FG000|Overall Study|husband illness|0|||
27800996|NCT02143583|54255948|FG001|Overall Study|husband illness|0|||
27800997|NCT02143583|54255949|FG002|Overall Study|husband illness|1|||
27800998|NCT02105987|54255959|FG000|Early Switch Phase (24 Weeks)|Adverse Event|10|||
27800999|NCT02105987|54255960|FG001|Early Switch Phase (24 Weeks)|Adverse Event|0|||
27801000|NCT02105987|54255961|FG002|Early Switch Phase (24 Weeks)|Adverse Event|0|||
27801001|NCT02105987|54255962|FG003|Early Switch Phase (24 Weeks)|Adverse Event|0|||
27801002|NCT02105987|54255963|FG004|Early Switch Phase (24 Weeks)|Adverse Event|0|||
28023477|NCT00642278|54682335|FG005|Overall Study|Physician Decision|0|||
27801003|NCT02105987|54255964|FG005|Early Switch Phase (24 Weeks)|Adverse Event|0|||
27801004|NCT02105987|54255959|FG000|Early Switch Phase (24 Weeks)|Protocol Violation|15|||
27801005|NCT02105987|54255960|FG001|Early Switch Phase (24 Weeks)|Protocol Violation|17|||
27801006|NCT02105987|54255961|FG002|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
27801007|NCT02105987|54255962|FG003|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
27801008|NCT02105987|54255963|FG004|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
27801009|NCT02105987|54255964|FG005|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
27801010|NCT02105987|54255959|FG000|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4|||
27801011|NCT02105987|54255960|FG001|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10|||
27801012|NCT02105987|54255961|FG002|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
27801013|NCT02105987|54255962|FG003|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
27801014|NCT02105987|54255963|FG004|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
27801015|NCT02105987|54255964|FG005|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
27801016|NCT02105987|54255959|FG000|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
27801017|NCT02105987|54255960|FG001|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
27801018|NCT02105987|54255961|FG002|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
27801019|NCT02105987|54255962|FG003|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
27801020|NCT02105987|54255963|FG004|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
27801021|NCT02105987|54255964|FG005|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
27801022|NCT02105987|54255959|FG000|Early Switch Phase (24 Weeks)|Physician Decision|4|||
27801023|NCT02105987|54255960|FG001|Early Switch Phase (24 Weeks)|Physician Decision|3|||
27801024|NCT02105987|54255961|FG002|Early Switch Phase (24 Weeks)|Physician Decision|0|||
27801025|NCT02105987|54255962|FG003|Early Switch Phase (24 Weeks)|Physician Decision|0|||
27801026|NCT02105987|54255963|FG004|Early Switch Phase (24 Weeks)|Physician Decision|0|||
27801027|NCT02105987|54255964|FG005|Early Switch Phase (24 Weeks)|Physician Decision|0|||
27801028|NCT02105987|54255959|FG000|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
27801029|NCT02105987|54255960|FG001|Early Switch Phase (24 Weeks)|Missing Disposition Data|1|||
27801030|NCT02105987|54255961|FG002|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
27801031|NCT02105987|54255962|FG003|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
27801032|NCT02105987|54255963|FG004|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
27801033|NCT02105987|54255964|FG005|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
27801034|NCT02105987|54255959|FG000|Late Switch Phase (24 Weeks)|Adverse Event|0|||
27801035|NCT02105987|54255960|FG001|Late Switch Phase (24 Weeks)|Adverse Event|0|||
27801036|NCT02105987|54255961|FG002|Late Switch Phase (24 Weeks)|Adverse Event|10|||
27801037|NCT02105987|54255962|FG003|Late Switch Phase (24 Weeks)|Adverse Event|4|||
27801038|NCT02105987|54255963|FG004|Late Switch Phase (24 Weeks)|Adverse Event|0|||
27801039|NCT02105987|54255964|FG005|Late Switch Phase (24 Weeks)|Adverse Event|0|||
28023478|NCT00642278|54682336|FG006|Overall Study|Physician Decision|0|||
28023479|NCT00642278|54682330|FG000|Overall Study|Protocol Violation|0|||
28023480|NCT00642278|54682331|FG001|Overall Study|Protocol Violation|0|||
27801040|NCT02105987|54255959|FG000|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
27842836|NCT01440881|54331709|FG001|Overall Study|Death|1|||
28023481|NCT00642278|54682332|FG002|Overall Study|Protocol Violation|1|||
28023482|NCT00642278|54682333|FG003|Overall Study|Protocol Violation|1|||
28023483|NCT00642278|54682334|FG004|Overall Study|Protocol Violation|0|||
28023484|NCT00642278|54682335|FG005|Overall Study|Protocol Violation|1|||
28023485|NCT00642278|54682336|FG006|Overall Study|Protocol Violation|2|||
28023486|NCT00642278|54682330|FG000|Overall Study|Withdrawal by Subject|1|||
28023487|NCT00642278|54682331|FG001|Overall Study|Withdrawal by Subject|1|||
28023488|NCT00642278|54682332|FG002|Overall Study|Withdrawal by Subject|1|||
28023489|NCT00642278|54682333|FG003|Overall Study|Withdrawal by Subject|3|||
28023490|NCT00642278|54682334|FG004|Overall Study|Withdrawal by Subject|6|||
28023491|NCT00642278|54682335|FG005|Overall Study|Withdrawal by Subject|2|||
28023492|NCT00642278|54682336|FG006|Overall Study|Withdrawal by Subject|2|||
28023493|NCT00642278|54682330|FG000|Overall Study|Noncompliance with study drug regimen|0|||
28023494|NCT00642278|54682331|FG001|Overall Study|Noncompliance with study drug regimen|0|||
28023495|NCT00642278|54682332|FG002|Overall Study|Noncompliance with study drug regimen|0|||
28023496|NCT00642278|54682333|FG003|Overall Study|Noncompliance with study drug regimen|1|||
28023497|NCT00642278|54682334|FG004|Overall Study|Noncompliance with study drug regimen|0|||
28023498|NCT00642278|54682335|FG005|Overall Study|Noncompliance with study drug regimen|0|||
28023499|NCT00642278|54682336|FG006|Overall Study|Noncompliance with study drug regimen|0|||
28023500|NCT00642278|54682330|FG000|Overall Study|Other|2|||
28023501|NCT00642278|54682331|FG001|Overall Study|Other|1|||
28023502|NCT00642278|54682332|FG002|Overall Study|Other|0|||
28023503|NCT00642278|54682333|FG003|Overall Study|Other|1|||
28023504|NCT00642278|54682334|FG004|Overall Study|Other|0|||
28023505|NCT00642278|54682335|FG005|Overall Study|Other|1|||
28023506|NCT00642278|54682336|FG006|Overall Study|Other|0|||
28023507|NCT00543543|54682356|FG000|Base Study|Adverse Event|1|||
28023508|NCT00543543|54682357|FG001|Base Study|Adverse Event|11|||
28023509|NCT00543543|54682358|FG002|Base Study|Adverse Event|0|||
28023510|NCT00543543|54682359|FG003|Base Study|Adverse Event|5|||
28023511|NCT00543543|54682356|FG000|Base Study|Lost to Follow-up|12|||
28023512|NCT00543543|54682357|FG001|Base Study|Lost to Follow-up|749|||
28023513|NCT00543543|54682358|FG002|Base Study|Lost to Follow-up|9|||
28023514|NCT00543543|54682359|FG003|Base Study|Lost to Follow-up|701|||
28023515|NCT00543543|54682356|FG000|Base Study|Physician Decision|0|||
28023516|NCT00543543|54682357|FG001|Base Study|Physician Decision|4|||
28023517|NCT00543543|54682358|FG002|Base Study|Physician Decision|0|||
28023518|NCT00543543|54682359|FG003|Base Study|Physician Decision|7|||
27801041|NCT02105987|54255960|FG001|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
27801042|NCT02105987|54255961|FG002|Late Switch Phase (24 Weeks)|Protocol Violation|15|||
27801043|NCT02105987|54255962|FG003|Late Switch Phase (24 Weeks)|Protocol Violation|1|||
27801044|NCT02105987|54255963|FG004|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
28023519|NCT00543543|54682356|FG000|Base Study|Protocol Violation|0|||
28023520|NCT00543543|54682357|FG001|Base Study|Protocol Violation|6|||
28023521|NCT00543543|54682358|FG002|Base Study|Protocol Violation|0|||
28023522|NCT00543543|54682359|FG003|Base Study|Protocol Violation|6|||
28023523|NCT00543543|54682356|FG000|Base Study|Withdrawal by Subject|7|||
28023524|NCT00543543|54682357|FG001|Base Study|Withdrawal by Subject|482|||
28023525|NCT00543543|54682358|FG002|Base Study|Withdrawal by Subject|5|||
28023526|NCT00543543|54682359|FG003|Base Study|Withdrawal by Subject|503|||
28023527|NCT00543543|54682356|FG000|Extension Study|Adverse Event|0|||
28023528|NCT00543543|54682357|FG001|Extension Study|Adverse Event|0|||
28023529|NCT00543543|54682358|FG002|Extension Study|Adverse Event|0|||
28023530|NCT00543543|54682359|FG003|Extension Study|Adverse Event|5|||
28023531|NCT00543543|54682356|FG000|Extension Study|Lost to Follow-up|0|||
28023532|NCT00543543|54682357|FG001|Extension Study|Lost to Follow-up|0|||
28023533|NCT00543543|54682358|FG002|Extension Study|Lost to Follow-up|0|||
28023534|NCT00543543|54682359|FG003|Extension Study|Lost to Follow-up|77|||
28023535|NCT00543543|54682356|FG000|Extension Study|Physician Decision|0|||
28023536|NCT00543543|54682357|FG001|Extension Study|Physician Decision|0|||
28023537|NCT00543543|54682358|FG002|Extension Study|Physician Decision|0|||
28023538|NCT00543543|54682359|FG003|Extension Study|Physician Decision|7|||
28023539|NCT00543543|54682356|FG000|Extension Study|Pregnancy|0|||
28023540|NCT00543543|54682357|FG001|Extension Study|Pregnancy|0|||
28023541|NCT00543543|54682358|FG002|Extension Study|Pregnancy|0|||
28023542|NCT00543543|54682359|FG003|Extension Study|Pregnancy|6|||
28023543|NCT00543543|54682356|FG000|Extension Study|Protocol Violation|0|||
28023544|NCT00543543|54682357|FG001|Extension Study|Protocol Violation|0|||
28023545|NCT00543543|54682358|FG002|Extension Study|Protocol Violation|0|||
27801045|NCT02105987|54255964|FG005|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
27801046|NCT02105987|54255959|FG000|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
27801047|NCT02105987|54255960|FG001|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
27801048|NCT02105987|54255961|FG002|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6|||
27801049|NCT02105987|54255962|FG003|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5|||
27801050|NCT02105987|54255963|FG004|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
27801051|NCT02105987|54255964|FG005|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
27801052|NCT02105987|54255959|FG000|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
27801053|NCT02105987|54255960|FG001|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
27801054|NCT02105987|54255961|FG002|Late Switch Phase (24 Weeks)|Lost to Follow-up|8|||
27801055|NCT02105987|54255962|FG003|Late Switch Phase (24 Weeks)|Lost to Follow-up|3|||
27801056|NCT02105987|54255963|FG004|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
27801057|NCT02105987|54255964|FG005|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
27801058|NCT02105987|54255959|FG000|Late Switch Phase (24 Weeks)|Physician Decision|0|||
27801059|NCT02105987|54255960|FG001|Late Switch Phase (24 Weeks)|Physician Decision|0|||
27801060|NCT02105987|54255961|FG002|Late Switch Phase (24 Weeks)|Physician Decision|5|||
27801061|NCT02105987|54255962|FG003|Late Switch Phase (24 Weeks)|Physician Decision|0|||
27801062|NCT02105987|54255963|FG004|Late Switch Phase (24 Weeks)|Physician Decision|0|||
27801063|NCT02105987|54255964|FG005|Late Switch Phase (24 Weeks)|Physician Decision|0|||
27801064|NCT02105987|54255959|FG000|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
27801065|NCT02105987|54255960|FG001|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
27801066|NCT02105987|54255961|FG002|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
27801067|NCT02105987|54255962|FG003|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1|||
27801068|NCT02105987|54255963|FG004|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
27801069|NCT02105987|54255964|FG005|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
27801070|NCT02105987|54255959|FG000|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
27801071|NCT02105987|54255960|FG001|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
27801072|NCT02105987|54255961|FG002|Late Switch Phase (24 Weeks)|Per sponsor request|1|||
27801073|NCT02105987|54255962|FG003|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
27801074|NCT02105987|54255963|FG004|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
27801075|NCT02105987|54255964|FG005|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
27801076|NCT02105987|54255959|FG000|Continuation Phase|Protocol Violation|0|||
28023546|NCT00543543|54682359|FG003|Extension Study|Protocol Violation|11|||
28023547|NCT00543543|54682356|FG000|Extension Study|Withdrawal by Subject|0|||
28023548|NCT00543543|54682357|FG001|Extension Study|Withdrawal by Subject|0|||
28023549|NCT00543543|54682358|FG002|Extension Study|Withdrawal by Subject|0|||
28023550|NCT00543543|54682359|FG003|Extension Study|Withdrawal by Subject|120|||
27801077|NCT02105987|54255960|FG001|Continuation Phase|Protocol Violation|0|||
28023551|NCT00645164|54682374|FG000|Overall Study|Lost to Follow-up|2|||
28023552|NCT00645164|54682374|FG000|Overall Study|Withdrawal by Subject|4|||
28023553|NCT00645164|54682374|FG000|Overall Study|Protocol Violation|1|||
28023554|NCT00723125|54682380|FG000|Overall Study|Met Dx|1|||
28023555|NCT00723125|54682381|FG001|Overall Study|Met Dx|0|||
28023556|NCT00723125|54682380|FG000|Overall Study|Withdrawal by Subject|15|||
28023557|NCT00723125|54682381|FG001|Overall Study|Withdrawal by Subject|6|||
28023558|NCT00723125|54682380|FG000|Overall Study|Adverse Event|2|||
28023559|NCT00723125|54682381|FG001|Overall Study|Adverse Event|0|||
28023560|NCT00722423|54682395|FG000|Overall Study|Protocol Violation|0|||
28023561|NCT00722423|54682396|FG001|Overall Study|Protocol Violation|1|||
28023562|NCT00640562|54682406|FG000|Overall Study|Adverse Event|8|||
28023563|NCT00640562|54682407|FG001|Overall Study|Adverse Event|5|||
28023564|NCT00640562|54682406|FG000|Overall Study|Lack of Efficacy|1|||
28023565|NCT00640562|54682407|FG001|Overall Study|Lack of Efficacy|4|||
28023566|NCT00640562|54682406|FG000|Overall Study|Protocol Violation|2|||
28023567|NCT00640562|54682407|FG001|Overall Study|Protocol Violation|4|||
28023568|NCT00640562|54682406|FG000|Overall Study|Withdrawal by Subject|6|||
28023569|NCT00640562|54682407|FG001|Overall Study|Withdrawal by Subject|10|||
28023570|NCT00640562|54682406|FG000|Overall Study|Known risperidone intolerance|0|||
28023571|NCT00640562|54682407|FG001|Overall Study|Known risperidone intolerance|1|||
28023572|NCT00640562|54682406|FG000|Overall Study|Past use of Seroquel -stopped due to AE|0|||
28023573|NCT00640562|54682407|FG001|Overall Study|Past use of Seroquel -stopped due to AE|1|||
28023574|NCT00640562|54682406|FG000|Overall Study|Low study drug dose|0|||
28023575|NCT00640562|54682407|FG001|Overall Study|Low study drug dose|1|||
28023576|NCT00640562|54682406|FG000|Overall Study|Glycosylated Hemoglobin >8|1|||
28023577|NCT00640562|54682407|FG001|Overall Study|Glycosylated Hemoglobin >8|0|||
28023578|NCT00585923|54682415|FG000|Overall Study|Physician decided not to continue|31|||
28023579|NCT00585923|54682416|FG001|Overall Study|Physician decided not to continue|33|||
28023580|NCT00721955|54682425|FG000|Overall Study|Adverse Event|0|||
28023581|NCT00721955|54682426|FG001|Overall Study|Adverse Event|0|||
28023582|NCT00721955|54682427|FG002|Overall Study|Adverse Event|2|||
28023583|NCT00585689|54682435|FG000|Overall Study|Received different ABI-007 schedule|3|||
28023584|NCT00585689|54682435|FG000|Overall Study|Adverse Event|1|||
28023585|NCT00585689|54682435|FG000|Overall Study|Patient Declined Surgery|1|||
28023586|NCT00585689|54682435|FG000|Overall Study|Patient had unresectable disease|1|||
28023587|NCT00585689|54682435|FG000|Overall Study|Death|1|||
28023588|NCT00721799|54682439|FG000|Overall Study|Withdrawal by Subject|7|||
28023589|NCT00721799|54682439|FG000|Overall Study|withdraw by subject after scan 1|1|||
28023590|NCT00729365|54682446|FG000|Overall Study|Physician Decision|33|||
28023591|NCT00729365|54682447|FG001|Overall Study|Physician Decision|6|||
28023592|NCT00729365|54682448|FG002|Overall Study|Physician Decision|7|||
28023593|NCT00254293|54682464|FG000|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
28023594|NCT00254293|54682465|FG001|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
28023595|NCT00254293|54682466|FG002|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
28023596|NCT00254293|54682467|FG003|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
28023597|NCT00254293|54682468|FG004|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
28023598|NCT00254293|54682469|FG005|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
28023599|NCT00254293|54682470|FG006|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
28023600|NCT00254293|54682464|FG000|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
28023601|NCT00254293|54682465|FG001|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
28023602|NCT00254293|54682466|FG002|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1|||
28023603|NCT00254293|54682467|FG003|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
28023604|NCT00254293|54682468|FG004|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
28023605|NCT00254293|54682469|FG005|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
28023606|NCT00254293|54682470|FG006|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
28023607|NCT00254293|54682464|FG000|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
28023608|NCT00254293|54682465|FG001|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
28023609|NCT00254293|54682466|FG002|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2|||
28023610|NCT00254293|54682467|FG003|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
28023611|NCT00254293|54682468|FG004|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
28023612|NCT00254293|54682469|FG005|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
27801078|NCT02105987|54255961|FG002|Continuation Phase|Protocol Violation|0|||
27801079|NCT02105987|54255962|FG003|Continuation Phase|Protocol Violation|0|||
27801080|NCT02105987|54255963|FG004|Continuation Phase|Protocol Violation|1|||
27801081|NCT02105987|54255964|FG005|Continuation Phase|Protocol Violation|0|||
27801082|NCT02141633|54255972|FG000|Overall Study|Physician Decision|1|||
27801083|NCT02141633|54255973|FG001|Overall Study|Physician Decision|0|||
27801084|NCT01846611|54255981|FG000|Overall Study|Lost to Follow-up|4|||
27801085|NCT01846611|54255982|FG001|Overall Study|Lost to Follow-up|6|||
27801086|NCT01846611|54255981|FG000|Overall Study|Withdrawal by Subject|15|||
27801087|NCT01846611|54255982|FG001|Overall Study|Withdrawal by Subject|19|||
27801088|NCT01846611|54255981|FG000|Overall Study|Other|19|||
28023613|NCT00254293|54682470|FG006|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
27801089|NCT01846611|54255982|FG001|Overall Study|Other|18|||
27801090|NCT02141399|54255988|FG000|Overall Study|Adverse Event|158|||
28023614|NCT00254293|54682464|FG000|LTE Open Label Variable SC Dosing|Death|0|||
28023615|NCT00254293|54682465|FG001|LTE Open Label Variable SC Dosing|Death|0|||
28023616|NCT00254293|54682466|FG002|LTE Open Label Variable SC Dosing|Death|1|||
28023617|NCT00254293|54682467|FG003|LTE Open Label Variable SC Dosing|Death|0|||
28023618|NCT00254293|54682468|FG004|LTE Open Label Variable SC Dosing|Death|0|||
28023619|NCT00254293|54682469|FG005|LTE Open Label Variable SC Dosing|Death|0|||
28023620|NCT00254293|54682470|FG006|LTE Open Label Variable SC Dosing|Death|0|||
28023621|NCT00254293|54682464|FG000|LTE Open Label Variable SC Dosing|Adverse Event|1|||
28023622|NCT00254293|54682465|FG001|LTE Open Label Variable SC Dosing|Adverse Event|0|||
28023623|NCT00254293|54682466|FG002|LTE Open Label Variable SC Dosing|Adverse Event|2|||
28023624|NCT00254293|54682467|FG003|LTE Open Label Variable SC Dosing|Adverse Event|0|||
28023625|NCT00254293|54682468|FG004|LTE Open Label Variable SC Dosing|Adverse Event|1|||
28023626|NCT00254293|54682469|FG005|LTE Open Label Variable SC Dosing|Adverse Event|0|||
28023627|NCT00254293|54682470|FG006|LTE Open Label Variable SC Dosing|Adverse Event|0|||
28023628|NCT00254293|54682464|FG000|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
28023629|NCT00254293|54682465|FG001|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
28023630|NCT00254293|54682466|FG002|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
28023631|NCT00254293|54682467|FG003|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
28023632|NCT00254293|54682468|FG004|LTE Open Label Variable SC Dosing|Lack of Efficacy|1|||
28023633|NCT00254293|54682469|FG005|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
28023634|NCT00254293|54682470|FG006|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
28023635|NCT00254293|54682464|FG000|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
28023636|NCT00254293|54682465|FG001|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
28023637|NCT00254293|54682466|FG002|LTE Open Label Variable SC Dosing|Lost to Follow-up|1|||
28023638|NCT00254293|54682467|FG003|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
28023639|NCT00254293|54682468|FG004|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
28023640|NCT00254293|54682469|FG005|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
28023641|NCT00254293|54682470|FG006|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
28023642|NCT00254293|54682464|FG000|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
28023643|NCT00254293|54682465|FG001|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
28023644|NCT00254293|54682466|FG002|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1|||
28023645|NCT00254293|54682467|FG003|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
28023646|NCT00254293|54682468|FG004|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
28023647|NCT00254293|54682469|FG005|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
28023648|NCT00254293|54682470|FG006|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
28023649|NCT00254293|54682464|FG000|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
28023650|NCT00254293|54682465|FG001|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
28023651|NCT00254293|54682466|FG002|LTE Open Label Variable SC Dosing|Poor or non-compliance|1|||
28023652|NCT00254293|54682467|FG003|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
28023653|NCT00254293|54682468|FG004|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
28023654|NCT00254293|54682469|FG005|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
28023655|NCT00254293|54682470|FG006|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
28023656|NCT00254293|54682464|FG000|LTE Open Label Variable SC Dosing|Other|0|||
28023657|NCT00254293|54682465|FG001|LTE Open Label Variable SC Dosing|Other|0|||
28023658|NCT00254293|54682466|FG002|LTE Open Label Variable SC Dosing|Other|2|||
28023659|NCT00254293|54682467|FG003|LTE Open Label Variable SC Dosing|Other|0|||
28023660|NCT00254293|54682468|FG004|LTE Open Label Variable SC Dosing|Other|0|||
28023661|NCT00254293|54682469|FG005|LTE Open Label Variable SC Dosing|Other|0|||
28023662|NCT00254293|54682470|FG006|LTE Open Label Variable SC Dosing|Other|0|||
28023663|NCT00254293|54682464|FG000|LTE Open Label Fixed Dosing|Death|0|||
28023664|NCT00254293|54682465|FG001|LTE Open Label Fixed Dosing|Death|0|||
28023665|NCT00254293|54682466|FG002|LTE Open Label Fixed Dosing|Death|0|||
28023666|NCT00254293|54682467|FG003|LTE Open Label Fixed Dosing|Death|0|||
28023667|NCT00254293|54682468|FG004|LTE Open Label Fixed Dosing|Death|0|||
28023668|NCT00254293|54682469|FG005|LTE Open Label Fixed Dosing|Death|0|||
28023669|NCT00254293|54682470|FG006|LTE Open Label Fixed Dosing|Death|3|||
27842837|NCT01575197|54331724|FG000|Overall Study|Migration out of study area|1|||
28023670|NCT00254293|54682464|FG000|LTE Open Label Fixed Dosing|Adverse Event|0|||
28023671|NCT00254293|54682465|FG001|LTE Open Label Fixed Dosing|Adverse Event|0|||
28023672|NCT00254293|54682466|FG002|LTE Open Label Fixed Dosing|Adverse Event|0|||
28023673|NCT00254293|54682467|FG003|LTE Open Label Fixed Dosing|Adverse Event|0|||
28023674|NCT00254293|54682468|FG004|LTE Open Label Fixed Dosing|Adverse Event|0|||
28023675|NCT00254293|54682469|FG005|LTE Open Label Fixed Dosing|Adverse Event|0|||
28023676|NCT00254293|54682470|FG006|LTE Open Label Fixed Dosing|Adverse Event|1|||
28023677|NCT00254293|54682464|FG000|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
28023678|NCT00254293|54682465|FG001|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
28023679|NCT00254293|54682466|FG002|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
27801091|NCT02141399|54255988|FG000|Overall Study|Lack of Efficacy|62|||
27801092|NCT02141399|54255988|FG000|Overall Study|Lost to Follow-up|151|||
27801093|NCT02141399|54255988|FG000|Overall Study|Non-compliance with study drug|18|||
27801094|NCT02141399|54255988|FG000|Overall Study|Other|45|||
27801095|NCT02141399|54255988|FG000|Overall Study|Physician Decision|17|||
27801096|NCT02141399|54255988|FG000|Overall Study|Pregnancy|3|||
27801097|NCT02141399|54255988|FG000|Overall Study|Protocol Violation|38|||
27801098|NCT02141399|54255988|FG000|Overall Study|Withdrawal by Subject|238|||
27801099|NCT02141399|54255988|FG000|Overall Study|Failure to meet eligibility criteria|14|||
27801100|NCT01846299|54255994|FG000|Overall Study|Physician Decision|4|||
28023680|NCT00254293|54682467|FG003|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
28023681|NCT00254293|54682468|FG004|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
28023682|NCT00254293|54682469|FG005|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
28023683|NCT00254293|54682470|FG006|LTE Open Label Fixed Dosing|Lack of Efficacy|3|||
28023684|NCT00254293|54682464|FG000|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
28023685|NCT00254293|54682465|FG001|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
28023686|NCT00254293|54682466|FG002|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
28023687|NCT00254293|54682467|FG003|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
28023688|NCT00254293|54682468|FG004|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
28023689|NCT00254293|54682469|FG005|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
27801101|NCT01846299|54255995|FG001|Overall Study|Physician Decision|2|||
27801102|NCT01846299|54255994|FG000|Overall Study|Protocol deviation|1|||
27801103|NCT01846299|54255995|FG001|Overall Study|Protocol deviation|0|||
27801104|NCT01846299|54255994|FG000|Overall Study|Death|1|||
27801105|NCT01846299|54255995|FG001|Overall Study|Death|2|||
27801106|NCT01846299|54255994|FG000|Overall Study|Lost to Follow-up|3|||
27801107|NCT01846299|54255995|FG001|Overall Study|Lost to Follow-up|0|||
27801108|NCT01846299|54255994|FG000|Overall Study|Withdrawal by Subject|1|||
27801109|NCT01846299|54255995|FG001|Overall Study|Withdrawal by Subject|6|||
27801110|NCT01846299|54255994|FG000|Overall Study|Adverse Event|2|||
27801111|NCT01846299|54255995|FG001|Overall Study|Adverse Event|0|||
27801112|NCT01628393|54256006|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|1|||
27801113|NCT01628393|54256007|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
27801114|NCT01628393|54256008|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
27801115|NCT01628393|54256009|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
27801116|NCT01628393|54256010|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
27801117|NCT01628393|54256006|FG000|Placebo-controlled Treatment Period|Protocol Violation|0|||
27801118|NCT01628393|54256007|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
27801119|NCT01628393|54256008|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
27801120|NCT01628393|54256009|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
27801121|NCT01628393|54256010|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
27801122|NCT01628393|54256006|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
27801123|NCT01628393|54256007|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
27801124|NCT01628393|54256008|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
27938786|NCT00967330|54595068|FG000|Overall Study|Regular|10|||
27938787|NCT00967330|54595069|FG001|Overall Study|Regular|3|||
27938788|NCT00967330|54595068|FG000|Overall Study|Withdrawal by Subject|6|||
27938789|NCT00967330|54595069|FG001|Overall Study|Withdrawal by Subject|0|||
27938790|NCT00967330|54595068|FG000|Overall Study|Lost to Follow-up|1|||
27938791|NCT00967330|54595069|FG001|Overall Study|Lost to Follow-up|1|||
27938792|NCT00967330|54595068|FG000|Overall Study|Death|102|||
28023690|NCT00254293|54682470|FG006|LTE Open Label Fixed Dosing|Lost to Follow-up|1|||
27938793|NCT00967330|54595069|FG001|Overall Study|Death|51|||
27938794|NCT00967330|54595068|FG000|Overall Study|Severe protocol deviation|0|||
27938795|NCT00967330|54595069|FG001|Overall Study|Severe protocol deviation|1|||
27938796|NCT00967018|54595075|FG000|Overall Study|Adverse Event|2|||
27938797|NCT00967018|54595075|FG000|Overall Study|Physician Decision|7|||
28023691|NCT00254293|54682464|FG000|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
27801125|NCT01628393|54256009|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
27801126|NCT01628393|54256010|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
27801127|NCT01628393|54256006|FG000|Blinded Active Extension Period|Adverse Event|0|||
27938798|NCT00967018|54595075|FG000|Overall Study|Lost to Follow-up|2|||
27938799|NCT00967018|54595075|FG000|Overall Study|Withdrawal by Subject|1|||
27801128|NCT01628393|54256007|FG001|Blinded Active Extension Period|Adverse Event|1|||
27801129|NCT01628393|54256008|FG002|Blinded Active Extension Period|Adverse Event|0|||
27801130|NCT01628393|54256009|FG003|Blinded Active Extension Period|Adverse Event|2|||
27801131|NCT01628393|54256010|FG004|Blinded Active Extension Period|Adverse Event|2|||
27801132|NCT01628393|54256006|FG000|Blinded Active Extension Period|Lack of Efficacy|0|||
27801133|NCT01628393|54256007|FG001|Blinded Active Extension Period|Lack of Efficacy|0|||
27801134|NCT01628393|54256008|FG002|Blinded Active Extension Period|Lack of Efficacy|2|||
27801135|NCT01628393|54256009|FG003|Blinded Active Extension Period|Lack of Efficacy|0|||
27801136|NCT01628393|54256010|FG004|Blinded Active Extension Period|Lack of Efficacy|2|||
27801137|NCT01628393|54256006|FG000|Blinded Active Extension Period|Physician Decision|0|||
27801138|NCT01628393|54256007|FG001|Blinded Active Extension Period|Physician Decision|3|||
27801139|NCT01628393|54256008|FG002|Blinded Active Extension Period|Physician Decision|0|||
27801140|NCT01628393|54256009|FG003|Blinded Active Extension Period|Physician Decision|1|||
27801141|NCT01628393|54256010|FG004|Blinded Active Extension Period|Physician Decision|0|||
27801142|NCT01628393|54256006|FG000|Blinded Active Extension Period|Protocol Violation|0|||
27801143|NCT01628393|54256007|FG001|Blinded Active Extension Period|Protocol Violation|0|||
27801144|NCT01628393|54256008|FG002|Blinded Active Extension Period|Protocol Violation|2|||
27801145|NCT01628393|54256009|FG003|Blinded Active Extension Period|Protocol Violation|1|||
28023692|NCT00254293|54682465|FG001|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
28023693|NCT00254293|54682466|FG002|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
28023694|NCT00254293|54682467|FG003|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
28023695|NCT00254293|54682468|FG004|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
28023696|NCT00254293|54682469|FG005|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
28023697|NCT00254293|54682470|FG006|LTE Open Label Fixed Dosing|Withdrawal by Subject|3|||
28023698|NCT00254293|54682464|FG000|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
28023699|NCT00254293|54682465|FG001|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
28023700|NCT00254293|54682466|FG002|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
28023701|NCT00254293|54682467|FG003|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
28023702|NCT00254293|54682468|FG004|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
28023703|NCT00254293|54682469|FG005|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
28023704|NCT00254293|54682470|FG006|LTE Open Label Fixed Dosing|Poor or non-compliance|1|||
28023705|NCT00254293|54682464|FG000|LTE Open Label Fixed Dosing|Other|0|||
28023706|NCT00254293|54682465|FG001|LTE Open Label Fixed Dosing|Other|0|||
28023707|NCT00254293|54682466|FG002|LTE Open Label Fixed Dosing|Other|0|||
28023708|NCT00254293|54682467|FG003|LTE Open Label Fixed Dosing|Other|0|||
28023709|NCT00254293|54682468|FG004|LTE Open Label Fixed Dosing|Other|0|||
28023710|NCT00254293|54682469|FG005|LTE Open Label Fixed Dosing|Other|0|||
28023711|NCT00254293|54682470|FG006|LTE Open Label Fixed Dosing|Other|1|||
28023712|NCT00736385|54682515|FG000|Overall Study|Withdrawal by Subject|2|||
28023713|NCT00736385|54682516|FG001|Overall Study|Withdrawal by Subject|2|||
28023714|NCT00736385|54682515|FG000|Overall Study|Adverse Event|0|||
28023715|NCT00736385|54682516|FG001|Overall Study|Adverse Event|1|||
28023716|NCT00585221|54682522|FG000|Overall Study|Protocol Violation|8|||
28023717|NCT00253747|54682528|FG000|Overall Study|Lost to Follow-up|13|||
28023718|NCT00253747|54682529|FG001|Overall Study|Lost to Follow-up|14|||
28023719|NCT00253747|54682528|FG000|Overall Study|Withdrawal by Subject|10|||
28023720|NCT00253747|54682529|FG001|Overall Study|Withdrawal by Subject|11|||
28023721|NCT00253747|54682528|FG000|Overall Study|Administrative Discharge (1), Other (2)|1|||
28023722|NCT00253747|54682529|FG001|Overall Study|Administrative Discharge (1), Other (2)|2|||
28023723|NCT00252733|54682547|FG000|Overall Study|Withdrawal by Subject|73|||
28023724|NCT00252733|54682548|FG001|Overall Study|Withdrawal by Subject|67|||
28023725|NCT00252733|54682547|FG000|Overall Study|Death|7|||
28023726|NCT00252733|54682548|FG001|Overall Study|Death|5|||
28023727|NCT00252733|54682547|FG000|Overall Study|Lost to Follow-up|12|||
28023728|NCT00252733|54682548|FG001|Overall Study|Lost to Follow-up|6|||
28023729|NCT00252733|54682547|FG000|Overall Study|Multiple Reasons|14|||
28023730|NCT00252733|54682548|FG001|Overall Study|Multiple Reasons|14|||
28023731|NCT00275821|54682557|FG000|Overall Study|Adverse Event|4|||
28023732|NCT00275821|54682558|FG001|Overall Study|Adverse Event|12|||
28023733|NCT00275821|54682559|FG002|Overall Study|Adverse Event|5|||
28023734|NCT00275821|54682557|FG000|Overall Study|Administrative problems|3|||
28023735|NCT00275821|54682558|FG001|Overall Study|Administrative problems|4|||
28023736|NCT00275821|54682559|FG002|Overall Study|Administrative problems|4|||
28023737|NCT00275821|54682557|FG000|Overall Study|Withdrawal by Subject|0|||
28023738|NCT00275821|54682558|FG001|Overall Study|Withdrawal by Subject|2|||
28023739|NCT00275821|54682559|FG002|Overall Study|Withdrawal by Subject|1|||
28023740|NCT00275821|54682557|FG000|Overall Study|Lost to Follow-up|0|||
28023741|NCT00275821|54682558|FG001|Overall Study|Lost to Follow-up|1|||
28023742|NCT00275821|54682559|FG002|Overall Study|Lost to Follow-up|1|||
28023743|NCT00275821|54682557|FG000|Overall Study|Death|0|||
28023744|NCT00275821|54682558|FG001|Overall Study|Death|2|||
28023745|NCT00275821|54682559|FG002|Overall Study|Death|1|||
27801146|NCT01628393|54256010|FG004|Blinded Active Extension Period|Protocol Violation|0|||
27801147|NCT01628393|54256006|FG000|Blinded Active Extension Period|Withdrawal by Subject|0|||
28023746|NCT00275821|54682557|FG000|Overall Study|Lack of Efficacy|2|||
28023747|NCT00275821|54682558|FG001|Overall Study|Lack of Efficacy|1|||
28023748|NCT00275821|54682559|FG002|Overall Study|Lack of Efficacy|0|||
28023749|NCT00275821|54682557|FG000|Overall Study|Protocol Violation|5|||
28023750|NCT00275821|54682558|FG001|Overall Study|Protocol Violation|1|||
28023751|NCT00275821|54682559|FG002|Overall Study|Protocol Violation|0|||
28023752|NCT00275509|54682569|FG000|Overall Study|graft thrombosis, post-operative day #8|0|||
28023753|NCT00275509|54682570|FG001|Overall Study|graft thrombosis, post-operative day #8|1|||
28023754|NCT00252577|54682576|FG000|Overall Study|Lost to Follow-up|20|||
28023755|NCT00252499|54682583|FG000|Overall Study|Lost to Follow-up|1|||
28023756|NCT00252499|54682584|FG001|Overall Study|Lost to Follow-up|0|||
28023757|NCT00252499|54682585|FG002|Overall Study|Lost to Follow-up|0|||
28023758|NCT00252187|54682595|FG000|Overall Study|Adverse Event|3|||
28023759|NCT00252187|54682596|FG001|Overall Study|Adverse Event|1|||
28023760|NCT00252187|54682595|FG000|Overall Study|Withdrawal by Subject|1|||
28023761|NCT00252187|54682596|FG001|Overall Study|Withdrawal by Subject|0|||
28023762|NCT00572910|54682608|FG000|Overall Study|Adverse Event|1|||
28023763|NCT00572910|54682609|FG001|Overall Study|Adverse Event|2|||
28023764|NCT00572910|54682610|FG002|Overall Study|Adverse Event|0|||
28023765|NCT00572910|54682611|FG003|Overall Study|Adverse Event|2|||
28023766|NCT00572910|54682612|FG004|Overall Study|Adverse Event|0|||
28023767|NCT00572910|54682613|FG005|Overall Study|Adverse Event|0|||
28023768|NCT00572910|54682614|FG006|Overall Study|Adverse Event|4|||
28023769|NCT00572910|54682615|FG007|Overall Study|Adverse Event|2|||
28023770|NCT00572910|54682616|FG008|Overall Study|Adverse Event|1|||
28023771|NCT00572910|54682617|FG009|Overall Study|Adverse Event|3|||
28023772|NCT00572910|54682618|FG010|Overall Study|Adverse Event|2|||
28023773|NCT00572910|54682608|FG000|Overall Study|Lost to Follow-up|0|||
28023774|NCT00572910|54682609|FG001|Overall Study|Lost to Follow-up|1|||
28023775|NCT00572910|54682610|FG002|Overall Study|Lost to Follow-up|1|||
28023776|NCT00572910|54682611|FG003|Overall Study|Lost to Follow-up|2|||
28023777|NCT00572910|54682612|FG004|Overall Study|Lost to Follow-up|1|||
28023778|NCT00572910|54682613|FG005|Overall Study|Lost to Follow-up|0|||
28023779|NCT00572910|54682614|FG006|Overall Study|Lost to Follow-up|0|||
28023780|NCT00572910|54682615|FG007|Overall Study|Lost to Follow-up|0|||
28023781|NCT00572910|54682616|FG008|Overall Study|Lost to Follow-up|0|||
28023782|NCT00572910|54682617|FG009|Overall Study|Lost to Follow-up|1|||
28023783|NCT00572910|54682618|FG010|Overall Study|Lost to Follow-up|0|||
28023784|NCT00572910|54682608|FG000|Overall Study|Withdrawal by Subject|3|||
28023785|NCT00572910|54682609|FG001|Overall Study|Withdrawal by Subject|0|||
28023786|NCT00572910|54682610|FG002|Overall Study|Withdrawal by Subject|1|||
28023787|NCT00572910|54682611|FG003|Overall Study|Withdrawal by Subject|0|||
28023788|NCT00572910|54682612|FG004|Overall Study|Withdrawal by Subject|1|||
28023789|NCT00572910|54682613|FG005|Overall Study|Withdrawal by Subject|3|||
28023790|NCT00572910|54682614|FG006|Overall Study|Withdrawal by Subject|0|||
28023791|NCT00572910|54682615|FG007|Overall Study|Withdrawal by Subject|2|||
28023792|NCT00572910|54682616|FG008|Overall Study|Withdrawal by Subject|2|||
28023793|NCT00572910|54682617|FG009|Overall Study|Withdrawal by Subject|2|||
28023794|NCT00572910|54682618|FG010|Overall Study|Withdrawal by Subject|1|||
28023795|NCT00163657|54682656|FG000|Overall Study|Death|12|||
28023796|NCT00163657|54682657|FG001|Overall Study|Death|14|||
28023797|NCT00163657|54682658|FG002|Overall Study|Death|19|||
28023798|NCT00163657|54682656|FG000|Overall Study|graft loss|4|||
28023799|NCT00163657|54682657|FG001|Overall Study|graft loss|1|||
28023800|NCT00163657|54682658|FG002|Overall Study|graft loss|2|||
28023801|NCT00163657|54682656|FG000|Overall Study|Withdrawal by Subject|2|||
28023802|NCT00163657|54682657|FG001|Overall Study|Withdrawal by Subject|3|||
28023803|NCT00163657|54682658|FG002|Overall Study|Withdrawal by Subject|2|||
28023804|NCT00163657|54682656|FG000|Overall Study|Physician Decision|0|||
28023805|NCT00163657|54682657|FG001|Overall Study|Physician Decision|1|||
28023806|NCT00163657|54682658|FG002|Overall Study|Physician Decision|1|||
28023807|NCT00163657|54682656|FG000|Overall Study|Non Compliance|1|||
28023808|NCT00163657|54682657|FG001|Overall Study|Non Compliance|0|||
28023809|NCT00163657|54682658|FG002|Overall Study|Non Compliance|0|||
28023810|NCT00163657|54682656|FG000|Overall Study|Lost to Follow-up|1|||
27801148|NCT01628393|54256007|FG001|Blinded Active Extension Period|Withdrawal by Subject|6|||
27801149|NCT01628393|54256008|FG002|Blinded Active Extension Period|Withdrawal by Subject|2|||
28023811|NCT00163657|54682657|FG001|Overall Study|Lost to Follow-up|3|||
27801150|NCT01628393|54256009|FG003|Blinded Active Extension Period|Withdrawal by Subject|0|||
28023812|NCT00163657|54682658|FG002|Overall Study|Lost to Follow-up|10|||
28023813|NCT00163657|54682656|FG000|Overall Study|Other reason|0|||
28023814|NCT00163657|54682657|FG001|Overall Study|Other reason|1|||
28023815|NCT00163657|54682658|FG002|Overall Study|Other reason|3|||
28023816|NCT00609492|54682669|FG000|Overall Study|Withdrawal by Subject|0|||
28023817|NCT00609492|54682670|FG001|Overall Study|Withdrawal by Subject|2|||
28023818|NCT00609492|54682671|FG002|Overall Study|Withdrawal by Subject|3|||
28023819|NCT00609492|54682669|FG000|Overall Study|Lost to Follow-up|1|||
28023820|NCT00609492|54682670|FG001|Overall Study|Lost to Follow-up|1|||
28023821|NCT00609492|54682671|FG002|Overall Study|Lost to Follow-up|4|||
27801151|NCT01628393|54256010|FG004|Blinded Active Extension Period|Withdrawal by Subject|2|||
27801152|NCT01846221|54256026|FG000|Overall Study|Catheter Failure|2|||
27801153|NCT01846221|54256027|FG001|Overall Study|Catheter Failure|0|||
27801154|NCT01846221|54256026|FG000|Overall Study|Age Exclusion|1|||
27801155|NCT01846221|54256027|FG001|Overall Study|Age Exclusion|0|||
28023822|NCT00230971|54682683|FG000|Randomization|No study drug administered|3|||
28023823|NCT00230971|54682684|FG001|Randomization|No study drug administered|3|||
28023824|NCT00230971|54682683|FG000|Baseline Participants|Lost to Follow-up|5|||
28023825|NCT00230971|54682684|FG001|Baseline Participants|Lost to Follow-up|12|||
28023826|NCT00230971|54682683|FG000|Baseline Participants|Death|6|||
28023827|NCT00230971|54682684|FG001|Baseline Participants|Death|5|||
28023828|NCT00230971|54682683|FG000|Baseline Participants|Withdrawal by Subject|7|||
28023829|NCT00230971|54682684|FG001|Baseline Participants|Withdrawal by Subject|1|||
28023830|NCT00230971|54682683|FG000|Baseline Participants|Adverse Event|1|||
28023831|NCT00230971|54682684|FG001|Baseline Participants|Adverse Event|0|||
28023832|NCT00230971|54682683|FG000|Baseline Participants|No bacteria observed|1|||
28023833|NCT00230971|54682684|FG001|Baseline Participants|No bacteria observed|0|||
28023834|NCT00230971|54682683|FG000|Baseline Participants|Failure to return|1|||
28023835|NCT00230971|54682684|FG001|Baseline Participants|Failure to return|1|||
28023836|NCT00230971|54682683|FG000|Baseline Participants|Reintervention|1|||
28023837|NCT00230971|54682684|FG001|Baseline Participants|Reintervention|0|||
28023838|NCT00211081|54682690|FG000|Overall Study|Withdrawal by Subject|2|||
28023839|NCT00609336|54682694|FG000|Overall Study|Protocol Violation|3|||
28023840|NCT00609336|54682694|FG000|Overall Study|Death|1|||
28023841|NCT00609336|54682694|FG000|Overall Study|LA or Met at Surgery|9|||
28023842|NCT00612066|54682699|FG000|Overall Study|Adverse Event|1|||
28023843|NCT00573144|54682705|FG000|Overall Study|Withdrawal by Subject|2|||
28023844|NCT00573144|54682706|FG001|Overall Study|Withdrawal by Subject|3|||
28023845|NCT00640328|54682718|FG000|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
28023846|NCT00640328|54682719|FG001|First Treatment Period (Weeks 0-24)|Adverse Event|1|||
28023847|NCT00640328|54682720|FG002|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
28023848|NCT00640328|54682721|FG003|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
28023849|NCT00640328|54682722|FG004|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
28023850|NCT00640328|54682723|FG005|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
28023851|NCT00640328|54682718|FG000|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
28023852|NCT00640328|54682719|FG001|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
28023853|NCT00640328|54682720|FG002|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
28023854|NCT00640328|54682721|FG003|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
28023855|NCT00640328|54682722|FG004|Second Treatment Period (Weeks 24-48)|Adverse Event|1|||
28023856|NCT00640328|54682723|FG005|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
28023857|NCT00640328|54682718|FG000|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
28023858|NCT00640328|54682719|FG001|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
28023859|NCT00640328|54682720|FG002|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1|||
28023860|NCT00640328|54682721|FG003|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
28023861|NCT00640328|54682722|FG004|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
28023862|NCT00640328|54682723|FG005|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
28023863|NCT00640328|54682718|FG000|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
28023864|NCT00640328|54682719|FG001|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
28023865|NCT00640328|54682720|FG002|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
28023866|NCT00640328|54682721|FG003|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
28023867|NCT00640328|54682722|FG004|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
28023868|NCT00640328|54682723|FG005|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
28023869|NCT00163189|54682744|FG000|Overall Study|Other|6|||
28023870|NCT00163189|54682744|FG000|Overall Study|Lost to Follow-up|1|||
28023871|NCT00163189|54682744|FG000|Overall Study|Protocol Violation|2|||
28023872|NCT00163189|54682744|FG000|Overall Study|Death|3|||
28023873|NCT00163189|54682744|FG000|Overall Study|Adverse Event|6|||
28023874|NCT00163189|54682744|FG000|Overall Study|Lack of Efficacy|7|||
28023875|NCT00163189|54682744|FG000|Overall Study|Study terminated by sponsor|11|||
28023876|NCT00163189|54682744|FG000|Overall Study|Withdrawal by Subject|11|||
28023877|NCT00163189|54682744|FG000|Overall Study|Did not meet continuation criterion|16|||
28023878|NCT00162097|54682752|FG000|Overall Study|Participant no longer met study criteria|0|||
28023879|NCT00162097|54682753|FG001|Overall Study|Participant no longer met study criteria|0|||
28023880|NCT00162097|54682754|FG002|Overall Study|Participant no longer met study criteria|0|||
28023881|NCT00162097|54682755|FG003|Overall Study|Participant no longer met study criteria|1|||
28023882|NCT00640016|54682775|FG000|Overall Study|Withdrawal by Subject|0|||
28023883|NCT00640016|54682776|FG001|Overall Study|Withdrawal by Subject|1|||
28023884|NCT00640016|54682777|FG002|Overall Study|Withdrawal by Subject|0|||
28023885|NCT00640016|54682778|FG003|Overall Study|Withdrawal by Subject|0|||
28023886|NCT00640016|54682775|FG000|Overall Study|Study termination|2|||
27801156|NCT01815099|54256033|FG000|Overall Study|Lack of Efficacy|1|||
28023887|NCT00640016|54682776|FG001|Overall Study|Study termination|1|||
28023888|NCT00640016|54682777|FG002|Overall Study|Study termination|3|||
28023889|NCT00640016|54682778|FG003|Overall Study|Study termination|2|||
28023890|NCT00640016|54682775|FG000|Overall Study|Adverse Event|0|||
28023891|NCT00640016|54682776|FG001|Overall Study|Adverse Event|0|||
28023892|NCT00640016|54682777|FG002|Overall Study|Adverse Event|0|||
28023893|NCT00640016|54682778|FG003|Overall Study|Adverse Event|1|||
28023894|NCT00608868|54682795|FG000|Overall Study|Withdrawal by Subject|7|||
28023895|NCT00608868|54682795|FG000|Overall Study|Protocol Violation|3|||
28023896|NCT00608868|54682795|FG000|Overall Study|Lost to Follow-up|2|||
28023897|NCT00608868|54682795|FG000|Overall Study|Adverse Event|1|||
28023898|NCT00608868|54682795|FG000|Overall Study|Physician Decision|2|||
28023899|NCT00608322|54682801|FG000|Overall Study|Death|2|||
28023900|NCT00608322|54682802|FG001|Overall Study|Death|1|||
28023901|NCT00608244|54682808|FG000|Overall Study|Adverse Event|1|||
28023902|NCT00608244|54682808|FG000|Overall Study|Low trough levels|1|||
28023903|NCT00605280|54682818|FG000|Year 1|Protocol Violation|0|||
28023904|NCT00605280|54682819|FG001|Year 1|Protocol Violation|0|||
28023905|NCT00605280|54682820|FG002|Year 1|Protocol Violation|0|||
28023906|NCT00605280|54682821|FG003|Year 1|Protocol Violation|1|||
28023907|NCT00605280|54682818|FG000|Year 1|Adverse Event|3|||
28023908|NCT00605280|54682819|FG001|Year 1|Adverse Event|1|||
28023909|NCT00605280|54682820|FG002|Year 1|Adverse Event|1|||
28023910|NCT00605280|54682821|FG003|Year 1|Adverse Event|5|||
28023911|NCT00605280|54682818|FG000|Year 1|Physician Decision|7|||
28023912|NCT00605280|54682819|FG001|Year 1|Physician Decision|4|||
28023913|NCT00605280|54682820|FG002|Year 1|Physician Decision|0|||
28023914|NCT00605280|54682821|FG003|Year 1|Physician Decision|6|||
28023915|NCT00605280|54682818|FG000|Year 1|Withdrawal by Subject|2|||
28023916|NCT00605280|54682819|FG001|Year 1|Withdrawal by Subject|4|||
28023917|NCT00605280|54682820|FG002|Year 1|Withdrawal by Subject|0|||
28023918|NCT00605280|54682821|FG003|Year 1|Withdrawal by Subject|4|||
28023919|NCT00605280|54682818|FG000|Year 1|Other|2|||
28023920|NCT00605280|54682819|FG001|Year 1|Other|1|||
28023921|NCT00605280|54682820|FG002|Year 1|Other|0|||
28023922|NCT00605280|54682821|FG003|Year 1|Other|1|||
28023923|NCT00605280|54682818|FG000|Year 1|Lost to Follow-up or Patient non-comply|5|||
28023924|NCT00605280|54682819|FG001|Year 1|Lost to Follow-up or Patient non-comply|1|||
28023925|NCT00605280|54682820|FG002|Year 1|Lost to Follow-up or Patient non-comply|0|||
28023926|NCT00605280|54682821|FG003|Year 1|Lost to Follow-up or Patient non-comply|2|||
28023927|NCT00605280|54682818|FG000|Year 2|Adverse Event|4|||
28023928|NCT00605280|54682819|FG001|Year 2|Adverse Event|0|||
28023929|NCT00605280|54682820|FG002|Year 2|Adverse Event|2|||
28023930|NCT00605280|54682821|FG003|Year 2|Adverse Event|4|||
28023931|NCT00605280|54682818|FG000|Year 2|Physician Decision|11|||
28023932|NCT00605280|54682819|FG001|Year 2|Physician Decision|6|||
28023933|NCT00605280|54682820|FG002|Year 2|Physician Decision|4|||
28023934|NCT00605280|54682821|FG003|Year 2|Physician Decision|11|||
28023935|NCT00605280|54682818|FG000|Year 2|Withdrawal by Subject|4|||
28023936|NCT00605280|54682819|FG001|Year 2|Withdrawal by Subject|0|||
28023937|NCT00605280|54682820|FG002|Year 2|Withdrawal by Subject|0|||
28023938|NCT00605280|54682821|FG003|Year 2|Withdrawal by Subject|4|||
28023939|NCT00605280|54682818|FG000|Year 2|Other|1|||
27801157|NCT01815099|54256033|FG000|Overall Study|unable to attend study visits|1|||
27801158|NCT01845831|54256040|FG000|Inpatient Phase|Withdrawal by Subject|1|||
27801159|NCT01845831|54256041|FG001|Inpatient Phase|Withdrawal by Subject|1|||
27801160|NCT01845831|54256042|FG002|Inpatient Phase|Withdrawal by Subject|0|||
27801161|NCT01845831|54256043|FG003|Inpatient Phase|Withdrawal by Subject|0|||
27801162|NCT01845831|54256044|FG004|Inpatient Phase|Withdrawal by Subject|0|||
27801163|NCT01627691|54256055|FG000|Overall Study|Death|11|||
27801164|NCT01627691|54256055|FG000|Overall Study|Lost to Follow-up|3|||
27801165|NCT01627691|54256055|FG000|Overall Study|Withdrawal by Subject|1|||
27801166|NCT01627691|54256055|FG000|Overall Study|Missed the visit|3|||
27801167|NCT01844895|54256059|FG000|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1|||
27801168|NCT01844895|54256059|FG000|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1|||
28023940|NCT00605280|54682819|FG001|Year 2|Other|0|||
28023941|NCT00605280|54682820|FG002|Year 2|Other|0|||
28023942|NCT00605280|54682821|FG003|Year 2|Other|1|||
27801169|NCT01844895|54256059|FG000|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1|||
27801170|NCT01844895|54256059|FG000|Day 29 - Day113 - Autoinjector|Adverse Event|1|||
28023943|NCT00605280|54682818|FG000|Year 2|Lost to Follow-up or Patient non-comply|4|||
28023944|NCT00605280|54682819|FG001|Year 2|Lost to Follow-up or Patient non-comply|0|||
28023945|NCT00605280|54682820|FG002|Year 2|Lost to Follow-up or Patient non-comply|0|||
28023946|NCT00605280|54682821|FG003|Year 2|Lost to Follow-up or Patient non-comply|2|||
28023947|NCT00605280|54682818|FG000|Year 3 Extension|Adverse Event|2|||
28023948|NCT00605280|54682819|FG001|Year 3 Extension|Adverse Event|0|||
28023949|NCT00605280|54682820|FG002|Year 3 Extension|Adverse Event|0|||
28023950|NCT00605280|54682821|FG003|Year 3 Extension|Adverse Event|2|||
27801171|NCT01844895|54256059|FG000|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1|||
27801172|NCT01844895|54256059|FG000|Day 29 - Day113 - Autoinjector|Difficulty using device|3|||
28023951|NCT00605280|54682818|FG000|Year 3 Extension|Physician Decision|0|||
28023952|NCT00605280|54682819|FG001|Year 3 Extension|Physician Decision|0|||
28023953|NCT00605280|54682820|FG002|Year 3 Extension|Physician Decision|0|||
28023954|NCT00605280|54682821|FG003|Year 3 Extension|Physician Decision|2|||
28023955|NCT00605280|54682818|FG000|Year 3 Extension|Withdrawal by Subject|2|||
28023956|NCT00605280|54682819|FG001|Year 3 Extension|Withdrawal by Subject|0|||
28023957|NCT00605280|54682820|FG002|Year 3 Extension|Withdrawal by Subject|0|||
28023958|NCT00605280|54682821|FG003|Year 3 Extension|Withdrawal by Subject|5|||
28023959|NCT00605280|54682818|FG000|Year 3 Extension|Other|2|||
28023960|NCT00605280|54682819|FG001|Year 3 Extension|Other|0|||
28023961|NCT00605280|54682820|FG002|Year 3 Extension|Other|0|||
28023962|NCT00605280|54682821|FG003|Year 3 Extension|Other|0|||
28023963|NCT00605280|54682818|FG000|Year 3 Extension|Lost to Follow-up or Patient non-comply|2|||
28023964|NCT00605280|54682819|FG001|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
28023965|NCT00605280|54682820|FG002|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
28023966|NCT00605280|54682821|FG003|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
28023967|NCT00607386|54682831|FG000|Overall Study|Physician Decision|1|||
28023968|NCT00638690|54682837|FG000|Overall Study|Death|655|||
28023969|NCT00638690|54682838|FG001|Overall Study|Death|335|||
28023970|NCT00638690|54682837|FG000|Overall Study|Withdrawal by Subject|22|||
28023971|NCT00638690|54682838|FG001|Overall Study|Withdrawal by Subject|5|||
28023972|NCT00638690|54682837|FG000|Overall Study|Lost to Follow-up|4|||
28023973|NCT00638690|54682838|FG001|Overall Study|Lost to Follow-up|2|||
28023974|NCT00543387|54682854|FG000|Panel 1 + Panel 2|Adverse Event|0|||
28023975|NCT00543387|54682855|FG001|Panel 1 + Panel 2|Adverse Event|1|||
28023976|NCT00543387|54682856|FG002|Panel 1 + Panel 2|Adverse Event|0|||
28023977|NCT00543387|54682857|FG003|Panel 1 + Panel 2|Adverse Event|0|||
28023978|NCT00543387|54682858|FG004|Panel 1 + Panel 2|Adverse Event|0|||
28023979|NCT00543387|54682859|FG005|Panel 1 + Panel 2|Adverse Event|0|||
28023980|NCT00543387|54682860|FG006|Panel 1 + Panel 2|Adverse Event|0|||
28023981|NCT00543387|54682861|FG007|Panel 1 + Panel 2|Adverse Event|1|||
28023982|NCT00543387|54682862|FG008|Panel 1 + Panel 2|Adverse Event|1|||
28023983|NCT00543387|54682863|FG009|Panel 1 + Panel 2|Adverse Event|0|||
28023984|NCT00543387|54682864|FG010|Panel 1 + Panel 2|Adverse Event|0|||
28023985|NCT00543387|54682854|FG000|Panel 1 + Panel 2|Physician Decision|0|||
28023986|NCT00543387|54682855|FG001|Panel 1 + Panel 2|Physician Decision|0|||
28023987|NCT00543387|54682856|FG002|Panel 1 + Panel 2|Physician Decision|1|||
28023988|NCT00543387|54682857|FG003|Panel 1 + Panel 2|Physician Decision|0|||
28023989|NCT00543387|54682858|FG004|Panel 1 + Panel 2|Physician Decision|0|||
28023990|NCT00543387|54682859|FG005|Panel 1 + Panel 2|Physician Decision|0|||
28023991|NCT00543387|54682860|FG006|Panel 1 + Panel 2|Physician Decision|0|||
28023992|NCT00543387|54682861|FG007|Panel 1 + Panel 2|Physician Decision|1|||
28023993|NCT00543387|54682862|FG008|Panel 1 + Panel 2|Physician Decision|0|||
28023994|NCT00543387|54682863|FG009|Panel 1 + Panel 2|Physician Decision|0|||
27801173|NCT01844895|54256059|FG000|Day 29 - Day113 - Autoinjector|planned surgery|1|||
28023995|NCT00543387|54682864|FG010|Panel 1 + Panel 2|Physician Decision|0|||
28023996|NCT00543387|54682854|FG000|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
28023997|NCT00543387|54682855|FG001|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
28023998|NCT00543387|54682856|FG002|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
28023999|NCT00543387|54682857|FG003|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
28024000|NCT00543387|54682858|FG004|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
28024001|NCT00543387|54682859|FG005|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
28024002|NCT00543387|54682860|FG006|Panel 1 + Panel 2|Progressive Disease (PD)|5|||
28024003|NCT00543387|54682861|FG007|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
28024004|NCT00543387|54682862|FG008|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
28024005|NCT00543387|54682863|FG009|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
28024006|NCT00543387|54682864|FG010|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
28024007|NCT00543387|54682854|FG000|Panel 1 + Panel 2|Withdrawal by Subject|0|||
28024008|NCT00543387|54682855|FG001|Panel 1 + Panel 2|Withdrawal by Subject|0|||
28024009|NCT00543387|54682856|FG002|Panel 1 + Panel 2|Withdrawal by Subject|0|||
27801174|NCT02116361|54256076|FG000|Overall Study|Pregnancy|0|||
27801175|NCT02116361|54256077|FG001|Overall Study|Pregnancy|0|||
27801176|NCT02116361|54256078|FG002|Overall Study|Pregnancy|0|||
27801177|NCT02116361|54256079|FG003|Overall Study|Pregnancy|1|||
27801178|NCT02116361|54256076|FG000|Overall Study|Protocol Violation|1|||
27801179|NCT02116361|54256077|FG001|Overall Study|Protocol Violation|0|||
27801180|NCT02116361|54256078|FG002|Overall Study|Protocol Violation|0|||
28024010|NCT00543387|54682857|FG003|Panel 1 + Panel 2|Withdrawal by Subject|0|||
28024011|NCT00543387|54682858|FG004|Panel 1 + Panel 2|Withdrawal by Subject|0|||
28024012|NCT00543387|54682859|FG005|Panel 1 + Panel 2|Withdrawal by Subject|0|||
28024013|NCT00543387|54682860|FG006|Panel 1 + Panel 2|Withdrawal by Subject|1|||
28024014|NCT00543387|54682861|FG007|Panel 1 + Panel 2|Withdrawal by Subject|0|||
27801181|NCT02116361|54256079|FG003|Overall Study|Protocol Violation|2|||
27801182|NCT02116361|54256076|FG000|Overall Study|Physician Decision|2|||
27801183|NCT02116361|54256077|FG001|Overall Study|Physician Decision|3|||
28024015|NCT00543387|54682862|FG008|Panel 1 + Panel 2|Withdrawal by Subject|0|||
28024016|NCT00543387|54682863|FG009|Panel 1 + Panel 2|Withdrawal by Subject|0|||
28024017|NCT00543387|54682864|FG010|Panel 1 + Panel 2|Withdrawal by Subject|0|||
28024018|NCT00543387|54682854|FG000|Crossover Participants|Progressive Disease|0|||
28024019|NCT00543387|54682855|FG001|Crossover Participants|Progressive Disease|0|||
28024020|NCT00543387|54682856|FG002|Crossover Participants|Progressive Disease|0|||
28024021|NCT00543387|54682857|FG003|Crossover Participants|Progressive Disease|0|||
28024022|NCT00543387|54682858|FG004|Crossover Participants|Progressive Disease|0|||
28024023|NCT00543387|54682859|FG005|Crossover Participants|Progressive Disease|0|||
28024024|NCT00543387|54682860|FG006|Crossover Participants|Progressive Disease|0|||
28024025|NCT00543387|54682861|FG007|Crossover Participants|Progressive Disease|0|||
28024026|NCT00543387|54682862|FG008|Crossover Participants|Progressive Disease|0|||
28024027|NCT00543387|54682863|FG009|Crossover Participants|Progressive Disease|1|||
28024028|NCT00543387|54682864|FG010|Crossover Participants|Progressive Disease|2|||
28024029|NCT00543387|54682854|FG000|Crossover Participants|Study Terminated by Sponsor|0|||
28024030|NCT00543387|54682855|FG001|Crossover Participants|Study Terminated by Sponsor|0|||
28024031|NCT00543387|54682856|FG002|Crossover Participants|Study Terminated by Sponsor|0|||
28024032|NCT00543387|54682857|FG003|Crossover Participants|Study Terminated by Sponsor|0|||
28024033|NCT00543387|54682858|FG004|Crossover Participants|Study Terminated by Sponsor|0|||
28024034|NCT00543387|54682859|FG005|Crossover Participants|Study Terminated by Sponsor|0|||
28024035|NCT00543387|54682860|FG006|Crossover Participants|Study Terminated by Sponsor|0|||
28024036|NCT00543387|54682861|FG007|Crossover Participants|Study Terminated by Sponsor|0|||
28024037|NCT00543387|54682862|FG008|Crossover Participants|Study Terminated by Sponsor|0|||
28024038|NCT00543387|54682863|FG009|Crossover Participants|Study Terminated by Sponsor|0|||
28024039|NCT00543387|54682864|FG010|Crossover Participants|Study Terminated by Sponsor|1|||
28024040|NCT00635570|54682894|FG000|Overall Study|Lost to Follow-up|8|||
28024041|NCT00635570|54682895|FG001|Overall Study|Lost to Follow-up|8|||
28024042|NCT00635570|54682894|FG000|Overall Study|Withdrawal by Subject|1|||
28024043|NCT00635570|54682895|FG001|Overall Study|Withdrawal by Subject|1|||
28024044|NCT00635570|54682894|FG000|Overall Study|Adverse Event|2|||
28024045|NCT00635570|54682895|FG001|Overall Study|Adverse Event|0|||
28024046|NCT00635570|54682894|FG000|Overall Study|Physician Decision|1|||
28024047|NCT00635570|54682895|FG001|Overall Study|Physician Decision|0|||
28024048|NCT00635570|54682894|FG000|Overall Study|Did not complete survey|2|||
28024049|NCT00635570|54682895|FG001|Overall Study|Did not complete survey|1|||
28024050|NCT00635570|54682894|FG000|Overall Study|Early termination(No sexual activity)|1|||
28024051|NCT00635570|54682895|FG001|Overall Study|Early termination(No sexual activity)|1|||
28024052|NCT00635492|54682903|FG000|Overall Study|Death|12|||
28024053|NCT00635492|54682904|FG001|Overall Study|Death|40|||
28024054|NCT00635492|54682903|FG000|Overall Study|Lost to Follow-up|151|||
28024055|NCT00635492|54682904|FG001|Overall Study|Lost to Follow-up|172|||
28024056|NCT00635492|54682903|FG000|Overall Study|Physician Decision|32|||
28024057|NCT00635492|54682904|FG001|Overall Study|Physician Decision|22|||
28024058|NCT00635492|54682903|FG000|Overall Study|Sponsor decision|2|||
28024059|NCT00635492|54682904|FG001|Overall Study|Sponsor decision|3|||
28024060|NCT00635492|54682903|FG000|Overall Study|Withdrawal by Subject|82|||
28024061|NCT00635492|54682904|FG001|Overall Study|Withdrawal by Subject|45|||
28024062|NCT00543309|54682917|FG000|Overall Study|Physician Decision|0|||
28024063|NCT00543309|54682918|FG001|Overall Study|Physician Decision|1|||
28024064|NCT00543309|54682919|FG002|Overall Study|Physician Decision|0|||
28024065|NCT00569582|54682928|FG000|Overall Study|Withdrawal by Subject|5|||
28024066|NCT00569582|54682928|FG000|Overall Study|Death|2|||
28024067|NCT00569582|54682928|FG000|Overall Study|Adverse Event|7|||
28024068|NCT00569582|54682928|FG000|Overall Study|Subject was too ill to travel.|1|||
28024069|NCT00569582|54682928|FG000|Overall Study|Subject was non-compliant.|1|||
28024070|NCT00721409|54682935|FG000|Overall Study|Global deterioration of health status|2|||
28024071|NCT00721409|54682936|FG001|Overall Study|Global deterioration of health status|6|||
28024072|NCT00721409|54682937|FG002|Overall Study|Global deterioration of health status|3|||
28024073|NCT00721409|54682935|FG000|Overall Study|Death|0|||
28024074|NCT00721409|54682936|FG001|Overall Study|Death|1|||
28024075|NCT00721409|54682937|FG002|Overall Study|Death|0|||
28024076|NCT00721409|54682935|FG000|Overall Study|Randomized not Treated|0|||
28024077|NCT00721409|54682936|FG001|Overall Study|Randomized not Treated|1|||
28024078|NCT00721409|54682937|FG002|Overall Study|Randomized not Treated|4|||
28024079|NCT00721409|54682935|FG000|Overall Study|Reason not specified|1|||
28024080|NCT00721409|54682936|FG001|Overall Study|Reason not specified|0|||
28024081|NCT00721409|54682937|FG002|Overall Study|Reason not specified|2|||
28024082|NCT00721409|54682935|FG000|Overall Study|Adverse Event|0|||
28024083|NCT00721409|54682936|FG001|Overall Study|Adverse Event|13|||
28024084|NCT00721409|54682937|FG002|Overall Study|Adverse Event|2|||
28024085|NCT00721409|54682935|FG000|Overall Study|Lost to Follow-up|0|||
28024086|NCT00721409|54682936|FG001|Overall Study|Lost to Follow-up|0|||
28024087|NCT00721409|54682937|FG002|Overall Study|Lost to Follow-up|1|||
28024088|NCT00721409|54682935|FG000|Overall Study|Withdrawal by Subject|1|||
28024089|NCT00721409|54682936|FG001|Overall Study|Withdrawal by Subject|6|||
28024090|NCT00721409|54682937|FG002|Overall Study|Withdrawal by Subject|5|||
28024091|NCT00721409|54682935|FG000|Overall Study|Objective progression or relapse|8|||
28024092|NCT00721409|54682936|FG001|Overall Study|Objective progression or relapse|55|||
28024093|NCT00721409|54682937|FG002|Overall Study|Objective progression or relapse|62|||
28024094|NCT00542997|54682961|FG000|Wash in / Wash Out Period|Withdrawal by Subject|2|||
28024095|NCT00542997|54682961|FG000|Wash in / Wash Out Period|Adverse Event|3|||
28024096|NCT00542997|54682961|FG000|Efficacy Period|Adverse Event|3|||
28024097|NCT00572832|54682970|FG000|Overall Study|Lost to Follow-up|0|||
28024098|NCT00572832|54682971|FG001|Overall Study|Lost to Follow-up|11|||
28024099|NCT00572832|54682970|FG000|Overall Study|Pregnancy|0|||
28024100|NCT00572832|54682971|FG001|Overall Study|Pregnancy|1|||
28024101|NCT03917823|54682979|FG000|Overall Study|Lost to Follow-up|1|||
28024102|NCT03917823|54682980|FG001|Overall Study|Lost to Follow-up|1|||
28024103|NCT03917823|54682979|FG000|Overall Study|Withdrawal by Subject|0|||
28024104|NCT03917823|54682980|FG001|Overall Study|Withdrawal by Subject|1|||
28024105|NCT00229723|54682993|FG000|Concomitant Phase|Adverse Event|4|||
28024106|NCT00229723|54682994|FG001|Concomitant Phase|Adverse Event|2|||
28024107|NCT00229723|54682995|FG002|Concomitant Phase|Adverse Event|5|||
28024108|NCT00229723|54682996|FG003|Concomitant Phase|Adverse Event|2|||
28024109|NCT00229723|54682997|FG004|Concomitant Phase|Adverse Event|0|||
28024110|NCT00229723|54682998|FG005|Concomitant Phase|Adverse Event|1|||
28024111|NCT00229723|54682999|FG006|Concomitant Phase|Adverse Event|2|||
28024112|NCT00229723|54682993|FG000|Concomitant Phase|Objective disease progression|0|||
28024113|NCT00229723|54682994|FG001|Concomitant Phase|Objective disease progression|0|||
28024114|NCT00229723|54682995|FG002|Concomitant Phase|Objective disease progression|0|||
28024115|NCT00229723|54682996|FG003|Concomitant Phase|Objective disease progression|0|||
28024116|NCT00229723|54682997|FG004|Concomitant Phase|Objective disease progression|0|||
28024117|NCT00229723|54682998|FG005|Concomitant Phase|Objective disease progression|0|||
28024118|NCT00229723|54682999|FG006|Concomitant Phase|Objective disease progression|0|||
28024119|NCT00229723|54682993|FG000|Concomitant Phase|Clinical progression|0|||
28024120|NCT00229723|54682994|FG001|Concomitant Phase|Clinical progression|0|||
28024121|NCT00229723|54682995|FG002|Concomitant Phase|Clinical progression|0|||
28024122|NCT00229723|54682996|FG003|Concomitant Phase|Clinical progression|0|||
28024123|NCT00229723|54682997|FG004|Concomitant Phase|Clinical progression|0|||
28024124|NCT00229723|54682998|FG005|Concomitant Phase|Clinical progression|0|||
28024125|NCT00229723|54682999|FG006|Concomitant Phase|Clinical progression|1|||
28024126|NCT00229723|54682993|FG000|Concomitant Phase|Lost to Follow-up|0|||
28024127|NCT00229723|54682994|FG001|Concomitant Phase|Lost to Follow-up|0|||
28024128|NCT00229723|54682995|FG002|Concomitant Phase|Lost to Follow-up|0|||
28024129|NCT00229723|54682996|FG003|Concomitant Phase|Lost to Follow-up|0|||
28024130|NCT00229723|54682997|FG004|Concomitant Phase|Lost to Follow-up|1|||
27801184|NCT02116361|54256078|FG002|Overall Study|Physician Decision|0|||
28024131|NCT00229723|54682998|FG005|Concomitant Phase|Lost to Follow-up|0|||
28024132|NCT00229723|54682999|FG006|Concomitant Phase|Lost to Follow-up|0|||
28024133|NCT00229723|54682993|FG000|Concomitant Phase|Informed consent withdrawn|3|||
28024134|NCT00229723|54682994|FG001|Concomitant Phase|Informed consent withdrawn|2|||
28024135|NCT00229723|54682995|FG002|Concomitant Phase|Informed consent withdrawn|0|||
28024136|NCT00229723|54682996|FG003|Concomitant Phase|Informed consent withdrawn|2|||
28024137|NCT00229723|54682997|FG004|Concomitant Phase|Informed consent withdrawn|0|||
28024138|NCT00229723|54682998|FG005|Concomitant Phase|Informed consent withdrawn|0|||
28024139|NCT00229723|54682999|FG006|Concomitant Phase|Informed consent withdrawn|0|||
28024140|NCT00229723|54682993|FG000|Concomitant Phase|Severe non-compliance|0|||
28024141|NCT00229723|54682994|FG001|Concomitant Phase|Severe non-compliance|1|||
28024142|NCT00229723|54682995|FG002|Concomitant Phase|Severe non-compliance|0|||
28024143|NCT00229723|54682996|FG003|Concomitant Phase|Severe non-compliance|0|||
28024144|NCT00229723|54682997|FG004|Concomitant Phase|Severe non-compliance|1|||
28024145|NCT00229723|54682998|FG005|Concomitant Phase|Severe non-compliance|0|||
28024146|NCT00229723|54682999|FG006|Concomitant Phase|Severe non-compliance|0|||
28024147|NCT00229723|54682993|FG000|Concomitant Phase|Other|3|||
28024148|NCT00229723|54682994|FG001|Concomitant Phase|Other|0|||
28024149|NCT00229723|54682995|FG002|Concomitant Phase|Other|1|||
28024150|NCT00229723|54682996|FG003|Concomitant Phase|Other|1|||
28024151|NCT00229723|54682997|FG004|Concomitant Phase|Other|0|||
28024152|NCT00229723|54682998|FG005|Concomitant Phase|Other|2|||
28024153|NCT00229723|54682999|FG006|Concomitant Phase|Other|0|||
28024154|NCT00229723|54682993|FG000|Maintenance Phase|Adverse Event|7|||
28024155|NCT00229723|54682994|FG001|Maintenance Phase|Adverse Event|2|||
28024156|NCT00229723|54682995|FG002|Maintenance Phase|Adverse Event|1|||
28024157|NCT00229723|54682996|FG003|Maintenance Phase|Adverse Event|4|||
28024158|NCT00229723|54682997|FG004|Maintenance Phase|Adverse Event|7|||
28024159|NCT00229723|54682998|FG005|Maintenance Phase|Adverse Event|5|||
28024160|NCT00229723|54682999|FG006|Maintenance Phase|Adverse Event|2|||
28024161|NCT00229723|54682993|FG000|Maintenance Phase|Objective disease progression|5|||
28024162|NCT00229723|54682994|FG001|Maintenance Phase|Objective disease progression|5|||
28024163|NCT00229723|54682995|FG002|Maintenance Phase|Objective disease progression|3|||
28024164|NCT00229723|54682996|FG003|Maintenance Phase|Objective disease progression|6|||
28024165|NCT00229723|54682997|FG004|Maintenance Phase|Objective disease progression|2|||
28024166|NCT00229723|54682998|FG005|Maintenance Phase|Objective disease progression|9|||
28024167|NCT00229723|54682999|FG006|Maintenance Phase|Objective disease progression|5|||
28024168|NCT00229723|54682993|FG000|Maintenance Phase|Clinical progression|4|||
28024169|NCT00229723|54682994|FG001|Maintenance Phase|Clinical progression|1|||
28024170|NCT00229723|54682995|FG002|Maintenance Phase|Clinical progression|2|||
28024171|NCT00229723|54682996|FG003|Maintenance Phase|Clinical progression|2|||
28024172|NCT00229723|54682997|FG004|Maintenance Phase|Clinical progression|1|||
28024173|NCT00229723|54682998|FG005|Maintenance Phase|Clinical progression|1|||
28024174|NCT00229723|54682999|FG006|Maintenance Phase|Clinical progression|1|||
28024175|NCT00229723|54682993|FG000|Maintenance Phase|Lost to Follow-up|0|||
28024176|NCT00229723|54682994|FG001|Maintenance Phase|Lost to Follow-up|1|||
28024177|NCT00229723|54682995|FG002|Maintenance Phase|Lost to Follow-up|2|||
28024178|NCT00229723|54682996|FG003|Maintenance Phase|Lost to Follow-up|2|||
28024179|NCT00229723|54682997|FG004|Maintenance Phase|Lost to Follow-up|0|||
28024180|NCT00229723|54682998|FG005|Maintenance Phase|Lost to Follow-up|0|||
28024181|NCT00229723|54682999|FG006|Maintenance Phase|Lost to Follow-up|1|||
28024182|NCT00229723|54682993|FG000|Maintenance Phase|Informed consent withdrawn|1|||
27801185|NCT02116361|54256079|FG003|Overall Study|Physician Decision|0|||
27801186|NCT02116361|54256076|FG000|Overall Study|Adverse Event|1|||
27801187|NCT02116361|54256077|FG001|Overall Study|Adverse Event|0|||
28024183|NCT00229723|54682994|FG001|Maintenance Phase|Informed consent withdrawn|0|||
28024184|NCT00229723|54682995|FG002|Maintenance Phase|Informed consent withdrawn|0|||
27801188|NCT02116361|54256078|FG002|Overall Study|Adverse Event|0|||
27801189|NCT02116361|54256079|FG003|Overall Study|Adverse Event|3|||
28024185|NCT00229723|54682996|FG003|Maintenance Phase|Informed consent withdrawn|1|||
28024186|NCT00229723|54682997|FG004|Maintenance Phase|Informed consent withdrawn|1|||
28024187|NCT00229723|54682998|FG005|Maintenance Phase|Informed consent withdrawn|1|||
28024188|NCT00229723|54682999|FG006|Maintenance Phase|Informed consent withdrawn|0|||
28024189|NCT00229723|54682993|FG000|Maintenance Phase|Severe non-compliance|3|||
28024190|NCT00229723|54682994|FG001|Maintenance Phase|Severe non-compliance|1|||
28024191|NCT00229723|54682995|FG002|Maintenance Phase|Severe non-compliance|0|||
28024192|NCT00229723|54682996|FG003|Maintenance Phase|Severe non-compliance|0|||
28024193|NCT00229723|54682997|FG004|Maintenance Phase|Severe non-compliance|1|||
28024194|NCT00229723|54682998|FG005|Maintenance Phase|Severe non-compliance|0|||
28024195|NCT00229723|54682999|FG006|Maintenance Phase|Severe non-compliance|0|||
28024196|NCT00229723|54682993|FG000|Maintenance Phase|Other|5|||
28024197|NCT00229723|54682994|FG001|Maintenance Phase|Other|4|||
28024198|NCT00229723|54682995|FG002|Maintenance Phase|Other|1|||
28024199|NCT00229723|54682996|FG003|Maintenance Phase|Other|2|||
28024200|NCT00229723|54682997|FG004|Maintenance Phase|Other|3|||
28024201|NCT00229723|54682998|FG005|Maintenance Phase|Other|3|||
28024202|NCT00229723|54682999|FG006|Maintenance Phase|Other|1|||
28024203|NCT00606684|54683021|FG000|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173|||
28024204|NCT00606684|54683022|FG001|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
28024205|NCT00606684|54683023|FG002|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
28024206|NCT00606684|54683024|FG003|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
28024207|NCT00606684|54683025|FG004|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
28024208|NCT00606684|54683026|FG005|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
28024209|NCT00606684|54683027|FG006|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
28024210|NCT00606684|54683021|FG000|2-week Single-Blind Run-in Period|Study Closed/Terminated|32|||
28024211|NCT00606684|54683022|FG001|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
28024212|NCT00606684|54683023|FG002|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
28024213|NCT00606684|54683024|FG003|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
28024214|NCT00606684|54683025|FG004|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
28024215|NCT00606684|54683026|FG005|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
28024216|NCT00606684|54683027|FG006|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
28024217|NCT00606684|54683021|FG000|2-week Single-Blind Run-in Period|Physician Decision|18|||
28024218|NCT00606684|54683022|FG001|2-week Single-Blind Run-in Period|Physician Decision|0|||
28024219|NCT00606684|54683023|FG002|2-week Single-Blind Run-in Period|Physician Decision|0|||
28024220|NCT00606684|54683024|FG003|2-week Single-Blind Run-in Period|Physician Decision|0|||
28024221|NCT00606684|54683025|FG004|2-week Single-Blind Run-in Period|Physician Decision|0|||
28024222|NCT00606684|54683026|FG005|2-week Single-Blind Run-in Period|Physician Decision|0|||
28024223|NCT00606684|54683027|FG006|2-week Single-Blind Run-in Period|Physician Decision|0|||
28024224|NCT00606684|54683021|FG000|2-week Single-Blind Run-in Period|Withdrawal by Subject|15|||
28024225|NCT00606684|54683022|FG001|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
28024226|NCT00606684|54683023|FG002|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
28024227|NCT00606684|54683024|FG003|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
28024228|NCT00606684|54683025|FG004|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
28024229|NCT00606684|54683026|FG005|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
28024230|NCT00606684|54683027|FG006|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
28024231|NCT00606684|54683021|FG000|2-week Single-Blind Run-in Period|Lost to Follow-up|5|||
28024232|NCT00606684|54683022|FG001|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
28024233|NCT00606684|54683023|FG002|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
28024234|NCT00606684|54683024|FG003|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
28024235|NCT00606684|54683025|FG004|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
28024236|NCT00606684|54683026|FG005|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
28024237|NCT00606684|54683027|FG006|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
28024238|NCT00606684|54683021|FG000|2-week Single-Blind Run-in Period|Adverse Event|2|||
28024239|NCT00606684|54683022|FG001|2-week Single-Blind Run-in Period|Adverse Event|0|||
28024240|NCT00606684|54683023|FG002|2-week Single-Blind Run-in Period|Adverse Event|0|||
28024241|NCT00606684|54683024|FG003|2-week Single-Blind Run-in Period|Adverse Event|0|||
28024242|NCT00606684|54683025|FG004|2-week Single-Blind Run-in Period|Adverse Event|0|||
28024243|NCT00606684|54683026|FG005|2-week Single-Blind Run-in Period|Adverse Event|0|||
28024244|NCT00606684|54683027|FG006|2-week Single-Blind Run-in Period|Adverse Event|0|||
28024245|NCT00606684|54683021|FG000|2-week Single-Blind Run-in Period|Received Study Medication in Error|1|||
27801190|NCT02116361|54256076|FG000|Overall Study|Other Reasons|3|||
27801191|NCT02116361|54256077|FG001|Overall Study|Other Reasons|3|||
27801192|NCT02116361|54256078|FG002|Overall Study|Other Reasons|3|||
27801193|NCT02116361|54256079|FG003|Overall Study|Other Reasons|3|||
27801194|NCT02116361|54256076|FG000|Overall Study|Lack of Efficacy|5|||
27801195|NCT02116361|54256077|FG001|Overall Study|Lack of Efficacy|7|||
27801196|NCT02116361|54256078|FG002|Overall Study|Lack of Efficacy|4|||
27801197|NCT02116361|54256079|FG003|Overall Study|Lack of Efficacy|3|||
27801198|NCT02116361|54256076|FG000|Overall Study|Lost to Follow-up|4|||
27801199|NCT02116361|54256077|FG001|Overall Study|Lost to Follow-up|5|||
27801200|NCT02116361|54256078|FG002|Overall Study|Lost to Follow-up|7|||
27801201|NCT02116361|54256079|FG003|Overall Study|Lost to Follow-up|5|||
28024246|NCT00606684|54683022|FG001|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
28024247|NCT00606684|54683023|FG002|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
28024248|NCT00606684|54683024|FG003|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
28024249|NCT00606684|54683025|FG004|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
28024250|NCT00606684|54683026|FG005|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
28024251|NCT00606684|54683027|FG006|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
28024252|NCT00606684|54683021|FG000|Double-Blind Treatment Period|Adverse Event|0|||
28024253|NCT00606684|54683022|FG001|Double-Blind Treatment Period|Adverse Event|3|||
28024254|NCT00606684|54683023|FG002|Double-Blind Treatment Period|Adverse Event|2|||
28024255|NCT00606684|54683024|FG003|Double-Blind Treatment Period|Adverse Event|4|||
28024256|NCT00606684|54683025|FG004|Double-Blind Treatment Period|Adverse Event|2|||
28024257|NCT00606684|54683026|FG005|Double-Blind Treatment Period|Adverse Event|0|||
28024258|NCT00606684|54683027|FG006|Double-Blind Treatment Period|Adverse Event|1|||
28024259|NCT00606684|54683021|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
28024260|NCT00606684|54683022|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
28024261|NCT00606684|54683023|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
28024262|NCT00606684|54683024|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
28024263|NCT00606684|54683025|FG004|Double-Blind Treatment Period|Lack of Efficacy|1|||
28024264|NCT00606684|54683026|FG005|Double-Blind Treatment Period|Lack of Efficacy|0|||
28024265|NCT00606684|54683027|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
28024266|NCT00606684|54683021|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
28024267|NCT00606684|54683022|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
28024268|NCT00606684|54683023|FG002|Double-Blind Treatment Period|Protocol Violation|5|||
28024269|NCT00606684|54683024|FG003|Double-Blind Treatment Period|Protocol Violation|3|||
28024270|NCT00606684|54683025|FG004|Double-Blind Treatment Period|Protocol Violation|0|||
28024271|NCT00606684|54683026|FG005|Double-Blind Treatment Period|Protocol Violation|3|||
28024272|NCT00606684|54683027|FG006|Double-Blind Treatment Period|Protocol Violation|4|||
28024273|NCT00606684|54683021|FG000|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0|||
28024274|NCT00606684|54683022|FG001|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
28024275|NCT00606684|54683023|FG002|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
28024276|NCT00606684|54683024|FG003|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
28024277|NCT00606684|54683025|FG004|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
28024278|NCT00606684|54683026|FG005|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3|||
28024279|NCT00606684|54683027|FG006|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
28024280|NCT00606684|54683021|FG000|Double-Blind Treatment Period|Physician Decision|0|||
28024281|NCT00606684|54683022|FG001|Double-Blind Treatment Period|Physician Decision|5|||
28024282|NCT00606684|54683023|FG002|Double-Blind Treatment Period|Physician Decision|1|||
28024283|NCT00606684|54683024|FG003|Double-Blind Treatment Period|Physician Decision|0|||
28024284|NCT00606684|54683025|FG004|Double-Blind Treatment Period|Physician Decision|3|||
28024285|NCT00606684|54683026|FG005|Double-Blind Treatment Period|Physician Decision|1|||
27801202|NCT02116361|54256076|FG000|Overall Study|Personal Reasons|6|||
27801203|NCT02116361|54256077|FG001|Overall Study|Personal Reasons|6|||
28024286|NCT00606684|54683027|FG006|Double-Blind Treatment Period|Physician Decision|2|||
28024287|NCT00606684|54683021|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
27801204|NCT02116361|54256078|FG002|Overall Study|Personal Reasons|4|||
27801205|NCT02116361|54256079|FG003|Overall Study|Personal Reasons|9|||
28024288|NCT00606684|54683022|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
28024289|NCT00606684|54683023|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
28024290|NCT00606684|54683024|FG003|Double-Blind Treatment Period|Withdrawal by Subject|2|||
28024291|NCT00606684|54683025|FG004|Double-Blind Treatment Period|Withdrawal by Subject|1|||
28024292|NCT00606684|54683026|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
28024293|NCT00606684|54683027|FG006|Double-Blind Treatment Period|Withdrawal by Subject|0|||
28024294|NCT00627926|54683044|FG000|Overall Study|Adverse Event|26|||
28024295|NCT00627926|54683045|FG001|Overall Study|Adverse Event|37|||
28024296|NCT00627926|54683046|FG002|Overall Study|Adverse Event|36|||
28024297|NCT00627926|54683044|FG000|Overall Study|Death|1|||
28024298|NCT00627926|54683045|FG001|Overall Study|Death|0|||
28024299|NCT00627926|54683046|FG002|Overall Study|Death|0|||
28024300|NCT00627926|54683044|FG000|Overall Study|Lost to Follow-up|4|||
28024301|NCT00627926|54683045|FG001|Overall Study|Lost to Follow-up|3|||
28024302|NCT00627926|54683046|FG002|Overall Study|Lost to Follow-up|4|||
28024303|NCT00627926|54683044|FG000|Overall Study|Withdrawal by Subject|2|||
28024304|NCT00627926|54683045|FG001|Overall Study|Withdrawal by Subject|1|||
28024305|NCT00627926|54683046|FG002|Overall Study|Withdrawal by Subject|0|||
28024306|NCT00627926|54683044|FG000|Overall Study|Lack of Efficacy|118|||
28024307|NCT00627926|54683045|FG001|Overall Study|Lack of Efficacy|40|||
28024308|NCT00627926|54683046|FG002|Overall Study|Lack of Efficacy|38|||
28024309|NCT00627926|54683044|FG000|Overall Study|Noncompliance/unspecified|8|||
28024310|NCT00627926|54683045|FG001|Overall Study|Noncompliance/unspecified|23|||
28024311|NCT00627926|54683046|FG002|Overall Study|Noncompliance/unspecified|17|||
28024312|NCT00228553|54683054|FG000|Overall Study|Adverse Event|112|||
28024313|NCT00228553|54683054|FG000|Overall Study|Lack of Efficacy|34|||
28024314|NCT00228553|54683054|FG000|Overall Study|Lost to Follow-up|67|||
28024315|NCT00228553|54683054|FG000|Overall Study|Physician Decision|48|||
28024316|NCT00228553|54683054|FG000|Overall Study|Protocol Violation|6|||
28024317|NCT00228553|54683054|FG000|Overall Study|Withdrawal by Subject|115|||
28024318|NCT00228553|54683054|FG000|Overall Study|Pregnancy|2|||
28024319|NCT00228553|54683054|FG000|Overall Study|Miscellaneous|46|||
28024320|NCT00643916|54683064|FG000|Overall Study|Protocol Violation|0|||
28024321|NCT00643916|54683065|FG001|Overall Study|Protocol Violation|1|||
28024322|NCT00643916|54683066|FG002|Overall Study|Protocol Violation|1|||
28024323|NCT00643916|54683067|FG003|Overall Study|Protocol Violation|1|||
28024324|NCT00643916|54683068|FG004|Overall Study|Protocol Violation|0|||
28024325|NCT00643916|54683069|FG005|Overall Study|Protocol Violation|0|||
28024326|NCT00643916|54683064|FG000|Overall Study|Lost to Follow-up|0|||
28024327|NCT00643916|54683065|FG001|Overall Study|Lost to Follow-up|1|||
28024328|NCT00643916|54683066|FG002|Overall Study|Lost to Follow-up|0|||
28024329|NCT00643916|54683067|FG003|Overall Study|Lost to Follow-up|0|||
28024330|NCT00643916|54683068|FG004|Overall Study|Lost to Follow-up|0|||
28024331|NCT00643916|54683069|FG005|Overall Study|Lost to Follow-up|0|||
28024332|NCT00643916|54683064|FG000|Overall Study|Withdrawal by Subject|2|||
28024333|NCT00643916|54683065|FG001|Overall Study|Withdrawal by Subject|2|||
28024334|NCT00643916|54683066|FG002|Overall Study|Withdrawal by Subject|2|||
28024335|NCT00643916|54683067|FG003|Overall Study|Withdrawal by Subject|1|||
28024336|NCT00643916|54683068|FG004|Overall Study|Withdrawal by Subject|0|||
28024337|NCT00643916|54683069|FG005|Overall Study|Withdrawal by Subject|1|||
27801206|NCT02116361|54256076|FG000|Overall Study|Investigator Decision - Relapse|9|||
27801207|NCT02116361|54256077|FG001|Overall Study|Investigator Decision - Relapse|7|||
27801208|NCT02116361|54256078|FG002|Overall Study|Investigator Decision - Relapse|8|||
27801209|NCT02116361|54256079|FG003|Overall Study|Investigator Decision - Relapse|5|||
27801210|NCT02140775|54256091|FG000|Overall Study|Withdrawal by Subject|30|||
27801211|NCT02140775|54256092|FG001|Overall Study|Withdrawal by Subject|7|||
27801212|NCT01844817|54256102|FG000|Enrolled and Randomized|Withdrawal by Subject|2|||
27801213|NCT01844817|54256103|FG001|Enrolled and Randomized|Withdrawal by Subject|3|||
27801214|NCT01844817|54256102|FG000|Treatment|Progressive Disease|27|||
27801215|NCT01844817|54256103|FG001|Treatment|Progressive Disease|36|||
27801216|NCT01844817|54256102|FG000|Treatment|Adverse Event|17|||
28024338|NCT00643916|54683064|FG000|Overall Study|Not Vaccinated|2|||
28024339|NCT00643916|54683065|FG001|Overall Study|Not Vaccinated|2|||
28024340|NCT00643916|54683066|FG002|Overall Study|Not Vaccinated|3|||
28024341|NCT00643916|54683067|FG003|Overall Study|Not Vaccinated|0|||
28024342|NCT00643916|54683068|FG004|Overall Study|Not Vaccinated|2|||
28024343|NCT00643916|54683069|FG005|Overall Study|Not Vaccinated|0|||
28024344|NCT00160693|54683083|FG000|Overall Study|Adverse Event|97|||
28024345|NCT00160693|54683083|FG000|Overall Study|Lack of Efficacy|30|||
28024346|NCT00160693|54683083|FG000|Overall Study|Protocol Violation|24|||
28024347|NCT00160693|54683083|FG000|Overall Study|Lost to Follow-up|15|||
28024348|NCT00160693|54683083|FG000|Overall Study|Withdrawal by Subject|54|||
28024349|NCT00160693|54683083|FG000|Overall Study|Study terminated by sponsor|15|||
28024350|NCT00643760|54683092|FG000|Overall Study|Adverse Event|11|||
28024351|NCT00643760|54683093|FG001|Overall Study|Adverse Event|5|||
28024352|NCT00643760|54683094|FG002|Overall Study|Adverse Event|12|||
28024353|NCT00643760|54683095|FG003|Overall Study|Adverse Event|21|||
28024354|NCT00643760|54683096|FG004|Overall Study|Adverse Event|6|||
28024355|NCT00643760|54683092|FG000|Overall Study|Lack of Efficacy|3|||
28024356|NCT00643760|54683093|FG001|Overall Study|Lack of Efficacy|1|||
27801217|NCT01844817|54256103|FG001|Treatment|Adverse Event|9|||
27801218|NCT01844817|54256102|FG000|Treatment|Withdrawal by Subject|10|||
27801219|NCT01844817|54256103|FG001|Treatment|Withdrawal by Subject|6|||
27801220|NCT01844817|54256102|FG000|Treatment|Death|10|||
28024357|NCT00643760|54683094|FG002|Overall Study|Lack of Efficacy|0|||
28024358|NCT00643760|54683095|FG003|Overall Study|Lack of Efficacy|4|||
27801221|NCT01844817|54256103|FG001|Treatment|Death|8|||
27801222|NCT01844817|54256102|FG000|Treatment|Lost to Follow-up|0|||
27801223|NCT01844817|54256103|FG001|Treatment|Lost to Follow-up|1|||
27801224|NCT01844817|54256102|FG000|Treatment|Other|0|||
27801225|NCT01844817|54256103|FG001|Treatment|Other|3|||
27801226|NCT01814553|54256112|FG000|Overall Study|PD per clinical progression|6|||
27801227|NCT01814553|54256113|FG001|Overall Study|PD per clinical progression|8|||
27801228|NCT01814553|54256112|FG000|Overall Study|Other Adverse Event|4|||
27801229|NCT01814553|54256113|FG001|Overall Study|Other Adverse Event|5|||
27801230|NCT01814553|54256112|FG000|Overall Study|Withdrawal by Subject|1|||
27801231|NCT01814553|54256113|FG001|Overall Study|Withdrawal by Subject|1|||
27801232|NCT01814553|54256112|FG000|Overall Study|Other than stated|7|||
27801233|NCT01814553|54256113|FG001|Overall Study|Other than stated|8|||
27801234|NCT02116205|54256123|FG000|Overall Study|Withdrawal by Subject|2|||
27801235|NCT02116205|54256124|FG001|Overall Study|Withdrawal by Subject|4|||
27801236|NCT02116205|54256125|FG002|Overall Study|Withdrawal by Subject|1|||
28024359|NCT00643760|54683096|FG004|Overall Study|Lack of Efficacy|3|||
28024360|NCT00643760|54683092|FG000|Overall Study|Protocol Violation|7|||
28024361|NCT00643760|54683093|FG001|Overall Study|Protocol Violation|6|||
28024362|NCT00643760|54683094|FG002|Overall Study|Protocol Violation|4|||
28024363|NCT00643760|54683095|FG003|Overall Study|Protocol Violation|4|||
27801237|NCT02116205|54256126|FG003|Overall Study|Withdrawal by Subject|3|||
27801238|NCT02116205|54256123|FG000|Overall Study|Lost to Follow-up|0|||
27801239|NCT02116205|54256124|FG001|Overall Study|Lost to Follow-up|2|||
27801240|NCT02116205|54256125|FG002|Overall Study|Lost to Follow-up|1|||
27801241|NCT02116205|54256126|FG003|Overall Study|Lost to Follow-up|2|||
27801242|NCT02116205|54256123|FG000|Overall Study|Physician Decision|0|||
27801243|NCT02116205|54256124|FG001|Overall Study|Physician Decision|1|||
27801244|NCT02116205|54256125|FG002|Overall Study|Physician Decision|1|||
27801245|NCT02116205|54256126|FG003|Overall Study|Physician Decision|1|||
27801246|NCT02116205|54256123|FG000|Overall Study|Exclusion criteria|0|||
27801247|NCT02116205|54256124|FG001|Overall Study|Exclusion criteria|0|||
27801248|NCT02116205|54256125|FG002|Overall Study|Exclusion criteria|1|||
27801249|NCT02116205|54256126|FG003|Overall Study|Exclusion criteria|0|||
27801250|NCT01844583|54256138|FG000|Overall Study|Didn't complete dosing;PK/ECG assessment|8|||
27801251|NCT01844583|54256139|FG001|Overall Study|Didn't complete dosing;PK/ECG assessment|10|||
27801252|NCT02115815|54256157|FG000|Overall Study|Withdrawal by Subject|2|||
27801253|NCT02115815|54256158|FG001|Overall Study|Withdrawal by Subject|0|||
27801254|NCT02115815|54256159|FG002|Overall Study|Withdrawal by Subject|0|||
27801255|NCT02115815|54256160|FG003|Overall Study|Withdrawal by Subject|0|||
27801256|NCT02115815|54256161|FG004|Overall Study|Withdrawal by Subject|0|||
27801257|NCT02115815|54256162|FG005|Overall Study|Withdrawal by Subject|0|||
27801258|NCT02115815|54256163|FG006|Overall Study|Withdrawal by Subject|0|||
27801259|NCT02115815|54256157|FG000|Overall Study|Not enough drug to dose participant|0|||
27801260|NCT02115815|54256158|FG001|Overall Study|Not enough drug to dose participant|0|||
27801261|NCT02115815|54256159|FG002|Overall Study|Not enough drug to dose participant|0|||
27801262|NCT02115815|54256160|FG003|Overall Study|Not enough drug to dose participant|0|||
27801263|NCT02115815|54256161|FG004|Overall Study|Not enough drug to dose participant|0|||
27801264|NCT02115815|54256162|FG005|Overall Study|Not enough drug to dose participant|1|||
28024364|NCT00643760|54683096|FG004|Overall Study|Protocol Violation|6|||
28024365|NCT00643760|54683092|FG000|Overall Study|Lost to Follow-up|6|||
28024366|NCT00643760|54683093|FG001|Overall Study|Lost to Follow-up|2|||
28024367|NCT00643760|54683094|FG002|Overall Study|Lost to Follow-up|1|||
28024368|NCT00643760|54683095|FG003|Overall Study|Lost to Follow-up|3|||
28024369|NCT00643760|54683096|FG004|Overall Study|Lost to Follow-up|3|||
28024370|NCT00643760|54683092|FG000|Overall Study|Investigator Discretion|0|||
27801265|NCT02115815|54256163|FG006|Overall Study|Not enough drug to dose participant|0|||
27801266|NCT02115815|54256157|FG000|Overall Study|Missed appointment, randomized in error|0|||
27801267|NCT02115815|54256158|FG001|Overall Study|Missed appointment, randomized in error|0|||
28024371|NCT00643760|54683093|FG001|Overall Study|Investigator Discretion|0|||
28024372|NCT00643760|54683094|FG002|Overall Study|Investigator Discretion|0|||
28024373|NCT00643760|54683095|FG003|Overall Study|Investigator Discretion|2|||
27801268|NCT02115815|54256159|FG002|Overall Study|Missed appointment, randomized in error|0|||
27801269|NCT02115815|54256160|FG003|Overall Study|Missed appointment, randomized in error|0|||
27801270|NCT02115815|54256161|FG004|Overall Study|Missed appointment, randomized in error|0|||
27801271|NCT02115815|54256162|FG005|Overall Study|Missed appointment, randomized in error|1|||
27801272|NCT02115815|54256163|FG006|Overall Study|Missed appointment, randomized in error|0|||
28024374|NCT00643760|54683096|FG004|Overall Study|Investigator Discretion|0|||
28024375|NCT00643760|54683092|FG000|Overall Study|Withdrawal by Subject|3|||
27801273|NCT02115269|54256179|FG000|Overall Study|Lost to Follow-up|43|||
27801274|NCT02115269|54256179|FG000|Overall Study|Did not complete patient diary|3|||
27801275|NCT02115269|54256179|FG000|Overall Study|Moved to another city|7|||
27801276|NCT02115269|54256179|FG000|Overall Study|Withdrawal by Subject|2|||
27801277|NCT02115269|54256179|FG000|Overall Study|Didn't take study drug|2|||
27801278|NCT02115113|54256194|FG000|Participants in Run-in Period|Death|0|||
27801279|NCT02115113|54256195|FG001|Participants in Run-in Period|Death|0|||
28024376|NCT00643760|54683093|FG001|Overall Study|Withdrawal by Subject|1|||
28024377|NCT00643760|54683094|FG002|Overall Study|Withdrawal by Subject|2|||
28024378|NCT00643760|54683095|FG003|Overall Study|Withdrawal by Subject|4|||
28024379|NCT00643760|54683096|FG004|Overall Study|Withdrawal by Subject|1|||
28024380|NCT00643682|54683110|FG000|Overall Study|did not keep appointment|522|||
28024381|NCT00643682|54683111|FG001|Overall Study|did not keep appointment|509|||
28024382|NCT00643604|54683117|FG000|Overall Study|Death|1|||
27801280|NCT02115113|54256196|FG002|Participants in Run-in Period|Death|1|||
27801281|NCT02115113|54256194|FG000|Participants in Run-in Period|Administrative problems|0|||
27801282|NCT02115113|54256195|FG001|Participants in Run-in Period|Administrative problems|0|||
28024383|NCT00603798|54683124|FG000|Overall Study|Adverse Event|4|||
28024384|NCT00603798|54683125|FG001|Overall Study|Adverse Event|2|||
28024385|NCT00603798|54683126|FG002|Overall Study|Adverse Event|1|||
28024386|NCT00603798|54683124|FG000|Overall Study|Withdrawal by Subject|4|||
28024387|NCT00603798|54683125|FG001|Overall Study|Withdrawal by Subject|3|||
28024388|NCT00603798|54683126|FG002|Overall Study|Withdrawal by Subject|4|||
28024389|NCT00603798|54683124|FG000|Overall Study|Lost to Follow-up|1|||
28024390|NCT00603798|54683125|FG001|Overall Study|Lost to Follow-up|0|||
28024391|NCT00603798|54683126|FG002|Overall Study|Lost to Follow-up|1|||
28024392|NCT00603798|54683124|FG000|Overall Study|Non-compliance with study procedures|0|||
28024393|NCT00603798|54683125|FG001|Overall Study|Non-compliance with study procedures|1|||
28024394|NCT00603798|54683126|FG002|Overall Study|Non-compliance with study procedures|0|||
28024395|NCT00603798|54683124|FG000|Overall Study|Not due to AE|1|||
28024396|NCT00603798|54683125|FG001|Overall Study|Not due to AE|1|||
28024397|NCT00603798|54683126|FG002|Overall Study|Not due to AE|4|||
28024398|NCT00630812|54683136|FG000|Randomisation to First Dose|Adverse Event|1|||
28024399|NCT00630812|54683137|FG001|Randomisation to First Dose|Adverse Event|1|||
28024400|NCT00630812|54683136|FG000|Randomisation to First Dose|Withdrawal by Subject|2|||
28024401|NCT00630812|54683137|FG001|Randomisation to First Dose|Withdrawal by Subject|3|||
27801283|NCT02115113|54256196|FG002|Participants in Run-in Period|Administrative problems|1|||
27801284|NCT02115113|54256194|FG000|Participants in Run-in Period|Lost to Follow-up|0|||
27801285|NCT02115113|54256195|FG001|Participants in Run-in Period|Lost to Follow-up|0|||
27801286|NCT02115113|54256196|FG002|Participants in Run-in Period|Lost to Follow-up|5|||
27801287|NCT02115113|54256194|FG000|Participants in Run-in Period|Withdrawal by Subject|0|||
27801288|NCT02115113|54256195|FG001|Participants in Run-in Period|Withdrawal by Subject|0|||
28024402|NCT00630812|54683136|FG000|Randomisation to First Dose|Lost to Follow-up|1|||
28024403|NCT00630812|54683137|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
28024404|NCT00630812|54683136|FG000|Randomisation to First Dose|Protocol Violation|4|||
28024405|NCT00630812|54683137|FG001|Randomisation to First Dose|Protocol Violation|1|||
28024406|NCT00630812|54683136|FG000|Double Blind Treatment Period|Adverse Event|13|||
28024407|NCT00630812|54683137|FG001|Double Blind Treatment Period|Adverse Event|5|||
28024408|NCT00630812|54683136|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
28024409|NCT00630812|54683137|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
28024410|NCT00630812|54683136|FG000|Double Blind Treatment Period|Physician Decision|2|||
28024411|NCT00630812|54683137|FG001|Double Blind Treatment Period|Physician Decision|1|||
28024412|NCT00630812|54683136|FG000|Double Blind Treatment Period|Protocol Violation|1|||
28024413|NCT00630812|54683137|FG001|Double Blind Treatment Period|Protocol Violation|0|||
28024414|NCT00630812|54683136|FG000|Double Blind Treatment Period|Withdrawal by Subject|13|||
28024415|NCT00630812|54683137|FG001|Double Blind Treatment Period|Withdrawal by Subject|7|||
28024416|NCT00630812|54683136|FG000|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1|||
28024417|NCT00630812|54683137|FG001|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0|||
28024418|NCT00630812|54683136|FG000|Double Blind Treatment Period|Non-compliance|0|||
28024419|NCT00630812|54683137|FG001|Double Blind Treatment Period|Non-compliance|1|||
28024420|NCT00629798|54683143|FG000|Overall Study|Not Treated|4|||
28024421|NCT00160615|54683149|FG000|Overall Study|Adverse Event|5|||
28024422|NCT00160615|54683150|FG001|Overall Study|Adverse Event|12|||
28024423|NCT00160615|54683149|FG000|Overall Study|Withdrawal by Subject|0|||
27801289|NCT02115113|54256196|FG002|Participants in Run-in Period|Withdrawal by Subject|3|||
27801290|NCT02115113|54256194|FG000|Participants Randomized|Lost to Follow-up|1|||
28024424|NCT00160615|54683150|FG001|Overall Study|Withdrawal by Subject|2|||
28024425|NCT00160615|54683149|FG000|Overall Study|Lack of Efficacy|11|||
28024426|NCT00160615|54683150|FG001|Overall Study|Lack of Efficacy|23|||
28024427|NCT00160615|54683149|FG000|Overall Study|Patient decision|1|||
28024428|NCT00160615|54683150|FG001|Overall Study|Patient decision|2|||
28024429|NCT00160615|54683149|FG000|Overall Study|Investigator decision|1|||
28024430|NCT00160615|54683150|FG001|Overall Study|Investigator decision|1|||
28024431|NCT00160615|54683149|FG000|Overall Study|AE agents had to be discontinued (exam.)|0|||
28024432|NCT00160615|54683150|FG001|Overall Study|AE agents had to be discontinued (exam.)|1|||
28024433|NCT00160615|54683149|FG000|Overall Study|Switch to surgical treatment|0|||
28024434|NCT00160615|54683150|FG001|Overall Study|Switch to surgical treatment|2|||
28024435|NCT00160615|54683149|FG000|Overall Study|Non-compliance was suspected|0|||
28024436|NCT00160615|54683150|FG001|Overall Study|Non-compliance was suspected|1|||
28024437|NCT00160615|54683149|FG000|Overall Study|Poor compliance|0|||
28024438|NCT00160615|54683150|FG001|Overall Study|Poor compliance|1|||
28024439|NCT00643448|54683161|FG000|Overall Study|Lack of Efficacy|2|||
28024440|NCT00643448|54683162|FG001|Overall Study|Lack of Efficacy|0|||
28024441|NCT00643448|54683163|FG002|Overall Study|Lack of Efficacy|4|||
27801291|NCT02115113|54256195|FG001|Participants Randomized|Lost to Follow-up|0|||
28024442|NCT00643448|54683161|FG000|Overall Study|Adverse Event|2|||
27801292|NCT02115113|54256196|FG002|Participants Randomized|Lost to Follow-up|0|||
27801293|NCT02115113|54256194|FG000|Participants Randomized|Death|1|||
28024443|NCT00643448|54683162|FG001|Overall Study|Adverse Event|2|||
28024444|NCT00643448|54683163|FG002|Overall Study|Adverse Event|2|||
28024445|NCT00643448|54683161|FG000|Overall Study|QTcF>550 ms|0|||
28024446|NCT00643448|54683162|FG001|Overall Study|QTcF>550 ms|3|||
28024447|NCT00643448|54683163|FG002|Overall Study|QTcF>550 ms|0|||
28024448|NCT00604500|54683173|FG000|Overall Study|Adverse Event|2|||
28024449|NCT00604500|54683173|FG000|Overall Study|Protocol Violation|2|||
28024450|NCT00604500|54683173|FG000|Overall Study|Treatment Failure|1|||
28024451|NCT00604500|54683173|FG000|Overall Study|Withdrawal by Subject|4|||
28024452|NCT00604500|54683173|FG000|Overall Study|Administrative|1|||
28024453|NCT00604500|54683173|FG000|Overall Study|Did not meet protocol eligibility|1|||
28024454|NCT00627458|54683180|FG000|Overall Study|Migrated from study area|1|||
28024455|NCT00627458|54683181|FG001|Overall Study|Migrated from study area|0|||
28024456|NCT00627458|54683182|FG002|Overall Study|Migrated from study area|1|||
28024457|NCT00627458|54683180|FG000|Overall Study|Withdrawal by Subject|2|||
28024458|NCT00627458|54683181|FG001|Overall Study|Withdrawal by Subject|6|||
28024459|NCT00627458|54683182|FG002|Overall Study|Withdrawal by Subject|5|||
28024460|NCT00627458|54683180|FG000|Overall Study|Lost to Follow-up|1|||
28024461|NCT00627458|54683181|FG001|Overall Study|Lost to Follow-up|1|||
28024462|NCT00627458|54683182|FG002|Overall Study|Lost to Follow-up|0|||
28024463|NCT00542919|54683194|FG000|Overall Study|Adverse Event|1|||
28024464|NCT00542919|54683195|FG001|Overall Study|Adverse Event|5|||
28024465|NCT00542919|54683196|FG002|Overall Study|Adverse Event|1|||
28024466|NCT00542919|54683194|FG000|Overall Study|Withdrawal by Subject|1|||
28024467|NCT00542919|54683195|FG001|Overall Study|Withdrawal by Subject|0|||
28024468|NCT00542919|54683196|FG002|Overall Study|Withdrawal by Subject|3|||
28024469|NCT00542919|54683194|FG000|Overall Study|Physician Decision|2|||
28024470|NCT00542919|54683195|FG001|Overall Study|Physician Decision|2|||
28024471|NCT00542919|54683196|FG002|Overall Study|Physician Decision|1|||
28024472|NCT00542919|54683194|FG000|Overall Study|Sponsor Decision|1|||
28024473|NCT00542919|54683195|FG001|Overall Study|Sponsor Decision|0|||
28024474|NCT00542919|54683196|FG002|Overall Study|Sponsor Decision|0|||
28024475|NCT00542919|54683194|FG000|Overall Study|Lost to Follow-up|2|||
28024476|NCT00542919|54683195|FG001|Overall Study|Lost to Follow-up|0|||
28024477|NCT00542919|54683196|FG002|Overall Study|Lost to Follow-up|1|||
28024478|NCT00159913|54683223|FG000|Overall Study|Adverse Event|1|||
28024479|NCT00159913|54683224|FG001|Overall Study|Adverse Event|0|||
28024480|NCT00159913|54683225|FG002|Overall Study|Adverse Event|1|||
28024481|NCT00159913|54683226|FG003|Overall Study|Adverse Event|0|||
28024482|NCT00159913|54683223|FG000|Overall Study|Withdrawal by Subject|0|||
28024483|NCT00159913|54683224|FG001|Overall Study|Withdrawal by Subject|0|||
28024484|NCT00159913|54683225|FG002|Overall Study|Withdrawal by Subject|0|||
28024485|NCT00159913|54683226|FG003|Overall Study|Withdrawal by Subject|1|||
27801294|NCT02115113|54256195|FG001|Participants Randomized|Death|0|||
27801295|NCT02115113|54256196|FG002|Participants Randomized|Death|0|||
27801296|NCT02114879|54256207|FG000|Overall Study|Withdrawal by Subject|9|||
27801297|NCT02114879|54256208|FG001|Overall Study|Withdrawal by Subject|5|||
27801298|NCT02114879|54256207|FG000|Overall Study|Death|6|||
27801299|NCT02114879|54256208|FG001|Overall Study|Death|11|||
27801300|NCT02114879|54256207|FG000|Overall Study|Lost to Follow-up|4|||
27842838|NCT01575197|54331725|FG001|Overall Study|Migration out of study area|5|||
28024486|NCT00159913|54683223|FG000|Overall Study|Lost to Follow-up|0|||
28024487|NCT00159913|54683224|FG001|Overall Study|Lost to Follow-up|0|||
28024488|NCT00159913|54683225|FG002|Overall Study|Lost to Follow-up|0|||
28024489|NCT00159913|54683226|FG003|Overall Study|Lost to Follow-up|1|||
28024490|NCT00159913|54683223|FG000|Overall Study|Protocol Violation|1|||
28024491|NCT00159913|54683224|FG001|Overall Study|Protocol Violation|0|||
27801301|NCT02114879|54256208|FG001|Overall Study|Lost to Follow-up|6|||
28024492|NCT00159913|54683225|FG002|Overall Study|Protocol Violation|1|||
28024493|NCT00159913|54683226|FG003|Overall Study|Protocol Violation|0|||
28024494|NCT00604188|54683240|FG000|Overall Study|Adverse Event|1|||
28024495|NCT00604188|54683241|FG001|Overall Study|Adverse Event|4|||
28024496|NCT00604188|54683240|FG000|Overall Study|Lost to Follow-up|17|||
28024497|NCT00604188|54683241|FG001|Overall Study|Lost to Follow-up|15|||
28024498|NCT00604188|54683240|FG000|Overall Study|Withdrawal by Subject|5|||
28024499|NCT00604188|54683241|FG001|Overall Study|Withdrawal by Subject|1|||
28024500|NCT00604188|54683240|FG000|Overall Study|Non-compliance with protocol|4|||
28024501|NCT00604188|54683241|FG001|Overall Study|Non-compliance with protocol|4|||
28024502|NCT00604188|54683240|FG000|Overall Study|Did not receive study drug|0|||
28024503|NCT00604188|54683241|FG001|Overall Study|Did not receive study drug|1|||
28024504|NCT03913377|54683249|FG000|Period 1|Test Article no longer available|0|||
28024505|NCT03913377|54683250|FG001|Period 1|Test Article no longer available|1|||
28024506|NCT03913377|54683251|FG002|Period 1|Test Article no longer available|0|||
28024507|NCT03913377|54683249|FG000|Period 1|No Longer Meets Eligibility Criteria|0|||
28024508|NCT03913377|54683250|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
28024509|NCT03913377|54683251|FG002|Period 1|No Longer Meets Eligibility Criteria|1|||
28024510|NCT00227539|54683258|FG000|Overall Study|Protocol Violation|1|||
28024511|NCT00227305|54683262|FG000|Overall Study|Adverse Event|40|||
28024512|NCT00227305|54683262|FG000|Overall Study|Withdrawal by Subject|42|||
28024513|NCT00227305|54683262|FG000|Overall Study|Lost to Follow-up|33|||
28024514|NCT00227305|54683262|FG000|Overall Study|Study specific discontinuation|13|||
28024515|NCT00227305|54683262|FG000|Overall Study|MOVED OUT OF AREA|3|||
28024516|NCT00227305|54683262|FG000|Overall Study|Lack of Efficacy|7|||
28024517|NCT00227305|54683262|FG000|Overall Study|Physician Decision|3|||
28024518|NCT00227305|54683262|FG000|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1|||
28024519|NCT00227305|54683262|FG000|Overall Study|LEAVING TOWN FOR 6 WEEKS|1|||
28024520|NCT00227305|54683262|FG000|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1|||
28024521|NCT00720941|54683268|FG000|Overall Study|Death|334|||
28024522|NCT00720941|54683269|FG001|Overall Study|Death|335|||
28024523|NCT00720941|54683268|FG000|Overall Study|Protocol Violation|0|||
28024524|NCT00720941|54683269|FG001|Overall Study|Protocol Violation|2|||
28024525|NCT00720941|54683268|FG000|Overall Study|Lost to Follow-up|17|||
28024526|NCT00720941|54683269|FG001|Overall Study|Lost to Follow-up|15|||
28024527|NCT00720941|54683268|FG000|Overall Study|Physician Decision|1|||
28024528|NCT00720941|54683269|FG001|Overall Study|Physician Decision|5|||
28024529|NCT00720941|54683268|FG000|Overall Study|Withdrawal by Subject|27|||
28024530|NCT00720941|54683269|FG001|Overall Study|Withdrawal by Subject|35|||
27801302|NCT02114879|54256207|FG000|Overall Study|Physician Decision|0|||
27801303|NCT02114879|54256208|FG001|Overall Study|Physician Decision|2|||
27801304|NCT02114177|54256216|FG000|Overall Study|Lost to Follow-up|1|||
27801305|NCT02114177|54256217|FG001|Overall Study|Lost to Follow-up|2|||
27801306|NCT02114177|54256216|FG000|Overall Study|Withdrawal by Subject|6|||
27801307|NCT02114177|54256217|FG001|Overall Study|Withdrawal by Subject|1|||
27801308|NCT02114177|54256216|FG000|Overall Study|Other|2|||
27801309|NCT02114177|54256217|FG001|Overall Study|Other|1|||
27801310|NCT02138825|54256225|FG000|Main Study Treatment|Adverse Event|11|||
27801311|NCT02138825|54256226|FG001|Main Study Treatment|Adverse Event|3|||
27801312|NCT02138825|54256225|FG000|Main Study Treatment|Death|1|||
27801313|NCT02138825|54256226|FG001|Main Study Treatment|Death|2|||
27801314|NCT02138825|54256225|FG000|Main Study Treatment|Protocol Violation|2|||
28024531|NCT00720941|54683268|FG000|Overall Study|Ongoing|34|||
28024532|NCT00720941|54683269|FG001|Overall Study|Ongoing|23|||
28024533|NCT00585533|54683275|FG000|Overall Study|objective or symptomatic progression|9|||
28024534|NCT00628862|54683282|FG000|Overall Study|Adverse Event|6|||
28024535|NCT00628862|54683283|FG001|Overall Study|Adverse Event|8|||
28024536|NCT00628862|54683284|FG002|Overall Study|Adverse Event|10|||
28024537|NCT00628862|54683282|FG000|Overall Study|Withdrawal by Subject|4|||
28024538|NCT00628862|54683283|FG001|Overall Study|Withdrawal by Subject|6|||
28024539|NCT00628862|54683284|FG002|Overall Study|Withdrawal by Subject|11|||
28024540|NCT00628862|54683282|FG000|Overall Study|Lost to Follow-up|0|||
28024541|NCT00628862|54683283|FG001|Overall Study|Lost to Follow-up|2|||
28024542|NCT00628862|54683284|FG002|Overall Study|Lost to Follow-up|1|||
28024543|NCT00628862|54683282|FG000|Overall Study|Protocol Violation|1|||
28024544|NCT00628862|54683283|FG001|Overall Study|Protocol Violation|0|||
28024545|NCT00628862|54683284|FG002|Overall Study|Protocol Violation|0|||
27801315|NCT02138825|54256226|FG001|Main Study Treatment|Protocol Violation|2|||
28024546|NCT00628862|54683282|FG000|Overall Study|COPD Exacerbation|0|||
28024547|NCT00628862|54683283|FG001|Overall Study|COPD Exacerbation|1|||
28024548|NCT00628862|54683284|FG002|Overall Study|COPD Exacerbation|0|||
28024549|NCT00584987|54683296|FG000|Overall Study|Protocol Violation|1|||
28024550|NCT00584987|54683297|FG001|Overall Study|Protocol Violation|1|||
28024551|NCT00584987|54683298|FG002|Overall Study|Protocol Violation|1|||
28024552|NCT00584987|54683299|FG003|Overall Study|Protocol Violation|0|||
28024553|NCT00584987|54683296|FG000|Overall Study|Adverse Event|0|||
28024554|NCT00584987|54683297|FG001|Overall Study|Adverse Event|0|||
28024555|NCT00584987|54683298|FG002|Overall Study|Adverse Event|0|||
28024556|NCT00584987|54683299|FG003|Overall Study|Adverse Event|1|||
28024557|NCT00727961|54683309|FG000|Overall Study|Lost to Follow-up|1|||
28024558|NCT00727961|54683309|FG000|Overall Study|Adverse Event|4|||
27801316|NCT02138825|54256225|FG000|Main Study Treatment|Sponsor decision|12|||
27801317|NCT02138825|54256226|FG001|Main Study Treatment|Sponsor decision|18|||
27801318|NCT02138825|54256225|FG000|Main Study Treatment|Study terminated by sponsor|10|||
27801319|NCT02138825|54256226|FG001|Main Study Treatment|Study terminated by sponsor|9|||
27801320|NCT02138825|54256225|FG000|Main Study Treatment|Withdrawal by Subject|3|||
28024559|NCT00727961|54683309|FG000|Overall Study|Patient's refusal|2|||
28024560|NCT00727961|54683309|FG000|Overall Study|Progression|30|||
28024561|NCT00568958|54683315|FG000|Allocation|Withdrawal by Subject|7|||
28024562|NCT00568958|54683316|FG001|Allocation|Withdrawal by Subject|3|||
28024563|NCT00568958|54683315|FG000|Allocation|Physician Decision|2|||
28024564|NCT00568958|54683316|FG001|Allocation|Physician Decision|0|||
28024565|NCT00568958|54683315|FG000|Follow-Up|Withdrawal by Subject|6|||
28024566|NCT00568958|54683316|FG001|Follow-Up|Withdrawal by Subject|6|||
28024567|NCT00568958|54683315|FG000|Follow-Up|Physician Decision|1|||
28024568|NCT00568958|54683316|FG001|Follow-Up|Physician Decision|1|||
28024569|NCT00568958|54683315|FG000|Follow-Up|Family Emergency|1|||
28024570|NCT00568958|54683316|FG001|Follow-Up|Family Emergency|0|||
28024571|NCT00568958|54683315|FG000|Follow-Up|Adverse Event|1|||
28024572|NCT00568958|54683316|FG001|Follow-Up|Adverse Event|0|||
28024573|NCT00727649|54683324|FG000|First Intervention (4-weeks)|Lost to Follow-up|1|||
28024574|NCT00727649|54683325|FG001|First Intervention (4-weeks)|Lost to Follow-up|2|||
28024575|NCT00727649|54683324|FG000|First Intervention (4-weeks)|Withdrawal by Subject|2|||
28024576|NCT00727649|54683325|FG001|First Intervention (4-weeks)|Withdrawal by Subject|1|||
28024577|NCT00727649|54683324|FG000|Wash-out (2-weeks)|Lost to Follow-up|3|||
28024578|NCT00727649|54683325|FG001|Wash-out (2-weeks)|Lost to Follow-up|1|||
28024579|NCT00727649|54683324|FG000|Wash-out (2-weeks)|Withdrawal by Subject|1|||
28024580|NCT00727649|54683325|FG001|Wash-out (2-weeks)|Withdrawal by Subject|2|||
28024581|NCT00727649|54683324|FG000|Second Intervention (4-weeks)|Death|1|||
28024582|NCT00727649|54683325|FG001|Second Intervention (4-weeks)|Death|0|||
28024583|NCT00727649|54683324|FG000|Second Intervention (4-weeks)|Lost to Follow-up|0|||
28024584|NCT00727649|54683325|FG001|Second Intervention (4-weeks)|Lost to Follow-up|1|||
28024585|NCT00727649|54683324|FG000|Second Intervention (4-weeks)|Withdrawal by Subject|0|||
28024586|NCT00727649|54683325|FG001|Second Intervention (4-weeks)|Withdrawal by Subject|2|||
28024587|NCT00568334|54683335|FG000|Overall Study|Withdrawal by Subject|0|||
28024588|NCT00568334|54683336|FG001|Overall Study|Withdrawal by Subject|1|||
28024589|NCT00568334|54683335|FG000|Overall Study|Lost to Follow-up|1|||
28024590|NCT00568334|54683336|FG001|Overall Study|Lost to Follow-up|0|||
27801321|NCT02138825|54256226|FG001|Main Study Treatment|Withdrawal by Subject|1|||
27801322|NCT02138825|54256225|FG000|Main Study Treatment|Medical decision|1|||
27801323|NCT02138825|54256226|FG001|Main Study Treatment|Medical decision|0|||
27801324|NCT02138825|54256225|FG000|Long-term Extension|Study termination by sponsor|32|||
27801325|NCT02138825|54256226|FG001|Long-term Extension|Study termination by sponsor|38|||
27801326|NCT02138825|54256225|FG000|Safety Follow-up|Adverse Event|4|||
27938800|NCT00967018|54595075|FG000|Overall Study|Miscellaneous Reasons|9|||
27938801|NCT00965146|54595079|FG000|Overall Study|Death|7|||
27938802|NCT00965146|54595079|FG000|Overall Study|Lost to Follow-up|22|||
27938803|NCT00965146|54595079|FG000|Overall Study|Withdrawal by Subject|17|||
27938804|NCT00965146|54595079|FG000|Overall Study|Unable to return|1|||
27938805|NCT00965146|54595079|FG000|Overall Study|Unwilling to return|11|||
27938806|NCT00965146|54595079|FG000|Overall Study|Intercurrent illness|1|||
27938807|NCT00965146|54595079|FG000|Overall Study|Revision / Removal of Study Implant|6|||
27938808|NCT00965146|54595079|FG000|Overall Study|Overall Study Termination|145|||
27938809|NCT00966940|54595085|FG000|Period 1, First 6 Weeks|Withdrawal by Subject|2|||
27938810|NCT00966940|54595086|FG001|Period 1, First 6 Weeks|Withdrawal by Subject|0|||
27938811|NCT00966940|54595085|FG000|Period 1, First 6 Weeks|Protocol Violation|1|||
27938812|NCT00966940|54595086|FG001|Period 1, First 6 Weeks|Protocol Violation|0|||
27938813|NCT00965848|54595092|FG000|Overall Study|Protocol Violation|3|||
27938814|NCT00965848|54595093|FG001|Overall Study|Protocol Violation|0|||
27938815|NCT00965848|54595094|FG002|Overall Study|Protocol Violation|1|||
27938816|NCT00965848|54595092|FG000|Overall Study|Death|11|||
28024591|NCT00727571|54683346|FG000|Overall Study|Ineligibility determined|1|||
28024592|NCT00727571|54683347|FG001|Overall Study|Ineligibility determined|1|||
28024593|NCT00727571|54683348|FG002|Overall Study|Ineligibility determined|1|||
28024594|NCT00727571|54683349|FG003|Overall Study|Ineligibility determined|0|||
27801327|NCT02138825|54256226|FG001|Safety Follow-up|Adverse Event|3|||
27801328|NCT02138825|54256225|FG000|Safety Follow-up|Death|11|||
27801329|NCT02138825|54256226|FG001|Safety Follow-up|Death|5|||
27801330|NCT02138825|54256225|FG000|Safety Follow-up|Withdrawal by Subject|5|||
27801331|NCT02138825|54256226|FG001|Safety Follow-up|Withdrawal by Subject|3|||
27801332|NCT02138825|54256225|FG000|Safety Follow-up|clinic worsening|1|||
27801333|NCT02138825|54256226|FG001|Safety Follow-up|clinic worsening|0|||
27801334|NCT02138825|54256225|FG000|Safety Follow-up|withdrawal by PI|1|||
27801335|NCT02138825|54256226|FG001|Safety Follow-up|withdrawal by PI|0|||
27801336|NCT02138825|54256225|FG000|Safety Follow-up|logistical difficulties|0|||
27801337|NCT02138825|54256226|FG001|Safety Follow-up|logistical difficulties|1|||
27801338|NCT02138825|54256225|FG000|Safety Follow-up|progressive disease|0|||
27801339|NCT02138825|54256226|FG001|Safety Follow-up|progressive disease|2|||
27801340|NCT02138825|54256225|FG000|Safety Follow-up|too unwell to attend the visit|0|||
27801341|NCT02138825|54256226|FG001|Safety Follow-up|too unwell to attend the visit|1|||
28024595|NCT00727571|54683346|FG000|Overall Study|Death|0|||
28024596|NCT00727571|54683347|FG001|Overall Study|Death|19|||
28024597|NCT00727571|54683348|FG002|Overall Study|Death|5|||
28024598|NCT00727571|54683349|FG003|Overall Study|Death|1|||
28024599|NCT00727571|54683346|FG000|Overall Study|Physician Decision|0|||
28024600|NCT00727571|54683347|FG001|Overall Study|Physician Decision|5|||
28024601|NCT00727571|54683348|FG002|Overall Study|Physician Decision|0|||
28024602|NCT00727571|54683349|FG003|Overall Study|Physician Decision|0|||
28024603|NCT00727571|54683346|FG000|Overall Study|Withdrawal by Subject|0|||
28024604|NCT00727571|54683347|FG001|Overall Study|Withdrawal by Subject|10|||
28024605|NCT00727571|54683348|FG002|Overall Study|Withdrawal by Subject|11|||
28024606|NCT00727571|54683349|FG003|Overall Study|Withdrawal by Subject|0|||
28024607|NCT00727571|54683346|FG000|Overall Study|Subject Non Compliance|0|||
28024608|NCT00727571|54683347|FG001|Overall Study|Subject Non Compliance|6|||
28024609|NCT00727571|54683348|FG002|Overall Study|Subject Non Compliance|0|||
28024610|NCT00727571|54683349|FG003|Overall Study|Subject Non Compliance|4|||
28024611|NCT00727571|54683346|FG000|Overall Study|Dismissed from nursing home|0|||
28024612|NCT00727571|54683347|FG001|Overall Study|Dismissed from nursing home|9|||
28024613|NCT00727571|54683348|FG002|Overall Study|Dismissed from nursing home|5|||
28024614|NCT00727571|54683349|FG003|Overall Study|Dismissed from nursing home|0|||
28024615|NCT00727571|54683346|FG000|Overall Study|Hospitalization|0|||
28024616|NCT00727571|54683347|FG001|Overall Study|Hospitalization|1|||
28024617|NCT00727571|54683348|FG002|Overall Study|Hospitalization|0|||
28024618|NCT00727571|54683349|FG003|Overall Study|Hospitalization|1|||
27801342|NCT02138825|54256225|FG000|Safety Follow-up|treatment unblinded|0|||
27801343|NCT02138825|54256226|FG001|Safety Follow-up|treatment unblinded|1|||
27801344|NCT02138825|54256225|FG000|Safety Follow-up|withdrawn due to lung transplant|0|||
28024619|NCT00727571|54683346|FG000|Overall Study|AE not leading to hospitalization|0|||
28024620|NCT00727571|54683347|FG001|Overall Study|AE not leading to hospitalization|0|||
28024621|NCT00727571|54683348|FG002|Overall Study|AE not leading to hospitalization|2|||
28024622|NCT00727571|54683349|FG003|Overall Study|AE not leading to hospitalization|0|||
28024623|NCT00727571|54683346|FG000|Overall Study|Other|0|||
27801345|NCT02138825|54256226|FG001|Safety Follow-up|withdrawn due to lung transplant|1|||
27801346|NCT02138747|54256241|FG000|Treatment Period 1|Adverse Event|10|||
27801347|NCT02138747|54256242|FG001|Treatment Period 1|Adverse Event|14|||
27801348|NCT02138747|54256243|FG002|Treatment Period 1|Adverse Event|2|||
27801349|NCT02138747|54256244|FG003|Treatment Period 1|Adverse Event|1|||
27801350|NCT02138747|54256241|FG000|Treatment Period 1|Lost to Follow-up|0|||
27801351|NCT02138747|54256242|FG001|Treatment Period 1|Lost to Follow-up|1|||
27801352|NCT02138747|54256243|FG002|Treatment Period 1|Lost to Follow-up|1|||
27801353|NCT02138747|54256244|FG003|Treatment Period 1|Lost to Follow-up|0|||
27801354|NCT02138747|54256241|FG000|Treatment Period 1|Protocol Violation|0|||
27801355|NCT02138747|54256242|FG001|Treatment Period 1|Protocol Violation|2|||
27801356|NCT02138747|54256243|FG002|Treatment Period 1|Protocol Violation|0|||
27801357|NCT02138747|54256244|FG003|Treatment Period 1|Protocol Violation|0|||
27801358|NCT02138747|54256241|FG000|Treatment Period 1|Withdrawal by Subject|8|||
27801359|NCT02138747|54256242|FG001|Treatment Period 1|Withdrawal by Subject|4|||
27801360|NCT02138747|54256243|FG002|Treatment Period 1|Withdrawal by Subject|1|||
27801361|NCT02138747|54256244|FG003|Treatment Period 1|Withdrawal by Subject|3|||
27801362|NCT02138747|54256241|FG000|Treatment Period 1|Other - Miscellaneous|2|||
27801363|NCT02138747|54256242|FG001|Treatment Period 1|Other - Miscellaneous|4|||
27801364|NCT02138747|54256243|FG002|Treatment Period 1|Other - Miscellaneous|0|||
27801365|NCT02138747|54256244|FG003|Treatment Period 1|Other - Miscellaneous|0|||
27801366|NCT02138747|54256241|FG000|Treatment Period 2|Adverse Event|6|||
27801367|NCT02138747|54256242|FG001|Treatment Period 2|Adverse Event|3|||
27801368|NCT02138747|54256243|FG002|Treatment Period 2|Adverse Event|1|||
27801369|NCT02138747|54256244|FG003|Treatment Period 2|Adverse Event|1|||
27801370|NCT02138747|54256241|FG000|Treatment Period 2|Lost to Follow-up|2|||
27801371|NCT02138747|54256242|FG001|Treatment Period 2|Lost to Follow-up|0|||
27801372|NCT02138747|54256243|FG002|Treatment Period 2|Lost to Follow-up|0|||
27801373|NCT02138747|54256244|FG003|Treatment Period 2|Lost to Follow-up|0|||
27801374|NCT02138747|54256241|FG000|Treatment Period 2|Protocol Violation|1|||
27801375|NCT02138747|54256242|FG001|Treatment Period 2|Protocol Violation|0|||
27801376|NCT02138747|54256243|FG002|Treatment Period 2|Protocol Violation|0|||
27801377|NCT02138747|54256244|FG003|Treatment Period 2|Protocol Violation|0|||
27801378|NCT02138747|54256241|FG000|Treatment Period 2|Withdrawal by Subject|5|||
27801379|NCT02138747|54256242|FG001|Treatment Period 2|Withdrawal by Subject|4|||
27801380|NCT02138747|54256243|FG002|Treatment Period 2|Withdrawal by Subject|1|||
27801381|NCT02138747|54256244|FG003|Treatment Period 2|Withdrawal by Subject|2|||
27801382|NCT02138747|54256241|FG000|Treatment Period 2|Other - Miscellaneous|3|||
27801383|NCT02138747|54256242|FG001|Treatment Period 2|Other - Miscellaneous|0|||
27801384|NCT02138747|54256243|FG002|Treatment Period 2|Other - Miscellaneous|0|||
27801385|NCT02138747|54256244|FG003|Treatment Period 2|Other - Miscellaneous|0|||
27801386|NCT02105285|54256257|FG000|Overall Study|Adverse Event|1|||
27801387|NCT02105285|54256258|FG001|Overall Study|Adverse Event|1|||
27801388|NCT02105285|54256259|FG002|Overall Study|Adverse Event|0|||
27801389|NCT02105285|54256257|FG000|Overall Study|Protocol Violation|0|||
27801390|NCT02105285|54256258|FG001|Overall Study|Protocol Violation|1|||
27801391|NCT02105285|54256259|FG002|Overall Study|Protocol Violation|0|||
27801392|NCT02105285|54256257|FG000|Overall Study|Withdrawal by Subject|1|||
27801393|NCT02105285|54256258|FG001|Overall Study|Withdrawal by Subject|0|||
27801394|NCT02105285|54256259|FG002|Overall Study|Withdrawal by Subject|0|||
27801395|NCT02104895|54256268|FG000|Overall Study|Withdrawal by Subject|0|||
27801396|NCT02104895|54256269|FG001|Overall Study|Withdrawal by Subject|14|||
27801397|NCT01621490|54256284|FG000|Overall Study|Participant completed treatment|4|||
27801398|NCT01621490|54256285|FG001|Overall Study|Participant completed treatment|4|||
27801399|NCT01621490|54256286|FG002|Overall Study|Participant completed treatment|1|||
27801400|NCT01621490|54256287|FG003|Overall Study|Participant completed treatment|0|||
27801401|NCT01621490|54256288|FG004|Overall Study|Participant completed treatment|0|||
27801402|NCT01621490|54256289|FG005|Overall Study|Participant completed treatment|0|||
27801403|NCT01621490|54256290|FG006|Overall Study|Participant completed treatment|0|||
27801404|NCT01621490|54256291|FG007|Overall Study|Participant completed treatment|1|||
27801405|NCT01621490|54256292|FG008|Overall Study|Participant completed treatment|0|||
27801406|NCT01621490|54256284|FG000|Overall Study|Patient could not travel|1|||
27801407|NCT01621490|54256285|FG001|Overall Study|Patient could not travel|0|||
27801408|NCT01621490|54256286|FG002|Overall Study|Patient could not travel|0|||
27801409|NCT01621490|54256287|FG003|Overall Study|Patient could not travel|0|||
27801410|NCT01621490|54256288|FG004|Overall Study|Patient could not travel|0|||
27801411|NCT01621490|54256289|FG005|Overall Study|Patient could not travel|0|||
27801412|NCT01621490|54256290|FG006|Overall Study|Patient could not travel|0|||
27801413|NCT01621490|54256291|FG007|Overall Study|Patient could not travel|0|||
27801414|NCT01621490|54256292|FG008|Overall Study|Patient could not travel|0|||
27801415|NCT01621490|54256284|FG000|Overall Study|Subject no longer meets study criteria|0|||
27801416|NCT01621490|54256285|FG001|Overall Study|Subject no longer meets study criteria|0|||
27801417|NCT01621490|54256286|FG002|Overall Study|Subject no longer meets study criteria|0|||
27801418|NCT01621490|54256287|FG003|Overall Study|Subject no longer meets study criteria|0|||
27801419|NCT01621490|54256288|FG004|Overall Study|Subject no longer meets study criteria|1|||
27801420|NCT01621490|54256289|FG005|Overall Study|Subject no longer meets study criteria|0|||
27801421|NCT01621490|54256290|FG006|Overall Study|Subject no longer meets study criteria|0|||
27801422|NCT01621490|54256291|FG007|Overall Study|Subject no longer meets study criteria|0|||
27801423|NCT01621490|54256292|FG008|Overall Study|Subject no longer meets study criteria|0|||
28024624|NCT00727571|54683347|FG001|Overall Study|Other|4|||
28024625|NCT00727571|54683348|FG002|Overall Study|Other|6|||
28024626|NCT00727571|54683349|FG003|Overall Study|Other|0|||
28024627|NCT00225277|54683361|FG000|Overall Study|Adverse Event|30|||
28024628|NCT00225277|54683362|FG001|Overall Study|Adverse Event|34|||
28024629|NCT00225277|54683361|FG000|Overall Study|Lack of Efficacy|4|||
28024630|NCT00225277|54683362|FG001|Overall Study|Lack of Efficacy|1|||
28024631|NCT00225277|54683361|FG000|Overall Study|Lost to Follow-up|4|||
28024632|NCT00225277|54683362|FG001|Overall Study|Lost to Follow-up|6|||
28024633|NCT00225277|54683361|FG000|Overall Study|Physician Decision|6|||
28024634|NCT00225277|54683362|FG001|Overall Study|Physician Decision|8|||
28024635|NCT00225277|54683361|FG000|Overall Study|Protocol Violation|6|||
28024636|NCT00225277|54683362|FG001|Overall Study|Protocol Violation|3|||
28024637|NCT00225277|54683361|FG000|Overall Study|Withdrawal by Subject|40|||
28024638|NCT00225277|54683362|FG001|Overall Study|Withdrawal by Subject|34|||
28024639|NCT00225277|54683361|FG000|Overall Study|Other|7|||
28024640|NCT00225277|54683362|FG001|Overall Study|Other|9|||
27801424|NCT01621490|54256284|FG000|Overall Study|Maximum clinical benefit|3|||
28024641|NCT00567996|54683371|FG000|Overall Study|Adverse Event|18|||
28024642|NCT00567996|54683372|FG001|Overall Study|Adverse Event|16|||
28024643|NCT00567996|54683373|FG002|Overall Study|Adverse Event|13|||
27801425|NCT01621490|54256285|FG001|Overall Study|Maximum clinical benefit|2|||
27801426|NCT01621490|54256286|FG002|Overall Study|Maximum clinical benefit|0|||
27801427|NCT01621490|54256287|FG003|Overall Study|Maximum clinical benefit|0|||
27801428|NCT01621490|54256288|FG004|Overall Study|Maximum clinical benefit|0|||
27801429|NCT01621490|54256289|FG005|Overall Study|Maximum clinical benefit|0|||
27801430|NCT01621490|54256290|FG006|Overall Study|Maximum clinical benefit|1|||
27801431|NCT01621490|54256291|FG007|Overall Study|Maximum clinical benefit|2|||
27801432|NCT01621490|54256292|FG008|Overall Study|Maximum clinical benefit|0|||
27801433|NCT01621490|54256284|FG000|Overall Study|Withdrawal by Subject|1|||
27801434|NCT01621490|54256285|FG001|Overall Study|Withdrawal by Subject|0|||
27801435|NCT01621490|54256286|FG002|Overall Study|Withdrawal by Subject|0|||
27801436|NCT01621490|54256287|FG003|Overall Study|Withdrawal by Subject|0|||
27801437|NCT01621490|54256288|FG004|Overall Study|Withdrawal by Subject|0|||
27938817|NCT00965848|54595093|FG001|Overall Study|Death|1|||
27938818|NCT00965848|54595094|FG002|Overall Study|Death|5|||
27938819|NCT00965848|54595092|FG000|Overall Study|Lost to Follow-up|0|||
27938820|NCT00965848|54595093|FG001|Overall Study|Lost to Follow-up|0|||
27938821|NCT00965848|54595094|FG002|Overall Study|Lost to Follow-up|1|||
27938822|NCT00965848|54595092|FG000|Overall Study|Withdrawal by Subject|1|||
27938823|NCT00965848|54595093|FG001|Overall Study|Withdrawal by Subject|0|||
27938824|NCT00965848|54595094|FG002|Overall Study|Withdrawal by Subject|0|||
27938825|NCT00965848|54595092|FG000|Overall Study|Indeterminate Clinical Outcome|2|||
27938826|NCT00965848|54595093|FG001|Overall Study|Indeterminate Clinical Outcome|0|||
27938827|NCT00965848|54595094|FG002|Overall Study|Indeterminate Clinical Outcome|1|||
27938828|NCT00965848|54595092|FG000|Overall Study|Not Clinically Evaluable|7|||
27938829|NCT00965848|54595093|FG001|Overall Study|Not Clinically Evaluable|1|||
27938830|NCT00965848|54595094|FG002|Overall Study|Not Clinically Evaluable|1|||
27938831|NCT00965848|54595092|FG000|Overall Study|Other|5|||
27938832|NCT00965848|54595093|FG001|Overall Study|Other|0|||
28024644|NCT00567996|54683371|FG000|Overall Study|Protocol Deviation|9|||
27801438|NCT01621490|54256289|FG005|Overall Study|Withdrawal by Subject|3|||
27801439|NCT01621490|54256290|FG006|Overall Study|Withdrawal by Subject|0|||
27801440|NCT01621490|54256291|FG007|Overall Study|Withdrawal by Subject|0|||
27801441|NCT01621490|54256292|FG008|Overall Study|Withdrawal by Subject|0|||
27801442|NCT01621490|54256284|FG000|Overall Study|Subject request to discontinue study|1|||
27938833|NCT00965848|54595094|FG002|Overall Study|Other|1|||
28024645|NCT00567996|54683372|FG001|Overall Study|Protocol Deviation|11|||
27938834|NCT00961636|54595105|FG000|Overall Study|Adverse Event|35|||
27938835|NCT00961636|54595106|FG001|Overall Study|Adverse Event|54|||
27938836|NCT00961636|54595107|FG002|Overall Study|Adverse Event|13|||
27938837|NCT00961636|54595105|FG000|Overall Study|Flushing Symptoms|29|||
27938838|NCT00961636|54595106|FG001|Overall Study|Flushing Symptoms|46|||
27938839|NCT00961636|54595107|FG002|Overall Study|Flushing Symptoms|3|||
28024646|NCT00567996|54683373|FG002|Overall Study|Protocol Deviation|13|||
28024647|NCT00567996|54683371|FG000|Overall Study|Withdrawal by Subject|8|||
27801443|NCT01621490|54256285|FG001|Overall Study|Subject request to discontinue study|3|||
27801444|NCT01621490|54256286|FG002|Overall Study|Subject request to discontinue study|1|||
27801445|NCT01621490|54256287|FG003|Overall Study|Subject request to discontinue study|1|||
27801446|NCT01621490|54256288|FG004|Overall Study|Subject request to discontinue study|0|||
27801447|NCT01621490|54256289|FG005|Overall Study|Subject request to discontinue study|2|||
27801448|NCT01621490|54256290|FG006|Overall Study|Subject request to discontinue study|1|||
27801449|NCT01621490|54256291|FG007|Overall Study|Subject request to discontinue study|0|||
27801450|NCT01621490|54256292|FG008|Overall Study|Subject request to discontinue study|1|||
27801451|NCT01621490|54256284|FG000|Overall Study|Adverse event unrelated to study drug|2|||
27801452|NCT01621490|54256285|FG001|Overall Study|Adverse event unrelated to study drug|1|||
27801453|NCT01621490|54256286|FG002|Overall Study|Adverse event unrelated to study drug|0|||
28024648|NCT00567996|54683372|FG001|Overall Study|Withdrawal by Subject|12|||
28024649|NCT00567996|54683373|FG002|Overall Study|Withdrawal by Subject|22|||
28024650|NCT00567996|54683371|FG000|Overall Study|Abnormal Lab value(s)|2|||
28024651|NCT00567996|54683372|FG001|Overall Study|Abnormal Lab value(s)|1|||
28024652|NCT00567996|54683373|FG002|Overall Study|Abnormal Lab value(s)|2|||
27801454|NCT01621490|54256287|FG003|Overall Study|Adverse event unrelated to study drug|0|||
28024653|NCT00567996|54683371|FG000|Overall Study|Abnormal test procedure result(s)|2|||
28024654|NCT00567996|54683372|FG001|Overall Study|Abnormal test procedure result(s)|1|||
28024655|NCT00567996|54683373|FG002|Overall Study|Abnormal test procedure result(s)|1|||
28024656|NCT00567996|54683371|FG000|Overall Study|Lost to Follow-up|2|||
28024657|NCT00567996|54683372|FG001|Overall Study|Lost to Follow-up|5|||
28024658|NCT00567996|54683373|FG002|Overall Study|Lost to Follow-up|2|||
28024659|NCT00567996|54683371|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
28024660|NCT00567996|54683372|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
28024661|NCT00567996|54683373|FG002|Overall Study|Unsatisfactory therapeutic effect|15|||
28024662|NCT00567996|54683371|FG000|Overall Study|Administrative problems|1|||
28024663|NCT00567996|54683372|FG001|Overall Study|Administrative problems|1|||
28024664|NCT00567996|54683373|FG002|Overall Study|Administrative problems|0|||
28024665|NCT00567996|54683371|FG000|Overall Study|Death|1|||
28024666|NCT00567996|54683372|FG001|Overall Study|Death|0|||
28024667|NCT00567996|54683373|FG002|Overall Study|Death|2|||
28024668|NCT00567996|54683371|FG000|Overall Study|Patient's inability to use the device|0|||
28024669|NCT00567996|54683372|FG001|Overall Study|Patient's inability to use the device|1|||
28024670|NCT00567996|54683373|FG002|Overall Study|Patient's inability to use the device|0|||
28024671|NCT00224887|54683387|FG000|Overall Study|Pregnancy|6|||
28024672|NCT00224887|54683388|FG001|Overall Study|Pregnancy|6|||
28024673|NCT00148759|54683396|FG000|Overall Study|Withdrawal by Subject|1|||
28024674|NCT00148759|54683397|FG001|Overall Study|Withdrawal by Subject|1|||
28024675|NCT00148759|54683396|FG000|Overall Study|Lost to Follow-up|1|||
28024676|NCT00148759|54683397|FG001|Overall Study|Lost to Follow-up|0|||
28024677|NCT00717275|54683403|FG000|Overall Study|Premature study termination.|3|||
28024678|NCT00584909|54683407|FG000|Overall Study|Adverse Event|4|||
28024679|NCT00147823|54683413|FG000|Overall Study|Lost to Follow-up|6|||
28024680|NCT00147823|54683414|FG001|Overall Study|Lost to Follow-up|12|||
28024681|NCT00147823|54683413|FG000|Overall Study|Physician Decision|1|||
28024682|NCT00147823|54683414|FG001|Overall Study|Physician Decision|0|||
28024683|NCT00147823|54683413|FG000|Overall Study|Withdrawal by Subject|0|||
28024684|NCT00147823|54683414|FG001|Overall Study|Withdrawal by Subject|1|||
28024685|NCT00147823|54683413|FG000|Overall Study|Did not receive vitoss due to infection|6|||
28024686|NCT00147823|54683414|FG001|Overall Study|Did not receive vitoss due to infection|2|||
28024687|NCT00717197|54683420|FG000|Overall Study|Unable to purchase study drug|5|||
28024688|NCT00717197|54683420|FG000|Overall Study|Tumor Progression|1|||
28024689|NCT00717197|54683420|FG000|Overall Study|Physician Decision|1|||
28024690|NCT00147745|54683427|FG000|Overall Study|Withdrawal by Subject|1|||
28024691|NCT00147745|54683428|FG001|Overall Study|Withdrawal by Subject|0|||
28024692|NCT00147745|54683429|FG002|Overall Study|Withdrawal by Subject|0|||
28024693|NCT00642902|54683441|FG000|Overall Study|Adverse Event|0|||
28024694|NCT00642902|54683442|FG001|Overall Study|Adverse Event|1|||
28024695|NCT00642902|54683443|FG002|Overall Study|Adverse Event|3|||
28024696|NCT00642902|54683444|FG003|Overall Study|Adverse Event|1|||
28024697|NCT00642902|54683441|FG000|Overall Study|Lost to Follow-up|1|||
28024698|NCT00642902|54683442|FG001|Overall Study|Lost to Follow-up|1|||
28105631|NCT04529109|54763131|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
28105632|NCT04529109|54763132|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
28105633|NCT04528641|54763144|FG000|Overall Study|Withdrawal by Subject|0|||
28105634|NCT04528641|54763145|FG001|Overall Study|Withdrawal by Subject|0|||
28105635|NCT04528641|54763146|FG002|Overall Study|Withdrawal by Subject|0|||
28105636|NCT04528641|54763147|FG003|Overall Study|Withdrawal by Subject|1|||
28105637|NCT04528641|54763148|FG004|Overall Study|Withdrawal by Subject|0|||
28024699|NCT00642902|54683443|FG002|Overall Study|Lost to Follow-up|0|||
28024700|NCT00642902|54683444|FG003|Overall Study|Lost to Follow-up|0|||
28024701|NCT00642902|54683441|FG000|Overall Study|Lack of Efficacy|0|||
28024702|NCT00642902|54683442|FG001|Overall Study|Lack of Efficacy|3|||
28024703|NCT00642902|54683443|FG002|Overall Study|Lack of Efficacy|3|||
28024704|NCT00642902|54683444|FG003|Overall Study|Lack of Efficacy|0|||
28024705|NCT00642902|54683441|FG000|Overall Study|Death|1|||
27801455|NCT01621490|54256288|FG004|Overall Study|Adverse event unrelated to study drug|0|||
28024706|NCT00642902|54683442|FG001|Overall Study|Death|0|||
28024707|NCT00642902|54683443|FG002|Overall Study|Death|0|||
28024708|NCT00642902|54683444|FG003|Overall Study|Death|0|||
28024709|NCT00642902|54683441|FG000|Overall Study|Premature termination of clinical trial|37|||
28024710|NCT00642902|54683442|FG001|Overall Study|Premature termination of clinical trial|32|||
28024711|NCT00642902|54683443|FG002|Overall Study|Premature termination of clinical trial|35|||
28024712|NCT00642902|54683444|FG003|Overall Study|Premature termination of clinical trial|35|||
28024713|NCT00642902|54683441|FG000|Overall Study|Randomized, but not treated|0|||
28024714|NCT00642902|54683442|FG001|Overall Study|Randomized, but not treated|0|||
28024715|NCT00642902|54683443|FG002|Overall Study|Randomized, but not treated|1|||
28024716|NCT00642902|54683444|FG003|Overall Study|Randomized, but not treated|0|||
28024717|NCT00642902|54683441|FG000|Overall Study|Other|1|||
28024718|NCT00642902|54683442|FG001|Overall Study|Other|5|||
28024719|NCT00642902|54683443|FG002|Overall Study|Other|1|||
28024720|NCT00642902|54683444|FG003|Overall Study|Other|4|||
28024721|NCT00224107|54683456|FG000|Overall Study|Adverse Event|20|||
28024722|NCT00224107|54683457|FG001|Overall Study|Adverse Event|6|||
28024723|NCT00224107|54683456|FG000|Overall Study|Protocol Violation|2|||
28024724|NCT00224107|54683457|FG001|Overall Study|Protocol Violation|3|||
28024725|NCT00224107|54683456|FG000|Overall Study|Withdrawal by Subject|1|||
27801456|NCT01621490|54256289|FG005|Overall Study|Adverse event unrelated to study drug|0|||
27801457|NCT01621490|54256290|FG006|Overall Study|Adverse event unrelated to study drug|0|||
27801458|NCT01621490|54256291|FG007|Overall Study|Adverse event unrelated to study drug|2|||
27801459|NCT01621490|54256292|FG008|Overall Study|Adverse event unrelated to study drug|1|||
27801460|NCT01621490|54256284|FG000|Overall Study|Disease progression|27|||
28024726|NCT00224107|54683457|FG001|Overall Study|Withdrawal by Subject|4|||
28024727|NCT00224107|54683456|FG000|Overall Study|Lack of Efficacy|2|||
28024728|NCT00224107|54683457|FG001|Overall Study|Lack of Efficacy|0|||
28024729|NCT00224107|54683456|FG000|Overall Study|Lost to Follow-up|4|||
28024730|NCT00224107|54683457|FG001|Overall Study|Lost to Follow-up|0|||
27801461|NCT01621490|54256285|FG001|Overall Study|Disease progression|28|||
27801462|NCT01621490|54256286|FG002|Overall Study|Disease progression|1|||
27801463|NCT01621490|54256287|FG003|Overall Study|Disease progression|5|||
28024731|NCT00224107|54683456|FG000|Overall Study|Physician Decision|1|||
28024732|NCT00224107|54683457|FG001|Overall Study|Physician Decision|0|||
28024733|NCT00224107|54683456|FG000|Overall Study|Other|1|||
28024734|NCT00224107|54683457|FG001|Overall Study|Other|1|||
28024735|NCT00720083|54683465|FG000|Overall Study|Ineligible|1|||
28024736|NCT00720083|54683466|FG001|Overall Study|Ineligible|2|||
28024737|NCT00209131|54683474|FG000|Overall Study|Lack of personnel due to turnovers.|15|||
28024738|NCT00209131|54683475|FG001|Overall Study|Lack of personnel due to turnovers.|11|||
28024739|NCT00224029|54683481|FG000|Overall Study|Lost to Follow-up|1|||
28024740|NCT00224029|54683481|FG000|Overall Study|Withdrawal by Subject|4|||
28024741|NCT00224029|54683481|FG000|Overall Study|Other|1|||
28024742|NCT00223795|54683485|FG000|First Intervention - Eight Weeks|Lost to Follow-up|7|||
28024743|NCT00223795|54683486|FG001|First Intervention - Eight Weeks|Lost to Follow-up|9|||
28024744|NCT00223795|54683485|FG000|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
28024745|NCT00223795|54683486|FG001|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
28024746|NCT00719849|54683495|FG000|Overall Study|Death|0|||
28024747|NCT00719849|54683496|FG001|Overall Study|Death|1|||
28024748|NCT03907683|54683502|FG000|Overall Study|Pregnancy|1|||
28024749|NCT03907683|54683502|FG000|Overall Study|Withdrawal by Subject|1|||
28024750|NCT00626522|54683512|FG000|Overall Study|Protocol Violation|0|||
28024751|NCT00626522|54683513|FG001|Overall Study|Protocol Violation|0|||
28024752|NCT00626522|54683514|FG002|Overall Study|Protocol Violation|0|||
28024753|NCT00626522|54683515|FG003|Overall Study|Protocol Violation|0|||
28024754|NCT00626522|54683516|FG004|Overall Study|Protocol Violation|1|||
27801464|NCT01621490|54256288|FG004|Overall Study|Disease progression|3|||
27801465|NCT01621490|54256289|FG005|Overall Study|Disease progression|8|||
27801466|NCT01621490|54256290|FG006|Overall Study|Disease progression|7|||
28024755|NCT00626522|54683517|FG005|Overall Study|Protocol Violation|0|||
28024756|NCT00626522|54683512|FG000|Overall Study|Adverse Event|2|||
28024757|NCT00626522|54683513|FG001|Overall Study|Adverse Event|1|||
28024758|NCT00626522|54683514|FG002|Overall Study|Adverse Event|2|||
28024759|NCT00626522|54683515|FG003|Overall Study|Adverse Event|0|||
28024760|NCT00626522|54683516|FG004|Overall Study|Adverse Event|1|||
28024761|NCT00626522|54683517|FG005|Overall Study|Adverse Event|1|||
28024762|NCT00626522|54683512|FG000|Overall Study|Withdrawal by Subject|2|||
28024763|NCT00626522|54683513|FG001|Overall Study|Withdrawal by Subject|5|||
28024764|NCT00626522|54683514|FG002|Overall Study|Withdrawal by Subject|5|||
28024765|NCT00626522|54683515|FG003|Overall Study|Withdrawal by Subject|0|||
28024766|NCT00626522|54683516|FG004|Overall Study|Withdrawal by Subject|4|||
27801467|NCT01621490|54256291|FG007|Overall Study|Disease progression|0|||
27801468|NCT01621490|54256292|FG008|Overall Study|Disease progression|4|||
27801469|NCT01621490|54256284|FG000|Overall Study|Study drug toxicity|1|||
27801470|NCT01621490|54256285|FG001|Overall Study|Study drug toxicity|4|||
27801471|NCT01621490|54256286|FG002|Overall Study|Study drug toxicity|5|||
27801472|NCT01621490|54256287|FG003|Overall Study|Study drug toxicity|3|||
27801473|NCT01621490|54256288|FG004|Overall Study|Study drug toxicity|1|||
27801474|NCT01621490|54256289|FG005|Overall Study|Study drug toxicity|10|||
27801475|NCT01621490|54256290|FG006|Overall Study|Study drug toxicity|1|||
27801476|NCT01621490|54256291|FG007|Overall Study|Study drug toxicity|4|||
27801477|NCT01621490|54256292|FG008|Overall Study|Study drug toxicity|1|||
27801478|NCT01621490|54256284|FG000|Overall Study|Death|0|||
27801479|NCT01621490|54256285|FG001|Overall Study|Death|0|||
27801480|NCT01621490|54256286|FG002|Overall Study|Death|0|||
27801481|NCT01621490|54256287|FG003|Overall Study|Death|0|||
27801482|NCT01621490|54256288|FG004|Overall Study|Death|0|||
27801483|NCT01621490|54256289|FG005|Overall Study|Death|0|||
27801484|NCT01621490|54256290|FG006|Overall Study|Death|0|||
27801485|NCT01621490|54256291|FG007|Overall Study|Death|1|||
27801486|NCT01621490|54256292|FG008|Overall Study|Death|0|||
27801487|NCT01621490|54256284|FG000|Overall Study|Grade 4 Lipase elevation|1|||
27801488|NCT01621490|54256285|FG001|Overall Study|Grade 4 Lipase elevation|0|||
27801489|NCT01621490|54256286|FG002|Overall Study|Grade 4 Lipase elevation|0|||
27801490|NCT01621490|54256287|FG003|Overall Study|Grade 4 Lipase elevation|0|||
27801491|NCT01621490|54256288|FG004|Overall Study|Grade 4 Lipase elevation|0|||
27801492|NCT01621490|54256289|FG005|Overall Study|Grade 4 Lipase elevation|0|||
27801493|NCT01621490|54256290|FG006|Overall Study|Grade 4 Lipase elevation|0|||
28024767|NCT00626522|54683517|FG005|Overall Study|Withdrawal by Subject|1|||
28024768|NCT00626522|54683512|FG000|Overall Study|COPD exacerbation|0|||
28024769|NCT00626522|54683513|FG001|Overall Study|COPD exacerbation|0|||
28024770|NCT00626522|54683514|FG002|Overall Study|COPD exacerbation|0|||
28024771|NCT00626522|54683515|FG003|Overall Study|COPD exacerbation|1|||
28024772|NCT00626522|54683516|FG004|Overall Study|COPD exacerbation|1|||
28024773|NCT00626522|54683517|FG005|Overall Study|COPD exacerbation|0|||
28024774|NCT00626522|54683512|FG000|Overall Study|Lost to Follow-up|0|||
27801494|NCT01621490|54256291|FG007|Overall Study|Grade 4 Lipase elevation|0|||
27801495|NCT01621490|54256292|FG008|Overall Study|Grade 4 Lipase elevation|0|||
27801496|NCT01621490|54256284|FG000|Overall Study|BMS informed of patient status|0|||
27801497|NCT01621490|54256285|FG001|Overall Study|BMS informed of patient status|0|||
27801498|NCT01621490|54256286|FG002|Overall Study|BMS informed of patient status|1|||
27801499|NCT01621490|54256287|FG003|Overall Study|BMS informed of patient status|0|||
27801500|NCT01621490|54256288|FG004|Overall Study|BMS informed of patient status|0|||
27801501|NCT01621490|54256289|FG005|Overall Study|BMS informed of patient status|0|||
28024775|NCT00626522|54683513|FG001|Overall Study|Lost to Follow-up|1|||
28024776|NCT00626522|54683514|FG002|Overall Study|Lost to Follow-up|0|||
28024777|NCT00626522|54683515|FG003|Overall Study|Lost to Follow-up|0|||
28024778|NCT00626522|54683516|FG004|Overall Study|Lost to Follow-up|0|||
28024779|NCT00626522|54683517|FG005|Overall Study|Lost to Follow-up|0|||
28024780|NCT00626522|54683512|FG000|Overall Study|Inconsistent reason reported|1|||
28024781|NCT00626522|54683513|FG001|Overall Study|Inconsistent reason reported|0|||
28024782|NCT00626522|54683514|FG002|Overall Study|Inconsistent reason reported|0|||
28024783|NCT00626522|54683515|FG003|Overall Study|Inconsistent reason reported|0|||
28024784|NCT00626522|54683516|FG004|Overall Study|Inconsistent reason reported|0|||
28024785|NCT00626522|54683517|FG005|Overall Study|Inconsistent reason reported|0|||
28024786|NCT00626522|54683512|FG000|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
28024787|NCT00626522|54683513|FG001|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
28024788|NCT00626522|54683514|FG002|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
28024789|NCT00626522|54683515|FG003|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
28024790|NCT00626522|54683516|FG004|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
28024791|NCT00626522|54683517|FG005|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
28024792|NCT00540423|54683542|FG000|Double-Blind Treatment Period|Adverse Event|0|||
28024793|NCT00540423|54683543|FG001|Double-Blind Treatment Period|Adverse Event|1|||
28024794|NCT00540423|54683544|FG002|Double-Blind Treatment Period|Adverse Event|0|||
28024795|NCT00540423|54683542|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
28024796|NCT00540423|54683543|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
28024797|NCT00540423|54683544|FG002|Open-Label Treatment Period|Lack of Efficacy|2|||
28024798|NCT00566982|54683564|FG000|Overall Study|Adverse Event|6|||
28024799|NCT00566982|54683565|FG001|Overall Study|Adverse Event|48|||
28024800|NCT00566982|54683564|FG000|Overall Study|Withdrawal by Subject|1|||
28024801|NCT00566982|54683565|FG001|Overall Study|Withdrawal by Subject|14|||
27801502|NCT01621490|54256290|FG006|Overall Study|BMS informed of patient status|0|||
27938840|NCT00961636|54595105|FG000|Overall Study|Lost to Follow-up|2|||
27938841|NCT00961636|54595106|FG001|Overall Study|Lost to Follow-up|3|||
27938842|NCT00961636|54595107|FG002|Overall Study|Lost to Follow-up|1|||
27938843|NCT00961636|54595105|FG000|Overall Study|Physician Decision|3|||
27938844|NCT00961636|54595106|FG001|Overall Study|Physician Decision|1|||
27938845|NCT00961636|54595107|FG002|Overall Study|Physician Decision|1|||
27938846|NCT00961636|54595105|FG000|Overall Study|Protocol Violation|9|||
27938847|NCT00961636|54595106|FG001|Overall Study|Protocol Violation|5|||
27938848|NCT00961636|54595107|FG002|Overall Study|Protocol Violation|1|||
27938849|NCT00961636|54595105|FG000|Overall Study|Withdrawal by Subject|29|||
27801503|NCT01621490|54256291|FG007|Overall Study|BMS informed of patient status|0|||
27801504|NCT01621490|54256292|FG008|Overall Study|BMS informed of patient status|0|||
27801505|NCT01621490|54256284|FG000|Overall Study|Investigator decision|0|||
27801506|NCT01621490|54256285|FG001|Overall Study|Investigator decision|0|||
27801507|NCT01621490|54256286|FG002|Overall Study|Investigator decision|1|||
27801508|NCT01621490|54256287|FG003|Overall Study|Investigator decision|0|||
28024802|NCT00566982|54683564|FG000|Overall Study|Protocol Violation|1|||
28024803|NCT00566982|54683565|FG001|Overall Study|Protocol Violation|4|||
28024804|NCT00566982|54683564|FG000|Overall Study|Lost to Follow-up|0|||
28024805|NCT00566982|54683565|FG001|Overall Study|Lost to Follow-up|1|||
28024806|NCT00566982|54683564|FG000|Overall Study|Other-family problems & doctor's request|0|||
28024807|NCT00566982|54683565|FG001|Overall Study|Other-family problems & doctor's request|2|||
28024808|NCT00624338|54683577|FG000|Overall Study|Adverse Event|14|||
28024809|NCT00624338|54683578|FG001|Overall Study|Adverse Event|14|||
28024810|NCT00624338|54683579|FG002|Overall Study|Adverse Event|18|||
28024811|NCT00624338|54683577|FG000|Overall Study|Lost to Follow-up|1|||
28024812|NCT00624338|54683578|FG001|Overall Study|Lost to Follow-up|0|||
28024813|NCT00624338|54683579|FG002|Overall Study|Lost to Follow-up|0|||
28024814|NCT00624338|54683577|FG000|Overall Study|Lack of Efficacy|11|||
28024815|NCT00624338|54683578|FG001|Overall Study|Lack of Efficacy|3|||
28024816|NCT00624338|54683579|FG002|Overall Study|Lack of Efficacy|14|||
28024817|NCT00624338|54683577|FG000|Overall Study|Protocol Violation|3|||
28024818|NCT00624338|54683578|FG001|Overall Study|Protocol Violation|3|||
28024819|NCT00624338|54683579|FG002|Overall Study|Protocol Violation|2|||
28024820|NCT00624338|54683577|FG000|Overall Study|Death|0|||
28024821|NCT00624338|54683578|FG001|Overall Study|Death|2|||
28024822|NCT00624338|54683579|FG002|Overall Study|Death|0|||
28024823|NCT00624338|54683577|FG000|Overall Study|Immunoglobulin less than 3gram per liter|1|||
28024824|NCT00624338|54683578|FG001|Overall Study|Immunoglobulin less than 3gram per liter|0|||
28024825|NCT00624338|54683579|FG002|Overall Study|Immunoglobulin less than 3gram per liter|0|||
28024826|NCT00624338|54683577|FG000|Overall Study|Termination of 150 mg group by Sponsor|0|||
28024827|NCT00624338|54683578|FG001|Overall Study|Termination of 150 mg group by Sponsor|55|||
28024828|NCT00624338|54683579|FG002|Overall Study|Termination of 150 mg group by Sponsor|0|||
28024829|NCT00624338|54683577|FG000|Overall Study|Other|15|||
28024830|NCT00624338|54683578|FG001|Overall Study|Other|5|||
28024831|NCT00624338|54683579|FG002|Overall Study|Other|9|||
27801509|NCT01621490|54256288|FG004|Overall Study|Investigator decision|1|||
27938850|NCT00961636|54595106|FG001|Overall Study|Withdrawal by Subject|22|||
27938851|NCT00961636|54595107|FG002|Overall Study|Withdrawal by Subject|13|||
28024832|NCT00624338|54683577|FG000|Overall Study|Randomized but not treated|2|||
28024833|NCT00624338|54683578|FG001|Overall Study|Randomized but not treated|1|||
28024834|NCT00624338|54683579|FG002|Overall Study|Randomized but not treated|3|||
28024835|NCT03977454|54683589|FG000|Overall Study|immediate postoperative revision|2|||
27842839|NCT01575197|54331726|FG002|Overall Study|Migration out of study area|4|||
27938852|NCT00964678|54595115|FG000|Overall Study|Physician Decision|4|||
27938853|NCT00964366|54595122|FG000|Overall Study|Did not qualify at Day 1|1|||
27938854|NCT00964366|54595123|FG001|Overall Study|Did not qualify at Day 1|0|||
27938855|NCT00964366|54595122|FG000|Overall Study|Withdrawal by Subject|0|||
27938856|NCT00964366|54595123|FG001|Overall Study|Withdrawal by Subject|1|||
27938857|NCT00960154|54595131|FG000|Overall Study|Study termination|25|||
27938858|NCT00960154|54595132|FG001|Overall Study|Study termination|25|||
27938859|NCT00960076|54595140|FG000|Overall Study|Adverse Event|1|||
27938860|NCT00960076|54595141|FG001|Overall Study|Adverse Event|7|||
27938861|NCT00960076|54595140|FG000|Overall Study|No longer met study criteria|1|||
27938862|NCT00960076|54595141|FG001|Overall Study|No longer met study criteria|5|||
27938863|NCT00960076|54595140|FG000|Overall Study|Withdrawal by Subject|1|||
27938864|NCT00960076|54595141|FG001|Overall Study|Withdrawal by Subject|2|||
28024836|NCT03977454|54683590|FG001|Overall Study|immediate postoperative revision|2|||
28024837|NCT00538785|54683598|FG000|Overall Study|Death|9|||
28024838|NCT00538785|54683599|FG001|Overall Study|Death|10|||
28024839|NCT00538785|54683598|FG000|Overall Study|Withdrawal of consent|9|||
28024840|NCT00538785|54683599|FG001|Overall Study|Withdrawal of consent|7|||
28024841|NCT00538785|54683598|FG000|Overall Study|Lost to Follow-up|1|||
28024842|NCT00538785|54683599|FG001|Overall Study|Lost to Follow-up|0|||
28024843|NCT00538629|54683605|FG000|Overall Study|At subject's request|1|||
27842840|NCT01575197|54331724|FG000|Overall Study|SAE|0|||
28024844|NCT00538629|54683605|FG000|Overall Study|Adverse Event|2|||
28024845|NCT00538629|54683605|FG000|Overall Study|Lack of Efficacy|12|||
28024846|NCT00538629|54683605|FG000|Overall Study|Lost to Follow-up|6|||
28024847|NCT00538629|54683605|FG000|Overall Study|Subject's untimely distrust of medicine|1|||
28024848|NCT00622700|54683612|FG000|Core Treatment Period|Randomized but Not Treated|0|||
28024849|NCT00622700|54683613|FG001|Core Treatment Period|Randomized but Not Treated|2|||
28024850|NCT00622700|54683614|FG002|Core Treatment Period|Randomized but Not Treated|2|||
28024851|NCT00622700|54683615|FG003|Core Treatment Period|Randomized but Not Treated|0|||
28024852|NCT00622700|54683616|FG004|Core Treatment Period|Randomized but Not Treated|0|||
28024853|NCT00622700|54683617|FG005|Core Treatment Period|Randomized but Not Treated|0|||
28024854|NCT00622700|54683618|FG006|Core Treatment Period|Randomized but Not Treated|0|||
28024855|NCT00622700|54683612|FG000|Core Treatment Period|Adverse Event|18|||
28024856|NCT00622700|54683613|FG001|Core Treatment Period|Adverse Event|25|||
28024857|NCT00622700|54683614|FG002|Core Treatment Period|Adverse Event|18|||
28024858|NCT00622700|54683615|FG003|Core Treatment Period|Adverse Event|0|||
28024859|NCT00622700|54683616|FG004|Core Treatment Period|Adverse Event|0|||
28024860|NCT00622700|54683617|FG005|Core Treatment Period|Adverse Event|0|||
28024861|NCT00622700|54683618|FG006|Core Treatment Period|Adverse Event|0|||
28024862|NCT00622700|54683612|FG000|Core Treatment Period|Lack of Efficacy|19|||
28024863|NCT00622700|54683613|FG001|Core Treatment Period|Lack of Efficacy|6|||
28024864|NCT00622700|54683614|FG002|Core Treatment Period|Lack of Efficacy|12|||
28024865|NCT00622700|54683615|FG003|Core Treatment Period|Lack of Efficacy|0|||
28024866|NCT00622700|54683616|FG004|Core Treatment Period|Lack of Efficacy|0|||
28024867|NCT00622700|54683617|FG005|Core Treatment Period|Lack of Efficacy|0|||
28024868|NCT00622700|54683618|FG006|Core Treatment Period|Lack of Efficacy|0|||
28024869|NCT00622700|54683612|FG000|Core Treatment Period|Lost to Follow-up|1|||
28024870|NCT00622700|54683613|FG001|Core Treatment Period|Lost to Follow-up|1|||
28024871|NCT00622700|54683614|FG002|Core Treatment Period|Lost to Follow-up|1|||
27938865|NCT00960076|54595140|FG000|Overall Study|Lost to Follow-up|3|||
27938866|NCT00960076|54595141|FG001|Overall Study|Lost to Follow-up|3|||
27938867|NCT00960076|54595140|FG000|Overall Study|Severe non-compliance to protocol|1|||
28024872|NCT00622700|54683615|FG003|Core Treatment Period|Lost to Follow-up|0|||
28024873|NCT00622700|54683616|FG004|Core Treatment Period|Lost to Follow-up|0|||
28024874|NCT00622700|54683617|FG005|Core Treatment Period|Lost to Follow-up|0|||
28024875|NCT00622700|54683618|FG006|Core Treatment Period|Lost to Follow-up|0|||
28024876|NCT00622700|54683612|FG000|Core Treatment Period|Death|1|||
28024877|NCT00622700|54683613|FG001|Core Treatment Period|Death|0|||
28024878|NCT00622700|54683614|FG002|Core Treatment Period|Death|0|||
28024879|NCT00622700|54683615|FG003|Core Treatment Period|Death|0|||
28024880|NCT00622700|54683616|FG004|Core Treatment Period|Death|0|||
28024881|NCT00622700|54683617|FG005|Core Treatment Period|Death|0|||
28024882|NCT00622700|54683618|FG006|Core Treatment Period|Death|0|||
28024883|NCT00622700|54683612|FG000|Core Treatment Period|Progressive Disease|3|||
28024884|NCT00622700|54683613|FG001|Core Treatment Period|Progressive Disease|1|||
28024885|NCT00622700|54683614|FG002|Core Treatment Period|Progressive Disease|0|||
28024886|NCT00622700|54683615|FG003|Core Treatment Period|Progressive Disease|0|||
28024887|NCT00622700|54683616|FG004|Core Treatment Period|Progressive Disease|0|||
28024888|NCT00622700|54683617|FG005|Core Treatment Period|Progressive Disease|0|||
28024889|NCT00622700|54683618|FG006|Core Treatment Period|Progressive Disease|0|||
28024890|NCT00622700|54683612|FG000|Core Treatment Period|Withdrawal by Subject|12|||
28024891|NCT00622700|54683613|FG001|Core Treatment Period|Withdrawal by Subject|18|||
28024892|NCT00622700|54683614|FG002|Core Treatment Period|Withdrawal by Subject|15|||
28024893|NCT00622700|54683615|FG003|Core Treatment Period|Withdrawal by Subject|0|||
28024894|NCT00622700|54683616|FG004|Core Treatment Period|Withdrawal by Subject|0|||
28024895|NCT00622700|54683617|FG005|Core Treatment Period|Withdrawal by Subject|0|||
28024896|NCT00622700|54683618|FG006|Core Treatment Period|Withdrawal by Subject|0|||
27938868|NCT00960076|54595141|FG001|Overall Study|Severe non-compliance to protocol|2|||
27938869|NCT00960076|54595140|FG000|Overall Study|Hyperglycemia|1|||
27938870|NCT00960076|54595141|FG001|Overall Study|Hyperglycemia|5|||
27938871|NCT00960076|54595140|FG000|Overall Study|Did not attend the termination visit|0|||
27938872|NCT00960076|54595141|FG001|Overall Study|Did not attend the termination visit|1|||
27938873|NCT01227629|54595157|FG000|Overall Study|Adverse Event|2|||
27938874|NCT01227629|54595158|FG001|Overall Study|Adverse Event|2|||
27938875|NCT01227629|54595159|FG002|Overall Study|Adverse Event|1|||
27938876|NCT01227629|54595160|FG003|Overall Study|Adverse Event|6|||
27938877|NCT01227629|54595161|FG004|Overall Study|Adverse Event|1|||
27938878|NCT01227629|54595162|FG005|Overall Study|Adverse Event|1|||
28024897|NCT00622700|54683612|FG000|Core Treatment Period|Other than specified above|2|||
28024898|NCT00622700|54683613|FG001|Core Treatment Period|Other than specified above|2|||
28024899|NCT00622700|54683614|FG002|Core Treatment Period|Other than specified above|5|||
28024900|NCT00622700|54683615|FG003|Core Treatment Period|Other than specified above|0|||
28024901|NCT00622700|54683616|FG004|Core Treatment Period|Other than specified above|0|||
28024902|NCT00622700|54683617|FG005|Core Treatment Period|Other than specified above|0|||
28024903|NCT00622700|54683618|FG006|Core Treatment Period|Other than specified above|0|||
28105638|NCT04528641|54763149|FG005|Overall Study|Withdrawal by Subject|1|||
28024904|NCT00622700|54683612|FG000|Extension Treatment Period|Adverse Event|0|||
28024905|NCT00622700|54683613|FG001|Extension Treatment Period|Adverse Event|0|||
28024906|NCT00622700|54683614|FG002|Extension Treatment Period|Adverse Event|0|||
28024907|NCT00622700|54683615|FG003|Extension Treatment Period|Adverse Event|5|||
28024908|NCT00622700|54683616|FG004|Extension Treatment Period|Adverse Event|9|||
28024909|NCT00622700|54683617|FG005|Extension Treatment Period|Adverse Event|6|||
27938879|NCT01227629|54595163|FG006|Overall Study|Adverse Event|6|||
27938880|NCT01227629|54595164|FG007|Overall Study|Adverse Event|6|||
27938881|NCT01227629|54595165|FG008|Overall Study|Adverse Event|4|||
28024910|NCT00622700|54683618|FG006|Extension Treatment Period|Adverse Event|8|||
28024911|NCT00622700|54683612|FG000|Extension Treatment Period|Lack of Efficacy|0|||
28024912|NCT00622700|54683613|FG001|Extension Treatment Period|Lack of Efficacy|0|||
28024913|NCT00622700|54683614|FG002|Extension Treatment Period|Lack of Efficacy|0|||
28024914|NCT00622700|54683615|FG003|Extension Treatment Period|Lack of Efficacy|2|||
28024915|NCT00622700|54683616|FG004|Extension Treatment Period|Lack of Efficacy|8|||
28024916|NCT00622700|54683617|FG005|Extension Treatment Period|Lack of Efficacy|1|||
28024917|NCT00622700|54683618|FG006|Extension Treatment Period|Lack of Efficacy|9|||
28024918|NCT00622700|54683612|FG000|Extension Treatment Period|Protocol Violation|0|||
28024919|NCT00622700|54683613|FG001|Extension Treatment Period|Protocol Violation|0|||
28024920|NCT00622700|54683614|FG002|Extension Treatment Period|Protocol Violation|0|||
28024921|NCT00622700|54683615|FG003|Extension Treatment Period|Protocol Violation|0|||
28024922|NCT00622700|54683616|FG004|Extension Treatment Period|Protocol Violation|0|||
28024923|NCT00622700|54683617|FG005|Extension Treatment Period|Protocol Violation|2|||
28024924|NCT00622700|54683618|FG006|Extension Treatment Period|Protocol Violation|0|||
28024925|NCT00622700|54683612|FG000|Extension Treatment Period|Lost to Follow-up|0|||
28024926|NCT00622700|54683613|FG001|Extension Treatment Period|Lost to Follow-up|0|||
28024927|NCT00622700|54683614|FG002|Extension Treatment Period|Lost to Follow-up|0|||
28024928|NCT00622700|54683615|FG003|Extension Treatment Period|Lost to Follow-up|0|||
28024929|NCT00622700|54683616|FG004|Extension Treatment Period|Lost to Follow-up|1|||
28024930|NCT00622700|54683617|FG005|Extension Treatment Period|Lost to Follow-up|0|||
28024931|NCT00622700|54683618|FG006|Extension Treatment Period|Lost to Follow-up|0|||
28024932|NCT00622700|54683612|FG000|Extension Treatment Period|Progressive Disease|0|||
27801510|NCT01621490|54256289|FG005|Overall Study|Investigator decision|0|||
27938882|NCT01227629|54595166|FG009|Overall Study|Adverse Event|0|||
27938883|NCT01227629|54595157|FG000|Overall Study|Protocol Violation|0|||
27938884|NCT01227629|54595158|FG001|Overall Study|Protocol Violation|0|||
27938885|NCT01227629|54595159|FG002|Overall Study|Protocol Violation|0|||
27938886|NCT01227629|54595160|FG003|Overall Study|Protocol Violation|1|||
27938887|NCT01227629|54595161|FG004|Overall Study|Protocol Violation|0|||
27938888|NCT01227629|54595162|FG005|Overall Study|Protocol Violation|0|||
28024933|NCT00622700|54683613|FG001|Extension Treatment Period|Progressive Disease|0|||
28024934|NCT00622700|54683614|FG002|Extension Treatment Period|Progressive Disease|0|||
28024935|NCT00622700|54683615|FG003|Extension Treatment Period|Progressive Disease|1|||
28024936|NCT00622700|54683616|FG004|Extension Treatment Period|Progressive Disease|2|||
28024937|NCT00622700|54683617|FG005|Extension Treatment Period|Progressive Disease|0|||
28024938|NCT00622700|54683618|FG006|Extension Treatment Period|Progressive Disease|2|||
28024939|NCT00622700|54683612|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
28024940|NCT00622700|54683613|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
28024941|NCT00622700|54683614|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
28024942|NCT00622700|54683615|FG003|Extension Treatment Period|Withdrawal by Subject|11|||
28024943|NCT00622700|54683616|FG004|Extension Treatment Period|Withdrawal by Subject|16|||
28024944|NCT00622700|54683617|FG005|Extension Treatment Period|Withdrawal by Subject|6|||
28024945|NCT00622700|54683618|FG006|Extension Treatment Period|Withdrawal by Subject|10|||
28024946|NCT00622700|54683612|FG000|Extension Treatment Period|Missing|0|||
28024947|NCT00622700|54683613|FG001|Extension Treatment Period|Missing|0|||
28024948|NCT00622700|54683614|FG002|Extension Treatment Period|Missing|0|||
28024949|NCT00622700|54683615|FG003|Extension Treatment Period|Missing|2|||
28024950|NCT00622700|54683616|FG004|Extension Treatment Period|Missing|3|||
28024951|NCT00622700|54683617|FG005|Extension Treatment Period|Missing|1|||
28024952|NCT00622700|54683618|FG006|Extension Treatment Period|Missing|0|||
28024953|NCT00622700|54683612|FG000|Extension Treatment Period|Other than specified above|0|||
28024954|NCT00622700|54683613|FG001|Extension Treatment Period|Other than specified above|0|||
28024955|NCT00622700|54683614|FG002|Extension Treatment Period|Other than specified above|0|||
28024956|NCT00622700|54683615|FG003|Extension Treatment Period|Other than specified above|0|||
28024957|NCT00622700|54683616|FG004|Extension Treatment Period|Other than specified above|0|||
28024958|NCT00622700|54683617|FG005|Extension Treatment Period|Other than specified above|1|||
28024959|NCT00622700|54683618|FG006|Extension Treatment Period|Other than specified above|1|||
28024960|NCT00538473|54683637|FG000|Overall Study|Adverse Event|1|||
28024961|NCT00538473|54683638|FG001|Overall Study|Adverse Event|0|||
28024962|NCT00622466|54683644|FG000|Overall Study|Death|1|||
28024963|NCT00622466|54683644|FG000|Overall Study|Adverse Event|1|||
28024964|NCT00622466|54683644|FG000|Overall Study|Withdrawal by Subject|2|||
28024965|NCT00537771|54683650|FG000|Overall Study|Withdrawal by Subject|6|||
28024966|NCT00537771|54683651|FG001|Overall Study|Withdrawal by Subject|23|||
28024967|NCT00537771|54683650|FG000|Overall Study|Adverse Event|8|||
28024968|NCT00537771|54683651|FG001|Overall Study|Adverse Event|15|||
28024969|NCT00537771|54683650|FG000|Overall Study|Lost to Follow-up|9|||
28024970|NCT00537771|54683651|FG001|Overall Study|Lost to Follow-up|15|||
28024971|NCT00537771|54683650|FG000|Overall Study|Protocol Violation|2|||
28024972|NCT00537771|54683651|FG001|Overall Study|Protocol Violation|6|||
28024973|NCT00537771|54683650|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
28024974|NCT00537771|54683651|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
28024975|NCT00623480|54683659|FG000|Overall Study|Lost to Follow-up|0|||
28024976|NCT00623480|54683660|FG001|Overall Study|Lost to Follow-up|1|||
28024977|NCT00623480|54683659|FG000|Overall Study|Withdrawal by Subject|2|||
28024978|NCT00623480|54683660|FG001|Overall Study|Withdrawal by Subject|4|||
28024979|NCT00623480|54683659|FG000|Overall Study|Lack of Efficacy|1|||
28024980|NCT00623480|54683660|FG001|Overall Study|Lack of Efficacy|0|||
28024981|NCT00623480|54683659|FG000|Overall Study|Non-compliant with study medication|4|||
28024982|NCT00623480|54683660|FG001|Overall Study|Non-compliant with study medication|0|||
28024983|NCT00623480|54683659|FG000|Overall Study|Protocol Violation|0|||
28024984|NCT00623480|54683660|FG001|Overall Study|Protocol Violation|1|||
28024985|NCT00623480|54683659|FG000|Overall Study|Site closed by sponsor|0|||
28024986|NCT00623480|54683660|FG001|Overall Study|Site closed by sponsor|1|||
28024987|NCT02513667|54683668|FG000|Overall Study|Withdrawal by Subject|0|||
28024988|NCT02513667|54683669|FG001|Overall Study|Withdrawal by Subject|1|||
28024989|NCT03823911|54683678|FG000|Overall Study|Lost to Follow-up|1|||
28024990|NCT03823911|54683679|FG001|Overall Study|Lost to Follow-up|5|||
28024991|NCT03823911|54683680|FG002|Overall Study|Lost to Follow-up|2|||
28024992|NCT03823911|54683678|FG000|Overall Study|Did not meet eligibility criteria|13|||
28024993|NCT03823911|54683679|FG001|Overall Study|Did not meet eligibility criteria|7|||
28024994|NCT03823911|54683680|FG002|Overall Study|Did not meet eligibility criteria|4|||
28024995|NCT03823911|54683678|FG000|Overall Study|Death|0|||
28024996|NCT03823911|54683679|FG001|Overall Study|Death|1|||
28024997|NCT03823911|54683680|FG002|Overall Study|Death|0|||
28024998|NCT00621764|54683691|FG000|Overall Study|Protocol Violation|0|||
28024999|NCT00621764|54683692|FG001|Overall Study|Protocol Violation|0|||
28025000|NCT00621764|54683693|FG002|Overall Study|Protocol Violation|0|||
28025001|NCT00621764|54683694|FG003|Overall Study|Protocol Violation|1|||
28025002|NCT00510718|54683712|FG000|Multiple Dose Period: 12 Weeks|Adverse Event|1|||
28025003|NCT00510718|54683713|FG001|Multiple Dose Period: 12 Weeks|Adverse Event|8|||
28025004|NCT00510718|54683712|FG000|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3|||
28025005|NCT00510718|54683713|FG001|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6|||
28025006|NCT00510718|54683712|FG000|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8|||
28025007|NCT00510718|54683713|FG001|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11|||
28105639|NCT04527471|54763168|FG000|Overall Study|Adverse Event|1|||
28025008|NCT00510718|54683712|FG000|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1|||
28025009|NCT00510718|54683713|FG001|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3|||
28025010|NCT00510718|54683712|FG000|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1|||
28025011|NCT00510718|54683713|FG001|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3|||
28025012|NCT00510718|54683712|FG000|Multiple Dose Period: 12 Weeks|Other|1|||
28025013|NCT00510718|54683713|FG001|Multiple Dose Period: 12 Weeks|Other|1|||
28025014|NCT00537381|54683734|FG000|Overall Study|Adverse Event|13|||
28025015|NCT00537381|54683735|FG001|Overall Study|Adverse Event|9|||
28025016|NCT00537381|54683734|FG000|Overall Study|Death|3|||
28025017|NCT00537381|54683735|FG001|Overall Study|Death|3|||
28025018|NCT00537381|54683734|FG000|Overall Study|Withdrawal by Subject|5|||
28025019|NCT00537381|54683735|FG001|Overall Study|Withdrawal by Subject|14|||
28025020|NCT00537381|54683734|FG000|Overall Study|Physician Decision|7|||
28025021|NCT00537381|54683735|FG001|Overall Study|Physician Decision|6|||
28025022|NCT00537381|54683734|FG000|Overall Study|Disease Progression|9|||
28025023|NCT00537381|54683735|FG001|Overall Study|Disease Progression|18|||
28025024|NCT00537381|54683734|FG000|Overall Study|Sponsor decision|14|||
28025025|NCT00537381|54683735|FG001|Overall Study|Sponsor decision|9|||
28025026|NCT00537381|54683734|FG000|Overall Study|Other|5|||
28025027|NCT00537381|54683735|FG001|Overall Study|Other|3|||
28025028|NCT03791398|54683746|FG000|Overall Study|Progression of Disease Under Study|2|||
28025029|NCT03791398|54683747|FG001|Overall Study|Progression of Disease Under Study|0|||
27801511|NCT01621490|54256290|FG006|Overall Study|Investigator decision|1|||
28025030|NCT03791398|54683748|FG002|Overall Study|Progression of Disease Under Study|0|||
28025031|NCT00517192|54683754|FG000|Overall Study|Adverse Event|1|||
28025032|NCT00517192|54683755|FG001|Overall Study|Adverse Event|1|||
28025033|NCT00517192|54683754|FG000|Overall Study|Lost to Follow-up|1|||
28025034|NCT00517192|54683755|FG001|Overall Study|Lost to Follow-up|1|||
27801512|NCT01621490|54256291|FG007|Overall Study|Investigator decision|0|||
27801513|NCT01621490|54256292|FG008|Overall Study|Investigator decision|0|||
27801514|NCT01621490|54256284|FG000|Overall Study|Documented disease progression|0|||
27801515|NCT01621490|54256285|FG001|Overall Study|Documented disease progression|0|||
27801516|NCT01621490|54256286|FG002|Overall Study|Documented disease progression|1|||
27801517|NCT01621490|54256287|FG003|Overall Study|Documented disease progression|0|||
27801518|NCT01621490|54256288|FG004|Overall Study|Documented disease progression|0|||
27801519|NCT01621490|54256289|FG005|Overall Study|Documented disease progression|0|||
27801520|NCT01621490|54256290|FG006|Overall Study|Documented disease progression|0|||
27801521|NCT01621490|54256291|FG007|Overall Study|Documented disease progression|0|||
27801522|NCT01621490|54256292|FG008|Overall Study|Documented disease progression|0|||
27801523|NCT01621490|54256284|FG000|Overall Study|Patient reached treatment 2 yr limit|0|||
27801524|NCT01621490|54256285|FG001|Overall Study|Patient reached treatment 2 yr limit|1|||
27801525|NCT01621490|54256286|FG002|Overall Study|Patient reached treatment 2 yr limit|0|||
27801526|NCT01621490|54256287|FG003|Overall Study|Patient reached treatment 2 yr limit|0|||
27801527|NCT01621490|54256288|FG004|Overall Study|Patient reached treatment 2 yr limit|0|||
27801528|NCT01621490|54256289|FG005|Overall Study|Patient reached treatment 2 yr limit|0|||
27801529|NCT01621490|54256290|FG006|Overall Study|Patient reached treatment 2 yr limit|0|||
27801530|NCT01621490|54256291|FG007|Overall Study|Patient reached treatment 2 yr limit|0|||
27801531|NCT01621490|54256292|FG008|Overall Study|Patient reached treatment 2 yr limit|0|||
27801532|NCT01621490|54256284|FG000|Overall Study|Clinical deterioration|0|||
27801533|NCT01621490|54256285|FG001|Overall Study|Clinical deterioration|1|||
27801534|NCT01621490|54256286|FG002|Overall Study|Clinical deterioration|0|||
27801535|NCT01621490|54256287|FG003|Overall Study|Clinical deterioration|0|||
27801536|NCT01621490|54256288|FG004|Overall Study|Clinical deterioration|0|||
27801537|NCT01621490|54256289|FG005|Overall Study|Clinical deterioration|0|||
27801538|NCT01621490|54256290|FG006|Overall Study|Clinical deterioration|0|||
27801539|NCT01621490|54256291|FG007|Overall Study|Clinical deterioration|0|||
27801540|NCT01621490|54256292|FG008|Overall Study|Clinical deterioration|0|||
27801541|NCT01621490|54256284|FG000|Overall Study|Complete response|0|||
27801542|NCT01621490|54256285|FG001|Overall Study|Complete response|0|||
27801543|NCT01621490|54256286|FG002|Overall Study|Complete response|0|||
27801544|NCT01621490|54256287|FG003|Overall Study|Complete response|0|||
27801545|NCT01621490|54256288|FG004|Overall Study|Complete response|0|||
27801546|NCT01621490|54256289|FG005|Overall Study|Complete response|0|||
27801547|NCT01621490|54256290|FG006|Overall Study|Complete response|0|||
27801548|NCT01621490|54256291|FG007|Overall Study|Complete response|0|||
27801549|NCT01621490|54256292|FG008|Overall Study|Complete response|1|||
27801550|NCT01621490|54256284|FG000|Overall Study|Patient delayed due to toxicity|0|||
27801551|NCT01621490|54256285|FG001|Overall Study|Patient delayed due to toxicity|0|||
27801552|NCT01621490|54256286|FG002|Overall Study|Patient delayed due to toxicity|0|||
27801553|NCT01621490|54256287|FG003|Overall Study|Patient delayed due to toxicity|0|||
27801554|NCT01621490|54256288|FG004|Overall Study|Patient delayed due to toxicity|0|||
27801555|NCT01621490|54256289|FG005|Overall Study|Patient delayed due to toxicity|1|||
27801556|NCT01621490|54256290|FG006|Overall Study|Patient delayed due to toxicity|0|||
27801557|NCT01621490|54256291|FG007|Overall Study|Patient delayed due to toxicity|0|||
27801558|NCT01621490|54256292|FG008|Overall Study|Patient delayed due to toxicity|0|||
27801559|NCT02018887|54256413|FG000|Part A: Cohorts 1-2: Period 3|Adverse Event|1|||
27801560|NCT02018887|54256414|FG001|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
27801561|NCT02018887|54256415|FG002|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
27801562|NCT02018887|54256416|FG003|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
27801563|NCT02018887|54256417|FG004|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
27801564|NCT02018887|54256418|FG005|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
27801565|NCT02018887|54256419|FG006|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
27801566|NCT02018887|54256420|FG007|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
27801567|NCT02018887|54256421|FG008|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
27801568|NCT02018887|54256422|FG009|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
27801569|NCT02018887|54256423|FG010|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
27801570|NCT02018887|54256413|FG000|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
27801571|NCT02018887|54256414|FG001|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
27801572|NCT02018887|54256415|FG002|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
27801573|NCT02018887|54256416|FG003|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
27801574|NCT02018887|54256417|FG004|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
27801575|NCT02018887|54256418|FG005|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
27801576|NCT02018887|54256419|FG006|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
27801577|NCT02018887|54256420|FG007|Part B: Cohorts 3-7 Overall|Adverse Event|4|||
27801578|NCT02018887|54256421|FG008|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
27801579|NCT02018887|54256422|FG009|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
27801580|NCT02018887|54256423|FG010|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
27801581|NCT02018887|54256413|FG000|Part C: Cohort 8 Overall|Adverse Event|0|||
27801582|NCT02018887|54256414|FG001|Part C: Cohort 8 Overall|Adverse Event|0|||
27801583|NCT02018887|54256415|FG002|Part C: Cohort 8 Overall|Adverse Event|0|||
27801584|NCT02018887|54256416|FG003|Part C: Cohort 8 Overall|Adverse Event|0|||
28025035|NCT00517192|54683754|FG000|Overall Study|Withdrawal by Subject|1|||
28025036|NCT00517192|54683755|FG001|Overall Study|Withdrawal by Subject|0|||
28025037|NCT00517192|54683754|FG000|Overall Study|Early termination of the trial|16|||
28025038|NCT00517192|54683755|FG001|Overall Study|Early termination of the trial|18|||
28025039|NCT00625820|54683761|FG000|Overall Study|Withdrawal by Subject|1|||
28025040|NCT00145327|54683769|FG000|Overall Study|Withdrawal by Subject|77|||
28025041|NCT00145327|54683770|FG001|Overall Study|Withdrawal by Subject|72|||
28025042|NCT00145327|54683771|FG002|Overall Study|Withdrawal by Subject|164|||
28025043|NCT00145327|54683769|FG000|Overall Study|Death|26|||
28025044|NCT00145327|54683770|FG001|Overall Study|Death|18|||
28025045|NCT00145327|54683771|FG002|Overall Study|Death|30|||
28025046|NCT00145327|54683769|FG000|Overall Study|Adverse Event|14|||
28025047|NCT00145327|54683770|FG001|Overall Study|Adverse Event|11|||
28025048|NCT00145327|54683771|FG002|Overall Study|Adverse Event|22|||
28025049|NCT00145327|54683769|FG000|Overall Study|Lost to Follow-up|9|||
28025050|NCT00145327|54683770|FG001|Overall Study|Lost to Follow-up|14|||
28025051|NCT00145327|54683771|FG002|Overall Study|Lost to Follow-up|14|||
28025052|NCT00145327|54683769|FG000|Overall Study|Administrative problems|12|||
28025053|NCT00145327|54683770|FG001|Overall Study|Administrative problems|9|||
28025054|NCT00145327|54683771|FG002|Overall Study|Administrative problems|13|||
28025055|NCT00145327|54683769|FG000|Overall Study|Protocol Violation|2|||
28025056|NCT00145327|54683770|FG001|Overall Study|Protocol Violation|0|||
28025057|NCT00145327|54683771|FG002|Overall Study|Protocol Violation|2|||
28025058|NCT00145327|54683769|FG000|Overall Study|Abnormal laboratory value(s)|1|||
28025059|NCT00145327|54683770|FG001|Overall Study|Abnormal laboratory value(s)|0|||
28025060|NCT00145327|54683771|FG002|Overall Study|Abnormal laboratory value(s)|2|||
28025061|NCT00145327|54683769|FG000|Overall Study|Missing - not stated|1|||
27801585|NCT02018887|54256417|FG004|Part C: Cohort 8 Overall|Adverse Event|0|||
27801586|NCT02018887|54256418|FG005|Part C: Cohort 8 Overall|Adverse Event|0|||
27801587|NCT02018887|54256419|FG006|Part C: Cohort 8 Overall|Adverse Event|0|||
27801588|NCT02018887|54256420|FG007|Part C: Cohort 8 Overall|Adverse Event|0|||
27801589|NCT02018887|54256421|FG008|Part C: Cohort 8 Overall|Adverse Event|1|||
27801590|NCT02018887|54256422|FG009|Part C: Cohort 8 Overall|Adverse Event|3|||
27801591|NCT02018887|54256423|FG010|Part C: Cohort 8 Overall|Adverse Event|0|||
27801592|NCT02018887|54256413|FG000|Part C: Cohort 8 Overall|Physician Decision|0|||
27801593|NCT02018887|54256414|FG001|Part C: Cohort 8 Overall|Physician Decision|0|||
27801594|NCT02018887|54256415|FG002|Part C: Cohort 8 Overall|Physician Decision|0|||
27801595|NCT02018887|54256416|FG003|Part C: Cohort 8 Overall|Physician Decision|0|||
27801596|NCT02018887|54256417|FG004|Part C: Cohort 8 Overall|Physician Decision|0|||
28025062|NCT00145327|54683770|FG001|Overall Study|Missing - not stated|0|||
28025063|NCT00145327|54683771|FG002|Overall Study|Missing - not stated|1|||
28025064|NCT00510484|54683781|FG000|Wash-out Period|Adverse Event|0|||
28025065|NCT00510484|54683782|FG001|Wash-out Period|Adverse Event|1|||
28025066|NCT00622388|54683788|FG000|Overall Study|Disease Progression|47|||
28025067|NCT00622388|54683788|FG000|Overall Study|Adverse Event|6|||
28025068|NCT00622388|54683788|FG000|Overall Study|Protocol Violation|3|||
28025069|NCT00622388|54683788|FG000|Overall Study|Participant Refusal|1|||
28025070|NCT00622388|54683788|FG000|Overall Study|Death|3|||
28025071|NCT00622388|54683788|FG000|Overall Study|Received Alternate Anticancer Therapy|8|||
28025072|NCT00622388|54683788|FG000|Overall Study|Took Prohibited Medication|2|||
28025073|NCT00622388|54683788|FG000|Overall Study|Withdrew Consent|1|||
27801597|NCT02018887|54256418|FG005|Part C: Cohort 8 Overall|Physician Decision|0|||
27842841|NCT01575197|54331725|FG001|Overall Study|SAE|1|||
27801598|NCT02018887|54256419|FG006|Part C: Cohort 8 Overall|Physician Decision|0|||
28025074|NCT00622388|54683788|FG000|Overall Study|Insurance Expired|1|||
28025075|NCT01156389|54683795|FG000|Overall Study|Elevated liver enzymes|4|||
28025076|NCT01156389|54683796|FG001|Overall Study|Elevated liver enzymes|0|||
27801599|NCT02018887|54256420|FG007|Part C: Cohort 8 Overall|Physician Decision|0|||
27801600|NCT02018887|54256421|FG008|Part C: Cohort 8 Overall|Physician Decision|2|||
28025077|NCT01156389|54683795|FG000|Overall Study|Vomiting|0|||
28025078|NCT01156389|54683796|FG001|Overall Study|Vomiting|1|||
28025079|NCT01105767|54683805|FG000|Overall Study|Lost to Follow-up|1160|||
28025080|NCT01105767|54683806|FG001|Overall Study|Lost to Follow-up|1614|||
28025081|NCT01105767|54683807|FG002|Overall Study|Lost to Follow-up|1184|||
28025082|NCT03693430|54683817|FG000|Overall Study|Lost to Follow-up|3|||
28025083|NCT03693430|54683818|FG001|Overall Study|Lost to Follow-up|14|||
28025084|NCT03693430|54683817|FG000|Overall Study|Death|1|||
28025085|NCT03693430|54683818|FG001|Overall Study|Death|0|||
28025086|NCT03693430|54683817|FG000|Overall Study|Withdrawal by Subject|0|||
28025087|NCT03693430|54683818|FG001|Overall Study|Withdrawal by Subject|4|||
28025088|NCT00625742|54683824|FG000|Overall Study|Disease Progression|2|||
28025089|NCT00625742|54683824|FG000|Overall Study|Withdrawal by Subject|1|||
28025090|NCT00625742|54683824|FG000|Overall Study|Adverse Event|4|||
28025091|NCT00625742|54683824|FG000|Overall Study|Lost to Follow-up|4|||
28025092|NCT00625742|54683824|FG000|Overall Study|Ineligible|1|||
28025093|NCT00621296|54683837|FG000|Overall Study|Adverse Event|2|||
28025094|NCT00621296|54683837|FG000|Overall Study|Lack of Efficacy|1|||
28025095|NCT00621296|54683837|FG000|Overall Study|Physician Decision|7|||
28025096|NCT00621296|54683837|FG000|Overall Study|Unmatch Criteria|1|||
27801601|NCT02018887|54256422|FG009|Part C: Cohort 8 Overall|Physician Decision|0|||
27801602|NCT02018887|54256423|FG010|Part C: Cohort 8 Overall|Physician Decision|1|||
27801603|NCT02030041|54256492|FG000|Overall Study|Withdrawal by Subject|2|||
27801604|NCT02030041|54256493|FG001|Overall Study|Withdrawal by Subject|2|||
27801605|NCT02030041|54256494|FG002|Overall Study|Withdrawal by Subject|1|||
27801606|NCT01844505|54256505|FG000|Overall Study|Disease progression|170|||
27801607|NCT01844505|54256506|FG001|Overall Study|Disease progression|88|||
27801608|NCT01844505|54256507|FG002|Overall Study|Disease progression|224|||
27801609|NCT01844505|54256505|FG000|Overall Study|Study drug toxicity|40|||
27801610|NCT01844505|54256506|FG001|Overall Study|Study drug toxicity|131|||
27801611|NCT01844505|54256507|FG002|Overall Study|Study drug toxicity|50|||
27801612|NCT01844505|54256505|FG000|Overall Study|Death|1|||
27801613|NCT01844505|54256506|FG001|Overall Study|Death|3|||
27801614|NCT01844505|54256507|FG002|Overall Study|Death|1|||
27801615|NCT01844505|54256505|FG000|Overall Study|Adverse event unrelated to study drug|7|||
27801616|NCT01844505|54256506|FG001|Overall Study|Adverse event unrelated to study drug|15|||
27801617|NCT01844505|54256507|FG002|Overall Study|Adverse event unrelated to study drug|6|||
27801618|NCT01844505|54256505|FG000|Overall Study|Subject request discontinue treatment|17|||
27801619|NCT01844505|54256506|FG001|Overall Study|Subject request discontinue treatment|14|||
27801620|NCT01844505|54256507|FG002|Overall Study|Subject request discontinue treatment|8|||
27801621|NCT01844505|54256505|FG000|Overall Study|Withdrawal by Subject|0|||
27801622|NCT01844505|54256506|FG001|Overall Study|Withdrawal by Subject|3|||
28025097|NCT00621296|54683837|FG000|Overall Study|Stopping Criteria|3|||
27801623|NCT01844505|54256507|FG002|Overall Study|Withdrawal by Subject|0|||
27801624|NCT01844505|54256505|FG000|Overall Study|Lost to Follow-up|1|||
27801625|NCT01844505|54256506|FG001|Overall Study|Lost to Follow-up|0|||
28025098|NCT00537303|54683843|FG000|Overall Study|Adverse Event|1|||
27801626|NCT01844505|54256507|FG002|Overall Study|Lost to Follow-up|0|||
27801627|NCT01844505|54256505|FG000|Overall Study|Maximum clinical benefit|8|||
28025099|NCT00537303|54683844|FG001|Overall Study|Adverse Event|4|||
28025100|NCT00537303|54683843|FG000|Overall Study|Lack of Efficacy|6|||
28025101|NCT00537303|54683844|FG001|Overall Study|Lack of Efficacy|7|||
28025102|NCT00537303|54683843|FG000|Overall Study|Protocol Violation|8|||
27801628|NCT01844505|54256506|FG001|Overall Study|Maximum clinical benefit|11|||
27801629|NCT01844505|54256507|FG002|Overall Study|Maximum clinical benefit|2|||
27801630|NCT01844505|54256505|FG000|Overall Study|Poor/non-compliance|1|||
27801631|NCT01844505|54256506|FG001|Overall Study|Poor/non-compliance|1|||
27801632|NCT01844505|54256507|FG002|Overall Study|Poor/non-compliance|1|||
27801633|NCT01844505|54256505|FG000|Overall Study|Subject no longer meets criteria|0|||
27801634|NCT01844505|54256506|FG001|Overall Study|Subject no longer meets criteria|1|||
28025103|NCT00537303|54683844|FG001|Overall Study|Protocol Violation|4|||
28025104|NCT00537303|54683843|FG000|Overall Study|Withdrawal criteria|3|||
27801635|NCT01844505|54256507|FG002|Overall Study|Subject no longer meets criteria|0|||
28025105|NCT00537303|54683844|FG001|Overall Study|Withdrawal criteria|3|||
28025106|NCT00537303|54683843|FG000|Overall Study|Unclassified|8|||
28025107|NCT00537303|54683844|FG001|Overall Study|Unclassified|7|||
28025108|NCT00505414|54683852|FG000|Titration Phase|Adverse Event|0|||
28025109|NCT00505414|54683853|FG001|Titration Phase|Adverse Event|0|||
28025110|NCT00505414|54683854|FG002|Titration Phase|Adverse Event|0|||
28025111|NCT00505414|54683855|FG003|Titration Phase|Adverse Event|8|||
28025112|NCT00505414|54683856|FG004|Titration Phase|Adverse Event|3|||
28025113|NCT00505414|54683852|FG000|Titration Phase|Death|0|||
28025114|NCT00505414|54683853|FG001|Titration Phase|Death|0|||
28025115|NCT00505414|54683854|FG002|Titration Phase|Death|0|||
28025116|NCT00505414|54683855|FG003|Titration Phase|Death|2|||
28025117|NCT00505414|54683856|FG004|Titration Phase|Death|0|||
28025118|NCT00505414|54683852|FG000|Titration Phase|Lack of Efficacy|0|||
28025119|NCT00505414|54683853|FG001|Titration Phase|Lack of Efficacy|0|||
28025120|NCT00505414|54683854|FG002|Titration Phase|Lack of Efficacy|0|||
28025121|NCT00505414|54683855|FG003|Titration Phase|Lack of Efficacy|10|||
28025122|NCT00505414|54683856|FG004|Titration Phase|Lack of Efficacy|1|||
28025123|NCT00505414|54683852|FG000|Titration Phase|Protocol Violation|0|||
28025124|NCT00505414|54683853|FG001|Titration Phase|Protocol Violation|0|||
28025125|NCT00505414|54683854|FG002|Titration Phase|Protocol Violation|0|||
28025126|NCT00505414|54683855|FG003|Titration Phase|Protocol Violation|0|||
28025127|NCT00505414|54683856|FG004|Titration Phase|Protocol Violation|1|||
28025128|NCT00505414|54683852|FG000|Titration Phase|Withdrawal by Subject|0|||
28025129|NCT00505414|54683853|FG001|Titration Phase|Withdrawal by Subject|0|||
28025130|NCT00505414|54683854|FG002|Titration Phase|Withdrawal by Subject|0|||
28025131|NCT00505414|54683855|FG003|Titration Phase|Withdrawal by Subject|3|||
28025132|NCT00505414|54683856|FG004|Titration Phase|Withdrawal by Subject|4|||
28025133|NCT00505414|54683852|FG000|Titration Phase|Underlying disease and therapy required|0|||
28025134|NCT00505414|54683853|FG001|Titration Phase|Underlying disease and therapy required|0|||
28025135|NCT00505414|54683854|FG002|Titration Phase|Underlying disease and therapy required|0|||
27801636|NCT01844505|54256505|FG000|Overall Study|Other Reasons|4|||
27801637|NCT01844505|54256506|FG001|Overall Study|Other Reasons|2|||
27801638|NCT01844505|54256507|FG002|Overall Study|Other Reasons|2|||
27801639|NCT01844505|54256505|FG000|Overall Study|Not Reported|0|||
27801640|NCT01844505|54256506|FG001|Overall Study|Not Reported|0|||
27801641|NCT01844505|54256507|FG002|Overall Study|Not Reported|1|||
28025136|NCT00505414|54683855|FG003|Titration Phase|Underlying disease and therapy required|7|||
28025137|NCT00505414|54683856|FG004|Titration Phase|Underlying disease and therapy required|3|||
28025138|NCT00505414|54683852|FG000|Maintenance Phase|Adverse Event|2|||
28025139|NCT00505414|54683853|FG001|Maintenance Phase|Adverse Event|2|||
28025140|NCT00505414|54683854|FG002|Maintenance Phase|Adverse Event|3|||
27801642|NCT01994720|54256517|FG000|Overall Study|Withdrawal by Subject|46|||
27801643|NCT01994720|54256518|FG001|Overall Study|Withdrawal by Subject|56|||
27801644|NCT01814397|54256524|FG000|Overall Study|Adverse Event|7|||
28025141|NCT00505414|54683855|FG003|Maintenance Phase|Adverse Event|0|||
28025142|NCT00505414|54683856|FG004|Maintenance Phase|Adverse Event|0|||
28025143|NCT00505414|54683852|FG000|Maintenance Phase|Death|2|||
28025144|NCT00505414|54683853|FG001|Maintenance Phase|Death|0|||
28025145|NCT00505414|54683854|FG002|Maintenance Phase|Death|1|||
28025146|NCT00505414|54683855|FG003|Maintenance Phase|Death|0|||
28025147|NCT00505414|54683856|FG004|Maintenance Phase|Death|0|||
28025148|NCT00505414|54683852|FG000|Maintenance Phase|Lack of Efficacy|2|||
28025149|NCT00505414|54683853|FG001|Maintenance Phase|Lack of Efficacy|1|||
28025150|NCT00505414|54683854|FG002|Maintenance Phase|Lack of Efficacy|1|||
28025151|NCT00505414|54683855|FG003|Maintenance Phase|Lack of Efficacy|0|||
28025152|NCT00505414|54683856|FG004|Maintenance Phase|Lack of Efficacy|0|||
28025153|NCT00505414|54683852|FG000|Maintenance Phase|Withdrawal by Subject|0|||
28025154|NCT00505414|54683853|FG001|Maintenance Phase|Withdrawal by Subject|0|||
28025155|NCT00505414|54683854|FG002|Maintenance Phase|Withdrawal by Subject|1|||
28025156|NCT00505414|54683855|FG003|Maintenance Phase|Withdrawal by Subject|0|||
28025157|NCT00505414|54683856|FG004|Maintenance Phase|Withdrawal by Subject|0|||
28025158|NCT00505414|54683852|FG000|Maintenance Phase|underlying disease and therapy required|0|||
28025159|NCT00505414|54683853|FG001|Maintenance Phase|underlying disease and therapy required|2|||
28025160|NCT00505414|54683854|FG002|Maintenance Phase|underlying disease and therapy required|2|||
28025161|NCT00505414|54683855|FG003|Maintenance Phase|underlying disease and therapy required|0|||
28025162|NCT00505414|54683856|FG004|Maintenance Phase|underlying disease and therapy required|0|||
28025163|NCT00625586|54683872|FG000|Overall Study|Adverse Event|1|||
28025164|NCT00144781|54683894|FG000|Overall Study|Adverse Event|0|||
28025165|NCT00144781|54683895|FG001|Overall Study|Adverse Event|1|||
28025166|NCT00144781|54683896|FG002|Overall Study|Adverse Event|0|||
28025167|NCT00144781|54683897|FG003|Overall Study|Adverse Event|0|||
28025168|NCT00144781|54683894|FG000|Overall Study|Non-compliant|0|||
28025169|NCT00144781|54683895|FG001|Overall Study|Non-compliant|1|||
28025170|NCT00144781|54683896|FG002|Overall Study|Non-compliant|0|||
28025171|NCT00144781|54683897|FG003|Overall Study|Non-compliant|0|||
28025172|NCT00621140|54683913|FG000|Overall Study|Adverse Event|4|||
28025173|NCT00621140|54683914|FG001|Overall Study|Adverse Event|5|||
28025174|NCT00621140|54683913|FG000|Overall Study|Lost to Follow-up|1|||
28025175|NCT00621140|54683914|FG001|Overall Study|Lost to Follow-up|2|||
28025176|NCT00621140|54683913|FG000|Overall Study|Withdrawal by Subject|4|||
28025177|NCT00621140|54683914|FG001|Overall Study|Withdrawal by Subject|6|||
28025178|NCT00621140|54683913|FG000|Overall Study|Other incl. lack of efficacy|6|||
28025179|NCT00621140|54683914|FG001|Overall Study|Other incl. lack of efficacy|5|||
28025180|NCT00207727|54683925|FG000|Overall Study|Withdrawal by Subject|0|||
27801645|NCT01814397|54256524|FG000|Overall Study|Withdrawal by Subject|7|||
27801646|NCT01814007|54256528|FG000|Overall Study|Withdrawal by Subject|1|||
27801647|NCT01844115|54256535|FG000|Overall Study|Adverse Event|4|||
27801648|NCT01844115|54256536|FG001|Overall Study|Adverse Event|22|||
27801649|NCT01844115|54256535|FG000|Overall Study|Lack of Efficacy|1|||
27801650|NCT01844115|54256536|FG001|Overall Study|Lack of Efficacy|4|||
27801651|NCT01844115|54256535|FG000|Overall Study|Protocol Violation|12|||
27801652|NCT01844115|54256536|FG001|Overall Study|Protocol Violation|10|||
28025181|NCT00207727|54683926|FG001|Overall Study|Withdrawal by Subject|0|||
28025182|NCT00207727|54683927|FG002|Overall Study|Withdrawal by Subject|0|||
28025183|NCT00207727|54683928|FG003|Overall Study|Withdrawal by Subject|0|||
28025184|NCT00207727|54683929|FG004|Overall Study|Withdrawal by Subject|1|||
27801653|NCT01844115|54256535|FG000|Overall Study|Withdrawal by Subject|11|||
27801654|NCT01844115|54256536|FG001|Overall Study|Withdrawal by Subject|11|||
27801655|NCT01844115|54256535|FG000|Overall Study|Lost to Follow-up|11|||
27801656|NCT01844115|54256536|FG001|Overall Study|Lost to Follow-up|10|||
27801657|NCT01844115|54256535|FG000|Overall Study|Pregnancy|0|||
27801658|NCT01844115|54256536|FG001|Overall Study|Pregnancy|1|||
27801659|NCT02018042|54256542|FG000|Overall Study|Withdrawal by Subject|1|||
28025185|NCT00207727|54683925|FG000|Overall Study|Lost to Follow-up|0|||
28025186|NCT00207727|54683926|FG001|Overall Study|Lost to Follow-up|1|||
28025187|NCT00207727|54683927|FG002|Overall Study|Lost to Follow-up|0|||
28025188|NCT00207727|54683928|FG003|Overall Study|Lost to Follow-up|0|||
28025189|NCT00207727|54683929|FG004|Overall Study|Lost to Follow-up|0|||
28025190|NCT00207727|54683925|FG000|Overall Study|Other|38|||
28025191|NCT00207727|54683926|FG001|Overall Study|Other|41|||
27801660|NCT01813305|54256548|FG000|Overall Study|Withdrawal by Subject|12|||
27801661|NCT01813305|54256549|FG001|Overall Study|Withdrawal by Subject|5|||
27801662|NCT01813305|54256548|FG000|Overall Study|Safety Concern|4|||
27801663|NCT01813305|54256549|FG001|Overall Study|Safety Concern|0|||
27801664|NCT01813305|54256548|FG000|Overall Study|Ulcer became worse|4|||
27801665|NCT01813305|54256549|FG001|Overall Study|Ulcer became worse|0|||
27801666|NCT01813305|54256548|FG000|Overall Study|Physician Decision|4|||
27801667|NCT01813305|54256549|FG001|Overall Study|Physician Decision|0|||
27801668|NCT01813305|54256548|FG000|Overall Study|Lost to Follow-up|3|||
27801669|NCT01813305|54256549|FG001|Overall Study|Lost to Follow-up|1|||
27801670|NCT01813305|54256548|FG000|Overall Study|Protocol Violation|1|||
27801671|NCT01813305|54256549|FG001|Overall Study|Protocol Violation|0|||
27801672|NCT01813305|54256548|FG000|Overall Study|Prohibited Medication Administration or Condition Worsening|7|||
27801673|NCT01813305|54256549|FG001|Overall Study|Prohibited Medication Administration or Condition Worsening|2|||
27801674|NCT01993940|54256559|FG000|Overall Study|Adverse Event|16|||
27801675|NCT01993940|54256560|FG001|Overall Study|Adverse Event|11|||
27801676|NCT01993940|54256559|FG000|Overall Study|Withdrawal by Subject|15|||
27801677|NCT01993940|54256560|FG001|Overall Study|Withdrawal by Subject|19|||
27801678|NCT01993940|54256559|FG000|Overall Study|Lost to Follow-up|2|||
27801679|NCT01993940|54256560|FG001|Overall Study|Lost to Follow-up|5|||
27801680|NCT01993940|54256559|FG000|Overall Study|Protocol Violation|5|||
27801681|NCT01993940|54256560|FG001|Overall Study|Protocol Violation|8|||
27801682|NCT01993940|54256559|FG000|Overall Study|Death|1|||
27801683|NCT01993940|54256560|FG001|Overall Study|Death|0|||
27801684|NCT01993940|54256559|FG000|Overall Study|Other - Miscellaneous|1|||
27801685|NCT01993940|54256560|FG001|Overall Study|Other - Miscellaneous|1|||
27801686|NCT01843803|54256568|FG000|Overall Study|not a Veteran, did not see provider|1|||
27801687|NCT01843803|54256569|FG001|Overall Study|not a Veteran, did not see provider|3|||
27801688|NCT02017171|54256577|FG000|Overall Study|Death|10|||
27801689|NCT02017171|54256578|FG001|Overall Study|Death|4|||
27801690|NCT02017171|54256577|FG000|Overall Study|Withdrawal by Subject|23|||
27801691|NCT02017171|54256578|FG001|Overall Study|Withdrawal by Subject|17|||
27801692|NCT02017171|54256577|FG000|Overall Study|Lost to Follow-up|21|||
27801693|NCT02017171|54256578|FG001|Overall Study|Lost to Follow-up|20|||
27801694|NCT02017171|54256577|FG000|Overall Study|ESKD|6|||
27801695|NCT02017171|54256578|FG001|Overall Study|ESKD|2|||
27801696|NCT02017171|54256577|FG000|Overall Study|Miscellaneous|2|||
27801697|NCT02017171|54256578|FG001|Overall Study|Miscellaneous|3|||
27801698|NCT02029417|54256585|FG000|Overall Study|Death|1|||
27801699|NCT02029417|54256585|FG000|Overall Study|Adverse Event|1|||
27801700|NCT02016716|54256592|FG000|Overall Study|Withdrawal by Subject|5|||
27801701|NCT02016716|54256593|FG001|Overall Study|Withdrawal by Subject|5|||
27801702|NCT02016716|54256594|FG002|Overall Study|Withdrawal by Subject|5|||
27801703|NCT02016716|54256592|FG000|Overall Study|Protocol-specified Criteria|0|||
27801704|NCT02016716|54256593|FG001|Overall Study|Protocol-specified Criteria|1|||
27801705|NCT02016716|54256594|FG002|Overall Study|Protocol-specified Criteria|0|||
27801706|NCT02016716|54256592|FG000|Overall Study|Lost to Follow-up|1|||
27801707|NCT02016716|54256593|FG001|Overall Study|Lost to Follow-up|2|||
27801708|NCT02016716|54256594|FG002|Overall Study|Lost to Follow-up|1|||
27801709|NCT02050321|54256603|FG000|Overall Study|Withdrawal by Subject|1|||
27801710|NCT02050321|54256603|FG000|Overall Study|Adverse Event|1|||
27801711|NCT02039414|54256609|FG000|Overall Study|Delivered|1|||
27801712|NCT02039414|54256610|FG001|Overall Study|Delivered|1|||
27801713|NCT02039414|54256609|FG000|Overall Study|Lost to Follow-up|2|||
27801714|NCT02039414|54256610|FG001|Overall Study|Lost to Follow-up|0|||
28025192|NCT00207727|54683927|FG002|Overall Study|Other|41|||
27801715|NCT02039414|54256609|FG000|Overall Study|Protocol Violation|3|||
27801716|NCT02039414|54256610|FG001|Overall Study|Protocol Violation|1|||
27801717|NCT02017015|54256616|FG000|Overall Study|Adverse Event|9|||
27801718|NCT02017015|54256616|FG000|Overall Study|Withdrawal by Subject|21|||
27801719|NCT02017015|54256616|FG000|Overall Study|Death|4|||
27801720|NCT02017015|54256616|FG000|Overall Study|Progressive Disease|31|||
27801721|NCT02017015|54256616|FG000|Overall Study|Non-compliance with study drug|2|||
27801722|NCT02017015|54256616|FG000|Overall Study|Physician Decision|2|||
27801723|NCT02016625|54256623|FG000|Cyclo or Tac (Single Dose, Day 1)|not treated|0|||
27801724|NCT02016625|54256624|FG001|Cyclo or Tac (Single Dose, Day 1)|not treated|1|||
27801725|NCT02016625|54256623|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1|||
27801726|NCT02016625|54256624|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0|||
27801727|NCT02016625|54256623|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2|||
27801728|NCT02016625|54256624|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0|||
27801729|NCT02016482|54256642|FG000|Period A|Adverse Event|3|||
27801730|NCT02016482|54256643|FG001|Period A|Adverse Event|5|||
27801731|NCT02016482|54256642|FG000|Period A|Withdrawal by Subject|3|||
27801732|NCT02016482|54256643|FG001|Period A|Withdrawal by Subject|4|||
27801733|NCT02016482|54256642|FG000|Period A|Lost to Follow-up|3|||
27801734|NCT02016482|54256643|FG001|Period A|Lost to Follow-up|3|||
27801735|NCT02016482|54256642|FG000|Period A|Lack of Efficacy|2|||
27801736|NCT02016482|54256643|FG001|Period A|Lack of Efficacy|1|||
27801737|NCT02016482|54256642|FG000|Period A|Other|3|||
27801738|NCT02016482|54256643|FG001|Period A|Other|0|||
27801739|NCT02016482|54256642|FG000|Period A|Protocol Violation|0|||
27801740|NCT02016482|54256643|FG001|Period A|Protocol Violation|1|||
28025193|NCT00207727|54683928|FG003|Overall Study|Other|37|||
28025194|NCT00207727|54683929|FG004|Overall Study|Other|33|||
28025195|NCT00504556|54683946|FG000|Overall Study|Adverse Event|11|||
28025196|NCT00504556|54683947|FG001|Overall Study|Adverse Event|11|||
28025197|NCT00504556|54683948|FG002|Overall Study|Adverse Event|14|||
28025198|NCT00504556|54683949|FG003|Overall Study|Adverse Event|13|||
28025199|NCT00504556|54683950|FG004|Overall Study|Adverse Event|5|||
28025200|NCT00504556|54683946|FG000|Overall Study|Death|3|||
28025201|NCT00504556|54683947|FG001|Overall Study|Death|3|||
28025202|NCT00504556|54683948|FG002|Overall Study|Death|1|||
28025203|NCT00504556|54683949|FG003|Overall Study|Death|0|||
28025204|NCT00504556|54683950|FG004|Overall Study|Death|2|||
28025205|NCT00504556|54683946|FG000|Overall Study|Protocol Violation|1|||
28025206|NCT00504556|54683947|FG001|Overall Study|Protocol Violation|3|||
28025207|NCT00504556|54683948|FG002|Overall Study|Protocol Violation|2|||
28025208|NCT00504556|54683949|FG003|Overall Study|Protocol Violation|1|||
28025209|NCT00504556|54683950|FG004|Overall Study|Protocol Violation|2|||
28025210|NCT00504556|54683946|FG000|Overall Study|Lost to Follow-up|0|||
28025211|NCT00504556|54683947|FG001|Overall Study|Lost to Follow-up|0|||
28025212|NCT00504556|54683948|FG002|Overall Study|Lost to Follow-up|1|||
28025213|NCT00504556|54683949|FG003|Overall Study|Lost to Follow-up|1|||
28025214|NCT00504556|54683950|FG004|Overall Study|Lost to Follow-up|1|||
28025215|NCT00504556|54683946|FG000|Overall Study|Withdrawal by Subject|16|||
28025216|NCT00504556|54683947|FG001|Overall Study|Withdrawal by Subject|16|||
28025217|NCT00504556|54683948|FG002|Overall Study|Withdrawal by Subject|7|||
28025218|NCT00504556|54683949|FG003|Overall Study|Withdrawal by Subject|8|||
28025219|NCT00504556|54683950|FG004|Overall Study|Withdrawal by Subject|12|||
28025220|NCT00504556|54683946|FG000|Overall Study|administrative reasons|0|||
28025221|NCT00504556|54683947|FG001|Overall Study|administrative reasons|2|||
28025222|NCT00504556|54683948|FG002|Overall Study|administrative reasons|2|||
28025223|NCT00504556|54683949|FG003|Overall Study|administrative reasons|1|||
28025224|NCT00504556|54683950|FG004|Overall Study|administrative reasons|2|||
28025225|NCT00504556|54683946|FG000|Overall Study|did not meet entry criteria|2|||
28025226|NCT00504556|54683947|FG001|Overall Study|did not meet entry criteria|0|||
28025227|NCT00504556|54683948|FG002|Overall Study|did not meet entry criteria|1|||
28025228|NCT00504556|54683949|FG003|Overall Study|did not meet entry criteria|1|||
28025229|NCT00504556|54683950|FG004|Overall Study|did not meet entry criteria|0|||
28025230|NCT00504556|54683946|FG000|Overall Study|data monitor committee decision|0|||
28025231|NCT00504556|54683947|FG001|Overall Study|data monitor committee decision|0|||
28025232|NCT00504556|54683948|FG002|Overall Study|data monitor committee decision|0|||
28025233|NCT00504556|54683949|FG003|Overall Study|data monitor committee decision|100|||
28025234|NCT00504556|54683950|FG004|Overall Study|data monitor committee decision|0|||
28025235|NCT00504556|54683946|FG000|Overall Study|Other|2|||
28025236|NCT00504556|54683947|FG001|Overall Study|Other|2|||
28025237|NCT00504556|54683948|FG002|Overall Study|Other|2|||
28025238|NCT00504556|54683949|FG003|Overall Study|Other|3|||
28025239|NCT00504556|54683950|FG004|Overall Study|Other|0|||
28025240|NCT00504556|54683946|FG000|Overall Study|not in safety analysis set|0|||
28025241|NCT00504556|54683947|FG001|Overall Study|not in safety analysis set|1|||
28025242|NCT00504556|54683948|FG002|Overall Study|not in safety analysis set|1|||
28025243|NCT00504556|54683949|FG003|Overall Study|not in safety analysis set|0|||
28025244|NCT00504556|54683950|FG004|Overall Study|not in safety analysis set|1|||
28025245|NCT00206323|54683964|FG000|Overall Study|Lack of Efficacy|4|||
27801741|NCT02016482|54256642|FG000|Period A|Required Alternative/Prohibited Therapy|0|||
27801742|NCT02016482|54256643|FG001|Period A|Required Alternative/Prohibited Therapy|1|||
27801743|NCT02016482|54256642|FG000|Period B|Withdrawal by Subject|1|||
27801744|NCT02016482|54256643|FG001|Period B|Withdrawal by Subject|1|||
27801745|NCT02016482|54256642|FG000|Period B|Lost to Follow-up|2|||
27801746|NCT02016482|54256643|FG001|Period B|Lost to Follow-up|0|||
28025246|NCT00206323|54683965|FG001|Overall Study|Lack of Efficacy|1|||
28025247|NCT00206323|54683964|FG000|Overall Study|Adverse Event|1|||
28025248|NCT00206323|54683965|FG001|Overall Study|Adverse Event|1|||
28025249|NCT00206323|54683964|FG000|Overall Study|Lost to Follow-up|1|||
28025250|NCT00206323|54683965|FG001|Overall Study|Lost to Follow-up|1|||
28025251|NCT03903159|54683971|FG000|Overall Study|Discharged with Staff Approval|2|||
28025252|NCT03903159|54683971|FG000|Overall Study|Discharged at Staff Request|2|||
27801747|NCT02016482|54256642|FG000|Period B|Lack of Efficacy|6|||
27801748|NCT02016482|54256643|FG001|Period B|Lack of Efficacy|4|||
27801749|NCT02016482|54256642|FG000|Period B|Other|4|||
28025253|NCT03903159|54683971|FG000|Overall Study|Discharged Against Staff Advice|1|||
28025254|NCT00205855|54683975|FG000|Overall Study|Only received temporary implants|16|||
28025255|NCT00205855|54683975|FG000|Overall Study|Withdrawal by Subject|5|||
28025256|NCT00536991|54683979|FG000|Overall Study|Withdrawal by Subject|10|||
28025257|NCT00536991|54683979|FG000|Overall Study|Physician Decision|1|||
28025258|NCT00536991|54683979|FG000|Overall Study|patient ineligible|2|||
27801750|NCT02016482|54256643|FG001|Period B|Other|0|||
27801751|NCT02016482|54256642|FG000|Period B|Required Alternative/Prohibited Therapy|0|||
27801752|NCT02016482|54256643|FG001|Period B|Required Alternative/Prohibited Therapy|2|||
27801753|NCT02028871|54256653|FG000|Overall Study|Positive urine drug screen|1|||
27801754|NCT02028871|54256654|FG001|Overall Study|Positive urine drug screen|1|||
27801755|NCT02028871|54256653|FG000|Overall Study|Withdrawal by Subject|1|||
27801756|NCT02028871|54256654|FG001|Overall Study|Withdrawal by Subject|2|||
27801757|NCT02028871|54256653|FG000|Overall Study|IV placement difficulty|1|||
27801758|NCT02028871|54256654|FG001|Overall Study|IV placement difficulty|0|||
27801759|NCT02028871|54256653|FG000|Overall Study|Current Illness|1|||
27801760|NCT02028871|54256654|FG001|Overall Study|Current Illness|0|||
27801761|NCT02028715|54256665|FG000|Overall Study|Adverse Event|2|||
27801762|NCT02028715|54256666|FG001|Overall Study|Adverse Event|2|||
27801763|NCT02028715|54256665|FG000|Overall Study|Physician Decision|1|||
27801764|NCT02028715|54256666|FG001|Overall Study|Physician Decision|0|||
27801765|NCT02028715|54256665|FG000|Overall Study|Did not complete satisfaction surveys|2|||
27801766|NCT02028715|54256666|FG001|Overall Study|Did not complete satisfaction surveys|2|||
27801767|NCT02016170|54256675|FG000|Overall Study|Adverse Event|1|||
27801768|NCT02016170|54256676|FG001|Overall Study|Adverse Event|1|||
27801769|NCT02016170|54256677|FG002|Overall Study|Adverse Event|0|||
27801770|NCT02016170|54256675|FG000|Overall Study|Protocol Violation|1|||
27801771|NCT02016170|54256676|FG001|Overall Study|Protocol Violation|0|||
27801772|NCT02016170|54256677|FG002|Overall Study|Protocol Violation|0|||
27801773|NCT02028169|54256684|FG000|Overall Study|Lost to Follow-up|21|||
27801774|NCT02028169|54256684|FG000|Overall Study|Lack of Efficacy|2|||
27801775|NCT02028169|54256684|FG000|Overall Study|Withdrawal by Subject|2|||
27801776|NCT02028169|54256684|FG000|Overall Study|Adverse Event|1|||
27801777|NCT02028169|54256684|FG000|Overall Study|Cessation of Drug|1|||
27801778|NCT02028169|54256684|FG000|Overall Study|Concomitant Medication Usage|1|||
27801779|NCT02015546|54256691|FG000|Overall Study|Withdrawal by Subject|1|||
27801780|NCT02015546|54256692|FG001|Overall Study|Withdrawal by Subject|1|||
27801781|NCT02015546|54256693|FG002|Overall Study|Withdrawal by Subject|1|||
27801782|NCT02015546|54256691|FG000|Overall Study|Screem Failure|2|||
27801783|NCT02015546|54256692|FG001|Overall Study|Screem Failure|1|||
27801784|NCT02015546|54256693|FG002|Overall Study|Screem Failure|3|||
27801785|NCT02027701|54256701|FG000|Overall Study|Adverse Event|3|||
27801786|NCT02027701|54256701|FG000|Overall Study|Lack of Efficacy|8|||
27801787|NCT02027701|54256701|FG000|Overall Study|Physician Decision|2|||
27801788|NCT02027701|54256701|FG000|Overall Study|Withdrawal by Subject|3|||
27801789|NCT02038790|54256707|FG000|Day 0 - First Treatment|Withdrawal by Subject|1|||
27801790|NCT02038790|54256708|FG001|Day 0 - First Treatment|Withdrawal by Subject|1|||
27801791|NCT02027623|54256717|FG000|Overall Study|Lost to Follow-up|3|||
27801792|NCT02027623|54256718|FG001|Overall Study|Lost to Follow-up|3|||
27801793|NCT02027623|54256717|FG000|Overall Study|Withdrawal by Subject|6|||
27801794|NCT02027623|54256718|FG001|Overall Study|Withdrawal by Subject|9|||
27801795|NCT02015221|54256727|FG000|Overall Study|Withdrawal by Subject|8|||
27801796|NCT02015221|54256728|FG001|Overall Study|Withdrawal by Subject|6|||
27801797|NCT02015221|54256727|FG000|Overall Study|Lost to Follow-up|1|||
27801798|NCT02015221|54256728|FG001|Overall Study|Lost to Follow-up|0|||
27801799|NCT02027311|54256736|FG000|Overall Study|Protocol Violation|3|||
27801800|NCT02027311|54256737|FG001|Overall Study|Protocol Violation|2|||
27801801|NCT02047903|54256745|FG000|Overall Study|Adverse Event|14|||
27801802|NCT02047903|54256745|FG000|Overall Study|Serious adverse event|10|||
27801803|NCT02047903|54256745|FG000|Overall Study|Withdrawal by Subject|16|||
27801804|NCT02047903|54256745|FG000|Overall Study|Lost to Follow-up|4|||
27801805|NCT02047903|54256745|FG000|Overall Study|Reason not listed|6|||
27801806|NCT02047903|54256745|FG000|Overall Study|Not Treated|9|||
27801807|NCT02015065|54256752|FG000|Overall Study|Death on study|1|||
27801808|NCT02015065|54256753|FG001|Overall Study|Death on study|2|||
27801809|NCT02015065|54256754|FG002|Overall Study|Death on study|1|||
27801810|NCT02026141|54256764|FG000|Overall Study|Protocol Violation|0|||
28025259|NCT03902613|54683984|FG000|Overall Study|Physician Decision|1|||
27938889|NCT01227629|54595163|FG006|Overall Study|Protocol Violation|0|||
27938890|NCT01227629|54595164|FG007|Overall Study|Protocol Violation|0|||
27801811|NCT02026141|54256765|FG001|Overall Study|Protocol Violation|1|||
27801812|NCT02026063|54256773|FG000|Overall Study|Physician Decision|0|||
27801813|NCT02026063|54256774|FG001|Overall Study|Physician Decision|10|||
27801814|NCT02026063|54256773|FG000|Overall Study|Noncompliance with Study Drug|1|||
27801815|NCT02026063|54256774|FG001|Overall Study|Noncompliance with Study Drug|1|||
27801816|NCT02026063|54256773|FG000|Overall Study|Withdrawal of Consent|1|||
27801817|NCT02026063|54256774|FG001|Overall Study|Withdrawal of Consent|6|||
27801818|NCT02026063|54256773|FG000|Overall Study|Adverse Event|5|||
27801819|NCT02026063|54256774|FG001|Overall Study|Adverse Event|20|||
27801820|NCT02026063|54256773|FG000|Overall Study|Lack of Efficacy|0|||
27801821|NCT02026063|54256774|FG001|Overall Study|Lack of Efficacy|4|||
27801822|NCT02026063|54256773|FG000|Overall Study|Lost to Follow-up|0|||
27801823|NCT02026063|54256774|FG001|Overall Study|Lost to Follow-up|1|||
27801824|NCT02026063|54256773|FG000|Overall Study|Reason not Specified|2|||
27801825|NCT02026063|54256774|FG001|Overall Study|Reason not Specified|7|||
27801826|NCT02025907|54256783|FG000|Overall Study|Lack of Efficacy|1|||
27801827|NCT02025907|54256784|FG001|Overall Study|Lack of Efficacy|0|||
27801828|NCT02025907|54256783|FG000|Overall Study|Withdrawal by Subject|15|||
27801829|NCT02025907|54256784|FG001|Overall Study|Withdrawal by Subject|8|||
27801830|NCT02025907|54256783|FG000|Overall Study|Protocol Violation|2|||
27801831|NCT02025907|54256784|FG001|Overall Study|Protocol Violation|0|||
27801832|NCT02025907|54256783|FG000|Overall Study|Physician Decision|2|||
27801833|NCT02025907|54256784|FG001|Overall Study|Physician Decision|0|||
27801834|NCT02025907|54256783|FG000|Overall Study|Lost to Follow-up|2|||
28025260|NCT00504166|54683990|FG000|Overall Study|Adverse Event|1|||
28025261|NCT00504166|54683991|FG001|Overall Study|Adverse Event|4|||
28025262|NCT00504166|54683990|FG000|Overall Study|Withdrawal by Subject|3|||
28025263|NCT00504166|54683991|FG001|Overall Study|Withdrawal by Subject|6|||
27801835|NCT02025907|54256784|FG001|Overall Study|Lost to Follow-up|2|||
27801836|NCT02025907|54256783|FG000|Overall Study|Adverse Event|3|||
27801837|NCT02025907|54256784|FG001|Overall Study|Adverse Event|1|||
27801838|NCT02025907|54256783|FG000|Overall Study|Potential misconduct,GCPcompliance issue|2|||
27801839|NCT02025907|54256784|FG001|Overall Study|Potential misconduct,GCPcompliance issue|1|||
28025264|NCT00504166|54683990|FG000|Overall Study|Physician Decision|1|||
28025265|NCT00504166|54683991|FG001|Overall Study|Physician Decision|1|||
28025266|NCT00504166|54683990|FG000|Overall Study|Lost to Follow-up|1|||
28025267|NCT00504166|54683991|FG001|Overall Study|Lost to Follow-up|3|||
28025268|NCT00509236|54683999|FG000|Overall Study|Adverse Event|7|||
28025269|NCT00509236|54684000|FG001|Overall Study|Adverse Event|9|||
28025270|NCT00509236|54683999|FG000|Overall Study|Withdrawal by Subject|5|||
28025271|NCT00509236|54684000|FG001|Overall Study|Withdrawal by Subject|10|||
28025272|NCT00509236|54683999|FG000|Overall Study|Protocol Violation|3|||
28025273|NCT00509236|54684000|FG001|Overall Study|Protocol Violation|0|||
28025274|NCT00509236|54683999|FG000|Overall Study|Excluded Medication|1|||
28025275|NCT00509236|54684000|FG001|Overall Study|Excluded Medication|1|||
28025276|NCT00509236|54683999|FG000|Overall Study|Scheduled Kidney Transplant|1|||
28025277|NCT00509236|54684000|FG001|Overall Study|Scheduled Kidney Transplant|0|||
28025278|NCT00508924|54684010|FG000|Overall Study|Protocol Violation|0|||
28025279|NCT00508924|54684011|FG001|Overall Study|Protocol Violation|0|||
28025280|NCT00508924|54684012|FG002|Overall Study|Protocol Violation|1|||
28025281|NCT00508924|54684013|FG003|Overall Study|Protocol Violation|1|||
28025282|NCT00620750|54684023|FG000|Overall Study|Lost to Follow-up|25|||
28025283|NCT00508144|54684027|FG000|Overall Study|Not eligible|6|||
27801840|NCT01813071|54256799|FG000|Overall Study|Protocol Violation|0|||
27801841|NCT01813071|54256800|FG001|Overall Study|Protocol Violation|0|||
27801842|NCT01813071|54256801|FG002|Overall Study|Protocol Violation|0|||
27801843|NCT01813071|54256802|FG003|Overall Study|Protocol Violation|0|||
27801844|NCT01813071|54256803|FG004|Overall Study|Protocol Violation|1|||
27801845|NCT01813071|54256804|FG005|Overall Study|Protocol Violation|4|||
27801846|NCT01813071|54256805|FG006|Overall Study|Protocol Violation|2|||
27801847|NCT01813071|54256806|FG007|Overall Study|Protocol Violation|4|||
27801848|NCT01813071|54256807|FG008|Overall Study|Protocol Violation|2|||
27801849|NCT01813071|54256799|FG000|Overall Study|Withdrawal by Subject|0|||
27801850|NCT01813071|54256800|FG001|Overall Study|Withdrawal by Subject|0|||
27801851|NCT01813071|54256801|FG002|Overall Study|Withdrawal by Subject|0|||
27801852|NCT01813071|54256802|FG003|Overall Study|Withdrawal by Subject|0|||
27801853|NCT01813071|54256803|FG004|Overall Study|Withdrawal by Subject|0|||
27801854|NCT01813071|54256804|FG005|Overall Study|Withdrawal by Subject|1|||
27801855|NCT01813071|54256805|FG006|Overall Study|Withdrawal by Subject|0|||
27938891|NCT01227629|54595165|FG008|Overall Study|Protocol Violation|0|||
27938892|NCT01227629|54595166|FG009|Overall Study|Protocol Violation|0|||
27938893|NCT01227629|54595157|FG000|Overall Study|Lost to Follow-up|0|||
27938894|NCT01227629|54595158|FG001|Overall Study|Lost to Follow-up|0|||
27938895|NCT01227629|54595159|FG002|Overall Study|Lost to Follow-up|0|||
27938896|NCT01227629|54595160|FG003|Overall Study|Lost to Follow-up|0|||
27938897|NCT01227629|54595161|FG004|Overall Study|Lost to Follow-up|1|||
27938898|NCT01227629|54595162|FG005|Overall Study|Lost to Follow-up|0|||
27938899|NCT01227629|54595163|FG006|Overall Study|Lost to Follow-up|0|||
27938900|NCT01227629|54595164|FG007|Overall Study|Lost to Follow-up|0|||
27801856|NCT01813071|54256806|FG007|Overall Study|Withdrawal by Subject|0|||
27801857|NCT01813071|54256807|FG008|Overall Study|Withdrawal by Subject|0|||
27801858|NCT01813071|54256799|FG000|Overall Study|Adverse Event|0|||
27801859|NCT01813071|54256800|FG001|Overall Study|Adverse Event|0|||
27938901|NCT01227629|54595165|FG008|Overall Study|Lost to Follow-up|0|||
27938902|NCT01227629|54595166|FG009|Overall Study|Lost to Follow-up|0|||
27938903|NCT01227629|54595157|FG000|Overall Study|Withdrawal by Subject|0|||
27938904|NCT01227629|54595158|FG001|Overall Study|Withdrawal by Subject|0|||
27801860|NCT01813071|54256801|FG002|Overall Study|Adverse Event|0|||
27801861|NCT01813071|54256802|FG003|Overall Study|Adverse Event|0|||
27801862|NCT01813071|54256803|FG004|Overall Study|Adverse Event|0|||
27938905|NCT01227629|54595159|FG002|Overall Study|Withdrawal by Subject|0|||
28025284|NCT00508144|54684027|FG000|Overall Study|Death|5|||
28025285|NCT00621842|54684031|FG000|Overall Study|Adverse Event|6|||
27801863|NCT01813071|54256804|FG005|Overall Study|Adverse Event|1|||
27801864|NCT01813071|54256805|FG006|Overall Study|Adverse Event|0|||
27801865|NCT01813071|54256806|FG007|Overall Study|Adverse Event|0|||
27801866|NCT01813071|54256807|FG008|Overall Study|Adverse Event|0|||
27801867|NCT01813071|54256799|FG000|Overall Study|Physician Decision|0|||
27801868|NCT01813071|54256800|FG001|Overall Study|Physician Decision|0|||
27801869|NCT01813071|54256801|FG002|Overall Study|Physician Decision|0|||
27801870|NCT01813071|54256802|FG003|Overall Study|Physician Decision|0|||
27801871|NCT01813071|54256803|FG004|Overall Study|Physician Decision|0|||
27801872|NCT01813071|54256804|FG005|Overall Study|Physician Decision|0|||
27801873|NCT01813071|54256805|FG006|Overall Study|Physician Decision|1|||
27801874|NCT01813071|54256806|FG007|Overall Study|Physician Decision|0|||
28025286|NCT00621842|54684031|FG000|Overall Study|Withdrawal by Subject|7|||
28025287|NCT00621842|54684031|FG000|Overall Study|Protocol Violation|4|||
28025288|NCT00621842|54684031|FG000|Overall Study|Lack of Efficacy|2|||
28025289|NCT00503776|54684039|FG000|Overall Study|Withdrawal by Subject|1|||
27801875|NCT01813071|54256807|FG008|Overall Study|Physician Decision|0|||
27801876|NCT01813071|54256799|FG000|Overall Study|Met inc/exc criteria|0|||
27801877|NCT01813071|54256800|FG001|Overall Study|Met inc/exc criteria|0|||
27801878|NCT01813071|54256801|FG002|Overall Study|Met inc/exc criteria|0|||
27801879|NCT01813071|54256802|FG003|Overall Study|Met inc/exc criteria|0|||
27801880|NCT01813071|54256803|FG004|Overall Study|Met inc/exc criteria|0|||
27801881|NCT01813071|54256804|FG005|Overall Study|Met inc/exc criteria|1|||
27801882|NCT01813071|54256805|FG006|Overall Study|Met inc/exc criteria|0|||
27801883|NCT01813071|54256806|FG007|Overall Study|Met inc/exc criteria|1|||
27801884|NCT01813071|54256807|FG008|Overall Study|Met inc/exc criteria|1|||
27801885|NCT02025751|54256843|FG000|Overall Study|Lost to Follow-up|1|||
27801886|NCT02025751|54256844|FG001|Overall Study|Lost to Follow-up|0|||
27801887|NCT02025751|54256843|FG000|Overall Study|Adverse Event|0|||
27801888|NCT02025751|54256844|FG001|Overall Study|Adverse Event|1|||
27938906|NCT01227629|54595160|FG003|Overall Study|Withdrawal by Subject|0|||
27938907|NCT01227629|54595161|FG004|Overall Study|Withdrawal by Subject|0|||
27938908|NCT01227629|54595162|FG005|Overall Study|Withdrawal by Subject|0|||
27938909|NCT01227629|54595163|FG006|Overall Study|Withdrawal by Subject|2|||
27938910|NCT01227629|54595164|FG007|Overall Study|Withdrawal by Subject|0|||
27938911|NCT01227629|54595165|FG008|Overall Study|Withdrawal by Subject|0|||
27938912|NCT01227629|54595166|FG009|Overall Study|Withdrawal by Subject|1|||
27938913|NCT01227629|54595157|FG000|Overall Study|Other|0|||
27938914|NCT01227629|54595158|FG001|Overall Study|Other|0|||
27938915|NCT01227629|54595159|FG002|Overall Study|Other|0|||
27938916|NCT01227629|54595160|FG003|Overall Study|Other|1|||
27938917|NCT01227629|54595161|FG004|Overall Study|Other|0|||
27938918|NCT01227629|54595162|FG005|Overall Study|Other|0|||
27938919|NCT01227629|54595163|FG006|Overall Study|Other|0|||
27938920|NCT01227629|54595164|FG007|Overall Study|Other|0|||
27938921|NCT01227629|54595165|FG008|Overall Study|Other|2|||
27938922|NCT01227629|54595166|FG009|Overall Study|Other|1|||
27938923|NCT00963820|54595212|FG000|Dose Escalation Phase|Progressive Disease|3|||
27938924|NCT00963820|54595213|FG001|Dose Escalation Phase|Progressive Disease|3|||
27938925|NCT00963820|54595214|FG002|Dose Escalation Phase|Progressive Disease|3|||
27938926|NCT00963820|54595215|FG003|Dose Escalation Phase|Progressive Disease|3|||
27938927|NCT00963820|54595216|FG004|Dose Escalation Phase|Progressive Disease|4|||
27938928|NCT00963820|54595217|FG005|Dose Escalation Phase|Progressive Disease|3|||
27938929|NCT00963820|54595218|FG006|Dose Escalation Phase|Progressive Disease|3|||
27938930|NCT00963820|54595219|FG007|Dose Escalation Phase|Progressive Disease|2|||
27938931|NCT00963820|54595220|FG008|Dose Escalation Phase|Progressive Disease|0|||
27938932|NCT00963820|54595221|FG009|Dose Escalation Phase|Progressive Disease|0|||
27938933|NCT00963820|54595222|FG010|Dose Escalation Phase|Progressive Disease|0|||
27938934|NCT00963820|54595223|FG011|Dose Escalation Phase|Progressive Disease|0|||
27938935|NCT00963820|54595212|FG000|Dose Escalation Phase|Adverse Event|0|||
27938936|NCT00963820|54595213|FG001|Dose Escalation Phase|Adverse Event|0|||
27938937|NCT00963820|54595214|FG002|Dose Escalation Phase|Adverse Event|0|||
27938938|NCT00963820|54595215|FG003|Dose Escalation Phase|Adverse Event|0|||
27938939|NCT00963820|54595216|FG004|Dose Escalation Phase|Adverse Event|0|||
27938940|NCT00963820|54595217|FG005|Dose Escalation Phase|Adverse Event|0|||
27938941|NCT00963820|54595218|FG006|Dose Escalation Phase|Adverse Event|3|||
27938942|NCT00963820|54595219|FG007|Dose Escalation Phase|Adverse Event|1|||
27938943|NCT00963820|54595220|FG008|Dose Escalation Phase|Adverse Event|0|||
27938944|NCT00963820|54595221|FG009|Dose Escalation Phase|Adverse Event|0|||
27938945|NCT00963820|54595222|FG010|Dose Escalation Phase|Adverse Event|0|||
27842842|NCT01575197|54331726|FG002|Overall Study|SAE|0|||
27938946|NCT00963820|54595223|FG011|Dose Escalation Phase|Adverse Event|0|||
27938947|NCT00963820|54595212|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
27938948|NCT00963820|54595213|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
28025290|NCT00503776|54684040|FG001|Overall Study|Withdrawal by Subject|0|||
27801889|NCT02025751|54256843|FG000|Overall Study|Physician Decision|0|||
27801890|NCT02025751|54256844|FG001|Overall Study|Physician Decision|1|||
27801891|NCT02025751|54256843|FG000|Overall Study|Withdrawal by Subject|0|||
27801892|NCT02025751|54256844|FG001|Overall Study|Withdrawal by Subject|1|||
27801893|NCT02025205|54256852|FG000|Overall Study|Withdrawal by Subject|1|||
27801894|NCT02025205|54256853|FG001|Overall Study|Withdrawal by Subject|1|||
27801895|NCT02025205|54256852|FG000|Overall Study|Protocol Violation|2|||
27801896|NCT02025205|54256853|FG001|Overall Study|Protocol Violation|1|||
27801897|NCT02025205|54256852|FG000|Overall Study|Death|0|||
27801898|NCT02025205|54256853|FG001|Overall Study|Death|1|||
27801899|NCT01812837|54256862|FG000|Overall Study|Lost to Follow-up|1|||
27801900|NCT01812837|54256863|FG001|Overall Study|Lost to Follow-up|1|||
27801901|NCT01812837|54256864|FG002|Overall Study|Lost to Follow-up|0|||
27801902|NCT01812837|54256862|FG000|Overall Study|Protocol Violation|1|||
27801903|NCT01812837|54256863|FG001|Overall Study|Protocol Violation|0|||
27801904|NCT01812837|54256864|FG002|Overall Study|Protocol Violation|0|||
27801905|NCT02024971|54256872|FG000|Overall Study|Data Not Available|30|||
27801906|NCT02024971|54256872|FG000|Overall Study|Lost to Follow-up|6|||
28025291|NCT00503776|54684041|FG002|Overall Study|Withdrawal by Subject|1|||
28025292|NCT00503776|54684042|FG003|Overall Study|Withdrawal by Subject|1|||
28025293|NCT00503776|54684039|FG000|Overall Study|Physician Decision|0|||
28025294|NCT00503776|54684040|FG001|Overall Study|Physician Decision|0|||
28025295|NCT00503776|54684041|FG002|Overall Study|Physician Decision|1|||
28025296|NCT00503776|54684042|FG003|Overall Study|Physician Decision|1|||
28025297|NCT00619112|54684059|FG000|Overall Study|Adverse Event|1|||
28025298|NCT00619112|54684060|FG001|Overall Study|Adverse Event|2|||
28025299|NCT00619502|54684071|FG000|Overall Study|Lost to Follow-up|8|||
28025300|NCT00619502|54684072|FG001|Overall Study|Lost to Follow-up|10|||
28025301|NCT00618956|54684082|FG000|Overall Study|Adverse Event|10|||
28025302|NCT00618956|54684083|FG001|Overall Study|Adverse Event|34|||
28025303|NCT00618956|54684082|FG000|Overall Study|Lack of Efficacy|2|||
28025304|NCT00618956|54684083|FG001|Overall Study|Lack of Efficacy|1|||
28025305|NCT00618956|54684082|FG000|Overall Study|Withdrawal by Subject|5|||
28025306|NCT00618956|54684083|FG001|Overall Study|Withdrawal by Subject|7|||
28025307|NCT00618956|54684082|FG000|Overall Study|Lost to Follow-up|4|||
28025308|NCT00618956|54684083|FG001|Overall Study|Lost to Follow-up|5|||
28025309|NCT00618956|54684082|FG000|Overall Study|Protocol Violation|2|||
28025310|NCT00618956|54684083|FG001|Overall Study|Protocol Violation|2|||
28025311|NCT00618956|54684082|FG000|Overall Study|did not meet criteria, non-compliance|2|||
28025312|NCT00618956|54684083|FG001|Overall Study|did not meet criteria, non-compliance|1|||
28025313|NCT00716417|54684105|FG000|Overall Study|Adverse Event|0|||
28025314|NCT00716417|54684106|FG001|Overall Study|Adverse Event|0|||
28025315|NCT00716417|54684107|FG002|Overall Study|Adverse Event|2|||
28025316|NCT00716417|54684108|FG003|Overall Study|Adverse Event|1|||
28025317|NCT00716417|54684109|FG004|Overall Study|Adverse Event|0|||
28025318|NCT00716417|54684110|FG005|Overall Study|Adverse Event|0|||
28025319|NCT00716417|54684111|FG006|Overall Study|Adverse Event|3|||
28025320|NCT00716417|54684112|FG007|Overall Study|Adverse Event|1|||
28025321|NCT00716417|54684113|FG008|Overall Study|Adverse Event|0|||
28025322|NCT00716417|54684114|FG009|Overall Study|Adverse Event|3|||
28025323|NCT00716417|54684105|FG000|Overall Study|Withdrawal by Subject|0|||
28025324|NCT00716417|54684106|FG001|Overall Study|Withdrawal by Subject|1|||
28025325|NCT00716417|54684107|FG002|Overall Study|Withdrawal by Subject|0|||
28025326|NCT00716417|54684108|FG003|Overall Study|Withdrawal by Subject|2|||
28025327|NCT00716417|54684109|FG004|Overall Study|Withdrawal by Subject|0|||
28025328|NCT00716417|54684110|FG005|Overall Study|Withdrawal by Subject|0|||
28025329|NCT00716417|54684111|FG006|Overall Study|Withdrawal by Subject|1|||
28025330|NCT00716417|54684112|FG007|Overall Study|Withdrawal by Subject|0|||
28025331|NCT00716417|54684113|FG008|Overall Study|Withdrawal by Subject|0|||
28025332|NCT00716417|54684114|FG009|Overall Study|Withdrawal by Subject|0|||
28025333|NCT00716417|54684105|FG000|Overall Study|Progressive disease|3|||
28025334|NCT00716417|54684106|FG001|Overall Study|Progressive disease|5|||
28025335|NCT00716417|54684107|FG002|Overall Study|Progressive disease|3|||
28025336|NCT00716417|54684108|FG003|Overall Study|Progressive disease|8|||
28025337|NCT00716417|54684109|FG004|Overall Study|Progressive disease|0|||
28025338|NCT00716417|54684110|FG005|Overall Study|Progressive disease|3|||
28025339|NCT00716417|54684111|FG006|Overall Study|Progressive disease|3|||
28025340|NCT00716417|54684112|FG007|Overall Study|Progressive disease|1|||
28025341|NCT00716417|54684113|FG008|Overall Study|Progressive disease|5|||
28025342|NCT00716417|54684114|FG009|Overall Study|Progressive disease|0|||
27801907|NCT01843023|54256878|FG000|Overall Study|Death|1|||
27801908|NCT01843023|54256879|FG001|Overall Study|Death|0|||
27842843|NCT01575197|54331724|FG000|Overall Study|Lost to Follow-up|0|||
28025343|NCT00716417|54684105|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
28025344|NCT00716417|54684106|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
27801909|NCT01843023|54256878|FG000|Overall Study|Lost to Follow-up|24|||
27801910|NCT01843023|54256879|FG001|Overall Study|Lost to Follow-up|29|||
27801911|NCT01843023|54256878|FG000|Overall Study|Withdrawal by Subject|8|||
28025345|NCT00716417|54684107|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
28025346|NCT00716417|54684108|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
28025347|NCT00716417|54684109|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
28025348|NCT00716417|54684110|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
27801912|NCT01843023|54256879|FG001|Overall Study|Withdrawal by Subject|6|||
27801913|NCT01812759|54256888|FG000|Overall Study|Physician Decision|0|||
27801914|NCT01812759|54256889|FG001|Overall Study|Physician Decision|0|||
27801915|NCT01812759|54256890|FG002|Overall Study|Physician Decision|1|||
27801916|NCT01812057|54256900|FG000|Overall Study|Protocol Violation|1|||
27801917|NCT01812057|54256901|FG001|Overall Study|Protocol Violation|0|||
27801918|NCT01812057|54256900|FG000|Overall Study|Physician Decision|1|||
27801919|NCT01812057|54256901|FG001|Overall Study|Physician Decision|0|||
28025349|NCT00716417|54684111|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
28025350|NCT00716417|54684112|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
28025351|NCT00716417|54684113|FG008|Overall Study|Dose limiting toxicity (DLT)|0|||
28025352|NCT00716417|54684114|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
28025353|NCT00716417|54684105|FG000|Overall Study|On patient request due to toxicities|0|||
28025354|NCT00716417|54684106|FG001|Overall Study|On patient request due to toxicities|0|||
28025355|NCT00716417|54684107|FG002|Overall Study|On patient request due to toxicities|0|||
28025356|NCT00716417|54684108|FG003|Overall Study|On patient request due to toxicities|0|||
28025357|NCT00716417|54684109|FG004|Overall Study|On patient request due to toxicities|0|||
28025358|NCT00716417|54684110|FG005|Overall Study|On patient request due to toxicities|0|||
28025359|NCT00716417|54684111|FG006|Overall Study|On patient request due to toxicities|0|||
28025360|NCT00716417|54684112|FG007|Overall Study|On patient request due to toxicities|1|||
28025361|NCT00716417|54684113|FG008|Overall Study|On patient request due to toxicities|0|||
28025362|NCT00716417|54684114|FG009|Overall Study|On patient request due to toxicities|0|||
28025363|NCT00719537|54684140|FG000|Overall Study|Withdrawal by Subject|1|||
28025364|NCT00719537|54684141|FG001|Overall Study|Withdrawal by Subject|0|||
28025365|NCT00719537|54684140|FG000|Overall Study|Lost to Follow-up|0|||
28025366|NCT00719537|54684141|FG001|Overall Study|Lost to Follow-up|1|||
28025367|NCT00715949|54684147|FG000|Overall Study|could not finish first test|4|||
28025368|NCT00503698|54684153|FG000|Overall Study|Protocol Violation|5|||
28025369|NCT00503698|54684154|FG001|Overall Study|Protocol Violation|6|||
28025370|NCT00503698|54684153|FG000|Overall Study|Adverse Event|52|||
28025371|NCT00503698|54684154|FG001|Overall Study|Adverse Event|41|||
28025372|NCT00503698|54684153|FG000|Overall Study|Death|1|||
28025373|NCT00503698|54684154|FG001|Overall Study|Death|0|||
28025374|NCT00503698|54684153|FG000|Overall Study|Lack of Efficacy|3|||
28025375|NCT00503698|54684154|FG001|Overall Study|Lack of Efficacy|4|||
28025376|NCT00503698|54684153|FG000|Overall Study|Trial terminated|216|||
28025377|NCT00503698|54684154|FG001|Overall Study|Trial terminated|253|||
28025378|NCT00503698|54684153|FG000|Overall Study|End hemodialysis due to renal transplant|10|||
28025379|NCT00503698|54684154|FG001|Overall Study|End hemodialysis due to renal transplant|4|||
28025380|NCT00503698|54684153|FG000|Overall Study|Pregnancy/intention to become pregnant|1|||
28025381|NCT00503698|54684154|FG001|Overall Study|Pregnancy/intention to become pregnant|0|||
28025382|NCT00503698|54684153|FG000|Overall Study|Any condition in exclusion criteria|4|||
28025383|NCT00503698|54684154|FG001|Overall Study|Any condition in exclusion criteria|6|||
28025384|NCT00503698|54684153|FG000|Overall Study|Switch to peritoneal or home dialysis|2|||
28025385|NCT00503698|54684154|FG001|Overall Study|Switch to peritoneal or home dialysis|2|||
28025386|NCT00503698|54684153|FG000|Overall Study|Move to nonparticipating dialysis center|2|||
28025387|NCT00503698|54684154|FG001|Overall Study|Move to nonparticipating dialysis center|1|||
28025388|NCT00503698|54684153|FG000|Overall Study|Critically ill|2|||
28025389|NCT00503698|54684154|FG001|Overall Study|Critically ill|0|||
28025390|NCT00503698|54684153|FG000|Overall Study|Unclassified|48|||
28025391|NCT00503698|54684154|FG001|Overall Study|Unclassified|32|||
28025392|NCT00503698|54684153|FG000|Overall Study|Not exposed to trial drug|11|||
28025393|NCT00503698|54684154|FG001|Overall Study|Not exposed to trial drug|6|||
28025394|NCT00573794|54684169|FG000|Overall Study|Adverse Event|81|||
28025395|NCT00573794|54684169|FG000|Overall Study|Withdrew Consent|90|||
28025396|NCT00573794|54684169|FG000|Overall Study|Lost to Follow-up|13|||
28025397|NCT00573794|54684169|FG000|Overall Study|Protocol Violation|6|||
28025398|NCT00573794|54684169|FG000|Overall Study|Lack of Efficacy|94|||
28025399|NCT00573794|54684169|FG000|Overall Study|Other|46|||
28025400|NCT00715793|54684173|FG000|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1|||
28025401|NCT00715793|54684174|FG001|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0|||
28025402|NCT00715793|54684173|FG000|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0|||
28025403|NCT00715793|54684174|FG001|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2|||
28025404|NCT00718523|54684183|FG000|Overall Study|Withdrawal by Subject|5|||
28025405|NCT00718523|54684184|FG001|Overall Study|Withdrawal by Subject|7|||
28025406|NCT00718523|54684183|FG000|Overall Study|Death|13|||
28025407|NCT00718523|54684184|FG001|Overall Study|Death|17|||
28105640|NCT04527471|54763169|FG001|Overall Study|Adverse Event|0|||
27801920|NCT01842633|54256914|FG000|Overall Study|Screen Failure|1|||
27801921|NCT01842633|54256915|FG001|Overall Study|Screen Failure|0|||
27801922|NCT01842633|54256916|FG002|Overall Study|Screen Failure|0|||
27801923|NCT01842633|54256914|FG000|Overall Study|Adverse Event|1|||
28025408|NCT00715559|54684190|FG000|Overall Study|medication not tolerated - nausea|1|||
28025409|NCT00620282|54684206|FG000|Overall Study|Adverse Event|0|||
28025410|NCT00620282|54684207|FG001|Overall Study|Adverse Event|1|||
28025411|NCT00620282|54684208|FG002|Overall Study|Adverse Event|0|||
28025412|NCT00620282|54684206|FG000|Overall Study|Arterial line unable to be placed|0|||
28025413|NCT00620282|54684207|FG001|Overall Study|Arterial line unable to be placed|0|||
28025414|NCT00620282|54684208|FG002|Overall Study|Arterial line unable to be placed|1|||
28025415|NCT00620282|54684206|FG000|Overall Study|Withdrawal by Subject|0|||
28025416|NCT00620282|54684207|FG001|Overall Study|Withdrawal by Subject|1|||
28025417|NCT00620282|54684208|FG002|Overall Study|Withdrawal by Subject|0|||
28025418|NCT00515086|54684220|FG000|Overall Study|Adverse Event|1|||
28025419|NCT00515086|54684221|FG001|Overall Study|Adverse Event|1|||
28025420|NCT00515086|54684222|FG002|Overall Study|Adverse Event|2|||
28025421|NCT00515086|54684223|FG003|Overall Study|Adverse Event|3|||
27801924|NCT01842633|54256915|FG001|Overall Study|Adverse Event|1|||
27801925|NCT01842633|54256916|FG002|Overall Study|Adverse Event|0|||
27801926|NCT01842633|54256914|FG000|Overall Study|Withdrawal by Subject|0|||
28025422|NCT00515086|54684220|FG000|Overall Study|Administrative|1|||
28025423|NCT00515086|54684221|FG001|Overall Study|Administrative|1|||
28025424|NCT00515086|54684222|FG002|Overall Study|Administrative|0|||
28025425|NCT00515086|54684223|FG003|Overall Study|Administrative|0|||
28025426|NCT00515086|54684220|FG000|Overall Study|Withdrawal by Subject|1|||
28025427|NCT00515086|54684221|FG001|Overall Study|Withdrawal by Subject|0|||
28025428|NCT00515086|54684222|FG002|Overall Study|Withdrawal by Subject|0|||
28025429|NCT00515086|54684223|FG003|Overall Study|Withdrawal by Subject|1|||
28025430|NCT00515086|54684220|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
28025431|NCT00515086|54684221|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
28025432|NCT00515086|54684222|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
28025433|NCT00515086|54684223|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
28025434|NCT00515086|54684220|FG000|Overall Study|Lost to Follow-up|1|||
28025435|NCT00515086|54684221|FG001|Overall Study|Lost to Follow-up|0|||
28025436|NCT00515086|54684222|FG002|Overall Study|Lost to Follow-up|0|||
28025437|NCT00515086|54684223|FG003|Overall Study|Lost to Follow-up|0|||
28025438|NCT00515086|54684220|FG000|Overall Study|Study drug no longer required|0|||
28025439|NCT00515086|54684221|FG001|Overall Study|Study drug no longer required|1|||
28025440|NCT00515086|54684222|FG002|Overall Study|Study drug no longer required|0|||
28025441|NCT00515086|54684223|FG003|Overall Study|Study drug no longer required|0|||
28025442|NCT00515086|54684220|FG000|Overall Study|Death|2|||
28025443|NCT00515086|54684221|FG001|Overall Study|Death|0|||
28025444|NCT00515086|54684222|FG002|Overall Study|Death|0|||
28025445|NCT00515086|54684223|FG003|Overall Study|Death|0|||
28025446|NCT00618410|54684239|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
28025447|NCT00618410|54684240|FG001|Washout Period (2 Weeks)|Physician Decision|1|||
28025448|NCT00618722|54684250|FG000|Overall Study|Refusal of Treatment|0|||
28025449|NCT00618722|54684251|FG001|Overall Study|Refusal of Treatment|0|||
28025450|NCT00618722|54684252|FG002|Overall Study|Refusal of Treatment|1|||
28025451|NCT00618722|54684253|FG003|Overall Study|Refusal of Treatment|0|||
28025452|NCT00618722|54684250|FG000|Overall Study|Patient Request|1|||
28025453|NCT00618722|54684251|FG001|Overall Study|Patient Request|1|||
28025454|NCT00618722|54684252|FG002|Overall Study|Patient Request|1|||
27801927|NCT01842633|54256915|FG001|Overall Study|Withdrawal by Subject|1|||
28025455|NCT00618722|54684253|FG003|Overall Study|Patient Request|1|||
28025456|NCT00618722|54684250|FG000|Overall Study|Inability to Complete Study Procedure|0|||
27801928|NCT01842633|54256916|FG002|Overall Study|Withdrawal by Subject|0|||
28025457|NCT00618722|54684251|FG001|Overall Study|Inability to Complete Study Procedure|1|||
27801929|NCT01842633|54256914|FG000|Overall Study|Technical issues|1|||
28025458|NCT00618722|54684252|FG002|Overall Study|Inability to Complete Study Procedure|0|||
28025459|NCT00618722|54684253|FG003|Overall Study|Inability to Complete Study Procedure|0|||
28025460|NCT00618722|54684250|FG000|Overall Study|Lost to Follow-up|2|||
28025461|NCT00618722|54684251|FG001|Overall Study|Lost to Follow-up|0|||
28025462|NCT00618722|54684252|FG002|Overall Study|Lost to Follow-up|0|||
28025463|NCT00618722|54684253|FG003|Overall Study|Lost to Follow-up|2|||
28025464|NCT00618722|54684250|FG000|Overall Study|Miscellaneous Reasons|0|||
28025465|NCT00618722|54684251|FG001|Overall Study|Miscellaneous Reasons|0|||
27801930|NCT01842633|54256915|FG001|Overall Study|Technical issues|0|||
28025466|NCT00618722|54684252|FG002|Overall Study|Miscellaneous Reasons|1|||
28025467|NCT00618722|54684253|FG003|Overall Study|Miscellaneous Reasons|1|||
28025468|NCT00507442|54684267|FG000|Overall Study|Adverse Event|8|||
28025469|NCT00507442|54684268|FG001|Overall Study|Adverse Event|11|||
28025470|NCT00507442|54684269|FG002|Overall Study|Adverse Event|4|||
28025471|NCT00507442|54684270|FG003|Overall Study|Adverse Event|1|||
27801931|NCT01842633|54256916|FG002|Overall Study|Technical issues|0|||
28025472|NCT00507442|54684267|FG000|Overall Study|Protocol Violation|0|||
28025473|NCT00507442|54684268|FG001|Overall Study|Protocol Violation|1|||
28025474|NCT00507442|54684269|FG002|Overall Study|Protocol Violation|0|||
27801932|NCT01810263|54256928|FG000|Overall Study|Lost to Follow-up|8|||
27801933|NCT01810263|54256929|FG001|Overall Study|Lost to Follow-up|7|||
28025475|NCT00507442|54684270|FG003|Overall Study|Protocol Violation|0|||
27938949|NCT00963820|54595214|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
27938950|NCT00963820|54595215|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
28025476|NCT00507442|54684267|FG000|Overall Study|Lost to Follow-up|0|||
28025477|NCT00507442|54684268|FG001|Overall Study|Lost to Follow-up|0|||
28025478|NCT00507442|54684269|FG002|Overall Study|Lost to Follow-up|1|||
28025479|NCT00507442|54684270|FG003|Overall Study|Lost to Follow-up|0|||
28025480|NCT00507442|54684267|FG000|Overall Study|Physician Decision|0|||
28025481|NCT00507442|54684268|FG001|Overall Study|Physician Decision|2|||
28025482|NCT00507442|54684269|FG002|Overall Study|Physician Decision|4|||
28025483|NCT00507442|54684270|FG003|Overall Study|Physician Decision|1|||
27801934|NCT01841697|54256937|FG000|Overall Study|Death|0|||
27801935|NCT01841697|54256938|FG001|Overall Study|Death|1|||
27801936|NCT01841697|54256937|FG000|Overall Study|Lost to Follow-up|4|||
27801937|NCT01841697|54256938|FG001|Overall Study|Lost to Follow-up|1|||
27801938|NCT01841697|54256937|FG000|Overall Study|Withdrawal by Subject|16|||
27801939|NCT01841697|54256938|FG001|Overall Study|Withdrawal by Subject|16|||
27801940|NCT01841073|54256946|FG000|Overall Study|Adverse Event|1|||
27801941|NCT01841073|54256947|FG001|Overall Study|Adverse Event|1|||
27801942|NCT01841073|54256946|FG000|Overall Study|Physician Decision|1|||
27801943|NCT01841073|54256947|FG001|Overall Study|Physician Decision|0|||
27801944|NCT01841073|54256946|FG000|Overall Study|Lost to Follow-up|0|||
27801945|NCT01841073|54256947|FG001|Overall Study|Lost to Follow-up|2|||
27801946|NCT01809327|54256960|FG000|Overall Study|Lost to Follow-up|5|||
27801947|NCT01809327|54256961|FG001|Overall Study|Lost to Follow-up|2|||
27801948|NCT01809327|54256962|FG002|Overall Study|Lost to Follow-up|4|||
27801949|NCT01809327|54256963|FG003|Overall Study|Lost to Follow-up|2|||
27801950|NCT01809327|54256964|FG004|Overall Study|Lost to Follow-up|3|||
27801951|NCT01809327|54256960|FG000|Overall Study|Withdrawal by Subject|6|||
27801952|NCT01809327|54256961|FG001|Overall Study|Withdrawal by Subject|4|||
27801953|NCT01809327|54256962|FG002|Overall Study|Withdrawal by Subject|4|||
27801954|NCT01809327|54256963|FG003|Overall Study|Withdrawal by Subject|2|||
27801955|NCT01809327|54256964|FG004|Overall Study|Withdrawal by Subject|5|||
27801956|NCT01809327|54256960|FG000|Overall Study|Adverse Event|4|||
27801957|NCT01809327|54256961|FG001|Overall Study|Adverse Event|3|||
27801958|NCT01809327|54256962|FG002|Overall Study|Adverse Event|7|||
27801959|NCT01809327|54256963|FG003|Overall Study|Adverse Event|4|||
27801960|NCT01809327|54256964|FG004|Overall Study|Adverse Event|8|||
27801961|NCT01809327|54256960|FG000|Overall Study|Death|1|||
27801962|NCT01809327|54256961|FG001|Overall Study|Death|0|||
27801963|NCT01809327|54256962|FG002|Overall Study|Death|0|||
27801964|NCT01809327|54256963|FG003|Overall Study|Death|0|||
27801965|NCT01809327|54256964|FG004|Overall Study|Death|0|||
27801966|NCT01809327|54256960|FG000|Overall Study|Protocol Violation|0|||
27801967|NCT01809327|54256961|FG001|Overall Study|Protocol Violation|1|||
27801968|NCT01809327|54256962|FG002|Overall Study|Protocol Violation|0|||
27801969|NCT01809327|54256963|FG003|Overall Study|Protocol Violation|0|||
27801970|NCT01809327|54256964|FG004|Overall Study|Protocol Violation|0|||
27801971|NCT01809327|54256960|FG000|Overall Study|Physician Decision|1|||
27801972|NCT01809327|54256961|FG001|Overall Study|Physician Decision|1|||
27801973|NCT01809327|54256962|FG002|Overall Study|Physician Decision|0|||
27801974|NCT01809327|54256963|FG003|Overall Study|Physician Decision|0|||
27801975|NCT01809327|54256964|FG004|Overall Study|Physician Decision|0|||
27801976|NCT01809327|54256960|FG000|Overall Study|Pregnancy|1|||
27801977|NCT01809327|54256961|FG001|Overall Study|Pregnancy|0|||
27801978|NCT01809327|54256962|FG002|Overall Study|Pregnancy|0|||
27801979|NCT01809327|54256963|FG003|Overall Study|Pregnancy|0|||
27801980|NCT01809327|54256964|FG004|Overall Study|Pregnancy|0|||
27801981|NCT01809327|54256960|FG000|Overall Study|Other|14|||
28025484|NCT00507442|54684267|FG000|Overall Study|Progressive Disease|2|||
27801982|NCT01809327|54256961|FG001|Overall Study|Other|15|||
27801983|NCT01809327|54256962|FG002|Overall Study|Other|7|||
27801984|NCT01809327|54256963|FG003|Overall Study|Other|4|||
27801985|NCT01809327|54256964|FG004|Overall Study|Other|9|||
27801986|NCT01808313|54256985|FG000|Overall Study|Adverse Event|5|||
27938951|NCT00963820|54595216|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
28025485|NCT00507442|54684268|FG001|Overall Study|Progressive Disease|4|||
28025486|NCT00507442|54684269|FG002|Overall Study|Progressive Disease|2|||
27801987|NCT01808313|54256985|FG000|Overall Study|Protocol Violation|2|||
27801988|NCT01808313|54256985|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
27801989|NCT01808313|54256985|FG000|Overall Study|Lost to Follow-up|1|||
27801990|NCT01808313|54256985|FG000|Overall Study|Physician Decision|1|||
27801991|NCT01840605|54256991|FG000|Overall Study|Adverse Event|0|||
27801992|NCT01840605|54256992|FG001|Overall Study|Adverse Event|1|||
27801993|NCT01840605|54256991|FG000|Overall Study|Physician Decision|2|||
27801994|NCT01840605|54256992|FG001|Overall Study|Physician Decision|1|||
27801995|NCT02023879|54257001|FG000|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
27801996|NCT02023879|54257002|FG001|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
27801997|NCT02023879|54257003|FG002|Period 1: 24-Week Double-blind Treatment|Adverse Event|5|||
28025487|NCT00507442|54684270|FG003|Overall Study|Progressive Disease|0|||
28025488|NCT00507442|54684267|FG000|Overall Study|Withdrawal by Subject|4|||
28025489|NCT00507442|54684268|FG001|Overall Study|Withdrawal by Subject|4|||
28025490|NCT00507442|54684269|FG002|Overall Study|Withdrawal by Subject|2|||
28025491|NCT00507442|54684270|FG003|Overall Study|Withdrawal by Subject|1|||
27801998|NCT02023879|54257001|FG000|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0|||
27801999|NCT02023879|54257002|FG001|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2|||
27802000|NCT02023879|54257003|FG002|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1|||
27802001|NCT02023879|54257001|FG000|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
27802002|NCT02023879|54257002|FG001|Period 1: 24-Week Double-blind Treatment|Physician Decision|1|||
27802003|NCT02023879|54257003|FG002|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
27802004|NCT02023879|54257001|FG000|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
27802005|NCT02023879|54257002|FG001|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0|||
27802006|NCT02023879|54257003|FG002|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
27802007|NCT02023879|54257001|FG000|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0|||
27802008|NCT02023879|54257002|FG001|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
27802009|NCT02023879|54257003|FG002|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
27802010|NCT02023879|54257001|FG000|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
27802011|NCT02023879|54257002|FG001|Period 1: 24-Week Double-blind Treatment|Other than specified above|3|||
27802012|NCT02023879|54257003|FG002|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
27802013|NCT02023879|54257001|FG000|Extension Open Label Treatment|Adverse Event|1|||
27802014|NCT02023879|54257002|FG001|Extension Open Label Treatment|Adverse Event|7|||
27802015|NCT02023879|54257003|FG002|Extension Open Label Treatment|Adverse Event|3|||
27802016|NCT02023879|54257001|FG000|Extension Open Label Treatment|Poor compliance to protocol|1|||
27802017|NCT02023879|54257002|FG001|Extension Open Label Treatment|Poor compliance to protocol|1|||
27802018|NCT02023879|54257003|FG002|Extension Open Label Treatment|Poor compliance to protocol|0|||
27802019|NCT02023879|54257001|FG000|Extension Open Label Treatment|Participant moved|1|||
27802020|NCT02023879|54257002|FG001|Extension Open Label Treatment|Participant moved|2|||
27802021|NCT02023879|54257003|FG002|Extension Open Label Treatment|Participant moved|0|||
27802022|NCT02023879|54257001|FG000|Extension Open Label Treatment|Other than specified above|2|||
27802023|NCT02023879|54257002|FG001|Extension Open Label Treatment|Other than specified above|7|||
27802024|NCT02023879|54257003|FG002|Extension Open Label Treatment|Other than specified above|2|||
27802025|NCT02014441|54257018|FG000|Overall Study|Withdrawal by Subject|12|||
27802026|NCT02013817|54257024|FG000|Overall Study|Adverse Event|12|||
27802027|NCT02013817|54257024|FG000|Overall Study|Withdrawal by Subject|4|||
27802028|NCT02013817|54257024|FG000|Overall Study|Death|2|||
27802029|NCT02013817|54257024|FG000|Overall Study|Other|9|||
27802030|NCT01994863|54257028|FG000|Period 1|Adverse Event|4|||
27802031|NCT01994863|54257029|FG001|Period 1|Adverse Event|0|||
27802032|NCT01994863|54257028|FG000|Period 1|Withdrawal by Subject|1|||
27802033|NCT01994863|54257029|FG001|Period 1|Withdrawal by Subject|0|||
27802034|NCT01994863|54257028|FG000|Period 1|Trial stopped by sponsor|1|||
27802035|NCT01994863|54257029|FG001|Period 1|Trial stopped by sponsor|3|||
27802036|NCT01994863|54257028|FG000|Period 1|Lack of Efficacy|1|||
27802037|NCT01994863|54257029|FG001|Period 1|Lack of Efficacy|0|||
27802038|NCT01994863|54257028|FG000|Period 2|Adverse Event|0|||
27802039|NCT01994863|54257029|FG001|Period 2|Adverse Event|1|||
27802040|NCT01994863|54257028|FG000|Period 2|Lack of Efficacy|0|||
27802041|NCT01994863|54257029|FG001|Period 2|Lack of Efficacy|2|||
27802042|NCT01994863|54257028|FG000|Period 2|Withdrawal by Subject|1|||
27802043|NCT01994863|54257029|FG001|Period 2|Withdrawal by Subject|1|||
27802044|NCT02023099|54257038|FG000|Overall Study|Non-fatal Adverse Event (AE)|0|||
27802045|NCT02023099|54257039|FG001|Overall Study|Non-fatal Adverse Event (AE)|0|||
27802046|NCT02023099|54257040|FG002|Overall Study|Non-fatal Adverse Event (AE)|1|||
27802047|NCT02023099|54257038|FG000|Overall Study|Withdrawn Consent|3|||
27938952|NCT00963820|54595217|FG005|Dose Escalation Phase|Withdrawal by Subject|0|||
27938953|NCT00963820|54595218|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
27938954|NCT00963820|54595219|FG007|Dose Escalation Phase|Withdrawal by Subject|2|||
27938955|NCT00963820|54595220|FG008|Dose Escalation Phase|Withdrawal by Subject|0|||
27938956|NCT00963820|54595221|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
27938957|NCT00963820|54595222|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
27938958|NCT00963820|54595223|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
27938959|NCT00963820|54595212|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
27802048|NCT02023099|54257039|FG001|Overall Study|Withdrawn Consent|0|||
27802049|NCT02023099|54257040|FG002|Overall Study|Withdrawn Consent|1|||
27802050|NCT02023099|54257038|FG000|Overall Study|Non-treatment-emergent Fatal AE|0|||
27802051|NCT02023099|54257039|FG001|Overall Study|Non-treatment-emergent Fatal AE|0|||
27802052|NCT02023099|54257040|FG002|Overall Study|Non-treatment-emergent Fatal AE|1|||
27802053|NCT02013037|54257048|FG000|Overall Study|Death|6|||
27802054|NCT02013037|54257048|FG000|Overall Study|Withdrawal by Subject|1|||
27802055|NCT02013037|54257048|FG000|Overall Study|Awaiting Transplantation|7|||
27802056|NCT02013037|54257048|FG000|Overall Study|Transplanted without DSA|2|||
27802057|NCT01967719|54257055|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
27802058|NCT01967719|54257056|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
27802059|NCT01967719|54257057|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
27802060|NCT01967719|54257058|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
27802061|NCT01967719|54257055|FG000|Second Intervention (Day 3)|Withdrawal by Subject|0|||
27802062|NCT01967719|54257056|FG001|Second Intervention (Day 3)|Withdrawal by Subject|1|||
28025492|NCT00507442|54684267|FG000|Overall Study|Other|2|||
28025493|NCT00507442|54684268|FG001|Overall Study|Other|5|||
28025494|NCT00507442|54684269|FG002|Overall Study|Other|2|||
28025495|NCT00507442|54684270|FG003|Overall Study|Other|2|||
28025496|NCT00619892|54684286|FG000|Overall Study|Adverse Event|3|||
28025497|NCT00619892|54684287|FG001|Overall Study|Adverse Event|0|||
28025498|NCT00619892|54684286|FG000|Overall Study|Lost to Follow-up|0|||
28025499|NCT00619892|54684287|FG001|Overall Study|Lost to Follow-up|1|||
28025500|NCT00619892|54684286|FG000|Overall Study|Intercurrent illness|0|||
28025501|NCT00619892|54684287|FG001|Overall Study|Intercurrent illness|1|||
28025502|NCT00507130|54684299|FG000|Overall Study|Lost to Follow-up|0|||
28025503|NCT00507130|54684300|FG001|Overall Study|Lost to Follow-up|0|||
28025504|NCT00507130|54684301|FG002|Overall Study|Lost to Follow-up|1|||
28025505|NCT00507130|54684302|FG003|Overall Study|Lost to Follow-up|1|||
28025506|NCT00507130|54684299|FG000|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1|||
28025507|NCT00507130|54684300|FG001|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
28025508|NCT00507130|54684301|FG002|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
28025509|NCT00507130|54684302|FG003|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
28025510|NCT00503308|54684314|FG000|Overall Study|Protocol Violation|2|||
28025511|NCT00503308|54684315|FG001|Overall Study|Protocol Violation|1|||
28025512|NCT03893565|54684326|FG000|Double-blind Induction Phase (10 Weeks)|Other|1|||
28025513|NCT03893565|54684327|FG001|Double-blind Induction Phase (10 Weeks)|Other|3|||
28025514|NCT03893565|54684328|FG002|Double-blind Induction Phase (10 Weeks)|Other|0|||
28025515|NCT03893565|54684329|FG003|Double-blind Induction Phase (10 Weeks)|Other|0|||
28025516|NCT03893565|54684330|FG004|Double-blind Induction Phase (10 Weeks)|Other|1|||
28025517|NCT03893565|54684331|FG005|Double-blind Induction Phase (10 Weeks)|Other|0|||
28025518|NCT03893565|54684332|FG006|Double-blind Induction Phase (10 Weeks)|Other|0|||
28025519|NCT03893565|54684333|FG007|Double-blind Induction Phase (10 Weeks)|Other|0|||
28025520|NCT03893565|54684334|FG008|Double-blind Induction Phase (10 Weeks)|Other|0|||
28025521|NCT03893565|54684326|FG000|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
28025522|NCT03893565|54684327|FG001|Double-blind Induction Phase (10 Weeks)|Physician Decision|1|||
28025523|NCT03893565|54684328|FG002|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
28025524|NCT03893565|54684329|FG003|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
28025525|NCT03893565|54684330|FG004|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
28025526|NCT03893565|54684331|FG005|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
28025527|NCT03893565|54684332|FG006|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
28025528|NCT03893565|54684333|FG007|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
28025529|NCT03893565|54684334|FG008|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
28025530|NCT03893565|54684326|FG000|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
28025531|NCT03893565|54684327|FG001|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|2|||
28025532|NCT03893565|54684328|FG002|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
28025533|NCT03893565|54684329|FG003|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|1|||
28025534|NCT03893565|54684330|FG004|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
27802063|NCT01967719|54257057|FG002|Second Intervention (Day 3)|Withdrawal by Subject|0|||
27802064|NCT01967719|54257058|FG003|Second Intervention (Day 3)|Withdrawal by Subject|0|||
27802065|NCT01967173|54257076|FG000|Overall Study|Lost to Follow-up|5|||
27802066|NCT01967173|54257077|FG001|Overall Study|Lost to Follow-up|3|||
27802067|NCT01967173|54257078|FG002|Overall Study|Lost to Follow-up|2|||
27802068|NCT01967173|54257079|FG003|Overall Study|Lost to Follow-up|4|||
27802069|NCT01967173|54257080|FG004|Overall Study|Lost to Follow-up|8|||
27802070|NCT01967173|54257081|FG005|Overall Study|Lost to Follow-up|12|||
27802071|NCT01967173|54257082|FG006|Overall Study|Lost to Follow-up|6|||
27802072|NCT01967173|54257083|FG007|Overall Study|Lost to Follow-up|8|||
27802073|NCT01967173|54257076|FG000|Overall Study|Physician Decision|2|||
27802074|NCT01967173|54257077|FG001|Overall Study|Physician Decision|0|||
27802075|NCT01967173|54257078|FG002|Overall Study|Physician Decision|2|||
27802076|NCT01967173|54257079|FG003|Overall Study|Physician Decision|1|||
27802077|NCT01967173|54257080|FG004|Overall Study|Physician Decision|1|||
27842844|NCT01575197|54331725|FG001|Overall Study|Lost to Follow-up|1|||
27842845|NCT01575197|54331726|FG002|Overall Study|Lost to Follow-up|0|||
28025535|NCT03893565|54684331|FG005|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
28025536|NCT03893565|54684332|FG006|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
28025537|NCT03893565|54684333|FG007|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
27802078|NCT01967173|54257081|FG005|Overall Study|Physician Decision|1|||
27802079|NCT01967173|54257082|FG006|Overall Study|Physician Decision|1|||
27802080|NCT01967173|54257083|FG007|Overall Study|Physician Decision|0|||
27802081|NCT01967173|54257076|FG000|Overall Study|Lack of Efficacy|2|||
27802082|NCT01967173|54257077|FG001|Overall Study|Lack of Efficacy|0|||
27802083|NCT01967173|54257078|FG002|Overall Study|Lack of Efficacy|2|||
27802084|NCT01967173|54257079|FG003|Overall Study|Lack of Efficacy|2|||
27802085|NCT01967173|54257080|FG004|Overall Study|Lack of Efficacy|0|||
27802086|NCT01967173|54257081|FG005|Overall Study|Lack of Efficacy|1|||
27802087|NCT01967173|54257082|FG006|Overall Study|Lack of Efficacy|0|||
27802088|NCT01967173|54257083|FG007|Overall Study|Lack of Efficacy|2|||
27802089|NCT01967173|54257076|FG000|Overall Study|Pregnancy|0|||
27802090|NCT01967173|54257077|FG001|Overall Study|Pregnancy|0|||
27802091|NCT01967173|54257078|FG002|Overall Study|Pregnancy|0|||
27802092|NCT01967173|54257079|FG003|Overall Study|Pregnancy|0|||
28025538|NCT03893565|54684334|FG008|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
28025539|NCT03893565|54684326|FG000|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
28025540|NCT03893565|54684327|FG001|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|1|||
28025541|NCT03893565|54684328|FG002|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
28025542|NCT03893565|54684329|FG003|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|6|||
28025543|NCT03893565|54684330|FG004|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
28025544|NCT03893565|54684331|FG005|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
28025545|NCT03893565|54684332|FG006|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
28025546|NCT03893565|54684333|FG007|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
28025547|NCT03893565|54684334|FG008|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
28025548|NCT03893565|54684326|FG000|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
28025549|NCT03893565|54684327|FG001|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
28025550|NCT03893565|54684328|FG002|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|9|||
28025551|NCT03893565|54684329|FG003|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
28025552|NCT03893565|54684330|FG004|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|6|||
28025553|NCT03893565|54684331|FG005|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
28025554|NCT03893565|54684332|FG006|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
28025555|NCT03893565|54684333|FG007|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
28025556|NCT03893565|54684334|FG008|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
28025557|NCT03893565|54684326|FG000|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
28025558|NCT03893565|54684327|FG001|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|2|||
28025559|NCT03893565|54684328|FG002|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
28025560|NCT03893565|54684329|FG003|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
28025561|NCT03893565|54684330|FG004|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
28025562|NCT03893565|54684331|FG005|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
28025563|NCT03893565|54684332|FG006|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
28025564|NCT03893565|54684333|FG007|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
28025565|NCT03893565|54684334|FG008|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
28025566|NCT03893565|54684326|FG000|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
28025567|NCT03893565|54684327|FG001|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
28025568|NCT03893565|54684328|FG002|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
28025569|NCT03893565|54684329|FG003|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|1|||
28025570|NCT03893565|54684330|FG004|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
28025571|NCT03893565|54684331|FG005|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
28025572|NCT03893565|54684332|FG006|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
28025573|NCT03893565|54684333|FG007|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
28025574|NCT03893565|54684334|FG008|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
28025575|NCT03893565|54684326|FG000|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
28025576|NCT03893565|54684327|FG001|Double-blind Induction Phase (10 Weeks)|Adverse Event|2|||
28025577|NCT03893565|54684328|FG002|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
28025578|NCT03893565|54684329|FG003|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
28025579|NCT03893565|54684330|FG004|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
28025580|NCT03893565|54684331|FG005|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
28025581|NCT03893565|54684332|FG006|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
28025582|NCT03893565|54684333|FG007|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
28025583|NCT03893565|54684334|FG008|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
27802093|NCT01967173|54257080|FG004|Overall Study|Pregnancy|0|||
27802094|NCT01967173|54257081|FG005|Overall Study|Pregnancy|0|||
27802095|NCT01967173|54257082|FG006|Overall Study|Pregnancy|1|||
27802096|NCT01967173|54257083|FG007|Overall Study|Pregnancy|1|||
27802097|NCT01967173|54257076|FG000|Overall Study|Adverse Event|0|||
27802098|NCT01967173|54257077|FG001|Overall Study|Adverse Event|0|||
27802099|NCT01967173|54257078|FG002|Overall Study|Adverse Event|0|||
28025584|NCT03893565|54684326|FG000|Double-blind Extended Treatment(20weeks)|Other|0|||
28025585|NCT03893565|54684327|FG001|Double-blind Extended Treatment(20weeks)|Other|0|||
28025586|NCT03893565|54684328|FG002|Double-blind Extended Treatment(20weeks)|Other|0|||
28025587|NCT03893565|54684329|FG003|Double-blind Extended Treatment(20weeks)|Other|0|||
28025588|NCT03893565|54684330|FG004|Double-blind Extended Treatment(20weeks)|Other|0|||
28025589|NCT03893565|54684331|FG005|Double-blind Extended Treatment(20weeks)|Other|1|||
28025590|NCT03893565|54684332|FG006|Double-blind Extended Treatment(20weeks)|Other|1|||
28025591|NCT03893565|54684333|FG007|Double-blind Extended Treatment(20weeks)|Other|0|||
28025592|NCT03893565|54684334|FG008|Double-blind Extended Treatment(20weeks)|Other|0|||
28025593|NCT03893565|54684326|FG000|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
28025594|NCT03893565|54684327|FG001|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
28025595|NCT03893565|54684328|FG002|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
28025596|NCT03893565|54684329|FG003|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
27802100|NCT01967173|54257079|FG003|Overall Study|Adverse Event|0|||
27802101|NCT01967173|54257080|FG004|Overall Study|Adverse Event|0|||
27802102|NCT01967173|54257081|FG005|Overall Study|Adverse Event|0|||
27802103|NCT01967173|54257082|FG006|Overall Study|Adverse Event|0|||
27802104|NCT01967173|54257083|FG007|Overall Study|Adverse Event|1|||
27802105|NCT01967173|54257076|FG000|Overall Study|Withdrawal by Subject|15|||
27802106|NCT01967173|54257077|FG001|Overall Study|Withdrawal by Subject|14|||
27802107|NCT01967173|54257078|FG002|Overall Study|Withdrawal by Subject|10|||
27802108|NCT01967173|54257079|FG003|Overall Study|Withdrawal by Subject|7|||
28025597|NCT03893565|54684330|FG004|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
28025598|NCT03893565|54684331|FG005|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
28025599|NCT03893565|54684332|FG006|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|1|||
28025600|NCT03893565|54684333|FG007|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
28025601|NCT03893565|54684334|FG008|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
28025602|NCT03893565|54684326|FG000|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
28025603|NCT03893565|54684327|FG001|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
28025604|NCT03893565|54684328|FG002|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
28025605|NCT03893565|54684329|FG003|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
28025606|NCT03893565|54684330|FG004|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
28025607|NCT03893565|54684331|FG005|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
28025608|NCT03893565|54684332|FG006|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
28025609|NCT03893565|54684333|FG007|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
28025610|NCT03893565|54684334|FG008|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
28025611|NCT03893565|54684326|FG000|Open-label Induction Phase (10 Weeks)|Other|0|||
28025612|NCT03893565|54684327|FG001|Open-label Induction Phase (10 Weeks)|Other|0|||
28025613|NCT03893565|54684328|FG002|Open-label Induction Phase (10 Weeks)|Other|0|||
28025614|NCT03893565|54684329|FG003|Open-label Induction Phase (10 Weeks)|Other|0|||
28025615|NCT03893565|54684330|FG004|Open-label Induction Phase (10 Weeks)|Other|0|||
28025616|NCT03893565|54684331|FG005|Open-label Induction Phase (10 Weeks)|Other|0|||
28025617|NCT03893565|54684332|FG006|Open-label Induction Phase (10 Weeks)|Other|0|||
28025618|NCT03893565|54684333|FG007|Open-label Induction Phase (10 Weeks)|Other|3|||
28025619|NCT03893565|54684334|FG008|Open-label Induction Phase (10 Weeks)|Other|0|||
28025620|NCT03893565|54684326|FG000|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
28025621|NCT03893565|54684327|FG001|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
28025622|NCT03893565|54684328|FG002|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
28025623|NCT03893565|54684329|FG003|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
28025624|NCT03893565|54684330|FG004|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
28025625|NCT03893565|54684331|FG005|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
28025626|NCT03893565|54684332|FG006|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
28025627|NCT03893565|54684333|FG007|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|5|||
28025628|NCT03893565|54684334|FG008|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
28025629|NCT03893565|54684326|FG000|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
28025630|NCT03893565|54684327|FG001|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
27802109|NCT01967173|54257080|FG004|Overall Study|Withdrawal by Subject|8|||
27842846|NCT01575197|54331724|FG000|Overall Study|Withdrawal by Subject|0|||
27842847|NCT01575197|54331725|FG001|Overall Study|Withdrawal by Subject|1|||
27842848|NCT01575197|54331726|FG002|Overall Study|Withdrawal by Subject|1|||
27802110|NCT01967173|54257081|FG005|Overall Study|Withdrawal by Subject|9|||
27802111|NCT01967173|54257082|FG006|Overall Study|Withdrawal by Subject|10|||
27842849|NCT01575197|54331724|FG000|Overall Study|Protocol Violation|2|||
27842850|NCT01575197|54331725|FG001|Overall Study|Protocol Violation|1|||
27842851|NCT01575197|54331726|FG002|Overall Study|Protocol Violation|1|||
27842852|NCT01574651|54331757|FG000|Overall Study|Lost to Follow-up|2|||
27842853|NCT01574651|54331758|FG001|Overall Study|Lost to Follow-up|4|||
27842854|NCT01574651|54331757|FG000|Overall Study|Administrative problems|0|||
27842855|NCT01574651|54331758|FG001|Overall Study|Administrative problems|1|||
27842856|NCT01574651|54331757|FG000|Overall Study|Death|3|||
27842857|NCT01574651|54331758|FG001|Overall Study|Death|3|||
28025631|NCT03893565|54684328|FG002|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
28025632|NCT03893565|54684329|FG003|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
28025633|NCT03893565|54684330|FG004|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
28025634|NCT03893565|54684331|FG005|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
28025635|NCT03893565|54684332|FG006|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
28025636|NCT03893565|54684333|FG007|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|15|||
28025637|NCT03893565|54684334|FG008|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
28025638|NCT03893565|54684326|FG000|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
28025639|NCT03893565|54684327|FG001|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
28025640|NCT03893565|54684328|FG002|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
28025641|NCT03893565|54684329|FG003|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
28025642|NCT03893565|54684330|FG004|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
28025643|NCT03893565|54684331|FG005|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
28025644|NCT03893565|54684332|FG006|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
28025645|NCT03893565|54684333|FG007|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|7|||
28025646|NCT03893565|54684334|FG008|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
28025647|NCT03893565|54684326|FG000|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
28025648|NCT03893565|54684327|FG001|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
28025649|NCT03893565|54684328|FG002|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
28025650|NCT03893565|54684329|FG003|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
28025651|NCT03893565|54684330|FG004|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
28025652|NCT03893565|54684331|FG005|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
28025653|NCT03893565|54684332|FG006|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
28025654|NCT03893565|54684333|FG007|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
28025655|NCT03893565|54684334|FG008|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|4|||
28025656|NCT00502996|54684353|FG000|Overall Study|Lost to Follow-up|9|||
28025657|NCT00502996|54684353|FG000|Overall Study|Protocol Violation|2|||
28025658|NCT00502996|54684353|FG000|Overall Study|Treatment failure|25|||
28025659|NCT00502996|54684353|FG000|Overall Study|Withdrawal Informed Consent|6|||
28025660|NCT00502996|54684353|FG000|Overall Study|Adverse Event|2|||
28025661|NCT00715403|54684364|FG000|Overall Study|Progressive disease|0|||
28025662|NCT00715403|54684365|FG001|Overall Study|Progressive disease|1|||
28025663|NCT00715403|54684366|FG002|Overall Study|Progressive disease|3|||
28025664|NCT00715403|54684367|FG003|Overall Study|Progressive disease|9|||
28025665|NCT00715403|54684368|FG004|Overall Study|Progressive disease|5|||
28025666|NCT00715403|54684369|FG005|Overall Study|Progressive disease|14|||
28025667|NCT00715403|54684370|FG006|Overall Study|Progressive disease|1|||
27802112|NCT01967173|54257083|FG007|Overall Study|Withdrawal by Subject|12|||
28025668|NCT00715403|54684364|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
28025669|NCT00715403|54684365|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
28025670|NCT00715403|54684366|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
28025671|NCT00715403|54684367|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
28025672|NCT00715403|54684368|FG004|Overall Study|Dose limiting Toxicity (DLT)|0|||
28025673|NCT00715403|54684369|FG005|Overall Study|Dose limiting Toxicity (DLT)|1|||
28025674|NCT00715403|54684370|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
28025675|NCT00715403|54684364|FG000|Overall Study|Other Adverse Event than DLT|1|||
28025676|NCT00715403|54684365|FG001|Overall Study|Other Adverse Event than DLT|0|||
27802113|NCT01994629|54257097|FG000|Overall Study|Withdrawal by Subject|1|||
27802114|NCT01994629|54257098|FG001|Overall Study|Withdrawal by Subject|0|||
27802115|NCT01994629|54257097|FG000|Overall Study|Lost to Follow-up|0|||
27802116|NCT01994629|54257098|FG001|Overall Study|Lost to Follow-up|3|||
27802117|NCT01994395|54257106|FG000|Overall Study|Withdrawal by Subject|1|||
27802118|NCT01994395|54257107|FG001|Overall Study|Withdrawal by Subject|2|||
27802119|NCT01992536|54257123|FG000|Overall Study|Administrative Reason|0|||
27802120|NCT01992536|54257124|FG001|Overall Study|Administrative Reason|0|||
27802121|NCT01992536|54257125|FG002|Overall Study|Administrative Reason|0|||
27802122|NCT01992536|54257126|FG003|Overall Study|Administrative Reason|0|||
27802123|NCT01992536|54257127|FG004|Overall Study|Administrative Reason|0|||
27802124|NCT01992536|54257128|FG005|Overall Study|Administrative Reason|0|||
27802125|NCT01992536|54257129|FG006|Overall Study|Administrative Reason|7|||
27802126|NCT01992536|54257130|FG007|Overall Study|Administrative Reason|0|||
27802127|NCT01992536|54257131|FG008|Overall Study|Administrative Reason|0|||
28025677|NCT00715403|54684366|FG002|Overall Study|Other Adverse Event than DLT|0|||
28025678|NCT00715403|54684367|FG003|Overall Study|Other Adverse Event than DLT|0|||
27802128|NCT01992536|54257132|FG009|Overall Study|Administrative Reason|0|||
27842858|NCT01574651|54331757|FG000|Overall Study|Patient's inability to use the device|0|||
28025679|NCT00715403|54684368|FG004|Overall Study|Other Adverse Event than DLT|0|||
28025680|NCT00715403|54684369|FG005|Overall Study|Other Adverse Event than DLT|2|||
28025681|NCT00715403|54684370|FG006|Overall Study|Other Adverse Event than DLT|0|||
28025682|NCT00715403|54684364|FG000|Overall Study|Protocol Violation|0|||
28025683|NCT00715403|54684365|FG001|Overall Study|Protocol Violation|0|||
28025684|NCT00715403|54684366|FG002|Overall Study|Protocol Violation|0|||
28025685|NCT00715403|54684367|FG003|Overall Study|Protocol Violation|0|||
28025686|NCT00715403|54684368|FG004|Overall Study|Protocol Violation|0|||
28025687|NCT00715403|54684369|FG005|Overall Study|Protocol Violation|1|||
28025688|NCT00715403|54684370|FG006|Overall Study|Protocol Violation|0|||
28025689|NCT00715403|54684364|FG000|Overall Study|Other reason not defined above|0|||
28025690|NCT00715403|54684365|FG001|Overall Study|Other reason not defined above|0|||
28025691|NCT00715403|54684366|FG002|Overall Study|Other reason not defined above|1|||
28025692|NCT00715403|54684367|FG003|Overall Study|Other reason not defined above|0|||
28025693|NCT00715403|54684368|FG004|Overall Study|Other reason not defined above|1|||
28025694|NCT00715403|54684369|FG005|Overall Study|Other reason not defined above|1|||
28025695|NCT00715403|54684370|FG006|Overall Study|Other reason not defined above|0|||
28025696|NCT00502840|54684386|FG000|Overall Study|Adverse Event|5|||
28025697|NCT00502840|54684386|FG000|Overall Study|Additional or changed therapy|48|||
28025698|NCT00502840|54684386|FG000|Overall Study|Lack of Efficacy|11|||
28025699|NCT00502840|54684386|FG000|Overall Study|Protocol Violation|4|||
28025700|NCT00502840|54684386|FG000|Overall Study|Withdrawal by Subject|5|||
28025701|NCT00502840|54684386|FG000|Overall Study|Lost to Follow-up|6|||
28025702|NCT00502840|54684386|FG000|Overall Study|Administrative problems|1|||
27802129|NCT01992536|54257123|FG000|Overall Study|Lost to Follow-up|4|||
27802130|NCT01992536|54257124|FG001|Overall Study|Lost to Follow-up|2|||
27802131|NCT01992536|54257125|FG002|Overall Study|Lost to Follow-up|1|||
27802132|NCT01992536|54257126|FG003|Overall Study|Lost to Follow-up|0|||
27802133|NCT01992536|54257127|FG004|Overall Study|Lost to Follow-up|0|||
27802134|NCT01992536|54257128|FG005|Overall Study|Lost to Follow-up|1|||
27802135|NCT01992536|54257129|FG006|Overall Study|Lost to Follow-up|0|||
27802136|NCT01992536|54257130|FG007|Overall Study|Lost to Follow-up|0|||
27802137|NCT01992536|54257131|FG008|Overall Study|Lost to Follow-up|1|||
27802138|NCT01992536|54257132|FG009|Overall Study|Lost to Follow-up|1|||
27802139|NCT01992536|54257123|FG000|Overall Study|Withdrawal by Subject|0|||
27802140|NCT01992536|54257124|FG001|Overall Study|Withdrawal by Subject|1|||
27802141|NCT01992536|54257125|FG002|Overall Study|Withdrawal by Subject|0|||
27802142|NCT01992536|54257126|FG003|Overall Study|Withdrawal by Subject|2|||
27802143|NCT01992536|54257127|FG004|Overall Study|Withdrawal by Subject|0|||
27802144|NCT01992536|54257128|FG005|Overall Study|Withdrawal by Subject|0|||
27802145|NCT01992536|54257129|FG006|Overall Study|Withdrawal by Subject|0|||
27802146|NCT01992536|54257130|FG007|Overall Study|Withdrawal by Subject|0|||
27802147|NCT01992536|54257131|FG008|Overall Study|Withdrawal by Subject|0|||
27802148|NCT01992536|54257132|FG009|Overall Study|Withdrawal by Subject|0|||
27802149|NCT01993927|54257174|FG000|Overall Study|Case Report Forms Uncollected|18|||
27802150|NCT01993927|54257174|FG000|Overall Study|Protocol Violation|11|||
27802151|NCT02015390|54257180|FG000|Overall Study|Lost to Follow-up|1|||
27802152|NCT02015390|54257181|FG001|Overall Study|Lost to Follow-up|0|||
27802153|NCT02015390|54257180|FG000|Overall Study|Adverse Event|0|||
27802154|NCT02015390|54257181|FG001|Overall Study|Adverse Event|3|||
27802155|NCT02015390|54257180|FG000|Overall Study|Physician Decision|0|||
27802156|NCT02015390|54257181|FG001|Overall Study|Physician Decision|1|||
27802157|NCT02012959|54257188|FG000|Treatment Phase A|Adverse Event|2|||
27802158|NCT02012959|54257189|FG001|Treatment Phase A|Adverse Event|0|||
27802159|NCT02012959|54257190|FG002|Treatment Phase A|Adverse Event|0|||
27802160|NCT02012959|54257191|FG003|Treatment Phase A|Adverse Event|0|||
27802161|NCT02012959|54257192|FG004|Treatment Phase A|Adverse Event|0|||
27802162|NCT01990742|54257204|FG000|Overall Study|Withdrawal by facility|407|||
27802163|NCT01990742|54257205|FG001|Overall Study|Withdrawal by facility|1083|||
27802164|NCT01990742|54257204|FG000|Overall Study|Facility closed|0|||
27802165|NCT01990742|54257205|FG001|Overall Study|Facility closed|270|||
27802166|NCT02012491|54257213|FG000|Overall Study|Lost to Follow-up|1|||
27802167|NCT02012491|54257214|FG001|Overall Study|Lost to Follow-up|0|||
27802168|NCT02012491|54257213|FG000|Overall Study|Protocol Violation|0|||
27802169|NCT02012491|54257214|FG001|Overall Study|Protocol Violation|1|||
27802170|NCT02012491|54257213|FG000|Overall Study|Withdrawal by Subject|1|||
27802171|NCT02012491|54257214|FG001|Overall Study|Withdrawal by Subject|0|||
27802172|NCT01990664|54257222|FG000|Overall Study|Lost to Follow-up|2|||
27802173|NCT01990664|54257223|FG001|Overall Study|Lost to Follow-up|6|||
27802174|NCT01990664|54257222|FG000|Overall Study|Withdrawal by Subject|2|||
27802175|NCT01990664|54257223|FG001|Overall Study|Withdrawal by Subject|3|||
27802176|NCT01990664|54257222|FG000|Overall Study|Protocol Violation|1|||
27802177|NCT01990664|54257223|FG001|Overall Study|Protocol Violation|0|||
28025703|NCT00502840|54684386|FG000|Overall Study|Other|20|||
28025704|NCT00515008|54684393|FG000|Overall Study|Lost to Follow-up|1|||
28025705|NCT00515008|54684394|FG001|Overall Study|Lost to Follow-up|0|||
28025706|NCT00515008|54684393|FG000|Overall Study|Declined|0|||
28025707|NCT00515008|54684394|FG001|Overall Study|Declined|3|||
28025708|NCT00515008|54684393|FG000|Overall Study|Left the Boston Area|1|||
28025709|NCT00515008|54684394|FG001|Overall Study|Left the Boston Area|1|||
28025710|NCT00515008|54684393|FG000|Overall Study|Scheduling conflict|1|||
28025711|NCT00515008|54684394|FG001|Overall Study|Scheduling conflict|0|||
28025712|NCT00514540|54684403|FG000|First-Line Chemo|Withdrawal by Subject|1|||
28025713|NCT00514540|54684403|FG000|First-Line Chemo|Protocol Violation|7|||
28025714|NCT00514540|54684403|FG000|Second-Line|Physician/Patient Decision|31|||
28025715|NCT00506662|54684413|FG000|Overall Study|Adverse Event|0|||
28025716|NCT00506662|54684414|FG001|Overall Study|Adverse Event|2|||
28025717|NCT00506662|54684413|FG000|Overall Study|Lack of Efficacy|1|||
28025718|NCT00506662|54684414|FG001|Overall Study|Lack of Efficacy|0|||
28025719|NCT00506662|54684413|FG000|Overall Study|Protocol Violation|2|||
28025720|NCT00506662|54684414|FG001|Overall Study|Protocol Violation|4|||
28025721|NCT00506662|54684413|FG000|Overall Study|Trial terminated|10|||
28025722|NCT00506662|54684414|FG001|Overall Study|Trial terminated|16|||
28025723|NCT00506662|54684413|FG000|Overall Study|Not recorded|4|||
28025724|NCT00506662|54684414|FG001|Overall Study|Not recorded|6|||
28025725|NCT00713609|54684430|FG000|Overall Study|Adverse Event|2|||
28025726|NCT00713609|54684431|FG001|Overall Study|Adverse Event|0|||
28025727|NCT00713609|54684432|FG002|Overall Study|Adverse Event|2|||
28025728|NCT00713609|54684433|FG003|Overall Study|Adverse Event|2|||
28025729|NCT00713609|54684434|FG004|Overall Study|Adverse Event|3|||
28025730|NCT00713609|54684435|FG005|Overall Study|Adverse Event|1|||
28025731|NCT00713609|54684430|FG000|Overall Study|Lost to Follow-up|5|||
28025732|NCT00713609|54684431|FG001|Overall Study|Lost to Follow-up|7|||
28025733|NCT00713609|54684432|FG002|Overall Study|Lost to Follow-up|5|||
28025734|NCT00713609|54684433|FG003|Overall Study|Lost to Follow-up|5|||
28025735|NCT00713609|54684434|FG004|Overall Study|Lost to Follow-up|7|||
28025736|NCT00713609|54684435|FG005|Overall Study|Lost to Follow-up|0|||
28025737|NCT00713609|54684430|FG000|Overall Study|Lack of Efficacy|1|||
28025738|NCT00713609|54684431|FG001|Overall Study|Lack of Efficacy|3|||
28025739|NCT00713609|54684432|FG002|Overall Study|Lack of Efficacy|0|||
28025740|NCT00713609|54684433|FG003|Overall Study|Lack of Efficacy|0|||
28025741|NCT00713609|54684434|FG004|Overall Study|Lack of Efficacy|1|||
28025742|NCT00713609|54684435|FG005|Overall Study|Lack of Efficacy|0|||
28025743|NCT00713609|54684430|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
28025744|NCT00713609|54684431|FG001|Overall Study|Non-Compliance with Study Treatment|1|||
28025745|NCT00713609|54684432|FG002|Overall Study|Non-Compliance with Study Treatment|2|||
28025746|NCT00713609|54684433|FG003|Overall Study|Non-Compliance with Study Treatment|0|||
28025747|NCT00713609|54684434|FG004|Overall Study|Non-Compliance with Study Treatment|1|||
28025748|NCT00713609|54684435|FG005|Overall Study|Non-Compliance with Study Treatment|0|||
28025749|NCT00713609|54684430|FG000|Overall Study|Withdrawal by Subject|6|||
28025750|NCT00713609|54684431|FG001|Overall Study|Withdrawal by Subject|1|||
28025751|NCT00713609|54684432|FG002|Overall Study|Withdrawal by Subject|5|||
28025752|NCT00713609|54684433|FG003|Overall Study|Withdrawal by Subject|1|||
28025753|NCT00713609|54684434|FG004|Overall Study|Withdrawal by Subject|5|||
28025754|NCT00713609|54684435|FG005|Overall Study|Withdrawal by Subject|7|||
27802178|NCT01990664|54257222|FG000|Overall Study|Lens Discomfort|1|||
27802179|NCT01990664|54257223|FG001|Overall Study|Lens Discomfort|1|||
27802180|NCT01990664|54257222|FG000|Overall Study|Lens Handling Difficulties|1|||
27802181|NCT01990664|54257223|FG001|Overall Study|Lens Handling Difficulties|0|||
27802182|NCT01990664|54257222|FG000|Overall Study|Unsatisfactory Visual Response|0|||
27802183|NCT01990664|54257223|FG001|Overall Study|Unsatisfactory Visual Response|1|||
27802184|NCT02038010|54257229|FG000|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
27802185|NCT02038010|54257230|FG001|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1|||
27802186|NCT02038010|54257231|FG002|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
27802187|NCT02038010|54257232|FG003|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
27802188|NCT02038010|54257229|FG000|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1|||
27802189|NCT02038010|54257230|FG001|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
27802190|NCT02038010|54257231|FG002|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
27802191|NCT02038010|54257232|FG003|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
28025755|NCT00713609|54684430|FG000|Overall Study|Protocol Violation|6|||
28025756|NCT00713609|54684431|FG001|Overall Study|Protocol Violation|3|||
27802192|NCT02038010|54257229|FG000|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
28025757|NCT00713609|54684432|FG002|Overall Study|Protocol Violation|1|||
28025758|NCT00713609|54684433|FG003|Overall Study|Protocol Violation|1|||
28025759|NCT00713609|54684434|FG004|Overall Study|Protocol Violation|2|||
28025760|NCT00713609|54684435|FG005|Overall Study|Protocol Violation|0|||
27842859|NCT01574651|54331758|FG001|Overall Study|Patient's inability to use the device|1|||
28025761|NCT00513682|54684449|FG000|Washout Phase|Adverse Event|2|||
28025762|NCT00493012|54684458|FG000|Overall Study|Lost to Follow-up|18|||
28025763|NCT00493012|54684459|FG001|Overall Study|Lost to Follow-up|17|||
28025764|NCT05144477|54684467|FG000|Overall Study|Withdrawal by Subject|1|||
28025765|NCT05144477|54684468|FG001|Overall Study|Withdrawal by Subject|1|||
28025766|NCT00617708|54684484|FG000|Overall Study|Adverse Event|0|||
28025767|NCT00617708|54684485|FG001|Overall Study|Adverse Event|6|||
27802193|NCT02038010|54257230|FG001|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1|||
27802194|NCT02038010|54257231|FG002|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
27802195|NCT02038010|54257232|FG003|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
27802196|NCT02038010|54257229|FG000|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
27802197|NCT02038010|54257230|FG001|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
27802198|NCT02038010|54257231|FG002|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
28025768|NCT00617708|54684486|FG002|Overall Study|Adverse Event|9|||
28025769|NCT00617708|54684484|FG000|Overall Study|Withdrawal by Subject|1|||
28025770|NCT00617708|54684485|FG001|Overall Study|Withdrawal by Subject|1|||
28025771|NCT00617708|54684486|FG002|Overall Study|Withdrawal by Subject|7|||
28025772|NCT00617708|54684484|FG000|Overall Study|Death|0|||
28025773|NCT00617708|54684485|FG001|Overall Study|Death|6|||
28025774|NCT00617708|54684486|FG002|Overall Study|Death|5|||
28025775|NCT00617708|54684484|FG000|Overall Study|Progression/Relapse|7|||
28025776|NCT00617708|54684485|FG001|Overall Study|Progression/Relapse|40|||
28025777|NCT00617708|54684486|FG002|Overall Study|Progression/Relapse|36|||
28025778|NCT00617708|54684484|FG000|Overall Study|Not protocol specified|1|||
28025779|NCT00617708|54684485|FG001|Overall Study|Not protocol specified|4|||
28025780|NCT00617708|54684486|FG002|Overall Study|Not protocol specified|2|||
28025781|NCT00617708|54684484|FG000|Overall Study|Not eligible|1|||
28025782|NCT00617708|54684485|FG001|Overall Study|Not eligible|3|||
28025783|NCT00617708|54684486|FG002|Overall Study|Not eligible|5|||
28025784|NCT03894969|54684501|FG000|Overall Study|Adverse Event|0|||
28025785|NCT03894969|54684502|FG001|Overall Study|Adverse Event|2|||
28025786|NCT03894969|54684503|FG002|Overall Study|Adverse Event|0|||
28025787|NCT03894969|54684504|FG003|Overall Study|Adverse Event|1|||
28025788|NCT03894969|54684505|FG004|Overall Study|Adverse Event|2|||
28025789|NCT03894969|54684501|FG000|Overall Study|Lost to Follow-up|3|||
28025790|NCT03894969|54684502|FG001|Overall Study|Lost to Follow-up|1|||
28025791|NCT03894969|54684503|FG002|Overall Study|Lost to Follow-up|1|||
28025792|NCT03894969|54684504|FG003|Overall Study|Lost to Follow-up|0|||
28025793|NCT03894969|54684505|FG004|Overall Study|Lost to Follow-up|0|||
28025794|NCT03894969|54684501|FG000|Overall Study|Withdrawal by Subject|2|||
28025795|NCT03894969|54684502|FG001|Overall Study|Withdrawal by Subject|1|||
28025796|NCT03894969|54684503|FG002|Overall Study|Withdrawal by Subject|3|||
28025797|NCT03894969|54684504|FG003|Overall Study|Withdrawal by Subject|4|||
28025798|NCT03894969|54684505|FG004|Overall Study|Withdrawal by Subject|8|||
28025799|NCT03894969|54684501|FG000|Overall Study|Other|0|||
28025800|NCT03894969|54684502|FG001|Overall Study|Other|0|||
28025801|NCT03894969|54684503|FG002|Overall Study|Other|0|||
28025802|NCT03894969|54684504|FG003|Overall Study|Other|0|||
28025803|NCT03894969|54684505|FG004|Overall Study|Other|3|||
28025804|NCT03894969|54684501|FG000|Overall Study|Unsolicited Non-Serious Advers Event|0|||
28025805|NCT03894969|54684502|FG001|Overall Study|Unsolicited Non-Serious Advers Event|0|||
28025806|NCT03894969|54684503|FG002|Overall Study|Unsolicited Non-Serious Advers Event|0|||
28025807|NCT03894969|54684504|FG003|Overall Study|Unsolicited Non-Serious Advers Event|2|||
28025808|NCT03894969|54684505|FG004|Overall Study|Unsolicited Non-Serious Advers Event|1|||
27802199|NCT02038010|54257232|FG003|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
27802200|NCT02038010|54257229|FG000|Follow Up|Death|4|||
27802201|NCT02038010|54257230|FG001|Follow Up|Death|3|||
27802202|NCT02038010|54257231|FG002|Follow Up|Death|0|||
27802203|NCT02038010|54257232|FG003|Follow Up|Death|0|||
27802204|NCT02038010|54257229|FG000|Follow Up|Other|3|||
27802205|NCT02038010|54257230|FG001|Follow Up|Other|0|||
27802206|NCT02038010|54257231|FG002|Follow Up|Other|0|||
27802207|NCT02038010|54257232|FG003|Follow Up|Other|0|||
27802208|NCT01989572|54257246|FG000|Overall Study|Lack of Efficacy|35|||
27842860|NCT01574651|54331757|FG000|Overall Study|Adverse Event|36|||
27938960|NCT00963820|54595213|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
27938961|NCT00963820|54595214|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
27938962|NCT00963820|54595215|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
27938963|NCT00963820|54595216|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
27938964|NCT00963820|54595217|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
27938965|NCT00963820|54595218|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
27938966|NCT00963820|54595219|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
27938967|NCT00963820|54595220|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
27938968|NCT00963820|54595221|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
28025809|NCT03894969|54684501|FG000|Overall Study|Solicited Adverse Event|0|||
28025810|NCT03894969|54684502|FG001|Overall Study|Solicited Adverse Event|1|||
28025811|NCT03894969|54684503|FG002|Overall Study|Solicited Adverse Event|0|||
28025812|NCT03894969|54684504|FG003|Overall Study|Solicited Adverse Event|0|||
28025813|NCT03894969|54684505|FG004|Overall Study|Solicited Adverse Event|0|||
28025814|NCT03894813|54684521|FG000|Overall Study|Adverse Event|1|||
27802209|NCT01989572|54257247|FG001|Overall Study|Lack of Efficacy|48|||
27802210|NCT01989572|54257248|FG002|Overall Study|Lack of Efficacy|48|||
27842861|NCT01574651|54331758|FG001|Overall Study|Adverse Event|27|||
28025815|NCT03894813|54684522|FG001|Overall Study|Adverse Event|1|||
28025816|NCT03894813|54684521|FG000|Overall Study|Lack of Efficacy|3|||
28025817|NCT03894813|54684522|FG001|Overall Study|Lack of Efficacy|3|||
28025818|NCT03894813|54684521|FG000|Overall Study|Lost to Follow-up|1|||
28025819|NCT03894813|54684522|FG001|Overall Study|Lost to Follow-up|0|||
28025820|NCT03894813|54684521|FG000|Overall Study|Pregnancy|2|||
28025821|NCT03894813|54684522|FG001|Overall Study|Pregnancy|1|||
28025822|NCT03894813|54684521|FG000|Overall Study|Protocol Violation|3|||
28025823|NCT03894813|54684522|FG001|Overall Study|Protocol Violation|7|||
28025824|NCT03894813|54684521|FG000|Overall Study|Withdrawal by Subject|1|||
28025825|NCT03894813|54684522|FG001|Overall Study|Withdrawal by Subject|3|||
28025826|NCT03894813|54684521|FG000|Overall Study|Complain of the research staff and refused to continue the trial|0|||
28025827|NCT03894813|54684522|FG001|Overall Study|Complain of the research staff and refused to continue the trial|1|||
28025828|NCT00615992|54684528|FG000|Overall Study|Protocol Violation|67|||
28025829|NCT03892707|54684534|FG000|Overall Study|Screen failure|6|||
28025830|NCT03892707|54684535|FG001|Overall Study|Screen failure|0|||
28025831|NCT03892707|54684534|FG000|Overall Study|Pain resolution|0|||
28025832|NCT03892707|54684535|FG001|Overall Study|Pain resolution|4|||
28025833|NCT03892707|54684534|FG000|Overall Study|Withdrawal by Subject|0|||
28025834|NCT03892707|54684535|FG001|Overall Study|Withdrawal by Subject|1|||
28025835|NCT03892707|54684534|FG000|Overall Study|Other (long business trip)|0|||
28025836|NCT03892707|54684535|FG001|Overall Study|Other (long business trip)|1|||
28025837|NCT00615914|54684542|FG000|Overall Study|Adverse Event|274|||
28025838|NCT00615914|54684542|FG000|Overall Study|Death|20|||
28025839|NCT00615914|54684542|FG000|Overall Study|Lack of Efficacy|59|||
28025840|NCT00615914|54684542|FG000|Overall Study|Lost to Follow-up|187|||
28025841|NCT00615914|54684542|FG000|Overall Study|Withdrawal by Subject|16|||
28025842|NCT00615914|54684542|FG000|Overall Study|Physician Decision|4|||
28025843|NCT00615914|54684542|FG000|Overall Study|No data was collected.|65|||
28025844|NCT00615914|54684542|FG000|Overall Study|No treatment|2|||
28025845|NCT00615914|54684542|FG000|Overall Study|Irregularly enrolled patients|10|||
28025846|NCT00513604|54684552|FG000|Overall Study|Not treated|2|||
28025847|NCT00513604|54684553|FG001|Overall Study|Not treated|0|||
28025848|NCT00513604|54684554|FG002|Overall Study|Not treated|1|||
28025849|NCT00513604|54684555|FG003|Overall Study|Not treated|0|||
28025850|NCT00513604|54684556|FG004|Overall Study|Not treated|0|||
28025851|NCT00513604|54684552|FG000|Overall Study|Death during treatment|0|||
28025852|NCT00513604|54684553|FG001|Overall Study|Death during treatment|3|||
28025853|NCT00513604|54684554|FG002|Overall Study|Death during treatment|2|||
28025854|NCT00513604|54684555|FG003|Overall Study|Death during treatment|0|||
28025855|NCT00513604|54684556|FG004|Overall Study|Death during treatment|0|||
28025856|NCT00534105|54684570|FG000|Overall Study|Lost to Follow-up|23|||
28025857|NCT00534105|54684571|FG001|Overall Study|Lost to Follow-up|39|||
28025858|NCT00573248|54684586|FG000|Overall Study|scheduling conflicts|15|||
28025859|NCT00573248|54684587|FG001|Overall Study|scheduling conflicts|11|||
28025860|NCT00532935|54684595|FG000|Overall Study|Adverse Event|11|||
28025861|NCT00532935|54684596|FG001|Overall Study|Adverse Event|12|||
28025862|NCT00532935|54684595|FG000|Overall Study|Lack of Efficacy|0|||
28025863|NCT00532935|54684596|FG001|Overall Study|Lack of Efficacy|3|||
28025864|NCT00532935|54684595|FG000|Overall Study|Lost to Follow-up|10|||
28025865|NCT00532935|54684596|FG001|Overall Study|Lost to Follow-up|6|||
28025866|NCT00532935|54684595|FG000|Overall Study|Physician Decision|4|||
28025867|NCT00532935|54684596|FG001|Overall Study|Physician Decision|5|||
28025868|NCT00532935|54684595|FG000|Overall Study|Pregnancy|1|||
27938969|NCT00963820|54595222|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
27938970|NCT00963820|54595223|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
27938971|NCT00963820|54595212|FG000|Expansion Phase|Progressive Disease|0|||
27938972|NCT00963820|54595213|FG001|Expansion Phase|Progressive Disease|0|||
27938973|NCT00963820|54595214|FG002|Expansion Phase|Progressive Disease|0|||
27938974|NCT00963820|54595215|FG003|Expansion Phase|Progressive Disease|0|||
27938975|NCT00963820|54595216|FG004|Expansion Phase|Progressive Disease|0|||
27938976|NCT00963820|54595217|FG005|Expansion Phase|Progressive Disease|0|||
27938977|NCT00963820|54595218|FG006|Expansion Phase|Progressive Disease|0|||
27938978|NCT00963820|54595219|FG007|Expansion Phase|Progressive Disease|0|||
27938979|NCT00963820|54595220|FG008|Expansion Phase|Progressive Disease|8|||
28025869|NCT00532935|54684596|FG001|Overall Study|Pregnancy|0|||
28025870|NCT00532935|54684595|FG000|Overall Study|Protocol Violation|4|||
28025871|NCT00532935|54684596|FG001|Overall Study|Protocol Violation|2|||
28025872|NCT00532935|54684595|FG000|Overall Study|Withdrawal by Subject|10|||
28025873|NCT00532935|54684596|FG001|Overall Study|Withdrawal by Subject|9|||
28025874|NCT00532935|54684595|FG000|Overall Study|Protocol Specific Criteria|11|||
28025875|NCT00532935|54684596|FG001|Overall Study|Protocol Specific Criteria|15|||
28025876|NCT03016312|54684604|FG000|Overall Study|Death|194|||
28025877|NCT03016312|54684605|FG001|Overall Study|Death|164|||
28025878|NCT03016312|54684604|FG000|Overall Study|Lost to Follow-up|11|||
28025879|NCT03016312|54684605|FG001|Overall Study|Lost to Follow-up|12|||
28025880|NCT03016312|54684604|FG000|Overall Study|Started new therapy, loss of contact|2|||
28025881|NCT03016312|54684605|FG001|Overall Study|Started new therapy, loss of contact|1|||
28025882|NCT03016312|54684604|FG000|Overall Study|Physician Decision|0|||
28025883|NCT03016312|54684605|FG001|Overall Study|Physician Decision|2|||
28025884|NCT03016312|54684604|FG000|Overall Study|Withdrawal by Subject|34|||
28025885|NCT03016312|54684605|FG001|Overall Study|Withdrawal by Subject|39|||
28025886|NCT00512902|54684611|FG000|Overall Study|Adverse Event|7|||
28025887|NCT00512902|54684611|FG000|Overall Study|Lost to Follow-up|1|||
28025888|NCT00492232|54684617|FG000|Placebo Run-in|Adverse Event|0|||
28025889|NCT00492232|54684618|FG001|Placebo Run-in|Adverse Event|2|||
28025890|NCT00492232|54684617|FG000|Placebo Run-in|Protocol Violation|0|||
28025891|NCT00492232|54684618|FG001|Placebo Run-in|Protocol Violation|3|||
28025892|NCT00492232|54684617|FG000|Placebo Run-in|Lost to Follow-up|0|||
28025893|NCT00492232|54684618|FG001|Placebo Run-in|Lost to Follow-up|3|||
28025894|NCT00492232|54684617|FG000|Placebo Run-in|Withdrawal by Subject|0|||
28025895|NCT00492232|54684618|FG001|Placebo Run-in|Withdrawal by Subject|8|||
28025896|NCT00492232|54684617|FG000|Placebo Run-in|Pregnancy|0|||
28025897|NCT00492232|54684618|FG001|Placebo Run-in|Pregnancy|1|||
28025898|NCT00492232|54684617|FG000|Placebo Run-in|Entrance criteria not met|0|||
28025899|NCT00492232|54684618|FG001|Placebo Run-in|Entrance criteria not met|45|||
28025900|NCT00492232|54684617|FG000|Placebo Run-in|Other|0|||
28025901|NCT00492232|54684618|FG001|Placebo Run-in|Other|6|||
28025902|NCT00492232|54684617|FG000|Placebo Run-in|Missing|0|||
28105641|NCT04527471|54763168|FG000|Overall Study|Lost to Follow-up|1|||
28105642|NCT04527471|54763169|FG001|Overall Study|Lost to Follow-up|0|||
28105643|NCT04471935|54763175|FG000|Overall Study|Withdrawal by Subject|1|||
28105644|NCT04471935|54763175|FG000|Overall Study|Deemed ineligible to participate|1|||
28105645|NCT04468347|54763183|FG000|Overall Study|Withdrawal by Subject|0|||
28025903|NCT00492232|54684618|FG001|Placebo Run-in|Missing|2|||
28025904|NCT00492232|54684617|FG000|Double-Blind Treatment|Adverse Event|1|||
28025905|NCT00492232|54684618|FG001|Double-Blind Treatment|Adverse Event|2|||
28025906|NCT00492232|54684617|FG000|Double-Blind Treatment|Protocol Violation|3|||
28025907|NCT00492232|54684618|FG001|Double-Blind Treatment|Protocol Violation|7|||
28025908|NCT00492232|54684617|FG000|Double-Blind Treatment|Lost to Follow-up|2|||
28025909|NCT00492232|54684618|FG001|Double-Blind Treatment|Lost to Follow-up|3|||
28025910|NCT00492232|54684617|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
28025911|NCT00492232|54684618|FG001|Double-Blind Treatment|Withdrawal by Subject|8|||
28025912|NCT00492232|54684617|FG000|Double-Blind Treatment|Lack of Efficacy|1|||
27802211|NCT01989572|54257249|FG003|Overall Study|Lack of Efficacy|43|||
27802212|NCT01989572|54257250|FG004|Overall Study|Lack of Efficacy|71|||
27802213|NCT01989572|54257251|FG005|Overall Study|Lack of Efficacy|79|||
27802214|NCT01989572|54257246|FG000|Overall Study|Adverse Event|2|||
27802215|NCT01989572|54257247|FG001|Overall Study|Adverse Event|1|||
27802216|NCT01989572|54257248|FG002|Overall Study|Adverse Event|3|||
27802217|NCT01989572|54257249|FG003|Overall Study|Adverse Event|0|||
27802218|NCT01989572|54257250|FG004|Overall Study|Adverse Event|3|||
27802219|NCT01989572|54257251|FG005|Overall Study|Adverse Event|0|||
27842862|NCT01574651|54331757|FG000|Overall Study|Abnormal laboratory value(s)|1|||
28025913|NCT00492232|54684618|FG001|Double-Blind Treatment|Lack of Efficacy|0|||
28025914|NCT00492232|54684617|FG000|Double-Blind Treatment|Other|6|||
28025915|NCT00492232|54684618|FG001|Double-Blind Treatment|Other|5|||
28025916|NCT00492232|54684617|FG000|Double-Blind Treatment|Randomized not treated|1|||
28025917|NCT00492232|54684618|FG001|Double-Blind Treatment|Randomized not treated|0|||
28025918|NCT00492232|54684617|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
28025919|NCT00492232|54684618|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
28025920|NCT00491764|54684630|FG000|Overall Study|Adverse Event|1|||
28025921|NCT00491764|54684631|FG001|Overall Study|Adverse Event|2|||
28025922|NCT00491764|54684632|FG002|Overall Study|Adverse Event|4|||
28025923|NCT00491764|54684633|FG003|Overall Study|Adverse Event|4|||
28025924|NCT00491764|54684634|FG004|Overall Study|Adverse Event|0|||
28025925|NCT00491764|54684635|FG005|Overall Study|Adverse Event|1|||
28025926|NCT00491764|54684630|FG000|Overall Study|Lost to Follow-up|0|||
28025927|NCT00491764|54684631|FG001|Overall Study|Lost to Follow-up|1|||
28025928|NCT00491764|54684632|FG002|Overall Study|Lost to Follow-up|0|||
28025929|NCT00491764|54684633|FG003|Overall Study|Lost to Follow-up|1|||
28025930|NCT00491764|54684634|FG004|Overall Study|Lost to Follow-up|0|||
28025931|NCT00491764|54684635|FG005|Overall Study|Lost to Follow-up|3|||
28025932|NCT00491764|54684630|FG000|Overall Study|Withdrawal by Subject|2|||
28025933|NCT00491764|54684631|FG001|Overall Study|Withdrawal by Subject|3|||
28025934|NCT00491764|54684632|FG002|Overall Study|Withdrawal by Subject|1|||
28025935|NCT00491764|54684633|FG003|Overall Study|Withdrawal by Subject|2|||
28025936|NCT00491764|54684634|FG004|Overall Study|Withdrawal by Subject|2|||
27802220|NCT01989572|54257246|FG000|Overall Study|Death|0|||
27802221|NCT01989572|54257247|FG001|Overall Study|Death|0|||
27842863|NCT01574651|54331758|FG001|Overall Study|Abnormal laboratory value(s)|0|||
28025937|NCT00491764|54684635|FG005|Overall Study|Withdrawal by Subject|4|||
28025938|NCT00491764|54684630|FG000|Overall Study|Non Compliance with the Protocol|1|||
28105646|NCT04468347|54763184|FG001|Overall Study|Withdrawal by Subject|1|||
27842864|NCT01574651|54331757|FG000|Overall Study|Abnormal test procedure result(s)|1|||
28025939|NCT00491764|54684631|FG001|Overall Study|Non Compliance with the Protocol|0|||
27802222|NCT01989572|54257248|FG002|Overall Study|Death|0|||
27802223|NCT01989572|54257249|FG003|Overall Study|Death|0|||
27802224|NCT01989572|54257250|FG004|Overall Study|Death|1|||
27802225|NCT01989572|54257251|FG005|Overall Study|Death|0|||
27802226|NCT01989572|54257246|FG000|Overall Study|Withdrawal by Subject|4|||
27802227|NCT01989572|54257247|FG001|Overall Study|Withdrawal by Subject|1|||
27802228|NCT01989572|54257248|FG002|Overall Study|Withdrawal by Subject|5|||
27802229|NCT01989572|54257249|FG003|Overall Study|Withdrawal by Subject|1|||
27802230|NCT01989572|54257250|FG004|Overall Study|Withdrawal by Subject|12|||
27802231|NCT01989572|54257251|FG005|Overall Study|Withdrawal by Subject|4|||
27802232|NCT01989572|54257246|FG000|Overall Study|complicating disease|1|||
27802233|NCT01989572|54257247|FG001|Overall Study|complicating disease|1|||
27802234|NCT01989572|54257248|FG002|Overall Study|complicating disease|2|||
27802235|NCT01989572|54257249|FG003|Overall Study|complicating disease|0|||
27802236|NCT01989572|54257250|FG004|Overall Study|complicating disease|1|||
27802237|NCT01989572|54257251|FG005|Overall Study|complicating disease|0|||
28025940|NCT00491764|54684632|FG002|Overall Study|Non Compliance with the Protocol|0|||
28025941|NCT00491764|54684633|FG003|Overall Study|Non Compliance with the Protocol|0|||
28025942|NCT00491764|54684634|FG004|Overall Study|Non Compliance with the Protocol|0|||
28025943|NCT00491764|54684635|FG005|Overall Study|Non Compliance with the Protocol|0|||
28025944|NCT00491764|54684630|FG000|Overall Study|Did not Meet Protocol Eligibility|0|||
28025945|NCT00491764|54684631|FG001|Overall Study|Did not Meet Protocol Eligibility|1|||
28025946|NCT00491764|54684632|FG002|Overall Study|Did not Meet Protocol Eligibility|1|||
28025947|NCT00491764|54684633|FG003|Overall Study|Did not Meet Protocol Eligibility|0|||
28025948|NCT00491764|54684634|FG004|Overall Study|Did not Meet Protocol Eligibility|1|||
28025949|NCT00491764|54684635|FG005|Overall Study|Did not Meet Protocol Eligibility|1|||
28025950|NCT00491764|54684630|FG000|Overall Study|Administrative|1|||
28025951|NCT00491764|54684631|FG001|Overall Study|Administrative|0|||
28025952|NCT00491764|54684632|FG002|Overall Study|Administrative|2|||
28025953|NCT00491764|54684633|FG003|Overall Study|Administrative|1|||
28025954|NCT00491764|54684634|FG004|Overall Study|Administrative|0|||
28025955|NCT00491764|54684635|FG005|Overall Study|Administrative|0|||
28025956|NCT00491608|54684649|FG000|Overall Study|Death|2|||
28025957|NCT00491608|54684649|FG000|Overall Study|Withdrawal by Subject|1|||
27802238|NCT01989572|54257246|FG000|Overall Study|error|2|||
28025958|NCT00615836|54684657|FG000|Extension Study (FE992026 CS31)|Adverse Event|7|||
28025959|NCT00615836|54684658|FG001|Extension Study (FE992026 CS31)|Adverse Event|12|||
28025960|NCT00615836|54684659|FG002|Extension Study (FE992026 CS31)|Adverse Event|15|||
28025961|NCT00615836|54684660|FG003|Extension Study (FE992026 CS31)|Adverse Event|13|||
28025962|NCT00615836|54684661|FG004|Extension Study (FE992026 CS31)|Adverse Event|0|||
28025963|NCT00615836|54684657|FG000|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1|||
28025964|NCT00615836|54684658|FG001|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
28025965|NCT00615836|54684659|FG002|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
28025966|NCT00615836|54684660|FG003|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
28025967|NCT00615836|54684661|FG004|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
28025968|NCT00615836|54684657|FG000|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
28025969|NCT00615836|54684658|FG001|Extension Study (FE992026 CS31)|Use of exclusionary medication|2|||
28025970|NCT00615836|54684659|FG002|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
28025971|NCT00615836|54684660|FG003|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
28025972|NCT00615836|54684661|FG004|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
28025973|NCT00615836|54684657|FG000|Extension Study (FE992026 CS31)|Protocol Violation|4|||
27802239|NCT01989572|54257247|FG001|Overall Study|error|1|||
27802240|NCT01989572|54257248|FG002|Overall Study|error|1|||
28025974|NCT00615836|54684658|FG001|Extension Study (FE992026 CS31)|Protocol Violation|5|||
28025975|NCT00615836|54684659|FG002|Extension Study (FE992026 CS31)|Protocol Violation|2|||
28025976|NCT00615836|54684660|FG003|Extension Study (FE992026 CS31)|Protocol Violation|3|||
28025977|NCT00615836|54684661|FG004|Extension Study (FE992026 CS31)|Protocol Violation|0|||
28025978|NCT00615836|54684657|FG000|Extension Study (FE992026 CS31)|Withdrawal by Subject|37|||
28025979|NCT00615836|54684658|FG001|Extension Study (FE992026 CS31)|Withdrawal by Subject|42|||
28025980|NCT00615836|54684659|FG002|Extension Study (FE992026 CS31)|Withdrawal by Subject|38|||
28025981|NCT00615836|54684660|FG003|Extension Study (FE992026 CS31)|Withdrawal by Subject|43|||
28025982|NCT00615836|54684661|FG004|Extension Study (FE992026 CS31)|Withdrawal by Subject|0|||
28025983|NCT00615836|54684657|FG000|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
28025984|NCT00615836|54684658|FG001|Extension Study (FE992026 CS31)|Lost to Follow-up|14|||
27802241|NCT01989572|54257249|FG003|Overall Study|error|1|||
27802242|NCT01989572|54257250|FG004|Overall Study|error|1|||
27802243|NCT01989572|54257251|FG005|Overall Study|error|1|||
27802244|NCT01989572|54257246|FG000|Overall Study|maximum dose reached|0|||
27802245|NCT01989572|54257247|FG001|Overall Study|maximum dose reached|1|||
27802246|NCT01989572|54257248|FG002|Overall Study|maximum dose reached|0|||
27802247|NCT01989572|54257249|FG003|Overall Study|maximum dose reached|0|||
27802248|NCT01989572|54257250|FG004|Overall Study|maximum dose reached|1|||
28025985|NCT00615836|54684659|FG002|Extension Study (FE992026 CS31)|Lost to Follow-up|5|||
28025986|NCT00615836|54684660|FG003|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
28025987|NCT00615836|54684661|FG004|Extension Study (FE992026 CS31)|Lost to Follow-up|0|||
28025988|NCT00615836|54684657|FG000|Extension Study (FE992026 CS31)|Other|10|||
28025989|NCT00615836|54684658|FG001|Extension Study (FE992026 CS31)|Other|7|||
28025990|NCT00615836|54684659|FG002|Extension Study (FE992026 CS31)|Other|8|||
28025991|NCT00615836|54684660|FG003|Extension Study (FE992026 CS31)|Other|8|||
28025992|NCT00615836|54684661|FG004|Extension Study (FE992026 CS31)|Other|0|||
28025993|NCT00615836|54684657|FG000|Extension Study (FE992026 CS31)|Not reported|6|||
28025994|NCT00615836|54684658|FG001|Extension Study (FE992026 CS31)|Not reported|4|||
28025995|NCT00615836|54684659|FG002|Extension Study (FE992026 CS31)|Not reported|1|||
28025996|NCT00615836|54684660|FG003|Extension Study (FE992026 CS31)|Not reported|4|||
28025997|NCT00615836|54684661|FG004|Extension Study (FE992026 CS31)|Not reported|0|||
28025998|NCT00615836|54684657|FG000|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65|||
28025999|NCT00615836|54684658|FG001|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
28026000|NCT00615836|54684659|FG002|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
28026001|NCT00615836|54684660|FG003|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
28026002|NCT00615836|54684661|FG004|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
28026003|NCT00491530|54684680|FG000|Overall Study|Adverse Event|6|||
28026004|NCT00491530|54684681|FG001|Overall Study|Adverse Event|1|||
28026005|NCT00491530|54684682|FG002|Overall Study|Adverse Event|2|||
28026006|NCT00491530|54684680|FG000|Overall Study|Withdrawal by Subject|3|||
28026007|NCT00491530|54684681|FG001|Overall Study|Withdrawal by Subject|0|||
28026008|NCT00491530|54684682|FG002|Overall Study|Withdrawal by Subject|0|||
28026009|NCT00491530|54684680|FG000|Overall Study|Lost to Follow-up|3|||
28026010|NCT00491530|54684681|FG001|Overall Study|Lost to Follow-up|2|||
28026011|NCT00491530|54684682|FG002|Overall Study|Lost to Follow-up|2|||
28026012|NCT00491530|54684680|FG000|Overall Study|Lack of Efficacy|0|||
28026013|NCT00491530|54684681|FG001|Overall Study|Lack of Efficacy|1|||
28026014|NCT00491530|54684682|FG002|Overall Study|Lack of Efficacy|0|||
28026015|NCT00491530|54684680|FG000|Overall Study|Investigator Discretion|0|||
28026016|NCT00491530|54684681|FG001|Overall Study|Investigator Discretion|1|||
28026017|NCT00491530|54684682|FG002|Overall Study|Investigator Discretion|0|||
28026018|NCT00491530|54684680|FG000|Overall Study|Patient Request|0|||
28026019|NCT00491530|54684681|FG001|Overall Study|Patient Request|1|||
28026020|NCT00491530|54684682|FG002|Overall Study|Patient Request|0|||
28026021|NCT00491530|54684680|FG000|Overall Study|Use of Prohibited Medication|0|||
28026022|NCT00491530|54684681|FG001|Overall Study|Use of Prohibited Medication|0|||
28026023|NCT00491530|54684682|FG002|Overall Study|Use of Prohibited Medication|1|||
28026024|NCT00617240|54684692|FG000|Overall Study|Lack of Efficacy|1|||
28026025|NCT00617240|54684693|FG001|Overall Study|Lack of Efficacy|0|||
28026026|NCT00615290|54684699|FG000|Overall Study|Adverse Event|2|||
28026027|NCT00615290|54684699|FG000|Overall Study|Lost to Follow-up|3|||
28026028|NCT00615290|54684699|FG000|Overall Study|Withdrawal by Subject|1|||
28026029|NCT00615290|54684699|FG000|Overall Study|Other|2|||
28026030|NCT00501046|54684705|FG000|Overall Study|Adverse Event|21|||
28026031|NCT00501046|54684706|FG001|Overall Study|Adverse Event|25|||
28026032|NCT00501046|54684705|FG000|Overall Study|Death|23|||
28026033|NCT00501046|54684706|FG001|Overall Study|Death|30|||
28026034|NCT00501046|54684705|FG000|Overall Study|Lost to Follow-up|14|||
28026035|NCT00501046|54684706|FG001|Overall Study|Lost to Follow-up|13|||
28026036|NCT00501046|54684705|FG000|Overall Study|Physician Decision|7|||
28026037|NCT00501046|54684706|FG001|Overall Study|Physician Decision|2|||
28026038|NCT00501046|54684705|FG000|Overall Study|Pregnancy|0|||
28026039|NCT00501046|54684706|FG001|Overall Study|Pregnancy|3|||
28026040|NCT00501046|54684705|FG000|Overall Study|Protocol Violation|2|||
28026041|NCT00501046|54684706|FG001|Overall Study|Protocol Violation|1|||
28026042|NCT00501046|54684705|FG000|Overall Study|Withdrawal by Subject|84|||
28026043|NCT00501046|54684706|FG001|Overall Study|Withdrawal by Subject|83|||
28026044|NCT00501046|54684705|FG000|Overall Study|Reaching endpoints,Noncompliance,etc|119|||
28026045|NCT00501046|54684706|FG001|Overall Study|Reaching endpoints,Noncompliance,etc|137|||
28026046|NCT00533949|54684716|FG000|Overall Study|Protocol Violation|12|||
28026047|NCT00533949|54684717|FG001|Overall Study|Protocol Violation|12|||
28026048|NCT00533949|54684718|FG002|Overall Study|Protocol Violation|9|||
28026049|NCT00533949|54684719|FG003|Overall Study|Protocol Violation|9|||
28026050|NCT00533949|54684716|FG000|Overall Study|Withdrawal by Subject|3|||
28026051|NCT00533949|54684717|FG001|Overall Study|Withdrawal by Subject|2|||
28026052|NCT00533949|54684718|FG002|Overall Study|Withdrawal by Subject|1|||
28026053|NCT00533949|54684719|FG003|Overall Study|Withdrawal by Subject|1|||
28026054|NCT00485134|54684745|FG000|Overall Study|Lost to Follow-up|1|||
28026055|NCT00485134|54684746|FG001|Overall Study|Lost to Follow-up|0|||
28026056|NCT00485134|54684747|FG002|Overall Study|Lost to Follow-up|0|||
28026057|NCT00485134|54684748|FG003|Overall Study|Lost to Follow-up|0|||
28026058|NCT00485134|54684749|FG004|Overall Study|Lost to Follow-up|0|||
28026059|NCT00485134|54684750|FG005|Overall Study|Lost to Follow-up|0|||
28105647|NCT04468347|54763185|FG002|Overall Study|Withdrawal by Subject|3|||
28026060|NCT00485134|54684751|FG006|Overall Study|Lost to Follow-up|0|||
28026061|NCT00485134|54684752|FG007|Overall Study|Lost to Follow-up|0|||
28026062|NCT00485134|54684745|FG000|Overall Study|Withdrawal by Subject|0|||
28026063|NCT00485134|54684746|FG001|Overall Study|Withdrawal by Subject|1|||
28026064|NCT00485134|54684747|FG002|Overall Study|Withdrawal by Subject|0|||
28026065|NCT00485134|54684748|FG003|Overall Study|Withdrawal by Subject|0|||
28026066|NCT00485134|54684749|FG004|Overall Study|Withdrawal by Subject|0|||
28026067|NCT00485134|54684750|FG005|Overall Study|Withdrawal by Subject|0|||
28026068|NCT00485134|54684751|FG006|Overall Study|Withdrawal by Subject|0|||
28026069|NCT00485134|54684752|FG007|Overall Study|Withdrawal by Subject|0|||
28026070|NCT00485134|54684745|FG000|Overall Study|Change in health status|0|||
28026071|NCT00485134|54684746|FG001|Overall Study|Change in health status|1|||
28026072|NCT00485134|54684747|FG002|Overall Study|Change in health status|2|||
28026073|NCT00485134|54684748|FG003|Overall Study|Change in health status|1|||
28026074|NCT00485134|54684749|FG004|Overall Study|Change in health status|0|||
28026075|NCT00485134|54684750|FG005|Overall Study|Change in health status|1|||
28026076|NCT00485134|54684751|FG006|Overall Study|Change in health status|0|||
28026077|NCT00485134|54684752|FG007|Overall Study|Change in health status|0|||
28026078|NCT00485134|54684745|FG000|Overall Study|Withdrew for adverse event|0|||
28026079|NCT00485134|54684746|FG001|Overall Study|Withdrew for adverse event|0|||
28026080|NCT00485134|54684747|FG002|Overall Study|Withdrew for adverse event|1|||
28026081|NCT00485134|54684748|FG003|Overall Study|Withdrew for adverse event|0|||
27802249|NCT01989572|54257251|FG005|Overall Study|maximum dose reached|0|||
27802250|NCT01989572|54257246|FG000|Overall Study|unknown/not specify|3|||
28026082|NCT00485134|54684749|FG004|Overall Study|Withdrew for adverse event|0|||
27802251|NCT01989572|54257247|FG001|Overall Study|unknown/not specify|4|||
27802252|NCT01989572|54257248|FG002|Overall Study|unknown/not specify|1|||
27802253|NCT01989572|54257249|FG003|Overall Study|unknown/not specify|3|||
27802254|NCT01989572|54257250|FG004|Overall Study|unknown/not specify|3|||
27802255|NCT01989572|54257251|FG005|Overall Study|unknown/not specify|5|||
27802256|NCT01989572|54257246|FG000|Overall Study|not start protocol therapy|5|||
27802257|NCT01989572|54257247|FG001|Overall Study|not start protocol therapy|1|||
27802258|NCT01989572|54257248|FG002|Overall Study|not start protocol therapy|2|||
27802259|NCT01989572|54257249|FG003|Overall Study|not start protocol therapy|3|||
27802260|NCT01989572|54257250|FG004|Overall Study|not start protocol therapy|4|||
27802261|NCT01989572|54257251|FG005|Overall Study|not start protocol therapy|18|||
27802262|NCT01989572|54257246|FG000|Overall Study|alternative therapy|3|||
27802263|NCT01989572|54257247|FG001|Overall Study|alternative therapy|0|||
27802264|NCT01989572|54257248|FG002|Overall Study|alternative therapy|0|||
27802265|NCT01989572|54257249|FG003|Overall Study|alternative therapy|0|||
27802266|NCT01989572|54257250|FG004|Overall Study|alternative therapy|1|||
27802267|NCT01989572|54257251|FG005|Overall Study|alternative therapy|3|||
27802268|NCT02036294|54257271|FG000|Overall Study|Death|7|||
27802269|NCT02036294|54257272|FG001|Overall Study|Death|8|||
27802270|NCT02036294|54257271|FG000|Overall Study|Withdrawal by Subject|2|||
27802271|NCT02036294|54257272|FG001|Overall Study|Withdrawal by Subject|3|||
27802272|NCT02035748|54257278|FG000|Overall Study|Adverse Event|5|||
27802273|NCT02035748|54257278|FG000|Overall Study|Death|3|||
28026083|NCT00485134|54684750|FG005|Overall Study|Withdrew for adverse event|0|||
28026084|NCT00485134|54684751|FG006|Overall Study|Withdrew for adverse event|0|||
28026085|NCT00485134|54684752|FG007|Overall Study|Withdrew for adverse event|0|||
28026086|NCT00485134|54684745|FG000|Overall Study|Positive drug test|0|||
28026087|NCT00485134|54684746|FG001|Overall Study|Positive drug test|0|||
28026088|NCT00485134|54684747|FG002|Overall Study|Positive drug test|0|||
28026089|NCT00485134|54684748|FG003|Overall Study|Positive drug test|0|||
28026090|NCT00485134|54684749|FG004|Overall Study|Positive drug test|2|||
28026091|NCT00485134|54684750|FG005|Overall Study|Positive drug test|1|||
28026092|NCT00485134|54684751|FG006|Overall Study|Positive drug test|0|||
28026093|NCT00485134|54684752|FG007|Overall Study|Positive drug test|0|||
28026094|NCT00485134|54684745|FG000|Overall Study|Non-compliance|0|||
28026095|NCT00485134|54684746|FG001|Overall Study|Non-compliance|0|||
28026096|NCT00485134|54684747|FG002|Overall Study|Non-compliance|0|||
28026097|NCT00485134|54684748|FG003|Overall Study|Non-compliance|0|||
28026098|NCT00485134|54684749|FG004|Overall Study|Non-compliance|1|||
28026099|NCT00485134|54684750|FG005|Overall Study|Non-compliance|2|||
28026100|NCT00485134|54684751|FG006|Overall Study|Non-compliance|2|||
28026101|NCT00485134|54684752|FG007|Overall Study|Non-compliance|0|||
28026102|NCT00485134|54684745|FG000|Overall Study|Unable to comply with study schedule|0|||
28026103|NCT00485134|54684746|FG001|Overall Study|Unable to comply with study schedule|0|||
28026104|NCT00485134|54684747|FG002|Overall Study|Unable to comply with study schedule|0|||
28026105|NCT00485134|54684748|FG003|Overall Study|Unable to comply with study schedule|0|||
27802274|NCT02035748|54257278|FG000|Overall Study|Lost to Follow-up|2|||
27802275|NCT02035748|54257278|FG000|Overall Study|Physician Decision|3|||
28026106|NCT00485134|54684749|FG004|Overall Study|Unable to comply with study schedule|0|||
27802276|NCT02035748|54257278|FG000|Overall Study|Withdrawal by Subject|6|||
27802277|NCT02035748|54257278|FG000|Overall Study|Progressive Disease|1|||
28026107|NCT00485134|54684750|FG005|Overall Study|Unable to comply with study schedule|0|||
28026108|NCT00485134|54684751|FG006|Overall Study|Unable to comply with study schedule|0|||
28026109|NCT00485134|54684752|FG007|Overall Study|Unable to comply with study schedule|1|||
28026110|NCT00485134|54684745|FG000|Overall Study|Pregnancy|0|||
28026111|NCT00485134|54684746|FG001|Overall Study|Pregnancy|0|||
28026112|NCT00485134|54684747|FG002|Overall Study|Pregnancy|0|||
28026113|NCT00485134|54684748|FG003|Overall Study|Pregnancy|0|||
28026114|NCT00485134|54684749|FG004|Overall Study|Pregnancy|0|||
28026115|NCT00485134|54684750|FG005|Overall Study|Pregnancy|0|||
28026116|NCT00485134|54684751|FG006|Overall Study|Pregnancy|1|||
28026117|NCT00485134|54684752|FG007|Overall Study|Pregnancy|0|||
28026118|NCT03890367|54684767|FG000|Overall Study|Withdrawal by parent/guardian|1|||
28026119|NCT03890367|54684768|FG001|Overall Study|Withdrawal by parent/guardian|3|||
28026120|NCT03890367|54684769|FG002|Overall Study|Withdrawal by parent/guardian|0|||
28026121|NCT03890367|54684767|FG000|Overall Study|Protocol deviation|2|||
28026122|NCT03890367|54684768|FG001|Overall Study|Protocol deviation|2|||
28026123|NCT03890367|54684769|FG002|Overall Study|Protocol deviation|1|||
28026124|NCT03890367|54684767|FG000|Overall Study|Lost to Follow-up|1|||
28026125|NCT03890367|54684768|FG001|Overall Study|Lost to Follow-up|1|||
28026126|NCT03890367|54684769|FG002|Overall Study|Lost to Follow-up|0|||
28026127|NCT00583115|54684777|FG000|Overall Study|Death|1|||
28026128|NCT00532779|54684784|FG000|Overall Study|Adverse Event|122|||
28026129|NCT00532779|54684785|FG001|Overall Study|Adverse Event|112|||
28026130|NCT00532779|54684786|FG002|Overall Study|Adverse Event|56|||
28026131|NCT00532779|54684784|FG000|Overall Study|Lost to Follow-up|76|||
28026132|NCT00532779|54684785|FG001|Overall Study|Lost to Follow-up|65|||
28026133|NCT00532779|54684786|FG002|Overall Study|Lost to Follow-up|66|||
28026134|NCT00532779|54684784|FG000|Overall Study|Withdrawal by Subject|63|||
28026135|NCT00532779|54684785|FG001|Overall Study|Withdrawal by Subject|60|||
28026136|NCT00532779|54684786|FG002|Overall Study|Withdrawal by Subject|90|||
28026137|NCT00532779|54684784|FG000|Overall Study|Lack of Efficacy|12|||
28026138|NCT00532779|54684785|FG001|Overall Study|Lack of Efficacy|12|||
28026139|NCT00532779|54684786|FG002|Overall Study|Lack of Efficacy|40|||
28026140|NCT00532779|54684784|FG000|Overall Study|Protocol Violation|5|||
28026141|NCT00532779|54684785|FG001|Overall Study|Protocol Violation|9|||
28026142|NCT00532779|54684786|FG002|Overall Study|Protocol Violation|7|||
28026143|NCT00532779|54684784|FG000|Overall Study|Pregnancy|2|||
28026144|NCT00532779|54684785|FG001|Overall Study|Pregnancy|5|||
28026145|NCT00532779|54684786|FG002|Overall Study|Pregnancy|3|||
28026146|NCT00532779|54684784|FG000|Overall Study|Death|0|||
28026147|NCT00532779|54684785|FG001|Overall Study|Death|1|||
28026148|NCT00532779|54684786|FG002|Overall Study|Death|0|||
28026149|NCT00532779|54684784|FG000|Overall Study|Drug noncompliance, moved, other|14|||
28026150|NCT00532779|54684785|FG001|Overall Study|Drug noncompliance, moved, other|23|||
28026151|NCT00532779|54684786|FG002|Overall Study|Drug noncompliance, moved, other|29|||
28026152|NCT00500266|54684794|FG000|Overall Study|Death|3|||
28026153|NCT00500266|54684794|FG000|Overall Study|Lost to Follow-up|3|||
28026154|NCT00500266|54684794|FG000|Overall Study|Withdrawal by Subject|3|||
28026155|NCT00500266|54684794|FG000|Overall Study|Assigned, not treated|4|||
28026156|NCT00500110|54684799|FG000|Overall Study|Withdrawal by Subject|3|||
28026157|NCT00534495|54684805|FG000|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
28026158|NCT00534495|54684806|FG001|Double Blind Placebo Phase Week 0-4|randomized in error|1|||
28026159|NCT00534495|54684807|FG002|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
28026160|NCT00534495|54684805|FG000|All Active Treatment Phase Week 4-24|Adverse Event|1|||
28026161|NCT00534495|54684806|FG001|All Active Treatment Phase Week 4-24|Adverse Event|0|||
28026162|NCT00534495|54684807|FG002|All Active Treatment Phase Week 4-24|Adverse Event|0|||
28026163|NCT00534495|54684805|FG000|All Active Treatment Phase Week 4-24|Lack of Efficacy|1|||
28026164|NCT00534495|54684806|FG001|All Active Treatment Phase Week 4-24|Lack of Efficacy|7|||
28026165|NCT00534495|54684807|FG002|All Active Treatment Phase Week 4-24|Lack of Efficacy|0|||
28026166|NCT00534495|54684805|FG000|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
28026167|NCT00534495|54684806|FG001|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
28026168|NCT00534495|54684807|FG002|All Active Treatment Phase Week 4-24|Lost to Follow-up|0|||
28026169|NCT00534495|54684805|FG000|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
28026170|NCT00534495|54684806|FG001|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
28026171|NCT00534495|54684807|FG002|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0|||
28026172|NCT00534495|54684805|FG000|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
28026173|NCT00534495|54684806|FG001|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
27938980|NCT00963820|54595221|FG009|Expansion Phase|Progressive Disease|6|||
27938981|NCT00963820|54595222|FG010|Expansion Phase|Progressive Disease|4|||
27938982|NCT00963820|54595223|FG011|Expansion Phase|Progressive Disease|2|||
27938983|NCT00963820|54595212|FG000|Expansion Phase|Adverse Event|0|||
27938984|NCT00963820|54595213|FG001|Expansion Phase|Adverse Event|0|||
27938985|NCT00963820|54595214|FG002|Expansion Phase|Adverse Event|0|||
27938986|NCT00963820|54595215|FG003|Expansion Phase|Adverse Event|0|||
27938987|NCT00963820|54595216|FG004|Expansion Phase|Adverse Event|0|||
27938988|NCT00963820|54595217|FG005|Expansion Phase|Adverse Event|0|||
28026174|NCT00534495|54684807|FG002|Long Term Ext. Phase Week 24-month 21|Adverse Event|1|||
28026175|NCT00534495|54684805|FG000|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
28026176|NCT00534495|54684806|FG001|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
28026177|NCT00534495|54684807|FG002|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5|||
28026178|NCT00534495|54684805|FG000|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
28026179|NCT00534495|54684806|FG001|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
28026180|NCT00534495|54684807|FG002|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3|||
28026181|NCT00534495|54684805|FG000|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
28026182|NCT00534495|54684806|FG001|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
28026183|NCT00534495|54684807|FG002|Long Term Ext. Phase Week 24-month 21|non compliance|2|||
28026184|NCT00484198|54684831|FG000|Overall Study|Participant Withdrew Consent|12|||
28026185|NCT00484198|54684832|FG001|Overall Study|Participant Withdrew Consent|21|||
28026186|NCT00484198|54684833|FG002|Overall Study|Participant Withdrew Consent|47|||
28026187|NCT00484198|54684834|FG003|Overall Study|Participant Withdrew Consent|59|||
28026188|NCT00484198|54684831|FG000|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|16|||
28026189|NCT00484198|54684832|FG001|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|17|||
28026190|NCT00484198|54684833|FG002|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|29|||
28026191|NCT00484198|54684834|FG003|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|38|||
28026192|NCT00484198|54684831|FG000|Overall Study|Therapeutic failure/ lack of efficacy|3|||
28026193|NCT00484198|54684832|FG001|Overall Study|Therapeutic failure/ lack of efficacy|2|||
28026194|NCT00484198|54684833|FG002|Overall Study|Therapeutic failure/ lack of efficacy|6|||
28026195|NCT00484198|54684834|FG003|Overall Study|Therapeutic failure/ lack of efficacy|8|||
28026196|NCT00484198|54684831|FG000|Overall Study|Adverse Event|3|||
28026197|NCT00484198|54684832|FG001|Overall Study|Adverse Event|11|||
28026198|NCT00484198|54684833|FG002|Overall Study|Adverse Event|32|||
28026199|NCT00484198|54684834|FG003|Overall Study|Adverse Event|31|||
28026200|NCT00484198|54684831|FG000|Overall Study|Protocol Violation|0|||
28026201|NCT00484198|54684832|FG001|Overall Study|Protocol Violation|5|||
28026202|NCT00484198|54684833|FG002|Overall Study|Protocol Violation|6|||
28026203|NCT00484198|54684834|FG003|Overall Study|Protocol Violation|8|||
28026204|NCT00484198|54684831|FG000|Overall Study|Other|7|||
28026205|NCT00484198|54684832|FG001|Overall Study|Other|10|||
28026206|NCT00484198|54684833|FG002|Overall Study|Other|31|||
28026207|NCT00484198|54684834|FG003|Overall Study|Other|28|||
28026208|NCT00499486|54684849|FG000|Overall Study|Withdrawal by Subject|16|||
28026209|NCT00499252|54684853|FG000|Overall Study|Adverse Event|3|||
28026210|NCT00499252|54684853|FG000|Overall Study|Refused further treatment|2|||
27938989|NCT00963820|54595218|FG006|Expansion Phase|Adverse Event|0|||
27938990|NCT00963820|54595219|FG007|Expansion Phase|Adverse Event|0|||
27938991|NCT00963820|54595220|FG008|Expansion Phase|Adverse Event|1|||
27938992|NCT00963820|54595221|FG009|Expansion Phase|Adverse Event|3|||
27938993|NCT00963820|54595222|FG010|Expansion Phase|Adverse Event|0|||
27938994|NCT00963820|54595223|FG011|Expansion Phase|Adverse Event|0|||
27938995|NCT00963820|54595212|FG000|Expansion Phase|Withdrawal by Subject|0|||
27938996|NCT00963820|54595213|FG001|Expansion Phase|Withdrawal by Subject|0|||
27938997|NCT00963820|54595214|FG002|Expansion Phase|Withdrawal by Subject|0|||
27938998|NCT00963820|54595215|FG003|Expansion Phase|Withdrawal by Subject|0|||
27938999|NCT00963820|54595216|FG004|Expansion Phase|Withdrawal by Subject|0|||
27939000|NCT00963820|54595217|FG005|Expansion Phase|Withdrawal by Subject|0|||
27939001|NCT00963820|54595218|FG006|Expansion Phase|Withdrawal by Subject|0|||
27939002|NCT00963820|54595219|FG007|Expansion Phase|Withdrawal by Subject|0|||
27939003|NCT00963820|54595220|FG008|Expansion Phase|Withdrawal by Subject|1|||
28026211|NCT00499252|54684853|FG000|Overall Study|Ineligible|4|||
28026212|NCT00499252|54684853|FG000|Overall Study|<no further label>|3|||
28026213|NCT00499174|54684863|FG000|Overall Study|Physician Decision|78|||
28026214|NCT00499174|54684864|FG001|Overall Study|Physician Decision|9|||
28026215|NCT03775421|54684872|FG000|Overall Study|Lost to Follow-up|2|||
28026216|NCT03775421|54684872|FG000|Overall Study|Withdrawal by Subject|10|||
27842865|NCT01574651|54331758|FG001|Overall Study|Abnormal test procedure result(s)|1|||
27939004|NCT00963820|54595221|FG009|Expansion Phase|Withdrawal by Subject|0|||
27939005|NCT00963820|54595222|FG010|Expansion Phase|Withdrawal by Subject|1|||
27939006|NCT00963820|54595223|FG011|Expansion Phase|Withdrawal by Subject|1|||
27939007|NCT00963820|54595212|FG000|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
27939008|NCT00963820|54595213|FG001|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
27939009|NCT00963820|54595214|FG002|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
27939010|NCT00963820|54595215|FG003|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
27939011|NCT00963820|54595216|FG004|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
27939012|NCT00963820|54595217|FG005|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
27939013|NCT00963820|54595218|FG006|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
27939014|NCT00963820|54595219|FG007|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
27939015|NCT00963820|54595220|FG008|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
27939016|NCT00963820|54595221|FG009|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
27939017|NCT00963820|54595222|FG010|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
27939018|NCT00963820|54595223|FG011|Expansion Phase|Unsatisfactory Therapeutic Response|1|||
27939019|NCT01227395|54595242|FG000|Overall Study|Protocol Violation|0|||
27939020|NCT01227395|54595243|FG001|Overall Study|Protocol Violation|1|||
27939021|NCT01226459|54595270|FG000|Overall Study|Adverse Event|2|||
27939022|NCT01226459|54595271|FG001|Overall Study|Adverse Event|8|||
27939023|NCT01226459|54595270|FG000|Overall Study|Protocol Violation|4|||
27939024|NCT01226459|54595271|FG001|Overall Study|Protocol Violation|3|||
27939025|NCT01226459|54595270|FG000|Overall Study|Withdrawal by Subject|10|||
27939026|NCT01226459|54595271|FG001|Overall Study|Withdrawal by Subject|13|||
28026217|NCT03775421|54684872|FG000|Overall Study|Physician Decision|3|||
28026218|NCT03775421|54684872|FG000|Overall Study|Death|1|||
28026219|NCT03775421|54684872|FG000|Overall Study|Study Terminated by Sponsor|94|||
28026220|NCT00532155|54684878|FG000|Overall Study|Adverse Event|66|||
28026221|NCT00532155|54684879|FG001|Overall Study|Adverse Event|123|||
28026222|NCT00532155|54684878|FG000|Overall Study|Lack of Efficacy|332|||
28026223|NCT00532155|54684879|FG001|Overall Study|Lack of Efficacy|255|||
28026224|NCT00532155|54684878|FG000|Overall Study|Protocol Violation|1|||
28026225|NCT00532155|54684879|FG001|Overall Study|Protocol Violation|3|||
28026226|NCT00532155|54684878|FG000|Overall Study|Lost to Follow-up|2|||
28026227|NCT00532155|54684879|FG001|Overall Study|Lost to Follow-up|0|||
28026228|NCT00532155|54684878|FG000|Overall Study|Physician Decision|16|||
28026229|NCT00532155|54684879|FG001|Overall Study|Physician Decision|15|||
28026230|NCT00532155|54684878|FG000|Overall Study|Withdrawal by Subject|23|||
28026231|NCT00532155|54684879|FG001|Overall Study|Withdrawal by Subject|44|||
28026232|NCT00532155|54684878|FG000|Overall Study|Consent withdrawn|5|||
28026233|NCT00532155|54684879|FG001|Overall Study|Consent withdrawn|7|||
28026234|NCT00532155|54684878|FG000|Overall Study|Moved|1|||
28026235|NCT00532155|54684879|FG001|Overall Study|Moved|0|||
28026236|NCT00532155|54684878|FG000|Overall Study|Pre-existing brain metastasis (by MRI)|1|||
28026237|NCT00532155|54684879|FG001|Overall Study|Pre-existing brain metastasis (by MRI)|0|||
28026238|NCT00532155|54684878|FG000|Overall Study|Occurence of a second cancer|0|||
28026239|NCT00532155|54684879|FG001|Overall Study|Occurence of a second cancer|1|||
28026240|NCT00532155|54684878|FG000|Overall Study|Occurence of a secondary cancer|0|||
28026241|NCT00532155|54684879|FG001|Overall Study|Occurence of a secondary cancer|1|||
28026242|NCT00532155|54684878|FG000|Overall Study|Promotor ended study|1|||
28026243|NCT00532155|54684879|FG001|Overall Study|Promotor ended study|0|||
28026244|NCT00532155|54684878|FG000|Overall Study|Progressive disease (by incorrect scan)|0|||
28026245|NCT00532155|54684879|FG001|Overall Study|Progressive disease (by incorrect scan)|1|||
28026246|NCT00532155|54684878|FG000|Overall Study|Had brain metastasis, was mis-randomized|1|||
28026247|NCT00532155|54684879|FG001|Overall Study|Had brain metastasis, was mis-randomized|0|||
28026248|NCT00532155|54684878|FG000|Overall Study|Study stopped|1|||
28026249|NCT00532155|54684879|FG001|Overall Study|Study stopped|0|||
28026250|NCT00532155|54684878|FG000|Overall Study|Study terminated by sponsor|1|||
28026251|NCT00532155|54684879|FG001|Overall Study|Study terminated by sponsor|0|||
28026252|NCT00532155|54684878|FG000|Overall Study|Study termination stop further treatment|4|||
28026253|NCT00532155|54684879|FG001|Overall Study|Study termination stop further treatment|0|||
28026254|NCT00532155|54684878|FG000|Overall Study|Did not receive study medication|2|||
28026255|NCT00532155|54684879|FG001|Overall Study|Did not receive study medication|6|||
28026256|NCT00205777|54684889|FG000|Core Study (Up to 3 Years)|Adverse Event|260|||
28026257|NCT00205777|54684890|FG001|Core Study (Up to 3 Years)|Adverse Event|267|||
28026258|NCT00205777|54684891|FG002|Core Study (Up to 3 Years)|Adverse Event|252|||
28026259|NCT00205777|54684892|FG003|Core Study (Up to 3 Years)|Adverse Event|232|||
28026260|NCT00205777|54684893|FG004|Core Study (Up to 3 Years)|Adverse Event|0|||
28026261|NCT00205777|54684894|FG005|Core Study (Up to 3 Years)|Adverse Event|0|||
28026262|NCT00205777|54684889|FG000|Core Study (Up to 3 Years)|Death|9|||
28026263|NCT00205777|54684890|FG001|Core Study (Up to 3 Years)|Death|7|||
28026264|NCT00205777|54684891|FG002|Core Study (Up to 3 Years)|Death|14|||
28026265|NCT00205777|54684892|FG003|Core Study (Up to 3 Years)|Death|7|||
28026266|NCT00205777|54684893|FG004|Core Study (Up to 3 Years)|Death|0|||
28026267|NCT00205777|54684894|FG005|Core Study (Up to 3 Years)|Death|0|||
28026268|NCT00205777|54684889|FG000|Core Study (Up to 3 Years)|Failed to return|40|||
28026269|NCT00205777|54684890|FG001|Core Study (Up to 3 Years)|Failed to return|25|||
28026270|NCT00205777|54684891|FG002|Core Study (Up to 3 Years)|Failed to return|27|||
28026271|NCT00205777|54684892|FG003|Core Study (Up to 3 Years)|Failed to return|27|||
28026272|NCT00205777|54684893|FG004|Core Study (Up to 3 Years)|Failed to return|0|||
28026273|NCT00205777|54684894|FG005|Core Study (Up to 3 Years)|Failed to return|0|||
28026274|NCT00205777|54684889|FG000|Core Study (Up to 3 Years)|Other Event|49|||
28026275|NCT00205777|54684890|FG001|Core Study (Up to 3 Years)|Other Event|52|||
28026276|NCT00205777|54684891|FG002|Core Study (Up to 3 Years)|Other Event|41|||
28026277|NCT00205777|54684892|FG003|Core Study (Up to 3 Years)|Other Event|58|||
28026278|NCT00205777|54684893|FG004|Core Study (Up to 3 Years)|Other Event|0|||
28026279|NCT00205777|54684894|FG005|Core Study (Up to 3 Years)|Other Event|0|||
28026280|NCT00205777|54684889|FG000|Core Study (Up to 3 Years)|Withdrawal by Subject|144|||
28026281|NCT00205777|54684890|FG001|Core Study (Up to 3 Years)|Withdrawal by Subject|169|||
28026282|NCT00205777|54684891|FG002|Core Study (Up to 3 Years)|Withdrawal by Subject|149|||
28026283|NCT00205777|54684892|FG003|Core Study (Up to 3 Years)|Withdrawal by Subject|162|||
28026284|NCT00205777|54684893|FG004|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
28026285|NCT00205777|54684894|FG005|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
28026286|NCT00205777|54684889|FG000|Core Study (Up to 3 Years)|Protocol Violation|53|||
28026287|NCT00205777|54684890|FG001|Core Study (Up to 3 Years)|Protocol Violation|55|||
28026288|NCT00205777|54684891|FG002|Core Study (Up to 3 Years)|Protocol Violation|50|||
28026289|NCT00205777|54684892|FG003|Core Study (Up to 3 Years)|Protocol Violation|42|||
27802278|NCT02014376|54257286|FG000|Overall Study|Adverse Event|1|||
27802279|NCT02014376|54257287|FG001|Overall Study|Adverse Event|1|||
27802280|NCT02014376|54257288|FG002|Overall Study|Adverse Event|0|||
27802281|NCT02014376|54257286|FG000|Overall Study|Lost to Follow-up|2|||
28026290|NCT00205777|54684893|FG004|Core Study (Up to 3 Years)|Protocol Violation|0|||
28026291|NCT00205777|54684894|FG005|Core Study (Up to 3 Years)|Protocol Violation|0|||
28026292|NCT00205777|54684889|FG000|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
28026293|NCT00205777|54684890|FG001|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
28026294|NCT00205777|54684891|FG002|Core Study (Up to 3 Years)|Lack of Efficacy|39|||
28026295|NCT00205777|54684892|FG003|Core Study (Up to 3 Years)|Lack of Efficacy|75|||
28026296|NCT00205777|54684893|FG004|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
28026297|NCT00205777|54684894|FG005|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
28026298|NCT00205777|54684889|FG000|Core Study (Up to 3 Years)|Randomized but not treated|21|||
28026299|NCT00205777|54684890|FG001|Core Study (Up to 3 Years)|Randomized but not treated|32|||
28026300|NCT00205777|54684891|FG002|Core Study (Up to 3 Years)|Randomized but not treated|35|||
28026301|NCT00205777|54684892|FG003|Core Study (Up to 3 Years)|Randomized but not treated|29|||
28026302|NCT00205777|54684893|FG004|Core Study (Up to 3 Years)|Randomized but not treated|0|||
28026303|NCT00205777|54684894|FG005|Core Study (Up to 3 Years)|Randomized but not treated|0|||
28026304|NCT00205777|54684889|FG000|Completed Core Study, Entered SE I|Withdrawal by Subject|180|||
28026305|NCT00205777|54684890|FG001|Completed Core Study, Entered SE I|Withdrawal by Subject|158|||
28026306|NCT00205777|54684891|FG002|Completed Core Study, Entered SE I|Withdrawal by Subject|160|||
28026307|NCT00205777|54684892|FG003|Completed Core Study, Entered SE I|Withdrawal by Subject|174|||
28026308|NCT00205777|54684893|FG004|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
28026309|NCT00205777|54684894|FG005|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
28026310|NCT00205777|54684889|FG000|Completed Core Study, Entered SE I|Other Event|52|||
28026311|NCT00205777|54684890|FG001|Completed Core Study, Entered SE I|Other Event|46|||
28026312|NCT00205777|54684891|FG002|Completed Core Study, Entered SE I|Other Event|47|||
28026313|NCT00205777|54684892|FG003|Completed Core Study, Entered SE I|Other Event|50|||
28026314|NCT00205777|54684893|FG004|Completed Core Study, Entered SE I|Other Event|0|||
28026315|NCT00205777|54684894|FG005|Completed Core Study, Entered SE I|Other Event|0|||
28026316|NCT00205777|54684889|FG000|Study Extension I|Adverse Event|57|||
28026317|NCT00205777|54684890|FG001|Study Extension I|Adverse Event|0|||
28026318|NCT00205777|54684891|FG002|Study Extension I|Adverse Event|0|||
28026319|NCT00205777|54684892|FG003|Study Extension I|Adverse Event|61|||
28026320|NCT00205777|54684893|FG004|Study Extension I|Adverse Event|58|||
28026321|NCT00205777|54684894|FG005|Study Extension I|Adverse Event|0|||
28026322|NCT00205777|54684889|FG000|Study Extension I|Death|5|||
28026323|NCT00205777|54684890|FG001|Study Extension I|Death|0|||
28026324|NCT00205777|54684891|FG002|Study Extension I|Death|0|||
28026325|NCT00205777|54684892|FG003|Study Extension I|Death|1|||
28026326|NCT00205777|54684893|FG004|Study Extension I|Death|2|||
28026327|NCT00205777|54684894|FG005|Study Extension I|Death|0|||
28026328|NCT00205777|54684889|FG000|Study Extension I|Withdrawal by Subject|99|||
28026329|NCT00205777|54684890|FG001|Study Extension I|Withdrawal by Subject|0|||
28026330|NCT00205777|54684891|FG002|Study Extension I|Withdrawal by Subject|0|||
28026331|NCT00205777|54684892|FG003|Study Extension I|Withdrawal by Subject|106|||
28026332|NCT00205777|54684893|FG004|Study Extension I|Withdrawal by Subject|89|||
28026333|NCT00205777|54684894|FG005|Study Extension I|Withdrawal by Subject|0|||
28026334|NCT00205777|54684889|FG000|Study Extension I|Protocol Violation|4|||
28026335|NCT00205777|54684890|FG001|Study Extension I|Protocol Violation|0|||
28026336|NCT00205777|54684891|FG002|Study Extension I|Protocol Violation|0|||
28026337|NCT00205777|54684892|FG003|Study Extension I|Protocol Violation|8|||
28026338|NCT00205777|54684893|FG004|Study Extension I|Protocol Violation|8|||
28026339|NCT00205777|54684894|FG005|Study Extension I|Protocol Violation|0|||
28026340|NCT00205777|54684889|FG000|Study Extension I|Lack of Efficacy|0|||
28026341|NCT00205777|54684890|FG001|Study Extension I|Lack of Efficacy|0|||
28026342|NCT00205777|54684891|FG002|Study Extension I|Lack of Efficacy|0|||
28026343|NCT00205777|54684892|FG003|Study Extension I|Lack of Efficacy|1|||
28026344|NCT00205777|54684893|FG004|Study Extension I|Lack of Efficacy|2|||
28026345|NCT00205777|54684894|FG005|Study Extension I|Lack of Efficacy|0|||
28026346|NCT00205777|54684889|FG000|Study Extension I|Failed to return|15|||
28026347|NCT00205777|54684890|FG001|Study Extension I|Failed to return|0|||
28026348|NCT00205777|54684891|FG002|Study Extension I|Failed to return|0|||
28026349|NCT00205777|54684892|FG003|Study Extension I|Failed to return|17|||
28026350|NCT00205777|54684893|FG004|Study Extension I|Failed to return|13|||
28026351|NCT00205777|54684894|FG005|Study Extension I|Failed to return|0|||
28026352|NCT00205777|54684889|FG000|Study Extension I|Other Event|34|||
28026353|NCT00205777|54684890|FG001|Study Extension I|Other Event|0|||
28026354|NCT00205777|54684891|FG002|Study Extension I|Other Event|0|||
28026355|NCT00205777|54684892|FG003|Study Extension I|Other Event|34|||
28026356|NCT00205777|54684893|FG004|Study Extension I|Other Event|29|||
28026357|NCT00205777|54684894|FG005|Study Extension I|Other Event|0|||
27939027|NCT01226459|54595270|FG000|Overall Study|Lost to Follow-up|4|||
27939028|NCT01226459|54595271|FG001|Overall Study|Lost to Follow-up|8|||
27939029|NCT01226459|54595270|FG000|Overall Study|Pregnancy|1|||
27939030|NCT01226459|54595271|FG001|Overall Study|Pregnancy|0|||
27939031|NCT01225991|54595277|FG000|Overall Study|Withdrawal by Subject|6|||
27939032|NCT00959374|54595281|FG000|Overall Study|Withdrawal by Subject|2|||
28026358|NCT00205777|54684889|FG000|Study Extension I|Withdrawn as per protocol|0|||
28026359|NCT00205777|54684890|FG001|Study Extension I|Withdrawn as per protocol|0|||
28026360|NCT00205777|54684891|FG002|Study Extension I|Withdrawn as per protocol|1070|||
28026361|NCT00205777|54684892|FG003|Study Extension I|Withdrawn as per protocol|0|||
28026362|NCT00205777|54684893|FG004|Study Extension I|Withdrawn as per protocol|0|||
28026363|NCT00205777|54684894|FG005|Study Extension I|Withdrawn as per protocol|0|||
28026364|NCT00205777|54684889|FG000|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273|||
28026365|NCT00205777|54684890|FG001|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
28026366|NCT00205777|54684891|FG002|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
28026367|NCT00205777|54684892|FG003|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240|||
28026368|NCT00205777|54684893|FG004|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258|||
28026369|NCT00205777|54684894|FG005|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
28026370|NCT00205777|54684889|FG000|Study Extension II|Adverse Event|0|||
28026371|NCT00205777|54684890|FG001|Study Extension II|Adverse Event|0|||
28026372|NCT00205777|54684891|FG002|Study Extension II|Adverse Event|0|||
28026373|NCT00205777|54684892|FG003|Study Extension II|Adverse Event|14|||
28026374|NCT00205777|54684893|FG004|Study Extension II|Adverse Event|0|||
28026375|NCT00205777|54684894|FG005|Study Extension II|Adverse Event|30|||
28026376|NCT00205777|54684889|FG000|Study Extension II|Death|0|||
28026377|NCT00205777|54684890|FG001|Study Extension II|Death|0|||
28026378|NCT00205777|54684891|FG002|Study Extension II|Death|0|||
28026379|NCT00205777|54684892|FG003|Study Extension II|Death|2|||
28026380|NCT00205777|54684893|FG004|Study Extension II|Death|0|||
28026381|NCT00205777|54684894|FG005|Study Extension II|Death|5|||
28026382|NCT00205777|54684889|FG000|Study Extension II|Withdrawal by Subject|0|||
28026383|NCT00205777|54684890|FG001|Study Extension II|Withdrawal by Subject|0|||
28026384|NCT00205777|54684891|FG002|Study Extension II|Withdrawal by Subject|0|||
28026385|NCT00205777|54684892|FG003|Study Extension II|Withdrawal by Subject|35|||
28026386|NCT00205777|54684893|FG004|Study Extension II|Withdrawal by Subject|0|||
28026387|NCT00205777|54684894|FG005|Study Extension II|Withdrawal by Subject|59|||
28026388|NCT00205777|54684889|FG000|Study Extension II|Protocol Violation|0|||
28026389|NCT00205777|54684890|FG001|Study Extension II|Protocol Violation|0|||
28026390|NCT00205777|54684891|FG002|Study Extension II|Protocol Violation|0|||
28026391|NCT00205777|54684892|FG003|Study Extension II|Protocol Violation|1|||
28026392|NCT00205777|54684893|FG004|Study Extension II|Protocol Violation|0|||
28026393|NCT00205777|54684894|FG005|Study Extension II|Protocol Violation|10|||
28026394|NCT00205777|54684889|FG000|Study Extension II|Lack of Efficacy|0|||
28026395|NCT00205777|54684890|FG001|Study Extension II|Lack of Efficacy|0|||
28026396|NCT00205777|54684891|FG002|Study Extension II|Lack of Efficacy|0|||
28026397|NCT00205777|54684892|FG003|Study Extension II|Lack of Efficacy|0|||
28026398|NCT00205777|54684893|FG004|Study Extension II|Lack of Efficacy|0|||
28026399|NCT00205777|54684894|FG005|Study Extension II|Lack of Efficacy|1|||
28026400|NCT00205777|54684889|FG000|Study Extension II|Failed to return|0|||
28026401|NCT00205777|54684890|FG001|Study Extension II|Failed to return|0|||
28026402|NCT00205777|54684891|FG002|Study Extension II|Failed to return|0|||
28026403|NCT00205777|54684892|FG003|Study Extension II|Failed to return|14|||
28026404|NCT00205777|54684893|FG004|Study Extension II|Failed to return|0|||
28026405|NCT00205777|54684894|FG005|Study Extension II|Failed to return|26|||
28026406|NCT00205777|54684889|FG000|Study Extension II|Other Event|0|||
27939033|NCT00959374|54595281|FG000|Overall Study|Lost to Follow-up|14|||
27939034|NCT00959374|54595281|FG000|Overall Study|Death|1|||
27939035|NCT00959374|54595281|FG000|Overall Study|Protocol Violation|1|||
27939036|NCT00959374|54595281|FG000|Overall Study|Implant Removed/Not Replaced|4|||
28026407|NCT00205777|54684890|FG001|Study Extension II|Other Event|0|||
28026408|NCT00205777|54684891|FG002|Study Extension II|Other Event|0|||
28026409|NCT00205777|54684892|FG003|Study Extension II|Other Event|12|||
28026410|NCT00205777|54684893|FG004|Study Extension II|Other Event|0|||
28026411|NCT00205777|54684894|FG005|Study Extension II|Other Event|20|||
28026412|NCT00205777|54684889|FG000|Study Extension II|Enrolled but not treated|0|||
28026413|NCT00205777|54684890|FG001|Study Extension II|Enrolled but not treated|0|||
28026414|NCT00205777|54684891|FG002|Study Extension II|Enrolled but not treated|0|||
28026415|NCT00205777|54684892|FG003|Study Extension II|Enrolled but not treated|71|||
28026416|NCT00205777|54684893|FG004|Study Extension II|Enrolled but not treated|0|||
28026417|NCT00205777|54684894|FG005|Study Extension II|Enrolled but not treated|131|||
28026418|NCT00483652|54684911|FG000|Double-blind Treatment Period|Protocol Violation|2|||
28026419|NCT00483652|54684912|FG001|Double-blind Treatment Period|Protocol Violation|1|||
28026420|NCT00483652|54684911|FG000|Double-blind Treatment Period|Adverse Event|3|||
28026421|NCT00483652|54684912|FG001|Double-blind Treatment Period|Adverse Event|4|||
28026422|NCT00483652|54684911|FG000|Double-blind Treatment Period|Protocol inclusion deviation|1|||
28026423|NCT00483652|54684912|FG001|Double-blind Treatment Period|Protocol inclusion deviation|0|||
28026424|NCT00483652|54684911|FG000|Double-blind Treatment Period|Withdrawal due to AE before study began|1|||
28026425|NCT00483652|54684912|FG001|Double-blind Treatment Period|Withdrawal due to AE before study began|0|||
28026426|NCT00483574|54684920|FG000|Overall Study|Adverse Event|6|||
28026427|NCT00483574|54684921|FG001|Overall Study|Adverse Event|0|||
28026428|NCT00483574|54684920|FG000|Overall Study|Protocol Violation|28|||
28026429|NCT00483574|54684921|FG001|Overall Study|Protocol Violation|9|||
28026430|NCT00483574|54684920|FG000|Overall Study|Lost to Follow-up|16|||
28026431|NCT00483574|54684921|FG001|Overall Study|Lost to Follow-up|4|||
28026432|NCT00483574|54684920|FG000|Overall Study|Withdrawal by Subject|52|||
28026433|NCT00483574|54684921|FG001|Overall Study|Withdrawal by Subject|0|||
28026434|NCT00483184|54684932|FG000|Overall Study|Withdrawal by Subject|2|||
28026435|NCT00483184|54684933|FG001|Overall Study|Withdrawal by Subject|2|||
28026436|NCT00483184|54684934|FG002|Overall Study|Withdrawal by Subject|0|||
28026437|NCT00483184|54684932|FG000|Overall Study|Lost to Follow-up|1|||
28026438|NCT00483184|54684933|FG001|Overall Study|Lost to Follow-up|0|||
28026439|NCT00483184|54684934|FG002|Overall Study|Lost to Follow-up|0|||
28026440|NCT00483184|54684932|FG000|Overall Study|Adverse Event|1|||
28026441|NCT00483184|54684933|FG001|Overall Study|Adverse Event|2|||
28026442|NCT00483184|54684934|FG002|Overall Study|Adverse Event|2|||
28026443|NCT00483184|54684932|FG000|Overall Study|Protocol Violation|1|||
28026444|NCT00483184|54684933|FG001|Overall Study|Protocol Violation|0|||
28026445|NCT00483184|54684934|FG002|Overall Study|Protocol Violation|1|||
28026446|NCT00482170|54684944|FG000|Overall Study|Adverse Event|5|||
28026447|NCT00482170|54684945|FG001|Overall Study|Adverse Event|14|||
28026448|NCT00482170|54684944|FG000|Overall Study|Withdrawal by Subject|6|||
28026449|NCT00482170|54684945|FG001|Overall Study|Withdrawal by Subject|1|||
28026450|NCT00482170|54684944|FG000|Overall Study|Protocol Violation|2|||
28026451|NCT00482170|54684945|FG001|Overall Study|Protocol Violation|3|||
28026452|NCT00482170|54684944|FG000|Overall Study|Lost to Follow-up|2|||
28026453|NCT00482170|54684945|FG001|Overall Study|Lost to Follow-up|0|||
28026454|NCT00482170|54684944|FG000|Overall Study|Unspecified reason|0|||
28026455|NCT00482170|54684945|FG001|Overall Study|Unspecified reason|2|||
28026456|NCT03883113|54684953|FG000|Overall Study|Physician Decision|4|||
28026457|NCT03883113|54684954|FG001|Overall Study|Physician Decision|2|||
28026458|NCT03883113|54684953|FG000|Overall Study|Challenge Criteria Not Met / Sponsor Decision|9|||
28026459|NCT03883113|54684954|FG001|Overall Study|Challenge Criteria Not Met / Sponsor Decision|7|||
28026460|NCT03883113|54684953|FG000|Overall Study|Pregnancy|1|||
28026461|NCT03883113|54684954|FG001|Overall Study|Pregnancy|0|||
28026462|NCT03883113|54684953|FG000|Overall Study|Adverse Event|0|||
28026463|NCT03883113|54684954|FG001|Overall Study|Adverse Event|1|||
28026464|NCT03883113|54684953|FG000|Overall Study|Withdrawal by Subject|1|||
28026465|NCT03883113|54684954|FG001|Overall Study|Withdrawal by Subject|2|||
28026466|NCT03883113|54684953|FG000|Overall Study|Lost to Follow-up|1|||
28026467|NCT03883113|54684954|FG001|Overall Study|Lost to Follow-up|0|||
28026468|NCT04218695|54684976|FG000|Overall Study|Adverse Event|1|||
28026469|NCT04218695|54684977|FG001|Overall Study|Adverse Event|0|||
28026470|NCT00490282|54684983|FG000|Overall Study|Withdrawal by Subject|3|||
28026471|NCT00615056|54684992|FG000|Overall Study|Death|31|||
28026472|NCT00615056|54684993|FG001|Overall Study|Death|31|||
28026473|NCT00615056|54684994|FG002|Overall Study|Death|21|||
28026474|NCT00615056|54684995|FG003|Overall Study|Death|23|||
28026475|NCT00615056|54684992|FG000|Overall Study|Lost to Follow-up|1|||
28026476|NCT00615056|54684993|FG001|Overall Study|Lost to Follow-up|2|||
28026477|NCT00615056|54684994|FG002|Overall Study|Lost to Follow-up|4|||
28026478|NCT00615056|54684995|FG003|Overall Study|Lost to Follow-up|5|||
28026479|NCT00615056|54684992|FG000|Overall Study|Other|13|||
28026480|NCT00615056|54684993|FG001|Overall Study|Other|15|||
28026481|NCT00615056|54684994|FG002|Overall Study|Other|10|||
28026482|NCT00615056|54684995|FG003|Overall Study|Other|7|||
28026483|NCT00615056|54684992|FG000|Overall Study|Objective progression or relapse|0|||
28026484|NCT00615056|54684993|FG001|Overall Study|Objective progression or relapse|2|||
28026485|NCT00615056|54684994|FG002|Overall Study|Objective progression or relapse|0|||
28026486|NCT00615056|54684995|FG003|Overall Study|Objective progression or relapse|0|||
28026487|NCT00615056|54684992|FG000|Overall Study|Withdrawal by Subject|0|||
27939037|NCT00959374|54595281|FG000|Overall Study|Physician Decision|1|||
27939038|NCT01225835|54595291|FG000|Overall Study|Completed protocol|2|||
27939039|NCT01225835|54595292|FG001|Overall Study|Completed protocol|1|||
27939040|NCT01225835|54595291|FG000|Overall Study|Did not meet hCG criterion|2|||
27939041|NCT01225835|54595292|FG001|Overall Study|Did not meet hCG criterion|0|||
27939042|NCT01225835|54595291|FG000|Overall Study|Adverse Event|2|||
27939043|NCT01225835|54595292|FG001|Overall Study|Adverse Event|1|||
27939044|NCT01225835|54595291|FG000|Overall Study|Other|1|||
27939045|NCT01225835|54595292|FG001|Overall Study|Other|1|||
27939046|NCT02923180|54595304|FG000|Overall Study|Off Study Due to Detectable PSA|13|||
27939047|NCT02923180|54595304|FG000|Overall Study|Remaining in Long Term Follow Up for PSA|13|||
27939048|NCT00962650|54595308|FG000|Overall Study|Transgastric DP was not completed|2|||
27939049|NCT00958828|54595316|FG000|Period 1, 1 Week of Wear|Randomization break|0|||
27939050|NCT00958828|54595317|FG001|Period 1, 1 Week of Wear|Randomization break|1|||
27939051|NCT00958828|54595316|FG000|Period 2, 1 Week of Wear|Unacceptable lens fit|0|||
27939052|NCT00958828|54595317|FG001|Period 2, 1 Week of Wear|Unacceptable lens fit|1|||
27939053|NCT00960934|54595329|FG000|Overall Study|Adverse Event|2|||
27939054|NCT00960934|54595330|FG001|Overall Study|Adverse Event|3|||
27939055|NCT00960934|54595331|FG002|Overall Study|Adverse Event|3|||
27939056|NCT00960934|54595332|FG003|Overall Study|Adverse Event|2|||
27939057|NCT00960934|54595333|FG004|Overall Study|Adverse Event|4|||
27939058|NCT00960934|54595334|FG005|Overall Study|Adverse Event|3|||
27939059|NCT00960934|54595329|FG000|Overall Study|Lack of Efficacy|1|||
27939060|NCT00960934|54595330|FG001|Overall Study|Lack of Efficacy|0|||
27939061|NCT00960934|54595331|FG002|Overall Study|Lack of Efficacy|0|||
27939062|NCT00960934|54595332|FG003|Overall Study|Lack of Efficacy|0|||
27939063|NCT00960934|54595333|FG004|Overall Study|Lack of Efficacy|0|||
27939064|NCT00960934|54595334|FG005|Overall Study|Lack of Efficacy|0|||
27939065|NCT00960934|54595329|FG000|Overall Study|Lost to Follow-up|0|||
27939066|NCT00960934|54595330|FG001|Overall Study|Lost to Follow-up|1|||
27939067|NCT00960934|54595331|FG002|Overall Study|Lost to Follow-up|0|||
27939068|NCT00960934|54595332|FG003|Overall Study|Lost to Follow-up|0|||
27939069|NCT00960934|54595333|FG004|Overall Study|Lost to Follow-up|0|||
27939070|NCT00960934|54595334|FG005|Overall Study|Lost to Follow-up|0|||
27939071|NCT00960934|54595329|FG000|Overall Study|Other|2|||
27939072|NCT00960934|54595330|FG001|Overall Study|Other|1|||
27939073|NCT00960934|54595331|FG002|Overall Study|Other|5|||
27939074|NCT00960934|54595332|FG003|Overall Study|Other|4|||
27939075|NCT00960934|54595333|FG004|Overall Study|Other|2|||
27939076|NCT00960934|54595334|FG005|Overall Study|Other|2|||
27939077|NCT00960934|54595329|FG000|Overall Study|Physician Decision|0|||
27939078|NCT00960934|54595330|FG001|Overall Study|Physician Decision|1|||
27939079|NCT00960934|54595331|FG002|Overall Study|Physician Decision|0|||
27939080|NCT00960934|54595332|FG003|Overall Study|Physician Decision|0|||
27939081|NCT00960934|54595333|FG004|Overall Study|Physician Decision|0|||
27939082|NCT00960934|54595334|FG005|Overall Study|Physician Decision|0|||
27939083|NCT00960934|54595329|FG000|Overall Study|Progressive Disease|1|||
27939084|NCT00960934|54595330|FG001|Overall Study|Progressive Disease|1|||
27939085|NCT00960934|54595331|FG002|Overall Study|Progressive Disease|0|||
27939086|NCT00960934|54595332|FG003|Overall Study|Progressive Disease|0|||
27939087|NCT00960934|54595333|FG004|Overall Study|Progressive Disease|1|||
27939088|NCT00960934|54595334|FG005|Overall Study|Progressive Disease|1|||
27939089|NCT00960934|54595329|FG000|Overall Study|Protocol Violation|3|||
27939090|NCT00960934|54595330|FG001|Overall Study|Protocol Violation|4|||
27939091|NCT00960934|54595331|FG002|Overall Study|Protocol Violation|0|||
27939092|NCT00960934|54595332|FG003|Overall Study|Protocol Violation|3|||
27939093|NCT00960934|54595333|FG004|Overall Study|Protocol Violation|3|||
27939094|NCT00960934|54595334|FG005|Overall Study|Protocol Violation|2|||
27939095|NCT00960934|54595329|FG000|Overall Study|Withdrawal by Subject|5|||
27939096|NCT00960934|54595330|FG001|Overall Study|Withdrawal by Subject|6|||
27939097|NCT00960934|54595331|FG002|Overall Study|Withdrawal by Subject|4|||
27939098|NCT00960934|54595332|FG003|Overall Study|Withdrawal by Subject|5|||
27939099|NCT00960934|54595333|FG004|Overall Study|Withdrawal by Subject|5|||
27939100|NCT00960934|54595334|FG005|Overall Study|Withdrawal by Subject|7|||
27939101|NCT00960934|54595329|FG000|Overall Study|Study Terminated by Sponsor|50|||
27939102|NCT00960934|54595330|FG001|Overall Study|Study Terminated by Sponsor|46|||
27939103|NCT00960934|54595331|FG002|Overall Study|Study Terminated by Sponsor|52|||
27939104|NCT00960934|54595332|FG003|Overall Study|Study Terminated by Sponsor|50|||
27939105|NCT00960934|54595333|FG004|Overall Study|Study Terminated by Sponsor|49|||
27939106|NCT00960934|54595334|FG005|Overall Study|Study Terminated by Sponsor|49|||
27939107|NCT00892177|54595351|FG000|Phase II|Ineligible|0|||
28026488|NCT00615056|54684993|FG001|Overall Study|Withdrawal by Subject|1|||
27939108|NCT00892177|54595352|FG001|Phase II|Ineligible|0|||
27939109|NCT00892177|54595353|FG002|Phase II|Ineligible|0|||
27939110|NCT00892177|54595354|FG003|Phase II|Ineligible|0|||
27939111|NCT00892177|54595355|FG004|Phase II|Ineligible|1|||
27939112|NCT00892177|54595356|FG005|Phase II|Ineligible|1|||
27939113|NCT00892177|54595351|FG000|Phase II|Withdrawal by Subject|0|||
27939114|NCT00892177|54595352|FG001|Phase II|Withdrawal by Subject|0|||
28026489|NCT00615056|54684994|FG002|Overall Study|Withdrawal by Subject|1|||
28026490|NCT00615056|54684995|FG003|Overall Study|Withdrawal by Subject|0|||
28026491|NCT00615056|54684992|FG000|Overall Study|Discontinued by Sponsor|1|||
28026492|NCT00615056|54684993|FG001|Overall Study|Discontinued by Sponsor|0|||
28026493|NCT00615056|54684994|FG002|Overall Study|Discontinued by Sponsor|0|||
28026494|NCT00615056|54684995|FG003|Overall Study|Discontinued by Sponsor|0|||
28026495|NCT00615056|54684992|FG000|Overall Study|Randomized but not treated|3|||
28026496|NCT00615056|54684993|FG001|Overall Study|Randomized but not treated|0|||
28026497|NCT00615056|54684994|FG002|Overall Study|Randomized but not treated|0|||
28026498|NCT00615056|54684995|FG003|Overall Study|Randomized but not treated|0|||
28026499|NCT00482014|54685009|FG000|Overall Study|Withdrawal by Subject|1|||
28026500|NCT00482014|54685010|FG001|Overall Study|Withdrawal by Subject|2|||
28026501|NCT00482014|54685011|FG002|Overall Study|Withdrawal by Subject|3|||
28026502|NCT00482014|54685012|FG003|Overall Study|Withdrawal by Subject|4|||
28026503|NCT00482014|54685009|FG000|Overall Study|Adverse Event|3|||
28026504|NCT00482014|54685010|FG001|Overall Study|Adverse Event|0|||
28026505|NCT00482014|54685011|FG002|Overall Study|Adverse Event|2|||
28026506|NCT00482014|54685012|FG003|Overall Study|Adverse Event|8|||
28026507|NCT00482014|54685009|FG000|Overall Study|Death|1|||
28026508|NCT00482014|54685010|FG001|Overall Study|Death|2|||
28026509|NCT00482014|54685011|FG002|Overall Study|Death|1|||
28026510|NCT00482014|54685012|FG003|Overall Study|Death|4|||
28026511|NCT00482014|54685009|FG000|Overall Study|Lack of Efficacy|1|||
28026512|NCT00482014|54685010|FG001|Overall Study|Lack of Efficacy|0|||
28026513|NCT00482014|54685011|FG002|Overall Study|Lack of Efficacy|4|||
28026514|NCT00482014|54685012|FG003|Overall Study|Lack of Efficacy|6|||
28026515|NCT00482014|54685009|FG000|Overall Study|Sponsor Decision|1|||
28026516|NCT00482014|54685010|FG001|Overall Study|Sponsor Decision|2|||
28026517|NCT00482014|54685011|FG002|Overall Study|Sponsor Decision|1|||
28026518|NCT00482014|54685012|FG003|Overall Study|Sponsor Decision|1|||
28026519|NCT03595553|54685026|FG000|Overall Study|Withdrawal by Subject|20|||
28026520|NCT03595553|54685027|FG001|Overall Study|Withdrawal by Subject|8|||
28026521|NCT03595553|54685026|FG000|Overall Study|Physician Decision|3|||
28026522|NCT03595553|54685027|FG001|Overall Study|Physician Decision|2|||
28026523|NCT03595553|54685026|FG000|Overall Study|Adverse Event|2|||
28026524|NCT03595553|54685027|FG001|Overall Study|Adverse Event|5|||
28026525|NCT03595553|54685026|FG000|Overall Study|Death|24|||
28026526|NCT03595553|54685027|FG001|Overall Study|Death|22|||
28026527|NCT03595553|54685026|FG000|Overall Study|Lost to Follow-up|6|||
27802282|NCT02014376|54257287|FG001|Overall Study|Lost to Follow-up|0|||
27802283|NCT02014376|54257288|FG002|Overall Study|Lost to Follow-up|0|||
27802284|NCT02035202|54257299|FG000|Overall Study|Lost to Follow-up|8|||
27802285|NCT02035202|54257300|FG001|Overall Study|Lost to Follow-up|16|||
27802286|NCT02035202|54257301|FG002|Overall Study|Lost to Follow-up|2|||
28026528|NCT03595553|54685027|FG001|Overall Study|Lost to Follow-up|7|||
28026529|NCT03595553|54685026|FG000|Overall Study|Other as indicated in CSR|3|||
28026530|NCT03595553|54685027|FG001|Overall Study|Other as indicated in CSR|3|||
27802287|NCT01988402|54257311|FG000|Overall Study|Adverse Event|1|||
27802288|NCT01988402|54257312|FG001|Overall Study|Adverse Event|2|||
27802289|NCT01988402|54257311|FG000|Overall Study|Withdrawal by Subject|1|||
28026531|NCT03595553|54685026|FG000|Overall Study|Sponsor Decision|0|||
28026532|NCT03595553|54685027|FG001|Overall Study|Sponsor Decision|1|||
28026533|NCT00614822|54685033|FG000|Overall Study|Adverse Event|3|||
28026534|NCT00529659|54685040|FG000|Overall Study|Adverse Event|8|||
28026535|NCT00529659|54685041|FG001|Overall Study|Adverse Event|7|||
28026536|NCT00529659|54685040|FG000|Overall Study|Lost to Follow-up|0|||
28026537|NCT00529659|54685041|FG001|Overall Study|Lost to Follow-up|2|||
28026538|NCT00529659|54685040|FG000|Overall Study|Physician Decision|0|||
28026539|NCT00529659|54685041|FG001|Overall Study|Physician Decision|2|||
28026540|NCT00529659|54685040|FG000|Overall Study|Protocol Violation|2|||
28026541|NCT00529659|54685041|FG001|Overall Study|Protocol Violation|6|||
28026542|NCT00529659|54685040|FG000|Overall Study|Withdrawal by Subject|1|||
28026543|NCT00529659|54685041|FG001|Overall Study|Withdrawal by Subject|6|||
28026544|NCT03569891|54685047|FG000|Lead-in|Ineligible during lead-in|8|||
28026545|NCT03569891|54685047|FG000|Lead-in|Withdrawal by Subject|3|||
28026546|NCT03569891|54685047|FG000|Lead-in|Risks related to COVID-19|2|||
28026547|NCT03569891|54685047|FG000|AMT-061|Adverse Event|1|||
28026548|NCT00143455|54685060|FG000|Cohort 1|Adverse Event|8|||
28026549|NCT00143455|54685061|FG001|Cohort 1|Adverse Event|4|||
28026550|NCT00143455|54685062|FG002|Cohort 1|Adverse Event|0|||
28026551|NCT00143455|54685063|FG003|Cohort 1|Adverse Event|0|||
28026552|NCT00143455|54685060|FG000|Cohort 1|Death|5|||
28026553|NCT00143455|54685061|FG001|Cohort 1|Death|2|||
28026554|NCT00143455|54685062|FG002|Cohort 1|Death|0|||
28026555|NCT00143455|54685063|FG003|Cohort 1|Death|0|||
28026556|NCT00143455|54685060|FG000|Cohort 1|Progressive Disease|0|||
28026557|NCT00143455|54685061|FG001|Cohort 1|Progressive Disease|6|||
28026558|NCT00143455|54685062|FG002|Cohort 1|Progressive Disease|0|||
28026559|NCT00143455|54685063|FG003|Cohort 1|Progressive Disease|0|||
28026560|NCT00143455|54685060|FG000|Cohort 1|Withdrawal by Subject|1|||
28026561|NCT00143455|54685061|FG001|Cohort 1|Withdrawal by Subject|4|||
28026562|NCT00143455|54685062|FG002|Cohort 1|Withdrawal by Subject|0|||
28026563|NCT00143455|54685063|FG003|Cohort 1|Withdrawal by Subject|0|||
28026564|NCT00143455|54685060|FG000|Cohort 1|Randomized But Not Treated|0|||
28026565|NCT00143455|54685061|FG001|Cohort 1|Randomized But Not Treated|1|||
28026566|NCT00143455|54685062|FG002|Cohort 1|Randomized But Not Treated|0|||
28026567|NCT00143455|54685063|FG003|Cohort 1|Randomized But Not Treated|0|||
28026568|NCT00143455|54685060|FG000|Cohort 2|Adverse Event|0|||
27802290|NCT01988402|54257312|FG001|Overall Study|Withdrawal by Subject|0|||
27802291|NCT01988090|54257320|FG000|Start Treament After Randomization|Withdrawal by Subject|2|||
28026569|NCT00143455|54685061|FG001|Cohort 2|Adverse Event|0|||
28026570|NCT00143455|54685062|FG002|Cohort 2|Adverse Event|42|||
28026571|NCT00143455|54685063|FG003|Cohort 2|Adverse Event|30|||
28026572|NCT00143455|54685060|FG000|Cohort 2|No Longer Required Study Treatment|0|||
28026573|NCT00143455|54685061|FG001|Cohort 2|No Longer Required Study Treatment|0|||
28026574|NCT00143455|54685062|FG002|Cohort 2|No Longer Required Study Treatment|1|||
28026575|NCT00143455|54685063|FG003|Cohort 2|No Longer Required Study Treatment|0|||
27802292|NCT01988090|54257321|FG001|Start Treament After Randomization|Withdrawal by Subject|3|||
27802293|NCT01988090|54257320|FG000|Start Treament After Randomization|Protocol Violation|0|||
27802294|NCT01988090|54257321|FG001|Start Treament After Randomization|Protocol Violation|1|||
27802295|NCT01988090|54257320|FG000|Complete Study After Start|Withdrawal by Subject|2|||
27802296|NCT01988090|54257321|FG001|Complete Study After Start|Withdrawal by Subject|0|||
27802297|NCT01988090|54257320|FG000|Complete Study After Start|Protocol Violation|1|||
27802298|NCT01988090|54257321|FG001|Complete Study After Start|Protocol Violation|1|||
27802299|NCT01988012|54257327|FG000|Overall Study|Adverse Event|5|||
27802300|NCT01988012|54257327|FG000|Overall Study|Insufficient Therapeutic Response|3|||
27802301|NCT01988012|54257327|FG000|Overall Study|Patient Withdrawal of Consent|4|||
27802302|NCT01988012|54257327|FG000|Overall Study|Lost to Follow-up|1|||
27802303|NCT01988012|54257327|FG000|Overall Study|Physician Decision|1|||
27802304|NCT01988012|54257327|FG000|Overall Study|Protocol Violation|1|||
27802305|NCT02011945|54257334|FG000|Overall Study|Participant requested to Discontinue|0|||
27802306|NCT02011945|54257335|FG001|Overall Study|Participant requested to Discontinue|1|||
28026576|NCT00143455|54685060|FG000|Cohort 2|Protocol Violation|0|||
28026577|NCT00143455|54685061|FG001|Cohort 2|Protocol Violation|0|||
28026578|NCT00143455|54685062|FG002|Cohort 2|Protocol Violation|1|||
28026579|NCT00143455|54685063|FG003|Cohort 2|Protocol Violation|1|||
28026580|NCT00143455|54685060|FG000|Cohort 2|Lost to Follow-up|0|||
27802307|NCT02011945|54257336|FG002|Overall Study|Participant requested to Discontinue|1|||
27802308|NCT02011945|54257334|FG000|Overall Study|Adverse Event unrelated to Drug|0|||
27802309|NCT02011945|54257335|FG001|Overall Study|Adverse Event unrelated to Drug|2|||
27802310|NCT02011945|54257336|FG002|Overall Study|Adverse Event unrelated to Drug|1|||
27939115|NCT00892177|54595353|FG002|Phase II|Withdrawal by Subject|0|||
27939116|NCT00892177|54595354|FG003|Phase II|Withdrawal by Subject|0|||
27939117|NCT00892177|54595355|FG004|Phase II|Withdrawal by Subject|4|||
27939118|NCT00892177|54595356|FG005|Phase II|Withdrawal by Subject|1|||
27939119|NCT00962104|54595373|FG000|Overall Study|Adverse Event|10|||
27939120|NCT00962104|54595374|FG001|Overall Study|Adverse Event|3|||
27939121|NCT00962104|54595373|FG000|Overall Study|Entry Criteria Not Met|1|||
27939122|NCT00962104|54595374|FG001|Overall Study|Entry Criteria Not Met|2|||
27939123|NCT00962104|54595373|FG000|Overall Study|Lack of Efficacy|0|||
27939124|NCT00962104|54595374|FG001|Overall Study|Lack of Efficacy|1|||
27939125|NCT00962104|54595373|FG000|Overall Study|Lost to Follow-up|10|||
28026581|NCT00143455|54685061|FG001|Cohort 2|Lost to Follow-up|0|||
28026582|NCT00143455|54685062|FG002|Cohort 2|Lost to Follow-up|1|||
28026583|NCT00143455|54685063|FG003|Cohort 2|Lost to Follow-up|4|||
28026584|NCT00143455|54685060|FG000|Cohort 2|Death|0|||
28026585|NCT00143455|54685061|FG001|Cohort 2|Death|0|||
28026586|NCT00143455|54685062|FG002|Cohort 2|Death|20|||
28026587|NCT00143455|54685063|FG003|Cohort 2|Death|12|||
28026588|NCT00143455|54685060|FG000|Cohort 2|Progressive Disease|0|||
28026589|NCT00143455|54685061|FG001|Cohort 2|Progressive Disease|0|||
28026590|NCT00143455|54685062|FG002|Cohort 2|Progressive Disease|20|||
28026591|NCT00143455|54685063|FG003|Cohort 2|Progressive Disease|27|||
28026592|NCT00143455|54685060|FG000|Cohort 2|Withdrawal by Subject|0|||
28026593|NCT00143455|54685061|FG001|Cohort 2|Withdrawal by Subject|0|||
28026594|NCT00143455|54685062|FG002|Cohort 2|Withdrawal by Subject|13|||
28026595|NCT00143455|54685063|FG003|Cohort 2|Withdrawal by Subject|12|||
28026596|NCT00143455|54685060|FG000|Cohort 2|Other|0|||
28026597|NCT00143455|54685061|FG001|Cohort 2|Other|0|||
28026598|NCT00143455|54685062|FG002|Cohort 2|Other|7|||
28026599|NCT00143455|54685063|FG003|Cohort 2|Other|6|||
28026600|NCT00143455|54685060|FG000|Cohort 2|Randomized But Not Treated|0|||
28026601|NCT00143455|54685061|FG001|Cohort 2|Randomized But Not Treated|0|||
28026602|NCT00143455|54685062|FG002|Cohort 2|Randomized But Not Treated|1|||
28026603|NCT00143455|54685063|FG003|Cohort 2|Randomized But Not Treated|1|||
28026604|NCT03529955|54685075|FG000|Overall Study|Adverse Event|1|||
28026605|NCT03529955|54685075|FG000|Overall Study|Lack of Efficacy|1|||
28026606|NCT00142909|54685091|FG000|Randomization|Various Reasons|7|||
28026607|NCT00142909|54685092|FG001|Randomization|Various Reasons|10|||
28026608|NCT00142909|54685091|FG000|Medications Begin|Protocol Violation|2|||
28026609|NCT00142909|54685092|FG001|Medications Begin|Protocol Violation|0|||
28026610|NCT00142909|54685091|FG000|Medications Begin|Withdrawal by Subject|5|||
28026611|NCT00142909|54685092|FG001|Medications Begin|Withdrawal by Subject|3|||
28026612|NCT00142909|54685091|FG000|Medications Begin|Withdrawal by Subject|2|||
28026613|NCT00142909|54685092|FG001|Medications Begin|Withdrawal by Subject|0|||
28026614|NCT00205699|54685101|FG000|Overall Study|Lost to Follow-up|1|||
28026615|NCT00205699|54685102|FG001|Overall Study|Lost to Follow-up|3|||
28026616|NCT00205699|54685103|FG002|Overall Study|Lost to Follow-up|5|||
28026617|NCT00205699|54685101|FG000|Overall Study|Adverse Event|1|||
28026618|NCT00205699|54685102|FG001|Overall Study|Adverse Event|0|||
28026619|NCT00205699|54685103|FG002|Overall Study|Adverse Event|0|||
28026620|NCT00205699|54685101|FG000|Overall Study|Withdrawal by Subject|1|||
28026621|NCT00205699|54685102|FG001|Overall Study|Withdrawal by Subject|2|||
28026622|NCT00205699|54685103|FG002|Overall Study|Withdrawal by Subject|1|||
28026623|NCT00205699|54685101|FG000|Overall Study|Lack of Efficacy|0|||
28026624|NCT00205699|54685102|FG001|Overall Study|Lack of Efficacy|1|||
28026625|NCT00205699|54685103|FG002|Overall Study|Lack of Efficacy|0|||
28026626|NCT03882801|54685116|FG000|Period 1|Adverse Event|0|||
27802311|NCT02011945|54257334|FG000|Overall Study|Study Drug Toxicity|0|||
27802312|NCT02011945|54257335|FG001|Overall Study|Study Drug Toxicity|0|||
27802313|NCT02011945|54257336|FG002|Overall Study|Study Drug Toxicity|1|||
27802314|NCT02011945|54257334|FG000|Overall Study|Treatment Failure|0|||
27802315|NCT02011945|54257335|FG001|Overall Study|Treatment Failure|7|||
27802316|NCT02011945|54257336|FG002|Overall Study|Treatment Failure|6|||
27802317|NCT02011945|54257334|FG000|Overall Study|No Longer Meets Study Criteria|1|||
27802318|NCT02011945|54257335|FG001|Overall Study|No Longer Meets Study Criteria|0|||
27802319|NCT02011945|54257336|FG002|Overall Study|No Longer Meets Study Criteria|0|||
27802320|NCT02011945|54257334|FG000|Overall Study|Proceeded to stem cell transplant|0|||
27802321|NCT02011945|54257335|FG001|Overall Study|Proceeded to stem cell transplant|0|||
27802322|NCT02011945|54257336|FG002|Overall Study|Proceeded to stem cell transplant|1|||
27802323|NCT02011945|54257334|FG000|Overall Study|Sub-Optimal Response to dasatinib|1|||
27802324|NCT02011945|54257335|FG001|Overall Study|Sub-Optimal Response to dasatinib|0|||
28026627|NCT03882801|54685117|FG001|Period 1|Adverse Event|1|||
28026628|NCT03882801|54685116|FG000|Period 1|Non-compliance with study drug|1|||
28026629|NCT03882801|54685117|FG001|Period 1|Non-compliance with study drug|1|||
28026630|NCT03882801|54685116|FG000|Period 1|Never treated with study drug|1|||
28026631|NCT03882801|54685117|FG001|Period 1|Never treated with study drug|0|||
28026632|NCT03882801|54685116|FG000|Washout Period|Physician Decision|0|||
28026633|NCT03882801|54685117|FG001|Washout Period|Physician Decision|1|||
27802325|NCT02011945|54257336|FG002|Overall Study|Sub-Optimal Response to dasatinib|0|||
27802326|NCT02013830|54257344|FG000|Overall Study|Adverse Event|3|||
27802327|NCT02013830|54257344|FG000|Overall Study|Death|1|||
27802328|NCT02013830|54257344|FG000|Overall Study|Insufficient therapeutic response|25|||
27802329|NCT02013830|54257344|FG000|Overall Study|Refused treatment|1|||
28026634|NCT03882801|54685116|FG000|Period 2|Non-compliance with study drug|0|||
28026635|NCT03882801|54685117|FG001|Period 2|Non-compliance with study drug|1|||
28026636|NCT03880227|54685127|FG000|First Visit|Withdrawal by Subject|1|||
28026637|NCT03880227|54685128|FG001|First Visit|Withdrawal by Subject|0|||
28026638|NCT03880227|54685129|FG002|First Visit|Withdrawal by Subject|0|||
28026639|NCT03880227|54685130|FG003|First Visit|Withdrawal by Subject|0|||
28026640|NCT03880227|54685127|FG000|1 Week Washout/ Delay|Lost to Follow-up|0|||
28026641|NCT03880227|54685128|FG001|1 Week Washout/ Delay|Lost to Follow-up|1|||
28026642|NCT03880227|54685129|FG002|1 Week Washout/ Delay|Lost to Follow-up|0|||
28026643|NCT03880227|54685130|FG003|1 Week Washout/ Delay|Lost to Follow-up|0|||
28026644|NCT03880227|54685127|FG000|1 Week Washout/ Delay|Withdrawal by Subject|0|||
28026645|NCT03880227|54685128|FG001|1 Week Washout/ Delay|Withdrawal by Subject|0|||
28026646|NCT03880227|54685129|FG002|1 Week Washout/ Delay|Withdrawal by Subject|2|||
28026647|NCT03880227|54685130|FG003|1 Week Washout/ Delay|Withdrawal by Subject|0|||
28026648|NCT03880227|54685127|FG000|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
28026649|NCT03880227|54685128|FG001|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
28026650|NCT03880227|54685129|FG002|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|1|||
28026651|NCT03880227|54685130|FG003|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
28026652|NCT00530439|54685154|FG000|Overall Study|GDM|9|||
28026653|NCT00530439|54685155|FG001|Overall Study|GDM|3|||
28026654|NCT00530439|54685154|FG000|Overall Study|Withdraw|18|||
28026655|NCT00530439|54685155|FG001|Overall Study|Withdraw|14|||
28026656|NCT00530439|54685154|FG000|Overall Study|Missed abortion|1|||
27802330|NCT02010775|54257353|FG000|Overall Study|Adverse Event|0|||
27802331|NCT02010775|54257354|FG001|Overall Study|Adverse Event|0|||
27802332|NCT02010775|54257355|FG002|Overall Study|Adverse Event|0|||
27802333|NCT02010775|54257356|FG003|Overall Study|Adverse Event|0|||
27802334|NCT02010775|54257357|FG004|Overall Study|Adverse Event|1|||
28026657|NCT00530439|54685155|FG001|Overall Study|Missed abortion|4|||
28026658|NCT00530439|54685154|FG000|Overall Study|Misclassification|2|||
28026659|NCT00530439|54685155|FG001|Overall Study|Misclassification|0|||
28026660|NCT00530439|54685154|FG000|Overall Study|Twin pregnancy|0|||
28026661|NCT00530439|54685155|FG001|Overall Study|Twin pregnancy|2|||
28026662|NCT00530439|54685154|FG000|Overall Study|Severe malformation/abortion|0|||
28026663|NCT00530439|54685155|FG001|Overall Study|Severe malformation/abortion|3|||
28026664|NCT00497146|54685163|FG000|Treatment Period|Adverse Event|6|||
28026665|NCT00497146|54685164|FG001|Treatment Period|Adverse Event|2|||
28026666|NCT00497146|54685163|FG000|Treatment Period|Withdrawal by Subject|5|||
28026667|NCT00497146|54685164|FG001|Treatment Period|Withdrawal by Subject|9|||
28026668|NCT00497146|54685163|FG000|Treatment Period|Lost to Follow-up|1|||
28026669|NCT00497146|54685164|FG001|Treatment Period|Lost to Follow-up|3|||
28026670|NCT00497146|54685163|FG000|Treatment Period|Required dialysis|4|||
28026671|NCT00497146|54685164|FG001|Treatment Period|Required dialysis|1|||
28026672|NCT00497146|54685163|FG000|Treatment Period|Change in RAAS inhibitor therapy|5|||
28026673|NCT00497146|54685164|FG001|Treatment Period|Change in RAAS inhibitor therapy|2|||
28026674|NCT00497146|54685163|FG000|Treatment Period|Unable to dose reduce per protocol|4|||
28026675|NCT00497146|54685164|FG001|Treatment Period|Unable to dose reduce per protocol|1|||
28026676|NCT00497146|54685163|FG000|Treatment Period|Other Reason|2|||
28026677|NCT00497146|54685164|FG001|Treatment Period|Other Reason|3|||
27802335|NCT02010775|54257353|FG000|Overall Study|Pregnancy|0|||
27802336|NCT02010775|54257354|FG001|Overall Study|Pregnancy|0|||
27802337|NCT02010775|54257355|FG002|Overall Study|Pregnancy|2|||
28026678|NCT00497146|54685163|FG000|Long-term Follow-up Period|Adverse Event|2|||
28026679|NCT00497146|54685164|FG001|Long-term Follow-up Period|Adverse Event|2|||
28026680|NCT00497146|54685163|FG000|Long-term Follow-up Period|Withdrawal by Subject|8|||
28026681|NCT00497146|54685164|FG001|Long-term Follow-up Period|Withdrawal by Subject|2|||
28026682|NCT00497146|54685163|FG000|Long-term Follow-up Period|Lost to Follow-up|5|||
28026683|NCT00497146|54685164|FG001|Long-term Follow-up Period|Lost to Follow-up|1|||
28026684|NCT00497146|54685163|FG000|Long-term Follow-up Period|Other|0|||
28026685|NCT00497146|54685164|FG001|Long-term Follow-up Period|Other|1|||
28026686|NCT00489970|54685175|FG000|Persistence Year 9|Lost to Follow-up|2|||
28026687|NCT00489970|54685176|FG001|Persistence Year 9|Lost to Follow-up|2|||
28026688|NCT00489970|54685177|FG002|Persistence Year 9|Lost to Follow-up|3|||
28026689|NCT00489970|54685175|FG000|Persistence Year 9|Other|1|||
28026690|NCT00489970|54685176|FG001|Persistence Year 9|Other|0|||
28026691|NCT00489970|54685177|FG002|Persistence Year 9|Other|2|||
28026692|NCT02798471|54685190|FG000|Overall Study|Adverse Event|7|||
27802338|NCT02010775|54257356|FG003|Overall Study|Pregnancy|0|||
28026693|NCT02798471|54685191|FG001|Overall Study|Adverse Event|2|||
28026694|NCT02798471|54685190|FG000|Overall Study|Physician Decision|3|||
28026695|NCT02798471|54685191|FG001|Overall Study|Physician Decision|7|||
28026696|NCT02798471|54685190|FG000|Overall Study|Death|2|||
28026697|NCT02798471|54685191|FG001|Overall Study|Death|3|||
28026698|NCT02798471|54685190|FG000|Overall Study|Lost to Follow-up|0|||
27802339|NCT02010775|54257357|FG004|Overall Study|Pregnancy|0|||
28026699|NCT02798471|54685191|FG001|Overall Study|Lost to Follow-up|1|||
28026700|NCT02798471|54685190|FG000|Overall Study|Other|5|||
28026701|NCT02798471|54685191|FG001|Overall Study|Other|3|||
28026702|NCT02798471|54685190|FG000|Overall Study|Subject withdrew consent|0|||
28026703|NCT02798471|54685191|FG001|Overall Study|Subject withdrew consent|6|||
27802340|NCT02010775|54257353|FG000|Overall Study|Lost to Follow-up|2|||
27802341|NCT02010775|54257354|FG001|Overall Study|Lost to Follow-up|0|||
27802342|NCT02010775|54257355|FG002|Overall Study|Lost to Follow-up|0|||
27802343|NCT02010775|54257356|FG003|Overall Study|Lost to Follow-up|1|||
27802344|NCT02010775|54257357|FG004|Overall Study|Lost to Follow-up|1|||
27802345|NCT02010775|54257353|FG000|Overall Study|Personal Reasons|3|||
27802346|NCT02010775|54257354|FG001|Overall Study|Personal Reasons|3|||
27802347|NCT02010775|54257355|FG002|Overall Study|Personal Reasons|1|||
27802348|NCT02010775|54257356|FG003|Overall Study|Personal Reasons|2|||
27802349|NCT02010775|54257357|FG004|Overall Study|Personal Reasons|4|||
27802350|NCT01993615|54257371|FG000|Overall Study|Death|1|||
27802351|NCT01993615|54257372|FG001|Overall Study|Death|0|||
27802352|NCT01619059|54257380|FG000|Short-Term (ST) Treatment Period|Adverse Event|1|||
27802353|NCT01619059|54257381|FG001|Short-Term (ST) Treatment Period|Adverse Event|0|||
27802354|NCT01619059|54257380|FG000|Short-Term (ST) Treatment Period|Withdrawal by Subject|2|||
27802355|NCT01619059|54257381|FG001|Short-Term (ST) Treatment Period|Withdrawal by Subject|5|||
27802356|NCT01619059|54257380|FG000|Short-Term (ST) Treatment Period|Lost to Follow-up|2|||
27802357|NCT01619059|54257381|FG001|Short-Term (ST) Treatment Period|Lost to Follow-up|4|||
27802358|NCT01619059|54257380|FG000|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1|||
27802359|NCT01619059|54257381|FG001|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2|||
27802360|NCT01619059|54257380|FG000|Long-Term (LT) Treatment Period|Lack of Efficacy|0|||
27802361|NCT01619059|54257381|FG001|Long-Term (LT) Treatment Period|Lack of Efficacy|1|||
27802362|NCT01619059|54257380|FG000|Long-Term (LT) Treatment Period|Adverse Event|2|||
27802363|NCT01619059|54257381|FG001|Long-Term (LT) Treatment Period|Adverse Event|3|||
27802364|NCT01619059|54257380|FG000|Long-Term (LT) Treatment Period|Withdrawal by Subject|3|||
27802365|NCT01619059|54257381|FG001|Long-Term (LT) Treatment Period|Withdrawal by Subject|2|||
27802366|NCT01619059|54257380|FG000|Long-Term (LT) Treatment Period|Death|1|||
27802367|NCT01619059|54257381|FG001|Long-Term (LT) Treatment Period|Death|0|||
27802368|NCT01619059|54257380|FG000|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
27802369|NCT01619059|54257381|FG001|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
27802370|NCT01619059|54257380|FG000|Long-Term (LT) Treatment Period|Not Met Study Criteria|0|||
27802371|NCT01619059|54257381|FG001|Long-Term (LT) Treatment Period|Not Met Study Criteria|1|||
27802372|NCT02013206|54257389|FG000|Overall Study|Progressive disease (PD)|14|||
27802373|NCT02013206|54257390|FG001|Overall Study|Progressive disease (PD)|17|||
27802374|NCT02013206|54257389|FG000|Overall Study|Symptomatic deterioration|3|||
27802375|NCT02013206|54257390|FG001|Overall Study|Symptomatic deterioration|1|||
27802376|NCT02013206|54257389|FG000|Overall Study|Adverse Event|1|||
27802377|NCT02013206|54257390|FG001|Overall Study|Adverse Event|0|||
27802378|NCT02013206|54257389|FG000|Overall Study|Patient refusal|2|||
27802379|NCT02013206|54257390|FG001|Overall Study|Patient refusal|0|||
27802380|NCT02013206|54257389|FG000|Overall Study|Patient non-compliance|1|||
27802381|NCT02013206|54257390|FG001|Overall Study|Patient non-compliance|0|||
27802382|NCT02013206|54257389|FG000|Overall Study|Death|1|||
27802383|NCT02013206|54257390|FG001|Overall Study|Death|2|||
27802384|NCT02013206|54257389|FG000|Overall Study|Other reasons off treatment|5|||
27802385|NCT02013206|54257390|FG001|Overall Study|Other reasons off treatment|2|||
27802386|NCT01807923|54257399|FG000|Overall Study|Adverse Event|2|||
27802387|NCT01807923|54257400|FG001|Overall Study|Adverse Event|1|||
27802388|NCT01807923|54257401|FG002|Overall Study|Adverse Event|2|||
27802389|NCT01807923|54257399|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
27802390|NCT01807923|54257400|FG001|Overall Study|Withdrawal of Consent (not due to AE)|3|||
27802391|NCT01807923|54257401|FG002|Overall Study|Withdrawal of Consent (not due to AE)|2|||
27802392|NCT01807923|54257399|FG000|Overall Study|Physician Decision|0|||
27802393|NCT01807923|54257400|FG001|Overall Study|Physician Decision|0|||
27802394|NCT01807923|54257401|FG002|Overall Study|Physician Decision|1|||
27802395|NCT01807923|54257399|FG000|Overall Study|Not Eligible (Genotype)|0|||
27802396|NCT01807923|54257400|FG001|Overall Study|Not Eligible (Genotype)|0|||
27802397|NCT01807923|54257401|FG002|Overall Study|Not Eligible (Genotype)|1|||
27802398|NCT01807923|54257399|FG000|Overall Study|Randomized But Not Treated|3|||
27802399|NCT01807923|54257400|FG001|Overall Study|Randomized But Not Treated|2|||
27802400|NCT01807923|54257401|FG002|Overall Study|Randomized But Not Treated|5|||
27802401|NCT01966003|54257413|FG000|Overall Study|Death|43|||
27802402|NCT01966003|54257414|FG001|Overall Study|Death|36|||
27802403|NCT01966003|54257413|FG000|Overall Study|Protocol Violation|6|||
27802404|NCT01966003|54257414|FG001|Overall Study|Protocol Violation|4|||
27802405|NCT01966003|54257413|FG000|Overall Study|Lost to Follow-up|4|||
27802406|NCT01966003|54257414|FG001|Overall Study|Lost to Follow-up|3|||
27802407|NCT01966003|54257413|FG000|Overall Study|Physician Decision|12|||
27802408|NCT01966003|54257414|FG001|Overall Study|Physician Decision|13|||
27802409|NCT01966003|54257413|FG000|Overall Study|Withdrawal by Subject|29|||
27802410|NCT01966003|54257414|FG001|Overall Study|Withdrawal by Subject|19|||
27802411|NCT01966003|54257413|FG000|Overall Study|Plan to Receive Other Anticancer Therapy|131|||
27802412|NCT01966003|54257414|FG001|Overall Study|Plan to Receive Other Anticancer Therapy|127|||
27802413|NCT01966003|54257413|FG000|Overall Study|Plan to Receive Commercial Bevacizumab|44|||
27802414|NCT01966003|54257414|FG001|Overall Study|Plan to Receive Commercial Bevacizumab|67|||
27802415|NCT01966003|54257413|FG000|Overall Study|Other|1|||
27802416|NCT01966003|54257414|FG001|Overall Study|Other|1|||
27802417|NCT01839279|54257423|FG000|Overall Study|Adverse Event|4|||
27802418|NCT01839279|54257424|FG001|Overall Study|Adverse Event|1|||
27802419|NCT01839279|54257425|FG002|Overall Study|Adverse Event|1|||
27802420|NCT01839279|54257423|FG000|Overall Study|Withdrawal by Subject|4|||
27802421|NCT01839279|54257424|FG001|Overall Study|Withdrawal by Subject|1|||
27802422|NCT01839279|54257425|FG002|Overall Study|Withdrawal by Subject|1|||
27802423|NCT01839279|54257423|FG000|Overall Study|Classified as 'Other'|5|||
27802424|NCT01839279|54257424|FG001|Overall Study|Classified as 'Other'|0|||
27802425|NCT01839279|54257425|FG002|Overall Study|Classified as 'Other'|0|||
27802426|NCT01807299|54257444|FG000|Overall Study|Protocol Violation|3|||
27802427|NCT01807299|54257445|FG001|Overall Study|Protocol Violation|1|||
27802428|NCT01807299|54257446|FG002|Overall Study|Protocol Violation|0|||
27802429|NCT01807299|54257447|FG003|Overall Study|Protocol Violation|2|||
27802430|NCT01965535|54257459|FG000|Overall Study|Lack of Efficacy|2|||
27802431|NCT01965535|54257460|FG001|Overall Study|Lack of Efficacy|1|||
27802432|NCT01964755|54257466|FG000|Overall Study|Death|2|||
27802433|NCT01964521|54257470|FG000|Overall Study|Lost to Follow-up|4|||
27802434|NCT01992757|54257475|FG000|Overall Study|2 patients excluded due to FFP given.|2|||
27802435|NCT01991743|54257484|FG000|Overall Study|external cephalic version not performed|0|||
27802436|NCT01991743|54257485|FG001|Overall Study|external cephalic version not performed|0|||
28026704|NCT02798471|54685190|FG000|Overall Study|Data entry error (reported as study completion and study discontinuation)|2|||
28026705|NCT02798471|54685191|FG001|Overall Study|Data entry error (reported as study completion and study discontinuation)|0|||
28026706|NCT02798471|54685190|FG000|Overall Study|Randomized, but not treated|0|||
28026707|NCT02798471|54685191|FG001|Overall Study|Randomized, but not treated|2|||
28026708|NCT00489736|54685199|FG000|Overall Study|Lack of Efficacy|53|||
28026709|NCT00489736|54685200|FG001|Overall Study|Lack of Efficacy|14|||
28026710|NCT00489736|54685199|FG000|Overall Study|Adverse Event|32|||
28026711|NCT00489736|54685200|FG001|Overall Study|Adverse Event|45|||
27802437|NCT01991743|54257486|FG002|Overall Study|external cephalic version not performed|1|||
27802438|NCT01991743|54257487|FG003|Overall Study|external cephalic version not performed|0|||
27802439|NCT01991197|54257499|FG000|Overall Study|Lost to Follow-up|1|||
27802440|NCT01991197|54257500|FG001|Overall Study|Lost to Follow-up|1|||
27802441|NCT01991197|54257499|FG000|Overall Study|Physician Decision|0|||
27802442|NCT01991197|54257500|FG001|Overall Study|Physician Decision|2|||
27802443|NCT01991197|54257499|FG000|Overall Study|Withdrawal by Subject|2|||
27802444|NCT01991197|54257500|FG001|Overall Study|Withdrawal by Subject|0|||
27802445|NCT01990573|54257514|FG000|Overall Study|Physician Decision|0|||
27802446|NCT01990573|54257515|FG001|Overall Study|Physician Decision|0|||
27802447|NCT01990573|54257516|FG002|Overall Study|Physician Decision|1|||
27802448|NCT01990495|54257526|FG000|Overall Study|Physician Decision|5|||
27802449|NCT01990495|54257527|FG001|Overall Study|Physician Decision|4|||
27802450|NCT01990339|54257535|FG000|Overall Study|Data Not Available|49|||
27802451|NCT01990339|54257535|FG000|Overall Study|Voluntary Withdrawal|1402|||
27802452|NCT01990339|54257535|FG000|Overall Study|Lost to Follow-up|861|||
27802453|NCT02007577|54257541|FG000|Overall Study|Adverse Event|1|||
27802454|NCT02007577|54257542|FG001|Overall Study|Adverse Event|0|||
27802455|NCT02007577|54257541|FG000|Overall Study|Withdrawal by Subject|0|||
27802456|NCT02007577|54257542|FG001|Overall Study|Withdrawal by Subject|1|||
27802457|NCT01990261|54257548|FG000|Overall Study|Death Before Treatment Start|2|||
27802458|NCT01990261|54257548|FG000|Overall Study|Death due to Disease Progression (PD)|10|||
27802459|NCT01990261|54257548|FG000|Overall Study|Death From other Causes|1|||
28026712|NCT00489736|54685199|FG000|Overall Study|Poor compliance|6|||
28026713|NCT00489736|54685200|FG001|Overall Study|Poor compliance|2|||
28026714|NCT00489736|54685199|FG000|Overall Study|Not coded/ Not pre-specified|5|||
28026715|NCT00489736|54685200|FG001|Overall Study|Not coded/ Not pre-specified|8|||
28026716|NCT00617084|54685208|FG000|Overall Study|Withdrawal by Subject|5|||
28026717|NCT00617084|54685209|FG001|Overall Study|Withdrawal by Subject|7|||
28026718|NCT00617084|54685208|FG000|Overall Study|Missed 12 Months visit|16|||
28026719|NCT00617084|54685209|FG001|Overall Study|Missed 12 Months visit|19|||
28026720|NCT00489424|54685218|FG000|Overall Study|Adverse Event|3|||
27802460|NCT01990261|54257548|FG000|Overall Study|Disease Progression (PD)|8|||
27802461|NCT01990261|54257548|FG000|Overall Study|PD Before Treatment Start|1|||
27802462|NCT01990261|54257548|FG000|Overall Study|Dossier not Approved|1|||
27802463|NCT01990261|54257548|FG000|Overall Study|Lost to Follow-up|2|||
27802464|NCT01963117|54257552|FG000|Overall Study|Death|1|||
27802465|NCT02007109|54257556|FG000|Overall Study|Diary not returned or excluded|102|||
28026721|NCT00489424|54685219|FG001|Overall Study|Adverse Event|3|||
28026722|NCT00489424|54685220|FG002|Overall Study|Adverse Event|4|||
28026723|NCT00489424|54685218|FG000|Overall Study|Lack of Efficacy|1|||
27802466|NCT02007109|54257556|FG000|Overall Study|Excluded - Age<7yo|9|||
27802467|NCT02006719|54257565|FG000|Overall Study|Withdrawal by Subject|10|||
28026724|NCT00489424|54685219|FG001|Overall Study|Lack of Efficacy|0|||
28026725|NCT00489424|54685220|FG002|Overall Study|Lack of Efficacy|0|||
28026726|NCT00489424|54685218|FG000|Overall Study|Administrative problems|0|||
28026727|NCT00489424|54685219|FG001|Overall Study|Administrative problems|2|||
28026728|NCT00489424|54685220|FG002|Overall Study|Administrative problems|1|||
28026729|NCT00614744|54685230|FG000|Overall Study|Lost to Follow-up|5|||
28026730|NCT00614744|54685231|FG001|Overall Study|Lost to Follow-up|4|||
28026731|NCT00614744|54685230|FG000|Overall Study|Incomplete for Behavior Issues|0|||
28026732|NCT00614744|54685231|FG001|Overall Study|Incomplete for Behavior Issues|2|||
28026733|NCT00565812|54685240|FG000|Overall Study|Death|2|||
28026734|NCT00565812|54685241|FG001|Overall Study|Death|1|||
28026735|NCT00565812|54685242|FG002|Overall Study|Death|3|||
28026736|NCT00565812|54685240|FG000|Overall Study|Did not Meet Entrance Criteria|1|||
28026737|NCT00565812|54685241|FG001|Overall Study|Did not Meet Entrance Criteria|0|||
28026738|NCT00565812|54685242|FG002|Overall Study|Did not Meet Entrance Criteria|1|||
28026739|NCT00565812|54685240|FG000|Overall Study|Lost to Follow-up|10|||
28026740|NCT00565812|54685241|FG001|Overall Study|Lost to Follow-up|8|||
28026741|NCT00565812|54685242|FG002|Overall Study|Lost to Follow-up|8|||
28026742|NCT00565812|54685240|FG000|Overall Study|Withdrawal by Subject|58|||
28026743|NCT00565812|54685241|FG001|Overall Study|Withdrawal by Subject|47|||
28026744|NCT00565812|54685242|FG002|Overall Study|Withdrawal by Subject|48|||
28026745|NCT00565812|54685240|FG000|Overall Study|Work Schedule|5|||
28026746|NCT00565812|54685241|FG001|Overall Study|Work Schedule|3|||
28026747|NCT00565812|54685242|FG002|Overall Study|Work Schedule|1|||
28026748|NCT00565812|54685240|FG000|Overall Study|Protocol Violation|2|||
28026749|NCT00565812|54685241|FG001|Overall Study|Protocol Violation|6|||
28026750|NCT00565812|54685242|FG002|Overall Study|Protocol Violation|4|||
28026751|NCT00565812|54685240|FG000|Overall Study|Adverse Event|41|||
28026752|NCT00565812|54685241|FG001|Overall Study|Adverse Event|54|||
28026753|NCT00565812|54685242|FG002|Overall Study|Adverse Event|40|||
28026754|NCT00565812|54685240|FG000|Overall Study|Jury Duty|1|||
28026755|NCT00565812|54685241|FG001|Overall Study|Jury Duty|0|||
28026756|NCT00565812|54685242|FG002|Overall Study|Jury Duty|0|||
28026757|NCT00565812|54685240|FG000|Overall Study|Relocated Out of Area|5|||
28026758|NCT00565812|54685241|FG001|Overall Study|Relocated Out of Area|8|||
28026759|NCT00565812|54685242|FG002|Overall Study|Relocated Out of Area|9|||
28026760|NCT00565812|54685240|FG000|Overall Study|Sponsor Decision|1|||
28026761|NCT00565812|54685241|FG001|Overall Study|Sponsor Decision|5|||
28026762|NCT00565812|54685242|FG002|Overall Study|Sponsor Decision|1|||
28026763|NCT00565812|54685240|FG000|Overall Study|Domestic Reasons|7|||
28026764|NCT00565812|54685241|FG001|Overall Study|Domestic Reasons|1|||
28026765|NCT00565812|54685242|FG002|Overall Study|Domestic Reasons|3|||
28026766|NCT00565812|54685240|FG000|Overall Study|Research Site Closure|6|||
28026767|NCT00565812|54685241|FG001|Overall Study|Research Site Closure|1|||
28026768|NCT00565812|54685242|FG002|Overall Study|Research Site Closure|8|||
28026769|NCT00565812|54685240|FG000|Overall Study|Surgical Intervention|0|||
28026770|NCT00565812|54685241|FG001|Overall Study|Surgical Intervention|1|||
28026771|NCT00565812|54685242|FG002|Overall Study|Surgical Intervention|2|||
28026772|NCT00565812|54685240|FG000|Overall Study|Low Compliance|1|||
28026773|NCT00565812|54685241|FG001|Overall Study|Low Compliance|0|||
28026774|NCT00565812|54685242|FG002|Overall Study|Low Compliance|1|||
28026775|NCT00565812|54685240|FG000|Overall Study|Follow-up Visit Not Completed|2|||
28026776|NCT00565812|54685241|FG001|Overall Study|Follow-up Visit Not Completed|0|||
28026777|NCT00565812|54685242|FG002|Overall Study|Follow-up Visit Not Completed|1|||
28026778|NCT00565812|54685240|FG000|Overall Study|Physician Decision|2|||
28026779|NCT00565812|54685241|FG001|Overall Study|Physician Decision|0|||
28026780|NCT00565812|54685242|FG002|Overall Study|Physician Decision|0|||
28026781|NCT03974334|54685250|FG000|Overall Study|Lost to Follow-up|1|||
28026782|NCT03970824|54685257|FG000|Overall Study|Withdrawal by Subject|1|||
28026783|NCT03970824|54685258|FG001|Overall Study|Withdrawal by Subject|1|||
28026784|NCT03970824|54685259|FG002|Overall Study|Withdrawal by Subject|3|||
28026785|NCT03970824|54685257|FG000|Overall Study|Lost to Follow-up|0|||
28026786|NCT03970824|54685258|FG001|Overall Study|Lost to Follow-up|2|||
28026787|NCT03970824|54685259|FG002|Overall Study|Lost to Follow-up|1|||
28026788|NCT03970824|54685257|FG000|Overall Study|Adverse Event|1|||
28026789|NCT03970824|54685258|FG001|Overall Study|Adverse Event|0|||
28026790|NCT03970824|54685259|FG002|Overall Study|Adverse Event|0|||
28026791|NCT00564486|54685270|FG000|Overall Study|Adverse Event|0|||
28026792|NCT00564486|54685271|FG001|Overall Study|Adverse Event|1|||
28026793|NCT00564486|54685272|FG002|Overall Study|Adverse Event|0|||
28026794|NCT00564486|54685273|FG003|Overall Study|Adverse Event|0|||
28026795|NCT00564486|54685270|FG000|Overall Study|Withdrawal by Subject|4|||
28026796|NCT00564486|54685271|FG001|Overall Study|Withdrawal by Subject|0|||
28026797|NCT00564486|54685272|FG002|Overall Study|Withdrawal by Subject|0|||
28026798|NCT00564486|54685273|FG003|Overall Study|Withdrawal by Subject|5|||
28026799|NCT00564486|54685270|FG000|Overall Study|Subject refused to have blood drawn|0|||
28026800|NCT00564486|54685271|FG001|Overall Study|Subject refused to have blood drawn|0|||
28026801|NCT00564486|54685272|FG002|Overall Study|Subject refused to have blood drawn|1|||
28026802|NCT00564486|54685273|FG003|Overall Study|Subject refused to have blood drawn|0|||
28026803|NCT00564486|54685270|FG000|Overall Study|Lost to Follow-up|3|||
28026804|NCT00564486|54685271|FG001|Overall Study|Lost to Follow-up|0|||
28026805|NCT00564486|54685272|FG002|Overall Study|Lost to Follow-up|2|||
27802468|NCT02006719|54257566|FG001|Overall Study|Withdrawal by Subject|2|||
27802469|NCT02006719|54257565|FG000|Overall Study|Lost to Follow-up|5|||
27802470|NCT02006719|54257566|FG001|Overall Study|Lost to Follow-up|1|||
27802471|NCT02006719|54257565|FG000|Overall Study|Protocol Violation|2|||
27802472|NCT02006719|54257566|FG001|Overall Study|Protocol Violation|0|||
27802473|NCT02006719|54257565|FG000|Overall Study|Adverse Event|1|||
27802474|NCT02006719|54257566|FG001|Overall Study|Adverse Event|1|||
27802475|NCT02006719|54257565|FG000|Overall Study|Other/Unknown|0|||
27802476|NCT02006719|54257566|FG001|Overall Study|Other/Unknown|1|||
27802477|NCT01962493|54257574|FG000|Overall Study|Adverse Event|1|||
27802478|NCT01962493|54257575|FG001|Overall Study|Adverse Event|2|||
27802479|NCT01962493|54257574|FG000|Overall Study|Protocol Violation|0|||
27802480|NCT01962493|54257575|FG001|Overall Study|Protocol Violation|1|||
27802481|NCT01962493|54257574|FG000|Overall Study|Withdrawal by Subject|4|||
27802482|NCT01962493|54257575|FG001|Overall Study|Withdrawal by Subject|2|||
27802483|NCT01989169|54257583|FG000|Period 2|Adverse Event|0|||
27802484|NCT01989169|54257584|FG001|Period 2|Adverse Event|1|||
27802485|NCT01988779|54257592|FG000|Overall Study|Withdrawal by Subject|2|||
27802486|NCT01988779|54257593|FG001|Overall Study|Withdrawal by Subject|2|||
27802487|NCT01988779|54257592|FG000|Overall Study|Protocol Violation|1|||
27802488|NCT01988779|54257593|FG001|Overall Study|Protocol Violation|0|||
27802489|NCT01988233|54257601|FG000|Overall Study|Lost to Follow-up|64|||
27802490|NCT01988233|54257602|FG001|Overall Study|Lost to Follow-up|51|||
27802491|NCT01987765|54257608|FG000|Overall Study|Protocol Violation|65|||
27802492|NCT01987765|54257608|FG000|Overall Study|Lost to Follow-up|37|||
27802493|NCT01987609|54257612|FG000|Overall Study|Adverse Event|1|||
27802494|NCT02013674|54257628|FG000|Overall Study|Death|0|||
27802495|NCT02013674|54257629|FG001|Overall Study|Death|1|||
27802496|NCT02013674|54257628|FG000|Overall Study|Lost to Follow-up|1|||
27802497|NCT02013674|54257629|FG001|Overall Study|Lost to Follow-up|0|||
27802498|NCT01987232|54257640|FG000|Overall Study|Ongoing in Study|0|||
27802499|NCT01987232|54257641|FG001|Overall Study|Ongoing in Study|0|||
27802500|NCT01987232|54257642|FG002|Overall Study|Ongoing in Study|0|||
27802501|NCT01987232|54257643|FG003|Overall Study|Ongoing in Study|1|||
27802502|NCT01987232|54257644|FG004|Overall Study|Ongoing in Study|0|||
27802503|NCT01986920|54257658|FG000|A- 101 25%|Withdrawal by Subject|1|||
27802504|NCT01986920|54257659|FG001|A- 101 25%|Withdrawal by Subject|0|||
27802505|NCT01986920|54257660|FG002|A- 101 25%|Withdrawal by Subject|0|||
27802506|NCT01986920|54257661|FG003|A- 101 25%|Withdrawal by Subject|0|||
27802507|NCT01986920|54257658|FG000|A-101 32.5%|Withdrawal by Subject|0|||
27802508|NCT01986920|54257659|FG001|A-101 32.5%|Withdrawal by Subject|1|||
27802509|NCT01986920|54257660|FG002|A-101 32.5%|Withdrawal by Subject|0|||
27802510|NCT01986920|54257661|FG003|A-101 32.5%|Withdrawal by Subject|0|||
27939126|NCT00962104|54595374|FG001|Overall Study|Lost to Follow-up|4|||
27939127|NCT00962104|54595373|FG000|Overall Study|Physician Decision|1|||
27939128|NCT00962104|54595374|FG001|Overall Study|Physician Decision|0|||
27939129|NCT00962104|54595373|FG000|Overall Study|Protocol Violation|6|||
27939130|NCT00962104|54595374|FG001|Overall Study|Protocol Violation|8|||
27939131|NCT00962104|54595373|FG000|Overall Study|Sponsor Decision|0|||
27939132|NCT00962104|54595374|FG001|Overall Study|Sponsor Decision|1|||
27939133|NCT00962104|54595373|FG000|Overall Study|Withdrawal by Subject|10|||
27939134|NCT00962104|54595374|FG001|Overall Study|Withdrawal by Subject|6|||
27939135|NCT00962104|54595373|FG000|Overall Study|Other|2|||
27939136|NCT00962104|54595374|FG001|Overall Study|Other|0|||
27939137|NCT02821000|54595380|FG000|Overall Study|Death|44|||
27939138|NCT02821000|54595380|FG000|Overall Study|Withdrawal by Subject|1|||
27939139|NCT02821000|54595380|FG000|Overall Study|Ongoing in Study|58|||
27939140|NCT00892099|54595387|FG000|Overall Study|Death|1|||
27939141|NCT00892099|54595388|FG001|Overall Study|Death|0|||
27939142|NCT00892099|54595389|FG002|Overall Study|Death|1|||
27802511|NCT01986920|54257658|FG000|A-101 40%|Withdrawal by Subject|0|||
27802512|NCT01986920|54257659|FG001|A-101 40%|Withdrawal by Subject|0|||
27802513|NCT01986920|54257660|FG002|A-101 40%|Withdrawal by Subject|1|||
27802514|NCT01986920|54257661|FG003|A-101 40%|Withdrawal by Subject|0|||
27802515|NCT01986920|54257658|FG000|Placebo|Withdrawal by Subject|0|||
27939143|NCT00892099|54595387|FG000|Overall Study|Adverse Event|1|||
28026806|NCT00564486|54685273|FG003|Overall Study|Lost to Follow-up|2|||
27802516|NCT01986920|54257659|FG001|Placebo|Withdrawal by Subject|0|||
27802517|NCT01986920|54257660|FG002|Placebo|Withdrawal by Subject|0|||
27802518|NCT01986920|54257661|FG003|Placebo|Withdrawal by Subject|1|||
27939144|NCT00892099|54595388|FG001|Overall Study|Adverse Event|0|||
27802519|NCT02010632|54257671|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
27802520|NCT02010632|54257672|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
27802521|NCT01986140|54257680|FG000|Overall Study|Withdrawal by Subject|31|||
27939145|NCT00892099|54595389|FG002|Overall Study|Adverse Event|0|||
27939146|NCT00892099|54595387|FG000|Overall Study|replocated|1|||
28026807|NCT00481078|54685289|FG000|Overall Study|Progression of disease|11|||
28026808|NCT00481078|54685290|FG001|Overall Study|Progression of disease|11|||
28026809|NCT00481078|54685289|FG000|Overall Study|Adverse Event|15|||
28026810|NCT00481078|54685290|FG001|Overall Study|Adverse Event|3|||
28026811|NCT00481078|54685289|FG000|Overall Study|Death|5|||
28026812|NCT00481078|54685290|FG001|Overall Study|Death|3|||
28026813|NCT00481078|54685289|FG000|Overall Study|Intercurrent illness|1|||
28026814|NCT00481078|54685290|FG001|Overall Study|Intercurrent illness|0|||
28026815|NCT00481078|54685289|FG000|Overall Study|Withdrawal by Subject|7|||
28026816|NCT00481078|54685290|FG001|Overall Study|Withdrawal by Subject|1|||
28026817|NCT00481078|54685289|FG000|Overall Study|Information not available|1|||
28026818|NCT00481078|54685290|FG001|Overall Study|Information not available|0|||
28026819|NCT00481078|54685289|FG000|Overall Study|Received other treatment|2|||
28026820|NCT00481078|54685290|FG001|Overall Study|Received other treatment|1|||
28026821|NCT00481078|54685289|FG000|Overall Study|Brain metastasis|0|||
28026822|NCT00481078|54685290|FG001|Overall Study|Brain metastasis|1|||
28026823|NCT00480532|54685300|FG000|Overall Study|Withdrawal by Subject|2|||
28026824|NCT00480532|54685301|FG001|Overall Study|Withdrawal by Subject|4|||
28026825|NCT00480532|54685302|FG002|Overall Study|Withdrawal by Subject|3|||
28026826|NCT00480532|54685303|FG003|Overall Study|Withdrawal by Subject|1|||
28026827|NCT00480532|54685300|FG000|Overall Study|Protocol Violation|0|||
28026828|NCT00480532|54685301|FG001|Overall Study|Protocol Violation|0|||
28026829|NCT00480532|54685302|FG002|Overall Study|Protocol Violation|1|||
28026830|NCT00480532|54685303|FG003|Overall Study|Protocol Violation|0|||
28026831|NCT00496366|54685313|FG000|Overall Study|Death|1|||
28026832|NCT00488644|54685317|FG000|Overall Study|Not Eligible|1|||
28026833|NCT00488644|54685317|FG000|Overall Study|Not Evaluable|1|||
28026834|NCT00564018|54685324|FG000|Overall Study|Withdrawal by Subject|2|||
28026835|NCT00564018|54685325|FG001|Overall Study|Withdrawal by Subject|3|||
28026836|NCT00564018|54685326|FG002|Overall Study|Withdrawal by Subject|1|||
28026837|NCT03381287|54685338|FG000|Overall Study|Withdrawal by Subject|0|||
28026838|NCT03381287|54685339|FG001|Overall Study|Withdrawal by Subject|1|||
28026839|NCT03381287|54685340|FG002|Overall Study|Withdrawal by Subject|0|||
28026840|NCT03381287|54685341|FG003|Overall Study|Withdrawal by Subject|0|||
28026841|NCT03381287|54685338|FG000|Overall Study|Adverse Event|0|||
27802522|NCT01986140|54257681|FG001|Overall Study|Withdrawal by Subject|25|||
28026842|NCT03381287|54685339|FG001|Overall Study|Adverse Event|0|||
28026843|NCT03381287|54685340|FG002|Overall Study|Adverse Event|0|||
28026844|NCT03381287|54685341|FG003|Overall Study|Adverse Event|1|||
28026845|NCT03381287|54685338|FG000|Overall Study|Physician Decision|0|||
28026846|NCT03381287|54685339|FG001|Overall Study|Physician Decision|0|||
28026847|NCT03381287|54685340|FG002|Overall Study|Physician Decision|0|||
28026848|NCT03381287|54685341|FG003|Overall Study|Physician Decision|1|||
28026849|NCT00616928|54685365|FG000|Overall Study|Adverse Event|6|||
28026850|NCT00616928|54685366|FG001|Overall Study|Adverse Event|3|||
28026851|NCT00616928|54685367|FG002|Overall Study|Adverse Event|2|||
28026852|NCT00616928|54685368|FG003|Overall Study|Adverse Event|2|||
28026853|NCT00616928|54685365|FG000|Overall Study|Other|51|||
28026854|NCT00616928|54685366|FG001|Overall Study|Other|8|||
28026855|NCT00616928|54685367|FG002|Overall Study|Other|15|||
28026856|NCT00616928|54685368|FG003|Overall Study|Other|5|||
28026857|NCT00616928|54685365|FG000|Overall Study|Lost to Follow-up|5|||
28026858|NCT00616928|54685366|FG001|Overall Study|Lost to Follow-up|7|||
28026859|NCT00616928|54685367|FG002|Overall Study|Lost to Follow-up|0|||
28026860|NCT00616928|54685368|FG003|Overall Study|Lost to Follow-up|0|||
28026861|NCT00563784|54685390|FG000|Overall Study|Withdrawal by Subject|2|||
28026862|NCT00563784|54685390|FG000|Overall Study|Screen Failures|20|||
28026863|NCT00203047|54685405|FG000|Overall Study|Ongoing: in database - January 29, 2009|131|||
28026864|NCT00203047|54685406|FG001|Overall Study|Ongoing: in database - January 29, 2009|109|||
28026865|NCT00203047|54685405|FG000|Overall Study|Ongoing: not in database - Jan 29, 2009|5|||
28026866|NCT00203047|54685406|FG001|Overall Study|Ongoing: not in database - Jan 29, 2009|1|||
28026867|NCT00203047|54685405|FG000|Overall Study|Withdrawal by Subject|13|||
28026868|NCT00203047|54685406|FG001|Overall Study|Withdrawal by Subject|47|||
28026869|NCT00203047|54685405|FG000|Overall Study|Teva requested participant withdrawal|1|||
27802523|NCT01986140|54257680|FG000|Overall Study|alternative treatment|1|||
27802524|NCT01986140|54257681|FG001|Overall Study|alternative treatment|1|||
28026870|NCT00203047|54685406|FG001|Overall Study|Teva requested participant withdrawal|1|||
28026871|NCT00203047|54685405|FG000|Overall Study|Physician Decision|8|||
28026872|NCT00203047|54685406|FG001|Overall Study|Physician Decision|7|||
28026873|NCT00203047|54685405|FG000|Overall Study|Non-compliance|4|||
28026874|NCT00203047|54685406|FG001|Overall Study|Non-compliance|8|||
28026875|NCT00203047|54685405|FG000|Overall Study|Protocol Violation|1|||
28026876|NCT00203047|54685406|FG001|Overall Study|Protocol Violation|0|||
28026877|NCT00203047|54685405|FG000|Overall Study|Lost to Follow-up|11|||
28026878|NCT00203047|54685406|FG001|Overall Study|Lost to Follow-up|5|||
28026879|NCT00203047|54685405|FG000|Overall Study|Adverse Event|8|||
28026880|NCT00203047|54685406|FG001|Overall Study|Adverse Event|18|||
28026881|NCT00203047|54685405|FG000|Overall Study|Death|1|||
28026882|NCT00203047|54685406|FG001|Overall Study|Death|2|||
28026883|NCT00203047|54685405|FG000|Overall Study|Pregnancy|3|||
28026884|NCT00203047|54685406|FG001|Overall Study|Pregnancy|0|||
28026885|NCT00203047|54685405|FG000|Overall Study|Other|5|||
28026886|NCT00203047|54685406|FG001|Overall Study|Other|5|||
28026887|NCT00142519|54685414|FG000|Overall Study|Not Treated|7|||
28026888|NCT00142519|54685415|FG001|Overall Study|Not Treated|9|||
27802525|NCT01986140|54257680|FG000|Overall Study|found not eligible|3|||
27802526|NCT01986140|54257681|FG001|Overall Study|found not eligible|0|||
27802527|NCT01986140|54257680|FG000|Overall Study|Adverse Event|0|||
27802528|NCT01986140|54257681|FG001|Overall Study|Adverse Event|1|||
28026889|NCT00142519|54685414|FG000|Overall Study|Protocol Violation|1|||
28026890|NCT00142519|54685415|FG001|Overall Study|Protocol Violation|0|||
28026891|NCT00142519|54685414|FG000|Overall Study|Withdrawal by Subject|10|||
28026892|NCT00142519|54685415|FG001|Overall Study|Withdrawal by Subject|7|||
28026893|NCT00141817|54685434|FG000|Overall Study|Protocol Violation|0|||
28026894|NCT00141817|54685435|FG001|Overall Study|Protocol Violation|0|||
28026895|NCT00141817|54685436|FG002|Overall Study|Protocol Violation|1|||
28026896|NCT00141817|54685437|FG003|Overall Study|Protocol Violation|0|||
28026897|NCT00141817|54685434|FG000|Overall Study|Parent request|1|||
28026898|NCT00141817|54685435|FG001|Overall Study|Parent request|0|||
28026899|NCT00141817|54685436|FG002|Overall Study|Parent request|0|||
27802529|NCT01986140|54257680|FG000|Overall Study|progression disease|0|||
27802530|NCT01986140|54257681|FG001|Overall Study|progression disease|1|||
28026900|NCT00141817|54685437|FG003|Overall Study|Parent request|0|||
28026901|NCT00573170|54685447|FG000|First Treatment Period|Did Not Treat Attack 1|0|||
28026902|NCT00573170|54685448|FG001|First Treatment Period|Did Not Treat Attack 1|0|||
28026903|NCT00573170|54685449|FG002|First Treatment Period|Did Not Treat Attack 1|0|||
28026904|NCT00573170|54685450|FG003|First Treatment Period|Did Not Treat Attack 1|0|||
28026905|NCT00573170|54685451|FG004|First Treatment Period|Did Not Treat Attack 1|1|||
28026906|NCT00573170|54685452|FG005|First Treatment Period|Did Not Treat Attack 1|0|||
28026907|NCT00573170|54685447|FG000|First Washout Period|Adverse Event|1|||
28026908|NCT00573170|54685448|FG001|First Washout Period|Adverse Event|1|||
28026909|NCT00573170|54685449|FG002|First Washout Period|Adverse Event|0|||
28026910|NCT00573170|54685450|FG003|First Washout Period|Adverse Event|0|||
28026911|NCT00573170|54685451|FG004|First Washout Period|Adverse Event|0|||
28026912|NCT00573170|54685452|FG005|First Washout Period|Adverse Event|1|||
28026913|NCT00573170|54685447|FG000|First Washout Period|Lack of Efficacy|0|||
28026914|NCT00573170|54685448|FG001|First Washout Period|Lack of Efficacy|0|||
27802531|NCT01986062|54257689|FG000|Overall Study|Lost to Follow-up|1|||
27802532|NCT01986062|54257690|FG001|Overall Study|Lost to Follow-up|0|||
27802533|NCT01986062|54257689|FG000|Overall Study|Withdrawal by Subject|0|||
27802534|NCT01986062|54257690|FG001|Overall Study|Withdrawal by Subject|1|||
27802535|NCT01985360|54257698|FG000|Overall Study|Withdrawal by Subject|4|||
28026915|NCT00573170|54685449|FG002|First Washout Period|Lack of Efficacy|0|||
28026916|NCT00573170|54685450|FG003|First Washout Period|Lack of Efficacy|0|||
28026917|NCT00573170|54685451|FG004|First Washout Period|Lack of Efficacy|0|||
28026918|NCT00573170|54685452|FG005|First Washout Period|Lack of Efficacy|1|||
28026919|NCT00573170|54685447|FG000|First Washout Period|Lost to Follow-up|1|||
28026920|NCT00573170|54685448|FG001|First Washout Period|Lost to Follow-up|1|||
28026921|NCT00573170|54685449|FG002|First Washout Period|Lost to Follow-up|0|||
28026922|NCT00573170|54685450|FG003|First Washout Period|Lost to Follow-up|2|||
28026923|NCT00573170|54685451|FG004|First Washout Period|Lost to Follow-up|0|||
28026924|NCT00573170|54685452|FG005|First Washout Period|Lost to Follow-up|2|||
28026925|NCT00573170|54685447|FG000|First Washout Period|Withdrawal by Subject|2|||
27802536|NCT01985360|54257699|FG001|Overall Study|Withdrawal by Subject|0|||
27802537|NCT01985360|54257698|FG000|Overall Study|Lost to Follow-up|5|||
27802538|NCT01985360|54257699|FG001|Overall Study|Lost to Follow-up|3|||
27802539|NCT02032706|54257705|FG000|Overall Study|Did not qualify|5|||
27802540|NCT02032706|54257705|FG000|Overall Study|Protocol Violation|1|||
27802541|NCT02032238|54257711|FG000|Overall Study|Lost to Follow-up|2|||
27802542|NCT02032238|54257712|FG001|Overall Study|Lost to Follow-up|0|||
27802543|NCT02009930|54257718|FG000|Overall Study|withdrawn|5|||
27802544|NCT01985126|54257731|FG000|Overall Study|Death|15|||
27802545|NCT01985126|54257732|FG001|Overall Study|Death|69|||
27802546|NCT01985126|54257731|FG000|Overall Study|Lost to Follow-up|0|||
27802547|NCT01985126|54257732|FG001|Overall Study|Lost to Follow-up|8|||
27802548|NCT01985126|54257731|FG000|Overall Study|Study Terminated By Sponsor|1|||
27802549|NCT01985126|54257732|FG001|Overall Study|Study Terminated By Sponsor|22|||
28026926|NCT00573170|54685448|FG001|First Washout Period|Withdrawal by Subject|0|||
28026927|NCT00573170|54685449|FG002|First Washout Period|Withdrawal by Subject|0|||
28026928|NCT00573170|54685450|FG003|First Washout Period|Withdrawal by Subject|2|||
28026929|NCT00573170|54685451|FG004|First Washout Period|Withdrawal by Subject|3|||
28026930|NCT00573170|54685452|FG005|First Washout Period|Withdrawal by Subject|3|||
28026931|NCT00573170|54685447|FG000|First Washout Period|Other|4|||
28026932|NCT00573170|54685448|FG001|First Washout Period|Other|0|||
28026933|NCT00573170|54685449|FG002|First Washout Period|Other|1|||
28026934|NCT00573170|54685450|FG003|First Washout Period|Other|1|||
28026935|NCT00573170|54685451|FG004|First Washout Period|Other|0|||
28026936|NCT00573170|54685452|FG005|First Washout Period|Other|0|||
28026937|NCT00573170|54685447|FG000|Second Washout Period|Adverse Event|1|||
28026938|NCT00573170|54685448|FG001|Second Washout Period|Adverse Event|0|||
28026939|NCT00573170|54685449|FG002|Second Washout Period|Adverse Event|0|||
28026940|NCT00573170|54685450|FG003|Second Washout Period|Adverse Event|0|||
28026941|NCT00573170|54685451|FG004|Second Washout Period|Adverse Event|1|||
28026942|NCT00573170|54685452|FG005|Second Washout Period|Adverse Event|0|||
28026943|NCT00573170|54685447|FG000|Second Washout Period|Protocol Violation|2|||
28026944|NCT00573170|54685448|FG001|Second Washout Period|Protocol Violation|1|||
28026945|NCT00573170|54685449|FG002|Second Washout Period|Protocol Violation|1|||
28026946|NCT00573170|54685450|FG003|Second Washout Period|Protocol Violation|0|||
28026947|NCT00573170|54685451|FG004|Second Washout Period|Protocol Violation|0|||
28026948|NCT00573170|54685452|FG005|Second Washout Period|Protocol Violation|0|||
28026949|NCT00573170|54685447|FG000|Second Washout Period|Withdrawal by Subject|1|||
28026950|NCT00573170|54685448|FG001|Second Washout Period|Withdrawal by Subject|1|||
28026951|NCT00573170|54685449|FG002|Second Washout Period|Withdrawal by Subject|2|||
28026952|NCT00573170|54685450|FG003|Second Washout Period|Withdrawal by Subject|0|||
28026953|NCT00573170|54685451|FG004|Second Washout Period|Withdrawal by Subject|1|||
28026954|NCT00573170|54685452|FG005|Second Washout Period|Withdrawal by Subject|0|||
28026955|NCT00573170|54685447|FG000|Second Washout Period|Lost to Follow-up|0|||
28026956|NCT00573170|54685448|FG001|Second Washout Period|Lost to Follow-up|0|||
28026957|NCT00573170|54685449|FG002|Second Washout Period|Lost to Follow-up|0|||
28026958|NCT00573170|54685450|FG003|Second Washout Period|Lost to Follow-up|1|||
28026959|NCT00573170|54685451|FG004|Second Washout Period|Lost to Follow-up|0|||
28026960|NCT00573170|54685452|FG005|Second Washout Period|Lost to Follow-up|0|||
28026961|NCT00573170|54685447|FG000|Second Washout Period|Other|1|||
28026962|NCT00573170|54685448|FG001|Second Washout Period|Other|2|||
28026963|NCT00573170|54685449|FG002|Second Washout Period|Other|1|||
28026964|NCT00573170|54685450|FG003|Second Washout Period|Other|4|||
28026965|NCT00573170|54685451|FG004|Second Washout Period|Other|6|||
28026966|NCT00573170|54685452|FG005|Second Washout Period|Other|2|||
28026967|NCT00573170|54685447|FG000|Third Treatment Period|Withdrawal by Subject|1|||
28026968|NCT00573170|54685448|FG001|Third Treatment Period|Withdrawal by Subject|0|||
28026969|NCT00573170|54685449|FG002|Third Treatment Period|Withdrawal by Subject|0|||
28026970|NCT00573170|54685450|FG003|Third Treatment Period|Withdrawal by Subject|0|||
28026971|NCT00573170|54685451|FG004|Third Treatment Period|Withdrawal by Subject|0|||
28026972|NCT00573170|54685452|FG005|Third Treatment Period|Withdrawal by Subject|0|||
28026973|NCT00573170|54685447|FG000|Third Treatment Period|Lost to Follow-up|0|||
28026974|NCT00573170|54685448|FG001|Third Treatment Period|Lost to Follow-up|0|||
28026975|NCT00573170|54685449|FG002|Third Treatment Period|Lost to Follow-up|0|||
28026976|NCT00573170|54685450|FG003|Third Treatment Period|Lost to Follow-up|0|||
28026977|NCT00573170|54685451|FG004|Third Treatment Period|Lost to Follow-up|0|||
28026978|NCT00573170|54685452|FG005|Third Treatment Period|Lost to Follow-up|2|||
28026979|NCT00201643|54685471|FG000|Overall Study|Withdrawal by Subject|5|||
28026980|NCT00201643|54685472|FG001|Overall Study|Withdrawal by Subject|4|||
28026981|NCT00130039|54685480|FG000|Overall Study|Withdrawal by Subject|15|||
28026982|NCT00130039|54685481|FG001|Overall Study|Withdrawal by Subject|11|||
28026983|NCT00130039|54685480|FG000|Overall Study|Lost to Follow-up|3|||
28026984|NCT00130039|54685481|FG001|Overall Study|Lost to Follow-up|1|||
28026985|NCT00130039|54685480|FG000|Overall Study|Adverse Event|4|||
28026986|NCT00130039|54685481|FG001|Overall Study|Adverse Event|2|||
28026987|NCT00130039|54685480|FG000|Overall Study|Physician Decision|3|||
28026988|NCT00130039|54685481|FG001|Overall Study|Physician Decision|0|||
28026989|NCT00130039|54685480|FG000|Overall Study|clinical events without follow up MRI|5|||
28026990|NCT00130039|54685481|FG001|Overall Study|clinical events without follow up MRI|4|||
28026991|NCT00475852|54685489|FG000|Overall Study|Death|444|||
28026992|NCT00475852|54685490|FG001|Overall Study|Death|456|||
28026993|NCT00475852|54685489|FG000|Overall Study|Withdrawal by Subject|19|||
28026994|NCT00475852|54685490|FG001|Overall Study|Withdrawal by Subject|24|||
28026995|NCT00475852|54685489|FG000|Overall Study|Lost to Follow-up|54|||
28026996|NCT00475852|54685490|FG001|Overall Study|Lost to Follow-up|68|||
28026997|NCT00141271|54685499|FG000|Overall Study|Adverse Event|31|||
28026998|NCT00141271|54685500|FG001|Overall Study|Adverse Event|19|||
28026999|NCT00141271|54685501|FG002|Overall Study|Adverse Event|17|||
28027000|NCT00141271|54685499|FG000|Overall Study|Laboratory Abnormality|2|||
28027001|NCT00141271|54685500|FG001|Overall Study|Laboratory Abnormality|1|||
28027002|NCT00141271|54685501|FG002|Overall Study|Laboratory Abnormality|1|||
28027003|NCT00141271|54685499|FG000|Overall Study|Lack of Efficacy|7|||
28027004|NCT00141271|54685500|FG001|Overall Study|Lack of Efficacy|7|||
28027005|NCT00141271|54685501|FG002|Overall Study|Lack of Efficacy|3|||
28027006|NCT00141271|54685499|FG000|Overall Study|Lost to Follow-up|15|||
28027007|NCT00141271|54685500|FG001|Overall Study|Lost to Follow-up|15|||
28027008|NCT00141271|54685501|FG002|Overall Study|Lost to Follow-up|21|||
27802550|NCT01985126|54257731|FG000|Overall Study|Withdrawal by Subject|2|||
27802551|NCT01985126|54257732|FG001|Overall Study|Withdrawal by Subject|7|||
27802552|NCT01984892|54257738|FG000|Overall Study|Progressive disease|7|||
27802553|NCT01807221|54257748|FG000|Overall Study|Progressive disease|1|||
27802554|NCT01807221|54257749|FG001|Overall Study|Progressive disease|0|||
27802555|NCT01807221|54257750|FG002|Overall Study|Progressive disease|1|||
27802556|NCT01807221|54257751|FG003|Overall Study|Progressive disease|0|||
28027009|NCT00141271|54685499|FG000|Overall Study|Withdrawal by Subject|14|||
28027010|NCT00141271|54685500|FG001|Overall Study|Withdrawal by Subject|9|||
28027011|NCT00141271|54685501|FG002|Overall Study|Withdrawal by Subject|10|||
28027012|NCT00141271|54685499|FG000|Overall Study|Other|11|||
28027013|NCT00141271|54685500|FG001|Overall Study|Other|12|||
28027014|NCT00141271|54685501|FG002|Overall Study|Other|5|||
28027015|NCT00614120|54685513|FG000|Overall Study|Adverse Event|9|||
28027016|NCT00614120|54685514|FG001|Overall Study|Adverse Event|22|||
28027017|NCT00614120|54685515|FG002|Overall Study|Adverse Event|30|||
28027018|NCT00614120|54685516|FG003|Overall Study|Adverse Event|3|||
28027019|NCT00614120|54685513|FG000|Overall Study|Lack of Efficacy|3|||
28027020|NCT00614120|54685514|FG001|Overall Study|Lack of Efficacy|3|||
28027021|NCT00614120|54685515|FG002|Overall Study|Lack of Efficacy|2|||
28027022|NCT00614120|54685516|FG003|Overall Study|Lack of Efficacy|2|||
28027023|NCT00614120|54685513|FG000|Overall Study|Protocol Violation|2|||
28027024|NCT00614120|54685514|FG001|Overall Study|Protocol Violation|5|||
28027025|NCT00614120|54685515|FG002|Overall Study|Protocol Violation|3|||
28027026|NCT00614120|54685516|FG003|Overall Study|Protocol Violation|1|||
28027027|NCT00614120|54685513|FG000|Overall Study|Withdrawal criteria|1|||
28027028|NCT00614120|54685514|FG001|Overall Study|Withdrawal criteria|0|||
28027029|NCT00614120|54685515|FG002|Overall Study|Withdrawal criteria|0|||
27802557|NCT01807221|54257752|FG004|Overall Study|Progressive disease|0|||
27939147|NCT00892099|54595388|FG001|Overall Study|replocated|0|||
27939148|NCT00892099|54595389|FG002|Overall Study|replocated|2|||
27939149|NCT00892099|54595387|FG000|Overall Study|Prolonged hospitalization|1|||
27939150|NCT00892099|54595388|FG001|Overall Study|Prolonged hospitalization|0|||
27939151|NCT00892099|54595389|FG002|Overall Study|Prolonged hospitalization|1|||
27939152|NCT00892099|54595387|FG000|Overall Study|no further details|1|||
27939153|NCT00892099|54595388|FG001|Overall Study|no further details|0|||
27939154|NCT00892099|54595389|FG002|Overall Study|no further details|1|||
27939155|NCT00892099|54595387|FG000|Overall Study|kidney function recovered|0|||
27939156|NCT00892099|54595388|FG001|Overall Study|kidney function recovered|1|||
27939157|NCT00892099|54595389|FG002|Overall Study|kidney function recovered|0|||
27939158|NCT00892099|54595387|FG000|Overall Study|investigator decision|0|||
27939159|NCT00892099|54595388|FG001|Overall Study|investigator decision|0|||
27939160|NCT00892099|54595389|FG002|Overall Study|investigator decision|1|||
27939161|NCT00892099|54595387|FG000|Overall Study|Lost to Follow-up|0|||
27939162|NCT00892099|54595388|FG001|Overall Study|Lost to Follow-up|0|||
27939163|NCT00892099|54595389|FG002|Overall Study|Lost to Follow-up|1|||
27939164|NCT00960856|54595397|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
27939165|NCT00960856|54595398|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
27939166|NCT00960856|54595399|FG002|Washout Period of 7 Days|Withdrawal by Subject|0|||
27939167|NCT00960856|54595400|FG003|Washout Period of 7 Days|Withdrawal by Subject|0|||
27939168|NCT00960856|54595397|FG000|Washout Period of 7 Days|Adverse Event|0|||
27939169|NCT00960856|54595398|FG001|Washout Period of 7 Days|Adverse Event|0|||
27939170|NCT00960856|54595399|FG002|Washout Period of 7 Days|Adverse Event|1|||
27939171|NCT00960856|54595400|FG003|Washout Period of 7 Days|Adverse Event|0|||
27939172|NCT00958438|54595413|FG000|Overall Study|Protocol Violation|3|||
27939173|NCT00958438|54595414|FG001|Overall Study|Protocol Violation|2|||
27939174|NCT00958438|54595415|FG002|Overall Study|Protocol Violation|2|||
27939175|NCT00958438|54595413|FG000|Overall Study|Withdrawal by Subject|4|||
27939176|NCT00958438|54595414|FG001|Overall Study|Withdrawal by Subject|2|||
27939177|NCT00958438|54595415|FG002|Overall Study|Withdrawal by Subject|1|||
27939178|NCT00958438|54595413|FG000|Overall Study|Adverse Event|0|||
27939179|NCT00958438|54595414|FG001|Overall Study|Adverse Event|3|||
27939180|NCT00958438|54595415|FG002|Overall Study|Adverse Event|0|||
27939181|NCT00958438|54595413|FG000|Overall Study|Physician Decision|1|||
27939182|NCT00958438|54595414|FG001|Overall Study|Physician Decision|0|||
27939183|NCT00958438|54595415|FG002|Overall Study|Physician Decision|1|||
28027030|NCT00614120|54685516|FG003|Overall Study|Withdrawal criteria|0|||
28027031|NCT00614120|54685513|FG000|Overall Study|Withdrawal by Subject|9|||
28027032|NCT00614120|54685514|FG001|Overall Study|Withdrawal by Subject|10|||
27802558|NCT01807221|54257753|FG005|Overall Study|Progressive disease|0|||
27802559|NCT01807221|54257748|FG000|Overall Study|Death|7|||
27802560|NCT01807221|54257749|FG001|Overall Study|Death|9|||
27802561|NCT01807221|54257750|FG002|Overall Study|Death|4|||
28027033|NCT00614120|54685515|FG002|Overall Study|Withdrawal by Subject|16|||
28027034|NCT00614120|54685516|FG003|Overall Study|Withdrawal by Subject|3|||
28027035|NCT00614120|54685513|FG000|Overall Study|Did not meet trial criteria|0|||
28027036|NCT00614120|54685514|FG001|Overall Study|Did not meet trial criteria|1|||
28027037|NCT00614120|54685515|FG002|Overall Study|Did not meet trial criteria|1|||
28027038|NCT00614120|54685516|FG003|Overall Study|Did not meet trial criteria|1|||
28027039|NCT00614120|54685513|FG000|Overall Study|hCG positive (not pregnant)|0|||
28027040|NCT00614120|54685514|FG001|Overall Study|hCG positive (not pregnant)|0|||
28027041|NCT00614120|54685515|FG002|Overall Study|hCG positive (not pregnant)|1|||
28027042|NCT00614120|54685516|FG003|Overall Study|hCG positive (not pregnant)|0|||
28027043|NCT00614120|54685513|FG000|Overall Study|Hypoglycaemia|0|||
28027044|NCT00614120|54685514|FG001|Overall Study|Hypoglycaemia|0|||
28027045|NCT00614120|54685515|FG002|Overall Study|Hypoglycaemia|0|||
28027046|NCT00614120|54685516|FG003|Overall Study|Hypoglycaemia|1|||
28027047|NCT00614120|54685513|FG000|Overall Study|Lack of trial product|3|||
28027048|NCT00614120|54685514|FG001|Overall Study|Lack of trial product|3|||
28027049|NCT00614120|54685515|FG002|Overall Study|Lack of trial product|2|||
28027050|NCT00614120|54685516|FG003|Overall Study|Lack of trial product|0|||
28027051|NCT00614120|54685513|FG000|Overall Study|Late syphilis, latent|1|||
28027052|NCT00614120|54685514|FG001|Overall Study|Late syphilis, latent|0|||
28027053|NCT00614120|54685515|FG002|Overall Study|Late syphilis, latent|0|||
28027054|NCT00614120|54685516|FG003|Overall Study|Late syphilis, latent|0|||
28027055|NCT00614120|54685513|FG000|Overall Study|Taken inhibition medication eg Prandin|0|||
28027056|NCT00614120|54685514|FG001|Overall Study|Taken inhibition medication eg Prandin|0|||
28027057|NCT00614120|54685515|FG002|Overall Study|Taken inhibition medication eg Prandin|1|||
28027058|NCT00614120|54685516|FG003|Overall Study|Taken inhibition medication eg Prandin|1|||
28027059|NCT00614120|54685513|FG000|Overall Study|Lost to Follow-up|1|||
28027060|NCT00614120|54685514|FG001|Overall Study|Lost to Follow-up|2|||
28027061|NCT00614120|54685515|FG002|Overall Study|Lost to Follow-up|3|||
28027062|NCT00614120|54685516|FG003|Overall Study|Lost to Follow-up|4|||
28027063|NCT00496054|54685526|FG000|Overall Study|Adverse Event|1|||
28027064|NCT00496054|54685526|FG000|Overall Study|Lost to Follow-up|7|||
28027065|NCT00495820|54685532|FG000|Overall Study|Adverse Event|1|||
28027066|NCT00495820|54685533|FG001|Overall Study|Adverse Event|1|||
28027067|NCT00495586|54685541|FG000|Overall Study|Withdrawal by Subject|4|||
28027068|NCT00495586|54685542|FG001|Overall Study|Withdrawal by Subject|4|||
28027069|NCT00613730|54685550|FG000|Overall Study|Disease progression|2|||
28027070|NCT00613730|54685550|FG000|Overall Study|Administrative decision|1|||
28027071|NCT00613574|54685554|FG000|Overall Study|Adverse Event|3|||
28027072|NCT00613574|54685554|FG000|Overall Study|Lost to Follow-up|2|||
28027073|NCT00613574|54685554|FG000|Overall Study|Other|1|||
28027074|NCT00613106|54685560|FG000|Overall Study|Adverse Event|3|||
28027075|NCT00613106|54685561|FG001|Overall Study|Adverse Event|1|||
28027076|NCT00613106|54685560|FG000|Overall Study|Withdrawal by Subject|6|||
28027077|NCT00613106|54685561|FG001|Overall Study|Withdrawal by Subject|3|||
28027078|NCT00613106|54685560|FG000|Overall Study|Lost to Follow-up|7|||
28027079|NCT00613106|54685561|FG001|Overall Study|Lost to Follow-up|2|||
28027080|NCT00613106|54685560|FG000|Overall Study|misc|4|||
28027081|NCT00613106|54685561|FG001|Overall Study|misc|3|||
28027082|NCT00141037|54685569|FG000|Overall Study|Physician Decision|1|||
28027083|NCT00141037|54685570|FG001|Overall Study|Physician Decision|2|||
28027084|NCT00141037|54685569|FG000|Overall Study|Lost to Follow-up|3|||
28027085|NCT00141037|54685570|FG001|Overall Study|Lost to Follow-up|1|||
28027086|NCT00141037|54685569|FG000|Overall Study|Protocol Violation|0|||
28027087|NCT00141037|54685570|FG001|Overall Study|Protocol Violation|2|||
28027088|NCT00141037|54685569|FG000|Overall Study|Withdrawal by Subject|2|||
28027089|NCT00141037|54685570|FG001|Overall Study|Withdrawal by Subject|1|||
28027090|NCT00141037|54685569|FG000|Overall Study|Other|0|||
28027091|NCT00141037|54685570|FG001|Overall Study|Other|1|||
28027092|NCT00141037|54685569|FG000|Overall Study|Moved from area|1|||
28027093|NCT00141037|54685570|FG001|Overall Study|Moved from area|7|||
28027094|NCT00141037|54685569|FG000|Overall Study|Graft Failure|3|||
28027095|NCT00141037|54685570|FG001|Overall Study|Graft Failure|4|||
28027096|NCT00140413|54685579|FG000|Overall Study|Lost to Follow-up|1|||
28027097|NCT00140413|54685580|FG001|Overall Study|Lost to Follow-up|0|||
28027098|NCT00140413|54685579|FG000|Overall Study|Withdrawal by Subject|2|||
28027099|NCT00140413|54685580|FG001|Overall Study|Withdrawal by Subject|0|||
28027100|NCT00563706|54685596|FG000|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4|||
28027101|NCT00563706|54685597|FG001|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
28027102|NCT00563706|54685598|FG002|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
28027103|NCT00563706|54685599|FG003|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
27842866|NCT01574651|54331757|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
28027104|NCT00563706|54685600|FG004|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
28027105|NCT00563706|54685601|FG005|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
28027106|NCT00563706|54685602|FG006|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
28027107|NCT00563706|54685603|FG007|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
28027108|NCT00563706|54685604|FG008|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5|||
28027109|NCT00563706|54685596|FG000|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
28027110|NCT00563706|54685597|FG001|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
28027111|NCT00563706|54685598|FG002|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
28027112|NCT00563706|54685599|FG003|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4|||
28027113|NCT00563706|54685600|FG004|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
28027114|NCT00563706|54685601|FG005|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
28027115|NCT00563706|54685602|FG006|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
28027116|NCT00563706|54685603|FG007|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5|||
28027117|NCT00563706|54685604|FG008|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
28027118|NCT00563706|54685596|FG000|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9|||
28027119|NCT00563706|54685597|FG001|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
28027120|NCT00563706|54685598|FG002|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2|||
28027121|NCT00563706|54685599|FG003|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5|||
28027122|NCT00563706|54685600|FG004|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4|||
28027123|NCT00563706|54685601|FG005|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
28027124|NCT00563706|54685602|FG006|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1|||
28027125|NCT00563706|54685603|FG007|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6|||
28027126|NCT00563706|54685604|FG008|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
28027127|NCT00563706|54685596|FG000|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2|||
28027128|NCT00563706|54685597|FG001|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
28027129|NCT00563706|54685598|FG002|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
28027130|NCT00563706|54685599|FG003|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
28027131|NCT00563706|54685600|FG004|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
28027132|NCT00563706|54685601|FG005|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
28027133|NCT00563706|54685602|FG006|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
28027134|NCT00563706|54685603|FG007|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1|||
28027135|NCT00563706|54685604|FG008|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
28027136|NCT00563706|54685596|FG000|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
28027137|NCT00563706|54685597|FG001|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
28027138|NCT00563706|54685598|FG002|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
28027139|NCT00563706|54685599|FG003|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
28027140|NCT00563706|54685600|FG004|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
28027141|NCT00563706|54685601|FG005|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
28027142|NCT00563706|54685602|FG006|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
28027143|NCT00563706|54685603|FG007|DB Treatment Period (Day 1 up to Day 28)|Other|1|||
28027144|NCT00563706|54685604|FG008|DB Treatment Period (Day 1 up to Day 28)|Other|2|||
28027145|NCT00129961|54685626|FG000|Overall Study|Adverse Event|1|||
28027146|NCT00129961|54685627|FG001|Overall Study|Adverse Event|0|||
28027147|NCT00129961|54685626|FG000|Overall Study|Death|1|||
28027148|NCT00129961|54685627|FG001|Overall Study|Death|1|||
28027149|NCT00129961|54685626|FG000|Overall Study|Withdrawal by Sponsor|14|||
28027150|NCT00129961|54685627|FG001|Overall Study|Withdrawal by Sponsor|20|||
28027151|NCT00129961|54685626|FG000|Overall Study|Physician Decision|1|||
28027152|NCT00129961|54685627|FG001|Overall Study|Physician Decision|0|||
28027153|NCT00129961|54685626|FG000|Overall Study|Withdrawal by Subject|2|||
28027154|NCT00129961|54685627|FG001|Overall Study|Withdrawal by Subject|1|||
28027155|NCT00129961|54685626|FG000|Overall Study|Missing Record|0|||
28027156|NCT00129961|54685627|FG001|Overall Study|Missing Record|1|||
28027157|NCT00528567|54685635|FG000|Overall Study|Death|4|||
28027158|NCT00528567|54685636|FG001|Overall Study|Death|5|||
28027159|NCT00528567|54685635|FG000|Overall Study|Breast Cancer Recurrence/2nd Primary|30|||
28027160|NCT00528567|54685636|FG001|Overall Study|Breast Cancer Recurrence/2nd Primary|60|||
28027161|NCT00528567|54685635|FG000|Overall Study|Adverse Event/Intermittent Illness|255|||
28027162|NCT00528567|54685636|FG001|Overall Study|Adverse Event/Intermittent Illness|29|||
28027163|NCT00528567|54685635|FG000|Overall Study|Violation Criteria at Entry|3|||
28027164|NCT00528567|54685636|FG001|Overall Study|Violation Criteria at Entry|17|||
28027165|NCT00528567|54685635|FG000|Overall Study|Withdrew Consent|59|||
28027166|NCT00528567|54685636|FG001|Overall Study|Withdrew Consent|55|||
27842867|NCT01574651|54331758|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
27842868|NCT01574651|54331757|FG000|Overall Study|Protocol Violation|3|||
28027167|NCT00528567|54685635|FG000|Overall Study|Refused Treatment/Did Not Cooperate|52|||
28027168|NCT00528567|54685636|FG001|Overall Study|Refused Treatment/Did Not Cooperate|42|||
28027169|NCT00528567|54685635|FG000|Overall Study|Failure to Return|1|||
27842869|NCT01574651|54331758|FG001|Overall Study|Protocol Violation|5|||
27939184|NCT00958438|54595413|FG000|Overall Study|Other than specified above|2|||
27939185|NCT00958438|54595414|FG001|Overall Study|Other than specified above|3|||
27939186|NCT00958438|54595415|FG002|Overall Study|Other than specified above|2|||
27939187|NCT00958360|54595425|FG000|Overall Study|Withdrawal by Subject|3|||
27939188|NCT00958360|54595426|FG001|Overall Study|Withdrawal by Subject|1|||
27939189|NCT00958360|54595425|FG000|Overall Study|Death|6|||
27939190|NCT00958360|54595426|FG001|Overall Study|Death|7|||
27939191|NCT00958360|54595425|FG000|Overall Study|Physician Decision|2|||
28027170|NCT00528567|54685636|FG001|Overall Study|Failure to Return|4|||
28027171|NCT00528567|54685635|FG000|Overall Study|Other Protocol Violation|5|||
28027172|NCT00528567|54685636|FG001|Overall Study|Other Protocol Violation|21|||
28027173|NCT00528567|54685635|FG000|Overall Study|Administrative/Other|22|||
28027174|NCT00528567|54685636|FG001|Overall Study|Administrative/Other|75|||
27842870|NCT01574651|54331757|FG000|Overall Study|Withdrawal by Subject|9|||
27939192|NCT00958360|54595426|FG001|Overall Study|Physician Decision|1|||
28027175|NCT00138151|54685649|FG000|Overall Study|Withdrawal by Subject|3|||
28027176|NCT00138151|54685649|FG000|Overall Study|Physician Decision|1|||
28027177|NCT00138073|54685653|FG000|Overall Study|lack of resources|55|||
28027178|NCT02581631|54685662|FG000|Overall Study|Disease progression|29|||
28027179|NCT02581631|54685663|FG001|Overall Study|Disease progression|19|||
28027180|NCT02581631|54685664|FG002|Overall Study|Disease progression|13|||
28027181|NCT02581631|54685665|FG003|Overall Study|Disease progression|5|||
28027182|NCT02581631|54685666|FG004|Overall Study|Disease progression|8|||
28027183|NCT02581631|54685662|FG000|Overall Study|Study drug toxicity|4|||
28027184|NCT02581631|54685663|FG001|Overall Study|Study drug toxicity|6|||
28027185|NCT02581631|54685664|FG002|Overall Study|Study drug toxicity|7|||
28027186|NCT02581631|54685665|FG003|Overall Study|Study drug toxicity|0|||
27939193|NCT00958360|54595425|FG000|Overall Study|Lost to Follow-up|0|||
27939194|NCT00958360|54595426|FG001|Overall Study|Lost to Follow-up|1|||
27939195|NCT00888433|54595434|FG000|Overall Study|Withdrawal by Subject|1|||
27939196|NCT00888433|54595435|FG001|Overall Study|Withdrawal by Subject|2|||
27939197|NCT00888433|54595434|FG000|Overall Study|Missed Visit|2|||
27939198|NCT00888433|54595435|FG001|Overall Study|Missed Visit|1|||
27939199|NCT01243424|54595443|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49|||
27939200|NCT01243424|54595444|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37|||
27939201|NCT01243424|54595443|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14|||
27939202|NCT01243424|54595444|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12|||
27939203|NCT01243424|54595443|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15|||
27939204|NCT01243424|54595444|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22|||
27939205|NCT01243424|54595443|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0|||
27939206|NCT01243424|54595444|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1|||
27939207|NCT01243424|54595443|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38|||
27939208|NCT01243424|54595444|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35|||
27939209|NCT01243424|54595443|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
27939210|NCT01243424|54595444|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
27939211|NCT01243424|54595443|FG000|Discontinuation From Study (Treated Set)|Not treated|5|||
27939212|NCT01243424|54595444|FG001|Discontinuation From Study (Treated Set)|Not treated|4|||
27939213|NCT01243424|54595443|FG000|Discontinuation From Treatment|Not treated|5|||
27939214|NCT01243424|54595444|FG001|Discontinuation From Treatment|Not treated|4|||
27939215|NCT01243424|54595443|FG000|Discontinuation From Treatment|Adverse Event|457|||
27939216|NCT01243424|54595444|FG001|Discontinuation From Treatment|Adverse Event|523|||
27939217|NCT01243424|54595443|FG000|Discontinuation From Treatment|Lack of Efficacy|61|||
27939218|NCT01243424|54595444|FG001|Discontinuation From Treatment|Lack of Efficacy|41|||
27939219|NCT01243424|54595443|FG000|Discontinuation From Treatment|Protocol Violation|46|||
27939220|NCT01243424|54595444|FG001|Discontinuation From Treatment|Protocol Violation|47|||
27939221|NCT01243424|54595443|FG000|Discontinuation From Treatment|Lost to Follow-up|24|||
27939222|NCT01243424|54595444|FG001|Discontinuation From Treatment|Lost to Follow-up|28|||
28027187|NCT02581631|54685666|FG004|Overall Study|Study drug toxicity|3|||
28027188|NCT02581631|54685662|FG000|Overall Study|AE unrelated to study drug|3|||
28027189|NCT02581631|54685663|FG001|Overall Study|AE unrelated to study drug|1|||
28027190|NCT02581631|54685664|FG002|Overall Study|AE unrelated to study drug|1|||
28027191|NCT02581631|54685665|FG003|Overall Study|AE unrelated to study drug|0|||
28027192|NCT02581631|54685666|FG004|Overall Study|AE unrelated to study drug|2|||
28027193|NCT02581631|54685662|FG000|Overall Study|Request to discontinue|1|||
28027194|NCT02581631|54685663|FG001|Overall Study|Request to discontinue|0|||
28027195|NCT02581631|54685664|FG002|Overall Study|Request to discontinue|3|||
28027196|NCT02581631|54685665|FG003|Overall Study|Request to discontinue|0|||
28027197|NCT02581631|54685666|FG004|Overall Study|Request to discontinue|1|||
28027198|NCT02581631|54685662|FG000|Overall Study|participant withdrew consent|3|||
27802562|NCT01807221|54257751|FG003|Overall Study|Death|2|||
28027199|NCT02581631|54685663|FG001|Overall Study|participant withdrew consent|0|||
28027200|NCT02581631|54685664|FG002|Overall Study|participant withdrew consent|1|||
28027201|NCT02581631|54685665|FG003|Overall Study|participant withdrew consent|0|||
28027202|NCT02581631|54685666|FG004|Overall Study|participant withdrew consent|0|||
28027203|NCT02581631|54685662|FG000|Overall Study|Maximum clinical benefit|1|||
28027204|NCT02581631|54685663|FG001|Overall Study|Maximum clinical benefit|7|||
28027205|NCT02581631|54685664|FG002|Overall Study|Maximum clinical benefit|1|||
28027206|NCT02581631|54685665|FG003|Overall Study|Maximum clinical benefit|3|||
28027207|NCT02581631|54685666|FG004|Overall Study|Maximum clinical benefit|13|||
28027208|NCT02581631|54685662|FG000|Overall Study|Other Reasons|1|||
28027209|NCT02581631|54685663|FG001|Overall Study|Other Reasons|0|||
28027210|NCT02581631|54685664|FG002|Overall Study|Other Reasons|2|||
28027211|NCT02581631|54685665|FG003|Overall Study|Other Reasons|2|||
28027212|NCT02581631|54685666|FG004|Overall Study|Other Reasons|3|||
28027213|NCT02581631|54685662|FG000|Overall Study|Poor/Non-Compliance|0|||
28027214|NCT02581631|54685663|FG001|Overall Study|Poor/Non-Compliance|0|||
28027215|NCT02581631|54685664|FG002|Overall Study|Poor/Non-Compliance|1|||
28027216|NCT02581631|54685665|FG003|Overall Study|Poor/Non-Compliance|0|||
28027217|NCT02581631|54685666|FG004|Overall Study|Poor/Non-Compliance|0|||
28027218|NCT00529035|54685678|FG000|Overall Study|Withdrawal by Subject|1|||
28027219|NCT00609674|54685691|FG000|Overall Study|Adverse Event|1|||
28027220|NCT00609674|54685692|FG001|Overall Study|Adverse Event|1|||
28027221|NCT00609674|54685691|FG000|Overall Study|Protocol Violation|3|||
28027222|NCT00609674|54685692|FG001|Overall Study|Protocol Violation|5|||
28027223|NCT00609674|54685691|FG000|Overall Study|Lost to Follow-up|1|||
28027224|NCT00609674|54685692|FG001|Overall Study|Lost to Follow-up|0|||
28027225|NCT00609674|54685691|FG000|Overall Study|Withdrew consent|2|||
28027226|NCT00609674|54685692|FG001|Overall Study|Withdrew consent|1|||
28027227|NCT00137839|54685698|FG000|Overall Study|Adverse Event|7|||
28027228|NCT00137839|54685698|FG000|Overall Study|Physician Decision|7|||
28027229|NCT00137839|54685698|FG000|Overall Study|Death|8|||
28027230|NCT00137839|54685698|FG000|Overall Study|Disease Progression|60|||
27802563|NCT01807221|54257752|FG004|Overall Study|Death|1|||
28027231|NCT00137839|54685698|FG000|Overall Study|Not Start Treatment|1|||
28027232|NCT00137839|54685698|FG000|Overall Study|Prolonged Treatment Delay|1|||
28027233|NCT00563316|54685705|FG000|Overall Study|Adverse Event|2|||
27802564|NCT01807221|54257753|FG005|Overall Study|Death|6|||
28027234|NCT00563316|54685705|FG000|Overall Study|Physician Decision|1|||
28027235|NCT00563316|54685705|FG000|Overall Study|Lost to Follow-up|2|||
28027236|NCT00563316|54685705|FG000|Overall Study|Death|1|||
28027237|NCT00563316|54685705|FG000|Overall Study|On-going in study as of 16 July 2009.|5|||
28027238|NCT00563316|54685705|FG000|Overall Study|Other|1|||
27802565|NCT01807221|54257748|FG000|Overall Study|Physician Decision|2|||
27842871|NCT01574651|54331758|FG001|Overall Study|Withdrawal by Subject|10|||
27842872|NCT01440803|54331770|FG000|Overall Study|Met study stopping rule|2|||
27842873|NCT01440803|54331771|FG001|Overall Study|Met study stopping rule|1|||
27842874|NCT01440803|54331770|FG000|Overall Study|Lost to Follow-up|0|||
27842875|NCT01440803|54331771|FG001|Overall Study|Lost to Follow-up|2|||
27842876|NCT01440803|54331770|FG000|Overall Study|Withdrawal by Subject|0|||
27842877|NCT01440803|54331771|FG001|Overall Study|Withdrawal by Subject|1|||
27842878|NCT01517282|54331782|FG000|Overall Study|Consent withdrawn|0|||
27842879|NCT01517282|54331783|FG001|Overall Study|Consent withdrawn|1|||
27842880|NCT01517282|54331784|FG002|Overall Study|Consent withdrawn|1|||
27842881|NCT01517282|54331785|FG003|Overall Study|Consent withdrawn|1|||
27842882|NCT01517282|54331782|FG000|Overall Study|Physician Decision|1|||
27802566|NCT01807221|54257749|FG001|Overall Study|Physician Decision|1|||
27802567|NCT01807221|54257750|FG002|Overall Study|Physician Decision|0|||
27802568|NCT01807221|54257751|FG003|Overall Study|Physician Decision|0|||
27802569|NCT01807221|54257752|FG004|Overall Study|Physician Decision|0|||
27802570|NCT01807221|54257753|FG005|Overall Study|Physician Decision|0|||
27802571|NCT01807221|54257748|FG000|Overall Study|Adverse Event|33|||
27802572|NCT01807221|54257749|FG001|Overall Study|Adverse Event|22|||
27842883|NCT01517282|54331783|FG001|Overall Study|Physician Decision|0|||
27842884|NCT01517282|54331784|FG002|Overall Study|Physician Decision|0|||
27842885|NCT01517282|54331785|FG003|Overall Study|Physician Decision|0|||
27842886|NCT01440647|54331806|FG000|Overall Study|Death|2|||
27842887|NCT01440647|54331807|FG001|Overall Study|Death|3|||
27842888|NCT01516970|54331815|FG000|Overall Study|Lost to Follow-up|7|||
27842889|NCT01516970|54331816|FG001|Overall Study|Lost to Follow-up|8|||
27842890|NCT01516970|54331815|FG000|Overall Study|Adverse Event|1|||
27842891|NCT01516970|54331816|FG001|Overall Study|Adverse Event|5|||
27842892|NCT01516970|54331815|FG000|Overall Study|Withdrawal by Subject|1|||
27842893|NCT01516970|54331816|FG001|Overall Study|Withdrawal by Subject|1|||
27802573|NCT01807221|54257750|FG002|Overall Study|Adverse Event|26|||
27802574|NCT01807221|54257751|FG003|Overall Study|Adverse Event|25|||
27802575|NCT01807221|54257752|FG004|Overall Study|Adverse Event|18|||
27842894|NCT01516970|54331815|FG000|Overall Study|Other|9|||
27842895|NCT01516970|54331816|FG001|Overall Study|Other|7|||
27842896|NCT01516892|54331837|FG000|Overall Study|Adverse Event|25|||
27802576|NCT01807221|54257753|FG005|Overall Study|Adverse Event|21|||
27802577|NCT01807221|54257748|FG000|Overall Study|Protocol Violation|0|||
27802578|NCT01807221|54257749|FG001|Overall Study|Protocol Violation|2|||
27802579|NCT01807221|54257750|FG002|Overall Study|Protocol Violation|1|||
27802580|NCT01807221|54257751|FG003|Overall Study|Protocol Violation|2|||
27842897|NCT01516892|54331837|FG000|Overall Study|Lack of Efficacy|35|||
27842898|NCT01516892|54331837|FG000|Overall Study|Pregnancy|5|||
27842899|NCT01516892|54331837|FG000|Overall Study|Lost to Follow-up|82|||
28027239|NCT03178487|54685715|FG000|Period 1|Adverse Event|1|||
27802581|NCT01807221|54257752|FG004|Overall Study|Protocol Violation|0|||
27802582|NCT01807221|54257753|FG005|Overall Study|Protocol Violation|1|||
27802583|NCT01807221|54257748|FG000|Overall Study|Non-compliance|1|||
27802584|NCT01807221|54257749|FG001|Overall Study|Non-compliance|2|||
27802585|NCT01807221|54257750|FG002|Overall Study|Non-compliance|0|||
27802586|NCT01807221|54257751|FG003|Overall Study|Non-compliance|1|||
27802587|NCT01807221|54257752|FG004|Overall Study|Non-compliance|0|||
27802588|NCT01807221|54257753|FG005|Overall Study|Non-compliance|0|||
27802589|NCT01807221|54257748|FG000|Overall Study|Logistical difficulties|0|||
27802590|NCT01807221|54257749|FG001|Overall Study|Logistical difficulties|1|||
27802591|NCT01807221|54257750|FG002|Overall Study|Logistical difficulties|0|||
27802592|NCT01807221|54257751|FG003|Overall Study|Logistical difficulties|0|||
27802593|NCT01807221|54257752|FG004|Overall Study|Logistical difficulties|1|||
27802594|NCT01807221|54257753|FG005|Overall Study|Logistical difficulties|0|||
27802595|NCT01807221|54257748|FG000|Overall Study|Withdrawal by Subject|33|||
27802596|NCT01807221|54257749|FG001|Overall Study|Withdrawal by Subject|15|||
27802597|NCT01807221|54257750|FG002|Overall Study|Withdrawal by Subject|8|||
27802598|NCT01807221|54257751|FG003|Overall Study|Withdrawal by Subject|14|||
27802599|NCT01807221|54257752|FG004|Overall Study|Withdrawal by Subject|16|||
27802600|NCT01807221|54257753|FG005|Overall Study|Withdrawal by Subject|13|||
27802601|NCT01807221|54257748|FG000|Overall Study|Sponsor decision|2|||
27802602|NCT01807221|54257749|FG001|Overall Study|Sponsor decision|0|||
27802603|NCT01807221|54257750|FG002|Overall Study|Sponsor decision|1|||
27802604|NCT01807221|54257751|FG003|Overall Study|Sponsor decision|1|||
27802605|NCT01807221|54257752|FG004|Overall Study|Sponsor decision|0|||
27802606|NCT01807221|54257753|FG005|Overall Study|Sponsor decision|0|||
27802607|NCT01807221|54257748|FG000|Overall Study|Lost to Follow-up|1|||
27842900|NCT01516892|54331837|FG000|Overall Study|Subject Withdrew Consent|92|||
27842901|NCT01516892|54331837|FG000|Overall Study|Protocol Violation|60|||
27842902|NCT01516892|54331837|FG000|Overall Study|Other Miscellaneous Reasons|43|||
27842903|NCT01516892|54331837|FG000|Overall Study|Missing|1|||
27842904|NCT01516736|54331862|FG000|Overall Study|Withdrawal by Subject|10|||
27842905|NCT01516736|54331863|FG001|Overall Study|Withdrawal by Subject|4|||
27842906|NCT01516736|54331862|FG000|Overall Study|Adverse Event|4|||
27842907|NCT01516736|54331863|FG001|Overall Study|Adverse Event|5|||
27842908|NCT01516736|54331862|FG000|Overall Study|Death|3|||
27842909|NCT01516736|54331863|FG001|Overall Study|Death|1|||
27802608|NCT01807221|54257749|FG001|Overall Study|Lost to Follow-up|0|||
27802609|NCT01807221|54257750|FG002|Overall Study|Lost to Follow-up|2|||
27802610|NCT01807221|54257751|FG003|Overall Study|Lost to Follow-up|1|||
27802611|NCT01807221|54257752|FG004|Overall Study|Lost to Follow-up|0|||
27802612|NCT01807221|54257753|FG005|Overall Study|Lost to Follow-up|0|||
27802613|NCT01838499|54257769|FG000|Overall Study|Protocol Violation|0|||
27802614|NCT01838499|54257770|FG001|Overall Study|Protocol Violation|1|||
27842910|NCT01516736|54331862|FG000|Overall Study|Physician Decision|2|||
27802615|NCT01838499|54257769|FG000|Overall Study|Lost to Follow-up|2|||
27802616|NCT01838499|54257770|FG001|Overall Study|Lost to Follow-up|4|||
27802617|NCT01838499|54257769|FG000|Overall Study|Lack of Efficacy|1|||
27802618|NCT01838499|54257770|FG001|Overall Study|Lack of Efficacy|2|||
27802619|NCT01838499|54257769|FG000|Overall Study|Adverse Event|2|||
27842911|NCT01516736|54331863|FG001|Overall Study|Physician Decision|1|||
27802620|NCT01838499|54257770|FG001|Overall Study|Adverse Event|1|||
27802621|NCT01838499|54257769|FG000|Overall Study|Withdrawal by Subject|19|||
27802622|NCT01838499|54257770|FG001|Overall Study|Withdrawal by Subject|9|||
27802623|NCT01807065|54257778|FG000|Overall Study|Receive no sip-T due to IV access|1|||
27802624|NCT01807065|54257779|FG001|Overall Study|Receive no sip-T due to IV access|1|||
27802625|NCT02031458|54257792|FG000|May 8, 2015 to January 11, 2019|Death|89|||
27802626|NCT02031458|54257793|FG001|May 8, 2015 to January 11, 2019|Death|193|||
27802627|NCT02031458|54257794|FG002|May 8, 2015 to January 11, 2019|Death|198|||
27802628|NCT02031458|54257792|FG000|May 8, 2015 to January 11, 2019|Lost to Follow-up|2|||
27802629|NCT02031458|54257793|FG001|May 8, 2015 to January 11, 2019|Lost to Follow-up|5|||
27802630|NCT02031458|54257794|FG002|May 8, 2015 to January 11, 2019|Lost to Follow-up|8|||
27802631|NCT02031458|54257792|FG000|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1|||
27802632|NCT02031458|54257793|FG001|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
27802633|NCT02031458|54257794|FG002|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
27802634|NCT02031458|54257792|FG000|May 8, 2015 to January 11, 2019|Physician Decision|2|||
27802635|NCT02031458|54257793|FG001|May 8, 2015 to January 11, 2019|Physician Decision|3|||
27802636|NCT02031458|54257794|FG002|May 8, 2015 to January 11, 2019|Physician Decision|3|||
27802637|NCT02031458|54257792|FG000|May 8, 2015 to January 11, 2019|Protocol Violation|7|||
27802638|NCT02031458|54257793|FG001|May 8, 2015 to January 11, 2019|Protocol Violation|4|||
27802639|NCT02031458|54257794|FG002|May 8, 2015 to January 11, 2019|Protocol Violation|0|||
27802640|NCT02031458|54257792|FG000|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24|||
27802641|NCT02031458|54257793|FG001|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42|||
27802642|NCT02031458|54257794|FG002|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23|||
27802643|NCT02031458|54257792|FG000|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13|||
27802644|NCT02031458|54257793|FG001|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16|||
27802645|NCT02031458|54257794|FG002|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14|||
27802646|NCT02031458|54257792|FG000|Baseline to May 8, 2015|Death|36|||
27802647|NCT02031458|54257793|FG001|Baseline to May 8, 2015|Death|87|||
27802648|NCT02031458|54257794|FG002|Baseline to May 8, 2015|Death|100|||
27802649|NCT02031458|54257792|FG000|Baseline to May 8, 2015|Protocol Violation|7|||
27802650|NCT02031458|54257793|FG001|Baseline to May 8, 2015|Protocol Violation|4|||
27802651|NCT02031458|54257794|FG002|Baseline to May 8, 2015|Protocol Violation|0|||
27802652|NCT02031458|54257792|FG000|Baseline to May 8, 2015|Physician Decision|0|||
28027240|NCT03178487|54685716|FG001|Period 1|Adverse Event|2|||
27802653|NCT02031458|54257793|FG001|Baseline to May 8, 2015|Physician Decision|1|||
28027241|NCT03178487|54685715|FG000|Period 1|Withdrawal by Subject|2|||
27802654|NCT02031458|54257794|FG002|Baseline to May 8, 2015|Physician Decision|0|||
27802655|NCT02031458|54257792|FG000|Baseline to May 8, 2015|Unknown Reason|0|||
27802656|NCT02031458|54257793|FG001|Baseline to May 8, 2015|Unknown Reason|1|||
27802657|NCT02031458|54257794|FG002|Baseline to May 8, 2015|Unknown Reason|2|||
27802658|NCT02031458|54257792|FG000|Baseline to May 8, 2015|Withdrawal by Subject|6|||
27802659|NCT02031458|54257793|FG001|Baseline to May 8, 2015|Withdrawal by Subject|9|||
27802660|NCT02031458|54257794|FG002|Baseline to May 8, 2015|Withdrawal by Subject|3|||
27802661|NCT02031458|54257792|FG000|Baseline to May 8, 2015|On Survival Follow-Up|46|||
27802662|NCT02031458|54257793|FG001|Baseline to May 8, 2015|On Survival Follow-Up|83|||
28027242|NCT03178487|54685716|FG001|Period 1|Withdrawal by Subject|1|||
27802663|NCT02031458|54257794|FG002|Baseline to May 8, 2015|On Survival Follow-Up|73|||
27802664|NCT02031458|54257792|FG000|Baseline to May 8, 2015|On Treatment|43|||
27802665|NCT02031458|54257793|FG001|Baseline to May 8, 2015|On Treatment|81|||
28027243|NCT03178487|54685715|FG000|Period 1|Lost to Follow-up|1|||
28027244|NCT03178487|54685716|FG001|Period 1|Lost to Follow-up|0|||
28027245|NCT03178487|54685715|FG000|Period 1|Other|0|||
28027246|NCT03178487|54685716|FG001|Period 1|Other|1|||
28027247|NCT03178487|54685715|FG000|Period 2|Adverse Event|4|||
28027248|NCT03178487|54685716|FG001|Period 2|Adverse Event|4|||
28027249|NCT03178487|54685715|FG000|Period 2|Withdrawal by Subject|6|||
28027250|NCT03178487|54685716|FG001|Period 2|Withdrawal by Subject|6|||
28027251|NCT03178487|54685715|FG000|Period 2|Lost to Follow-up|2|||
28027252|NCT03178487|54685716|FG001|Period 2|Lost to Follow-up|2|||
28027253|NCT03178487|54685715|FG000|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|1|||
28027254|NCT03178487|54685716|FG001|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|0|||
28027255|NCT03178487|54685715|FG000|Period 2|Other|8|||
28027256|NCT03178487|54685716|FG001|Period 2|Other|7|||
28027257|NCT00528957|54685725|FG000|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2|||
28027258|NCT00528957|54685726|FG001|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1|||
28027259|NCT00528957|54685725|FG000|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2|||
28027260|NCT00528957|54685726|FG001|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0|||
28027261|NCT00528957|54685725|FG000|First Extension (Week 48 to Week 144)|Investigator's Discretion|2|||
28027262|NCT00528957|54685726|FG001|First Extension (Week 48 to Week 144)|Investigator's Discretion|0|||
28027263|NCT00528957|54685725|FG000|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1|||
28027264|NCT00528957|54685726|FG001|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0|||
28027265|NCT00528957|54685725|FG000|First Extension (Week 48 to Week 144)|Withdrew Consent|0|||
28027266|NCT00528957|54685726|FG001|First Extension (Week 48 to Week 144)|Withdrew Consent|1|||
28027267|NCT00528957|54685725|FG000|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4|||
28027268|NCT00528957|54685726|FG001|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3|||
28027269|NCT00528957|54685725|FG000|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3|||
28027270|NCT00528957|54685726|FG001|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0|||
28027271|NCT00528957|54685725|FG000|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5|||
28027272|NCT00528957|54685726|FG001|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4|||
28027273|NCT00528957|54685725|FG000|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0|||
28027274|NCT00528957|54685726|FG001|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3|||
28027275|NCT00528957|54685725|FG000|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
28027276|NCT00528957|54685726|FG001|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
28027277|NCT00528957|54685725|FG000|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0|||
28027278|NCT00528957|54685726|FG001|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1|||
28027279|NCT00528957|54685725|FG000|Third Extension (Week 240 to Week 336)|Withdrew Consent|0|||
28027280|NCT00528957|54685726|FG001|Third Extension (Week 240 to Week 336)|Withdrew Consent|1|||
28027281|NCT00528957|54685725|FG000|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4|||
28027282|NCT00528957|54685726|FG001|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10|||
28027283|NCT00528957|54685725|FG000|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3|||
28027284|NCT00528957|54685726|FG001|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5|||
28027285|NCT00528957|54685725|FG000|Long-Term Extension (Week 336 and On)|Withdrew Consent|2|||
28027286|NCT00528957|54685726|FG001|Long-Term Extension (Week 336 and On)|Withdrew Consent|1|||
28027287|NCT00528957|54685725|FG000|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
28027288|NCT00528957|54685726|FG001|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
28027289|NCT00560508|54685744|FG000|12 Week Double-blind Period|Adverse Event|3|||
28027290|NCT00560508|54685745|FG001|12 Week Double-blind Period|Adverse Event|2|||
28027291|NCT00560508|54685744|FG000|12 Week Double-blind Period|Protocol Violation|1|||
28027292|NCT00560508|54685745|FG001|12 Week Double-blind Period|Protocol Violation|0|||
28027293|NCT00560508|54685744|FG000|12 Week Double-blind Period|Withdrawal by Subject|1|||
28027294|NCT00560508|54685745|FG001|12 Week Double-blind Period|Withdrawal by Subject|1|||
28027295|NCT00560508|54685744|FG000|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
28027296|NCT00560508|54685745|FG001|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
28027297|NCT00560508|54685744|FG000|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
28027298|NCT00560508|54685745|FG001|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
28027299|NCT00560508|54685744|FG000|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0|||
28027300|NCT00560508|54685745|FG001|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3|||
27802666|NCT02031458|54257794|FG002|Baseline to May 8, 2015|On Treatment|73|||
27802667|NCT02031458|54257792|FG000|Baseline to May 8, 2015|Lost to Follow-up|1|||
28027301|NCT00560508|54685744|FG000|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
28027302|NCT00560508|54685745|FG001|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
28027303|NCT03962790|54685756|FG000|Period 1|Adverse Event|0|||
28027304|NCT03962790|54685757|FG001|Period 1|Adverse Event|1|||
28027305|NCT03962790|54685756|FG000|Period 1|Failed to meet all eligibility criteria|1|||
28027306|NCT03962790|54685757|FG001|Period 1|Failed to meet all eligibility criteria|1|||
28027307|NCT03962790|54685756|FG000|Period 1|No Longer Meets Eligibility Criteria|1|||
28027308|NCT03962790|54685757|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
28027309|NCT03962790|54685756|FG000|Period 1|Withdrawal by Subject|1|||
28027310|NCT03962790|54685757|FG001|Period 1|Withdrawal by Subject|0|||
28027311|NCT00609518|54685765|FG000|Overall Study|Death from Study Disease|32|||
28027312|NCT00609518|54685766|FG001|Overall Study|Death from Study Disease|32|||
28027313|NCT00609518|54685765|FG000|Overall Study|Withdrawal by Subject|5|||
28027314|NCT00609518|54685766|FG001|Overall Study|Withdrawal by Subject|3|||
28027315|NCT00609518|54685765|FG000|Overall Study|Lost to Follow-up|3|||
28027316|NCT00609518|54685766|FG001|Overall Study|Lost to Follow-up|0|||
28027317|NCT00609518|54685765|FG000|Overall Study|Physician Decision|1|||
28027318|NCT00609518|54685766|FG001|Overall Study|Physician Decision|3|||
28027319|NCT00609518|54685765|FG000|Overall Study|Death from Adverse Event|2|||
28027320|NCT00609518|54685766|FG001|Overall Study|Death from Adverse Event|2|||
28027321|NCT00609362|54685774|FG000|Overall Study|Withdrawal by Subject|2|||
27939223|NCT01243424|54595443|FG000|Discontinuation From Treatment|Withdrawal by Subject|309|||
27939224|NCT01243424|54595444|FG001|Discontinuation From Treatment|Withdrawal by Subject|328|||
28027322|NCT00609362|54685775|FG001|Overall Study|Withdrawal by Subject|1|||
28027323|NCT00609362|54685774|FG000|Overall Study|Adverse Event|1|||
28027324|NCT00609362|54685775|FG001|Overall Study|Adverse Event|0|||
28027325|NCT00611858|54685781|FG000|Overall Study|Adverse Event|2|||
28027326|NCT00611858|54685781|FG000|Overall Study|Withdrawal by Subject|2|||
28027327|NCT00137449|54685789|FG000|Overall Study|Disease Progression|8|||
28027328|NCT00137449|54685790|FG001|Overall Study|Disease Progression|13|||
28027329|NCT00137449|54685789|FG000|Overall Study|Death|4|||
28027330|NCT00137449|54685790|FG001|Overall Study|Death|3|||
28027331|NCT00137449|54685789|FG000|Overall Study|Adverse Event|3|||
28027332|NCT00137449|54685790|FG001|Overall Study|Adverse Event|1|||
28027333|NCT00137449|54685789|FG000|Overall Study|Withdrawal by Subject|1|||
28027334|NCT00137449|54685790|FG001|Overall Study|Withdrawal by Subject|1|||
28027335|NCT00528879|54685801|FG000|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3|||
28027336|NCT00528879|54685802|FG001|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
28027337|NCT00528879|54685803|FG002|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1|||
28027338|NCT00528879|54685804|FG003|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
28027339|NCT00528879|54685801|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
28027340|NCT00528879|54685802|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
28027341|NCT00528879|54685803|FG002|Short-term Period (Day 1 to Week 24)|Adverse Event|2|||
28027342|NCT00528879|54685804|FG003|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
28027343|NCT00528879|54685801|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7|||
28027344|NCT00528879|54685802|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
28027345|NCT00528879|54685803|FG002|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
28027346|NCT00528879|54685804|FG003|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3|||
28027347|NCT00528879|54685801|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
28027348|NCT00528879|54685802|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
28027349|NCT00528879|54685803|FG002|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
28027350|NCT00528879|54685804|FG003|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
28027351|NCT00528879|54685801|FG000|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
28027352|NCT00528879|54685802|FG001|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
28027353|NCT00528879|54685803|FG002|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2|||
28027354|NCT00528879|54685804|FG003|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
28027355|NCT00528879|54685801|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
27939225|NCT01243424|54595443|FG000|Discontinuation From Treatment|Other than listed above|230|||
27939226|NCT01243424|54595444|FG001|Discontinuation From Treatment|Other than listed above|211|||
27939227|NCT00887809|54595453|FG000|Overall Study|Patient Not Treated|3|||
27939228|NCT00887809|54595454|FG001|Overall Study|Patient Not Treated|0|||
27939229|NCT00887809|54595453|FG000|Overall Study|Death|1|||
27939230|NCT00887809|54595454|FG001|Overall Study|Death|0|||
27939231|NCT00958126|54595468|FG000|Overall Study|Serious Adverse Event|0|||
27939232|NCT00958126|54595469|FG001|Overall Study|Serious Adverse Event|2|||
28027356|NCT00528879|54685802|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3|||
28027357|NCT00528879|54685803|FG002|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
28027358|NCT00528879|54685804|FG003|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
28027359|NCT00528879|54685801|FG000|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
27939233|NCT00958126|54595470|FG002|Overall Study|Serious Adverse Event|0|||
28027360|NCT00528879|54685802|FG001|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
28027361|NCT00528879|54685803|FG002|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0|||
28027362|NCT00528879|54685804|FG003|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
28027363|NCT00528879|54685801|FG000|Short-term Period (Day 1 to Week 24)|Other|0|||
28027364|NCT00528879|54685802|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
28027365|NCT00528879|54685803|FG002|Short-term Period (Day 1 to Week 24)|Other|1|||
28027366|NCT00528879|54685804|FG003|Short-term Period (Day 1 to Week 24)|Other|1|||
28027367|NCT00528879|54685801|FG000|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27|||
28027368|NCT00528879|54685802|FG001|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16|||
28027369|NCT00528879|54685803|FG002|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17|||
28027370|NCT00528879|54685804|FG003|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9|||
28027371|NCT00528879|54685801|FG000|Long-term Period (Weeks 24 to 102)|Adverse Event|5|||
28027372|NCT00528879|54685802|FG001|Long-term Period (Weeks 24 to 102)|Adverse Event|4|||
28027373|NCT00528879|54685803|FG002|Long-term Period (Weeks 24 to 102)|Adverse Event|3|||
28027374|NCT00528879|54685804|FG003|Long-term Period (Weeks 24 to 102)|Adverse Event|2|||
28027375|NCT00528879|54685801|FG000|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
28027376|NCT00528879|54685802|FG001|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6|||
28027377|NCT00528879|54685803|FG002|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8|||
28027378|NCT00528879|54685804|FG003|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
28027379|NCT00528879|54685801|FG000|Long-term Period (Weeks 24 to 102)|Death|0|||
28027380|NCT00528879|54685802|FG001|Long-term Period (Weeks 24 to 102)|Death|1|||
28027381|NCT00528879|54685803|FG002|Long-term Period (Weeks 24 to 102)|Death|0|||
28027382|NCT00528879|54685804|FG003|Long-term Period (Weeks 24 to 102)|Death|0|||
28027383|NCT00528879|54685801|FG000|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4|||
28027384|NCT00528879|54685802|FG001|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5|||
28027385|NCT00528879|54685803|FG002|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3|||
28027386|NCT00528879|54685804|FG003|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7|||
28027387|NCT00528879|54685801|FG000|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0|||
28027388|NCT00528879|54685802|FG001|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5|||
28027389|NCT00528879|54685803|FG002|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1|||
28027390|NCT00528879|54685804|FG003|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2|||
28027391|NCT00528879|54685801|FG000|Long-term Period (Weeks 24 to 102)|Pregnancy|1|||
28027392|NCT00528879|54685802|FG001|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
28027393|NCT00528879|54685803|FG002|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
28027394|NCT00528879|54685804|FG003|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
28027395|NCT00528879|54685801|FG000|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
28027396|NCT00528879|54685802|FG001|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
28027397|NCT00528879|54685803|FG002|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
28027398|NCT00528879|54685804|FG003|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0|||
28027399|NCT00608894|54685816|FG000|Overall Study|Withdrawal by Subject|0|||
28027400|NCT00608894|54685817|FG001|Overall Study|Withdrawal by Subject|2|||
28027401|NCT00557856|54685825|FG000|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
28027402|NCT00557856|54685826|FG001|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
28027403|NCT00557856|54685827|FG002|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
28027404|NCT00557856|54685828|FG003|Part 1: Dose Escalation Phase|objective progression or relapse|1|||
28027405|NCT00557856|54685829|FG004|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
28027406|NCT00557856|54685830|FG005|Part 1: Dose Escalation Phase|objective progression or relapse|2|||
28027407|NCT00557856|54685831|FG006|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
28027408|NCT00557856|54685832|FG007|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
28027409|NCT00557856|54685833|FG008|Part 1: Dose Escalation Phase|objective progression or relapse|0|||
28027410|NCT00557856|54685825|FG000|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
28027411|NCT00557856|54685826|FG001|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
28027412|NCT00557856|54685827|FG002|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
28027413|NCT00557856|54685828|FG003|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
28027414|NCT00557856|54685829|FG004|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
28027415|NCT00557856|54685830|FG005|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
28027416|NCT00557856|54685831|FG006|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
28027417|NCT00557856|54685832|FG007|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
28027418|NCT00557856|54685833|FG008|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
28027419|NCT00557856|54685825|FG000|Part 1: Dose Escalation Phase|Adverse Event|1|||
28027420|NCT00557856|54685826|FG001|Part 1: Dose Escalation Phase|Adverse Event|0|||
28027421|NCT00557856|54685827|FG002|Part 1: Dose Escalation Phase|Adverse Event|1|||
28027422|NCT00557856|54685828|FG003|Part 1: Dose Escalation Phase|Adverse Event|1|||
28027423|NCT00557856|54685829|FG004|Part 1: Dose Escalation Phase|Adverse Event|1|||
27802668|NCT02031458|54257793|FG001|Baseline to May 8, 2015|Lost to Follow-up|1|||
27802669|NCT02031458|54257794|FG002|Baseline to May 8, 2015|Lost to Follow-up|2|||
27802670|NCT02009696|54257804|FG000|Overall Study|Withdrawal by Subject|2|||
27802671|NCT01806597|54257811|FG000|Period 1 (Baseline to Week 16)|Adverse Event|1|||
27802672|NCT01806597|54257812|FG001|Period 1 (Baseline to Week 16)|Adverse Event|1|||
27802673|NCT01806597|54257813|FG002|Period 1 (Baseline to Week 16)|Adverse Event|0|||
27802674|NCT01806597|54257814|FG003|Period 1 (Baseline to Week 16)|Adverse Event|0|||
27802675|NCT01806597|54257815|FG004|Period 1 (Baseline to Week 16)|Adverse Event|2|||
27802676|NCT01806597|54257816|FG005|Period 1 (Baseline to Week 16)|Adverse Event|0|||
27802677|NCT01806597|54257811|FG000|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
27802678|NCT01806597|54257812|FG001|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
27802679|NCT01806597|54257813|FG002|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
27802680|NCT01806597|54257814|FG003|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
27802681|NCT01806597|54257815|FG004|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
27802682|NCT01806597|54257816|FG005|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
27802683|NCT01806597|54257811|FG000|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
27802684|NCT01806597|54257812|FG001|Period 1 (Baseline to Week 16)|Protocol Violation|1|||
27802685|NCT01806597|54257813|FG002|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
27802686|NCT01806597|54257814|FG003|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
27802687|NCT01806597|54257815|FG004|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
27802688|NCT01806597|54257816|FG005|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
27802689|NCT01806597|54257811|FG000|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3|||
27802690|NCT01806597|54257812|FG001|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
27802691|NCT01806597|54257813|FG002|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
27802692|NCT01806597|54257814|FG003|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
27802693|NCT01806597|54257815|FG004|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
27802694|NCT01806597|54257816|FG005|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
27802695|NCT01806597|54257811|FG000|Period 1 (Baseline to Week 16)|Physician Decision|0|||
27802696|NCT01806597|54257812|FG001|Period 1 (Baseline to Week 16)|Physician Decision|1|||
27802697|NCT01806597|54257813|FG002|Period 1 (Baseline to Week 16)|Physician Decision|0|||
27802698|NCT01806597|54257814|FG003|Period 1 (Baseline to Week 16)|Physician Decision|0|||
27802699|NCT01806597|54257815|FG004|Period 1 (Baseline to Week 16)|Physician Decision|0|||
27802700|NCT01806597|54257816|FG005|Period 1 (Baseline to Week 16)|Physician Decision|0|||
27802701|NCT01806597|54257811|FG000|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9|||
27802702|NCT01806597|54257812|FG001|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6|||
27802703|NCT01806597|54257813|FG002|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4|||
27802704|NCT01806597|54257814|FG003|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3|||
27802705|NCT01806597|54257815|FG004|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1|||
27939234|NCT00958126|54595471|FG003|Overall Study|Serious Adverse Event|0|||
27939235|NCT00958126|54595472|FG004|Overall Study|Serious Adverse Event|0|||
27939236|NCT00958126|54595473|FG005|Overall Study|Serious Adverse Event|0|||
27939237|NCT00958126|54595474|FG006|Overall Study|Serious Adverse Event|1|||
27939238|NCT00958126|54595475|FG007|Overall Study|Serious Adverse Event|0|||
27939239|NCT00958126|54595468|FG000|Overall Study|Withdrawal by Subject|0|||
27939240|NCT00958126|54595469|FG001|Overall Study|Withdrawal by Subject|2|||
27939241|NCT00958126|54595470|FG002|Overall Study|Withdrawal by Subject|0|||
27939242|NCT00958126|54595471|FG003|Overall Study|Withdrawal by Subject|0|||
27939243|NCT00958126|54595472|FG004|Overall Study|Withdrawal by Subject|0|||
27939244|NCT00958126|54595473|FG005|Overall Study|Withdrawal by Subject|0|||
27939245|NCT00958126|54595474|FG006|Overall Study|Withdrawal by Subject|0|||
28027424|NCT00557856|54685830|FG005|Part 1: Dose Escalation Phase|Adverse Event|3|||
27802706|NCT01806597|54257816|FG005|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0|||
27802707|NCT01806597|54257811|FG000|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12|||
27802708|NCT01806597|54257812|FG001|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5|||
27802709|NCT01806597|54257813|FG002|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3|||
27802710|NCT01806597|54257814|FG003|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1|||
27939246|NCT00958126|54595475|FG007|Overall Study|Withdrawal by Subject|0|||
27939247|NCT00958126|54595468|FG000|Overall Study|Moved away from study area|0|||
27939248|NCT00958126|54595469|FG001|Overall Study|Moved away from study area|0|||
27802711|NCT01806597|54257815|FG004|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
27802712|NCT01806597|54257816|FG005|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
27802713|NCT01806597|54257811|FG000|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2|||
27802714|NCT01806597|54257812|FG001|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
27802715|NCT01806597|54257813|FG002|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
27802716|NCT01806597|54257814|FG003|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
27802717|NCT01806597|54257815|FG004|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
27802718|NCT01806597|54257816|FG005|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
27802719|NCT01806597|54257811|FG000|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
27802720|NCT01806597|54257812|FG001|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
27802721|NCT01806597|54257813|FG002|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
27802722|NCT01806597|54257814|FG003|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
27802723|NCT01806597|54257815|FG004|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
27802724|NCT01806597|54257816|FG005|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
27802725|NCT01806597|54257811|FG000|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2|||
27802726|NCT01806597|54257812|FG001|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
27802727|NCT01806597|54257813|FG002|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
27802728|NCT01806597|54257814|FG003|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
27802729|NCT01806597|54257815|FG004|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
27802730|NCT01806597|54257816|FG005|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
27802731|NCT01806597|54257811|FG000|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
27802732|NCT01806597|54257812|FG001|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
27802733|NCT01806597|54257813|FG002|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
27802734|NCT01806597|54257814|FG003|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
28027425|NCT00557856|54685831|FG006|Part 1: Dose Escalation Phase|Adverse Event|1|||
28027426|NCT00557856|54685832|FG007|Part 1: Dose Escalation Phase|Adverse Event|2|||
28027427|NCT00557856|54685833|FG008|Part 1: Dose Escalation Phase|Adverse Event|0|||
28027428|NCT00557856|54685825|FG000|Part 1: Dose Escalation Phase|Other|0|||
28027429|NCT00557856|54685826|FG001|Part 1: Dose Escalation Phase|Other|0|||
28027430|NCT00557856|54685827|FG002|Part 1: Dose Escalation Phase|Other|1|||
28027431|NCT00557856|54685828|FG003|Part 1: Dose Escalation Phase|Other|1|||
28027432|NCT00557856|54685829|FG004|Part 1: Dose Escalation Phase|Other|0|||
28027433|NCT00557856|54685830|FG005|Part 1: Dose Escalation Phase|Other|0|||
28027434|NCT00557856|54685831|FG006|Part 1: Dose Escalation Phase|Other|0|||
28027435|NCT00557856|54685832|FG007|Part 1: Dose Escalation Phase|Other|1|||
28027436|NCT00557856|54685833|FG008|Part 1: Dose Escalation Phase|Other|0|||
28027437|NCT00557856|54685825|FG000|Part 1: Dose Escalation Phase|Death|0|||
28027438|NCT00557856|54685826|FG001|Part 1: Dose Escalation Phase|Death|0|||
28027439|NCT00557856|54685827|FG002|Part 1: Dose Escalation Phase|Death|0|||
28027440|NCT00557856|54685828|FG003|Part 1: Dose Escalation Phase|Death|0|||
28027441|NCT00557856|54685829|FG004|Part 1: Dose Escalation Phase|Death|0|||
28027442|NCT00557856|54685830|FG005|Part 1: Dose Escalation Phase|Death|1|||
28027443|NCT00557856|54685831|FG006|Part 1: Dose Escalation Phase|Death|0|||
28027444|NCT00557856|54685832|FG007|Part 1: Dose Escalation Phase|Death|0|||
28027445|NCT00557856|54685833|FG008|Part 1: Dose Escalation Phase|Death|0|||
28027446|NCT00557856|54685825|FG000|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
28027447|NCT00557856|54685826|FG001|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
28027448|NCT00557856|54685827|FG002|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
28027449|NCT00557856|54685828|FG003|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
28027450|NCT00557856|54685829|FG004|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
28027451|NCT00557856|54685830|FG005|Part 1: Dose Escalation Phase|global deterioration of health status|2|||
28027452|NCT00557856|54685831|FG006|Part 1: Dose Escalation Phase|global deterioration of health status|1|||
28027453|NCT00557856|54685832|FG007|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
28027454|NCT00557856|54685833|FG008|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
28027455|NCT00557856|54685825|FG000|Part 1: Dose Escalation Phase|randomized but not treated|2|||
28027456|NCT00557856|54685826|FG001|Part 1: Dose Escalation Phase|randomized but not treated|0|||
28027457|NCT00557856|54685827|FG002|Part 1: Dose Escalation Phase|randomized but not treated|0|||
28027458|NCT00557856|54685828|FG003|Part 1: Dose Escalation Phase|randomized but not treated|0|||
28027459|NCT00557856|54685829|FG004|Part 1: Dose Escalation Phase|randomized but not treated|0|||
28027460|NCT00557856|54685830|FG005|Part 1: Dose Escalation Phase|randomized but not treated|0|||
28027461|NCT00557856|54685831|FG006|Part 1: Dose Escalation Phase|randomized but not treated|0|||
28027462|NCT00557856|54685832|FG007|Part 1: Dose Escalation Phase|randomized but not treated|0|||
28027463|NCT00557856|54685833|FG008|Part 1: Dose Escalation Phase|randomized but not treated|0|||
28027464|NCT00557856|54685825|FG000|Part 2: Exploratory Phase|objective progression or relapse|0|||
27842912|NCT01516736|54331862|FG000|Overall Study|Lack of Efficacy|1|||
27802735|NCT01806597|54257815|FG004|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
27802736|NCT01806597|54257816|FG005|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
27802737|NCT01806597|54257811|FG000|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10|||
27802738|NCT01806597|54257812|FG001|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
27802739|NCT01806597|54257813|FG002|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6|||
27802740|NCT01806597|54257814|FG003|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
27802741|NCT01806597|54257815|FG004|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
27802742|NCT01806597|54257816|FG005|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
27802743|NCT01806597|54257811|FG000|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
27802744|NCT01806597|54257812|FG001|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
27802745|NCT01806597|54257813|FG002|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
27802746|NCT01806597|54257814|FG003|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
27802747|NCT01806597|54257815|FG004|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
27802748|NCT01806597|54257816|FG005|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
27802749|NCT01806597|54257811|FG000|Treatment Period 2 (Week 16 to Week 132)|Death|1|||
27802750|NCT01806597|54257812|FG001|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
27802751|NCT01806597|54257813|FG002|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
27802752|NCT01806597|54257814|FG003|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
27802753|NCT01806597|54257815|FG004|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
27802754|NCT01806597|54257816|FG005|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
27802755|NCT01806597|54257811|FG000|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
27939249|NCT00958126|54595470|FG002|Overall Study|Moved away from study area|1|||
27939250|NCT00958126|54595471|FG003|Overall Study|Moved away from study area|1|||
27939251|NCT00958126|54595472|FG004|Overall Study|Moved away from study area|0|||
27939252|NCT00958126|54595473|FG005|Overall Study|Moved away from study area|0|||
27939253|NCT00958126|54595474|FG006|Overall Study|Moved away from study area|0|||
27939254|NCT00958126|54595475|FG007|Overall Study|Moved away from study area|0|||
27939255|NCT00958126|54595468|FG000|Overall Study|Lost to Follow-up|1|||
27802756|NCT01806597|54257812|FG001|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
27842913|NCT01516736|54331863|FG001|Overall Study|Lack of Efficacy|0|||
27939256|NCT00958126|54595469|FG001|Overall Study|Lost to Follow-up|5|||
28027465|NCT00557856|54685826|FG001|Part 2: Exploratory Phase|objective progression or relapse|0|||
28027466|NCT00557856|54685827|FG002|Part 2: Exploratory Phase|objective progression or relapse|0|||
27802757|NCT01806597|54257813|FG002|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
27802758|NCT01806597|54257814|FG003|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
27802759|NCT01806597|54257815|FG004|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
27802760|NCT01806597|54257816|FG005|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5|||
27802761|NCT01806597|54257811|FG000|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
27802762|NCT01806597|54257812|FG001|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
27802763|NCT01806597|54257813|FG002|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
27802764|NCT01806597|54257814|FG003|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
27802765|NCT01806597|54257815|FG004|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
27802766|NCT01806597|54257816|FG005|Follow-up Period (Week 132 to Week 140)|Adverse Event|2|||
27802767|NCT01806597|54257811|FG000|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
27802768|NCT01806597|54257812|FG001|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
27802769|NCT01806597|54257813|FG002|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
27802770|NCT01806597|54257814|FG003|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
27802771|NCT01806597|54257815|FG004|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
27802772|NCT01806597|54257816|FG005|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2|||
27802773|NCT01806597|54257811|FG000|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
27802774|NCT01806597|54257812|FG001|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
27802775|NCT01806597|54257813|FG002|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
27802776|NCT01806597|54257814|FG003|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
27802777|NCT01806597|54257815|FG004|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
27802778|NCT01806597|54257816|FG005|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2|||
27802779|NCT01806597|54257811|FG000|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
27802780|NCT01806597|54257812|FG001|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
27802781|NCT01806597|54257813|FG002|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
27802782|NCT01806597|54257814|FG003|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
27802783|NCT01806597|54257815|FG004|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
27802784|NCT01806597|54257816|FG005|Follow-up Period (Week 132 to Week 140)|Physician Decision|1|||
27802785|NCT02031302|54257832|FG000|Overall Study|Death|115|||
27802786|NCT02031302|54257833|FG001|Overall Study|Death|0|||
27802787|NCT02031302|54257832|FG000|Overall Study|Not treated with study valve system|18|||
27802788|NCT02031302|54257833|FG001|Overall Study|Not treated with study valve system|0|||
27802789|NCT02031302|54257832|FG000|Overall Study|Missed Follow Up|27|||
27802790|NCT02031302|54257833|FG001|Overall Study|Missed Follow Up|0|||
27802791|NCT02031302|54257832|FG000|Overall Study|Lost to Follow-up|4|||
27802792|NCT02031302|54257833|FG001|Overall Study|Lost to Follow-up|0|||
27802793|NCT01610037|54257843|FG000|All Patients|Adverse Event|27|||
27802794|NCT01610037|54257844|FG001|All Patients|Adverse Event|22|||
27802795|NCT01610037|54257845|FG002|All Patients|Adverse Event|26|||
27802796|NCT01610037|54257843|FG000|All Patients|Withdrawal by Subject|12|||
27802797|NCT01610037|54257844|FG001|All Patients|Withdrawal by Subject|10|||
27802798|NCT01610037|54257845|FG002|All Patients|Withdrawal by Subject|20|||
27802799|NCT01610037|54257843|FG000|All Patients|Unsatisfactory therapeutic effect|9|||
27802800|NCT01610037|54257844|FG001|All Patients|Unsatisfactory therapeutic effect|8|||
27802801|NCT01610037|54257845|FG002|All Patients|Unsatisfactory therapeutic effect|27|||
27802802|NCT01610037|54257843|FG000|All Patients|Death|4|||
27802803|NCT01610037|54257844|FG001|All Patients|Death|2|||
27802804|NCT01610037|54257845|FG002|All Patients|Death|1|||
27802805|NCT01610037|54257843|FG000|All Patients|Protocol deviation|4|||
27802806|NCT01610037|54257844|FG001|All Patients|Protocol deviation|3|||
27802807|NCT01610037|54257845|FG002|All Patients|Protocol deviation|3|||
27802808|NCT01610037|54257843|FG000|All Patients|Abnormal laboratory value|1|||
27802809|NCT01610037|54257844|FG001|All Patients|Abnormal laboratory value|1|||
28027467|NCT00557856|54685828|FG003|Part 2: Exploratory Phase|objective progression or relapse|0|||
27802810|NCT01610037|54257845|FG002|All Patients|Abnormal laboratory value|0|||
27802811|NCT01610037|54257843|FG000|All Patients|Administrative problems|1|||
27802812|NCT01610037|54257844|FG001|All Patients|Administrative problems|4|||
27802813|NCT01610037|54257845|FG002|All Patients|Administrative problems|4|||
27802814|NCT01610037|54257843|FG000|All Patients|Lost to Follow-up|1|||
27802815|NCT01610037|54257844|FG001|All Patients|Lost to Follow-up|0|||
27802816|NCT01610037|54257845|FG002|All Patients|Lost to Follow-up|0|||
27802817|NCT01610037|54257843|FG000|All Patients|Abnormal test procedure result(s)|0|||
27802818|NCT01610037|54257844|FG001|All Patients|Abnormal test procedure result(s)|1|||
27802819|NCT01610037|54257845|FG002|All Patients|Abnormal test procedure result(s)|3|||
27802820|NCT01610037|54257843|FG000|Treatment and Follow up Period|Subject withdrew consent|13|||
27802821|NCT01610037|54257844|FG001|Treatment and Follow up Period|Subject withdrew consent|14|||
27802822|NCT01610037|54257845|FG002|Treatment and Follow up Period|Subject withdrew consent|16|||
27802823|NCT01610037|54257843|FG000|Treatment and Follow up Period|Death|10|||
28027468|NCT00557856|54685829|FG004|Part 2: Exploratory Phase|objective progression or relapse|0|||
28027469|NCT00557856|54685830|FG005|Part 2: Exploratory Phase|objective progression or relapse|0|||
28027470|NCT00557856|54685831|FG006|Part 2: Exploratory Phase|objective progression or relapse|0|||
28027471|NCT00557856|54685832|FG007|Part 2: Exploratory Phase|objective progression or relapse|0|||
28027472|NCT00557856|54685833|FG008|Part 2: Exploratory Phase|objective progression or relapse|15|||
28027473|NCT00557856|54685825|FG000|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
28027474|NCT00557856|54685826|FG001|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
28027475|NCT00557856|54685827|FG002|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
28027476|NCT00557856|54685828|FG003|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
28027477|NCT00557856|54685829|FG004|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
28027478|NCT00557856|54685830|FG005|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
28027479|NCT00557856|54685831|FG006|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
28027480|NCT00557856|54685832|FG007|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
28027481|NCT00557856|54685833|FG008|Part 2: Exploratory Phase|Withdrawal by Subject|1|||
28027482|NCT00557856|54685825|FG000|Part 2: Exploratory Phase|Adverse Event|0|||
28027483|NCT00557856|54685826|FG001|Part 2: Exploratory Phase|Adverse Event|0|||
28027484|NCT00557856|54685827|FG002|Part 2: Exploratory Phase|Adverse Event|0|||
28027485|NCT00557856|54685828|FG003|Part 2: Exploratory Phase|Adverse Event|0|||
28027486|NCT00557856|54685829|FG004|Part 2: Exploratory Phase|Adverse Event|0|||
28027487|NCT00557856|54685830|FG005|Part 2: Exploratory Phase|Adverse Event|0|||
28027488|NCT00557856|54685831|FG006|Part 2: Exploratory Phase|Adverse Event|0|||
27842914|NCT01516736|54331862|FG000|Overall Study|Protocol Violation|0|||
28027489|NCT00557856|54685832|FG007|Part 2: Exploratory Phase|Adverse Event|0|||
27802824|NCT01610037|54257844|FG001|Treatment and Follow up Period|Death|5|||
27802825|NCT01610037|54257845|FG002|Treatment and Follow up Period|Death|4|||
27802826|NCT01610037|54257843|FG000|Treatment and Follow up Period|Administrative problems|1|||
27802827|NCT01610037|54257844|FG001|Treatment and Follow up Period|Administrative problems|3|||
27802828|NCT01610037|54257845|FG002|Treatment and Follow up Period|Administrative problems|2|||
27802829|NCT01610037|54257843|FG000|Treatment and Follow up Period|Lost to Follow-up|1|||
27802830|NCT01610037|54257844|FG001|Treatment and Follow up Period|Lost to Follow-up|6|||
27802831|NCT01610037|54257845|FG002|Treatment and Follow up Period|Lost to Follow-up|4|||
27802832|NCT01806051|54257853|FG000|Overall Study|Withdrawal by Subject|6|||
27802833|NCT01837797|54257862|FG000|Period 1|Adverse Event|9|||
27802834|NCT01837797|54257863|FG001|Period 1|Adverse Event|0|||
27802835|NCT01837797|54257864|FG002|Period 1|Adverse Event|0|||
27802836|NCT01837797|54257865|FG003|Period 1|Adverse Event|0|||
27802837|NCT01837797|54257866|FG004|Period 1|Adverse Event|0|||
27802838|NCT01837797|54257862|FG000|Period 1|Withdrawal by Subject|6|||
27802839|NCT01837797|54257863|FG001|Period 1|Withdrawal by Subject|0|||
27802840|NCT01837797|54257864|FG002|Period 1|Withdrawal by Subject|0|||
27802841|NCT01837797|54257865|FG003|Period 1|Withdrawal by Subject|0|||
27802842|NCT01837797|54257866|FG004|Period 1|Withdrawal by Subject|0|||
27802843|NCT01837797|54257862|FG000|Period 1|Administrative reasons|76|||
27802844|NCT01837797|54257863|FG001|Period 1|Administrative reasons|0|||
27802845|NCT01837797|54257864|FG002|Period 1|Administrative reasons|0|||
27802846|NCT01837797|54257865|FG003|Period 1|Administrative reasons|0|||
27802847|NCT01837797|54257866|FG004|Period 1|Administrative reasons|0|||
27802848|NCT01837797|54257862|FG000|Period 1|Withdrawal of consent before treatment|1|||
27842915|NCT01516736|54331863|FG001|Overall Study|Protocol Violation|1|||
27842916|NCT01516736|54331862|FG000|Overall Study|Other (not specified)|0|||
28027490|NCT00557856|54685833|FG008|Part 2: Exploratory Phase|Adverse Event|4|||
28027491|NCT00557856|54685825|FG000|Part 2: Exploratory Phase|Other|0|||
28027492|NCT00557856|54685826|FG001|Part 2: Exploratory Phase|Other|0|||
28027493|NCT00557856|54685827|FG002|Part 2: Exploratory Phase|Other|0|||
28027494|NCT00557856|54685828|FG003|Part 2: Exploratory Phase|Other|0|||
28027495|NCT00557856|54685829|FG004|Part 2: Exploratory Phase|Other|0|||
28027496|NCT00557856|54685830|FG005|Part 2: Exploratory Phase|Other|0|||
28027497|NCT00557856|54685831|FG006|Part 2: Exploratory Phase|Other|0|||
27802849|NCT01837797|54257863|FG001|Period 1|Withdrawal of consent before treatment|0|||
27802850|NCT01837797|54257864|FG002|Period 1|Withdrawal of consent before treatment|0|||
27802851|NCT01837797|54257865|FG003|Period 1|Withdrawal of consent before treatment|0|||
27802852|NCT01837797|54257866|FG004|Period 1|Withdrawal of consent before treatment|0|||
27802853|NCT01837797|54257862|FG000|Period 1|Other|10|||
27802854|NCT01837797|54257863|FG001|Period 1|Other|0|||
27802855|NCT01837797|54257864|FG002|Period 1|Other|0|||
27802856|NCT01837797|54257865|FG003|Period 1|Other|0|||
27802857|NCT01837797|54257866|FG004|Period 1|Other|0|||
27802858|NCT01837797|54257862|FG000|Period 2|Administrative or other reasons|0|||
27802859|NCT01837797|54257863|FG001|Period 2|Administrative or other reasons|5|||
27802860|NCT01837797|54257864|FG002|Period 2|Administrative or other reasons|2|||
27802861|NCT01837797|54257865|FG003|Period 2|Administrative or other reasons|4|||
27802862|NCT01837797|54257866|FG004|Period 2|Administrative or other reasons|0|||
27802863|NCT01837797|54257862|FG000|Period 2|Adverse Event|0|||
27802864|NCT01837797|54257863|FG001|Period 2|Adverse Event|0|||
27939257|NCT00958126|54595470|FG002|Overall Study|Lost to Follow-up|9|||
27939258|NCT00958126|54595471|FG003|Overall Study|Lost to Follow-up|8|||
27802865|NCT01837797|54257864|FG002|Period 2|Adverse Event|0|||
27802866|NCT01837797|54257865|FG003|Period 2|Adverse Event|1|||
27802867|NCT01837797|54257866|FG004|Period 2|Adverse Event|0|||
27802868|NCT01837797|54257862|FG000|Period 3|Adverse Event|0|||
27802869|NCT01837797|54257863|FG001|Period 3|Adverse Event|0|||
27802870|NCT01837797|54257864|FG002|Period 3|Adverse Event|0|||
27802871|NCT01837797|54257865|FG003|Period 3|Adverse Event|0|||
27802872|NCT01837797|54257866|FG004|Period 3|Adverse Event|1|||
27802873|NCT01837797|54257862|FG000|Period 3|Administrative reasons|0|||
27802874|NCT01837797|54257863|FG001|Period 3|Administrative reasons|0|||
27802875|NCT01837797|54257864|FG002|Period 3|Administrative reasons|0|||
27802876|NCT01837797|54257865|FG003|Period 3|Administrative reasons|0|||
27802877|NCT01837797|54257866|FG004|Period 3|Administrative reasons|20|||
27802878|NCT01837797|54257862|FG000|Period 3|Other|0|||
27802879|NCT01837797|54257863|FG001|Period 3|Other|0|||
27802880|NCT01837797|54257864|FG002|Period 3|Other|0|||
27802881|NCT01837797|54257865|FG003|Period 3|Other|0|||
27802882|NCT01837797|54257866|FG004|Period 3|Other|2|||
27802883|NCT01984424|54257876|FG000|Overall Study|Withdrawal by Subject|3|||
27802884|NCT01984424|54257877|FG001|Overall Study|Withdrawal by Subject|5|||
27802885|NCT01984424|54257876|FG000|Overall Study|Sponsor Decision|0|||
27802886|NCT01984424|54257877|FG001|Overall Study|Sponsor Decision|1|||
27802887|NCT01984424|54257876|FG000|Overall Study|Lost to Follow-up|0|||
27802888|NCT01984424|54257877|FG001|Overall Study|Lost to Follow-up|1|||
27802889|NCT01837719|54257883|FG000|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1|||
27802890|NCT01837719|54257883|FG000|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1|||
27802891|NCT01984268|54257898|FG000|Overall Study|Study Terminated|15|||
27802892|NCT02031146|54257904|FG000|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
27802893|NCT02031146|54257905|FG001|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
27802894|NCT02031146|54257906|FG002|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
27802895|NCT02031146|54257907|FG003|Overall Study|Did not meet criteria for inclusion in data analysis|100|||
27802896|NCT02031146|54257908|FG004|Overall Study|Did not meet criteria for inclusion in data analysis|26|||
27802897|NCT02031146|54257909|FG005|Overall Study|Did not meet criteria for inclusion in data analysis|4|||
27802898|NCT02031146|54257910|FG006|Overall Study|Did not meet criteria for inclusion in data analysis|5|||
27802899|NCT02009384|54257920|FG000|Overall Study|Death|2|||
27802900|NCT01805037|54257924|FG000|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0|||
27802901|NCT01805037|54257925|FG001|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2|||
27802902|NCT01805037|54257924|FG000|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0|||
27802903|NCT01805037|54257925|FG001|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2|||
27802904|NCT01805037|54257924|FG000|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0|||
27802905|NCT01805037|54257925|FG001|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1|||
27802906|NCT01805037|54257924|FG000|1st Cycle of Maintenance (3 Weeks)|Death|0|||
27802907|NCT01805037|54257925|FG001|1st Cycle of Maintenance (3 Weeks)|Death|1|||
27802908|NCT01805037|54257924|FG000|2nd Cycle of Maintenance and Beyond|Adverse Event|0|||
27802909|NCT01805037|54257925|FG001|2nd Cycle of Maintenance and Beyond|Adverse Event|10|||
27802910|NCT01805037|54257924|FG000|2nd Cycle of Maintenance and Beyond|Progressive Disease|0|||
27802911|NCT01805037|54257925|FG001|2nd Cycle of Maintenance and Beyond|Progressive Disease|1|||
27802912|NCT01805037|54257924|FG000|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0|||
27802913|NCT01805037|54257925|FG001|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1|||
27802914|NCT01805037|54257924|FG000|Follow Up (up to 3 Years)|Death|0|||
27802915|NCT01805037|54257925|FG001|Follow Up (up to 3 Years)|Death|2|||
27802916|NCT01805037|54257924|FG000|Follow Up (up to 3 Years)|Withdrawal by Subject|0|||
27802917|NCT01805037|54257925|FG001|Follow Up (up to 3 Years)|Withdrawal by Subject|3|||
27802918|NCT01805037|54257924|FG000|Follow Up (up to 3 Years)|Lost to Follow-up|0|||
27802919|NCT01805037|54257925|FG001|Follow Up (up to 3 Years)|Lost to Follow-up|1|||
27802920|NCT01803711|54257931|FG000|Overall Study|Adverse Event|1|||
27802921|NCT01803711|54257932|FG001|Overall Study|Adverse Event|1|||
27802922|NCT01836549|54257946|FG000|Overall Study|Did not receive study drug|0|||
27802923|NCT01836549|54257947|FG001|Overall Study|Did not receive study drug|0|||
27802924|NCT01836549|54257948|FG002|Overall Study|Did not receive study drug|1|||
27802925|NCT01836549|54257949|FG003|Overall Study|Did not receive study drug|0|||
27802926|NCT01836549|54257950|FG004|Overall Study|Did not receive study drug|0|||
27802927|NCT01836549|54257951|FG005|Overall Study|Did not receive study drug|0|||
27802928|NCT01836549|54257952|FG006|Overall Study|Did not receive study drug|0|||
27802929|NCT01836549|54257946|FG000|Overall Study|Patient declared ineligible|0|||
27802930|NCT01836549|54257947|FG001|Overall Study|Patient declared ineligible|0|||
27802931|NCT01836549|54257948|FG002|Overall Study|Patient declared ineligible|0|||
27802932|NCT01836549|54257949|FG003|Overall Study|Patient declared ineligible|1|||
27802933|NCT01836549|54257950|FG004|Overall Study|Patient declared ineligible|0|||
27802934|NCT01836549|54257951|FG005|Overall Study|Patient declared ineligible|0|||
27802935|NCT01836549|54257952|FG006|Overall Study|Patient declared ineligible|0|||
27802936|NCT01836549|54257946|FG000|Overall Study|Patient inevaluable to start therapy|0|||
27802937|NCT01836549|54257947|FG001|Overall Study|Patient inevaluable to start therapy|0|||
27802938|NCT01836549|54257948|FG002|Overall Study|Patient inevaluable to start therapy|0|||
27802939|NCT01836549|54257949|FG003|Overall Study|Patient inevaluable to start therapy|0|||
27802940|NCT01836549|54257950|FG004|Overall Study|Patient inevaluable to start therapy|0|||
27802941|NCT01836549|54257951|FG005|Overall Study|Patient inevaluable to start therapy|0|||
27802942|NCT01836549|54257952|FG006|Overall Study|Patient inevaluable to start therapy|1|||
27802943|NCT01836471|54257973|FG000|Overall Study|Pregnancy|1|||
27802944|NCT01836471|54257974|FG001|Overall Study|Pregnancy|0|||
27802945|NCT01836471|54257975|FG002|Overall Study|Pregnancy|0|||
27802946|NCT01836471|54257976|FG003|Overall Study|Pregnancy|0|||
27802947|NCT01836471|54257977|FG004|Overall Study|Pregnancy|0|||
27802948|NCT01836471|54257973|FG000|Overall Study|Withdrawal by Subject|3|||
27802949|NCT01836471|54257974|FG001|Overall Study|Withdrawal by Subject|4|||
27802950|NCT01836471|54257975|FG002|Overall Study|Withdrawal by Subject|1|||
27802951|NCT01836471|54257976|FG003|Overall Study|Withdrawal by Subject|0|||
27802952|NCT01836471|54257977|FG004|Overall Study|Withdrawal by Subject|2|||
27802953|NCT01836471|54257973|FG000|Overall Study|Physician Decision|0|||
27802954|NCT01836471|54257974|FG001|Overall Study|Physician Decision|1|||
27802955|NCT01836471|54257975|FG002|Overall Study|Physician Decision|0|||
27802956|NCT01836471|54257976|FG003|Overall Study|Physician Decision|0|||
27802957|NCT01836471|54257977|FG004|Overall Study|Physician Decision|0|||
27802958|NCT01836471|54257973|FG000|Overall Study|Lost to Follow-up|0|||
27802959|NCT01836471|54257974|FG001|Overall Study|Lost to Follow-up|0|||
28027498|NCT00557856|54685832|FG007|Part 2: Exploratory Phase|Other|0|||
28027499|NCT00557856|54685833|FG008|Part 2: Exploratory Phase|Other|1|||
28027500|NCT00557856|54685825|FG000|Part 2: Exploratory Phase|Death|0|||
28027501|NCT00557856|54685826|FG001|Part 2: Exploratory Phase|Death|0|||
28027502|NCT00557856|54685827|FG002|Part 2: Exploratory Phase|Death|0|||
28027503|NCT00557856|54685828|FG003|Part 2: Exploratory Phase|Death|0|||
28027504|NCT00557856|54685829|FG004|Part 2: Exploratory Phase|Death|0|||
28027505|NCT00557856|54685830|FG005|Part 2: Exploratory Phase|Death|0|||
28027506|NCT00557856|54685831|FG006|Part 2: Exploratory Phase|Death|0|||
27939259|NCT00958126|54595472|FG004|Overall Study|Lost to Follow-up|0|||
27939260|NCT00958126|54595473|FG005|Overall Study|Lost to Follow-up|0|||
27939261|NCT00958126|54595474|FG006|Overall Study|Lost to Follow-up|0|||
27939262|NCT00958126|54595475|FG007|Overall Study|Lost to Follow-up|0|||
27939263|NCT00958126|54595468|FG000|Overall Study|Sponsor/Investigator decision|0|||
27939264|NCT00958126|54595469|FG001|Overall Study|Sponsor/Investigator decision|0|||
27939265|NCT00958126|54595470|FG002|Overall Study|Sponsor/Investigator decision|0|||
27939266|NCT00958126|54595471|FG003|Overall Study|Sponsor/Investigator decision|1|||
27939267|NCT00958126|54595472|FG004|Overall Study|Sponsor/Investigator decision|0|||
27939268|NCT00958126|54595473|FG005|Overall Study|Sponsor/Investigator decision|0|||
27939269|NCT00958126|54595474|FG006|Overall Study|Sponsor/Investigator decision|0|||
27939270|NCT00958126|54595475|FG007|Overall Study|Sponsor/Investigator decision|0|||
27939271|NCT00958126|54595468|FG000|Overall Study|Other Reason|0|||
27939272|NCT00958126|54595469|FG001|Overall Study|Other Reason|0|||
27939273|NCT00958126|54595470|FG002|Overall Study|Other Reason|0|||
27939274|NCT00958126|54595471|FG003|Overall Study|Other Reason|1|||
27939275|NCT00958126|54595472|FG004|Overall Study|Other Reason|0|||
27939276|NCT00958126|54595473|FG005|Overall Study|Other Reason|1|||
27939277|NCT00958126|54595474|FG006|Overall Study|Other Reason|0|||
27939278|NCT00958126|54595475|FG007|Overall Study|Other Reason|0|||
27939279|NCT00887341|54595499|FG000|Overall Study|Refused treatment|1|||
27939280|NCT00887341|54595500|FG001|Overall Study|Refused treatment|0|||
27939281|NCT00887341|54595499|FG000|Overall Study|Withdrawal by Subject|1|||
27939282|NCT00887341|54595500|FG001|Overall Study|Withdrawal by Subject|1|||
27802960|NCT01836471|54257975|FG002|Overall Study|Lost to Follow-up|0|||
28027507|NCT00557856|54685832|FG007|Part 2: Exploratory Phase|Death|0|||
28027508|NCT00557856|54685833|FG008|Part 2: Exploratory Phase|Death|2|||
28027509|NCT00557856|54685825|FG000|Part 2: Exploratory Phase|global deterioration of health status|0|||
28027510|NCT00557856|54685826|FG001|Part 2: Exploratory Phase|global deterioration of health status|0|||
28027511|NCT00557856|54685827|FG002|Part 2: Exploratory Phase|global deterioration of health status|0|||
28027512|NCT00557856|54685828|FG003|Part 2: Exploratory Phase|global deterioration of health status|0|||
28027513|NCT00557856|54685829|FG004|Part 2: Exploratory Phase|global deterioration of health status|0|||
28027514|NCT00557856|54685830|FG005|Part 2: Exploratory Phase|global deterioration of health status|0|||
28027515|NCT00557856|54685831|FG006|Part 2: Exploratory Phase|global deterioration of health status|0|||
28027516|NCT00557856|54685832|FG007|Part 2: Exploratory Phase|global deterioration of health status|0|||
28027517|NCT00557856|54685833|FG008|Part 2: Exploratory Phase|global deterioration of health status|1|||
28027518|NCT00191113|54685850|FG000|Core Study|Withdrawal by Subject|25|||
28027519|NCT00191113|54685851|FG001|Core Study|Withdrawal by Subject|9|||
28027520|NCT00191113|54685850|FG000|Core Study|Protocol Violation|6|||
28027521|NCT00191113|54685851|FG001|Core Study|Protocol Violation|2|||
28027522|NCT00191113|54685850|FG000|Core Study|Lost to Follow-up|3|||
28027523|NCT00191113|54685851|FG001|Core Study|Lost to Follow-up|0|||
28027524|NCT00191113|54685850|FG000|Core Study|Adverse Event|0|||
28027525|NCT00191113|54685851|FG001|Core Study|Adverse Event|2|||
28027526|NCT00191113|54685850|FG000|Core Study|Lack of Efficacy|0|||
28027527|NCT00191113|54685851|FG001|Core Study|Lack of Efficacy|2|||
28027528|NCT00191113|54685850|FG000|Core Study|Death|1|||
28027529|NCT00191113|54685851|FG001|Core Study|Death|0|||
28027530|NCT00608582|54685865|FG000|Overall Study|Lost to Follow-up|2|||
28027531|NCT00608582|54685866|FG001|Overall Study|Lost to Follow-up|0|||
28027532|NCT00608582|54685865|FG000|Overall Study|No Best Response in Phase 1 located|1|||
28027533|NCT00608582|54685866|FG001|Overall Study|No Best Response in Phase 1 located|1|||
28027534|NCT00608582|54685865|FG000|Overall Study|Illicit Drug Use|1|||
28027535|NCT00608582|54685866|FG001|Overall Study|Illicit Drug Use|0|||
28027536|NCT00608582|54685865|FG000|Overall Study|Early stage Design Change|0|||
28027537|NCT00608582|54685866|FG001|Overall Study|Early stage Design Change|3|||
28027538|NCT03965052|54685876|FG000|Overall Study|Protocol Violation|1|||
28027539|NCT03965052|54685877|FG001|Overall Study|Protocol Violation|0|||
28027540|NCT03964974|54685885|FG000|Overall Study|Lost to Follow-up|3|||
28027541|NCT03964974|54685886|FG001|Overall Study|Lost to Follow-up|2|||
28027542|NCT03964974|54685885|FG000|Overall Study|Withdrawal by Subject|0|||
28027543|NCT03964974|54685886|FG001|Overall Study|Withdrawal by Subject|3|||
28027544|NCT00606320|54685892|FG000|Overall Study|Adverse Event|3|||
28027545|NCT00606320|54685892|FG000|Overall Study|Lack of Efficacy|5|||
28027546|NCT00606320|54685892|FG000|Overall Study|Physician Decision|7|||
28027547|NCT00606320|54685892|FG000|Overall Study|Protocol Violation|8|||
28027548|NCT00606320|54685892|FG000|Overall Study|Withdrawal by Subject|10|||
28027549|NCT00606320|54685892|FG000|Overall Study|Progression to depressive phase|4|||
28027550|NCT00528411|54685899|FG000|Overall Study|Adverse Event|4|||
28027551|NCT00528411|54685900|FG001|Overall Study|Adverse Event|0|||
27802961|NCT01836471|54257976|FG003|Overall Study|Lost to Follow-up|1|||
27802962|NCT01836471|54257977|FG004|Overall Study|Lost to Follow-up|1|||
27939283|NCT00887341|54595499|FG000|Overall Study|Adverse Event|0|||
27939284|NCT00887341|54595500|FG001|Overall Study|Adverse Event|1|||
27939285|NCT00887341|54595499|FG000|Overall Study|Lost to Follow-up|0|||
27939286|NCT00887341|54595500|FG001|Overall Study|Lost to Follow-up|1|||
27939287|NCT00886795|54595506|FG000|Overall Study|Lack of Efficacy|1|||
27939288|NCT00889681|54595523|FG000|Overall Study|Not meeting qualification Criteria|2|||
28027552|NCT00528411|54685901|FG002|Overall Study|Adverse Event|1|||
28027553|NCT00528411|54685899|FG000|Overall Study|Incorrect Enrolment|1|||
27939289|NCT00889681|54595523|FG000|Overall Study|Insurance disapproval|1|||
27939290|NCT00957658|54595527|FG000|Overall Study|Death|1|||
28027554|NCT00528411|54685900|FG001|Overall Study|Incorrect Enrolment|1|||
28027555|NCT00528411|54685901|FG002|Overall Study|Incorrect Enrolment|0|||
27939291|NCT00957658|54595527|FG000|Overall Study|Lost to Follow-up|4|||
28027556|NCT00528411|54685899|FG000|Overall Study|Severe non-compliance to protocol|0|||
28027557|NCT00528411|54685900|FG001|Overall Study|Severe non-compliance to protocol|1|||
28027558|NCT00528411|54685901|FG002|Overall Study|Severe non-compliance to protocol|0|||
28027559|NCT00528411|54685899|FG000|Overall Study|Prior commitment medication|0|||
28027560|NCT00528411|54685900|FG001|Overall Study|Prior commitment medication|1|||
28027561|NCT00528411|54685901|FG002|Overall Study|Prior commitment medication|0|||
28027562|NCT00136357|54685911|FG000|Overall Study|Withdrawal by Subject|3|||
28027563|NCT00136357|54685912|FG001|Overall Study|Withdrawal by Subject|2|||
28027564|NCT00129649|54685920|FG000|Overall Study|Withdrawal by Subject|76|||
28027565|NCT00129649|54685921|FG001|Overall Study|Withdrawal by Subject|65|||
28027566|NCT00187135|54685933|FG000|Visit One|Withdrawal by Subject|1|||
28027567|NCT00187135|54685934|FG001|Visit One|Withdrawal by Subject|0|||
28027568|NCT00187135|54685935|FG002|Visit One|Withdrawal by Subject|0|||
28027569|NCT00187135|54685936|FG003|Visit One|Withdrawal by Subject|0|||
28027570|NCT00187135|54685937|FG004|Visit One|Withdrawal by Subject|0|||
28027571|NCT00187135|54685938|FG005|Visit One|Withdrawal by Subject|1|||
28027572|NCT00187135|54685933|FG000|Visit One|Physician Decision|3|||
28027573|NCT00187135|54685934|FG001|Visit One|Physician Decision|1|||
28027574|NCT00187135|54685935|FG002|Visit One|Physician Decision|0|||
27939292|NCT00957658|54595527|FG000|Overall Study|Withdrawal by Subject|12|||
27939293|NCT00957658|54595527|FG000|Overall Study|Revision|1|||
27939294|NCT00957658|54595527|FG000|Overall Study|Incomplete 2 yr data|28|||
27939295|NCT00957658|54595527|FG000|Overall Study|Site termination|10|||
28027575|NCT00187135|54685936|FG003|Visit One|Physician Decision|0|||
28027576|NCT00187135|54685937|FG004|Visit One|Physician Decision|0|||
28027577|NCT00187135|54685938|FG005|Visit One|Physician Decision|1|||
28027578|NCT00187135|54685933|FG000|Visit Two|Death|0|||
28027579|NCT00187135|54685934|FG001|Visit Two|Death|0|||
28027580|NCT00187135|54685935|FG002|Visit Two|Death|0|||
28027581|NCT00187135|54685936|FG003|Visit Two|Death|1|||
28027582|NCT00187135|54685937|FG004|Visit Two|Death|0|||
28027583|NCT00187135|54685938|FG005|Visit Two|Death|1|||
28027584|NCT00187135|54685933|FG000|Visit Two|Physician Decision|1|||
28027585|NCT00187135|54685934|FG001|Visit Two|Physician Decision|0|||
28027586|NCT00187135|54685935|FG002|Visit Two|Physician Decision|0|||
28027587|NCT00187135|54685936|FG003|Visit Two|Physician Decision|0|||
28027588|NCT00187135|54685937|FG004|Visit Two|Physician Decision|0|||
28027589|NCT00187135|54685938|FG005|Visit Two|Physician Decision|0|||
28027590|NCT00187135|54685933|FG000|Visit Two|Withdrawal by Subject|1|||
28027591|NCT00187135|54685934|FG001|Visit Two|Withdrawal by Subject|1|||
28027592|NCT00187135|54685935|FG002|Visit Two|Withdrawal by Subject|1|||
28027593|NCT00187135|54685936|FG003|Visit Two|Withdrawal by Subject|0|||
28027594|NCT00187135|54685937|FG004|Visit Two|Withdrawal by Subject|1|||
27802963|NCT01836471|54257973|FG000|Overall Study|Adverse Event|6|||
27802964|NCT01836471|54257974|FG001|Overall Study|Adverse Event|3|||
27802965|NCT01836471|54257975|FG002|Overall Study|Adverse Event|1|||
27802966|NCT01836471|54257976|FG003|Overall Study|Adverse Event|1|||
27802967|NCT01836471|54257977|FG004|Overall Study|Adverse Event|2|||
27802968|NCT01836471|54257973|FG000|Overall Study|Non compliance with tx|1|||
27802969|NCT01836471|54257974|FG001|Overall Study|Non compliance with tx|1|||
27802970|NCT01836471|54257975|FG002|Overall Study|Non compliance with tx|0|||
27802971|NCT01836471|54257976|FG003|Overall Study|Non compliance with tx|0|||
27802972|NCT01836471|54257977|FG004|Overall Study|Non compliance with tx|0|||
27802973|NCT02030600|54257992|FG000|Treatment Period 1|Adverse Event|5|||
27802974|NCT02030600|54257993|FG001|Treatment Period 1|Adverse Event|7|||
27802975|NCT02030600|54257992|FG000|Treatment Period 1|Lack of Efficacy|0|||
27802976|NCT02030600|54257993|FG001|Treatment Period 1|Lack of Efficacy|1|||
27802977|NCT02030600|54257992|FG000|Treatment Period 1|Lost to Follow-up|11|||
27802978|NCT02030600|54257993|FG001|Treatment Period 1|Lost to Follow-up|3|||
27802979|NCT02030600|54257992|FG000|Treatment Period 1|Protocol Violation|22|||
27802980|NCT02030600|54257993|FG001|Treatment Period 1|Protocol Violation|17|||
27802981|NCT02030600|54257992|FG000|Treatment Period 1|Withdrawal by Subject|13|||
27802982|NCT02030600|54257993|FG001|Treatment Period 1|Withdrawal by Subject|17|||
27802983|NCT02030600|54257992|FG000|Treatment Period 1|Casebook Unsigned|1|||
27802984|NCT02030600|54257993|FG001|Treatment Period 1|Casebook Unsigned|0|||
27802985|NCT02030600|54257992|FG000|Treatment Period 1|Unclassified|1|||
27802986|NCT02030600|54257993|FG001|Treatment Period 1|Unclassified|0|||
27802987|NCT02030600|54257992|FG000|Treatment Period 2|Adverse Event|4|||
27802988|NCT02030600|54257993|FG001|Treatment Period 2|Adverse Event|4|||
27802989|NCT02030600|54257992|FG000|Treatment Period 2|Lack of Efficacy|2|||
27802990|NCT02030600|54257993|FG001|Treatment Period 2|Lack of Efficacy|1|||
27802991|NCT02030600|54257992|FG000|Treatment Period 2|Lost to Follow-up|4|||
27802992|NCT02030600|54257993|FG001|Treatment Period 2|Lost to Follow-up|2|||
27802993|NCT02030600|54257992|FG000|Treatment Period 2|Protocol Violation|1|||
27802994|NCT02030600|54257993|FG001|Treatment Period 2|Protocol Violation|2|||
27802995|NCT02030600|54257992|FG000|Treatment Period 2|Withdrawal by Subject|13|||
27939296|NCT00957658|54595527|FG000|Overall Study|unwilling/unable to return|2|||
27939297|NCT00957658|54595527|FG000|Overall Study|surgery cancelled|2|||
27939298|NCT00957658|54595527|FG000|Overall Study|Protocol Violation|5|||
27939299|NCT00953680|54595533|FG000|Period 1|Withdrawal by Subject|0|||
27939300|NCT00953680|54595534|FG001|Period 1|Withdrawal by Subject|1|||
27939301|NCT00890929|54595540|FG000|Overall Study|Death before treatment|2|||
28027595|NCT00187135|54685938|FG005|Visit Two|Withdrawal by Subject|1|||
28027596|NCT00187135|54685933|FG000|Visit Two|Study Discontinued|3|||
28027597|NCT00187135|54685934|FG001|Visit Two|Study Discontinued|2|||
28027598|NCT00187135|54685935|FG002|Visit Two|Study Discontinued|1|||
28027599|NCT00187135|54685936|FG003|Visit Two|Study Discontinued|7|||
28027600|NCT00187135|54685937|FG004|Visit Two|Study Discontinued|5|||
28027601|NCT00187135|54685938|FG005|Visit Two|Study Discontinued|6|||
28027602|NCT00187135|54685933|FG000|Visit Three|Death|0|||
28027603|NCT00187135|54685934|FG001|Visit Three|Death|0|||
27802996|NCT02030600|54257993|FG001|Treatment Period 2|Withdrawal by Subject|9|||
27802997|NCT02030600|54257992|FG000|Treatment Period 2|Unclassified|1|||
27802998|NCT02030600|54257993|FG001|Treatment Period 2|Unclassified|0|||
27802999|NCT01802775|54258003|FG000|Overall Study|Death|0|||
27803000|NCT01802775|54258004|FG001|Overall Study|Death|3|||
27939302|NCT00890929|54595540|FG000|Overall Study|Withdrawal by Subject|3|||
27939303|NCT00890929|54595540|FG000|Overall Study|Physician Decision|1|||
27939304|NCT00886639|54595544|FG000|Overall Study|acute exacerbation|14|||
27803001|NCT01802775|54258003|FG000|Overall Study|Reason not provided|0|||
27803002|NCT01802775|54258004|FG001|Overall Study|Reason not provided|1|||
28027604|NCT00187135|54685935|FG002|Visit Three|Death|1|||
28027605|NCT00187135|54685936|FG003|Visit Three|Death|0|||
28027606|NCT00187135|54685937|FG004|Visit Three|Death|1|||
27939305|NCT00886639|54595544|FG000|Overall Study|non-compliance|2|||
27939306|NCT00889603|54595548|FG000|Overall Study|Adverse Event|7|||
27939307|NCT00889603|54595548|FG000|Overall Study|Death|3|||
27939308|NCT00889603|54595548|FG000|Overall Study|Lost to Follow-up|19|||
27939309|NCT00889603|54595548|FG000|Overall Study|No longer willing to participant in stud|4|||
27939310|NCT00889603|54595548|FG000|Overall Study|Other|4|||
27939311|NCT00886483|54595554|FG000|Overall Study|Lost to Follow-up|0|||
27939312|NCT00886483|54595555|FG001|Overall Study|Lost to Follow-up|1|||
27939313|NCT00886483|54595554|FG000|Overall Study|Pursue medications|1|||
27939314|NCT00886483|54595555|FG001|Overall Study|Pursue medications|2|||
27939315|NCT00886483|54595554|FG000|Overall Study|Distance to center, poor grades|1|||
28027607|NCT00187135|54685938|FG005|Visit Three|Death|0|||
28027608|NCT00187135|54685933|FG000|Visit Three|Withdrawal by Subject|0|||
28027609|NCT00187135|54685934|FG001|Visit Three|Withdrawal by Subject|1|||
27939316|NCT00886483|54595555|FG001|Overall Study|Distance to center, poor grades|0|||
27939317|NCT00886015|54595571|FG000|Overall Study|Death|0|||
27939318|NCT00886015|54595572|FG001|Overall Study|Death|2|||
27939319|NCT00890695|54595580|FG000|Overall Study|Protocol Violation|1|||
27939320|NCT00890695|54595581|FG001|Overall Study|Protocol Violation|0|||
27939321|NCT00957580|54595590|FG000|Overall Study|Ongoing at data cut-off|0|||
27939322|NCT00957580|54595591|FG001|Overall Study|Ongoing at data cut-off|1|||
27939323|NCT00957580|54595592|FG002|Overall Study|Ongoing at data cut-off|0|||
27939324|NCT00957580|54595590|FG000|Overall Study|Enrolled but not treated|0|||
27939325|NCT00957580|54595591|FG001|Overall Study|Enrolled but not treated|1|||
27939326|NCT00957580|54595592|FG002|Overall Study|Enrolled but not treated|0|||
27939327|NCT00957424|54595613|FG000|Overall Study|Lost to Follow-up|19|||
27939328|NCT00957424|54595613|FG000|Overall Study|Protocol Violation|3|||
27939329|NCT00957424|54595613|FG000|Overall Study|Withdrawal by Subject|1|||
27939330|NCT01061151|54595621|FG000|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2|||
27939331|NCT01061151|54595622|FG001|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
27939332|NCT01061151|54595623|FG002|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
27939333|NCT01061151|54595624|FG003|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1|||
27939334|NCT01061151|54595621|FG000|Protocol Version 2.0: 04/2011-09/2012|Death|6|||
27939335|NCT01061151|54595622|FG001|Protocol Version 2.0: 04/2011-09/2012|Death|9|||
27939336|NCT01061151|54595623|FG002|Protocol Version 2.0: 04/2011-09/2012|Death|1|||
27939337|NCT01061151|54595624|FG003|Protocol Version 2.0: 04/2011-09/2012|Death|2|||
27939338|NCT01061151|54595621|FG000|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89|||
28027610|NCT00187135|54685935|FG002|Visit Three|Withdrawal by Subject|1|||
28027611|NCT00187135|54685936|FG003|Visit Three|Withdrawal by Subject|2|||
28027612|NCT00187135|54685937|FG004|Visit Three|Withdrawal by Subject|0|||
28027613|NCT00187135|54685938|FG005|Visit Three|Withdrawal by Subject|0|||
27803003|NCT01802775|54258003|FG000|Overall Study|Physician Decision|1|||
27803004|NCT01802775|54258004|FG001|Overall Study|Physician Decision|0|||
27803005|NCT01802775|54258003|FG000|Overall Study|Adverse Event|1|||
27803006|NCT01802775|54258004|FG001|Overall Study|Adverse Event|1|||
27803007|NCT01802775|54258003|FG000|Overall Study|Withdrawal by Subject|3|||
27803008|NCT01802775|54258004|FG001|Overall Study|Withdrawal by Subject|5|||
27803009|NCT01802775|54258003|FG000|Overall Study|Lost to Follow-up|1|||
27803010|NCT01802775|54258004|FG001|Overall Study|Lost to Follow-up|2|||
27803011|NCT01802385|54258012|FG000|Overall Study|Death|106|||
27803012|NCT01802385|54258013|FG001|Overall Study|Death|120|||
27803013|NCT01773993|54258019|FG000|Overall Study|No Visit After Treatment|35|||
27803014|NCT01802073|54258025|FG000|Overall Study|Lost to Follow-up|0|||
27803015|NCT01802073|54258026|FG001|Overall Study|Lost to Follow-up|1|||
27803016|NCT01802073|54258025|FG000|Overall Study|Non-compliant|4|||
27803017|NCT01802073|54258026|FG001|Overall Study|Non-compliant|2|||
27803018|NCT01802073|54258025|FG000|Overall Study|Withdrawal by Subject|1|||
27803019|NCT01802073|54258026|FG001|Overall Study|Withdrawal by Subject|1|||
27803020|NCT01802073|54258025|FG000|Overall Study|Physician Decision|0|||
27803021|NCT01802073|54258026|FG001|Overall Study|Physician Decision|7|||
27803022|NCT01607073|54258032|FG000|Overall Study|Adverse Event|1|||
27803023|NCT01773291|54258042|FG000|Overall Study|Protocol Violation|1|||
27803024|NCT01773291|54258043|FG001|Overall Study|Protocol Violation|0|||
27803025|NCT01773291|54258044|FG002|Overall Study|Protocol Violation|0|||
27803026|NCT01773291|54258042|FG000|Overall Study|Withdrawal by Subject|0|||
27803027|NCT01773291|54258043|FG001|Overall Study|Withdrawal by Subject|0|||
27803028|NCT01773291|54258044|FG002|Overall Study|Withdrawal by Subject|1|||
27803029|NCT01801917|54258057|FG000|Period 1 - Randomized|Adverse Event|1|||
27939339|NCT01061151|54595622|FG001|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82|||
27939340|NCT01061151|54595623|FG002|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2|||
27803030|NCT01801917|54258058|FG001|Period 1 - Randomized|Adverse Event|0|||
27803031|NCT01801917|54258059|FG002|Period 1 - Randomized|Adverse Event|1|||
27939341|NCT01061151|54595624|FG003|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10|||
27803032|NCT01801917|54258060|FG003|Period 1 - Randomized|Adverse Event|0|||
27803033|NCT02008916|54258074|FG000|Primary Assessment (up to Week 16)|Withdrawal by Subject|0|||
27803034|NCT02008916|54258075|FG001|Primary Assessment (up to Week 16)|Withdrawal by Subject|1|||
27803035|NCT02008916|54258076|FG002|Primary Assessment (up to Week 16)|Withdrawal by Subject|3|||
27803036|NCT02008916|54258074|FG000|Week 16 - 156|Adverse Event|4|||
27803037|NCT02008916|54258075|FG001|Week 16 - 156|Adverse Event|2|||
27803038|NCT02008916|54258076|FG002|Week 16 - 156|Adverse Event|3|||
27803039|NCT02008916|54258074|FG000|Week 16 - 156|Withdrawal by Subject|7|||
27803040|NCT02008916|54258075|FG001|Week 16 - 156|Withdrawal by Subject|3|||
27803041|NCT02008916|54258076|FG002|Week 16 - 156|Withdrawal by Subject|5|||
27803042|NCT02008916|54258074|FG000|Week 16 - 156|No longer requires treatment|0|||
27803043|NCT02008916|54258075|FG001|Week 16 - 156|No longer requires treatment|1|||
27803044|NCT02008916|54258076|FG002|Week 16 - 156|No longer requires treatment|0|||
27803045|NCT02008916|54258074|FG000|Week 16 - 156|Lost to Follow-up|5|||
28027614|NCT00187135|54685933|FG000|Visit Three|Study Discontinued|7|||
28027615|NCT00187135|54685934|FG001|Visit Three|Study Discontinued|6|||
28027616|NCT00187135|54685935|FG002|Visit Three|Study Discontinued|7|||
28027617|NCT00187135|54685936|FG003|Visit Three|Study Discontinued|7|||
28027618|NCT00187135|54685937|FG004|Visit Three|Study Discontinued|7|||
28027619|NCT00187135|54685938|FG005|Visit Three|Study Discontinued|6|||
28027620|NCT00528021|54685954|FG000|Overall Study|Lack of Efficacy|17|||
28027621|NCT00528021|54685955|FG001|Overall Study|Lack of Efficacy|13|||
28027622|NCT00528021|54685956|FG002|Overall Study|Lack of Efficacy|7|||
28027623|NCT00528021|54685957|FG003|Overall Study|Lack of Efficacy|9|||
28027624|NCT00560352|54685970|FG000|Overall Study|Adverse event unrelated to study drug|2|||
27803046|NCT02008916|54258075|FG001|Week 16 - 156|Lost to Follow-up|0|||
28027625|NCT00560352|54685971|FG001|Overall Study|Adverse event unrelated to study drug|1|||
28027626|NCT00560352|54685972|FG002|Overall Study|Adverse event unrelated to study drug|1|||
28027627|NCT00560352|54685970|FG000|Overall Study|Study drug toxicity|3|||
28027628|NCT00560352|54685971|FG001|Overall Study|Study drug toxicity|0|||
28027629|NCT00560352|54685972|FG002|Overall Study|Study drug toxicity|1|||
28027630|NCT00560352|54685970|FG000|Overall Study|Disease progression|0|||
28027631|NCT00560352|54685971|FG001|Overall Study|Disease progression|1|||
28027632|NCT00560352|54685972|FG002|Overall Study|Disease progression|1|||
28027633|NCT00560352|54685970|FG000|Overall Study|Withdrawal by Subject|1|||
28027634|NCT00560352|54685971|FG001|Overall Study|Withdrawal by Subject|1|||
28027635|NCT00560352|54685972|FG002|Overall Study|Withdrawal by Subject|1|||
28027636|NCT00560352|54685970|FG000|Overall Study|Maximum clinical benefit|1|||
28027637|NCT00560352|54685971|FG001|Overall Study|Maximum clinical benefit|0|||
28027638|NCT00560352|54685972|FG002|Overall Study|Maximum clinical benefit|0|||
28027639|NCT00527787|54685986|FG000|Overall Study|Adverse Event|14|||
27803047|NCT02008916|54258076|FG002|Week 16 - 156|Lost to Follow-up|0|||
27803048|NCT02008916|54258074|FG000|Week 16 - 156|Lack of Efficacy|3|||
27803049|NCT02008916|54258075|FG001|Week 16 - 156|Lack of Efficacy|5|||
27803050|NCT02008916|54258076|FG002|Week 16 - 156|Lack of Efficacy|2|||
27803051|NCT02008916|54258074|FG000|Week 16 - 156|Pregnancy|0|||
27803052|NCT02008916|54258075|FG001|Week 16 - 156|Pregnancy|1|||
27803053|NCT02008916|54258076|FG002|Week 16 - 156|Pregnancy|0|||
27803054|NCT02008916|54258074|FG000|Week 16 - 156|Physician Decision|0|||
27803055|NCT02008916|54258075|FG001|Week 16 - 156|Physician Decision|1|||
27803056|NCT02008916|54258076|FG002|Week 16 - 156|Physician Decision|0|||
27803057|NCT01772823|54258087|FG000|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1|||
27803058|NCT01772823|54258088|FG001|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0|||
27803059|NCT01772823|54258087|FG000|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
27803060|NCT01772823|54258088|FG001|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
27803061|NCT01772823|54258087|FG000|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1|||
27803062|NCT01772823|54258088|FG001|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0|||
27803063|NCT01772823|54258087|FG000|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2|||
27803064|NCT01772823|54258088|FG001|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1|||
27803065|NCT01772823|54258087|FG000|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6|||
27842917|NCT01516736|54331863|FG001|Overall Study|Other (not specified)|1|||
27842918|NCT01546688|54331875|FG000|Overall Study|Adverse Event|0|||
28027640|NCT00527787|54685987|FG001|Overall Study|Adverse Event|24|||
28027641|NCT00527787|54685986|FG000|Overall Study|Withdrawal by Subject|13|||
28027642|NCT00527787|54685987|FG001|Overall Study|Withdrawal by Subject|25|||
28027643|NCT00527787|54685986|FG000|Overall Study|Lost to Follow-up|5|||
28027644|NCT00527787|54685987|FG001|Overall Study|Lost to Follow-up|2|||
27803066|NCT01772823|54258088|FG001|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0|||
27842919|NCT01546688|54331876|FG001|Overall Study|Adverse Event|4|||
27803067|NCT01772823|54258087|FG000|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1|||
27803068|NCT01772823|54258088|FG001|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0|||
27803069|NCT01772823|54258087|FG000|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15|||
27803070|NCT01772823|54258088|FG001|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13|||
27803071|NCT01772823|54258087|FG000|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6|||
27803072|NCT01772823|54258088|FG001|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1|||
27803073|NCT01772823|54258087|FG000|Treatment Phase (Week 0- Week 48)|Moved out of area|4|||
27803074|NCT01772823|54258088|FG001|Treatment Phase (Week 0- Week 48)|Moved out of area|3|||
27803075|NCT01772823|54258087|FG000|Treatment Phase (Week 0- Week 48)|Incarcerated|1|||
27803076|NCT01772823|54258088|FG001|Treatment Phase (Week 0- Week 48)|Incarcerated|0|||
27803077|NCT01772823|54258087|FG000|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1|||
27803078|NCT01772823|54258088|FG001|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0|||
27803079|NCT01772823|54258087|FG000|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
27803080|NCT01772823|54258088|FG001|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
27803081|NCT01772823|54258087|FG000|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6|||
27803082|NCT01772823|54258088|FG001|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5|||
27803083|NCT01772823|54258087|FG000|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1|||
27803084|NCT01772823|54258088|FG001|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2|||
27803085|NCT01772823|54258087|FG000|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
27803086|NCT01772823|54258088|FG001|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
27803087|NCT01772823|54258087|FG000|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1|||
27803088|NCT01772823|54258088|FG001|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0|||
27803089|NCT02029976|54258101|FG000|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12|||
27803090|NCT02029976|54258102|FG001|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8|||
27803091|NCT02029976|54258101|FG000|YR-2 Follow Up vs Baseline|Lost to Follow-up|8|||
27803092|NCT02029976|54258102|FG001|YR-2 Follow Up vs Baseline|Lost to Follow-up|4|||
27803093|NCT02029976|54258101|FG000|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
27803094|NCT02029976|54258102|FG001|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
27803095|NCT02029976|54258101|FG000|YR-2 Follow Up vs Baseline|Moved from area|0|||
27803096|NCT02029976|54258102|FG001|YR-2 Follow Up vs Baseline|Moved from area|2|||
27803097|NCT01983254|54258110|FG000|Overall Study|Death|6|||
27803098|NCT01983254|54258111|FG001|Overall Study|Death|6|||
27803099|NCT01983254|54258110|FG000|Overall Study|Lost to Follow-up|17|||
27803100|NCT01983254|54258111|FG001|Overall Study|Lost to Follow-up|16|||
27803101|NCT01983254|54258110|FG000|Overall Study|too ill|11|||
27803102|NCT01983254|54258111|FG001|Overall Study|too ill|8|||
27803103|NCT01771809|54258119|FG000|Overall Study|Adverse Event|4|||
27803104|NCT01771809|54258120|FG001|Overall Study|Adverse Event|12|||
27803105|NCT01771809|54258119|FG000|Overall Study|Protocol Violation|0|||
27803106|NCT01771809|54258120|FG001|Overall Study|Protocol Violation|1|||
27803107|NCT01771809|54258119|FG000|Overall Study|Withdrawal by Subject|34|||
27803108|NCT01771809|54258120|FG001|Overall Study|Withdrawal by Subject|42|||
27803109|NCT01771809|54258119|FG000|Overall Study|Lost to Follow-up|1|||
27803110|NCT01771809|54258120|FG001|Overall Study|Lost to Follow-up|3|||
27803111|NCT01771809|54258119|FG000|Overall Study|Other (Insufficient clinical response)|22|||
27803112|NCT01771809|54258120|FG001|Overall Study|Other (Insufficient clinical response)|20|||
27803113|NCT01771809|54258119|FG000|Overall Study|Death|1|||
27842920|NCT01546688|54331875|FG000|Overall Study|Withdrawal by Subject|2|||
27803114|NCT01771809|54258120|FG001|Overall Study|Death|0|||
27803115|NCT01771809|54258119|FG000|Overall Study|Other (other)|9|||
27803116|NCT01771809|54258120|FG001|Overall Study|Other (other)|5|||
27803117|NCT01771731|54258128|FG000|Overall Study|Physician Decision|1|||
27803118|NCT01771731|54258129|FG001|Overall Study|Physician Decision|0|||
27803119|NCT01771731|54258128|FG000|Overall Study|Protocol Violation|0|||
27803120|NCT01771731|54258129|FG001|Overall Study|Protocol Violation|1|||
27803121|NCT01771731|54258128|FG000|Overall Study|Adverse event: Pain Crisis|1|||
28027645|NCT00527787|54685986|FG000|Overall Study|Duodenal Ulcer|1|||
28027646|NCT00527787|54685987|FG001|Overall Study|Duodenal Ulcer|10|||
28027647|NCT00527787|54685986|FG000|Overall Study|misc|5|||
28027648|NCT00527787|54685987|FG001|Overall Study|misc|2|||
28027649|NCT00608426|54685995|FG000|Overall Study|Death|32|||
28027650|NCT00608426|54685996|FG001|Overall Study|Death|36|||
28027651|NCT00608426|54685995|FG000|Overall Study|Lost to Follow-up|485|||
28027652|NCT00608426|54685996|FG001|Overall Study|Lost to Follow-up|521|||
28027653|NCT00608426|54685995|FG000|Overall Study|refused, health issues, wrong address|319|||
28027654|NCT00608426|54685996|FG001|Overall Study|refused, health issues, wrong address|348|||
28027655|NCT00557076|54686004|FG000|Overall Study|Unblinding|0|||
28027656|NCT00557076|54686005|FG001|Overall Study|Unblinding|1|||
28027657|NCT00129259|54686013|FG000|Overall Study|Lost to Follow-up|1|||
28027658|NCT00129259|54686014|FG001|Overall Study|Lost to Follow-up|1|||
28027659|NCT00129259|54686013|FG000|Overall Study|Withdrawal by Subject|2|||
28027660|NCT00129259|54686014|FG001|Overall Study|Withdrawal by Subject|1|||
28027661|NCT00129259|54686013|FG000|Overall Study|Only available minimal phone assessments|0|||
28027662|NCT00129259|54686014|FG001|Overall Study|Only available minimal phone assessments|1|||
28027663|NCT00186901|54686023|FG000|Overall Study|Pregnancy|6|||
28027664|NCT00186901|54686024|FG001|Overall Study|Pregnancy|3|||
28027665|NCT00186901|54686025|FG002|Overall Study|Pregnancy|0|||
28027666|NCT00186901|54686023|FG000|Overall Study|Lost to Follow-up|6|||
28027667|NCT00186901|54686024|FG001|Overall Study|Lost to Follow-up|3|||
28027668|NCT00186901|54686025|FG002|Overall Study|Lost to Follow-up|0|||
28027669|NCT00186901|54686023|FG000|Overall Study|Bone Mineral Density dropped > 5%|9|||
28027670|NCT00186901|54686024|FG001|Overall Study|Bone Mineral Density dropped > 5%|7|||
28027671|NCT00186901|54686025|FG002|Overall Study|Bone Mineral Density dropped > 5%|0|||
28027672|NCT00186901|54686023|FG000|Overall Study|ALL relapse or second malignancy|1|||
28027673|NCT00186901|54686024|FG001|Overall Study|ALL relapse or second malignancy|2|||
28027674|NCT00186901|54686025|FG002|Overall Study|ALL relapse or second malignancy|0|||
28027675|NCT00186901|54686023|FG000|Overall Study|Withdrawal by Subject|4|||
28027676|NCT00186901|54686024|FG001|Overall Study|Withdrawal by Subject|5|||
28027677|NCT00186901|54686025|FG002|Overall Study|Withdrawal by Subject|0|||
28027678|NCT00186901|54686023|FG000|Overall Study|Open label|3|||
28027679|NCT00186901|54686024|FG001|Overall Study|Open label|2|||
28027680|NCT00186901|54686025|FG002|Overall Study|Open label|0|||
28027681|NCT00186901|54686023|FG000|Overall Study|Limited adherence to study requirements|20|||
28027682|NCT00186901|54686024|FG001|Overall Study|Limited adherence to study requirements|23|||
28027683|NCT00186901|54686025|FG002|Overall Study|Limited adherence to study requirements|0|||
28027684|NCT00186901|54686023|FG000|Overall Study|Bone Mineral Density > 0|0|||
28027685|NCT00186901|54686024|FG001|Overall Study|Bone Mineral Density > 0|0|||
28027686|NCT00186901|54686025|FG002|Overall Study|Bone Mineral Density > 0|149|||
28027687|NCT00186121|54686062|FG000|Overall Study|Subject withdrawal (no treatment)|1|||
28027688|NCT00186121|54686062|FG000|Overall Study|Underwent oophorectomy (no treatment)|1|||
28027689|NCT00186121|54686062|FG000|Overall Study|Not eligible (no treatment)|1|||
28027690|NCT00186043|54686068|FG000|Overall Study|Lack of Efficacy|1|||
28027691|NCT00186043|54686069|FG001|Overall Study|Lack of Efficacy|3|||
28027692|NCT00186043|54686068|FG000|Overall Study|Lost to Follow-up|4|||
27803122|NCT01771731|54258129|FG001|Overall Study|Adverse event: Pain Crisis|1|||
27842921|NCT01546688|54331876|FG001|Overall Study|Withdrawal by Subject|1|||
28027693|NCT00186043|54686069|FG001|Overall Study|Lost to Follow-up|6|||
28027694|NCT00186043|54686068|FG000|Overall Study|Withdrawal by Subject|1|||
28027695|NCT00186043|54686069|FG001|Overall Study|Withdrawal by Subject|0|||
28027696|NCT00186043|54686068|FG000|Overall Study|Adverse Event|7|||
28027697|NCT00186043|54686069|FG001|Overall Study|Adverse Event|3|||
28027698|NCT00186043|54686068|FG000|Overall Study|Protocol Violation|2|||
28027699|NCT00186043|54686069|FG001|Overall Study|Protocol Violation|1|||
28027700|NCT00185965|54686077|FG000|Overall Study|Adverse Event|0|||
27803123|NCT01982942|54258137|FG000|Overall Study|Adverse Event|10|||
27803124|NCT01982942|54258138|FG001|Overall Study|Adverse Event|5|||
28027701|NCT00185965|54686078|FG001|Overall Study|Adverse Event|1|||
27803125|NCT01982942|54258137|FG000|Overall Study|Lost to Follow-up|4|||
27803126|NCT01982942|54258138|FG001|Overall Study|Lost to Follow-up|3|||
27803127|NCT01982942|54258137|FG000|Overall Study|Multiple sclerosis progression|3|||
27803128|NCT01982942|54258138|FG001|Overall Study|Multiple sclerosis progression|2|||
27803129|NCT01982942|54258137|FG000|Overall Study|Wanted to try therapy not permitted|1|||
27803130|NCT01982942|54258138|FG001|Overall Study|Wanted to try therapy not permitted|0|||
27803131|NCT01982942|54258137|FG000|Overall Study|Subject declined future visits|0|||
27803132|NCT01982942|54258138|FG001|Overall Study|Subject declined future visits|1|||
27803133|NCT01982942|54258137|FG000|Overall Study|Left geographical area|2|||
27803134|NCT01982942|54258138|FG001|Overall Study|Left geographical area|0|||
27803135|NCT01982942|54258137|FG000|Overall Study|Too many pills|1|||
27803136|NCT01982942|54258138|FG001|Overall Study|Too many pills|0|||
27803137|NCT01982942|54258137|FG000|Overall Study|MS Relapse|0|||
27803138|NCT01982942|54258138|FG001|Overall Study|MS Relapse|1|||
27803139|NCT01982942|54258137|FG000|Overall Study|Chose to join a stem cell trial|0|||
27803140|NCT01982942|54258138|FG001|Overall Study|Chose to join a stem cell trial|1|||
27803141|NCT01982942|54258137|FG000|Overall Study|Subject bedridden, rapidly declining|0|||
27803142|NCT01982942|54258138|FG001|Overall Study|Subject bedridden, rapidly declining|1|||
27803143|NCT01769469|54258144|FG000|Overall Study|Consent Withdrawn|5|||
27803144|NCT01769469|54258144|FG000|Overall Study|Moved Out Of Area|3|||
27803145|NCT01769469|54258144|FG000|Overall Study|Lost to Follow-up|17|||
27803146|NCT01769469|54258144|FG000|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7|||
28027702|NCT00607880|54686086|FG000|Overall Study|Unable to place port due to occlusion|1|||
28027703|NCT00607880|54686087|FG001|Overall Study|Unable to place port due to occlusion|0|||
28027704|NCT00127933|54686095|FG000|Overall Study|Randomized but not dosed|1|||
28027705|NCT00127933|54686096|FG001|Overall Study|Randomized but not dosed|0|||
28027706|NCT03875313|54686107|FG000|Overall Study|Withdrawal by Subject|1|||
28027707|NCT03875313|54686108|FG001|Overall Study|Withdrawal by Subject|3|||
27803147|NCT01769469|54258144|FG000|Overall Study|Subject Confirmed HIV Positive|3|||
28027708|NCT03875313|54686109|FG002|Overall Study|Withdrawal by Subject|0|||
28027709|NCT03875313|54686110|FG003|Overall Study|Withdrawal by Subject|0|||
28027710|NCT03875313|54686111|FG004|Overall Study|Withdrawal by Subject|0|||
28027711|NCT03875313|54686107|FG000|Overall Study|Death|0|||
28027712|NCT03875313|54686108|FG001|Overall Study|Death|0|||
28027713|NCT03875313|54686109|FG002|Overall Study|Death|0|||
28027714|NCT03875313|54686110|FG003|Overall Study|Death|0|||
28027715|NCT03875313|54686111|FG004|Overall Study|Death|1|||
28027716|NCT03875313|54686107|FG000|Overall Study|Lost to Follow-up|0|||
28027717|NCT03875313|54686108|FG001|Overall Study|Lost to Follow-up|0|||
28027718|NCT03875313|54686109|FG002|Overall Study|Lost to Follow-up|0|||
28027719|NCT03875313|54686110|FG003|Overall Study|Lost to Follow-up|0|||
28027720|NCT03875313|54686111|FG004|Overall Study|Lost to Follow-up|1|||
28027721|NCT03875313|54686107|FG000|Overall Study|Study Termination by Sponsor|0|||
28027722|NCT03875313|54686108|FG001|Overall Study|Study Termination by Sponsor|1|||
28027723|NCT03875313|54686109|FG002|Overall Study|Study Termination by Sponsor|1|||
28027724|NCT03875313|54686110|FG003|Overall Study|Study Termination by Sponsor|0|||
28027725|NCT03875313|54686111|FG004|Overall Study|Study Termination by Sponsor|1|||
28027726|NCT03875313|54686107|FG000|Overall Study|New Anticancer Treatment|0|||
28027727|NCT03875313|54686108|FG001|Overall Study|New Anticancer Treatment|1|||
28027728|NCT03875313|54686109|FG002|Overall Study|New Anticancer Treatment|2|||
28027729|NCT03875313|54686110|FG003|Overall Study|New Anticancer Treatment|1|||
28027730|NCT03875313|54686111|FG004|Overall Study|New Anticancer Treatment|0|||
28027731|NCT03875313|54686107|FG000|Overall Study|Other, Not Specified|2|||
28027732|NCT03875313|54686108|FG001|Overall Study|Other, Not Specified|11|||
28027733|NCT03875313|54686109|FG002|Overall Study|Other, Not Specified|3|||
28027734|NCT03875313|54686110|FG003|Overall Study|Other, Not Specified|3|||
28027735|NCT03875313|54686111|FG004|Overall Study|Other, Not Specified|1|||
28027736|NCT00556998|54686123|FG000|Voriconazole Intravenous (IV)|Adverse Event|1|||
28027737|NCT00556998|54686123|FG000|Voriconazole Intravenous (IV)|Other|4|||
28027738|NCT00556998|54686123|FG000|Voriconazole Oral|Adverse Event|1|||
28027739|NCT00556998|54686123|FG000|Voriconazole Oral|Intolerant of oral treatment|1|||
28027740|NCT00528801|54686133|FG000|Overall Study|Withdrawal by Subject|1|||
28027741|NCT00528801|54686134|FG001|Overall Study|Withdrawal by Subject|1|||
28027742|NCT00528801|54686133|FG000|Overall Study|Protocol Violation|11|||
28027743|NCT00528801|54686134|FG001|Overall Study|Protocol Violation|5|||
28027744|NCT00528801|54686133|FG000|Overall Study|Lost to Follow-up|15|||
28027745|NCT00528801|54686134|FG001|Overall Study|Lost to Follow-up|4|||
28027746|NCT00528801|54686133|FG000|Overall Study|Administrative Reasons|0|||
28027747|NCT00528801|54686134|FG001|Overall Study|Administrative Reasons|1|||
28027748|NCT00527397|54686140|FG000|Overall Study|Adverse Event|3|||
28027749|NCT00527397|54686140|FG000|Overall Study|Lack of Efficacy|1|||
27803148|NCT02008526|54258153|FG000|Overall Study|Death|0|||
27803149|NCT02008526|54258154|FG001|Overall Study|Death|2|||
28027750|NCT00527397|54686140|FG000|Overall Study|Protocol Violation|1|||
28027751|NCT00527397|54686140|FG000|Overall Study|Withdrawal by Subject|6|||
27803150|NCT02008526|54258155|FG002|Overall Study|Death|1|||
27803151|NCT02008526|54258153|FG000|Overall Study|Withdrawal by Subject|3|||
27803152|NCT02008526|54258154|FG001|Overall Study|Withdrawal by Subject|3|||
27803153|NCT02008526|54258155|FG002|Overall Study|Withdrawal by Subject|2|||
27803154|NCT02008526|54258153|FG000|Overall Study|Lost to Follow-up|5|||
27803155|NCT02008526|54258154|FG001|Overall Study|Lost to Follow-up|9|||
27803156|NCT02008526|54258155|FG002|Overall Study|Lost to Follow-up|6|||
27803157|NCT01769391|54258165|FG000|Overall Study|Death|10|||
27803158|NCT01769391|54258166|FG001|Overall Study|Death|1|||
27803159|NCT01769391|54258165|FG000|Overall Study|Adverse Event|0|||
27803160|NCT01769391|54258166|FG001|Overall Study|Adverse Event|3|||
27803161|NCT01769391|54258165|FG000|Overall Study|Progressive Disease|1|||
27803162|NCT01769391|54258166|FG001|Overall Study|Progressive Disease|2|||
27803163|NCT01769391|54258165|FG000|Overall Study|Withdrawal by Subject|4|||
27803164|NCT01769391|54258166|FG001|Overall Study|Withdrawal by Subject|3|||
27803165|NCT01769391|54258165|FG000|Overall Study|Investigator Decision|2|||
27803166|NCT01769391|54258166|FG001|Overall Study|Investigator Decision|0|||
27803167|NCT01800903|54258178|FG000|Second Test Period|unable to catheterise|1|||
27803168|NCT01800903|54258179|FG001|Second Test Period|unable to catheterise|0|||
27803169|NCT01800903|54258180|FG002|Second Test Period|unable to catheterise|0|||
27803170|NCT01800903|54258181|FG003|Second Test Period|unable to catheterise|0|||
27803171|NCT01800903|54258182|FG004|Second Test Period|unable to catheterise|0|||
27803172|NCT01800903|54258183|FG005|Second Test Period|unable to catheterise|0|||
27803173|NCT01767987|54258191|FG000|Overall Study|Physician Decision|4|||
27803174|NCT01767987|54258192|FG001|Overall Study|Physician Decision|1|||
27803175|NCT01800201|54258200|FG000|Overall Study|Withdrawal by Subject|2|||
27803176|NCT01800201|54258201|FG001|Overall Study|Withdrawal by Subject|0|||
27803177|NCT01800201|54258200|FG000|Overall Study|patient privacy concerns|1|||
27803178|NCT01800201|54258201|FG001|Overall Study|patient privacy concerns|1|||
27803179|NCT01800201|54258200|FG000|Overall Study|did not want to use device|0|||
27803180|NCT01800201|54258201|FG001|Overall Study|did not want to use device|1|||
27803181|NCT01800201|54258200|FG000|Overall Study|PI withdrawal, cognitive concerns|0|||
27803182|NCT01800201|54258201|FG001|Overall Study|PI withdrawal, cognitive concerns|1|||
27803183|NCT01767909|54258210|FG000|Overall Study|Withdrawal by Subject|4|||
27803184|NCT01767909|54258211|FG001|Overall Study|Withdrawal by Subject|7|||
27803185|NCT01767909|54258210|FG000|Overall Study|Adverse Event|3|||
27803186|NCT01767909|54258211|FG001|Overall Study|Adverse Event|1|||
27803187|NCT01767909|54258210|FG000|Overall Study|Withdrawal by Study Partner|3|||
27803188|NCT01767909|54258211|FG001|Overall Study|Withdrawal by Study Partner|1|||
27803189|NCT01767909|54258210|FG000|Overall Study|Non-Compliance|2|||
28027752|NCT00527397|54686140|FG000|Overall Study|Study terminated by sponsor|13|||
27803190|NCT01767909|54258211|FG001|Overall Study|Non-Compliance|0|||
27803191|NCT01767909|54258210|FG000|Overall Study|Perceived Lack of Efficacy|1|||
27803192|NCT01767909|54258211|FG001|Overall Study|Perceived Lack of Efficacy|0|||
27803193|NCT01767909|54258210|FG000|Overall Study|Investigator Recommendation|0|||
27803194|NCT01767909|54258211|FG001|Overall Study|Investigator Recommendation|1|||
27803195|NCT01767909|54258210|FG000|Overall Study|Lost to Follow-up|0|||
27803196|NCT01767909|54258211|FG001|Overall Study|Lost to Follow-up|1|||
27803197|NCT01767909|54258210|FG000|Overall Study|LP uncessessful|0|||
27803198|NCT01767909|54258211|FG001|Overall Study|LP uncessessful|1|||
27803199|NCT02029274|54258223|FG000|Overall Study|Adverse Event|1|||
27803200|NCT02029274|54258224|FG001|Overall Study|Adverse Event|0|||
27803201|NCT02029274|54258225|FG002|Overall Study|Adverse Event|2|||
27803202|NCT02029274|54258226|FG003|Overall Study|Adverse Event|2|||
27803203|NCT02008370|54258240|FG000|Overall Study|Lost to Follow-up|7|||
27803204|NCT01981616|54258246|FG000|Overall Study|Adverse Event|0|||
27803205|NCT01981616|54258247|FG001|Overall Study|Adverse Event|1|||
27803206|NCT01981616|54258246|FG000|Overall Study|Protocol Violation|1|||
27803207|NCT01981616|54258247|FG001|Overall Study|Protocol Violation|0|||
27803208|NCT02104817|54258255|FG000|Overall Study|Death|363|||
28027753|NCT00527319|54686150|FG000|Overall Study|Withdrawal by Subject|5|||
27803209|NCT02104817|54258256|FG001|Overall Study|Death|330|||
27939342|NCT01061151|54595621|FG000|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73|||
28027754|NCT00527319|54686151|FG001|Overall Study|Withdrawal by Subject|0|||
27803210|NCT02104817|54258255|FG000|Overall Study|Lost to Follow-up|3|||
27803211|NCT02104817|54258256|FG001|Overall Study|Lost to Follow-up|2|||
27803212|NCT02104817|54258255|FG000|Overall Study|Protocol Violation|0|||
27842922|NCT01546688|54331875|FG000|Overall Study|Lack of Efficacy|1|||
28027755|NCT00527319|54686152|FG002|Overall Study|Withdrawal by Subject|1|||
28027756|NCT00527319|54686150|FG000|Overall Study|Lost to Follow-up|1|||
28027757|NCT00527319|54686151|FG001|Overall Study|Lost to Follow-up|0|||
28027758|NCT00527319|54686152|FG002|Overall Study|Lost to Follow-up|0|||
28027759|NCT00527319|54686150|FG000|Overall Study|Death|0|||
28027760|NCT00527319|54686151|FG001|Overall Study|Death|3|||
28027761|NCT00527319|54686152|FG002|Overall Study|Death|1|||
28027762|NCT00527319|54686150|FG000|Overall Study|Intercurrent Medical Illness|0|||
28027763|NCT00527319|54686151|FG001|Overall Study|Intercurrent Medical Illness|1|||
28027764|NCT00527319|54686152|FG002|Overall Study|Intercurrent Medical Illness|3|||
28027765|NCT00527319|54686150|FG000|Overall Study|Adverse Event|0|||
28027766|NCT00527319|54686151|FG001|Overall Study|Adverse Event|0|||
28027767|NCT00527319|54686152|FG002|Overall Study|Adverse Event|1|||
28027768|NCT00562302|54686162|FG000|Overall Study|Lost to Follow-up|3|||
28027769|NCT00562302|54686163|FG001|Overall Study|Lost to Follow-up|3|||
28027770|NCT00562302|54686162|FG000|Overall Study|Adverse Event|0|||
28027771|NCT00562302|54686163|FG001|Overall Study|Adverse Event|6|||
28027772|NCT00562302|54686162|FG000|Overall Study|Non-compliance|1|||
28027773|NCT00562302|54686163|FG001|Overall Study|Non-compliance|2|||
28027774|NCT00562302|54686162|FG000|Overall Study|Withdrawal by Subject|7|||
28027775|NCT00562302|54686163|FG001|Overall Study|Withdrawal by Subject|8|||
28027776|NCT00562302|54686162|FG000|Overall Study|Death|1|||
28027777|NCT00562302|54686163|FG001|Overall Study|Death|2|||
28027778|NCT00562302|54686162|FG000|Overall Study|Lung resection prior to study completion|7|||
28027779|NCT00562302|54686163|FG001|Overall Study|Lung resection prior to study completion|7|||
28027780|NCT00562302|54686162|FG000|Overall Study|Not stated|1|||
28027781|NCT00562302|54686163|FG001|Overall Study|Not stated|4|||
28027782|NCT00134719|54686172|FG000|Primary Vaccination Phase|Adverse Event|4|||
28027783|NCT00134719|54686173|FG001|Primary Vaccination Phase|Adverse Event|0|||
28027784|NCT00134719|54686174|FG002|Primary Vaccination Phase|Adverse Event|0|||
28027785|NCT00134719|54686172|FG000|Primary Vaccination Phase|Protocol Violation|1|||
28027786|NCT00134719|54686173|FG001|Primary Vaccination Phase|Protocol Violation|0|||
28027787|NCT00134719|54686174|FG002|Primary Vaccination Phase|Protocol Violation|0|||
27939343|NCT01061151|54595622|FG001|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65|||
27939344|NCT01061151|54595623|FG002|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2|||
27939345|NCT01061151|54595624|FG003|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10|||
27939346|NCT01061151|54595621|FG000|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15|||
27939347|NCT01061151|54595622|FG001|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19|||
27939348|NCT01061151|54595623|FG002|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1|||
27939349|NCT01061151|54595624|FG003|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0|||
27939350|NCT01061151|54595621|FG000|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44|||
27939351|NCT01061151|54595622|FG001|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61|||
27939352|NCT01061151|54595623|FG002|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2|||
27939353|NCT01061151|54595624|FG003|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5|||
27939354|NCT01061151|54595621|FG000|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3|||
27939355|NCT01061151|54595622|FG001|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5|||
27939356|NCT01061151|54595623|FG002|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1|||
27939357|NCT01061151|54595624|FG003|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0|||
27939358|NCT01061151|54595621|FG000|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
27939359|NCT01061151|54595622|FG001|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
27939360|NCT01061151|54595623|FG002|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2|||
27939361|NCT01061151|54595624|FG003|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4|||
27939362|NCT01061151|54595621|FG000|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1|||
27939363|NCT01061151|54595622|FG001|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
27939364|NCT01061151|54595623|FG002|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
27939365|NCT01061151|54595624|FG003|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
27939366|NCT01061151|54595621|FG000|Protocol Version 3.0: 10/2012-10/2014|Death|3|||
27939367|NCT01061151|54595622|FG001|Protocol Version 3.0: 10/2012-10/2014|Death|5|||
27939368|NCT01061151|54595623|FG002|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
27939369|NCT01061151|54595624|FG003|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
28027788|NCT00134719|54686172|FG000|Primary Vaccination Phase|Withdrawal by Subject|2|||
28027789|NCT00134719|54686173|FG001|Primary Vaccination Phase|Withdrawal by Subject|3|||
28027790|NCT00134719|54686174|FG002|Primary Vaccination Phase|Withdrawal by Subject|2|||
28027791|NCT00134719|54686172|FG000|Primary Vaccination Phase|Lost to Follow-up|7|||
28027792|NCT00134719|54686173|FG001|Primary Vaccination Phase|Lost to Follow-up|3|||
27803213|NCT02104817|54258256|FG001|Overall Study|Protocol Violation|1|||
27939370|NCT01061151|54595621|FG000|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54|||
28027793|NCT00134719|54686174|FG002|Primary Vaccination Phase|Lost to Follow-up|3|||
27803214|NCT02104817|54258255|FG000|Overall Study|Study terminated by sponsor|5854|||
27803215|NCT02104817|54258256|FG001|Overall Study|Study terminated by sponsor|5901|||
27803216|NCT02104817|54258255|FG000|Overall Study|Withdrawal by Subject|111|||
27803217|NCT02104817|54258256|FG001|Overall Study|Withdrawal by Subject|78|||
27803218|NCT02104817|54258255|FG000|Overall Study|Other reasons|128|||
27803219|NCT02104817|54258256|FG001|Overall Study|Other reasons|135|||
27803220|NCT01962103|54258271|FG000|Phase 1|Adverse Event|4|||
27803221|NCT01962103|54258272|FG001|Phase 1|Adverse Event|0|||
27803222|NCT01962103|54258273|FG002|Phase 1|Adverse Event|2|||
27803223|NCT01962103|54258274|FG003|Phase 1|Adverse Event|1|||
27803224|NCT01962103|54258275|FG004|Phase 1|Adverse Event|2|||
27803225|NCT01962103|54258276|FG005|Phase 1|Adverse Event|2|||
27803226|NCT01962103|54258277|FG006|Phase 1|Adverse Event|0|||
27842923|NCT01546688|54331876|FG001|Overall Study|Lack of Efficacy|0|||
27803227|NCT01962103|54258278|FG007|Phase 1|Adverse Event|0|||
27803228|NCT01962103|54258279|FG008|Phase 1|Adverse Event|0|||
27803229|NCT01962103|54258271|FG000|Phase 1|Progressive Disease|8|||
27803230|NCT01962103|54258272|FG001|Phase 1|Progressive Disease|6|||
27803231|NCT01962103|54258273|FG002|Phase 1|Progressive Disease|8|||
27803232|NCT01962103|54258274|FG003|Phase 1|Progressive Disease|4|||
27803233|NCT01962103|54258275|FG004|Phase 1|Progressive Disease|5|||
27803234|NCT01962103|54258276|FG005|Phase 1|Progressive Disease|4|||
27803235|NCT01962103|54258277|FG006|Phase 1|Progressive Disease|0|||
27803236|NCT01962103|54258278|FG007|Phase 1|Progressive Disease|0|||
28027794|NCT00134719|54686172|FG000|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
28027795|NCT00134719|54686173|FG001|Fourth Dose Vaccination Phase|Lost to Follow-up|3|||
28027796|NCT00134719|54686174|FG002|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
28027797|NCT00134719|54686172|FG000|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1|||
28027798|NCT00134719|54686173|FG001|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
28027799|NCT00134719|54686174|FG002|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
28027800|NCT00526071|54686182|FG000|Overall Study|Adverse Event|1|||
27803237|NCT01962103|54258279|FG008|Phase 1|Progressive Disease|0|||
27803238|NCT01962103|54258271|FG000|Phase 1|Withdrawal by Subject|0|||
27803239|NCT01962103|54258272|FG001|Phase 1|Withdrawal by Subject|0|||
27803240|NCT01962103|54258273|FG002|Phase 1|Withdrawal by Subject|0|||
27803241|NCT01962103|54258274|FG003|Phase 1|Withdrawal by Subject|2|||
27803242|NCT01962103|54258275|FG004|Phase 1|Withdrawal by Subject|0|||
27803243|NCT01962103|54258276|FG005|Phase 1|Withdrawal by Subject|0|||
27803244|NCT01962103|54258277|FG006|Phase 1|Withdrawal by Subject|0|||
27803245|NCT01962103|54258278|FG007|Phase 1|Withdrawal by Subject|0|||
27803246|NCT01962103|54258279|FG008|Phase 1|Withdrawal by Subject|0|||
27803247|NCT01962103|54258271|FG000|Phase 1|Withdrawal by Parent/Guardian|0|||
27803248|NCT01962103|54258272|FG001|Phase 1|Withdrawal by Parent/Guardian|0|||
27803249|NCT01962103|54258273|FG002|Phase 1|Withdrawal by Parent/Guardian|2|||
27803250|NCT01962103|54258274|FG003|Phase 1|Withdrawal by Parent/Guardian|1|||
27803251|NCT01962103|54258275|FG004|Phase 1|Withdrawal by Parent/Guardian|0|||
27803252|NCT01962103|54258276|FG005|Phase 1|Withdrawal by Parent/Guardian|0|||
27803253|NCT01962103|54258277|FG006|Phase 1|Withdrawal by Parent/Guardian|0|||
27803254|NCT01962103|54258278|FG007|Phase 1|Withdrawal by Parent/Guardian|0|||
27803255|NCT01962103|54258279|FG008|Phase 1|Withdrawal by Parent/Guardian|0|||
27803256|NCT01962103|54258271|FG000|Phase 1|Physician Decision|0|||
27803257|NCT01962103|54258272|FG001|Phase 1|Physician Decision|0|||
27803258|NCT01962103|54258273|FG002|Phase 1|Physician Decision|0|||
27803259|NCT01962103|54258274|FG003|Phase 1|Physician Decision|1|||
27803260|NCT01962103|54258275|FG004|Phase 1|Physician Decision|0|||
27803261|NCT01962103|54258276|FG005|Phase 1|Physician Decision|0|||
27803262|NCT01962103|54258277|FG006|Phase 1|Physician Decision|0|||
27803263|NCT01962103|54258278|FG007|Phase 1|Physician Decision|0|||
27803264|NCT01962103|54258279|FG008|Phase 1|Physician Decision|0|||
27803265|NCT01962103|54258271|FG000|Phase 1|Symptomatic Deterioration|3|||
27803266|NCT01962103|54258272|FG001|Phase 1|Symptomatic Deterioration|2|||
27803267|NCT01962103|54258273|FG002|Phase 1|Symptomatic Deterioration|2|||
27803268|NCT01962103|54258274|FG003|Phase 1|Symptomatic Deterioration|2|||
27803269|NCT01962103|54258275|FG004|Phase 1|Symptomatic Deterioration|1|||
27803270|NCT01962103|54258276|FG005|Phase 1|Symptomatic Deterioration|1|||
27803271|NCT01962103|54258277|FG006|Phase 1|Symptomatic Deterioration|0|||
27803272|NCT01962103|54258278|FG007|Phase 1|Symptomatic Deterioration|0|||
27803273|NCT01962103|54258279|FG008|Phase 1|Symptomatic Deterioration|0|||
27803274|NCT01962103|54258271|FG000|Phase 1|Miscellaneous|1|||
27803275|NCT01962103|54258272|FG001|Phase 1|Miscellaneous|0|||
27803276|NCT01962103|54258273|FG002|Phase 1|Miscellaneous|0|||
27803277|NCT01962103|54258274|FG003|Phase 1|Miscellaneous|0|||
27803278|NCT01962103|54258275|FG004|Phase 1|Miscellaneous|0|||
27803279|NCT01962103|54258276|FG005|Phase 1|Miscellaneous|0|||
27803280|NCT01962103|54258277|FG006|Phase 1|Miscellaneous|0|||
27803281|NCT01962103|54258278|FG007|Phase 1|Miscellaneous|0|||
27803282|NCT01962103|54258279|FG008|Phase 1|Miscellaneous|0|||
27803283|NCT01962103|54258271|FG000|Phase 2|Adverse Event|0|||
27803284|NCT01962103|54258272|FG001|Phase 2|Adverse Event|0|||
27803285|NCT01962103|54258273|FG002|Phase 2|Adverse Event|0|||
27803286|NCT01962103|54258274|FG003|Phase 2|Adverse Event|0|||
27803287|NCT01962103|54258275|FG004|Phase 2|Adverse Event|0|||
27803288|NCT01962103|54258276|FG005|Phase 2|Adverse Event|0|||
27803289|NCT01962103|54258277|FG006|Phase 2|Adverse Event|1|||
27803290|NCT01962103|54258278|FG007|Phase 2|Adverse Event|0|||
27803291|NCT01962103|54258279|FG008|Phase 2|Adverse Event|3|||
27803292|NCT01962103|54258271|FG000|Phase 2|Progressive Disease|0|||
27803293|NCT01962103|54258272|FG001|Phase 2|Progressive Disease|0|||
28027801|NCT00526071|54686182|FG000|Overall Study|Withdrawal by Subject|1|||
28027802|NCT00526071|54686182|FG000|Overall Study|Lack of Response to Study Drug|4|||
28027803|NCT00525915|54686192|FG000|Overall Study|Non-Compliance|0|||
28027804|NCT00525915|54686193|FG001|Overall Study|Non-Compliance|1|||
28027805|NCT00525915|54686192|FG000|Overall Study|Disease Progression|5|||
28027806|NCT00525915|54686193|FG001|Overall Study|Disease Progression|6|||
28027807|NCT00525915|54686192|FG000|Overall Study|Withdrawal by Subject|1|||
28027808|NCT00525915|54686193|FG001|Overall Study|Withdrawal by Subject|0|||
28027809|NCT00525915|54686192|FG000|Overall Study|Refused Surgery|1|||
28027810|NCT00525915|54686193|FG001|Overall Study|Refused Surgery|2|||
28027811|NCT00525915|54686192|FG000|Overall Study|Unrelated illness|1|||
28027812|NCT00525915|54686193|FG001|Overall Study|Unrelated illness|0|||
28027813|NCT00521079|54686201|FG000|Overall Study|Adverse Event|7|||
28027814|NCT00521079|54686202|FG001|Overall Study|Adverse Event|1|||
28027815|NCT00521079|54686201|FG000|Overall Study|Lost to Follow-up|2|||
28027816|NCT00521079|54686202|FG001|Overall Study|Lost to Follow-up|1|||
28027817|NCT00521079|54686201|FG000|Overall Study|Withdrawal by Subject|5|||
28027818|NCT00521079|54686202|FG001|Overall Study|Withdrawal by Subject|3|||
28027819|NCT00521001|54686208|FG000|Overall Study|Ineligible|1|||
27803294|NCT01962103|54258273|FG002|Phase 2|Progressive Disease|0|||
28027820|NCT00134563|54686215|FG000|Overall Study|Not treated due to protocol violation|0|||
28027821|NCT00134563|54686216|FG001|Overall Study|Not treated due to protocol violation|1|||
28027822|NCT00134563|54686217|FG002|Overall Study|Not treated due to protocol violation|1|||
28027823|NCT00134563|54686215|FG000|Overall Study|Adverse Event|29|||
28027824|NCT00134563|54686216|FG001|Overall Study|Adverse Event|37|||
27803295|NCT01962103|54258274|FG003|Phase 2|Progressive Disease|0|||
27803296|NCT01962103|54258275|FG004|Phase 2|Progressive Disease|0|||
27803297|NCT01962103|54258276|FG005|Phase 2|Progressive Disease|0|||
27803298|NCT01962103|54258277|FG006|Phase 2|Progressive Disease|11|||
27803299|NCT01962103|54258278|FG007|Phase 2|Progressive Disease|12|||
27803300|NCT01962103|54258279|FG008|Phase 2|Progressive Disease|11|||
27803301|NCT01962103|54258271|FG000|Phase 2|Symptomatic Deterioration|0|||
27803302|NCT01962103|54258272|FG001|Phase 2|Symptomatic Deterioration|0|||
27803303|NCT01962103|54258273|FG002|Phase 2|Symptomatic Deterioration|0|||
27803304|NCT01962103|54258274|FG003|Phase 2|Symptomatic Deterioration|0|||
27803305|NCT01962103|54258275|FG004|Phase 2|Symptomatic Deterioration|0|||
27803306|NCT01962103|54258276|FG005|Phase 2|Symptomatic Deterioration|0|||
27803307|NCT01962103|54258277|FG006|Phase 2|Symptomatic Deterioration|2|||
27803308|NCT01962103|54258278|FG007|Phase 2|Symptomatic Deterioration|2|||
27803309|NCT01962103|54258279|FG008|Phase 2|Symptomatic Deterioration|0|||
27842924|NCT01516034|54331882|FG000|Overall Study|Physician Decision|1|||
28027825|NCT00134563|54686217|FG002|Overall Study|Adverse Event|38|||
28027826|NCT00134563|54686215|FG000|Overall Study|Lack of Efficacy|24|||
28027827|NCT00134563|54686216|FG001|Overall Study|Lack of Efficacy|14|||
28027828|NCT00134563|54686217|FG002|Overall Study|Lack of Efficacy|17|||
28027829|NCT00134563|54686215|FG000|Overall Study|Protocol Violation|3|||
28027830|NCT00134563|54686216|FG001|Overall Study|Protocol Violation|2|||
28027831|NCT00134563|54686217|FG002|Overall Study|Protocol Violation|5|||
28027832|NCT00134563|54686215|FG000|Overall Study|Lost to Follow-up|4|||
28027833|NCT00134563|54686216|FG001|Overall Study|Lost to Follow-up|0|||
28027834|NCT00134563|54686217|FG002|Overall Study|Lost to Follow-up|2|||
28027835|NCT00134563|54686215|FG000|Overall Study|progressive disease|11|||
28027836|NCT00134563|54686216|FG001|Overall Study|progressive disease|4|||
28027837|NCT00134563|54686217|FG002|Overall Study|progressive disease|2|||
28027838|NCT00134563|54686215|FG000|Overall Study|did not wish to continue|33|||
27803310|NCT01961323|54258299|FG000|Overall Study|Withdrawal by Subject|7|||
27803311|NCT01961323|54258299|FG000|Overall Study|Lost to Follow-up|8|||
27803312|NCT01961323|54258299|FG000|Overall Study|screen failure|34|||
27803313|NCT01960855|54258308|FG000|Overall Study|Subject noncompliant|1|||
27803314|NCT01960855|54258309|FG001|Overall Study|Subject noncompliant|0|||
27803315|NCT01960855|54258310|FG002|Overall Study|Subject noncompliant|0|||
28027839|NCT00134563|54686216|FG001|Overall Study|did not wish to continue|32|||
28027840|NCT00134563|54686217|FG002|Overall Study|did not wish to continue|26|||
27803316|NCT01960855|54258311|FG003|Overall Study|Subject noncompliant|0|||
27803317|NCT01960855|54258312|FG004|Overall Study|Subject noncompliant|0|||
28027841|NCT00134563|54686215|FG000|Overall Study|Reason other than above|0|||
27803318|NCT01960855|54258308|FG000|Overall Study|Adverse Event|2|||
27803319|NCT01960855|54258309|FG001|Overall Study|Adverse Event|0|||
27803320|NCT01960855|54258310|FG002|Overall Study|Adverse Event|6|||
27803321|NCT01960855|54258311|FG003|Overall Study|Adverse Event|2|||
27803322|NCT01960855|54258312|FG004|Overall Study|Adverse Event|2|||
27803323|NCT01960855|54258308|FG000|Overall Study|Lack of Efficacy|1|||
27803324|NCT01960855|54258309|FG001|Overall Study|Lack of Efficacy|1|||
27803325|NCT01960855|54258310|FG002|Overall Study|Lack of Efficacy|0|||
27803326|NCT01960855|54258311|FG003|Overall Study|Lack of Efficacy|0|||
27803327|NCT01960855|54258312|FG004|Overall Study|Lack of Efficacy|0|||
27803328|NCT01960855|54258308|FG000|Overall Study|Other|2|||
27803329|NCT01960855|54258309|FG001|Overall Study|Other|1|||
27803330|NCT01960855|54258310|FG002|Overall Study|Other|1|||
27803331|NCT01960855|54258311|FG003|Overall Study|Other|1|||
27803332|NCT01960855|54258312|FG004|Overall Study|Other|0|||
27803333|NCT01960855|54258308|FG000|Overall Study|Consent withdrawn by subject|3|||
27803334|NCT01960855|54258309|FG001|Overall Study|Consent withdrawn by subject|1|||
27803335|NCT01960855|54258310|FG002|Overall Study|Consent withdrawn by subject|2|||
27803336|NCT01960855|54258311|FG003|Overall Study|Consent withdrawn by subject|1|||
27803337|NCT01960855|54258312|FG004|Overall Study|Consent withdrawn by subject|1|||
27803338|NCT01960855|54258308|FG000|Overall Study|Lost to Follow-up|2|||
27803339|NCT01960855|54258309|FG001|Overall Study|Lost to Follow-up|1|||
27803340|NCT01960855|54258310|FG002|Overall Study|Lost to Follow-up|0|||
27803341|NCT01960855|54258311|FG003|Overall Study|Lost to Follow-up|0|||
27803342|NCT01960855|54258312|FG004|Overall Study|Lost to Follow-up|2|||
27803343|NCT02007434|54258332|FG000|Overall Study|Lost to Follow-up|0|||
27803344|NCT02007434|54258333|FG001|Overall Study|Lost to Follow-up|1|||
27803345|NCT02007434|54258334|FG002|Overall Study|Lost to Follow-up|0|||
27803346|NCT02007434|54258335|FG003|Overall Study|Lost to Follow-up|0|||
27803347|NCT02007434|54258336|FG004|Overall Study|Lost to Follow-up|0|||
27803348|NCT02007434|54258337|FG005|Overall Study|Lost to Follow-up|0|||
27803349|NCT02007434|54258338|FG006|Overall Study|Lost to Follow-up|0|||
27803350|NCT02007434|54258339|FG007|Overall Study|Lost to Follow-up|0|||
27803351|NCT02007434|54258332|FG000|Overall Study|Non-compliance|1|||
27803352|NCT02007434|54258333|FG001|Overall Study|Non-compliance|0|||
27803353|NCT02007434|54258334|FG002|Overall Study|Non-compliance|1|||
27803354|NCT02007434|54258335|FG003|Overall Study|Non-compliance|0|||
27803355|NCT02007434|54258336|FG004|Overall Study|Non-compliance|0|||
27803356|NCT02007434|54258337|FG005|Overall Study|Non-compliance|0|||
27803357|NCT02007434|54258338|FG006|Overall Study|Non-compliance|0|||
27803358|NCT02007434|54258339|FG007|Overall Study|Non-compliance|0|||
27803359|NCT01987453|54258361|FG000|Overall Study|Death|0|||
27803360|NCT01987453|54258362|FG001|Overall Study|Death|0|||
27803361|NCT01987453|54258363|FG002|Overall Study|Death|1|||
27803362|NCT01987453|54258361|FG000|Overall Study|Lack of Efficacy|1|||
27803363|NCT01987453|54258362|FG001|Overall Study|Lack of Efficacy|12|||
27803364|NCT01987453|54258363|FG002|Overall Study|Lack of Efficacy|0|||
27803365|NCT02006641|54258378|FG000|Overall Study|Withdrawal before treatment|2|||
27803366|NCT02006641|54258379|FG001|Overall Study|Withdrawal before treatment|5|||
27803367|NCT02006641|54258380|FG002|Overall Study|Withdrawal before treatment|3|||
27803368|NCT02006641|54258378|FG000|Overall Study|Adverse Event|15|||
27803369|NCT02006641|54258379|FG001|Overall Study|Adverse Event|11|||
27803370|NCT02006641|54258380|FG002|Overall Study|Adverse Event|15|||
27803371|NCT02006641|54258378|FG000|Overall Study|Protocol Violation|0|||
27803372|NCT02006641|54258379|FG001|Overall Study|Protocol Violation|2|||
27803373|NCT02006641|54258380|FG002|Overall Study|Protocol Violation|2|||
27803374|NCT02006641|54258378|FG000|Overall Study|Lost to Follow-up|0|||
27803375|NCT02006641|54258379|FG001|Overall Study|Lost to Follow-up|1|||
27803376|NCT02006641|54258380|FG002|Overall Study|Lost to Follow-up|0|||
27803377|NCT02006641|54258378|FG000|Overall Study|Withdrawal by Subject|7|||
27803378|NCT02006641|54258379|FG001|Overall Study|Withdrawal by Subject|12|||
27803379|NCT02006641|54258380|FG002|Overall Study|Withdrawal by Subject|11|||
27803380|NCT02006641|54258378|FG000|Overall Study|Other reason: patient didn't show up|1|||
27803381|NCT02006641|54258379|FG001|Overall Study|Other reason: patient didn't show up|0|||
27803382|NCT02006641|54258380|FG002|Overall Study|Other reason: patient didn't show up|0|||
27803383|NCT02006641|54258378|FG000|Overall Study|Other reason:patient didn't want to come|0|||
27803384|NCT02006641|54258379|FG001|Overall Study|Other reason:patient didn't want to come|0|||
27803385|NCT02006641|54258380|FG002|Overall Study|Other reason:patient didn't want to come|1|||
27803386|NCT02006641|54258378|FG000|Overall Study|Other reason: patient has moved|1|||
27803387|NCT02006641|54258379|FG001|Overall Study|Other reason: patient has moved|0|||
27803388|NCT02006641|54258380|FG002|Overall Study|Other reason: patient has moved|1|||
27803389|NCT02006641|54258378|FG000|Overall Study|Other reason: caregiver in hospital|0|||
27803390|NCT02006641|54258379|FG001|Overall Study|Other reason: caregiver in hospital|1|||
27803391|NCT02006641|54258380|FG002|Overall Study|Other reason: caregiver in hospital|0|||
28027842|NCT00134563|54686216|FG001|Overall Study|Reason other than above|2|||
28027843|NCT00134563|54686217|FG002|Overall Study|Reason other than above|5|||
28027844|NCT00520845|54686225|FG000|Overall Study|Death|3|||
28027845|NCT00520845|54686225|FG000|Overall Study|Adverse Event|4|||
28027846|NCT00520845|54686225|FG000|Overall Study|Disease Progression, relapse|13|||
28027847|NCT00520845|54686225|FG000|Overall Study|Withdrawal by Subject|1|||
28027848|NCT00520845|54686225|FG000|Overall Study|Alternative Therapy|1|||
28027849|NCT00185731|54686229|FG000|Overall Study|Withdrawal by Subject|1|||
28027850|NCT00185731|54686229|FG000|Overall Study|Not Eligible|1|||
28027851|NCT00582491|54686237|FG000|Overall Study|Withdrawal by Subject|1|||
28027852|NCT00582491|54686238|FG001|Overall Study|Withdrawal by Subject|0|||
28027853|NCT00520767|54686244|FG000|Overall Study|Death|2|||
28027854|NCT04679051|54686250|FG000|Overall Study|felt tired after restricted time in bed|3|||
28027855|NCT04679051|54686251|FG001|Overall Study|felt tired after restricted time in bed|0|||
28027856|NCT04679051|54686250|FG000|Overall Study|discomfort with blood pressure cuff|2|||
28027857|NCT04679051|54686251|FG001|Overall Study|discomfort with blood pressure cuff|0|||
28027858|NCT04679051|54686250|FG000|Overall Study|scheduling conflict|1|||
28027859|NCT04679051|54686251|FG001|Overall Study|scheduling conflict|1|||
28027860|NCT04679051|54686250|FG000|Overall Study|Protocol Violation|0|||
28027861|NCT04679051|54686251|FG001|Overall Study|Protocol Violation|4|||
28027862|NCT03873987|54686262|FG000|Overall Study|Adverse Event|1|||
28027863|NCT03873987|54686263|FG001|Overall Study|Adverse Event|0|||
28027864|NCT03873987|54686262|FG000|Overall Study|staff was unable to start a new IV line|1|||
28027865|NCT03873987|54686263|FG001|Overall Study|staff was unable to start a new IV line|0|||
28027866|NCT03873987|54686262|FG000|Overall Study|Lost to Follow-up|0|||
28027867|NCT03873987|54686263|FG001|Overall Study|Lost to Follow-up|1|||
27803392|NCT02006641|54258378|FG000|Overall Study|Other reason: patient's wife has died|0|||
27803393|NCT02006641|54258379|FG001|Overall Study|Other reason: patient's wife has died|0|||
27803394|NCT02006641|54258380|FG002|Overall Study|Other reason: patient's wife has died|1|||
27803395|NCT02006641|54258378|FG000|Overall Study|Other reason: hospitalisation|0|||
27803396|NCT02006641|54258379|FG001|Overall Study|Other reason: hospitalisation|1|||
27803397|NCT02006641|54258380|FG002|Overall Study|Other reason: hospitalisation|0|||
27803398|NCT02006641|54258378|FG000|Overall Study|Other reason: caregiver impossibility|0|||
28027868|NCT00474760|54686281|FG000|Overall Study|Death|0|||
28027869|NCT00474760|54686282|FG001|Overall Study|Death|0|||
28027870|NCT00474760|54686283|FG002|Overall Study|Death|0|||
28027871|NCT00474760|54686284|FG003|Overall Study|Death|0|||
28027872|NCT00474760|54686285|FG004|Overall Study|Death|2|||
28027873|NCT00474760|54686286|FG005|Overall Study|Death|0|||
27803399|NCT02006641|54258379|FG001|Overall Study|Other reason: caregiver impossibility|0|||
27803400|NCT02006641|54258380|FG002|Overall Study|Other reason: caregiver impossibility|1|||
27842925|NCT01516034|54331882|FG000|Overall Study|Lack of Efficacy|7|||
27803401|NCT02006641|54258378|FG000|Overall Study|Other reason: protocol non-compliance|0|||
27803402|NCT02006641|54258379|FG001|Overall Study|Other reason: protocol non-compliance|0|||
27803403|NCT02006641|54258380|FG002|Overall Study|Other reason: protocol non-compliance|1|||
27803404|NCT01959919|54258388|FG000|Overall Study|Did not meet the eligibility criteria|2|||
27803405|NCT01986985|54258396|FG000|Overall Study|Withdrawal by Subject|4|||
27803406|NCT01986985|54258396|FG000|Overall Study|Scan not completed due to malfunction|3|||
27803407|NCT01986907|54258400|FG000|Overall Study|Adverse Event|11|||
27803408|NCT01986907|54258400|FG000|Overall Study|Unsatisfactory therapeutic effect|24|||
27803409|NCT01986907|54258400|FG000|Overall Study|Protocol Violation|4|||
27803410|NCT01986907|54258400|FG000|Overall Study|Withdrawal by Subject|76|||
27803411|NCT01986907|54258400|FG000|Overall Study|Lost to Follow-up|38|||
27803412|NCT01986907|54258400|FG000|Overall Study|Death|9|||
27803413|NCT01959841|54258410|FG000|Overall Study|Adverse Event|1|||
27803414|NCT01959841|54258411|FG001|Overall Study|Adverse Event|3|||
27803415|NCT01959841|54258412|FG002|Overall Study|Adverse Event|2|||
27803416|NCT01959841|54258410|FG000|Overall Study|Lack of Efficacy|5|||
27803417|NCT01959841|54258411|FG001|Overall Study|Lack of Efficacy|0|||
27803418|NCT01959841|54258412|FG002|Overall Study|Lack of Efficacy|0|||
27803419|NCT01959841|54258410|FG000|Overall Study|Lost to Follow-up|1|||
27803420|NCT01959841|54258411|FG001|Overall Study|Lost to Follow-up|1|||
27803421|NCT01959841|54258412|FG002|Overall Study|Lost to Follow-up|0|||
27803422|NCT01959841|54258410|FG000|Overall Study|Physician Decision|0|||
27803423|NCT01959841|54258411|FG001|Overall Study|Physician Decision|2|||
27803424|NCT01959841|54258412|FG002|Overall Study|Physician Decision|3|||
27803425|NCT01959841|54258410|FG000|Overall Study|Protocol Violation|16|||
27803426|NCT01959841|54258411|FG001|Overall Study|Protocol Violation|23|||
27803427|NCT01959841|54258412|FG002|Overall Study|Protocol Violation|16|||
27803428|NCT01959841|54258410|FG000|Overall Study|Withdrawal by Subject|7|||
27803429|NCT01959841|54258411|FG001|Overall Study|Withdrawal by Subject|7|||
27803430|NCT01959841|54258412|FG002|Overall Study|Withdrawal by Subject|5|||
27803431|NCT01959841|54258410|FG000|Overall Study|Clinical laboratory value|2|||
27803432|NCT01959841|54258411|FG001|Overall Study|Clinical laboratory value|6|||
27803433|NCT01959841|54258412|FG002|Overall Study|Clinical laboratory value|6|||
27803434|NCT01959841|54258410|FG000|Overall Study|Platelet count below on day1 or 4|11|||
27803435|NCT01959841|54258411|FG001|Overall Study|Platelet count below on day1 or 4|15|||
27803436|NCT01959841|54258412|FG002|Overall Study|Platelet count below on day1 or 4|11|||
27803437|NCT02005627|54258422|FG000|Overall Study|Lost to Follow-up|1|||
27803438|NCT02005627|54258423|FG001|Overall Study|Lost to Follow-up|2|||
27803439|NCT02005627|54258422|FG000|Overall Study|Withdrawal by Subject|1|||
27803440|NCT02005627|54258423|FG001|Overall Study|Withdrawal by Subject|2|||
27803441|NCT02104583|54258435|FG000|Overall Study|New ICD or CRT-D implanted|2|||
27803442|NCT02104583|54258436|FG001|Overall Study|New ICD or CRT-D implanted|0|||
27803443|NCT02104583|54258437|FG002|Overall Study|New ICD or CRT-D implanted|1|||
27803444|NCT02104583|54258438|FG003|Overall Study|New ICD or CRT-D implanted|0|||
27803445|NCT02104583|54258439|FG004|Overall Study|New ICD or CRT-D implanted|0|||
27803446|NCT02104583|54258435|FG000|Overall Study|Death|2|||
27803447|NCT02104583|54258436|FG001|Overall Study|Death|1|||
27803448|NCT02104583|54258437|FG002|Overall Study|Death|3|||
27803449|NCT02104583|54258438|FG003|Overall Study|Death|3|||
27803450|NCT02104583|54258439|FG004|Overall Study|Death|5|||
27803451|NCT02104583|54258435|FG000|Overall Study|Subject required cardiac ablation|6|||
27803452|NCT02104583|54258436|FG001|Overall Study|Subject required cardiac ablation|4|||
27803453|NCT02104583|54258437|FG002|Overall Study|Subject required cardiac ablation|4|||
27803454|NCT02104583|54258438|FG003|Overall Study|Subject required cardiac ablation|5|||
27803455|NCT02104583|54258439|FG004|Overall Study|Subject required cardiac ablation|4|||
27803456|NCT02104583|54258435|FG000|Overall Study|Subject required prohibited medication|0|||
27803457|NCT02104583|54258436|FG001|Overall Study|Subject required prohibited medication|1|||
27803458|NCT02104583|54258437|FG002|Overall Study|Subject required prohibited medication|1|||
27803459|NCT02104583|54258438|FG003|Overall Study|Subject required prohibited medication|0|||
27803460|NCT02104583|54258439|FG004|Overall Study|Subject required prohibited medication|1|||
27803461|NCT02104583|54258435|FG000|Overall Study|Withdrew Consent|3|||
27803462|NCT02104583|54258436|FG001|Overall Study|Withdrew Consent|2|||
27803463|NCT02104583|54258437|FG002|Overall Study|Withdrew Consent|0|||
27803464|NCT02104583|54258438|FG003|Overall Study|Withdrew Consent|2|||
27803465|NCT02104583|54258439|FG004|Overall Study|Withdrew Consent|1|||
27803466|NCT02104583|54258435|FG000|Overall Study|Investigator's Discretion|1|||
27803467|NCT02104583|54258436|FG001|Overall Study|Investigator's Discretion|0|||
27803468|NCT02104583|54258437|FG002|Overall Study|Investigator's Discretion|0|||
27803469|NCT02104583|54258438|FG003|Overall Study|Investigator's Discretion|0|||
27803470|NCT02104583|54258439|FG004|Overall Study|Investigator's Discretion|0|||
27803471|NCT02104583|54258435|FG000|Overall Study|Protocol Violation|0|||
27803472|NCT02104583|54258436|FG001|Overall Study|Protocol Violation|0|||
27803473|NCT02104583|54258437|FG002|Overall Study|Protocol Violation|1|||
27803474|NCT02104583|54258438|FG003|Overall Study|Protocol Violation|0|||
27803475|NCT02104583|54258439|FG004|Overall Study|Protocol Violation|0|||
27803476|NCT02104583|54258435|FG000|Overall Study|Adverse Event|3|||
27803477|NCT02104583|54258436|FG001|Overall Study|Adverse Event|3|||
27803478|NCT02104583|54258437|FG002|Overall Study|Adverse Event|6|||
27803479|NCT02104583|54258438|FG003|Overall Study|Adverse Event|6|||
27803480|NCT02104583|54258439|FG004|Overall Study|Adverse Event|1|||
27803481|NCT02104583|54258435|FG000|Overall Study|Lost to Follow-up|1|||
27803482|NCT02104583|54258436|FG001|Overall Study|Lost to Follow-up|0|||
27803483|NCT02104583|54258437|FG002|Overall Study|Lost to Follow-up|0|||
27803484|NCT02104583|54258438|FG003|Overall Study|Lost to Follow-up|0|||
27803485|NCT02104583|54258439|FG004|Overall Study|Lost to Follow-up|0|||
27803486|NCT02104583|54258435|FG000|Overall Study|Randomized but Never Treated|0|||
27803487|NCT02104583|54258436|FG001|Overall Study|Randomized but Never Treated|0|||
27803488|NCT02104583|54258437|FG002|Overall Study|Randomized but Never Treated|0|||
28027874|NCT00474760|54686287|FG006|Overall Study|Death|0|||
27803489|NCT02104583|54258438|FG003|Overall Study|Randomized but Never Treated|1|||
27803490|NCT02104583|54258439|FG004|Overall Study|Randomized but Never Treated|0|||
28027875|NCT00474760|54686281|FG000|Overall Study|Adverse Event|0|||
28027876|NCT00474760|54686282|FG001|Overall Study|Adverse Event|0|||
27803491|NCT02074553|54258462|FG000|Intervention Period 1|Family Emergency|0|||
27803492|NCT02074553|54258463|FG001|Intervention Period 1|Family Emergency|0|||
27803493|NCT02074553|54258464|FG002|Intervention Period 1|Family Emergency|0|||
27803494|NCT02074553|54258465|FG003|Intervention Period 1|Family Emergency|1|||
27803495|NCT02074553|54258466|FG004|Intervention Period 1|Family Emergency|0|||
27803496|NCT02074553|54258467|FG005|Intervention Period 1|Family Emergency|0|||
27803497|NCT02074553|54258468|FG006|Intervention Period 1|Family Emergency|0|||
27803498|NCT02074553|54258469|FG007|Intervention Period 1|Family Emergency|0|||
27803499|NCT02074553|54258462|FG000|Washout Period 1|Adverse Event|1|||
27803500|NCT02074553|54258463|FG001|Washout Period 1|Adverse Event|0|||
27803501|NCT02074553|54258464|FG002|Washout Period 1|Adverse Event|0|||
27803502|NCT02074553|54258465|FG003|Washout Period 1|Adverse Event|0|||
27803503|NCT02074553|54258466|FG004|Washout Period 1|Adverse Event|0|||
27803504|NCT02074553|54258467|FG005|Washout Period 1|Adverse Event|0|||
27803505|NCT02074553|54258468|FG006|Washout Period 1|Adverse Event|0|||
27803506|NCT02074553|54258469|FG007|Washout Period 1|Adverse Event|0|||
27803507|NCT02074553|54258462|FG000|Washout Period 1|Physician Decision|0|||
27803508|NCT02074553|54258463|FG001|Washout Period 1|Physician Decision|0|||
27803509|NCT02074553|54258464|FG002|Washout Period 1|Physician Decision|0|||
27803510|NCT02074553|54258465|FG003|Washout Period 1|Physician Decision|1|||
27803511|NCT02074553|54258466|FG004|Washout Period 1|Physician Decision|0|||
27803512|NCT02074553|54258467|FG005|Washout Period 1|Physician Decision|0|||
27803513|NCT02074553|54258468|FG006|Washout Period 1|Physician Decision|0|||
27803514|NCT02074553|54258469|FG007|Washout Period 1|Physician Decision|0|||
27803515|NCT02074553|54258462|FG000|Washout Period 1|Other|0|||
27803516|NCT02074553|54258463|FG001|Washout Period 1|Other|0|||
27803517|NCT02074553|54258464|FG002|Washout Period 1|Other|0|||
28027877|NCT00474760|54686283|FG002|Overall Study|Adverse Event|0|||
27803518|NCT02074553|54258465|FG003|Washout Period 1|Other|0|||
27803519|NCT02074553|54258466|FG004|Washout Period 1|Other|0|||
27803520|NCT02074553|54258467|FG005|Washout Period 1|Other|1|||
27803521|NCT02074553|54258468|FG006|Washout Period 1|Other|0|||
28027878|NCT00474760|54686284|FG003|Overall Study|Adverse Event|0|||
28027879|NCT00474760|54686285|FG004|Overall Study|Adverse Event|1|||
28027880|NCT00474760|54686286|FG005|Overall Study|Adverse Event|7|||
28027881|NCT00474760|54686287|FG006|Overall Study|Adverse Event|0|||
28027882|NCT00474760|54686281|FG000|Overall Study|Laboratory abnormality|0|||
28027883|NCT00474760|54686282|FG001|Overall Study|Laboratory abnormality|0|||
28027884|NCT00474760|54686283|FG002|Overall Study|Laboratory abnormality|0|||
28027885|NCT00474760|54686284|FG003|Overall Study|Laboratory abnormality|0|||
28027886|NCT00474760|54686285|FG004|Overall Study|Laboratory abnormality|0|||
28027887|NCT00474760|54686286|FG005|Overall Study|Laboratory abnormality|1|||
28027888|NCT00474760|54686287|FG006|Overall Study|Laboratory abnormality|0|||
28027889|NCT00474760|54686281|FG000|Overall Study|Withdrawal by Subject|0|||
28027890|NCT00474760|54686282|FG001|Overall Study|Withdrawal by Subject|0|||
28027891|NCT00474760|54686283|FG002|Overall Study|Withdrawal by Subject|0|||
28027892|NCT00474760|54686284|FG003|Overall Study|Withdrawal by Subject|1|||
28027893|NCT00474760|54686285|FG004|Overall Study|Withdrawal by Subject|0|||
28027894|NCT00474760|54686286|FG005|Overall Study|Withdrawal by Subject|1|||
28027895|NCT00474760|54686287|FG006|Overall Study|Withdrawal by Subject|1|||
28027896|NCT00474760|54686281|FG000|Overall Study|Other|0|||
28027897|NCT00474760|54686282|FG001|Overall Study|Other|1|||
28027898|NCT00474760|54686283|FG002|Overall Study|Other|0|||
28027899|NCT00474760|54686284|FG003|Overall Study|Other|0|||
28027900|NCT00474760|54686285|FG004|Overall Study|Other|1|||
28027901|NCT00474760|54686286|FG005|Overall Study|Other|0|||
28027902|NCT00474760|54686287|FG006|Overall Study|Other|0|||
28027903|NCT00474760|54686281|FG000|Overall Study|Progressive disease|3|||
28027904|NCT00474760|54686282|FG001|Overall Study|Progressive disease|2|||
28027905|NCT00474760|54686283|FG002|Overall Study|Progressive disease|3|||
28027906|NCT00474760|54686284|FG003|Overall Study|Progressive disease|2|||
28027907|NCT00474760|54686285|FG004|Overall Study|Progressive disease|8|||
28027908|NCT00474760|54686286|FG005|Overall Study|Progressive disease|20|||
28027909|NCT00474760|54686287|FG006|Overall Study|Progressive disease|7|||
28027910|NCT00474760|54686281|FG000|Overall Study|Terminated by sponsor|0|||
28027911|NCT00474760|54686282|FG001|Overall Study|Terminated by sponsor|0|||
28027912|NCT00474760|54686283|FG002|Overall Study|Terminated by sponsor|0|||
28027913|NCT00474760|54686284|FG003|Overall Study|Terminated by sponsor|0|||
28027914|NCT00474760|54686285|FG004|Overall Study|Terminated by sponsor|0|||
28027915|NCT00474760|54686286|FG005|Overall Study|Terminated by sponsor|0|||
28027916|NCT00474760|54686287|FG006|Overall Study|Terminated by sponsor|2|||
28027917|NCT00528645|54686310|FG000|Overall Study|Adverse Event|3|||
28027918|NCT00524745|54686319|FG000|Overall Study|subject withdrawal or lost to follow up|34|||
28027919|NCT00524745|54686320|FG001|Overall Study|subject withdrawal or lost to follow up|13|||
28027920|NCT00524745|54686321|FG002|Overall Study|subject withdrawal or lost to follow up|29|||
28027921|NCT00524745|54686322|FG003|Overall Study|subject withdrawal or lost to follow up|22|||
28027922|NCT00495040|54686332|FG000|Overall Study|Withdrawal by Subject|3|||
28027923|NCT00494026|54686340|FG000|Overall Study|Sponsor Decision|4|||
28027924|NCT00524589|54686344|FG000|Overall Study|Withdrawal by Subject|2|||
28027925|NCT00524589|54686344|FG000|Overall Study|Disease Progression|16|||
28027926|NCT00472030|54686350|FG000|Overall Study|Physician Decision|1|||
28027927|NCT00472030|54686351|FG001|Overall Study|Physician Decision|0|||
28027928|NCT00127855|54686366|FG000|Primary Vaccination Course|Adverse Event|0|||
28027929|NCT00127855|54686367|FG001|Primary Vaccination Course|Adverse Event|0|||
28027930|NCT00127855|54686368|FG002|Primary Vaccination Course|Adverse Event|1|||
28027931|NCT00127855|54686369|FG003|Primary Vaccination Course|Adverse Event|0|||
28027932|NCT00127855|54686370|FG004|Primary Vaccination Course|Adverse Event|0|||
28027933|NCT00127855|54686366|FG000|Primary Vaccination Course|Withdrawal by Subject|1|||
28027934|NCT00127855|54686367|FG001|Primary Vaccination Course|Withdrawal by Subject|0|||
28027935|NCT00127855|54686368|FG002|Primary Vaccination Course|Withdrawal by Subject|0|||
28027936|NCT00127855|54686369|FG003|Primary Vaccination Course|Withdrawal by Subject|0|||
28027937|NCT00127855|54686370|FG004|Primary Vaccination Course|Withdrawal by Subject|1|||
28027938|NCT00127855|54686366|FG000|Primary Vaccination Course|Lost to Follow-up|1|||
28027939|NCT00127855|54686367|FG001|Primary Vaccination Course|Lost to Follow-up|1|||
28027940|NCT00127855|54686368|FG002|Primary Vaccination Course|Lost to Follow-up|1|||
28027941|NCT00127855|54686369|FG003|Primary Vaccination Course|Lost to Follow-up|0|||
28027942|NCT00127855|54686370|FG004|Primary Vaccination Course|Lost to Follow-up|2|||
28027943|NCT00127855|54686366|FG000|Primary Vaccination Course|Other|0|||
28027944|NCT00127855|54686367|FG001|Primary Vaccination Course|Other|0|||
28027945|NCT00127855|54686368|FG002|Primary Vaccination Course|Other|0|||
28027946|NCT00127855|54686369|FG003|Primary Vaccination Course|Other|0|||
28027947|NCT00127855|54686370|FG004|Primary Vaccination Course|Other|1|||
27939371|NCT01061151|54595622|FG001|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52|||
27939372|NCT01061151|54595623|FG002|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31|||
27939373|NCT01061151|54595624|FG003|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3|||
27939374|NCT01061151|54595621|FG000|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49|||
27939375|NCT01061151|54595622|FG001|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36|||
28027948|NCT00493636|54686384|FG000|Overall Study|Withdrawal by Subject|1|||
28027949|NCT00493636|54686385|FG001|Overall Study|Withdrawal by Subject|0|||
28027950|NCT00493636|54686384|FG000|Overall Study|Disease progression/recurrence/relapse|0|||
28027951|NCT00493636|54686385|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
28027952|NCT00493636|54686384|FG000|Overall Study|Mis-randomization|1|||
28027953|NCT00493636|54686385|FG001|Overall Study|Mis-randomization|1|||
28027954|NCT00524121|54686391|FG000|Overall Study|Disease progression|6|||
28027955|NCT00524121|54686391|FG000|Overall Study|Adverse Event|4|||
28027956|NCT00524121|54686391|FG000|Overall Study|Patient refused|2|||
28027957|NCT00524121|54686391|FG000|Overall Study|Other|1|||
28027958|NCT00524121|54686391|FG000|Overall Study|Death|1|||
28027959|NCT00524121|54686391|FG000|Overall Study|Not treated (became ineligible)|4|||
28027960|NCT00524121|54686391|FG000|Overall Study|Not treated (changed mind)|1|||
28027961|NCT00470626|54686406|FG000|Overall Study|Lost to Follow-up|10|||
28027962|NCT00470626|54686406|FG000|Overall Study|Withdrawal by Subject|7|||
28027963|NCT00133705|54686412|FG000|Overall Study|Withdrawal by Subject|2|||
28027964|NCT00133705|54686413|FG001|Overall Study|Withdrawal by Subject|3|||
28027965|NCT00132769|54686421|FG000|Overall Study|Withdrawal by Subject|1|||
28027966|NCT00132769|54686422|FG001|Overall Study|Withdrawal by Subject|3|||
28027967|NCT00132769|54686421|FG000|Overall Study|Lack of Efficacy|7|||
28027968|NCT00132769|54686422|FG001|Overall Study|Lack of Efficacy|6|||
27803522|NCT02074553|54258469|FG007|Washout Period 1|Other|0|||
27803523|NCT02074553|54258462|FG000|Washout Period 2|Adverse Event|0|||
27803524|NCT02074553|54258463|FG001|Washout Period 2|Adverse Event|0|||
27803525|NCT02074553|54258464|FG002|Washout Period 2|Adverse Event|0|||
28027969|NCT00132769|54686421|FG000|Overall Study|Adverse Event|2|||
28027970|NCT00132769|54686422|FG001|Overall Study|Adverse Event|1|||
28027971|NCT00132769|54686421|FG000|Overall Study|Protocol Violation|1|||
28027972|NCT00132769|54686422|FG001|Overall Study|Protocol Violation|1|||
28027973|NCT00520299|54686431|FG000|Overall Study|Withdrawal by Subject|0|||
28027974|NCT00520299|54686432|FG001|Overall Study|Withdrawal by Subject|0|||
28027975|NCT00520299|54686433|FG002|Overall Study|Withdrawal by Subject|2|||
28027976|NCT00520299|54686431|FG000|Overall Study|Progressive disease|0|||
28027977|NCT00520299|54686432|FG001|Overall Study|Progressive disease|3|||
28027978|NCT00520299|54686433|FG002|Overall Study|Progressive disease|4|||
28027979|NCT02478255|54686443|FG000|Overall Study|Physician Decision|6|||
28027980|NCT02478255|54686444|FG001|Overall Study|Physician Decision|0|||
28027981|NCT02478255|54686443|FG000|Overall Study|Withdrawal by Subject|2|||
28027982|NCT02478255|54686444|FG001|Overall Study|Withdrawal by Subject|0|||
28027983|NCT00132691|54686452|FG000|Overall Study|Lost to Follow-up|5|||
28027984|NCT00132691|54686453|FG001|Overall Study|Lost to Follow-up|8|||
28027985|NCT00132691|54686452|FG000|Overall Study|Missed 2-year visit|4|||
28027986|NCT00132691|54686453|FG001|Overall Study|Missed 2-year visit|4|||
28027987|NCT00132691|54686452|FG000|Overall Study|Death|2|||
28027988|NCT00132691|54686453|FG001|Overall Study|Death|0|||
28027989|NCT00125359|54686464|FG000|Overall Study|Death|4|||
28027990|NCT00125359|54686464|FG000|Overall Study|Adverse Event|5|||
28027991|NCT00125359|54686464|FG000|Overall Study|Physician Decision|14|||
28027992|NCT00524043|54686471|FG000|Overall Study|Lack of Efficacy|15|||
28027993|NCT00524043|54686472|FG001|Overall Study|Lack of Efficacy|13|||
28027994|NCT00524043|54686473|FG002|Overall Study|Lack of Efficacy|14|||
28027995|NCT00524043|54686471|FG000|Overall Study|Withdrawal by Subject|5|||
28027996|NCT00524043|54686472|FG001|Overall Study|Withdrawal by Subject|7|||
28027997|NCT00524043|54686473|FG002|Overall Study|Withdrawal by Subject|7|||
28027998|NCT00524043|54686471|FG000|Overall Study|Adverse Event|5|||
28027999|NCT00524043|54686472|FG001|Overall Study|Adverse Event|2|||
28028000|NCT00524043|54686473|FG002|Overall Study|Adverse Event|7|||
28028001|NCT00524043|54686471|FG000|Overall Study|Lost to Follow-up|3|||
28028002|NCT00524043|54686472|FG001|Overall Study|Lost to Follow-up|5|||
28028003|NCT00524043|54686473|FG002|Overall Study|Lost to Follow-up|3|||
28028004|NCT00524043|54686471|FG000|Overall Study|Various (eg, incarceration)|2|||
28028005|NCT00524043|54686472|FG001|Overall Study|Various (eg, incarceration)|1|||
28028006|NCT00524043|54686473|FG002|Overall Study|Various (eg, incarceration)|0|||
28028007|NCT00523419|54686481|FG000|Overall Study|Adverse Event|1|||
28028008|NCT00523419|54686481|FG000|Overall Study|Withdrawal by Subject|1|||
28028009|NCT00523419|54686481|FG000|Overall Study|Physician Decision|2|||
28028010|NCT00523419|54686481|FG000|Overall Study|Progressive Disease|22|||
28028011|NCT00523419|54686481|FG000|Overall Study|Death due to Study Disease|4|||
28028012|NCT00523419|54686481|FG000|Overall Study|Death due to Adverse Event|2|||
28028013|NCT03868059|54686485|FG000|Overall Study|Adverse Event|3|||
27842926|NCT01440569|54331893|FG000|Main Study|Enrolled but not treated|1|||
28028014|NCT03868059|54686485|FG000|Overall Study|Lost to Follow-up|3|||
28028015|NCT03868059|54686485|FG000|Overall Study|Withdrawal by Subject|6|||
28028016|NCT00522951|54686489|FG000|Period 1|body motion|0|||
28028017|NCT00522951|54686490|FG001|Period 1|body motion|1|||
28028018|NCT00522951|54686489|FG000|Washout Period|Adverse Event|0|||
28028019|NCT00522951|54686490|FG001|Washout Period|Adverse Event|1|||
28028020|NCT00522951|54686489|FG000|Washout Period|Death|0|||
28028021|NCT00522951|54686490|FG001|Washout Period|Death|1|||
28028022|NCT00522951|54686489|FG000|Period 2|Withdrawal by Subject|1|||
28028023|NCT00522951|54686490|FG001|Period 2|Withdrawal by Subject|0|||
28028024|NCT00522951|54686489|FG000|Period 2|residual contrast medium|1|||
28028025|NCT00522951|54686490|FG001|Period 2|residual contrast medium|1|||
28028026|NCT03865953|54686502|FG000|First Intervention (4 Weeks)|Lost to Follow-up|2|||
28028027|NCT03865953|54686503|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
28028028|NCT03865953|54686502|FG000|First Intervention (4 Weeks)|Protocol Violation|0|||
28028029|NCT03865953|54686503|FG001|First Intervention (4 Weeks)|Protocol Violation|1|||
28028030|NCT03865953|54686502|FG000|Second Intervention (4 Weeks)|Lost to Follow-up|0|||
27803526|NCT02074553|54258465|FG003|Washout Period 2|Adverse Event|0|||
27803527|NCT02074553|54258466|FG004|Washout Period 2|Adverse Event|0|||
27803528|NCT02074553|54258467|FG005|Washout Period 2|Adverse Event|0|||
27939376|NCT01061151|54595623|FG002|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25|||
27939377|NCT01061151|54595624|FG003|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4|||
27939378|NCT01061151|54595621|FG000|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12|||
27939379|NCT01061151|54595622|FG001|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11|||
27939380|NCT01061151|54595623|FG002|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2|||
27939381|NCT01061151|54595624|FG003|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0|||
27939382|NCT01061151|54595621|FG000|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28|||
27939383|NCT01061151|54595622|FG001|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26|||
27939384|NCT01061151|54595623|FG002|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15|||
27939385|NCT01061151|54595624|FG003|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5|||
27939386|NCT01061151|54595621|FG000|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5|||
27939387|NCT01061151|54595622|FG001|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8|||
27939388|NCT01061151|54595623|FG002|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1|||
28028031|NCT03865953|54686503|FG001|Second Intervention (4 Weeks)|Lost to Follow-up|2|||
28028032|NCT03865407|54686511|FG000|Overall Study|Adverse Event|1|||
28028033|NCT03865407|54686512|FG001|Overall Study|Adverse Event|0|||
28028034|NCT03865407|54686511|FG000|Overall Study|Withdrawal by Subject|1|||
28028035|NCT03865407|54686512|FG001|Overall Study|Withdrawal by Subject|0|||
28028036|NCT03865407|54686511|FG000|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|1|||
28028037|NCT03865407|54686512|FG001|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|0|||
28028038|NCT00487942|54686522|FG000|Overall Study|Adverse Event|1|||
28028039|NCT00487942|54686523|FG001|Overall Study|Adverse Event|1|||
28028040|NCT00487942|54686524|FG002|Overall Study|Adverse Event|1|||
28028041|NCT00487942|54686525|FG003|Overall Study|Adverse Event|1|||
28028042|NCT00487942|54686522|FG000|Overall Study|Lost to Follow-up|1|||
28028043|NCT00487942|54686523|FG001|Overall Study|Lost to Follow-up|0|||
28028044|NCT00487942|54686524|FG002|Overall Study|Lost to Follow-up|0|||
28028045|NCT00487942|54686525|FG003|Overall Study|Lost to Follow-up|1|||
28028046|NCT00487942|54686522|FG000|Overall Study|Protocol Violation|1|||
28028047|NCT00487942|54686523|FG001|Overall Study|Protocol Violation|1|||
28028048|NCT00487942|54686524|FG002|Overall Study|Protocol Violation|0|||
28028049|NCT00487942|54686525|FG003|Overall Study|Protocol Violation|0|||
28028050|NCT00487942|54686522|FG000|Overall Study|Withdrawal by Subject|0|||
28028051|NCT00487942|54686523|FG001|Overall Study|Withdrawal by Subject|1|||
27803529|NCT02074553|54258468|FG006|Washout Period 2|Adverse Event|1|||
27803530|NCT02074553|54258469|FG007|Washout Period 2|Adverse Event|0|||
27803531|NCT02074553|54258462|FG000|Washout Period 2|Physician Decision|0|||
27803532|NCT02074553|54258463|FG001|Washout Period 2|Physician Decision|0|||
27803533|NCT02074553|54258464|FG002|Washout Period 2|Physician Decision|0|||
27803534|NCT02074553|54258465|FG003|Washout Period 2|Physician Decision|0|||
27803535|NCT02074553|54258466|FG004|Washout Period 2|Physician Decision|0|||
27803536|NCT02074553|54258467|FG005|Washout Period 2|Physician Decision|1|||
27803537|NCT02074553|54258468|FG006|Washout Period 2|Physician Decision|0|||
27803538|NCT02074553|54258469|FG007|Washout Period 2|Physician Decision|0|||
27803539|NCT02074553|54258462|FG000|Washout Period 2|Lost to Follow-up|0|||
28028052|NCT00487942|54686524|FG002|Overall Study|Withdrawal by Subject|2|||
28028053|NCT00487942|54686525|FG003|Overall Study|Withdrawal by Subject|0|||
28028054|NCT00132301|54686537|FG000|Overall Study|Death|7|||
28028055|NCT00132301|54686538|FG001|Overall Study|Death|6|||
27803540|NCT02074553|54258463|FG001|Washout Period 2|Lost to Follow-up|0|||
27803541|NCT02074553|54258464|FG002|Washout Period 2|Lost to Follow-up|1|||
27803542|NCT02074553|54258465|FG003|Washout Period 2|Lost to Follow-up|0|||
27803543|NCT02074553|54258466|FG004|Washout Period 2|Lost to Follow-up|0|||
27803544|NCT02074553|54258467|FG005|Washout Period 2|Lost to Follow-up|0|||
27803545|NCT02074553|54258468|FG006|Washout Period 2|Lost to Follow-up|0|||
27803546|NCT02074553|54258469|FG007|Washout Period 2|Lost to Follow-up|0|||
27803547|NCT02074553|54258462|FG000|Washout Period 3|Physician Decision|0|||
27803548|NCT02074553|54258463|FG001|Washout Period 3|Physician Decision|0|||
27803549|NCT02074553|54258464|FG002|Washout Period 3|Physician Decision|0|||
27803550|NCT02074553|54258465|FG003|Washout Period 3|Physician Decision|0|||
27803551|NCT02074553|54258466|FG004|Washout Period 3|Physician Decision|0|||
27803552|NCT02074553|54258467|FG005|Washout Period 3|Physician Decision|0|||
27803553|NCT02074553|54258468|FG006|Washout Period 3|Physician Decision|0|||
27803554|NCT02074553|54258469|FG007|Washout Period 3|Physician Decision|1|||
27803555|NCT02073929|54258489|FG000|Overall Study|Lost to Follow-up|2|||
27803556|NCT02073929|54258490|FG001|Overall Study|Lost to Follow-up|1|||
27803557|NCT02073929|54258489|FG000|Overall Study|Adverse Event|2|||
27803558|NCT02073929|54258490|FG001|Overall Study|Adverse Event|1|||
27803559|NCT02073929|54258489|FG000|Overall Study|Withdrawal by Subject|0|||
27803560|NCT02073929|54258490|FG001|Overall Study|Withdrawal by Subject|1|||
27803561|NCT02113007|54258496|FG000|Overall Study|Progressive disease|2|||
27803562|NCT02005471|54258502|FG000|Overall Study|Ongoing in Study|144|||
27803563|NCT02005471|54258503|FG001|Overall Study|Ongoing in Study|171|||
27803564|NCT02005471|54258502|FG000|Overall Study|Adverse Event|1|||
27803565|NCT02005471|54258503|FG001|Overall Study|Adverse Event|0|||
27803566|NCT02005471|54258502|FG000|Overall Study|Death|26|||
27803567|NCT02005471|54258503|FG001|Overall Study|Death|15|||
27803568|NCT02005471|54258502|FG000|Overall Study|Lost to Follow-up|1|||
27803569|NCT02005471|54258503|FG001|Overall Study|Lost to Follow-up|0|||
27803570|NCT02005471|54258502|FG000|Overall Study|Physician Decision|2|||
27803571|NCT02005471|54258503|FG001|Overall Study|Physician Decision|1|||
27803572|NCT02005471|54258502|FG000|Overall Study|Progressive Disease|3|||
27803573|NCT02005471|54258503|FG001|Overall Study|Progressive Disease|0|||
28028056|NCT00132301|54686537|FG000|Overall Study|Withdrawal by Subject|5|||
28028057|NCT00132301|54686538|FG001|Overall Study|Withdrawal by Subject|2|||
28028058|NCT00132301|54686537|FG000|Overall Study|Physician Decision|1|||
28028059|NCT00132301|54686538|FG001|Overall Study|Physician Decision|1|||
28028060|NCT00132301|54686537|FG000|Overall Study|Lost to Follow-up|5|||
28028061|NCT00132301|54686538|FG001|Overall Study|Lost to Follow-up|3|||
27803574|NCT02005471|54258502|FG000|Overall Study|Withdrawal by Subject|18|||
27803575|NCT02005471|54258503|FG001|Overall Study|Withdrawal by Subject|7|||
28028062|NCT00132301|54686537|FG000|Overall Study|Other|1|||
28028063|NCT00132301|54686538|FG001|Overall Study|Other|1|||
28028064|NCT00132301|54686537|FG000|Overall Study|Excluded by Data Monitoring Committee|1|||
28028065|NCT00132301|54686538|FG001|Overall Study|Excluded by Data Monitoring Committee|0|||
28028066|NCT00522873|54686546|FG000|Overall Study|Adverse Event|41|||
28028067|NCT00522873|54686547|FG001|Overall Study|Adverse Event|26|||
28028068|NCT00522873|54686546|FG000|Overall Study|Withdrawal by Subject|20|||
28028069|NCT00522873|54686547|FG001|Overall Study|Withdrawal by Subject|9|||
28028070|NCT00522873|54686546|FG000|Overall Study|Protocol Violation|14|||
28028071|NCT00522873|54686547|FG001|Overall Study|Protocol Violation|4|||
28028072|NCT00522873|54686546|FG000|Overall Study|Lost to Follow-up|11|||
28028073|NCT00522873|54686547|FG001|Overall Study|Lost to Follow-up|3|||
28028074|NCT00522873|54686546|FG000|Overall Study|Personal Reasons|8|||
28028075|NCT00522873|54686547|FG001|Overall Study|Personal Reasons|1|||
28028076|NCT00522873|54686546|FG000|Overall Study|Medication Errors|1|||
28028077|NCT00522873|54686547|FG001|Overall Study|Medication Errors|1|||
28028078|NCT00522873|54686546|FG000|Overall Study|Never Received Medication|1|||
28028079|NCT00522873|54686547|FG001|Overall Study|Never Received Medication|0|||
28028080|NCT03684057|54686555|FG000|Overall Study|Withdrawal by Subject|4|||
28028081|NCT03684057|54686556|FG001|Overall Study|Withdrawal by Subject|5|||
28028082|NCT03864627|54686565|FG000|Overall Study|Adverse Event|0|||
28028083|NCT03864627|54686566|FG001|Overall Study|Adverse Event|1|||
28028084|NCT03864627|54686565|FG000|Overall Study|Lack of Efficacy|0|||
28028085|NCT03864627|54686566|FG001|Overall Study|Lack of Efficacy|1|||
28028086|NCT03864627|54686565|FG000|Overall Study|Lost to Follow-up|0|||
28028087|NCT03864627|54686566|FG001|Overall Study|Lost to Follow-up|1|||
28028088|NCT03864627|54686565|FG000|Overall Study|Withdrawal by Subject|4|||
28028089|NCT03864627|54686566|FG001|Overall Study|Withdrawal by Subject|8|||
28028090|NCT03864627|54686565|FG000|Overall Study|Study terminated by sponsor|0|||
28028091|NCT03864627|54686566|FG001|Overall Study|Study terminated by sponsor|1|||
28028092|NCT00519831|54686573|FG000|Overall Study|Adverse Event|3|||
28028093|NCT00131911|54686583|FG000|Overall Study|Withdrawal by Subject|1|||
28028094|NCT00131911|54686584|FG001|Overall Study|Withdrawal by Subject|0|||
28028095|NCT00184093|54686589|FG000|Overall Study|Adverse Event|3|||
28028096|NCT00184093|54686589|FG000|Overall Study|Lost to Follow-up|3|||
28028097|NCT00184093|54686589|FG000|Overall Study|Physician Decision|1|||
28028098|NCT00184093|54686589|FG000|Overall Study|Withdrawal by Subject|2|||
28028099|NCT00183625|54686595|FG000|Overall Study|Withdrawal by Subject|18|||
28028100|NCT00183625|54686596|FG001|Overall Study|Withdrawal by Subject|18|||
28028101|NCT00183625|54686597|FG002|Overall Study|Withdrawal by Subject|19|||
28028102|NCT00183625|54686598|FG003|Overall Study|Withdrawal by Subject|14|||
28028103|NCT00511875|54686608|FG000|Overall Study|Lost to Follow-up|4|||
28028104|NCT00511875|54686609|FG001|Overall Study|Lost to Follow-up|0|||
28028105|NCT00511875|54686608|FG000|Overall Study|Missing variables|1|||
28028106|NCT00511875|54686609|FG001|Overall Study|Missing variables|0|||
28028107|NCT00183391|54686617|FG000|Block 1 - 5 Weeks|Withdrawal by Subject|13|||
28028108|NCT00183391|54686618|FG001|Block 1 - 5 Weeks|Withdrawal by Subject|14|||
28028109|NCT00183391|54686617|FG000|Block 2 - 5 Weeks|Withdrawal by Subject|4|||
28028110|NCT00183391|54686618|FG001|Block 2 - 5 Weeks|Withdrawal by Subject|2|||
28028111|NCT00493246|54686634|FG000|Overall Study|Withdrawal by Subject|0|||
28028112|NCT00493246|54686635|FG001|Overall Study|Withdrawal by Subject|0|||
28028113|NCT00493246|54686636|FG002|Overall Study|Withdrawal by Subject|0|||
28028114|NCT00493246|54686637|FG003|Overall Study|Withdrawal by Subject|0|||
28028115|NCT00493246|54686638|FG004|Overall Study|Withdrawal by Subject|1|||
28028116|NCT00493246|54686639|FG005|Overall Study|Withdrawal by Subject|0|||
28028117|NCT00493246|54686640|FG006|Overall Study|Withdrawal by Subject|0|||
28028118|NCT00493246|54686641|FG007|Overall Study|Withdrawal by Subject|0|||
28028119|NCT00493246|54686634|FG000|Overall Study|No access to draw blood|0|||
28028120|NCT00493246|54686635|FG001|Overall Study|No access to draw blood|0|||
28028121|NCT00493246|54686636|FG002|Overall Study|No access to draw blood|0|||
28028122|NCT00493246|54686637|FG003|Overall Study|No access to draw blood|0|||
28028123|NCT00493246|54686638|FG004|Overall Study|No access to draw blood|0|||
28028124|NCT00493246|54686639|FG005|Overall Study|No access to draw blood|1|||
28028125|NCT00493246|54686640|FG006|Overall Study|No access to draw blood|0|||
28028126|NCT00493246|54686641|FG007|Overall Study|No access to draw blood|0|||
28028127|NCT00493246|54686634|FG000|Overall Study|Lost to Follow-up|0|||
28028128|NCT00493246|54686635|FG001|Overall Study|Lost to Follow-up|0|||
28028129|NCT00493246|54686636|FG002|Overall Study|Lost to Follow-up|0|||
28028130|NCT00493246|54686637|FG003|Overall Study|Lost to Follow-up|0|||
28028131|NCT00493246|54686638|FG004|Overall Study|Lost to Follow-up|0|||
28028132|NCT00493246|54686639|FG005|Overall Study|Lost to Follow-up|0|||
28028133|NCT00493246|54686640|FG006|Overall Study|Lost to Follow-up|1|||
27803576|NCT02104505|54258514|FG000|First Intervention (14 Days)|Adverse Event|2|||
27803577|NCT02104505|54258515|FG001|First Intervention (14 Days)|Adverse Event|0|||
27803578|NCT02104505|54258514|FG000|First Intervention (14 Days)|Withdrawal by Subject|0|||
27803579|NCT02104505|54258515|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
27803580|NCT02104505|54258514|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
27803581|NCT02104505|54258515|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
27803582|NCT02104505|54258514|FG000|First Intervention (14 Days)|exclusionary condition|0|||
27803583|NCT02104505|54258515|FG001|First Intervention (14 Days)|exclusionary condition|1|||
27803584|NCT02104505|54258514|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
27803585|NCT02104505|54258515|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
27803586|NCT02104505|54258514|FG000|Second Intervention (14 Days)|Adverse Event|2|||
27803587|NCT02104505|54258515|FG001|Second Intervention (14 Days)|Adverse Event|0|||
27803588|NCT02111993|54258524|FG000|Overall Study|Physician Decision|5|||
27803589|NCT02111993|54258525|FG001|Overall Study|Physician Decision|4|||
27803590|NCT01959607|54258535|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
27803591|NCT01959607|54258536|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
27803592|NCT01959607|54258537|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
27803593|NCT01959607|54258538|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
27803594|NCT02111603|54258547|FG000|Overall Study|Withdrawal by Subject|1|||
27803595|NCT02102399|54258553|FG000|Overall Study|Withdrawal by Subject|6|||
27803596|NCT02102399|54258554|FG001|Overall Study|Withdrawal by Subject|4|||
27803597|NCT02111369|54258565|FG000|Overall Study|Lost to Follow-up|2|||
28028134|NCT00493246|54686641|FG007|Overall Study|Lost to Follow-up|0|||
27803598|NCT02111369|54258565|FG000|Overall Study|Withdrawal by Subject|1|||
27803599|NCT02111213|54258571|FG000|Overall Study|Withdrawal by Subject|3|||
27803600|NCT02111213|54258572|FG001|Overall Study|Withdrawal by Subject|2|||
27803601|NCT02111213|54258571|FG000|Overall Study|Lost to Follow-up|3|||
27803602|NCT02111213|54258572|FG001|Overall Study|Lost to Follow-up|4|||
27803603|NCT02110901|54258580|FG000|Overall Study|Death|6|||
27803604|NCT02110901|54258581|FG001|Overall Study|Death|3|||
27803605|NCT02110901|54258580|FG000|Overall Study|Lost to Follow-up|12|||
27803606|NCT02110901|54258581|FG001|Overall Study|Lost to Follow-up|8|||
27803607|NCT02110901|54258580|FG000|Overall Study|Withdrawal by Subject|7|||
27803608|NCT02110901|54258581|FG001|Overall Study|Withdrawal by Subject|3|||
27803609|NCT02110901|54258580|FG000|Overall Study|received a kidney transplant|5|||
27803610|NCT02110901|54258581|FG001|Overall Study|received a kidney transplant|0|||
27803611|NCT02070965|54258591|FG000|Overall Study|Lost to Follow-up|0|||
27803612|NCT02070965|54258592|FG001|Overall Study|Lost to Follow-up|1|||
27803613|NCT02070965|54258593|FG002|Overall Study|Lost to Follow-up|0|||
27803614|NCT02070965|54258591|FG000|Overall Study|Withdrawal by Subject|1|||
27803615|NCT02070965|54258592|FG001|Overall Study|Withdrawal by Subject|1|||
27803616|NCT02070965|54258593|FG002|Overall Study|Withdrawal by Subject|1|||
27803617|NCT02070965|54258591|FG000|Overall Study|Subject moved|1|||
27803618|NCT02070965|54258592|FG001|Overall Study|Subject moved|0|||
27803619|NCT02070965|54258593|FG002|Overall Study|Subject moved|0|||
27803620|NCT02109107|54258601|FG000|Overall Study|Lost to Follow-up|2|||
27803621|NCT02100839|54258607|FG000|Multiple Ascending Dose|Adverse Event|2|||
27803622|NCT02100839|54258608|FG001|Multiple Ascending Dose|Adverse Event|0|||
27803623|NCT02100839|54258607|FG000|Multiple Ascending Dose|Withdrawal by Subject|2|||
28028135|NCT02281955|54686659|FG000|Overall Study|Death|1|||
28028136|NCT00511797|54686667|FG000|Overall Study|Adverse Event|1|||
28028137|NCT00511797|54686668|FG001|Overall Study|Adverse Event|2|||
28028138|NCT00511797|54686669|FG002|Overall Study|Adverse Event|2|||
28028139|NCT00511797|54686670|FG003|Overall Study|Adverse Event|2|||
28028140|NCT00511797|54686667|FG000|Overall Study|Lost to Follow-up|1|||
28028141|NCT00511797|54686668|FG001|Overall Study|Lost to Follow-up|0|||
28028142|NCT00511797|54686669|FG002|Overall Study|Lost to Follow-up|0|||
28028143|NCT00511797|54686670|FG003|Overall Study|Lost to Follow-up|1|||
28028144|NCT00511797|54686667|FG000|Overall Study|Pregnancy|0|||
28028145|NCT00511797|54686668|FG001|Overall Study|Pregnancy|0|||
28028146|NCT00511797|54686669|FG002|Overall Study|Pregnancy|0|||
28028147|NCT00511797|54686670|FG003|Overall Study|Pregnancy|1|||
28028148|NCT00511797|54686667|FG000|Overall Study|Protocol Violation|0|||
28028149|NCT00511797|54686668|FG001|Overall Study|Protocol Violation|2|||
28028150|NCT00511797|54686669|FG002|Overall Study|Protocol Violation|2|||
28028151|NCT00511797|54686670|FG003|Overall Study|Protocol Violation|3|||
28028152|NCT00511797|54686667|FG000|Overall Study|Withdrawal by Subject|3|||
28028153|NCT00511797|54686668|FG001|Overall Study|Withdrawal by Subject|3|||
28028154|NCT00511797|54686669|FG002|Overall Study|Withdrawal by Subject|4|||
28028155|NCT00511797|54686670|FG003|Overall Study|Withdrawal by Subject|2|||
28028156|NCT00511797|54686667|FG000|Overall Study|Never dispensed|1|||
28028157|NCT00511797|54686668|FG001|Overall Study|Never dispensed|0|||
28028158|NCT00511797|54686669|FG002|Overall Study|Never dispensed|1|||
28028159|NCT00511797|54686670|FG003|Overall Study|Never dispensed|3|||
28028160|NCT00511797|54686667|FG000|Overall Study|Study drug not taken|0|||
28028161|NCT00511797|54686668|FG001|Overall Study|Study drug not taken|1|||
28028162|NCT00511797|54686669|FG002|Overall Study|Study drug not taken|0|||
28028163|NCT00511797|54686670|FG003|Overall Study|Study drug not taken|1|||
28028164|NCT00511797|54686667|FG000|Overall Study|Partially missing diary|0|||
28028165|NCT00511797|54686668|FG001|Overall Study|Partially missing diary|0|||
28028166|NCT00511797|54686669|FG002|Overall Study|Partially missing diary|1|||
28028167|NCT00511797|54686670|FG003|Overall Study|Partially missing diary|0|||
28028168|NCT00511797|54686667|FG000|Overall Study|Other (moving etc)|1|||
28028169|NCT00511797|54686668|FG001|Overall Study|Other (moving etc)|0|||
28028170|NCT00511797|54686669|FG002|Overall Study|Other (moving etc)|1|||
28028171|NCT00511797|54686670|FG003|Overall Study|Other (moving etc)|2|||
27803624|NCT02100839|54258608|FG001|Multiple Ascending Dose|Withdrawal by Subject|0|||
28028172|NCT00487552|54686680|FG000|Overall Study|Unsuccessful magnet placements|3|||
28028173|NCT00487552|54686680|FG000|Overall Study|Death due to progressive malignancy|2|||
28028174|NCT00487552|54686680|FG000|Overall Study|Stent not placed|1|||
27803625|NCT02069093|54258614|FG000|Overall Study|Disease progression|14|||
27803626|NCT02069093|54258614|FG000|Overall Study|New cancer therapy|1|||
28028175|NCT00182689|54686687|FG000|Overall Study|Adverse Event|8|||
28028176|NCT00182689|54686688|FG001|Overall Study|Adverse Event|11|||
28028177|NCT00182689|54686687|FG000|Overall Study|Withdrawal by Subject|2|||
28028178|NCT00182689|54686688|FG001|Overall Study|Withdrawal by Subject|2|||
27803627|NCT02069093|54258614|FG000|Overall Study|Death|1|||
27803628|NCT02069093|54258614|FG000|Overall Study|Administrative problems|1|||
27803629|NCT02069093|54258614|FG000|Overall Study|Withdrawal by Subject|2|||
27803630|NCT02069093|54258614|FG000|Overall Study|Abnormal laboratory values|1|||
27803631|NCT02069093|54258614|FG000|Overall Study|Adverse Event|10|||
27803632|NCT02109029|54258621|FG000|Part B|Adverse Event|0|||
27803633|NCT02109029|54258622|FG001|Part B|Adverse Event|0|||
27803634|NCT02109029|54258623|FG002|Part B|Adverse Event|0|||
27803635|NCT02109029|54258624|FG003|Part B|Adverse Event|0|||
27803636|NCT02109029|54258625|FG004|Part B|Adverse Event|1|||
27803637|NCT02109029|54258626|FG005|Part B|Adverse Event|1|||
27803638|NCT02069015|54258639|FG000|Overall Study|Lost to Follow-up|39|||
27803639|NCT02069015|54258640|FG001|Overall Study|Lost to Follow-up|32|||
27803640|NCT02069015|54258639|FG000|Overall Study|Withdrawal by Subject|1|||
27803641|NCT02069015|54258640|FG001|Overall Study|Withdrawal by Subject|1|||
27803642|NCT01598129|54258647|FG000|Overall Study|Disease progression|6|||
27803643|NCT01598129|54258647|FG000|Overall Study|Deterioration of WHO status to WHO 4|2|||
27803644|NCT01598129|54258647|FG000|Overall Study|Withdrawal by Subject|1|||
27803645|NCT02068547|54258654|FG000|Overall Study|Lost to Follow-up|3|||
27803646|NCT02068547|54258655|FG001|Overall Study|Lost to Follow-up|3|||
27803647|NCT02068547|54258654|FG000|Overall Study|Physician Decision|1|||
27803648|NCT02068547|54258655|FG001|Overall Study|Physician Decision|0|||
27803649|NCT02108951|54258661|FG000|Overall Study|Lost to Follow-up|1|||
28028179|NCT00182689|54686687|FG000|Overall Study|Progression|27|||
27803650|NCT02108951|54258661|FG000|Overall Study|Patient's/guardian's decision|1|||
27803651|NCT02108951|54258661|FG000|Overall Study|Study Terminated by Sponsor|14|||
28028180|NCT00182689|54686688|FG001|Overall Study|Progression|29|||
28028181|NCT00182689|54686687|FG000|Overall Study|Death|1|||
28028182|NCT00182689|54686688|FG001|Overall Study|Death|0|||
28028183|NCT00182689|54686687|FG000|Overall Study|not protocol specified|0|||
28028184|NCT00182689|54686688|FG001|Overall Study|not protocol specified|3|||
28028185|NCT00182689|54686687|FG000|Overall Study|Ineligible|1|||
28028186|NCT00182689|54686688|FG001|Overall Study|Ineligible|4|||
28028187|NCT00182689|54686687|FG000|Overall Study|Never received treatment|1|||
28028188|NCT00182689|54686688|FG001|Overall Study|Never received treatment|0|||
28028189|NCT03860259|54686700|FG000|Overall Study|Lost to Follow-up|5|||
28028190|NCT03860259|54686701|FG001|Overall Study|Lost to Follow-up|5|||
28028191|NCT03860259|54686700|FG000|Overall Study|Protocol Violation|1|||
28028192|NCT03860259|54686701|FG001|Overall Study|Protocol Violation|0|||
28028193|NCT00131365|54686707|FG000|Overall Study|Withdrawal by Subject|1|||
28028194|NCT00131365|54686707|FG000|Overall Study|Alternative treatment|3|||
28028195|NCT00487240|54686714|FG000|Overall Study|Withdrawal by Subject|12|||
28028196|NCT00487240|54686715|FG001|Overall Study|Withdrawal by Subject|6|||
28028197|NCT00487240|54686714|FG000|Overall Study|Lost to Follow-up|7|||
28028198|NCT00487240|54686715|FG001|Overall Study|Lost to Follow-up|6|||
28028199|NCT00487240|54686714|FG000|Overall Study|Adverse Event|0|||
28028200|NCT00487240|54686715|FG001|Overall Study|Adverse Event|4|||
28028201|NCT00487240|54686714|FG000|Overall Study|Protocol Violation|5|||
28028202|NCT00487240|54686715|FG001|Overall Study|Protocol Violation|5|||
28028203|NCT00487240|54686714|FG000|Overall Study|Entry Criteria Not Met|3|||
28028204|NCT00487240|54686715|FG001|Overall Study|Entry Criteria Not Met|4|||
28028205|NCT00487240|54686714|FG000|Overall Study|Sponsor Decision|2|||
28028206|NCT00487240|54686715|FG001|Overall Study|Sponsor Decision|1|||
28028207|NCT00487240|54686714|FG000|Overall Study|Physician Decision|2|||
28028208|NCT00487240|54686715|FG001|Overall Study|Physician Decision|0|||
28028209|NCT02224391|54686723|FG000|Overall Study|Lost to Follow-up|26|||
28028210|NCT02224391|54686724|FG001|Overall Study|Lost to Follow-up|19|||
28028211|NCT02224391|54686723|FG000|Overall Study|Withdrawal by Subject|6|||
28028212|NCT02224391|54686724|FG001|Overall Study|Withdrawal by Subject|5|||
28028213|NCT00487162|54686732|FG000|Overall Study|Adverse Event|0|||
28028214|NCT00487162|54686733|FG001|Overall Study|Adverse Event|1|||
27803652|NCT02107859|54258665|FG000|Overall Study|Withdrawal by Subject|14|||
27803653|NCT02107859|54258665|FG000|Overall Study|Adverse Event|3|||
27803654|NCT02107859|54258665|FG000|Overall Study|Study closure|41|||
27803655|NCT02107859|54258665|FG000|Overall Study|Other than specified|3|||
27803656|NCT02007278|54258671|FG000|Overall Study|Failure to comply with an eligibility|0|||
27803657|NCT02007278|54258672|FG001|Overall Study|Failure to comply with an eligibility|1|||
27803658|NCT02007278|54258671|FG000|Overall Study|Ingestion of drugs not allowed in study|0|||
27803659|NCT02007278|54258672|FG001|Overall Study|Ingestion of drugs not allowed in study|1|||
27803660|NCT02007278|54258671|FG000|Overall Study|Incorrect medication administration|1|||
27803661|NCT02007278|54258672|FG001|Overall Study|Incorrect medication administration|0|||
27803662|NCT02007278|54258671|FG000|Overall Study|Mis-randomization|1|||
27803663|NCT02007278|54258672|FG001|Overall Study|Mis-randomization|1|||
27803664|NCT02107313|54258678|FG000|Overall Study|One participant did not do the FED cohor|0|||
27803665|NCT02107313|54258679|FG001|Overall Study|One participant did not do the FED cohor|1|||
27803666|NCT02028338|54258687|FG000|Overall Study|Withdrawal by Subject|3|||
27803667|NCT02028338|54258688|FG001|Overall Study|Withdrawal by Subject|1|||
27803668|NCT02028338|54258687|FG000|Overall Study|Unable to contact participant|1|||
27803669|NCT02028338|54258688|FG001|Overall Study|Unable to contact participant|0|||
27803670|NCT01625897|54258696|FG000|Overall Study|Adverse Event|27|||
27803671|NCT01625897|54258697|FG001|Overall Study|Adverse Event|10|||
27803672|NCT01625897|54258696|FG000|Overall Study|Physician Decision|0|||
27803673|NCT01625897|54258697|FG001|Overall Study|Physician Decision|1|||
27803674|NCT01625897|54258696|FG000|Overall Study|Withdrawal by Subject|25|||
27803675|NCT01625897|54258697|FG001|Overall Study|Withdrawal by Subject|3|||
27803676|NCT02106923|54258706|FG000|Overall Study|Protocol Violation|0|||
27803677|NCT02106923|54258707|FG001|Overall Study|Protocol Violation|0|||
27939389|NCT01061151|54595624|FG003|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3|||
27939390|NCT01241552|54595648|FG000|Overall Study|Lack of Efficacy|1|||
27939391|NCT01241552|54595649|FG001|Overall Study|Lack of Efficacy|0|||
27939392|NCT01241552|54595650|FG002|Overall Study|Lack of Efficacy|0|||
27939393|NCT01241552|54595651|FG003|Overall Study|Lack of Efficacy|0|||
27939394|NCT01241552|54595648|FG000|Overall Study|Death|26|||
27939395|NCT01241552|54595649|FG001|Overall Study|Death|30|||
27939396|NCT01241552|54595650|FG002|Overall Study|Death|20|||
27939397|NCT01241552|54595651|FG003|Overall Study|Death|25|||
27939398|NCT01241552|54595648|FG000|Overall Study|Adverse Event|1|||
27939399|NCT01241552|54595649|FG001|Overall Study|Adverse Event|1|||
28028215|NCT00487162|54686732|FG000|Overall Study|Physician Decision|0|||
28028216|NCT00487162|54686733|FG001|Overall Study|Physician Decision|1|||
28028217|NCT00487162|54686732|FG000|Overall Study|Withdrawal by Subject|2|||
28028218|NCT00487162|54686733|FG001|Overall Study|Withdrawal by Subject|3|||
28028219|NCT00487084|54686742|FG000|Overall Study|Did not receive intervention|4|||
27803678|NCT02106923|54258708|FG002|Overall Study|Protocol Violation|0|||
27803679|NCT02106923|54258709|FG003|Overall Study|Protocol Violation|0|||
27803680|NCT02106923|54258710|FG004|Overall Study|Protocol Violation|0|||
28028220|NCT00487084|54686743|FG001|Overall Study|Did not receive intervention|3|||
28028221|NCT00487084|54686744|FG002|Overall Study|Did not receive intervention|5|||
28028222|NCT00466726|54686752|FG000|Overall Study|Not evaluable for response|14|||
28028223|NCT01721291|54686758|FG000|Overall Study|Withdrawal by Subject|1|||
28028224|NCT01721291|54686759|FG001|Overall Study|Withdrawal by Subject|0|||
27803681|NCT02106923|54258711|FG005|Overall Study|Protocol Violation|1|||
27803682|NCT02006732|54258729|FG000|Overall Study|Adverse Event|10|||
28028225|NCT01721291|54686758|FG000|Overall Study|did not like the treatment|1|||
28028226|NCT01721291|54686759|FG001|Overall Study|did not like the treatment|0|||
28028227|NCT00486226|54686785|FG000|Overall Study|Death|3|||
28028228|NCT00486226|54686785|FG000|Overall Study|Adverse Event|1|||
28028229|NCT00486226|54686785|FG000|Overall Study|Withdrawal by Subject|1|||
28028230|NCT00486226|54686785|FG000|Overall Study|Lost to Follow-up|8|||
28028231|NCT00485758|54686794|FG000|Overall Study|Adverse Event|102|||
28028232|NCT00485758|54686795|FG001|Overall Study|Adverse Event|31|||
28028233|NCT00485758|54686794|FG000|Overall Study|Death|0|||
28028234|NCT00485758|54686795|FG001|Overall Study|Death|1|||
28028235|NCT00485758|54686794|FG000|Overall Study|Lost to Follow-up|5|||
28028236|NCT00485758|54686795|FG001|Overall Study|Lost to Follow-up|1|||
28028237|NCT00485758|54686794|FG000|Overall Study|Physician Decision|3|||
28028238|NCT00485758|54686795|FG001|Overall Study|Physician Decision|3|||
28028239|NCT00485758|54686794|FG000|Overall Study|Protocol Violation|11|||
28028240|NCT00485758|54686795|FG001|Overall Study|Protocol Violation|2|||
28028241|NCT00485758|54686794|FG000|Overall Study|Withdrawal by Subject|32|||
28028242|NCT00485758|54686795|FG001|Overall Study|Withdrawal by Subject|27|||
28028243|NCT00485758|54686794|FG000|Overall Study|Study Terminated by Sponsor|3|||
28028244|NCT00485758|54686795|FG001|Overall Study|Study Terminated by Sponsor|0|||
28028245|NCT03850444|54686803|FG000|Overall Study|Adverse Event|12|||
28028246|NCT03850444|54686804|FG001|Overall Study|Adverse Event|9|||
27803683|NCT02006732|54258730|FG001|Overall Study|Adverse Event|7|||
27803684|NCT02006732|54258731|FG002|Overall Study|Adverse Event|4|||
27803685|NCT02006732|54258732|FG003|Overall Study|Adverse Event|2|||
27803686|NCT02006732|54258729|FG000|Overall Study|Lack of Efficacy|6|||
27803687|NCT02006732|54258730|FG001|Overall Study|Lack of Efficacy|3|||
27803688|NCT02006732|54258731|FG002|Overall Study|Lack of Efficacy|1|||
27803689|NCT02006732|54258732|FG003|Overall Study|Lack of Efficacy|1|||
27803690|NCT02006732|54258729|FG000|Overall Study|Protocol Violation|1|||
27803691|NCT02006732|54258730|FG001|Overall Study|Protocol Violation|1|||
27803692|NCT02006732|54258731|FG002|Overall Study|Protocol Violation|0|||
27803693|NCT02006732|54258732|FG003|Overall Study|Protocol Violation|0|||
28028247|NCT03850444|54686803|FG000|Overall Study|Death|38|||
28028248|NCT03850444|54686804|FG001|Overall Study|Death|64|||
27803694|NCT02006732|54258729|FG000|Overall Study|Lost to Follow-up|0|||
27803695|NCT02006732|54258730|FG001|Overall Study|Lost to Follow-up|1|||
28028249|NCT03850444|54686803|FG000|Overall Study|Lost to Follow-up|0|||
27803696|NCT02006732|54258731|FG002|Overall Study|Lost to Follow-up|0|||
27803697|NCT02006732|54258732|FG003|Overall Study|Lost to Follow-up|0|||
27803698|NCT02006732|54258729|FG000|Overall Study|Withdrawal by Subject|3|||
27803699|NCT02006732|54258730|FG001|Overall Study|Withdrawal by Subject|0|||
27803700|NCT02006732|54258731|FG002|Overall Study|Withdrawal by Subject|4|||
28028250|NCT03850444|54686804|FG001|Overall Study|Lost to Follow-up|1|||
28028251|NCT03850444|54686803|FG000|Overall Study|Withdrawal by Subject|0|||
28028252|NCT03850444|54686804|FG001|Overall Study|Withdrawal by Subject|1|||
28028253|NCT03850444|54686803|FG000|Overall Study|Ongoing in Study|78|||
28028254|NCT03850444|54686804|FG001|Overall Study|Ongoing in Study|59|||
28028255|NCT00469612|54686812|FG000|Overall Study|Study terminated before data collected|2|||
28028256|NCT00469612|54686813|FG001|Overall Study|Study terminated before data collected|0|||
28028257|NCT00469456|54686821|FG000|Overall Study|Adverse Event|4|||
28028258|NCT00469456|54686822|FG001|Overall Study|Adverse Event|3|||
28028259|NCT00469456|54686821|FG000|Overall Study|Protocol Violation|1|||
28028260|NCT00469456|54686822|FG001|Overall Study|Protocol Violation|0|||
28028261|NCT00469456|54686821|FG000|Overall Study|Withdrawal by Subject|4|||
28028262|NCT00469456|54686822|FG001|Overall Study|Withdrawal by Subject|1|||
28028263|NCT00581555|54686830|FG000|Overall Study|Adverse Event|4|||
28028264|NCT00581555|54686831|FG001|Overall Study|Adverse Event|3|||
28028265|NCT00581555|54686830|FG000|Overall Study|Physician Decision|3|||
28028266|NCT00581555|54686831|FG001|Overall Study|Physician Decision|2|||
28028267|NCT00581555|54686830|FG000|Overall Study|Withdrawal by Subject|18|||
28028268|NCT00581555|54686831|FG001|Overall Study|Withdrawal by Subject|9|||
28028269|NCT00581555|54686830|FG000|Overall Study|Lost to Follow-up|2|||
28028270|NCT00581555|54686831|FG001|Overall Study|Lost to Follow-up|2|||
28028271|NCT00581555|54686830|FG000|Overall Study|Other reasons|16|||
28028272|NCT00581555|54686831|FG001|Overall Study|Other reasons|4|||
28028273|NCT00469144|54686839|FG000|Overall Study|Death|0|||
28028274|NCT00469144|54686840|FG001|Overall Study|Death|1|||
28028275|NCT00469144|54686839|FG000|Overall Study|No Response|5|||
28028276|NCT00469144|54686840|FG001|Overall Study|No Response|5|||
28028277|NCT00469144|54686839|FG000|Overall Study|Progressive Disease|1|||
28028278|NCT00469144|54686840|FG001|Overall Study|Progressive Disease|0|||
28028279|NCT00468910|54686852|FG000|Overall Study|Lost to Follow-up|2|||
28028280|NCT00468910|54686853|FG001|Overall Study|Lost to Follow-up|1|||
28028281|NCT00468910|54686852|FG000|Overall Study|Withdrawal by Subject|2|||
28028282|NCT00468910|54686853|FG001|Overall Study|Withdrawal by Subject|1|||
28028283|NCT00468910|54686852|FG000|Overall Study|Medical Contraindication|0|||
28028284|NCT00468910|54686853|FG001|Overall Study|Medical Contraindication|1|||
28028285|NCT01412333|54686862|FG000|Overall Study|Death|1|||
28028286|NCT01412333|54686863|FG001|Overall Study|Death|1|||
28028287|NCT01412333|54686862|FG000|Overall Study|Physician Decision|0|||
28028288|NCT01412333|54686863|FG001|Overall Study|Physician Decision|1|||
28028289|NCT01412333|54686862|FG000|Overall Study|Reason not specified|16|||
28028290|NCT01412333|54686863|FG001|Overall Study|Reason not specified|10|||
27803701|NCT02006732|54258732|FG003|Overall Study|Withdrawal by Subject|1|||
27803702|NCT02098733|54258742|FG000|Overall Study|Data Not Available|5|||
27803703|NCT02098733|54258742|FG000|Overall Study|Lost to Follow-up|5|||
27803704|NCT02028182|54258746|FG000|Overall Study|Protocol Violation|2|||
27803705|NCT02098109|54258753|FG000|Overall Study|Protocol Violation|3|||
28028291|NCT01412333|54686862|FG000|Overall Study|Non-compliance with study drug|1|||
27803706|NCT02098109|54258754|FG001|Overall Study|Protocol Violation|0|||
27803707|NCT02097719|54258762|FG000|Overall Study|Subject Withdrew Consent|1|||
28028292|NCT01412333|54686863|FG001|Overall Study|Non-compliance with study drug|1|||
28028293|NCT01412333|54686862|FG000|Overall Study|Protocol Violation|1|||
28028294|NCT01412333|54686863|FG001|Overall Study|Protocol Violation|1|||
28028295|NCT01412333|54686862|FG000|Overall Study|Non-compliance|1|||
28028296|NCT01412333|54686863|FG001|Overall Study|Non-compliance|3|||
28028297|NCT01412333|54686862|FG000|Overall Study|Lack of Efficacy|15|||
28028298|NCT01412333|54686863|FG001|Overall Study|Lack of Efficacy|6|||
28028299|NCT01412333|54686862|FG000|Overall Study|Pregnancy|3|||
28028300|NCT01412333|54686863|FG001|Overall Study|Pregnancy|0|||
27803708|NCT02097719|54258763|FG001|Overall Study|Subject Withdrew Consent|0|||
27803709|NCT02097719|54258762|FG000|Overall Study|Lost to Follow-up|0|||
27803710|NCT02097719|54258763|FG001|Overall Study|Lost to Follow-up|1|||
27803711|NCT02097719|54258762|FG000|Overall Study|Adverse Event|2|||
27803712|NCT02097719|54258763|FG001|Overall Study|Adverse Event|0|||
27803713|NCT01449370|54258794|FG000|Overall Study|Disease Progression|5|||
27803714|NCT01449370|54258795|FG001|Overall Study|Disease Progression|4|||
27803715|NCT01449370|54258796|FG002|Overall Study|Disease Progression|8|||
27803716|NCT01449370|54258797|FG003|Overall Study|Disease Progression|3|||
27803717|NCT01449370|54258798|FG004|Overall Study|Disease Progression|3|||
27803718|NCT01449370|54258799|FG005|Overall Study|Disease Progression|3|||
27803719|NCT01449370|54258800|FG006|Overall Study|Disease Progression|3|||
27803720|NCT01449370|54258801|FG007|Overall Study|Disease Progression|2|||
27803721|NCT01449370|54258802|FG008|Overall Study|Disease Progression|9|||
27803722|NCT01449370|54258803|FG009|Overall Study|Disease Progression|1|||
27803723|NCT01449370|54258804|FG010|Overall Study|Disease Progression|3|||
27803724|NCT01449370|54258805|FG011|Overall Study|Disease Progression|3|||
27803725|NCT01449370|54258806|FG012|Overall Study|Disease Progression|2|||
27803726|NCT01449370|54258807|FG013|Overall Study|Disease Progression|8|||
27803727|NCT01449370|54258808|FG014|Overall Study|Disease Progression|3|||
27803728|NCT01449370|54258809|FG015|Overall Study|Disease Progression|1|||
27803729|NCT01449370|54258810|FG016|Overall Study|Disease Progression|4|||
27803730|NCT01449370|54258811|FG017|Overall Study|Disease Progression|3|||
27803731|NCT01449370|54258812|FG018|Overall Study|Disease Progression|1|||
27803732|NCT01449370|54258813|FG019|Overall Study|Disease Progression|2|||
27803733|NCT01449370|54258814|FG020|Overall Study|Disease Progression|5|||
27803734|NCT01449370|54258815|FG021|Overall Study|Disease Progression|2|||
27803735|NCT01449370|54258816|FG022|Overall Study|Disease Progression|3|||
27803736|NCT01449370|54258817|FG023|Overall Study|Disease Progression|7|||
27803737|NCT01449370|54258818|FG024|Overall Study|Disease Progression|3|||
27803738|NCT01449370|54258794|FG000|Overall Study|Adverse Event|1|||
28028301|NCT01412333|54686862|FG000|Overall Study|Consent withdrawn by participant|25|||
28028302|NCT01412333|54686863|FG001|Overall Study|Consent withdrawn by participant|12|||
28028303|NCT01412333|54686862|FG000|Overall Study|Adverse Event|25|||
28028304|NCT01412333|54686863|FG001|Overall Study|Adverse Event|16|||
28028305|NCT01412333|54686862|FG000|Overall Study|Lost to Follow-up|10|||
28028306|NCT01412333|54686863|FG001|Overall Study|Lost to Follow-up|6|||
28028307|NCT00519285|54686872|FG000|Overall Study|Adverse Event|127|||
28028308|NCT00519285|54686873|FG001|Overall Study|Adverse Event|266|||
28028309|NCT00519285|54686872|FG000|Overall Study|Disease progression|334|||
28028310|NCT00519285|54686873|FG001|Overall Study|Disease progression|186|||
28028311|NCT00519285|54686872|FG000|Overall Study|Physician Decision|75|||
28028312|NCT00519285|54686873|FG001|Overall Study|Physician Decision|47|||
28028313|NCT00519285|54686872|FG000|Overall Study|Participant's request|53|||
28028314|NCT00519285|54686873|FG001|Overall Study|Participant's request|84|||
28028315|NCT00519285|54686872|FG000|Overall Study|Consent withdrawn|4|||
28028316|NCT00519285|54686873|FG001|Overall Study|Consent withdrawn|5|||
28028317|NCT00519285|54686872|FG000|Overall Study|Poor compliance to protocol|5|||
28028318|NCT00519285|54686873|FG001|Overall Study|Poor compliance to protocol|7|||
28028319|NCT00519285|54686872|FG000|Overall Study|Reason unspecified|5|||
28028320|NCT00519285|54686873|FG001|Overall Study|Reason unspecified|8|||
28028321|NCT00519285|54686872|FG000|Overall Study|Not treated|8|||
28028322|NCT00519285|54686873|FG001|Overall Study|Not treated|7|||
28028323|NCT00519285|54686872|FG000|Overall Study|Treatment ongoing|1|||
28028324|NCT00519285|54686873|FG001|Overall Study|Treatment ongoing|2|||
28028325|NCT00464620|54686879|FG000|Overall Study|Physician Decision|1|||
28028326|NCT00464620|54686880|FG001|Overall Study|Physician Decision|0|||
28028327|NCT00464620|54686881|FG002|Overall Study|Physician Decision|0|||
28028328|NCT00464620|54686879|FG000|Overall Study|Withdrawal by Subject|1|||
28028329|NCT00464620|54686880|FG001|Overall Study|Withdrawal by Subject|0|||
28028330|NCT00464620|54686881|FG002|Overall Study|Withdrawal by Subject|3|||
28028331|NCT00464620|54686879|FG000|Overall Study|Ineligible sarcoma subtype|0|||
28028332|NCT00464620|54686880|FG001|Overall Study|Ineligible sarcoma subtype|2|||
28028333|NCT00464620|54686881|FG002|Overall Study|Ineligible sarcoma subtype|2|||
28028334|NCT00464620|54686879|FG000|Overall Study|Use of prohibited concomitant medication|0|||
28028335|NCT00464620|54686880|FG001|Overall Study|Use of prohibited concomitant medication|0|||
28028336|NCT00464620|54686881|FG002|Overall Study|Use of prohibited concomitant medication|2|||
28028337|NCT00464542|54686894|FG000|Pre-treatment|Withdrawal by Subject|2|||
28028338|NCT00468676|54686900|FG000|Overall Study|Lost to Follow-up|14|||
28028339|NCT00468676|54686901|FG001|Overall Study|Lost to Follow-up|11|||
28028340|NCT00468676|54686900|FG000|Overall Study|Death|2|||
28028341|NCT00468676|54686901|FG001|Overall Study|Death|1|||
28028342|NCT00464308|54686912|FG000|Overall Study|Adverse Event|22|||
28028343|NCT00464308|54686913|FG001|Overall Study|Adverse Event|27|||
28028344|NCT00464308|54686914|FG002|Overall Study|Adverse Event|16|||
28028345|NCT00464308|54686912|FG000|Overall Study|Lost to Follow-up|29|||
28028346|NCT00464308|54686913|FG001|Overall Study|Lost to Follow-up|19|||
28028347|NCT00464308|54686914|FG002|Overall Study|Lost to Follow-up|20|||
28028348|NCT00464308|54686912|FG000|Overall Study|Patient discontinued and other reasons|17|||
28028349|NCT00464308|54686913|FG001|Overall Study|Patient discontinued and other reasons|17|||
28028350|NCT00464308|54686914|FG002|Overall Study|Patient discontinued and other reasons|23|||
28028351|NCT00464308|54686912|FG000|Overall Study|Physician Decision|1|||
28028352|NCT00464308|54686913|FG001|Overall Study|Physician Decision|0|||
28028353|NCT00464308|54686914|FG002|Overall Study|Physician Decision|0|||
28028354|NCT00468286|54686924|FG000|Overall Study|Adverse Event|1|||
28028355|NCT00468286|54686925|FG001|Overall Study|Adverse Event|6|||
27803739|NCT01449370|54258795|FG001|Overall Study|Adverse Event|2|||
27803740|NCT01449370|54258796|FG002|Overall Study|Adverse Event|0|||
27803741|NCT01449370|54258797|FG003|Overall Study|Adverse Event|1|||
27803742|NCT01449370|54258798|FG004|Overall Study|Adverse Event|0|||
27803743|NCT01449370|54258799|FG005|Overall Study|Adverse Event|0|||
27803744|NCT01449370|54258800|FG006|Overall Study|Adverse Event|0|||
27803745|NCT01449370|54258801|FG007|Overall Study|Adverse Event|0|||
27803746|NCT01449370|54258802|FG008|Overall Study|Adverse Event|1|||
27803747|NCT01449370|54258803|FG009|Overall Study|Adverse Event|1|||
27803748|NCT01449370|54258804|FG010|Overall Study|Adverse Event|0|||
27803749|NCT01449370|54258805|FG011|Overall Study|Adverse Event|0|||
27803750|NCT01449370|54258806|FG012|Overall Study|Adverse Event|0|||
27803751|NCT01449370|54258807|FG013|Overall Study|Adverse Event|2|||
27803752|NCT01449370|54258808|FG014|Overall Study|Adverse Event|0|||
27803753|NCT01449370|54258809|FG015|Overall Study|Adverse Event|1|||
27803754|NCT01449370|54258810|FG016|Overall Study|Adverse Event|0|||
27803755|NCT01449370|54258811|FG017|Overall Study|Adverse Event|0|||
27803756|NCT01449370|54258812|FG018|Overall Study|Adverse Event|1|||
27803757|NCT01449370|54258813|FG019|Overall Study|Adverse Event|1|||
27803758|NCT01449370|54258814|FG020|Overall Study|Adverse Event|0|||
27803759|NCT01449370|54258815|FG021|Overall Study|Adverse Event|1|||
27803760|NCT01449370|54258816|FG022|Overall Study|Adverse Event|0|||
27803761|NCT01449370|54258817|FG023|Overall Study|Adverse Event|1|||
27803762|NCT01449370|54258818|FG024|Overall Study|Adverse Event|3|||
27803763|NCT01449370|54258794|FG000|Overall Study|Participant Decision|0|||
27803764|NCT01449370|54258795|FG001|Overall Study|Participant Decision|0|||
27803765|NCT01449370|54258796|FG002|Overall Study|Participant Decision|0|||
27803766|NCT01449370|54258797|FG003|Overall Study|Participant Decision|0|||
27803767|NCT01449370|54258798|FG004|Overall Study|Participant Decision|0|||
27803768|NCT01449370|54258799|FG005|Overall Study|Participant Decision|0|||
27803769|NCT01449370|54258800|FG006|Overall Study|Participant Decision|0|||
27803770|NCT01449370|54258801|FG007|Overall Study|Participant Decision|1|||
27803771|NCT01449370|54258802|FG008|Overall Study|Participant Decision|1|||
27803772|NCT01449370|54258803|FG009|Overall Study|Participant Decision|0|||
27803773|NCT01449370|54258804|FG010|Overall Study|Participant Decision|0|||
27803774|NCT01449370|54258805|FG011|Overall Study|Participant Decision|0|||
27803775|NCT01449370|54258806|FG012|Overall Study|Participant Decision|1|||
27803776|NCT01449370|54258807|FG013|Overall Study|Participant Decision|1|||
27803777|NCT01449370|54258808|FG014|Overall Study|Participant Decision|0|||
27803778|NCT01449370|54258809|FG015|Overall Study|Participant Decision|1|||
27803779|NCT01449370|54258810|FG016|Overall Study|Participant Decision|3|||
27803780|NCT01449370|54258811|FG017|Overall Study|Participant Decision|0|||
27803781|NCT01449370|54258812|FG018|Overall Study|Participant Decision|1|||
27803782|NCT01449370|54258813|FG019|Overall Study|Participant Decision|0|||
27842927|NCT01440569|54331894|FG001|Main Study|Enrolled but not treated|0|||
27803783|NCT01449370|54258814|FG020|Overall Study|Participant Decision|0|||
27803784|NCT01449370|54258815|FG021|Overall Study|Participant Decision|1|||
28028356|NCT00468286|54686924|FG000|Overall Study|Protocol Violation|2|||
28028357|NCT00468286|54686925|FG001|Overall Study|Protocol Violation|2|||
28028358|NCT00468286|54686924|FG000|Overall Study|Withdrawal by Subject|4|||
28028359|NCT00468286|54686925|FG001|Overall Study|Withdrawal by Subject|3|||
28028360|NCT00468286|54686924|FG000|Overall Study|Physician Decision|0|||
28028361|NCT00468286|54686925|FG001|Overall Study|Physician Decision|1|||
28028362|NCT00463840|54686931|FG000|Overall Study|Disease progression|7|||
28028363|NCT00463840|54686931|FG000|Overall Study|Withdrawal by Subject|2|||
28028364|NCT00463840|54686931|FG000|Overall Study|Adverse Event|3|||
28028365|NCT00129389|54686937|FG000|Overall Study|Adverse Event|19|||
28028366|NCT00129389|54686938|FG001|Overall Study|Adverse Event|87|||
28028367|NCT00129389|54686937|FG000|Overall Study|Death|0|||
28028368|NCT00129389|54686938|FG001|Overall Study|Death|1|||
28028369|NCT00129389|54686937|FG000|Overall Study|Lost to Follow-up|2|||
28028370|NCT00129389|54686938|FG001|Overall Study|Lost to Follow-up|1|||
28028371|NCT00129389|54686937|FG000|Overall Study|Physician Decision|0|||
28028372|NCT00129389|54686938|FG001|Overall Study|Physician Decision|4|||
28028373|NCT00129389|54686937|FG000|Overall Study|Protocol Violation|0|||
28028374|NCT00129389|54686938|FG001|Overall Study|Protocol Violation|6|||
28028375|NCT00129389|54686937|FG000|Overall Study|Withdrawal by Subject|9|||
28028376|NCT00129389|54686938|FG001|Overall Study|Withdrawal by Subject|23|||
28028377|NCT00129389|54686937|FG000|Overall Study|Relapse|1|||
28028378|NCT00129389|54686938|FG001|Overall Study|Relapse|0|||
28028379|NCT00129389|54686937|FG000|Overall Study|Not eligible|1|||
28028380|NCT00129389|54686938|FG001|Overall Study|Not eligible|2|||
28028381|NCT00129389|54686937|FG000|Overall Study|Crossed to the other arm|1|||
28028382|NCT00129389|54686938|FG001|Overall Study|Crossed to the other arm|16|||
28028383|NCT00468052|54686946|FG000|Overall Study|Protocol Violation|7|||
28028384|NCT00468052|54686947|FG001|Overall Study|Protocol Violation|8|||
28028385|NCT00453310|54686955|FG000|Overall Study|Progression of Disease|10|||
28028386|NCT00124657|54686962|FG000|Overall Study|Toxicity|0|||
28028387|NCT00124657|54686963|FG001|Overall Study|Toxicity|0|||
28028388|NCT00124657|54686964|FG002|Overall Study|Toxicity|1|||
28028389|NCT00124657|54686962|FG000|Overall Study|Non-compliance|1|||
28028390|NCT00124657|54686963|FG001|Overall Study|Non-compliance|0|||
28028391|NCT00124657|54686964|FG002|Overall Study|Non-compliance|4|||
27803785|NCT01449370|54258816|FG022|Overall Study|Participant Decision|0|||
28028392|NCT00124657|54686962|FG000|Overall Study|Progressive disease|14|||
28028393|NCT00124657|54686963|FG001|Overall Study|Progressive disease|5|||
28028394|NCT00124657|54686964|FG002|Overall Study|Progressive disease|27|||
28028395|NCT00124657|54686962|FG000|Overall Study|Intercurrent illness|1|||
28028396|NCT00124657|54686963|FG001|Overall Study|Intercurrent illness|0|||
28028397|NCT00124657|54686964|FG002|Overall Study|Intercurrent illness|0|||
28028398|NCT00581945|54686987|FG000|Overall Study|Adverse Event|4|||
28028399|NCT00581945|54686988|FG001|Overall Study|Adverse Event|4|||
28028400|NCT00581945|54686987|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
28028401|NCT00581945|54686988|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
27803786|NCT01449370|54258817|FG023|Overall Study|Participant Decision|0|||
27803787|NCT01449370|54258818|FG024|Overall Study|Participant Decision|1|||
27803788|NCT01449370|54258794|FG000|Overall Study|Lost to Follow-up|0|||
27803789|NCT01449370|54258795|FG001|Overall Study|Lost to Follow-up|0|||
27803790|NCT01449370|54258796|FG002|Overall Study|Lost to Follow-up|0|||
27803791|NCT01449370|54258797|FG003|Overall Study|Lost to Follow-up|0|||
27803792|NCT01449370|54258798|FG004|Overall Study|Lost to Follow-up|0|||
27803793|NCT01449370|54258799|FG005|Overall Study|Lost to Follow-up|0|||
27803794|NCT01449370|54258800|FG006|Overall Study|Lost to Follow-up|0|||
27803795|NCT01449370|54258801|FG007|Overall Study|Lost to Follow-up|0|||
27803796|NCT01449370|54258802|FG008|Overall Study|Lost to Follow-up|0|||
27803797|NCT01449370|54258803|FG009|Overall Study|Lost to Follow-up|0|||
27803798|NCT01449370|54258804|FG010|Overall Study|Lost to Follow-up|0|||
27803799|NCT01449370|54258805|FG011|Overall Study|Lost to Follow-up|0|||
27803800|NCT01449370|54258806|FG012|Overall Study|Lost to Follow-up|0|||
27803801|NCT01449370|54258807|FG013|Overall Study|Lost to Follow-up|0|||
27803802|NCT01449370|54258808|FG014|Overall Study|Lost to Follow-up|0|||
27803803|NCT01449370|54258809|FG015|Overall Study|Lost to Follow-up|0|||
27803804|NCT01449370|54258810|FG016|Overall Study|Lost to Follow-up|0|||
27803805|NCT01449370|54258811|FG017|Overall Study|Lost to Follow-up|0|||
27803806|NCT01449370|54258812|FG018|Overall Study|Lost to Follow-up|0|||
27803807|NCT01449370|54258813|FG019|Overall Study|Lost to Follow-up|0|||
27803808|NCT01449370|54258814|FG020|Overall Study|Lost to Follow-up|1|||
27803809|NCT01449370|54258815|FG021|Overall Study|Lost to Follow-up|0|||
27803810|NCT01449370|54258816|FG022|Overall Study|Lost to Follow-up|0|||
27803811|NCT01449370|54258817|FG023|Overall Study|Lost to Follow-up|0|||
27803812|NCT01449370|54258818|FG024|Overall Study|Lost to Follow-up|0|||
27803813|NCT01449370|54258794|FG000|Overall Study|Other|0|||
27803814|NCT01449370|54258795|FG001|Overall Study|Other|0|||
27803815|NCT01449370|54258796|FG002|Overall Study|Other|0|||
27803816|NCT01449370|54258797|FG003|Overall Study|Other|0|||
27803817|NCT01449370|54258798|FG004|Overall Study|Other|0|||
27803818|NCT01449370|54258799|FG005|Overall Study|Other|0|||
27803819|NCT01449370|54258800|FG006|Overall Study|Other|0|||
27803820|NCT01449370|54258801|FG007|Overall Study|Other|0|||
27803821|NCT01449370|54258802|FG008|Overall Study|Other|1|||
27803822|NCT01449370|54258803|FG009|Overall Study|Other|1|||
27803823|NCT01449370|54258804|FG010|Overall Study|Other|0|||
27803824|NCT01449370|54258805|FG011|Overall Study|Other|0|||
27803825|NCT01449370|54258806|FG012|Overall Study|Other|0|||
27803826|NCT01449370|54258807|FG013|Overall Study|Other|0|||
27803827|NCT01449370|54258808|FG014|Overall Study|Other|0|||
28028402|NCT00581945|54686987|FG000|Overall Study|Withdrawal by Subject|2|||
28028403|NCT00581945|54686988|FG001|Overall Study|Withdrawal by Subject|6|||
28028404|NCT00581945|54686987|FG000|Overall Study|Death|1|||
28028405|NCT00581945|54686988|FG001|Overall Study|Death|0|||
28028406|NCT00555906|54686997|FG000|Phase 1|Objective Progression or Relapse|3|||
28028407|NCT00555906|54686998|FG001|Phase 1|Objective Progression or Relapse|5|||
28028408|NCT00555906|54686999|FG002|Phase 1|Objective Progression or Relapse|3|||
28028409|NCT00555906|54687000|FG003|Phase 1|Objective Progression or Relapse|1|||
28028410|NCT00555906|54687001|FG004|Phase 1|Objective Progression or Relapse|0|||
28028411|NCT00555906|54686997|FG000|Phase 1|Global Deterioration of Health Status|0|||
28028412|NCT00555906|54686998|FG001|Phase 1|Global Deterioration of Health Status|1|||
28028413|NCT00555906|54686999|FG002|Phase 1|Global Deterioration of Health Status|1|||
28028414|NCT00555906|54687000|FG003|Phase 1|Global Deterioration of Health Status|1|||
28028415|NCT00555906|54687001|FG004|Phase 1|Global Deterioration of Health Status|0|||
28028416|NCT00555906|54686997|FG000|Phase 1|Adverse Event|0|||
28028417|NCT00555906|54686998|FG001|Phase 1|Adverse Event|0|||
28028418|NCT00555906|54686999|FG002|Phase 1|Adverse Event|3|||
28028419|NCT00555906|54687000|FG003|Phase 1|Adverse Event|2|||
28028420|NCT00555906|54687001|FG004|Phase 1|Adverse Event|0|||
28028421|NCT00555906|54686997|FG000|Phase 1|Withdrawal by Subject|0|||
28028422|NCT00555906|54686998|FG001|Phase 1|Withdrawal by Subject|0|||
28028423|NCT00555906|54686999|FG002|Phase 1|Withdrawal by Subject|0|||
28028424|NCT00555906|54687000|FG003|Phase 1|Withdrawal by Subject|1|||
28028425|NCT00555906|54687001|FG004|Phase 1|Withdrawal by Subject|0|||
28028426|NCT00555906|54686997|FG000|Phase 2|Adverse Event|0|||
28028427|NCT00555906|54686998|FG001|Phase 2|Adverse Event|0|||
28028428|NCT00555906|54686999|FG002|Phase 2|Adverse Event|0|||
28028429|NCT00555906|54687000|FG003|Phase 2|Adverse Event|0|||
28028430|NCT00555906|54687001|FG004|Phase 2|Adverse Event|4|||
28028431|NCT00555906|54686997|FG000|Phase 2|Global Deterioration of Health Status|0|||
28028432|NCT00555906|54686998|FG001|Phase 2|Global Deterioration of Health Status|0|||
28028433|NCT00555906|54686999|FG002|Phase 2|Global Deterioration of Health Status|0|||
28028434|NCT00555906|54687000|FG003|Phase 2|Global Deterioration of Health Status|0|||
28028435|NCT00555906|54687001|FG004|Phase 2|Global Deterioration of Health Status|2|||
28028436|NCT00555906|54686997|FG000|Phase 2|Objective Progression or Relapse|0|||
28028437|NCT00555906|54686998|FG001|Phase 2|Objective Progression or Relapse|0|||
28028438|NCT00555906|54686999|FG002|Phase 2|Objective Progression or Relapse|0|||
28028439|NCT00555906|54687000|FG003|Phase 2|Objective Progression or Relapse|0|||
28028440|NCT00555906|54687001|FG004|Phase 2|Objective Progression or Relapse|16|||
28028441|NCT00555906|54686997|FG000|Phase 2|Withdrawal by Subject|0|||
28028442|NCT00555906|54686998|FG001|Phase 2|Withdrawal by Subject|0|||
28028443|NCT00555906|54686999|FG002|Phase 2|Withdrawal by Subject|0|||
28028444|NCT00555906|54687000|FG003|Phase 2|Withdrawal by Subject|0|||
28028445|NCT00555906|54687001|FG004|Phase 2|Withdrawal by Subject|2|||
28028446|NCT00555906|54686997|FG000|Phase 2|Other|0|||
28028447|NCT00555906|54686998|FG001|Phase 2|Other|0|||
28028448|NCT00555906|54686999|FG002|Phase 2|Other|0|||
28028449|NCT00555906|54687000|FG003|Phase 2|Other|0|||
27939400|NCT01241552|54595650|FG002|Overall Study|Adverse Event|0|||
27939401|NCT01241552|54595651|FG003|Overall Study|Adverse Event|0|||
27939402|NCT01241552|54595648|FG000|Overall Study|Technical Problems|2|||
27939403|NCT01241552|54595649|FG001|Overall Study|Technical Problems|0|||
27939404|NCT01241552|54595650|FG002|Overall Study|Technical Problems|2|||
27939405|NCT01241552|54595651|FG003|Overall Study|Technical Problems|2|||
27939406|NCT01241552|54595648|FG000|Overall Study|Progressive Disease|0|||
27939407|NCT01241552|54595649|FG001|Overall Study|Progressive Disease|0|||
27939408|NCT01241552|54595650|FG002|Overall Study|Progressive Disease|1|||
27939409|NCT01241552|54595651|FG003|Overall Study|Progressive Disease|2|||
27939410|NCT01241552|54595648|FG000|Overall Study|Protocol Violation|0|||
27939411|NCT01241552|54595649|FG001|Overall Study|Protocol Violation|2|||
27939412|NCT01241552|54595650|FG002|Overall Study|Protocol Violation|6|||
27939413|NCT01241552|54595651|FG003|Overall Study|Protocol Violation|1|||
27939414|NCT01241552|54595648|FG000|Overall Study|Withdrawal by Subject|7|||
28028450|NCT00555906|54687001|FG004|Phase 2|Other|6|||
28028451|NCT00555906|54686997|FG000|Phase 2|Randomized but not Treated|0|||
28028452|NCT00555906|54686998|FG001|Phase 2|Randomized but not Treated|0|||
28028453|NCT00555906|54686999|FG002|Phase 2|Randomized but not Treated|0|||
28028454|NCT00555906|54687000|FG003|Phase 2|Randomized but not Treated|0|||
28028455|NCT00555906|54687001|FG004|Phase 2|Randomized but not Treated|2|||
28028456|NCT03817879|54687018|FG000|Overall Study|Drop out|5|||
28028457|NCT03817879|54687019|FG001|Overall Study|Drop out|12|||
27803828|NCT01449370|54258809|FG015|Overall Study|Other|0|||
27803829|NCT01449370|54258810|FG016|Overall Study|Other|0|||
27803830|NCT01449370|54258811|FG017|Overall Study|Other|0|||
27803831|NCT01449370|54258812|FG018|Overall Study|Other|0|||
27803832|NCT01449370|54258813|FG019|Overall Study|Other|0|||
27803833|NCT01449370|54258814|FG020|Overall Study|Other|0|||
27803834|NCT01449370|54258815|FG021|Overall Study|Other|0|||
27803835|NCT01449370|54258816|FG022|Overall Study|Other|1|||
27803836|NCT01449370|54258817|FG023|Overall Study|Other|1|||
27803837|NCT01449370|54258818|FG024|Overall Study|Other|0|||
27803838|NCT01449370|54258794|FG000|Overall Study|Medication Prohibited by Protocol|0|||
27803839|NCT01449370|54258795|FG001|Overall Study|Medication Prohibited by Protocol|0|||
27803840|NCT01449370|54258796|FG002|Overall Study|Medication Prohibited by Protocol|0|||
27803841|NCT01449370|54258797|FG003|Overall Study|Medication Prohibited by Protocol|0|||
28028458|NCT03817879|54687018|FG000|Overall Study|Withdrawal by Subject|0|||
28028459|NCT03817879|54687019|FG001|Overall Study|Withdrawal by Subject|1|||
28028460|NCT00555672|54687027|FG000|Overall Study|Death|0|||
28028461|NCT00555672|54687028|FG001|Overall Study|Death|2|||
28028462|NCT00555672|54687027|FG000|Overall Study|Adverse Event|8|||
28028463|NCT00555672|54687028|FG001|Overall Study|Adverse Event|2|||
28028464|NCT00555672|54687027|FG000|Overall Study|Objective progression or relapse|11|||
28028465|NCT00555672|54687028|FG001|Overall Study|Objective progression or relapse|5|||
28028466|NCT00555672|54687027|FG000|Overall Study|Other|3|||
28028467|NCT00555672|54687028|FG001|Overall Study|Other|1|||
28028468|NCT00555672|54687027|FG000|Overall Study|Participant refused|2|||
28028469|NCT00555672|54687028|FG001|Overall Study|Participant refused|0|||
28028470|NCT03958656|54687038|FG000|Overall Study|Received anti-myeloma prescription (Rx)|0|||
28028471|NCT03958656|54687039|FG001|Overall Study|Received anti-myeloma prescription (Rx)|1|||
28028472|NCT03958656|54687040|FG002|Overall Study|Received anti-myeloma prescription (Rx)|0|||
28028473|NCT03958656|54687041|FG003|Overall Study|Received anti-myeloma prescription (Rx)|0|||
28028474|NCT03958656|54687038|FG000|Overall Study|No longer meets eligibility criteria|0|||
28028475|NCT03958656|54687039|FG001|Overall Study|No longer meets eligibility criteria|0|||
28028476|NCT03958656|54687040|FG002|Overall Study|No longer meets eligibility criteria|1|||
28028477|NCT03958656|54687041|FG003|Overall Study|No longer meets eligibility criteria|0|||
28028478|NCT03958656|54687038|FG000|Overall Study|Started anti-cancer treatment|0|||
28028479|NCT03958656|54687039|FG001|Overall Study|Started anti-cancer treatment|0|||
28028480|NCT03958656|54687040|FG002|Overall Study|Started anti-cancer treatment|1|||
28028481|NCT03958656|54687041|FG003|Overall Study|Started anti-cancer treatment|0|||
28028482|NCT00561912|54687051|FG000|Overall Study|ineligible|1|||
28028483|NCT00561678|54687057|FG000|Overall Study|Withdrawal by Subject|4|||
27842928|NCT01440569|54331893|FG000|Main Study|Adverse Event|9|||
27803842|NCT01449370|54258798|FG004|Overall Study|Medication Prohibited by Protocol|0|||
27803843|NCT01449370|54258799|FG005|Overall Study|Medication Prohibited by Protocol|0|||
27803844|NCT01449370|54258800|FG006|Overall Study|Medication Prohibited by Protocol|0|||
27803845|NCT01449370|54258801|FG007|Overall Study|Medication Prohibited by Protocol|0|||
27803846|NCT01449370|54258802|FG008|Overall Study|Medication Prohibited by Protocol|0|||
27803847|NCT01449370|54258803|FG009|Overall Study|Medication Prohibited by Protocol|0|||
27803848|NCT01449370|54258804|FG010|Overall Study|Medication Prohibited by Protocol|0|||
27803849|NCT01449370|54258805|FG011|Overall Study|Medication Prohibited by Protocol|0|||
27803850|NCT01449370|54258806|FG012|Overall Study|Medication Prohibited by Protocol|0|||
27803851|NCT01449370|54258807|FG013|Overall Study|Medication Prohibited by Protocol|0|||
27803852|NCT01449370|54258808|FG014|Overall Study|Medication Prohibited by Protocol|0|||
27803853|NCT01449370|54258809|FG015|Overall Study|Medication Prohibited by Protocol|0|||
27803854|NCT01449370|54258810|FG016|Overall Study|Medication Prohibited by Protocol|0|||
27803855|NCT01449370|54258811|FG017|Overall Study|Medication Prohibited by Protocol|0|||
27803856|NCT01449370|54258812|FG018|Overall Study|Medication Prohibited by Protocol|0|||
27803857|NCT01449370|54258813|FG019|Overall Study|Medication Prohibited by Protocol|0|||
27803858|NCT01449370|54258814|FG020|Overall Study|Medication Prohibited by Protocol|0|||
27803859|NCT01449370|54258815|FG021|Overall Study|Medication Prohibited by Protocol|0|||
27803860|NCT01449370|54258816|FG022|Overall Study|Medication Prohibited by Protocol|0|||
27803861|NCT01449370|54258817|FG023|Overall Study|Medication Prohibited by Protocol|1|||
27803862|NCT01449370|54258818|FG024|Overall Study|Medication Prohibited by Protocol|0|||
27803863|NCT01449370|54258794|FG000|Overall Study|Death|0|||
27803864|NCT01449370|54258795|FG001|Overall Study|Death|0|||
27803865|NCT01449370|54258796|FG002|Overall Study|Death|0|||
27803866|NCT01449370|54258797|FG003|Overall Study|Death|0|||
27803867|NCT01449370|54258798|FG004|Overall Study|Death|0|||
27803868|NCT01449370|54258799|FG005|Overall Study|Death|0|||
27803869|NCT01449370|54258800|FG006|Overall Study|Death|0|||
27803870|NCT01449370|54258801|FG007|Overall Study|Death|0|||
27803871|NCT01449370|54258802|FG008|Overall Study|Death|0|||
27803872|NCT01449370|54258803|FG009|Overall Study|Death|0|||
27803873|NCT01449370|54258804|FG010|Overall Study|Death|0|||
27803874|NCT01449370|54258805|FG011|Overall Study|Death|0|||
27803875|NCT01449370|54258806|FG012|Overall Study|Death|0|||
27803876|NCT01449370|54258807|FG013|Overall Study|Death|0|||
27803877|NCT01449370|54258808|FG014|Overall Study|Death|0|||
27803878|NCT01449370|54258809|FG015|Overall Study|Death|0|||
27842929|NCT01440569|54331894|FG001|Main Study|Adverse Event|0|||
28028484|NCT00561678|54687058|FG001|Overall Study|Withdrawal by Subject|3|||
28028485|NCT00561678|54687057|FG000|Overall Study|surgery cancelled|1|||
27842930|NCT01440569|54331893|FG000|Main Study|Pregnancy|1|||
27803879|NCT01449370|54258810|FG016|Overall Study|Death|0|||
27803880|NCT01449370|54258811|FG017|Overall Study|Death|0|||
27803881|NCT01449370|54258812|FG018|Overall Study|Death|0|||
27803882|NCT01449370|54258813|FG019|Overall Study|Death|0|||
27803883|NCT01449370|54258814|FG020|Overall Study|Death|0|||
27803884|NCT01449370|54258815|FG021|Overall Study|Death|0|||
27939415|NCT01241552|54595649|FG001|Overall Study|Withdrawal by Subject|15|||
28028486|NCT00561678|54687058|FG001|Overall Study|surgery cancelled|1|||
28028487|NCT00561678|54687057|FG000|Overall Study|surgery rescheduled to different site|2|||
28028488|NCT00561678|54687058|FG001|Overall Study|surgery rescheduled to different site|2|||
28028489|NCT00561678|54687057|FG000|Overall Study|anesthesia provider refusal|1|||
27939416|NCT01241552|54595650|FG002|Overall Study|Withdrawal by Subject|14|||
27939417|NCT01241552|54595651|FG003|Overall Study|Withdrawal by Subject|15|||
27939418|NCT01241552|54595648|FG000|Overall Study|Physician Decision|2|||
27939419|NCT01241552|54595649|FG001|Overall Study|Physician Decision|4|||
27939420|NCT01241552|54595650|FG002|Overall Study|Physician Decision|2|||
27803885|NCT01449370|54258816|FG022|Overall Study|Death|0|||
27803886|NCT01449370|54258817|FG023|Overall Study|Death|0|||
27939421|NCT01241552|54595651|FG003|Overall Study|Physician Decision|3|||
27939422|NCT01241552|54595648|FG000|Overall Study|Lost to Follow-up|2|||
27939423|NCT01241552|54595649|FG001|Overall Study|Lost to Follow-up|11|||
27939424|NCT01241552|54595650|FG002|Overall Study|Lost to Follow-up|15|||
27939425|NCT01241552|54595651|FG003|Overall Study|Lost to Follow-up|16|||
27939426|NCT00948922|54595664|FG000|Overall Study|Did not start study treatment|2|||
27803887|NCT01449370|54258818|FG024|Overall Study|Death|1|||
28028490|NCT00561678|54687058|FG001|Overall Study|anesthesia provider refusal|0|||
28028491|NCT00463684|54687064|FG000|Overall Study|Withdrawal by Subject|1|||
28028492|NCT00463684|54687064|FG000|Overall Study|Lost to Follow-up|3|||
28028493|NCT00463606|54687071|FG000|Overall Study|Adverse Event|21|||
28028494|NCT00463606|54687072|FG001|Overall Study|Adverse Event|18|||
28028495|NCT00463606|54687073|FG002|Overall Study|Adverse Event|11|||
28028496|NCT00463606|54687071|FG000|Overall Study|Withdrawal by Subject|11|||
28028497|NCT00463606|54687072|FG001|Overall Study|Withdrawal by Subject|11|||
28028498|NCT00463606|54687073|FG002|Overall Study|Withdrawal by Subject|5|||
28028499|NCT00463606|54687071|FG000|Overall Study|Lost to Follow-up|2|||
28028500|NCT00463606|54687072|FG001|Overall Study|Lost to Follow-up|2|||
28028501|NCT00463606|54687073|FG002|Overall Study|Lost to Follow-up|3|||
28028502|NCT00463606|54687071|FG000|Overall Study|Subject noncompliance|1|||
28028503|NCT00463606|54687072|FG001|Overall Study|Subject noncompliance|1|||
28028504|NCT00463606|54687073|FG002|Overall Study|Subject noncompliance|0|||
28028505|NCT00463606|54687071|FG000|Overall Study|Subject moved out of town|1|||
28028506|NCT00463606|54687072|FG001|Overall Study|Subject moved out of town|0|||
28028507|NCT00463606|54687073|FG002|Overall Study|Subject moved out of town|0|||
28028508|NCT00463606|54687071|FG000|Overall Study|Physician Decision|0|||
28028509|NCT00463606|54687072|FG001|Overall Study|Physician Decision|1|||
28028510|NCT00463606|54687073|FG002|Overall Study|Physician Decision|0|||
28028511|NCT00463606|54687071|FG000|Overall Study|Sponsor request|0|||
28028512|NCT00463606|54687072|FG001|Overall Study|Sponsor request|1|||
28028513|NCT00463606|54687073|FG002|Overall Study|Sponsor request|0|||
28028514|NCT00463606|54687071|FG000|Overall Study|Exclusion criteria violation|2|||
28028515|NCT00463606|54687072|FG001|Overall Study|Exclusion criteria violation|0|||
28028516|NCT00463606|54687073|FG002|Overall Study|Exclusion criteria violation|0|||
28028517|NCT00463606|54687071|FG000|Overall Study|Coordinator error|1|||
28028518|NCT00463606|54687072|FG001|Overall Study|Coordinator error|0|||
28028519|NCT00463606|54687073|FG002|Overall Study|Coordinator error|0|||
28028520|NCT00463606|54687071|FG000|Overall Study|Patient randomized in error|1|||
28028521|NCT00463606|54687072|FG001|Overall Study|Patient randomized in error|0|||
28028522|NCT00463606|54687073|FG002|Overall Study|Patient randomized in error|0|||
27803888|NCT02067533|54258893|FG000|Overall Study|Lost to Follow-up|4|||
27803889|NCT02067533|54258894|FG001|Overall Study|Lost to Follow-up|2|||
27803890|NCT02066129|54258902|FG000|Overall Study|Lost to Follow-up|13|||
27803891|NCT02066129|54258903|FG001|Overall Study|Lost to Follow-up|12|||
27803892|NCT02066129|54258902|FG000|Overall Study|Withdrawal by Subject|7|||
27803893|NCT02066129|54258903|FG001|Overall Study|Withdrawal by Subject|10|||
27803894|NCT02066129|54258902|FG000|Overall Study|Lack of Efficacy|8|||
27803895|NCT02066129|54258903|FG001|Overall Study|Lack of Efficacy|10|||
27803896|NCT02066129|54258902|FG000|Overall Study|Physician Decision|1|||
27803897|NCT02066129|54258903|FG001|Overall Study|Physician Decision|1|||
27803898|NCT02066051|54258909|FG000|Overall Study|Subject developed active GVHD|1|||
27803899|NCT01980992|54258915|FG000|52 Weeks Blinded Study Treatment|Dosing Symptoms|0|||
28028523|NCT00463606|54687071|FG000|Overall Study|Participation in another ABT-335 trial|1|||
28028524|NCT00463606|54687072|FG001|Overall Study|Participation in another ABT-335 trial|0|||
28028525|NCT00463606|54687073|FG002|Overall Study|Participation in another ABT-335 trial|0|||
28028526|NCT00463606|54687071|FG000|Overall Study|Protocol Violation|0|||
27803900|NCT01980992|54258916|FG001|52 Weeks Blinded Study Treatment|Dosing Symptoms|3|||
27803901|NCT01980992|54258915|FG000|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
28028527|NCT00463606|54687072|FG001|Overall Study|Protocol Violation|0|||
27803902|NCT01980992|54258916|FG001|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
27803903|NCT01980992|54258915|FG000|52 Weeks Blinded Study Treatment|Non-compliance|1|||
27803904|NCT01980992|54258916|FG001|52 Weeks Blinded Study Treatment|Non-compliance|0|||
27803905|NCT01980992|54258915|FG000|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2|||
27803906|NCT01980992|54258916|FG001|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0|||
27803907|NCT01980992|54258915|FG000|52 Weeks Open Label Active Wheat OIT|Non-compliance|1|||
27803908|NCT01980992|54258916|FG001|52 Weeks Open Label Active Wheat OIT|Non-compliance|0|||
27803909|NCT01980992|54258915|FG000|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0|||
27803910|NCT01980992|54258916|FG001|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1|||
27803911|NCT02065895|54258929|FG000|Overall Study|Protocol Violation|1|||
27803912|NCT02065895|54258930|FG001|Overall Study|Protocol Violation|0|||
27803913|NCT02065895|54258931|FG002|Overall Study|Protocol Violation|0|||
27803914|NCT02065895|54258932|FG003|Overall Study|Protocol Violation|1|||
27803915|NCT02065895|54258933|FG004|Overall Study|Protocol Violation|0|||
27803916|NCT02065895|54258934|FG005|Overall Study|Protocol Violation|0|||
27803917|NCT02065895|54258929|FG000|Overall Study|Scheduling conflicts|0|||
27803918|NCT02065895|54258930|FG001|Overall Study|Scheduling conflicts|1|||
27803919|NCT02065895|54258931|FG002|Overall Study|Scheduling conflicts|0|||
27803920|NCT02065895|54258932|FG003|Overall Study|Scheduling conflicts|0|||
27803921|NCT02065895|54258933|FG004|Overall Study|Scheduling conflicts|0|||
27803922|NCT02065895|54258934|FG005|Overall Study|Scheduling conflicts|0|||
27803923|NCT02106455|54258951|FG000|Overall Study|Case Report Form Uncollected|6|||
27803924|NCT02106455|54258951|FG000|Overall Study|Protocol Deviation|2|||
27803925|NCT02006654|54258957|FG000|Overall Study|Withdrawal before treatment|4|||
27803926|NCT02006654|54258958|FG001|Overall Study|Withdrawal before treatment|2|||
27803927|NCT02006654|54258957|FG000|Overall Study|Adverse Event|16|||
27803928|NCT02006654|54258958|FG001|Overall Study|Adverse Event|17|||
27803929|NCT02006654|54258957|FG000|Overall Study|Death|1|||
27803930|NCT02006654|54258958|FG001|Overall Study|Death|0|||
27803931|NCT02006654|54258957|FG000|Overall Study|Withdrawal by Subject|14|||
27803932|NCT02006654|54258958|FG001|Overall Study|Withdrawal by Subject|12|||
27803933|NCT02006654|54258957|FG000|Overall Study|Protocol Violation|5|||
27803934|NCT02006654|54258958|FG001|Overall Study|Protocol Violation|8|||
27803935|NCT02006654|54258957|FG000|Overall Study|Lost to Follow-up|1|||
27803936|NCT02006654|54258958|FG001|Overall Study|Lost to Follow-up|0|||
27803937|NCT02006654|54258957|FG000|Overall Study|patient's will|2|||
27803938|NCT02006654|54258958|FG001|Overall Study|patient's will|1|||
27803939|NCT02006654|54258957|FG000|Overall Study|insufficient compliance|1|||
27803940|NCT02006654|54258958|FG001|Overall Study|insufficient compliance|0|||
27803941|NCT02006654|54258957|FG000|Overall Study|worsening cognitive condition|0|||
27803942|NCT02006654|54258958|FG001|Overall Study|worsening cognitive condition|1|||
27803943|NCT02006654|54258957|FG000|Overall Study|faecal incontinence|0|||
27803944|NCT02006654|54258958|FG001|Overall Study|faecal incontinence|1|||
27803945|NCT02006654|54258957|FG000|Overall Study|mood disorder|0|||
27803946|NCT02006654|54258958|FG001|Overall Study|mood disorder|1|||
27803947|NCT02006654|54258957|FG000|Overall Study|disallowed medication|1|||
27803948|NCT02006654|54258958|FG001|Overall Study|disallowed medication|0|||
27803949|NCT02006654|54258957|FG000|Overall Study|moving out of state|0|||
27803950|NCT02006654|54258958|FG001|Overall Study|moving out of state|1|||
27803951|NCT01980056|54258968|FG000|Overall Study|Death|1|||
27803952|NCT01980056|54258969|FG001|Overall Study|Death|1|||
27803953|NCT01980056|54258970|FG002|Overall Study|Death|0|||
27803954|NCT02027558|54258984|FG000|Overall Study|Death|0|||
27803955|NCT02027558|54258985|FG001|Overall Study|Death|1|||
27803956|NCT02027558|54258984|FG000|Overall Study|Withdrawal by Subject|2|||
27803957|NCT02027558|54258985|FG001|Overall Study|Withdrawal by Subject|0|||
27803958|NCT02027558|54258984|FG000|Overall Study|Lost to Follow-up|4|||
27939427|NCT00948922|54595665|FG001|Overall Study|Did not start study treatment|5|||
27939428|NCT00948922|54595666|FG002|Overall Study|Did not start study treatment|0|||
27803959|NCT02027558|54258985|FG001|Overall Study|Lost to Follow-up|1|||
27803960|NCT02027558|54258984|FG000|Overall Study|Refused assessment|3|||
27803961|NCT02027558|54258985|FG001|Overall Study|Refused assessment|0|||
27803962|NCT02006576|54258996|FG000|Overall Study|Withdrawal by Subject|4|||
27803963|NCT02006576|54258997|FG001|Overall Study|Withdrawal by Subject|6|||
27803964|NCT02006576|54258998|FG002|Overall Study|Withdrawal by Subject|2|||
27803965|NCT02006576|54258996|FG000|Overall Study|Death|0|||
27803966|NCT02006576|54258997|FG001|Overall Study|Death|0|||
27803967|NCT02006576|54258998|FG002|Overall Study|Death|1|||
27803968|NCT02006576|54258996|FG000|Overall Study|Lost to Follow-up|1|||
27803969|NCT02006576|54258997|FG001|Overall Study|Lost to Follow-up|0|||
27803970|NCT02006576|54258998|FG002|Overall Study|Lost to Follow-up|1|||
27803971|NCT02006576|54258996|FG000|Overall Study|Screen Failure, too sick, other|13|||
27803972|NCT02006576|54258997|FG001|Overall Study|Screen Failure, too sick, other|1|||
27803973|NCT02006576|54258998|FG002|Overall Study|Screen Failure, too sick, other|13|||
27803974|NCT02027402|54259008|FG000|Overall Study|Withdrawal by Subject|4|||
27803975|NCT02027402|54259009|FG001|Overall Study|Withdrawal by Subject|1|||
27803976|NCT01448824|54259025|FG000|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
27803977|NCT01448824|54259026|FG001|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
27803978|NCT01448824|54259027|FG002|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
27803979|NCT01448824|54259028|FG003|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
27803980|NCT01448824|54259029|FG004|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
27803981|NCT01448824|54259030|FG005|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
27803982|NCT01448824|54259031|FG006|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1|||
27803983|NCT01448824|54259032|FG007|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
27803984|NCT01448824|54259025|FG000|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
27803985|NCT01448824|54259026|FG001|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
28028528|NCT00463606|54687073|FG002|Overall Study|Protocol Violation|1|||
28028529|NCT03961308|54687083|FG000|Overall Study|Withdrawal by Subject|1|||
28028530|NCT03961308|54687084|FG001|Overall Study|Withdrawal by Subject|0|||
28028531|NCT03961308|54687083|FG000|Overall Study|Other|1|||
28028532|NCT03961308|54687084|FG001|Overall Study|Other|0|||
28028533|NCT03961308|54687083|FG000|Overall Study|Lost to Follow-up|0|||
28028534|NCT03961308|54687084|FG001|Overall Study|Lost to Follow-up|1|||
28028535|NCT03961308|54687083|FG000|Overall Study|Adverse Event|0|||
28028536|NCT03961308|54687084|FG001|Overall Study|Adverse Event|1|||
28028537|NCT00174187|54687092|FG000|Period 1 (up to 3 Years)|Serious adverse event|0|||
28028538|NCT00174187|54687093|FG001|Period 1 (up to 3 Years)|Serious adverse event|1|||
28028539|NCT00174187|54687094|FG002|Period 1 (up to 3 Years)|Serious adverse event|0|||
28028540|NCT00174187|54687092|FG000|Period 1 (up to 3 Years)|Non compliance|0|||
28028541|NCT00174187|54687093|FG001|Period 1 (up to 3 Years)|Non compliance|1|||
28028542|NCT00174187|54687094|FG002|Period 1 (up to 3 Years)|Non compliance|0|||
28028543|NCT00174187|54687092|FG000|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
28028544|NCT00174187|54687093|FG001|Period 1 (up to 3 Years)|Withdrawal by Subject|1|||
28028545|NCT00174187|54687094|FG002|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
28028546|NCT00174187|54687092|FG000|Period 1 (up to 3 Years)|Other|0|||
28028547|NCT00174187|54687093|FG001|Period 1 (up to 3 Years)|Other|1|||
28028548|NCT00174187|54687094|FG002|Period 1 (up to 3 Years)|Other|0|||
28028549|NCT00174187|54687092|FG000|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
28028550|NCT00174187|54687093|FG001|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
28028551|NCT00174187|54687094|FG002|Between Period 1 and Period 2|Did not consent to continue treatment|2|||
28028552|NCT00174187|54687092|FG000|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
28028553|NCT00174187|54687093|FG001|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
28028554|NCT00174187|54687094|FG002|Between Period 1 and Period 2|Consented, not assigned to treatment|3|||
28028555|NCT00174187|54687092|FG000|Period 2 (After 3 Years)|Lost to Follow-up|0|||
28028556|NCT00174187|54687093|FG001|Period 2 (After 3 Years)|Lost to Follow-up|0|||
28028557|NCT00174187|54687094|FG002|Period 2 (After 3 Years)|Lost to Follow-up|2|||
28028558|NCT00174187|54687092|FG000|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
28028559|NCT00174187|54687093|FG001|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
28028560|NCT00174187|54687094|FG002|Period 2 (After 3 Years)|Withdrawal by Subject|1|||
28028561|NCT00174187|54687092|FG000|Period 2 (After 3 Years)|Other|0|||
28028562|NCT00174187|54687093|FG001|Period 2 (After 3 Years)|Other|0|||
28028563|NCT00174187|54687094|FG002|Period 2 (After 3 Years)|Other|5|||
28028564|NCT01011335|54687106|FG000|Overall Study|Lost to Follow-up|0|||
28028565|NCT01011335|54687107|FG001|Overall Study|Lost to Follow-up|0|||
28028566|NCT01011335|54687108|FG002|Overall Study|Lost to Follow-up|1|||
28028567|NCT01011335|54687109|FG003|Overall Study|Lost to Follow-up|1|||
28028568|NCT01011335|54687110|FG004|Overall Study|Lost to Follow-up|1|||
28028569|NCT01011335|54687111|FG005|Overall Study|Lost to Follow-up|1|||
28028570|NCT01011335|54687112|FG006|Overall Study|Lost to Follow-up|2|||
28028571|NCT01011335|54687113|FG007|Overall Study|Lost to Follow-up|2|||
28028572|NCT01011335|54687114|FG008|Overall Study|Lost to Follow-up|1|||
28028573|NCT01011335|54687115|FG009|Overall Study|Lost to Follow-up|0|||
28028574|NCT01011335|54687116|FG010|Overall Study|Lost to Follow-up|0|||
28028575|NCT01011335|54687117|FG011|Overall Study|Lost to Follow-up|1|||
28028576|NCT01011335|54687118|FG012|Overall Study|Lost to Follow-up|2|||
28028577|NCT01011335|54687106|FG000|Overall Study|Protocol Violation|0|||
28028578|NCT01011335|54687107|FG001|Overall Study|Protocol Violation|1|||
28028579|NCT01011335|54687108|FG002|Overall Study|Protocol Violation|0|||
28028580|NCT01011335|54687109|FG003|Overall Study|Protocol Violation|0|||
28028581|NCT01011335|54687110|FG004|Overall Study|Protocol Violation|0|||
28028582|NCT01011335|54687111|FG005|Overall Study|Protocol Violation|0|||
28028583|NCT01011335|54687112|FG006|Overall Study|Protocol Violation|0|||
28028584|NCT01011335|54687113|FG007|Overall Study|Protocol Violation|0|||
28028585|NCT01011335|54687114|FG008|Overall Study|Protocol Violation|0|||
28028586|NCT01011335|54687115|FG009|Overall Study|Protocol Violation|0|||
28028587|NCT01011335|54687116|FG010|Overall Study|Protocol Violation|0|||
28028588|NCT01011335|54687117|FG011|Overall Study|Protocol Violation|0|||
28028589|NCT01011335|54687118|FG012|Overall Study|Protocol Violation|0|||
28028590|NCT01011335|54687106|FG000|Overall Study|Moved/deployed or no booster|1|||
28028591|NCT01011335|54687107|FG001|Overall Study|Moved/deployed or no booster|0|||
28028592|NCT01011335|54687108|FG002|Overall Study|Moved/deployed or no booster|0|||
28028593|NCT01011335|54687109|FG003|Overall Study|Moved/deployed or no booster|1|||
28028594|NCT01011335|54687110|FG004|Overall Study|Moved/deployed or no booster|0|||
28028595|NCT01011335|54687111|FG005|Overall Study|Moved/deployed or no booster|0|||
27803986|NCT01448824|54259027|FG002|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
28028596|NCT01011335|54687112|FG006|Overall Study|Moved/deployed or no booster|1|||
28028597|NCT01011335|54687113|FG007|Overall Study|Moved/deployed or no booster|0|||
28028598|NCT01011335|54687114|FG008|Overall Study|Moved/deployed or no booster|1|||
28028599|NCT01011335|54687115|FG009|Overall Study|Moved/deployed or no booster|0|||
28028600|NCT01011335|54687116|FG010|Overall Study|Moved/deployed or no booster|2|||
28028601|NCT01011335|54687117|FG011|Overall Study|Moved/deployed or no booster|0|||
28028602|NCT01011335|54687118|FG012|Overall Study|Moved/deployed or no booster|0|||
28028603|NCT01011335|54687106|FG000|Overall Study|Adverse Event|0|||
28028604|NCT01011335|54687107|FG001|Overall Study|Adverse Event|0|||
28028605|NCT01011335|54687108|FG002|Overall Study|Adverse Event|0|||
28028606|NCT01011335|54687109|FG003|Overall Study|Adverse Event|0|||
28028607|NCT01011335|54687110|FG004|Overall Study|Adverse Event|0|||
28028608|NCT01011335|54687111|FG005|Overall Study|Adverse Event|0|||
28028609|NCT01011335|54687112|FG006|Overall Study|Adverse Event|0|||
28028610|NCT01011335|54687113|FG007|Overall Study|Adverse Event|0|||
28028611|NCT01011335|54687114|FG008|Overall Study|Adverse Event|0|||
28028612|NCT01011335|54687115|FG009|Overall Study|Adverse Event|0|||
28028613|NCT01011335|54687116|FG010|Overall Study|Adverse Event|4|||
28028614|NCT01011335|54687117|FG011|Overall Study|Adverse Event|0|||
28028615|NCT01011335|54687118|FG012|Overall Study|Adverse Event|1|||
28028616|NCT00467896|54687155|FG000|Overall Study|Consent Withdrawal|18|||
28028617|NCT00467896|54687155|FG000|Overall Study|Adverse Event|7|||
28028618|NCT00467896|54687155|FG000|Overall Study|Serious Adverse Event|13|||
28028619|NCT00467896|54687155|FG000|Overall Study|Non-compliance|3|||
28028620|NCT00467896|54687155|FG000|Overall Study|Changed therapy|2|||
28028621|NCT00467896|54687155|FG000|Overall Study|Patient received transplant|2|||
28028622|NCT00467896|54687155|FG000|Overall Study|Patient had atrial septostomy|1|||
28028623|NCT00467896|54687155|FG000|Overall Study|Patient weaned off iloprost|1|||
28028624|NCT00467896|54687155|FG000|Overall Study|Mainly used Prodose not I-neb® device|1|||
28028625|NCT00467896|54687155|FG000|Overall Study|Started intravenous prostacyclin|1|||
28028626|NCT00467896|54687155|FG000|Overall Study|Started inhaled Remodulin|1|||
28028627|NCT00467896|54687155|FG000|Overall Study|Patient had no improvement|1|||
27939429|NCT00948922|54595664|FG000|Overall Study|Withdrawal by Subject|0|||
27803987|NCT01448824|54259028|FG003|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
27803988|NCT01448824|54259029|FG004|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2|||
27803989|NCT01448824|54259030|FG005|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
27803990|NCT01448824|54259031|FG006|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
27803991|NCT01448824|54259032|FG007|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
27803992|NCT01448824|54259025|FG000|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
27803993|NCT01448824|54259026|FG001|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
27803994|NCT01448824|54259027|FG002|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
27803995|NCT01448824|54259028|FG003|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
27803996|NCT01448824|54259029|FG004|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
27803997|NCT01448824|54259030|FG005|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1|||
27803998|NCT01448824|54259031|FG006|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
27803999|NCT01448824|54259032|FG007|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
27804000|NCT01448824|54259025|FG000|Part 1: Washout Period|Lost to Follow-up|1|||
27804001|NCT01448824|54259026|FG001|Part 1: Washout Period|Lost to Follow-up|0|||
28028628|NCT00579059|54687163|FG000|Overall Study|Study Canceled at 1 Year|21|||
28028629|NCT00579059|54687164|FG001|Overall Study|Study Canceled at 1 Year|10|||
28028630|NCT00467818|54687172|FG000|Overall Study|Adverse Event|1|||
28028631|NCT00467818|54687173|FG001|Overall Study|Adverse Event|0|||
28028632|NCT00467818|54687172|FG000|Overall Study|Lost to Follow-up|2|||
28028633|NCT00467818|54687173|FG001|Overall Study|Lost to Follow-up|2|||
28028634|NCT00467740|54687186|FG000|Overall Study|Adverse Event|0|||
28028635|NCT00467740|54687187|FG001|Overall Study|Adverse Event|0|||
27804002|NCT01448824|54259027|FG002|Part 1: Washout Period|Lost to Follow-up|0|||
27804003|NCT01448824|54259028|FG003|Part 1: Washout Period|Lost to Follow-up|0|||
27804004|NCT01448824|54259029|FG004|Part 1: Washout Period|Lost to Follow-up|0|||
27804005|NCT01448824|54259030|FG005|Part 1: Washout Period|Lost to Follow-up|0|||
27804006|NCT01448824|54259031|FG006|Part 1: Washout Period|Lost to Follow-up|0|||
27804007|NCT01448824|54259032|FG007|Part 1: Washout Period|Lost to Follow-up|0|||
27804008|NCT01448824|54259025|FG000|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
27804009|NCT01448824|54259026|FG001|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
27804010|NCT01448824|54259027|FG002|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
27804011|NCT01448824|54259028|FG003|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
27804012|NCT01448824|54259029|FG004|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
28028636|NCT00467740|54687188|FG002|Overall Study|Adverse Event|1|||
28028637|NCT00467740|54687189|FG003|Overall Study|Adverse Event|0|||
28028638|NCT00467740|54687190|FG004|Overall Study|Adverse Event|0|||
27804013|NCT01448824|54259030|FG005|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
28028639|NCT00467740|54687186|FG000|Overall Study|Protocol Violation|0|||
28028640|NCT00467740|54687187|FG001|Overall Study|Protocol Violation|0|||
28028641|NCT00467740|54687188|FG002|Overall Study|Protocol Violation|1|||
28028642|NCT00467740|54687189|FG003|Overall Study|Protocol Violation|0|||
28028643|NCT00467740|54687190|FG004|Overall Study|Protocol Violation|0|||
28028644|NCT00467740|54687186|FG000|Overall Study|Lost to Follow-up|0|||
28028645|NCT00467740|54687187|FG001|Overall Study|Lost to Follow-up|1|||
28028646|NCT00467740|54687188|FG002|Overall Study|Lost to Follow-up|0|||
28028647|NCT00467740|54687189|FG003|Overall Study|Lost to Follow-up|0|||
28028648|NCT00467740|54687190|FG004|Overall Study|Lost to Follow-up|0|||
28028649|NCT00467740|54687186|FG000|Overall Study|Withdrawal by Subject|1|||
28028650|NCT00467740|54687187|FG001|Overall Study|Withdrawal by Subject|1|||
27804014|NCT01448824|54259031|FG006|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
27804015|NCT01448824|54259032|FG007|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1|||
27804016|NCT01448824|54259025|FG000|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
27804017|NCT01448824|54259026|FG001|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
27804018|NCT01448824|54259027|FG002|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
27804019|NCT01448824|54259028|FG003|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
27804020|NCT01448824|54259029|FG004|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
28028651|NCT00467740|54687188|FG002|Overall Study|Withdrawal by Subject|0|||
28028652|NCT00467740|54687189|FG003|Overall Study|Withdrawal by Subject|1|||
28028653|NCT00467740|54687190|FG004|Overall Study|Withdrawal by Subject|0|||
28028654|NCT00467740|54687186|FG000|Overall Study|Lack of Efficacy|0|||
28028655|NCT00467740|54687187|FG001|Overall Study|Lack of Efficacy|1|||
28028656|NCT00467740|54687188|FG002|Overall Study|Lack of Efficacy|0|||
28028657|NCT00467740|54687189|FG003|Overall Study|Lack of Efficacy|0|||
28028658|NCT00467740|54687190|FG004|Overall Study|Lack of Efficacy|0|||
28028659|NCT00553254|54687204|FG000|Overall Study|Death|3|||
28028660|NCT00553254|54687205|FG001|Overall Study|Death|6|||
28028661|NCT00553254|54687206|FG002|Overall Study|Death|25|||
28028662|NCT00553254|54687204|FG000|Overall Study|Lost to Follow-up|0|||
28028663|NCT00553254|54687205|FG001|Overall Study|Lost to Follow-up|0|||
28028664|NCT00553254|54687206|FG002|Overall Study|Lost to Follow-up|2|||
28028665|NCT00553254|54687204|FG000|Overall Study|Withdrawal by Subject|2|||
28028666|NCT00553254|54687205|FG001|Overall Study|Withdrawal by Subject|0|||
28028667|NCT00553254|54687206|FG002|Overall Study|Withdrawal by Subject|2|||
28028668|NCT00553254|54687204|FG000|Overall Study|Study terminated by Sponsor|0|||
28028669|NCT00553254|54687205|FG001|Overall Study|Study terminated by Sponsor|0|||
28028670|NCT00553254|54687206|FG002|Overall Study|Study terminated by Sponsor|1|||
28028671|NCT00553254|54687204|FG000|Overall Study|Other|1|||
28028672|NCT00553254|54687205|FG001|Overall Study|Other|0|||
28028673|NCT00553254|54687206|FG002|Overall Study|Other|13|||
28028674|NCT00168805|54687221|FG000|Overall Study|Adverse Event|7|||
27804021|NCT01448824|54259030|FG005|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
28028675|NCT00168805|54687222|FG001|Overall Study|Adverse Event|11|||
28028676|NCT00168805|54687223|FG002|Overall Study|Adverse Event|16|||
28028677|NCT00168805|54687221|FG000|Overall Study|Protocol Violation|12|||
28028678|NCT00168805|54687222|FG001|Overall Study|Protocol Violation|11|||
27804022|NCT01448824|54259031|FG006|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
28028679|NCT00168805|54687223|FG002|Overall Study|Protocol Violation|8|||
28028680|NCT00168805|54687221|FG000|Overall Study|Lost to Follow-up|12|||
28028681|NCT00168805|54687222|FG001|Overall Study|Lost to Follow-up|17|||
28028682|NCT00168805|54687223|FG002|Overall Study|Lost to Follow-up|11|||
27804023|NCT01448824|54259032|FG007|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1|||
27804024|NCT01448824|54259025|FG000|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
27804025|NCT01448824|54259026|FG001|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
27804026|NCT01448824|54259027|FG002|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
27804027|NCT01448824|54259028|FG003|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
27804028|NCT01448824|54259029|FG004|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
27804029|NCT01448824|54259030|FG005|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
27804030|NCT01448824|54259031|FG006|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
27804031|NCT01448824|54259032|FG007|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1|||
27804032|NCT01448824|54259025|FG000|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
27804033|NCT01448824|54259026|FG001|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
27804034|NCT01448824|54259027|FG002|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
27804035|NCT01448824|54259028|FG003|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
27804036|NCT01448824|54259029|FG004|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
27804037|NCT01448824|54259030|FG005|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
27804038|NCT01448824|54259031|FG006|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
27804039|NCT01448824|54259032|FG007|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1|||
27804040|NCT02005562|54259062|FG000|Overall Study|Death|2|||
28028683|NCT00168805|54687221|FG000|Overall Study|Withdrawal by Subject|16|||
28028684|NCT00168805|54687222|FG001|Overall Study|Withdrawal by Subject|18|||
28028685|NCT00168805|54687223|FG002|Overall Study|Withdrawal by Subject|21|||
28028686|NCT00168805|54687221|FG000|Overall Study|Other|24|||
28028687|NCT00168805|54687222|FG001|Overall Study|Other|21|||
28028688|NCT00168805|54687223|FG002|Overall Study|Other|22|||
28028689|NCT00168805|54687221|FG000|Treatment|Adverse Event|25|||
28028690|NCT00168805|54687222|FG001|Treatment|Adverse Event|26|||
28028691|NCT00168805|54687223|FG002|Treatment|Adverse Event|32|||
28028692|NCT00168805|54687221|FG000|Treatment|Protocol Violation|3|||
28028693|NCT00168805|54687222|FG001|Treatment|Protocol Violation|5|||
28028694|NCT00168805|54687223|FG002|Treatment|Protocol Violation|5|||
28028695|NCT00168805|54687221|FG000|Treatment|Withdrawal by Subject|3|||
28028696|NCT00168805|54687222|FG001|Treatment|Withdrawal by Subject|7|||
28028697|NCT00168805|54687223|FG002|Treatment|Withdrawal by Subject|8|||
28028698|NCT00168805|54687221|FG000|Treatment|Other|18|||
28028699|NCT00168805|54687222|FG001|Treatment|Other|18|||
28028700|NCT00168805|54687223|FG002|Treatment|Other|17|||
28028701|NCT00467584|54687234|FG000|Overall Study|Withdrawal by Subject|4|||
28028702|NCT00467584|54687235|FG001|Overall Study|Withdrawal by Subject|5|||
28028703|NCT00467584|54687236|FG002|Overall Study|Withdrawal by Subject|1|||
28028704|NCT03839212|54687244|FG000|Overall Study|COVID-19 related suspension of research activities.|4|||
28028705|NCT00168103|54687251|FG000|Overall Study|Withdrawal by Subject|1|||
28028706|NCT00168103|54687252|FG001|Overall Study|Withdrawal by Subject|2|||
28028707|NCT00168103|54687253|FG002|Overall Study|Withdrawal by Subject|1|||
28028708|NCT00168103|54687254|FG003|Overall Study|Withdrawal by Subject|0|||
28028709|NCT00168103|54687251|FG000|Overall Study|Lost to Follow-up|1|||
28028710|NCT00168103|54687252|FG001|Overall Study|Lost to Follow-up|3|||
28028711|NCT00168103|54687253|FG002|Overall Study|Lost to Follow-up|0|||
27804041|NCT02005562|54259063|FG001|Overall Study|Death|2|||
27804042|NCT02005562|54259062|FG000|Overall Study|Graft loss|7|||
27804043|NCT02005562|54259063|FG001|Overall Study|Graft loss|6|||
27804044|NCT02005562|54259062|FG000|Overall Study|Withdrawal by Subject|2|||
27804045|NCT02005562|54259063|FG001|Overall Study|Withdrawal by Subject|2|||
27804046|NCT02005562|54259062|FG000|Overall Study|No transplant|1|||
27804047|NCT02005562|54259063|FG001|Overall Study|No transplant|4|||
27804048|NCT02005562|54259062|FG000|Overall Study|Physician Decision|0|||
27804049|NCT02005562|54259063|FG001|Overall Study|Physician Decision|1|||
27804050|NCT01448044|54259071|FG000|Treatment Period|Adverse Event|4|||
27804051|NCT01448044|54259072|FG001|Treatment Period|Adverse Event|3|||
27804052|NCT01448044|54259071|FG000|Treatment Period|Lack of Efficacy|5|||
27804053|NCT01448044|54259072|FG001|Treatment Period|Lack of Efficacy|12|||
27804054|NCT01448044|54259071|FG000|Treatment Period|Subject requested discontinue study drug|1|||
27804055|NCT01448044|54259072|FG001|Treatment Period|Subject requested discontinue study drug|0|||
27804056|NCT01448044|54259071|FG000|Treatment Period|Completed 24 weeks treatment period only|8|||
27804057|NCT01448044|54259072|FG001|Treatment Period|Completed 24 weeks treatment period only|0|||
27804058|NCT01448044|54259071|FG000|Treatment Period|Participant does not meet study criteria|1|||
27804059|NCT01448044|54259072|FG001|Treatment Period|Participant does not meet study criteria|0|||
27804060|NCT01448044|54259071|FG000|Treatment Period|Lost to Follow-up|2|||
27804061|NCT01448044|54259072|FG001|Treatment Period|Lost to Follow-up|1|||
27804062|NCT01448044|54259071|FG000|Treatment Period|Other reason|2|||
27804063|NCT01448044|54259072|FG001|Treatment Period|Other reason|0|||
27804064|NCT01448044|54259071|FG000|Follow Up Period|Withdrawal by Subject|1|||
27804065|NCT01448044|54259072|FG001|Follow Up Period|Withdrawal by Subject|1|||
27939430|NCT00948922|54595665|FG001|Overall Study|Withdrawal by Subject|2|||
27939431|NCT00948922|54595666|FG002|Overall Study|Withdrawal by Subject|1|||
28028712|NCT00168103|54687254|FG003|Overall Study|Lost to Follow-up|0|||
27939432|NCT00948922|54595664|FG000|Overall Study|Death|3|||
27804066|NCT01448044|54259071|FG000|Follow Up Period|Lost to Follow-up|6|||
27842931|NCT01440569|54331894|FG001|Main Study|Pregnancy|0|||
27804067|NCT01448044|54259072|FG001|Follow Up Period|Lost to Follow-up|2|||
27804068|NCT01448044|54259071|FG000|Follow Up Period|Other|5|||
27842932|NCT01440569|54331893|FG000|Main Study|Investigator's Discretion|1|||
27804069|NCT01448044|54259072|FG001|Follow Up Period|Other|11|||
27804070|NCT02025530|54259080|FG000|Overall Study|No longer met elligibility criteria|5|||
27804071|NCT02025530|54259081|FG001|Overall Study|No longer met elligibility criteria|1|||
27804072|NCT01472380|54259087|FG000|Efavirenz Alone|Withdrawal by Subject|1|||
27804073|NCT01472380|54259087|FG000|1 Day Period Between Dosing|Protocol Violation|1|||
27804074|NCT01978262|54259094|FG000|Overall Study|Withdrawal by Subject|9|||
27804075|NCT01978262|54259094|FG000|Overall Study|Lost to Follow-up|2|||
27842933|NCT01440569|54331894|FG001|Main Study|Investigator's Discretion|1|||
27842934|NCT01440569|54331893|FG000|Main Study|Withdrew Consent|7|||
27804076|NCT01447576|54259099|FG000|Overall Study|Lost to Follow-up|52|||
27804077|NCT01447576|54259099|FG000|Overall Study|Adverse Event|127|||
27804078|NCT01447576|54259099|FG000|Overall Study|Participant met withdrawal criteria|40|||
27804079|NCT01447576|54259099|FG000|Overall Study|Withdrawal by Subject|100|||
27804080|NCT01447576|54259099|FG000|Overall Study|Protocol deviation|83|||
27804081|NCT01447576|54259099|FG000|Overall Study|Lack of Efficacy|68|||
27804082|NCT01447576|54259099|FG000|Overall Study|Physician Decision|6|||
27804083|NCT01447420|54259106|FG000|Overall Study|Adverse Event|2|||
27804084|NCT01447420|54259107|FG001|Overall Study|Adverse Event|4|||
27804085|NCT01447420|54259108|FG002|Overall Study|Adverse Event|2|||
27804086|NCT01447420|54259106|FG000|Overall Study|Protocol Violation|3|||
27804087|NCT01447420|54259107|FG001|Overall Study|Protocol Violation|3|||
27804088|NCT01447420|54259108|FG002|Overall Study|Protocol Violation|0|||
27842935|NCT01440569|54331894|FG001|Main Study|Withdrew Consent|1|||
27939433|NCT00948922|54595665|FG001|Overall Study|Death|0|||
27804089|NCT01447420|54259106|FG000|Overall Study|Withdrawal by Subject|4|||
27804090|NCT01447420|54259107|FG001|Overall Study|Withdrawal by Subject|1|||
27842936|NCT01440569|54331893|FG000|Main Study|Lost to Follow-up|13|||
27804091|NCT01447420|54259108|FG002|Overall Study|Withdrawal by Subject|0|||
27804092|NCT01447420|54259106|FG000|Overall Study|Lack of Efficacy|1|||
27804093|NCT01447420|54259107|FG001|Overall Study|Lack of Efficacy|19|||
27804094|NCT01447420|54259108|FG002|Overall Study|Lack of Efficacy|8|||
27804095|NCT01446874|54259118|FG000|Overall Study|Not eligible|1|||
27804096|NCT01446874|54259119|FG001|Overall Study|Not eligible|0|||
27804097|NCT01446874|54259120|FG002|Overall Study|Not eligible|0|||
27804098|NCT01446874|54259118|FG000|Overall Study|No surgery/No qualifying surgery|1|||
27804099|NCT01446874|54259119|FG001|Overall Study|No surgery/No qualifying surgery|0|||
27804100|NCT01446874|54259120|FG002|Overall Study|No surgery/No qualifying surgery|12|||
27804101|NCT01446874|54259118|FG000|Overall Study|Non-compliance|0|||
27804102|NCT01446874|54259119|FG001|Overall Study|Non-compliance|4|||
27804103|NCT01446874|54259120|FG002|Overall Study|Non-compliance|0|||
27804104|NCT01446874|54259118|FG000|Overall Study|Antibiotics for pre-op infection|0|||
27804105|NCT01446874|54259119|FG001|Overall Study|Antibiotics for pre-op infection|0|||
27804106|NCT01446874|54259120|FG002|Overall Study|Antibiotics for pre-op infection|2|||
27804107|NCT01446874|54259118|FG000|Overall Study|Withdrawal by Subject|0|||
27804108|NCT01446874|54259119|FG001|Overall Study|Withdrawal by Subject|0|||
27804109|NCT01446874|54259120|FG002|Overall Study|Withdrawal by Subject|4|||
27804110|NCT01446796|54259128|FG000|Overall Study|Withdrawal by Subject|1|||
27804111|NCT01446796|54259129|FG001|Overall Study|Withdrawal by Subject|0|||
27804112|NCT01439074|54259139|FG000|Overall Study|Lost to Follow-up|3|||
27804113|NCT01439074|54259140|FG001|Overall Study|Lost to Follow-up|4|||
27804114|NCT01439074|54259139|FG000|Overall Study|Subject shedding|1|||
27804115|NCT01439074|54259140|FG001|Overall Study|Subject shedding|0|||
27804116|NCT01439074|54259139|FG000|Overall Study|Withdrawal by Subject|1|||
27804117|NCT01439074|54259140|FG001|Overall Study|Withdrawal by Subject|5|||
27804118|NCT01439074|54259139|FG000|Overall Study|Other|4|||
27804119|NCT01439074|54259140|FG001|Overall Study|Other|4|||
27804120|NCT01438996|54259149|FG000|Overall Study|Not meeting Inclusion Criteria|4|||
27804121|NCT01438996|54259150|FG001|Overall Study|Not meeting Inclusion Criteria|1|||
27804122|NCT01438996|54259151|FG002|Overall Study|Not meeting Inclusion Criteria|0|||
27804123|NCT01438840|54259161|FG000|Core Study|Adverse Event|0|||
27804124|NCT01438840|54259162|FG001|Core Study|Adverse Event|3|||
27804125|NCT01438840|54259163|FG002|Core Study|Adverse Event|0|||
27804126|NCT01438840|54259161|FG000|Core Study|Lack of Efficacy|15|||
27804127|NCT01438840|54259162|FG001|Core Study|Lack of Efficacy|7|||
27804128|NCT01438840|54259163|FG002|Core Study|Lack of Efficacy|0|||
27804129|NCT01438840|54259161|FG000|Core Study|Withdrawal of consent|1|||
27804130|NCT01438840|54259162|FG001|Core Study|Withdrawal of consent|0|||
27804131|NCT01438840|54259163|FG002|Core Study|Withdrawal of consent|0|||
27804132|NCT01438840|54259161|FG000|Extension Phase|Adverse Event|0|||
27804133|NCT01438840|54259162|FG001|Extension Phase|Adverse Event|0|||
27804134|NCT01438840|54259163|FG002|Extension Phase|Adverse Event|3|||
27804135|NCT01438840|54259161|FG000|Extension Phase|Lost to Follow-up|0|||
27804136|NCT01438840|54259162|FG001|Extension Phase|Lost to Follow-up|0|||
27804137|NCT01438840|54259163|FG002|Extension Phase|Lost to Follow-up|1|||
27804138|NCT01438840|54259161|FG000|Extension Phase|Withdrawal by Subject|0|||
27804139|NCT01438840|54259162|FG001|Extension Phase|Withdrawal by Subject|0|||
27804140|NCT01438840|54259163|FG002|Extension Phase|Withdrawal by Subject|3|||
27842937|NCT01440569|54331894|FG001|Main Study|Lost to Follow-up|2|||
27804141|NCT01438840|54259161|FG000|Extension Phase|Lack of Efficacy|0|||
27939434|NCT00948922|54595666|FG002|Overall Study|Death|0|||
27804142|NCT01438840|54259162|FG001|Extension Phase|Lack of Efficacy|0|||
27804143|NCT01438840|54259163|FG002|Extension Phase|Lack of Efficacy|2|||
27939435|NCT00948922|54595664|FG000|Overall Study|Disease progression|0|||
27804144|NCT01438840|54259161|FG000|Extension Phase|Other|0|||
27804145|NCT01438840|54259162|FG001|Extension Phase|Other|0|||
27804146|NCT01438840|54259163|FG002|Extension Phase|Other|1|||
27804147|NCT01471054|54259172|FG000|Overall Study|Study terminated prematurely|4|||
27804148|NCT01471054|54259173|FG001|Overall Study|Study terminated prematurely|0|||
27804149|NCT01978184|54259191|FG000|Overall Study|Progressive disease|5|||
27804150|NCT01978184|54259192|FG001|Overall Study|Progressive disease|5|||
27804151|NCT01978184|54259191|FG000|Overall Study|Other than PDA|2|||
27842938|NCT01440569|54331893|FG000|Main Study|Subject Non-Compliance|3|||
27842939|NCT01440569|54331894|FG001|Main Study|Subject Non-Compliance|0|||
27842940|NCT01440569|54331893|FG000|Main Study|Protocol Violation|1|||
28028713|NCT00463060|54687264|FG000|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5|||
27804152|NCT01978184|54259192|FG001|Overall Study|Other than PDA|2|||
27804153|NCT01978184|54259191|FG000|Overall Study|Physician Decision|0|||
27804154|NCT01978184|54259192|FG001|Overall Study|Physician Decision|3|||
27804155|NCT01978184|54259191|FG000|Overall Study|Noncompliance|1|||
27804156|NCT01978184|54259192|FG001|Overall Study|Noncompliance|2|||
27804157|NCT01978184|54259191|FG000|Overall Study|Death|1|||
27804158|NCT01978184|54259192|FG001|Overall Study|Death|0|||
27804159|NCT01978184|54259191|FG000|Overall Study|Withdrew- toxicities or physical decline|4|||
27804160|NCT01978184|54259192|FG001|Overall Study|Withdrew- toxicities or physical decline|8|||
27804161|NCT01445548|54259198|FG000|Overall Study|Adverse Event|1|||
27804162|NCT01977794|54259204|FG000|Overall Study|Adverse Event|2|||
27804163|NCT01977794|54259205|FG001|Overall Study|Adverse Event|2|||
27804164|NCT01977794|54259204|FG000|Overall Study|Lost to Follow-up|2|||
27804165|NCT01977794|54259205|FG001|Overall Study|Lost to Follow-up|1|||
27804166|NCT01977794|54259204|FG000|Overall Study|Protocol Violation|1|||
27804167|NCT01977794|54259205|FG001|Overall Study|Protocol Violation|0|||
27804168|NCT01977794|54259204|FG000|Overall Study|Death|1|||
27939436|NCT00948922|54595665|FG001|Overall Study|Disease progression|1|||
27804169|NCT01977794|54259205|FG001|Overall Study|Death|1|||
27804170|NCT01977794|54259204|FG000|Overall Study|Withdrew consent|2|||
27804171|NCT01977794|54259205|FG001|Overall Study|Withdrew consent|1|||
27804172|NCT01977794|54259204|FG000|Overall Study|Other|0|||
27804173|NCT01977794|54259205|FG001|Overall Study|Other|1|||
27804174|NCT02005484|54259211|FG000|Overall Study|Death|1|||
27804175|NCT02005484|54259211|FG000|Overall Study|Disease progression|1|||
27804176|NCT02005484|54259211|FG000|Overall Study|Changed to a Different Study|1|||
27842941|NCT01440569|54331894|FG001|Main Study|Protocol Violation|0|||
27842942|NCT01440569|54331893|FG000|Open-Label Rollover Phase|Adverse Event|3|||
27939437|NCT00948922|54595666|FG002|Overall Study|Disease progression|0|||
27939438|NCT00948922|54595664|FG000|Overall Study|Insurance issues|1|||
27804177|NCT02005484|54259211|FG000|Overall Study|Sponsor decision|1|||
27804178|NCT02005250|54259217|FG000|Overall Study|Lost to Follow-up|15|||
27804179|NCT02005250|54259218|FG001|Overall Study|Lost to Follow-up|5|||
27804180|NCT02024750|54259226|FG000|Overall Study|Withdrawal by Subject|2|||
27804181|NCT02024750|54259227|FG001|Overall Study|Withdrawal by Subject|1|||
27804182|NCT01597973|54259235|FG000|Overall Study|Found ineligible before study medication started|4|||
27804183|NCT01597973|54259236|FG001|Overall Study|Found ineligible before study medication started|2|||
27804184|NCT01597973|54259235|FG000|Overall Study|Eligible pathogen not confirmed|14|||
27804185|NCT01597973|54259236|FG001|Overall Study|Eligible pathogen not confirmed|15|||
27804186|NCT01597973|54259235|FG000|Overall Study|LAR not authorized to consent|0|||
27804187|NCT01597973|54259236|FG001|Overall Study|LAR not authorized to consent|1|||
27804188|NCT01597973|54259235|FG000|Overall Study|Ineligible due to early seizures|1|||
27804189|NCT01597973|54259236|FG001|Overall Study|Ineligible due to early seizures|0|||
27804190|NCT01597973|54259235|FG000|Overall Study|Ineligible due to non-target infection|1|||
27804191|NCT01597973|54259236|FG001|Overall Study|Ineligible due to non-target infection|1|||
27804192|NCT02023268|54259246|FG000|Overall Study|Lack of Efficacy|0|||
27804193|NCT02023268|54259247|FG001|Overall Study|Lack of Efficacy|1|||
27804194|NCT02023268|54259246|FG000|Overall Study|Adverse Event|0|||
27804195|NCT02023268|54259247|FG001|Overall Study|Adverse Event|2|||
27804196|NCT02023268|54259246|FG000|Overall Study|Withdrawal by Subject|0|||
27804197|NCT02023268|54259247|FG001|Overall Study|Withdrawal by Subject|1|||
27804198|NCT02047253|54259253|FG000|Overall Study|Lost to Follow-up|8|||
27804199|NCT02096705|54259259|FG000|Treatment|Adverse Event|6|||
27804200|NCT02096705|54259260|FG001|Treatment|Adverse Event|3|||
27804201|NCT02096705|54259259|FG000|Treatment|Subject request to discontinue treatment|1|||
27804202|NCT02096705|54259260|FG001|Treatment|Subject request to discontinue treatment|1|||
27804203|NCT02096705|54259259|FG000|Treatment|Withdrawal by Subject|1|||
27804204|NCT02096705|54259260|FG001|Treatment|Withdrawal by Subject|0|||
27804205|NCT02096705|54259259|FG000|Treatment|Other|1|||
27804206|NCT02096705|54259260|FG001|Treatment|Other|1|||
27804207|NCT02096705|54259259|FG000|Follow-up|Withdrawal by Subject|1|||
27804208|NCT02096705|54259260|FG001|Follow-up|Withdrawal by Subject|0|||
27804209|NCT02096705|54259259|FG000|Follow-up|Adverse Event|2|||
27804210|NCT02096705|54259260|FG001|Follow-up|Adverse Event|2|||
27804211|NCT02096705|54259259|FG000|Follow-up|Subjects not reporting status|1|||
28028714|NCT00463060|54687264|FG000|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1|||
28028715|NCT00462982|54687273|FG000|Overall Study|Adverse Event|1|||
27804212|NCT02096705|54259260|FG001|Follow-up|Subjects not reporting status|2|||
27804213|NCT02096471|54259266|FG000|Overall Study|Adverse Event|1|||
28028716|NCT00462982|54687273|FG000|Overall Study|Patient Not Treated|2|||
28028717|NCT00462904|54687294|FG000|Overall Study|Lost to Follow-up|1|||
28028718|NCT00467272|54687298|FG000|Overall Study|Pneumonia|2|||
28028719|NCT00467272|54687298|FG000|Overall Study|Thrombophlebitis|1|||
27939439|NCT00948922|54595665|FG001|Overall Study|Insurance issues|0|||
27939440|NCT00948922|54595666|FG002|Overall Study|Insurance issues|0|||
27939441|NCT00948922|54595664|FG000|Overall Study|Transplant eligibility issues|2|||
27939442|NCT00948922|54595665|FG001|Overall Study|Transplant eligibility issues|3|||
27939443|NCT00948922|54595666|FG002|Overall Study|Transplant eligibility issues|0|||
27939444|NCT00948922|54595664|FG000|Overall Study|Not evaluable at time of analysis|0|||
27939445|NCT00948922|54595665|FG001|Overall Study|Not evaluable at time of analysis|3|||
27939446|NCT00948922|54595666|FG002|Overall Study|Not evaluable at time of analysis|0|||
27939447|NCT01239992|54595678|FG000|Overall Study|Withdrawal by Subject|2|||
27939448|NCT01072539|54595682|FG000|Overall Study|Treated prior to the Site Initiation|1|||
27939449|NCT01072539|54595682|FG000|Overall Study|Protocol Violation|2|||
27939450|NCT01239680|54595688|FG000|Overall Study|Withdrawal by Subject|2|||
27939451|NCT01239680|54595689|FG001|Overall Study|Withdrawal by Subject|0|||
27939452|NCT01238900|54595695|FG000|<12 Months Post Stent Removal|Lost to Follow-up|4|||
27939453|NCT01238900|54595695|FG000|<12 Months Post Stent Removal|persistent stricture after stenting|1|||
27939454|NCT01238822|54595700|FG000|Overall Study|COULD NOT SWALLOW PILLS|3|||
27939455|NCT01238588|54595710|FG000|Overall Study|Withdrawal by Subject|1|||
27939456|NCT01238588|54595710|FG000|Overall Study|Physician Decision|2|||
27939457|NCT01047501|54595717|FG000|Overall Study|Adverse Event|7|||
27939458|NCT01047501|54595718|FG001|Overall Study|Adverse Event|8|||
27939459|NCT01047501|54595719|FG002|Overall Study|Adverse Event|5|||
27939460|NCT01047501|54595717|FG000|Overall Study|Withdrew Consent|6|||
27939461|NCT01047501|54595718|FG001|Overall Study|Withdrew Consent|2|||
27939462|NCT01047501|54595719|FG002|Overall Study|Withdrew Consent|4|||
27939463|NCT01047501|54595717|FG000|Overall Study|Lost to Follow-up|0|||
27939464|NCT01047501|54595718|FG001|Overall Study|Lost to Follow-up|1|||
27939465|NCT01047501|54595719|FG002|Overall Study|Lost to Follow-up|1|||
27939466|NCT01047501|54595717|FG000|Overall Study|Triglycerides >800 mg/dL|1|||
27939467|NCT01047501|54595718|FG001|Overall Study|Triglycerides >800 mg/dL|0|||
27939468|NCT01047501|54595719|FG002|Overall Study|Triglycerides >800 mg/dL|0|||
27939469|NCT01047501|54595717|FG000|Overall Study|Death|1|||
27939470|NCT01047501|54595718|FG001|Overall Study|Death|0|||
27939471|NCT01047501|54595719|FG002|Overall Study|Death|0|||
27939472|NCT01047501|54595717|FG000|Overall Study|Other discontinuation|1|||
27939473|NCT01047501|54595718|FG001|Overall Study|Other discontinuation|0|||
27939474|NCT01047501|54595719|FG002|Overall Study|Other discontinuation|1|||
27939475|NCT01047501|54595717|FG000|Overall Study|Investigator judgement|0|||
27939476|NCT01047501|54595718|FG001|Overall Study|Investigator judgement|0|||
27939477|NCT01047501|54595719|FG002|Overall Study|Investigator judgement|1|||
27939478|NCT01238120|54595731|FG000|Overall Study|Withdrawal by Subject|4|||
27939479|NCT01238120|54595732|FG001|Overall Study|Withdrawal by Subject|1|||
27939480|NCT01238120|54595733|FG002|Overall Study|Withdrawal by Subject|2|||
27939481|NCT01238120|54595734|FG003|Overall Study|Withdrawal by Subject|5|||
27939482|NCT01238120|54595731|FG000|Overall Study|Lost to Follow-up|2|||
28028720|NCT00462826|54687302|FG000|Overall Study|Ineligible - second primary|1|||
28028721|NCT00462826|54687302|FG000|Overall Study|Ineligible - wrong cell type|1|||
28028722|NCT00462826|54687302|FG000|Overall Study|Ineligible - wrong primary|2|||
27804214|NCT02096471|54259266|FG000|Overall Study|Lack of Efficacy|7|||
27804215|NCT02096471|54259266|FG000|Overall Study|Withdrawal by Subject|3|||
27804216|NCT02096471|54259266|FG000|Overall Study|Non-Compliant|2|||
27804217|NCT02096003|54259272|FG000|Overall Study|Protocol Violation|0|||
27804218|NCT02096003|54259273|FG001|Overall Study|Protocol Violation|2|||
27804219|NCT02096003|54259272|FG000|Overall Study|additional surgery|2|||
27804220|NCT02096003|54259273|FG001|Overall Study|additional surgery|1|||
27804221|NCT02062385|54259283|FG000|Overall Study|Adverse Event|19|||
27804222|NCT02062385|54259284|FG001|Overall Study|Adverse Event|13|||
27804223|NCT02062385|54259285|FG002|Overall Study|Adverse Event|1|||
27804224|NCT02062385|54259286|FG003|Overall Study|Adverse Event|0|||
27804225|NCT02062385|54259283|FG000|Overall Study|Protocol Violation|1|||
27804226|NCT02062385|54259284|FG001|Overall Study|Protocol Violation|0|||
27804227|NCT02062385|54259285|FG002|Overall Study|Protocol Violation|0|||
27804228|NCT02062385|54259286|FG003|Overall Study|Protocol Violation|0|||
27804229|NCT02062385|54259283|FG000|Overall Study|Incomplete EPI by database lock|2|||
27804230|NCT02062385|54259284|FG001|Overall Study|Incomplete EPI by database lock|0|||
27804231|NCT02062385|54259285|FG002|Overall Study|Incomplete EPI by database lock|0|||
27804232|NCT02062385|54259286|FG003|Overall Study|Incomplete EPI by database lock|0|||
27804233|NCT02062385|54259283|FG000|Overall Study|Moved|10|||
27804234|NCT02062385|54259284|FG001|Overall Study|Moved|11|||
27804235|NCT02062385|54259285|FG002|Overall Study|Moved|1|||
27804236|NCT02062385|54259286|FG003|Overall Study|Moved|0|||
27804237|NCT02062385|54259283|FG000|Overall Study|Withdrawn by parent/guardian|46|||
27804238|NCT02062385|54259284|FG001|Overall Study|Withdrawn by parent/guardian|41|||
27804239|NCT02062385|54259285|FG002|Overall Study|Withdrawn by parent/guardian|9|||
27804240|NCT02062385|54259286|FG003|Overall Study|Withdrawn by parent/guardian|8|||
27804241|NCT02062385|54259283|FG000|Overall Study|Death|0|||
27804242|NCT02062385|54259284|FG001|Overall Study|Death|0|||
27804243|NCT02062385|54259285|FG002|Overall Study|Death|0|||
27804244|NCT02062385|54259286|FG003|Overall Study|Death|1|||
27804245|NCT02062385|54259283|FG000|Overall Study|Lost to Follow-up|0|||
27804246|NCT02062385|54259284|FG001|Overall Study|Lost to Follow-up|0|||
27804247|NCT02062385|54259285|FG002|Overall Study|Lost to Follow-up|1|||
27804248|NCT02062385|54259286|FG003|Overall Study|Lost to Follow-up|0|||
27804249|NCT02062151|54259294|FG000|Overall Study|screen failure|1|||
27804250|NCT02060903|54259300|FG000|Overall Study|Lost to Follow-up|4|||
27804251|NCT02060903|54259301|FG001|Overall Study|Lost to Follow-up|0|||
27804252|NCT02060903|54259300|FG000|Overall Study|Withdrawal by Subject|0|||
27804253|NCT02060903|54259301|FG001|Overall Study|Withdrawal by Subject|7|||
27804254|NCT02095691|54259307|FG000|Overall Study|Physician Decision|1|||
27804255|NCT02095535|54259323|FG000|Recruitment|Protocol Violation|2|||
27804256|NCT02095223|54259329|FG000|Overall Study|Withdrawal by Subject|1|||
27804257|NCT02095223|54259330|FG001|Overall Study|Withdrawal by Subject|0|||
27804258|NCT02095145|54259338|FG000|Overall Study|Withdrawal by Subject|1|||
27804259|NCT02095145|54259339|FG001|Overall Study|Withdrawal by Subject|0|||
27804260|NCT02059187|54259349|FG000|Overall Study|Adverse Event|0|||
27804261|NCT02059187|54259350|FG001|Overall Study|Adverse Event|3|||
27804262|NCT02059187|54259349|FG000|Overall Study|Death|1|||
27804263|NCT02059187|54259350|FG001|Overall Study|Death|1|||
27804264|NCT02059187|54259349|FG000|Overall Study|Lost to Follow-up|9|||
27804265|NCT02059187|54259350|FG001|Overall Study|Lost to Follow-up|8|||
27804266|NCT02059187|54259349|FG000|Overall Study|Non-compliance with study drug|1|||
27804267|NCT02059187|54259350|FG001|Overall Study|Non-compliance with study drug|0|||
27804268|NCT02059187|54259349|FG000|Overall Study|Physician Decision|1|||
27804269|NCT02059187|54259350|FG001|Overall Study|Physician Decision|2|||
27804270|NCT02059187|54259349|FG000|Overall Study|Protocol Violation|1|||
27804271|NCT02059187|54259350|FG001|Overall Study|Protocol Violation|0|||
27939483|NCT01238120|54595732|FG001|Overall Study|Lost to Follow-up|0|||
27939484|NCT01238120|54595733|FG002|Overall Study|Lost to Follow-up|1|||
27939485|NCT01238120|54595734|FG003|Overall Study|Lost to Follow-up|1|||
27939486|NCT01238120|54595731|FG000|Overall Study|Withdrawn due to Medical Problem|2|||
27939487|NCT01238120|54595732|FG001|Overall Study|Withdrawn due to Medical Problem|0|||
27939488|NCT01238120|54595733|FG002|Overall Study|Withdrawn due to Medical Problem|1|||
27939489|NCT01238120|54595734|FG003|Overall Study|Withdrawn due to Medical Problem|0|||
27939490|NCT01237340|54595744|FG000|Overall Study|Adverse Event|3|||
27804272|NCT02059187|54259349|FG000|Overall Study|Withdrawal by Subject|12|||
27804273|NCT02059187|54259350|FG001|Overall Study|Withdrawal by Subject|8|||
27804274|NCT02043899|54259356|FG000|Overall Study|Adverse Event|3|||
27804275|NCT02043899|54259356|FG000|Overall Study|Physician Decision|1|||
27804276|NCT02043899|54259356|FG000|Overall Study|Withdrawal by Subject|2|||
27804277|NCT02043899|54259356|FG000|Overall Study|Failure to meet the clinical criteria for [124I]mIBG imaging|5|||
27804278|NCT02043899|54259356|FG000|Overall Study|Technical manufacturing issue or logistical difficulties of [123I]mIBG or [124I]mIBG supply|12|||
27804279|NCT02043899|54259356|FG000|Overall Study|Temporary halt due to out of specification radioactivity|2|||
27804280|NCT02043899|54259356|FG000|Overall Study|Clinical progression necessitating urgent treatment|1|||
27939491|NCT01237340|54595744|FG000|Overall Study|Withdrawal by Subject|1|||
27939492|NCT01237340|54595744|FG000|Overall Study|Early termination of the trial|36|||
27804281|NCT02043899|54259356|FG000|Overall Study|Treatment delayed|1|||
27804282|NCT02043509|54259362|FG000|Baseline to 1st Follow-up|Lost to Follow-up|61|||
27804283|NCT02043509|54259363|FG001|Baseline to 1st Follow-up|Lost to Follow-up|47|||
27804284|NCT02043509|54259362|FG000|Baseline to 1st Follow-up|Withdrawal by Subject|4|||
27804285|NCT02043509|54259363|FG001|Baseline to 1st Follow-up|Withdrawal by Subject|0|||
27804286|NCT02043509|54259362|FG000|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
27804287|NCT02043509|54259363|FG001|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
27804288|NCT02043509|54259362|FG000|Baseline to 2nd Follow-up|Withdrawal by Subject|7|||
27804289|NCT02043509|54259363|FG001|Baseline to 2nd Follow-up|Withdrawal by Subject|5|||
27804290|NCT02058563|54259371|FG000|Overall Study|Lost to Follow-up|26|||
27804291|NCT02058563|54259372|FG001|Overall Study|Lost to Follow-up|22|||
27804292|NCT02058563|54259371|FG000|Overall Study|Other (vaccinated later as new subject)|1|||
27804293|NCT02058563|54259372|FG001|Overall Study|Other (vaccinated later as new subject)|0|||
27804294|NCT02058563|54259371|FG000|Overall Study|Consent Withdrawal|1|||
27804295|NCT02058563|54259372|FG001|Overall Study|Consent Withdrawal|1|||
27804296|NCT02058563|54259371|FG000|Overall Study|Other (patient incarcerated)|0|||
27939493|NCT01045707|54595753|FG000|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5|||
28028723|NCT00462826|54687302|FG000|Overall Study|Never treated|1|||
28028724|NCT00551616|54687314|FG000|Overall Study|Lost to Follow-up|48|||
28028725|NCT00551616|54687315|FG001|Overall Study|Lost to Follow-up|40|||
28028726|NCT00452530|54687323|FG000|Overall Study|Death|1|||
28028727|NCT00452530|54687324|FG001|Overall Study|Death|0|||
28028728|NCT00452530|54687323|FG000|Overall Study|Adverse Event|40|||
28028729|NCT00452530|54687324|FG001|Overall Study|Adverse Event|44|||
28028730|NCT00452530|54687323|FG000|Overall Study|Withdrawal by Subject|68|||
28028731|NCT00452530|54687324|FG001|Overall Study|Withdrawal by Subject|57|||
28028732|NCT00452530|54687323|FG000|Overall Study|Lost to Follow-up|1|||
28028733|NCT00452530|54687324|FG001|Overall Study|Lost to Follow-up|0|||
28028734|NCT00452530|54687323|FG000|Overall Study|Poor compliance/noncompliance|1|||
28028735|NCT00452530|54687324|FG001|Overall Study|Poor compliance/noncompliance|2|||
28028736|NCT00452530|54687323|FG000|Overall Study|No longer met study criteria|18|||
28028737|NCT00452530|54687324|FG001|Overall Study|No longer met study criteria|22|||
28028738|NCT00452530|54687323|FG000|Overall Study|Other|7|||
28028739|NCT00452530|54687324|FG001|Overall Study|Other|11|||
28028740|NCT00549198|54687336|FG000|Overall Study|Adverse Event|28|||
28028741|NCT00549198|54687337|FG001|Overall Study|Adverse Event|26|||
28028742|NCT00549198|54687336|FG000|Overall Study|Insufficient Viral Load Response|4|||
28028743|NCT00549198|54687337|FG001|Overall Study|Insufficient Viral Load Response|2|||
28028744|NCT00549198|54687336|FG000|Overall Study|Protocol-defined Virological Failure|7|||
28028745|NCT00549198|54687337|FG001|Overall Study|Protocol-defined Virological Failure|0|||
28028746|NCT00549198|54687336|FG000|Overall Study|Non-compliance|2|||
28028747|NCT00549198|54687337|FG001|Overall Study|Non-compliance|4|||
28028748|NCT00549198|54687336|FG000|Overall Study|Lost to Follow-up|7|||
28028749|NCT00549198|54687337|FG001|Overall Study|Lost to Follow-up|8|||
28028750|NCT00549198|54687336|FG000|Overall Study|Treatment Eligibility Criteria Not Met|3|||
28028751|NCT00549198|54687337|FG001|Overall Study|Treatment Eligibility Criteria Not Met|0|||
28028752|NCT00549198|54687336|FG000|Overall Study|Protocol Violation|7|||
28028753|NCT00549198|54687337|FG001|Overall Study|Protocol Violation|2|||
28028754|NCT00549198|54687336|FG000|Overall Study|Investigator Decision|4|||
28028755|NCT00549198|54687337|FG001|Overall Study|Investigator Decision|3|||
28028756|NCT00549198|54687336|FG000|Overall Study|Withdrawal by Subject|7|||
28028757|NCT00549198|54687337|FG001|Overall Study|Withdrawal by Subject|7|||
28028758|NCT00549198|54687336|FG000|Overall Study|Disease Progression|1|||
28028759|NCT00549198|54687337|FG001|Overall Study|Disease Progression|0|||
28028760|NCT00549198|54687336|FG000|Overall Study|Participant Moved|2|||
28028761|NCT00549198|54687337|FG001|Overall Study|Participant Moved|0|||
27804297|NCT02058563|54259372|FG001|Overall Study|Other (patient incarcerated)|1|||
27804298|NCT01622231|54259378|FG000|Overall Study|Physician Decision|1|||
27939494|NCT01045707|54595754|FG001|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3|||
27939495|NCT01045707|54595753|FG000|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4|||
27939496|NCT01045707|54595754|FG001|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2|||
27939497|NCT01045707|54595753|FG000|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6|||
27939498|NCT01045707|54595754|FG001|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5|||
27939499|NCT01045707|54595753|FG000|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22|||
27939500|NCT01045707|54595754|FG001|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11|||
27939501|NCT01045707|54595753|FG000|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10|||
28028762|NCT00549198|54687336|FG000|Overall Study|Participant not able to perform Week 96|1|||
28028763|NCT00549198|54687337|FG001|Overall Study|Participant not able to perform Week 96|0|||
28028764|NCT00549198|54687336|FG000|Overall Study|Participant moved.Week 96 visit, no scan|1|||
28028765|NCT00549198|54687337|FG001|Overall Study|Participant moved.Week 96 visit, no scan|0|||
28028766|NCT00549198|54687336|FG000|Overall Study|Prohibited Medication|1|||
28028767|NCT00549198|54687337|FG001|Overall Study|Prohibited Medication|2|||
28028768|NCT00549198|54687336|FG000|Overall Study|Participant planning pregnancy|1|||
28028769|NCT00549198|54687337|FG001|Overall Study|Participant planning pregnancy|0|||
28028770|NCT00549198|54687336|FG000|Overall Study|Participant overweight, no scan possible|1|||
28028771|NCT00549198|54687337|FG001|Overall Study|Participant overweight, no scan possible|0|||
28028772|NCT00549198|54687336|FG000|Overall Study|No scan facilities|0|||
28028773|NCT00549198|54687337|FG001|Overall Study|No scan facilities|2|||
28028774|NCT00549198|54687336|FG000|Overall Study|Pregnancy|0|||
28028775|NCT00549198|54687337|FG001|Overall Study|Pregnancy|3|||
28028776|NCT00549198|54687336|FG000|Overall Study|Not Exposed to Study Drug|3|||
28028777|NCT00549198|54687337|FG001|Overall Study|Not Exposed to Study Drug|4|||
28028778|NCT00607724|54687350|FG000|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7|||
28028779|NCT00607724|54687351|FG001|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8|||
28028780|NCT00607724|54687352|FG002|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4|||
28028781|NCT00607724|54687353|FG003|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
28028782|NCT00607724|54687354|FG004|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
28028783|NCT00607724|54687355|FG005|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
28028784|NCT00607724|54687356|FG006|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
28028785|NCT00607724|54687350|FG000|Stage 2: Expanded Cohort|Adverse Event|0|||
27804299|NCT01622231|54259378|FG000|Overall Study|Withdrawal by Subject|1|||
28028786|NCT00607724|54687351|FG001|Stage 2: Expanded Cohort|Adverse Event|0|||
28028787|NCT00607724|54687352|FG002|Stage 2: Expanded Cohort|Adverse Event|0|||
28028788|NCT00607724|54687353|FG003|Stage 2: Expanded Cohort|Adverse Event|0|||
28028789|NCT00607724|54687354|FG004|Stage 2: Expanded Cohort|Adverse Event|0|||
28028790|NCT00607724|54687355|FG005|Stage 2: Expanded Cohort|Adverse Event|0|||
28028791|NCT00607724|54687356|FG006|Stage 2: Expanded Cohort|Adverse Event|1|||
28028792|NCT00607724|54687350|FG000|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
27804300|NCT02042183|54259384|FG000|Overall Study|Physician Decision|7|||
27804301|NCT02042183|54259385|FG001|Overall Study|Physician Decision|2|||
27804302|NCT02042183|54259384|FG000|Overall Study|Lack of Efficacy|4|||
27804303|NCT02042183|54259385|FG001|Overall Study|Lack of Efficacy|3|||
27804304|NCT02042183|54259384|FG000|Overall Study|Non-compliance with Study Drug|2|||
27804305|NCT02042183|54259385|FG001|Overall Study|Non-compliance with Study Drug|3|||
27804306|NCT02042183|54259384|FG000|Overall Study|Adverse Event|17|||
27804307|NCT02042183|54259385|FG001|Overall Study|Adverse Event|6|||
27804308|NCT02042183|54259384|FG000|Overall Study|Other|3|||
27804309|NCT02042183|54259385|FG001|Overall Study|Other|3|||
27804310|NCT02042183|54259384|FG000|Overall Study|Withdrawal by Subject|21|||
27804311|NCT02042183|54259385|FG001|Overall Study|Withdrawal by Subject|16|||
27804312|NCT02042183|54259384|FG000|Overall Study|Site Terminated by Sponsor|2|||
27804313|NCT02042183|54259385|FG001|Overall Study|Site Terminated by Sponsor|1|||
27804314|NCT02042183|54259384|FG000|Overall Study|Lost to Follow-up|9|||
27804315|NCT02042183|54259385|FG001|Overall Study|Lost to Follow-up|2|||
27804316|NCT01977482|54259399|FG000|Overall Study|Adverse Event|0|||
27804317|NCT01977482|54259400|FG001|Overall Study|Adverse Event|1|||
27804318|NCT01977482|54259401|FG002|Overall Study|Adverse Event|1|||
27804319|NCT01977482|54259402|FG003|Overall Study|Adverse Event|0|||
27804320|NCT01977482|54259403|FG004|Overall Study|Adverse Event|2|||
27804321|NCT01977482|54259404|FG005|Overall Study|Adverse Event|0|||
27804322|NCT01977482|54259399|FG000|Overall Study|Lost to Follow-up|1|||
27804323|NCT01977482|54259400|FG001|Overall Study|Lost to Follow-up|0|||
27804324|NCT01977482|54259401|FG002|Overall Study|Lost to Follow-up|0|||
27804325|NCT01977482|54259402|FG003|Overall Study|Lost to Follow-up|0|||
27804326|NCT01977482|54259403|FG004|Overall Study|Lost to Follow-up|0|||
27804327|NCT01977482|54259404|FG005|Overall Study|Lost to Follow-up|0|||
27804328|NCT01977482|54259399|FG000|Overall Study|Physician Decision|0|||
27804329|NCT01977482|54259400|FG001|Overall Study|Physician Decision|1|||
27804330|NCT01977482|54259401|FG002|Overall Study|Physician Decision|0|||
27804331|NCT01977482|54259402|FG003|Overall Study|Physician Decision|0|||
27804332|NCT01977482|54259403|FG004|Overall Study|Physician Decision|0|||
27804333|NCT01977482|54259404|FG005|Overall Study|Physician Decision|0|||
27804334|NCT01977482|54259399|FG000|Overall Study|Protocol Violation|0|||
27804335|NCT01977482|54259400|FG001|Overall Study|Protocol Violation|0|||
27804336|NCT01977482|54259401|FG002|Overall Study|Protocol Violation|1|||
27804337|NCT01977482|54259402|FG003|Overall Study|Protocol Violation|0|||
27804338|NCT01977482|54259403|FG004|Overall Study|Protocol Violation|0|||
27804339|NCT01977482|54259404|FG005|Overall Study|Protocol Violation|0|||
27804340|NCT01977482|54259399|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
27804341|NCT01977482|54259400|FG001|Overall Study|Other-Protocol-defined Stopping Criteria|3|||
27804342|NCT01977482|54259401|FG002|Overall Study|Other-Protocol-defined Stopping Criteria|2|||
27804343|NCT01977482|54259402|FG003|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
28028793|NCT00607724|54687351|FG001|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
28028794|NCT00607724|54687352|FG002|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
28028795|NCT00607724|54687353|FG003|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4|||
27804344|NCT01977482|54259403|FG004|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
27804345|NCT01977482|54259404|FG005|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
27804346|NCT01977482|54259399|FG000|Overall Study|Withdrawal by Subject|2|||
27804347|NCT01977482|54259400|FG001|Overall Study|Withdrawal by Subject|4|||
27804348|NCT01977482|54259401|FG002|Overall Study|Withdrawal by Subject|1|||
27804349|NCT01977482|54259402|FG003|Overall Study|Withdrawal by Subject|3|||
27804350|NCT01977482|54259403|FG004|Overall Study|Withdrawal by Subject|1|||
27804351|NCT01977482|54259404|FG005|Overall Study|Withdrawal by Subject|5|||
27804352|NCT02058095|54259425|FG000|Overall Study|Adverse Event|1|||
27804353|NCT02058095|54259426|FG001|Overall Study|Adverse Event|0|||
27804354|NCT02023112|54259434|FG000|Overall Study|Withdrawal by Subject|2|||
27804355|NCT02023112|54259435|FG001|Overall Study|Withdrawal by Subject|1|||
27804356|NCT01977092|54259445|FG000|Overall Study|Death|3|||
27804357|NCT01977092|54259446|FG001|Overall Study|Death|4|||
27804358|NCT01977092|54259445|FG000|Overall Study|Lost to Follow-up|23|||
27804359|NCT01977092|54259446|FG001|Overall Study|Lost to Follow-up|14|||
27804360|NCT01977092|54259445|FG000|Overall Study|Withdrawal by Subject|2|||
27804361|NCT01977092|54259446|FG001|Overall Study|Withdrawal by Subject|1|||
27804362|NCT01977092|54259445|FG000|Overall Study|In prison|3|||
27804363|NCT01977092|54259446|FG001|Overall Study|In prison|11|||
27804364|NCT01976624|54259452|FG000|Overall Study|Participants contraindicated|2|||
27804365|NCT01976624|54259452|FG000|Overall Study|Participants age less than 19 years|12|||
27804366|NCT02041091|54259458|FG000|Treatment|Adverse Event|3|||
27804367|NCT02041091|54259459|FG001|Treatment|Adverse Event|3|||
27804368|NCT02041091|54259458|FG000|Treatment|Withdrawal by Subject|2|||
27804369|NCT02041091|54259459|FG001|Treatment|Withdrawal by Subject|4|||
27804370|NCT02041091|54259458|FG000|Treatment|Physician Decision|1|||
27804371|NCT02041091|54259459|FG001|Treatment|Physician Decision|0|||
27804372|NCT02041091|54259458|FG000|Treatment|Sponsor Decision|15|||
27804373|NCT02041091|54259459|FG001|Treatment|Sponsor Decision|16|||
27804374|NCT02041091|54259458|FG000|Treatment|Lost to Follow-up|1|||
27804375|NCT02041091|54259459|FG001|Treatment|Lost to Follow-up|0|||
27804376|NCT02041091|54259458|FG000|Optional Safety Extension Period|Adverse Event|4|||
27804377|NCT02041091|54259459|FG001|Optional Safety Extension Period|Adverse Event|2|||
27804378|NCT02041091|54259458|FG000|Optional Safety Extension Period|Withdrawal by Subject|5|||
27804379|NCT02041091|54259459|FG001|Optional Safety Extension Period|Withdrawal by Subject|2|||
27804380|NCT02041091|54259458|FG000|Optional Safety Extension Period|Protocol Violation|2|||
27804381|NCT02041091|54259459|FG001|Optional Safety Extension Period|Protocol Violation|0|||
27804382|NCT02041091|54259458|FG000|Optional Safety Extension Period|Physician Decision|2|||
27804383|NCT02041091|54259459|FG001|Optional Safety Extension Period|Physician Decision|1|||
27804384|NCT02041091|54259458|FG000|Optional Safety Extension Period|Sponsor Decision|70|||
27804385|NCT02041091|54259459|FG001|Optional Safety Extension Period|Sponsor Decision|74|||
27804386|NCT02041091|54259458|FG000|Optional Safety Extension Period|Lost to Follow-up|2|||
27804387|NCT02041091|54259459|FG001|Optional Safety Extension Period|Lost to Follow-up|3|||
27939502|NCT01045707|54595754|FG001|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11|||
28028796|NCT00607724|54687354|FG004|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8|||
28028797|NCT00607724|54687355|FG005|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11|||
28028798|NCT00607724|54687356|FG006|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10|||
28028799|NCT00607724|54687350|FG000|Stage 2: Expanded Cohort|Physician Decision|0|||
28028800|NCT00607724|54687351|FG001|Stage 2: Expanded Cohort|Physician Decision|0|||
28028801|NCT00607724|54687352|FG002|Stage 2: Expanded Cohort|Physician Decision|0|||
28028802|NCT00607724|54687353|FG003|Stage 2: Expanded Cohort|Physician Decision|0|||
28028803|NCT00607724|54687354|FG004|Stage 2: Expanded Cohort|Physician Decision|1|||
28028804|NCT00607724|54687355|FG005|Stage 2: Expanded Cohort|Physician Decision|1|||
28028805|NCT00607724|54687356|FG006|Stage 2: Expanded Cohort|Physician Decision|0|||
28028806|NCT00607724|54687350|FG000|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
28028807|NCT00607724|54687351|FG001|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
28028808|NCT00607724|54687352|FG002|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
28028809|NCT00607724|54687353|FG003|Stage 2: Expanded Cohort|Withdrawal by Subject|1|||
27804388|NCT02057549|54259473|FG000|Overall Study|Lost to Follow-up|1|||
27804389|NCT02057549|54259474|FG001|Overall Study|Lost to Follow-up|0|||
27804390|NCT02057549|54259473|FG000|Overall Study|Physician Decision|1|||
27939503|NCT01045707|54595753|FG000|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
27804391|NCT02057549|54259474|FG001|Overall Study|Physician Decision|0|||
27804392|NCT02057549|54259473|FG000|Overall Study|Withdrawal by Subject|1|||
27804393|NCT02057549|54259474|FG001|Overall Study|Withdrawal by Subject|0|||
27939504|NCT01045707|54595754|FG001|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
27939505|NCT01045707|54595753|FG000|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2|||
27939506|NCT01045707|54595754|FG001|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3|||
27939507|NCT01045707|54595753|FG000|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2|||
27939508|NCT01045707|54595754|FG001|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1|||
27939509|NCT01045707|54595753|FG000|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6|||
27939510|NCT01045707|54595754|FG001|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5|||
27804394|NCT02057393|54259480|FG000|Overall Study|Withdrawal by Subject|1|||
27804395|NCT02057393|54259480|FG000|Overall Study|Patient did not meet criteria|1|||
27804396|NCT02040779|54259487|FG000|Overall Study|Adverse Event|1|||
27804397|NCT02040779|54259488|FG001|Overall Study|Adverse Event|0|||
27804398|NCT02040779|54259489|FG002|Overall Study|Adverse Event|0|||
27804399|NCT02040779|54259487|FG000|Overall Study|Withdrawal by Subject|4|||
27804400|NCT02040779|54259488|FG001|Overall Study|Withdrawal by Subject|1|||
27804401|NCT02040779|54259489|FG002|Overall Study|Withdrawal by Subject|3|||
27804402|NCT02040779|54259487|FG000|Overall Study|Non-compliance|0|||
27804403|NCT02040779|54259488|FG001|Overall Study|Non-compliance|1|||
27804404|NCT02040779|54259489|FG002|Overall Study|Non-compliance|0|||
27804405|NCT02040779|54259487|FG000|Overall Study|Protocol Violation|2|||
27804406|NCT02040779|54259488|FG001|Overall Study|Protocol Violation|1|||
27804407|NCT02040779|54259489|FG002|Overall Study|Protocol Violation|0|||
27804408|NCT02040779|54259487|FG000|Overall Study|Lost to Follow-up|1|||
27804409|NCT02040779|54259488|FG001|Overall Study|Lost to Follow-up|2|||
27804410|NCT02040779|54259489|FG002|Overall Study|Lost to Follow-up|1|||
27804411|NCT02040779|54259487|FG000|Overall Study|Lack of Efficacy|4|||
27804412|NCT02040779|54259488|FG001|Overall Study|Lack of Efficacy|2|||
27804413|NCT02040779|54259489|FG002|Overall Study|Lack of Efficacy|0|||
27804414|NCT02056301|54259499|FG000|Overall Study|Protocol Violation|1|||
27804415|NCT02056301|54259500|FG001|Overall Study|Protocol Violation|2|||
27804416|NCT02056301|54259499|FG000|Overall Study|Surgical complications req. 2nd surgery|1|||
27804417|NCT02056301|54259500|FG001|Overall Study|Surgical complications req. 2nd surgery|0|||
27804418|NCT02056301|54259499|FG000|Overall Study|Withdrawal by Subject|0|||
27804419|NCT02056301|54259500|FG001|Overall Study|Withdrawal by Subject|1|||
27804420|NCT02056301|54259499|FG000|Overall Study|Issues with epidural|0|||
27804421|NCT02056301|54259500|FG001|Overall Study|Issues with epidural|3|||
27804422|NCT01967732|54259508|FG000|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
27804423|NCT01967732|54259509|FG001|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1|||
27804424|NCT01967732|54259510|FG002|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
27804425|NCT01967732|54259511|FG003|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
27804426|NCT01967732|54259508|FG000|First Intervention (Day 1)|Poor venous access|0|||
27804427|NCT01967732|54259509|FG001|First Intervention (Day 1)|Poor venous access|1|||
27804428|NCT01967732|54259510|FG002|First Intervention (Day 1)|Poor venous access|0|||
27804429|NCT01967732|54259511|FG003|First Intervention (Day 1)|Poor venous access|0|||
27804430|NCT01967576|54259519|FG000|Overall Study|Withdrawal by Subject|3|||
27804431|NCT01967576|54259519|FG000|Overall Study|Progressed/Removed from treatment|1|||
27804432|NCT01967576|54259519|FG000|Overall Study|Study closing at site|1|||
27804433|NCT01967576|54259519|FG000|Overall Study|Adverse Event|1|||
27804434|NCT01967576|54259519|FG000|Overall Study|Refused further treatment|1|||
27804435|NCT02039687|54259527|FG000|Overall Study|Adverse Event|0|||
27804436|NCT02039687|54259528|FG001|Overall Study|Adverse Event|0|||
27804437|NCT02039687|54259529|FG002|Overall Study|Adverse Event|1|||
27804438|NCT02039687|54259530|FG003|Overall Study|Adverse Event|0|||
27804439|NCT02039687|54259527|FG000|Overall Study|Withdrawal by Subject|0|||
27804440|NCT02039687|54259528|FG001|Overall Study|Withdrawal by Subject|1|||
27804441|NCT02039687|54259529|FG002|Overall Study|Withdrawal by Subject|0|||
27804442|NCT02039687|54259530|FG003|Overall Study|Withdrawal by Subject|0|||
27804443|NCT02039687|54259527|FG000|Overall Study|treatment assignment could not be confir|0|||
27804444|NCT02039687|54259528|FG001|Overall Study|treatment assignment could not be confir|0|||
27804445|NCT02039687|54259529|FG002|Overall Study|treatment assignment could not be confir|2|||
27804446|NCT02039687|54259530|FG003|Overall Study|treatment assignment could not be confir|0|||
27804447|NCT02003534|54259540|FG000|Overall Study|Lost to Follow-up|47|||
27804448|NCT02055365|54259544|FG000|Overall Study|Prematurely Withdrawn|1|||
27804449|NCT02039375|54259555|FG000|Overall Study|Lost to Follow-up|2|||
27804450|NCT02054897|54259562|FG000|Overall Study|Withdrawal by Subject|2|||
27804451|NCT02054897|54259563|FG001|Overall Study|Withdrawal by Subject|0|||
27804452|NCT02054897|54259564|FG002|Overall Study|Withdrawal by Subject|2|||
27804453|NCT02054897|54259562|FG000|Overall Study|Missing follow-up information|3|||
27804454|NCT02054897|54259563|FG001|Overall Study|Missing follow-up information|5|||
27804455|NCT02054897|54259564|FG002|Overall Study|Missing follow-up information|3|||
27804456|NCT02054897|54259562|FG000|Overall Study|Lost to Follow-up|4|||
27804457|NCT02054897|54259563|FG001|Overall Study|Lost to Follow-up|2|||
27804458|NCT02054897|54259564|FG002|Overall Study|Lost to Follow-up|7|||
27804459|NCT02054897|54259562|FG000|Overall Study|Randomized but not exposed|1|||
27804460|NCT02054897|54259563|FG001|Overall Study|Randomized but not exposed|0|||
27804461|NCT02054897|54259564|FG002|Overall Study|Randomized but not exposed|0|||
27804462|NCT01976312|54259574|FG000|Overall Study|Pregnancy|0|||
27804463|NCT01976312|54259575|FG001|Overall Study|Pregnancy|1|||
27804464|NCT01976312|54259574|FG000|Overall Study|Lost to Follow-up|2|||
27804465|NCT01976312|54259575|FG001|Overall Study|Lost to Follow-up|0|||
27804466|NCT01976312|54259574|FG000|Overall Study|Withdrawal by Subject|7|||
27804467|NCT01976312|54259575|FG001|Overall Study|Withdrawal by Subject|2|||
27804468|NCT01976312|54259574|FG000|Overall Study|Adverse Event|6|||
27804469|NCT01976312|54259575|FG001|Overall Study|Adverse Event|6|||
27804470|NCT01976312|54259574|FG000|Overall Study|Protocol Violation|2|||
27804471|NCT01976312|54259575|FG001|Overall Study|Protocol Violation|0|||
27804472|NCT02039219|54259584|FG000|Treatment|Withdrawal by Subject|1|||
27804473|NCT02039219|54259585|FG001|Treatment|Withdrawal by Subject|0|||
27804474|NCT02039219|54259584|FG000|Treatment|Adverse Event|0|||
27804475|NCT02039219|54259585|FG001|Treatment|Adverse Event|1|||
27804476|NCT02039219|54259584|FG000|Treatment|Physician Decision|1|||
27804477|NCT02039219|54259585|FG001|Treatment|Physician Decision|0|||
27804478|NCT02039219|54259584|FG000|Treatment|Lost to Follow-up|0|||
27804479|NCT02039219|54259585|FG001|Treatment|Lost to Follow-up|1|||
27804480|NCT02039219|54259584|FG000|Treatment|Protocol Violation|1|||
27804481|NCT02039219|54259585|FG001|Treatment|Protocol Violation|0|||
27804482|NCT02039219|54259584|FG000|Treatment|Death|1|||
27804483|NCT02039219|54259585|FG001|Treatment|Death|0|||
27804484|NCT02039219|54259584|FG000|Follow up|Adverse Event|0|||
27804485|NCT02039219|54259585|FG001|Follow up|Adverse Event|1|||
27804486|NCT02053493|54259593|FG000|Overall Study|Withdrawal by Subject|1|||
27804487|NCT02053493|54259594|FG001|Overall Study|Withdrawal by Subject|1|||
27804488|NCT02003144|54259602|FG000|Open Label Maintenance Phase|Other than specified|2|||
27804489|NCT02003144|54259603|FG001|Open Label Maintenance Phase|Other than specified|4|||
27804490|NCT02003144|54259602|FG000|Open Label Maintenance Phase|Withdrawal by Subject|4|||
27804491|NCT02003144|54259603|FG001|Open Label Maintenance Phase|Withdrawal by Subject|5|||
27804492|NCT02003144|54259602|FG000|Open Label Maintenance Phase|Pregnancy|0|||
27804493|NCT02003144|54259603|FG001|Open Label Maintenance Phase|Pregnancy|2|||
27804494|NCT02003144|54259602|FG000|Open Label Maintenance Phase|Physician Decision|1|||
27804495|NCT02003144|54259603|FG001|Open Label Maintenance Phase|Physician Decision|1|||
27804496|NCT02003144|54259602|FG000|Open Label Maintenance Phase|Lost to Follow-up|0|||
27804497|NCT02003144|54259603|FG001|Open Label Maintenance Phase|Lost to Follow-up|1|||
27804498|NCT02003144|54259602|FG000|Open Label Maintenance Phase|Adverse Event|2|||
27804499|NCT02003144|54259603|FG001|Open Label Maintenance Phase|Adverse Event|1|||
27804500|NCT02001194|54259614|FG000|Intervention Period (13 Weeks)|No longer interested|1|||
27804501|NCT02001194|54259615|FG001|Intervention Period (13 Weeks)|No longer interested|0|||
27804502|NCT02001194|54259616|FG002|Intervention Period (13 Weeks)|No longer interested|2|||
27804503|NCT02001194|54259617|FG003|Intervention Period (13 Weeks)|No longer interested|2|||
27804504|NCT02001194|54259614|FG000|Follow-Up Period (13 Weeks)|No longer interested|3|||
27804505|NCT02001194|54259615|FG001|Follow-Up Period (13 Weeks)|No longer interested|2|||
27804506|NCT02001194|54259616|FG002|Follow-Up Period (13 Weeks)|No longer interested|1|||
27804507|NCT02001194|54259617|FG003|Follow-Up Period (13 Weeks)|No longer interested|0|||
27804508|NCT02038907|54259641|FG000|Overall Study|Protocol Violation|0|||
27804509|NCT02038907|54259642|FG001|Overall Study|Protocol Violation|0|||
27804510|NCT02038907|54259643|FG002|Overall Study|Protocol Violation|0|||
27804511|NCT02038907|54259644|FG003|Overall Study|Protocol Violation|0|||
27804512|NCT02038907|54259645|FG004|Overall Study|Protocol Violation|0|||
27804513|NCT02038907|54259646|FG005|Overall Study|Protocol Violation|0|||
27804514|NCT02038907|54259647|FG006|Overall Study|Protocol Violation|0|||
28028810|NCT00607724|54687354|FG004|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
28028811|NCT00607724|54687355|FG005|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
28028812|NCT00607724|54687356|FG006|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
28028813|NCT00506415|54687380|FG000|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272|||
28028814|NCT00506415|54687381|FG001|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
28028815|NCT00506415|54687382|FG002|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
28028816|NCT00506415|54687383|FG003|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
28028817|NCT00506415|54687380|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1|||
28028818|NCT00506415|54687381|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
28028819|NCT00506415|54687382|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
28028820|NCT00506415|54687383|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
28028821|NCT00506415|54687380|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1|||
28028822|NCT00506415|54687381|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
28028823|NCT00506415|54687382|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
28028824|NCT00506415|54687383|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
28028825|NCT00506415|54687380|FG000|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58|||
28028826|NCT00506415|54687381|FG001|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
28028827|NCT00506415|54687382|FG002|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
27804515|NCT02038907|54259648|FG007|Overall Study|Protocol Violation|0|||
27804516|NCT02038907|54259649|FG008|Overall Study|Protocol Violation|0|||
27804517|NCT02038907|54259650|FG009|Overall Study|Protocol Violation|0|||
27804518|NCT02038907|54259651|FG010|Overall Study|Protocol Violation|1|||
27804519|NCT02038907|54259652|FG011|Overall Study|Protocol Violation|0|||
27804520|NCT02038907|54259653|FG012|Overall Study|Protocol Violation|0|||
27804521|NCT02038907|54259654|FG013|Overall Study|Protocol Violation|0|||
27804522|NCT02038907|54259641|FG000|Overall Study|Withdrawal by Subject|0|||
27804523|NCT02038907|54259642|FG001|Overall Study|Withdrawal by Subject|0|||
27804524|NCT02038907|54259643|FG002|Overall Study|Withdrawal by Subject|0|||
27804525|NCT02038907|54259644|FG003|Overall Study|Withdrawal by Subject|0|||
27804526|NCT02038907|54259645|FG004|Overall Study|Withdrawal by Subject|0|||
27804527|NCT02038907|54259646|FG005|Overall Study|Withdrawal by Subject|0|||
27804528|NCT02038907|54259647|FG006|Overall Study|Withdrawal by Subject|0|||
27804529|NCT02038907|54259648|FG007|Overall Study|Withdrawal by Subject|0|||
27804530|NCT02038907|54259649|FG008|Overall Study|Withdrawal by Subject|0|||
27804531|NCT02038907|54259650|FG009|Overall Study|Withdrawal by Subject|0|||
27804532|NCT02038907|54259651|FG010|Overall Study|Withdrawal by Subject|1|||
27804533|NCT02038907|54259652|FG011|Overall Study|Withdrawal by Subject|0|||
27804534|NCT02038907|54259653|FG012|Overall Study|Withdrawal by Subject|0|||
27804535|NCT02038907|54259654|FG013|Overall Study|Withdrawal by Subject|0|||
27804536|NCT02038829|54259686|FG000|Washout Period 1|Death|0|||
27804537|NCT02038829|54259687|FG001|Washout Period 1|Death|0|||
27804538|NCT02038829|54259688|FG002|Washout Period 1|Death|0|||
27804539|NCT02038829|54259689|FG003|Washout Period 1|Death|0|||
27804540|NCT02038829|54259690|FG004|Washout Period 1|Death|1|||
27804541|NCT02038829|54259691|FG005|Washout Period 1|Death|0|||
27804542|NCT02038829|54259692|FG006|Washout Period 1|Death|0|||
27804543|NCT02038829|54259693|FG007|Washout Period 1|Death|0|||
27804544|NCT02038829|54259694|FG008|Washout Period 1|Death|0|||
27804545|NCT02038829|54259695|FG009|Washout Period 1|Death|0|||
27804546|NCT02038829|54259696|FG010|Washout Period 1|Death|0|||
27804547|NCT02038829|54259697|FG011|Washout Period 1|Death|0|||
27804548|NCT02038829|54259686|FG000|Treatment Period 2|Adverse Event|0|||
27804549|NCT02038829|54259687|FG001|Treatment Period 2|Adverse Event|0|||
27804550|NCT02038829|54259688|FG002|Treatment Period 2|Adverse Event|0|||
27804551|NCT02038829|54259689|FG003|Treatment Period 2|Adverse Event|0|||
27804552|NCT02038829|54259690|FG004|Treatment Period 2|Adverse Event|0|||
27804553|NCT02038829|54259691|FG005|Treatment Period 2|Adverse Event|0|||
27804554|NCT02038829|54259692|FG006|Treatment Period 2|Adverse Event|0|||
27804555|NCT02038829|54259693|FG007|Treatment Period 2|Adverse Event|0|||
27804556|NCT02038829|54259694|FG008|Treatment Period 2|Adverse Event|0|||
27804557|NCT02038829|54259695|FG009|Treatment Period 2|Adverse Event|0|||
27804558|NCT02038829|54259696|FG010|Treatment Period 2|Adverse Event|1|||
27804559|NCT02038829|54259697|FG011|Treatment Period 2|Adverse Event|0|||
27804560|NCT02038829|54259686|FG000|Treatment Period 2|Withdrawal by Subject|1|||
27804561|NCT02038829|54259687|FG001|Treatment Period 2|Withdrawal by Subject|0|||
27804562|NCT02038829|54259688|FG002|Treatment Period 2|Withdrawal by Subject|0|||
27804563|NCT02038829|54259689|FG003|Treatment Period 2|Withdrawal by Subject|0|||
27804564|NCT02038829|54259690|FG004|Treatment Period 2|Withdrawal by Subject|0|||
27804565|NCT02038829|54259691|FG005|Treatment Period 2|Withdrawal by Subject|0|||
27804566|NCT02038829|54259692|FG006|Treatment Period 2|Withdrawal by Subject|0|||
27804567|NCT02038829|54259693|FG007|Treatment Period 2|Withdrawal by Subject|0|||
27804568|NCT02038829|54259694|FG008|Treatment Period 2|Withdrawal by Subject|0|||
27804569|NCT02038829|54259695|FG009|Treatment Period 2|Withdrawal by Subject|0|||
27804570|NCT02038829|54259696|FG010|Treatment Period 2|Withdrawal by Subject|0|||
27804571|NCT02038829|54259697|FG011|Treatment Period 2|Withdrawal by Subject|0|||
27804572|NCT02038829|54259686|FG000|Washout Period 2|Adverse Event|0|||
27804573|NCT02038829|54259687|FG001|Washout Period 2|Adverse Event|0|||
27804574|NCT02038829|54259688|FG002|Washout Period 2|Adverse Event|0|||
27804575|NCT02038829|54259689|FG003|Washout Period 2|Adverse Event|0|||
27804576|NCT02038829|54259690|FG004|Washout Period 2|Adverse Event|0|||
27804577|NCT02038829|54259691|FG005|Washout Period 2|Adverse Event|0|||
27804578|NCT02038829|54259692|FG006|Washout Period 2|Adverse Event|0|||
27804579|NCT02038829|54259693|FG007|Washout Period 2|Adverse Event|0|||
27804580|NCT02038829|54259694|FG008|Washout Period 2|Adverse Event|1|||
27804581|NCT02038829|54259695|FG009|Washout Period 2|Adverse Event|0|||
27804582|NCT02038829|54259696|FG010|Washout Period 2|Adverse Event|0|||
27804583|NCT02038829|54259697|FG011|Washout Period 2|Adverse Event|0|||
27804584|NCT02038829|54259686|FG000|Washout Period 2|Withdrawal by Subject|0|||
27804585|NCT02038829|54259687|FG001|Washout Period 2|Withdrawal by Subject|0|||
27804586|NCT02038829|54259688|FG002|Washout Period 2|Withdrawal by Subject|0|||
27804587|NCT02038829|54259689|FG003|Washout Period 2|Withdrawal by Subject|0|||
27804588|NCT02038829|54259690|FG004|Washout Period 2|Withdrawal by Subject|0|||
27804589|NCT02038829|54259691|FG005|Washout Period 2|Withdrawal by Subject|1|||
27804590|NCT02038829|54259692|FG006|Washout Period 2|Withdrawal by Subject|0|||
27804591|NCT02038829|54259693|FG007|Washout Period 2|Withdrawal by Subject|0|||
27804592|NCT02038829|54259694|FG008|Washout Period 2|Withdrawal by Subject|0|||
27804593|NCT02038829|54259695|FG009|Washout Period 2|Withdrawal by Subject|0|||
27804594|NCT02038829|54259696|FG010|Washout Period 2|Withdrawal by Subject|0|||
27804595|NCT02038829|54259697|FG011|Washout Period 2|Withdrawal by Subject|0|||
27804596|NCT02038829|54259686|FG000|Treatment Period 4|Adverse Event|0|||
27804597|NCT02038829|54259687|FG001|Treatment Period 4|Adverse Event|1|||
27804598|NCT02038829|54259688|FG002|Treatment Period 4|Adverse Event|0|||
27804599|NCT02038829|54259689|FG003|Treatment Period 4|Adverse Event|0|||
27804600|NCT02038829|54259690|FG004|Treatment Period 4|Adverse Event|0|||
27804601|NCT02038829|54259691|FG005|Treatment Period 4|Adverse Event|0|||
27804602|NCT02038829|54259692|FG006|Treatment Period 4|Adverse Event|0|||
27804603|NCT02038829|54259693|FG007|Treatment Period 4|Adverse Event|0|||
27804604|NCT02038829|54259694|FG008|Treatment Period 4|Adverse Event|0|||
27804605|NCT02038829|54259695|FG009|Treatment Period 4|Adverse Event|0|||
27804606|NCT02038829|54259696|FG010|Treatment Period 4|Adverse Event|0|||
27804607|NCT02038829|54259697|FG011|Treatment Period 4|Adverse Event|0|||
27804608|NCT02038829|54259686|FG000|Washout Period 4|Adverse Event|0|||
27804609|NCT02038829|54259687|FG001|Washout Period 4|Adverse Event|0|||
27804610|NCT02038829|54259688|FG002|Washout Period 4|Adverse Event|0|||
27804611|NCT02038829|54259689|FG003|Washout Period 4|Adverse Event|0|||
27804612|NCT02038829|54259690|FG004|Washout Period 4|Adverse Event|0|||
27804613|NCT02038829|54259691|FG005|Washout Period 4|Adverse Event|0|||
27804614|NCT02038829|54259692|FG006|Washout Period 4|Adverse Event|1|||
27804615|NCT02038829|54259693|FG007|Washout Period 4|Adverse Event|0|||
27804616|NCT02038829|54259694|FG008|Washout Period 4|Adverse Event|0|||
27804617|NCT02038829|54259695|FG009|Washout Period 4|Adverse Event|0|||
27804618|NCT02038829|54259696|FG010|Washout Period 4|Adverse Event|0|||
27804619|NCT02038829|54259697|FG011|Washout Period 4|Adverse Event|0|||
27804620|NCT02038829|54259686|FG000|Treatment Period 6|Adverse Event|0|||
27804621|NCT02038829|54259687|FG001|Treatment Period 6|Adverse Event|0|||
27804622|NCT02038829|54259688|FG002|Treatment Period 6|Adverse Event|1|||
27804623|NCT02038829|54259689|FG003|Treatment Period 6|Adverse Event|0|||
27804624|NCT02038829|54259690|FG004|Treatment Period 6|Adverse Event|0|||
27804625|NCT02038829|54259691|FG005|Treatment Period 6|Adverse Event|0|||
27804626|NCT02038829|54259692|FG006|Treatment Period 6|Adverse Event|0|||
27804627|NCT02038829|54259693|FG007|Treatment Period 6|Adverse Event|0|||
27804628|NCT02038829|54259694|FG008|Treatment Period 6|Adverse Event|0|||
27804629|NCT02038829|54259695|FG009|Treatment Period 6|Adverse Event|0|||
27804630|NCT02038829|54259696|FG010|Treatment Period 6|Adverse Event|0|||
27804631|NCT02038829|54259697|FG011|Treatment Period 6|Adverse Event|0|||
27804632|NCT02038049|54259714|FG000|Overall Study|Lost to Follow-up|1|||
27804633|NCT02038049|54259715|FG001|Overall Study|Lost to Follow-up|0|||
27804634|NCT02052011|54259727|FG000|Overall Study|Lost to Follow-up|3|||
27804635|NCT02052011|54259728|FG001|Overall Study|Lost to Follow-up|0|||
27804636|NCT02052011|54259727|FG000|Overall Study|Withdrawal by Subject|1|||
27804637|NCT02052011|54259728|FG001|Overall Study|Withdrawal by Subject|2|||
27804638|NCT02036645|54259746|FG000|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
27804639|NCT02036645|54259747|FG001|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
27804640|NCT02036645|54259748|FG002|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
27804641|NCT02036645|54259749|FG003|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
27804642|NCT02036645|54259750|FG004|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
27804643|NCT02036645|54259751|FG005|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
27804644|NCT02036645|54259752|FG006|SAD Cohorts : Study Part 1|Lost to Follow-up|1|||
27804645|NCT02036645|54259753|FG007|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
27804646|NCT02036645|54259754|FG008|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
27804647|NCT02036645|54259755|FG009|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
27804648|NCT02036645|54259756|FG010|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
27804649|NCT02036645|54259757|FG011|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
27804650|NCT02036645|54259746|FG000|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
27804651|NCT02036645|54259747|FG001|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
27804652|NCT02036645|54259748|FG002|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
27804653|NCT02036645|54259749|FG003|SAD Cohorts : Study Part 1|Withdrawal by Subject|1|||
27804654|NCT02036645|54259750|FG004|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
27804655|NCT02036645|54259751|FG005|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
27804656|NCT02036645|54259752|FG006|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
28028828|NCT00506415|54687383|FG003|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
27804657|NCT02036645|54259753|FG007|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
27804658|NCT02036645|54259754|FG008|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
27804659|NCT02036645|54259755|FG009|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
27804660|NCT02036645|54259756|FG010|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
27804661|NCT02036645|54259757|FG011|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
27804662|NCT02051933|54259797|FG000|Overall Study|Physician Decision|0|||
27804663|NCT02051933|54259798|FG001|Overall Study|Physician Decision|1|||
27804664|NCT02050373|54259811|FG000|Overall Study|Adverse Event|4|||
27804665|NCT02050373|54259812|FG001|Overall Study|Adverse Event|7|||
27804666|NCT02050373|54259811|FG000|Overall Study|Death|3|||
27804667|NCT02050373|54259812|FG001|Overall Study|Death|3|||
27804668|NCT02049437|54259821|FG000|Period 1|Adverse Event|1|||
27804669|NCT02049437|54259822|FG001|Period 1|Adverse Event|1|||
27804670|NCT02049437|54259821|FG000|Period 1|Adverse Event|1|||
27804671|NCT02049437|54259822|FG001|Period 1|Adverse Event|0|||
27804672|NCT02035553|54259830|FG000|Overall Study|Death (See All-Cause Mortality Table)|0|||
27804673|NCT02035553|54259831|FG001|Overall Study|Death (See All-Cause Mortality Table)|1|||
27804674|NCT02035553|54259830|FG000|Overall Study|Adverse Event|10|||
28028829|NCT00506415|54687380|FG000|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88|||
27804675|NCT02035553|54259831|FG001|Overall Study|Adverse Event|6|||
27804676|NCT02035553|54259830|FG000|Overall Study|Physician Decision|3|||
27804677|NCT02035553|54259831|FG001|Overall Study|Physician Decision|2|||
27804678|NCT02035553|54259830|FG000|Overall Study|Lack of Efficacy|1|||
27804679|NCT02035553|54259831|FG001|Overall Study|Lack of Efficacy|1|||
27804680|NCT02035553|54259830|FG000|Overall Study|Withdrawal by Subject|4|||
27804681|NCT02035553|54259831|FG001|Overall Study|Withdrawal by Subject|7|||
27804682|NCT02035553|54259830|FG000|Overall Study|Non-compliance with Study Drug|0|||
27804683|NCT02035553|54259831|FG001|Overall Study|Non-compliance with Study Drug|1|||
27804684|NCT02035553|54259830|FG000|Overall Study|Lost to Follow-up|0|||
27804685|NCT02035553|54259831|FG001|Overall Study|Lost to Follow-up|1|||
27804686|NCT02035553|54259830|FG000|Overall Study|Other Reason|0|||
27804687|NCT02035553|54259831|FG001|Overall Study|Other Reason|4|||
27804688|NCT01445080|54259846|FG000|Overall Study|Adverse Event|5|||
27804689|NCT01445080|54259847|FG001|Overall Study|Adverse Event|3|||
27804690|NCT01445080|54259848|FG002|Overall Study|Adverse Event|11|||
27804691|NCT01445080|54259849|FG003|Overall Study|Adverse Event|6|||
27804692|NCT01445080|54259850|FG004|Overall Study|Adverse Event|2|||
27804693|NCT01445080|54259851|FG005|Overall Study|Adverse Event|3|||
27804694|NCT01445080|54259852|FG006|Overall Study|Adverse Event|0|||
27804695|NCT01445080|54259853|FG007|Overall Study|Adverse Event|3|||
28028830|NCT00506415|54687381|FG001|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
28028831|NCT00506415|54687382|FG002|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
28028832|NCT00506415|54687383|FG003|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
28028833|NCT00506415|54687380|FG000|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22|||
28028834|NCT00506415|54687381|FG001|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
27804696|NCT01445080|54259854|FG008|Overall Study|Adverse Event|10|||
27804697|NCT01445080|54259846|FG000|Overall Study|Physician Decision|0|||
27804698|NCT01445080|54259847|FG001|Overall Study|Physician Decision|0|||
27804699|NCT01445080|54259848|FG002|Overall Study|Physician Decision|1|||
28028835|NCT00506415|54687382|FG002|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
28028836|NCT00506415|54687383|FG003|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
28028837|NCT00506415|54687380|FG000|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7|||
28028838|NCT00506415|54687381|FG001|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
28028839|NCT00506415|54687382|FG002|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
28028840|NCT00506415|54687383|FG003|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
28028841|NCT00506415|54687380|FG000|Initial Open Label (Maximum 48 Weeks)|Death|22|||
28028842|NCT00506415|54687381|FG001|Initial Open Label (Maximum 48 Weeks)|Death|0|||
28028843|NCT00506415|54687382|FG002|Initial Open Label (Maximum 48 Weeks)|Death|0|||
28028844|NCT00506415|54687383|FG003|Initial Open Label (Maximum 48 Weeks)|Death|0|||
28028845|NCT00506415|54687380|FG000|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28|||
28028846|NCT00506415|54687381|FG001|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
28028847|NCT00506415|54687382|FG002|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
28028848|NCT00506415|54687383|FG003|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
28028849|NCT00506415|54687380|FG000|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
28028850|NCT00506415|54687381|FG001|Double Blind (Maximum 48 Weeks )|Adverse Event|33|||
28028851|NCT00506415|54687382|FG002|Double Blind (Maximum 48 Weeks )|Adverse Event|28|||
28028852|NCT00506415|54687383|FG003|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
28028853|NCT00506415|54687380|FG000|Double Blind (Maximum 48 Weeks )|Death|0|||
28028854|NCT00506415|54687381|FG001|Double Blind (Maximum 48 Weeks )|Death|5|||
28028855|NCT00506415|54687382|FG002|Double Blind (Maximum 48 Weeks )|Death|3|||
28028856|NCT00506415|54687383|FG003|Double Blind (Maximum 48 Weeks )|Death|0|||
28028857|NCT00506415|54687380|FG000|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
28028858|NCT00506415|54687381|FG001|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
28028859|NCT00506415|54687382|FG002|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
28028860|NCT00506415|54687383|FG003|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
28028861|NCT00506415|54687380|FG000|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
28028862|NCT00506415|54687381|FG001|Double Blind (Maximum 48 Weeks )|Protocol Violation|5|||
28028863|NCT00506415|54687382|FG002|Double Blind (Maximum 48 Weeks )|Protocol Violation|3|||
28028864|NCT00506415|54687383|FG003|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
28028865|NCT00506415|54687380|FG000|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
28028866|NCT00506415|54687381|FG001|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4|||
28028867|NCT00506415|54687382|FG002|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6|||
28028868|NCT00506415|54687383|FG003|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
28028869|NCT00506415|54687380|FG000|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
27804700|NCT01445080|54259849|FG003|Overall Study|Physician Decision|0|||
27842943|NCT01440569|54331894|FG001|Open-Label Rollover Phase|Adverse Event|0|||
27804701|NCT01445080|54259850|FG004|Overall Study|Physician Decision|0|||
27842944|NCT01440569|54331893|FG000|Open-Label Rollover Phase|Pregnancy|1|||
27842945|NCT01440569|54331894|FG001|Open-Label Rollover Phase|Pregnancy|0|||
27842946|NCT01440569|54331893|FG000|Open-Label Rollover Phase|Lack of Efficacy|2|||
28028870|NCT00506415|54687381|FG001|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20|||
28028871|NCT00506415|54687382|FG002|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17|||
27804702|NCT01445080|54259851|FG005|Overall Study|Physician Decision|3|||
28028872|NCT00506415|54687383|FG003|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
28028873|NCT00506415|54687380|FG000|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
28028874|NCT00506415|54687381|FG001|Double Blind (Maximum 48 Weeks )|Administrative problems|3|||
27804703|NCT01445080|54259852|FG006|Overall Study|Physician Decision|2|||
27804704|NCT01445080|54259853|FG007|Overall Study|Physician Decision|2|||
27804705|NCT01445080|54259854|FG008|Overall Study|Physician Decision|0|||
27804706|NCT01445080|54259846|FG000|Overall Study|Withdrawal by Subject|1|||
27804707|NCT01445080|54259847|FG001|Overall Study|Withdrawal by Subject|0|||
27804708|NCT01445080|54259848|FG002|Overall Study|Withdrawal by Subject|0|||
27804709|NCT01445080|54259849|FG003|Overall Study|Withdrawal by Subject|1|||
27804710|NCT01445080|54259850|FG004|Overall Study|Withdrawal by Subject|0|||
27804711|NCT01445080|54259851|FG005|Overall Study|Withdrawal by Subject|0|||
27804712|NCT01445080|54259852|FG006|Overall Study|Withdrawal by Subject|0|||
27804713|NCT01445080|54259853|FG007|Overall Study|Withdrawal by Subject|0|||
27804714|NCT01445080|54259854|FG008|Overall Study|Withdrawal by Subject|2|||
27804715|NCT01445080|54259846|FG000|Overall Study|Ineligible/Inevaluable|1|||
27804716|NCT01445080|54259847|FG001|Overall Study|Ineligible/Inevaluable|2|||
27804717|NCT01445080|54259848|FG002|Overall Study|Ineligible/Inevaluable|0|||
27804718|NCT01445080|54259849|FG003|Overall Study|Ineligible/Inevaluable|1|||
27804719|NCT01445080|54259850|FG004|Overall Study|Ineligible/Inevaluable|2|||
27804720|NCT01445080|54259851|FG005|Overall Study|Ineligible/Inevaluable|3|||
27804721|NCT01445080|54259852|FG006|Overall Study|Ineligible/Inevaluable|0|||
27804722|NCT01445080|54259853|FG007|Overall Study|Ineligible/Inevaluable|0|||
27804723|NCT01445080|54259854|FG008|Overall Study|Ineligible/Inevaluable|6|||
27804724|NCT02035475|54259889|FG000|Overall Study|Withdrawal by Subject|4|||
27804725|NCT02035475|54259889|FG000|Overall Study|Physician Decision|1|||
27804726|NCT02035475|54259889|FG000|Overall Study|Equipment Error|1|||
27804727|NCT01444456|54259895|FG000|Overall Study|Withdrawal by Subject|21|||
27804728|NCT01444456|54259895|FG000|Overall Study|Physician Decision|9|||
27804729|NCT01444456|54259895|FG000|Overall Study|Lost to Follow-up|37|||
27804730|NCT01444456|54259895|FG000|Overall Study|Death|73|||
27804731|NCT01444456|54259895|FG000|Overall Study|Ineligibility determined|23|||
27804732|NCT01444456|54259895|FG000|Overall Study|Other|18|||
27804733|NCT01444456|54259895|FG000|Overall Study|Not treated|104|||
27804734|NCT01438294|54259901|FG000|Overall Study|Lost to Follow-up|3|||
27804735|NCT01438294|54259902|FG001|Overall Study|Lost to Follow-up|7|||
27804736|NCT02033759|54259910|FG000|Overall Study|Withdrawal by Subject|2|||
27804737|NCT02033759|54259911|FG001|Overall Study|Withdrawal by Subject|1|||
27804738|NCT02033759|54259910|FG000|Overall Study|Protocol Violation|1|||
27804739|NCT02033759|54259911|FG001|Overall Study|Protocol Violation|1|||
27804740|NCT01959529|54259919|FG000|Overall Study|Adverse event (not hypoglycaemia)|0|||
27804741|NCT01959529|54259920|FG001|Overall Study|Adverse event (not hypoglycaemia)|1|||
27804742|NCT01959529|54259919|FG000|Overall Study|Lost to Follow-up|4|||
27804743|NCT01959529|54259920|FG001|Overall Study|Lost to Follow-up|1|||
27804744|NCT01959529|54259919|FG000|Overall Study|Other|70|||
27804745|NCT01959529|54259920|FG001|Overall Study|Other|68|||
27804746|NCT01959529|54259919|FG000|Overall Study|Hypoglycaemia|1|||
27804747|NCT01959529|54259920|FG001|Overall Study|Hypoglycaemia|1|||
27804748|NCT01959529|54259919|FG000|Overall Study|Lack of glycaemic control|1|||
27804749|NCT01959529|54259920|FG001|Overall Study|Lack of glycaemic control|1|||
27804750|NCT02033369|54259928|FG000|Overall Study|Physician Decision|1|||
27804751|NCT02033369|54259929|FG001|Overall Study|Physician Decision|2|||
27804752|NCT02033369|54259928|FG000|Overall Study|Not a good demographic match|0|||
27804753|NCT02033369|54259929|FG001|Overall Study|Not a good demographic match|2|||
27804754|NCT02033369|54259928|FG000|Overall Study|Withdrawal by Subject|1|||
27804755|NCT02033369|54259929|FG001|Overall Study|Withdrawal by Subject|1|||
27804756|NCT02033369|54259928|FG000|Overall Study|Lost to Follow-up|1|||
27804757|NCT02033369|54259929|FG001|Overall Study|Lost to Follow-up|0|||
27804758|NCT02033369|54259928|FG000|Overall Study|Protocol Violation|2|||
27804759|NCT02033369|54259929|FG001|Overall Study|Protocol Violation|0|||
27804760|NCT02032901|54259935|FG000|Treatment Period (12 Weeks)|Pregnancy|1|||
27804761|NCT02032901|54259936|FG001|Treatment Period (12 Weeks)|Pregnancy|0|||
28028875|NCT00506415|54687382|FG002|Double Blind (Maximum 48 Weeks )|Administrative problems|2|||
27804762|NCT02032901|54259935|FG000|Follow-Up Period (24 Weeks)|Lost to Follow-up|0|||
27804763|NCT02032901|54259936|FG001|Follow-Up Period (24 Weeks)|Lost to Follow-up|1|||
27804764|NCT02020967|54259946|FG000|Overall Study|Withdrawal by Subject|51|||
27804765|NCT01986829|54259952|FG000|Overall Study|Death|1|||
27804766|NCT01986751|54259961|FG000|Overall Study|improperly consented|10|||
27804767|NCT01986751|54259962|FG001|Overall Study|improperly consented|2|||
27804768|NCT02004847|54259974|FG000|Overall Study|Protocol Violation|1|||
27804769|NCT02004847|54259975|FG001|Overall Study|Protocol Violation|1|||
27804770|NCT01438060|54259992|FG000|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7|||
27804771|NCT01438060|54259993|FG001|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9|||
27804772|NCT01438060|54259992|FG000|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6|||
27804773|NCT01438060|54259993|FG001|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3|||
27804774|NCT01438060|54259992|FG000|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3|||
27804775|NCT01438060|54259993|FG001|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4|||
27804776|NCT01438060|54259992|FG000|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1|||
27804777|NCT01438060|54259993|FG001|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0|||
27804778|NCT01438060|54259992|FG000|Acute Phase: Double-blind, 10 Weeks|Death|0|||
27804779|NCT01438060|54259993|FG001|Acute Phase: Double-blind, 10 Weeks|Death|2|||
27804780|NCT01438060|54259992|FG000|Acute Phase: Double-blind, 10 Weeks|Other Reason|1|||
27804781|NCT01438060|54259993|FG001|Acute Phase: Double-blind, 10 Weeks|Other Reason|0|||
27804782|NCT01438060|54259992|FG000|Extension Phase: Week 10 to Week 130|Adverse Event|15|||
27804783|NCT01438060|54259993|FG001|Extension Phase: Week 10 to Week 130|Adverse Event|16|||
27804784|NCT01438060|54259992|FG000|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
27804785|NCT01438060|54259993|FG001|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
27804786|NCT01438060|54259992|FG000|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3|||
27804787|NCT01438060|54259993|FG001|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5|||
27804788|NCT01438060|54259992|FG000|Extension Phase: Week 10 to Week 130|Participant Unreliability|1|||
27804789|NCT01438060|54259993|FG001|Extension Phase: Week 10 to Week 130|Participant Unreliability|0|||
27804790|NCT01438060|54259992|FG000|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2|||
27804791|NCT01438060|54259993|FG001|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0|||
27804792|NCT01438060|54259992|FG000|Extension Phase: Week 10 to Week 130|Death|22|||
27804793|NCT01438060|54259993|FG001|Extension Phase: Week 10 to Week 130|Death|12|||
27804794|NCT01438060|54259992|FG000|Extension Phase: Week 10 to Week 130|Other Reason|7|||
27804795|NCT01438060|54259993|FG001|Extension Phase: Week 10 to Week 130|Other Reason|15|||
27804796|NCT01438060|54259992|FG000|On Study Beyond Week 140|Adverse Event|0|||
27804797|NCT01438060|54259993|FG001|On Study Beyond Week 140|Adverse Event|2|||
27804798|NCT01438060|54259992|FG000|On Study Beyond Week 140|Lack of Efficacy|0|||
27804799|NCT01438060|54259993|FG001|On Study Beyond Week 140|Lack of Efficacy|1|||
27804800|NCT01438060|54259992|FG000|On Study Beyond Week 140|Withdrawal by Subject|0|||
27804801|NCT01438060|54259993|FG001|On Study Beyond Week 140|Withdrawal by Subject|1|||
27804802|NCT01438060|54259992|FG000|On Study Beyond Week 140|Death|0|||
27804803|NCT01438060|54259993|FG001|On Study Beyond Week 140|Death|1|||
27804804|NCT01438060|54259992|FG000|On Study Beyond Week 140|Other Reason|0|||
27804805|NCT01438060|54259993|FG001|On Study Beyond Week 140|Other Reason|3|||
27804806|NCT01469182|54260006|FG000|Overall Study|Adverse Event|21|||
27804807|NCT01469182|54260007|FG001|Overall Study|Adverse Event|3|||
27804808|NCT01469182|54260006|FG000|Overall Study|Lost to Follow-up|3|||
27804809|NCT01469182|54260007|FG001|Overall Study|Lost to Follow-up|0|||
27804810|NCT01469182|54260006|FG000|Overall Study|Withdrawal by Subject|4|||
27804811|NCT01469182|54260007|FG001|Overall Study|Withdrawal by Subject|1|||
27804812|NCT01469182|54260006|FG000|Overall Study|Protocol Violation|4|||
27804813|NCT01469182|54260007|FG001|Overall Study|Protocol Violation|2|||
27804814|NCT01469182|54260006|FG000|Overall Study|Did not meet Protocol Eligibility|3|||
27804815|NCT01469182|54260007|FG001|Overall Study|Did not meet Protocol Eligibility|0|||
27804816|NCT01444378|54260013|FG000|Overall Study|Lost to Follow-up|1|||
27804817|NCT01444378|54260013|FG000|Overall Study|Withdrawal by Subject|1|||
27804818|NCT01444378|54260013|FG000|Overall Study|Death|3|||
27804819|NCT01444378|54260013|FG000|Overall Study|Administrative Closure Of The Study|2|||
27804820|NCT01444378|54260013|FG000|Overall Study|Missed Visits|10|||
27804821|NCT02020889|54260022|FG000|Overall Study|Adverse Event|0|||
27804822|NCT02020889|54260023|FG001|Overall Study|Adverse Event|1|||
27804823|NCT02020889|54260022|FG000|Overall Study|Lack of Efficacy|1|||
27804824|NCT02020889|54260023|FG001|Overall Study|Lack of Efficacy|0|||
27804825|NCT02020889|54260022|FG000|Overall Study|Lost to Follow-up|1|||
27804826|NCT02020889|54260023|FG001|Overall Study|Lost to Follow-up|0|||
27804827|NCT02020889|54260022|FG000|Overall Study|Physician Decision|2|||
27804828|NCT02020889|54260023|FG001|Overall Study|Physician Decision|0|||
27804829|NCT02020889|54260022|FG000|Overall Study|Withdrawal by Subject|3|||
27804830|NCT02020889|54260023|FG001|Overall Study|Withdrawal by Subject|2|||
27804831|NCT01444300|54260031|FG000|Overall Study|Adverse Event|4|||
27804832|NCT01444300|54260032|FG001|Overall Study|Adverse Event|0|||
27804833|NCT01443364|54260039|FG000|Overall Study|Lack of Efficacy|14|||
27804834|NCT01443364|54260039|FG000|Overall Study|Lost to Follow-up|3|||
27804835|NCT01443364|54260039|FG000|Overall Study|Withdrawal by Subject|5|||
27804836|NCT01443364|54260039|FG000|Overall Study|Other Reason|4|||
27804837|NCT01443364|54260039|FG000|Overall Study|SAE, non-fatal|6|||
27804838|NCT01443364|54260039|FG000|Overall Study|AE, non-serious non-fatal|8|||
28028876|NCT00506415|54687383|FG003|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
27804839|NCT01443364|54260039|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
27804840|NCT02020577|54260045|FG000|Overall Study|Progressive disease|3|||
27804841|NCT02020577|54260046|FG001|Overall Study|Progressive disease|38|||
27804842|NCT02020577|54260045|FG000|Overall Study|Other AE or clinical progression|0|||
27804843|NCT02020577|54260046|FG001|Overall Study|Other AE or clinical progression|15|||
27804844|NCT02020577|54260045|FG000|Overall Study|Withdrawal by Subject|0|||
27804845|NCT02020577|54260046|FG001|Overall Study|Withdrawal by Subject|1|||
27804846|NCT02020577|54260045|FG000|Overall Study|Other than stated above|0|||
27804847|NCT02020577|54260046|FG001|Overall Study|Other than stated above|1|||
27804848|NCT02020031|54260056|FG000|Overall Study|Physician Decision|1|||
27804849|NCT02020031|54260057|FG001|Overall Study|Physician Decision|1|||
27804850|NCT04179305|54260067|FG000|Overall Study|Death|1|||
27804851|NCT04179305|54260068|FG001|Overall Study|Death|1|||
27804852|NCT04179305|54260069|FG002|Overall Study|Death|0|||
27804853|NCT04179305|54260070|FG003|Overall Study|Death|0|||
27804854|NCT04179305|54260067|FG000|Overall Study|Lost to Follow-up|1|||
27804855|NCT04179305|54260068|FG001|Overall Study|Lost to Follow-up|1|||
27804856|NCT04179305|54260069|FG002|Overall Study|Lost to Follow-up|0|||
27804857|NCT04179305|54260070|FG003|Overall Study|Lost to Follow-up|0|||
27804858|NCT04179305|54260067|FG000|Overall Study|Withdrawal by Subject|0|||
27804859|NCT04179305|54260068|FG001|Overall Study|Withdrawal by Subject|1|||
27804860|NCT04179305|54260069|FG002|Overall Study|Withdrawal by Subject|0|||
27804861|NCT04179305|54260070|FG003|Overall Study|Withdrawal by Subject|0|||
27804862|NCT04179305|54260067|FG000|Overall Study|Did not have scan|1|||
27804863|NCT04179305|54260068|FG001|Overall Study|Did not have scan|0|||
27804864|NCT04179305|54260069|FG002|Overall Study|Did not have scan|0|||
27804865|NCT04179305|54260070|FG003|Overall Study|Did not have scan|0|||
27804866|NCT04179305|54260067|FG000|Overall Study|In hospice care|3|||
27804867|NCT04179305|54260068|FG001|Overall Study|In hospice care|0|||
27804868|NCT04179305|54260069|FG002|Overall Study|In hospice care|0|||
27804869|NCT04179305|54260070|FG003|Overall Study|In hospice care|0|||
27804870|NCT02019719|54260086|FG000|Overall Study|Adverse Event|1|||
27804871|NCT02019719|54260087|FG001|Overall Study|Adverse Event|0|||
27804872|NCT02019719|54260088|FG002|Overall Study|Adverse Event|0|||
27804873|NCT02019719|54260089|FG003|Overall Study|Adverse Event|1|||
27804874|NCT02019719|54260090|FG004|Overall Study|Adverse Event|1|||
27804875|NCT02019719|54260086|FG000|Overall Study|Protocol Violation|1|||
27804876|NCT02019719|54260087|FG001|Overall Study|Protocol Violation|1|||
27804877|NCT02019719|54260088|FG002|Overall Study|Protocol Violation|0|||
27804878|NCT02019719|54260089|FG003|Overall Study|Protocol Violation|0|||
27804879|NCT02019719|54260090|FG004|Overall Study|Protocol Violation|0|||
27804880|NCT02019719|54260086|FG000|Overall Study|Protocol defined stopping criteria|2|||
27804881|NCT02019719|54260087|FG001|Overall Study|Protocol defined stopping criteria|0|||
27804882|NCT02019719|54260088|FG002|Overall Study|Protocol defined stopping criteria|0|||
27804883|NCT02019719|54260089|FG003|Overall Study|Protocol defined stopping criteria|1|||
27804884|NCT02019719|54260090|FG004|Overall Study|Protocol defined stopping criteria|1|||
27804885|NCT02019719|54260086|FG000|Overall Study|Physician Decision|2|||
27804886|NCT02019719|54260087|FG001|Overall Study|Physician Decision|0|||
27804887|NCT02019719|54260088|FG002|Overall Study|Physician Decision|0|||
27804888|NCT02019719|54260089|FG003|Overall Study|Physician Decision|0|||
27804889|NCT02019719|54260090|FG004|Overall Study|Physician Decision|0|||
27804890|NCT02030405|54260109|FG000|Overall Study|Withdrawal by Subject|1|||
27804891|NCT02030405|54260109|FG000|Overall Study|Lost to Follow-up|1|||
27804892|NCT01975376|54260116|FG000|Overall Study|Adverse Event|5|||
27804893|NCT01975376|54260117|FG001|Overall Study|Adverse Event|5|||
27804894|NCT01975376|54260116|FG000|Overall Study|Death|65|||
27804895|NCT01975376|54260117|FG001|Overall Study|Death|72|||
27804896|NCT01975376|54260116|FG000|Overall Study|Lost to Follow-up|70|||
27804897|NCT01975376|54260117|FG001|Overall Study|Lost to Follow-up|66|||
27804898|NCT01975376|54260116|FG000|Overall Study|Withdrew consent|68|||
27804899|NCT01975376|54260117|FG001|Overall Study|Withdrew consent|62|||
27804900|NCT01975376|54260116|FG000|Overall Study|Other|2|||
27804901|NCT01975376|54260117|FG001|Overall Study|Other|4|||
27804902|NCT01975376|54260116|FG000|Overall Study|Randomized, Not Treated|16|||
27804903|NCT01975376|54260117|FG001|Overall Study|Randomized, Not Treated|8|||
27804904|NCT01443130|54260129|FG000|Overall Study|Lost to Follow-up|44|||
27804905|NCT01443130|54260130|FG001|Overall Study|Lost to Follow-up|42|||
27804906|NCT01443130|54260131|FG002|Overall Study|Lost to Follow-up|50|||
27804907|NCT01443130|54260132|FG003|Overall Study|Lost to Follow-up|23|||
27804908|NCT01443130|54260133|FG004|Overall Study|Lost to Follow-up|25|||
27804909|NCT01443130|54260134|FG005|Overall Study|Lost to Follow-up|21|||
27804910|NCT01443130|54260129|FG000|Overall Study|Death|0|||
27804911|NCT01443130|54260130|FG001|Overall Study|Death|1|||
27804912|NCT01443130|54260131|FG002|Overall Study|Death|0|||
27804913|NCT01443130|54260132|FG003|Overall Study|Death|7|||
27804914|NCT01443130|54260133|FG004|Overall Study|Death|10|||
27804915|NCT01443130|54260134|FG005|Overall Study|Death|8|||
27804916|NCT01443130|54260129|FG000|Overall Study|Adverse Event|2|||
27804917|NCT01443130|54260130|FG001|Overall Study|Adverse Event|1|||
27804918|NCT01443130|54260131|FG002|Overall Study|Adverse Event|1|||
27804919|NCT01443130|54260132|FG003|Overall Study|Adverse Event|0|||
27804920|NCT01443130|54260133|FG004|Overall Study|Adverse Event|0|||
27804921|NCT01443130|54260134|FG005|Overall Study|Adverse Event|0|||
27804922|NCT01443130|54260129|FG000|Overall Study|Protocol Violation|2|||
27804923|NCT01443130|54260130|FG001|Overall Study|Protocol Violation|1|||
27804924|NCT01443130|54260131|FG002|Overall Study|Protocol Violation|3|||
27804925|NCT01443130|54260132|FG003|Overall Study|Protocol Violation|2|||
27804926|NCT01443130|54260133|FG004|Overall Study|Protocol Violation|2|||
27804927|NCT01443130|54260134|FG005|Overall Study|Protocol Violation|3|||
27804928|NCT01443130|54260129|FG000|Overall Study|Withdrawal by Subject|15|||
27804929|NCT01443130|54260130|FG001|Overall Study|Withdrawal by Subject|14|||
27804930|NCT01443130|54260131|FG002|Overall Study|Withdrawal by Subject|12|||
27804931|NCT01443130|54260132|FG003|Overall Study|Withdrawal by Subject|7|||
27804932|NCT01443130|54260133|FG004|Overall Study|Withdrawal by Subject|7|||
27804933|NCT01443130|54260134|FG005|Overall Study|Withdrawal by Subject|2|||
27804934|NCT01443130|54260129|FG000|Overall Study|Death of Subject's Infant|5|||
28028877|NCT00506415|54687380|FG000|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
28028878|NCT00506415|54687381|FG001|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
28028879|NCT00506415|54687382|FG002|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1|||
28028880|NCT00506415|54687383|FG003|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
28028881|NCT00506415|54687380|FG000|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
28028882|NCT00506415|54687381|FG001|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
28028883|NCT00506415|54687382|FG002|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
28028884|NCT00506415|54687383|FG003|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4|||
28028885|NCT00506415|54687380|FG000|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
28028886|NCT00506415|54687381|FG001|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
28028887|NCT00506415|54687382|FG002|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
28028888|NCT00506415|54687383|FG003|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18|||
28028889|NCT00506415|54687380|FG000|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
28028890|NCT00506415|54687381|FG001|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
28028891|NCT00506415|54687382|FG002|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
28028892|NCT00506415|54687383|FG003|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8|||
28028893|NCT00506415|54687380|FG000|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
28028894|NCT00506415|54687381|FG001|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
28028895|NCT00506415|54687382|FG002|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
28028896|NCT00506415|54687383|FG003|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14|||
28028897|NCT00506415|54687380|FG000|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
28028898|NCT00506415|54687381|FG001|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
28028899|NCT00506415|54687382|FG002|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
28028900|NCT00506415|54687383|FG003|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5|||
28028901|NCT00506415|54687380|FG000|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
28028902|NCT00506415|54687381|FG001|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
28028903|NCT00506415|54687382|FG002|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
28028904|NCT00506415|54687383|FG003|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6|||
28028905|NCT00506415|54687380|FG000|Extended Open Label (Maximum 48 Weeks)|Death|0|||
28028906|NCT00506415|54687381|FG001|Extended Open Label (Maximum 48 Weeks)|Death|0|||
27804935|NCT01443130|54260130|FG001|Overall Study|Death of Subject's Infant|10|||
27804936|NCT01443130|54260131|FG002|Overall Study|Death of Subject's Infant|11|||
27804937|NCT01443130|54260132|FG003|Overall Study|Death of Subject's Infant|0|||
27804938|NCT01443130|54260133|FG004|Overall Study|Death of Subject's Infant|0|||
27804939|NCT01443130|54260134|FG005|Overall Study|Death of Subject's Infant|0|||
27804940|NCT01436500|54260150|FG000|Overall Study|Death|1|||
27804941|NCT01436500|54260151|FG001|Overall Study|Death|0|||
27804942|NCT01436500|54260152|FG002|Overall Study|Death|0|||
27804943|NCT01436500|54260153|FG003|Overall Study|Death|0|||
27804944|NCT01436500|54260154|FG004|Overall Study|Death|0|||
27804945|NCT01436500|54260150|FG000|Overall Study|Adverse Event|0|||
27804946|NCT01436500|54260151|FG001|Overall Study|Adverse Event|2|||
27804947|NCT01436500|54260152|FG002|Overall Study|Adverse Event|2|||
27804948|NCT01436500|54260153|FG003|Overall Study|Adverse Event|0|||
27804949|NCT01436500|54260154|FG004|Overall Study|Adverse Event|1|||
27804950|NCT01436500|54260150|FG000|Overall Study|Withdrawal by Subject|0|||
27804951|NCT01436500|54260151|FG001|Overall Study|Withdrawal by Subject|0|||
27804952|NCT01436500|54260152|FG002|Overall Study|Withdrawal by Subject|2|||
28028907|NCT00506415|54687382|FG002|Extended Open Label (Maximum 48 Weeks)|Death|0|||
27804953|NCT01436500|54260153|FG003|Overall Study|Withdrawal by Subject|0|||
27804954|NCT01436500|54260154|FG004|Overall Study|Withdrawal by Subject|2|||
27804955|NCT01436500|54260150|FG000|Overall Study|Physician Decision|0|||
27804956|NCT01436500|54260151|FG001|Overall Study|Physician Decision|0|||
27804957|NCT01436500|54260152|FG002|Overall Study|Physician Decision|1|||
27804958|NCT01436500|54260153|FG003|Overall Study|Physician Decision|0|||
27804959|NCT01436500|54260154|FG004|Overall Study|Physician Decision|0|||
27804960|NCT01436500|54260150|FG000|Overall Study|liver transplant|1|||
27804961|NCT01436500|54260151|FG001|Overall Study|liver transplant|0|||
27804962|NCT01436500|54260152|FG002|Overall Study|liver transplant|0|||
27804963|NCT01436500|54260153|FG003|Overall Study|liver transplant|0|||
27804964|NCT01436500|54260154|FG004|Overall Study|liver transplant|0|||
27804965|NCT01436500|54260150|FG000|Overall Study|initiation of dialysis|0|||
27804966|NCT01436500|54260151|FG001|Overall Study|initiation of dialysis|0|||
27804967|NCT01436500|54260152|FG002|Overall Study|initiation of dialysis|0|||
27804968|NCT01436500|54260153|FG003|Overall Study|initiation of dialysis|0|||
27804969|NCT01436500|54260154|FG004|Overall Study|initiation of dialysis|1|||
27804970|NCT01436500|54260150|FG000|Overall Study|discontinued study drug|1|||
27804971|NCT01436500|54260151|FG001|Overall Study|discontinued study drug|0|||
27804972|NCT01436500|54260152|FG002|Overall Study|discontinued study drug|0|||
27804973|NCT01436500|54260153|FG003|Overall Study|discontinued study drug|0|||
27804974|NCT01436500|54260154|FG004|Overall Study|discontinued study drug|0|||
27804975|NCT01436500|54260150|FG000|Overall Study|Other|0|||
27804976|NCT01436500|54260151|FG001|Overall Study|Other|1|||
27804977|NCT01436500|54260152|FG002|Overall Study|Other|0|||
27804978|NCT01436500|54260153|FG003|Overall Study|Other|1|||
27804979|NCT01436500|54260154|FG004|Overall Study|Other|0|||
27804980|NCT01958827|54260167|FG000|Overall Study|Adverse Event|3|||
27804981|NCT01958827|54260167|FG000|Overall Study|Lack of Efficacy|6|||
27804982|NCT01958827|54260167|FG000|Overall Study|Concomitant Prohibited Medicine for AE|1|||
27804983|NCT01620086|54260173|FG000|Overall Study|Withdrawal by Subject|3|||
27804984|NCT01620086|54260174|FG001|Overall Study|Withdrawal by Subject|3|||
27804985|NCT01620086|54260175|FG002|Overall Study|Withdrawal by Subject|0|||
27804986|NCT01620086|54260173|FG000|Overall Study|failed study criteria|1|||
27804987|NCT01620086|54260174|FG001|Overall Study|failed study criteria|4|||
27804988|NCT01620086|54260175|FG002|Overall Study|failed study criteria|0|||
27804989|NCT01620086|54260173|FG000|Overall Study|Physician Decision|1|||
27804990|NCT01620086|54260174|FG001|Overall Study|Physician Decision|0|||
27804991|NCT01620086|54260175|FG002|Overall Study|Physician Decision|0|||
27804992|NCT01436110|54260187|FG000|Overall Study|Lack of Efficacy|23|||
27804993|NCT01436110|54260188|FG001|Overall Study|Lack of Efficacy|14|||
27804994|NCT01436110|54260189|FG002|Overall Study|Lack of Efficacy|9|||
27804995|NCT01436110|54260187|FG000|Overall Study|Withdrawal by Subject|6|||
27804996|NCT01436110|54260188|FG001|Overall Study|Withdrawal by Subject|8|||
27804997|NCT01436110|54260189|FG002|Overall Study|Withdrawal by Subject|4|||
27804998|NCT01436110|54260187|FG000|Overall Study|Adverse Event|2|||
27804999|NCT01436110|54260188|FG001|Overall Study|Adverse Event|1|||
27805000|NCT01436110|54260189|FG002|Overall Study|Adverse Event|2|||
27805001|NCT01436110|54260187|FG000|Overall Study|Physician Decision|3|||
27805002|NCT01436110|54260188|FG001|Overall Study|Physician Decision|1|||
27805003|NCT01436110|54260189|FG002|Overall Study|Physician Decision|1|||
27805004|NCT01436110|54260187|FG000|Overall Study|Lost to Follow-up|1|||
27805005|NCT01436110|54260188|FG001|Overall Study|Lost to Follow-up|1|||
27805006|NCT01436110|54260189|FG002|Overall Study|Lost to Follow-up|3|||
27805007|NCT01436110|54260187|FG000|Overall Study|Protocol Violation|3|||
27805008|NCT01436110|54260188|FG001|Overall Study|Protocol Violation|1|||
27805009|NCT01436110|54260189|FG002|Overall Study|Protocol Violation|1|||
27805010|NCT01436110|54260187|FG000|Overall Study|Did Not Receive Trial Medication|1|||
27805011|NCT01436110|54260188|FG001|Overall Study|Did Not Receive Trial Medication|0|||
27805012|NCT01436110|54260189|FG002|Overall Study|Did Not Receive Trial Medication|3|||
27805013|NCT01619852|54260199|FG000|24 Hour Assessment|Withdrawal by Subject|1|||
27805014|NCT01619852|54260200|FG001|24 Hour Assessment|Withdrawal by Subject|1|||
27805015|NCT01619852|54260199|FG000|3 Month Follow up|Lost to Follow-up|31|||
27805016|NCT01619852|54260200|FG001|3 Month Follow up|Lost to Follow-up|34|||
27805017|NCT02000882|54260207|FG000|Overall Study|Adverse Event|3|||
27805018|NCT02000882|54260207|FG000|Overall Study|Physician Decision|2|||
27805019|NCT02000882|54260207|FG000|Overall Study|Withdrawal by Subject|1|||
27805020|NCT01965938|54260213|FG000|Overall Study|Withdrawal by Subject|1|||
28028908|NCT00506415|54687383|FG003|Extended Open Label (Maximum 48 Weeks)|Death|7|||
28028909|NCT00452452|54687399|FG000|Overall Study|Protocol Violation|0|||
27805021|NCT01965938|54260214|FG001|Overall Study|Withdrawal by Subject|0|||
27805022|NCT01965860|54260225|FG000|Overall Study|Pregnancy|1|||
27805023|NCT01965860|54260226|FG001|Overall Study|Pregnancy|0|||
27805024|NCT01965860|54260227|FG002|Overall Study|Pregnancy|1|||
27805025|NCT01965860|54260225|FG000|Overall Study|Logistics|1|||
27805026|NCT01965860|54260226|FG001|Overall Study|Logistics|0|||
27805027|NCT01965860|54260227|FG002|Overall Study|Logistics|0|||
27805028|NCT01965704|54260248|FG000|Overall Study|Withdrawal by Subject|2|||
27805029|NCT01965704|54260249|FG001|Overall Study|Withdrawal by Subject|2|||
27805030|NCT01965704|54260250|FG002|Overall Study|Withdrawal by Subject|1|||
27805031|NCT01965704|54260251|FG003|Overall Study|Withdrawal by Subject|1|||
27805032|NCT01965704|54260248|FG000|Overall Study|Delivered at home|1|||
27805033|NCT01965704|54260249|FG001|Overall Study|Delivered at home|1|||
27805034|NCT01965704|54260250|FG002|Overall Study|Delivered at home|0|||
27805035|NCT01965704|54260251|FG003|Overall Study|Delivered at home|0|||
27805036|NCT01965704|54260248|FG000|Overall Study|Experienced complications|0|||
27805037|NCT01965704|54260249|FG001|Overall Study|Experienced complications|0|||
27805038|NCT01965704|54260250|FG002|Overall Study|Experienced complications|2|||
27805039|NCT01965704|54260251|FG003|Overall Study|Experienced complications|2|||
27805040|NCT01965704|54260248|FG000|Overall Study|Adverse Event|0|||
27805041|NCT01965704|54260249|FG001|Overall Study|Adverse Event|0|||
27805042|NCT01965704|54260250|FG002|Overall Study|Adverse Event|1|||
27805043|NCT01965704|54260251|FG003|Overall Study|Adverse Event|1|||
27805044|NCT01965704|54260248|FG000|Overall Study|Did not meet inclusion criteria|0|||
27805045|NCT01965704|54260249|FG001|Overall Study|Did not meet inclusion criteria|0|||
27805046|NCT01965704|54260250|FG002|Overall Study|Did not meet inclusion criteria|1|||
27805047|NCT01965704|54260251|FG003|Overall Study|Did not meet inclusion criteria|1|||
27805048|NCT02003365|54260262|FG000|Overall Study|Lost to Follow-up|0|||
27805049|NCT02003365|54260263|FG001|Overall Study|Lost to Follow-up|0|||
27805050|NCT02003365|54260264|FG002|Overall Study|Lost to Follow-up|1|||
27805051|NCT01975220|54260275|FG000|Test Period 1|Not treated|0|||
27805052|NCT01975220|54260276|FG001|Test Period 1|Not treated|1|||
27805053|NCT01975220|54260277|FG002|Test Period 1|Not treated|0|||
27805054|NCT01975220|54260278|FG003|Test Period 1|Not treated|0|||
27805055|NCT01975220|54260279|FG004|Test Period 1|Not treated|0|||
27805056|NCT01975220|54260280|FG005|Test Period 1|Not treated|0|||
27805057|NCT01958437|54260297|FG000|Overall Study|Incidental MRI findings|0|||
27805058|NCT01958437|54260298|FG001|Overall Study|Incidental MRI findings|0|||
27805059|NCT01958437|54260299|FG002|Overall Study|Incidental MRI findings|1|||
27805060|NCT01958437|54260300|FG003|Overall Study|Incidental MRI findings|1|||
27805061|NCT01974752|54260319|FG000|Overall Study|Death|33|||
27805062|NCT01974752|54260320|FG001|Overall Study|Death|11|||
27805063|NCT01974752|54260319|FG000|Overall Study|Lost to Follow-up|2|||
27805064|NCT01974752|54260320|FG001|Overall Study|Lost to Follow-up|0|||
27805065|NCT01974752|54260319|FG000|Overall Study|Withdrawal by Subject|2|||
27805066|NCT01974752|54260320|FG001|Overall Study|Withdrawal by Subject|3|||
27805067|NCT01974752|54260319|FG000|Overall Study|Other Eligibility Criteria|0|||
27805068|NCT01974752|54260320|FG001|Overall Study|Other Eligibility Criteria|1|||
27805069|NCT01999946|54260329|FG000|Overall Study|Participant not released from jail|2|||
27805070|NCT01999946|54260330|FG001|Overall Study|Participant not released from jail|2|||
27805071|NCT01999946|54260331|FG002|Overall Study|Participant not released from jail|0|||
27805072|NCT01999946|54260329|FG000|Overall Study|Not included in primary outcome analysis|0|||
27805073|NCT01999946|54260330|FG001|Overall Study|Not included in primary outcome analysis|0|||
28028910|NCT00452452|54687400|FG001|Overall Study|Protocol Violation|0|||
28028911|NCT00452452|54687401|FG002|Overall Study|Protocol Violation|1|||
28028912|NCT00452452|54687399|FG000|Overall Study|Withdrawal by Subject|1|||
28028913|NCT00452452|54687400|FG001|Overall Study|Withdrawal by Subject|0|||
28028914|NCT00452452|54687401|FG002|Overall Study|Withdrawal by Subject|0|||
28028915|NCT00452452|54687399|FG000|Overall Study|Lost to Follow-up|1|||
28028916|NCT00452452|54687400|FG001|Overall Study|Lost to Follow-up|0|||
28028917|NCT00452452|54687401|FG002|Overall Study|Lost to Follow-up|0|||
28028918|NCT00510783|54687417|FG000|Overall Study|Lost to Follow-up|29|||
28028919|NCT00510783|54687418|FG001|Overall Study|Lost to Follow-up|25|||
28028920|NCT00510783|54687417|FG000|Overall Study|Withdrawal by Subject|2|||
28028921|NCT00510783|54687418|FG001|Overall Study|Withdrawal by Subject|3|||
28028922|NCT00510783|54687417|FG000|Overall Study|Protocol Violation|0|||
28028923|NCT00510783|54687418|FG001|Overall Study|Protocol Violation|1|||
28028924|NCT00518973|54687426|FG000|Overall Study|Withdrawal by Subject|3|||
28028925|NCT00518973|54687427|FG001|Overall Study|Withdrawal by Subject|2|||
28028926|NCT00462670|54687435|FG000|Overall Study|Adverse Event|3|||
28028927|NCT00462670|54687436|FG001|Overall Study|Adverse Event|5|||
28028928|NCT00462670|54687435|FG000|Overall Study|Lack of Efficacy|1|||
27805074|NCT01999946|54260331|FG002|Overall Study|Not included in primary outcome analysis|79|||
27805075|NCT01958281|54260341|FG000|Overall Study|Lack of Efficacy|5|||
27805076|NCT01958281|54260342|FG001|Overall Study|Lack of Efficacy|2|||
27805077|NCT01958281|54260343|FG002|Overall Study|Lack of Efficacy|0|||
27805078|NCT01958281|54260341|FG000|Overall Study|Adverse Event|0|||
28028929|NCT00462670|54687436|FG001|Overall Study|Lack of Efficacy|0|||
28028930|NCT00462670|54687435|FG000|Overall Study|Protocol Violation|1|||
28028931|NCT00462670|54687436|FG001|Overall Study|Protocol Violation|0|||
28028932|NCT00462670|54687435|FG000|Overall Study|Resolution of signs and symptoms|0|||
28028933|NCT00462670|54687436|FG001|Overall Study|Resolution of signs and symptoms|2|||
28028934|NCT00606086|54687444|FG000|Overall Study|Adverse Event|1|||
28028935|NCT00606086|54687445|FG001|Overall Study|Adverse Event|1|||
28028936|NCT00606086|54687444|FG000|Overall Study|Lost to Follow-up|4|||
28028937|NCT00606086|54687445|FG001|Overall Study|Lost to Follow-up|8|||
27805079|NCT01958281|54260342|FG001|Overall Study|Adverse Event|2|||
27805080|NCT01958281|54260343|FG002|Overall Study|Adverse Event|0|||
27805081|NCT01958281|54260341|FG000|Overall Study|Withdrew Consent|1|||
27805082|NCT01958281|54260342|FG001|Overall Study|Withdrew Consent|0|||
27805083|NCT01958281|54260343|FG002|Overall Study|Withdrew Consent|0|||
27805084|NCT01958125|54260354|FG000|Overall Study|Missing diary data|2|||
27805085|NCT01958125|54260355|FG001|Overall Study|Missing diary data|6|||
27805086|NCT01958125|54260354|FG000|Overall Study|No headache attacks|0|||
28028938|NCT00606086|54687444|FG000|Overall Study|Protocol Violation|1|||
27805087|NCT01958125|54260355|FG001|Overall Study|No headache attacks|2|||
27805088|NCT02002975|54260361|FG000|Overall Study|Case Report Forms Uncollected|135|||
27805089|NCT02002975|54260361|FG000|Overall Study|Protocol Deviation|437|||
27805090|NCT02001181|54260367|FG000|Overall Study|Adverse Event|0|||
27805091|NCT02001181|54260368|FG001|Overall Study|Adverse Event|2|||
27805092|NCT02001181|54260367|FG000|Overall Study|Lost to Follow-up|1|||
27805093|NCT02001181|54260368|FG001|Overall Study|Lost to Follow-up|0|||
27805094|NCT02001181|54260367|FG000|Overall Study|Withdrawal by Subject|0|||
27805095|NCT02001181|54260368|FG001|Overall Study|Withdrawal by Subject|1|||
27805096|NCT01999465|54260376|FG000|Overall Study|Lost to Follow-up|0|||
27805097|NCT01999465|54260377|FG001|Overall Study|Lost to Follow-up|2|||
27805098|NCT01999465|54260376|FG000|Overall Study|Protocol Violation|0|||
27805099|NCT01999465|54260377|FG001|Overall Study|Protocol Violation|1|||
27805100|NCT01982773|54260385|FG000|Overall Study|Withdrawal by Subject|1|||
27805101|NCT01982773|54260386|FG001|Overall Study|Withdrawal by Subject|3|||
27805102|NCT01982773|54260385|FG000|Overall Study|Lost to Follow-up|7|||
27805103|NCT01982773|54260386|FG001|Overall Study|Lost to Follow-up|1|||
27805104|NCT01974206|54260394|FG000|Overall Study|Did Not Take Study Drug|0|||
27805105|NCT01974206|54260395|FG001|Overall Study|Did Not Take Study Drug|1|||
27805106|NCT01974206|54260394|FG000|Overall Study|Physician Decision|1|||
27805107|NCT01974206|54260395|FG001|Overall Study|Physician Decision|0|||
27805108|NCT01974206|54260394|FG000|Overall Study|Withdrawal by Subject|3|||
27805109|NCT01974206|54260395|FG001|Overall Study|Withdrawal by Subject|0|||
27805110|NCT01974206|54260394|FG000|Overall Study|Lost to Follow-up|1|||
27805111|NCT01974206|54260395|FG001|Overall Study|Lost to Follow-up|0|||
27805112|NCT01974206|54260394|FG000|Overall Study|Death|1|||
27805113|NCT01974206|54260395|FG001|Overall Study|Death|0|||
27805114|NCT01999868|54260404|FG000|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
27805115|NCT01999868|54260405|FG001|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
27805116|NCT01999868|54260406|FG002|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5|||
27805117|NCT01999868|54260404|FG000|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
27805118|NCT01999868|54260405|FG001|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
27805119|NCT01999868|54260406|FG002|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0|||
27805120|NCT01999868|54260404|FG000|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3|||
27805121|NCT01999868|54260405|FG001|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4|||
27805122|NCT01999868|54260406|FG002|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0|||
27805123|NCT01999868|54260404|FG000|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
27805124|NCT01999868|54260405|FG001|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1|||
27805125|NCT01999868|54260406|FG002|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
27805126|NCT01999868|54260404|FG000|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
27805127|NCT01999868|54260405|FG001|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2|||
27805128|NCT01999868|54260406|FG002|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
27805129|NCT01999868|54260404|FG000|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1|||
27805130|NCT01999868|54260405|FG001|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2|||
27805131|NCT01999868|54260406|FG002|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0|||
27805132|NCT01999868|54260404|FG000|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8|||
27805133|NCT01999868|54260405|FG001|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1|||
27805134|NCT01999868|54260406|FG002|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0|||
27805135|NCT01999868|54260404|FG000|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1|||
27805136|NCT01999868|54260405|FG001|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
27805137|NCT01999868|54260406|FG002|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
27805138|NCT01999868|54260404|FG000|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4|||
27805139|NCT01999868|54260405|FG001|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
27805140|NCT01999868|54260406|FG002|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
27805141|NCT01999868|54260404|FG000|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
27805142|NCT01999868|54260405|FG001|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1|||
27805143|NCT01999868|54260406|FG002|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
27805144|NCT01999868|54260404|FG000|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
27805145|NCT01999868|54260405|FG001|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1|||
27805146|NCT01999868|54260406|FG002|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
27805147|NCT01999868|54260404|FG000|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1|||
27805148|NCT01999868|54260405|FG001|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2|||
27805149|NCT01999868|54260406|FG002|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0|||
27805150|NCT01999868|54260404|FG000|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10|||
27805151|NCT01999868|54260405|FG001|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19|||
27805152|NCT01999868|54260406|FG002|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0|||
27805153|NCT01999868|54260404|FG000|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
27805154|NCT01999868|54260405|FG001|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2|||
27805155|NCT01999868|54260406|FG002|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
27805156|NCT01999868|54260404|FG000|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12|||
27805157|NCT01999868|54260405|FG001|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4|||
27805158|NCT01999868|54260406|FG002|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0|||
27805159|NCT01957579|54260418|FG000|Overall Study|Withdrawal of concent|0|||
27805160|NCT01957579|54260419|FG001|Overall Study|Withdrawal of concent|1|||
27805161|NCT01957579|54260420|FG002|Overall Study|Withdrawal of concent|0|||
27805162|NCT01957579|54260421|FG003|Overall Study|Withdrawal of concent|0|||
27805163|NCT01957579|54260418|FG000|Overall Study|Death|0|||
27805164|NCT01957579|54260419|FG001|Overall Study|Death|0|||
27805165|NCT01957579|54260420|FG002|Overall Study|Death|2|||
27805166|NCT01957579|54260421|FG003|Overall Study|Death|0|||
27805167|NCT01999322|54260450|FG000|Overall Study|Adverse Event|1|||
27805168|NCT01999322|54260451|FG001|Overall Study|Adverse Event|0|||
27805169|NCT01996982|54260457|FG000|Overall Study|PI/team left institution|7|||
27805170|NCT01965158|54260463|FG000|Overall Study|Adverse Event|14|||
27805171|NCT01965158|54260464|FG001|Overall Study|Adverse Event|5|||
27805172|NCT01965158|54260463|FG000|Overall Study|Withdrawal by Subject|16|||
27805173|NCT01965158|54260464|FG001|Overall Study|Withdrawal by Subject|24|||
27805174|NCT01965158|54260463|FG000|Overall Study|Lost to Follow-up|7|||
27805175|NCT01965158|54260464|FG001|Overall Study|Lost to Follow-up|5|||
27805176|NCT01965158|54260463|FG000|Overall Study|Protocol Violation|1|||
27805177|NCT01965158|54260464|FG001|Overall Study|Protocol Violation|1|||
28028939|NCT00606086|54687445|FG001|Overall Study|Protocol Violation|0|||
28028940|NCT00606086|54687444|FG000|Overall Study|Withdrawal by Subject|5|||
28028941|NCT00606086|54687445|FG001|Overall Study|Withdrawal by Subject|3|||
28028942|NCT00606086|54687444|FG000|Overall Study|Non-compliance|0|||
28028943|NCT00606086|54687445|FG001|Overall Study|Non-compliance|1|||
28028944|NCT00606086|54687444|FG000|Overall Study|Randomized, not treated|1|||
28028945|NCT00606086|54687445|FG001|Overall Study|Randomized, not treated|2|||
28028946|NCT00609986|54687453|FG000|Overall Study|Did not receive transplant or treatment|8|||
28028947|NCT00609986|54687454|FG001|Overall Study|Did not receive transplant or treatment|3|||
28028948|NCT00451906|54687460|FG000|Overall Study|Adverse Event|515|||
28028949|NCT00451906|54687460|FG000|Overall Study|Lost to Follow-up|31|||
28028950|NCT00451906|54687460|FG000|Overall Study|Withdrawal by Subject|111|||
28028951|NCT00451906|54687460|FG000|Overall Study|Protocol Violation|21|||
28028952|NCT00451906|54687460|FG000|Overall Study|Progressive disease|1328|||
28028953|NCT00451906|54687460|FG000|Overall Study|Termination of the study|108|||
28028954|NCT00451906|54687460|FG000|Overall Study|Other Reasons|121|||
28028955|NCT00451906|54687460|FG000|Overall Study|Did not complete final visit|4|||
28028956|NCT00451282|54687466|FG000|Overall Study|Lost to Follow-up|6|||
28028957|NCT00451282|54687467|FG001|Overall Study|Lost to Follow-up|5|||
28028958|NCT03838198|54687475|FG000|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
28028959|NCT03838198|54687476|FG001|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
28028960|NCT03838198|54687477|FG002|Phase 2: Added Booster Call or Not|Withdrawal by Subject|1|||
28028961|NCT03838198|54687478|FG003|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
28028962|NCT03838198|54687475|FG000|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
28028963|NCT03838198|54687476|FG001|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
28028964|NCT03838198|54687477|FG002|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
28028965|NCT03838198|54687478|FG003|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
28028966|NCT00115765|54687493|FG000|Overall Study|Withdrawal by Subject|22|||
27805178|NCT01965158|54260463|FG000|Overall Study|Other - Miscellaneous|3|||
27805179|NCT01965158|54260464|FG001|Overall Study|Other - Miscellaneous|0|||
27805180|NCT01964924|54260470|FG000|Trametinib Monotherapy|Progression|19|||
27805181|NCT01964924|54260471|FG001|Trametinib Monotherapy|Progression|0|||
27805182|NCT01964378|54260482|FG000|Overall Study|Disc. due to death before first dosing|0|||
27805183|NCT01964378|54260483|FG001|Overall Study|Disc. due to death before first dosing|1|||
27805184|NCT01964378|54260482|FG000|Overall Study|Disc. due to AE before first dosing|1|||
27805185|NCT01964378|54260483|FG001|Overall Study|Disc. due to AE before first dosing|0|||
27805186|NCT01964378|54260482|FG000|Overall Study|Death|3|||
27805187|NCT01964378|54260483|FG001|Overall Study|Death|2|||
27805188|NCT01964378|54260482|FG000|Overall Study|Adverse Event|12|||
28028967|NCT00115765|54687494|FG001|Overall Study|Withdrawal by Subject|53|||
28028968|NCT00115765|54687495|FG002|Overall Study|Withdrawal by Subject|76|||
28028969|NCT00115765|54687496|FG003|Overall Study|Withdrawal by Subject|15|||
27805189|NCT01964378|54260483|FG001|Overall Study|Adverse Event|5|||
27805190|NCT01964378|54260482|FG000|Overall Study|Lack of Efficacy|0|||
27805191|NCT01964378|54260483|FG001|Overall Study|Lack of Efficacy|1|||
27805192|NCT01964378|54260482|FG000|Overall Study|Protocol Violation|0|||
27805193|NCT01964378|54260483|FG001|Overall Study|Protocol Violation|1|||
27805194|NCT01964378|54260482|FG000|Overall Study|Lost to Follow-up|0|||
27805195|NCT01964378|54260483|FG001|Overall Study|Lost to Follow-up|1|||
27805196|NCT01964378|54260482|FG000|Overall Study|Withdrawal by Subject|7|||
27805197|NCT01964378|54260483|FG001|Overall Study|Withdrawal by Subject|5|||
27805198|NCT01964378|54260482|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
27805199|NCT01964378|54260483|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
27805200|NCT01964378|54260482|FG000|Overall Study|Other|1|||
27805201|NCT01964378|54260483|FG001|Overall Study|Other|2|||
27805202|NCT01442038|54260491|FG000|Overall Study|Death|35|||
27805203|NCT01442038|54260492|FG001|Overall Study|Death|29|||
27805204|NCT01442038|54260491|FG000|Overall Study|Investigator-Initiated Early Closure|44|||
27805205|NCT01442038|54260492|FG001|Overall Study|Investigator-Initiated Early Closure|43|||
27805206|NCT01442038|54260491|FG000|Overall Study|Participant Withdrew Consent|137|||
27805207|NCT01442038|54260492|FG001|Overall Study|Participant Withdrew Consent|102|||
27805208|NCT01442038|54260491|FG000|Overall Study|Lost to Follow-up|37|||
27805209|NCT01442038|54260492|FG001|Overall Study|Lost to Follow-up|51|||
27805210|NCT01442038|54260491|FG000|Overall Study|Adverse Event|26|||
27805211|NCT01442038|54260492|FG001|Overall Study|Adverse Event|15|||
27805212|NCT01442038|54260491|FG000|Overall Study|Protocol Deviation|9|||
27805213|NCT01442038|54260492|FG001|Overall Study|Protocol Deviation|20|||
27805214|NCT01442038|54260491|FG000|Overall Study|Investigator's Discretion|13|||
27805215|NCT01442038|54260492|FG001|Overall Study|Investigator's Discretion|16|||
27805216|NCT01442038|54260491|FG000|Overall Study|Study Terminated By Sponsor|2|||
27805217|NCT01442038|54260492|FG001|Overall Study|Study Terminated By Sponsor|3|||
27805218|NCT01998919|54260500|FG000|Overall Study|Death|2|||
27805219|NCT01998919|54260501|FG001|Overall Study|Death|2|||
27805220|NCT01998919|54260500|FG000|Overall Study|Adverse Event|0|||
27805221|NCT01998919|54260501|FG001|Overall Study|Adverse Event|5|||
27805222|NCT01998919|54260500|FG000|Overall Study|Disease progression|31|||
27805223|NCT01998919|54260501|FG001|Overall Study|Disease progression|22|||
27805224|NCT01998919|54260500|FG000|Overall Study|Withdrawal by Subject|2|||
27805225|NCT01998919|54260501|FG001|Overall Study|Withdrawal by Subject|4|||
27805226|NCT01998919|54260500|FG000|Overall Study|Lost to Follow-up|2|||
27805227|NCT01998919|54260501|FG001|Overall Study|Lost to Follow-up|0|||
27805228|NCT01998919|54260500|FG000|Overall Study|Other|5|||
27805229|NCT01998919|54260501|FG001|Overall Study|Other|2|||
27805230|NCT01957111|54260509|FG000|Overall Study|Withdrawal by Subject|1|||
27805231|NCT01957111|54260510|FG001|Overall Study|Withdrawal by Subject|1|||
27805232|NCT01964300|54260518|FG000|Overall Study|Ineligible after enrollment|0|||
27805233|NCT01964300|54260519|FG001|Overall Study|Ineligible after enrollment|1|||
27805234|NCT01964300|54260518|FG000|Overall Study|Adverse Event|1|||
27805235|NCT01964300|54260519|FG001|Overall Study|Adverse Event|1|||
27805236|NCT01964300|54260518|FG000|Overall Study|Lack of Efficacy|3|||
27805237|NCT01964300|54260519|FG001|Overall Study|Lack of Efficacy|5|||
27805238|NCT01964300|54260518|FG000|Overall Study|Withdrawal by Subject|0|||
27805239|NCT01964300|54260519|FG001|Overall Study|Withdrawal by Subject|1|||
27805240|NCT01964300|54260518|FG000|Overall Study|To receive alternative therapy|1|||
28028970|NCT00115765|54687493|FG000|Overall Study|Physician Decision|4|||
28028971|NCT00115765|54687494|FG001|Overall Study|Physician Decision|15|||
28028972|NCT00115765|54687495|FG002|Overall Study|Physician Decision|18|||
28028973|NCT00115765|54687496|FG003|Overall Study|Physician Decision|13|||
27805241|NCT01964300|54260519|FG001|Overall Study|To receive alternative therapy|2|||
27805242|NCT01964300|54260518|FG000|Overall Study|Enlargement of cyst requiring drainage|1|||
27805243|NCT01964300|54260519|FG001|Overall Study|Enlargement of cyst requiring drainage|0|||
27805244|NCT01964300|54260518|FG000|Overall Study|Weight criteria not met|0|||
27805245|NCT01964300|54260519|FG001|Overall Study|Weight criteria not met|1|||
27805246|NCT01964222|54260527|FG000|Overall Study|Lost to Follow-up|7|||
27805247|NCT01964222|54260528|FG001|Overall Study|Lost to Follow-up|5|||
27805248|NCT01964222|54260527|FG000|Overall Study|Withdrawal by Subject|6|||
27805249|NCT01964222|54260528|FG001|Overall Study|Withdrawal by Subject|6|||
28028974|NCT00115765|54687493|FG000|Overall Study|Lost to Follow-up|3|||
28028975|NCT00115765|54687494|FG001|Overall Study|Lost to Follow-up|20|||
28028976|NCT00115765|54687495|FG002|Overall Study|Lost to Follow-up|18|||
27805250|NCT01964222|54260527|FG000|Overall Study|Screening Failure|2|||
27805251|NCT01964222|54260528|FG001|Overall Study|Screening Failure|0|||
27805252|NCT01467700|54260538|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
27805253|NCT01467700|54260539|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
27805254|NCT01467700|54260540|FG002|Overall Study|Pretreatment Event or Adverse Event|2|||
28028977|NCT00115765|54687496|FG003|Overall Study|Lost to Follow-up|1|||
28028978|NCT00115765|54687493|FG000|Overall Study|Other|6|||
28028979|NCT00115765|54687494|FG001|Overall Study|Other|12|||
28028980|NCT00115765|54687495|FG002|Overall Study|Other|9|||
27805255|NCT01467700|54260541|FG003|Overall Study|Pretreatment Event or Adverse Event|3|||
27805256|NCT01467700|54260538|FG000|Overall Study|Major Protocol Deviation|3|||
27805257|NCT01467700|54260539|FG001|Overall Study|Major Protocol Deviation|3|||
27805258|NCT01467700|54260540|FG002|Overall Study|Major Protocol Deviation|2|||
27805259|NCT01467700|54260541|FG003|Overall Study|Major Protocol Deviation|3|||
28028981|NCT00115765|54687496|FG003|Overall Study|Other|2|||
27805260|NCT01467700|54260538|FG000|Overall Study|Lost to Follow-up|6|||
27805261|NCT01467700|54260539|FG001|Overall Study|Lost to Follow-up|5|||
27805262|NCT01467700|54260540|FG002|Overall Study|Lost to Follow-up|2|||
27805263|NCT01467700|54260541|FG003|Overall Study|Lost to Follow-up|3|||
27805264|NCT01467700|54260538|FG000|Overall Study|Voluntary Withdrawal|5|||
27805265|NCT01467700|54260539|FG001|Overall Study|Voluntary Withdrawal|7|||
27805266|NCT01467700|54260540|FG002|Overall Study|Voluntary Withdrawal|6|||
27805267|NCT01467700|54260541|FG003|Overall Study|Voluntary Withdrawal|2|||
27805268|NCT01467700|54260538|FG000|Overall Study|Study Termination|6|||
27805269|NCT01467700|54260539|FG001|Overall Study|Study Termination|5|||
27805270|NCT01467700|54260540|FG002|Overall Study|Study Termination|10|||
27805271|NCT01467700|54260541|FG003|Overall Study|Study Termination|7|||
28028982|NCT00606008|54687504|FG000|Overall Study|Adverse Event|1|||
28028983|NCT00606008|54687504|FG000|Overall Study|Withdrawal by Subject|4|||
28028984|NCT00461812|54687516|FG000|Overall Study|study terminated|10|||
28028985|NCT00123955|54687523|FG000|Overall Study|Adverse Event|1|||
28028986|NCT00123955|54687524|FG001|Overall Study|Adverse Event|0|||
28028987|NCT00123955|54687523|FG000|Overall Study|Withdrawal by Subject|4|||
28028988|NCT00123955|54687524|FG001|Overall Study|Withdrawal by Subject|3|||
28028989|NCT00123955|54687523|FG000|Overall Study|Death|0|||
28028990|NCT00123955|54687524|FG001|Overall Study|Death|1|||
28028991|NCT03837028|54687534|FG000|Overall Study|Lost to Follow-up|4|||
28028992|NCT03837028|54687535|FG001|Overall Study|Lost to Follow-up|0|||
28028993|NCT03837028|54687536|FG002|Overall Study|Lost to Follow-up|2|||
28028994|NCT03837028|54687537|FG003|Overall Study|Lost to Follow-up|0|||
28028995|NCT03837028|54687534|FG000|Overall Study|Withdrawal by Subject|12|||
27805272|NCT01467700|54260538|FG000|Overall Study|Pregnancy|0|||
27805273|NCT01467700|54260539|FG001|Overall Study|Pregnancy|1|||
27805274|NCT01467700|54260540|FG002|Overall Study|Pregnancy|1|||
27805275|NCT01467700|54260541|FG003|Overall Study|Pregnancy|0|||
27805276|NCT01467700|54260538|FG000|Overall Study|Lack of Efficacy|2|||
27805277|NCT01467700|54260539|FG001|Overall Study|Lack of Efficacy|0|||
28028996|NCT03837028|54687535|FG001|Overall Study|Withdrawal by Subject|11|||
28028997|NCT03837028|54687536|FG002|Overall Study|Withdrawal by Subject|11|||
28028998|NCT03837028|54687537|FG003|Overall Study|Withdrawal by Subject|7|||
28028999|NCT00115063|54687549|FG000|Overall Study|Lost to Follow-up|98|||
28029000|NCT00115063|54687550|FG001|Overall Study|Lost to Follow-up|104|||
28029001|NCT00115063|54687549|FG000|Overall Study|Death|1|||
28029002|NCT00115063|54687550|FG001|Overall Study|Death|0|||
28029003|NCT00461500|54687558|FG000|Overall Study|Adverse Event|1|||
28029004|NCT00461500|54687559|FG001|Overall Study|Adverse Event|0|||
28029005|NCT00461500|54687558|FG000|Overall Study|Lack of Efficacy|0|||
28029006|NCT00461500|54687559|FG001|Overall Study|Lack of Efficacy|1|||
28029007|NCT00461500|54687558|FG000|Overall Study|Expired Drug Treatment|1|||
28029008|NCT00461500|54687559|FG001|Overall Study|Expired Drug Treatment|1|||
28029009|NCT00461500|54687558|FG000|Overall Study|Study Stopped|1|||
28029010|NCT00461500|54687559|FG001|Overall Study|Study Stopped|2|||
28029011|NCT00461500|54687558|FG000|Overall Study|Drug Treatment Misuse|1|||
28029012|NCT00461500|54687559|FG001|Overall Study|Drug Treatment Misuse|0|||
28029013|NCT00461500|54687558|FG000|Overall Study|No Longer Willing to Take Part in Study|1|||
28029014|NCT00461500|54687559|FG001|Overall Study|No Longer Willing to Take Part in Study|0|||
28029015|NCT00461500|54687558|FG000|Overall Study|Lost to Follow-up|2|||
28029016|NCT00461500|54687559|FG001|Overall Study|Lost to Follow-up|2|||
28029017|NCT00167245|54687567|FG000|Overall Study|Lost to Follow-up|20|||
28029018|NCT00167245|54687568|FG001|Overall Study|Lost to Follow-up|31|||
28029019|NCT00167245|54687567|FG000|Overall Study|Withdrawal by Subject|5|||
28029020|NCT00167245|54687568|FG001|Overall Study|Withdrawal by Subject|8|||
28029021|NCT00167245|54687567|FG000|Overall Study|Incarcerated|3|||
28029022|NCT00167245|54687568|FG001|Overall Study|Incarcerated|2|||
28029023|NCT00167245|54687567|FG000|Overall Study|Drowsy|1|||
28029024|NCT00167245|54687568|FG001|Overall Study|Drowsy|0|||
28029025|NCT00443560|54687579|FG000|Overall Study|No intrathecal dose|58|||
28029026|NCT00443560|54687580|FG001|Overall Study|No intrathecal dose|26|||
28029027|NCT00443560|54687579|FG000|Overall Study|Multiple pregnancies or fetal demise|2|||
28029028|NCT00443560|54687580|FG001|Overall Study|Multiple pregnancies or fetal demise|4|||
27805278|NCT01467700|54260540|FG002|Overall Study|Lack of Efficacy|2|||
27805279|NCT01467700|54260541|FG003|Overall Study|Lack of Efficacy|1|||
27805280|NCT01467700|54260538|FG000|Overall Study|Reason not Specified|1|||
28029029|NCT00451204|54687588|FG000|Overall Study|Adverse Event|4|||
28029030|NCT00451204|54687589|FG001|Overall Study|Adverse Event|6|||
28029031|NCT00451204|54687588|FG000|Overall Study|Lack of Efficacy|4|||
28029032|NCT00451204|54687589|FG001|Overall Study|Lack of Efficacy|4|||
28029033|NCT00451204|54687588|FG000|Overall Study|Lost to Follow-up|4|||
28029034|NCT00451204|54687589|FG001|Overall Study|Lost to Follow-up|4|||
28029035|NCT00451204|54687588|FG000|Overall Study|Protocol Violation|1|||
27805281|NCT01467700|54260539|FG001|Overall Study|Reason not Specified|3|||
27805282|NCT01467700|54260540|FG002|Overall Study|Reason not Specified|2|||
27805283|NCT01467700|54260541|FG003|Overall Study|Reason not Specified|8|||
27805284|NCT01972724|54260554|FG000|Double-Blind|Rescue Criteria Met|1|||
27805285|NCT01972724|54260555|FG001|Double-Blind|Rescue Criteria Met|0|||
27805286|NCT01972724|54260556|FG002|Double-Blind|Rescue Criteria Met|0|||
27805287|NCT01972724|54260554|FG000|Double-Blind|Adverse Event|1|||
27805288|NCT01972724|54260555|FG001|Double-Blind|Adverse Event|0|||
27805289|NCT01972724|54260556|FG002|Double-Blind|Adverse Event|0|||
27805290|NCT01972724|54260554|FG000|Double-Blind|Withdrawal of Consent|2|||
27805291|NCT01972724|54260555|FG001|Double-Blind|Withdrawal of Consent|1|||
27805292|NCT01972724|54260556|FG002|Double-Blind|Withdrawal of Consent|0|||
27805293|NCT01972724|54260554|FG000|Double-Blind|Significant Protocol Deviation|5|||
27805294|NCT01972724|54260555|FG001|Double-Blind|Significant Protocol Deviation|8|||
27805295|NCT01972724|54260556|FG002|Double-Blind|Significant Protocol Deviation|0|||
27805296|NCT01972724|54260554|FG000|Open-Label|Withdrew Consent|0|||
27805297|NCT01972724|54260555|FG001|Open-Label|Withdrew Consent|0|||
27805298|NCT01972724|54260556|FG002|Open-Label|Withdrew Consent|3|||
27805299|NCT01972724|54260554|FG000|Open-Label|Significant Protocol Deviation|0|||
27805300|NCT01972724|54260555|FG001|Open-Label|Significant Protocol Deviation|0|||
27805301|NCT01972724|54260556|FG002|Open-Label|Significant Protocol Deviation|2|||
27805302|NCT01441960|54260564|FG000|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6|||
27805303|NCT01441960|54260565|FG001|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5|||
27805304|NCT01441960|54260564|FG000|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
27805305|NCT01441960|54260565|FG001|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
27805306|NCT01441960|54260564|FG000|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1|||
27805307|NCT01441960|54260565|FG001|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0|||
27805308|NCT01955707|54260577|FG000|Overall Study|Adverse Event|1|||
27805309|NCT01955707|54260578|FG001|Overall Study|Adverse Event|2|||
27805310|NCT01955707|54260577|FG000|Overall Study|Lost to Follow-up|2|||
27805311|NCT01955707|54260578|FG001|Overall Study|Lost to Follow-up|1|||
27805312|NCT01955707|54260577|FG000|Overall Study|Withdrawal by Subject|0|||
27805313|NCT01955707|54260578|FG001|Overall Study|Withdrawal by Subject|3|||
27805314|NCT01955707|54260577|FG000|Overall Study|Death|13|||
27805315|NCT01955707|54260578|FG001|Overall Study|Death|14|||
27805316|NCT01955707|54260577|FG000|Overall Study|Other|4|||
27805317|NCT01955707|54260578|FG001|Overall Study|Other|2|||
27805318|NCT01435798|54260584|FG000|Overall Study|Withdrawal by Subject|1|||
27805319|NCT01972568|54260597|FG000|Overall Study|Other events|3|||
27805320|NCT01972568|54260598|FG001|Overall Study|Other events|0|||
27805321|NCT01972568|54260599|FG002|Overall Study|Other events|0|||
27805322|NCT01972568|54260597|FG000|Overall Study|Lack of Efficacy|0|||
27805323|NCT01972568|54260598|FG001|Overall Study|Lack of Efficacy|1|||
27805324|NCT01972568|54260599|FG002|Overall Study|Lack of Efficacy|2|||
27805325|NCT01972568|54260597|FG000|Overall Study|Protocol Violation|1|||
27805326|NCT01972568|54260598|FG001|Overall Study|Protocol Violation|2|||
27805327|NCT01972568|54260599|FG002|Overall Study|Protocol Violation|2|||
27805328|NCT01972568|54260597|FG000|Overall Study|Withdrawal by Subject|6|||
27805329|NCT01972568|54260598|FG001|Overall Study|Withdrawal by Subject|3|||
27805330|NCT01972568|54260599|FG002|Overall Study|Withdrawal by Subject|7|||
27805331|NCT01972568|54260597|FG000|Overall Study|Lost to Follow-up|1|||
27805332|NCT01972568|54260598|FG001|Overall Study|Lost to Follow-up|0|||
27805333|NCT01972568|54260599|FG002|Overall Study|Lost to Follow-up|0|||
27805334|NCT01972568|54260597|FG000|Overall Study|Adverse Event|5|||
27805335|NCT01972568|54260598|FG001|Overall Study|Adverse Event|6|||
27805336|NCT01972568|54260599|FG002|Overall Study|Adverse Event|5|||
27805337|NCT01955161|54260610|FG000|Overall Study|Withdrawal before treatment|2|||
27805338|NCT01955161|54260611|FG001|Overall Study|Withdrawal before treatment|0|||
27805339|NCT01955161|54260612|FG002|Overall Study|Withdrawal before treatment|1|||
27805340|NCT01955161|54260610|FG000|Overall Study|Adverse Event|10|||
27805341|NCT01955161|54260611|FG001|Overall Study|Adverse Event|14|||
27805342|NCT01955161|54260612|FG002|Overall Study|Adverse Event|15|||
27805343|NCT01955161|54260610|FG000|Overall Study|Death|1|||
27805344|NCT01955161|54260611|FG001|Overall Study|Death|1|||
27805345|NCT01955161|54260612|FG002|Overall Study|Death|3|||
27805346|NCT01955161|54260610|FG000|Overall Study|Withdrawal by Subject|9|||
27805347|NCT01955161|54260611|FG001|Overall Study|Withdrawal by Subject|8|||
27805348|NCT01955161|54260612|FG002|Overall Study|Withdrawal by Subject|12|||
27805349|NCT01955161|54260610|FG000|Overall Study|Protocol Violation|2|||
27805350|NCT01955161|54260611|FG001|Overall Study|Protocol Violation|0|||
27805351|NCT01955161|54260612|FG002|Overall Study|Protocol Violation|0|||
27805352|NCT01955161|54260610|FG000|Overall Study|Other reason: physician decision|0|||
27805353|NCT01955161|54260611|FG001|Overall Study|Other reason: physician decision|1|||
27805354|NCT01955161|54260612|FG002|Overall Study|Other reason: physician decision|1|||
27805355|NCT01955161|54260610|FG000|Overall Study|Other reason: disallowed medication|1|||
27805356|NCT01955161|54260611|FG001|Overall Study|Other reason: disallowed medication|0|||
27805357|NCT01955161|54260612|FG002|Overall Study|Other reason: disallowed medication|1|||
28029036|NCT00451204|54687589|FG001|Overall Study|Protocol Violation|0|||
28029037|NCT00451204|54687588|FG000|Overall Study|Patient refusal|8|||
28029038|NCT00451204|54687589|FG001|Overall Study|Patient refusal|4|||
27805358|NCT01955161|54260610|FG000|Overall Study|Other reason: caregiver unavailable|1|||
27805359|NCT01955161|54260611|FG001|Overall Study|Other reason: caregiver unavailable|0|||
27805360|NCT01955161|54260612|FG002|Overall Study|Other reason: caregiver unavailable|0|||
27805361|NCT01955161|54260610|FG000|Overall Study|Other reason: moved to nursing home|0|||
27805362|NCT01955161|54260611|FG001|Overall Study|Other reason: moved to nursing home|1|||
27805363|NCT01955161|54260612|FG002|Overall Study|Other reason: moved to nursing home|0|||
27805364|NCT01955161|54260610|FG000|Overall Study|Other reason: insufficient compliance|0|||
27805365|NCT01955161|54260611|FG001|Overall Study|Other reason: insufficient compliance|0|||
27805366|NCT01955161|54260612|FG002|Overall Study|Other reason: insufficient compliance|1|||
27805367|NCT01955161|54260610|FG000|Overall Study|Other reason: primary biliary cirrhosis|1|||
27805368|NCT01955161|54260611|FG001|Overall Study|Other reason: primary biliary cirrhosis|0|||
27805369|NCT01955161|54260612|FG002|Overall Study|Other reason: primary biliary cirrhosis|0|||
27805370|NCT01955161|54260610|FG000|Overall Study|Other reason: patient's will|0|||
27805371|NCT01955161|54260611|FG001|Overall Study|Other reason: patient's will|0|||
27805372|NCT01955161|54260612|FG002|Overall Study|Other reason: patient's will|1|||
27805373|NCT01441414|54260620|FG000|Overall Study|Participant died|9|||
27805374|NCT01441414|54260620|FG000|Overall Study|Other reasons|3|||
27805375|NCT01441414|54260620|FG000|Overall Study|Study terminated by sponsor|2|||
27805376|NCT01441414|54260620|FG000|Overall Study|Subject refused further follow-up|1|||
27805377|NCT01971554|54260640|FG000|Overall Study|Lost to Follow-up|1|||
27805378|NCT01971554|54260641|FG001|Overall Study|Lost to Follow-up|0|||
27805379|NCT01971554|54260642|FG002|Overall Study|Lost to Follow-up|0|||
27805380|NCT01971554|54260643|FG003|Overall Study|Lost to Follow-up|0|||
27805381|NCT01955083|54260655|FG000|Overall Study|Lost to Follow-up|1|||
27805382|NCT01955083|54260656|FG001|Overall Study|Lost to Follow-up|1|||
27805383|NCT01955005|54260688|FG000|Overall Study|Withdrawal by Subject|3|||
27805384|NCT01955005|54260689|FG001|Overall Study|Withdrawal by Subject|5|||
27805385|NCT01954927|54260697|FG000|Overall Study|Withdrawal by Subject|3|||
27805386|NCT01954927|54260698|FG001|Overall Study|Withdrawal by Subject|1|||
27805387|NCT01954771|54260707|FG000|Overall Study|Missing HbA1c of end-point|1|||
27805388|NCT01954771|54260708|FG001|Overall Study|Missing HbA1c of end-point|1|||
27805389|NCT01954771|54260709|FG002|Overall Study|Missing HbA1c of end-point|0|||
27805390|NCT01954771|54260707|FG000|Overall Study|Missing CGMS of end-point|1|||
27805391|NCT01954771|54260708|FG001|Overall Study|Missing CGMS of end-point|1|||
27805392|NCT01954771|54260709|FG002|Overall Study|Missing CGMS of end-point|0|||
27805393|NCT01954771|54260707|FG000|Overall Study|Missing HbA1c and CGMS of end-point|5|||
27805394|NCT01954771|54260708|FG001|Overall Study|Missing HbA1c and CGMS of end-point|1|||
28029039|NCT00451204|54687588|FG000|Overall Study|Other|1|||
28029040|NCT00451204|54687589|FG001|Overall Study|Other|2|||
28029041|NCT00605540|54687598|FG000|Overall Study|Death|15|||
28029042|NCT00605540|54687598|FG000|Overall Study|Lost to Follow-up|23|||
28029043|NCT00605306|54687604|FG000|Overall Study|Adverse Event|0|||
28029044|NCT00605306|54687605|FG001|Overall Study|Adverse Event|1|||
28029045|NCT00607022|54687614|FG000|Overall Study|Withdrawal by Subject|1|||
28029046|NCT00607022|54687615|FG001|Overall Study|Withdrawal by Subject|0|||
28029047|NCT00607022|54687616|FG002|Overall Study|Withdrawal by Subject|0|||
28029048|NCT00606632|54687624|FG000|Overall Study|Withdrawal by Subject|13|||
28029049|NCT00606632|54687624|FG000|Overall Study|Miscellaneous reasons|9|||
28029050|NCT00450814|54687643|FG000|Overall Study|Failed to complete the initial therapy|0|||
28029051|NCT00450814|54687644|FG001|Overall Study|Failed to complete the initial therapy|0|||
28029052|NCT00450814|54687645|FG002|Overall Study|Failed to complete the initial therapy|0|||
28029053|NCT00450814|54687646|FG003|Overall Study|Failed to complete the initial therapy|1|||
27805395|NCT01954771|54260709|FG002|Overall Study|Missing HbA1c and CGMS of end-point|3|||
27805396|NCT01997281|54260722|FG000|Overall Study|Withdrawal by Subject|1|||
27805397|NCT01997281|54260723|FG001|Overall Study|Withdrawal by Subject|0|||
27805398|NCT01996033|54260729|FG000|Overall Study|Death|1|||
27805399|NCT01996033|54260729|FG000|Overall Study|Physician Decision|1|||
27805400|NCT01996033|54260729|FG000|Overall Study|Withdrawal by Subject|4|||
27805401|NCT01996033|54260729|FG000|Overall Study|Lost to Follow-up|3|||
27805402|NCT01953913|54260733|FG000|Overall Study|Disease Progression|349|||
27805403|NCT01953913|54260733|FG000|Overall Study|Worsening of underlying cancer|22|||
27805404|NCT01953913|54260733|FG000|Overall Study|Adverse Event|20|||
27805405|NCT01953913|54260733|FG000|Overall Study|Protocol Violation|6|||
27805406|NCT01953913|54260733|FG000|Overall Study|Lost to Follow-up|4|||
28029054|NCT00450814|54687647|FG004|Overall Study|Failed to complete the initial therapy|1|||
27805407|NCT01953913|54260733|FG000|Overall Study|Withdrawal by Subject|32|||
27805408|NCT01953913|54260733|FG000|Overall Study|Other than listed|108|||
27805409|NCT01953913|54260733|FG000|Overall Study|Not Treated|1|||
27805410|NCT01971476|54260740|FG000|Cohort 1: 2 to <12 Years|Other not defined|3|||
27805411|NCT01971476|54260741|FG001|Cohort 1: 2 to <12 Years|Other not defined|3|||
27805412|NCT01971476|54260742|FG002|Cohort 1: 2 to <12 Years|Other not defined|6|||
27805413|NCT01971476|54260740|FG000|Cohort 2: 12 to <18 Years|Other not defined|6|||
27805414|NCT01971476|54260741|FG001|Cohort 2: 12 to <18 Years|Other not defined|3|||
27805415|NCT01971476|54260742|FG002|Cohort 2: 12 to <18 Years|Other not defined|0|||
27805416|NCT01971476|54260740|FG000|Cohort 2: 12 to <18 Years|Adverse Event|0|||
27805417|NCT01971476|54260741|FG001|Cohort 2: 12 to <18 Years|Adverse Event|1|||
27805418|NCT01971476|54260742|FG002|Cohort 2: 12 to <18 Years|Adverse Event|0|||
27805419|NCT01996904|54260761|FG000|Overall Study|Lost to Follow-up|38|||
27805420|NCT01996904|54260762|FG001|Overall Study|Lost to Follow-up|27|||
27805421|NCT01970540|54260771|FG000|Overall Study|Non-treatment-related AE|0|||
27805422|NCT01970540|54260772|FG001|Overall Study|Non-treatment-related AE|0|||
27805423|NCT01970540|54260773|FG002|Overall Study|Non-treatment-related AE|1|||
27805424|NCT01970540|54260771|FG000|Overall Study|Progressive disease|55|||
28029055|NCT00450814|54687648|FG005|Overall Study|Failed to complete the initial therapy|1|||
28029056|NCT00450814|54687649|FG006|Overall Study|Failed to complete the initial therapy|0|||
28029057|NCT00450814|54687650|FG007|Overall Study|Failed to complete the initial therapy|0|||
28029058|NCT00450814|54687651|FG008|Overall Study|Failed to complete the initial therapy|0|||
28029059|NCT00450814|54687652|FG009|Overall Study|Failed to complete the initial therapy|0|||
28029060|NCT00450814|54687653|FG010|Overall Study|Failed to complete the initial therapy|0|||
28029061|NCT00450814|54687643|FG000|Overall Study|Patient withdrawal prior to treatment|0|||
28029062|NCT00450814|54687644|FG001|Overall Study|Patient withdrawal prior to treatment|0|||
28029063|NCT00450814|54687645|FG002|Overall Study|Patient withdrawal prior to treatment|0|||
28029064|NCT00450814|54687646|FG003|Overall Study|Patient withdrawal prior to treatment|0|||
28029065|NCT00450814|54687647|FG004|Overall Study|Patient withdrawal prior to treatment|0|||
28029066|NCT00450814|54687648|FG005|Overall Study|Patient withdrawal prior to treatment|0|||
28029067|NCT00450814|54687649|FG006|Overall Study|Patient withdrawal prior to treatment|0|||
28029068|NCT00450814|54687650|FG007|Overall Study|Patient withdrawal prior to treatment|0|||
28029069|NCT00450814|54687651|FG008|Overall Study|Patient withdrawal prior to treatment|0|||
28029070|NCT00450814|54687652|FG009|Overall Study|Patient withdrawal prior to treatment|1|||
28029071|NCT00450814|54687653|FG010|Overall Study|Patient withdrawal prior to treatment|0|||
28029072|NCT00518115|54687688|FG000|Overall Study|Adverse Event|6|||
28029073|NCT00518115|54687689|FG001|Overall Study|Adverse Event|1|||
28029074|NCT00518115|54687690|FG002|Overall Study|Adverse Event|5|||
28029075|NCT00518115|54687691|FG003|Overall Study|Adverse Event|6|||
28029076|NCT00518115|54687692|FG004|Overall Study|Adverse Event|5|||
28029077|NCT00518115|54687693|FG005|Overall Study|Adverse Event|5|||
28029078|NCT00518115|54687694|FG006|Overall Study|Adverse Event|5|||
28029079|NCT00518115|54687695|FG007|Overall Study|Adverse Event|10|||
28029080|NCT00518115|54687696|FG008|Overall Study|Adverse Event|2|||
28029081|NCT00518115|54687697|FG009|Overall Study|Adverse Event|9|||
28029082|NCT00518115|54687688|FG000|Overall Study|Lost to Follow-up|0|||
28029083|NCT00518115|54687689|FG001|Overall Study|Lost to Follow-up|0|||
28029084|NCT00518115|54687690|FG002|Overall Study|Lost to Follow-up|2|||
28029085|NCT00518115|54687691|FG003|Overall Study|Lost to Follow-up|3|||
28029086|NCT00518115|54687692|FG004|Overall Study|Lost to Follow-up|1|||
28029087|NCT00518115|54687693|FG005|Overall Study|Lost to Follow-up|3|||
28029088|NCT00518115|54687694|FG006|Overall Study|Lost to Follow-up|0|||
28029089|NCT00518115|54687695|FG007|Overall Study|Lost to Follow-up|1|||
28029090|NCT00518115|54687696|FG008|Overall Study|Lost to Follow-up|1|||
28029091|NCT00518115|54687697|FG009|Overall Study|Lost to Follow-up|1|||
28029092|NCT00518115|54687688|FG000|Overall Study|Protocol Violation|1|||
28029093|NCT00518115|54687689|FG001|Overall Study|Protocol Violation|3|||
28029094|NCT00518115|54687690|FG002|Overall Study|Protocol Violation|1|||
28029095|NCT00518115|54687691|FG003|Overall Study|Protocol Violation|0|||
28029096|NCT00518115|54687692|FG004|Overall Study|Protocol Violation|0|||
28029097|NCT00518115|54687693|FG005|Overall Study|Protocol Violation|0|||
28029098|NCT00518115|54687694|FG006|Overall Study|Protocol Violation|0|||
28029099|NCT00518115|54687695|FG007|Overall Study|Protocol Violation|0|||
28029100|NCT00518115|54687696|FG008|Overall Study|Protocol Violation|0|||
28029101|NCT00518115|54687697|FG009|Overall Study|Protocol Violation|0|||
28029102|NCT00518115|54687688|FG000|Overall Study|Withdrawal by Subject|1|||
28029103|NCT00518115|54687689|FG001|Overall Study|Withdrawal by Subject|1|||
28029104|NCT00518115|54687690|FG002|Overall Study|Withdrawal by Subject|5|||
28029105|NCT00518115|54687691|FG003|Overall Study|Withdrawal by Subject|0|||
27805425|NCT01970540|54260772|FG001|Overall Study|Progressive disease|23|||
28029106|NCT00518115|54687692|FG004|Overall Study|Withdrawal by Subject|2|||
28029107|NCT00518115|54687693|FG005|Overall Study|Withdrawal by Subject|1|||
27805426|NCT01970540|54260773|FG002|Overall Study|Progressive disease|10|||
28029108|NCT00518115|54687694|FG006|Overall Study|Withdrawal by Subject|0|||
27805427|NCT01970540|54260771|FG000|Overall Study|Treatment delay over protocol|0|||
28029109|NCT00518115|54687695|FG007|Overall Study|Withdrawal by Subject|2|||
28029110|NCT00518115|54687696|FG008|Overall Study|Withdrawal by Subject|1|||
28029111|NCT00518115|54687697|FG009|Overall Study|Withdrawal by Subject|3|||
27805428|NCT01970540|54260772|FG001|Overall Study|Treatment delay over protocol|0|||
27805429|NCT01970540|54260773|FG002|Overall Study|Treatment delay over protocol|1|||
27805430|NCT01970540|54260771|FG000|Overall Study|Physician Decision|7|||
27805431|NCT01970540|54260772|FG001|Overall Study|Physician Decision|2|||
27805432|NCT01970540|54260773|FG002|Overall Study|Physician Decision|0|||
27805433|NCT01970540|54260771|FG000|Overall Study|Clinical progression|0|||
27805434|NCT01970540|54260772|FG001|Overall Study|Clinical progression|1|||
27805435|NCT01970540|54260773|FG002|Overall Study|Clinical progression|1|||
27805436|NCT01970540|54260771|FG000|Overall Study|End of study|2|||
27805437|NCT01970540|54260772|FG001|Overall Study|End of study|0|||
27805438|NCT01970540|54260773|FG002|Overall Study|End of study|2|||
27805439|NCT01970540|54260771|FG000|Overall Study|Adverse Event|0|||
27805440|NCT01970540|54260772|FG001|Overall Study|Adverse Event|2|||
27805441|NCT01970540|54260773|FG002|Overall Study|Adverse Event|1|||
27805442|NCT01970540|54260771|FG000|Overall Study|Treatment-related AE|4|||
27805443|NCT01970540|54260772|FG001|Overall Study|Treatment-related AE|0|||
27805444|NCT01970540|54260773|FG002|Overall Study|Treatment-related AE|2|||
27805445|NCT01970540|54260771|FG000|Overall Study|Withdrawal by Subject|4|||
27805446|NCT01970540|54260772|FG001|Overall Study|Withdrawal by Subject|0|||
27805447|NCT01970540|54260773|FG002|Overall Study|Withdrawal by Subject|1|||
27805448|NCT01970540|54260771|FG000|Overall Study|Clinical deterioration|1|||
27805449|NCT01970540|54260772|FG001|Overall Study|Clinical deterioration|0|||
27805450|NCT01970540|54260773|FG002|Overall Study|Clinical deterioration|0|||
27805451|NCT01963676|54260794|FG000|Overall Study|Withdrawal by Subject|1|||
27805452|NCT01963676|54260795|FG001|Overall Study|Withdrawal by Subject|0|||
27805453|NCT01996826|54260803|FG000|Overall Study|Lost to Follow-up|6|||
27805454|NCT01996826|54260804|FG001|Overall Study|Lost to Follow-up|2|||
27805455|NCT01996826|54260803|FG000|Overall Study|Physician Decision|1|||
27805456|NCT01996826|54260804|FG001|Overall Study|Physician Decision|1|||
27805457|NCT01996748|54260812|FG000|Overall Study|Personal reason|1|||
27805458|NCT01996748|54260813|FG001|Overall Study|Personal reason|0|||
27805459|NCT01996748|54260812|FG000|Overall Study|Physician Decision|2|||
27805460|NCT01996748|54260813|FG001|Overall Study|Physician Decision|0|||
27805461|NCT01996748|54260812|FG000|Overall Study|Adverse Event|1|||
27805462|NCT01996748|54260813|FG001|Overall Study|Adverse Event|4|||
27805463|NCT01996748|54260812|FG000|Overall Study|Withdrawal by Subject|0|||
27805464|NCT01996748|54260813|FG001|Overall Study|Withdrawal by Subject|1|||
27805465|NCT01996748|54260812|FG000|Overall Study|Lost to Follow-up|4|||
27805466|NCT01996748|54260813|FG001|Overall Study|Lost to Follow-up|1|||
27805467|NCT01621178|54260824|FG000|Overall Study|Adverse Event|5|||
27805468|NCT01621178|54260825|FG001|Overall Study|Adverse Event|2|||
27805469|NCT01621178|54260826|FG002|Overall Study|Adverse Event|8|||
27805470|NCT01621178|54260824|FG000|Overall Study|Death|6|||
27805471|NCT01621178|54260825|FG001|Overall Study|Death|7|||
27805472|NCT01621178|54260826|FG002|Overall Study|Death|2|||
27805473|NCT01621178|54260824|FG000|Overall Study|Lost to Follow-up|1|||
27805474|NCT01621178|54260825|FG001|Overall Study|Lost to Follow-up|2|||
27805475|NCT01621178|54260826|FG002|Overall Study|Lost to Follow-up|1|||
27805476|NCT01621178|54260824|FG000|Overall Study|Withdrawal by Subject|14|||
27805477|NCT01621178|54260825|FG001|Overall Study|Withdrawal by Subject|17|||
27805478|NCT01621178|54260826|FG002|Overall Study|Withdrawal by Subject|18|||
27805479|NCT01621178|54260824|FG000|Overall Study|Physician Decision|5|||
27805480|NCT01621178|54260825|FG001|Overall Study|Physician Decision|2|||
27805481|NCT01621178|54260826|FG002|Overall Study|Physician Decision|7|||
27805482|NCT01962974|54260838|FG000|Overall Study|Study termination|7|||
27805483|NCT01996592|54260842|FG000|Overall Study|no response to text/no diary entry|32|||
27805484|NCT01996592|54260842|FG000|Overall Study|change in surgical date|4|||
27805485|NCT01996592|54260842|FG000|Overall Study|Withdrawal by Subject|5|||
27805486|NCT01996592|54260842|FG000|Overall Study|change in mode of delivery|4|||
27805487|NCT01962896|54260851|FG000|Overall Study|Lack of Efficacy|4|||
27805488|NCT01970462|54260858|FG000|Overall Study|Lost to Follow-up|0|||
27805489|NCT01970462|54260859|FG001|Overall Study|Lost to Follow-up|2|||
27805490|NCT01958671|54260868|FG000|Overall Study|Adverse Event|1|||
27805491|NCT01958671|54260869|FG001|Overall Study|Adverse Event|1|||
27805492|NCT01958671|54260870|FG002|Overall Study|Adverse Event|5|||
27805493|NCT01958671|54260868|FG000|Overall Study|Death|1|||
27805494|NCT01958671|54260869|FG001|Overall Study|Death|0|||
27805495|NCT01958671|54260870|FG002|Overall Study|Death|0|||
27805496|NCT01958671|54260868|FG000|Overall Study|Excluded medication|0|||
27805497|NCT01958671|54260869|FG001|Overall Study|Excluded medication|0|||
27805498|NCT01958671|54260870|FG002|Overall Study|Excluded medication|1|||
27805499|NCT01958671|54260868|FG000|Overall Study|Hyperglycemia|0|||
27805500|NCT01958671|54260869|FG001|Overall Study|Hyperglycemia|0|||
27805501|NCT01958671|54260870|FG002|Overall Study|Hyperglycemia|2|||
27805502|NCT01958671|54260868|FG000|Overall Study|Lost to Follow-up|7|||
27805503|NCT01958671|54260869|FG001|Overall Study|Lost to Follow-up|11|||
27805504|NCT01958671|54260870|FG002|Overall Study|Lost to Follow-up|7|||
27805505|NCT01958671|54260868|FG000|Overall Study|Non-compliance with study drug|1|||
27805506|NCT01958671|54260869|FG001|Overall Study|Non-compliance with study drug|1|||
27805507|NCT01958671|54260870|FG002|Overall Study|Non-compliance with study drug|1|||
27805508|NCT01958671|54260868|FG000|Overall Study|Pregnancy|0|||
27805509|NCT01958671|54260869|FG001|Overall Study|Pregnancy|0|||
27805510|NCT01958671|54260870|FG002|Overall Study|Pregnancy|1|||
27805511|NCT01958671|54260868|FG000|Overall Study|Protocol Violation|0|||
27805512|NCT01958671|54260869|FG001|Overall Study|Protocol Violation|1|||
27805513|NCT01958671|54260870|FG002|Overall Study|Protocol Violation|0|||
27805514|NCT01958671|54260868|FG000|Overall Study|Study site terminated by sponsor|1|||
27805515|NCT01958671|54260869|FG001|Overall Study|Study site terminated by sponsor|0|||
27805516|NCT01958671|54260870|FG002|Overall Study|Study site terminated by sponsor|1|||
27805517|NCT01958671|54260868|FG000|Overall Study|Participant moved|0|||
27805518|NCT01958671|54260869|FG001|Overall Study|Participant moved|0|||
27805519|NCT01958671|54260870|FG002|Overall Study|Participant moved|1|||
27805520|NCT01958671|54260868|FG000|Overall Study|Withdrawal by Subject|8|||
27805521|NCT01958671|54260869|FG001|Overall Study|Withdrawal by Subject|10|||
27805522|NCT01958671|54260870|FG002|Overall Study|Withdrawal by Subject|13|||
27805523|NCT01995266|54260882|FG000|Overall Study|Death|1|||
27805524|NCT01995266|54260882|FG000|Overall Study|Lack of Efficacy|6|||
27805525|NCT01995266|54260882|FG000|Overall Study|Adverse Event|2|||
27805526|NCT01969058|54260888|FG000|Overall Study|Withdrawal by Subject|2|||
27805527|NCT01969058|54260889|FG001|Overall Study|Withdrawal by Subject|0|||
27805528|NCT01969058|54260888|FG000|Overall Study|Adverse Event|1|||
27805529|NCT01969058|54260889|FG001|Overall Study|Adverse Event|0|||
27805530|NCT01968980|54260897|FG000|Overall Study|Death|0|||
27805531|NCT01968980|54260898|FG001|Overall Study|Death|1|||
27805532|NCT01968980|54260897|FG000|Overall Study|Adverse Event|1|||
27805533|NCT01968980|54260898|FG001|Overall Study|Adverse Event|3|||
27805534|NCT01968980|54260897|FG000|Overall Study|Does not meet entry criteria|1|||
27805535|NCT01968980|54260898|FG001|Overall Study|Does not meet entry criteria|3|||
27805536|NCT01968980|54260897|FG000|Overall Study|Withdrawal by Subject|13|||
27805537|NCT01968980|54260898|FG001|Overall Study|Withdrawal by Subject|5|||
27805538|NCT01968980|54260897|FG000|Overall Study|Other unspecified|1|||
27805539|NCT01968980|54260898|FG001|Overall Study|Other unspecified|2|||
27805540|NCT01961882|54260907|FG000|Overall Study|Adverse Event|3|||
27805541|NCT01961882|54260908|FG001|Overall Study|Adverse Event|2|||
27805542|NCT01961882|54260907|FG000|Overall Study|Physician Decision|1|||
27805543|NCT01961882|54260908|FG001|Overall Study|Physician Decision|0|||
27805544|NCT01961882|54260907|FG000|Overall Study|Withdrawal by Subject|4|||
27805545|NCT01961882|54260908|FG001|Overall Study|Withdrawal by Subject|1|||
27805546|NCT01961882|54260907|FG000|Overall Study|Relapse of AML|39|||
27805547|NCT01961882|54260908|FG001|Overall Study|Relapse of AML|37|||
27805548|NCT01961882|54260907|FG000|Overall Study|Use of prohibited concomitant drug or therapy|2|||
27805549|NCT01961882|54260908|FG001|Overall Study|Use of prohibited concomitant drug or therapy|2|||
27805550|NCT01961882|54260907|FG000|Overall Study|Subject found to be ineligible for the trial after registration|1|||
27805551|NCT01961882|54260908|FG001|Overall Study|Subject found to be ineligible for the trial after registration|0|||
27805552|NCT01968434|54260916|FG000|Overall Study|Lost to Follow-up|3|||
27805553|NCT01968434|54260917|FG001|Overall Study|Lost to Follow-up|6|||
27805554|NCT01946438|54260927|FG000|Overall Study|Adverse Event|0|||
27805555|NCT01946438|54260928|FG001|Overall Study|Adverse Event|0|||
27805556|NCT01946438|54260929|FG002|Overall Study|Adverse Event|0|||
27805557|NCT01946438|54260930|FG003|Overall Study|Adverse Event|1|||
27805558|NCT01946438|54260927|FG000|Overall Study|Serious Adverse event|1|||
27805559|NCT01946438|54260928|FG001|Overall Study|Serious Adverse event|0|||
27805560|NCT01946438|54260929|FG002|Overall Study|Serious Adverse event|0|||
27805561|NCT01946438|54260930|FG003|Overall Study|Serious Adverse event|0|||
27805562|NCT01946438|54260927|FG000|Overall Study|Protocol Violation|0|||
27805563|NCT01946438|54260928|FG001|Overall Study|Protocol Violation|0|||
27805564|NCT01946438|54260929|FG002|Overall Study|Protocol Violation|1|||
27805565|NCT01946438|54260930|FG003|Overall Study|Protocol Violation|0|||
27805566|NCT01946438|54260927|FG000|Overall Study|Withdrawal by Subject|1|||
27805567|NCT01946438|54260928|FG001|Overall Study|Withdrawal by Subject|0|||
27805568|NCT01946438|54260929|FG002|Overall Study|Withdrawal by Subject|0|||
27805569|NCT01946438|54260930|FG003|Overall Study|Withdrawal by Subject|0|||
27805570|NCT01946282|54260949|FG000|Year 1|Did not return FIT kit|4186|||
27805571|NCT01946282|54260950|FG001|Year 1|Did not return FIT kit|608|||
27805572|NCT01946282|54260951|FG002|Year 1|Did not return FIT kit|654|||
27805573|NCT01946282|54260949|FG000|Year 2|Did not return FIT kit|803|||
27805574|NCT01946282|54260950|FG001|Year 2|Did not return FIT kit|131|||
27805575|NCT01946282|54260951|FG002|Year 2|Did not return FIT kit|115|||
27805576|NCT01946282|54260949|FG000|Year 3|Did not return FIT kit|288|||
27842947|NCT01440569|54331894|FG001|Open-Label Rollover Phase|Lack of Efficacy|0|||
27805577|NCT01946282|54260950|FG001|Year 3|Did not return FIT kit|43|||
27805578|NCT01946282|54260951|FG002|Year 3|Did not return FIT kit|30|||
27805579|NCT01945580|54260963|FG000|Overall Study|Withdrawal by Subject|13|||
28029112|NCT00518115|54687688|FG000|Overall Study|Lack of Efficacy|1|||
28029113|NCT00518115|54687689|FG001|Overall Study|Lack of Efficacy|0|||
28029114|NCT00518115|54687690|FG002|Overall Study|Lack of Efficacy|1|||
28029115|NCT00518115|54687691|FG003|Overall Study|Lack of Efficacy|1|||
28029116|NCT00518115|54687692|FG004|Overall Study|Lack of Efficacy|0|||
28029117|NCT00518115|54687693|FG005|Overall Study|Lack of Efficacy|0|||
28029118|NCT00518115|54687694|FG006|Overall Study|Lack of Efficacy|0|||
28029119|NCT00518115|54687695|FG007|Overall Study|Lack of Efficacy|1|||
28029120|NCT00518115|54687696|FG008|Overall Study|Lack of Efficacy|0|||
28029121|NCT00518115|54687697|FG009|Overall Study|Lack of Efficacy|0|||
28029122|NCT00518115|54687688|FG000|Overall Study|Non-Compliance|1|||
28029123|NCT00518115|54687689|FG001|Overall Study|Non-Compliance|0|||
28029124|NCT00518115|54687690|FG002|Overall Study|Non-Compliance|1|||
28029125|NCT00518115|54687691|FG003|Overall Study|Non-Compliance|0|||
28029126|NCT00518115|54687692|FG004|Overall Study|Non-Compliance|1|||
28029127|NCT00518115|54687693|FG005|Overall Study|Non-Compliance|1|||
28029128|NCT00518115|54687694|FG006|Overall Study|Non-Compliance|1|||
28029129|NCT00518115|54687695|FG007|Overall Study|Non-Compliance|1|||
28029130|NCT00518115|54687696|FG008|Overall Study|Non-Compliance|0|||
28029131|NCT00518115|54687697|FG009|Overall Study|Non-Compliance|1|||
28029132|NCT00518115|54687688|FG000|Overall Study|Treatment Eligibility Criteria Not Met|1|||
28029133|NCT00518115|54687689|FG001|Overall Study|Treatment Eligibility Criteria Not Met|1|||
28029134|NCT00518115|54687690|FG002|Overall Study|Treatment Eligibility Criteria Not Met|0|||
28029135|NCT00518115|54687691|FG003|Overall Study|Treatment Eligibility Criteria Not Met|0|||
28029136|NCT00518115|54687692|FG004|Overall Study|Treatment Eligibility Criteria Not Met|0|||
28029137|NCT00518115|54687693|FG005|Overall Study|Treatment Eligibility Criteria Not Met|4|||
28029138|NCT00518115|54687694|FG006|Overall Study|Treatment Eligibility Criteria Not Met|0|||
28029139|NCT00518115|54687695|FG007|Overall Study|Treatment Eligibility Criteria Not Met|0|||
28029140|NCT00518115|54687696|FG008|Overall Study|Treatment Eligibility Criteria Not Met|0|||
28029141|NCT00518115|54687697|FG009|Overall Study|Treatment Eligibility Criteria Not Met|0|||
28029142|NCT00518115|54687688|FG000|Overall Study|Physician Prescribed Antidiabetic Drug|1|||
28029143|NCT00518115|54687689|FG001|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
28029144|NCT00518115|54687690|FG002|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
28029145|NCT00518115|54687691|FG003|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
28029146|NCT00518115|54687692|FG004|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
28029147|NCT00518115|54687693|FG005|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
28029148|NCT00518115|54687694|FG006|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
28029149|NCT00518115|54687695|FG007|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
28029150|NCT00518115|54687696|FG008|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
28029151|NCT00518115|54687697|FG009|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
28029152|NCT00518115|54687688|FG000|Overall Study|Different Monotherapy Diabetic Drug|0|||
28029153|NCT00518115|54687689|FG001|Overall Study|Different Monotherapy Diabetic Drug|0|||
28029154|NCT00518115|54687690|FG002|Overall Study|Different Monotherapy Diabetic Drug|1|||
28029155|NCT00518115|54687691|FG003|Overall Study|Different Monotherapy Diabetic Drug|0|||
28029156|NCT00518115|54687692|FG004|Overall Study|Different Monotherapy Diabetic Drug|0|||
28029157|NCT00518115|54687693|FG005|Overall Study|Different Monotherapy Diabetic Drug|0|||
28029158|NCT00518115|54687694|FG006|Overall Study|Different Monotherapy Diabetic Drug|0|||
28029159|NCT00518115|54687695|FG007|Overall Study|Different Monotherapy Diabetic Drug|0|||
28029160|NCT00518115|54687696|FG008|Overall Study|Different Monotherapy Diabetic Drug|1|||
28029161|NCT00518115|54687697|FG009|Overall Study|Different Monotherapy Diabetic Drug|0|||
28029162|NCT00518115|54687688|FG000|Overall Study|Wrong Monotherapy Administered|0|||
28029163|NCT00518115|54687689|FG001|Overall Study|Wrong Monotherapy Administered|0|||
28029164|NCT00518115|54687690|FG002|Overall Study|Wrong Monotherapy Administered|1|||
28029165|NCT00518115|54687691|FG003|Overall Study|Wrong Monotherapy Administered|0|||
28029166|NCT00518115|54687692|FG004|Overall Study|Wrong Monotherapy Administered|0|||
28029167|NCT00518115|54687693|FG005|Overall Study|Wrong Monotherapy Administered|0|||
28029168|NCT00518115|54687694|FG006|Overall Study|Wrong Monotherapy Administered|1|||
28029169|NCT00518115|54687695|FG007|Overall Study|Wrong Monotherapy Administered|0|||
28029170|NCT00518115|54687696|FG008|Overall Study|Wrong Monotherapy Administered|0|||
28029171|NCT00518115|54687697|FG009|Overall Study|Wrong Monotherapy Administered|0|||
28029172|NCT00518115|54687688|FG000|Overall Study|Violation of Exclusion Criteria|0|||
28029173|NCT00518115|54687689|FG001|Overall Study|Violation of Exclusion Criteria|0|||
28029174|NCT00518115|54687690|FG002|Overall Study|Violation of Exclusion Criteria|0|||
28029175|NCT00518115|54687691|FG003|Overall Study|Violation of Exclusion Criteria|1|||
28029176|NCT00518115|54687692|FG004|Overall Study|Violation of Exclusion Criteria|0|||
28029177|NCT00518115|54687693|FG005|Overall Study|Violation of Exclusion Criteria|0|||
28029178|NCT00518115|54687694|FG006|Overall Study|Violation of Exclusion Criteria|1|||
28029179|NCT00518115|54687695|FG007|Overall Study|Violation of Exclusion Criteria|0|||
28029180|NCT00518115|54687696|FG008|Overall Study|Violation of Exclusion Criteria|0|||
27805580|NCT01945580|54260964|FG001|Overall Study|Withdrawal by Subject|35|||
27805581|NCT01945580|54260963|FG000|Overall Study|Physician Decision|3|||
27805582|NCT01945580|54260964|FG001|Overall Study|Physician Decision|2|||
27805583|NCT01945580|54260963|FG000|Overall Study|Lost to Follow-up|26|||
27805584|NCT01945580|54260964|FG001|Overall Study|Lost to Follow-up|39|||
27805585|NCT01945580|54260963|FG000|Overall Study|Death|7|||
27805586|NCT01945580|54260964|FG001|Overall Study|Death|2|||
27805587|NCT01945580|54260963|FG000|Overall Study|Patient moved out of state|0|||
27805588|NCT01945580|54260964|FG001|Overall Study|Patient moved out of state|1|||
27805589|NCT01945580|54260963|FG000|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|1|||
27805590|NCT01945580|54260964|FG001|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|0|||
27805591|NCT01945580|54260963|FG000|Overall Study|Family illness - unable to return|0|||
27805592|NCT01945580|54260964|FG001|Overall Study|Family illness - unable to return|1|||
27805593|NCT01945580|54260963|FG000|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|0|||
27842948|NCT01440569|54331893|FG000|Open-Label Rollover Phase|Investigator's Discretion|3|||
27842949|NCT01440569|54331894|FG001|Open-Label Rollover Phase|Investigator's Discretion|1|||
27842950|NCT01440569|54331893|FG000|Open-Label Rollover Phase|Withdrew Consent|11|||
27842951|NCT01440569|54331894|FG001|Open-Label Rollover Phase|Withdrew Consent|1|||
27842952|NCT01440569|54331893|FG000|Open-Label Rollover Phase|Lost to Follow-up|26|||
27842953|NCT01440569|54331894|FG001|Open-Label Rollover Phase|Lost to Follow-up|3|||
27805594|NCT01945580|54260964|FG001|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|1|||
27805595|NCT01945580|54260963|FG000|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|0|||
27805596|NCT01945580|54260964|FG001|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|1|||
27805597|NCT01945580|54260963|FG000|Overall Study|Noncompliance with 36 month visit|1|||
27805598|NCT01945580|54260964|FG001|Overall Study|Noncompliance with 36 month visit|0|||
27805599|NCT01945580|54260963|FG000|Overall Study|The patient moved.|1|||
27805600|NCT01945580|54260964|FG001|Overall Study|The patient moved.|0|||
27842954|NCT01440569|54331893|FG000|Open-Label Rollover Phase|Subject Non-Compliance|1|||
27842955|NCT01440569|54331894|FG001|Open-Label Rollover Phase|Subject Non-Compliance|1|||
27842956|NCT01546142|54331917|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
27842957|NCT01546142|54331918|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
27842958|NCT01546142|54331917|FG000|Overall Study|Subject Noncompliance|1|||
27842959|NCT01546142|54331918|FG001|Overall Study|Subject Noncompliance|1|||
27842960|NCT01546142|54331917|FG000|Overall Study|Adverse Event|6|||
27842961|NCT01546142|54331918|FG001|Overall Study|Adverse Event|3|||
27842962|NCT01546142|54331917|FG000|Overall Study|Lost to Follow-up|20|||
27842963|NCT01546142|54331918|FG001|Overall Study|Lost to Follow-up|15|||
27842964|NCT01546142|54331917|FG000|Overall Study|Consent Withdrawn (Subject Discomfort)|1|||
27842965|NCT01546142|54331918|FG001|Overall Study|Consent Withdrawn (Subject Discomfort)|0|||
27842966|NCT01546142|54331917|FG000|Overall Study|Subject Randomized but Not Treated|1|||
27842967|NCT01546142|54331918|FG001|Overall Study|Subject Randomized but Not Treated|0|||
27842968|NCT01440101|54331952|FG000|Overall Study|Adverse Event|2|||
27842969|NCT01440101|54331953|FG001|Overall Study|Adverse Event|0|||
27842970|NCT01440101|54331954|FG002|Overall Study|Adverse Event|0|||
27842971|NCT01440101|54331952|FG000|Overall Study|Withdrawal by Subject|0|||
27842972|NCT01440101|54331953|FG001|Overall Study|Withdrawal by Subject|3|||
27842973|NCT01440101|54331954|FG002|Overall Study|Withdrawal by Subject|1|||
27842974|NCT01440101|54331952|FG000|Overall Study|Other|0|||
27842975|NCT01440101|54331953|FG001|Overall Study|Other|1|||
27842976|NCT01440101|54331954|FG002|Overall Study|Other|0|||
27842977|NCT01530464|54331965|FG000|Washout (24h)|Withdrawal by Subject|1|||
27842978|NCT01530464|54331966|FG001|Washout (24h)|Withdrawal by Subject|0|||
27842979|NCT01530464|54331965|FG000|Washout (24h)|Withdrawal by Subject|0|||
27842980|NCT01530464|54331966|FG001|Washout (24h)|Withdrawal by Subject|1|||
27842981|NCT01439945|54332033|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
27842982|NCT01439945|54332034|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
27842983|NCT01439945|54332035|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
27842984|NCT01439945|54332036|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
27842985|NCT01439945|54332033|FG000|Double-Blind Treatment Phase|Ineligible|1|||
27842986|NCT01439945|54332034|FG001|Double-Blind Treatment Phase|Ineligible|2|||
27842987|NCT01439945|54332035|FG002|Double-Blind Treatment Phase|Ineligible|0|||
27842988|NCT01439945|54332036|FG003|Double-Blind Treatment Phase|Ineligible|1|||
27842989|NCT01420081|54332141|FG000|Overall Study|Death|1|||
27805601|NCT01945580|54260963|FG000|Overall Study|No data available|0|||
27805602|NCT01945580|54260964|FG001|Overall Study|No data available|2|||
27805603|NCT01945034|54260977|FG000|Overall Study|Medication Error|0|||
27842990|NCT01420081|54332142|FG001|Overall Study|Death|0|||
27842991|NCT01420081|54332143|FG002|Overall Study|Death|8|||
27842992|NCT01420081|54332144|FG003|Overall Study|Death|0|||
27842993|NCT01420081|54332145|FG004|Overall Study|Death|7|||
27842994|NCT01420081|54332146|FG005|Overall Study|Death|12|||
27842995|NCT01420081|54332147|FG006|Overall Study|Death|0|||
27842996|NCT01420081|54332148|FG007|Overall Study|Death|1|||
27842997|NCT01420081|54332149|FG008|Overall Study|Death|1|||
27842998|NCT01420081|54332141|FG000|Overall Study|Lost to Follow-up|0|||
27842999|NCT01420081|54332142|FG001|Overall Study|Lost to Follow-up|0|||
27843000|NCT01420081|54332143|FG002|Overall Study|Lost to Follow-up|0|||
27805604|NCT01945034|54260978|FG001|Overall Study|Medication Error|1|||
27805605|NCT01945034|54260979|FG002|Overall Study|Medication Error|0|||
27805606|NCT01945034|54260977|FG000|Overall Study|Withdrawal by Subject|0|||
27805607|NCT01945034|54260978|FG001|Overall Study|Withdrawal by Subject|3|||
27805608|NCT01945034|54260979|FG002|Overall Study|Withdrawal by Subject|1|||
27805609|NCT01945034|54260977|FG000|Overall Study|Other|0|||
27805610|NCT01945034|54260978|FG001|Overall Study|Other|1|||
27805611|NCT01945034|54260979|FG002|Overall Study|Other|3|||
27805612|NCT01945034|54260977|FG000|Overall Study|Lost to Follow-up|0|||
27805613|NCT01945034|54260978|FG001|Overall Study|Lost to Follow-up|0|||
27805614|NCT01945034|54260979|FG002|Overall Study|Lost to Follow-up|2|||
27805615|NCT01945034|54260977|FG000|Overall Study|Protocol Violation|1|||
27843001|NCT01420081|54332144|FG003|Overall Study|Lost to Follow-up|0|||
27805616|NCT01945034|54260978|FG001|Overall Study|Protocol Violation|0|||
27805617|NCT01945034|54260979|FG002|Overall Study|Protocol Violation|1|||
27805618|NCT01960790|54260987|FG000|Overall Study|Survey forms could not be recovered|3|||
27805619|NCT01960790|54260987|FG000|Overall Study|Treat with Humira outside survey period|3|||
27805620|NCT01960790|54260987|FG000|Overall Study|Transferred to another hospital|4|||
27805621|NCT01960790|54260987|FG000|Overall Study|Unevaluable for safety|1|||
27805622|NCT01618214|54260993|FG000|Overall Study|Adverse Event|3|||
27805623|NCT01618214|54260994|FG001|Overall Study|Adverse Event|1|||
27805624|NCT01618214|54260993|FG000|Overall Study|Lack of Efficacy|1|||
27805625|NCT01618214|54260994|FG001|Overall Study|Lack of Efficacy|1|||
27805626|NCT01618214|54260993|FG000|Overall Study|Protocol Violation|1|||
27805627|NCT01618214|54260994|FG001|Overall Study|Protocol Violation|4|||
27805628|NCT01618214|54260993|FG000|Overall Study|Withdrawal Criteria|1|||
27805629|NCT01618214|54260994|FG001|Overall Study|Withdrawal Criteria|2|||
27805630|NCT01618214|54260993|FG000|Overall Study|Unclassified|4|||
27805631|NCT01618214|54260994|FG001|Overall Study|Unclassified|5|||
27805632|NCT01917968|54261002|FG000|Overall Study|Death|3|||
27805633|NCT01917968|54261003|FG001|Overall Study|Death|2|||
27843002|NCT01420081|54332145|FG004|Overall Study|Lost to Follow-up|1|||
27843003|NCT01420081|54332146|FG005|Overall Study|Lost to Follow-up|1|||
27843004|NCT01420081|54332147|FG006|Overall Study|Lost to Follow-up|0|||
27843005|NCT01420081|54332148|FG007|Overall Study|Lost to Follow-up|0|||
27843006|NCT01420081|54332149|FG008|Overall Study|Lost to Follow-up|0|||
27843007|NCT01420081|54332141|FG000|Overall Study|Study Terminated by Sponsor|2|||
27843008|NCT01420081|54332142|FG001|Overall Study|Study Terminated by Sponsor|1|||
27843009|NCT01420081|54332143|FG002|Overall Study|Study Terminated by Sponsor|1|||
27843010|NCT01420081|54332144|FG003|Overall Study|Study Terminated by Sponsor|3|||
27843011|NCT01420081|54332145|FG004|Overall Study|Study Terminated by Sponsor|11|||
27843012|NCT01420081|54332146|FG005|Overall Study|Study Terminated by Sponsor|7|||
27843013|NCT01420081|54332147|FG006|Overall Study|Study Terminated by Sponsor|3|||
27843014|NCT01420081|54332148|FG007|Overall Study|Study Terminated by Sponsor|2|||
27843015|NCT01420081|54332149|FG008|Overall Study|Study Terminated by Sponsor|2|||
27843016|NCT01420081|54332141|FG000|Overall Study|Subject Refused Futher Follow-up|0|||
27843017|NCT01420081|54332142|FG001|Overall Study|Subject Refused Futher Follow-up|0|||
27843018|NCT01420081|54332143|FG002|Overall Study|Subject Refused Futher Follow-up|1|||
27843019|NCT01420081|54332144|FG003|Overall Study|Subject Refused Futher Follow-up|0|||
27843020|NCT01420081|54332145|FG004|Overall Study|Subject Refused Futher Follow-up|1|||
27805634|NCT01917968|54261002|FG000|Overall Study|Lost to Follow-up|21|||
27805635|NCT01917968|54261003|FG001|Overall Study|Lost to Follow-up|39|||
27805636|NCT01917968|54261002|FG000|Overall Study|Physician Decision|1|||
27805637|NCT01917968|54261003|FG001|Overall Study|Physician Decision|2|||
27805638|NCT01917968|54261002|FG000|Overall Study|Withdrawal by Subject|20|||
27805639|NCT01917968|54261003|FG001|Overall Study|Withdrawal by Subject|35|||
27805640|NCT01917968|54261002|FG000|Overall Study|Subject Relocation|5|||
27805641|NCT01917968|54261003|FG001|Overall Study|Subject Relocation|1|||
27843021|NCT01420081|54332146|FG005|Overall Study|Subject Refused Futher Follow-up|0|||
27843022|NCT01420081|54332147|FG006|Overall Study|Subject Refused Futher Follow-up|0|||
27805642|NCT01917968|54261002|FG000|Overall Study|36M Missed Visit|3|||
27843023|NCT01420081|54332148|FG007|Overall Study|Subject Refused Futher Follow-up|0|||
27805643|NCT01917968|54261003|FG001|Overall Study|36M Missed Visit|2|||
27805644|NCT01917968|54261002|FG000|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|1|||
27805645|NCT01917968|54261003|FG001|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|0|||
27805646|NCT01917968|54261002|FG000|Overall Study|Change in Family Circumstances|0|||
27805647|NCT01917968|54261003|FG001|Overall Study|Change in Family Circumstances|1|||
27805648|NCT01917968|54261002|FG000|Overall Study|No Data Available|0|||
27805649|NCT01917968|54261003|FG001|Overall Study|No Data Available|2|||
27805650|NCT01917656|54261018|FG000|Overall Study|Adverse Event|11|||
27805651|NCT01917656|54261019|FG001|Overall Study|Adverse Event|0|||
27805652|NCT01917656|54261018|FG000|Overall Study|Withdrawal criteria|8|||
27805653|NCT01917656|54261019|FG001|Overall Study|Withdrawal criteria|14|||
27805654|NCT01917656|54261018|FG000|Overall Study|Unclassified|0|||
27805655|NCT01917656|54261019|FG001|Overall Study|Unclassified|3|||
27805656|NCT01917656|54261018|FG000|Overall Study|Withdrawal by Subject|4|||
27805657|NCT01917656|54261019|FG001|Overall Study|Withdrawal by Subject|3|||
27805658|NCT01917656|54261018|FG000|Overall Study|Lost to Follow-up|3|||
27805659|NCT01917656|54261019|FG001|Overall Study|Lost to Follow-up|4|||
27805660|NCT02018861|54261035|FG000|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
27843024|NCT01420081|54332149|FG008|Overall Study|Subject Refused Futher Follow-up|0|||
27843025|NCT01420081|54332141|FG000|Overall Study|Other Reasons|0|||
27843026|NCT01420081|54332142|FG001|Overall Study|Other Reasons|0|||
27843027|NCT01420081|54332143|FG002|Overall Study|Other Reasons|1|||
27843028|NCT01420081|54332144|FG003|Overall Study|Other Reasons|0|||
27843029|NCT01420081|54332145|FG004|Overall Study|Other Reasons|0|||
27843030|NCT01420081|54332146|FG005|Overall Study|Other Reasons|0|||
27843031|NCT01420081|54332147|FG006|Overall Study|Other Reasons|0|||
27843032|NCT01420081|54332148|FG007|Overall Study|Other Reasons|0|||
27843033|NCT01420081|54332149|FG008|Overall Study|Other Reasons|0|||
27843034|NCT01439867|54332167|FG000|Overall Study|Non-compliance|0|||
27843035|NCT01439867|54332168|FG001|Overall Study|Non-compliance|1|||
27843036|NCT01439867|54332167|FG000|Overall Study|Withdrawal by Subject|1|||
27843037|NCT01439867|54332168|FG001|Overall Study|Withdrawal by Subject|2|||
27843038|NCT01439867|54332167|FG000|Overall Study|Administrative Decision|4|||
27843039|NCT01439867|54332168|FG001|Overall Study|Administrative Decision|5|||
27843040|NCT01439867|54332167|FG000|Overall Study|Protocol-specified Criteria|1|||
27843041|NCT01439867|54332168|FG001|Overall Study|Protocol-specified Criteria|0|||
27843042|NCT01439711|54332185|FG000|Overall Study|Ineligible|13|||
27843043|NCT01439711|54332185|FG000|Overall Study|Cancel|3|||
27843044|NCT01439711|54332185|FG000|Overall Study|Progression Prior to Beginning Tx|1|||
27843045|NCT01439711|54332185|FG000|Overall Study|Adverse Event|5|||
27843046|NCT01439711|54332185|FG000|Overall Study|Withdrawal by Subject|3|||
27843047|NCT01439711|54332185|FG000|Overall Study|Progression During Active Tx|3|||
27843048|NCT01439711|54332185|FG000|Overall Study|Noncompliance|3|||
27843049|NCT01439711|54332185|FG000|Overall Study|No MRI|9|||
27843050|NCT01439555|54332189|FG000|Overall Study|Protocol Violation|1|||
27843051|NCT01544582|54332209|FG000|Screening/Eligibility|Initiated Different CHC Treatment|1|||
27843052|NCT01544582|54332210|FG001|Screening/Eligibility|Initiated Different CHC Treatment|0|||
27843053|NCT01544582|54332211|FG002|Screening/Eligibility|Initiated Different CHC Treatment|0|||
27843054|NCT01544582|54332212|FG003|Screening/Eligibility|Initiated Different CHC Treatment|0|||
27843055|NCT01544582|54332209|FG000|Screening/Eligibility|Eligibility Criteria Not Met|33|||
27843056|NCT01544582|54332210|FG001|Screening/Eligibility|Eligibility Criteria Not Met|0|||
27843057|NCT01544582|54332211|FG002|Screening/Eligibility|Eligibility Criteria Not Met|0|||
27843058|NCT01544582|54332212|FG003|Screening/Eligibility|Eligibility Criteria Not Met|0|||
27843059|NCT01544582|54332209|FG000|Analysis Population|Participant Refuses to Continue Study|0|||
27843060|NCT01544582|54332210|FG001|Analysis Population|Participant Refuses to Continue Study|15|||
27805661|NCT02018861|54261036|FG001|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|2|||
27805662|NCT02018861|54261037|FG002|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
27805663|NCT02018861|54261038|FG003|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|6|||
27805664|NCT02018861|54261039|FG004|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|4|||
27805665|NCT02018861|54261040|FG005|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
27805666|NCT02018861|54261041|FG006|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
27805667|NCT02018861|54261042|FG007|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
27805668|NCT02018861|54261043|FG008|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
27805669|NCT02018861|54261044|FG009|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
27805670|NCT02018861|54261035|FG000|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
27805671|NCT02018861|54261036|FG001|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
27843061|NCT01544582|54332211|FG002|Analysis Population|Participant Refuses to Continue Study|17|||
27843062|NCT01544582|54332212|FG003|Analysis Population|Participant Refuses to Continue Study|4|||
27843063|NCT01544582|54332209|FG000|Analysis Population|Physician Decision|0|||
27843064|NCT01544582|54332210|FG001|Analysis Population|Physician Decision|13|||
27843065|NCT01544582|54332211|FG002|Analysis Population|Physician Decision|10|||
27843066|NCT01544582|54332212|FG003|Analysis Population|Physician Decision|9|||
27843067|NCT01544582|54332209|FG000|Analysis Population|Safety Reason|0|||
27843068|NCT01544582|54332210|FG001|Analysis Population|Safety Reason|33|||
27843069|NCT01544582|54332211|FG002|Analysis Population|Safety Reason|31|||
27843070|NCT01544582|54332212|FG003|Analysis Population|Safety Reason|8|||
27843071|NCT01544582|54332209|FG000|Analysis Population|Effectiveness Reason|0|||
27843072|NCT01544582|54332210|FG001|Analysis Population|Effectiveness Reason|48|||
27843073|NCT01544582|54332211|FG002|Analysis Population|Effectiveness Reason|29|||
27843074|NCT01544582|54332212|FG003|Analysis Population|Effectiveness Reason|12|||
27843075|NCT01544582|54332209|FG000|Analysis Population|New Contraindication-Alcohol Abuse|0|||
27843076|NCT01544582|54332210|FG001|Analysis Population|New Contraindication-Alcohol Abuse|0|||
27843077|NCT01544582|54332211|FG002|Analysis Population|New Contraindication-Alcohol Abuse|0|||
27843078|NCT01544582|54332212|FG003|Analysis Population|New Contraindication-Alcohol Abuse|1|||
27843079|NCT01544582|54332209|FG000|Analysis Population|Lost to Follow-up|0|||
27843080|NCT01544582|54332210|FG001|Analysis Population|Lost to Follow-up|6|||
27843081|NCT01544582|54332211|FG002|Analysis Population|Lost to Follow-up|6|||
27843082|NCT01544582|54332212|FG003|Analysis Population|Lost to Follow-up|5|||
27843083|NCT01544582|54332209|FG000|Analysis Population|Bad Tolerance to Treatment|0|||
28029181|NCT00518115|54687697|FG009|Overall Study|Violation of Exclusion Criteria|0|||
28029182|NCT00518115|54687688|FG000|Overall Study|Family Emergency; Had to Go to England|0|||
28029183|NCT00518115|54687689|FG001|Overall Study|Family Emergency; Had to Go to England|0|||
28029184|NCT00518115|54687690|FG002|Overall Study|Family Emergency; Had to Go to England|0|||
27805672|NCT02018861|54261037|FG002|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
27805673|NCT02018861|54261038|FG003|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
27805674|NCT02018861|54261039|FG004|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
27805675|NCT02018861|54261040|FG005|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
27805676|NCT02018861|54261041|FG006|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
27805677|NCT02018861|54261042|FG007|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
27805678|NCT02018861|54261043|FG008|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
27805679|NCT02018861|54261044|FG009|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
27805680|NCT02018861|54261035|FG000|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
27805681|NCT02018861|54261036|FG001|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
27843084|NCT01544582|54332210|FG001|Analysis Population|Bad Tolerance to Treatment|0|||
27843085|NCT01544582|54332211|FG002|Analysis Population|Bad Tolerance to Treatment|2|||
27843086|NCT01544582|54332212|FG003|Analysis Population|Bad Tolerance to Treatment|0|||
27939511|NCT01054599|54595762|FG000|Overall Study|Dizziness due to phenytoin toxicity|1|||
27939512|NCT01054599|54595763|FG001|Overall Study|Dizziness due to phenytoin toxicity|0|||
27843087|NCT01544582|54332209|FG000|Analysis Population|Did Not Meet Inclusion Criteria|0|||
27843088|NCT01544582|54332210|FG001|Analysis Population|Did Not Meet Inclusion Criteria|0|||
27843089|NCT01544582|54332211|FG002|Analysis Population|Did Not Meet Inclusion Criteria|3|||
27843090|NCT01544582|54332212|FG003|Analysis Population|Did Not Meet Inclusion Criteria|0|||
27843091|NCT01544582|54332209|FG000|Analysis Population|Intolerance|0|||
27843092|NCT01544582|54332210|FG001|Analysis Population|Intolerance|1|||
27843093|NCT01544582|54332211|FG002|Analysis Population|Intolerance|0|||
27843094|NCT01544582|54332212|FG003|Analysis Population|Intolerance|0|||
27843095|NCT01544582|54332209|FG000|Analysis Population|Liver Transplantation|0|||
27843096|NCT01544582|54332210|FG001|Analysis Population|Liver Transplantation|0|||
27843097|NCT01544582|54332211|FG002|Analysis Population|Liver Transplantation|1|||
27843098|NCT01544582|54332212|FG003|Analysis Population|Liver Transplantation|0|||
27843099|NCT01544582|54332209|FG000|Analysis Population|No Social Insurance|0|||
27843100|NCT01544582|54332210|FG001|Analysis Population|No Social Insurance|0|||
27843101|NCT01544582|54332211|FG002|Analysis Population|No Social Insurance|1|||
27843102|NCT01544582|54332212|FG003|Analysis Population|No Social Insurance|0|||
27843103|NCT01544582|54332209|FG000|Analysis Population|Poor Adherence|0|||
27843104|NCT01544582|54332210|FG001|Analysis Population|Poor Adherence|0|||
27843105|NCT01544582|54332211|FG002|Analysis Population|Poor Adherence|1|||
27843106|NCT01544582|54332212|FG003|Analysis Population|Poor Adherence|0|||
27843107|NCT01544582|54332209|FG000|Analysis Population|Poor Participant Compliance|0|||
27843108|NCT01544582|54332210|FG001|Analysis Population|Poor Participant Compliance|1|||
27843109|NCT01544582|54332211|FG002|Analysis Population|Poor Participant Compliance|0|||
27843110|NCT01544582|54332212|FG003|Analysis Population|Poor Participant Compliance|0|||
27843111|NCT01544582|54332209|FG000|Analysis Population|Programmed Surgery|0|||
27843112|NCT01544582|54332210|FG001|Analysis Population|Programmed Surgery|1|||
27843113|NCT01544582|54332211|FG002|Analysis Population|Programmed Surgery|0|||
27843114|NCT01544582|54332212|FG003|Analysis Population|Programmed Surgery|0|||
27843115|NCT01544582|54332209|FG000|Analysis Population|Participant in Jail|0|||
27843116|NCT01544582|54332210|FG001|Analysis Population|Participant in Jail|0|||
27843117|NCT01544582|54332211|FG002|Analysis Population|Participant in Jail|1|||
27843118|NCT01544582|54332212|FG003|Analysis Population|Participant in Jail|0|||
27843119|NCT01439165|54332240|FG000|Overall Study|Protocol Violation|3|||
27843120|NCT01439165|54332241|FG001|Overall Study|Protocol Violation|0|||
27843121|NCT01439165|54332240|FG000|Overall Study|Lost to Follow-up|11|||
27843122|NCT01439165|54332241|FG001|Overall Study|Lost to Follow-up|1|||
27843123|NCT01439165|54332240|FG000|Overall Study|Withdrawal by Subject|7|||
27843124|NCT01439165|54332241|FG001|Overall Study|Withdrawal by Subject|1|||
27843125|NCT01529606|54332255|FG000|Overall Study|Lost to Follow-up|21|||
27843126|NCT01529606|54332256|FG001|Overall Study|Lost to Follow-up|18|||
27843127|NCT01439009|54332273|FG000|Overall Study|Physician Decision|5|||
27843128|NCT01439009|54332274|FG001|Overall Study|Physician Decision|3|||
27843129|NCT01439009|54332273|FG000|Overall Study|Protocol Violation|2|||
27843130|NCT01439009|54332274|FG001|Overall Study|Protocol Violation|0|||
27843131|NCT01439009|54332273|FG000|Overall Study|Deviation of exclusion criteria|1|||
27843132|NCT01439009|54332274|FG001|Overall Study|Deviation of exclusion criteria|0|||
27843133|NCT01572389|54332293|FG000|Overall Study|Death|1|||
27843134|NCT01572389|54332294|FG001|Overall Study|Death|3|||
27843135|NCT01572389|54332293|FG000|Overall Study|Withdrawal by Subject|14|||
27843136|NCT01572389|54332294|FG001|Overall Study|Withdrawal by Subject|2|||
27843137|NCT01572389|54332293|FG000|Overall Study|Lost to Follow-up|25|||
27843138|NCT01572389|54332294|FG001|Overall Study|Lost to Follow-up|14|||
27843139|NCT01572389|54332293|FG000|Overall Study|Only A1C or Assessment was Collected|6|||
27843140|NCT01572389|54332294|FG001|Overall Study|Only A1C or Assessment was Collected|2|||
27843141|NCT01571453|54332306|FG000|Overall Study|Adverse Event|14|||
27843142|NCT01571453|54332307|FG001|Overall Study|Adverse Event|32|||
27843143|NCT01571453|54332306|FG000|Overall Study|Lack of Efficacy|8|||
27843144|NCT01571453|54332307|FG001|Overall Study|Lack of Efficacy|3|||
27843145|NCT01571453|54332306|FG000|Overall Study|Non-compliance|2|||
27843146|NCT01571453|54332307|FG001|Overall Study|Non-compliance|4|||
27843147|NCT01571453|54332306|FG000|Overall Study|Protocol Violation|1|||
27843148|NCT01571453|54332307|FG001|Overall Study|Protocol Violation|5|||
27843149|NCT01571453|54332306|FG000|Overall Study|Withdrawal of consent|5|||
27843150|NCT01571453|54332307|FG001|Overall Study|Withdrawal of consent|13|||
27843151|NCT01571453|54332306|FG000|Overall Study|Lost to Follow-up|4|||
27939513|NCT01054599|54595762|FG000|Overall Study|Protocol Violation|1|||
27843152|NCT01571453|54332307|FG001|Overall Study|Lost to Follow-up|2|||
27843153|NCT01571453|54332306|FG000|Overall Study|Administrative or other reason(s)|4|||
27843154|NCT01571453|54332307|FG001|Overall Study|Administrative or other reason(s)|3|||
27843155|NCT01446289|54332317|FG000|Overall Study|Withdrawal by Subject|1|||
27843156|NCT01446289|54332318|FG001|Overall Study|Withdrawal by Subject|0|||
27843157|NCT01446289|54332319|FG002|Overall Study|Withdrawal by Subject|1|||
27843158|NCT01446289|54332320|FG003|Overall Study|Withdrawal by Subject|0|||
27843159|NCT01438541|54332332|FG000|Overall Study|Physician Decision|1|||
27843160|NCT01438541|54332332|FG000|Overall Study|Withdrawal by Subject|1|||
27843161|NCT01438541|54332332|FG000|Overall Study|discharge from the hospital|5|||
27843162|NCT01419769|54332336|FG000|Overall Study|Did not receive the AXIOS stent|3|||
27843163|NCT01419769|54332336|FG000|Overall Study|Not evaluable due to pigtail stents|1|||
27843164|NCT01438307|54332342|FG000|Overall Study|Death|1|||
27843165|NCT01438307|54332343|FG001|Overall Study|Death|1|||
27843166|NCT01444651|54332351|FG000|Overall Study|Adverse Event|3|||
27843167|NCT01444651|54332352|FG001|Overall Study|Adverse Event|2|||
27843168|NCT01444651|54332351|FG000|Overall Study|Lost to Follow-up|5|||
27843169|NCT01444651|54332352|FG001|Overall Study|Lost to Follow-up|5|||
27843170|NCT01444651|54332351|FG000|Overall Study|Non-fasting|2|||
27843171|NCT01444651|54332352|FG001|Overall Study|Non-fasting|1|||
27843172|NCT01444651|54332351|FG000|Overall Study|Missing data|1|||
27843173|NCT01444651|54332352|FG001|Overall Study|Missing data|1|||
27843174|NCT01570751|54332360|FG000|Period A (16 Weeks)|Protocol Violation|1|||
27843175|NCT01570751|54332361|FG001|Period A (16 Weeks)|Protocol Violation|1|||
27843176|NCT01570751|54332360|FG000|Period A (16 Weeks)|Withdrawal criteria|0|||
27843177|NCT01570751|54332361|FG001|Period A (16 Weeks)|Withdrawal criteria|1|||
27843178|NCT01570751|54332360|FG000|Period A (16 Weeks)|Unclassified|2|||
27843179|NCT01570751|54332361|FG001|Period A (16 Weeks)|Unclassified|3|||
27843180|NCT01570751|54332360|FG000|Period B (16 Weeks)|Adverse Event|1|||
27843181|NCT01570751|54332361|FG001|Period B (16 Weeks)|Adverse Event|0|||
27843182|NCT01570751|54332360|FG000|Period B (16 Weeks)|Protocol Violation|0|||
27843183|NCT01570751|54332361|FG001|Period B (16 Weeks)|Protocol Violation|1|||
27843184|NCT01419535|54332371|FG000|Overall Study|could not maintain iv line|1|||
27843185|NCT01419535|54332372|FG001|Overall Study|could not maintain iv line|1|||
27843186|NCT01419535|54332371|FG000|Overall Study|Withdrawal by Subject|0|||
27843187|NCT01419535|54332372|FG001|Overall Study|Withdrawal by Subject|1|||
27843188|NCT01438151|54332378|FG000|Overall Study|study terminated|8|||
27843189|NCT01418365|54332404|FG000|First Intervention|Withdrawal by Subject|0|||
27843190|NCT01418365|54332405|FG001|First Intervention|Withdrawal by Subject|1|||
27843191|NCT01418365|54332404|FG000|First Intervention|Non-compliance|1|||
27843192|NCT01418365|54332405|FG001|First Intervention|Non-compliance|0|||
27843193|NCT01418365|54332404|FG000|Second Intervention|Withdrawal by Subject|0|||
27843194|NCT01418365|54332405|FG001|Second Intervention|Withdrawal by Subject|1|||
27843195|NCT01437995|54332440|FG000|Overall Study|Lost to Follow-up|11|||
27843196|NCT01437995|54332441|FG001|Overall Study|Lost to Follow-up|18|||
27843197|NCT01437995|54332442|FG002|Overall Study|Lost to Follow-up|20|||
27843198|NCT01439347|54332491|FG000|Overall Study|Death|10|||
27843199|NCT01439347|54332492|FG001|Overall Study|Death|9|||
27843200|NCT01439347|54332491|FG000|Overall Study|Withdrawal by Subject|0|||
27843201|NCT01439347|54332492|FG001|Overall Study|Withdrawal by Subject|1|||
27843202|NCT01439347|54332491|FG000|Overall Study|Physician Decision|1|||
27843203|NCT01439347|54332492|FG001|Overall Study|Physician Decision|0|||
27843204|NCT01439347|54332491|FG000|Overall Study|Sponsor Terminated Study|2|||
27843205|NCT01439347|54332492|FG001|Overall Study|Sponsor Terminated Study|3|||
27843206|NCT01438957|54332539|FG000|Overall Study|Physician Decision|1|||
27843207|NCT01438957|54332540|FG001|Overall Study|Physician Decision|1|||
27843208|NCT01438957|54332541|FG002|Overall Study|Physician Decision|0|||
27843209|NCT01438957|54332542|FG003|Overall Study|Physician Decision|1|||
27843210|NCT01438957|54332543|FG004|Overall Study|Physician Decision|0|||
27843211|NCT01444417|54332592|FG000|Overall Study|Ineligibility Determined|0|||
27843212|NCT01444417|54332593|FG001|Overall Study|Ineligibility Determined|1|||
27843213|NCT01444417|54332592|FG000|Overall Study|Withdrawal by Subject|2|||
27843214|NCT01444417|54332593|FG001|Overall Study|Withdrawal by Subject|0|||
27843215|NCT01444027|54332620|FG000|Overall Study|Withdrawal by Subject|4|||
27843216|NCT01444027|54332621|FG001|Overall Study|Withdrawal by Subject|10|||
27843217|NCT01444027|54332622|FG002|Overall Study|Withdrawal by Subject|24|||
27843218|NCT01444027|54332620|FG000|Overall Study|Lost to Follow-up|26|||
27843219|NCT01444027|54332621|FG001|Overall Study|Lost to Follow-up|20|||
27843220|NCT01444027|54332622|FG002|Overall Study|Lost to Follow-up|14|||
27843221|NCT01438489|54332664|FG000|Overall Study|Lost to Follow-up|4|||
27939514|NCT01054599|54595763|FG001|Overall Study|Protocol Violation|0|||
27843222|NCT01438489|54332665|FG001|Overall Study|Lost to Follow-up|2|||
27843223|NCT01438489|54332666|FG002|Overall Study|Lost to Follow-up|2|||
27843224|NCT01438489|54332664|FG000|Overall Study|Withdrawal by Subject|11|||
27843225|NCT01438489|54332665|FG001|Overall Study|Withdrawal by Subject|3|||
27843226|NCT01438489|54332666|FG002|Overall Study|Withdrawal by Subject|8|||
27843227|NCT01438489|54332664|FG000|Overall Study|Death|0|||
27843228|NCT01438489|54332665|FG001|Overall Study|Death|0|||
27843229|NCT01438489|54332666|FG002|Overall Study|Death|1|||
27843230|NCT01438489|54332664|FG000|Overall Study|Sponsor decision|4|||
27843231|NCT01438489|54332665|FG001|Overall Study|Sponsor decision|1|||
27843232|NCT01438489|54332666|FG002|Overall Study|Sponsor decision|4|||
27843233|NCT01438489|54332664|FG000|Overall Study|Subject choice/Subject moved|2|||
27843234|NCT01438489|54332665|FG001|Overall Study|Subject choice/Subject moved|1|||
27843235|NCT01438489|54332666|FG002|Overall Study|Subject choice/Subject moved|1|||
27843236|NCT01438489|54332664|FG000|Overall Study|Investigator decision|0|||
27843237|NCT01438489|54332665|FG001|Overall Study|Investigator decision|1|||
27843238|NCT01438489|54332666|FG002|Overall Study|Investigator decision|0|||
27843239|NCT01438489|54332664|FG000|Overall Study|AE/SAEs|2|||
27843240|NCT01438489|54332665|FG001|Overall Study|AE/SAEs|1|||
27843241|NCT01438489|54332666|FG002|Overall Study|AE/SAEs|1|||
27843242|NCT01438489|54332664|FG000|Overall Study|Received prohibited medication|1|||
27843243|NCT01438489|54332665|FG001|Overall Study|Received prohibited medication|0|||
27843244|NCT01438489|54332666|FG002|Overall Study|Received prohibited medication|0|||
27843245|NCT01438489|54332664|FG000|Overall Study|Did not complete all 3 follow-up visits|2|||
27843246|NCT01438489|54332665|FG001|Overall Study|Did not complete all 3 follow-up visits|5|||
27843247|NCT01438489|54332666|FG002|Overall Study|Did not complete all 3 follow-up visits|2|||
27843248|NCT01438489|54332664|FG000|Overall Study|Inadequate venous access|0|||
27843249|NCT01438489|54332665|FG001|Overall Study|Inadequate venous access|2|||
27843250|NCT01438489|54332666|FG002|Overall Study|Inadequate venous access|0|||
27805682|NCT02018861|54261037|FG002|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
27805683|NCT02018861|54261038|FG003|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|13|||
27805684|NCT02018861|54261039|FG004|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|18|||
27843251|NCT01418209|54332692|FG000|Overall Study|Withdrawal by Subject|1|||
27843252|NCT01418209|54332693|FG001|Overall Study|Withdrawal by Subject|0|||
27843253|NCT01418209|54332694|FG002|Overall Study|Withdrawal by Subject|1|||
27843254|NCT01418209|54332692|FG000|Overall Study|Did not provide hot flash diary data|1|||
27843255|NCT01418209|54332693|FG001|Overall Study|Did not provide hot flash diary data|3|||
27843256|NCT01418209|54332694|FG002|Overall Study|Did not provide hot flash diary data|3|||
27843257|NCT01570361|54332713|FG000|Overall Study|Subject discontinued|1|||
27843258|NCT01570361|54332714|FG001|Overall Study|Subject discontinued|2|||
27843259|NCT01570361|54332713|FG000|Overall Study|Sponsor closing the study|51|||
27843260|NCT01570361|54332714|FG001|Overall Study|Sponsor closing the study|50|||
27843261|NCT01570361|54332713|FG000|Overall Study|Subject excluded|5|||
27843262|NCT01570361|54332714|FG001|Overall Study|Subject excluded|3|||
27843263|NCT01570361|54332713|FG000|Overall Study|Subject withdrew consent|14|||
27843264|NCT01570361|54332714|FG001|Overall Study|Subject withdrew consent|9|||
27843265|NCT01570361|54332713|FG000|Overall Study|Adverse Event|2|||
27843266|NCT01570361|54332714|FG001|Overall Study|Adverse Event|1|||
27843267|NCT01570361|54332713|FG000|Overall Study|Lost to Follow-up|4|||
27843268|NCT01570361|54332714|FG001|Overall Study|Lost to Follow-up|4|||
27843269|NCT01570361|54332713|FG000|Overall Study|Death|5|||
27843270|NCT01570361|54332714|FG001|Overall Study|Death|4|||
27843271|NCT01570361|54332713|FG000|Overall Study|Other|0|||
27843272|NCT01570361|54332714|FG001|Overall Study|Other|2|||
27843273|NCT01417195|54332725|FG000|Overall Study|Stimulation failure|1|||
27843274|NCT01417195|54332726|FG001|Overall Study|Stimulation failure|0|||
27843275|NCT01417195|54332725|FG000|Overall Study|No embryos for transfer|0|||
27843276|NCT01417195|54332726|FG001|Overall Study|No embryos for transfer|1|||
27805685|NCT02018861|54261040|FG005|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
27805686|NCT02018861|54261041|FG006|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
27805687|NCT02018861|54261042|FG007|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
27805688|NCT02018861|54261043|FG008|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
27805689|NCT02018861|54261044|FG009|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
27805690|NCT02018861|54261035|FG000|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
27805691|NCT02018861|54261036|FG001|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
27805692|NCT02018861|54261037|FG002|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
27805693|NCT02018861|54261038|FG003|Parsaclisib Monotherapy: 21-day Cycles|Death|3|||
27805694|NCT02018861|54261039|FG004|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
27805695|NCT02018861|54261040|FG005|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
27805696|NCT02018861|54261041|FG006|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
27805697|NCT02018861|54261042|FG007|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
27843277|NCT01417195|54332725|FG000|Overall Study|No transfer due to risk of OHSS|1|||
27843278|NCT01417195|54332726|FG001|Overall Study|No transfer due to risk of OHSS|0|||
27843279|NCT01417195|54332725|FG000|Overall Study|No transfer due to elevated progesterone|1|||
27843280|NCT01417195|54332726|FG001|Overall Study|No transfer due to elevated progesterone|0|||
27843281|NCT01438411|54332751|FG000|Overall Study|Adverse Event|8|||
27843282|NCT01438411|54332751|FG000|Overall Study|Lost to Follow-up|1|||
27843283|NCT01438411|54332751|FG000|Overall Study|Lack of Efficacy|1|||
27843284|NCT01438411|54332751|FG000|Overall Study|Withdrawal by Subject|3|||
27843285|NCT01443403|54332763|FG000|Overall Study|Adverse Event|1|||
27843286|NCT01443403|54332764|FG001|Overall Study|Adverse Event|1|||
27843287|NCT01443403|54332765|FG002|Overall Study|Adverse Event|4|||
27843288|NCT01443403|54332766|FG003|Overall Study|Adverse Event|5|||
27843289|NCT01443403|54332763|FG000|Overall Study|Withdrawal by Subject|0|||
27843290|NCT01443403|54332764|FG001|Overall Study|Withdrawal by Subject|1|||
27843291|NCT01443403|54332765|FG002|Overall Study|Withdrawal by Subject|2|||
27843292|NCT01443403|54332766|FG003|Overall Study|Withdrawal by Subject|1|||
27843293|NCT01443403|54332763|FG000|Overall Study|Lost to Follow-up|0|||
27843294|NCT01443403|54332764|FG001|Overall Study|Lost to Follow-up|0|||
27843295|NCT01443403|54332765|FG002|Overall Study|Lost to Follow-up|0|||
27843296|NCT01443403|54332766|FG003|Overall Study|Lost to Follow-up|1|||
27843297|NCT01443403|54332763|FG000|Overall Study|Protocol Violation|2|||
27843298|NCT01443403|54332764|FG001|Overall Study|Protocol Violation|1|||
27843299|NCT01443403|54332765|FG002|Overall Study|Protocol Violation|1|||
27843300|NCT01443403|54332766|FG003|Overall Study|Protocol Violation|1|||
27843301|NCT01443403|54332763|FG000|Overall Study|Use of Prohibited Treatment|2|||
27843302|NCT01443403|54332764|FG001|Overall Study|Use of Prohibited Treatment|3|||
27843303|NCT01443403|54332765|FG002|Overall Study|Use of Prohibited Treatment|0|||
27843304|NCT01443403|54332766|FG003|Overall Study|Use of Prohibited Treatment|0|||
27843305|NCT01443403|54332763|FG000|Overall Study|Other - Miscellaneous|1|||
27843306|NCT01443403|54332764|FG001|Overall Study|Other - Miscellaneous|0|||
27843307|NCT01443403|54332765|FG002|Overall Study|Other - Miscellaneous|0|||
27843308|NCT01443403|54332766|FG003|Overall Study|Other - Miscellaneous|1|||
27843309|NCT01438177|54332779|FG000|Overall Study|Withdrawal by Subject|1|||
27843310|NCT01438177|54332779|FG000|Overall Study|Initiation of new therapy|1|||
27843311|NCT01442779|54332783|FG000|Overall Study|Withdrawal by Subject|3|||
27843312|NCT01442779|54332783|FG000|Overall Study|Death|3|||
27843313|NCT01442779|54332783|FG000|Overall Study|Non-compliance|1|||
27843314|NCT01416805|54332789|FG000|Overall Study|Lost to Follow-up|4|||
27843315|NCT01416805|54332790|FG001|Overall Study|Lost to Follow-up|4|||
27843316|NCT01437943|54332798|FG000|Overall Study|Aliskiren trials terminated by Novartis|4|||
27843317|NCT01437943|54332799|FG001|Overall Study|Aliskiren trials terminated by Novartis|2|||
27843318|NCT01437943|54332798|FG000|Overall Study|Subject expressed pregnancy plans|1|||
28029185|NCT00518115|54687691|FG003|Overall Study|Family Emergency; Had to Go to England|0|||
28029186|NCT00518115|54687692|FG004|Overall Study|Family Emergency; Had to Go to England|1|||
27843319|NCT01437943|54332799|FG001|Overall Study|Subject expressed pregnancy plans|0|||
27843320|NCT01437943|54332798|FG000|Overall Study|Adverse Event|2|||
27843321|NCT01437943|54332799|FG001|Overall Study|Adverse Event|0|||
27843322|NCT01570283|54332808|FG000|Cohort 1: Dose Level 1|Death|0|||
27843323|NCT01570283|54332809|FG001|Cohort 1: Dose Level 1|Death|1|||
27843324|NCT01570283|54332810|FG002|Cohort 1: Dose Level 1|Death|0|||
27843325|NCT01570283|54332811|FG003|Cohort 1: Dose Level 1|Death|0|||
27843326|NCT01570283|54332812|FG004|Cohort 1: Dose Level 1|Death|0|||
27843327|NCT01570283|54332813|FG005|Cohort 1: Dose Level 1|Death|0|||
27843328|NCT01570283|54332808|FG000|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
27843329|NCT01570283|54332809|FG001|Cohort 1: Dose Level 1|Received other hematopoietic cells|1|||
27843330|NCT01570283|54332810|FG002|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
27843331|NCT01570283|54332811|FG003|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
27843332|NCT01570283|54332812|FG004|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
27843333|NCT01570283|54332813|FG005|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
27843334|NCT01570283|54332808|FG000|Cohort 2: Dose Level 2|Death|0|||
27843335|NCT01570283|54332809|FG001|Cohort 2: Dose Level 2|Death|0|||
27843336|NCT01570283|54332810|FG002|Cohort 2: Dose Level 2|Death|1|||
28029187|NCT00518115|54687693|FG005|Overall Study|Family Emergency; Had to Go to England|0|||
28029188|NCT00518115|54687694|FG006|Overall Study|Family Emergency; Had to Go to England|0|||
28029189|NCT00518115|54687695|FG007|Overall Study|Family Emergency; Had to Go to England|0|||
28029190|NCT00518115|54687696|FG008|Overall Study|Family Emergency; Had to Go to England|0|||
28029191|NCT00518115|54687697|FG009|Overall Study|Family Emergency; Had to Go to England|0|||
28029192|NCT00518115|54687688|FG000|Overall Study|Withdrew Consent|0|||
28029193|NCT00518115|54687689|FG001|Overall Study|Withdrew Consent|0|||
28029194|NCT00518115|54687690|FG002|Overall Study|Withdrew Consent|0|||
28029195|NCT00518115|54687691|FG003|Overall Study|Withdrew Consent|0|||
28029196|NCT00518115|54687692|FG004|Overall Study|Withdrew Consent|0|||
28029197|NCT00518115|54687693|FG005|Overall Study|Withdrew Consent|1|||
28029198|NCT00518115|54687694|FG006|Overall Study|Withdrew Consent|0|||
28029199|NCT00518115|54687695|FG007|Overall Study|Withdrew Consent|0|||
28029200|NCT00518115|54687696|FG008|Overall Study|Withdrew Consent|0|||
28029201|NCT00518115|54687697|FG009|Overall Study|Withdrew Consent|0|||
28029202|NCT00518115|54687688|FG000|Overall Study|Moved Out of State|0|||
28029203|NCT00518115|54687689|FG001|Overall Study|Moved Out of State|0|||
28029204|NCT00518115|54687690|FG002|Overall Study|Moved Out of State|0|||
28029205|NCT00518115|54687691|FG003|Overall Study|Moved Out of State|0|||
27843337|NCT01570283|54332811|FG003|Cohort 2: Dose Level 2|Death|0|||
27843338|NCT01570283|54332812|FG004|Cohort 2: Dose Level 2|Death|0|||
27843339|NCT01570283|54332813|FG005|Cohort 2: Dose Level 2|Death|0|||
28029206|NCT00518115|54687692|FG004|Overall Study|Moved Out of State|0|||
28029207|NCT00518115|54687693|FG005|Overall Study|Moved Out of State|0|||
28029208|NCT00518115|54687694|FG006|Overall Study|Moved Out of State|0|||
28029209|NCT00518115|54687695|FG007|Overall Study|Moved Out of State|0|||
28029210|NCT00518115|54687696|FG008|Overall Study|Moved Out of State|0|||
28029211|NCT00518115|54687697|FG009|Overall Study|Moved Out of State|1|||
28029212|NCT00450658|54687722|FG000|Overall Study|Adverse Event|24|||
28029213|NCT00450658|54687723|FG001|Overall Study|Adverse Event|15|||
28029214|NCT00450658|54687722|FG000|Overall Study|Withdrawal by Subject|43|||
28029215|NCT00450658|54687723|FG001|Overall Study|Withdrawal by Subject|26|||
28029216|NCT00450658|54687722|FG000|Overall Study|Lost to Follow-up|22|||
28029217|NCT00450658|54687723|FG001|Overall Study|Lost to Follow-up|5|||
28029218|NCT00450658|54687722|FG000|Overall Study|UGI ulcer|33|||
28029219|NCT00450658|54687723|FG001|Overall Study|UGI ulcer|34|||
28029220|NCT00450658|54687722|FG000|Overall Study|misc|21|||
28029221|NCT00450658|54687723|FG001|Overall Study|misc|10|||
28029222|NCT00517881|54687729|FG000|Overall Study|Protocol Violation|2|||
28029223|NCT00517881|54687729|FG000|Overall Study|Adverse Event|1|||
27843340|NCT01570283|54332808|FG000|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
27843341|NCT01570283|54332809|FG001|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
27843342|NCT01570283|54332810|FG002|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
27843343|NCT01570283|54332811|FG003|Cohort 2: Dose Level 2|Received other hematopoietic cells|1|||
27843344|NCT01570283|54332812|FG004|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
27843345|NCT01570283|54332813|FG005|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
27843346|NCT01570283|54332808|FG000|Cohort 3: Dose Level 3|Death|0|||
27843347|NCT01570283|54332809|FG001|Cohort 3: Dose Level 3|Death|0|||
27843348|NCT01570283|54332810|FG002|Cohort 3: Dose Level 3|Death|0|||
27843349|NCT01570283|54332811|FG003|Cohort 3: Dose Level 3|Death|0|||
28029224|NCT00517881|54687729|FG000|Overall Study|Renal transplantation|2|||
28029225|NCT00517413|54687750|FG000|Overall Study|Adverse Event|7|||
28029226|NCT00517413|54687750|FG000|Overall Study|Death|13|||
28029227|NCT00517413|54687750|FG000|Overall Study|Protocol Violation|15|||
28029228|NCT00517413|54687750|FG000|Overall Study|Withdrawal by Subject|2|||
28029229|NCT00517413|54687750|FG000|Overall Study|Failure to return|1|||
28029230|NCT00517413|54687750|FG000|Overall Study|Other-Reasons|23|||
28029231|NCT00604214|54687764|FG000|Baseline to Day 28|Death|223|||
28029232|NCT00604214|54687765|FG001|Baseline to Day 28|Death|202|||
28029233|NCT00604214|54687764|FG000|Baseline to Day 28|Lost to Follow-up|2|||
28029234|NCT00604214|54687765|FG001|Baseline to Day 28|Lost to Follow-up|4|||
28029235|NCT00604214|54687764|FG000|Baseline to Day 28|Withdrawal by Subject|3|||
28029236|NCT00604214|54687765|FG001|Baseline to Day 28|Withdrawal by Subject|7|||
27805698|NCT02018861|54261043|FG008|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
27805699|NCT02018861|54261044|FG009|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
27805700|NCT02018861|54261035|FG000|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
27805701|NCT02018861|54261036|FG001|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
27805702|NCT02018861|54261037|FG002|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
27843350|NCT01570283|54332812|FG004|Cohort 3: Dose Level 3|Death|0|||
27843351|NCT01570283|54332813|FG005|Cohort 3: Dose Level 3|Death|1|||
27843352|NCT01570283|54332808|FG000|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
27843353|NCT01570283|54332809|FG001|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
27843354|NCT01570283|54332810|FG002|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
27843355|NCT01570283|54332811|FG003|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
27843356|NCT01570283|54332812|FG004|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
27843357|NCT01570283|54332813|FG005|Cohort 3: Dose Level 3|Received other hematopoietic cells|1|||
27843358|NCT01436357|54332829|FG000|Overall Study|Death|5|||
27843359|NCT01436357|54332830|FG001|Overall Study|Death|1|||
27843360|NCT01436357|54332829|FG000|Overall Study|Enrolled but not vaccinated|1|||
27843361|NCT01436357|54332830|FG001|Overall Study|Enrolled but not vaccinated|1|||
27843362|NCT01436357|54332829|FG000|Overall Study|Incarceration|18|||
27805703|NCT02018861|54261038|FG003|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
27805704|NCT02018861|54261039|FG004|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
27805705|NCT02018861|54261040|FG005|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
27805706|NCT02018861|54261041|FG006|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
27843363|NCT01436357|54332830|FG001|Overall Study|Incarceration|20|||
27843364|NCT01436357|54332829|FG000|Overall Study|Lost to Follow-up|67|||
27843365|NCT01436357|54332830|FG001|Overall Study|Lost to Follow-up|61|||
27843366|NCT01436357|54332829|FG000|Overall Study|Protocol Violation|1|||
27843367|NCT01436357|54332830|FG001|Overall Study|Protocol Violation|0|||
28029237|NCT00604214|54687764|FG000|Day 29 to Day 90|Death|64|||
28029238|NCT00604214|54687765|FG001|Day 29 to Day 90|Death|67|||
28029239|NCT00604214|54687764|FG000|Day 29 to Day 90|Lost to Follow-up|4|||
28029240|NCT00604214|54687765|FG001|Day 29 to Day 90|Lost to Follow-up|6|||
28029241|NCT00604214|54687764|FG000|Day 29 to Day 90|Withdrawal by Subject|0|||
28029242|NCT00604214|54687765|FG001|Day 29 to Day 90|Withdrawal by Subject|6|||
27805707|NCT02018861|54261042|FG007|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
27843368|NCT01436357|54332829|FG000|Overall Study|Withdrawal by Subject|26|||
27843369|NCT01436357|54332830|FG001|Overall Study|Withdrawal by Subject|38|||
27843370|NCT01436357|54332829|FG000|Overall Study|Physician Decision|3|||
27843371|NCT01436357|54332830|FG001|Overall Study|Physician Decision|4|||
27843372|NCT01436357|54332829|FG000|Overall Study|Moved out of area|1|||
27843373|NCT01436357|54332830|FG001|Overall Study|Moved out of area|2|||
28029243|NCT00604214|54687764|FG000|Day 91 to Day 180|Death|19|||
28029244|NCT00604214|54687765|FG001|Day 91 to Day 180|Death|23|||
28029245|NCT00604214|54687764|FG000|Day 91 to Day 180|Lost to Follow-up|6|||
28029246|NCT00604214|54687765|FG001|Day 91 to Day 180|Lost to Follow-up|8|||
28029247|NCT00604214|54687764|FG000|Day 91 to Day 180|Withdrawal by Subject|1|||
28029248|NCT00604214|54687765|FG001|Day 91 to Day 180|Withdrawal by Subject|1|||
28029249|NCT00450580|54687773|FG000|Overall Study|Adverse Event|5|||
28029250|NCT00450580|54687774|FG001|Overall Study|Adverse Event|7|||
28029251|NCT00450580|54687773|FG000|Overall Study|Lost to Follow-up|4|||
28029252|NCT00450580|54687774|FG001|Overall Study|Lost to Follow-up|5|||
28029253|NCT00450580|54687773|FG000|Overall Study|Withdrawal by Subject|2|||
28029254|NCT00450580|54687774|FG001|Overall Study|Withdrawal by Subject|2|||
28029255|NCT00450580|54687773|FG000|Overall Study|Protocol Violation|1|||
28029256|NCT00450580|54687774|FG001|Overall Study|Protocol Violation|1|||
28029257|NCT00450580|54687773|FG000|Overall Study|Protocol-defined virologic failure|1|||
28029258|NCT00450580|54687774|FG001|Overall Study|Protocol-defined virologic failure|0|||
28029259|NCT00450580|54687773|FG000|Overall Study|Could not comply with scheduled visits|1|||
28029260|NCT00450580|54687774|FG001|Overall Study|Could not comply with scheduled visits|0|||
28029261|NCT00450580|54687773|FG000|Overall Study|Patient went to Brazil|1|||
28029262|NCT00450580|54687774|FG001|Overall Study|Patient went to Brazil|0|||
28029263|NCT00450580|54687773|FG000|Overall Study|Patient could not swallow Norvir|1|||
28029264|NCT00450580|54687774|FG001|Overall Study|Patient could not swallow Norvir|0|||
28029265|NCT00450580|54687773|FG000|Overall Study|Withdrawal due to pregnancy|0|||
28029266|NCT00450580|54687774|FG001|Overall Study|Withdrawal due to pregnancy|1|||
28029267|NCT00123487|54687782|FG000|Randomized|Death prior to starting treatment|0|||
27805708|NCT02018861|54261043|FG008|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
27805709|NCT02018861|54261044|FG009|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
27805710|NCT02018861|54261035|FG000|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
27805711|NCT02018861|54261036|FG001|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
27805712|NCT02018861|54261037|FG002|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
27805713|NCT02018861|54261038|FG003|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
27805714|NCT02018861|54261039|FG004|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|1|||
27843374|NCT01436357|54332829|FG000|Overall Study|Subject in rehab|0|||
27843375|NCT01436357|54332830|FG001|Overall Study|Subject in rehab|1|||
27843376|NCT01436201|54332836|FG000|Overall Study|Adverse Event|2|||
27805715|NCT02018861|54261040|FG005|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
27805716|NCT02018861|54261041|FG006|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
27805717|NCT02018861|54261042|FG007|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
27805718|NCT02018861|54261043|FG008|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
27805719|NCT02018861|54261044|FG009|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
27805720|NCT02018861|54261035|FG000|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
27805721|NCT02018861|54261036|FG001|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
27805722|NCT02018861|54261037|FG002|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
27805723|NCT02018861|54261038|FG003|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|4|||
27805724|NCT02018861|54261039|FG004|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|1|||
27805725|NCT02018861|54261040|FG005|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|2|||
27805726|NCT02018861|54261041|FG006|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
27805727|NCT02018861|54261042|FG007|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
27805728|NCT02018861|54261043|FG008|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
27805729|NCT02018861|54261044|FG009|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
27805730|NCT02018861|54261035|FG000|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
27805731|NCT02018861|54261036|FG001|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
27843377|NCT01436201|54332836|FG000|Overall Study|Withdrawal by Subject|1|||
27843378|NCT01436201|54332836|FG000|Overall Study|Protocol Violation|1|||
27843379|NCT01437397|54332847|FG000|Overall Study|Lost to Follow-up|9|||
27843380|NCT01437397|54332848|FG001|Overall Study|Lost to Follow-up|4|||
27843381|NCT01437397|54332849|FG002|Overall Study|Lost to Follow-up|2|||
27843382|NCT01437397|54332850|FG003|Overall Study|Lost to Follow-up|4|||
27843383|NCT01437397|54332851|FG004|Overall Study|Lost to Follow-up|5|||
28029268|NCT00123487|54687783|FG001|Randomized|Death prior to starting treatment|1|||
28029269|NCT00123487|54687782|FG000|Randomized|SAE prior to starting treatment|1|||
28029270|NCT00123487|54687783|FG001|Randomized|SAE prior to starting treatment|0|||
28029271|NCT00123487|54687782|FG000|Treated With Study Drug|Adverse Event|23|||
28029272|NCT00123487|54687783|FG001|Treated With Study Drug|Adverse Event|22|||
27805732|NCT02018861|54261037|FG002|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
27805733|NCT02018861|54261038|FG003|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|2|||
27805734|NCT02018861|54261039|FG004|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|1|||
27805735|NCT02018861|54261040|FG005|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
27805736|NCT02018861|54261041|FG006|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
27805737|NCT02018861|54261042|FG007|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
27805738|NCT02018861|54261043|FG008|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
27805739|NCT02018861|54261044|FG009|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
27805740|NCT02018861|54261035|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
27805741|NCT02018861|54261036|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
28029273|NCT00123487|54687782|FG000|Treated With Study Drug|Disease Progression|141|||
28029274|NCT00123487|54687783|FG001|Treated With Study Drug|Disease Progression|122|||
27805742|NCT02018861|54261037|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
27805743|NCT02018861|54261038|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
27805744|NCT02018861|54261039|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
27805745|NCT02018861|54261040|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
27805746|NCT02018861|54261041|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|5|||
27805747|NCT02018861|54261042|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|2|||
27805748|NCT02018861|54261043|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
27805749|NCT02018861|54261044|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
27805750|NCT02018861|54261035|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
27805751|NCT02018861|54261036|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
27805752|NCT02018861|54261037|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
27805753|NCT02018861|54261038|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
27805754|NCT02018861|54261039|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
27805755|NCT02018861|54261040|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
27805756|NCT02018861|54261041|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|3|||
27805757|NCT02018861|54261042|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|1|||
27805758|NCT02018861|54261043|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
27805759|NCT02018861|54261044|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
27805760|NCT02018861|54261035|FG000|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
27805761|NCT02018861|54261036|FG001|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
27805762|NCT02018861|54261037|FG002|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
27805763|NCT02018861|54261038|FG003|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
27805764|NCT02018861|54261039|FG004|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
27805765|NCT02018861|54261040|FG005|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
27805766|NCT02018861|54261041|FG006|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
27805767|NCT02018861|54261042|FG007|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
27805768|NCT02018861|54261043|FG008|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|1|||
27805769|NCT02018861|54261044|FG009|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
27805770|NCT02018861|54261035|FG000|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
27805771|NCT02018861|54261036|FG001|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
27805772|NCT02018861|54261037|FG002|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
27805773|NCT02018861|54261038|FG003|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
27805774|NCT02018861|54261039|FG004|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
27805775|NCT02018861|54261040|FG005|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
27805776|NCT02018861|54261041|FG006|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
27805777|NCT02018861|54261042|FG007|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
27805778|NCT02018861|54261043|FG008|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|1|||
27805779|NCT02018861|54261044|FG009|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
27805780|NCT02018861|54261035|FG000|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
27805781|NCT02018861|54261036|FG001|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
27805782|NCT02018861|54261037|FG002|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
27805783|NCT02018861|54261038|FG003|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
27805784|NCT02018861|54261039|FG004|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
27805785|NCT02018861|54261040|FG005|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
27805786|NCT02018861|54261041|FG006|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
27805787|NCT02018861|54261042|FG007|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
27805788|NCT02018861|54261043|FG008|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|1|||
27805789|NCT02018861|54261044|FG009|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
27805790|NCT01944722|54261075|FG000|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171|||
27805791|NCT01944722|54261075|FG000|Overall Study|Specimen Shipping Issues|34|||
27805792|NCT01944722|54261075|FG000|Overall Study|Improper Storage/Transport|5|||
27805793|NCT01944722|54261075|FG000|Overall Study|Insufficient Volume for Test|1|||
27805794|NCT01944722|54261075|FG000|Overall Study|Missing Specimens|3|||
27805795|NCT01944722|54261075|FG000|Overall Study|Specimens Mislabeled|2|||
27805796|NCT01944722|54261075|FG000|Overall Study|Withdrawal by Subject|8|||
27805797|NCT01944722|54261075|FG000|Overall Study|NILM Subjects <30 years old|8106|||
27805798|NCT01944722|54261075|FG000|Overall Study|Unsatisfactory Cytology Result|63|||
27805799|NCT01944722|54261075|FG000|Overall Study|>ASCUS Cytology|1122|||
27805800|NCT01917344|54261084|FG000|Overall Study|Withdrawal by Subject|1|||
27805801|NCT02017535|54261092|FG000|Overall Study|Withdrawal by Subject|1|||
27805802|NCT02017535|54261093|FG001|Overall Study|Withdrawal by Subject|0|||
27939515|NCT01054599|54595762|FG000|Overall Study|Spells/seizure-like episodes|1|||
28029275|NCT00123487|54687782|FG000|Treated With Study Drug|Physician Decision|8|||
28029276|NCT00123487|54687783|FG001|Treated With Study Drug|Physician Decision|9|||
28029277|NCT00123487|54687782|FG000|Treated With Study Drug|Other|59|||
28029278|NCT00123487|54687783|FG001|Treated With Study Drug|Other|58|||
28029279|NCT00123487|54687782|FG000|Treated With Study Drug|Study Drug Toxicity|62|||
28029280|NCT00123487|54687783|FG001|Treated With Study Drug|Study Drug Toxicity|80|||
28029281|NCT00123487|54687782|FG000|Treated With Study Drug|Withdrawal by Subject|11|||
28029282|NCT00123487|54687783|FG001|Treated With Study Drug|Withdrawal by Subject|13|||
28029283|NCT00123487|54687782|FG000|Treated With Study Drug|Unknown (case report form lost)|0|||
28029284|NCT00123487|54687783|FG001|Treated With Study Drug|Unknown (case report form lost)|1|||
28029285|NCT00509925|54687790|FG000|Overall Study|Personal reasons|0|||
28029286|NCT00509925|54687791|FG001|Overall Study|Personal reasons|1|||
28029287|NCT00504777|54687799|FG000|Overall Study|Adverse Event|1|||
28029288|NCT00509769|54687803|FG000|Overall Study|Progressive disease|77|||
27805803|NCT02017535|54261094|FG002|Overall Study|Withdrawal by Subject|0|||
27805804|NCT02017535|54261095|FG003|Overall Study|Withdrawal by Subject|0|||
27805805|NCT01944098|54261107|FG000|Overall Study|Physician Decision|1|||
27805806|NCT01944098|54261108|FG001|Overall Study|Physician Decision|0|||
27805807|NCT02017223|54261114|FG000|Overall Study|Algorithm problems|2|||
27805808|NCT01944020|54261120|FG000|Overall Study|Withdrawal by Subject|5|||
27805809|NCT01944020|54261121|FG001|Overall Study|Withdrawal by Subject|0|||
27805810|NCT01943552|54261129|FG000|Overall Study|Adverse Event|3|||
27805811|NCT01943552|54261130|FG001|Overall Study|Adverse Event|2|||
27805812|NCT01943552|54261129|FG000|Overall Study|Withdrawal by Subject|6|||
27805813|NCT01943552|54261130|FG001|Overall Study|Withdrawal by Subject|6|||
27805814|NCT01943552|54261129|FG000|Overall Study|Other Reasons|16|||
27805815|NCT01943552|54261130|FG001|Overall Study|Other Reasons|17|||
27805816|NCT01915940|54261138|FG000|Pre-randomization Washout Period|Not Qualified for Randomization|39|||
27805817|NCT01915940|54261139|FG001|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
27805818|NCT01915940|54261140|FG002|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
27805819|NCT01915940|54261138|FG000|Treatment Period|Decision of Participant|0|||
27805820|NCT01915940|54261139|FG001|Treatment Period|Decision of Participant|1|||
27805821|NCT01915940|54261140|FG002|Treatment Period|Decision of Participant|3|||
27805822|NCT01915940|54261138|FG000|Treatment Period|Adverse Event|0|||
27805823|NCT01915940|54261139|FG001|Treatment Period|Adverse Event|9|||
27805824|NCT01915940|54261140|FG002|Treatment Period|Adverse Event|1|||
27805825|NCT01915940|54261138|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
27805826|NCT01915940|54261139|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
27805827|NCT01915940|54261140|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
27805828|NCT01914926|54261148|FG000|Overall Study|Adverse Event|1|||
27805829|NCT01914926|54261149|FG001|Overall Study|Adverse Event|0|||
27805830|NCT01914926|54261148|FG000|Overall Study|uncooperative, agitated and removed|0|||
27805831|NCT01914926|54261149|FG001|Overall Study|uncooperative, agitated and removed|1|||
27805832|NCT02016755|54261155|FG000|Overall Study|Major amputation of index limb|2|||
27805833|NCT02016755|54261155|FG000|Overall Study|Adverse Event|2|||
27805834|NCT02016755|54261155|FG000|Overall Study|Physician Decision|1|||
27805835|NCT02016755|54261155|FG000|Overall Study|Death|2|||
27805836|NCT01942148|54261159|FG000|Overall Study|Adverse Event|4|||
27805837|NCT01942148|54261159|FG000|Overall Study|Lack of Efficacy|2|||
27805838|NCT01942148|54261159|FG000|Overall Study|Physician Decision|11|||
27805839|NCT01942148|54261159|FG000|Overall Study|Protocol Violation|1|||
27805840|NCT01942148|54261159|FG000|Overall Study|Withdrawal by Subject|8|||
27805841|NCT01942148|54261159|FG000|Overall Study|Use of the prohibition medicine|1|||
27805842|NCT02030015|54261163|FG000|Overall Study|Withdrawal by Subject|3|||
27805843|NCT02030015|54261163|FG000|Overall Study|Death|13|||
27805844|NCT02029235|54261169|FG000|Overall Study|Non-compliance with study meds or diary|4|||
27805845|NCT02029235|54261170|FG001|Overall Study|Non-compliance with study meds or diary|1|||
27805846|NCT01617434|54261178|FG000|Overall Study|Adverse Event|12|||
27939516|NCT01054599|54595763|FG001|Overall Study|Spells/seizure-like episodes|1|||
27939517|NCT01054599|54595762|FG000|Overall Study|Timing/scheduling difficulties|1|||
27939518|NCT01054599|54595763|FG001|Overall Study|Timing/scheduling difficulties|1|||
27939519|NCT01054599|54595762|FG000|Overall Study|Visual impairment, WTAR <80|0|||
27939520|NCT01054599|54595763|FG001|Overall Study|Visual impairment, WTAR <80|1|||
27939521|NCT01054599|54595762|FG000|Overall Study|Lost to Follow-up|0|||
27939522|NCT01054599|54595763|FG001|Overall Study|Lost to Follow-up|2|||
27939523|NCT01054599|54595762|FG000|Overall Study|Adverse Event|0|||
28029289|NCT00509769|54687803|FG000|Overall Study|Adverse Event|4|||
28029290|NCT00509769|54687803|FG000|Overall Study|Patient's decision|1|||
28029291|NCT00509769|54687803|FG000|Overall Study|Physician Decision|8|||
28029292|NCT00509769|54687803|FG000|Overall Study|Use of prohibited therapies during study|1|||
28029293|NCT00114127|54687809|FG000|Overall Study|Adverse Event|2|||
28029294|NCT00114127|54687810|FG001|Overall Study|Adverse Event|1|||
28029295|NCT00114127|54687809|FG000|Overall Study|Lost to Follow-up|1|||
28029296|NCT00114127|54687810|FG001|Overall Study|Lost to Follow-up|0|||
28029297|NCT00114127|54687809|FG000|Overall Study|Withdrawal by Subject|1|||
28029298|NCT00114127|54687810|FG001|Overall Study|Withdrawal by Subject|3|||
28029299|NCT00572624|54687818|FG000|Overall Study|Lost to Follow-up|10|||
28029300|NCT00572624|54687819|FG001|Overall Study|Lost to Follow-up|4|||
28029301|NCT00572624|54687818|FG000|Overall Study|Wanted to do a different diet program|1|||
28029302|NCT00572624|54687819|FG001|Overall Study|Wanted to do a different diet program|0|||
28029303|NCT00572624|54687818|FG000|Overall Study|Medication change|1|||
28029304|NCT00572624|54687819|FG001|Overall Study|Medication change|0|||
28029305|NCT00572624|54687818|FG000|Overall Study|Started a new job-- no time for study|1|||
28029306|NCT00572624|54687819|FG001|Overall Study|Started a new job-- no time for study|0|||
28029307|NCT00572624|54687818|FG000|Overall Study|Admitted to being a smoker|1|||
28029308|NCT00572624|54687819|FG001|Overall Study|Admitted to being a smoker|0|||
27805847|NCT01617434|54261179|FG001|Overall Study|Adverse Event|3|||
27805848|NCT01617434|54261178|FG000|Overall Study|Protocol Violation|8|||
27805849|NCT01617434|54261179|FG001|Overall Study|Protocol Violation|7|||
27805850|NCT01617434|54261178|FG000|Overall Study|Withdrawal Criteria|12|||
27805851|NCT01617434|54261179|FG001|Overall Study|Withdrawal Criteria|37|||
27805852|NCT01617434|54261178|FG000|Overall Study|Unclassified|3|||
27805853|NCT01617434|54261179|FG001|Overall Study|Unclassified|4|||
27805854|NCT01940900|54261187|FG000|Overall Study|Physician Decision|4|||
27805855|NCT01940900|54261188|FG001|Overall Study|Physician Decision|0|||
27805856|NCT01940900|54261187|FG000|Overall Study|Adverse Event|10|||
27805857|NCT01940900|54261188|FG001|Overall Study|Adverse Event|15|||
27805858|NCT01940900|54261187|FG000|Overall Study|Withdrawal by Subject|11|||
27805859|NCT01940900|54261188|FG001|Overall Study|Withdrawal by Subject|15|||
27805860|NCT01940900|54261187|FG000|Overall Study|Lost to Follow-up|1|||
27805861|NCT01940900|54261188|FG001|Overall Study|Lost to Follow-up|0|||
27805862|NCT01940900|54261187|FG000|Overall Study|Sponsor Decision|1|||
28029309|NCT00572624|54687818|FG000|Overall Study|Refused to do the stress test|1|||
27805863|NCT01940900|54261188|FG001|Overall Study|Sponsor Decision|0|||
27805864|NCT01940900|54261187|FG000|Overall Study|subject non-compliance|1|||
27805865|NCT01940900|54261188|FG001|Overall Study|subject non-compliance|1|||
27805866|NCT01940900|54261187|FG000|Overall Study|other|1|||
27805867|NCT01940900|54261188|FG001|Overall Study|other|0|||
27805868|NCT01940354|54261196|FG000|Overall Study|Withdrawal by Subject|4|||
27805869|NCT01940354|54261197|FG001|Overall Study|Withdrawal by Subject|2|||
27805870|NCT01940120|54261203|FG000|Overall Study|Death|40|||
27805871|NCT01940120|54261203|FG000|Overall Study|Withdrawal by Subject|8|||
27805872|NCT01911260|54261212|FG000|Supplementation Period|transference or evasion of school|7|||
28029310|NCT00572624|54687819|FG001|Overall Study|Refused to do the stress test|0|||
28029311|NCT00572624|54687818|FG000|Overall Study|Problem with vascular access|1|||
28029312|NCT00572624|54687819|FG001|Overall Study|Problem with vascular access|0|||
27805873|NCT01911260|54261213|FG001|Supplementation Period|transference or evasion of school|9|||
27805874|NCT01911260|54261214|FG002|Supplementation Period|transference or evasion of school|7|||
27805875|NCT01911260|54261215|FG003|Supplementation Period|transference or evasion of school|6|||
27805876|NCT01911260|54261212|FG000|Supplementation Period|Adverse Event|2|||
27805877|NCT01911260|54261213|FG001|Supplementation Period|Adverse Event|0|||
27805878|NCT01911260|54261214|FG002|Supplementation Period|Adverse Event|1|||
27805879|NCT01911260|54261215|FG003|Supplementation Period|Adverse Event|0|||
27805880|NCT01911260|54261212|FG000|Supplementation Period|refused to receive supplement|1|||
27805881|NCT01911260|54261213|FG001|Supplementation Period|refused to receive supplement|0|||
27805882|NCT01911260|54261214|FG002|Supplementation Period|refused to receive supplement|1|||
27805883|NCT01911260|54261215|FG003|Supplementation Period|refused to receive supplement|0|||
27805884|NCT01911260|54261212|FG000|Supplementation Period|less than 12 weeks supplementation|0|||
27805885|NCT01911260|54261213|FG001|Supplementation Period|less than 12 weeks supplementation|3|||
27805886|NCT01911260|54261214|FG002|Supplementation Period|less than 12 weeks supplementation|1|||
27805887|NCT01911260|54261215|FG003|Supplementation Period|less than 12 weeks supplementation|2|||
28029313|NCT00572624|54687818|FG000|Overall Study|Health issues unrelated to the study|1|||
28029314|NCT00572624|54687819|FG001|Overall Study|Health issues unrelated to the study|0|||
28029315|NCT00122317|54687825|FG000|Overall Study|Death|3|||
27805888|NCT01911260|54261212|FG000|Follow-up Period|transference or evasion of school|13|||
28029316|NCT00122317|54687825|FG000|Overall Study|Adverse Event|4|||
28029317|NCT00122317|54687825|FG000|Overall Study|Physician Decision|2|||
28029318|NCT00122317|54687825|FG000|Overall Study|patient non-compliance|1|||
28029319|NCT00122317|54687825|FG000|Overall Study|Withdrawal by Subject|1|||
27805889|NCT01911260|54261213|FG001|Follow-up Period|transference or evasion of school|20|||
28029320|NCT03870555|54687832|FG000|Period 3 (2 Days)|Adverse Event|1|||
28029321|NCT03870555|54687833|FG001|Period 3 (2 Days)|Adverse Event|0|||
28029322|NCT03870555|54687834|FG002|Period 3 (2 Days)|Adverse Event|0|||
28029323|NCT03870477|54687845|FG000|Overall Study|Early Study Termination|1|||
28029324|NCT00165841|54687851|FG000|Overall Study|Adverse Event|2|||
28029325|NCT00165841|54687852|FG001|Overall Study|Adverse Event|3|||
28029326|NCT00165841|54687851|FG000|Overall Study|Lack of Efficacy|6|||
28029327|NCT00165841|54687852|FG001|Overall Study|Lack of Efficacy|33|||
28029328|NCT00165841|54687851|FG000|Overall Study|Lost to Follow-up|4|||
28029329|NCT00165841|54687852|FG001|Overall Study|Lost to Follow-up|4|||
27805890|NCT01911260|54261214|FG002|Follow-up Period|transference or evasion of school|15|||
27805891|NCT01911260|54261215|FG003|Follow-up Period|transference or evasion of school|12|||
28029330|NCT00165841|54687851|FG000|Overall Study|Withdrawal by Subject|7|||
28029331|NCT00165841|54687852|FG001|Overall Study|Withdrawal by Subject|8|||
27805892|NCT02015819|54261229|FG000|Overall Study|Rickham catheter was misaligned|0|||
27805893|NCT02015819|54261230|FG001|Overall Study|Rickham catheter was misaligned|0|||
27805894|NCT02015819|54261231|FG002|Overall Study|Rickham catheter was misaligned|0|||
27805895|NCT02015819|54261232|FG003|Overall Study|Rickham catheter was misaligned|1|||
28029332|NCT00165841|54687851|FG000|Overall Study|Physician Decision|1|||
28029333|NCT00165841|54687852|FG001|Overall Study|Physician Decision|0|||
28029334|NCT00165841|54687851|FG000|Overall Study|Protocol Violation|6|||
28029335|NCT00165841|54687852|FG001|Overall Study|Protocol Violation|8|||
28029336|NCT00165841|54687851|FG000|Overall Study|Other|3|||
28029337|NCT00165841|54687852|FG001|Overall Study|Other|5|||
28029338|NCT00165841|54687851|FG000|Overall Study|Medication Noncompliance|1|||
28029339|NCT00165841|54687852|FG001|Overall Study|Medication Noncompliance|1|||
28029340|NCT00509223|54687860|FG000|Overall Study|Lost to Follow-up|1|||
28029341|NCT00509223|54687861|FG001|Overall Study|Lost to Follow-up|1|||
28029342|NCT00509223|54687860|FG000|Overall Study|Adverse Event|1|||
28029343|NCT00509223|54687861|FG001|Overall Study|Adverse Event|1|||
28029344|NCT00509223|54687860|FG000|Overall Study|Withdrawal by Subject|25|||
27805896|NCT01939496|54261249|FG000|Overall Study|Adverse Event|2|||
27939524|NCT01054599|54595763|FG001|Overall Study|Adverse Event|1|||
27939525|NCT01054599|54595762|FG000|Overall Study|Withdrawal by Subject|0|||
27939526|NCT01054599|54595763|FG001|Overall Study|Withdrawal by Subject|1|||
27939527|NCT00948766|54595771|FG000|Core Study|Adverse Event|73|||
27939528|NCT00948766|54595772|FG001|Core Study|Adverse Event|51|||
27939529|NCT00948766|54595771|FG000|Core Study|Unsatisfactory Therapeutic Effect|13|||
27939530|NCT00948766|54595772|FG001|Core Study|Unsatisfactory Therapeutic Effect|14|||
27939531|NCT00948766|54595771|FG000|Core Study|Patient Withdrew Consent|27|||
27939532|NCT00948766|54595772|FG001|Core Study|Patient Withdrew Consent|46|||
27939533|NCT00948766|54595771|FG000|Core Study|Lost to Follow-up|3|||
27939534|NCT00948766|54595772|FG001|Core Study|Lost to Follow-up|2|||
27805897|NCT01939496|54261250|FG001|Overall Study|Adverse Event|0|||
27939535|NCT00948766|54595771|FG000|Core Study|Administrative Problems|2|||
27939536|NCT00948766|54595772|FG001|Core Study|Administrative Problems|2|||
27939537|NCT00948766|54595771|FG000|Core Study|Death|1|||
27939538|NCT00948766|54595772|FG001|Core Study|Death|1|||
27939539|NCT00948766|54595771|FG000|Core Study|Protocol Deviation|8|||
27939540|NCT00948766|54595772|FG001|Core Study|Protocol Deviation|10|||
27939541|NCT00948766|54595771|FG000|Extension Study|Adverse Event|43|||
27939542|NCT00948766|54595772|FG001|Extension Study|Adverse Event|0|||
27939543|NCT00948766|54595771|FG000|Extension Study|Unsatisfactory Therapeutic Effect|2|||
27939544|NCT00948766|54595772|FG001|Extension Study|Unsatisfactory Therapeutic Effect|0|||
27939545|NCT00948766|54595771|FG000|Extension Study|Study Drug No Longer Required|1|||
27939546|NCT00948766|54595772|FG001|Extension Study|Study Drug No Longer Required|0|||
27939547|NCT00948766|54595771|FG000|Extension Study|Patient Withdrew Consent|32|||
27939548|NCT00948766|54595772|FG001|Extension Study|Patient Withdrew Consent|0|||
27939549|NCT00948766|54595771|FG000|Extension Study|Lost to Follow-up|8|||
27939550|NCT00948766|54595772|FG001|Extension Study|Lost to Follow-up|0|||
27805898|NCT01939496|54261251|FG002|Overall Study|Adverse Event|0|||
27939551|NCT00948766|54595771|FG000|Extension Study|Administrative Problems|1|||
27939552|NCT00948766|54595772|FG001|Extension Study|Administrative Problems|0|||
27805899|NCT01939496|54261249|FG000|Overall Study|Lost to Follow-up|1|||
27805900|NCT01939496|54261250|FG001|Overall Study|Lost to Follow-up|1|||
27805901|NCT01939496|54261251|FG002|Overall Study|Lost to Follow-up|0|||
27939553|NCT00948766|54595771|FG000|Extension Study|Death|4|||
27939554|NCT00948766|54595772|FG001|Extension Study|Death|0|||
27939555|NCT01053663|54595782|FG000|Overall Study|Death|2|||
27939556|NCT01053663|54595782|FG000|Overall Study|Lost to Follow-up|1|||
27939557|NCT01053663|54595782|FG000|Overall Study|Poor IV Access|1|||
27939558|NCT01053663|54595782|FG000|Overall Study|Transferred to Another Hospital|1|||
27939559|NCT01053663|54595782|FG000|Overall Study|Negative Influenza Diagnosis|1|||
27939560|NCT01235546|54595794|FG000|Overall Study|Staff error, medication not administered|1|||
27939561|NCT01235546|54595795|FG001|Overall Study|Staff error, medication not administered|0|||
28029345|NCT00509223|54687861|FG001|Overall Study|Withdrawal by Subject|6|||
28029346|NCT00509223|54687860|FG000|Overall Study|Including: subject change of address|5|||
28029347|NCT00509223|54687861|FG001|Overall Study|Including: subject change of address|2|||
28029348|NCT00509223|54687860|FG000|Overall Study|Did not meet revised inclusion criteria|56|||
28029349|NCT00509223|54687861|FG001|Overall Study|Did not meet revised inclusion criteria|62|||
28029350|NCT00460798|54687867|FG000|Overall Study|Death|59|||
28029351|NCT00460798|54687867|FG000|Overall Study|Adverse Event|27|||
28029352|NCT00460798|54687867|FG000|Overall Study|Lost to Follow-up|19|||
28029353|NCT00460798|54687867|FG000|Overall Study|Progressive Disease|99|||
28029354|NCT00460798|54687867|FG000|Overall Study|Other|27|||
28029355|NCT00460798|54687867|FG000|Overall Study|Ongoing at Date of Cut-Off|82|||
28029356|NCT00460798|54687867|FG000|Overall Study|Missing/Incomplete Dosing Information|27|||
28029357|NCT00603980|54687871|FG000|Study Qualification|Protocol Violation|3|||
28029358|NCT00603980|54687871|FG000|Study Qualification|Inconsistent data reporting|13|||
28029359|NCT00603980|54687871|FG000|Main Study|14th subject completed trial|1|||
28029360|NCT00450190|54687891|FG000|Overall Study|Withdrawal by Subject|2|||
28029361|NCT00450112|54687897|FG000|Overall Study|Other Treatment Required|5|||
28029362|NCT00450112|54687898|FG001|Overall Study|Other Treatment Required|1|||
28029363|NCT00450112|54687897|FG000|Overall Study|Withdrawal by Subject|4|||
28029364|NCT00450112|54687898|FG001|Overall Study|Withdrawal by Subject|1|||
28029365|NCT00450112|54687897|FG000|Overall Study|Lost to Follow-up|2|||
28029366|NCT00450112|54687898|FG001|Overall Study|Lost to Follow-up|1|||
28029367|NCT00450112|54687897|FG000|Overall Study|Others|2|||
28029368|NCT00450112|54687898|FG001|Overall Study|Others|3|||
28029369|NCT00449956|54687907|FG000|Overall Study|Adverse Event|7|||
28029370|NCT00449956|54687908|FG001|Overall Study|Adverse Event|1|||
28029371|NCT00449956|54687909|FG002|Overall Study|Adverse Event|6|||
28029372|NCT00449956|54687907|FG000|Overall Study|Lack of Efficacy|0|||
28029373|NCT00449956|54687908|FG001|Overall Study|Lack of Efficacy|0|||
28029374|NCT00449956|54687909|FG002|Overall Study|Lack of Efficacy|1|||
28029375|NCT00449956|54687907|FG000|Overall Study|Protocol Violation|1|||
28029376|NCT00449956|54687908|FG001|Overall Study|Protocol Violation|1|||
28029377|NCT00449956|54687909|FG002|Overall Study|Protocol Violation|1|||
28029378|NCT00449956|54687907|FG000|Overall Study|Withdrawal by Subject|0|||
28029379|NCT00449956|54687908|FG001|Overall Study|Withdrawal by Subject|1|||
28029380|NCT00449956|54687909|FG002|Overall Study|Withdrawal by Subject|0|||
28029381|NCT00449956|54687907|FG000|Overall Study|Physician Decision|2|||
28029382|NCT00449956|54687908|FG001|Overall Study|Physician Decision|1|||
28029383|NCT00449956|54687909|FG002|Overall Study|Physician Decision|1|||
28029384|NCT00509145|54687919|FG000|Overall Study|Death|0|||
28029385|NCT00509145|54687920|FG001|Overall Study|Death|2|||
28029386|NCT00509145|54687919|FG000|Overall Study|Adverse Event|42|||
28029387|NCT00509145|54687920|FG001|Overall Study|Adverse Event|28|||
28029388|NCT00509145|54687919|FG000|Overall Study|Withdrawal by Subject|32|||
28029389|NCT00509145|54687920|FG001|Overall Study|Withdrawal by Subject|38|||
28029390|NCT00509145|54687919|FG000|Overall Study|Physician Decision|11|||
28029391|NCT00509145|54687920|FG001|Overall Study|Physician Decision|14|||
28029392|NCT00509145|54687919|FG000|Overall Study|Protocol Violation|1|||
28029393|NCT00509145|54687920|FG001|Overall Study|Protocol Violation|6|||
28029394|NCT00509145|54687919|FG000|Overall Study|Pregnancy|3|||
28029395|NCT00509145|54687920|FG001|Overall Study|Pregnancy|8|||
28029396|NCT00509145|54687919|FG000|Overall Study|Lost to Follow-up|6|||
28029397|NCT00509145|54687920|FG001|Overall Study|Lost to Follow-up|5|||
28029398|NCT00509145|54687919|FG000|Overall Study|Withdrawal by participant after confirmed relapse|12|||
28029399|NCT00509145|54687920|FG001|Overall Study|Withdrawal by participant after confirmed relapse|22|||
28029400|NCT00509145|54687919|FG000|Overall Study|Other|6|||
28029401|NCT00509145|54687920|FG001|Overall Study|Other|6|||
28029402|NCT00509067|54687928|FG000|Overall Study|Lost to Follow-up|1|||
28029403|NCT00509067|54687929|FG001|Overall Study|Lost to Follow-up|1|||
28029404|NCT00509067|54687928|FG000|Overall Study|Adverse Event|3|||
28029405|NCT00509067|54687929|FG001|Overall Study|Adverse Event|1|||
28029406|NCT00509067|54687928|FG000|Overall Study|Protocol Violation|0|||
28029407|NCT00509067|54687929|FG001|Overall Study|Protocol Violation|3|||
28029408|NCT00504309|54687945|FG000|Overall Study|Death|0|||
28029409|NCT00504309|54687946|FG001|Overall Study|Death|0|||
28029410|NCT00504309|54687947|FG002|Overall Study|Death|0|||
28029411|NCT00504309|54687948|FG003|Overall Study|Death|0|||
28029412|NCT00504309|54687949|FG004|Overall Study|Death|1|||
28029413|NCT00504309|54687950|FG005|Overall Study|Death|0|||
28029414|NCT00504309|54687945|FG000|Overall Study|Withdrawal by Subject|0|||
28029415|NCT00504309|54687946|FG001|Overall Study|Withdrawal by Subject|0|||
28029416|NCT00504309|54687947|FG002|Overall Study|Withdrawal by Subject|1|||
28029417|NCT00504309|54687948|FG003|Overall Study|Withdrawal by Subject|0|||
28029418|NCT00504309|54687949|FG004|Overall Study|Withdrawal by Subject|0|||
28029419|NCT00504309|54687950|FG005|Overall Study|Withdrawal by Subject|0|||
28029420|NCT00508755|54687962|FG000|Overall Study|Withdrawal by Subject|1|||
28029421|NCT00504231|54687972|FG000|Overall Study|Discrepant chart documentation re route|0|||
28029422|NCT00504231|54687973|FG001|Overall Study|Discrepant chart documentation re route|0|||
28029423|NCT00504231|54687974|FG002|Overall Study|Discrepant chart documentation re route|1|||
28029424|NCT00504231|54687975|FG003|Overall Study|Discrepant chart documentation re route|0|||
28029425|NCT00568178|54688027|FG000|Double Blind Base Study|Adverse Event|0|||
28029426|NCT00568178|54688028|FG001|Double Blind Base Study|Adverse Event|2|||
28029427|NCT00568178|54688029|FG002|Double Blind Base Study|Adverse Event|1|||
28029428|NCT00568178|54688030|FG003|Double Blind Base Study|Adverse Event|2|||
28029429|NCT00568178|54688031|FG004|Double Blind Base Study|Adverse Event|0|||
28029430|NCT00568178|54688032|FG005|Double Blind Base Study|Adverse Event|0|||
28029431|NCT00568178|54688027|FG000|Double Blind Base Study|Lost to Follow-up|1|||
28029432|NCT00568178|54688028|FG001|Double Blind Base Study|Lost to Follow-up|0|||
28029433|NCT00568178|54688029|FG002|Double Blind Base Study|Lost to Follow-up|0|||
28029434|NCT00568178|54688030|FG003|Double Blind Base Study|Lost to Follow-up|1|||
28029435|NCT00568178|54688031|FG004|Double Blind Base Study|Lost to Follow-up|0|||
28029436|NCT00568178|54688032|FG005|Double Blind Base Study|Lost to Follow-up|0|||
28029437|NCT00568178|54688027|FG000|Double Blind Base Study|Physician Decision|1|||
28029438|NCT00568178|54688028|FG001|Double Blind Base Study|Physician Decision|1|||
28029439|NCT00568178|54688029|FG002|Double Blind Base Study|Physician Decision|0|||
28029440|NCT00568178|54688030|FG003|Double Blind Base Study|Physician Decision|1|||
28029441|NCT00568178|54688031|FG004|Double Blind Base Study|Physician Decision|0|||
28029442|NCT00568178|54688032|FG005|Double Blind Base Study|Physician Decision|0|||
28029443|NCT00568178|54688027|FG000|Double Blind Base Study|Protocol Violation|3|||
28029444|NCT00568178|54688028|FG001|Double Blind Base Study|Protocol Violation|2|||
28029445|NCT00568178|54688029|FG002|Double Blind Base Study|Protocol Violation|0|||
28029446|NCT00568178|54688030|FG003|Double Blind Base Study|Protocol Violation|0|||
28029447|NCT00568178|54688031|FG004|Double Blind Base Study|Protocol Violation|0|||
28029448|NCT00568178|54688032|FG005|Double Blind Base Study|Protocol Violation|0|||
28029449|NCT00568178|54688027|FG000|Double Blind Base Study|Withdrawal by Subject|1|||
28029450|NCT00568178|54688028|FG001|Double Blind Base Study|Withdrawal by Subject|1|||
28029451|NCT00568178|54688029|FG002|Double Blind Base Study|Withdrawal by Subject|0|||
28029452|NCT00568178|54688030|FG003|Double Blind Base Study|Withdrawal by Subject|0|||
28029453|NCT00568178|54688031|FG004|Double Blind Base Study|Withdrawal by Subject|0|||
28029454|NCT00568178|54688032|FG005|Double Blind Base Study|Withdrawal by Subject|0|||
28029455|NCT00568178|54688027|FG000|Double Blind Base Study|Progressive Disease|0|||
28029456|NCT00568178|54688028|FG001|Double Blind Base Study|Progressive Disease|0|||
28029457|NCT00568178|54688029|FG002|Double Blind Base Study|Progressive Disease|0|||
28029458|NCT00568178|54688030|FG003|Double Blind Base Study|Progressive Disease|1|||
28029459|NCT00568178|54688031|FG004|Double Blind Base Study|Progressive Disease|0|||
28029460|NCT00568178|54688032|FG005|Double Blind Base Study|Progressive Disease|0|||
28029461|NCT00568178|54688027|FG000|Open Label Extension|Adverse Event|0|||
28029462|NCT00568178|54688028|FG001|Open Label Extension|Adverse Event|0|||
27805902|NCT01939496|54261249|FG000|Overall Study|Physician Decision|1|||
27805903|NCT01939496|54261250|FG001|Overall Study|Physician Decision|0|||
27805904|NCT01939496|54261251|FG002|Overall Study|Physician Decision|0|||
27805905|NCT01939496|54261249|FG000|Overall Study|Protocol Violation|3|||
27805906|NCT01939496|54261250|FG001|Overall Study|Protocol Violation|0|||
27805907|NCT01939496|54261251|FG002|Overall Study|Protocol Violation|0|||
27805908|NCT01939496|54261249|FG000|Overall Study|Withdrawal by Subject|0|||
27805909|NCT01939496|54261250|FG001|Overall Study|Withdrawal by Subject|1|||
27805910|NCT01939496|54261251|FG002|Overall Study|Withdrawal by Subject|1|||
27805911|NCT01939496|54261249|FG000|Overall Study|Blood Pressure Withdrawal Criteria|0|||
27805912|NCT01939496|54261250|FG001|Overall Study|Blood Pressure Withdrawal Criteria|1|||
27805913|NCT01939496|54261251|FG002|Overall Study|Blood Pressure Withdrawal Criteria|0|||
27805914|NCT01939496|54261249|FG000|Overall Study|Other|2|||
27805915|NCT01939496|54261250|FG001|Overall Study|Other|0|||
27805916|NCT01939496|54261251|FG002|Overall Study|Other|1|||
27939562|NCT01235546|54595794|FG000|Overall Study|Protocol Violation|1|||
27939563|NCT01235546|54595795|FG001|Overall Study|Protocol Violation|1|||
27939564|NCT01053429|54595810|FG000|Overall Study|Adverse Event|64|||
27939565|NCT01053429|54595810|FG000|Overall Study|Other|309|||
27939566|NCT01233284|54595814|FG000|Period 1 (4 Weeks)|Lost to Follow-up|1|||
27939567|NCT01233284|54595815|FG001|Period 1 (4 Weeks)|Lost to Follow-up|0|||
27939568|NCT01233284|54595816|FG002|Period 1 (4 Weeks)|Lost to Follow-up|0|||
27939569|NCT01233284|54595817|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
27939570|NCT01233284|54595818|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
27939571|NCT01233284|54595814|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
27939572|NCT01233284|54595815|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
27939573|NCT01233284|54595816|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
27939574|NCT01233284|54595817|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
27939575|NCT01233284|54595818|FG004|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
27939576|NCT01233284|54595814|FG000|Period 1 (4 Weeks)|Other|0|||
27939577|NCT01233284|54595815|FG001|Period 1 (4 Weeks)|Other|0|||
27939578|NCT01233284|54595816|FG002|Period 1 (4 Weeks)|Other|1|||
27939579|NCT01233284|54595817|FG003|Period 1 (4 Weeks)|Other|0|||
27939580|NCT01233284|54595818|FG004|Period 1 (4 Weeks)|Other|0|||
27939581|NCT01233284|54595814|FG000|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
28029463|NCT00568178|54688029|FG002|Open Label Extension|Adverse Event|0|||
28029464|NCT00568178|54688030|FG003|Open Label Extension|Adverse Event|0|||
28029465|NCT00568178|54688031|FG004|Open Label Extension|Adverse Event|11|||
28029466|NCT00568178|54688032|FG005|Open Label Extension|Adverse Event|8|||
28029467|NCT00568178|54688027|FG000|Open Label Extension|Protocol Violation|0|||
28029468|NCT00568178|54688028|FG001|Open Label Extension|Protocol Violation|0|||
28029469|NCT00568178|54688029|FG002|Open Label Extension|Protocol Violation|0|||
28029470|NCT00568178|54688030|FG003|Open Label Extension|Protocol Violation|0|||
28029471|NCT00568178|54688031|FG004|Open Label Extension|Protocol Violation|1|||
28029472|NCT00568178|54688032|FG005|Open Label Extension|Protocol Violation|0|||
27805917|NCT01939028|54261259|FG000|Overall Study|Withdrawal by Subject|5|||
27805918|NCT01939028|54261259|FG000|Overall Study|Physician Decision|7|||
27805919|NCT01938716|54261263|FG000|Overall Study|Physician Decision|2|||
27805920|NCT01938716|54261263|FG000|Overall Study|Withdrawal by Subject|2|||
27805921|NCT01937390|54261267|FG000|Overall Study|Death|2|||
27805922|NCT01937390|54261267|FG000|Overall Study|Lost to Follow-up|7|||
27805923|NCT01937390|54261267|FG000|Overall Study|Withdrawal by Subject|5|||
27805924|NCT01937390|54261267|FG000|Overall Study|Fail to return|21|||
27805925|NCT02028767|54261271|FG000|Treatment Period 2|Non compliant with protocol|1|||
27805926|NCT02028767|54261272|FG001|Treatment Period 2|Non compliant with protocol|0|||
27805927|NCT02028767|54261271|FG000|Treatment Period 2|Reason other than those specified above|1|||
27805928|NCT02028767|54261272|FG001|Treatment Period 2|Reason other than those specified above|0|||
27805929|NCT01959932|54261281|FG000|Overall Study|Withdrawal by Subject|1|||
27805930|NCT01959932|54261282|FG001|Overall Study|Withdrawal by Subject|0|||
27805931|NCT01959932|54261283|FG002|Overall Study|Withdrawal by Subject|0|||
27805932|NCT02028065|54261295|FG000|Randomization Through Start Treatment|Not treated|1|||
27805933|NCT02028065|54261296|FG001|Randomization Through Start Treatment|Not treated|3|||
27805934|NCT02028065|54261297|FG002|Randomization Through Start Treatment|Not treated|3|||
27805935|NCT02028065|54261295|FG000|Treatment Through Study Completion|Lost to Follow-up|2|||
27805936|NCT02028065|54261296|FG001|Treatment Through Study Completion|Lost to Follow-up|4|||
27805937|NCT02028065|54261297|FG002|Treatment Through Study Completion|Lost to Follow-up|6|||
27805938|NCT02028065|54261295|FG000|Treatment Through Study Completion|Physician Decision|1|||
27805939|NCT02028065|54261296|FG001|Treatment Through Study Completion|Physician Decision|0|||
27805940|NCT02028065|54261297|FG002|Treatment Through Study Completion|Physician Decision|0|||
27805941|NCT02028065|54261295|FG000|Treatment Through Study Completion|Protocol Violation|1|||
27805942|NCT02028065|54261296|FG001|Treatment Through Study Completion|Protocol Violation|4|||
27805943|NCT02028065|54261297|FG002|Treatment Through Study Completion|Protocol Violation|0|||
27805944|NCT02028065|54261295|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
27805945|NCT02028065|54261296|FG001|Treatment Through Study Completion|Withdrawal by Subject|4|||
27805946|NCT02028065|54261297|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
27805947|NCT02028065|54261295|FG000|Treatment Through Study Completion|Adverse Event|3|||
27805948|NCT02028065|54261296|FG001|Treatment Through Study Completion|Adverse Event|3|||
27805949|NCT02028065|54261297|FG002|Treatment Through Study Completion|Adverse Event|5|||
27805950|NCT02015195|54261312|FG000|Overall Study|Adverse Event|0|||
27805951|NCT02015195|54261313|FG001|Overall Study|Adverse Event|0|||
27805952|NCT02015195|54261314|FG002|Overall Study|Adverse Event|0|||
27805953|NCT02015195|54261315|FG003|Overall Study|Adverse Event|1|||
27805954|NCT02015195|54261316|FG004|Overall Study|Adverse Event|0|||
27805955|NCT02015195|54261317|FG005|Overall Study|Adverse Event|0|||
27805956|NCT02015195|54261318|FG006|Overall Study|Adverse Event|0|||
27805957|NCT02015039|54261335|FG000|Overall Study|Not eligible|0|||
27805958|NCT02015039|54261336|FG001|Overall Study|Not eligible|1|||
27805959|NCT02025725|54261344|FG000|Overall Study|Adverse Event|5|||
27805960|NCT02025725|54261345|FG001|Overall Study|Adverse Event|0|||
27805961|NCT02025725|54261344|FG000|Overall Study|Lost to Follow-up|2|||
27805962|NCT02025725|54261345|FG001|Overall Study|Lost to Follow-up|0|||
27805963|NCT02025725|54261344|FG000|Overall Study|Protocol Violation|1|||
27805964|NCT02025725|54261345|FG001|Overall Study|Protocol Violation|1|||
27805965|NCT02025725|54261344|FG000|Overall Study|Withdrawal by Subject|3|||
27805966|NCT02025725|54261345|FG001|Overall Study|Withdrawal by Subject|2|||
27805967|NCT02025725|54261344|FG000|Overall Study|Post-dose QTcB > 270 msec|0|||
27805968|NCT02025725|54261345|FG001|Overall Study|Post-dose QTcB > 270 msec|1|||
28029473|NCT00568178|54688027|FG000|Open Label Extension|Lost to Follow-up|0|||
28029474|NCT00568178|54688028|FG001|Open Label Extension|Lost to Follow-up|0|||
28029475|NCT00568178|54688029|FG002|Open Label Extension|Lost to Follow-up|0|||
28029476|NCT00568178|54688030|FG003|Open Label Extension|Lost to Follow-up|0|||
28029477|NCT00568178|54688031|FG004|Open Label Extension|Lost to Follow-up|6|||
27805969|NCT02025179|54261356|FG000|Overall Study|Lost to Follow-up|0|||
27805970|NCT02025179|54261357|FG001|Overall Study|Lost to Follow-up|0|||
27805971|NCT02025179|54261358|FG002|Overall Study|Lost to Follow-up|1|||
27805972|NCT02013791|54261375|FG000|Period 1|Lost to Follow-up|0|||
27805973|NCT02013791|54261376|FG001|Period 1|Lost to Follow-up|0|||
27805974|NCT02013791|54261377|FG002|Period 1|Lost to Follow-up|0|||
28029478|NCT00568178|54688032|FG005|Open Label Extension|Lost to Follow-up|11|||
27805975|NCT02013791|54261378|FG003|Period 1|Lost to Follow-up|1|||
27805976|NCT02013791|54261379|FG004|Period 1|Lost to Follow-up|0|||
27805977|NCT02013791|54261380|FG005|Period 1|Lost to Follow-up|0|||
27805978|NCT02013791|54261381|FG006|Period 1|Lost to Follow-up|1|||
27805979|NCT02013791|54261382|FG007|Period 1|Lost to Follow-up|1|||
27805980|NCT02013791|54261383|FG008|Period 1|Lost to Follow-up|0|||
27805981|NCT02013791|54261375|FG000|Period 1|Other Miscellaneous Reasons|0|||
27805982|NCT02013791|54261376|FG001|Period 1|Other Miscellaneous Reasons|2|||
27805983|NCT02013791|54261377|FG002|Period 1|Other Miscellaneous Reasons|0|||
27805984|NCT02013791|54261378|FG003|Period 1|Other Miscellaneous Reasons|0|||
27805985|NCT02013791|54261379|FG004|Period 1|Other Miscellaneous Reasons|0|||
27805986|NCT02013791|54261380|FG005|Period 1|Other Miscellaneous Reasons|0|||
27805987|NCT02013791|54261381|FG006|Period 1|Other Miscellaneous Reasons|0|||
27805988|NCT02013791|54261382|FG007|Period 1|Other Miscellaneous Reasons|0|||
27805989|NCT02013791|54261383|FG008|Period 1|Other Miscellaneous Reasons|0|||
27805990|NCT02024867|54261406|FG000|Overall Study|Protocol Violation|3|||
27805991|NCT02024867|54261407|FG001|Overall Study|Protocol Violation|3|||
27805992|NCT02024867|54261406|FG000|Overall Study|Lost to Follow-up|6|||
28029479|NCT00568178|54688027|FG000|Open Label Extension|Physician Decision|0|||
28029480|NCT00568178|54688028|FG001|Open Label Extension|Physician Decision|0|||
28029481|NCT00568178|54688029|FG002|Open Label Extension|Physician Decision|0|||
28029482|NCT00568178|54688030|FG003|Open Label Extension|Physician Decision|0|||
28029483|NCT00568178|54688031|FG004|Open Label Extension|Physician Decision|9|||
28029484|NCT00568178|54688032|FG005|Open Label Extension|Physician Decision|8|||
28029485|NCT00568178|54688027|FG000|Open Label Extension|Pregnancy|0|||
28029486|NCT00568178|54688028|FG001|Open Label Extension|Pregnancy|0|||
28029487|NCT00568178|54688029|FG002|Open Label Extension|Pregnancy|0|||
28029488|NCT00568178|54688030|FG003|Open Label Extension|Pregnancy|0|||
28029489|NCT00568178|54688031|FG004|Open Label Extension|Pregnancy|0|||
28029490|NCT00568178|54688032|FG005|Open Label Extension|Pregnancy|1|||
28029491|NCT00568178|54688027|FG000|Open Label Extension|Progressive Disease|0|||
28029492|NCT00568178|54688028|FG001|Open Label Extension|Progressive Disease|0|||
28029493|NCT00568178|54688029|FG002|Open Label Extension|Progressive Disease|0|||
28029494|NCT00568178|54688030|FG003|Open Label Extension|Progressive Disease|0|||
28029495|NCT00568178|54688031|FG004|Open Label Extension|Progressive Disease|3|||
28029496|NCT00568178|54688032|FG005|Open Label Extension|Progressive Disease|1|||
28029497|NCT00568178|54688027|FG000|Open Label Extension|Termination of Trial|0|||
28029498|NCT00568178|54688028|FG001|Open Label Extension|Termination of Trial|0|||
28029499|NCT00568178|54688029|FG002|Open Label Extension|Termination of Trial|0|||
28029500|NCT00568178|54688030|FG003|Open Label Extension|Termination of Trial|0|||
27805993|NCT02024867|54261407|FG001|Overall Study|Lost to Follow-up|4|||
27805994|NCT01953601|54261416|FG000|Part 1 (Base Study)|Adverse Event|24|||
27805995|NCT01953601|54261417|FG001|Part 1 (Base Study)|Adverse Event|37|||
27805996|NCT01953601|54261418|FG002|Part 1 (Base Study)|Adverse Event|15|||
27805997|NCT01953601|54261416|FG000|Part 1 (Base Study)|Death|2|||
27805998|NCT01953601|54261417|FG001|Part 1 (Base Study)|Death|0|||
27805999|NCT01953601|54261418|FG002|Part 1 (Base Study)|Death|3|||
27806000|NCT01953601|54261416|FG000|Part 1 (Base Study)|Lack of Efficacy|3|||
27806001|NCT01953601|54261417|FG001|Part 1 (Base Study)|Lack of Efficacy|1|||
27806002|NCT01953601|54261418|FG002|Part 1 (Base Study)|Lack of Efficacy|4|||
27806003|NCT01953601|54261416|FG000|Part 1 (Base Study)|Lost to Follow-up|1|||
27806004|NCT01953601|54261417|FG001|Part 1 (Base Study)|Lost to Follow-up|3|||
27806005|NCT01953601|54261418|FG002|Part 1 (Base Study)|Lost to Follow-up|6|||
27806006|NCT01953601|54261416|FG000|Part 1 (Base Study)|Non-compliance with study drug|0|||
27806007|NCT01953601|54261417|FG001|Part 1 (Base Study)|Non-compliance with study drug|3|||
27806008|NCT01953601|54261418|FG002|Part 1 (Base Study)|Non-compliance with study drug|1|||
27806009|NCT01953601|54261416|FG000|Part 1 (Base Study)|Physician Decision|3|||
27806010|NCT01953601|54261417|FG001|Part 1 (Base Study)|Physician Decision|7|||
27806011|NCT01953601|54261418|FG002|Part 1 (Base Study)|Physician Decision|4|||
27806012|NCT01953601|54261416|FG000|Part 1 (Base Study)|Screen failure|1|||
27806013|NCT01953601|54261417|FG001|Part 1 (Base Study)|Screen failure|0|||
27806014|NCT01953601|54261418|FG002|Part 1 (Base Study)|Screen failure|1|||
27806015|NCT01953601|54261416|FG000|Part 1 (Base Study)|Site discontinued study participation|2|||
27806016|NCT01953601|54261417|FG001|Part 1 (Base Study)|Site discontinued study participation|0|||
27806017|NCT01953601|54261418|FG002|Part 1 (Base Study)|Site discontinued study participation|0|||
27806018|NCT01953601|54261416|FG000|Part 1 (Base Study)|Study terminated by sponsor|174|||
28029501|NCT00568178|54688031|FG004|Open Label Extension|Termination of Trial|45|||
28029502|NCT00568178|54688032|FG005|Open Label Extension|Termination of Trial|47|||
28029503|NCT00568178|54688027|FG000|Open Label Extension|Withdrawal by Subject|0|||
28029504|NCT00568178|54688028|FG001|Open Label Extension|Withdrawal by Subject|0|||
28029505|NCT00568178|54688029|FG002|Open Label Extension|Withdrawal by Subject|0|||
27806019|NCT01953601|54261417|FG001|Part 1 (Base Study)|Study terminated by sponsor|169|||
27806020|NCT01953601|54261418|FG002|Part 1 (Base Study)|Study terminated by sponsor|179|||
27806021|NCT01953601|54261416|FG000|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7|||
27806022|NCT01953601|54261417|FG001|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8|||
27806023|NCT01953601|54261418|FG002|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10|||
27806024|NCT01953601|54261416|FG000|Part 1 (Base Study)|Subject moved|2|||
27806025|NCT01953601|54261417|FG001|Part 1 (Base Study)|Subject moved|2|||
27806026|NCT01953601|54261418|FG002|Part 1 (Base Study)|Subject moved|1|||
27806027|NCT01953601|54261416|FG000|Part 1 (Base Study)|Withdrawal by Subject|32|||
27806028|NCT01953601|54261417|FG001|Part 1 (Base Study)|Withdrawal by Subject|23|||
27806029|NCT01953601|54261418|FG002|Part 1 (Base Study)|Withdrawal by Subject|22|||
27806030|NCT01953601|54261416|FG000|Part 2 (Extension Study)|Adverse Event|1|||
27806031|NCT01953601|54261417|FG001|Part 2 (Extension Study)|Adverse Event|1|||
27806032|NCT01953601|54261418|FG002|Part 2 (Extension Study)|Adverse Event|10|||
27806033|NCT01953601|54261416|FG000|Part 2 (Extension Study)|Death|0|||
27806034|NCT01953601|54261417|FG001|Part 2 (Extension Study)|Death|3|||
27806035|NCT01953601|54261418|FG002|Part 2 (Extension Study)|Death|0|||
27806036|NCT01953601|54261416|FG000|Part 2 (Extension Study)|Lack of Efficacy|2|||
27806037|NCT01953601|54261417|FG001|Part 2 (Extension Study)|Lack of Efficacy|0|||
27806038|NCT01953601|54261418|FG002|Part 2 (Extension Study)|Lack of Efficacy|0|||
27806039|NCT01953601|54261416|FG000|Part 2 (Extension Study)|Lost to Follow-up|2|||
27806040|NCT01953601|54261417|FG001|Part 2 (Extension Study)|Lost to Follow-up|1|||
27806041|NCT01953601|54261418|FG002|Part 2 (Extension Study)|Lost to Follow-up|1|||
27806042|NCT01953601|54261416|FG000|Part 2 (Extension Study)|Physician Decision|2|||
27806043|NCT01953601|54261417|FG001|Part 2 (Extension Study)|Physician Decision|0|||
27806044|NCT01953601|54261418|FG002|Part 2 (Extension Study)|Physician Decision|2|||
27806045|NCT01953601|54261416|FG000|Part 2 (Extension Study)|Site discontinued study participation|0|||
27806046|NCT01953601|54261417|FG001|Part 2 (Extension Study)|Site discontinued study participation|1|||
27806047|NCT01953601|54261418|FG002|Part 2 (Extension Study)|Site discontinued study participation|1|||
27806048|NCT01953601|54261416|FG000|Part 2 (Extension Study)|Study terminated by sponsor|185|||
27806049|NCT01953601|54261417|FG001|Part 2 (Extension Study)|Study terminated by sponsor|178|||
27806050|NCT01953601|54261418|FG002|Part 2 (Extension Study)|Study terminated by sponsor|187|||
27806051|NCT01953601|54261416|FG000|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1|||
27806052|NCT01953601|54261417|FG001|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3|||
27806053|NCT01953601|54261418|FG002|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0|||
27806054|NCT01953601|54261416|FG000|Part 2 (Extension Study)|Subject moved|0|||
27806055|NCT01953601|54261417|FG001|Part 2 (Extension Study)|Subject moved|0|||
27806056|NCT01953601|54261418|FG002|Part 2 (Extension Study)|Subject moved|1|||
27806057|NCT01953601|54261416|FG000|Part 2 (Extension Study)|Withdrawal by Subject|5|||
27806058|NCT01953601|54261417|FG001|Part 2 (Extension Study)|Withdrawal by Subject|4|||
27806059|NCT01953601|54261418|FG002|Part 2 (Extension Study)|Withdrawal by Subject|2|||
27806060|NCT01952665|54261431|FG000|Overall Study|Physician Decision|3|||
27806061|NCT01952665|54261432|FG001|Overall Study|Physician Decision|2|||
27806062|NCT01952665|54261431|FG000|Overall Study|Lost to Follow-up|1|||
27806063|NCT01952665|54261432|FG001|Overall Study|Lost to Follow-up|2|||
27806064|NCT01952665|54261431|FG000|Overall Study|Adverse Event|2|||
27806065|NCT01952665|54261432|FG001|Overall Study|Adverse Event|1|||
27806066|NCT01952665|54261431|FG000|Overall Study|Protocol Violation|0|||
27806067|NCT01952665|54261432|FG001|Overall Study|Protocol Violation|1|||
27806068|NCT01952041|54261443|FG000|Overall Study|Lost to Follow-up|9|||
27806069|NCT01952041|54261444|FG001|Overall Study|Lost to Follow-up|16|||
27806070|NCT01952041|54261443|FG000|Overall Study|Withdrawal by Subject|7|||
27806071|NCT01952041|54261444|FG001|Overall Study|Withdrawal by Subject|5|||
27806072|NCT01952041|54261443|FG000|Overall Study|Death|1|||
27806073|NCT01952041|54261444|FG001|Overall Study|Death|0|||
27806074|NCT01951573|54261450|FG000|Washout Period|Adverse Event|0|||
27806075|NCT01951573|54261451|FG001|Washout Period|Adverse Event|1|||
27806076|NCT02023697|54261460|FG000|Treatment Period|Radiological progression|13|||
27806077|NCT02023697|54261461|FG001|Treatment Period|Radiological progression|17|||
27806078|NCT02023697|54261462|FG002|Treatment Period|Radiological progression|26|||
27806079|NCT02023697|54261460|FG000|Treatment Period|Never Treated|5|||
27806080|NCT02023697|54261461|FG001|Treatment Period|Never Treated|6|||
27806081|NCT02023697|54261462|FG002|Treatment Period|Never Treated|10|||
27806082|NCT02023697|54261460|FG000|Treatment Period|Adverse Event|13|||
27806083|NCT02023697|54261461|FG001|Treatment Period|Adverse Event|25|||
27806084|NCT02023697|54261462|FG002|Treatment Period|Adverse Event|23|||
27806085|NCT02023697|54261460|FG000|Treatment Period|Logistical difficulties|1|||
27806086|NCT02023697|54261461|FG001|Treatment Period|Logistical difficulties|1|||
27806087|NCT02023697|54261462|FG002|Treatment Period|Logistical difficulties|1|||
27806088|NCT02023697|54261460|FG000|Treatment Period|Clinical progression|10|||
27806089|NCT02023697|54261461|FG001|Treatment Period|Clinical progression|8|||
27806090|NCT02023697|54261462|FG002|Treatment Period|Clinical progression|28|||
27806091|NCT02023697|54261460|FG000|Treatment Period|Withdrawal by Subject|4|||
27806092|NCT02023697|54261461|FG001|Treatment Period|Withdrawal by Subject|5|||
27806093|NCT02023697|54261462|FG002|Treatment Period|Withdrawal by Subject|13|||
27806094|NCT02023697|54261460|FG000|Treatment Period|Safety outcome reached|0|||
27806095|NCT02023697|54261461|FG001|Treatment Period|Safety outcome reached|1|||
27806096|NCT02023697|54261462|FG002|Treatment Period|Safety outcome reached|0|||
27806097|NCT02023697|54261460|FG000|Treatment Period|Physician Decision|0|||
28029506|NCT00568178|54688030|FG003|Open Label Extension|Withdrawal by Subject|0|||
28029507|NCT00568178|54688031|FG004|Open Label Extension|Withdrawal by Subject|4|||
28029508|NCT00568178|54688032|FG005|Open Label Extension|Withdrawal by Subject|4|||
28029509|NCT00577889|54688049|FG000|Overall Study|Withdrawal by Subject|1|||
28029510|NCT00577889|54688050|FG001|Overall Study|Withdrawal by Subject|0|||
28029511|NCT00577889|54688051|FG002|Overall Study|Withdrawal by Subject|0|||
28029512|NCT00460564|54688063|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
28029513|NCT00460564|54688064|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|1|||
27806098|NCT02023697|54261461|FG001|Treatment Period|Physician Decision|0|||
27806099|NCT02023697|54261462|FG002|Treatment Period|Physician Decision|1|||
28029514|NCT00460564|54688065|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
28029515|NCT00460564|54688066|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
28029516|NCT00460564|54688067|FG004|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
28029517|NCT00460564|54688068|FG005|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
28029518|NCT00460564|54688069|FG006|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
28029519|NCT00460564|54688070|FG007|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
28029520|NCT00460564|54688063|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1|||
27806100|NCT02023697|54261460|FG000|Active Follow-up Period|Withdrawal by Subject|5|||
27806101|NCT02023697|54261461|FG001|Active Follow-up Period|Withdrawal by Subject|13|||
27806102|NCT02023697|54261462|FG002|Active Follow-up Period|Withdrawal by Subject|7|||
27806103|NCT02023697|54261460|FG000|Active Follow-up Period|Lost to Follow-up|1|||
27806104|NCT02023697|54261461|FG001|Active Follow-up Period|Lost to Follow-up|1|||
28029521|NCT00460564|54688064|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
28029522|NCT00460564|54688065|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
28029523|NCT00460564|54688066|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
28029524|NCT00460564|54688067|FG004|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
28029525|NCT00460564|54688068|FG005|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
28029526|NCT00460564|54688069|FG006|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
28029527|NCT00460564|54688070|FG007|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
28029528|NCT00460564|54688063|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
28029529|NCT00460564|54688064|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
28029530|NCT00460564|54688065|FG002|Open-Label Phase (36 Weeks)|Adverse Event|0|||
28029531|NCT00460564|54688066|FG003|Open-Label Phase (36 Weeks)|Adverse Event|0|||
28029532|NCT00460564|54688067|FG004|Open-Label Phase (36 Weeks)|Adverse Event|3|||
28029533|NCT00460564|54688068|FG005|Open-Label Phase (36 Weeks)|Adverse Event|5|||
28029534|NCT00460564|54688069|FG006|Open-Label Phase (36 Weeks)|Adverse Event|2|||
28029535|NCT00460564|54688070|FG007|Open-Label Phase (36 Weeks)|Adverse Event|0|||
28029536|NCT00460564|54688063|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
28029537|NCT00460564|54688064|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
28029538|NCT00460564|54688065|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
28029539|NCT00460564|54688066|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
28029540|NCT00460564|54688067|FG004|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5|||
28029541|NCT00460564|54688068|FG005|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1|||
28029542|NCT00460564|54688069|FG006|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
28029543|NCT00460564|54688070|FG007|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
27806105|NCT02023697|54261462|FG002|Active Follow-up Period|Lost to Follow-up|1|||
27843384|NCT01437397|54332847|FG000|Overall Study|Withdrawal by Subject|11|||
27843385|NCT01437397|54332848|FG001|Overall Study|Withdrawal by Subject|12|||
27843386|NCT01437397|54332849|FG002|Overall Study|Withdrawal by Subject|24|||
27843387|NCT01437397|54332850|FG003|Overall Study|Withdrawal by Subject|11|||
27843388|NCT01437397|54332851|FG004|Overall Study|Withdrawal by Subject|22|||
27843389|NCT01437397|54332847|FG000|Overall Study|Protocol Violation|10|||
27843390|NCT01437397|54332848|FG001|Overall Study|Protocol Violation|12|||
27843391|NCT01437397|54332849|FG002|Overall Study|Protocol Violation|13|||
27843392|NCT01437397|54332850|FG003|Overall Study|Protocol Violation|21|||
27843393|NCT01437397|54332851|FG004|Overall Study|Protocol Violation|19|||
27843394|NCT01437397|54332847|FG000|Overall Study|Lack of Efficacy|5|||
27843395|NCT01437397|54332848|FG001|Overall Study|Lack of Efficacy|4|||
27843396|NCT01437397|54332849|FG002|Overall Study|Lack of Efficacy|8|||
27843397|NCT01437397|54332850|FG003|Overall Study|Lack of Efficacy|10|||
27843398|NCT01437397|54332851|FG004|Overall Study|Lack of Efficacy|20|||
27843399|NCT01437397|54332847|FG000|Overall Study|Adverse Event|21|||
27843400|NCT01437397|54332848|FG001|Overall Study|Adverse Event|22|||
27843401|NCT01437397|54332849|FG002|Overall Study|Adverse Event|16|||
27843402|NCT01437397|54332850|FG003|Overall Study|Adverse Event|14|||
27843403|NCT01437397|54332851|FG004|Overall Study|Adverse Event|21|||
27843404|NCT01437397|54332847|FG000|Overall Study|Site termination/COPD exacerbation/other|10|||
27843405|NCT01437397|54332848|FG001|Overall Study|Site termination/COPD exacerbation/other|8|||
27843406|NCT01437397|54332849|FG002|Overall Study|Site termination/COPD exacerbation/other|9|||
28029544|NCT00460564|54688063|FG000|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
28029545|NCT00460564|54688064|FG001|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
28029546|NCT00460564|54688065|FG002|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
27843407|NCT01437397|54332850|FG003|Overall Study|Site termination/COPD exacerbation/other|9|||
27843408|NCT01437397|54332851|FG004|Overall Study|Site termination/COPD exacerbation/other|14|||
27843409|NCT01437319|54332863|FG000|Phase I|Lost to Follow-up|2|||
27843410|NCT01437319|54332864|FG001|Phase I|Lost to Follow-up|0|||
27843411|NCT01437319|54332865|FG002|Phase I|Lost to Follow-up|0|||
27843412|NCT01437319|54332863|FG000|Phase I|Protocol Violation|1|||
27843413|NCT01437319|54332864|FG001|Phase I|Protocol Violation|0|||
27806106|NCT02023697|54261460|FG000|Active Follow-up Period|Deterioration of general condition|1|||
27806107|NCT02023697|54261461|FG001|Active Follow-up Period|Deterioration of general condition|1|||
27843414|NCT01437319|54332865|FG002|Phase I|Protocol Violation|0|||
27843415|NCT01437319|54332863|FG000|Phase I|Study related symptoms/complaints|27|||
27843416|NCT01437319|54332864|FG001|Phase I|Study related symptoms/complaints|0|||
27843417|NCT01437319|54332865|FG002|Phase I|Study related symptoms/complaints|0|||
27843418|NCT01437319|54332863|FG000|Phase I|Withdrawal by Subject|25|||
27843419|NCT01437319|54332864|FG001|Phase I|Withdrawal by Subject|0|||
27843420|NCT01437319|54332865|FG002|Phase I|Withdrawal by Subject|0|||
27843421|NCT01437319|54332863|FG000|Phase II|Withdrawal by Subject|0|||
27843422|NCT01437319|54332864|FG001|Phase II|Withdrawal by Subject|8|||
27843423|NCT01437319|54332865|FG002|Phase II|Withdrawal by Subject|16|||
27843424|NCT01437319|54332863|FG000|Phase II|Lost to Follow-up|0|||
27843425|NCT01437319|54332864|FG001|Phase II|Lost to Follow-up|7|||
27843426|NCT01437319|54332865|FG002|Phase II|Lost to Follow-up|2|||
27843427|NCT01437319|54332863|FG000|Phase II|Study related symptoms/complaints|0|||
27806108|NCT02023697|54261462|FG002|Active Follow-up Period|Deterioration of general condition|1|||
27806109|NCT02023697|54261460|FG000|Active Follow-up Period|Other unspecified|2|||
27806110|NCT02023697|54261461|FG001|Active Follow-up Period|Other unspecified|0|||
27806111|NCT02023697|54261462|FG002|Active Follow-up Period|Other unspecified|1|||
27806112|NCT02023697|54261460|FG000|Active Follow-up Period|Clinical progression|0|||
27806113|NCT02023697|54261461|FG001|Active Follow-up Period|Clinical progression|2|||
27806114|NCT02023697|54261462|FG002|Active Follow-up Period|Clinical progression|1|||
27806115|NCT02023697|54261460|FG000|Active Follow-up Period|Radiological progression|0|||
27806116|NCT02023697|54261461|FG001|Active Follow-up Period|Radiological progression|0|||
27806117|NCT02023697|54261462|FG002|Active Follow-up Period|Radiological progression|1|||
27806118|NCT02023697|54261460|FG000|Active Follow-up Period|Death|83|||
27806119|NCT02023697|54261461|FG001|Active Follow-up Period|Death|82|||
27806120|NCT02023697|54261462|FG002|Active Follow-up Period|Death|87|||
27806121|NCT02023697|54261460|FG000|Long-term Follow-up Period|Death|9|||
27806122|NCT02023697|54261461|FG001|Long-term Follow-up Period|Death|6|||
27806123|NCT02023697|54261462|FG002|Long-term Follow-up Period|Death|4|||
27806124|NCT02023697|54261460|FG000|Long-term Follow-up Period|Withdrawal by Subject|6|||
27806125|NCT02023697|54261461|FG001|Long-term Follow-up Period|Withdrawal by Subject|3|||
27806126|NCT02023697|54261462|FG002|Long-term Follow-up Period|Withdrawal by Subject|0|||
27806127|NCT02023697|54261460|FG000|Long-term Follow-up Period|Lost to Follow-up|1|||
27843428|NCT01437319|54332864|FG001|Phase II|Study related symptoms/complaints|28|||
27843429|NCT01437319|54332865|FG002|Phase II|Study related symptoms/complaints|19|||
27843430|NCT01437319|54332863|FG000|Phase II|Protocol Violation|0|||
27843431|NCT01437319|54332864|FG001|Phase II|Protocol Violation|1|||
27843432|NCT01437319|54332865|FG002|Phase II|Protocol Violation|0|||
27843433|NCT01416571|54332874|FG000|Overall Study|Lost to Follow-up|2|||
27939582|NCT01233284|54595815|FG001|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
27939583|NCT01233284|54595816|FG002|Period 2 (4 Weeks)|Withdrawal by Subject|1|||
27806128|NCT02023697|54261461|FG001|Long-term Follow-up Period|Lost to Follow-up|0|||
27806129|NCT02023697|54261462|FG002|Long-term Follow-up Period|Lost to Follow-up|1|||
27806130|NCT02023697|54261460|FG000|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
27806131|NCT02023697|54261461|FG001|Long-term Follow-up Period|Entered the long-term follow-up study|9|||
27806132|NCT02023697|54261462|FG002|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
27806133|NCT02023697|54261460|FG000|Long-term Follow-up Period|Technical problems|0|||
27806134|NCT02023697|54261461|FG001|Long-term Follow-up Period|Technical problems|0|||
27806135|NCT02023697|54261462|FG002|Long-term Follow-up Period|Technical problems|1|||
27806136|NCT02023697|54261460|FG000|Long-term Follow-up Period|Other unspecified|6|||
27843434|NCT01442155|54332895|FG000|Overall Study|Complete remission|35|||
27843435|NCT01442155|54332895|FG000|Overall Study|Recurrence|26|||
27843436|NCT01442155|54332895|FG000|Overall Study|Adverse Event|2|||
27843437|NCT01442155|54332895|FG000|Overall Study|Lost to Follow-up|2|||
27843438|NCT01416181|54332901|FG000|Part 1|Other|10|||
27806137|NCT02023697|54261461|FG001|Long-term Follow-up Period|Other unspecified|3|||
27843439|NCT01416181|54332902|FG001|Part 1|Other|24|||
27843440|NCT01416181|54332901|FG000|Part 1|Death|0|||
27843441|NCT01416181|54332902|FG001|Part 1|Death|1|||
27843442|NCT01416181|54332901|FG000|Part 1|Investigator Decision|7|||
27939584|NCT01233284|54595817|FG003|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
27843443|NCT01416181|54332902|FG001|Part 1|Investigator Decision|6|||
27843444|NCT01416181|54332901|FG000|Part 1|Withdrawal by Subject|74|||
27843445|NCT01416181|54332902|FG001|Part 1|Withdrawal by Subject|48|||
27843446|NCT01416181|54332901|FG000|Part 1|Lack of Efficacy|16|||
27939585|NCT01233284|54595818|FG004|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
27806138|NCT02023697|54261462|FG002|Long-term Follow-up Period|Other unspecified|5|||
27806139|NCT01951417|54261477|FG000|Overall Study|Withdrawal by Subject|1|||
27806140|NCT01951417|54261477|FG000|Overall Study|Protocol Violation|2|||
27806141|NCT01951417|54261477|FG000|Overall Study|Lost to Follow-up|6|||
27806142|NCT01951261|54261487|FG000|Overall Study|Death|1|||
27806143|NCT01951261|54261488|FG001|Overall Study|Death|0|||
27806144|NCT01951261|54261487|FG000|Overall Study|Lost to Follow-up|4|||
27806145|NCT01951261|54261488|FG001|Overall Study|Lost to Follow-up|3|||
27806146|NCT01951261|54261487|FG000|Overall Study|Protocol Violation|4|||
27843447|NCT01416181|54332902|FG001|Part 1|Lack of Efficacy|8|||
27843448|NCT01416181|54332901|FG000|Part 1|Lost to Follow-up|1|||
27843449|NCT01416181|54332902|FG001|Part 1|Lost to Follow-up|1|||
27843450|NCT01416181|54332901|FG000|Part 1|Adverse Event|15|||
27843451|NCT01416181|54332902|FG001|Part 1|Adverse Event|18|||
27843452|NCT01416181|54332901|FG000|Part 1|Ongoing in Follow-Up|14|||
27843453|NCT01416181|54332902|FG001|Part 1|Ongoing in Follow-Up|8|||
27843454|NCT01416181|54332901|FG000|Part 2|Adverse Event|11|||
27843455|NCT01416181|54332902|FG001|Part 2|Adverse Event|4|||
27843456|NCT01416181|54332901|FG000|Part 2|Other|234|||
27843457|NCT01416181|54332902|FG001|Part 2|Other|267|||
28029547|NCT00460564|54688066|FG003|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
28029548|NCT00460564|54688067|FG004|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1|||
28029549|NCT00460564|54688068|FG005|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
28029550|NCT00460564|54688069|FG006|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
28029551|NCT00460564|54688070|FG007|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
28029552|NCT00567476|54688092|FG000|Overall Study|Adverse Event|2|||
28029553|NCT00567476|54688093|FG001|Overall Study|Adverse Event|0|||
28029554|NCT00567476|54688092|FG000|Overall Study|Pregnancy|1|||
28029555|NCT00567476|54688093|FG001|Overall Study|Pregnancy|0|||
28029556|NCT00567476|54688092|FG000|Overall Study|Protocol Violation|4|||
28029557|NCT00567476|54688093|FG001|Overall Study|Protocol Violation|1|||
28029558|NCT00567476|54688092|FG000|Overall Study|Lost to Follow-up|0|||
28029559|NCT00567476|54688093|FG001|Overall Study|Lost to Follow-up|1|||
28029560|NCT00567476|54688092|FG000|Overall Study|Administrative issues|1|||
28029561|NCT00567476|54688093|FG001|Overall Study|Administrative issues|0|||
28029562|NCT00567476|54688092|FG000|Overall Study|Medical Decision|0|||
28029563|NCT00567476|54688093|FG001|Overall Study|Medical Decision|1|||
28029564|NCT00567476|54688092|FG000|Overall Study|Non-adherence to protocol|0|||
28029565|NCT00567476|54688093|FG001|Overall Study|Non-adherence to protocol|1|||
28029566|NCT00516321|54688101|FG000|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11|||
28029567|NCT00516321|54688102|FG001|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
28029568|NCT00516321|54688103|FG002|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
28029569|NCT00516321|54688101|FG000|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9|||
28029570|NCT00516321|54688102|FG001|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
28029571|NCT00516321|54688103|FG002|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
28029572|NCT00516321|54688101|FG000|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1|||
28029573|NCT00516321|54688102|FG001|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
28029574|NCT00516321|54688103|FG002|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
28029575|NCT00516321|54688101|FG000|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2|||
28029576|NCT00516321|54688102|FG001|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
28029577|NCT00516321|54688103|FG002|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
28029578|NCT00516321|54688101|FG000|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7|||
28029579|NCT00516321|54688102|FG001|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
28029580|NCT00516321|54688103|FG002|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
28029581|NCT00516321|54688101|FG000|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3|||
28029582|NCT00516321|54688102|FG001|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
27806147|NCT01951261|54261488|FG001|Overall Study|Protocol Violation|3|||
27806148|NCT02023151|54261494|FG000|Overall Study|Lost to Follow-up|4|||
27806149|NCT01979185|54261500|FG000|Period 2|Other|0|||
27806150|NCT01979185|54261501|FG001|Period 2|Other|1|||
27806151|NCT01946425|54261509|FG000|Overall Study|Protocol Violation|1|||
27843458|NCT01416181|54332901|FG000|Part 2|Investigator Decision|6|||
28029583|NCT00516321|54688103|FG002|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
28029584|NCT00516321|54688101|FG000|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0|||
28029585|NCT00516321|54688102|FG001|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12|||
28029586|NCT00516321|54688103|FG002|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22|||
27806152|NCT01946425|54261510|FG001|Overall Study|Protocol Violation|0|||
27806153|NCT01946425|54261509|FG000|Overall Study|Withdrawal by Subject|1|||
27806154|NCT01946425|54261510|FG001|Overall Study|Withdrawal by Subject|0|||
27806155|NCT01946191|54261519|FG000|Allocation|Did not complete orientation|1|||
27843459|NCT01416181|54332902|FG001|Part 2|Investigator Decision|7|||
27843460|NCT01416181|54332901|FG000|Part 2|Withdrawal by Subject|14|||
27843461|NCT01416181|54332902|FG001|Part 2|Withdrawal by Subject|5|||
27843462|NCT01416181|54332901|FG000|Part 2|Lack of Efficacy|4|||
27843463|NCT01416181|54332902|FG001|Part 2|Lack of Efficacy|1|||
27806156|NCT01946191|54261520|FG001|Allocation|Did not complete orientation|1|||
27806157|NCT01946191|54261519|FG000|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4|||
27806158|NCT01946191|54261520|FG001|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2|||
27806159|NCT01946191|54261519|FG000|Follow-Up, 24-mo Endpoint|Protocol Violation|0|||
27806160|NCT01946191|54261520|FG001|Follow-Up, 24-mo Endpoint|Protocol Violation|1|||
27806161|NCT01946191|54261519|FG000|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13|||
27806162|NCT01946191|54261520|FG001|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15|||
27939586|NCT01233284|54595814|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
27939587|NCT01233284|54595815|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
27843464|NCT01416181|54332901|FG000|Part 2|Lost to Follow-up|2|||
27843465|NCT01416181|54332902|FG001|Part 2|Lost to Follow-up|2|||
27843466|NCT01441765|54332910|FG000|Overall Study|Death|1|||
27939588|NCT01233284|54595816|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
27939589|NCT01233284|54595817|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
27939590|NCT01233284|54595818|FG004|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
27939591|NCT01233284|54595814|FG000|Period 3 (4 Weeks)|Other|0|||
27939592|NCT01233284|54595815|FG001|Period 3 (4 Weeks)|Other|0|||
27939593|NCT01233284|54595816|FG002|Period 3 (4 Weeks)|Other|0|||
27939594|NCT01233284|54595817|FG003|Period 3 (4 Weeks)|Other|1|||
27939595|NCT01233284|54595818|FG004|Period 3 (4 Weeks)|Other|0|||
27939596|NCT01233284|54595814|FG000|Period 4 (4 Weeks)|Adverse Event|0|||
27939597|NCT01233284|54595815|FG001|Period 4 (4 Weeks)|Adverse Event|1|||
27939598|NCT01233284|54595816|FG002|Period 4 (4 Weeks)|Adverse Event|0|||
27939599|NCT01233284|54595817|FG003|Period 4 (4 Weeks)|Adverse Event|0|||
27939600|NCT01233284|54595818|FG004|Period 4 (4 Weeks)|Adverse Event|0|||
27939601|NCT01233284|54595814|FG000|Period 4 (4 Weeks)|Lost to Follow-up|0|||
27939602|NCT01233284|54595815|FG001|Period 4 (4 Weeks)|Lost to Follow-up|0|||
27939603|NCT01233284|54595816|FG002|Period 4 (4 Weeks)|Lost to Follow-up|0|||
27939604|NCT01233284|54595817|FG003|Period 4 (4 Weeks)|Lost to Follow-up|1|||
27939605|NCT01233284|54595818|FG004|Period 4 (4 Weeks)|Lost to Follow-up|0|||
27939606|NCT00948688|54595828|FG000|Period 1: 200 mg Vorinostat|Adverse Event|1|||
27939607|NCT00948688|54595829|FG001|Period 1: 200 mg Vorinostat|Adverse Event|0|||
27843467|NCT01441765|54332911|FG001|Overall Study|Death|0|||
27843468|NCT01419665|54332919|FG000|Combination Treatment|Adverse Event|7|||
27843469|NCT01419665|54332920|FG001|Combination Treatment|Adverse Event|10|||
27843470|NCT01419665|54332919|FG000|Combination Treatment|Physician Decision|5|||
27843471|NCT01419665|54332920|FG001|Combination Treatment|Physician Decision|8|||
27843472|NCT01419665|54332919|FG000|Combination Treatment|Protocol Violation|6|||
27843473|NCT01419665|54332920|FG001|Combination Treatment|Protocol Violation|2|||
27843474|NCT01419665|54332919|FG000|Combination Treatment|disease progression|10|||
27843475|NCT01419665|54332920|FG001|Combination Treatment|disease progression|9|||
27843476|NCT01419665|54332919|FG000|Combination Treatment|Death|5|||
27843477|NCT01419665|54332920|FG001|Combination Treatment|Death|7|||
27939608|NCT00948688|54595828|FG000|Period 1: 200 mg Vorinostat|Protocol Violation|1|||
27939609|NCT00948688|54595829|FG001|Period 1: 200 mg Vorinostat|Protocol Violation|0|||
27939610|NCT00948688|54595828|FG000|Period 2: 100 mg Vorinostat|Adverse Event|0|||
27939611|NCT00948688|54595829|FG001|Period 2: 100 mg Vorinostat|Adverse Event|1|||
27939612|NCT01233050|54595838|FG000|Overall Study|protocol deviation (inclusion/exclusion)|8|||
27939613|NCT01233050|54595839|FG001|Overall Study|protocol deviation (inclusion/exclusion)|6|||
27939614|NCT01232894|54595847|FG000|Overall Study|Lost to Follow-up|0|||
27843478|NCT01419665|54332919|FG000|Combination Treatment|administrative problems|0|||
27843479|NCT01419665|54332920|FG001|Combination Treatment|administrative problems|1|||
27843480|NCT01419665|54332919|FG000|Combination Treatment|Withdrawal by Subject|5|||
27843481|NCT01419665|54332920|FG001|Combination Treatment|Withdrawal by Subject|4|||
27939615|NCT01232894|54595848|FG001|Overall Study|Lost to Follow-up|1|||
27939616|NCT01232894|54595847|FG000|Overall Study|Death|1|||
27939617|NCT01232894|54595848|FG001|Overall Study|Death|0|||
27939618|NCT01232894|54595847|FG000|Overall Study|Protocol Violation|1|||
27843482|NCT01419665|54332919|FG000|Maintenance Treatment and/or Follow up|switch to open label|44|||
27843483|NCT01419665|54332920|FG001|Maintenance Treatment and/or Follow up|switch to open label|39|||
27806197|NCT01937312|54261570|FG000|Overall Study|Adverse Event|10|||
27806198|NCT01937312|54261571|FG001|Overall Study|Adverse Event|1|||
27806199|NCT01937312|54261570|FG000|Overall Study|Lack of Efficacy|0|||
27806200|NCT01937312|54261571|FG001|Overall Study|Lack of Efficacy|1|||
27843484|NCT01419665|54332919|FG000|Maintenance Treatment and/or Follow up|administrative problems|0|||
27843485|NCT01419665|54332920|FG001|Maintenance Treatment and/or Follow up|administrative problems|6|||
27843486|NCT01419665|54332919|FG000|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
27843487|NCT01419665|54332920|FG001|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
27843488|NCT01419665|54332919|FG000|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
27843489|NCT01419665|54332920|FG001|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
27843490|NCT01419665|54332919|FG000|Maintenance Treatment and/or Follow up|Physician Decision|5|||
27843491|NCT01419665|54332920|FG001|Maintenance Treatment and/or Follow up|Physician Decision|2|||
27843492|NCT01419665|54332919|FG000|Maintenance Treatment and/or Follow up|disease progression|53|||
27843493|NCT01419665|54332920|FG001|Maintenance Treatment and/or Follow up|disease progression|37|||
27843494|NCT01419665|54332919|FG000|Maintenance Treatment and/or Follow up|Death|1|||
27843495|NCT01419665|54332920|FG001|Maintenance Treatment and/or Follow up|Death|2|||
27843496|NCT01419665|54332919|FG000|Maintenance Treatment and/or Follow up|Adverse Event|11|||
27843497|NCT01419665|54332920|FG001|Maintenance Treatment and/or Follow up|Adverse Event|7|||
27843498|NCT01419665|54332919|FG000|Maintenance Treatment and/or Follow up|Lost to Follow-up|1|||
27843499|NCT01419665|54332920|FG001|Maintenance Treatment and/or Follow up|Lost to Follow-up|2|||
27843500|NCT01419665|54332919|FG000|Open Label Phase|Death|1|||
27843501|NCT01419665|54332920|FG001|Open Label Phase|Death|0|||
27843502|NCT01419665|54332919|FG000|Open Label Phase|disease progression|0|||
27843503|NCT01419665|54332920|FG001|Open Label Phase|disease progression|1|||
27843504|NCT01436305|54332931|FG000|Overall Study|Death|1|||
28029587|NCT00516321|54688101|FG000|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0|||
28029588|NCT00516321|54688102|FG001|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13|||
28029589|NCT00516321|54688103|FG002|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18|||
28029590|NCT00516321|54688101|FG000|Double-blind (DB) Antiviral Treatment|Adverse Event|0|||
28029591|NCT00516321|54688102|FG001|Double-blind (DB) Antiviral Treatment|Adverse Event|8|||
28029592|NCT00516321|54688103|FG002|Double-blind (DB) Antiviral Treatment|Adverse Event|13|||
28029593|NCT00516321|54688101|FG000|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
28029594|NCT00516321|54688102|FG001|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
28029595|NCT00516321|54688103|FG002|Double-blind (DB) Antiviral Treatment|Protocol Violation|1|||
28029596|NCT00516321|54688101|FG000|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
28029597|NCT00516321|54688102|FG001|Double-blind (DB) Antiviral Treatment|Physician Decision|2|||
28029598|NCT00516321|54688103|FG002|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
28029599|NCT00460408|54688115|FG000|Overall Study|Adverse Event|1|||
28029600|NCT00460408|54688116|FG001|Overall Study|Adverse Event|0|||
28029601|NCT00460408|54688117|FG002|Overall Study|Adverse Event|0|||
28029602|NCT00460408|54688118|FG003|Overall Study|Adverse Event|0|||
28029603|NCT00460408|54688115|FG000|Overall Study|Death|7|||
28029604|NCT00460408|54688116|FG001|Overall Study|Death|0|||
28029605|NCT00460408|54688117|FG002|Overall Study|Death|0|||
28029606|NCT00460408|54688118|FG003|Overall Study|Death|0|||
28029607|NCT00460408|54688115|FG000|Overall Study|Lost to Follow-up|11|||
28029608|NCT00460408|54688116|FG001|Overall Study|Lost to Follow-up|0|||
28029609|NCT00460408|54688117|FG002|Overall Study|Lost to Follow-up|1|||
28029610|NCT00460408|54688118|FG003|Overall Study|Lost to Follow-up|0|||
27806201|NCT01937312|54261570|FG000|Overall Study|Withdrawal of subject prior to treatment|1|||
27806202|NCT01937312|54261571|FG001|Overall Study|Withdrawal of subject prior to treatment|1|||
27806203|NCT01909934|54261578|FG000|Overall Study|Ongoing|23|||
27806204|NCT01909934|54261578|FG000|Overall Study|Withdrawal by Subject|3|||
27806205|NCT01909934|54261578|FG000|Overall Study|Lost to Follow-up|1|||
27806206|NCT01909934|54261578|FG000|Overall Study|Withdrawal of Informed Consent|1|||
27806207|NCT01909934|54261578|FG000|Overall Study|Death|22|||
27806208|NCT01935128|54261582|FG000|Overall Study|Death|1|||
27806209|NCT01935128|54261582|FG000|Overall Study|Adverse Event|6|||
27806210|NCT01934972|54261588|FG000|Overall Study|Withdrawal by Subject|9|||
27843505|NCT01436305|54332932|FG001|Overall Study|Death|0|||
27843506|NCT01436305|54332933|FG002|Overall Study|Death|0|||
27843507|NCT01436305|54332931|FG000|Overall Study|Lost to Follow-up|0|||
27843508|NCT01436305|54332932|FG001|Overall Study|Lost to Follow-up|1|||
27843509|NCT01436305|54332933|FG002|Overall Study|Lost to Follow-up|0|||
27843510|NCT01436305|54332931|FG000|Overall Study|Withdrawal by Subject|1|||
27843511|NCT01436305|54332932|FG001|Overall Study|Withdrawal by Subject|3|||
28029611|NCT00460408|54688115|FG000|Overall Study|Withdrawal by Subject|31|||
28029612|NCT00460408|54688116|FG001|Overall Study|Withdrawal by Subject|0|||
28029613|NCT00460408|54688117|FG002|Overall Study|Withdrawal by Subject|0|||
28029614|NCT00460408|54688118|FG003|Overall Study|Withdrawal by Subject|0|||
27806211|NCT01934972|54261589|FG001|Overall Study|Withdrawal by Subject|6|||
27806212|NCT01959230|54261597|FG000|Overall Study|Failure to follow study procedures|0|||
27806213|NCT01959230|54261598|FG001|Overall Study|Failure to follow study procedures|1|||
27806214|NCT01959230|54261597|FG000|Overall Study|Administrative reasons|2|||
27843512|NCT01436305|54332933|FG002|Overall Study|Withdrawal by Subject|0|||
27843513|NCT01436149|54332943|FG000|Antidepressant Lead-in Phase|Adverse Event|39|||
27843514|NCT01436149|54332944|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
27843515|NCT01436149|54332945|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
27843516|NCT01436149|54332943|FG000|Antidepressant Lead-in Phase|Protocol Violation|29|||
27843517|NCT01436149|54332944|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
27843518|NCT01436149|54332945|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
27843519|NCT01436149|54332943|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|61|||
27843520|NCT01436149|54332944|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
27843521|NCT01436149|54332945|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
27843522|NCT01436149|54332943|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|96|||
27843523|NCT01436149|54332944|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
27843524|NCT01436149|54332945|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
27843525|NCT01436149|54332943|FG000|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22|||
27843526|NCT01436149|54332944|FG001|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
27843527|NCT01436149|54332945|FG002|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
27843528|NCT01436149|54332943|FG000|Antidepressant Lead-in Phase|Other|119|||
27843529|NCT01436149|54332944|FG001|Antidepressant Lead-in Phase|Other|0|||
27843530|NCT01436149|54332945|FG002|Antidepressant Lead-in Phase|Other|0|||
27843531|NCT01436149|54332943|FG000|Randomized Phase|Adverse Event|9|||
27843532|NCT01436149|54332944|FG001|Randomized Phase|Adverse Event|10|||
27843533|NCT01436149|54332945|FG002|Randomized Phase|Adverse Event|11|||
27843534|NCT01436149|54332943|FG000|Randomized Phase|Protocol Violation|4|||
27843535|NCT01436149|54332944|FG001|Randomized Phase|Protocol Violation|5|||
27843536|NCT01436149|54332945|FG002|Randomized Phase|Protocol Violation|0|||
27843537|NCT01436149|54332943|FG000|Randomized Phase|Withdrawal by Subject|16|||
27843538|NCT01436149|54332944|FG001|Randomized Phase|Withdrawal by Subject|10|||
27843539|NCT01436149|54332945|FG002|Randomized Phase|Withdrawal by Subject|10|||
27843540|NCT01436149|54332943|FG000|Randomized Phase|Lost to Follow-up|34|||
27843541|NCT01436149|54332944|FG001|Randomized Phase|Lost to Follow-up|5|||
27843542|NCT01436149|54332945|FG002|Randomized Phase|Lost to Follow-up|6|||
27843543|NCT01436149|54332943|FG000|Randomized Phase|Lack of Efficacy|0|||
27843544|NCT01436149|54332944|FG001|Randomized Phase|Lack of Efficacy|0|||
27843545|NCT01436149|54332945|FG002|Randomized Phase|Lack of Efficacy|1|||
27843546|NCT01436149|54332943|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
27843547|NCT01436149|54332944|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
27843548|NCT01436149|54332945|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
27843549|NCT01436149|54332943|FG000|Randomized Phase|Other|12|||
27843550|NCT01436149|54332944|FG001|Randomized Phase|Other|5|||
27843551|NCT01436149|54332945|FG002|Randomized Phase|Other|11|||
27843552|NCT01415401|54332951|FG000|Overall Study|Adverse Event|5|||
27843553|NCT01415401|54332951|FG000|Overall Study|DId not meet inclusion/exclusion criteri|1|||
27843554|NCT01415401|54332951|FG000|Overall Study|Terminated by Sponsor|1|||
27843555|NCT01414855|54332955|FG000|Overall Study|Death|17|||
27843556|NCT01414855|54332955|FG000|Overall Study|Lost to Follow-up|5|||
27843557|NCT01414855|54332955|FG000|Overall Study|Withdrawal by Subject|7|||
27843558|NCT01527500|54332963|FG000|Part A|Administrative|11|||
27843559|NCT01527500|54332964|FG001|Part A|Administrative|7|||
27806215|NCT01959230|54261598|FG001|Overall Study|Administrative reasons|0|||
27806216|NCT01959230|54261597|FG000|Overall Study|Withdrawal by Subject|2|||
27806217|NCT01959230|54261598|FG001|Overall Study|Withdrawal by Subject|0|||
27806218|NCT01909778|54261604|FG000|Overall Study|failed screening|1|||
27806219|NCT01977937|54261612|FG000|Overall Study|Withdrawal by Subject|2|||
27806220|NCT01977937|54261613|FG001|Overall Study|Withdrawal by Subject|1|||
27806221|NCT01977937|54261612|FG000|Overall Study|Adverse Event|1|||
27806222|NCT01977937|54261613|FG001|Overall Study|Adverse Event|0|||
27806223|NCT01977937|54261612|FG000|Overall Study|Physician Decision|0|||
27806224|NCT01977937|54261613|FG001|Overall Study|Physician Decision|1|||
27806225|NCT02015663|54261621|FG000|Overall Study|unsatisfactory therapeutic effect|1|||
27806226|NCT02015663|54261622|FG001|Overall Study|unsatisfactory therapeutic effect|0|||
27806227|NCT02015663|54261621|FG000|Overall Study|Withdrawal by Subject|1|||
27806228|NCT02015663|54261622|FG001|Overall Study|Withdrawal by Subject|0|||
27843560|NCT01527500|54332963|FG000|Part A|Adverse Event|4|||
27843561|NCT01527500|54332964|FG001|Part A|Adverse Event|2|||
27843562|NCT01527500|54332963|FG000|Part A|Death|4|||
27843563|NCT01527500|54332964|FG001|Part A|Death|1|||
27843564|NCT01527500|54332963|FG000|Part A|Lost to Follow-up|0|||
27843565|NCT01527500|54332964|FG001|Part A|Lost to Follow-up|1|||
27843566|NCT01527500|54332963|FG000|Part A|Protocol Deviation|9|||
27843567|NCT01527500|54332964|FG001|Part A|Protocol Deviation|2|||
27806229|NCT02015663|54261621|FG000|Overall Study|Protocol Violation|0|||
27806230|NCT02015663|54261622|FG001|Overall Study|Protocol Violation|1|||
27806231|NCT02015663|54261621|FG000|Overall Study|Adverse Event|3|||
27843568|NCT01527500|54332963|FG000|Part A|Withdrawal by Subject|2|||
27843569|NCT01527500|54332964|FG001|Part A|Withdrawal by Subject|0|||
27843570|NCT01527500|54332963|FG000|Part B|Adverse Event|1|||
27843571|NCT01527500|54332964|FG001|Part B|Adverse Event|0|||
27843572|NCT01527110|54332989|FG000|Overall Study|Adverse Event|1|||
28029615|NCT00460408|54688115|FG000|Overall Study|Insufficient clinical response|5|||
28029616|NCT00460408|54688116|FG001|Overall Study|Insufficient clinical response|1|||
28029617|NCT00460408|54688117|FG002|Overall Study|Insufficient clinical response|5|||
28029618|NCT00460408|54688118|FG003|Overall Study|Insufficient clinical response|0|||
27806232|NCT02015663|54261622|FG001|Overall Study|Adverse Event|0|||
27806233|NCT02015663|54261621|FG000|Overall Study|Administrative problems|10|||
27806234|NCT02015663|54261622|FG001|Overall Study|Administrative problems|11|||
27806235|NCT01978093|54261631|FG000|Overall Study|Death|1|||
28029619|NCT00460408|54688115|FG000|Overall Study|Other|12|||
28029620|NCT00460408|54688116|FG001|Overall Study|Other|2|||
28029621|NCT00460408|54688117|FG002|Overall Study|Other|0|||
28029622|NCT00460408|54688118|FG003|Overall Study|Other|0|||
28029623|NCT00507819|54688128|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
28029624|NCT00507819|54688129|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
28029625|NCT00442936|54688159|FG000|Overall Study|Protocol Violation|1|||
28029626|NCT00442936|54688160|FG001|Overall Study|Protocol Violation|0|||
28029627|NCT00442936|54688161|FG002|Overall Study|Protocol Violation|1|||
28029628|NCT00442936|54688162|FG003|Overall Study|Protocol Violation|1|||
28029629|NCT00577655|54688174|FG000|Overall Study|Patient Request|0|||
28029630|NCT00577655|54688175|FG001|Overall Study|Patient Request|2|||
28029631|NCT00577655|54688174|FG000|Overall Study|Protocol Violation|0|||
28029632|NCT00577655|54688175|FG001|Overall Study|Protocol Violation|1|||
28029633|NCT00577655|54688174|FG000|Overall Study|Lost to Follow-up|1|||
28029634|NCT00577655|54688175|FG001|Overall Study|Lost to Follow-up|1|||
28029635|NCT00113269|54688186|FG000|Overall Study|Not transplanted, donor issues|4|||
28029636|NCT00113269|54688187|FG001|Overall Study|Not transplanted, donor issues|0|||
28029637|NCT00113269|54688188|FG002|Overall Study|Not transplanted, donor issues|2|||
28029638|NCT00113269|54688189|FG003|Overall Study|Not transplanted, donor issues|2|||
28029639|NCT00113269|54688186|FG000|Overall Study|Not transplanted, recipient issues|2|||
28029640|NCT00113269|54688187|FG001|Overall Study|Not transplanted, recipient issues|1|||
28029641|NCT00113269|54688188|FG002|Overall Study|Not transplanted, recipient issues|7|||
28029642|NCT00113269|54688189|FG003|Overall Study|Not transplanted, recipient issues|4|||
28029643|NCT00113269|54688186|FG000|Overall Study|Early graft loss, technical|0|||
28029644|NCT00113269|54688187|FG001|Overall Study|Early graft loss, technical|0|||
28029645|NCT00113269|54688188|FG002|Overall Study|Early graft loss, technical|2|||
28029646|NCT00113269|54688189|FG003|Overall Study|Early graft loss, technical|0|||
28029647|NCT00113269|54688186|FG000|Overall Study|Death in operating room|0|||
28029648|NCT00113269|54688187|FG001|Overall Study|Death in operating room|0|||
28029649|NCT00113269|54688188|FG002|Overall Study|Death in operating room|0|||
28029650|NCT00113269|54688189|FG003|Overall Study|Death in operating room|1|||
28029651|NCT00113269|54688186|FG000|Overall Study|Did not meet eligibility - pre-treatment|0|||
28029652|NCT00113269|54688187|FG001|Overall Study|Did not meet eligibility - pre-treatment|0|||
28029653|NCT00113269|54688188|FG002|Overall Study|Did not meet eligibility - pre-treatment|0|||
28029654|NCT00113269|54688189|FG003|Overall Study|Did not meet eligibility - pre-treatment|2|||
28029655|NCT00113269|54688186|FG000|Overall Study|Adverse Event|2|||
28029656|NCT00113269|54688187|FG001|Overall Study|Adverse Event|7|||
28029657|NCT00113269|54688188|FG002|Overall Study|Adverse Event|11|||
28029658|NCT00113269|54688189|FG003|Overall Study|Adverse Event|7|||
28029659|NCT00113269|54688186|FG000|Overall Study|Withdrawal by Subject|4|||
28029660|NCT00113269|54688187|FG001|Overall Study|Withdrawal by Subject|3|||
28029661|NCT00113269|54688188|FG002|Overall Study|Withdrawal by Subject|4|||
28029662|NCT00113269|54688189|FG003|Overall Study|Withdrawal by Subject|2|||
28029663|NCT00113269|54688186|FG000|Overall Study|Graft loss|6|||
28029664|NCT00113269|54688187|FG001|Overall Study|Graft loss|6|||
28029665|NCT00113269|54688188|FG002|Overall Study|Graft loss|4|||
27806236|NCT01978093|54261632|FG001|Overall Study|Death|0|||
27806237|NCT01978093|54261631|FG000|Overall Study|Adverse Event|0|||
27806238|NCT01978093|54261632|FG001|Overall Study|Adverse Event|5|||
27806239|NCT01978093|54261631|FG000|Overall Study|Protocol Violation|8|||
27806240|NCT01978093|54261632|FG001|Overall Study|Protocol Violation|2|||
27806241|NCT01978093|54261631|FG000|Overall Study|Withdrawal by Subject|29|||
27806242|NCT01978093|54261632|FG001|Overall Study|Withdrawal by Subject|25|||
27806243|NCT01978093|54261631|FG000|Overall Study|Lost to Follow-up|11|||
28029666|NCT00113269|54688189|FG003|Overall Study|Graft loss|9|||
27806244|NCT01978093|54261632|FG001|Overall Study|Lost to Follow-up|15|||
27806245|NCT01978093|54261631|FG000|Overall Study|Migrated/moved from study area|11|||
27806246|NCT01978093|54261632|FG001|Overall Study|Migrated/moved from study area|13|||
27806247|NCT01978093|54261631|FG000|Overall Study|Loss of kaiser coverage|4|||
27806248|NCT01978093|54261632|FG001|Overall Study|Loss of kaiser coverage|10|||
27939619|NCT01232894|54595848|FG001|Overall Study|Protocol Violation|1|||
27939620|NCT01232894|54595847|FG000|Overall Study|Withdrawal by Subject|8|||
27939621|NCT01232894|54595848|FG001|Overall Study|Withdrawal by Subject|5|||
27939622|NCT01232894|54595847|FG000|Overall Study|Physician Decision|2|||
27939623|NCT01232894|54595848|FG001|Overall Study|Physician Decision|1|||
27939624|NCT01049217|54595856|FG000|Overall Study|Adverse Event|2|||
27939625|NCT01049217|54595857|FG001|Overall Study|Adverse Event|1|||
27939626|NCT01049217|54595856|FG000|Overall Study|Lack of Efficacy|1|||
27806249|NCT01978093|54261631|FG000|Overall Study|Lost kaiser health plan unable to contac|1|||
27806250|NCT01978093|54261632|FG001|Overall Study|Lost kaiser health plan unable to contac|0|||
27806251|NCT01978093|54261631|FG000|Overall Study|Mother lost custody of child|0|||
27806252|NCT01978093|54261632|FG001|Overall Study|Mother lost custody of child|1|||
27806253|NCT01978093|54261631|FG000|Overall Study|Child was in care of grandmother|0|||
27806254|NCT01978093|54261632|FG001|Overall Study|Child was in care of grandmother|1|||
27806255|NCT01978093|54261631|FG000|Overall Study|N/A for vaccine administration|0|||
27806256|NCT01978093|54261632|FG001|Overall Study|N/A for vaccine administration|1|||
27806257|NCT01951105|54261644|FG000|Overall Study|Adverse Event|0|||
27806258|NCT01951105|54261645|FG001|Overall Study|Adverse Event|5|||
27806259|NCT01951105|54261646|FG002|Overall Study|Adverse Event|0|||
27806260|NCT01951105|54261644|FG000|Overall Study|Lost to Follow-up|0|||
27806261|NCT01951105|54261645|FG001|Overall Study|Lost to Follow-up|1|||
27806262|NCT01951105|54261646|FG002|Overall Study|Lost to Follow-up|0|||
27806263|NCT01951105|54261644|FG000|Overall Study|Protocol Violation|1|||
27806264|NCT01951105|54261645|FG001|Overall Study|Protocol Violation|1|||
27806265|NCT01951105|54261646|FG002|Overall Study|Protocol Violation|1|||
27806266|NCT01951105|54261644|FG000|Overall Study|Withdrawal by Subject|0|||
27806267|NCT01951105|54261645|FG001|Overall Study|Withdrawal by Subject|3|||
27806268|NCT01951105|54261646|FG002|Overall Study|Withdrawal by Subject|1|||
27806269|NCT01958918|54261662|FG000|Overall Study|Death|1|||
27806270|NCT01958918|54261663|FG001|Overall Study|Death|3|||
27806271|NCT01958918|54261662|FG000|Overall Study|Lost to Follow-up|4|||
27806272|NCT01958918|54261663|FG001|Overall Study|Lost to Follow-up|7|||
27806273|NCT01958918|54261662|FG000|Overall Study|Withdrawal by Subject|13|||
27806274|NCT01958918|54261663|FG001|Overall Study|Withdrawal by Subject|8|||
27806275|NCT01958918|54261662|FG000|Overall Study|Lack of Efficacy|13|||
27806276|NCT01958918|54261663|FG001|Overall Study|Lack of Efficacy|10|||
27806277|NCT01958918|54261662|FG000|Overall Study|Adverse Event|12|||
27806278|NCT01958918|54261663|FG001|Overall Study|Adverse Event|12|||
27806279|NCT01958918|54261662|FG000|Overall Study|administrative problems|0|||
27806280|NCT01958918|54261663|FG001|Overall Study|administrative problems|2|||
27806281|NCT01945489|54261671|FG000|Cycle 1|Adverse Event|2|||
27806282|NCT01945489|54261672|FG001|Cycle 1|Adverse Event|0|||
27806283|NCT01945489|54261671|FG000|Cycle 1|Lost to Follow-up|4|||
27806284|NCT01945489|54261672|FG001|Cycle 1|Lost to Follow-up|0|||
27806285|NCT01945489|54261671|FG000|Cycle 1|Personal Reasons|4|||
27806286|NCT01945489|54261672|FG001|Cycle 1|Personal Reasons|2|||
27806287|NCT01945489|54261671|FG000|Cycle 1|Protocol Violation|0|||
27806288|NCT01945489|54261672|FG001|Cycle 1|Protocol Violation|1|||
27806289|NCT01945489|54261671|FG000|Cycle 1|Other Miscellaneous Reasons|3|||
27806290|NCT01945489|54261672|FG001|Cycle 1|Other Miscellaneous Reasons|1|||
27806291|NCT01945489|54261671|FG000|Cycle 2|Adverse Event|1|||
27806292|NCT01945489|54261672|FG001|Cycle 2|Adverse Event|0|||
27806293|NCT01945489|54261671|FG000|Cycle 2|Lost to Follow-up|0|||
27806294|NCT01945489|54261672|FG001|Cycle 2|Lost to Follow-up|1|||
27806295|NCT01934894|54261681|FG000|Overall Study|Adverse Event|1|||
27806296|NCT01934894|54261682|FG001|Overall Study|Adverse Event|2|||
27806297|NCT01934894|54261681|FG000|Overall Study|Death|2|||
27806298|NCT01934894|54261682|FG001|Overall Study|Death|0|||
27806299|NCT01934894|54261681|FG000|Overall Study|Withdrawal by Subject|0|||
27806300|NCT01934894|54261682|FG001|Overall Study|Withdrawal by Subject|1|||
27806301|NCT01934894|54261681|FG000|Overall Study|Progressive Disease|3|||
27806302|NCT01934894|54261682|FG001|Overall Study|Progressive Disease|2|||
27806303|NCT01950169|54261694|FG000|Overall Study|Withdrawal by Subject|2|||
27806304|NCT01950169|54261695|FG001|Overall Study|Withdrawal by Subject|8|||
27806305|NCT01950169|54261696|FG002|Overall Study|Withdrawal by Subject|1|||
27806306|NCT01950169|54261694|FG000|Overall Study|Death|1|||
27806307|NCT01950169|54261695|FG001|Overall Study|Death|0|||
27806308|NCT01950169|54261696|FG002|Overall Study|Death|0|||
27806309|NCT01934504|54261709|FG000|Overall Study|Protocol Deviation|0|||
27806310|NCT01934504|54261710|FG001|Overall Study|Protocol Deviation|0|||
27806311|NCT01934504|54261711|FG002|Overall Study|Protocol Deviation|0|||
27806312|NCT01934504|54261712|FG003|Overall Study|Protocol Deviation|2|||
27806313|NCT01934504|54261709|FG000|Overall Study|Study Terminated by Sponsor|1|||
27806314|NCT01934504|54261710|FG001|Overall Study|Study Terminated by Sponsor|0|||
27806315|NCT01934504|54261711|FG002|Overall Study|Study Terminated by Sponsor|5|||
27806316|NCT01934504|54261712|FG003|Overall Study|Study Terminated by Sponsor|5|||
27806317|NCT01950013|54261725|FG000|Overall Study|Withdrawal by Subject|0|||
27806318|NCT01950013|54261726|FG001|Overall Study|Withdrawal by Subject|2|||
27806319|NCT01950013|54261727|FG002|Overall Study|Withdrawal by Subject|0|||
27806320|NCT01949155|54261737|FG000|Overall Study|Lost to Follow-up|1|||
27806321|NCT01949155|54261738|FG001|Overall Study|Lost to Follow-up|0|||
27806322|NCT01949155|54261737|FG000|Overall Study|Protocol Violation|1|||
27806323|NCT01949155|54261738|FG001|Overall Study|Protocol Violation|0|||
27806324|NCT01909466|54261745|FG000|Overall Study|Lost to Follow-up|5|||
27806325|NCT01909466|54261746|FG001|Overall Study|Lost to Follow-up|7|||
27806326|NCT01909466|54261745|FG000|Overall Study|Adverse Event|3|||
27806327|NCT01909466|54261746|FG001|Overall Study|Adverse Event|4|||
27806328|NCT01909466|54261745|FG000|Overall Study|Met Withdrawal Criteria|0|||
27806329|NCT01909466|54261746|FG001|Overall Study|Met Withdrawal Criteria|3|||
27806330|NCT01909466|54261745|FG000|Overall Study|Physician Decision|2|||
27806331|NCT01909466|54261746|FG001|Overall Study|Physician Decision|0|||
27806332|NCT01909466|54261745|FG000|Overall Study|Withdrawal by Subject|11|||
27806333|NCT01909466|54261746|FG001|Overall Study|Withdrawal by Subject|9|||
27806334|NCT01909466|54261745|FG000|Overall Study|Lack of Efficacy|1|||
27806335|NCT01909466|54261746|FG001|Overall Study|Lack of Efficacy|0|||
27806336|NCT01977625|54261750|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
27806337|NCT01977625|54261751|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
27806338|NCT01977625|54261750|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
27806339|NCT01977625|54261751|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
27806340|NCT01944631|54261761|FG000|Overall Study|Adverse Event|1|||
27806341|NCT01944631|54261762|FG001|Overall Study|Adverse Event|0|||
27806342|NCT01944631|54261761|FG000|Overall Study|Lost to Follow-up|3|||
27806343|NCT01944631|54261762|FG001|Overall Study|Lost to Follow-up|1|||
27806344|NCT01944631|54261761|FG000|Overall Study|Withdrawal by Subject|0|||
27806345|NCT01944631|54261762|FG001|Overall Study|Withdrawal by Subject|1|||
27806346|NCT01948063|54261770|FG000|Overall Study|Boston MCI halted research protocol|0|||
27806347|NCT01948063|54261771|FG001|Overall Study|Boston MCI halted research protocol|1|||
27806348|NCT01948063|54261770|FG000|Overall Study|Discovered an enrollment in other study|0|||
27806349|NCT01948063|54261771|FG001|Overall Study|Discovered an enrollment in other study|1|||
27806350|NCT01948063|54261770|FG000|Overall Study|Blood samples were accidentally thawed|1|||
27806351|NCT01948063|54261771|FG001|Overall Study|Blood samples were accidentally thawed|0|||
27806352|NCT01995071|54261789|FG000|Overall Study|Adverse Event|0|||
27806353|NCT01995071|54261790|FG001|Overall Study|Adverse Event|0|||
27806354|NCT01995071|54261791|FG002|Overall Study|Adverse Event|0|||
27806355|NCT01995071|54261792|FG003|Overall Study|Adverse Event|0|||
27806356|NCT01995071|54261793|FG004|Overall Study|Adverse Event|0|||
27806357|NCT01995071|54261794|FG005|Overall Study|Adverse Event|0|||
27806358|NCT01995071|54261795|FG006|Overall Study|Adverse Event|1|||
27806359|NCT01995071|54261796|FG007|Overall Study|Adverse Event|0|||
27806360|NCT01995071|54261797|FG008|Overall Study|Adverse Event|0|||
27806361|NCT01995071|54261798|FG009|Overall Study|Adverse Event|0|||
27806362|NCT01995071|54261799|FG010|Overall Study|Adverse Event|0|||
27806363|NCT01995071|54261800|FG011|Overall Study|Adverse Event|0|||
27806364|NCT01995071|54261789|FG000|Overall Study|Moved|0|||
27806365|NCT01995071|54261790|FG001|Overall Study|Moved|0|||
27806366|NCT01995071|54261791|FG002|Overall Study|Moved|1|||
27806367|NCT01995071|54261792|FG003|Overall Study|Moved|0|||
27806368|NCT01995071|54261793|FG004|Overall Study|Moved|1|||
27806369|NCT01995071|54261794|FG005|Overall Study|Moved|0|||
27806370|NCT01995071|54261795|FG006|Overall Study|Moved|0|||
27806371|NCT01995071|54261796|FG007|Overall Study|Moved|0|||
27806372|NCT01995071|54261797|FG008|Overall Study|Moved|0|||
27806373|NCT01995071|54261798|FG009|Overall Study|Moved|0|||
27806374|NCT01995071|54261799|FG010|Overall Study|Moved|1|||
27806375|NCT01995071|54261800|FG011|Overall Study|Moved|0|||
27806376|NCT01995071|54261789|FG000|Overall Study|Lost to Follow-up|1|||
27806377|NCT01995071|54261790|FG001|Overall Study|Lost to Follow-up|0|||
27806378|NCT01995071|54261791|FG002|Overall Study|Lost to Follow-up|0|||
27806379|NCT01995071|54261792|FG003|Overall Study|Lost to Follow-up|0|||
27806380|NCT01995071|54261793|FG004|Overall Study|Lost to Follow-up|0|||
27806381|NCT01995071|54261794|FG005|Overall Study|Lost to Follow-up|0|||
27806382|NCT01995071|54261795|FG006|Overall Study|Lost to Follow-up|0|||
27806383|NCT01995071|54261796|FG007|Overall Study|Lost to Follow-up|1|||
27806384|NCT01995071|54261797|FG008|Overall Study|Lost to Follow-up|1|||
27806385|NCT01995071|54261798|FG009|Overall Study|Lost to Follow-up|0|||
27806386|NCT01995071|54261799|FG010|Overall Study|Lost to Follow-up|0|||
27806387|NCT01995071|54261800|FG011|Overall Study|Lost to Follow-up|0|||
27806388|NCT01995071|54261789|FG000|Overall Study|Incarcerated|0|||
27806389|NCT01995071|54261790|FG001|Overall Study|Incarcerated|0|||
27806390|NCT01995071|54261791|FG002|Overall Study|Incarcerated|0|||
27806391|NCT01995071|54261792|FG003|Overall Study|Incarcerated|0|||
27806392|NCT01995071|54261793|FG004|Overall Study|Incarcerated|0|||
27806393|NCT01995071|54261794|FG005|Overall Study|Incarcerated|0|||
27806394|NCT01995071|54261795|FG006|Overall Study|Incarcerated|0|||
27806395|NCT01995071|54261796|FG007|Overall Study|Incarcerated|1|||
27806396|NCT01995071|54261797|FG008|Overall Study|Incarcerated|0|||
27806397|NCT01995071|54261798|FG009|Overall Study|Incarcerated|0|||
27806398|NCT01995071|54261799|FG010|Overall Study|Incarcerated|0|||
27806399|NCT01995071|54261800|FG011|Overall Study|Incarcerated|0|||
27806400|NCT01994837|54261832|FG000|Overall Study|Progressive disease per protocol|23|||
27806401|NCT01994837|54261832|FG000|Overall Study|Adv event related to progressive disease|3|||
27806402|NCT01994837|54261832|FG000|Overall Study|Fatal progressive disease|2|||
27806403|NCT01994837|54261832|FG000|Overall Study|Adverse event not related to progression|1|||
28029667|NCT00113269|54688186|FG000|Overall Study|Protocol Violation|1|||
27939627|NCT01049217|54595857|FG001|Overall Study|Lack of Efficacy|1|||
27806404|NCT01994837|54261832|FG000|Overall Study|Chose palliative care|1|||
27806405|NCT01994837|54261832|FG000|Overall Study|Proceeded to transplant|1|||
27806406|NCT01994837|54261832|FG000|Overall Study|Removed from study due to no response|1|||
27806407|NCT02010593|54261838|FG000|Overall Study|Lost to Follow-up|1|||
27806408|NCT02010593|54261839|FG001|Overall Study|Lost to Follow-up|0|||
27806409|NCT02010593|54261838|FG000|Overall Study|Physician Decision|1|||
27806410|NCT02010593|54261839|FG001|Overall Study|Physician Decision|0|||
27806411|NCT02010593|54261838|FG000|Overall Study|Unable to adhere to visit schedule|0|||
27806412|NCT02010593|54261839|FG001|Overall Study|Unable to adhere to visit schedule|2|||
27806413|NCT01994291|54261848|FG000|Overall Study|Adverse Event|4|||
27806414|NCT01994291|54261849|FG001|Overall Study|Adverse Event|1|||
27806415|NCT01994291|54261850|FG002|Overall Study|Adverse Event|3|||
27806416|NCT01994291|54261848|FG000|Overall Study|Lost to Follow-up|1|||
27806417|NCT01994291|54261849|FG001|Overall Study|Lost to Follow-up|1|||
27806418|NCT01994291|54261850|FG002|Overall Study|Lost to Follow-up|0|||
27806419|NCT01994291|54261848|FG000|Overall Study|Does not meet entrance criteria|1|||
27806420|NCT01994291|54261849|FG001|Overall Study|Does not meet entrance criteria|0|||
27806421|NCT01994291|54261850|FG002|Overall Study|Does not meet entrance criteria|0|||
27806422|NCT01994291|54261848|FG000|Overall Study|Medication error without associated AE|1|||
27806423|NCT01994291|54261849|FG001|Overall Study|Medication error without associated AE|0|||
27806424|NCT01994291|54261850|FG002|Overall Study|Medication error without associated AE|1|||
27806425|NCT01994291|54261848|FG000|Overall Study|Protocol Violation|1|||
27806426|NCT01994291|54261849|FG001|Overall Study|Protocol Violation|0|||
27806427|NCT01994291|54261850|FG002|Overall Study|Protocol Violation|0|||
27806428|NCT01994291|54261848|FG000|Overall Study|Withdrawal by Subject|6|||
27806429|NCT01994291|54261849|FG001|Overall Study|Withdrawal by Subject|3|||
27806430|NCT01994291|54261850|FG002|Overall Study|Withdrawal by Subject|5|||
27806431|NCT01994291|54261848|FG000|Overall Study|Other|1|||
27806432|NCT01994291|54261849|FG001|Overall Study|Other|2|||
27806433|NCT01994291|54261850|FG002|Overall Study|Other|0|||
27806434|NCT02094677|54261861|FG000|Overall Study|Screening|3|||
27806435|NCT02094677|54261862|FG001|Overall Study|Screening|1|||
27806436|NCT01993823|54261877|FG000|Overall Study|Requested by the patient|6|||
27806437|NCT01993823|54261878|FG001|Overall Study|Requested by the patient|11|||
27806438|NCT01993823|54261877|FG000|Overall Study|Protocol Violation|0|||
27806439|NCT01993823|54261878|FG001|Overall Study|Protocol Violation|1|||
27806440|NCT01993823|54261877|FG000|Overall Study|Lost to Follow-up|1|||
27806441|NCT01993823|54261878|FG001|Overall Study|Lost to Follow-up|4|||
27806442|NCT01993667|54261886|FG000|Overall Study|Insufficient data to analyze|16|||
27806443|NCT01993667|54261887|FG001|Overall Study|Insufficient data to analyze|16|||
27806444|NCT01993667|54261886|FG000|Overall Study|Insufficient altitude reached|3|||
27806445|NCT01993667|54261887|FG001|Overall Study|Insufficient altitude reached|1|||
27806446|NCT01993667|54261886|FG000|Overall Study|Lost to Follow-up|2|||
27806447|NCT01993667|54261887|FG001|Overall Study|Lost to Follow-up|2|||
27806448|NCT01992107|54261896|FG000|Overall Study|Administrative reasons|2|||
27806449|NCT01992107|54261897|FG001|Overall Study|Administrative reasons|0|||
27806450|NCT01992107|54261898|FG002|Overall Study|Administrative reasons|0|||
27806451|NCT01992107|54261896|FG000|Overall Study|Adverse Event|0|||
27806452|NCT01992107|54261897|FG001|Overall Study|Adverse Event|1|||
27806453|NCT01992107|54261898|FG002|Overall Study|Adverse Event|0|||
28029668|NCT00113269|54688187|FG001|Overall Study|Protocol Violation|0|||
27806454|NCT01992107|54261896|FG000|Overall Study|Lost to Follow-up|46|||
27806455|NCT01992107|54261897|FG001|Overall Study|Lost to Follow-up|22|||
27806456|NCT01992107|54261898|FG002|Overall Study|Lost to Follow-up|26|||
27806457|NCT01992107|54261896|FG000|Overall Study|noncompliance and were unavailable|7|||
27806458|NCT01992107|54261897|FG001|Overall Study|noncompliance and were unavailable|3|||
27806459|NCT01992107|54261898|FG002|Overall Study|noncompliance and were unavailable|2|||
27806460|NCT01992107|54261896|FG000|Overall Study|Withdrawal by Subject|13|||
27806461|NCT01992107|54261897|FG001|Overall Study|Withdrawal by Subject|7|||
27806462|NCT01992107|54261898|FG002|Overall Study|Withdrawal by Subject|8|||
27806463|NCT01934192|54261927|FG000|Overall Study|Protocol Violation|0|||
27806464|NCT01934192|54261928|FG001|Overall Study|Protocol Violation|0|||
27806465|NCT01934192|54261929|FG002|Overall Study|Protocol Violation|0|||
27806466|NCT01934192|54261930|FG003|Overall Study|Protocol Violation|1|||
27806467|NCT01934192|54261927|FG000|Overall Study|Other: reached stopping criteria|6|||
27806468|NCT01934192|54261928|FG001|Overall Study|Other: reached stopping criteria|5|||
27806469|NCT01934192|54261929|FG002|Overall Study|Other: reached stopping criteria|1|||
27806470|NCT01934192|54261930|FG003|Overall Study|Other: reached stopping criteria|0|||
27806471|NCT01934192|54261927|FG000|Overall Study|Physician Decision|3|||
27806472|NCT01934192|54261928|FG001|Overall Study|Physician Decision|2|||
27806473|NCT01934192|54261929|FG002|Overall Study|Physician Decision|0|||
27806474|NCT01934192|54261930|FG003|Overall Study|Physician Decision|0|||
27806475|NCT01933880|54261953|FG000|Overall Study|Withdrawal by Subject|5|||
27806476|NCT01933880|54261954|FG001|Overall Study|Withdrawal by Subject|0|||
27806477|NCT01933880|54261953|FG000|Overall Study|Lack of Efficacy|1|||
27806478|NCT01933880|54261954|FG001|Overall Study|Lack of Efficacy|0|||
27806479|NCT01933880|54261953|FG000|Overall Study|Concomitant medication Interference|0|||
27806480|NCT01933880|54261954|FG001|Overall Study|Concomitant medication Interference|1|||
27806481|NCT01933880|54261953|FG000|Overall Study|Followup exceeded 4 days to visit window|19|||
27806482|NCT01933880|54261954|FG001|Overall Study|Followup exceeded 4 days to visit window|0|||
27806483|NCT01933880|54261953|FG000|Overall Study|Other|4|||
27806484|NCT01933880|54261954|FG001|Overall Study|Other|0|||
27806485|NCT01933880|54261953|FG000|Overall Study|Protocol Violation|1|||
27806486|NCT01933880|54261954|FG001|Overall Study|Protocol Violation|0|||
27806487|NCT02008877|54261965|FG000|Overall Study|Inevaluable|0|||
27806488|NCT02008877|54261966|FG001|Overall Study|Inevaluable|1|||
27806489|NCT02008877|54261967|FG002|Overall Study|Inevaluable|0|||
27806490|NCT01933334|54261978|FG000|Overall Study|Adverse Event|5|||
27806491|NCT01933334|54261979|FG001|Overall Study|Adverse Event|1|||
27806492|NCT01933334|54261978|FG000|Overall Study|Withdrawal by Subject|0|||
27806493|NCT01933334|54261979|FG001|Overall Study|Withdrawal by Subject|1|||
27806494|NCT01908140|54261987|FG000|Overall Study|Other or Progressive Disease|5|||
27806495|NCT01908140|54261988|FG001|Overall Study|Other or Progressive Disease|12|||
27806496|NCT01908140|54261987|FG000|Overall Study|Lack of Efficacy|7|||
27806497|NCT01908140|54261988|FG001|Overall Study|Lack of Efficacy|5|||
27806498|NCT01908140|54261987|FG000|Overall Study|Withdrawal by Subject|23|||
27806499|NCT01908140|54261988|FG001|Overall Study|Withdrawal by Subject|24|||
27806500|NCT01908140|54261987|FG000|Overall Study|Lost to Follow-up|1|||
27806501|NCT01908140|54261988|FG001|Overall Study|Lost to Follow-up|6|||
27806502|NCT01908140|54261987|FG000|Overall Study|Protocol Violation|8|||
27806503|NCT01908140|54261988|FG001|Overall Study|Protocol Violation|9|||
27806504|NCT01908140|54261987|FG000|Overall Study|Adverse Event|22|||
27806505|NCT01908140|54261988|FG001|Overall Study|Adverse Event|23|||
27806506|NCT02008565|54261998|FG000|Overall Study|Protocol Violation|1|||
27806507|NCT02008565|54261999|FG001|Overall Study|Protocol Violation|1|||
27806508|NCT02008565|54262000|FG002|Overall Study|Protocol Violation|2|||
27806509|NCT02008565|54262001|FG003|Overall Study|Protocol Violation|0|||
27806510|NCT01907906|54262015|FG000|Overall Study|Withdrawal by Subject|1|||
27806511|NCT01907906|54262016|FG001|Overall Study|Withdrawal by Subject|0|||
27806512|NCT01907906|54262015|FG000|Overall Study|Physician Decision|3|||
27806513|NCT01907906|54262016|FG001|Overall Study|Physician Decision|1|||
27806514|NCT01907828|54262026|FG000|Overall Study|Exclusion criteria not met|0|||
27806515|NCT01907828|54262027|FG001|Overall Study|Exclusion criteria not met|1|||
27806516|NCT01907828|54262026|FG000|Overall Study|Withdrawal by Subject|3|||
27806517|NCT01907828|54262027|FG001|Overall Study|Withdrawal by Subject|4|||
27806518|NCT01907828|54262026|FG000|Overall Study|Lost to Follow-up|3|||
27806519|NCT01907828|54262027|FG001|Overall Study|Lost to Follow-up|0|||
27806520|NCT01907828|54262026|FG000|Overall Study|Participant refused 24-month follow-up|1|||
27806521|NCT01907828|54262027|FG001|Overall Study|Participant refused 24-month follow-up|0|||
27806522|NCT01907828|54262026|FG000|Overall Study|Participant met exclusion criteria|0|||
27806523|NCT01907828|54262027|FG001|Overall Study|Participant met exclusion criteria|1|||
27806524|NCT01907516|54262035|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|5|||
27806525|NCT01907516|54262036|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|9|||
27806526|NCT01907516|54262035|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
27806527|NCT01907516|54262036|FG001|First Intervention (3 Weeks)|Lost to Follow-up|3|||
27806528|NCT01907516|54262035|FG000|First Intervention (3 Weeks)|Delivered before second arm|3|||
27806529|NCT01907516|54262036|FG001|First Intervention (3 Weeks)|Delivered before second arm|4|||
27806530|NCT01907516|54262035|FG000|First Intervention (3 Weeks)|Developed DKA during study|1|||
27806531|NCT01907516|54262036|FG001|First Intervention (3 Weeks)|Developed DKA during study|0|||
27806532|NCT01931462|54262043|FG000|Overall Study|Withdrawal by Subject|1|||
27806533|NCT01931150|54262049|FG000|Overall Study|Withdrawal by Subject|1|||
27806534|NCT01931150|54262050|FG001|Overall Study|Withdrawal by Subject|2|||
27806535|NCT01930214|54262059|FG000|Overall Study|Death|4|||
27806536|NCT01930214|54262060|FG001|Overall Study|Death|4|||
27806537|NCT01930214|54262061|FG002|Overall Study|Death|11|||
27806538|NCT01930214|54262059|FG000|Overall Study|Lost to Follow-up|12|||
27806539|NCT01930214|54262060|FG001|Overall Study|Lost to Follow-up|13|||
27806540|NCT01930214|54262061|FG002|Overall Study|Lost to Follow-up|12|||
27806541|NCT01930214|54262059|FG000|Overall Study|Voluntary withdrawal of infomed consent|2|||
27806542|NCT01930214|54262060|FG001|Overall Study|Voluntary withdrawal of infomed consent|4|||
27806543|NCT01930214|54262061|FG002|Overall Study|Voluntary withdrawal of infomed consent|2|||
27806544|NCT01930214|54262059|FG000|Overall Study|Physician Decision|2|||
27806545|NCT01930214|54262060|FG001|Overall Study|Physician Decision|0|||
27806546|NCT01930214|54262061|FG002|Overall Study|Physician Decision|0|||
27806547|NCT01958294|54262069|FG000|Overall Study|Clinical Circumstances|2|||
27806548|NCT01906346|54262073|FG000|Overall Study|AEs|1|||
27806549|NCT01958060|54262085|FG000|Overall Study|Not treated|2|||
27806550|NCT01958060|54262086|FG001|Overall Study|Not treated|0|||
27806551|NCT01958060|54262087|FG002|Overall Study|Not treated|0|||
27806552|NCT01958060|54262088|FG003|Overall Study|Not treated|0|||
27843573|NCT01441063|54332993|FG000|Tocilizumab Alone|Required AZT/VGC addition|3|||
27806553|NCT01958060|54262089|FG004|Overall Study|Not treated|1|||
27806554|NCT01958060|54262090|FG005|Overall Study|Not treated|0|||
27806555|NCT01929980|54262109|FG000|Overall Study|Physician Decision|1|||
27806556|NCT01363076|54262115|FG000|Overall Study|Withdrawal by Subject|0|||
27806557|NCT01363076|54262116|FG001|Overall Study|Withdrawal by Subject|1|||
27806558|NCT01929044|54262124|FG000|Overall Study|Adverse Event|1|||
27806559|NCT01929044|54262125|FG001|Overall Study|Adverse Event|0|||
27806560|NCT01929044|54262124|FG000|Overall Study|Protocol Violation|9|||
27806561|NCT01929044|54262125|FG001|Overall Study|Protocol Violation|14|||
27806562|NCT01929044|54262124|FG000|Overall Study|Not Treated|1|||
27806563|NCT01929044|54262125|FG001|Overall Study|Not Treated|3|||
27806564|NCT01903460|54262135|FG000|Overall Study|Adverse Event|0|||
27806565|NCT01903460|54262136|FG001|Overall Study|Adverse Event|0|||
27806566|NCT01903460|54262137|FG002|Overall Study|Adverse Event|0|||
27806567|NCT01903460|54262138|FG003|Overall Study|Adverse Event|1|||
27806568|NCT01957202|54262147|FG000|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
27806569|NCT01957202|54262148|FG001|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
27806570|NCT01957202|54262149|FG002|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
27806571|NCT01957202|54262150|FG003|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
27806572|NCT01957202|54262151|FG004|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
27806573|NCT01957202|54262152|FG005|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
27806574|NCT01957202|54262153|FG006|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
27806575|NCT01957202|54262154|FG007|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
27806576|NCT01957202|54262155|FG008|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
27806577|NCT01957202|54262156|FG009|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
27806578|NCT01957202|54262157|FG010|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
27806579|NCT01957202|54262158|FG011|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
27806580|NCT01957202|54262159|FG012|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
27806581|NCT01957202|54262160|FG013|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
27806582|NCT01957202|54262161|FG014|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
27806583|NCT01957202|54262162|FG015|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
27806584|NCT01957202|54262163|FG016|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
27806585|NCT01957202|54262164|FG017|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
27806586|NCT01957202|54262147|FG000|Treatment Period 3 (8 Days)|Adverse Event|0|||
27806587|NCT01957202|54262148|FG001|Treatment Period 3 (8 Days)|Adverse Event|0|||
27806588|NCT01957202|54262149|FG002|Treatment Period 3 (8 Days)|Adverse Event|0|||
27806589|NCT01957202|54262150|FG003|Treatment Period 3 (8 Days)|Adverse Event|0|||
27806590|NCT01957202|54262151|FG004|Treatment Period 3 (8 Days)|Adverse Event|0|||
27806591|NCT01957202|54262152|FG005|Treatment Period 3 (8 Days)|Adverse Event|0|||
27806592|NCT01957202|54262153|FG006|Treatment Period 3 (8 Days)|Adverse Event|0|||
27806593|NCT01957202|54262154|FG007|Treatment Period 3 (8 Days)|Adverse Event|0|||
27806594|NCT01957202|54262155|FG008|Treatment Period 3 (8 Days)|Adverse Event|0|||
27806595|NCT01957202|54262156|FG009|Treatment Period 3 (8 Days)|Adverse Event|0|||
27806596|NCT01957202|54262157|FG010|Treatment Period 3 (8 Days)|Adverse Event|0|||
27806597|NCT01957202|54262158|FG011|Treatment Period 3 (8 Days)|Adverse Event|0|||
27806598|NCT01957202|54262159|FG012|Treatment Period 3 (8 Days)|Adverse Event|0|||
27806599|NCT01957202|54262160|FG013|Treatment Period 3 (8 Days)|Adverse Event|0|||
27806600|NCT01957202|54262161|FG014|Treatment Period 3 (8 Days)|Adverse Event|0|||
27806601|NCT01957202|54262162|FG015|Treatment Period 3 (8 Days)|Adverse Event|0|||
27806602|NCT01957202|54262163|FG016|Treatment Period 3 (8 Days)|Adverse Event|1|||
27806603|NCT01957202|54262164|FG017|Treatment Period 3 (8 Days)|Adverse Event|0|||
27806604|NCT01616654|54262179|FG000|Overall Study|Lack of Efficacy|1|||
27806605|NCT01616654|54262180|FG001|Overall Study|Lack of Efficacy|0|||
27806606|NCT01616654|54262181|FG002|Overall Study|Lack of Efficacy|0|||
27806607|NCT01616654|54262182|FG003|Overall Study|Lack of Efficacy|0|||
27806608|NCT01616654|54262183|FG004|Overall Study|Lack of Efficacy|1|||
27806609|NCT01616654|54262179|FG000|Overall Study|Adverse Event|0|||
27806610|NCT01616654|54262180|FG001|Overall Study|Adverse Event|1|||
27806611|NCT01616654|54262181|FG002|Overall Study|Adverse Event|2|||
27806612|NCT01616654|54262182|FG003|Overall Study|Adverse Event|1|||
27806613|NCT01616654|54262183|FG004|Overall Study|Adverse Event|0|||
27806614|NCT01616654|54262179|FG000|Overall Study|Withdrawal by Subject|2|||
27806615|NCT01616654|54262180|FG001|Overall Study|Withdrawal by Subject|2|||
27806616|NCT01616654|54262181|FG002|Overall Study|Withdrawal by Subject|3|||
27806617|NCT01616654|54262182|FG003|Overall Study|Withdrawal by Subject|1|||
27806618|NCT01616654|54262183|FG004|Overall Study|Withdrawal by Subject|5|||
27806619|NCT01616654|54262179|FG000|Overall Study|Protocol Violation|0|||
27806620|NCT01616654|54262180|FG001|Overall Study|Protocol Violation|5|||
27806621|NCT01616654|54262181|FG002|Overall Study|Protocol Violation|2|||
27806622|NCT01616654|54262182|FG003|Overall Study|Protocol Violation|4|||
27806623|NCT01616654|54262183|FG004|Overall Study|Protocol Violation|4|||
27806624|NCT01616654|54262179|FG000|Overall Study|Lost to Follow-up|1|||
27806625|NCT01616654|54262180|FG001|Overall Study|Lost to Follow-up|0|||
27806626|NCT01616654|54262181|FG002|Overall Study|Lost to Follow-up|3|||
27806627|NCT01616654|54262182|FG003|Overall Study|Lost to Follow-up|2|||
27806628|NCT01616654|54262183|FG004|Overall Study|Lost to Follow-up|1|||
27806629|NCT01616654|54262179|FG000|Overall Study|Pregnancy|1|||
27806630|NCT01616654|54262180|FG001|Overall Study|Pregnancy|0|||
27806631|NCT01616654|54262181|FG002|Overall Study|Pregnancy|0|||
27806632|NCT01616654|54262182|FG003|Overall Study|Pregnancy|0|||
27806633|NCT01616654|54262183|FG004|Overall Study|Pregnancy|1|||
27806634|NCT01902290|54262198|FG000|Overall Study|Withdrawal by Subject|19|||
27806635|NCT01902290|54262199|FG001|Overall Study|Withdrawal by Subject|27|||
27806636|NCT01902290|54262198|FG000|Overall Study|Lost to Follow-up|2|||
27806637|NCT01902290|54262199|FG001|Overall Study|Lost to Follow-up|2|||
27806638|NCT01902290|54262198|FG000|Overall Study|Death|1|||
27806639|NCT01902290|54262199|FG001|Overall Study|Death|0|||
27806640|NCT01902290|54262198|FG000|Overall Study|Sponsor Decision|26|||
27806641|NCT01902290|54262199|FG001|Overall Study|Sponsor Decision|24|||
27806642|NCT01927562|54262206|FG000|Overall Study|Lost to Follow-up|30|||
27806643|NCT01927562|54262206|FG000|Overall Study|Withdrawal by Subject|3|||
27806644|NCT01927562|54262206|FG000|Overall Study|Physician Decision|5|||
27806645|NCT01467466|54262214|FG000|Overall Study|Withdrawal by Subject|15|||
27806646|NCT01467466|54262215|FG001|Overall Study|Withdrawal by Subject|18|||
27806647|NCT01467466|54262216|FG002|Overall Study|Withdrawal by Subject|13|||
27806648|NCT01467466|54262217|FG003|Overall Study|Withdrawal by Subject|11|||
27806649|NCT01467466|54262214|FG000|Overall Study|Revoked Consent Prior To Procedure|10|||
27806650|NCT01467466|54262215|FG001|Overall Study|Revoked Consent Prior To Procedure|9|||
27806651|NCT01467466|54262216|FG002|Overall Study|Revoked Consent Prior To Procedure|15|||
27806652|NCT01467466|54262217|FG003|Overall Study|Revoked Consent Prior To Procedure|5|||
27806653|NCT01467466|54262214|FG000|Overall Study|Procedure Cancelled|46|||
27806654|NCT01467466|54262215|FG001|Overall Study|Procedure Cancelled|45|||
27806655|NCT01467466|54262216|FG002|Overall Study|Procedure Cancelled|25|||
27806656|NCT01467466|54262217|FG003|Overall Study|Procedure Cancelled|29|||
27806657|NCT01467466|54262214|FG000|Overall Study|No Endpoint Blood Draw|38|||
27806658|NCT01467466|54262215|FG001|Overall Study|No Endpoint Blood Draw|32|||
27806659|NCT01467466|54262216|FG002|Overall Study|No Endpoint Blood Draw|51|||
27806660|NCT01467466|54262217|FG003|Overall Study|No Endpoint Blood Draw|43|||
27806661|NCT01441180|54262230|FG000|Overall Study|Lost to Follow-up|1|||
27806662|NCT01441180|54262231|FG001|Overall Study|Lost to Follow-up|1|||
27806663|NCT01441180|54262232|FG002|Overall Study|Lost to Follow-up|1|||
27806664|NCT01441180|54262230|FG000|Overall Study|Discontinued|0|||
27806665|NCT01441180|54262231|FG001|Overall Study|Discontinued|0|||
27806666|NCT01441180|54262232|FG002|Overall Study|Discontinued|2|||
27806667|NCT01441102|54262243|FG000|Overall Study|Adverse Event|1|||
27806668|NCT01441102|54262243|FG000|Overall Study|Withdrawal by Subject|2|||
27806669|NCT01467076|54262250|FG000|Overall Study|Lost to Follow-up|1|||
27806670|NCT01467076|54262251|FG001|Overall Study|Lost to Follow-up|0|||
27806671|NCT01467076|54262252|FG002|Overall Study|Lost to Follow-up|0|||
27806672|NCT01466062|54262260|FG000|Overall Study|Adverse Event|1|||
27806673|NCT01466062|54262260|FG000|Overall Study|Withdrawal by Subject|1|||
27806674|NCT01435018|54262267|FG000|Overall Study|Death|37|||
27806675|NCT01435018|54262268|FG001|Overall Study|Death|18|||
27806676|NCT01435018|54262269|FG002|Overall Study|Death|25|||
27806677|NCT01435018|54262267|FG000|Overall Study|Site is closing|4|||
27806678|NCT01435018|54262268|FG001|Overall Study|Site is closing|9|||
27806679|NCT01435018|54262269|FG002|Overall Study|Site is closing|7|||
27806680|NCT01435018|54262267|FG000|Overall Study|Withdrew consent|0|||
27806681|NCT01435018|54262268|FG001|Overall Study|Withdrew consent|3|||
27806682|NCT01435018|54262269|FG002|Overall Study|Withdrew consent|1|||
27806683|NCT01435018|54262267|FG000|Overall Study|Not willing to adhere to requirements|0|||
27806684|NCT01435018|54262268|FG001|Overall Study|Not willing to adhere to requirements|2|||
27806685|NCT01435018|54262269|FG002|Overall Study|Not willing to adhere to requirements|3|||
27806686|NCT01435018|54262267|FG000|Overall Study|Not able to get to clinic|2|||
27806687|NCT01435018|54262268|FG001|Overall Study|Not able to get to clinic|0|||
27806688|NCT01435018|54262269|FG002|Overall Study|Not able to get to clinic|2|||
27806689|NCT01435018|54262267|FG000|Overall Study|Severe debilitation, unable to continue|0|||
27806690|NCT01435018|54262268|FG001|Overall Study|Severe debilitation, unable to continue|0|||
27806691|NCT01435018|54262269|FG002|Overall Study|Severe debilitation, unable to continue|1|||
27806692|NCT01435018|54262267|FG000|Overall Study|Unable to contact participant/parent|1|||
27843574|NCT01441063|54332993|FG000|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1|||
27843575|NCT01436071|54333002|FG000|Overall Study|Adverse Event|1|||
27843576|NCT01436071|54333003|FG001|Overall Study|Adverse Event|0|||
27843577|NCT01436071|54333002|FG000|Overall Study|Lack of Efficacy|16|||
28029669|NCT00113269|54688188|FG002|Overall Study|Protocol Violation|4|||
28029670|NCT00113269|54688189|FG003|Overall Study|Protocol Violation|2|||
27806693|NCT01435018|54262268|FG001|Overall Study|Unable to contact participant/parent|1|||
27806694|NCT01435018|54262269|FG002|Overall Study|Unable to contact participant/parent|1|||
28029671|NCT00113269|54688186|FG000|Overall Study|Lost to Follow-up|2|||
27806695|NCT01435018|54262267|FG000|Overall Study|Enrollment Violation|0|||
27806696|NCT01435018|54262268|FG001|Overall Study|Enrollment Violation|1|||
27806697|NCT01435018|54262269|FG002|Overall Study|Enrollment Violation|0|||
27806698|NCT01435018|54262267|FG000|Overall Study|Never started chemotherapy|3|||
27806699|NCT01435018|54262268|FG001|Overall Study|Never started chemotherapy|0|||
27806700|NCT01435018|54262269|FG002|Overall Study|Never started chemotherapy|1|||
27806701|NCT01419184|54262281|FG000|Overall Study|Site data not available|3|||
28029672|NCT00113269|54688187|FG001|Overall Study|Lost to Follow-up|3|||
27806702|NCT01419184|54262282|FG001|Overall Study|Site data not available|2|||
27806703|NCT01419184|54262281|FG000|Overall Study|No IRLOS-No in-patient end date reported|3|||
27806704|NCT01419184|54262282|FG001|Overall Study|No IRLOS-No in-patient end date reported|6|||
27806705|NCT01419184|54262281|FG000|Overall Study|No IRLOS-randomized, not treated|2|||
27806706|NCT01419184|54262282|FG001|Overall Study|No IRLOS-randomized, not treated|4|||
27806707|NCT01419184|54262281|FG000|Overall Study|No IRLOS-non trial antibiotic used|1|||
27806708|NCT01419184|54262282|FG001|Overall Study|No IRLOS-non trial antibiotic used|2|||
27806709|NCT01419184|54262281|FG000|Overall Study|No IRLOS-No adverse event treatment date|0|||
27806710|NCT01419184|54262282|FG001|Overall Study|No IRLOS-No adverse event treatment date|1|||
27806711|NCT01419184|54262281|FG000|Overall Study|Participant randomized, not treated|1|||
27806712|NCT01419184|54262282|FG001|Overall Study|Participant randomized, not treated|0|||
27806713|NCT01417234|54262288|FG000|Overall Study|Subject non-compliant|3|||
27806714|NCT01417156|54262292|FG000|Overall Study|Adverse Event|12|||
27806715|NCT01417156|54262292|FG000|Overall Study|Protocol Violation|2|||
27806716|NCT01417078|54262296|FG000|Overall Study|Withdrawal by Subject|1|||
27806717|NCT01954394|54262304|FG000|Overall Study|Enrolled but not treated|1|||
27806718|NCT01954394|54262305|FG001|Overall Study|Enrolled but not treated|0|||
27806719|NCT01954394|54262304|FG000|Overall Study|Adverse Event|10|||
27806720|NCT01954394|54262305|FG001|Overall Study|Adverse Event|23|||
27806721|NCT01954394|54262304|FG000|Overall Study|Poor compliance to protocol|7|||
27806722|NCT01954394|54262305|FG001|Overall Study|Poor compliance to protocol|7|||
27806723|NCT01954394|54262304|FG000|Overall Study|Participant Moved|0|||
27806724|NCT01954394|54262305|FG001|Overall Study|Participant Moved|4|||
27806725|NCT01954394|54262304|FG000|Overall Study|Related to Study Drug administration|2|||
27806726|NCT01954394|54262305|FG001|Overall Study|Related to Study Drug administration|2|||
27806727|NCT01954394|54262304|FG000|Overall Study|Other than specified above|10|||
27806728|NCT01954394|54262305|FG001|Overall Study|Other than specified above|21|||
27806729|NCT01464424|54262313|FG000|Period 1, First 6 Weeks|Adverse Event|0|||
27806730|NCT01464424|54262314|FG001|Period 1, First 6 Weeks|Adverse Event|1|||
27806731|NCT01902134|54262326|FG000|Overall Study|Adverse Event|3|||
27806732|NCT01902134|54262327|FG001|Overall Study|Adverse Event|1|||
27806733|NCT01902134|54262328|FG002|Overall Study|Adverse Event|2|||
27806734|NCT01902134|54262329|FG003|Overall Study|Adverse Event|1|||
27806735|NCT01902134|54262330|FG004|Overall Study|Adverse Event|1|||
27806736|NCT01902134|54262331|FG005|Overall Study|Adverse Event|3|||
27806737|NCT01902134|54262326|FG000|Overall Study|Lack of Efficacy|0|||
27806738|NCT01902134|54262327|FG001|Overall Study|Lack of Efficacy|0|||
27806739|NCT01902134|54262328|FG002|Overall Study|Lack of Efficacy|2|||
27806740|NCT01902134|54262329|FG003|Overall Study|Lack of Efficacy|0|||
27806741|NCT01902134|54262330|FG004|Overall Study|Lack of Efficacy|0|||
27806742|NCT01902134|54262331|FG005|Overall Study|Lack of Efficacy|1|||
27806743|NCT01902134|54262326|FG000|Overall Study|Physician Decision|0|||
27806744|NCT01902134|54262327|FG001|Overall Study|Physician Decision|1|||
27806745|NCT01902134|54262328|FG002|Overall Study|Physician Decision|0|||
27806746|NCT01902134|54262329|FG003|Overall Study|Physician Decision|0|||
27806747|NCT01902134|54262330|FG004|Overall Study|Physician Decision|0|||
27806748|NCT01902134|54262331|FG005|Overall Study|Physician Decision|0|||
27806749|NCT01902134|54262326|FG000|Overall Study|Protocol Violation|0|||
27806750|NCT01902134|54262327|FG001|Overall Study|Protocol Violation|0|||
27806751|NCT01902134|54262328|FG002|Overall Study|Protocol Violation|0|||
27806752|NCT01902134|54262329|FG003|Overall Study|Protocol Violation|0|||
27806753|NCT01902134|54262330|FG004|Overall Study|Protocol Violation|0|||
27806754|NCT01902134|54262331|FG005|Overall Study|Protocol Violation|1|||
27806755|NCT01902134|54262326|FG000|Overall Study|Withdrawal by Subject|4|||
27806756|NCT01902134|54262327|FG001|Overall Study|Withdrawal by Subject|8|||
27806757|NCT01902134|54262328|FG002|Overall Study|Withdrawal by Subject|9|||
27806758|NCT01902134|54262329|FG003|Overall Study|Withdrawal by Subject|1|||
27806759|NCT01902134|54262330|FG004|Overall Study|Withdrawal by Subject|5|||
27806760|NCT01902134|54262331|FG005|Overall Study|Withdrawal by Subject|4|||
27806761|NCT01902134|54262326|FG000|Overall Study|no compliance|1|||
27806762|NCT01902134|54262327|FG001|Overall Study|no compliance|0|||
27806763|NCT01902134|54262328|FG002|Overall Study|no compliance|0|||
27806764|NCT01902134|54262329|FG003|Overall Study|no compliance|0|||
27806765|NCT01902134|54262330|FG004|Overall Study|no compliance|0|||
27806766|NCT01902134|54262331|FG005|Overall Study|no compliance|0|||
27939628|NCT01049217|54595856|FG000|Overall Study|Lost to Follow-up|3|||
27806767|NCT01902134|54262326|FG000|Overall Study|Other|0|||
27806768|NCT01902134|54262327|FG001|Overall Study|Other|1|||
27806769|NCT01902134|54262328|FG002|Overall Study|Other|2|||
27806770|NCT01902134|54262329|FG003|Overall Study|Other|0|||
27806771|NCT01902134|54262330|FG004|Overall Study|Other|1|||
27806772|NCT01902134|54262331|FG005|Overall Study|Other|0|||
27806773|NCT01954082|54262349|FG000|Overall Study|Study Suspension|42|||
27806774|NCT01954082|54262350|FG001|Overall Study|Study Suspension|36|||
27806775|NCT01954082|54262349|FG000|Overall Study|Adverse Event|10|||
27806776|NCT01954082|54262350|FG001|Overall Study|Adverse Event|4|||
27806777|NCT01954082|54262349|FG000|Overall Study|Intolerance|0|||
27806778|NCT01954082|54262350|FG001|Overall Study|Intolerance|1|||
27806779|NCT01954082|54262349|FG000|Overall Study|Non-compliance|6|||
27806780|NCT01954082|54262350|FG001|Overall Study|Non-compliance|4|||
27806781|NCT01954082|54262349|FG000|Overall Study|Physician Decision|2|||
27806782|NCT01954082|54262350|FG001|Overall Study|Physician Decision|0|||
27806783|NCT01954082|54262349|FG000|Overall Study|Parent Decision|1|||
27806784|NCT01954082|54262350|FG001|Overall Study|Parent Decision|0|||
27806785|NCT01954082|54262349|FG000|Overall Study|Withdrawal by Subject|0|||
27806786|NCT01954082|54262350|FG001|Overall Study|Withdrawal by Subject|1|||
27806787|NCT01954082|54262349|FG000|Overall Study|Discontinued Early Prior to Transfer|3|||
27806788|NCT01954082|54262350|FG001|Overall Study|Discontinued Early Prior to Transfer|2|||
27806789|NCT01954082|54262349|FG000|Overall Study|Redirection of Care|0|||
27806790|NCT01954082|54262350|FG001|Overall Study|Redirection of Care|2|||
27806791|NCT01954082|54262349|FG000|Overall Study|Miscalculation of Final Dose Day|0|||
27806792|NCT01954082|54262350|FG001|Overall Study|Miscalculation of Final Dose Day|3|||
27806793|NCT01954082|54262349|FG000|Overall Study|Comfort Care|0|||
27806794|NCT01954082|54262350|FG001|Overall Study|Comfort Care|1|||
27806795|NCT01954082|54262349|FG000|Overall Study|Infant Moved|0|||
27806796|NCT01954082|54262350|FG001|Overall Study|Infant Moved|1|||
27806797|NCT01954082|54262349|FG000|Overall Study|Randomized not Treated|4|||
27806798|NCT01954082|54262350|FG001|Overall Study|Randomized not Treated|2|||
27806799|NCT01417000|54262358|FG000|Overall Study|Death|59|||
27806800|NCT01417000|54262359|FG001|Overall Study|Death|28|||
27806801|NCT01417000|54262358|FG000|Overall Study|Lost to Follow-up|1|||
27806802|NCT01417000|54262359|FG001|Overall Study|Lost to Follow-up|0|||
27806803|NCT01417000|54262358|FG000|Overall Study|Study Terminated by Sponsor|1|||
27806804|NCT01417000|54262359|FG001|Overall Study|Study Terminated by Sponsor|1|||
27806805|NCT01416610|54262365|FG000|Overall Study|Adverse Event|4|||
27806806|NCT01416610|54262365|FG000|Overall Study|Adverse Event -Patient decision|3|||
27806807|NCT01416610|54262365|FG000|Overall Study|Lack of Efficacy|4|||
27806808|NCT01416610|54262365|FG000|Overall Study|No reason given|5|||
27806809|NCT01416610|54262365|FG000|Overall Study|Withdrawal by Subject|13|||
27806810|NCT01416610|54262365|FG000|Overall Study|Lost to Follow-up|7|||
27843578|NCT01436071|54333003|FG001|Overall Study|Lack of Efficacy|7|||
27843579|NCT01436071|54333002|FG000|Overall Study|Protocol Violation|0|||
27843580|NCT01436071|54333003|FG001|Overall Study|Protocol Violation|1|||
27843581|NCT01436071|54333002|FG000|Overall Study|Lost to Follow-up|3|||
27843582|NCT01436071|54333003|FG001|Overall Study|Lost to Follow-up|1|||
27843583|NCT01436071|54333002|FG000|Overall Study|Physician Decision|1|||
27843584|NCT01436071|54333003|FG001|Overall Study|Physician Decision|0|||
27843585|NCT01436071|54333002|FG000|Overall Study|Withdrawal by Subject|2|||
28029673|NCT00113269|54688188|FG002|Overall Study|Lost to Follow-up|6|||
28029674|NCT00113269|54688189|FG003|Overall Study|Lost to Follow-up|3|||
28029675|NCT00113269|54688186|FG000|Overall Study|Sponsor elected to discontinue patient|1|||
28029676|NCT00113269|54688187|FG001|Overall Study|Sponsor elected to discontinue patient|0|||
28029677|NCT00113269|54688188|FG002|Overall Study|Sponsor elected to discontinue patient|0|||
28029678|NCT00113269|54688189|FG003|Overall Study|Sponsor elected to discontinue patient|1|||
28029679|NCT00113269|54688186|FG000|Overall Study|Discontinued due to rejection|0|||
28029680|NCT00113269|54688187|FG001|Overall Study|Discontinued due to rejection|0|||
28029681|NCT00113269|54688188|FG002|Overall Study|Discontinued due to rejection|1|||
28029682|NCT00113269|54688189|FG003|Overall Study|Discontinued due to rejection|0|||
28029683|NCT00113269|54688186|FG000|Overall Study|Moved|0|||
28029684|NCT00113269|54688187|FG001|Overall Study|Moved|1|||
28029685|NCT00113269|54688188|FG002|Overall Study|Moved|0|||
28029686|NCT00113269|54688189|FG003|Overall Study|Moved|3|||
28029687|NCT00113269|54688186|FG000|Overall Study|Received pancreas transplant|0|||
28029688|NCT00113269|54688187|FG001|Overall Study|Received pancreas transplant|0|||
28029689|NCT00113269|54688188|FG002|Overall Study|Received pancreas transplant|0|||
27806811|NCT01416610|54262365|FG000|Overall Study|Sufficient treatment duration (PCR neg.)|7|||
27806812|NCT01416142|54262373|FG000|PureVision2 HD|Inability to maintain lens wear|0|||
27806813|NCT01416142|54262374|FG001|PureVision2 HD|Inability to maintain lens wear|0|||
27806814|NCT01416142|54262375|FG002|PureVision2 HD|Inability to maintain lens wear|1|||
27806815|NCT01415986|54262383|FG000|Overall Study|Lost to Follow-up|1|||
27843586|NCT01436071|54333003|FG001|Overall Study|Withdrawal by Subject|2|||
27843587|NCT01436071|54333002|FG000|Overall Study|Did Not Receive Trial Medication|3|||
28029690|NCT00113269|54688189|FG003|Overall Study|Received pancreas transplant|2|||
28029691|NCT00113269|54688186|FG000|Overall Study|Withdrew consent, Prednisone initiated|0|||
28029692|NCT00113269|54688187|FG001|Overall Study|Withdrew consent, Prednisone initiated|0|||
28029693|NCT00113269|54688188|FG002|Overall Study|Withdrew consent, Prednisone initiated|0|||
28029694|NCT00113269|54688189|FG003|Overall Study|Withdrew consent, Prednisone initiated|1|||
28029695|NCT00113269|54688186|FG000|Overall Study|Did not meet eligibility criteria|1|||
27806816|NCT01415908|54262390|FG000|Overall Study|Withdrawal by Subject|1|||
27806817|NCT01415908|54262391|FG001|Overall Study|Withdrawal by Subject|0|||
28029696|NCT00113269|54688187|FG001|Overall Study|Did not meet eligibility criteria|0|||
27843588|NCT01436071|54333003|FG001|Overall Study|Did Not Receive Trial Medication|3|||
27843589|NCT01514864|54333011|FG000|Overall Study|Disease progression|7|||
27843590|NCT01514864|54333012|FG001|Overall Study|Disease progression|5|||
27843591|NCT01514864|54333011|FG000|Overall Study|Study drug toxicity|2|||
27843592|NCT01514864|54333012|FG001|Overall Study|Study drug toxicity|0|||
27843593|NCT01514240|54333021|FG000|Overall Study|Adverse Event|4|||
27843594|NCT01514240|54333022|FG001|Overall Study|Adverse Event|4|||
27843595|NCT01514240|54333021|FG000|Overall Study|Subject Decision|2|||
27843596|NCT01514240|54333022|FG001|Overall Study|Subject Decision|7|||
27843597|NCT01435759|54333033|FG000|Antidepressant Lead-in Phase|Adverse Event|40|||
27843598|NCT01435759|54333034|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
27843599|NCT01435759|54333035|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
27843600|NCT01435759|54333036|FG003|Antidepressant Lead-in Phase|Adverse Event|0|||
28029697|NCT00113269|54688188|FG002|Overall Study|Did not meet eligibility criteria|0|||
28029698|NCT00113269|54688189|FG003|Overall Study|Did not meet eligibility criteria|1|||
27806818|NCT01415518|54262399|FG000|Overall Study|Withdrawal by Subject|2|||
27806819|NCT01415518|54262400|FG001|Overall Study|Withdrawal by Subject|12|||
27806820|NCT01415518|54262399|FG000|Overall Study|Protocol Violation|6|||
27806821|NCT01415518|54262400|FG001|Overall Study|Protocol Violation|8|||
27806822|NCT01415518|54262399|FG000|Overall Study|Lost to Follow-up|3|||
27806823|NCT01415518|54262400|FG001|Overall Study|Lost to Follow-up|5|||
27806824|NCT01415518|54262399|FG000|Overall Study|Adverse Event|3|||
27806825|NCT01415518|54262400|FG001|Overall Study|Adverse Event|4|||
27843601|NCT01435759|54333037|FG004|Antidepressant Lead-in Phase|Adverse Event|0|||
27843602|NCT01435759|54333038|FG005|Antidepressant Lead-in Phase|Adverse Event|0|||
27843603|NCT01435759|54333033|FG000|Antidepressant Lead-in Phase|Protocol Violation|16|||
27843604|NCT01435759|54333034|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
27843605|NCT01435759|54333035|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
27843606|NCT01435759|54333036|FG003|Antidepressant Lead-in Phase|Protocol Violation|0|||
27843607|NCT01435759|54333037|FG004|Antidepressant Lead-in Phase|Protocol Violation|0|||
27843608|NCT01435759|54333038|FG005|Antidepressant Lead-in Phase|Protocol Violation|0|||
27843609|NCT01435759|54333033|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|74|||
27843610|NCT01435759|54333034|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
27843611|NCT01435759|54333035|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
27843612|NCT01435759|54333036|FG003|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
27843613|NCT01435759|54333037|FG004|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
27843614|NCT01435759|54333038|FG005|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
27843615|NCT01435759|54333033|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|83|||
27843616|NCT01435759|54333034|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
27843617|NCT01435759|54333035|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
27843618|NCT01435759|54333036|FG003|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
27843619|NCT01435759|54333037|FG004|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
27843620|NCT01435759|54333038|FG005|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
27843621|NCT01435759|54333033|FG000|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10|||
27843622|NCT01435759|54333034|FG001|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
27843623|NCT01435759|54333035|FG002|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
27843624|NCT01435759|54333036|FG003|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
27843625|NCT01435759|54333037|FG004|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
27843626|NCT01435759|54333038|FG005|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
27843627|NCT01435759|54333033|FG000|Antidepressant Lead-in Phase|Other|119|||
27843628|NCT01435759|54333034|FG001|Antidepressant Lead-in Phase|Other|0|||
27843629|NCT01435759|54333035|FG002|Antidepressant Lead-in Phase|Other|0|||
27843630|NCT01435759|54333036|FG003|Antidepressant Lead-in Phase|Other|0|||
27843631|NCT01435759|54333037|FG004|Antidepressant Lead-in Phase|Other|0|||
27843632|NCT01435759|54333038|FG005|Antidepressant Lead-in Phase|Other|0|||
27843633|NCT01435759|54333033|FG000|Double-blind Phase|Adverse Event|7|||
27843634|NCT01435759|54333034|FG001|Double-blind Phase|Adverse Event|0|||
27843635|NCT01435759|54333035|FG002|Double-blind Phase|Adverse Event|1|||
27939629|NCT01049217|54595857|FG001|Overall Study|Lost to Follow-up|8|||
27939630|NCT01049217|54595856|FG000|Overall Study|Withdrawal by Subject|4|||
27939631|NCT01049217|54595857|FG001|Overall Study|Withdrawal by Subject|3|||
27939632|NCT01049217|54595856|FG000|Overall Study|Protocol Violation|1|||
27806826|NCT01415518|54262399|FG000|Overall Study|Death|1|||
28029699|NCT00113269|54688186|FG000|Overall Study|Unable to return for follow up|2|||
27806827|NCT01415518|54262400|FG001|Overall Study|Death|1|||
27843636|NCT01435759|54333036|FG003|Double-blind Phase|Adverse Event|1|||
27939633|NCT01049217|54595857|FG001|Overall Study|Protocol Violation|3|||
27843637|NCT01435759|54333037|FG004|Double-blind Phase|Adverse Event|1|||
27843638|NCT01435759|54333038|FG005|Double-blind Phase|Adverse Event|3|||
28029700|NCT00113269|54688187|FG001|Overall Study|Unable to return for follow up|1|||
28029701|NCT00113269|54688188|FG002|Overall Study|Unable to return for follow up|0|||
28029702|NCT00113269|54688189|FG003|Overall Study|Unable to return for follow up|0|||
28029703|NCT00515619|54688199|FG000|Overall Study|Adverse Event|34|||
28029704|NCT00515619|54688199|FG000|Overall Study|Lack of Efficacy|92|||
28029705|NCT00515619|54688199|FG000|Overall Study|Withdrawal by Subject|66|||
28029706|NCT00515619|54688199|FG000|Overall Study|Protocol Violation|3|||
28029707|NCT00515619|54688199|FG000|Overall Study|Lost to Follow-up|4|||
28029708|NCT00515619|54688199|FG000|Overall Study|Unsatisfactory compliance|6|||
28029709|NCT00515619|54688199|FG000|Overall Study|Other: Site discontinuing trials|2|||
28029710|NCT00515619|54688199|FG000|Overall Study|Other: Subject cannot attend visits|2|||
28029711|NCT00515619|54688199|FG000|Overall Study|Other: Subject required surgery|1|||
28029712|NCT00515619|54688199|FG000|Overall Study|Other: Subject moved to another country|1|||
28029713|NCT00515619|54688199|FG000|Overall Study|Other: Investigator decision|1|||
28029714|NCT00515619|54688199|FG000|Overall Study|Other: Subject became pregnant|1|||
27806828|NCT01415518|54262399|FG000|Overall Study|Condition under Investigation Worsened|1|||
27806829|NCT01415518|54262400|FG001|Overall Study|Condition under Investigation Worsened|1|||
27806830|NCT01393600|54262406|FG000|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
28029715|NCT00515619|54688199|FG000|Overall Study|Other: Request from sponsor|1|||
28029716|NCT00515619|54688199|FG000|Overall Study|Other: Drug available on license|1|||
28029717|NCT00515619|54688199|FG000|Overall Study|Other: Subject interested in other AED|1|||
28029718|NCT00449644|54688207|FG000|Overall Study|Adverse Event|0|||
28029719|NCT00449644|54688208|FG001|Overall Study|Adverse Event|0|||
28029720|NCT00449644|54688209|FG002|Overall Study|Adverse Event|3|||
28029721|NCT00449644|54688210|FG003|Overall Study|Adverse Event|5|||
28029722|NCT00449644|54688207|FG000|Overall Study|Death|1|||
28029723|NCT00449644|54688208|FG001|Overall Study|Death|0|||
28029724|NCT00449644|54688209|FG002|Overall Study|Death|6|||
28029725|NCT00449644|54688210|FG003|Overall Study|Death|1|||
28029726|NCT00449644|54688207|FG000|Overall Study|Lost to Follow-up|1|||
28029727|NCT00449644|54688208|FG001|Overall Study|Lost to Follow-up|1|||
28029728|NCT00449644|54688209|FG002|Overall Study|Lost to Follow-up|5|||
28029729|NCT00449644|54688210|FG003|Overall Study|Lost to Follow-up|3|||
28029730|NCT00449644|54688207|FG000|Overall Study|Pregnancy|0|||
28029731|NCT00449644|54688208|FG001|Overall Study|Pregnancy|0|||
28029732|NCT00449644|54688209|FG002|Overall Study|Pregnancy|3|||
28029733|NCT00449644|54688210|FG003|Overall Study|Pregnancy|2|||
28029734|NCT00449644|54688207|FG000|Overall Study|Protocol Violation|4|||
28029735|NCT00449644|54688208|FG001|Overall Study|Protocol Violation|4|||
28029736|NCT00449644|54688209|FG002|Overall Study|Protocol Violation|3|||
28029737|NCT00449644|54688210|FG003|Overall Study|Protocol Violation|7|||
28029738|NCT00449644|54688207|FG000|Overall Study|Withdrawal by Subject|3|||
28029739|NCT00449644|54688208|FG001|Overall Study|Withdrawal by Subject|4|||
28029740|NCT00449644|54688209|FG002|Overall Study|Withdrawal by Subject|6|||
28029741|NCT00449644|54688210|FG003|Overall Study|Withdrawal by Subject|7|||
28029742|NCT00449644|54688207|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
28029743|NCT00449644|54688208|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
28029744|NCT00449644|54688209|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
28029745|NCT00449644|54688210|FG003|Overall Study|Inclusion/exclusion criteria not met|6|||
28029746|NCT00449644|54688207|FG000|Overall Study|Other|1|||
27806831|NCT01393600|54262407|FG001|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1|||
27806832|NCT01393600|54262408|FG002|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
27806833|NCT01393600|54262409|FG003|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
27806834|NCT01393600|54262406|FG000|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
27806835|NCT01393600|54262407|FG001|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
27806836|NCT01393600|54262408|FG002|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1|||
27806837|NCT01393600|54262409|FG003|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
27806838|NCT01393600|54262406|FG000|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
27806839|NCT01393600|54262407|FG001|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
27806840|NCT01393600|54262408|FG002|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
27806841|NCT01393600|54262409|FG003|Treatment Period 1 (Day 1 to 14)|Adverse Event|1|||
27806842|NCT01393600|54262406|FG000|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
27806843|NCT01393600|54262407|FG001|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
27806844|NCT01393600|54262408|FG002|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
28029747|NCT00449644|54688208|FG001|Overall Study|Other|4|||
28029748|NCT00449644|54688209|FG002|Overall Study|Other|1|||
28029749|NCT00449644|54688210|FG003|Overall Study|Other|0|||
28029750|NCT00449644|54688207|FG000|Overall Study|Rolled-over to treatment with TMC207|0|||
28029751|NCT00449644|54688208|FG001|Overall Study|Rolled-over to treatment with TMC207|0|||
28029752|NCT00449644|54688209|FG002|Overall Study|Rolled-over to treatment with TMC207|0|||
28029753|NCT00449644|54688210|FG003|Overall Study|Rolled-over to treatment with TMC207|1|||
27843639|NCT01435759|54333033|FG000|Double-blind Phase|Protocol Violation|2|||
27843640|NCT01435759|54333034|FG001|Double-blind Phase|Protocol Violation|0|||
27843641|NCT01435759|54333035|FG002|Double-blind Phase|Protocol Violation|1|||
27843642|NCT01435759|54333036|FG003|Double-blind Phase|Protocol Violation|2|||
27843643|NCT01435759|54333037|FG004|Double-blind Phase|Protocol Violation|0|||
27843644|NCT01435759|54333038|FG005|Double-blind Phase|Protocol Violation|1|||
27843645|NCT01435759|54333033|FG000|Double-blind Phase|Withdrawal by Subject|17|||
27843646|NCT01435759|54333034|FG001|Double-blind Phase|Withdrawal by Subject|4|||
27806845|NCT01393600|54262409|FG003|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1|||
27806846|NCT01393600|54262406|FG000|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
27806847|NCT01393600|54262407|FG001|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
27806848|NCT01393600|54262408|FG002|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1|||
27843647|NCT01435759|54333035|FG002|Double-blind Phase|Withdrawal by Subject|3|||
27843648|NCT01435759|54333036|FG003|Double-blind Phase|Withdrawal by Subject|4|||
27843649|NCT01435759|54333037|FG004|Double-blind Phase|Withdrawal by Subject|2|||
27843650|NCT01435759|54333038|FG005|Double-blind Phase|Withdrawal by Subject|2|||
27843651|NCT01435759|54333033|FG000|Double-blind Phase|Lost to Follow-up|31|||
27843652|NCT01435759|54333034|FG001|Double-blind Phase|Lost to Follow-up|1|||
27843653|NCT01435759|54333035|FG002|Double-blind Phase|Lost to Follow-up|2|||
27843654|NCT01435759|54333036|FG003|Double-blind Phase|Lost to Follow-up|0|||
27843655|NCT01435759|54333037|FG004|Double-blind Phase|Lost to Follow-up|3|||
27843656|NCT01435759|54333038|FG005|Double-blind Phase|Lost to Follow-up|3|||
27843657|NCT01435759|54333033|FG000|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1|||
27843658|NCT01435759|54333034|FG001|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
27843659|NCT01435759|54333035|FG002|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
27843660|NCT01435759|54333036|FG003|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
27843661|NCT01435759|54333037|FG004|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3|||
27843662|NCT01435759|54333038|FG005|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
27843663|NCT01435759|54333033|FG000|Double-blind Phase|Other|8|||
27843664|NCT01435759|54333034|FG001|Double-blind Phase|Other|2|||
27843665|NCT01435759|54333035|FG002|Double-blind Phase|Other|0|||
27843666|NCT01435759|54333036|FG003|Double-blind Phase|Other|2|||
27843667|NCT01435759|54333037|FG004|Double-blind Phase|Other|0|||
27843668|NCT01435759|54333038|FG005|Double-blind Phase|Other|0|||
27843669|NCT01393405|54333050|FG000|Induction Period (week1-16)|Lack of Efficacy|70|||
27843670|NCT01393405|54333051|FG001|Induction Period (week1-16)|Lack of Efficacy|0|||
27843671|NCT01393405|54333052|FG002|Induction Period (week1-16)|Lack of Efficacy|0|||
27843672|NCT01393405|54333050|FG000|Induction Period (week1-16)|Adverse Event|16|||
27843673|NCT01393405|54333051|FG001|Induction Period (week1-16)|Adverse Event|0|||
27843674|NCT01393405|54333052|FG002|Induction Period (week1-16)|Adverse Event|0|||
27843675|NCT01393405|54333050|FG000|Induction Period (week1-16)|Withdrawal by Subject|9|||
27843676|NCT01393405|54333051|FG001|Induction Period (week1-16)|Withdrawal by Subject|0|||
27843677|NCT01393405|54333052|FG002|Induction Period (week1-16)|Withdrawal by Subject|0|||
27843678|NCT01393405|54333050|FG000|Maintenance Period Week|Lack of Efficacy|0|||
27843679|NCT01393405|54333051|FG001|Maintenance Period Week|Lack of Efficacy|22|||
27843680|NCT01393405|54333052|FG002|Maintenance Period Week|Lack of Efficacy|22|||
27843681|NCT01393405|54333050|FG000|Maintenance Period Week|Adverse Event|0|||
27843682|NCT01393405|54333051|FG001|Maintenance Period Week|Adverse Event|5|||
27843683|NCT01393405|54333052|FG002|Maintenance Period Week|Adverse Event|2|||
27843684|NCT01393405|54333050|FG000|Maintenance Period Week|Withdrawal by Subject|0|||
27843685|NCT01393405|54333051|FG001|Maintenance Period Week|Withdrawal by Subject|1|||
27843686|NCT01393405|54333052|FG002|Maintenance Period Week|Withdrawal by Subject|0|||
27843687|NCT01393405|54333050|FG000|Maintenance Period Week|Lost to Follow-up|0|||
27843688|NCT01393405|54333051|FG001|Maintenance Period Week|Lost to Follow-up|1|||
27843689|NCT01393405|54333052|FG002|Maintenance Period Week|Lost to Follow-up|0|||
27843690|NCT01419197|54333064|FG000|Overall Study|Death|247|||
27843691|NCT01419197|54333065|FG001|Overall Study|Death|122|||
27843692|NCT01419197|54333064|FG000|Overall Study|Physician Decision|4|||
27843693|NCT01419197|54333065|FG001|Overall Study|Physician Decision|4|||
27806849|NCT01393600|54262409|FG003|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
27806850|NCT01393600|54262406|FG000|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
27806851|NCT01393600|54262407|FG001|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
27843694|NCT01419197|54333064|FG000|Overall Study|Non-compliance|3|||
27843695|NCT01419197|54333065|FG001|Overall Study|Non-compliance|1|||
27843696|NCT01419197|54333064|FG000|Overall Study|Withdrawal by Subject|33|||
27843697|NCT01419197|54333065|FG001|Overall Study|Withdrawal by Subject|32|||
27843698|NCT01419197|54333064|FG000|Overall Study|Study Completed by Sponsor|103|||
27843699|NCT01419197|54333065|FG001|Overall Study|Study Completed by Sponsor|34|||
27843700|NCT01419197|54333064|FG000|Overall Study|Reason Not Specified|0|||
27843701|NCT01419197|54333065|FG001|Overall Study|Reason Not Specified|1|||
27843702|NCT01419197|54333064|FG000|Overall Study|Lost to Follow-up|14|||
27843703|NCT01419197|54333065|FG001|Overall Study|Lost to Follow-up|4|||
27843704|NCT01414075|54333076|FG000|Overall Study|Adverse Event|1|||
27806852|NCT01393600|54262408|FG002|Treatment Period 2 (Day 15 to 28)|Physician Decision|1|||
27843705|NCT01414075|54333077|FG001|Overall Study|Adverse Event|0|||
27843706|NCT01414075|54333078|FG002|Overall Study|Adverse Event|1|||
27843707|NCT01414075|54333079|FG003|Overall Study|Adverse Event|0|||
27843708|NCT01414075|54333076|FG000|Overall Study|Death|1|||
27843709|NCT01414075|54333077|FG001|Overall Study|Death|0|||
27843710|NCT01414075|54333078|FG002|Overall Study|Death|0|||
27843711|NCT01414075|54333079|FG003|Overall Study|Death|1|||
27843712|NCT01414075|54333076|FG000|Overall Study|Withdrawal by Subject|0|||
27843713|NCT01414075|54333077|FG001|Overall Study|Withdrawal by Subject|0|||
27843714|NCT01414075|54333078|FG002|Overall Study|Withdrawal by Subject|0|||
27843715|NCT01414075|54333079|FG003|Overall Study|Withdrawal by Subject|1|||
27843716|NCT01414075|54333076|FG000|Overall Study|Other than specified|1|||
27843717|NCT01414075|54333077|FG001|Overall Study|Other than specified|0|||
27843718|NCT01414075|54333078|FG002|Overall Study|Other than specified|1|||
27843719|NCT01414075|54333079|FG003|Overall Study|Other than specified|0|||
27843720|NCT01434823|54333091|FG000|Overall Study|Incomplete data in medical record|4|||
27843721|NCT01434823|54333092|FG001|Overall Study|Incomplete data in medical record|7|||
27843722|NCT01513460|54333102|FG000|Overall Study|Death|0|||
27843723|NCT01513460|54333103|FG001|Overall Study|Death|0|||
27806853|NCT01393600|54262409|FG003|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
27806854|NCT01393600|54262406|FG000|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
27843724|NCT01513460|54333104|FG002|Overall Study|Death|1|||
27843725|NCT01513460|54333102|FG000|Overall Study|Lost to Follow-up|0|||
27843726|NCT01513460|54333103|FG001|Overall Study|Lost to Follow-up|0|||
27843727|NCT01513460|54333104|FG002|Overall Study|Lost to Follow-up|2|||
27843728|NCT01513460|54333102|FG000|Overall Study|Abnormal laboratory value|1|||
27843729|NCT01513460|54333103|FG001|Overall Study|Abnormal laboratory value|0|||
27843730|NCT01513460|54333104|FG002|Overall Study|Abnormal laboratory value|1|||
27843731|NCT01513460|54333102|FG000|Overall Study|Lack of Efficacy|1|||
27843732|NCT01513460|54333103|FG001|Overall Study|Lack of Efficacy|2|||
27843733|NCT01513460|54333104|FG002|Overall Study|Lack of Efficacy|5|||
27843734|NCT01513460|54333102|FG000|Overall Study|Protocol deviations|3|||
27843735|NCT01513460|54333103|FG001|Overall Study|Protocol deviations|4|||
27843736|NCT01513460|54333104|FG002|Overall Study|Protocol deviations|3|||
27843737|NCT01513460|54333102|FG000|Overall Study|Withdrawal by Subject|7|||
27843738|NCT01513460|54333103|FG001|Overall Study|Withdrawal by Subject|8|||
27843739|NCT01513460|54333104|FG002|Overall Study|Withdrawal by Subject|21|||
27843740|NCT01513460|54333102|FG000|Overall Study|Adverse Event|16|||
27939634|NCT01049217|54595856|FG000|Overall Study|Pregnancy|1|||
27939635|NCT01049217|54595857|FG001|Overall Study|Pregnancy|0|||
27939636|NCT01049217|54595856|FG000|Overall Study|Study Terminated by Sponsor|43|||
27806855|NCT01393600|54262407|FG001|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
27806856|NCT01393600|54262408|FG002|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1|||
27806857|NCT01393600|54262409|FG003|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
27806858|NCT01432756|54262425|FG000|Overall Study|Lost to Follow-up|1|||
27806859|NCT01432756|54262426|FG001|Overall Study|Lost to Follow-up|0|||
27806860|NCT01432756|54262427|FG002|Overall Study|Lost to Follow-up|2|||
27806861|NCT01432756|54262428|FG003|Overall Study|Lost to Follow-up|1|||
27806862|NCT01432600|54262439|FG000|Overall Study|Rapid PD, allocated intv. not rec'd|0|||
27843741|NCT01513460|54333103|FG001|Overall Study|Adverse Event|18|||
27843742|NCT01513460|54333104|FG002|Overall Study|Adverse Event|23|||
27843743|NCT01513460|54333102|FG000|Overall Study|Abnormal test procedure|1|||
27939637|NCT01049217|54595857|FG001|Overall Study|Study Terminated by Sponsor|43|||
27939638|NCT01049217|54595856|FG000|Overall Study|Other|1|||
27939639|NCT01049217|54595857|FG001|Overall Study|Other|2|||
27939640|NCT01049217|54595856|FG000|Overall Study|Randomized but not Treated|0|||
27939641|NCT01049217|54595857|FG001|Overall Study|Randomized but not Treated|2|||
27939642|NCT01232738|54595863|FG000|Overall Study|Death|3|||
27939643|NCT01232738|54595863|FG000|Overall Study|Physician Decision|2|||
27939644|NCT01232738|54595863|FG000|Overall Study|Lost to Follow-up|1|||
27939645|NCT01232738|54595863|FG000|Overall Study|Withdrawal by Subject|2|||
27939646|NCT01232738|54595863|FG000|Overall Study|Adverse Event|5|||
27939647|NCT00957268|54595876|FG000|Overall Study|Voluntary Withdrawal|0|||
27939648|NCT00957268|54595877|FG001|Overall Study|Voluntary Withdrawal|0|||
27806863|NCT01432600|54262440|FG001|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
27806864|NCT01432600|54262441|FG002|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
27806865|NCT01432444|54262451|FG000|Tolerability/Cross-titration Phase|Lost to Follow-up|10|||
27843744|NCT01513460|54333103|FG001|Overall Study|Abnormal test procedure|0|||
27843745|NCT01513460|54333104|FG002|Overall Study|Abnormal test procedure|0|||
27843746|NCT01392547|54333114|FG000|Overall Study|Adverse Event|2|||
27843747|NCT01392547|54333114|FG000|Overall Study|Non-compliance|2|||
27843748|NCT01392547|54333114|FG000|Overall Study|Withdrawal criteria|3|||
27843749|NCT01392547|54333114|FG000|Overall Study|Unclassified|1|||
27939649|NCT00957268|54595878|FG002|Overall Study|Voluntary Withdrawal|1|||
27939650|NCT00957268|54595879|FG003|Overall Study|Voluntary Withdrawal|0|||
27939651|NCT00957268|54595880|FG004|Overall Study|Voluntary Withdrawal|0|||
27939652|NCT01230788|54595892|FG000|Overall Study|Prescribed exclusion drug|1|||
27939653|NCT01230710|54595896|FG000|Overall Study|Disease Progression|41|||
27843750|NCT01435655|54333120|FG000|Overall Study|Death|2|||
27843751|NCT01435655|54333120|FG000|Overall Study|Other|1|||
27843752|NCT01434667|54333126|FG000|Overall Study|Lost to Follow-up|5|||
27843753|NCT01434667|54333127|FG001|Overall Study|Lost to Follow-up|10|||
27843754|NCT01513148|54333135|FG000|Overall Study|Protocol Violation|2|||
27843755|NCT01513148|54333136|FG001|Overall Study|Protocol Violation|2|||
27843756|NCT01418339|54333184|FG000|Overall Study|Adverse Event|5|||
27843757|NCT01418339|54333185|FG001|Overall Study|Adverse Event|2|||
27843758|NCT01418339|54333184|FG000|Overall Study|Subject Withdrew Consent|1|||
27843759|NCT01418339|54333185|FG001|Overall Study|Subject Withdrew Consent|2|||
27843760|NCT01418339|54333184|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
27843761|NCT01418339|54333185|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
27843762|NCT01512368|54333191|FG000|Overall Study|Protocol Violation|3|||
27843763|NCT01412983|54333195|FG000|1st Period|Ineligible|0|||
27843764|NCT01412983|54333196|FG001|1st Period|Ineligible|1|||
27843765|NCT01412983|54333195|FG000|1st Period|Positive slit lamp finding|0|||
27843766|NCT01412983|54333196|FG001|1st Period|Positive slit lamp finding|1|||
27843767|NCT01412983|54333195|FG000|1st Period|Unacceptable lens movement|0|||
27843768|NCT01412983|54333196|FG001|1st Period|Unacceptable lens movement|1|||
27843769|NCT01412983|54333195|FG000|1st Period|Inability to maintain wear|0|||
27843770|NCT01412983|54333196|FG001|1st Period|Inability to maintain wear|1|||
27843771|NCT01417481|54333205|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
27843772|NCT01417481|54333206|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
27843773|NCT01392469|54333212|FG000|Overall Study|Adverse Event|2|||
27843774|NCT01392469|54333212|FG000|Overall Study|Withdrawal by Subject|1|||
27843775|NCT01392469|54333212|FG000|Overall Study|Protocol Violation|1|||
27843776|NCT01435577|54333229|FG000|Overall Study|Adverse Event|10|||
27843777|NCT01435577|54333230|FG001|Overall Study|Adverse Event|0|||
27843778|NCT01435577|54333229|FG000|Overall Study|Lack of Efficacy|7|||
27843779|NCT01435577|54333230|FG001|Overall Study|Lack of Efficacy|51|||
27843780|NCT01435577|54333229|FG000|Overall Study|Alternative treatment started|0|||
28105648|NCT04468347|54763186|FG003|Overall Study|Withdrawal by Subject|3|||
27939654|NCT01230710|54595896|FG000|Overall Study|Lost to Follow-up|3|||
27939655|NCT01230710|54595896|FG000|Overall Study|Death|4|||
27939656|NCT01230710|54595896|FG000|Overall Study|Withdrawal of Consent|1|||
27806866|NCT01432444|54262452|FG001|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
27939657|NCT01230554|54595900|FG000|Overall Study|Lost to Follow-up|2|||
27806867|NCT01432444|54262453|FG002|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
27806868|NCT01432444|54262451|FG000|Tolerability/Cross-titration Phase|Adverse Event|16|||
27806869|NCT01432444|54262452|FG001|Tolerability/Cross-titration Phase|Adverse Event|0|||
27806870|NCT01432444|54262453|FG002|Tolerability/Cross-titration Phase|Adverse Event|0|||
27806871|NCT01432444|54262451|FG000|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5|||
27806872|NCT01432444|54262452|FG001|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
27806873|NCT01432444|54262453|FG002|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
27806874|NCT01432444|54262451|FG000|Tolerability/Cross-titration Phase|Physician Decision|8|||
27843781|NCT01435577|54333230|FG001|Overall Study|Alternative treatment started|1|||
28105649|NCT04468347|54763183|FG000|Overall Study|Lost to Follow-up|0|||
28105650|NCT04468347|54763184|FG001|Overall Study|Lost to Follow-up|0|||
28105651|NCT04468347|54763185|FG002|Overall Study|Lost to Follow-up|1|||
28105652|NCT04468347|54763186|FG003|Overall Study|Lost to Follow-up|1|||
28105653|NCT04468347|54763183|FG000|Overall Study|Physician Decision|1|||
28105654|NCT04468347|54763184|FG001|Overall Study|Physician Decision|0|||
28105655|NCT04468347|54763185|FG002|Overall Study|Physician Decision|2|||
28105656|NCT04468347|54763186|FG003|Overall Study|Physician Decision|0|||
28105657|NCT04468347|54763183|FG000|Overall Study|Protocol Violation|1|||
28105658|NCT04468347|54763184|FG001|Overall Study|Protocol Violation|0|||
28105659|NCT04468347|54763185|FG002|Overall Study|Protocol Violation|0|||
27939658|NCT01230554|54595900|FG000|Overall Study|Inability to maintain visit schedule|1|||
27939659|NCT01040793|54595904|FG000|Overall Study|Adverse Event|5|||
27939660|NCT01040793|54595905|FG001|Overall Study|Adverse Event|3|||
27939661|NCT01040793|54595906|FG002|Overall Study|Adverse Event|0|||
27939662|NCT01040793|54595907|FG003|Overall Study|Adverse Event|2|||
27939663|NCT01040793|54595908|FG004|Overall Study|Adverse Event|2|||
27939664|NCT01040793|54595909|FG005|Overall Study|Adverse Event|1|||
27939665|NCT01040793|54595904|FG000|Overall Study|Protocol Violation|1|||
27939666|NCT01040793|54595905|FG001|Overall Study|Protocol Violation|1|||
27939667|NCT01040793|54595906|FG002|Overall Study|Protocol Violation|1|||
28105660|NCT04468347|54763186|FG003|Overall Study|Protocol Violation|0|||
28105661|NCT04822701|54763202|FG000|Overall Study|Not treated|2|||
27843782|NCT01411891|54333242|FG000|Overall Study|Catheter dislodgement or loss to follow-|3|||
27939668|NCT01040793|54595907|FG003|Overall Study|Protocol Violation|0|||
27939669|NCT01040793|54595908|FG004|Overall Study|Protocol Violation|1|||
27939670|NCT01040793|54595909|FG005|Overall Study|Protocol Violation|0|||
27939671|NCT01040793|54595904|FG000|Overall Study|Lost to Follow-up|0|||
28105662|NCT04822701|54763203|FG001|Overall Study|Not treated|0|||
28105663|NCT04822701|54763202|FG000|Overall Study|Lost to Follow-up|1|||
27806875|NCT01432444|54262452|FG001|Tolerability/Cross-titration Phase|Physician Decision|0|||
27806876|NCT01432444|54262453|FG002|Tolerability/Cross-titration Phase|Physician Decision|0|||
27806877|NCT01432444|54262451|FG000|Tolerability/Cross-titration Phase|Withdrawal by Subject|15|||
27806878|NCT01432444|54262452|FG001|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
27806879|NCT01432444|54262453|FG002|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
27806880|NCT01432444|54262451|FG000|Tolerability/Cross-titration Phase|Protocol Deviation|1|||
27806881|NCT01432444|54262452|FG001|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
27806882|NCT01432444|54262453|FG002|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
27806883|NCT01432444|54262451|FG000|Tolerability/Cross-titration Phase|Lack of Efficacy|5|||
27806884|NCT01432444|54262452|FG001|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
27806885|NCT01432444|54262453|FG002|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
27806886|NCT01432444|54262451|FG000|Treatment Phase|Lost to Follow-up|0|||
27806887|NCT01432444|54262452|FG001|Treatment Phase|Lost to Follow-up|33|||
27806888|NCT01432444|54262453|FG002|Treatment Phase|Lost to Follow-up|0|||
27806889|NCT01432444|54262451|FG000|Treatment Phase|Adverse Event|0|||
27806890|NCT01432444|54262452|FG001|Treatment Phase|Adverse Event|37|||
27806891|NCT01432444|54262453|FG002|Treatment Phase|Adverse Event|0|||
27806892|NCT01432444|54262451|FG000|Treatment Phase|Met Withdrawal Criteria|0|||
27806893|NCT01432444|54262452|FG001|Treatment Phase|Met Withdrawal Criteria|11|||
27806894|NCT01432444|54262453|FG002|Treatment Phase|Met Withdrawal Criteria|0|||
27806895|NCT01432444|54262451|FG000|Treatment Phase|Physician Decision|0|||
27806896|NCT01432444|54262452|FG001|Treatment Phase|Physician Decision|5|||
27806897|NCT01432444|54262453|FG002|Treatment Phase|Physician Decision|0|||
27806898|NCT01432444|54262451|FG000|Treatment Phase|Withdrawal by Subject|0|||
27806899|NCT01432444|54262452|FG001|Treatment Phase|Withdrawal by Subject|41|||
27806900|NCT01432444|54262453|FG002|Treatment Phase|Withdrawal by Subject|0|||
27806901|NCT01432444|54262451|FG000|Treatment Phase|Protocol Deviation|0|||
27806902|NCT01432444|54262452|FG001|Treatment Phase|Protocol Deviation|3|||
27806903|NCT01432444|54262453|FG002|Treatment Phase|Protocol Deviation|0|||
27806904|NCT01432444|54262451|FG000|Treatment Phase|Lack of Efficacy|0|||
27806905|NCT01432444|54262452|FG001|Treatment Phase|Lack of Efficacy|10|||
27806906|NCT01432444|54262453|FG002|Treatment Phase|Lack of Efficacy|0|||
27806907|NCT01432444|54262451|FG000|Extension Phase|Lost to Follow-up|0|||
27806908|NCT01432444|54262452|FG001|Extension Phase|Lost to Follow-up|0|||
27806909|NCT01432444|54262453|FG002|Extension Phase|Lost to Follow-up|17|||
27806910|NCT01432444|54262451|FG000|Extension Phase|Adverse Event|0|||
27806911|NCT01432444|54262452|FG001|Extension Phase|Adverse Event|0|||
27806912|NCT01432444|54262453|FG002|Extension Phase|Adverse Event|10|||
27806913|NCT01432444|54262451|FG000|Extension Phase|Sponsor Discontinued Trial|0|||
27806914|NCT01432444|54262452|FG001|Extension Phase|Sponsor Discontinued Trial|0|||
27806915|NCT01432444|54262453|FG002|Extension Phase|Sponsor Discontinued Trial|7|||
27806916|NCT01432444|54262451|FG000|Extension Phase|Met Withdrawal Criteria|0|||
27806917|NCT01432444|54262452|FG001|Extension Phase|Met Withdrawal Criteria|0|||
27806918|NCT01432444|54262453|FG002|Extension Phase|Met Withdrawal Criteria|144|||
27806919|NCT01432444|54262451|FG000|Extension Phase|Physician Decision|0|||
27806920|NCT01432444|54262452|FG001|Extension Phase|Physician Decision|0|||
27806921|NCT01432444|54262453|FG002|Extension Phase|Physician Decision|1|||
27806922|NCT01432444|54262451|FG000|Extension Phase|Withdrawal by Subject|0|||
27806923|NCT01432444|54262452|FG001|Extension Phase|Withdrawal by Subject|0|||
27806924|NCT01432444|54262453|FG002|Extension Phase|Withdrawal by Subject|13|||
27806925|NCT01432366|54262458|FG000|Overall Study|Non-Responder|7|||
27806926|NCT01432366|54262458|FG000|Overall Study|Adverse Event|8|||
27806927|NCT01432366|54262458|FG000|Overall Study|Withdrawal Due to Non-Compliance|3|||
27806928|NCT01432366|54262458|FG000|Overall Study|Pregnancy|1|||
27806929|NCT01432366|54262458|FG000|Overall Study|Lost to Follow-up|13|||
27806930|NCT01432366|54262458|FG000|Overall Study|Lack of Efficacy|1|||
27806931|NCT01432366|54262458|FG000|Overall Study|Site Closed|20|||
27806932|NCT01432366|54262458|FG000|Overall Study|Investigator Forget to Complete Visits|1|||
27806933|NCT01432366|54262458|FG000|Overall Study|Other|14|||
27806934|NCT01415440|54262465|FG000|Overall Study|Lost to Follow-up|0|||
27806935|NCT01415440|54262466|FG001|Overall Study|Lost to Follow-up|1|||
27806936|NCT01415440|54262467|FG002|Overall Study|Lost to Follow-up|2|||
27806937|NCT01415440|54262465|FG000|Overall Study|Physician Decision|3|||
27806938|NCT01415440|54262466|FG001|Overall Study|Physician Decision|0|||
27806939|NCT01415440|54262467|FG002|Overall Study|Physician Decision|0|||
27806940|NCT01415440|54262465|FG000|Overall Study|Withdrawal by Subject|1|||
27939672|NCT01040793|54595905|FG001|Overall Study|Lost to Follow-up|1|||
28029754|NCT00515541|54688227|FG000|Overall Study|Physician Decision|0|||
27806941|NCT01415440|54262466|FG001|Overall Study|Withdrawal by Subject|0|||
27806942|NCT01415440|54262467|FG002|Overall Study|Withdrawal by Subject|0|||
27806943|NCT01932788|54262485|FG000|Overall Study|Protocol Violation|18|||
27806944|NCT01932788|54262486|FG001|Overall Study|Protocol Violation|0|||
27806945|NCT01932788|54262485|FG000|Overall Study|Lost to Follow-up|18|||
27806946|NCT01932788|54262486|FG001|Overall Study|Lost to Follow-up|46|||
27806947|NCT01932788|54262485|FG000|Overall Study|Lack of Efficacy|2|||
27939673|NCT01040793|54595906|FG002|Overall Study|Lost to Follow-up|1|||
27806948|NCT01932788|54262486|FG001|Overall Study|Lack of Efficacy|0|||
27806949|NCT01932788|54262485|FG000|Overall Study|Withdrawal by Subject|0|||
27806950|NCT01932788|54262486|FG001|Overall Study|Withdrawal by Subject|5|||
27806951|NCT01414738|54262492|FG000|Overall Study|Death|26|||
27806952|NCT01414738|54262492|FG000|Overall Study|Refused testing|5|||
27806953|NCT01414738|54262492|FG000|Overall Study|Lost to Follow-up|2|||
27806954|NCT01414738|54262492|FG000|Overall Study|Refused, disease progression|8|||
28029755|NCT00515541|54688228|FG001|Overall Study|Physician Decision|2|||
28029756|NCT00515541|54688229|FG002|Overall Study|Physician Decision|0|||
28029757|NCT00515541|54688230|FG003|Overall Study|Physician Decision|1|||
28029758|NCT00515541|54688227|FG000|Overall Study|No show for appointments|0|||
28029759|NCT00515541|54688228|FG001|Overall Study|No show for appointments|1|||
27806955|NCT01414738|54262492|FG000|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3|||
28029760|NCT00515541|54688229|FG002|Overall Study|No show for appointments|0|||
28029761|NCT00515541|54688230|FG003|Overall Study|No show for appointments|2|||
28029762|NCT00515541|54688227|FG000|Overall Study|Withdrawal by Subject|0|||
28029763|NCT00515541|54688228|FG001|Overall Study|Withdrawal by Subject|2|||
28029764|NCT00515541|54688229|FG002|Overall Study|Withdrawal by Subject|0|||
28029765|NCT00515541|54688230|FG003|Overall Study|Withdrawal by Subject|2|||
28029766|NCT00112489|54688240|FG000|Overall Study|Refused further treatment|8|||
28029767|NCT00112489|54688240|FG000|Overall Study|Adverse Event|12|||
28029768|NCT00112489|54688240|FG000|Overall Study|Death|2|||
28029769|NCT00112489|54688240|FG000|Overall Study|Other, Not Specified|9|||
28029770|NCT00112489|54688240|FG000|Overall Study|Patient never treated|2|||
28029771|NCT00112489|54688240|FG000|Overall Study|Ineligible|7|||
28029772|NCT00711971|54688253|FG000|Overall Study|Lost to Follow-up|3|||
28029773|NCT00711971|54688254|FG001|Overall Study|Lost to Follow-up|4|||
28029774|NCT00711971|54688255|FG002|Overall Study|Lost to Follow-up|1|||
28029775|NCT00515463|54688269|FG000|Overall Study|Physician Decision|4|||
28029776|NCT00515463|54688270|FG001|Overall Study|Physician Decision|2|||
28029777|NCT00515463|54688269|FG000|Overall Study|Adverse Event|1|||
28029778|NCT00515463|54688270|FG001|Overall Study|Adverse Event|2|||
28029779|NCT00515463|54688269|FG000|Overall Study|Withdrawal by Subject|3|||
28029780|NCT00515463|54688270|FG001|Overall Study|Withdrawal by Subject|4|||
28029781|NCT00515463|54688269|FG000|Overall Study|Lost to Follow-up|6|||
28029782|NCT00515463|54688270|FG001|Overall Study|Lost to Follow-up|5|||
28029783|NCT00515463|54688269|FG000|Overall Study|Other|0|||
28029784|NCT00515463|54688270|FG001|Overall Study|Other|1|||
28029785|NCT00507507|54688279|FG000|Treatment Period|Lost to Follow-up|0|||
27806956|NCT01414114|54262496|FG000|Overall Study|Adverse Event|2|||
27806957|NCT01414114|54262496|FG000|Overall Study|Withdrawal by Subject|1|||
27806958|NCT01414114|54262496|FG000|Overall Study|Other|2|||
28029786|NCT00507507|54688280|FG001|Treatment Period|Lost to Follow-up|2|||
28029787|NCT00507507|54688279|FG000|Treatment Period|Physician Decision|4|||
28029788|NCT00507507|54688280|FG001|Treatment Period|Physician Decision|1|||
28029789|NCT00507507|54688279|FG000|Treatment Period|Protocol Violation|1|||
28029790|NCT00507507|54688280|FG001|Treatment Period|Protocol Violation|2|||
28029791|NCT00507507|54688279|FG000|Treatment Period|Adverse Event|1|||
28029792|NCT00507507|54688280|FG001|Treatment Period|Adverse Event|1|||
28029793|NCT00507507|54688279|FG000|Treatment Period|Withdrawal by Subject|46|||
28029794|NCT00507507|54688280|FG001|Treatment Period|Withdrawal by Subject|47|||
28029795|NCT00507507|54688279|FG000|24-week Treatment-free Follow-up Period|Physician Decision|1|||
28029796|NCT00507507|54688280|FG001|24-week Treatment-free Follow-up Period|Physician Decision|0|||
28029797|NCT00507507|54688279|FG000|24-week Treatment-free Follow-up Period|Adverse Event|0|||
28029798|NCT00507507|54688280|FG001|24-week Treatment-free Follow-up Period|Adverse Event|1|||
28029799|NCT00507507|54688279|FG000|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9|||
28029800|NCT00507507|54688280|FG001|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16|||
28029801|NCT00459706|54688290|FG000|Overall Study|Adverse Event|19|||
28029802|NCT00459706|54688291|FG001|Overall Study|Adverse Event|13|||
28029803|NCT00459706|54688290|FG000|Overall Study|Withdrawal by Subject|1|||
28029804|NCT00459706|54688291|FG001|Overall Study|Withdrawal by Subject|6|||
28029805|NCT00459706|54688290|FG000|Overall Study|Physician Decision|2|||
27806959|NCT01393444|54262502|FG000|Overall Study|Withdrawal by Subject|1|||
27806960|NCT01393444|54262502|FG000|Overall Study|Determined ineligible during screening.|2|||
27806961|NCT01431976|54262506|FG000|Overall Study|Adverse Event|6|||
27806962|NCT01431976|54262506|FG000|Overall Study|Lack of Efficacy|2|||
27806963|NCT01431976|54262506|FG000|Overall Study|Met Protocol-defined Stopping Criteria|4|||
28029806|NCT00459706|54688291|FG001|Overall Study|Physician Decision|0|||
28029807|NCT00459706|54688290|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
28029808|NCT00459706|54688291|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
28029809|NCT00459706|54688290|FG000|Overall Study|Protocol Violation|2|||
28029810|NCT00459706|54688291|FG001|Overall Study|Protocol Violation|1|||
28029811|NCT00459706|54688290|FG000|Overall Study|Failed to Return|1|||
28029812|NCT00459706|54688291|FG001|Overall Study|Failed to Return|0|||
28029813|NCT00459706|54688290|FG000|Overall Study|Other|0|||
28029814|NCT00459706|54688291|FG001|Overall Study|Other|1|||
28029815|NCT00507429|54688299|FG000|Treatment Phase|Disease Progression|12|||
27806964|NCT01431976|54262506|FG000|Overall Study|Physician Decision|1|||
27806965|NCT01431976|54262506|FG000|Overall Study|Withdrawal by Subject|1|||
27806966|NCT01392742|54262510|FG000|Overall Study|Premature study termination|42|||
27806967|NCT01392742|54262510|FG000|Overall Study|Failure to return|35|||
27806968|NCT01392742|54262510|FG000|Overall Study|No treatment/no cooperation/withdrew|12|||
27806969|NCT01392742|54262510|FG000|Overall Study|Lost to Follow-up|34|||
27806970|NCT01392742|54262510|FG000|Overall Study|Insufficient therapeutic response (ITR)|30|||
27806971|NCT01392742|54262510|FG000|Overall Study|ITR and Protocol deviation|1|||
27806972|NCT01392742|54262510|FG000|Overall Study|Adverse event/intercurrent illness|17|||
27806973|NCT01392742|54262510|FG000|Overall Study|Protocol Violation|14|||
27806974|NCT01392742|54262510|FG000|Overall Study|Other|3|||
27806975|NCT01392742|54262510|FG000|Overall Study|Missing information|13|||
27806976|NCT01413958|54262516|FG000|Overall Study|Lost to Follow-up|0|||
27806977|NCT01413958|54262517|FG001|Overall Study|Lost to Follow-up|1|||
27806978|NCT01413178|54262526|FG000|Overall Study|Toxicity|1|||
27806979|NCT01413178|54262527|FG001|Overall Study|Toxicity|0|||
27806980|NCT01413178|54262526|FG000|Overall Study|Ineligible|0|||
27806981|NCT01413178|54262527|FG001|Overall Study|Ineligible|2|||
27806982|NCT01799889|54262545|FG000|Overall Study|Adverse Event|4|||
27806983|NCT01799889|54262546|FG001|Overall Study|Adverse Event|4|||
27806984|NCT01799889|54262547|FG002|Overall Study|Adverse Event|5|||
27806985|NCT01799889|54262548|FG003|Overall Study|Adverse Event|1|||
27806986|NCT01799889|54262549|FG004|Overall Study|Adverse Event|11|||
27806987|NCT01799889|54262550|FG005|Overall Study|Adverse Event|1|||
27806988|NCT01799889|54262551|FG006|Overall Study|Adverse Event|5|||
27806989|NCT01799889|54262552|FG007|Overall Study|Adverse Event|2|||
27806990|NCT01799889|54262553|FG008|Overall Study|Adverse Event|3|||
27806991|NCT01799889|54262554|FG009|Overall Study|Adverse Event|1|||
27806992|NCT01799889|54262555|FG010|Overall Study|Adverse Event|1|||
27806993|NCT01799889|54262556|FG011|Overall Study|Adverse Event|0|||
27806994|NCT01799889|54262545|FG000|Overall Study|Death|1|||
27806995|NCT01799889|54262546|FG001|Overall Study|Death|0|||
27843783|NCT01411891|54333243|FG001|Overall Study|Catheter dislodgement or loss to follow-|2|||
27843784|NCT01416389|54333251|FG000|Overall Study|Lost to Follow-up|1|||
27843785|NCT01416389|54333252|FG001|Overall Study|Lost to Follow-up|0|||
27843786|NCT01416389|54333251|FG000|Overall Study|Started New Therapy|2|||
27843787|NCT01416389|54333252|FG001|Overall Study|Started New Therapy|0|||
27843788|NCT01544348|54333268|FG000|Overall Study|Lost to Follow-up|1|||
27843789|NCT01544348|54333269|FG001|Overall Study|Lost to Follow-up|0|||
27843790|NCT01544348|54333270|FG002|Overall Study|Lost to Follow-up|0|||
27843791|NCT01544348|54333271|FG003|Overall Study|Lost to Follow-up|0|||
27843792|NCT01544348|54333272|FG004|Overall Study|Lost to Follow-up|0|||
27843793|NCT01544348|54333273|FG005|Overall Study|Lost to Follow-up|0|||
27843794|NCT01544348|54333274|FG006|Overall Study|Lost to Follow-up|1|||
27843795|NCT01544348|54333275|FG007|Overall Study|Lost to Follow-up|0|||
27843796|NCT01544348|54333268|FG000|Overall Study|Withdrawal by Subject|1|||
27843797|NCT01544348|54333269|FG001|Overall Study|Withdrawal by Subject|0|||
27843798|NCT01544348|54333270|FG002|Overall Study|Withdrawal by Subject|0|||
27843799|NCT01544348|54333271|FG003|Overall Study|Withdrawal by Subject|0|||
27843800|NCT01544348|54333272|FG004|Overall Study|Withdrawal by Subject|1|||
27843801|NCT01544348|54333273|FG005|Overall Study|Withdrawal by Subject|2|||
27843802|NCT01544348|54333274|FG006|Overall Study|Withdrawal by Subject|1|||
27843803|NCT01544348|54333275|FG007|Overall Study|Withdrawal by Subject|0|||
27843804|NCT01544348|54333268|FG000|Overall Study|Physician Decision|0|||
27843805|NCT01544348|54333269|FG001|Overall Study|Physician Decision|0|||
27843806|NCT01544348|54333270|FG002|Overall Study|Physician Decision|0|||
27843807|NCT01544348|54333271|FG003|Overall Study|Physician Decision|0|||
27806996|NCT01799889|54262547|FG002|Overall Study|Death|5|||
27806997|NCT01799889|54262548|FG003|Overall Study|Death|3|||
27806998|NCT01799889|54262549|FG004|Overall Study|Death|1|||
27806999|NCT01799889|54262550|FG005|Overall Study|Death|0|||
27843808|NCT01544348|54333272|FG004|Overall Study|Physician Decision|0|||
27843809|NCT01544348|54333273|FG005|Overall Study|Physician Decision|1|||
27843810|NCT01544348|54333274|FG006|Overall Study|Physician Decision|0|||
27843811|NCT01544348|54333275|FG007|Overall Study|Physician Decision|0|||
27843812|NCT01416155|54333300|FG000|Overall Study|Adverse Event|8|||
27843813|NCT01416155|54333300|FG000|Overall Study|Positive for anti-BG00002 antibodies|2|||
27843814|NCT01416155|54333300|FG000|Overall Study|Withdrawal by Subject|33|||
27843815|NCT01416155|54333300|FG000|Overall Study|Investigator decision|8|||
27843816|NCT01416155|54333300|FG000|Overall Study|Other|7|||
28029816|NCT00507429|54688300|FG001|Treatment Phase|Disease Progression|5|||
27807000|NCT01799889|54262551|FG006|Overall Study|Death|0|||
27807001|NCT01799889|54262552|FG007|Overall Study|Death|0|||
27807002|NCT01799889|54262553|FG008|Overall Study|Death|1|||
27807003|NCT01799889|54262554|FG009|Overall Study|Death|0|||
27807004|NCT01799889|54262555|FG010|Overall Study|Death|1|||
27807005|NCT01799889|54262556|FG011|Overall Study|Death|0|||
27807006|NCT01799889|54262545|FG000|Overall Study|Lack of Efficacy|1|||
27843817|NCT01415921|54333306|FG000|Overall Study|Adverse Event|0|||
27843818|NCT01415921|54333307|FG001|Overall Study|Adverse Event|1|||
27843819|NCT01415921|54333306|FG000|Overall Study|Physician Decision|1|||
27843820|NCT01415921|54333307|FG001|Overall Study|Physician Decision|1|||
27843821|NCT01415921|54333306|FG000|Overall Study|Withdrawal by Subject|0|||
27843822|NCT01415921|54333307|FG001|Overall Study|Withdrawal by Subject|1|||
27843823|NCT01415921|54333306|FG000|Overall Study|Other|2|||
27843824|NCT01415921|54333307|FG001|Overall Study|Other|0|||
27843825|NCT01415531|54333315|FG000|Overall Study|Adverse Event|7|||
27843826|NCT01415531|54333316|FG001|Overall Study|Adverse Event|10|||
27843827|NCT01415531|54333315|FG000|Overall Study|Lack of Efficacy|3|||
27843828|NCT01415531|54333316|FG001|Overall Study|Lack of Efficacy|2|||
27843829|NCT01415531|54333315|FG000|Overall Study|Protocol Violation|0|||
27843830|NCT01415531|54333316|FG001|Overall Study|Protocol Violation|1|||
27843831|NCT01415531|54333315|FG000|Overall Study|Withdrawal by Subject|5|||
27843832|NCT01415531|54333316|FG001|Overall Study|Withdrawal by Subject|4|||
27843833|NCT01415531|54333315|FG000|Overall Study|Lost to Follow-up|6|||
27843834|NCT01415531|54333316|FG001|Overall Study|Lost to Follow-up|14|||
27843835|NCT01415531|54333315|FG000|Overall Study|Lack of Compliance|1|||
27843836|NCT01415531|54333316|FG001|Overall Study|Lack of Compliance|4|||
27843837|NCT01415531|54333315|FG000|Overall Study|Other Reasons|3|||
28029817|NCT00507429|54688299|FG000|Treatment Phase|Adverse Event|12|||
28029818|NCT00507429|54688300|FG001|Treatment Phase|Adverse Event|5|||
28029819|NCT00507429|54688299|FG000|Treatment Phase|Withdrawal by Subject|3|||
28029820|NCT00507429|54688300|FG001|Treatment Phase|Withdrawal by Subject|3|||
28029821|NCT00507429|54688299|FG000|Treatment Phase|Physician Decision|4|||
28029822|NCT00507429|54688300|FG001|Treatment Phase|Physician Decision|2|||
28029823|NCT00507429|54688299|FG000|Treatment Phase|Other|6|||
28029824|NCT00507429|54688300|FG001|Treatment Phase|Other|3|||
28029825|NCT00507429|54688299|FG000|Maintenance Phase|Progressive Disease|14|||
28029826|NCT00507429|54688300|FG001|Maintenance Phase|Progressive Disease|0|||
28029827|NCT00449176|54688311|FG000|Overall Study|Withdrawal by Subject|39|||
28029828|NCT00449176|54688312|FG001|Overall Study|Withdrawal by Subject|43|||
28029829|NCT00449176|54688313|FG002|Overall Study|Withdrawal by Subject|59|||
28029830|NCT00449176|54688311|FG000|Overall Study|Lost to Follow-up|13|||
28029831|NCT00449176|54688312|FG001|Overall Study|Lost to Follow-up|8|||
28029832|NCT00449176|54688313|FG002|Overall Study|Lost to Follow-up|12|||
28029833|NCT00449176|54688311|FG000|Overall Study|Adverse Event|51|||
28029834|NCT00449176|54688312|FG001|Overall Study|Adverse Event|107|||
28029835|NCT00449176|54688313|FG002|Overall Study|Adverse Event|15|||
28029836|NCT00449176|54688311|FG000|Overall Study|Lack of Efficacy|13|||
28029837|NCT00449176|54688312|FG001|Overall Study|Lack of Efficacy|7|||
28029838|NCT00449176|54688313|FG002|Overall Study|Lack of Efficacy|50|||
28029839|NCT00449176|54688311|FG000|Overall Study|Study drug non-compliant|14|||
28029840|NCT00449176|54688312|FG001|Overall Study|Study drug non-compliant|11|||
28029841|NCT00449176|54688313|FG002|Overall Study|Study drug non-compliant|11|||
28029842|NCT00449176|54688311|FG000|Overall Study|all other|22|||
28029843|NCT00449176|54688312|FG001|Overall Study|all other|19|||
28029844|NCT00449176|54688313|FG002|Overall Study|all other|20|||
28029845|NCT00515073|54688321|FG000|Overall Study|Withdrawal by Subject|1|||
28029846|NCT00515073|54688321|FG000|Overall Study|Physician Decision|1|||
28029847|NCT00710021|54688328|FG000|Overall Study|Lost to Follow-up|1|||
28029848|NCT00710021|54688329|FG001|Overall Study|Lost to Follow-up|0|||
28029849|NCT00710021|54688330|FG002|Overall Study|Lost to Follow-up|0|||
28029850|NCT00710021|54688328|FG000|Overall Study|Subject's Decision|0|||
28029851|NCT00710021|54688329|FG001|Overall Study|Subject's Decision|1|||
28029852|NCT00710021|54688330|FG002|Overall Study|Subject's Decision|0|||
28029853|NCT00710021|54688328|FG000|Overall Study|Subject misrandomized|0|||
28029854|NCT00710021|54688329|FG001|Overall Study|Subject misrandomized|1|||
28029855|NCT00710021|54688330|FG002|Overall Study|Subject misrandomized|1|||
27939674|NCT01040793|54595907|FG003|Overall Study|Lost to Follow-up|0|||
27939675|NCT01040793|54595908|FG004|Overall Study|Lost to Follow-up|0|||
27939676|NCT01040793|54595909|FG005|Overall Study|Lost to Follow-up|0|||
27939677|NCT01040793|54595904|FG000|Overall Study|Withdrawal by Subject|0|||
27939678|NCT01040793|54595905|FG001|Overall Study|Withdrawal by Subject|0|||
27939679|NCT01040793|54595906|FG002|Overall Study|Withdrawal by Subject|0|||
27939680|NCT01040793|54595907|FG003|Overall Study|Withdrawal by Subject|2|||
27939681|NCT01040793|54595908|FG004|Overall Study|Withdrawal by Subject|0|||
27939682|NCT01040793|54595909|FG005|Overall Study|Withdrawal by Subject|0|||
27939683|NCT01040793|54595904|FG000|Overall Study|Other reasons not listed above|0|||
27939684|NCT01040793|54595905|FG001|Overall Study|Other reasons not listed above|0|||
27939685|NCT01040793|54595906|FG002|Overall Study|Other reasons not listed above|1|||
28029856|NCT00710021|54688328|FG000|Overall Study|Physician Decision|0|||
28029857|NCT00710021|54688329|FG001|Overall Study|Physician Decision|1|||
28029858|NCT00710021|54688330|FG002|Overall Study|Physician Decision|0|||
28029859|NCT00504153|54688339|FG000|Overall Study|Withdrawal by Subject|1|||
27939686|NCT01040793|54595907|FG003|Overall Study|Other reasons not listed above|0|||
28029860|NCT00504153|54688339|FG000|Overall Study|Adverse Event|4|||
27843838|NCT01415531|54333316|FG001|Overall Study|Other Reasons|2|||
27843839|NCT01544114|54333325|FG000|Overall Study|Withdrawal by Subject|0|||
28029861|NCT00504153|54688339|FG000|Overall Study|Death|1|||
27843840|NCT01544114|54333326|FG001|Overall Study|Withdrawal by Subject|0|||
27843841|NCT01544114|54333327|FG002|Overall Study|Withdrawal by Subject|3|||
27843842|NCT01544114|54333325|FG000|Overall Study|Lost to Follow-up|0|||
27843843|NCT01544114|54333326|FG001|Overall Study|Lost to Follow-up|2|||
27843844|NCT01544114|54333327|FG002|Overall Study|Lost to Follow-up|0|||
27843845|NCT01544114|54333325|FG000|Overall Study|Adverse Event|1|||
27843846|NCT01544114|54333326|FG001|Overall Study|Adverse Event|1|||
27843847|NCT01544114|54333327|FG002|Overall Study|Adverse Event|2|||
27843848|NCT01544114|54333325|FG000|Overall Study|Protocol Violation|0|||
27843849|NCT01544114|54333326|FG001|Overall Study|Protocol Violation|1|||
27843850|NCT01544114|54333327|FG002|Overall Study|Protocol Violation|0|||
27843851|NCT01435265|54333339|FG000|Overall Study|Lost to Follow-up|0|||
27843852|NCT01435265|54333340|FG001|Overall Study|Lost to Follow-up|1|||
27843853|NCT01433263|54333348|FG000|Overall Study|Adverse Event|3|||
27843854|NCT01433263|54333349|FG001|Overall Study|Adverse Event|1|||
27843855|NCT01433263|54333348|FG000|Overall Study|Death|5|||
27843856|NCT01433263|54333349|FG001|Overall Study|Death|3|||
27843857|NCT01433263|54333348|FG000|Overall Study|Lost to Follow-up|0|||
27843858|NCT01433263|54333349|FG001|Overall Study|Lost to Follow-up|1|||
27807007|NCT01799889|54262546|FG001|Overall Study|Lack of Efficacy|1|||
27843859|NCT01433263|54333348|FG000|Overall Study|Protocol Deviation|1|||
27843860|NCT01433263|54333349|FG001|Overall Study|Protocol Deviation|0|||
27843861|NCT01433263|54333348|FG000|Overall Study|Withdrawal by Subject|10|||
27843862|NCT01433263|54333349|FG001|Overall Study|Withdrawal by Subject|7|||
27843863|NCT01432951|54333358|FG000|Treatment Phase (Day 1 to 30)|Never Treated|1|||
27843864|NCT01432327|54333367|FG000|Posttest 3 Months|depression|3|||
27843865|NCT01432327|54333368|FG001|Posttest 3 Months|depression|0|||
27843866|NCT01432327|54333369|FG002|Posttest 3 Months|depression|0|||
27843867|NCT01432327|54333370|FG003|Posttest 3 Months|depression|0|||
27843868|NCT01432327|54333367|FG000|Posttest 3 Months|Lost to Follow-up|1|||
27843869|NCT01432327|54333368|FG001|Posttest 3 Months|Lost to Follow-up|0|||
27843870|NCT01432327|54333369|FG002|Posttest 3 Months|Lost to Follow-up|2|||
27843871|NCT01432327|54333370|FG003|Posttest 3 Months|Lost to Follow-up|1|||
27807008|NCT01799889|54262547|FG002|Overall Study|Lack of Efficacy|0|||
27807009|NCT01799889|54262548|FG003|Overall Study|Lack of Efficacy|1|||
27807010|NCT01799889|54262549|FG004|Overall Study|Lack of Efficacy|2|||
27807011|NCT01799889|54262550|FG005|Overall Study|Lack of Efficacy|2|||
27843872|NCT01432327|54333367|FG000|Posttest 3 Months|Allergic reaction|0|||
27843873|NCT01432327|54333368|FG001|Posttest 3 Months|Allergic reaction|2|||
27843874|NCT01432327|54333369|FG002|Posttest 3 Months|Allergic reaction|0|||
27843875|NCT01432327|54333370|FG003|Posttest 3 Months|Allergic reaction|0|||
27843876|NCT01432327|54333367|FG000|Posttest 6 Months|Lost to Follow-up|0|||
27843877|NCT01432327|54333368|FG001|Posttest 6 Months|Lost to Follow-up|0|||
27843878|NCT01432327|54333369|FG002|Posttest 6 Months|Lost to Follow-up|3|||
27843879|NCT01432327|54333370|FG003|Posttest 6 Months|Lost to Follow-up|2|||
27843880|NCT01432327|54333367|FG000|Posttest 6 Months|Allergic reaction|0|||
27843881|NCT01432327|54333368|FG001|Posttest 6 Months|Allergic reaction|0|||
27843882|NCT01432327|54333369|FG002|Posttest 6 Months|Allergic reaction|1|||
27843883|NCT01432327|54333370|FG003|Posttest 6 Months|Allergic reaction|0|||
27807012|NCT01799889|54262551|FG006|Overall Study|Lack of Efficacy|0|||
27807013|NCT01799889|54262552|FG007|Overall Study|Lack of Efficacy|0|||
27807014|NCT01799889|54262553|FG008|Overall Study|Lack of Efficacy|2|||
27807015|NCT01799889|54262554|FG009|Overall Study|Lack of Efficacy|0|||
27807016|NCT01799889|54262555|FG010|Overall Study|Lack of Efficacy|1|||
27807017|NCT01799889|54262556|FG011|Overall Study|Lack of Efficacy|0|||
27807018|NCT01799889|54262545|FG000|Overall Study|Lost to Follow-up|0|||
27807019|NCT01799889|54262546|FG001|Overall Study|Lost to Follow-up|1|||
27807020|NCT01799889|54262547|FG002|Overall Study|Lost to Follow-up|0|||
27807021|NCT01799889|54262548|FG003|Overall Study|Lost to Follow-up|0|||
27807022|NCT01799889|54262549|FG004|Overall Study|Lost to Follow-up|0|||
27807023|NCT01799889|54262550|FG005|Overall Study|Lost to Follow-up|0|||
27843884|NCT01432327|54333367|FG000|Posttest 6 Months|Withdrawal by Subject|0|||
27843885|NCT01432327|54333368|FG001|Posttest 6 Months|Withdrawal by Subject|0|||
27843886|NCT01432327|54333369|FG002|Posttest 6 Months|Withdrawal by Subject|1|||
27843887|NCT01432327|54333370|FG003|Posttest 6 Months|Withdrawal by Subject|0|||
27843888|NCT01432327|54333367|FG000|Posttest 1 Year|Measurement have to take place in future|24|||
27843889|NCT01432327|54333368|FG001|Posttest 1 Year|Measurement have to take place in future|28|||
27843890|NCT01432327|54333369|FG002|Posttest 1 Year|Measurement have to take place in future|15|||
28029862|NCT00442702|54688345|FG000|Titration Period|Adverse Event|2|||
27807024|NCT01799889|54262551|FG006|Overall Study|Lost to Follow-up|0|||
27807025|NCT01799889|54262552|FG007|Overall Study|Lost to Follow-up|0|||
27807026|NCT01799889|54262553|FG008|Overall Study|Lost to Follow-up|0|||
28029863|NCT00442702|54688346|FG001|Titration Period|Adverse Event|0|||
28029864|NCT00442702|54688345|FG000|Titration Period|Death|3|||
27807027|NCT01799889|54262554|FG009|Overall Study|Lost to Follow-up|0|||
27807028|NCT01799889|54262555|FG010|Overall Study|Lost to Follow-up|0|||
27843891|NCT01432327|54333370|FG003|Posttest 1 Year|Measurement have to take place in future|20|||
27843892|NCT01432327|54333367|FG000|Posttest 1 Year|Lost to Follow-up|0|||
27843893|NCT01432327|54333368|FG001|Posttest 1 Year|Lost to Follow-up|0|||
27843894|NCT01432327|54333369|FG002|Posttest 1 Year|Lost to Follow-up|4|||
27843895|NCT01432327|54333370|FG003|Posttest 1 Year|Lost to Follow-up|2|||
27843896|NCT01432327|54333367|FG000|Posttest 1 Year|Allergic reaction|0|||
27843897|NCT01432327|54333368|FG001|Posttest 1 Year|Allergic reaction|0|||
27843898|NCT01432327|54333369|FG002|Posttest 1 Year|Allergic reaction|1|||
27843899|NCT01432327|54333370|FG003|Posttest 1 Year|Allergic reaction|1|||
27843900|NCT01410799|54333380|FG000|Overall Study|PI decision|13|||
27843901|NCT01432171|54333386|FG000|Overall Study|Death|1|||
27843902|NCT01432171|54333387|FG001|Overall Study|Death|2|||
27843903|NCT01432171|54333386|FG000|Overall Study|Lost to Follow-up|6|||
27843904|NCT01432171|54333387|FG001|Overall Study|Lost to Follow-up|5|||
27843905|NCT01432171|54333386|FG000|Overall Study|Withdrawal by Subject|3|||
27843906|NCT01432171|54333387|FG001|Overall Study|Withdrawal by Subject|1|||
27843907|NCT01432171|54333386|FG000|Overall Study|Noncompliance|2|||
27843908|NCT01432171|54333387|FG001|Overall Study|Noncompliance|3|||
27843909|NCT01432171|54333386|FG000|Overall Study|Insurance denial trial coverage|1|||
27843910|NCT01432171|54333387|FG001|Overall Study|Insurance denial trial coverage|0|||
27843911|NCT01432171|54333386|FG000|Overall Study|Patient moved to palliative care|1|||
27843912|NCT01432171|54333387|FG001|Overall Study|Patient moved to palliative care|0|||
27843913|NCT01435031|54333397|FG000|ITT at 1 Month|Withdrawal by Subject|1|||
27843914|NCT01435031|54333397|FG000|ITT at 1 Month|Death|1|||
27843915|NCT01435031|54333397|FG000|ITT at 1 Month|Lost to Follow-up|4|||
27843916|NCT01435031|54333397|FG000|ITT at 6 Months|Death|2|||
27843917|NCT01435031|54333397|FG000|ITT at 6 Months|Lost to Follow-up|3|||
27843918|NCT01435031|54333397|FG000|ITT at 1 Year|Death|1|||
27843919|NCT01435031|54333397|FG000|ITT at 1 Year|Withdrawal by Subject|2|||
27843920|NCT01435031|54333397|FG000|ITT at 1 Year|Lost to Follow-up|6|||
27843921|NCT01435031|54333397|FG000|ITT at 2 Years|Death|7|||
27843922|NCT01435031|54333397|FG000|ITT at 2 Years|Withdrawal by Subject|2|||
27843923|NCT01435031|54333397|FG000|ITT at 2 Years|Lost to Follow-up|4|||
27843924|NCT01435031|54333397|FG000|ITT at 3 Years|Death|5|||
27843925|NCT01435031|54333397|FG000|ITT at 3 Years|Withdrawal by Subject|2|||
27843926|NCT01435031|54333397|FG000|ITT at 3 Years|Lost to Follow-up|4|||
27843927|NCT01435031|54333397|FG000|ITT at 4 Years|Death|4|||
27843928|NCT01435031|54333397|FG000|ITT at 4 Years|Withdrawal by Subject|2|||
27843929|NCT01435031|54333397|FG000|ITT at 4 Years|Lost to Follow-up|1|||
27843930|NCT01433549|54333401|FG000|Phase 2: Second Study Product|Adverse Event|0|||
27843931|NCT01433549|54333402|FG001|Phase 2: Second Study Product|Adverse Event|1|||
27843932|NCT01414205|54333410|FG000|Overall Study|Death|5|||
27843933|NCT01414205|54333411|FG001|Overall Study|Death|1|||
27843934|NCT01414205|54333410|FG000|Overall Study|Lost to Follow-up|1|||
27843935|NCT01414205|54333411|FG001|Overall Study|Lost to Follow-up|4|||
27843936|NCT01414205|54333410|FG000|Overall Study|Physician Decision|0|||
27843937|NCT01414205|54333411|FG001|Overall Study|Physician Decision|1|||
27843938|NCT01414205|54333410|FG000|Overall Study|Randomized but not Treated|1|||
27843939|NCT01414205|54333411|FG001|Overall Study|Randomized but not Treated|1|||
27843940|NCT01433471|54333419|FG000|Overall Study|Withdrawal by Subject|0|||
27843941|NCT01433471|54333420|FG001|Overall Study|Withdrawal by Subject|1|||
27843942|NCT01433159|54333430|FG000|Overall Study|Adverse Event|1|||
27843943|NCT01433159|54333431|FG001|Overall Study|Adverse Event|0|||
27843944|NCT01433159|54333430|FG000|Overall Study|Physician Decision|1|||
27843945|NCT01433159|54333431|FG001|Overall Study|Physician Decision|0|||
27843946|NCT01433159|54333430|FG000|Overall Study|Protocol Violation|0|||
27843947|NCT01433159|54333431|FG001|Overall Study|Protocol Violation|1|||
27843948|NCT01413503|54333446|FG000|Overall Study|Lost to Follow-up|1|||
27843949|NCT01413191|54333450|FG000|Overall Study|Lost to Follow-up|5|||
27843950|NCT01413191|54333450|FG000|Overall Study|Disease Progression|5|||
27843951|NCT01413191|54333450|FG000|Overall Study|Death|1|||
27843952|NCT02036970|54333464|FG000|Part 1: Day 1 Through Week 16|Adverse Event|0|||
27843953|NCT02036970|54333465|FG001|Part 1: Day 1 Through Week 16|Adverse Event|0|||
27843954|NCT02036970|54333466|FG002|Part 1: Day 1 Through Week 16|Adverse Event|3|||
27843955|NCT02036970|54333467|FG003|Part 1: Day 1 Through Week 16|Adverse Event|2|||
27843956|NCT02036970|54333468|FG004|Part 1: Day 1 Through Week 16|Adverse Event|0|||
27843957|NCT02036970|54333469|FG005|Part 1: Day 1 Through Week 16|Adverse Event|1|||
27843958|NCT02036970|54333470|FG006|Part 1: Day 1 Through Week 16|Adverse Event|0|||
27843959|NCT02036970|54333471|FG007|Part 1: Day 1 Through Week 16|Adverse Event|1|||
27843960|NCT02036970|54333472|FG008|Part 1: Day 1 Through Week 16|Adverse Event|3|||
27843961|NCT02036970|54333473|FG009|Part 1: Day 1 Through Week 16|Adverse Event|1|||
27843962|NCT02036970|54333464|FG000|Part 1: Day 1 Through Week 16|Death|0|||
27843963|NCT02036970|54333465|FG001|Part 1: Day 1 Through Week 16|Death|0|||
27843964|NCT02036970|54333466|FG002|Part 1: Day 1 Through Week 16|Death|0|||
27843965|NCT02036970|54333467|FG003|Part 1: Day 1 Through Week 16|Death|0|||
27843966|NCT02036970|54333468|FG004|Part 1: Day 1 Through Week 16|Death|0|||
27843967|NCT02036970|54333469|FG005|Part 1: Day 1 Through Week 16|Death|0|||
27843968|NCT02036970|54333470|FG006|Part 1: Day 1 Through Week 16|Death|0|||
27843969|NCT02036970|54333471|FG007|Part 1: Day 1 Through Week 16|Death|0|||
27843970|NCT02036970|54333472|FG008|Part 1: Day 1 Through Week 16|Death|1|||
27843971|NCT02036970|54333473|FG009|Part 1: Day 1 Through Week 16|Death|0|||
27843972|NCT02036970|54333464|FG000|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
27843973|NCT02036970|54333465|FG001|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
27843974|NCT02036970|54333466|FG002|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
27843975|NCT02036970|54333467|FG003|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
27843976|NCT02036970|54333468|FG004|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
27843977|NCT02036970|54333469|FG005|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
27843978|NCT02036970|54333470|FG006|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
27843979|NCT02036970|54333471|FG007|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
27843980|NCT02036970|54333472|FG008|Part 1: Day 1 Through Week 16|Protocol Violation|2|||
27843981|NCT02036970|54333473|FG009|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
27843982|NCT02036970|54333464|FG000|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
27843983|NCT02036970|54333465|FG001|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
27843984|NCT02036970|54333466|FG002|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
27843985|NCT02036970|54333467|FG003|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
27843986|NCT02036970|54333468|FG004|Part 1: Day 1 Through Week 16|Withdrawal by Subject|1|||
27843987|NCT02036970|54333469|FG005|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
27843988|NCT02036970|54333470|FG006|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
27843989|NCT02036970|54333471|FG007|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
27843990|NCT02036970|54333472|FG008|Part 1: Day 1 Through Week 16|Withdrawal by Subject|2|||
27843991|NCT02036970|54333473|FG009|Part 1: Day 1 Through Week 16|Withdrawal by Subject|4|||
27843992|NCT02036970|54333464|FG000|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
27843993|NCT02036970|54333465|FG001|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
27843994|NCT02036970|54333466|FG002|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
27843995|NCT02036970|54333467|FG003|Part 1: Day 1 Through Week 16|Progressive Disease|1|||
27843996|NCT02036970|54333468|FG004|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
27843997|NCT02036970|54333469|FG005|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
27843998|NCT02036970|54333470|FG006|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
27843999|NCT02036970|54333471|FG007|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
27844000|NCT02036970|54333472|FG008|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
27844001|NCT02036970|54333473|FG009|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
27844002|NCT02036970|54333464|FG000|Part 2: Week 16 Onwards|Adverse Event|0|||
27844003|NCT02036970|54333465|FG001|Part 2: Week 16 Onwards|Adverse Event|2|||
27807029|NCT01799889|54262556|FG011|Overall Study|Lost to Follow-up|0|||
27807030|NCT01799889|54262545|FG000|Overall Study|Physician Decision|3|||
27807031|NCT01799889|54262546|FG001|Overall Study|Physician Decision|2|||
27807032|NCT01799889|54262547|FG002|Overall Study|Physician Decision|4|||
27807033|NCT01799889|54262548|FG003|Overall Study|Physician Decision|4|||
27807034|NCT01799889|54262549|FG004|Overall Study|Physician Decision|5|||
27807035|NCT01799889|54262550|FG005|Overall Study|Physician Decision|5|||
27807036|NCT01799889|54262551|FG006|Overall Study|Physician Decision|5|||
27807037|NCT01799889|54262552|FG007|Overall Study|Physician Decision|2|||
27844004|NCT02036970|54333466|FG002|Part 2: Week 16 Onwards|Adverse Event|1|||
27844005|NCT02036970|54333467|FG003|Part 2: Week 16 Onwards|Adverse Event|1|||
27844006|NCT02036970|54333468|FG004|Part 2: Week 16 Onwards|Adverse Event|1|||
27844007|NCT02036970|54333469|FG005|Part 2: Week 16 Onwards|Adverse Event|0|||
27844008|NCT02036970|54333470|FG006|Part 2: Week 16 Onwards|Adverse Event|1|||
27844009|NCT02036970|54333471|FG007|Part 2: Week 16 Onwards|Adverse Event|0|||
27844010|NCT02036970|54333472|FG008|Part 2: Week 16 Onwards|Adverse Event|6|||
27844011|NCT02036970|54333473|FG009|Part 2: Week 16 Onwards|Adverse Event|3|||
27844012|NCT02036970|54333464|FG000|Part 2: Week 16 Onwards|Protocol Violation|0|||
27844013|NCT02036970|54333465|FG001|Part 2: Week 16 Onwards|Protocol Violation|0|||
27844014|NCT02036970|54333466|FG002|Part 2: Week 16 Onwards|Protocol Violation|0|||
27844015|NCT02036970|54333467|FG003|Part 2: Week 16 Onwards|Protocol Violation|0|||
27844016|NCT02036970|54333468|FG004|Part 2: Week 16 Onwards|Protocol Violation|0|||
27844017|NCT02036970|54333469|FG005|Part 2: Week 16 Onwards|Protocol Violation|0|||
27844018|NCT02036970|54333470|FG006|Part 2: Week 16 Onwards|Protocol Violation|0|||
27844019|NCT02036970|54333471|FG007|Part 2: Week 16 Onwards|Protocol Violation|1|||
27844020|NCT02036970|54333472|FG008|Part 2: Week 16 Onwards|Protocol Violation|0|||
27844021|NCT02036970|54333473|FG009|Part 2: Week 16 Onwards|Protocol Violation|0|||
27844022|NCT02036970|54333464|FG000|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
27844023|NCT02036970|54333465|FG001|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
28029865|NCT00442702|54688346|FG001|Titration Period|Death|2|||
28029866|NCT00442702|54688345|FG000|Titration Period|Insufficient Therapeutic Response|1|||
27844024|NCT02036970|54333466|FG002|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
27844025|NCT02036970|54333467|FG003|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
27844026|NCT02036970|54333468|FG004|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
27844027|NCT02036970|54333469|FG005|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
28029867|NCT00442702|54688346|FG001|Titration Period|Insufficient Therapeutic Response|0|||
28029868|NCT00442702|54688345|FG000|Titration Period|Refused Treatment|4|||
27807038|NCT01799889|54262553|FG008|Overall Study|Physician Decision|6|||
27807039|NCT01799889|54262554|FG009|Overall Study|Physician Decision|0|||
27844028|NCT02036970|54333470|FG006|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
27844029|NCT02036970|54333471|FG007|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
27844030|NCT02036970|54333472|FG008|Part 2: Week 16 Onwards|Withdrawal by Subject|3|||
27844031|NCT02036970|54333473|FG009|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
27844032|NCT02036970|54333464|FG000|Part 2: Week 16 Onwards|Progressive Disease|0|||
27844033|NCT02036970|54333465|FG001|Part 2: Week 16 Onwards|Progressive Disease|2|||
27844034|NCT02036970|54333466|FG002|Part 2: Week 16 Onwards|Progressive Disease|1|||
27844035|NCT02036970|54333467|FG003|Part 2: Week 16 Onwards|Progressive Disease|1|||
27844036|NCT02036970|54333468|FG004|Part 2: Week 16 Onwards|Progressive Disease|0|||
27844037|NCT02036970|54333469|FG005|Part 2: Week 16 Onwards|Progressive Disease|0|||
27807040|NCT01799889|54262555|FG010|Overall Study|Physician Decision|0|||
27807041|NCT01799889|54262556|FG011|Overall Study|Physician Decision|1|||
27807042|NCT01799889|54262545|FG000|Overall Study|Progressive Disease|30|||
27844038|NCT02036970|54333470|FG006|Part 2: Week 16 Onwards|Progressive Disease|0|||
27844039|NCT02036970|54333471|FG007|Part 2: Week 16 Onwards|Progressive Disease|0|||
27844040|NCT02036970|54333472|FG008|Part 2: Week 16 Onwards|Progressive Disease|0|||
27844041|NCT02036970|54333473|FG009|Part 2: Week 16 Onwards|Progressive Disease|2|||
27844042|NCT01412957|54333507|FG000|Overall Study|Withdrawal by Subject|6|||
27844043|NCT01412957|54333508|FG001|Overall Study|Withdrawal by Subject|22|||
27844044|NCT01412957|54333507|FG000|Overall Study|Lost to Follow-up|7|||
27844045|NCT01412957|54333508|FG001|Overall Study|Lost to Follow-up|2|||
28029869|NCT00442702|54688346|FG001|Titration Period|Refused Treatment|1|||
28029870|NCT00442702|54688345|FG000|Titration Period|Failure to return|1|||
28029871|NCT00442702|54688346|FG001|Titration Period|Failure to return|0|||
28029872|NCT00442702|54688345|FG000|Titration Period|Hospitalized in another hospital|1|||
28029873|NCT00442702|54688346|FG001|Titration Period|Hospitalized in another hospital|0|||
28029874|NCT00442702|54688345|FG000|Evaluation Period|Adverse Event|1|||
28029875|NCT00442702|54688346|FG001|Evaluation Period|Adverse Event|0|||
28029876|NCT00442702|54688345|FG000|Evaluation Period|Death|1|||
28029877|NCT00442702|54688346|FG001|Evaluation Period|Death|1|||
28029878|NCT00442702|54688345|FG000|Evaluation Period|Insufficient Therapeutic Response|1|||
28029879|NCT00442702|54688346|FG001|Evaluation Period|Insufficient Therapeutic Response|0|||
28029880|NCT00442702|54688345|FG000|Evaluation Period|Refused treatment|1|||
28029881|NCT00442702|54688346|FG001|Evaluation Period|Refused treatment|1|||
28029882|NCT00442702|54688345|FG000|Evaluation Period|Renal transplant|0|||
28029883|NCT00442702|54688346|FG001|Evaluation Period|Renal transplant|1|||
28029884|NCT00442702|54688345|FG000|Evaluation Period|Failure to return|1|||
28029885|NCT00442702|54688346|FG001|Evaluation Period|Failure to return|0|||
28029886|NCT00442702|54688345|FG000|Evaluation Period|Site closure|0|||
28029887|NCT00442702|54688346|FG001|Evaluation Period|Site closure|1|||
28029888|NCT00514917|54688354|FG000|Overall Study|Death|4|||
28029889|NCT00514917|54688355|FG001|Overall Study|Death|10|||
28029890|NCT00514917|54688354|FG000|Overall Study|Protocol Violation|1|||
28029891|NCT00514917|54688355|FG001|Overall Study|Protocol Violation|0|||
28029892|NCT00514917|54688354|FG000|Overall Study|Lost to Follow-up|4|||
28029893|NCT00514917|54688355|FG001|Overall Study|Lost to Follow-up|3|||
28029894|NCT00514917|54688354|FG000|Overall Study|Withdrawal by Subject|18|||
28029895|NCT00514917|54688355|FG001|Overall Study|Withdrawal by Subject|16|||
28029896|NCT00514917|54688354|FG000|Overall Study|Discontinued due to study closure|88|||
27807043|NCT01799889|54262546|FG001|Overall Study|Progressive Disease|26|||
27807044|NCT01799889|54262547|FG002|Overall Study|Progressive Disease|25|||
27807045|NCT01799889|54262548|FG003|Overall Study|Progressive Disease|30|||
27807046|NCT01799889|54262549|FG004|Overall Study|Progressive Disease|23|||
27807047|NCT01799889|54262550|FG005|Overall Study|Progressive Disease|9|||
27807048|NCT01799889|54262551|FG006|Overall Study|Progressive Disease|8|||
27844046|NCT01412957|54333507|FG000|Overall Study|Death|136|||
27844047|NCT01412957|54333508|FG001|Overall Study|Death|133|||
28029897|NCT00514917|54688355|FG001|Overall Study|Discontinued due to study closure|81|||
28029898|NCT00514917|54688354|FG000|Overall Study|Undefined|11|||
28029899|NCT00514917|54688355|FG001|Overall Study|Undefined|5|||
28029900|NCT00711425|54688363|FG000|Overall Study|Protocol Violation|1|||
28029901|NCT00711425|54688363|FG000|Overall Study|Death|2|||
28029902|NCT00711425|54688363|FG000|Overall Study|Lost to Follow-up|1|||
28029903|NCT00504075|54688367|FG000|Overall Study|Adverse Event|1|||
28029904|NCT00504075|54688367|FG000|Overall Study|Lost to Follow-up|5|||
27939687|NCT01040793|54595908|FG004|Overall Study|Other reasons not listed above|1|||
27939688|NCT01040793|54595909|FG005|Overall Study|Other reasons not listed above|0|||
27939689|NCT00948064|54595922|FG000|Phase I|No treatment received|1|||
27939690|NCT00948064|54595923|FG001|Phase I|No treatment received|0|||
28029905|NCT00504075|54688367|FG000|Overall Study|Withdrawal by Subject|1|||
27807049|NCT01799889|54262552|FG007|Overall Study|Progressive Disease|13|||
27939691|NCT00948064|54595924|FG002|Phase I|No treatment received|0|||
28029906|NCT00504075|54688367|FG000|Overall Study|Required other therapeutic intervention|1|||
28029907|NCT00503997|54688372|FG000|Overall Study|disease progression|1|||
28029908|NCT00503997|54688372|FG000|Overall Study|Adverse Event|5|||
27807050|NCT01799889|54262553|FG008|Overall Study|Progressive Disease|18|||
27807051|NCT01799889|54262554|FG009|Overall Study|Progressive Disease|5|||
27807052|NCT01799889|54262555|FG010|Overall Study|Progressive Disease|3|||
27807053|NCT01799889|54262556|FG011|Overall Study|Progressive Disease|1|||
27807054|NCT01799889|54262545|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
27807055|NCT01799889|54262546|FG001|Overall Study|Specified Criteria for Withdrawal|1|||
27807056|NCT01799889|54262547|FG002|Overall Study|Specified Criteria for Withdrawal|1|||
27807057|NCT01799889|54262548|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
27807058|NCT01799889|54262549|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
27807059|NCT01799889|54262550|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
27844048|NCT01432457|54333517|FG000|Overall Study|Adverse Event|7|||
27844049|NCT01432457|54333518|FG001|Overall Study|Adverse Event|10|||
27844050|NCT01432457|54333519|FG002|Overall Study|Adverse Event|16|||
27844051|NCT01432457|54333517|FG000|Overall Study|Lack of Efficacy|2|||
27844052|NCT01432457|54333518|FG001|Overall Study|Lack of Efficacy|1|||
27844053|NCT01432457|54333519|FG002|Overall Study|Lack of Efficacy|1|||
27844054|NCT01432457|54333517|FG000|Overall Study|Lost to Follow-up|11|||
27844055|NCT01432457|54333518|FG001|Overall Study|Lost to Follow-up|15|||
27844056|NCT01432457|54333519|FG002|Overall Study|Lost to Follow-up|20|||
27844057|NCT01432457|54333517|FG000|Overall Study|Protocol Violation|3|||
27844058|NCT01432457|54333518|FG001|Overall Study|Protocol Violation|2|||
27844059|NCT01432457|54333519|FG002|Overall Study|Protocol Violation|6|||
27844060|NCT01432457|54333517|FG000|Overall Study|Withdrawal by Subject|6|||
27844061|NCT01432457|54333518|FG001|Overall Study|Withdrawal by Subject|11|||
27844062|NCT01432457|54333519|FG002|Overall Study|Withdrawal by Subject|9|||
27844063|NCT01432457|54333517|FG000|Overall Study|Reasons not defined|2|||
27844064|NCT01432457|54333518|FG001|Overall Study|Reasons not defined|3|||
27844065|NCT01432457|54333519|FG002|Overall Study|Reasons not defined|4|||
27844066|NCT01432457|54333517|FG000|Overall Study|Did not take study drug|6|||
27844067|NCT01432457|54333518|FG001|Overall Study|Did not take study drug|6|||
27844068|NCT01432457|54333519|FG002|Overall Study|Did not take study drug|3|||
27844069|NCT01390441|54333541|FG000|Treatment Period|Protocol Violation|0|||
27844070|NCT01390441|54333542|FG001|Treatment Period|Protocol Violation|1|||
27844071|NCT01390441|54333543|FG002|Treatment Period|Protocol Violation|0|||
27844072|NCT01390441|54333544|FG003|Treatment Period|Protocol Violation|0|||
27939692|NCT00948064|54595922|FG000|Phase II|Physician Decision|0|||
28029909|NCT00503997|54688372|FG000|Overall Study|Death|1|||
28029910|NCT00503997|54688372|FG000|Overall Study|Withdrawal by Subject|1|||
28029911|NCT00096265|54688379|FG000|Overall Study|Ineligible|1|||
28029912|NCT00096265|54688380|FG001|Overall Study|Ineligible|0|||
28029913|NCT00096265|54688381|FG002|Overall Study|Ineligible|0|||
28029914|NCT00711191|54688393|FG000|Overall Study|Adverse Event|1|||
28029915|NCT00711191|54688394|FG001|Overall Study|Adverse Event|1|||
28029916|NCT00711191|54688395|FG002|Overall Study|Adverse Event|2|||
28029917|NCT00711191|54688393|FG000|Overall Study|Objective progression or relapse|2|||
28029918|NCT00711191|54688394|FG001|Overall Study|Objective progression or relapse|3|||
28029919|NCT00711191|54688395|FG002|Overall Study|Objective progression or relapse|7|||
28029920|NCT00711191|54688393|FG000|Overall Study|Withdrawal by Subject|0|||
28029921|NCT00711191|54688394|FG001|Overall Study|Withdrawal by Subject|1|||
28029922|NCT00711191|54688395|FG002|Overall Study|Withdrawal by Subject|3|||
28029923|NCT00706511|54688410|FG000|Overall Study|Withdrawal by Subject|1|||
28029924|NCT00706511|54688411|FG001|Overall Study|Withdrawal by Subject|0|||
28029925|NCT00706511|54688412|FG002|Overall Study|Withdrawal by Subject|0|||
28029926|NCT00706511|54688413|FG003|Overall Study|Withdrawal by Subject|0|||
27807060|NCT01799889|54262551|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
27807061|NCT01799889|54262552|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
27807062|NCT01799889|54262553|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
27807063|NCT01799889|54262554|FG009|Overall Study|Specified Criteria for Withdrawal|0|||
27807064|NCT01799889|54262555|FG010|Overall Study|Specified Criteria for Withdrawal|0|||
27807065|NCT01799889|54262556|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
27807066|NCT01799889|54262545|FG000|Overall Study|Study Terminated By Sponsor|1|||
27844073|NCT01390441|54333545|FG004|Treatment Period|Protocol Violation|0|||
27844074|NCT01390441|54333541|FG000|Treatment Period|Physician Decision|0|||
27844075|NCT01390441|54333542|FG001|Treatment Period|Physician Decision|0|||
28029927|NCT00448864|54688424|FG000|Overall Study|Death|1|||
28029928|NCT00448864|54688425|FG001|Overall Study|Death|0|||
28029929|NCT00448864|54688426|FG002|Overall Study|Death|0|||
28029930|NCT00448864|54688424|FG000|Overall Study|Lost to Follow-up|3|||
27939693|NCT00948064|54595923|FG001|Phase II|Physician Decision|0|||
27939694|NCT00948064|54595924|FG002|Phase II|Physician Decision|1|||
28029931|NCT00448864|54688425|FG001|Overall Study|Lost to Follow-up|1|||
27807067|NCT01799889|54262546|FG001|Overall Study|Study Terminated By Sponsor|0|||
27807068|NCT01799889|54262547|FG002|Overall Study|Study Terminated By Sponsor|0|||
27807069|NCT01799889|54262548|FG003|Overall Study|Study Terminated By Sponsor|0|||
27844076|NCT01390441|54333543|FG002|Treatment Period|Physician Decision|0|||
28029932|NCT00448864|54688426|FG002|Overall Study|Lost to Follow-up|0|||
28029933|NCT00448864|54688424|FG000|Overall Study|Physician Decision|1|||
28029934|NCT00448864|54688425|FG001|Overall Study|Physician Decision|0|||
28029935|NCT00448864|54688426|FG002|Overall Study|Physician Decision|1|||
28029936|NCT00448864|54688424|FG000|Overall Study|Withdrawal by Subject|0|||
28029937|NCT00448864|54688425|FG001|Overall Study|Withdrawal by Subject|2|||
28029938|NCT00448864|54688426|FG002|Overall Study|Withdrawal by Subject|0|||
28029939|NCT00448864|54688424|FG000|Overall Study|Protocol Violation|0|||
28029940|NCT00448864|54688425|FG001|Overall Study|Protocol Violation|2|||
28029941|NCT00448864|54688426|FG002|Overall Study|Protocol Violation|0|||
28029942|NCT00567398|54688438|FG000|Overall Study|Adverse Event|6|||
28029943|NCT00567398|54688439|FG001|Overall Study|Adverse Event|14|||
28029944|NCT00567398|54688438|FG000|Overall Study|Physician Decision|0|||
28029945|NCT00567398|54688439|FG001|Overall Study|Physician Decision|4|||
28029946|NCT00567398|54688438|FG000|Overall Study|Withdrawal by Subject|0|||
28029947|NCT00567398|54688439|FG001|Overall Study|Withdrawal by Subject|2|||
28029948|NCT00567398|54688438|FG000|Overall Study|Renal Transplantation|0|||
28029949|NCT00567398|54688439|FG001|Overall Study|Renal Transplantation|3|||
28029950|NCT00567398|54688438|FG000|Overall Study|Other|1|||
28029951|NCT00567398|54688439|FG001|Overall Study|Other|0|||
28029952|NCT00448708|54688447|FG000|Overall Study|Death|21|||
28029953|NCT00448708|54688448|FG001|Overall Study|Death|17|||
28029954|NCT00448708|54688447|FG000|Overall Study|Withdrawal by Subject|8|||
28029955|NCT00448708|54688448|FG001|Overall Study|Withdrawal by Subject|4|||
28029956|NCT00448708|54688447|FG000|Overall Study|Lost to Follow-up|6|||
28029957|NCT00448708|54688448|FG001|Overall Study|Lost to Follow-up|8|||
28029958|NCT00448708|54688447|FG000|Overall Study|not listed|0|||
28029959|NCT00448708|54688448|FG001|Overall Study|not listed|2|||
28029960|NCT00706355|54688458|FG000|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1|||
28029961|NCT00706355|54688459|FG001|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
28029962|NCT00706355|54688460|FG002|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
28029963|NCT00706355|54688461|FG003|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
28029964|NCT00706355|54688458|FG000|Period 1: PF-04217903 50 mg|Objective progression or relapse|2|||
28029965|NCT00706355|54688459|FG001|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
28029966|NCT00706355|54688460|FG002|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
28029967|NCT00706355|54688461|FG003|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
28029968|NCT00706355|54688458|FG000|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
28029969|NCT00706355|54688459|FG001|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1|||
28029970|NCT00706355|54688460|FG002|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
28029971|NCT00706355|54688461|FG003|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
28029972|NCT00706355|54688458|FG000|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
28029973|NCT00706355|54688459|FG001|Period 2: PF-04217903 100 mg|Global deterioration of health status|1|||
28029974|NCT00706355|54688460|FG002|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
28029975|NCT00706355|54688461|FG003|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
28029976|NCT00706355|54688458|FG000|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
28029977|NCT00706355|54688459|FG001|Period 2: PF-04217903 100 mg|Objective progression or relapse|5|||
28029978|NCT00706355|54688460|FG002|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
28029979|NCT00706355|54688461|FG003|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
28029980|NCT00706355|54688458|FG000|Period 3: PF-04217903 200 mg|Adverse Event|0|||
28029981|NCT00706355|54688459|FG001|Period 3: PF-04217903 200 mg|Adverse Event|0|||
28029982|NCT00706355|54688460|FG002|Period 3: PF-04217903 200 mg|Adverse Event|1|||
28029983|NCT00706355|54688461|FG003|Period 3: PF-04217903 200 mg|Adverse Event|0|||
28029984|NCT00706355|54688458|FG000|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
28029985|NCT00706355|54688459|FG001|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
28029986|NCT00706355|54688460|FG002|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1|||
28029987|NCT00706355|54688461|FG003|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
28029988|NCT00706355|54688458|FG000|Period 4: PF-04217903 150 mg|Adverse Event|0|||
28029989|NCT00706355|54688459|FG001|Period 4: PF-04217903 150 mg|Adverse Event|0|||
28029990|NCT00706355|54688460|FG002|Period 4: PF-04217903 150 mg|Adverse Event|0|||
28029991|NCT00706355|54688461|FG003|Period 4: PF-04217903 150 mg|Adverse Event|2|||
28029992|NCT00706355|54688458|FG000|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
28029993|NCT00706355|54688459|FG001|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
28029994|NCT00706355|54688460|FG002|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
28029995|NCT00706355|54688461|FG003|Period 4: PF-04217903 150 mg|Objective progression or relapse|2|||
28029996|NCT00711113|54688473|FG000|Overall Study|Lost to Follow-up|9|||
28029997|NCT00711113|54688473|FG000|Overall Study|Implant lost|2|||
28029998|NCT00710879|54688483|FG000|Overall Study|Lost to Follow-up|2|||
27807070|NCT01799889|54262549|FG004|Overall Study|Study Terminated By Sponsor|2|||
27807071|NCT01799889|54262550|FG005|Overall Study|Study Terminated By Sponsor|1|||
27807072|NCT01799889|54262551|FG006|Overall Study|Study Terminated By Sponsor|0|||
27807073|NCT01799889|54262552|FG007|Overall Study|Study Terminated By Sponsor|2|||
27939695|NCT00948064|54595922|FG000|Phase II|Withdrawal by Subject|0|||
27939696|NCT00948064|54595923|FG001|Phase II|Withdrawal by Subject|1|||
28029999|NCT00710879|54688484|FG001|Overall Study|Lost to Follow-up|1|||
28030000|NCT00710879|54688483|FG000|Overall Study|Protocol Violation|0|||
28030001|NCT00710879|54688484|FG001|Overall Study|Protocol Violation|3|||
28030002|NCT03979274|54688490|FG000|Treatment Period 2|Withdrawal by Subject|0|||
27807074|NCT01799889|54262553|FG008|Overall Study|Study Terminated By Sponsor|1|||
27807075|NCT01799889|54262554|FG009|Overall Study|Study Terminated By Sponsor|1|||
27807076|NCT01799889|54262555|FG010|Overall Study|Study Terminated By Sponsor|0|||
27807077|NCT01799889|54262556|FG011|Overall Study|Study Terminated By Sponsor|0|||
27807078|NCT01799889|54262545|FG000|Overall Study|Withdrawal by Subject|1|||
27807079|NCT01799889|54262546|FG001|Overall Study|Withdrawal by Subject|6|||
27807080|NCT01799889|54262547|FG002|Overall Study|Withdrawal by Subject|4|||
27807081|NCT01799889|54262548|FG003|Overall Study|Withdrawal by Subject|0|||
27807082|NCT01799889|54262549|FG004|Overall Study|Withdrawal by Subject|5|||
27807083|NCT01799889|54262550|FG005|Overall Study|Withdrawal by Subject|1|||
27807084|NCT01799889|54262551|FG006|Overall Study|Withdrawal by Subject|3|||
27807085|NCT01799889|54262552|FG007|Overall Study|Withdrawal by Subject|1|||
27807086|NCT01799889|54262553|FG008|Overall Study|Withdrawal by Subject|2|||
27807087|NCT01799889|54262554|FG009|Overall Study|Withdrawal by Subject|1|||
27807088|NCT01799889|54262555|FG010|Overall Study|Withdrawal by Subject|1|||
28030003|NCT03979274|54688491|FG001|Treatment Period 2|Withdrawal by Subject|1|||
28030004|NCT00459316|54688501|FG000|Steps 1 & 2|Other eligibility failure|1|||
28030005|NCT00459316|54688502|FG001|Steps 1 & 2|Other eligibility failure|1|||
27939697|NCT00948064|54595924|FG002|Phase II|Withdrawal by Subject|0|||
27807089|NCT01799889|54262556|FG011|Overall Study|Withdrawal by Subject|1|||
27807090|NCT01799889|54262545|FG000|Overall Study|Non-Compliance With Study Drug|0|||
27807091|NCT01799889|54262546|FG001|Overall Study|Non-Compliance With Study Drug|0|||
27807092|NCT01799889|54262547|FG002|Overall Study|Non-Compliance With Study Drug|0|||
27807093|NCT01799889|54262548|FG003|Overall Study|Non-Compliance With Study Drug|0|||
27807094|NCT01799889|54262549|FG004|Overall Study|Non-Compliance With Study Drug|0|||
27807095|NCT01799889|54262550|FG005|Overall Study|Non-Compliance With Study Drug|1|||
27807096|NCT01799889|54262551|FG006|Overall Study|Non-Compliance With Study Drug|0|||
27807097|NCT01799889|54262552|FG007|Overall Study|Non-Compliance With Study Drug|0|||
27807098|NCT01799889|54262553|FG008|Overall Study|Non-Compliance With Study Drug|0|||
27807099|NCT01799889|54262554|FG009|Overall Study|Non-Compliance With Study Drug|0|||
27807100|NCT01799889|54262555|FG010|Overall Study|Non-Compliance With Study Drug|0|||
27807101|NCT01799889|54262556|FG011|Overall Study|Non-Compliance With Study Drug|0|||
27807102|NCT01412944|54262595|FG000|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
27807103|NCT01412944|54262596|FG001|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
27807104|NCT01412944|54262597|FG002|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1|||
27807105|NCT01412944|54262598|FG003|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
27807106|NCT01412944|54262599|FG004|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
27807107|NCT01412944|54262600|FG005|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
27807108|NCT01412944|54262595|FG000|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
27807109|NCT01412944|54262596|FG001|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
27807110|NCT01412944|54262597|FG002|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
27807111|NCT01412944|54262598|FG003|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
27807112|NCT01412944|54262599|FG004|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
27807113|NCT01412944|54262600|FG005|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1|||
27807114|NCT01412944|54262595|FG000|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
27807115|NCT01412944|54262596|FG001|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
27807116|NCT01412944|54262597|FG002|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
27807117|NCT01412944|54262598|FG003|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
27807118|NCT01412944|54262599|FG004|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
27939698|NCT00953524|54595938|FG000|Overall Study|Adverse Event|2|||
27939699|NCT00953524|54595939|FG001|Overall Study|Adverse Event|0|||
27939700|NCT00953524|54595940|FG002|Overall Study|Adverse Event|1|||
27939701|NCT00953524|54595941|FG003|Overall Study|Adverse Event|2|||
27939702|NCT00953524|54595938|FG000|Overall Study|Protocol Violation|18|||
27939703|NCT00953524|54595939|FG001|Overall Study|Protocol Violation|10|||
27939704|NCT00953524|54595940|FG002|Overall Study|Protocol Violation|11|||
27939705|NCT00953524|54595941|FG003|Overall Study|Protocol Violation|6|||
27939706|NCT00953524|54595938|FG000|Overall Study|Lost to Follow-up|0|||
27939707|NCT00953524|54595939|FG001|Overall Study|Lost to Follow-up|1|||
27939708|NCT00953524|54595940|FG002|Overall Study|Lost to Follow-up|1|||
27807119|NCT01412944|54262600|FG005|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1|||
27807120|NCT01412944|54262595|FG000|IV: Per CAIN457A2307|Withdrawal by Subject|1|||
27807121|NCT01412944|54262596|FG001|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
27844077|NCT01390441|54333544|FG003|Treatment Period|Physician Decision|1|||
28030006|NCT00459316|54688503|FG002|Steps 1 & 2|Other eligibility failure|0|||
28030007|NCT00459316|54688501|FG000|Steps 1 & 2|Death|1|||
28030008|NCT00459316|54688502|FG001|Steps 1 & 2|Death|1|||
28030009|NCT00459316|54688503|FG002|Steps 1 & 2|Death|0|||
28030010|NCT00459316|54688501|FG000|Steps 1 & 2|Not able to get to clinic|7|||
28030011|NCT00459316|54688502|FG001|Steps 1 & 2|Not able to get to clinic|4|||
28030012|NCT00459316|54688503|FG002|Steps 1 & 2|Not able to get to clinic|0|||
28030013|NCT00459316|54688501|FG000|Steps 1 & 2|Withdrawal by Subject|6|||
28030014|NCT00459316|54688502|FG001|Steps 1 & 2|Withdrawal by Subject|1|||
28030015|NCT00459316|54688503|FG002|Steps 1 & 2|Withdrawal by Subject|0|||
28030016|NCT00459316|54688501|FG000|Steps 1 & 2|Not willing to adhere to regulations|1|||
28030017|NCT00459316|54688502|FG001|Steps 1 & 2|Not willing to adhere to regulations|0|||
28030018|NCT00459316|54688503|FG002|Steps 1 & 2|Not willing to adhere to regulations|0|||
28030019|NCT00459316|54688501|FG000|Steps 1 & 2|Lost to Follow-up|5|||
28030020|NCT00459316|54688502|FG001|Steps 1 & 2|Lost to Follow-up|0|||
28030021|NCT00459316|54688503|FG002|Steps 1 & 2|Lost to Follow-up|2|||
28030022|NCT00459316|54688501|FG000|Step 3|Withdrawal by Subject|3|||
28030023|NCT00459316|54688502|FG001|Step 3|Withdrawal by Subject|0|||
28030024|NCT00459316|54688503|FG002|Step 3|Withdrawal by Subject|1|||
28030025|NCT00567164|54688529|FG000|Overall Study|Withdrawal by Subject|171|||
28030026|NCT00567164|54688530|FG001|Overall Study|Withdrawal by Subject|21|||
28030027|NCT00567164|54688531|FG002|Overall Study|Withdrawal by Subject|17|||
28030028|NCT00567164|54688529|FG000|Overall Study|Protocol Violation|23|||
28030029|NCT00567164|54688530|FG001|Overall Study|Protocol Violation|4|||
28030030|NCT00567164|54688531|FG002|Overall Study|Protocol Violation|2|||
28030031|NCT00567164|54688529|FG000|Overall Study|Adverse Event|92|||
28030032|NCT00567164|54688530|FG001|Overall Study|Adverse Event|13|||
28030033|NCT00567164|54688531|FG002|Overall Study|Adverse Event|9|||
28030034|NCT00567164|54688529|FG000|Overall Study|Death|0|||
28030035|NCT00567164|54688530|FG001|Overall Study|Death|0|||
28030036|NCT00567164|54688531|FG002|Overall Study|Death|1|||
28030037|NCT00567164|54688529|FG000|Overall Study|Lost to Follow-up|202|||
28030038|NCT00567164|54688530|FG001|Overall Study|Lost to Follow-up|23|||
28030039|NCT00567164|54688531|FG002|Overall Study|Lost to Follow-up|21|||
28030040|NCT00567164|54688529|FG000|Overall Study|Pregnancy|20|||
28030041|NCT00567164|54688530|FG001|Overall Study|Pregnancy|4|||
28030042|NCT00567164|54688531|FG002|Overall Study|Pregnancy|6|||
27807122|NCT01412944|54262597|FG002|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
28030043|NCT00567164|54688529|FG000|Overall Study|Primary Reason coded as 'Other'|37|||
28030044|NCT00567164|54688530|FG001|Overall Study|Primary Reason coded as 'Other'|8|||
27807123|NCT01412944|54262598|FG003|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
28030045|NCT00567164|54688531|FG002|Overall Study|Primary Reason coded as 'Other'|16|||
28030046|NCT00567164|54688529|FG000|Overall Study|Missing|1|||
28030047|NCT00567164|54688530|FG001|Overall Study|Missing|0|||
28030048|NCT00567164|54688531|FG002|Overall Study|Missing|0|||
28030049|NCT00713219|54688543|FG000|Overall Study|Death|1|||
28030050|NCT00713219|54688543|FG000|Overall Study|Protocol Violation|1|||
28030051|NCT00712985|54688547|FG000|Overall Study|1 withdrew prior to start of drug|1|||
28030052|NCT00712985|54688547|FG000|Overall Study|1 patient moved out of state|1|||
28030053|NCT00712985|54688547|FG000|Overall Study|Lack of Efficacy|3|||
28030054|NCT00700115|54688553|FG000|Overall Study|Withdrawal by Subject|1|||
28030055|NCT00700115|54688554|FG001|Overall Study|Withdrawal by Subject|0|||
27807124|NCT01412944|54262599|FG004|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
27807125|NCT01412944|54262600|FG005|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
28030056|NCT00700115|54688553|FG000|Overall Study|Lost to Follow-up|0|||
28030057|NCT00700115|54688554|FG001|Overall Study|Lost to Follow-up|1|||
28030058|NCT00566852|54688562|FG000|Overall Study|Protocol Violation|22|||
28030059|NCT00566852|54688563|FG001|Overall Study|Protocol Violation|24|||
28030060|NCT00566852|54688562|FG000|Overall Study|Death|95|||
28030061|NCT00566852|54688563|FG001|Overall Study|Death|78|||
28030062|NCT00566852|54688562|FG000|Overall Study|Withdrawal by Subject|30|||
27807126|NCT01412944|54262595|FG000|IV: Per CAIN457A2307|Protocol deviation|0|||
27807127|NCT01412944|54262596|FG001|IV: Per CAIN457A2307|Protocol deviation|1|||
27807128|NCT01412944|54262597|FG002|IV: Per CAIN457A2307|Protocol deviation|0|||
27807129|NCT01412944|54262598|FG003|IV: Per CAIN457A2307|Protocol deviation|0|||
27807130|NCT01412944|54262599|FG004|IV: Per CAIN457A2307|Protocol deviation|0|||
27939709|NCT00953524|54595941|FG003|Overall Study|Lost to Follow-up|0|||
27939710|NCT00953524|54595938|FG000|Overall Study|Withdrawal by Subject|2|||
28030063|NCT00566852|54688563|FG001|Overall Study|Withdrawal by Subject|25|||
28030064|NCT00566852|54688562|FG000|Overall Study|Patient refusal|37|||
28030065|NCT00566852|54688563|FG001|Overall Study|Patient refusal|37|||
28030066|NCT00566852|54688562|FG000|Overall Study|Not tested due to disability|6|||
28030067|NCT00566852|54688563|FG001|Overall Study|Not tested due to disability|12|||
28030068|NCT00566852|54688562|FG000|Overall Study|Missing reason not specified|1|||
28030069|NCT00566852|54688563|FG001|Overall Study|Missing reason not specified|2|||
28030070|NCT00566852|54688562|FG000|Overall Study|Missing reason not reported|16|||
28030071|NCT00566852|54688563|FG001|Overall Study|Missing reason not reported|20|||
28030072|NCT00442546|54688572|FG000|Overall Study|Adverse Event|11|||
28030073|NCT00442546|54688573|FG001|Overall Study|Adverse Event|17|||
28030074|NCT00442546|54688574|FG002|Overall Study|Adverse Event|13|||
28030075|NCT00442546|54688572|FG000|Overall Study|Lost to Follow-up|1|||
28030076|NCT00442546|54688573|FG001|Overall Study|Lost to Follow-up|2|||
28030077|NCT00442546|54688574|FG002|Overall Study|Lost to Follow-up|1|||
28030078|NCT00442546|54688572|FG000|Overall Study|Other|4|||
28030079|NCT00442546|54688573|FG001|Overall Study|Other|9|||
28030080|NCT00442546|54688574|FG002|Overall Study|Other|6|||
28030081|NCT00442546|54688572|FG000|Overall Study|Withdrawal by Subject|5|||
28030082|NCT00442546|54688573|FG001|Overall Study|Withdrawal by Subject|5|||
28030083|NCT00442546|54688574|FG002|Overall Study|Withdrawal by Subject|7|||
27844078|NCT01390441|54333545|FG004|Treatment Period|Physician Decision|0|||
27844079|NCT01390441|54333541|FG000|Treatment Period|Lack of Efficacy|0|||
27844080|NCT01390441|54333542|FG001|Treatment Period|Lack of Efficacy|0|||
27844081|NCT01390441|54333543|FG002|Treatment Period|Lack of Efficacy|0|||
27844082|NCT01390441|54333544|FG003|Treatment Period|Lack of Efficacy|0|||
27844083|NCT01390441|54333545|FG004|Treatment Period|Lack of Efficacy|1|||
27844084|NCT01390441|54333541|FG000|Treatment Period|Unknown due to early stopping of study|0|||
27844085|NCT01390441|54333542|FG001|Treatment Period|Unknown due to early stopping of study|0|||
27844086|NCT01390441|54333543|FG002|Treatment Period|Unknown due to early stopping of study|8|||
27844087|NCT01390441|54333544|FG003|Treatment Period|Unknown due to early stopping of study|11|||
27844088|NCT01390441|54333545|FG004|Treatment Period|Unknown due to early stopping of study|7|||
27844089|NCT01390441|54333541|FG000|Treatment Period|Adverse Event|0|||
28030084|NCT00442546|54688572|FG000|Overall Study|Randomized But Not Treated|5|||
28030085|NCT00442546|54688573|FG001|Overall Study|Randomized But Not Treated|4|||
28030086|NCT00442546|54688574|FG002|Overall Study|Randomized But Not Treated|6|||
28030087|NCT00514683|54688589|FG000|Overall Study|Not treated|2|||
28030088|NCT00514683|54688590|FG001|Overall Study|Not treated|1|||
28030089|NCT00514683|54688591|FG002|Overall Study|Not treated|0|||
27807131|NCT01412944|54262600|FG005|IV: Per CAIN457A2307|Protocol deviation|0|||
27807132|NCT01412944|54262595|FG000|IV: Per CAIN457A2307|Lost to Follow-up|0|||
27807133|NCT01412944|54262596|FG001|IV: Per CAIN457A2307|Lost to Follow-up|1|||
27807134|NCT01412944|54262597|FG002|IV: Per CAIN457A2307|Lost to Follow-up|0|||
27807135|NCT01412944|54262598|FG003|IV: Per CAIN457A2307|Lost to Follow-up|0|||
27807136|NCT01412944|54262599|FG004|IV: Per CAIN457A2307|Lost to Follow-up|0|||
27807137|NCT01412944|54262600|FG005|IV: Per CAIN457A2307|Lost to Follow-up|0|||
27807138|NCT01412944|54262595|FG000|Entire: IV + Maintenance|Withdrawal by Subject|0|||
27807139|NCT01412944|54262596|FG001|Entire: IV + Maintenance|Withdrawal by Subject|0|||
27807140|NCT01412944|54262597|FG002|Entire: IV + Maintenance|Withdrawal by Subject|1|||
27807141|NCT01412944|54262598|FG003|Entire: IV + Maintenance|Withdrawal by Subject|1|||
27807142|NCT01412944|54262599|FG004|Entire: IV + Maintenance|Withdrawal by Subject|1|||
27807143|NCT01412944|54262600|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
27807144|NCT01412944|54262595|FG000|Entire: IV + Maintenance|Adverse Event|0|||
27807145|NCT01412944|54262596|FG001|Entire: IV + Maintenance|Adverse Event|0|||
27807146|NCT01412944|54262597|FG002|Entire: IV + Maintenance|Adverse Event|0|||
27807147|NCT01412944|54262598|FG003|Entire: IV + Maintenance|Adverse Event|0|||
27807148|NCT01412944|54262599|FG004|Entire: IV + Maintenance|Adverse Event|1|||
27807149|NCT01412944|54262600|FG005|Entire: IV + Maintenance|Adverse Event|0|||
27807150|NCT01412944|54262595|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
27807151|NCT01412944|54262596|FG001|Entire: IV + Maintenance|Protocol deviation|0|||
27807152|NCT01412944|54262597|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
27807153|NCT01412944|54262598|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
27807154|NCT01412944|54262599|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
27844090|NCT01390441|54333542|FG001|Treatment Period|Adverse Event|0|||
27844091|NCT01390441|54333543|FG002|Treatment Period|Adverse Event|1|||
27844092|NCT01390441|54333544|FG003|Treatment Period|Adverse Event|1|||
27807155|NCT01412944|54262600|FG005|Entire: IV + Maintenance|Protocol deviation|1|||
27807156|NCT01412944|54262595|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
27807157|NCT01412944|54262596|FG001|Entire: IV + Maintenance|Lost to Follow-up|0|||
27807158|NCT01412944|54262597|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
27807159|NCT01412944|54262598|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
27807160|NCT01412944|54262599|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
27807161|NCT01412944|54262600|FG005|Entire: IV + Maintenance|Lost to Follow-up|1|||
27807162|NCT01412944|54262595|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
27807163|NCT01412944|54262596|FG001|Entire: IV + Maintenance|Lack of Efficacy|0|||
27807164|NCT01412944|54262597|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
27844093|NCT01390441|54333545|FG004|Treatment Period|Adverse Event|2|||
27844094|NCT01390441|54333541|FG000|Treatment Period|Withdrawal by Subject|0|||
27844095|NCT01390441|54333542|FG001|Treatment Period|Withdrawal by Subject|0|||
27807165|NCT01412944|54262598|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
27844096|NCT01390441|54333543|FG002|Treatment Period|Withdrawal by Subject|1|||
27844097|NCT01390441|54333544|FG003|Treatment Period|Withdrawal by Subject|0|||
27807166|NCT01412944|54262599|FG004|Entire: IV + Maintenance|Lack of Efficacy|1|||
27807167|NCT01412944|54262600|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
28030090|NCT00514683|54688592|FG003|Overall Study|Not treated|0|||
28030091|NCT00514683|54688593|FG004|Overall Study|Not treated|1|||
28030092|NCT00514683|54688589|FG000|Overall Study|Adverse Event|21|||
28030093|NCT00514683|54688590|FG001|Overall Study|Adverse Event|20|||
27807168|NCT01412944|54262595|FG000|Entire: IV + Maintenance|Withdrawal by Subject|2|||
27807169|NCT01412944|54262596|FG001|Entire: IV + Maintenance|Withdrawal by Subject|1|||
27807170|NCT01412944|54262597|FG002|Entire: IV + Maintenance|Withdrawal by Subject|0|||
27807171|NCT01412944|54262598|FG003|Entire: IV + Maintenance|Withdrawal by Subject|0|||
27807172|NCT01412944|54262599|FG004|Entire: IV + Maintenance|Withdrawal by Subject|0|||
27807173|NCT01412944|54262600|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
27807174|NCT01412944|54262595|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
28030094|NCT00514683|54688591|FG002|Overall Study|Adverse Event|15|||
28030095|NCT00514683|54688592|FG003|Overall Study|Adverse Event|13|||
28030096|NCT00514683|54688593|FG004|Overall Study|Adverse Event|27|||
28030097|NCT00514683|54688589|FG000|Overall Study|Protocol Violation|1|||
28030098|NCT00514683|54688590|FG001|Overall Study|Protocol Violation|1|||
28030099|NCT00514683|54688591|FG002|Overall Study|Protocol Violation|0|||
28030100|NCT00514683|54688592|FG003|Overall Study|Protocol Violation|1|||
28030101|NCT00514683|54688593|FG004|Overall Study|Protocol Violation|0|||
28030102|NCT00514683|54688589|FG000|Overall Study|Withdrawal by Subject|2|||
28030103|NCT00514683|54688590|FG001|Overall Study|Withdrawal by Subject|2|||
28030104|NCT00514683|54688591|FG002|Overall Study|Withdrawal by Subject|1|||
28030105|NCT00514683|54688592|FG003|Overall Study|Withdrawal by Subject|0|||
28030106|NCT00514683|54688593|FG004|Overall Study|Withdrawal by Subject|4|||
28030107|NCT00514683|54688589|FG000|Overall Study|Reason other than listed above|0|||
28030108|NCT00514683|54688590|FG001|Overall Study|Reason other than listed above|1|||
28030109|NCT00514683|54688591|FG002|Overall Study|Reason other than listed above|2|||
28030110|NCT00514683|54688592|FG003|Overall Study|Reason other than listed above|0|||
28030111|NCT00514683|54688593|FG004|Overall Study|Reason other than listed above|1|||
28030112|NCT00566696|54688609|FG000|Overall Study|Met Exclusion Criteria|2|||
28030113|NCT00566696|54688609|FG000|Overall Study|Muromonab not available|1|||
28030114|NCT00566696|54688609|FG000|Overall Study|Health Status Change|1|||
28030115|NCT00566696|54688609|FG000|Overall Study|Physician Decision|1|||
28030116|NCT00566696|54688609|FG000|Overall Study|Non-Patient Donors|37|||
28030117|NCT00503841|54688613|FG000|Overall Study|All screen failures|44|||
28030118|NCT00442468|54688619|FG000|Overall Study|Adverse Event|4|||
28030119|NCT00442468|54688619|FG000|Overall Study|Withdrawal by Subject|91|||
28030120|NCT00442468|54688619|FG000|Overall Study|Did not complete all study procedures|88|||
28030121|NCT00506883|54688626|FG000|Overall Study|Lost to Follow-up|1|||
28030122|NCT00506883|54688627|FG001|Overall Study|Lost to Follow-up|1|||
27807175|NCT01412944|54262596|FG001|Entire: IV + Maintenance|Protocol deviation|1|||
27807176|NCT01412944|54262597|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
27807177|NCT01412944|54262598|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
27807178|NCT01412944|54262599|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
27807179|NCT01412944|54262600|FG005|Entire: IV + Maintenance|Protocol deviation|0|||
27807180|NCT01412944|54262595|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
27807181|NCT01412944|54262596|FG001|Entire: IV + Maintenance|Lost to Follow-up|1|||
27807182|NCT01412944|54262597|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
27807183|NCT01412944|54262598|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
27807184|NCT01412944|54262599|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
27807185|NCT01412944|54262600|FG005|Entire: IV + Maintenance|Lost to Follow-up|0|||
27807186|NCT01412944|54262595|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
27807187|NCT01412944|54262596|FG001|Entire: IV + Maintenance|Lack of Efficacy|1|||
27807188|NCT01412944|54262597|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
27807189|NCT01412944|54262598|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
27807190|NCT01412944|54262599|FG004|Entire: IV + Maintenance|Lack of Efficacy|0|||
27807191|NCT01412944|54262600|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
27807192|NCT01412944|54262595|FG000|Entire: IV + Maintenance|Adverse Event|0|||
27807193|NCT01412944|54262596|FG001|Entire: IV + Maintenance|Adverse Event|1|||
27807194|NCT01412944|54262597|FG002|Entire: IV + Maintenance|Adverse Event|0|||
27807195|NCT01412944|54262598|FG003|Entire: IV + Maintenance|Adverse Event|0|||
27807196|NCT01412944|54262599|FG004|Entire: IV + Maintenance|Adverse Event|0|||
27807197|NCT01412944|54262600|FG005|Entire: IV + Maintenance|Adverse Event|0|||
27807198|NCT01798485|54262618|FG000|Overall Study|Adverse Event|32|||
27807199|NCT01798485|54262619|FG001|Overall Study|Adverse Event|40|||
27807200|NCT01798485|54262618|FG000|Overall Study|Withdrawal by Subject|27|||
28030123|NCT00506883|54688628|FG002|Overall Study|Lost to Follow-up|1|||
28030124|NCT00506883|54688626|FG000|Overall Study|Withdrawal by Subject|1|||
28030125|NCT00506883|54688627|FG001|Overall Study|Withdrawal by Subject|0|||
28030126|NCT00506883|54688628|FG002|Overall Study|Withdrawal by Subject|1|||
28030127|NCT00506883|54688626|FG000|Overall Study|Lack of Efficacy|0|||
28030128|NCT00506883|54688627|FG001|Overall Study|Lack of Efficacy|1|||
28030129|NCT00506883|54688628|FG002|Overall Study|Lack of Efficacy|1|||
28030130|NCT00506883|54688626|FG000|Overall Study|Other|5|||
28030131|NCT00506883|54688627|FG001|Overall Study|Other|1|||
28030132|NCT00506883|54688628|FG002|Overall Study|Other|1|||
28030133|NCT00503685|54688639|FG000|Overall Study|Adverse Event|0|||
28030134|NCT00503685|54688640|FG001|Overall Study|Adverse Event|0|||
28030135|NCT00503685|54688641|FG002|Overall Study|Adverse Event|2|||
28030136|NCT00503685|54688639|FG000|Overall Study|Withdrawal by Subject|0|||
28030137|NCT00503685|54688640|FG001|Overall Study|Withdrawal by Subject|1|||
28030138|NCT00503685|54688641|FG002|Overall Study|Withdrawal by Subject|0|||
28030139|NCT00503685|54688639|FG000|Overall Study|Protocol Violation|0|||
28030140|NCT00503685|54688640|FG001|Overall Study|Protocol Violation|1|||
28030141|NCT00503685|54688641|FG002|Overall Study|Protocol Violation|0|||
28030142|NCT00503685|54688639|FG000|Overall Study|Eligibility Criteria Not Met|0|||
28030143|NCT00503685|54688640|FG001|Overall Study|Eligibility Criteria Not Met|1|||
28030144|NCT00503685|54688641|FG002|Overall Study|Eligibility Criteria Not Met|0|||
28030145|NCT00712673|54688653|FG000|Overall Study|Adverse Event|3|||
28030146|NCT00712673|54688654|FG001|Overall Study|Adverse Event|3|||
28030147|NCT00712673|54688655|FG002|Overall Study|Adverse Event|21|||
28030148|NCT00712673|54688656|FG003|Overall Study|Adverse Event|26|||
28030149|NCT00712673|54688653|FG000|Overall Study|Lack of Efficacy|2|||
28030150|NCT00712673|54688654|FG001|Overall Study|Lack of Efficacy|8|||
28030151|NCT00712673|54688655|FG002|Overall Study|Lack of Efficacy|8|||
28030152|NCT00712673|54688656|FG003|Overall Study|Lack of Efficacy|6|||
28030153|NCT00712673|54688653|FG000|Overall Study|Poor Compliance to Protocol|3|||
28030154|NCT00712673|54688654|FG001|Overall Study|Poor Compliance to Protocol|3|||
28030155|NCT00712673|54688655|FG002|Overall Study|Poor Compliance to Protocol|4|||
28030156|NCT00712673|54688656|FG003|Overall Study|Poor Compliance to Protocol|16|||
28030157|NCT00712673|54688653|FG000|Overall Study|Lost to Follow-up|1|||
28030158|NCT00712673|54688654|FG001|Overall Study|Lost to Follow-up|0|||
28030159|NCT00712673|54688655|FG002|Overall Study|Lost to Follow-up|2|||
28030160|NCT00712673|54688656|FG003|Overall Study|Lost to Follow-up|0|||
28030161|NCT00712673|54688653|FG000|Overall Study|Withdrawal by Subject|6|||
28030162|NCT00712673|54688654|FG001|Overall Study|Withdrawal by Subject|7|||
28030163|NCT00712673|54688655|FG002|Overall Study|Withdrawal by Subject|15|||
28030164|NCT00712673|54688656|FG003|Overall Study|Withdrawal by Subject|20|||
28030165|NCT00712673|54688653|FG000|Overall Study|Familial and Personal Reasons|5|||
28030166|NCT00712673|54688654|FG001|Overall Study|Familial and Personal Reasons|0|||
28030167|NCT00712673|54688655|FG002|Overall Study|Familial and Personal Reasons|5|||
28030168|NCT00712673|54688656|FG003|Overall Study|Familial and Personal Reasons|2|||
28030169|NCT00712673|54688653|FG000|Overall Study|Investigator's Decision|1|||
28030170|NCT00712673|54688654|FG001|Overall Study|Investigator's Decision|0|||
28030171|NCT00712673|54688655|FG002|Overall Study|Investigator's Decision|0|||
28030172|NCT00712673|54688656|FG003|Overall Study|Investigator's Decision|0|||
28030173|NCT00712673|54688653|FG000|Overall Study|Protocol Violation|0|||
28030174|NCT00712673|54688654|FG001|Overall Study|Protocol Violation|0|||
28030175|NCT00712673|54688655|FG002|Overall Study|Protocol Violation|2|||
28030176|NCT00712673|54688656|FG003|Overall Study|Protocol Violation|0|||
28030177|NCT03976466|54688677|FG000|Overall Study|Lost to Follow-up|1|||
28030178|NCT03976466|54688678|FG001|Overall Study|Lost to Follow-up|3|||
28030179|NCT02536755|54688686|FG000|Overall Study|Adverse Event|4|||
28030180|NCT03303105|54688695|FG000|Overall Study|Adverse Event|0|||
28030181|NCT03303105|54688696|FG001|Overall Study|Adverse Event|2|||
28030182|NCT03303105|54688695|FG000|Overall Study|Lack of Efficacy|1|||
28030183|NCT03303105|54688696|FG001|Overall Study|Lack of Efficacy|0|||
28030184|NCT03303105|54688695|FG000|Overall Study|Protocol Violation|1|||
28030185|NCT03303105|54688696|FG001|Overall Study|Protocol Violation|0|||
27844098|NCT01390441|54333545|FG004|Treatment Period|Withdrawal by Subject|1|||
27844099|NCT01390441|54333541|FG000|Treatment Period|Lost to Follow-up|1|||
27844100|NCT01390441|54333542|FG001|Treatment Period|Lost to Follow-up|0|||
27844101|NCT01390441|54333543|FG002|Treatment Period|Lost to Follow-up|0|||
27844102|NCT01390441|54333544|FG003|Treatment Period|Lost to Follow-up|0|||
27844103|NCT01390441|54333545|FG004|Treatment Period|Lost to Follow-up|0|||
28030186|NCT03303105|54688695|FG000|Overall Study|Withdrawal by Subject|0|||
28030187|NCT03303105|54688696|FG001|Overall Study|Withdrawal by Subject|2|||
28030188|NCT00447694|54688702|FG000|Overall Study|Adverse Event|2|||
27844104|NCT01390441|54333541|FG000|Extension Period|Protocol Violation|3|||
27844105|NCT01390441|54333542|FG001|Extension Period|Protocol Violation|1|||
27844106|NCT01390441|54333543|FG002|Extension Period|Protocol Violation|0|||
28030189|NCT00447694|54688702|FG000|Overall Study|Abnormal laboratory value|1|||
28030190|NCT00447694|54688702|FG000|Overall Study|Abnormal test procedure result|1|||
28030191|NCT00447694|54688702|FG000|Overall Study|Withdrawal by Subject|2|||
28030192|NCT00564278|54688708|FG000|Overall Study|Lost to Follow-up|35|||
27939711|NCT00953524|54595939|FG001|Overall Study|Withdrawal by Subject|4|||
28030193|NCT00564278|54688709|FG001|Overall Study|Lost to Follow-up|33|||
28030194|NCT00564278|54688708|FG000|Overall Study|Physician Decision|1|||
28030195|NCT00564278|54688709|FG001|Overall Study|Physician Decision|2|||
28030196|NCT00564278|54688708|FG000|Overall Study|Withdrawal by Subject|11|||
28030197|NCT00564278|54688709|FG001|Overall Study|Withdrawal by Subject|7|||
28030198|NCT00565604|54688715|FG000|Overall Study|Failure to treat|2|||
28030199|NCT00565604|54688715|FG000|Overall Study|Lost to Follow-up|2|||
28030200|NCT00447382|54688721|FG000|Overall Study|Adverse Event|1|||
28030201|NCT00447382|54688722|FG001|Overall Study|Adverse Event|1|||
27844107|NCT01390441|54333544|FG003|Extension Period|Protocol Violation|1|||
27844108|NCT01390441|54333545|FG004|Extension Period|Protocol Violation|0|||
28030202|NCT00447382|54688721|FG000|Overall Study|Lack of Efficacy|1|||
28030203|NCT00447382|54688722|FG001|Overall Study|Lack of Efficacy|0|||
28030204|NCT00447382|54688721|FG000|Overall Study|Protocol Violation|2|||
28030205|NCT00447382|54688722|FG001|Overall Study|Protocol Violation|0|||
28030206|NCT00447382|54688721|FG000|Overall Study|Unclassified|2|||
28030207|NCT00447382|54688722|FG001|Overall Study|Unclassified|5|||
28030208|NCT00447226|54688728|FG000|12-Week Open-label Phase|Adverse Event|0|||
28030209|NCT00447226|54688729|FG001|12-Week Open-label Phase|Adverse Event|3|||
28030210|NCT00447226|54688728|FG000|12-Week Open-label Phase|Protocol Violation|0|||
28030211|NCT00447226|54688729|FG001|12-Week Open-label Phase|Protocol Violation|1|||
28030212|NCT00447226|54688728|FG000|12-Week Open-label Phase|Disease Progression|0|||
28030213|NCT00447226|54688729|FG001|12-Week Open-label Phase|Disease Progression|20|||
27844109|NCT01412879|54333594|FG000|Initial Registration (Induction Therapy)|Adverse Event|5|||
27844110|NCT01412879|54333595|FG001|Initial Registration (Induction Therapy)|Adverse Event|3|||
27844111|NCT01412879|54333596|FG002|Initial Registration (Induction Therapy)|Adverse Event|0|||
28030214|NCT00447226|54688728|FG000|12-Week Open-label Phase|Physician Decision|0|||
28030215|NCT00447226|54688729|FG001|12-Week Open-label Phase|Physician Decision|1|||
28030216|NCT00447226|54688728|FG000|Double-blind Phase|Disease Progression|4|||
28030217|NCT00447226|54688729|FG001|Double-blind Phase|Disease Progression|3|||
28030218|NCT00446992|54688744|FG000|Overall Study|Adverse Event|11|||
28030219|NCT00446992|54688744|FG000|Overall Study|Lost to Follow-up|5|||
28030220|NCT00503139|54688748|FG000|Overall Study|Case Report Forms were not collected|4|||
28030221|NCT00503139|54688748|FG000|Overall Study|Protocol Violation|4|||
28030222|NCT00577031|54688752|FG000|Overall Study|Adverse Event|52|||
28030223|NCT00577031|54688752|FG000|Overall Study|Progression of disease|93|||
28030224|NCT00577031|54688752|FG000|Overall Study|Protocol Violation|5|||
28030225|NCT00577031|54688752|FG000|Overall Study|Participant withdrew consent|13|||
28030226|NCT00577031|54688752|FG000|Overall Study|Participant non-compliance|5|||
28030227|NCT00577031|54688752|FG000|Overall Study|Need for surgery|17|||
28030228|NCT00577031|54688752|FG000|Overall Study|Medical decision|14|||
28030229|NCT00577031|54688752|FG000|Overall Study|Death|6|||
28030230|NCT00565448|54688761|FG000|Overall Study|Adverse Event|1|||
28030231|NCT00565448|54688762|FG001|Overall Study|Adverse Event|2|||
28030232|NCT00565448|54688761|FG000|Overall Study|Disease progression|1|||
28030233|NCT00565448|54688762|FG001|Overall Study|Disease progression|0|||
28030234|NCT00565448|54688761|FG000|Overall Study|Withdrawal by Subject|1|||
28030235|NCT00565448|54688762|FG001|Overall Study|Withdrawal by Subject|0|||
28030236|NCT00446446|54688771|FG000|Overall Study|Death|10|||
28030237|NCT00446446|54688771|FG000|Overall Study|Withdrawal by Subject|6|||
28030238|NCT00446446|54688771|FG000|Overall Study|Other|4|||
28030239|NCT00446446|54688771|FG000|Overall Study|Disease Progession|2|||
28030240|NCT00446446|54688771|FG000|Overall Study|Adverse Event|1|||
28030241|NCT00446446|54688771|FG000|Overall Study|On Treatment at Time of Data Cut-off|1|||
28030242|NCT00506493|54688775|FG000|Overall Study|Death|6|||
28030243|NCT00506493|54688775|FG000|Overall Study|Withdrawal by Subject|5|||
28030244|NCT00514449|54688783|FG000|Overall Study|Withdrawal by Subject|1|||
28030245|NCT00514449|54688784|FG001|Overall Study|Withdrawal by Subject|2|||
28030246|NCT00514449|54688783|FG000|Overall Study|Protocol Violation|1|||
28030247|NCT00514449|54688784|FG001|Overall Study|Protocol Violation|2|||
28030248|NCT00514449|54688783|FG000|Overall Study|Lost to Follow-up|1|||
28030249|NCT00514449|54688784|FG001|Overall Study|Lost to Follow-up|0|||
28030250|NCT00565136|54688793|FG000|Overall Study|Lost to Follow-up|1|||
28030251|NCT00565136|54688793|FG000|Overall Study|Withdrawal by Subject|1|||
28030252|NCT00565136|54688793|FG000|Overall Study|Protocol Violation|1|||
28030253|NCT00492921|54688797|FG000|Overall Study|Death|1|||
28030254|NCT00492921|54688798|FG001|Overall Study|Death|0|||
28030255|NCT00492921|54688799|FG002|Overall Study|Death|1|||
28030256|NCT00502671|54688807|FG000|Overall Study|Disease Progression|13|||
28030257|NCT00502671|54688807|FG000|Overall Study|Personal Reasons|22|||
28030258|NCT00502671|54688807|FG000|Overall Study|Lost to Follow-up|7|||
28030259|NCT00502671|54688807|FG000|Overall Study|Protocol Violation|16|||
27844112|NCT01412879|54333594|FG000|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1|||
27844113|NCT01412879|54333595|FG001|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3|||
28105664|NCT04822701|54763203|FG001|Overall Study|Lost to Follow-up|0|||
27939712|NCT00953524|54595940|FG002|Overall Study|Withdrawal by Subject|1|||
28030260|NCT00502671|54688807|FG000|Overall Study|Adverse Event|19|||
28030261|NCT00697463|54688811|FG000|Overall Study|Withdrawal by Subject|1|||
28030262|NCT00492531|54688817|FG000|Overall Study|Withdrawn(More than one reason selected)|22|||
28030263|NCT00492531|54688818|FG001|Overall Study|Withdrawn(More than one reason selected)|23|||
28030264|NCT00111475|54688834|FG000|Overall Study|Lost to Follow-up|0|||
28030265|NCT00111475|54688835|FG001|Overall Study|Lost to Follow-up|0|||
28030266|NCT00111475|54688836|FG002|Overall Study|Lost to Follow-up|0|||
28030267|NCT00111475|54688837|FG003|Overall Study|Lost to Follow-up|0|||
28030268|NCT00111475|54688838|FG004|Overall Study|Lost to Follow-up|0|||
28105665|NCT04822701|54763202|FG000|Overall Study|Withdrawal by Subject|1|||
28030269|NCT00111475|54688839|FG005|Overall Study|Lost to Follow-up|1|||
28030270|NCT00111475|54688840|FG006|Overall Study|Lost to Follow-up|0|||
28030271|NCT00111475|54688841|FG007|Overall Study|Lost to Follow-up|0|||
28030272|NCT00111475|54688842|FG008|Overall Study|Lost to Follow-up|0|||
28030273|NCT00111475|54688843|FG009|Overall Study|Lost to Follow-up|0|||
28030274|NCT00111241|54688872|FG000|Overall Study|Lost to Follow-up|1|||
28030275|NCT00111241|54688873|FG001|Overall Study|Lost to Follow-up|0|||
28030276|NCT00111241|54688872|FG000|Overall Study|Withdrawal by Subject|4|||
28030277|NCT00111241|54688873|FG001|Overall Study|Withdrawal by Subject|0|||
28030278|NCT00111241|54688872|FG000|Overall Study|Protocol Violation|9|||
28030279|NCT00111241|54688873|FG001|Overall Study|Protocol Violation|8|||
28030280|NCT00111241|54688872|FG000|Overall Study|Adverse Event|1|||
28030281|NCT00111241|54688873|FG001|Overall Study|Adverse Event|0|||
28030282|NCT00492297|54688881|FG000|Treatment|Death|2|||
28030283|NCT00492297|54688881|FG000|Treatment|Study terminated by sponsor|3|||
28030284|NCT00492297|54688881|FG000|Active Follow-up 30(+4) Days Duration|Death|17|||
28030285|NCT00492297|54688881|FG000|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2|||
28030286|NCT00492297|54688881|FG000|Survival Only Follow-up|Death|46|||
28030287|NCT00492297|54688881|FG000|Survival Only Follow-up|Lack of Efficacy|1|||
28030288|NCT00492297|54688881|FG000|Survival Only Follow-up|Study terminated by sponsor|12|||
28030289|NCT00565058|54688887|FG000|Overall Study|Adverse Event|1|||
28030290|NCT00565058|54688888|FG001|Overall Study|Adverse Event|0|||
28030291|NCT00564902|54688897|FG000|Overall Study|Withdrawal by Subject|0|||
28030292|NCT00564902|54688898|FG001|Overall Study|Withdrawal by Subject|3|||
28030293|NCT00564902|54688899|FG002|Overall Study|Withdrawal by Subject|4|||
28030294|NCT00564902|54688897|FG000|Overall Study|Death|1|||
28030295|NCT00564902|54688898|FG001|Overall Study|Death|1|||
28030296|NCT00564902|54688899|FG002|Overall Study|Death|0|||
28030297|NCT00446134|54688911|FG000|Overall Study|Adverse Event|7|||
28030298|NCT00446134|54688912|FG001|Overall Study|Adverse Event|17|||
28030299|NCT00446134|54688913|FG002|Overall Study|Adverse Event|13|||
28030300|NCT00446134|54688914|FG003|Overall Study|Adverse Event|18|||
28030301|NCT00446134|54688911|FG000|Overall Study|Lack of Efficacy|19|||
28030302|NCT00446134|54688912|FG001|Overall Study|Lack of Efficacy|19|||
28030303|NCT00446134|54688913|FG002|Overall Study|Lack of Efficacy|24|||
28030304|NCT00446134|54688914|FG003|Overall Study|Lack of Efficacy|19|||
28030305|NCT00446134|54688911|FG000|Overall Study|Protocol Violation|0|||
28030306|NCT00446134|54688912|FG001|Overall Study|Protocol Violation|2|||
28030307|NCT00446134|54688913|FG002|Overall Study|Protocol Violation|1|||
28030308|NCT00446134|54688914|FG003|Overall Study|Protocol Violation|0|||
28030309|NCT00446134|54688911|FG000|Overall Study|Lost to Follow-up|1|||
28030310|NCT00446134|54688912|FG001|Overall Study|Lost to Follow-up|3|||
28030311|NCT00446134|54688913|FG002|Overall Study|Lost to Follow-up|1|||
28030312|NCT00446134|54688914|FG003|Overall Study|Lost to Follow-up|1|||
28030313|NCT00446134|54688911|FG000|Overall Study|Withdrawal by Subject|3|||
28030314|NCT00446134|54688912|FG001|Overall Study|Withdrawal by Subject|3|||
28030315|NCT00446134|54688913|FG002|Overall Study|Withdrawal by Subject|1|||
28030316|NCT00446134|54688914|FG003|Overall Study|Withdrawal by Subject|3|||
28030317|NCT00446134|54688911|FG000|Overall Study|Physician Decision|0|||
28030318|NCT00446134|54688912|FG001|Overall Study|Physician Decision|0|||
28030319|NCT00446134|54688913|FG002|Overall Study|Physician Decision|0|||
28030320|NCT00446134|54688914|FG003|Overall Study|Physician Decision|2|||
28030321|NCT00446134|54688911|FG000|Overall Study|Adverse Event-Diarrhea|1|||
28030322|NCT00446134|54688912|FG001|Overall Study|Adverse Event-Diarrhea|1|||
28030323|NCT00446134|54688913|FG002|Overall Study|Adverse Event-Diarrhea|2|||
28030324|NCT00446134|54688914|FG003|Overall Study|Adverse Event-Diarrhea|0|||
28030325|NCT00446134|54688911|FG000|Overall Study|Reason Not Completed|3|||
28030326|NCT00446134|54688912|FG001|Overall Study|Reason Not Completed|0|||
28030327|NCT00446134|54688913|FG002|Overall Study|Reason Not Completed|1|||
28030328|NCT00446134|54688914|FG003|Overall Study|Reason Not Completed|2|||
28030329|NCT00563186|54688926|FG000|Overall Study|LOS<48 hours|97|||
28030330|NCT00563186|54688927|FG001|Overall Study|LOS<48 hours|74|||
28030331|NCT00563186|54688926|FG000|Overall Study|Incomplete data|1|||
28030332|NCT00563186|54688927|FG001|Overall Study|Incomplete data|1|||
28030333|NCT00699413|54688938|FG000|Overall Study|Withdrawal by Subject|0|||
28030334|NCT00699413|54688939|FG001|Overall Study|Withdrawal by Subject|2|||
28030335|NCT00699413|54688938|FG000|Overall Study|Study terminated by sponsor|4|||
28030336|NCT00699413|54688939|FG001|Overall Study|Study terminated by sponsor|2|||
28030337|NCT04808609|54688947|FG000|Overall Study|Lost to Follow-up|0|||
28030338|NCT04808609|54688948|FG001|Overall Study|Lost to Follow-up|2|||
28030339|NCT04808609|54688947|FG000|Overall Study|Administrative Withdrawal|0|||
28030340|NCT04808609|54688948|FG001|Overall Study|Administrative Withdrawal|1|||
28030341|NCT00111007|54688956|FG000|Double-blind (DB) Treatment|Adverse Event|12|||
28030342|NCT00111007|54688957|FG001|Double-blind (DB) Treatment|Adverse Event|4|||
28030343|NCT00111007|54688956|FG000|Double-blind (DB) Treatment|Death|5|||
28030344|NCT00111007|54688957|FG001|Double-blind (DB) Treatment|Death|2|||
28030345|NCT00111007|54688956|FG000|Double-blind (DB) Treatment|Protocol Violation|0|||
28030346|NCT00111007|54688957|FG001|Double-blind (DB) Treatment|Protocol Violation|1|||
28030347|NCT00111007|54688956|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|6|||
28030348|NCT00111007|54688957|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|8|||
28030349|NCT00111007|54688956|FG000|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1|||
28030350|NCT00111007|54688957|FG001|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0|||
28030351|NCT00111007|54688956|FG000|Double-blind (DB) Treatment|Relapse|1|||
28030352|NCT00111007|54688957|FG001|Double-blind (DB) Treatment|Relapse|0|||
28030353|NCT00111007|54688956|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|0|||
28030354|NCT00111007|54688957|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
28030355|NCT00111007|54688956|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|83|||
28030356|NCT00111007|54688957|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|93|||
28030357|NCT00111007|54688956|FG000|Double-blind (DB) Treatment|Primary reason with other category|0|||
28030358|NCT00111007|54688957|FG001|Double-blind (DB) Treatment|Primary reason with other category|1|||
28030359|NCT00111007|54688956|FG000|Active Follow-up|Adverse Event|1|||
28030360|NCT00111007|54688957|FG001|Active Follow-up|Adverse Event|0|||
28030361|NCT00111007|54688956|FG000|Active Follow-up|Death|2|||
28030362|NCT00111007|54688957|FG001|Active Follow-up|Death|0|||
28030363|NCT00111007|54688956|FG000|Active Follow-up|Disease progression/recurrence/relapse|3|||
28030364|NCT00111007|54688957|FG001|Active Follow-up|Disease progression/recurrence/relapse|2|||
28030365|NCT00111007|54688956|FG000|Long Term Follow-up|Death|34|||
28030366|NCT00111007|54688957|FG001|Long Term Follow-up|Death|39|||
28030367|NCT00111007|54688956|FG000|Long Term Follow-up|Lost to Follow-up|1|||
28030368|NCT00111007|54688957|FG001|Long Term Follow-up|Lost to Follow-up|1|||
28030369|NCT00111007|54688956|FG000|Long Term Follow-up|Withdrawal by Subject|0|||
28030370|NCT00111007|54688957|FG001|Long Term Follow-up|Withdrawal by Subject|1|||
28030371|NCT00111007|54688956|FG000|Long Term Follow-up|Disease progression/recurrence/relapse|2|||
28030372|NCT00111007|54688957|FG001|Long Term Follow-up|Disease progression/recurrence/relapse|1|||
28030373|NCT00111007|54688956|FG000|Long Term Follow-up|Missing|10|||
28030374|NCT00111007|54688957|FG001|Long Term Follow-up|Missing|3|||
28030375|NCT03975920|54688965|FG000|Overall Study|Lost to Follow-up|1|||
28030376|NCT03975920|54688966|FG001|Overall Study|Lost to Follow-up|2|||
28030377|NCT03975920|54688965|FG000|Overall Study|Protocol Violation|1|||
28030378|NCT03975920|54688966|FG001|Overall Study|Protocol Violation|1|||
28030379|NCT03975920|54688965|FG000|Overall Study|Did not complete survey|2|||
28030380|NCT03975920|54688966|FG001|Overall Study|Did not complete survey|1|||
28030381|NCT00699335|54688972|FG000|Overall Study|Combination of multiple reasons|176|||
28030382|NCT00699335|54688972|FG000|Overall Study|Missing data|52|||
28030383|NCT00445978|54688979|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1|||
28030384|NCT00445978|54688979|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1|||
28030385|NCT00445978|54688979|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1|||
28030386|NCT00445978|54688979|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1|||
28030387|NCT00445978|54688979|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1|||
28030388|NCT00445978|54688979|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1|||
28030389|NCT00445978|54688979|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1|||
28030390|NCT00445978|54688979|FG000|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1|||
28030391|NCT00445978|54688979|FG000|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1|||
28030392|NCT00566228|54688992|FG000|Overall Study|Withdrawal by Subject|1|||
28030393|NCT00566228|54688993|FG001|Overall Study|Withdrawal by Subject|0|||
28030394|NCT00566228|54688992|FG000|Overall Study|Attempt to mobilize stem cells failed|2|||
28030395|NCT00566228|54688993|FG001|Overall Study|Attempt to mobilize stem cells failed|2|||
27807201|NCT01798485|54262619|FG001|Overall Study|Withdrawal by Subject|31|||
27807202|NCT01798485|54262618|FG000|Overall Study|Lost to Follow-up|0|||
27807203|NCT01798485|54262619|FG001|Overall Study|Lost to Follow-up|3|||
27807204|NCT01798485|54262618|FG000|Overall Study|Physician Decision|14|||
27807205|NCT01798485|54262619|FG001|Overall Study|Physician Decision|10|||
27807206|NCT01798485|54262618|FG000|Overall Study|Objective Disease Progression|152|||
27807207|NCT01798485|54262619|FG001|Overall Study|Objective Disease Progression|106|||
27807208|NCT01798485|54262618|FG000|Overall Study|Death|25|||
27807209|NCT01798485|54262619|FG001|Overall Study|Death|22|||
27807210|NCT01798485|54262618|FG000|Overall Study|Sponsor Decision|61|||
27807211|NCT01798485|54262619|FG001|Overall Study|Sponsor Decision|54|||
27807212|NCT01798485|54262618|FG000|Overall Study|Clinical Progression|35|||
27807213|NCT01798485|54262619|FG001|Overall Study|Clinical Progression|24|||
27807214|NCT01767597|54262627|FG000|Overall Study|Incomplete intervention|3|||
27807215|NCT01767597|54262628|FG001|Overall Study|Incomplete intervention|1|||
27807216|NCT01767597|54262627|FG000|Overall Study|Withdrawal by Subject|1|||
27807217|NCT01767597|54262628|FG001|Overall Study|Withdrawal by Subject|0|||
27807218|NCT01767519|54262637|FG000|Overall Study|Other Reasons|4|||
27807219|NCT01767519|54262638|FG001|Overall Study|Other Reasons|4|||
27807220|NCT01767519|54262639|FG002|Overall Study|Other Reasons|2|||
28030396|NCT00566228|54688992|FG000|Overall Study|Unable to collect sufficient CD34 cells|3|||
28030397|NCT00566228|54688993|FG001|Overall Study|Unable to collect sufficient CD34 cells|2|||
28030398|NCT00566228|54688992|FG000|Overall Study|progressed before infusion could occur|0|||
28030399|NCT00566228|54688993|FG001|Overall Study|progressed before infusion could occur|1|||
28030400|NCT00698009|54688999|FG000|Overall Study|Withdrawal by Subject|1|||
28030401|NCT03968978|54689005|FG000|Overall Study|Adverse Event|1|||
28030402|NCT03968978|54689006|FG001|Overall Study|Adverse Event|0|||
28030403|NCT00562718|54689012|FG000|Overall Study|Death|1|||
28030404|NCT00562718|54689012|FG000|Overall Study|Withdrawal by Subject|3|||
28030405|NCT00562718|54689012|FG000|Overall Study|Adverse Event|4|||
28030406|NCT00562718|54689012|FG000|Overall Study|Lack of Efficacy|2|||
28030407|NCT00562718|54689012|FG000|Overall Study|not stated|1|||
28030408|NCT00697619|54689018|FG000|Overall Study|Lack of Efficacy|2|||
28030409|NCT00697619|54689019|FG001|Overall Study|Lack of Efficacy|2|||
28030410|NCT00697619|54689018|FG000|Overall Study|Adverse Event|4|||
28030411|NCT00697619|54689019|FG001|Overall Study|Adverse Event|6|||
28030412|NCT00445432|54689028|FG000|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1|||
28030413|NCT00445432|54689029|FG001|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2|||
28030414|NCT00445432|54689030|FG002|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7|||
28030415|NCT00445432|54689031|FG003|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0|||
28030416|NCT00445432|54689028|FG000|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
28030417|NCT00445432|54689029|FG001|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
28030418|NCT00445432|54689030|FG002|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2|||
28030419|NCT00445432|54689031|FG003|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
28030420|NCT00445432|54689028|FG000|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14|||
28030421|NCT00445432|54689029|FG001|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20|||
28030422|NCT00445432|54689030|FG002|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
28030423|NCT00445432|54689031|FG003|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
28030424|NCT00445432|54689028|FG000|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
28030425|NCT00445432|54689029|FG001|Through Week 52 of NCT00445432 (M06-837)|Other|1|||
28030426|NCT00445432|54689030|FG002|Through Week 52 of NCT00445432 (M06-837)|Other|2|||
28030427|NCT00445432|54689031|FG003|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
28030428|NCT00445432|54689028|FG000|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
28030429|NCT00445432|54689029|FG001|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
28030430|NCT00445432|54689030|FG002|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
28030431|NCT00445432|54689031|FG003|148 Weeks of Adalimumab Treatment|Adverse Event|32|||
28030432|NCT00445432|54689028|FG000|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
28030433|NCT00445432|54689029|FG001|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
28030434|NCT00445432|54689030|FG002|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
28030435|NCT00445432|54689031|FG003|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3|||
28030436|NCT00445432|54689028|FG000|148 Weeks of Adalimumab Treatment|Other|0|||
28030437|NCT00445432|54689029|FG001|148 Weeks of Adalimumab Treatment|Other|0|||
28030438|NCT00445432|54689030|FG002|148 Weeks of Adalimumab Treatment|Other|0|||
28030439|NCT00445432|54689031|FG003|148 Weeks of Adalimumab Treatment|Other|9|||
28030440|NCT03370133|54689045|FG000|Initial Treatment Period (WK 16)|Adverse Event|5|||
28030441|NCT03370133|54689046|FG001|Initial Treatment Period (WK 16)|Adverse Event|5|||
28030442|NCT03370133|54689047|FG002|Initial Treatment Period (WK 16)|Adverse Event|2|||
28030443|NCT03370133|54689048|FG003|Initial Treatment Period (WK 16)|Adverse Event|0|||
28030444|NCT03370133|54689049|FG004|Initial Treatment Period (WK 16)|Adverse Event|0|||
28030445|NCT03370133|54689050|FG005|Initial Treatment Period (WK 16)|Adverse Event|0|||
27807221|NCT01767519|54262637|FG000|Overall Study|Protocol Violation|0|||
27807222|NCT01767519|54262638|FG001|Overall Study|Protocol Violation|3|||
27807223|NCT01767519|54262639|FG002|Overall Study|Protocol Violation|0|||
27807224|NCT01767519|54262637|FG000|Overall Study|Personal Reasons|1|||
27807225|NCT01767519|54262638|FG001|Overall Study|Personal Reasons|0|||
27807226|NCT01767519|54262639|FG002|Overall Study|Personal Reasons|0|||
27807227|NCT01767519|54262637|FG000|Overall Study|Lost to Follow-up|3|||
27807228|NCT01767519|54262638|FG001|Overall Study|Lost to Follow-up|1|||
27807229|NCT01767519|54262639|FG002|Overall Study|Lost to Follow-up|2|||
27807230|NCT01767519|54262637|FG000|Overall Study|Lack of Efficacy|1|||
27807231|NCT01767519|54262638|FG001|Overall Study|Lack of Efficacy|0|||
27807232|NCT01767519|54262639|FG002|Overall Study|Lack of Efficacy|0|||
27807233|NCT01767519|54262637|FG000|Overall Study|Adverse Event|5|||
27807234|NCT01767519|54262638|FG001|Overall Study|Adverse Event|5|||
27807235|NCT01767519|54262639|FG002|Overall Study|Adverse Event|1|||
27807236|NCT01797783|54262649|FG000|Overall Study|Adverse Event|1|||
27807237|NCT01797783|54262650|FG001|Overall Study|Adverse Event|1|||
27807238|NCT01797783|54262649|FG000|Overall Study|Withdrawal by Subject|1|||
27807239|NCT01797783|54262650|FG001|Overall Study|Withdrawal by Subject|0|||
27807240|NCT01766817|54262667|FG000|Overall Study|Drug-related adverse event|1|||
27807241|NCT01766817|54262668|FG001|Overall Study|Drug-related adverse event|2|||
27807242|NCT01766817|54262669|FG002|Overall Study|Drug-related adverse event|1|||
27807243|NCT01766817|54262667|FG000|Overall Study|Drug-unrelated adverse event|3|||
27807244|NCT01766817|54262668|FG001|Overall Study|Drug-unrelated adverse event|3|||
27807245|NCT01766817|54262669|FG002|Overall Study|Drug-unrelated adverse event|3|||
28030446|NCT03370133|54689045|FG000|Initial Treatment Period (WK 16)|Death|1|||
27807246|NCT01766817|54262667|FG000|Overall Study|Death|1|||
28030447|NCT03370133|54689046|FG001|Initial Treatment Period (WK 16)|Death|1|||
28030448|NCT03370133|54689047|FG002|Initial Treatment Period (WK 16)|Death|1|||
28030449|NCT03370133|54689048|FG003|Initial Treatment Period (WK 16)|Death|0|||
28030450|NCT03370133|54689049|FG004|Initial Treatment Period (WK 16)|Death|0|||
28030451|NCT03370133|54689050|FG005|Initial Treatment Period (WK 16)|Death|0|||
28030452|NCT03370133|54689045|FG000|Initial Treatment Period (WK 16)|Lack of Efficacy|2|||
28030453|NCT03370133|54689046|FG001|Initial Treatment Period (WK 16)|Lack of Efficacy|1|||
28030454|NCT03370133|54689047|FG002|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
28030455|NCT03370133|54689048|FG003|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
28030456|NCT03370133|54689049|FG004|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
28030457|NCT03370133|54689050|FG005|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
28030458|NCT03370133|54689045|FG000|Initial Treatment Period (WK 16)|Protocol Violation|0|||
28030459|NCT03370133|54689046|FG001|Initial Treatment Period (WK 16)|Protocol Violation|0|||
28030460|NCT03370133|54689047|FG002|Initial Treatment Period (WK 16)|Protocol Violation|2|||
28030461|NCT03370133|54689048|FG003|Initial Treatment Period (WK 16)|Protocol Violation|0|||
28030462|NCT03370133|54689049|FG004|Initial Treatment Period (WK 16)|Protocol Violation|0|||
28030463|NCT03370133|54689050|FG005|Initial Treatment Period (WK 16)|Protocol Violation|0|||
28030464|NCT03370133|54689045|FG000|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
28030465|NCT03370133|54689046|FG001|Initial Treatment Period (WK 16)|Lost to Follow-up|3|||
28030466|NCT03370133|54689047|FG002|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
28030467|NCT03370133|54689048|FG003|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
28030468|NCT03370133|54689049|FG004|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
28030469|NCT03370133|54689050|FG005|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
28030470|NCT03370133|54689045|FG000|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
28030471|NCT03370133|54689046|FG001|Initial Treatment Period (WK 16)|Withdrawal by Subject|2|||
28030472|NCT03370133|54689047|FG002|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
28030473|NCT03370133|54689048|FG003|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
28030474|NCT03370133|54689049|FG004|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
28030475|NCT03370133|54689050|FG005|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
28030476|NCT03370133|54689045|FG000|Initial Treatment Period (WK 16)|Non-compliance|0|||
27807247|NCT01766817|54262668|FG001|Overall Study|Death|1|||
27807248|NCT01766817|54262669|FG002|Overall Study|Death|0|||
28030477|NCT03370133|54689046|FG001|Initial Treatment Period (WK 16)|Non-compliance|1|||
28030478|NCT03370133|54689047|FG002|Initial Treatment Period (WK 16)|Non-compliance|0|||
28030479|NCT03370133|54689048|FG003|Initial Treatment Period (WK 16)|Non-compliance|0|||
28030480|NCT03370133|54689049|FG004|Initial Treatment Period (WK 16)|Non-compliance|0|||
28030481|NCT03370133|54689050|FG005|Initial Treatment Period (WK 16)|Non-compliance|0|||
28030482|NCT03370133|54689045|FG000|Initial Treatment Period (WK 16)|Site closed|0|||
28030483|NCT03370133|54689046|FG001|Initial Treatment Period (WK 16)|Site closed|2|||
28030484|NCT03370133|54689047|FG002|Initial Treatment Period (WK 16)|Site closed|0|||
28030485|NCT03370133|54689048|FG003|Initial Treatment Period (WK 16)|Site closed|0|||
28030486|NCT03370133|54689049|FG004|Initial Treatment Period (WK 16)|Site closed|0|||
28030487|NCT03370133|54689050|FG005|Initial Treatment Period (WK 16)|Site closed|0|||
28030488|NCT03370133|54689045|FG000|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
28030489|NCT03370133|54689046|FG001|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
28030490|NCT03370133|54689047|FG002|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
28105666|NCT04822701|54763203|FG001|Overall Study|Withdrawal by Subject|0|||
27807249|NCT01766817|54262667|FG000|Overall Study|Unable to take study drug|0|||
27807250|NCT01766817|54262668|FG001|Overall Study|Unable to take study drug|1|||
27807251|NCT01766817|54262669|FG002|Overall Study|Unable to take study drug|0|||
27807252|NCT01766817|54262667|FG000|Overall Study|Withdrawal by Subject|2|||
27807253|NCT01766817|54262668|FG001|Overall Study|Withdrawal by Subject|0|||
27807254|NCT01766817|54262669|FG002|Overall Study|Withdrawal by Subject|3|||
27807255|NCT01766817|54262667|FG000|Overall Study|Subject non-compliance|0|||
27807256|NCT01766817|54262668|FG001|Overall Study|Subject non-compliance|1|||
27807257|NCT01766817|54262669|FG002|Overall Study|Subject non-compliance|2|||
27807258|NCT01766817|54262667|FG000|Overall Study|Physician Decision|3|||
27807259|NCT01766817|54262668|FG001|Overall Study|Physician Decision|3|||
27807260|NCT01766817|54262669|FG002|Overall Study|Physician Decision|4|||
27807261|NCT01766817|54262667|FG000|Overall Study|Other|1|||
27807262|NCT01766817|54262668|FG001|Overall Study|Other|0|||
27807263|NCT01766817|54262669|FG002|Overall Study|Other|0|||
27807264|NCT01797705|54262677|FG000|Overall Study|Equipment anomalies during sleep studies|4|||
27807265|NCT01797705|54262677|FG000|Overall Study|Withdrawal by Subject|1|||
27807266|NCT01797081|54262685|FG000|Overall Study|Adverse Event|1|||
27807267|NCT01797081|54262686|FG001|Overall Study|Adverse Event|0|||
28030491|NCT03370133|54689048|FG003|Maintenance Treatment Period (WK 52)|Adverse Event|3|||
28030492|NCT03370133|54689049|FG004|Maintenance Treatment Period (WK 52)|Adverse Event|12|||
27807268|NCT01797081|54262687|FG002|Overall Study|Adverse Event|1|||
27807269|NCT01797081|54262688|FG003|Overall Study|Adverse Event|0|||
27807270|NCT01797081|54262685|FG000|Overall Study|Pregnancy|1|||
28030493|NCT03370133|54689050|FG005|Maintenance Treatment Period (WK 52)|Adverse Event|4|||
28030494|NCT03370133|54689045|FG000|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
28030495|NCT03370133|54689046|FG001|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
28030496|NCT03370133|54689047|FG002|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
28030497|NCT03370133|54689048|FG003|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
28030498|NCT03370133|54689049|FG004|Maintenance Treatment Period (WK 52)|Lack of Efficacy|1|||
28030499|NCT03370133|54689050|FG005|Maintenance Treatment Period (WK 52)|Lack of Efficacy|4|||
28030500|NCT03370133|54689045|FG000|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
28030501|NCT03370133|54689046|FG001|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
28030502|NCT03370133|54689047|FG002|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
28030503|NCT03370133|54689048|FG003|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
28030504|NCT03370133|54689049|FG004|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
28030505|NCT03370133|54689050|FG005|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
28030506|NCT03370133|54689045|FG000|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
28030507|NCT03370133|54689046|FG001|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
28030508|NCT03370133|54689047|FG002|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
28030509|NCT03370133|54689048|FG003|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
28030510|NCT03370133|54689049|FG004|Maintenance Treatment Period (WK 52)|Lost to Follow-up|4|||
28030511|NCT03370133|54689050|FG005|Maintenance Treatment Period (WK 52)|Lost to Follow-up|3|||
28030512|NCT03370133|54689045|FG000|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
28030513|NCT03370133|54689046|FG001|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
28030514|NCT03370133|54689047|FG002|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
28030515|NCT03370133|54689048|FG003|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|1|||
28030516|NCT03370133|54689049|FG004|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
28030517|NCT03370133|54689050|FG005|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
28030518|NCT03370133|54689045|FG000|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
28030519|NCT03370133|54689046|FG001|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
28030520|NCT03370133|54689047|FG002|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
28030521|NCT03370133|54689048|FG003|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
28030522|NCT03370133|54689049|FG004|Maintenance Treatment Period (WK 52)|Non-compliance|1|||
28030523|NCT03370133|54689050|FG005|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
28030524|NCT03370133|54689045|FG000|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
28030525|NCT03370133|54689046|FG001|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
28030526|NCT03370133|54689047|FG002|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
28030527|NCT03370133|54689048|FG003|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
28030528|NCT03370133|54689049|FG004|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
28030529|NCT03370133|54689050|FG005|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|1|||
28030530|NCT00696137|54689068|FG000|Overall Study|Withdrawal by Subject|2|||
28030531|NCT00441142|54689076|FG000|Overall Study|Adverse Event|2|||
28030532|NCT00441142|54689077|FG001|Overall Study|Adverse Event|3|||
28030533|NCT00441142|54689078|FG002|Overall Study|Adverse Event|3|||
28030534|NCT00441142|54689079|FG003|Overall Study|Adverse Event|22|||
28030535|NCT00441142|54689076|FG000|Overall Study|Lack of Efficacy|3|||
28030536|NCT00441142|54689077|FG001|Overall Study|Lack of Efficacy|3|||
28030537|NCT00441142|54689078|FG002|Overall Study|Lack of Efficacy|17|||
28030538|NCT00441142|54689079|FG003|Overall Study|Lack of Efficacy|32|||
28030539|NCT00441142|54689076|FG000|Overall Study|Withdrawal by Subject|0|||
28030540|NCT00441142|54689077|FG001|Overall Study|Withdrawal by Subject|0|||
28030541|NCT00441142|54689078|FG002|Overall Study|Withdrawal by Subject|2|||
28030542|NCT00441142|54689079|FG003|Overall Study|Withdrawal by Subject|10|||
28030543|NCT00441142|54689076|FG000|Overall Study|Patient still receiving active study tx|1|||
28030544|NCT00441142|54689077|FG001|Overall Study|Patient still receiving active study tx|0|||
28030545|NCT00441142|54689078|FG002|Overall Study|Patient still receiving active study tx|0|||
28030546|NCT00441142|54689079|FG003|Overall Study|Patient still receiving active study tx|2|||
28030547|NCT00441142|54689076|FG000|Overall Study|Physician Decision|0|||
27807271|NCT01797081|54262686|FG001|Overall Study|Pregnancy|0|||
27807272|NCT01797081|54262687|FG002|Overall Study|Pregnancy|0|||
28030548|NCT00441142|54689077|FG001|Overall Study|Physician Decision|1|||
28030549|NCT00441142|54689078|FG002|Overall Study|Physician Decision|0|||
27807273|NCT01797081|54262688|FG003|Overall Study|Pregnancy|0|||
27807274|NCT01797081|54262685|FG000|Overall Study|Personal Reasons|12|||
27807275|NCT01797081|54262686|FG001|Overall Study|Personal Reasons|4|||
27807276|NCT01797081|54262687|FG002|Overall Study|Personal Reasons|4|||
27807277|NCT01797081|54262688|FG003|Overall Study|Personal Reasons|8|||
27807278|NCT01797081|54262685|FG000|Overall Study|Protocol Violation|0|||
27807279|NCT01797081|54262686|FG001|Overall Study|Protocol Violation|0|||
27807280|NCT01797081|54262687|FG002|Overall Study|Protocol Violation|0|||
27807281|NCT01797081|54262688|FG003|Overall Study|Protocol Violation|1|||
27807282|NCT01794117|54262700|FG000|Overall Study|Adverse Event|1|||
28030550|NCT00441142|54689079|FG003|Overall Study|Physician Decision|1|||
28030551|NCT00441142|54689076|FG000|Overall Study|Death|0|||
28030552|NCT00441142|54689077|FG001|Overall Study|Death|0|||
28030553|NCT00441142|54689078|FG002|Overall Study|Death|0|||
28030554|NCT00441142|54689079|FG003|Overall Study|Death|1|||
28030555|NCT04025021|54689093|FG000|Overall Study|Study discontinued with onset of COVID-19 pandemic|2|||
28030556|NCT04025021|54689094|FG001|Overall Study|Study discontinued with onset of COVID-19 pandemic|1|||
28030557|NCT03848416|54689104|FG000|Overall Study|Withdrawal by Subject|1|||
28030558|NCT03848416|54689105|FG001|Overall Study|Withdrawal by Subject|0|||
28030559|NCT03848416|54689106|FG002|Overall Study|Withdrawal by Subject|0|||
28030560|NCT03848416|54689104|FG000|Overall Study|Death|0|||
28030561|NCT03848416|54689105|FG001|Overall Study|Death|0|||
28030562|NCT03848416|54689106|FG002|Overall Study|Death|1|||
28030563|NCT00458302|54689116|FG000|Overall Study|Adverse Event|4|||
28030564|NCT00458302|54689117|FG001|Overall Study|Adverse Event|14|||
28030565|NCT00458302|54689116|FG000|Overall Study|Pregnancy|2|||
28030566|NCT00458302|54689117|FG001|Overall Study|Pregnancy|1|||
28030567|NCT00458302|54689116|FG000|Overall Study|Protocol Violation|0|||
28030568|NCT00458302|54689117|FG001|Overall Study|Protocol Violation|2|||
28030569|NCT00458302|54689116|FG000|Overall Study|Withdrawal by Subject|6|||
28030570|NCT00458302|54689117|FG001|Overall Study|Withdrawal by Subject|4|||
28030571|NCT00458302|54689116|FG000|Overall Study|Inc/Exc Criteria Not Met|1|||
28030572|NCT00458302|54689117|FG001|Overall Study|Inc/Exc Criteria Not Met|1|||
28030573|NCT00458302|54689116|FG000|Overall Study|Study Termination By Sponsor|1|||
28030574|NCT00458302|54689117|FG001|Overall Study|Study Termination By Sponsor|0|||
28030575|NCT00458302|54689116|FG000|Overall Study|Lost to Follow-up|2|||
28030576|NCT00458302|54689117|FG001|Overall Study|Lost to Follow-up|0|||
28030577|NCT00458302|54689116|FG000|Overall Study|Other|4|||
28030578|NCT00458302|54689117|FG001|Overall Study|Other|2|||
28030579|NCT00444106|54689127|FG000|Overall Study|Lost to Follow-up|2|||
28030580|NCT00444106|54689128|FG001|Overall Study|Lost to Follow-up|1|||
28030581|NCT00444106|54689129|FG002|Overall Study|Lost to Follow-up|0|||
28030582|NCT00444106|54689127|FG000|Overall Study|Abnormal Test Procedure Results|0|||
28030583|NCT00444106|54689128|FG001|Overall Study|Abnormal Test Procedure Results|0|||
28030584|NCT00444106|54689129|FG002|Overall Study|Abnormal Test Procedure Results|1|||
28030585|NCT00561470|54689142|FG000|Overall Study|Adverse Event|74|||
28030586|NCT00561470|54689143|FG001|Overall Study|Adverse Event|163|||
28030587|NCT00561470|54689142|FG000|Overall Study|Disease progression|437|||
28030588|NCT00561470|54689143|FG001|Overall Study|Disease progression|305|||
28030589|NCT00561470|54689142|FG000|Overall Study|poor compliance to protocol|4|||
28030590|NCT00561470|54689143|FG001|Overall Study|poor compliance to protocol|4|||
28030591|NCT00561470|54689142|FG000|Overall Study|Lost to Follow-up|2|||
28030592|NCT00561470|54689143|FG001|Overall Study|Lost to Follow-up|0|||
28030593|NCT00561470|54689142|FG000|Overall Study|Physician Decision|21|||
28030594|NCT00561470|54689143|FG001|Overall Study|Physician Decision|20|||
28030595|NCT00561470|54689142|FG000|Overall Study|Consent Withdrawn|2|||
28030596|NCT00561470|54689143|FG001|Overall Study|Consent Withdrawn|6|||
28030597|NCT00561470|54689142|FG000|Overall Study|Subject request|43|||
28030598|NCT00561470|54689143|FG001|Overall Study|Subject request|77|||
28030599|NCT00561470|54689142|FG000|Overall Study|Metastatic surgery|10|||
28030600|NCT00561470|54689143|FG001|Overall Study|Metastatic surgery|12|||
28030601|NCT00561470|54689142|FG000|Overall Study|Unauthorized procedure|3|||
28030602|NCT00561470|54689143|FG001|Overall Study|Unauthorized procedure|1|||
28030603|NCT00561470|54689142|FG000|Overall Study|Randomized but not treated|5|||
28030604|NCT00561470|54689143|FG001|Overall Study|Randomized but not treated|5|||
28030605|NCT00561470|54689142|FG000|Overall Study|Missed visit window|1|||
28030606|NCT00561470|54689143|FG001|Overall Study|Missed visit window|4|||
28030607|NCT00561470|54689142|FG000|Overall Study|Planning surgery|1|||
28030608|NCT00561470|54689143|FG001|Overall Study|Planning surgery|1|||
28030609|NCT00561470|54689142|FG000|Overall Study|Ongoing Treatment|11|||
28030610|NCT00561470|54689143|FG001|Overall Study|Ongoing Treatment|14|||
28030611|NCT00443872|54689151|FG000|Overall Study|Protocol Violation|7|||
28030612|NCT00443872|54689151|FG000|Overall Study|Lost to Follow-up|2|||
28030613|NCT00443872|54689151|FG000|Overall Study|Adverse Event|8|||
28030614|NCT00441064|54689166|FG000|Overall Study|Adverse Event|1|||
28030615|NCT00441064|54689167|FG001|Overall Study|Adverse Event|0|||
28030616|NCT00441064|54689166|FG000|Overall Study|Abnormal laboratory values|0|||
28030617|NCT00441064|54689167|FG001|Overall Study|Abnormal laboratory values|2|||
28030618|NCT00441064|54689166|FG000|Overall Study|Abnormal test procedure results|0|||
28030619|NCT00441064|54689167|FG001|Overall Study|Abnormal test procedure results|1|||
28030620|NCT00441064|54689166|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
28030621|NCT00441064|54689167|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
28030622|NCT00441064|54689166|FG000|Overall Study|Protocol Deviation|3|||
28030623|NCT00441064|54689167|FG001|Overall Study|Protocol Deviation|2|||
28030624|NCT00441064|54689166|FG000|Overall Study|Patient withdrew consent|5|||
28030625|NCT00441064|54689167|FG001|Overall Study|Patient withdrew consent|2|||
28030626|NCT03962738|54689177|FG000|Overall Study|Protocol Deviation|3|||
28030627|NCT03962738|54689178|FG001|Overall Study|Protocol Deviation|0|||
28030628|NCT03962738|54689179|FG002|Overall Study|Protocol Deviation|1|||
28030629|NCT03962738|54689180|FG003|Overall Study|Protocol Deviation|1|||
28030630|NCT03962738|54689177|FG000|Overall Study|Withdrawal by Subject|4|||
27844114|NCT01412879|54333596|FG002|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0|||
27844115|NCT01412879|54333594|FG000|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
28030631|NCT03962738|54689178|FG001|Overall Study|Withdrawal by Subject|0|||
28030632|NCT03962738|54689179|FG002|Overall Study|Withdrawal by Subject|0|||
28030633|NCT03962738|54689180|FG003|Overall Study|Withdrawal by Subject|0|||
28030634|NCT03962738|54689177|FG000|Overall Study|Lost to Follow-up|0|||
28030635|NCT03962738|54689178|FG001|Overall Study|Lost to Follow-up|0|||
28030636|NCT03962738|54689179|FG002|Overall Study|Lost to Follow-up|1|||
28030637|NCT03962738|54689180|FG003|Overall Study|Lost to Follow-up|0|||
28030638|NCT00561392|54689198|FG000|Overall Study|Adverse Event|38|||
28030639|NCT00561392|54689198|FG000|Overall Study|Lack of Efficacy|2|||
28030640|NCT00561392|54689198|FG000|Overall Study|Protocol Violation|1|||
28030641|NCT00561392|54689198|FG000|Overall Study|Withdrawal by Subject|8|||
28030642|NCT00561392|54689198|FG000|Overall Study|Administrative problems|4|||
28030643|NCT00694109|54689202|FG000|Overall Study|Physician Decision|3|||
28030644|NCT00694109|54689202|FG000|Overall Study|Adverse Event|74|||
28030645|NCT00694109|54689202|FG000|Overall Study|Not consent of more 2 years of treatment|18|||
28030646|NCT00694109|54689202|FG000|Overall Study|Lack of Efficacy|2|||
28030647|NCT00694109|54689202|FG000|Overall Study|Withdrawal by Subject|13|||
28030648|NCT00694109|54689202|FG000|Overall Study|Pregnancy|1|||
28030649|NCT00694109|54689202|FG000|Overall Study|Enrolled but not treated|1|||
28030650|NCT00694109|54689202|FG000|Overall Study|Other|2|||
28030651|NCT00694109|54689202|FG000|Overall Study|Consented but no additional treatment|3|||
28030652|NCT00562484|54689213|FG000|Overall Study|Adverse Event|6|||
28030653|NCT00562484|54689214|FG001|Overall Study|Adverse Event|1|||
28030654|NCT00562484|54689213|FG000|Overall Study|Protocol Violation|11|||
28030655|NCT00562484|54689214|FG001|Overall Study|Protocol Violation|2|||
28030656|NCT00562484|54689213|FG000|Overall Study|Withdrawal by Subject|12|||
28030657|NCT00562484|54689214|FG001|Overall Study|Withdrawal by Subject|9|||
28030658|NCT00562484|54689213|FG000|Overall Study|Moved away from the study area|20|||
28030659|NCT00562484|54689214|FG001|Overall Study|Moved away from the study area|9|||
28030660|NCT00562484|54689213|FG000|Overall Study|Lost to Follow-up|132|||
28030661|NCT00562484|54689214|FG001|Overall Study|Lost to Follow-up|71|||
28030662|NCT00562484|54689213|FG000|Overall Study|Reason not provided or not specified|25|||
28030663|NCT00562484|54689214|FG001|Overall Study|Reason not provided or not specified|12|||
28030664|NCT00561080|54689223|FG000|Vaccination Period (up to Month 4)|Adverse Event|0|||
28030665|NCT00561080|54689224|FG001|Vaccination Period (up to Month 4)|Adverse Event|4|||
28030666|NCT00561080|54689225|FG002|Vaccination Period (up to Month 4)|Adverse Event|6|||
28030667|NCT00561080|54689223|FG000|Vaccination Period (up to Month 4)|Definitive Contra-indication|0|||
28030668|NCT00561080|54689224|FG001|Vaccination Period (up to Month 4)|Definitive Contra-indication|2|||
28030669|NCT00561080|54689225|FG002|Vaccination Period (up to Month 4)|Definitive Contra-indication|3|||
28030670|NCT00561080|54689223|FG000|Vaccination Period (up to Month 4)|Protocol Violation|0|||
28030671|NCT00561080|54689224|FG001|Vaccination Period (up to Month 4)|Protocol Violation|1|||
28030672|NCT00561080|54689225|FG002|Vaccination Period (up to Month 4)|Protocol Violation|3|||
28030673|NCT00561080|54689223|FG000|Vaccination Period (up to Month 4)|Withdrawal by Subject|3|||
28030674|NCT00561080|54689224|FG001|Vaccination Period (up to Month 4)|Withdrawal by Subject|16|||
28030675|NCT00561080|54689225|FG002|Vaccination Period (up to Month 4)|Withdrawal by Subject|13|||
28030676|NCT00561080|54689223|FG000|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
28030677|NCT00561080|54689224|FG001|Vaccination Period (up to Month 4)|Lost to Follow-up|1|||
28030678|NCT00561080|54689225|FG002|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
28030679|NCT00561080|54689223|FG000|Vaccination Period (up to Month 4)|Other|0|||
28030680|NCT00561080|54689224|FG001|Vaccination Period (up to Month 4)|Other|2|||
28030681|NCT00561080|54689225|FG002|Vaccination Period (up to Month 4)|Other|1|||
28030682|NCT00561080|54689223|FG000|12-month Post Last Dose Follow-up|Adverse Event|3|||
28030683|NCT00561080|54689224|FG001|12-month Post Last Dose Follow-up|Adverse Event|3|||
28030684|NCT00561080|54689225|FG002|12-month Post Last Dose Follow-up|Adverse Event|1|||
28030685|NCT00561080|54689223|FG000|12-month Post Last Dose Follow-up|Protocol Violation|0|||
27844116|NCT01412879|54333595|FG001|Initial Registration (Induction Therapy)|Progression/Relapse|1|||
27844117|NCT01412879|54333596|FG002|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
28030686|NCT00561080|54689224|FG001|12-month Post Last Dose Follow-up|Protocol Violation|0|||
28030687|NCT00561080|54689225|FG002|12-month Post Last Dose Follow-up|Protocol Violation|4|||
28030688|NCT00561080|54689223|FG000|12-month Post Last Dose Follow-up|Withdrawal by Subject|2|||
28030689|NCT00561080|54689224|FG001|12-month Post Last Dose Follow-up|Withdrawal by Subject|6|||
28030690|NCT00561080|54689225|FG002|12-month Post Last Dose Follow-up|Withdrawal by Subject|5|||
28030691|NCT00561080|54689223|FG000|12-month Post Last Dose Follow-up|Lost to Follow-up|2|||
28030692|NCT00561080|54689224|FG001|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
28030693|NCT00561080|54689225|FG002|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
28030694|NCT00562094|54689235|FG000|Overall Study|Lost to Follow-up|62|||
28030695|NCT03817853|54689243|FG000|Induction Phase|Adverse Event|5|||
28030696|NCT03817853|54689244|FG001|Induction Phase|Adverse Event|0|||
28030697|NCT03817853|54689245|FG002|Induction Phase|Adverse Event|0|||
28030698|NCT03817853|54689243|FG000|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|3|||
28030699|NCT03817853|54689244|FG001|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
28030700|NCT03817853|54689245|FG002|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
28030701|NCT03817853|54689243|FG000|Induction Phase|Physician Decision|2|||
28030702|NCT03817853|54689244|FG001|Induction Phase|Physician Decision|0|||
28030703|NCT03817853|54689245|FG002|Induction Phase|Physician Decision|0|||
27844118|NCT01412879|54333594|FG000|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6|||
27844119|NCT01412879|54333595|FG001|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1|||
27844120|NCT01412879|54333596|FG002|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0|||
27844121|NCT01412879|54333594|FG000|Initial Registration (Induction Therapy)|Treatment not Given|1|||
27844122|NCT01412879|54333595|FG001|Initial Registration (Induction Therapy)|Treatment not Given|0|||
27844123|NCT01412879|54333596|FG002|Initial Registration (Induction Therapy)|Treatment not Given|0|||
28030704|NCT03817853|54689243|FG000|Induction Phase|Progressive Disease|4|||
28030705|NCT03817853|54689244|FG001|Induction Phase|Progressive Disease|0|||
27844124|NCT01431079|54333608|FG000|Overall Study|Lost to Follow-up|35|||
27844125|NCT01431079|54333609|FG001|Overall Study|Lost to Follow-up|39|||
28030706|NCT03817853|54689245|FG002|Induction Phase|Progressive Disease|0|||
28030707|NCT03817853|54689243|FG000|Induction Phase|Withdrawal by Subject|3|||
28030708|NCT03817853|54689244|FG001|Induction Phase|Withdrawal by Subject|0|||
28030709|NCT03817853|54689245|FG002|Induction Phase|Withdrawal by Subject|0|||
28030710|NCT03817853|54689243|FG000|Induction Phase|Continuing on Study|34|||
28030711|NCT03817853|54689244|FG001|Induction Phase|Continuing on Study|0|||
28030712|NCT03817853|54689245|FG002|Induction Phase|Continuing on Study|0|||
28030713|NCT03817853|54689243|FG000|Maintenance/ Follow-up Phase|Adverse Event|0|||
28030714|NCT03817853|54689244|FG001|Maintenance/ Follow-up Phase|Adverse Event|1|||
28030715|NCT03817853|54689245|FG002|Maintenance/ Follow-up Phase|Adverse Event|0|||
28030716|NCT03817853|54689243|FG000|Maintenance/ Follow-up Phase|Death|0|||
28030717|NCT03817853|54689244|FG001|Maintenance/ Follow-up Phase|Death|1|||
28030718|NCT03817853|54689245|FG002|Maintenance/ Follow-up Phase|Death|1|||
28030719|NCT03817853|54689243|FG000|Maintenance/ Follow-up Phase|Progressive Disease|0|||
28030720|NCT03817853|54689244|FG001|Maintenance/ Follow-up Phase|Progressive Disease|1|||
28030721|NCT03817853|54689245|FG002|Maintenance/ Follow-up Phase|Progressive Disease|3|||
28030722|NCT03817853|54689243|FG000|Maintenance/ Follow-up Phase|Withdrawal by Subject|0|||
28030723|NCT03817853|54689244|FG001|Maintenance/ Follow-up Phase|Withdrawal by Subject|1|||
28030724|NCT03817853|54689245|FG002|Maintenance/ Follow-up Phase|Withdrawal by Subject|0|||
28030725|NCT03817853|54689243|FG000|Maintenance/ Follow-up Phase|Continuing on Study|0|||
28030726|NCT03817853|54689244|FG001|Maintenance/ Follow-up Phase|Continuing on Study|52|||
28030727|NCT03817853|54689245|FG002|Maintenance/ Follow-up Phase|Continuing on Study|2|||
28030728|NCT00439270|54689258|FG000|Phase 1 (18.1 Months)|Disease progression|3|||
28030729|NCT00439270|54689259|FG001|Phase 1 (18.1 Months)|Disease progression|2|||
28030730|NCT00439270|54689260|FG002|Phase 1 (18.1 Months)|Disease progression|3|||
28030731|NCT00439270|54689261|FG003|Phase 1 (18.1 Months)|Disease progression|0|||
28030732|NCT00439270|54689262|FG004|Phase 1 (18.1 Months)|Disease progression|3|||
28030733|NCT00439270|54689258|FG000|Phase 1 (18.1 Months)|Study drug toxicity|0|||
28030734|NCT00439270|54689259|FG001|Phase 1 (18.1 Months)|Study drug toxicity|1|||
28030735|NCT00439270|54689260|FG002|Phase 1 (18.1 Months)|Study drug toxicity|0|||
28030736|NCT00439270|54689261|FG003|Phase 1 (18.1 Months)|Study drug toxicity|0|||
28030737|NCT00439270|54689262|FG004|Phase 1 (18.1 Months)|Study drug toxicity|0|||
28030738|NCT00439270|54689258|FG000|Phase 2 (51.6 Months)|Disease progression|0|||
28030739|NCT00439270|54689259|FG001|Phase 2 (51.6 Months)|Disease progression|0|||
28030740|NCT00439270|54689260|FG002|Phase 2 (51.6 Months)|Disease progression|0|||
28030741|NCT00439270|54689261|FG003|Phase 2 (51.6 Months)|Disease progression|18|||
28030742|NCT00439270|54689262|FG004|Phase 2 (51.6 Months)|Disease progression|0|||
28105667|NCT04461795|54763209|FG000|Overall Study|Lost to Follow-up|2|||
27807283|NCT01794117|54262701|FG001|Overall Study|Adverse Event|0|||
27807284|NCT01794117|54262702|FG002|Overall Study|Adverse Event|0|||
27807285|NCT01794117|54262703|FG003|Overall Study|Adverse Event|0|||
27807286|NCT01794117|54262700|FG000|Overall Study|Participant noncompliance|0|||
27807287|NCT01794117|54262701|FG001|Overall Study|Participant noncompliance|1|||
27807288|NCT01794117|54262702|FG002|Overall Study|Participant noncompliance|0|||
27807289|NCT01794117|54262703|FG003|Overall Study|Participant noncompliance|0|||
27807290|NCT01794117|54262700|FG000|Overall Study|Refused further treatment|0|||
27807291|NCT01794117|54262701|FG001|Overall Study|Refused further treatment|2|||
27807292|NCT01794117|54262702|FG002|Overall Study|Refused further treatment|0|||
27844126|NCT01430611|54333641|FG000|Overall Study|Adverse Event|0|||
27939713|NCT00953524|54595941|FG003|Overall Study|Withdrawal by Subject|0|||
27807293|NCT01794117|54262703|FG003|Overall Study|Refused further treatment|0|||
27807294|NCT01766037|54262716|FG000|Overall Study|Adverse Event|1|||
27807295|NCT01766037|54262717|FG001|Overall Study|Adverse Event|0|||
28030743|NCT00439270|54689258|FG000|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
28030744|NCT00439270|54689259|FG001|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
28030745|NCT00439270|54689260|FG002|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
28030746|NCT00439270|54689261|FG003|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1|||
28030747|NCT00439270|54689262|FG004|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
28030748|NCT00439270|54689258|FG000|Phase 2 (51.6 Months)|Study drug toxicity|0|||
28030749|NCT00439270|54689259|FG001|Phase 2 (51.6 Months)|Study drug toxicity|0|||
28030750|NCT00439270|54689260|FG002|Phase 2 (51.6 Months)|Study drug toxicity|0|||
28030751|NCT00439270|54689261|FG003|Phase 2 (51.6 Months)|Study drug toxicity|6|||
28030752|NCT00439270|54689262|FG004|Phase 2 (51.6 Months)|Study drug toxicity|0|||
28030753|NCT00439270|54689258|FG000|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
28030754|NCT00439270|54689259|FG001|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
28030755|NCT00439270|54689260|FG002|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
28030756|NCT00439270|54689261|FG003|Phase 2 (51.6 Months)|Maximum clinical benefit|3|||
28030757|NCT00439270|54689262|FG004|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
28030758|NCT00439270|54689258|FG000|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
28030759|NCT00439270|54689259|FG001|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
28030760|NCT00439270|54689260|FG002|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
27844127|NCT01430611|54333642|FG001|Overall Study|Adverse Event|1|||
27844128|NCT01430611|54333641|FG000|Overall Study|Protocol Violation|1|||
27844129|NCT01430611|54333642|FG001|Overall Study|Protocol Violation|0|||
27844130|NCT01430611|54333641|FG000|Overall Study|Lost to Follow-up|1|||
27844131|NCT01430611|54333642|FG001|Overall Study|Lost to Follow-up|0|||
27844132|NCT01430611|54333641|FG000|Overall Study|Withdrawal by Subject|15|||
28030761|NCT00439270|54689261|FG003|Phase 2 (51.6 Months)|No longer meets study criteria|1|||
28030762|NCT00439270|54689262|FG004|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
28030763|NCT00439270|54689258|FG000|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
28030764|NCT00439270|54689259|FG001|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
28030765|NCT00439270|54689260|FG002|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
28030766|NCT00439270|54689261|FG003|Phase 2 (51.6 Months)|Withdrawal by Subject|2|||
27844133|NCT01430611|54333642|FG001|Overall Study|Withdrawal by Subject|14|||
27844134|NCT01409707|54333651|FG000|Overall Study|Withdrawal by Subject|5|||
27844135|NCT01409707|54333652|FG001|Overall Study|Withdrawal by Subject|17|||
27844136|NCT01409707|54333653|FG002|Overall Study|Withdrawal by Subject|16|||
27844137|NCT01389973|54333660|FG000|Overall Study|Lost to Follow-up|1|||
27844138|NCT01389973|54333660|FG000|Overall Study|Trial Stopped by Sponsor|9|||
27844139|NCT01389973|54333660|FG000|Overall Study|Other|10|||
27844140|NCT01389817|54333680|FG000|Overall Study|Physician Decision|1|||
27844141|NCT01389817|54333681|FG001|Overall Study|Physician Decision|0|||
27844142|NCT01389817|54333680|FG000|Overall Study|Lost to Follow-up|1|||
27844143|NCT01389817|54333681|FG001|Overall Study|Lost to Follow-up|0|||
27844144|NCT01389817|54333680|FG000|Overall Study|Withdrawal by Subject|2|||
27844145|NCT01389817|54333681|FG001|Overall Study|Withdrawal by Subject|0|||
27844146|NCT01430455|54333696|FG000|Overall Study|Withdrawal by Subject|1|||
27807296|NCT01766037|54262716|FG000|Overall Study|Lack of Efficacy|1|||
27807297|NCT01766037|54262717|FG001|Overall Study|Lack of Efficacy|0|||
27807298|NCT01766037|54262716|FG000|Overall Study|Lost to Follow-up|0|||
27807299|NCT01766037|54262717|FG001|Overall Study|Lost to Follow-up|10|||
28030767|NCT00439270|54689262|FG004|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
28030768|NCT00439270|54689258|FG000|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
28030769|NCT00439270|54689259|FG001|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
28030770|NCT00439270|54689260|FG002|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
28030771|NCT00439270|54689261|FG003|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2|||
28030772|NCT00439270|54689262|FG004|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
27807300|NCT01766037|54262716|FG000|Overall Study|Physician Decision|0|||
27807301|NCT01766037|54262717|FG001|Overall Study|Physician Decision|1|||
27844147|NCT01430455|54333696|FG000|Overall Study|Switched to follow-up phase|1|||
27844148|NCT01429441|54333724|FG000|Overall Study|Adverse Event|5|||
27844149|NCT01429441|54333725|FG001|Overall Study|Adverse Event|1|||
27844150|NCT01429441|54333724|FG000|Overall Study|Death|0|||
27844151|NCT01429441|54333725|FG001|Overall Study|Death|2|||
27844152|NCT01429441|54333724|FG000|Overall Study|Lost to Follow-up|5|||
27844153|NCT01429441|54333725|FG001|Overall Study|Lost to Follow-up|2|||
27844154|NCT01429441|54333724|FG000|Overall Study|Physician Decision|1|||
27939714|NCT01040403|54595960|FG000|Overall Study|Adverse Event|10|||
28030773|NCT00439270|54689258|FG000|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
28030774|NCT00439270|54689259|FG001|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
27807302|NCT01766037|54262716|FG000|Overall Study|Withdrawal by Subject|18|||
27807303|NCT01766037|54262717|FG001|Overall Study|Withdrawal by Subject|16|||
27807304|NCT01766037|54262716|FG000|Overall Study|Moved from area|5|||
27844155|NCT01429441|54333725|FG001|Overall Study|Physician Decision|0|||
27844156|NCT01429441|54333724|FG000|Overall Study|Withdrawal by Subject|27|||
27939715|NCT01040403|54595960|FG000|Overall Study|Protocol Violation|2|||
27844157|NCT01429441|54333725|FG001|Overall Study|Withdrawal by Subject|18|||
28030775|NCT00439270|54689260|FG002|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
28030776|NCT00439270|54689261|FG003|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1|||
28030777|NCT00439270|54689262|FG004|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
28030778|NCT00553280|54689281|FG000|Overall Study|Adverse Event|19|||
28030779|NCT00553280|54689281|FG000|Overall Study|Lack of Efficacy|3|||
28030780|NCT00553280|54689281|FG000|Overall Study|Withdrawal by Subject|3|||
28030781|NCT00553280|54689281|FG000|Overall Study|Physician Decision|1|||
28030782|NCT00440518|54689288|FG000|Randomized /Titration Period|Lack of Efficacy|1|||
28030783|NCT00440518|54689289|FG001|Randomized /Titration Period|Lack of Efficacy|0|||
28030784|NCT00440518|54689290|FG002|Randomized /Titration Period|Lack of Efficacy|1|||
28030785|NCT00440518|54689288|FG000|Randomized /Titration Period|Subject Withdrew Consent|4|||
27844158|NCT01429285|54333760|FG000|Overall Study|Protocol Violation|9|||
27844159|NCT01429285|54333761|FG001|Overall Study|Protocol Violation|4|||
27844160|NCT01429285|54333760|FG000|Overall Study|Missing Data|5|||
27844161|NCT01429285|54333761|FG001|Overall Study|Missing Data|3|||
27844162|NCT01429285|54333760|FG000|Overall Study|Erroneously Enrolled Twice|8|||
28030786|NCT00440518|54689289|FG001|Randomized /Titration Period|Subject Withdrew Consent|1|||
28030787|NCT00440518|54689290|FG002|Randomized /Titration Period|Subject Withdrew Consent|0|||
28030788|NCT00440518|54689288|FG000|Randomized /Titration Period|Protocol Deviation|1|||
28030789|NCT00440518|54689289|FG001|Randomized /Titration Period|Protocol Deviation|0|||
28030790|NCT00440518|54689290|FG002|Randomized /Titration Period|Protocol Deviation|0|||
27844163|NCT01429285|54333761|FG001|Overall Study|Erroneously Enrolled Twice|2|||
28030791|NCT00440518|54689288|FG000|Randomized /Titration Period|Unsatisfactory Compliance|2|||
28030792|NCT00440518|54689289|FG001|Randomized /Titration Period|Unsatisfactory Compliance|3|||
28030793|NCT00440518|54689290|FG002|Randomized /Titration Period|Unsatisfactory Compliance|2|||
28030794|NCT00440518|54689288|FG000|Randomized /Titration Period|Other|1|||
28030795|NCT00440518|54689289|FG001|Randomized /Titration Period|Other|0|||
28030796|NCT00440518|54689290|FG002|Randomized /Titration Period|Other|0|||
28030797|NCT00440518|54689288|FG000|Randomized /Titration Period|Lost to Follow-up|2|||
28030798|NCT00440518|54689289|FG001|Randomized /Titration Period|Lost to Follow-up|2|||
28030799|NCT00440518|54689290|FG002|Randomized /Titration Period|Lost to Follow-up|1|||
28030800|NCT00440518|54689288|FG000|Randomized /Titration Period|Adverse Event|2|||
28030801|NCT00440518|54689289|FG001|Randomized /Titration Period|Adverse Event|3|||
28030802|NCT00440518|54689290|FG002|Randomized /Titration Period|Adverse Event|0|||
28030803|NCT00440518|54689288|FG000|Maintenance and Safety Follow-up Periods|Adverse Event|3|||
28030804|NCT00440518|54689289|FG001|Maintenance and Safety Follow-up Periods|Adverse Event|4|||
28030805|NCT00440518|54689290|FG002|Maintenance and Safety Follow-up Periods|Adverse Event|2|||
28030806|NCT00440518|54689288|FG000|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0|||
28030807|NCT00440518|54689289|FG001|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
28030808|NCT00440518|54689290|FG002|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
28030809|NCT00440518|54689288|FG000|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3|||
28030810|NCT00440518|54689289|FG001|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2|||
28030811|NCT00440518|54689290|FG002|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4|||
28030812|NCT00440518|54689288|FG000|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0|||
28030813|NCT00440518|54689289|FG001|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3|||
28030814|NCT00440518|54689290|FG002|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6|||
28030815|NCT00440518|54689288|FG000|Maintenance and Safety Follow-up Periods|Other|0|||
28030816|NCT00440518|54689289|FG001|Maintenance and Safety Follow-up Periods|Other|0|||
28030817|NCT00440518|54689290|FG002|Maintenance and Safety Follow-up Periods|Other|2|||
28030818|NCT00440518|54689288|FG000|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1|||
28030819|NCT00440518|54689289|FG001|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2|||
28030820|NCT00440518|54689290|FG002|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0|||
28030821|NCT00438256|54689298|FG000|Overall Study|Ineligible for Resection|2|||
28030822|NCT00438256|54689299|FG001|Overall Study|Ineligible for Resection|1|||
28030823|NCT00438256|54689300|FG002|Overall Study|Ineligible for Resection|1|||
28030824|NCT00438256|54689301|FG003|Overall Study|Ineligible for Resection|7|||
28030825|NCT00438256|54689298|FG000|Overall Study|Excluded final Diagnosis|0|||
28030826|NCT00438256|54689299|FG001|Overall Study|Excluded final Diagnosis|0|||
28030827|NCT00438256|54689300|FG002|Overall Study|Excluded final Diagnosis|0|||
28030828|NCT00438256|54689301|FG003|Overall Study|Excluded final Diagnosis|2|||
28030829|NCT00436852|54689320|FG000|Overall Study|Death|23|||
28030830|NCT00436852|54689321|FG001|Overall Study|Death|34|||
28030831|NCT00436852|54689320|FG000|Overall Study|Lack of Efficacy|9|||
27844164|NCT01429051|54333838|FG000|Titration Phase|Death|1|||
27844165|NCT01429051|54333838|FG000|Titration Phase|Withdrawal by Subject|7|||
27844166|NCT01429051|54333838|FG000|Titration Phase|Physician Decision|1|||
27844167|NCT01429051|54333838|FG000|Titration Phase|Unsuccessful titration at any dose|1|||
27844168|NCT01429051|54333838|FG000|Titration Phase|Less than 3 BTP episodes per week|2|||
27844169|NCT01429051|54333838|FG000|Efficacy Phase|Adverse Event|1|||
28030832|NCT00436852|54689321|FG001|Overall Study|Lack of Efficacy|7|||
28030833|NCT00436852|54689320|FG000|Overall Study|Withdrawal by Subject|2|||
28030834|NCT00436852|54689321|FG001|Overall Study|Withdrawal by Subject|4|||
28030835|NCT00436852|54689320|FG000|Overall Study|Ineligible|1|||
28030836|NCT00436852|54689321|FG001|Overall Study|Ineligible|0|||
28030837|NCT00120289|54689332|FG000|Overall Study|Death|96|||
28030838|NCT00120289|54689333|FG001|Overall Study|Death|82|||
28030839|NCT00120289|54689332|FG000|Overall Study|Lost to Follow-up|11|||
28030840|NCT00120289|54689333|FG001|Overall Study|Lost to Follow-up|14|||
28030841|NCT00120289|54689332|FG000|Overall Study|Withdrawal by Subject|14|||
28030842|NCT00120289|54689333|FG001|Overall Study|Withdrawal by Subject|13|||
28030843|NCT00550446|54689346|FG000|Up To Week 12|Adverse Event|2|||
28030844|NCT00550446|54689347|FG001|Up To Week 12|Adverse Event|2|||
28030845|NCT00550446|54689348|FG002|Up To Week 12|Adverse Event|0|||
28030846|NCT00550446|54689349|FG003|Up To Week 12|Adverse Event|0|||
28030847|NCT00550446|54689350|FG004|Up To Week 12|Adverse Event|2|||
28030848|NCT00550446|54689351|FG005|Up To Week 12|Adverse Event|2|||
28030849|NCT00550446|54689352|FG006|Up To Week 12|Adverse Event|1|||
28030850|NCT00550446|54689353|FG007|Up To Week 12|Adverse Event|0|||
28030851|NCT00550446|54689354|FG008|Up To Week 12|Adverse Event|0|||
28030852|NCT00550446|54689355|FG009|Up To Week 12|Adverse Event|0|||
28030853|NCT00550446|54689356|FG010|Up To Week 12|Adverse Event|0|||
28030854|NCT00550446|54689346|FG000|Up To Week 12|Lack of Efficacy|3|||
28030855|NCT00550446|54689347|FG001|Up To Week 12|Lack of Efficacy|1|||
28030856|NCT00550446|54689348|FG002|Up To Week 12|Lack of Efficacy|0|||
28030857|NCT00550446|54689349|FG003|Up To Week 12|Lack of Efficacy|1|||
28030858|NCT00550446|54689350|FG004|Up To Week 12|Lack of Efficacy|0|||
28030859|NCT00550446|54689351|FG005|Up To Week 12|Lack of Efficacy|3|||
28030860|NCT00550446|54689352|FG006|Up To Week 12|Lack of Efficacy|3|||
28030861|NCT00550446|54689353|FG007|Up To Week 12|Lack of Efficacy|0|||
28030862|NCT00550446|54689354|FG008|Up To Week 12|Lack of Efficacy|0|||
28030863|NCT00550446|54689355|FG009|Up To Week 12|Lack of Efficacy|0|||
28030864|NCT00550446|54689356|FG010|Up To Week 12|Lack of Efficacy|0|||
28030865|NCT00550446|54689346|FG000|Up To Week 12|Lost to Follow-up|0|||
28030866|NCT00550446|54689347|FG001|Up To Week 12|Lost to Follow-up|1|||
28030867|NCT00550446|54689348|FG002|Up To Week 12|Lost to Follow-up|0|||
28030868|NCT00550446|54689349|FG003|Up To Week 12|Lost to Follow-up|0|||
28030869|NCT00550446|54689350|FG004|Up To Week 12|Lost to Follow-up|1|||
28030870|NCT00550446|54689351|FG005|Up To Week 12|Lost to Follow-up|1|||
28030871|NCT00550446|54689352|FG006|Up To Week 12|Lost to Follow-up|2|||
28030872|NCT00550446|54689353|FG007|Up To Week 12|Lost to Follow-up|0|||
28030873|NCT00550446|54689354|FG008|Up To Week 12|Lost to Follow-up|0|||
28030874|NCT00550446|54689355|FG009|Up To Week 12|Lost to Follow-up|0|||
28030875|NCT00550446|54689356|FG010|Up To Week 12|Lost to Follow-up|0|||
28030876|NCT00550446|54689346|FG000|Up To Week 12|Withdrawal by Subject|2|||
28030877|NCT00550446|54689347|FG001|Up To Week 12|Withdrawal by Subject|0|||
28030878|NCT00550446|54689348|FG002|Up To Week 12|Withdrawal by Subject|3|||
28030879|NCT00550446|54689349|FG003|Up To Week 12|Withdrawal by Subject|2|||
28030880|NCT00550446|54689350|FG004|Up To Week 12|Withdrawal by Subject|0|||
28030881|NCT00550446|54689351|FG005|Up To Week 12|Withdrawal by Subject|1|||
28030882|NCT00550446|54689352|FG006|Up To Week 12|Withdrawal by Subject|3|||
28030883|NCT00550446|54689353|FG007|Up To Week 12|Withdrawal by Subject|0|||
28030884|NCT00550446|54689354|FG008|Up To Week 12|Withdrawal by Subject|0|||
28030885|NCT00550446|54689355|FG009|Up To Week 12|Withdrawal by Subject|0|||
28030886|NCT00550446|54689356|FG010|Up To Week 12|Withdrawal by Subject|0|||
28030887|NCT00550446|54689346|FG000|Up To Week 12|Other|3|||
28030888|NCT00550446|54689347|FG001|Up To Week 12|Other|0|||
28030889|NCT00550446|54689348|FG002|Up To Week 12|Other|0|||
28030890|NCT00550446|54689349|FG003|Up To Week 12|Other|0|||
28030891|NCT00550446|54689350|FG004|Up To Week 12|Other|0|||
28030892|NCT00550446|54689351|FG005|Up To Week 12|Other|1|||
28030893|NCT00550446|54689352|FG006|Up To Week 12|Other|4|||
27844170|NCT01429051|54333838|FG000|Efficacy Phase|Death|1|||
27844171|NCT01429051|54333838|FG000|Tolerability Phase|Death|5|||
27844172|NCT01429051|54333838|FG000|Tolerability Phase|Adverse Event|2|||
27844173|NCT01429051|54333838|FG000|Tolerability Phase|Withdrawal by Subject|5|||
27939716|NCT01040403|54595960|FG000|Overall Study|Lost to Follow-up|1|||
28030894|NCT00550446|54689353|FG007|Up To Week 12|Other|0|||
28030895|NCT00550446|54689354|FG008|Up To Week 12|Other|0|||
28030896|NCT00550446|54689355|FG009|Up To Week 12|Other|0|||
28030897|NCT00550446|54689356|FG010|Up To Week 12|Other|0|||
28030898|NCT00550446|54689346|FG000|Up To Week 12|Randomized not treated|0|||
28030899|NCT00550446|54689347|FG001|Up To Week 12|Randomized not treated|1|||
28030900|NCT00550446|54689348|FG002|Up To Week 12|Randomized not treated|1|||
28030901|NCT00550446|54689349|FG003|Up To Week 12|Randomized not treated|0|||
28030902|NCT00550446|54689350|FG004|Up To Week 12|Randomized not treated|0|||
28030903|NCT00550446|54689351|FG005|Up To Week 12|Randomized not treated|0|||
28030904|NCT00550446|54689352|FG006|Up To Week 12|Randomized not treated|0|||
28030905|NCT00550446|54689353|FG007|Up To Week 12|Randomized not treated|0|||
28030906|NCT00550446|54689354|FG008|Up To Week 12|Randomized not treated|0|||
28030907|NCT00550446|54689355|FG009|Up To Week 12|Randomized not treated|0|||
28030908|NCT00550446|54689356|FG010|Up To Week 12|Randomized not treated|0|||
28030909|NCT00550446|54689346|FG000|Post Week 12|Adverse Event|2|||
28030910|NCT00550446|54689347|FG001|Post Week 12|Adverse Event|1|||
28030911|NCT00550446|54689348|FG002|Post Week 12|Adverse Event|1|||
28030912|NCT00550446|54689349|FG003|Post Week 12|Adverse Event|1|||
28030913|NCT00550446|54689350|FG004|Post Week 12|Adverse Event|1|||
28030914|NCT00550446|54689351|FG005|Post Week 12|Adverse Event|1|||
28030915|NCT00550446|54689352|FG006|Post Week 12|Adverse Event|0|||
28030916|NCT00550446|54689353|FG007|Post Week 12|Adverse Event|0|||
28030917|NCT00550446|54689354|FG008|Post Week 12|Adverse Event|0|||
28030918|NCT00550446|54689355|FG009|Post Week 12|Adverse Event|4|||
28030919|NCT00550446|54689356|FG010|Post Week 12|Adverse Event|0|||
28030920|NCT00550446|54689346|FG000|Post Week 12|Lack of Efficacy|0|||
28030921|NCT00550446|54689347|FG001|Post Week 12|Lack of Efficacy|0|||
28030922|NCT00550446|54689348|FG002|Post Week 12|Lack of Efficacy|1|||
28030923|NCT00550446|54689349|FG003|Post Week 12|Lack of Efficacy|0|||
28030924|NCT00550446|54689350|FG004|Post Week 12|Lack of Efficacy|0|||
28030925|NCT00550446|54689351|FG005|Post Week 12|Lack of Efficacy|0|||
28030926|NCT00550446|54689352|FG006|Post Week 12|Lack of Efficacy|0|||
28030927|NCT00550446|54689353|FG007|Post Week 12|Lack of Efficacy|1|||
28030928|NCT00550446|54689354|FG008|Post Week 12|Lack of Efficacy|1|||
28030929|NCT00550446|54689355|FG009|Post Week 12|Lack of Efficacy|2|||
28030930|NCT00550446|54689356|FG010|Post Week 12|Lack of Efficacy|1|||
28030931|NCT00550446|54689346|FG000|Post Week 12|Lost to Follow-up|0|||
28030932|NCT00550446|54689347|FG001|Post Week 12|Lost to Follow-up|0|||
28030933|NCT00550446|54689348|FG002|Post Week 12|Lost to Follow-up|1|||
28030934|NCT00550446|54689349|FG003|Post Week 12|Lost to Follow-up|1|||
28030935|NCT00550446|54689350|FG004|Post Week 12|Lost to Follow-up|0|||
28030936|NCT00550446|54689351|FG005|Post Week 12|Lost to Follow-up|0|||
28030937|NCT00550446|54689352|FG006|Post Week 12|Lost to Follow-up|1|||
28030938|NCT00550446|54689353|FG007|Post Week 12|Lost to Follow-up|0|||
28030939|NCT00550446|54689354|FG008|Post Week 12|Lost to Follow-up|0|||
28030940|NCT00550446|54689355|FG009|Post Week 12|Lost to Follow-up|0|||
28030941|NCT00550446|54689356|FG010|Post Week 12|Lost to Follow-up|0|||
28030942|NCT00550446|54689346|FG000|Post Week 12|Withdrawal by Subject|0|||
28030943|NCT00550446|54689347|FG001|Post Week 12|Withdrawal by Subject|0|||
28030944|NCT00550446|54689348|FG002|Post Week 12|Withdrawal by Subject|0|||
28030945|NCT00550446|54689349|FG003|Post Week 12|Withdrawal by Subject|0|||
28030946|NCT00550446|54689350|FG004|Post Week 12|Withdrawal by Subject|1|||
28030947|NCT00550446|54689351|FG005|Post Week 12|Withdrawal by Subject|0|||
28030948|NCT00550446|54689352|FG006|Post Week 12|Withdrawal by Subject|0|||
28030949|NCT00550446|54689353|FG007|Post Week 12|Withdrawal by Subject|0|||
28030950|NCT00550446|54689354|FG008|Post Week 12|Withdrawal by Subject|0|||
28030951|NCT00550446|54689355|FG009|Post Week 12|Withdrawal by Subject|0|||
28030952|NCT00550446|54689356|FG010|Post Week 12|Withdrawal by Subject|0|||
28030953|NCT00550446|54689346|FG000|Post Week 12|Other|1|||
28030954|NCT00550446|54689347|FG001|Post Week 12|Other|1|||
28030955|NCT00550446|54689348|FG002|Post Week 12|Other|0|||
28030956|NCT00550446|54689349|FG003|Post Week 12|Other|1|||
28030957|NCT00550446|54689350|FG004|Post Week 12|Other|0|||
28030958|NCT00550446|54689351|FG005|Post Week 12|Other|0|||
28030959|NCT00550446|54689352|FG006|Post Week 12|Other|1|||
28030960|NCT00550446|54689353|FG007|Post Week 12|Other|0|||
28030961|NCT00550446|54689354|FG008|Post Week 12|Other|1|||
28030962|NCT00550446|54689355|FG009|Post Week 12|Other|1|||
28030963|NCT00550446|54689356|FG010|Post Week 12|Other|0|||
28030964|NCT00436618|54689397|FG000|Overall Study|Withdrawal by Subject|5|||
28030965|NCT00436618|54689398|FG001|Overall Study|Withdrawal by Subject|8|||
28030966|NCT00436618|54689399|FG002|Overall Study|Withdrawal by Subject|11|||
28030967|NCT00436618|54689397|FG000|Overall Study|Adverse Event|8|||
28030968|NCT00436618|54689398|FG001|Overall Study|Adverse Event|8|||
28030969|NCT00436618|54689399|FG002|Overall Study|Adverse Event|9|||
28030970|NCT00436618|54689397|FG000|Overall Study|Alternate Treatment|3|||
28030971|NCT00436618|54689398|FG001|Overall Study|Alternate Treatment|4|||
28030972|NCT00436618|54689399|FG002|Overall Study|Alternate Treatment|12|||
28030973|NCT00436618|54689397|FG000|Overall Study|Other Medical Problems|3|||
28030974|NCT00436618|54689398|FG001|Overall Study|Other Medical Problems|1|||
28030975|NCT00436618|54689399|FG002|Overall Study|Other Medical Problems|7|||
28030976|NCT00436618|54689397|FG000|Overall Study|Death|4|||
28030977|NCT00436618|54689398|FG001|Overall Study|Death|2|||
28030978|NCT00436618|54689399|FG002|Overall Study|Death|3|||
28030979|NCT00436618|54689397|FG000|Overall Study|New Primary or Other Reasons|6|||
28030980|NCT00436618|54689398|FG001|Overall Study|New Primary or Other Reasons|2|||
28030981|NCT00436618|54689399|FG002|Overall Study|New Primary or Other Reasons|12|||
28030982|NCT00436618|54689397|FG000|Overall Study|Still on treatment|1|||
27807305|NCT01766037|54262717|FG001|Overall Study|Moved from area|0|||
28030983|NCT00436618|54689398|FG001|Overall Study|Still on treatment|2|||
28030984|NCT00436618|54689399|FG002|Overall Study|Still on treatment|7|||
28030985|NCT00548808|54689436|FG000|Overall Study|Lost to Follow-up|9|||
28030986|NCT00548808|54689437|FG001|Overall Study|Lost to Follow-up|3|||
28030987|NCT00548808|54689436|FG000|Overall Study|Protocol Violation|8|||
28030988|NCT00548808|54689437|FG001|Overall Study|Protocol Violation|8|||
28030989|NCT00548808|54689436|FG000|Overall Study|Withdrawal by Subject|8|||
28030990|NCT00548808|54689437|FG001|Overall Study|Withdrawal by Subject|4|||
28030991|NCT00548808|54689436|FG000|Overall Study|Physician Decision|6|||
28030992|NCT00548808|54689437|FG001|Overall Study|Physician Decision|3|||
28030993|NCT00548808|54689436|FG000|Overall Study|Adverse Event|4|||
28030994|NCT00548808|54689437|FG001|Overall Study|Adverse Event|5|||
28030995|NCT00548808|54689436|FG000|Overall Study|Death|2|||
28030996|NCT00548808|54689437|FG001|Overall Study|Death|0|||
28030997|NCT00548808|54689436|FG000|Overall Study|Entry Criteria Not Met|2|||
28030998|NCT00548808|54689437|FG001|Overall Study|Entry Criteria Not Met|2|||
28030999|NCT00548808|54689436|FG000|Overall Study|Lack of Efficacy|2|||
28031000|NCT00548808|54689437|FG001|Overall Study|Lack of Efficacy|0|||
28031001|NCT00548808|54689436|FG000|Overall Study|Sponsor Decision|1|||
28031002|NCT00548808|54689437|FG001|Overall Study|Sponsor Decision|1|||
28031003|NCT00110617|54689445|FG000|Overall Study|Adverse Event|2|||
28031004|NCT00110617|54689446|FG001|Overall Study|Adverse Event|4|||
28031005|NCT00110617|54689445|FG000|Overall Study|Abnormal Laboratory Value|4|||
28031006|NCT00110617|54689446|FG001|Overall Study|Abnormal Laboratory Value|2|||
28031007|NCT00110617|54689445|FG000|Overall Study|Lack of Efficacy|1|||
28031008|NCT00110617|54689446|FG001|Overall Study|Lack of Efficacy|0|||
28031009|NCT00110617|54689445|FG000|Overall Study|Patient no longer requires study drug|1|||
28031010|NCT00110617|54689446|FG001|Overall Study|Patient no longer requires study drug|0|||
28031011|NCT00110617|54689445|FG000|Overall Study|Protocol Violation|5|||
28031012|NCT00110617|54689446|FG001|Overall Study|Protocol Violation|0|||
28031013|NCT00110617|54689445|FG000|Overall Study|Withdrawal by Subject|10|||
28031014|NCT00110617|54689446|FG001|Overall Study|Withdrawal by Subject|4|||
28031015|NCT00110617|54689445|FG000|Overall Study|Lost to Follow-up|9|||
28031016|NCT00110617|54689446|FG001|Overall Study|Lost to Follow-up|1|||
28031017|NCT00110617|54689445|FG000|Overall Study|Administrative problems|6|||
28031018|NCT00110617|54689446|FG001|Overall Study|Administrative problems|5|||
28031019|NCT00110617|54689445|FG000|Overall Study|Death|1|||
28031020|NCT00110617|54689446|FG001|Overall Study|Death|1|||
28031021|NCT00110617|54689445|FG000|Overall Study|Did not receive study drug|0|||
28031022|NCT00110617|54689446|FG001|Overall Study|Did not receive study drug|12|||
28031023|NCT03956862|54689456|FG000|Overall Study|Lost to Follow-up|1|||
28031024|NCT03956862|54689457|FG001|Overall Study|Lost to Follow-up|1|||
28031025|NCT03956862|54689456|FG000|Overall Study|Withdrawal by Subject|1|||
28031026|NCT03956862|54689457|FG001|Overall Study|Withdrawal by Subject|1|||
28031027|NCT00550238|54689463|FG000|Overall Study|Adverse Event|88|||
28031028|NCT00550238|54689463|FG000|Overall Study|Death|34|||
28031029|NCT00550238|54689463|FG000|Overall Study|Disease progression|46|||
28031030|NCT00550238|54689463|FG000|Overall Study|Withdrawal by Subject|167|||
27844174|NCT01429051|54333838|FG000|Tolerability Phase|Physician Decision|1|||
27844175|NCT01429051|54333838|FG000|Tolerability Phase|Other|2|||
27844176|NCT01428661|54333871|FG000|Double-Masked Phase|Protocol Violation|9|||
27844177|NCT01428661|54333872|FG001|Double-Masked Phase|Protocol Violation|4|||
28031031|NCT00550238|54689463|FG000|Overall Study|Physician Decision|31|||
28031032|NCT00550238|54689463|FG000|Overall Study|Patient noncompliance|25|||
28031033|NCT00550238|54689463|FG000|Overall Study|Lost to Follow-up|13|||
28031034|NCT00550238|54689463|FG000|Overall Study|Sponsor decision|55|||
28031035|NCT03956550|54689470|FG000|Overall Study|Sponsor decision|65|||
28031036|NCT03956550|54689471|FG001|Overall Study|Sponsor decision|66|||
28031037|NCT03956550|54689472|FG002|Overall Study|Sponsor decision|64|||
28031038|NCT03956550|54689470|FG000|Overall Study|Adverse Event|0|||
28031039|NCT03956550|54689471|FG001|Overall Study|Adverse Event|1|||
28031040|NCT03956550|54689472|FG002|Overall Study|Adverse Event|0|||
28031041|NCT03956550|54689470|FG000|Overall Study|Withdrawal by Subject|5|||
28031042|NCT03956550|54689471|FG001|Overall Study|Withdrawal by Subject|5|||
28031043|NCT03956550|54689472|FG002|Overall Study|Withdrawal by Subject|6|||
28031044|NCT00110305|54689484|FG000|Overall Study|Adverse Event|46|||
28031045|NCT00110305|54689485|FG001|Overall Study|Adverse Event|13|||
28031046|NCT00110305|54689484|FG000|Overall Study|Sponsors Decision|1|||
28031047|NCT00110305|54689485|FG001|Overall Study|Sponsors Decision|0|||
28031048|NCT00110305|54689484|FG000|Overall Study|Subject Non-Compliant|9|||
27844178|NCT01428661|54333873|FG002|Double-Masked Phase|Protocol Violation|0|||
28031049|NCT00110305|54689485|FG001|Overall Study|Subject Non-Compliant|2|||
28031050|NCT00110305|54689484|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
28031051|NCT00110305|54689485|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
28031052|NCT00110305|54689484|FG000|Overall Study|Subject Reached A Virologic Endpoint|21|||
28031053|NCT00110305|54689485|FG001|Overall Study|Subject Reached A Virologic Endpoint|3|||
28031054|NCT00110305|54689484|FG000|Overall Study|Protocol Violation|0|||
28031055|NCT00110305|54689485|FG001|Overall Study|Protocol Violation|1|||
28031056|NCT00110305|54689484|FG000|Overall Study|Withdrawal by Subject|7|||
28031057|NCT00110305|54689485|FG001|Overall Study|Withdrawal by Subject|7|||
27844179|NCT01428661|54333871|FG000|Double-Masked Phase|Adverse Event|13|||
28031058|NCT00110305|54689484|FG000|Overall Study|Lost to Follow-up|20|||
28031059|NCT00110305|54689485|FG001|Overall Study|Lost to Follow-up|3|||
28031060|NCT00110305|54689484|FG000|Overall Study|Other|8|||
27844180|NCT01428661|54333872|FG001|Double-Masked Phase|Adverse Event|4|||
27844181|NCT01428661|54333873|FG002|Double-Masked Phase|Adverse Event|0|||
28031061|NCT00110305|54689485|FG001|Overall Study|Other|2|||
28031062|NCT00428116|54689504|FG000|Overall Study|Death|1|||
28031063|NCT00428116|54689505|FG001|Overall Study|Death|0|||
28031064|NCT00428116|54689504|FG000|Overall Study|Withdrawal by Subject|1|||
28031065|NCT00428116|54689505|FG001|Overall Study|Withdrawal by Subject|0|||
28031066|NCT00428116|54689504|FG000|Overall Study|Lost to Follow-up|1|||
28031067|NCT00428116|54689505|FG001|Overall Study|Lost to Follow-up|0|||
28031068|NCT00560066|54689514|FG000|Overall Study|Death|2|||
28031069|NCT00560066|54689515|FG001|Overall Study|Death|1|||
28031070|NCT00560066|54689514|FG000|Overall Study|Withdrawal by Subject|0|||
28031071|NCT00560066|54689515|FG001|Overall Study|Withdrawal by Subject|3|||
28031072|NCT00560066|54689514|FG000|Overall Study|Lost to Follow-up|4|||
28031073|NCT00560066|54689515|FG001|Overall Study|Lost to Follow-up|10|||
28031074|NCT00560066|54689514|FG000|Overall Study|Protocol Violation|0|||
28031075|NCT00560066|54689515|FG001|Overall Study|Protocol Violation|1|||
28031076|NCT00560066|54689514|FG000|Overall Study|Administrative reason|0|||
28031077|NCT00560066|54689515|FG001|Overall Study|Administrative reason|5|||
28031078|NCT00560066|54689514|FG000|Overall Study|Missing primary reason|0|||
28031079|NCT00560066|54689515|FG001|Overall Study|Missing primary reason|2|||
28031080|NCT00549900|54689526|FG000|Overall Study|Adverse Event|1|||
28031081|NCT00435994|54689533|FG000|Overall Study|Lost to Follow-up|7|||
28031082|NCT00435994|54689534|FG001|Overall Study|Lost to Follow-up|0|||
28031083|NCT00435994|54689535|FG002|Overall Study|Lost to Follow-up|0|||
28031084|NCT00435370|54689546|FG000|Overall Study|Adverse Event|8|||
28031085|NCT00435370|54689547|FG001|Overall Study|Adverse Event|8|||
28031086|NCT00435370|54689546|FG000|Overall Study|Withdrawal by Subject|10|||
28031087|NCT00435370|54689547|FG001|Overall Study|Withdrawal by Subject|10|||
28031088|NCT00435370|54689546|FG000|Overall Study|Antipsychotic medication changed|4|||
28031089|NCT00435370|54689547|FG001|Overall Study|Antipsychotic medication changed|2|||
28031090|NCT00096031|54689553|FG000|Overall Study|Adverse Event|3|||
28031091|NCT00096031|54689553|FG000|Overall Study|Lack of Efficacy|42|||
28031092|NCT00096031|54689553|FG000|Overall Study|Death|4|||
28031093|NCT00096031|54689553|FG000|Overall Study|Withdrawal by Subject|1|||
28031094|NCT00096031|54689553|FG000|Overall Study|Ineligible|8|||
28031095|NCT00096031|54689553|FG000|Overall Study|Not protocol specified|5|||
28031096|NCT00118417|54689557|FG000|Phase I (Weeks 0 to 6)|Remission|8|||
28031097|NCT00118417|54689558|FG001|Phase I (Weeks 0 to 6)|Remission|0|||
28031098|NCT00118417|54689557|FG000|Phase I (Weeks 0 to 6)|Lost to Follow-up|6|||
28031099|NCT00118417|54689558|FG001|Phase I (Weeks 0 to 6)|Lost to Follow-up|0|||
28031100|NCT00118417|54689557|FG000|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4|||
28031101|NCT00118417|54689558|FG001|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0|||
28031102|NCT00118417|54689557|FG000|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
27844182|NCT01428661|54333871|FG000|Double-Masked Phase|Lost to Follow-up|14|||
27844183|NCT01428661|54333872|FG001|Double-Masked Phase|Lost to Follow-up|14|||
27844184|NCT01428661|54333873|FG002|Double-Masked Phase|Lost to Follow-up|0|||
27844185|NCT01428661|54333871|FG000|Double-Masked Phase|Withdrawal by Subject|18|||
28031103|NCT00118417|54689558|FG001|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
28031104|NCT00118417|54689557|FG000|Phase II (Weeks 6 to 12)|Remission|1|||
28031105|NCT00118417|54689558|FG001|Phase II (Weeks 6 to 12)|Remission|2|||
28031106|NCT00549848|54689571|FG000|Overall Study|Death|1|||
28031107|NCT00549848|54689572|FG001|Overall Study|Death|4|||
28031108|NCT00549848|54689573|FG002|Overall Study|Death|13|||
28031109|NCT00549848|54689571|FG000|Overall Study|Physician Decision|0|||
28031110|NCT00549848|54689572|FG001|Overall Study|Physician Decision|0|||
28031111|NCT00549848|54689573|FG002|Overall Study|Physician Decision|4|||
28031112|NCT00549848|54689571|FG000|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|3|||
28031113|NCT00549848|54689572|FG001|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
28031114|NCT00549848|54689573|FG002|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
28031115|NCT00549848|54689571|FG000|Overall Study|Failure to achieve Complete Remission (CR)|1|||
27844186|NCT01428661|54333872|FG001|Double-Masked Phase|Withdrawal by Subject|20|||
28031116|NCT00549848|54689572|FG001|Overall Study|Failure to achieve Complete Remission (CR)|0|||
28031117|NCT00549848|54689573|FG002|Overall Study|Failure to achieve Complete Remission (CR)|1|||
28031118|NCT00549848|54689571|FG000|Overall Study|Participant/Family Withdraw|2|||
28031119|NCT00549848|54689572|FG001|Overall Study|Participant/Family Withdraw|3|||
28031120|NCT00549848|54689573|FG002|Overall Study|Participant/Family Withdraw|5|||
28031121|NCT00549848|54689571|FG000|Overall Study|Second Malignancy|1|||
28031122|NCT00549848|54689572|FG001|Overall Study|Second Malignancy|0|||
28031123|NCT00549848|54689573|FG002|Overall Study|Second Malignancy|0|||
28031124|NCT00549848|54689571|FG000|Overall Study|Transplant|3|||
28031125|NCT00549848|54689572|FG001|Overall Study|Transplant|3|||
28031126|NCT00549848|54689573|FG002|Overall Study|Transplant|18|||
28031127|NCT00549848|54689571|FG000|Overall Study|Unacceptable Toxicity|1|||
28031128|NCT00549848|54689572|FG001|Overall Study|Unacceptable Toxicity|6|||
28031129|NCT00549848|54689573|FG002|Overall Study|Unacceptable Toxicity|6|||
28031130|NCT00549770|54689597|FG000|Overall Study|Protocol deviation|1|||
28031131|NCT00549770|54689598|FG001|Overall Study|Protocol deviation|1|||
28031132|NCT00549770|54689599|FG002|Overall Study|Protocol deviation|1|||
28031133|NCT00549770|54689600|FG003|Overall Study|Protocol deviation|2|||
28031134|NCT00549770|54689601|FG004|Overall Study|Protocol deviation|2|||
28031135|NCT00549770|54689602|FG005|Overall Study|Protocol deviation|2|||
28031136|NCT00549770|54689603|FG006|Overall Study|Protocol deviation|1|||
28031137|NCT00549770|54689604|FG007|Overall Study|Protocol deviation|2|||
28031138|NCT00549770|54689597|FG000|Overall Study|Administrative problems|0|||
28031139|NCT00549770|54689598|FG001|Overall Study|Administrative problems|1|||
28031140|NCT00549770|54689599|FG002|Overall Study|Administrative problems|0|||
28031141|NCT00549770|54689600|FG003|Overall Study|Administrative problems|0|||
28031142|NCT00549770|54689601|FG004|Overall Study|Administrative problems|0|||
28031143|NCT00549770|54689602|FG005|Overall Study|Administrative problems|0|||
28031144|NCT00549770|54689603|FG006|Overall Study|Administrative problems|0|||
28031145|NCT00549770|54689604|FG007|Overall Study|Administrative problems|1|||
28031146|NCT00549770|54689597|FG000|Overall Study|Lost to Follow-up|0|||
28031147|NCT00549770|54689598|FG001|Overall Study|Lost to Follow-up|0|||
28031148|NCT00549770|54689599|FG002|Overall Study|Lost to Follow-up|2|||
28031149|NCT00549770|54689600|FG003|Overall Study|Lost to Follow-up|2|||
28031150|NCT00549770|54689601|FG004|Overall Study|Lost to Follow-up|3|||
28031151|NCT00549770|54689602|FG005|Overall Study|Lost to Follow-up|2|||
28031152|NCT00549770|54689603|FG006|Overall Study|Lost to Follow-up|0|||
28031153|NCT00549770|54689604|FG007|Overall Study|Lost to Follow-up|0|||
28031154|NCT00549770|54689597|FG000|Overall Study|Withdrawal by Subject|4|||
28031155|NCT00549770|54689598|FG001|Overall Study|Withdrawal by Subject|6|||
28031156|NCT00549770|54689599|FG002|Overall Study|Withdrawal by Subject|4|||
28031157|NCT00549770|54689600|FG003|Overall Study|Withdrawal by Subject|5|||
28031158|NCT00549770|54689601|FG004|Overall Study|Withdrawal by Subject|6|||
28031159|NCT00549770|54689602|FG005|Overall Study|Withdrawal by Subject|6|||
28031160|NCT00549770|54689603|FG006|Overall Study|Withdrawal by Subject|4|||
28031161|NCT00549770|54689604|FG007|Overall Study|Withdrawal by Subject|9|||
28031162|NCT00549770|54689597|FG000|Overall Study|Lack of Efficacy|1|||
28031163|NCT00549770|54689598|FG001|Overall Study|Lack of Efficacy|0|||
28031164|NCT00549770|54689599|FG002|Overall Study|Lack of Efficacy|2|||
28031165|NCT00549770|54689600|FG003|Overall Study|Lack of Efficacy|3|||
28031166|NCT00549770|54689601|FG004|Overall Study|Lack of Efficacy|5|||
28031167|NCT00549770|54689602|FG005|Overall Study|Lack of Efficacy|1|||
28031168|NCT00549770|54689603|FG006|Overall Study|Lack of Efficacy|3|||
28031169|NCT00549770|54689604|FG007|Overall Study|Lack of Efficacy|8|||
28031170|NCT00549770|54689597|FG000|Overall Study|Abnormal test procedure results|0|||
28031171|NCT00549770|54689598|FG001|Overall Study|Abnormal test procedure results|0|||
28031172|NCT00549770|54689599|FG002|Overall Study|Abnormal test procedure results|0|||
28031173|NCT00549770|54689600|FG003|Overall Study|Abnormal test procedure results|2|||
27807306|NCT01766037|54262716|FG000|Overall Study|medical - unrelated|1|||
27807307|NCT01766037|54262717|FG001|Overall Study|medical - unrelated|2|||
27807308|NCT01766037|54262716|FG000|Overall Study|nausea / discomfort|3|||
28031174|NCT00549770|54689601|FG004|Overall Study|Abnormal test procedure results|0|||
28031175|NCT00549770|54689602|FG005|Overall Study|Abnormal test procedure results|1|||
28031176|NCT00549770|54689603|FG006|Overall Study|Abnormal test procedure results|1|||
28031177|NCT00549770|54689604|FG007|Overall Study|Abnormal test procedure results|1|||
28031178|NCT00549770|54689597|FG000|Overall Study|Abnormal laboratory values|0|||
28031179|NCT00549770|54689598|FG001|Overall Study|Abnormal laboratory values|0|||
28031180|NCT00549770|54689599|FG002|Overall Study|Abnormal laboratory values|0|||
28031181|NCT00549770|54689600|FG003|Overall Study|Abnormal laboratory values|0|||
28031182|NCT00549770|54689601|FG004|Overall Study|Abnormal laboratory values|0|||
28031183|NCT00549770|54689602|FG005|Overall Study|Abnormal laboratory values|1|||
27939717|NCT01040403|54595960|FG000|Overall Study|Not treated|1|||
27939718|NCT01040403|54595960|FG000|Overall Study|Other reason not defined above|6|||
27939719|NCT00957034|54595982|FG000|Overall Study|Adverse Event|0|||
28031184|NCT00549770|54689603|FG006|Overall Study|Abnormal laboratory values|0|||
27807309|NCT01766037|54262717|FG001|Overall Study|nausea / discomfort|0|||
27939720|NCT00957034|54595983|FG001|Overall Study|Adverse Event|1|||
28031185|NCT00549770|54689604|FG007|Overall Study|Abnormal laboratory values|0|||
28031186|NCT00549770|54689597|FG000|Overall Study|Adverse Event|1|||
28031187|NCT00549770|54689598|FG001|Overall Study|Adverse Event|3|||
28031188|NCT00549770|54689599|FG002|Overall Study|Adverse Event|1|||
28031189|NCT00549770|54689600|FG003|Overall Study|Adverse Event|2|||
28031190|NCT00549770|54689601|FG004|Overall Study|Adverse Event|1|||
28031191|NCT00549770|54689602|FG005|Overall Study|Adverse Event|0|||
28031192|NCT00549770|54689603|FG006|Overall Study|Adverse Event|5|||
28031193|NCT00549770|54689604|FG007|Overall Study|Adverse Event|4|||
27807310|NCT01765569|54262723|FG000|Period B|Withdrawal by Subject|1|||
28031194|NCT00548184|54689622|FG000|Overall Study|Adverse Event|3|||
28031195|NCT00548184|54689622|FG000|Overall Study|took other drug|1|||
27807311|NCT01765569|54262723|FG000|Period C|Death|1|||
28031196|NCT00548184|54689622|FG000|Overall Study|Found Her2 negative|1|||
28031197|NCT00454636|54689630|FG000|Overall Study|Adverse Event|10|||
28031198|NCT00454636|54689631|FG001|Overall Study|Adverse Event|6|||
28031199|NCT00454636|54689632|FG002|Overall Study|Adverse Event|9|||
28031200|NCT00454636|54689633|FG003|Overall Study|Adverse Event|15|||
28031201|NCT00454636|54689630|FG000|Overall Study|Disease Progression|11|||
28031202|NCT00454636|54689631|FG001|Overall Study|Disease Progression|12|||
28031203|NCT00454636|54689632|FG002|Overall Study|Disease Progression|4|||
28031204|NCT00454636|54689633|FG003|Overall Study|Disease Progression|11|||
28031205|NCT00454636|54689630|FG000|Overall Study|Protocol Violation|3|||
28031206|NCT00454636|54689631|FG001|Overall Study|Protocol Violation|2|||
28031207|NCT00454636|54689632|FG002|Overall Study|Protocol Violation|3|||
28031208|NCT00454636|54689633|FG003|Overall Study|Protocol Violation|3|||
28031209|NCT00454636|54689630|FG000|Overall Study|Death|6|||
28031210|NCT00454636|54689631|FG001|Overall Study|Death|1|||
28031211|NCT00454636|54689632|FG002|Overall Study|Death|1|||
28031212|NCT00454636|54689633|FG003|Overall Study|Death|1|||
28031213|NCT00454636|54689630|FG000|Overall Study|Patient refusal|1|||
28031214|NCT00454636|54689631|FG001|Overall Study|Patient refusal|1|||
28031215|NCT00454636|54689632|FG002|Overall Study|Patient refusal|3|||
28031216|NCT00454636|54689633|FG003|Overall Study|Patient refusal|2|||
28031217|NCT00454636|54689630|FG000|Overall Study|Lost to Follow-up|0|||
28031218|NCT00454636|54689631|FG001|Overall Study|Lost to Follow-up|1|||
28031219|NCT00454636|54689632|FG002|Overall Study|Lost to Follow-up|0|||
28031220|NCT00454636|54689633|FG003|Overall Study|Lost to Follow-up|0|||
28031221|NCT00427960|54689645|FG000|Overall Study|Adverse Event|2|||
28031222|NCT00427960|54689646|FG001|Overall Study|Adverse Event|0|||
28031223|NCT00427960|54689645|FG000|Overall Study|Withdrawal by Subject|0|||
28031224|NCT00427960|54689646|FG001|Overall Study|Withdrawal by Subject|3|||
28031225|NCT00427960|54689645|FG000|Overall Study|Other|0|||
28031226|NCT00427960|54689646|FG001|Overall Study|Other|1|||
28031227|NCT00548340|54689655|FG000|Overall Study|Protocol Violation|2|||
27939721|NCT00957034|54595984|FG002|Overall Study|Adverse Event|1|||
27939722|NCT00957034|54595982|FG000|Overall Study|Sponsor Terminated Study|6|||
27939723|NCT00957034|54595983|FG001|Overall Study|Sponsor Terminated Study|1|||
27939724|NCT00957034|54595984|FG002|Overall Study|Sponsor Terminated Study|5|||
28031228|NCT00548340|54689656|FG001|Overall Study|Protocol Violation|3|||
28031229|NCT00548340|54689657|FG002|Overall Study|Protocol Violation|3|||
27939725|NCT00957034|54595982|FG000|Overall Study|Withdrawal by Subject|0|||
27939726|NCT00957034|54595983|FG001|Overall Study|Withdrawal by Subject|2|||
27939727|NCT00957034|54595984|FG002|Overall Study|Withdrawal by Subject|0|||
27939728|NCT00953056|54595998|FG000|Overall Study|Withdrew Consent|0|||
27939729|NCT00953056|54595999|FG001|Overall Study|Withdrew Consent|0|||
27939730|NCT00953056|54596000|FG002|Overall Study|Withdrew Consent|0|||
27939731|NCT00953056|54596001|FG003|Overall Study|Withdrew Consent|0|||
28031230|NCT00548340|54689655|FG000|Overall Study|Adverse Event|2|||
28031231|NCT00548340|54689656|FG001|Overall Study|Adverse Event|2|||
28031232|NCT00548340|54689657|FG002|Overall Study|Adverse Event|2|||
28031233|NCT00548340|54689655|FG000|Overall Study|Lost to Follow-up|1|||
28031234|NCT00548340|54689656|FG001|Overall Study|Lost to Follow-up|1|||
28031235|NCT00548340|54689657|FG002|Overall Study|Lost to Follow-up|0|||
28031236|NCT00548340|54689655|FG000|Overall Study|Withdrawal by Subject|2|||
28031237|NCT00548340|54689656|FG001|Overall Study|Withdrawal by Subject|4|||
28031238|NCT00548340|54689657|FG002|Overall Study|Withdrawal by Subject|3|||
28031239|NCT00548340|54689655|FG000|Overall Study|Other|1|||
28031240|NCT00548340|54689656|FG001|Overall Study|Other|1|||
28031241|NCT00548340|54689657|FG002|Overall Study|Other|1|||
28031242|NCT00454246|54689668|FG000|Overall Study|Adverse Event|2|||
28031243|NCT00454246|54689669|FG001|Overall Study|Adverse Event|2|||
27807312|NCT01609257|54262732|FG000|Overall Study|Lost to Follow-up|2|||
27807313|NCT01609257|54262733|FG001|Overall Study|Lost to Follow-up|1|||
27807314|NCT01609257|54262732|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
27807315|NCT01609257|54262733|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
27807316|NCT01609257|54262732|FG000|Overall Study|Non-compliance/Protocol deviation|4|||
27807317|NCT01609257|54262733|FG001|Overall Study|Non-compliance/Protocol deviation|6|||
27807318|NCT01609023|54262742|FG000|Overall Study|Lack of Efficacy|3|||
27807319|NCT01609023|54262742|FG000|Overall Study|Withdrawal by Subject|4|||
27807320|NCT01609023|54262742|FG000|Overall Study|Lost to Follow-up|8|||
27807321|NCT01609023|54262742|FG000|Overall Study|Toxicity|3|||
27807322|NCT01609023|54262742|FG000|Overall Study|Disease progression|10|||
28031244|NCT00454246|54689670|FG002|Overall Study|Adverse Event|0|||
28031245|NCT00454246|54689668|FG000|Overall Study|Violation of selection criteria at entry|6|||
28031246|NCT00454246|54689669|FG001|Overall Study|Violation of selection criteria at entry|0|||
28031247|NCT00454246|54689670|FG002|Overall Study|Violation of selection criteria at entry|0|||
28031248|NCT00454246|54689668|FG000|Overall Study|Protocol Violation|1|||
28031249|NCT00454246|54689669|FG001|Overall Study|Protocol Violation|0|||
28031250|NCT00454246|54689670|FG002|Overall Study|Protocol Violation|0|||
28031251|NCT00454246|54689668|FG000|Overall Study|Refused Treatment|1|||
28031252|NCT00454246|54689669|FG001|Overall Study|Refused Treatment|1|||
28031253|NCT00454246|54689670|FG002|Overall Study|Refused Treatment|0|||
28031254|NCT00454246|54689668|FG000|Overall Study|Failure to return|1|||
28031255|NCT00454246|54689669|FG001|Overall Study|Failure to return|0|||
28031256|NCT00454246|54689670|FG002|Overall Study|Failure to return|0|||
28031257|NCT00454246|54689668|FG000|Overall Study|Early termination of study|62|||
28031258|NCT00454246|54689669|FG001|Overall Study|Early termination of study|26|||
28031259|NCT00454246|54689670|FG002|Overall Study|Early termination of study|9|||
28031260|NCT00434590|54689680|FG000|Overall Study|Administrative problems|5|||
28031261|NCT00434590|54689681|FG001|Overall Study|Administrative problems|5|||
28031262|NCT02891837|54689689|FG000|Overall Study|Lost to Follow-up|2|||
28031263|NCT02891837|54689690|FG001|Overall Study|Lost to Follow-up|0|||
28031264|NCT02891837|54689689|FG000|Overall Study|Withdrawal by Subject|1|||
28031265|NCT02891837|54689690|FG001|Overall Study|Withdrawal by Subject|0|||
28031266|NCT00695903|54689714|FG000|Had End of Therapy (EOT) Assessment|Randomized not treated|0|||
28031267|NCT00695903|54689715|FG001|Had End of Therapy (EOT) Assessment|Randomized not treated|2|||
28031268|NCT00695903|54689714|FG000|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
28031269|NCT00695903|54689715|FG001|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
28031270|NCT00695903|54689714|FG000|Had End of Therapy (EOT) Assessment|Adverse Event|1|||
28031271|NCT00695903|54689715|FG001|Had End of Therapy (EOT) Assessment|Adverse Event|0|||
28031272|NCT00695903|54689714|FG000|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
28031273|NCT00695903|54689715|FG001|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
28031274|NCT00695903|54689714|FG000|Had End of Therapy (EOT) Assessment|Physician Decision|0|||
28031275|NCT00695903|54689715|FG001|Had End of Therapy (EOT) Assessment|Physician Decision|1|||
28031276|NCT00695903|54689714|FG000|Had End of Therapy (EOT) Assessment|Protocol Violation|1|||
28031277|NCT00695903|54689715|FG001|Had End of Therapy (EOT) Assessment|Protocol Violation|2|||
28031278|NCT00695903|54689714|FG000|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1|||
28031279|NCT00695903|54689715|FG001|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0|||
28031280|NCT00695903|54689714|FG000|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1|||
28031281|NCT00695903|54689715|FG001|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0|||
28031282|NCT00695903|54689714|FG000|Had Test of Cure (TOC) Assessment|Adverse Event|0|||
28031283|NCT00695903|54689715|FG001|Had Test of Cure (TOC) Assessment|Adverse Event|1|||
28031284|NCT02759861|54689721|FG000|Overall Study|Death|1|||
28031285|NCT00548262|54689726|FG000|Overall Study|Death|21|||
28031286|NCT00548262|54689726|FG000|Overall Study|Adverse Event|2|||
28031287|NCT00548262|54689726|FG000|Overall Study|Lack of Efficacy|4|||
28031288|NCT00548262|54689726|FG000|Overall Study|Lost to Follow-up|1|||
28031289|NCT00548262|54689726|FG000|Overall Study|Other|3|||
28031290|NCT00548262|54689726|FG000|Overall Study|Withdrawal by Subject|1|||
28031291|NCT00095173|54689730|FG000|Open-Label Lead-In Phase (Period A)|Adverse Event|1|||
28031292|NCT00095173|54689731|FG001|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
28031293|NCT00095173|54689732|FG002|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
28031294|NCT00095173|54689733|FG003|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
28031295|NCT00095173|54689734|FG004|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
27807323|NCT01609023|54262742|FG000|Overall Study|Physician Decision|2|||
27807324|NCT01609023|54262742|FG000|Overall Study|Death|2|||
27807325|NCT01609023|54262742|FG000|Overall Study|Personal reasons|1|||
27807326|NCT01765179|54262746|FG000|Overall Study|Adverse Event|3|||
27807327|NCT01765179|54262746|FG000|Overall Study|Lost to Follow-up|5|||
27939732|NCT00953056|54596002|FG004|Overall Study|Withdrew Consent|2|||
27939733|NCT00953056|54596003|FG005|Overall Study|Withdrew Consent|3|||
27939734|NCT00953056|54595998|FG000|Overall Study|Serious Adverse Event|0|||
28031296|NCT00095173|54689735|FG005|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
27807328|NCT01765179|54262746|FG000|Overall Study|Non-compliance with study drug|2|||
27807329|NCT01765179|54262746|FG000|Overall Study|Protocol Violation|1|||
27807330|NCT01765179|54262746|FG000|Overall Study|Withdrawal by Subject|8|||
27807331|NCT01765179|54262746|FG000|Overall Study|Hematocrit >54%|3|||
28031297|NCT00095173|54689730|FG000|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17|||
28031298|NCT00095173|54689731|FG001|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
28031299|NCT00095173|54689732|FG002|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
28031300|NCT00095173|54689733|FG003|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
28031301|NCT00095173|54689734|FG004|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
28031302|NCT00095173|54689735|FG005|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
28031303|NCT00095173|54689730|FG000|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1|||
28031304|NCT00095173|54689731|FG001|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
28031305|NCT00095173|54689732|FG002|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
28031306|NCT00095173|54689733|FG003|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
28031307|NCT00095173|54689734|FG004|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
28031308|NCT00095173|54689735|FG005|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
28031309|NCT00095173|54689730|FG000|Open-Label Lead-In Phase (Period A)|Other|1|||
28031310|NCT00095173|54689731|FG001|Open-Label Lead-In Phase (Period A)|Other|0|||
27807332|NCT01765179|54262746|FG000|Overall Study|prohibited med|1|||
27807333|NCT01765179|54262746|FG000|Overall Study|Out of country unable to finish study|1|||
27939735|NCT00953056|54595999|FG001|Overall Study|Serious Adverse Event|0|||
28031311|NCT00095173|54689732|FG002|Open-Label Lead-In Phase (Period A)|Other|0|||
28031312|NCT00095173|54689733|FG003|Open-Label Lead-In Phase (Period A)|Other|0|||
28031313|NCT00095173|54689734|FG004|Open-Label Lead-In Phase (Period A)|Other|0|||
28031314|NCT00095173|54689735|FG005|Open-Label Lead-In Phase (Period A)|Other|0|||
28031315|NCT00095173|54689730|FG000|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
28031316|NCT00095173|54689731|FG001|Double-Blind Phase (Period B)|Lack of Efficacy|10|||
28031317|NCT00095173|54689732|FG002|Double-Blind Phase (Period B)|Lack of Efficacy|31|||
28031318|NCT00095173|54689733|FG003|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
28031319|NCT00095173|54689734|FG004|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
28031320|NCT00095173|54689735|FG005|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
28031321|NCT00095173|54689730|FG000|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
28031322|NCT00095173|54689731|FG001|Double-Blind Phase (Period B)|Withdrawal by Subject|1|||
28031323|NCT00095173|54689732|FG002|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
28031324|NCT00095173|54689733|FG003|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
28031325|NCT00095173|54689734|FG004|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
28031326|NCT00095173|54689735|FG005|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
28031327|NCT00095173|54689730|FG000|Open-Label Extension Phase (Period C)|Death|0|||
28031328|NCT00095173|54689731|FG001|Open-Label Extension Phase (Period C)|Death|0|||
28031329|NCT00095173|54689732|FG002|Open-Label Extension Phase (Period C)|Death|0|||
28031330|NCT00095173|54689733|FG003|Open-Label Extension Phase (Period C)|Death|0|||
28031331|NCT00095173|54689734|FG004|Open-Label Extension Phase (Period C)|Death|0|||
27844187|NCT01428661|54333873|FG002|Double-Masked Phase|Withdrawal by Subject|0|||
28031332|NCT00095173|54689735|FG005|Open-Label Extension Phase (Period C)|Death|1|||
28031333|NCT00095173|54689730|FG000|Open-Label Extension Phase (Period C)|Adverse Event|0|||
28031334|NCT00095173|54689731|FG001|Open-Label Extension Phase (Period C)|Adverse Event|0|||
28031335|NCT00095173|54689732|FG002|Open-Label Extension Phase (Period C)|Adverse Event|0|||
28031336|NCT00095173|54689733|FG003|Open-Label Extension Phase (Period C)|Adverse Event|1|||
28031337|NCT00095173|54689734|FG004|Open-Label Extension Phase (Period C)|Adverse Event|2|||
28031338|NCT00095173|54689735|FG005|Open-Label Extension Phase (Period C)|Adverse Event|3|||
28031339|NCT00095173|54689730|FG000|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
28031340|NCT00095173|54689731|FG001|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
28031341|NCT00095173|54689732|FG002|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
28031342|NCT00095173|54689733|FG003|Open-Label Extension Phase (Period C)|Lack of Efficacy|11|||
28031343|NCT00095173|54689734|FG004|Open-Label Extension Phase (Period C)|Lack of Efficacy|5|||
28031344|NCT00095173|54689735|FG005|Open-Label Extension Phase (Period C)|Lack of Efficacy|8|||
28031345|NCT00095173|54689730|FG000|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
28031346|NCT00095173|54689731|FG001|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
28031347|NCT00095173|54689732|FG002|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
28031348|NCT00095173|54689733|FG003|Open-Label Extension Phase (Period C)|Lost to Follow-up|2|||
28031349|NCT00095173|54689734|FG004|Open-Label Extension Phase (Period C)|Lost to Follow-up|5|||
28031350|NCT00095173|54689735|FG005|Open-Label Extension Phase (Period C)|Lost to Follow-up|6|||
28031351|NCT00095173|54689730|FG000|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
28031352|NCT00095173|54689731|FG001|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
28031353|NCT00095173|54689732|FG002|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
28031354|NCT00095173|54689733|FG003|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4|||
28031355|NCT00095173|54689734|FG004|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6|||
28031356|NCT00095173|54689735|FG005|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
28031357|NCT00095173|54689730|FG000|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
28031358|NCT00095173|54689731|FG001|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
28031359|NCT00095173|54689732|FG002|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
28031360|NCT00095173|54689733|FG003|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
28031361|NCT00095173|54689734|FG004|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
28031362|NCT00095173|54689735|FG005|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
28031363|NCT00095173|54689730|FG000|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
28031364|NCT00095173|54689731|FG001|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
28031365|NCT00095173|54689732|FG002|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
28031366|NCT00095173|54689733|FG003|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
28031367|NCT00095173|54689734|FG004|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
28031368|NCT00095173|54689735|FG005|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
28031369|NCT00095173|54689730|FG000|Open-Label Extension Phase (Period C)|Pregnancy|0|||
28031370|NCT00095173|54689731|FG001|Open-Label Extension Phase (Period C)|Pregnancy|0|||
27844188|NCT01428661|54333871|FG000|Double-Masked Phase|Lack of Efficacy|2|||
28031371|NCT00095173|54689732|FG002|Open-Label Extension Phase (Period C)|Pregnancy|0|||
28031372|NCT00095173|54689733|FG003|Open-Label Extension Phase (Period C)|Pregnancy|1|||
28031373|NCT00095173|54689734|FG004|Open-Label Extension Phase (Period C)|Pregnancy|2|||
28031374|NCT00095173|54689735|FG005|Open-Label Extension Phase (Period C)|Pregnancy|3|||
27844189|NCT01428661|54333872|FG001|Double-Masked Phase|Lack of Efficacy|1|||
27844190|NCT01428661|54333873|FG002|Double-Masked Phase|Lack of Efficacy|0|||
28031375|NCT00095173|54689730|FG000|Open-Label Extension Phase (Period C)|Other|0|||
28031376|NCT00095173|54689731|FG001|Open-Label Extension Phase (Period C)|Other|0|||
28031377|NCT00095173|54689732|FG002|Open-Label Extension Phase (Period C)|Other|0|||
28031378|NCT00095173|54689733|FG003|Open-Label Extension Phase (Period C)|Other|4|||
28031379|NCT00095173|54689734|FG004|Open-Label Extension Phase (Period C)|Other|6|||
28031380|NCT00095173|54689735|FG005|Open-Label Extension Phase (Period C)|Other|8|||
28031381|NCT00690443|54689751|FG000|Overall Study|Adverse Event|1|||
28031382|NCT00690443|54689752|FG001|Overall Study|Adverse Event|2|||
28031383|NCT03954834|54689762|FG000|Overall Study|Adverse Event|1|||
28031384|NCT03954834|54689763|FG001|Overall Study|Adverse Event|3|||
28031385|NCT03954834|54689764|FG002|Overall Study|Adverse Event|1|||
28031386|NCT03954834|54689765|FG003|Overall Study|Adverse Event|1|||
28031387|NCT03954834|54689762|FG000|Overall Study|Death|0|||
28031388|NCT03954834|54689763|FG001|Overall Study|Death|0|||
28031389|NCT03954834|54689764|FG002|Overall Study|Death|0|||
28031390|NCT03954834|54689765|FG003|Overall Study|Death|1|||
28031391|NCT03954834|54689762|FG000|Overall Study|Physician Decision|0|||
28031392|NCT03954834|54689763|FG001|Overall Study|Physician Decision|1|||
28031393|NCT03954834|54689764|FG002|Overall Study|Physician Decision|0|||
28031394|NCT03954834|54689765|FG003|Overall Study|Physician Decision|2|||
28031395|NCT03954834|54689762|FG000|Overall Study|Protocol Violation|1|||
28031396|NCT03954834|54689763|FG001|Overall Study|Protocol Violation|0|||
28031397|NCT03954834|54689764|FG002|Overall Study|Protocol Violation|0|||
28031398|NCT03954834|54689765|FG003|Overall Study|Protocol Violation|1|||
28031399|NCT03954834|54689762|FG000|Overall Study|Withdrawal by Subject|2|||
28031400|NCT03954834|54689763|FG001|Overall Study|Withdrawal by Subject|3|||
28031401|NCT03954834|54689764|FG002|Overall Study|Withdrawal by Subject|13|||
28031402|NCT03954834|54689765|FG003|Overall Study|Withdrawal by Subject|6|||
28031403|NCT03954834|54689762|FG000|Overall Study|Participant left the country|0|||
28031404|NCT03954834|54689763|FG001|Overall Study|Participant left the country|0|||
28031405|NCT03954834|54689764|FG002|Overall Study|Participant left the country|1|||
28031406|NCT03954834|54689765|FG003|Overall Study|Participant left the country|0|||
28031407|NCT03954834|54689762|FG000|Overall Study|Lost to Follow-up|3|||
28031408|NCT03954834|54689763|FG001|Overall Study|Lost to Follow-up|2|||
28031409|NCT03954834|54689764|FG002|Overall Study|Lost to Follow-up|3|||
28031410|NCT03954834|54689765|FG003|Overall Study|Lost to Follow-up|5|||
28031411|NCT00693017|54689777|FG000|Overall Study|Sponsor Decision|2|||
28031412|NCT00693017|54689778|FG001|Overall Study|Sponsor Decision|1|||
28031413|NCT00693017|54689777|FG000|Overall Study|Death|0|||
28031414|NCT00693017|54689778|FG001|Overall Study|Death|1|||
28031415|NCT00692237|54689786|FG000|Overall Study|Withdrawal by Subject|1|||
28031416|NCT00692237|54689787|FG001|Overall Study|Withdrawal by Subject|3|||
28031417|NCT00692237|54689786|FG000|Overall Study|Adverse Event|0|||
28031418|NCT00692237|54689787|FG001|Overall Study|Adverse Event|1|||
28031419|NCT00110149|54689793|FG000|Overall Study|Physician Decision|3|||
28031420|NCT03954444|54689801|FG000|Overall Study|Withdrawal by Subject|5|||
28031421|NCT03954444|54689802|FG001|Overall Study|Withdrawal by Subject|5|||
28031422|NCT03954444|54689803|FG002|Overall Study|Withdrawal by Subject|5|||
28031423|NCT03954444|54689801|FG000|Overall Study|Adverse Event|1|||
28031424|NCT03954444|54689802|FG001|Overall Study|Adverse Event|3|||
28031425|NCT03954444|54689803|FG002|Overall Study|Adverse Event|2|||
28031426|NCT03954444|54689801|FG000|Overall Study|Protocol Violation|0|||
28031427|NCT03954444|54689802|FG001|Overall Study|Protocol Violation|3|||
28031428|NCT03954444|54689803|FG002|Overall Study|Protocol Violation|5|||
28031429|NCT03954444|54689801|FG000|Overall Study|Use of prohibited therapy|1|||
28031430|NCT03954444|54689802|FG001|Overall Study|Use of prohibited therapy|1|||
28031431|NCT03954444|54689803|FG002|Overall Study|Use of prohibited therapy|2|||
27844191|NCT01428661|54333871|FG000|Double-Masked Phase|*Various|1|||
28031432|NCT03954444|54689801|FG000|Overall Study|Lost to Follow-up|1|||
28031433|NCT03954444|54689802|FG001|Overall Study|Lost to Follow-up|0|||
28031434|NCT03954444|54689803|FG002|Overall Study|Lost to Follow-up|1|||
28031435|NCT03954444|54689801|FG000|Overall Study|Non-compliant with study drug application|2|||
28031436|NCT03954444|54689802|FG001|Overall Study|Non-compliant with study drug application|2|||
28031437|NCT03954444|54689803|FG002|Overall Study|Non-compliant with study drug application|0|||
28031438|NCT03954444|54689801|FG000|Overall Study|Administrative reasons|0|||
28031439|NCT03954444|54689802|FG001|Overall Study|Administrative reasons|0|||
28031440|NCT03954444|54689803|FG002|Overall Study|Administrative reasons|1|||
28031441|NCT03954444|54689801|FG000|Overall Study|Miscellaneous|3|||
28031442|NCT03954444|54689802|FG001|Overall Study|Miscellaneous|2|||
28031443|NCT03954444|54689803|FG002|Overall Study|Miscellaneous|1|||
28031444|NCT03953820|54689811|FG000|Two-Sequence, Two-Way Crossover|Adverse Event|1|||
28031445|NCT03953820|54689812|FG001|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
28031446|NCT03953820|54689813|FG002|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
28031447|NCT03953820|54689811|FG000|Two-Sequence, Two-Way Crossover|Physician Decision|1|||
27844192|NCT01428661|54333872|FG001|Double-Masked Phase|*Various|6|||
28031448|NCT03953820|54689812|FG001|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
28031449|NCT03953820|54689813|FG002|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
28031450|NCT00117949|54689830|FG000|Overall Study|Testosterone >1.0 ng/mL|10|||
28031451|NCT00117949|54689831|FG001|Overall Study|Testosterone >1.0 ng/mL|18|||
28031452|NCT00117949|54689832|FG002|Overall Study|Testosterone >1.0 ng/mL|17|||
28031453|NCT00117949|54689833|FG003|Overall Study|Testosterone >1.0 ng/mL|15|||
28031454|NCT00117949|54689830|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
28031455|NCT00117949|54689831|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
28031456|NCT00117949|54689832|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
28031457|NCT00117949|54689833|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
28031458|NCT00117949|54689830|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
28031459|NCT00117949|54689831|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
28031460|NCT00117949|54689832|FG002|Overall Study|Prostate-specific antigen increase >=25%|1|||
28031461|NCT00117949|54689833|FG003|Overall Study|Prostate-specific antigen increase >=25%|2|||
28031462|NCT00117949|54689830|FG000|Overall Study|PSA increase >=10ng/mL|0|||
28031463|NCT00117949|54689831|FG001|Overall Study|PSA increase >=10ng/mL|1|||
28031464|NCT00117949|54689832|FG002|Overall Study|PSA increase >=10ng/mL|1|||
28031465|NCT00117949|54689833|FG003|Overall Study|PSA increase >=10ng/mL|0|||
28031466|NCT00117949|54689830|FG000|Overall Study|PSA reduction <=50%|0|||
28031467|NCT00117949|54689831|FG001|Overall Study|PSA reduction <=50%|2|||
28031468|NCT00117949|54689832|FG002|Overall Study|PSA reduction <=50%|2|||
28031469|NCT00117949|54689833|FG003|Overall Study|PSA reduction <=50%|4|||
28031470|NCT00117949|54689830|FG000|Overall Study|Hepatic abnormalities|0|||
28031471|NCT00117949|54689831|FG001|Overall Study|Hepatic abnormalities|1|||
28031472|NCT00117949|54689832|FG002|Overall Study|Hepatic abnormalities|0|||
28031473|NCT00117949|54689833|FG003|Overall Study|Hepatic abnormalities|1|||
28031474|NCT02611037|54689843|FG000|Overall Study|Withdrawal prior to treatment|2|||
28031475|NCT02611037|54689844|FG001|Overall Study|Withdrawal prior to treatment|0|||
28031476|NCT00117793|54689849|FG000|Overall Study|Withdrawal by Subject|12|||
27844193|NCT01428661|54333873|FG002|Double-Masked Phase|*Various|0|||
28031477|NCT00695669|54689858|FG000|Overall Study|Adverse Event|0|||
28031478|NCT00695669|54689859|FG001|Overall Study|Adverse Event|0|||
28031479|NCT00695669|54689860|FG002|Overall Study|Adverse Event|2|||
28031480|NCT00695669|54689861|FG003|Overall Study|Adverse Event|0|||
28031481|NCT00695669|54689858|FG000|Overall Study|Lost to Follow-up|4|||
27844194|NCT01428661|54333871|FG000|Open Label Extension|Protocol Violation|0|||
28031482|NCT00695669|54689859|FG001|Overall Study|Lost to Follow-up|4|||
28031483|NCT00695669|54689860|FG002|Overall Study|Lost to Follow-up|1|||
28031484|NCT00695669|54689861|FG003|Overall Study|Lost to Follow-up|4|||
28031485|NCT03671369|54689874|FG000|Overall Study|Other|1|||
28031486|NCT03671369|54689874|FG000|Overall Study|Withdrawal by Subject|289|||
28031487|NCT03671369|54689874|FG000|Overall Study|Not willing to be vaccinated|1|||
27844195|NCT01428661|54333872|FG001|Open Label Extension|Protocol Violation|0|||
27844196|NCT01428661|54333873|FG002|Open Label Extension|Protocol Violation|9|||
27844197|NCT01428661|54333871|FG000|Open Label Extension|Adverse Event|0|||
27844198|NCT01428661|54333872|FG001|Open Label Extension|Adverse Event|0|||
27844199|NCT01428661|54333873|FG002|Open Label Extension|Adverse Event|15|||
27844200|NCT01428661|54333871|FG000|Open Label Extension|Lost to Follow-up|0|||
27844201|NCT01428661|54333872|FG001|Open Label Extension|Lost to Follow-up|0|||
27844202|NCT01428661|54333873|FG002|Open Label Extension|Lost to Follow-up|38|||
27844203|NCT01428661|54333871|FG000|Open Label Extension|Withdrawal by Subject|0|||
27844204|NCT01428661|54333872|FG001|Open Label Extension|Withdrawal by Subject|0|||
27844205|NCT01428661|54333873|FG002|Open Label Extension|Withdrawal by Subject|49|||
27844206|NCT01428661|54333871|FG000|Open Label Extension|Lack of Efficacy|0|||
27844207|NCT01428661|54333872|FG001|Open Label Extension|Lack of Efficacy|0|||
27844208|NCT01428661|54333873|FG002|Open Label Extension|Lack of Efficacy|24|||
27844209|NCT01428661|54333871|FG000|Open Label Extension|**Various|0|||
27844210|NCT01428661|54333872|FG001|Open Label Extension|**Various|0|||
27844211|NCT01428661|54333873|FG002|Open Label Extension|**Various|185|||
27844212|NCT01428583|54333881|FG000|Overall Study|Adverse Event|75|||
27844213|NCT01428583|54333881|FG000|Overall Study|Withdrawal by Subject|51|||
27844214|NCT01428583|54333881|FG000|Overall Study|Lack of Efficacy|37|||
27844215|NCT01428583|54333881|FG000|Overall Study|Lost to Follow-up|17|||
27844216|NCT01428583|54333881|FG000|Overall Study|Death|1|||
27844217|NCT01428583|54333881|FG000|Overall Study|Pregnancy|1|||
27844218|NCT01428583|54333881|FG000|Overall Study|Protocol Violation|1|||
27844219|NCT01428583|54333881|FG000|Overall Study|Physician Decision|12|||
27844220|NCT01428583|54333881|FG000|Overall Study|Non-compliant|25|||
27844221|NCT01428583|54333881|FG000|Overall Study|Confirmed positive urine drug test|8|||
27844222|NCT01428583|54333881|FG000|Overall Study|Sponsor's request|3|||
27844223|NCT01428583|54333881|FG000|Overall Study|Other|6|||
27844224|NCT01428193|54333898|FG000|Overall Study|Physician Decision|1|||
27844225|NCT01428193|54333898|FG000|Overall Study|Elevated screening liver enzymes|1|||
27844226|NCT01428115|54333902|FG000|Overall Study|Lack of Efficacy|3|||
27844227|NCT01428115|54333902|FG000|Overall Study|Lost to Follow-up|10|||
27844228|NCT01428115|54333902|FG000|Overall Study|Pregnancy|1|||
27844229|NCT01428115|54333902|FG000|Overall Study|Protocol Violation|3|||
27844230|NCT01428115|54333902|FG000|Overall Study|Withdrawal by Subject|4|||
27844231|NCT01427803|54333909|FG000|Overall Study|Lost to Follow-up|32|||
27844232|NCT01427803|54333910|FG001|Overall Study|Lost to Follow-up|26|||
28031488|NCT00692003|54689880|FG000|Overall Study|Sponsor Decision|5|||
28031489|NCT00692003|54689881|FG001|Overall Study|Sponsor Decision|1|||
28031490|NCT00434512|54689893|FG000|Overall Study|Migrated/moved from study area|0|||
28031491|NCT00434512|54689894|FG001|Overall Study|Migrated/moved from study area|0|||
28031492|NCT00434512|54689895|FG002|Overall Study|Migrated/moved from study area|0|||
28031493|NCT00434512|54689896|FG003|Overall Study|Migrated/moved from study area|1|||
28031494|NCT00434512|54689897|FG004|Overall Study|Migrated/moved from study area|1|||
28031495|NCT00434512|54689898|FG005|Overall Study|Migrated/moved from study area|1|||
28031496|NCT00434512|54689893|FG000|Overall Study|Other|0|||
28031497|NCT00434512|54689894|FG001|Overall Study|Other|1|||
28031498|NCT00434512|54689895|FG002|Overall Study|Other|0|||
28031499|NCT00434512|54689896|FG003|Overall Study|Other|0|||
28031500|NCT00434512|54689897|FG004|Overall Study|Other|0|||
28031501|NCT00434512|54689898|FG005|Overall Study|Other|0|||
28031502|NCT00427648|54689918|FG000|Overall Study|Protocol Violation|1|||
28031503|NCT00427648|54689919|FG001|Overall Study|Protocol Violation|2|||
28031504|NCT00427648|54689918|FG000|Overall Study|Adverse Event|0|||
28031505|NCT00427648|54689919|FG001|Overall Study|Adverse Event|1|||
28031506|NCT00416884|54689927|FG000|Overall Study|Study terminated due to low accrual|1|||
28031507|NCT00434122|54689933|FG000|Overall Study|Non-compliance with protocol|0|||
28031508|NCT00434122|54689934|FG001|Overall Study|Non-compliance with protocol|1|||
28031509|NCT00434122|54689933|FG000|Overall Study|loss of subject contact|1|||
28031510|NCT00434122|54689934|FG001|Overall Study|loss of subject contact|1|||
28031511|NCT00434122|54689933|FG000|Overall Study|Personal reasons|1|||
28031512|NCT00434122|54689934|FG001|Overall Study|Personal reasons|1|||
28031513|NCT00434122|54689933|FG000|Overall Study|Large follicle size|2|||
28031514|NCT00434122|54689934|FG001|Overall Study|Large follicle size|2|||
28031515|NCT00434122|54689933|FG000|Overall Study|Low follicular response.|1|||
28031516|NCT00434122|54689934|FG001|Overall Study|Low follicular response.|2|||
28031517|NCT00434122|54689933|FG000|Overall Study|Travelling of subject.|1|||
28031518|NCT00434122|54689934|FG001|Overall Study|Travelling of subject.|0|||
28031519|NCT00555620|54689948|FG000|Overall Study|Death|0|||
28031520|NCT00555620|54689949|FG001|Overall Study|Death|1|||
28031521|NCT00555620|54689950|FG002|Overall Study|Death|0|||
28031522|NCT00555620|54689951|FG003|Overall Study|Death|0|||
28031523|NCT00555620|54689952|FG004|Overall Study|Death|0|||
28031524|NCT00555620|54689953|FG005|Overall Study|Death|1|||
28031525|NCT00555620|54689948|FG000|Overall Study|Study terminated by sponsor|0|||
28031526|NCT00555620|54689949|FG001|Overall Study|Study terminated by sponsor|0|||
28031527|NCT00555620|54689950|FG002|Overall Study|Study terminated by sponsor|1|||
28031528|NCT00555620|54689951|FG003|Overall Study|Study terminated by sponsor|0|||
28031529|NCT00555620|54689952|FG004|Overall Study|Study terminated by sponsor|0|||
28031530|NCT00555620|54689953|FG005|Overall Study|Study terminated by sponsor|0|||
28031531|NCT00555620|54689948|FG000|Overall Study|Adverse Event|0|||
28031532|NCT00555620|54689949|FG001|Overall Study|Adverse Event|0|||
28031533|NCT00555620|54689950|FG002|Overall Study|Adverse Event|1|||
28031534|NCT00555620|54689951|FG003|Overall Study|Adverse Event|5|||
28031535|NCT00555620|54689952|FG004|Overall Study|Adverse Event|0|||
28031536|NCT00555620|54689953|FG005|Overall Study|Adverse Event|1|||
28031537|NCT00555620|54689948|FG000|Overall Study|Objective progression or relapse|6|||
27844233|NCT01427803|54333909|FG000|Overall Study|Withdrawal by Subject|20|||
27844234|NCT01427803|54333910|FG001|Overall Study|Withdrawal by Subject|0|||
27844235|NCT01427803|54333909|FG000|Overall Study|Unable to complete full treatment period|6|||
28031538|NCT00555620|54689949|FG001|Overall Study|Objective progression or relapse|5|||
28031539|NCT00555620|54689950|FG002|Overall Study|Objective progression or relapse|12|||
28105668|NCT04461795|54763209|FG000|Overall Study|Withdrawal by Subject|2|||
27844236|NCT01427803|54333910|FG001|Overall Study|Unable to complete full treatment period|0|||
27844237|NCT01427803|54333909|FG000|Overall Study|Protocol Violation|1|||
27844238|NCT01427803|54333910|FG001|Overall Study|Protocol Violation|0|||
27844239|NCT01427803|54333909|FG000|Overall Study|Physician Decision|3|||
27844240|NCT01427803|54333910|FG001|Overall Study|Physician Decision|0|||
28031540|NCT00555620|54689951|FG003|Overall Study|Objective progression or relapse|17|||
28031541|NCT00555620|54689952|FG004|Overall Study|Objective progression or relapse|3|||
28031542|NCT00555620|54689953|FG005|Overall Study|Objective progression or relapse|16|||
28105669|NCT04461795|54763209|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|1|||
28031543|NCT00555620|54689948|FG000|Overall Study|Participant refused treatment|0|||
28031544|NCT00555620|54689949|FG001|Overall Study|Participant refused treatment|1|||
28031545|NCT00555620|54689950|FG002|Overall Study|Participant refused treatment|1|||
28031546|NCT00555620|54689951|FG003|Overall Study|Participant refused treatment|0|||
28031547|NCT00555620|54689952|FG004|Overall Study|Participant refused treatment|0|||
28031548|NCT00555620|54689953|FG005|Overall Study|Participant refused treatment|1|||
28031549|NCT00555620|54689948|FG000|Overall Study|Other|0|||
28031550|NCT00555620|54689949|FG001|Overall Study|Other|0|||
28031551|NCT00555620|54689950|FG002|Overall Study|Other|0|||
28031552|NCT00555620|54689951|FG003|Overall Study|Other|1|||
28031553|NCT00555620|54689952|FG004|Overall Study|Other|0|||
28031554|NCT00555620|54689953|FG005|Overall Study|Other|3|||
28031555|NCT00433966|54689973|FG000|Pharmacology Intervention/Randomization|Withdrawal by Subject|40|||
28031556|NCT00433966|54689974|FG001|Pharmacology Intervention/Randomization|Withdrawal by Subject|43|||
28031557|NCT00433966|54689975|FG002|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
28031558|NCT00433966|54689976|FG003|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
28031559|NCT00433966|54689973|FG000|Pharmacology Intervention/Randomization|Lost to Follow-up|97|||
28031560|NCT00433966|54689974|FG001|Pharmacology Intervention/Randomization|Lost to Follow-up|103|||
28031561|NCT00433966|54689975|FG002|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
28031562|NCT00433966|54689976|FG003|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
28031563|NCT00433966|54689973|FG000|Pharmacology Intervention/Randomization|Not true myocardial infarction|29|||
28031564|NCT00433966|54689974|FG001|Pharmacology Intervention/Randomization|Not true myocardial infarction|28|||
28031565|NCT00433966|54689975|FG002|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
28031566|NCT00433966|54689976|FG003|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
28031567|NCT00433966|54689973|FG000|Stent Intervention/Randomization|Withdrawal by Subject|0|||
28031568|NCT00433966|54689974|FG001|Stent Intervention/Randomization|Withdrawal by Subject|0|||
28031569|NCT00433966|54689975|FG002|Stent Intervention/Randomization|Withdrawal by Subject|41|||
28031570|NCT00433966|54689976|FG003|Stent Intervention/Randomization|Withdrawal by Subject|15|||
28031571|NCT00433966|54689973|FG000|Stent Intervention/Randomization|Lost to Follow-up|0|||
28031572|NCT00433966|54689974|FG001|Stent Intervention/Randomization|Lost to Follow-up|0|||
28031573|NCT00433966|54689975|FG002|Stent Intervention/Randomization|Lost to Follow-up|113|||
28031574|NCT00433966|54689976|FG003|Stent Intervention/Randomization|Lost to Follow-up|47|||
28031575|NCT03952650|54689993|FG000|Overall Study|TRAVEL|0|||
28031576|NCT03952650|54689994|FG001|Overall Study|TRAVEL|4|||
28031577|NCT03952650|54689995|FG002|Overall Study|TRAVEL|0|||
28031578|NCT03952650|54689996|FG003|Overall Study|TRAVEL|4|||
28031579|NCT03952650|54689997|FG004|Overall Study|TRAVEL|0|||
28031580|NCT03952650|54689998|FG005|Overall Study|TRAVEL|3|||
28031581|NCT03952650|54689999|FG006|Overall Study|TRAVEL|2|||
28031582|NCT03952650|54689993|FG000|Overall Study|Withdrawal by Subject|0|||
28031583|NCT03952650|54689994|FG001|Overall Study|Withdrawal by Subject|2|||
28031584|NCT03952650|54689995|FG002|Overall Study|Withdrawal by Subject|0|||
28031585|NCT03952650|54689996|FG003|Overall Study|Withdrawal by Subject|3|||
28031586|NCT03952650|54689997|FG004|Overall Study|Withdrawal by Subject|0|||
28031587|NCT03952650|54689998|FG005|Overall Study|Withdrawal by Subject|1|||
28031588|NCT03952650|54689999|FG006|Overall Study|Withdrawal by Subject|1|||
28031589|NCT03952650|54689993|FG000|Overall Study|Lost to Follow-up|0|||
28031590|NCT03952650|54689994|FG001|Overall Study|Lost to Follow-up|1|||
28031591|NCT03952650|54689995|FG002|Overall Study|Lost to Follow-up|0|||
28031592|NCT03952650|54689996|FG003|Overall Study|Lost to Follow-up|0|||
28031593|NCT03952650|54689997|FG004|Overall Study|Lost to Follow-up|0|||
28031594|NCT03952650|54689998|FG005|Overall Study|Lost to Follow-up|1|||
28031595|NCT03952650|54689999|FG006|Overall Study|Lost to Follow-up|1|||
28031596|NCT03952650|54689993|FG000|Overall Study|Received wrong vaccine and travelled|0|||
28031597|NCT03952650|54689994|FG001|Overall Study|Received wrong vaccine and travelled|0|||
27807334|NCT01765179|54262746|FG000|Overall Study|lack of venous access|1|||
27807335|NCT01765179|54262746|FG000|Overall Study|work conflict|1|||
27807336|NCT01765179|54262746|FG000|Overall Study|Ca elevated 10.6|1|||
28031598|NCT03952650|54689995|FG002|Overall Study|Received wrong vaccine and travelled|0|||
28031599|NCT03952650|54689996|FG003|Overall Study|Received wrong vaccine and travelled|0|||
28031600|NCT03952650|54689997|FG004|Overall Study|Received wrong vaccine and travelled|0|||
28031601|NCT03952650|54689998|FG005|Overall Study|Received wrong vaccine and travelled|1|||
27807337|NCT01764945|54262758|FG000|Overall Study|Adverse Event|0|||
27807338|NCT01764945|54262759|FG001|Overall Study|Adverse Event|1|||
27807339|NCT01764945|54262760|FG002|Overall Study|Adverse Event|0|||
27807340|NCT01764945|54262761|FG003|Overall Study|Adverse Event|0|||
28031602|NCT03952650|54689999|FG006|Overall Study|Received wrong vaccine and travelled|0|||
28031603|NCT03952650|54689993|FG000|Overall Study|Unable to make study visit|0|||
28031604|NCT03952650|54689994|FG001|Overall Study|Unable to make study visit|0|||
28031605|NCT03952650|54689995|FG002|Overall Study|Unable to make study visit|0|||
28031606|NCT03952650|54689996|FG003|Overall Study|Unable to make study visit|0|||
28031607|NCT03952650|54689997|FG004|Overall Study|Unable to make study visit|0|||
28031608|NCT03952650|54689998|FG005|Overall Study|Unable to make study visit|1|||
28031609|NCT03952650|54689999|FG006|Overall Study|Unable to make study visit|0|||
28031610|NCT00691301|54690015|FG000|Overall Study|Adverse Event|10|||
28031611|NCT00691301|54690015|FG000|Overall Study|Death|2|||
28031612|NCT00691301|54690015|FG000|Overall Study|Lack of Efficacy|32|||
28031613|NCT00691301|54690015|FG000|Overall Study|Withdrawal by Subject|4|||
28031614|NCT00691301|54690015|FG000|Overall Study|Concurrent illness|2|||
28031615|NCT00691301|54690015|FG000|Overall Study|other reason|3|||
28031616|NCT00691301|54690015|FG000|Overall Study|Did not initiate study treatment|1|||
28031617|NCT00927563|54690025|FG000|Overall Study|Lost to Follow-up|1|||
27844241|NCT01427803|54333909|FG000|Overall Study|did not take product|1|||
27844242|NCT01427803|54333910|FG001|Overall Study|did not take product|0|||
27844243|NCT01408537|54333914|FG000|Overall Study|Withdrawal by Subject|2|||
28031618|NCT00927563|54690025|FG000|Overall Study|Withdrawal by Subject|1|||
28031619|NCT00653159|54690040|FG000|Overall Study|Adverse Event|4|||
28031620|NCT00653159|54690041|FG001|Overall Study|Adverse Event|1|||
28031621|NCT00653159|54690040|FG000|Overall Study|Lost to Follow-up|1|||
28031622|NCT00653159|54690041|FG001|Overall Study|Lost to Follow-up|2|||
28031623|NCT00117637|54690049|FG000|First Intervention (Period 1)|Adverse Event|11|||
28031624|NCT00117637|54690050|FG001|First Intervention (Period 1)|Adverse Event|16|||
28031625|NCT00117637|54690049|FG000|First Intervention (Period 1)|Lost to Follow-up|0|||
28031626|NCT00117637|54690050|FG001|First Intervention (Period 1)|Lost to Follow-up|2|||
28031627|NCT00117637|54690049|FG000|First Intervention (Period 1)|Protocol Violation|1|||
28031628|NCT00117637|54690050|FG001|First Intervention (Period 1)|Protocol Violation|0|||
28031629|NCT00117637|54690049|FG000|First Intervention (Period 1)|Withdrawal by Subject|2|||
28031630|NCT00117637|54690050|FG001|First Intervention (Period 1)|Withdrawal by Subject|4|||
28031631|NCT00117637|54690049|FG000|First Intervention (Period 1)|study terminated by the sponsor|3|||
28031632|NCT00117637|54690050|FG001|First Intervention (Period 1)|study terminated by the sponsor|1|||
28031633|NCT00117637|54690049|FG000|First Intervention (Period 1)|protocol driven decision point|1|||
28031634|NCT00117637|54690050|FG001|First Intervention (Period 1)|protocol driven decision point|0|||
28031635|NCT00117637|54690049|FG000|First Intervention (Period 1)|investig. decision, not protocol driven|0|||
28031636|NCT00117637|54690050|FG001|First Intervention (Period 1)|investig. decision, not protocol driven|1|||
28031637|NCT00117637|54690049|FG000|First Intervention (Period 1)|reason not reported|0|||
28031638|NCT00117637|54690050|FG001|First Intervention (Period 1)|reason not reported|1|||
27807341|NCT01764945|54262762|FG004|Overall Study|Adverse Event|0|||
27807342|NCT01764945|54262763|FG005|Overall Study|Adverse Event|0|||
27807343|NCT01764945|54262764|FG006|Overall Study|Adverse Event|1|||
28031639|NCT00117637|54690049|FG000|Second Intervention (Period 2)|Adverse Event|0|||
28031640|NCT00117637|54690050|FG001|Second Intervention (Period 2)|Adverse Event|9|||
28031641|NCT00117637|54690049|FG000|Second Intervention (Period 2)|Lost to Follow-up|1|||
28031642|NCT00117637|54690050|FG001|Second Intervention (Period 2)|Lost to Follow-up|0|||
28031643|NCT00117637|54690049|FG000|Second Intervention (Period 2)|Protocol Violation|1|||
28031644|NCT00117637|54690050|FG001|Second Intervention (Period 2)|Protocol Violation|0|||
28031645|NCT00117637|54690049|FG000|Second Intervention (Period 2)|Withdrawal by Subject|4|||
28031646|NCT00117637|54690050|FG001|Second Intervention (Period 2)|Withdrawal by Subject|3|||
28031647|NCT00117637|54690049|FG000|Second Intervention (Period 2)|study terminated by the sponsor|2|||
28031648|NCT00117637|54690050|FG001|Second Intervention (Period 2)|study terminated by the sponsor|9|||
28031649|NCT00117637|54690049|FG000|Second Intervention (Period 2)|non compliant with study medication|1|||
28031650|NCT00117637|54690050|FG001|Second Intervention (Period 2)|non compliant with study medication|1|||
28031651|NCT00117637|54690049|FG000|Second Intervention (Period 2)|reason not reported|1|||
28031652|NCT00117637|54690050|FG001|Second Intervention (Period 2)|reason not reported|0|||
28031653|NCT00690755|54690070|FG000|Overall Study|Physician Decision|2|||
27807344|NCT01764945|54262765|FG007|Overall Study|Adverse Event|0|||
27807345|NCT01793883|54262786|FG000|Overall Study|Withdrawal by Subject|3|||
28031654|NCT00690755|54690071|FG001|Overall Study|Physician Decision|0|||
28031655|NCT00690755|54690072|FG002|Overall Study|Physician Decision|46|||
28031656|NCT00690755|54690073|FG003|Overall Study|Physician Decision|5|||
28031657|NCT00690755|54690074|FG004|Overall Study|Physician Decision|0|||
28031658|NCT00690755|54690075|FG005|Overall Study|Physician Decision|4|||
28031659|NCT00690755|54690076|FG006|Overall Study|Physician Decision|0|||
27807346|NCT01793883|54262787|FG001|Overall Study|Withdrawal by Subject|7|||
27844244|NCT01408537|54333914|FG000|Overall Study|Protocol Violation|3|||
27807347|NCT01793883|54262788|FG002|Overall Study|Withdrawal by Subject|3|||
28031660|NCT00549302|54690094|FG000|Double-Blind|Death|2|||
28031661|NCT00549302|54690095|FG001|Double-Blind|Death|9|||
28031662|NCT00549302|54690096|FG002|Double-Blind|Death|0|||
28031663|NCT00549302|54690094|FG000|Double-Blind|Adverse Event|3|||
28031664|NCT00549302|54690095|FG001|Double-Blind|Adverse Event|16|||
28031665|NCT00549302|54690096|FG002|Double-Blind|Adverse Event|0|||
27807348|NCT01793883|54262786|FG000|Overall Study|Subject noncompliance|0|||
27807349|NCT01793883|54262787|FG001|Overall Study|Subject noncompliance|1|||
27807350|NCT01793883|54262788|FG002|Overall Study|Subject noncompliance|1|||
27807351|NCT01793883|54262786|FG000|Overall Study|Lost to Follow-up|5|||
27807352|NCT01793883|54262787|FG001|Overall Study|Lost to Follow-up|1|||
27807353|NCT01793883|54262788|FG002|Overall Study|Lost to Follow-up|3|||
27807354|NCT01793883|54262786|FG000|Overall Study|Randomized in error|1|||
27807355|NCT01793883|54262787|FG001|Overall Study|Randomized in error|0|||
27807356|NCT01793883|54262788|FG002|Overall Study|Randomized in error|0|||
27807357|NCT01793883|54262786|FG000|Overall Study|Unable to complete spriometry|1|||
27807358|NCT01793883|54262787|FG001|Overall Study|Unable to complete spriometry|0|||
27807359|NCT01793883|54262788|FG002|Overall Study|Unable to complete spriometry|0|||
27807360|NCT01793883|54262786|FG000|Overall Study|Unable to complete measurements|1|||
27807361|NCT01793883|54262787|FG001|Overall Study|Unable to complete measurements|0|||
27807362|NCT01793883|54262788|FG002|Overall Study|Unable to complete measurements|0|||
27807363|NCT01793883|54262786|FG000|Overall Study|Met exclusion criteria|1|||
27807364|NCT01793883|54262787|FG001|Overall Study|Met exclusion criteria|0|||
27807365|NCT01793883|54262788|FG002|Overall Study|Met exclusion criteria|0|||
27807366|NCT01793883|54262786|FG000|Overall Study|Dosing error|0|||
27807367|NCT01793883|54262787|FG001|Overall Study|Dosing error|1|||
27807368|NCT01793883|54262788|FG002|Overall Study|Dosing error|0|||
27939736|NCT00953056|54596000|FG002|Overall Study|Serious Adverse Event|0|||
27939737|NCT00953056|54596001|FG003|Overall Study|Serious Adverse Event|0|||
28031666|NCT00549302|54690094|FG000|Double-Blind|Withdrawal by Subject|3|||
28031667|NCT00549302|54690095|FG001|Double-Blind|Withdrawal by Subject|8|||
28031668|NCT00549302|54690096|FG002|Double-Blind|Withdrawal by Subject|0|||
28031669|NCT00549302|54690094|FG000|Double-Blind|Investigator Decision|1|||
28031670|NCT00549302|54690095|FG001|Double-Blind|Investigator Decision|5|||
28031671|NCT00549302|54690096|FG002|Double-Blind|Investigator Decision|0|||
28031672|NCT00549302|54690094|FG000|Double-Blind|Sponsor Decision|0|||
28031673|NCT00549302|54690095|FG001|Double-Blind|Sponsor Decision|1|||
28031674|NCT00549302|54690096|FG002|Double-Blind|Sponsor Decision|0|||
28031675|NCT00549302|54690094|FG000|Double-Blind|Lost to Follow-up|1|||
28031676|NCT00549302|54690095|FG001|Double-Blind|Lost to Follow-up|2|||
28031677|NCT00549302|54690096|FG002|Double-Blind|Lost to Follow-up|0|||
28031678|NCT00549302|54690094|FG000|Double-Blind|New Drug Pulmonary Atrial Hypertension|1|||
28031679|NCT00549302|54690095|FG001|Double-Blind|New Drug Pulmonary Atrial Hypertension|10|||
28031680|NCT00549302|54690096|FG002|Double-Blind|New Drug Pulmonary Atrial Hypertension|0|||
28031681|NCT00549302|54690094|FG000|Double-Blind|New condition or starts new therapy|0|||
28031682|NCT00549302|54690095|FG001|Double-Blind|New condition or starts new therapy|2|||
28031683|NCT00549302|54690096|FG002|Double-Blind|New condition or starts new therapy|0|||
28031684|NCT00549302|54690094|FG000|Open-Label|Adverse Event|0|||
28031685|NCT00549302|54690095|FG001|Open-Label|Adverse Event|0|||
28031686|NCT00549302|54690096|FG002|Open-Label|Adverse Event|11|||
28031687|NCT00549302|54690094|FG000|Open-Label|Death|0|||
28031688|NCT00549302|54690095|FG001|Open-Label|Death|0|||
28031689|NCT00549302|54690096|FG002|Open-Label|Death|40|||
28031690|NCT00549302|54690094|FG000|Open-Label|Investigator Decision|0|||
28031691|NCT00549302|54690095|FG001|Open-Label|Investigator Decision|0|||
28031692|NCT00549302|54690096|FG002|Open-Label|Investigator Decision|5|||
28031693|NCT00549302|54690094|FG000|Open-Label|Lost to Follow-up|0|||
28031694|NCT00549302|54690095|FG001|Open-Label|Lost to Follow-up|0|||
28031695|NCT00549302|54690096|FG002|Open-Label|Lost to Follow-up|2|||
28031696|NCT00549302|54690094|FG000|Open-Label|Other|0|||
28031697|NCT00549302|54690095|FG001|Open-Label|Other|0|||
28031698|NCT00549302|54690096|FG002|Open-Label|Other|3|||
28031699|NCT00549302|54690094|FG000|Open-Label|New drug pulmonary atrial hypertension|0|||
28031700|NCT00549302|54690095|FG001|Open-Label|New drug pulmonary atrial hypertension|0|||
27939738|NCT00953056|54596002|FG004|Overall Study|Serious Adverse Event|0|||
27939739|NCT00953056|54596003|FG005|Overall Study|Serious Adverse Event|1|||
28031701|NCT00549302|54690096|FG002|Open-Label|New drug pulmonary atrial hypertension|2|||
28031702|NCT00549302|54690094|FG000|Open-Label|Withdrawal by Subject|0|||
28031703|NCT00549302|54690095|FG001|Open-Label|Withdrawal by Subject|0|||
28031704|NCT00549302|54690096|FG002|Open-Label|Withdrawal by Subject|6|||
28031705|NCT00117325|54690106|FG000|Overall Study|Adverse Event|3|||
28031706|NCT00117325|54690107|FG001|Overall Study|Adverse Event|3|||
27807369|NCT01793883|54262786|FG000|Overall Study|Respiratory distress during spirometry|0|||
27807370|NCT01793883|54262787|FG001|Overall Study|Respiratory distress during spirometry|0|||
28031707|NCT00117325|54690106|FG000|Overall Study|Lost to Follow-up|1|||
28031708|NCT00117325|54690107|FG001|Overall Study|Lost to Follow-up|1|||
28031709|NCT00117325|54690106|FG000|Overall Study|Protocol Violation|2|||
28031710|NCT00117325|54690107|FG001|Overall Study|Protocol Violation|3|||
28031711|NCT00117325|54690106|FG000|Overall Study|Withdrawal by Subject|3|||
28031712|NCT00117325|54690107|FG001|Overall Study|Withdrawal by Subject|2|||
28031713|NCT00117325|54690106|FG000|Overall Study|Lack of Efficacy|1|||
28031714|NCT00117325|54690107|FG001|Overall Study|Lack of Efficacy|0|||
28031715|NCT00117325|54690106|FG000|Overall Study|Use of prohibited medicine|1|||
28031716|NCT00117325|54690107|FG001|Overall Study|Use of prohibited medicine|2|||
28031717|NCT00117325|54690106|FG000|Overall Study|Early termination|1|||
28031718|NCT00117325|54690107|FG001|Overall Study|Early termination|1|||
28031719|NCT00117325|54690106|FG000|Overall Study|Admisnitrative|1|||
28031720|NCT00117325|54690107|FG001|Overall Study|Admisnitrative|0|||
28031721|NCT00108433|54690116|FG000|Overall Study|Lack of Efficacy|1|||
28031722|NCT00108433|54690117|FG001|Overall Study|Lack of Efficacy|2|||
28031723|NCT00108433|54690116|FG000|Overall Study|Death|3|||
28031724|NCT00108433|54690117|FG001|Overall Study|Death|0|||
28031725|NCT00108433|54690116|FG000|Overall Study|Adverse Event|3|||
28031726|NCT00108433|54690117|FG001|Overall Study|Adverse Event|1|||
28031727|NCT00108433|54690116|FG000|Overall Study|Other|14|||
28031728|NCT00108433|54690117|FG001|Overall Study|Other|14|||
28031729|NCT00116779|54690125|FG000|Overall Study|Adverse Event|4|||
28031730|NCT00116779|54690126|FG001|Overall Study|Adverse Event|2|||
28031731|NCT00116779|54690125|FG000|Overall Study|Protocol Violation|1|||
28031732|NCT00116779|54690126|FG001|Overall Study|Protocol Violation|4|||
28031733|NCT00116779|54690125|FG000|Overall Study|Withdrawal by Subject|4|||
28031734|NCT00116779|54690126|FG001|Overall Study|Withdrawal by Subject|1|||
28031735|NCT00116779|54690125|FG000|Overall Study|Inadequate testosterone suppression|7|||
28031736|NCT00116779|54690126|FG001|Overall Study|Inadequate testosterone suppression|9|||
28031737|NCT00116779|54690125|FG000|Overall Study|Physician Decision|3|||
28031738|NCT00116779|54690126|FG001|Overall Study|Physician Decision|1|||
28031739|NCT00116779|54690125|FG000|Overall Study|Elevated PSA levels|2|||
28031740|NCT00116779|54690126|FG001|Overall Study|Elevated PSA levels|2|||
28031741|NCT03943290|54690141|FG000|Overall Study|Sponsor Terminated Study|6|||
28031742|NCT03943290|54690142|FG001|Overall Study|Sponsor Terminated Study|1|||
28031743|NCT03943290|54690143|FG002|Overall Study|Sponsor Terminated Study|11|||
28031744|NCT03943290|54690144|FG003|Overall Study|Sponsor Terminated Study|6|||
27844245|NCT01408537|54333914|FG000|Overall Study|Lost to Follow-up|3|||
27844246|NCT01408459|54333947|FG000|Overall Study|Withdrawal by Subject|1|||
27844247|NCT01408459|54333948|FG001|Overall Study|Withdrawal by Subject|1|||
27844248|NCT01408303|54333967|FG000|Overall Study|Adverse Event|3|||
27844249|NCT01408303|54333968|FG001|Overall Study|Adverse Event|7|||
27844250|NCT01408303|54333969|FG002|Overall Study|Adverse Event|2|||
27844251|NCT01408303|54333967|FG000|Overall Study|Lost to Follow-up|0|||
27844252|NCT01408303|54333968|FG001|Overall Study|Lost to Follow-up|1|||
27844253|NCT01408303|54333969|FG002|Overall Study|Lost to Follow-up|2|||
27844254|NCT01408303|54333967|FG000|Overall Study|Withdrawal by Subject|2|||
27844255|NCT01408303|54333968|FG001|Overall Study|Withdrawal by Subject|3|||
27844256|NCT01408303|54333969|FG002|Overall Study|Withdrawal by Subject|1|||
27844257|NCT01408303|54333967|FG000|Overall Study|Protocol Violation|0|||
27844258|NCT01408303|54333968|FG001|Overall Study|Protocol Violation|1|||
27844259|NCT01408303|54333969|FG002|Overall Study|Protocol Violation|0|||
27844260|NCT01408303|54333967|FG000|Overall Study|Noncompliance|1|||
27844261|NCT01408303|54333968|FG001|Overall Study|Noncompliance|0|||
27844262|NCT01408303|54333969|FG002|Overall Study|Noncompliance|1|||
27844263|NCT01408147|54333990|FG000|Overall Study|Withdrawal by Subject|0|||
27844264|NCT01408147|54333991|FG001|Overall Study|Withdrawal by Subject|1|||
27844265|NCT01407367|54333999|FG000|Overall Study|Death|24|||
27844266|NCT01407367|54334000|FG001|Overall Study|Death|32|||
27844267|NCT01407367|54333999|FG000|Overall Study|Renal Replacement Therapy (RRT)|12|||
27844268|NCT01407367|54334000|FG001|Overall Study|Renal Replacement Therapy (RRT)|29|||
27844269|NCT01407367|54333999|FG000|Overall Study|Withdrawal by Subject|4|||
28031745|NCT03943290|54690145|FG004|Overall Study|Sponsor Terminated Study|7|||
28031746|NCT03943290|54690146|FG005|Overall Study|Sponsor Terminated Study|6|||
27844270|NCT01407367|54334000|FG001|Overall Study|Withdrawal by Subject|15|||
27844271|NCT01407367|54333999|FG000|Overall Study|Lost to Follow-up|0|||
27844272|NCT01407367|54334000|FG001|Overall Study|Lost to Follow-up|2|||
27844273|NCT01405027|54334036|FG000|Overall Study|Withdrawn consent|3|||
28031747|NCT03943290|54690147|FG006|Overall Study|Sponsor Terminated Study|6|||
27844274|NCT01405027|54334037|FG001|Overall Study|Withdrawn consent|0|||
27844275|NCT01405027|54334036|FG000|Overall Study|Lost to Follow-up|16|||
27844276|NCT01405027|54334037|FG001|Overall Study|Lost to Follow-up|24|||
28031748|NCT03943290|54690148|FG007|Overall Study|Sponsor Terminated Study|7|||
28031749|NCT03943290|54690149|FG008|Overall Study|Sponsor Terminated Study|8|||
28031750|NCT03943290|54690141|FG000|Overall Study|Lost to Follow-up|1|||
28031751|NCT03943290|54690142|FG001|Overall Study|Lost to Follow-up|0|||
27844277|NCT01405027|54334036|FG000|Overall Study|Investigator judgement|0|||
27844278|NCT01405027|54334037|FG001|Overall Study|Investigator judgement|2|||
27844279|NCT01405027|54334036|FG000|Overall Study|Death|1|||
27844280|NCT01405027|54334037|FG001|Overall Study|Death|0|||
27844281|NCT01405027|54334036|FG000|Overall Study|Other or Unknown|12|||
27844282|NCT01405027|54334037|FG001|Overall Study|Other or Unknown|25|||
27844283|NCT01412801|54334058|FG000|Overall Study|Death|0|||
27844284|NCT01412801|54334059|FG001|Overall Study|Death|1|||
27844285|NCT01412801|54334060|FG002|Overall Study|Death|0|||
27844286|NCT01412801|54334061|FG003|Overall Study|Death|4|||
27844287|NCT01412801|54334062|FG004|Overall Study|Death|2|||
27844288|NCT01412801|54334063|FG005|Overall Study|Death|2|||
27844289|NCT01412801|54334058|FG000|Overall Study|Lost to Follow-up|1|||
27844290|NCT01412801|54334059|FG001|Overall Study|Lost to Follow-up|2|||
28031752|NCT03943290|54690143|FG002|Overall Study|Lost to Follow-up|1|||
28031753|NCT03943290|54690144|FG003|Overall Study|Lost to Follow-up|0|||
28031754|NCT03943290|54690145|FG004|Overall Study|Lost to Follow-up|0|||
28031755|NCT03943290|54690146|FG005|Overall Study|Lost to Follow-up|0|||
28031756|NCT03943290|54690147|FG006|Overall Study|Lost to Follow-up|0|||
28031757|NCT03943290|54690148|FG007|Overall Study|Lost to Follow-up|1|||
28031758|NCT03943290|54690149|FG008|Overall Study|Lost to Follow-up|0|||
28031759|NCT03943290|54690141|FG000|Overall Study|Withdrawal by Subject|0|||
28031760|NCT03943290|54690142|FG001|Overall Study|Withdrawal by Subject|0|||
28031761|NCT03943290|54690143|FG002|Overall Study|Withdrawal by Subject|1|||
28031762|NCT03943290|54690144|FG003|Overall Study|Withdrawal by Subject|0|||
28031763|NCT03943290|54690145|FG004|Overall Study|Withdrawal by Subject|0|||
28031764|NCT03943290|54690146|FG005|Overall Study|Withdrawal by Subject|0|||
28031765|NCT03943290|54690147|FG006|Overall Study|Withdrawal by Subject|0|||
28031766|NCT03943290|54690148|FG007|Overall Study|Withdrawal by Subject|0|||
28031767|NCT03943290|54690149|FG008|Overall Study|Withdrawal by Subject|0|||
28031768|NCT00108355|54690184|FG000|Overall Study|Peritonitis at index paracentesis|1|||
28031769|NCT00108355|54690185|FG001|Overall Study|Peritonitis at index paracentesis|1|||
28031770|NCT00108355|54690184|FG000|Overall Study|Loculated ascites, limiting paracentesis|1|||
28031771|NCT00108355|54690185|FG001|Overall Study|Loculated ascites, limiting paracentesis|1|||
28031772|NCT00094861|54690206|FG000|Overall Study|Adverse Event|5|||
28031773|NCT00094861|54690207|FG001|Overall Study|Adverse Event|2|||
28031774|NCT00094861|54690206|FG000|Overall Study|Withdrawal by Subject|5|||
28031775|NCT00094861|54690207|FG001|Overall Study|Withdrawal by Subject|3|||
28031776|NCT00094861|54690206|FG000|Overall Study|Physician Decision|1|||
28031777|NCT00094861|54690207|FG001|Overall Study|Physician Decision|1|||
28031778|NCT00094861|54690206|FG000|Overall Study|Lost to Follow-up|0|||
28031779|NCT00094861|54690207|FG001|Overall Study|Lost to Follow-up|1|||
28031780|NCT00094861|54690206|FG000|Overall Study|Death|4|||
28031781|NCT00094861|54690207|FG001|Overall Study|Death|2|||
28031782|NCT00094861|54690206|FG000|Overall Study|Other|3|||
28031783|NCT00094861|54690207|FG001|Overall Study|Other|0|||
28031784|NCT00426556|54690217|FG000|Phase I - Core Phase|Disease Progression|0|||
28031785|NCT00426556|54690218|FG001|Phase I - Core Phase|Disease Progression|6|||
28031786|NCT00426556|54690219|FG002|Phase I - Core Phase|Disease Progression|2|||
28031787|NCT00426556|54690220|FG003|Phase I - Core Phase|Disease Progression|0|||
28031788|NCT00426556|54690217|FG000|Phase I - Core Phase|Adverse Event|1|||
28031789|NCT00426556|54690218|FG001|Phase I - Core Phase|Adverse Event|3|||
28031790|NCT00426556|54690219|FG002|Phase I - Core Phase|Adverse Event|1|||
28031791|NCT00426556|54690220|FG003|Phase I - Core Phase|Adverse Event|0|||
28031792|NCT00426556|54690217|FG000|Phase I - Core Phase|Death|0|||
28031793|NCT00426556|54690218|FG001|Phase I - Core Phase|Death|1|||
28031794|NCT00426556|54690219|FG002|Phase I - Core Phase|Death|0|||
28031795|NCT00426556|54690220|FG003|Phase I - Core Phase|Death|0|||
28031796|NCT00426556|54690217|FG000|Phase I - Extension Phase|Adverse Event|0|||
28031797|NCT00426556|54690218|FG001|Phase I - Extension Phase|Adverse Event|1|||
28031798|NCT00426556|54690219|FG002|Phase I - Extension Phase|Adverse Event|1|||
28031799|NCT00426556|54690220|FG003|Phase I - Extension Phase|Adverse Event|0|||
28031800|NCT00426556|54690217|FG000|Phase I - Extension Phase|Disease Progression|5|||
28031801|NCT00426556|54690218|FG001|Phase I - Extension Phase|Disease Progression|5|||
28031802|NCT00426556|54690219|FG002|Phase I - Extension Phase|Disease Progression|6|||
28031803|NCT00426556|54690220|FG003|Phase I - Extension Phase|Disease Progression|0|||
28031804|NCT00426556|54690217|FG000|Phase II - Core Phase|Withdrawal by Subject|0|||
28031805|NCT00426556|54690218|FG001|Phase II - Core Phase|Withdrawal by Subject|0|||
28031806|NCT00426556|54690219|FG002|Phase II - Core Phase|Withdrawal by Subject|0|||
28031807|NCT00426556|54690220|FG003|Phase II - Core Phase|Withdrawal by Subject|3|||
28031808|NCT00426556|54690217|FG000|Phase II - Core Phase|Disease Progression|0|||
28031809|NCT00426556|54690218|FG001|Phase II - Core Phase|Disease Progression|0|||
28031810|NCT00426556|54690219|FG002|Phase II - Core Phase|Disease Progression|0|||
27844291|NCT01412801|54334060|FG002|Overall Study|Lost to Follow-up|4|||
28031811|NCT00426556|54690220|FG003|Phase II - Core Phase|Disease Progression|16|||
28031812|NCT00426556|54690217|FG000|Phase II - Core Phase|Adverse Event|0|||
28031813|NCT00426556|54690218|FG001|Phase II - Core Phase|Adverse Event|0|||
27844292|NCT01412801|54334061|FG003|Overall Study|Lost to Follow-up|0|||
27844293|NCT01412801|54334062|FG004|Overall Study|Lost to Follow-up|1|||
27844294|NCT01412801|54334063|FG005|Overall Study|Lost to Follow-up|1|||
28031814|NCT00426556|54690219|FG002|Phase II - Core Phase|Adverse Event|0|||
28031815|NCT00426556|54690220|FG003|Phase II - Core Phase|Adverse Event|8|||
28031816|NCT00426556|54690217|FG000|Phase II - Extension Phase|Disease Progression|0|||
28031817|NCT00426556|54690218|FG001|Phase II - Extension Phase|Disease Progression|0|||
28031818|NCT00426556|54690219|FG002|Phase II - Extension Phase|Disease Progression|0|||
28031819|NCT00426556|54690220|FG003|Phase II - Extension Phase|Disease Progression|21|||
28031820|NCT00426556|54690217|FG000|Phase II - Extension Phase|Adverse Event|0|||
28031821|NCT00426556|54690218|FG001|Phase II - Extension Phase|Adverse Event|0|||
28031822|NCT00426556|54690219|FG002|Phase II - Extension Phase|Adverse Event|0|||
28031823|NCT00426556|54690220|FG003|Phase II - Extension Phase|Adverse Event|2|||
28031824|NCT00107653|54690232|FG000|Overall Study|Adverse Event|24|||
28031825|NCT00107653|54690233|FG001|Overall Study|Adverse Event|43|||
28031826|NCT00107653|54690232|FG000|Overall Study|Insufficient Therapeutic Response|25|||
28031827|NCT00107653|54690233|FG001|Overall Study|Insufficient Therapeutic Response|11|||
28031828|NCT00107653|54690232|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
28031829|NCT00107653|54690233|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
28031830|NCT00107653|54690232|FG000|Overall Study|Protocol Violation|1|||
28031831|NCT00107653|54690233|FG001|Overall Study|Protocol Violation|0|||
28031832|NCT00107653|54690232|FG000|Overall Study|Withdrawal by Subject|12|||
28031833|NCT00107653|54690233|FG001|Overall Study|Withdrawal by Subject|13|||
28031834|NCT00107653|54690232|FG000|Overall Study|Lost to Follow-up|13|||
28031835|NCT00107653|54690233|FG001|Overall Study|Lost to Follow-up|5|||
28031836|NCT00107653|54690232|FG000|Overall Study|Administrative Reasons|3|||
28031837|NCT00107653|54690233|FG001|Overall Study|Administrative Reasons|3|||
28031838|NCT03950856|54690243|FG000|Overall Study|Death|1|||
28031839|NCT03950856|54690244|FG001|Overall Study|Death|2|||
28031840|NCT03950856|54690245|FG002|Overall Study|Death|0|||
28031841|NCT03950856|54690246|FG003|Overall Study|Death|0|||
28031842|NCT03950856|54690243|FG000|Overall Study|Lost to Follow-up|5|||
28031843|NCT03950856|54690244|FG001|Overall Study|Lost to Follow-up|6|||
28031844|NCT03950856|54690245|FG002|Overall Study|Lost to Follow-up|8|||
28031845|NCT03950856|54690246|FG003|Overall Study|Lost to Follow-up|2|||
28031846|NCT03950856|54690243|FG000|Overall Study|Protocol Violation|2|||
28031847|NCT03950856|54690244|FG001|Overall Study|Protocol Violation|0|||
28031848|NCT03950856|54690245|FG002|Overall Study|Protocol Violation|0|||
28031849|NCT03950856|54690246|FG003|Overall Study|Protocol Violation|1|||
28031850|NCT03950856|54690243|FG000|Overall Study|Withdrawal by Subject|4|||
28031851|NCT03950856|54690244|FG001|Overall Study|Withdrawal by Subject|1|||
28031852|NCT03950856|54690245|FG002|Overall Study|Withdrawal by Subject|3|||
28031853|NCT03950856|54690246|FG003|Overall Study|Withdrawal by Subject|1|||
28031854|NCT03950856|54690243|FG000|Overall Study|Unable to phone|7|||
28031855|NCT03950856|54690244|FG001|Overall Study|Unable to phone|6|||
28031856|NCT03950856|54690245|FG002|Overall Study|Unable to phone|7|||
28031857|NCT03950856|54690246|FG003|Overall Study|Unable to phone|2|||
28031858|NCT00433654|54690260|FG000|Overall Study|Death|4|||
28031859|NCT00433654|54690261|FG001|Overall Study|Death|0|||
28031860|NCT00433654|54690260|FG000|Overall Study|Missed visit|6|||
28031861|NCT00433654|54690261|FG001|Overall Study|Missed visit|3|||
28031862|NCT00433654|54690260|FG000|Overall Study|Subject not yet due for visit|4|||
28031863|NCT00433654|54690261|FG001|Overall Study|Subject not yet due for visit|0|||
27807371|NCT01793883|54262788|FG002|Overall Study|Respiratory distress during spirometry|1|||
27807372|NCT01792635|54262799|FG000|Part B|Adverse Event|0|||
27807373|NCT01792635|54262800|FG001|Part B|Adverse Event|0|||
27807374|NCT01792635|54262801|FG002|Part B|Adverse Event|1|||
27807375|NCT01792635|54262799|FG000|Part B|Study terminated|0|||
27807376|NCT01792635|54262800|FG001|Part B|Study terminated|4|||
27807377|NCT01792635|54262801|FG002|Part B|Study terminated|3|||
27807378|NCT01953692|54262819|FG000|Overall Study|Adverse Event|5|||
27807379|NCT01953692|54262820|FG001|Overall Study|Adverse Event|2|||
27807380|NCT01953692|54262821|FG002|Overall Study|Adverse Event|4|||
27807381|NCT01953692|54262822|FG003|Overall Study|Adverse Event|2|||
27807382|NCT01953692|54262823|FG004|Overall Study|Adverse Event|1|||
27807383|NCT01953692|54262824|FG005|Overall Study|Adverse Event|2|||
28031864|NCT00433654|54690260|FG000|Overall Study|Withdrawal by Subject|1|||
28031865|NCT00433654|54690261|FG001|Overall Study|Withdrawal by Subject|2|||
28031866|NCT00689351|54690275|FG000|Infant Series of Dosing|Parent/legal guardian request|5|||
27807384|NCT01953692|54262825|FG006|Overall Study|Adverse Event|0|||
28031867|NCT00689351|54690276|FG001|Infant Series of Dosing|Parent/legal guardian request|0|||
27807385|NCT01953692|54262826|FG007|Overall Study|Adverse Event|0|||
28031868|NCT00689351|54690275|FG000|Infant Series of Dosing|Adverse Event|1|||
27807386|NCT01953692|54262827|FG008|Overall Study|Adverse Event|0|||
27807387|NCT01953692|54262819|FG000|Overall Study|Clinical Progression|0|||
28031869|NCT00689351|54690276|FG001|Infant Series of Dosing|Adverse Event|0|||
28031870|NCT00689351|54690275|FG000|Infant Series of Dosing|Lost to Follow-up|0|||
28031871|NCT00689351|54690276|FG001|Infant Series of Dosing|Lost to Follow-up|1|||
28031872|NCT00689351|54690275|FG000|After Infant Series|Parent/legal guardian request|1|||
28031873|NCT00689351|54690276|FG001|After Infant Series|Parent/legal guardian request|0|||
27807388|NCT01953692|54262820|FG001|Overall Study|Clinical Progression|15|||
28031874|NCT03950622|54690288|FG000|Overall Study|Withdrawal by Subject|1|||
28031875|NCT03950622|54690289|FG001|Overall Study|Withdrawal by Subject|0|||
28031876|NCT03950622|54690288|FG000|Overall Study|Protocol Deviation|0|||
28031877|NCT03950622|54690289|FG001|Overall Study|Protocol Deviation|1|||
28031878|NCT03950622|54690288|FG000|Overall Study|Physician Decision|1|||
28031879|NCT03950622|54690289|FG001|Overall Study|Physician Decision|0|||
28031880|NCT03950622|54690288|FG000|Overall Study|Lost to Follow-up|5|||
28031881|NCT03950622|54690289|FG001|Overall Study|Lost to Follow-up|5|||
28031882|NCT03950622|54690288|FG000|Overall Study|Death|1|||
28031883|NCT03950622|54690289|FG001|Overall Study|Death|1|||
28031884|NCT03937908|54690295|FG000|Overall Study|Study discontinuation due to pandemic restrictions|0|||
28031885|NCT03937908|54690296|FG001|Overall Study|Study discontinuation due to pandemic restrictions|1|||
28031886|NCT00689273|54690304|FG000|Overall Study|Adverse Event|3|||
28031887|NCT00689273|54690305|FG001|Overall Study|Adverse Event|1|||
28031888|NCT00689273|54690304|FG000|Overall Study|Lack of Efficacy|3|||
28031889|NCT00689273|54690305|FG001|Overall Study|Lack of Efficacy|0|||
28031890|NCT00689273|54690304|FG000|Overall Study|Lost to Follow-up|0|||
28031891|NCT00689273|54690305|FG001|Overall Study|Lost to Follow-up|2|||
28031892|NCT00689273|54690304|FG000|Overall Study|Other|6|||
28031893|NCT00689273|54690305|FG001|Overall Study|Other|2|||
28031894|NCT00689273|54690304|FG000|Overall Study|Randomized but not Treated|1|||
28031895|NCT00689273|54690305|FG001|Overall Study|Randomized but not Treated|0|||
28031896|NCT00553358|54690314|FG000|Overall Study|Randomized but did not receive treatment|3|||
28031897|NCT00553358|54690315|FG001|Overall Study|Randomized but did not receive treatment|3|||
28031898|NCT00553358|54690316|FG002|Overall Study|Randomized but did not receive treatment|1|||
28031899|NCT00553358|54690314|FG000|Overall Study|Lost to Follow-up|22|||
28031900|NCT00553358|54690315|FG001|Overall Study|Lost to Follow-up|26|||
28031901|NCT00553358|54690316|FG002|Overall Study|Lost to Follow-up|18|||
28031902|NCT00553358|54690314|FG000|Overall Study|Withdrew completely|23|||
28031903|NCT00553358|54690315|FG001|Overall Study|Withdrew completely|33|||
28031904|NCT00553358|54690316|FG002|Overall Study|Withdrew completely|34|||
28031905|NCT00553358|54690314|FG000|Overall Study|Died during clinical follow-up|25|||
28031906|NCT00553358|54690315|FG001|Overall Study|Died during clinical follow-up|29|||
28031907|NCT00553358|54690316|FG002|Overall Study|Died during clinical follow-up|32|||
28031908|NCT00553358|54690314|FG000|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4|||
28031909|NCT00553358|54690315|FG001|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
28031910|NCT00553358|54690316|FG002|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
28031911|NCT00553358|54690314|FG000|Overall Study|Died after clinical follow-up ended|1|||
28031912|NCT00553358|54690315|FG001|Overall Study|Died after clinical follow-up ended|2|||
28031913|NCT00553358|54690316|FG002|Overall Study|Died after clinical follow-up ended|0|||
28031914|NCT00553358|54690314|FG000|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
27807389|NCT01953692|54262821|FG002|Overall Study|Clinical Progression|7|||
28031915|NCT00553358|54690315|FG001|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
28031916|NCT00553358|54690316|FG002|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
28031917|NCT00688259|54690332|FG000|Overall Study|Lost to Follow-up|2|||
28031918|NCT00688259|54690333|FG001|Overall Study|Lost to Follow-up|4|||
28031919|NCT00688259|54690332|FG000|Overall Study|Physician Decision|1|||
28031920|NCT00688259|54690333|FG001|Overall Study|Physician Decision|0|||
28031921|NCT00688259|54690332|FG000|Overall Study|Withdrawal by Subject|2|||
28031922|NCT00688259|54690333|FG001|Overall Study|Withdrawal by Subject|0|||
28031923|NCT00688259|54690332|FG000|Overall Study|Declined Interview|2|||
28031924|NCT00688259|54690333|FG001|Overall Study|Declined Interview|3|||
28031925|NCT00688259|54690332|FG000|Overall Study|Hospitalized at Follow-up|0|||
27807390|NCT01953692|54262822|FG003|Overall Study|Clinical Progression|5|||
27807391|NCT01953692|54262823|FG004|Overall Study|Clinical Progression|0|||
27807392|NCT01953692|54262824|FG005|Overall Study|Clinical Progression|7|||
27807393|NCT01953692|54262825|FG006|Overall Study|Clinical Progression|20|||
27807394|NCT01953692|54262826|FG007|Overall Study|Clinical Progression|3|||
27807395|NCT01953692|54262827|FG008|Overall Study|Clinical Progression|3|||
27807396|NCT01953692|54262819|FG000|Overall Study|Death|5|||
28031926|NCT00688259|54690333|FG001|Overall Study|Hospitalized at Follow-up|1|||
28031927|NCT00688181|54690339|FG000|Overall Study|Lost to Follow-up|17|||
28031928|NCT00688181|54690339|FG000|Overall Study|Unknown Reason|4|||
28031929|NCT00688181|54690339|FG000|Overall Study|Non-clinical Reason|2|||
28031930|NCT00689117|54690358|FG000|Overall Study|Adverse Event|6|||
28031931|NCT00689117|54690359|FG001|Overall Study|Adverse Event|0|||
27807397|NCT01953692|54262820|FG001|Overall Study|Death|0|||
27807398|NCT01953692|54262821|FG002|Overall Study|Death|2|||
28031932|NCT00689117|54690360|FG002|Overall Study|Adverse Event|5|||
28031933|NCT00689117|54690361|FG003|Overall Study|Adverse Event|0|||
28031934|NCT00689117|54690358|FG000|Overall Study|Lost to Follow-up|26|||
28031935|NCT00689117|54690359|FG001|Overall Study|Lost to Follow-up|19|||
28031936|NCT00689117|54690360|FG002|Overall Study|Lost to Follow-up|17|||
28031937|NCT00689117|54690361|FG003|Overall Study|Lost to Follow-up|11|||
28031938|NCT00689117|54690358|FG000|Overall Study|Lack of Efficacy|1|||
28031939|NCT00689117|54690359|FG001|Overall Study|Lack of Efficacy|2|||
28031940|NCT00689117|54690360|FG002|Overall Study|Lack of Efficacy|2|||
28031941|NCT00689117|54690361|FG003|Overall Study|Lack of Efficacy|2|||
28031942|NCT00689117|54690358|FG000|Overall Study|Non-Compliance with Study Treatment|3|||
28031943|NCT00689117|54690359|FG001|Overall Study|Non-Compliance with Study Treatment|3|||
28031944|NCT00689117|54690360|FG002|Overall Study|Non-Compliance with Study Treatment|3|||
28031945|NCT00689117|54690361|FG003|Overall Study|Non-Compliance with Study Treatment|1|||
28031946|NCT00689117|54690358|FG000|Overall Study|Withdrawal by Subject|19|||
28031947|NCT00689117|54690359|FG001|Overall Study|Withdrawal by Subject|18|||
28031948|NCT00689117|54690360|FG002|Overall Study|Withdrawal by Subject|26|||
28031949|NCT00689117|54690361|FG003|Overall Study|Withdrawal by Subject|13|||
28031950|NCT00689117|54690358|FG000|Overall Study|Unable to Comply with Visit Schedule|0|||
28031951|NCT00689117|54690359|FG001|Overall Study|Unable to Comply with Visit Schedule|0|||
28031952|NCT00689117|54690360|FG002|Overall Study|Unable to Comply with Visit Schedule|1|||
28031953|NCT00689117|54690361|FG003|Overall Study|Unable to Comply with Visit Schedule|1|||
28031954|NCT00689117|54690358|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
28031955|NCT00689117|54690359|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
28031956|NCT00689117|54690360|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
28031957|NCT00689117|54690361|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
28031958|NCT00689117|54690358|FG000|Overall Study|Non-compliance with Treatment Regimen|0|||
28031959|NCT00689117|54690359|FG001|Overall Study|Non-compliance with Treatment Regimen|1|||
28031960|NCT00689117|54690360|FG002|Overall Study|Non-compliance with Treatment Regimen|0|||
28031961|NCT00689117|54690361|FG003|Overall Study|Non-compliance with Treatment Regimen|0|||
28031962|NCT00689117|54690358|FG000|Overall Study|Change/Discontinuation of Birth Control|1|||
28031963|NCT00689117|54690359|FG001|Overall Study|Change/Discontinuation of Birth Control|1|||
28031964|NCT00689117|54690360|FG002|Overall Study|Change/Discontinuation of Birth Control|1|||
28031965|NCT00689117|54690361|FG003|Overall Study|Change/Discontinuation of Birth Control|0|||
28031966|NCT00689117|54690358|FG000|Overall Study|Use of Prohibitive Medication|2|||
28031967|NCT00689117|54690359|FG001|Overall Study|Use of Prohibitive Medication|1|||
28031968|NCT00689117|54690360|FG002|Overall Study|Use of Prohibitive Medication|3|||
28031969|NCT00689117|54690361|FG003|Overall Study|Use of Prohibitive Medication|0|||
28031970|NCT00689117|54690358|FG000|Overall Study|Pregnancy|0|||
28031971|NCT00689117|54690359|FG001|Overall Study|Pregnancy|2|||
28031972|NCT00689117|54690360|FG002|Overall Study|Pregnancy|0|||
28031973|NCT00689117|54690361|FG003|Overall Study|Pregnancy|2|||
28031974|NCT00689117|54690358|FG000|Overall Study|Incarceration|2|||
28031975|NCT00689117|54690359|FG001|Overall Study|Incarceration|0|||
28031976|NCT00689117|54690360|FG002|Overall Study|Incarceration|0|||
28031977|NCT00689117|54690361|FG003|Overall Study|Incarceration|0|||
28031978|NCT00689117|54690358|FG000|Overall Study|Fear of Birth Defects|0|||
27807399|NCT01953692|54262822|FG003|Overall Study|Death|2|||
27807400|NCT01953692|54262823|FG004|Overall Study|Death|1|||
27807401|NCT01953692|54262824|FG005|Overall Study|Death|3|||
27807402|NCT01953692|54262825|FG006|Overall Study|Death|6|||
27807403|NCT01953692|54262826|FG007|Overall Study|Death|2|||
27807404|NCT01953692|54262827|FG008|Overall Study|Death|1|||
27807405|NCT01953692|54262819|FG000|Overall Study|Excluded Medication|1|||
27807406|NCT01953692|54262820|FG001|Overall Study|Excluded Medication|0|||
27807407|NCT01953692|54262821|FG002|Overall Study|Excluded Medication|0|||
27807408|NCT01953692|54262822|FG003|Overall Study|Excluded Medication|0|||
27807409|NCT01953692|54262823|FG004|Overall Study|Excluded Medication|0|||
27807410|NCT01953692|54262824|FG005|Overall Study|Excluded Medication|0|||
27807411|NCT01953692|54262825|FG006|Overall Study|Excluded Medication|0|||
27807412|NCT01953692|54262826|FG007|Overall Study|Excluded Medication|0|||
27807413|NCT01953692|54262827|FG008|Overall Study|Excluded Medication|0|||
27807414|NCT01953692|54262819|FG000|Overall Study|Lost to Follow-up|1|||
27807415|NCT01953692|54262820|FG001|Overall Study|Lost to Follow-up|0|||
27807416|NCT01953692|54262821|FG002|Overall Study|Lost to Follow-up|3|||
27807417|NCT01953692|54262822|FG003|Overall Study|Lost to Follow-up|1|||
27807418|NCT01953692|54262823|FG004|Overall Study|Lost to Follow-up|0|||
27807419|NCT01953692|54262824|FG005|Overall Study|Lost to Follow-up|1|||
28031979|NCT00689117|54690359|FG001|Overall Study|Fear of Birth Defects|0|||
28031980|NCT00689117|54690360|FG002|Overall Study|Fear of Birth Defects|1|||
28031981|NCT00689117|54690361|FG003|Overall Study|Fear of Birth Defects|0|||
28031982|NCT00689117|54690358|FG000|Overall Study|Transportation|1|||
28031983|NCT00689117|54690359|FG001|Overall Study|Transportation|0|||
28031984|NCT00689117|54690360|FG002|Overall Study|Transportation|0|||
27807420|NCT01953692|54262825|FG006|Overall Study|Lost to Follow-up|0|||
27807421|NCT01953692|54262826|FG007|Overall Study|Lost to Follow-up|0|||
27807422|NCT01953692|54262827|FG008|Overall Study|Lost to Follow-up|0|||
27807423|NCT01953692|54262819|FG000|Overall Study|Physician Decision|11|||
27807424|NCT01953692|54262820|FG001|Overall Study|Physician Decision|4|||
27807425|NCT01953692|54262821|FG002|Overall Study|Physician Decision|2|||
28031985|NCT00689117|54690361|FG003|Overall Study|Transportation|0|||
28031986|NCT00689117|54690358|FG000|Overall Study|Patient Withdrew from Study|0|||
28031987|NCT00689117|54690359|FG001|Overall Study|Patient Withdrew from Study|0|||
28031988|NCT00689117|54690360|FG002|Overall Study|Patient Withdrew from Study|0|||
28031989|NCT00689117|54690361|FG003|Overall Study|Patient Withdrew from Study|1|||
28031990|NCT00689117|54690358|FG000|Overall Study|Personal Reason|0|||
28031991|NCT00689117|54690359|FG001|Overall Study|Personal Reason|1|||
28031992|NCT00689117|54690360|FG002|Overall Study|Personal Reason|0|||
28031993|NCT00689117|54690361|FG003|Overall Study|Personal Reason|0|||
28031994|NCT00689117|54690358|FG000|Overall Study|Dispensing Error|0|||
28031995|NCT00689117|54690359|FG001|Overall Study|Dispensing Error|1|||
28031996|NCT00689117|54690360|FG002|Overall Study|Dispensing Error|0|||
28031997|NCT00689117|54690361|FG003|Overall Study|Dispensing Error|0|||
28031998|NCT00547248|54690375|FG000|Overall Study|Protocol Violation|0|||
28031999|NCT00547248|54690376|FG001|Overall Study|Protocol Violation|0|||
28032000|NCT00547248|54690377|FG002|Overall Study|Protocol Violation|1|||
28032001|NCT00547248|54690378|FG003|Overall Study|Protocol Violation|1|||
28032002|NCT00547248|54690375|FG000|Overall Study|Migrated/moved from study area|0|||
28032003|NCT00547248|54690376|FG001|Overall Study|Migrated/moved from study area|0|||
28032004|NCT00547248|54690377|FG002|Overall Study|Migrated/moved from study area|2|||
28032005|NCT00547248|54690378|FG003|Overall Study|Migrated/moved from study area|0|||
28032006|NCT00547248|54690375|FG000|Overall Study|Withdrawal by Subject|0|||
28032007|NCT00547248|54690376|FG001|Overall Study|Withdrawal by Subject|0|||
28032008|NCT00547248|54690377|FG002|Overall Study|Withdrawal by Subject|7|||
28032009|NCT00547248|54690378|FG003|Overall Study|Withdrawal by Subject|1|||
28032010|NCT00688103|54690393|FG000|Overall Study|Adverse Event|4|||
28032011|NCT00688103|54690394|FG001|Overall Study|Adverse Event|1|||
28032012|NCT00688103|54690393|FG000|Overall Study|Lack of Efficacy|11|||
28032013|NCT00688103|54690394|FG001|Overall Study|Lack of Efficacy|1|||
28032014|NCT00688103|54690393|FG000|Overall Study|Withdrawal by Subject|4|||
28032015|NCT00688103|54690394|FG001|Overall Study|Withdrawal by Subject|2|||
28032016|NCT00688103|54690393|FG000|Overall Study|complex reasons|11|||
28032017|NCT00688103|54690394|FG001|Overall Study|complex reasons|9|||
28032018|NCT00686855|54690404|FG000|Overall Study|Lost to Follow-up|1|||
28032019|NCT00686855|54690405|FG001|Overall Study|Lost to Follow-up|0|||
28032020|NCT00686855|54690404|FG000|Overall Study|Progressive GVHD|0|||
28032021|NCT00686855|54690405|FG001|Overall Study|Progressive GVHD|1|||
28032022|NCT00686777|54690411|FG000|Overall Study|Adverse Event|2|||
28032023|NCT00686777|54690411|FG000|Overall Study|Pregnancy|1|||
28032024|NCT00686777|54690411|FG000|Overall Study|Withdrawal by Subject|2|||
28032025|NCT00686777|54690411|FG000|Overall Study|Discontinuance Criteria (specified AEs)|4|||
28032026|NCT00686777|54690411|FG000|Overall Study|No Visit|1|||
28032027|NCT00686699|54690417|FG000|Treatment Period 1|Adverse Event|0|||
28032028|NCT00686699|54690418|FG001|Treatment Period 1|Adverse Event|2|||
28032029|NCT00106639|54690427|FG000|Overall Study|Adverse Event|3|||
28032030|NCT00106639|54690428|FG001|Overall Study|Adverse Event|4|||
28032031|NCT00106639|54690429|FG002|Overall Study|Adverse Event|1|||
28032032|NCT00106639|54690427|FG000|Overall Study|Protocol Violation|0|||
28032033|NCT00106639|54690428|FG001|Overall Study|Protocol Violation|1|||
28032034|NCT00106639|54690429|FG002|Overall Study|Protocol Violation|0|||
28032035|NCT00106639|54690427|FG000|Overall Study|Withdrawal by Subject|0|||
28032036|NCT00106639|54690428|FG001|Overall Study|Withdrawal by Subject|1|||
28032037|NCT00106639|54690429|FG002|Overall Study|Withdrawal by Subject|0|||
28032038|NCT00106639|54690427|FG000|Overall Study|Participant defaulted|0|||
28032039|NCT00106639|54690428|FG001|Overall Study|Participant defaulted|1|||
28032040|NCT00106639|54690429|FG002|Overall Study|Participant defaulted|1|||
28032041|NCT00106249|54690440|FG000|Overall Study|Lost to Follow-up|3|||
28032042|NCT00106249|54690441|FG001|Overall Study|Lost to Follow-up|2|||
27807426|NCT01953692|54262822|FG003|Overall Study|Physician Decision|2|||
27807427|NCT01953692|54262823|FG004|Overall Study|Physician Decision|1|||
27807428|NCT01953692|54262824|FG005|Overall Study|Physician Decision|2|||
27807429|NCT01953692|54262825|FG006|Overall Study|Physician Decision|4|||
27807430|NCT01953692|54262826|FG007|Overall Study|Physician Decision|1|||
28032043|NCT00105469|54690449|FG000|Overall Study|Adverse Event|9|||
28032044|NCT00105469|54690450|FG001|Overall Study|Adverse Event|8|||
28032045|NCT00105469|54690449|FG000|Overall Study|Protocol Violation|4|||
28032046|NCT00105469|54690450|FG001|Overall Study|Protocol Violation|0|||
28032047|NCT00105469|54690449|FG000|Overall Study|Withdrawal by Subject|2|||
28032048|NCT00105469|54690450|FG001|Overall Study|Withdrawal by Subject|3|||
28032049|NCT00105469|54690449|FG000|Overall Study|Lost to Follow-up|1|||
28032050|NCT00105469|54690450|FG001|Overall Study|Lost to Follow-up|0|||
28032051|NCT00105469|54690449|FG000|Overall Study|Lack of Efficacy|2|||
28032052|NCT00105469|54690450|FG001|Overall Study|Lack of Efficacy|0|||
28032053|NCT00105469|54690449|FG000|Overall Study|Other Reason|4|||
28032054|NCT00105469|54690450|FG001|Overall Study|Other Reason|0|||
28032055|NCT00105235|54690456|FG000|Overall Study|Death|4|||
27807431|NCT01953692|54262827|FG008|Overall Study|Physician Decision|0|||
27807432|NCT01953692|54262819|FG000|Overall Study|Protocol Violation|0|||
27844295|NCT01412801|54334058|FG000|Overall Study|Withdrawal by Subject|3|||
27844296|NCT01412801|54334059|FG001|Overall Study|Withdrawal by Subject|2|||
27844297|NCT01412801|54334060|FG002|Overall Study|Withdrawal by Subject|1|||
27844298|NCT01412801|54334061|FG003|Overall Study|Withdrawal by Subject|0|||
28032056|NCT00105235|54690456|FG000|Overall Study|Physician Decision|1|||
28032057|NCT00105235|54690456|FG000|Overall Study|Withdrawal by Subject|2|||
28032058|NCT00547118|54690466|FG000|Overall Study|Did not qualify prior to starting drug|1|||
28032059|NCT00547118|54690467|FG001|Overall Study|Did not qualify prior to starting drug|1|||
28032060|NCT00547118|54690466|FG000|Overall Study|Study suspended|7|||
28032061|NCT00547118|54690467|FG001|Overall Study|Study suspended|8|||
28032062|NCT00502593|54690487|FG000|Overall Study|Withdrawn unspecified reason|1|||
28032063|NCT00502593|54690488|FG001|Overall Study|Withdrawn unspecified reason|1|||
28032064|NCT00502593|54690489|FG002|Overall Study|Withdrawn unspecified reason|3|||
28032065|NCT00502593|54690490|FG003|Overall Study|Withdrawn unspecified reason|1|||
28032066|NCT00502593|54690491|FG004|Overall Study|Withdrawn unspecified reason|2|||
28032067|NCT00502593|54690492|FG005|Overall Study|Withdrawn unspecified reason|0|||
28032068|NCT00502593|54690493|FG006|Overall Study|Withdrawn unspecified reason|2|||
28032069|NCT00502593|54690494|FG007|Overall Study|Withdrawn unspecified reason|0|||
28032070|NCT00502593|54690495|FG008|Overall Study|Withdrawn unspecified reason|0|||
28032071|NCT00502593|54690496|FG009|Overall Study|Withdrawn unspecified reason|0|||
28032072|NCT00502593|54690497|FG010|Overall Study|Withdrawn unspecified reason|0|||
28032073|NCT00502593|54690498|FG011|Overall Study|Withdrawn unspecified reason|0|||
28032074|NCT00502593|54690487|FG000|Overall Study|Withdrawal by Subject|0|||
28032075|NCT00502593|54690488|FG001|Overall Study|Withdrawal by Subject|0|||
28032076|NCT00502593|54690489|FG002|Overall Study|Withdrawal by Subject|6|||
28032077|NCT00502593|54690490|FG003|Overall Study|Withdrawal by Subject|2|||
28032078|NCT00502593|54690491|FG004|Overall Study|Withdrawal by Subject|2|||
28032079|NCT00502593|54690492|FG005|Overall Study|Withdrawal by Subject|0|||
28032080|NCT00502593|54690493|FG006|Overall Study|Withdrawal by Subject|3|||
28032081|NCT00502593|54690494|FG007|Overall Study|Withdrawal by Subject|0|||
28032082|NCT00502593|54690495|FG008|Overall Study|Withdrawal by Subject|3|||
28032083|NCT00502593|54690496|FG009|Overall Study|Withdrawal by Subject|0|||
27939740|NCT00952822|54596028|FG000|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
27939741|NCT00952822|54596029|FG001|1st Pharmacokinetic Evaluation|Lost to Follow-up|1|||
27939742|NCT00952822|54596030|FG002|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
27939743|NCT00952822|54596031|FG003|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
27939744|NCT00952822|54596028|FG000|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
27939745|NCT00952822|54596029|FG001|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
27939746|NCT00952822|54596030|FG002|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1|||
27939747|NCT00952822|54596031|FG003|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
27844299|NCT01412801|54334062|FG004|Overall Study|Withdrawal by Subject|0|||
27939748|NCT01038297|54596045|FG000|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|1|||
27844300|NCT01412801|54334063|FG005|Overall Study|Withdrawal by Subject|0|||
27844301|NCT01412801|54334058|FG000|Overall Study|Relocated to another area|0|||
27844302|NCT01412801|54334059|FG001|Overall Study|Relocated to another area|0|||
27844303|NCT01412801|54334060|FG002|Overall Study|Relocated to another area|2|||
27844304|NCT01412801|54334061|FG003|Overall Study|Relocated to another area|0|||
27844305|NCT01412801|54334062|FG004|Overall Study|Relocated to another area|0|||
27844306|NCT01412801|54334063|FG005|Overall Study|Relocated to another area|0|||
27844307|NCT01525628|54334111|FG000|Overall Study|Adverse Event|1|||
27844308|NCT01525628|54334112|FG001|Overall Study|Adverse Event|1|||
27844309|NCT01525628|54334113|FG002|Overall Study|Adverse Event|2|||
27939749|NCT01038297|54596046|FG001|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
27939750|NCT01038297|54596047|FG002|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
27939751|NCT00955708|54596064|FG000|Overall Study|Death|269|||
27939752|NCT00955708|54596064|FG000|Overall Study|Lost to Follow-up|72|||
27939753|NCT00955708|54596064|FG000|Overall Study|Physician Decision|36|||
27939754|NCT00955708|54596064|FG000|Overall Study|Protocol Violation|134|||
27939755|NCT00955708|54596064|FG000|Overall Study|Registry Conclusion|186|||
27939756|NCT00955708|54596064|FG000|Overall Study|Product removed from service|94|||
27939757|NCT00955708|54596064|FG000|Overall Study|Patient Refused to participate further|116|||
27939758|NCT00955708|54596064|FG000|Overall Study|Closure of study location|60|||
27939759|NCT00955708|54596064|FG000|Overall Study|Patient changed care provider/moved|91|||
27939760|NCT01037985|54596068|FG000|Part A: Skin Testing (50 Days)|Withdrawal by Subject|3|||
27939761|NCT01037985|54596069|FG001|Part A: Skin Testing (50 Days)|Withdrawal by Subject|0|||
27844310|NCT01525628|54334114|FG003|Overall Study|Adverse Event|0|||
27939762|NCT01037985|54596068|FG000|Part A: Skin Testing (50 Days)|Physician Decision|1|||
27939763|NCT01037985|54596069|FG001|Part A: Skin Testing (50 Days)|Physician Decision|0|||
27844311|NCT01525628|54334115|FG004|Overall Study|Adverse Event|1|||
27939764|NCT01037985|54596068|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|0|||
28032084|NCT00502593|54690497|FG010|Overall Study|Withdrawal by Subject|1|||
28032085|NCT00502593|54690498|FG011|Overall Study|Withdrawal by Subject|0|||
28032086|NCT00502593|54690487|FG000|Overall Study|Lost to Follow-up|2|||
28032087|NCT00502593|54690488|FG001|Overall Study|Lost to Follow-up|1|||
28032088|NCT00502593|54690489|FG002|Overall Study|Lost to Follow-up|1|||
28032089|NCT00502593|54690490|FG003|Overall Study|Lost to Follow-up|1|||
28032090|NCT00502593|54690491|FG004|Overall Study|Lost to Follow-up|0|||
28032091|NCT00502593|54690492|FG005|Overall Study|Lost to Follow-up|0|||
28032092|NCT00502593|54690493|FG006|Overall Study|Lost to Follow-up|0|||
28032093|NCT00502593|54690494|FG007|Overall Study|Lost to Follow-up|0|||
28032094|NCT00502593|54690495|FG008|Overall Study|Lost to Follow-up|3|||
28032095|NCT00502593|54690496|FG009|Overall Study|Lost to Follow-up|0|||
28032096|NCT00502593|54690497|FG010|Overall Study|Lost to Follow-up|1|||
28032097|NCT00502593|54690498|FG011|Overall Study|Lost to Follow-up|0|||
28032098|NCT00686543|54690551|FG000|Overall Study|Adverse Event|9|||
28032099|NCT00686543|54690552|FG001|Overall Study|Adverse Event|1|||
28032100|NCT00686543|54690553|FG002|Overall Study|Adverse Event|3|||
28032101|NCT00686543|54690554|FG003|Overall Study|Adverse Event|2|||
28032102|NCT00686543|54690551|FG000|Overall Study|Withdrawal by Subject|2|||
28032103|NCT00686543|54690552|FG001|Overall Study|Withdrawal by Subject|0|||
28032104|NCT00686543|54690553|FG002|Overall Study|Withdrawal by Subject|0|||
28032105|NCT00686543|54690554|FG003|Overall Study|Withdrawal by Subject|0|||
28032106|NCT00686543|54690551|FG000|Overall Study|Protocol Violation|3|||
28032107|NCT00686543|54690552|FG001|Overall Study|Protocol Violation|0|||
28032108|NCT00686543|54690553|FG002|Overall Study|Protocol Violation|2|||
28032109|NCT00686543|54690554|FG003|Overall Study|Protocol Violation|1|||
28032110|NCT00545688|54690568|FG000|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
28032111|NCT00545688|54690569|FG001|Neo-Adjuvant Treatment Period|Protocol Violation|2|||
28032112|NCT00545688|54690570|FG002|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
28032113|NCT00545688|54690571|FG003|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
28032114|NCT00545688|54690568|FG000|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
28032115|NCT00545688|54690569|FG001|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
28032116|NCT00545688|54690570|FG002|Neo-Adjuvant Treatment Period|Refused Treatment|4|||
28032117|NCT00545688|54690571|FG003|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
28032118|NCT00545688|54690568|FG000|Neo-Adjuvant Treatment Period|Lost to Follow-up|1|||
28032119|NCT00545688|54690569|FG001|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
28032120|NCT00545688|54690570|FG002|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
28032121|NCT00545688|54690571|FG003|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
28032122|NCT00545688|54690568|FG000|Neo-Adjuvant Treatment Period|Death|0|||
28032123|NCT00545688|54690569|FG001|Neo-Adjuvant Treatment Period|Death|1|||
28032124|NCT00545688|54690570|FG002|Neo-Adjuvant Treatment Period|Death|0|||
28032125|NCT00545688|54690571|FG003|Neo-Adjuvant Treatment Period|Death|0|||
28032126|NCT00545688|54690568|FG000|Neo-Adjuvant Treatment Period|Disease Progression|0|||
28032127|NCT00545688|54690569|FG001|Neo-Adjuvant Treatment Period|Disease Progression|1|||
28032128|NCT00545688|54690570|FG002|Neo-Adjuvant Treatment Period|Disease Progression|7|||
28032129|NCT00545688|54690571|FG003|Neo-Adjuvant Treatment Period|Disease Progression|2|||
28032130|NCT00545688|54690568|FG000|Neo-Adjuvant Treatment Period|Unknown Reason|1|||
28032131|NCT00545688|54690569|FG001|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
28032132|NCT00545688|54690570|FG002|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
28032133|NCT00545688|54690571|FG003|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
28032134|NCT00545688|54690568|FG000|Neo-Adjuvant Treatment Period|Adverse Event|0|||
28032135|NCT00545688|54690569|FG001|Neo-Adjuvant Treatment Period|Adverse Event|0|||
28032136|NCT00545688|54690570|FG002|Neo-Adjuvant Treatment Period|Adverse Event|2|||
28032137|NCT00545688|54690571|FG003|Neo-Adjuvant Treatment Period|Adverse Event|2|||
28032138|NCT00545688|54690568|FG000|Adjuvant Treatment Period|Disease Progression|3|||
28032139|NCT00545688|54690569|FG001|Adjuvant Treatment Period|Disease Progression|3|||
28032140|NCT00545688|54690570|FG002|Adjuvant Treatment Period|Disease Progression|0|||
28032141|NCT00545688|54690571|FG003|Adjuvant Treatment Period|Disease Progression|7|||
28032142|NCT00545688|54690568|FG000|Adjuvant Treatment Period|Refused Treatment|1|||
28032143|NCT00545688|54690569|FG001|Adjuvant Treatment Period|Refused Treatment|1|||
28032144|NCT00545688|54690570|FG002|Adjuvant Treatment Period|Refused Treatment|1|||
28032145|NCT00545688|54690571|FG003|Adjuvant Treatment Period|Refused Treatment|5|||
28032146|NCT00545688|54690568|FG000|Adjuvant Treatment Period|Lost to Follow-up|1|||
28032147|NCT00545688|54690569|FG001|Adjuvant Treatment Period|Lost to Follow-up|0|||
28032148|NCT00545688|54690570|FG002|Adjuvant Treatment Period|Lost to Follow-up|1|||
28032149|NCT00545688|54690571|FG003|Adjuvant Treatment Period|Lost to Follow-up|0|||
28032150|NCT00545688|54690568|FG000|Adjuvant Treatment Period|Adverse Event|0|||
28032151|NCT00545688|54690569|FG001|Adjuvant Treatment Period|Adverse Event|3|||
28032152|NCT00545688|54690570|FG002|Adjuvant Treatment Period|Adverse Event|2|||
28032153|NCT00545688|54690571|FG003|Adjuvant Treatment Period|Adverse Event|2|||
28032154|NCT00545688|54690568|FG000|Adjuvant Treatment Period|Unknown Reason|0|||
28032155|NCT00545688|54690569|FG001|Adjuvant Treatment Period|Unknown Reason|1|||
28032156|NCT00545688|54690570|FG002|Adjuvant Treatment Period|Unknown Reason|0|||
28032157|NCT00545688|54690571|FG003|Adjuvant Treatment Period|Unknown Reason|0|||
28032158|NCT00545688|54690568|FG000|Follow-Up Period|Death|4|||
28032159|NCT00545688|54690569|FG001|Follow-Up Period|Death|2|||
28032160|NCT00545688|54690570|FG002|Follow-Up Period|Death|2|||
28032161|NCT00545688|54690571|FG003|Follow-Up Period|Death|6|||
28032162|NCT00545688|54690568|FG000|Follow-Up Period|Disease Progression|6|||
28032163|NCT00545688|54690569|FG001|Follow-Up Period|Disease Progression|5|||
28032164|NCT00545688|54690570|FG002|Follow-Up Period|Disease Progression|9|||
28032165|NCT00545688|54690571|FG003|Follow-Up Period|Disease Progression|9|||
28032166|NCT00545688|54690568|FG000|Follow-Up Period|Refused Treatment|6|||
28032167|NCT00545688|54690569|FG001|Follow-Up Period|Refused Treatment|2|||
28032168|NCT00545688|54690570|FG002|Follow-Up Period|Refused Treatment|0|||
28032169|NCT00545688|54690571|FG003|Follow-Up Period|Refused Treatment|2|||
28032170|NCT00545688|54690568|FG000|Follow-Up Period|Lost to Follow-up|3|||
28032171|NCT00545688|54690569|FG001|Follow-Up Period|Lost to Follow-up|3|||
28032172|NCT00545688|54690570|FG002|Follow-Up Period|Lost to Follow-up|3|||
28032173|NCT00545688|54690571|FG003|Follow-Up Period|Lost to Follow-up|1|||
28032174|NCT00545688|54690568|FG000|Follow-Up Period|Unspecified Reason|2|||
28032175|NCT00545688|54690569|FG001|Follow-Up Period|Unspecified Reason|5|||
28032176|NCT00545688|54690570|FG002|Follow-Up Period|Unspecified Reason|6|||
28032177|NCT00545688|54690571|FG003|Follow-Up Period|Unspecified Reason|8|||
28032178|NCT00545688|54690568|FG000|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
28032179|NCT00545688|54690569|FG001|Follow-Up Period|Violation of Selection Criteria at Entry|2|||
28032180|NCT00545688|54690570|FG002|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
28032181|NCT00545688|54690571|FG003|Follow-Up Period|Violation of Selection Criteria at Entry|1|||
28032182|NCT00502203|54690584|FG000|Overall Study|Inevaluable|1|||
28032183|NCT00546078|54690590|FG000|Overall Study|Lost to Follow-up|1|||
28032184|NCT00546078|54690591|FG001|Overall Study|Lost to Follow-up|3|||
28032185|NCT00546078|54690590|FG000|Overall Study|Withdrawal by Subject|2|||
28032186|NCT00546078|54690591|FG001|Overall Study|Withdrawal by Subject|3|||
28032187|NCT00546078|54690590|FG000|Overall Study|Other reason|1|||
28032188|NCT00546078|54690591|FG001|Overall Study|Other reason|1|||
28032189|NCT00546000|54690597|FG000|Overall Study|Adverse Event|1|||
28032190|NCT00546000|54690597|FG000|Overall Study|Lost to Follow-up|1|||
28032191|NCT00546000|54690597|FG000|Overall Study|Baseline HPA Axis Supression|2|||
28032192|NCT00501969|54690601|FG000|Overall Study|Major Protocol Violation|4|||
28032193|NCT00501969|54690601|FG000|Overall Study|Lack of Efficacy|29|||
28032194|NCT00501969|54690601|FG000|Overall Study|Adverse Event|76|||
28032195|NCT00501969|54690601|FG000|Overall Study|Unsatisfactory compliance of subject|7|||
28032196|NCT00501969|54690601|FG000|Overall Study|Subject withdrew consent|51|||
27939765|NCT01037985|54596069|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|1|||
27939766|NCT01037985|54596068|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|0|||
27939767|NCT01037985|54596069|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|4|||
27939768|NCT00955474|54596081|FG000|Overall Study|Physician Decision|7|||
28032197|NCT00501969|54690601|FG000|Overall Study|Lost to Follow-up|4|||
28032198|NCT00501969|54690601|FG000|Overall Study|Other: Tired Of Clinical Trial Process|1|||
28032199|NCT00501969|54690601|FG000|Overall Study|Other: Sponsors Request|10|||
28032200|NCT00501969|54690601|FG000|Overall Study|Other: Sponsor Termination at Site|1|||
28032201|NCT00501969|54690601|FG000|Overall Study|Other: Sponsor Stopped Study|12|||
28032202|NCT00501969|54690601|FG000|Overall Study|Other: Severe Dementia Unable Sign PIC|1|||
28032203|NCT00501969|54690601|FG000|Overall Study|Other: Patients + Investigator Agreement|1|||
28032204|NCT00501969|54690601|FG000|Overall Study|Other: Patient is Going to Have DBS|1|||
28032205|NCT00501969|54690601|FG000|Overall Study|Other: Pat Pending Surgery for PD|1|||
28032206|NCT00501969|54690601|FG000|Overall Study|Other: DX Changed - Parkinsons to PSNP|1|||
28032207|NCT00501969|54690601|FG000|Overall Study|Other: As Required by Local EC|2|||
28032208|NCT00501969|54690601|FG000|Overall Study|Other: Admin Request from the Sponsor|3|||
28032209|NCT00501969|54690601|FG000|Overall Study|Other: Sponsor Termination/Commercial RX|1|||
28032210|NCT03942042|54690607|FG000|Induction Dosing Period (12 Weeks)|Adverse Event|0|||
28032211|NCT03942042|54690608|FG001|Induction Dosing Period (12 Weeks)|Adverse Event|1|||
28032212|NCT03942042|54690607|FG000|Induction Dosing Period (12 Weeks)|Lack of Efficacy|1|||
28032213|NCT03942042|54690608|FG001|Induction Dosing Period (12 Weeks)|Lack of Efficacy|0|||
28032214|NCT00104299|54690620|FG000|Overall Study|Adverse Event|3|||
28032215|NCT00104299|54690621|FG001|Overall Study|Adverse Event|1|||
28032216|NCT00104299|54690620|FG000|Overall Study|Death|2|||
27807433|NCT01953692|54262820|FG001|Overall Study|Protocol Violation|2|||
27807434|NCT01953692|54262821|FG002|Overall Study|Protocol Violation|1|||
27807435|NCT01953692|54262822|FG003|Overall Study|Protocol Violation|0|||
28032217|NCT00104299|54690621|FG001|Overall Study|Death|2|||
28032218|NCT00104299|54690620|FG000|Overall Study|Withdrawal by Subject|2|||
28032219|NCT00104299|54690621|FG001|Overall Study|Withdrawal by Subject|6|||
28032220|NCT00104299|54690620|FG000|Overall Study|Physician Decision|1|||
28032221|NCT00104299|54690621|FG001|Overall Study|Physician Decision|1|||
28032222|NCT00104299|54690620|FG000|Overall Study|To have renal transplant|1|||
28032223|NCT00104299|54690621|FG001|Overall Study|To have renal transplant|0|||
27807436|NCT01953692|54262823|FG004|Overall Study|Protocol Violation|0|||
28032224|NCT03939312|54690627|FG000|OL Treatment Period (40 Weeks)|Withdrawal Criteria at Visit 1|43|||
28032225|NCT03939312|54690627|FG000|OL Treatment Period (40 Weeks)|Adverse Event|25|||
28032226|NCT03939312|54690627|FG000|OL Treatment Period (40 Weeks)|Lack of Efficacy|4|||
28032227|NCT03939312|54690627|FG000|OL Treatment Period (40 Weeks)|Withdrawal by Subject|35|||
28032228|NCT03939312|54690627|FG000|OL Treatment Period (40 Weeks)|Lost to Follow-up|19|||
28032229|NCT03939312|54690627|FG000|OL Treatment Period (40 Weeks)|Pregnancy|3|||
28032230|NCT03939312|54690627|FG000|OL Treatment Period (40 Weeks)|Protocol Deviation|16|||
28032231|NCT03939312|54690627|FG000|OL Treatment Period (40 Weeks)|Non-compliance With Study Drug|4|||
28032232|NCT03939312|54690627|FG000|OL Treatment Period (40 Weeks)|Site Terminated by Sponsor|3|||
28032233|NCT03939312|54690627|FG000|OL Treatment Period (40 Weeks)|Reason Not Specified|22|||
28032234|NCT03939312|54690627|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Withdrawal by Subject|12|||
28032235|NCT03939312|54690627|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Lost to Follow-up|4|||
28032236|NCT00082381|54690635|FG000|Overall Study|Adverse Event|27|||
28032237|NCT00082381|54690636|FG001|Overall Study|Adverse Event|2|||
28032238|NCT00082381|54690635|FG000|Overall Study|Lost to Follow-up|5|||
28032239|NCT00082381|54690636|FG001|Overall Study|Lost to Follow-up|7|||
28032240|NCT00082381|54690635|FG000|Overall Study|Patient Decision|8|||
28032241|NCT00082381|54690636|FG001|Overall Study|Patient Decision|4|||
28032242|NCT00082381|54690635|FG000|Overall Study|Physician Decision|1|||
28032243|NCT00082381|54690636|FG001|Overall Study|Physician Decision|2|||
28032244|NCT00082381|54690635|FG000|Overall Study|Protocol Violation|10|||
27807437|NCT01953692|54262824|FG005|Overall Study|Protocol Violation|0|||
27807438|NCT01953692|54262825|FG006|Overall Study|Protocol Violation|0|||
27807439|NCT01953692|54262826|FG007|Overall Study|Protocol Violation|1|||
27807440|NCT01953692|54262827|FG008|Overall Study|Protocol Violation|0|||
27807441|NCT01953692|54262819|FG000|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
27807442|NCT01953692|54262820|FG001|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
27807443|NCT01953692|54262821|FG002|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
27807444|NCT01953692|54262822|FG003|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
28032245|NCT00082381|54690636|FG001|Overall Study|Protocol Violation|11|||
28032246|NCT00082381|54690635|FG000|Overall Study|Loss of Glucose Control|4|||
28032247|NCT00082381|54690636|FG001|Overall Study|Loss of Glucose Control|0|||
28032248|NCT00545844|54690642|FG000|Overall Study|Lost to Follow-up|9|||
28032249|NCT00545844|54690642|FG000|Overall Study|Protocol Violation|1|||
28032250|NCT00545844|54690642|FG000|Overall Study|Withdrawal by Subject|2|||
28032251|NCT00492063|54690652|FG000|Overall Study|Death|0|||
28032252|NCT00492063|54690653|FG001|Overall Study|Death|0|||
28032253|NCT00492063|54690654|FG002|Overall Study|Death|1|||
28032254|NCT00492063|54690655|FG003|Overall Study|Death|2|||
28032255|NCT00492063|54690652|FG000|Overall Study|Withdrawal by Subject|4|||
28032256|NCT00492063|54690653|FG001|Overall Study|Withdrawal by Subject|3|||
28032257|NCT00492063|54690654|FG002|Overall Study|Withdrawal by Subject|5|||
28032258|NCT00492063|54690655|FG003|Overall Study|Withdrawal by Subject|4|||
27807445|NCT01953692|54262823|FG004|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
27807446|NCT01953692|54262824|FG005|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
27807447|NCT01953692|54262825|FG006|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
27807448|NCT01953692|54262826|FG007|Overall Study|Study for Cohort 5 Terminated by Sponsor|2|||
27807449|NCT01953692|54262827|FG008|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
27807450|NCT01953692|54262819|FG000|Overall Study|Withdrawal by Subject|4|||
27939769|NCT00955474|54596082|FG001|Overall Study|Physician Decision|5|||
27939770|NCT01229150|54596094|FG000|Overall Study|Toxicity|2|||
28032259|NCT00492063|54690652|FG000|Overall Study|Lost to Follow-up|6|||
28032260|NCT00492063|54690653|FG001|Overall Study|Lost to Follow-up|11|||
28032261|NCT00492063|54690654|FG002|Overall Study|Lost to Follow-up|5|||
28032262|NCT00492063|54690655|FG003|Overall Study|Lost to Follow-up|3|||
28032263|NCT00492063|54690652|FG000|Overall Study|Protocol Violation|0|||
28032264|NCT00492063|54690653|FG001|Overall Study|Protocol Violation|0|||
28032265|NCT00492063|54690654|FG002|Overall Study|Protocol Violation|0|||
28032266|NCT00492063|54690655|FG003|Overall Study|Protocol Violation|1|||
28032267|NCT00093145|54690665|FG000|Overall Study|Unacceptable Toxicity Only|2|||
28032268|NCT00093145|54690665|FG000|Overall Study|Physician Decision|5|||
28032269|NCT00093145|54690665|FG000|Overall Study|Withdrawal by Subject|9|||
28032270|NCT00093145|54690665|FG000|Overall Study|Other|1|||
28032271|NCT00513357|54690671|FG000|Overall Study|did not receive allocated placebo|2|||
28032272|NCT00513357|54690672|FG001|Overall Study|did not receive allocated placebo|3|||
28032273|NCT00513357|54690671|FG000|Overall Study|Adverse Event|4|||
28032274|NCT00513357|54690672|FG001|Overall Study|Adverse Event|2|||
28032275|NCT00513357|54690671|FG000|Overall Study|Death|2|||
28032276|NCT00513357|54690672|FG001|Overall Study|Death|0|||
28032277|NCT00513357|54690671|FG000|Overall Study|Withdrawal by Subject|5|||
28032278|NCT00513357|54690672|FG001|Overall Study|Withdrawal by Subject|4|||
28032279|NCT00513357|54690671|FG000|Overall Study|Disease Progression|2|||
28032280|NCT00513357|54690672|FG001|Overall Study|Disease Progression|1|||
28032281|NCT03933462|54690678|FG000|Overall Study|Adverse Event|2|||
28032282|NCT03933462|54690679|FG001|Overall Study|Adverse Event|0|||
28032283|NCT03929562|54690687|FG000|From Baseline to 1 Month Follow Up|Lost to Follow-up|2|||
28032284|NCT03929562|54690688|FG001|From Baseline to 1 Month Follow Up|Lost to Follow-up|1|||
28032285|NCT03929562|54690687|FG000|From Baseline to 1 Month Follow Up|Withdrawal by Subject|2|||
28032286|NCT03929562|54690688|FG001|From Baseline to 1 Month Follow Up|Withdrawal by Subject|0|||
28032287|NCT03929562|54690687|FG000|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|2|||
28032288|NCT03929562|54690688|FG001|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|0|||
28032289|NCT00415636|54690702|FG000|Overall Study|Symptomatic deterioration|1|||
28032290|NCT00415636|54690703|FG001|Overall Study|Symptomatic deterioration|0|||
28032291|NCT00415636|54690704|FG002|Overall Study|Symptomatic deterioration|1|||
28032292|NCT00415636|54690705|FG003|Overall Study|Symptomatic deterioration|2|||
28032293|NCT00415636|54690706|FG004|Overall Study|Symptomatic deterioration|0|||
28032294|NCT00415636|54690707|FG005|Overall Study|Symptomatic deterioration|1|||
28032295|NCT00415636|54690702|FG000|Overall Study|Adverse Event|0|||
28032296|NCT00415636|54690703|FG001|Overall Study|Adverse Event|0|||
28032297|NCT00415636|54690704|FG002|Overall Study|Adverse Event|0|||
28032298|NCT00415636|54690705|FG003|Overall Study|Adverse Event|1|||
28032299|NCT00415636|54690706|FG004|Overall Study|Adverse Event|1|||
28032300|NCT00415636|54690707|FG005|Overall Study|Adverse Event|0|||
28032301|NCT00415636|54690702|FG000|Overall Study|Withdrawal by Subject|0|||
28032302|NCT00415636|54690703|FG001|Overall Study|Withdrawal by Subject|0|||
28032303|NCT00415636|54690704|FG002|Overall Study|Withdrawal by Subject|0|||
28032304|NCT00415636|54690705|FG003|Overall Study|Withdrawal by Subject|0|||
28032305|NCT00415636|54690706|FG004|Overall Study|Withdrawal by Subject|1|||
28032306|NCT00415636|54690707|FG005|Overall Study|Withdrawal by Subject|0|||
28032307|NCT00415636|54690702|FG000|Overall Study|Disease progression|0|||
28032308|NCT00415636|54690703|FG001|Overall Study|Disease progression|0|||
28032309|NCT00415636|54690704|FG002|Overall Study|Disease progression|0|||
28032310|NCT00415636|54690705|FG003|Overall Study|Disease progression|3|||
28032311|NCT00415636|54690706|FG004|Overall Study|Disease progression|0|||
28032312|NCT00415636|54690707|FG005|Overall Study|Disease progression|1|||
28032313|NCT00425854|54690731|FG000|Overall Study|Progressive Disease|19|||
28032314|NCT00425854|54690732|FG001|Overall Study|Progressive Disease|12|||
28032315|NCT00425854|54690731|FG000|Overall Study|Dose reduction toxicity AE|8|||
28032316|NCT00425854|54690732|FG001|Overall Study|Dose reduction toxicity AE|7|||
28032317|NCT00425854|54690731|FG000|Overall Study|Other Adverse Event|2|||
28032318|NCT00425854|54690732|FG001|Overall Study|Other Adverse Event|2|||
28032319|NCT00425698|54690741|FG000|Overall Study|Adverse Event|3|||
28032320|NCT00425698|54690742|FG001|Overall Study|Adverse Event|1|||
28032321|NCT00425698|54690741|FG000|Overall Study|Withdrawal by Subject|0|||
28032322|NCT00425698|54690742|FG001|Overall Study|Withdrawal by Subject|1|||
28032323|NCT00425308|54690750|FG000|Overall Study|Adverse Event|2|||
28032324|NCT00425308|54690751|FG001|Overall Study|Adverse Event|1|||
28032325|NCT00425308|54690750|FG000|Overall Study|Withdrawal by Subject|1|||
28032326|NCT00425308|54690751|FG001|Overall Study|Withdrawal by Subject|0|||
28032327|NCT00425308|54690750|FG000|Overall Study|Death|1|||
28032328|NCT00425308|54690751|FG001|Overall Study|Death|0|||
28032329|NCT00545064|54690757|FG000|Overall Study|Lost to Follow-up|3|||
28032330|NCT00545064|54690757|FG000|Overall Study|Withdrawal by Subject|2|||
28032331|NCT00545064|54690757|FG000|Overall Study|did not complete course of treatment|1|||
28032332|NCT00545064|54690757|FG000|Overall Study|cancel all appointments, no rebooking|1|||
28032333|NCT00545064|54690757|FG000|Overall Study|inclement weather|1|||
28032334|NCT00432562|54690765|FG000|Overall Study|Death|3|||
28032335|NCT00432562|54690766|FG001|Overall Study|Death|0|||
28032336|NCT00432172|54690776|FG000|Overall Study|Physician Decision|0|||
28032337|NCT00432172|54690777|FG001|Overall Study|Physician Decision|0|||
28032338|NCT00432172|54690778|FG002|Overall Study|Physician Decision|2|||
28032339|NCT00432172|54690779|FG003|Overall Study|Physician Decision|0|||
28032340|NCT00432172|54690776|FG000|Overall Study|Adverse Event|4|||
28032341|NCT00432172|54690777|FG001|Overall Study|Adverse Event|2|||
28032342|NCT00432172|54690778|FG002|Overall Study|Adverse Event|4|||
28032343|NCT00432172|54690779|FG003|Overall Study|Adverse Event|3|||
27844312|NCT01525628|54334111|FG000|Overall Study|Lack of Efficacy|0|||
28032344|NCT00432172|54690776|FG000|Overall Study|Disease progression|0|||
28032345|NCT00432172|54690777|FG001|Overall Study|Disease progression|2|||
28032346|NCT00432172|54690778|FG002|Overall Study|Disease progression|5|||
28032347|NCT00432172|54690779|FG003|Overall Study|Disease progression|1|||
28032348|NCT00432172|54690776|FG000|Overall Study|Withdrawal by Subject|0|||
28032349|NCT00432172|54690777|FG001|Overall Study|Withdrawal by Subject|1|||
28032350|NCT00432172|54690778|FG002|Overall Study|Withdrawal by Subject|0|||
28032351|NCT00432172|54690779|FG003|Overall Study|Withdrawal by Subject|2|||
28032352|NCT00432172|54690776|FG000|Overall Study|No treatment received|2|||
28032353|NCT00432172|54690777|FG001|Overall Study|No treatment received|2|||
28032354|NCT00432172|54690778|FG002|Overall Study|No treatment received|0|||
28032355|NCT00432172|54690779|FG003|Overall Study|No treatment received|1|||
28032356|NCT00415168|54690791|FG000|Overall Study|Death|26|||
28032357|NCT00415168|54690791|FG000|Overall Study|Lost to Follow-up|3|||
28032358|NCT00415168|54690791|FG000|Overall Study|Physician Decision|13|||
28032359|NCT00415168|54690791|FG000|Overall Study|Sponsor Decision|4|||
28032360|NCT00415168|54690791|FG000|Overall Study|Withdrawal by Subject|6|||
28032361|NCT00424762|54690797|FG000|Overall Study|Withdrawal by Subject|18|||
28032362|NCT00424762|54690798|FG001|Overall Study|Withdrawal by Subject|19|||
28032363|NCT00424762|54690797|FG000|Overall Study|Lost to Follow-up|2|||
28032364|NCT00424762|54690798|FG001|Overall Study|Lost to Follow-up|3|||
28032365|NCT00414544|54690804|FG000|Overall Study|Lost to Follow-up|14|||
28032366|NCT00414466|54690814|FG000|Overall Study|Adverse Event|0|||
28032367|NCT00414466|54690815|FG001|Overall Study|Adverse Event|0|||
28032368|NCT00414466|54690816|FG002|Overall Study|Adverse Event|1|||
28032369|NCT00414466|54690817|FG003|Overall Study|Adverse Event|1|||
28032370|NCT00414466|54690814|FG000|Overall Study|Lack of Efficacy|1|||
28032371|NCT00414466|54690815|FG001|Overall Study|Lack of Efficacy|0|||
28032372|NCT00414466|54690816|FG002|Overall Study|Lack of Efficacy|0|||
28032373|NCT00414466|54690817|FG003|Overall Study|Lack of Efficacy|0|||
28032374|NCT00414466|54690814|FG000|Overall Study|Withdrawn by Sponsor|1|||
28032375|NCT00414466|54690815|FG001|Overall Study|Withdrawn by Sponsor|0|||
28032376|NCT00414466|54690816|FG002|Overall Study|Withdrawn by Sponsor|0|||
28032377|NCT00414466|54690817|FG003|Overall Study|Withdrawn by Sponsor|0|||
28032378|NCT00424528|54690833|FG000|Overall Study|Adverse Event|2|||
28032379|NCT00424528|54690834|FG001|Overall Study|Adverse Event|1|||
28032380|NCT00424528|54690835|FG002|Overall Study|Adverse Event|2|||
28032381|NCT00424528|54690833|FG000|Overall Study|Protocol Violation|1|||
28032382|NCT00424528|54690834|FG001|Overall Study|Protocol Violation|1|||
28032383|NCT00424528|54690835|FG002|Overall Study|Protocol Violation|0|||
28032384|NCT00424528|54690833|FG000|Overall Study|Lost to Follow-up|0|||
28032385|NCT00424528|54690834|FG001|Overall Study|Lost to Follow-up|1|||
28032386|NCT00424528|54690835|FG002|Overall Study|Lost to Follow-up|0|||
28032387|NCT00424528|54690833|FG000|Overall Study|noncompliance with study requirements|2|||
28032388|NCT00424528|54690834|FG001|Overall Study|noncompliance with study requirements|1|||
28032389|NCT00424528|54690835|FG002|Overall Study|noncompliance with study requirements|2|||
28032390|NCT00545532|54690845|FG000|Overall Study|Withdrawal by Subject|1|||
28032391|NCT00545532|54690846|FG001|Overall Study|Withdrawal by Subject|3|||
28032392|NCT00545532|54690845|FG000|Overall Study|Lost to Follow-up|5|||
28032393|NCT00545532|54690846|FG001|Overall Study|Lost to Follow-up|6|||
28032394|NCT00545532|54690845|FG000|Overall Study|Death|0|||
28032395|NCT00545532|54690846|FG001|Overall Study|Death|1|||
28032396|NCT00544440|54690854|FG000|Overall Study|Other|1|||
28032397|NCT00544440|54690854|FG000|Overall Study|Adverse Event|1|||
28032398|NCT00544440|54690854|FG000|Overall Study|Withdrawal by Subject|2|||
28032399|NCT00544440|54690854|FG000|Overall Study|Subject Non-compliance|1|||
28032400|NCT00544440|54690854|FG000|Overall Study|Progressive Disease|47|||
28032401|NCT00544440|54690854|FG000|Overall Study|Other|5|||
28032402|NCT03920670|54690860|FG000|Overall Study|Protocol Violation|2|||
28032403|NCT03920670|54690861|FG001|Overall Study|Protocol Violation|2|||
28032404|NCT03920670|54690860|FG000|Overall Study|Adverse Event|1|||
28032405|NCT03920670|54690861|FG001|Overall Study|Adverse Event|0|||
28032406|NCT00430300|54690871|FG000|Overall Study|Adverse Event|0|||
28032407|NCT00430300|54690872|FG001|Overall Study|Adverse Event|2|||
28032408|NCT00430300|54690873|FG002|Overall Study|Adverse Event|1|||
28032409|NCT00430300|54690874|FG003|Overall Study|Adverse Event|1|||
28032410|NCT00430300|54690871|FG000|Overall Study|Withdrawal by Subject|1|||
28032411|NCT00430300|54690872|FG001|Overall Study|Withdrawal by Subject|0|||
28032412|NCT00430300|54690873|FG002|Overall Study|Withdrawal by Subject|5|||
28032413|NCT00430300|54690874|FG003|Overall Study|Withdrawal by Subject|0|||
28032414|NCT00430300|54690871|FG000|Overall Study|Laboratory abnormality|1|||
28032415|NCT00430300|54690872|FG001|Overall Study|Laboratory abnormality|0|||
28032416|NCT00430300|54690873|FG002|Overall Study|Laboratory abnormality|0|||
27844313|NCT01525628|54334112|FG001|Overall Study|Lack of Efficacy|2|||
27844314|NCT01525628|54334113|FG002|Overall Study|Lack of Efficacy|2|||
27844315|NCT01525628|54334114|FG003|Overall Study|Lack of Efficacy|1|||
27844316|NCT01525628|54334115|FG004|Overall Study|Lack of Efficacy|2|||
28032417|NCT00430300|54690874|FG003|Overall Study|Laboratory abnormality|0|||
28032418|NCT00430300|54690871|FG000|Overall Study|Other|0|||
28032419|NCT00430300|54690872|FG001|Overall Study|Other|0|||
28032420|NCT00430300|54690873|FG002|Overall Study|Other|0|||
28032421|NCT00430300|54690874|FG003|Overall Study|Other|1|||
28032422|NCT03927846|54690886|FG000|Overall Study|Lost to Follow-up|10|||
28032423|NCT03927846|54690887|FG001|Overall Study|Lost to Follow-up|11|||
28032424|NCT03927144|54690895|FG000|Overall Study|Adverse Event|9|||
28032425|NCT03927144|54690896|FG001|Overall Study|Adverse Event|5|||
28032426|NCT03927144|54690895|FG000|Overall Study|Lost to Follow-up|3|||
28032427|NCT03927144|54690896|FG001|Overall Study|Lost to Follow-up|2|||
28032428|NCT03927144|54690895|FG000|Overall Study|New Therapy for Study Indication|0|||
27844317|NCT01525628|54334111|FG000|Overall Study|Protocol Violation|0|||
28032429|NCT03927144|54690896|FG001|Overall Study|New Therapy for Study Indication|1|||
28032430|NCT03927144|54690895|FG000|Overall Study|No Longer Clinically Benefiting|4|||
28032431|NCT03927144|54690896|FG001|Overall Study|No Longer Clinically Benefiting|4|||
28032432|NCT03927144|54690895|FG000|Overall Study|Physician Decision|2|||
28032433|NCT03927144|54690896|FG001|Overall Study|Physician Decision|8|||
28032434|NCT03927144|54690895|FG000|Overall Study|Protocol Violation|2|||
28032435|NCT03927144|54690896|FG001|Overall Study|Protocol Violation|2|||
28032436|NCT03927144|54690895|FG000|Overall Study|Withdrawal by Subject|16|||
28032437|NCT03927144|54690896|FG001|Overall Study|Withdrawal by Subject|40|||
28032438|NCT00545298|54690905|FG000|Overall Study|Issues with Standard of Care|2|||
28032439|NCT00545298|54690906|FG001|Overall Study|Issues with Standard of Care|0|||
28032440|NCT00545298|54690907|FG002|Overall Study|Issues with Standard of Care|1|||
28032441|NCT00429364|54690920|FG000|Overall Study|Withdrawal by Subject|11|||
28032442|NCT00429364|54690921|FG001|Overall Study|Withdrawal by Subject|5|||
28032443|NCT00429364|54690920|FG000|Overall Study|Physician Decision|4|||
28032444|NCT00429364|54690921|FG001|Overall Study|Physician Decision|2|||
28032445|NCT00429364|54690920|FG000|Overall Study|Lost to Follow-up|7|||
28032446|NCT00429364|54690921|FG001|Overall Study|Lost to Follow-up|6|||
28032447|NCT00429364|54690920|FG000|Overall Study|Death|0|||
28032448|NCT00429364|54690921|FG001|Overall Study|Death|1|||
28032449|NCT00429364|54690920|FG000|Overall Study|Underwent aortic root surgery|10|||
28032450|NCT00429364|54690921|FG001|Overall Study|Underwent aortic root surgery|18|||
28032451|NCT00429364|54690920|FG000|Overall Study|Pregnancy|0|||
28032452|NCT00429364|54690921|FG001|Overall Study|Pregnancy|1|||
28032453|NCT00414388|54690927|FG000|Overall Study|Adverse Event|1|||
28032454|NCT03920280|54690934|FG000|Overall Study|Adverse Event|2|||
28032455|NCT03920280|54690935|FG001|Overall Study|Adverse Event|3|||
28032456|NCT03920280|54690934|FG000|Overall Study|Lost to Follow-up|0|||
28032457|NCT03920280|54690935|FG001|Overall Study|Lost to Follow-up|1|||
28032458|NCT03920280|54690934|FG000|Overall Study|Withdrawal by Subject|1|||
28032459|NCT03920280|54690935|FG001|Overall Study|Withdrawal by Subject|1|||
28032460|NCT03920280|54690934|FG000|Overall Study|Corneal cylinder greater than 1.00 diopter|0|||
28032461|NCT03920280|54690935|FG001|Overall Study|Corneal cylinder greater than 1.00 diopter|1|||
28032462|NCT00424372|54690944|FG000|Overall Study|Death|1|||
28032463|NCT00424372|54690944|FG000|Overall Study|Adverse Event|18|||
28032464|NCT00424372|54690944|FG000|Overall Study|Lack of Efficacy|6|||
28032465|NCT00424372|54690944|FG000|Overall Study|Withdrawal by Subject|4|||
28032466|NCT00424372|54690944|FG000|Overall Study|Protocol Violation|1|||
28032467|NCT00424372|54690944|FG000|Overall Study|Health deterioration|1|||
28032468|NCT00414310|54690950|FG000|Overall Study|Not treated|1|||
28032469|NCT00414310|54690951|FG001|Overall Study|Not treated|0|||
28032470|NCT00542880|54690961|FG000|Period 1|Eligibility criteria not fulfilled|2|||
28032471|NCT00542880|54690962|FG001|Period 1|Eligibility criteria not fulfilled|6|||
28032472|NCT00542880|54690961|FG000|Period 1|Adverse Event|2|||
28032473|NCT00542880|54690962|FG001|Period 1|Adverse Event|2|||
28032474|NCT00542880|54690961|FG000|Period 1|Development of study-specific criteria|1|||
28032475|NCT00542880|54690962|FG001|Period 1|Development of study-specific criteria|2|||
28032476|NCT00542880|54690961|FG000|Period 1|Withdrawal by Subject|1|||
28032477|NCT00542880|54690962|FG001|Period 1|Withdrawal by Subject|1|||
28032478|NCT00542880|54690961|FG000|Period 1|Protocol Violation|0|||
28032479|NCT00542880|54690962|FG001|Period 1|Protocol Violation|1|||
28032480|NCT00542880|54690961|FG000|Period 2|Adverse Event|5|||
28032481|NCT00542880|54690962|FG001|Period 2|Adverse Event|7|||
28032482|NCT00542880|54690961|FG000|Period 2|Eligibility not fulfilled|0|||
28032483|NCT00542880|54690962|FG001|Period 2|Eligibility not fulfilled|1|||
28032484|NCT00542880|54690961|FG000|Period 2|Discontinuation criteria|2|||
28032485|NCT00542880|54690962|FG001|Period 2|Discontinuation criteria|0|||
28032486|NCT00542880|54690961|FG000|Period 2|Severe non-compliance|0|||
28032487|NCT00542880|54690962|FG001|Period 2|Severe non-compliance|1|||
28032488|NCT00542880|54690961|FG000|Period 2|Other|0|||
28032489|NCT00542880|54690962|FG001|Period 2|Other|1|||
28032490|NCT00542880|54690961|FG000|Period 3|Adverse Event|0|||
28032491|NCT00542880|54690962|FG001|Period 3|Adverse Event|2|||
28032492|NCT00414076|54690971|FG000|Overall Study|Progression|1|||
28032493|NCT00414076|54690972|FG001|Overall Study|Progression|2|||
28032494|NCT00414076|54690971|FG000|Overall Study|Withdrawal by Subject|1|||
28032495|NCT00414076|54690972|FG001|Overall Study|Withdrawal by Subject|3|||
28032496|NCT00414076|54690971|FG000|Overall Study|Adverse Event|1|||
28032497|NCT00414076|54690972|FG001|Overall Study|Adverse Event|0|||
28032498|NCT00092677|54690980|FG000|Overall Study|Lost to Follow-up|0|||
28032499|NCT00092677|54690981|FG001|Overall Study|Lost to Follow-up|2|||
28032500|NCT00092677|54690980|FG000|Overall Study|Adminstrative|5|||
28032501|NCT00092677|54690981|FG001|Overall Study|Adminstrative|9|||
28032502|NCT00542178|54690993|FG000|Overall Study|did not complete year 4 follow-up|75|||
28032503|NCT00542178|54690994|FG001|Overall Study|did not complete year 4 follow-up|80|||
28032504|NCT00542178|54690995|FG002|Overall Study|did not complete year 4 follow-up|74|||
28032505|NCT00542178|54690996|FG003|Overall Study|did not complete year 4 follow-up|62|||
28032506|NCT00542178|54690997|FG004|Overall Study|did not complete year 4 follow-up|64|||
28032507|NCT00542178|54690998|FG005|Overall Study|did not complete year 4 follow-up|89|||
28032508|NCT00542178|54690999|FG006|Overall Study|did not complete year 4 follow-up|87|||
28032509|NCT00542178|54691000|FG007|Overall Study|did not complete year 4 follow-up|85|||
28032510|NCT00424294|54691016|FG000|Overall Study|Adverse Event|4|||
28032511|NCT00424294|54691017|FG001|Overall Study|Adverse Event|10|||
28032512|NCT00424294|54691016|FG000|Overall Study|Lack of Efficacy|2|||
28032513|NCT00424294|54691017|FG001|Overall Study|Lack of Efficacy|1|||
28032514|NCT00424294|54691016|FG000|Overall Study|Withdrawal by Subject|1|||
28032515|NCT00424294|54691017|FG001|Overall Study|Withdrawal by Subject|2|||
28032516|NCT00424294|54691016|FG000|Overall Study|Other|0|||
28032517|NCT00424294|54691017|FG001|Overall Study|Other|2|||
28032518|NCT00424294|54691016|FG000|Overall Study|Randomized but not Treated|1|||
28032519|NCT00424294|54691017|FG001|Overall Study|Randomized but not Treated|0|||
28032520|NCT00092521|54691026|FG000|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6|||
28032521|NCT00092521|54691027|FG001|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
28032522|NCT00092521|54691028|FG002|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7|||
28032523|NCT00092521|54691029|FG003|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
28032524|NCT00092521|54691026|FG000|Vaccination (Day 1 Through Month 7)|Adverse Event|1|||
28032525|NCT00092521|54691027|FG001|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
28032526|NCT00092521|54691028|FG002|Vaccination (Day 1 Through Month 7)|Adverse Event|7|||
28032527|NCT00092521|54691029|FG003|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
28032528|NCT00092521|54691026|FG000|Vaccination (Day 1 Through Month 7)|Death|0|||
28032529|NCT00092521|54691027|FG001|Vaccination (Day 1 Through Month 7)|Death|0|||
28032530|NCT00092521|54691028|FG002|Vaccination (Day 1 Through Month 7)|Death|1|||
28032531|NCT00092521|54691029|FG003|Vaccination (Day 1 Through Month 7)|Death|0|||
28032532|NCT00092521|54691026|FG000|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51|||
28032533|NCT00092521|54691027|FG001|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6|||
28032534|NCT00092521|54691028|FG002|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44|||
28032535|NCT00092521|54691029|FG003|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0|||
28032536|NCT00092521|54691026|FG000|Vaccination (Day 1 Through Month 7)|Pregnancy|5|||
28032537|NCT00092521|54691027|FG001|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
28032538|NCT00092521|54691028|FG002|Vaccination (Day 1 Through Month 7)|Pregnancy|7|||
28032539|NCT00092521|54691029|FG003|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
28032540|NCT00092521|54691026|FG000|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59|||
28032541|NCT00092521|54691027|FG001|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7|||
28032542|NCT00092521|54691028|FG002|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62|||
28032543|NCT00092521|54691029|FG003|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0|||
28032544|NCT00092521|54691026|FG000|Vaccination (Day 1 Through Month 7)|Moved|14|||
28032545|NCT00092521|54691027|FG001|Vaccination (Day 1 Through Month 7)|Moved|1|||
28032546|NCT00092521|54691028|FG002|Vaccination (Day 1 Through Month 7)|Moved|18|||
28032547|NCT00092521|54691029|FG003|Vaccination (Day 1 Through Month 7)|Moved|0|||
28032548|NCT00092521|54691026|FG000|Vaccination (Day 1 Through Month 7)|Unblinded|2|||
28032549|NCT00092521|54691027|FG001|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
28032550|NCT00092521|54691028|FG002|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
28032551|NCT00092521|54691029|FG003|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
28032552|NCT00092521|54691026|FG000|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2|||
28032553|NCT00092521|54691027|FG001|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
28032554|NCT00092521|54691028|FG002|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
28032555|NCT00092521|54691029|FG003|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
28032556|NCT00092521|54691026|FG000|Follow-Up (After Month 7)|Subjects Continuing|34|||
28032557|NCT00092521|54691027|FG001|Follow-Up (After Month 7)|Subjects Continuing|4|||
28032558|NCT00092521|54691028|FG002|Follow-Up (After Month 7)|Subjects Continuing|35|||
28032559|NCT00092521|54691029|FG003|Follow-Up (After Month 7)|Subjects Continuing|0|||
28032560|NCT00092521|54691026|FG000|Follow-Up (After Month 7)|Subjects in Extension|13|||
28032561|NCT00092521|54691027|FG001|Follow-Up (After Month 7)|Subjects in Extension|109|||
28032562|NCT00092521|54691028|FG002|Follow-Up (After Month 7)|Subjects in Extension|412|||
28032563|NCT00092521|54691029|FG003|Follow-Up (After Month 7)|Subjects in Extension|0|||
28032564|NCT00092521|54691026|FG000|Follow-Up (After Month 7)|Adverse Event|1|||
28032565|NCT00092521|54691027|FG001|Follow-Up (After Month 7)|Adverse Event|0|||
28032566|NCT00092521|54691028|FG002|Follow-Up (After Month 7)|Adverse Event|0|||
28032567|NCT00092521|54691029|FG003|Follow-Up (After Month 7)|Adverse Event|0|||
28032568|NCT00092521|54691026|FG000|Follow-Up (After Month 7)|Death|2|||
28032569|NCT00092521|54691027|FG001|Follow-Up (After Month 7)|Death|0|||
28032570|NCT00092521|54691028|FG002|Follow-Up (After Month 7)|Death|1|||
28032571|NCT00092521|54691029|FG003|Follow-Up (After Month 7)|Death|0|||
28032572|NCT00092521|54691026|FG000|Follow-Up (After Month 7)|Lost to Follow-up|113|||
28032573|NCT00092521|54691027|FG001|Follow-Up (After Month 7)|Lost to Follow-up|14|||
28032574|NCT00092521|54691028|FG002|Follow-Up (After Month 7)|Lost to Follow-up|108|||
28032575|NCT00092521|54691029|FG003|Follow-Up (After Month 7)|Lost to Follow-up|0|||
27844318|NCT01525628|54334112|FG001|Overall Study|Protocol Violation|0|||
28032576|NCT00092521|54691026|FG000|Follow-Up (After Month 7)|Protocol Violation|1|||
28032577|NCT00092521|54691027|FG001|Follow-Up (After Month 7)|Protocol Violation|1|||
28032578|NCT00092521|54691028|FG002|Follow-Up (After Month 7)|Protocol Violation|5|||
28032579|NCT00092521|54691029|FG003|Follow-Up (After Month 7)|Protocol Violation|0|||
28032580|NCT00092521|54691026|FG000|Follow-Up (After Month 7)|Withdrawal by Subject|40|||
28032581|NCT00092521|54691027|FG001|Follow-Up (After Month 7)|Withdrawal by Subject|6|||
28032582|NCT00092521|54691028|FG002|Follow-Up (After Month 7)|Withdrawal by Subject|51|||
28032583|NCT00092521|54691029|FG003|Follow-Up (After Month 7)|Withdrawal by Subject|0|||
28032584|NCT00092521|54691026|FG000|Follow-Up (After Month 7)|Moved|32|||
28032585|NCT00092521|54691027|FG001|Follow-Up (After Month 7)|Moved|2|||
28032586|NCT00092521|54691028|FG002|Follow-Up (After Month 7)|Moved|28|||
28032587|NCT00092521|54691029|FG003|Follow-Up (After Month 7)|Moved|0|||
28032588|NCT00092521|54691026|FG000|Follow-Up (After Month 7)|Site Terminated|3|||
28032589|NCT00092521|54691027|FG001|Follow-Up (After Month 7)|Site Terminated|0|||
28032590|NCT00092521|54691028|FG002|Follow-Up (After Month 7)|Site Terminated|3|||
28032591|NCT00092521|54691029|FG003|Follow-Up (After Month 7)|Site Terminated|0|||
28032592|NCT00092521|54691026|FG000|Follow-Up (After Month 7)|Travel|2|||
28032593|NCT00092521|54691027|FG001|Follow-Up (After Month 7)|Travel|0|||
28032594|NCT00092521|54691028|FG002|Follow-Up (After Month 7)|Travel|0|||
28032595|NCT00092521|54691029|FG003|Follow-Up (After Month 7)|Travel|0|||
28032596|NCT00092521|54691026|FG000|Follow-Up (After Month 7)|Visits Compressed|5|||
28032597|NCT00092521|54691027|FG001|Follow-Up (After Month 7)|Visits Compressed|0|||
28032598|NCT00092521|54691028|FG002|Follow-Up (After Month 7)|Visits Compressed|5|||
28032599|NCT00092521|54691029|FG003|Follow-Up (After Month 7)|Visits Compressed|0|||
28032600|NCT00092521|54691026|FG000|Extension Study (Group 4)|Excluded ineligible for extension|0|||
28032601|NCT00092521|54691027|FG001|Extension Study (Group 4)|Excluded ineligible for extension|0|||
27807451|NCT01953692|54262820|FG001|Overall Study|Withdrawal by Subject|2|||
27807452|NCT01953692|54262821|FG002|Overall Study|Withdrawal by Subject|1|||
27807453|NCT01953692|54262822|FG003|Overall Study|Withdrawal by Subject|2|||
27807454|NCT01953692|54262823|FG004|Overall Study|Withdrawal by Subject|0|||
27807455|NCT01953692|54262824|FG005|Overall Study|Withdrawal by Subject|3|||
27807456|NCT01953692|54262825|FG006|Overall Study|Withdrawal by Subject|2|||
27807457|NCT01953692|54262826|FG007|Overall Study|Withdrawal by Subject|1|||
28032602|NCT00092521|54691028|FG002|Extension Study (Group 4)|Excluded ineligible for extension|0|||
28032603|NCT00092521|54691029|FG003|Extension Study (Group 4)|Excluded ineligible for extension|23|||
28032604|NCT00092521|54691026|FG000|Extension Study (Group 4)|Adverse Event|0|||
28032605|NCT00092521|54691027|FG001|Extension Study (Group 4)|Adverse Event|0|||
28032606|NCT00092521|54691028|FG002|Extension Study (Group 4)|Adverse Event|0|||
28032607|NCT00092521|54691029|FG003|Extension Study (Group 4)|Adverse Event|2|||
28032608|NCT00092521|54691026|FG000|Extension Study (Group 4)|Lost to Follow-up|0|||
28032609|NCT00092521|54691027|FG001|Extension Study (Group 4)|Lost to Follow-up|0|||
28032610|NCT00092521|54691028|FG002|Extension Study (Group 4)|Lost to Follow-up|0|||
28032611|NCT00092521|54691029|FG003|Extension Study (Group 4)|Lost to Follow-up|87|||
28032612|NCT00092521|54691026|FG000|Extension Study (Group 4)|Pregnancy|0|||
28032613|NCT00092521|54691027|FG001|Extension Study (Group 4)|Pregnancy|0|||
28032614|NCT00092521|54691028|FG002|Extension Study (Group 4)|Pregnancy|0|||
28032615|NCT00092521|54691029|FG003|Extension Study (Group 4)|Pregnancy|4|||
28032616|NCT00092521|54691026|FG000|Extension Study (Group 4)|Protocol Violation|0|||
27844319|NCT01525628|54334113|FG002|Overall Study|Protocol Violation|1|||
27844320|NCT01525628|54334114|FG003|Overall Study|Protocol Violation|0|||
27844321|NCT01525628|54334115|FG004|Overall Study|Protocol Violation|0|||
27844322|NCT01525628|54334111|FG000|Overall Study|Lost to Follow-up|1|||
27844323|NCT01525628|54334112|FG001|Overall Study|Lost to Follow-up|1|||
27844324|NCT01525628|54334113|FG002|Overall Study|Lost to Follow-up|0|||
27844325|NCT01525628|54334114|FG003|Overall Study|Lost to Follow-up|0|||
27844326|NCT01525628|54334115|FG004|Overall Study|Lost to Follow-up|0|||
28032617|NCT00092521|54691027|FG001|Extension Study (Group 4)|Protocol Violation|0|||
27807458|NCT01953692|54262827|FG008|Overall Study|Withdrawal by Subject|1|||
28032618|NCT00092521|54691028|FG002|Extension Study (Group 4)|Protocol Violation|0|||
28032619|NCT00092521|54691029|FG003|Extension Study (Group 4)|Protocol Violation|2|||
27807459|NCT01791153|54262861|FG000|Part 1: Blinded Period|Adverse Event|7|||
27807460|NCT01791153|54262862|FG001|Part 1: Blinded Period|Adverse Event|3|||
27807461|NCT01791153|54262863|FG002|Part 1: Blinded Period|Adverse Event|2|||
28032620|NCT00092521|54691026|FG000|Extension Study (Group 4)|Withdrawal by Subject|0|||
28032621|NCT00092521|54691027|FG001|Extension Study (Group 4)|Withdrawal by Subject|0|||
27807462|NCT01791153|54262864|FG003|Part 1: Blinded Period|Adverse Event|0|||
28032622|NCT00092521|54691028|FG002|Extension Study (Group 4)|Withdrawal by Subject|0|||
27844327|NCT01525628|54334111|FG000|Overall Study|Withdrawal by Subject|0|||
27807463|NCT01791153|54262865|FG004|Part 1: Blinded Period|Adverse Event|0|||
27807464|NCT01791153|54262866|FG005|Part 1: Blinded Period|Adverse Event|0|||
27807465|NCT01791153|54262867|FG006|Part 1: Blinded Period|Adverse Event|0|||
27807466|NCT01791153|54262868|FG007|Part 1: Blinded Period|Adverse Event|0|||
27844328|NCT01525628|54334112|FG001|Overall Study|Withdrawal by Subject|1|||
27807467|NCT01791153|54262861|FG000|Part 1: Blinded Period|Lack of Efficacy|1|||
27807468|NCT01791153|54262862|FG001|Part 1: Blinded Period|Lack of Efficacy|3|||
27807469|NCT01791153|54262863|FG002|Part 1: Blinded Period|Lack of Efficacy|2|||
27807470|NCT01791153|54262864|FG003|Part 1: Blinded Period|Lack of Efficacy|2|||
27807471|NCT01791153|54262865|FG004|Part 1: Blinded Period|Lack of Efficacy|0|||
27807472|NCT01791153|54262866|FG005|Part 1: Blinded Period|Lack of Efficacy|0|||
27807473|NCT01791153|54262867|FG006|Part 1: Blinded Period|Lack of Efficacy|0|||
27807474|NCT01791153|54262868|FG007|Part 1: Blinded Period|Lack of Efficacy|0|||
27807475|NCT01791153|54262861|FG000|Part 1: Blinded Period|Non-Compliance|1|||
27807476|NCT01791153|54262862|FG001|Part 1: Blinded Period|Non-Compliance|0|||
28032623|NCT00092521|54691029|FG003|Extension Study (Group 4)|Withdrawal by Subject|46|||
28032624|NCT00092521|54691026|FG000|Extension Study (Group 4)|Moved|0|||
28032625|NCT00092521|54691027|FG001|Extension Study (Group 4)|Moved|0|||
27807477|NCT01791153|54262863|FG002|Part 1: Blinded Period|Non-Compliance|0|||
28032626|NCT00092521|54691028|FG002|Extension Study (Group 4)|Moved|0|||
28032627|NCT00092521|54691029|FG003|Extension Study (Group 4)|Moved|16|||
28032628|NCT00092521|54691026|FG000|Extension Study (Group 4)|Site Terminated|0|||
28032629|NCT00092521|54691027|FG001|Extension Study (Group 4)|Site Terminated|0|||
28032630|NCT00092521|54691028|FG002|Extension Study (Group 4)|Site Terminated|0|||
28032631|NCT00092521|54691029|FG003|Extension Study (Group 4)|Site Terminated|4|||
28032632|NCT00092521|54691026|FG000|Extension Study (Group 4)|Unable/unwilling to return|0|||
28032633|NCT00092521|54691027|FG001|Extension Study (Group 4)|Unable/unwilling to return|0|||
28032634|NCT00092521|54691028|FG002|Extension Study (Group 4)|Unable/unwilling to return|0|||
27844329|NCT01525628|54334113|FG002|Overall Study|Withdrawal by Subject|0|||
27844330|NCT01525628|54334114|FG003|Overall Study|Withdrawal by Subject|0|||
27844331|NCT01525628|54334115|FG004|Overall Study|Withdrawal by Subject|0|||
27844332|NCT01525628|54334111|FG000|Overall Study|Other reason not defined above|0|||
27844333|NCT01525628|54334112|FG001|Overall Study|Other reason not defined above|0|||
27844334|NCT01525628|54334113|FG002|Overall Study|Other reason not defined above|0|||
28032635|NCT00092521|54691029|FG003|Extension Study (Group 4)|Unable/unwilling to return|25|||
28032636|NCT03908970|54691039|FG000|Overall Study|Adverse Event|7|||
28032637|NCT03908970|54691040|FG001|Overall Study|Adverse Event|21|||
28032638|NCT03908970|54691039|FG000|Overall Study|Physician Decision|1|||
28032639|NCT03908970|54691040|FG001|Overall Study|Physician Decision|4|||
28032640|NCT03908970|54691039|FG000|Overall Study|Withdrawal by Subject|9|||
27844335|NCT01525628|54334114|FG003|Overall Study|Other reason not defined above|3|||
27844336|NCT01525628|54334115|FG004|Overall Study|Other reason not defined above|0|||
27844337|NCT01412021|54334133|FG000|Overall Study|Case Report Forms Not Retrieved|7|||
27844338|NCT01412021|54334133|FG000|Overall Study|Treatment Prior to Approval|3|||
28032641|NCT03908970|54691040|FG001|Overall Study|Withdrawal by Subject|22|||
28032642|NCT00092443|54691048|FG000|Overall Study|Adverse Event|9|||
28032643|NCT00092443|54691049|FG001|Overall Study|Adverse Event|13|||
28032644|NCT00092443|54691048|FG000|Overall Study|Lost to Follow-up|7|||
28032645|NCT00092443|54691049|FG001|Overall Study|Lost to Follow-up|3|||
28032646|NCT00092443|54691048|FG000|Overall Study|Protocol Violation|11|||
27844339|NCT01412021|54334133|FG000|Overall Study|Transferred to Other Hospital|9|||
27844340|NCT01426789|54334139|FG000|Part 1|Protocol deviation|0|||
28032647|NCT00092443|54691049|FG001|Overall Study|Protocol Violation|9|||
28032648|NCT00092443|54691048|FG000|Overall Study|Withdrawal by Subject|9|||
28032649|NCT00092443|54691049|FG001|Overall Study|Withdrawal by Subject|11|||
28032650|NCT00092443|54691048|FG000|Overall Study|Moved|5|||
27807478|NCT01791153|54262864|FG003|Part 1: Blinded Period|Non-Compliance|0|||
27844341|NCT01426789|54334140|FG001|Part 1|Protocol deviation|1|||
27807479|NCT01791153|54262865|FG004|Part 1: Blinded Period|Non-Compliance|0|||
27807480|NCT01791153|54262866|FG005|Part 1: Blinded Period|Non-Compliance|0|||
27807481|NCT01791153|54262867|FG006|Part 1: Blinded Period|Non-Compliance|0|||
27807482|NCT01791153|54262868|FG007|Part 1: Blinded Period|Non-Compliance|0|||
27807483|NCT01791153|54262861|FG000|Part 1: Blinded Period|Physician Decision|0|||
27807484|NCT01791153|54262862|FG001|Part 1: Blinded Period|Physician Decision|0|||
27844342|NCT01426789|54334141|FG002|Part 1|Protocol deviation|0|||
27844343|NCT01426789|54334142|FG003|Part 1|Protocol deviation|0|||
27844344|NCT01426789|54334143|FG004|Part 1|Protocol deviation|0|||
28032651|NCT00092443|54691049|FG001|Overall Study|Moved|5|||
28032652|NCT00092443|54691048|FG000|Overall Study|Other|17|||
28032653|NCT00092443|54691049|FG001|Overall Study|Other|13|||
27844345|NCT01426789|54334144|FG005|Part 1|Protocol deviation|0|||
27844346|NCT01426789|54334139|FG000|Part 1|Lost to Follow-up|1|||
27844347|NCT01426789|54334140|FG001|Part 1|Lost to Follow-up|2|||
27844348|NCT01426789|54334141|FG002|Part 1|Lost to Follow-up|0|||
28032654|NCT00413920|54691067|FG000|Overall Study|Adverse Event|9|||
28032655|NCT00413920|54691068|FG001|Overall Study|Adverse Event|11|||
27807485|NCT01791153|54262863|FG002|Part 1: Blinded Period|Physician Decision|0|||
27807486|NCT01791153|54262864|FG003|Part 1: Blinded Period|Physician Decision|1|||
27807487|NCT01791153|54262865|FG004|Part 1: Blinded Period|Physician Decision|0|||
27844349|NCT01426789|54334142|FG003|Part 1|Lost to Follow-up|0|||
28032656|NCT00413920|54691067|FG000|Overall Study|Lack of Efficacy|11|||
28032657|NCT00413920|54691068|FG001|Overall Study|Lack of Efficacy|9|||
28032658|NCT00413920|54691067|FG000|Overall Study|Death|3|||
27844350|NCT01426789|54334143|FG004|Part 1|Lost to Follow-up|0|||
27844351|NCT01426789|54334144|FG005|Part 1|Lost to Follow-up|0|||
27844352|NCT01426789|54334139|FG000|Part 1|Lack of Efficacy|2|||
27844353|NCT01426789|54334140|FG001|Part 1|Lack of Efficacy|1|||
27844354|NCT01426789|54334141|FG002|Part 1|Lack of Efficacy|0|||
27844355|NCT01426789|54334142|FG003|Part 1|Lack of Efficacy|0|||
27844356|NCT01426789|54334143|FG004|Part 1|Lack of Efficacy|0|||
27844357|NCT01426789|54334144|FG005|Part 1|Lack of Efficacy|0|||
27844358|NCT01426789|54334139|FG000|Part 1|Adverse Event|3|||
28032659|NCT00413920|54691068|FG001|Overall Study|Death|5|||
28032660|NCT00413920|54691067|FG000|Overall Study|Graft Loss|5|||
28032661|NCT00413920|54691068|FG001|Overall Study|Graft Loss|3|||
28032662|NCT00091819|54691076|FG000|Overall Study|Adverse Event|1|||
28032663|NCT00091819|54691077|FG001|Overall Study|Adverse Event|1|||
28032664|NCT00091819|54691076|FG000|Overall Study|Death|4|||
28032665|NCT00091819|54691077|FG001|Overall Study|Death|5|||
28032666|NCT00091819|54691076|FG000|Overall Study|Lost to Follow-up|26|||
28032667|NCT00091819|54691077|FG001|Overall Study|Lost to Follow-up|23|||
28032668|NCT00091819|54691076|FG000|Overall Study|Withdrawal by Subject|5|||
28032669|NCT00091819|54691077|FG001|Overall Study|Withdrawal by Subject|8|||
28032670|NCT00091819|54691076|FG000|Overall Study|Protocol Violation|1|||
28032671|NCT00091819|54691077|FG001|Overall Study|Protocol Violation|2|||
28032672|NCT00091819|54691076|FG000|Overall Study|Other|2|||
28032673|NCT00091819|54691077|FG001|Overall Study|Other|3|||
28032674|NCT00091819|54691076|FG000|Overall Study|Never received study treatment|3|||
28032675|NCT00091819|54691077|FG001|Overall Study|Never received study treatment|4|||
28032676|NCT00540228|54691088|FG000|Overall Study|Adverse Event|2|||
28032677|NCT00540228|54691089|FG001|Overall Study|Adverse Event|0|||
28032678|NCT00540228|54691090|FG002|Overall Study|Adverse Event|0|||
28032679|NCT00540228|54691091|FG003|Overall Study|Adverse Event|0|||
28032680|NCT00540228|54691092|FG004|Overall Study|Adverse Event|0|||
28032681|NCT00540228|54691088|FG000|Overall Study|Lost to Follow-up|1|||
27807488|NCT01791153|54262866|FG005|Part 1: Blinded Period|Physician Decision|0|||
28032682|NCT00540228|54691089|FG001|Overall Study|Lost to Follow-up|1|||
28032683|NCT00540228|54691090|FG002|Overall Study|Lost to Follow-up|0|||
27807489|NCT01791153|54262867|FG006|Part 1: Blinded Period|Physician Decision|0|||
28032684|NCT00540228|54691091|FG003|Overall Study|Lost to Follow-up|0|||
28032685|NCT00540228|54691092|FG004|Overall Study|Lost to Follow-up|0|||
28032686|NCT05013385|54691117|FG000|Overall Study|Sponsor's decision to terminate the trial|5|||
28032687|NCT04250636|54691140|FG000|Overall Study|Lost to Follow-up|2|||
28032688|NCT03989115|54691152|FG000|Overall Study|Withdrawal by Subject|2|||
28032689|NCT03989115|54691153|FG001|Overall Study|Withdrawal by Subject|1|||
28032690|NCT03989115|54691154|FG002|Overall Study|Withdrawal by Subject|3|||
28032691|NCT03989115|54691155|FG003|Overall Study|Withdrawal by Subject|0|||
28032692|NCT03989115|54691156|FG004|Overall Study|Withdrawal by Subject|17|||
28032693|NCT03989115|54691157|FG005|Overall Study|Withdrawal by Subject|1|||
28032694|NCT03989115|54691158|FG006|Overall Study|Withdrawal by Subject|0|||
28032695|NCT03989115|54691159|FG007|Overall Study|Withdrawal by Subject|0|||
28032696|NCT03989115|54691152|FG000|Overall Study|Sponsor decision to terminate the study|1|||
28032697|NCT03989115|54691153|FG001|Overall Study|Sponsor decision to terminate the study|1|||
28032698|NCT03989115|54691154|FG002|Overall Study|Sponsor decision to terminate the study|0|||
28032699|NCT03989115|54691155|FG003|Overall Study|Sponsor decision to terminate the study|1|||
28032700|NCT03989115|54691156|FG004|Overall Study|Sponsor decision to terminate the study|11|||
28032701|NCT03989115|54691157|FG005|Overall Study|Sponsor decision to terminate the study|0|||
28032702|NCT03989115|54691158|FG006|Overall Study|Sponsor decision to terminate the study|2|||
28032703|NCT03989115|54691159|FG007|Overall Study|Sponsor decision to terminate the study|1|||
27807490|NCT01791153|54262868|FG007|Part 1: Blinded Period|Physician Decision|0|||
27807491|NCT01791153|54262861|FG000|Part 1: Blinded Period|Protocol Violation|0|||
27807492|NCT01791153|54262862|FG001|Part 1: Blinded Period|Protocol Violation|0|||
27807493|NCT01791153|54262863|FG002|Part 1: Blinded Period|Protocol Violation|0|||
27807494|NCT01791153|54262864|FG003|Part 1: Blinded Period|Protocol Violation|1|||
27844359|NCT01426789|54334140|FG001|Part 1|Adverse Event|0|||
27844360|NCT01426789|54334141|FG002|Part 1|Adverse Event|0|||
27844361|NCT01426789|54334142|FG003|Part 1|Adverse Event|0|||
27844362|NCT01426789|54334143|FG004|Part 1|Adverse Event|0|||
27844363|NCT01426789|54334144|FG005|Part 1|Adverse Event|0|||
27939771|NCT01229150|54596095|FG001|Overall Study|Toxicity|2|||
28032704|NCT03989115|54691152|FG000|Overall Study|Lost to Follow-up|2|||
28032705|NCT03989115|54691153|FG001|Overall Study|Lost to Follow-up|0|||
28032706|NCT03989115|54691154|FG002|Overall Study|Lost to Follow-up|0|||
28032707|NCT03989115|54691155|FG003|Overall Study|Lost to Follow-up|0|||
28032708|NCT03989115|54691156|FG004|Overall Study|Lost to Follow-up|1|||
28032709|NCT03989115|54691157|FG005|Overall Study|Lost to Follow-up|0|||
27807495|NCT01791153|54262865|FG004|Part 1: Blinded Period|Protocol Violation|0|||
27807496|NCT01791153|54262866|FG005|Part 1: Blinded Period|Protocol Violation|0|||
27844364|NCT01426789|54334139|FG000|Part 2|Protocol deviation|0|||
27844365|NCT01426789|54334140|FG001|Part 2|Protocol deviation|0|||
27844366|NCT01426789|54334141|FG002|Part 2|Protocol deviation|1|||
27844367|NCT01426789|54334142|FG003|Part 2|Protocol deviation|0|||
28032710|NCT03989115|54691158|FG006|Overall Study|Lost to Follow-up|0|||
28032711|NCT03989115|54691159|FG007|Overall Study|Lost to Follow-up|0|||
28032712|NCT03989115|54691152|FG000|Overall Study|Death|2|||
28032713|NCT03989115|54691153|FG001|Overall Study|Death|2|||
28032714|NCT03989115|54691154|FG002|Overall Study|Death|9|||
28032715|NCT03989115|54691155|FG003|Overall Study|Death|6|||
28032716|NCT03989115|54691156|FG004|Overall Study|Death|31|||
28032717|NCT03989115|54691157|FG005|Overall Study|Death|6|||
28032718|NCT03989115|54691158|FG006|Overall Study|Death|2|||
28032719|NCT03989115|54691159|FG007|Overall Study|Death|3|||
28032720|NCT03989115|54691152|FG000|Overall Study|Other|1|||
28032721|NCT03989115|54691153|FG001|Overall Study|Other|2|||
28032722|NCT03989115|54691154|FG002|Overall Study|Other|0|||
28032723|NCT03989115|54691155|FG003|Overall Study|Other|0|||
28032724|NCT03989115|54691156|FG004|Overall Study|Other|5|||
28032725|NCT03989115|54691157|FG005|Overall Study|Other|0|||
28032726|NCT03989115|54691158|FG006|Overall Study|Other|0|||
28032727|NCT03989115|54691159|FG007|Overall Study|Other|0|||
28032728|NCT03797898|54691188|FG000|Overall Study|Lost to Follow-up|60|||
28032729|NCT03797898|54691189|FG001|Overall Study|Lost to Follow-up|69|||
28032730|NCT03797898|54691188|FG000|Overall Study|Withdrawal by Subject|9|||
27807497|NCT01791153|54262867|FG006|Part 1: Blinded Period|Protocol Violation|0|||
27807498|NCT01791153|54262868|FG007|Part 1: Blinded Period|Protocol Violation|0|||
28032731|NCT03797898|54691189|FG001|Overall Study|Withdrawal by Subject|7|||
28032732|NCT03797898|54691188|FG000|Overall Study|Became ineligible|5|||
28032733|NCT03797898|54691189|FG001|Overall Study|Became ineligible|2|||
28032734|NCT03559192|54691220|FG000|Lead-in Period (3 Weeks)|Protocol Violation|1|||
28032735|NCT03559192|54691221|FG001|Lead-in Period (3 Weeks)|Protocol Violation|0|||
28032736|NCT03559192|54691222|FG002|Lead-in Period (3 Weeks)|Protocol Violation|0|||
28032737|NCT03559192|54691220|FG000|Lead-in Period (3 Weeks)|Withdrawal by Subject|6|||
28032738|NCT03559192|54691221|FG001|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
28032739|NCT03559192|54691222|FG002|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
28032740|NCT03559192|54691220|FG000|Lead-in Period (3 Weeks)|Adverse Event|5|||
28032741|NCT03559192|54691221|FG001|Lead-in Period (3 Weeks)|Adverse Event|0|||
28032742|NCT03559192|54691222|FG002|Lead-in Period (3 Weeks)|Adverse Event|0|||
28032743|NCT03559192|54691220|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
28032744|NCT03559192|54691221|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
28032745|NCT03559192|54691222|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|1|||
28032746|NCT03559192|54691220|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
28032747|NCT03559192|54691221|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|1|||
28032748|NCT03559192|54691222|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
28032749|NCT03559192|54691220|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
28032750|NCT03559192|54691221|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
28032751|NCT03559192|54691222|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|2|||
28032752|NCT03559192|54691220|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|0|||
28032753|NCT03559192|54691221|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
28032754|NCT03559192|54691222|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
28032755|NCT03559192|54691220|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
28032756|NCT03559192|54691221|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
28032757|NCT03559192|54691222|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|1|||
28032758|NCT03559192|54691220|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|0|||
28032759|NCT03559192|54691221|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
28032760|NCT03559192|54691222|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
28032761|NCT03523585|54691233|FG000|Overall Study|Progressive Disease|174|||
28032762|NCT03523585|54691234|FG001|Overall Study|Progressive Disease|64|||
28032763|NCT03523585|54691235|FG002|Overall Study|Progressive Disease|77|||
28032764|NCT03523585|54691233|FG000|Overall Study|Adverse Event|74|||
28032765|NCT03523585|54691234|FG001|Overall Study|Adverse Event|5|||
28032766|NCT03523585|54691235|FG002|Overall Study|Adverse Event|9|||
28032767|NCT03523585|54691233|FG000|Overall Study|Withdrawal by Subject|30|||
28032768|NCT03523585|54691234|FG001|Overall Study|Withdrawal by Subject|11|||
28032769|NCT03523585|54691235|FG002|Overall Study|Withdrawal by Subject|6|||
28032770|NCT03523585|54691233|FG000|Overall Study|Clinical Progression|23|||
28032771|NCT03523585|54691234|FG001|Overall Study|Clinical Progression|5|||
28032772|NCT03523585|54691235|FG002|Overall Study|Clinical Progression|10|||
28032773|NCT03523585|54691233|FG000|Overall Study|Death|4|||
28032774|NCT03523585|54691234|FG001|Overall Study|Death|0|||
28032775|NCT03523585|54691235|FG002|Overall Study|Death|1|||
28032776|NCT03523585|54691233|FG000|Overall Study|Physician Decision|2|||
28032777|NCT03523585|54691234|FG001|Overall Study|Physician Decision|1|||
28032778|NCT03523585|54691235|FG002|Overall Study|Physician Decision|0|||
28032779|NCT03523585|54691233|FG000|Overall Study|Lost to Follow-up|1|||
27807499|NCT01791153|54262861|FG000|Part 1: Blinded Period|Withdrawal by Subject|6|||
28032780|NCT03523585|54691234|FG001|Overall Study|Lost to Follow-up|0|||
28032781|NCT03523585|54691235|FG002|Overall Study|Lost to Follow-up|0|||
28032782|NCT03523585|54691233|FG000|Overall Study|Miscellaneous|1|||
28032783|NCT03523585|54691234|FG001|Overall Study|Miscellaneous|0|||
28032784|NCT03523585|54691235|FG002|Overall Study|Miscellaneous|0|||
28032785|NCT03523585|54691233|FG000|Overall Study|Protocol Deviation|1|||
28032786|NCT03523585|54691234|FG001|Overall Study|Protocol Deviation|0|||
28032787|NCT03523585|54691235|FG002|Overall Study|Protocol Deviation|1|||
28032788|NCT03523585|54691233|FG000|Overall Study|Randomized But Not Treated|2|||
28032789|NCT03523585|54691234|FG001|Overall Study|Randomized But Not Treated|4|||
28032790|NCT03523585|54691235|FG002|Overall Study|Randomized But Not Treated|3|||
28032791|NCT03485911|54691245|FG000|Part 1|Perceived lack of efficacy|1|||
28032792|NCT03485911|54691246|FG001|Part 1|Perceived lack of efficacy|1|||
28032793|NCT03485911|54691247|FG002|Part 1|Perceived lack of efficacy|2|||
28032794|NCT03485911|54691248|FG003|Part 1|Perceived lack of efficacy|0|||
28032795|NCT03485911|54691245|FG000|Part 1|Subject withdrew consent|0|||
28032796|NCT03485911|54691246|FG001|Part 1|Subject withdrew consent|1|||
28032797|NCT03485911|54691247|FG002|Part 1|Subject withdrew consent|0|||
28032798|NCT03485911|54691248|FG003|Part 1|Subject withdrew consent|1|||
28032799|NCT03485911|54691245|FG000|Part 1|Lab abnormalities/AEs|3|||
28032800|NCT03485911|54691246|FG001|Part 1|Lab abnormalities/AEs|1|||
28032801|NCT03485911|54691247|FG002|Part 1|Lab abnormalities/AEs|1|||
28032802|NCT03485911|54691248|FG003|Part 1|Lab abnormalities/AEs|0|||
28032803|NCT03485911|54691245|FG000|Part 1|Withdrew Consent prior to dosing|0|||
28032804|NCT03485911|54691246|FG001|Part 1|Withdrew Consent prior to dosing|0|||
28032805|NCT03485911|54691247|FG002|Part 1|Withdrew Consent prior to dosing|0|||
28032806|NCT03485911|54691248|FG003|Part 1|Withdrew Consent prior to dosing|1|||
28032807|NCT03485911|54691245|FG000|Part 1|Other NOS|0|||
28032808|NCT03485911|54691246|FG001|Part 1|Other NOS|0|||
28032809|NCT03485911|54691247|FG002|Part 1|Other NOS|0|||
28032810|NCT03485911|54691248|FG003|Part 1|Other NOS|1|||
28032811|NCT03485911|54691245|FG000|Part 2|Perceived lack of efficacy|5|||
28032812|NCT03485911|54691246|FG001|Part 2|Perceived lack of efficacy|3|||
28032813|NCT03485911|54691247|FG002|Part 2|Perceived lack of efficacy|0|||
27844368|NCT01426789|54334143|FG004|Part 2|Protocol deviation|0|||
27844369|NCT01426789|54334144|FG005|Part 2|Protocol deviation|0|||
28032814|NCT03485911|54691248|FG003|Part 2|Perceived lack of efficacy|2|||
28032815|NCT03485911|54691245|FG000|Part 2|Subject withdrew consent|1|||
27844370|NCT01426789|54334139|FG000|Part 2|Death|0|||
27844371|NCT01426789|54334140|FG001|Part 2|Death|0|||
27844372|NCT01426789|54334141|FG002|Part 2|Death|1|||
28032816|NCT03485911|54691246|FG001|Part 2|Subject withdrew consent|0|||
28032817|NCT03485911|54691247|FG002|Part 2|Subject withdrew consent|2|||
28032818|NCT03485911|54691248|FG003|Part 2|Subject withdrew consent|1|||
28032819|NCT03485911|54691245|FG000|Part 2|Lab abnormalities/AEs|1|||
28032820|NCT03485911|54691246|FG001|Part 2|Lab abnormalities/AEs|2|||
28032821|NCT03485911|54691247|FG002|Part 2|Lab abnormalities/AEs|0|||
28032822|NCT03485911|54691248|FG003|Part 2|Lab abnormalities/AEs|0|||
28032823|NCT03485911|54691245|FG000|Part 2|Other NOS|0|||
28032824|NCT03485911|54691246|FG001|Part 2|Other NOS|1|||
28032825|NCT03485911|54691247|FG002|Part 2|Other NOS|0|||
28032826|NCT03485911|54691248|FG003|Part 2|Other NOS|0|||
28032827|NCT03485911|54691245|FG000|Part 2|Intercurrent illness/new medical condition|1|||
28032828|NCT03485911|54691246|FG001|Part 2|Intercurrent illness/new medical condition|0|||
28032829|NCT03485911|54691247|FG002|Part 2|Intercurrent illness/new medical condition|0|||
28032830|NCT03485911|54691248|FG003|Part 2|Intercurrent illness/new medical condition|0|||
28032831|NCT03485911|54691245|FG000|Part 2|Investigator judgement|1|||
28032832|NCT03485911|54691246|FG001|Part 2|Investigator judgement|0|||
28032833|NCT03485911|54691247|FG002|Part 2|Investigator judgement|0|||
28032834|NCT03485911|54691248|FG003|Part 2|Investigator judgement|0|||
28032835|NCT03485911|54691245|FG000|Part 3|Perceived lack of efficacy|2|||
27844373|NCT01426789|54334142|FG003|Part 2|Death|0|||
28032836|NCT03485911|54691246|FG001|Part 3|Perceived lack of efficacy|2|||
28032837|NCT03485911|54691247|FG002|Part 3|Perceived lack of efficacy|2|||
28032838|NCT03485911|54691248|FG003|Part 3|Perceived lack of efficacy|0|||
28032839|NCT03485911|54691245|FG000|Part 3|Subject withdrew consent|1|||
28032840|NCT03485911|54691246|FG001|Part 3|Subject withdrew consent|4|||
28032841|NCT03485911|54691247|FG002|Part 3|Subject withdrew consent|0|||
27844374|NCT01426789|54334143|FG004|Part 2|Death|1|||
28032842|NCT03485911|54691248|FG003|Part 3|Subject withdrew consent|1|||
28032843|NCT03485911|54691245|FG000|Part 3|Lab abnormalities/AEs|1|||
27844375|NCT01426789|54334144|FG005|Part 2|Death|0|||
27844376|NCT01426789|54334139|FG000|Part 2|Administrative problems|0|||
28032844|NCT03485911|54691246|FG001|Part 3|Lab abnormalities/AEs|1|||
28032845|NCT03485911|54691247|FG002|Part 3|Lab abnormalities/AEs|0|||
28032846|NCT03485911|54691248|FG003|Part 3|Lab abnormalities/AEs|2|||
28032847|NCT03485911|54691245|FG000|Part 3|Other NOS|1|||
28032848|NCT03485911|54691246|FG001|Part 3|Other NOS|1|||
28032849|NCT03485911|54691247|FG002|Part 3|Other NOS|0|||
27844377|NCT01426789|54334140|FG001|Part 2|Administrative problems|0|||
28032850|NCT03485911|54691248|FG003|Part 3|Other NOS|0|||
28032851|NCT03485911|54691245|FG000|Part 3|Intercurrent illness/new medical condition|0|||
28032852|NCT03485911|54691246|FG001|Part 3|Intercurrent illness/new medical condition|1|||
28032853|NCT03485911|54691247|FG002|Part 3|Intercurrent illness/new medical condition|1|||
28032854|NCT03485911|54691248|FG003|Part 3|Intercurrent illness/new medical condition|0|||
28032855|NCT03485911|54691245|FG000|Part 3|Sponsor discontinuation|1|||
28032856|NCT03485911|54691246|FG001|Part 3|Sponsor discontinuation|0|||
28032857|NCT03485911|54691247|FG002|Part 3|Sponsor discontinuation|0|||
28032858|NCT03485911|54691248|FG003|Part 3|Sponsor discontinuation|0|||
28032859|NCT03485911|54691245|FG000|Part 3|Berotralstat provided by alternative means|13|||
28032860|NCT03485911|54691246|FG001|Part 3|Berotralstat provided by alternative means|13|||
28032861|NCT03485911|54691247|FG002|Part 3|Berotralstat provided by alternative means|7|||
28032862|NCT03485911|54691248|FG003|Part 3|Berotralstat provided by alternative means|7|||
28032863|NCT02933489|54691307|FG000|Overall Study|Ineligible|3|||
28032864|NCT02933489|54691308|FG001|Overall Study|Ineligible|3|||
28032865|NCT02933489|54691307|FG000|Overall Study|Withdrawal by Subject|27|||
28032866|NCT02933489|54691308|FG001|Overall Study|Withdrawal by Subject|18|||
28032867|NCT02933489|54691307|FG000|Overall Study|Unable to complete exams (other)|14|||
28032868|NCT02933489|54691308|FG001|Overall Study|Unable to complete exams (other)|7|||
28032869|NCT02886936|54691344|FG000|Overall Study|Lost to Follow-up|4|||
28032870|NCT02886936|54691345|FG001|Overall Study|Lost to Follow-up|3|||
28032871|NCT02886936|54691346|FG002|Overall Study|Lost to Follow-up|0|||
28032872|NCT02589522|54691359|FG000|Overall Study|Physician Decision|1|||
28032873|NCT02589522|54691360|FG001|Overall Study|Physician Decision|2|||
28032874|NCT02589522|54691361|FG002|Overall Study|Physician Decision|0|||
28032875|NCT02589522|54691359|FG000|Overall Study|Did not start treatment|1|||
28032876|NCT02589522|54691360|FG001|Overall Study|Did not start treatment|0|||
28032877|NCT02589522|54691361|FG002|Overall Study|Did not start treatment|0|||
28032878|NCT02542293|54691371|FG000|Overall Study|Death|367|||
28032879|NCT02542293|54691372|FG001|Overall Study|Death|377|||
28032880|NCT02542293|54691371|FG000|Overall Study|Withdrawal by Subject|8|||
28032881|NCT02542293|54691372|FG001|Overall Study|Withdrawal by Subject|19|||
28032882|NCT02242942|54691401|FG000|Overall Study|Death|17|||
28032883|NCT02242942|54691402|FG001|Overall Study|Death|20|||
28032884|NCT02242942|54691403|FG002|Overall Study|Death|2|||
28032885|NCT02242942|54691401|FG000|Overall Study|Physician Decision|1|||
28032886|NCT02242942|54691402|FG001|Overall Study|Physician Decision|0|||
28032887|NCT02242942|54691403|FG002|Overall Study|Physician Decision|0|||
28032888|NCT02242942|54691401|FG000|Overall Study|Withdrawal by Subject|8|||
28032889|NCT02242942|54691402|FG001|Overall Study|Withdrawal by Subject|10|||
28032890|NCT02242942|54691403|FG002|Overall Study|Withdrawal by Subject|0|||
28032891|NCT02242942|54691401|FG000|Overall Study|On-going in Study|190|||
28032892|NCT02242942|54691402|FG001|Overall Study|On-going in Study|186|||
28032893|NCT02242942|54691403|FG002|Overall Study|On-going in Study|11|||
28032894|NCT02162511|54691425|FG000|Overall Study|Lack of Efficacy|0|||
28032895|NCT02162511|54691426|FG001|Overall Study|Lack of Efficacy|0|||
28032896|NCT02162511|54691427|FG002|Overall Study|Lack of Efficacy|2|||
28032897|NCT02065869|54691431|FG000|Overall Study|Death|7|||
28032898|NCT02065869|54691431|FG000|Overall Study|Disease relapse|16|||
28032899|NCT02065869|54691431|FG000|Overall Study|Lost to Follow-up|4|||
28032900|NCT02065869|54691431|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
28032901|NCT02065869|54691431|FG000|Overall Study|Withdrawal by Subject|1|||
28032902|NCT00539994|54691496|FG000|Overall Study|Lost to Follow-up|2|||
28032903|NCT00539994|54691497|FG001|Overall Study|Lost to Follow-up|1|||
28032904|NCT00539994|54691498|FG002|Overall Study|Lost to Follow-up|0|||
28032905|NCT00539994|54691496|FG000|Overall Study|Withdrawal by Subject|1|||
28032906|NCT00539994|54691497|FG001|Overall Study|Withdrawal by Subject|0|||
28032907|NCT00539994|54691498|FG002|Overall Study|Withdrawal by Subject|1|||
28032908|NCT00539994|54691496|FG000|Overall Study|Physician Decision|0|||
28032909|NCT00539994|54691497|FG001|Overall Study|Physician Decision|0|||
28032910|NCT00539994|54691498|FG002|Overall Study|Physician Decision|1|||
28032911|NCT00098839|54691515|FG000|Overall Study|Adverse Event|5|||
28032912|NCT00098839|54691516|FG001|Overall Study|Adverse Event|2|||
28032913|NCT00098839|54691515|FG000|Overall Study|Death|1|||
28032914|NCT00098839|54691516|FG001|Overall Study|Death|2|||
28032915|NCT00098839|54691515|FG000|Overall Study|Physician Decision|4|||
28032916|NCT00098839|54691516|FG001|Overall Study|Physician Decision|14|||
28032917|NCT00098839|54691515|FG000|Overall Study|Withdrawal by Subject|1|||
28032918|NCT00098839|54691516|FG001|Overall Study|Withdrawal by Subject|0|||
28032919|NCT00098839|54691515|FG000|Overall Study|Refusal of further protocol therapy|3|||
28032920|NCT00098839|54691516|FG001|Overall Study|Refusal of further protocol therapy|1|||
28032921|NCT00098839|54691515|FG000|Overall Study|Relapse|6|||
28032922|NCT00098839|54691516|FG001|Overall Study|Relapse|3|||
28032923|NCT00098839|54691515|FG000|Overall Study|M2/M3 marrow on Day 15 of Block 2|10|||
28032924|NCT00098839|54691516|FG001|Overall Study|M2/M3 marrow on Day 15 of Block 2|11|||
28032925|NCT00098839|54691515|FG000|Overall Study|Ineligible|2|||
28032926|NCT00098839|54691516|FG001|Overall Study|Ineligible|0|||
28032927|NCT03811093|54691525|FG000|Overall Study|Lack of Efficacy, Withdrawal by Subject|0|||
28032928|NCT03811093|54691526|FG001|Overall Study|Lack of Efficacy, Withdrawal by Subject|4|||
28032929|NCT03811093|54691525|FG000|Overall Study|Unable to measure body fat percentage|2|||
28032930|NCT03811093|54691526|FG001|Overall Study|Unable to measure body fat percentage|0|||
28032931|NCT00485589|54691538|FG000|Overall Study|Death|2|||
28032932|NCT00485589|54691539|FG001|Overall Study|Death|2|||
27939772|NCT01229150|54596096|FG002|Overall Study|Toxicity|0|||
27939773|NCT01229150|54596097|FG003|Overall Study|Toxicity|0|||
28032933|NCT00485589|54691540|FG002|Overall Study|Death|0|||
28032934|NCT00485589|54691538|FG000|Overall Study|Failure to return|6|||
28032935|NCT00485589|54691539|FG001|Overall Study|Failure to return|5|||
28032936|NCT00485589|54691540|FG002|Overall Study|Failure to return|1|||
28032937|NCT00485589|54691538|FG000|Overall Study|Protocol Violation|1|||
28032938|NCT00485589|54691539|FG001|Overall Study|Protocol Violation|0|||
28032939|NCT00485589|54691540|FG002|Overall Study|Protocol Violation|0|||
28032940|NCT00485589|54691538|FG000|Overall Study|Violation of selection criteria at entry|0|||
28032941|NCT00485589|54691539|FG001|Overall Study|Violation of selection criteria at entry|3|||
28032942|NCT00485589|54691540|FG002|Overall Study|Violation of selection criteria at entry|1|||
28032943|NCT00485589|54691538|FG000|Overall Study|Administrative/Other|1|||
28032944|NCT00485589|54691539|FG001|Overall Study|Administrative/Other|2|||
28032945|NCT00485589|54691540|FG002|Overall Study|Administrative/Other|1|||
28032946|NCT00485589|54691538|FG000|Overall Study|Insufficient therapeutic response|10|||
28032947|NCT00485589|54691539|FG001|Overall Study|Insufficient therapeutic response|3|||
28032948|NCT00485589|54691540|FG002|Overall Study|Insufficient therapeutic response|1|||
28032949|NCT00485589|54691538|FG000|Overall Study|Refused treatment/did not cooperate|1|||
28032950|NCT00485589|54691539|FG001|Overall Study|Refused treatment/did not cooperate|0|||
28032951|NCT00485589|54691540|FG002|Overall Study|Refused treatment/did not cooperate|2|||
28032952|NCT00485589|54691538|FG000|Overall Study|Withdrawal by Subject|3|||
28032953|NCT00485589|54691539|FG001|Overall Study|Withdrawal by Subject|2|||
28032954|NCT00485589|54691540|FG002|Overall Study|Withdrawal by Subject|2|||
28032955|NCT00485589|54691538|FG000|Overall Study|Adverse Event|3|||
28032956|NCT00485589|54691539|FG001|Overall Study|Adverse Event|3|||
28032957|NCT00485589|54691540|FG002|Overall Study|Adverse Event|10|||
28032958|NCT00490971|54691559|FG000|Acute/Continuation|Adverse Event|62|||
28032959|NCT00490971|54691560|FG001|Acute/Continuation|Adverse Event|13|||
28032960|NCT00490971|54691561|FG002|Acute/Continuation|Adverse Event|0|||
28032961|NCT00490971|54691562|FG003|Acute/Continuation|Adverse Event|0|||
28032962|NCT00490971|54691563|FG004|Acute/Continuation|Adverse Event|0|||
28032963|NCT00490971|54691559|FG000|Acute/Continuation|Death|2|||
28032964|NCT00490971|54691560|FG001|Acute/Continuation|Death|0|||
28032965|NCT00490971|54691561|FG002|Acute/Continuation|Death|0|||
28032966|NCT00490971|54691562|FG003|Acute/Continuation|Death|0|||
28032967|NCT00490971|54691563|FG004|Acute/Continuation|Death|0|||
28032968|NCT00490971|54691559|FG000|Acute/Continuation|Lack of Efficacy|106|||
28032969|NCT00490971|54691560|FG001|Acute/Continuation|Lack of Efficacy|12|||
28032970|NCT00490971|54691561|FG002|Acute/Continuation|Lack of Efficacy|0|||
28032971|NCT00490971|54691562|FG003|Acute/Continuation|Lack of Efficacy|0|||
28032972|NCT00490971|54691563|FG004|Acute/Continuation|Lack of Efficacy|0|||
28032973|NCT00490971|54691559|FG000|Acute/Continuation|Lost to Follow-up|23|||
28032974|NCT00490971|54691560|FG001|Acute/Continuation|Lost to Follow-up|7|||
28032975|NCT00490971|54691561|FG002|Acute/Continuation|Lost to Follow-up|0|||
28032976|NCT00490971|54691562|FG003|Acute/Continuation|Lost to Follow-up|0|||
28032977|NCT00490971|54691563|FG004|Acute/Continuation|Lost to Follow-up|0|||
28032978|NCT00490971|54691559|FG000|Acute/Continuation|Protocol Violation|10|||
28032979|NCT00490971|54691560|FG001|Acute/Continuation|Protocol Violation|2|||
28032980|NCT00490971|54691561|FG002|Acute/Continuation|Protocol Violation|0|||
28032981|NCT00490971|54691562|FG003|Acute/Continuation|Protocol Violation|0|||
28032982|NCT00490971|54691563|FG004|Acute/Continuation|Protocol Violation|0|||
28032983|NCT00490971|54691559|FG000|Acute/Continuation|Withdrawal by Subject|92|||
28032984|NCT00490971|54691560|FG001|Acute/Continuation|Withdrawal by Subject|24|||
28032985|NCT00490971|54691561|FG002|Acute/Continuation|Withdrawal by Subject|0|||
28032986|NCT00490971|54691562|FG003|Acute/Continuation|Withdrawal by Subject|0|||
28032987|NCT00490971|54691563|FG004|Acute/Continuation|Withdrawal by Subject|0|||
28032988|NCT00490971|54691559|FG000|Acute/Continuation|Other|11|||
27807500|NCT01791153|54262862|FG001|Part 1: Blinded Period|Withdrawal by Subject|2|||
27807501|NCT01791153|54262863|FG002|Part 1: Blinded Period|Withdrawal by Subject|2|||
27807502|NCT01791153|54262864|FG003|Part 1: Blinded Period|Withdrawal by Subject|1|||
27807503|NCT01791153|54262865|FG004|Part 1: Blinded Period|Withdrawal by Subject|0|||
27807504|NCT01791153|54262866|FG005|Part 1: Blinded Period|Withdrawal by Subject|0|||
27807505|NCT01791153|54262867|FG006|Part 1: Blinded Period|Withdrawal by Subject|0|||
27807506|NCT01791153|54262868|FG007|Part 1: Blinded Period|Withdrawal by Subject|0|||
27807507|NCT01791153|54262861|FG000|Part 2: Open-label Period|Adverse Event|0|||
28032989|NCT00490971|54691560|FG001|Acute/Continuation|Other|4|||
28032990|NCT00490971|54691561|FG002|Acute/Continuation|Other|0|||
27939774|NCT00952588|54596113|FG000|Overall Study|Death|28|||
27939775|NCT00952588|54596114|FG001|Overall Study|Death|13|||
28032991|NCT00490971|54691562|FG003|Acute/Continuation|Other|0|||
28032992|NCT00490971|54691563|FG004|Acute/Continuation|Other|0|||
28032993|NCT00490971|54691559|FG000|Maintenance|Adverse Event|0|||
28032994|NCT00490971|54691560|FG001|Maintenance|Adverse Event|0|||
28032995|NCT00490971|54691561|FG002|Maintenance|Adverse Event|4|||
28032996|NCT00490971|54691562|FG003|Maintenance|Adverse Event|5|||
28032997|NCT00490971|54691563|FG004|Maintenance|Adverse Event|7|||
28032998|NCT00490971|54691559|FG000|Maintenance|Death|0|||
28032999|NCT00490971|54691560|FG001|Maintenance|Death|0|||
28033000|NCT00490971|54691561|FG002|Maintenance|Death|0|||
28033001|NCT00490971|54691562|FG003|Maintenance|Death|2|||
28033002|NCT00490971|54691563|FG004|Maintenance|Death|0|||
28033003|NCT00490971|54691559|FG000|Maintenance|Lost to Follow-up|0|||
28033004|NCT00490971|54691560|FG001|Maintenance|Lost to Follow-up|0|||
28033005|NCT00490971|54691561|FG002|Maintenance|Lost to Follow-up|5|||
28033006|NCT00490971|54691562|FG003|Maintenance|Lost to Follow-up|8|||
28033007|NCT00490971|54691563|FG004|Maintenance|Lost to Follow-up|10|||
28033008|NCT00490971|54691559|FG000|Maintenance|Pregnancy|0|||
28033009|NCT00490971|54691560|FG001|Maintenance|Pregnancy|0|||
28033010|NCT00490971|54691561|FG002|Maintenance|Pregnancy|1|||
28033011|NCT00490971|54691562|FG003|Maintenance|Pregnancy|0|||
28033012|NCT00490971|54691563|FG004|Maintenance|Pregnancy|0|||
28033013|NCT00490971|54691559|FG000|Maintenance|Protocol Violation|0|||
28033014|NCT00490971|54691560|FG001|Maintenance|Protocol Violation|0|||
28033015|NCT00490971|54691561|FG002|Maintenance|Protocol Violation|4|||
28033016|NCT00490971|54691562|FG003|Maintenance|Protocol Violation|1|||
28033017|NCT00490971|54691563|FG004|Maintenance|Protocol Violation|1|||
28033018|NCT00490971|54691559|FG000|Maintenance|Withdrawal by Subject|0|||
28033019|NCT00490971|54691560|FG001|Maintenance|Withdrawal by Subject|0|||
27807508|NCT01791153|54262862|FG001|Part 2: Open-label Period|Adverse Event|0|||
28033020|NCT00490971|54691561|FG002|Maintenance|Withdrawal by Subject|26|||
27807509|NCT01791153|54262863|FG002|Part 2: Open-label Period|Adverse Event|0|||
27807510|NCT01791153|54262864|FG003|Part 2: Open-label Period|Adverse Event|0|||
27807511|NCT01791153|54262865|FG004|Part 2: Open-label Period|Adverse Event|0|||
27807512|NCT01791153|54262866|FG005|Part 2: Open-label Period|Adverse Event|1|||
27807513|NCT01791153|54262867|FG006|Part 2: Open-label Period|Adverse Event|1|||
27807514|NCT01791153|54262868|FG007|Part 2: Open-label Period|Adverse Event|2|||
27807515|NCT01791153|54262861|FG000|Part 2: Open-label Period|Death|0|||
27807516|NCT01791153|54262862|FG001|Part 2: Open-label Period|Death|0|||
27807517|NCT01791153|54262863|FG002|Part 2: Open-label Period|Death|0|||
27844378|NCT01426789|54334141|FG002|Part 2|Administrative problems|2|||
27844379|NCT01426789|54334142|FG003|Part 2|Administrative problems|0|||
27844380|NCT01426789|54334143|FG004|Part 2|Administrative problems|1|||
27844381|NCT01426789|54334144|FG005|Part 2|Administrative problems|0|||
27844382|NCT01426789|54334139|FG000|Part 2|Lost to Follow-up|0|||
27844383|NCT01426789|54334140|FG001|Part 2|Lost to Follow-up|0|||
27844384|NCT01426789|54334141|FG002|Part 2|Lost to Follow-up|4|||
27844385|NCT01426789|54334142|FG003|Part 2|Lost to Follow-up|0|||
27844386|NCT01426789|54334143|FG004|Part 2|Lost to Follow-up|1|||
27844387|NCT01426789|54334144|FG005|Part 2|Lost to Follow-up|0|||
27844388|NCT01426789|54334139|FG000|Part 2|Withdrawal by Subject|0|||
27844389|NCT01426789|54334140|FG001|Part 2|Withdrawal by Subject|0|||
27844390|NCT01426789|54334141|FG002|Part 2|Withdrawal by Subject|0|||
27844391|NCT01426789|54334142|FG003|Part 2|Withdrawal by Subject|1|||
28033021|NCT00490971|54691562|FG003|Maintenance|Withdrawal by Subject|28|||
28033022|NCT00490971|54691563|FG004|Maintenance|Withdrawal by Subject|18|||
28033023|NCT00490971|54691559|FG000|Maintenance|Other|0|||
28033024|NCT00490971|54691560|FG001|Maintenance|Other|0|||
28033025|NCT00490971|54691561|FG002|Maintenance|Other|11|||
28033026|NCT00490971|54691562|FG003|Maintenance|Other|9|||
27807518|NCT01791153|54262864|FG003|Part 2: Open-label Period|Death|0|||
27807519|NCT01791153|54262865|FG004|Part 2: Open-label Period|Death|0|||
27807520|NCT01791153|54262866|FG005|Part 2: Open-label Period|Death|1|||
27807521|NCT01791153|54262867|FG006|Part 2: Open-label Period|Death|1|||
27807522|NCT01791153|54262868|FG007|Part 2: Open-label Period|Death|1|||
27807523|NCT01791153|54262861|FG000|Part 2: Open-label Period|Lost to Follow-up|0|||
27844392|NCT01426789|54334143|FG004|Part 2|Withdrawal by Subject|2|||
28033027|NCT00490971|54691563|FG004|Maintenance|Other|3|||
28033028|NCT00686075|54691585|FG000|Overall Study|Withdrawal by Subject|4|||
28033029|NCT00686075|54691586|FG001|Overall Study|Withdrawal by Subject|3|||
28033030|NCT00686075|54691587|FG002|Overall Study|Withdrawal by Subject|3|||
28033031|NCT00686075|54691588|FG003|Overall Study|Withdrawal by Subject|7|||
27807524|NCT01791153|54262862|FG001|Part 2: Open-label Period|Lost to Follow-up|0|||
27807525|NCT01791153|54262863|FG002|Part 2: Open-label Period|Lost to Follow-up|0|||
27807526|NCT01791153|54262864|FG003|Part 2: Open-label Period|Lost to Follow-up|0|||
28033032|NCT00686075|54691589|FG004|Overall Study|Withdrawal by Subject|1|||
28033033|NCT00686075|54691590|FG005|Overall Study|Withdrawal by Subject|0|||
27844393|NCT01426789|54334144|FG005|Part 2|Withdrawal by Subject|0|||
27844394|NCT01426789|54334139|FG000|Part 2|Lack of Efficacy|0|||
27844395|NCT01426789|54334140|FG001|Part 2|Lack of Efficacy|0|||
27844396|NCT01426789|54334141|FG002|Part 2|Lack of Efficacy|5|||
28033034|NCT00686075|54691591|FG006|Overall Study|Withdrawal by Subject|0|||
28033035|NCT00686075|54691592|FG007|Overall Study|Withdrawal by Subject|2|||
28033036|NCT00686075|54691593|FG008|Overall Study|Withdrawal by Subject|4|||
28033037|NCT00686075|54691594|FG009|Overall Study|Withdrawal by Subject|6|||
28033038|NCT00686075|54691585|FG000|Overall Study|Lost to Follow-up|3|||
27844397|NCT01426789|54334142|FG003|Part 2|Lack of Efficacy|0|||
27844398|NCT01426789|54334143|FG004|Part 2|Lack of Efficacy|2|||
28033039|NCT00686075|54691586|FG001|Overall Study|Lost to Follow-up|6|||
28033040|NCT00686075|54691587|FG002|Overall Study|Lost to Follow-up|3|||
28033041|NCT00686075|54691588|FG003|Overall Study|Lost to Follow-up|2|||
28033042|NCT00686075|54691589|FG004|Overall Study|Lost to Follow-up|3|||
28033043|NCT00686075|54691590|FG005|Overall Study|Lost to Follow-up|3|||
28033044|NCT00686075|54691591|FG006|Overall Study|Lost to Follow-up|0|||
28033045|NCT00686075|54691592|FG007|Overall Study|Lost to Follow-up|0|||
28033046|NCT00686075|54691593|FG008|Overall Study|Lost to Follow-up|2|||
28033047|NCT00686075|54691594|FG009|Overall Study|Lost to Follow-up|3|||
28033048|NCT00686075|54691585|FG000|Overall Study|Other|1|||
28033049|NCT00686075|54691586|FG001|Overall Study|Other|1|||
28033050|NCT00686075|54691587|FG002|Overall Study|Other|0|||
28033051|NCT00686075|54691588|FG003|Overall Study|Other|0|||
28033052|NCT00686075|54691589|FG004|Overall Study|Other|0|||
28033053|NCT00686075|54691590|FG005|Overall Study|Other|0|||
28033054|NCT00686075|54691591|FG006|Overall Study|Other|0|||
28033055|NCT00686075|54691592|FG007|Overall Study|Other|0|||
28033056|NCT00686075|54691593|FG008|Overall Study|Other|0|||
28033057|NCT00686075|54691594|FG009|Overall Study|Other|1|||
28033058|NCT00685763|54691616|FG000|Overall Study|Intercurrent death-incomplete treatment|1|||
28033059|NCT00685763|54691616|FG000|Overall Study|Protocol Violation|1|||
28033060|NCT00098293|54691623|FG000|Double-blind (DB) Phase|Adverse Event|14|||
28033061|NCT00098293|54691624|FG001|Double-blind (DB) Phase|Adverse Event|27|||
28033062|NCT00098293|54691625|FG002|Double-blind (DB) Phase|Adverse Event|60|||
28033063|NCT00098293|54691626|FG003|Double-blind (DB) Phase|Adverse Event|0|||
28033064|NCT00098293|54691627|FG004|Double-blind (DB) Phase|Adverse Event|0|||
28033065|NCT00098293|54691623|FG000|Double-blind (DB) Phase|Pregnancy|0|||
28033066|NCT00098293|54691624|FG001|Double-blind (DB) Phase|Pregnancy|7|||
28033067|NCT00098293|54691625|FG002|Double-blind (DB) Phase|Pregnancy|9|||
28033068|NCT00098293|54691626|FG003|Double-blind (DB) Phase|Pregnancy|0|||
28033069|NCT00098293|54691627|FG004|Double-blind (DB) Phase|Pregnancy|0|||
28033070|NCT00098293|54691623|FG000|Double-blind (DB) Phase|Participant Defaulted|11|||
28033071|NCT00098293|54691624|FG001|Double-blind (DB) Phase|Participant Defaulted|40|||
28033072|NCT00098293|54691625|FG002|Double-blind (DB) Phase|Participant Defaulted|36|||
28033073|NCT00098293|54691626|FG003|Double-blind (DB) Phase|Participant Defaulted|0|||
28033074|NCT00098293|54691627|FG004|Double-blind (DB) Phase|Participant Defaulted|0|||
28033075|NCT00098293|54691623|FG000|Double-blind (DB) Phase|Lack of Efficacy|11|||
28033076|NCT00098293|54691624|FG001|Double-blind (DB) Phase|Lack of Efficacy|64|||
28033077|NCT00098293|54691625|FG002|Double-blind (DB) Phase|Lack of Efficacy|30|||
28033078|NCT00098293|54691626|FG003|Double-blind (DB) Phase|Lack of Efficacy|0|||
28033079|NCT00098293|54691627|FG004|Double-blind (DB) Phase|Lack of Efficacy|0|||
28033080|NCT00098293|54691623|FG000|Double-blind (DB) Phase|Death|1|||
28033081|NCT00098293|54691624|FG001|Double-blind (DB) Phase|Death|2|||
28033082|NCT00098293|54691625|FG002|Double-blind (DB) Phase|Death|2|||
28033083|NCT00098293|54691626|FG003|Double-blind (DB) Phase|Death|0|||
28033084|NCT00098293|54691627|FG004|Double-blind (DB) Phase|Death|0|||
28033085|NCT00098293|54691623|FG000|Double-blind (DB) Phase|Randomized, Not Treated|3|||
28033086|NCT00098293|54691624|FG001|Double-blind (DB) Phase|Randomized, Not Treated|8|||
28033087|NCT00098293|54691625|FG002|Double-blind (DB) Phase|Randomized, Not Treated|11|||
28033088|NCT00098293|54691626|FG003|Double-blind (DB) Phase|Randomized, Not Treated|0|||
28033089|NCT00098293|54691627|FG004|Double-blind (DB) Phase|Randomized, Not Treated|0|||
28033090|NCT00098293|54691623|FG000|Double-blind (DB) Phase|Protocol Violation|2|||
28033091|NCT00098293|54691624|FG001|Double-blind (DB) Phase|Protocol Violation|18|||
28033092|NCT00098293|54691625|FG002|Double-blind (DB) Phase|Protocol Violation|22|||
28033093|NCT00098293|54691626|FG003|Double-blind (DB) Phase|Protocol Violation|0|||
28033094|NCT00098293|54691627|FG004|Double-blind (DB) Phase|Protocol Violation|0|||
28033095|NCT00098293|54691623|FG000|Double-blind (DB) Phase|Terminated by sponsor|135|||
28033096|NCT00098293|54691624|FG001|Double-blind (DB) Phase|Terminated by sponsor|0|||
28033097|NCT00098293|54691625|FG002|Double-blind (DB) Phase|Terminated by sponsor|0|||
28033098|NCT00098293|54691626|FG003|Double-blind (DB) Phase|Terminated by sponsor|0|||
28033099|NCT00098293|54691627|FG004|Double-blind (DB) Phase|Terminated by sponsor|0|||
27807527|NCT01791153|54262865|FG004|Part 2: Open-label Period|Lost to Follow-up|0|||
27807528|NCT01791153|54262866|FG005|Part 2: Open-label Period|Lost to Follow-up|0|||
27807529|NCT01791153|54262867|FG006|Part 2: Open-label Period|Lost to Follow-up|1|||
27807530|NCT01791153|54262868|FG007|Part 2: Open-label Period|Lost to Follow-up|0|||
27807531|NCT01791153|54262861|FG000|Part 2: Open-label Period|Lack of Efficacy|0|||
28033100|NCT00098293|54691623|FG000|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
27807532|NCT01791153|54262862|FG001|Part 2: Open-label Period|Lack of Efficacy|0|||
27807533|NCT01791153|54262863|FG002|Part 2: Open-label Period|Lack of Efficacy|0|||
28033101|NCT00098293|54691624|FG001|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
28033102|NCT00098293|54691625|FG002|Between DB and OL Phase|Did Not Enter Open-label Phase|3|||
28033103|NCT00098293|54691626|FG003|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
28033104|NCT00098293|54691627|FG004|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
28033105|NCT00098293|54691623|FG000|Open-label (OL) Phase|Adverse Event|0|||
28033106|NCT00098293|54691624|FG001|Open-label (OL) Phase|Adverse Event|3|||
28033107|NCT00098293|54691625|FG002|Open-label (OL) Phase|Adverse Event|7|||
28033108|NCT00098293|54691626|FG003|Open-label (OL) Phase|Adverse Event|6|||
28033109|NCT00098293|54691627|FG004|Open-label (OL) Phase|Adverse Event|0|||
28033110|NCT00098293|54691623|FG000|Open-label (OL) Phase|Lack of Efficacy|0|||
28033111|NCT00098293|54691624|FG001|Open-label (OL) Phase|Lack of Efficacy|7|||
28033112|NCT00098293|54691625|FG002|Open-label (OL) Phase|Lack of Efficacy|2|||
28033113|NCT00098293|54691626|FG003|Open-label (OL) Phase|Lack of Efficacy|20|||
28033114|NCT00098293|54691627|FG004|Open-label (OL) Phase|Lack of Efficacy|0|||
28033115|NCT00098293|54691623|FG000|Open-label (OL) Phase|Pregnancy|0|||
28033116|NCT00098293|54691624|FG001|Open-label (OL) Phase|Pregnancy|1|||
28033117|NCT00098293|54691625|FG002|Open-label (OL) Phase|Pregnancy|0|||
28033118|NCT00098293|54691626|FG003|Open-label (OL) Phase|Pregnancy|3|||
28033119|NCT00098293|54691627|FG004|Open-label (OL) Phase|Pregnancy|0|||
28033120|NCT00098293|54691623|FG000|Open-label (OL) Phase|Protocol Violation|0|||
28033121|NCT00098293|54691624|FG001|Open-label (OL) Phase|Protocol Violation|6|||
28033122|NCT00098293|54691625|FG002|Open-label (OL) Phase|Protocol Violation|13|||
28033123|NCT00098293|54691626|FG003|Open-label (OL) Phase|Protocol Violation|16|||
28033124|NCT00098293|54691627|FG004|Open-label (OL) Phase|Protocol Violation|0|||
28033125|NCT00098293|54691623|FG000|Open-label (OL) Phase|Participant Defaulted|0|||
28033126|NCT00098293|54691624|FG001|Open-label (OL) Phase|Participant Defaulted|6|||
28033127|NCT00098293|54691625|FG002|Open-label (OL) Phase|Participant Defaulted|16|||
28033128|NCT00098293|54691626|FG003|Open-label (OL) Phase|Participant Defaulted|20|||
28033129|NCT00098293|54691627|FG004|Open-label (OL) Phase|Participant Defaulted|0|||
28033130|NCT00098293|54691623|FG000|Open-label (OL) Phase|Death|0|||
28033131|NCT00098293|54691624|FG001|Open-label (OL) Phase|Death|2|||
28033132|NCT00098293|54691625|FG002|Open-label (OL) Phase|Death|3|||
28033133|NCT00098293|54691626|FG003|Open-label (OL) Phase|Death|0|||
28033134|NCT00098293|54691627|FG004|Open-label (OL) Phase|Death|0|||
28033135|NCT00098293|54691623|FG000|Supplemental Phase (SP)|Death|0|||
28033136|NCT00098293|54691624|FG001|Supplemental Phase (SP)|Death|0|||
28033137|NCT00098293|54691625|FG002|Supplemental Phase (SP)|Death|0|||
28033138|NCT00098293|54691626|FG003|Supplemental Phase (SP)|Death|0|||
28033139|NCT00098293|54691627|FG004|Supplemental Phase (SP)|Death|1|||
28033140|NCT00098293|54691623|FG000|Supplemental Phase (SP)|Lost to Follow-up|0|||
28033141|NCT00098293|54691624|FG001|Supplemental Phase (SP)|Lost to Follow-up|0|||
28033142|NCT00098293|54691625|FG002|Supplemental Phase (SP)|Lost to Follow-up|0|||
28033143|NCT00098293|54691626|FG003|Supplemental Phase (SP)|Lost to Follow-up|0|||
28033144|NCT00098293|54691627|FG004|Supplemental Phase (SP)|Lost to Follow-up|2|||
28033145|NCT00098293|54691623|FG000|Supplemental Phase (SP)|Withdrawal by Subject|0|||
28033146|NCT00098293|54691624|FG001|Supplemental Phase (SP)|Withdrawal by Subject|0|||
28033147|NCT00098293|54691625|FG002|Supplemental Phase (SP)|Withdrawal by Subject|0|||
28033148|NCT00098293|54691626|FG003|Supplemental Phase (SP)|Withdrawal by Subject|0|||
28033149|NCT00098293|54691627|FG004|Supplemental Phase (SP)|Withdrawal by Subject|8|||
28033150|NCT00098293|54691623|FG000|Supplemental Phase (SP)|Other|0|||
28033151|NCT00098293|54691624|FG001|Supplemental Phase (SP)|Other|0|||
28033152|NCT00098293|54691625|FG002|Supplemental Phase (SP)|Other|0|||
28033153|NCT00098293|54691626|FG003|Supplemental Phase (SP)|Other|0|||
28033154|NCT00098293|54691627|FG004|Supplemental Phase (SP)|Other|22|||
28033155|NCT00685685|54691638|FG000|Washout Period of 7 Days|Adverse Event|2|||
28033156|NCT00685685|54691639|FG001|Washout Period of 7 Days|Adverse Event|0|||
28033157|NCT00685685|54691638|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
28033158|NCT00685685|54691639|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
28033159|NCT00684671|54691648|FG000|Overall Study|Adverse Event|1|||
28033160|NCT00684671|54691649|FG001|Overall Study|Adverse Event|0|||
28033161|NCT00684671|54691650|FG002|Overall Study|Adverse Event|0|||
28033162|NCT00684671|54691648|FG000|Overall Study|Lost to Follow-up|1|||
28033163|NCT00684671|54691649|FG001|Overall Study|Lost to Follow-up|0|||
28033164|NCT00684671|54691650|FG002|Overall Study|Lost to Follow-up|0|||
28033165|NCT00684671|54691648|FG000|Overall Study|Alcoholic dependance|1|||
28033166|NCT00684671|54691649|FG001|Overall Study|Alcoholic dependance|0|||
28033167|NCT00684671|54691650|FG002|Overall Study|Alcoholic dependance|0|||
28033168|NCT03859323|54691671|FG000|Overall Study|Lost to Follow-up|0|||
28033169|NCT03859323|54691672|FG001|Overall Study|Lost to Follow-up|0|||
28033170|NCT03859323|54691673|FG002|Overall Study|Lost to Follow-up|0|||
28033171|NCT03859323|54691674|FG003|Overall Study|Lost to Follow-up|0|||
28033172|NCT03859323|54691675|FG004|Overall Study|Lost to Follow-up|0|||
28033173|NCT03859323|54691676|FG005|Overall Study|Lost to Follow-up|0|||
28033174|NCT03859323|54691677|FG006|Overall Study|Lost to Follow-up|1|||
27844399|NCT01426789|54334144|FG005|Part 2|Lack of Efficacy|0|||
28033175|NCT03859323|54691678|FG007|Overall Study|Lost to Follow-up|0|||
28033176|NCT03859323|54691679|FG008|Overall Study|Lost to Follow-up|0|||
28033177|NCT03859323|54691680|FG009|Overall Study|Lost to Follow-up|0|||
28033178|NCT03859323|54691681|FG010|Overall Study|Lost to Follow-up|0|||
28033179|NCT03859323|54691682|FG011|Overall Study|Lost to Follow-up|0|||
28033180|NCT03859323|54691683|FG012|Overall Study|Lost to Follow-up|0|||
28033181|NCT03859323|54691671|FG000|Overall Study|Withdrawal by Subject|0|||
28033182|NCT03859323|54691672|FG001|Overall Study|Withdrawal by Subject|0|||
28033183|NCT03859323|54691673|FG002|Overall Study|Withdrawal by Subject|1|||
28033184|NCT03859323|54691674|FG003|Overall Study|Withdrawal by Subject|0|||
28033185|NCT03859323|54691675|FG004|Overall Study|Withdrawal by Subject|0|||
28033186|NCT03859323|54691676|FG005|Overall Study|Withdrawal by Subject|1|||
28033187|NCT03859323|54691677|FG006|Overall Study|Withdrawal by Subject|0|||
28033188|NCT03859323|54691678|FG007|Overall Study|Withdrawal by Subject|0|||
28033189|NCT03859323|54691679|FG008|Overall Study|Withdrawal by Subject|0|||
28033190|NCT03859323|54691680|FG009|Overall Study|Withdrawal by Subject|1|||
28033191|NCT03859323|54691681|FG010|Overall Study|Withdrawal by Subject|1|||
28033192|NCT03859323|54691682|FG011|Overall Study|Withdrawal by Subject|2|||
28033193|NCT03859323|54691683|FG012|Overall Study|Withdrawal by Subject|1|||
28033194|NCT03859323|54691671|FG000|Overall Study|Pregnancy|0|||
28033195|NCT03859323|54691672|FG001|Overall Study|Pregnancy|0|||
28033196|NCT03859323|54691673|FG002|Overall Study|Pregnancy|0|||
28033197|NCT03859323|54691674|FG003|Overall Study|Pregnancy|0|||
28033198|NCT03859323|54691675|FG004|Overall Study|Pregnancy|0|||
28033199|NCT03859323|54691676|FG005|Overall Study|Pregnancy|0|||
28033200|NCT03859323|54691677|FG006|Overall Study|Pregnancy|0|||
28033201|NCT03859323|54691678|FG007|Overall Study|Pregnancy|0|||
28033202|NCT03859323|54691679|FG008|Overall Study|Pregnancy|0|||
28033203|NCT03859323|54691680|FG009|Overall Study|Pregnancy|1|||
28033204|NCT03859323|54691681|FG010|Overall Study|Pregnancy|0|||
28033205|NCT03859323|54691682|FG011|Overall Study|Pregnancy|0|||
28033206|NCT03859323|54691683|FG012|Overall Study|Pregnancy|0|||
28033207|NCT03857841|54691726|FG000|Overall Study|Death|1|||
28033208|NCT03857841|54691727|FG001|Overall Study|Death|0|||
28033209|NCT03857841|54691728|FG002|Overall Study|Death|0|||
28033210|NCT03857841|54691729|FG003|Overall Study|Death|0|||
28033211|NCT03857841|54691726|FG000|Overall Study|Study Terminated by Sponsor|1|||
27844400|NCT01426789|54334139|FG000|Part 2|Adverse Event|0|||
27844401|NCT01426789|54334140|FG001|Part 2|Adverse Event|0|||
27844402|NCT01426789|54334141|FG002|Part 2|Adverse Event|2|||
27844403|NCT01426789|54334142|FG003|Part 2|Adverse Event|0|||
27844404|NCT01426789|54334143|FG004|Part 2|Adverse Event|1|||
27844405|NCT01426789|54334144|FG005|Part 2|Adverse Event|0|||
27844406|NCT01426009|54334165|FG000|Period 1-First Intervention (7 Days)|Adverse Event|1|||
27844407|NCT01426009|54334165|FG000|Period 1-First Intervention (7 Days)|Personal Reasons|1|||
27844408|NCT01426009|54334165|FG000|Washout 1|Withdrawal by Subject|1|||
27844409|NCT01426009|54334165|FG000|Washout 1|Personal Reasons|1|||
27844410|NCT01426009|54334165|FG000|Period 2-Second Intervention (7 Days)|Adverse Event|4|||
27844411|NCT01426009|54334165|FG000|Period 2-Second Intervention (7 Days)|personal reasons|1|||
27844412|NCT01426009|54334165|FG000|Washout 2|electrive surgery|1|||
27844413|NCT01426009|54334165|FG000|Washout 3|personal reasons|1|||
27844414|NCT01426009|54334165|FG000|Period 4-Fourth Intervention (7 Days)|personal reasons|1|||
27844415|NCT01426009|54334165|FG000|Washout 4|Lost to Follow-up|1|||
27844416|NCT01411319|54334194|FG000|Overall Study|Lost to Follow-up|1|||
27844417|NCT01543958|54334198|FG000|Overall Study|Loss to follow-up|3|||
28033212|NCT03857841|54691727|FG001|Overall Study|Study Terminated by Sponsor|0|||
28033213|NCT03857841|54691728|FG002|Overall Study|Study Terminated by Sponsor|0|||
28033214|NCT03857841|54691729|FG003|Overall Study|Study Terminated by Sponsor|0|||
28033215|NCT00500331|54691746|FG000|Overall Study|Adverse Event|0|||
28033216|NCT00500331|54691747|FG001|Overall Study|Adverse Event|2|||
28033217|NCT00500331|54691748|FG002|Overall Study|Adverse Event|0|||
28033218|NCT00500331|54691749|FG003|Overall Study|Adverse Event|1|||
28033219|NCT00500331|54691750|FG004|Overall Study|Adverse Event|2|||
28033220|NCT00500331|54691751|FG005|Overall Study|Adverse Event|2|||
28033221|NCT00500331|54691752|FG006|Overall Study|Adverse Event|0|||
27844418|NCT01543958|54334198|FG000|Overall Study|ART initiation|1|||
27844419|NCT01411085|54334202|FG000|Overall Study|Physician Decision|1|||
28033222|NCT00500331|54691746|FG000|Overall Study|Lost to Follow-up|1|||
28033223|NCT00500331|54691747|FG001|Overall Study|Lost to Follow-up|1|||
28033224|NCT00500331|54691748|FG002|Overall Study|Lost to Follow-up|1|||
28033225|NCT00500331|54691749|FG003|Overall Study|Lost to Follow-up|2|||
27844420|NCT01411085|54334202|FG000|Overall Study|Protocol Violation|1|||
27844421|NCT01411085|54334202|FG000|Overall Study|Adverse Event|1|||
27844422|NCT01543490|54334208|FG000|Overall Study|Adverse Event|4|||
27844423|NCT01543490|54334209|FG001|Overall Study|Adverse Event|0|||
27844424|NCT01543490|54334208|FG000|Overall Study|Physician Decision|1|||
27844425|NCT01543490|54334209|FG001|Overall Study|Physician Decision|0|||
28033226|NCT00500331|54691750|FG004|Overall Study|Lost to Follow-up|1|||
27844426|NCT01543490|54334208|FG000|Overall Study|Lack of Efficacy|3|||
27844427|NCT01543490|54334209|FG001|Overall Study|Lack of Efficacy|3|||
27844428|NCT01543490|54334208|FG000|Overall Study|Lost to Follow-up|5|||
27844429|NCT01543490|54334209|FG001|Overall Study|Lost to Follow-up|0|||
27844430|NCT01543490|54334208|FG000|Overall Study|Withdrawal by Subject|2|||
28033227|NCT00500331|54691751|FG005|Overall Study|Lost to Follow-up|0|||
28033228|NCT00500331|54691752|FG006|Overall Study|Lost to Follow-up|0|||
28033229|NCT00500331|54691746|FG000|Overall Study|Protocol Violation|3|||
28033230|NCT00500331|54691747|FG001|Overall Study|Protocol Violation|1|||
28033231|NCT00500331|54691748|FG002|Overall Study|Protocol Violation|1|||
28033232|NCT00500331|54691749|FG003|Overall Study|Protocol Violation|0|||
28033233|NCT00500331|54691750|FG004|Overall Study|Protocol Violation|1|||
28033234|NCT00500331|54691751|FG005|Overall Study|Protocol Violation|1|||
28033235|NCT00500331|54691752|FG006|Overall Study|Protocol Violation|1|||
28033236|NCT00500331|54691746|FG000|Overall Study|Withdrawal by Subject|4|||
28033237|NCT00500331|54691747|FG001|Overall Study|Withdrawal by Subject|0|||
28033238|NCT00500331|54691748|FG002|Overall Study|Withdrawal by Subject|1|||
27844431|NCT01543490|54334209|FG001|Overall Study|Withdrawal by Subject|0|||
27844432|NCT01543490|54334208|FG000|Overall Study|Other-Various Administrative Reasons|1|||
27844433|NCT01543490|54334209|FG001|Overall Study|Other-Various Administrative Reasons|2|||
27844434|NCT01404949|54334215|FG000|Overall Study|Not Treated|1|||
27844435|NCT01431521|54334223|FG000|Overall Study|Withdrawal by Subject|0|||
27844436|NCT01431521|54334224|FG001|Overall Study|Withdrawal by Subject|0|||
28033239|NCT00500331|54691749|FG003|Overall Study|Withdrawal by Subject|5|||
28033240|NCT00500331|54691750|FG004|Overall Study|Withdrawal by Subject|0|||
28033241|NCT00500331|54691751|FG005|Overall Study|Withdrawal by Subject|1|||
28033242|NCT00500331|54691752|FG006|Overall Study|Withdrawal by Subject|1|||
28033243|NCT00500331|54691746|FG000|Overall Study|Lack of Efficacy|3|||
28033244|NCT00500331|54691747|FG001|Overall Study|Lack of Efficacy|1|||
28033245|NCT00500331|54691748|FG002|Overall Study|Lack of Efficacy|0|||
28033246|NCT00500331|54691749|FG003|Overall Study|Lack of Efficacy|0|||
28033247|NCT00500331|54691750|FG004|Overall Study|Lack of Efficacy|0|||
28033248|NCT00500331|54691751|FG005|Overall Study|Lack of Efficacy|0|||
28033249|NCT00500331|54691752|FG006|Overall Study|Lack of Efficacy|0|||
28033250|NCT00500331|54691746|FG000|Overall Study|Liver function test abnormality|0|||
28033251|NCT00500331|54691747|FG001|Overall Study|Liver function test abnormality|0|||
28033252|NCT00500331|54691748|FG002|Overall Study|Liver function test abnormality|1|||
28033253|NCT00500331|54691749|FG003|Overall Study|Liver function test abnormality|0|||
28033254|NCT00500331|54691750|FG004|Overall Study|Liver function test abnormality|0|||
28033255|NCT00500331|54691751|FG005|Overall Study|Liver function test abnormality|0|||
28033256|NCT00500331|54691752|FG006|Overall Study|Liver function test abnormality|0|||
28033257|NCT00500331|54691746|FG000|Overall Study|Increased serum creatinine from Baseline|0|||
28033258|NCT00500331|54691747|FG001|Overall Study|Increased serum creatinine from Baseline|0|||
28033259|NCT00500331|54691748|FG002|Overall Study|Increased serum creatinine from Baseline|0|||
28033260|NCT00500331|54691749|FG003|Overall Study|Increased serum creatinine from Baseline|0|||
28033261|NCT00500331|54691750|FG004|Overall Study|Increased serum creatinine from Baseline|0|||
28033262|NCT00500331|54691751|FG005|Overall Study|Increased serum creatinine from Baseline|1|||
28033263|NCT00500331|54691752|FG006|Overall Study|Increased serum creatinine from Baseline|0|||
28033264|NCT00500331|54691746|FG000|Overall Study|Didn't return for continuation of study|1|||
28033265|NCT00500331|54691747|FG001|Overall Study|Didn't return for continuation of study|0|||
28033266|NCT00500331|54691748|FG002|Overall Study|Didn't return for continuation of study|0|||
28033267|NCT00500331|54691749|FG003|Overall Study|Didn't return for continuation of study|0|||
28033268|NCT00500331|54691750|FG004|Overall Study|Didn't return for continuation of study|0|||
28033269|NCT00500331|54691751|FG005|Overall Study|Didn't return for continuation of study|0|||
28033270|NCT00500331|54691752|FG006|Overall Study|Didn't return for continuation of study|0|||
28033271|NCT00500331|54691746|FG000|Overall Study|Exclusion citeria not met on Visit 4|1|||
28033272|NCT00500331|54691747|FG001|Overall Study|Exclusion citeria not met on Visit 4|0|||
28033273|NCT00500331|54691748|FG002|Overall Study|Exclusion citeria not met on Visit 4|0|||
28033274|NCT00500331|54691749|FG003|Overall Study|Exclusion citeria not met on Visit 4|0|||
28033275|NCT00500331|54691750|FG004|Overall Study|Exclusion citeria not met on Visit 4|0|||
28033276|NCT00500331|54691751|FG005|Overall Study|Exclusion citeria not met on Visit 4|0|||
27844437|NCT01431521|54334225|FG002|Overall Study|Withdrawal by Subject|1|||
27844438|NCT01431521|54334226|FG003|Overall Study|Withdrawal by Subject|0|||
27844439|NCT01404325|54334311|FG000|Overall Study|Lost to Follow-up|1|||
27844440|NCT01404325|54334312|FG001|Overall Study|Lost to Follow-up|0|||
27844441|NCT01404325|54334311|FG000|Overall Study|Death|2|||
27844442|NCT01404325|54334312|FG001|Overall Study|Death|0|||
28033277|NCT00500331|54691752|FG006|Overall Study|Exclusion citeria not met on Visit 4|0|||
28033278|NCT00500331|54691746|FG000|Overall Study|Sponsor decided to withdraw participant|1|||
28033279|NCT00500331|54691747|FG001|Overall Study|Sponsor decided to withdraw participant|0|||
28033280|NCT00500331|54691748|FG002|Overall Study|Sponsor decided to withdraw participant|0|||
28033281|NCT00500331|54691749|FG003|Overall Study|Sponsor decided to withdraw participant|0|||
28033282|NCT00500331|54691750|FG004|Overall Study|Sponsor decided to withdraw participant|0|||
28033283|NCT00500331|54691751|FG005|Overall Study|Sponsor decided to withdraw participant|0|||
28033284|NCT00500331|54691752|FG006|Overall Study|Sponsor decided to withdraw participant|0|||
28033285|NCT00500331|54691746|FG000|Overall Study|Participant was randomized by mistake|1|||
28033286|NCT00500331|54691747|FG001|Overall Study|Participant was randomized by mistake|0|||
28033287|NCT00500331|54691748|FG002|Overall Study|Participant was randomized by mistake|0|||
28033288|NCT00500331|54691749|FG003|Overall Study|Participant was randomized by mistake|0|||
28033289|NCT00500331|54691750|FG004|Overall Study|Participant was randomized by mistake|0|||
27844443|NCT01404325|54334311|FG000|Overall Study|Graft loss/Retransplantation|1|||
28033290|NCT00500331|54691751|FG005|Overall Study|Participant was randomized by mistake|0|||
28033291|NCT00500331|54691752|FG006|Overall Study|Participant was randomized by mistake|0|||
28033292|NCT00500331|54691746|FG000|Overall Study|Diabetologist nurse in the study|0|||
28033293|NCT00500331|54691747|FG001|Overall Study|Diabetologist nurse in the study|0|||
28033294|NCT00500331|54691748|FG002|Overall Study|Diabetologist nurse in the study|1|||
28033295|NCT00500331|54691749|FG003|Overall Study|Diabetologist nurse in the study|0|||
28033296|NCT00500331|54691750|FG004|Overall Study|Diabetologist nurse in the study|0|||
28033297|NCT00500331|54691751|FG005|Overall Study|Diabetologist nurse in the study|0|||
28033298|NCT00500331|54691752|FG006|Overall Study|Diabetologist nurse in the study|0|||
28033299|NCT00500331|54691746|FG000|Overall Study|State ban of biological samples export|0|||
28033300|NCT00500331|54691747|FG001|Overall Study|State ban of biological samples export|0|||
28033301|NCT00500331|54691748|FG002|Overall Study|State ban of biological samples export|0|||
28033302|NCT00500331|54691749|FG003|Overall Study|State ban of biological samples export|1|||
28033303|NCT00500331|54691750|FG004|Overall Study|State ban of biological samples export|0|||
28033304|NCT00500331|54691751|FG005|Overall Study|State ban of biological samples export|0|||
28033305|NCT00500331|54691752|FG006|Overall Study|State ban of biological samples export|0|||
28033306|NCT00500331|54691746|FG000|Overall Study|Protocol violated|0|||
28033307|NCT00500331|54691747|FG001|Overall Study|Protocol violated|0|||
28033308|NCT00500331|54691748|FG002|Overall Study|Protocol violated|0|||
28033309|NCT00500331|54691749|FG003|Overall Study|Protocol violated|1|||
28033310|NCT00500331|54691750|FG004|Overall Study|Protocol violated|0|||
28033311|NCT00500331|54691751|FG005|Overall Study|Protocol violated|0|||
28033312|NCT00500331|54691752|FG006|Overall Study|Protocol violated|0|||
28033313|NCT00499863|54691771|FG000|Overall Study|Lack of Efficacy|21|||
28033314|NCT00499863|54691772|FG001|Overall Study|Lack of Efficacy|27|||
28033315|NCT00499863|54691771|FG000|Overall Study|Protocol Violation|12|||
28033316|NCT00499863|54691772|FG001|Overall Study|Protocol Violation|7|||
28033317|NCT00499863|54691771|FG000|Overall Study|Withdrawal by Subject|6|||
28033318|NCT00499863|54691772|FG001|Overall Study|Withdrawal by Subject|4|||
28033319|NCT00499863|54691771|FG000|Overall Study|Adverse Event|8|||
28033320|NCT00499863|54691772|FG001|Overall Study|Adverse Event|2|||
28033321|NCT00499863|54691771|FG000|Overall Study|Sponsor decision|2|||
28033322|NCT00499863|54691772|FG001|Overall Study|Sponsor decision|2|||
28033323|NCT00499863|54691771|FG000|Overall Study|Lost to Follow-up|1|||
28033324|NCT00499863|54691772|FG001|Overall Study|Lost to Follow-up|1|||
28033325|NCT00484185|54691778|FG000|Overall Study|Lost to Follow-up|44|||
28033326|NCT00484185|54691778|FG000|Overall Study|Other|20|||
28033327|NCT00484185|54691778|FG000|Overall Study|Randomized but not treated|5|||
28033328|NCT00484185|54691778|FG000|Overall Study|Death|2|||
28033329|NCT00097981|54691784|FG000|Overall Study|Adverse Event|31|||
28033330|NCT00097981|54691785|FG001|Overall Study|Adverse Event|44|||
28033331|NCT00097981|54691784|FG000|Overall Study|Withdrawal by Subject|10|||
28033332|NCT00097981|54691785|FG001|Overall Study|Withdrawal by Subject|8|||
28033333|NCT00097981|54691784|FG000|Overall Study|Protocol Violation|1|||
28033334|NCT00097981|54691785|FG001|Overall Study|Protocol Violation|1|||
28033335|NCT00097981|54691784|FG000|Overall Study|Death|2|||
28033336|NCT00097981|54691785|FG001|Overall Study|Death|4|||
28033337|NCT00097981|54691784|FG000|Overall Study|Physician Decision|7|||
27807534|NCT01791153|54262864|FG003|Part 2: Open-label Period|Lack of Efficacy|0|||
27807535|NCT01791153|54262865|FG004|Part 2: Open-label Period|Lack of Efficacy|0|||
27807536|NCT01791153|54262866|FG005|Part 2: Open-label Period|Lack of Efficacy|0|||
27807537|NCT01791153|54262867|FG006|Part 2: Open-label Period|Lack of Efficacy|0|||
27807538|NCT01791153|54262868|FG007|Part 2: Open-label Period|Lack of Efficacy|1|||
28033338|NCT00097981|54691785|FG001|Overall Study|Physician Decision|1|||
28033339|NCT00097981|54691784|FG000|Overall Study|Disease Progression|8|||
28033340|NCT00097981|54691785|FG001|Overall Study|Disease Progression|2|||
28033341|NCT00097981|54691784|FG000|Overall Study|Transplant planned|28|||
28033342|NCT00097981|54691785|FG001|Overall Study|Transplant planned|27|||
28033343|NCT00097981|54691784|FG000|Overall Study|Other|19|||
28033344|NCT00097981|54691785|FG001|Overall Study|Other|13|||
28033345|NCT00499083|54691791|FG000|Overall Study|Not evaluable|3|||
28033346|NCT00572195|54691795|FG000|Overall Study|Withdrawal by Subject|50|||
28033347|NCT00572195|54691795|FG000|Overall Study|Death|9|||
28033348|NCT00572195|54691795|FG000|Overall Study|Adverse Event|4|||
28033349|NCT00572195|54691795|FG000|Overall Study|Lost to Follow-up|5|||
28033350|NCT00572039|54691801|FG000|Overall Study|Withdrawal by Subject|9|||
28033351|NCT00572039|54691802|FG001|Overall Study|Withdrawal by Subject|6|||
28033352|NCT00572039|54691801|FG000|Overall Study|Death|2|||
28033353|NCT00572039|54691802|FG001|Overall Study|Death|3|||
28033354|NCT00572039|54691801|FG000|Overall Study|Ill|5|||
28033355|NCT00572039|54691802|FG001|Overall Study|Ill|1|||
28033356|NCT00684593|54691812|FG000|Overall Study|Adverse Event|0|||
28033357|NCT00684593|54691813|FG001|Overall Study|Adverse Event|2|||
28033358|NCT00685373|54691819|FG000|Overall Study|Adverse Event|3|||
28033359|NCT00685373|54691819|FG000|Overall Study|Withdrawal by Subject|5|||
28033360|NCT00685373|54691819|FG000|Overall Study|Lack of Efficacy|3|||
28033361|NCT00685373|54691819|FG000|Overall Study|Condition no longer requires study drug|1|||
28033362|NCT00685373|54691819|FG000|Overall Study|Lost to Follow-up|2|||
28033363|NCT00685373|54691819|FG000|Overall Study|Protocol Violation|1|||
28033364|NCT00684515|54691826|FG000|Overall Study|Adverse Event|3|||
28033365|NCT00684515|54691827|FG001|Overall Study|Adverse Event|3|||
28033366|NCT00684515|54691828|FG002|Overall Study|Adverse Event|1|||
28033367|NCT00684515|54691826|FG000|Overall Study|Protocol-Defined Clinical Event|1|||
28033368|NCT00684515|54691827|FG001|Overall Study|Protocol-Defined Clinical Event|0|||
28033369|NCT00684515|54691828|FG002|Overall Study|Protocol-Defined Clinical Event|0|||
28033370|NCT00490815|54691838|FG000|Overall Study|Adverse Event|2|||
28033371|NCT00490815|54691839|FG001|Overall Study|Adverse Event|3|||
28033372|NCT00490815|54691838|FG000|Overall Study|Withdrawal by Subject|4|||
28033373|NCT00490815|54691839|FG001|Overall Study|Withdrawal by Subject|0|||
28033374|NCT00490815|54691838|FG000|Overall Study|Lost to Follow-up|1|||
28033375|NCT00490815|54691839|FG001|Overall Study|Lost to Follow-up|3|||
28033376|NCT00490815|54691838|FG000|Overall Study|Death|1|||
28033377|NCT00490815|54691839|FG001|Overall Study|Death|3|||
28033378|NCT03855189|54691848|FG000|Overall Study|Adverse Event|5|||
28033379|NCT03855189|54691849|FG001|Overall Study|Adverse Event|2|||
28033380|NCT03855189|54691850|FG002|Overall Study|Adverse Event|4|||
28033381|NCT03855189|54691848|FG000|Overall Study|Treatment Failure|1|||
28033382|NCT03855189|54691849|FG001|Overall Study|Treatment Failure|1|||
28033383|NCT03855189|54691850|FG002|Overall Study|Treatment Failure|2|||
28033384|NCT03855189|54691848|FG000|Overall Study|Noncompliance with Protocol|0|||
28033385|NCT03855189|54691849|FG001|Overall Study|Noncompliance with Protocol|1|||
28033386|NCT03855189|54691850|FG002|Overall Study|Noncompliance with Protocol|0|||
28033387|NCT03855189|54691848|FG000|Overall Study|Did Not Return|4|||
28033388|NCT03855189|54691849|FG001|Overall Study|Did Not Return|3|||
28033389|NCT03855189|54691850|FG002|Overall Study|Did Not Return|0|||
28033390|NCT03853551|54691858|FG000|Overall Study|Death|2|||
28033391|NCT03853551|54691858|FG000|Overall Study|7 patients discontinued the study because of disease progression.|7|||
28033392|NCT00423670|54691869|FG000|Treatment Period|Switched to Arm 8 at TW 24|36|||
28033393|NCT00423670|54691870|FG001|Treatment Period|Switched to Arm 8 at TW 24|0|||
28033394|NCT00423670|54691871|FG002|Treatment Period|Switched to Arm 8 at TW 24|0|||
28033395|NCT00423670|54691872|FG003|Treatment Period|Switched to Arm 8 at TW 24|0|||
28033396|NCT00423670|54691873|FG004|Treatment Period|Switched to Arm 8 at TW 24|0|||
28033397|NCT00423670|54691874|FG005|Treatment Period|Switched to Arm 8 at TW 24|0|||
28033398|NCT00423670|54691875|FG006|Treatment Period|Switched to Arm 8 at TW 24|0|||
28033399|NCT00423670|54691876|FG007|Treatment Period|Switched to Arm 8 at TW 24|0|||
27807539|NCT01791153|54262861|FG000|Part 2: Open-label Period|Withdrawal by Subject|0|||
27807540|NCT01791153|54262862|FG001|Part 2: Open-label Period|Withdrawal by Subject|0|||
27807541|NCT01791153|54262863|FG002|Part 2: Open-label Period|Withdrawal by Subject|0|||
27807542|NCT01791153|54262864|FG003|Part 2: Open-label Period|Withdrawal by Subject|0|||
27807543|NCT01791153|54262865|FG004|Part 2: Open-label Period|Withdrawal by Subject|1|||
27807544|NCT01791153|54262866|FG005|Part 2: Open-label Period|Withdrawal by Subject|1|||
28033400|NCT00423670|54691869|FG000|Treatment Period|Adverse Event|8|||
28033401|NCT00423670|54691870|FG001|Treatment Period|Adverse Event|12|||
28033402|NCT00423670|54691871|FG002|Treatment Period|Adverse Event|15|||
28033403|NCT00423670|54691872|FG003|Treatment Period|Adverse Event|20|||
28033404|NCT00423670|54691873|FG004|Treatment Period|Adverse Event|9|||
28033405|NCT00423670|54691874|FG005|Treatment Period|Adverse Event|4|||
28033406|NCT00423670|54691875|FG006|Treatment Period|Adverse Event|7|||
28033407|NCT00423670|54691876|FG007|Treatment Period|Adverse Event|2|||
28033408|NCT00423670|54691869|FG000|Treatment Period|Protocol-defined clinical event|0|||
28033409|NCT00423670|54691870|FG001|Treatment Period|Protocol-defined clinical event|7|||
28033410|NCT00423670|54691871|FG002|Treatment Period|Protocol-defined clinical event|4|||
28033411|NCT00423670|54691872|FG003|Treatment Period|Protocol-defined clinical event|12|||
28033412|NCT00423670|54691873|FG004|Treatment Period|Protocol-defined clinical event|5|||
28033413|NCT00423670|54691874|FG005|Treatment Period|Protocol-defined clinical event|4|||
28033414|NCT00423670|54691875|FG006|Treatment Period|Protocol-defined clinical event|16|||
28033415|NCT00423670|54691876|FG007|Treatment Period|Protocol-defined clinical event|15|||
27807545|NCT01791153|54262867|FG006|Part 2: Open-label Period|Withdrawal by Subject|3|||
27807546|NCT01791153|54262868|FG007|Part 2: Open-label Period|Withdrawal by Subject|2|||
27807547|NCT01791153|54262861|FG000|Part 2: Open-label Period|Physician Decision|0|||
27807548|NCT01791153|54262862|FG001|Part 2: Open-label Period|Physician Decision|0|||
27807549|NCT01791153|54262863|FG002|Part 2: Open-label Period|Physician Decision|0|||
28033416|NCT00423670|54691869|FG000|Treatment Period|Lost to Follow-up|2|||
28033417|NCT00423670|54691870|FG001|Treatment Period|Lost to Follow-up|1|||
28033418|NCT00423670|54691871|FG002|Treatment Period|Lost to Follow-up|3|||
28033419|NCT00423670|54691872|FG003|Treatment Period|Lost to Follow-up|1|||
28033420|NCT00423670|54691873|FG004|Treatment Period|Lost to Follow-up|6|||
28033421|NCT00423670|54691874|FG005|Treatment Period|Lost to Follow-up|0|||
27807550|NCT01791153|54262864|FG003|Part 2: Open-label Period|Physician Decision|0|||
27807551|NCT01791153|54262865|FG004|Part 2: Open-label Period|Physician Decision|1|||
28033422|NCT00423670|54691875|FG006|Treatment Period|Lost to Follow-up|3|||
28033423|NCT00423670|54691876|FG007|Treatment Period|Lost to Follow-up|1|||
27807552|NCT01791153|54262866|FG005|Part 2: Open-label Period|Physician Decision|1|||
28033424|NCT00423670|54691869|FG000|Treatment Period|Subject withdrew (not treatment related)|3|||
28033425|NCT00423670|54691870|FG001|Treatment Period|Subject withdrew (not treatment related)|9|||
28033426|NCT00423670|54691871|FG002|Treatment Period|Subject withdrew (not treatment related)|4|||
27844444|NCT01404325|54334312|FG001|Overall Study|Graft loss/Retransplantation|0|||
27844445|NCT01404325|54334311|FG000|Overall Study|non-specified reason|0|||
27844446|NCT01404325|54334312|FG001|Overall Study|non-specified reason|2|||
27844447|NCT01425463|54334333|FG000|Overall Study|Adverse Event|5|||
27844448|NCT01425463|54334334|FG001|Overall Study|Adverse Event|7|||
27844449|NCT01425463|54334333|FG000|Overall Study|Lack of Efficacy|1|||
27844450|NCT01425463|54334334|FG001|Overall Study|Lack of Efficacy|1|||
27844451|NCT01425463|54334333|FG000|Overall Study|Protocol Violation|2|||
27844452|NCT01425463|54334334|FG001|Overall Study|Protocol Violation|2|||
27844453|NCT01425463|54334333|FG000|Overall Study|Lost to Follow-up|5|||
27844454|NCT01425463|54334334|FG001|Overall Study|Lost to Follow-up|2|||
27844455|NCT01425463|54334333|FG000|Overall Study|Withdrawal by Subject|7|||
27844456|NCT01425463|54334334|FG001|Overall Study|Withdrawal by Subject|5|||
27844457|NCT01425463|54334333|FG000|Overall Study|Unknown Reason|4|||
27844458|NCT01425463|54334334|FG001|Overall Study|Unknown Reason|7|||
27844459|NCT04655586|54334356|FG000|Overall Study|Physician Decision|1|||
27844460|NCT04655586|54334357|FG001|Overall Study|Physician Decision|3|||
27844461|NCT04655586|54334358|FG002|Overall Study|Physician Decision|4|||
27844462|NCT04655586|54334356|FG000|Overall Study|Withdrawal by Subject|1|||
27844463|NCT04655586|54334357|FG001|Overall Study|Withdrawal by Subject|3|||
27844464|NCT04655586|54334358|FG002|Overall Study|Withdrawal by Subject|1|||
27844465|NCT01388647|54334381|FG000|Overall Study|Adverse Event|1|||
27844466|NCT01388647|54334382|FG001|Overall Study|Adverse Event|2|||
28033427|NCT00423670|54691872|FG003|Treatment Period|Subject withdrew (not treatment related)|4|||
28033428|NCT00423670|54691873|FG004|Treatment Period|Subject withdrew (not treatment related)|5|||
28033429|NCT00423670|54691874|FG005|Treatment Period|Subject withdrew (not treatment related)|0|||
28033430|NCT00423670|54691875|FG006|Treatment Period|Subject withdrew (not treatment related)|3|||
27844467|NCT01402063|54334457|FG000|Overall Study|Withdrawal by Subject|3|||
27844468|NCT01402063|54334458|FG001|Overall Study|Withdrawal by Subject|3|||
27844469|NCT01796301|54334466|FG000|Overall Study|Withdrawal by Subject|15|||
27844470|NCT01796301|54334467|FG001|Overall Study|Withdrawal by Subject|15|||
27844471|NCT01796301|54334466|FG000|Overall Study|Lost to Follow-up|3|||
27844472|NCT01796301|54334467|FG001|Overall Study|Lost to Follow-up|3|||
27844473|NCT01796301|54334466|FG000|Overall Study|Death|0|||
27844474|NCT01796301|54334467|FG001|Overall Study|Death|1|||
27844475|NCT01796301|54334466|FG000|Overall Study|Decision by Sponsor|0|||
27844476|NCT01796301|54334467|FG001|Overall Study|Decision by Sponsor|1|||
27844477|NCT01388335|54334486|FG000|Period 1|Progressive Disease|1|||
27844478|NCT01388335|54334486|FG000|Period 2|Progressive Disease|2|||
27844479|NCT01388335|54334486|FG000|Period 2|Sponsor Decision|1|||
27844480|NCT01388335|54334486|FG000|Safety Extension|Progressive Disease|7|||
27844481|NCT01401361|54334533|FG000|Overall Study|Withdrawal by Subject|16|||
27844482|NCT01401361|54334533|FG000|Overall Study|Lack of Efficacy|6|||
28033431|NCT00423670|54691876|FG007|Treatment Period|Subject withdrew (not treatment related)|0|||
28033432|NCT00423670|54691869|FG000|Treatment Period|Investigator decision|0|||
28033433|NCT00423670|54691870|FG001|Treatment Period|Investigator decision|0|||
28033434|NCT00423670|54691871|FG002|Treatment Period|Investigator decision|0|||
28033435|NCT00423670|54691872|FG003|Treatment Period|Investigator decision|0|||
27807553|NCT01791153|54262867|FG006|Part 2: Open-label Period|Physician Decision|0|||
27807554|NCT01791153|54262868|FG007|Part 2: Open-label Period|Physician Decision|0|||
27807555|NCT01926782|54262889|FG000|Overall Study|Participant moved|2|||
27807556|NCT01926782|54262890|FG001|Overall Study|Participant moved|0|||
27807557|NCT01926782|54262891|FG002|Overall Study|Participant moved|1|||
27807558|NCT01926782|54262892|FG003|Overall Study|Participant moved|1|||
27807559|NCT01926782|54262893|FG004|Overall Study|Participant moved|0|||
27807560|NCT01926782|54262894|FG005|Overall Study|Participant moved|3|||
27807561|NCT01926782|54262889|FG000|Overall Study|Physician Decision|0|||
27807562|NCT01926782|54262890|FG001|Overall Study|Physician Decision|2|||
27807563|NCT01926782|54262891|FG002|Overall Study|Physician Decision|1|||
27807564|NCT01926782|54262892|FG003|Overall Study|Physician Decision|1|||
27807565|NCT01926782|54262893|FG004|Overall Study|Physician Decision|0|||
27807566|NCT01926782|54262894|FG005|Overall Study|Physician Decision|0|||
27807567|NCT01926782|54262889|FG000|Overall Study|Other than specified|2|||
27807568|NCT01926782|54262890|FG001|Overall Study|Other than specified|3|||
27807569|NCT01926782|54262891|FG002|Overall Study|Other than specified|5|||
27844483|NCT01401361|54334533|FG000|Overall Study|Physician Decision|1|||
27844484|NCT01401361|54334533|FG000|Overall Study|Lost to Follow-up|3|||
27844485|NCT01401361|54334533|FG000|Overall Study|Subject/family decision post procedure|2|||
27844486|NCT01401283|54334539|FG000|Overall Study|surgery cancelled|5|||
27844487|NCT01401283|54334540|FG001|Overall Study|surgery cancelled|8|||
27844488|NCT01401283|54334539|FG000|Overall Study|preoperative arrhythmia|5|||
27844489|NCT01401283|54334540|FG001|Overall Study|preoperative arrhythmia|0|||
27844490|NCT01401283|54334539|FG000|Overall Study|no central venous access|0|||
27844491|NCT01401283|54334540|FG001|Overall Study|no central venous access|1|||
27844492|NCT01401283|54334539|FG000|Overall Study|suspicion of malignant hyperthermia|0|||
27844493|NCT01401283|54334540|FG001|Overall Study|suspicion of malignant hyperthermia|1|||
27844494|NCT01422889|54334563|FG000|Overall Study|No Data Entered for Study Stent|9|||
27844495|NCT01400971|54334567|FG000|Overall Study|Death|82|||
27844496|NCT01400971|54334567|FG000|Overall Study|Lost to Follow-up|196|||
27844497|NCT01400971|54334567|FG000|Overall Study|Lost to follow up + Subject Decision|2|||
27844498|NCT01400971|54334567|FG000|Overall Study|Physician Decision|57|||
28033436|NCT00423670|54691873|FG004|Treatment Period|Investigator decision|0|||
28033437|NCT00423670|54691874|FG005|Treatment Period|Investigator decision|0|||
28033438|NCT00423670|54691875|FG006|Treatment Period|Investigator decision|0|||
28033439|NCT00423670|54691876|FG007|Treatment Period|Investigator decision|1|||
28033440|NCT00423670|54691869|FG000|Treatment Period|Non-compliance with protocol|3|||
28033441|NCT00423670|54691870|FG001|Treatment Period|Non-compliance with protocol|1|||
28033442|NCT00423670|54691871|FG002|Treatment Period|Non-compliance with protocol|1|||
28033443|NCT00423670|54691872|FG003|Treatment Period|Non-compliance with protocol|3|||
28033444|NCT00423670|54691873|FG004|Treatment Period|Non-compliance with protocol|2|||
28033445|NCT00423670|54691874|FG005|Treatment Period|Non-compliance with protocol|0|||
28033446|NCT00423670|54691875|FG006|Treatment Period|Non-compliance with protocol|2|||
28033447|NCT00423670|54691876|FG007|Treatment Period|Non-compliance with protocol|2|||
28033448|NCT00423670|54691869|FG000|Follow-up Period|Lost to Follow-up|0|||
28033449|NCT00423670|54691870|FG001|Follow-up Period|Lost to Follow-up|12|||
28033450|NCT00423670|54691871|FG002|Follow-up Period|Lost to Follow-up|8|||
28033451|NCT00423670|54691872|FG003|Follow-up Period|Lost to Follow-up|3|||
28033452|NCT00423670|54691873|FG004|Follow-up Period|Lost to Follow-up|1|||
28033453|NCT00423670|54691874|FG005|Follow-up Period|Lost to Follow-up|0|||
28033454|NCT00423670|54691875|FG006|Follow-up Period|Lost to Follow-up|5|||
28033455|NCT00423670|54691876|FG007|Follow-up Period|Lost to Follow-up|0|||
28033456|NCT00423670|54691869|FG000|Follow-up Period|Subject withdrew (not treatment related)|1|||
28033457|NCT00423670|54691870|FG001|Follow-up Period|Subject withdrew (not treatment related)|4|||
28033458|NCT00423670|54691871|FG002|Follow-up Period|Subject withdrew (not treatment related)|2|||
28033459|NCT00423670|54691872|FG003|Follow-up Period|Subject withdrew (not treatment related)|1|||
28033460|NCT00423670|54691873|FG004|Follow-up Period|Subject withdrew (not treatment related)|1|||
28033461|NCT00423670|54691874|FG005|Follow-up Period|Subject withdrew (not treatment related)|0|||
28033462|NCT00423670|54691875|FG006|Follow-up Period|Subject withdrew (not treatment related)|1|||
28033463|NCT00423670|54691876|FG007|Follow-up Period|Subject withdrew (not treatment related)|1|||
28033464|NCT00423670|54691869|FG000|Follow-up Period|Non-compliance with protocol|2|||
28033465|NCT00423670|54691870|FG001|Follow-up Period|Non-compliance with protocol|0|||
28033466|NCT00423670|54691871|FG002|Follow-up Period|Non-compliance with protocol|1|||
28033467|NCT00423670|54691872|FG003|Follow-up Period|Non-compliance with protocol|1|||
28033468|NCT00423670|54691873|FG004|Follow-up Period|Non-compliance with protocol|0|||
28033469|NCT00423670|54691874|FG005|Follow-up Period|Non-compliance with protocol|0|||
28033470|NCT00423670|54691875|FG006|Follow-up Period|Non-compliance with protocol|3|||
28033471|NCT00423670|54691876|FG007|Follow-up Period|Non-compliance with protocol|2|||
28033472|NCT00483717|54691899|FG000|Overall Study|Protocol Violation|5|||
28033473|NCT00483717|54691900|FG001|Overall Study|Protocol Violation|7|||
28033474|NCT00483717|54691899|FG000|Overall Study|Time of dosing missing|1|||
28033475|NCT00483717|54691900|FG001|Overall Study|Time of dosing missing|1|||
28033476|NCT00483717|54691899|FG000|Overall Study|No treatment for migraine|16|||
28033477|NCT00483717|54691900|FG001|Overall Study|No treatment for migraine|13|||
28033478|NCT00483717|54691899|FG000|Overall Study|Lost to Follow-up|1|||
28033479|NCT00483717|54691900|FG001|Overall Study|Lost to Follow-up|0|||
28033480|NCT00483717|54691899|FG000|Overall Study|Withdrawal by Subject|1|||
28033481|NCT00483717|54691900|FG001|Overall Study|Withdrawal by Subject|0|||
28033482|NCT00406354|54691909|FG000|All Randomized Patients|Protocol Violation|0|||
27807570|NCT01926782|54262892|FG003|Overall Study|Other than specified|12|||
27807571|NCT01926782|54262893|FG004|Overall Study|Other than specified|4|||
27807572|NCT01926782|54262894|FG005|Overall Study|Other than specified|11|||
27807573|NCT01926782|54262889|FG000|Overall Study|Adverse Event|13|||
27807574|NCT01926782|54262890|FG001|Overall Study|Adverse Event|4|||
27807575|NCT01926782|54262891|FG002|Overall Study|Adverse Event|17|||
27807576|NCT01926782|54262892|FG003|Overall Study|Adverse Event|4|||
27844499|NCT01400971|54334567|FG000|Overall Study|Withdrawal by Subject|158|||
27844500|NCT01400971|54334567|FG000|Overall Study|Other|422|||
28033483|NCT00406354|54691910|FG001|All Randomized Patients|Protocol Violation|0|||
28033484|NCT00406354|54691911|FG002|All Randomized Patients|Protocol Violation|1|||
28033485|NCT00406354|54691909|FG000|All Randomized and Treated Patients|Lack of Efficacy|7|||
27807577|NCT01926782|54262893|FG004|Overall Study|Adverse Event|3|||
27807578|NCT01926782|54262894|FG005|Overall Study|Adverse Event|14|||
27807579|NCT01926782|54262889|FG000|Overall Study|Poor compliance to protocol|5|||
27807580|NCT01926782|54262890|FG001|Overall Study|Poor compliance to protocol|3|||
27807581|NCT01926782|54262891|FG002|Overall Study|Poor compliance to protocol|8|||
27807582|NCT01926782|54262892|FG003|Overall Study|Poor compliance to protocol|0|||
27807583|NCT01926782|54262893|FG004|Overall Study|Poor compliance to protocol|1|||
27807584|NCT01926782|54262894|FG005|Overall Study|Poor compliance to protocol|6|||
28033486|NCT00406354|54691910|FG001|All Randomized and Treated Patients|Lack of Efficacy|4|||
28033487|NCT00406354|54691911|FG002|All Randomized and Treated Patients|Lack of Efficacy|17|||
28033488|NCT00406354|54691909|FG000|All Randomized and Treated Patients|Adverse Event|6|||
28033489|NCT00406354|54691910|FG001|All Randomized and Treated Patients|Adverse Event|2|||
28033490|NCT00406354|54691911|FG002|All Randomized and Treated Patients|Adverse Event|1|||
28033491|NCT00406354|54691909|FG000|All Randomized and Treated Patients|Parent/Caregiver Decision|2|||
27807585|NCT01926782|54262889|FG000|Overall Study|Randomized and not treated|0|||
27807586|NCT01926782|54262890|FG001|Overall Study|Randomized and not treated|0|||
27807587|NCT01926782|54262891|FG002|Overall Study|Randomized and not treated|0|||
27807588|NCT01926782|54262892|FG003|Overall Study|Randomized and not treated|1|||
27807589|NCT01926782|54262893|FG004|Overall Study|Randomized and not treated|0|||
27844501|NCT01387789|54334571|FG000|Overall Study|Adverse Event|5|||
27844502|NCT01387789|54334571|FG000|Overall Study|Lack of Efficacy|2|||
27844503|NCT01387789|54334571|FG000|Overall Study|Lost to Follow-up|1|||
28033492|NCT00406354|54691910|FG001|All Randomized and Treated Patients|Parent/Caregiver Decision|6|||
28033493|NCT00406354|54691911|FG002|All Randomized and Treated Patients|Parent/Caregiver Decision|1|||
28033494|NCT00406354|54691909|FG000|All Randomized and Treated Patients|Withdrawal by Subject|1|||
28033495|NCT00406354|54691910|FG001|All Randomized and Treated Patients|Withdrawal by Subject|1|||
28033496|NCT00406354|54691911|FG002|All Randomized and Treated Patients|Withdrawal by Subject|2|||
28033497|NCT00406354|54691909|FG000|All Randomized and Treated Patients|Physician Decision|0|||
28033498|NCT00406354|54691910|FG001|All Randomized and Treated Patients|Physician Decision|0|||
27844504|NCT01400893|54334582|FG000|Overall Study|Death|27|||
27844505|NCT01400893|54334583|FG001|Overall Study|Death|21|||
28033499|NCT00406354|54691911|FG002|All Randomized and Treated Patients|Physician Decision|1|||
28033500|NCT00483405|54691919|FG000|Overall Study|Adverse Event|8|||
28033501|NCT00483405|54691919|FG000|Overall Study|Lack of Efficacy|14|||
28033502|NCT00483405|54691919|FG000|Overall Study|Death|3|||
28033503|NCT00483405|54691919|FG000|Overall Study|Withdrawal by Subject|2|||
28033504|NCT00483405|54691919|FG000|Overall Study|Other complicating disease|1|||
28033505|NCT00483327|54691927|FG000|Overall Study|Adverse Event|1|||
28033506|NCT00483327|54691927|FG000|Overall Study|Withdrawal by Subject|3|||
28033507|NCT00483327|54691927|FG000|Overall Study|Lost to Follow-up|4|||
28033508|NCT00483327|54691927|FG000|Overall Study|Patient Non Compliance|2|||
28033509|NCT00684203|54691939|FG000|Overall Study|Adverse Event|6|||
28033510|NCT00684203|54691940|FG001|Overall Study|Adverse Event|4|||
28033511|NCT00684203|54691941|FG002|Overall Study|Adverse Event|8|||
28033512|NCT00684203|54691942|FG003|Overall Study|Adverse Event|0|||
28033513|NCT00684203|54691943|FG004|Overall Study|Adverse Event|0|||
28033514|NCT00684203|54691944|FG005|Overall Study|Adverse Event|0|||
28033515|NCT00684203|54691939|FG000|Overall Study|Protocol-defined clinical event|3|||
28033516|NCT00684203|54691940|FG001|Overall Study|Protocol-defined clinical event|1|||
28033517|NCT00684203|54691941|FG002|Overall Study|Protocol-defined clinical event|0|||
28033518|NCT00684203|54691942|FG003|Overall Study|Protocol-defined clinical event|0|||
28033519|NCT00684203|54691943|FG004|Overall Study|Protocol-defined clinical event|0|||
28033520|NCT00684203|54691944|FG005|Overall Study|Protocol-defined clinical event|0|||
28033521|NCT00684203|54691939|FG000|Overall Study|Withdrawal by Subject|0|||
28033522|NCT00684203|54691940|FG001|Overall Study|Withdrawal by Subject|2|||
28033523|NCT00684203|54691941|FG002|Overall Study|Withdrawal by Subject|1|||
28033524|NCT00684203|54691942|FG003|Overall Study|Withdrawal by Subject|0|||
28033525|NCT00684203|54691943|FG004|Overall Study|Withdrawal by Subject|0|||
28033526|NCT00684203|54691944|FG005|Overall Study|Withdrawal by Subject|0|||
28033527|NCT00684203|54691939|FG000|Overall Study|Did not meet protocol eligibility|0|||
28033528|NCT00684203|54691940|FG001|Overall Study|Did not meet protocol eligibility|1|||
28033529|NCT00684203|54691941|FG002|Overall Study|Did not meet protocol eligibility|0|||
27807590|NCT01926782|54262894|FG005|Overall Study|Randomized and not treated|0|||
27844506|NCT01400893|54334582|FG000|Overall Study|Lost to Follow-up|0|||
28033530|NCT00684203|54691942|FG003|Overall Study|Did not meet protocol eligibility|0|||
28033531|NCT00684203|54691943|FG004|Overall Study|Did not meet protocol eligibility|0|||
28033532|NCT00684203|54691944|FG005|Overall Study|Did not meet protocol eligibility|0|||
28033533|NCT00423592|54691965|FG000|Overall Study|Adverse Event (through Week 12)|2|||
28033534|NCT00423592|54691965|FG000|Overall Study|Adverse Event (post Week 12)|5|||
28033535|NCT00683657|54691971|FG000|Overall Study|Adverse Event|0|||
28033536|NCT00683657|54691972|FG001|Overall Study|Adverse Event|1|||
28033537|NCT00683657|54691971|FG000|Overall Study|Subject Withdrew Consent|1|||
28033538|NCT00683657|54691972|FG001|Overall Study|Subject Withdrew Consent|0|||
28033539|NCT00680771|54691980|FG000|Overall Study|Withdrawal by Subject|1|||
28033540|NCT00680771|54691981|FG001|Overall Study|Withdrawal by Subject|0|||
28033541|NCT00680771|54691980|FG000|Overall Study|Sleep Apnea suspected after PSG|1|||
28033542|NCT00680771|54691981|FG001|Overall Study|Sleep Apnea suspected after PSG|0|||
28033543|NCT00680771|54691980|FG000|Overall Study|Prior Exposure to Hepatitus B Vaccine|4|||
28033544|NCT00680771|54691981|FG001|Overall Study|Prior Exposure to Hepatitus B Vaccine|2|||
28033545|NCT00482703|54691989|FG000|Overall Study|Poor compliance|1|||
28033546|NCT00482703|54691990|FG001|Overall Study|Poor compliance|0|||
28033547|NCT00482391|54692003|FG000|Overall Study|Withdrawal by Subject|1|||
28033548|NCT00482391|54692003|FG000|Overall Study|Adverse Event|1|||
28033549|NCT00482391|54692003|FG000|Overall Study|Death|1|||
28033550|NCT00423046|54692010|FG000|Overall Study|Other|340|||
28033551|NCT00423046|54692011|FG001|Overall Study|Other|345|||
28033552|NCT00496587|54692019|FG000|Overall Study|Adverse Event|2|||
28033553|NCT00496587|54692019|FG000|Overall Study|Progressive Disease|24|||
28033554|NCT00496587|54692019|FG000|Overall Study|Withdrawal by Subject|2|||
28033555|NCT00496587|54692019|FG000|Overall Study|Death|1|||
28033556|NCT00496587|54692019|FG000|Overall Study|Complications unrelated|2|||
28033557|NCT00405652|54692023|FG000|Overall Study|Adverse Event|4|||
28033558|NCT00422734|54692029|FG000|Overall Study|Physician Decision|1|||
28033559|NCT00422734|54692030|FG001|Overall Study|Physician Decision|1|||
28033560|NCT00422734|54692029|FG000|Overall Study|Protocol Violation|1|||
28033561|NCT00422734|54692030|FG001|Overall Study|Protocol Violation|6|||
28033562|NCT00422734|54692029|FG000|Overall Study|Withdrawal by Subject|12|||
28033563|NCT00422734|54692030|FG001|Overall Study|Withdrawal by Subject|8|||
28033564|NCT00422734|54692029|FG000|Overall Study|Adverse Event|0|||
28033565|NCT00422734|54692030|FG001|Overall Study|Adverse Event|3|||
28033566|NCT00422734|54692029|FG000|Overall Study|Partner Decision|0|||
28033567|NCT00422734|54692030|FG001|Overall Study|Partner Decision|3|||
28033568|NCT00422422|54692036|FG000|Overall Study|Lack of Efficacy|1|||
28033569|NCT00422422|54692036|FG000|Overall Study|Protocol Violation|1|||
28033570|NCT00422422|54692036|FG000|Overall Study|Withdrawal by Subject|2|||
28033571|NCT00422422|54692036|FG000|Overall Study|SAE, non-fatal|1|||
28033572|NCT00422422|54692036|FG000|Overall Study|AE, non-serious non-fatal|5|||
27844507|NCT01400893|54334583|FG001|Overall Study|Lost to Follow-up|6|||
27844508|NCT01400815|54334623|FG000|Overall Study|Adverse Event|3|||
28033573|NCT00413374|54692044|FG000|Overall Study|Ineligible due to screening criteria.|3|||
28033574|NCT00413374|54692045|FG001|Overall Study|Ineligible due to screening criteria.|0|||
28033575|NCT00413374|54692044|FG000|Overall Study|Adverse Event|1|||
28033576|NCT00413374|54692045|FG001|Overall Study|Adverse Event|0|||
28033577|NCT00413374|54692044|FG000|Overall Study|Lost to Follow-up|1|||
28033578|NCT00413374|54692045|FG001|Overall Study|Lost to Follow-up|0|||
28033579|NCT00413374|54692044|FG000|Overall Study|Surgery|1|||
28033580|NCT00413374|54692045|FG001|Overall Study|Surgery|0|||
28033581|NCT00682643|54692056|FG000|Overall Study|Adverse Event|12|||
28033582|NCT00682643|54692057|FG001|Overall Study|Adverse Event|23|||
28033583|NCT00682643|54692056|FG000|Overall Study|Lack of Efficacy|2|||
28033584|NCT00682643|54692057|FG001|Overall Study|Lack of Efficacy|0|||
28033585|NCT00682643|54692056|FG000|Overall Study|Protocol Violation|38|||
28033586|NCT00682643|54692057|FG001|Overall Study|Protocol Violation|76|||
28033587|NCT00682643|54692056|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
28033588|NCT00682643|54692057|FG001|Overall Study|Met Protocol-defined Stopping Criteria|4|||
28033589|NCT00682643|54692056|FG000|Overall Study|Lost to Follow-up|1|||
28033590|NCT00682643|54692057|FG001|Overall Study|Lost to Follow-up|6|||
28033591|NCT00682643|54692056|FG000|Overall Study|Physician Decision|2|||
28033592|NCT00682643|54692057|FG001|Overall Study|Physician Decision|6|||
28033593|NCT00682643|54692056|FG000|Overall Study|Withdrawal by Subject|19|||
28033594|NCT00682643|54692057|FG001|Overall Study|Withdrawal by Subject|53|||
28033595|NCT00682643|54692056|FG000|Overall Study|Did Not Receive Study Drug|1|||
28033596|NCT00682643|54692057|FG001|Overall Study|Did Not Receive Study Drug|1|||
28033597|NCT00421408|54692066|FG000|Overall Study|Lost to Follow-up|30|||
28033598|NCT00421408|54692067|FG001|Overall Study|Lost to Follow-up|20|||
27844509|NCT01400815|54334624|FG001|Overall Study|Adverse Event|0|||
28033599|NCT00421408|54692066|FG000|Overall Study|Discountinued from treatment/ f/u cont.|12|||
28033600|NCT00421408|54692067|FG001|Overall Study|Discountinued from treatment/ f/u cont.|25|||
28033601|NCT00679913|54692075|FG000|Overall Study|Protocol Violation|18|||
28033602|NCT00679913|54692076|FG001|Overall Study|Protocol Violation|13|||
28033603|NCT00482001|54692085|FG000|Overall Study|Protocol Violation|1|||
28033604|NCT00482001|54692086|FG001|Overall Study|Protocol Violation|1|||
28033605|NCT00490035|54692098|FG000|Overall Study|AE, non-serious non-fatal|3|||
28033606|NCT00490035|54692099|FG001|Overall Study|AE, non-serious non-fatal|4|||
28033607|NCT00490035|54692100|FG002|Overall Study|AE, non-serious non-fatal|4|||
28033608|NCT00490035|54692101|FG003|Overall Study|AE, non-serious non-fatal|5|||
28033609|NCT00490035|54692098|FG000|Overall Study|Lost to Follow-up|2|||
28033610|NCT00490035|54692099|FG001|Overall Study|Lost to Follow-up|0|||
28033611|NCT00490035|54692100|FG002|Overall Study|Lost to Follow-up|1|||
28033612|NCT00490035|54692101|FG003|Overall Study|Lost to Follow-up|0|||
27844510|NCT01400815|54334623|FG000|Overall Study|Death|0|||
27844511|NCT01400815|54334624|FG001|Overall Study|Death|1|||
27844512|NCT01400815|54334623|FG000|Overall Study|Lost to Follow-up|18|||
27844513|NCT01400815|54334624|FG001|Overall Study|Lost to Follow-up|11|||
27844514|NCT01400815|54334623|FG000|Overall Study|Protocol Violation|0|||
27844515|NCT01400815|54334624|FG001|Overall Study|Protocol Violation|1|||
27844516|NCT01400815|54334623|FG000|Overall Study|Physician Decision|1|||
27844517|NCT01400815|54334624|FG001|Overall Study|Physician Decision|0|||
27844518|NCT01400815|54334623|FG000|Overall Study|Withdrawal by Subject|15|||
27844519|NCT01400815|54334624|FG001|Overall Study|Withdrawal by Subject|8|||
27844520|NCT01400815|54334623|FG000|Overall Study|Subject in jail|1|||
27844521|NCT01400815|54334624|FG001|Overall Study|Subject in jail|0|||
27844522|NCT01400503|54334678|FG000|Overall Study|Withdrawal by Subject|1|||
27844523|NCT01400503|54334678|FG000|Overall Study|Study Terminated by Sponsor|58|||
27844524|NCT01400503|54334678|FG000|Overall Study|Other|1|||
27844525|NCT01400425|54334694|FG000|Overall Study|Withdrawal by Subject|10|||
27844526|NCT01421719|54334700|FG000|Overall Study|Withdrawal by Subject|4|||
27844527|NCT01421641|54334707|FG000|Overall Study|Protocol Violation|2|||
27844528|NCT01421641|54334708|FG001|Overall Study|Protocol Violation|2|||
27844529|NCT01385995|54334716|FG000|Period 1, 2 Months|Physician Decision|1|||
27844530|NCT01385995|54334717|FG001|Period 1, 2 Months|Physician Decision|0|||
27844531|NCT01421017|54334728|FG000|Overall Study|Withdrawal by Subject|2|||
27844532|NCT01421017|54334729|FG001|Overall Study|Withdrawal by Subject|0|||
27844533|NCT01421017|54334730|FG002|Overall Study|Withdrawal by Subject|0|||
27844534|NCT01421017|54334728|FG000|Overall Study|POD|0|||
27844535|NCT01421017|54334729|FG001|Overall Study|POD|6|||
27844536|NCT01421017|54334730|FG002|Overall Study|POD|3|||
27844537|NCT01420627|54334777|FG000|EZN-2279 Treatment Period|Adverse Event|1|||
27844538|NCT01400113|54334787|FG000|Overall Study|Withdrawal by Subject|1|||
27844539|NCT01400113|54334788|FG001|Overall Study|Withdrawal by Subject|1|||
28033613|NCT00490035|54692098|FG000|Overall Study|Withdrawal by Subject|2|||
28033614|NCT00490035|54692099|FG001|Overall Study|Withdrawal by Subject|1|||
28033615|NCT00490035|54692100|FG002|Overall Study|Withdrawal by Subject|1|||
27844540|NCT01399723|54334796|FG000|Overall Study|Lost to Follow-up|0|||
27844541|NCT01399723|54334797|FG001|Overall Study|Lost to Follow-up|1|||
27844542|NCT01385371|54334806|FG000|Overall Study|Adverse Event|54|||
27844543|NCT01385371|54334807|FG001|Overall Study|Adverse Event|19|||
27844544|NCT01385371|54334806|FG000|Overall Study|Lost to Follow-up|16|||
27844545|NCT01385371|54334807|FG001|Overall Study|Lost to Follow-up|16|||
28033616|NCT00490035|54692101|FG003|Overall Study|Withdrawal by Subject|0|||
28033617|NCT00490035|54692098|FG000|Overall Study|Other reason|0|||
28033618|NCT00490035|54692099|FG001|Overall Study|Other reason|1|||
28033619|NCT00490035|54692100|FG002|Overall Study|Other reason|3|||
28033620|NCT00490035|54692101|FG003|Overall Study|Other reason|1|||
28033621|NCT00490035|54692098|FG000|Overall Study|AE, serious fatal|1|||
28033622|NCT00490035|54692099|FG001|Overall Study|AE, serious fatal|0|||
28033623|NCT00490035|54692100|FG002|Overall Study|AE, serious fatal|0|||
28033624|NCT00490035|54692101|FG003|Overall Study|AE, serious fatal|0|||
28033625|NCT00490035|54692098|FG000|Overall Study|Serious adverse event (SAE), non-fatal|0|||
28033626|NCT00490035|54692099|FG001|Overall Study|Serious adverse event (SAE), non-fatal|0|||
27844546|NCT01385371|54334806|FG000|Overall Study|Withdrawal by Subject|52|||
28033627|NCT00490035|54692100|FG002|Overall Study|Serious adverse event (SAE), non-fatal|1|||
27844547|NCT01385371|54334807|FG001|Overall Study|Withdrawal by Subject|39|||
27844548|NCT01385371|54334806|FG000|Overall Study|Protocol Violation|25|||
27844549|NCT01385371|54334807|FG001|Overall Study|Protocol Violation|21|||
27844550|NCT01385371|54334806|FG000|Overall Study|Administrative|2|||
28033628|NCT00490035|54692101|FG003|Overall Study|Serious adverse event (SAE), non-fatal|0|||
27844551|NCT01385371|54334807|FG001|Overall Study|Administrative|2|||
27844552|NCT01399099|54334813|FG000|Overall Study|Lost to Follow-up|11|||
27844553|NCT01399099|54334813|FG000|Overall Study|Physician Decision|1|||
27844554|NCT01399099|54334813|FG000|Overall Study|Protocol Violation|1|||
27844555|NCT01399099|54334813|FG000|Overall Study|Skin Irritation|13|||
27844556|NCT01399099|54334813|FG000|Overall Study|Infection|1|||
27844557|NCT01399099|54334813|FG000|Overall Study|Miscellaneous|4|||
28033629|NCT00490035|54692098|FG000|Overall Study|AE of unknown type|0|||
28033630|NCT00490035|54692099|FG001|Overall Study|AE of unknown type|0|||
28033631|NCT00490035|54692100|FG002|Overall Study|AE of unknown type|2|||
28033632|NCT00490035|54692101|FG003|Overall Study|AE of unknown type|0|||
28033633|NCT00404248|54692114|FG000|Overall Study|pts declining status|0|||
28033634|NCT00404248|54692115|FG001|Overall Study|pts declining status|1|||
28033635|NCT00404248|54692116|FG002|Overall Study|pts declining status|0|||
28033636|NCT00404248|54692117|FG003|Overall Study|pts declining status|0|||
28033637|NCT00404248|54692118|FG004|Overall Study|pts declining status|0|||
28033638|NCT00404248|54692119|FG005|Overall Study|pts declining status|0|||
28033639|NCT00404248|54692120|FG006|Overall Study|pts declining status|0|||
28033640|NCT00404248|54692121|FG007|Overall Study|pts declining status|0|||
28033641|NCT00404248|54692122|FG008|Overall Study|pts declining status|0|||
28033642|NCT00421174|54692150|FG000|Overall Study|Withdrawal by Subject|0|||
28033643|NCT00421174|54692151|FG001|Overall Study|Withdrawal by Subject|1|||
28033644|NCT00421174|54692150|FG000|Overall Study|Ineligible due to infection|2|||
27844558|NCT01398787|54334818|FG000|Overall Study|Adverse Event|1|||
28033645|NCT00421174|54692151|FG001|Overall Study|Ineligible due to infection|0|||
28033646|NCT00496197|54692157|FG000|Overall Study|Discontinued study due to death|43|||
28033647|NCT00496197|54692157|FG000|Overall Study|Adverse Event|13|||
28033648|NCT00496197|54692157|FG000|Overall Study|Does not meet entrance criteria|5|||
28033649|NCT00496197|54692157|FG000|Overall Study|Insufficient clinical response|3|||
28033650|NCT00496197|54692157|FG000|Overall Study|Insufficient bacteriological response|10|||
28033651|NCT00496197|54692157|FG000|Overall Study|Lost to Follow-up|11|||
28033652|NCT00496197|54692157|FG000|Overall Study|Withdrawal by Subject|11|||
28033653|NCT00496197|54692157|FG000|Overall Study|Pathogen not isolated baseline specimen|4|||
28033654|NCT00496197|54692157|FG000|Overall Study|Other|14|||
28033655|NCT00496197|54692157|FG000|Overall Study|Protocol Violation|8|||
28033656|NCT00495495|54692161|FG000|Overall Study|Protocol Violation|99|||
28033657|NCT00404092|54692170|FG000|Overall Study|Death|1|||
28033658|NCT00404092|54692171|FG001|Overall Study|Death|0|||
28033659|NCT00404092|54692172|FG002|Overall Study|Death|0|||
28033660|NCT00404092|54692173|FG003|Overall Study|Death|0|||
28033661|NCT00404092|54692170|FG000|Overall Study|Adverse Event|0|||
28033662|NCT00404092|54692171|FG001|Overall Study|Adverse Event|0|||
28033663|NCT00404092|54692172|FG002|Overall Study|Adverse Event|1|||
28033664|NCT00404092|54692173|FG003|Overall Study|Adverse Event|0|||
28033665|NCT00481767|54692185|FG000|Overall Study|Withdrawal by Subject|16|||
28033666|NCT00481767|54692186|FG001|Overall Study|Withdrawal by Subject|11|||
28033667|NCT00481767|54692185|FG000|Overall Study|Lost to Follow-up|16|||
28033668|NCT00481767|54692186|FG001|Overall Study|Lost to Follow-up|10|||
28033669|NCT00489489|54692195|FG000|Overall Study|Not treated due to protocol violation|0|||
28033670|NCT00489489|54692196|FG001|Overall Study|Not treated due to protocol violation|1|||
28033671|NCT00489489|54692197|FG002|Overall Study|Not treated due to protocol violation|1|||
28033672|NCT00489489|54692195|FG000|Overall Study|Adverse Event|1|||
28033673|NCT00489489|54692196|FG001|Overall Study|Adverse Event|1|||
28033674|NCT00489489|54692197|FG002|Overall Study|Adverse Event|1|||
28033675|NCT00489489|54692195|FG000|Overall Study|Protocol Violation|1|||
28033676|NCT00489489|54692196|FG001|Overall Study|Protocol Violation|0|||
28033677|NCT00489489|54692197|FG002|Overall Study|Protocol Violation|1|||
28033678|NCT00489489|54692195|FG000|Overall Study|Progressive disease|0|||
28033679|NCT00489489|54692196|FG001|Overall Study|Progressive disease|1|||
28033680|NCT00489489|54692197|FG002|Overall Study|Progressive disease|0|||
28033681|NCT00489489|54692195|FG000|Overall Study|Participant did not wish to continue|1|||
28033682|NCT00489489|54692196|FG001|Overall Study|Participant did not wish to continue|1|||
28033683|NCT00489489|54692197|FG002|Overall Study|Participant did not wish to continue|0|||
28033684|NCT00489489|54692195|FG000|Overall Study|Other than above|0|||
28033685|NCT00489489|54692196|FG001|Overall Study|Other than above|1|||
28033686|NCT00489489|54692197|FG002|Overall Study|Other than above|0|||
28033687|NCT00489411|54692209|FG000|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6|||
27844559|NCT01383499|54334824|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
27844560|NCT01383499|54334825|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
28033688|NCT00489411|54692210|FG001|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5|||
28033689|NCT00489411|54692209|FG000|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21|||
28033690|NCT00489411|54692210|FG001|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12|||
28033691|NCT00489411|54692209|FG000|Initial Treatment Period (Weeks 1-5)|Incomplete data|1|||
28033692|NCT00489411|54692210|FG001|Initial Treatment Period (Weeks 1-5)|Incomplete data|5|||
28033693|NCT00489411|54692209|FG000|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11|||
28033694|NCT00489411|54692210|FG001|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12|||
27844561|NCT01383499|54334826|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
27844562|NCT01383499|54334827|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
27844563|NCT01397461|54334843|FG000|Overall Study|Withdrawal by Subject|2|||
27844564|NCT01397461|54334844|FG001|Overall Study|Withdrawal by Subject|1|||
27844565|NCT01397461|54334845|FG002|Overall Study|Withdrawal by Subject|0|||
27844566|NCT01397461|54334843|FG000|Overall Study|Lost to Follow-up|0|||
27844567|NCT01397461|54334844|FG001|Overall Study|Lost to Follow-up|2|||
27844568|NCT01397461|54334845|FG002|Overall Study|Lost to Follow-up|1|||
27844569|NCT01397461|54334843|FG000|Overall Study|Lack of Efficacy|0|||
27844570|NCT01397461|54334844|FG001|Overall Study|Lack of Efficacy|3|||
27844571|NCT01397461|54334845|FG002|Overall Study|Lack of Efficacy|0|||
27844572|NCT01397461|54334843|FG000|Overall Study|Not treated|0|||
27844573|NCT01397461|54334844|FG001|Overall Study|Not treated|0|||
27844574|NCT01397461|54334845|FG002|Overall Study|Not treated|1|||
27844575|NCT01382251|54334855|FG000|Overall Study|Surgeries cancelled or delayed|16|||
27844576|NCT01382251|54334856|FG001|Overall Study|Surgeries cancelled or delayed|16|||
28033695|NCT00489411|54692209|FG000|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
28033696|NCT00489411|54692210|FG001|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
28033697|NCT00420784|54692220|FG000|Overall Study|Adverse Event|11|||
28033698|NCT00420784|54692221|FG001|Overall Study|Adverse Event|29|||
28033699|NCT00420784|54692222|FG002|Overall Study|Adverse Event|10|||
28033700|NCT00420784|54692223|FG003|Overall Study|Adverse Event|5|||
28033701|NCT00420784|54692220|FG000|Overall Study|Withdrawal by Subject|0|||
28033702|NCT00420784|54692221|FG001|Overall Study|Withdrawal by Subject|1|||
28033703|NCT00420784|54692222|FG002|Overall Study|Withdrawal by Subject|0|||
28033704|NCT00420784|54692223|FG003|Overall Study|Withdrawal by Subject|0|||
28033705|NCT00420784|54692220|FG000|Overall Study|Lost to Follow-up|0|||
28033706|NCT00420784|54692221|FG001|Overall Study|Lost to Follow-up|0|||
28033707|NCT00420784|54692222|FG002|Overall Study|Lost to Follow-up|2|||
28033708|NCT00420784|54692223|FG003|Overall Study|Lost to Follow-up|1|||
28033709|NCT00420784|54692220|FG000|Overall Study|Virologic Stopping Rule|17|||
28033710|NCT00420784|54692221|FG001|Overall Study|Virologic Stopping Rule|26|||
28033711|NCT00420784|54692222|FG002|Overall Study|Virologic Stopping Rule|41|||
28033712|NCT00420784|54692223|FG003|Overall Study|Virologic Stopping Rule|67|||
28033713|NCT00420784|54692220|FG000|Overall Study|Other|1|||
28033714|NCT00420784|54692221|FG001|Overall Study|Other|2|||
28033715|NCT00420784|54692222|FG002|Overall Study|Other|0|||
28033716|NCT00420784|54692223|FG003|Overall Study|Other|5|||
28033717|NCT00420628|54692236|FG000|Overall Study|Withdrawn by parent or gaurdian|5|||
28033718|NCT00420628|54692237|FG001|Overall Study|Withdrawn by parent or gaurdian|2|||
28033719|NCT00420628|54692236|FG000|Overall Study|Lost to Follow-up|3|||
28033720|NCT00420628|54692237|FG001|Overall Study|Lost to Follow-up|2|||
28033721|NCT00420628|54692236|FG000|Overall Study|Adverse Event|1|||
28033722|NCT00420628|54692237|FG001|Overall Study|Adverse Event|0|||
28033723|NCT00489255|54692245|FG000|Screening and Initial Randomization|Discontinued prior to taking study drug|9|||
28033724|NCT00489255|54692246|FG001|Screening and Initial Randomization|Discontinued prior to taking study drug|3|||
28033725|NCT00489255|54692245|FG000|Period 1: Days 1 to 28|Adverse Event|21|||
28033726|NCT00489255|54692246|FG001|Period 1: Days 1 to 28|Adverse Event|8|||
28033727|NCT00489255|54692245|FG000|Period 1: Days 1 to 28|Withdrawal by Subject|5|||
28033728|NCT00489255|54692246|FG001|Period 1: Days 1 to 28|Withdrawal by Subject|0|||
28033729|NCT00489255|54692245|FG000|Period 1: Days 1 to 28|Physician Decision|1|||
28033730|NCT00489255|54692246|FG001|Period 1: Days 1 to 28|Physician Decision|4|||
28033731|NCT00489255|54692245|FG000|Period 1: Days 1 to 28|Noncompliance|2|||
28033732|NCT00489255|54692246|FG001|Period 1: Days 1 to 28|Noncompliance|0|||
28033733|NCT00489255|54692245|FG000|Period 2: Days 29 to 56|Adverse Event|3|||
28033734|NCT00489255|54692246|FG001|Period 2: Days 29 to 56|Adverse Event|1|||
28033735|NCT00489255|54692245|FG000|Period 2: Days 29 to 56|Withdrawal by Subject|0|||
28033736|NCT00489255|54692246|FG001|Period 2: Days 29 to 56|Withdrawal by Subject|3|||
28033737|NCT00489255|54692245|FG000|Period 3: Days 57 to 84|Adverse Event|3|||
28033738|NCT00489255|54692246|FG001|Period 3: Days 57 to 84|Adverse Event|3|||
27844577|NCT01382251|54334855|FG000|Overall Study|Lost to Follow-up|4|||
27844578|NCT01382251|54334856|FG001|Overall Study|Lost to Follow-up|4|||
28033739|NCT00489255|54692245|FG000|Period 3: Days 57 to 84|Withdrawal by Subject|1|||
28033740|NCT00489255|54692246|FG001|Period 3: Days 57 to 84|Withdrawal by Subject|0|||
28033741|NCT00489255|54692245|FG000|Period 3: Days 57 to 84|Lost to Follow-up|0|||
28033742|NCT00489255|54692246|FG001|Period 3: Days 57 to 84|Lost to Follow-up|1|||
28033743|NCT00413218|54692254|FG000|Overall Study|Randomized but didn't receive study drug|2|||
28033744|NCT00413218|54692255|FG001|Overall Study|Randomized but didn't receive study drug|8|||
27844579|NCT01382251|54334855|FG000|Overall Study|Contacted after study closed|1|||
27844580|NCT01382251|54334856|FG001|Overall Study|Contacted after study closed|1|||
27844581|NCT01396525|54334861|FG000|Overall Study|Withdrawal by Subject|8|||
27844582|NCT01396525|54334861|FG000|Overall Study|Death|14|||
27844583|NCT01396525|54334861|FG000|Overall Study|Lost to Follow-up|4|||
27844584|NCT02849652|54334873|FG000|Overall Study|Lost to Follow-up|104|||
27844585|NCT02849652|54334874|FG001|Overall Study|Lost to Follow-up|35|||
28033745|NCT00413218|54692254|FG000|Overall Study|Death|57|||
28033746|NCT00413218|54692255|FG001|Overall Study|Death|56|||
28033747|NCT00413218|54692254|FG000|Overall Study|Lost to Follow-up|14|||
28033748|NCT00413218|54692255|FG001|Overall Study|Lost to Follow-up|17|||
28033749|NCT00413218|54692254|FG000|Overall Study|Admin|20|||
28033750|NCT00413218|54692255|FG001|Overall Study|Admin|14|||
28033751|NCT00413218|54692254|FG000|Overall Study|Missing|1|||
28033752|NCT00413218|54692255|FG001|Overall Study|Missing|0|||
28033753|NCT00413218|54692254|FG000|Overall Study|Withdrawal by Subject|9|||
28033754|NCT00413218|54692255|FG001|Overall Study|Withdrawal by Subject|1|||
28033755|NCT00420316|54692264|FG000|Overall Study|Withdrawal by Subject|0|||
28033756|NCT00420316|54692265|FG001|Overall Study|Withdrawal by Subject|1|||
28033757|NCT00420316|54692264|FG000|Overall Study|Lost to Follow-up|12|||
28033758|NCT00420316|54692265|FG001|Overall Study|Lost to Follow-up|8|||
28033759|NCT00494871|54692273|FG000|Double-blind (DB) Treatment Period|Adverse Event|73|||
28033760|NCT00494871|54692274|FG001|Double-blind (DB) Treatment Period|Adverse Event|70|||
28033761|NCT00494871|54692273|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|26|||
28033762|NCT00494871|54692274|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|35|||
28033763|NCT00494871|54692273|FG000|Double-blind (DB) Treatment Period|Death|8|||
28033764|NCT00494871|54692274|FG001|Double-blind (DB) Treatment Period|Death|3|||
27844586|NCT02849652|54334875|FG002|Overall Study|Lost to Follow-up|116|||
27844587|NCT02849652|54334876|FG003|Overall Study|Lost to Follow-up|22|||
27844588|NCT02849652|54334873|FG000|Overall Study|Withdrawal by Subject|10|||
27844589|NCT02849652|54334874|FG001|Overall Study|Withdrawal by Subject|2|||
27939776|NCT00952588|54596113|FG000|Overall Study|Withdrawal by Subject|2|||
27939777|NCT00952588|54596114|FG001|Overall Study|Withdrawal by Subject|5|||
28033765|NCT00494871|54692273|FG000|Double-blind (DB) Treatment Period|Physician Decision|4|||
27844590|NCT02849652|54334875|FG002|Overall Study|Withdrawal by Subject|8|||
28033766|NCT00494871|54692274|FG001|Double-blind (DB) Treatment Period|Physician Decision|13|||
28033767|NCT00494871|54692273|FG000|Double-blind (DB) Treatment Period|Lost to Follow-up|4|||
28033768|NCT00494871|54692274|FG001|Double-blind (DB) Treatment Period|Lost to Follow-up|1|||
28033769|NCT00494871|54692273|FG000|Double-blind (DB) Treatment Period|Protocol Violation|9|||
28033770|NCT00494871|54692274|FG001|Double-blind (DB) Treatment Period|Protocol Violation|9|||
27844591|NCT02849652|54334876|FG003|Overall Study|Withdrawal by Subject|4|||
27844592|NCT01396447|54334888|FG000|Overall Study|Did Not Receive Treatment|3|||
27844593|NCT01396447|54334889|FG001|Overall Study|Did Not Receive Treatment|2|||
27844594|NCT01396447|54334890|FG002|Overall Study|Did Not Receive Treatment|1|||
27844595|NCT01396447|54334891|FG003|Overall Study|Did Not Receive Treatment|0|||
27844596|NCT01396447|54334888|FG000|Overall Study|Adverse Event|15|||
27844597|NCT01396447|54334889|FG001|Overall Study|Adverse Event|12|||
27844598|NCT01396447|54334890|FG002|Overall Study|Adverse Event|12|||
27844599|NCT01396447|54334891|FG003|Overall Study|Adverse Event|17|||
28033771|NCT00494871|54692273|FG000|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18|||
28033772|NCT00494871|54692274|FG001|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28|||
28033773|NCT00494871|54692273|FG000|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3|||
28033774|NCT00494871|54692274|FG001|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1|||
28033775|NCT00494871|54692273|FG000|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12|||
28033776|NCT00494871|54692274|FG001|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8|||
28033777|NCT00494871|54692273|FG000|Double-blind (DB) Treatment Period|Site Closed by Investigator|1|||
28033778|NCT00494871|54692274|FG001|Double-blind (DB) Treatment Period|Site Closed by Investigator|2|||
28033779|NCT00494871|54692273|FG000|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
28033780|NCT00494871|54692274|FG001|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
28033781|NCT00494871|54692273|FG000|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
28033782|NCT00494871|54692274|FG001|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
28033783|NCT00494871|54692273|FG000|Follow-up (FU) Period|Adverse Event|1|||
28033784|NCT00494871|54692274|FG001|Follow-up (FU) Period|Adverse Event|1|||
28033785|NCT00494871|54692273|FG000|Follow-up (FU) Period|Death|13|||
28033786|NCT00494871|54692274|FG001|Follow-up (FU) Period|Death|12|||
28033787|NCT00494871|54692273|FG000|Follow-up (FU) Period|Lost to Follow-up|6|||
28033788|NCT00494871|54692274|FG001|Follow-up (FU) Period|Lost to Follow-up|2|||
28033789|NCT00494871|54692273|FG000|Follow-up (FU) Period|Physician Decision|0|||
28033790|NCT00494871|54692274|FG001|Follow-up (FU) Period|Physician Decision|1|||
28033791|NCT00494871|54692273|FG000|Follow-up (FU) Period|Protocol Violation|1|||
28033792|NCT00494871|54692274|FG001|Follow-up (FU) Period|Protocol Violation|0|||
28033793|NCT00494871|54692273|FG000|Follow-up (FU) Period|Withdrawal by Subject|5|||
28033794|NCT00494871|54692274|FG001|Follow-up (FU) Period|Withdrawal by Subject|5|||
28033795|NCT00494871|54692273|FG000|Follow-up (FU) Period|Clinical Endpoint Reached|3|||
28033796|NCT00494871|54692274|FG001|Follow-up (FU) Period|Clinical Endpoint Reached|2|||
28033797|NCT00420238|54692284|FG000|12 Week Double-Blind Treatment Period 1|Adverse Event|1|||
28033798|NCT00420238|54692285|FG001|12 Week Double-Blind Treatment Period 1|Adverse Event|0|||
28033799|NCT00420238|54692284|FG000|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0|||
28033800|NCT00420238|54692285|FG001|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2|||
28033801|NCT00420238|54692284|FG000|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0|||
28033802|NCT00420238|54692285|FG001|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1|||
28033803|NCT00420238|54692284|FG000|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0|||
28033804|NCT00420238|54692285|FG001|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1|||
28033805|NCT00420238|54692284|FG000|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1|||
28033806|NCT00420238|54692285|FG001|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0|||
28033807|NCT00420238|54692284|FG000|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
28033808|NCT00420238|54692285|FG001|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
28033809|NCT00420004|54692300|FG000|Overall Study|Adverse Event|4|||
28033810|NCT00420004|54692301|FG001|Overall Study|Adverse Event|1|||
28033811|NCT00420004|54692302|FG002|Overall Study|Adverse Event|1|||
28033812|NCT00420004|54692300|FG000|Overall Study|Lack of Efficacy|5|||
28033813|NCT00420004|54692301|FG001|Overall Study|Lack of Efficacy|4|||
28033814|NCT00420004|54692302|FG002|Overall Study|Lack of Efficacy|1|||
28033815|NCT00420004|54692300|FG000|Overall Study|Lost to Follow-up|31|||
28033816|NCT00420004|54692301|FG001|Overall Study|Lost to Follow-up|12|||
28033817|NCT00420004|54692302|FG002|Overall Study|Lost to Follow-up|10|||
28033818|NCT00420004|54692300|FG000|Overall Study|Entry Criteria Not Met|0|||
28033819|NCT00420004|54692301|FG001|Overall Study|Entry Criteria Not Met|1|||
28033820|NCT00420004|54692302|FG002|Overall Study|Entry Criteria Not Met|0|||
28033821|NCT00420004|54692300|FG000|Overall Study|Physician Decision|14|||
28033822|NCT00420004|54692301|FG001|Overall Study|Physician Decision|4|||
28033823|NCT00420004|54692302|FG002|Overall Study|Physician Decision|2|||
28033824|NCT00420004|54692300|FG000|Overall Study|Protocol Violation|5|||
28033825|NCT00420004|54692301|FG001|Overall Study|Protocol Violation|4|||
28033826|NCT00420004|54692302|FG002|Overall Study|Protocol Violation|3|||
28033827|NCT00420004|54692300|FG000|Overall Study|Withdrawal by Subject|67|||
28033828|NCT00420004|54692301|FG001|Overall Study|Withdrawal by Subject|42|||
28033829|NCT00420004|54692302|FG002|Overall Study|Withdrawal by Subject|14|||
28033830|NCT00420004|54692300|FG000|Overall Study|Sponsor Decision|3|||
28033831|NCT00420004|54692301|FG001|Overall Study|Sponsor Decision|3|||
28033832|NCT00420004|54692302|FG002|Overall Study|Sponsor Decision|1|||
27844600|NCT01396447|54334888|FG000|Overall Study|Insufficient Therapeutic Response|5|||
28033833|NCT00494481|54692316|FG000|Overall Study|Condition under investigation worsened|11|||
28033834|NCT00494481|54692317|FG001|Overall Study|Condition under investigation worsened|13|||
28033835|NCT00494481|54692316|FG000|Overall Study|Adverse Event|15|||
28033836|NCT00494481|54692317|FG001|Overall Study|Adverse Event|11|||
28033837|NCT00494481|54692316|FG000|Overall Study|Other|1|||
28033838|NCT00494481|54692317|FG001|Overall Study|Other|0|||
28033839|NCT00494481|54692316|FG000|Overall Study|Never received IP|2|||
28033840|NCT00494481|54692317|FG001|Overall Study|Never received IP|0|||
28033841|NCT00097591|54692325|FG000|Overall Study|Withdrawal of consent|342|||
28033842|NCT00097591|54692326|FG001|Overall Study|Withdrawal of consent|323|||
28033843|NCT00097591|54692325|FG000|Overall Study|Less than 6 months on study drug|9|||
27807591|NCT01926782|54262889|FG000|Overall Study|Withdrawal by Subject|6|||
28033844|NCT00097591|54692326|FG001|Overall Study|Less than 6 months on study drug|7|||
28033845|NCT00097591|54692325|FG000|Overall Study|Unable to attend termination visit|53|||
28033846|NCT00097591|54692326|FG001|Overall Study|Unable to attend termination visit|51|||
28033847|NCT00097591|54692325|FG000|Overall Study|Lost to follow up|6|||
28033848|NCT00097591|54692326|FG001|Overall Study|Lost to follow up|10|||
28033849|NCT00097591|54692325|FG000|Overall Study|Other|0|||
28033850|NCT00097591|54692326|FG001|Overall Study|Other|3|||
28033851|NCT00419926|54692334|FG000|Overall Study|Withdrawal by Subject|7|||
28033852|NCT00419926|54692335|FG001|Overall Study|Withdrawal by Subject|3|||
28033853|NCT00419926|54692334|FG000|Overall Study|Administrative Problem|4|||
28033854|NCT00419926|54692335|FG001|Overall Study|Administrative Problem|4|||
28033855|NCT00419926|54692334|FG000|Overall Study|Lost to Follow-up|1|||
28033856|NCT00419926|54692335|FG001|Overall Study|Lost to Follow-up|2|||
28033857|NCT00419926|54692334|FG000|Overall Study|Death|2|||
28033858|NCT00419926|54692335|FG001|Overall Study|Death|1|||
28033859|NCT00419770|54692343|FG000|Overall Study|Withdrawal by Subject|5|||
28033860|NCT00419770|54692344|FG001|Overall Study|Withdrawal by Subject|1|||
28033861|NCT00080119|54692354|FG000|Overall Study|Discontinued because of study closure|0|||
28033862|NCT00080119|54692355|FG001|Overall Study|Discontinued because of study closure|0|||
28033863|NCT00080119|54692356|FG002|Overall Study|Discontinued because of study closure|130|||
28033864|NCT00080119|54692357|FG003|Overall Study|Discontinued because of study closure|141|||
28033865|NCT00080119|54692354|FG000|Overall Study|Unable to get to clinic|24|||
28033866|NCT00080119|54692355|FG001|Overall Study|Unable to get to clinic|24|||
27807592|NCT01926782|54262890|FG001|Overall Study|Withdrawal by Subject|1|||
27807593|NCT01926782|54262891|FG002|Overall Study|Withdrawal by Subject|8|||
27807594|NCT01926782|54262892|FG003|Overall Study|Withdrawal by Subject|1|||
27807595|NCT01926782|54262893|FG004|Overall Study|Withdrawal by Subject|0|||
27807596|NCT01926782|54262894|FG005|Overall Study|Withdrawal by Subject|5|||
27807597|NCT01926782|54262889|FG000|Overall Study|Related to study drug administration|0|||
27807598|NCT01926782|54262890|FG001|Overall Study|Related to study drug administration|0|||
27807599|NCT01926782|54262891|FG002|Overall Study|Related to study drug administration|0|||
27807600|NCT01926782|54262892|FG003|Overall Study|Related to study drug administration|0|||
27807601|NCT01926782|54262893|FG004|Overall Study|Related to study drug administration|0|||
27807602|NCT01926782|54262894|FG005|Overall Study|Related to study drug administration|2|||
27807603|NCT01926626|54262909|FG000|Overall Study|Withdrawal by Subject|15|||
27807604|NCT01926626|54262909|FG000|Overall Study|Lost to Follow-up|7|||
27807605|NCT01953224|54262915|FG000|Overall Study|Lost to Follow-up|1|||
27939778|NCT00952588|54596113|FG000|Overall Study|Adverse Event|2|||
28033867|NCT00080119|54692356|FG002|Overall Study|Unable to get to clinic|7|||
28033868|NCT00080119|54692357|FG003|Overall Study|Unable to get to clinic|1|||
28033869|NCT00080119|54692354|FG000|Overall Study|Consent withdrawn|13|||
28033870|NCT00080119|54692355|FG001|Overall Study|Consent withdrawn|17|||
28033871|NCT00080119|54692356|FG002|Overall Study|Consent withdrawn|4|||
28033872|NCT00080119|54692357|FG003|Overall Study|Consent withdrawn|6|||
28033873|NCT00080119|54692354|FG000|Overall Study|Unwilling to adhere to study requirement|3|||
28033874|NCT00080119|54692355|FG001|Overall Study|Unwilling to adhere to study requirement|2|||
28033875|NCT00080119|54692356|FG002|Overall Study|Unwilling to adhere to study requirement|5|||
28033876|NCT00080119|54692357|FG003|Overall Study|Unwilling to adhere to study requirement|1|||
28033877|NCT00080119|54692354|FG000|Overall Study|Lost to Follow-up|16|||
28033878|NCT00080119|54692355|FG001|Overall Study|Lost to Follow-up|19|||
28033879|NCT00080119|54692356|FG002|Overall Study|Lost to Follow-up|19|||
28033880|NCT00080119|54692357|FG003|Overall Study|Lost to Follow-up|14|||
28033881|NCT00419380|54692371|FG000|Overall Study|Lack of Efficacy|1|||
28033882|NCT00419380|54692372|FG001|Overall Study|Lack of Efficacy|7|||
28033883|NCT00419380|54692371|FG000|Overall Study|Physician Decision|0|||
28033884|NCT00419380|54692372|FG001|Overall Study|Physician Decision|1|||
28033885|NCT00419380|54692371|FG000|Overall Study|Lost to Follow-up|0|||
28033886|NCT00419380|54692372|FG001|Overall Study|Lost to Follow-up|1|||
28033887|NCT00419380|54692371|FG000|Overall Study|Withdrawal by Subject|0|||
28033888|NCT00419380|54692372|FG001|Overall Study|Withdrawal by Subject|1|||
28033889|NCT00413062|54692380|FG000|Overall Study|Adverse event/serious adverse event|289|||
28033890|NCT00413062|54692381|FG001|Overall Study|Adverse event/serious adverse event|56|||
28033891|NCT00413062|54692380|FG000|Overall Study|Pre-treatment (serious) adverse event|1|||
28033892|NCT00413062|54692381|FG001|Overall Study|Pre-treatment (serious) adverse event|0|||
28033893|NCT00413062|54692380|FG000|Overall Study|Withdrawal of informed consent|111|||
28033894|NCT00413062|54692381|FG001|Overall Study|Withdrawal of informed consent|36|||
28033895|NCT00413062|54692380|FG000|Overall Study|Pregnancy|15|||
28033896|NCT00413062|54692381|FG001|Overall Study|Pregnancy|5|||
28033897|NCT00413062|54692380|FG000|Overall Study|Pregnancy wish|17|||
28033898|NCT00413062|54692381|FG001|Overall Study|Pregnancy wish|6|||
28033899|NCT00413062|54692380|FG000|Overall Study|Lost to Follow-up|175|||
28033900|NCT00413062|54692381|FG001|Overall Study|Lost to Follow-up|73|||
28033901|NCT00413062|54692380|FG000|Overall Study|Other reason|70|||
28033902|NCT00413062|54692381|FG001|Overall Study|Other reason|34|||
28033903|NCT00494091|54692391|FG000|Overall Study|Death|5|||
28033904|NCT00494091|54692392|FG001|Overall Study|Death|54|||
28033905|NCT00494091|54692391|FG000|Overall Study|Lost to Follow-up|0|||
28033906|NCT00494091|54692392|FG001|Overall Study|Lost to Follow-up|4|||
28033907|NCT00494091|54692391|FG000|Overall Study|Other|1|||
28033908|NCT00494091|54692392|FG001|Overall Study|Other|11|||
28033909|NCT00494091|54692391|FG000|Overall Study|Withdrawal by Subject|0|||
28033910|NCT00494091|54692392|FG001|Overall Study|Withdrawal by Subject|7|||
28033911|NCT00494013|54692401|FG000|Overall Study|Adverse Event|0|||
28033912|NCT00494013|54692402|FG001|Overall Study|Adverse Event|1|||
28033913|NCT00494013|54692401|FG000|Overall Study|Entry Criteria Not Met|1|||
28033914|NCT00494013|54692402|FG001|Overall Study|Entry Criteria Not Met|4|||
28033915|NCT00494013|54692401|FG000|Overall Study|Lost to Follow-up|5|||
28033916|NCT00494013|54692402|FG001|Overall Study|Lost to Follow-up|6|||
28033917|NCT00494013|54692401|FG000|Overall Study|Physician Decision|3|||
28033918|NCT00494013|54692402|FG001|Overall Study|Physician Decision|5|||
28033919|NCT00494013|54692401|FG000|Overall Study|Protocol Violation|8|||
28033920|NCT00494013|54692402|FG001|Overall Study|Protocol Violation|5|||
28033921|NCT00494013|54692401|FG000|Overall Study|Withdrawal by Subject|13|||
28033922|NCT00494013|54692402|FG001|Overall Study|Withdrawal by Subject|14|||
28033923|NCT00494013|54692401|FG000|Overall Study|Sponsor Decision|0|||
28033924|NCT00494013|54692402|FG001|Overall Study|Sponsor Decision|1|||
28033925|NCT00079339|54692411|FG000|Overall Study|Adverse Event|1|||
28033926|NCT00079339|54692412|FG001|Overall Study|Adverse Event|7|||
28033927|NCT00079339|54692413|FG002|Overall Study|Adverse Event|2|||
28033928|NCT00079339|54692411|FG000|Overall Study|Death|1|||
28033929|NCT00079339|54692412|FG001|Overall Study|Death|0|||
27844601|NCT01396447|54334889|FG001|Overall Study|Insufficient Therapeutic Response|5|||
27939779|NCT00952588|54596114|FG001|Overall Study|Adverse Event|3|||
27939780|NCT00952588|54596113|FG000|Overall Study|Lost to Follow-up|2|||
28033930|NCT00079339|54692413|FG002|Overall Study|Death|0|||
28033931|NCT00079339|54692411|FG000|Overall Study|Non-compliance|0|||
28033932|NCT00079339|54692412|FG001|Overall Study|Non-compliance|0|||
28033933|NCT00079339|54692413|FG002|Overall Study|Non-compliance|1|||
28033934|NCT00079339|54692411|FG000|Overall Study|Withdrawal by Subject|0|||
28033935|NCT00079339|54692412|FG001|Overall Study|Withdrawal by Subject|4|||
28033936|NCT00079339|54692413|FG002|Overall Study|Withdrawal by Subject|1|||
28033937|NCT00079339|54692411|FG000|Overall Study|Disease progression|3|||
28033938|NCT00079339|54692412|FG001|Overall Study|Disease progression|28|||
28033939|NCT00079339|54692413|FG002|Overall Study|Disease progression|2|||
28033940|NCT00493779|54692426|FG000|Overall Study|Logistical issue at site|1|||
28033941|NCT00541866|54692436|FG000|Overall Study|Adverse Event|3|||
28033942|NCT00541866|54692437|FG001|Overall Study|Adverse Event|0|||
27939781|NCT00952588|54596114|FG001|Overall Study|Lost to Follow-up|0|||
28033943|NCT00541866|54692438|FG002|Overall Study|Adverse Event|0|||
28033944|NCT00541866|54692439|FG003|Overall Study|Adverse Event|0|||
28033945|NCT00541866|54692440|FG004|Overall Study|Adverse Event|0|||
28033946|NCT00541866|54692436|FG000|Overall Study|Death|1|||
28033947|NCT00541866|54692437|FG001|Overall Study|Death|0|||
28033948|NCT00541866|54692438|FG002|Overall Study|Death|0|||
28033949|NCT00541866|54692439|FG003|Overall Study|Death|0|||
28033950|NCT00541866|54692440|FG004|Overall Study|Death|0|||
28033951|NCT00541866|54692436|FG000|Overall Study|Lack of Efficacy|19|||
27844602|NCT01396447|54334890|FG002|Overall Study|Insufficient Therapeutic Response|2|||
27844603|NCT01396447|54334891|FG003|Overall Study|Insufficient Therapeutic Response|4|||
27844604|NCT01396447|54334888|FG000|Overall Study|Protocol Violation|5|||
27844605|NCT01396447|54334889|FG001|Overall Study|Protocol Violation|2|||
27844606|NCT01396447|54334890|FG002|Overall Study|Protocol Violation|3|||
27844607|NCT01396447|54334891|FG003|Overall Study|Protocol Violation|7|||
27844608|NCT01396447|54334888|FG000|Overall Study|Withdrawal of Consent|11|||
27844609|NCT01396447|54334889|FG001|Overall Study|Withdrawal of Consent|9|||
27844610|NCT01396447|54334890|FG002|Overall Study|Withdrawal of Consent|4|||
27844611|NCT01396447|54334891|FG003|Overall Study|Withdrawal of Consent|15|||
27844612|NCT01396447|54334888|FG000|Overall Study|Lost to Follow-up|4|||
27844613|NCT01396447|54334889|FG001|Overall Study|Lost to Follow-up|8|||
27844614|NCT01396447|54334890|FG002|Overall Study|Lost to Follow-up|7|||
27844615|NCT01396447|54334891|FG003|Overall Study|Lost to Follow-up|9|||
27844616|NCT01396447|54334888|FG000|Overall Study|Other Miscellaneous Reasons|0|||
28033952|NCT00541866|54692437|FG001|Overall Study|Lack of Efficacy|15|||
28033953|NCT00541866|54692438|FG002|Overall Study|Lack of Efficacy|10|||
28033954|NCT00541866|54692439|FG003|Overall Study|Lack of Efficacy|12|||
28033955|NCT00541866|54692440|FG004|Overall Study|Lack of Efficacy|14|||
28033956|NCT00541866|54692436|FG000|Overall Study|Not Reported or Other|11|||
28033957|NCT00541866|54692437|FG001|Overall Study|Not Reported or Other|3|||
28033958|NCT00541866|54692438|FG002|Overall Study|Not Reported or Other|3|||
28033959|NCT00541866|54692439|FG003|Overall Study|Not Reported or Other|3|||
28033960|NCT00541866|54692440|FG004|Overall Study|Not Reported or Other|1|||
28033961|NCT00541866|54692436|FG000|Overall Study|Physician Decision|0|||
28033962|NCT00541866|54692437|FG001|Overall Study|Physician Decision|0|||
28033963|NCT00541866|54692438|FG002|Overall Study|Physician Decision|2|||
28033964|NCT00541866|54692439|FG003|Overall Study|Physician Decision|1|||
28033965|NCT00541866|54692440|FG004|Overall Study|Physician Decision|0|||
28033966|NCT00493467|54692468|FG000|Overall Study|Death|1|||
28033967|NCT00090493|54692472|FG000|Overall Study|Physician Decision|2|||
28033968|NCT04329702|54692479|FG000|Overall Study|illness|3|||
28033969|NCT04329702|54692480|FG001|Overall Study|illness|4|||
28033970|NCT04329702|54692481|FG002|Overall Study|illness|0|||
28033971|NCT04329702|54692479|FG000|Overall Study|Lost to Follow-up|0|||
28033972|NCT04329702|54692480|FG001|Overall Study|Lost to Follow-up|0|||
28033973|NCT04329702|54692481|FG002|Overall Study|Lost to Follow-up|2|||
28033974|NCT04329702|54692479|FG000|Overall Study|Death|0|||
28033975|NCT04329702|54692480|FG001|Overall Study|Death|2|||
28033976|NCT04329702|54692481|FG002|Overall Study|Death|0|||
28033977|NCT00481065|54692502|FG000|Overall Study|Adverse event or death|1|||
28033978|NCT00481065|54692503|FG001|Overall Study|Adverse event or death|1|||
28033979|NCT00481065|54692504|FG002|Overall Study|Adverse event or death|3|||
28033980|NCT00481065|54692505|FG003|Overall Study|Adverse event or death|0|||
28033981|NCT00481065|54692506|FG004|Overall Study|Adverse event or death|2|||
28033982|NCT00481065|54692507|FG005|Overall Study|Adverse event or death|0|||
28033983|NCT00481065|54692508|FG006|Overall Study|Adverse event or death|1|||
28033984|NCT00481065|54692509|FG007|Overall Study|Adverse event or death|1|||
28033985|NCT00481065|54692502|FG000|Overall Study|Withdrawal by Subject|11|||
28033986|NCT00481065|54692503|FG001|Overall Study|Withdrawal by Subject|12|||
28033987|NCT00481065|54692504|FG002|Overall Study|Withdrawal by Subject|7|||
28033988|NCT00481065|54692505|FG003|Overall Study|Withdrawal by Subject|11|||
28033989|NCT00481065|54692506|FG004|Overall Study|Withdrawal by Subject|13|||
28033990|NCT00481065|54692507|FG005|Overall Study|Withdrawal by Subject|12|||
28033991|NCT00481065|54692508|FG006|Overall Study|Withdrawal by Subject|9|||
28033992|NCT00481065|54692509|FG007|Overall Study|Withdrawal by Subject|10|||
28033993|NCT00481065|54692502|FG000|Overall Study|Lost to Follow-up|4|||
28033994|NCT00481065|54692503|FG001|Overall Study|Lost to Follow-up|2|||
28033995|NCT00481065|54692504|FG002|Overall Study|Lost to Follow-up|4|||
28033996|NCT00481065|54692505|FG003|Overall Study|Lost to Follow-up|3|||
28033997|NCT00481065|54692506|FG004|Overall Study|Lost to Follow-up|3|||
28033998|NCT00481065|54692507|FG005|Overall Study|Lost to Follow-up|3|||
28033999|NCT00481065|54692508|FG006|Overall Study|Lost to Follow-up|2|||
27939782|NCT00952588|54596113|FG000|Overall Study|Physician Decision|0|||
28034000|NCT00481065|54692509|FG007|Overall Study|Lost to Follow-up|5|||
28034001|NCT00481065|54692502|FG000|Overall Study|Inappropriate enrollment|4|||
28034002|NCT00481065|54692503|FG001|Overall Study|Inappropriate enrollment|0|||
27844617|NCT01396447|54334889|FG001|Overall Study|Other Miscellaneous Reasons|2|||
27844618|NCT01396447|54334890|FG002|Overall Study|Other Miscellaneous Reasons|1|||
28034003|NCT00481065|54692504|FG002|Overall Study|Inappropriate enrollment|2|||
28034004|NCT00481065|54692505|FG003|Overall Study|Inappropriate enrollment|0|||
28034005|NCT00481065|54692506|FG004|Overall Study|Inappropriate enrollment|2|||
28034006|NCT00481065|54692507|FG005|Overall Study|Inappropriate enrollment|1|||
28034007|NCT00481065|54692508|FG006|Overall Study|Inappropriate enrollment|0|||
28034008|NCT00481065|54692509|FG007|Overall Study|Inappropriate enrollment|1|||
28034009|NCT00481065|54692502|FG000|Overall Study|Administrative reason|0|||
28034010|NCT00481065|54692503|FG001|Overall Study|Administrative reason|0|||
28034011|NCT00481065|54692504|FG002|Overall Study|Administrative reason|0|||
28034012|NCT00481065|54692505|FG003|Overall Study|Administrative reason|0|||
28034013|NCT00481065|54692506|FG004|Overall Study|Administrative reason|0|||
28034014|NCT00481065|54692507|FG005|Overall Study|Administrative reason|2|||
28034015|NCT00481065|54692508|FG006|Overall Study|Administrative reason|1|||
28034016|NCT00481065|54692509|FG007|Overall Study|Administrative reason|0|||
28034017|NCT00481065|54692502|FG000|Overall Study|Protocol Violation|2|||
28034018|NCT00481065|54692503|FG001|Overall Study|Protocol Violation|1|||
28034019|NCT00481065|54692504|FG002|Overall Study|Protocol Violation|1|||
28034020|NCT00481065|54692505|FG003|Overall Study|Protocol Violation|1|||
28034021|NCT00481065|54692506|FG004|Overall Study|Protocol Violation|2|||
28034022|NCT00481065|54692507|FG005|Overall Study|Protocol Violation|6|||
28034023|NCT00481065|54692508|FG006|Overall Study|Protocol Violation|3|||
28034024|NCT00481065|54692509|FG007|Overall Study|Protocol Violation|2|||
28034025|NCT00481065|54692502|FG000|Overall Study|Unable to classify|0|||
28034026|NCT00481065|54692503|FG001|Overall Study|Unable to classify|1|||
28034027|NCT00481065|54692504|FG002|Overall Study|Unable to classify|2|||
28034028|NCT00481065|54692505|FG003|Overall Study|Unable to classify|0|||
28034029|NCT00481065|54692506|FG004|Overall Study|Unable to classify|1|||
28034030|NCT00481065|54692507|FG005|Overall Study|Unable to classify|0|||
28034031|NCT00481065|54692508|FG006|Overall Study|Unable to classify|0|||
28034032|NCT00481065|54692509|FG007|Overall Study|Unable to classify|0|||
28034033|NCT00493311|54692531|FG000|Overall Study|Need for rescue medication|2|||
28034034|NCT00493311|54692532|FG001|Overall Study|Need for rescue medication|2|||
28034035|NCT00571649|54692540|FG000|Treatment Period|Adverse Event|438|||
28034036|NCT00571649|54692541|FG001|Treatment Period|Adverse Event|385|||
28034037|NCT00571649|54692540|FG000|Treatment Period|Clinical endpoint reached|50|||
28034038|NCT00571649|54692541|FG001|Treatment Period|Clinical endpoint reached|56|||
28034039|NCT00571649|54692540|FG000|Treatment Period|Withdrawal by Subject|285|||
28034040|NCT00571649|54692541|FG001|Treatment Period|Withdrawal by Subject|255|||
28034041|NCT00571649|54692540|FG000|Treatment Period|Death|76|||
28034042|NCT00571649|54692541|FG001|Treatment Period|Death|59|||
28034043|NCT00571649|54692540|FG000|Treatment Period|Physician Decision|8|||
28034044|NCT00571649|54692541|FG001|Treatment Period|Physician Decision|9|||
28034045|NCT00571649|54692540|FG000|Treatment Period|Lost to Follow-up|43|||
28034046|NCT00571649|54692541|FG001|Treatment Period|Lost to Follow-up|41|||
28034047|NCT00571649|54692540|FG000|Treatment Period|Non-compliant with study medication|88|||
28034048|NCT00571649|54692541|FG001|Treatment Period|Non-compliant with study medication|89|||
28034049|NCT00571649|54692540|FG000|Treatment Period|Patient convenience|11|||
28034050|NCT00571649|54692541|FG001|Treatment Period|Patient convenience|13|||
28034051|NCT00571649|54692540|FG000|Treatment Period|Protocol Violation|90|||
28034052|NCT00571649|54692541|FG001|Treatment Period|Protocol Violation|92|||
28034053|NCT00571649|54692540|FG000|Treatment Period|Technical problems|3|||
28034054|NCT00571649|54692541|FG001|Treatment Period|Technical problems|5|||
28034055|NCT00571649|54692540|FG000|Follow-up Period|Adverse Event|46|||
28034056|NCT00571649|54692541|FG001|Follow-up Period|Adverse Event|40|||
28034057|NCT00571649|54692540|FG000|Follow-up Period|Clinical endpoint reached|5|||
28034058|NCT00571649|54692541|FG001|Follow-up Period|Clinical endpoint reached|2|||
28034059|NCT00571649|54692540|FG000|Follow-up Period|Withdrawal by Subject|119|||
28034060|NCT00571649|54692541|FG001|Follow-up Period|Withdrawal by Subject|115|||
28034061|NCT00571649|54692540|FG000|Follow-up Period|Death|132|||
28034062|NCT00571649|54692541|FG001|Follow-up Period|Death|133|||
28034063|NCT00571649|54692540|FG000|Follow-up Period|Physician Decision|7|||
28034064|NCT00571649|54692541|FG001|Follow-up Period|Physician Decision|13|||
28034065|NCT00571649|54692540|FG000|Follow-up Period|Lost to Follow-up|95|||
28034066|NCT00571649|54692541|FG001|Follow-up Period|Lost to Follow-up|92|||
28034067|NCT00571649|54692540|FG000|Follow-up Period|Patient convenience|136|||
28034068|NCT00571649|54692541|FG001|Follow-up Period|Patient convenience|121|||
28034069|NCT00571649|54692540|FG000|Follow-up Period|Protocol Violation|5|||
28034070|NCT00571649|54692541|FG001|Follow-up Period|Protocol Violation|12|||
28034071|NCT00546572|54692549|FG000|Vax 1 / Year 0|Randomized, not treated|1|||
28034072|NCT00546572|54692550|FG001|Vax 1 / Year 0|Randomized, not treated|1|||
28034073|NCT00546572|54692549|FG000|Vax 1 / Year 0|Withdrawal by Subject|3|||
28034074|NCT00546572|54692550|FG001|Vax 1 / Year 0|Withdrawal by Subject|2|||
28034075|NCT00546572|54692549|FG000|Vax 1 / Year 0|Protocol Violation|3|||
28034076|NCT00546572|54692550|FG001|Vax 1 / Year 0|Protocol Violation|4|||
28034077|NCT00546572|54692549|FG000|Vax 1 / Year 0|Death|2|||
28034078|NCT00546572|54692550|FG001|Vax 1 / Year 0|Death|2|||
28034079|NCT00546572|54692549|FG000|Vax 1 / Year 0|Adverse Event|0|||
28034080|NCT00546572|54692550|FG001|Vax 1 / Year 0|Adverse Event|1|||
28034081|NCT00546572|54692549|FG000|Vax 1 / Year 0|Lost to Follow-up|0|||
28034082|NCT00546572|54692550|FG001|Vax 1 / Year 0|Lost to Follow-up|1|||
28034083|NCT00546572|54692549|FG000|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64|||
28034084|NCT00546572|54692550|FG001|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59|||
27807606|NCT01953224|54262916|FG001|Overall Study|Lost to Follow-up|1|||
28034085|NCT00546572|54692549|FG000|Vax 2 / Year 1|Other|1|||
28034086|NCT00546572|54692550|FG001|Vax 2 / Year 1|Other|1|||
28034087|NCT00546572|54692549|FG000|Vax 2 / Year 1|Adverse Event|1|||
28034088|NCT00546572|54692550|FG001|Vax 2 / Year 1|Adverse Event|0|||
28034089|NCT00546572|54692549|FG000|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2|||
28034090|NCT00546572|54692550|FG001|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1|||
28034091|NCT03917472|54692569|FG000|Overall Study|Physician Decision|4|||
28034092|NCT03917472|54692570|FG001|Overall Study|Physician Decision|0|||
28034093|NCT03917472|54692569|FG000|Overall Study|Adverse Event|3|||
28034094|NCT03917472|54692570|FG001|Overall Study|Adverse Event|1|||
28034095|NCT03917472|54692569|FG000|Overall Study|Death|7|||
28034096|NCT03917472|54692570|FG001|Overall Study|Death|5|||
28034097|NCT03917472|54692569|FG000|Overall Study|Withdrawal by Subject|11|||
28034098|NCT03917472|54692570|FG001|Overall Study|Withdrawal by Subject|4|||
28034099|NCT03917472|54692569|FG000|Overall Study|Lost to Follow-up|10|||
28034100|NCT03917472|54692570|FG001|Overall Study|Lost to Follow-up|5|||
28034101|NCT00681863|54692577|FG000|Overall Study|Adverse Event|1|||
28034102|NCT00681863|54692577|FG000|Overall Study|Lost to Follow-up|2|||
28034103|NCT00681863|54692577|FG000|Overall Study|Lack of Efficacy|2|||
28034104|NCT00681863|54692577|FG000|Overall Study|Other|18|||
28034105|NCT00681629|54692583|FG000|Overall Study|Study termination|4|||
28034106|NCT00681629|54692584|FG001|Overall Study|Study termination|2|||
28034107|NCT00681629|54692583|FG000|Overall Study|Adverse Event|1|||
28034108|NCT00681629|54692584|FG001|Overall Study|Adverse Event|0|||
28034109|NCT00546260|54692592|FG000|Overall Study|Drug not given pre diagnostic angiogr|8|||
28034110|NCT00546260|54692593|FG001|Overall Study|Drug not given pre diagnostic angiogr|2|||
27807607|NCT01953224|54262915|FG000|Overall Study|Withdrawal by Subject|1|||
27807608|NCT01953224|54262916|FG001|Overall Study|Withdrawal by Subject|2|||
27807609|NCT01900730|54262924|FG000|Overall Study|Withdrawal by Subject|1|||
27807610|NCT01900730|54262925|FG001|Overall Study|Withdrawal by Subject|0|||
27807611|NCT01900730|54262924|FG000|Overall Study|Screen Failure|1|||
27807612|NCT01900730|54262925|FG001|Overall Study|Screen Failure|0|||
27807613|NCT01952834|54262931|FG000|Overall Study|Adverse Event|1|||
27807614|NCT01952366|54262936|FG000|Overall Study|Death|22|||
28034111|NCT00679367|54692599|FG000|Overall Study|Adverse Event|7|||
28034112|NCT00679367|54692599|FG000|Overall Study|inability to swallow oral drugs|1|||
28034113|NCT00679367|54692599|FG000|Overall Study|Lack of Efficacy|3|||
28034114|NCT00679367|54692599|FG000|Overall Study|Withdrawal by Subject|1|||
28034115|NCT03937778|54692604|FG000|Overall Study|Withdrawal by Subject|1|||
28034116|NCT03937778|54692604|FG000|Overall Study|Unable to obtain loss of A-beta sensation prior to loss of C-fiber sensation|1|||
28034117|NCT03935126|54692608|FG000|Overall Study|Study termination by sponsor|3|||
28034118|NCT00545714|54692612|FG000|Induction Phase (6 Months)|Physician Decision|3|||
28034119|NCT00545714|54692612|FG000|Induction Phase (6 Months)|Unacceptable Toxicity|6|||
27807615|NCT01952366|54262936|FG000|Overall Study|Withdrawal by Subject|9|||
27807616|NCT01952054|54262943|FG000|Overall Study|Physician Decision|1|||
28034120|NCT00545714|54692612|FG000|Induction Phase (6 Months)|Disease Progression|1|||
28034121|NCT00545714|54692612|FG000|Induction Phase (6 Months)|Eligibility Criteria Violation|2|||
28034122|NCT00545714|54692612|FG000|Maintenance Phase (36 Months)|Unacceptable Toxicity|16|||
28034123|NCT00545714|54692612|FG000|Maintenance Phase (36 Months)|Disease Progression|9|||
28034124|NCT00545714|54692612|FG000|Maintenance Phase (36 Months)|Physician Decision|1|||
28034125|NCT00545714|54692612|FG000|Maintenance Phase (36 Months)|Protocol Violation|1|||
28034126|NCT00545714|54692612|FG000|Maintenance Phase (36 Months)|Withdrawal by Subject|3|||
28034127|NCT00545714|54692612|FG000|Maintenance Phase (36 Months)|Death|2|||
28034128|NCT00539838|54692619|FG000|Overall Study|Fail to return|2|||
28034129|NCT00539838|54692620|FG001|Overall Study|Fail to return|0|||
28034130|NCT00539838|54692621|FG002|Overall Study|Fail to return|0|||
28034131|NCT00539838|54692619|FG000|Overall Study|Withdrawal by Subject|0|||
28034132|NCT00539838|54692620|FG001|Overall Study|Withdrawal by Subject|4|||
28034133|NCT00539838|54692621|FG002|Overall Study|Withdrawal by Subject|0|||
28034134|NCT00539838|54692619|FG000|Overall Study|Death|0|||
28034135|NCT00539838|54692620|FG001|Overall Study|Death|2|||
28034136|NCT00539838|54692621|FG002|Overall Study|Death|0|||
28034137|NCT00539838|54692619|FG000|Overall Study|Did not cooperate|1|||
28034138|NCT00539838|54692620|FG001|Overall Study|Did not cooperate|0|||
28034139|NCT00539838|54692621|FG002|Overall Study|Did not cooperate|1|||
28034140|NCT00539838|54692619|FG000|Overall Study|Administrative|4|||
28034141|NCT00539838|54692620|FG001|Overall Study|Administrative|0|||
28034142|NCT00539838|54692621|FG002|Overall Study|Administrative|8|||
28034143|NCT00679289|54692634|FG000|Overall Study|Progressive disease|4|||
28034144|NCT00679289|54692635|FG001|Overall Study|Progressive disease|5|||
28034145|NCT00679289|54692636|FG002|Overall Study|Progressive disease|18|||
28034146|NCT00679289|54692634|FG000|Overall Study|Withdrawal by Subject|0|||
28034147|NCT00679289|54692635|FG001|Overall Study|Withdrawal by Subject|1|||
28034148|NCT00679289|54692636|FG002|Overall Study|Withdrawal by Subject|1|||
28034149|NCT00679289|54692634|FG000|Overall Study|Adverse Event|0|||
28034150|NCT00679289|54692635|FG001|Overall Study|Adverse Event|0|||
28034151|NCT00679289|54692636|FG002|Overall Study|Adverse Event|3|||
28034152|NCT00679289|54692634|FG000|Overall Study|Physician Decision|1|||
28034153|NCT00679289|54692635|FG001|Overall Study|Physician Decision|0|||
28034154|NCT00679289|54692636|FG002|Overall Study|Physician Decision|1|||
28034155|NCT00679211|54692646|FG000|Overall Study|Progressive disease|82|||
28034156|NCT00679211|54692646|FG000|Overall Study|Adverse Event|7|||
28034157|NCT00679211|54692646|FG000|Overall Study|Withdrawal by Subject|2|||
28034158|NCT00679211|54692646|FG000|Overall Study|Physician Decision|5|||
28034159|NCT00679211|54692646|FG000|Overall Study|Refused to undergo protocol procedures|1|||
28034160|NCT00679211|54692646|FG000|Overall Study|Transferred to extension study TDM4529g|12|||
28034161|NCT00679211|54692646|FG000|Overall Study|Other|1|||
28034162|NCT00545948|54692655|FG000|Overall Study|Not Treated|1|||
28034163|NCT00545948|54692656|FG001|Overall Study|Not Treated|1|||
28034164|NCT00545948|54692657|FG002|Overall Study|Not Treated|7|||
28034165|NCT00679055|54692668|FG000|Overall Study|Adverse Event|0|||
28034166|NCT00679055|54692669|FG001|Overall Study|Adverse Event|1|||
28034167|NCT00679055|54692668|FG000|Overall Study|Other|0|||
27807617|NCT01925768|54262949|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
27807618|NCT01925768|54262950|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
27807619|NCT01925768|54262949|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
27807620|NCT01925768|54262950|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2|||
27807621|NCT01925768|54262949|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
27807622|NCT01925768|54262950|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
27807623|NCT01925768|54262949|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
27807624|NCT01925768|54262950|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
27807625|NCT01925768|54262949|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
27807626|NCT01925768|54262950|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
27807627|NCT01925768|54262949|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0|||
27807628|NCT01925768|54262950|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1|||
27807629|NCT01925768|54262949|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
27807630|NCT01925768|54262950|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
27807631|NCT01925768|54262949|FG000|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7|||
27807632|NCT01925768|54262950|FG001|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9|||
28034168|NCT00679055|54692669|FG001|Overall Study|Other|3|||
28034169|NCT00679055|54692668|FG000|Overall Study|Study Terminated|2|||
28034170|NCT00679055|54692669|FG001|Overall Study|Study Terminated|1|||
28034171|NCT03927950|54692675|FG000|Overall Study|Adverse Event|9|||
28034172|NCT00678899|54692680|FG000|Overall Study|Adverse Event|1|||
28034173|NCT00678587|54692687|FG000|Overall Study|Adverse Event|3|||
28034174|NCT00678587|54692688|FG001|Overall Study|Adverse Event|3|||
28034175|NCT00678587|54692687|FG000|Overall Study|Lack of Efficacy|1|||
28034176|NCT00678587|54692688|FG001|Overall Study|Lack of Efficacy|0|||
28034177|NCT00678587|54692687|FG000|Overall Study|Protocol Violation|2|||
28034178|NCT00678587|54692688|FG001|Overall Study|Protocol Violation|1|||
28034179|NCT00678587|54692687|FG000|Overall Study|Study Closed/Terminated|1|||
28034180|NCT00678587|54692688|FG001|Overall Study|Study Closed/Terminated|0|||
28034181|NCT00678587|54692687|FG000|Overall Study|Lost to Follow-up|3|||
27807633|NCT01925768|54262949|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2|||
27807634|NCT01925768|54262950|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1|||
27807635|NCT01925768|54262949|FG000|ActiveTreatment/Extension (Weeks 24-104)|Death|0|||
27807636|NCT01925768|54262950|FG001|ActiveTreatment/Extension (Weeks 24-104)|Death|1|||
27807637|NCT01925768|54262949|FG000|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5|||
27807638|NCT01925768|54262950|FG001|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1|||
27807639|NCT01431274|54262965|FG000|Overall Study|Adverse Event|51|||
28034182|NCT00678587|54692688|FG001|Overall Study|Lost to Follow-up|5|||
28034183|NCT00678587|54692687|FG000|Overall Study|Investigator Discretion|2|||
28034184|NCT00678587|54692688|FG001|Overall Study|Investigator Discretion|6|||
27844619|NCT01396447|54334891|FG003|Overall Study|Other Miscellaneous Reasons|0|||
28034185|NCT00678587|54692687|FG000|Overall Study|Withdrew Consent|8|||
28034186|NCT00678587|54692688|FG001|Overall Study|Withdrew Consent|3|||
28034187|NCT03523728|54692700|FG000|Stage 1 (24 Months)|Adverse Event|2|||
27844620|NCT01678560|54334975|FG000|Overall Study|Physician Decision|4|||
28034188|NCT03523728|54692701|FG001|Stage 1 (24 Months)|Adverse Event|2|||
28034189|NCT03523728|54692702|FG002|Stage 1 (24 Months)|Adverse Event|4|||
28034190|NCT03523728|54692703|FG003|Stage 1 (24 Months)|Adverse Event|0|||
28034191|NCT03523728|54692704|FG004|Stage 1 (24 Months)|Adverse Event|0|||
28034192|NCT03523728|54692700|FG000|Stage 1 (24 Months)|Progressive disease|0|||
28034193|NCT03523728|54692701|FG001|Stage 1 (24 Months)|Progressive disease|0|||
28034194|NCT03523728|54692702|FG002|Stage 1 (24 Months)|Progressive disease|1|||
28034195|NCT03523728|54692703|FG003|Stage 1 (24 Months)|Progressive disease|0|||
27844621|NCT01678560|54334976|FG001|Overall Study|Physician Decision|4|||
27844622|NCT01678560|54334975|FG000|Overall Study|Death|0|||
27844623|NCT01678560|54334976|FG001|Overall Study|Death|1|||
27844624|NCT01678560|54334975|FG000|Overall Study|Withdrawal by Subject|0|||
27844625|NCT01678560|54334976|FG001|Overall Study|Withdrawal by Subject|1|||
27844626|NCT01381549|54335015|FG000|Overall Study|Ineligible: No organisms isolated|0|||
27844627|NCT01381549|54335016|FG001|Overall Study|Ineligible: No organisms isolated|0|||
27844628|NCT01381549|54335017|FG002|Overall Study|Ineligible: No organisms isolated|1|||
28034196|NCT03523728|54692704|FG004|Stage 1 (24 Months)|Progressive disease|0|||
28034197|NCT03523728|54692700|FG000|Stage 1 (24 Months)|Lack of Efficacy|2|||
27844629|NCT00159432|54335026|FG000|Overall Study|Adverse Event|1|||
28034198|NCT03523728|54692701|FG001|Stage 1 (24 Months)|Lack of Efficacy|0|||
28034199|NCT03523728|54692702|FG002|Stage 1 (24 Months)|Lack of Efficacy|0|||
28034200|NCT03523728|54692703|FG003|Stage 1 (24 Months)|Lack of Efficacy|0|||
28034201|NCT03523728|54692704|FG004|Stage 1 (24 Months)|Lack of Efficacy|0|||
28034202|NCT03523728|54692700|FG000|Stage 1 (24 Months)|Poor compliance to protocol|1|||
28034203|NCT03523728|54692701|FG001|Stage 1 (24 Months)|Poor compliance to protocol|0|||
27844630|NCT00159432|54335026|FG000|Overall Study|Death|1|||
27844631|NCT00159432|54335026|FG000|Overall Study|Lack of Efficacy|8|||
27844632|NCT01396057|54335032|FG000|Overall Study|Adverse Event|2|||
27844633|NCT01396057|54335033|FG001|Overall Study|Adverse Event|6|||
27844634|NCT01396057|54335032|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
27844635|NCT01396057|54335033|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
27844636|NCT01396057|54335032|FG000|Overall Study|Protocol deviation|4|||
28034204|NCT03523728|54692702|FG002|Stage 1 (24 Months)|Poor compliance to protocol|0|||
28034205|NCT03523728|54692703|FG003|Stage 1 (24 Months)|Poor compliance to protocol|0|||
28034206|NCT03523728|54692704|FG004|Stage 1 (24 Months)|Poor compliance to protocol|0|||
28034207|NCT03523728|54692700|FG000|Stage 1 (24 Months)|Withdrawal by Subject|6|||
28034208|NCT03523728|54692701|FG001|Stage 1 (24 Months)|Withdrawal by Subject|5|||
28034209|NCT03523728|54692702|FG002|Stage 1 (24 Months)|Withdrawal by Subject|7|||
28034210|NCT03523728|54692703|FG003|Stage 1 (24 Months)|Withdrawal by Subject|0|||
27807640|NCT01431274|54262966|FG001|Overall Study|Adverse Event|37|||
27807641|NCT01431274|54262967|FG002|Overall Study|Adverse Event|43|||
27807642|NCT01431274|54262968|FG003|Overall Study|Adverse Event|30|||
27807643|NCT01431274|54262969|FG004|Overall Study|Adverse Event|37|||
27807644|NCT01431274|54262965|FG000|Overall Study|Consent withdrawn not due to AE|29|||
27807645|NCT01431274|54262966|FG001|Overall Study|Consent withdrawn not due to AE|20|||
27807646|NCT01431274|54262967|FG002|Overall Study|Consent withdrawn not due to AE|17|||
27844637|NCT01396057|54335033|FG001|Overall Study|Protocol deviation|4|||
27844638|NCT01396057|54335032|FG000|Overall Study|Consent withdrawn|3|||
28034211|NCT03523728|54692704|FG004|Stage 1 (24 Months)|Withdrawal by Subject|0|||
28034212|NCT03523728|54692700|FG000|Stage 1 (24 Months)|Study terminated by sponsor|54|||
28034213|NCT03523728|54692701|FG001|Stage 1 (24 Months)|Study terminated by sponsor|59|||
28034214|NCT03523728|54692702|FG002|Stage 1 (24 Months)|Study terminated by sponsor|56|||
28034215|NCT03523728|54692703|FG003|Stage 1 (24 Months)|Study terminated by sponsor|0|||
27844639|NCT01396057|54335033|FG001|Overall Study|Consent withdrawn|2|||
28034216|NCT03523728|54692704|FG004|Stage 1 (24 Months)|Study terminated by sponsor|0|||
28034217|NCT03523728|54692700|FG000|Stage 1 (24 Months)|Other-Unspecified|1|||
28034218|NCT03523728|54692701|FG001|Stage 1 (24 Months)|Other-Unspecified|2|||
28034219|NCT03523728|54692702|FG002|Stage 1 (24 Months)|Other-Unspecified|0|||
28034220|NCT03523728|54692703|FG003|Stage 1 (24 Months)|Other-Unspecified|0|||
28034221|NCT03523728|54692704|FG004|Stage 1 (24 Months)|Other-Unspecified|0|||
28034222|NCT03523728|54692700|FG000|Stage 2 (24 Months)|Adverse Event|0|||
28034223|NCT03523728|54692701|FG001|Stage 2 (24 Months)|Adverse Event|0|||
28034224|NCT03523728|54692702|FG002|Stage 2 (24 Months)|Adverse Event|0|||
28034225|NCT03523728|54692703|FG003|Stage 2 (24 Months)|Adverse Event|1|||
28034226|NCT03523728|54692704|FG004|Stage 2 (24 Months)|Adverse Event|2|||
28034227|NCT03523728|54692700|FG000|Stage 2 (24 Months)|Withdrawal by Subject|0|||
28034228|NCT03523728|54692701|FG001|Stage 2 (24 Months)|Withdrawal by Subject|0|||
28034229|NCT03523728|54692702|FG002|Stage 2 (24 Months)|Withdrawal by Subject|0|||
28034230|NCT03523728|54692703|FG003|Stage 2 (24 Months)|Withdrawal by Subject|0|||
28034231|NCT03523728|54692704|FG004|Stage 2 (24 Months)|Withdrawal by Subject|4|||
28034232|NCT03523728|54692700|FG000|Stage 2 (24 Months)|Study terminated by sponsor|0|||
28034233|NCT03523728|54692701|FG001|Stage 2 (24 Months)|Study terminated by sponsor|0|||
28034234|NCT03523728|54692702|FG002|Stage 2 (24 Months)|Study terminated by sponsor|0|||
28034235|NCT03523728|54692703|FG003|Stage 2 (24 Months)|Study terminated by sponsor|119|||
28034236|NCT03523728|54692704|FG004|Stage 2 (24 Months)|Study terminated by sponsor|110|||
28034237|NCT03523728|54692700|FG000|Stage 2 (24 Months)|Other-Unspecified|0|||
28034238|NCT03523728|54692701|FG001|Stage 2 (24 Months)|Other-Unspecified|0|||
28034239|NCT03523728|54692702|FG002|Stage 2 (24 Months)|Other-Unspecified|0|||
28034240|NCT03523728|54692703|FG003|Stage 2 (24 Months)|Other-Unspecified|2|||
28034241|NCT03523728|54692704|FG004|Stage 2 (24 Months)|Other-Unspecified|3|||
28034242|NCT03523728|54692700|FG000|Stage 2 (24 Months)|Randomized and not treated|0|||
28034243|NCT03523728|54692701|FG001|Stage 2 (24 Months)|Randomized and not treated|0|||
28034244|NCT03523728|54692702|FG002|Stage 2 (24 Months)|Randomized and not treated|0|||
28034245|NCT03523728|54692703|FG003|Stage 2 (24 Months)|Randomized and not treated|1|||
28034246|NCT03523728|54692704|FG004|Stage 2 (24 Months)|Randomized and not treated|0|||
28034247|NCT00538590|54692723|FG000|Overall Study|Death|1|||
28034248|NCT00538590|54692724|FG001|Overall Study|Death|0|||
28034249|NCT00466947|54692732|FG000|Primary Outcome Analysis Period|Other: study still ongoing|11875|||
28034250|NCT00466947|54692733|FG001|Primary Outcome Analysis Period|Other: study still ongoing|11863|||
28034251|NCT00466947|54692732|FG000|Study End Analysis Period|Adverse Event|35|||
28034252|NCT00466947|54692733|FG001|Study End Analysis Period|Adverse Event|43|||
28034253|NCT00466947|54692732|FG000|Study End Analysis Period|Lost to Follow-up|1137|||
28034254|NCT00466947|54692733|FG001|Study End Analysis Period|Lost to Follow-up|1167|||
28034255|NCT00466947|54692732|FG000|Study End Analysis Period|Physician Decision|29|||
28034256|NCT00466947|54692733|FG001|Study End Analysis Period|Physician Decision|29|||
28034257|NCT00466947|54692732|FG000|Study End Analysis Period|Protocol Violation|9|||
28034258|NCT00466947|54692733|FG001|Study End Analysis Period|Protocol Violation|17|||
28034259|NCT00466947|54692732|FG000|Study End Analysis Period|Withdrawal by Subject|1264|||
28034260|NCT00466947|54692733|FG001|Study End Analysis Period|Withdrawal by Subject|1267|||
28034261|NCT00466947|54692732|FG000|Study End Analysis Period|Other - Forbidden vaccination|21|||
28034262|NCT00466947|54692733|FG001|Study End Analysis Period|Other - Forbidden vaccination|10|||
28034263|NCT00466947|54692732|FG000|Study End Analysis Period|Other - Subject without a legal guardian|1|||
28034264|NCT00466947|54692733|FG001|Study End Analysis Period|Other - Subject without a legal guardian|0|||
28034265|NCT00466947|54692732|FG000|Study End Analysis Period|Other - Unconformity in team's treatment|0|||
28034266|NCT00466947|54692733|FG001|Study End Analysis Period|Other - Unconformity in team's treatment|1|||
28034267|NCT00537810|54692744|FG000|Overall Study|Withdrawal by Subject|4|||
28034268|NCT00537810|54692745|FG001|Overall Study|Withdrawal by Subject|11|||
28034269|NCT00537810|54692746|FG002|Overall Study|Withdrawal by Subject|4|||
28034270|NCT00537810|54692747|FG003|Overall Study|Withdrawal by Subject|3|||
28034271|NCT00537810|54692744|FG000|Overall Study|Medically withdrawn|2|||
27807647|NCT01431274|54262968|FG003|Overall Study|Consent withdrawn not due to AE|20|||
27807648|NCT01431274|54262969|FG004|Overall Study|Consent withdrawn not due to AE|11|||
27807649|NCT01431274|54262965|FG000|Overall Study|Non compliant with protocol|5|||
27807650|NCT01431274|54262966|FG001|Overall Study|Non compliant with protocol|8|||
27807651|NCT01431274|54262967|FG002|Overall Study|Non compliant with protocol|4|||
27807652|NCT01431274|54262968|FG003|Overall Study|Non compliant with protocol|4|||
27807653|NCT01431274|54262969|FG004|Overall Study|Non compliant with protocol|4|||
27807654|NCT01431274|54262965|FG000|Overall Study|Lost to Follow-up|6|||
27807655|NCT01431274|54262966|FG001|Overall Study|Lost to Follow-up|7|||
27807656|NCT01431274|54262967|FG002|Overall Study|Lost to Follow-up|1|||
27807657|NCT01431274|54262968|FG003|Overall Study|Lost to Follow-up|4|||
28034272|NCT00537810|54692745|FG001|Overall Study|Medically withdrawn|2|||
28034273|NCT00537810|54692746|FG002|Overall Study|Medically withdrawn|0|||
28034274|NCT00537810|54692747|FG003|Overall Study|Medically withdrawn|1|||
28034275|NCT01287936|54692760|FG000|Overall Study|Lost to Follow-up|0|||
28034276|NCT01287936|54692761|FG001|Overall Study|Lost to Follow-up|1|||
27807658|NCT01431274|54262969|FG004|Overall Study|Lost to Follow-up|0|||
27807659|NCT01431274|54262965|FG000|Overall Study|Other reason not stated above|6|||
27807660|NCT01431274|54262966|FG001|Overall Study|Other reason not stated above|5|||
27807661|NCT01431274|54262967|FG002|Overall Study|Other reason not stated above|7|||
28034277|NCT01287936|54692762|FG002|Overall Study|Lost to Follow-up|1|||
28034278|NCT00090259|54692772|FG000|Overall Study|Lost to Follow-up|30|||
28034279|NCT00090259|54692773|FG001|Overall Study|Lost to Follow-up|26|||
28034280|NCT00090259|54692772|FG000|Overall Study|Withdrawal by Subject|21|||
28034281|NCT00090259|54692773|FG001|Overall Study|Withdrawal by Subject|15|||
28034282|NCT00090259|54692772|FG000|Overall Study|Investigator site closed|11|||
28034283|NCT00090259|54692773|FG001|Overall Study|Investigator site closed|7|||
28034284|NCT00079183|54692779|FG000|Overall Study|Withdrawal by Subject|4|||
28034285|NCT00079183|54692779|FG000|Overall Study|Study medication non-compliance|2|||
28034286|NCT00079183|54692779|FG000|Overall Study|Specimen collection non-compliance|1|||
28034287|NCT00676403|54692790|FG000|Overall Study|Adverse Event|1|||
28034288|NCT00676403|54692791|FG001|Overall Study|Adverse Event|2|||
28034289|NCT00676403|54692792|FG002|Overall Study|Adverse Event|0|||
28034290|NCT00676403|54692793|FG003|Overall Study|Adverse Event|5|||
28034291|NCT00676403|54692794|FG004|Overall Study|Adverse Event|1|||
28034292|NCT00676403|54692795|FG005|Overall Study|Adverse Event|2|||
28034293|NCT00676403|54692790|FG000|Overall Study|Lost to Follow-up|0|||
28034294|NCT00676403|54692791|FG001|Overall Study|Lost to Follow-up|0|||
28034295|NCT00676403|54692792|FG002|Overall Study|Lost to Follow-up|0|||
28034296|NCT00676403|54692793|FG003|Overall Study|Lost to Follow-up|0|||
28034297|NCT00676403|54692794|FG004|Overall Study|Lost to Follow-up|0|||
28034298|NCT00676403|54692795|FG005|Overall Study|Lost to Follow-up|1|||
28034299|NCT00676403|54692790|FG000|Overall Study|Reason Unspecified|1|||
28034300|NCT00676403|54692791|FG001|Overall Study|Reason Unspecified|0|||
28034301|NCT00676403|54692792|FG002|Overall Study|Reason Unspecified|1|||
28034302|NCT00676403|54692793|FG003|Overall Study|Reason Unspecified|0|||
28034303|NCT00676403|54692794|FG004|Overall Study|Reason Unspecified|0|||
28034304|NCT00676403|54692795|FG005|Overall Study|Reason Unspecified|1|||
28034305|NCT00676403|54692790|FG000|Overall Study|Withdrawal by Subject|0|||
28034306|NCT00676403|54692791|FG001|Overall Study|Withdrawal by Subject|0|||
28034307|NCT00676403|54692792|FG002|Overall Study|Withdrawal by Subject|0|||
28034308|NCT00676403|54692793|FG003|Overall Study|Withdrawal by Subject|0|||
28034309|NCT00676403|54692794|FG004|Overall Study|Withdrawal by Subject|0|||
28034310|NCT00676403|54692795|FG005|Overall Study|Withdrawal by Subject|1|||
28034311|NCT00078325|54692818|FG000|Overall Study|Adverse Event|15|||
28034312|NCT00078325|54692819|FG001|Overall Study|Adverse Event|10|||
28034313|NCT00078325|54692820|FG002|Overall Study|Adverse Event|5|||
28034314|NCT00078325|54692818|FG000|Overall Study|Protocol Violation|2|||
28034315|NCT00078325|54692819|FG001|Overall Study|Protocol Violation|2|||
28034316|NCT00078325|54692820|FG002|Overall Study|Protocol Violation|0|||
28034317|NCT00078325|54692818|FG000|Overall Study|Withdrawal by Subject|1|||
28034318|NCT00078325|54692819|FG001|Overall Study|Withdrawal by Subject|5|||
28034319|NCT00078325|54692820|FG002|Overall Study|Withdrawal by Subject|3|||
28034320|NCT00078325|54692818|FG000|Overall Study|Lost to Follow-up|0|||
28034321|NCT00078325|54692819|FG001|Overall Study|Lost to Follow-up|1|||
28034322|NCT00078325|54692820|FG002|Overall Study|Lost to Follow-up|1|||
28034323|NCT00078325|54692818|FG000|Overall Study|Physician Decision|2|||
28034324|NCT00078325|54692819|FG001|Overall Study|Physician Decision|0|||
28034325|NCT00078325|54692820|FG002|Overall Study|Physician Decision|1|||
28034326|NCT00078325|54692818|FG000|Overall Study|Miscellaneous|1|||
28034327|NCT00078325|54692819|FG001|Overall Study|Miscellaneous|1|||
28034328|NCT00078325|54692820|FG002|Overall Study|Miscellaneous|1|||
28034329|NCT00077857|54692830|FG000|Overall Study|Adverse Event|30|||
28034330|NCT00077857|54692831|FG001|Overall Study|Adverse Event|32|||
28034331|NCT00077857|54692830|FG000|Overall Study|Death|7|||
28034332|NCT00077857|54692831|FG001|Overall Study|Death|3|||
28034333|NCT00077857|54692830|FG000|Overall Study|Insufficient therapeutic response|112|||
28034334|NCT00077857|54692831|FG001|Overall Study|Insufficient therapeutic response|128|||
28034335|NCT00077857|54692830|FG000|Overall Study|Violation of selection criteria at entry|3|||
28034336|NCT00077857|54692831|FG001|Overall Study|Violation of selection criteria at entry|1|||
28034337|NCT00077857|54692830|FG000|Overall Study|Other protocol violation|0|||
28034338|NCT00077857|54692831|FG001|Overall Study|Other protocol violation|1|||
28034339|NCT00077857|54692830|FG000|Overall Study|Refused treatment|29|||
28034340|NCT00077857|54692831|FG001|Overall Study|Refused treatment|21|||
28034341|NCT00077857|54692830|FG000|Overall Study|Failure to return|5|||
28034342|NCT00077857|54692831|FG001|Overall Study|Failure to return|5|||
28034343|NCT00077857|54692830|FG000|Overall Study|Other|15|||
28034344|NCT00077857|54692831|FG001|Overall Study|Other|13|||
28034345|NCT00545402|54692839|FG000|Overall Study|Discontinuation of treatment|17|||
28034346|NCT00545402|54692840|FG001|Overall Study|Discontinuation of treatment|9|||
28034347|NCT00545402|54692839|FG000|Overall Study|Use of unauthorized immunosuppressant|8|||
28034348|NCT00545402|54692840|FG001|Overall Study|Use of unauthorized immunosuppressant|7|||
28034349|NCT00545402|54692839|FG000|Overall Study|Death|5|||
28034350|NCT00545402|54692840|FG001|Overall Study|Death|7|||
28034351|NCT00545402|54692839|FG000|Overall Study|Graft loss|2|||
28034352|NCT00545402|54692840|FG001|Overall Study|Graft loss|4|||
28034353|NCT00545402|54692839|FG000|Overall Study|Withdrawal by Subject|0|||
28034354|NCT00545402|54692840|FG001|Overall Study|Withdrawal by Subject|1|||
28034355|NCT00545402|54692839|FG000|Overall Study|Protocol Violation|1|||
28034356|NCT00545402|54692840|FG001|Overall Study|Protocol Violation|0|||
28034357|NCT00545402|54692839|FG000|Overall Study|Reason not specified|1|||
28034358|NCT00545402|54692840|FG001|Overall Study|Reason not specified|1|||
28034359|NCT00545792|54692846|FG000|Overall Study|Withdrawal by Subject|1|||
28034360|NCT00545168|54692853|FG000|Overall Study|Lost to Follow-up|5|||
28034361|NCT00545168|54692854|FG001|Overall Study|Lost to Follow-up|5|||
28034362|NCT00545168|54692855|FG002|Overall Study|Lost to Follow-up|5|||
28034363|NCT00545168|54692853|FG000|Overall Study|Withdrawal by Subject|9|||
28034364|NCT00545168|54692854|FG001|Overall Study|Withdrawal by Subject|0|||
28034365|NCT00545168|54692855|FG002|Overall Study|Withdrawal by Subject|13|||
28034366|NCT00545168|54692853|FG000|Overall Study|Protocol Violation|1|||
28034367|NCT00545168|54692854|FG001|Overall Study|Protocol Violation|0|||
28034368|NCT00545168|54692855|FG002|Overall Study|Protocol Violation|1|||
28034369|NCT00545168|54692853|FG000|Overall Study|Visit for Day 21 was not done in error|1|||
28034370|NCT00545168|54692854|FG001|Overall Study|Visit for Day 21 was not done in error|0|||
28034371|NCT00545168|54692855|FG002|Overall Study|Visit for Day 21 was not done in error|2|||
28034372|NCT00544544|54692864|FG000|Overall Study|Withdrawal by Subject|1|||
28034373|NCT00544544|54692864|FG000|Overall Study|Adverse Event|1|||
28034374|NCT00544544|54692864|FG000|Overall Study|Lost to Follow-up|1|||
28034375|NCT00541346|54692868|FG000|Follow-up|Adverse Event|1|||
28034376|NCT00077623|54692875|FG000|Overall Study|Adverse Event|1|||
28034377|NCT00077623|54692876|FG001|Overall Study|Adverse Event|0|||
28034378|NCT00077623|54692877|FG002|Overall Study|Adverse Event|1|||
28034379|NCT00077623|54692875|FG000|Overall Study|Withdrawal by Subject|2|||
28034380|NCT00077623|54692876|FG001|Overall Study|Withdrawal by Subject|10|||
28034381|NCT00077623|54692877|FG002|Overall Study|Withdrawal by Subject|1|||
28034382|NCT00077623|54692875|FG000|Overall Study|Other-Non safety reason|18|||
28034383|NCT00077623|54692876|FG001|Overall Study|Other-Non safety reason|15|||
28034384|NCT00077623|54692877|FG002|Overall Study|Other-Non safety reason|19|||
28034385|NCT00077623|54692875|FG000|Overall Study|Insufficient therapeutic response|2|||
28034386|NCT00077623|54692876|FG001|Overall Study|Insufficient therapeutic response|0|||
28034387|NCT00077623|54692877|FG002|Overall Study|Insufficient therapeutic response|0|||
28034388|NCT00077623|54692875|FG000|Overall Study|Death|12|||
28034389|NCT00077623|54692876|FG001|Overall Study|Death|18|||
28034390|NCT00077623|54692877|FG002|Overall Study|Death|11|||
28034391|NCT00077623|54692875|FG000|Overall Study|Failure to return|1|||
28034392|NCT00077623|54692876|FG001|Overall Study|Failure to return|0|||
28034393|NCT00077623|54692877|FG002|Overall Study|Failure to return|0|||
28034394|NCT00541034|54692885|FG000|Overall Study|Non-Compliance|3|||
28034395|NCT00540644|54692891|FG000|Overall Study|Adverse Event|3|||
28034396|NCT00540644|54692892|FG001|Overall Study|Adverse Event|1|||
28034397|NCT00540644|54692891|FG000|Overall Study|Disease Progression|3|||
28034398|NCT00540644|54692892|FG001|Overall Study|Disease Progression|1|||
28034399|NCT00540644|54692891|FG000|Overall Study|Physician Decision|0|||
28034400|NCT00540644|54692892|FG001|Overall Study|Physician Decision|5|||
28034401|NCT00540644|54692891|FG000|Overall Study|Withdrawal by Subject|2|||
28034402|NCT00540644|54692892|FG001|Overall Study|Withdrawal by Subject|2|||
28034403|NCT00540644|54692891|FG000|Overall Study|Noncomplilance|1|||
28034404|NCT00540644|54692892|FG001|Overall Study|Noncomplilance|0|||
28034405|NCT00543296|54692898|FG000|Overall Study|Physician Decision|7|||
28034406|NCT00543140|54692902|FG000|Overall Study|Lost to Follow-up|33|||
28034407|NCT00543140|54692902|FG000|Overall Study|Withdrawal by Subject|13|||
28034408|NCT00543140|54692902|FG000|Overall Study|Protocol Violation|10|||
28034409|NCT00543140|54692902|FG000|Overall Study|Insufficient weight loss|10|||
28034410|NCT00543140|54692902|FG000|Overall Study|SAE leading to explant of SAGB|3|||
28034411|NCT00543140|54692902|FG000|Overall Study|Death|1|||
28034412|NCT00543140|54692902|FG000|Overall Study|Subject moved|1|||
28034413|NCT00543140|54692902|FG000|Overall Study|Conversion to different procedure|1|||
28034414|NCT00543062|54692906|FG000|Overall Study|Withdrawal by Subject|1|||
28034415|NCT00543062|54692907|FG001|Overall Study|Withdrawal by Subject|0|||
28034416|NCT00543062|54692908|FG002|Overall Study|Withdrawal by Subject|2|||
28034417|NCT00543062|54692909|FG003|Overall Study|Withdrawal by Subject|0|||
28034418|NCT00543062|54692906|FG000|Overall Study|Adverse Event|0|||
28034419|NCT00543062|54692907|FG001|Overall Study|Adverse Event|1|||
28034420|NCT00543062|54692908|FG002|Overall Study|Adverse Event|1|||
28034421|NCT00543062|54692909|FG003|Overall Study|Adverse Event|1|||
28034422|NCT00543062|54692906|FG000|Overall Study|Protocol Violation|1|||
28034423|NCT00543062|54692907|FG001|Overall Study|Protocol Violation|0|||
28034424|NCT00543062|54692908|FG002|Overall Study|Protocol Violation|0|||
28034425|NCT00543062|54692909|FG003|Overall Study|Protocol Violation|0|||
28034426|NCT03911960|54692929|FG000|Overall Study|Lost to Follow-up|5|||
28034427|NCT03911960|54692930|FG001|Overall Study|Lost to Follow-up|3|||
28034428|NCT00676091|54692939|FG000|Infant Series|Parent or legal guardian request|10|||
28034429|NCT00676091|54692940|FG001|Infant Series|Parent or legal guardian request|8|||
28034430|NCT00676091|54692939|FG000|Infant Series|Protocol Violation|6|||
28034431|NCT00676091|54692940|FG001|Infant Series|Protocol Violation|3|||
28034432|NCT00676091|54692939|FG000|Infant Series|Adverse Event|2|||
28034433|NCT00676091|54692940|FG001|Infant Series|Adverse Event|3|||
28034434|NCT00676091|54692939|FG000|Infant Series|Failed to return|1|||
28034435|NCT00676091|54692940|FG001|Infant Series|Failed to return|3|||
28034436|NCT00676091|54692939|FG000|Infant Series|Lost to Follow-up|1|||
28034437|NCT00676091|54692940|FG001|Infant Series|Lost to Follow-up|0|||
28034438|NCT00676091|54692939|FG000|Infant Series|Died prior to receiving 7vPnC|0|||
28034439|NCT00676091|54692940|FG001|Infant Series|Died prior to receiving 7vPnC|1|||
28034440|NCT00676091|54692939|FG000|After Infant Series|Adverse Event|0|||
28034441|NCT00676091|54692940|FG001|After Infant Series|Adverse Event|1|||
28034442|NCT00676091|54692939|FG000|After Infant Series|Protocol Violation|0|||
28034443|NCT00676091|54692940|FG001|After Infant Series|Protocol Violation|1|||
28034444|NCT00676091|54692939|FG000|After Infant Series|Failed to return|1|||
28034445|NCT00676091|54692940|FG001|After Infant Series|Failed to return|1|||
28034446|NCT00676091|54692939|FG000|Toddler Dose|Failed to return|2|||
28034447|NCT00676091|54692940|FG001|Toddler Dose|Failed to return|0|||
28034448|NCT00676091|54692939|FG000|Toddler Dose|Parent or legal guardian request|1|||
28034449|NCT00676091|54692940|FG001|Toddler Dose|Parent or legal guardian request|0|||
28034450|NCT00678041|54692952|FG000|Overall Study|Physician Decision|5|||
28034451|NCT00678041|54692953|FG001|Overall Study|Physician Decision|5|||
28034452|NCT03903822|54692968|FG000|Treatment Phase (6 Weeks)|Adverse Event|3|||
28034453|NCT03903822|54692969|FG001|Treatment Phase (6 Weeks)|Adverse Event|3|||
28034454|NCT03903822|54692970|FG002|Treatment Phase (6 Weeks)|Adverse Event|1|||
28034455|NCT03903822|54692971|FG003|Treatment Phase (6 Weeks)|Adverse Event|1|||
28034456|NCT03903822|54692972|FG004|Treatment Phase (6 Weeks)|Adverse Event|1|||
28034457|NCT03903822|54692973|FG005|Treatment Phase (6 Weeks)|Adverse Event|6|||
28034458|NCT03903822|54692974|FG006|Treatment Phase (6 Weeks)|Adverse Event|1|||
28034459|NCT03903822|54692975|FG007|Treatment Phase (6 Weeks)|Adverse Event|0|||
28034460|NCT03903822|54692968|FG000|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
28034461|NCT03903822|54692969|FG001|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
28034462|NCT03903822|54692970|FG002|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
28034463|NCT03903822|54692971|FG003|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
28034464|NCT03903822|54692972|FG004|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
28034465|NCT03903822|54692973|FG005|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
28034466|NCT03903822|54692974|FG006|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
28034467|NCT03903822|54692975|FG007|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
28034468|NCT03903822|54692968|FG000|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
27807662|NCT01431274|54262968|FG003|Overall Study|Other reason not stated above|2|||
27807663|NCT01431274|54262969|FG004|Overall Study|Other reason not stated above|4|||
27807664|NCT01991795|54262983|FG000|Overall Study|Lost to Follow-up|6|||
27807665|NCT01991795|54262984|FG001|Overall Study|Lost to Follow-up|4|||
27807666|NCT01991795|54262983|FG000|Overall Study|Withdrawal by Subject|117|||
27807667|NCT01991795|54262984|FG001|Overall Study|Withdrawal by Subject|94|||
28034469|NCT03903822|54692969|FG001|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
28034470|NCT03903822|54692970|FG002|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
28034471|NCT03903822|54692971|FG003|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
28034472|NCT03903822|54692972|FG004|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
28034473|NCT03903822|54692973|FG005|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
28034474|NCT03903822|54692974|FG006|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
28034475|NCT03903822|54692975|FG007|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
27807668|NCT01991795|54262983|FG000|Overall Study|Site prematurely closed by sponsor|26|||
28034476|NCT03903822|54692968|FG000|Treatment Phase (6 Weeks)|Physician Decision|0|||
28034477|NCT03903822|54692969|FG001|Treatment Phase (6 Weeks)|Physician Decision|2|||
28034478|NCT03903822|54692970|FG002|Treatment Phase (6 Weeks)|Physician Decision|0|||
28034479|NCT03903822|54692971|FG003|Treatment Phase (6 Weeks)|Physician Decision|0|||
28034480|NCT03903822|54692972|FG004|Treatment Phase (6 Weeks)|Physician Decision|0|||
28034481|NCT03903822|54692973|FG005|Treatment Phase (6 Weeks)|Physician Decision|0|||
28034482|NCT03903822|54692974|FG006|Treatment Phase (6 Weeks)|Physician Decision|0|||
28034483|NCT03903822|54692975|FG007|Treatment Phase (6 Weeks)|Physician Decision|0|||
28034484|NCT03903822|54692968|FG000|Treatment Phase (6 Weeks)|Pregnancy|0|||
28034485|NCT03903822|54692969|FG001|Treatment Phase (6 Weeks)|Pregnancy|0|||
28034486|NCT03903822|54692970|FG002|Treatment Phase (6 Weeks)|Pregnancy|0|||
28034487|NCT03903822|54692971|FG003|Treatment Phase (6 Weeks)|Pregnancy|1|||
28034488|NCT03903822|54692972|FG004|Treatment Phase (6 Weeks)|Pregnancy|1|||
28034489|NCT03903822|54692973|FG005|Treatment Phase (6 Weeks)|Pregnancy|0|||
28034490|NCT03903822|54692974|FG006|Treatment Phase (6 Weeks)|Pregnancy|0|||
28034491|NCT03903822|54692975|FG007|Treatment Phase (6 Weeks)|Pregnancy|0|||
28034492|NCT03903822|54692968|FG000|Treatment Phase (6 Weeks)|Protocol Violation|0|||
28034493|NCT03903822|54692969|FG001|Treatment Phase (6 Weeks)|Protocol Violation|0|||
28034494|NCT03903822|54692970|FG002|Treatment Phase (6 Weeks)|Protocol Violation|0|||
28034495|NCT03903822|54692971|FG003|Treatment Phase (6 Weeks)|Protocol Violation|1|||
28034496|NCT03903822|54692972|FG004|Treatment Phase (6 Weeks)|Protocol Violation|0|||
28034497|NCT03903822|54692973|FG005|Treatment Phase (6 Weeks)|Protocol Violation|0|||
28034498|NCT03903822|54692974|FG006|Treatment Phase (6 Weeks)|Protocol Violation|0|||
28034499|NCT03903822|54692975|FG007|Treatment Phase (6 Weeks)|Protocol Violation|0|||
28034500|NCT03903822|54692968|FG000|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
28034501|NCT03903822|54692969|FG001|Treatment Phase (6 Weeks)|Withdrawal by Subject|4|||
28034502|NCT03903822|54692970|FG002|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
28034503|NCT03903822|54692971|FG003|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
28034504|NCT03903822|54692972|FG004|Treatment Phase (6 Weeks)|Withdrawal by Subject|1|||
28034505|NCT03903822|54692973|FG005|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
28034506|NCT03903822|54692974|FG006|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
28034507|NCT03903822|54692975|FG007|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
28034508|NCT03903822|54692968|FG000|Treatment Phase (6 Weeks)|Refused Further Treatment|2|||
28034509|NCT03903822|54692969|FG001|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
28034510|NCT03903822|54692970|FG002|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
28034511|NCT03903822|54692971|FG003|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
28034512|NCT03903822|54692972|FG004|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
28034513|NCT03903822|54692973|FG005|Treatment Phase (6 Weeks)|Refused Further Treatment|1|||
28034514|NCT03903822|54692974|FG006|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
28034515|NCT03903822|54692975|FG007|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
28034516|NCT03903822|54692968|FG000|Treatment Phase (6 Weeks)|Other|2|||
28034517|NCT03903822|54692969|FG001|Treatment Phase (6 Weeks)|Other|1|||
28034518|NCT03903822|54692970|FG002|Treatment Phase (6 Weeks)|Other|0|||
28034519|NCT03903822|54692971|FG003|Treatment Phase (6 Weeks)|Other|0|||
28034520|NCT03903822|54692972|FG004|Treatment Phase (6 Weeks)|Other|1|||
28034521|NCT03903822|54692973|FG005|Treatment Phase (6 Weeks)|Other|1|||
28034522|NCT03903822|54692974|FG006|Treatment Phase (6 Weeks)|Other|0|||
28034523|NCT03903822|54692975|FG007|Treatment Phase (6 Weeks)|Other|0|||
28034524|NCT03903822|54692968|FG000|Follow up Phase (4 Weeks)|Adverse Event|3|||
28034525|NCT03903822|54692969|FG001|Follow up Phase (4 Weeks)|Adverse Event|2|||
28034526|NCT03903822|54692970|FG002|Follow up Phase (4 Weeks)|Adverse Event|1|||
28034527|NCT03903822|54692971|FG003|Follow up Phase (4 Weeks)|Adverse Event|1|||
28034528|NCT03903822|54692972|FG004|Follow up Phase (4 Weeks)|Adverse Event|0|||
28034529|NCT03903822|54692973|FG005|Follow up Phase (4 Weeks)|Adverse Event|5|||
28034530|NCT03903822|54692974|FG006|Follow up Phase (4 Weeks)|Adverse Event|1|||
28034531|NCT03903822|54692975|FG007|Follow up Phase (4 Weeks)|Adverse Event|0|||
28034532|NCT03903822|54692968|FG000|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
28034533|NCT03903822|54692969|FG001|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
28034534|NCT03903822|54692970|FG002|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
28034535|NCT03903822|54692971|FG003|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
28034536|NCT03903822|54692972|FG004|Follow up Phase (4 Weeks)|Lack of Efficacy|1|||
28034537|NCT03903822|54692973|FG005|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
28034538|NCT03903822|54692974|FG006|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
28034539|NCT03903822|54692975|FG007|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
28034540|NCT03903822|54692968|FG000|Follow up Phase (4 Weeks)|Lost to Follow-up|2|||
28034541|NCT03903822|54692969|FG001|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
28034542|NCT03903822|54692970|FG002|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
28034543|NCT03903822|54692971|FG003|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
28034544|NCT03903822|54692972|FG004|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
28034545|NCT03903822|54692973|FG005|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
28034546|NCT03903822|54692974|FG006|Follow up Phase (4 Weeks)|Lost to Follow-up|1|||
28034547|NCT03903822|54692975|FG007|Follow up Phase (4 Weeks)|Lost to Follow-up|3|||
28034548|NCT03903822|54692968|FG000|Follow up Phase (4 Weeks)|Pregnancy|0|||
28034549|NCT03903822|54692969|FG001|Follow up Phase (4 Weeks)|Pregnancy|0|||
28034550|NCT03903822|54692970|FG002|Follow up Phase (4 Weeks)|Pregnancy|0|||
28034551|NCT03903822|54692971|FG003|Follow up Phase (4 Weeks)|Pregnancy|1|||
28034552|NCT03903822|54692972|FG004|Follow up Phase (4 Weeks)|Pregnancy|1|||
28034553|NCT03903822|54692973|FG005|Follow up Phase (4 Weeks)|Pregnancy|0|||
28034554|NCT03903822|54692974|FG006|Follow up Phase (4 Weeks)|Pregnancy|0|||
28034555|NCT03903822|54692975|FG007|Follow up Phase (4 Weeks)|Pregnancy|0|||
28034556|NCT03903822|54692968|FG000|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
28034557|NCT03903822|54692969|FG001|Follow up Phase (4 Weeks)|Withdrawal by Subject|5|||
28034558|NCT03903822|54692970|FG002|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
28034559|NCT03903822|54692971|FG003|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
28034560|NCT03903822|54692972|FG004|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
28034561|NCT03903822|54692973|FG005|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
28034562|NCT03903822|54692974|FG006|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
28034563|NCT03903822|54692975|FG007|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
28034564|NCT03903822|54692968|FG000|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
28034565|NCT03903822|54692969|FG001|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
28034566|NCT03903822|54692970|FG002|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
28034567|NCT03903822|54692971|FG003|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
28034568|NCT03903822|54692972|FG004|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
28034569|NCT03903822|54692973|FG005|Follow up Phase (4 Weeks)|Refused Further Study Procedures|1|||
28034570|NCT03903822|54692974|FG006|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
28034571|NCT03903822|54692975|FG007|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
28034572|NCT03903822|54692968|FG000|Follow up Phase (4 Weeks)|Other|1|||
28034573|NCT03903822|54692969|FG001|Follow up Phase (4 Weeks)|Other|1|||
28034574|NCT03903822|54692970|FG002|Follow up Phase (4 Weeks)|Other|0|||
28034575|NCT03903822|54692971|FG003|Follow up Phase (4 Weeks)|Other|0|||
28034576|NCT03903822|54692972|FG004|Follow up Phase (4 Weeks)|Other|0|||
28034577|NCT03903822|54692973|FG005|Follow up Phase (4 Weeks)|Other|0|||
28034578|NCT03903822|54692974|FG006|Follow up Phase (4 Weeks)|Other|0|||
28034579|NCT03903822|54692975|FG007|Follow up Phase (4 Weeks)|Other|0|||
28034580|NCT00677807|54692996|FG000|Overall Study|Adverse Event|4|||
28034581|NCT00677807|54692997|FG001|Overall Study|Adverse Event|1|||
28034582|NCT00677807|54692998|FG002|Overall Study|Adverse Event|6|||
28034583|NCT00677807|54692996|FG000|Overall Study|Lack of Efficacy|0|||
28034584|NCT00677807|54692997|FG001|Overall Study|Lack of Efficacy|0|||
28034585|NCT00677807|54692998|FG002|Overall Study|Lack of Efficacy|2|||
28034586|NCT00677807|54692996|FG000|Overall Study|Participant no longer needs study drug|0|||
28034587|NCT00677807|54692997|FG001|Overall Study|Participant no longer needs study drug|0|||
28034588|NCT00677807|54692998|FG002|Overall Study|Participant no longer needs study drug|1|||
28034589|NCT00677807|54692996|FG000|Overall Study|Withdrawal by Subject|10|||
28034590|NCT00677807|54692997|FG001|Overall Study|Withdrawal by Subject|3|||
28034591|NCT00677807|54692998|FG002|Overall Study|Withdrawal by Subject|6|||
28034592|NCT00677807|54692996|FG000|Overall Study|Lost to Follow-up|2|||
28034593|NCT00677807|54692997|FG001|Overall Study|Lost to Follow-up|2|||
28034594|NCT00677807|54692998|FG002|Overall Study|Lost to Follow-up|2|||
28034595|NCT00677807|54692996|FG000|Overall Study|Administrative problems|1|||
28034596|NCT00677807|54692997|FG001|Overall Study|Administrative problems|1|||
28034597|NCT00677807|54692998|FG002|Overall Study|Administrative problems|2|||
28034598|NCT00677807|54692996|FG000|Overall Study|Death|0|||
28034599|NCT00677807|54692997|FG001|Overall Study|Death|1|||
28034600|NCT00677807|54692998|FG002|Overall Study|Death|1|||
28034601|NCT00677807|54692996|FG000|Overall Study|Protocol Deviation|1|||
28034602|NCT00677807|54692997|FG001|Overall Study|Protocol Deviation|3|||
28034603|NCT00677807|54692998|FG002|Overall Study|Protocol Deviation|0|||
27807669|NCT01991795|54262984|FG001|Overall Study|Site prematurely closed by sponsor|25|||
28034604|NCT00687401|54693006|FG000|Overall Study|Protocol Violation|7|||
28034605|NCT00687401|54693006|FG000|Overall Study|Adverse Event|6|||
28034606|NCT00687401|54693006|FG000|Overall Study|Lack of Efficacy|6|||
28034607|NCT00687401|54693006|FG000|Overall Study|Withdrawal by Subject|4|||
27807670|NCT01411852|54263025|FG000|Prehospital Intervention Phase|No qualifying SBP|5|||
27807671|NCT01411852|54263026|FG001|Prehospital Intervention Phase|No qualifying SBP|4|||
27807672|NCT01411852|54263025|FG000|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
28034608|NCT00687401|54693006|FG000|Overall Study|Did not return for visit|3|||
28034609|NCT00687401|54693006|FG000|Overall Study|For reasons different from those above|4|||
28034610|NCT00538902|54693026|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1|||
27807673|NCT01411852|54263026|FG001|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
27807674|NCT01411852|54263025|FG000|Prehospital Intervention Phase|Found to be under age|0|||
27807675|NCT01411852|54263026|FG001|Prehospital Intervention Phase|Found to be under age|1|||
27807676|NCT01411852|54263025|FG000|Prehospital Intervention Phase|Severe head injury with GCS≤8|5|||
27807677|NCT01411852|54263026|FG001|Prehospital Intervention Phase|Severe head injury with GCS≤8|0|||
28034611|NCT00538902|54693027|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2|||
28034612|NCT00538902|54693028|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3|||
28034613|NCT00538902|54693026|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
28034614|NCT00538902|54693027|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
28034615|NCT00538902|54693028|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1|||
28034616|NCT00538902|54693026|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
28034617|NCT00538902|54693027|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
28034618|NCT00538902|54693028|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1|||
28034619|NCT00538902|54693026|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
28034620|NCT00538902|54693027|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
28034621|NCT00538902|54693028|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
28034622|NCT00538902|54693026|FG000|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2|||
28034623|NCT00538902|54693027|FG001|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10|||
28034624|NCT00538902|54693028|FG002|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11|||
28034625|NCT00538902|54693026|FG000|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15|||
28034626|NCT00538902|54693027|FG001|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19|||
28034627|NCT00538902|54693028|FG002|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25|||
28034628|NCT00538902|54693026|FG000|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1|||
28034629|NCT00538902|54693027|FG001|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10|||
28034630|NCT00538902|54693028|FG002|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6|||
28034631|NCT00538902|54693026|FG000|OL Wk 24 to End (Primary D/C Reasons)|Various|18|||
28034632|NCT00538902|54693027|FG001|OL Wk 24 to End (Primary D/C Reasons)|Various|25|||
28034633|NCT00538902|54693028|FG002|OL Wk 24 to End (Primary D/C Reasons)|Various|22|||
27807678|NCT01411852|54263025|FG000|Hospital Intervention Phase|Severe head injury|5|||
27807679|NCT01411852|54263026|FG001|Hospital Intervention Phase|Severe head injury|4|||
27807680|NCT01411852|54263025|FG000|Hospital Intervention Phase|No qualifying SBP|5|||
27807681|NCT01411852|54263026|FG001|Hospital Intervention Phase|No qualifying SBP|1|||
27807682|NCT01411852|54263025|FG000|Hospital Intervention Phase|Miscommunication error|1|||
27807683|NCT01411852|54263026|FG001|Hospital Intervention Phase|Miscommunication error|2|||
27807684|NCT01411852|54263025|FG000|Hospital Intervention Phase|CPR administered|3|||
27807685|NCT01411852|54263026|FG001|Hospital Intervention Phase|CPR administered|1|||
27844640|NCT01380769|54335050|FG000|Overall Study|Withdrawal by Subject|7|||
27844641|NCT01380769|54335051|FG001|Overall Study|Withdrawal by Subject|11|||
27844642|NCT01380769|54335050|FG000|Overall Study|Physician Decision|1|||
27844643|NCT01380769|54335051|FG001|Overall Study|Physician Decision|1|||
27844644|NCT01380769|54335050|FG000|Overall Study|Adverse Event|1|||
27844645|NCT01380769|54335051|FG001|Overall Study|Adverse Event|1|||
27844646|NCT01380769|54335050|FG000|Overall Study|Protocol Violation|0|||
27844647|NCT01380769|54335051|FG001|Overall Study|Protocol Violation|1|||
27844648|NCT01395901|54335059|FG000|Overall Study|Lost to Follow-up|4|||
27807686|NCT01411852|54263025|FG000|Hospital Intervention Phase|Misunderstanding of protocol|4|||
27807687|NCT01411852|54263026|FG001|Hospital Intervention Phase|Misunderstanding of protocol|1|||
27807688|NCT01411852|54263025|FG000|Hospital Intervention Phase|Diagnosis of sepsis|0|||
27844649|NCT01395901|54335060|FG001|Overall Study|Lost to Follow-up|0|||
27844650|NCT01395901|54335059|FG000|Overall Study|Randomized but not received study drug|5|||
27844651|NCT01395901|54335060|FG001|Overall Study|Randomized but not received study drug|4|||
27844652|NCT01395901|54335059|FG000|Overall Study|Adverse Event|0|||
27844653|NCT01395901|54335060|FG001|Overall Study|Adverse Event|1|||
27844654|NCT01395901|54335059|FG000|Overall Study|Withdrawal of consent|1|||
27844655|NCT01395901|54335060|FG001|Overall Study|Withdrawal of consent|0|||
27844656|NCT01395823|54335068|FG000|Overall Study|Death|4|||
27844657|NCT01395823|54335069|FG001|Overall Study|Death|4|||
27844658|NCT01395823|54335068|FG000|Overall Study|Physician Decision|3|||
27844659|NCT01395823|54335069|FG001|Overall Study|Physician Decision|1|||
27844660|NCT01395823|54335068|FG000|Overall Study|Lost to Follow-up|1|||
27844661|NCT01395823|54335069|FG001|Overall Study|Lost to Follow-up|0|||
27807689|NCT01411852|54263026|FG001|Hospital Intervention Phase|Diagnosis of sepsis|2|||
27807690|NCT01411852|54263025|FG000|Hospital Intervention Phase|Diagnosis of dehydration|0|||
27807691|NCT01411852|54263026|FG001|Hospital Intervention Phase|Diagnosis of dehydration|1|||
27807692|NCT01411852|54263025|FG000|Hospital Intervention Phase|Physician/hospital staff noncompliance|0|||
27807693|NCT01411852|54263026|FG001|Hospital Intervention Phase|Physician/hospital staff noncompliance|4|||
27807694|NCT01411852|54263025|FG000|Hospital Intervention Phase|Other ineligible|2|||
27807695|NCT01411852|54263026|FG001|Hospital Intervention Phase|Other ineligible|2|||
27844662|NCT01395823|54335068|FG000|Overall Study|Transplant|1|||
28034634|NCT00541970|54693042|FG000|Month 7|Protocol Violation|9|||
27844663|NCT01395823|54335069|FG001|Overall Study|Transplant|0|||
27844664|NCT01395823|54335068|FG000|Overall Study|GI symptoms|1|||
27844665|NCT01395823|54335069|FG001|Overall Study|GI symptoms|0|||
28034635|NCT00541970|54693043|FG001|Month 7|Protocol Violation|13|||
27844666|NCT01395823|54335068|FG000|Overall Study|Withdrawal by Subject|5|||
27844667|NCT01395823|54335069|FG001|Overall Study|Withdrawal by Subject|4|||
28034636|NCT00541970|54693044|FG002|Month 7|Protocol Violation|11|||
28034637|NCT00541970|54693045|FG003|Month 7|Protocol Violation|5|||
28034638|NCT00541970|54693042|FG000|Month 12|Adverse Event|0|||
28034639|NCT00541970|54693043|FG001|Month 12|Adverse Event|1|||
28034640|NCT00541970|54693044|FG002|Month 12|Adverse Event|1|||
28034641|NCT00541970|54693045|FG003|Month 12|Adverse Event|1|||
28034642|NCT00541970|54693042|FG000|Month 12|Protocol Violation|12|||
28034643|NCT00541970|54693043|FG001|Month 12|Protocol Violation|21|||
28034644|NCT00541970|54693044|FG002|Month 12|Protocol Violation|20|||
28034645|NCT00541970|54693045|FG003|Month 12|Protocol Violation|15|||
28034646|NCT00541970|54693042|FG000|Month 18|Adverse Event|0|||
28034647|NCT00541970|54693043|FG001|Month 18|Adverse Event|1|||
28034648|NCT00541970|54693044|FG002|Month 18|Adverse Event|1|||
27807696|NCT01411852|54263025|FG000|Hospital Intervention Phase|Spinal cord injury|2|||
28034649|NCT00541970|54693045|FG003|Month 18|Adverse Event|1|||
28034650|NCT00541970|54693042|FG000|Month 18|Protocol Violation|14|||
28034651|NCT00541970|54693043|FG001|Month 18|Protocol Violation|23|||
28034652|NCT00541970|54693044|FG002|Month 18|Protocol Violation|24|||
28034653|NCT00541970|54693045|FG003|Month 18|Protocol Violation|16|||
28034654|NCT00541970|54693042|FG000|Month 24|Adverse Event|0|||
28034655|NCT00541970|54693043|FG001|Month 24|Adverse Event|1|||
28034656|NCT00541970|54693044|FG002|Month 24|Adverse Event|1|||
28034657|NCT00541970|54693045|FG003|Month 24|Adverse Event|1|||
28034658|NCT00541970|54693042|FG000|Month 24|Protocol Violation|29|||
28034659|NCT00541970|54693043|FG001|Month 24|Protocol Violation|31|||
28034660|NCT00541970|54693044|FG002|Month 24|Protocol Violation|31|||
28034661|NCT00541970|54693045|FG003|Month 24|Protocol Violation|21|||
28034662|NCT00541970|54693042|FG000|Month 36|Protocol Violation|61|||
28034663|NCT00541970|54693043|FG001|Month 36|Protocol Violation|66|||
28034664|NCT00541970|54693044|FG002|Month 36|Protocol Violation|66|||
28034665|NCT00541970|54693045|FG003|Month 36|Protocol Violation|60|||
28034666|NCT00541970|54693042|FG000|Month 48|Withdrawal by Subject|2|||
28034667|NCT00541970|54693043|FG001|Month 48|Withdrawal by Subject|4|||
28034668|NCT00541970|54693044|FG002|Month 48|Withdrawal by Subject|4|||
28034669|NCT00541970|54693045|FG003|Month 48|Withdrawal by Subject|2|||
28034670|NCT00541970|54693042|FG000|Month 48|Other|3|||
28034671|NCT00541970|54693043|FG001|Month 48|Other|1|||
28034672|NCT00541970|54693044|FG002|Month 48|Other|1|||
28034673|NCT00541970|54693045|FG003|Month 48|Other|0|||
28034674|NCT00541970|54693042|FG000|Month 48|Lost to Follow-up|66|||
28034675|NCT00541970|54693043|FG001|Month 48|Lost to Follow-up|68|||
28034676|NCT00541970|54693044|FG002|Month 48|Lost to Follow-up|68|||
28034677|NCT00541970|54693045|FG003|Month 48|Lost to Follow-up|73|||
28034678|NCT00541970|54693042|FG000|Month 60|Protocol Violation|78|||
28034679|NCT00541970|54693043|FG001|Month 60|Protocol Violation|77|||
27807697|NCT01411852|54263026|FG001|Hospital Intervention Phase|Spinal cord injury|0|||
28034680|NCT00541970|54693044|FG002|Month 60|Protocol Violation|82|||
28034681|NCT00541970|54693045|FG003|Month 60|Protocol Violation|72|||
28034682|NCT00687323|54693055|FG000|Overall Study|Death|25|||
28034683|NCT00687323|54693055|FG000|Overall Study|Withdrawal by Subject|1|||
28034684|NCT00687323|54693055|FG000|Overall Study|Excluded from efficacy evaluations|6|||
27807698|NCT01411852|54263025|FG000|Hospital Intervention Phase|Withdrawal by Subject|1|||
27807699|NCT01411852|54263026|FG001|Hospital Intervention Phase|Withdrawal by Subject|0|||
27807700|NCT01411852|54263025|FG000|Hospital Intervention Phase|Vascular access failed|1|||
28034685|NCT00687323|54693055|FG000|Overall Study|Screen failure|148|||
28034686|NCT03899064|54693072|FG000|Overall Study|Lost to Follow-up|1|||
28034687|NCT03899064|54693072|FG000|Overall Study|Protocol Violation|2|||
28034688|NCT03899064|54693072|FG000|Overall Study|Withdrawal by Subject|2|||
28034689|NCT03899064|54693072|FG000|Overall Study|Other|2|||
28034690|NCT03902574|54693079|FG000|Overall Study|Urinary drug test was positive on Day 20|0|||
28034691|NCT03902574|54693080|FG001|Overall Study|Urinary drug test was positive on Day 20|0|||
28034692|NCT03902574|54693081|FG002|Overall Study|Urinary drug test was positive on Day 20|1|||
28034693|NCT00542828|54693093|FG000|Overall Study|Physician Decision|1|||
28034694|NCT00542828|54693093|FG000|Overall Study|Need for Prohibited Treatment|3|||
28034695|NCT00542828|54693093|FG000|Overall Study|Study Prematurely Discontinued|7|||
28034696|NCT00542828|54693093|FG000|Overall Study|Did Not Receive Thymoglobulin Treatment|2|||
28034697|NCT00090103|54693100|FG000|Four-Year Double-Blind Treatment Period|Adverse Event|211|||
28034698|NCT00090103|54693101|FG001|Four-Year Double-Blind Treatment Period|Adverse Event|185|||
28034699|NCT00090103|54693102|FG002|Four-Year Double-Blind Treatment Period|Adverse Event|210|||
28034700|NCT00090103|54693100|FG000|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114|||
28034701|NCT00090103|54693101|FG001|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160|||
28034702|NCT00090103|54693102|FG002|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148|||
28034703|NCT00090103|54693100|FG000|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53|||
28034704|NCT00090103|54693101|FG001|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48|||
28034705|NCT00090103|54693102|FG002|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58|||
28034706|NCT00090103|54693100|FG000|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
28034707|NCT00090103|54693101|FG001|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
28034708|NCT00090103|54693102|FG002|Four-Year Double-Blind Treatment Period|Protocol Violation|34|||
28034709|NCT00090103|54693100|FG000|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53|||
28034710|NCT00090103|54693101|FG001|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71|||
28034711|NCT00090103|54693102|FG002|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104|||
28034712|NCT00090103|54693100|FG000|Four-Year Double-Blind Treatment Period|Participant Relocated|7|||
28034713|NCT00090103|54693101|FG001|Four-Year Double-Blind Treatment Period|Participant Relocated|2|||
28034714|NCT00090103|54693102|FG002|Four-Year Double-Blind Treatment Period|Participant Relocated|8|||
28034715|NCT00090103|54693100|FG000|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
28034716|NCT00090103|54693101|FG001|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
28034717|NCT00090103|54693102|FG002|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4|||
28034718|NCT00090103|54693100|FG000|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6|||
28034719|NCT00090103|54693101|FG001|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4|||
28034720|NCT00090103|54693102|FG002|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7|||
28034721|NCT00090103|54693100|FG000|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3|||
28034722|NCT00090103|54693101|FG001|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7|||
27939783|NCT00952588|54596114|FG001|Overall Study|Physician Decision|1|||
27939784|NCT00952588|54596113|FG000|Overall Study|Lack of Efficacy|2|||
27939785|NCT00952588|54596114|FG001|Overall Study|Lack of Efficacy|2|||
28034723|NCT00090103|54693102|FG002|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19|||
28034724|NCT00090103|54693100|FG000|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2|||
28034725|NCT00090103|54693101|FG001|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0|||
28034726|NCT00090103|54693102|FG002|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4|||
28034727|NCT00090103|54693100|FG000|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2|||
28034728|NCT00090103|54693101|FG001|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3|||
28034729|NCT00090103|54693102|FG002|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6|||
28034730|NCT00090103|54693100|FG000|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
28034731|NCT00090103|54693101|FG001|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
28034732|NCT00090103|54693102|FG002|Four-Year Double-Blind Treatment Period|Prohibited Medication|8|||
28034733|NCT00090103|54693100|FG000|Four-Year Double-Blind Treatment Period|Investigator Departure|2|||
28034734|NCT00090103|54693101|FG001|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
28034735|NCT00090103|54693102|FG002|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
28034736|NCT00090103|54693100|FG000|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1|||
28034737|NCT00090103|54693101|FG001|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
28034738|NCT00090103|54693102|FG002|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
28034739|NCT00090103|54693100|FG000|Four-Year Double-Blind Treatment Period|Screen Failure|1|||
28034740|NCT00090103|54693101|FG001|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
28034741|NCT00090103|54693102|FG002|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
28034742|NCT00090103|54693100|FG000|Four-Year Double-Blind Treatment Period|No Improvement|1|||
28034743|NCT00090103|54693101|FG001|Four-Year Double-Blind Treatment Period|No Improvement|0|||
28034744|NCT00090103|54693102|FG002|Four-Year Double-Blind Treatment Period|No Improvement|0|||
28034745|NCT00090103|54693100|FG000|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1|||
28034746|NCT00090103|54693101|FG001|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0|||
28034747|NCT00090103|54693102|FG002|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5|||
28034748|NCT00090103|54693100|FG000|Four-Year Double-Blind Treatment Period|Financial Problems|1|||
28034749|NCT00090103|54693101|FG001|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
28034750|NCT00090103|54693102|FG002|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
28034751|NCT00090103|54693100|FG000|Four-Year Double-Blind Treatment Period|Loss of Libido|1|||
28034752|NCT00090103|54693101|FG001|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
28034753|NCT00090103|54693102|FG002|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
28034754|NCT00090103|54693100|FG000|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
28034755|NCT00090103|54693101|FG001|Four-Year Double-Blind Treatment Period|Angina Pectoris|2|||
28034756|NCT00090103|54693102|FG002|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
28034757|NCT00090103|54693100|FG000|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
28034758|NCT00090103|54693101|FG001|Four-Year Double-Blind Treatment Period|Loss of Contact|1|||
27807701|NCT01411852|54263026|FG001|Hospital Intervention Phase|Vascular access failed|0|||
27807702|NCT01411774|54263036|FG000|Overall Study|Withdrawal by Subject|0|||
27807703|NCT01411774|54263037|FG001|Overall Study|Withdrawal by Subject|3|||
27807704|NCT01411228|54263046|FG000|Overall Study|Lost to Follow-up|0|||
27807705|NCT01411228|54263047|FG001|Overall Study|Lost to Follow-up|0|||
27807706|NCT01411228|54263048|FG002|Overall Study|Lost to Follow-up|1|||
27939786|NCT01227902|54596124|FG000|Overall Study|Adverse Event|12|||
27939787|NCT01227902|54596125|FG001|Overall Study|Adverse Event|8|||
28034759|NCT00090103|54693102|FG002|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
28034760|NCT00090103|54693100|FG000|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0|||
28034761|NCT00090103|54693101|FG001|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
28034762|NCT00090103|54693102|FG002|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
28034763|NCT00090103|54693100|FG000|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
28034764|NCT00090103|54693101|FG001|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2|||
28034765|NCT00090103|54693102|FG002|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
28034766|NCT00090103|54693100|FG000|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
28034767|NCT00090103|54693101|FG001|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1|||
28034768|NCT00090103|54693102|FG002|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
28034769|NCT00090103|54693100|FG000|Four-Year Double-Blind Treatment Period|Back Pain|0|||
28034770|NCT00090103|54693101|FG001|Four-Year Double-Blind Treatment Period|Back Pain|1|||
28034771|NCT00090103|54693102|FG002|Four-Year Double-Blind Treatment Period|Back Pain|0|||
28034772|NCT00090103|54693100|FG000|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
28034773|NCT00090103|54693101|FG001|Four-Year Double-Blind Treatment Period|Scheduling Issues|1|||
28034774|NCT00090103|54693102|FG002|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
28034775|NCT00090103|54693100|FG000|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
28034776|NCT00090103|54693101|FG001|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1|||
28034777|NCT00090103|54693102|FG002|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
28034778|NCT00090103|54693100|FG000|Four-Year Double-Blind Treatment Period|Investigator Decision|0|||
28034779|NCT00090103|54693101|FG001|Four-Year Double-Blind Treatment Period|Investigator Decision|1|||
28034780|NCT00090103|54693102|FG002|Four-Year Double-Blind Treatment Period|Investigator Decision|3|||
27844668|NCT00158184|54335077|FG000|Overall Study|personal issues|3|||
27844669|NCT00158184|54335078|FG001|Overall Study|personal issues|1|||
27844670|NCT00158184|54335077|FG000|Overall Study|failed for follow unit/study rules|2|||
27844671|NCT00158184|54335078|FG001|Overall Study|failed for follow unit/study rules|0|||
28034781|NCT00090103|54693100|FG000|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
28034782|NCT00090103|54693101|FG001|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
28034783|NCT00090103|54693102|FG002|Four-Year Double-Blind Treatment Period|Enrollment Error|2|||
28034784|NCT00090103|54693100|FG000|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
28034785|NCT00090103|54693101|FG001|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
28034786|NCT00090103|54693102|FG002|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1|||
28034787|NCT00090103|54693100|FG000|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
28034788|NCT00090103|54693101|FG001|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1|||
28034789|NCT00090103|54693102|FG002|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
28034790|NCT00090103|54693100|FG000|16-Week Safety Follow-up Period|Adverse Event|34|||
28034791|NCT00090103|54693101|FG001|16-Week Safety Follow-up Period|Adverse Event|39|||
28034792|NCT00090103|54693102|FG002|16-Week Safety Follow-up Period|Adverse Event|44|||
28034793|NCT00090103|54693100|FG000|16-Week Safety Follow-up Period|Withdrawal by Subject|185|||
28034794|NCT00090103|54693101|FG001|16-Week Safety Follow-up Period|Withdrawal by Subject|212|||
28034795|NCT00090103|54693102|FG002|16-Week Safety Follow-up Period|Withdrawal by Subject|229|||
28034796|NCT00090103|54693100|FG000|16-Week Safety Follow-up Period|Lost to Follow-up|101|||
28034797|NCT00090103|54693101|FG001|16-Week Safety Follow-up Period|Lost to Follow-up|97|||
28034798|NCT00090103|54693102|FG002|16-Week Safety Follow-up Period|Lost to Follow-up|111|||
28034799|NCT00090103|54693100|FG000|16-Week Safety Follow-up Period|Protocol Violation|18|||
28034800|NCT00090103|54693101|FG001|16-Week Safety Follow-up Period|Protocol Violation|18|||
28034801|NCT00090103|54693102|FG002|16-Week Safety Follow-up Period|Protocol Violation|17|||
28034802|NCT00090103|54693100|FG000|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8|||
28034803|NCT00090103|54693101|FG001|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5|||
28034804|NCT00090103|54693102|FG002|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4|||
28034805|NCT00090103|54693100|FG000|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8|||
28034806|NCT00090103|54693101|FG001|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6|||
28034807|NCT00090103|54693102|FG002|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4|||
28034808|NCT00090103|54693100|FG000|16-Week Safety Follow-up Period|Loss of Contact|4|||
28034809|NCT00090103|54693101|FG001|16-Week Safety Follow-up Period|Loss of Contact|0|||
28034810|NCT00090103|54693102|FG002|16-Week Safety Follow-up Period|Loss of Contact|2|||
28034811|NCT00090103|54693100|FG000|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3|||
28034812|NCT00090103|54693101|FG001|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
28034813|NCT00090103|54693102|FG002|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
27844672|NCT00158184|54335077|FG000|Overall Study|Adverse Event|1|||
27844673|NCT00158184|54335078|FG001|Overall Study|Adverse Event|1|||
27844674|NCT01380691|54335086|FG000|Washout (7 Days)|Protocol Violation|0|||
27844675|NCT01380691|54335087|FG001|Washout (7 Days)|Protocol Violation|0|||
27844676|NCT01380691|54335088|FG002|Washout (7 Days)|Protocol Violation|0|||
28034814|NCT00090103|54693100|FG000|16-Week Safety Follow-up Period|Participant relocated|2|||
28034815|NCT00090103|54693101|FG001|16-Week Safety Follow-up Period|Participant relocated|3|||
28034816|NCT00090103|54693102|FG002|16-Week Safety Follow-up Period|Participant relocated|1|||
28034817|NCT00090103|54693100|FG000|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
28034818|NCT00090103|54693101|FG001|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1|||
28034819|NCT00090103|54693102|FG002|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
28034820|NCT00090103|54693100|FG000|16-Week Safety Follow-up Period|Prohibited Medication|2|||
28034821|NCT00090103|54693101|FG001|16-Week Safety Follow-up Period|Prohibited Medication|3|||
27844677|NCT01380691|54335089|FG003|Washout (7 Days)|Protocol Violation|1|||
27844678|NCT01380691|54335086|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
27844679|NCT01380691|54335087|FG001|Washout (7 Days)|Withdrawal by Subject|0|||
27844680|NCT01380691|54335088|FG002|Washout (7 Days)|Withdrawal by Subject|1|||
27844681|NCT01380691|54335089|FG003|Washout (7 Days)|Withdrawal by Subject|0|||
27844682|NCT01380535|54335115|FG000|Overall Study|Adverse Event|3|||
27844683|NCT01380535|54335116|FG001|Overall Study|Adverse Event|3|||
27844684|NCT01380535|54335115|FG000|Overall Study|Death|3|||
27844685|NCT01380535|54335116|FG001|Overall Study|Death|0|||
27844686|NCT01380535|54335115|FG000|Overall Study|Study site closed|0|||
27844687|NCT01380535|54335116|FG001|Overall Study|Study site closed|5|||
27844688|NCT01380535|54335115|FG000|Overall Study|Withdrawal by Subject|1|||
28034822|NCT00090103|54693102|FG002|16-Week Safety Follow-up Period|Prohibited Medication|5|||
28034823|NCT00090103|54693100|FG000|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
28034824|NCT00090103|54693101|FG001|16-Week Safety Follow-up Period|Alcohol Dependent|0|||
28034825|NCT00090103|54693102|FG002|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
28034826|NCT00090103|54693100|FG000|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1|||
28034827|NCT00090103|54693101|FG001|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5|||
28034828|NCT00090103|54693102|FG002|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13|||
28034829|NCT00090103|54693100|FG000|16-Week Safety Follow-up Period|Loss of Libido|1|||
28034830|NCT00090103|54693101|FG001|16-Week Safety Follow-up Period|Loss of Libido|0|||
28034831|NCT00090103|54693102|FG002|16-Week Safety Follow-up Period|Loss of Libido|0|||
28034832|NCT00090103|54693100|FG000|16-Week Safety Follow-up Period|Enrollment Error|1|||
28034833|NCT00090103|54693101|FG001|16-Week Safety Follow-up Period|Enrollment Error|0|||
28034834|NCT00090103|54693102|FG002|16-Week Safety Follow-up Period|Enrollment Error|2|||
28034835|NCT00090103|54693100|FG000|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1|||
28034836|NCT00090103|54693101|FG001|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3|||
28034837|NCT00090103|54693102|FG002|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6|||
28034838|NCT00090103|54693100|FG000|16-Week Safety Follow-up Period|Death|1|||
28034839|NCT00090103|54693101|FG001|16-Week Safety Follow-up Period|Death|0|||
28034840|NCT00090103|54693102|FG002|16-Week Safety Follow-up Period|Death|1|||
27807707|NCT01411228|54263046|FG000|Overall Study|Withdrawal by Subject|1|||
27807708|NCT01411228|54263047|FG001|Overall Study|Withdrawal by Subject|0|||
27807709|NCT01411228|54263048|FG002|Overall Study|Withdrawal by Subject|0|||
27807710|NCT01410604|54263058|FG000|Overall Study|Adverse Event|2|||
27807711|NCT01410604|54263059|FG001|Overall Study|Adverse Event|1|||
27844689|NCT01380535|54335116|FG001|Overall Study|Withdrawal by Subject|2|||
27844690|NCT01380535|54335115|FG000|Overall Study|Protocol Violation|0|||
27844691|NCT01380535|54335116|FG001|Overall Study|Protocol Violation|2|||
27844692|NCT01380535|54335115|FG000|Overall Study|Lack of Efficacy|0|||
27844693|NCT01380535|54335116|FG001|Overall Study|Lack of Efficacy|3|||
27807712|NCT01410604|54263058|FG000|Overall Study|Lost to Follow-up|1|||
27807713|NCT01410604|54263059|FG001|Overall Study|Lost to Follow-up|0|||
27807714|NCT01410604|54263058|FG000|Overall Study|Physician Decision|0|||
27807715|NCT01410604|54263059|FG001|Overall Study|Physician Decision|1|||
27807716|NCT01991483|54263069|FG000|Dose Level 600 mg|Withdrawal by Subject|0|||
27807717|NCT01991483|54263070|FG001|Dose Level 600 mg|Withdrawal by Subject|0|||
27807718|NCT01991483|54263071|FG002|Dose Level 600 mg|Withdrawal by Subject|1|||
27807719|NCT01991483|54263072|FG003|Dose Level 600 mg|Withdrawal by Subject|0|||
27807720|NCT01991483|54263069|FG000|Dose Level 600 mg|Physician Decision|0|||
27807721|NCT01991483|54263070|FG001|Dose Level 600 mg|Physician Decision|0|||
27807722|NCT01991483|54263071|FG002|Dose Level 600 mg|Physician Decision|1|||
27807723|NCT01991483|54263072|FG003|Dose Level 600 mg|Physician Decision|0|||
27807724|NCT01991483|54263069|FG000|Dose Level 1000 mg|Protocol Violation|0|||
27807725|NCT01991483|54263070|FG001|Dose Level 1000 mg|Protocol Violation|0|||
27807726|NCT01991483|54263071|FG002|Dose Level 1000 mg|Protocol Violation|0|||
27807727|NCT01991483|54263072|FG003|Dose Level 1000 mg|Protocol Violation|1|||
27807728|NCT01410448|54263087|FG000|Overall Study|No conversion to everolimus|0|||
27844694|NCT01380379|54335126|FG000|Overall Study|Pregnancy|1|||
27844695|NCT01380145|54335130|FG000|Overall Study|Progressive disease|4|||
27844696|NCT03420222|54335156|FG000|Overall Study|Withdrawal by Subject|5|||
27844697|NCT03420222|54335157|FG001|Overall Study|Withdrawal by Subject|0|||
27807729|NCT01410448|54263088|FG001|Overall Study|No conversion to everolimus|24|||
27844698|NCT03420222|54335156|FG000|Overall Study|Physician Decision|0|||
27807730|NCT01410448|54263087|FG000|Overall Study|Graft loss|4|||
27807731|NCT01410448|54263088|FG001|Overall Study|Graft loss|1|||
27807732|NCT01410448|54263087|FG000|Overall Study|Administrative issues|2|||
27807733|NCT01410448|54263088|FG001|Overall Study|Administrative issues|1|||
27807734|NCT01410448|54263087|FG000|Overall Study|Lost to Follow-up|1|||
27807735|NCT01410448|54263088|FG001|Overall Study|Lost to Follow-up|0|||
27807736|NCT01410448|54263087|FG000|Overall Study|Withdrawal by Subject|3|||
27807737|NCT01410448|54263088|FG001|Overall Study|Withdrawal by Subject|2|||
27807738|NCT01410448|54263087|FG000|Overall Study|Protocol Violation|0|||
27807739|NCT01410448|54263088|FG001|Overall Study|Protocol Violation|4|||
27807740|NCT01410448|54263087|FG000|Overall Study|Death|2|||
27807741|NCT01410448|54263088|FG001|Overall Study|Death|3|||
27807742|NCT01943851|54263112|FG000|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
27807743|NCT01943851|54263113|FG001|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
27807744|NCT01943851|54263114|FG002|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
27844699|NCT03420222|54335157|FG001|Overall Study|Physician Decision|1|||
27844700|NCT01394185|54335163|FG000|Overall Study|Withdrawal by Subject|2|||
27844701|NCT01394185|54335164|FG001|Overall Study|Withdrawal by Subject|0|||
27844702|NCT01394185|54335165|FG002|Overall Study|Withdrawal by Subject|0|||
27844703|NCT01394185|54335166|FG003|Overall Study|Withdrawal by Subject|0|||
27844704|NCT01394185|54335167|FG004|Overall Study|Withdrawal by Subject|1|||
27844705|NCT01394185|54335168|FG005|Overall Study|Withdrawal by Subject|0|||
27844706|NCT01394185|54335163|FG000|Overall Study|Change in protocol|3|||
27844707|NCT01394185|54335164|FG001|Overall Study|Change in protocol|0|||
27844708|NCT01394185|54335165|FG002|Overall Study|Change in protocol|0|||
27844709|NCT01394185|54335166|FG003|Overall Study|Change in protocol|0|||
27844710|NCT01394185|54335167|FG004|Overall Study|Change in protocol|3|||
27844711|NCT01394185|54335168|FG005|Overall Study|Change in protocol|0|||
27844712|NCT01394185|54335163|FG000|Overall Study|Protocol Violation|1|||
27844713|NCT01394185|54335164|FG001|Overall Study|Protocol Violation|0|||
27844714|NCT01394185|54335165|FG002|Overall Study|Protocol Violation|0|||
27844715|NCT01394185|54335166|FG003|Overall Study|Protocol Violation|1|||
27844716|NCT01394185|54335167|FG004|Overall Study|Protocol Violation|0|||
27844717|NCT01394185|54335168|FG005|Overall Study|Protocol Violation|1|||
27844718|NCT01677936|54335201|FG000|Overall Study|Lost to Follow-up|4|||
27844719|NCT01677936|54335202|FG001|Overall Study|Lost to Follow-up|1|||
27844720|NCT01677936|54335201|FG000|Overall Study|Protocol Violation|3|||
27844721|NCT01677936|54335202|FG001|Overall Study|Protocol Violation|0|||
27844722|NCT01677936|54335201|FG000|Overall Study|Adverse Event|1|||
27844723|NCT01677936|54335202|FG001|Overall Study|Adverse Event|0|||
27844724|NCT01677936|54335201|FG000|Overall Study|Lost to Follow-up|1|||
27844725|NCT01677936|54335202|FG001|Overall Study|Lost to Follow-up|0|||
27844726|NCT01677936|54335201|FG000|Overall Study|Protocol Violation|0|||
27844727|NCT01677936|54335202|FG001|Overall Study|Protocol Violation|4|||
27844728|NCT01525550|54335233|FG000|Overall Study|Lost to Follow-up|8|||
27807745|NCT01943851|54263115|FG003|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
27807746|NCT01943851|54263116|FG004|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
27807747|NCT01943851|54263117|FG005|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
27807748|NCT01943851|54263118|FG006|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
27807749|NCT01943851|54263119|FG007|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
27807750|NCT01943851|54263120|FG008|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
27807751|NCT01943851|54263121|FG009|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
27807752|NCT01943851|54263122|FG010|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
27807753|NCT01943851|54263123|FG011|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
27807754|NCT01943851|54263124|FG012|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
27807755|NCT01943851|54263125|FG013|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
27807756|NCT01943851|54263126|FG014|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
27807757|NCT01943851|54263127|FG015|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
27807758|NCT01943851|54263128|FG016|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
27807759|NCT01943851|54263129|FG017|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
27844729|NCT01525550|54335234|FG001|Overall Study|Lost to Follow-up|2|||
27844730|NCT01525550|54335233|FG000|Overall Study|Death|19|||
27844731|NCT01525550|54335234|FG001|Overall Study|Death|28|||
27844732|NCT01525550|54335233|FG000|Overall Study|Other|0|||
27844733|NCT01525550|54335234|FG001|Overall Study|Other|4|||
27807760|NCT01943851|54263112|FG000|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
27807761|NCT01943851|54263113|FG001|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
27807762|NCT01943851|54263114|FG002|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
27807763|NCT01943851|54263115|FG003|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
27807764|NCT01943851|54263116|FG004|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
27844734|NCT01525550|54335233|FG000|Overall Study|Sponsor's Decision|30|||
27844735|NCT01525550|54335234|FG001|Overall Study|Sponsor's Decision|11|||
27844736|NCT01525550|54335233|FG000|Overall Study|Withdrawal by Subject|4|||
27844737|NCT01525550|54335234|FG001|Overall Study|Withdrawal by Subject|0|||
27844738|NCT00211237|54335255|FG000|Baseline|Withdrew|1|||
27844739|NCT00211237|54335256|FG001|Baseline|Withdrew|3|||
27844740|NCT00211237|54335257|FG002|Baseline|Withdrew|0|||
27844741|NCT00211237|54335255|FG000|Baseline|Refused random assignment|1|||
27807765|NCT01943851|54263117|FG005|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
27807766|NCT01943851|54263118|FG006|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
27807767|NCT01943851|54263119|FG007|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
27807768|NCT01943851|54263120|FG008|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
27807769|NCT01943851|54263121|FG009|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
27807770|NCT01943851|54263122|FG010|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
27807771|NCT01943851|54263123|FG011|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
27807772|NCT01943851|54263124|FG012|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
27807773|NCT01943851|54263125|FG013|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
27807774|NCT01943851|54263126|FG014|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
27807775|NCT01943851|54263127|FG015|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
27807776|NCT01943851|54263128|FG016|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
27807777|NCT01943851|54263129|FG017|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
27807778|NCT01943851|54263112|FG000|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
27807779|NCT01943851|54263113|FG001|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
27807780|NCT01943851|54263114|FG002|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
27807781|NCT01943851|54263115|FG003|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
27807782|NCT01943851|54263116|FG004|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
27807783|NCT01943851|54263117|FG005|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
27807784|NCT01943851|54263118|FG006|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
27807785|NCT01943851|54263119|FG007|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
27807786|NCT01943851|54263120|FG008|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
27807787|NCT01943851|54263121|FG009|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
27807788|NCT01943851|54263122|FG010|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
27807789|NCT01943851|54263123|FG011|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
27807790|NCT01943851|54263124|FG012|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
27807791|NCT01943851|54263125|FG013|Part 1 (Up to 86.9 Weeks)|Investigator discretion|1|||
27807792|NCT01943851|54263126|FG014|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
27807793|NCT01943851|54263127|FG015|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
27807794|NCT01943851|54263128|FG016|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
27807795|NCT01943851|54263129|FG017|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
27807796|NCT01943851|54263112|FG000|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
27807797|NCT01943851|54263113|FG001|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
27807798|NCT01943851|54263114|FG002|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
27807799|NCT01943851|54263115|FG003|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
28034841|NCT00090103|54693100|FG000|16-Week Safety Follow-up Period|Gyneomastia|1|||
28034842|NCT00090103|54693101|FG001|16-Week Safety Follow-up Period|Gyneomastia|0|||
28034843|NCT00090103|54693102|FG002|16-Week Safety Follow-up Period|Gyneomastia|0|||
28034844|NCT00090103|54693100|FG000|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0|||
28034845|NCT00090103|54693101|FG001|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5|||
28034846|NCT00090103|54693102|FG002|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4|||
28034847|NCT00090103|54693100|FG000|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0|||
28034848|NCT00090103|54693101|FG001|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2|||
28034849|NCT00090103|54693102|FG002|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3|||
28034850|NCT00090103|54693100|FG000|16-Week Safety Follow-up Period|Angina Pectoris|0|||
28034851|NCT00090103|54693101|FG001|16-Week Safety Follow-up Period|Angina Pectoris|1|||
28034852|NCT00090103|54693102|FG002|16-Week Safety Follow-up Period|Angina Pectoris|0|||
28034853|NCT00090103|54693100|FG000|16-Week Safety Follow-up Period|Back Pain|0|||
28034854|NCT00090103|54693101|FG001|16-Week Safety Follow-up Period|Back Pain|1|||
28034855|NCT00090103|54693102|FG002|16-Week Safety Follow-up Period|Back Pain|0|||
28034856|NCT00090103|54693100|FG000|16-Week Safety Follow-up Period|Scheduling Issues|0|||
28034857|NCT00090103|54693101|FG001|16-Week Safety Follow-up Period|Scheduling Issues|2|||
28034858|NCT00090103|54693102|FG002|16-Week Safety Follow-up Period|Scheduling Issues|4|||
28034859|NCT00090103|54693100|FG000|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0|||
28034860|NCT00090103|54693101|FG001|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2|||
28034861|NCT00090103|54693102|FG002|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3|||
28034862|NCT00090103|54693100|FG000|16-Week Safety Follow-up Period|Depression|0|||
28034863|NCT00090103|54693101|FG001|16-Week Safety Follow-up Period|Depression|1|||
28034864|NCT00090103|54693102|FG002|16-Week Safety Follow-up Period|Depression|0|||
28034865|NCT00090103|54693100|FG000|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
28034866|NCT00090103|54693101|FG001|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1|||
28034867|NCT00090103|54693102|FG002|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
28034868|NCT00090103|54693100|FG000|16-Week Safety Follow-up Period|Jailed|0|||
27807800|NCT01943851|54263116|FG004|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
27807801|NCT01943851|54263117|FG005|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
27807802|NCT01943851|54263118|FG006|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
27807803|NCT01943851|54263119|FG007|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
27807804|NCT01943851|54263120|FG008|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
28034869|NCT00090103|54693101|FG001|16-Week Safety Follow-up Period|Jailed|1|||
27844742|NCT00211237|54335256|FG001|Baseline|Refused random assignment|0|||
27844743|NCT00211237|54335257|FG002|Baseline|Refused random assignment|0|||
27844744|NCT00211237|54335255|FG000|1 Month|Death|2|||
27844745|NCT00211237|54335256|FG001|1 Month|Death|1|||
27844746|NCT00211237|54335257|FG002|1 Month|Death|0|||
27844747|NCT00211237|54335255|FG000|1 Month|Lost to Follow-up|0|||
27844748|NCT00211237|54335256|FG001|1 Month|Lost to Follow-up|2|||
27844749|NCT00211237|54335257|FG002|1 Month|Lost to Follow-up|0|||
27844750|NCT00211237|54335255|FG000|1 Month|Withdrew|0|||
27844751|NCT00211237|54335256|FG001|1 Month|Withdrew|4|||
27844752|NCT00211237|54335257|FG002|1 Month|Withdrew|0|||
27844753|NCT00211237|54335255|FG000|1 Month|Additional surgery needed|1|||
27844754|NCT00211237|54335256|FG001|1 Month|Additional surgery needed|0|||
27844755|NCT00211237|54335257|FG002|1 Month|Additional surgery needed|0|||
27844756|NCT00211237|54335255|FG000|1 Month|Non-medical problem|0|||
27844757|NCT00211237|54335256|FG001|1 Month|Non-medical problem|2|||
27844758|NCT00211237|54335257|FG002|1 Month|Non-medical problem|0|||
27844759|NCT00211237|54335255|FG000|3 Months|Death|7|||
27844760|NCT00211237|54335256|FG001|3 Months|Death|3|||
27844761|NCT00211237|54335257|FG002|3 Months|Death|0|||
27844762|NCT00211237|54335255|FG000|3 Months|Could not comply with protocol|1|||
27844763|NCT00211237|54335256|FG001|3 Months|Could not comply with protocol|0|||
27844764|NCT00211237|54335257|FG002|3 Months|Could not comply with protocol|0|||
27844765|NCT00211237|54335255|FG000|3 Months|Withdrew|0|||
27844766|NCT00211237|54335256|FG001|3 Months|Withdrew|1|||
27844767|NCT00211237|54335257|FG002|3 Months|Withdrew|0|||
27844768|NCT00211237|54335255|FG000|3 Months|Non-medical problem|0|||
27844769|NCT00211237|54335256|FG001|3 Months|Non-medical problem|0|||
27844770|NCT00211237|54335257|FG002|3 Months|Non-medical problem|1|||
27844771|NCT00211237|54335255|FG000|6 Months|Death|6|||
27844772|NCT00211237|54335256|FG001|6 Months|Death|0|||
27844773|NCT00211237|54335257|FG002|6 Months|Death|3|||
27844774|NCT00211237|54335255|FG000|6 Months|Lost to Follow-up|2|||
27844775|NCT00211237|54335256|FG001|6 Months|Lost to Follow-up|0|||
27844776|NCT00211237|54335257|FG002|6 Months|Lost to Follow-up|0|||
28034870|NCT00090103|54693102|FG002|16-Week Safety Follow-up Period|Jailed|0|||
28034871|NCT00090103|54693100|FG000|16-Week Safety Follow-up Period|Other|0|||
28034872|NCT00090103|54693101|FG001|16-Week Safety Follow-up Period|Other|1|||
28034873|NCT00090103|54693102|FG002|16-Week Safety Follow-up Period|Other|0|||
28034874|NCT00087607|54693112|FG000|Overall Study|Adverse Event|14|||
28034875|NCT00087607|54693113|FG001|Overall Study|Adverse Event|24|||
28034876|NCT00087607|54693112|FG000|Overall Study|Death|0|||
28034877|NCT00087607|54693113|FG001|Overall Study|Death|1|||
28034878|NCT00087607|54693112|FG000|Overall Study|Insufficient Therapeutic Response|53|||
28034879|NCT00087607|54693113|FG001|Overall Study|Insufficient Therapeutic Response|42|||
28034880|NCT00087607|54693112|FG000|Overall Study|Failure to return|21|||
28034881|NCT00087607|54693113|FG001|Overall Study|Failure to return|17|||
28034882|NCT00087607|54693112|FG000|Overall Study|Withdrew Consent|12|||
28034883|NCT00087607|54693113|FG001|Overall Study|Withdrew Consent|16|||
28034884|NCT00087607|54693112|FG000|Overall Study|Administrative|12|||
28034885|NCT00087607|54693113|FG001|Overall Study|Administrative|12|||
28034886|NCT00087607|54693112|FG000|Overall Study|Refused Treatment|5|||
28034887|NCT00087607|54693113|FG001|Overall Study|Refused Treatment|7|||
28034888|NCT00087607|54693112|FG000|Overall Study|Other Protocol Violation|5|||
28034889|NCT00087607|54693113|FG001|Overall Study|Other Protocol Violation|2|||
28034890|NCT00087607|54693112|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
28034891|NCT00087607|54693113|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
27807805|NCT01943851|54263121|FG009|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
27807806|NCT01943851|54263122|FG010|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
27807807|NCT01943851|54263123|FG011|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
27807808|NCT01943851|54263124|FG012|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
27807809|NCT01943851|54263125|FG013|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
27807810|NCT01943851|54263126|FG014|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
27807811|NCT01943851|54263127|FG015|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|2|||
27807812|NCT01943851|54263128|FG016|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
27807813|NCT01943851|54263129|FG017|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
27807814|NCT01943851|54263112|FG000|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
27844777|NCT00211237|54335255|FG000|6 Months|Could not comply with protocol|0|||
27844778|NCT00211237|54335256|FG001|6 Months|Could not comply with protocol|2|||
27844779|NCT00211237|54335257|FG002|6 Months|Could not comply with protocol|0|||
28034892|NCT00069823|54693125|FG000|Overall Study|Did not have follow-up diary cards|6|||
28034893|NCT00069823|54693126|FG001|Overall Study|Did not have follow-up diary cards|3|||
28034894|NCT00086515|54693138|FG000|Phase A (Weeks 0-24)|Adverse Event|17|||
28034895|NCT00086515|54693139|FG001|Phase A (Weeks 0-24)|Adverse Event|9|||
28034896|NCT00086515|54693138|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|7|||
27844780|NCT00211237|54335255|FG000|12 Months|Death|8|||
27844781|NCT00211237|54335256|FG001|12 Months|Death|2|||
27844782|NCT00211237|54335257|FG002|12 Months|Death|3|||
27844783|NCT00211237|54335255|FG000|12 Months|Lost to Follow-up|1|||
27844784|NCT00211237|54335256|FG001|12 Months|Lost to Follow-up|0|||
27807815|NCT01943851|54263113|FG001|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
27807816|NCT01943851|54263114|FG002|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
27807817|NCT01943851|54263115|FG003|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
27807818|NCT01943851|54263116|FG004|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
27807819|NCT01943851|54263117|FG005|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
27807820|NCT01943851|54263118|FG006|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
27807821|NCT01943851|54263119|FG007|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
27807822|NCT01943851|54263120|FG008|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
27807823|NCT01943851|54263121|FG009|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
27807824|NCT01943851|54263122|FG010|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
27807825|NCT01943851|54263123|FG011|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
27807826|NCT01943851|54263124|FG012|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
27807827|NCT01943851|54263125|FG013|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
27807828|NCT01943851|54263126|FG014|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
27807829|NCT01943851|54263127|FG015|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|4|||
27807830|NCT01943851|54263128|FG016|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|3|||
27807831|NCT01943851|54263129|FG017|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|1|||
27807832|NCT01430104|54263170|FG000|28-Day Teriparatide Treatment Period|Adverse Event|1|||
27807833|NCT01990859|54263177|FG000|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5|||
27807834|NCT01990859|54263177|FG000|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17|||
27807835|NCT02093897|54263182|FG000|Overall Study|Physician Decision|1|||
27807836|NCT02093897|54263182|FG000|Overall Study|Planned age group closure - no's reached|17|||
27807837|NCT02093897|54263182|FG000|Overall Study|Adverse event, non-fatal|1|||
27807838|NCT01990313|54263193|FG000|Overall Study|Lost to Follow-up|1|||
27807839|NCT01947517|54263199|FG000|Overall Study|Withdrawal by Subject|1|||
27807840|NCT01947517|54263200|FG001|Overall Study|Withdrawal by Subject|1|||
27807841|NCT02006927|54263206|FG000|Overall Study|Adverse Event|2|||
27807842|NCT02006927|54263206|FG000|Overall Study|Withdrawal by Subject|1|||
27807843|NCT01947283|54263217|FG000|Overall Study|Death|1|||
27807844|NCT01947283|54263218|FG001|Overall Study|Death|1|||
27807845|NCT01947283|54263219|FG002|Overall Study|Death|1|||
27844785|NCT00211237|54335257|FG002|12 Months|Lost to Follow-up|1|||
27844786|NCT00211237|54335255|FG000|12 Months|Withdrew|0|||
27844787|NCT00211237|54335256|FG001|12 Months|Withdrew|0|||
27844788|NCT00211237|54335257|FG002|12 Months|Withdrew|1|||
27844789|NCT00211237|54335255|FG000|12 Months|unrelated medical problem|0|||
27844790|NCT00211237|54335256|FG001|12 Months|unrelated medical problem|0|||
27844791|NCT00211237|54335257|FG002|12 Months|unrelated medical problem|1|||
27844792|NCT01489358|54335277|FG000|Overall Study|Lost to Follow-up|0|||
27844793|NCT01489358|54335278|FG001|Overall Study|Lost to Follow-up|0|||
27844794|NCT01489358|54335279|FG002|Overall Study|Lost to Follow-up|2|||
27844795|NCT01525238|54335290|FG000|Overall Study|Withdrawal by Subject|1|||
27844796|NCT01525238|54335291|FG001|Overall Study|Withdrawal by Subject|0|||
27844797|NCT01525238|54335292|FG002|Overall Study|Withdrawal by Subject|0|||
27844798|NCT01525082|54335313|FG000|Overall Study|Death|1|||
27844799|NCT01488578|54335320|FG000|Overall Study|Protocol Violation|1836|||
27844800|NCT01524770|54335361|FG000|First Intervention|Withdrawal by Subject|1|||
27844801|NCT01524770|54335362|FG001|First Intervention|Withdrawal by Subject|0|||
27844802|NCT01524770|54335361|FG000|First Intervention|Adverse Event|1|||
27844803|NCT01524770|54335362|FG001|First Intervention|Adverse Event|1|||
27844804|NCT01524770|54335361|FG000|First Intervention|Protocol Violation|1|||
27844805|NCT01524770|54335362|FG001|First Intervention|Protocol Violation|0|||
27844806|NCT01524692|54335368|FG000|Overall Study|Withdrawal by Subject|3|||
27844807|NCT01431287|54335387|FG000|Overall Study|not treated|0|||
27844808|NCT01431287|54335388|FG001|Overall Study|not treated|0|||
27844809|NCT01431287|54335389|FG002|Overall Study|not treated|1|||
27844810|NCT01431287|54335390|FG003|Overall Study|not treated|0|||
27844811|NCT01431287|54335391|FG004|Overall Study|not treated|0|||
27844812|NCT01431287|54335387|FG000|Overall Study|Adverse Event|59|||
27844813|NCT01431287|54335388|FG001|Overall Study|Adverse Event|57|||
27844814|NCT01431287|54335389|FG002|Overall Study|Adverse Event|53|||
27844815|NCT01431287|54335390|FG003|Overall Study|Adverse Event|33|||
27844816|NCT01431287|54335391|FG004|Overall Study|Adverse Event|41|||
27844817|NCT01431287|54335387|FG000|Overall Study|Non compliant with protocol|6|||
27844818|NCT01431287|54335388|FG001|Overall Study|Non compliant with protocol|6|||
27939788|NCT01227902|54596126|FG002|Overall Study|Adverse Event|11|||
27807846|NCT01947283|54263220|FG003|Overall Study|Death|0|||
27807847|NCT01947283|54263221|FG004|Overall Study|Death|0|||
27807848|NCT01947283|54263222|FG005|Overall Study|Death|0|||
27807849|NCT01947283|54263223|FG006|Overall Study|Death|0|||
27844819|NCT01431287|54335389|FG002|Overall Study|Non compliant with protocol|5|||
27844820|NCT01431287|54335390|FG003|Overall Study|Non compliant with protocol|6|||
27844821|NCT01431287|54335391|FG004|Overall Study|Non compliant with protocol|5|||
27844822|NCT01431287|54335387|FG000|Overall Study|Lost to Follow-up|0|||
27844823|NCT01431287|54335388|FG001|Overall Study|Lost to Follow-up|3|||
27844824|NCT01431287|54335389|FG002|Overall Study|Lost to Follow-up|2|||
27844825|NCT01431287|54335390|FG003|Overall Study|Lost to Follow-up|3|||
27844826|NCT01431287|54335391|FG004|Overall Study|Lost to Follow-up|1|||
27844827|NCT01431287|54335387|FG000|Overall Study|Consent withdrawn not due to AE|29|||
27844828|NCT01431287|54335388|FG001|Overall Study|Consent withdrawn not due to AE|30|||
27807850|NCT01947283|54263217|FG000|Overall Study|Lost to Follow-up|4|||
27807851|NCT01947283|54263218|FG001|Overall Study|Lost to Follow-up|6|||
27807852|NCT01947283|54263219|FG002|Overall Study|Lost to Follow-up|5|||
27807853|NCT01947283|54263220|FG003|Overall Study|Lost to Follow-up|5|||
27807854|NCT01947283|54263221|FG004|Overall Study|Lost to Follow-up|0|||
27844829|NCT01431287|54335389|FG002|Overall Study|Consent withdrawn not due to AE|34|||
27844830|NCT01431287|54335390|FG003|Overall Study|Consent withdrawn not due to AE|19|||
27844831|NCT01431287|54335391|FG004|Overall Study|Consent withdrawn not due to AE|29|||
27844832|NCT01431287|54335387|FG000|Overall Study|not stated above|4|||
27844833|NCT01431287|54335388|FG001|Overall Study|not stated above|2|||
27844834|NCT01431287|54335389|FG002|Overall Study|not stated above|2|||
27844835|NCT01431287|54335390|FG003|Overall Study|not stated above|2|||
27844836|NCT01431287|54335391|FG004|Overall Study|not stated above|1|||
27844837|NCT01274715|54335437|FG000|Overall Study|Lost to Follow-up|1|||
27844838|NCT01274715|54335437|FG000|Overall Study|After consent, met exclusion criteria.|1|||
27844839|NCT01274715|54335437|FG000|Overall Study|After consent, met exclusion criteria.|1|||
27844840|NCT01274715|54335437|FG000|Overall Study|After consent, met exclusion criteria.|1|||
27844841|NCT01410227|54335441|FG000|Overall Study|Adverse Event|1|||
27844842|NCT01410227|54335442|FG001|Overall Study|Adverse Event|0|||
27844843|NCT01410227|54335443|FG002|Overall Study|Adverse Event|0|||
27844844|NCT01410227|54335444|FG003|Overall Study|Adverse Event|0|||
27844845|NCT01410227|54335441|FG000|Overall Study|Withdrawal by Subject|3|||
27844846|NCT01410227|54335442|FG001|Overall Study|Withdrawal by Subject|0|||
27844847|NCT01410227|54335443|FG002|Overall Study|Withdrawal by Subject|1|||
27844848|NCT01410227|54335444|FG003|Overall Study|Withdrawal by Subject|0|||
27844849|NCT01410227|54335441|FG000|Overall Study|Pregnancy|0|||
27844850|NCT01410227|54335442|FG001|Overall Study|Pregnancy|0|||
27844851|NCT01410227|54335443|FG002|Overall Study|Pregnancy|0|||
27844852|NCT01410227|54335444|FG003|Overall Study|Pregnancy|1|||
27844853|NCT01410227|54335441|FG000|Overall Study|Met Excl. Criteria After Starting Study|0|||
27844854|NCT01410227|54335442|FG001|Overall Study|Met Excl. Criteria After Starting Study|0|||
27844855|NCT01410227|54335443|FG002|Overall Study|Met Excl. Criteria After Starting Study|1|||
27844856|NCT01410227|54335444|FG003|Overall Study|Met Excl. Criteria After Starting Study|0|||
27844857|NCT01274559|54335456|FG000|Overall Study|Adverse Event|57|||
27844858|NCT01274559|54335457|FG001|Overall Study|Adverse Event|13|||
27844859|NCT01274559|54335456|FG000|Overall Study|Death|1|||
27844860|NCT01274559|54335457|FG001|Overall Study|Death|1|||
27844861|NCT01274559|54335456|FG000|Overall Study|Lost to Follow-up|3|||
27844862|NCT01274559|54335457|FG001|Overall Study|Lost to Follow-up|3|||
27844863|NCT01274559|54335456|FG000|Overall Study|Non-compliance with Study Drug|2|||
27844864|NCT01274559|54335457|FG001|Overall Study|Non-compliance with Study Drug|4|||
27844865|NCT01274559|54335456|FG000|Overall Study|Physician Decision|2|||
27844866|NCT01274559|54335457|FG001|Overall Study|Physician Decision|1|||
27844867|NCT01274559|54335456|FG000|Overall Study|Protocol Violation|28|||
27844868|NCT01274559|54335457|FG001|Overall Study|Protocol Violation|23|||
27844869|NCT01274559|54335456|FG000|Overall Study|Study Terminated by Sponsor|79|||
27844870|NCT01274559|54335457|FG001|Overall Study|Study Terminated by Sponsor|87|||
27844871|NCT01274559|54335456|FG000|Overall Study|Withdrawal by Subject|25|||
27844872|NCT01274559|54335457|FG001|Overall Study|Withdrawal by Subject|13|||
27844873|NCT01409993|54335465|FG000|Overall Study|Adverse Event|4|||
27939789|NCT01227902|54596127|FG003|Overall Study|Adverse Event|4|||
27939790|NCT01227902|54596124|FG000|Overall Study|Lack of Efficacy|1|||
27939791|NCT01227902|54596125|FG001|Overall Study|Lack of Efficacy|2|||
27807855|NCT01947283|54263222|FG005|Overall Study|Lost to Follow-up|2|||
27807856|NCT01947283|54263223|FG006|Overall Study|Lost to Follow-up|5|||
27807857|NCT01947283|54263217|FG000|Overall Study|Withdrawal by Subject|10|||
27807858|NCT01947283|54263218|FG001|Overall Study|Withdrawal by Subject|8|||
27807859|NCT01947283|54263219|FG002|Overall Study|Withdrawal by Subject|4|||
27807860|NCT01947283|54263220|FG003|Overall Study|Withdrawal by Subject|1|||
27807861|NCT01947283|54263221|FG004|Overall Study|Withdrawal by Subject|0|||
27807862|NCT01947283|54263222|FG005|Overall Study|Withdrawal by Subject|0|||
27807863|NCT01947283|54263223|FG006|Overall Study|Withdrawal by Subject|2|||
27807864|NCT01947283|54263217|FG000|Overall Study|No Clinical Recording|12|||
27807865|NCT01947283|54263218|FG001|Overall Study|No Clinical Recording|6|||
27844874|NCT01409993|54335466|FG001|Overall Study|Adverse Event|4|||
27844875|NCT01409993|54335467|FG002|Overall Study|Adverse Event|3|||
27844876|NCT01409993|54335468|FG003|Overall Study|Adverse Event|1|||
27844877|NCT01409993|54335465|FG000|Overall Study|Withdrawal by Subject|0|||
27844878|NCT01409993|54335466|FG001|Overall Study|Withdrawal by Subject|0|||
27844879|NCT01409993|54335467|FG002|Overall Study|Withdrawal by Subject|0|||
27844880|NCT01409993|54335468|FG003|Overall Study|Withdrawal by Subject|4|||
27844881|NCT01409993|54335465|FG000|Overall Study|Lost to Follow-up|0|||
27844882|NCT01409993|54335466|FG001|Overall Study|Lost to Follow-up|1|||
27844883|NCT01409993|54335467|FG002|Overall Study|Lost to Follow-up|0|||
27844884|NCT01409993|54335468|FG003|Overall Study|Lost to Follow-up|0|||
27807866|NCT01947283|54263219|FG002|Overall Study|No Clinical Recording|8|||
27807867|NCT01947283|54263220|FG003|Overall Study|No Clinical Recording|10|||
27807868|NCT01947283|54263221|FG004|Overall Study|No Clinical Recording|0|||
27844885|NCT01273623|54335482|FG000|Overall Study|did not meet IVUS criteria|29|||
27844886|NCT01409915|54335490|FG000|Overall Study|Adverse Event|0|||
27844887|NCT01409915|54335491|FG001|Overall Study|Adverse Event|2|||
27844888|NCT01409915|54335490|FG000|Overall Study|Withdrawal by Subject|0|||
27844889|NCT01409915|54335491|FG001|Overall Study|Withdrawal by Subject|1|||
27844890|NCT01409915|54335490|FG000|Overall Study|Protocol Violation|1|||
27844891|NCT01409915|54335491|FG001|Overall Study|Protocol Violation|0|||
27844892|NCT01272921|54335499|FG000|Overall Study|Protocol Violation|2|||
27844893|NCT01272921|54335500|FG001|Overall Study|Protocol Violation|1|||
27844894|NCT01409837|54335510|FG000|Overall Study|Withdrawal by Subject|2|||
27844895|NCT01409837|54335511|FG001|Overall Study|Withdrawal by Subject|1|||
27844896|NCT01409837|54335510|FG000|Overall Study|Lost to Follow-up|1|||
27844897|NCT01409837|54335511|FG001|Overall Study|Lost to Follow-up|0|||
27844898|NCT01409837|54335510|FG000|Overall Study|Physician Decision|0|||
27844899|NCT01409837|54335511|FG001|Overall Study|Physician Decision|1|||
27844900|NCT01430585|54335530|FG000|Overall Study|Death|1|||
27844901|NCT01430585|54335530|FG000|Overall Study|Objective Progression or Relapse|3|||
27844902|NCT01430585|54335530|FG000|Overall Study|Study Terminated by Sponsor|3|||
27844903|NCT01430585|54335530|FG000|Overall Study|Other|7|||
27844904|NCT01408901|54335553|FG000|6-Week Follow-Up|Lost to Follow-up|2|||
27844905|NCT01408901|54335554|FG001|6-Week Follow-Up|Lost to Follow-up|1|||
27844906|NCT01408901|54335555|FG002|6-Week Follow-Up|Lost to Follow-up|3|||
27844907|NCT01408901|54335556|FG003|6-Week Follow-Up|Lost to Follow-up|2|||
27844908|NCT01408901|54335553|FG000|6-Week Follow-Up|Death|1|||
27844909|NCT01408901|54335554|FG001|6-Week Follow-Up|Death|0|||
27844910|NCT01408901|54335555|FG002|6-Week Follow-Up|Death|0|||
27844911|NCT01408901|54335556|FG003|6-Week Follow-Up|Death|0|||
27844912|NCT01408901|54335553|FG000|6-Week Follow-Up|Cancelled visit|0|||
27844913|NCT01408901|54335554|FG001|6-Week Follow-Up|Cancelled visit|1|||
27844914|NCT01408901|54335555|FG002|6-Week Follow-Up|Cancelled visit|0|||
27807869|NCT01947283|54263222|FG005|Overall Study|No Clinical Recording|0|||
27807870|NCT01947283|54263223|FG006|Overall Study|No Clinical Recording|0|||
27807871|NCT01947283|54263217|FG000|Overall Study|Non-coding Clinical Recording language|0|||
27807872|NCT01947283|54263218|FG001|Overall Study|Non-coding Clinical Recording language|0|||
27807873|NCT01947283|54263219|FG002|Overall Study|Non-coding Clinical Recording language|0|||
27807874|NCT01947283|54263220|FG003|Overall Study|Non-coding Clinical Recording language|1|||
27807875|NCT01947283|54263221|FG004|Overall Study|Non-coding Clinical Recording language|0|||
27807876|NCT01947283|54263222|FG005|Overall Study|Non-coding Clinical Recording language|0|||
28034897|NCT00086515|54693139|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|13|||
28034898|NCT00086515|54693138|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|4|||
28034899|NCT00086515|54693139|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
28034900|NCT00086515|54693138|FG000|Phase A (Weeks 0-24)|Protocol Violation|3|||
28034901|NCT00086515|54693139|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
28034902|NCT00086515|54693138|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
28034903|NCT00086515|54693139|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
28034904|NCT00086515|54693138|FG000|Phase A (Weeks 0-24)|Patient Moved|2|||
28034905|NCT00086515|54693139|FG001|Phase A (Weeks 0-24)|Patient Moved|3|||
27807877|NCT01947283|54263223|FG006|Overall Study|Non-coding Clinical Recording language|0|||
27807878|NCT01947283|54263217|FG000|Overall Study|Missing Follow-up Assessment|2|||
27807879|NCT01947283|54263218|FG001|Overall Study|Missing Follow-up Assessment|2|||
27807880|NCT01947283|54263219|FG002|Overall Study|Missing Follow-up Assessment|3|||
27844915|NCT01408901|54335556|FG003|6-Week Follow-Up|Cancelled visit|2|||
27844916|NCT01408901|54335553|FG000|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
27844917|NCT01408901|54335554|FG001|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
27844918|NCT01408901|54335555|FG002|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
27844919|NCT01408901|54335556|FG003|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2|||
27844920|NCT01408901|54335553|FG000|12-Week Follow-Up (Primary Endpoint)|Death|1|||
27844921|NCT01408901|54335554|FG001|12-Week Follow-Up (Primary Endpoint)|Death|0|||
27807881|NCT01947283|54263220|FG003|Overall Study|Missing Follow-up Assessment|0|||
27844922|NCT01408901|54335555|FG002|12-Week Follow-Up (Primary Endpoint)|Death|0|||
27844923|NCT01408901|54335556|FG003|12-Week Follow-Up (Primary Endpoint)|Death|0|||
27844924|NCT01408901|54335553|FG000|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
27844925|NCT01408901|54335554|FG001|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2|||
27844926|NCT01408901|54335555|FG002|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
27844927|NCT01408901|54335556|FG003|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1|||
27844928|NCT01408901|54335553|FG000|26-Week Follow-Up|Lost to Follow-up|1|||
27844929|NCT01408901|54335554|FG001|26-Week Follow-Up|Lost to Follow-up|1|||
27844930|NCT01408901|54335555|FG002|26-Week Follow-Up|Lost to Follow-up|0|||
27844931|NCT01408901|54335556|FG003|26-Week Follow-Up|Lost to Follow-up|1|||
27844932|NCT01408901|54335553|FG000|26-Week Follow-Up|Death|0|||
27844933|NCT01408901|54335554|FG001|26-Week Follow-Up|Death|1|||
27844934|NCT01408901|54335555|FG002|26-Week Follow-Up|Death|0|||
27844935|NCT01408901|54335556|FG003|26-Week Follow-Up|Death|0|||
27844936|NCT01428713|54335572|FG000|Overall Study|Non-compliance|2|||
27844937|NCT01428713|54335573|FG001|Overall Study|Non-compliance|2|||
27844938|NCT01428713|54335572|FG000|Overall Study|Withdrawal by Subject|1|||
27844939|NCT01428713|54335573|FG001|Overall Study|Withdrawal by Subject|1|||
27844940|NCT01428713|54335572|FG000|Overall Study|Adverse Event|0|||
27844941|NCT01428713|54335573|FG001|Overall Study|Adverse Event|2|||
27844942|NCT01408277|54335581|FG000|Overall Study|Adverse Event|3|||
27844943|NCT01408277|54335582|FG001|Overall Study|Adverse Event|4|||
27844944|NCT01408277|54335581|FG000|Overall Study|Lost to Follow-up|1|||
27844945|NCT01408277|54335582|FG001|Overall Study|Lost to Follow-up|0|||
27844946|NCT01408277|54335581|FG000|Overall Study|Withdrawal by Subject|2|||
27844947|NCT01408277|54335582|FG001|Overall Study|Withdrawal by Subject|0|||
27844948|NCT01408277|54335581|FG000|Overall Study|Protocol Violation|2|||
27844949|NCT01408277|54335582|FG001|Overall Study|Protocol Violation|0|||
27844950|NCT01408043|54335588|FG000|Overall Study|unable to collect cells|1|||
27844951|NCT01524224|54335600|FG000|Overall Study|Progressive Disease|1|||
27844952|NCT01524224|54335601|FG001|Overall Study|Progressive Disease|0|||
27844953|NCT01524224|54335602|FG002|Overall Study|Progressive Disease|2|||
27844954|NCT01524224|54335603|FG003|Overall Study|Progressive Disease|1|||
27844955|NCT01524224|54335604|FG004|Overall Study|Progressive Disease|2|||
27844956|NCT01524224|54335605|FG005|Overall Study|Progressive Disease|1|||
27844957|NCT01524224|54335606|FG006|Overall Study|Progressive Disease|1|||
27844958|NCT01524224|54335607|FG007|Overall Study|Progressive Disease|5|||
27844959|NCT01524224|54335600|FG000|Overall Study|Withdrawal by Subject|2|||
27844960|NCT01524224|54335601|FG001|Overall Study|Withdrawal by Subject|0|||
27844961|NCT01524224|54335602|FG002|Overall Study|Withdrawal by Subject|0|||
27844962|NCT01524224|54335603|FG003|Overall Study|Withdrawal by Subject|0|||
27844963|NCT01524224|54335604|FG004|Overall Study|Withdrawal by Subject|0|||
27844964|NCT01524224|54335605|FG005|Overall Study|Withdrawal by Subject|0|||
27844965|NCT01524224|54335606|FG006|Overall Study|Withdrawal by Subject|2|||
27844966|NCT01524224|54335607|FG007|Overall Study|Withdrawal by Subject|0|||
27844967|NCT01524224|54335600|FG000|Overall Study|Adverse Event|0|||
27844968|NCT01524224|54335601|FG001|Overall Study|Adverse Event|1|||
27844969|NCT01524224|54335602|FG002|Overall Study|Adverse Event|0|||
27844970|NCT01524224|54335603|FG003|Overall Study|Adverse Event|0|||
27844971|NCT01524224|54335604|FG004|Overall Study|Adverse Event|0|||
27844972|NCT01524224|54335605|FG005|Overall Study|Adverse Event|1|||
27844973|NCT01524224|54335606|FG006|Overall Study|Adverse Event|0|||
27807882|NCT01947283|54263221|FG004|Overall Study|Missing Follow-up Assessment|0|||
27807883|NCT01947283|54263222|FG005|Overall Study|Missing Follow-up Assessment|2|||
27807884|NCT01947283|54263223|FG006|Overall Study|Missing Follow-up Assessment|0|||
27807885|NCT01947283|54263217|FG000|Overall Study|No patients were enrolled in study|0|||
27844974|NCT01524224|54335607|FG007|Overall Study|Adverse Event|0|||
27844975|NCT01524224|54335600|FG000|Overall Study|Physician Decision|0|||
27844976|NCT01524224|54335601|FG001|Overall Study|Physician Decision|0|||
27844977|NCT01524224|54335602|FG002|Overall Study|Physician Decision|0|||
27844978|NCT01524224|54335603|FG003|Overall Study|Physician Decision|1|||
27807886|NCT01947283|54263218|FG001|Overall Study|No patients were enrolled in study|0|||
27807887|NCT01947283|54263219|FG002|Overall Study|No patients were enrolled in study|0|||
27807888|NCT01947283|54263220|FG003|Overall Study|No patients were enrolled in study|0|||
27807889|NCT01947283|54263221|FG004|Overall Study|No patients were enrolled in study|0|||
27807890|NCT01947283|54263222|FG005|Overall Study|No patients were enrolled in study|3|||
27807891|NCT01947283|54263223|FG006|Overall Study|No patients were enrolled in study|1|||
27807892|NCT02006693|54263242|FG000|Overall Study|No Reason Specified|6|||
27807893|NCT02006693|54263243|FG001|Overall Study|No Reason Specified|8|||
27807894|NCT02006693|54263242|FG000|Overall Study|Another Glaucoma-related Surgery|12|||
27844979|NCT01524224|54335604|FG004|Overall Study|Physician Decision|1|||
27844980|NCT01524224|54335605|FG005|Overall Study|Physician Decision|0|||
27844981|NCT01524224|54335606|FG006|Overall Study|Physician Decision|0|||
27844982|NCT01524224|54335607|FG007|Overall Study|Physician Decision|1|||
27844983|NCT01524224|54335600|FG000|Overall Study|Sponsor Decision|0|||
27844984|NCT01524224|54335601|FG001|Overall Study|Sponsor Decision|0|||
27844985|NCT01524224|54335602|FG002|Overall Study|Sponsor Decision|0|||
27844986|NCT01524224|54335603|FG003|Overall Study|Sponsor Decision|0|||
27844987|NCT01524224|54335604|FG004|Overall Study|Sponsor Decision|1|||
27844988|NCT01524224|54335605|FG005|Overall Study|Sponsor Decision|0|||
27844989|NCT01524224|54335606|FG006|Overall Study|Sponsor Decision|0|||
27844990|NCT01524224|54335607|FG007|Overall Study|Sponsor Decision|0|||
27844991|NCT00219349|54335625|FG000|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6|||
27844992|NCT00219349|54335625|FG000|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2|||
27844993|NCT00219349|54335625|FG000|Cognitive Behavioral Therapy Phase|Protocol Violation|2|||
27844994|NCT00219349|54335625|FG000|Escitalopram Phase|Withdrawal by Subject|3|||
27844995|NCT01523756|54335629|FG000|Baseline Period|Adverse Event|0|||
27844996|NCT01523756|54335630|FG001|Baseline Period|Adverse Event|1|||
27844997|NCT01523756|54335629|FG000|Test Period 1|Adverse Event|1|||
27844998|NCT01523756|54335630|FG001|Test Period 1|Adverse Event|0|||
27844999|NCT01523756|54335629|FG000|Test Period 2|Withdrawal by Subject|0|||
27845000|NCT01523756|54335630|FG001|Test Period 2|Withdrawal by Subject|1|||
27845001|NCT00218257|54335638|FG000|Period Between Visit 1 and 2|Lost to Follow-up|4|||
27845002|NCT00218257|54335639|FG001|Period Between Visit 1 and 2|Lost to Follow-up|3|||
27845003|NCT01523366|54335650|FG000|Treatment Period 1|Withdrawal by Subject|1|||
27845004|NCT01523366|54335651|FG001|Treatment Period 1|Withdrawal by Subject|0|||
27845005|NCT01523366|54335650|FG000|Treatment Period 2|Not completed at least 7 days treatment|1|||
27845006|NCT01523366|54335651|FG001|Treatment Period 2|Not completed at least 7 days treatment|0|||
27845007|NCT01427933|54335661|FG000|Overall Study|Withdrawal by Subject|5|||
27845008|NCT01427933|54335662|FG001|Overall Study|Withdrawal by Subject|8|||
27845009|NCT01427933|54335661|FG000|Overall Study|Lost to Follow-up|1|||
27845010|NCT01427933|54335662|FG001|Overall Study|Lost to Follow-up|5|||
27845011|NCT01427933|54335661|FG000|Overall Study|Other|1|||
27845012|NCT01427933|54335662|FG001|Overall Study|Other|0|||
27845013|NCT01427933|54335661|FG000|Overall Study|Investigator's Decision|1|||
27845014|NCT01427933|54335662|FG001|Overall Study|Investigator's Decision|0|||
27845015|NCT00217087|54335671|FG000|Overall Study|decided to have esophagectomy|1|||
27845016|NCT00217087|54335672|FG001|Overall Study|decided to have esophagectomy|2|||
27845017|NCT00217087|54335671|FG000|Overall Study|completed less than 12 months return|10|||
27845018|NCT00217087|54335672|FG001|Overall Study|completed less than 12 months return|18|||
27845019|NCT01406873|54335686|FG000|Overall Study|Withdrawal by Subject|1|||
27845020|NCT01406873|54335687|FG001|Overall Study|Withdrawal by Subject|1|||
27845021|NCT01406795|54335703|FG000|Overall Study|Withdrawal by Subject|1|||
27845022|NCT01406717|54335709|FG000|Overall Study|Subject non-compliance|4|||
27845023|NCT01406717|54335710|FG001|Overall Study|Subject non-compliance|3|||
27845024|NCT01406717|54335709|FG000|Overall Study|Protocol Violation|5|||
27845025|NCT01406717|54335710|FG001|Overall Study|Protocol Violation|1|||
27845026|NCT01406717|54335709|FG000|Overall Study|Lost to Follow-up|14|||
27845027|NCT01406717|54335710|FG001|Overall Study|Lost to Follow-up|8|||
27845028|NCT01406717|54335709|FG000|Overall Study|Withdrawal by Subject|19|||
27845029|NCT01406717|54335710|FG001|Overall Study|Withdrawal by Subject|15|||
27845030|NCT01406717|54335709|FG000|Overall Study|Adverse Event|1|||
27845031|NCT01406717|54335710|FG001|Overall Study|Adverse Event|2|||
27845032|NCT01406717|54335709|FG000|Overall Study|Lack of Efficacy|0|||
27845033|NCT01406717|54335710|FG001|Overall Study|Lack of Efficacy|1|||
27845034|NCT01406717|54335709|FG000|Overall Study|Non-completion of visit activity|0|||
27845035|NCT01406717|54335710|FG001|Overall Study|Non-completion of visit activity|1|||
27845036|NCT01406015|54335728|FG000|Overall Study|Withdrawal by Subject|3|||
28034906|NCT00086515|54693138|FG000|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4|||
28034907|NCT00086515|54693139|FG001|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3|||
28034908|NCT00086515|54693138|FG000|Phase A (Weeks 0-24)|Poor compliance|1|||
28034909|NCT00086515|54693139|FG001|Phase A (Weeks 0-24)|Poor compliance|0|||
28034910|NCT00086515|54693138|FG000|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0|||
28034911|NCT00086515|54693139|FG001|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1|||
28034912|NCT00086515|54693138|FG000|Phase A (Weeks 0-24)|Personal Circumstance|1|||
28034913|NCT00086515|54693139|FG001|Phase A (Weeks 0-24)|Personal Circumstance|0|||
28034914|NCT00086515|54693138|FG000|Phase A to Phase B Transition Period|Adverse Event|2|||
27845037|NCT01406015|54335729|FG001|Overall Study|Withdrawal by Subject|3|||
27807895|NCT02006693|54263243|FG001|Overall Study|Another Glaucoma-related Surgery|1|||
27807896|NCT02006693|54263242|FG000|Overall Study|XEN Implant Explantation|0|||
27807897|NCT02006693|54263243|FG001|Overall Study|XEN Implant Explantation|1|||
27807898|NCT02006693|54263242|FG000|Overall Study|Death|2|||
27807899|NCT02006693|54263243|FG001|Overall Study|Death|2|||
27807900|NCT02006693|54263242|FG000|Overall Study|Lost to Follow-up|4|||
27807901|NCT02006693|54263243|FG001|Overall Study|Lost to Follow-up|1|||
27807902|NCT02006693|54263242|FG000|Overall Study|Patient Decision|4|||
27807903|NCT02006693|54263243|FG001|Overall Study|Patient Decision|0|||
27807904|NCT01947127|54263251|FG000|Overall Study|Protocol Violation|18|||
27845038|NCT00215683|54335738|FG000|Overall Study|Adverse Event|15|||
28034915|NCT00086515|54693139|FG001|Phase A to Phase B Transition Period|Adverse Event|1|||
28034916|NCT00086515|54693138|FG000|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
27807905|NCT01947127|54263252|FG001|Overall Study|Protocol Violation|38|||
27807906|NCT01947127|54263251|FG000|Overall Study|Withdrawal by Subject|1|||
27807907|NCT01947127|54263252|FG001|Overall Study|Withdrawal by Subject|1|||
27807908|NCT01947127|54263251|FG000|Overall Study|Data loss|4|||
27807909|NCT01947127|54263252|FG001|Overall Study|Data loss|4|||
27845039|NCT00215683|54335739|FG001|Overall Study|Adverse Event|16|||
27845040|NCT00215683|54335740|FG002|Overall Study|Adverse Event|15|||
27845041|NCT00215683|54335738|FG000|Overall Study|Lack of Efficacy|5|||
27845042|NCT00215683|54335739|FG001|Overall Study|Lack of Efficacy|1|||
27807910|NCT01976845|54263261|FG000|Overall Study|Physician Decision|8|||
27845043|NCT00215683|54335740|FG002|Overall Study|Lack of Efficacy|2|||
27845044|NCT00215683|54335738|FG000|Overall Study|Lost to Follow-up|0|||
27845045|NCT00215683|54335739|FG001|Overall Study|Lost to Follow-up|2|||
27845046|NCT00215683|54335740|FG002|Overall Study|Lost to Follow-up|1|||
27845047|NCT00215683|54335738|FG000|Overall Study|Withdrawal by Subject|9|||
27845048|NCT00215683|54335739|FG001|Overall Study|Withdrawal by Subject|4|||
27845049|NCT00215683|54335740|FG002|Overall Study|Withdrawal by Subject|13|||
27845050|NCT00215683|54335738|FG000|Overall Study|Physician Decision|0|||
27845051|NCT00215683|54335739|FG001|Overall Study|Physician Decision|0|||
27845052|NCT00215683|54335740|FG002|Overall Study|Physician Decision|1|||
27845053|NCT00215683|54335738|FG000|Overall Study|Difficult to attend visits|0|||
27845054|NCT00215683|54335739|FG001|Overall Study|Difficult to attend visits|1|||
27845055|NCT00215683|54335740|FG002|Overall Study|Difficult to attend visits|0|||
27845056|NCT00215683|54335738|FG000|Overall Study|No study drug available|0|||
27845057|NCT00215683|54335739|FG001|Overall Study|No study drug available|1|||
27845058|NCT00215683|54335740|FG002|Overall Study|No study drug available|0|||
27845059|NCT00215683|54335738|FG000|Overall Study|Intermittent therapy required|0|||
27845060|NCT00215683|54335739|FG001|Overall Study|Intermittent therapy required|1|||
27845061|NCT00215683|54335740|FG002|Overall Study|Intermittent therapy required|0|||
27845062|NCT00215137|54335748|FG000|Open Label Escitalopram|Lack of Efficacy|1|||
27845063|NCT00215137|54335749|FG001|Open Label Escitalopram|Lack of Efficacy|0|||
27845064|NCT00215137|54335750|FG002|Open Label Escitalopram|Lack of Efficacy|0|||
27845065|NCT00215137|54335748|FG000|Randomization Period|Lost to Follow-up|0|||
27845066|NCT00215137|54335749|FG001|Randomization Period|Lost to Follow-up|1|||
27845067|NCT00215137|54335750|FG002|Randomization Period|Lost to Follow-up|0|||
27845068|NCT00215137|54335748|FG000|Randomization Period|Withdrawal by Subject|0|||
27845069|NCT00215137|54335749|FG001|Randomization Period|Withdrawal by Subject|1|||
27845070|NCT00215137|54335750|FG002|Randomization Period|Withdrawal by Subject|0|||
27845071|NCT00214201|54335760|FG000|Overall Study|Withdrawal by Subject|2|||
27845072|NCT00214201|54335761|FG001|Overall Study|Withdrawal by Subject|0|||
27845073|NCT00214201|54335760|FG000|Overall Study|Death|0|||
27845074|NCT00214201|54335761|FG001|Overall Study|Death|2|||
27845075|NCT01486784|54335774|FG000|Overall Study|Withdrawal by Subject|0|||
27845076|NCT01486784|54335775|FG001|Overall Study|Withdrawal by Subject|0|||
27845077|NCT01486784|54335776|FG002|Overall Study|Withdrawal by Subject|1|||
27845078|NCT01486784|54335777|FG003|Overall Study|Withdrawal by Subject|0|||
27845079|NCT01486784|54335778|FG004|Overall Study|Withdrawal by Subject|1|||
27845080|NCT01486784|54335779|FG005|Overall Study|Withdrawal by Subject|2|||
27845081|NCT01486784|54335774|FG000|Overall Study|Subject did not meet entry criteria|0|||
27845082|NCT01486784|54335775|FG001|Overall Study|Subject did not meet entry criteria|0|||
27845083|NCT01486784|54335776|FG002|Overall Study|Subject did not meet entry criteria|0|||
27845084|NCT01486784|54335777|FG003|Overall Study|Subject did not meet entry criteria|0|||
27845085|NCT01486784|54335778|FG004|Overall Study|Subject did not meet entry criteria|1|||
27845086|NCT01486784|54335779|FG005|Overall Study|Subject did not meet entry criteria|0|||
27845087|NCT01486784|54335774|FG000|Overall Study|Death|0|||
27845088|NCT01486784|54335775|FG001|Overall Study|Death|0|||
28034917|NCT00086515|54693139|FG001|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
28034918|NCT00086515|54693138|FG000|Phase A to Phase B Transition Period|Withdrawal by Subject|1|||
28034919|NCT00086515|54693139|FG001|Phase A to Phase B Transition Period|Withdrawal by Subject|0|||
28034920|NCT00086515|54693138|FG000|Phase A to Phase B Transition Period|Protocol Violation|0|||
28034921|NCT00086515|54693139|FG001|Phase A to Phase B Transition Period|Protocol Violation|1|||
28034922|NCT00086515|54693138|FG000|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16|||
28034923|NCT00086515|54693139|FG001|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23|||
27807911|NCT01976845|54263262|FG001|Overall Study|Physician Decision|8|||
27807912|NCT01976845|54263263|FG002|Overall Study|Physician Decision|3|||
27807913|NCT01989689|54263273|FG000|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0|||
27807914|NCT01989689|54263274|FG001|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2|||
27807915|NCT01989689|54263273|FG000|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0|||
27807916|NCT01989689|54263274|FG001|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1|||
27807917|NCT01943539|54263282|FG000|Overall Study|Non-compliance with at-home intervention|4|||
27807918|NCT01943539|54263283|FG001|Overall Study|Non-compliance with at-home intervention|0|||
27807919|NCT01942993|54263290|FG000|Overall Study|Lost to Follow-up|1|||
27807920|NCT01942993|54263290|FG000|Overall Study|Physician Decision|1|||
27807921|NCT01989455|54263299|FG000|Overall Study|Adverse Event|0|||
27807922|NCT01989455|54263300|FG001|Overall Study|Adverse Event|1|||
27807923|NCT01989455|54263301|FG002|Overall Study|Adverse Event|0|||
27807924|NCT01989455|54263302|FG003|Overall Study|Adverse Event|0|||
27845089|NCT01486784|54335776|FG002|Overall Study|Death|0|||
27807925|NCT01989455|54263303|FG004|Overall Study|Adverse Event|0|||
27807926|NCT01989455|54263299|FG000|Overall Study|Withdrawal by Subject|0|||
27807927|NCT01989455|54263300|FG001|Overall Study|Withdrawal by Subject|1|||
27845090|NCT01486784|54335777|FG003|Overall Study|Death|0|||
27807928|NCT01989455|54263301|FG002|Overall Study|Withdrawal by Subject|0|||
27845091|NCT01486784|54335778|FG004|Overall Study|Death|0|||
27845092|NCT01486784|54335779|FG005|Overall Study|Death|1|||
27845093|NCT01521884|54335793|FG000|Overall Study|Non Responders|10|||
27845094|NCT01521884|54335793|FG000|Overall Study|Adverse Event|5|||
27845095|NCT01521884|54335793|FG000|Overall Study|Pregnancy|1|||
27845096|NCT01521884|54335793|FG000|Overall Study|Withdrawal by Subject|1|||
27845097|NCT01521884|54335793|FG000|Overall Study|Physician Decision|2|||
27845098|NCT01521884|54335793|FG000|Overall Study|Protocol Violation|3|||
27845099|NCT01521884|54335793|FG000|Overall Study|Participant non-eligible|1|||
27845100|NCT01521884|54335793|FG000|Overall Study|Lost to Follow-up|4|||
27845101|NCT01677858|54335802|FG000|Overall Study|Adverse Event|0|||
27845102|NCT01677858|54335803|FG001|Overall Study|Adverse Event|0|||
27845103|NCT01677858|54335804|FG002|Overall Study|Adverse Event|2|||
27845104|NCT01677858|54335805|FG003|Overall Study|Adverse Event|3|||
27845105|NCT01677858|54335806|FG004|Overall Study|Adverse Event|13|||
27845106|NCT01677858|54335802|FG000|Overall Study|Death|0|||
27845107|NCT01677858|54335803|FG001|Overall Study|Death|0|||
27845108|NCT01677858|54335804|FG002|Overall Study|Death|0|||
27845109|NCT01677858|54335805|FG003|Overall Study|Death|0|||
27845110|NCT01677858|54335806|FG004|Overall Study|Death|1|||
27845111|NCT01677858|54335802|FG000|Overall Study|Physician Decision|1|||
27845112|NCT01677858|54335803|FG001|Overall Study|Physician Decision|0|||
27807929|NCT01989455|54263302|FG003|Overall Study|Withdrawal by Subject|0|||
27807930|NCT01989455|54263303|FG004|Overall Study|Withdrawal by Subject|0|||
27807931|NCT01989455|54263299|FG000|Overall Study|Technical problems with infusion|0|||
27807932|NCT01989455|54263300|FG001|Overall Study|Technical problems with infusion|0|||
27807933|NCT01989455|54263301|FG002|Overall Study|Technical problems with infusion|1|||
27807934|NCT01989455|54263302|FG003|Overall Study|Technical problems with infusion|0|||
27807935|NCT01989455|54263303|FG004|Overall Study|Technical problems with infusion|1|||
27807936|NCT01942837|54263319|FG000|Overall Study|Death|1|||
27807937|NCT01942837|54263319|FG000|Overall Study|Symptomatic or radiographic progression|49|||
27807938|NCT01942837|54263319|FG000|Overall Study|Adverse Event|6|||
27807939|NCT01942837|54263319|FG000|Overall Study|Physician Decision|3|||
27807940|NCT01942837|54263319|FG000|Overall Study|Withdrawal by Subject|2|||
27807941|NCT01942837|54263319|FG000|Overall Study|Intercurrent Illness|1|||
27807942|NCT01942837|54263319|FG000|Overall Study|On treatment|3|||
27807943|NCT01942837|54263319|FG000|Overall Study|Never initiate the treatment|2|||
27807944|NCT01987895|54263326|FG000|Overall Study|Withdrawal by Subject|12|||
27845113|NCT01677858|54335804|FG002|Overall Study|Physician Decision|2|||
27845114|NCT01677858|54335805|FG003|Overall Study|Physician Decision|0|||
27845115|NCT01677858|54335806|FG004|Overall Study|Physician Decision|12|||
27845116|NCT01677858|54335802|FG000|Overall Study|Progressive Disease|2|||
27845117|NCT01677858|54335803|FG001|Overall Study|Progressive Disease|1|||
28034924|NCT00086515|54693138|FG000|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
28034925|NCT00086515|54693139|FG001|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
28034926|NCT00086515|54693138|FG000|Phase A to Phase B Transition Period|Poor compliance|1|||
28034927|NCT00086515|54693139|FG001|Phase A to Phase B Transition Period|Poor compliance|0|||
28034928|NCT00086515|54693138|FG000|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1|||
28034929|NCT00086515|54693139|FG001|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0|||
28034930|NCT00086515|54693138|FG000|Phase B (Weeks 24-104)|Adverse Event|16|||
28034931|NCT00086515|54693139|FG001|Phase B (Weeks 24-104)|Adverse Event|10|||
28034932|NCT00086515|54693138|FG000|Phase B (Weeks 24-104)|Lack of Efficacy|94|||
28034933|NCT00086515|54693139|FG001|Phase B (Weeks 24-104)|Lack of Efficacy|19|||
28034934|NCT00086515|54693138|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|13|||
28034935|NCT00086515|54693139|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|4|||
28034936|NCT00086515|54693138|FG000|Phase B (Weeks 24-104)|Physician Decision|3|||
28034937|NCT00086515|54693139|FG001|Phase B (Weeks 24-104)|Physician Decision|0|||
28034938|NCT00086515|54693138|FG000|Phase B (Weeks 24-104)|Protocol Violation|1|||
27845118|NCT01677858|54335804|FG002|Overall Study|Progressive Disease|9|||
27845119|NCT01677858|54335805|FG003|Overall Study|Progressive Disease|3|||
28034939|NCT00086515|54693139|FG001|Phase B (Weeks 24-104)|Protocol Violation|0|||
28034940|NCT00086515|54693138|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|15|||
28034941|NCT00086515|54693139|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|5|||
28034942|NCT00086515|54693138|FG000|Phase B (Weeks 24-104)|Patient Moved|2|||
28034943|NCT00086515|54693139|FG001|Phase B (Weeks 24-104)|Patient Moved|2|||
28034944|NCT00086515|54693138|FG000|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5|||
27807945|NCT01987895|54263327|FG001|Overall Study|Withdrawal by Subject|7|||
27807946|NCT01987895|54263326|FG000|Overall Study|Physician Decision|8|||
27807947|NCT01987895|54263327|FG001|Overall Study|Physician Decision|10|||
27807948|NCT01987895|54263326|FG000|Overall Study|Death|7|||
27807949|NCT01987895|54263327|FG001|Overall Study|Death|7|||
27845120|NCT01677858|54335806|FG004|Overall Study|Progressive Disease|43|||
27845121|NCT01677858|54335802|FG000|Overall Study|Withdrawal by Subject|0|||
27845122|NCT01677858|54335803|FG001|Overall Study|Withdrawal by Subject|1|||
27845123|NCT01677858|54335804|FG002|Overall Study|Withdrawal by Subject|1|||
27845124|NCT01677858|54335805|FG003|Overall Study|Withdrawal by Subject|0|||
27845125|NCT01677858|54335806|FG004|Overall Study|Withdrawal by Subject|15|||
28034945|NCT00086515|54693139|FG001|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3|||
28034946|NCT00086515|54693138|FG000|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36|||
28034947|NCT00086515|54693139|FG001|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10|||
28034948|NCT00086515|54693138|FG000|Phase B (Weeks 24-104)|Patient Died|3|||
28034949|NCT00086515|54693139|FG001|Phase B (Weeks 24-104)|Patient Died|1|||
27845126|NCT01677858|54335802|FG000|Overall Study|Lost to Follow-up|0|||
27845127|NCT01677858|54335803|FG001|Overall Study|Lost to Follow-up|0|||
27845128|NCT01677858|54335804|FG002|Overall Study|Lost to Follow-up|0|||
27845129|NCT01677858|54335805|FG003|Overall Study|Lost to Follow-up|0|||
27845130|NCT01677858|54335806|FG004|Overall Study|Lost to Follow-up|1|||
27845131|NCT01486316|54335826|FG000|Overall Study|Device explanted with/without re-implant|3|||
27845132|NCT01486316|54335827|FG001|Overall Study|Device explanted with/without re-implant|2|||
27845133|NCT01486316|54335828|FG002|Overall Study|Device explanted with/without re-implant|0|||
28034950|NCT00086515|54693138|FG000|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0|||
28034951|NCT00086515|54693139|FG001|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1|||
28034952|NCT00086515|54693138|FG000|Phase B (Weeks 24-104)|Personal Circumstance|1|||
28034953|NCT00086515|54693139|FG001|Phase B (Weeks 24-104)|Personal Circumstance|0|||
28034954|NCT00086515|54693138|FG000|Phase B (Weeks 24-104)|Discontinued in error|1|||
28034955|NCT00086515|54693139|FG001|Phase B (Weeks 24-104)|Discontinued in error|0|||
27845134|NCT01486316|54335829|FG003|Overall Study|Device explanted with/without re-implant|2|||
27845135|NCT01486316|54335826|FG000|Overall Study|Not meeting eligibility criteria|0|||
27845136|NCT01486316|54335827|FG001|Overall Study|Not meeting eligibility criteria|0|||
27845137|NCT01486316|54335828|FG002|Overall Study|Not meeting eligibility criteria|1|||
27845138|NCT01486316|54335829|FG003|Overall Study|Not meeting eligibility criteria|0|||
27845139|NCT01486316|54335826|FG000|Overall Study|Withdrawal by Subject|1|||
27845140|NCT01486316|54335827|FG001|Overall Study|Withdrawal by Subject|0|||
27845141|NCT01486316|54335828|FG002|Overall Study|Withdrawal by Subject|3|||
27845142|NCT01486316|54335829|FG003|Overall Study|Withdrawal by Subject|0|||
27845143|NCT01486316|54335826|FG000|Overall Study|Physician Decision|0|||
27845144|NCT01486316|54335827|FG001|Overall Study|Physician Decision|0|||
27845145|NCT01486316|54335828|FG002|Overall Study|Physician Decision|1|||
27845146|NCT01486316|54335829|FG003|Overall Study|Physician Decision|0|||
27845147|NCT01486316|54335826|FG000|Overall Study|Death|0|||
28034956|NCT00541658|54693148|FG000|Overall Study|Adverse Event|28|||
28034957|NCT00541658|54693149|FG001|Overall Study|Adverse Event|37|||
28034958|NCT00541658|54693150|FG002|Overall Study|Adverse Event|25|||
28034959|NCT00541658|54693148|FG000|Overall Study|Physician Decision|0|||
28034960|NCT00541658|54693149|FG001|Overall Study|Physician Decision|0|||
28034961|NCT00541658|54693150|FG002|Overall Study|Physician Decision|4|||
28034962|NCT00541658|54693148|FG000|Overall Study|Lost to Follow-up|3|||
28034963|NCT00541658|54693149|FG001|Overall Study|Lost to Follow-up|3|||
27807950|NCT01987895|54263326|FG000|Overall Study|Lost to Follow-up|3|||
27807951|NCT01987895|54263327|FG001|Overall Study|Lost to Follow-up|5|||
27807952|NCT01987895|54263326|FG000|Overall Study|randomized before giving IC|0|||
27807953|NCT01987895|54263327|FG001|Overall Study|randomized before giving IC|1|||
27807954|NCT02005445|54263335|FG000|Overall Study|Dual study enrollment|0|||
27807955|NCT02005445|54263336|FG001|Overall Study|Dual study enrollment|1|||
27807956|NCT01618669|54263344|FG000|Overall Study|Lost to Follow-up|1|||
27807957|NCT01618669|54263345|FG001|Overall Study|Lost to Follow-up|1|||
27807958|NCT01618669|54263344|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
27807959|NCT01618669|54263345|FG001|Overall Study|Randomized but Never Received Study Drug|2|||
27807960|NCT01618669|54263344|FG000|Overall Study|Adverse Event|16|||
27807961|NCT01618669|54263345|FG001|Overall Study|Adverse Event|7|||
27807962|NCT01618669|54263344|FG000|Overall Study|Protocol Violation|5|||
27807963|NCT01618669|54263345|FG001|Overall Study|Protocol Violation|3|||
27807964|NCT01618669|54263344|FG000|Overall Study|Withdrawal by Subject|9|||
27807965|NCT01618669|54263345|FG001|Overall Study|Withdrawal by Subject|9|||
27807966|NCT01618669|54263344|FG000|Overall Study|Miscellaneous Reason|0|||
27807967|NCT01618669|54263345|FG001|Overall Study|Miscellaneous Reason|1|||
27807968|NCT01390948|54263366|FG000|Overall Study|End of Study|1|||
27807969|NCT01390948|54263367|FG001|Overall Study|End of Study|0|||
27807970|NCT01390948|54263368|FG002|Overall Study|End of Study|0|||
27807971|NCT01390948|54263366|FG000|Overall Study|Withdrew consent|2|||
27845148|NCT01486316|54335827|FG001|Overall Study|Death|1|||
27845149|NCT01486316|54335828|FG002|Overall Study|Death|0|||
27845150|NCT01486316|54335829|FG003|Overall Study|Death|0|||
28034964|NCT00541658|54693150|FG002|Overall Study|Lost to Follow-up|6|||
28034965|NCT00541658|54693148|FG000|Overall Study|Protocol Violation|0|||
28034966|NCT00541658|54693149|FG001|Overall Study|Protocol Violation|1|||
28034967|NCT00541658|54693150|FG002|Overall Study|Protocol Violation|1|||
27807972|NCT01390948|54263367|FG001|Overall Study|Withdrew consent|2|||
27807973|NCT01390948|54263368|FG002|Overall Study|Withdrew consent|0|||
27807974|NCT01390948|54263366|FG000|Overall Study|Progressive Disease|2|||
27807975|NCT01390948|54263367|FG001|Overall Study|Progressive Disease|5|||
27807976|NCT01390948|54263368|FG002|Overall Study|Progressive Disease|0|||
27845151|NCT01486238|54335840|FG000|Overall Study|Death|0|||
27845152|NCT01486238|54335841|FG001|Overall Study|Death|2|||
27845153|NCT01486238|54335840|FG000|Overall Study|Withdrawal by Subject|2|||
27845154|NCT01486238|54335841|FG001|Overall Study|Withdrawal by Subject|1|||
28034968|NCT00541658|54693148|FG000|Overall Study|Withdrawal by Subject|28|||
28034969|NCT00541658|54693149|FG001|Overall Study|Withdrawal by Subject|32|||
28034970|NCT00541658|54693150|FG002|Overall Study|Withdrawal by Subject|32|||
27807977|NCT01390948|54263366|FG000|Overall Study|Death during follow-up|10|||
28034971|NCT00541658|54693148|FG000|Overall Study|Took No Study Drug|1|||
28034972|NCT00541658|54693149|FG001|Overall Study|Took No Study Drug|0|||
28034973|NCT00541658|54693150|FG002|Overall Study|Took No Study Drug|0|||
28034974|NCT03907280|54693174|FG000|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
28034975|NCT03907280|54693175|FG001|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|1|||
28034976|NCT03907280|54693176|FG002|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
28034977|NCT04120376|54693188|FG000|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|9|||
28034978|NCT04120376|54693189|FG001|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|0|||
28034979|NCT03905642|54693196|FG000|Overall Study|Withdrawal by Subject|3|||
28034980|NCT03905642|54693196|FG000|Overall Study|Pregnancy|1|||
28034981|NCT03905642|54693196|FG000|Overall Study|Adverse Event|1|||
28034982|NCT03905642|54693196|FG000|Overall Study|Lack of Efficacy|1|||
28034983|NCT03905642|54693196|FG000|Overall Study|Completed study but not 24 of 28 days|2|||
28034984|NCT00412984|54693236|FG000|Overall Study|Death|331|||
28034985|NCT00412984|54693237|FG001|Overall Study|Death|349|||
28034986|NCT00412984|54693236|FG000|Overall Study|Adverse Event|679|||
28034987|NCT00412984|54693237|FG001|Overall Study|Adverse Event|738|||
28034988|NCT00412984|54693236|FG000|Overall Study|Withdrawal by Subject|921|||
28034989|NCT00412984|54693237|FG001|Overall Study|Withdrawal by Subject|989|||
28034990|NCT00412984|54693236|FG000|Overall Study|Lost to Follow-up|51|||
28034991|NCT00412984|54693237|FG001|Overall Study|Lost to Follow-up|39|||
28034992|NCT00412984|54693236|FG000|Overall Study|Poor/Noncompliance|57|||
28034993|NCT00412984|54693237|FG001|Overall Study|Poor/Noncompliance|77|||
28034994|NCT00412984|54693236|FG000|Overall Study|Pregnancy|1|||
28034995|NCT00412984|54693237|FG001|Overall Study|Pregnancy|0|||
27807978|NCT01390948|54263367|FG001|Overall Study|Death during follow-up|11|||
27807979|NCT01390948|54263368|FG002|Overall Study|Death during follow-up|1|||
28034996|NCT00412984|54693236|FG000|Overall Study|Subject No Longer Meets Study Criteria|87|||
28034997|NCT00412984|54693237|FG001|Overall Study|Subject No Longer Meets Study Criteria|100|||
28034998|NCT00412984|54693236|FG000|Overall Study|Administrative Reason by Sponsor|11|||
28034999|NCT00412984|54693237|FG001|Overall Study|Administrative Reason by Sponsor|8|||
28035000|NCT00412984|54693236|FG000|Overall Study|Physician Refused to Continue Treatment|81|||
28035001|NCT00412984|54693237|FG001|Overall Study|Physician Refused to Continue Treatment|89|||
28035002|NCT00412984|54693236|FG000|Overall Study|Other Reason|80|||
28035003|NCT00412984|54693237|FG001|Overall Study|Other Reason|92|||
28035004|NCT00412984|54693236|FG000|Overall Study|Not Reported|11|||
28035005|NCT00412984|54693237|FG001|Overall Study|Not Reported|12|||
27807980|NCT02005211|54263382|FG000|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
27807981|NCT02005211|54263383|FG001|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
27807982|NCT02005211|54263384|FG002|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
27807983|NCT02005211|54263385|FG003|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
27807984|NCT02005211|54263386|FG004|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1|||
27807985|NCT02005211|54263387|FG005|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
27807986|NCT02005211|54263388|FG006|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
27807987|NCT01429792|54263411|FG000|Overall Study|Other Reasons|67|||
27807988|NCT01429792|54263411|FG000|Overall Study|Unknown Disposition|94|||
27807989|NCT01429792|54263411|FG000|Overall Study|Negative HCV-RNA at Week 4|1|||
27807990|NCT01429792|54263411|FG000|Overall Study|Negative HCV-RNA at Week 12|4|||
27807991|NCT01429792|54263411|FG000|Overall Study|Decrease of less than 2-log in HCV RNA|32|||
27807992|NCT01429792|54263411|FG000|Overall Study|Positive HCV-RNA at Week 24|50|||
27807993|NCT01429792|54263411|FG000|Overall Study|Withdrawal by Subject|70|||
27807994|NCT01429792|54263411|FG000|Overall Study|Lost to Follow-up|88|||
27807995|NCT01409434|54263415|FG000|Overall Study|Protocol Violation|4|||
27807996|NCT01940887|54263421|FG000|Year 1|Protocol Violation|0|||
27807997|NCT01940887|54263422|FG001|Year 1|Protocol Violation|1|||
27845155|NCT01486238|54335840|FG000|Overall Study|Lost to Follow-up|0|||
27845156|NCT01486238|54335841|FG001|Overall Study|Lost to Follow-up|3|||
27845157|NCT01602744|54335849|FG000|Overall Study|Death|17|||
28035006|NCT00539864|54693245|FG000|Overall Study|Lost to Follow-up|0|||
27807998|NCT01940887|54263421|FG000|Year 1|Physician Decision|7|||
27807999|NCT01940887|54263422|FG001|Year 1|Physician Decision|3|||
27808000|NCT01940887|54263421|FG000|Year 1|Death|5|||
27845158|NCT01602744|54335850|FG001|Overall Study|Death|15|||
27808001|NCT01940887|54263422|FG001|Year 1|Death|3|||
27845159|NCT01602744|54335849|FG000|Overall Study|Lost to Follow-up|13|||
27845160|NCT01602744|54335850|FG001|Overall Study|Lost to Follow-up|8|||
27845161|NCT03598777|54335861|FG000|Overall Study|Study Terminated by Sponsor|3|||
27808002|NCT01940887|54263421|FG000|Year 1|Adverse Event|7|||
27845162|NCT03598777|54335862|FG001|Overall Study|Study Terminated by Sponsor|0|||
27845163|NCT03598777|54335863|FG002|Overall Study|Study Terminated by Sponsor|0|||
27845164|NCT03598777|54335864|FG003|Overall Study|Study Terminated by Sponsor|0|||
27845165|NCT03598777|54335865|FG004|Overall Study|Study Terminated by Sponsor|15|||
27845166|NCT03598777|54335861|FG000|Overall Study|Withdrawal by Subject|1|||
27845167|NCT03598777|54335862|FG001|Overall Study|Withdrawal by Subject|1|||
27845168|NCT03598777|54335863|FG002|Overall Study|Withdrawal by Subject|0|||
27845169|NCT03598777|54335864|FG003|Overall Study|Withdrawal by Subject|0|||
27845170|NCT03598777|54335865|FG004|Overall Study|Withdrawal by Subject|0|||
27845171|NCT03598777|54335861|FG000|Overall Study|Adverse Event|1|||
27808003|NCT01940887|54263422|FG001|Year 1|Adverse Event|6|||
27808004|NCT01940887|54263421|FG000|Year 1|Withdrawal by Subject|18|||
27808005|NCT01940887|54263422|FG001|Year 1|Withdrawal by Subject|9|||
27808006|NCT01940887|54263421|FG000|Year 1|Lost to Follow-up|2|||
27808007|NCT01940887|54263422|FG001|Year 1|Lost to Follow-up|1|||
27808008|NCT01940887|54263421|FG000|Year 2|Physician Decision|8|||
27808009|NCT01940887|54263422|FG001|Year 2|Physician Decision|1|||
27808010|NCT01940887|54263421|FG000|Year 2|Death|0|||
27808011|NCT01940887|54263422|FG001|Year 2|Death|2|||
27808012|NCT01940887|54263421|FG000|Year 2|Sponsor Decision, early termination|192|||
27808013|NCT01940887|54263422|FG001|Year 2|Sponsor Decision, early termination|203|||
27808014|NCT01940887|54263421|FG000|Year 2|Adverse Event|8|||
27808015|NCT01940887|54263422|FG001|Year 2|Adverse Event|2|||
27808016|NCT01940887|54263421|FG000|Year 2|Withdrawal by Subject|8|||
27808017|NCT01940887|54263422|FG001|Year 2|Withdrawal by Subject|8|||
27808018|NCT01940887|54263421|FG000|Year 2|Lost to Follow-up|1|||
27808019|NCT01940887|54263422|FG001|Year 2|Lost to Follow-up|6|||
27808020|NCT01925612|54263433|FG000|Overall Study|Progressive Disease|1|||
27808021|NCT01925612|54263434|FG001|Overall Study|Progressive Disease|1|||
27808022|NCT01925612|54263435|FG002|Overall Study|Progressive Disease|1|||
27808023|NCT01925612|54263436|FG003|Overall Study|Progressive Disease|0|||
27808024|NCT01925612|54263437|FG004|Overall Study|Progressive Disease|0|||
27808025|NCT01925612|54263433|FG000|Overall Study|Adverse Event|3|||
27808026|NCT01925612|54263434|FG001|Overall Study|Adverse Event|3|||
27808027|NCT01925612|54263435|FG002|Overall Study|Adverse Event|0|||
27808028|NCT01925612|54263436|FG003|Overall Study|Adverse Event|1|||
27845172|NCT03598777|54335862|FG001|Overall Study|Adverse Event|0|||
27845173|NCT03598777|54335863|FG002|Overall Study|Adverse Event|0|||
27845174|NCT03598777|54335864|FG003|Overall Study|Adverse Event|0|||
27845175|NCT03598777|54335865|FG004|Overall Study|Adverse Event|0|||
27845176|NCT03598777|54335861|FG000|Overall Study|Lost to Follow-up|1|||
27845177|NCT03598777|54335862|FG001|Overall Study|Lost to Follow-up|0|||
27845178|NCT03598777|54335863|FG002|Overall Study|Lost to Follow-up|0|||
27845179|NCT03598777|54335864|FG003|Overall Study|Lost to Follow-up|0|||
27845180|NCT03598777|54335865|FG004|Overall Study|Lost to Follow-up|0|||
27845181|NCT03594955|54335880|FG000|Overall Study|Adverse Event|1|||
27845182|NCT03594955|54335880|FG000|Overall Study|Progressive disease|5|||
27845183|NCT03594955|54335880|FG000|Overall Study|Sponsor's decision|1|||
27845184|NCT01677624|54335908|FG000|Overall Study|Insuf Resp: intra-articular hemorrhage|1|||
27845185|NCT01272219|54335929|FG000|Main Period: Week 0 to Week 56|Adverse Event|86|||
27845186|NCT01272219|54335930|FG001|Main Period: Week 0 to Week 56|Adverse Event|0|||
27845187|NCT01272219|54335931|FG002|Main Period: Week 0 to Week 56|Adverse Event|0|||
27845188|NCT01272219|54335932|FG003|Main Period: Week 0 to Week 56|Adverse Event|16|||
27808029|NCT01925612|54263437|FG004|Overall Study|Adverse Event|2|||
27808030|NCT02093663|54263449|FG000|Double Blind Acute Phase (8 Weeks)|Adverse Event|1|||
27808031|NCT02093663|54263450|FG001|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
27808032|NCT02093663|54263451|FG002|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
27808033|NCT02093663|54263452|FG003|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
27845189|NCT01272219|54335933|FG004|Main Period: Week 0 to Week 56|Adverse Event|152|||
27845190|NCT01272219|54335934|FG005|Main Period: Week 0 to Week 56|Adverse Event|29|||
27845191|NCT01272219|54335929|FG000|Main Period: Week 0 to Week 56|Lack of Efficacy|11|||
27808034|NCT02093663|54263453|FG004|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
27808035|NCT02093663|54263449|FG000|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5|||
27808036|NCT02093663|54263450|FG001|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
27808037|NCT02093663|54263451|FG002|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
27808038|NCT02093663|54263452|FG003|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
27845192|NCT01272219|54335930|FG001|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
27845193|NCT01272219|54335931|FG002|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
27845194|NCT01272219|54335932|FG003|Main Period: Week 0 to Week 56|Lack of Efficacy|14|||
27808039|NCT02093663|54263453|FG004|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
27808040|NCT02093663|54263449|FG000|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2|||
27845195|NCT01272219|54335933|FG004|Main Period: Week 0 to Week 56|Lack of Efficacy|12|||
27845196|NCT01272219|54335934|FG005|Main Period: Week 0 to Week 56|Lack of Efficacy|22|||
27808041|NCT02093663|54263450|FG001|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4|||
27808042|NCT02093663|54263451|FG002|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
27808043|NCT02093663|54263452|FG003|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
27808044|NCT02093663|54263453|FG004|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
27808045|NCT02093663|54263449|FG000|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
27808046|NCT02093663|54263450|FG001|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
27808047|NCT02093663|54263451|FG002|Open Label Acute Phase (8 Weeks)|Adverse Event|1|||
27808048|NCT02093663|54263452|FG003|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
27808049|NCT02093663|54263453|FG004|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
27808050|NCT02093663|54263449|FG000|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
27808051|NCT02093663|54263450|FG001|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
27808052|NCT02093663|54263451|FG002|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5|||
27808053|NCT02093663|54263452|FG003|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
27808054|NCT02093663|54263453|FG004|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
27808055|NCT02093663|54263449|FG000|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
27808056|NCT02093663|54263450|FG001|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
27808057|NCT02093663|54263451|FG002|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
27808058|NCT02093663|54263452|FG003|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3|||
27808059|NCT02093663|54263453|FG004|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2|||
27808060|NCT02093663|54263449|FG000|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
27808061|NCT02093663|54263450|FG001|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
27808062|NCT02093663|54263451|FG002|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
27808063|NCT02093663|54263452|FG003|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6|||
27808064|NCT02093663|54263453|FG004|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7|||
27845197|NCT01272219|54335929|FG000|Main Period: Week 0 to Week 56|Protocol Violation|25|||
27845198|NCT01272219|54335930|FG001|Main Period: Week 0 to Week 56|Protocol Violation|0|||
27845199|NCT01272219|54335931|FG002|Main Period: Week 0 to Week 56|Protocol Violation|0|||
27845200|NCT01272219|54335932|FG003|Main Period: Week 0 to Week 56|Protocol Violation|18|||
27845201|NCT01272219|54335933|FG004|Main Period: Week 0 to Week 56|Protocol Violation|40|||
27845202|NCT01272219|54335934|FG005|Main Period: Week 0 to Week 56|Protocol Violation|20|||
27808065|NCT02093663|54263449|FG000|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
27845203|NCT01272219|54335929|FG000|Main Period: Week 0 to Week 56|Withdrawal criteria|122|||
27845204|NCT01272219|54335930|FG001|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
27845205|NCT01272219|54335931|FG002|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
27808066|NCT02093663|54263450|FG001|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
27808067|NCT02093663|54263451|FG002|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
27845206|NCT01272219|54335932|FG003|Main Period: Week 0 to Week 56|Withdrawal criteria|114|||
27845207|NCT01272219|54335933|FG004|Main Period: Week 0 to Week 56|Withdrawal criteria|172|||
27845208|NCT01272219|54335934|FG005|Main Period: Week 0 to Week 56|Withdrawal criteria|147|||
27845209|NCT01272219|54335929|FG000|Main Period: Week 0 to Week 56|Unclassified|36|||
27845210|NCT01272219|54335930|FG001|Main Period: Week 0 to Week 56|Unclassified|0|||
27845211|NCT01272219|54335931|FG002|Main Period: Week 0 to Week 56|Unclassified|0|||
27845212|NCT01272219|54335932|FG003|Main Period: Week 0 to Week 56|Unclassified|29|||
27845213|NCT01272219|54335933|FG004|Main Period: Week 0 to Week 56|Unclassified|42|||
27845214|NCT01272219|54335934|FG005|Main Period: Week 0 to Week 56|Unclassified|34|||
27845215|NCT01272219|54335929|FG000|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
27845216|NCT01272219|54335930|FG001|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
27845217|NCT01272219|54335931|FG002|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
27845218|NCT01272219|54335932|FG003|Re-randomised Period: Week 56 to Week 68|Adverse Event|2|||
27845219|NCT01272219|54335933|FG004|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
27845220|NCT01272219|54335934|FG005|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
27845221|NCT01272219|54335929|FG000|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
27845222|NCT01272219|54335930|FG001|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
27845223|NCT01272219|54335931|FG002|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
27845224|NCT01272219|54335932|FG003|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1|||
27845225|NCT01272219|54335933|FG004|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
27845226|NCT01272219|54335934|FG005|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
27845227|NCT01272219|54335929|FG000|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
27845228|NCT01272219|54335930|FG001|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1|||
27845229|NCT01272219|54335931|FG002|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
27845230|NCT01272219|54335932|FG003|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3|||
27845231|NCT01272219|54335933|FG004|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
27808068|NCT02093663|54263452|FG003|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
27808069|NCT02093663|54263453|FG004|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
27845232|NCT01272219|54335934|FG005|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
27845233|NCT01272219|54335929|FG000|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
27845234|NCT01272219|54335930|FG001|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6|||
27845235|NCT01272219|54335931|FG002|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4|||
27845236|NCT01272219|54335932|FG003|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7|||
27845237|NCT01272219|54335933|FG004|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
27845238|NCT01272219|54335934|FG005|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
27845239|NCT01272219|54335929|FG000|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
27845240|NCT01272219|54335930|FG001|Re-randomised Period: Week 56 to Week 68|Unclassified|1|||
27845241|NCT01272219|54335931|FG002|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
27845242|NCT01272219|54335932|FG003|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
27845243|NCT01272219|54335933|FG004|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
27845244|NCT01272219|54335934|FG005|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
27845245|NCT01272219|54335929|FG000|Main + Extension Period: Week 0-172|Adverse Event|0|||
27845246|NCT01272219|54335930|FG001|Main + Extension Period: Week 0-172|Adverse Event|0|||
27845247|NCT01272219|54335931|FG002|Main + Extension Period: Week 0-172|Adverse Event|0|||
27845248|NCT01272219|54335932|FG003|Main + Extension Period: Week 0-172|Adverse Event|0|||
27845249|NCT01272219|54335933|FG004|Main + Extension Period: Week 0-172|Adverse Event|191|||
27845250|NCT01272219|54335934|FG005|Main + Extension Period: Week 0-172|Adverse Event|43|||
27845251|NCT01272219|54335929|FG000|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
27845252|NCT01272219|54335930|FG001|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
27845253|NCT01272219|54335931|FG002|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
27845254|NCT01272219|54335932|FG003|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
27845255|NCT01272219|54335933|FG004|Main + Extension Period: Week 0-172|Lack of Efficacy|29|||
27845256|NCT01272219|54335934|FG005|Main + Extension Period: Week 0-172|Lack of Efficacy|36|||
27845257|NCT01272219|54335929|FG000|Main + Extension Period: Week 0-172|Protocol Violation|0|||
27845258|NCT01272219|54335930|FG001|Main + Extension Period: Week 0-172|Protocol Violation|0|||
27845259|NCT01272219|54335931|FG002|Main + Extension Period: Week 0-172|Protocol Violation|0|||
27845260|NCT01272219|54335932|FG003|Main + Extension Period: Week 0-172|Protocol Violation|0|||
27845261|NCT01272219|54335933|FG004|Main + Extension Period: Week 0-172|Protocol Violation|76|||
27845262|NCT01272219|54335934|FG005|Main + Extension Period: Week 0-172|Protocol Violation|36|||
27845263|NCT01272219|54335929|FG000|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
27845264|NCT01272219|54335930|FG001|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
27845265|NCT01272219|54335931|FG002|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
27845266|NCT01272219|54335932|FG003|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
27845267|NCT01272219|54335933|FG004|Main + Extension Period: Week 0-172|Withdrawal criteria|364|||
27845268|NCT01272219|54335934|FG005|Main + Extension Period: Week 0-172|Withdrawal criteria|256|||
27845269|NCT01272219|54335929|FG000|Main + Extension Period: Week 0-172|Missing reason|0|||
27845270|NCT01272219|54335930|FG001|Main + Extension Period: Week 0-172|Missing reason|0|||
27845271|NCT01272219|54335931|FG002|Main + Extension Period: Week 0-172|Missing reason|0|||
27845272|NCT01272219|54335932|FG003|Main + Extension Period: Week 0-172|Missing reason|0|||
27845273|NCT01272219|54335933|FG004|Main + Extension Period: Week 0-172|Missing reason|1|||
27845274|NCT01272219|54335934|FG005|Main + Extension Period: Week 0-172|Missing reason|0|||
27845275|NCT01272219|54335929|FG000|Main + Extension Period: Week 0-172|Unclassified|0|||
27845276|NCT01272219|54335930|FG001|Main + Extension Period: Week 0-172|Unclassified|0|||
27845277|NCT01272219|54335931|FG002|Main + Extension Period: Week 0-172|Unclassified|0|||
27845278|NCT01272219|54335932|FG003|Main + Extension Period: Week 0-172|Unclassified|0|||
27845279|NCT01272219|54335933|FG004|Main + Extension Period: Week 0-172|Unclassified|61|||
27845280|NCT01272219|54335934|FG005|Main + Extension Period: Week 0-172|Unclassified|51|||
27845281|NCT01510028|54335951|FG000|Overall Study|Lack of Efficacy|1|||
27845282|NCT01510028|54335952|FG001|Overall Study|Lack of Efficacy|0|||
27845283|NCT01510028|54335953|FG002|Overall Study|Lack of Efficacy|0|||
27845284|NCT01510028|54335954|FG003|Overall Study|Lack of Efficacy|0|||
27845285|NCT01521494|54335975|FG000|Overall Study|Adverse Event|1|||
27845286|NCT01521494|54335976|FG001|Overall Study|Adverse Event|2|||
27845287|NCT01521494|54335977|FG002|Overall Study|Adverse Event|9|||
27845288|NCT01521494|54335978|FG003|Overall Study|Adverse Event|6|||
27845289|NCT01521494|54335979|FG004|Overall Study|Adverse Event|2|||
27808070|NCT02093663|54263449|FG000|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
27808071|NCT02093663|54263450|FG001|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
27808072|NCT02093663|54263451|FG002|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
27808073|NCT02093663|54263452|FG003|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
27808074|NCT02093663|54263453|FG004|Double Blind Maintenance Phase(26 Weeks)|Missing|1|||
27808075|NCT01408888|54263470|FG000|First Intervention|Adverse Event|0|||
27808076|NCT01408888|54263471|FG001|First Intervention|Adverse Event|1|||
27808077|NCT01408888|54263470|FG000|First Intervention|Withdrawal by Subject|0|||
27808078|NCT01408888|54263471|FG001|First Intervention|Withdrawal by Subject|2|||
27845290|NCT01521494|54335975|FG000|Overall Study|Lack of Efficacy|0|||
27845291|NCT01521494|54335976|FG001|Overall Study|Lack of Efficacy|0|||
27808079|NCT01408888|54263470|FG000|Second Intervention|Withdrawal by Subject|1|||
27808080|NCT01408888|54263471|FG001|Second Intervention|Withdrawal by Subject|0|||
27845292|NCT01521494|54335977|FG002|Overall Study|Lack of Efficacy|0|||
27845293|NCT01521494|54335978|FG003|Overall Study|Lack of Efficacy|0|||
27845294|NCT01521494|54335979|FG004|Overall Study|Lack of Efficacy|2|||
27845295|NCT01521494|54335975|FG000|Overall Study|Withdrawal by Subject|1|||
27845296|NCT01521494|54335976|FG001|Overall Study|Withdrawal by Subject|1|||
27845297|NCT01521494|54335977|FG002|Overall Study|Withdrawal by Subject|0|||
27845298|NCT01521494|54335978|FG003|Overall Study|Withdrawal by Subject|2|||
27845299|NCT01521494|54335979|FG004|Overall Study|Withdrawal by Subject|0|||
27845300|NCT01521494|54335975|FG000|Overall Study|Decrease in serum phosphate|0|||
27845301|NCT01521494|54335976|FG001|Overall Study|Decrease in serum phosphate|2|||
27845302|NCT01521494|54335977|FG002|Overall Study|Decrease in serum phosphate|3|||
27845303|NCT01521494|54335978|FG003|Overall Study|Decrease in serum phosphate|12|||
27845304|NCT01521494|54335979|FG004|Overall Study|Decrease in serum phosphate|0|||
27845305|NCT01521494|54335975|FG000|Overall Study|Decrease in serum calcium|0|||
27845306|NCT01521494|54335976|FG001|Overall Study|Decrease in serum calcium|0|||
27845307|NCT01521494|54335977|FG002|Overall Study|Decrease in serum calcium|0|||
27845308|NCT01521494|54335978|FG003|Overall Study|Decrease in serum calcium|1|||
27845309|NCT01521494|54335979|FG004|Overall Study|Decrease in serum calcium|1|||
27845310|NCT01521494|54335975|FG000|Overall Study|Physician Decision|0|||
27845311|NCT01521494|54335976|FG001|Overall Study|Physician Decision|0|||
27845312|NCT01521494|54335977|FG002|Overall Study|Physician Decision|0|||
27845313|NCT01521494|54335978|FG003|Overall Study|Physician Decision|0|||
27845314|NCT01521494|54335979|FG004|Overall Study|Physician Decision|2|||
27845315|NCT01270971|54335993|FG000|Overall Study|Withdrawal by Subject|24|||
27845316|NCT01270971|54335994|FG001|Overall Study|Withdrawal by Subject|11|||
27845317|NCT01270971|54335993|FG000|Overall Study|Lost to Follow-up|18|||
27845318|NCT01270971|54335994|FG001|Overall Study|Lost to Follow-up|5|||
27845319|NCT01270971|54335993|FG000|Overall Study|Adverse Event|1|||
27845320|NCT01270971|54335994|FG001|Overall Study|Adverse Event|2|||
27845321|NCT01270971|54335993|FG000|Overall Study|Non compliance|2|||
27845322|NCT01270971|54335994|FG001|Overall Study|Non compliance|2|||
27845323|NCT01270971|54335993|FG000|Overall Study|Non-specific|7|||
27845324|NCT01270971|54335994|FG001|Overall Study|Non-specific|3|||
27845325|NCT01270503|54336021|FG000|Overall Study|Lost to Follow-up|1|||
27845326|NCT01277211|54336038|FG000|Overall Study|Adverse Event|60|||
27808081|NCT01408888|54263470|FG000|Second Intervention|Adverse Event|1|||
27808082|NCT01408888|54263471|FG001|Second Intervention|Adverse Event|0|||
27808083|NCT01918033|54263490|FG000|Overall Study|Adverse Event|1|||
27808084|NCT01918033|54263491|FG001|Overall Study|Adverse Event|0|||
27808085|NCT01918033|54263492|FG002|Overall Study|Adverse Event|2|||
27808086|NCT01918033|54263490|FG000|Overall Study|Lost to Follow-up|0|||
27808087|NCT01918033|54263491|FG001|Overall Study|Lost to Follow-up|1|||
27808088|NCT01918033|54263492|FG002|Overall Study|Lost to Follow-up|0|||
27808089|NCT01918033|54263490|FG000|Overall Study|Protocol Violation|2|||
27808090|NCT01918033|54263491|FG001|Overall Study|Protocol Violation|0|||
27808091|NCT01918033|54263492|FG002|Overall Study|Protocol Violation|1|||
27808092|NCT01918033|54263490|FG000|Overall Study|Withdrawal by Subject|2|||
27808093|NCT01918033|54263491|FG001|Overall Study|Withdrawal by Subject|1|||
27808094|NCT01918033|54263492|FG002|Overall Study|Withdrawal by Subject|0|||
27808095|NCT01408732|54263500|FG000|Overall Study|Withdrawal by Subject|2|||
27808096|NCT01408732|54263501|FG001|Overall Study|Withdrawal by Subject|2|||
27808097|NCT01390402|54263507|FG000|Overall Study|Death|1|||
27808098|NCT01390402|54263507|FG000|Overall Study|Disease Progression|4|||
27808099|NCT01976299|54263513|FG000|Overall Study|Withdrawal by Subject|3|||
27808100|NCT01976299|54263514|FG001|Overall Study|Withdrawal by Subject|1|||
27808101|NCT01976299|54263513|FG000|Overall Study|Death|4|||
27808102|NCT01976299|54263514|FG001|Overall Study|Death|2|||
27808103|NCT01976299|54263513|FG000|Overall Study|Lost to Follow-up|7|||
27845327|NCT01277211|54336039|FG001|Overall Study|Adverse Event|22|||
27845328|NCT01277211|54336038|FG000|Overall Study|Pregnancy|9|||
27808104|NCT01976299|54263514|FG001|Overall Study|Lost to Follow-up|1|||
27845329|NCT01277211|54336039|FG001|Overall Study|Pregnancy|4|||
27845330|NCT01277211|54336038|FG000|Overall Study|Lost to Follow-up|14|||
27808105|NCT01976299|54263513|FG000|Overall Study|See clarification above in comments|9|||
27808106|NCT01976299|54263514|FG001|Overall Study|See clarification above in comments|2|||
27808107|NCT01428076|54263522|FG000|Overall Study|Adverse Event|0|||
27808108|NCT01428076|54263523|FG001|Overall Study|Adverse Event|1|||
27808109|NCT01900652|54263533|FG000|Overall Study|Progressive Disease|1|||
27845331|NCT01277211|54336039|FG001|Overall Study|Lost to Follow-up|9|||
27845332|NCT01277211|54336038|FG000|Overall Study|Did not wish to continue|17|||
27845333|NCT01277211|54336039|FG001|Overall Study|Did not wish to continue|0|||
27845334|NCT01277211|54336038|FG000|Overall Study|Withdrew Consent|9|||
27845335|NCT01277211|54336039|FG001|Overall Study|Withdrew Consent|9|||
27845336|NCT01277211|54336038|FG000|Overall Study|Non-compliance with protocol|13|||
27845337|NCT01277211|54336039|FG001|Overall Study|Non-compliance with protocol|4|||
27845338|NCT01277211|54336038|FG000|Overall Study|Did not meet protocol eligibility|1|||
27845339|NCT01277211|54336039|FG001|Overall Study|Did not meet protocol eligibility|0|||
27808110|NCT01900652|54263534|FG001|Overall Study|Progressive Disease|0|||
27845340|NCT01277211|54336038|FG000|Overall Study|Administrative|3|||
27845341|NCT01277211|54336039|FG001|Overall Study|Administrative|0|||
27845342|NCT01277211|54336038|FG000|Overall Study|Pregnancy wish|0|||
27845343|NCT01277211|54336039|FG001|Overall Study|Pregnancy wish|2|||
27845344|NCT01277211|54336038|FG000|Overall Study|Discontinued prior to treatment|24|||
27845345|NCT01277211|54336039|FG001|Overall Study|Discontinued prior to treatment|13|||
27845346|NCT01676220|54336047|FG000|Overall Study|Randomized But Not Treated|4|||
27845347|NCT01676220|54336048|FG001|Overall Study|Randomized But Not Treated|1|||
27845348|NCT01676220|54336047|FG000|Overall Study|Adverse Event|10|||
27845349|NCT01676220|54336048|FG001|Overall Study|Adverse Event|8|||
27845350|NCT01676220|54336047|FG000|Overall Study|Lack of Efficacy|2|||
27845351|NCT01676220|54336048|FG001|Overall Study|Lack of Efficacy|5|||
27845352|NCT01676220|54336047|FG000|Overall Study|Protocol Violation|11|||
27845353|NCT01676220|54336048|FG001|Overall Study|Protocol Violation|12|||
27845354|NCT01676220|54336047|FG000|Overall Study|Received Rescue Therapy|14|||
27845355|NCT01676220|54336048|FG001|Overall Study|Received Rescue Therapy|22|||
27845356|NCT01676220|54336047|FG000|Overall Study|Personal Reason|34|||
27845357|NCT01676220|54336048|FG001|Overall Study|Personal Reason|45|||
27845358|NCT01676220|54336047|FG000|Overall Study|Lost to Follow-up|11|||
27845359|NCT01676220|54336048|FG001|Overall Study|Lost to Follow-up|18|||
27845360|NCT01676220|54336047|FG000|Overall Study|Selection Criterion/Protocol Violation|9|||
27845361|NCT01676220|54336048|FG001|Overall Study|Selection Criterion/Protocol Violation|9|||
27845362|NCT01676220|54336047|FG000|Overall Study|Site Closure/Site Withdrawal|1|||
27845363|NCT01676220|54336048|FG001|Overall Study|Site Closure/Site Withdrawal|4|||
27845364|NCT01676220|54336047|FG000|Overall Study|Perceived Lack of Efficacy|3|||
27845365|NCT01676220|54336048|FG001|Overall Study|Perceived Lack of Efficacy|1|||
27845366|NCT01676220|54336047|FG000|Overall Study|Non Serious Hypoglycemia|2|||
27845367|NCT01676220|54336048|FG001|Overall Study|Non Serious Hypoglycemia|0|||
27845368|NCT01676220|54336047|FG000|Overall Study|No More Need of Insulin|1|||
27845369|NCT01676220|54336048|FG001|Overall Study|No More Need of Insulin|0|||
27845370|NCT01485614|54336078|FG000|Randomization|Not Treated|1|||
27845371|NCT01485614|54336079|FG001|Randomization|Not Treated|0|||
27845372|NCT01485614|54336080|FG002|Randomization|Not Treated|0|||
27808111|NCT01900652|54263533|FG000|Overall Study|Consent withdrawn by subject|1|||
27808112|NCT01900652|54263534|FG001|Overall Study|Consent withdrawn by subject|1|||
27808113|NCT01900652|54263533|FG000|Overall Study|Death|3|||
27808114|NCT01900652|54263534|FG001|Overall Study|Death|0|||
27808115|NCT01900652|54263533|FG000|Overall Study|Adverse Event|2|||
27808116|NCT01900652|54263534|FG001|Overall Study|Adverse Event|1|||
27808117|NCT01900652|54263533|FG000|Overall Study|Physician Decision|1|||
27808118|NCT01900652|54263534|FG001|Overall Study|Physician Decision|1|||
27808119|NCT02093351|54263548|FG000|Part A|Adverse Event|0|||
27808120|NCT02093351|54263549|FG001|Part A|Adverse Event|1|||
27808121|NCT02093351|54263550|FG002|Part A|Adverse Event|1|||
27808122|NCT02093351|54263551|FG003|Part A|Adverse Event|0|||
27808123|NCT02093351|54263548|FG000|Part A|Condition under investigation worsened|2|||
27808124|NCT02093351|54263549|FG001|Part A|Condition under investigation worsened|0|||
27808125|NCT02093351|54263550|FG002|Part A|Condition under investigation worsened|2|||
27808126|NCT02093351|54263551|FG003|Part A|Condition under investigation worsened|0|||
27808127|NCT02093351|54263548|FG000|Part A|Death|0|||
27808128|NCT02093351|54263549|FG001|Part A|Death|1|||
27808129|NCT02093351|54263550|FG002|Part A|Death|0|||
27808130|NCT02093351|54263551|FG003|Part A|Death|0|||
27808131|NCT02093351|54263548|FG000|Part B|Patient decision|0|||
27808132|NCT02093351|54263549|FG001|Part B|Patient decision|0|||
27845373|NCT01485614|54336081|FG003|Randomization|Not Treated|0|||
27845374|NCT01485614|54336078|FG000|Weeks 0-20|Lost to Follow-up|2|||
27845375|NCT01485614|54336079|FG001|Weeks 0-20|Lost to Follow-up|0|||
27845376|NCT01485614|54336080|FG002|Weeks 0-20|Lost to Follow-up|0|||
28035007|NCT00539864|54693246|FG001|Overall Study|Lost to Follow-up|1|||
27808133|NCT02093351|54263550|FG002|Part B|Patient decision|0|||
27808134|NCT02093351|54263551|FG003|Part B|Patient decision|3|||
27808135|NCT02093351|54263548|FG000|Part B|Disease progression|0|||
27808136|NCT02093351|54263549|FG001|Part B|Disease progression|0|||
27808137|NCT02093351|54263550|FG002|Part B|Disease progression|0|||
27845377|NCT01485614|54336081|FG003|Weeks 0-20|Lost to Follow-up|0|||
27845378|NCT01485614|54336078|FG000|Weeks 0-20|Withdrawal by Parent/Guardian|5|||
28035008|NCT00539864|54693245|FG000|Overall Study|Withdrawal by Subject|1|||
28035009|NCT00539864|54693246|FG001|Overall Study|Withdrawal by Subject|1|||
27808138|NCT02093351|54263551|FG003|Part B|Disease progression|4|||
27808139|NCT02093351|54263548|FG000|Part B|Complete response|0|||
27808140|NCT02093351|54263549|FG001|Part B|Complete response|0|||
27808141|NCT02093351|54263550|FG002|Part B|Complete response|0|||
27845379|NCT01485614|54336079|FG001|Weeks 0-20|Withdrawal by Parent/Guardian|2|||
27845380|NCT01485614|54336080|FG002|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
27845381|NCT01485614|54336081|FG003|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
27845382|NCT01485614|54336078|FG000|Weeks 0-20|Withdrawal by Subject|3|||
27808142|NCT02093351|54263551|FG003|Part B|Complete response|1|||
27808143|NCT02093351|54263548|FG000|Part B|Adverse event + disease progression|0|||
27845383|NCT01485614|54336079|FG001|Weeks 0-20|Withdrawal by Subject|2|||
27808144|NCT02093351|54263549|FG001|Part B|Adverse event + disease progression|0|||
27808145|NCT02093351|54263550|FG002|Part B|Adverse event + disease progression|0|||
27808146|NCT02093351|54263551|FG003|Part B|Adverse event + disease progression|1|||
27845384|NCT01485614|54336080|FG002|Weeks 0-20|Withdrawal by Subject|1|||
27845385|NCT01485614|54336081|FG003|Weeks 0-20|Withdrawal by Subject|0|||
27845386|NCT01485614|54336078|FG000|Weeks 20-54|Lost to Follow-up|4|||
27845387|NCT01485614|54336079|FG001|Weeks 20-54|Lost to Follow-up|3|||
27845388|NCT01485614|54336080|FG002|Weeks 20-54|Lost to Follow-up|1|||
27845389|NCT01485614|54336081|FG003|Weeks 20-54|Lost to Follow-up|0|||
27845390|NCT01485614|54336078|FG000|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
27845391|NCT01485614|54336079|FG001|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
27808147|NCT02093351|54263548|FG000|Part B|Lack of therapeutic response|0|||
27808148|NCT02093351|54263549|FG001|Part B|Lack of therapeutic response|0|||
27808149|NCT02093351|54263550|FG002|Part B|Lack of therapeutic response|0|||
27808150|NCT02093351|54263551|FG003|Part B|Lack of therapeutic response|12|||
27808151|NCT02093351|54263548|FG000|Part B|Condition under investigation worsened|0|||
27845392|NCT01485614|54336080|FG002|Weeks 20-54|Withdrawal by Parent/Guardian|1|||
27845393|NCT01485614|54336081|FG003|Weeks 20-54|Withdrawal by Parent/Guardian|0|||
27845394|NCT01485614|54336078|FG000|Weeks 20-54|Withdrawal by Subject|5|||
27845395|NCT01485614|54336079|FG001|Weeks 20-54|Withdrawal by Subject|3|||
27845396|NCT01485614|54336080|FG002|Weeks 20-54|Withdrawal by Subject|0|||
27845397|NCT01485614|54336081|FG003|Weeks 20-54|Withdrawal by Subject|0|||
27845398|NCT01485536|54336131|FG000|Overall Study|Withdrawal by Subject|3|||
27845399|NCT01485536|54336131|FG000|Overall Study|Adverse Event|1|||
27845400|NCT02658630|54336135|FG000|Overall Study|Withdrawal by Subject|4|||
27845401|NCT01484912|54336141|FG000|Overall Study|Withdrawal by Subject|1|||
27845402|NCT01484912|54336142|FG001|Overall Study|Withdrawal by Subject|0|||
27845403|NCT01484912|54336141|FG000|Overall Study|Physician Decision|0|||
27845404|NCT01484912|54336142|FG001|Overall Study|Physician Decision|1|||
27845405|NCT01520870|54336148|FG000|Overall Study|Withdrawal by Subject|2|||
27845406|NCT01520714|54336154|FG000|Overall Study|Protocol Violation|0|||
27845407|NCT01520714|54336155|FG001|Overall Study|Protocol Violation|3|||
27845408|NCT01520714|54336154|FG000|Overall Study|Adverse Event|0|||
27845409|NCT01520714|54336155|FG001|Overall Study|Adverse Event|2|||
27845410|NCT01520714|54336154|FG000|Overall Study|Lack of Efficacy|0|||
27845411|NCT01520714|54336155|FG001|Overall Study|Lack of Efficacy|1|||
27845412|NCT02659098|54336174|FG000|Overall Study|Withdrawal by Subject|7|||
27845413|NCT01508936|54336185|FG000|Overall Study|Adverse Event|11|||
27845414|NCT01508936|54336186|FG001|Overall Study|Adverse Event|32|||
27845415|NCT01508936|54336185|FG000|Overall Study|Lack of Efficacy|0|||
27845416|NCT01508936|54336186|FG001|Overall Study|Lack of Efficacy|1|||
27845417|NCT01508936|54336185|FG000|Overall Study|Withdrawal by Subject|4|||
27845418|NCT01508936|54336186|FG001|Overall Study|Withdrawal by Subject|18|||
27845419|NCT01508936|54336185|FG000|Overall Study|Protocol Violation|2|||
27845420|NCT01508936|54336186|FG001|Overall Study|Protocol Violation|3|||
27845421|NCT01508936|54336185|FG000|Overall Study|Lost to Follow-up|2|||
27845422|NCT01508936|54336186|FG001|Overall Study|Lost to Follow-up|9|||
27845423|NCT01508936|54336185|FG000|Overall Study|Other|0|||
27845424|NCT01508936|54336186|FG001|Overall Study|Other|5|||
27845425|NCT01508936|54336185|FG000|Overall Study|Data from 2 sites deemed invalid|4|||
27845426|NCT01508936|54336186|FG001|Overall Study|Data from 2 sites deemed invalid|11|||
27845427|NCT01508702|54336207|FG000|Overall Study|Adverse Event|7|||
27845428|NCT01508702|54336208|FG001|Overall Study|Adverse Event|3|||
27845429|NCT01508702|54336207|FG000|Overall Study|Gout flare|2|||
27845430|NCT01508702|54336208|FG001|Overall Study|Gout flare|0|||
27845431|NCT01508702|54336207|FG000|Overall Study|Protocol Violation|2|||
27845432|NCT01508702|54336208|FG001|Overall Study|Protocol Violation|1|||
27845433|NCT01508702|54336207|FG000|Overall Study|Lost to Follow-up|1|||
27845434|NCT01508702|54336208|FG001|Overall Study|Lost to Follow-up|2|||
27845435|NCT01508702|54336207|FG000|Overall Study|Withdrawal by Subject|11|||
27845436|NCT01508702|54336208|FG001|Overall Study|Withdrawal by Subject|7|||
27845437|NCT01484834|54336222|FG000|Overall Study|Lost to Follow-up|5|||
27845438|NCT01484834|54336223|FG001|Overall Study|Lost to Follow-up|8|||
27845439|NCT01484834|54336224|FG002|Overall Study|Lost to Follow-up|1|||
27845440|NCT01484834|54336225|FG003|Overall Study|Lost to Follow-up|4|||
27845441|NCT01484132|54336235|FG000|Overall Study|Lost to Follow-up|8|||
27845442|NCT01484132|54336235|FG000|Overall Study|Difficulty with time commitment|2|||
27845443|NCT01484132|54336235|FG000|Overall Study|Ineligible|1|||
27845444|NCT01484132|54336235|FG000|Overall Study|No pre-treatment urine sample collected|1|||
27808152|NCT02093351|54263549|FG001|Part B|Condition under investigation worsened|0|||
27808153|NCT02093351|54263550|FG002|Part B|Condition under investigation worsened|0|||
27845445|NCT01484132|54336235|FG000|Overall Study|No post-treatment urine sample collected|10|||
27845446|NCT01276041|54336239|FG000|Overall Study|Adverse Event|2|||
27845447|NCT01276041|54336239|FG000|Overall Study|Protocol Violation|1|||
27939792|NCT01227902|54596126|FG002|Overall Study|Lack of Efficacy|2|||
27808154|NCT02093351|54263551|FG003|Part B|Condition under investigation worsened|39|||
27845448|NCT01275339|54336247|FG000|Overall Study|Referred for surgery for AS symptoms|1|||
27845449|NCT01275339|54336248|FG001|Overall Study|Referred for surgery for AS symptoms|0|||
27845450|NCT01275339|54336249|FG002|Overall Study|Referred for surgery for AS symptoms|0|||
27845451|NCT01275339|54336250|FG003|Overall Study|Referred for surgery for AS symptoms|0|||
27845452|NCT01275339|54336247|FG000|Overall Study|Withdrawal by Subject|0|||
27845453|NCT01275339|54336248|FG001|Overall Study|Withdrawal by Subject|0|||
27845454|NCT01275339|54336249|FG002|Overall Study|Withdrawal by Subject|1|||
27845455|NCT01275339|54336250|FG003|Overall Study|Withdrawal by Subject|0|||
27845456|NCT01520402|54336260|FG000|Overall Study|Withdrawal by Subject|2|||
27845457|NCT01520402|54336260|FG000|Overall Study|Physician Decision|3|||
27845458|NCT01520324|54336275|FG000|Overall Study|Subject discontinued (moderate illness)|1|||
27845459|NCT01519934|54336279|FG000|Overall Study|Lost to Follow-up|3|||
27845460|NCT01484054|54336283|FG000|Period 1|Withdrawal by Subject|0|||
27845461|NCT01484054|54336284|FG001|Period 1|Withdrawal by Subject|1|||
27845462|NCT01483820|54336291|FG000|Overall Study|Lack of Efficacy|6|||
27845463|NCT01483820|54336291|FG000|Overall Study|Adverse Event|1|||
27845464|NCT01483820|54336291|FG000|Overall Study|Death|1|||
27845465|NCT01507298|54336306|FG000|Overall Study|Protocol Violation|0|||
27845466|NCT01507298|54336307|FG001|Overall Study|Protocol Violation|6|||
27845467|NCT01483118|54336316|FG000|Overall Study|Lost to Follow-up|12|||
27845468|NCT01483118|54336317|FG001|Overall Study|Lost to Follow-up|16|||
27845469|NCT01506908|54336327|FG000|Overall Study|Adverse Event|1|||
27845470|NCT01506908|54336328|FG001|Overall Study|Adverse Event|0|||
27845471|NCT01519778|54336336|FG000|Overall Study|Withdrawal by Subject|3|||
27845472|NCT01519778|54336336|FG000|Overall Study|Lost to Follow-up|10|||
27845473|NCT01519778|54336336|FG000|Overall Study|Physician Decision|1|||
27845474|NCT01519700|54336344|FG000|Overall Study|Death|1|||
27845475|NCT01519700|54336345|FG001|Overall Study|Death|0|||
27845476|NCT01519700|54336346|FG002|Overall Study|Death|0|||
27845477|NCT01519700|54336347|FG003|Overall Study|Death|0|||
27845478|NCT01519700|54336344|FG000|Overall Study|Lost to Follow-up|0|||
27845479|NCT01519700|54336345|FG001|Overall Study|Lost to Follow-up|0|||
27845480|NCT01519700|54336346|FG002|Overall Study|Lost to Follow-up|1|||
27845481|NCT01519700|54336347|FG003|Overall Study|Lost to Follow-up|1|||
27845482|NCT01519700|54336344|FG000|Overall Study|Physician Decision|1|||
27845483|NCT01519700|54336345|FG001|Overall Study|Physician Decision|1|||
27845484|NCT01519700|54336346|FG002|Overall Study|Physician Decision|3|||
27845485|NCT01519700|54336347|FG003|Overall Study|Physician Decision|0|||
27845486|NCT01519700|54336344|FG000|Overall Study|Withdrawal by Subject|5|||
27845487|NCT01519700|54336345|FG001|Overall Study|Withdrawal by Subject|3|||
27845488|NCT01519700|54336346|FG002|Overall Study|Withdrawal by Subject|3|||
27845489|NCT01519700|54336347|FG003|Overall Study|Withdrawal by Subject|2|||
27845490|NCT01519700|54336344|FG000|Overall Study|Other Reason|2|||
27845491|NCT01519700|54336345|FG001|Overall Study|Other Reason|2|||
27845492|NCT01519700|54336346|FG002|Overall Study|Other Reason|0|||
27845493|NCT01519700|54336347|FG003|Overall Study|Other Reason|4|||
27845494|NCT02656680|54336365|FG000|Overall Study|Lost to Follow-up|0|||
27845495|NCT02656680|54336366|FG001|Overall Study|Lost to Follow-up|1|||
27845496|NCT02658084|54336402|FG000|Overall Study|Withdrawal by Subject|1|||
27845497|NCT02658084|54336403|FG001|Overall Study|Withdrawal by Subject|0|||
27845498|NCT02658084|54336402|FG000|Overall Study|Study Termination|1|||
27845499|NCT02658084|54336403|FG001|Overall Study|Study Termination|0|||
27845500|NCT01482962|54336419|FG000|Overall Study|Progressive Disease|65|||
27845501|NCT01482962|54336420|FG001|Overall Study|Progressive Disease|53|||
27845502|NCT01482962|54336419|FG000|Overall Study|Unsatisfactory Therapeutic Response|37|||
27845503|NCT01482962|54336420|FG001|Overall Study|Unsatisfactory Therapeutic Response|23|||
27845504|NCT01482962|54336419|FG000|Overall Study|Adverse Event|18|||
27845505|NCT01482962|54336420|FG001|Overall Study|Adverse Event|22|||
27845506|NCT01482962|54336419|FG000|Overall Study|Withdrawal by Participant|8|||
27845507|NCT01482962|54336420|FG001|Overall Study|Withdrawal by Participant|13|||
27845508|NCT01482962|54336419|FG000|Overall Study|Hematopoietic Stem Cell Transplant|3|||
27845509|NCT01482962|54336420|FG001|Overall Study|Hematopoietic Stem Cell Transplant|9|||
27845510|NCT01482962|54336419|FG000|Overall Study|Other Reason|1|||
27845511|NCT01482962|54336420|FG001|Overall Study|Other Reason|5|||
27845512|NCT01482962|54336419|FG000|Overall Study|Study Terminated by Sponsor|5|||
28035010|NCT00673049|54693254|FG000|Before Progression on Erlotinib|Randomized but not treated|3|||
27845513|NCT01482962|54336420|FG001|Overall Study|Study Terminated by Sponsor|2|||
27845514|NCT01482962|54336419|FG000|Overall Study|Did not Receive Study Drug|1|||
27845515|NCT01482962|54336420|FG001|Overall Study|Did not Receive Study Drug|6|||
27845516|NCT02655666|54336428|FG000|Overall Study|Sponsor stopped this clinical research.|12|||
27845517|NCT01506596|54336432|FG000|Overall Study|ineligible pathology|1|||
27845518|NCT01482884|54336451|FG000|Overall Study|Medical decision due to lack of efficacy|0|||
27845519|NCT01482884|54336452|FG001|Overall Study|Medical decision due to lack of efficacy|1|||
27845520|NCT01482884|54336451|FG000|Overall Study|Protocol Violation|1|||
27845521|NCT01482884|54336452|FG001|Overall Study|Protocol Violation|0|||
27845522|NCT01482884|54336451|FG000|Overall Study|Lost to Follow-up|2|||
27845523|NCT01482884|54336452|FG001|Overall Study|Lost to Follow-up|2|||
27845524|NCT01482884|54336451|FG000|Overall Study|Lack of Efficacy|0|||
27845525|NCT01482884|54336452|FG001|Overall Study|Lack of Efficacy|1|||
27845526|NCT01482884|54336451|FG000|Overall Study|Adverse Event|2|||
27845527|NCT01482884|54336452|FG001|Overall Study|Adverse Event|1|||
27845528|NCT01482884|54336451|FG000|Overall Study|Withdrawal by Subject|8|||
27845529|NCT01482884|54336452|FG001|Overall Study|Withdrawal by Subject|13|||
27845530|NCT01518374|54336458|FG000|Overall Study|Withdrawal by Subject|2|||
27845531|NCT01518374|54336458|FG000|Overall Study|Protocol Violation|3|||
27845532|NCT01518374|54336458|FG000|Overall Study|Lost to Follow-up|2|||
27845533|NCT01481324|54336465|FG000|Overall Study|Missing Data|0|||
27845534|NCT01481324|54336466|FG001|Overall Study|Missing Data|2|||
27845535|NCT01481324|54336467|FG002|Overall Study|Missing Data|2|||
27845536|NCT04591626|54336477|FG000|Overall Study|Adverse Event|4|||
27845537|NCT04591626|54336478|FG001|Overall Study|Adverse Event|0|||
27845538|NCT04591626|54336477|FG000|Overall Study|Withdrawal by Subject|5|||
27845539|NCT04591626|54336478|FG001|Overall Study|Withdrawal by Subject|3|||
27845540|NCT04591626|54336477|FG000|Overall Study|Physician Decision|0|||
27845541|NCT04591626|54336478|FG001|Overall Study|Physician Decision|1|||
27845542|NCT04591626|54336477|FG000|Overall Study|Death|0|||
27845543|NCT04591626|54336478|FG001|Overall Study|Death|1|||
27845544|NCT04591626|54336477|FG000|Overall Study|Non-Compliance with Study Drug|1|||
27845545|NCT04591626|54336478|FG001|Overall Study|Non-Compliance with Study Drug|0|||
27845546|NCT03583333|54336486|FG000|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|8|||
27845547|NCT03583333|54336487|FG001|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|6|||
27845548|NCT03583333|54336486|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
27845549|NCT03583333|54336487|FG001|Overall Study|Withdrawal by Parent/Guardian|10|||
27845550|NCT03583333|54336486|FG000|Overall Study|Withdrawal by Subject|9|||
27845551|NCT03583333|54336487|FG001|Overall Study|Withdrawal by Subject|5|||
27845552|NCT03583333|54336486|FG000|Overall Study|Physician Decision|3|||
27845553|NCT03583333|54336487|FG001|Overall Study|Physician Decision|2|||
27845554|NCT03583333|54336486|FG000|Overall Study|Death|12|||
27845555|NCT03583333|54336487|FG001|Overall Study|Death|7|||
27845556|NCT01602510|54336493|FG000|Open Label Phase|Adverse Event|46|||
27845557|NCT01602510|54336494|FG001|Open Label Phase|Adverse Event|0|||
27845558|NCT01602510|54336495|FG002|Open Label Phase|Adverse Event|0|||
27845559|NCT01602510|54336493|FG000|Open Label Phase|Lack of Efficacy|22|||
27845560|NCT01602510|54336494|FG001|Open Label Phase|Lack of Efficacy|0|||
27845561|NCT01602510|54336495|FG002|Open Label Phase|Lack of Efficacy|0|||
27845562|NCT01602510|54336493|FG000|Open Label Phase|Protocol Violation|15|||
27845563|NCT01602510|54336494|FG001|Open Label Phase|Protocol Violation|0|||
27845564|NCT01602510|54336495|FG002|Open Label Phase|Protocol Violation|0|||
27845565|NCT01602510|54336493|FG000|Open Label Phase|Met protocol-defined stopping criteria|122|||
27845566|NCT01602510|54336494|FG001|Open Label Phase|Met protocol-defined stopping criteria|0|||
27845567|NCT01602510|54336495|FG002|Open Label Phase|Met protocol-defined stopping criteria|0|||
27845568|NCT01602510|54336493|FG000|Open Label Phase|Lost to Follow-up|22|||
27845569|NCT01602510|54336494|FG001|Open Label Phase|Lost to Follow-up|0|||
27845570|NCT01602510|54336495|FG002|Open Label Phase|Lost to Follow-up|0|||
27845571|NCT01602510|54336493|FG000|Open Label Phase|Physician Decision|19|||
27845572|NCT01602510|54336494|FG001|Open Label Phase|Physician Decision|0|||
27845573|NCT01602510|54336495|FG002|Open Label Phase|Physician Decision|0|||
27845574|NCT01602510|54336493|FG000|Open Label Phase|Withdrawal by Subject|57|||
27845575|NCT01602510|54336494|FG001|Open Label Phase|Withdrawal by Subject|0|||
27845576|NCT01602510|54336495|FG002|Open Label Phase|Withdrawal by Subject|0|||
27845577|NCT01602510|54336493|FG000|Randomized Phase|Adverse Event|0|||
27939793|NCT01227902|54596127|FG003|Overall Study|Lack of Efficacy|1|||
27808155|NCT02093351|54263548|FG000|Part B|Adverse Event|0|||
27808156|NCT02093351|54263549|FG001|Part B|Adverse Event|0|||
27808157|NCT02093351|54263550|FG002|Part B|Adverse Event|0|||
27808158|NCT02093351|54263551|FG003|Part B|Adverse Event|2|||
27808159|NCT02093351|54263548|FG000|Part B|Death|0|||
27808160|NCT02093351|54263549|FG001|Part B|Death|0|||
27808161|NCT02093351|54263550|FG002|Part B|Death|0|||
27808162|NCT02093351|54263551|FG003|Part B|Death|1|||
27808163|NCT02092961|54263590|FG000|Overall Study|Not reported|1|||
27808164|NCT02092961|54263591|FG001|Overall Study|Not reported|0|||
27808165|NCT02092961|54263592|FG002|Overall Study|Not reported|1|||
27808166|NCT02092961|54263590|FG000|Overall Study|Study stopped|13|||
27808167|NCT02092961|54263591|FG001|Overall Study|Study stopped|9|||
27845578|NCT01602510|54336494|FG001|Randomized Phase|Adverse Event|2|||
27845579|NCT01602510|54336495|FG002|Randomized Phase|Adverse Event|6|||
27845580|NCT01602510|54336493|FG000|Randomized Phase|Lack of Efficacy|0|||
27845581|NCT01602510|54336494|FG001|Randomized Phase|Lack of Efficacy|4|||
27845582|NCT01602510|54336495|FG002|Randomized Phase|Lack of Efficacy|4|||
27845583|NCT01602510|54336493|FG000|Randomized Phase|Protocol Violation|0|||
27845584|NCT01602510|54336494|FG001|Randomized Phase|Protocol Violation|3|||
27845585|NCT01602510|54336495|FG002|Randomized Phase|Protocol Violation|3|||
27808168|NCT02092961|54263592|FG002|Overall Study|Study stopped|12|||
27808169|NCT02092961|54263590|FG000|Overall Study|Lack of therapeutic response|2|||
27939794|NCT01227902|54596124|FG000|Overall Study|Protocol Violation|1|||
27808170|NCT02092961|54263591|FG001|Overall Study|Lack of therapeutic response|1|||
27808171|NCT02092961|54263592|FG002|Overall Study|Lack of therapeutic response|3|||
27808172|NCT02092961|54263590|FG000|Overall Study|Dev. of study specific discont. criteria|3|||
27808173|NCT02092961|54263591|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
27808174|NCT02092961|54263592|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
27808175|NCT02092961|54263590|FG000|Overall Study|Adverse Event|2|||
27808176|NCT02092961|54263591|FG001|Overall Study|Adverse Event|4|||
27808177|NCT02092961|54263592|FG002|Overall Study|Adverse Event|0|||
27808178|NCT01898078|54263603|FG000|Overall Study|Progressive Disease|1|||
27808179|NCT01898078|54263604|FG001|Overall Study|Progressive Disease|5|||
27808180|NCT01898078|54263603|FG000|Overall Study|Adverse Event|2|||
27808181|NCT01898078|54263604|FG001|Overall Study|Adverse Event|1|||
27808182|NCT01898078|54263603|FG000|Overall Study|Withdrawal by Subject|1|||
27808183|NCT01898078|54263604|FG001|Overall Study|Withdrawal by Subject|1|||
27808184|NCT01898078|54263603|FG000|Overall Study|Symptomatic Deterioration|2|||
27808185|NCT01898078|54263604|FG001|Overall Study|Symptomatic Deterioration|0|||
27808186|NCT01898078|54263603|FG000|Overall Study|Reason not Specified|0|||
27808187|NCT01898078|54263604|FG001|Overall Study|Reason not Specified|1|||
27808188|NCT01987817|54263614|FG000|Overall Study|Adverse Event|4|||
27808189|NCT01987817|54263615|FG001|Overall Study|Adverse Event|0|||
27808190|NCT01987817|54263614|FG000|Overall Study|Withdrawal by Subject|1|||
27808191|NCT01987817|54263615|FG001|Overall Study|Withdrawal by Subject|1|||
27808192|NCT01987817|54263614|FG000|Overall Study|Physician Decision|1|||
27808193|NCT01987817|54263615|FG001|Overall Study|Physician Decision|0|||
27808194|NCT01940497|54263624|FG000|Overall Study|Adverse Event/Intercurrent Illness|11|||
27808195|NCT01940497|54263625|FG001|Overall Study|Adverse Event/Intercurrent Illness|8|||
27808196|NCT01940497|54263624|FG000|Overall Study|Recurrence of Disease Postsurgery|1|||
27845586|NCT01602510|54336493|FG000|Randomized Phase|Met protocol-defined stopping criteria|0|||
27845587|NCT01602510|54336494|FG001|Randomized Phase|Met protocol-defined stopping criteria|58|||
27845588|NCT01602510|54336495|FG002|Randomized Phase|Met protocol-defined stopping criteria|48|||
27845589|NCT01602510|54336493|FG000|Randomized Phase|Lost to Follow-up|0|||
27845590|NCT01602510|54336494|FG001|Randomized Phase|Lost to Follow-up|1|||
27845591|NCT01602510|54336495|FG002|Randomized Phase|Lost to Follow-up|3|||
27808197|NCT01940497|54263625|FG001|Overall Study|Recurrence of Disease Postsurgery|3|||
27808198|NCT01940497|54263624|FG000|Overall Study|Violation of Entry Criteria|1|||
27808199|NCT01940497|54263625|FG001|Overall Study|Violation of Entry Criteria|1|||
27808200|NCT01940497|54263624|FG000|Overall Study|Refused Treatment|1|||
27808201|NCT01940497|54263625|FG001|Overall Study|Refused Treatment|3|||
27808202|NCT01940497|54263624|FG000|Overall Study|Withdrew Consent|6|||
27808203|NCT01940497|54263625|FG001|Overall Study|Withdrew Consent|2|||
27808204|NCT01940497|54263624|FG000|Overall Study|Administrative/Other|1|||
27808205|NCT01940497|54263625|FG001|Overall Study|Administrative/Other|1|||
27808206|NCT01924754|54263645|FG000|Overall Study|Lost to Follow-up|1|||
27808207|NCT01924754|54263646|FG001|Overall Study|Lost to Follow-up|2|||
27808208|NCT01924754|54263647|FG002|Overall Study|Lost to Follow-up|1|||
27808209|NCT01924754|54263645|FG000|Overall Study|Pregnancy|0|||
27808210|NCT01924754|54263646|FG001|Overall Study|Pregnancy|1|||
27808211|NCT01924754|54263647|FG002|Overall Study|Pregnancy|2|||
27808212|NCT01924364|54263658|FG000|Overall Study|Physician Decision|3|||
27808213|NCT01987505|54263675|FG000|Overall Study|Other|9|||
27808214|NCT01987505|54263675|FG000|Overall Study|Withdrawal by Subject|2|||
27808215|NCT01987505|54263675|FG000|Overall Study|Other Reason|2|||
27808216|NCT01987505|54263675|FG000|Overall Study|Lost to Follow-up|15|||
27808217|NCT01987505|54263675|FG000|Overall Study|Investigator Decision|2|||
27808218|NCT01987505|54263675|FG000|Overall Study|Death|4|||
27808219|NCT01923896|54263683|FG000|Overall Study|Adverse Event|1|||
27808220|NCT01923896|54263684|FG001|Overall Study|Adverse Event|0|||
27808221|NCT02004353|54263690|FG000|Overall Study|Voluntary participation|1334|||
27808222|NCT01938625|54263696|FG000|Overall Study|Withdrawal by Subject|0|||
27808223|NCT01938625|54263697|FG001|Overall Study|Withdrawal by Subject|1|||
27808224|NCT01938625|54263696|FG000|Overall Study|Adverse Event|0|||
27808225|NCT01938625|54263697|FG001|Overall Study|Adverse Event|1|||
27808226|NCT01975675|54263707|FG000|Overall Study|Death|0|||
27808227|NCT01975675|54263708|FG001|Overall Study|Death|1|||
27808228|NCT01975675|54263709|FG002|Overall Study|Death|0|||
27808229|NCT01975675|54263710|FG003|Overall Study|Death|0|||
27808230|NCT01975285|54263722|FG000|Overall Study|Failed Block and follow up|2|||
27808231|NCT01975285|54263723|FG001|Overall Study|Failed Block and follow up|2|||
27808232|NCT01974895|54263731|FG000|Overall Study|Protocol Violation|1|||
27808233|NCT01974895|54263732|FG001|Overall Study|Protocol Violation|0|||
27845592|NCT01602510|54336493|FG000|Randomized Phase|Physician Decision|0|||
27808234|NCT01974895|54263731|FG000|Overall Study|Lost to Follow-up|4|||
27808235|NCT01974895|54263732|FG001|Overall Study|Lost to Follow-up|6|||
27808236|NCT01974895|54263731|FG000|Overall Study|Withdrawal by Subject|0|||
27808237|NCT01974895|54263732|FG001|Overall Study|Withdrawal by Subject|1|||
27808238|NCT01974895|54263731|FG000|Overall Study|Other (Missed Visit)|1|||
27808239|NCT01974895|54263732|FG001|Overall Study|Other (Missed Visit)|0|||
27808240|NCT01974895|54263731|FG000|Overall Study|Other (Reason unknown)|9|||
27808241|NCT01974895|54263732|FG001|Overall Study|Other (Reason unknown)|8|||
27808242|NCT01974817|54263738|FG000|Overall Study|Death|4|||
27808243|NCT01974817|54263738|FG000|Overall Study|Lost to Follow-up|2|||
27808244|NCT01974817|54263738|FG000|Overall Study|Protocol Violation|2|||
27808245|NCT01915849|54263746|FG000|Treatment Period 1 (4 Days)|Protocol Violation|1|||
27808246|NCT01915849|54263747|FG001|Treatment Period 1 (4 Days)|Protocol Violation|0|||
27808247|NCT01915849|54263748|FG002|Treatment Period 1 (4 Days)|Protocol Violation|0|||
27808248|NCT01915849|54263749|FG003|Treatment Period 1 (4 Days)|Protocol Violation|0|||
27808249|NCT01915849|54263746|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
27808250|NCT01915849|54263747|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
27808251|NCT01915849|54263748|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
27808252|NCT01915849|54263749|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
27808253|NCT01915771|54263759|FG000|Day 1|Withdrawal by Subject|1|||
27845593|NCT01602510|54336494|FG001|Randomized Phase|Physician Decision|0|||
27845594|NCT01602510|54336495|FG002|Randomized Phase|Physician Decision|2|||
27845595|NCT01602510|54336493|FG000|Randomized Phase|Withdrawal by Subject|0|||
27845596|NCT01602510|54336494|FG001|Randomized Phase|Withdrawal by Subject|6|||
27845597|NCT01602510|54336495|FG002|Randomized Phase|Withdrawal by Subject|7|||
27845598|NCT01675596|54336510|FG000|Overall Study|Death|6|||
27845599|NCT01675596|54336510|FG000|Overall Study|Exit with other reason|1|||
27845600|NCT01675596|54336510|FG000|Overall Study|Missed Visit|1|||
27845601|NCT02653326|54336520|FG000|Overall Study|Lost to Follow-up|10|||
27845602|NCT02653326|54336521|FG001|Overall Study|Lost to Follow-up|7|||
27845603|NCT02653170|54336530|FG000|Overall Study|Withdrawal by Subject|3|||
27845604|NCT02653170|54336531|FG001|Overall Study|Withdrawal by Subject|8|||
27845605|NCT02653170|54336532|FG002|Overall Study|Withdrawal by Subject|3|||
27845606|NCT02653170|54336530|FG000|Overall Study|withdrawn by study team|2|||
27845607|NCT02653170|54336531|FG001|Overall Study|withdrawn by study team|4|||
27845608|NCT02653170|54336532|FG002|Overall Study|withdrawn by study team|5|||
27845609|NCT02653170|54336530|FG000|Overall Study|Lost to Follow-up|12|||
27845610|NCT02653170|54336531|FG001|Overall Study|Lost to Follow-up|4|||
27845611|NCT02653170|54336532|FG002|Overall Study|Lost to Follow-up|10|||
27808254|NCT01915771|54263759|FG000|Day 15|Withdrawal by Subject|1|||
27808255|NCT01938391|54263767|FG000|6 Month Follow up|Withdrawal by Subject|1|||
27808256|NCT01938391|54263767|FG000|12 Month Follow up|Physician Decision|1|||
27808257|NCT01938391|54263767|FG000|12 Month Follow up|Withdrawal by Subject|1|||
27808258|NCT01915303|54263771|FG000|Core Phase|Adverse Event|7|||
27845612|NCT01463696|54336552|FG000|Overall Study|Adverse Event|0|||
27845613|NCT01463696|54336553|FG001|Overall Study|Adverse Event|1|||
27845614|NCT01463696|54336554|FG002|Overall Study|Adverse Event|0|||
27845615|NCT01463696|54336555|FG003|Overall Study|Adverse Event|2|||
27845616|NCT01463696|54336556|FG004|Overall Study|Adverse Event|0|||
27845617|NCT01463696|54336557|FG005|Overall Study|Adverse Event|1|||
27845618|NCT01463696|54336558|FG006|Overall Study|Adverse Event|3|||
27845619|NCT01463696|54336559|FG007|Overall Study|Adverse Event|2|||
27845620|NCT01463696|54336552|FG000|Overall Study|Lost to Follow-up|0|||
27845621|NCT01463696|54336553|FG001|Overall Study|Lost to Follow-up|0|||
27845622|NCT01463696|54336554|FG002|Overall Study|Lost to Follow-up|1|||
27845623|NCT01463696|54336555|FG003|Overall Study|Lost to Follow-up|0|||
27845624|NCT01463696|54336556|FG004|Overall Study|Lost to Follow-up|0|||
27845625|NCT01463696|54336557|FG005|Overall Study|Lost to Follow-up|0|||
27845626|NCT01463696|54336558|FG006|Overall Study|Lost to Follow-up|0|||
27845627|NCT01463696|54336559|FG007|Overall Study|Lost to Follow-up|0|||
27845628|NCT01463696|54336552|FG000|Overall Study|Progressive Disease|0|||
27845629|NCT01463696|54336553|FG001|Overall Study|Progressive Disease|1|||
27845630|NCT01463696|54336554|FG002|Overall Study|Progressive Disease|0|||
27845631|NCT01463696|54336555|FG003|Overall Study|Progressive Disease|1|||
27845632|NCT01463696|54336556|FG004|Overall Study|Progressive Disease|0|||
27845633|NCT01463696|54336557|FG005|Overall Study|Progressive Disease|1|||
27845634|NCT01463696|54336558|FG006|Overall Study|Progressive Disease|4|||
27845635|NCT01463696|54336559|FG007|Overall Study|Progressive Disease|2|||
27845636|NCT01463696|54336552|FG000|Overall Study|Withdrawal by Subject|0|||
27845637|NCT01463696|54336553|FG001|Overall Study|Withdrawal by Subject|0|||
27845638|NCT01463696|54336554|FG002|Overall Study|Withdrawal by Subject|0|||
27845639|NCT01463696|54336555|FG003|Overall Study|Withdrawal by Subject|1|||
27845640|NCT01463696|54336556|FG004|Overall Study|Withdrawal by Subject|1|||
27845641|NCT01463696|54336557|FG005|Overall Study|Withdrawal by Subject|1|||
28035011|NCT00673049|54693255|FG001|Before Progression on Erlotinib|Randomized but not treated|1|||
27808259|NCT01915303|54263771|FG000|Core Phase|Unsatisfactory therapeutic effect|3|||
27808260|NCT01915303|54263771|FG000|Core Phase|Death|2|||
27808261|NCT01915303|54263771|FG000|Core Phase|Protocol Violation|2|||
27808262|NCT01915303|54263771|FG000|Core Phase|Abnormal lab value|1|||
27845642|NCT01463696|54336558|FG006|Overall Study|Withdrawal by Subject|2|||
27845643|NCT01463696|54336559|FG007|Overall Study|Withdrawal by Subject|0|||
27845644|NCT01463696|54336552|FG000|Overall Study|Not Treated|0|||
27808263|NCT01915303|54263771|FG000|Core Phase|Withdrawal by Subject|1|||
27845645|NCT01463696|54336553|FG001|Overall Study|Not Treated|0|||
27845646|NCT01463696|54336554|FG002|Overall Study|Not Treated|0|||
27845647|NCT01463696|54336555|FG003|Overall Study|Not Treated|0|||
27845648|NCT01463696|54336556|FG004|Overall Study|Not Treated|0|||
27845649|NCT01463696|54336557|FG005|Overall Study|Not Treated|0|||
27845650|NCT01463696|54336558|FG006|Overall Study|Not Treated|1|||
27845651|NCT01463696|54336559|FG007|Overall Study|Not Treated|0|||
27845652|NCT02653482|54336583|FG000|Overall Study|Death|1|||
27845653|NCT02653482|54336584|FG001|Overall Study|Death|1|||
27845654|NCT01362348|54336590|FG000|Overall Study|Protocol-defined stopping criteria|9|||
27845655|NCT01362348|54336590|FG000|Overall Study|Study closed/terminated|5|||
27845656|NCT01675128|54336660|FG000|Overall Study|Disease progression on study|1|||
27845657|NCT01675128|54336661|FG001|Overall Study|Disease progression on study|1|||
27845658|NCT01675128|54336662|FG002|Overall Study|Disease progression on study|1|||
27845659|NCT01675128|54336660|FG000|Overall Study|Refused further treatment|1|||
27845660|NCT01675128|54336661|FG001|Overall Study|Refused further treatment|0|||
27845661|NCT01675128|54336662|FG002|Overall Study|Refused further treatment|0|||
27845662|NCT01675128|54336660|FG000|Overall Study|Pulmonary complication; off study|0|||
27845663|NCT01675128|54336661|FG001|Overall Study|Pulmonary complication; off study|1|||
27845664|NCT01675128|54336662|FG002|Overall Study|Pulmonary complication; off study|0|||
27845665|NCT01427309|54336708|FG000|Overall Study|Lost to Follow-up|130|||
27845666|NCT01427309|54336709|FG001|Overall Study|Lost to Follow-up|145|||
27845667|NCT01427309|54336710|FG002|Overall Study|Lost to Follow-up|122|||
27845668|NCT01427309|54336711|FG003|Overall Study|Lost to Follow-up|135|||
27845669|NCT01427309|54336708|FG000|Overall Study|Protocol Violation|42|||
27845670|NCT01427309|54336709|FG001|Overall Study|Protocol Violation|69|||
27845671|NCT01427309|54336710|FG002|Overall Study|Protocol Violation|125|||
27845672|NCT01427309|54336711|FG003|Overall Study|Protocol Violation|124|||
27845673|NCT01427309|54336708|FG000|Overall Study|Adverse Event|0|||
27845674|NCT01427309|54336709|FG001|Overall Study|Adverse Event|0|||
27845675|NCT01427309|54336710|FG002|Overall Study|Adverse Event|3|||
27845676|NCT01427309|54336711|FG003|Overall Study|Adverse Event|1|||
27845677|NCT01427309|54336708|FG000|Overall Study|Serious adverse event|52|||
27845678|NCT01427309|54336709|FG001|Overall Study|Serious adverse event|45|||
27845679|NCT01427309|54336710|FG002|Overall Study|Serious adverse event|50|||
27845680|NCT01427309|54336711|FG003|Overall Study|Serious adverse event|61|||
27845681|NCT01427309|54336708|FG000|Overall Study|Withdrawal by Subject|148|||
27845682|NCT01427309|54336709|FG001|Overall Study|Withdrawal by Subject|148|||
27845683|NCT01427309|54336710|FG002|Overall Study|Withdrawal by Subject|61|||
27845684|NCT01427309|54336711|FG003|Overall Study|Withdrawal by Subject|55|||
27845685|NCT01426373|54336721|FG000|Overall Study|Adverse Event|6|||
27845686|NCT01426373|54336721|FG000|Overall Study|Lost to Follow-up|14|||
27845687|NCT01426373|54336721|FG000|Overall Study|Participant Convenience|10|||
27845688|NCT01426373|54336721|FG000|Overall Study|Miscellaneous Reasons|4|||
27845689|NCT01426217|54336729|FG000|Overall Study|lost sample|8|||
27845690|NCT01426217|54336730|FG001|Overall Study|lost sample|14|||
27845691|NCT01425749|54336738|FG000|Overall Study|progression of melanoma|0|||
27845692|NCT01425749|54336739|FG001|Overall Study|progression of melanoma|1|||
27845693|NCT01403987|54336755|FG000|Overall Study|Residents forgot their secret PIN|18|||
27845694|NCT01403987|54336756|FG001|Overall Study|Residents forgot their secret PIN|17|||
27845695|NCT01403987|54336757|FG002|Overall Study|Residents forgot their secret PIN|18|||
27845696|NCT01425359|54336767|FG000|Overall Study|Randomized but Not Treated|2|||
27845697|NCT01425359|54336768|FG001|Overall Study|Randomized but Not Treated|3|||
27845698|NCT01425359|54336767|FG000|Overall Study|Adverse Event|9|||
27845699|NCT01425359|54336768|FG001|Overall Study|Adverse Event|8|||
27845700|NCT01425359|54336767|FG000|Overall Study|Revascularization|0|||
27845701|NCT01425359|54336768|FG001|Overall Study|Revascularization|1|||
27845702|NCT01425359|54336767|FG000|Overall Study|Death|0|||
27845703|NCT01425359|54336768|FG001|Overall Study|Death|1|||
27845704|NCT01425359|54336767|FG000|Overall Study|Unsatisfactory Response|1|||
27845705|NCT01425359|54336768|FG001|Overall Study|Unsatisfactory Response|0|||
27845706|NCT01425359|54336767|FG000|Overall Study|Protocol Violation|1|||
27845707|NCT01425359|54336768|FG001|Overall Study|Protocol Violation|2|||
27845708|NCT01425359|54336767|FG000|Overall Study|Subject Withdrew Consent|1|||
27845709|NCT01425359|54336768|FG001|Overall Study|Subject Withdrew Consent|2|||
27845710|NCT01425359|54336767|FG000|Overall Study|Investigator's Discretion|2|||
27845711|NCT01425359|54336768|FG001|Overall Study|Investigator's Discretion|0|||
27845712|NCT01425359|54336767|FG000|Overall Study|Did Not Meet Qualifying Criteria|3|||
27845713|NCT01425359|54336768|FG001|Overall Study|Did Not Meet Qualifying Criteria|5|||
27845714|NCT01403051|54336788|FG000|Overall Study|Protocol Violation|2|||
27845715|NCT01403051|54336789|FG001|Overall Study|Protocol Violation|0|||
27845716|NCT01403051|54336788|FG000|Overall Study|Death|1|||
27845717|NCT01403051|54336789|FG001|Overall Study|Death|0|||
27845718|NCT01403051|54336788|FG000|Overall Study|Withdrawal by Subject|2|||
27845719|NCT01403051|54336789|FG001|Overall Study|Withdrawal by Subject|1|||
27845720|NCT01403051|54336788|FG000|Overall Study|Lost to Follow-up|5|||
27845721|NCT01403051|54336789|FG001|Overall Study|Lost to Follow-up|5|||
27845722|NCT04115748|54336804|FG000|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
27845723|NCT04115748|54336805|FG001|Main Study (Up to 16 Weeks)|Study terminated by sponsor|16|||
27845724|NCT04115748|54336806|FG002|Main Study (Up to 16 Weeks)|Study terminated by sponsor|7|||
27845725|NCT04115748|54336807|FG003|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
27845726|NCT04115748|54336808|FG004|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
27845727|NCT04115748|54336809|FG005|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
27845728|NCT04115748|54336810|FG006|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
27845729|NCT04115748|54336811|FG007|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
27845730|NCT04115748|54336812|FG008|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
27845731|NCT04115748|54336813|FG009|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
27845732|NCT04115748|54336804|FG000|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
27845733|NCT04115748|54336805|FG001|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
27845734|NCT04115748|54336806|FG002|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
27845735|NCT04115748|54336807|FG003|Main Study (Up to 16 Weeks)|Withdrew consent|1|||
27845736|NCT04115748|54336808|FG004|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
27845737|NCT04115748|54336809|FG005|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
27845738|NCT04115748|54336810|FG006|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
27845739|NCT04115748|54336811|FG007|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
27845740|NCT04115748|54336812|FG008|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
27845741|NCT04115748|54336813|FG009|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
27845742|NCT04115748|54336804|FG000|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
27845743|NCT04115748|54336805|FG001|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
27845744|NCT04115748|54336806|FG002|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
27845745|NCT04115748|54336807|FG003|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
27845746|NCT04115748|54336808|FG004|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|4|||
27845747|NCT04115748|54336809|FG005|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|3|||
27845748|NCT04115748|54336810|FG006|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
27845749|NCT04115748|54336811|FG007|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
27808264|NCT01915303|54263771|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
27808265|NCT01915303|54263771|FG000|Extension Phase|Withdrawal by Subject|4|||
27808266|NCT01915303|54263771|FG000|Extension Phase|Adverse Event|3|||
27808267|NCT01915303|54263771|FG000|Extension Phase|Death|1|||
27808268|NCT01915303|54263771|FG000|Extension Phase|Protocol Violation|1|||
27808269|NCT01987427|54263778|FG000|Overall Study|Adverse Event|4|||
27808270|NCT01987427|54263779|FG001|Overall Study|Adverse Event|2|||
27808271|NCT01987427|54263780|FG002|Overall Study|Adverse Event|8|||
27845750|NCT04115748|54336812|FG008|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
27845751|NCT04115748|54336813|FG009|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|2|||
27845752|NCT04115748|54336804|FG000|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
27845753|NCT04115748|54336805|FG001|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
27845754|NCT04115748|54336806|FG002|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
27845755|NCT04115748|54336807|FG003|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
27845756|NCT04115748|54336808|FG004|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
27845757|NCT04115748|54336809|FG005|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
27845758|NCT04115748|54336810|FG006|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
27845759|NCT04115748|54336811|FG007|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
27845760|NCT04115748|54336812|FG008|LTE (After 16 Weeks to Week 50)|Adverse Event|1|||
27845761|NCT04115748|54336813|FG009|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
27845762|NCT02652624|54336870|FG000|Randomized Phase|Pregnancy|3|||
27939795|NCT01227902|54596125|FG001|Overall Study|Protocol Violation|0|||
27939796|NCT01227902|54596126|FG002|Overall Study|Protocol Violation|0|||
27808272|NCT01987427|54263778|FG000|Overall Study|Lost to Follow-up|6|||
27808273|NCT01987427|54263779|FG001|Overall Study|Lost to Follow-up|6|||
27808274|NCT01987427|54263780|FG002|Overall Study|Lost to Follow-up|9|||
27808275|NCT01987427|54263778|FG000|Overall Study|Withdrawal by Subject|2|||
27808276|NCT01987427|54263779|FG001|Overall Study|Withdrawal by Subject|1|||
27808277|NCT01987427|54263780|FG002|Overall Study|Withdrawal by Subject|3|||
27808278|NCT01987427|54263778|FG000|Overall Study|Lack of Efficacy|1|||
27808279|NCT01987427|54263779|FG001|Overall Study|Lack of Efficacy|0|||
27808280|NCT01987427|54263780|FG002|Overall Study|Lack of Efficacy|0|||
27808281|NCT01987427|54263778|FG000|Overall Study|Other|1|||
27808282|NCT01987427|54263779|FG001|Overall Study|Other|1|||
27808283|NCT01987427|54263780|FG002|Overall Study|Other|0|||
27808284|NCT01937299|54263790|FG000|Overall Study|Adverse Event|13|||
27808285|NCT01937299|54263791|FG001|Overall Study|Adverse Event|0|||
27808286|NCT01937299|54263790|FG000|Overall Study|Lack of Efficacy|0|||
27808287|NCT01937299|54263791|FG001|Overall Study|Lack of Efficacy|4|||
27808288|NCT01937299|54263790|FG000|Overall Study|Withdrawal by Subject|1|||
27808289|NCT01937299|54263791|FG001|Overall Study|Withdrawal by Subject|0|||
27808290|NCT02003963|54263800|FG000|Overall Study|Lost to Follow-up|2|||
27808291|NCT02003963|54263801|FG001|Overall Study|Lost to Follow-up|1|||
27808292|NCT01606761|54263812|FG000|Prior to Week 24|Lost to Follow-up|0|||
27808293|NCT01606761|54263813|FG001|Prior to Week 24|Lost to Follow-up|3|||
27808294|NCT01606761|54263814|FG002|Prior to Week 24|Lost to Follow-up|2|||
27845763|NCT02652624|54336871|FG001|Randomized Phase|Pregnancy|1|||
27845764|NCT02652624|54336870|FG000|Randomized Phase|Investigator's Discretion|0|||
27845765|NCT02652624|54336871|FG001|Randomized Phase|Investigator's Discretion|2|||
27845766|NCT02652624|54336870|FG000|Randomized Phase|Death|0|||
27845767|NCT02652624|54336871|FG001|Randomized Phase|Death|1|||
27845768|NCT02652624|54336870|FG000|Randomized Phase|Lost to Follow-up|0|||
27845769|NCT02652624|54336871|FG001|Randomized Phase|Lost to Follow-up|1|||
27808295|NCT01606761|54263815|FG003|Prior to Week 24|Lost to Follow-up|0|||
27808296|NCT01606761|54263816|FG004|Prior to Week 24|Lost to Follow-up|0|||
27845770|NCT02652624|54336870|FG000|Extension Phase|Lost to Follow-up|3|||
27845771|NCT02652624|54336871|FG001|Extension Phase|Lost to Follow-up|1|||
27845772|NCT02652624|54336870|FG000|Extension Phase|Pregnancy|1|||
27845773|NCT02652624|54336871|FG001|Extension Phase|Pregnancy|1|||
27845774|NCT02652624|54336870|FG000|Extension Phase|Adverse Event|0|||
27845775|NCT02652624|54336871|FG001|Extension Phase|Adverse Event|1|||
27845776|NCT02652624|54336870|FG000|Extension Phase|Withdrew Consent|0|||
27845777|NCT02652624|54336871|FG001|Extension Phase|Withdrew Consent|1|||
27845778|NCT00249795|54336881|FG000|Overall Study|Not treated|16|||
27845779|NCT00249795|54336882|FG001|Overall Study|Not treated|14|||
27845780|NCT00249795|54336881|FG000|Overall Study|Symptomatic hypotension|127|||
27845781|NCT00249795|54336882|FG001|Overall Study|Symptomatic hypotension|64|||
27845782|NCT00249795|54336881|FG000|Overall Study|Other Serious Adverse Event|84|||
27845783|NCT00249795|54336882|FG001|Overall Study|Other Serious Adverse Event|93|||
27845784|NCT00249795|54336881|FG000|Overall Study|Qualifying condition not present|26|||
27845785|NCT00249795|54336882|FG001|Overall Study|Qualifying condition not present|29|||
27845786|NCT00249795|54336881|FG000|Overall Study|Withdrawal by Subject|678|||
27845787|NCT00249795|54336882|FG001|Overall Study|Withdrawal by Subject|742|||
27845788|NCT00249795|54336881|FG000|Overall Study|Thromboembolic / outcome event|39|||
27845789|NCT00249795|54336882|FG001|Overall Study|Thromboembolic / outcome event|45|||
27845790|NCT00249795|54336881|FG000|Overall Study|Oral anticoagulant required|2|||
27845791|NCT00249795|54336882|FG001|Overall Study|Oral anticoagulant required|0|||
27845792|NCT00249795|54336881|FG000|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7|||
27845793|NCT00249795|54336882|FG001|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3|||
27845794|NCT00249795|54336881|FG000|Overall Study|Non-compliance|71|||
27845795|NCT00249795|54336882|FG001|Overall Study|Non-compliance|69|||
27845796|NCT00249795|54336881|FG000|Overall Study|Study drug intolerance|3|||
27845797|NCT00249795|54336882|FG001|Overall Study|Study drug intolerance|3|||
27845798|NCT00249795|54336881|FG000|Overall Study|Other adverse events (non-serious)|188|||
27845799|NCT00249795|54336882|FG001|Overall Study|Other adverse events (non-serious)|159|||
27845800|NCT00249795|54336881|FG000|Overall Study|Physician withdrew consent|71|||
27845801|NCT00249795|54336882|FG001|Overall Study|Physician withdrew consent|63|||
27845802|NCT00249795|54336881|FG000|Overall Study|Surgery / procedure|4|||
27845803|NCT00249795|54336882|FG001|Overall Study|Surgery / procedure|5|||
27845804|NCT00249795|54336881|FG000|Overall Study|Angiotensin II receptor blocker required|35|||
27845805|NCT00249795|54336882|FG001|Overall Study|Angiotensin II receptor blocker required|58|||
27845806|NCT00249795|54336881|FG000|Overall Study|Lightheadedness / dizziness|15|||
27845807|NCT00249795|54336882|FG001|Overall Study|Lightheadedness / dizziness|11|||
27845808|NCT00249795|54336881|FG000|Overall Study|Hypotension (non-symptomatic)|5|||
27845809|NCT00249795|54336882|FG001|Overall Study|Hypotension (non-symptomatic)|5|||
27845810|NCT00249795|54336881|FG000|Overall Study|Other contraindicated medication|1|||
27845811|NCT00249795|54336882|FG001|Overall Study|Other contraindicated medication|1|||
27845812|NCT00249795|54336881|FG000|Overall Study|Event related to cardiac condition|17|||
27845813|NCT00249795|54336882|FG001|Overall Study|Event related to cardiac condition|16|||
27808297|NCT01606761|54263812|FG000|Prior to Week 24|Withdrawal by Subject|12|||
27808298|NCT01606761|54263813|FG001|Prior to Week 24|Withdrawal by Subject|10|||
27808299|NCT01606761|54263814|FG002|Prior to Week 24|Withdrawal by Subject|9|||
27808300|NCT01606761|54263815|FG003|Prior to Week 24|Withdrawal by Subject|0|||
27808301|NCT01606761|54263816|FG004|Prior to Week 24|Withdrawal by Subject|0|||
27808302|NCT01606761|54263812|FG000|Prior to Week 24|Adverse Event|11|||
27808303|NCT01606761|54263813|FG001|Prior to Week 24|Adverse Event|18|||
27808304|NCT01606761|54263814|FG002|Prior to Week 24|Adverse Event|22|||
27808305|NCT01606761|54263815|FG003|Prior to Week 24|Adverse Event|0|||
27808306|NCT01606761|54263816|FG004|Prior to Week 24|Adverse Event|0|||
27808307|NCT01606761|54263812|FG000|Prior to Week 24|Lack of Efficacy|15|||
27808308|NCT01606761|54263813|FG001|Prior to Week 24|Lack of Efficacy|14|||
27808309|NCT01606761|54263814|FG002|Prior to Week 24|Lack of Efficacy|8|||
27808310|NCT01606761|54263815|FG003|Prior to Week 24|Lack of Efficacy|0|||
27845814|NCT00249795|54336881|FG000|Overall Study|Patient not wish to continue after May08|4|||
27845815|NCT00249795|54336882|FG001|Overall Study|Patient not wish to continue after May08|6|||
27845816|NCT00249795|54336881|FG000|Overall Study|Site not agree to continue after May08|1|||
27845817|NCT00249795|54336882|FG001|Overall Study|Site not agree to continue after May08|1|||
27845818|NCT00249795|54336881|FG000|Overall Study|Lost to Follow-up|0|||
27845819|NCT00249795|54336882|FG001|Overall Study|Lost to Follow-up|2|||
27845820|NCT00249795|54336881|FG000|Overall Study|Missing|0|||
27808311|NCT01606761|54263816|FG004|Prior to Week 24|Lack of Efficacy|0|||
27845821|NCT00249795|54336882|FG001|Overall Study|Missing|1|||
27845822|NCT02651220|54336891|FG000|Overall Study|Adverse Event|1|||
27845823|NCT02651220|54336892|FG001|Overall Study|Adverse Event|5|||
27845824|NCT02651220|54336893|FG002|Overall Study|Adverse Event|1|||
27845825|NCT02651220|54336891|FG000|Overall Study|Lost to Follow-up|8|||
27845826|NCT02651220|54336892|FG001|Overall Study|Lost to Follow-up|14|||
27845827|NCT02651220|54336893|FG002|Overall Study|Lost to Follow-up|14|||
27845828|NCT02651220|54336891|FG000|Overall Study|Non-Compliance with Study Drug|4|||
27845829|NCT02651220|54336892|FG001|Overall Study|Non-Compliance with Study Drug|0|||
27845830|NCT02651220|54336893|FG002|Overall Study|Non-Compliance with Study Drug|1|||
27845831|NCT02651220|54336891|FG000|Overall Study|Pregnancy|1|||
27845832|NCT02651220|54336892|FG001|Overall Study|Pregnancy|0|||
27845833|NCT02651220|54336893|FG002|Overall Study|Pregnancy|1|||
27845834|NCT02651220|54336891|FG000|Overall Study|Protocol Violation|0|||
27845835|NCT02651220|54336892|FG001|Overall Study|Protocol Violation|0|||
27845836|NCT02651220|54336893|FG002|Overall Study|Protocol Violation|1|||
27845837|NCT02651220|54336891|FG000|Overall Study|Withdrawal by Subject|5|||
27845838|NCT02651220|54336892|FG001|Overall Study|Withdrawal by Subject|6|||
27845839|NCT02651220|54336893|FG002|Overall Study|Withdrawal by Subject|8|||
27845840|NCT02651220|54336891|FG000|Overall Study|Miscellaneous|4|||
27845841|NCT02651220|54336892|FG001|Overall Study|Miscellaneous|1|||
27845842|NCT02651220|54336893|FG002|Overall Study|Miscellaneous|2|||
27845843|NCT02651220|54336891|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
27845844|NCT02651220|54336892|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
27845845|NCT02651220|54336893|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
27845846|NCT00247611|54336941|FG000|Baselined|Completed baseline, never placed on ARVs|8|||
27845847|NCT00247611|54336942|FG001|Baselined|Completed baseline, never placed on ARVs|5|||
27845848|NCT00247611|54336941|FG000|Baselined|Completed baseline only|9|||
27845849|NCT00247611|54336942|FG001|Baselined|Completed baseline only|8|||
27845850|NCT00246753|54336958|FG000|Overall Study|Withdrawal by Subject|2|||
27845851|NCT00246753|54336958|FG000|Overall Study|Physician Decision|2|||
27845852|NCT00246753|54336958|FG000|Overall Study|Adverse Event|2|||
27845853|NCT00246753|54336958|FG000|Overall Study|Unacceptable toxicity|2|||
27845854|NCT00246129|54336975|FG000|Overall Study|Lost to Follow-up|1|||
27845855|NCT00246129|54336976|FG001|Overall Study|Lost to Follow-up|0|||
27845856|NCT00246129|54336975|FG000|Overall Study|Death|2|||
27845857|NCT00246129|54336976|FG001|Overall Study|Death|1|||
27845858|NCT00246129|54336975|FG000|Overall Study|suffered primary non-function|1|||
27845859|NCT00246129|54336976|FG001|Overall Study|suffered primary non-function|0|||
27845860|NCT00246129|54336975|FG000|Overall Study|grafts failed|3|||
27845861|NCT00246129|54336976|FG001|Overall Study|grafts failed|1|||
27845862|NCT03182868|54336999|FG000|Overall Study|Protocol Violation|3|||
27845863|NCT03182868|54337000|FG001|Overall Study|Protocol Violation|0|||
27845864|NCT03182868|54337001|FG002|Overall Study|Protocol Violation|4|||
27845865|NCT03182868|54337002|FG003|Overall Study|Protocol Violation|1|||
27845866|NCT03182868|54337003|FG004|Overall Study|Protocol Violation|8|||
27845867|NCT00245583|54337027|FG000|Overall Study|Lost to Follow-up|1|||
27845868|NCT00245583|54337028|FG001|Overall Study|Lost to Follow-up|5|||
27845869|NCT00245583|54337027|FG000|Overall Study|Adverse Event|2|||
27845870|NCT00245583|54337028|FG001|Overall Study|Adverse Event|1|||
27845871|NCT00245583|54337027|FG000|Overall Study|Lack of Efficacy|1|||
27845872|NCT00245583|54337028|FG001|Overall Study|Lack of Efficacy|0|||
27845873|NCT00245583|54337027|FG000|Overall Study|Withdrawal by Subject|2|||
27845874|NCT00245583|54337028|FG001|Overall Study|Withdrawal by Subject|3|||
27845875|NCT02652156|54337048|FG000|Overall Study|Physician Decision|1|||
27845876|NCT02652156|54337049|FG001|Overall Study|Physician Decision|0|||
27808312|NCT01606761|54263812|FG000|Prior to Week 24|Physician Decision|0|||
27808313|NCT01606761|54263813|FG001|Prior to Week 24|Physician Decision|3|||
27808314|NCT01606761|54263814|FG002|Prior to Week 24|Physician Decision|1|||
27808315|NCT01606761|54263815|FG003|Prior to Week 24|Physician Decision|0|||
27808316|NCT01606761|54263816|FG004|Prior to Week 24|Physician Decision|0|||
27808317|NCT01606761|54263812|FG000|Prior to Week 24|Other|4|||
27808318|NCT01606761|54263813|FG001|Prior to Week 24|Other|7|||
27845877|NCT02652156|54337050|FG002|Overall Study|Physician Decision|0|||
27808319|NCT01606761|54263814|FG002|Prior to Week 24|Other|5|||
27845878|NCT01675050|54337097|FG000|Period One Treatment|Withdrawal by Subject|1|||
27845879|NCT01675050|54337098|FG001|Period One Treatment|Withdrawal by Subject|0|||
27845880|NCT00244881|54337117|FG000|Overall Study|Withdrawal by Subject|3|||
27845881|NCT00244725|54337148|FG000|Overall Study|Lost to Follow-up|3|||
27845882|NCT00244725|54337149|FG001|Overall Study|Lost to Follow-up|4|||
27939797|NCT01227902|54596127|FG003|Overall Study|Protocol Violation|0|||
27845883|NCT00244725|54337150|FG002|Overall Study|Lost to Follow-up|9|||
27845884|NCT00244725|54337151|FG003|Overall Study|Lost to Follow-up|2|||
27845885|NCT00244725|54337148|FG000|Overall Study|Withdrawal by Subject|9|||
27845886|NCT00244725|54337149|FG001|Overall Study|Withdrawal by Subject|7|||
27845887|NCT00244725|54337150|FG002|Overall Study|Withdrawal by Subject|7|||
27845888|NCT00244725|54337151|FG003|Overall Study|Withdrawal by Subject|8|||
27845889|NCT00244725|54337148|FG000|Overall Study|Not meet treatment eligibility criteria|1|||
27808320|NCT01606761|54263815|FG003|Prior to Week 24|Other|0|||
27845890|NCT00244725|54337149|FG001|Overall Study|Not meet treatment eligibility criteria|2|||
27845891|NCT00244725|54337150|FG002|Overall Study|Not meet treatment eligibility criteria|0|||
27845892|NCT00244725|54337151|FG003|Overall Study|Not meet treatment eligibility criteria|0|||
27845893|NCT00244725|54337148|FG000|Overall Study|Physician Decision|3|||
27845894|NCT00244725|54337149|FG001|Overall Study|Physician Decision|0|||
27845895|NCT00244725|54337150|FG002|Overall Study|Physician Decision|1|||
27845896|NCT00244725|54337151|FG003|Overall Study|Physician Decision|2|||
27845897|NCT00244725|54337148|FG000|Overall Study|Adverse Events|3|||
27845898|NCT00244725|54337149|FG001|Overall Study|Adverse Events|1|||
27845899|NCT00244725|54337150|FG002|Overall Study|Adverse Events|4|||
27845900|NCT00244725|54337151|FG003|Overall Study|Adverse Events|4|||
27845901|NCT00244725|54337148|FG000|Overall Study|Withdrwal by participant|1|||
27845902|NCT00244725|54337149|FG001|Overall Study|Withdrwal by participant|0|||
27845903|NCT00244725|54337150|FG002|Overall Study|Withdrwal by participant|0|||
27845904|NCT00244725|54337151|FG003|Overall Study|Withdrwal by participant|1|||
27845905|NCT00244725|54337148|FG000|Overall Study|Liver function test abnormality|2|||
27845906|NCT00244725|54337149|FG001|Overall Study|Liver function test abnormality|0|||
27845907|NCT00244725|54337150|FG002|Overall Study|Liver function test abnormality|0|||
27845908|NCT00244725|54337151|FG003|Overall Study|Liver function test abnormality|1|||
27845909|NCT00244725|54337148|FG000|Overall Study|Sponsor withdrew the participant|1|||
27845910|NCT00244725|54337149|FG001|Overall Study|Sponsor withdrew the participant|0|||
27845911|NCT00244725|54337150|FG002|Overall Study|Sponsor withdrew the participant|0|||
27845912|NCT00244725|54337151|FG003|Overall Study|Sponsor withdrew the participant|1|||
27845913|NCT00244725|54337148|FG000|Overall Study|Mediciation Error|0|||
27845914|NCT00244725|54337149|FG001|Overall Study|Mediciation Error|1|||
27845915|NCT00244725|54337150|FG002|Overall Study|Mediciation Error|0|||
27845916|NCT00244725|54337151|FG003|Overall Study|Mediciation Error|0|||
27845917|NCT00244725|54337148|FG000|Overall Study|Rehab Refused to allow participantion|0|||
27845918|NCT00244725|54337149|FG001|Overall Study|Rehab Refused to allow participantion|1|||
27845919|NCT00244725|54337150|FG002|Overall Study|Rehab Refused to allow participantion|0|||
27845920|NCT00244725|54337151|FG003|Overall Study|Rehab Refused to allow participantion|0|||
27845921|NCT00244725|54337148|FG000|Overall Study|Headache|0|||
27845922|NCT00244725|54337149|FG001|Overall Study|Headache|1|||
27845923|NCT00244725|54337150|FG002|Overall Study|Headache|0|||
27845924|NCT00244725|54337151|FG003|Overall Study|Headache|0|||
27845925|NCT00244725|54337148|FG000|Overall Study|Received prohibited medication|0|||
27845926|NCT00244725|54337149|FG001|Overall Study|Received prohibited medication|1|||
27845927|NCT00244725|54337150|FG002|Overall Study|Received prohibited medication|0|||
27845928|NCT00244725|54337151|FG003|Overall Study|Received prohibited medication|1|||
27845929|NCT00244725|54337148|FG000|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
27845930|NCT00244725|54337149|FG001|Overall Study|Confirmed venous thromboembolism (VTE)|1|||
27845931|NCT00244725|54337150|FG002|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
27845932|NCT00244725|54337151|FG003|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
27845933|NCT00244725|54337148|FG000|Overall Study|Administrative reason|0|||
27845934|NCT00244725|54337149|FG001|Overall Study|Administrative reason|0|||
27845935|NCT00244725|54337150|FG002|Overall Study|Administrative reason|1|||
27845936|NCT00244725|54337151|FG003|Overall Study|Administrative reason|0|||
27845937|NCT00244725|54337148|FG000|Overall Study|Vomit|0|||
27845938|NCT00244725|54337149|FG001|Overall Study|Vomit|0|||
27845939|NCT00244725|54337150|FG002|Overall Study|Vomit|1|||
27845940|NCT00244725|54337151|FG003|Overall Study|Vomit|0|||
27845941|NCT00244725|54337148|FG000|Overall Study|Failed to follow-up|0|||
27845942|NCT00244725|54337149|FG001|Overall Study|Failed to follow-up|0|||
27845943|NCT00244725|54337150|FG002|Overall Study|Failed to follow-up|1|||
27845944|NCT00244725|54337151|FG003|Overall Study|Failed to follow-up|1|||
27845945|NCT02649894|54337163|FG000|Overall Study|Adverse Event|1|||
27845946|NCT02649894|54337164|FG001|Overall Study|Adverse Event|0|||
27845947|NCT02649894|54337163|FG000|Overall Study|Physician Decision|0|||
27845948|NCT02649894|54337164|FG001|Overall Study|Physician Decision|1|||
27845949|NCT02649894|54337163|FG000|Overall Study|Withdrawal by Subject|5|||
27845950|NCT02649894|54337164|FG001|Overall Study|Withdrawal by Subject|2|||
27845951|NCT02649894|54337163|FG000|Overall Study|Lost to Follow-up|2|||
27845952|NCT02649894|54337164|FG001|Overall Study|Lost to Follow-up|1|||
27845953|NCT02649894|54337163|FG000|Overall Study|Death|30|||
27845954|NCT02649894|54337164|FG001|Overall Study|Death|7|||
27845955|NCT02649894|54337163|FG000|Overall Study|Other, not specified|6|||
27845956|NCT02649894|54337164|FG001|Overall Study|Other, not specified|0|||
27845957|NCT01278615|54337170|FG000|Overall Study|Withdrawal by Subject|2|||
27845958|NCT01505114|54337196|FG000|Overall Study|Withdrawal by Subject|5|||
27845959|NCT01505114|54337197|FG001|Overall Study|Withdrawal by Subject|4|||
27845960|NCT01505114|54337198|FG002|Overall Study|Withdrawal by Subject|4|||
27845961|NCT01505114|54337199|FG003|Overall Study|Withdrawal by Subject|7|||
27845962|NCT01505114|54337196|FG000|Overall Study|Death|1|||
27845963|NCT01505114|54337197|FG001|Overall Study|Death|0|||
27845964|NCT01505114|54337198|FG002|Overall Study|Death|0|||
27845965|NCT01505114|54337199|FG003|Overall Study|Death|1|||
27845966|NCT01505114|54337196|FG000|Overall Study|unable to adhere to visit schedule|3|||
27845967|NCT01505114|54337197|FG001|Overall Study|unable to adhere to visit schedule|2|||
27845968|NCT01505114|54337198|FG002|Overall Study|unable to adhere to visit schedule|3|||
27845969|NCT01505114|54337199|FG003|Overall Study|unable to adhere to visit schedule|3|||
27845970|NCT01505114|54337196|FG000|Overall Study|Lost to Follow-up|11|||
27845971|NCT01505114|54337197|FG001|Overall Study|Lost to Follow-up|5|||
27845972|NCT01505114|54337198|FG002|Overall Study|Lost to Follow-up|8|||
27845973|NCT01505114|54337199|FG003|Overall Study|Lost to Follow-up|7|||
27845974|NCT01505114|54337196|FG000|Overall Study|relocated|4|||
27845975|NCT01505114|54337197|FG001|Overall Study|relocated|2|||
27845976|NCT01505114|54337198|FG002|Overall Study|relocated|2|||
27845977|NCT01505114|54337199|FG003|Overall Study|relocated|3|||
27845978|NCT01505114|54337196|FG000|Overall Study|inadvertent enrollment due to peanut all|0|||
27845979|NCT01505114|54337197|FG001|Overall Study|inadvertent enrollment due to peanut all|0|||
27845980|NCT01505114|54337198|FG002|Overall Study|inadvertent enrollment due to peanut all|0|||
27845981|NCT01505114|54337199|FG003|Overall Study|inadvertent enrollment due to peanut all|1|||
27845982|NCT01505114|54337196|FG000|Overall Study|staff safety concerns|0|||
27845983|NCT01505114|54337197|FG001|Overall Study|staff safety concerns|0|||
27845984|NCT01505114|54337198|FG002|Overall Study|staff safety concerns|0|||
27845985|NCT01505114|54337199|FG003|Overall Study|staff safety concerns|1|||
27845986|NCT01505114|54337196|FG000|Overall Study|investigator decision|1|||
27845987|NCT01505114|54337197|FG001|Overall Study|investigator decision|0|||
27845988|NCT01505114|54337198|FG002|Overall Study|investigator decision|1|||
27845989|NCT01505114|54337199|FG003|Overall Study|investigator decision|0|||
27845990|NCT02651922|54337231|FG000|Overall Study|due to exclusion criteria|2|||
27845991|NCT01277757|54337235|FG000|Overall Study|Disease Progression|1|||
27845992|NCT01277757|54337235|FG000|Overall Study|Withdrawal by Subject|1|||
27845993|NCT01276821|54337241|FG000|Overall Study|Protocol Violation|0|||
27845994|NCT01276821|54337242|FG001|Overall Study|Protocol Violation|1|||
27845995|NCT00245037|54337248|FG000|Overall Study|Death|17|||
27845996|NCT00241839|54337254|FG000|Overall Study|Withdrawal by Subject|18|||
27845997|NCT00241839|54337255|FG001|Overall Study|Withdrawal by Subject|17|||
27845998|NCT00241839|54337254|FG000|Overall Study|Adverse Event|1|||
27845999|NCT00241839|54337255|FG001|Overall Study|Adverse Event|1|||
27846000|NCT02651688|54337264|FG000|Overall Study|Non-compliance|0|||
27846001|NCT02651688|54337265|FG001|Overall Study|Non-compliance|0|||
27846002|NCT02651688|54337266|FG002|Overall Study|Non-compliance|1|||
27846003|NCT02651688|54337264|FG000|Overall Study|Principal Investigator (PI) decision|0|||
27846004|NCT02651688|54337265|FG001|Overall Study|Principal Investigator (PI) decision|2|||
27846005|NCT02651688|54337266|FG002|Overall Study|Principal Investigator (PI) decision|0|||
27846006|NCT02651688|54337264|FG000|Overall Study|Lost to Follow-up|1|||
27846007|NCT02651688|54337265|FG001|Overall Study|Lost to Follow-up|3|||
27846008|NCT02651688|54337266|FG002|Overall Study|Lost to Follow-up|0|||
27846009|NCT02651688|54337264|FG000|Overall Study|Withdrawal by Subject|1|||
27846010|NCT02651688|54337265|FG001|Overall Study|Withdrawal by Subject|0|||
27846011|NCT02651688|54337266|FG002|Overall Study|Withdrawal by Subject|2|||
27846012|NCT01276353|54337276|FG000|Double-blind|Adverse Event|2|||
27846013|NCT01276353|54337277|FG001|Double-blind|Adverse Event|0|||
27846014|NCT01276353|54337276|FG000|Double-blind|Withdrawal by Subject|1|||
27846015|NCT01276353|54337277|FG001|Double-blind|Withdrawal by Subject|0|||
27808321|NCT01606761|54263816|FG004|Prior to Week 24|Other|0|||
27808322|NCT01606761|54263812|FG000|Week 24 to Week 52|Lost to Follow-up|0|||
27808323|NCT01606761|54263813|FG001|Week 24 to Week 52|Lost to Follow-up|1|||
27808324|NCT01606761|54263814|FG002|Week 24 to Week 52|Lost to Follow-up|1|||
27808325|NCT01606761|54263815|FG003|Week 24 to Week 52|Lost to Follow-up|1|||
27808326|NCT01606761|54263816|FG004|Week 24 to Week 52|Lost to Follow-up|0|||
27808327|NCT01606761|54263812|FG000|Week 24 to Week 52|Withdrawal by Subject|0|||
27808328|NCT01606761|54263813|FG001|Week 24 to Week 52|Withdrawal by Subject|6|||
27808329|NCT01606761|54263814|FG002|Week 24 to Week 52|Withdrawal by Subject|3|||
27808330|NCT01606761|54263815|FG003|Week 24 to Week 52|Withdrawal by Subject|0|||
27808331|NCT01606761|54263816|FG004|Week 24 to Week 52|Withdrawal by Subject|0|||
27808332|NCT01606761|54263812|FG000|Week 24 to Week 52|Adverse Event|0|||
27808333|NCT01606761|54263813|FG001|Week 24 to Week 52|Adverse Event|11|||
27808334|NCT01606761|54263814|FG002|Week 24 to Week 52|Adverse Event|14|||
27808335|NCT01606761|54263815|FG003|Week 24 to Week 52|Adverse Event|3|||
27808336|NCT01606761|54263816|FG004|Week 24 to Week 52|Adverse Event|15|||
27808337|NCT01606761|54263812|FG000|Week 24 to Week 52|Death|0|||
27846016|NCT01276353|54337276|FG000|Extension|Adverse Event|2|||
27846017|NCT01276353|54337277|FG001|Extension|Adverse Event|5|||
27846018|NCT01276353|54337276|FG000|Extension|Withdrawal by Subject|1|||
27808338|NCT01606761|54263813|FG001|Week 24 to Week 52|Death|0|||
27846019|NCT01276353|54337277|FG001|Extension|Withdrawal by Subject|2|||
27846020|NCT01276353|54337276|FG000|Extension|Withdrawal of study drug 4 days in a row|3|||
27846021|NCT01276353|54337277|FG001|Extension|Withdrawal of study drug 4 days in a row|1|||
27846022|NCT01276353|54337276|FG000|Extension|Physician Decision|1|||
27846023|NCT01276353|54337277|FG001|Extension|Physician Decision|0|||
27846024|NCT01276353|54337276|FG000|Extension|Prohibited concomitant medications|0|||
27846025|NCT01276353|54337277|FG001|Extension|Prohibited concomitant medications|1|||
27846026|NCT02536794|54337312|FG000|Reached 1st Response Assessment|Adverse Event|2|||
27846027|NCT02536794|54337312|FG000|Reached 1st Response Assessment|Progressive Disease|2|||
27846028|NCT02536794|54337312|FG000|Reached 1st Response Assessment|Withdrawal by Subject|1|||
27846029|NCT02536794|54337312|FG000|Reached 1st Response Assessment|Protocol Violation|1|||
27846030|NCT02536794|54337312|FG000|Continued Treatment After 1st Response|Progressive disease|7|||
27846031|NCT02536794|54337312|FG000|Continued Treatment After 1st Response|Adverse Event|1|||
27846032|NCT01480076|54337391|FG000|Overall Study|Run-in Failure|52|||
27846033|NCT01480076|54337391|FG000|Overall Study|Adverse Event|39|||
27846034|NCT01480076|54337391|FG000|Overall Study|Death|2|||
27846035|NCT01480076|54337391|FG000|Overall Study|Disease Progression|5|||
27846036|NCT01480076|54337391|FG000|Overall Study|Non-compliance With Study Protocol|15|||
27846037|NCT01480076|54337391|FG000|Overall Study|Withdrawal by Subject|105|||
27846038|NCT01480076|54337391|FG000|Overall Study|Lost to Follow-up|7|||
27846039|NCT01480076|54337391|FG000|Overall Study|Investigator Decision|13|||
27846040|NCT01480076|54337391|FG000|Overall Study|Other|52|||
27846041|NCT02650128|54337479|FG000|Overall Study|Death|2|||
27846042|NCT01362270|54337494|FG000|Overall Study|Withdrawal by Subject|1|||
27846043|NCT01362270|54337495|FG001|Overall Study|Withdrawal by Subject|0|||
27846044|NCT01362270|54337494|FG000|Overall Study|Met exclusion criteria after 1st session|0|||
27846045|NCT01362270|54337495|FG001|Overall Study|Met exclusion criteria after 1st session|1|||
27846046|NCT01362270|54337494|FG000|Overall Study|Met excl. criteria before 1st session|1|||
27846047|NCT01362270|54337495|FG001|Overall Study|Met excl. criteria before 1st session|1|||
27846048|NCT00089479|54337516|FG000|Overall Study|Death|108|||
27846049|NCT00089479|54337517|FG001|Overall Study|Death|75|||
27846050|NCT00089479|54337516|FG000|Overall Study|Withdrawal by Subject|86|||
27846051|NCT00089479|54337517|FG001|Overall Study|Withdrawal by Subject|107|||
27846052|NCT00089479|54337516|FG000|Overall Study|Lost to Follow-up|137|||
27846053|NCT00089479|54337517|FG001|Overall Study|Lost to Follow-up|107|||
27846054|NCT01463306|54337526|FG000|Overall Study|Adverse Event|6|||
27846055|NCT01463306|54337527|FG001|Overall Study|Adverse Event|9|||
27846056|NCT01463306|54337528|FG002|Overall Study|Adverse Event|3|||
27846057|NCT01463306|54337526|FG000|Overall Study|Death|3|||
27846058|NCT01463306|54337527|FG001|Overall Study|Death|3|||
27846059|NCT01463306|54337528|FG002|Overall Study|Death|0|||
27846060|NCT01463306|54337526|FG000|Overall Study|Lack of Efficacy|22|||
27846061|NCT01463306|54337527|FG001|Overall Study|Lack of Efficacy|16|||
27846062|NCT01463306|54337528|FG002|Overall Study|Lack of Efficacy|1|||
27846063|NCT01463306|54337526|FG000|Overall Study|Lost to Follow-up|5|||
27846064|NCT01463306|54337527|FG001|Overall Study|Lost to Follow-up|2|||
27846065|NCT01463306|54337528|FG002|Overall Study|Lost to Follow-up|0|||
27846066|NCT01463306|54337526|FG000|Overall Study|Protocol Violation|4|||
27846067|NCT01463306|54337527|FG001|Overall Study|Protocol Violation|0|||
27846068|NCT01463306|54337528|FG002|Overall Study|Protocol Violation|0|||
27846069|NCT01463306|54337526|FG000|Overall Study|Withdrawal by Subject|19|||
27846070|NCT01463306|54337527|FG001|Overall Study|Withdrawal by Subject|9|||
27846071|NCT01463306|54337528|FG002|Overall Study|Withdrawal by Subject|1|||
27846072|NCT01463306|54337526|FG000|Overall Study|Other|26|||
27846073|NCT01463306|54337527|FG001|Overall Study|Other|13|||
27846074|NCT01463306|54337528|FG002|Overall Study|Other|0|||
27846075|NCT01463306|54337526|FG000|Overall Study|Approval expiry at site|1|||
27846076|NCT01463306|54337527|FG001|Overall Study|Approval expiry at site|0|||
27846077|NCT01463306|54337528|FG002|Overall Study|Approval expiry at site|0|||
27846078|NCT01504412|54337557|FG000|Overall Study|Adverse Event|1|||
27846079|NCT01504412|54337558|FG001|Overall Study|Adverse Event|8|||
27808339|NCT01606761|54263814|FG002|Week 24 to Week 52|Death|2|||
27808340|NCT01606761|54263815|FG003|Week 24 to Week 52|Death|1|||
27808341|NCT01606761|54263816|FG004|Week 24 to Week 52|Death|0|||
27808342|NCT01606761|54263812|FG000|Week 24 to Week 52|Lack of Efficacy|0|||
27808343|NCT01606761|54263813|FG001|Week 24 to Week 52|Lack of Efficacy|13|||
27808344|NCT01606761|54263814|FG002|Week 24 to Week 52|Lack of Efficacy|7|||
27808345|NCT01606761|54263815|FG003|Week 24 to Week 52|Lack of Efficacy|10|||
27846080|NCT01504412|54337559|FG002|Overall Study|Adverse Event|1|||
28035012|NCT00673049|54693256|FG002|Before Progression on Erlotinib|Randomized but not treated|0|||
28035013|NCT00673049|54693257|FG003|Before Progression on Erlotinib|Randomized but not treated|0|||
28035014|NCT00673049|54693254|FG000|Before Progression on Erlotinib|Death|235|||
27808346|NCT01606761|54263816|FG004|Week 24 to Week 52|Lack of Efficacy|3|||
27808347|NCT01606761|54263812|FG000|Week 24 to Week 52|Physician Decision|0|||
27808348|NCT01606761|54263813|FG001|Week 24 to Week 52|Physician Decision|1|||
27808349|NCT01606761|54263814|FG002|Week 24 to Week 52|Physician Decision|1|||
27808350|NCT01606761|54263815|FG003|Week 24 to Week 52|Physician Decision|0|||
27846081|NCT01504412|54337560|FG003|Overall Study|Adverse Event|7|||
27808351|NCT01606761|54263816|FG004|Week 24 to Week 52|Physician Decision|0|||
27846082|NCT01504412|54337561|FG004|Overall Study|Adverse Event|10|||
27846083|NCT01504412|54337557|FG000|Overall Study|Withdrawal by Subject|2|||
27846084|NCT01504412|54337558|FG001|Overall Study|Withdrawal by Subject|1|||
27939798|NCT01227902|54596124|FG000|Overall Study|Lost to Follow-up|0|||
27846085|NCT01504412|54337559|FG002|Overall Study|Withdrawal by Subject|1|||
27846086|NCT01504412|54337560|FG003|Overall Study|Withdrawal by Subject|5|||
27846087|NCT01504412|54337561|FG004|Overall Study|Withdrawal by Subject|1|||
27846088|NCT01504412|54337557|FG000|Overall Study|Other|2|||
27846089|NCT01504412|54337558|FG001|Overall Study|Other|1|||
27846090|NCT01504412|54337559|FG002|Overall Study|Other|1|||
27846091|NCT01504412|54337560|FG003|Overall Study|Other|6|||
27846092|NCT01504412|54337561|FG004|Overall Study|Other|1|||
27846093|NCT01504412|54337557|FG000|Overall Study|Lost to Follow-up|0|||
27846094|NCT01504412|54337558|FG001|Overall Study|Lost to Follow-up|2|||
27846095|NCT01504412|54337559|FG002|Overall Study|Lost to Follow-up|0|||
27846096|NCT01504412|54337560|FG003|Overall Study|Lost to Follow-up|0|||
27846097|NCT01504412|54337561|FG004|Overall Study|Lost to Follow-up|0|||
27846098|NCT01504412|54337557|FG000|Overall Study|Lack of Efficacy|0|||
27846099|NCT01504412|54337558|FG001|Overall Study|Lack of Efficacy|0|||
27846100|NCT01504412|54337559|FG002|Overall Study|Lack of Efficacy|1|||
27846101|NCT01504412|54337560|FG003|Overall Study|Lack of Efficacy|0|||
27846102|NCT01504412|54337561|FG004|Overall Study|Lack of Efficacy|1|||
27846103|NCT01504412|54337557|FG000|Overall Study|Death|0|||
27846104|NCT01504412|54337558|FG001|Overall Study|Death|0|||
27846105|NCT01504412|54337559|FG002|Overall Study|Death|0|||
27846106|NCT01504412|54337560|FG003|Overall Study|Death|1|||
27846107|NCT01504412|54337561|FG004|Overall Study|Death|0|||
27846108|NCT01503164|54337591|FG000|Overall Study|Withdrawal by Subject|2|||
27846109|NCT01503164|54337592|FG001|Overall Study|Withdrawal by Subject|1|||
27846110|NCT00088465|54337598|FG000|Overall Study|Withdrawal by Subject|290|||
27846111|NCT00088465|54337598|FG000|Overall Study|Adverse Event|77|||
27846112|NCT00088465|54337598|FG000|Overall Study|Lost to Follow-up|57|||
27846113|NCT00088465|54337598|FG000|Overall Study|Physician Decision|45|||
27846114|NCT00088465|54337598|FG000|Overall Study|Sponsor Decision|37|||
27846115|NCT00088465|54337598|FG000|Overall Study|Lack of Efficacy|27|||
27846116|NCT00088465|54337598|FG000|Overall Study|Protocol Violation|17|||
27846117|NCT00088465|54337598|FG000|Overall Study|Death|11|||
27846118|NCT00088153|54337626|FG000|Overall Study|Physician Decision|3|||
27846119|NCT00088153|54337627|FG001|Overall Study|Physician Decision|3|||
27846120|NCT00088153|54337626|FG000|Overall Study|Withdrawal by Subject|10|||
27846121|NCT00088153|54337627|FG001|Overall Study|Withdrawal by Subject|10|||
27846122|NCT00088153|54337626|FG000|Overall Study|Lost to Follow-up|11|||
27846123|NCT00088153|54337627|FG001|Overall Study|Lost to Follow-up|12|||
27846124|NCT00087685|54337646|FG000|Overall Study|Adverse Event|5|||
27846125|NCT00087685|54337646|FG000|Overall Study|Non-Compliance|1|||
27846126|NCT00087685|54337646|FG000|Overall Study|Progressive Disease|5|||
27846127|NCT00087685|54337646|FG000|Overall Study|Withdrawal by Subject|3|||
27846128|NCT01502228|54337650|FG000|Overall Study|Death|1|||
27846129|NCT01502072|54337657|FG000|Overall Study|Withdrawal by Subject|1|||
27846130|NCT01502072|54337658|FG001|Overall Study|Withdrawal by Subject|0|||
27846131|NCT01502072|54337659|FG002|Overall Study|Withdrawal by Subject|0|||
27846132|NCT01502072|54337657|FG000|Overall Study|Death|0|||
27808352|NCT01606761|54263812|FG000|Week 24 to Week 52|Other|0|||
27808353|NCT01606761|54263813|FG001|Week 24 to Week 52|Other|1|||
27808354|NCT01606761|54263814|FG002|Week 24 to Week 52|Other|5|||
27808355|NCT01606761|54263815|FG003|Week 24 to Week 52|Other|2|||
27808356|NCT01606761|54263816|FG004|Week 24 to Week 52|Other|2|||
27808357|NCT01606761|54263812|FG000|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
27808358|NCT01606761|54263813|FG001|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
27808359|NCT01606761|54263814|FG002|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2|||
27808360|NCT01606761|54263815|FG003|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
27808361|NCT01606761|54263816|FG004|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
27808362|NCT01606761|54263812|FG000|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4|||
27808363|NCT01606761|54263813|FG001|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
27808364|NCT01606761|54263814|FG002|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
27808365|NCT01606761|54263815|FG003|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1|||
27808366|NCT01606761|54263816|FG004|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3|||
27846133|NCT01502072|54337658|FG001|Overall Study|Death|1|||
27808367|NCT01606761|54263812|FG000|Safety Follow-up Period (Week 52-68)|Death|0|||
27846134|NCT01502072|54337659|FG002|Overall Study|Death|0|||
27846135|NCT01462370|54337667|FG000|Overall Study|Lack of Qualifying Event|1|||
27846136|NCT01462370|54337668|FG001|Overall Study|Lack of Qualifying Event|1|||
27846137|NCT01462370|54337667|FG000|Overall Study|Physician Decision|0|||
27846138|NCT01462370|54337668|FG001|Overall Study|Physician Decision|1|||
27846139|NCT01462370|54337667|FG000|Overall Study|Withdrawal by Subject|0|||
27939799|NCT01227902|54596125|FG001|Overall Study|Lost to Follow-up|0|||
27939800|NCT01227902|54596126|FG002|Overall Study|Lost to Follow-up|1|||
27846140|NCT01462370|54337668|FG001|Overall Study|Withdrawal by Subject|3|||
27846141|NCT01479764|54337676|FG000|Randomized|Adverse Event|1|||
27846142|NCT01479764|54337677|FG001|Randomized|Adverse Event|1|||
27846143|NCT01479764|54337676|FG000|Randomized|Withdrawal by Subject|1|||
27846144|NCT01479764|54337677|FG001|Randomized|Withdrawal by Subject|0|||
27846145|NCT01479764|54337676|FG000|Treated|Lost to Follow-up|0|||
27846146|NCT01479764|54337677|FG001|Treated|Lost to Follow-up|2|||
27846147|NCT01479530|54337685|FG000|Overall Study|Adverse Event|5|||
27846148|NCT01479530|54337686|FG001|Overall Study|Adverse Event|6|||
27846149|NCT01479530|54337685|FG000|Overall Study|Lack of Efficacy|0|||
27846150|NCT01479530|54337686|FG001|Overall Study|Lack of Efficacy|1|||
27846151|NCT01479530|54337685|FG000|Overall Study|Protocol Violation|2|||
27846152|NCT01479530|54337686|FG001|Overall Study|Protocol Violation|3|||
27846153|NCT01479530|54337685|FG000|Overall Study|Withdrawal of Consent|3|||
27846154|NCT01479530|54337686|FG001|Overall Study|Withdrawal of Consent|2|||
27846155|NCT01479374|54337695|FG000|Overall Study|Adverse Event|2|||
27846156|NCT01479374|54337696|FG001|Overall Study|Adverse Event|1|||
27846157|NCT01479374|54337697|FG002|Overall Study|Adverse Event|0|||
27846158|NCT01479374|54337695|FG000|Overall Study|Lost to Follow-up|1|||
27808368|NCT01606761|54263813|FG001|Safety Follow-up Period (Week 52-68)|Death|0|||
27808369|NCT01606761|54263814|FG002|Safety Follow-up Period (Week 52-68)|Death|0|||
27808370|NCT01606761|54263815|FG003|Safety Follow-up Period (Week 52-68)|Death|0|||
27808371|NCT01606761|54263816|FG004|Safety Follow-up Period (Week 52-68)|Death|1|||
27808372|NCT01606761|54263812|FG000|Safety Follow-up Period (Week 52-68)|Other|0|||
27808373|NCT01606761|54263813|FG001|Safety Follow-up Period (Week 52-68)|Other|3|||
27846159|NCT01479374|54337696|FG001|Overall Study|Lost to Follow-up|2|||
27846160|NCT01479374|54337697|FG002|Overall Study|Lost to Follow-up|0|||
27846161|NCT01479374|54337695|FG000|Overall Study|Decision Unrelated to Adverse Event|0|||
27846162|NCT01479374|54337696|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
27846163|NCT01479374|54337697|FG002|Overall Study|Decision Unrelated to Adverse Event|0|||
27846164|NCT01479374|54337695|FG000|Overall Study|Other|0|||
27846165|NCT01479374|54337696|FG001|Overall Study|Other|4|||
27846166|NCT01479374|54337697|FG002|Overall Study|Other|5|||
27846167|NCT00087529|54337707|FG000|Overall Study|Death|1|||
27846168|NCT00087529|54337708|FG001|Overall Study|Death|0|||
27846169|NCT00087529|54337707|FG000|Overall Study|Adverse Event|0|||
27846170|NCT00087529|54337708|FG001|Overall Study|Adverse Event|8|||
27846171|NCT00087529|54337707|FG000|Overall Study|Pregnancy|0|||
27846172|NCT00087529|54337708|FG001|Overall Study|Pregnancy|1|||
27808374|NCT01606761|54263814|FG002|Safety Follow-up Period (Week 52-68)|Other|9|||
27808375|NCT01606761|54263815|FG003|Safety Follow-up Period (Week 52-68)|Other|1|||
27808376|NCT01606761|54263816|FG004|Safety Follow-up Period (Week 52-68)|Other|3|||
27808377|NCT01790295|54263831|FG000|Overall Study|Adverse Event|1|||
27846173|NCT00087529|54337707|FG000|Overall Study|Lost to Follow-up|2|||
27846174|NCT00087529|54337708|FG001|Overall Study|Lost to Follow-up|3|||
27846175|NCT00087529|54337707|FG000|Overall Study|Participant Decision|14|||
27846176|NCT00087529|54337708|FG001|Overall Study|Participant Decision|37|||
27846177|NCT00087529|54337707|FG000|Overall Study|Physician Decision|4|||
27846178|NCT00087529|54337708|FG001|Overall Study|Physician Decision|8|||
27846179|NCT00087529|54337707|FG000|Overall Study|Initiation of Excluded Therapy|0|||
27846180|NCT00087529|54337708|FG001|Overall Study|Initiation of Excluded Therapy|1|||
27846181|NCT00087529|54337707|FG000|Overall Study|Participant Noncompliance|0|||
27808378|NCT01790295|54263831|FG000|Overall Study|Death|4|||
27808379|NCT01790295|54263831|FG000|Overall Study|Lack of Efficacy|2|||
27808380|NCT01790295|54263831|FG000|Overall Study|Study closure|4|||
27808381|NCT01597557|54263838|FG000|Overall Study|Did not undergo cardioversion procedure|4|||
27808382|NCT01597557|54263839|FG001|Overall Study|Did not undergo cardioversion procedure|3|||
27808383|NCT01760733|54263845|FG000|Waiting List|Death|18|||
27808384|NCT01760733|54263845|FG000|Waiting List|Removed from waiting list|41|||
27808385|NCT01760733|54263845|FG000|Waiting List|Not received a transplant yet|13|||
28035015|NCT00673049|54693255|FG001|Before Progression on Erlotinib|Death|167|||
28035016|NCT00673049|54693256|FG002|Before Progression on Erlotinib|Death|1|||
27808386|NCT01760733|54263845|FG000|Transplanted|Not reached 10 years post transplant|184|||
27808387|NCT01760733|54263845|FG000|Transplanted|Death|26|||
27808388|NCT01760733|54263845|FG000|Transplanted|Graft loss|7|||
27808389|NCT01914757|54263853|FG000|Overall Study|Severe non-compliance to protocol|3|||
27808390|NCT01914757|54263854|FG001|Overall Study|Severe non-compliance to protocol|1|||
27808391|NCT01914757|54263855|FG002|Overall Study|Severe non-compliance to protocol|2|||
27808392|NCT01914757|54263853|FG000|Overall Study|Lost to Follow-up|5|||
27808393|NCT01914757|54263854|FG001|Overall Study|Lost to Follow-up|8|||
27808394|NCT01914757|54263855|FG002|Overall Study|Lost to Follow-up|6|||
27846182|NCT00087529|54337708|FG001|Overall Study|Participant Noncompliance|1|||
27846183|NCT00087529|54337707|FG000|Overall Study|Disease Progression|5|||
27846184|NCT00087529|54337708|FG001|Overall Study|Disease Progression|4|||
28035017|NCT00673049|54693257|FG003|Before Progression on Erlotinib|Death|0|||
27846185|NCT00087529|54337707|FG000|Overall Study|Did Not Continue to Safety Follow-Up|5|||
27808395|NCT01914757|54263853|FG000|Overall Study|Withdrawal by Subject|15|||
27846186|NCT00087529|54337708|FG001|Overall Study|Did Not Continue to Safety Follow-Up|5|||
27846187|NCT01500434|54337731|FG000|Overall Study|Death|1|||
27846188|NCT01500434|54337731|FG000|Overall Study|Withdrawal by Subject|1|||
27846189|NCT01500434|54337731|FG000|Overall Study|Missed 12-month follow-up|5|||
27846190|NCT00087139|54337738|FG000|Overall Study|Adverse Event|18|||
27846191|NCT00087139|54337739|FG001|Overall Study|Adverse Event|17|||
27808396|NCT01914757|54263854|FG001|Overall Study|Withdrawal by Subject|27|||
27808397|NCT01914757|54263855|FG002|Overall Study|Withdrawal by Subject|19|||
27808398|NCT01914757|54263853|FG000|Overall Study|Death|2|||
27808399|NCT01914757|54263854|FG001|Overall Study|Death|2|||
27808400|NCT01914757|54263855|FG002|Overall Study|Death|1|||
27808401|NCT01914757|54263853|FG000|Overall Study|Adverse Event|4|||
27808402|NCT01914757|54263854|FG001|Overall Study|Adverse Event|3|||
27808403|NCT01914757|54263855|FG002|Overall Study|Adverse Event|4|||
27808404|NCT01914757|54263853|FG000|Overall Study|Study specific withdrawal criteria|0|||
27808405|NCT01914757|54263854|FG001|Overall Study|Study specific withdrawal criteria|1|||
27808406|NCT01914757|54263855|FG002|Overall Study|Study specific withdrawal criteria|0|||
27808407|NCT01914757|54263853|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
27846192|NCT00087139|54337740|FG002|Overall Study|Adverse Event|13|||
28035018|NCT00673049|54693254|FG000|Before Progression on Erlotinib|Lost to Follow-up|9|||
28035019|NCT00673049|54693255|FG001|Before Progression on Erlotinib|Lost to Follow-up|5|||
28035020|NCT00673049|54693256|FG002|Before Progression on Erlotinib|Lost to Follow-up|0|||
28035021|NCT00673049|54693257|FG003|Before Progression on Erlotinib|Lost to Follow-up|0|||
28035022|NCT00673049|54693254|FG000|Before Progression on Erlotinib|Withdrawal by Subject|26|||
28035023|NCT00673049|54693255|FG001|Before Progression on Erlotinib|Withdrawal by Subject|18|||
28035024|NCT00673049|54693256|FG002|Before Progression on Erlotinib|Withdrawal by Subject|0|||
28035025|NCT00673049|54693257|FG003|Before Progression on Erlotinib|Withdrawal by Subject|0|||
28035026|NCT00673049|54693254|FG000|Before Progression on Erlotinib|Other|1|||
28035027|NCT00673049|54693255|FG001|Before Progression on Erlotinib|Other|2|||
28035028|NCT00673049|54693256|FG002|Before Progression on Erlotinib|Other|0|||
28035029|NCT00673049|54693257|FG003|Before Progression on Erlotinib|Other|0|||
28035030|NCT00673049|54693254|FG000|Before Progression on Erlotinib|study terminated by sponsor|18|||
28035031|NCT00673049|54693255|FG001|Before Progression on Erlotinib|study terminated by sponsor|14|||
28035032|NCT00673049|54693256|FG002|Before Progression on Erlotinib|study terminated by sponsor|0|||
28035033|NCT00673049|54693257|FG003|Before Progression on Erlotinib|study terminated by sponsor|0|||
28035034|NCT00673049|54693254|FG000|Before Progression on Erlotinib|Switched to figitumumab|0|||
28035035|NCT00673049|54693255|FG001|Before Progression on Erlotinib|Switched to figitumumab|83|||
28035036|NCT00673049|54693256|FG002|Before Progression on Erlotinib|Switched to figitumumab|0|||
28035037|NCT00673049|54693257|FG003|Before Progression on Erlotinib|Switched to figitumumab|0|||
28035038|NCT00673049|54693254|FG000|After Progression on Erlotinib|Death|0|||
28035039|NCT00673049|54693255|FG001|After Progression on Erlotinib|Death|0|||
28035040|NCT00673049|54693256|FG002|After Progression on Erlotinib|Death|0|||
28035041|NCT00673049|54693257|FG003|After Progression on Erlotinib|Death|71|||
28035042|NCT00673049|54693254|FG000|After Progression on Erlotinib|Lost to Follow-up|0|||
28035043|NCT00673049|54693255|FG001|After Progression on Erlotinib|Lost to Follow-up|0|||
28035044|NCT00673049|54693256|FG002|After Progression on Erlotinib|Lost to Follow-up|0|||
28035045|NCT00673049|54693257|FG003|After Progression on Erlotinib|Lost to Follow-up|3|||
28035046|NCT00673049|54693254|FG000|After Progression on Erlotinib|Withdrawal by Subject|0|||
28035047|NCT00673049|54693255|FG001|After Progression on Erlotinib|Withdrawal by Subject|0|||
28035048|NCT00673049|54693256|FG002|After Progression on Erlotinib|Withdrawal by Subject|0|||
28035049|NCT00673049|54693257|FG003|After Progression on Erlotinib|Withdrawal by Subject|5|||
28035050|NCT00673049|54693254|FG000|After Progression on Erlotinib|study terminated by sponsor|0|||
28035051|NCT00673049|54693255|FG001|After Progression on Erlotinib|study terminated by sponsor|0|||
28035052|NCT00673049|54693256|FG002|After Progression on Erlotinib|study terminated by sponsor|0|||
28035053|NCT00673049|54693257|FG003|After Progression on Erlotinib|study terminated by sponsor|4|||
28035054|NCT00412750|54693268|FG000|Overall Study|Abnormal laboratory value(s)|1|||
28035055|NCT00412750|54693269|FG001|Overall Study|Abnormal laboratory value(s)|0|||
28035056|NCT00412750|54693270|FG002|Overall Study|Abnormal laboratory value(s)|0|||
28035057|NCT00412750|54693268|FG000|Overall Study|Administrative problems|21|||
28035058|NCT00412750|54693269|FG001|Overall Study|Administrative problems|17|||
28035059|NCT00412750|54693270|FG002|Overall Study|Administrative problems|14|||
28035060|NCT00412750|54693268|FG000|Overall Study|Adverse Event|8|||
28035061|NCT00412750|54693269|FG001|Overall Study|Adverse Event|3|||
28035062|NCT00412750|54693270|FG002|Overall Study|Adverse Event|3|||
28035063|NCT00412750|54693268|FG000|Overall Study|Lost to Follow-up|1|||
28035064|NCT00412750|54693269|FG001|Overall Study|Lost to Follow-up|0|||
28035065|NCT00412750|54693270|FG002|Overall Study|Lost to Follow-up|1|||
28035066|NCT00412750|54693268|FG000|Overall Study|Withdrawal by Subject|0|||
28035067|NCT00412750|54693269|FG001|Overall Study|Withdrawal by Subject|1|||
28035068|NCT00412750|54693270|FG002|Overall Study|Withdrawal by Subject|2|||
27808408|NCT01914757|54263854|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
27846193|NCT00087139|54337738|FG000|Overall Study|Death|2|||
28035069|NCT00412750|54693268|FG000|Overall Study|Lack of Efficacy|0|||
27808409|NCT01914757|54263855|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
27939801|NCT01227902|54596127|FG003|Overall Study|Lost to Follow-up|2|||
27808410|NCT01914757|54263853|FG000|Overall Study|Other reasons|5|||
27846194|NCT00087139|54337739|FG001|Overall Study|Death|1|||
27846195|NCT00087139|54337740|FG002|Overall Study|Death|0|||
27846196|NCT00087139|54337738|FG000|Overall Study|Withdrawal by Subject|3|||
27846197|NCT00087139|54337739|FG001|Overall Study|Withdrawal by Subject|2|||
27846198|NCT00087139|54337740|FG002|Overall Study|Withdrawal by Subject|2|||
27846199|NCT00087139|54337738|FG000|Overall Study|Physician Decision|1|||
27846200|NCT00087139|54337739|FG001|Overall Study|Physician Decision|1|||
27846201|NCT00087139|54337740|FG002|Overall Study|Physician Decision|1|||
27846202|NCT00087139|54337738|FG000|Overall Study|Disease progression|9|||
27846203|NCT00087139|54337739|FG001|Overall Study|Disease progression|19|||
27846204|NCT00087139|54337740|FG002|Overall Study|Disease progression|12|||
27846205|NCT00087139|54337738|FG000|Overall Study|Ineligible|4|||
27846206|NCT00087139|54337739|FG001|Overall Study|Ineligible|7|||
27846207|NCT00087139|54337740|FG002|Overall Study|Ineligible|4|||
27846208|NCT00087139|54337738|FG000|Overall Study|Symptomatic deterioration|1|||
27846209|NCT00087139|54337739|FG001|Overall Study|Symptomatic deterioration|1|||
27846210|NCT00087139|54337740|FG002|Overall Study|Symptomatic deterioration|3|||
27846211|NCT00087139|54337738|FG000|Overall Study|Use of coumadin|1|||
27846212|NCT00087139|54337739|FG001|Overall Study|Use of coumadin|0|||
27846213|NCT00087139|54337740|FG002|Overall Study|Use of coumadin|0|||
27846214|NCT00087139|54337738|FG000|Overall Study|Response achieved|0|||
27846215|NCT00087139|54337739|FG001|Overall Study|Response achieved|1|||
27846216|NCT00087139|54337740|FG002|Overall Study|Response achieved|0|||
27846217|NCT00087139|54337738|FG000|Overall Study|Extradural disease|0|||
27846218|NCT00087139|54337739|FG001|Overall Study|Extradural disease|0|||
27846219|NCT00087139|54337740|FG002|Overall Study|Extradural disease|1|||
27846220|NCT01500278|54337792|FG000|Week 0 - Week 12|Lack of Efficacy|0|||
27846221|NCT01500278|54337793|FG001|Week 0 - Week 12|Lack of Efficacy|1|||
27846222|NCT01500278|54337792|FG000|Week 0 - Week 12|Protocol Violation|10|||
27846223|NCT01500278|54337793|FG001|Week 0 - Week 12|Protocol Violation|16|||
27846224|NCT01500278|54337792|FG000|Week 0 - Week 12|Lost to Follow-up|1|||
27846225|NCT01500278|54337793|FG001|Week 0 - Week 12|Lost to Follow-up|1|||
27846226|NCT01500278|54337792|FG000|Week 0 - Week 12|Withdrawal by Subject|7|||
27846227|NCT01500278|54337793|FG001|Week 0 - Week 12|Withdrawal by Subject|2|||
27846228|NCT01500278|54337792|FG000|Week 0 - Week 12|Protocol violation on screening X-ray|1|||
27846229|NCT01500278|54337793|FG001|Week 0 - Week 12|Protocol violation on screening X-ray|0|||
27846230|NCT01500278|54337792|FG000|Week 0 - Week 12|Patient decision|1|||
27846231|NCT01500278|54337793|FG001|Week 0 - Week 12|Patient decision|0|||
27846232|NCT01500278|54337792|FG000|Week 0 - Week 12|Exclusion criteria not met|1|||
27846233|NCT01500278|54337793|FG001|Week 0 - Week 12|Exclusion criteria not met|0|||
27846234|NCT01500278|54337792|FG000|Week 0 - Week 12|Investigator decision|1|||
27846235|NCT01500278|54337793|FG001|Week 0 - Week 12|Investigator decision|0|||
27846236|NCT01500278|54337792|FG000|Week 0 - Week 12|Prior history of serious disease|1|||
27846237|NCT01500278|54337793|FG001|Week 0 - Week 12|Prior history of serious disease|0|||
27846238|NCT01500278|54337792|FG000|Week 0 - Week 12|Sponsor decision|1|||
27846239|NCT01500278|54337793|FG001|Week 0 - Week 12|Sponsor decision|0|||
27846240|NCT01500278|54337792|FG000|Week 0 - Week 12|Personal reason|0|||
27846241|NCT01500278|54337793|FG001|Week 0 - Week 12|Personal reason|1|||
27846242|NCT01500278|54337792|FG000|Week 0 - Week 12|Other serious disease|0|||
27846243|NCT01500278|54337793|FG001|Week 0 - Week 12|Other serious disease|1|||
27846244|NCT01500278|54337792|FG000|Week 0 - Week 12|Adverse event (AE), not fatal|7|||
27846245|NCT01500278|54337793|FG001|Week 0 - Week 12|Adverse event (AE), not fatal|8|||
27846246|NCT01500278|54337792|FG000|Week 13 - Week 104|Lack of Efficacy|11|||
27846247|NCT01500278|54337793|FG001|Week 13 - Week 104|Lack of Efficacy|12|||
27846248|NCT01500278|54337792|FG000|Week 13 - Week 104|Protocol Violation|6|||
27846249|NCT01500278|54337793|FG001|Week 13 - Week 104|Protocol Violation|6|||
27846250|NCT01500278|54337792|FG000|Week 13 - Week 104|Lost to Follow-up|6|||
27846251|NCT01500278|54337793|FG001|Week 13 - Week 104|Lost to Follow-up|5|||
27846252|NCT01500278|54337792|FG000|Week 13 - Week 104|Withdrawal by Subject|22|||
27846253|NCT01500278|54337793|FG001|Week 13 - Week 104|Withdrawal by Subject|13|||
27846254|NCT01500278|54337792|FG000|Week 13 - Week 104|Week 24 Non-Responder|20|||
27846255|NCT01500278|54337793|FG001|Week 13 - Week 104|Week 24 Non-Responder|16|||
27846256|NCT01500278|54337792|FG000|Week 13 - Week 104|Non/bad compliance|7|||
27846257|NCT01500278|54337793|FG001|Week 13 - Week 104|Non/bad compliance|5|||
27846258|NCT01500278|54337792|FG000|Week 13 - Week 104|Recurrent infections|1|||
27846259|NCT01500278|54337793|FG001|Week 13 - Week 104|Recurrent infections|0|||
27846260|NCT01500278|54337792|FG000|Week 13 - Week 104|False positive test|1|||
27846261|NCT01500278|54337793|FG001|Week 13 - Week 104|False positive test|2|||
27846262|NCT01500278|54337792|FG000|Week 13 - Week 104|Sponsor request|4|||
27846263|NCT01500278|54337793|FG001|Week 13 - Week 104|Sponsor request|0|||
27846264|NCT01500278|54337792|FG000|Week 13 - Week 104|Withdrawn in error|1|||
27846265|NCT01500278|54337793|FG001|Week 13 - Week 104|Withdrawn in error|0|||
27846266|NCT01500278|54337792|FG000|Week 13 - Week 104|Exclusion criteria not met|1|||
27846267|NCT01500278|54337793|FG001|Week 13 - Week 104|Exclusion criteria not met|0|||
27846268|NCT01500278|54337792|FG000|Week 13 - Week 104|Protocol deviation|1|||
27846269|NCT01500278|54337793|FG001|Week 13 - Week 104|Protocol deviation|0|||
27846270|NCT01500278|54337792|FG000|Week 13 - Week 104|Principal investigator retiring|1|||
27846271|NCT01500278|54337793|FG001|Week 13 - Week 104|Principal investigator retiring|0|||
27846272|NCT01500278|54337792|FG000|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1|||
27846273|NCT01500278|54337793|FG001|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0|||
27846274|NCT01500278|54337792|FG000|Week 13 - Week 104|Abnormal questionable chest X-ray|0|||
27846275|NCT01500278|54337793|FG001|Week 13 - Week 104|Abnormal questionable chest X-ray|2|||
27846276|NCT01500278|54337792|FG000|Week 13 - Week 104|Relocation|0|||
27846277|NCT01500278|54337793|FG001|Week 13 - Week 104|Relocation|1|||
27846278|NCT01500278|54337792|FG000|Week 13 - Week 104|Sponsor decision|0|||
27846279|NCT01500278|54337793|FG001|Week 13 - Week 104|Sponsor decision|2|||
27846280|NCT01500278|54337792|FG000|Week 13 - Week 104|Medical monitor decision|0|||
27846281|NCT01500278|54337793|FG001|Week 13 - Week 104|Medical monitor decision|2|||
27846282|NCT01500278|54337792|FG000|Week 13 - Week 104|Personal reason|0|||
27846283|NCT01500278|54337793|FG001|Week 13 - Week 104|Personal reason|1|||
27846284|NCT01500278|54337792|FG000|Week 13 - Week 104|Not completed|0|||
27846285|NCT01500278|54337793|FG001|Week 13 - Week 104|Not completed|1|||
27846286|NCT01500278|54337792|FG000|Week 13 - Week 104|Death|2|||
27846287|NCT01500278|54337793|FG001|Week 13 - Week 104|Death|4|||
27846288|NCT01500278|54337792|FG000|Week 13 - Week 104|Adverse Event|54|||
27846289|NCT01500278|54337793|FG001|Week 13 - Week 104|Adverse Event|54|||
27846290|NCT00086281|54337816|FG000|Phase 1|Adverse Event|0|||
27846291|NCT00086281|54337817|FG001|Phase 1|Adverse Event|0|||
27846292|NCT00086281|54337818|FG002|Phase 1|Adverse Event|0|||
27846293|NCT00086281|54337819|FG003|Phase 1|Adverse Event|0|||
27808411|NCT01914757|54263854|FG001|Overall Study|Other reasons|9|||
27808412|NCT01914757|54263855|FG002|Overall Study|Other reasons|4|||
27808413|NCT02003573|54263866|FG000|Overall Study|Progressive disease|2|||
27808414|NCT02003573|54263867|FG001|Overall Study|Progressive disease|0|||
27808415|NCT02003573|54263868|FG002|Overall Study|Progressive disease|1|||
27808416|NCT02003573|54263866|FG000|Overall Study|Other Adverse event|0|||
27808417|NCT02003573|54263867|FG001|Overall Study|Other Adverse event|1|||
27808418|NCT02003573|54263868|FG002|Overall Study|Other Adverse event|1|||
27808419|NCT02003573|54263866|FG000|Overall Study|Refuse to take trial medication|0|||
27808420|NCT02003573|54263867|FG001|Overall Study|Refuse to take trial medication|1|||
27808421|NCT02003573|54263868|FG002|Overall Study|Refuse to take trial medication|1|||
27808422|NCT02003573|54263866|FG000|Overall Study|Other than specified|1|||
27808423|NCT02003573|54263867|FG001|Overall Study|Other than specified|2|||
27808424|NCT02003573|54263868|FG002|Overall Study|Other than specified|3|||
27808425|NCT01914679|54263878|FG000|Overall Study|Lack of Efficacy|1|||
27808426|NCT01914679|54263878|FG000|Overall Study|Sponsor terminated study|4|||
27808427|NCT01789281|54263884|FG000|Overall Study|Disease progression|15|||
27808428|NCT01789281|54263885|FG001|Overall Study|Disease progression|4|||
27808429|NCT01789281|54263884|FG000|Overall Study|Adverse Event|5|||
27808430|NCT01789281|54263885|FG001|Overall Study|Adverse Event|5|||
27808431|NCT01789281|54263884|FG000|Overall Study|Withdrawal by Subject|1|||
27846294|NCT00086281|54337820|FG004|Phase 1|Adverse Event|0|||
27846295|NCT00086281|54337821|FG005|Phase 1|Adverse Event|0|||
27846296|NCT00086281|54337822|FG006|Phase 1|Adverse Event|0|||
27846297|NCT00086281|54337823|FG007|Phase 1|Adverse Event|0|||
27846298|NCT00086281|54337824|FG008|Phase 1|Adverse Event|0|||
27846299|NCT00086281|54337825|FG009|Phase 1|Adverse Event|1|||
27846300|NCT00086281|54337826|FG010|Phase 1|Adverse Event|2|||
27808432|NCT01789281|54263885|FG001|Overall Study|Withdrawal by Subject|0|||
27808433|NCT01789281|54263884|FG000|Overall Study|Lost to Follow-up|1|||
27808434|NCT01789281|54263885|FG001|Overall Study|Lost to Follow-up|0|||
27808435|NCT01789281|54263884|FG000|Overall Study|Administrative problems|0|||
27846301|NCT00086281|54337827|FG011|Phase 1|Adverse Event|1|||
27846302|NCT00086281|54337828|FG012|Phase 1|Adverse Event|1|||
27846303|NCT00086281|54337829|FG013|Phase 1|Adverse Event|1|||
27846304|NCT00086281|54337830|FG014|Phase 1|Adverse Event|2|||
27846305|NCT00086281|54337816|FG000|Phase 1|Protocol Violation|0|||
27846306|NCT00086281|54337817|FG001|Phase 1|Protocol Violation|0|||
27846307|NCT00086281|54337818|FG002|Phase 1|Protocol Violation|0|||
27846308|NCT00086281|54337819|FG003|Phase 1|Protocol Violation|0|||
27846309|NCT00086281|54337820|FG004|Phase 1|Protocol Violation|0|||
27846310|NCT00086281|54337821|FG005|Phase 1|Protocol Violation|0|||
27846311|NCT00086281|54337822|FG006|Phase 1|Protocol Violation|0|||
27846312|NCT00086281|54337823|FG007|Phase 1|Protocol Violation|0|||
27846313|NCT00086281|54337824|FG008|Phase 1|Protocol Violation|0|||
27846314|NCT00086281|54337825|FG009|Phase 1|Protocol Violation|0|||
27846315|NCT00086281|54337826|FG010|Phase 1|Protocol Violation|1|||
27846316|NCT00086281|54337827|FG011|Phase 1|Protocol Violation|0|||
27846317|NCT00086281|54337828|FG012|Phase 1|Protocol Violation|0|||
27846318|NCT00086281|54337829|FG013|Phase 1|Protocol Violation|0|||
27846319|NCT00086281|54337830|FG014|Phase 1|Protocol Violation|0|||
27846320|NCT00086281|54337816|FG000|Phase 1|Serious Adverse Event|0|||
27846321|NCT00086281|54337817|FG001|Phase 1|Serious Adverse Event|0|||
27846322|NCT00086281|54337818|FG002|Phase 1|Serious Adverse Event|0|||
27846323|NCT00086281|54337819|FG003|Phase 1|Serious Adverse Event|0|||
27846324|NCT00086281|54337820|FG004|Phase 1|Serious Adverse Event|0|||
27846325|NCT00086281|54337821|FG005|Phase 1|Serious Adverse Event|0|||
27846326|NCT00086281|54337822|FG006|Phase 1|Serious Adverse Event|0|||
27846327|NCT00086281|54337823|FG007|Phase 1|Serious Adverse Event|0|||
27846328|NCT00086281|54337824|FG008|Phase 1|Serious Adverse Event|0|||
27846329|NCT00086281|54337825|FG009|Phase 1|Serious Adverse Event|0|||
27846330|NCT00086281|54337826|FG010|Phase 1|Serious Adverse Event|0|||
27846331|NCT00086281|54337827|FG011|Phase 1|Serious Adverse Event|0|||
27846332|NCT00086281|54337828|FG012|Phase 1|Serious Adverse Event|0|||
27846333|NCT00086281|54337829|FG013|Phase 1|Serious Adverse Event|0|||
27846334|NCT00086281|54337830|FG014|Phase 1|Serious Adverse Event|1|||
27846335|NCT00086281|54337816|FG000|Phase 2|Adverse Event|0|||
27846336|NCT00086281|54337817|FG001|Phase 2|Adverse Event|0|||
27846337|NCT00086281|54337818|FG002|Phase 2|Adverse Event|0|||
27846338|NCT00086281|54337819|FG003|Phase 2|Adverse Event|0|||
27846339|NCT00086281|54337820|FG004|Phase 2|Adverse Event|0|||
27846340|NCT00086281|54337821|FG005|Phase 2|Adverse Event|0|||
27846341|NCT00086281|54337822|FG006|Phase 2|Adverse Event|0|||
27846342|NCT00086281|54337823|FG007|Phase 2|Adverse Event|0|||
27846343|NCT00086281|54337824|FG008|Phase 2|Adverse Event|0|||
27846344|NCT00086281|54337825|FG009|Phase 2|Adverse Event|0|||
27846345|NCT00086281|54337826|FG010|Phase 2|Adverse Event|0|||
27846346|NCT00086281|54337827|FG011|Phase 2|Adverse Event|0|||
27846347|NCT00086281|54337828|FG012|Phase 2|Adverse Event|1|||
27846348|NCT00086281|54337829|FG013|Phase 2|Adverse Event|1|||
27846349|NCT00086281|54337830|FG014|Phase 2|Adverse Event|0|||
27846350|NCT00086047|54337842|FG000|Overall Study|Lost to Follow-up|7|||
27846351|NCT00086047|54337843|FG001|Overall Study|Lost to Follow-up|6|||
28035070|NCT00412750|54693269|FG001|Overall Study|Lack of Efficacy|0|||
27846352|NCT00086047|54337842|FG000|Overall Study|Physician Decision|0|||
27846353|NCT00086047|54337843|FG001|Overall Study|Physician Decision|1|||
27846354|NCT01478828|54337855|FG000|Overall Study|Adverse Event|1|||
27846355|NCT00085423|54337860|FG000|Overall Study|Withdrawal by Subject|1|||
27846356|NCT00085423|54337860|FG000|Overall Study|screen failure|1|||
27846357|NCT00084487|54337864|FG000|Overall Study|Death|1|||
27846358|NCT01425281|54337904|FG000|At 30-day Clinical Follow-up|Withdrawal by Subject|1|||
27846359|NCT01425281|54337905|FG001|At 30-day Clinical Follow-up|Withdrawal by Subject|0|||
27939802|NCT01227902|54596124|FG000|Overall Study|Physician Decision|0|||
27939803|NCT01227902|54596125|FG001|Overall Study|Physician Decision|1|||
27846360|NCT01425281|54337904|FG000|At 180-day Clinical Follow-up|Withdrawal by Subject|3|||
27846361|NCT01425281|54337905|FG001|At 180-day Clinical Follow-up|Withdrawal by Subject|0|||
27846362|NCT01425281|54337904|FG000|At 180-day Clinical Follow-up|Death|0|||
27846363|NCT01425281|54337905|FG001|At 180-day Clinical Follow-up|Death|1|||
27846364|NCT01425281|54337904|FG000|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
27846365|NCT01425281|54337905|FG001|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
27846366|NCT01425281|54337904|FG000|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1|||
27846367|NCT01425281|54337905|FG001|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0|||
27939804|NCT01227902|54596126|FG002|Overall Study|Physician Decision|1|||
27846368|NCT01425281|54337904|FG000|At 2-year Clinical Follow-up|Withdrawal by Subject|2|||
27846369|NCT01425281|54337905|FG001|At 2-year Clinical Follow-up|Withdrawal by Subject|1|||
27846370|NCT01425281|54337904|FG000|At 2-year Clinical Follow-up|Death|2|||
27846371|NCT01425281|54337905|FG001|At 2-year Clinical Follow-up|Death|0|||
27846372|NCT01425281|54337904|FG000|At 2-year Clinical Follow-up|Lost to Follow-up|1|||
27846373|NCT01425281|54337905|FG001|At 2-year Clinical Follow-up|Lost to Follow-up|0|||
27846374|NCT01425281|54337904|FG000|At 2-year Clinical Follow-up|Patient did not want to participate in t|1|||
27846375|NCT01425281|54337905|FG001|At 2-year Clinical Follow-up|Patient did not want to participate in t|0|||
27846376|NCT01425281|54337904|FG000|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
27846377|NCT01425281|54337905|FG001|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
27846378|NCT01425281|54337904|FG000|At 3-year Clinical Follow-up|Death|2|||
27846379|NCT01425281|54337905|FG001|At 3-year Clinical Follow-up|Death|3|||
27846380|NCT01425281|54337904|FG000|At 4-year Clinical Follow-up|Death|7|||
27846381|NCT01425281|54337905|FG001|At 4-year Clinical Follow-up|Death|3|||
27846382|NCT01425281|54337904|FG000|At 4-year Clinical Follow-up|Withdrawal by Subject|3|||
27846383|NCT01425281|54337905|FG001|At 4-year Clinical Follow-up|Withdrawal by Subject|2|||
27846384|NCT01425281|54337904|FG000|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
27846385|NCT01425281|54337905|FG001|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
27846386|NCT01425281|54337904|FG000|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6|||
27846387|NCT01425281|54337905|FG001|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5|||
27846388|NCT01425281|54337904|FG000|At 4-year Clinical Follow-up|Lost to Follow-up|4|||
27846389|NCT01425281|54337905|FG001|At 4-year Clinical Follow-up|Lost to Follow-up|1|||
27846390|NCT01425281|54337904|FG000|At 5-year Clinical Follow-up|Death|2|||
27846391|NCT01425281|54337905|FG001|At 5-year Clinical Follow-up|Death|0|||
27846392|NCT01425281|54337904|FG000|At 5-year Clinical Follow-up|Lost to Follow-up|2|||
27846393|NCT01425281|54337905|FG001|At 5-year Clinical Follow-up|Lost to Follow-up|1|||
27846394|NCT01425281|54337904|FG000|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19|||
27846395|NCT01425281|54337905|FG001|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7|||
27846396|NCT01425281|54337904|FG000|At 5-year Clinical Follow-up|Refused/terminated|9|||
28035071|NCT00412750|54693270|FG002|Overall Study|Lack of Efficacy|3|||
27808436|NCT01789281|54263885|FG001|Overall Study|Administrative problems|1|||
27808437|NCT01923740|54263894|FG000|Overall Study|Lost to Follow-up|4|||
27808438|NCT01923740|54263895|FG001|Overall Study|Lost to Follow-up|9|||
27808439|NCT01923740|54263894|FG000|Overall Study|Withdrawal by Subject|2|||
27808440|NCT01923740|54263895|FG001|Overall Study|Withdrawal by Subject|0|||
27808441|NCT01789203|54263903|FG000|Overall Study|Adverse Event|2|||
27808442|NCT01789203|54263904|FG001|Overall Study|Adverse Event|2|||
27808443|NCT01789203|54263903|FG000|Overall Study|Withdrawal by Subject|1|||
27808444|NCT01789203|54263904|FG001|Overall Study|Withdrawal by Subject|0|||
27808445|NCT01789203|54263903|FG000|Overall Study|Death|1|||
27808446|NCT01789203|54263904|FG001|Overall Study|Death|0|||
27808447|NCT01789203|54263903|FG000|Overall Study|Protocol Violation|2|||
27808448|NCT01789203|54263904|FG001|Overall Study|Protocol Violation|1|||
27808449|NCT01789203|54263903|FG000|Overall Study|Other|1|||
27808450|NCT01789203|54263904|FG001|Overall Study|Other|1|||
27846397|NCT01425281|54337905|FG001|At 5-year Clinical Follow-up|Refused/terminated|3|||
27846398|NCT02648724|54337933|FG000|Overall Study|Withdrawal by Subject|0|||
27846399|NCT02648724|54337934|FG001|Overall Study|Withdrawal by Subject|1|||
27808451|NCT01789203|54263903|FG000|Overall Study|patient non-adherent|2|||
27808452|NCT01789203|54263904|FG001|Overall Study|patient non-adherent|0|||
27808453|NCT01789047|54263914|FG000|Overall Study|Adverse Event|3|||
27808454|NCT01789047|54263915|FG001|Overall Study|Adverse Event|2|||
27808455|NCT01789047|54263914|FG000|Overall Study|Withdrawal by Subject|1|||
27846400|NCT02648724|54337935|FG002|Overall Study|Withdrawal by Subject|1|||
27846401|NCT02648724|54337936|FG003|Overall Study|Withdrawal by Subject|0|||
27846402|NCT02648724|54337937|FG004|Overall Study|Withdrawal by Subject|1|||
27846403|NCT02648724|54337938|FG005|Overall Study|Withdrawal by Subject|0|||
27846404|NCT02648724|54337939|FG006|Overall Study|Withdrawal by Subject|0|||
27846405|NCT02648724|54337933|FG000|Overall Study|Progressive disease|2|||
27846406|NCT02648724|54337934|FG001|Overall Study|Progressive disease|2|||
27808456|NCT01789047|54263915|FG001|Overall Study|Withdrawal by Subject|2|||
27808457|NCT01788423|54263924|FG000|Overall Study|See Comments in Completed (above)|0|||
27808458|NCT01788423|54263925|FG001|Overall Study|See Comments in Completed (above)|4|||
27808459|NCT01788423|54263926|FG002|Overall Study|See Comments in Completed (above)|5|||
27808460|NCT01617187|54263938|FG000|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
27808461|NCT01617187|54263939|FG001|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
27808462|NCT01617187|54263940|FG002|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
27808463|NCT01617187|54263941|FG003|Randomization Through Start Treatment|Not Treated: Administrative Reason|1|||
27846407|NCT02648724|54337935|FG002|Overall Study|Progressive disease|2|||
27846408|NCT02648724|54337936|FG003|Overall Study|Progressive disease|3|||
27846409|NCT02648724|54337937|FG004|Overall Study|Progressive disease|22|||
27846410|NCT02648724|54337938|FG005|Overall Study|Progressive disease|7|||
27846411|NCT02648724|54337939|FG006|Overall Study|Progressive disease|8|||
27846412|NCT02648724|54337933|FG000|Overall Study|Other reason (unknown)|1|||
27846413|NCT02648724|54337934|FG001|Overall Study|Other reason (unknown)|0|||
27846414|NCT02648724|54337935|FG002|Overall Study|Other reason (unknown)|0|||
27846415|NCT02648724|54337936|FG003|Overall Study|Other reason (unknown)|0|||
27846416|NCT02648724|54337937|FG004|Overall Study|Other reason (unknown)|0|||
27846417|NCT02648724|54337938|FG005|Overall Study|Other reason (unknown)|0|||
27846418|NCT02648724|54337939|FG006|Overall Study|Other reason (unknown)|0|||
27846419|NCT02648724|54337933|FG000|Overall Study|Protocol Violation|0|||
27846420|NCT02648724|54337934|FG001|Overall Study|Protocol Violation|0|||
27808464|NCT01617187|54263938|FG000|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
27808465|NCT01617187|54263939|FG001|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
27846421|NCT02648724|54337935|FG002|Overall Study|Protocol Violation|0|||
27846422|NCT02648724|54337936|FG003|Overall Study|Protocol Violation|0|||
27846423|NCT02648724|54337937|FG004|Overall Study|Protocol Violation|1|||
27846424|NCT02648724|54337938|FG005|Overall Study|Protocol Violation|0|||
27846425|NCT02648724|54337939|FG006|Overall Study|Protocol Violation|0|||
27846426|NCT02648724|54337933|FG000|Overall Study|Death|0|||
27846427|NCT02648724|54337934|FG001|Overall Study|Death|0|||
27846428|NCT02648724|54337935|FG002|Overall Study|Death|0|||
27846429|NCT02648724|54337936|FG003|Overall Study|Death|0|||
27846430|NCT02648724|54337937|FG004|Overall Study|Death|0|||
27846431|NCT02648724|54337938|FG005|Overall Study|Death|0|||
27846432|NCT02648724|54337939|FG006|Overall Study|Death|3|||
27846433|NCT02648724|54337933|FG000|Overall Study|Physician Decision|0|||
27846434|NCT02648724|54337934|FG001|Overall Study|Physician Decision|0|||
27846435|NCT02648724|54337935|FG002|Overall Study|Physician Decision|0|||
27846436|NCT02648724|54337936|FG003|Overall Study|Physician Decision|0|||
27846437|NCT02648724|54337937|FG004|Overall Study|Physician Decision|1|||
27846438|NCT02648724|54337938|FG005|Overall Study|Physician Decision|0|||
27846439|NCT02648724|54337939|FG006|Overall Study|Physician Decision|1|||
27846440|NCT02648724|54337933|FG000|Overall Study|Transferred to named patient program|0|||
27846441|NCT02648724|54337934|FG001|Overall Study|Transferred to named patient program|0|||
27846442|NCT02648724|54337935|FG002|Overall Study|Transferred to named patient program|0|||
27846443|NCT02648724|54337936|FG003|Overall Study|Transferred to named patient program|0|||
27846444|NCT02648724|54337937|FG004|Overall Study|Transferred to named patient program|0|||
28035072|NCT00076999|54693284|FG000|Overall Study|Adverse Event|2|||
28035073|NCT00076999|54693285|FG001|Overall Study|Adverse Event|8|||
27808466|NCT01617187|54263940|FG002|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
27808467|NCT01617187|54263941|FG003|Randomization Through Start Treatment|Not Treated: Adverse Event|1|||
27846445|NCT02648724|54337938|FG005|Overall Study|Transferred to named patient program|1|||
27846446|NCT02648724|54337939|FG006|Overall Study|Transferred to named patient program|0|||
27846447|NCT01402817|54337971|FG000|Overall Study|Withdrawal by Subject|3|||
27846448|NCT01402817|54337971|FG000|Overall Study|Study Suspended by FDA|8|||
27846449|NCT01425203|54337978|FG000|Treatment Phase|DC during PR Lead-in Phase|3|||
27846450|NCT01425203|54337979|FG001|Treatment Phase|DC during PR Lead-in Phase|1|||
27846451|NCT01425203|54337980|FG002|Treatment Phase|DC during PR Lead-in Phase|0|||
27846452|NCT01425203|54337978|FG000|Treatment Phase|Failure at futility timepoint|8|||
27846453|NCT01425203|54337979|FG001|Treatment Phase|Failure at futility timepoint|27|||
27846454|NCT01425203|54337980|FG002|Treatment Phase|Failure at futility timepoint|0|||
27846455|NCT01425203|54337978|FG000|Treatment Phase|Other virologic failure criteria|5|||
27846456|NCT01425203|54337979|FG001|Treatment Phase|Other virologic failure criteria|3|||
27808468|NCT01617187|54263938|FG000|Randomization Through Start Treatment|Not Treated: Completed study in database|1|||
27808469|NCT01617187|54263939|FG001|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
27808470|NCT01617187|54263940|FG002|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
27808471|NCT01617187|54263941|FG003|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
27808472|NCT01617187|54263938|FG000|Treatment Through Study Completion|Adverse Event|1|||
27808473|NCT01617187|54263939|FG001|Treatment Through Study Completion|Adverse Event|1|||
27808474|NCT01617187|54263940|FG002|Treatment Through Study Completion|Adverse Event|0|||
27808475|NCT01617187|54263941|FG003|Treatment Through Study Completion|Adverse Event|1|||
27846457|NCT01425203|54337980|FG002|Treatment Phase|Other virologic failure criteria|0|||
27846458|NCT01425203|54337978|FG000|Treatment Phase|Unidentified reasons|11|||
27846459|NCT01425203|54337979|FG001|Treatment Phase|Unidentified reasons|5|||
27846460|NCT01425203|54337980|FG002|Treatment Phase|Unidentified reasons|0|||
27846461|NCT01425203|54337978|FG000|Treatment Phase|Did not receive treatment|0|||
27846462|NCT01425203|54337979|FG001|Treatment Phase|Did not receive treatment|1|||
27846463|NCT01425203|54337980|FG002|Treatment Phase|Did not receive treatment|0|||
27846464|NCT01425203|54337978|FG000|Crossover Phase|Failure at futility timepoint|0|||
27846465|NCT01425203|54337979|FG001|Crossover Phase|Failure at futility timepoint|0|||
27846466|NCT01425203|54337980|FG002|Crossover Phase|Failure at futility timepoint|3|||
27846467|NCT01425203|54337978|FG000|Crossover Phase|Other virologic failure criteria|0|||
27846468|NCT01425203|54337979|FG001|Crossover Phase|Other virologic failure criteria|0|||
27846469|NCT01425203|54337980|FG002|Crossover Phase|Other virologic failure criteria|3|||
27846470|NCT00081289|54337990|FG000|Overall Study|Accrued prior to chemotherapy amendment|18|||
27846471|NCT00081289|54337991|FG001|Overall Study|Accrued prior to chemotherapy amendment|17|||
27846472|NCT00081289|54337990|FG000|Overall Study|Ineligible / no protocol treatment|3|||
27846473|NCT00081289|54337991|FG001|Overall Study|Ineligible / no protocol treatment|4|||
27846474|NCT01478594|54338000|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
27846475|NCT01478594|54338001|FG001|Overall Study|Randomized but Never Received Study Drug|1|||
27846476|NCT01478594|54338000|FG000|Overall Study|Death|45|||
27846477|NCT01478594|54338001|FG001|Overall Study|Death|18|||
27846478|NCT01478594|54338000|FG000|Overall Study|Lost to Follow-up|3|||
27846479|NCT01478594|54338001|FG001|Overall Study|Lost to Follow-up|1|||
27846480|NCT01478594|54338000|FG000|Overall Study|Withdrawal by Subject|9|||
27846481|NCT01478594|54338001|FG001|Overall Study|Withdrawal by Subject|3|||
27846482|NCT01478594|54338000|FG000|Overall Study|Study Closed by Sponsor|8|||
27846483|NCT01478594|54338001|FG001|Overall Study|Study Closed by Sponsor|5|||
27846484|NCT01424813|54338062|FG000|Overall Study|Withdrawal by Subject|3|||
27846485|NCT01424813|54338063|FG001|Overall Study|Withdrawal by Subject|0|||
28105670|NCT04461015|54763216|FG000|Overall Study|IV access lost during the study|0|||
27846486|NCT01424813|54338062|FG000|Overall Study|Protocol Violation|1|||
27846487|NCT01424813|54338063|FG001|Overall Study|Protocol Violation|0|||
27846488|NCT01424813|54338062|FG000|Overall Study|Other|1|||
27846489|NCT01424813|54338063|FG001|Overall Study|Other|2|||
27846490|NCT00080899|54338069|FG000|Overall Study|Adverse Event|1|||
27846491|NCT00089635|54338073|FG000|Overall Study|Adverse Event|2|||
27846492|NCT00089635|54338073|FG000|Overall Study|Death|17|||
27846493|NCT00089635|54338073|FG000|Overall Study|Disease Progression|12|||
27846494|NCT00089635|54338073|FG000|Overall Study|Lost to Follow-up|3|||
27846495|NCT00089635|54338073|FG000|Overall Study|Withdrawal by Subject|6|||
27939805|NCT01227902|54596127|FG003|Overall Study|Physician Decision|0|||
27808476|NCT01617187|54263938|FG000|Treatment Through Study Completion|Lost to Follow-up|4|||
27808477|NCT01617187|54263939|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
27808478|NCT01617187|54263940|FG002|Treatment Through Study Completion|Lost to Follow-up|2|||
27808479|NCT01617187|54263941|FG003|Treatment Through Study Completion|Lost to Follow-up|2|||
27808480|NCT01617187|54263938|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
27808481|NCT01617187|54263939|FG001|Treatment Through Study Completion|Withdrawal by Subject|8|||
27808482|NCT01617187|54263940|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
27808483|NCT01617187|54263941|FG003|Treatment Through Study Completion|Withdrawal by Subject|6|||
27846496|NCT00089635|54338073|FG000|Overall Study|Ineligibility determined|1|||
27846497|NCT00089635|54338073|FG000|Overall Study|Other|2|||
27846498|NCT01500200|54338087|FG000|Stage 1|Adverse Event|1|||
27846499|NCT01500200|54338088|FG001|Stage 1|Adverse Event|4|||
27846500|NCT01500200|54338089|FG002|Stage 1|Adverse Event|5|||
27846501|NCT01500200|54338090|FG003|Stage 1|Adverse Event|0|||
27846502|NCT01500200|54338091|FG004|Stage 1|Adverse Event|0|||
27846503|NCT01500200|54338092|FG005|Stage 1|Adverse Event|0|||
27846504|NCT01500200|54338087|FG000|Stage 1|Lost to Follow-up|2|||
27846505|NCT01500200|54338088|FG001|Stage 1|Lost to Follow-up|2|||
27846506|NCT01500200|54338089|FG002|Stage 1|Lost to Follow-up|1|||
27846507|NCT01500200|54338090|FG003|Stage 1|Lost to Follow-up|0|||
27846508|NCT01500200|54338091|FG004|Stage 1|Lost to Follow-up|0|||
27846509|NCT01500200|54338092|FG005|Stage 1|Lost to Follow-up|0|||
27846510|NCT01500200|54338087|FG000|Stage 1|Withdrawal by Subject|3|||
27846511|NCT01500200|54338088|FG001|Stage 1|Withdrawal by Subject|0|||
27846512|NCT01500200|54338089|FG002|Stage 1|Withdrawal by Subject|0|||
27846513|NCT01500200|54338090|FG003|Stage 1|Withdrawal by Subject|0|||
27846514|NCT01500200|54338091|FG004|Stage 1|Withdrawal by Subject|0|||
27846515|NCT01500200|54338092|FG005|Stage 1|Withdrawal by Subject|0|||
27846516|NCT01500200|54338087|FG000|Stage 1|Noncompliance with Study Drug|1|||
27846517|NCT01500200|54338088|FG001|Stage 1|Noncompliance with Study Drug|0|||
27808484|NCT01617187|54263938|FG000|Treatment Through Study Completion|Protocol Violation|1|||
27846518|NCT01500200|54338089|FG002|Stage 1|Noncompliance with Study Drug|0|||
27846519|NCT01500200|54338090|FG003|Stage 1|Noncompliance with Study Drug|0|||
27846520|NCT01500200|54338091|FG004|Stage 1|Noncompliance with Study Drug|0|||
27846521|NCT01500200|54338092|FG005|Stage 1|Noncompliance with Study Drug|0|||
27846522|NCT01500200|54338087|FG000|Stage 1|Physician Decision|1|||
27846523|NCT01500200|54338088|FG001|Stage 1|Physician Decision|0|||
27846524|NCT01500200|54338089|FG002|Stage 1|Physician Decision|0|||
27846525|NCT01500200|54338090|FG003|Stage 1|Physician Decision|0|||
27808485|NCT01617187|54263939|FG001|Treatment Through Study Completion|Protocol Violation|0|||
27808486|NCT01617187|54263940|FG002|Treatment Through Study Completion|Protocol Violation|0|||
27808487|NCT01617187|54263941|FG003|Treatment Through Study Completion|Protocol Violation|1|||
27846526|NCT01500200|54338091|FG004|Stage 1|Physician Decision|0|||
27846527|NCT01500200|54338092|FG005|Stage 1|Physician Decision|0|||
27846528|NCT01500200|54338087|FG000|Stage 2|Adverse Event|0|||
27846529|NCT01500200|54338088|FG001|Stage 2|Adverse Event|0|||
27846530|NCT01500200|54338089|FG002|Stage 2|Adverse Event|0|||
27846531|NCT01500200|54338090|FG003|Stage 2|Adverse Event|0|||
27846532|NCT01500200|54338091|FG004|Stage 2|Adverse Event|5|||
27846533|NCT01500200|54338092|FG005|Stage 2|Adverse Event|4|||
27846534|NCT01478360|54338108|FG000|Overall Study|Lost to Follow-up|1|||
27846535|NCT01478360|54338109|FG001|Overall Study|Lost to Follow-up|0|||
27846536|NCT01478360|54338108|FG000|Overall Study|Adverse Event|0|||
27846537|NCT01478360|54338109|FG001|Overall Study|Adverse Event|1|||
27846538|NCT01478360|54338108|FG000|Overall Study|Administrative problems|1|||
27846539|NCT01478360|54338109|FG001|Overall Study|Administrative problems|2|||
27846540|NCT01461980|54338127|FG000|Overall Study|Other|9|||
27846541|NCT01461980|54338128|FG001|Overall Study|Other|8|||
27846542|NCT01461980|54338129|FG002|Overall Study|Other|6|||
27846543|NCT01461980|54338127|FG000|Overall Study|Medication error|7|||
28035074|NCT00076999|54693286|FG002|Overall Study|Adverse Event|6|||
28035075|NCT00076999|54693287|FG003|Overall Study|Adverse Event|0|||
28035076|NCT00076999|54693288|FG004|Overall Study|Adverse Event|2|||
28035077|NCT00076999|54693284|FG000|Overall Study|Protocol Violation|0|||
27808488|NCT01759407|54263953|FG000|Overall Study|Protocol Violation|0|||
27808489|NCT01759407|54263954|FG001|Overall Study|Protocol Violation|2|||
27808490|NCT01787331|54263960|FG000|Overall Study|Physician Decision|1|||
27808491|NCT01787331|54263960|FG000|Overall Study|Withdrawal by Subject|1|||
27808492|NCT01757847|54263966|FG000|Overall Study|Withdrawal by Subject|3|||
27808493|NCT01757847|54263967|FG001|Overall Study|Withdrawal by Subject|4|||
27808494|NCT01787097|54263973|FG000|Overall Study|Withdrawal by Subject|1|||
27808495|NCT01787097|54263974|FG001|Overall Study|Withdrawal by Subject|0|||
27808496|NCT01787097|54263975|FG002|Overall Study|Withdrawal by Subject|0|||
27808497|NCT01787097|54263976|FG003|Overall Study|Withdrawal by Subject|0|||
27808498|NCT01757691|54263996|FG000|Overall Study|Administrative problems|2|||
27808499|NCT01757691|54263997|FG001|Overall Study|Administrative problems|0|||
27808500|NCT01786707|54264005|FG000|Overall Study|Lost to Follow-up|1|||
27808501|NCT01786707|54264006|FG001|Overall Study|Lost to Follow-up|1|||
27808502|NCT01786629|54264014|FG000|Overall Study|Lack of Efficacy|0|||
27808503|NCT01786629|54264015|FG001|Overall Study|Lack of Efficacy|4|||
27808504|NCT01786629|54264014|FG000|Overall Study|Adverse Event|0|||
27808505|NCT01786629|54264015|FG001|Overall Study|Adverse Event|1|||
27808506|NCT01786551|54264021|FG000|Overall Study|Participant withdrew consent|2|||
27808507|NCT01973569|54264028|FG000|Overall Study|Adverse Event|9|||
27846544|NCT01461980|54338128|FG001|Overall Study|Medication error|5|||
27846545|NCT01461980|54338129|FG002|Overall Study|Medication error|6|||
27846546|NCT01461980|54338127|FG000|Overall Study|Adverse Event|12|||
27846547|NCT01461980|54338128|FG001|Overall Study|Adverse Event|5|||
27846548|NCT01461980|54338129|FG002|Overall Study|Adverse Event|6|||
27846549|NCT01461980|54338127|FG000|Overall Study|Protocol Violation|12|||
27846550|NCT01461980|54338128|FG001|Overall Study|Protocol Violation|19|||
27846551|NCT01461980|54338129|FG002|Overall Study|Protocol Violation|16|||
27846552|NCT01461980|54338127|FG000|Overall Study|No longer meets eligibility criteria|18|||
27846553|NCT01461980|54338128|FG001|Overall Study|No longer meets eligibility criteria|9|||
27846554|NCT01461980|54338129|FG002|Overall Study|No longer meets eligibility criteria|19|||
27846555|NCT01461980|54338127|FG000|Overall Study|Lost to Follow-up|52|||
27846556|NCT01461980|54338128|FG001|Overall Study|Lost to Follow-up|53|||
27846557|NCT01461980|54338129|FG002|Overall Study|Lost to Follow-up|51|||
27808508|NCT01973569|54264029|FG001|Overall Study|Adverse Event|2|||
27808509|NCT01973569|54264030|FG002|Overall Study|Adverse Event|4|||
27808510|NCT01973569|54264028|FG000|Overall Study|Protocol Violation|2|||
27846558|NCT01461980|54338127|FG000|Overall Study|No longer willing to participate|52|||
27846559|NCT01461980|54338128|FG001|Overall Study|No longer willing to participate|38|||
27846560|NCT01461980|54338129|FG002|Overall Study|No longer willing to participate|54|||
27846561|NCT01461980|54338127|FG000|Overall Study|Randomized but not vaccinated|4|||
27808511|NCT01973569|54264029|FG001|Overall Study|Protocol Violation|1|||
27808512|NCT01973569|54264030|FG002|Overall Study|Protocol Violation|3|||
27846562|NCT01461980|54338128|FG001|Overall Study|Randomized but not vaccinated|8|||
27846563|NCT01461980|54338129|FG002|Overall Study|Randomized but not vaccinated|7|||
27846564|NCT01424501|54338144|FG000|Overall Study|Withdrawal by Subject|1|||
27846565|NCT01424501|54338145|FG001|Overall Study|Withdrawal by Subject|0|||
27846566|NCT01424501|54338146|FG002|Overall Study|Withdrawal by Subject|1|||
27846567|NCT01424501|54338147|FG003|Overall Study|Withdrawal by Subject|0|||
27846568|NCT01424501|54338148|FG004|Overall Study|Withdrawal by Subject|0|||
27846569|NCT01424501|54338149|FG005|Overall Study|Withdrawal by Subject|0|||
27846570|NCT01424501|54338144|FG000|Overall Study|Lost to Follow-up|0|||
27846571|NCT01424501|54338145|FG001|Overall Study|Lost to Follow-up|1|||
27846572|NCT01424501|54338146|FG002|Overall Study|Lost to Follow-up|1|||
27846573|NCT01424501|54338147|FG003|Overall Study|Lost to Follow-up|0|||
27846574|NCT01424501|54338148|FG004|Overall Study|Lost to Follow-up|0|||
27846575|NCT01424501|54338149|FG005|Overall Study|Lost to Follow-up|0|||
27846576|NCT01401959|54338230|FG000|Enrolled|Withdrawal by Subject|1|||
27846577|NCT01401959|54338231|FG001|Enrolled|Withdrawal by Subject|0|||
27846578|NCT01401959|54338232|FG002|Enrolled|Withdrawal by Subject|0|||
27846579|NCT01401959|54338230|FG000|Treated|Disease Progression|2|||
27846580|NCT01401959|54338231|FG001|Treated|Disease Progression|2|||
27846581|NCT01401959|54338232|FG002|Treated|Disease Progression|1|||
27846582|NCT01401959|54338230|FG000|Treated|Adverse Event|4|||
27846583|NCT01401959|54338231|FG001|Treated|Adverse Event|3|||
27846584|NCT01401959|54338232|FG002|Treated|Adverse Event|2|||
27846585|NCT01401959|54338230|FG000|Treated|Withdrawal by Subject|1|||
27846586|NCT01401959|54338231|FG001|Treated|Withdrawal by Subject|2|||
27846587|NCT01401959|54338232|FG002|Treated|Withdrawal by Subject|2|||
27846588|NCT01401959|54338230|FG000|Treated|Protocol Violation|0|||
27846589|NCT01401959|54338231|FG001|Treated|Protocol Violation|1|||
27846590|NCT01401959|54338232|FG002|Treated|Protocol Violation|0|||
27846591|NCT01478048|54338262|FG000|Overall Study|Disease Progression|52|||
27846592|NCT01478048|54338263|FG001|Overall Study|Disease Progression|35|||
27846593|NCT01478048|54338262|FG000|Overall Study|study drug toxicity|11|||
27846594|NCT01478048|54338263|FG001|Overall Study|study drug toxicity|14|||
27846595|NCT01478048|54338262|FG000|Overall Study|Adverse Event|2|||
27846596|NCT01478048|54338263|FG001|Overall Study|Adverse Event|11|||
27846597|NCT01478048|54338262|FG000|Overall Study|subject request to discontinue treatment|3|||
27846598|NCT01478048|54338263|FG001|Overall Study|subject request to discontinue treatment|5|||
27846599|NCT01478048|54338262|FG000|Overall Study|Withdrawal by Subject|2|||
27846600|NCT01478048|54338263|FG001|Overall Study|Withdrawal by Subject|5|||
27846601|NCT01478048|54338262|FG000|Overall Study|non-specified|6|||
27846602|NCT01478048|54338263|FG001|Overall Study|non-specified|4|||
27846603|NCT01478048|54338262|FG000|Overall Study|poor/non-compliance|0|||
27846604|NCT01478048|54338263|FG001|Overall Study|poor/non-compliance|1|||
28035078|NCT00076999|54693285|FG001|Overall Study|Protocol Violation|3|||
27808513|NCT01973569|54264028|FG000|Overall Study|Withdrawal by Subject|7|||
27808514|NCT01973569|54264029|FG001|Overall Study|Withdrawal by Subject|5|||
27808515|NCT01973569|54264030|FG002|Overall Study|Withdrawal by Subject|2|||
27808516|NCT01973569|54264028|FG000|Overall Study|Invasive dental treatment|3|||
27808517|NCT01973569|54264029|FG001|Overall Study|Invasive dental treatment|5|||
27808518|NCT01973569|54264030|FG002|Overall Study|Invasive dental treatment|6|||
27808519|NCT01973569|54264028|FG000|Overall Study|Prohibited concomitant d|1|||
27808520|NCT01973569|54264029|FG001|Overall Study|Prohibited concomitant d|5|||
27808521|NCT01973569|54264030|FG002|Overall Study|Prohibited concomitant d|0|||
27808522|NCT01973569|54264028|FG000|Overall Study|Disease progression|0|||
27846605|NCT01478048|54338262|FG000|Overall Study|no longer meets study criteria|1|||
27846606|NCT01478048|54338263|FG001|Overall Study|no longer meets study criteria|0|||
27846607|NCT01424189|54338271|FG000|Overall Study|Adverse Event|1|||
27846608|NCT01424189|54338272|FG001|Overall Study|Adverse Event|0|||
27846609|NCT01424189|54338271|FG000|Overall Study|Lost to Follow-up|4|||
27846610|NCT01424189|54338272|FG001|Overall Study|Lost to Follow-up|1|||
27846611|NCT01424189|54338271|FG000|Overall Study|Withdrawal by Subject|4|||
27846612|NCT01424189|54338272|FG001|Overall Study|Withdrawal by Subject|4|||
27846613|NCT01424189|54338271|FG000|Overall Study|Subject moved|1|||
27846614|NCT01424189|54338272|FG001|Overall Study|Subject moved|0|||
27846615|NCT01424189|54338271|FG000|Overall Study|Death|3|||
27846616|NCT01424189|54338272|FG001|Overall Study|Death|1|||
27846617|NCT01401647|54338285|FG000|Overall Study|Withdrawal by Subject|1|||
27846618|NCT01401647|54338286|FG001|Overall Study|Withdrawal by Subject|5|||
27846619|NCT01401647|54338287|FG002|Overall Study|Withdrawal by Subject|2|||
27846620|NCT01401647|54338285|FG000|Overall Study|Lost to Follow-up|3|||
27846621|NCT01401647|54338286|FG001|Overall Study|Lost to Follow-up|3|||
27846622|NCT01401647|54338287|FG002|Overall Study|Lost to Follow-up|1|||
27846623|NCT01499810|54338295|FG000|Overall Study|Lost to Follow-up|10|||
27846624|NCT01499810|54338295|FG000|Overall Study|Protocol Violation|1|||
27846625|NCT01499810|54338295|FG000|Overall Study|Withdrawal by Subject|1|||
27846626|NCT01423253|54338300|FG000|Overall Study|Adverse Event|2|||
27846627|NCT01423253|54338300|FG000|Overall Study|Lack of Efficacy|2|||
27846628|NCT01423253|54338300|FG000|Overall Study|Lost to Follow-up|1|||
27846629|NCT01423253|54338300|FG000|Overall Study|Protocol Violation|2|||
27846630|NCT01423253|54338300|FG000|Overall Study|Withdrawal by Subject|2|||
27846631|NCT01477892|54338306|FG000|Overall Study|Withdrawal by Subject|0|||
27846632|NCT01477892|54338307|FG001|Overall Study|Withdrawal by Subject|2|||
27846633|NCT01422239|54338320|FG000|Overall Study|Lost to Follow-up|4|||
27846634|NCT01422239|54338321|FG001|Overall Study|Lost to Follow-up|3|||
27846635|NCT01499576|54338327|FG000|Overall Study|Physician Decision|12|||
27846636|NCT01499576|54338327|FG000|Overall Study|Withdrawal by Subject|9|||
27846637|NCT01476722|54338341|FG000|Overall Study|Adverse Event|1|||
27846638|NCT01476644|54338354|FG000|Overall Study|Death|5|||
27846639|NCT01476644|54338354|FG000|Overall Study|moved to another state|2|||
27846640|NCT01476644|54338354|FG000|Overall Study|Lost to Follow-up|19|||
27846641|NCT01476644|54338354|FG000|Overall Study|Withdrawal by Subject|13|||
27846642|NCT01421459|54338378|FG000|Overall Study|Adverse Event|6|||
27846643|NCT01421459|54338379|FG001|Overall Study|Adverse Event|10|||
27846644|NCT01421459|54338378|FG000|Overall Study|Death|1|||
27846645|NCT01421459|54338379|FG001|Overall Study|Death|1|||
27846646|NCT01421459|54338378|FG000|Overall Study|Lack of Efficacy|1|||
27846647|NCT01421459|54338379|FG001|Overall Study|Lack of Efficacy|2|||
27846648|NCT01421459|54338378|FG000|Overall Study|Lost to Follow-up|8|||
27846649|NCT01421459|54338379|FG001|Overall Study|Lost to Follow-up|9|||
27846650|NCT01421459|54338378|FG000|Overall Study|Physician Decision|9|||
27846651|NCT01421459|54338379|FG001|Overall Study|Physician Decision|9|||
27846652|NCT01421459|54338378|FG000|Overall Study|Protocol Violation|8|||
27846653|NCT01421459|54338379|FG001|Overall Study|Protocol Violation|5|||
27846654|NCT01421459|54338378|FG000|Overall Study|Withdrawal by Subject|12|||
27846655|NCT01421459|54338379|FG001|Overall Study|Withdrawal by Subject|16|||
27846656|NCT01498952|54338387|FG000|Overall Study|Death|2|||
27846657|NCT01498952|54338388|FG001|Overall Study|Death|2|||
27846658|NCT01498952|54338389|FG002|Overall Study|Death|0|||
27846659|NCT01498952|54338390|FG003|Overall Study|Death|0|||
27846660|NCT01498952|54338391|FG004|Overall Study|Death|0|||
27846661|NCT01461044|54338423|FG000|Overall Study|Death|58|||
27846662|NCT01461044|54338424|FG001|Overall Study|Death|35|||
27846663|NCT01461044|54338423|FG000|Overall Study|Lost to Follow-up|12|||
27846664|NCT01461044|54338424|FG001|Overall Study|Lost to Follow-up|5|||
27846665|NCT01421303|54338457|FG000|Overall Study|Lost to Follow-up|13|||
27846666|NCT01421303|54338457|FG000|Overall Study|Non compliance with study procedure|1|||
27846667|NCT01421303|54338457|FG000|Overall Study|Other|7|||
27846668|NCT01421303|54338457|FG000|Overall Study|Withdrawal by Subject|1|||
27846669|NCT01475474|54338461|FG000|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4|||
27846670|NCT01475474|54338461|FG000|Baseline Period - 4 Weeks|Withdrawal by Subject|2|||
27846671|NCT01400243|54338468|FG000|Overall Study|Protocol Violation|8|||
27846672|NCT01400243|54338469|FG001|Overall Study|Protocol Violation|11|||
27846673|NCT01475162|54338486|FG000|Overall Study|Physician Decision|1|||
27846674|NCT01475162|54338486|FG000|Overall Study|Death|10|||
27846675|NCT01475162|54338486|FG000|Overall Study|Study closed for safety|3|||
27846676|NCT01421225|54338493|FG000|Overall Study|Withdrawal by Subject|0|||
27846677|NCT01421225|54338494|FG001|Overall Study|Withdrawal by Subject|1|||
27846678|NCT01498640|54338510|FG000|Overall Study|Lost to Follow-up|1|||
27846679|NCT01498640|54338510|FG000|Overall Study|Death|1|||
27846680|NCT01498640|54338510|FG000|Overall Study|Other|3|||
27846681|NCT01498484|54338522|FG000|Overall Study|Death|6|||
27846682|NCT01498484|54338523|FG001|Overall Study|Death|3|||
27846683|NCT01498484|54338524|FG002|Overall Study|Death|1|||
27846684|NCT01498484|54338525|FG003|Overall Study|Death|1|||
27846685|NCT01498484|54338526|FG004|Overall Study|Death|0|||
27846686|NCT01498484|54338527|FG005|Overall Study|Death|0|||
27846687|NCT01498484|54338528|FG006|Overall Study|Death|10|||
27846688|NCT01498484|54338529|FG007|Overall Study|Death|1|||
27846689|NCT01498484|54338530|FG008|Overall Study|Death|0|||
27846690|NCT01498484|54338522|FG000|Overall Study|Physician Decision|3|||
27846691|NCT01498484|54338523|FG001|Overall Study|Physician Decision|2|||
27846692|NCT01498484|54338524|FG002|Overall Study|Physician Decision|1|||
27846693|NCT01498484|54338525|FG003|Overall Study|Physician Decision|1|||
27846694|NCT01498484|54338526|FG004|Overall Study|Physician Decision|0|||
27846695|NCT01498484|54338527|FG005|Overall Study|Physician Decision|0|||
27846696|NCT01498484|54338528|FG006|Overall Study|Physician Decision|8|||
27846697|NCT01498484|54338529|FG007|Overall Study|Physician Decision|13|||
27846698|NCT01498484|54338530|FG008|Overall Study|Physician Decision|1|||
27846699|NCT01498484|54338522|FG000|Overall Study|Adverse Event|0|||
27846700|NCT01498484|54338523|FG001|Overall Study|Adverse Event|0|||
27846701|NCT01498484|54338524|FG002|Overall Study|Adverse Event|0|||
27846702|NCT01498484|54338525|FG003|Overall Study|Adverse Event|0|||
27846703|NCT01498484|54338526|FG004|Overall Study|Adverse Event|0|||
27846704|NCT01498484|54338527|FG005|Overall Study|Adverse Event|1|||
27846705|NCT01498484|54338528|FG006|Overall Study|Adverse Event|0|||
27846706|NCT01498484|54338529|FG007|Overall Study|Adverse Event|0|||
27846707|NCT01498484|54338530|FG008|Overall Study|Adverse Event|0|||
27846708|NCT01498484|54338522|FG000|Overall Study|Withdrawal by Subject|0|||
27846709|NCT01498484|54338523|FG001|Overall Study|Withdrawal by Subject|0|||
27846710|NCT01498484|54338524|FG002|Overall Study|Withdrawal by Subject|0|||
27846711|NCT01498484|54338525|FG003|Overall Study|Withdrawal by Subject|1|||
27846712|NCT01498484|54338526|FG004|Overall Study|Withdrawal by Subject|0|||
27846713|NCT01498484|54338527|FG005|Overall Study|Withdrawal by Subject|0|||
27846714|NCT01498484|54338528|FG006|Overall Study|Withdrawal by Subject|1|||
27846715|NCT01498484|54338529|FG007|Overall Study|Withdrawal by Subject|0|||
27846716|NCT01498484|54338530|FG008|Overall Study|Withdrawal by Subject|0|||
27846717|NCT01498484|54338522|FG000|Overall Study|Other|5|||
27846718|NCT01498484|54338523|FG001|Overall Study|Other|2|||
27846719|NCT01498484|54338524|FG002|Overall Study|Other|0|||
27846720|NCT01498484|54338525|FG003|Overall Study|Other|0|||
27846721|NCT01498484|54338526|FG004|Overall Study|Other|1|||
27846722|NCT01498484|54338527|FG005|Overall Study|Other|0|||
27846723|NCT01498484|54338528|FG006|Overall Study|Other|3|||
27846724|NCT01498484|54338529|FG007|Overall Study|Other|0|||
27846725|NCT01498484|54338530|FG008|Overall Study|Other|1|||
27846726|NCT01474772|54338539|FG000|Period 1|Adverse Event (AE) Related to Study Drug|6|||
27846727|NCT01474772|54338540|FG001|Period 1|Adverse Event (AE) Related to Study Drug|1|||
27846728|NCT01474772|54338539|FG000|Period 1|AE not Related to Study Drug|1|||
27846729|NCT01474772|54338540|FG001|Period 1|AE not Related to Study Drug|0|||
27846730|NCT01474772|54338539|FG000|Period 1|Withdrawal by Subject|3|||
27846731|NCT01474772|54338540|FG001|Period 1|Withdrawal by Subject|1|||
27846732|NCT01474772|54338539|FG000|Period 1|Lost to Follow-up|1|||
27846733|NCT01474772|54338540|FG001|Period 1|Lost to Follow-up|0|||
27846734|NCT01474772|54338539|FG000|Period 1|Reason not Specified|1|||
27846735|NCT01474772|54338540|FG001|Period 1|Reason not Specified|1|||
27846736|NCT01474772|54338539|FG000|Washout|AE not Related to Study Drug|2|||
27846737|NCT01474772|54338540|FG001|Washout|AE not Related to Study Drug|0|||
27846738|NCT01474772|54338539|FG000|Washout|Withdrawal by Subject|1|||
27846739|NCT01474772|54338540|FG001|Washout|Withdrawal by Subject|0|||
27846740|NCT01474772|54338539|FG000|Washout|Lost to Follow-up|0|||
27846741|NCT01474772|54338540|FG001|Washout|Lost to Follow-up|1|||
27846742|NCT01474772|54338539|FG000|Washout|Reason not Specified|0|||
27846743|NCT01474772|54338540|FG001|Washout|Reason not Specified|1|||
27846744|NCT01474772|54338539|FG000|Period 2|Death|0|||
27846745|NCT01474772|54338540|FG001|Period 2|Death|1|||
27846746|NCT01474772|54338539|FG000|Period 2|AE Related to Study Drug|0|||
27846747|NCT01474772|54338540|FG001|Period 2|AE Related to Study Drug|1|||
27846748|NCT01474772|54338539|FG000|Period 2|AE not Related to Study Drug|4|||
27846749|NCT01474772|54338540|FG001|Period 2|AE not Related to Study Drug|1|||
27846750|NCT01474772|54338539|FG000|Period 2|Lack of Efficacy|1|||
27846751|NCT01474772|54338540|FG001|Period 2|Lack of Efficacy|0|||
27846752|NCT01474772|54338539|FG000|Period 2|Withdrawal by Subject|3|||
27846753|NCT01474772|54338540|FG001|Period 2|Withdrawal by Subject|4|||
28035079|NCT00076999|54693286|FG002|Overall Study|Protocol Violation|4|||
27808523|NCT01973569|54264029|FG001|Overall Study|Disease progression|3|||
27808524|NCT01973569|54264030|FG002|Overall Study|Disease progression|0|||
27808525|NCT01973569|54264028|FG000|Overall Study|Other|1|||
27808526|NCT01973569|54264029|FG001|Overall Study|Other|1|||
27808527|NCT01973569|54264030|FG002|Overall Study|Other|0|||
27808528|NCT01973569|54264028|FG000|Overall Study|Did not receive study drug|6|||
27808529|NCT01973569|54264029|FG001|Overall Study|Did not receive study drug|3|||
27808530|NCT01973569|54264030|FG002|Overall Study|Did not receive study drug|3|||
27808531|NCT01973491|54264038|FG000|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17|||
27808532|NCT01973491|54264038|FG000|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1|||
27808533|NCT01973491|54264038|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
27808534|NCT01951586|54264044|FG000|Overall Study|Death|61|||
27808535|NCT01951586|54264045|FG001|Overall Study|Death|120|||
27808536|NCT01951586|54264044|FG000|Overall Study|Withdrawal by Subject|8|||
27808537|NCT01951586|54264045|FG001|Overall Study|Withdrawal by Subject|17|||
27808538|NCT01951586|54264044|FG000|Overall Study|Lost to Follow-up|0|||
28035080|NCT00076999|54693287|FG003|Overall Study|Protocol Violation|0|||
27808539|NCT01951586|54264045|FG001|Overall Study|Lost to Follow-up|1|||
27808540|NCT01951586|54264044|FG000|Overall Study|Sponsor Decision|9|||
27808541|NCT01951586|54264045|FG001|Overall Study|Sponsor Decision|10|||
27808542|NCT01785849|54264054|FG000|Overall Study|Death|7|||
27846754|NCT01474772|54338539|FG000|Period 2|Lost to Follow-up|1|||
27846755|NCT01474772|54338540|FG001|Period 2|Lost to Follow-up|1|||
27846756|NCT01474772|54338539|FG000|Period 2|Reason not Specified|0|||
27846757|NCT01474772|54338540|FG001|Period 2|Reason not Specified|2|||
27846758|NCT01474772|54338539|FG000|Follow-up|AE not Related to Study Drug|0|||
27846759|NCT01474772|54338540|FG001|Follow-up|AE not Related to Study Drug|1|||
27846760|NCT01421147|54338548|FG000|Treatment Period|Adverse Event|2|||
27846761|NCT01421147|54338549|FG001|Treatment Period|Adverse Event|3|||
27846762|NCT01421147|54338548|FG000|Treatment Period|Lost to Follow-up|2|||
27846763|NCT01421147|54338549|FG001|Treatment Period|Lost to Follow-up|1|||
27846764|NCT01421147|54338548|FG000|Treatment Period|Physician Decision|2|||
27846765|NCT01421147|54338549|FG001|Treatment Period|Physician Decision|2|||
27846766|NCT01421147|54338548|FG000|Treatment Period|Withdrawal by Subject|10|||
27846767|NCT01421147|54338549|FG001|Treatment Period|Withdrawal by Subject|5|||
27846768|NCT01421147|54338548|FG000|Extension Period|Adverse Event|0|||
27846769|NCT01421147|54338549|FG001|Extension Period|Adverse Event|2|||
27846770|NCT01421147|54338548|FG000|Extension Period|Death|0|||
27846771|NCT01421147|54338549|FG001|Extension Period|Death|1|||
27846772|NCT01421147|54338548|FG000|Extension Period|Lost to Follow-up|2|||
27846773|NCT01421147|54338549|FG001|Extension Period|Lost to Follow-up|5|||
27846774|NCT01421147|54338548|FG000|Extension Period|Physician Decision|1|||
27846775|NCT01421147|54338549|FG001|Extension Period|Physician Decision|0|||
27846776|NCT01421147|54338548|FG000|Extension Period|Withdrawal by Subject|5|||
27846777|NCT01421147|54338549|FG001|Extension Period|Withdrawal by Subject|3|||
27846778|NCT01497938|54338566|FG000|Overall Study|Adverse Event|0|||
27846779|NCT01497938|54338567|FG001|Overall Study|Adverse Event|1|||
27846780|NCT01497938|54338566|FG000|Overall Study|Physician Decision|0|||
27846781|NCT01497938|54338567|FG001|Overall Study|Physician Decision|1|||
27846782|NCT01497938|54338566|FG000|Overall Study|Withdrawal by Subject|4|||
27846783|NCT01497938|54338567|FG001|Overall Study|Withdrawal by Subject|0|||
27846784|NCT01497938|54338566|FG000|Overall Study|Device Violation|1|||
27846785|NCT01497938|54338567|FG001|Overall Study|Device Violation|0|||
27846786|NCT01460342|54338617|FG000|Overall Study|Adverse Event|5|||
27846787|NCT01460342|54338618|FG001|Overall Study|Adverse Event|4|||
27846788|NCT01460342|54338617|FG000|Overall Study|Lost to Follow-up|1|||
27846789|NCT01460342|54338618|FG001|Overall Study|Lost to Follow-up|2|||
27846790|NCT01460342|54338617|FG000|Overall Study|Protocol Violation|0|||
27846791|NCT01460342|54338618|FG001|Overall Study|Protocol Violation|1|||
27846792|NCT01460342|54338617|FG000|Overall Study|Withdrawal by Subject|3|||
27846793|NCT01460342|54338618|FG001|Overall Study|Withdrawal by Subject|4|||
27846794|NCT01460342|54338617|FG000|Overall Study|Physician Decision|1|||
27846795|NCT01460342|54338618|FG001|Overall Study|Physician Decision|3|||
27846796|NCT01460342|54338617|FG000|Overall Study|Lack of Efficacy|1|||
27846797|NCT01460342|54338618|FG001|Overall Study|Lack of Efficacy|0|||
27846798|NCT01459796|54338650|FG000|Overall Study|Non compliance with protocol|2|||
27846799|NCT01459796|54338651|FG001|Overall Study|Non compliance with protocol|4|||
27846800|NCT01459796|54338650|FG000|Overall Study|Adverse Event|5|||
27846801|NCT01459796|54338651|FG001|Overall Study|Adverse Event|5|||
27846802|NCT01459796|54338650|FG000|Overall Study|Withdrawal by Subject|6|||
27846803|NCT01459796|54338651|FG001|Overall Study|Withdrawal by Subject|3|||
27808543|NCT01785849|54264055|FG001|Overall Study|Death|9|||
27808544|NCT01785849|54264054|FG000|Overall Study|Protocol Specified Criteria|29|||
27808545|NCT01785849|54264055|FG001|Overall Study|Protocol Specified Criteria|1|||
27808546|NCT01785849|54264054|FG000|Overall Study|Withdrawal by Subject|15|||
27808547|NCT01785849|54264055|FG001|Overall Study|Withdrawal by Subject|12|||
27808548|NCT01785849|54264054|FG000|Overall Study|Sponsor Decision|0|||
27808549|NCT01785849|54264055|FG001|Overall Study|Sponsor Decision|1|||
27808550|NCT01785849|54264054|FG000|Overall Study|Lost to Follow-up|10|||
27808551|NCT01785849|54264055|FG001|Overall Study|Lost to Follow-up|11|||
27846804|NCT01459796|54338650|FG000|Overall Study|Lost to Follow-up|5|||
27846805|NCT01459796|54338651|FG001|Overall Study|Lost to Follow-up|4|||
27846806|NCT01459796|54338650|FG000|Overall Study|Reason unspecified|1|||
27846807|NCT01459796|54338651|FG001|Overall Study|Reason unspecified|2|||
27846808|NCT01459796|54338650|FG000|Overall Study|Decision by the sponsor|75|||
27846809|NCT01459796|54338651|FG001|Overall Study|Decision by the sponsor|108|||
27846810|NCT01459718|54338661|FG000|Overall Study|Physician Decision|1|||
27846811|NCT01459718|54338661|FG000|Overall Study|Lost to Follow-up|1|||
27846812|NCT01459718|54338661|FG000|Overall Study|Adverse Event|1|||
27846813|NCT02970318|54338671|FG000|Overall for Arm A & Main for Arm B|Lost to Follow-up|2|||
27846814|NCT02970318|54338672|FG001|Overall for Arm A & Main for Arm B|Lost to Follow-up|1|||
27808552|NCT01756833|54264063|FG000|Overall Study|Withdrawal by Subject|4|||
27846815|NCT02970318|54338673|FG002|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
27846816|NCT02970318|54338674|FG003|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
27846817|NCT02970318|54338671|FG000|Overall for Arm A & Main for Arm B|Withdrawal by Subject|13|||
27846818|NCT02970318|54338672|FG001|Overall for Arm A & Main for Arm B|Withdrawal by Subject|14|||
27846819|NCT02970318|54338673|FG002|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
27846820|NCT02970318|54338674|FG003|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
27846821|NCT02970318|54338671|FG000|Overall for Arm A & Main for Arm B|Death|41|||
27846822|NCT02970318|54338672|FG001|Overall for Arm A & Main for Arm B|Death|33|||
27846823|NCT02970318|54338673|FG002|Overall for Arm A & Main for Arm B|Death|0|||
27846824|NCT02970318|54338674|FG003|Overall for Arm A & Main for Arm B|Death|0|||
27846825|NCT02970318|54338671|FG000|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
27846826|NCT02970318|54338672|FG001|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|80|||
27846827|NCT02970318|54338673|FG002|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
27846828|NCT02970318|54338674|FG003|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
27846829|NCT02970318|54338671|FG000|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
27846830|NCT02970318|54338672|FG001|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
27846831|NCT02970318|54338673|FG002|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|2|||
27846832|NCT02970318|54338674|FG003|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
27939806|NCT01227902|54596124|FG000|Overall Study|Withdrawal by Subject|4|||
28035081|NCT00076999|54693288|FG004|Overall Study|Protocol Violation|9|||
28035082|NCT00076999|54693284|FG000|Overall Study|Lost to Follow-up|2|||
28035083|NCT00076999|54693285|FG001|Overall Study|Lost to Follow-up|1|||
28035084|NCT00076999|54693286|FG002|Overall Study|Lost to Follow-up|0|||
28035085|NCT00076999|54693287|FG003|Overall Study|Lost to Follow-up|0|||
28035086|NCT00076999|54693288|FG004|Overall Study|Lost to Follow-up|0|||
28035087|NCT00076999|54693284|FG000|Overall Study|Withdrawal by Subject|0|||
28035088|NCT00076999|54693285|FG001|Overall Study|Withdrawal by Subject|4|||
28035089|NCT00076999|54693286|FG002|Overall Study|Withdrawal by Subject|3|||
28035090|NCT00076999|54693287|FG003|Overall Study|Withdrawal by Subject|0|||
28035091|NCT00076999|54693288|FG004|Overall Study|Withdrawal by Subject|1|||
28035092|NCT00076999|54693284|FG000|Overall Study|Other reason (not specified)|8|||
28035093|NCT00076999|54693285|FG001|Overall Study|Other reason (not specified)|8|||
28035094|NCT00076999|54693286|FG002|Overall Study|Other reason (not specified)|4|||
28035095|NCT00076999|54693287|FG003|Overall Study|Other reason (not specified)|1|||
28035096|NCT00076999|54693288|FG004|Overall Study|Other reason (not specified)|13|||
28035097|NCT03905096|54693303|FG000|Period 2 for Trial Part 1 and 2|Adverse Event|1|||
28035098|NCT03905096|54693304|FG001|Period 2 for Trial Part 1 and 2|Adverse Event|0|||
28035099|NCT00412360|54693319|FG000|Overall Study|Lost to Follow-up|0|||
28035100|NCT00412360|54693320|FG001|Overall Study|Lost to Follow-up|1|||
28035101|NCT00412360|54693319|FG000|Overall Study|Not Transplanted|1|||
28035102|NCT00412360|54693320|FG001|Overall Study|Not Transplanted|2|||
28035103|NCT00571103|54693326|FG000|Overall Study|Withdrawal by Subject|1|||
28035104|NCT00571103|54693326|FG000|Overall Study|Lost to Follow-up|1|||
28035105|NCT00084799|54693332|FG000|Overall Study|Disease Progression|1|||
28035106|NCT00084799|54693333|FG001|Overall Study|Disease Progression|0|||
28035107|NCT00069277|54693339|FG000|Overall Study|Adverse Event|3|||
28035108|NCT00069277|54693339|FG000|Overall Study|Withdrawal by Subject|1|||
28035109|NCT00069277|54693339|FG000|Overall Study|Progressive Disease|15|||
28035110|NCT00069277|54693339|FG000|Overall Study|Physician Decision|2|||
28035111|NCT00418522|54693345|FG000|Overall Study|Adverse Event|7|||
28035112|NCT00418522|54693346|FG001|Overall Study|Adverse Event|1|||
28035113|NCT00418522|54693345|FG000|Overall Study|Lack of Efficacy|1|||
28035114|NCT00418522|54693346|FG001|Overall Study|Lack of Efficacy|3|||
28035115|NCT00418522|54693345|FG000|Overall Study|Lost to Follow-up|10|||
28035116|NCT00418522|54693346|FG001|Overall Study|Lost to Follow-up|4|||
28035117|NCT00418522|54693345|FG000|Overall Study|Withdrawal by Subject|31|||
28035118|NCT00418522|54693346|FG001|Overall Study|Withdrawal by Subject|7|||
28035119|NCT00418522|54693345|FG000|Overall Study|Other|27|||
28035120|NCT00418522|54693346|FG001|Overall Study|Other|23|||
28035121|NCT00418522|54693345|FG000|Overall Study|Randomized but did not receive treatment|7|||
28035122|NCT00418522|54693346|FG001|Overall Study|Randomized but did not receive treatment|4|||
28035123|NCT00403546|54693354|FG000|Signed Informed Consent/Open-Label|Withdrew Consent|6|||
28035124|NCT00403546|54693355|FG001|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
28035125|NCT00403546|54693356|FG002|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
28035126|NCT00403546|54693354|FG000|Signed Informed Consent/Open-Label|Early Termination|8|||
28035127|NCT00403546|54693355|FG001|Signed Informed Consent/Open-Label|Early Termination|0|||
28035128|NCT00403546|54693356|FG002|Signed Informed Consent/Open-Label|Early Termination|0|||
28035129|NCT00403546|54693354|FG000|Signed Informed Consent/Open-Label|Terminated by Investigator|9|||
28035130|NCT00403546|54693355|FG001|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
28035131|NCT00403546|54693356|FG002|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
28035132|NCT00403546|54693354|FG000|Signed Informed Consent/Open-Label|Adverse Event|5|||
28035133|NCT00403546|54693355|FG001|Signed Informed Consent/Open-Label|Adverse Event|0|||
28035134|NCT00403546|54693356|FG002|Signed Informed Consent/Open-Label|Adverse Event|0|||
28035135|NCT00403546|54693354|FG000|Screening Phase|Screening Failure|22|||
28035136|NCT00403546|54693355|FG001|Screening Phase|Screening Failure|0|||
28035137|NCT00403546|54693356|FG002|Screening Phase|Screening Failure|0|||
28035138|NCT00403546|54693354|FG000|Screening Phase|Adverse Event|1|||
28035139|NCT00403546|54693355|FG001|Screening Phase|Adverse Event|0|||
28035140|NCT00403546|54693356|FG002|Screening Phase|Adverse Event|0|||
28035141|NCT00403546|54693354|FG000|Screening Phase|Terminated Prior to Randomization|5|||
28035142|NCT00403546|54693355|FG001|Screening Phase|Terminated Prior to Randomization|0|||
28035143|NCT00403546|54693356|FG002|Screening Phase|Terminated Prior to Randomization|0|||
27846833|NCT02970318|54338671|FG000|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
27846834|NCT02970318|54338672|FG001|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
27846835|NCT02970318|54338673|FG002|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
27846836|NCT02970318|54338674|FG003|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
27846837|NCT02970318|54338671|FG000|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
27846838|NCT02970318|54338672|FG001|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
27846839|NCT02970318|54338673|FG002|ArmB: Inv.Choice Crossed Over to Acala|Death|18|||
27846840|NCT02970318|54338674|FG003|ArmB: Inv.Choice Crossed Over to Acala|Death|2|||
27846841|NCT02900976|54338684|FG000|Overall Study|Adverse Event|0|||
27846842|NCT02900976|54338685|FG001|Overall Study|Adverse Event|1|||
27846843|NCT02900976|54338684|FG000|Overall Study|Physician Decision|0|||
27846844|NCT02900976|54338685|FG001|Overall Study|Physician Decision|2|||
27846845|NCT02900976|54338684|FG000|Overall Study|Progressive disease|0|||
27846846|NCT02900976|54338685|FG001|Overall Study|Progressive disease|6|||
27808553|NCT01756833|54264064|FG001|Overall Study|Withdrawal by Subject|3|||
27808554|NCT01617967|54264076|FG000|Overall Study|Protocol Violation|0|||
27808555|NCT01617967|54264077|FG001|Overall Study|Protocol Violation|0|||
27808556|NCT01617967|54264078|FG002|Overall Study|Protocol Violation|0|||
27808557|NCT01617967|54264079|FG003|Overall Study|Protocol Violation|1|||
27808558|NCT01617967|54264080|FG004|Overall Study|Protocol Violation|0|||
27808559|NCT01617967|54264081|FG005|Overall Study|Protocol Violation|0|||
27808560|NCT01617967|54264076|FG000|Overall Study|Withdrawal by Subject|0|||
27808561|NCT01617967|54264077|FG001|Overall Study|Withdrawal by Subject|0|||
27808562|NCT01617967|54264078|FG002|Overall Study|Withdrawal by Subject|0|||
27808563|NCT01617967|54264079|FG003|Overall Study|Withdrawal by Subject|0|||
27808564|NCT01617967|54264080|FG004|Overall Study|Withdrawal by Subject|0|||
27808565|NCT01617967|54264081|FG005|Overall Study|Withdrawal by Subject|1|||
27808566|NCT01617967|54264076|FG000|Overall Study|Dosing Suspended by Sponsor|1|||
27808567|NCT01617967|54264077|FG001|Overall Study|Dosing Suspended by Sponsor|0|||
27808568|NCT01617967|54264078|FG002|Overall Study|Dosing Suspended by Sponsor|0|||
27808569|NCT01617967|54264079|FG003|Overall Study|Dosing Suspended by Sponsor|0|||
27808570|NCT01617967|54264080|FG004|Overall Study|Dosing Suspended by Sponsor|0|||
27808571|NCT01617967|54264081|FG005|Overall Study|Dosing Suspended by Sponsor|0|||
27808572|NCT01785615|54264099|FG000|Dietary Phase|Lost to Follow-up|0|||
27808573|NCT01785615|54264100|FG001|Dietary Phase|Lost to Follow-up|0|||
27808574|NCT01785615|54264101|FG002|Dietary Phase|Lost to Follow-up|0|||
27808575|NCT01785615|54264102|FG003|Dietary Phase|Lost to Follow-up|24|||
27808576|NCT01913041|54264114|FG000|Overall Study|Protocol Violation|35|||
27808577|NCT01913041|54264114|FG000|Overall Study|Withdrawal by Subject|3|||
27808578|NCT01913041|54264114|FG000|Overall Study|Physician Decision|1|||
27808579|NCT01756053|54264118|FG000|Period 1 (10 Days)|Protocol Violation|1|||
27808580|NCT01756053|54264119|FG001|Period 1 (10 Days)|Protocol Violation|1|||
27808581|NCT01756053|54264118|FG000|Period 2 (10 Days)|Protocol Violation|0|||
27808582|NCT01756053|54264119|FG001|Period 2 (10 Days)|Protocol Violation|2|||
27808583|NCT01785069|54264129|FG000|Overall Study|Implanted with nonstudy device|1|||
27808584|NCT01785069|54264130|FG001|Overall Study|Implanted with nonstudy device|2|||
27808585|NCT01785069|54264131|FG002|Overall Study|Implanted with nonstudy device|1|||
27808586|NCT01785069|54264132|FG003|Overall Study|Implanted with nonstudy device|0|||
27808587|NCT01785069|54264129|FG000|Overall Study|Death|0|||
27808588|NCT01785069|54264130|FG001|Overall Study|Death|0|||
27808589|NCT01785069|54264131|FG002|Overall Study|Death|2|||
27808590|NCT01785069|54264132|FG003|Overall Study|Death|0|||
27808591|NCT01785069|54264129|FG000|Overall Study|Subject choice|2|||
27808592|NCT01785069|54264130|FG001|Overall Study|Subject choice|2|||
27808593|NCT01785069|54264131|FG002|Overall Study|Subject choice|0|||
27808594|NCT01785069|54264132|FG003|Overall Study|Subject choice|1|||
27808595|NCT01785069|54264129|FG000|Overall Study|Lost to Follow-up|1|||
27808596|NCT01785069|54264130|FG001|Overall Study|Lost to Follow-up|2|||
27808597|NCT01785069|54264131|FG002|Overall Study|Lost to Follow-up|4|||
27808598|NCT01785069|54264132|FG003|Overall Study|Lost to Follow-up|1|||
27808599|NCT01785069|54264129|FG000|Overall Study|Reason not Specified|1|||
27808600|NCT01785069|54264130|FG001|Overall Study|Reason not Specified|2|||
27808601|NCT01785069|54264131|FG002|Overall Study|Reason not Specified|1|||
27808602|NCT01785069|54264132|FG003|Overall Study|Reason not Specified|4|||
27846847|NCT01474538|54338698|FG000|Treatment Period 1|Death|1|||
27846848|NCT01474538|54338699|FG001|Treatment Period 1|Death|0|||
27846849|NCT01474538|54338698|FG000|Treatment Period 1|Physician Decision|1|||
27808603|NCT01785069|54264129|FG000|Overall Study|Not evaluable|7|||
27808604|NCT01785069|54264130|FG001|Overall Study|Not evaluable|4|||
27808605|NCT01785069|54264131|FG002|Overall Study|Not evaluable|5|||
27808606|NCT01785069|54264132|FG003|Overall Study|Not evaluable|8|||
27808607|NCT01784523|54264144|FG000|Overall Study|Study closed early|7|||
27846850|NCT01474538|54338699|FG001|Treatment Period 1|Physician Decision|0|||
27846851|NCT01474538|54338698|FG000|Treatment Period 1|Withdrawal by Subject|1|||
27808608|NCT01784523|54264145|FG001|Overall Study|Study closed early|4|||
27808609|NCT01784211|54264153|FG000|Part A (Days 1-15)|Adverse Event|1|||
27808610|NCT01784211|54264154|FG001|Part A (Days 1-15)|Adverse Event|1|||
27808611|NCT01784211|54264155|FG002|Part A (Days 1-15)|Adverse Event|0|||
27808612|NCT01784211|54264156|FG003|Part A (Days 1-15)|Adverse Event|0|||
27808613|NCT01784211|54264157|FG004|Part A (Days 1-15)|Adverse Event|0|||
27846852|NCT01474538|54338699|FG001|Treatment Period 1|Withdrawal by Subject|3|||
27846853|NCT01474538|54338698|FG000|Treatment Period 1|Protocol Violation|0|||
27846854|NCT01474538|54338699|FG001|Treatment Period 1|Protocol Violation|1|||
27846855|NCT01474538|54338698|FG000|Treatment Period 2|Death|1|||
27846856|NCT01474538|54338699|FG001|Treatment Period 2|Death|0|||
27846857|NCT01474538|54338698|FG000|Treatment Period 2|Adverse Event|1|||
27846858|NCT01474538|54338699|FG001|Treatment Period 2|Adverse Event|1|||
27846859|NCT01474538|54338698|FG000|Treatment Period 2|Withdrawal by Subject|2|||
27846860|NCT01474538|54338699|FG001|Treatment Period 2|Withdrawal by Subject|0|||
28035144|NCT00403546|54693354|FG000|Randomized Trial|Early Terminations|0|||
28035145|NCT00403546|54693355|FG001|Randomized Trial|Early Terminations|17|||
28035146|NCT00403546|54693356|FG002|Randomized Trial|Early Terminations|16|||
28035147|NCT00403390|54693367|FG000|Overall Study|Withdrawal by Subject|1|||
28035148|NCT00403390|54693368|FG001|Overall Study|Withdrawal by Subject|0|||
28035149|NCT00403390|54693367|FG000|Overall Study|samples lost|1|||
28035150|NCT00403390|54693368|FG001|Overall Study|samples lost|0|||
28035151|NCT00403390|54693367|FG000|Overall Study|non-compliant|1|||
28035152|NCT00403390|54693368|FG001|Overall Study|non-compliant|0|||
28035153|NCT00403234|54693378|FG000|Overall Study|Withdrawal by Subject|0|||
28035154|NCT00403234|54693379|FG001|Overall Study|Withdrawal by Subject|1|||
28035155|NCT00403234|54693380|FG002|Overall Study|Withdrawal by Subject|0|||
28035156|NCT00403234|54693381|FG003|Overall Study|Withdrawal by Subject|0|||
28035157|NCT00403234|54693378|FG000|Overall Study|Adverse Event|1|||
28035158|NCT00403234|54693379|FG001|Overall Study|Adverse Event|0|||
28035159|NCT00403234|54693380|FG002|Overall Study|Adverse Event|1|||
28035160|NCT00403234|54693381|FG003|Overall Study|Adverse Event|0|||
28035161|NCT00402688|54693394|FG000|Overall Study|Adverse Event|12|||
28035162|NCT00402688|54693395|FG001|Overall Study|Adverse Event|9|||
28035163|NCT00402688|54693396|FG002|Overall Study|Adverse Event|3|||
28035164|NCT00402688|54693394|FG000|Overall Study|Withdrawal by Subject|3|||
28035165|NCT00402688|54693395|FG001|Overall Study|Withdrawal by Subject|1|||
28035166|NCT00402688|54693396|FG002|Overall Study|Withdrawal by Subject|1|||
28035167|NCT00402688|54693394|FG000|Overall Study|Physician Decision|0|||
28035168|NCT00402688|54693395|FG001|Overall Study|Physician Decision|0|||
28035169|NCT00402688|54693396|FG002|Overall Study|Physician Decision|1|||
27808614|NCT01784211|54264158|FG005|Part A (Days 1-15)|Adverse Event|0|||
27808615|NCT01784211|54264153|FG000|Part A (Days 1-15)|Withdrawal by Subject|2|||
27808616|NCT01784211|54264154|FG001|Part A (Days 1-15)|Withdrawal by Subject|1|||
27808617|NCT01784211|54264155|FG002|Part A (Days 1-15)|Withdrawal by Subject|0|||
27808618|NCT01784211|54264156|FG003|Part A (Days 1-15)|Withdrawal by Subject|0|||
27808619|NCT01784211|54264157|FG004|Part A (Days 1-15)|Withdrawal by Subject|0|||
27808620|NCT01784211|54264158|FG005|Part A (Days 1-15)|Withdrawal by Subject|0|||
27808621|NCT01783821|54264172|FG000|Overall Study|Screen Failure|1|||
27808622|NCT01783821|54264173|FG001|Overall Study|Screen Failure|1|||
27808623|NCT01783743|54264181|FG000|Screening of Subjects by CTA During MDA|Absent at MDA|3427|||
27808624|NCT01783743|54264182|FG001|Screening of Subjects by CTA During MDA|Absent at MDA|4439|||
27808625|NCT01783743|54264181|FG000|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591|||
27808626|NCT01783743|54264182|FG001|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684|||
27808627|NCT01783743|54264181|FG000|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305|||
27808628|NCT01783743|54264182|FG001|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236|||
27808629|NCT01608321|54264190|FG000|Overall Study|Withdrawal by Subject|1|||
27808630|NCT01608321|54264191|FG001|Overall Study|Withdrawal by Subject|0|||
27808631|NCT01608087|54264200|FG000|Overall Study|Lost to Follow-up|0|||
27808632|NCT01608087|54264201|FG001|Overall Study|Lost to Follow-up|1|||
27808633|NCT01608087|54264202|FG002|Overall Study|Lost to Follow-up|0|||
27808634|NCT01608087|54264200|FG000|Overall Study|Other Reason|0|||
27808635|NCT01608087|54264201|FG001|Overall Study|Other Reason|1|||
27808636|NCT01608087|54264202|FG002|Overall Study|Other Reason|0|||
27808637|NCT01912963|54264213|FG000|Overall Study|Disease Progression (RECIST1.1)|6|||
27846861|NCT01474538|54338698|FG000|Treatment Period 2|Sponsor decision|1|||
27846862|NCT01474538|54338699|FG001|Treatment Period 2|Sponsor decision|0|||
27846863|NCT01474538|54338698|FG000|Treatment Period 2|Physician Decision|0|||
27808638|NCT01912963|54264214|FG001|Overall Study|Disease Progression (RECIST1.1)|9|||
27846864|NCT01474538|54338699|FG001|Treatment Period 2|Physician Decision|1|||
27846865|NCT01474538|54338698|FG000|Treatment Period 2|Protocol Violation|1|||
28035170|NCT00402688|54693394|FG000|Overall Study|Lack of Efficacy|4|||
28035171|NCT00402688|54693395|FG001|Overall Study|Lack of Efficacy|4|||
28035172|NCT00402688|54693396|FG002|Overall Study|Lack of Efficacy|5|||
28035173|NCT00402688|54693394|FG000|Overall Study|Protocol Violation|1|||
28035174|NCT00402688|54693395|FG001|Overall Study|Protocol Violation|1|||
28035175|NCT00402688|54693396|FG002|Overall Study|Protocol Violation|1|||
27846866|NCT01474538|54338699|FG001|Treatment Period 2|Protocol Violation|0|||
28035176|NCT00402688|54693394|FG000|Overall Study|Lost to Follow-up|1|||
28035177|NCT00402688|54693395|FG001|Overall Study|Lost to Follow-up|0|||
28035178|NCT00402688|54693396|FG002|Overall Study|Lost to Follow-up|2|||
28035179|NCT00402688|54693394|FG000|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
28035180|NCT00402688|54693395|FG001|Overall Study|Culture Show Fluoroquinolone Resistance|1|||
28035181|NCT00402688|54693396|FG002|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
28035182|NCT00402688|54693394|FG000|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
28035183|NCT00402688|54693395|FG001|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
28035184|NCT00402688|54693396|FG002|Overall Study|Urine Cult. Yield Resistant to Levaquin|1|||
28035185|NCT00402688|54693394|FG000|Overall Study|Patient Left Town and Forgot Medication|0|||
28035186|NCT00402688|54693395|FG001|Overall Study|Patient Left Town and Forgot Medication|0|||
28035187|NCT00402688|54693396|FG002|Overall Study|Patient Left Town and Forgot Medication|1|||
28035188|NCT00671879|54693407|FG000|Overall Study|Withdrawal by Subject|0|||
28035189|NCT00671879|54693408|FG001|Overall Study|Withdrawal by Subject|4|||
28035190|NCT00671879|54693409|FG002|Overall Study|Withdrawal by Subject|6|||
28035191|NCT00402298|54693420|FG000|Overall Study|Withdrawal by Subject|1|||
28035192|NCT00402298|54693421|FG001|Overall Study|Withdrawal by Subject|0|||
28035193|NCT00401830|54693429|FG000|Overall Study|Adverse Event|10|||
28035194|NCT00401830|54693430|FG001|Overall Study|Adverse Event|18|||
28035195|NCT00401830|54693429|FG000|Overall Study|Lack of Efficacy|11|||
28035196|NCT00401830|54693430|FG001|Overall Study|Lack of Efficacy|5|||
28035197|NCT00401830|54693429|FG000|Overall Study|Withdrawal by Subject|4|||
28035198|NCT00401830|54693430|FG001|Overall Study|Withdrawal by Subject|3|||
28035199|NCT00401830|54693429|FG000|Overall Study|Protocol Violation|3|||
28035200|NCT00401830|54693430|FG001|Overall Study|Protocol Violation|3|||
28035201|NCT00401830|54693429|FG000|Overall Study|Non-compliance with drug study|1|||
28035202|NCT00401830|54693430|FG001|Overall Study|Non-compliance with drug study|0|||
28035203|NCT00401830|54693429|FG000|Overall Study|Lost to Follow-up|1|||
28035204|NCT00401830|54693430|FG001|Overall Study|Lost to Follow-up|3|||
28035205|NCT00401830|54693429|FG000|Overall Study|Other: Personal / Family problems|1|||
28035206|NCT00401830|54693430|FG001|Overall Study|Other: Personal / Family problems|0|||
28035207|NCT00401752|54693438|FG000|Overall Study|Adverse Event|2|||
28035208|NCT00401752|54693439|FG001|Overall Study|Adverse Event|5|||
28035209|NCT00401752|54693438|FG000|Overall Study|Withdrawal by Subject|2|||
28035210|NCT00401752|54693439|FG001|Overall Study|Withdrawal by Subject|6|||
28035211|NCT00401752|54693438|FG000|Overall Study|Lost to Follow-up|1|||
28035212|NCT00401752|54693439|FG001|Overall Study|Lost to Follow-up|4|||
28035213|NCT00401752|54693438|FG000|Overall Study|Development of any exclusion criteria|4|||
28035214|NCT00401752|54693439|FG001|Overall Study|Development of any exclusion criteria|2|||
28035215|NCT00401752|54693438|FG000|Overall Study|Physician Decision|1|||
28035216|NCT00401752|54693439|FG001|Overall Study|Physician Decision|1|||
28035217|NCT00539240|54693448|FG000|Overall Study|Withdrawal by Subject|0|||
28035218|NCT00539240|54693449|FG001|Overall Study|Withdrawal by Subject|2|||
28035219|NCT00539240|54693450|FG002|Overall Study|Withdrawal by Subject|0|||
28035220|NCT00539240|54693448|FG000|Overall Study|Protocol Violation|1|||
28035221|NCT00539240|54693449|FG001|Overall Study|Protocol Violation|1|||
28035222|NCT00539240|54693450|FG002|Overall Study|Protocol Violation|4|||
28035223|NCT00539240|54693448|FG000|Overall Study|Lost to Follow-up|2|||
28035224|NCT00539240|54693449|FG001|Overall Study|Lost to Follow-up|3|||
28035225|NCT00539240|54693450|FG002|Overall Study|Lost to Follow-up|1|||
28035226|NCT00539240|54693448|FG000|Overall Study|Adverse Event|3|||
28035227|NCT00539240|54693449|FG001|Overall Study|Adverse Event|1|||
28035228|NCT00539240|54693450|FG002|Overall Study|Adverse Event|10|||
28035229|NCT00417976|54693458|FG000|Overall Study|Non compliance unrelated to toxicity|1|||
28035230|NCT00417976|54693458|FG000|Overall Study|Treatment -related toxicity|2|||
28035231|NCT00673673|54693463|FG000|Overall Study|Progressive disease|27|||
28035232|NCT00673673|54693463|FG000|Overall Study|Adverse Event|4|||
27808639|NCT01912963|54264215|FG002|Overall Study|Disease Progression (RECIST1.1)|5|||
27808640|NCT01912963|54264213|FG000|Overall Study|Disease Progression (not RECIST1.1)|0|||
27808641|NCT01912963|54264214|FG001|Overall Study|Disease Progression (not RECIST1.1)|7|||
27808642|NCT01912963|54264215|FG002|Overall Study|Disease Progression (not RECIST1.1)|1|||
27808643|NCT01912963|54264213|FG000|Overall Study|Adverse Event|0|||
27808644|NCT01912963|54264214|FG001|Overall Study|Adverse Event|1|||
27808645|NCT01912963|54264215|FG002|Overall Study|Adverse Event|1|||
27808646|NCT01912963|54264213|FG000|Overall Study|Withdrawal by Subject|0|||
28035233|NCT00673673|54693463|FG000|Overall Study|Withdrawal by Subject|3|||
28035234|NCT00673673|54693463|FG000|Overall Study|Investigators' discretion|2|||
28035235|NCT00069121|54693469|FG000|Overall Study|Death|286|||
28035236|NCT00069121|54693470|FG001|Overall Study|Death|242|||
28035237|NCT00069121|54693469|FG000|Overall Study|Withdrawal by Subject|18|||
28035238|NCT00069121|54693470|FG001|Overall Study|Withdrawal by Subject|20|||
28035239|NCT00069121|54693469|FG000|Overall Study|Lost to Follow-up|63|||
28035240|NCT00069121|54693470|FG001|Overall Study|Lost to Follow-up|63|||
28035241|NCT00399802|54693482|FG000|Overall Study|Adverse Event|0|||
27808647|NCT01912963|54264214|FG001|Overall Study|Withdrawal by Subject|1|||
27808648|NCT01912963|54264215|FG002|Overall Study|Withdrawal by Subject|0|||
27808649|NCT01912963|54264213|FG000|Overall Study|Sought treatment locally|0|||
27808650|NCT01912963|54264214|FG001|Overall Study|Sought treatment locally|1|||
27808651|NCT01912963|54264215|FG002|Overall Study|Sought treatment locally|0|||
27808652|NCT01754727|54264223|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
27808653|NCT01912807|54264229|FG000|Overall Study|Did not meet elegibility criteria|6|||
27808654|NCT01912807|54264230|FG001|Overall Study|Did not meet elegibility criteria|4|||
27808655|NCT01912807|54264229|FG000|Overall Study|Lost to Follow-up|36|||
27808656|NCT01912807|54264230|FG001|Overall Study|Lost to Follow-up|37|||
27808657|NCT01782885|54264238|FG000|Overall Study|Lost to Follow-up|4|||
27808658|NCT01782885|54264239|FG001|Overall Study|Lost to Follow-up|6|||
27808659|NCT01912729|54264247|FG000|Overall Study|Withdrawal by Subject|0|||
27808660|NCT01912729|54264248|FG001|Overall Study|Withdrawal by Subject|1|||
27808661|NCT01754493|54264254|FG000|Overall Study|Adverse Event|1|||
27808662|NCT01754493|54264254|FG000|Overall Study|Lost to Follow-up|3|||
27808663|NCT01754493|54264254|FG000|Overall Study|Withdrawal by Subject|1|||
27808664|NCT01754493|54264254|FG000|Overall Study|Moved out of town|1|||
27808665|NCT01754493|54264254|FG000|Overall Study|Scheduling conflict|1|||
27808666|NCT01972789|54264260|FG000|Overall Study|Adverse Event|11|||
27808667|NCT01972789|54264261|FG001|Overall Study|Adverse Event|4|||
27808668|NCT01972789|54264260|FG000|Overall Study|Subject withdrew consent|14|||
27808669|NCT01972789|54264261|FG001|Overall Study|Subject withdrew consent|12|||
27808670|NCT01972789|54264260|FG000|Overall Study|Lost to Follow-up|4|||
27808671|NCT01972789|54264261|FG001|Overall Study|Lost to Follow-up|7|||
27808672|NCT01972789|54264260|FG000|Overall Study|Death|7|||
27808673|NCT01972789|54264261|FG001|Overall Study|Death|5|||
27808674|NCT01972789|54264260|FG000|Overall Study|Protocol deviation|1|||
27808675|NCT01972789|54264261|FG001|Overall Study|Protocol deviation|0|||
27808676|NCT01972789|54264260|FG000|Overall Study|Physician Decision|3|||
27808677|NCT01972789|54264261|FG001|Overall Study|Physician Decision|2|||
27808678|NCT01934335|54264269|FG000|Overall Study|Withdrawal by Subject|1|||
27808679|NCT01934335|54264270|FG001|Overall Study|Withdrawal by Subject|1|||
27808680|NCT01912339|54264278|FG000|Blinded (0 to 3 Months)|Declined to participate|1|||
27808681|NCT01912339|54264279|FG001|Blinded (0 to 3 Months)|Declined to participate|0|||
27808682|NCT01912339|54264280|FG002|Blinded (0 to 3 Months)|Declined to participate|0|||
27808683|NCT01912339|54264278|FG000|Blinded (0 to 3 Months)|Open Prostatectomy|1|||
27808684|NCT01912339|54264279|FG001|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
27808685|NCT01912339|54264280|FG002|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
27808686|NCT01912339|54264278|FG000|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1|||
27808687|NCT01912339|54264279|FG001|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
27808688|NCT01912339|54264280|FG002|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
27808689|NCT01912339|54264278|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5|||
27808690|NCT01912339|54264279|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
27808691|NCT01912339|54264280|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
27808692|NCT01912339|54264278|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5|||
27808693|NCT01912339|54264279|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
27808694|NCT01912339|54264280|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
27808695|NCT01912339|54264278|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1|||
27808696|NCT01912339|54264279|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0|||
27808697|NCT01912339|54264280|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3|||
27808698|NCT01912339|54264278|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1|||
27808699|NCT01912339|54264279|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
27808700|NCT01912339|54264280|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
27808701|NCT01912339|54264278|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1|||
27808702|NCT01912339|54264279|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
27808703|NCT01912339|54264280|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
27808704|NCT01912339|54264278|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
27808705|NCT01912339|54264279|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
27808706|NCT01912339|54264280|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1|||
27808707|NCT01912339|54264278|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
27808708|NCT01912339|54264279|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
27846867|NCT02647788|54338707|FG000|Overall Study|Lost to Follow-up|13|||
27846868|NCT02647788|54338708|FG001|Overall Study|Lost to Follow-up|11|||
27846869|NCT02647788|54338707|FG000|Overall Study|Did not want opiate|0|||
27808709|NCT01912339|54264280|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1|||
27808710|NCT01912339|54264278|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
27808711|NCT01912339|54264279|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
27808712|NCT01912339|54264280|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1|||
27846870|NCT02647788|54338708|FG001|Overall Study|Did not want opiate|1|||
27808713|NCT01912339|54264278|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
27808714|NCT01912339|54264279|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
27808715|NCT01912339|54264280|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1|||
27808716|NCT01912339|54264278|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120|||
27808717|NCT01912339|54264279|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0|||
27808718|NCT01912339|54264280|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46|||
27808719|NCT01911793|54264288|FG000|Overall Study|Physician Decision|1|||
27808720|NCT01911793|54264289|FG001|Overall Study|Physician Decision|5|||
27808721|NCT01933789|54264304|FG000|Overall Study|Death|0|||
27808722|NCT01933789|54264305|FG001|Overall Study|Death|0|||
27808723|NCT01933789|54264306|FG002|Overall Study|Death|0|||
27808724|NCT01933789|54264307|FG003|Overall Study|Death|0|||
27808725|NCT01933789|54264308|FG004|Overall Study|Death|21|||
27808726|NCT01933789|54264309|FG005|Overall Study|Death|32|||
27808727|NCT01933789|54264310|FG006|Overall Study|Death|0|||
27808728|NCT01933789|54264311|FG007|Overall Study|Death|0|||
27808729|NCT01933789|54264312|FG008|Overall Study|Death|0|||
27808730|NCT01933789|54264304|FG000|Overall Study|Lost to Follow-up|0|||
27808731|NCT01933789|54264305|FG001|Overall Study|Lost to Follow-up|0|||
27808732|NCT01933789|54264306|FG002|Overall Study|Lost to Follow-up|0|||
27808733|NCT01933789|54264307|FG003|Overall Study|Lost to Follow-up|1|||
27808734|NCT01933789|54264308|FG004|Overall Study|Lost to Follow-up|8|||
27808735|NCT01933789|54264309|FG005|Overall Study|Lost to Follow-up|9|||
27808736|NCT01933789|54264310|FG006|Overall Study|Lost to Follow-up|1|||
27808737|NCT01933789|54264311|FG007|Overall Study|Lost to Follow-up|4|||
27808738|NCT01933789|54264312|FG008|Overall Study|Lost to Follow-up|0|||
27808739|NCT01933789|54264304|FG000|Overall Study|Withdrawal by Subject|2|||
27808740|NCT01933789|54264305|FG001|Overall Study|Withdrawal by Subject|1|||
27808741|NCT01933789|54264306|FG002|Overall Study|Withdrawal by Subject|0|||
27808742|NCT01933789|54264307|FG003|Overall Study|Withdrawal by Subject|0|||
27808743|NCT01933789|54264308|FG004|Overall Study|Withdrawal by Subject|17|||
27808744|NCT01933789|54264309|FG005|Overall Study|Withdrawal by Subject|16|||
27808745|NCT01933789|54264310|FG006|Overall Study|Withdrawal by Subject|1|||
27808746|NCT01933789|54264311|FG007|Overall Study|Withdrawal by Subject|4|||
27808747|NCT01933789|54264312|FG008|Overall Study|Withdrawal by Subject|0|||
27808748|NCT01933789|54264304|FG000|Overall Study|Became Ineligible|4|||
27808749|NCT01933789|54264305|FG001|Overall Study|Became Ineligible|0|||
27808750|NCT01933789|54264306|FG002|Overall Study|Became Ineligible|0|||
27808751|NCT01933789|54264307|FG003|Overall Study|Became Ineligible|0|||
27808752|NCT01933789|54264308|FG004|Overall Study|Became Ineligible|13|||
27808753|NCT01933789|54264309|FG005|Overall Study|Became Ineligible|10|||
27808754|NCT01933789|54264310|FG006|Overall Study|Became Ineligible|13|||
27808755|NCT01933789|54264311|FG007|Overall Study|Became Ineligible|6|||
27808756|NCT01933789|54264312|FG008|Overall Study|Became Ineligible|0|||
27808757|NCT01910389|54264334|FG000|Overall Study|Withdrawal by Subject|2|||
27808758|NCT01910389|54264335|FG001|Overall Study|Withdrawal by Subject|0|||
27808759|NCT01910389|54264334|FG000|Overall Study|Study Closed|13|||
27808760|NCT01910389|54264335|FG001|Overall Study|Study Closed|8|||
27808761|NCT01970995|54264344|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
27808762|NCT01970995|54264345|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
27808763|NCT01970995|54264346|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
28035242|NCT00399802|54693483|FG001|Overall Study|Adverse Event|2|||
28035243|NCT00399802|54693482|FG000|Overall Study|Participant discontinued by mistake|0|||
28035244|NCT00399802|54693483|FG001|Overall Study|Participant discontinued by mistake|1|||
28035245|NCT00399568|54693491|FG000|Overall Study|Adverse Event|1|||
28035246|NCT00399568|54693492|FG001|Overall Study|Adverse Event|2|||
28035247|NCT00399568|54693491|FG000|Overall Study|Withdrawal by Subject|7|||
28035248|NCT00399568|54693492|FG001|Overall Study|Withdrawal by Subject|3|||
28035249|NCT00399568|54693491|FG000|Overall Study|Protocol non-compliance|2|||
28035250|NCT00399568|54693492|FG001|Overall Study|Protocol non-compliance|2|||
28035251|NCT00399568|54693491|FG000|Overall Study|Lost to Follow-up|2|||
28035252|NCT00399568|54693492|FG001|Overall Study|Lost to Follow-up|2|||
27808764|NCT01970995|54264344|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
27808765|NCT01970995|54264345|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|0|||
27808766|NCT01970995|54264346|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
28035253|NCT03900728|54693503|FG000|Overall Study|No text responses|0|||
28035254|NCT03900728|54693504|FG001|Overall Study|No text responses|0|||
27808767|NCT01932697|54264356|FG000|Overall Study|Received a different amount of tx|1|||
27808768|NCT01932697|54264357|FG001|Overall Study|Received a different amount of tx|0|||
27808769|NCT01932697|54264356|FG000|Overall Study|Ineligible|1|||
27808770|NCT01932697|54264357|FG001|Overall Study|Ineligible|0|||
27808771|NCT01970527|54264367|FG000|Pre-treatment/Baseline|Screen fail- participant had brain mets|1|||
27808772|NCT01970527|54264368|FG001|Pre-treatment/Baseline|Screen fail- participant had brain mets|0|||
27808773|NCT01970527|54264367|FG000|Treatment|Disease progression|0|||
28035255|NCT03900728|54693505|FG002|Overall Study|No text responses|4|||
28035256|NCT00068419|54693513|FG000|Overall Study|Adverse Event|3|||
28035257|NCT00068419|54693513|FG000|Overall Study|Lack of Efficacy|24|||
28035258|NCT00068419|54693513|FG000|Overall Study|Lost to Follow-up|1|||
28035259|NCT00068419|54693513|FG000|Overall Study|Physician Decision|7|||
28035260|NCT00068419|54693513|FG000|Overall Study|Withdrawal by Subject|14|||
28035261|NCT00068419|54693513|FG000|Overall Study|Ineligible|11|||
28035262|NCT00068107|54693517|FG000|Overall Study|end-stage renal disease|6|||
28035263|NCT00068107|54693517|FG000|Overall Study|Death|2|||
28035264|NCT00068107|54693517|FG000|Overall Study|Withdrawal by Subject|1|||
28035265|NCT00394654|54693526|FG000|Overall Study|Lost to Follow-up|1|||
28035266|NCT00394654|54693527|FG001|Overall Study|Lost to Follow-up|0|||
28035267|NCT00394654|54693526|FG000|Overall Study|PARTICIPANT LEFT STDUY REGION|1|||
28035268|NCT00394654|54693527|FG001|Overall Study|PARTICIPANT LEFT STDUY REGION|0|||
28035269|NCT03900416|54693535|FG000|Six Week Follow-up|Lost to Follow-up|1|||
28035270|NCT03900416|54693536|FG001|Six Week Follow-up|Lost to Follow-up|0|||
28035271|NCT03900416|54693535|FG000|Six Week Follow-up|Withdrawal by Subject|1|||
28035272|NCT03900416|54693536|FG001|Six Week Follow-up|Withdrawal by Subject|0|||
28035273|NCT03900416|54693535|FG000|Twelve Week Follow-up|Lost to Follow-up|0|||
28035274|NCT03900416|54693536|FG001|Twelve Week Follow-up|Lost to Follow-up|2|||
28035275|NCT03900416|54693535|FG000|Twelve Week Follow-up|Withdrawal by Subject|0|||
28035276|NCT03900416|54693536|FG001|Twelve Week Follow-up|Withdrawal by Subject|1|||
28035277|NCT03900416|54693535|FG000|Twelve Week Follow-up|Adverse Event|1|||
28035278|NCT03900416|54693536|FG001|Twelve Week Follow-up|Adverse Event|1|||
28035279|NCT03900416|54693535|FG000|Six Month Follow-up|Lost to Follow-up|4|||
28035280|NCT03900416|54693536|FG001|Six Month Follow-up|Lost to Follow-up|3|||
28035281|NCT03900416|54693535|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
28035282|NCT03900416|54693536|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
28035283|NCT00399490|54693542|FG000|Overall Study|Adverse Event|19|||
28035284|NCT00399490|54693542|FG000|Overall Study|Lack of Efficacy|31|||
28035285|NCT00399490|54693542|FG000|Overall Study|Lost to Follow-up|5|||
28035286|NCT00399490|54693542|FG000|Overall Study|Withdrawal by Subject|18|||
28035287|NCT00399490|54693542|FG000|Overall Study|Other|25|||
28035288|NCT00398866|54693551|FG000|Overall Study|Adverse Event|1|||
28035289|NCT00398866|54693552|FG001|Overall Study|Adverse Event|0|||
28035290|NCT00398866|54693553|FG002|Overall Study|Adverse Event|0|||
27808774|NCT01970527|54264368|FG001|Treatment|Disease progression|1|||
27846871|NCT02647788|54338707|FG000|Overall Study|Withdrawal by Subject|1|||
27846872|NCT02647788|54338708|FG001|Overall Study|Withdrawal by Subject|0|||
27846873|NCT02647788|54338707|FG000|Overall Study|Felt itchy with assigned medication|1|||
27846874|NCT02647788|54338708|FG001|Overall Study|Felt itchy with assigned medication|0|||
27808775|NCT01970527|54264367|FG000|Treatment|Participant did not tolerate Ipilimumab|0|||
27808776|NCT01970527|54264368|FG001|Treatment|Participant did not tolerate Ipilimumab|1|||
27808777|NCT01970527|54264367|FG000|Treatment|Death|0|||
27808778|NCT01970527|54264368|FG001|Treatment|Death|1|||
27808779|NCT01970527|54264367|FG000|Follow-up Clinic Visit|Disease progression|1|||
27808780|NCT01970527|54264368|FG001|Follow-up Clinic Visit|Disease progression|1|||
27808781|NCT01970527|54264367|FG000|Follow-up Clinic Visit|Withdrawal by Subject|0|||
27808782|NCT01970527|54264368|FG001|Follow-up Clinic Visit|Withdrawal by Subject|1|||
27846875|NCT02647788|54338707|FG000|Overall Study|Felt nauseous with assigned medication|1|||
27846876|NCT02647788|54338708|FG001|Overall Study|Felt nauseous with assigned medication|1|||
27846877|NCT01459016|54338714|FG000|Overall Study|Withdrawal by Subject|11|||
27846878|NCT01459016|54338714|FG000|Overall Study|Amendment Discontinuation Criteria|4|||
27846879|NCT01458392|54338756|FG000|Overall Study|Death|2|||
27846880|NCT01458392|54338757|FG001|Overall Study|Death|11|||
27846881|NCT01458392|54338758|FG002|Overall Study|Death|22|||
27846882|NCT01458392|54338756|FG000|Overall Study|At the discretion of the sponsor|0|||
27846883|NCT01458392|54338757|FG001|Overall Study|At the discretion of the sponsor|2|||
27846884|NCT01458392|54338758|FG002|Overall Study|At the discretion of the sponsor|7|||
27846885|NCT01458392|54338756|FG000|Overall Study|Patient unwilling to comply with protoco|0|||
27846886|NCT01458392|54338757|FG001|Overall Study|Patient unwilling to comply with protoco|0|||
27846887|NCT01458392|54338758|FG002|Overall Study|Patient unwilling to comply with protoco|2|||
27846888|NCT01421069|54338770|FG000|Parent Study|drug ineffective+prohibited drug taken|1|||
28035291|NCT00398866|54693551|FG000|Overall Study|Lack of Efficacy|0|||
28035292|NCT00398866|54693552|FG001|Overall Study|Lack of Efficacy|0|||
27846889|NCT01421069|54338770|FG000|Parent Study|Failed to return|3|||
27846890|NCT01421069|54338770|FG000|Parent Study|Withdrawal by Subject|1|||
28035293|NCT00398866|54693553|FG002|Overall Study|Lack of Efficacy|1|||
28035294|NCT00398866|54693551|FG000|Overall Study|Lost to Follow-up|7|||
28035295|NCT00398866|54693552|FG001|Overall Study|Lost to Follow-up|6|||
28035296|NCT00398866|54693553|FG002|Overall Study|Lost to Follow-up|4|||
27808783|NCT01970527|54264367|FG000|Follow-up Clinic Visit|Lost to Follow-up|0|||
27808784|NCT01970527|54264368|FG001|Follow-up Clinic Visit|Lost to Follow-up|1|||
27846891|NCT01421069|54338770|FG000|Parent Study|Lost to Follow-up|2|||
27846892|NCT01421069|54338770|FG000|Parent Study|Lack of Efficacy|1|||
27846893|NCT01421069|54338770|FG000|Overall Period for Extension Study|Other|2|||
27851617|NCT00985673|54351074|FG000|Overall Study|Withdrawal by Subject|0|||
27846894|NCT01421069|54338770|FG000|Overall Period for Extension Study|Medication error without associated adverse event|1|||
27846895|NCT01421069|54338770|FG000|Overall Period for Extension Study|No longer willing to participate|14|||
27808785|NCT01931995|54264379|FG000|First Intervention (1 Day)|Withdrawal by Subject|2|||
27808786|NCT01931995|54264380|FG001|First Intervention (1 Day)|Withdrawal by Subject|2|||
27808787|NCT01931995|54264379|FG000|First Intervention (1 Day)|Physician Decision|1|||
27808788|NCT01931995|54264380|FG001|First Intervention (1 Day)|Physician Decision|1|||
27808789|NCT01931995|54264379|FG000|First Intervention (1 Day)|Lost to Follow-up|1|||
27808790|NCT01931995|54264380|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
27808791|NCT01408576|54264389|FG000|Overall Study|Lack of Efficacy|17|||
27808792|NCT01408576|54264390|FG001|Overall Study|Lack of Efficacy|30|||
27808793|NCT01408576|54264391|FG002|Overall Study|Lack of Efficacy|48|||
27808794|NCT01408576|54264389|FG000|Overall Study|Protocol Violation|1|||
27808795|NCT01408576|54264390|FG001|Overall Study|Protocol Violation|2|||
27808796|NCT01408576|54264391|FG002|Overall Study|Protocol Violation|2|||
27808797|NCT01408576|54264389|FG000|Overall Study|Lost to Follow-up|10|||
27808798|NCT01408576|54264390|FG001|Overall Study|Lost to Follow-up|9|||
27808799|NCT01408576|54264391|FG002|Overall Study|Lost to Follow-up|17|||
27808800|NCT01408576|54264389|FG000|Overall Study|Withdrawal by Subject|34|||
27808801|NCT01408576|54264390|FG001|Overall Study|Withdrawal by Subject|60|||
27808802|NCT01408576|54264391|FG002|Overall Study|Withdrawal by Subject|66|||
27808803|NCT01408576|54264389|FG000|Overall Study|Sponsor terminated study|89|||
27808804|NCT01408576|54264390|FG001|Overall Study|Sponsor terminated study|333|||
27808805|NCT01408576|54264391|FG002|Overall Study|Sponsor terminated study|330|||
27808806|NCT01408576|54264389|FG000|Overall Study|AE, serious fatal|4|||
27808807|NCT01408576|54264390|FG001|Overall Study|AE, serious fatal|4|||
27808808|NCT01408576|54264391|FG002|Overall Study|AE, serious fatal|1|||
27808809|NCT01408576|54264389|FG000|Overall Study|SAE, non-fatal|11|||
27808810|NCT01408576|54264390|FG001|Overall Study|SAE, non-fatal|23|||
27808811|NCT01408576|54264391|FG002|Overall Study|SAE, non-fatal|14|||
27808812|NCT01408576|54264389|FG000|Overall Study|AE, non-serious non-fatal|12|||
27808813|NCT01408576|54264390|FG001|Overall Study|AE, non-serious non-fatal|19|||
27808814|NCT01408576|54264391|FG002|Overall Study|AE, non-serious non-fatal|11|||
27808815|NCT01408576|54264389|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
27808816|NCT01408576|54264390|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
27808817|NCT01408576|54264391|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
27808818|NCT01408576|54264389|FG000|Overall Study|AE, unknown type|0|||
27808819|NCT01408576|54264390|FG001|Overall Study|AE, unknown type|1|||
27808820|NCT01408576|54264391|FG002|Overall Study|AE, unknown type|0|||
27808821|NCT01408576|54264389|FG000|Overall Study|Other|10|||
27808822|NCT01408576|54264390|FG001|Overall Study|Other|16|||
27808823|NCT01408576|54264391|FG002|Overall Study|Other|18|||
27808824|NCT01427920|54264413|FG000|Overall Study|Adverse Event|1|||
27808825|NCT01427920|54264414|FG001|Overall Study|Adverse Event|2|||
27808826|NCT01427920|54264413|FG000|Overall Study|Lack of Efficacy|1|||
27808827|NCT01427920|54264414|FG001|Overall Study|Lack of Efficacy|0|||
27808828|NCT01427920|54264413|FG000|Overall Study|Protocol Violation|1|||
27808829|NCT01427920|54264414|FG001|Overall Study|Protocol Violation|3|||
27808830|NCT01427920|54264413|FG000|Overall Study|Withdrawal Criteria|4|||
27808831|NCT01427920|54264414|FG001|Overall Study|Withdrawal Criteria|4|||
27808832|NCT01427920|54264413|FG000|Overall Study|Unclassified|2|||
27808833|NCT01427920|54264414|FG001|Overall Study|Unclassified|8|||
27808834|NCT01427608|54264422|FG000|Overall Study|Death|1|||
28035297|NCT00398866|54693551|FG000|Overall Study|Withdrawal by Subject|5|||
27808835|NCT01427608|54264423|FG001|Overall Study|Death|0|||
27808836|NCT01427608|54264422|FG000|Overall Study|Withdrawal by Subject|7|||
27808837|NCT01427608|54264423|FG001|Overall Study|Withdrawal by Subject|3|||
27808838|NCT01427608|54264422|FG000|Overall Study|Relapsed-all cause|13|||
27808839|NCT01427608|54264423|FG001|Overall Study|Relapsed-all cause|34|||
27808840|NCT01427608|54264422|FG000|Overall Study|Events not attributed to study meds|0|||
27808841|NCT01427608|54264423|FG001|Overall Study|Events not attributed to study meds|1|||
27808842|NCT01408030|54264435|FG000|Treatment Phase (on Drug)|Lost to Follow-up|1|||
27808843|NCT01408030|54264436|FG001|Treatment Phase (on Drug)|Lost to Follow-up|0|||
27808844|NCT01408030|54264437|FG002|Treatment Phase (on Drug)|Lost to Follow-up|1|||
27808845|NCT01408030|54264438|FG003|Treatment Phase (on Drug)|Lost to Follow-up|0|||
27808846|NCT01408030|54264435|FG000|Treatment Phase (on Drug)|Lack of Efficacy|2|||
27808847|NCT01408030|54264436|FG001|Treatment Phase (on Drug)|Lack of Efficacy|6|||
27808848|NCT01408030|54264437|FG002|Treatment Phase (on Drug)|Lack of Efficacy|0|||
27808849|NCT01408030|54264438|FG003|Treatment Phase (on Drug)|Lack of Efficacy|3|||
27846896|NCT01421069|54338770|FG000|Overall Period for Extension Study|Pregnancy|1|||
27846897|NCT01421069|54338770|FG000|Overall Period for Extension Study|Adverse Event|1|||
27846898|NCT01421069|54338770|FG000|Overall Period for Extension Study|Protocol Violation|1|||
27846899|NCT01421069|54338770|FG000|Overall Period for Extension Study|Lost to Follow-up|4|||
27846900|NCT01421069|54338770|FG000|Overall Period for Extension Study|Lack of Efficacy|1|||
27846901|NCT01421069|54338770|FG000|Active Treatment Period|Other|1|||
27846902|NCT01421069|54338770|FG000|Active Treatment Period|No longer willing to participate in study|8|||
27846903|NCT01421069|54338770|FG000|Active Treatment Period|Insufficient clinical response|1|||
27846904|NCT01421069|54338770|FG000|Active Treatment Period|Medication error without associated adverse event|1|||
27846905|NCT01421069|54338770|FG000|Active Treatment Period|Pregnancy|1|||
27846906|NCT01421069|54338770|FG000|Active Treatment Period|Adverse Event|1|||
27846907|NCT01421069|54338770|FG000|Active Treatment Period|Enrolled in withdrawal period|30|||
27846908|NCT01421069|54338770|FG000|Active Treatment Period|Enrolled in observational period|29|||
27846909|NCT01421069|54338770|FG000|2a. Withdrawal Period|No longer willing to participate in study|2|||
28035298|NCT00398866|54693552|FG001|Overall Study|Withdrawal by Subject|1|||
28035299|NCT00398866|54693553|FG002|Overall Study|Withdrawal by Subject|2|||
28035300|NCT00398866|54693551|FG000|Overall Study|Unable to complete requirements of study|1|||
28035301|NCT00398866|54693552|FG001|Overall Study|Unable to complete requirements of study|1|||
28035302|NCT00398866|54693553|FG002|Overall Study|Unable to complete requirements of study|1|||
28035303|NCT00398632|54693562|FG000|Overall Study|Withdrawal by Subject|1|||
28035304|NCT00398632|54693562|FG000|Overall Study|Lack of Efficacy|1|||
28035305|NCT00673361|54693567|FG000|Overall Study|Screen Failure|2|||
28035306|NCT00393718|54693573|FG000|Overall Study|Adverse Event|20|||
28035307|NCT00393718|54693574|FG001|Overall Study|Adverse Event|8|||
28035308|NCT00393718|54693573|FG000|Overall Study|Protocol Violation|1|||
28035309|NCT00393718|54693574|FG001|Overall Study|Protocol Violation|2|||
28035310|NCT00393718|54693573|FG000|Overall Study|Lack of Efficacy|10|||
28035311|NCT00393718|54693574|FG001|Overall Study|Lack of Efficacy|9|||
28035312|NCT00393718|54693573|FG000|Overall Study|Hypoglycaemia|3|||
28035313|NCT00393718|54693574|FG001|Overall Study|Hypoglycaemia|2|||
28035314|NCT00393718|54693573|FG000|Overall Study|Subject decision|5|||
28035315|NCT00393718|54693574|FG001|Overall Study|Subject decision|0|||
28035316|NCT00393718|54693573|FG000|Overall Study|Withdrawal of consent|2|||
28035317|NCT00393718|54693574|FG001|Overall Study|Withdrawal of consent|1|||
28035318|NCT00393718|54693573|FG000|Overall Study|Missed measurement|1|||
28035319|NCT00393718|54693574|FG001|Overall Study|Missed measurement|0|||
28035320|NCT00393718|54693573|FG000|Overall Study|Move|1|||
28035321|NCT00393718|54693574|FG001|Overall Study|Move|0|||
28035322|NCT00669071|54693580|FG000|Overall Study|Lost to Follow-up|3|||
28035323|NCT00669071|54693580|FG000|Overall Study|Final visit 40 days out of window|1|||
28035324|NCT00398320|54693586|FG000|Overall Study|Death|1|||
28035325|NCT00398320|54693586|FG000|Overall Study|Adverse Event|4|||
27846910|NCT01421069|54338770|FG000|2a. Withdrawal Period|Lost to Follow-up|1|||
28035326|NCT00398320|54693586|FG000|Overall Study|Physician Decision|1|||
28035327|NCT00670007|54693590|FG000|Overall Study|Drug abuse|1|||
28035328|NCT00670007|54693590|FG000|Overall Study|Lung transplant|1|||
27846911|NCT01421069|54338770|FG000|2a. Withdrawal Period|Enrolled in observational period|7|||
27846912|NCT01421069|54338770|FG000|2a. Withdrawal Period|Enrolled in re-treatment period|13|||
27846913|NCT01421069|54338770|FG000|2b. Retreatment Period|Enrolled in observational period|7|||
27846914|NCT01421069|54338770|FG000|2b. Retreatment Period|Protocol Violation|1|||
27846915|NCT01421069|54338770|FG000|Observational Period|Other|1|||
27846916|NCT01421069|54338770|FG000|Observational Period|No longer willing to participate in study|4|||
27846917|NCT01421069|54338770|FG000|Observational Period|Lost to Follow-up|3|||
27846918|NCT01473836|54338802|FG000|Overall Study|Adverse Event|4|||
27846919|NCT01473836|54338802|FG000|Overall Study|Lack of Efficacy|1|||
27846920|NCT01473836|54338802|FG000|Overall Study|Does not meet entrance criteria|1|||
27846921|NCT01473758|54338842|FG000|Cycle 1|Adverse Event|10|||
27846922|NCT01473758|54338843|FG001|Cycle 1|Adverse Event|2|||
27846923|NCT01473758|54338844|FG002|Cycle 1|Adverse Event|0|||
27846924|NCT01473758|54338845|FG003|Cycle 1|Adverse Event|0|||
27846925|NCT01473758|54338842|FG000|Cycle 1|Withdrawal by Subject|1|||
27846926|NCT01473758|54338843|FG001|Cycle 1|Withdrawal by Subject|1|||
28035329|NCT00670007|54693590|FG000|Overall Study|Travel/Vacation|1|||
28035330|NCT00670007|54693590|FG000|Overall Study|Adverse event, serious fatal|1|||
28035331|NCT00670007|54693590|FG000|Overall Study|Adverse Event|1|||
28035332|NCT00670007|54693590|FG000|Overall Study|Withdrawal by Subject|4|||
28035333|NCT00535496|54693597|FG000|Overall Study|Lost to Follow-up|0|||
28035334|NCT00535496|54693598|FG001|Overall Study|Lost to Follow-up|1|||
27846927|NCT01473758|54338844|FG002|Cycle 1|Withdrawal by Subject|0|||
27846928|NCT01473758|54338845|FG003|Cycle 1|Withdrawal by Subject|0|||
27846929|NCT01473758|54338842|FG000|Cycle 2|Adverse Event|0|||
27846930|NCT01473758|54338843|FG001|Cycle 2|Adverse Event|0|||
27846931|NCT01473758|54338844|FG002|Cycle 2|Adverse Event|5|||
27846932|NCT01473758|54338845|FG003|Cycle 2|Adverse Event|0|||
28035335|NCT00535496|54693599|FG002|Overall Study|Lost to Follow-up|0|||
28035336|NCT00535496|54693600|FG003|Overall Study|Lost to Follow-up|0|||
27846933|NCT01420679|54338855|FG000|Overall Study|Disease Progression|3|||
27846934|NCT01420679|54338856|FG001|Overall Study|Disease Progression|2|||
27846935|NCT01420679|54338855|FG000|Overall Study|Adverse Event|4|||
27846936|NCT01420679|54338856|FG001|Overall Study|Adverse Event|0|||
27846937|NCT01420679|54338855|FG000|Overall Study|More Than 28 Days Between Doses of Drug|1|||
27846938|NCT01420679|54338856|FG001|Overall Study|More Than 28 Days Between Doses of Drug|0|||
27846939|NCT01420679|54338855|FG000|Overall Study|Patient Decision|1|||
27846940|NCT01420679|54338856|FG001|Overall Study|Patient Decision|0|||
27846941|NCT01420679|54338855|FG000|Overall Study|Investigator Decision|1|||
27846942|NCT01420679|54338856|FG001|Overall Study|Investigator Decision|2|||
27846943|NCT01420679|54338855|FG000|Overall Study|Sponsor Decision|3|||
27846944|NCT01420679|54338856|FG001|Overall Study|Sponsor Decision|3|||
27846945|NCT01420679|54338855|FG000|Overall Study|Other|1|||
27846946|NCT01420679|54338856|FG001|Overall Study|Other|0|||
27846947|NCT01496846|54338873|FG000|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
27846948|NCT01496846|54338874|FG001|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
28035337|NCT00535496|54693597|FG000|Overall Study|Not treated with sugammadex|0|||
28035338|NCT00535496|54693598|FG001|Overall Study|Not treated with sugammadex|1|||
28035339|NCT00535496|54693599|FG002|Overall Study|Not treated with sugammadex|0|||
28035340|NCT00535496|54693600|FG003|Overall Study|Not treated with sugammadex|0|||
28035341|NCT00539006|54693611|FG000|Pre-treatment|Other|0|||
28035342|NCT00539006|54693612|FG001|Pre-treatment|Other|1|||
28035343|NCT00539006|54693613|FG002|Pre-treatment|Other|0|||
28035344|NCT00539006|54693614|FG003|Pre-treatment|Other|0|||
28035345|NCT00539006|54693611|FG000|Treatment Period 1|Lost to Follow-up|0|||
28035346|NCT00539006|54693612|FG001|Treatment Period 1|Lost to Follow-up|0|||
28035347|NCT00539006|54693613|FG002|Treatment Period 1|Lost to Follow-up|1|||
28035348|NCT00539006|54693614|FG003|Treatment Period 1|Lost to Follow-up|0|||
28035349|NCT00539006|54693611|FG000|Treatment Period 1|Protocol Violation|0|||
27846949|NCT01496846|54338875|FG002|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
27846950|NCT01496846|54338876|FG003|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
27846951|NCT01496846|54338877|FG004|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
27846952|NCT01496846|54338878|FG005|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
27846953|NCT00964002|54338889|FG000|Overall Study|Protocol Violation|8|||
27846954|NCT01399697|54338901|FG000|Overall Study|Adverse Event|13|||
27846955|NCT01399697|54338902|FG001|Overall Study|Adverse Event|3|||
27846956|NCT01399697|54338903|FG002|Overall Study|Adverse Event|1|||
27846957|NCT01399697|54338901|FG000|Overall Study|Lost to Follow-up|2|||
27846958|NCT01399697|54338902|FG001|Overall Study|Lost to Follow-up|0|||
27846959|NCT01399697|54338903|FG002|Overall Study|Lost to Follow-up|0|||
27846960|NCT01399697|54338901|FG000|Overall Study|Withdrawal by Subject|8|||
27846961|NCT01399697|54338902|FG001|Overall Study|Withdrawal by Subject|0|||
27846962|NCT01399697|54338903|FG002|Overall Study|Withdrawal by Subject|0|||
27846963|NCT01399697|54338901|FG000|Overall Study|Investigator Decisión|1|||
27846964|NCT01399697|54338902|FG001|Overall Study|Investigator Decisión|0|||
27846965|NCT01399697|54338903|FG002|Overall Study|Investigator Decisión|2|||
27846966|NCT01399697|54338901|FG000|Overall Study|Lack of Efficacy|9|||
27846967|NCT01399697|54338902|FG001|Overall Study|Lack of Efficacy|0|||
27846968|NCT01399697|54338903|FG002|Overall Study|Lack of Efficacy|1|||
27846969|NCT01399697|54338901|FG000|Overall Study|Protocol Violation|2|||
27846970|NCT01399697|54338902|FG001|Overall Study|Protocol Violation|0|||
27846971|NCT01399697|54338903|FG002|Overall Study|Protocol Violation|0|||
28035350|NCT00539006|54693612|FG001|Treatment Period 1|Protocol Violation|0|||
28035351|NCT00539006|54693613|FG002|Treatment Period 1|Protocol Violation|1|||
28035352|NCT00539006|54693614|FG003|Treatment Period 1|Protocol Violation|0|||
28035353|NCT00539006|54693611|FG000|Treatment Period 1|Lack of Efficacy|0|||
28035354|NCT00539006|54693612|FG001|Treatment Period 1|Lack of Efficacy|0|||
27846972|NCT01399697|54338901|FG000|Overall Study|Non-Compliant|1|||
27846973|NCT01399697|54338902|FG001|Overall Study|Non-Compliant|0|||
27846974|NCT01399697|54338903|FG002|Overall Study|Non-Compliant|0|||
27846975|NCT01399697|54338901|FG000|Overall Study|Inclusion Error|2|||
27846976|NCT01399697|54338902|FG001|Overall Study|Inclusion Error|0|||
27846977|NCT01399697|54338903|FG002|Overall Study|Inclusion Error|0|||
28035355|NCT00539006|54693613|FG002|Treatment Period 1|Lack of Efficacy|0|||
28035356|NCT00539006|54693614|FG003|Treatment Period 1|Lack of Efficacy|1|||
28035357|NCT00539006|54693611|FG000|Washout|Adverse Event|2|||
28035358|NCT00539006|54693612|FG001|Washout|Adverse Event|1|||
28035359|NCT00539006|54693613|FG002|Washout|Adverse Event|0|||
28035360|NCT00539006|54693614|FG003|Washout|Adverse Event|0|||
27846978|NCT01399697|54338901|FG000|Overall Study|Positive result for hepatitis B|1|||
27846979|NCT01399697|54338902|FG001|Overall Study|Positive result for hepatitis B|0|||
27846980|NCT01399697|54338903|FG002|Overall Study|Positive result for hepatitis B|0|||
27846981|NCT01399697|54338901|FG000|Overall Study|Clinical RA remission|1|||
27846982|NCT01399697|54338902|FG001|Overall Study|Clinical RA remission|0|||
27846983|NCT01399697|54338903|FG002|Overall Study|Clinical RA remission|0|||
27846984|NCT01399697|54338901|FG000|Overall Study|Sponsor Decision|1|||
27846985|NCT01399697|54338902|FG001|Overall Study|Sponsor Decision|0|||
27846986|NCT01399697|54338903|FG002|Overall Study|Sponsor Decision|0|||
27846987|NCT01473602|54338937|FG000|Overall Study|Adverse Event|1|||
27846988|NCT01473602|54338938|FG001|Overall Study|Adverse Event|2|||
27846989|NCT01473602|54338937|FG000|Overall Study|Death|0|||
27846990|NCT01473602|54338938|FG001|Overall Study|Death|1|||
27808850|NCT01408030|54264435|FG000|Treatment Phase (on Drug)|Protocol Violation|0|||
27808851|NCT01408030|54264436|FG001|Treatment Phase (on Drug)|Protocol Violation|1|||
27808852|NCT01408030|54264437|FG002|Treatment Phase (on Drug)|Protocol Violation|0|||
27808853|NCT01408030|54264438|FG003|Treatment Phase (on Drug)|Protocol Violation|0|||
27808854|NCT01408030|54264435|FG000|Observation Phase (Off Drug)|Lost to Follow-up|0|||
27808855|NCT01408030|54264436|FG001|Observation Phase (Off Drug)|Lost to Follow-up|2|||
27808856|NCT01408030|54264437|FG002|Observation Phase (Off Drug)|Lost to Follow-up|2|||
27808857|NCT01408030|54264438|FG003|Observation Phase (Off Drug)|Lost to Follow-up|0|||
27808858|NCT01408030|54264435|FG000|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
27808859|NCT01408030|54264436|FG001|Observation Phase (Off Drug)|Withdrawal by Subject|2|||
27808860|NCT01408030|54264437|FG002|Observation Phase (Off Drug)|Withdrawal by Subject|1|||
27808861|NCT01408030|54264438|FG003|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
27808862|NCT01408030|54264435|FG000|Observation Phase (Off Drug)|Physician Decision|0|||
27808863|NCT01408030|54264436|FG001|Observation Phase (Off Drug)|Physician Decision|1|||
28035361|NCT00539006|54693611|FG000|Washout|Protocol Violation|1|||
28035362|NCT00539006|54693612|FG001|Washout|Protocol Violation|1|||
28035363|NCT00539006|54693613|FG002|Washout|Protocol Violation|0|||
28035364|NCT00539006|54693614|FG003|Washout|Protocol Violation|0|||
28035365|NCT00539006|54693611|FG000|Washout|Withdrawal by Subject|0|||
28035366|NCT00539006|54693612|FG001|Washout|Withdrawal by Subject|2|||
28035367|NCT00539006|54693613|FG002|Washout|Withdrawal by Subject|0|||
28035368|NCT00539006|54693614|FG003|Washout|Withdrawal by Subject|0|||
28035369|NCT00539006|54693611|FG000|Washout|Failed to meet continuation criteria|16|||
28035370|NCT00539006|54693612|FG001|Washout|Failed to meet continuation criteria|5|||
28035371|NCT00539006|54693613|FG002|Washout|Failed to meet continuation criteria|14|||
28035372|NCT00539006|54693614|FG003|Washout|Failed to meet continuation criteria|6|||
27846991|NCT01473602|54338937|FG000|Overall Study|Lost to Follow-up|1|||
27846992|NCT01473602|54338938|FG001|Overall Study|Lost to Follow-up|1|||
27846993|NCT01473602|54338937|FG000|Overall Study|Withdrawal by Subject|5|||
27846994|NCT01473602|54338938|FG001|Overall Study|Withdrawal by Subject|4|||
27846995|NCT01473602|54338937|FG000|Overall Study|Physician Decision|1|||
28035373|NCT00539006|54693611|FG000|Washout|Other|1|||
28035374|NCT00539006|54693612|FG001|Washout|Other|1|||
28035375|NCT00539006|54693613|FG002|Washout|Other|2|||
28035376|NCT00539006|54693614|FG003|Washout|Other|3|||
28035377|NCT00539006|54693611|FG000|Treatment Period 2|Protocol Violation|1|||
28035378|NCT00539006|54693612|FG001|Treatment Period 2|Protocol Violation|0|||
28035379|NCT00539006|54693613|FG002|Treatment Period 2|Protocol Violation|0|||
28035380|NCT00539006|54693614|FG003|Treatment Period 2|Protocol Violation|0|||
28035381|NCT00539006|54693611|FG000|Treatment Period 2|Other|0|||
28035382|NCT00539006|54693612|FG001|Treatment Period 2|Other|1|||
28035383|NCT00539006|54693613|FG002|Treatment Period 2|Other|0|||
28035384|NCT00539006|54693614|FG003|Treatment Period 2|Other|0|||
28035385|NCT00537056|54693630|FG000|Interim PET/CT|scheduling conflicts and/or exposure|5|||
28035386|NCT00535262|54693636|FG000|Overall Study|No funding|3|||
28035387|NCT00074581|54693642|FG000|Overall Study|Death|15|||
28035388|NCT00074581|54693643|FG001|Overall Study|Death|16|||
28035389|NCT00074581|54693642|FG000|Overall Study|Withdrawal by Subject|50|||
28035390|NCT00074581|54693643|FG001|Overall Study|Withdrawal by Subject|49|||
27808864|NCT01408030|54264437|FG002|Observation Phase (Off Drug)|Physician Decision|2|||
27846996|NCT01473602|54338938|FG001|Overall Study|Physician Decision|0|||
27846997|NCT01496612|54338946|FG000|1st Intervention|Adverse Event|1|||
27846998|NCT01496612|54338947|FG001|1st Intervention|Adverse Event|0|||
27846999|NCT01496612|54338946|FG000|1st Intervention|Withdrawal by Subject|1|||
27847000|NCT01496612|54338947|FG001|1st Intervention|Withdrawal by Subject|0|||
28035391|NCT00074581|54693642|FG000|Overall Study|Unable to adhere to visit schedule|13|||
28035392|NCT00074581|54693643|FG001|Overall Study|Unable to adhere to visit schedule|14|||
28035393|NCT00074581|54693642|FG000|Overall Study|Relocated|14|||
28035394|NCT00074581|54693643|FG001|Overall Study|Relocated|9|||
28035395|NCT00074581|54693642|FG000|Overall Study|Were withdrawn by investigator|5|||
28035396|NCT00074581|54693643|FG001|Overall Study|Were withdrawn by investigator|2|||
28035397|NCT00074581|54693642|FG000|Overall Study|Lost to Follow-up|16|||
28035398|NCT00074581|54693643|FG001|Overall Study|Lost to Follow-up|11|||
28035399|NCT00074581|54693642|FG000|Overall Study|Ended relationship w. index participant|117|||
27808865|NCT01408030|54264438|FG003|Observation Phase (Off Drug)|Physician Decision|0|||
27847001|NCT00790218|54338964|FG000|Overall Study|Death|1|||
27847002|NCT00790218|54338965|FG001|Overall Study|Death|0|||
27847003|NCT00790218|54338966|FG002|Overall Study|Death|0|||
27847004|NCT01457924|54338992|FG000|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
28035400|NCT00074581|54693643|FG001|Overall Study|Ended relationship w. index participant|106|||
28035401|NCT00074581|54693642|FG000|Overall Study|Other|14|||
28035402|NCT00074581|54693643|FG001|Overall Study|Other|19|||
28035403|NCT03895034|54693649|FG000|Overall Study|Lost to Follow-up|2|||
28035404|NCT00536978|54693653|FG000|Overall Study|Not eligible for Adback Infusion|22|||
28035405|NCT03809611|54693659|FG000|Overall Study|Withdrawal by Subject|1|||
28035406|NCT03809611|54693660|FG001|Overall Study|Withdrawal by Subject|1|||
28035407|NCT03807739|54693671|FG000|Overall Study|Adverse Event|1|||
28035408|NCT03807739|54693672|FG001|Overall Study|Adverse Event|0|||
28035409|NCT03807739|54693673|FG002|Overall Study|Adverse Event|0|||
28035410|NCT03807739|54693674|FG003|Overall Study|Adverse Event|0|||
28035411|NCT03807739|54693671|FG000|Overall Study|Withdrawal by Subject|1|||
28035412|NCT03807739|54693672|FG001|Overall Study|Withdrawal by Subject|0|||
28035413|NCT03807739|54693673|FG002|Overall Study|Withdrawal by Subject|0|||
28035414|NCT03807739|54693674|FG003|Overall Study|Withdrawal by Subject|0|||
28035415|NCT00536744|54693686|FG000|Overall Study|Adverse Event|13|||
28035416|NCT00536744|54693687|FG001|Overall Study|Adverse Event|10|||
28035417|NCT00536744|54693686|FG000|Overall Study|Death|2|||
28035418|NCT00536744|54693687|FG001|Overall Study|Death|1|||
28035419|NCT00536744|54693686|FG000|Overall Study|Physician Decision|3|||
28035420|NCT00536744|54693687|FG001|Overall Study|Physician Decision|1|||
28035421|NCT00536744|54693686|FG000|Overall Study|Lost to Follow-up|3|||
28035422|NCT00536744|54693687|FG001|Overall Study|Lost to Follow-up|5|||
28035423|NCT00536744|54693686|FG000|Overall Study|Withdrawal by Subject|7|||
28035424|NCT00536744|54693687|FG001|Overall Study|Withdrawal by Subject|8|||
28035425|NCT00536744|54693686|FG000|Overall Study|PI tried alternative treatment|1|||
28035426|NCT00536744|54693687|FG001|Overall Study|PI tried alternative treatment|3|||
28035427|NCT00536510|54693704|FG000|Overall Study|Adverse Event|27|||
28035428|NCT00536510|54693705|FG001|Overall Study|Adverse Event|4|||
28035429|NCT00536510|54693704|FG000|Overall Study|Lost to Follow-up|11|||
28035430|NCT00536510|54693705|FG001|Overall Study|Lost to Follow-up|8|||
28035431|NCT00536510|54693704|FG000|Overall Study|Protocol Violation|4|||
28035432|NCT00536510|54693705|FG001|Overall Study|Protocol Violation|5|||
28035433|NCT00536510|54693704|FG000|Overall Study|Withdrawal by Subject|16|||
28035434|NCT00536510|54693705|FG001|Overall Study|Withdrawal by Subject|9|||
28035435|NCT00536510|54693704|FG000|Overall Study|Flushing with Product|20|||
28035436|NCT00536510|54693705|FG001|Overall Study|Flushing with Product|0|||
28035437|NCT00536510|54693704|FG000|Overall Study|Laboratory Adverse Event|2|||
28035438|NCT00536510|54693705|FG001|Overall Study|Laboratory Adverse Event|1|||
28035439|NCT00536510|54693704|FG000|Overall Study|Patient Discontinued for Other Reasons|2|||
28035440|NCT00536510|54693705|FG001|Overall Study|Patient Discontinued for Other Reasons|2|||
28035441|NCT00398086|54693714|FG000|Overall Study|Unacceptable Toxicity|2|||
28035442|NCT00398086|54693715|FG001|Overall Study|Unacceptable Toxicity|8|||
28035443|NCT00398086|54693716|FG002|Overall Study|Unacceptable Toxicity|2|||
28035444|NCT00398086|54693714|FG000|Overall Study|Adverse Event|1|||
28035445|NCT00398086|54693715|FG001|Overall Study|Adverse Event|4|||
28035446|NCT00398086|54693716|FG002|Overall Study|Adverse Event|0|||
28035447|NCT00398086|54693714|FG000|Overall Study|Physician Decision|1|||
28035448|NCT00398086|54693715|FG001|Overall Study|Physician Decision|4|||
28035449|NCT00398086|54693716|FG002|Overall Study|Physician Decision|0|||
28035450|NCT00398086|54693714|FG000|Overall Study|Withdrawal by Subject|5|||
28035451|NCT00398086|54693715|FG001|Overall Study|Withdrawal by Subject|7|||
28035452|NCT00398086|54693716|FG002|Overall Study|Withdrawal by Subject|0|||
28035453|NCT00536198|54693726|FG000|Overall Study|Lost to Follow-up|15|||
28035454|NCT00536198|54693727|FG001|Overall Study|Lost to Follow-up|14|||
28035455|NCT00536198|54693726|FG000|Overall Study|Withdrawal by Subject|16|||
28035456|NCT00536198|54693727|FG001|Overall Study|Withdrawal by Subject|12|||
28035457|NCT00536198|54693726|FG000|Overall Study|Adverse Event|2|||
28035458|NCT00536198|54693727|FG001|Overall Study|Adverse Event|2|||
28035459|NCT00536198|54693726|FG000|Overall Study|Rescue|3|||
28035460|NCT00536198|54693727|FG001|Overall Study|Rescue|9|||
28035461|NCT00536198|54693726|FG000|Overall Study|Pregnancy|1|||
28035462|NCT00536198|54693727|FG001|Overall Study|Pregnancy|1|||
28035463|NCT00536198|54693726|FG000|Overall Study|Protocol Violation|0|||
28035464|NCT00536198|54693727|FG001|Overall Study|Protocol Violation|1|||
28035465|NCT00393484|54693737|FG000|Double-blind Period (Day 1 to Week 96)|Adverse Event|0|||
28035466|NCT00393484|54693738|FG001|Double-blind Period (Day 1 to Week 96)|Adverse Event|1|||
28035467|NCT00393484|54693737|FG000|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2|||
28035468|NCT00393484|54693738|FG001|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0|||
28035469|NCT00393484|54693737|FG000|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0|||
28035470|NCT00393484|54693738|FG001|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3|||
28035471|NCT00393484|54693737|FG000|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0|||
28035472|NCT00393484|54693738|FG001|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6|||
28035473|NCT00393484|54693737|FG000|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0|||
28035474|NCT00393484|54693738|FG001|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2|||
28035475|NCT00393484|54693737|FG000|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4|||
28035476|NCT00393484|54693738|FG001|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1|||
28035477|NCT00393484|54693737|FG000|Open-label Period (Weeks 96 to 240)|Death|1|||
28035478|NCT00393484|54693738|FG001|Open-label Period (Weeks 96 to 240)|Death|0|||
28035479|NCT00393484|54693737|FG000|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1|||
28035480|NCT00393484|54693738|FG001|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2|||
27847005|NCT01457924|54338993|FG001|Treatment Phase (Weeks 0-24)|Adverse Event|4|||
27847006|NCT01457924|54338994|FG002|Treatment Phase (Weeks 0-24)|Adverse Event|1|||
27847007|NCT01457924|54338995|FG003|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
27847008|NCT01457924|54338996|FG004|Treatment Phase (Weeks 0-24)|Adverse Event|2|||
27847009|NCT01457924|54338992|FG000|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
27847010|NCT01457924|54338993|FG001|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
27847011|NCT01457924|54338994|FG002|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
27847012|NCT01457924|54338995|FG003|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
27847013|NCT01457924|54338996|FG004|Treatment Phase (Weeks 0-24)|Physician Decision|1|||
27847014|NCT01457924|54338992|FG000|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1|||
27847015|NCT01457924|54338993|FG001|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
28035481|NCT00393484|54693737|FG000|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
28035482|NCT00393484|54693738|FG001|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
28035483|NCT00393484|54693737|FG000|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0|||
28035484|NCT00393484|54693738|FG001|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18|||
28035485|NCT00667823|54693746|FG000|Overall Study|Lost to Follow-up|5|||
28035486|NCT00667823|54693746|FG000|Overall Study|Adverse Event|7|||
27847016|NCT01457924|54338994|FG002|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
27847017|NCT01457924|54338995|FG003|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
27847018|NCT01457924|54338996|FG004|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
28035487|NCT00667823|54693746|FG000|Overall Study|Death|182|||
28035488|NCT00667823|54693746|FG000|Overall Study|Withdrawal by Subject|12|||
28035489|NCT00667823|54693746|FG000|Overall Study|Other|8|||
28035490|NCT00667823|54693746|FG000|Overall Study|Missing (completion page missing)|2|||
28035491|NCT00397930|54693752|FG000|Overall Study|Personal reasons|14|||
28035492|NCT00397930|54693753|FG001|Overall Study|Personal reasons|8|||
28035493|NCT00397930|54693752|FG000|Overall Study|Other medical|9|||
28035494|NCT00397930|54693753|FG001|Overall Study|Other medical|4|||
28035495|NCT00397930|54693752|FG000|Overall Study|Unknown reasons|9|||
28035496|NCT00397930|54693753|FG001|Overall Study|Unknown reasons|14|||
28035497|NCT00397930|54693752|FG000|Overall Study|Noncompliant|3|||
28035498|NCT00397930|54693753|FG001|Overall Study|Noncompliant|2|||
28035499|NCT00397930|54693752|FG000|Overall Study|Too time-consuming|2|||
28035500|NCT00397930|54693753|FG001|Overall Study|Too time-consuming|9|||
28035501|NCT00397930|54693752|FG000|Overall Study|Started own yoga program|1|||
28035502|NCT00397930|54693753|FG001|Overall Study|Started own yoga program|1|||
28035503|NCT00397930|54693752|FG000|Overall Study|Did not want to be in control group|0|||
28035504|NCT00397930|54693753|FG001|Overall Study|Did not want to be in control group|1|||
28035505|NCT00397930|54693752|FG000|Overall Study|Withdrawal by Subject|0|||
28035506|NCT00397930|54693753|FG001|Overall Study|Withdrawal by Subject|8|||
28035507|NCT00397930|54693752|FG000|Overall Study|Missing data|0|||
28035508|NCT00397930|54693753|FG001|Overall Study|Missing data|4|||
28035509|NCT00397540|54693761|FG000|Overall Study|short follow-up duration < 12 months|1|||
28035510|NCT00397540|54693762|FG001|Overall Study|short follow-up duration < 12 months|0|||
28035511|NCT00536120|54693771|FG000|Overall Study|Lost to Follow-up|1|||
28035512|NCT00536120|54693772|FG001|Overall Study|Lost to Follow-up|0|||
28035513|NCT00536120|54693771|FG000|Overall Study|Positive for Anti-natalizumab Antibodies|3|||
28035514|NCT00536120|54693772|FG001|Overall Study|Positive for Anti-natalizumab Antibodies|0|||
28035515|NCT00536120|54693771|FG000|Overall Study|Non-compliance|1|||
28035516|NCT00536120|54693772|FG001|Overall Study|Non-compliance|0|||
28035517|NCT00536120|54693771|FG000|Overall Study|Sponsor Decision Due to Lab Values|1|||
28035518|NCT00536120|54693772|FG001|Overall Study|Sponsor Decision Due to Lab Values|0|||
28035519|NCT00536120|54693771|FG000|Overall Study|Steroid Use|0|||
28035520|NCT00536120|54693772|FG001|Overall Study|Steroid Use|2|||
28035521|NCT00536120|54693771|FG000|Overall Study|Missed Study Visit|0|||
28035522|NCT00536120|54693772|FG001|Overall Study|Missed Study Visit|1|||
28035523|NCT00057811|54693780|FG000|Overall Study|Lack of Efficacy|1|||
27847019|NCT01457924|54338992|FG000|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
27847020|NCT01457924|54338993|FG001|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
27939807|NCT01227902|54596125|FG001|Overall Study|Withdrawal by Subject|2|||
27847021|NCT01457924|54338994|FG002|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
27847022|NCT01457924|54338995|FG003|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
27847023|NCT01457924|54338996|FG004|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
27939808|NCT01227902|54596126|FG002|Overall Study|Withdrawal by Subject|4|||
27939809|NCT01227902|54596127|FG003|Overall Study|Withdrawal by Subject|3|||
27939810|NCT00946192|54596141|FG000|Overall Study|Lost to Follow-up|6|||
27939811|NCT00946192|54596142|FG001|Overall Study|Lost to Follow-up|11|||
27939812|NCT00946192|54596143|FG002|Overall Study|Lost to Follow-up|9|||
28035524|NCT00057811|54693781|FG001|Overall Study|Lack of Efficacy|4|||
28035525|NCT00057811|54693780|FG000|Overall Study|Physician Decision|1|||
28035526|NCT00057811|54693781|FG001|Overall Study|Physician Decision|0|||
27847024|NCT01457924|54338992|FG000|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
27939813|NCT00946192|54596141|FG000|Overall Study|Withdrawal by Subject|10|||
27939814|NCT00946192|54596142|FG001|Overall Study|Withdrawal by Subject|7|||
28035527|NCT00057811|54693780|FG000|Overall Study|Withdrawal by Subject|3|||
28035528|NCT00057811|54693781|FG001|Overall Study|Withdrawal by Subject|4|||
28035529|NCT00057811|54693780|FG000|Overall Study|Ineligible|4|||
28035530|NCT00057811|54693781|FG001|Overall Study|Ineligible|2|||
28035531|NCT00057811|54693780|FG000|Overall Study|Inevaluable|1|||
28035532|NCT00057811|54693781|FG001|Overall Study|Inevaluable|2|||
28035533|NCT02866682|54693794|FG000|Overall Study|Death|0|||
28035534|NCT02866682|54693795|FG001|Overall Study|Death|1|||
28035535|NCT02866682|54693794|FG000|Overall Study|Lost to Follow-up|0|||
28035536|NCT02866682|54693795|FG001|Overall Study|Lost to Follow-up|4|||
28035537|NCT02866682|54693794|FG000|Overall Study|Tacrolimus Discontinued During Study|0|||
28035538|NCT02866682|54693795|FG001|Overall Study|Tacrolimus Discontinued During Study|6|||
28035539|NCT02866682|54693794|FG000|Overall Study|Other|0|||
28035540|NCT02866682|54693795|FG001|Overall Study|Other|1|||
28035541|NCT00570713|54693812|FG000|Overall Study|Adverse Event|16|||
28035542|NCT00570713|54693813|FG001|Overall Study|Adverse Event|9|||
28035543|NCT00570713|54693812|FG000|Overall Study|Death|7|||
28035544|NCT00570713|54693813|FG001|Overall Study|Death|7|||
27808866|NCT01408030|54264435|FG000|Observation Phase (Off Drug)|Other|1|||
27808867|NCT01408030|54264436|FG001|Observation Phase (Off Drug)|Other|1|||
27808868|NCT01408030|54264437|FG002|Observation Phase (Off Drug)|Other|1|||
27808869|NCT01408030|54264438|FG003|Observation Phase (Off Drug)|Other|1|||
27808870|NCT01897532|54264450|FG000|Discontinuation From Treatment|Not Treated|7|||
28035545|NCT00570713|54693812|FG000|Overall Study|Lack of Efficacy|40|||
28035546|NCT00570713|54693813|FG001|Overall Study|Lack of Efficacy|49|||
28035547|NCT00570713|54693812|FG000|Overall Study|Physician Decision|2|||
28035548|NCT00570713|54693813|FG001|Overall Study|Physician Decision|2|||
28035549|NCT00570713|54693812|FG000|Overall Study|Withdrawal by Subject|3|||
28035550|NCT00570713|54693813|FG001|Overall Study|Withdrawal by Subject|3|||
28035551|NCT00570713|54693812|FG000|Overall Study|Discontinuation of Study by the Sponsor|10|||
28035552|NCT00570713|54693813|FG001|Overall Study|Discontinuation of Study by the Sponsor|7|||
28035553|NCT00669617|54693823|FG000|Period 1|Withdrawal by Subject|0|||
28035554|NCT00669617|54693824|FG001|Period 1|Withdrawal by Subject|0|||
28035555|NCT00669617|54693825|FG002|Period 1|Withdrawal by Subject|1|||
28035556|NCT00669617|54693826|FG003|Period 1|Withdrawal by Subject|0|||
27847025|NCT01457924|54338993|FG001|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
27847026|NCT01457924|54338994|FG002|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
28035557|NCT00669617|54693827|FG004|Period 1|Withdrawal by Subject|0|||
28035558|NCT00669617|54693823|FG000|Period 1|Protocol Deviation|0|||
28035559|NCT00669617|54693824|FG001|Period 1|Protocol Deviation|0|||
28035560|NCT00669617|54693825|FG002|Period 1|Protocol Deviation|0|||
28035561|NCT00669617|54693826|FG003|Period 1|Protocol Deviation|0|||
28035562|NCT00669617|54693827|FG004|Period 1|Protocol Deviation|1|||
28035563|NCT00669617|54693823|FG000|Period 3|Lost to Follow-up|1|||
28035564|NCT00669617|54693824|FG001|Period 3|Lost to Follow-up|0|||
28035565|NCT00669617|54693825|FG002|Period 3|Lost to Follow-up|0|||
28035566|NCT00669617|54693826|FG003|Period 3|Lost to Follow-up|0|||
27808871|NCT01897532|54264451|FG001|Discontinuation From Treatment|Not Treated|5|||
27808872|NCT01897532|54264450|FG000|Discontinuation From Treatment|Other reason than specified|196|||
27808873|NCT01897532|54264451|FG001|Discontinuation From Treatment|Other reason than specified|176|||
27808874|NCT01897532|54264450|FG000|Discontinuation From Treatment|Withdrawal by Subject|333|||
27808875|NCT01897532|54264451|FG001|Discontinuation From Treatment|Withdrawal by Subject|281|||
27808876|NCT01897532|54264450|FG000|Discontinuation From Treatment|Non compliance|24|||
27808877|NCT01897532|54264451|FG001|Discontinuation From Treatment|Non compliance|15|||
27808878|NCT01897532|54264450|FG000|Discontinuation From Treatment|Adverse event/ CV outcome event|402|||
27808879|NCT01897532|54264451|FG001|Discontinuation From Treatment|Adverse event/ CV outcome event|362|||
27847027|NCT01457924|54338995|FG003|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
27847028|NCT01457924|54338996|FG004|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
27847029|NCT01457924|54338992|FG000|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
27847030|NCT01457924|54338993|FG001|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
27847031|NCT01457924|54338994|FG002|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
28035567|NCT00669617|54693827|FG004|Period 3|Lost to Follow-up|0|||
28035568|NCT00535730|54693841|FG000|Overall Study|Adverse Event|1|||
28035569|NCT00535730|54693842|FG001|Overall Study|Adverse Event|1|||
28035570|NCT00535730|54693841|FG000|Overall Study|Lost to Follow-up|0|||
28035571|NCT00535730|54693842|FG001|Overall Study|Lost to Follow-up|1|||
28035572|NCT00535730|54693841|FG000|Overall Study|Physician Decision|0|||
28035573|NCT00535730|54693842|FG001|Overall Study|Physician Decision|1|||
28035574|NCT00535730|54693841|FG000|Overall Study|Protocol Violation|1|||
28035575|NCT00535730|54693842|FG001|Overall Study|Protocol Violation|0|||
28035576|NCT00535730|54693841|FG000|Overall Study|Withdrawal by Subject|0|||
28035577|NCT00535730|54693842|FG001|Overall Study|Withdrawal by Subject|4|||
27847032|NCT01457924|54338995|FG003|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
27847033|NCT01457924|54338996|FG004|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2|||
27847034|NCT01457924|54338992|FG000|FUP (Weeks 24-48)|Adverse Event|0|||
27847035|NCT01457924|54338993|FG001|FUP (Weeks 24-48)|Adverse Event|0|||
27847036|NCT01457924|54338994|FG002|FUP (Weeks 24-48)|Adverse Event|1|||
27808880|NCT01897532|54264450|FG000|Discontinuation From Trial|Not Treated|7|||
27808881|NCT01897532|54264451|FG001|Discontinuation From Trial|Not Treated|5|||
27808882|NCT01897532|54264450|FG000|Discontinuation From Trial|Patient lost to follow-up for MACE|55|||
27808883|NCT01897532|54264451|FG001|Discontinuation From Trial|Patient lost to follow-up for MACE|36|||
27808884|NCT01923428|54264461|FG000|Overall Study|Adverse Event|8|||
27808885|NCT01923428|54264462|FG001|Overall Study|Adverse Event|6|||
27808886|NCT01923428|54264463|FG002|Overall Study|Adverse Event|3|||
27808887|NCT01923428|54264464|FG003|Overall Study|Adverse Event|3|||
27847037|NCT01457924|54338995|FG003|FUP (Weeks 24-48)|Adverse Event|0|||
27847038|NCT01457924|54338996|FG004|FUP (Weeks 24-48)|Adverse Event|0|||
27847039|NCT01457924|54338992|FG000|FUP (Weeks 24-48)|Physician Decision|1|||
27847040|NCT01457924|54338993|FG001|FUP (Weeks 24-48)|Physician Decision|0|||
27847041|NCT01457924|54338994|FG002|FUP (Weeks 24-48)|Physician Decision|1|||
27847042|NCT01457924|54338995|FG003|FUP (Weeks 24-48)|Physician Decision|0|||
27847043|NCT01457924|54338996|FG004|FUP (Weeks 24-48)|Physician Decision|0|||
27847044|NCT01457924|54338992|FG000|FUP (Weeks 24-48)|Lost to Follow-up|0|||
27847045|NCT01457924|54338993|FG001|FUP (Weeks 24-48)|Lost to Follow-up|0|||
27847046|NCT01457924|54338994|FG002|FUP (Weeks 24-48)|Lost to Follow-up|0|||
27847047|NCT01457924|54338995|FG003|FUP (Weeks 24-48)|Lost to Follow-up|1|||
27847048|NCT01457924|54338996|FG004|FUP (Weeks 24-48)|Lost to Follow-up|0|||
27847049|NCT01457924|54338992|FG000|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
27847050|NCT01457924|54338993|FG001|FUP (Weeks 24-48)|Withdrawal by Subject|1|||
27847051|NCT01457924|54338994|FG002|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
27847052|NCT01457924|54338995|FG003|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
27847053|NCT01457924|54338996|FG004|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
27847054|NCT01457924|54338992|FG000|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
27847055|NCT01457924|54338993|FG001|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
27847056|NCT01457924|54338994|FG002|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
27847057|NCT01457924|54338995|FG003|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
27847058|NCT01457924|54338996|FG004|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
27847059|NCT01457924|54338992|FG000|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
27847060|NCT01457924|54338993|FG001|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4|||
27847061|NCT01457924|54338994|FG002|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2|||
27847062|NCT01457924|54338995|FG003|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
27847063|NCT01457924|54338996|FG004|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5|||
28035578|NCT00666965|54693853|FG000|Overall Study|Adverse Event|0|||
28035579|NCT00666965|54693854|FG001|Overall Study|Adverse Event|2|||
28035580|NCT00666965|54693855|FG002|Overall Study|Adverse Event|1|||
28035581|NCT00666965|54693856|FG003|Overall Study|Adverse Event|9|||
28035582|NCT00666965|54693853|FG000|Overall Study|Lack of Efficacy|1|||
28035583|NCT00666965|54693854|FG001|Overall Study|Lack of Efficacy|1|||
28035584|NCT00666965|54693855|FG002|Overall Study|Lack of Efficacy|0|||
28035585|NCT00666965|54693856|FG003|Overall Study|Lack of Efficacy|0|||
28035586|NCT00666965|54693853|FG000|Overall Study|Protocol Violation|0|||
28035587|NCT00666965|54693854|FG001|Overall Study|Protocol Violation|0|||
28035588|NCT00666965|54693855|FG002|Overall Study|Protocol Violation|0|||
28035589|NCT00666965|54693856|FG003|Overall Study|Protocol Violation|2|||
28035590|NCT00666965|54693853|FG000|Overall Study|Discontinuation criteria|2|||
28035591|NCT00666965|54693854|FG001|Overall Study|Discontinuation criteria|1|||
28035592|NCT00666965|54693855|FG002|Overall Study|Discontinuation criteria|1|||
28035593|NCT00666965|54693856|FG003|Overall Study|Discontinuation criteria|2|||
28035594|NCT00666965|54693853|FG000|Overall Study|Withdrawal by Subject|0|||
28035595|NCT00666965|54693854|FG001|Overall Study|Withdrawal by Subject|0|||
28035596|NCT00666965|54693855|FG002|Overall Study|Withdrawal by Subject|0|||
28035597|NCT00666965|54693856|FG003|Overall Study|Withdrawal by Subject|2|||
27808888|NCT01923428|54264461|FG000|Overall Study|Withdrawal by Subject|5|||
27847064|NCT01457924|54338992|FG000|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
27847065|NCT01457924|54338993|FG001|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0|||
27847066|NCT01457924|54338994|FG002|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
27847067|NCT01457924|54338995|FG003|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2|||
27847068|NCT01457924|54338996|FG004|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
28035598|NCT03889886|54693870|FG000|Overall Study|Other|0|||
28035599|NCT03889886|54693871|FG001|Overall Study|Other|1|||
28035600|NCT03889886|54693872|FG002|Overall Study|Other|0|||
28035601|NCT03889886|54693873|FG003|Overall Study|Other|1|||
28035602|NCT03889886|54693870|FG000|Overall Study|Withdrawal by Subject|0|||
27808889|NCT01923428|54264462|FG001|Overall Study|Withdrawal by Subject|3|||
28035603|NCT03889886|54693871|FG001|Overall Study|Withdrawal by Subject|0|||
28035604|NCT03889886|54693872|FG002|Overall Study|Withdrawal by Subject|1|||
28035605|NCT03889886|54693873|FG003|Overall Study|Withdrawal by Subject|0|||
28035606|NCT03889886|54693870|FG000|Overall Study|Adverse Event|0|||
28035607|NCT03889886|54693871|FG001|Overall Study|Adverse Event|0|||
28035608|NCT03889886|54693872|FG002|Overall Study|Adverse Event|0|||
28035609|NCT03889886|54693873|FG003|Overall Study|Adverse Event|6|||
28035610|NCT03888482|54693885|FG000|Second Wear (8 -1/+2 Days)|Adverse Event|0|||
28035611|NCT03888482|54693886|FG001|Second Wear (8 -1/+2 Days)|Adverse Event|1|||
28035612|NCT03888482|54693885|FG000|Second Wear (8 -1/+2 Days)|Other|1|||
28035613|NCT03888482|54693886|FG001|Second Wear (8 -1/+2 Days)|Other|0|||
28035614|NCT00667355|54693894|FG000|Overall Study|Adverse Event|5|||
28035615|NCT00667355|54693894|FG000|Overall Study|Lost to Follow-up|1|||
27808890|NCT01923428|54264463|FG002|Overall Study|Withdrawal by Subject|0|||
27808891|NCT01923428|54264464|FG003|Overall Study|Withdrawal by Subject|4|||
27808892|NCT01923428|54264461|FG000|Overall Study|Lost to Follow-up|2|||
27808893|NCT01923428|54264462|FG001|Overall Study|Lost to Follow-up|1|||
28035616|NCT00667355|54693894|FG000|Overall Study|Other reason was not specified|5|||
28035617|NCT00532844|54693900|FG000|Treatment Period - Day 1 to Day 14|Withdrawal of consent|0|||
28035618|NCT00532844|54693901|FG001|Treatment Period - Day 1 to Day 14|Withdrawal of consent|1|||
28035619|NCT00532844|54693900|FG000|Treatment Period - Day 15 to Day 28|Pregnancy|1|||
28035620|NCT00532844|54693901|FG001|Treatment Period - Day 15 to Day 28|Pregnancy|0|||
28035621|NCT00532844|54693900|FG000|Treatment Period - Day 15 to Day 28|Personal reasons|1|||
27808894|NCT01923428|54264463|FG002|Overall Study|Lost to Follow-up|5|||
27808895|NCT01923428|54264464|FG003|Overall Study|Lost to Follow-up|0|||
27808896|NCT01923428|54264461|FG000|Overall Study|Protocol Violation|3|||
27808897|NCT01923428|54264462|FG001|Overall Study|Protocol Violation|0|||
27808898|NCT01923428|54264463|FG002|Overall Study|Protocol Violation|2|||
27808899|NCT01923428|54264464|FG003|Overall Study|Protocol Violation|1|||
27808900|NCT01923428|54264461|FG000|Overall Study|Non Compliance to treatment|1|||
27808901|NCT01923428|54264462|FG001|Overall Study|Non Compliance to treatment|2|||
27808902|NCT01923428|54264463|FG002|Overall Study|Non Compliance to treatment|0|||
27808903|NCT01923428|54264464|FG003|Overall Study|Non Compliance to treatment|1|||
27808904|NCT01923428|54264461|FG000|Overall Study|Lack of Efficacy|0|||
27808905|NCT01923428|54264462|FG001|Overall Study|Lack of Efficacy|0|||
27808906|NCT01923428|54264463|FG002|Overall Study|Lack of Efficacy|1|||
28035622|NCT00532844|54693901|FG001|Treatment Period - Day 15 to Day 28|Personal reasons|0|||
28035623|NCT00532844|54693900|FG000|Treatment Period - Day 15 to Day 28|Adverse Event|1|||
28035624|NCT00532844|54693901|FG001|Treatment Period - Day 15 to Day 28|Adverse Event|0|||
28035625|NCT00532844|54693900|FG000|Treatment Period - Day 15 to Day 28|withdrawal of consent|1|||
28035626|NCT00532844|54693901|FG001|Treatment Period - Day 15 to Day 28|withdrawal of consent|0|||
28035627|NCT00666263|54693929|FG000|Study Part 1 (Stabilization Phase 1)|Adverse Event|0|||
28035628|NCT00666263|54693930|FG001|Study Part 1 (Stabilization Phase 1)|Adverse Event|1|||
28035629|NCT00666263|54693929|FG000|Study Part 4 (Cross-over Period 2)|Adverse Event|1|||
28035630|NCT00666263|54693930|FG001|Study Part 4 (Cross-over Period 2)|Adverse Event|0|||
28035631|NCT00666263|54693929|FG000|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0|||
28035632|NCT00666263|54693930|FG001|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1|||
28035633|NCT00667277|54693975|FG000|Overall Study|Withdrawal by Subject|2|||
28035634|NCT00534638|54693981|FG000|Overall Study|Withdrawal by Subject|3|||
28035635|NCT00534638|54693982|FG001|Overall Study|Withdrawal by Subject|4|||
28035636|NCT00534638|54693981|FG000|Overall Study|Migrated/moved from study area|13|||
28035637|NCT00534638|54693982|FG001|Overall Study|Migrated/moved from study area|11|||
28035638|NCT00534638|54693981|FG000|Overall Study|Lost to follow-up,incomplete vaccination|83|||
28035639|NCT00534638|54693982|FG001|Overall Study|Lost to follow-up,incomplete vaccination|117|||
28035640|NCT00534638|54693981|FG000|Overall Study|Lost to follow-up, complete vaccination|4707|||
28035641|NCT00534638|54693982|FG001|Overall Study|Lost to follow-up, complete vaccination|10757|||
28035642|NCT00534638|54693981|FG000|Overall Study|Other|1685|||
28035643|NCT00534638|54693982|FG001|Overall Study|Other|902|||
28035644|NCT00662129|54693993|FG000|Overall Study|Protocol Violation|1|||
28035645|NCT00662129|54693993|FG000|Overall Study|Cancel prior to beginning treatment|1|||
28035646|NCT00662129|54693993|FG000|Overall Study|Ineligible|1|||
28035647|NCT00664859|54694000|FG000|Overall Study|Adverse Event|2|||
28035648|NCT00664859|54694001|FG001|Overall Study|Adverse Event|1|||
28035649|NCT00664859|54694002|FG002|Overall Study|Adverse Event|3|||
28035650|NCT00664859|54694000|FG000|Overall Study|DB Study (LCP-AtorFen-2001) AE|6|||
28035651|NCT00664859|54694001|FG001|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
28035652|NCT00664859|54694002|FG002|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
28035653|NCT00664859|54694000|FG000|Overall Study|Noncompliance with protocol|1|||
28035654|NCT00664859|54694001|FG001|Overall Study|Noncompliance with protocol|0|||
27808907|NCT01923428|54264464|FG003|Overall Study|Lack of Efficacy|1|||
27808908|NCT01896986|54264476|FG000|Overall Study|samples lost|14|||
27808909|NCT01896986|54264477|FG001|Overall Study|samples lost|23|||
27808910|NCT01896128|54264485|FG000|Overall Study|Withdrawal by Subject|3|||
28035655|NCT00664859|54694002|FG002|Overall Study|Noncompliance with protocol|4|||
28035656|NCT00664859|54694000|FG000|Overall Study|Laboratory abnormality|2|||
28035657|NCT00664859|54694001|FG001|Overall Study|Laboratory abnormality|1|||
28035658|NCT00664859|54694002|FG002|Overall Study|Laboratory abnormality|4|||
28035659|NCT00664859|54694000|FG000|Overall Study|Withdrawal by Subject|4|||
28035660|NCT00664859|54694001|FG001|Overall Study|Withdrawal by Subject|1|||
28035661|NCT00664859|54694002|FG002|Overall Study|Withdrawal by Subject|3|||
28035662|NCT00664859|54694000|FG000|Overall Study|Lost to Follow-up|2|||
28035663|NCT00664859|54694001|FG001|Overall Study|Lost to Follow-up|2|||
28035664|NCT00664859|54694002|FG002|Overall Study|Lost to Follow-up|1|||
28035665|NCT00664859|54694000|FG000|Overall Study|Other|0|||
28035666|NCT00664859|54694001|FG001|Overall Study|Other|1|||
28035667|NCT00664859|54694002|FG002|Overall Study|Other|2|||
28035668|NCT00570401|54694010|FG000|Overall Study|Adverse Event|2|||
28035669|NCT00532298|54694020|FG000|Overall Study|Adverse Event|1|||
28035670|NCT00532298|54694021|FG001|Overall Study|Adverse Event|0|||
28035671|NCT00532298|54694022|FG002|Overall Study|Adverse Event|0|||
28035672|NCT00532298|54694023|FG003|Overall Study|Adverse Event|0|||
28035673|NCT00532298|54694024|FG004|Overall Study|Adverse Event|1|||
28035674|NCT00532298|54694025|FG005|Overall Study|Adverse Event|1|||
28035675|NCT00532298|54694020|FG000|Overall Study|Lost to Follow-up|1|||
28035676|NCT00532298|54694021|FG001|Overall Study|Lost to Follow-up|1|||
28035677|NCT00532298|54694022|FG002|Overall Study|Lost to Follow-up|1|||
28035678|NCT00532298|54694023|FG003|Overall Study|Lost to Follow-up|0|||
28035679|NCT00532298|54694024|FG004|Overall Study|Lost to Follow-up|0|||
28035680|NCT00532298|54694025|FG005|Overall Study|Lost to Follow-up|1|||
28035681|NCT00410410|54694045|FG000|Induction Period (IP)|Death|1|||
28035682|NCT00410410|54694046|FG001|Induction Period (IP)|Death|0|||
28035683|NCT00410410|54694047|FG002|Induction Period (IP)|Death|0|||
28035684|NCT00410410|54694048|FG003|Induction Period (IP)|Death|0|||
28035685|NCT00410410|54694049|FG004|Induction Period (IP)|Death|0|||
28035686|NCT00410410|54694050|FG005|Induction Period (IP)|Death|0|||
28035687|NCT00410410|54694051|FG006|Induction Period (IP)|Death|0|||
28035688|NCT00410410|54694052|FG007|Induction Period (IP)|Death|0|||
28035689|NCT00410410|54694053|FG008|Induction Period (IP)|Death|0|||
28035690|NCT00410410|54694045|FG000|Induction Period (IP)|Adverse Event|3|||
28035691|NCT00410410|54694046|FG001|Induction Period (IP)|Adverse Event|4|||
28035692|NCT00410410|54694047|FG002|Induction Period (IP)|Adverse Event|2|||
28035693|NCT00410410|54694048|FG003|Induction Period (IP)|Adverse Event|4|||
28035694|NCT00410410|54694049|FG004|Induction Period (IP)|Adverse Event|1|||
28035695|NCT00410410|54694050|FG005|Induction Period (IP)|Adverse Event|0|||
28035696|NCT00410410|54694051|FG006|Induction Period (IP)|Adverse Event|0|||
28035697|NCT00410410|54694052|FG007|Induction Period (IP)|Adverse Event|0|||
28035698|NCT00410410|54694053|FG008|Induction Period (IP)|Adverse Event|0|||
28035699|NCT00410410|54694045|FG000|Induction Period (IP)|Lack of Efficacy|26|||
28035700|NCT00410410|54694046|FG001|Induction Period (IP)|Lack of Efficacy|24|||
28035701|NCT00410410|54694047|FG002|Induction Period (IP)|Lack of Efficacy|8|||
28035702|NCT00410410|54694048|FG003|Induction Period (IP)|Lack of Efficacy|8|||
28035703|NCT00410410|54694049|FG004|Induction Period (IP)|Lack of Efficacy|7|||
28035704|NCT00410410|54694050|FG005|Induction Period (IP)|Lack of Efficacy|7|||
28035705|NCT00410410|54694051|FG006|Induction Period (IP)|Lack of Efficacy|0|||
28035706|NCT00410410|54694052|FG007|Induction Period (IP)|Lack of Efficacy|0|||
28035707|NCT00410410|54694053|FG008|Induction Period (IP)|Lack of Efficacy|0|||
28035708|NCT00410410|54694045|FG000|Induction Period (IP)|Lost to Follow-up|2|||
28035709|NCT00410410|54694046|FG001|Induction Period (IP)|Lost to Follow-up|2|||
28035710|NCT00410410|54694047|FG002|Induction Period (IP)|Lost to Follow-up|2|||
28035711|NCT00410410|54694048|FG003|Induction Period (IP)|Lost to Follow-up|3|||
28035712|NCT00410410|54694049|FG004|Induction Period (IP)|Lost to Follow-up|0|||
28035713|NCT00410410|54694050|FG005|Induction Period (IP)|Lost to Follow-up|1|||
28035714|NCT00410410|54694051|FG006|Induction Period (IP)|Lost to Follow-up|0|||
28035715|NCT00410410|54694052|FG007|Induction Period (IP)|Lost to Follow-up|0|||
28035716|NCT00410410|54694053|FG008|Induction Period (IP)|Lost to Follow-up|0|||
28035717|NCT00410410|54694045|FG000|Induction Period (IP)|Withdrawal by Subject|3|||
28035718|NCT00410410|54694046|FG001|Induction Period (IP)|Withdrawal by Subject|5|||
28035719|NCT00410410|54694047|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
28035720|NCT00410410|54694048|FG003|Induction Period (IP)|Withdrawal by Subject|5|||
28035721|NCT00410410|54694049|FG004|Induction Period (IP)|Withdrawal by Subject|2|||
28035722|NCT00410410|54694050|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
28035723|NCT00410410|54694051|FG006|Induction Period (IP)|Withdrawal by Subject|0|||
28035724|NCT00410410|54694052|FG007|Induction Period (IP)|Withdrawal by Subject|0|||
28035725|NCT00410410|54694053|FG008|Induction Period (IP)|Withdrawal by Subject|0|||
28035726|NCT00410410|54694045|FG000|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
28035727|NCT00410410|54694046|FG001|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
28035728|NCT00410410|54694047|FG002|Induction Period (IP)|Subject No Longer Meets Study Criteria|1|||
28035729|NCT00410410|54694048|FG003|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
28035730|NCT00410410|54694049|FG004|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
28035731|NCT00410410|54694050|FG005|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
28035732|NCT00410410|54694051|FG006|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
28035733|NCT00410410|54694052|FG007|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
28035734|NCT00410410|54694053|FG008|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
28035735|NCT00410410|54694045|FG000|Induction Period (IP)|Administrative Reason By Sponsor|0|||
28035736|NCT00410410|54694046|FG001|Induction Period (IP)|Administrative Reason By Sponsor|0|||
28035737|NCT00410410|54694047|FG002|Induction Period (IP)|Administrative Reason By Sponsor|0|||
28035738|NCT00410410|54694048|FG003|Induction Period (IP)|Administrative Reason By Sponsor|0|||
28035739|NCT00410410|54694049|FG004|Induction Period (IP)|Administrative Reason By Sponsor|22|||
28035740|NCT00410410|54694050|FG005|Induction Period (IP)|Administrative Reason By Sponsor|21|||
28035741|NCT00410410|54694051|FG006|Induction Period (IP)|Administrative Reason By Sponsor|0|||
28035742|NCT00410410|54694052|FG007|Induction Period (IP)|Administrative Reason By Sponsor|0|||
28035743|NCT00410410|54694053|FG008|Induction Period (IP)|Administrative Reason By Sponsor|0|||
28035744|NCT00410410|54694045|FG000|Induction Period (IP)|Other|0|||
28035745|NCT00410410|54694046|FG001|Induction Period (IP)|Other|0|||
28035746|NCT00410410|54694047|FG002|Induction Period (IP)|Other|1|||
28035747|NCT00410410|54694048|FG003|Induction Period (IP)|Other|0|||
28035748|NCT00410410|54694049|FG004|Induction Period (IP)|Other|0|||
28035749|NCT00410410|54694050|FG005|Induction Period (IP)|Other|0|||
28035750|NCT00410410|54694051|FG006|Induction Period (IP)|Other|0|||
28035751|NCT00410410|54694052|FG007|Induction Period (IP)|Other|0|||
28035752|NCT00410410|54694053|FG008|Induction Period (IP)|Other|0|||
28035753|NCT00410410|54694045|FG000|Maintenance Period (MP)|Death|0|||
28035754|NCT00410410|54694046|FG001|Maintenance Period (MP)|Death|0|||
28035755|NCT00410410|54694047|FG002|Maintenance Period (MP)|Death|0|||
28035756|NCT00410410|54694048|FG003|Maintenance Period (MP)|Death|0|||
28035757|NCT00410410|54694049|FG004|Maintenance Period (MP)|Death|0|||
27847069|NCT01399619|54339017|FG000|Overall Study|Adverse Event|10|||
27847070|NCT01399619|54339018|FG001|Overall Study|Adverse Event|0|||
28035758|NCT00410410|54694050|FG005|Maintenance Period (MP)|Death|0|||
28035759|NCT00410410|54694051|FG006|Maintenance Period (MP)|Death|1|||
27808911|NCT01896128|54264486|FG001|Overall Study|Withdrawal by Subject|3|||
27808912|NCT01949870|54264492|FG000|Overall Study|Lack of Efficacy|2|||
27808913|NCT01949870|54264492|FG000|Overall Study|Adverse Event|1|||
27808914|NCT01949870|54264492|FG000|Overall Study|Study termination|1|||
27808915|NCT01949870|54264492|FG000|Overall Study|Eligibility requirements not fulfilled|2|||
27808916|NCT01949480|54264498|FG000|Overall Study|Physician Decision|5|||
27808917|NCT01949480|54264499|FG001|Overall Study|Physician Decision|8|||
27808918|NCT01949090|54264510|FG000|Overall Study|Serious Adverse Event|0|||
27808919|NCT01949090|54264511|FG001|Overall Study|Serious Adverse Event|1|||
27808920|NCT01949090|54264512|FG002|Overall Study|Serious Adverse Event|2|||
27808921|NCT01949090|54264513|FG003|Overall Study|Serious Adverse Event|0|||
27808922|NCT01949090|54264514|FG004|Overall Study|Serious Adverse Event|1|||
27808923|NCT01949090|54264510|FG000|Overall Study|Withdrawal by Subject|2|||
27808924|NCT01949090|54264511|FG001|Overall Study|Withdrawal by Subject|0|||
27808925|NCT01949090|54264512|FG002|Overall Study|Withdrawal by Subject|0|||
27808926|NCT01949090|54264513|FG003|Overall Study|Withdrawal by Subject|0|||
27808927|NCT01949090|54264514|FG004|Overall Study|Withdrawal by Subject|1|||
27808928|NCT01949090|54264510|FG000|Overall Study|Protocol non-compliance|0|||
27808929|NCT01949090|54264511|FG001|Overall Study|Protocol non-compliance|0|||
27808930|NCT01949090|54264512|FG002|Overall Study|Protocol non-compliance|0|||
27808931|NCT01949090|54264513|FG003|Overall Study|Protocol non-compliance|0|||
27808932|NCT01949090|54264514|FG004|Overall Study|Protocol non-compliance|1|||
27808933|NCT01949090|54264510|FG000|Overall Study|Lost to Follow-up|2|||
27808934|NCT01949090|54264511|FG001|Overall Study|Lost to Follow-up|1|||
27808935|NCT01949090|54264512|FG002|Overall Study|Lost to Follow-up|0|||
27847071|NCT01399619|54339019|FG002|Overall Study|Adverse Event|4|||
28035760|NCT00410410|54694052|FG007|Maintenance Period (MP)|Death|0|||
28035761|NCT00410410|54694053|FG008|Maintenance Period (MP)|Death|0|||
28035762|NCT00410410|54694045|FG000|Maintenance Period (MP)|Adverse Event|0|||
28035763|NCT00410410|54694046|FG001|Maintenance Period (MP)|Adverse Event|0|||
28035764|NCT00410410|54694047|FG002|Maintenance Period (MP)|Adverse Event|0|||
28035765|NCT00410410|54694048|FG003|Maintenance Period (MP)|Adverse Event|0|||
28035766|NCT00410410|54694049|FG004|Maintenance Period (MP)|Adverse Event|0|||
28035767|NCT00410410|54694050|FG005|Maintenance Period (MP)|Adverse Event|0|||
28035768|NCT00410410|54694051|FG006|Maintenance Period (MP)|Adverse Event|1|||
28035769|NCT00410410|54694052|FG007|Maintenance Period (MP)|Adverse Event|3|||
28035770|NCT00410410|54694053|FG008|Maintenance Period (MP)|Adverse Event|0|||
27808936|NCT01949090|54264513|FG003|Overall Study|Lost to Follow-up|1|||
27808937|NCT01949090|54264514|FG004|Overall Study|Lost to Follow-up|1|||
27808938|NCT01948076|54264529|FG000|Overall Study|Withdrawal by Subject|0|||
27808939|NCT01948076|54264530|FG001|Overall Study|Withdrawal by Subject|1|||
27808940|NCT01922258|54264540|FG000|Overall Study|Lost to Follow-up|1|||
27847072|NCT01399619|54339020|FG003|Overall Study|Adverse Event|10|||
28035771|NCT00410410|54694045|FG000|Maintenance Period (MP)|Lack of Efficacy|0|||
28035772|NCT00410410|54694046|FG001|Maintenance Period (MP)|Lack of Efficacy|0|||
28035773|NCT00410410|54694047|FG002|Maintenance Period (MP)|Lack of Efficacy|0|||
28035774|NCT00410410|54694048|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
28035775|NCT00410410|54694049|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
28035776|NCT00410410|54694050|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
28035777|NCT00410410|54694051|FG006|Maintenance Period (MP)|Lack of Efficacy|25|||
28035778|NCT00410410|54694052|FG007|Maintenance Period (MP)|Lack of Efficacy|24|||
28035779|NCT00410410|54694053|FG008|Maintenance Period (MP)|Lack of Efficacy|0|||
28035780|NCT00410410|54694045|FG000|Maintenance Period (MP)|Lost to Follow-up|0|||
28035781|NCT00410410|54694046|FG001|Maintenance Period (MP)|Lost to Follow-up|0|||
28035782|NCT00410410|54694047|FG002|Maintenance Period (MP)|Lost to Follow-up|0|||
28035783|NCT00410410|54694048|FG003|Maintenance Period (MP)|Lost to Follow-up|0|||
28035784|NCT00410410|54694049|FG004|Maintenance Period (MP)|Lost to Follow-up|0|||
28035785|NCT00410410|54694050|FG005|Maintenance Period (MP)|Lost to Follow-up|0|||
28035786|NCT00410410|54694051|FG006|Maintenance Period (MP)|Lost to Follow-up|1|||
28035787|NCT00410410|54694052|FG007|Maintenance Period (MP)|Lost to Follow-up|2|||
28035788|NCT00410410|54694053|FG008|Maintenance Period (MP)|Lost to Follow-up|0|||
28035789|NCT00410410|54694045|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
28035790|NCT00410410|54694046|FG001|Maintenance Period (MP)|Withdrawal by Subject|0|||
28035791|NCT00410410|54694047|FG002|Maintenance Period (MP)|Withdrawal by Subject|0|||
28035792|NCT00410410|54694048|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
28035793|NCT00410410|54694049|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
28035794|NCT00410410|54694050|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
28035795|NCT00410410|54694051|FG006|Maintenance Period (MP)|Withdrawal by Subject|1|||
28035796|NCT00410410|54694052|FG007|Maintenance Period (MP)|Withdrawal by Subject|1|||
28035797|NCT00410410|54694053|FG008|Maintenance Period (MP)|Withdrawal by Subject|0|||
28035798|NCT00410410|54694045|FG000|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
28035799|NCT00410410|54694046|FG001|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
28035800|NCT00410410|54694047|FG002|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
28035801|NCT00410410|54694048|FG003|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
28035802|NCT00410410|54694049|FG004|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
28035803|NCT00410410|54694050|FG005|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
28035804|NCT00410410|54694051|FG006|Maintenance Period (MP)|Administrative Reason By Sponsor|21|||
28035805|NCT00410410|54694052|FG007|Maintenance Period (MP)|Administrative Reason By Sponsor|25|||
28035806|NCT00410410|54694053|FG008|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
28035807|NCT00410410|54694045|FG000|Open-Label Period (OL)|Death|0|||
28035808|NCT00410410|54694046|FG001|Open-Label Period (OL)|Death|0|||
28035809|NCT00410410|54694047|FG002|Open-Label Period (OL)|Death|0|||
28035810|NCT00410410|54694048|FG003|Open-Label Period (OL)|Death|0|||
28035811|NCT00410410|54694049|FG004|Open-Label Period (OL)|Death|0|||
28035812|NCT00410410|54694050|FG005|Open-Label Period (OL)|Death|0|||
28035813|NCT00410410|54694051|FG006|Open-Label Period (OL)|Death|0|||
28035814|NCT00410410|54694052|FG007|Open-Label Period (OL)|Death|0|||
28035815|NCT00410410|54694053|FG008|Open-Label Period (OL)|Death|1|||
28035816|NCT00410410|54694045|FG000|Open-Label Period (OL)|Adverse Event|0|||
28035817|NCT00410410|54694046|FG001|Open-Label Period (OL)|Adverse Event|0|||
28035818|NCT00410410|54694047|FG002|Open-Label Period (OL)|Adverse Event|0|||
28035819|NCT00410410|54694048|FG003|Open-Label Period (OL)|Adverse Event|0|||
28035820|NCT00410410|54694049|FG004|Open-Label Period (OL)|Adverse Event|0|||
28035821|NCT00410410|54694050|FG005|Open-Label Period (OL)|Adverse Event|0|||
28035822|NCT00410410|54694051|FG006|Open-Label Period (OL)|Adverse Event|0|||
28035823|NCT00410410|54694052|FG007|Open-Label Period (OL)|Adverse Event|0|||
28035824|NCT00410410|54694053|FG008|Open-Label Period (OL)|Adverse Event|10|||
28035825|NCT00410410|54694045|FG000|Open-Label Period (OL)|Lack of Efficacy|0|||
28035826|NCT00410410|54694046|FG001|Open-Label Period (OL)|Lack of Efficacy|0|||
28035827|NCT00410410|54694047|FG002|Open-Label Period (OL)|Lack of Efficacy|0|||
28035828|NCT00410410|54694048|FG003|Open-Label Period (OL)|Lack of Efficacy|0|||
28035829|NCT00410410|54694049|FG004|Open-Label Period (OL)|Lack of Efficacy|0|||
28035830|NCT00410410|54694050|FG005|Open-Label Period (OL)|Lack of Efficacy|0|||
28035831|NCT00410410|54694051|FG006|Open-Label Period (OL)|Lack of Efficacy|0|||
28035832|NCT00410410|54694052|FG007|Open-Label Period (OL)|Lack of Efficacy|0|||
28035833|NCT00410410|54694053|FG008|Open-Label Period (OL)|Lack of Efficacy|161|||
28035834|NCT00410410|54694045|FG000|Open-Label Period (OL)|Lost to Follow-up|0|||
28035835|NCT00410410|54694046|FG001|Open-Label Period (OL)|Lost to Follow-up|0|||
28035836|NCT00410410|54694047|FG002|Open-Label Period (OL)|Lost to Follow-up|0|||
28035837|NCT00410410|54694048|FG003|Open-Label Period (OL)|Lost to Follow-up|0|||
28035838|NCT00410410|54694049|FG004|Open-Label Period (OL)|Lost to Follow-up|0|||
28035839|NCT00410410|54694050|FG005|Open-Label Period (OL)|Lost to Follow-up|0|||
28035840|NCT00410410|54694051|FG006|Open-Label Period (OL)|Lost to Follow-up|0|||
28035841|NCT00410410|54694052|FG007|Open-Label Period (OL)|Lost to Follow-up|0|||
28035842|NCT00410410|54694053|FG008|Open-Label Period (OL)|Lost to Follow-up|4|||
28035843|NCT00410410|54694045|FG000|Open-Label Period (OL)|Withdrawal by Subject|0|||
28035844|NCT00410410|54694046|FG001|Open-Label Period (OL)|Withdrawal by Subject|0|||
28035845|NCT00410410|54694047|FG002|Open-Label Period (OL)|Withdrawal by Subject|0|||
28035846|NCT00410410|54694048|FG003|Open-Label Period (OL)|Withdrawal by Subject|0|||
28035847|NCT00410410|54694049|FG004|Open-Label Period (OL)|Withdrawal by Subject|0|||
28035848|NCT00410410|54694050|FG005|Open-Label Period (OL)|Withdrawal by Subject|0|||
28035849|NCT00410410|54694051|FG006|Open-Label Period (OL)|Withdrawal by Subject|0|||
28035850|NCT00410410|54694052|FG007|Open-Label Period (OL)|Withdrawal by Subject|0|||
28035851|NCT00410410|54694053|FG008|Open-Label Period (OL)|Withdrawal by Subject|20|||
27808941|NCT01922258|54264541|FG001|Overall Study|Lost to Follow-up|1|||
27808942|NCT01922258|54264540|FG000|Overall Study|Adverse Event|9|||
27808943|NCT01922258|54264541|FG001|Overall Study|Adverse Event|2|||
27808944|NCT01922258|54264540|FG000|Overall Study|Met Withdrawal Criteria|0|||
27808945|NCT01922258|54264541|FG001|Overall Study|Met Withdrawal Criteria|4|||
27808946|NCT01922258|54264540|FG000|Overall Study|Withdrawn by the Investigator|1|||
27808947|NCT01922258|54264541|FG001|Overall Study|Withdrawn by the Investigator|4|||
27808948|NCT01922258|54264540|FG000|Overall Study|Withdrawal by participant|5|||
27847073|NCT01399619|54339017|FG000|Overall Study|Lack of Efficacy|9|||
27847074|NCT01399619|54339018|FG001|Overall Study|Lack of Efficacy|0|||
27847075|NCT01399619|54339019|FG002|Overall Study|Lack of Efficacy|5|||
27847076|NCT01399619|54339020|FG003|Overall Study|Lack of Efficacy|0|||
27847077|NCT01399619|54339017|FG000|Overall Study|Withdrawal by Subject|6|||
27847078|NCT01399619|54339018|FG001|Overall Study|Withdrawal by Subject|0|||
27847079|NCT01399619|54339019|FG002|Overall Study|Withdrawal by Subject|3|||
27847080|NCT01399619|54339020|FG003|Overall Study|Withdrawal by Subject|4|||
27847081|NCT01399619|54339017|FG000|Overall Study|Protocol Violation|0|||
27847082|NCT01399619|54339018|FG001|Overall Study|Protocol Violation|0|||
27847083|NCT01399619|54339019|FG002|Overall Study|Protocol Violation|0|||
27847084|NCT01399619|54339020|FG003|Overall Study|Protocol Violation|1|||
27847085|NCT01399619|54339017|FG000|Overall Study|Not treated|0|||
27847086|NCT01399619|54339018|FG001|Overall Study|Not treated|0|||
27847087|NCT01399619|54339019|FG002|Overall Study|Not treated|0|||
27847088|NCT01399619|54339020|FG003|Overall Study|Not treated|2|||
27847089|NCT01496456|54339035|FG000|Overall Study|Protocol Violation|1|||
27847090|NCT01496456|54339035|FG000|Overall Study|Lost to Follow-up|7|||
27847091|NCT04999111|54339198|FG000|Overall Study|Lost to Follow-up|0|||
27847092|NCT04999111|54339199|FG001|Overall Study|Lost to Follow-up|3|||
27847093|NCT04999111|54339200|FG002|Overall Study|Lost to Follow-up|1|||
27847094|NCT04999111|54339201|FG003|Overall Study|Lost to Follow-up|1|||
27847095|NCT04999111|54339202|FG004|Overall Study|Lost to Follow-up|1|||
27847096|NCT04999111|54339203|FG005|Overall Study|Lost to Follow-up|1|||
27847097|NCT04999111|54339198|FG000|Overall Study|Physician Decision|0|||
27847098|NCT04999111|54339199|FG001|Overall Study|Physician Decision|0|||
27847099|NCT04999111|54339200|FG002|Overall Study|Physician Decision|0|||
27847100|NCT04999111|54339201|FG003|Overall Study|Physician Decision|1|||
27847101|NCT04999111|54339202|FG004|Overall Study|Physician Decision|0|||
28035852|NCT00410410|54694045|FG000|Open-Label Period (OL)|Pregnancy|0|||
28035853|NCT00410410|54694046|FG001|Open-Label Period (OL)|Pregnancy|0|||
28035854|NCT00410410|54694047|FG002|Open-Label Period (OL)|Pregnancy|0|||
28035855|NCT00410410|54694048|FG003|Open-Label Period (OL)|Pregnancy|0|||
28035856|NCT00410410|54694049|FG004|Open-Label Period (OL)|Pregnancy|0|||
28035857|NCT00410410|54694050|FG005|Open-Label Period (OL)|Pregnancy|0|||
28035858|NCT00410410|54694051|FG006|Open-Label Period (OL)|Pregnancy|0|||
28035859|NCT00410410|54694052|FG007|Open-Label Period (OL)|Pregnancy|0|||
28035860|NCT00410410|54694053|FG008|Open-Label Period (OL)|Pregnancy|1|||
28035861|NCT00410410|54694045|FG000|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
27808949|NCT01922258|54264541|FG001|Overall Study|Withdrawal by participant|5|||
27808950|NCT01406938|54264549|FG000|Induction Period|Subject/guardian decision|6|||
27847102|NCT04999111|54339203|FG005|Overall Study|Physician Decision|0|||
27847103|NCT04999111|54339198|FG000|Overall Study|Withdrawal by Subject|3|||
27847104|NCT04999111|54339199|FG001|Overall Study|Withdrawal by Subject|3|||
27847105|NCT04999111|54339200|FG002|Overall Study|Withdrawal by Subject|2|||
27847106|NCT04999111|54339201|FG003|Overall Study|Withdrawal by Subject|1|||
27847107|NCT04999111|54339202|FG004|Overall Study|Withdrawal by Subject|3|||
27847108|NCT04999111|54339203|FG005|Overall Study|Withdrawal by Subject|0|||
27847109|NCT04999111|54339198|FG000|Overall Study|Other|1|||
27847110|NCT04999111|54339199|FG001|Overall Study|Other|1|||
27847111|NCT04999111|54339200|FG002|Overall Study|Other|1|||
27847112|NCT04999111|54339201|FG003|Overall Study|Other|0|||
27847113|NCT04999111|54339202|FG004|Overall Study|Other|0|||
27847114|NCT04999111|54339203|FG005|Overall Study|Other|0|||
28035862|NCT00410410|54694046|FG001|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
28035863|NCT00410410|54694047|FG002|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
28035864|NCT00410410|54694048|FG003|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
28035865|NCT00410410|54694049|FG004|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
28035866|NCT00410410|54694050|FG005|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
28035867|NCT00410410|54694051|FG006|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
28035868|NCT00410410|54694052|FG007|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
28035869|NCT00410410|54694053|FG008|Open-Label Period (OL)|Administrative Reason By Sponsor|145|||
28035870|NCT00410410|54694045|FG000|Open-Label Period (OL)|Other|0|||
28035871|NCT00410410|54694046|FG001|Open-Label Period (OL)|Other|0|||
28035872|NCT00410410|54694047|FG002|Open-Label Period (OL)|Other|0|||
28035873|NCT00410410|54694048|FG003|Open-Label Period (OL)|Other|0|||
28035874|NCT00410410|54694049|FG004|Open-Label Period (OL)|Other|0|||
28035875|NCT00410410|54694050|FG005|Open-Label Period (OL)|Other|0|||
28035876|NCT00410410|54694051|FG006|Open-Label Period (OL)|Other|0|||
28035877|NCT00410410|54694052|FG007|Open-Label Period (OL)|Other|0|||
27808951|NCT01406938|54264550|FG001|Induction Period|Subject/guardian decision|8|||
27808952|NCT01406938|54264551|FG002|Induction Period|Subject/guardian decision|0|||
28035878|NCT00410410|54694053|FG008|Open-Label Period (OL)|Other|7|||
28035879|NCT00534404|54694091|FG000|Overall Study|Death|0|||
28035880|NCT00534404|54694092|FG001|Overall Study|Death|0|||
28035881|NCT00534404|54694093|FG002|Overall Study|Death|2|||
28035882|NCT00534404|54694091|FG000|Overall Study|Withdrawal by Subject|8|||
28035883|NCT00534404|54694092|FG001|Overall Study|Withdrawal by Subject|2|||
28035884|NCT00534404|54694093|FG002|Overall Study|Withdrawal by Subject|38|||
28035885|NCT00534404|54694091|FG000|Overall Study|Removed by study staff|2|||
28035886|NCT00534404|54694092|FG001|Overall Study|Removed by study staff|3|||
28035887|NCT00534404|54694093|FG002|Overall Study|Removed by study staff|1|||
28035888|NCT00534404|54694091|FG000|Overall Study|Lost to Follow-up|170|||
28035889|NCT00534404|54694092|FG001|Overall Study|Lost to Follow-up|138|||
28035890|NCT00534404|54694093|FG002|Overall Study|Lost to Follow-up|201|||
27808953|NCT01406938|54264552|FG003|Induction Period|Subject/guardian decision|0|||
27808954|NCT01406938|54264553|FG004|Induction Period|Subject/guardian decision|0|||
27808955|NCT01406938|54264554|FG005|Induction Period|Subject/guardian decision|0|||
27808956|NCT01406938|54264549|FG000|Induction Period|Protocol deviation|1|||
27808957|NCT01406938|54264550|FG001|Induction Period|Protocol deviation|0|||
27808958|NCT01406938|54264551|FG002|Induction Period|Protocol deviation|0|||
27808959|NCT01406938|54264552|FG003|Induction Period|Protocol deviation|0|||
27808960|NCT01406938|54264553|FG004|Induction Period|Protocol deviation|0|||
27808961|NCT01406938|54264554|FG005|Induction Period|Protocol deviation|0|||
27847115|NCT04999111|54339198|FG000|Overall Study|Ongoing|326|||
28035891|NCT00393094|54694101|FG000|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1|||
28035892|NCT00393094|54694101|FG000|Disease Progression After Trtmt: Onstudy|Refused further treatment|1|||
28035893|NCT00409786|54694107|FG000|Overall Study|Withdrawal by Subject|3|||
28035894|NCT00409708|54694113|FG000|Treatment|Abnormal test procedure result(s)|1|||
28035895|NCT00409708|54694114|FG001|Treatment|Abnormal test procedure result(s)|0|||
28035896|NCT00409708|54694113|FG000|Treatment|Lack of Efficacy|0|||
28035897|NCT00409708|54694114|FG001|Treatment|Lack of Efficacy|1|||
28035898|NCT00409708|54694113|FG000|Treatment|Protocol Violation|6|||
27808962|NCT01406938|54264549|FG000|Induction Period|Adverse Event|8|||
27808963|NCT01406938|54264550|FG001|Induction Period|Adverse Event|9|||
27847116|NCT04999111|54339199|FG001|Overall Study|Ongoing|321|||
27847117|NCT04999111|54339200|FG002|Overall Study|Ongoing|112|||
27847118|NCT04999111|54339201|FG003|Overall Study|Ongoing|323|||
27847119|NCT04999111|54339202|FG004|Overall Study|Ongoing|322|||
27847120|NCT04999111|54339203|FG005|Overall Study|Ongoing|105|||
27847121|NCT04999111|54339198|FG000|Overall Study|Randomized but not vaccinated|1|||
27847122|NCT04999111|54339199|FG001|Overall Study|Randomized but not vaccinated|2|||
27847123|NCT04999111|54339200|FG002|Overall Study|Randomized but not vaccinated|0|||
27847124|NCT04999111|54339201|FG003|Overall Study|Randomized but not vaccinated|3|||
28035899|NCT00409708|54694114|FG001|Treatment|Protocol Violation|2|||
28035900|NCT00409708|54694113|FG000|Treatment|Withdrawal by Subject|3|||
28035901|NCT00409708|54694114|FG001|Treatment|Withdrawal by Subject|8|||
28035902|NCT00409708|54694113|FG000|Treatment|Lost to Follow-up|0|||
28035903|NCT00409708|54694114|FG001|Treatment|Lost to Follow-up|6|||
28035904|NCT00409708|54694113|FG000|Treatment|Administrative problems|5|||
28035905|NCT00409708|54694114|FG001|Treatment|Administrative problems|0|||
28035906|NCT00409708|54694113|FG000|Washout|Lack of Efficacy|9|||
28035907|NCT00409708|54694114|FG001|Washout|Lack of Efficacy|1|||
28035908|NCT00409708|54694113|FG000|Washout|Protocol Violation|0|||
28035909|NCT00409708|54694114|FG001|Washout|Protocol Violation|1|||
28035910|NCT00409708|54694113|FG000|Washout|Withdrawal by Subject|11|||
28035911|NCT00409708|54694114|FG001|Washout|Withdrawal by Subject|5|||
28035912|NCT00409708|54694113|FG000|Washout|Lost to Follow-up|1|||
28035913|NCT00409708|54694114|FG001|Washout|Lost to Follow-up|3|||
28035914|NCT00391846|54694131|FG000|Overall Study|Adverse Event|4|||
28035915|NCT00391846|54694132|FG001|Overall Study|Adverse Event|1|||
28035916|NCT00391846|54694131|FG000|Overall Study|Did not meet the required elig. crit|2|||
28035917|NCT00391846|54694132|FG001|Overall Study|Did not meet the required elig. crit|2|||
28035918|NCT00391846|54694131|FG000|Overall Study|Withdrawal by Subject|2|||
28035919|NCT00391846|54694132|FG001|Overall Study|Withdrawal by Subject|3|||
28035920|NCT00391846|54694131|FG000|Overall Study|Developed study specific DC criteria|0|||
28035921|NCT00391846|54694132|FG001|Overall Study|Developed study specific DC criteria|1|||
28035922|NCT00534248|54694157|FG000|Overall Study|Adverse Event|19|||
28035923|NCT00534248|54694158|FG001|Overall Study|Adverse Event|29|||
28035924|NCT00534248|54694157|FG000|Overall Study|Lost to Follow-up|353|||
28035925|NCT00534248|54694158|FG001|Overall Study|Lost to Follow-up|375|||
28035926|NCT00534248|54694157|FG000|Overall Study|Other protocol specified criteria|13|||
28035927|NCT00534248|54694158|FG001|Overall Study|Other protocol specified criteria|3|||
28035928|NCT00534248|54694157|FG000|Overall Study|Physician Decision|10|||
28035929|NCT00534248|54694158|FG001|Overall Study|Physician Decision|7|||
28035930|NCT00534248|54694157|FG000|Overall Study|Protocol Violation|3|||
28035931|NCT00534248|54694158|FG001|Overall Study|Protocol Violation|4|||
28035932|NCT00534248|54694157|FG000|Overall Study|Withdrawal by Subject|263|||
28035933|NCT00534248|54694158|FG001|Overall Study|Withdrawal by Subject|255|||
28035934|NCT00391768|54694171|FG000|Overall Study|Withdrawal by Subject|0|||
28035935|NCT00391768|54694172|FG001|Overall Study|Withdrawal by Subject|0|||
28035936|NCT00391768|54694173|FG002|Overall Study|Withdrawal by Subject|1|||
28035937|NCT00391768|54694174|FG003|Overall Study|Withdrawal by Subject|0|||
28035938|NCT00391768|54694175|FG004|Overall Study|Withdrawal by Subject|0|||
28035939|NCT00391768|54694176|FG005|Overall Study|Withdrawal by Subject|1|||
28035940|NCT00391768|54694177|FG006|Overall Study|Withdrawal by Subject|1|||
28035941|NCT00391768|54694171|FG000|Overall Study|Lost to Follow-up|0|||
28035942|NCT00391768|54694172|FG001|Overall Study|Lost to Follow-up|0|||
28035943|NCT00391768|54694173|FG002|Overall Study|Lost to Follow-up|0|||
28035944|NCT00391768|54694174|FG003|Overall Study|Lost to Follow-up|1|||
28035945|NCT00391768|54694175|FG004|Overall Study|Lost to Follow-up|2|||
28035946|NCT00391768|54694176|FG005|Overall Study|Lost to Follow-up|2|||
28035947|NCT00391768|54694177|FG006|Overall Study|Lost to Follow-up|3|||
28035948|NCT00391222|54694214|FG000|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
28035949|NCT00391222|54694215|FG001|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
28035950|NCT00391222|54694216|FG002|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
28035951|NCT00391222|54694217|FG003|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26|||
28035952|NCT00391222|54694214|FG000|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
28035953|NCT00391222|54694215|FG001|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
28035954|NCT00391222|54694216|FG002|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
27847125|NCT04999111|54339202|FG004|Overall Study|Randomized but not vaccinated|3|||
27847126|NCT04999111|54339203|FG005|Overall Study|Randomized but not vaccinated|0|||
27939815|NCT00946192|54596143|FG002|Overall Study|Withdrawal by Subject|3|||
28035955|NCT00391222|54694217|FG003|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5|||
28035956|NCT00391222|54694214|FG000|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
28035957|NCT00391222|54694215|FG001|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
28035958|NCT00391222|54694216|FG002|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
28035959|NCT00391222|54694217|FG003|Period II (Open-label Risperidone LAI)|Adverse Event|10|||
28035960|NCT00391222|54694214|FG000|Period II (Open-label Risperidone LAI)|Non-responder|0|||
28035961|NCT00391222|54694215|FG001|Period II (Open-label Risperidone LAI)|Non-responder|0|||
28035962|NCT00391222|54694216|FG002|Period II (Open-label Risperidone LAI)|Non-responder|0|||
28035963|NCT00391222|54694217|FG003|Period II (Open-label Risperidone LAI)|Non-responder|97|||
28035964|NCT00391222|54694214|FG000|Period II (Open-label Risperidone LAI)|Other|0|||
27847127|NCT01673646|54339264|FG000|Overall Study|Adverse Event|2|||
27847128|NCT01673646|54339265|FG001|Overall Study|Adverse Event|1|||
27847129|NCT01673646|54339266|FG002|Overall Study|Adverse Event|1|||
28035965|NCT00391222|54694215|FG001|Period II (Open-label Risperidone LAI)|Other|0|||
28035966|NCT00391222|54694216|FG002|Period II (Open-label Risperidone LAI)|Other|0|||
28035967|NCT00391222|54694217|FG003|Period II (Open-label Risperidone LAI)|Other|24|||
28035968|NCT00391222|54694214|FG000|Period III (Double-Blind Treatment)|Withdrawal by Subject|15|||
28035969|NCT00391222|54694215|FG001|Period III (Double-Blind Treatment)|Withdrawal by Subject|12|||
28035970|NCT00391222|54694216|FG002|Period III (Double-Blind Treatment)|Withdrawal by Subject|6|||
28035971|NCT00391222|54694217|FG003|Period III (Double-Blind Treatment)|Withdrawal by Subject|0|||
28035972|NCT00391222|54694214|FG000|Period III (Double-Blind Treatment)|Lost to Follow-up|2|||
28035973|NCT00391222|54694215|FG001|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
28035974|NCT00391222|54694216|FG002|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
28035975|NCT00391222|54694217|FG003|Period III (Double-Blind Treatment)|Lost to Follow-up|0|||
28035976|NCT00391222|54694214|FG000|Period III (Double-Blind Treatment)|Adverse Event|5|||
28035977|NCT00391222|54694215|FG001|Period III (Double-Blind Treatment)|Adverse Event|2|||
28035978|NCT00391222|54694216|FG002|Period III (Double-Blind Treatment)|Adverse Event|4|||
28035979|NCT00391222|54694217|FG003|Period III (Double-Blind Treatment)|Adverse Event|0|||
28035980|NCT00391222|54694214|FG000|Period III (Double-Blind Treatment)|Pregnancy|0|||
28035981|NCT00391222|54694215|FG001|Period III (Double-Blind Treatment)|Pregnancy|2|||
28035982|NCT00391222|54694216|FG002|Period III (Double-Blind Treatment)|Pregnancy|0|||
28035983|NCT00391222|54694217|FG003|Period III (Double-Blind Treatment)|Pregnancy|0|||
28035984|NCT00391222|54694214|FG000|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
28035985|NCT00391222|54694215|FG001|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1|||
28035986|NCT00391222|54694216|FG002|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3|||
28035987|NCT00391222|54694217|FG003|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
28035988|NCT00391222|54694214|FG000|Period III (Double-Blind Treatment)|Other|6|||
28035989|NCT00391222|54694215|FG001|Period III (Double-Blind Treatment)|Other|1|||
28035990|NCT00391222|54694216|FG002|Period III (Double-Blind Treatment)|Other|6|||
28035991|NCT00391222|54694217|FG003|Period III (Double-Blind Treatment)|Other|0|||
28035992|NCT00409006|54694229|FG000|Overall Study|Death|15|||
28035993|NCT00409006|54694230|FG001|Overall Study|Death|6|||
28035994|NCT00409006|54694229|FG000|Overall Study|Lost to Follow-up|1|||
28035995|NCT00409006|54694230|FG001|Overall Study|Lost to Follow-up|2|||
28035996|NCT00409006|54694229|FG000|Overall Study|Withdrawal by Subject|3|||
28035997|NCT00409006|54694230|FG001|Overall Study|Withdrawal by Subject|2|||
28035998|NCT00409006|54694229|FG000|Overall Study|Physician Decision|1|||
28035999|NCT00409006|54694230|FG001|Overall Study|Physician Decision|2|||
28036000|NCT00534092|54694238|FG000|Overall Study|Lost to Follow-up|1|||
28036001|NCT00534092|54694239|FG001|Overall Study|Lost to Follow-up|0|||
28036002|NCT00534092|54694238|FG000|Overall Study|personal reasons/family concerns|1|||
28036003|NCT00534092|54694239|FG001|Overall Study|personal reasons/family concerns|0|||
27808964|NCT01406938|54264551|FG002|Induction Period|Adverse Event|0|||
27808965|NCT01406938|54264552|FG003|Induction Period|Adverse Event|0|||
27808966|NCT01406938|54264553|FG004|Induction Period|Adverse Event|0|||
27808967|NCT01406938|54264554|FG005|Induction Period|Adverse Event|0|||
27808968|NCT01406938|54264549|FG000|Induction Period|Lack of Efficacy|1|||
27808969|NCT01406938|54264550|FG001|Induction Period|Lack of Efficacy|0|||
27808970|NCT01406938|54264551|FG002|Induction Period|Lack of Efficacy|0|||
27808971|NCT01406938|54264552|FG003|Induction Period|Lack of Efficacy|0|||
27808972|NCT01406938|54264553|FG004|Induction Period|Lack of Efficacy|0|||
27808973|NCT01406938|54264554|FG005|Induction Period|Lack of Efficacy|0|||
27808974|NCT01406938|54264549|FG000|Induction Period|Lost to Follow-up|2|||
27808975|NCT01406938|54264550|FG001|Induction Period|Lost to Follow-up|3|||
27808976|NCT01406938|54264551|FG002|Induction Period|Lost to Follow-up|0|||
27808977|NCT01406938|54264552|FG003|Induction Period|Lost to Follow-up|0|||
27808978|NCT01406938|54264553|FG004|Induction Period|Lost to Follow-up|0|||
27808979|NCT01406938|54264554|FG005|Induction Period|Lost to Follow-up|0|||
27808980|NCT01406938|54264549|FG000|Maintenance Period|Adverse Event|0|||
28036004|NCT00408928|54694247|FG000|Overall Study|Withdrawal by Subject|1|||
28036005|NCT00408928|54694247|FG000|Overall Study|Death|1|||
27808981|NCT01406938|54264550|FG001|Maintenance Period|Adverse Event|0|||
27808982|NCT01406938|54264551|FG002|Maintenance Period|Adverse Event|2|||
27808983|NCT01406938|54264552|FG003|Maintenance Period|Adverse Event|8|||
27808984|NCT01406938|54264553|FG004|Maintenance Period|Adverse Event|4|||
27808985|NCT01406938|54264554|FG005|Maintenance Period|Adverse Event|2|||
27808986|NCT01406938|54264549|FG000|Maintenance Period|Death|0|||
27808987|NCT01406938|54264550|FG001|Maintenance Period|Death|0|||
27808988|NCT01406938|54264551|FG002|Maintenance Period|Death|0|||
27847130|NCT01673646|54339264|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
28036006|NCT00408928|54694247|FG000|Overall Study|Infection indistinguishable from GVHD|1|||
28036007|NCT00390910|54694254|FG000|Overall Study|Adverse Event|1|||
28036008|NCT00390910|54694255|FG001|Overall Study|Adverse Event|0|||
28036009|NCT00390910|54694256|FG002|Overall Study|Adverse Event|0|||
28036010|NCT00390910|54694254|FG000|Overall Study|Lost to Follow-up|0|||
28036011|NCT00390910|54694255|FG001|Overall Study|Lost to Follow-up|1|||
28036012|NCT00390910|54694256|FG002|Overall Study|Lost to Follow-up|5|||
28036013|NCT00390910|54694254|FG000|Overall Study|Withdrawal by Subject|1|||
28036014|NCT00390910|54694255|FG001|Overall Study|Withdrawal by Subject|3|||
28036015|NCT00390910|54694256|FG002|Overall Study|Withdrawal by Subject|2|||
28036016|NCT00390910|54694254|FG000|Overall Study|Migrated/moved from study area|0|||
28036017|NCT00390910|54694255|FG001|Overall Study|Migrated/moved from study area|0|||
28036018|NCT00390910|54694256|FG002|Overall Study|Migrated/moved from study area|3|||
28036019|NCT00533702|54694268|FG000|Overall Study|Withdrawal by Subject|3|||
28036020|NCT00533702|54694269|FG001|Overall Study|Withdrawal by Subject|1|||
28036021|NCT00533702|54694268|FG000|Overall Study|Found ineligible after randomization|2|||
28036022|NCT00533702|54694269|FG001|Overall Study|Found ineligible after randomization|1|||
28036023|NCT00408694|54694275|FG000|Overall Study|Ineligible|1|||
28036024|NCT00408694|54694275|FG000|Overall Study|No protocol treatment|1|||
28036025|NCT00396136|54694279|FG000|Overall Study|Death|43|||
28036026|NCT00396136|54694279|FG000|Overall Study|Withdrawal by Subject|59|||
28036027|NCT00396136|54694279|FG000|Overall Study|Lost to Follow-up|15|||
28036028|NCT00396136|54694279|FG000|Overall Study|Study device explanted|8|||
28036029|NCT00530894|54694287|FG000|Overall Study|Death|84|||
28036030|NCT00530894|54694288|FG001|Overall Study|Death|89|||
28036031|NCT00530894|54694289|FG002|Overall Study|Death|55|||
28036032|NCT00530894|54694290|FG003|Overall Study|Death|89|||
28036033|NCT00530894|54694287|FG000|Overall Study|Lost to Follow-up|1|||
28036034|NCT00530894|54694288|FG001|Overall Study|Lost to Follow-up|3|||
28036035|NCT00530894|54694289|FG002|Overall Study|Lost to Follow-up|0|||
28036036|NCT00530894|54694290|FG003|Overall Study|Lost to Follow-up|0|||
28036037|NCT00530894|54694287|FG000|Overall Study|Withdrawal by Subject|1|||
28036038|NCT00530894|54694288|FG001|Overall Study|Withdrawal by Subject|23|||
28036039|NCT00530894|54694289|FG002|Overall Study|Withdrawal by Subject|0|||
28036040|NCT00530894|54694290|FG003|Overall Study|Withdrawal by Subject|5|||
28036041|NCT00530894|54694287|FG000|Overall Study|Alive and censored prior to 1 year|2|||
28036042|NCT00530894|54694288|FG001|Overall Study|Alive and censored prior to 1 year|0|||
28036043|NCT00530894|54694289|FG002|Overall Study|Alive and censored prior to 1 year|0|||
28036044|NCT00530894|54694290|FG003|Overall Study|Alive and censored prior to 1 year|0|||
28036045|NCT00056407|54694304|FG000|Overall Study|Adverse Event|282|||
28036046|NCT00056407|54694305|FG001|Overall Study|Adverse Event|364|||
28036047|NCT00056407|54694304|FG000|Overall Study|Withdrawal by Subject|377|||
28036048|NCT00056407|54694305|FG001|Overall Study|Withdrawal by Subject|361|||
28036049|NCT00056407|54694304|FG000|Overall Study|Lost to Follow-up|123|||
28036050|NCT00056407|54694305|FG001|Overall Study|Lost to Follow-up|113|||
28036051|NCT00056407|54694304|FG000|Overall Study|Protocol Violation|104|||
28036052|NCT00056407|54694305|FG001|Overall Study|Protocol Violation|95|||
28036053|NCT00056407|54694304|FG000|Overall Study|Diagnosed with Prostate Cancer|202|||
28036054|NCT00056407|54694305|FG001|Overall Study|Diagnosed with Prostate Cancer|166|||
28036055|NCT00056407|54694304|FG000|Overall Study|"Listed as Other on Case Report Form"|98|||
28036056|NCT00056407|54694305|FG001|Overall Study|"Listed as Other on Case Report Form"|60|||
28036057|NCT00056407|54694304|FG000|Overall Study|Missing|25|||
28036058|NCT00056407|54694305|FG001|Overall Study|Missing|34|||
28036059|NCT00388726|54694313|FG000|Overall Study|Adverse Event|50|||
28036060|NCT00388726|54694314|FG001|Overall Study|Adverse Event|24|||
28036061|NCT00388726|54694313|FG000|Overall Study|Progressive Disease|336|||
28036062|NCT00388726|54694314|FG001|Overall Study|Progressive Disease|153|||
28036063|NCT00388726|54694313|FG000|Overall Study|Clinical Progression|61|||
28036064|NCT00388726|54694314|FG001|Overall Study|Clinical Progression|36|||
28036065|NCT00388726|54694313|FG000|Overall Study|Withdrawal by Subject|10|||
28036066|NCT00388726|54694314|FG001|Overall Study|Withdrawal by Subject|7|||
28036067|NCT00388726|54694313|FG000|Overall Study|Administrative|6|||
28036068|NCT00388726|54694314|FG001|Overall Study|Administrative|9|||
28036069|NCT00388726|54694313|FG000|Overall Study|Physician Decision|18|||
28036070|NCT00388726|54694314|FG001|Overall Study|Physician Decision|13|||
28036071|NCT00388726|54694313|FG000|Overall Study|Death|3|||
28036072|NCT00388726|54694314|FG001|Overall Study|Death|2|||
28036073|NCT00387790|54694320|FG000|Overall Study|Adverse Event|5|||
28036074|NCT00387790|54694320|FG000|Overall Study|Lack of Efficacy|2|||
28036075|NCT00387790|54694320|FG000|Overall Study|Physician Decision|2|||
27808989|NCT01406938|54264552|FG003|Maintenance Period|Death|0|||
27808990|NCT01406938|54264553|FG004|Maintenance Period|Death|1|||
27808991|NCT01406938|54264554|FG005|Maintenance Period|Death|0|||
27808992|NCT01406938|54264549|FG000|Maintenance Period|Subject/guardian decision|0|||
27808993|NCT01406938|54264550|FG001|Maintenance Period|Subject/guardian decision|0|||
27808994|NCT01406938|54264551|FG002|Maintenance Period|Subject/guardian decision|11|||
27808995|NCT01406938|54264552|FG003|Maintenance Period|Subject/guardian decision|7|||
28036076|NCT00387790|54694320|FG000|Overall Study|Withdrawal by Subject|3|||
27808996|NCT01406938|54264553|FG004|Maintenance Period|Subject/guardian decision|10|||
28036077|NCT00387790|54694320|FG000|Overall Study|Ineligible for study|2|||
28036078|NCT00073021|54694326|FG000|Overall Study|Protocol Violation|2|||
27847131|NCT01673646|54339265|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
27847132|NCT01673646|54339266|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
27847133|NCT01673646|54339264|FG000|Overall Study|Condition no longer requires study drug|0|||
27847134|NCT01673646|54339265|FG001|Overall Study|Condition no longer requires study drug|1|||
27847135|NCT01673646|54339266|FG002|Overall Study|Condition no longer requires study drug|0|||
27847136|NCT01673646|54339264|FG000|Overall Study|Withdrawal by Subject|0|||
27847137|NCT01673646|54339265|FG001|Overall Study|Withdrawal by Subject|2|||
27847138|NCT01673646|54339266|FG002|Overall Study|Withdrawal by Subject|2|||
27847139|NCT01673646|54339264|FG000|Overall Study|Completed Core/did not enter Ext.|2|||
27847140|NCT01673646|54339265|FG001|Overall Study|Completed Core/did not enter Ext.|1|||
27847141|NCT01673646|54339266|FG002|Overall Study|Completed Core/did not enter Ext.|1|||
27847142|NCT02647944|54339306|FG000|Overall Study|Withdrawal by Subject|0|||
27847143|NCT02647944|54339307|FG001|Overall Study|Withdrawal by Subject|3|||
27847144|NCT02647944|54339306|FG000|Overall Study|Adverse Event|2|||
27847145|NCT02647944|54339307|FG001|Overall Study|Adverse Event|0|||
27847146|NCT01397825|54339362|FG000|Overall Study|Progressive Disease|10|||
27847147|NCT01397825|54339363|FG001|Overall Study|Progressive Disease|3|||
27847148|NCT01397825|54339364|FG002|Overall Study|Progressive Disease|11|||
27847149|NCT01397825|54339365|FG003|Overall Study|Progressive Disease|1|||
27847150|NCT01397825|54339366|FG004|Overall Study|Progressive Disease|0|||
27847151|NCT01397825|54339362|FG000|Overall Study|Symptomatic Deterioration|2|||
27847152|NCT01397825|54339363|FG001|Overall Study|Symptomatic Deterioration|0|||
27847153|NCT01397825|54339364|FG002|Overall Study|Symptomatic Deterioration|4|||
27847154|NCT01397825|54339365|FG003|Overall Study|Symptomatic Deterioration|0|||
27847155|NCT01397825|54339366|FG004|Overall Study|Symptomatic Deterioration|0|||
27847156|NCT01397825|54339362|FG000|Overall Study|Adverse Event|0|||
28036079|NCT00073021|54694327|FG001|Overall Study|Protocol Violation|1|||
28036080|NCT00073021|54694326|FG000|Overall Study|Adverse Event|4|||
28036081|NCT00073021|54694327|FG001|Overall Study|Adverse Event|4|||
28036082|NCT00073021|54694326|FG000|Overall Study|Withdrawal by Subject|6|||
28036083|NCT00073021|54694327|FG001|Overall Study|Withdrawal by Subject|5|||
28036084|NCT00073021|54694326|FG000|Overall Study|Physician Decision|3|||
27808997|NCT01406938|54264554|FG005|Maintenance Period|Subject/guardian decision|7|||
27847157|NCT01397825|54339363|FG001|Overall Study|Adverse Event|1|||
27847158|NCT01397825|54339364|FG002|Overall Study|Adverse Event|5|||
27847159|NCT01397825|54339365|FG003|Overall Study|Adverse Event|1|||
27847160|NCT01397825|54339366|FG004|Overall Study|Adverse Event|0|||
27847161|NCT01397825|54339362|FG000|Overall Study|Withdrawal by Subject|1|||
27847162|NCT01397825|54339363|FG001|Overall Study|Withdrawal by Subject|0|||
27847163|NCT01397825|54339364|FG002|Overall Study|Withdrawal by Subject|5|||
27847164|NCT01397825|54339365|FG003|Overall Study|Withdrawal by Subject|1|||
27847165|NCT01397825|54339366|FG004|Overall Study|Withdrawal by Subject|0|||
27847166|NCT01397747|54339389|FG000|Overall Study|Multitarget DNA test excluded|689|||
27847167|NCT01397747|54339389|FG000|Overall Study|Colonoscopy excluded|304|||
27847168|NCT01397747|54339389|FG000|Overall Study|FIT excluded|34|||
27847169|NCT01397201|54339427|FG000|Overall Study|Not treated|0|||
27847170|NCT01397201|54339428|FG001|Overall Study|Not treated|0|||
27847171|NCT01397201|54339429|FG002|Overall Study|Not treated|1|||
27847172|NCT01397201|54339430|FG003|Overall Study|Not treated|0|||
27847173|NCT01397201|54339431|FG004|Overall Study|Not treated|0|||
27847174|NCT01397201|54339427|FG000|Overall Study|Not yet defined|3|||
27847175|NCT01397201|54339428|FG001|Overall Study|Not yet defined|6|||
27847176|NCT01397201|54339429|FG002|Overall Study|Not yet defined|5|||
27847177|NCT01397201|54339430|FG003|Overall Study|Not yet defined|5|||
27847178|NCT01397201|54339431|FG004|Overall Study|Not yet defined|4|||
28036085|NCT00073021|54694327|FG001|Overall Study|Physician Decision|1|||
27808998|NCT01406938|54264549|FG000|Maintenance Period|Protocol Violation|0|||
27808999|NCT01406938|54264550|FG001|Maintenance Period|Protocol Violation|0|||
27809000|NCT01406938|54264551|FG002|Maintenance Period|Protocol Violation|2|||
27809001|NCT01406938|54264552|FG003|Maintenance Period|Protocol Violation|2|||
27809002|NCT01406938|54264553|FG004|Maintenance Period|Protocol Violation|2|||
27809003|NCT01406938|54264554|FG005|Maintenance Period|Protocol Violation|2|||
27809004|NCT01406938|54264549|FG000|Maintenance Period|Pregnancy|0|||
27809005|NCT01406938|54264550|FG001|Maintenance Period|Pregnancy|0|||
27809006|NCT01406938|54264551|FG002|Maintenance Period|Pregnancy|0|||
27809007|NCT01406938|54264552|FG003|Maintenance Period|Pregnancy|0|||
27809008|NCT01406938|54264553|FG004|Maintenance Period|Pregnancy|1|||
27809009|NCT01406938|54264554|FG005|Maintenance Period|Pregnancy|0|||
27847179|NCT01397201|54339427|FG000|Overall Study|Adverse Event|2|||
27847180|NCT01397201|54339428|FG001|Overall Study|Adverse Event|0|||
27847181|NCT01397201|54339429|FG002|Overall Study|Adverse Event|0|||
27847182|NCT01397201|54339430|FG003|Overall Study|Adverse Event|0|||
27847183|NCT01397201|54339431|FG004|Overall Study|Adverse Event|0|||
27847184|NCT01393613|54339465|FG000|Overall Study|Adverse Event|11|||
28036086|NCT00073021|54694326|FG000|Overall Study|Lack of Efficacy|11|||
28036087|NCT00073021|54694327|FG001|Overall Study|Lack of Efficacy|5|||
28036088|NCT00407758|54694333|FG000|Overall Study|ineligible -improper prior treatment|1|||
28036089|NCT00531752|54694341|FG000|First Double-blind Intervention Period|Adverse Event|2|||
28036090|NCT00531752|54694342|FG001|First Double-blind Intervention Period|Adverse Event|0|||
28036091|NCT00531752|54694343|FG002|First Double-blind Intervention Period|Adverse Event|1|||
28036092|NCT00531752|54694344|FG003|First Double-blind Intervention Period|Adverse Event|1|||
28036093|NCT00531752|54694341|FG000|First Double-blind Intervention Period|Other|1|||
28036094|NCT00531752|54694342|FG001|First Double-blind Intervention Period|Other|4|||
28036095|NCT00531752|54694343|FG002|First Double-blind Intervention Period|Other|4|||
28036096|NCT00531752|54694344|FG003|First Double-blind Intervention Period|Other|0|||
28036097|NCT00531752|54694341|FG000|First Double-blind Intervention Period|Withdrawal by Subject|2|||
28036098|NCT00531752|54694342|FG001|First Double-blind Intervention Period|Withdrawal by Subject|0|||
28036099|NCT00531752|54694343|FG002|First Double-blind Intervention Period|Withdrawal by Subject|1|||
28036100|NCT00531752|54694344|FG003|First Double-blind Intervention Period|Withdrawal by Subject|1|||
28036101|NCT00531752|54694341|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
28036102|NCT00531752|54694342|FG001|First Double-blind Intervention Period|Lost to Follow-up|0|||
28036103|NCT00531752|54694343|FG002|First Double-blind Intervention Period|Lost to Follow-up|1|||
28036104|NCT00531752|54694344|FG003|First Double-blind Intervention Period|Lost to Follow-up|1|||
28036105|NCT00531752|54694341|FG000|First Double-blind Intervention Period|Randomized but not treated|1|||
28036106|NCT00531752|54694342|FG001|First Double-blind Intervention Period|Randomized but not treated|0|||
28036107|NCT00531752|54694343|FG002|First Double-blind Intervention Period|Randomized but not treated|0|||
28036108|NCT00531752|54694344|FG003|First Double-blind Intervention Period|Randomized but not treated|0|||
28036109|NCT00531752|54694341|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
28036110|NCT00531752|54694342|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
28036111|NCT00531752|54694343|FG002|Second Double-blind Intervention Period|Adverse Event|0|||
28036112|NCT00531752|54694344|FG003|Second Double-blind Intervention Period|Adverse Event|0|||
28036113|NCT00531752|54694341|FG000|Second Double-blind Intervention Period|Other|1|||
28036114|NCT00531752|54694342|FG001|Second Double-blind Intervention Period|Other|1|||
28036115|NCT00531752|54694343|FG002|Second Double-blind Intervention Period|Other|0|||
28036116|NCT00531752|54694344|FG003|Second Double-blind Intervention Period|Other|0|||
27809010|NCT01406938|54264549|FG000|Maintenance Period|Lost to Follow-up|0|||
28036117|NCT00531752|54694341|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
28036118|NCT00531752|54694342|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
28036119|NCT00531752|54694343|FG002|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
28036120|NCT00531752|54694344|FG003|Second Double-blind Intervention Period|Withdrawal by Subject|1|||
28036121|NCT00531752|54694341|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
28036122|NCT00531752|54694342|FG001|Second Double-blind Intervention Period|Lost to Follow-up|0|||
28036123|NCT00531752|54694343|FG002|Second Double-blind Intervention Period|Lost to Follow-up|0|||
28036124|NCT00531752|54694344|FG003|Second Double-blind Intervention Period|Lost to Follow-up|1|||
28036125|NCT00395746|54694355|FG000|Overall Study|Adverse Event|5|||
28036126|NCT00395746|54694356|FG001|Overall Study|Adverse Event|2|||
28036127|NCT00395746|54694357|FG002|Overall Study|Adverse Event|2|||
28036128|NCT00395746|54694355|FG000|Overall Study|Protocol Violation|0|||
28036129|NCT00395746|54694356|FG001|Overall Study|Protocol Violation|1|||
28036130|NCT00395746|54694357|FG002|Overall Study|Protocol Violation|0|||
28036131|NCT00395746|54694355|FG000|Overall Study|Lack of Efficacy|2|||
28036132|NCT00395746|54694356|FG001|Overall Study|Lack of Efficacy|0|||
28036133|NCT00395746|54694357|FG002|Overall Study|Lack of Efficacy|17|||
28036134|NCT00395746|54694355|FG000|Overall Study|Hypoglycaemia|2|||
28036135|NCT00395746|54694356|FG001|Overall Study|Hypoglycaemia|1|||
28036136|NCT00395746|54694357|FG002|Overall Study|Hypoglycaemia|0|||
28036137|NCT00395746|54694355|FG000|Overall Study|Subject decision|0|||
28036138|NCT00395746|54694356|FG001|Overall Study|Subject decision|0|||
28036139|NCT00395746|54694357|FG002|Overall Study|Subject decision|1|||
28036140|NCT00395746|54694355|FG000|Overall Study|Withdrawal of consent|0|||
28036141|NCT00395746|54694356|FG001|Overall Study|Withdrawal of consent|0|||
27809011|NCT01406938|54264550|FG001|Maintenance Period|Lost to Follow-up|0|||
27809012|NCT01406938|54264551|FG002|Maintenance Period|Lost to Follow-up|0|||
27809013|NCT01406938|54264552|FG003|Maintenance Period|Lost to Follow-up|0|||
27809014|NCT01406938|54264553|FG004|Maintenance Period|Lost to Follow-up|4|||
27809015|NCT01406938|54264554|FG005|Maintenance Period|Lost to Follow-up|0|||
27809016|NCT01406938|54264549|FG000|Maintenance Period|Lack of Efficacy|0|||
27809017|NCT01406938|54264550|FG001|Maintenance Period|Lack of Efficacy|0|||
27809018|NCT01406938|54264551|FG002|Maintenance Period|Lack of Efficacy|2|||
27809019|NCT01406938|54264552|FG003|Maintenance Period|Lack of Efficacy|1|||
27809020|NCT01406938|54264553|FG004|Maintenance Period|Lack of Efficacy|3|||
28036142|NCT00395746|54694357|FG002|Overall Study|Withdrawal of consent|1|||
28036143|NCT00395746|54694355|FG000|Overall Study|Difficultulty in use of device|0|||
28036144|NCT00395746|54694356|FG001|Overall Study|Difficultulty in use of device|0|||
28036145|NCT00395746|54694357|FG002|Overall Study|Difficultulty in use of device|1|||
27847185|NCT01393613|54339466|FG001|Overall Study|Adverse Event|11|||
27809021|NCT01406938|54264554|FG005|Maintenance Period|Lack of Efficacy|5|||
27809022|NCT01406938|54264549|FG000|Follow up|Lack of Efficacy|3|||
27809023|NCT01406938|54264550|FG001|Follow up|Lack of Efficacy|2|||
27809024|NCT01406938|54264551|FG002|Follow up|Lack of Efficacy|1|||
27809025|NCT01406938|54264552|FG003|Follow up|Lack of Efficacy|0|||
27809026|NCT01406938|54264553|FG004|Follow up|Lack of Efficacy|0|||
27809027|NCT01406938|54264554|FG005|Follow up|Lack of Efficacy|0|||
27809028|NCT01406938|54264549|FG000|Follow up|Patient/guardian decision|4|||
27809029|NCT01406938|54264550|FG001|Follow up|Patient/guardian decision|2|||
27809030|NCT01406938|54264551|FG002|Follow up|Patient/guardian decision|4|||
27809031|NCT01406938|54264552|FG003|Follow up|Patient/guardian decision|2|||
27809032|NCT01406938|54264553|FG004|Follow up|Patient/guardian decision|4|||
27809033|NCT01406938|54264554|FG005|Follow up|Patient/guardian decision|1|||
27809034|NCT01406938|54264549|FG000|Follow up|Protocol Violation|0|||
27809035|NCT01406938|54264550|FG001|Follow up|Protocol Violation|0|||
28036146|NCT00395746|54694355|FG000|Overall Study|Unable to visit site on schedule|1|||
28036147|NCT00395746|54694356|FG001|Overall Study|Unable to visit site on schedule|0|||
28036148|NCT00395746|54694357|FG002|Overall Study|Unable to visit site on schedule|0|||
28036149|NCT00055471|54694368|FG000|Period 1: Dose Escalation Period|Adverse Event|0|||
28036150|NCT00055471|54694369|FG001|Period 1: Dose Escalation Period|Adverse Event|1|||
28036151|NCT00055471|54694370|FG002|Period 1: Dose Escalation Period|Adverse Event|2|||
28036152|NCT00055471|54694368|FG000|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
28036153|NCT00055471|54694369|FG001|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
28036154|NCT00055471|54694370|FG002|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1|||
28036155|NCT00055471|54694368|FG000|Period 1: Dose Escalation Period|Disease progression|0|||
28036156|NCT00055471|54694369|FG001|Period 1: Dose Escalation Period|Disease progression|1|||
28036157|NCT00055471|54694370|FG002|Period 1: Dose Escalation Period|Disease progression|0|||
28036158|NCT00395512|54694382|FG000|Overall Study|Adverse Event|3|||
28036159|NCT00395512|54694383|FG001|Overall Study|Adverse Event|8|||
28036160|NCT00395512|54694384|FG002|Overall Study|Adverse Event|6|||
28036161|NCT00395512|54694385|FG003|Overall Study|Adverse Event|6|||
28036162|NCT00395512|54694382|FG000|Overall Study|Protocol Violation|2|||
28036163|NCT00395512|54694383|FG001|Overall Study|Protocol Violation|3|||
28036164|NCT00395512|54694384|FG002|Overall Study|Protocol Violation|6|||
28036165|NCT00395512|54694385|FG003|Overall Study|Protocol Violation|7|||
28036166|NCT00395512|54694382|FG000|Overall Study|Lost to Follow-up|2|||
28036167|NCT00395512|54694383|FG001|Overall Study|Lost to Follow-up|6|||
28036168|NCT00395512|54694384|FG002|Overall Study|Lost to Follow-up|5|||
28036169|NCT00395512|54694385|FG003|Overall Study|Lost to Follow-up|5|||
28036170|NCT00395512|54694382|FG000|Overall Study|Withdrawal by Subject|6|||
28036171|NCT00395512|54694383|FG001|Overall Study|Withdrawal by Subject|5|||
28036172|NCT00395512|54694384|FG002|Overall Study|Withdrawal by Subject|5|||
28036173|NCT00395512|54694385|FG003|Overall Study|Withdrawal by Subject|12|||
28036174|NCT00395512|54694382|FG000|Overall Study|Physician Decision|6|||
28036175|NCT00395512|54694383|FG001|Overall Study|Physician Decision|4|||
28036176|NCT00395512|54694384|FG002|Overall Study|Physician Decision|2|||
28036177|NCT00395512|54694385|FG003|Overall Study|Physician Decision|2|||
28036178|NCT00395512|54694382|FG000|Overall Study|Other|1|||
28036179|NCT00395512|54694383|FG001|Overall Study|Other|1|||
28036180|NCT00395512|54694384|FG002|Overall Study|Other|0|||
28036181|NCT00395512|54694385|FG003|Overall Study|Other|0|||
28036182|NCT00395512|54694382|FG000|Overall Study|Hyperglycemic Rescue|18|||
28036183|NCT00395512|54694383|FG001|Overall Study|Hyperglycemic Rescue|10|||
28036184|NCT00395512|54694384|FG002|Overall Study|Hyperglycemic Rescue|4|||
28036185|NCT00395512|54694385|FG003|Overall Study|Hyperglycemic Rescue|6|||
28036186|NCT00054691|54694395|FG000|Overall Study|Unmeasurable Disease|2|||
28036187|NCT00054691|54694395|FG000|Overall Study|Noncompliant|1|||
28036188|NCT00387712|54694401|FG000|Overall Study|Physician Decision|6|||
28036189|NCT00387712|54694402|FG001|Overall Study|Physician Decision|4|||
28036190|NCT00387712|54694401|FG000|Overall Study|Lost to Follow-up|17|||
28036191|NCT00387712|54694402|FG001|Overall Study|Lost to Follow-up|20|||
28036192|NCT00387712|54694401|FG000|Overall Study|Withdrawal by Subject|6|||
28036193|NCT00387712|54694402|FG001|Overall Study|Withdrawal by Subject|12|||
28036194|NCT00066703|54694410|FG000|Overall Study|Adverse Event|80|||
28036195|NCT00066703|54694411|FG001|Overall Study|Adverse Event|111|||
28036196|NCT00066703|54694410|FG000|Overall Study|Death|3|||
28036197|NCT00066703|54694411|FG001|Overall Study|Death|0|||
28036198|NCT00066703|54694410|FG000|Overall Study|Lack of Efficacy|114|||
28036199|NCT00066703|54694411|FG001|Overall Study|Lack of Efficacy|69|||
28036200|NCT00066703|54694410|FG000|Overall Study|Lost to Follow-up|31|||
27809036|NCT01406938|54264551|FG002|Follow up|Protocol Violation|1|||
28036201|NCT00066703|54694411|FG001|Overall Study|Lost to Follow-up|28|||
27809037|NCT01406938|54264552|FG003|Follow up|Protocol Violation|0|||
28036202|NCT00066703|54694410|FG000|Overall Study|Withdrawal by Subject|38|||
28036203|NCT00066703|54694411|FG001|Overall Study|Withdrawal by Subject|63|||
28036204|NCT00066703|54694410|FG000|Overall Study|Treatment ongoing|346|||
28036205|NCT00066703|54694411|FG001|Overall Study|Treatment ongoing|311|||
28036206|NCT00072475|54694417|FG000|Overall Study|Adverse Event|44|||
28036207|NCT00072475|54694417|FG000|Overall Study|Death|3|||
28036208|NCT00072475|54694417|FG000|Overall Study|Withdrawal by Subject|46|||
28036209|NCT00072475|54694417|FG000|Overall Study|Patient/Investigator Decision|4|||
28036210|NCT00066469|54694421|FG000|Overall Study|Death|3|||
28036211|NCT00066469|54694421|FG000|Overall Study|Lack of Efficacy|9|||
28036212|NCT00066469|54694421|FG000|Overall Study|Lost to Follow-up|1|||
28036213|NCT00066469|54694421|FG000|Overall Study|Physician Decision|1|||
28036214|NCT00066469|54694421|FG000|Overall Study|Withdrawal by Subject|1|||
28036215|NCT00066469|54694421|FG000|Overall Study|ineligible|1|||
28036216|NCT00387088|54694427|FG000|Overall Study|Adverse Event|143|||
28036217|NCT00387088|54694428|FG001|Overall Study|Adverse Event|156|||
28036218|NCT00387088|54694427|FG000|Overall Study|Protocol Violation|47|||
28036219|NCT00387088|54694428|FG001|Overall Study|Protocol Violation|35|||
28036220|NCT00387088|54694427|FG000|Overall Study|Withdrawal by Subject|20|||
28036221|NCT00387088|54694428|FG001|Overall Study|Withdrawal by Subject|35|||
28036222|NCT00387088|54694427|FG000|Overall Study|Lack of Efficacy|28|||
28036223|NCT00387088|54694428|FG001|Overall Study|Lack of Efficacy|67|||
27847186|NCT01393613|54339467|FG002|Overall Study|Adverse Event|13|||
28036224|NCT00387088|54694427|FG000|Overall Study|Lost to Follow-up|22|||
28036225|NCT00387088|54694428|FG001|Overall Study|Lost to Follow-up|28|||
28036226|NCT00387088|54694427|FG000|Overall Study|Other|58|||
28036227|NCT00387088|54694428|FG001|Overall Study|Other|52|||
28036228|NCT00053365|54694434|FG000|Overall Study|Incorrect cell type|1|||
28036229|NCT00053365|54694434|FG000|Overall Study|Platinum-sensitive interval >12 months|1|||
28036230|NCT00053365|54694434|FG000|Overall Study|Never treated|4|||
28036231|NCT00387010|54694440|FG000|Dose Titration Period|Adverse Event|12|||
28036232|NCT00387010|54694440|FG000|Dose Titration Period|Lack of Efficacy|5|||
28036233|NCT00387010|54694440|FG000|Dose Titration Period|Withdrawal by Subject|3|||
28036234|NCT00387010|54694440|FG000|Dose Titration Period|Protocol Violation|1|||
28036235|NCT00387010|54694440|FG000|Dose Titration Period|Lost to Follow-up|2|||
28036236|NCT00387010|54694440|FG000|Dose Titration Period|Noncompliance with study medication|8|||
28036237|NCT00387010|54694440|FG000|Dose Titration Period|Noncompliance with study procedures|7|||
28036238|NCT00387010|54694440|FG000|Treatment Period|Adverse Event|4|||
28036239|NCT00387010|54694440|FG000|Treatment Period|Withdrawal by Subject|1|||
28036240|NCT00387010|54694440|FG000|Treatment Period|Noncompliance with study medication|2|||
28036241|NCT00387010|54694440|FG000|Treatment Period|Noncompliance with study procedures|3|||
28036242|NCT00387010|54694440|FG000|Treatment Period|Participant reported study drug stolen|1|||
28036243|NCT00386776|54694444|FG000|Overall Study|Withdrawal by Subject|8|||
28036244|NCT00065065|54694452|FG000|Overall Study|Adverse Event|3|||
28036245|NCT00065065|54694453|FG001|Overall Study|Adverse Event|2|||
28036246|NCT00065065|54694452|FG000|Overall Study|Withdrawal by Subject|1|||
28036247|NCT00065065|54694453|FG001|Overall Study|Withdrawal by Subject|5|||
28036248|NCT00065065|54694452|FG000|Overall Study|Lack of Efficacy|4|||
28036249|NCT00065065|54694453|FG001|Overall Study|Lack of Efficacy|11|||
28036250|NCT00065065|54694452|FG000|Overall Study|Other|2|||
28036251|NCT00065065|54694453|FG001|Overall Study|Other|2|||
28036252|NCT00386308|54694463|FG000|Overall Study|Adverse Event|3|||
28036253|NCT00386308|54694464|FG001|Overall Study|Adverse Event|3|||
28036254|NCT00386308|54694463|FG000|Overall Study|Protocol Violation|2|||
28036255|NCT00386308|54694464|FG001|Overall Study|Protocol Violation|5|||
28036256|NCT00386308|54694463|FG000|Overall Study|Lack of Efficacy|0|||
28036257|NCT00386308|54694464|FG001|Overall Study|Lack of Efficacy|2|||
27847187|NCT01393613|54339468|FG003|Overall Study|Adverse Event|22|||
27847188|NCT01393613|54339465|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
27847189|NCT01393613|54339466|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
27847190|NCT01393613|54339467|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
27847191|NCT01393613|54339468|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
27847192|NCT01393613|54339465|FG000|Overall Study|Physician Decision|2|||
27847193|NCT01393613|54339466|FG001|Overall Study|Physician Decision|0|||
27847194|NCT01393613|54339467|FG002|Overall Study|Physician Decision|0|||
27847195|NCT01393613|54339468|FG003|Overall Study|Physician Decision|1|||
27847196|NCT01393613|54339465|FG000|Overall Study|Withdrawal by Subject|15|||
27847197|NCT01393613|54339466|FG001|Overall Study|Withdrawal by Subject|25|||
28036258|NCT00386308|54694463|FG000|Overall Study|Lost to Follow-up|10|||
28036259|NCT00386308|54694464|FG001|Overall Study|Lost to Follow-up|6|||
28036260|NCT00386308|54694463|FG000|Overall Study|Withdrawal by Subject|6|||
28036261|NCT00386308|54694464|FG001|Overall Study|Withdrawal by Subject|2|||
28036262|NCT00386308|54694463|FG000|Overall Study|Other Event|8|||
28036263|NCT00386308|54694464|FG001|Overall Study|Other Event|1|||
28036264|NCT00064987|54694472|FG000|Overall Study|Physician Decision|3|||
28036265|NCT00064987|54694473|FG001|Overall Study|Physician Decision|0|||
28036266|NCT00374452|54694481|FG000|Overall Study|Left clinic before intervention started|4|||
28036267|NCT00374452|54694482|FG001|Overall Study|Left clinic before intervention started|1|||
28036268|NCT00374452|54694481|FG000|Overall Study|Change in job role before intervention|0|||
28036269|NCT00374452|54694482|FG001|Overall Study|Change in job role before intervention|1|||
27847198|NCT01393613|54339467|FG002|Overall Study|Withdrawal by Subject|23|||
28036270|NCT00374452|54694481|FG000|Overall Study|Left clinic after intervention started|1|||
28036271|NCT00374452|54694482|FG001|Overall Study|Left clinic after intervention started|1|||
28036272|NCT00374452|54694481|FG000|Overall Study|Withdrawal by Subject|0|||
28036273|NCT00374452|54694482|FG001|Overall Study|Withdrawal by Subject|2|||
28036274|NCT00064753|54694490|FG000|Overall Study|Death|251|||
28036275|NCT00064753|54694491|FG001|Overall Study|Death|242|||
28036276|NCT00064753|54694490|FG000|Overall Study|Withdrawal by Subject|198|||
28036277|NCT00064753|54694491|FG001|Overall Study|Withdrawal by Subject|171|||
28036278|NCT00064753|54694490|FG000|Overall Study|Lost to Follow-up|225|||
28036279|NCT00064753|54694491|FG001|Overall Study|Lost to Follow-up|235|||
28036280|NCT00374140|54694497|FG000|Overall Study|Lost to Follow-up|1|||
28036281|NCT00374140|54694497|FG000|Overall Study|Protocol Violation|1|||
28036282|NCT00665561|54694503|FG000|Overall Study|Death recorded on subject summary pages|75|||
28036283|NCT00665561|54694504|FG001|Overall Study|Death recorded on subject summary pages|75|||
28036284|NCT00665561|54694503|FG000|Overall Study|Does not meet entrance criteria|19|||
28036285|NCT00665561|54694504|FG001|Overall Study|Does not meet entrance criteria|21|||
28036286|NCT00665561|54694503|FG000|Overall Study|Lost to Follow-up|203|||
28036287|NCT00665561|54694504|FG001|Overall Study|Lost to Follow-up|264|||
28036288|NCT00665561|54694503|FG000|Overall Study|Withdrawal by Subject|74|||
28036289|NCT00665561|54694504|FG001|Overall Study|Withdrawal by Subject|65|||
28036290|NCT00665561|54694503|FG000|Overall Study|Other|123|||
28036291|NCT00665561|54694504|FG001|Overall Study|Other|108|||
28036292|NCT00665561|54694503|FG000|Overall Study|Site closed|8|||
28036293|NCT00665561|54694504|FG001|Overall Study|Site closed|0|||
28036294|NCT00665561|54694503|FG000|Overall Study|Withdrawn due to pregnancy|0|||
28036295|NCT00665561|54694504|FG001|Overall Study|Withdrawn due to pregnancy|1|||
28036296|NCT00663923|54694510|FG000|Overall Study|Lost to Follow-up|2|||
28036297|NCT00386152|54694519|FG000|Overall Study|Adverse Event|6|||
28036298|NCT00386152|54694520|FG001|Overall Study|Adverse Event|5|||
28036299|NCT00386152|54694521|FG002|Overall Study|Adverse Event|4|||
28036300|NCT00386152|54694519|FG000|Overall Study|Chang from original chemo stratification|4|||
28036301|NCT00386152|54694520|FG001|Overall Study|Chang from original chemo stratification|5|||
28036302|NCT00386152|54694521|FG002|Overall Study|Chang from original chemo stratification|6|||
28036303|NCT00386152|54694519|FG000|Overall Study|Death|3|||
28036304|NCT00386152|54694520|FG001|Overall Study|Death|0|||
28036305|NCT00386152|54694521|FG002|Overall Study|Death|1|||
28036306|NCT00386152|54694519|FG000|Overall Study|Disease progression|7|||
28036307|NCT00386152|54694520|FG001|Overall Study|Disease progression|4|||
28036308|NCT00386152|54694521|FG002|Overall Study|Disease progression|5|||
28036309|NCT00386152|54694519|FG000|Overall Study|Physician Decision|13|||
28036310|NCT00386152|54694520|FG001|Overall Study|Physician Decision|10|||
28036311|NCT00386152|54694521|FG002|Overall Study|Physician Decision|4|||
28036312|NCT00386152|54694519|FG000|Overall Study|Lost to Follow-up|1|||
28036313|NCT00386152|54694520|FG001|Overall Study|Lost to Follow-up|0|||
28036314|NCT00386152|54694521|FG002|Overall Study|Lost to Follow-up|0|||
28036315|NCT00386152|54694519|FG000|Overall Study|Completed chemotherapy|4|||
28036316|NCT00386152|54694520|FG001|Overall Study|Completed chemotherapy|5|||
28036317|NCT00386152|54694521|FG002|Overall Study|Completed chemotherapy|1|||
28036318|NCT00386152|54694519|FG000|Overall Study|Protocol Violation|3|||
28036319|NCT00386152|54694520|FG001|Overall Study|Protocol Violation|5|||
28036320|NCT00386152|54694521|FG002|Overall Study|Protocol Violation|2|||
28036321|NCT00386152|54694519|FG000|Overall Study|Withdrawal by Subject|3|||
28036322|NCT00386152|54694520|FG001|Overall Study|Withdrawal by Subject|6|||
28036323|NCT00386152|54694521|FG002|Overall Study|Withdrawal by Subject|10|||
28036324|NCT00385918|54694531|FG000|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
27809038|NCT01406938|54264553|FG004|Follow up|Protocol Violation|0|||
27809039|NCT01406938|54264554|FG005|Follow up|Protocol Violation|0|||
27847199|NCT01393613|54339468|FG003|Overall Study|Withdrawal by Subject|21|||
27847200|NCT01393613|54339465|FG000|Overall Study|Protocol Deviation|2|||
27809040|NCT01406938|54264549|FG000|Follow up|Physician Decision|0|||
27809041|NCT01406938|54264550|FG001|Follow up|Physician Decision|0|||
27809042|NCT01406938|54264551|FG002|Follow up|Physician Decision|2|||
27809043|NCT01406938|54264552|FG003|Follow up|Physician Decision|0|||
27809044|NCT01406938|54264553|FG004|Follow up|Physician Decision|3|||
27809045|NCT01406938|54264554|FG005|Follow up|Physician Decision|1|||
27809046|NCT01406938|54264549|FG000|Follow up|Lost to Follow-up|1|||
28036325|NCT00385918|54694532|FG001|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
27809047|NCT01406938|54264550|FG001|Follow up|Lost to Follow-up|1|||
27809048|NCT01406938|54264551|FG002|Follow up|Lost to Follow-up|0|||
28036326|NCT00385918|54694533|FG002|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8|||
28036327|NCT00385918|54694531|FG000|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
28036328|NCT00385918|54694532|FG001|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
28036329|NCT00385918|54694533|FG002|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5|||
28036330|NCT00385918|54694531|FG000|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
27847201|NCT01393613|54339466|FG001|Overall Study|Protocol Deviation|1|||
27809049|NCT01406938|54264552|FG003|Follow up|Lost to Follow-up|1|||
27809050|NCT01406938|54264553|FG004|Follow up|Lost to Follow-up|2|||
27809051|NCT01406938|54264554|FG005|Follow up|Lost to Follow-up|1|||
27809052|NCT01405924|54264574|FG000|Overall Study|Protocol Violation|8|||
27809053|NCT01405924|54264574|FG000|Overall Study|Missing/Incomplete Data|2|||
27809054|NCT01426438|54264582|FG000|Overall Study|Lost to Follow-up|1|||
27809055|NCT01426438|54264583|FG001|Overall Study|Lost to Follow-up|3|||
28036331|NCT00385918|54694532|FG001|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
28036332|NCT00385918|54694533|FG002|Feasibility & Baseline Measurement Phase|Physician Decision|1|||
28036333|NCT00385918|54694531|FG000|Intervention Phase After Randomization|Withdrawal by Subject|1|||
28036334|NCT00385918|54694532|FG001|Intervention Phase After Randomization|Withdrawal by Subject|0|||
28036335|NCT00385918|54694533|FG002|Intervention Phase After Randomization|Withdrawal by Subject|0|||
28036336|NCT00385918|54694531|FG000|Intervention Phase After Randomization|Physician Decision|1|||
28036337|NCT00385918|54694532|FG001|Intervention Phase After Randomization|Physician Decision|0|||
28036338|NCT00385918|54694533|FG002|Intervention Phase After Randomization|Physician Decision|0|||
28036339|NCT00385918|54694531|FG000|Intervention Phase After Randomization|Lost to Follow-up|1|||
28036340|NCT00385918|54694532|FG001|Intervention Phase After Randomization|Lost to Follow-up|0|||
28036341|NCT00385918|54694533|FG002|Intervention Phase After Randomization|Lost to Follow-up|0|||
28036342|NCT00385840|54694542|FG000|Overall Study|Adverse Event|1|||
28036343|NCT00385840|54694543|FG001|Overall Study|Adverse Event|1|||
28036344|NCT00385840|54694542|FG000|Overall Study|Lost to Follow-up|3|||
28036345|NCT00385840|54694543|FG001|Overall Study|Lost to Follow-up|13|||
28036346|NCT00385762|54694549|FG000|Overall Study|Adverse Event|1|||
28036347|NCT00385762|54694549|FG000|Overall Study|Lost to Follow-up|1|||
28036348|NCT00385684|54694553|FG000|FIRST INTERVENTION OF PHASE A|Death|1|||
28036349|NCT00385684|54694554|FG001|FIRST INTERVENTION OF PHASE A|Death|0|||
28036350|NCT00385684|54694553|FG000|SECOND INTERVENTION OF PHASE A|Adverse Event|0|||
28036351|NCT00385684|54694554|FG001|SECOND INTERVENTION OF PHASE A|Adverse Event|1|||
28036352|NCT00385684|54694553|FG000|SECOND INTERVENTION OF PHASE A|study drug recall|0|||
28036353|NCT00385684|54694554|FG001|SECOND INTERVENTION OF PHASE A|study drug recall|1|||
28036354|NCT00661661|54694562|FG000|Overall Study|Adverse Event|99|||
28036355|NCT00661661|54694563|FG001|Overall Study|Adverse Event|24|||
28036356|NCT00661661|54694562|FG000|Overall Study|Lack of Efficacy|3|||
28036357|NCT00661661|54694563|FG001|Overall Study|Lack of Efficacy|2|||
28036358|NCT00661661|54694562|FG000|Overall Study|Lost to Follow-up|0|||
28036359|NCT00661661|54694563|FG001|Overall Study|Lost to Follow-up|1|||
28036360|NCT00661661|54694562|FG000|Overall Study|Withdrawal by Subject|15|||
28036361|NCT00661661|54694563|FG001|Overall Study|Withdrawal by Subject|5|||
28036362|NCT00661661|54694562|FG000|Overall Study|Other|22|||
28036363|NCT00661661|54694563|FG001|Overall Study|Other|7|||
28036364|NCT00661661|54694562|FG000|Overall Study|Not assigned treatment|1|||
28036365|NCT00661661|54694563|FG001|Overall Study|Not assigned treatment|0|||
28036366|NCT00038467|54694573|FG000|Overall Study|Adverse Event|170|||
28036367|NCT00038467|54694574|FG001|Overall Study|Adverse Event|145|||
28036368|NCT00038467|54694573|FG000|Overall Study|Withdrawal by Subject|150|||
28036369|NCT00038467|54694574|FG001|Overall Study|Withdrawal by Subject|107|||
27809056|NCT01426438|54264582|FG000|Overall Study|Off study Treatment|9|||
27809057|NCT01426438|54264583|FG001|Overall Study|Off study Treatment|3|||
27809058|NCT01426438|54264582|FG000|Overall Study|Poor scan quality|3|||
27809059|NCT01426438|54264583|FG001|Overall Study|Poor scan quality|2|||
27809060|NCT01426438|54264582|FG000|Overall Study|Missed Scan|2|||
28036370|NCT00038467|54694573|FG000|Overall Study|Protocol Violation|19|||
28036371|NCT00038467|54694574|FG001|Overall Study|Protocol Violation|22|||
28036372|NCT00038467|54694573|FG000|Overall Study|Death|22|||
28036373|NCT00038467|54694574|FG001|Overall Study|Death|16|||
28036374|NCT00038467|54694573|FG000|Overall Study|Lost to Follow-up|15|||
28036375|NCT00038467|54694574|FG001|Overall Study|Lost to Follow-up|10|||
28036376|NCT00038467|54694573|FG000|Overall Study|Recurrence|109|||
28036377|NCT00038467|54694574|FG001|Overall Study|Recurrence|179|||
28036378|NCT00038467|54694573|FG000|Overall Study|Randomized, but not treated|31|||
28036379|NCT00038467|54694574|FG001|Overall Study|Randomized, but not treated|35|||
28036380|NCT00038467|54694573|FG000|Overall Study|Other|26|||
28036381|NCT00038467|54694574|FG001|Overall Study|Other|28|||
28036382|NCT00051025|54694582|FG000|Overall Study|Progressive Disease|1|||
28036383|NCT00051025|54694583|FG001|Overall Study|Progressive Disease|1|||
28036384|NCT00051025|54694582|FG000|Overall Study|Adverse Event|1|||
27809061|NCT01426438|54264583|FG001|Overall Study|Missed Scan|2|||
27809062|NCT01425814|54264589|FG000|Period 1|Stability criteria not fulfilled|0|||
27809063|NCT01425814|54264590|FG001|Period 1|Stability criteria not fulfilled|1|||
27847202|NCT01393613|54339467|FG002|Overall Study|Protocol Deviation|0|||
28036385|NCT00051025|54694583|FG001|Overall Study|Adverse Event|1|||
28036386|NCT00051025|54694582|FG000|Overall Study|Withdrawal by Subject|0|||
28036387|NCT00051025|54694583|FG001|Overall Study|Withdrawal by Subject|1|||
28036388|NCT00051025|54694582|FG000|Overall Study|Death|0|||
28036389|NCT00051025|54694583|FG001|Overall Study|Death|1|||
28036390|NCT00660179|54694592|FG000|Overall Study|Death|44|||
28036391|NCT00660179|54694593|FG001|Overall Study|Death|47|||
28036392|NCT00660179|54694594|FG002|Overall Study|Death|34|||
28036393|NCT00660179|54694592|FG000|Overall Study|Withdrawal of consent|4|||
28036394|NCT00660179|54694593|FG001|Overall Study|Withdrawal of consent|6|||
28036395|NCT00660179|54694594|FG002|Overall Study|Withdrawal of consent|4|||
28036396|NCT00660179|54694592|FG000|Overall Study|Lost to Follow-up|7|||
28036397|NCT00660179|54694593|FG001|Overall Study|Lost to Follow-up|5|||
28036398|NCT00660179|54694594|FG002|Overall Study|Lost to Follow-up|2|||
28036399|NCT00660179|54694592|FG000|Overall Study|Administrative reason|0|||
28036400|NCT00660179|54694593|FG001|Overall Study|Administrative reason|0|||
28036401|NCT00660179|54694594|FG002|Overall Study|Administrative reason|1|||
28036402|NCT00660179|54694592|FG000|Overall Study|Incorrect randomization|1|||
28036403|NCT00660179|54694593|FG001|Overall Study|Incorrect randomization|0|||
28036404|NCT00660179|54694594|FG002|Overall Study|Incorrect randomization|0|||
28036405|NCT00050167|54694604|FG000|Overall Study|not eligible not invasive|1|||
28036406|NCT00050167|54694605|FG001|Overall Study|not eligible not invasive|1|||
28036407|NCT00660023|54694611|FG000|Overall Study|Adverse Event|2|||
28036408|NCT00660023|54694611|FG000|Overall Study|Death|8|||
28036409|NCT00660023|54694611|FG000|Overall Study|Blood Transfusion|5|||
28036410|NCT00660023|54694611|FG000|Overall Study|Renal Transplantation|3|||
28036411|NCT00660023|54694611|FG000|Overall Study|Withdrawal by Subject|1|||
28036412|NCT00660023|54694611|FG000|Overall Study|Missed Pregnancy Test|1|||
28036413|NCT00660023|54694611|FG000|Overall Study|Other Screening Failure|9|||
28036414|NCT00062647|54694617|FG000|Overall Study|Death|2|||
28036415|NCT00062647|54694618|FG001|Overall Study|Death|2|||
28036416|NCT00062647|54694617|FG000|Overall Study|Adverse Event|1|||
28036417|NCT00062647|54694618|FG001|Overall Study|Adverse Event|1|||
28036418|NCT00062647|54694617|FG000|Overall Study|Withdrawal by Subject|2|||
28036419|NCT00062647|54694618|FG001|Overall Study|Withdrawal by Subject|1|||
28036420|NCT00062647|54694617|FG000|Overall Study|Protocol Violation|1|||
27847203|NCT01393613|54339468|FG003|Overall Study|Protocol Deviation|0|||
27847204|NCT01393613|54339465|FG000|Overall Study|Lack of Efficacy|9|||
27847205|NCT01393613|54339466|FG001|Overall Study|Lack of Efficacy|20|||
27847206|NCT01393613|54339467|FG002|Overall Study|Lack of Efficacy|16|||
27847207|NCT01393613|54339468|FG003|Overall Study|Lack of Efficacy|21|||
27847208|NCT01396421|54339518|FG000|Overall Study|Lost to Follow-up|0|||
27847209|NCT01396421|54339519|FG001|Overall Study|Lost to Follow-up|0|||
27847210|NCT01396421|54339520|FG002|Overall Study|Lost to Follow-up|0|||
27847211|NCT01396421|54339521|FG003|Overall Study|Lost to Follow-up|1|||
27847212|NCT01396421|54339518|FG000|Overall Study|Adverse Event|17|||
27847213|NCT01396421|54339519|FG001|Overall Study|Adverse Event|15|||
27847214|NCT01396421|54339520|FG002|Overall Study|Adverse Event|12|||
27809064|NCT01425814|54264591|FG002|Period 1|Stability criteria not fulfilled|0|||
27809065|NCT01425814|54264592|FG003|Period 1|Stability criteria not fulfilled|0|||
27847215|NCT01396421|54339521|FG003|Overall Study|Adverse Event|32|||
27847216|NCT01396421|54339518|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
27847217|NCT01396421|54339519|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
28036421|NCT00062647|54694618|FG001|Overall Study|Protocol Violation|0|||
28036422|NCT00062647|54694617|FG000|Overall Study|Lost to Follow-up|1|||
28036423|NCT00062647|54694618|FG001|Overall Study|Lost to Follow-up|2|||
28036424|NCT00062647|54694617|FG000|Overall Study|Failed continuation criteria|4|||
28036425|NCT00062647|54694618|FG001|Overall Study|Failed continuation criteria|2|||
28036426|NCT00062647|54694617|FG000|Overall Study|Other|4|||
28036427|NCT00062647|54694618|FG001|Overall Study|Other|4|||
28036428|NCT00062647|54694617|FG000|Overall Study|Never received study treatment|1|||
28036429|NCT00062647|54694618|FG001|Overall Study|Never received study treatment|1|||
28036430|NCT00570323|54694626|FG000|Started Treatment After Randomization|Withdrawal by Subject|0|||
28036431|NCT00570323|54694627|FG001|Started Treatment After Randomization|Withdrawal by Subject|1|||
28036432|NCT00570323|54694626|FG000|Started Treatment After Randomization|Protocol Violation|1|||
28036433|NCT00570323|54694627|FG001|Started Treatment After Randomization|Protocol Violation|0|||
27809066|NCT01425814|54264593|FG004|Period 1|Stability criteria not fulfilled|0|||
27809067|NCT01425814|54264594|FG005|Period 1|Stability criteria not fulfilled|0|||
27809068|NCT01425814|54264589|FG000|Period 2|Stability criteria not fulfilled|0|||
27809069|NCT01425814|54264590|FG001|Period 2|Stability criteria not fulfilled|1|||
27809070|NCT01425814|54264591|FG002|Period 2|Stability criteria not fulfilled|0|||
27809071|NCT01425814|54264592|FG003|Period 2|Stability criteria not fulfilled|0|||
27809072|NCT01425814|54264593|FG004|Period 2|Stability criteria not fulfilled|0|||
27847218|NCT01396421|54339520|FG002|Overall Study|Participant Met Withdrawal Criteria|1|||
27847219|NCT01396421|54339521|FG003|Overall Study|Participant Met Withdrawal Criteria|0|||
27847220|NCT01396421|54339518|FG000|Overall Study|Physician Decision|1|||
27847221|NCT01396421|54339519|FG001|Overall Study|Physician Decision|1|||
27847222|NCT01396421|54339520|FG002|Overall Study|Physician Decision|0|||
28036434|NCT00570323|54694626|FG000|Started Treatment After Randomization|Physician Decision|1|||
28036435|NCT00570323|54694627|FG001|Started Treatment After Randomization|Physician Decision|0|||
28036436|NCT00570323|54694626|FG000|Complete Study After Start|Lost to Follow-up|0|||
28036437|NCT00570323|54694627|FG001|Complete Study After Start|Lost to Follow-up|1|||
28036438|NCT00570323|54694626|FG000|Complete Study After Start|Withdrawal by Subject|2|||
28036439|NCT00570323|54694627|FG001|Complete Study After Start|Withdrawal by Subject|0|||
28036440|NCT00570323|54694626|FG000|Complete Study After Start|Physician Decision|1|||
28036441|NCT00570323|54694627|FG001|Complete Study After Start|Physician Decision|0|||
28036442|NCT00661505|54694635|FG000|Overall Study|Adverse Event|3|||
28036443|NCT00661505|54694635|FG000|Overall Study|Protocol Violation|14|||
28036444|NCT00661505|54694635|FG000|Overall Study|Withdrawal by Subject|8|||
28036445|NCT00661505|54694635|FG000|Overall Study|Lost to Follow-up|3|||
28036446|NCT00661505|54694635|FG000|Overall Study|Other|2|||
28036447|NCT00662909|54694643|FG000|Overall Study|Adverse Event|17|||
28036448|NCT00662909|54694644|FG001|Overall Study|Adverse Event|18|||
28036449|NCT00662909|54694645|FG002|Overall Study|Adverse Event|19|||
28036450|NCT00662909|54694643|FG000|Overall Study|Lack of Efficacy|9|||
28036451|NCT00662909|54694644|FG001|Overall Study|Lack of Efficacy|1|||
28036452|NCT00662909|54694645|FG002|Overall Study|Lack of Efficacy|5|||
28036453|NCT00662909|54694643|FG000|Overall Study|Withdrawal by Subject|29|||
28036454|NCT00662909|54694644|FG001|Overall Study|Withdrawal by Subject|22|||
28036455|NCT00662909|54694645|FG002|Overall Study|Withdrawal by Subject|16|||
28036456|NCT00662909|54694643|FG000|Overall Study|Lost to Follow-up|2|||
28036457|NCT00662909|54694644|FG001|Overall Study|Lost to Follow-up|9|||
28036458|NCT00662909|54694645|FG002|Overall Study|Lost to Follow-up|3|||
28036459|NCT00662909|54694643|FG000|Overall Study|Protocol Violation|7|||
28036460|NCT00662909|54694644|FG001|Overall Study|Protocol Violation|4|||
28036461|NCT00662909|54694645|FG002|Overall Study|Protocol Violation|5|||
28036462|NCT00662909|54694643|FG000|Overall Study|Randomized- never received study drug|1|||
28036463|NCT00662909|54694644|FG001|Overall Study|Randomized- never received study drug|0|||
28036464|NCT00662909|54694645|FG002|Overall Study|Randomized- never received study drug|0|||
28036465|NCT00662909|54694643|FG000|Overall Study|Non-compliance with study procedures|3|||
28036466|NCT00662909|54694644|FG001|Overall Study|Non-compliance with study procedures|3|||
28036467|NCT00662909|54694645|FG002|Overall Study|Non-compliance with study procedures|2|||
28036468|NCT00662909|54694643|FG000|Overall Study|Physician Decision|1|||
28036469|NCT00662909|54694644|FG001|Overall Study|Physician Decision|1|||
28036470|NCT00662909|54694645|FG002|Overall Study|Physician Decision|2|||
28036471|NCT00662909|54694643|FG000|Overall Study|Eligibility criterion not met|0|||
28036472|NCT00662909|54694644|FG001|Overall Study|Eligibility criterion not met|1|||
28036473|NCT00662909|54694645|FG002|Overall Study|Eligibility criterion not met|1|||
28036474|NCT00050011|54694655|FG000|Overall Study|Adverse Event|41|||
28036475|NCT00050011|54694656|FG001|Overall Study|Adverse Event|46|||
28036476|NCT00050011|54694655|FG000|Overall Study|Abnormal laboratory value(s)|1|||
28036477|NCT00050011|54694656|FG001|Overall Study|Abnormal laboratory value(s)|1|||
28036478|NCT00050011|54694655|FG000|Overall Study|Abnormal test procedure results|0|||
28036479|NCT00050011|54694656|FG001|Overall Study|Abnormal test procedure results|1|||
27847223|NCT01396421|54339521|FG003|Overall Study|Physician Decision|3|||
27847224|NCT01396421|54339518|FG000|Overall Study|Withdrawal by Subject|31|||
27847225|NCT01396421|54339519|FG001|Overall Study|Withdrawal by Subject|24|||
27847226|NCT01396421|54339520|FG002|Overall Study|Withdrawal by Subject|13|||
27847227|NCT01396421|54339521|FG003|Overall Study|Withdrawal by Subject|21|||
27847228|NCT01396421|54339518|FG000|Overall Study|Protocol Deviation|2|||
28036480|NCT00050011|54694655|FG000|Overall Study|Lack of Efficacy|16|||
28036481|NCT00050011|54694656|FG001|Overall Study|Lack of Efficacy|21|||
28036482|NCT00050011|54694655|FG000|Overall Study|Participant condition no longer required|1|||
28036483|NCT00050011|54694656|FG001|Overall Study|Participant condition no longer required|0|||
28036484|NCT00050011|54694655|FG000|Overall Study|Protocol Violation|4|||
28036485|NCT00050011|54694656|FG001|Overall Study|Protocol Violation|10|||
28036486|NCT00050011|54694655|FG000|Overall Study|Withdrawal by Subject|34|||
28036487|NCT00050011|54694656|FG001|Overall Study|Withdrawal by Subject|26|||
28036488|NCT00050011|54694655|FG000|Overall Study|Lost to Follow-up|7|||
28036489|NCT00050011|54694656|FG001|Overall Study|Lost to Follow-up|9|||
28036490|NCT00050011|54694655|FG000|Overall Study|Administrative problems|10|||
28036491|NCT00050011|54694656|FG001|Overall Study|Administrative problems|6|||
28036492|NCT00050011|54694655|FG000|Overall Study|Death|7|||
28036493|NCT00050011|54694656|FG001|Overall Study|Death|4|||
28036494|NCT00050011|54694655|FG000|Overall Study|Unknown - Reason is missing|0|||
28036495|NCT00050011|54694656|FG001|Overall Study|Unknown - Reason is missing|2|||
28036496|NCT00661427|54694665|FG000|Overall Study|Adverse Event|5|||
28036497|NCT00661427|54694666|FG001|Overall Study|Adverse Event|5|||
27847229|NCT01396421|54339519|FG001|Overall Study|Protocol Deviation|1|||
27847230|NCT01396421|54339520|FG002|Overall Study|Protocol Deviation|1|||
27847231|NCT01396421|54339521|FG003|Overall Study|Protocol Deviation|0|||
28036498|NCT00661427|54694665|FG000|Overall Study|Patient not treated|0|||
28036499|NCT00661427|54694666|FG001|Overall Study|Patient not treated|2|||
28036500|NCT00049543|54694674|FG000|Overall Study|still on treatment|2|||
28036501|NCT00049543|54694675|FG001|Overall Study|still on treatment|9|||
28036502|NCT00048997|54694683|FG000|Overall Study|Protocol Violation|7|||
28036503|NCT00048997|54694684|FG001|Overall Study|Protocol Violation|2|||
28036504|NCT00048997|54694683|FG000|Overall Study|Withdrawal by Subject|6|||
28036505|NCT00048997|54694684|FG001|Overall Study|Withdrawal by Subject|1|||
28036506|NCT00035815|54694691|FG000|Overall Study|Withdrawal by Subject|17|||
28036507|NCT00035815|54694692|FG001|Overall Study|Withdrawal by Subject|11|||
28036508|NCT00662831|54694700|FG000|Overall Study|Death|4|||
28036509|NCT00662831|54694701|FG001|Overall Study|Death|1|||
28036510|NCT00662831|54694700|FG000|Overall Study|Lack of Efficacy|6|||
28036511|NCT00662831|54694701|FG001|Overall Study|Lack of Efficacy|6|||
28036512|NCT00662831|54694700|FG000|Overall Study|Lost to Follow-up|1|||
28036513|NCT00662831|54694701|FG001|Overall Study|Lost to Follow-up|0|||
28036514|NCT00662831|54694700|FG000|Overall Study|Withdrawal by Subject|2|||
28036515|NCT00662831|54694701|FG001|Overall Study|Withdrawal by Subject|1|||
28036516|NCT00662831|54694700|FG000|Overall Study|Other|62|||
28036517|NCT00662831|54694701|FG001|Overall Study|Other|31|||
28036518|NCT00662831|54694700|FG000|Overall Study|Protocol Violation|8|||
28036519|NCT00662831|54694701|FG001|Overall Study|Protocol Violation|4|||
28036520|NCT00662831|54694700|FG000|Overall Study|Adverse Event|23|||
28036521|NCT00662831|54694701|FG001|Overall Study|Adverse Event|16|||
28036522|NCT00662363|54694709|FG000|Overall Study|Withdrawal by Subject|6|||
28036523|NCT00662363|54694710|FG001|Overall Study|Withdrawal by Subject|5|||
28036524|NCT00662363|54694709|FG000|Overall Study|Adverse Event|0|||
28036525|NCT00662363|54694710|FG001|Overall Study|Adverse Event|3|||
28036526|NCT00662363|54694709|FG000|Overall Study|Discharged early from rehab|4|||
28036527|NCT00662363|54694710|FG001|Overall Study|Discharged early from rehab|1|||
28036528|NCT00662363|54694709|FG000|Overall Study|Protocol Violation|1|||
28036529|NCT00662363|54694710|FG001|Overall Study|Protocol Violation|1|||
28036530|NCT00661271|54694720|FG000|Overall Study|Lost to Follow-up|28|||
28036531|NCT00661271|54694721|FG001|Overall Study|Lost to Follow-up|25|||
28036532|NCT00661193|54694729|FG000|Overall Study|Adverse Event|2|||
28036533|NCT00661193|54694730|FG001|Overall Study|Adverse Event|1|||
28036534|NCT00661193|54694729|FG000|Overall Study|Withdrawal by Subject|3|||
28036535|NCT00661193|54694730|FG001|Overall Study|Withdrawal by Subject|1|||
28036536|NCT00661193|54694729|FG000|Overall Study|Progression|27|||
28036537|NCT00661193|54694730|FG001|Overall Study|Progression|24|||
28036538|NCT00661193|54694729|FG000|Overall Study|Not protocol specified|1|||
28036539|NCT00661193|54694730|FG001|Overall Study|Not protocol specified|0|||
28036540|NCT00658541|54694736|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
28036541|NCT00658541|54694737|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
28036542|NCT00658541|54694736|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
28036543|NCT00658541|54694737|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
28036544|NCT00048061|54694747|FG000|Overall Study|Adverse Event|41|||
28036545|NCT00048061|54694748|FG001|Overall Study|Adverse Event|32|||
28036546|NCT00048061|54694749|FG002|Overall Study|Adverse Event|44|||
28036547|NCT00048061|54694750|FG003|Overall Study|Adverse Event|37|||
28036548|NCT00048061|54694747|FG000|Overall Study|Lost to Follow-up|3|||
28036549|NCT00048061|54694748|FG001|Overall Study|Lost to Follow-up|2|||
28036550|NCT00048061|54694749|FG002|Overall Study|Lost to Follow-up|4|||
28036551|NCT00048061|54694750|FG003|Overall Study|Lost to Follow-up|5|||
28036552|NCT00048061|54694747|FG000|Overall Study|Withdrawal by Subject|20|||
28036553|NCT00048061|54694748|FG001|Overall Study|Withdrawal by Subject|29|||
28036554|NCT00048061|54694749|FG002|Overall Study|Withdrawal by Subject|29|||
28036555|NCT00048061|54694750|FG003|Overall Study|Withdrawal by Subject|32|||
28036556|NCT00048061|54694747|FG000|Overall Study|Did not follow-up|5|||
28036557|NCT00048061|54694748|FG001|Overall Study|Did not follow-up|5|||
28036558|NCT00048061|54694749|FG002|Overall Study|Did not follow-up|4|||
28036559|NCT00048061|54694750|FG003|Overall Study|Did not follow-up|5|||
28036560|NCT00048061|54694747|FG000|Overall Study|Early improvement|6|||
28036561|NCT00048061|54694748|FG001|Overall Study|Early improvement|5|||
28036562|NCT00048061|54694749|FG002|Overall Study|Early improvement|3|||
28036563|NCT00048061|54694750|FG003|Overall Study|Early improvement|0|||
28036564|NCT00656513|54694763|FG000|Overall Study|Protocol Violation|1|||
28036565|NCT00656513|54694764|FG001|Overall Study|Protocol Violation|0|||
28036566|NCT00656513|54694765|FG002|Overall Study|Protocol Violation|2|||
28036567|NCT00656513|54694763|FG000|Overall Study|Withdrawal by Subject|0|||
28036568|NCT00656513|54694764|FG001|Overall Study|Withdrawal by Subject|11|||
28036569|NCT00656513|54694765|FG002|Overall Study|Withdrawal by Subject|4|||
28036570|NCT00656513|54694763|FG000|Overall Study|Death|0|||
28036571|NCT00656513|54694764|FG001|Overall Study|Death|0|||
27809073|NCT01425814|54264594|FG005|Period 2|Stability criteria not fulfilled|0|||
28036572|NCT00656513|54694765|FG002|Overall Study|Death|1|||
28036573|NCT00656513|54694763|FG000|Overall Study|Missing data|0|||
27809074|NCT01425814|54264589|FG000|Period 3|Adverse Event|0|||
28036574|NCT00656513|54694764|FG001|Overall Study|Missing data|11|||
28036575|NCT00656513|54694765|FG002|Overall Study|Missing data|9|||
28036576|NCT00656513|54694763|FG000|Overall Study|Incomplete treatment|3|||
28036577|NCT00656513|54694764|FG001|Overall Study|Incomplete treatment|0|||
28036578|NCT00656513|54694765|FG002|Overall Study|Incomplete treatment|0|||
28036579|NCT00656513|54694763|FG000|Overall Study|Treatment completed outside of timeframe|0|||
28036580|NCT00656513|54694764|FG001|Overall Study|Treatment completed outside of timeframe|3|||
28036581|NCT00656513|54694765|FG002|Overall Study|Treatment completed outside of timeframe|1|||
28036582|NCT00656513|54694763|FG000|Overall Study|Missing baseline form|0|||
28036583|NCT00656513|54694764|FG001|Overall Study|Missing baseline form|5|||
27847232|NCT01396421|54339518|FG000|Overall Study|Lack of Efficacy|7|||
27847233|NCT01396421|54339519|FG001|Overall Study|Lack of Efficacy|17|||
27847234|NCT01396421|54339520|FG002|Overall Study|Lack of Efficacy|7|||
27847235|NCT01396421|54339521|FG003|Overall Study|Lack of Efficacy|18|||
27847236|NCT01396265|54339579|FG000|Rifa+Afatinib|Withdrawal by Subject|1|||
27847237|NCT02647866|54339624|FG000|Overall Study|Adverse Event|0|||
28036584|NCT00656513|54694765|FG002|Overall Study|Missing baseline form|5|||
28036585|NCT00655889|54694773|FG000|Overall Study|Inadequate cell growth|1|||
28036586|NCT00655889|54694773|FG000|Overall Study|Protocol Violation|1|||
28036587|NCT00655733|54694779|FG000|Overall Study|Lost to Follow-up|2|||
28036588|NCT00655733|54694780|FG001|Overall Study|Lost to Follow-up|2|||
28036589|NCT00655733|54694779|FG000|Overall Study|Adverse Event|2|||
28036590|NCT00655733|54694780|FG001|Overall Study|Adverse Event|2|||
28036591|NCT00655733|54694779|FG000|Overall Study|Withdrawal by Subject|3|||
28036592|NCT00655733|54694780|FG001|Overall Study|Withdrawal by Subject|3|||
28036593|NCT00655733|54694779|FG000|Overall Study|Physician Decision|0|||
28036594|NCT00655733|54694780|FG001|Overall Study|Physician Decision|1|||
28036595|NCT00657371|54694788|FG000|Overall Study|Poor bowel preparation|15|||
28036596|NCT00657371|54694788|FG000|Overall Study|Unable to intubate the cecum|5|||
28036597|NCT00657371|54694788|FG000|Overall Study|Protocol Violation|2|||
28036598|NCT00657371|54694788|FG000|Overall Study|Device- related reasons|13|||
28036599|NCT00657371|54694788|FG000|Overall Study|Pre-existing medical condition|4|||
28036600|NCT00658775|54694794|FG000|Overall Study|Adverse Event|4|||
28036601|NCT00658775|54694795|FG001|Overall Study|Adverse Event|6|||
28036602|NCT00658775|54694794|FG000|Overall Study|Lost to Follow-up|17|||
28036603|NCT00658775|54694795|FG001|Overall Study|Lost to Follow-up|18|||
28036604|NCT00658775|54694794|FG000|Overall Study|Withdrawal by Subject|6|||
28036605|NCT00658775|54694795|FG001|Overall Study|Withdrawal by Subject|4|||
28036606|NCT00658775|54694794|FG000|Overall Study|Withdrawal of consent|8|||
27847238|NCT02647866|54339625|FG001|Overall Study|Adverse Event|0|||
27847239|NCT02647866|54339626|FG002|Overall Study|Adverse Event|2|||
27847240|NCT02647866|54339627|FG003|Overall Study|Adverse Event|2|||
28036607|NCT00658775|54694795|FG001|Overall Study|Withdrawal of consent|7|||
28036608|NCT00658775|54694794|FG000|Overall Study|Other|7|||
28036609|NCT00658775|54694795|FG001|Overall Study|Other|8|||
28036610|NCT00488631|54694807|FG000|Double Blind Period (Week 0-54)|Adverse Event|17|||
28036611|NCT00488631|54694808|FG001|Double Blind Period (Week 0-54)|Adverse Event|12|||
28036612|NCT00488631|54694809|FG002|Double Blind Period (Week 0-54)|Adverse Event|12|||
28036613|NCT00488631|54694810|FG003|Double Blind Period (Week 0-54)|Adverse Event|12|||
28036614|NCT00488631|54694811|FG004|Double Blind Period (Week 0-54)|Adverse Event|30|||
28036615|NCT00488631|54694812|FG005|Double Blind Period (Week 0-54)|Adverse Event|50|||
28036616|NCT00488631|54694813|FG006|Double Blind Period (Week 0-54)|Adverse Event|0|||
28036617|NCT00488631|54694814|FG007|Double Blind Period (Week 0-54)|Adverse Event|0|||
28036618|NCT00488631|54694815|FG008|Double Blind Period (Week 0-54)|Adverse Event|0|||
28036619|NCT00488631|54694816|FG009|Double Blind Period (Week 0-54)|Adverse Event|0|||
28036620|NCT00488631|54694807|FG000|Double Blind Period (Week 0-54)|Death|0|||
28036621|NCT00488631|54694808|FG001|Double Blind Period (Week 0-54)|Death|0|||
28036622|NCT00488631|54694809|FG002|Double Blind Period (Week 0-54)|Death|0|||
28036623|NCT00488631|54694810|FG003|Double Blind Period (Week 0-54)|Death|0|||
28036624|NCT00488631|54694811|FG004|Double Blind Period (Week 0-54)|Death|0|||
28036625|NCT00488631|54694812|FG005|Double Blind Period (Week 0-54)|Death|1|||
28036626|NCT00488631|54694813|FG006|Double Blind Period (Week 0-54)|Death|0|||
28036627|NCT00488631|54694814|FG007|Double Blind Period (Week 0-54)|Death|0|||
28036628|NCT00488631|54694815|FG008|Double Blind Period (Week 0-54)|Death|0|||
28036629|NCT00488631|54694816|FG009|Double Blind Period (Week 0-54)|Death|0|||
28036630|NCT00488631|54694807|FG000|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19|||
28036631|NCT00488631|54694808|FG001|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17|||
28036632|NCT00488631|54694809|FG002|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22|||
28036633|NCT00488631|54694810|FG003|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18|||
28036634|NCT00488631|54694811|FG004|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56|||
28036635|NCT00488631|54694812|FG005|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124|||
28036636|NCT00488631|54694813|FG006|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
28036637|NCT00488631|54694814|FG007|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
28036638|NCT00488631|54694815|FG008|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
28036639|NCT00488631|54694816|FG009|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
28036640|NCT00488631|54694807|FG000|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
27847241|NCT02647866|54339628|FG004|Overall Study|Adverse Event|1|||
27847242|NCT02647866|54339624|FG000|Overall Study|Disease Worsening|3|||
27847243|NCT02647866|54339625|FG001|Overall Study|Disease Worsening|1|||
28036641|NCT00488631|54694808|FG001|Double Blind Period (Week 0-54)|Lost to Follow-up|2|||
28036642|NCT00488631|54694809|FG002|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
28036643|NCT00488631|54694810|FG003|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
28036644|NCT00488631|54694811|FG004|Double Blind Period (Week 0-54)|Lost to Follow-up|3|||
28036645|NCT00488631|54694812|FG005|Double Blind Period (Week 0-54)|Lost to Follow-up|7|||
28036646|NCT00488631|54694813|FG006|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
27847244|NCT02647866|54339626|FG002|Overall Study|Disease Worsening|0|||
27847245|NCT02647866|54339627|FG003|Overall Study|Disease Worsening|0|||
27847246|NCT02647866|54339628|FG004|Overall Study|Disease Worsening|1|||
27847247|NCT02647866|54339624|FG000|Overall Study|Withdrawal by Subject|1|||
27847248|NCT02647866|54339625|FG001|Overall Study|Withdrawal by Subject|1|||
27847249|NCT02647866|54339626|FG002|Overall Study|Withdrawal by Subject|2|||
27847250|NCT02647866|54339627|FG003|Overall Study|Withdrawal by Subject|4|||
27847251|NCT02647866|54339628|FG004|Overall Study|Withdrawal by Subject|4|||
27847252|NCT02647866|54339624|FG000|Overall Study|Physician Decision|0|||
27847253|NCT02647866|54339625|FG001|Overall Study|Physician Decision|1|||
27847254|NCT02647866|54339626|FG002|Overall Study|Physician Decision|1|||
27847255|NCT02647866|54339627|FG003|Overall Study|Physician Decision|0|||
27847256|NCT02647866|54339628|FG004|Overall Study|Physician Decision|2|||
27847257|NCT02647866|54339624|FG000|Overall Study|Death|0|||
27847258|NCT02647866|54339625|FG001|Overall Study|Death|1|||
28036647|NCT00488631|54694814|FG007|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
28036648|NCT00488631|54694815|FG008|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
28036649|NCT00488631|54694816|FG009|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
28036650|NCT00488631|54694807|FG000|Double Blind Period (Week 0-54)|Other|6|||
28036651|NCT00488631|54694808|FG001|Double Blind Period (Week 0-54)|Other|12|||
28036652|NCT00488631|54694809|FG002|Double Blind Period (Week 0-54)|Other|10|||
28036653|NCT00488631|54694810|FG003|Double Blind Period (Week 0-54)|Other|11|||
28036654|NCT00488631|54694811|FG004|Double Blind Period (Week 0-54)|Other|14|||
28036655|NCT00488631|54694812|FG005|Double Blind Period (Week 0-54)|Other|34|||
28036656|NCT00488631|54694813|FG006|Double Blind Period (Week 0-54)|Other|0|||
28036657|NCT00488631|54694814|FG007|Double Blind Period (Week 0-54)|Other|0|||
28036658|NCT00488631|54694815|FG008|Double Blind Period (Week 0-54)|Other|0|||
28036659|NCT00488631|54694816|FG009|Double Blind Period (Week 0-54)|Other|0|||
28036660|NCT00488631|54694807|FG000|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
28036661|NCT00488631|54694808|FG001|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
28036662|NCT00488631|54694809|FG002|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
28036663|NCT00488631|54694810|FG003|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
28036664|NCT00488631|54694811|FG004|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
28036665|NCT00488631|54694812|FG005|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
28036666|NCT00488631|54694813|FG006|Open Label Study Extension (Week 54-228)|Adverse Event|10|||
28036667|NCT00488631|54694814|FG007|Open Label Study Extension (Week 54-228)|Adverse Event|8|||
28036668|NCT00488631|54694815|FG008|Open Label Study Extension (Week 54-228)|Adverse Event|54|||
28036669|NCT00488631|54694816|FG009|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
28036670|NCT00488631|54694807|FG000|Open Label Study Extension (Week 54-228)|Death|0|||
28036671|NCT00488631|54694808|FG001|Open Label Study Extension (Week 54-228)|Death|0|||
28036672|NCT00488631|54694809|FG002|Open Label Study Extension (Week 54-228)|Death|0|||
28036673|NCT00488631|54694810|FG003|Open Label Study Extension (Week 54-228)|Death|0|||
28036674|NCT00488631|54694811|FG004|Open Label Study Extension (Week 54-228)|Death|0|||
28036675|NCT00488631|54694812|FG005|Open Label Study Extension (Week 54-228)|Death|0|||
28036676|NCT00488631|54694813|FG006|Open Label Study Extension (Week 54-228)|Death|0|||
28036677|NCT00488631|54694814|FG007|Open Label Study Extension (Week 54-228)|Death|0|||
28036678|NCT00488631|54694815|FG008|Open Label Study Extension (Week 54-228)|Death|1|||
28036679|NCT00488631|54694816|FG009|Open Label Study Extension (Week 54-228)|Death|0|||
28036680|NCT00488631|54694807|FG000|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
28036681|NCT00488631|54694808|FG001|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
28036682|NCT00488631|54694809|FG002|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
28036683|NCT00488631|54694810|FG003|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
28036684|NCT00488631|54694811|FG004|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
28036685|NCT00488631|54694812|FG005|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
28036686|NCT00488631|54694813|FG006|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
28036687|NCT00488631|54694814|FG007|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
28036688|NCT00488631|54694815|FG008|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34|||
28036689|NCT00488631|54694816|FG009|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3|||
28036690|NCT00488631|54694807|FG000|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
28036691|NCT00488631|54694808|FG001|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
28036692|NCT00488631|54694809|FG002|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
28105671|NCT04461015|54763217|FG001|Overall Study|IV access lost during the study|1|||
27847259|NCT02647866|54339626|FG002|Overall Study|Death|0|||
27847260|NCT02647866|54339627|FG003|Overall Study|Death|0|||
27847261|NCT02647866|54339628|FG004|Overall Study|Death|0|||
27847262|NCT02647866|54339624|FG000|Overall Study|Subject moved to different country|1|||
27847263|NCT02647866|54339625|FG001|Overall Study|Subject moved to different country|0|||
27847264|NCT02647866|54339626|FG002|Overall Study|Subject moved to different country|0|||
28036693|NCT00488631|54694810|FG003|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
28036694|NCT00488631|54694811|FG004|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
28036695|NCT00488631|54694812|FG005|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
28036696|NCT00488631|54694813|FG006|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2|||
28036697|NCT00488631|54694814|FG007|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
28036698|NCT00488631|54694815|FG008|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6|||
28036699|NCT00488631|54694816|FG009|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
28036700|NCT00488631|54694807|FG000|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
28036701|NCT00488631|54694808|FG001|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
28036702|NCT00488631|54694809|FG002|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
28036703|NCT00488631|54694810|FG003|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
28036704|NCT00488631|54694811|FG004|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
28036705|NCT00488631|54694812|FG005|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
28036706|NCT00488631|54694813|FG006|Open Label Study Extension (Week 54-228)|Unspecified reasons|63|||
27847265|NCT02647866|54339627|FG003|Overall Study|Subject moved to different country|0|||
27847266|NCT02647866|54339628|FG004|Overall Study|Subject moved to different country|0|||
27847267|NCT01396187|54339688|FG000|Overall Study|Adverse Event|0|||
27809075|NCT01425814|54264590|FG001|Period 3|Adverse Event|0|||
27809076|NCT01425814|54264591|FG002|Period 3|Adverse Event|0|||
27809077|NCT01425814|54264592|FG003|Period 3|Adverse Event|0|||
27809078|NCT01425814|54264593|FG004|Period 3|Adverse Event|0|||
27809079|NCT01425814|54264594|FG005|Period 3|Adverse Event|1|||
27809080|NCT01425814|54264589|FG000|Period 4|Adverse Event|1|||
27847268|NCT01396187|54339689|FG001|Overall Study|Adverse Event|1|||
27847269|NCT01396187|54339690|FG002|Overall Study|Adverse Event|0|||
27847270|NCT01396187|54339691|FG003|Overall Study|Adverse Event|0|||
27847271|NCT01396187|54339692|FG004|Overall Study|Adverse Event|0|||
27847272|NCT01396187|54339688|FG000|Overall Study|Withdrawal by Subject|0|||
27847273|NCT01396187|54339689|FG001|Overall Study|Withdrawal by Subject|1|||
28036707|NCT00488631|54694814|FG007|Open Label Study Extension (Week 54-228)|Unspecified reasons|14|||
28036708|NCT00488631|54694815|FG008|Open Label Study Extension (Week 54-228)|Unspecified reasons|87|||
28036709|NCT00488631|54694816|FG009|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
28036710|NCT00655499|54694839|FG000|Overall Study|not eligible|4|||
28036711|NCT00654875|54694846|FG000|Overall Study|Adverse Event|5|||
28036712|NCT00654875|54694847|FG001|Overall Study|Adverse Event|5|||
28036713|NCT00654875|54694846|FG000|Overall Study|Withdrawal by Subject|4|||
28036714|NCT00654875|54694847|FG001|Overall Study|Withdrawal by Subject|4|||
28036715|NCT00654875|54694846|FG000|Overall Study|Protocol Violation|3|||
28036716|NCT00654875|54694847|FG001|Overall Study|Protocol Violation|3|||
28036717|NCT00654875|54694846|FG000|Overall Study|Lack of Efficacy|2|||
28036718|NCT00654875|54694847|FG001|Overall Study|Lack of Efficacy|2|||
28036719|NCT00654875|54694846|FG000|Overall Study|Lost to Follow-up|1|||
28036720|NCT00654875|54694847|FG001|Overall Study|Lost to Follow-up|3|||
28036721|NCT00654875|54694846|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
28036722|NCT00654875|54694847|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
28036723|NCT00654875|54694846|FG000|Overall Study|Administrative Problems|1|||
28036724|NCT00654875|54694847|FG001|Overall Study|Administrative Problems|0|||
28036725|NCT00651755|54694853|FG000|Cycle 1 (First 21 Days)|Withdrawal by Subject|1|||
28036726|NCT00651755|54694854|FG001|Cycle 1 (First 21 Days)|Withdrawal by Subject|0|||
28036727|NCT00651755|54694853|FG000|Cycle 2 (Second 21 Days)|Not Evaluable|0|||
28036728|NCT00651755|54694854|FG001|Cycle 2 (Second 21 Days)|Not Evaluable|1|||
28036729|NCT00654641|54694863|FG000|Overall Study|Lost to Follow-up|2|||
28036730|NCT00654641|54694864|FG001|Overall Study|Lost to Follow-up|3|||
28036731|NCT00569777|54694872|FG000|Overall Study|Withdrawal by Subject|4|||
28036732|NCT00569777|54694873|FG001|Overall Study|Withdrawal by Subject|0|||
28036733|NCT00569777|54694872|FG000|Overall Study|Adverse Event|3|||
28036734|NCT00569777|54694873|FG001|Overall Study|Adverse Event|0|||
28036735|NCT00569777|54694872|FG000|Overall Study|Lost to Follow-up|1|||
28036736|NCT00569777|54694873|FG001|Overall Study|Lost to Follow-up|0|||
28036737|NCT00569777|54694872|FG000|Overall Study|scheduled eye surgery|0|||
28036738|NCT00569777|54694873|FG001|Overall Study|scheduled eye surgery|1|||
28036739|NCT00569777|54694872|FG000|Overall Study|did not meet exclusion criteria|1|||
28036740|NCT00569777|54694873|FG001|Overall Study|did not meet exclusion criteria|2|||
28036741|NCT00569777|54694872|FG000|Overall Study|pregnant|1|||
27809081|NCT01425814|54264590|FG001|Period 4|Adverse Event|0|||
27809082|NCT01425814|54264591|FG002|Period 4|Adverse Event|1|||
27809083|NCT01425814|54264592|FG003|Period 4|Adverse Event|0|||
27809084|NCT01425814|54264593|FG004|Period 4|Adverse Event|0|||
27809085|NCT01425814|54264594|FG005|Period 4|Adverse Event|0|||
27809086|NCT01425814|54264589|FG000|Period 5|Stability criteria not fulfilled|0|||
27809087|NCT01425814|54264590|FG001|Period 5|Stability criteria not fulfilled|0|||
27809088|NCT01425814|54264591|FG002|Period 5|Stability criteria not fulfilled|1|||
27847274|NCT01396187|54339690|FG002|Overall Study|Withdrawal by Subject|1|||
27847275|NCT01396187|54339691|FG003|Overall Study|Withdrawal by Subject|0|||
28036742|NCT00569777|54694873|FG001|Overall Study|pregnant|0|||
28036743|NCT00569231|54694879|FG000|Overall Study|Study unrelated surgery|1|||
28036744|NCT00569231|54694879|FG000|Overall Study|Airfare expense|2|||
28036745|NCT00569231|54694879|FG000|Overall Study|Withdrawal by Subject|1|||
28036746|NCT00569231|54694879|FG000|Overall Study|Car accident injury|1|||
28036747|NCT00569231|54694879|FG000|Overall Study|Non-compliance|2|||
28036748|NCT00654095|54694883|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
28036749|NCT00654095|54694883|FG000|Overall Study|Elevated triglyceride level (2)|1|||
28036750|NCT00654095|54694883|FG000|Overall Study|Elevated alanine aminotransferase (3)|1|||
28036751|NCT00654095|54694883|FG000|Overall Study|Adverse Event|11|||
28036752|NCT00654095|54694883|FG000|Overall Study|Withdrawal by Subject|5|||
28036753|NCT00654095|54694883|FG000|Overall Study|Elevated alanine aminotransferase (4)|7|||
28036754|NCT00654095|54694883|FG000|Overall Study|Adverse reaction did not improve (5)|4|||
28036755|NCT00654095|54694883|FG000|Overall Study|Did not meet inclusion criteria|1|||
28036756|NCT00650585|54694889|FG000|Overall Study|Lost to Follow-up|505|||
28036757|NCT00650585|54694890|FG001|Overall Study|Lost to Follow-up|482|||
28036758|NCT00650585|54694889|FG000|Overall Study|No parental consent|935|||
28036759|NCT00650585|54694890|FG001|Overall Study|No parental consent|866|||
28036760|NCT00650585|54694889|FG000|Overall Study|Excluded/ruled ineligible|357|||
28036761|NCT00650585|54694890|FG001|Overall Study|Excluded/ruled ineligible|129|||
28036762|NCT00653939|54694898|FG000|Overall Study|Adverse Event|1|||
28036763|NCT00653939|54694899|FG001|Overall Study|Adverse Event|3|||
28036764|NCT00653939|54694898|FG000|Overall Study|Withdrawal by Subject|3|||
27809089|NCT01425814|54264592|FG003|Period 5|Stability criteria not fulfilled|0|||
27809090|NCT01425814|54264593|FG004|Period 5|Stability criteria not fulfilled|0|||
27809091|NCT01425814|54264594|FG005|Period 5|Stability criteria not fulfilled|1|||
27809092|NCT01782495|54264619|FG000|Overall Study|Adverse Event|0|||
27809093|NCT01782495|54264620|FG001|Overall Study|Adverse Event|0|||
27809094|NCT01782495|54264621|FG002|Overall Study|Adverse Event|0|||
27809095|NCT01782495|54264622|FG003|Overall Study|Adverse Event|0|||
27809096|NCT01782495|54264623|FG004|Overall Study|Adverse Event|0|||
27847276|NCT01396187|54339692|FG004|Overall Study|Withdrawal by Subject|0|||
27847277|NCT01396187|54339688|FG000|Overall Study|Other|1|||
28036765|NCT00653939|54694899|FG001|Overall Study|Withdrawal by Subject|3|||
28036766|NCT00653939|54694898|FG000|Overall Study|Physician Decision|4|||
28036767|NCT00653939|54694899|FG001|Overall Study|Physician Decision|0|||
28036768|NCT00653939|54694898|FG000|Overall Study|Disease Progression|2|||
28036769|NCT00653939|54694899|FG001|Overall Study|Disease Progression|3|||
28036770|NCT00653939|54694898|FG000|Overall Study|Other|2|||
28036771|NCT00653939|54694899|FG001|Overall Study|Other|6|||
28036772|NCT00646451|54694907|FG000|Overall Study|Adverse Event|3|||
28036773|NCT00646451|54694908|FG001|Overall Study|Adverse Event|0|||
28036774|NCT00646451|54694907|FG000|Overall Study|Exacerbation of pre-existing condition|1|||
28036775|NCT00646451|54694908|FG001|Overall Study|Exacerbation of pre-existing condition|0|||
28036776|NCT00642707|54694920|FG000|Overall Study|Adverse Event|0|||
28036777|NCT00642707|54694921|FG001|Overall Study|Adverse Event|0|||
28036778|NCT00642707|54694922|FG002|Overall Study|Adverse Event|0|||
28036779|NCT00642707|54694923|FG003|Overall Study|Adverse Event|2|||
28036780|NCT00642707|54694920|FG000|Overall Study|Withdrawal by Subject|1|||
28036781|NCT00642707|54694921|FG001|Overall Study|Withdrawal by Subject|0|||
28036782|NCT00642707|54694922|FG002|Overall Study|Withdrawal by Subject|0|||
28036783|NCT00642707|54694923|FG003|Overall Study|Withdrawal by Subject|0|||
28036784|NCT00568685|54694936|FG000|Overall Study|Adverse Event|2|||
28036785|NCT00568685|54694937|FG001|Overall Study|Adverse Event|3|||
28036786|NCT00568685|54694938|FG002|Overall Study|Adverse Event|3|||
28036787|NCT00568685|54694936|FG000|Overall Study|Withdrawal by Subject|7|||
28036788|NCT00568685|54694937|FG001|Overall Study|Withdrawal by Subject|2|||
28036789|NCT00568685|54694938|FG002|Overall Study|Withdrawal by Subject|2|||
28036790|NCT00568685|54694936|FG000|Overall Study|Protocol Violation|1|||
28036791|NCT00568685|54694937|FG001|Overall Study|Protocol Violation|0|||
28036792|NCT00568685|54694938|FG002|Overall Study|Protocol Violation|0|||
27847278|NCT01396187|54339689|FG001|Overall Study|Other|1|||
27847279|NCT01396187|54339690|FG002|Overall Study|Other|0|||
27847280|NCT01396187|54339691|FG003|Overall Study|Other|0|||
27847281|NCT01396187|54339692|FG004|Overall Study|Other|1|||
27847282|NCT01392677|54339739|FG000|Overall Study|Adverse Event|3|||
27847283|NCT01392677|54339740|FG001|Overall Study|Adverse Event|1|||
27847284|NCT01392677|54339739|FG000|Overall Study|Withdrawal by Subject|0|||
27847285|NCT01392677|54339740|FG001|Overall Study|Withdrawal by Subject|2|||
28036793|NCT00061945|54694952|FG000|Registration Through Course 3|Not Alemtuzumab Eligible|18|||
28036794|NCT00061945|54694953|FG001|Registration Through Course 3|Not Alemtuzumab Eligible|25|||
27809097|NCT01782495|54264624|FG005|Overall Study|Adverse Event|0|||
28036795|NCT00061945|54694952|FG000|Registration Through Course 3|Early discontinuation during course I-IV|76|||
27847286|NCT01392677|54339739|FG000|Overall Study|Incorrect enrollment|2|||
27847287|NCT01392677|54339740|FG001|Overall Study|Incorrect enrollment|3|||
28036796|NCT00061945|54694953|FG001|Registration Through Course 3|Early discontinuation during course I-IV|90|||
28036797|NCT00061945|54694952|FG000|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
28036798|NCT00061945|54694953|FG001|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
28036799|NCT00061945|54694952|FG000|Course IV: Alemtuzumab|Early exits|6|||
28036800|NCT00061945|54694953|FG001|Course IV: Alemtuzumab|Early exits|15|||
28036801|NCT00642473|54694964|FG000|Overall Study|Withdrawal by Subject|0|||
28036802|NCT00642473|54694965|FG001|Overall Study|Withdrawal by Subject|5|||
28036803|NCT00642473|54694964|FG000|Overall Study|Progression or death|2|||
28036804|NCT00642473|54694965|FG001|Overall Study|Progression or death|4|||
28036805|NCT00642473|54694964|FG000|Overall Study|Other|2|||
28036806|NCT00642473|54694965|FG001|Overall Study|Other|2|||
28036807|NCT00645671|54694976|FG000|Overall Study|Protocol Violation|1|||
27809098|NCT01782495|54264625|FG006|Overall Study|Adverse Event|0|||
27809099|NCT01782495|54264626|FG007|Overall Study|Adverse Event|2|||
27809100|NCT01782495|54264627|FG008|Overall Study|Adverse Event|0|||
27809101|NCT01782495|54264628|FG009|Overall Study|Adverse Event|0|||
27809102|NCT01782495|54264629|FG010|Overall Study|Adverse Event|0|||
27809103|NCT01782495|54264619|FG000|Overall Study|Withdrew Consent|0|||
28036808|NCT00645671|54694977|FG001|Overall Study|Protocol Violation|0|||
28036809|NCT00645671|54694976|FG000|Overall Study|Withdrawal by Subject|0|||
28036810|NCT00645671|54694977|FG001|Overall Study|Withdrawal by Subject|4|||
28036811|NCT00645671|54694976|FG000|Overall Study|Adverse Event|0|||
28036812|NCT00645671|54694977|FG001|Overall Study|Adverse Event|1|||
28036813|NCT00645671|54694976|FG000|Overall Study|Physician Decision|0|||
28036814|NCT00645671|54694977|FG001|Overall Study|Physician Decision|1|||
28036815|NCT00366340|54694985|FG000|Infant Series|Protocol Violation|3|||
28036816|NCT00366340|54694986|FG001|Infant Series|Protocol Violation|4|||
28036817|NCT00366340|54694985|FG000|Infant Series|Withdrawal by Subject|3|||
28036818|NCT00366340|54694986|FG001|Infant Series|Withdrawal by Subject|3|||
28036819|NCT00366340|54694985|FG000|Infant Series|Adverse Event|0|||
27809104|NCT01782495|54264620|FG001|Overall Study|Withdrew Consent|1|||
27809105|NCT01782495|54264621|FG002|Overall Study|Withdrew Consent|0|||
27809106|NCT01782495|54264622|FG003|Overall Study|Withdrew Consent|0|||
27809107|NCT01782495|54264623|FG004|Overall Study|Withdrew Consent|0|||
27809108|NCT01782495|54264624|FG005|Overall Study|Withdrew Consent|0|||
27809109|NCT01782495|54264625|FG006|Overall Study|Withdrew Consent|0|||
27809110|NCT01782495|54264626|FG007|Overall Study|Withdrew Consent|1|||
27809111|NCT01782495|54264627|FG008|Overall Study|Withdrew Consent|0|||
27809112|NCT01782495|54264628|FG009|Overall Study|Withdrew Consent|0|||
27809113|NCT01782495|54264629|FG010|Overall Study|Withdrew Consent|0|||
27809114|NCT01922102|54264656|FG000|Overall Study|Withdrawal by Subject|7|||
27809115|NCT01922102|54264657|FG001|Overall Study|Withdrawal by Subject|3|||
27809116|NCT01922102|54264658|FG002|Overall Study|Withdrawal by Subject|7|||
27809117|NCT01922102|54264656|FG000|Overall Study|Physician Decision|0|||
27809118|NCT01922102|54264657|FG001|Overall Study|Physician Decision|2|||
27809119|NCT01922102|54264658|FG002|Overall Study|Physician Decision|1|||
27809120|NCT01922102|54264656|FG000|Overall Study|Adverse Event|1|||
27809121|NCT01922102|54264657|FG001|Overall Study|Adverse Event|2|||
27809122|NCT01922102|54264658|FG002|Overall Study|Adverse Event|0|||
27809123|NCT01922102|54264656|FG000|Overall Study|Lost to Follow-up|1|||
27809124|NCT01922102|54264657|FG001|Overall Study|Lost to Follow-up|0|||
27809125|NCT01922102|54264658|FG002|Overall Study|Lost to Follow-up|0|||
27809126|NCT01922102|54264656|FG000|Overall Study|Administrative problems|0|||
27809127|NCT01922102|54264657|FG001|Overall Study|Administrative problems|2|||
27809128|NCT01922102|54264658|FG002|Overall Study|Administrative problems|0|||
27809129|NCT01405768|54264672|FG000|Overall Study|Didn't complete questionnaire correctly|4|||
27809130|NCT01405768|54264673|FG001|Overall Study|Didn't complete questionnaire correctly|0|||
27809131|NCT01913353|54264681|FG000|Overall Study|Adverse Event|2|||
27809132|NCT01913353|54264682|FG001|Overall Study|Adverse Event|0|||
27809133|NCT01913353|54264681|FG000|Overall Study|Physician Decision|0|||
27809134|NCT01913353|54264682|FG001|Overall Study|Physician Decision|2|||
27809135|NCT01913353|54264681|FG000|Overall Study|Withdrawal by Subject|20|||
27809136|NCT01913353|54264682|FG001|Overall Study|Withdrawal by Subject|6|||
27809137|NCT01913353|54264681|FG000|Overall Study|multiple reasons|10|||
27809138|NCT01913353|54264682|FG001|Overall Study|multiple reasons|7|||
27847288|NCT01392677|54339739|FG000|Overall Study|Other reason|3|||
28036820|NCT00366340|54694986|FG001|Infant Series|Adverse Event|2|||
27809139|NCT01754259|54264697|FG000|Overall Study|Withdrawal by Subject|2|||
27809140|NCT01754259|54264698|FG001|Overall Study|Withdrawal by Subject|4|||
27809141|NCT01754259|54264697|FG000|Overall Study|Adverse Event|3|||
27809142|NCT01754259|54264698|FG001|Overall Study|Adverse Event|1|||
27809143|NCT01754259|54264697|FG000|Overall Study|Lost to Follow-up|0|||
27809144|NCT01754259|54264698|FG001|Overall Study|Lost to Follow-up|1|||
27809145|NCT01405456|54264706|FG000|Overall Study|Lost to Follow-up|2|||
27809146|NCT01405456|54264707|FG001|Overall Study|Lost to Follow-up|1|||
27809147|NCT01405456|54264706|FG000|Overall Study|Physician Decision|1|||
27809148|NCT01405456|54264707|FG001|Overall Study|Physician Decision|0|||
28036821|NCT00366340|54694985|FG000|Infant Series|Lost to Follow-up|1|||
28036822|NCT00366340|54694986|FG001|Infant Series|Lost to Follow-up|1|||
28036823|NCT00366340|54694985|FG000|Infant Series|Failure to return|1|||
27809149|NCT01404988|54264716|FG000|Overall Study|Death|2|||
28036824|NCT00366340|54694986|FG001|Infant Series|Failure to return|0|||
28036825|NCT00366340|54694985|FG000|After the Infant Series|Parent/legal guardian request|1|||
28036826|NCT00366340|54694986|FG001|After the Infant Series|Parent/legal guardian request|1|||
28036827|NCT00366340|54694985|FG000|After the Infant Series|Failed to return|0|||
28036828|NCT00366340|54694986|FG001|After the Infant Series|Failed to return|1|||
28036829|NCT00366340|54694985|FG000|After the Infant Series|Protocol Violation|2|||
28036830|NCT00366340|54694986|FG001|After the Infant Series|Protocol Violation|2|||
28036831|NCT00366340|54694985|FG000|After the Infant Series|Adverse Event|0|||
28036832|NCT00366340|54694986|FG001|After the Infant Series|Adverse Event|1|||
27847289|NCT01392677|54339740|FG001|Overall Study|Other reason|2|||
27847290|NCT01392443|54339789|FG000|Overall Study|Disease progression|30|||
27847291|NCT01392443|54339789|FG000|Overall Study|Adverse Event|24|||
27847292|NCT01392443|54339789|FG000|Overall Study|Death|7|||
27847293|NCT01392443|54339789|FG000|Overall Study|Withdrawal by Subject|5|||
27847294|NCT01392443|54339789|FG000|Overall Study|Lost to Follow-up|1|||
27847295|NCT01392443|54339789|FG000|Overall Study|Protocol Violation|1|||
27847296|NCT01391819|54339793|FG000|Overall Study|Withdrawal by Subject|56|||
27847297|NCT01391819|54339793|FG000|Overall Study|Migrated/moved from study area|82|||
27847298|NCT01391819|54339793|FG000|Overall Study|Lost to Follow-up|252|||
27847299|NCT01391819|54339793|FG000|Overall Study|Death|3|||
27847300|NCT01391819|54339793|FG000|Overall Study|Other|9|||
27847301|NCT03845023|54339804|FG000|Follow-Up (14 Days)|Lost to Follow-up|1|||
27847302|NCT03845023|54339805|FG001|Follow-Up (14 Days)|Lost to Follow-up|0|||
27847303|NCT03845023|54339806|FG002|Follow-Up (14 Days)|Lost to Follow-up|0|||
27847304|NCT03845023|54339807|FG003|Follow-Up (14 Days)|Lost to Follow-up|0|||
27847305|NCT03845023|54339804|FG000|Follow-Up (14 Days)|Adverse Event|0|||
27847306|NCT03845023|54339805|FG001|Follow-Up (14 Days)|Adverse Event|0|||
27847307|NCT03845023|54339806|FG002|Follow-Up (14 Days)|Adverse Event|1|||
27847308|NCT03845023|54339807|FG003|Follow-Up (14 Days)|Adverse Event|1|||
27847309|NCT01395017|54339869|FG000|Overall Study|Lost to Follow-up|1|||
27847310|NCT01395017|54339870|FG001|Overall Study|Lost to Follow-up|0|||
27847311|NCT01395017|54339869|FG000|Overall Study|Adverse Event|26|||
27809150|NCT01404988|54264717|FG001|Overall Study|Death|0|||
27809151|NCT01404988|54264718|FG002|Overall Study|Death|2|||
27847312|NCT01395017|54339870|FG001|Overall Study|Adverse Event|12|||
27847313|NCT01395017|54339869|FG000|Overall Study|Physician Decision|11|||
27847314|NCT01395017|54339870|FG001|Overall Study|Physician Decision|15|||
27847315|NCT01395017|54339869|FG000|Overall Study|Withdrawal by Subject|14|||
27847316|NCT01395017|54339870|FG001|Overall Study|Withdrawal by Subject|8|||
27847317|NCT01395017|54339869|FG000|Overall Study|Protocol deviation|1|||
27847318|NCT01395017|54339870|FG001|Overall Study|Protocol deviation|2|||
28036833|NCT00366340|54694985|FG000|After the Infant Series|Lost to Follow-up|0|||
28036834|NCT00366340|54694986|FG001|After the Infant Series|Lost to Follow-up|1|||
28036835|NCT00366340|54694985|FG000|Toddler Dose|Failed to return|1|||
28036836|NCT00366340|54694986|FG001|Toddler Dose|Failed to return|0|||
28036837|NCT00366340|54694985|FG000|Toddler Dose|Parent/legal guardian request|0|||
28036838|NCT00366340|54694986|FG001|Toddler Dose|Parent/legal guardian request|1|||
28036839|NCT00061633|54695018|FG000|Overall Study|Adverse Event|1|||
28036840|NCT00061633|54695019|FG001|Overall Study|Adverse Event|2|||
28036841|NCT00061633|54695018|FG000|Overall Study|Withdrawal by Subject|2|||
28036842|NCT00061633|54695019|FG001|Overall Study|Withdrawal by Subject|2|||
28036843|NCT00061633|54695018|FG000|Overall Study|Lost to Follow-up|1|||
28036844|NCT00061633|54695019|FG001|Overall Study|Lost to Follow-up|4|||
28036845|NCT00061633|54695018|FG000|Overall Study|Other|1|||
27847319|NCT01395017|54339869|FG000|Overall Study|Death|4|||
27847320|NCT01395017|54339870|FG001|Overall Study|Death|3|||
27847321|NCT01395017|54339869|FG000|Overall Study|Disease progression|42|||
28036846|NCT00061633|54695019|FG001|Overall Study|Other|1|||
27809152|NCT01404988|54264716|FG000|Overall Study|Adverse Event|1|||
27809153|NCT01404988|54264717|FG001|Overall Study|Adverse Event|0|||
27809154|NCT01404988|54264718|FG002|Overall Study|Adverse Event|0|||
27847322|NCT01395017|54339870|FG001|Overall Study|Disease progression|58|||
27847323|NCT01395017|54339869|FG000|Overall Study|Sponsor discontinued study|1|||
27847324|NCT01395017|54339870|FG001|Overall Study|Sponsor discontinued study|4|||
27847325|NCT02647320|54339899|FG000|Overall Study|Adverse Event|0|||
27939816|NCT00946192|54596141|FG000|Overall Study|Did not start medication|2|||
27939817|NCT00946192|54596142|FG001|Overall Study|Did not start medication|0|||
28036847|NCT00061633|54695018|FG000|Overall Study|Never received study treatment|0|||
28036848|NCT00061633|54695019|FG001|Overall Study|Never received study treatment|2|||
28036849|NCT00645593|54695027|FG000|Overall Study|Later found to be ineligible|1|||
27809155|NCT01404988|54264716|FG000|Overall Study|Withdrawal by Subject|2|||
27809156|NCT01404988|54264717|FG001|Overall Study|Withdrawal by Subject|2|||
27809157|NCT01404988|54264718|FG002|Overall Study|Withdrawal by Subject|0|||
28036850|NCT00645593|54695028|FG001|Overall Study|Later found to be ineligible|0|||
27809158|NCT01404988|54264716|FG000|Overall Study|Lost to Follow-up|1|||
28036851|NCT03832738|54695037|FG000|Overall Study|Withdrawal by Subject|6|||
27847326|NCT02647320|54339900|FG001|Overall Study|Adverse Event|1|||
27847327|NCT02647320|54339901|FG002|Overall Study|Adverse Event|3|||
28036852|NCT03832738|54695038|FG001|Overall Study|Withdrawal by Subject|7|||
28036853|NCT03832738|54695039|FG002|Overall Study|Withdrawal by Subject|16|||
28036854|NCT03832738|54695037|FG000|Overall Study|Physician Decision|0|||
28036855|NCT03832738|54695038|FG001|Overall Study|Physician Decision|1|||
28036856|NCT03832738|54695039|FG002|Overall Study|Physician Decision|2|||
28036857|NCT03832738|54695037|FG000|Overall Study|Adverse Event|2|||
28036858|NCT03832738|54695038|FG001|Overall Study|Adverse Event|3|||
28036859|NCT03832738|54695039|FG002|Overall Study|Adverse Event|1|||
28036860|NCT03832738|54695037|FG000|Overall Study|Pregnancy|0|||
28036861|NCT03832738|54695038|FG001|Overall Study|Pregnancy|1|||
28036862|NCT03832738|54695039|FG002|Overall Study|Pregnancy|0|||
28036863|NCT00046891|54695049|FG000|Overall Study|Cancels|5|||
28036864|NCT00046891|54695050|FG001|Overall Study|Cancels|9|||
28036865|NCT00046891|54695049|FG000|Overall Study|Ineligible|1|||
28036866|NCT00046891|54695050|FG001|Overall Study|Ineligible|1|||
28036867|NCT00046891|54695049|FG000|Overall Study|Withdrawal by Subject|18|||
28036868|NCT00046891|54695050|FG001|Overall Study|Withdrawal by Subject|15|||
28036869|NCT00046891|54695049|FG000|Overall Study|Adverse Event|5|||
28036870|NCT00046891|54695050|FG001|Overall Study|Adverse Event|5|||
28036871|NCT00365794|54695064|FG000|Overall Study|Withdrawal by Subject|2|||
28036872|NCT00383500|54695072|FG000|Overall Study|Withdrawal by Subject|8|||
28036873|NCT00383500|54695073|FG001|Overall Study|Withdrawal by Subject|3|||
28036874|NCT00383500|54695074|FG002|Overall Study|Withdrawal by Subject|0|||
28036875|NCT00383500|54695072|FG000|Overall Study|Lost to Follow-up|0|||
28036876|NCT00383500|54695073|FG001|Overall Study|Lost to Follow-up|0|||
28036877|NCT00383500|54695074|FG002|Overall Study|Lost to Follow-up|2|||
28036878|NCT00365716|54695088|FG000|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1|||
28036879|NCT00365716|54695089|FG001|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2|||
28036880|NCT00365716|54695090|FG002|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
28036881|NCT00365716|54695091|FG003|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
28036882|NCT00365716|54695092|FG004|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
28036883|NCT00365716|54695093|FG005|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
28036884|NCT00365716|54695094|FG006|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
28036885|NCT00365716|54695088|FG000|Base Study (Day 1 to Month 7)|Adverse Event|0|||
28036886|NCT00365716|54695089|FG001|Base Study (Day 1 to Month 7)|Adverse Event|2|||
28036887|NCT00365716|54695090|FG002|Base Study (Day 1 to Month 7)|Adverse Event|0|||
28036888|NCT00365716|54695091|FG003|Base Study (Day 1 to Month 7)|Adverse Event|0|||
28036889|NCT00365716|54695092|FG004|Base Study (Day 1 to Month 7)|Adverse Event|1|||
28036890|NCT00365716|54695093|FG005|Base Study (Day 1 to Month 7)|Adverse Event|0|||
28036891|NCT00365716|54695094|FG006|Base Study (Day 1 to Month 7)|Adverse Event|0|||
27847328|NCT02647320|54339902|FG003|Overall Study|Adverse Event|2|||
27847329|NCT02647320|54339903|FG004|Overall Study|Adverse Event|1|||
27847330|NCT02647320|54339899|FG000|Overall Study|Protocol Violation|0|||
27847331|NCT02647320|54339900|FG001|Overall Study|Protocol Violation|0|||
28036892|NCT00365716|54695088|FG000|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
27809159|NCT01404988|54264717|FG001|Overall Study|Lost to Follow-up|2|||
28036893|NCT00365716|54695089|FG001|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
28036894|NCT00365716|54695090|FG002|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
28036895|NCT00365716|54695091|FG003|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
28036896|NCT00365716|54695092|FG004|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
28036897|NCT00365716|54695093|FG005|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
28036898|NCT00365716|54695094|FG006|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
28036899|NCT00365716|54695088|FG000|Base Study (Day 1 to Month 7)|Other|0|||
28036900|NCT00365716|54695089|FG001|Base Study (Day 1 to Month 7)|Other|1|||
27809160|NCT01404988|54264718|FG002|Overall Study|Lost to Follow-up|1|||
27809161|NCT01389232|54264729|FG000|Overall Study|Had scaffold removed|15|||
27809162|NCT01389232|54264729|FG000|Overall Study|Personal reasons|2|||
27809163|NCT01389232|54264729|FG000|Overall Study|Adverse Event|1|||
27809164|NCT01389232|54264729|FG000|Overall Study|Death|1|||
27809165|NCT01404208|54264745|FG000|Overall Study|Discontinued|3|||
27809166|NCT01404208|54264746|FG001|Overall Study|Discontinued|0|||
27847332|NCT02647320|54339901|FG002|Overall Study|Protocol Violation|3|||
27847333|NCT02647320|54339902|FG003|Overall Study|Protocol Violation|0|||
27847334|NCT02647320|54339903|FG004|Overall Study|Protocol Violation|0|||
28036901|NCT00365716|54695090|FG002|Base Study (Day 1 to Month 7)|Other|0|||
28036902|NCT00365716|54695091|FG003|Base Study (Day 1 to Month 7)|Other|0|||
27809167|NCT01617668|54264754|FG000|Overall Study|Adverse Event|7|||
27809168|NCT01617668|54264755|FG001|Overall Study|Adverse Event|0|||
27847335|NCT02647320|54339899|FG000|Overall Study|Withdrawal by Subject|7|||
28036903|NCT00365716|54695092|FG004|Base Study (Day 1 to Month 7)|Other|0|||
28036904|NCT00365716|54695093|FG005|Base Study (Day 1 to Month 7)|Other|0|||
28036905|NCT00365716|54695094|FG006|Base Study (Day 1 to Month 7)|Other|0|||
28036906|NCT00365716|54695088|FG000|Base Study (Day 1 to Month 7)|Pregnancy|3|||
28036907|NCT00365716|54695089|FG001|Base Study (Day 1 to Month 7)|Pregnancy|2|||
27847336|NCT02647320|54339900|FG001|Overall Study|Withdrawal by Subject|4|||
27809169|NCT01617668|54264756|FG002|Overall Study|Adverse Event|12|||
28036908|NCT00365716|54695090|FG002|Base Study (Day 1 to Month 7)|Pregnancy|3|||
28036909|NCT00365716|54695091|FG003|Base Study (Day 1 to Month 7)|Pregnancy|1|||
28036910|NCT00365716|54695092|FG004|Base Study (Day 1 to Month 7)|Pregnancy|1|||
28036911|NCT00365716|54695093|FG005|Base Study (Day 1 to Month 7)|Pregnancy|0|||
28036912|NCT00365716|54695094|FG006|Base Study (Day 1 to Month 7)|Pregnancy|0|||
28036913|NCT00365716|54695088|FG000|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
28036914|NCT00365716|54695089|FG001|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
28036915|NCT00365716|54695090|FG002|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
28036916|NCT00365716|54695091|FG003|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
28036917|NCT00365716|54695092|FG004|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
28036918|NCT00365716|54695093|FG005|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
28036919|NCT00365716|54695094|FG006|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
28036920|NCT00365716|54695088|FG000|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
28036921|NCT00365716|54695089|FG001|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9|||
28036922|NCT00365716|54695090|FG002|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
28036923|NCT00365716|54695091|FG003|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4|||
28036924|NCT00365716|54695092|FG004|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3|||
28036925|NCT00365716|54695093|FG005|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
28036926|NCT00365716|54695094|FG006|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
28036927|NCT00365716|54695088|FG000|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114|||
28036928|NCT00365716|54695089|FG001|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
28036929|NCT00365716|54695090|FG002|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
28036930|NCT00365716|54695091|FG003|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69|||
28036931|NCT00365716|54695092|FG004|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75|||
28036932|NCT00365716|54695093|FG005|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
28036933|NCT00365716|54695094|FG006|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
28036934|NCT00365716|54695088|FG000|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6|||
28036935|NCT00365716|54695089|FG001|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8|||
28036936|NCT00365716|54695090|FG002|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5|||
28036937|NCT00365716|54695091|FG003|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4|||
28036938|NCT00365716|54695092|FG004|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3|||
28036939|NCT00365716|54695093|FG005|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
28036940|NCT00365716|54695094|FG006|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
28036941|NCT00365716|54695088|FG000|Long Term Follow-up (Month 7 toMonth 36)|Moved|3|||
28036942|NCT00365716|54695089|FG001|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
28036943|NCT00365716|54695090|FG002|Long Term Follow-up (Month 7 toMonth 36)|Moved|1|||
28036944|NCT00365716|54695091|FG003|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
28036945|NCT00365716|54695092|FG004|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
28036946|NCT00365716|54695093|FG005|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
28036947|NCT00365716|54695094|FG006|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
28036948|NCT00365716|54695088|FG000|Long Term Follow-up (Month 7 toMonth 36)|Other|2|||
28036949|NCT00365716|54695089|FG001|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
28036950|NCT00365716|54695090|FG002|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
28036951|NCT00365716|54695091|FG003|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
28036952|NCT00365716|54695092|FG004|Long Term Follow-up (Month 7 toMonth 36)|Other|1|||
28036953|NCT00365716|54695093|FG005|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
28036954|NCT00365716|54695094|FG006|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
28036955|NCT00365716|54695088|FG000|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
28036956|NCT00365716|54695089|FG001|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
28036957|NCT00365716|54695090|FG002|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
28036958|NCT00365716|54695091|FG003|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
28036959|NCT00365716|54695092|FG004|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
28036960|NCT00365716|54695093|FG005|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
28036961|NCT00365716|54695094|FG006|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
28036962|NCT00365716|54695088|FG000|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7|||
28036963|NCT00365716|54695089|FG001|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
28036964|NCT00365716|54695090|FG002|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13|||
28036965|NCT00365716|54695091|FG003|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
28036966|NCT00365716|54695092|FG004|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3|||
28036967|NCT00365716|54695093|FG005|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
28036968|NCT00365716|54695094|FG006|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
28036969|NCT00365716|54695088|FG000|Extension 1|Lost to Follow-up|0|||
28036970|NCT00365716|54695089|FG001|Extension 1|Lost to Follow-up|0|||
28036971|NCT00365716|54695090|FG002|Extension 1|Lost to Follow-up|0|||
28036972|NCT00365716|54695091|FG003|Extension 1|Lost to Follow-up|0|||
28036973|NCT00365716|54695092|FG004|Extension 1|Lost to Follow-up|0|||
28036974|NCT00365716|54695093|FG005|Extension 1|Lost to Follow-up|1|||
28036975|NCT00365716|54695094|FG006|Extension 1|Lost to Follow-up|0|||
28036976|NCT00365716|54695088|FG000|Extension 1|Other|0|||
28036977|NCT00365716|54695089|FG001|Extension 1|Other|0|||
28036978|NCT00365716|54695090|FG002|Extension 1|Other|0|||
28036979|NCT00365716|54695091|FG003|Extension 1|Other|0|||
27847337|NCT02647320|54339901|FG002|Overall Study|Withdrawal by Subject|2|||
28036980|NCT00365716|54695092|FG004|Extension 1|Other|0|||
28036981|NCT00365716|54695093|FG005|Extension 1|Other|9|||
28036982|NCT00365716|54695094|FG006|Extension 1|Other|0|||
28036983|NCT00365716|54695088|FG000|Extension 1|Moved|0|||
27809170|NCT01617668|54264757|FG003|Overall Study|Adverse Event|5|||
27809171|NCT01617668|54264754|FG000|Overall Study|Physician Decision|1|||
27809172|NCT01617668|54264755|FG001|Overall Study|Physician Decision|2|||
27809173|NCT01617668|54264756|FG002|Overall Study|Physician Decision|3|||
27809174|NCT01617668|54264757|FG003|Overall Study|Physician Decision|0|||
27809175|NCT01617668|54264754|FG000|Overall Study|Progressive Disease|4|||
27809176|NCT01617668|54264755|FG001|Overall Study|Progressive Disease|4|||
27809177|NCT01617668|54264756|FG002|Overall Study|Progressive Disease|6|||
27809178|NCT01617668|54264757|FG003|Overall Study|Progressive Disease|9|||
28036984|NCT00365716|54695089|FG001|Extension 1|Moved|0|||
28036985|NCT00365716|54695090|FG002|Extension 1|Moved|0|||
28036986|NCT00365716|54695091|FG003|Extension 1|Moved|0|||
28036987|NCT00365716|54695092|FG004|Extension 1|Moved|0|||
28036988|NCT00365716|54695093|FG005|Extension 1|Moved|4|||
28036989|NCT00365716|54695094|FG006|Extension 1|Moved|0|||
28036990|NCT00365716|54695088|FG000|Extension 1|Withdrawal by Subject|0|||
28036991|NCT00365716|54695089|FG001|Extension 1|Withdrawal by Subject|0|||
28036992|NCT00365716|54695090|FG002|Extension 1|Withdrawal by Subject|0|||
28036993|NCT00365716|54695091|FG003|Extension 1|Withdrawal by Subject|0|||
28036994|NCT00365716|54695092|FG004|Extension 1|Withdrawal by Subject|0|||
28036995|NCT00365716|54695093|FG005|Extension 1|Withdrawal by Subject|3|||
28036996|NCT00365716|54695094|FG006|Extension 1|Withdrawal by Subject|0|||
28036997|NCT00365716|54695088|FG000|Extension 1|Pregnancy|0|||
28036998|NCT00365716|54695089|FG001|Extension 1|Pregnancy|0|||
28036999|NCT00365716|54695090|FG002|Extension 1|Pregnancy|0|||
28037000|NCT00365716|54695091|FG003|Extension 1|Pregnancy|0|||
28037001|NCT00365716|54695092|FG004|Extension 1|Pregnancy|0|||
28037002|NCT00365716|54695093|FG005|Extension 1|Pregnancy|4|||
28037003|NCT00365716|54695094|FG006|Extension 1|Pregnancy|0|||
28037004|NCT00365716|54695088|FG000|Extension 1|Protocol Violation|0|||
28037005|NCT00365716|54695089|FG001|Extension 1|Protocol Violation|0|||
27809179|NCT01617668|54264754|FG000|Overall Study|Subject/guardian decision|1|||
27809180|NCT01617668|54264755|FG001|Overall Study|Subject/guardian decision|3|||
27809181|NCT01617668|54264756|FG002|Overall Study|Subject/guardian decision|2|||
27847338|NCT02647320|54339902|FG003|Overall Study|Withdrawal by Subject|2|||
27847339|NCT02647320|54339903|FG004|Overall Study|Withdrawal by Subject|7|||
28037006|NCT00365716|54695090|FG002|Extension 1|Protocol Violation|0|||
28037007|NCT00365716|54695091|FG003|Extension 1|Protocol Violation|0|||
27847340|NCT02647320|54339899|FG000|Overall Study|Persistent hyperglycemia|0|||
27847341|NCT02647320|54339900|FG001|Overall Study|Persistent hyperglycemia|1|||
27847342|NCT02647320|54339901|FG002|Overall Study|Persistent hyperglycemia|1|||
27847343|NCT02647320|54339902|FG003|Overall Study|Persistent hyperglycemia|1|||
27847344|NCT02647320|54339903|FG004|Overall Study|Persistent hyperglycemia|1|||
27847345|NCT02647320|54339899|FG000|Overall Study|Study terminated by sponsor|1|||
27847346|NCT02647320|54339900|FG001|Overall Study|Study terminated by sponsor|1|||
27847347|NCT02647320|54339901|FG002|Overall Study|Study terminated by sponsor|1|||
27847348|NCT02647320|54339902|FG003|Overall Study|Study terminated by sponsor|1|||
27847349|NCT02647320|54339903|FG004|Overall Study|Study terminated by sponsor|2|||
27939818|NCT00946192|54596143|FG002|Overall Study|Did not start medication|0|||
27939819|NCT01037127|54596153|FG000|Overall Study|Lost to Follow-up|2|||
27939820|NCT01037127|54596154|FG001|Overall Study|Lost to Follow-up|4|||
28037008|NCT00365716|54695092|FG004|Extension 1|Protocol Violation|0|||
28037009|NCT00365716|54695093|FG005|Extension 1|Protocol Violation|1|||
28037010|NCT00365716|54695094|FG006|Extension 1|Protocol Violation|0|||
28037011|NCT00365716|54695088|FG000|Extension 2|Lost to Follow-up|0|||
28037012|NCT00365716|54695089|FG001|Extension 2|Lost to Follow-up|0|||
28037013|NCT00365716|54695090|FG002|Extension 2|Lost to Follow-up|0|||
28037014|NCT00365716|54695091|FG003|Extension 2|Lost to Follow-up|0|||
28037015|NCT00365716|54695092|FG004|Extension 2|Lost to Follow-up|0|||
28037016|NCT00365716|54695093|FG005|Extension 2|Lost to Follow-up|0|||
27809182|NCT01617668|54264757|FG003|Overall Study|Subject/guardian decision|1|||
27809183|NCT01425268|54264773|FG000|Overall Study|Withdrawal by Subject|2|||
27847350|NCT02647320|54339899|FG000|Overall Study|Reason not provided|0|||
27847351|NCT02647320|54339900|FG001|Overall Study|Reason not provided|0|||
28105672|NCT04461015|54763216|FG000|Overall Study|Withdrawal by Subject|0|||
27809184|NCT01425268|54264774|FG001|Overall Study|Withdrawal by Subject|0|||
27809185|NCT01425268|54264773|FG000|Overall Study|Sponsor Decision|5|||
28037017|NCT00365716|54695094|FG006|Extension 2|Lost to Follow-up|2|||
28037018|NCT00365716|54695088|FG000|Extension 2|Other|0|||
28037019|NCT00365716|54695089|FG001|Extension 2|Other|0|||
28037020|NCT00365716|54695090|FG002|Extension 2|Other|0|||
28037021|NCT00365716|54695091|FG003|Extension 2|Other|0|||
28037022|NCT00365716|54695092|FG004|Extension 2|Other|0|||
27847352|NCT02647320|54339901|FG002|Overall Study|Reason not provided|1|||
27847353|NCT02647320|54339902|FG003|Overall Study|Reason not provided|0|||
27847354|NCT02647320|54339903|FG004|Overall Study|Reason not provided|2|||
27847355|NCT02647320|54339899|FG000|Overall Study|Lost to Follow-up|1|||
27847356|NCT02647320|54339900|FG001|Overall Study|Lost to Follow-up|1|||
27847357|NCT02647320|54339901|FG002|Overall Study|Lost to Follow-up|0|||
27847358|NCT02647320|54339902|FG003|Overall Study|Lost to Follow-up|0|||
28037023|NCT00365716|54695093|FG005|Extension 2|Other|0|||
28037024|NCT00365716|54695094|FG006|Extension 2|Other|3|||
28037025|NCT00365716|54695088|FG000|Extension 2|Withdrawal by Subject|0|||
28037026|NCT00365716|54695089|FG001|Extension 2|Withdrawal by Subject|0|||
28037027|NCT00365716|54695090|FG002|Extension 2|Withdrawal by Subject|0|||
28037028|NCT00365716|54695091|FG003|Extension 2|Withdrawal by Subject|0|||
28037029|NCT00365716|54695092|FG004|Extension 2|Withdrawal by Subject|0|||
28037030|NCT00365716|54695093|FG005|Extension 2|Withdrawal by Subject|0|||
28037031|NCT00365716|54695094|FG006|Extension 2|Withdrawal by Subject|5|||
28037032|NCT00059839|54695110|FG000|Overall Study|Death|1|||
28037033|NCT00059839|54695111|FG001|Overall Study|Death|1|||
28037034|NCT00059839|54695110|FG000|Overall Study|Lack of Efficacy|6|||
28037035|NCT00059839|54695111|FG001|Overall Study|Lack of Efficacy|5|||
28037036|NCT00059839|54695110|FG000|Overall Study|Lost to Follow-up|2|||
28037037|NCT00059839|54695111|FG001|Overall Study|Lost to Follow-up|0|||
28037038|NCT00059839|54695110|FG000|Overall Study|Physician Decision|1|||
28037039|NCT00059839|54695111|FG001|Overall Study|Physician Decision|2|||
28037040|NCT00059839|54695110|FG000|Overall Study|Withdrawal by Subject|1|||
28037041|NCT00059839|54695111|FG001|Overall Study|Withdrawal by Subject|6|||
28037042|NCT00059839|54695110|FG000|Overall Study|Ineligible|1|||
28037043|NCT00059839|54695111|FG001|Overall Study|Ineligible|3|||
28037044|NCT00059215|54695121|FG000|Overall Study|Adverse Event|5|||
28037045|NCT00059215|54695122|FG001|Overall Study|Adverse Event|5|||
28037046|NCT00059215|54695123|FG002|Overall Study|Adverse Event|9|||
28037047|NCT00059215|54695124|FG003|Overall Study|Adverse Event|9|||
28037048|NCT00059215|54695121|FG000|Overall Study|Death|0|||
28037049|NCT00059215|54695122|FG001|Overall Study|Death|0|||
28037050|NCT00059215|54695123|FG002|Overall Study|Death|3|||
28037051|NCT00059215|54695124|FG003|Overall Study|Death|0|||
28037052|NCT00059215|54695121|FG000|Overall Study|Lost to Follow-up|1|||
28037053|NCT00059215|54695122|FG001|Overall Study|Lost to Follow-up|2|||
28037054|NCT00059215|54695123|FG002|Overall Study|Lost to Follow-up|0|||
28037055|NCT00059215|54695124|FG003|Overall Study|Lost to Follow-up|0|||
28037056|NCT00059215|54695121|FG000|Overall Study|Withdrawal by Subject|4|||
27847359|NCT02647320|54339903|FG004|Overall Study|Lost to Follow-up|0|||
27847360|NCT02647320|54339899|FG000|Overall Study|Develop anemia|1|||
27847361|NCT02647320|54339900|FG001|Overall Study|Develop anemia|0|||
27847362|NCT02647320|54339901|FG002|Overall Study|Develop anemia|0|||
27847363|NCT02647320|54339902|FG003|Overall Study|Develop anemia|0|||
27847364|NCT02647320|54339903|FG004|Overall Study|Develop anemia|0|||
28037057|NCT00059215|54695122|FG001|Overall Study|Withdrawal by Subject|4|||
28037058|NCT00059215|54695123|FG002|Overall Study|Withdrawal by Subject|1|||
28037059|NCT00059215|54695124|FG003|Overall Study|Withdrawal by Subject|3|||
28037060|NCT00059215|54695121|FG000|Overall Study|Protocol Violation|1|||
28037061|NCT00059215|54695122|FG001|Overall Study|Protocol Violation|0|||
28037062|NCT00059215|54695123|FG002|Overall Study|Protocol Violation|1|||
27847365|NCT02647320|54339899|FG000|Overall Study|Lack of Efficacy|0|||
27847366|NCT02647320|54339900|FG001|Overall Study|Lack of Efficacy|0|||
27847367|NCT02647320|54339901|FG002|Overall Study|Lack of Efficacy|0|||
27847368|NCT02647320|54339902|FG003|Overall Study|Lack of Efficacy|1|||
27847369|NCT02647320|54339903|FG004|Overall Study|Lack of Efficacy|0|||
27847370|NCT02647320|54339899|FG000|Overall Study|Disposition Missing Due to Fire at Site|2|||
27847371|NCT02647320|54339900|FG001|Overall Study|Disposition Missing Due to Fire at Site|3|||
27847372|NCT02647320|54339901|FG002|Overall Study|Disposition Missing Due to Fire at Site|4|||
27847373|NCT02647320|54339902|FG003|Overall Study|Disposition Missing Due to Fire at Site|3|||
27847374|NCT02647320|54339903|FG004|Overall Study|Disposition Missing Due to Fire at Site|4|||
27847375|NCT03458325|54339926|FG000|Overall Study|Withdrawal by Subject|1|||
28037063|NCT00059215|54695124|FG003|Overall Study|Protocol Violation|0|||
28037064|NCT00059215|54695121|FG000|Overall Study|Protocol entry criteria not met|1|||
28037065|NCT00059215|54695122|FG001|Overall Study|Protocol entry criteria not met|1|||
28037066|NCT00059215|54695123|FG002|Overall Study|Protocol entry criteria not met|0|||
28037067|NCT00059215|54695124|FG003|Overall Study|Protocol entry criteria not met|2|||
28037068|NCT00059215|54695121|FG000|Overall Study|Physician Decision|1|||
28037069|NCT00059215|54695122|FG001|Overall Study|Physician Decision|2|||
28037070|NCT00059215|54695123|FG002|Overall Study|Physician Decision|1|||
28037071|NCT00059215|54695124|FG003|Overall Study|Physician Decision|1|||
27847376|NCT02646618|54339935|FG000|Overall Study|Lost to Follow-up|10|||
27847377|NCT02646618|54339936|FG001|Overall Study|Lost to Follow-up|14|||
27847378|NCT02644122|54339972|FG000|Overall Study|Withdrawal by Subject|1|||
28037072|NCT00058825|54695135|FG000|Overall Study|Relapse|9|||
28037073|NCT00058825|54695135|FG000|Overall Study|Progressive Disease|5|||
28037074|NCT00058825|54695135|FG000|Overall Study|Graft Failure|5|||
28037075|NCT00058825|54695135|FG000|Overall Study|Death|3|||
27847379|NCT01394939|54339998|FG000|Overall Study|Adverse Event|1|||
27847380|NCT01394939|54339999|FG001|Overall Study|Adverse Event|3|||
27847381|NCT01394939|54340000|FG002|Overall Study|Adverse Event|0|||
27847382|NCT01394939|54340001|FG003|Overall Study|Adverse Event|2|||
27847383|NCT01394939|54339998|FG000|Overall Study|Death|0|||
28037076|NCT00364858|54695143|FG000|Overall Study|Adverse Event|1|||
28037077|NCT00364858|54695144|FG001|Overall Study|Adverse Event|5|||
28037078|NCT00364858|54695143|FG000|Overall Study|Withdrawal by Subject|1|||
28037079|NCT00364858|54695144|FG001|Overall Study|Withdrawal by Subject|1|||
28037080|NCT00364858|54695143|FG000|Overall Study|Pregnancy|1|||
27847384|NCT01394939|54339999|FG001|Overall Study|Death|2|||
27847385|NCT01394939|54340000|FG002|Overall Study|Death|0|||
27847386|NCT01394939|54340001|FG003|Overall Study|Death|0|||
28037081|NCT00364858|54695144|FG001|Overall Study|Pregnancy|1|||
28037082|NCT00364858|54695143|FG000|Overall Study|Clinical failure|2|||
28037083|NCT00364858|54695144|FG001|Overall Study|Clinical failure|13|||
28037084|NCT00364858|54695143|FG000|Overall Study|Discontinuation at baseline|1|||
28037085|NCT00364858|54695144|FG001|Overall Study|Discontinuation at baseline|0|||
28037086|NCT00364858|54695143|FG000|Overall Study|Non-compliant|1|||
28037087|NCT00364858|54695144|FG001|Overall Study|Non-compliant|0|||
28037088|NCT00364858|54695143|FG000|Overall Study|Return to Q2 regimen|0|||
28037089|NCT00364858|54695144|FG001|Overall Study|Return to Q2 regimen|1|||
28037090|NCT00364858|54695143|FG000|Overall Study|Clinical baseline issue|0|||
28037091|NCT00364858|54695144|FG001|Overall Study|Clinical baseline issue|1|||
28037092|NCT03803059|54695151|FG000|Overall Study|Protocol Violation|2|||
27809186|NCT01425268|54264774|FG001|Overall Study|Sponsor Decision|0|||
27809187|NCT01425268|54264773|FG000|Overall Study|Physician Decision|1|||
27809188|NCT01425268|54264774|FG001|Overall Study|Physician Decision|0|||
28037093|NCT03803059|54695151|FG000|Overall Study|Lost to Follow-up|1|||
28037094|NCT00372424|54695156|FG000|Overall Study|Adverse Event|2|||
28037095|NCT00372424|54695156|FG000|Overall Study|Withdrawal by Subject|1|||
28037096|NCT00372424|54695156|FG000|Overall Study|Death|1|||
28037097|NCT00372424|54695156|FG000|Overall Study|Objective Progression or Relapse|14|||
28037098|NCT00372424|54695156|FG000|Overall Study|Other|7|||
28037099|NCT00372424|54695156|FG000|Overall Study|Enrolled, Not Treated|1|||
28037100|NCT00372190|54695162|FG000|Overall Study|Lost to Follow-up|3|||
28037101|NCT00372190|54695163|FG001|Overall Study|Lost to Follow-up|1|||
28037102|NCT00044083|54695173|FG000|First Intervention (One Week)- HV's|Adverse Event|1|||
28037103|NCT00044083|54695174|FG001|First Intervention (One Week)- HV's|Adverse Event|0|||
28037104|NCT00044083|54695173|FG000|First Intervention (One Week)- HV's|Not follow directions|2|||
28037105|NCT00044083|54695174|FG001|First Intervention (One Week)- HV's|Not follow directions|2|||
28037106|NCT00044083|54695173|FG000|First Intervention (One Week)- HV's|Withdrawal by Subject|5|||
28037107|NCT00044083|54695174|FG001|First Intervention (One Week)- HV's|Withdrawal by Subject|3|||
27809189|NCT01425190|54264783|FG000|Overall Study|Full dose not consumed.|1|||
27809190|NCT01425190|54264784|FG001|Overall Study|Full dose not consumed.|0|||
27809191|NCT01425190|54264785|FG002|Overall Study|Full dose not consumed.|0|||
27809192|NCT01388530|54264793|FG000|Overall Study|Lost to Follow-up|5|||
27809193|NCT01895270|54264799|FG000|Study Medications Induction (W1-4)|Withdrawal by Subject|0|||
27809194|NCT01895270|54264800|FG001|Study Medications Induction (W1-4)|Withdrawal by Subject|2|||
27809195|NCT01895270|54264799|FG000|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3|||
27809196|NCT01895270|54264800|FG001|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2|||
27809197|NCT01895270|54264799|FG000|Study Medications Induction (W1-4)|noncompliance- missed medications|3|||
27809198|NCT01895270|54264800|FG001|Study Medications Induction (W1-4)|noncompliance- missed medications|1|||
27809199|NCT01895270|54264799|FG000|Study Medications Induction (W1-4)|Blood pressure issues|0|||
27809200|NCT01895270|54264800|FG001|Study Medications Induction (W1-4)|Blood pressure issues|1|||
27809201|NCT01895270|54264799|FG000|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3|||
27809202|NCT01895270|54264800|FG001|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5|||
27809203|NCT01895270|54264799|FG000|Isradipine Taper (W7-8)|Lost to Follow-up|0|||
27847387|NCT01394939|54339998|FG000|Overall Study|Physician Decision|0|||
27847388|NCT01394939|54339999|FG001|Overall Study|Physician Decision|1|||
27847389|NCT01394939|54340000|FG002|Overall Study|Physician Decision|0|||
27847390|NCT01394939|54340001|FG003|Overall Study|Physician Decision|0|||
28037108|NCT00044083|54695173|FG000|First Intervention (One Week)- HV's|Pregnancy|1|||
28037109|NCT00044083|54695174|FG001|First Intervention (One Week)- HV's|Pregnancy|0|||
28037110|NCT00044083|54695173|FG000|First Intervention (One Week)- HV's|Used illegal drugs|1|||
28037111|NCT00044083|54695174|FG001|First Intervention (One Week)- HV's|Used illegal drugs|0|||
28037112|NCT00044083|54695173|FG000|First Intervention (One Week)- HV's|Abnormal MRI|0|||
28037113|NCT00044083|54695174|FG001|First Intervention (One Week)- HV's|Abnormal MRI|1|||
27809204|NCT01895270|54264800|FG001|Isradipine Taper (W7-8)|Lost to Follow-up|1|||
27809205|NCT01895270|54264799|FG000|Isradipine Taper (W7-8)|Withdrawal by Subject|0|||
27809206|NCT01895270|54264800|FG001|Isradipine Taper (W7-8)|Withdrawal by Subject|1|||
27847391|NCT01394939|54339998|FG000|Overall Study|Withdrawal by Subject|0|||
28037114|NCT00044083|54695173|FG000|First Intervention (One Week)- HV's|Drank while on protocol|0|||
27809207|NCT01424722|54264806|FG000|Overall Study|Sponsor terminated investigation|2258|||
28037115|NCT00044083|54695174|FG001|First Intervention (One Week)- HV's|Drank while on protocol|1|||
28037116|NCT00044083|54695173|FG000|First Intervention (One Week) Patients|Not follow directions|0|||
28037117|NCT00044083|54695174|FG001|First Intervention (One Week) Patients|Not follow directions|2|||
28037118|NCT00044083|54695173|FG000|First Intervention (One Week) Patients|Used illegal drug|1|||
28037119|NCT00044083|54695174|FG001|First Intervention (One Week) Patients|Used illegal drug|0|||
28037120|NCT00044083|54695173|FG000|Second Intervention (One Week) Patients|Withdrawal by Subject|0|||
28037121|NCT00044083|54695174|FG001|Second Intervention (One Week) Patients|Withdrawal by Subject|1|||
28037122|NCT00058123|54695207|FG000|Overall Study|Wrong histology|9|||
28037123|NCT00058123|54695207|FG000|Overall Study|Received >3 prior treatments|1|||
28037124|NCT00022633|54695214|FG000|Overall Study|Adverse Event|11|||
28037125|NCT00022633|54695215|FG001|Overall Study|Adverse Event|1|||
28037126|NCT00022633|54695214|FG000|Overall Study|Refusal unrelated to adverse event|1|||
28037127|NCT00022633|54695215|FG001|Overall Study|Refusal unrelated to adverse event|0|||
28037128|NCT00022633|54695214|FG000|Overall Study|Progression/relapse|9|||
28037129|NCT00022633|54695215|FG001|Overall Study|Progression/relapse|2|||
28037130|NCT00022633|54695214|FG000|Overall Study|Death|4|||
28037131|NCT00022633|54695215|FG001|Overall Study|Death|0|||
28037132|NCT00022633|54695214|FG000|Overall Study|Other - not protocol specified|3|||
28037133|NCT00022633|54695215|FG001|Overall Study|Other - not protocol specified|2|||
28037134|NCT00022633|54695214|FG000|Overall Study|Ineligible|4|||
28037135|NCT00022633|54695215|FG001|Overall Study|Ineligible|0|||
28037136|NCT00021541|54695222|FG000|Period 1-First Treatment|Withdrawal by Subject|3|||
28037137|NCT00021541|54695223|FG001|Period 1-First Treatment|Withdrawal by Subject|3|||
28037138|NCT00021541|54695222|FG000|Period 1-First Treatment|Adverse Event|2|||
28037139|NCT00021541|54695223|FG001|Period 1-First Treatment|Adverse Event|1|||
28037140|NCT00021541|54695222|FG000|Period 1-First Treatment|non-adherence|3|||
28037141|NCT00021541|54695223|FG001|Period 1-First Treatment|non-adherence|0|||
28037142|NCT00021541|54695222|FG000|Period 1-First Treatment|Death|1|||
28037143|NCT00021541|54695223|FG001|Period 1-First Treatment|Death|0|||
28037144|NCT00021541|54695222|FG000|Period 1-First Treatment|Pts that did not progress|2|||
28037145|NCT00021541|54695223|FG001|Period 1-First Treatment|Pts that did not progress|2|||
28037146|NCT00021541|54695222|FG000|Period 1-First Treatment|Ineligible|0|||
28037147|NCT00021541|54695223|FG001|Period 1-First Treatment|Ineligible|2|||
28037148|NCT00021541|54695222|FG000|Period 2-crossover|refused phase B|2|||
28037149|NCT00021541|54695223|FG001|Period 2-crossover|refused phase B|2|||
28037150|NCT00021541|54695222|FG000|Period 2-crossover|Withdrawal by Subject|3|||
28037151|NCT00021541|54695223|FG001|Period 2-crossover|Withdrawal by Subject|4|||
28037152|NCT00021541|54695222|FG000|Period 2-crossover|Adverse Event|2|||
28037153|NCT00021541|54695223|FG001|Period 2-crossover|Adverse Event|2|||
28037154|NCT00021541|54695222|FG000|Period 2-crossover|non-adherence|1|||
28037155|NCT00021541|54695223|FG001|Period 2-crossover|non-adherence|0|||
28037156|NCT00021541|54695222|FG000|Period 2-crossover|Pts that did not progress|2|||
28037157|NCT00021541|54695223|FG001|Period 2-crossover|Pts that did not progress|3|||
28037158|NCT00021229|54695234|FG000|Overall Study|Adverse Event|10|||
28037159|NCT00021229|54695235|FG001|Overall Study|Adverse Event|5|||
28037160|NCT00021229|54695236|FG002|Overall Study|Adverse Event|2|||
28037161|NCT00021229|54695234|FG000|Overall Study|Death|0|||
28037162|NCT00021229|54695235|FG001|Overall Study|Death|1|||
28037163|NCT00021229|54695236|FG002|Overall Study|Death|0|||
28037164|NCT00021229|54695234|FG000|Overall Study|Withdrawal by Subject|7|||
28037165|NCT00021229|54695235|FG001|Overall Study|Withdrawal by Subject|7|||
28037166|NCT00021229|54695236|FG002|Overall Study|Withdrawal by Subject|1|||
28037167|NCT00021229|54695234|FG000|Overall Study|Progressive Disease|15|||
28037168|NCT00021229|54695235|FG001|Overall Study|Progressive Disease|19|||
28037169|NCT00021229|54695236|FG002|Overall Study|Progressive Disease|12|||
28037170|NCT00021229|54695234|FG000|Overall Study|Protocol Violation|1|||
28037171|NCT00021229|54695235|FG001|Overall Study|Protocol Violation|1|||
28037172|NCT00021229|54695236|FG002|Overall Study|Protocol Violation|0|||
28037173|NCT00021229|54695234|FG000|Overall Study|Physician Decision|0|||
28037174|NCT00021229|54695235|FG001|Overall Study|Physician Decision|0|||
28037175|NCT00021229|54695236|FG002|Overall Study|Physician Decision|1|||
28037176|NCT00021229|54695234|FG000|Overall Study|Punctate hemmorrhage post RT|2|||
28037177|NCT00021229|54695235|FG001|Overall Study|Punctate hemmorrhage post RT|0|||
27847392|NCT01394939|54339999|FG001|Overall Study|Withdrawal by Subject|2|||
27939821|NCT01037127|54596153|FG000|Overall Study|Physician Decision|1|||
28037178|NCT00021229|54695236|FG002|Overall Study|Punctate hemmorrhage post RT|0|||
28037179|NCT00372112|54695250|FG000|Overall Study|Adverse Event|0|||
28037180|NCT00372112|54695251|FG001|Overall Study|Adverse Event|1|||
28037181|NCT00372112|54695252|FG002|Overall Study|Adverse Event|1|||
27847393|NCT01394939|54340000|FG002|Overall Study|Withdrawal by Subject|0|||
28037182|NCT00372112|54695253|FG003|Overall Study|Adverse Event|1|||
28037183|NCT00372112|54695250|FG000|Overall Study|Withdrawal by Subject|0|||
28037184|NCT00372112|54695251|FG001|Overall Study|Withdrawal by Subject|0|||
28037185|NCT00372112|54695252|FG002|Overall Study|Withdrawal by Subject|2|||
28037186|NCT00372112|54695253|FG003|Overall Study|Withdrawal by Subject|1|||
28037187|NCT00372112|54695250|FG000|Overall Study|Exacerbation|0|||
27847394|NCT01394939|54340001|FG003|Overall Study|Withdrawal by Subject|2|||
27847395|NCT01394939|54339998|FG000|Overall Study|Others|0|||
27847396|NCT01394939|54339999|FG001|Overall Study|Others|2|||
27847397|NCT01394939|54340000|FG002|Overall Study|Others|0|||
27847398|NCT01394939|54340001|FG003|Overall Study|Others|3|||
28037188|NCT00372112|54695251|FG001|Overall Study|Exacerbation|0|||
28037189|NCT00372112|54695252|FG002|Overall Study|Exacerbation|0|||
28037190|NCT00372112|54695253|FG003|Overall Study|Exacerbation|1|||
28037191|NCT00372112|54695250|FG000|Overall Study|PR >240 at Visit 3|0|||
28037192|NCT00372112|54695251|FG001|Overall Study|PR >240 at Visit 3|0|||
28037193|NCT00372112|54695252|FG002|Overall Study|PR >240 at Visit 3|0|||
28037194|NCT00372112|54695253|FG003|Overall Study|PR >240 at Visit 3|1|||
28037195|NCT00372112|54695250|FG000|Overall Study|Hepatitis B|1|||
28037196|NCT00372112|54695251|FG001|Overall Study|Hepatitis B|0|||
28037197|NCT00372112|54695252|FG002|Overall Study|Hepatitis B|0|||
28037198|NCT00372112|54695253|FG003|Overall Study|Hepatitis B|0|||
28037199|NCT00372112|54695250|FG000|Overall Study|Other-protocol violation|0|||
28037200|NCT00372112|54695251|FG001|Overall Study|Other-protocol violation|0|||
28037201|NCT00372112|54695252|FG002|Overall Study|Other-protocol violation|1|||
28037202|NCT00372112|54695253|FG003|Overall Study|Other-protocol violation|0|||
28037203|NCT00488475|54695266|FG000|Overall Study|Other|1754|||
28037204|NCT00042991|54695277|FG000|Overall Study|Adverse Event|1|||
28037205|NCT00042991|54695278|FG001|Overall Study|Adverse Event|4|||
28037206|NCT00042991|54695279|FG002|Overall Study|Adverse Event|2|||
28037207|NCT00042991|54695280|FG003|Overall Study|Adverse Event|0|||
28037208|NCT00042991|54695281|FG004|Overall Study|Adverse Event|0|||
28037209|NCT00042991|54695282|FG005|Overall Study|Adverse Event|1|||
28037210|NCT00042991|54695283|FG006|Overall Study|Adverse Event|0|||
28037211|NCT00042991|54695277|FG000|Overall Study|Withdrawal by Subject|0|||
28037212|NCT00042991|54695278|FG001|Overall Study|Withdrawal by Subject|7|||
27809208|NCT01424644|54264812|FG000|Overall Study|Adverse Event|2|||
27809209|NCT01424644|54264813|FG001|Overall Study|Adverse Event|0|||
28037213|NCT00042991|54695279|FG002|Overall Study|Withdrawal by Subject|2|||
28037214|NCT00042991|54695280|FG003|Overall Study|Withdrawal by Subject|0|||
28037215|NCT00042991|54695281|FG004|Overall Study|Withdrawal by Subject|1|||
28037216|NCT00042991|54695282|FG005|Overall Study|Withdrawal by Subject|0|||
28037217|NCT00042991|54695283|FG006|Overall Study|Withdrawal by Subject|0|||
28037218|NCT00042991|54695277|FG000|Overall Study|Disease Progression|5|||
28037219|NCT00042991|54695278|FG001|Overall Study|Disease Progression|29|||
28037220|NCT00042991|54695279|FG002|Overall Study|Disease Progression|2|||
28037221|NCT00042991|54695280|FG003|Overall Study|Disease Progression|2|||
28037222|NCT00042991|54695281|FG004|Overall Study|Disease Progression|1|||
28037223|NCT00042991|54695282|FG005|Overall Study|Disease Progression|4|||
28037224|NCT00042991|54695283|FG006|Overall Study|Disease Progression|2|||
28037225|NCT00042991|54695277|FG000|Overall Study|Alternative Therapy|0|||
28037226|NCT00042991|54695278|FG001|Overall Study|Alternative Therapy|0|||
28037227|NCT00042991|54695279|FG002|Overall Study|Alternative Therapy|0|||
28037228|NCT00042991|54695280|FG003|Overall Study|Alternative Therapy|0|||
28037229|NCT00042991|54695281|FG004|Overall Study|Alternative Therapy|1|||
28037230|NCT00042991|54695282|FG005|Overall Study|Alternative Therapy|0|||
28037231|NCT00042991|54695283|FG006|Overall Study|Alternative Therapy|0|||
28037232|NCT00466167|54695304|FG000|Overall Study|Adverse Event|8|||
27809210|NCT01424644|54264812|FG000|Overall Study|Withdrawal by Subject|9|||
27809211|NCT01424644|54264813|FG001|Overall Study|Withdrawal by Subject|12|||
27809212|NCT01424644|54264812|FG000|Overall Study|Lost to Follow-up|16|||
27809213|NCT01424644|54264813|FG001|Overall Study|Lost to Follow-up|12|||
27809214|NCT01424644|54264812|FG000|Overall Study|Protocol Violation|4|||
27809215|NCT01424644|54264813|FG001|Overall Study|Protocol Violation|3|||
27809216|NCT01424644|54264812|FG000|Overall Study|Administrative Reason|1|||
27809217|NCT01424644|54264813|FG001|Overall Study|Administrative Reason|0|||
27809218|NCT01424644|54264812|FG000|Overall Study|Unable to Classify|1|||
27847399|NCT01394627|54340019|FG000|First Intervention (1 Day)|poor intravenous access|0|||
28037233|NCT00466167|54695305|FG001|Overall Study|Adverse Event|8|||
28037234|NCT00466167|54695306|FG002|Overall Study|Adverse Event|7|||
28037235|NCT00466167|54695304|FG000|Overall Study|Lack of Efficacy|2|||
28037236|NCT00466167|54695305|FG001|Overall Study|Lack of Efficacy|0|||
28037237|NCT00466167|54695306|FG002|Overall Study|Lack of Efficacy|3|||
27809219|NCT01424644|54264813|FG001|Overall Study|Unable to Classify|0|||
27847400|NCT01394627|54340020|FG001|First Intervention (1 Day)|poor intravenous access|1|||
27939822|NCT01037127|54596154|FG001|Overall Study|Physician Decision|0|||
28037238|NCT00466167|54695304|FG000|Overall Study|Protocol Violation|1|||
28037239|NCT00466167|54695305|FG001|Overall Study|Protocol Violation|1|||
28037240|NCT00466167|54695306|FG002|Overall Study|Protocol Violation|2|||
28037241|NCT00466167|54695304|FG000|Overall Study|Lost to Follow-up|3|||
28037242|NCT00466167|54695305|FG001|Overall Study|Lost to Follow-up|2|||
28037243|NCT00466167|54695306|FG002|Overall Study|Lost to Follow-up|2|||
27809220|NCT01920854|54264826|FG000|Overall Study|Withdrawal by Subject|1|||
27809221|NCT01920854|54264827|FG001|Overall Study|Withdrawal by Subject|0|||
27809222|NCT01920854|54264828|FG002|Overall Study|Withdrawal by Subject|0|||
28037244|NCT00466167|54695304|FG000|Overall Study|Withdrawal by Subject|4|||
28037245|NCT00466167|54695305|FG001|Overall Study|Withdrawal by Subject|1|||
28037246|NCT00466167|54695306|FG002|Overall Study|Withdrawal by Subject|6|||
28037247|NCT00466167|54695304|FG000|Overall Study|patient did not meet inclusion criteria|1|||
28037248|NCT00466167|54695305|FG001|Overall Study|patient did not meet inclusion criteria|0|||
28037249|NCT00466167|54695306|FG002|Overall Study|patient did not meet inclusion criteria|1|||
28037250|NCT00466167|54695304|FG000|Overall Study|Not treated|1|||
28037251|NCT00466167|54695305|FG001|Overall Study|Not treated|0|||
28037252|NCT00466167|54695306|FG002|Overall Study|Not treated|0|||
28037253|NCT00480441|54695316|FG000|Screening|Not Eligible|37|||
28037254|NCT00480441|54695317|FG001|Screening|Not Eligible|0|||
28037255|NCT00480441|54695318|FG002|Screening|Not Eligible|0|||
28037256|NCT00480441|54695316|FG000|Baseline Functional MRI|Functional MRI data not usable|4|||
28037257|NCT00480441|54695317|FG001|Baseline Functional MRI|Functional MRI data not usable|0|||
28037258|NCT00480441|54695318|FG002|Baseline Functional MRI|Functional MRI data not usable|0|||
28037259|NCT00480441|54695316|FG000|Baseline Functional MRI|Lost to Follow-up|4|||
28037260|NCT00480441|54695317|FG001|Baseline Functional MRI|Lost to Follow-up|0|||
28037261|NCT00480441|54695318|FG002|Baseline Functional MRI|Lost to Follow-up|0|||
28037262|NCT00480441|54695316|FG000|Baseline Functional MRI|physical contraindication|4|||
28037263|NCT00480441|54695317|FG001|Baseline Functional MRI|physical contraindication|0|||
28037264|NCT00480441|54695318|FG002|Baseline Functional MRI|physical contraindication|0|||
28037265|NCT00480441|54695316|FG000|Randomization|Lost to Follow-up|0|||
28037266|NCT00480441|54695317|FG001|Randomization|Lost to Follow-up|7|||
28037267|NCT00480441|54695318|FG002|Randomization|Lost to Follow-up|2|||
28037268|NCT00488319|54695328|FG000|Overall Study|Adverse Event|1|||
28037269|NCT00488319|54695329|FG001|Overall Study|Adverse Event|2|||
28037270|NCT00488319|54695330|FG002|Overall Study|Adverse Event|23|||
28037271|NCT00488319|54695328|FG000|Overall Study|Lack of Efficacy|6|||
28037272|NCT00488319|54695329|FG001|Overall Study|Lack of Efficacy|12|||
28037273|NCT00488319|54695330|FG002|Overall Study|Lack of Efficacy|27|||
28037274|NCT00488319|54695328|FG000|Overall Study|Lost to Follow-up|3|||
28037275|NCT00488319|54695329|FG001|Overall Study|Lost to Follow-up|5|||
28037276|NCT00488319|54695330|FG002|Overall Study|Lost to Follow-up|16|||
28037277|NCT00488319|54695328|FG000|Overall Study|Withdrawal by Subject|5|||
28037278|NCT00488319|54695329|FG001|Overall Study|Withdrawal by Subject|20|||
28037279|NCT00488319|54695330|FG002|Overall Study|Withdrawal by Subject|44|||
28037280|NCT00488319|54695328|FG000|Overall Study|Other reasons for withdrawal|0|||
28037281|NCT00488319|54695329|FG001|Overall Study|Other reasons for withdrawal|4|||
28037282|NCT00488319|54695330|FG002|Overall Study|Other reasons for withdrawal|12|||
28037283|NCT00463047|54695339|FG000|Titration Period 1|Adverse Event|10|||
28037284|NCT00463047|54695340|FG001|Titration Period 1|Adverse Event|8|||
28037285|NCT00463047|54695339|FG000|Titration Period 1|Lack of Efficacy|10|||
28037286|NCT00463047|54695340|FG001|Titration Period 1|Lack of Efficacy|4|||
28037287|NCT00463047|54695339|FG000|Titration Period 1|Lost to Follow-up|2|||
28037288|NCT00463047|54695340|FG001|Titration Period 1|Lost to Follow-up|0|||
28037289|NCT00463047|54695339|FG000|Titration Period 1|Non-compliance with study medication|3|||
28037290|NCT00463047|54695340|FG001|Titration Period 1|Non-compliance with study medication|5|||
28037291|NCT00463047|54695339|FG000|Titration Period 1|Protocol Violation|5|||
28037292|NCT00463047|54695340|FG001|Titration Period 1|Protocol Violation|5|||
28037293|NCT00463047|54695339|FG000|Titration Period 1|Withdrawal by Subject|3|||
28037294|NCT00463047|54695340|FG001|Titration Period 1|Withdrawal by Subject|5|||
28037295|NCT00463047|54695339|FG000|Titration Period 1|Non-compliance procedures|4|||
28037296|NCT00463047|54695340|FG001|Titration Period 1|Non-compliance procedures|10|||
28037297|NCT00463047|54695339|FG000|Titration Period 1|Other|0|||
28037298|NCT00463047|54695340|FG001|Titration Period 1|Other|2|||
28037299|NCT00463047|54695339|FG000|Titration Period 2|Adverse Event|9|||
28037300|NCT00463047|54695340|FG001|Titration Period 2|Adverse Event|9|||
28037301|NCT00463047|54695339|FG000|Titration Period 2|Lack of Efficacy|6|||
28037302|NCT00463047|54695340|FG001|Titration Period 2|Lack of Efficacy|4|||
28037303|NCT00463047|54695339|FG000|Titration Period 2|Withdrawal by Subject|1|||
28037304|NCT00463047|54695340|FG001|Titration Period 2|Withdrawal by Subject|0|||
28037305|NCT00463047|54695339|FG000|Titration Period 2|Protocol Violation|2|||
28037306|NCT00463047|54695340|FG001|Titration Period 2|Protocol Violation|3|||
28037307|NCT00463047|54695339|FG000|Titration Period 2|Lost to Follow-up|1|||
28037308|NCT00463047|54695340|FG001|Titration Period 2|Lost to Follow-up|2|||
27809223|NCT01920854|54264829|FG003|Overall Study|Withdrawal by Subject|0|||
27809224|NCT01920854|54264830|FG004|Overall Study|Withdrawal by Subject|1|||
27809225|NCT01920854|54264831|FG005|Overall Study|Withdrawal by Subject|0|||
27809226|NCT01920854|54264832|FG006|Overall Study|Withdrawal by Subject|1|||
27939823|NCT01037127|54596153|FG000|Overall Study|Study Closed Terminated|2|||
28037309|NCT00463047|54695339|FG000|Titration Period 2|Non-compliance study medication|4|||
28037310|NCT00463047|54695340|FG001|Titration Period 2|Non-compliance study medication|2|||
28037311|NCT00463047|54695339|FG000|Titration Period 2|Non-compliance procedures|4|||
28037312|NCT00463047|54695340|FG001|Titration Period 2|Non-compliance procedures|1|||
28037313|NCT00463047|54695339|FG000|Titration Period 2|Other|3|||
28037314|NCT00463047|54695340|FG001|Titration Period 2|Other|2|||
27809227|NCT01403194|54264867|FG000|Overall Study|Screen Failure|2|||
27847401|NCT01394627|54340019|FG000|Washout (1-3 Months)|concurrent enrollment in another study|1|||
27847402|NCT01394627|54340020|FG001|Washout (1-3 Months)|concurrent enrollment in another study|0|||
27847403|NCT01391663|54340039|FG000|Overall Study|Withdrawal by Subject|0|||
27847404|NCT01391663|54340040|FG001|Overall Study|Withdrawal by Subject|0|||
27847405|NCT01391663|54340041|FG002|Overall Study|Withdrawal by Subject|1|||
27847406|NCT01391663|54340042|FG003|Overall Study|Withdrawal by Subject|0|||
27847407|NCT02641392|54340063|FG000|Overall Study|Lost to Follow-up|0|||
27847408|NCT02641392|54340064|FG001|Overall Study|Lost to Follow-up|0|||
27847409|NCT02641392|54340065|FG002|Overall Study|Lost to Follow-up|2|||
27847410|NCT02641392|54340063|FG000|Overall Study|Withdrawal by Subject|0|||
27847411|NCT02641392|54340064|FG001|Overall Study|Withdrawal by Subject|0|||
27847412|NCT02641392|54340065|FG002|Overall Study|Withdrawal by Subject|17|||
27847413|NCT02641392|54340063|FG000|Overall Study|Adverse Event|0|||
27847414|NCT02641392|54340064|FG001|Overall Study|Adverse Event|1|||
27847415|NCT02641392|54340065|FG002|Overall Study|Adverse Event|25|||
27847416|NCT02641392|54340063|FG000|Overall Study|Study Terminated by Sponsor|4|||
28037315|NCT00463047|54695339|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
28037316|NCT00463047|54695340|FG001|Double-Blind Treatment Period 1|Adverse Event|2|||
28037317|NCT00463047|54695339|FG000|Double-Blind Treatment Period 1|Protocol Violation|1|||
28037318|NCT00463047|54695340|FG001|Double-Blind Treatment Period 1|Protocol Violation|2|||
28037319|NCT00463047|54695339|FG000|Double-Blind Treatment Period 1|Non-compliance with procedures|1|||
28037320|NCT00463047|54695340|FG001|Double-Blind Treatment Period 1|Non-compliance with procedures|0|||
28037321|NCT00463047|54695339|FG000|Double-Blind Treatment Period 1|Other|1|||
28037322|NCT00463047|54695340|FG001|Double-Blind Treatment Period 1|Other|0|||
28037323|NCT00463047|54695339|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
28037324|NCT00463047|54695340|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
28037325|NCT00463047|54695339|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
28037326|NCT00463047|54695340|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
28037327|NCT00463047|54695339|FG000|Double-Blind Treatment Period 2|Non-compliance with procedures|1|||
28037328|NCT00463047|54695340|FG001|Double-Blind Treatment Period 2|Non-compliance with procedures|0|||
27847417|NCT02641392|54340064|FG001|Overall Study|Study Terminated by Sponsor|12|||
27939824|NCT01037127|54596154|FG001|Overall Study|Study Closed Terminated|17|||
27939825|NCT00946114|54596172|FG000|Overall Study|Death|5|||
27939826|NCT00946114|54596173|FG001|Overall Study|Death|2|||
27939827|NCT00946114|54596172|FG000|Overall Study|Other|1|||
27939828|NCT00946114|54596173|FG001|Overall Study|Other|0|||
27939829|NCT00946114|54596172|FG000|Overall Study|Withdrawal by Subject|2|||
27939830|NCT00946114|54596173|FG001|Overall Study|Withdrawal by Subject|0|||
27939831|NCT01038921|54596181|FG000|Overall Study|Withdrawal by Subject|1|||
27939832|NCT01038921|54596182|FG001|Overall Study|Withdrawal by Subject|0|||
27939833|NCT01038921|54596181|FG000|Overall Study|Physician Decision|1|||
27939834|NCT01038921|54596182|FG001|Overall Study|Physician Decision|0|||
28037329|NCT00487695|54695347|FG000|First Procedure|invasive cancer on EGD (excl criteria)|1|||
28037330|NCT00487695|54695348|FG001|First Procedure|invasive cancer on EGD (excl criteria)|0|||
28037331|NCT00487695|54695347|FG000|First Procedure|active wheezing (did not have procedure)|1|||
28037332|NCT00487695|54695348|FG001|First Procedure|active wheezing (did not have procedure)|0|||
28037333|NCT00487695|54695347|FG000|First Procedure|esophageal stricture found (excl crit)|1|||
28037334|NCT00487695|54695348|FG001|First Procedure|esophageal stricture found (excl crit)|0|||
28037335|NCT00487695|54695347|FG000|Second Procedure|active wheezing|0|||
28037336|NCT00487695|54695348|FG001|Second Procedure|active wheezing|1|||
28037337|NCT00487695|54695347|FG000|Second Procedure|Withdrawal by Subject|1|||
28037338|NCT00487695|54695348|FG001|Second Procedure|Withdrawal by Subject|2|||
28037339|NCT00487539|54695358|FG000|Overall Study|Adverse Event|3|||
28037340|NCT00487539|54695359|FG001|Overall Study|Adverse Event|2|||
28037341|NCT00487539|54695360|FG002|Overall Study|Adverse Event|1|||
28037342|NCT00487539|54695361|FG003|Overall Study|Adverse Event|1|||
27809228|NCT01403194|54264867|FG000|Overall Study|Lost to Follow-up|8|||
27809229|NCT01403116|54264873|FG000|Overall Study|Adverse Event|7|||
27809230|NCT01403116|54264874|FG001|Overall Study|Adverse Event|4|||
27809231|NCT01403116|54264873|FG000|Overall Study|Lost to Follow-up|7|||
27809232|NCT01403116|54264874|FG001|Overall Study|Lost to Follow-up|5|||
27809233|NCT01403116|54264873|FG000|Overall Study|Withdrawal by Subject|12|||
27809234|NCT01403116|54264874|FG001|Overall Study|Withdrawal by Subject|15|||
27809235|NCT01403116|54264873|FG000|Overall Study|Non-compliance of study drug|3|||
27809236|NCT01403116|54264874|FG001|Overall Study|Non-compliance of study drug|0|||
27939835|NCT01038687|54596191|FG000|Overall Study|Adverse Event|0|||
27939836|NCT01038687|54596192|FG001|Overall Study|Adverse Event|2|||
27809237|NCT01403116|54264873|FG000|Overall Study|Protocol Violation|0|||
27847418|NCT02641392|54340065|FG002|Overall Study|Study Terminated by Sponsor|144|||
27847419|NCT02641392|54340063|FG000|Overall Study|Lack of Efficacy|0|||
27809238|NCT01403116|54264874|FG001|Overall Study|Protocol Violation|1|||
27847420|NCT02641392|54340064|FG001|Overall Study|Lack of Efficacy|0|||
27939837|NCT01038687|54596193|FG002|Overall Study|Adverse Event|1|||
27939838|NCT01081912|54596201|FG000|Conversion/Titration|Adverse Event|47|||
27809239|NCT01403116|54264873|FG000|Overall Study|undisclosed Hx of Prostate Ca|1|||
27809240|NCT01403116|54264874|FG001|Overall Study|undisclosed Hx of Prostate Ca|0|||
27809241|NCT01403116|54264873|FG000|Overall Study|Hct >54%|2|||
27809242|NCT01403116|54264874|FG001|Overall Study|Hct >54%|0|||
27809243|NCT01403116|54264873|FG000|Overall Study|unable to keep appointments|0|||
27809244|NCT01403116|54264874|FG001|Overall Study|unable to keep appointments|2|||
28037343|NCT00487539|54695358|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
28037344|NCT00487539|54695359|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
28037345|NCT00487539|54695360|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
28037346|NCT00487539|54695361|FG003|Overall Study|Unsatisfactory therapeutic effect|1|||
28037347|NCT00487539|54695358|FG000|Overall Study|Other|3|||
28037348|NCT00487539|54695359|FG001|Overall Study|Other|1|||
28037349|NCT00487539|54695360|FG002|Overall Study|Other|2|||
28037350|NCT00487539|54695361|FG003|Overall Study|Other|2|||
28037351|NCT00486837|54695372|FG000|Overall Study|Withdrawal by Subject|1|||
28037352|NCT00486837|54695373|FG001|Overall Study|Withdrawal by Subject|0|||
27809245|NCT01402570|54264880|FG000|Overall Study|Adverse Event|1|||
27809246|NCT01753401|54264887|FG000|Double-blind Period (8 Weeks)|Adverse Event|0|||
27847421|NCT02641392|54340065|FG002|Overall Study|Lack of Efficacy|101|||
27847422|NCT02641392|54340063|FG000|Overall Study|Miscellaneous|0|||
27847423|NCT02641392|54340064|FG001|Overall Study|Miscellaneous|0|||
27847424|NCT02641392|54340065|FG002|Overall Study|Miscellaneous|3|||
27847425|NCT02641392|54340063|FG000|Overall Study|Death|0|||
27847426|NCT02641392|54340064|FG001|Overall Study|Death|0|||
27847427|NCT02641392|54340065|FG002|Overall Study|Death|1|||
27847428|NCT04440007|54340075|FG000|Overall Study|Adverse Event|0|||
27847429|NCT04440007|54340076|FG001|Overall Study|Adverse Event|1|||
27847430|NCT04440007|54340075|FG000|Overall Study|Lost to Follow-up|1|||
28037353|NCT00486837|54695372|FG000|Overall Study|Adverse Event|1|||
27809247|NCT01753401|54264888|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
27809248|NCT01753401|54264889|FG002|Double-blind Period (8 Weeks)|Adverse Event|0|||
27809249|NCT01753401|54264890|FG003|Double-blind Period (8 Weeks)|Adverse Event|0|||
27809250|NCT01753401|54264887|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
27809251|NCT01753401|54264888|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
27809252|NCT01753401|54264889|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
27809253|NCT01753401|54264890|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
27809254|NCT01753401|54264887|FG000|Double-blind Period (8 Weeks)|Protocol Violation|0|||
27809255|NCT01753401|54264888|FG001|Double-blind Period (8 Weeks)|Protocol Violation|1|||
27809256|NCT01753401|54264889|FG002|Double-blind Period (8 Weeks)|Protocol Violation|0|||
27809257|NCT01753401|54264890|FG003|Double-blind Period (8 Weeks)|Protocol Violation|0|||
27809258|NCT01753401|54264887|FG000|Open Label Period (44 Weeks)|Adverse Event|0|||
27809259|NCT01753401|54264888|FG001|Open Label Period (44 Weeks)|Adverse Event|0|||
27809260|NCT01753401|54264889|FG002|Open Label Period (44 Weeks)|Adverse Event|3|||
27809261|NCT01753401|54264890|FG003|Open Label Period (44 Weeks)|Adverse Event|4|||
27809262|NCT01753401|54264887|FG000|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
27809263|NCT01753401|54264888|FG001|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
27809264|NCT01753401|54264889|FG002|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
27809265|NCT01753401|54264890|FG003|Open Label Period (44 Weeks)|Withdrawal by Subject|2|||
27809266|NCT01753401|54264887|FG000|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
27809267|NCT01753401|54264888|FG001|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
27809268|NCT01753401|54264889|FG002|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
27809269|NCT01753401|54264890|FG003|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
27809270|NCT01753401|54264887|FG000|Open Label Period (44 Weeks)|Reason not provided|0|||
27809271|NCT01753401|54264888|FG001|Open Label Period (44 Weeks)|Reason not provided|0|||
27809272|NCT01753401|54264889|FG002|Open Label Period (44 Weeks)|Reason not provided|0|||
27809273|NCT01753401|54264890|FG003|Open Label Period (44 Weeks)|Reason not provided|2|||
27809274|NCT01618916|54264906|FG000|Overall Study|Adverse Event|1|||
27809275|NCT01618916|54264907|FG001|Overall Study|Adverse Event|0|||
27809276|NCT01618916|54264908|FG002|Overall Study|Adverse Event|0|||
27809277|NCT01618916|54264909|FG003|Overall Study|Adverse Event|0|||
27809278|NCT01618916|54264910|FG004|Overall Study|Adverse Event|0|||
27847431|NCT04440007|54340076|FG001|Overall Study|Lost to Follow-up|3|||
28037354|NCT00486837|54695373|FG001|Overall Study|Adverse Event|1|||
28037355|NCT00486837|54695372|FG000|Overall Study|Protocol Violation|4|||
28037356|NCT00486837|54695373|FG001|Overall Study|Protocol Violation|2|||
27809279|NCT01618916|54264911|FG005|Overall Study|Adverse Event|0|||
27809280|NCT01618916|54264906|FG000|Overall Study|Withdrawal by Subject|0|||
27809281|NCT01618916|54264907|FG001|Overall Study|Withdrawal by Subject|1|||
28037357|NCT00486837|54695372|FG000|Overall Study|No sputum, devise issues, exacerbation|3|||
28037358|NCT00486837|54695373|FG001|Overall Study|No sputum, devise issues, exacerbation|4|||
27809282|NCT01618916|54264908|FG002|Overall Study|Withdrawal by Subject|1|||
27809283|NCT01618916|54264909|FG003|Overall Study|Withdrawal by Subject|0|||
27847432|NCT04440007|54340075|FG000|Overall Study|Death|7|||
27847433|NCT04440007|54340076|FG001|Overall Study|Death|2|||
27847434|NCT04440007|54340075|FG000|Overall Study|Physician Decision|1|||
28037359|NCT00486759|54695383|FG000|Treatment|Adverse event/intercurrent illness|86|||
28037360|NCT00486759|54695384|FG001|Treatment|Adverse event/intercurrent illness|39|||
28037361|NCT00486759|54695383|FG000|Treatment|Insufficient therapeutic response|37|||
28037362|NCT00486759|54695384|FG001|Treatment|Insufficient therapeutic response|39|||
28037363|NCT00486759|54695383|FG000|Treatment|Death|17|||
28037364|NCT00486759|54695384|FG001|Treatment|Death|10|||
28037365|NCT00486759|54695383|FG000|Treatment|Withdrew consent|15|||
28037366|NCT00486759|54695384|FG001|Treatment|Withdrew consent|12|||
28037367|NCT00486759|54695383|FG000|Treatment|Administrative/reason not specified|17|||
28037368|NCT00486759|54695384|FG001|Treatment|Administrative/reason not specified|21|||
28037369|NCT00486759|54695383|FG000|Treatment|Refused treatment|10|||
28037370|NCT00486759|54695384|FG001|Treatment|Refused treatment|7|||
28037371|NCT00486759|54695383|FG000|Treatment|Violation of selection criteria at entry|3|||
28037372|NCT00486759|54695384|FG001|Treatment|Violation of selection criteria at entry|3|||
28037373|NCT00486759|54695383|FG000|Treatment|Other protocol violation|1|||
28037374|NCT00486759|54695384|FG001|Treatment|Other protocol violation|5|||
28037375|NCT00486759|54695383|FG000|Treatment|Failure to return|1|||
28037376|NCT00486759|54695384|FG001|Treatment|Failure to return|1|||
28037377|NCT00486759|54695383|FG000|Safety Follow-up|Insufficient therapeutic response|40|||
28037378|NCT00486759|54695384|FG001|Safety Follow-up|Insufficient therapeutic response|50|||
28037379|NCT00486759|54695383|FG000|Safety Follow-up|Death|40|||
28037380|NCT00486759|54695384|FG001|Safety Follow-up|Death|29|||
28037381|NCT00486759|54695383|FG000|Safety Follow-up|Withdrew consent|32|||
28037382|NCT00486759|54695384|FG001|Safety Follow-up|Withdrew consent|23|||
28037383|NCT00486759|54695383|FG000|Safety Follow-up|Failure to return|9|||
28037384|NCT00486759|54695384|FG001|Safety Follow-up|Failure to return|6|||
28037385|NCT00486759|54695383|FG000|Safety Follow-up|Administrative/not specified|8|||
28037386|NCT00486759|54695384|FG001|Safety Follow-up|Administrative/not specified|6|||
28037387|NCT00486759|54695383|FG000|Safety Follow-up|Refused treatment/did not cooperate|6|||
28037388|NCT00486759|54695384|FG001|Safety Follow-up|Refused treatment/did not cooperate|4|||
28037389|NCT00486759|54695383|FG000|Safety Follow-up|Adverse event/intercurrent illness|4|||
28037390|NCT00486759|54695384|FG001|Safety Follow-up|Adverse event/intercurrent illness|0|||
28037391|NCT00486603|54695392|FG000|Overall Study|Withdrawal by Subject|1|||
28037392|NCT00486603|54695393|FG001|Overall Study|Withdrawal by Subject|0|||
28037393|NCT00486603|54695394|FG002|Overall Study|Withdrawal by Subject|0|||
28037394|NCT00486603|54695395|FG003|Overall Study|Withdrawal by Subject|0|||
28037395|NCT00486603|54695396|FG004|Overall Study|Withdrawal by Subject|0|||
28037396|NCT00486603|54695392|FG000|Overall Study|Physician Decision|0|||
28037397|NCT00486603|54695393|FG001|Overall Study|Physician Decision|1|||
28037398|NCT00486603|54695394|FG002|Overall Study|Physician Decision|0|||
28037399|NCT00486603|54695395|FG003|Overall Study|Physician Decision|0|||
28037400|NCT00486603|54695396|FG004|Overall Study|Physician Decision|0|||
28037401|NCT00486291|54695413|FG000|Overall Study|Adverse Event|3|||
28037402|NCT00486291|54695414|FG001|Overall Study|Adverse Event|4|||
28037403|NCT00486291|54695413|FG000|Overall Study|Lost to Follow-up|3|||
28037404|NCT00486291|54695414|FG001|Overall Study|Lost to Follow-up|7|||
28037405|NCT00486291|54695413|FG000|Overall Study|protocol non-compliance|10|||
28037406|NCT00486291|54695414|FG001|Overall Study|protocol non-compliance|15|||
28037407|NCT00486291|54695413|FG000|Overall Study|requirement for restricted medication|0|||
28037408|NCT00486291|54695414|FG001|Overall Study|requirement for restricted medication|3|||
28037409|NCT00474045|54695422|FG000|Overall Study|Adverse Event|18|||
28037410|NCT00474045|54695423|FG001|Overall Study|Adverse Event|8|||
28037411|NCT00474045|54695422|FG000|Overall Study|Unclassified|1|||
28037412|NCT00474045|54695423|FG001|Overall Study|Unclassified|3|||
28037413|NCT00474045|54695422|FG000|Overall Study|Lack of Efficacy|0|||
28037414|NCT00474045|54695423|FG001|Overall Study|Lack of Efficacy|9|||
28037415|NCT00474045|54695422|FG000|Overall Study|Lost to Follow-up|1|||
28037416|NCT00474045|54695423|FG001|Overall Study|Lost to Follow-up|1|||
28037417|NCT00474045|54695422|FG000|Overall Study|Protocol Violation|10|||
28037418|NCT00474045|54695423|FG001|Overall Study|Protocol Violation|12|||
28037419|NCT00474045|54695422|FG000|Overall Study|Withdrawal by Subject|16|||
28037420|NCT00474045|54695423|FG001|Overall Study|Withdrawal by Subject|18|||
28037421|NCT00474045|54695422|FG000|Overall Study|Withdrawal criteria|60|||
28037422|NCT00474045|54695423|FG001|Overall Study|Withdrawal criteria|50|||
28037423|NCT00462501|54695429|FG000|Overall Study|Not treated|3|||
27809284|NCT01618916|54264910|FG004|Overall Study|Withdrawal by Subject|1|||
27809285|NCT01618916|54264911|FG005|Overall Study|Withdrawal by Subject|0|||
27809286|NCT01618916|54264906|FG000|Overall Study|Lost to Follow-up|1|||
27809287|NCT01618916|54264907|FG001|Overall Study|Lost to Follow-up|0|||
27809288|NCT01618916|54264908|FG002|Overall Study|Lost to Follow-up|0|||
27809289|NCT01618916|54264909|FG003|Overall Study|Lost to Follow-up|2|||
27809290|NCT01618916|54264910|FG004|Overall Study|Lost to Follow-up|0|||
28037424|NCT00462501|54695429|FG000|Overall Study|Adverse Event|2|||
27809291|NCT01618916|54264911|FG005|Overall Study|Lost to Follow-up|0|||
27809292|NCT01753323|54264927|FG000|Overall Study|Lack of Efficacy|0|||
27809293|NCT01753323|54264928|FG001|Overall Study|Lack of Efficacy|0|||
28037425|NCT00383188|54695438|FG000|Overall Study|Adverse Event|4|||
28037426|NCT00383188|54695439|FG001|Overall Study|Adverse Event|7|||
28037427|NCT00383188|54695440|FG002|Overall Study|Adverse Event|9|||
28037428|NCT00383188|54695441|FG003|Overall Study|Adverse Event|8|||
28037429|NCT00383188|54695442|FG004|Overall Study|Adverse Event|8|||
28037430|NCT00383188|54695438|FG000|Overall Study|Lack of Efficacy|9|||
28037431|NCT00383188|54695439|FG001|Overall Study|Lack of Efficacy|3|||
28037432|NCT00383188|54695440|FG002|Overall Study|Lack of Efficacy|3|||
28037433|NCT00383188|54695441|FG003|Overall Study|Lack of Efficacy|2|||
28037434|NCT00383188|54695442|FG004|Overall Study|Lack of Efficacy|6|||
28037435|NCT00383188|54695438|FG000|Overall Study|Other|3|||
28037436|NCT00383188|54695439|FG001|Overall Study|Other|1|||
28037437|NCT00383188|54695440|FG002|Overall Study|Other|0|||
28037438|NCT00383188|54695441|FG003|Overall Study|Other|2|||
28037439|NCT00383188|54695442|FG004|Overall Study|Other|6|||
28037440|NCT00383188|54695438|FG000|Overall Study|No longer willing to participate|1|||
28037441|NCT00383188|54695439|FG001|Overall Study|No longer willing to participate|0|||
28037442|NCT00383188|54695440|FG002|Overall Study|No longer willing to participate|1|||
28037443|NCT00383188|54695441|FG003|Overall Study|No longer willing to participate|0|||
28037444|NCT00383188|54695442|FG004|Overall Study|No longer willing to participate|2|||
28037445|NCT00383188|54695438|FG000|Overall Study|Lost to Follow-up|0|||
28037446|NCT00383188|54695439|FG001|Overall Study|Lost to Follow-up|0|||
28037447|NCT00383188|54695440|FG002|Overall Study|Lost to Follow-up|0|||
28037448|NCT00383188|54695441|FG003|Overall Study|Lost to Follow-up|0|||
28037449|NCT00383188|54695442|FG004|Overall Study|Lost to Follow-up|1|||
28037450|NCT00462345|54695456|FG000|Overall Study|Withdrawal by Subject|2|||
28037451|NCT00462345|54695456|FG000|Overall Study|Did not complete second course|1|||
28037452|NCT00453999|54695463|FG000|Overall Study|Adverse Event|1|||
28037453|NCT00453999|54695464|FG001|Overall Study|Adverse Event|2|||
28037454|NCT00453999|54695465|FG002|Overall Study|Adverse Event|1|||
28037455|NCT00453999|54695463|FG000|Overall Study|Lost to Follow-up|0|||
28037456|NCT00453999|54695464|FG001|Overall Study|Lost to Follow-up|1|||
28037457|NCT00453999|54695465|FG002|Overall Study|Lost to Follow-up|1|||
28037458|NCT00453999|54695463|FG000|Overall Study|Withdrawal by Subject|2|||
28037459|NCT00453999|54695464|FG001|Overall Study|Withdrawal by Subject|1|||
28037460|NCT00453999|54695465|FG002|Overall Study|Withdrawal by Subject|1|||
28037461|NCT00453999|54695463|FG000|Overall Study|Subject Request|2|||
28037462|NCT00453999|54695464|FG001|Overall Study|Subject Request|1|||
28037463|NCT00453999|54695465|FG002|Overall Study|Subject Request|0|||
28037464|NCT00453921|54695478|FG000|Overall Study|Withdrawal by Subject|1|||
28037465|NCT00453921|54695479|FG001|Overall Study|Withdrawal by Subject|1|||
28037466|NCT00453921|54695480|FG002|Overall Study|Withdrawal by Subject|1|||
28037467|NCT00453921|54695481|FG003|Overall Study|Withdrawal by Subject|1|||
28037468|NCT00453921|54695478|FG000|Overall Study|Lost to Follow-up|0|||
28037469|NCT00453921|54695479|FG001|Overall Study|Lost to Follow-up|0|||
28037470|NCT00453921|54695480|FG002|Overall Study|Lost to Follow-up|1|||
28037471|NCT00453921|54695481|FG003|Overall Study|Lost to Follow-up|0|||
28037472|NCT00382720|54695498|FG000|Overall Study|Adverse Event|21|||
28037473|NCT00382720|54695499|FG001|Overall Study|Adverse Event|23|||
28037474|NCT00382720|54695500|FG002|Overall Study|Adverse Event|15|||
28037475|NCT00382720|54695498|FG000|Overall Study|Protocol Violation|2|||
28037476|NCT00382720|54695499|FG001|Overall Study|Protocol Violation|5|||
28037477|NCT00382720|54695500|FG002|Overall Study|Protocol Violation|1|||
28037478|NCT00382720|54695498|FG000|Overall Study|Death|0|||
28037479|NCT00382720|54695499|FG001|Overall Study|Death|1|||
28037480|NCT00382720|54695500|FG002|Overall Study|Death|2|||
28037481|NCT00382720|54695498|FG000|Overall Study|Progressive disease|37|||
28037482|NCT00382720|54695499|FG001|Overall Study|Progressive disease|28|||
28037483|NCT00382720|54695500|FG002|Overall Study|Progressive disease|38|||
28037484|NCT00382720|54695498|FG000|Overall Study|Withdrew consent|1|||
28037485|NCT00382720|54695499|FG001|Overall Study|Withdrew consent|1|||
28037486|NCT00382720|54695500|FG002|Overall Study|Withdrew consent|2|||
28037487|NCT00382720|54695498|FG000|Overall Study|Withdrawal by Subject|11|||
28037488|NCT00382720|54695499|FG001|Overall Study|Withdrawal by Subject|20|||
28037489|NCT00382720|54695500|FG002|Overall Study|Withdrawal by Subject|12|||
28037490|NCT00382720|54695498|FG000|Overall Study|Surgery|1|||
27809294|NCT01753323|54264929|FG002|Overall Study|Lack of Efficacy|8|||
28037491|NCT00382720|54695499|FG001|Overall Study|Surgery|1|||
28037492|NCT00382720|54695500|FG002|Overall Study|Surgery|4|||
28037493|NCT00382720|54695498|FG000|Overall Study|Patient did not receive study medication|1|||
27939839|NCT01081912|54596202|FG001|Conversion/Titration|Adverse Event|0|||
28037494|NCT00382720|54695499|FG001|Overall Study|Patient did not receive study medication|1|||
28037495|NCT00382720|54695500|FG002|Overall Study|Patient did not receive study medication|4|||
28037496|NCT00382720|54695498|FG000|Overall Study|Clinically progressive disease|0|||
28037497|NCT00382720|54695499|FG001|Overall Study|Clinically progressive disease|1|||
28037498|NCT00382720|54695500|FG002|Overall Study|Clinically progressive disease|0|||
28037499|NCT00382720|54695498|FG000|Overall Study|Good prognosis|0|||
28037500|NCT00382720|54695499|FG001|Overall Study|Good prognosis|1|||
28037501|NCT00382720|54695500|FG002|Overall Study|Good prognosis|0|||
28037502|NCT00382720|54695498|FG000|Overall Study|Investigator/Clinical decision|5|||
28037503|NCT00382720|54695499|FG001|Overall Study|Investigator/Clinical decision|6|||
28037504|NCT00382720|54695500|FG002|Overall Study|Investigator/Clinical decision|6|||
28037505|NCT00382720|54695498|FG000|Overall Study|Discontinued at end of study|0|||
28037506|NCT00382720|54695499|FG001|Overall Study|Discontinued at end of study|1|||
28037507|NCT00382720|54695500|FG002|Overall Study|Discontinued at end of study|2|||
28037508|NCT00453063|54695510|FG000|Overall Study|Adverse Event|1|||
28037509|NCT00453063|54695511|FG001|Overall Study|Adverse Event|2|||
28037510|NCT00453063|54695510|FG000|Overall Study|Withdrawal by Subject|1|||
28037511|NCT00453063|54695511|FG001|Overall Study|Withdrawal by Subject|1|||
28037512|NCT00453063|54695510|FG000|Overall Study|Protocol Violation|1|||
28037513|NCT00453063|54695511|FG001|Overall Study|Protocol Violation|0|||
28037514|NCT00371566|54695519|FG000|Treatment Phase|Withdrawal by Subject|0|||
28037515|NCT00371566|54695520|FG001|Treatment Phase|Withdrawal by Subject|1|||
28037516|NCT00371566|54695519|FG000|Treatment Phase|Adverse Event|0|||
28037517|NCT00371566|54695520|FG001|Treatment Phase|Adverse Event|1|||
28037518|NCT00371566|54695519|FG000|Treatment Phase|Protocol Violation|0|||
28037519|NCT00371566|54695520|FG001|Treatment Phase|Protocol Violation|1|||
28037520|NCT00371566|54695519|FG000|Chemoradiation Phase|Physician Decision|2|||
28037521|NCT00371566|54695520|FG001|Chemoradiation Phase|Physician Decision|0|||
28037522|NCT00371566|54695519|FG000|Chemoradiation Phase|Withdrawal by Subject|0|||
28037523|NCT00371566|54695520|FG001|Chemoradiation Phase|Withdrawal by Subject|1|||
28037524|NCT00371566|54695519|FG000|Chemoradiation Phase|Non compliant|0|||
28037525|NCT00371566|54695520|FG001|Chemoradiation Phase|Non compliant|1|||
28037526|NCT00371566|54695519|FG000|Chemoradiation Phase|Progressive Disease|1|||
28037527|NCT00371566|54695520|FG001|Chemoradiation Phase|Progressive Disease|1|||
28037528|NCT00371566|54695519|FG000|Chemoradiation Phase|Death|2|||
28037529|NCT00371566|54695520|FG001|Chemoradiation Phase|Death|0|||
28037530|NCT00371566|54695519|FG000|Follow Up Phase|Death|0|||
28037531|NCT00371566|54695520|FG001|Follow Up Phase|Death|5|||
28037532|NCT00371566|54695519|FG000|Follow Up Phase|Disease progression|1|||
28037533|NCT00371566|54695520|FG001|Follow Up Phase|Disease progression|0|||
28037534|NCT00371566|54695519|FG000|Follow Up Phase|Withdrawal by Subject|0|||
28037535|NCT00371566|54695520|FG001|Follow Up Phase|Withdrawal by Subject|1|||
28037536|NCT00371566|54695519|FG000|Follow Up Phase|Physician Decision|1|||
28037537|NCT00371566|54695520|FG001|Follow Up Phase|Physician Decision|1|||
28037538|NCT00371566|54695519|FG000|Follow Up Phase|Lost to Follow-up|1|||
28037539|NCT00371566|54695520|FG001|Follow Up Phase|Lost to Follow-up|0|||
28037540|NCT00382408|54695528|FG000|Overall Study|Did not meet protocol requirement|3|||
28105673|NCT04461015|54763217|FG001|Overall Study|Withdrawal by Subject|1|||
27809295|NCT01753323|54264927|FG000|Overall Study|Protocol deviation|1|||
27809296|NCT01753323|54264928|FG001|Overall Study|Protocol deviation|0|||
27809297|NCT01753323|54264929|FG002|Overall Study|Protocol deviation|0|||
27809298|NCT01753323|54264927|FG000|Overall Study|Adverse Event|0|||
27809299|NCT01753323|54264928|FG001|Overall Study|Adverse Event|0|||
27809300|NCT01753323|54264929|FG002|Overall Study|Adverse Event|1|||
27809301|NCT01894568|54264940|FG000|Overall Study|Adverse Event|2|||
27809302|NCT01894568|54264941|FG001|Overall Study|Adverse Event|3|||
27809303|NCT01894568|54264940|FG000|Overall Study|Protocol required discontinuation|2|||
27809304|NCT01894568|54264941|FG001|Overall Study|Protocol required discontinuation|1|||
27809305|NCT01894568|54264940|FG000|Overall Study|Withdrawal by Subject|5|||
27809306|NCT01894568|54264941|FG001|Overall Study|Withdrawal by Subject|5|||
27809307|NCT01894568|54264940|FG000|Overall Study|Physician Decision|1|||
27809308|NCT01894568|54264941|FG001|Overall Study|Physician Decision|0|||
27809309|NCT01894568|54264940|FG000|Overall Study|Lost to Follow-up|0|||
27809310|NCT01894568|54264941|FG001|Overall Study|Lost to Follow-up|1|||
27809311|NCT01618838|54264948|FG000|Overall Study|slow accrual, trial closed prematurely.|4|||
27809312|NCT01920152|54264955|FG000|Overall Study|Withdrawal by Subject|1|||
27809313|NCT01920152|54264956|FG001|Overall Study|Withdrawal by Subject|2|||
27809314|NCT01752933|54264964|FG000|Treatment|Disease Progression|3|||
27809315|NCT01752933|54264965|FG001|Treatment|Disease Progression|29|||
27809316|NCT01752933|54264964|FG000|Treatment|Withdrawal by Subject|0|||
27809317|NCT01752933|54264965|FG001|Treatment|Withdrawal by Subject|5|||
27809318|NCT01752933|54264964|FG000|Treatment|Adverse Event|1|||
27809319|NCT01752933|54264965|FG001|Treatment|Adverse Event|4|||
27809320|NCT01752933|54264964|FG000|Treatment|Physician Decision|0|||
27809321|NCT01752933|54264965|FG001|Treatment|Physician Decision|3|||
27809322|NCT01752933|54264964|FG000|Treatment|Death|0|||
27809323|NCT01752933|54264965|FG001|Treatment|Death|2|||
27809324|NCT01752933|54264964|FG000|Treatment|Hepatocellular carcinoma not confirmed|0|||
27809325|NCT01752933|54264965|FG001|Treatment|Hepatocellular carcinoma not confirmed|1|||
27809326|NCT01752933|54264964|FG000|Treatment|Patient noncompliant|0|||
27809327|NCT01752933|54264965|FG001|Treatment|Patient noncompliant|1|||
27809328|NCT01752933|54264964|FG000|Treatment|Patient unable to travel to appointments|0|||
27809329|NCT01752933|54264965|FG001|Treatment|Patient unable to travel to appointments|1|||
28037541|NCT00382408|54695529|FG001|Overall Study|Did not meet protocol requirement|3|||
28037542|NCT00382408|54695528|FG000|Overall Study|Protocol Violation|2|||
28037543|NCT00382408|54695529|FG001|Overall Study|Protocol Violation|2|||
27809330|NCT01752933|54264964|FG000|Overall Study and Follow-up|Death|4|||
27809331|NCT01752933|54264965|FG001|Overall Study and Follow-up|Death|34|||
27809332|NCT01752933|54264964|FG000|Overall Study and Follow-up|Sponsor terminated study/Database lock|0|||
27809333|NCT01752933|54264965|FG001|Overall Study and Follow-up|Sponsor terminated study/Database lock|7|||
27809334|NCT01752933|54264964|FG000|Overall Study and Follow-up|Withdrawal by Subject|0|||
27809335|NCT01752933|54264965|FG001|Overall Study and Follow-up|Withdrawal by Subject|3|||
27809336|NCT01752933|54264964|FG000|Overall Study and Follow-up|Lost to Follow-up|0|||
27809337|NCT01752933|54264965|FG001|Overall Study and Follow-up|Lost to Follow-up|2|||
27809338|NCT01752855|54264974|FG000|Overall Study|Adverse Event|1|||
27809339|NCT01752855|54264975|FG001|Overall Study|Adverse Event|0|||
27809340|NCT01752855|54264974|FG000|Overall Study|Withdrew Consent|0|||
27809341|NCT01752855|54264975|FG001|Overall Study|Withdrew Consent|2|||
27809342|NCT01752855|54264974|FG000|Overall Study|Lack of Efficacy|0|||
27809343|NCT01752855|54264975|FG001|Overall Study|Lack of Efficacy|2|||
27809344|NCT01402492|54264984|FG000|Overall Study|Withdrawal by Subject|17|||
27809345|NCT01402492|54264985|FG001|Overall Study|Withdrawal by Subject|11|||
27847435|NCT04440007|54340076|FG001|Overall Study|Physician Decision|1|||
27847436|NCT04440007|54340075|FG000|Overall Study|Withdrawal by Subject|2|||
27847437|NCT04440007|54340076|FG001|Overall Study|Withdrawal by Subject|1|||
27847438|NCT04440007|54340075|FG000|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|1|||
27847439|NCT04440007|54340076|FG001|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|2|||
27847440|NCT04440007|54340075|FG000|Overall Study|Discontinued prior to dosing|0|||
27847441|NCT04440007|54340076|FG001|Overall Study|Discontinued prior to dosing|2|||
27847442|NCT01391507|54340095|FG000|Overall Study|Death|0|||
27847443|NCT01391507|54340096|FG001|Overall Study|Death|0|||
27847444|NCT01391507|54340097|FG002|Overall Study|Death|0|||
27809346|NCT01402492|54264986|FG002|Overall Study|Withdrawal by Subject|11|||
27809347|NCT01402492|54264984|FG000|Overall Study|Adverse Event|2|||
27809348|NCT01402492|54264985|FG001|Overall Study|Adverse Event|3|||
27809349|NCT01402492|54264986|FG002|Overall Study|Adverse Event|4|||
27809350|NCT01402492|54264984|FG000|Overall Study|Physician Decision|0|||
27809351|NCT01402492|54264985|FG001|Overall Study|Physician Decision|3|||
27809352|NCT01402492|54264986|FG002|Overall Study|Physician Decision|0|||
27809353|NCT01402492|54264984|FG000|Overall Study|Incarcerated (N=3)|2|||
27809354|NCT01402492|54264985|FG001|Overall Study|Incarcerated (N=3)|0|||
27809355|NCT01402492|54264986|FG002|Overall Study|Incarcerated (N=3)|1|||
27809356|NCT01402102|54264996|FG000|Overall Study|Protocol Violation|1|||
27809357|NCT01402102|54264997|FG001|Overall Study|Protocol Violation|0|||
27809358|NCT01402102|54264996|FG000|Overall Study|Insufficiency of compliance|1|||
27809359|NCT01402102|54264997|FG001|Overall Study|Insufficiency of compliance|1|||
27847445|NCT01391507|54340098|FG003|Overall Study|Death|1|||
27847446|NCT01391507|54340095|FG000|Overall Study|Adverse Event|1|||
27809360|NCT01402102|54264996|FG000|Overall Study|Withdrawal by Subject|0|||
27809361|NCT01402102|54264997|FG001|Overall Study|Withdrawal by Subject|2|||
27809362|NCT01423084|54265007|FG000|Overall Study|Adverse Event|0|||
27809363|NCT01423084|54265008|FG001|Overall Study|Adverse Event|1|||
27809364|NCT01423084|54265007|FG000|Overall Study|Withdrawal by Subject|2|||
27809365|NCT01423084|54265008|FG001|Overall Study|Withdrawal by Subject|3|||
27809366|NCT01894256|54265018|FG000|Part A|Adverse Event|0|||
27809367|NCT01894256|54265019|FG001|Part A|Adverse Event|1|||
27809368|NCT01894256|54265020|FG002|Part A|Adverse Event|0|||
27809369|NCT01894256|54265018|FG000|Part B|Death|0|||
27809370|NCT01894256|54265019|FG001|Part B|Death|1|||
27809371|NCT01894256|54265020|FG002|Part B|Death|1|||
27809372|NCT01894256|54265018|FG000|Part B|Withdrawal by Subject|0|||
27809373|NCT01894256|54265019|FG001|Part B|Withdrawal by Subject|1|||
27809374|NCT01894256|54265020|FG002|Part B|Withdrawal by Subject|0|||
27809375|NCT01894256|54265018|FG000|Part B|Lack of Efficacy|15|||
27809376|NCT01894256|54265019|FG001|Part B|Lack of Efficacy|12|||
27809377|NCT01894256|54265020|FG002|Part B|Lack of Efficacy|13|||
27809378|NCT01780935|54265033|FG000|Overall Study|Admin problems due to early termination|321|||
27809379|NCT01780935|54265034|FG001|Overall Study|Admin problems due to early termination|309|||
27809380|NCT01780935|54265033|FG000|Overall Study|Adverse Event|2|||
27809381|NCT01780935|54265034|FG001|Overall Study|Adverse Event|4|||
27809382|NCT01780935|54265033|FG000|Overall Study|Death|1|||
27809383|NCT01780935|54265034|FG001|Overall Study|Death|6|||
27809384|NCT01780935|54265033|FG000|Overall Study|Lost to Follow-up|2|||
27809385|NCT01780935|54265034|FG001|Overall Study|Lost to Follow-up|6|||
27809386|NCT01780935|54265033|FG000|Overall Study|Physician Decision|1|||
27809387|NCT01780935|54265034|FG001|Overall Study|Physician Decision|1|||
27809388|NCT01780935|54265033|FG000|Overall Study|Protocol deviation|0|||
27809389|NCT01780935|54265034|FG001|Overall Study|Protocol deviation|1|||
27847447|NCT01391507|54340096|FG001|Overall Study|Adverse Event|1|||
27809390|NCT01780935|54265033|FG000|Overall Study|Patient withdrew consent|8|||
27809391|NCT01780935|54265034|FG001|Overall Study|Patient withdrew consent|9|||
27809392|NCT01894100|54265042|FG000|Overall Study|Lost to Follow-up|0|||
27809393|NCT01894100|54265043|FG001|Overall Study|Lost to Follow-up|1|||
27809394|NCT01894100|54265042|FG000|Overall Study|Withdrawal by Subject|3|||
27847448|NCT01391507|54340097|FG002|Overall Study|Adverse Event|2|||
27847449|NCT01391507|54340098|FG003|Overall Study|Adverse Event|2|||
27847450|NCT01391507|54340095|FG000|Overall Study|Withdrawal by Subject|1|||
27847451|NCT01391507|54340096|FG001|Overall Study|Withdrawal by Subject|2|||
27847452|NCT01391507|54340097|FG002|Overall Study|Withdrawal by Subject|1|||
27847453|NCT01391507|54340098|FG003|Overall Study|Withdrawal by Subject|1|||
27847454|NCT01391507|54340095|FG000|Overall Study|Lack of Efficacy|0|||
27847455|NCT01391507|54340096|FG001|Overall Study|Lack of Efficacy|0|||
27847456|NCT01391507|54340097|FG002|Overall Study|Lack of Efficacy|0|||
27847457|NCT01391507|54340098|FG003|Overall Study|Lack of Efficacy|1|||
27847458|NCT01391507|54340095|FG000|Overall Study|Protocol Violation|2|||
27847459|NCT01391507|54340096|FG001|Overall Study|Protocol Violation|1|||
27847460|NCT01391507|54340097|FG002|Overall Study|Protocol Violation|1|||
27847461|NCT01391507|54340098|FG003|Overall Study|Protocol Violation|2|||
27847462|NCT01473524|54340120|FG000|DB Phase|Adverse Event|4|||
27847463|NCT01473524|54340121|FG001|DB Phase|Adverse Event|8|||
27847464|NCT01473524|54340122|FG002|DB Phase|Adverse Event|2|||
27847465|NCT01473524|54340123|FG003|DB Phase|Adverse Event|0|||
27847466|NCT01473524|54340124|FG004|DB Phase|Adverse Event|0|||
27847467|NCT01473524|54340125|FG005|DB Phase|Adverse Event|0|||
27847468|NCT01473524|54340120|FG000|DB Phase|Death|1|||
27847469|NCT01473524|54340121|FG001|DB Phase|Death|0|||
27847470|NCT01473524|54340122|FG002|DB Phase|Death|0|||
27847471|NCT01473524|54340123|FG003|DB Phase|Death|0|||
27847472|NCT01473524|54340124|FG004|DB Phase|Death|0|||
27847473|NCT01473524|54340125|FG005|DB Phase|Death|0|||
27847474|NCT01473524|54340120|FG000|DB Phase|Withdrawal by Subject|2|||
27847475|NCT01473524|54340121|FG001|DB Phase|Withdrawal by Subject|1|||
27847476|NCT01473524|54340122|FG002|DB Phase|Withdrawal by Subject|1|||
27847477|NCT01473524|54340123|FG003|DB Phase|Withdrawal by Subject|0|||
27847478|NCT01473524|54340124|FG004|DB Phase|Withdrawal by Subject|0|||
27847479|NCT01473524|54340125|FG005|DB Phase|Withdrawal by Subject|0|||
27847480|NCT01473524|54340120|FG000|LTSE Phase|Withdrawal by Subject|0|||
27847481|NCT01473524|54340121|FG001|LTSE Phase|Withdrawal by Subject|0|||
27847482|NCT01473524|54340122|FG002|LTSE Phase|Withdrawal by Subject|0|||
27847483|NCT01473524|54340123|FG003|LTSE Phase|Withdrawal by Subject|3|||
27847484|NCT01473524|54340124|FG004|LTSE Phase|Withdrawal by Subject|3|||
27847485|NCT01473524|54340125|FG005|LTSE Phase|Withdrawal by Subject|6|||
27847486|NCT01473524|54340120|FG000|LTSE Phase|Death|0|||
27847487|NCT01473524|54340121|FG001|LTSE Phase|Death|0|||
27847488|NCT01473524|54340122|FG002|LTSE Phase|Death|0|||
27847489|NCT01473524|54340123|FG003|LTSE Phase|Death|0|||
27847490|NCT01473524|54340124|FG004|LTSE Phase|Death|1|||
27847491|NCT01473524|54340125|FG005|LTSE Phase|Death|0|||
27847492|NCT01473524|54340120|FG000|LTSE Phase|Adverse Event of Pruritus|0|||
27847493|NCT01473524|54340121|FG001|LTSE Phase|Adverse Event of Pruritus|0|||
27847494|NCT01473524|54340122|FG002|LTSE Phase|Adverse Event of Pruritus|0|||
27847495|NCT01473524|54340123|FG003|LTSE Phase|Adverse Event of Pruritus|1|||
27847496|NCT01473524|54340124|FG004|LTSE Phase|Adverse Event of Pruritus|5|||
27847497|NCT01473524|54340125|FG005|LTSE Phase|Adverse Event of Pruritus|2|||
27847498|NCT01473524|54340120|FG000|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
27847499|NCT01473524|54340121|FG001|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
27847500|NCT01473524|54340122|FG002|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
27847501|NCT01473524|54340123|FG003|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2|||
27847502|NCT01473524|54340124|FG004|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4|||
27847503|NCT01473524|54340125|FG005|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6|||
27847504|NCT01473524|54340120|FG000|LTSE Phase|Lost to Follow-up|0|||
27847505|NCT01473524|54340121|FG001|LTSE Phase|Lost to Follow-up|0|||
27847506|NCT01473524|54340122|FG002|LTSE Phase|Lost to Follow-up|0|||
27847507|NCT01473524|54340123|FG003|LTSE Phase|Lost to Follow-up|1|||
27847508|NCT01473524|54340124|FG004|LTSE Phase|Lost to Follow-up|3|||
27847509|NCT01473524|54340125|FG005|LTSE Phase|Lost to Follow-up|2|||
27847510|NCT01473524|54340120|FG000|LTSE Phase|Principal Investigator Decision|0|||
27847511|NCT01473524|54340121|FG001|LTSE Phase|Principal Investigator Decision|0|||
27847512|NCT01473524|54340122|FG002|LTSE Phase|Principal Investigator Decision|0|||
27847513|NCT01473524|54340123|FG003|LTSE Phase|Principal Investigator Decision|1|||
27847514|NCT01473524|54340124|FG004|LTSE Phase|Principal Investigator Decision|1|||
27847515|NCT01473524|54340125|FG005|LTSE Phase|Principal Investigator Decision|3|||
27847516|NCT01473524|54340120|FG000|LTSE Phase|Liver Transplantation|0|||
27847517|NCT01473524|54340121|FG001|LTSE Phase|Liver Transplantation|0|||
27847518|NCT01473524|54340122|FG002|LTSE Phase|Liver Transplantation|0|||
27847519|NCT01473524|54340123|FG003|LTSE Phase|Liver Transplantation|0|||
27847520|NCT01473524|54340124|FG004|LTSE Phase|Liver Transplantation|0|||
27847521|NCT01473524|54340125|FG005|LTSE Phase|Liver Transplantation|1|||
27847522|NCT01473524|54340120|FG000|LTSE Phase|Pregnancy|0|||
27847523|NCT01473524|54340121|FG001|LTSE Phase|Pregnancy|0|||
27847524|NCT01473524|54340122|FG002|LTSE Phase|Pregnancy|0|||
27847525|NCT01473524|54340123|FG003|LTSE Phase|Pregnancy|1|||
27847526|NCT01473524|54340124|FG004|LTSE Phase|Pregnancy|0|||
27847527|NCT01473524|54340125|FG005|LTSE Phase|Pregnancy|0|||
27847528|NCT01473524|54340120|FG000|LTSE Phase|Protocol Violation|0|||
27809395|NCT01894100|54265043|FG001|Overall Study|Withdrawal by Subject|0|||
27809396|NCT01401478|54265089|FG000|Overall Study|Study drug not available|6|||
27809397|NCT01401478|54265089|FG000|Overall Study|Adverse Event|5|||
27809398|NCT01401478|54265089|FG000|Overall Study|Hyperphosphatemia|5|||
27809399|NCT01401478|54265089|FG000|Overall Study|Lost to Follow-up|5|||
27809400|NCT01401478|54265089|FG000|Overall Study|Kidney transplantation|3|||
27809401|NCT01401478|54265089|FG000|Overall Study|Withdrawal by Subject|3|||
27809402|NCT01401478|54265089|FG000|Overall Study|Blood samples not available|1|||
27847529|NCT01473524|54340121|FG001|LTSE Phase|Protocol Violation|0|||
27847530|NCT01473524|54340122|FG002|LTSE Phase|Protocol Violation|0|||
27847531|NCT01473524|54340123|FG003|LTSE Phase|Protocol Violation|0|||
27847532|NCT01473524|54340124|FG004|LTSE Phase|Protocol Violation|0|||
27847533|NCT01473524|54340125|FG005|LTSE Phase|Protocol Violation|1|||
27847534|NCT01390649|54340156|FG000|Overall Study|Physician Decision|1|||
27847535|NCT01390181|54340160|FG000|Overall Study|Lost to Follow-up|1|||
27847536|NCT01390181|54340160|FG000|Overall Study|Study Terminated due to Low Accrual|3|||
27847537|NCT02641080|54340166|FG000|Overall Study|Physician Decision|2|||
27847538|NCT02641080|54340167|FG001|Overall Study|Physician Decision|0|||
27847539|NCT02641080|54340166|FG000|Overall Study|Withdrawal by Subject|0|||
27847540|NCT02641080|54340167|FG001|Overall Study|Withdrawal by Subject|1|||
27847541|NCT02641080|54340166|FG000|Overall Study|Rehab Center denied use of pumps|0|||
27847542|NCT02641080|54340167|FG001|Overall Study|Rehab Center denied use of pumps|3|||
27847543|NCT02641080|54340166|FG000|Overall Study|Lost to Follow-up|0|||
27847544|NCT02641080|54340167|FG001|Overall Study|Lost to Follow-up|3|||
27847545|NCT01457846|54340175|FG000|Overall Study|Death before treatment|1|||
27847546|NCT01457846|54340176|FG001|Overall Study|Death before treatment|2|||
27847547|NCT01457846|54340175|FG000|Overall Study|Did not receive treatment|0|||
27847548|NCT01457846|54340176|FG001|Overall Study|Did not receive treatment|1|||
27847549|NCT01457846|54340175|FG000|Overall Study|Death|27|||
27847550|NCT01457846|54340176|FG001|Overall Study|Death|16|||
27847551|NCT01457846|54340175|FG000|Overall Study|Unclassified reason for not completed|11|||
27847552|NCT01457846|54340176|FG001|Overall Study|Unclassified reason for not completed|10|||
27847553|NCT01457846|54340175|FG000|Overall Study|Withdrawal by Subject|1|||
27847554|NCT01457846|54340176|FG001|Overall Study|Withdrawal by Subject|1|||
27847555|NCT01457846|54340175|FG000|Overall Study|Lost to Follow-up|1|||
27847556|NCT01457846|54340176|FG001|Overall Study|Lost to Follow-up|0|||
27847557|NCT01496066|54340188|FG000|Overall Study|Lost to Follow-up|8|||
27847558|NCT01496066|54340189|FG001|Overall Study|Lost to Follow-up|5|||
27847559|NCT01496066|54340188|FG000|Overall Study|Explant|3|||
27847560|NCT01496066|54340189|FG001|Overall Study|Explant|0|||
27847561|NCT01496066|54340188|FG000|Overall Study|Death|1|||
27847562|NCT01496066|54340189|FG001|Overall Study|Death|4|||
27847563|NCT01389323|54340202|FG000|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41|||
27847564|NCT01389323|54340202|FG000|Treatment Period (up to 48 Weeks)|Adverse Event|24|||
27809403|NCT01401478|54265089|FG000|Overall Study|Hyperphosphatemia and adverse event|1|||
27809404|NCT01401478|54265089|FG000|Overall Study|Low intact parathyroid hormone|1|||
27809405|NCT01401478|54265089|FG000|Overall Study|Serious adverse event|1|||
27809406|NCT01422850|54265093|FG000|Overall Study|Physician Decision|3|||
27809407|NCT01422538|54265102|FG000|Overall Study|Lost to Follow-up|0|||
27809408|NCT01422538|54265103|FG001|Overall Study|Lost to Follow-up|1|||
27809409|NCT01422538|54265104|FG002|Overall Study|Lost to Follow-up|1|||
27809410|NCT01422538|54265102|FG000|Overall Study|Missed visit|0|||
27809411|NCT01422538|54265103|FG001|Overall Study|Missed visit|1|||
27809412|NCT01422538|54265104|FG002|Overall Study|Missed visit|1|||
27809413|NCT01422382|54265113|FG000|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1|||
27809414|NCT01401322|54265117|FG000|Overall Study|Withdrawal by Subject|1|||
27809415|NCT01401322|54265117|FG000|Overall Study|Physician Decision|1|||
27809416|NCT01387594|54265123|FG000|Overall Study|Withdrawal by Subject|0|||
27809417|NCT01387594|54265124|FG001|Overall Study|Withdrawal by Subject|2|||
27809418|NCT01387594|54265123|FG000|Overall Study|Lost to Follow-up|0|||
27809419|NCT01387594|54265124|FG001|Overall Study|Lost to Follow-up|1|||
27847565|NCT01389323|54340202|FG000|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6|||
27847566|NCT01389323|54340202|FG000|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7|||
27847567|NCT01389323|54340202|FG000|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10|||
27847568|NCT01389323|54340202|FG000|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5|||
27847569|NCT01389323|54340202|FG000|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2|||
27809420|NCT01401010|54265135|FG000|Overall Study|Could not interpret assay results|1|||
27809421|NCT01401010|54265136|FG001|Overall Study|Could not interpret assay results|0|||
27809422|NCT01400932|54265149|FG000|Overall Study|Adverse Event|10|||
27809423|NCT01400932|54265150|FG001|Overall Study|Adverse Event|5|||
27847570|NCT01389323|54340202|FG000|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10|||
27847571|NCT01389323|54340202|FG000|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22|||
27847572|NCT01389323|54340202|FG000|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2|||
27847573|NCT01389323|54340202|FG000|Follow-up Period (up to 48 Weeks)|Other|3|||
27847574|NCT01389245|54340213|FG000|Overall Study|Protocol Violation|10|||
27847575|NCT01389245|54340213|FG000|Overall Study|Lost to Follow-up|3|||
27847576|NCT01389245|54340213|FG000|Overall Study|Withdrawal by Subject|2|||
27847577|NCT01494818|54340219|FG000|Overall Study|Relocation|1|||
27847578|NCT01494818|54340220|FG001|Overall Study|Relocation|2|||
27847579|NCT01494818|54340219|FG000|Overall Study|Lost to Follow-up|1|||
27847580|NCT01494818|54340220|FG001|Overall Study|Lost to Follow-up|0|||
27847581|NCT01494584|54340226|FG000|Overall Study|Study Closed/Terminated|1|||
27847582|NCT01388543|54340251|FG000|Day 14|Adverse Event|1|||
27847583|NCT01388543|54340252|FG001|Day 14|Adverse Event|4|||
27847584|NCT00512317|54340271|FG000|Overall Study|Insufficient clinical response|36|||
27847585|NCT00512317|54340271|FG000|Overall Study|Withdrawal by Subject|23|||
27847586|NCT00512317|54340271|FG000|Overall Study|Sponsor closure of study|21|||
27847587|NCT00512317|54340271|FG000|Overall Study|<50% reduction in seizure frequency on or after Visit 7|18|||
27809424|NCT01400932|54265149|FG000|Overall Study|Lack of Efficacy|0|||
27809425|NCT01400932|54265150|FG001|Overall Study|Lack of Efficacy|3|||
27809426|NCT01400932|54265149|FG000|Overall Study|Withdrawal by Subject|2|||
27809427|NCT01400932|54265150|FG001|Overall Study|Withdrawal by Subject|6|||
27809428|NCT01400932|54265149|FG000|Overall Study|Lost to Follow-up|1|||
27809429|NCT01400932|54265150|FG001|Overall Study|Lost to Follow-up|0|||
27809430|NCT01400932|54265149|FG000|Overall Study|Protocol Deviation|0|||
27809431|NCT01400932|54265150|FG001|Overall Study|Protocol Deviation|1|||
27809432|NCT01400932|54265149|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
27809433|NCT01400932|54265150|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
27809434|NCT01400698|54265160|FG000|Overall Study|Lost to Follow-up|2|||
27809435|NCT01400698|54265161|FG001|Overall Study|Lost to Follow-up|5|||
27809436|NCT01400698|54265162|FG002|Overall Study|Lost to Follow-up|2|||
27809437|NCT01400698|54265163|FG003|Overall Study|Lost to Follow-up|1|||
27809438|NCT01400698|54265164|FG004|Overall Study|Lost to Follow-up|4|||
27809439|NCT01400698|54265165|FG005|Overall Study|Lost to Follow-up|3|||
27809440|NCT01400698|54265160|FG000|Overall Study|Withdrawal by Subject|8|||
27809441|NCT01400698|54265161|FG001|Overall Study|Withdrawal by Subject|2|||
27809442|NCT01400698|54265162|FG002|Overall Study|Withdrawal by Subject|0|||
27809443|NCT01400698|54265163|FG003|Overall Study|Withdrawal by Subject|4|||
27809444|NCT01400698|54265164|FG004|Overall Study|Withdrawal by Subject|1|||
27809445|NCT01400698|54265165|FG005|Overall Study|Withdrawal by Subject|3|||
27809446|NCT01400698|54265160|FG000|Overall Study|Protocol Violation|0|||
27809447|NCT01400698|54265161|FG001|Overall Study|Protocol Violation|1|||
27809448|NCT01400698|54265162|FG002|Overall Study|Protocol Violation|0|||
27809449|NCT01400698|54265163|FG003|Overall Study|Protocol Violation|0|||
27809450|NCT01400698|54265164|FG004|Overall Study|Protocol Violation|1|||
27809451|NCT01400698|54265165|FG005|Overall Study|Protocol Violation|0|||
27809452|NCT01400698|54265160|FG000|Overall Study|Non-compliance|0|||
27809453|NCT01400698|54265161|FG001|Overall Study|Non-compliance|1|||
27809454|NCT01400698|54265162|FG002|Overall Study|Non-compliance|0|||
27809455|NCT01400698|54265163|FG003|Overall Study|Non-compliance|1|||
27809456|NCT01400698|54265164|FG004|Overall Study|Non-compliance|0|||
27809457|NCT01400698|54265165|FG005|Overall Study|Non-compliance|0|||
27809458|NCT01400698|54265160|FG000|Overall Study|Adverse Event|1|||
27809459|NCT01400698|54265161|FG001|Overall Study|Adverse Event|0|||
27809460|NCT01400698|54265162|FG002|Overall Study|Adverse Event|0|||
27809461|NCT01400698|54265163|FG003|Overall Study|Adverse Event|0|||
27809462|NCT01400698|54265164|FG004|Overall Study|Adverse Event|0|||
27809463|NCT01400698|54265165|FG005|Overall Study|Adverse Event|0|||
27809464|NCT01400698|54265160|FG000|Overall Study|Other|4|||
27809465|NCT01400698|54265161|FG001|Overall Study|Other|2|||
27809466|NCT01400698|54265162|FG002|Overall Study|Other|0|||
27809467|NCT01400698|54265163|FG003|Overall Study|Other|2|||
27809468|NCT01400698|54265164|FG004|Overall Study|Other|1|||
27809469|NCT01400698|54265165|FG005|Overall Study|Other|0|||
27809470|NCT01890746|54265177|FG000|Overall Study|Death|39|||
27809471|NCT01890746|54265178|FG001|Overall Study|Death|30|||
27809472|NCT01890746|54265177|FG000|Overall Study|Adverse Event|1|||
27809473|NCT01890746|54265178|FG001|Overall Study|Adverse Event|0|||
27809474|NCT01890746|54265177|FG000|Overall Study|Lost to Follow-up|4|||
27809475|NCT01890746|54265178|FG001|Overall Study|Lost to Follow-up|1|||
27809476|NCT01890746|54265177|FG000|Overall Study|Physician Decision|3|||
27809477|NCT01890746|54265178|FG001|Overall Study|Physician Decision|2|||
27809478|NCT01890746|54265177|FG000|Overall Study|Withdrawal by Subject|5|||
27809479|NCT01890746|54265178|FG001|Overall Study|Withdrawal by Subject|8|||
27809480|NCT01422304|54265186|FG000|Overall Study|Adverse Event|0|||
27809481|NCT01422304|54265187|FG001|Overall Study|Adverse Event|1|||
27809482|NCT01422304|54265186|FG000|Overall Study|Lost to Follow-up|14|||
27809483|NCT01422304|54265187|FG001|Overall Study|Lost to Follow-up|20|||
27809484|NCT01422304|54265186|FG000|Overall Study|Never Entered Follow-up|2|||
27809485|NCT01422304|54265187|FG001|Overall Study|Never Entered Follow-up|1|||
27809486|NCT01422304|54265186|FG000|Overall Study|Protocol Violation|1|||
27809487|NCT01422304|54265187|FG001|Overall Study|Protocol Violation|0|||
27809488|NCT01422304|54265186|FG000|Overall Study|Withdrawal by Subject|4|||
27847588|NCT00512317|54340271|FG000|Overall Study|Adverse Event|13|||
27847589|NCT00512317|54340271|FG000|Overall Study|Discretion of the investigator or sponsor|2|||
27847590|NCT00512317|54340271|FG000|Overall Study|Lost to Follow-up|2|||
27809489|NCT01422304|54265187|FG001|Overall Study|Withdrawal by Subject|2|||
27809490|NCT01422304|54265186|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
27809491|NCT01422304|54265187|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
27809492|NCT01422304|54265186|FG000|Overall Study|Not Treated|3|||
27809493|NCT01422304|54265187|FG001|Overall Study|Not Treated|11|||
27809494|NCT01387516|54265197|FG000|Overall Study|Lost to Follow-up|4|||
27809495|NCT01387516|54265198|FG001|Overall Study|Lost to Follow-up|4|||
27809496|NCT01387516|54265199|FG002|Overall Study|Lost to Follow-up|2|||
27809497|NCT01387516|54265200|FG003|Overall Study|Lost to Follow-up|3|||
27809498|NCT01387516|54265197|FG000|Overall Study|Withdrawal by Subject|1|||
27809499|NCT01387516|54265198|FG001|Overall Study|Withdrawal by Subject|1|||
27809500|NCT01387516|54265199|FG002|Overall Study|Withdrawal by Subject|2|||
27809501|NCT01387516|54265200|FG003|Overall Study|Withdrawal by Subject|0|||
27809502|NCT01387516|54265197|FG000|Overall Study|Death|0|||
27809503|NCT01387516|54265198|FG001|Overall Study|Death|0|||
27809504|NCT01387516|54265199|FG002|Overall Study|Death|0|||
27809505|NCT01387516|54265200|FG003|Overall Study|Death|1|||
27809506|NCT01421134|54265221|FG000|Overall Study|Adverse Event|3|||
27809507|NCT01421134|54265222|FG001|Overall Study|Adverse Event|5|||
27809508|NCT01421134|54265221|FG000|Overall Study|Lack of Efficacy|2|||
27809509|NCT01421134|54265222|FG001|Overall Study|Lack of Efficacy|4|||
27809510|NCT01421134|54265221|FG000|Overall Study|Protocol Violation|0|||
27809511|NCT01421134|54265222|FG001|Overall Study|Protocol Violation|3|||
27809512|NCT01421134|54265221|FG000|Overall Study|Withdrawal by Subject|1|||
27809513|NCT01421134|54265222|FG001|Overall Study|Withdrawal by Subject|1|||
27809514|NCT01421134|54265221|FG000|Overall Study|Administrative|0|||
27809515|NCT01421134|54265222|FG001|Overall Study|Administrative|1|||
28037544|NCT00382408|54695528|FG000|Overall Study|Physician Decision|1|||
28037545|NCT00382408|54695529|FG001|Overall Study|Physician Decision|0|||
28037546|NCT00382408|54695528|FG000|Overall Study|Withdrawal by Subject|17|||
28037547|NCT00382408|54695529|FG001|Overall Study|Withdrawal by Subject|6|||
28037548|NCT00382408|54695528|FG000|Overall Study|Pregnancy|2|||
28037549|NCT00382408|54695529|FG001|Overall Study|Pregnancy|0|||
28037550|NCT00382408|54695528|FG000|Overall Study|Lost to Follow-up|19|||
28037551|NCT00382408|54695529|FG001|Overall Study|Lost to Follow-up|8|||
28037552|NCT00382408|54695528|FG000|Overall Study|Other|100|||
27809516|NCT01421134|54265221|FG000|Overall Study|Lost to Follow-up|1|||
28037553|NCT00382408|54695529|FG001|Overall Study|Other|35|||
27809517|NCT01421134|54265222|FG001|Overall Study|Lost to Follow-up|1|||
28037554|NCT00371254|54695537|FG000|Overall Study|Disease progression|13|||
28037555|NCT00371254|54695538|FG001|Overall Study|Disease progression|13|||
28037556|NCT00371254|54695537|FG000|Overall Study|Study drug toxicity|3|||
28037557|NCT00371254|54695538|FG001|Overall Study|Study drug toxicity|5|||
28037558|NCT00371254|54695537|FG000|Overall Study|Subject request|5|||
28037559|NCT00371254|54695538|FG001|Overall Study|Subject request|0|||
28037560|NCT00371254|54695537|FG000|Overall Study|Investigator Decision|2|||
27809518|NCT01894022|54265230|FG000|Overall Study|Death|1|||
27809519|NCT01894022|54265231|FG001|Overall Study|Death|0|||
28037561|NCT00371254|54695538|FG001|Overall Study|Investigator Decision|0|||
28037562|NCT00371254|54695537|FG000|Overall Study|Adverse event unrelated to study drug|0|||
28037563|NCT00371254|54695538|FG001|Overall Study|Adverse event unrelated to study drug|1|||
27809520|NCT01894022|54265230|FG000|Overall Study|Adverse Event, non-fatal|1|||
27809521|NCT01894022|54265231|FG001|Overall Study|Adverse Event, non-fatal|0|||
28037564|NCT00371254|54695537|FG000|Overall Study|Lost to Follow-up|0|||
28037565|NCT00371254|54695538|FG001|Overall Study|Lost to Follow-up|1|||
28037566|NCT00371254|54695537|FG000|Overall Study|Withdrawal by Subject|0|||
28037567|NCT00371254|54695538|FG001|Overall Study|Withdrawal by Subject|1|||
28037568|NCT00452673|54695548|FG000|Dose Escalation Period|Disease Progression|6|||
28037569|NCT00452673|54695549|FG001|Dose Escalation Period|Disease Progression|6|||
28037570|NCT00452673|54695550|FG002|Dose Escalation Period|Disease Progression|2|||
28037571|NCT00452673|54695551|FG003|Dose Escalation Period|Disease Progression|6|||
28037572|NCT00452673|54695552|FG004|Dose Escalation Period|Disease Progression|0|||
28037573|NCT00452673|54695548|FG000|Dose Escalation Period|study drug toxicity|1|||
28037574|NCT00452673|54695549|FG001|Dose Escalation Period|study drug toxicity|3|||
28037575|NCT00452673|54695550|FG002|Dose Escalation Period|study drug toxicity|3|||
28037576|NCT00452673|54695551|FG003|Dose Escalation Period|study drug toxicity|1|||
28037577|NCT00452673|54695552|FG004|Dose Escalation Period|study drug toxicity|0|||
28037578|NCT00452673|54695548|FG000|Dose Escalation Period|Other|0|||
28037579|NCT00452673|54695549|FG001|Dose Escalation Period|Other|0|||
28037580|NCT00452673|54695550|FG002|Dose Escalation Period|Other|1|||
28037581|NCT00452673|54695551|FG003|Dose Escalation Period|Other|0|||
28037582|NCT00452673|54695552|FG004|Dose Escalation Period|Other|0|||
28037583|NCT00452673|54695548|FG000|Dose Escalation Period|Adverse Event|0|||
28037584|NCT00452673|54695549|FG001|Dose Escalation Period|Adverse Event|0|||
28037585|NCT00452673|54695550|FG002|Dose Escalation Period|Adverse Event|0|||
28037586|NCT00452673|54695551|FG003|Dose Escalation Period|Adverse Event|1|||
28037587|NCT00452673|54695552|FG004|Dose Escalation Period|Adverse Event|0|||
28037588|NCT00452673|54695548|FG000|Dose Escalation Period|Withdrawal by Subject|0|||
28037589|NCT00452673|54695549|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
28037590|NCT00452673|54695550|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
27809522|NCT01894022|54265230|FG000|Overall Study|Study Closed/terminated|7|||
27809523|NCT01894022|54265231|FG001|Overall Study|Study Closed/terminated|10|||
27809524|NCT01615328|54265240|FG000|Overall Study|Lost to Follow-up|3|||
27809525|NCT01615328|54265241|FG001|Overall Study|Lost to Follow-up|5|||
27809526|NCT01890512|54265251|FG000|Overall Study|Physician Decision|1|||
27809527|NCT01890512|54265251|FG000|Overall Study|Withdrawal by Subject|1|||
27809528|NCT01890512|54265251|FG000|Overall Study|Protocol Violation|1|||
27809529|NCT01387282|54265257|FG000|Overall Study|Death|47|||
28037591|NCT00452673|54695551|FG003|Dose Escalation Period|Withdrawal by Subject|1|||
28037592|NCT00452673|54695552|FG004|Dose Escalation Period|Withdrawal by Subject|0|||
28037593|NCT00452673|54695548|FG000|Dose Expansion Period|Disease Progression|0|||
28037594|NCT00452673|54695549|FG001|Dose Expansion Period|Disease Progression|0|||
28037595|NCT00452673|54695550|FG002|Dose Expansion Period|Disease Progression|0|||
28037596|NCT00452673|54695551|FG003|Dose Expansion Period|Disease Progression|0|||
28037597|NCT00452673|54695552|FG004|Dose Expansion Period|Disease Progression|19|||
28037598|NCT00452673|54695548|FG000|Dose Expansion Period|Other|0|||
28037599|NCT00452673|54695549|FG001|Dose Expansion Period|Other|0|||
28037600|NCT00452673|54695550|FG002|Dose Expansion Period|Other|0|||
28037601|NCT00452673|54695551|FG003|Dose Expansion Period|Other|0|||
28037602|NCT00452673|54695552|FG004|Dose Expansion Period|Other|2|||
28037603|NCT00461253|54695565|FG000|Overall Study|Death|985|||
28037604|NCT00461253|54695566|FG001|Overall Study|Death|0|||
28037605|NCT00461253|54695565|FG000|Overall Study|Protocol Violation|613|||
28037606|NCT00461253|54695566|FG001|Overall Study|Protocol Violation|236|||
28037607|NCT00461253|54695565|FG000|Overall Study|no response|2609|||
28037608|NCT00461253|54695566|FG001|Overall Study|no response|11789|||
28037609|NCT00461253|54695565|FG000|Overall Study|administrative|773|||
28037610|NCT00461253|54695566|FG001|Overall Study|administrative|7773|||
28037611|NCT00469833|54695572|FG000|Overall Study|No IV access|2|||
28037612|NCT00382174|54695584|FG000|Overall Study|Lost to Follow-up|1|||
28037613|NCT00382174|54695585|FG001|Overall Study|Lost to Follow-up|4|||
28037614|NCT00382174|54695586|FG002|Overall Study|Lost to Follow-up|5|||
28037615|NCT00382174|54695584|FG000|Overall Study|Adverse Event|1|||
28037616|NCT00382174|54695585|FG001|Overall Study|Adverse Event|4|||
28037617|NCT00382174|54695586|FG002|Overall Study|Adverse Event|5|||
28037618|NCT00382174|54695584|FG000|Overall Study|Withdrawal by Subject|1|||
28037619|NCT00382174|54695585|FG001|Overall Study|Withdrawal by Subject|4|||
28037620|NCT00382174|54695586|FG002|Overall Study|Withdrawal by Subject|5|||
28037621|NCT00382174|54695584|FG000|Overall Study|Non compliance|1|||
27809530|NCT01387282|54265258|FG001|Overall Study|Death|16|||
28037622|NCT00382174|54695585|FG001|Overall Study|Non compliance|0|||
28037623|NCT00382174|54695586|FG002|Overall Study|Non compliance|1|||
28037624|NCT00382174|54695584|FG000|Overall Study|Physician Decision|0|||
28037625|NCT00382174|54695585|FG001|Overall Study|Physician Decision|2|||
28037626|NCT00382174|54695586|FG002|Overall Study|Physician Decision|2|||
28037627|NCT00382174|54695584|FG000|Overall Study|Failed to meet criteria|0|||
28037628|NCT00382174|54695585|FG001|Overall Study|Failed to meet criteria|1|||
28037629|NCT00382174|54695586|FG002|Overall Study|Failed to meet criteria|1|||
28037630|NCT00382174|54695584|FG000|Overall Study|Wounds merged|0|||
28037631|NCT00382174|54695585|FG001|Overall Study|Wounds merged|2|||
28037632|NCT00382174|54695586|FG002|Overall Study|Wounds merged|2|||
28037633|NCT00641537|54695599|FG000|96-week Period|Adverse Event|0|||
28037634|NCT00641537|54695600|FG001|96-week Period|Adverse Event|1|||
28037635|NCT00641537|54695601|FG002|96-week Period|Adverse Event|3|||
28037636|NCT00641537|54695602|FG003|96-week Period|Adverse Event|0|||
28037637|NCT00641537|54695603|FG004|96-week Period|Adverse Event|2|||
28037638|NCT00641537|54695604|FG005|96-week Period|Adverse Event|0|||
28037639|NCT00641537|54695605|FG006|96-week Period|Adverse Event|0|||
27809531|NCT01387282|54265257|FG000|Overall Study|Other|5|||
27809532|NCT01387282|54265258|FG001|Overall Study|Other|1|||
27809533|NCT01387282|54265257|FG000|Overall Study|Unrelated AE|6|||
27809534|NCT01387282|54265258|FG001|Overall Study|Unrelated AE|4|||
27809535|NCT01387282|54265257|FG000|Overall Study|Withdrawal by patient|33|||
27809536|NCT01387282|54265258|FG001|Overall Study|Withdrawal by patient|23|||
27809537|NCT01387282|54265257|FG000|Overall Study|Study drug-related AE|2|||
27809538|NCT01387282|54265258|FG001|Overall Study|Study drug-related AE|2|||
27809539|NCT01387282|54265257|FG000|Overall Study|Lost to Follow-up|4|||
27809540|NCT01387282|54265258|FG001|Overall Study|Lost to Follow-up|1|||
27809541|NCT01386970|54265266|FG000|Overall Study|Withdrawal by Subject|0|||
27809542|NCT01386970|54265267|FG001|Overall Study|Withdrawal by Subject|1|||
27809543|NCT01386970|54265266|FG000|Overall Study|Adverse Event|4|||
27809544|NCT01386970|54265267|FG001|Overall Study|Adverse Event|1|||
27809545|NCT01890434|54265275|FG000|Overall Study|Adverse Event|8|||
27809546|NCT01890434|54265275|FG000|Overall Study|PCI at external hospital|1|||
27809547|NCT01890434|54265275|FG000|Overall Study|Assessment discrepancy|1|||
27809548|NCT01890434|54265275|FG000|Overall Study|CRC didn't contact participant for FU|1|||
27809549|NCT01890434|54265275|FG000|Overall Study|Could not get whole set of images|1|||
27809550|NCT01890434|54265275|FG000|Overall Study|Decline to return for GSPECT|1|||
27809551|NCT01890434|54265275|FG000|Overall Study|GSPECT at rest was not done|1|||
27809552|NCT01890434|54265275|FG000|Overall Study|Participant didn't complete MRI|1|||
27809553|NCT01890434|54265275|FG000|Overall Study|Uncontactable by phone|1|||
27809554|NCT01890434|54265275|FG000|Overall Study|Moved out of position|1|||
28037640|NCT00641537|54695606|FG007|96-week Period|Adverse Event|0|||
28037641|NCT00641537|54695599|FG000|96-week Period|Lost to Follow-up|3|||
28037642|NCT00641537|54695600|FG001|96-week Period|Lost to Follow-up|1|||
28037643|NCT00641537|54695601|FG002|96-week Period|Lost to Follow-up|2|||
28037644|NCT00641537|54695602|FG003|96-week Period|Lost to Follow-up|2|||
28037645|NCT00641537|54695603|FG004|96-week Period|Lost to Follow-up|4|||
28037646|NCT00641537|54695604|FG005|96-week Period|Lost to Follow-up|0|||
28037647|NCT00641537|54695605|FG006|96-week Period|Lost to Follow-up|1|||
28037648|NCT00641537|54695606|FG007|96-week Period|Lost to Follow-up|0|||
28037649|NCT00641537|54695599|FG000|96-week Period|Protocol Violation|0|||
28037650|NCT00641537|54695600|FG001|96-week Period|Protocol Violation|1|||
28037651|NCT00641537|54695601|FG002|96-week Period|Protocol Violation|0|||
28037652|NCT00641537|54695602|FG003|96-week Period|Protocol Violation|1|||
28037653|NCT00641537|54695603|FG004|96-week Period|Protocol Violation|0|||
28037654|NCT00641537|54695604|FG005|96-week Period|Protocol Violation|1|||
28037655|NCT00641537|54695605|FG006|96-week Period|Protocol Violation|0|||
28037656|NCT00641537|54695606|FG007|96-week Period|Protocol Violation|0|||
28037657|NCT00641537|54695599|FG000|96-week Period|Death|2|||
28037658|NCT00641537|54695600|FG001|96-week Period|Death|0|||
28037659|NCT00641537|54695601|FG002|96-week Period|Death|1|||
28037660|NCT00641537|54695602|FG003|96-week Period|Death|0|||
28037661|NCT00641537|54695603|FG004|96-week Period|Death|0|||
28037662|NCT00641537|54695604|FG005|96-week Period|Death|0|||
28037663|NCT00641537|54695605|FG006|96-week Period|Death|0|||
28037664|NCT00641537|54695606|FG007|96-week Period|Death|0|||
28037665|NCT00641537|54695599|FG000|96-week Period|Other|4|||
28037666|NCT00641537|54695600|FG001|96-week Period|Other|7|||
28037667|NCT00641537|54695601|FG002|96-week Period|Other|14|||
28037668|NCT00641537|54695602|FG003|96-week Period|Other|9|||
28037669|NCT00641537|54695603|FG004|96-week Period|Other|11|||
28037670|NCT00641537|54695604|FG005|96-week Period|Other|6|||
28037671|NCT00641537|54695605|FG006|96-week Period|Other|4|||
28037672|NCT00641537|54695606|FG007|96-week Period|Other|6|||
28037673|NCT00641537|54695599|FG000|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
28037674|NCT00641537|54695600|FG001|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
28037675|NCT00641537|54695601|FG002|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
28037676|NCT00641537|54695602|FG003|24-Week Supplemental Follow-up Period|Lost to Follow-up|3|||
27809555|NCT01890434|54265275|FG000|Overall Study|Unable to contact|1|||
27809556|NCT01890434|54265275|FG000|Overall Study|Withdrawal by PI for ICA not performed|2|||
27809557|NCT01385566|54265285|FG000|Overall Study|Lost to Follow-up|1|||
27809558|NCT01385566|54265286|FG001|Overall Study|Lost to Follow-up|0|||
27809559|NCT01385566|54265287|FG002|Overall Study|Lost to Follow-up|0|||
27809560|NCT01385566|54265288|FG003|Overall Study|Lost to Follow-up|0|||
27809561|NCT01385566|54265289|FG004|Overall Study|Lost to Follow-up|0|||
28037677|NCT00641537|54695603|FG004|24-Week Supplemental Follow-up Period|Lost to Follow-up|2|||
28037678|NCT00641537|54695604|FG005|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
28037679|NCT00641537|54695605|FG006|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
28037680|NCT00641537|54695606|FG007|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
28037681|NCT00641537|54695599|FG000|24-Week Supplemental Follow-up Period|Other|0|||
28037682|NCT00641537|54695600|FG001|24-Week Supplemental Follow-up Period|Other|2|||
28037683|NCT00641537|54695601|FG002|24-Week Supplemental Follow-up Period|Other|2|||
28037684|NCT00641537|54695602|FG003|24-Week Supplemental Follow-up Period|Other|1|||
28037685|NCT00641537|54695603|FG004|24-Week Supplemental Follow-up Period|Other|3|||
28037686|NCT00641537|54695604|FG005|24-Week Supplemental Follow-up Period|Other|0|||
28037687|NCT00641537|54695605|FG006|24-Week Supplemental Follow-up Period|Other|1|||
28037688|NCT00641537|54695606|FG007|24-Week Supplemental Follow-up Period|Other|1|||
28037689|NCT03840135|54695626|FG000|Overall Study|Protocol Violation|6|||
28037690|NCT03840135|54695627|FG001|Overall Study|Protocol Violation|1|||
28037691|NCT03840135|54695626|FG000|Overall Study|Withdrawal by Subject|1|||
28037692|NCT03840135|54695627|FG001|Overall Study|Withdrawal by Subject|0|||
28037693|NCT00461175|54695639|FG000|Overall Study|Protocol Violation|522|||
28037694|NCT00461175|54695640|FG001|Overall Study|Protocol Violation|365|||
28037695|NCT00641147|54695648|FG000|Completed 4 Months.|Physician Decision|1|||
28037696|NCT00641147|54695649|FG001|Completed 4 Months.|Physician Decision|0|||
28037697|NCT00641147|54695648|FG000|Completed 4 Months.|Adverse Event|1|||
28037698|NCT00641147|54695649|FG001|Completed 4 Months.|Adverse Event|0|||
27809562|NCT01385566|54265290|FG005|Overall Study|Lost to Follow-up|0|||
27809563|NCT01385566|54265285|FG000|Overall Study|Withdrawal by Subject|0|||
27809564|NCT01385566|54265286|FG001|Overall Study|Withdrawal by Subject|0|||
27809565|NCT01385566|54265287|FG002|Overall Study|Withdrawal by Subject|0|||
27809566|NCT01385566|54265288|FG003|Overall Study|Withdrawal by Subject|1|||
27809567|NCT01385566|54265289|FG004|Overall Study|Withdrawal by Subject|0|||
27809568|NCT01385566|54265290|FG005|Overall Study|Withdrawal by Subject|0|||
27809569|NCT01780545|54265308|FG000|Overall Study|Withdrawal by Subject|3|||
27809570|NCT01780545|54265309|FG001|Overall Study|Withdrawal by Subject|1|||
27809571|NCT01780545|54265308|FG000|Overall Study|Lost to Follow-up|1|||
27809572|NCT01780545|54265309|FG001|Overall Study|Lost to Follow-up|1|||
27809573|NCT01780389|54265318|FG000|Overall Study|Adverse Event|1|||
28037699|NCT00641147|54695648|FG000|Completed 8 Months.|Physician Decision|2|||
28037700|NCT00641147|54695649|FG001|Completed 8 Months.|Physician Decision|1|||
28037701|NCT00641147|54695648|FG000|Completed 8 Months.|non compliance|1|||
28037702|NCT00641147|54695649|FG001|Completed 8 Months.|non compliance|0|||
28037703|NCT00641147|54695648|FG000|Completed 8 Months.|Withdrawal by Subject|0|||
28037704|NCT00641147|54695649|FG001|Completed 8 Months.|Withdrawal by Subject|1|||
28037705|NCT00641147|54695648|FG000|Completed 12 Months.|Physician Decision|1|||
28037706|NCT00641147|54695649|FG001|Completed 12 Months.|Physician Decision|1|||
28037707|NCT00641147|54695648|FG000|Completed 12 Months.|Withdrawal by Subject|0|||
28037708|NCT00641147|54695649|FG001|Completed 12 Months.|Withdrawal by Subject|1|||
28037709|NCT00641147|54695648|FG000|Completed 16 Months.|Physician Decision|1|||
28037710|NCT00641147|54695649|FG001|Completed 16 Months.|Physician Decision|0|||
28037711|NCT00641147|54695648|FG000|Completed 16 Months.|Lost to Follow-up|1|||
28037712|NCT00641147|54695649|FG001|Completed 16 Months.|Lost to Follow-up|0|||
28037713|NCT00460239|54695659|FG000|Overall Study|Physician Decision|0|||
28037714|NCT00460239|54695660|FG001|Overall Study|Physician Decision|1|||
28037715|NCT00460239|54695661|FG002|Overall Study|Physician Decision|0|||
28037716|NCT00460239|54695662|FG003|Overall Study|Physician Decision|0|||
28037717|NCT00460239|54695663|FG004|Overall Study|Physician Decision|0|||
28037718|NCT00460239|54695664|FG005|Overall Study|Physician Decision|2|||
27809574|NCT01778985|54265325|FG000|Overall Study|Lost to Follow-up|1|||
27809575|NCT01778985|54265326|FG001|Overall Study|Lost to Follow-up|0|||
27809576|NCT01778985|54265325|FG000|Overall Study|Physician Decision|2|||
27809577|NCT01778985|54265326|FG001|Overall Study|Physician Decision|2|||
27809578|NCT01778985|54265325|FG000|Overall Study|Protocol Violation|4|||
27809579|NCT01778985|54265326|FG001|Overall Study|Protocol Violation|1|||
27809580|NCT01778751|54265334|FG000|Overall Study|Lost to Follow-up|1|||
27809581|NCT01778751|54265335|FG001|Overall Study|Lost to Follow-up|0|||
27809582|NCT01778751|54265334|FG000|Overall Study|Withdrawal by Subject|0|||
27809583|NCT01778751|54265335|FG001|Overall Study|Withdrawal by Subject|2|||
27809584|NCT01778751|54265334|FG000|Overall Study|Transfered care|1|||
28037719|NCT00460239|54695665|FG006|Overall Study|Physician Decision|0|||
28037720|NCT00460239|54695666|FG007|Overall Study|Physician Decision|0|||
28037721|NCT00460239|54695667|FG008|Overall Study|Physician Decision|0|||
28037722|NCT00460239|54695659|FG000|Overall Study|Withdrawal by Subject|0|||
28037723|NCT00460239|54695660|FG001|Overall Study|Withdrawal by Subject|0|||
28037724|NCT00460239|54695661|FG002|Overall Study|Withdrawal by Subject|0|||
28037725|NCT00460239|54695662|FG003|Overall Study|Withdrawal by Subject|0|||
28037726|NCT00460239|54695663|FG004|Overall Study|Withdrawal by Subject|0|||
28037727|NCT00460239|54695664|FG005|Overall Study|Withdrawal by Subject|1|||
27809585|NCT01778751|54265335|FG001|Overall Study|Transfered care|0|||
27809586|NCT01865084|54265344|FG000|Double Blind Period (DB)|Adverse Event|2|||
27809587|NCT01865084|54265345|FG001|Double Blind Period (DB)|Adverse Event|2|||
27809588|NCT01865084|54265346|FG002|Double Blind Period (DB)|Adverse Event|1|||
27809589|NCT01865084|54265344|FG000|Double Blind Period (DB)|Protocol Violation|0|||
27809590|NCT01865084|54265345|FG001|Double Blind Period (DB)|Protocol Violation|0|||
27809591|NCT01865084|54265346|FG002|Double Blind Period (DB)|Protocol Violation|1|||
27809592|NCT01865084|54265344|FG000|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
27809593|NCT01865084|54265345|FG001|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
27809594|NCT01865084|54265346|FG002|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4|||
27809595|NCT01865084|54265344|FG000|Double Blind Period (DB)|Withdrawal by Subject|1|||
27809596|NCT01865084|54265345|FG001|Double Blind Period (DB)|Withdrawal by Subject|0|||
27809597|NCT01865084|54265346|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
27809598|NCT01865084|54265344|FG000|Open Label Extension (OLE) Period|Adverse Event|0|||
27809599|NCT01865084|54265345|FG001|Open Label Extension (OLE) Period|Adverse Event|0|||
27809600|NCT01865084|54265346|FG002|Open Label Extension (OLE) Period|Adverse Event|1|||
28037728|NCT00460239|54695665|FG006|Overall Study|Withdrawal by Subject|0|||
28037729|NCT00460239|54695666|FG007|Overall Study|Withdrawal by Subject|0|||
28037730|NCT00460239|54695667|FG008|Overall Study|Withdrawal by Subject|0|||
28037731|NCT00640835|54695682|FG000|Overall Study|Adverse Event|5|||
28037732|NCT00640835|54695683|FG001|Overall Study|Adverse Event|3|||
28037733|NCT00640835|54695682|FG000|Overall Study|Withdrawal by Subject|12|||
27809601|NCT01865084|54265344|FG000|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
27809602|NCT01865084|54265345|FG001|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
27809603|NCT01865084|54265346|FG002|Open Label Extension (OLE) Period|Lack of Efficacy|2|||
27847591|NCT00512317|54340271|FG000|Overall Study|Other|2|||
27847592|NCT01494506|54340287|FG000|Overall Study|Lack of Efficacy|77|||
27847593|NCT01494506|54340288|FG001|Overall Study|Lack of Efficacy|83|||
28037734|NCT00640835|54695683|FG001|Overall Study|Withdrawal by Subject|14|||
28037735|NCT00640835|54695682|FG000|Overall Study|Physician Decision|10|||
28037736|NCT00640835|54695683|FG001|Overall Study|Physician Decision|14|||
28037737|NCT00640835|54695682|FG000|Overall Study|Sponsor's Decision|11|||
28037738|NCT00640835|54695683|FG001|Overall Study|Sponsor's Decision|7|||
28037739|NCT00640835|54695682|FG000|Overall Study|Protocol Violation|2|||
28037740|NCT00640835|54695683|FG001|Overall Study|Protocol Violation|2|||
27847594|NCT01494506|54340289|FG002|Overall Study|Lack of Efficacy|57|||
27847595|NCT01494506|54340287|FG000|Overall Study|Adverse Event|17|||
27847596|NCT01494506|54340288|FG001|Overall Study|Adverse Event|10|||
27847597|NCT01494506|54340289|FG002|Overall Study|Adverse Event|11|||
27847598|NCT01494506|54340287|FG000|Overall Study|Death|9|||
27847599|NCT01494506|54340288|FG001|Overall Study|Death|5|||
27847600|NCT01494506|54340289|FG002|Overall Study|Death|2|||
27847601|NCT01494506|54340287|FG000|Overall Study|Physician Decision|7|||
27847602|NCT01494506|54340288|FG001|Overall Study|Physician Decision|5|||
27847603|NCT01494506|54340289|FG002|Overall Study|Physician Decision|4|||
27847604|NCT01494506|54340287|FG000|Overall Study|Withdrawal by Subject|17|||
27847605|NCT01494506|54340288|FG001|Overall Study|Withdrawal by Subject|20|||
27847606|NCT01494506|54340289|FG002|Overall Study|Withdrawal by Subject|14|||
27847607|NCT01494506|54340287|FG000|Overall Study|Clinical Deterioration|21|||
27847608|NCT01494506|54340288|FG001|Overall Study|Clinical Deterioration|17|||
27847609|NCT01494506|54340289|FG002|Overall Study|Clinical Deterioration|13|||
27847610|NCT01494506|54340287|FG000|Overall Study|Sponsor Decision|0|||
27847611|NCT01494506|54340288|FG001|Overall Study|Sponsor Decision|0|||
27847612|NCT01494506|54340289|FG002|Overall Study|Sponsor Decision|1|||
27847613|NCT01494506|54340287|FG000|Overall Study|Other|0|||
27847614|NCT01494506|54340288|FG001|Overall Study|Other|3|||
27847615|NCT01494506|54340289|FG002|Overall Study|Other|1|||
27847616|NCT02643420|54340301|FG000|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|6|||
27847617|NCT02643420|54340302|FG001|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|12|||
27847618|NCT02643420|54340301|FG000|Overall Study|Withdrawal by Subject|25|||
27847619|NCT02643420|54340302|FG001|Overall Study|Withdrawal by Subject|19|||
27847620|NCT02643420|54340301|FG000|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|6|||
27847621|NCT02643420|54340302|FG001|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|10|||
27847622|NCT02643420|54340301|FG000|Overall Study|Lost to Follow-up|6|||
27847623|NCT02643420|54340302|FG001|Overall Study|Lost to Follow-up|10|||
27847624|NCT02643420|54340301|FG000|Overall Study|Investigator Decision|2|||
27847625|NCT02643420|54340302|FG001|Overall Study|Investigator Decision|4|||
27847626|NCT02643420|54340301|FG000|Overall Study|Sponsor decision|1|||
27847627|NCT02643420|54340302|FG001|Overall Study|Sponsor decision|1|||
27847628|NCT02643420|54340301|FG000|Overall Study|Death|0|||
27847629|NCT02643420|54340302|FG001|Overall Study|Death|2|||
28037741|NCT00640835|54695682|FG000|Overall Study|Lost to Follow-up|17|||
28037742|NCT00640835|54695683|FG001|Overall Study|Lost to Follow-up|13|||
28037743|NCT00640835|54695682|FG000|Overall Study|Other Reason|19|||
28037744|NCT00640835|54695683|FG001|Overall Study|Other Reason|4|||
27809604|NCT01865084|54265344|FG000|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
27809605|NCT01865084|54265345|FG001|Open Label Extension (OLE) Period|Lost to Follow-up|1|||
27809606|NCT01865084|54265346|FG002|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
27809607|NCT01865084|54265344|FG000|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0|||
27847630|NCT02643420|54340301|FG000|Overall Study|Reason not Specified|8|||
28037745|NCT03839355|54695691|FG000|Overall Study|Withdrawal by Subject|1|||
28037746|NCT03839355|54695692|FG001|Overall Study|Withdrawal by Subject|0|||
27809608|NCT01865084|54265345|FG001|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8|||
27809609|NCT01865084|54265346|FG002|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2|||
27809610|NCT01865084|54265344|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
27809611|NCT01865084|54265345|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
27809612|NCT01865084|54265346|FG002|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
27809613|NCT01778127|54265361|FG000|Overall Study|Lost to Follow-up|5|||
27809614|NCT01778127|54265362|FG001|Overall Study|Lost to Follow-up|1|||
27847631|NCT02643420|54340302|FG001|Overall Study|Reason not Specified|7|||
27847632|NCT01456130|54340325|FG000|Overall Study|Adverse Event|4|||
27847633|NCT01456130|54340325|FG000|Overall Study|Voluntary Withdrawal|1|||
27847634|NCT01456130|54340325|FG000|Overall Study|Lack of Efficacy|4|||
27847635|NCT01456130|54340325|FG000|Overall Study|Other|1|||
27847636|NCT01456052|54340332|FG000|Overall Study|Adverse Event|1|||
27847637|NCT01456052|54340333|FG001|Overall Study|Adverse Event|1|||
27847638|NCT01456052|54340334|FG002|Overall Study|Adverse Event|2|||
27847639|NCT01456052|54340332|FG000|Overall Study|Consent withdrawn|0|||
27847640|NCT01456052|54340333|FG001|Overall Study|Consent withdrawn|2|||
27847641|NCT01456052|54340334|FG002|Overall Study|Consent withdrawn|1|||
27847642|NCT01456052|54340332|FG000|Overall Study|Protocol Violation|0|||
27847643|NCT01456052|54340333|FG001|Overall Study|Protocol Violation|1|||
27847644|NCT01456052|54340334|FG002|Overall Study|Protocol Violation|0|||
27847645|NCT01456052|54340332|FG000|Overall Study|Physician Decision|1|||
27847646|NCT01456052|54340333|FG001|Overall Study|Physician Decision|0|||
27847647|NCT01456052|54340334|FG002|Overall Study|Physician Decision|1|||
27847648|NCT01456052|54340332|FG000|Overall Study|Treatment Failure|0|||
27847649|NCT01456052|54340333|FG001|Overall Study|Treatment Failure|1|||
27847650|NCT01456052|54340334|FG002|Overall Study|Treatment Failure|1|||
27847651|NCT01387607|54340345|FG000|Overall Study|Adverse Event|23|||
27847652|NCT01387607|54340346|FG001|Overall Study|Adverse Event|11|||
27847653|NCT01387607|54340345|FG000|Overall Study|Lack of Efficacy|8|||
27847654|NCT01387607|54340346|FG001|Overall Study|Lack of Efficacy|6|||
27847655|NCT01387607|54340345|FG000|Overall Study|Lost to Follow-up|2|||
27847656|NCT01387607|54340346|FG001|Overall Study|Lost to Follow-up|1|||
27847657|NCT01387607|54340345|FG000|Overall Study|No longer meets eligibility criteria|0|||
27847658|NCT01387607|54340346|FG001|Overall Study|No longer meets eligibility criteria|1|||
27847659|NCT01387607|54340345|FG000|Overall Study|Protocol Violation|1|||
27847660|NCT01387607|54340346|FG001|Overall Study|Protocol Violation|5|||
27847661|NCT01387607|54340345|FG000|Overall Study|Withdrawal by Subject|13|||
27847662|NCT01387607|54340346|FG001|Overall Study|Withdrawal by Subject|14|||
27847663|NCT01387607|54340345|FG000|Overall Study|Other|1|||
27847664|NCT01387607|54340346|FG001|Overall Study|Other|1|||
27847665|NCT01387607|54340345|FG000|Overall Study|Randomized, not treated|3|||
27847666|NCT01387607|54340346|FG001|Overall Study|Randomized, not treated|6|||
27847667|NCT03451045|54340355|FG000|Overall Study|Lack of Efficacy|3|||
27847668|NCT03451045|54340356|FG001|Overall Study|Lack of Efficacy|2|||
27847669|NCT03451045|54340357|FG002|Overall Study|Lack of Efficacy|2|||
27847670|NCT03451045|54340355|FG000|Overall Study|Physician Decision|1|||
27847671|NCT03451045|54340356|FG001|Overall Study|Physician Decision|1|||
27847672|NCT03451045|54340357|FG002|Overall Study|Physician Decision|1|||
27847673|NCT03451045|54340355|FG000|Overall Study|Withdrawal by Subject|4|||
27847674|NCT03451045|54340356|FG001|Overall Study|Withdrawal by Subject|0|||
27847675|NCT03451045|54340357|FG002|Overall Study|Withdrawal by Subject|5|||
27847676|NCT03451045|54340355|FG000|Overall Study|Pregnancy|0|||
27847677|NCT03451045|54340356|FG001|Overall Study|Pregnancy|0|||
27847678|NCT03451045|54340357|FG002|Overall Study|Pregnancy|2|||
27847679|NCT03451045|54340355|FG000|Overall Study|Adverse Event|7|||
27809615|NCT01778127|54265363|FG002|Overall Study|Lost to Follow-up|2|||
27809616|NCT01778127|54265361|FG000|Overall Study|Withdrawal by Subject|3|||
27809617|NCT01778127|54265362|FG001|Overall Study|Withdrawal by Subject|1|||
27809618|NCT01778127|54265363|FG002|Overall Study|Withdrawal by Subject|4|||
27809619|NCT01892540|54265374|FG000|Overall Study|Did not complete PET/MRI|0|||
27809620|NCT01892540|54265375|FG001|Overall Study|Did not complete PET/MRI|0|||
27809621|NCT01892540|54265376|FG002|Overall Study|Did not complete PET/MRI|2|||
27847680|NCT03451045|54340356|FG001|Overall Study|Adverse Event|1|||
28037747|NCT00382018|54695702|FG000|Overall Study|Progression|0|||
27847681|NCT03451045|54340357|FG002|Overall Study|Adverse Event|3|||
27847682|NCT03451045|54340355|FG000|Overall Study|Non-compliance with study|2|||
27847683|NCT03451045|54340356|FG001|Overall Study|Non-compliance with study|0|||
27847684|NCT03451045|54340357|FG002|Overall Study|Non-compliance with study|1|||
27847685|NCT03451045|54340355|FG000|Overall Study|any other reason|10|||
27847686|NCT03451045|54340356|FG001|Overall Study|any other reason|2|||
27847687|NCT03451045|54340357|FG002|Overall Study|any other reason|13|||
27847688|NCT03219567|54340368|FG000|Overall Study|Withdrawal by Subject|0|||
27847689|NCT03219567|54340369|FG001|Overall Study|Withdrawal by Subject|1|||
27847690|NCT01386125|54340378|FG000|Overall Study|Lost to Follow-up|3|||
27809622|NCT01892540|54265374|FG000|Overall Study|Did not fit in scanner|0|||
27847691|NCT01386125|54340379|FG001|Overall Study|Lost to Follow-up|9|||
27847692|NCT01386125|54340378|FG000|Overall Study|Physician Decision|0|||
27847693|NCT01386125|54340379|FG001|Overall Study|Physician Decision|1|||
27847694|NCT01386125|54340378|FG000|Overall Study|Protocol Violation|5|||
27847695|NCT01386125|54340379|FG001|Overall Study|Protocol Violation|7|||
27847696|NCT01386125|54340378|FG000|Overall Study|Disease Progress|1|||
27847697|NCT01386125|54340379|FG001|Overall Study|Disease Progress|2|||
27847698|NCT01386125|54340378|FG000|Overall Study|Withdrawal by Subject|13|||
27847699|NCT01386125|54340379|FG001|Overall Study|Withdrawal by Subject|12|||
27847700|NCT01386125|54340378|FG000|Overall Study|Adverse Event|2|||
27847701|NCT01386125|54340379|FG001|Overall Study|Adverse Event|5|||
27847702|NCT01386125|54340378|FG000|Overall Study|Lack of Efficacy|0|||
27847703|NCT01386125|54340379|FG001|Overall Study|Lack of Efficacy|1|||
27847704|NCT01386125|54340378|FG000|Overall Study|Participant Leaving Country|1|||
27847705|NCT01386125|54340379|FG001|Overall Study|Participant Leaving Country|0|||
27847706|NCT01384877|54340387|FG000|Treatment 2|Lost to Follow-up|2|||
27847707|NCT01384877|54340388|FG001|Treatment 2|Lost to Follow-up|2|||
27847708|NCT00114517|54340398|FG000|Overall Study|Adverse Event|6|||
27847709|NCT00114517|54340399|FG001|Overall Study|Adverse Event|1|||
27847710|NCT00114517|54340400|FG002|Overall Study|Adverse Event|6|||
27847711|NCT00114517|54340401|FG003|Overall Study|Adverse Event|3|||
27847712|NCT00114517|54340398|FG000|Overall Study|Lost to Follow-up|2|||
27847713|NCT00114517|54340399|FG001|Overall Study|Lost to Follow-up|2|||
27847714|NCT00114517|54340400|FG002|Overall Study|Lost to Follow-up|2|||
27847715|NCT00114517|54340401|FG003|Overall Study|Lost to Follow-up|1|||
27847716|NCT00114517|54340398|FG000|Overall Study|Too busy|3|||
27847717|NCT00114517|54340399|FG001|Overall Study|Too busy|1|||
27847718|NCT00114517|54340400|FG002|Overall Study|Too busy|1|||
27847719|NCT00114517|54340401|FG003|Overall Study|Too busy|2|||
27847720|NCT00114517|54340398|FG000|Overall Study|Moved from area|0|||
27847721|NCT00114517|54340399|FG001|Overall Study|Moved from area|3|||
27847722|NCT00114517|54340400|FG002|Overall Study|Moved from area|2|||
27847723|NCT00114517|54340401|FG003|Overall Study|Moved from area|1|||
27847724|NCT00114517|54340398|FG000|Overall Study|Did not want estradiol|1|||
27847725|NCT00114517|54340399|FG001|Overall Study|Did not want estradiol|1|||
27847726|NCT00114517|54340400|FG002|Overall Study|Did not want estradiol|0|||
27847727|NCT00114517|54340401|FG003|Overall Study|Did not want estradiol|0|||
27847728|NCT00114517|54340398|FG000|Overall Study|Armed-services duty|0|||
27847729|NCT00114517|54340399|FG001|Overall Study|Armed-services duty|1|||
27847730|NCT00114517|54340400|FG002|Overall Study|Armed-services duty|0|||
27847731|NCT00114517|54340401|FG003|Overall Study|Armed-services duty|1|||
27847732|NCT00114517|54340398|FG000|Overall Study|Competing family issue|0|||
27847733|NCT00114517|54340399|FG001|Overall Study|Competing family issue|1|||
27847734|NCT00114517|54340400|FG002|Overall Study|Competing family issue|0|||
27847735|NCT00114517|54340401|FG003|Overall Study|Competing family issue|1|||
27847736|NCT00114517|54340398|FG000|Overall Study|Physician Decision|0|||
27847737|NCT00114517|54340399|FG001|Overall Study|Physician Decision|1|||
27847738|NCT00114517|54340400|FG002|Overall Study|Physician Decision|0|||
27847739|NCT00114517|54340401|FG003|Overall Study|Physician Decision|0|||
27847740|NCT00114517|54340398|FG000|Overall Study|Lost interest|0|||
27847741|NCT00114517|54340399|FG001|Overall Study|Lost interest|0|||
27847742|NCT00114517|54340400|FG002|Overall Study|Lost interest|1|||
27847743|NCT00114517|54340401|FG003|Overall Study|Lost interest|0|||
27847744|NCT00114517|54340398|FG000|Overall Study|Weight increase|0|||
27847745|NCT00114517|54340399|FG001|Overall Study|Weight increase|0|||
27847746|NCT00114517|54340400|FG002|Overall Study|Weight increase|1|||
27847747|NCT00114517|54340401|FG003|Overall Study|Weight increase|0|||
27847748|NCT00114517|54340398|FG000|Overall Study|Concern about blood clots|0|||
27847749|NCT00114517|54340399|FG001|Overall Study|Concern about blood clots|0|||
27847750|NCT00114517|54340400|FG002|Overall Study|Concern about blood clots|1|||
27847751|NCT00114517|54340401|FG003|Overall Study|Concern about blood clots|0|||
27847752|NCT00114517|54340398|FG000|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
27847753|NCT00114517|54340399|FG001|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
27847754|NCT00114517|54340400|FG002|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
27847755|NCT00114517|54340401|FG003|Overall Study|Breast cancer diagnosis on baseline mammogram|1|||
27847756|NCT01384019|54340454|FG000|Overall Study|Withdrawal by Subject|3|||
27847757|NCT01384019|54340455|FG001|Overall Study|Withdrawal by Subject|0|||
27847758|NCT01384019|54340454|FG000|Overall Study|Death|1|||
27847759|NCT01384019|54340455|FG001|Overall Study|Death|0|||
27847760|NCT01384019|54340454|FG000|Overall Study|MRI refusal|6|||
27847761|NCT01384019|54340455|FG001|Overall Study|MRI refusal|6|||
27847762|NCT00033631|54340463|FG000|Overall Study|Protocol Violation|14|||
27847763|NCT00033631|54340464|FG001|Overall Study|Protocol Violation|11|||
27847764|NCT00033631|54340463|FG000|Overall Study|Withdrawal by Subject|4|||
27847765|NCT00033631|54340464|FG001|Overall Study|Withdrawal by Subject|4|||
27847766|NCT01471574|54340475|FG000|Treatment Period|Lack of Efficacy|12|||
27847767|NCT01471574|54340476|FG001|Treatment Period|Lack of Efficacy|4|||
27847768|NCT01471574|54340477|FG002|Treatment Period|Lack of Efficacy|14|||
27847769|NCT01471574|54340478|FG003|Treatment Period|Lack of Efficacy|1|||
27847770|NCT01471574|54340475|FG000|Treatment Period|Adverse Event|7|||
27847771|NCT01471574|54340476|FG001|Treatment Period|Adverse Event|3|||
27847772|NCT01471574|54340477|FG002|Treatment Period|Adverse Event|6|||
27847773|NCT01471574|54340478|FG003|Treatment Period|Adverse Event|1|||
27847774|NCT01471574|54340475|FG000|Treatment Period|Withdrawal by Subject|5|||
27847775|NCT01471574|54340476|FG001|Treatment Period|Withdrawal by Subject|1|||
27847776|NCT01471574|54340477|FG002|Treatment Period|Withdrawal by Subject|1|||
27847777|NCT01471574|54340478|FG003|Treatment Period|Withdrawal by Subject|0|||
27847778|NCT01471574|54340475|FG000|Treatment Period|Patient Requested Discontinue Study drug|4|||
27847779|NCT01471574|54340476|FG001|Treatment Period|Patient Requested Discontinue Study drug|0|||
27847780|NCT01471574|54340477|FG002|Treatment Period|Patient Requested Discontinue Study drug|1|||
27847781|NCT01471574|54340478|FG003|Treatment Period|Patient Requested Discontinue Study drug|1|||
27847782|NCT01471574|54340475|FG000|Treatment Period|Lost to Follow-up|1|||
27847783|NCT01471574|54340476|FG001|Treatment Period|Lost to Follow-up|2|||
27847784|NCT01471574|54340477|FG002|Treatment Period|Lost to Follow-up|2|||
27847785|NCT01471574|54340478|FG003|Treatment Period|Lost to Follow-up|0|||
27847786|NCT01471574|54340475|FG000|Treatment Period|Patient no Longer Meets Study Criteria|1|||
27847787|NCT01471574|54340476|FG001|Treatment Period|Patient no Longer Meets Study Criteria|0|||
27847788|NCT01471574|54340477|FG002|Treatment Period|Patient no Longer Meets Study Criteria|0|||
27847789|NCT01471574|54340478|FG003|Treatment Period|Patient no Longer Meets Study Criteria|0|||
27847790|NCT01471574|54340475|FG000|Treatment Period|Other|1|||
27847791|NCT01471574|54340476|FG001|Treatment Period|Other|0|||
27847792|NCT01471574|54340477|FG002|Treatment Period|Other|0|||
27847793|NCT01471574|54340478|FG003|Treatment Period|Other|0|||
27847794|NCT01471574|54340475|FG000|Follow-up Period|Withdrawal by Subject|3|||
27847795|NCT01471574|54340476|FG001|Follow-up Period|Withdrawal by Subject|0|||
27847796|NCT01471574|54340477|FG002|Follow-up Period|Withdrawal by Subject|3|||
27847797|NCT01471574|54340478|FG003|Follow-up Period|Withdrawal by Subject|1|||
27847798|NCT01471574|54340475|FG000|Follow-up Period|Lost to Follow-up|4|||
27847799|NCT01471574|54340476|FG001|Follow-up Period|Lost to Follow-up|1|||
27847800|NCT01471574|54340477|FG002|Follow-up Period|Lost to Follow-up|3|||
27847801|NCT01471574|54340478|FG003|Follow-up Period|Lost to Follow-up|2|||
27847802|NCT01471574|54340475|FG000|Follow-up Period|Death|0|||
27847803|NCT01471574|54340476|FG001|Follow-up Period|Death|0|||
27847804|NCT01471574|54340477|FG002|Follow-up Period|Death|1|||
27847805|NCT01471574|54340478|FG003|Follow-up Period|Death|0|||
27847806|NCT01471574|54340475|FG000|Follow-up Period|Follow-up no longer required|0|||
27847807|NCT01471574|54340476|FG001|Follow-up Period|Follow-up no longer required|1|||
27847808|NCT01471574|54340477|FG002|Follow-up Period|Follow-up no longer required|0|||
27847809|NCT01471574|54340478|FG003|Follow-up Period|Follow-up no longer required|0|||
27847810|NCT01383707|54340494|FG000|Overall Study|Consent withdrawal|6|||
27847811|NCT01383707|54340494|FG000|Overall Study|Death|19|||
27847812|NCT01383707|54340494|FG000|Overall Study|Other|8|||
27847813|NCT01383707|54340494|FG000|Overall Study|Sponsor's decision|2|||
27847814|NCT01383707|54340494|FG000|Overall Study|Adverse Event|14|||
27847815|NCT01383707|54340494|FG000|Overall Study|Progressive disease|23|||
27847816|NCT01383317|54340500|FG000|Overall Study|Lost to Follow-up|2|||
27847817|NCT01383317|54340501|FG001|Overall Study|Lost to Follow-up|1|||
27847818|NCT01383317|54340500|FG000|Overall Study|Death|1|||
27847819|NCT01383317|54340501|FG001|Overall Study|Death|0|||
27847820|NCT01383317|54340500|FG000|Overall Study|Adverse Event|0|||
27847821|NCT01383317|54340501|FG001|Overall Study|Adverse Event|1|||
27847822|NCT01455428|54340509|FG000|Overall Study|Protocol Violation|2|||
27847823|NCT01455428|54340510|FG001|Overall Study|Protocol Violation|1|||
27847824|NCT01455428|54340509|FG000|Overall Study|Adverse Event|6|||
27847825|NCT01455428|54340510|FG001|Overall Study|Adverse Event|2|||
28037748|NCT00382018|54695703|FG001|Overall Study|Progression|136|||
28037749|NCT00382018|54695704|FG002|Overall Study|Progression|51|||
28037750|NCT00382018|54695705|FG003|Overall Study|Progression|43|||
28037751|NCT00382018|54695702|FG000|Overall Study|Death|0|||
28037752|NCT00382018|54695703|FG001|Overall Study|Death|9|||
28037753|NCT00382018|54695704|FG002|Overall Study|Death|7|||
28037754|NCT00382018|54695705|FG003|Overall Study|Death|11|||
28037755|NCT00382018|54695702|FG000|Overall Study|Withdrawal by Subject|0|||
28037756|NCT00382018|54695703|FG001|Overall Study|Withdrawal by Subject|4|||
28037757|NCT00382018|54695704|FG002|Overall Study|Withdrawal by Subject|3|||
27847826|NCT01455428|54340509|FG000|Overall Study|Lost to Follow-up|1|||
27847827|NCT01455428|54340510|FG001|Overall Study|Lost to Follow-up|1|||
27847828|NCT01455428|54340509|FG000|Overall Study|Withdrawal by Subject|2|||
27847829|NCT01455428|54340510|FG001|Overall Study|Withdrawal by Subject|5|||
27847830|NCT01455428|54340509|FG000|Overall Study|Did not meet entrance criteria|0|||
27847831|NCT01455428|54340510|FG001|Overall Study|Did not meet entrance criteria|2|||
27847832|NCT01455428|54340509|FG000|Overall Study|Insufficient clinical response|0|||
27847833|NCT01455428|54340510|FG001|Overall Study|Insufficient clinical response|2|||
27847834|NCT01455428|54340509|FG000|Overall Study|Did not receive treatment|1|||
27847835|NCT01455428|54340510|FG001|Overall Study|Did not receive treatment|1|||
27847836|NCT01455428|54340509|FG000|Overall Study|Other|2|||
27847837|NCT01455428|54340510|FG001|Overall Study|Other|4|||
28037758|NCT00382018|54695705|FG003|Overall Study|Withdrawal by Subject|4|||
28037759|NCT00382018|54695702|FG000|Overall Study|Other, not protocol specified|0|||
28037760|NCT00382018|54695703|FG001|Overall Study|Other, not protocol specified|16|||
28037761|NCT00382018|54695704|FG002|Overall Study|Other, not protocol specified|3|||
28037762|NCT00382018|54695705|FG003|Overall Study|Other, not protocol specified|1|||
28037763|NCT00640601|54695718|FG000|Overall Study|Adverse Event|43|||
28037764|NCT00640601|54695718|FG000|Overall Study|Withdrawal by Subject|20|||
28037765|NCT00640601|54695718|FG000|Overall Study|Protocol Violation|6|||
28037766|NCT00640601|54695718|FG000|Overall Study|Lack of Efficacy|16|||
28037767|NCT00640601|54695718|FG000|Overall Study|Lost to Follow-up|9|||
28037768|NCT00640601|54695718|FG000|Overall Study|Physician Decision|8|||
28037769|NCT00640601|54695718|FG000|Overall Study|treatment naive, combination therapy|10|||
28037770|NCT03838731|54695724|FG000|Overall Study|Pregnancy|0|||
28037771|NCT03838731|54695725|FG001|Overall Study|Pregnancy|1|||
28037772|NCT03838731|54695724|FG000|Overall Study|Withdrawal of consent|1|||
28037773|NCT03838731|54695725|FG001|Overall Study|Withdrawal of consent|0|||
28037774|NCT00452439|54695733|FG000|Overall Study|Lost to Follow-up|1|||
28037775|NCT00452439|54695734|FG001|Overall Study|Lost to Follow-up|1|||
28037776|NCT00452439|54695733|FG000|Overall Study|Refused Treatment|4|||
28037777|NCT00452439|54695734|FG001|Overall Study|Refused Treatment|3|||
28037778|NCT00452439|54695733|FG000|Overall Study|Death|3|||
28037779|NCT00452439|54695734|FG001|Overall Study|Death|1|||
28037780|NCT00452439|54695733|FG000|Overall Study|Bone Marrow Transplant|0|||
28037781|NCT00452439|54695734|FG001|Overall Study|Bone Marrow Transplant|1|||
28037782|NCT00452439|54695733|FG000|Overall Study|Too Ill to Continue|0|||
28037783|NCT00452439|54695734|FG001|Overall Study|Too Ill to Continue|1|||
28037784|NCT00452439|54695733|FG000|Overall Study|Failed to achieve complete response|2|||
28037785|NCT00452439|54695734|FG001|Overall Study|Failed to achieve complete response|0|||
28037786|NCT00452439|54695733|FG000|Overall Study|Relapse|3|||
28037787|NCT00452439|54695734|FG001|Overall Study|Relapse|0|||
28037788|NCT00452439|54695733|FG000|Overall Study|Fracture|1|||
28037789|NCT00452439|54695734|FG001|Overall Study|Fracture|0|||
28037790|NCT00381940|54695740|FG000|Overall Study|Lack of Efficacy|3|||
28037791|NCT00381940|54695740|FG000|Overall Study|Protocol Violation|1|||
28037792|NCT00381940|54695740|FG000|Overall Study|Ineligible|1|||
28037793|NCT00364156|54695746|FG000|Overall Study|Withdrawal by Subject|73|||
28037794|NCT00364156|54695747|FG001|Overall Study|Withdrawal by Subject|80|||
28037795|NCT00364156|54695746|FG000|Overall Study|Protocol Violation|6|||
28037796|NCT00364156|54695747|FG001|Overall Study|Protocol Violation|1|||
28037797|NCT00452361|54695755|FG000|Overall Study|Adverse Event|8|||
28037798|NCT00452361|54695756|FG001|Overall Study|Adverse Event|0|||
28037799|NCT00452361|54695755|FG000|Overall Study|Withdrawal by Subject|0|||
28037800|NCT00452361|54695756|FG001|Overall Study|Withdrawal by Subject|1|||
28037801|NCT00452361|54695755|FG000|Overall Study|Premature termination|13|||
28037802|NCT00452361|54695756|FG001|Overall Study|Premature termination|9|||
28037803|NCT00640289|54695762|FG000|Overall Study|Death|3|||
28037804|NCT00640289|54695762|FG000|Overall Study|Withdrawal by Subject|1|||
28037805|NCT00640289|54695762|FG000|Overall Study|Lost to Follow-up|1|||
28037806|NCT00640289|54695762|FG000|Overall Study|Data collected under different amendment|2|||
28037807|NCT00640289|54695762|FG000|Overall Study|Transferred to another center|1|||
28037808|NCT00640289|54695762|FG000|Overall Study|Missing status|5|||
28037809|NCT00568451|54695770|FG000|Overall Study|Disease Progression|0|||
28037810|NCT00568451|54695771|FG001|Overall Study|Disease Progression|0|||
28037811|NCT00568451|54695772|FG002|Overall Study|Disease Progression|2|||
28037812|NCT00568451|54695773|FG003|Overall Study|Disease Progression|7|||
28037813|NCT00459537|54695786|FG000|Overall Study|Adverse Event|1|||
28037814|NCT00459537|54695787|FG001|Overall Study|Adverse Event|6|||
28037815|NCT00459537|54695786|FG000|Overall Study|Lack of Efficacy|10|||
28037816|NCT00459537|54695787|FG001|Overall Study|Lack of Efficacy|11|||
28037817|NCT00459537|54695786|FG000|Overall Study|Withdrawal by Subject|20|||
28037818|NCT00459537|54695787|FG001|Overall Study|Withdrawal by Subject|26|||
27847838|NCT01383161|54340518|FG000|Overall Study|Adverse Event|5|||
27847839|NCT01383161|54340519|FG001|Overall Study|Adverse Event|1|||
28037819|NCT00459537|54695786|FG000|Overall Study|Lost to Follow-up|27|||
28037820|NCT00459537|54695787|FG001|Overall Study|Lost to Follow-up|30|||
28037821|NCT00459537|54695786|FG000|Overall Study|Administrative problems|3|||
27847840|NCT01383161|54340518|FG000|Overall Study|Withdrawal by Subject|0|||
28037822|NCT00459537|54695787|FG001|Overall Study|Administrative problems|0|||
28037823|NCT00459537|54695786|FG000|Overall Study|Protocol Violation|4|||
28037824|NCT00459537|54695787|FG001|Overall Study|Protocol Violation|3|||
28037825|NCT00459537|54695786|FG000|Overall Study|Missing|1|||
28037826|NCT00459537|54695787|FG001|Overall Study|Missing|0|||
28037827|NCT03850509|54695795|FG000|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|2|||
28037828|NCT03850509|54695796|FG001|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|1|||
27847841|NCT01383161|54340519|FG001|Overall Study|Withdrawal by Subject|2|||
28037829|NCT00635999|54695805|FG000|Overall Study|Withdrawal by Subject|4|||
28037830|NCT00635999|54695806|FG001|Overall Study|Withdrawal by Subject|2|||
28037831|NCT00635999|54695807|FG002|Overall Study|Withdrawal by Subject|1|||
27847842|NCT01383161|54340518|FG000|Overall Study|Lack of Efficacy|0|||
28037832|NCT00469209|54695818|FG000|Overall Study|Adverse Event|1|||
28037833|NCT00469209|54695819|FG001|Overall Study|Adverse Event|0|||
28037834|NCT00469209|54695820|FG002|Overall Study|Adverse Event|1|||
28037835|NCT00635219|54695833|FG000|Overall Study|Adverse Event|12|||
28037836|NCT00635219|54695834|FG001|Overall Study|Adverse Event|10|||
28037837|NCT00635219|54695835|FG002|Overall Study|Adverse Event|18|||
28037838|NCT00635219|54695836|FG003|Overall Study|Adverse Event|15|||
28037839|NCT00635219|54695837|FG004|Overall Study|Adverse Event|19|||
28037840|NCT00635219|54695833|FG000|Overall Study|Lack of Efficacy|5|||
28037841|NCT00635219|54695834|FG001|Overall Study|Lack of Efficacy|6|||
28037842|NCT00635219|54695835|FG002|Overall Study|Lack of Efficacy|3|||
28037843|NCT00635219|54695836|FG003|Overall Study|Lack of Efficacy|4|||
28037844|NCT00635219|54695837|FG004|Overall Study|Lack of Efficacy|6|||
28037845|NCT00635219|54695833|FG000|Overall Study|Non-compliance With Study Product|0|||
28037846|NCT00635219|54695834|FG001|Overall Study|Non-compliance With Study Product|0|||
28037847|NCT00635219|54695835|FG002|Overall Study|Non-compliance With Study Product|0|||
28037848|NCT00635219|54695836|FG003|Overall Study|Non-compliance With Study Product|2|||
28037849|NCT00635219|54695837|FG004|Overall Study|Non-compliance With Study Product|1|||
28037850|NCT00635219|54695833|FG000|Overall Study|Protocol Violation|0|||
28037851|NCT00635219|54695834|FG001|Overall Study|Protocol Violation|2|||
28037852|NCT00635219|54695835|FG002|Overall Study|Protocol Violation|3|||
28037853|NCT00635219|54695836|FG003|Overall Study|Protocol Violation|2|||
28037854|NCT00635219|54695837|FG004|Overall Study|Protocol Violation|4|||
28037855|NCT00635219|54695833|FG000|Overall Study|Withdrawal of Consent|8|||
28037856|NCT00635219|54695834|FG001|Overall Study|Withdrawal of Consent|6|||
28037857|NCT00635219|54695835|FG002|Overall Study|Withdrawal of Consent|8|||
28037858|NCT00635219|54695836|FG003|Overall Study|Withdrawal of Consent|11|||
28037859|NCT00635219|54695837|FG004|Overall Study|Withdrawal of Consent|8|||
28037860|NCT00635219|54695833|FG000|Overall Study|Lost to Follow-up|0|||
28037861|NCT00635219|54695834|FG001|Overall Study|Lost to Follow-up|0|||
28037862|NCT00635219|54695835|FG002|Overall Study|Lost to Follow-up|2|||
28037863|NCT00635219|54695836|FG003|Overall Study|Lost to Follow-up|0|||
28037864|NCT00635219|54695837|FG004|Overall Study|Lost to Follow-up|3|||
28037865|NCT00635219|54695833|FG000|Overall Study|Administrative or Other Reasons|0|||
28037866|NCT00635219|54695834|FG001|Overall Study|Administrative or Other Reasons|1|||
28037867|NCT00635219|54695835|FG002|Overall Study|Administrative or Other Reasons|1|||
28037868|NCT00635219|54695836|FG003|Overall Study|Administrative or Other Reasons|0|||
28037869|NCT00635219|54695837|FG004|Overall Study|Administrative or Other Reasons|1|||
28037870|NCT00363766|54695851|FG000|Overall Study|Progressive Disease|15|||
28037871|NCT00363766|54695852|FG001|Overall Study|Progressive Disease|9|||
28037872|NCT00363766|54695851|FG000|Overall Study|Adverse Event|10|||
28037873|NCT00363766|54695852|FG001|Overall Study|Adverse Event|2|||
28037874|NCT00363766|54695851|FG000|Overall Study|Disease Related Death|1|||
28037875|NCT00363766|54695852|FG001|Overall Study|Disease Related Death|3|||
28037876|NCT00363766|54695851|FG000|Overall Study|Not Disease Related Death|3|||
28037877|NCT00363766|54695852|FG001|Overall Study|Not Disease Related Death|4|||
28037878|NCT00363766|54695851|FG000|Overall Study|Withdrawal by Subject|2|||
28037879|NCT00363766|54695852|FG001|Overall Study|Withdrawal by Subject|0|||
28037880|NCT00363766|54695851|FG000|Overall Study|Physician Decision|1|||
28037881|NCT00363766|54695852|FG001|Overall Study|Physician Decision|2|||
28037882|NCT00468819|54695862|FG000|Overall Study|Withdrawal by Subject|4|||
28037883|NCT00468819|54695863|FG001|Overall Study|Withdrawal by Subject|0|||
28037884|NCT00468819|54695864|FG002|Overall Study|Withdrawal by Subject|1|||
28037885|NCT00468819|54695862|FG000|Overall Study|Lost to Follow-up|0|||
28037886|NCT00468819|54695863|FG001|Overall Study|Lost to Follow-up|0|||
28037887|NCT00468819|54695864|FG002|Overall Study|Lost to Follow-up|1|||
28037888|NCT00468819|54695862|FG000|Overall Study|Drop-outs (Treatment never received)|2|||
28037889|NCT00468819|54695863|FG001|Overall Study|Drop-outs (Treatment never received)|0|||
28037890|NCT00468819|54695864|FG002|Overall Study|Drop-outs (Treatment never received)|0|||
28037891|NCT00451191|54695876|FG000|Overall Study|withdrawal or received alternate tx|15|||
28037892|NCT00451191|54695877|FG001|Overall Study|withdrawal or received alternate tx|11|||
28037893|NCT00451035|54695883|FG000|Overall Study|Disease progression|11|||
28037894|NCT00451035|54695883|FG000|Overall Study|Death|3|||
28037895|NCT00451035|54695883|FG000|Overall Study|New anti-neoplastic therapy|3|||
28037896|NCT00468585|54695892|FG000|Overall Study|Patient not treated|1|||
27847843|NCT01383161|54340519|FG001|Overall Study|Lack of Efficacy|1|||
28037897|NCT00468585|54695893|FG001|Overall Study|Patient not treated|0|||
28037898|NCT00468585|54695894|FG002|Overall Study|Patient not treated|1|||
28037899|NCT00468585|54695895|FG003|Overall Study|Patient not treated|0|||
28037900|NCT00468585|54695892|FG000|Overall Study|Patient found to be ineligible|0|||
28037901|NCT00468585|54695893|FG001|Overall Study|Patient found to be ineligible|0|||
28037902|NCT00468585|54695894|FG002|Overall Study|Patient found to be ineligible|1|||
28037903|NCT00468585|54695895|FG003|Overall Study|Patient found to be ineligible|0|||
28037904|NCT00468585|54695892|FG000|Overall Study|Adverse Event|0|||
28037905|NCT00468585|54695893|FG001|Overall Study|Adverse Event|0|||
28037906|NCT00468585|54695894|FG002|Overall Study|Adverse Event|1|||
28037907|NCT00468585|54695895|FG003|Overall Study|Adverse Event|0|||
28037908|NCT00468585|54695892|FG000|Overall Study|Withdrawal by Subject|0|||
28037909|NCT00468585|54695893|FG001|Overall Study|Withdrawal by Subject|0|||
28037910|NCT00468585|54695894|FG002|Overall Study|Withdrawal by Subject|2|||
28037911|NCT00468585|54695895|FG003|Overall Study|Withdrawal by Subject|1|||
28037912|NCT00450801|54695905|FG000|Overall Study|Death|1|||
28037913|NCT00458211|54695914|FG000|Overall Study|Lack of Efficacy|12|||
28037914|NCT00458211|54695914|FG000|Overall Study|Withdrawal by Subject|2|||
28037915|NCT00458211|54695914|FG000|Overall Study|Protocol Violation|2|||
28037916|NCT00450723|54695922|FG000|Overall Study|Physician Decision|5|||
28037917|NCT00467961|54695927|FG000|Overall Study|Technical Failures|5|||
28037918|NCT00467961|54695927|FG000|Overall Study|Disease Progression|2|||
28037919|NCT00457821|54695939|FG000|Part 2|Withdrawal by Subject|0|||
28037920|NCT00457821|54695940|FG001|Part 2|Withdrawal by Subject|0|||
28037921|NCT00457821|54695941|FG002|Part 2|Withdrawal by Subject|0|||
28037922|NCT00457821|54695942|FG003|Part 2|Withdrawal by Subject|0|||
28037923|NCT00457821|54695943|FG004|Part 2|Withdrawal by Subject|0|||
28037924|NCT00457821|54695944|FG005|Part 2|Withdrawal by Subject|0|||
28037925|NCT00457821|54695945|FG006|Part 2|Withdrawal by Subject|0|||
28037926|NCT00457821|54695946|FG007|Part 2|Withdrawal by Subject|1|||
28037927|NCT00633893|54695966|FG000|Overall Study|Death|1|||
28037928|NCT00633893|54695967|FG001|Overall Study|Death|3|||
28037929|NCT00633893|54695968|FG002|Overall Study|Death|9|||
28037930|NCT00633893|54695966|FG000|Overall Study|Adverse Event|65|||
27939840|NCT01081912|54596203|FG002|Conversion/Titration|Adverse Event|0|||
28037931|NCT00633893|54695967|FG001|Overall Study|Adverse Event|58|||
28037932|NCT00633893|54695968|FG002|Overall Study|Adverse Event|126|||
28037933|NCT00633893|54695966|FG000|Overall Study|Withdrawal by Subject|7|||
28037934|NCT00633893|54695967|FG001|Overall Study|Withdrawal by Subject|12|||
28037935|NCT00633893|54695968|FG002|Overall Study|Withdrawal by Subject|6|||
28037936|NCT00633893|54695966|FG000|Overall Study|Lost to Follow-up|2|||
28037937|NCT00633893|54695967|FG001|Overall Study|Lost to Follow-up|4|||
28037938|NCT00633893|54695968|FG002|Overall Study|Lost to Follow-up|8|||
28037939|NCT00633893|54695966|FG000|Overall Study|Poor/non-compliance|5|||
28037940|NCT00633893|54695967|FG001|Overall Study|Poor/non-compliance|12|||
28037941|NCT00633893|54695968|FG002|Overall Study|Poor/non-compliance|3|||
27809623|NCT01892540|54265375|FG001|Overall Study|Did not fit in scanner|0|||
27809624|NCT01892540|54265376|FG002|Overall Study|Did not fit in scanner|1|||
27809625|NCT01385098|54265384|FG000|Overall Study|Adverse Event|10|||
27809626|NCT01385098|54265384|FG000|Overall Study|Lost to Follow-up|4|||
27809627|NCT01398514|54265392|FG000|Overall Study|Adverse Event|1|||
28037942|NCT00633893|54695966|FG000|Overall Study|Pregnancy|2|||
28037943|NCT00633893|54695967|FG001|Overall Study|Pregnancy|1|||
28037944|NCT00633893|54695968|FG002|Overall Study|Pregnancy|1|||
28037945|NCT00633893|54695966|FG000|Overall Study|Not meet/no longer meets criteria|4|||
28037946|NCT00633893|54695967|FG001|Overall Study|Not meet/no longer meets criteria|6|||
28037947|NCT00633893|54695968|FG002|Overall Study|Not meet/no longer meets criteria|4|||
28037948|NCT00633893|54695966|FG000|Overall Study|Other|28|||
28037949|NCT00633893|54695967|FG001|Overall Study|Other|33|||
28037950|NCT00633893|54695968|FG002|Overall Study|Other|31|||
28037951|NCT00457743|54695979|FG000|Overall Study|Adverse Event|0|||
28037952|NCT00457743|54695980|FG001|Overall Study|Adverse Event|4|||
28037953|NCT00457743|54695981|FG002|Overall Study|Adverse Event|0|||
28037954|NCT00457743|54695979|FG000|Overall Study|Lack of Efficacy|3|||
28037955|NCT00457743|54695980|FG001|Overall Study|Lack of Efficacy|23|||
28037956|NCT00457743|54695981|FG002|Overall Study|Lack of Efficacy|3|||
28037957|NCT00450411|54695990|FG000|Overall Study|Protocol Violation|6|||
28037958|NCT00450411|54695990|FG000|Overall Study|No protocol treatment|2|||
28037959|NCT00644969|54695996|FG000|Treatment Phase|Randomized, not treated|1|||
28037960|NCT00644969|54695997|FG001|Treatment Phase|Randomized, not treated|0|||
28037961|NCT00644969|54695996|FG000|Treatment Phase|Adverse Event|3|||
27809628|NCT01398514|54265393|FG001|Overall Study|Adverse Event|0|||
27809629|NCT01398514|54265392|FG000|Overall Study|Non-compliance with study procedures|2|||
27939841|NCT01081912|54596201|FG000|Conversion/Titration|Lack of Efficacy|17|||
28037962|NCT00644969|54695997|FG001|Treatment Phase|Adverse Event|0|||
28037963|NCT00644969|54695996|FG000|Treatment Phase|Withdrawal by Subject|4|||
28037964|NCT00644969|54695997|FG001|Treatment Phase|Withdrawal by Subject|0|||
28037965|NCT00644969|54695996|FG000|Treatment Phase|Lost to Follow-up|2|||
28037966|NCT00644969|54695997|FG001|Treatment Phase|Lost to Follow-up|2|||
28037967|NCT00644969|54695996|FG000|Treatment Phase|Other|4|||
28037968|NCT00644969|54695997|FG001|Treatment Phase|Other|1|||
28037969|NCT00644969|54695996|FG000|Post Treatment Phase|Death|1|||
28037970|NCT00644969|54695997|FG001|Post Treatment Phase|Death|0|||
28037971|NCT00644969|54695996|FG000|Post Treatment Phase|Withdrawal by Subject|4|||
28037972|NCT00644969|54695997|FG001|Post Treatment Phase|Withdrawal by Subject|2|||
28037973|NCT00644969|54695996|FG000|Post Treatment Phase|Lost to Follow-up|4|||
28037974|NCT00644969|54695997|FG001|Post Treatment Phase|Lost to Follow-up|1|||
28037975|NCT00644969|54695996|FG000|Post Treatment Phase|Other|1|||
27809630|NCT01398514|54265393|FG001|Overall Study|Non-compliance with study procedures|0|||
28037976|NCT00644969|54695997|FG001|Post Treatment Phase|Other|0|||
28037977|NCT00644423|54696005|FG000|Overall Study|Lost to Follow-up|1|||
28037978|NCT00644423|54696006|FG001|Overall Study|Lost to Follow-up|1|||
28037979|NCT00628355|54696014|FG000|Overall Study|Withdrawal by Subject|1|||
28037980|NCT00628355|54696015|FG001|Overall Study|Withdrawal by Subject|1|||
28037981|NCT00627497|54696026|FG000|Overall Study|Lost to Follow-up|1|||
28037982|NCT00627497|54696027|FG001|Overall Study|Lost to Follow-up|1|||
28037983|NCT00627497|54696028|FG002|Overall Study|Lost to Follow-up|0|||
28037984|NCT00627497|54696029|FG003|Overall Study|Lost to Follow-up|0|||
28037985|NCT00648167|54696039|FG000|Overall Study|Adverse Event|6|||
28037986|NCT00648167|54696039|FG000|Overall Study|unable to swallow tablets|1|||
28037987|NCT00647699|54696073|FG000|Overall Study|Lost to Follow-up|5|||
28037988|NCT00647699|54696074|FG001|Overall Study|Lost to Follow-up|4|||
28037989|NCT00647699|54696073|FG000|Overall Study|Withdrawal by Subject|3|||
28037990|NCT00647699|54696074|FG001|Overall Study|Withdrawal by Subject|8|||
28037991|NCT00467649|54696082|FG000|Phase 1 (Randomized Population)|Adverse Event|2|||
28037992|NCT00467649|54696083|FG001|Phase 1 (Randomized Population)|Adverse Event|0|||
28037993|NCT00467649|54696084|FG002|Phase 1 (Randomized Population)|Adverse Event|0|||
28037994|NCT00467649|54696085|FG003|Phase 1 (Randomized Population)|Adverse Event|0|||
28037995|NCT00467649|54696086|FG004|Phase 1 (Randomized Population)|Adverse Event|0|||
28037996|NCT00467649|54696087|FG005|Phase 1 (Randomized Population)|Adverse Event|0|||
28037997|NCT00467649|54696082|FG000|Phase 1 (Randomized Population)|Investigator Decision|1|||
28037998|NCT00467649|54696083|FG001|Phase 1 (Randomized Population)|Investigator Decision|0|||
28037999|NCT00467649|54696084|FG002|Phase 1 (Randomized Population)|Investigator Decision|0|||
28038000|NCT00467649|54696085|FG003|Phase 1 (Randomized Population)|Investigator Decision|0|||
28038001|NCT00467649|54696086|FG004|Phase 1 (Randomized Population)|Investigator Decision|0|||
28038002|NCT00467649|54696087|FG005|Phase 1 (Randomized Population)|Investigator Decision|0|||
28038003|NCT00467649|54696082|FG000|Phase 1 (Randomized Population)|Lost to Follow-up|2|||
28038004|NCT00467649|54696083|FG001|Phase 1 (Randomized Population)|Lost to Follow-up|4|||
28038005|NCT00467649|54696084|FG002|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
28038006|NCT00467649|54696085|FG003|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
28038007|NCT00467649|54696086|FG004|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
28038008|NCT00467649|54696087|FG005|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
28038009|NCT00467649|54696082|FG000|Phase 1 (Randomized Population)|Withdrawal of Consent|4|||
28038010|NCT00467649|54696083|FG001|Phase 1 (Randomized Population)|Withdrawal of Consent|2|||
28038011|NCT00467649|54696084|FG002|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
28038012|NCT00467649|54696085|FG003|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
28038013|NCT00467649|54696086|FG004|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
28038014|NCT00467649|54696087|FG005|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
28038015|NCT00467649|54696082|FG000|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
28038016|NCT00467649|54696083|FG001|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
28038017|NCT00467649|54696084|FG002|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
28038018|NCT00467649|54696085|FG003|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1|||
28038019|NCT00467649|54696086|FG004|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
28038020|NCT00467649|54696087|FG005|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
28038021|NCT00467649|54696082|FG000|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
28038022|NCT00467649|54696083|FG001|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
28038023|NCT00467649|54696084|FG002|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
28038024|NCT00467649|54696085|FG003|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1|||
28038025|NCT00467649|54696086|FG004|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
28038026|NCT00467649|54696087|FG005|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
28038027|NCT00467649|54696082|FG000|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
28038028|NCT00467649|54696083|FG001|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
28038029|NCT00467649|54696084|FG002|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
28038030|NCT00467649|54696085|FG003|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
28038031|NCT00467649|54696086|FG004|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
28038032|NCT00467649|54696087|FG005|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1|||
28038033|NCT00450333|54696109|FG000|Overall Study|Study terminated|47|||
28038034|NCT00450333|54696110|FG001|Overall Study|Study terminated|54|||
28038035|NCT00450333|54696111|FG002|Overall Study|Study terminated|16|||
28038036|NCT00450333|54696112|FG003|Overall Study|Study terminated|21|||
28038037|NCT00450333|54696109|FG000|Overall Study|Adverse Event|1|||
28038038|NCT00450333|54696110|FG001|Overall Study|Adverse Event|7|||
28038039|NCT00450333|54696111|FG002|Overall Study|Adverse Event|2|||
28038040|NCT00450333|54696112|FG003|Overall Study|Adverse Event|2|||
28038041|NCT00450333|54696109|FG000|Overall Study|Protocol Violation|1|||
28038042|NCT00450333|54696110|FG001|Overall Study|Protocol Violation|0|||
28038043|NCT00450333|54696111|FG002|Overall Study|Protocol Violation|1|||
28038044|NCT00450333|54696112|FG003|Overall Study|Protocol Violation|0|||
27939842|NCT01081912|54596202|FG001|Conversion/Titration|Lack of Efficacy|0|||
28038045|NCT00450333|54696109|FG000|Overall Study|Withdrawal by Subject|1|||
28038046|NCT00450333|54696110|FG001|Overall Study|Withdrawal by Subject|0|||
28038047|NCT00450333|54696111|FG002|Overall Study|Withdrawal by Subject|3|||
28038048|NCT00450333|54696112|FG003|Overall Study|Withdrawal by Subject|0|||
28038049|NCT00450333|54696109|FG000|Overall Study|Kidney transplant|1|||
28038050|NCT00450333|54696110|FG001|Overall Study|Kidney transplant|0|||
28038051|NCT00450333|54696111|FG002|Overall Study|Kidney transplant|1|||
28038052|NCT00450333|54696112|FG003|Overall Study|Kidney transplant|3|||
28038053|NCT00450333|54696109|FG000|Overall Study|Death|3|||
28038054|NCT00450333|54696110|FG001|Overall Study|Death|2|||
28038055|NCT00450333|54696111|FG002|Overall Study|Death|2|||
28038056|NCT00450333|54696112|FG003|Overall Study|Death|2|||
28038057|NCT00643565|54696124|FG000|Overall Study|Death|12|||
28038058|NCT00643565|54696125|FG001|Overall Study|Death|11|||
28038059|NCT00643565|54696124|FG000|Overall Study|Withdrawal by Subject|4|||
28038060|NCT00643565|54696125|FG001|Overall Study|Withdrawal by Subject|1|||
28038061|NCT00643565|54696124|FG000|Overall Study|Lost to Follow-up|0|||
28038062|NCT00643565|54696125|FG001|Overall Study|Lost to Follow-up|6|||
28038063|NCT00643565|54696124|FG000|Overall Study|Other|7|||
28038064|NCT00643565|54696125|FG001|Overall Study|Other|8|||
28038065|NCT00643565|54696124|FG000|Overall Study|Refused Treatment / Did Not Cooperate|0|||
28038066|NCT00643565|54696125|FG001|Overall Study|Refused Treatment / Did Not Cooperate|1|||
28038067|NCT00643565|54696124|FG000|Overall Study|Recurrence of Disease|2|||
28038068|NCT00643565|54696125|FG001|Overall Study|Recurrence of Disease|1|||
28038069|NCT00643565|54696124|FG000|Overall Study|Progression of Disease|18|||
28038070|NCT00643565|54696125|FG001|Overall Study|Progression of Disease|14|||
28038071|NCT00643565|54696124|FG000|Overall Study|Protocol Violation|3|||
28038072|NCT00643565|54696125|FG001|Overall Study|Protocol Violation|0|||
28038073|NCT00643565|54696124|FG000|Overall Study|Did Not Cooperate|0|||
28038074|NCT00643565|54696125|FG001|Overall Study|Did Not Cooperate|1|||
28038075|NCT00643565|54696124|FG000|Overall Study|Administrative|22|||
28038076|NCT00643565|54696125|FG001|Overall Study|Administrative|16|||
28038077|NCT00643565|54696124|FG000|Overall Study|Adverse Event|5|||
28038078|NCT00643565|54696125|FG001|Overall Study|Adverse Event|8|||
28038079|NCT00643487|54696132|FG000|Overall Study|Technical difficulty|3|||
28038080|NCT00450255|54696136|FG000|Overall Study|Prior RFA ablation of liver|1|||
28038081|NCT00450177|54696143|FG000|Overall Study|Adverse Event|7|||
28038082|NCT00450177|54696144|FG001|Overall Study|Adverse Event|4|||
28038083|NCT00450177|54696143|FG000|Overall Study|Withdrawal by Subject|1|||
28038084|NCT00450177|54696144|FG001|Overall Study|Withdrawal by Subject|6|||
28038085|NCT00450177|54696143|FG000|Overall Study|Withdrawal by Primary Team|1|||
28038086|NCT00450177|54696144|FG001|Overall Study|Withdrawal by Primary Team|1|||
28038087|NCT03848949|54696152|FG000|Overall Study|Lost to Follow-up|5|||
28038088|NCT03848949|54696153|FG001|Overall Study|Lost to Follow-up|7|||
28038089|NCT00467259|54696161|FG000|Overall Study|Adverse Event|24|||
28038090|NCT00467259|54696162|FG001|Overall Study|Adverse Event|90|||
28038091|NCT00467259|54696161|FG000|Overall Study|Protocol Violation|1|||
28038092|NCT00467259|54696162|FG001|Overall Study|Protocol Violation|7|||
28038093|NCT00467259|54696161|FG000|Overall Study|Withdrawal by Subject|34|||
28038094|NCT00467259|54696162|FG001|Overall Study|Withdrawal by Subject|108|||
28038095|NCT00467259|54696161|FG000|Overall Study|Physician Decision|0|||
28038096|NCT00467259|54696162|FG001|Overall Study|Physician Decision|2|||
28038097|NCT00467259|54696161|FG000|Overall Study|Lost to Follow-up|14|||
28038098|NCT00467259|54696162|FG001|Overall Study|Lost to Follow-up|34|||
28038099|NCT00467259|54696161|FG000|Overall Study|Site Closed|2|||
28038100|NCT00467259|54696162|FG001|Overall Study|Site Closed|1|||
28038101|NCT00449865|54696170|FG000|Overall Study|Withdrawal by Subject|110|||
28038102|NCT00449865|54696171|FG001|Overall Study|Withdrawal by Subject|110|||
28038103|NCT00449865|54696170|FG000|Overall Study|Lost to Follow-up|36|||
28038104|NCT00449865|54696171|FG001|Overall Study|Lost to Follow-up|37|||
28038105|NCT00449865|54696170|FG000|Overall Study|Physician Decision|13|||
28038106|NCT00449865|54696171|FG001|Overall Study|Physician Decision|12|||
28038107|NCT00449865|54696170|FG000|Overall Study|Death|31|||
28038108|NCT00449865|54696171|FG001|Overall Study|Death|40|||
28038109|NCT00449865|54696170|FG000|Overall Study|Protocol Violation|8|||
28038110|NCT00449865|54696171|FG001|Overall Study|Protocol Violation|7|||
28038111|NCT00449865|54696170|FG000|Overall Study|Study was stopped|324|||
28038112|NCT00449865|54696171|FG001|Overall Study|Study was stopped|328|||
28038113|NCT00449787|54696179|FG000|Overall Study|Lost to Follow-up|10|||
28038114|NCT00449787|54696180|FG001|Overall Study|Lost to Follow-up|8|||
28038115|NCT00449787|54696179|FG000|Overall Study|Did not require medication|95|||
28038116|NCT00449787|54696180|FG001|Overall Study|Did not require medication|92|||
28038117|NCT00449163|54696188|FG000|Overall Study|Physician Decision|3|||
28038118|NCT00448539|54696194|FG000|Overall Study|Medication non-compliance|4|||
28038119|NCT00448539|54696195|FG001|Overall Study|Medication non-compliance|1|||
28038120|NCT00448539|54696194|FG000|Overall Study|Protocol Violation|1|||
28038121|NCT00448539|54696195|FG001|Overall Study|Protocol Violation|0|||
28038122|NCT00448539|54696194|FG000|Overall Study|Request of the investigator or sponsor|67|||
28038123|NCT00448539|54696195|FG001|Overall Study|Request of the investigator or sponsor|54|||
28038124|NCT00448539|54696194|FG000|Overall Study|Withdrawal by Subject|20|||
28038125|NCT00448539|54696195|FG001|Overall Study|Withdrawal by Subject|24|||
28038126|NCT00448539|54696194|FG000|Overall Study|Diary non-compliance|1|||
28038127|NCT00448539|54696195|FG001|Overall Study|Diary non-compliance|0|||
28038128|NCT00448539|54696194|FG000|Overall Study|Adverse Event|9|||
28038129|NCT00448539|54696195|FG001|Overall Study|Adverse Event|26|||
28038130|NCT00448539|54696194|FG000|Overall Study|Lack of Efficacy|27|||
28038131|NCT00448539|54696195|FG001|Overall Study|Lack of Efficacy|40|||
28038132|NCT00448539|54696194|FG000|Overall Study|Miscellaneous|2|||
28038133|NCT00448539|54696195|FG001|Overall Study|Miscellaneous|1|||
28038134|NCT00448539|54696194|FG000|Overall Study|Change of meds|2|||
28038135|NCT00448539|54696195|FG001|Overall Study|Change of meds|3|||
28038136|NCT00448539|54696194|FG000|Overall Study|Lost to Follow-up|1|||
28038137|NCT00448539|54696195|FG001|Overall Study|Lost to Follow-up|3|||
28038138|NCT00457665|54696203|FG000|12 Months|Drug allergy|1|||
28038139|NCT00457665|54696204|FG001|12 Months|Drug allergy|1|||
28038140|NCT00457665|54696203|FG000|12 Months|High HIV viral load|5|||
28038141|NCT00457665|54696204|FG001|12 Months|High HIV viral load|1|||
28038142|NCT00457665|54696203|FG000|12 Months|Lipodystrophy|2|||
28038143|NCT00457665|54696204|FG001|12 Months|Lipodystrophy|0|||
28038144|NCT00457665|54696203|FG000|12 Months|Withdrawal by Subject|0|||
28038145|NCT00457665|54696204|FG001|12 Months|Withdrawal by Subject|2|||
28038146|NCT00457665|54696203|FG000|12 Months|Abnormal Liver function tests|0|||
28038147|NCT00457665|54696204|FG001|12 Months|Abnormal Liver function tests|5|||
28038148|NCT00457665|54696203|FG000|24 Months|Withdrawal by Subject|3|||
28038149|NCT00457665|54696204|FG001|24 Months|Withdrawal by Subject|2|||
28038150|NCT00457665|54696203|FG000|24 Months|Lipodystrophy|1|||
28038151|NCT00457665|54696204|FG001|24 Months|Lipodystrophy|1|||
28038152|NCT00457665|54696203|FG000|24 Months|Abnormal liver function tests|1|||
28038153|NCT00457665|54696204|FG001|24 Months|Abnormal liver function tests|5|||
28038154|NCT00447603|54696210|FG000|Screening|Withdrawal by Subject|1|||
28038155|NCT00447603|54696211|FG001|Screening|Withdrawal by Subject|0|||
28038156|NCT00447603|54696212|FG002|Screening|Withdrawal by Subject|0|||
28038157|NCT00447603|54696210|FG000|Screening|Protocol Violation|1|||
28038158|NCT00447603|54696211|FG001|Screening|Protocol Violation|0|||
28038159|NCT00447603|54696212|FG002|Screening|Protocol Violation|0|||
28038160|NCT00447603|54696210|FG000|Screening|Screen Failure|4|||
28038161|NCT00447603|54696211|FG001|Screening|Screen Failure|0|||
28038162|NCT00447603|54696212|FG002|Screening|Screen Failure|0|||
28038163|NCT00447603|54696210|FG000|Screening|Study Terminated by Sponsor|15|||
28038164|NCT00447603|54696211|FG001|Screening|Study Terminated by Sponsor|0|||
28038165|NCT00447603|54696212|FG002|Screening|Study Terminated by Sponsor|0|||
28038166|NCT00447603|54696210|FG000|Filter Period|Adverse Event|0|||
28038167|NCT00447603|54696211|FG001|Filter Period|Adverse Event|0|||
28038168|NCT00447603|54696212|FG002|Filter Period|Adverse Event|1|||
28038169|NCT00447603|54696210|FG000|Filter Period|Screen Failure|0|||
28038170|NCT00447603|54696211|FG001|Filter Period|Screen Failure|3|||
28038171|NCT00447603|54696212|FG002|Filter Period|Screen Failure|4|||
28038172|NCT00447603|54696210|FG000|Filter Period|Study terminated by Sponsor|0|||
28038173|NCT00447603|54696211|FG001|Filter Period|Study terminated by Sponsor|1|||
28038174|NCT00447603|54696212|FG002|Filter Period|Study terminated by Sponsor|10|||
28038175|NCT00447057|54696224|FG000|Overall Study|Adverse Event|4|||
28038176|NCT00447057|54696225|FG001|Overall Study|Adverse Event|10|||
28038177|NCT00447057|54696226|FG002|Overall Study|Adverse Event|0|||
28038178|NCT00447057|54696227|FG003|Overall Study|Adverse Event|3|||
28038179|NCT00447057|54696224|FG000|Overall Study|Death due to study disease|6|||
28038180|NCT00447057|54696225|FG001|Overall Study|Death due to study disease|4|||
28038181|NCT00447057|54696226|FG002|Overall Study|Death due to study disease|1|||
28038182|NCT00447057|54696227|FG003|Overall Study|Death due to study disease|1|||
28038183|NCT00447057|54696224|FG000|Overall Study|Lost to Follow-up|0|||
28038184|NCT00447057|54696225|FG001|Overall Study|Lost to Follow-up|1|||
28038185|NCT00447057|54696226|FG002|Overall Study|Lost to Follow-up|0|||
28038186|NCT00447057|54696227|FG003|Overall Study|Lost to Follow-up|0|||
28038187|NCT00447057|54696224|FG000|Overall Study|Entry criteria not met|1|||
28038188|NCT00447057|54696225|FG001|Overall Study|Entry criteria not met|1|||
28038189|NCT00447057|54696226|FG002|Overall Study|Entry criteria not met|0|||
28038190|NCT00447057|54696227|FG003|Overall Study|Entry criteria not met|0|||
28038191|NCT00447057|54696224|FG000|Overall Study|Protocol Violation|0|||
28038192|NCT00447057|54696225|FG001|Overall Study|Protocol Violation|1|||
28038193|NCT00447057|54696226|FG002|Overall Study|Protocol Violation|0|||
28038194|NCT00447057|54696227|FG003|Overall Study|Protocol Violation|0|||
28038195|NCT00447057|54696224|FG000|Overall Study|Withdrawal by Subject|4|||
28038196|NCT00447057|54696225|FG001|Overall Study|Withdrawal by Subject|5|||
28038197|NCT00447057|54696226|FG002|Overall Study|Withdrawal by Subject|1|||
28038198|NCT00447057|54696227|FG003|Overall Study|Withdrawal by Subject|1|||
28038199|NCT00447057|54696224|FG000|Overall Study|Physician Decision|9|||
28038200|NCT00447057|54696225|FG001|Overall Study|Physician Decision|6|||
28038201|NCT00447057|54696226|FG002|Overall Study|Physician Decision|3|||
28038202|NCT00447057|54696227|FG003|Overall Study|Physician Decision|1|||
28038203|NCT00447057|54696224|FG000|Overall Study|Sponsor decision|1|||
28038204|NCT00447057|54696225|FG001|Overall Study|Sponsor decision|1|||
28038205|NCT00447057|54696226|FG002|Overall Study|Sponsor decision|0|||
28038206|NCT00447057|54696227|FG003|Overall Study|Sponsor decision|0|||
28038207|NCT00447057|54696224|FG000|Overall Study|Progressive disease|58|||
28038208|NCT00447057|54696225|FG001|Overall Study|Progressive disease|43|||
28038209|NCT00447057|54696226|FG002|Overall Study|Progressive disease|13|||
28038210|NCT00447057|54696227|FG003|Overall Study|Progressive disease|18|||
28038211|NCT00447057|54696224|FG000|Overall Study|Death due to adverse event|0|||
28038212|NCT00447057|54696225|FG001|Overall Study|Death due to adverse event|0|||
28038213|NCT00447057|54696226|FG002|Overall Study|Death due to adverse event|1|||
28038214|NCT00447057|54696227|FG003|Overall Study|Death due to adverse event|2|||
28038215|NCT00447057|54696224|FG000|Overall Study|Death, study drug related|0|||
28038216|NCT00447057|54696225|FG001|Overall Study|Death, study drug related|1|||
28038217|NCT00447057|54696226|FG002|Overall Study|Death, study drug related|0|||
28038218|NCT00447057|54696227|FG003|Overall Study|Death, study drug related|0|||
28038219|NCT00446511|54696239|FG000|Overall Study|Adverse Event|7|||
28038220|NCT00446511|54696240|FG001|Overall Study|Adverse Event|2|||
28038221|NCT00446511|54696241|FG002|Overall Study|Adverse Event|3|||
28038222|NCT00446511|54696242|FG003|Overall Study|Adverse Event|1|||
28038223|NCT00446511|54696239|FG000|Overall Study|Protocol Violation|0|||
28038224|NCT00446511|54696240|FG001|Overall Study|Protocol Violation|0|||
28038225|NCT00446511|54696241|FG002|Overall Study|Protocol Violation|0|||
28038226|NCT00446511|54696242|FG003|Overall Study|Protocol Violation|1|||
28038227|NCT00446511|54696239|FG000|Overall Study|Withdrawal by Subject|0|||
28038228|NCT00446511|54696240|FG001|Overall Study|Withdrawal by Subject|0|||
28038229|NCT00446511|54696241|FG002|Overall Study|Withdrawal by Subject|0|||
28038230|NCT00446511|54696242|FG003|Overall Study|Withdrawal by Subject|3|||
28038231|NCT00446511|54696239|FG000|Overall Study|Administrative Problems|3|||
28038232|NCT00446511|54696240|FG001|Overall Study|Administrative Problems|0|||
28038233|NCT00446511|54696241|FG002|Overall Study|Administrative Problems|4|||
28038234|NCT00446511|54696242|FG003|Overall Study|Administrative Problems|1|||
28038235|NCT00446199|54696258|FG000|Overall Study|Adverse Event|7|||
28038236|NCT00446199|54696259|FG001|Overall Study|Adverse Event|4|||
28038237|NCT00446199|54696260|FG002|Overall Study|Adverse Event|6|||
28038238|NCT00446199|54696261|FG003|Overall Study|Adverse Event|4|||
28038239|NCT00446199|54696258|FG000|Overall Study|Lost to Follow-up|4|||
28038240|NCT00446199|54696259|FG001|Overall Study|Lost to Follow-up|5|||
28038241|NCT00446199|54696260|FG002|Overall Study|Lost to Follow-up|2|||
28038242|NCT00446199|54696261|FG003|Overall Study|Lost to Follow-up|6|||
28038243|NCT00446199|54696258|FG000|Overall Study|Protocol Violation|1|||
28038244|NCT00446199|54696259|FG001|Overall Study|Protocol Violation|2|||
28038245|NCT00446199|54696260|FG002|Overall Study|Protocol Violation|1|||
28038246|NCT00446199|54696261|FG003|Overall Study|Protocol Violation|3|||
28038247|NCT00446199|54696258|FG000|Overall Study|Withdrawal by Subject|2|||
28038248|NCT00446199|54696259|FG001|Overall Study|Withdrawal by Subject|5|||
28038249|NCT00446199|54696260|FG002|Overall Study|Withdrawal by Subject|9|||
28038250|NCT00446199|54696261|FG003|Overall Study|Withdrawal by Subject|10|||
28038251|NCT00446199|54696258|FG000|Overall Study|Site termination|2|||
28038252|NCT00446199|54696259|FG001|Overall Study|Site termination|0|||
28038253|NCT00446199|54696260|FG002|Overall Study|Site termination|0|||
28038254|NCT00446199|54696261|FG003|Overall Study|Site termination|1|||
28038255|NCT00446199|54696258|FG000|Overall Study|Randomization in Error|2|||
28038256|NCT00446199|54696259|FG001|Overall Study|Randomization in Error|0|||
28038257|NCT00446199|54696260|FG002|Overall Study|Randomization in Error|1|||
28038258|NCT00446199|54696261|FG003|Overall Study|Randomization in Error|1|||
28038259|NCT00446199|54696258|FG000|Overall Study|Lack of Efficacy|1|||
28038260|NCT00446199|54696259|FG001|Overall Study|Lack of Efficacy|0|||
28038261|NCT00446199|54696260|FG002|Overall Study|Lack of Efficacy|0|||
28038262|NCT00446199|54696261|FG003|Overall Study|Lack of Efficacy|1|||
28038263|NCT00446199|54696258|FG000|Overall Study|Non-compliant with study drug|1|||
28038264|NCT00446199|54696259|FG001|Overall Study|Non-compliant with study drug|0|||
28038265|NCT00446199|54696260|FG002|Overall Study|Non-compliant with study drug|5|||
28038266|NCT00446199|54696261|FG003|Overall Study|Non-compliant with study drug|0|||
28038267|NCT00446199|54696258|FG000|Overall Study|Non-compliant with visit schedule|1|||
28038268|NCT00446199|54696259|FG001|Overall Study|Non-compliant with visit schedule|1|||
28038269|NCT00446199|54696260|FG002|Overall Study|Non-compliant with visit schedule|1|||
28038270|NCT00446199|54696261|FG003|Overall Study|Non-compliant with visit schedule|2|||
28038271|NCT00446199|54696258|FG000|Overall Study|Hormone fear|0|||
28038272|NCT00446199|54696259|FG001|Overall Study|Hormone fear|0|||
28038273|NCT00446199|54696260|FG002|Overall Study|Hormone fear|0|||
28038274|NCT00446199|54696261|FG003|Overall Study|Hormone fear|1|||
28038275|NCT00446199|54696258|FG000|Overall Study|Lost interest in study participation|0|||
28038276|NCT00446199|54696259|FG001|Overall Study|Lost interest in study participation|1|||
28038277|NCT00446199|54696260|FG002|Overall Study|Lost interest in study participation|0|||
28038278|NCT00446199|54696261|FG003|Overall Study|Lost interest in study participation|0|||
28038279|NCT00446199|54696258|FG000|Overall Study|In-/Exclusion criterion violated|2|||
28038280|NCT00446199|54696259|FG001|Overall Study|In-/Exclusion criterion violated|1|||
28038281|NCT00446199|54696260|FG002|Overall Study|In-/Exclusion criterion violated|2|||
28105674|NCT04810221|54763223|FG000|Overall Study|Physician Decision|3|||
28038282|NCT00446199|54696261|FG003|Overall Study|In-/Exclusion criterion violated|1|||
28038283|NCT00446199|54696258|FG000|Overall Study|Move|0|||
28038284|NCT00446199|54696259|FG001|Overall Study|Move|1|||
28038285|NCT00446199|54696260|FG002|Overall Study|Move|0|||
28038286|NCT00446199|54696261|FG003|Overall Study|Move|0|||
28038287|NCT00456495|54696271|FG000|Overall Study|Physician Decision|2|||
28038288|NCT00445341|54696276|FG000|Overall Study|refused further treatment|1|||
28038289|NCT00445341|54696276|FG000|Overall Study|taken off treatment too early|1|||
28038290|NCT03846453|54696282|FG000|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|465|||
28038291|NCT03846453|54696283|FG001|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
28038292|NCT03846453|54696284|FG002|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
27809631|NCT01398514|54265392|FG000|Overall Study|Physiologic non-responsiveness|1|||
27809632|NCT01398514|54265393|FG001|Overall Study|Physiologic non-responsiveness|3|||
27809633|NCT01398514|54265392|FG000|Overall Study|Failure to show a conditioned response|4|||
27809634|NCT01398514|54265393|FG001|Overall Study|Failure to show a conditioned response|3|||
27809635|NCT01398358|54265404|FG000|Overall Study|Lost to Follow-up|11|||
27809636|NCT01398358|54265405|FG001|Overall Study|Lost to Follow-up|21|||
27809637|NCT01398358|54265406|FG002|Overall Study|Lost to Follow-up|18|||
27809638|NCT01398358|54265404|FG000|Overall Study|Withdrawal by Subject|3|||
27809639|NCT01398358|54265405|FG001|Overall Study|Withdrawal by Subject|2|||
27809640|NCT01398358|54265406|FG002|Overall Study|Withdrawal by Subject|2|||
27809641|NCT01398358|54265404|FG000|Overall Study|no longer eligible|1|||
27809642|NCT01398358|54265405|FG001|Overall Study|no longer eligible|0|||
27809643|NCT01398358|54265406|FG002|Overall Study|no longer eligible|1|||
27809644|NCT01778049|54265416|FG000|Open Label Treatment Period|Adverse Event|5|||
27809645|NCT01778049|54265417|FG001|Open Label Treatment Period|Adverse Event|15|||
27809646|NCT01778049|54265418|FG002|Open Label Treatment Period|Adverse Event|0|||
27809647|NCT01778049|54265419|FG003|Open Label Treatment Period|Adverse Event|0|||
28038293|NCT03846453|54696282|FG000|Placebo Run-in (14 Days)|Withdrawal by Subject|3|||
28038294|NCT03846453|54696283|FG001|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
28038295|NCT03846453|54696284|FG002|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
28038296|NCT03846453|54696282|FG000|Placebo Run-in (14 Days)|Physician Decision|1|||
28038297|NCT03846453|54696283|FG001|Placebo Run-in (14 Days)|Physician Decision|0|||
28038298|NCT03846453|54696284|FG002|Placebo Run-in (14 Days)|Physician Decision|0|||
28038299|NCT03846453|54696282|FG000|Placebo Run-in (14 Days)|Other|2|||
28038300|NCT03846453|54696283|FG001|Placebo Run-in (14 Days)|Other|0|||
28038301|NCT03846453|54696284|FG002|Placebo Run-in (14 Days)|Other|0|||
28038302|NCT03846453|54696282|FG000|Randomized Treatment Period (Days 57±3)|Adverse Event|0|||
28038303|NCT03846453|54696283|FG001|Randomized Treatment Period (Days 57±3)|Adverse Event|16|||
28038304|NCT03846453|54696284|FG002|Randomized Treatment Period (Days 57±3)|Adverse Event|8|||
28038305|NCT03846453|54696282|FG000|Randomized Treatment Period (Days 57±3)|Protocol Violation|0|||
28038306|NCT03846453|54696283|FG001|Randomized Treatment Period (Days 57±3)|Protocol Violation|6|||
28038307|NCT03846453|54696284|FG002|Randomized Treatment Period (Days 57±3)|Protocol Violation|5|||
28038308|NCT03846453|54696282|FG000|Randomized Treatment Period (Days 57±3)|Administrative Reasons|0|||
28038309|NCT03846453|54696283|FG001|Randomized Treatment Period (Days 57±3)|Administrative Reasons|2|||
28038310|NCT03846453|54696284|FG002|Randomized Treatment Period (Days 57±3)|Administrative Reasons|4|||
28038311|NCT03846453|54696282|FG000|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|0|||
28038312|NCT03846453|54696283|FG001|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|2|||
28038313|NCT03846453|54696284|FG002|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|4|||
28038314|NCT03846453|54696282|FG000|Randomized Treatment Period (Days 57±3)|Other|0|||
28038315|NCT03846453|54696283|FG001|Randomized Treatment Period (Days 57±3)|Other|1|||
28038316|NCT03846453|54696284|FG002|Randomized Treatment Period (Days 57±3)|Other|4|||
28038317|NCT00444951|54696295|FG000|Overall Study|Lost to Follow-up|1|||
28038318|NCT00444951|54696296|FG001|Overall Study|Lost to Follow-up|1|||
28038319|NCT00444951|54696297|FG002|Overall Study|Lost to Follow-up|0|||
28038320|NCT00444951|54696295|FG000|Overall Study|Withdrawal by Subject|4|||
28038321|NCT00444951|54696296|FG001|Overall Study|Withdrawal by Subject|5|||
27809648|NCT01778049|54265420|FG004|Open Label Treatment Period|Adverse Event|0|||
27809649|NCT01778049|54265421|FG005|Open Label Treatment Period|Adverse Event|0|||
27809650|NCT01778049|54265416|FG000|Open Label Treatment Period|Lack of Efficacy|1|||
27809651|NCT01778049|54265417|FG001|Open Label Treatment Period|Lack of Efficacy|1|||
28038322|NCT00444951|54696297|FG002|Overall Study|Withdrawal by Subject|3|||
28038323|NCT00444795|54696305|FG000|Overall Study|Not Treated|1|||
28038324|NCT00444795|54696305|FG000|Overall Study|Treated Prior to the Contract Date|2|||
28038325|NCT03846219|54696312|FG000|Overall Study|Withdrawal by Subject|3|||
28038326|NCT03846219|54696313|FG001|Overall Study|Withdrawal by Subject|2|||
27809652|NCT01778049|54265418|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
27809653|NCT01778049|54265419|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
27809654|NCT01778049|54265420|FG004|Open Label Treatment Period|Lack of Efficacy|0|||
27809655|NCT01778049|54265421|FG005|Open Label Treatment Period|Lack of Efficacy|0|||
27809656|NCT01778049|54265416|FG000|Open Label Treatment Period|Protocol Violation|5|||
27847844|NCT01382225|54340545|FG000|Overall Study|Adverse Event|3|||
28038327|NCT03846219|54696314|FG002|Overall Study|Withdrawal by Subject|2|||
28038328|NCT03846219|54696312|FG000|Overall Study|Fulfilled hepatoxicity-related stopping rules|0|||
28038329|NCT03846219|54696313|FG001|Overall Study|Fulfilled hepatoxicity-related stopping rules|2|||
28038330|NCT03846219|54696314|FG002|Overall Study|Fulfilled hepatoxicity-related stopping rules|1|||
28038331|NCT03846219|54696312|FG000|Overall Study|Physician Decision|0|||
28038332|NCT03846219|54696313|FG001|Overall Study|Physician Decision|0|||
28038333|NCT03846219|54696314|FG002|Overall Study|Physician Decision|2|||
28038334|NCT00455325|54696330|FG000|Cohort 1: Placebo|Started exclusionary drug|1|||
28038335|NCT00455325|54696331|FG001|Cohort 1: Placebo|Started exclusionary drug|0|||
28038336|NCT00455325|54696332|FG002|Cohort 1: Placebo|Started exclusionary drug|0|||
28038337|NCT00455325|54696333|FG003|Cohort 1: Placebo|Started exclusionary drug|0|||
28038338|NCT00455325|54696330|FG000|Cohort 1: Placebo|Withdrawal by Subject|4|||
28038339|NCT00455325|54696331|FG001|Cohort 1: Placebo|Withdrawal by Subject|0|||
28038340|NCT00455325|54696332|FG002|Cohort 1: Placebo|Withdrawal by Subject|0|||
28038341|NCT00455325|54696333|FG003|Cohort 1: Placebo|Withdrawal by Subject|0|||
28038342|NCT00455325|54696330|FG000|Cohort 1: Placebo|Lost to Follow-up|1|||
28038343|NCT00455325|54696331|FG001|Cohort 1: Placebo|Lost to Follow-up|0|||
28038344|NCT00455325|54696332|FG002|Cohort 1: Placebo|Lost to Follow-up|0|||
28038345|NCT00455325|54696333|FG003|Cohort 1: Placebo|Lost to Follow-up|0|||
28038346|NCT00455325|54696330|FG000|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|1|||
28038347|NCT00455325|54696331|FG001|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
28038348|NCT00455325|54696332|FG002|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
28038349|NCT00455325|54696333|FG003|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
28038350|NCT00455325|54696330|FG000|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|1|||
28038351|NCT00455325|54696331|FG001|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
28038352|NCT00455325|54696332|FG002|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
28038353|NCT00455325|54696333|FG003|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
28038354|NCT00455325|54696330|FG000|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
28038355|NCT00455325|54696331|FG001|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|1|||
28038356|NCT00455325|54696332|FG002|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
28038357|NCT00455325|54696333|FG003|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
28038358|NCT00455325|54696330|FG000|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
28038359|NCT00455325|54696331|FG001|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
28038360|NCT00455325|54696332|FG002|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|1|||
28038361|NCT00455325|54696333|FG003|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
28038362|NCT00443781|54696344|FG000|Overall Study|Lost to Follow-up|10|||
28038363|NCT00443781|54696344|FG000|Overall Study|Physician Decision|2|||
28038364|NCT00443781|54696344|FG000|Overall Study|Protocol Violation|1|||
28038365|NCT00443781|54696344|FG000|Overall Study|Withdrawal by Subject|6|||
28038366|NCT00443781|54696344|FG000|Overall Study|Unable to comply with study follow up|2|||
28038367|NCT00443781|54696344|FG000|Overall Study|Investigator terminated participation|1|||
28038368|NCT00443781|54696344|FG000|Overall Study|Insurance not covered|2|||
28038369|NCT00443781|54696344|FG000|Overall Study|PD/FAD not done|1|||
28038370|NCT00443703|54696350|FG000|Overall Study|Never Treated|3|||
28038371|NCT00443703|54696351|FG001|Overall Study|Never Treated|1|||
28038372|NCT00443703|54696350|FG000|Overall Study|Adverse Event|7|||
28038373|NCT00443703|54696351|FG001|Overall Study|Adverse Event|3|||
28038374|NCT00443703|54696350|FG000|Overall Study|Lack of Efficacy|3|||
28038375|NCT00443703|54696351|FG001|Overall Study|Lack of Efficacy|1|||
28038376|NCT00443703|54696350|FG000|Overall Study|Lost to Follow-up|0|||
28038377|NCT00443703|54696351|FG001|Overall Study|Lost to Follow-up|4|||
28038378|NCT00443703|54696350|FG000|Overall Study|Physician Decision|4|||
28038379|NCT00443703|54696351|FG001|Overall Study|Physician Decision|2|||
28038380|NCT00443703|54696350|FG000|Overall Study|Protocol Violation|1|||
28038381|NCT00443703|54696351|FG001|Overall Study|Protocol Violation|1|||
28038382|NCT00443703|54696350|FG000|Overall Study|Withdrawal by Subject|9|||
28038383|NCT00443703|54696351|FG001|Overall Study|Withdrawal by Subject|6|||
28038384|NCT00443703|54696350|FG000|Overall Study|Progressive Disease|1|||
28038385|NCT00443703|54696351|FG001|Overall Study|Progressive Disease|0|||
28038386|NCT00381706|54696363|FG000|Overall Study|Never treated|7|||
28038387|NCT00381706|54696364|FG001|Overall Study|Never treated|2|||
28038388|NCT00381706|54696365|FG002|Overall Study|Never treated|1|||
28038389|NCT00535236|54696389|FG000|Overall Study|Adverse Event|1|||
28038390|NCT00535236|54696390|FG001|Overall Study|Adverse Event|0|||
28038391|NCT00535236|54696391|FG002|Overall Study|Adverse Event|9|||
28038392|NCT00535236|54696392|FG003|Overall Study|Adverse Event|3|||
28038393|NCT00535236|54696393|FG004|Overall Study|Adverse Event|3|||
28038394|NCT00535236|54696394|FG005|Overall Study|Adverse Event|0|||
28038395|NCT00535236|54696395|FG006|Overall Study|Adverse Event|5|||
28038396|NCT00535236|54696396|FG007|Overall Study|Adverse Event|1|||
28038397|NCT00535236|54696397|FG008|Overall Study|Adverse Event|2|||
27847845|NCT01382225|54340546|FG001|Overall Study|Adverse Event|2|||
28038398|NCT00535236|54696398|FG009|Overall Study|Adverse Event|1|||
28038399|NCT00535236|54696389|FG000|Overall Study|Lost to Follow-up|1|||
28038400|NCT00535236|54696390|FG001|Overall Study|Lost to Follow-up|2|||
28038401|NCT00535236|54696391|FG002|Overall Study|Lost to Follow-up|0|||
28038402|NCT00535236|54696392|FG003|Overall Study|Lost to Follow-up|0|||
28038403|NCT00535236|54696393|FG004|Overall Study|Lost to Follow-up|2|||
28038404|NCT00535236|54696394|FG005|Overall Study|Lost to Follow-up|0|||
28038405|NCT00535236|54696395|FG006|Overall Study|Lost to Follow-up|0|||
28038406|NCT00535236|54696396|FG007|Overall Study|Lost to Follow-up|0|||
28038407|NCT00535236|54696397|FG008|Overall Study|Lost to Follow-up|6|||
28038408|NCT00535236|54696398|FG009|Overall Study|Lost to Follow-up|1|||
28038409|NCT00535236|54696389|FG000|Overall Study|Physician Decision|0|||
28038410|NCT00535236|54696390|FG001|Overall Study|Physician Decision|0|||
28038411|NCT00535236|54696391|FG002|Overall Study|Physician Decision|0|||
28038412|NCT00535236|54696392|FG003|Overall Study|Physician Decision|0|||
28038413|NCT00535236|54696393|FG004|Overall Study|Physician Decision|1|||
28038414|NCT00535236|54696394|FG005|Overall Study|Physician Decision|0|||
28038415|NCT00535236|54696395|FG006|Overall Study|Physician Decision|1|||
27809657|NCT01778049|54265417|FG001|Open Label Treatment Period|Protocol Violation|5|||
27809658|NCT01778049|54265418|FG002|Open Label Treatment Period|Protocol Violation|0|||
27809659|NCT01778049|54265419|FG003|Open Label Treatment Period|Protocol Violation|0|||
27809660|NCT01778049|54265420|FG004|Open Label Treatment Period|Protocol Violation|0|||
27809661|NCT01778049|54265421|FG005|Open Label Treatment Period|Protocol Violation|0|||
27809662|NCT01778049|54265416|FG000|Open Label Treatment Period|Lost to Follow-up|4|||
28038416|NCT00535236|54696396|FG007|Overall Study|Physician Decision|0|||
28038417|NCT00535236|54696397|FG008|Overall Study|Physician Decision|0|||
28038418|NCT00535236|54696398|FG009|Overall Study|Physician Decision|0|||
28038419|NCT00535236|54696389|FG000|Overall Study|Protocol Violation|2|||
28038420|NCT00535236|54696390|FG001|Overall Study|Protocol Violation|0|||
28038421|NCT00535236|54696391|FG002|Overall Study|Protocol Violation|1|||
28038422|NCT00535236|54696392|FG003|Overall Study|Protocol Violation|0|||
28038423|NCT00535236|54696393|FG004|Overall Study|Protocol Violation|0|||
28038424|NCT00535236|54696394|FG005|Overall Study|Protocol Violation|0|||
28038425|NCT00535236|54696395|FG006|Overall Study|Protocol Violation|0|||
28038426|NCT00535236|54696396|FG007|Overall Study|Protocol Violation|0|||
28038427|NCT00535236|54696397|FG008|Overall Study|Protocol Violation|1|||
28038428|NCT00535236|54696398|FG009|Overall Study|Protocol Violation|0|||
28038429|NCT00535236|54696389|FG000|Overall Study|Withdrawal by Subject|3|||
28038430|NCT00535236|54696390|FG001|Overall Study|Withdrawal by Subject|0|||
28038431|NCT00535236|54696391|FG002|Overall Study|Withdrawal by Subject|2|||
28038432|NCT00535236|54696392|FG003|Overall Study|Withdrawal by Subject|1|||
28038433|NCT00535236|54696393|FG004|Overall Study|Withdrawal by Subject|6|||
28038434|NCT00535236|54696394|FG005|Overall Study|Withdrawal by Subject|1|||
28038435|NCT00535236|54696395|FG006|Overall Study|Withdrawal by Subject|5|||
28038436|NCT00535236|54696396|FG007|Overall Study|Withdrawal by Subject|0|||
28038437|NCT00535236|54696397|FG008|Overall Study|Withdrawal by Subject|4|||
28038438|NCT00535236|54696398|FG009|Overall Study|Withdrawal by Subject|2|||
28038439|NCT00370552|54696426|FG000|Overall Study|Adverse Event|2|||
28038440|NCT00370552|54696427|FG001|Overall Study|Adverse Event|2|||
28038441|NCT00370552|54696428|FG002|Overall Study|Adverse Event|2|||
28038442|NCT00370552|54696426|FG000|Overall Study|Disease progression|23|||
28038443|NCT00370552|54696427|FG001|Overall Study|Disease progression|23|||
28038444|NCT00370552|54696428|FG002|Overall Study|Disease progression|15|||
28038445|NCT00370552|54696426|FG000|Overall Study|Maximum clinical benefit|3|||
28038446|NCT00370552|54696427|FG001|Overall Study|Maximum clinical benefit|5|||
28038447|NCT00370552|54696428|FG002|Overall Study|Maximum clinical benefit|5|||
28038448|NCT00370552|54696426|FG000|Overall Study|Poor or noncompliance|0|||
28038449|NCT00370552|54696427|FG001|Overall Study|Poor or noncompliance|0|||
28038450|NCT00370552|54696428|FG002|Overall Study|Poor or noncompliance|1|||
28038451|NCT00370552|54696426|FG000|Overall Study|Study drug toxicity|11|||
28038452|NCT00370552|54696427|FG001|Overall Study|Study drug toxicity|8|||
28038453|NCT00370552|54696428|FG002|Overall Study|Study drug toxicity|6|||
28038454|NCT00370552|54696426|FG000|Overall Study|Withdrawal by Subject|2|||
28038455|NCT00370552|54696427|FG001|Overall Study|Withdrawal by Subject|0|||
28038456|NCT00370552|54696428|FG002|Overall Study|Withdrawal by Subject|1|||
28038457|NCT00370552|54696426|FG000|Overall Study|Still on treatment|1|||
28038458|NCT00370552|54696427|FG001|Overall Study|Still on treatment|3|||
28038459|NCT00370552|54696428|FG002|Overall Study|Still on treatment|2|||
28038460|NCT00370552|54696426|FG000|Overall Study|Never treated|1|||
28038461|NCT00370552|54696427|FG001|Overall Study|Never treated|0|||
28038462|NCT00370552|54696428|FG002|Overall Study|Never treated|0|||
28038463|NCT00370552|54696426|FG000|Overall Study|Physician Decision|1|||
28038464|NCT00370552|54696427|FG001|Overall Study|Physician Decision|1|||
28038465|NCT00370552|54696428|FG002|Overall Study|Physician Decision|0|||
28038466|NCT00370552|54696426|FG000|Overall Study|Investigator decision|2|||
28038467|NCT00370552|54696427|FG001|Overall Study|Investigator decision|1|||
28038468|NCT00370552|54696428|FG002|Overall Study|Investigator decision|0|||
28038469|NCT00370552|54696426|FG000|Overall Study|High risk of allergic reaction|0|||
28038470|NCT00370552|54696427|FG001|Overall Study|High risk of allergic reaction|1|||
28038471|NCT00370552|54696428|FG002|Overall Study|High risk of allergic reaction|0|||
28038472|NCT00370552|54696426|FG000|Overall Study|Planned radiation for palliation|0|||
28038473|NCT00370552|54696427|FG001|Overall Study|Planned radiation for palliation|1|||
28038474|NCT00370552|54696428|FG002|Overall Study|Planned radiation for palliation|0|||
28038475|NCT00537030|54696436|FG000|Overall Study|Physician Decision|2|||
28038476|NCT00537030|54696436|FG000|Overall Study|Withdrawal by Subject|2|||
28038477|NCT00537030|54696436|FG000|Overall Study|≥ Grade 2 allergy|7|||
28038478|NCT00537030|54696436|FG000|Overall Study|Disease progression/ relapse during Tx|1|||
28038479|NCT00537030|54696436|FG000|Overall Study|Ineligible|2|||
28038480|NCT00537030|54696436|FG000|Overall Study|Inevaluable|2|||
28038481|NCT00381238|54696440|FG000|Overall Study|Adverse Event|3|||
28038482|NCT00381238|54696440|FG000|Overall Study|Protocol Violation|1|||
28038483|NCT00381238|54696440|FG000|Overall Study|Withdrawal by Subject|4|||
28038484|NCT00381238|54696440|FG000|Overall Study|Lack of Efficacy|2|||
28038485|NCT00381238|54696440|FG000|Overall Study|Withdrew by physician|1|||
28038486|NCT00381238|54696440|FG000|Overall Study|Disease progression|1|||
28038487|NCT03896022|54696447|FG000|Overall Study|Withdrawal by Subject|1|||
28038488|NCT03896022|54696448|FG001|Overall Study|Withdrawal by Subject|0|||
28038489|NCT03896022|54696449|FG002|Overall Study|Withdrawal by Subject|0|||
28038490|NCT03896022|54696447|FG000|Overall Study|Did not have procedure|3|||
28038491|NCT03896022|54696448|FG001|Overall Study|Did not have procedure|0|||
28038492|NCT03896022|54696449|FG002|Overall Study|Did not have procedure|0|||
28038493|NCT03831880|54696461|FG000|Period 1 (12 Weeks)|Adverse event, not serious|0|||
28038494|NCT03831880|54696462|FG001|Period 1 (12 Weeks)|Adverse event, not serious|1|||
28038495|NCT03831880|54696461|FG000|Period 2 (12 Weeks)|Protocol Deviation|0|||
28038496|NCT03831880|54696462|FG001|Period 2 (12 Weeks)|Protocol Deviation|1|||
28038497|NCT00380692|54696485|FG000|Study Period II - Double Blind|Adverse Event|1|||
28038498|NCT00380692|54696486|FG001|Study Period II - Double Blind|Adverse Event|0|||
28038499|NCT00380692|54696485|FG000|Study Period II - Double Blind|Protocol Violation|2|||
28038500|NCT00380692|54696486|FG001|Study Period II - Double Blind|Protocol Violation|2|||
28038501|NCT00380692|54696485|FG000|Study Period II - Double Blind|Withdrawal by Subject|0|||
28038502|NCT00380692|54696486|FG001|Study Period II - Double Blind|Withdrawal by Subject|0|||
28038503|NCT00380692|54696485|FG000|Study Period II - Double Blind|Physician Decision|0|||
28038504|NCT00380692|54696486|FG001|Study Period II - Double Blind|Physician Decision|1|||
28038505|NCT00380692|54696485|FG000|Study Period II - Double Blind|Lack of Efficacy|1|||
28038506|NCT00380692|54696486|FG001|Study Period II - Double Blind|Lack of Efficacy|0|||
28038507|NCT00380692|54696485|FG000|Study Period II - Double Blind|Parent/Caregiver Decision|1|||
28038508|NCT00380692|54696486|FG001|Study Period II - Double Blind|Parent/Caregiver Decision|0|||
28038509|NCT00380692|54696485|FG000|Study Period III - Open Label|Adverse Event|5|||
28038510|NCT00380692|54696486|FG001|Study Period III - Open Label|Adverse Event|3|||
28038511|NCT00380692|54696485|FG000|Study Period III - Open Label|Protocol Violation|0|||
28038512|NCT00380692|54696486|FG001|Study Period III - Open Label|Protocol Violation|0|||
28038513|NCT00380692|54696485|FG000|Study Period III - Open Label|Withdrawal by Subject|0|||
28038514|NCT00380692|54696486|FG001|Study Period III - Open Label|Withdrawal by Subject|1|||
28038515|NCT00380692|54696485|FG000|Study Period III - Open Label|Physician Decision|0|||
28038516|NCT00380692|54696486|FG001|Study Period III - Open Label|Physician Decision|3|||
28038517|NCT00380692|54696485|FG000|Study Period III - Open Label|Lack of Efficacy|0|||
28038518|NCT00380692|54696486|FG001|Study Period III - Open Label|Lack of Efficacy|4|||
28038519|NCT00380692|54696485|FG000|Study Period III - Open Label|Parent/Caregiver Decision|1|||
28038520|NCT00380692|54696486|FG001|Study Period III - Open Label|Parent/Caregiver Decision|1|||
28038521|NCT00536874|54696492|FG000|Overall Study|Adverse Event|1|||
28038522|NCT00536874|54696492|FG000|Overall Study|Death|2|||
28038523|NCT00536874|54696492|FG000|Overall Study|Withdrawal by Subject|1|||
28038524|NCT00380068|54696496|FG000|Overall Study|Adverse Event|40|||
28038525|NCT00380068|54696496|FG000|Overall Study|Withdrawal by Subject|10|||
28038526|NCT00380068|54696496|FG000|Overall Study|Not compliant|6|||
28038527|NCT00380068|54696496|FG000|Overall Study|Lost to Follow-up|1|||
28038528|NCT00380068|54696496|FG000|Overall Study|Addition of other PAH therapeutic agent|1|||
28038529|NCT00380068|54696496|FG000|Overall Study|Lung transplant|3|||
28038530|NCT00380068|54696496|FG000|Overall Study|Physician Decision|2|||
28038531|NCT00380068|54696496|FG000|Overall Study|Partipant moved away|1|||
28038532|NCT00380068|54696496|FG000|Overall Study|Lack of Efficacy|5|||
28038533|NCT00536484|54696502|FG000|Overall Study|Adverse Event|21|||
28038534|NCT00536484|54696503|FG001|Overall Study|Adverse Event|34|||
28038535|NCT00536484|54696502|FG000|Overall Study|Withdrawal by Subject|11|||
28038536|NCT00536484|54696503|FG001|Overall Study|Withdrawal by Subject|11|||
28038537|NCT00536484|54696502|FG000|Overall Study|Lost to Follow-up|8|||
28038538|NCT00536484|54696503|FG001|Overall Study|Lost to Follow-up|6|||
28038539|NCT00536484|54696502|FG000|Overall Study|Lack of Efficacy|16|||
28038540|NCT00536484|54696503|FG001|Overall Study|Lack of Efficacy|5|||
28038541|NCT00536484|54696502|FG000|Overall Study|Other|4|||
27939843|NCT01081912|54596203|FG002|Conversion/Titration|Lack of Efficacy|0|||
28038542|NCT00536484|54696503|FG001|Overall Study|Other|0|||
28038543|NCT00370396|54696512|FG000|Overall Study|Withdrawal by Subject|0|||
28038544|NCT00370396|54696513|FG001|Overall Study|Withdrawal by Subject|0|||
28038545|NCT00370396|54696514|FG002|Overall Study|Withdrawal by Subject|1|||
28038546|NCT00370396|54696512|FG000|Overall Study|Lost to Follow-up|11|||
28038547|NCT00370396|54696513|FG001|Overall Study|Lost to Follow-up|1|||
27809663|NCT01778049|54265417|FG001|Open Label Treatment Period|Lost to Follow-up|3|||
27809664|NCT01778049|54265418|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
27809665|NCT01778049|54265419|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
27809666|NCT01778049|54265420|FG004|Open Label Treatment Period|Lost to Follow-up|0|||
27809667|NCT01778049|54265421|FG005|Open Label Treatment Period|Lost to Follow-up|0|||
27809668|NCT01778049|54265416|FG000|Open Label Treatment Period|Withdrawal by Subject|4|||
27809669|NCT01778049|54265417|FG001|Open Label Treatment Period|Withdrawal by Subject|10|||
27809670|NCT01778049|54265418|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
27809671|NCT01778049|54265419|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
27809672|NCT01778049|54265420|FG004|Open Label Treatment Period|Withdrawal by Subject|0|||
27809673|NCT01778049|54265421|FG005|Open Label Treatment Period|Withdrawal by Subject|0|||
27809674|NCT01778049|54265416|FG000|Open Label Treatment Period|Not treated|2|||
27809675|NCT01778049|54265417|FG001|Open Label Treatment Period|Not treated|1|||
27809676|NCT01778049|54265418|FG002|Open Label Treatment Period|Not treated|0|||
27809677|NCT01778049|54265419|FG003|Open Label Treatment Period|Not treated|0|||
27809678|NCT01778049|54265420|FG004|Open Label Treatment Period|Not treated|0|||
27809679|NCT01778049|54265421|FG005|Open Label Treatment Period|Not treated|0|||
27809680|NCT01778049|54265416|FG000|Open Label Treatment Period|Other reason not defined above|77|||
27809681|NCT01778049|54265417|FG001|Open Label Treatment Period|Other reason not defined above|94|||
27809682|NCT01778049|54265418|FG002|Open Label Treatment Period|Other reason not defined above|0|||
27809683|NCT01778049|54265419|FG003|Open Label Treatment Period|Other reason not defined above|0|||
27809684|NCT01778049|54265420|FG004|Open Label Treatment Period|Other reason not defined above|0|||
27809685|NCT01778049|54265421|FG005|Open Label Treatment Period|Other reason not defined above|0|||
27809686|NCT01778049|54265416|FG000|Double Blind Treatment Period|Adverse Event|0|||
27809687|NCT01778049|54265417|FG001|Double Blind Treatment Period|Adverse Event|0|||
27809688|NCT01778049|54265418|FG002|Double Blind Treatment Period|Adverse Event|4|||
27809689|NCT01778049|54265419|FG003|Double Blind Treatment Period|Adverse Event|5|||
27809690|NCT01778049|54265420|FG004|Double Blind Treatment Period|Adverse Event|3|||
27809691|NCT01778049|54265421|FG005|Double Blind Treatment Period|Adverse Event|2|||
27809692|NCT01778049|54265416|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
27809693|NCT01778049|54265417|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
27809694|NCT01778049|54265418|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
27809695|NCT01778049|54265419|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
27809696|NCT01778049|54265420|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
27809697|NCT01778049|54265421|FG005|Double Blind Treatment Period|Lack of Efficacy|1|||
27809698|NCT01778049|54265416|FG000|Double Blind Treatment Period|Protocol Violation|0|||
27809699|NCT01778049|54265417|FG001|Double Blind Treatment Period|Protocol Violation|0|||
27809700|NCT01778049|54265418|FG002|Double Blind Treatment Period|Protocol Violation|2|||
27809701|NCT01778049|54265419|FG003|Double Blind Treatment Period|Protocol Violation|0|||
27809702|NCT01778049|54265420|FG004|Double Blind Treatment Period|Protocol Violation|0|||
27809703|NCT01778049|54265421|FG005|Double Blind Treatment Period|Protocol Violation|0|||
27809704|NCT01778049|54265416|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
27809705|NCT01778049|54265417|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
27809706|NCT01778049|54265418|FG002|Double Blind Treatment Period|Lost to Follow-up|4|||
27809707|NCT01778049|54265419|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
27809708|NCT01778049|54265420|FG004|Double Blind Treatment Period|Lost to Follow-up|5|||
27847846|NCT01382225|54340545|FG000|Overall Study|Protocol Violation|2|||
27847847|NCT01382225|54340546|FG001|Overall Study|Protocol Violation|1|||
27847848|NCT01382225|54340545|FG000|Overall Study|Subject Withdrew Consent|5|||
27847849|NCT01382225|54340546|FG001|Overall Study|Subject Withdrew Consent|2|||
27847850|NCT01382225|54340545|FG000|Overall Study|Other|4|||
27847851|NCT01382225|54340546|FG001|Overall Study|Other|2|||
27809709|NCT01778049|54265421|FG005|Double Blind Treatment Period|Lost to Follow-up|2|||
27809710|NCT01778049|54265416|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
27809711|NCT01778049|54265417|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
27847852|NCT01381679|54340552|FG000|Overall Study|Adverse Event|3|||
27847853|NCT01381679|54340552|FG000|Overall Study|Lost to Follow-up|885|||
27847854|NCT01455194|54340559|FG000|Overall Study|Screen Failure|20|||
27847855|NCT01455194|54340560|FG001|Overall Study|Screen Failure|0|||
27939844|NCT01081912|54596201|FG000|Conversion/Titration|Lost to Follow-up|5|||
28038548|NCT00370396|54696514|FG002|Overall Study|Lost to Follow-up|0|||
27847856|NCT01455194|54340561|FG002|Overall Study|Screen Failure|0|||
27939845|NCT01081912|54596202|FG001|Conversion/Titration|Lost to Follow-up|0|||
28038549|NCT00455013|54696525|FG000|Short Term Period|Adverse Event|2|||
28038550|NCT00455013|54696526|FG001|Short Term Period|Adverse Event|5|||
27809712|NCT01778049|54265418|FG002|Double Blind Treatment Period|Withdrawal by Subject|1|||
27809713|NCT01778049|54265419|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
27809714|NCT01778049|54265420|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
27847857|NCT01455194|54340562|FG003|Overall Study|Screen Failure|0|||
27809715|NCT01778049|54265421|FG005|Double Blind Treatment Period|Withdrawal by Subject|1|||
28038551|NCT00455013|54696527|FG002|Short Term Period|Adverse Event|0|||
28038552|NCT00455013|54696525|FG000|Short Term Period|Withdrawal by Subject|0|||
28038553|NCT00455013|54696526|FG001|Short Term Period|Withdrawal by Subject|0|||
28038554|NCT00455013|54696527|FG002|Short Term Period|Withdrawal by Subject|1|||
28038555|NCT00455013|54696525|FG000|Short Term Period|Lack of Efficacy|4|||
28038556|NCT00455013|54696526|FG001|Short Term Period|Lack of Efficacy|0|||
28038557|NCT00455013|54696527|FG002|Short Term Period|Lack of Efficacy|0|||
28038558|NCT00455013|54696525|FG000|Short Term Period|Other|0|||
28038559|NCT00455013|54696526|FG001|Short Term Period|Other|0|||
28038560|NCT00455013|54696527|FG002|Short Term Period|Other|1|||
28038561|NCT00455013|54696525|FG000|Long Term Extension (LTE)|Adverse Event|0|||
27809716|NCT01778049|54265416|FG000|Double Blind Treatment Period|Not treated|0|||
27809717|NCT01778049|54265417|FG001|Double Blind Treatment Period|Not treated|0|||
27809718|NCT01778049|54265418|FG002|Double Blind Treatment Period|Not treated|0|||
27809719|NCT01778049|54265419|FG003|Double Blind Treatment Period|Not treated|2|||
28038562|NCT00455013|54696526|FG001|Long Term Extension (LTE)|Adverse Event|1|||
28038563|NCT00455013|54696527|FG002|Long Term Extension (LTE)|Adverse Event|1|||
28038564|NCT00455013|54696525|FG000|Long Term Extension (LTE)|Withdrawal by Subject|1|||
28038565|NCT00455013|54696526|FG001|Long Term Extension (LTE)|Withdrawal by Subject|0|||
28038566|NCT00455013|54696527|FG002|Long Term Extension (LTE)|Withdrawal by Subject|1|||
28038567|NCT00455013|54696525|FG000|Long Term Extension (LTE)|Death|1|||
28038568|NCT00455013|54696526|FG001|Long Term Extension (LTE)|Death|1|||
28038569|NCT00455013|54696527|FG002|Long Term Extension (LTE)|Death|0|||
28038570|NCT00455013|54696525|FG000|Long Term Extension (LTE)|No longer met criteria|0|||
28038571|NCT00455013|54696526|FG001|Long Term Extension (LTE)|No longer met criteria|0|||
28038572|NCT00455013|54696527|FG002|Long Term Extension (LTE)|No longer met criteria|1|||
28038573|NCT00455013|54696525|FG000|Long Term Extension (LTE)|Subject Request or refused|0|||
28038574|NCT00455013|54696526|FG001|Long Term Extension (LTE)|Subject Request or refused|0|||
28038575|NCT00455013|54696527|FG002|Long Term Extension (LTE)|Subject Request or refused|3|||
28038576|NCT00455013|54696525|FG000|Long Term Extension (LTE)|Poor non-compliance|0|||
28038577|NCT00455013|54696526|FG001|Long Term Extension (LTE)|Poor non-compliance|1|||
28038578|NCT00455013|54696527|FG002|Long Term Extension (LTE)|Poor non-compliance|0|||
28038579|NCT00455013|54696525|FG000|Long Term Extension (LTE)|non-specified|0|||
28038580|NCT00455013|54696526|FG001|Long Term Extension (LTE)|non-specified|0|||
28038581|NCT00455013|54696527|FG002|Long Term Extension (LTE)|non-specified|1|||
28038582|NCT00363298|54696537|FG000|First Study Week|Lack of Efficacy|6|||
28038583|NCT00363298|54696538|FG001|First Study Week|Lack of Efficacy|5|||
28038584|NCT00363298|54696537|FG000|4-week Study Continuation Phase|Lack of Efficacy|1|||
28038585|NCT00363298|54696538|FG001|4-week Study Continuation Phase|Lack of Efficacy|0|||
28038586|NCT00363142|54696547|FG000|Overall Study|Adverse Event|2|||
28038587|NCT00363142|54696548|FG001|Overall Study|Adverse Event|0|||
28038588|NCT00363142|54696547|FG000|Overall Study|Lack of Efficacy|0|||
28038589|NCT00363142|54696548|FG001|Overall Study|Lack of Efficacy|1|||
28038590|NCT00363142|54696547|FG000|Overall Study|Lost to Follow-up|1|||
28038591|NCT00363142|54696548|FG001|Overall Study|Lost to Follow-up|0|||
28038592|NCT00363142|54696547|FG000|Overall Study|Non-compliance|1|||
28038593|NCT00363142|54696548|FG001|Overall Study|Non-compliance|1|||
28038594|NCT00363142|54696547|FG000|Overall Study|Withdrawal by Subject|3|||
28038595|NCT00363142|54696548|FG001|Overall Study|Withdrawal by Subject|1|||
28038596|NCT00454857|54696557|FG000|Overall Study|Withdrawal by Subject|15|||
28038597|NCT00454857|54696557|FG000|Overall Study|Lost to Follow-up|16|||
28038598|NCT00454857|54696557|FG000|Overall Study|Noncompliance|6|||
28038599|NCT00454857|54696557|FG000|Overall Study|Death|5|||
28038600|NCT00454857|54696557|FG000|Overall Study|Other|11|||
28038601|NCT00454857|54696557|FG000|Overall Study|Reason unknown|1|||
28038602|NCT00379912|54696563|FG000|Overall Study|Lack of Efficacy|1|||
27809720|NCT01778049|54265420|FG004|Double Blind Treatment Period|Not treated|2|||
27809721|NCT01778049|54265421|FG005|Double Blind Treatment Period|Not treated|0|||
27809722|NCT01778049|54265416|FG000|Double Blind Treatment Period|Other reason not defined above|0|||
27809723|NCT01778049|54265417|FG001|Double Blind Treatment Period|Other reason not defined above|0|||
27809724|NCT01778049|54265418|FG002|Double Blind Treatment Period|Other reason not defined above|4|||
27809725|NCT01778049|54265419|FG003|Double Blind Treatment Period|Other reason not defined above|2|||
27847858|NCT01455194|54340559|FG000|Overall Study|Randomisation Failure|90|||
28038603|NCT00379912|54696564|FG001|Overall Study|Lack of Efficacy|0|||
27809726|NCT01778049|54265420|FG004|Double Blind Treatment Period|Other reason not defined above|2|||
27939846|NCT01081912|54596203|FG002|Conversion/Titration|Lost to Follow-up|0|||
28038604|NCT00379834|54696576|FG000|Overall Study|Time constraints|2|||
28038605|NCT00379210|54696582|FG000|Overall Study|Withdrawal by Subject|10|||
28038606|NCT00379210|54696583|FG001|Overall Study|Withdrawal by Subject|7|||
28038607|NCT00378898|54696591|FG000|Overall Study|Withdrawal by Subject|10|||
28038608|NCT00378898|54696592|FG001|Overall Study|Withdrawal by Subject|5|||
28038609|NCT00378898|54696591|FG000|Overall Study|Protocol Violation|1|||
28038610|NCT00378898|54696592|FG001|Overall Study|Protocol Violation|1|||
27809727|NCT01778049|54265421|FG005|Double Blind Treatment Period|Other reason not defined above|1|||
28038611|NCT00378508|54696602|FG000|Overall Study|Withdrawal by Subject|1|||
28038612|NCT00378508|54696603|FG001|Overall Study|Withdrawal by Subject|3|||
28038613|NCT00378508|54696602|FG000|Overall Study|Lost to Follow-up|1|||
28038614|NCT00378508|54696603|FG001|Overall Study|Lost to Follow-up|0|||
28038615|NCT00454779|54696612|FG000|First-line Treatment Phase|Lack of Efficacy|0|||
28038616|NCT00454779|54696613|FG001|First-line Treatment Phase|Lack of Efficacy|2|||
28038617|NCT00454779|54696612|FG000|First-line Treatment Phase|Withdrawal by Subject|2|||
28038618|NCT00454779|54696613|FG001|First-line Treatment Phase|Withdrawal by Subject|4|||
28038619|NCT00454779|54696612|FG000|First-line Treatment Phase|Lost to Follow-up|1|||
28038620|NCT00454779|54696613|FG001|First-line Treatment Phase|Lost to Follow-up|0|||
28038621|NCT00454779|54696612|FG000|First-line Treatment Phase|Protocol Violation|0|||
28038622|NCT00454779|54696613|FG001|First-line Treatment Phase|Protocol Violation|1|||
28038623|NCT00454779|54696612|FG000|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
27809728|NCT01777581|54265435|FG000|Overall Study|Lost to Follow-up|1|||
27809729|NCT01777581|54265436|FG001|Overall Study|Lost to Follow-up|1|||
27809730|NCT01777581|54265435|FG000|Overall Study|Adverse Event|2|||
27809731|NCT01777581|54265436|FG001|Overall Study|Adverse Event|0|||
27809732|NCT01777581|54265435|FG000|Overall Study|Lack of Efficacy|0|||
27809733|NCT01777581|54265436|FG001|Overall Study|Lack of Efficacy|1|||
27809734|NCT01864148|54265447|FG000|Overall Study|Other|2|||
27809735|NCT01864148|54265448|FG001|Overall Study|Other|1|||
27809736|NCT01864148|54265449|FG002|Overall Study|Other|1|||
27809737|NCT01864148|54265450|FG003|Overall Study|Other|3|||
27809738|NCT01864148|54265451|FG004|Overall Study|Other|1|||
27809739|NCT01864148|54265447|FG000|Overall Study|Death|0|||
27809740|NCT01864148|54265448|FG001|Overall Study|Death|0|||
27809741|NCT01864148|54265449|FG002|Overall Study|Death|0|||
27809742|NCT01864148|54265450|FG003|Overall Study|Death|1|||
27809743|NCT01864148|54265451|FG004|Overall Study|Death|0|||
27809744|NCT01864148|54265447|FG000|Overall Study|Investigator Decision|5|||
27847859|NCT01455194|54340560|FG001|Overall Study|Randomisation Failure|0|||
27847860|NCT01455194|54340561|FG002|Overall Study|Randomisation Failure|0|||
28038624|NCT00454779|54696613|FG001|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
28038625|NCT00454779|54696612|FG000|First-line Treatment Phase|Ongoing|1|||
28038626|NCT00454779|54696613|FG001|First-line Treatment Phase|Ongoing|0|||
27809745|NCT01864148|54265448|FG001|Overall Study|Investigator Decision|0|||
27809746|NCT01864148|54265449|FG002|Overall Study|Investigator Decision|0|||
27809747|NCT01864148|54265450|FG003|Overall Study|Investigator Decision|4|||
27809748|NCT01864148|54265451|FG004|Overall Study|Investigator Decision|6|||
27809749|NCT01864148|54265447|FG000|Overall Study|Withdrawal by Subject|9|||
27809750|NCT01864148|54265448|FG001|Overall Study|Withdrawal by Subject|2|||
27809751|NCT01864148|54265449|FG002|Overall Study|Withdrawal by Subject|6|||
27809752|NCT01864148|54265450|FG003|Overall Study|Withdrawal by Subject|8|||
27809753|NCT01864148|54265451|FG004|Overall Study|Withdrawal by Subject|8|||
27809754|NCT01864148|54265447|FG000|Overall Study|Lost to Follow-up|0|||
27809755|NCT01864148|54265448|FG001|Overall Study|Lost to Follow-up|0|||
27809756|NCT01864148|54265449|FG002|Overall Study|Lost to Follow-up|0|||
27809757|NCT01864148|54265450|FG003|Overall Study|Lost to Follow-up|2|||
27809758|NCT01864148|54265451|FG004|Overall Study|Lost to Follow-up|1|||
27809759|NCT01864148|54265447|FG000|Overall Study|Adverse Event|4|||
27809760|NCT01864148|54265448|FG001|Overall Study|Adverse Event|2|||
27809761|NCT01864148|54265449|FG002|Overall Study|Adverse Event|4|||
27809762|NCT01864148|54265450|FG003|Overall Study|Adverse Event|7|||
27809763|NCT01864148|54265451|FG004|Overall Study|Adverse Event|7|||
27809764|NCT01864148|54265447|FG000|Overall Study|Not Dosed|0|||
27809765|NCT01864148|54265448|FG001|Overall Study|Not Dosed|0|||
27809766|NCT01864148|54265449|FG002|Overall Study|Not Dosed|0|||
27809767|NCT01864148|54265450|FG003|Overall Study|Not Dosed|1|||
27809768|NCT01864148|54265451|FG004|Overall Study|Not Dosed|0|||
27809769|NCT01751139|54265468|FG000|Overall Study|Other|135|||
27809770|NCT01751139|54265468|FG000|Overall Study|Sponsor study termination|1609|||
27809771|NCT01751139|54265468|FG000|Overall Study|Lost to Follow-up|240|||
27809772|NCT01751139|54265468|FG000|Overall Study|Withdrawal by Subject|251|||
27809773|NCT01751139|54265468|FG000|Overall Study|Adverse Event|1|||
27809774|NCT01751139|54265468|FG000|Overall Study|Death|31|||
27809775|NCT01890122|54265476|FG000|Overall Study|Adverse Event|1|||
27809776|NCT01890122|54265477|FG001|Overall Study|Adverse Event|1|||
27809777|NCT01890122|54265478|FG002|Overall Study|Adverse Event|1|||
27809778|NCT01890122|54265479|FG003|Overall Study|Adverse Event|2|||
27809779|NCT01890122|54265476|FG000|Overall Study|Major Protocol Deviation|3|||
27809780|NCT01890122|54265477|FG001|Overall Study|Major Protocol Deviation|1|||
27809781|NCT01890122|54265478|FG002|Overall Study|Major Protocol Deviation|0|||
27809782|NCT01890122|54265479|FG003|Overall Study|Major Protocol Deviation|1|||
27809783|NCT01890122|54265476|FG000|Overall Study|Lost to Follow-up|0|||
27809784|NCT01890122|54265477|FG001|Overall Study|Lost to Follow-up|1|||
27809785|NCT01890122|54265478|FG002|Overall Study|Lost to Follow-up|2|||
27809786|NCT01890122|54265479|FG003|Overall Study|Lost to Follow-up|2|||
27809787|NCT01890122|54265476|FG000|Overall Study|Voluntary Withdrawal|8|||
27809788|NCT01890122|54265477|FG001|Overall Study|Voluntary Withdrawal|8|||
27809789|NCT01890122|54265478|FG002|Overall Study|Voluntary Withdrawal|2|||
27809790|NCT01890122|54265479|FG003|Overall Study|Voluntary Withdrawal|11|||
28038627|NCT00454779|54696612|FG000|Second-line Treatment Phase|Withdrawal by Subject|0|||
28038628|NCT00454779|54696613|FG001|Second-line Treatment Phase|Withdrawal by Subject|1|||
28038629|NCT00454779|54696612|FG000|Second-line Treatment Phase|Ended follow-up prior to analysis|0|||
28038630|NCT00454779|54696613|FG001|Second-line Treatment Phase|Ended follow-up prior to analysis|1|||
28038631|NCT00454779|54696612|FG000|Second-line Treatment Phase|Ongoing|0|||
28038632|NCT00454779|54696613|FG001|Second-line Treatment Phase|Ongoing|1|||
28038633|NCT00439569|54696623|FG000|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1|||
28038634|NCT00439569|54696623|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3|||
28038635|NCT00439569|54696623|FG000|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
28038636|NCT00443079|54696629|FG000|Overall Study|Lost to Follow-up|0|||
28038637|NCT00443079|54696630|FG001|Overall Study|Lost to Follow-up|1|||
28038638|NCT00427635|54696666|FG000|Treatment Phase|Withdrawal by Subject|1|||
28038639|NCT00427635|54696667|FG001|Treatment Phase|Withdrawal by Subject|0|||
28038640|NCT00427635|54696666|FG000|Study Completion to Safety Follow-up|Lost to Follow-up|0|||
28038641|NCT00427635|54696667|FG001|Study Completion to Safety Follow-up|Lost to Follow-up|1|||
28038642|NCT00427011|54696673|FG000|Overall Study|Adverse Event|10|||
28038643|NCT00427011|54696673|FG000|Overall Study|Withdrawal by Subject|1|||
28038644|NCT00427011|54696673|FG000|Overall Study|Lack of Efficacy|2|||
28038645|NCT00427011|54696673|FG000|Overall Study|Other|12|||
28038646|NCT03891264|54696678|FG000|Overall Study|Adverse Event|1|||
28038647|NCT03891264|54696678|FG000|Overall Study|Withdrawal by Subject|2|||
28038648|NCT03891264|54696678|FG000|Overall Study|Physician Decision|2|||
28038649|NCT00439179|54696686|FG000|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
28038650|NCT00439179|54696687|FG001|Overall Study|* 1 pt inelig, 1 pt numb not used|2|||
28038651|NCT00439179|54696688|FG002|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
28038652|NCT00439179|54696689|FG003|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
28038653|NCT00438633|54696704|FG000|Overall Study|Withdrawal by Subject|1|||
27809791|NCT01890122|54265476|FG000|Overall Study|Lack of Efficacy|14|||
27809792|NCT01890122|54265477|FG001|Overall Study|Lack of Efficacy|24|||
27809793|NCT01890122|54265478|FG002|Overall Study|Lack of Efficacy|7|||
27809794|NCT01890122|54265479|FG003|Overall Study|Lack of Efficacy|41|||
27847861|NCT01455194|54340562|FG003|Overall Study|Randomisation Failure|0|||
27809795|NCT01890122|54265476|FG000|Overall Study|Reason not Specified|0|||
27809796|NCT01890122|54265477|FG001|Overall Study|Reason not Specified|1|||
27809797|NCT01890122|54265478|FG002|Overall Study|Reason not Specified|1|||
27809798|NCT01890122|54265479|FG003|Overall Study|Reason not Specified|2|||
28038654|NCT00438633|54696705|FG001|Overall Study|Withdrawal by Subject|0|||
28038655|NCT00438633|54696704|FG000|Overall Study|Lost to Follow-up|15|||
28038656|NCT00438633|54696705|FG001|Overall Study|Lost to Follow-up|17|||
28038657|NCT00438399|54696714|FG000|Overall Study|Lost to Follow-up|2|||
28038658|NCT00438399|54696715|FG001|Overall Study|Lost to Follow-up|2|||
28038659|NCT00438399|54696716|FG002|Overall Study|Lost to Follow-up|1|||
28038660|NCT00438399|54696717|FG003|Overall Study|Lost to Follow-up|1|||
28038661|NCT00438399|54696718|FG004|Overall Study|Lost to Follow-up|1|||
28038662|NCT00438399|54696719|FG005|Overall Study|Lost to Follow-up|1|||
28038663|NCT00438399|54696714|FG000|Overall Study|Adverse Event|0|||
28038664|NCT00438399|54696715|FG001|Overall Study|Adverse Event|0|||
28038665|NCT00438399|54696716|FG002|Overall Study|Adverse Event|1|||
28038666|NCT00438399|54696717|FG003|Overall Study|Adverse Event|1|||
28038667|NCT00438399|54696718|FG004|Overall Study|Adverse Event|0|||
28038668|NCT00438399|54696719|FG005|Overall Study|Adverse Event|1|||
28038669|NCT00438399|54696714|FG000|Overall Study|Withdrawal by Subject|5|||
28038670|NCT00438399|54696715|FG001|Overall Study|Withdrawal by Subject|6|||
28038671|NCT00438399|54696716|FG002|Overall Study|Withdrawal by Subject|3|||
28038672|NCT00438399|54696717|FG003|Overall Study|Withdrawal by Subject|2|||
28038673|NCT00438399|54696718|FG004|Overall Study|Withdrawal by Subject|2|||
28038674|NCT00438399|54696719|FG005|Overall Study|Withdrawal by Subject|2|||
28038675|NCT00438399|54696714|FG000|Overall Study|Protocol Violation|0|||
28038676|NCT00438399|54696715|FG001|Overall Study|Protocol Violation|0|||
28038677|NCT00438399|54696716|FG002|Overall Study|Protocol Violation|1|||
28038678|NCT00438399|54696717|FG003|Overall Study|Protocol Violation|0|||
28038679|NCT00438399|54696718|FG004|Overall Study|Protocol Violation|0|||
28038680|NCT00438399|54696719|FG005|Overall Study|Protocol Violation|1|||
28038681|NCT00438399|54696714|FG000|Overall Study|Subje stopped study|0|||
28038682|NCT00438399|54696715|FG001|Overall Study|Subje stopped study|0|||
28038683|NCT00438399|54696716|FG002|Overall Study|Subje stopped study|1|||
28038684|NCT00438399|54696717|FG003|Overall Study|Subje stopped study|0|||
28038685|NCT00438399|54696718|FG004|Overall Study|Subje stopped study|0|||
28038686|NCT00438399|54696719|FG005|Overall Study|Subje stopped study|0|||
28038687|NCT00438399|54696714|FG000|Overall Study|Pregnancy|0|||
28038688|NCT00438399|54696715|FG001|Overall Study|Pregnancy|0|||
28038689|NCT00438399|54696716|FG002|Overall Study|Pregnancy|0|||
28038690|NCT00438399|54696717|FG003|Overall Study|Pregnancy|0|||
28038691|NCT00438399|54696718|FG004|Overall Study|Pregnancy|0|||
28038692|NCT00438399|54696719|FG005|Overall Study|Pregnancy|1|||
28038693|NCT00438399|54696714|FG000|Overall Study|Patien stopped study at visit 4 by error|1|||
27809799|NCT01890122|54265476|FG000|Overall Study|Randomized but not Treated|1|||
27809800|NCT01890122|54265477|FG001|Overall Study|Randomized but not Treated|1|||
27809801|NCT01890122|54265478|FG002|Overall Study|Randomized but not Treated|0|||
27809802|NCT01890122|54265479|FG003|Overall Study|Randomized but not Treated|0|||
27809803|NCT01397890|54265491|FG000|Overall Study|Withdrawal by Subject|7|||
27809804|NCT01397890|54265492|FG001|Overall Study|Withdrawal by Subject|11|||
28038694|NCT00438399|54696715|FG001|Overall Study|Patien stopped study at visit 4 by error|0|||
28038695|NCT00438399|54696716|FG002|Overall Study|Patien stopped study at visit 4 by error|0|||
28038696|NCT00438399|54696717|FG003|Overall Study|Patien stopped study at visit 4 by error|0|||
28038697|NCT00438399|54696718|FG004|Overall Study|Patien stopped study at visit 4 by error|0|||
28038698|NCT00438399|54696719|FG005|Overall Study|Patien stopped study at visit 4 by error|0|||
28038699|NCT00426231|54696730|FG000|Overall Study|Withdrawal by Subject|9|||
28038700|NCT00426231|54696731|FG001|Overall Study|Withdrawal by Subject|12|||
28038701|NCT00425607|54696737|FG000|Overall Study|Death|1|||
28038702|NCT00425607|54696737|FG000|Overall Study|Withdrawal by Subject|1|||
28038703|NCT00437073|54696743|FG000|Overall Study|Sponsor Terminated Study|1|||
28038704|NCT00437073|54696744|FG001|Overall Study|Sponsor Terminated Study|0|||
28038705|NCT00437073|54696743|FG000|Overall Study|Physician Decision|0|||
28038706|NCT00437073|54696744|FG001|Overall Study|Physician Decision|1|||
28038707|NCT00425373|54696759|FG000|Overall Study|Adverse Event|2|||
28038708|NCT00425373|54696760|FG001|Overall Study|Adverse Event|2|||
28038709|NCT00425373|54696761|FG002|Overall Study|Adverse Event|0|||
28038710|NCT00425373|54696762|FG003|Overall Study|Adverse Event|1|||
28038711|NCT00425373|54696763|FG004|Overall Study|Adverse Event|4|||
28038712|NCT00425373|54696764|FG005|Overall Study|Adverse Event|6|||
27809805|NCT01397890|54265491|FG000|Overall Study|Eligibility Criteria Not Fulfilled|7|||
27809806|NCT01397890|54265492|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
27809807|NCT01397890|54265491|FG000|Overall Study|Death|2|||
28038713|NCT00425373|54696765|FG006|Overall Study|Adverse Event|2|||
28038714|NCT00425373|54696766|FG007|Overall Study|Adverse Event|3|||
28038715|NCT00425373|54696767|FG008|Overall Study|Adverse Event|8|||
28038716|NCT00425373|54696759|FG000|Overall Study|Lost to Follow-up|0|||
27809808|NCT01397890|54265492|FG001|Overall Study|Death|3|||
27809809|NCT01397890|54265491|FG000|Overall Study|Lost to Follow-up|1|||
28038717|NCT00425373|54696760|FG001|Overall Study|Lost to Follow-up|1|||
28038718|NCT00425373|54696761|FG002|Overall Study|Lost to Follow-up|0|||
28038719|NCT00425373|54696762|FG003|Overall Study|Lost to Follow-up|0|||
28038720|NCT00425373|54696763|FG004|Overall Study|Lost to Follow-up|1|||
28038721|NCT00425373|54696764|FG005|Overall Study|Lost to Follow-up|0|||
28038722|NCT00425373|54696765|FG006|Overall Study|Lost to Follow-up|0|||
28038723|NCT00425373|54696766|FG007|Overall Study|Lost to Follow-up|0|||
28038724|NCT00425373|54696767|FG008|Overall Study|Lost to Follow-up|0|||
28038725|NCT00425373|54696759|FG000|Overall Study|Protocol Violation|1|||
28038726|NCT00425373|54696760|FG001|Overall Study|Protocol Violation|0|||
28038727|NCT00425373|54696761|FG002|Overall Study|Protocol Violation|1|||
28038728|NCT00425373|54696762|FG003|Overall Study|Protocol Violation|0|||
28038729|NCT00425373|54696763|FG004|Overall Study|Protocol Violation|0|||
28038730|NCT00425373|54696764|FG005|Overall Study|Protocol Violation|0|||
27809810|NCT01397890|54265492|FG001|Overall Study|Lost to Follow-up|4|||
27809811|NCT01397890|54265491|FG000|Overall Study|Condition under Investigation Worsened|1|||
27809812|NCT01397890|54265492|FG001|Overall Study|Condition under Investigation Worsened|3|||
28038731|NCT00425373|54696765|FG006|Overall Study|Protocol Violation|0|||
28038732|NCT00425373|54696766|FG007|Overall Study|Protocol Violation|5|||
28038733|NCT00425373|54696767|FG008|Overall Study|Protocol Violation|3|||
28038734|NCT00425373|54696759|FG000|Overall Study|Withdrawal by Subject|2|||
28038735|NCT00425373|54696760|FG001|Overall Study|Withdrawal by Subject|0|||
28038736|NCT00425373|54696761|FG002|Overall Study|Withdrawal by Subject|2|||
28038737|NCT00425373|54696762|FG003|Overall Study|Withdrawal by Subject|1|||
28038738|NCT00425373|54696763|FG004|Overall Study|Withdrawal by Subject|4|||
28038739|NCT00425373|54696764|FG005|Overall Study|Withdrawal by Subject|0|||
28038740|NCT00425373|54696765|FG006|Overall Study|Withdrawal by Subject|2|||
28038741|NCT00425373|54696766|FG007|Overall Study|Withdrawal by Subject|2|||
28038742|NCT00425373|54696767|FG008|Overall Study|Withdrawal by Subject|2|||
28038743|NCT00425373|54696759|FG000|Overall Study|Lack of Efficacy|0|||
28038744|NCT00425373|54696760|FG001|Overall Study|Lack of Efficacy|0|||
28038745|NCT00425373|54696761|FG002|Overall Study|Lack of Efficacy|0|||
28038746|NCT00425373|54696762|FG003|Overall Study|Lack of Efficacy|0|||
28038747|NCT00425373|54696763|FG004|Overall Study|Lack of Efficacy|1|||
28038748|NCT00425373|54696764|FG005|Overall Study|Lack of Efficacy|3|||
28038749|NCT00425373|54696765|FG006|Overall Study|Lack of Efficacy|3|||
28038750|NCT00425373|54696766|FG007|Overall Study|Lack of Efficacy|0|||
28038751|NCT00425373|54696767|FG008|Overall Study|Lack of Efficacy|5|||
28038752|NCT03894540|54696793|FG000|Overall Study|Adverse Event|0|||
28038753|NCT03894540|54696794|FG001|Overall Study|Adverse Event|0|||
28038754|NCT03894540|54696795|FG002|Overall Study|Adverse Event|0|||
28038755|NCT03894540|54696796|FG003|Overall Study|Adverse Event|0|||
28038756|NCT03894540|54696797|FG004|Overall Study|Adverse Event|1|||
28038757|NCT03894540|54696798|FG005|Overall Study|Adverse Event|0|||
28038758|NCT03894540|54696793|FG000|Overall Study|Withdrawal by Subject|0|||
27809813|NCT01397890|54265491|FG000|Overall Study|Adverse Event|1|||
27809814|NCT01397890|54265492|FG001|Overall Study|Adverse Event|2|||
27809815|NCT01397890|54265491|FG000|Overall Study|Severe Non-Compliance to Protocol|2|||
27809816|NCT01397890|54265492|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
28038759|NCT03894540|54696794|FG001|Overall Study|Withdrawal by Subject|0|||
28038760|NCT03894540|54696795|FG002|Overall Study|Withdrawal by Subject|0|||
28038761|NCT03894540|54696796|FG003|Overall Study|Withdrawal by Subject|0|||
28038762|NCT03894540|54696797|FG004|Overall Study|Withdrawal by Subject|1|||
28038763|NCT03894540|54696798|FG005|Overall Study|Withdrawal by Subject|0|||
28038764|NCT03894540|54696793|FG000|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
28038765|NCT03894540|54696794|FG001|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
28038766|NCT03894540|54696795|FG002|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|1|||
28038767|NCT03894540|54696796|FG003|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
28038768|NCT03894540|54696797|FG004|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|2|||
28038769|NCT03894540|54696798|FG005|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
28038770|NCT03894540|54696793|FG000|Overall Study|Progressive Disease Clinical|1|||
27809817|NCT01397890|54265491|FG000|Overall Study|Others|2|||
27809818|NCT01397890|54265492|FG001|Overall Study|Others|1|||
27809819|NCT01777269|54265500|FG000|Overall Study|Adverse Event|24|||
27809820|NCT01777269|54265501|FG001|Overall Study|Adverse Event|33|||
27809821|NCT01777269|54265500|FG000|Overall Study|Lack of Efficacy|8|||
27809822|NCT01777269|54265501|FG001|Overall Study|Lack of Efficacy|10|||
27809823|NCT01777269|54265500|FG000|Overall Study|Protocol Violation|4|||
27809824|NCT01777269|54265501|FG001|Overall Study|Protocol Violation|4|||
27809825|NCT01777269|54265500|FG000|Overall Study|Participants reached stopping criteria|1|||
27809826|NCT01777269|54265501|FG001|Overall Study|Participants reached stopping criteria|1|||
27809827|NCT01777269|54265500|FG000|Overall Study|Lost to Follow-up|4|||
27809828|NCT01777269|54265501|FG001|Overall Study|Lost to Follow-up|0|||
28038771|NCT03894540|54696794|FG001|Overall Study|Progressive Disease Clinical|1|||
28038772|NCT03894540|54696795|FG002|Overall Study|Progressive Disease Clinical|0|||
28038773|NCT03894540|54696796|FG003|Overall Study|Progressive Disease Clinical|1|||
28038774|NCT03894540|54696797|FG004|Overall Study|Progressive Disease Clinical|5|||
28038775|NCT03894540|54696798|FG005|Overall Study|Progressive Disease Clinical|1|||
28038776|NCT03894540|54696793|FG000|Overall Study|Study termination by sponsor|0|||
27809829|NCT01777269|54265500|FG000|Overall Study|Physician Decision|5|||
27809830|NCT01777269|54265501|FG001|Overall Study|Physician Decision|2|||
27809831|NCT01777269|54265500|FG000|Overall Study|Withdrawal by Subject|9|||
27809832|NCT01777269|54265501|FG001|Overall Study|Withdrawal by Subject|9|||
27809833|NCT04016272|54265509|FG000|Overall Study|Withdrawal by Subject|1|||
27809834|NCT04016272|54265510|FG001|Overall Study|Withdrawal by Subject|2|||
27809835|NCT01751061|54265518|FG000|Overall Study|Death|1|||
27809836|NCT01751061|54265519|FG001|Overall Study|Death|0|||
27809837|NCT01751061|54265518|FG000|Overall Study|patient death|5|||
27809838|NCT01751061|54265519|FG001|Overall Study|patient death|0|||
27809839|NCT01751061|54265518|FG000|Overall Study|Lost to Follow-up|40|||
27809840|NCT01751061|54265519|FG001|Overall Study|Lost to Follow-up|25|||
27809841|NCT01751061|54265518|FG000|Overall Study|patient regained decisional capacity|4|||
27809842|NCT01751061|54265519|FG001|Overall Study|patient regained decisional capacity|8|||
27809843|NCT01751061|54265518|FG000|Overall Study|Withdrawal by Subject|4|||
27809844|NCT01751061|54265519|FG001|Overall Study|Withdrawal by Subject|1|||
27809845|NCT01751061|54265518|FG000|Overall Study|Physician Decision|2|||
27809846|NCT01751061|54265519|FG001|Overall Study|Physician Decision|0|||
27809847|NCT01777191|54265527|FG000|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2|||
28038777|NCT03894540|54696794|FG001|Overall Study|Study termination by sponsor|0|||
28038778|NCT03894540|54696795|FG002|Overall Study|Study termination by sponsor|0|||
28038779|NCT03894540|54696796|FG003|Overall Study|Study termination by sponsor|0|||
28038780|NCT03894540|54696797|FG004|Overall Study|Study termination by sponsor|2|||
28038781|NCT03894540|54696798|FG005|Overall Study|Study termination by sponsor|0|||
28038782|NCT00535626|54696816|FG000|Overall Study|Death|15|||
28038783|NCT00535626|54696816|FG000|Overall Study|Lost to Follow-up|29|||
28038784|NCT00535626|54696816|FG000|Overall Study|Withdrawal by Subject|20|||
28038785|NCT00535626|54696816|FG000|Overall Study|Removal/revision of study component|8|||
28038786|NCT00535626|54696816|FG000|Overall Study|Subject terminated|31|||
28038787|NCT00535626|54696816|FG000|Overall Study|Unable to return|2|||
28038788|NCT03889704|54696839|FG000|Overall Study|Study terminated due to pandemic|1|||
28038789|NCT03887442|54696845|FG000|Overall Study|Adverse Event|1|||
28038790|NCT03887442|54696846|FG001|Overall Study|Adverse Event|0|||
28038791|NCT00425061|54696861|FG000|Overall Study|Adverse Event|1|||
28038792|NCT00425061|54696862|FG001|Overall Study|Adverse Event|0|||
28038793|NCT00425061|54696863|FG002|Overall Study|Adverse Event|0|||
28038794|NCT00425061|54696864|FG003|Overall Study|Adverse Event|2|||
28038795|NCT00425061|54696865|FG004|Overall Study|Adverse Event|2|||
28038796|NCT00425061|54696866|FG005|Overall Study|Adverse Event|0|||
28038797|NCT00425061|54696867|FG006|Overall Study|Adverse Event|0|||
28038798|NCT00425061|54696861|FG000|Overall Study|Lost to Follow-up|0|||
28038799|NCT00425061|54696862|FG001|Overall Study|Lost to Follow-up|1|||
28038800|NCT00425061|54696863|FG002|Overall Study|Lost to Follow-up|0|||
28038801|NCT00425061|54696864|FG003|Overall Study|Lost to Follow-up|0|||
28038802|NCT00425061|54696865|FG004|Overall Study|Lost to Follow-up|0|||
28038803|NCT00425061|54696866|FG005|Overall Study|Lost to Follow-up|0|||
28038804|NCT00425061|54696867|FG006|Overall Study|Lost to Follow-up|0|||
28038805|NCT00425061|54696861|FG000|Overall Study|Protocol Violation|1|||
28038806|NCT00425061|54696862|FG001|Overall Study|Protocol Violation|0|||
28038807|NCT00425061|54696863|FG002|Overall Study|Protocol Violation|0|||
27809848|NCT01777191|54265528|FG001|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1|||
27809849|NCT01777191|54265527|FG000|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
27809850|NCT01777191|54265528|FG001|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
27809851|NCT01777191|54265527|FG000|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1|||
27809852|NCT01777191|54265528|FG001|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2|||
27809853|NCT01777191|54265527|FG000|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0|||
27809854|NCT01777191|54265528|FG001|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3|||
27809855|NCT01777191|54265527|FG000|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
27809856|NCT01777191|54265528|FG001|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
27809857|NCT01777191|54265527|FG000|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1|||
27809858|NCT01777191|54265528|FG001|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0|||
27809859|NCT01777191|54265527|FG000|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
27809860|NCT01777191|54265528|FG001|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
27809861|NCT01777191|54265527|FG000|Safety Extension Per (Week 12-Week 48)|Death|0|||
27809862|NCT01777191|54265528|FG001|Safety Extension Per (Week 12-Week 48)|Death|1|||
27809863|NCT01777191|54265527|FG000|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
28038808|NCT00425061|54696864|FG003|Overall Study|Protocol Violation|0|||
28038809|NCT00425061|54696865|FG004|Overall Study|Protocol Violation|0|||
27809864|NCT01777191|54265528|FG001|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
27809865|NCT01777191|54265527|FG000|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1|||
27809866|NCT01777191|54265528|FG001|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2|||
27809867|NCT01777191|54265527|FG000|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1|||
28038810|NCT00425061|54696866|FG005|Overall Study|Protocol Violation|0|||
28038811|NCT00425061|54696867|FG006|Overall Study|Protocol Violation|0|||
28038812|NCT00425061|54696861|FG000|Overall Study|Withdrawal by Subject|0|||
28038813|NCT00425061|54696862|FG001|Overall Study|Withdrawal by Subject|1|||
28038814|NCT00425061|54696863|FG002|Overall Study|Withdrawal by Subject|0|||
28038815|NCT00425061|54696864|FG003|Overall Study|Withdrawal by Subject|0|||
28038816|NCT00425061|54696865|FG004|Overall Study|Withdrawal by Subject|1|||
28038817|NCT00425061|54696866|FG005|Overall Study|Withdrawal by Subject|0|||
28038818|NCT00425061|54696867|FG006|Overall Study|Withdrawal by Subject|3|||
28038819|NCT00425061|54696861|FG000|Overall Study|Sponsor's request|0|||
28038820|NCT00425061|54696862|FG001|Overall Study|Sponsor's request|0|||
28038821|NCT00425061|54696863|FG002|Overall Study|Sponsor's request|0|||
28038822|NCT00425061|54696864|FG003|Overall Study|Sponsor's request|0|||
28038823|NCT00425061|54696865|FG004|Overall Study|Sponsor's request|19|||
28038824|NCT00425061|54696866|FG005|Overall Study|Sponsor's request|4|||
28038825|NCT00425061|54696867|FG006|Overall Study|Sponsor's request|15|||
28038826|NCT00425061|54696861|FG000|Overall Study|Physician Decision|0|||
28038827|NCT00425061|54696862|FG001|Overall Study|Physician Decision|0|||
28038828|NCT00425061|54696863|FG002|Overall Study|Physician Decision|0|||
28038829|NCT00425061|54696864|FG003|Overall Study|Physician Decision|0|||
28038830|NCT00425061|54696865|FG004|Overall Study|Physician Decision|1|||
28038831|NCT00425061|54696866|FG005|Overall Study|Physician Decision|0|||
28038832|NCT00425061|54696867|FG006|Overall Study|Physician Decision|0|||
28038833|NCT00425061|54696861|FG000|Overall Study|Other|0|||
28038834|NCT00425061|54696862|FG001|Overall Study|Other|0|||
28038835|NCT00425061|54696863|FG002|Overall Study|Other|0|||
28038836|NCT00425061|54696864|FG003|Overall Study|Other|0|||
28038837|NCT00425061|54696865|FG004|Overall Study|Other|3|||
28038838|NCT00425061|54696866|FG005|Overall Study|Other|0|||
28038839|NCT00425061|54696867|FG006|Overall Study|Other|1|||
28038840|NCT00424827|54696885|FG000|Overall Study|Adverse Event|1|||
28038841|NCT03885726|54696890|FG000|Overall Study|Staffing issues/lost interest|1|||
28038842|NCT03885726|54696890|FG000|Overall Study|Early discharge from hospital|3|||
28038843|NCT00377962|54696900|FG000|Core Study: 0-12 Months|Adverse Event|18|||
28038844|NCT00377962|54696901|FG001|Core Study: 0-12 Months|Adverse Event|2|||
28038845|NCT00377962|54696900|FG000|Core Study: 0-12 Months|Death|3|||
28038846|NCT00377962|54696901|FG001|Core Study: 0-12 Months|Death|0|||
28038847|NCT00377962|54696900|FG000|Core Study: 0-12 Months|Withdrew Consent|5|||
28038848|NCT00377962|54696901|FG001|Core Study: 0-12 Months|Withdrew Consent|2|||
28038849|NCT00377962|54696900|FG000|Core Study: 0-12 Months|Administrative Reason|1|||
28038850|NCT00377962|54696901|FG001|Core Study: 0-12 Months|Administrative Reason|1|||
28038851|NCT00377962|54696900|FG000|Core Study: 0-12 Months|Unspecified reasons|1|||
28038852|NCT00377962|54696901|FG001|Core Study: 0-12 Months|Unspecified reasons|4|||
28038853|NCT00377962|54696900|FG000|Extension Study: 12-24 Months|Death|1|||
28038854|NCT00377962|54696901|FG001|Extension Study: 12-24 Months|Death|1|||
28038855|NCT00377962|54696900|FG000|Extension Study: 12-24 Months|Adverse Event|8|||
28038856|NCT00377962|54696901|FG001|Extension Study: 12-24 Months|Adverse Event|0|||
28038857|NCT00377962|54696900|FG000|Extension Study: 12-24 Months|Abnormal laboratory value|1|||
28038858|NCT00377962|54696901|FG001|Extension Study: 12-24 Months|Abnormal laboratory value|0|||
28038859|NCT00377962|54696900|FG000|Extension Study: 12-24 Months|Unspecified reason|0|||
28038860|NCT00377962|54696901|FG001|Extension Study: 12-24 Months|Unspecified reason|3|||
28038861|NCT00424749|54696913|FG000|Overall Study|Withdrawal by Subject|1|||
28038862|NCT00424593|54696919|FG000|Acute Double-Blind Period|Adverse Event|16|||
28038863|NCT00424593|54696920|FG001|Acute Double-Blind Period|Adverse Event|7|||
28038864|NCT00424593|54696919|FG000|Acute Double-Blind Period|Withdrawal by Subject|11|||
28038865|NCT00424593|54696920|FG001|Acute Double-Blind Period|Withdrawal by Subject|10|||
28038866|NCT00424593|54696919|FG000|Acute Double-Blind Period|Protocol Violation|2|||
28038867|NCT00424593|54696920|FG001|Acute Double-Blind Period|Protocol Violation|2|||
28038868|NCT00424593|54696919|FG000|Acute Double-Blind Period|Physician Decision|1|||
28038869|NCT00424593|54696920|FG001|Acute Double-Blind Period|Physician Decision|2|||
28038870|NCT00424593|54696919|FG000|Acute Double-Blind Period|Lost to Follow-up|1|||
28038871|NCT00424593|54696920|FG001|Acute Double-Blind Period|Lost to Follow-up|1|||
28038872|NCT00424593|54696919|FG000|Acute Double-Blind Period|Lack of Efficacy|0|||
28038873|NCT00424593|54696920|FG001|Acute Double-Blind Period|Lack of Efficacy|1|||
28038874|NCT00424593|54696919|FG000|Dose-Blind Extension Period|Withdrawal by Subject|19|||
28038875|NCT00424593|54696920|FG001|Dose-Blind Extension Period|Withdrawal by Subject|0|||
28038876|NCT00424593|54696919|FG000|Dose-Blind Extension Period|Adverse Event|18|||
28038877|NCT00424593|54696920|FG001|Dose-Blind Extension Period|Adverse Event|0|||
28038878|NCT00424593|54696919|FG000|Dose-Blind Extension Period|Lack of Efficacy|9|||
28038879|NCT00424593|54696920|FG001|Dose-Blind Extension Period|Lack of Efficacy|0|||
28038880|NCT00424593|54696919|FG000|Dose-Blind Extension Period|Protocol Violation|9|||
27809868|NCT01777191|54265528|FG001|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3|||
27809869|NCT01896050|54265539|FG000|Overall Study|Adverse Event|37|||
27809870|NCT01896050|54265540|FG001|Overall Study|Adverse Event|2|||
28038881|NCT00424593|54696920|FG001|Dose-Blind Extension Period|Protocol Violation|0|||
28038882|NCT00424593|54696919|FG000|Dose-Blind Extension Period|Lost to Follow-up|6|||
28038883|NCT00424593|54696920|FG001|Dose-Blind Extension Period|Lost to Follow-up|0|||
28038884|NCT00424593|54696919|FG000|Dose-Blind Extension Period|Physician Decision|3|||
27809871|NCT01896050|54265539|FG000|Overall Study|Death|1|||
28038885|NCT00424593|54696920|FG001|Dose-Blind Extension Period|Physician Decision|0|||
28038886|NCT00369382|54696928|FG000|Overall Study|Death|0|||
28038887|NCT00369382|54696929|FG001|Overall Study|Death|2|||
28038888|NCT00369382|54696928|FG000|Overall Study|Physician Decision|2|||
28038889|NCT00369382|54696929|FG001|Overall Study|Physician Decision|1|||
27809872|NCT01896050|54265540|FG001|Overall Study|Death|0|||
27809873|NCT01775787|54265548|FG000|First 7-10 Days|Adverse Event|0|||
27809874|NCT01775787|54265549|FG001|First 7-10 Days|Adverse Event|1|||
27809875|NCT01775787|54265548|FG000|First 7-10 Days|family emergency|0|||
27809876|NCT01775787|54265549|FG001|First 7-10 Days|family emergency|1|||
27809877|NCT01775787|54265548|FG000|First 7-10 Days|time commitment|0|||
27809878|NCT01775787|54265549|FG001|First 7-10 Days|time commitment|2|||
27809879|NCT01775787|54265548|FG000|First 7-10 Days|concerns with using IV|1|||
27809880|NCT01775787|54265549|FG001|First 7-10 Days|concerns with using IV|2|||
27809881|NCT01775787|54265548|FG000|Second 7-10 Days|time commitment|0|||
27809882|NCT01775787|54265549|FG001|Second 7-10 Days|time commitment|1|||
27809883|NCT01775787|54265548|FG000|Second 7-10 Days|concerns with using IV|0|||
27809884|NCT01775787|54265549|FG001|Second 7-10 Days|concerns with using IV|1|||
27809885|NCT01775553|54265557|FG000|Overall Study|Adverse Event|1|||
27809886|NCT01775553|54265557|FG000|Overall Study|Disease Progression|12|||
27809887|NCT01775475|54265563|FG000|Overall Study|Death|3|||
27809888|NCT01775475|54265564|FG001|Overall Study|Death|3|||
27809889|NCT01774929|54265570|FG000|Overall Study|Adverse Event|3|||
27809890|NCT01888874|54265581|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
27809891|NCT01888874|54265582|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
27809892|NCT01888874|54265583|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
27809893|NCT01888874|54265584|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4|||
27809894|NCT01888874|54265585|FG004|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
27809895|NCT01888874|54265586|FG005|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
27809896|NCT01888874|54265587|FG006|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
27809897|NCT01888874|54265581|FG000|Period 1 (Baseline up to Week 12)|Other|1|||
27809898|NCT01888874|54265582|FG001|Period 1 (Baseline up to Week 12)|Other|0|||
27809899|NCT01888874|54265583|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
27809900|NCT01888874|54265584|FG003|Period 1 (Baseline up to Week 12)|Other|1|||
27809901|NCT01888874|54265585|FG004|Period 1 (Baseline up to Week 12)|Other|3|||
27809902|NCT01888874|54265586|FG005|Period 1 (Baseline up to Week 12)|Other|3|||
27809903|NCT01888874|54265587|FG006|Period 1 (Baseline up to Week 12)|Other|0|||
27809904|NCT01888874|54265581|FG000|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
27809905|NCT01888874|54265582|FG001|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
27809906|NCT01888874|54265583|FG002|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
27809907|NCT01888874|54265584|FG003|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
27809908|NCT01888874|54265585|FG004|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
27809909|NCT01888874|54265586|FG005|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
27809910|NCT01888874|54265587|FG006|Period 1 (Baseline up to Week 12)|Physician Decision|1|||
27809911|NCT01888874|54265581|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
27809912|NCT01888874|54265582|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
27809913|NCT01888874|54265583|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|3|||
27809914|NCT01888874|54265584|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
27809915|NCT01888874|54265585|FG004|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
27809916|NCT01888874|54265586|FG005|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
27809917|NCT01888874|54265587|FG006|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
27809918|NCT01888874|54265581|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
27809919|NCT01888874|54265582|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
27809920|NCT01888874|54265583|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
28038890|NCT00369382|54696928|FG000|Overall Study|Withdrawal by Subject|5|||
28038891|NCT00369382|54696929|FG001|Overall Study|Withdrawal by Subject|0|||
28038892|NCT00369382|54696928|FG000|Overall Study|Randomized, not treated|2|||
28038893|NCT00369382|54696929|FG001|Overall Study|Randomized, not treated|0|||
28038894|NCT00369382|54696928|FG000|Overall Study|Other|1|||
28038895|NCT00369382|54696929|FG001|Overall Study|Other|0|||
28038896|NCT00424515|54696938|FG000|Overall Study|Progressive Disease|10|||
28038897|NCT00424515|54696939|FG001|Overall Study|Progressive Disease|11|||
27809921|NCT01888874|54265584|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
27809922|NCT01888874|54265585|FG004|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1|||
27809923|NCT01888874|54265586|FG005|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
27809924|NCT01888874|54265587|FG006|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
27809925|NCT01888874|54265581|FG000|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
27809926|NCT01888874|54265582|FG001|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1|||
27809927|NCT01888874|54265583|FG002|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
27809928|NCT01888874|54265584|FG003|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
27809929|NCT01888874|54265585|FG004|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
28038898|NCT00424515|54696938|FG000|Overall Study|Adverse Event|0|||
28038899|NCT00424515|54696939|FG001|Overall Study|Adverse Event|1|||
28038900|NCT00424515|54696938|FG000|Overall Study|Intercurrent Illness|0|||
28038901|NCT00424515|54696939|FG001|Overall Study|Intercurrent Illness|1|||
28038902|NCT00424515|54696938|FG000|Overall Study|Withdrawal by Subject|1|||
28038903|NCT00424515|54696939|FG001|Overall Study|Withdrawal by Subject|0|||
28038904|NCT00377260|54696947|FG000|Overall Study|Lost to Follow-up|0|||
28038905|NCT00377260|54696948|FG001|Overall Study|Lost to Follow-up|1|||
28038906|NCT00377260|54696947|FG000|Overall Study|Withdrawal by Subject|2|||
28038907|NCT00377260|54696948|FG001|Overall Study|Withdrawal by Subject|4|||
28038908|NCT00441441|54696956|FG000|Overall Study|Adverse Event|2|||
28038909|NCT00441441|54696957|FG001|Overall Study|Adverse Event|1|||
28038910|NCT00441441|54696956|FG000|Overall Study|Protocol Violation|4|||
28038911|NCT00441441|54696957|FG001|Overall Study|Protocol Violation|6|||
28038912|NCT00441441|54696956|FG000|Overall Study|Exacerbation of asthma|1|||
28038913|NCT00441441|54696957|FG001|Overall Study|Exacerbation of asthma|2|||
28038914|NCT00441441|54696956|FG000|Overall Study|Withdrawal by Subject|1|||
28038915|NCT00441441|54696957|FG001|Overall Study|Withdrawal by Subject|2|||
28038916|NCT00441441|54696956|FG000|Overall Study|Other|3|||
28038917|NCT00441441|54696957|FG001|Overall Study|Other|3|||
28038918|NCT00436917|54696977|FG000|Overall Study|Withdrawal by Subject|13|||
27809930|NCT01888874|54265586|FG005|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
27809931|NCT01888874|54265587|FG006|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
27809932|NCT01888874|54265581|FG000|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
27809933|NCT01888874|54265582|FG001|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
27809934|NCT01888874|54265583|FG002|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
27809935|NCT01888874|54265584|FG003|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
27809936|NCT01888874|54265585|FG004|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
27809937|NCT01888874|54265586|FG005|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
27809938|NCT01888874|54265587|FG006|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
27809939|NCT01888874|54265581|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
27809940|NCT01888874|54265582|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
27809941|NCT01888874|54265583|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
27809942|NCT01888874|54265584|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
27809943|NCT01888874|54265585|FG004|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
27809944|NCT01888874|54265586|FG005|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
27809945|NCT01888874|54265587|FG006|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
27809946|NCT01888874|54265581|FG000|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
27809947|NCT01888874|54265582|FG001|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
27809948|NCT01888874|54265583|FG002|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
27809949|NCT01888874|54265584|FG003|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
27809950|NCT01888874|54265585|FG004|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1|||
27809951|NCT01888874|54265586|FG005|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
27809952|NCT01888874|54265587|FG006|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
27809953|NCT01888874|54265581|FG000|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
27809954|NCT01888874|54265582|FG001|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
27809955|NCT01888874|54265583|FG002|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2|||
28038919|NCT00436917|54696977|FG000|Overall Study|Adverse Event|2|||
28038920|NCT00436917|54696977|FG000|Overall Study|Physician Decision|1|||
28038921|NCT00436917|54696977|FG000|Overall Study|Death|1|||
28038922|NCT00436917|54696977|FG000|Overall Study|Lost to Follow-up|1|||
28038923|NCT00436917|54696977|FG000|Overall Study|Treatment for polymyalgia rheumatic|1|||
28038924|NCT00436917|54696977|FG000|Overall Study|Increased creatinine|1|||
28038925|NCT00436917|54696977|FG000|Overall Study|Personal conflicts of patient|1|||
28038926|NCT00436605|54696981|FG000|Overall Study|Protocol Violation|3|||
28038927|NCT00368992|54696985|FG000|Overall Study|Ineligible|5|||
28038928|NCT00368992|54696985|FG000|Overall Study|Refused treatment|3|||
28038929|NCT00368992|54696985|FG000|Overall Study|Lack of Efficacy|63|||
28038930|NCT00368992|54696985|FG000|Overall Study|Adverse Event|26|||
28038931|NCT00368992|54696985|FG000|Overall Study|Death|4|||
28038932|NCT00368992|54696985|FG000|Overall Study|Other|9|||
28038933|NCT00376246|54696990|FG000|First Intervention (2 Weeks)|Adverse Event|2|||
28038934|NCT00376246|54696991|FG001|First Intervention (2 Weeks)|Adverse Event|0|||
28038935|NCT00376246|54696990|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
28038936|NCT00376246|54696991|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
28038937|NCT00376246|54696990|FG000|First Intervention (2 Weeks)|Lost to Follow-up|1|||
28038938|NCT00376246|54696991|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
28038939|NCT00368836|54697001|FG000|Phase II|Screen Failure|1|||
28038940|NCT00368836|54697001|FG000|Phase II|Withdrawal by Subject|1|||
28038941|NCT00368836|54697001|FG000|Phase II|unable to collect blood and/or breath|17|||
28038942|NCT00368836|54697001|FG000|Phase II|Protocol Violation|2|||
28038943|NCT00376168|54697010|FG000|Overall Study|Adverse Event|1|||
28038944|NCT00376168|54697011|FG001|Overall Study|Adverse Event|1|||
28038945|NCT00376168|54697010|FG000|Overall Study|Pregnancy|1|||
28038946|NCT00376168|54697011|FG001|Overall Study|Pregnancy|0|||
28038947|NCT00375934|54697019|FG000|Overall Study|Adverse Event|1|||
28038948|NCT00375934|54697020|FG001|Overall Study|Adverse Event|1|||
28038949|NCT00375934|54697019|FG000|Overall Study|Withdrawal by Subject|2|||
28038950|NCT00375934|54697020|FG001|Overall Study|Withdrawal by Subject|2|||
28038951|NCT00375934|54697019|FG000|Overall Study|Lack of Efficacy|0|||
28038952|NCT00375934|54697020|FG001|Overall Study|Lack of Efficacy|2|||
28038953|NCT00375934|54697019|FG000|Overall Study|Physician Decision|0|||
28038954|NCT00375934|54697020|FG001|Overall Study|Physician Decision|1|||
28038955|NCT00642941|54697038|FG000|Overall Study|Physician Decision|3|||
28038956|NCT00642941|54697039|FG001|Overall Study|Physician Decision|1|||
28038957|NCT00642941|54697040|FG002|Overall Study|Physician Decision|0|||
28038958|NCT00642941|54697041|FG003|Overall Study|Physician Decision|0|||
28038959|NCT00642941|54697042|FG004|Overall Study|Physician Decision|0|||
28038960|NCT00642941|54697043|FG005|Overall Study|Physician Decision|0|||
28038961|NCT00642941|54697044|FG006|Overall Study|Physician Decision|1|||
28038962|NCT00642941|54697045|FG007|Overall Study|Physician Decision|0|||
28038963|NCT00642941|54697046|FG008|Overall Study|Physician Decision|0|||
28038964|NCT00642941|54697047|FG009|Overall Study|Physician Decision|1|||
28038965|NCT00642941|54697048|FG010|Overall Study|Physician Decision|0|||
28038966|NCT00642941|54697049|FG011|Overall Study|Physician Decision|1|||
28038967|NCT00642941|54697038|FG000|Overall Study|Death|4|||
28038968|NCT00642941|54697039|FG001|Overall Study|Death|0|||
28038969|NCT00642941|54697040|FG002|Overall Study|Death|1|||
28038970|NCT00642941|54697041|FG003|Overall Study|Death|1|||
28038971|NCT00642941|54697042|FG004|Overall Study|Death|2|||
28038972|NCT00642941|54697043|FG005|Overall Study|Death|1|||
28038973|NCT00642941|54697044|FG006|Overall Study|Death|0|||
28038974|NCT00642941|54697045|FG007|Overall Study|Death|0|||
28038975|NCT00642941|54697046|FG008|Overall Study|Death|0|||
28038976|NCT00642941|54697047|FG009|Overall Study|Death|0|||
28038977|NCT00642941|54697048|FG010|Overall Study|Death|0|||
28038978|NCT00642941|54697049|FG011|Overall Study|Death|1|||
28038979|NCT00642941|54697038|FG000|Overall Study|Study closed by Sponsor|0|||
28038980|NCT00642941|54697039|FG001|Overall Study|Study closed by Sponsor|1|||
28038981|NCT00642941|54697040|FG002|Overall Study|Study closed by Sponsor|0|||
28038982|NCT00642941|54697041|FG003|Overall Study|Study closed by Sponsor|0|||
28038983|NCT00642941|54697042|FG004|Overall Study|Study closed by Sponsor|0|||
28038984|NCT00642941|54697043|FG005|Overall Study|Study closed by Sponsor|0|||
28038985|NCT00642941|54697044|FG006|Overall Study|Study closed by Sponsor|0|||
28038986|NCT00642941|54697045|FG007|Overall Study|Study closed by Sponsor|0|||
28038987|NCT00642941|54697046|FG008|Overall Study|Study closed by Sponsor|0|||
28038988|NCT00642941|54697047|FG009|Overall Study|Study closed by Sponsor|0|||
28038989|NCT00642941|54697048|FG010|Overall Study|Study closed by Sponsor|0|||
28038990|NCT00642941|54697049|FG011|Overall Study|Study closed by Sponsor|0|||
28038991|NCT00642941|54697038|FG000|Overall Study|Withdrawal by Subject|1|||
28038992|NCT00642941|54697039|FG001|Overall Study|Withdrawal by Subject|0|||
28038993|NCT00642941|54697040|FG002|Overall Study|Withdrawal by Subject|0|||
28038994|NCT00642941|54697041|FG003|Overall Study|Withdrawal by Subject|2|||
28038995|NCT00642941|54697042|FG004|Overall Study|Withdrawal by Subject|0|||
28038996|NCT00642941|54697043|FG005|Overall Study|Withdrawal by Subject|0|||
28038997|NCT00642941|54697044|FG006|Overall Study|Withdrawal by Subject|2|||
28038998|NCT00642941|54697045|FG007|Overall Study|Withdrawal by Subject|0|||
28038999|NCT00642941|54697046|FG008|Overall Study|Withdrawal by Subject|1|||
28039000|NCT00642941|54697047|FG009|Overall Study|Withdrawal by Subject|0|||
28039001|NCT00642941|54697048|FG010|Overall Study|Withdrawal by Subject|0|||
28039002|NCT00642941|54697049|FG011|Overall Study|Withdrawal by Subject|1|||
28039003|NCT00642941|54697038|FG000|Overall Study|Protocol Violation|0|||
28039004|NCT00642941|54697039|FG001|Overall Study|Protocol Violation|0|||
28039005|NCT00642941|54697040|FG002|Overall Study|Protocol Violation|0|||
28039006|NCT00642941|54697041|FG003|Overall Study|Protocol Violation|0|||
28039007|NCT00642941|54697042|FG004|Overall Study|Protocol Violation|0|||
28039008|NCT00642941|54697043|FG005|Overall Study|Protocol Violation|0|||
28039009|NCT00642941|54697044|FG006|Overall Study|Protocol Violation|1|||
28039010|NCT00642941|54697045|FG007|Overall Study|Protocol Violation|0|||
28039011|NCT00642941|54697046|FG008|Overall Study|Protocol Violation|0|||
28039012|NCT00642941|54697047|FG009|Overall Study|Protocol Violation|0|||
28039013|NCT00642941|54697048|FG010|Overall Study|Protocol Violation|0|||
27831256|NCT01813019|54307655|FG001|Overall Study|administrative problems|0|||
28039014|NCT00642941|54697049|FG011|Overall Study|Protocol Violation|0|||
28039015|NCT00642941|54697038|FG000|Overall Study|Adverse Event|1|||
28039016|NCT00642941|54697039|FG001|Overall Study|Adverse Event|1|||
28039017|NCT00642941|54697040|FG002|Overall Study|Adverse Event|0|||
28039018|NCT00642941|54697041|FG003|Overall Study|Adverse Event|0|||
28039019|NCT00642941|54697042|FG004|Overall Study|Adverse Event|0|||
28039020|NCT00642941|54697043|FG005|Overall Study|Adverse Event|0|||
28039021|NCT00642941|54697044|FG006|Overall Study|Adverse Event|1|||
28039022|NCT00642941|54697045|FG007|Overall Study|Adverse Event|1|||
28039023|NCT00642941|54697046|FG008|Overall Study|Adverse Event|0|||
27939847|NCT01081912|54596201|FG000|Conversion/Titration|Physician Decision|2|||
27939848|NCT01081912|54596202|FG001|Conversion/Titration|Physician Decision|0|||
28039024|NCT00642941|54697047|FG009|Overall Study|Adverse Event|1|||
28039025|NCT00642941|54697048|FG010|Overall Study|Adverse Event|0|||
28039026|NCT00642941|54697049|FG011|Overall Study|Adverse Event|0|||
28039027|NCT00642941|54697038|FG000|Overall Study|Other|1|||
28039028|NCT00642941|54697039|FG001|Overall Study|Other|1|||
28039029|NCT00642941|54697040|FG002|Overall Study|Other|1|||
28039030|NCT00642941|54697041|FG003|Overall Study|Other|1|||
28039031|NCT00642941|54697042|FG004|Overall Study|Other|0|||
28039032|NCT00642941|54697043|FG005|Overall Study|Other|1|||
28039033|NCT00642941|54697044|FG006|Overall Study|Other|0|||
28039034|NCT00642941|54697045|FG007|Overall Study|Other|1|||
28039035|NCT00642941|54697046|FG008|Overall Study|Other|0|||
28039036|NCT00642941|54697047|FG009|Overall Study|Other|0|||
28039037|NCT00642941|54697048|FG010|Overall Study|Other|0|||
28039038|NCT00642941|54697049|FG011|Overall Study|Other|1|||
27809956|NCT01888874|54265584|FG003|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
27809957|NCT01888874|54265585|FG004|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
27809958|NCT01888874|54265586|FG005|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1|||
27809959|NCT01888874|54265587|FG006|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
27809960|NCT01888874|54265581|FG000|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
27809961|NCT01888874|54265582|FG001|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
27809962|NCT01888874|54265583|FG002|Period 2 (Week 13 to Week 24)|Treatment failure|1|||
27809963|NCT01888874|54265584|FG003|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
27809964|NCT01888874|54265585|FG004|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
27809965|NCT01888874|54265586|FG005|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
27809966|NCT01888874|54265587|FG006|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
27809967|NCT01888874|54265581|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
27809968|NCT01888874|54265582|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
27809969|NCT01888874|54265583|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
27809970|NCT01888874|54265584|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
27809971|NCT01888874|54265585|FG004|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
27809972|NCT01888874|54265586|FG005|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
27809973|NCT01888874|54265587|FG006|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
27809974|NCT01888874|54265581|FG000|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
27809975|NCT01888874|54265582|FG001|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
27809976|NCT01888874|54265583|FG002|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
28039039|NCT00642941|54697038|FG000|Overall Study|Disease progression|60|||
28039040|NCT00642941|54697039|FG001|Overall Study|Disease progression|50|||
28039041|NCT00642941|54697040|FG002|Overall Study|Disease progression|5|||
28039042|NCT00642941|54697041|FG003|Overall Study|Disease progression|36|||
28039043|NCT00642941|54697042|FG004|Overall Study|Disease progression|23|||
28039044|NCT00642941|54697043|FG005|Overall Study|Disease progression|39|||
28039045|NCT00642941|54697044|FG006|Overall Study|Disease progression|18|||
28039046|NCT00642941|54697045|FG007|Overall Study|Disease progression|12|||
28039047|NCT00642941|54697046|FG008|Overall Study|Disease progression|10|||
28039048|NCT00642941|54697047|FG009|Overall Study|Disease progression|7|||
28039049|NCT00642941|54697048|FG010|Overall Study|Disease progression|12|||
28039050|NCT00642941|54697049|FG011|Overall Study|Disease progression|7|||
27847862|NCT01455194|54340559|FG000|Overall Study|Deterioration in asthma|12|||
27847863|NCT01455194|54340560|FG001|Overall Study|Deterioration in asthma|6|||
28039051|NCT00531960|54697098|FG000|Overall Study|Adverse Event|5|||
28039052|NCT00531960|54697099|FG001|Overall Study|Adverse Event|4|||
28039053|NCT00531960|54697098|FG000|Overall Study|Death|3|||
28039054|NCT00531960|54697099|FG001|Overall Study|Death|2|||
28039055|NCT00531960|54697098|FG000|Overall Study|Lack of Efficacy|42|||
28039056|NCT00531960|54697099|FG001|Overall Study|Lack of Efficacy|41|||
28039057|NCT00531960|54697098|FG000|Overall Study|Violation of Selection Criteria|2|||
28039058|NCT00531960|54697099|FG001|Overall Study|Violation of Selection Criteria|0|||
28039059|NCT00531960|54697098|FG000|Overall Study|Refused Treatment|5|||
28039060|NCT00531960|54697099|FG001|Overall Study|Refused Treatment|6|||
27809977|NCT01888874|54265584|FG003|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
27809978|NCT01888874|54265585|FG004|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
27809979|NCT01888874|54265586|FG005|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
27809980|NCT01888874|54265587|FG006|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
28039061|NCT00531960|54697098|FG000|Overall Study|Other|4|||
28039062|NCT00531960|54697099|FG001|Overall Study|Other|10|||
28039063|NCT00361504|54697107|FG000|Overall Study|Withdrawal by Subject|94|||
28039064|NCT00361504|54697108|FG001|Overall Study|Withdrawal by Subject|31|||
28039065|NCT00361504|54697107|FG000|Overall Study|Lost to Follow-up|40|||
28039066|NCT00361504|54697108|FG001|Overall Study|Lost to Follow-up|7|||
28039067|NCT00361504|54697107|FG000|Overall Study|Adverse Event|203|||
28039068|NCT00361504|54697108|FG001|Overall Study|Adverse Event|82|||
28039069|NCT00361504|54697107|FG000|Overall Study|Lack of Efficacy|72|||
28039070|NCT00361504|54697108|FG001|Overall Study|Lack of Efficacy|7|||
27809981|NCT01749735|54265606|FG000|Overall Study|Withdrawal by Subject|1|||
27809982|NCT01749735|54265607|FG001|Overall Study|Withdrawal by Subject|0|||
27809983|NCT01749033|54265616|FG000|Overall Study|Did not receive allocated intervention|3|||
27809984|NCT01749033|54265617|FG001|Overall Study|Did not receive allocated intervention|3|||
27847864|NCT01455194|54340561|FG002|Overall Study|Deterioration in asthma|14|||
27847865|NCT01455194|54340562|FG003|Overall Study|Deterioration in asthma|9|||
27847866|NCT01455194|54340559|FG000|Overall Study|Adverse Event|1|||
27847867|NCT01455194|54340560|FG001|Overall Study|Adverse Event|1|||
27847868|NCT01455194|54340561|FG002|Overall Study|Adverse Event|1|||
27847869|NCT01455194|54340562|FG003|Overall Study|Adverse Event|3|||
27847870|NCT01455194|54340559|FG000|Overall Study|Withdrawal by Subject|21|||
27847871|NCT01455194|54340560|FG001|Overall Study|Withdrawal by Subject|16|||
27847872|NCT01455194|54340561|FG002|Overall Study|Withdrawal by Subject|12|||
27847873|NCT01455194|54340562|FG003|Overall Study|Withdrawal by Subject|9|||
27847874|NCT01455194|54340559|FG000|Overall Study|Lost to Follow-up|2|||
27847875|NCT01455194|54340560|FG001|Overall Study|Lost to Follow-up|0|||
27847876|NCT01455194|54340561|FG002|Overall Study|Lost to Follow-up|1|||
27847877|NCT01455194|54340562|FG003|Overall Study|Lost to Follow-up|1|||
27847878|NCT01455194|54340559|FG000|Overall Study|Pregnancy|0|||
27847879|NCT01455194|54340560|FG001|Overall Study|Pregnancy|1|||
27847880|NCT01455194|54340561|FG002|Overall Study|Pregnancy|1|||
27847881|NCT01455194|54340562|FG003|Overall Study|Pregnancy|0|||
27847882|NCT01455194|54340559|FG000|Overall Study|Discontinuation criterion fulfilled|3|||
27847883|NCT01455194|54340560|FG001|Overall Study|Discontinuation criterion fulfilled|2|||
27847884|NCT01455194|54340561|FG002|Overall Study|Discontinuation criterion fulfilled|0|||
27847885|NCT01455194|54340562|FG003|Overall Study|Discontinuation criterion fulfilled|2|||
27847886|NCT01455194|54340559|FG000|Overall Study|Miscellaneous|4|||
27847887|NCT01455194|54340560|FG001|Overall Study|Miscellaneous|5|||
28039071|NCT00361504|54697107|FG000|Overall Study|Resolution of Pain|2|||
28039072|NCT00361504|54697108|FG001|Overall Study|Resolution of Pain|0|||
28039073|NCT00361504|54697107|FG000|Overall Study|Study medication non compliant|42|||
28039074|NCT00361504|54697108|FG001|Overall Study|Study medication non compliant|15|||
28039075|NCT00361504|54697107|FG000|Overall Study|All other|28|||
28039076|NCT00361504|54697108|FG001|Overall Study|All other|3|||
28039077|NCT00361270|54697118|FG000|Overall Study|Death|0|||
28039078|NCT00361270|54697119|FG001|Overall Study|Death|0|||
28039079|NCT00361270|54697120|FG002|Overall Study|Death|0|||
28039080|NCT00361270|54697121|FG003|Overall Study|Death|2|||
28039081|NCT00361270|54697118|FG000|Overall Study|Lost to Follow-up|4|||
28039082|NCT00361270|54697119|FG001|Overall Study|Lost to Follow-up|1|||
28039083|NCT00361270|54697120|FG002|Overall Study|Lost to Follow-up|0|||
27809985|NCT01749033|54265618|FG002|Overall Study|Did not receive allocated intervention|0|||
27809986|NCT01749033|54265616|FG000|Overall Study|Lost to Follow-up|0|||
27809987|NCT01749033|54265617|FG001|Overall Study|Lost to Follow-up|2|||
27809988|NCT01749033|54265618|FG002|Overall Study|Lost to Follow-up|1|||
27809989|NCT01774305|54265629|FG000|Overall Study|Physician Decision|1|||
27809990|NCT01774305|54265630|FG001|Overall Study|Physician Decision|0|||
27809991|NCT01737021|54265638|FG000|Overall Study|Lost to Follow-up|5|||
27809992|NCT01737021|54265639|FG001|Overall Study|Lost to Follow-up|3|||
27809993|NCT01397422|54265649|FG000|Overall Study|Adverse Event|0|||
27809994|NCT01397422|54265650|FG001|Overall Study|Adverse Event|3|||
27809995|NCT01397422|54265651|FG002|Overall Study|Adverse Event|3|||
27809996|NCT01397422|54265652|FG003|Overall Study|Adverse Event|8|||
27809997|NCT01397422|54265649|FG000|Overall Study|Withdrawal by Subject|1|||
27939849|NCT01081912|54596203|FG002|Conversion/Titration|Physician Decision|0|||
28039084|NCT00361270|54697121|FG003|Overall Study|Lost to Follow-up|0|||
28039085|NCT00361270|54697118|FG000|Overall Study|Physician Decision|0|||
28039086|NCT00361270|54697119|FG001|Overall Study|Physician Decision|0|||
28039087|NCT00361270|54697120|FG002|Overall Study|Physician Decision|1|||
28039088|NCT00361270|54697121|FG003|Overall Study|Physician Decision|0|||
28039089|NCT00361270|54697118|FG000|Overall Study|Protocol Violation|9|||
28039090|NCT00361270|54697119|FG001|Overall Study|Protocol Violation|4|||
28039091|NCT00361270|54697120|FG002|Overall Study|Protocol Violation|5|||
28039092|NCT00361270|54697121|FG003|Overall Study|Protocol Violation|4|||
28039093|NCT00361270|54697118|FG000|Overall Study|Withdrawal by Subject|6|||
27809998|NCT01397422|54265650|FG001|Overall Study|Withdrawal by Subject|0|||
27809999|NCT01397422|54265651|FG002|Overall Study|Withdrawal by Subject|0|||
27810000|NCT01397422|54265652|FG003|Overall Study|Withdrawal by Subject|0|||
27810001|NCT01397422|54265649|FG000|Overall Study|Increased bradykinesia related to PD|1|||
27847888|NCT01455194|54340561|FG002|Overall Study|Miscellaneous|1|||
28039094|NCT00361270|54697119|FG001|Overall Study|Withdrawal by Subject|6|||
28039095|NCT00361270|54697120|FG002|Overall Study|Withdrawal by Subject|3|||
28039096|NCT00361270|54697121|FG003|Overall Study|Withdrawal by Subject|7|||
28039097|NCT00361270|54697118|FG000|Overall Study|Afraid of Hypnosis|1|||
27847889|NCT01455194|54340562|FG003|Overall Study|Miscellaneous|4|||
28039098|NCT00361270|54697119|FG001|Overall Study|Afraid of Hypnosis|2|||
28039099|NCT00361270|54697120|FG002|Overall Study|Afraid of Hypnosis|0|||
28039100|NCT00361270|54697121|FG003|Overall Study|Afraid of Hypnosis|0|||
28039101|NCT00361270|54697118|FG000|Overall Study|Problems with Transportation|4|||
28039102|NCT00361270|54697119|FG001|Overall Study|Problems with Transportation|0|||
27810002|NCT01397422|54265650|FG001|Overall Study|Increased bradykinesia related to PD|0|||
27810003|NCT01397422|54265651|FG002|Overall Study|Increased bradykinesia related to PD|0|||
27810004|NCT01397422|54265652|FG003|Overall Study|Increased bradykinesia related to PD|0|||
27810005|NCT01736553|54265666|FG000|Overall Study|Death|12|||
27810006|NCT01736553|54265667|FG001|Overall Study|Death|0|||
27810007|NCT01736553|54265666|FG000|Overall Study|Withdrawal by Subject|5|||
27810008|NCT01736553|54265667|FG001|Overall Study|Withdrawal by Subject|2|||
27810009|NCT01736553|54265666|FG000|Overall Study|Lost to Follow-up|2|||
27810010|NCT01736553|54265667|FG001|Overall Study|Lost to Follow-up|2|||
27810011|NCT01888640|54265694|FG000|Overall Study|Lost to Follow-up|1|||
27810012|NCT01888640|54265695|FG001|Overall Study|Lost to Follow-up|2|||
27810013|NCT01888640|54265696|FG002|Overall Study|Lost to Follow-up|0|||
27810014|NCT01888640|54265694|FG000|Overall Study|Withdrawal by Subject|15|||
27810015|NCT01888640|54265695|FG001|Overall Study|Withdrawal by Subject|11|||
27810016|NCT01888640|54265696|FG002|Overall Study|Withdrawal by Subject|4|||
27810017|NCT01888640|54265694|FG000|Overall Study|Minimum dose not met|10|||
28039103|NCT00361270|54697120|FG002|Overall Study|Problems with Transportation|0|||
28039104|NCT00361270|54697121|FG003|Overall Study|Problems with Transportation|0|||
28039105|NCT00361270|54697118|FG000|Overall Study|Adverse Event|0|||
28039106|NCT00361270|54697119|FG001|Overall Study|Adverse Event|1|||
28039107|NCT00361270|54697120|FG002|Overall Study|Adverse Event|1|||
28039108|NCT00361270|54697121|FG003|Overall Study|Adverse Event|0|||
28039109|NCT00367744|54697140|FG000|Overall Study|Lost to Follow-up|4|||
28039110|NCT00367744|54697141|FG001|Overall Study|Lost to Follow-up|5|||
28039111|NCT03883386|54697150|FG000|First Assignment|Lost to Follow-up|1|||
28039112|NCT03883386|54697151|FG001|First Assignment|Lost to Follow-up|0|||
28039113|NCT03883386|54697150|FG000|First Assignment|Withdrawal by Subject|1|||
28039114|NCT03883386|54697151|FG001|First Assignment|Withdrawal by Subject|1|||
28039115|NCT00530946|54697161|FG000|Overall Study|Adverse Event|1|||
28039116|NCT00530946|54697162|FG001|Overall Study|Adverse Event|2|||
28039117|NCT00530946|54697163|FG002|Overall Study|Adverse Event|1|||
28039118|NCT00530946|54697164|FG003|Overall Study|Adverse Event|1|||
28039119|NCT00530946|54697161|FG000|Overall Study|Protocol Violation|0|||
28039120|NCT00530946|54697162|FG001|Overall Study|Protocol Violation|0|||
28039121|NCT00530946|54697163|FG002|Overall Study|Protocol Violation|0|||
28039122|NCT00530946|54697164|FG003|Overall Study|Protocol Violation|1|||
28039123|NCT00530946|54697161|FG000|Overall Study|Noncompliance|1|||
28039124|NCT00530946|54697162|FG001|Overall Study|Noncompliance|0|||
28039125|NCT00530946|54697163|FG002|Overall Study|Noncompliance|0|||
28039126|NCT00530946|54697164|FG003|Overall Study|Noncompliance|0|||
28039127|NCT00424047|54697176|FG000|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18|||
28039128|NCT00424047|54697177|FG001|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12|||
28039129|NCT00424047|54697176|FG000|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67|||
28039130|NCT00424047|54697177|FG001|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122|||
28039131|NCT00424047|54697176|FG000|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1|||
28039132|NCT00424047|54697177|FG001|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3|||
28039133|NCT00424047|54697176|FG000|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23|||
28039134|NCT00424047|54697177|FG001|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8|||
28039135|NCT00424047|54697176|FG000|Blinded Treatment (Up to 03 Aug 2005)|Death|11|||
28039136|NCT00424047|54697177|FG001|Blinded Treatment (Up to 03 Aug 2005)|Death|10|||
28039137|NCT00424047|54697176|FG000|Blinded Treatment (Up to 03 Aug 2005)|Other|2|||
28039138|NCT00424047|54697177|FG001|Blinded Treatment (Up to 03 Aug 2005)|Other|1|||
28039139|NCT00424047|54697176|FG000|On Study at Time of Unblinding|Adverse Event|22|||
28039140|NCT00424047|54697177|FG001|On Study at Time of Unblinding|Adverse Event|12|||
27810018|NCT01888640|54265695|FG001|Overall Study|Minimum dose not met|16|||
28039141|NCT00424047|54697176|FG000|On Study at Time of Unblinding|Progression of disease|92|||
28039142|NCT00424047|54697177|FG001|On Study at Time of Unblinding|Progression of disease|128|||
28039143|NCT00424047|54697176|FG000|On Study at Time of Unblinding|Lack of Efficacy|1|||
28039144|NCT00424047|54697177|FG001|On Study at Time of Unblinding|Lack of Efficacy|3|||
28039145|NCT00424047|54697176|FG000|On Study at Time of Unblinding|Withdrawal by Subject|24|||
28039146|NCT00424047|54697177|FG001|On Study at Time of Unblinding|Withdrawal by Subject|9|||
28039147|NCT00424047|54697176|FG000|On Study at Time of Unblinding|Death|11|||
28039148|NCT00424047|54697177|FG001|On Study at Time of Unblinding|Death|11|||
28039149|NCT00424047|54697176|FG000|On Study at Time of Unblinding|Other|5|||
27810019|NCT01888640|54265696|FG002|Overall Study|Minimum dose not met|0|||
27810020|NCT01888640|54265694|FG000|Overall Study|Given wrong unit (placebo)|1|||
27810021|NCT01888640|54265695|FG001|Overall Study|Given wrong unit (placebo)|0|||
27810022|NCT01888640|54265696|FG002|Overall Study|Given wrong unit (placebo)|0|||
28039150|NCT00424047|54697177|FG001|On Study at Time of Unblinding|Other|4|||
27810023|NCT01888640|54265694|FG000|Overall Study|Excluded for prior TENS|0|||
27831257|NCT01813019|54307654|FG000|Overall Study|Protocol Deviation|2|||
28039151|NCT00424047|54697176|FG000|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1|||
28039152|NCT00424047|54697177|FG001|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0|||
28039153|NCT00424047|54697176|FG000|Long Term Extension (Up to 25 Jun 2013)|Death|0|||
28039154|NCT00424047|54697177|FG001|Long Term Extension (Up to 25 Jun 2013)|Death|1|||
28039155|NCT00424047|54697176|FG000|Long Term Extension (Up to 25 Jun 2013)|Other|12|||
28039156|NCT00424047|54697177|FG001|Long Term Extension (Up to 25 Jun 2013)|Other|4|||
28039157|NCT00424047|54697176|FG000|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7|||
28039158|NCT00424047|54697177|FG001|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3|||
27810024|NCT01888640|54265695|FG001|Overall Study|Excluded for prior TENS|1|||
27810025|NCT01888640|54265696|FG002|Overall Study|Excluded for prior TENS|0|||
27810026|NCT01888640|54265694|FG000|Overall Study|Researcher Termination of Participant|0|||
27810027|NCT01888640|54265695|FG001|Overall Study|Researcher Termination of Participant|1|||
27810028|NCT01888640|54265696|FG002|Overall Study|Researcher Termination of Participant|1|||
27810029|NCT01736475|54265709|FG000|Overall Study|Adverse Event|4|||
27810030|NCT01736475|54265710|FG001|Overall Study|Adverse Event|0|||
27810031|NCT01736475|54265709|FG000|Overall Study|Withdrawal by Subject|2|||
27810032|NCT01736475|54265710|FG001|Overall Study|Withdrawal by Subject|0|||
27810033|NCT01736475|54265709|FG000|Overall Study|Protocol Violation|4|||
27810034|NCT01736475|54265710|FG001|Overall Study|Protocol Violation|0|||
27810035|NCT01736475|54265709|FG000|Overall Study|Other - Screen failure|1|||
27847890|NCT01454726|54340586|FG000|Overall Study|Withdrawal by Subject|0|||
27847891|NCT01454726|54340587|FG001|Overall Study|Withdrawal by Subject|1|||
27847892|NCT01361568|54340599|FG000|Overall Study|Adverse Event|0|||
27847893|NCT01361568|54340600|FG001|Overall Study|Adverse Event|0|||
27847894|NCT01361568|54340601|FG002|Overall Study|Adverse Event|0|||
28039159|NCT00424047|54697176|FG000|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1|||
28039160|NCT00424047|54697177|FG001|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0|||
28039161|NCT00530790|54697188|FG000|Overall Study|Adverse Event|2|||
28039162|NCT00530790|54697188|FG000|Overall Study|Withdrawal by Subject|2|||
28039163|NCT00530790|54697188|FG000|Overall Study|Physician Decision|1|||
28039164|NCT00530088|54697192|FG000|Overall Study|Disease Progression|4|||
28039165|NCT00530088|54697192|FG000|Overall Study|Physician Decision|4|||
28039166|NCT00530088|54697192|FG000|Overall Study|Other Not Specified|2|||
28039167|NCT00360568|54697198|FG000|Overall Study|Adverse Event|1|||
28039168|NCT00360568|54697199|FG001|Overall Study|Adverse Event|2|||
28039169|NCT00360568|54697198|FG000|Overall Study|Lack of Efficacy|1|||
28039170|NCT00360568|54697199|FG001|Overall Study|Lack of Efficacy|0|||
28039171|NCT00360568|54697198|FG000|Overall Study|Withdrawal by Subject|0|||
28039172|NCT00360568|54697199|FG001|Overall Study|Withdrawal by Subject|3|||
28039173|NCT00436215|54697207|FG000|Overall Study|Refused further treatment|3|||
28039174|NCT00436215|54697207|FG000|Overall Study|Small bowel obstruction|1|||
28039175|NCT00441363|54697213|FG000|Overall Study|Adverse Event|4|||
28039176|NCT00441363|54697214|FG001|Overall Study|Adverse Event|2|||
28039177|NCT00441363|54697213|FG000|Overall Study|Withdrawal by Subject|3|||
28039178|NCT00441363|54697214|FG001|Overall Study|Withdrawal by Subject|4|||
28039179|NCT00441363|54697213|FG000|Overall Study|Physician Decision|6|||
28039180|NCT00441363|54697214|FG001|Overall Study|Physician Decision|7|||
28039181|NCT00441363|54697213|FG000|Overall Study|Lost to Follow-up|2|||
28039182|NCT00441363|54697214|FG001|Overall Study|Lost to Follow-up|2|||
28039183|NCT00441363|54697213|FG000|Overall Study|Other|2|||
28039184|NCT00441363|54697214|FG001|Overall Study|Other|0|||
28039185|NCT00530712|54697220|FG000|30 Day Follow-up Visit|Withdrawal by Subject|2|||
28039186|NCT00530712|54697220|FG000|30 Day Follow-up Visit|Missed Visit|5|||
28039187|NCT00530712|54697220|FG000|6 Month Follow-up Visit|Withdrawal by Subject|4|||
28039188|NCT00530712|54697220|FG000|6 Month Follow-up Visit|Missed Visit|3|||
28039189|NCT00530712|54697220|FG000|6 Month Follow-up Visit|Lost to Follow-up|3|||
28039190|NCT00530712|54697220|FG000|6 Month Follow-up Visit|Death|2|||
28039191|NCT00530712|54697220|FG000|12 Month Follow-up Visit|Withdrawal by Subject|5|||
28039192|NCT00530712|54697220|FG000|12 Month Follow-up Visit|Missed Visit|3|||
28039193|NCT00530712|54697220|FG000|12 Month Follow-up Visit|Lost to Follow-up|7|||
28039194|NCT00530712|54697220|FG000|12 Month Follow-up Visit|Death|9|||
28039195|NCT00626795|54697228|FG000|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
28039196|NCT00626795|54697229|FG001|Open-label TD1414 Cream TID Treatment|Adverse Event|1|||
28039197|NCT00626795|54697230|FG002|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
28039198|NCT00626795|54697228|FG000|Blinded Treatment|Lack of Efficacy|2|||
28039199|NCT00626795|54697229|FG001|Blinded Treatment|Lack of Efficacy|0|||
28039200|NCT00626795|54697230|FG002|Blinded Treatment|Lack of Efficacy|0|||
27847895|NCT01361568|54340602|FG003|Overall Study|Adverse Event|0|||
28039201|NCT00626795|54697228|FG000|Blinded Treatment|Unacceptable adverse event|0|||
28039202|NCT00626795|54697229|FG001|Blinded Treatment|Unacceptable adverse event|0|||
28039203|NCT00626795|54697230|FG002|Blinded Treatment|Unacceptable adverse event|1|||
27810036|NCT01736475|54265710|FG001|Overall Study|Other - Screen failure|0|||
28039204|NCT00626795|54697228|FG000|Blinded Treatment|Protocol Violation|0|||
27847896|NCT01361568|54340603|FG004|Overall Study|Adverse Event|1|||
28039205|NCT00626795|54697229|FG001|Blinded Treatment|Protocol Violation|1|||
28039206|NCT00626795|54697230|FG002|Blinded Treatment|Protocol Violation|1|||
28039207|NCT00626795|54697228|FG000|Blinded Treatment|Withdrawal by Subject|1|||
28039208|NCT00626795|54697229|FG001|Blinded Treatment|Withdrawal by Subject|1|||
28039209|NCT00626795|54697230|FG002|Blinded Treatment|Withdrawal by Subject|0|||
28039210|NCT00626795|54697228|FG000|Blinded Treatment|Other reasons|2|||
28039211|NCT00626795|54697229|FG001|Blinded Treatment|Other reasons|0|||
28039212|NCT00626795|54697230|FG002|Blinded Treatment|Other reasons|2|||
28039213|NCT00626795|54697228|FG000|Blinded Treatment|Missing reason for withdrawal|5|||
28039214|NCT00626795|54697229|FG001|Blinded Treatment|Missing reason for withdrawal|3|||
28039215|NCT00626795|54697230|FG002|Blinded Treatment|Missing reason for withdrawal|5|||
28039216|NCT00626639|54697244|FG000|Overall Study|Occurrence of grade 3 oral mucositis|2|||
28039217|NCT00626639|54697245|FG001|Overall Study|Occurrence of grade 3 oral mucositis|2|||
28039218|NCT00626561|54697253|FG000|Overall Study|Withdrawal by Subject|2|||
28039219|NCT00626561|54697253|FG000|Overall Study|Disease Progression|2|||
28039220|NCT03880266|54697265|FG000|Overall Study|Withdrawal by Subject|0|||
28039221|NCT03880266|54697266|FG001|Overall Study|Withdrawal by Subject|1|||
28039222|NCT03880266|54697267|FG002|Overall Study|Withdrawal by Subject|1|||
28039223|NCT03880266|54697268|FG003|Overall Study|Withdrawal by Subject|0|||
28039224|NCT03880266|54697269|FG004|Overall Study|Withdrawal by Subject|0|||
28039225|NCT03880266|54697270|FG005|Overall Study|Withdrawal by Subject|0|||
27810037|NCT01736475|54265709|FG000|Overall Study|Other - Surgical procedure|1|||
27810038|NCT01736475|54265710|FG001|Overall Study|Other - Surgical procedure|0|||
27810039|NCT01863758|54265727|FG000|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1|||
27810040|NCT01863758|54265727|FG000|Prophylactic Treatment-Phase II|Lost to Follow-up|1|||
27810041|NCT01863680|54265731|FG000|Overall Study|Adverse Event|17|||
27810042|NCT01863680|54265731|FG000|Overall Study|Risk of OHSS|17|||
27810043|NCT01863680|54265731|FG000|Overall Study|Spontaneous pregnancy|2|||
27810044|NCT01863680|54265731|FG000|Overall Study|Withdrawal by Subject|1|||
27810045|NCT01863680|54265731|FG000|Overall Study|Did not undergo IVF/ET|14|||
27810046|NCT01863680|54265731|FG000|Overall Study|Other|6|||
27810047|NCT01747629|54265737|FG000|Overall Study|Adverse Event|1|||
27810048|NCT01747629|54265738|FG001|Overall Study|Adverse Event|2|||
27810049|NCT01747629|54265737|FG000|Overall Study|Withdrawal by Subject|2|||
27810050|NCT01747629|54265738|FG001|Overall Study|Withdrawal by Subject|2|||
27810051|NCT01747629|54265737|FG000|Overall Study|Noncompliance|1|||
27810052|NCT01747629|54265738|FG001|Overall Study|Noncompliance|1|||
27810053|NCT01747629|54265737|FG000|Overall Study|Inclusion criteria not met|1|||
27810054|NCT01747629|54265738|FG001|Overall Study|Inclusion criteria not met|0|||
28039226|NCT03880266|54697271|FG006|Overall Study|Withdrawal by Subject|0|||
28039227|NCT03880266|54697272|FG007|Overall Study|Withdrawal by Subject|0|||
28039228|NCT00423891|54697293|FG000|Enrolled|Withdrawal by Subject|0|||
28039229|NCT00423891|54697294|FG001|Enrolled|Withdrawal by Subject|0|||
28039230|NCT00423891|54697295|FG002|Enrolled|Withdrawal by Subject|1|||
27810055|NCT01747629|54265737|FG000|Overall Study|Not treated|1|||
28039231|NCT00423891|54697293|FG000|Enrolled|Lost to Follow-up|0|||
28039232|NCT00423891|54697294|FG001|Enrolled|Lost to Follow-up|0|||
28039233|NCT00423891|54697295|FG002|Enrolled|Lost to Follow-up|1|||
28039234|NCT00423891|54697293|FG000|Enrolled|No longer met criteria|11|||
28039235|NCT00423891|54697294|FG001|Enrolled|No longer met criteria|2|||
28039236|NCT00423891|54697295|FG002|Enrolled|No longer met criteria|1|||
28039237|NCT00423891|54697293|FG000|Treatment|Withdrawal by Subject|1|||
28039238|NCT00423891|54697294|FG001|Treatment|Withdrawal by Subject|0|||
28039239|NCT00423891|54697295|FG002|Treatment|Withdrawal by Subject|0|||
28039240|NCT00423891|54697293|FG000|Treatment|Lost to Follow-up|1|||
28039241|NCT00423891|54697294|FG001|Treatment|Lost to Follow-up|0|||
28039242|NCT00423891|54697295|FG002|Treatment|Lost to Follow-up|0|||
28039243|NCT00423891|54697293|FG000|Post-Dosing Follow Up|Withdrawal by Subject|0|||
28039244|NCT00423891|54697294|FG001|Post-Dosing Follow Up|Withdrawal by Subject|3|||
28039245|NCT00423891|54697295|FG002|Post-Dosing Follow Up|Withdrawal by Subject|2|||
28039246|NCT00423891|54697293|FG000|Post-Dosing Follow Up|Lost to Follow-up|2|||
28039247|NCT00423891|54697294|FG001|Post-Dosing Follow Up|Lost to Follow-up|0|||
28039248|NCT00423891|54697295|FG002|Post-Dosing Follow Up|Lost to Follow-up|0|||
28039249|NCT00423813|54697308|FG000|Overall Study|Adverse Event|11|||
28039250|NCT00423813|54697309|FG001|Overall Study|Adverse Event|30|||
27810056|NCT01747629|54265738|FG001|Overall Study|Not treated|0|||
27810057|NCT01747629|54265737|FG000|Overall Study|Other|2|||
27810058|NCT01747629|54265738|FG001|Overall Study|Other|1|||
27810059|NCT01863368|54265746|FG000|Phase I, Day 0 to Day 35|Adverse Event|2|||
28039251|NCT00423813|54697310|FG002|Overall Study|Adverse Event|40|||
28039252|NCT00423813|54697308|FG000|Overall Study|Withdrawal by Subject|6|||
28039253|NCT00423813|54697309|FG001|Overall Study|Withdrawal by Subject|8|||
28039254|NCT00423813|54697310|FG002|Overall Study|Withdrawal by Subject|5|||
28039255|NCT00423813|54697308|FG000|Overall Study|Lost to Follow-up|5|||
28039256|NCT00423813|54697309|FG001|Overall Study|Lost to Follow-up|4|||
27810060|NCT01863368|54265747|FG001|Phase I, Day 0 to Day 35|Adverse Event|4|||
27810061|NCT01863368|54265746|FG000|Phase I, Day 0 to Day 35|Lost to Follow-up|1|||
28039257|NCT00423813|54697310|FG002|Overall Study|Lost to Follow-up|4|||
28039258|NCT00423813|54697308|FG000|Overall Study|Lack of Efficacy|23|||
28039259|NCT00423813|54697309|FG001|Overall Study|Lack of Efficacy|18|||
28039260|NCT00423813|54697310|FG002|Overall Study|Lack of Efficacy|19|||
28039261|NCT00423813|54697308|FG000|Overall Study|Physician Decision|2|||
28039262|NCT00423813|54697309|FG001|Overall Study|Physician Decision|0|||
28039263|NCT00423813|54697310|FG002|Overall Study|Physician Decision|0|||
28039264|NCT00423813|54697308|FG000|Overall Study|Sponsor Decision|0|||
28039265|NCT00423813|54697309|FG001|Overall Study|Sponsor Decision|1|||
28039266|NCT00423813|54697310|FG002|Overall Study|Sponsor Decision|0|||
28039267|NCT00423813|54697308|FG000|Overall Study|Protocol Violation|9|||
28039268|NCT00423813|54697309|FG001|Overall Study|Protocol Violation|4|||
28039269|NCT00423813|54697310|FG002|Overall Study|Protocol Violation|4|||
27939850|NCT01081912|54596201|FG000|Conversion/Titration|Protocol Violation|67|||
27939851|NCT01081912|54596202|FG001|Conversion/Titration|Protocol Violation|0|||
28039270|NCT00423813|54697308|FG000|Overall Study|Pregnancy|0|||
28039271|NCT00423813|54697309|FG001|Overall Study|Pregnancy|0|||
28039272|NCT00423813|54697310|FG002|Overall Study|Pregnancy|1|||
28039273|NCT00423813|54697308|FG000|Overall Study|Subject started night shift work|1|||
28039274|NCT00423813|54697309|FG001|Overall Study|Subject started night shift work|0|||
28039275|NCT00423813|54697310|FG002|Overall Study|Subject started night shift work|0|||
28039276|NCT00423813|54697308|FG000|Overall Study|Will start exclusionary medications|0|||
28039277|NCT00423813|54697309|FG001|Overall Study|Will start exclusionary medications|1|||
28039278|NCT00423813|54697310|FG002|Overall Study|Will start exclusionary medications|0|||
28039279|NCT00423813|54697308|FG000|Overall Study|Undergoing tests for Cushings Syndrome|0|||
28039280|NCT00423813|54697309|FG001|Overall Study|Undergoing tests for Cushings Syndrome|0|||
28039281|NCT00423813|54697310|FG002|Overall Study|Undergoing tests for Cushings Syndrome|1|||
28039282|NCT03687372|54697320|FG000|Overall Study|Lost to Follow-up|12|||
28039283|NCT03687372|54697321|FG001|Overall Study|Lost to Follow-up|21|||
28039284|NCT03687372|54697320|FG000|Overall Study|Withdrawal by Subject|4|||
28039285|NCT03687372|54697321|FG001|Overall Study|Withdrawal by Subject|17|||
28039286|NCT03687372|54697320|FG000|Overall Study|Investigator Decision|1|||
28039287|NCT03687372|54697321|FG001|Overall Study|Investigator Decision|1|||
28039288|NCT00626405|54697331|FG000|Overall Study|Deemed Ineligible|1|||
28039289|NCT00626405|54697332|FG001|Overall Study|Deemed Ineligible|0|||
28039290|NCT00626405|54697331|FG000|Overall Study|Withdrawal by Subject|0|||
28039291|NCT00626405|54697332|FG001|Overall Study|Withdrawal by Subject|1|||
28039292|NCT00358150|54697338|FG000|Overall Study|Adverse Event|3|||
28039293|NCT00358150|54697338|FG000|Overall Study|Withdrawal by Subject|1|||
28039294|NCT00358150|54697338|FG000|Overall Study|Undefined|3|||
28039295|NCT05061966|54697365|FG000|Overall Study|Lost to Follow-up|13|||
28039296|NCT05061966|54697366|FG001|Overall Study|Lost to Follow-up|13|||
28039297|NCT05027815|54697374|FG000|Overall Study|Death|2|||
28039298|NCT05027815|54697375|FG001|Overall Study|Death|1|||
28039299|NCT04827134|54697385|FG000|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
28039300|NCT04827134|54697386|FG001|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
28039301|NCT04827134|54697387|FG002|Treatment Period 1 (1 Day)|Withdrawal by Subject|1|||
28039302|NCT04827134|54697388|FG003|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
28039303|NCT04818593|54697402|FG000|Overall Study|Low Oocyte Yield|8|||
28039304|NCT04818593|54697403|FG001|Overall Study|Low Oocyte Yield|8|||
28039305|NCT04818593|54697402|FG000|Overall Study|Not ICSI Insemination|7|||
28039306|NCT04818593|54697403|FG001|Overall Study|Not ICSI Insemination|7|||
28039307|NCT04818593|54697402|FG000|Overall Study|Poor Sperm Quality|2|||
28039308|NCT04818593|54697403|FG001|Overall Study|Poor Sperm Quality|2|||
28039309|NCT04818593|54697402|FG000|Overall Study|Withdrawal by Subject|2|||
28039310|NCT04818593|54697403|FG001|Overall Study|Withdrawal by Subject|2|||
28039311|NCT04818593|54697402|FG000|Overall Study|Conversion to IUI due to low response|1|||
28039312|NCT04818593|54697403|FG001|Overall Study|Conversion to IUI due to low response|1|||
28039313|NCT04680975|54697409|FG000|Overall Study|Adverse Event|3|||
28039314|NCT04680975|54697409|FG000|Overall Study|Death|1|||
28039315|NCT04680975|54697409|FG000|Overall Study|Progressive Disease|1|||
28039316|NCT04680975|54697409|FG000|Overall Study|Withdrawal by Subject|1|||
28039317|NCT04673786|54697415|FG000|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
28039318|NCT04673786|54697416|FG001|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
28039319|NCT04673786|54697417|FG002|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|0|||
27847897|NCT01361568|54340604|FG005|Overall Study|Adverse Event|0|||
28039320|NCT04673786|54697415|FG000|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
28039321|NCT04673786|54697416|FG001|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|1|||
28039322|NCT04673786|54697417|FG002|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
28039323|NCT04673786|54697415|FG000|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|9|||
28039324|NCT04673786|54697416|FG001|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|3|||
28039325|NCT04673786|54697417|FG002|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|1|||
28039326|NCT04673786|54697415|FG000|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|2|||
28039327|NCT04673786|54697416|FG001|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
27939852|NCT01081912|54596203|FG002|Conversion/Titration|Protocol Violation|0|||
28039328|NCT04673786|54697417|FG002|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
28039329|NCT04673786|54697415|FG000|Treatment Period II (Weeks 16 to 52)|Death|1|||
28039330|NCT04673786|54697416|FG001|Treatment Period II (Weeks 16 to 52)|Death|0|||
28039331|NCT04673786|54697417|FG002|Treatment Period II (Weeks 16 to 52)|Death|0|||
28039332|NCT04673786|54697415|FG000|Treatment Period II (Weeks 16 to 52)|Adverse Event|2|||
28039333|NCT04673786|54697416|FG001|Treatment Period II (Weeks 16 to 52)|Adverse Event|0|||
28039334|NCT04673786|54697417|FG002|Treatment Period II (Weeks 16 to 52)|Adverse Event|1|||
28039335|NCT04583969|54697441|FG000|Overall Study|Death|31|||
28039336|NCT04583969|54697442|FG001|Overall Study|Death|38|||
28039337|NCT04583969|54697441|FG000|Overall Study|Lost to Follow-up|16|||
28039338|NCT04583969|54697442|FG001|Overall Study|Lost to Follow-up|13|||
28039339|NCT04583969|54697441|FG000|Overall Study|Protocol Violation|1|||
28039340|NCT04583969|54697442|FG001|Overall Study|Protocol Violation|0|||
28039341|NCT04583969|54697441|FG000|Overall Study|Withdrawal by Subject|3|||
28039342|NCT04583969|54697442|FG001|Overall Study|Withdrawal by Subject|3|||
28039343|NCT04583969|54697441|FG000|Overall Study|RANDOMIZED BUT NOT DOSED|2|||
28039344|NCT04583969|54697442|FG001|Overall Study|RANDOMIZED BUT NOT DOSED|4|||
28039345|NCT04583969|54697441|FG000|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|1|||
28039346|NCT04583969|54697442|FG001|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|0|||
28039347|NCT04583969|54697441|FG000|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|1|||
28039348|NCT04583969|54697442|FG001|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|0|||
28039349|NCT04583969|54697441|FG000|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
28039350|NCT04583969|54697442|FG001|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
28039351|NCT04583969|54697441|FG000|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|1|||
28039352|NCT04583969|54697442|FG001|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|0|||
28039353|NCT04561115|54697448|FG000|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|1|||
28039354|NCT04561115|54697449|FG001|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|0|||
28039355|NCT04561115|54697448|FG000|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
28039356|NCT04561115|54697449|FG001|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
28039357|NCT04561115|54697448|FG000|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
28039358|NCT04561115|54697449|FG001|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
28039359|NCT04546425|54697457|FG000|Overall Study|Protocol Violation|2|||
28039360|NCT04546425|54697458|FG001|Overall Study|Protocol Violation|1|||
28039361|NCT04546425|54697457|FG000|Overall Study|Adverse Event|3|||
28039362|NCT04546425|54697458|FG001|Overall Study|Adverse Event|0|||
28039363|NCT04546425|54697457|FG000|Overall Study|No Longer met eligibility criteria|3|||
28039364|NCT04546425|54697458|FG001|Overall Study|No Longer met eligibility criteria|3|||
28039365|NCT04546425|54697457|FG000|Overall Study|Withdrawal by parent/guardian|7|||
28039366|NCT04546425|54697458|FG001|Overall Study|Withdrawal by parent/guardian|5|||
28039367|NCT04546425|54697457|FG000|Overall Study|Lost to Follow-up|5|||
28039368|NCT04546425|54697458|FG001|Overall Study|Lost to Follow-up|4|||
28039369|NCT04546425|54697457|FG000|Overall Study|Other|0|||
28039370|NCT04546425|54697458|FG001|Overall Study|Other|1|||
28039371|NCT04366258|54697464|FG000|Baseline Assessments|Screen Failure|21|||
28039372|NCT04366258|54697464|FG000|Baseline Assessments|Early Termination|3|||
28039373|NCT04101331|54697512|FG000|Overall Study|Adverse Event|7|||
28039374|NCT04101331|54697512|FG000|Overall Study|Disease progression|79|||
28039375|NCT04101331|54697512|FG000|Overall Study|Withdrawal by Subject|1|||
28039376|NCT04101331|54697512|FG000|Overall Study|Investigator decision|6|||
28039377|NCT04101331|54697512|FG000|Overall Study|Death|6|||
28039378|NCT04101331|54697512|FG000|Overall Study|Allogenic transplant|1|||
28039379|NCT04082884|54697516|FG000|Overall Study|Withdrawal by Subject|1|||
28039380|NCT03891667|54697533|FG000|Overall Study|Physician Decision|1|||
28039381|NCT03891667|54697534|FG001|Overall Study|Physician Decision|0|||
28039382|NCT03891667|54697533|FG000|Overall Study|COVID related pause|1|||
28039383|NCT03891667|54697534|FG001|Overall Study|COVID related pause|1|||
28039384|NCT03891667|54697533|FG000|Overall Study|Withdrawal by Subject|0|||
28039385|NCT03891667|54697534|FG001|Overall Study|Withdrawal by Subject|1|||
28039386|NCT03891667|54697533|FG000|Overall Study|Adverse Event|0|||
28039387|NCT03891667|54697534|FG001|Overall Study|Adverse Event|1|||
28039388|NCT03715153|54697558|FG000|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
28039389|NCT03715153|54697559|FG001|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
28039390|NCT03715153|54697558|FG000|Double-blind Period (From W0 to W26)|Non medical reason|8|||
28039391|NCT03715153|54697559|FG001|Double-blind Period (From W0 to W26)|Non medical reason|2|||
28039392|NCT03715153|54697558|FG000|Double-blind Period (From W0 to W26)|Adverse Event|8|||
28039393|NCT03715153|54697559|FG001|Double-blind Period (From W0 to W26)|Adverse Event|6|||
28039394|NCT03715153|54697558|FG000|Open-label Period (From W26 to W52)|Adverse Event|8|||
28039395|NCT03715153|54697559|FG001|Open-label Period (From W26 to W52)|Adverse Event|3|||
28039396|NCT03715153|54697558|FG000|Open-label Period (From W26 to W52)|Non medical reason|31|||
28039397|NCT03715153|54697559|FG001|Open-label Period (From W26 to W52)|Non medical reason|38|||
28039398|NCT03715153|54697558|FG000|Open-label Period (From W26 to W52)|Protocol Violation|1|||
28039399|NCT03715153|54697559|FG001|Open-label Period (From W26 to W52)|Protocol Violation|1|||
28039400|NCT03569293|54697588|FG000|Overall Study|Adverse Event|4|||
28039401|NCT03569293|54697589|FG001|Overall Study|Adverse Event|1|||
28039402|NCT03569293|54697590|FG002|Overall Study|Adverse Event|5|||
27810062|NCT01863368|54265747|FG001|Phase I, Day 0 to Day 35|Lost to Follow-up|0|||
27810063|NCT01863368|54265746|FG000|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0|||
27810064|NCT01863368|54265747|FG001|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1|||
27810065|NCT01863368|54265746|FG000|Phase I, Day 0 to Day 35|Withdrawal by Subject|0|||
27810066|NCT01863368|54265747|FG001|Phase I, Day 0 to Day 35|Withdrawal by Subject|2|||
27810067|NCT01863368|54265746|FG000|Phase II, Day 35 to Day 90|Adverse Event|1|||
27810068|NCT01863368|54265747|FG001|Phase II, Day 35 to Day 90|Adverse Event|0|||
27810069|NCT01863368|54265746|FG000|Phase II, Day 35 to Day 90|Lost to Follow-up|1|||
28039403|NCT03569293|54697591|FG003|Overall Study|Adverse Event|1|||
28039404|NCT03569293|54697592|FG004|Overall Study|Adverse Event|0|||
28039405|NCT03569293|54697593|FG005|Overall Study|Adverse Event|0|||
28039406|NCT03569293|54697588|FG000|Overall Study|Withdrawal by Subject|16|||
28039407|NCT03569293|54697589|FG001|Overall Study|Withdrawal by Subject|2|||
28039408|NCT03569293|54697590|FG002|Overall Study|Withdrawal by Subject|4|||
28039409|NCT03569293|54697591|FG003|Overall Study|Withdrawal by Subject|1|||
28039410|NCT03569293|54697592|FG004|Overall Study|Withdrawal by Subject|0|||
28039411|NCT03569293|54697593|FG005|Overall Study|Withdrawal by Subject|0|||
28039412|NCT03569293|54697588|FG000|Overall Study|Lost to Follow-up|1|||
28039413|NCT03569293|54697589|FG001|Overall Study|Lost to Follow-up|3|||
28039414|NCT03569293|54697590|FG002|Overall Study|Lost to Follow-up|1|||
28039415|NCT03569293|54697591|FG003|Overall Study|Lost to Follow-up|1|||
28039416|NCT03569293|54697592|FG004|Overall Study|Lost to Follow-up|0|||
28039417|NCT03569293|54697593|FG005|Overall Study|Lost to Follow-up|0|||
28039418|NCT03569293|54697588|FG000|Overall Study|Other|8|||
28039419|NCT03569293|54697589|FG001|Overall Study|Other|2|||
28039420|NCT03569293|54697590|FG002|Overall Study|Other|1|||
28039421|NCT03569293|54697591|FG003|Overall Study|Other|1|||
28039422|NCT03569293|54697592|FG004|Overall Study|Other|0|||
28039423|NCT03569293|54697593|FG005|Overall Study|Other|0|||
28039424|NCT03569293|54697588|FG000|Overall Study|Ongoing at Time of Analysis|8|||
28039425|NCT03569293|54697589|FG001|Overall Study|Ongoing at Time of Analysis|1|||
28039426|NCT03569293|54697590|FG002|Overall Study|Ongoing at Time of Analysis|3|||
28039427|NCT03569293|54697591|FG003|Overall Study|Ongoing at Time of Analysis|0|||
28039428|NCT03569293|54697592|FG004|Overall Study|Ongoing at Time of Analysis|0|||
28039429|NCT03569293|54697593|FG005|Overall Study|Ongoing at Time of Analysis|0|||
28039430|NCT03464136|54697609|FG000|Overall Study|Lost to Follow-up|5|||
28039431|NCT03464136|54697610|FG001|Overall Study|Lost to Follow-up|8|||
28039432|NCT03464136|54697609|FG000|Overall Study|Withdrawal by Subject|16|||
28039433|NCT03464136|54697610|FG001|Overall Study|Withdrawal by Subject|13|||
28039434|NCT03464136|54697609|FG000|Overall Study|Death|1|||
28039435|NCT03464136|54697610|FG001|Overall Study|Death|0|||
28039436|NCT03464136|54697609|FG000|Overall Study|Other|8|||
28039437|NCT03464136|54697610|FG001|Overall Study|Other|4|||
28039438|NCT03020823|54697634|FG000|Overall Study|Physician Decision|4|||
28039439|NCT03020823|54697634|FG000|Overall Study|Lack of Efficacy|4|||
28039440|NCT03020823|54697634|FG000|Overall Study|Adverse Event|2|||
28039441|NCT02969369|54697642|FG000|Study|Adverse Event|1|||
28039442|NCT02969369|54697643|FG001|Study|Adverse Event|6|||
28039443|NCT02969369|54697642|FG000|Study|Lack of Efficacy|0|||
28039444|NCT02969369|54697643|FG001|Study|Lack of Efficacy|1|||
28039445|NCT02969369|54697642|FG000|Study|Lost to Follow-up|0|||
28039446|NCT02969369|54697643|FG001|Study|Lost to Follow-up|1|||
28039447|NCT02969369|54697642|FG000|Study|Withdrawal by Subject|3|||
28039448|NCT02969369|54697643|FG001|Study|Withdrawal by Subject|5|||
28039449|NCT02969369|54697642|FG000|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
28039450|NCT02969369|54697643|FG001|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
27810070|NCT01863368|54265747|FG001|Phase II, Day 35 to Day 90|Lost to Follow-up|0|||
27810071|NCT01886690|54265756|FG000|Overall Study|Protocol Violation|0|||
28039451|NCT02969369|54697642|FG000|Double-blind Period|Adverse Event|1|||
28039452|NCT02969369|54697643|FG001|Double-blind Period|Adverse Event|5|||
28039453|NCT02969369|54697642|FG000|Double-blind Period|Lost to Follow-up|0|||
28039454|NCT02969369|54697643|FG001|Double-blind Period|Lost to Follow-up|1|||
27810072|NCT01886690|54265757|FG001|Overall Study|Protocol Violation|1|||
27810073|NCT01886690|54265756|FG000|Overall Study|Personal Reasons|0|||
28039455|NCT02969369|54697642|FG000|Double-blind Period|Withdrawal by Subject|2|||
28039456|NCT02969369|54697643|FG001|Double-blind Period|Withdrawal by Subject|3|||
28039457|NCT02969369|54697642|FG000|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
28039458|NCT02969369|54697643|FG001|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
28039459|NCT02969369|54697642|FG000|Open-label SEP-363856 Period|Adverse Event|0|||
28039460|NCT02969369|54697643|FG001|Open-label SEP-363856 Period|Adverse Event|1|||
28039461|NCT02969369|54697642|FG000|Open-label SEP-363856 Period|Lack of Efficacy|0|||
27810074|NCT01886690|54265757|FG001|Overall Study|Personal Reasons|1|||
27810075|NCT01886378|54265763|FG000|Overall Study|Adverse Event|1|||
27810076|NCT01886378|54265763|FG000|Overall Study|Withdrawal by Subject|4|||
28039462|NCT02969369|54697643|FG001|Open-label SEP-363856 Period|Lack of Efficacy|1|||
28039463|NCT02969369|54697642|FG000|Open-label SEP-363856 Period|Withdrawal by Subject|1|||
28039464|NCT02969369|54697643|FG001|Open-label SEP-363856 Period|Withdrawal by Subject|2|||
28039465|NCT02583269|54697672|FG000|Overall Study|Patient hospitalized prior to start|1|||
28039466|NCT02583269|54697673|FG001|Overall Study|Patient hospitalized prior to start|0|||
28039467|NCT02583269|54697674|FG002|Overall Study|Patient hospitalized prior to start|0|||
28039468|NCT02583269|54697675|FG003|Overall Study|Patient hospitalized prior to start|0|||
28039469|NCT02583269|54697676|FG004|Overall Study|Patient hospitalized prior to start|0|||
28039470|NCT02546921|54697696|FG000|Overall Study|Adverse Event|0|||
27810077|NCT01886300|54265767|FG000|Overall Study|Trial terminated by sponsor|16|||
27939853|NCT01081912|54596201|FG000|Conversion/Titration|Withdrawal by Subject|23|||
27939854|NCT01081912|54596202|FG001|Conversion/Titration|Withdrawal by Subject|0|||
28039471|NCT02546921|54697697|FG001|Overall Study|Adverse Event|5|||
28039472|NCT02546921|54697698|FG002|Overall Study|Adverse Event|2|||
28039473|NCT02546921|54697699|FG003|Overall Study|Adverse Event|0|||
28039474|NCT02546921|54697700|FG004|Overall Study|Adverse Event|0|||
28039475|NCT02546921|54697701|FG005|Overall Study|Adverse Event|0|||
28039476|NCT02546921|54697702|FG006|Overall Study|Adverse Event|0|||
28039477|NCT02546921|54697696|FG000|Overall Study|Evidence of Disease Progression|1|||
28039478|NCT02546921|54697697|FG001|Overall Study|Evidence of Disease Progression|0|||
28039479|NCT02546921|54697698|FG002|Overall Study|Evidence of Disease Progression|0|||
28039480|NCT02546921|54697699|FG003|Overall Study|Evidence of Disease Progression|0|||
28039481|NCT02546921|54697700|FG004|Overall Study|Evidence of Disease Progression|1|||
28039482|NCT02546921|54697701|FG005|Overall Study|Evidence of Disease Progression|0|||
28039483|NCT02546921|54697702|FG006|Overall Study|Evidence of Disease Progression|0|||
28039484|NCT02546921|54697696|FG000|Overall Study|Patient Choice|0|||
28039485|NCT02546921|54697697|FG001|Overall Study|Patient Choice|1|||
28039486|NCT02546921|54697698|FG002|Overall Study|Patient Choice|0|||
28039487|NCT02546921|54697699|FG003|Overall Study|Patient Choice|0|||
28039488|NCT02546921|54697700|FG004|Overall Study|Patient Choice|0|||
28039489|NCT02546921|54697701|FG005|Overall Study|Patient Choice|1|||
28039490|NCT02546921|54697702|FG006|Overall Study|Patient Choice|0|||
28039491|NCT02513329|54697736|FG000|Overall Study|Lost to Follow-up|5|||
28039492|NCT02513329|54697737|FG001|Overall Study|Lost to Follow-up|2|||
28039493|NCT02425826|54697747|FG000|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5|||
28039494|NCT02425826|54697748|FG001|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2|||
28039495|NCT02425826|54697749|FG002|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0|||
28039496|NCT02425826|54697747|FG000|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
28039497|NCT02425826|54697748|FG001|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1|||
28039498|NCT02425826|54697749|FG002|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
28039499|NCT02425826|54697747|FG000|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9|||
28039500|NCT02425826|54697748|FG001|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1|||
28039501|NCT02425826|54697749|FG002|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0|||
28039502|NCT02425826|54697747|FG000|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10|||
28039503|NCT02425826|54697748|FG001|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4|||
28039504|NCT02425826|54697749|FG002|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0|||
28039505|NCT02425826|54697747|FG000|Placebo-controlled Phase (Week 0 - 16)|Other|3|||
28039506|NCT02425826|54697748|FG001|Placebo-controlled Phase (Week 0 - 16)|Other|1|||
28039507|NCT02425826|54697749|FG002|Placebo-controlled Phase (Week 0 - 16)|Other|0|||
28039508|NCT02425826|54697747|FG000|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7|||
28039509|NCT02425826|54697748|FG001|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0|||
28039510|NCT02425826|54697749|FG002|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2|||
28039511|NCT02425826|54697747|FG000|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8|||
28039512|NCT02425826|54697748|FG001|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0|||
28039513|NCT02425826|54697749|FG002|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6|||
28039514|NCT02425826|54697747|FG000|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12|||
28039515|NCT02425826|54697748|FG001|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0|||
28039516|NCT02425826|54697749|FG002|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4|||
28039517|NCT02425826|54697747|FG000|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8|||
28039518|NCT02425826|54697748|FG001|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0|||
28039519|NCT02425826|54697749|FG002|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1|||
28039520|NCT02425826|54697747|FG000|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
28039521|NCT02425826|54697748|FG001|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
28039522|NCT02425826|54697749|FG002|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1|||
28039523|NCT02406027|54697762|FG000|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
27810078|NCT01885208|54265773|FG000|Overall Study|Unclassified|32|||
27810079|NCT01885208|54265774|FG001|Overall Study|Unclassified|38|||
28039524|NCT02406027|54697763|FG001|Double-blind Treatment Phase (Period 1)|Adverse Event|2|||
28039525|NCT02406027|54697764|FG002|Double-blind Treatment Phase (Period 1)|Adverse Event|1|||
28039526|NCT02406027|54697765|FG003|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
28039527|NCT02406027|54697766|FG004|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
28039528|NCT02406027|54697767|FG005|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
28039529|NCT02406027|54697768|FG006|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
28039530|NCT02406027|54697762|FG000|Double-blind Treatment Phase (Period 1)|Physician Decision|3|||
28039531|NCT02406027|54697763|FG001|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
28039532|NCT02406027|54697764|FG002|Double-blind Treatment Phase (Period 1)|Physician Decision|1|||
28039533|NCT02406027|54697765|FG003|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
28039534|NCT02406027|54697766|FG004|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
28039535|NCT02406027|54697767|FG005|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
28039536|NCT02406027|54697768|FG006|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
28039537|NCT02406027|54697762|FG000|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2|||
28039538|NCT02406027|54697763|FG001|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
28039539|NCT02406027|54697764|FG002|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
28039540|NCT02406027|54697765|FG003|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
28039541|NCT02406027|54697766|FG004|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
28039542|NCT02406027|54697767|FG005|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
28039543|NCT02406027|54697768|FG006|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
28039544|NCT02406027|54697762|FG000|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
28039545|NCT02406027|54697763|FG001|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
28039546|NCT02406027|54697764|FG002|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
28039547|NCT02406027|54697765|FG003|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
28039548|NCT02406027|54697766|FG004|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
28039549|NCT02406027|54697767|FG005|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
28039550|NCT02406027|54697768|FG006|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
28039551|NCT02406027|54697762|FG000|Open-label Phase (Period 2)|Adverse Event|0|||
28039552|NCT02406027|54697763|FG001|Open-label Phase (Period 2)|Adverse Event|0|||
28039553|NCT02406027|54697764|FG002|Open-label Phase (Period 2)|Adverse Event|0|||
28039554|NCT02406027|54697765|FG003|Open-label Phase (Period 2)|Adverse Event|2|||
28039555|NCT02406027|54697766|FG004|Open-label Phase (Period 2)|Adverse Event|2|||
28039556|NCT02406027|54697767|FG005|Open-label Phase (Period 2)|Adverse Event|0|||
28039557|NCT02406027|54697768|FG006|Open-label Phase (Period 2)|Adverse Event|0|||
28039558|NCT02406027|54697762|FG000|Open-label Phase (Period 2)|Physician Decision|0|||
28039559|NCT02406027|54697763|FG001|Open-label Phase (Period 2)|Physician Decision|0|||
28039560|NCT02406027|54697764|FG002|Open-label Phase (Period 2)|Physician Decision|0|||
28039561|NCT02406027|54697765|FG003|Open-label Phase (Period 2)|Physician Decision|0|||
28039562|NCT02406027|54697766|FG004|Open-label Phase (Period 2)|Physician Decision|0|||
28039563|NCT02406027|54697767|FG005|Open-label Phase (Period 2)|Physician Decision|1|||
28039564|NCT02406027|54697768|FG006|Open-label Phase (Period 2)|Physician Decision|1|||
28039565|NCT02406027|54697762|FG000|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
28039566|NCT02406027|54697763|FG001|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
28039567|NCT02406027|54697764|FG002|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
28039568|NCT02406027|54697765|FG003|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
28039569|NCT02406027|54697766|FG004|Open-label Phase (Period 2)|Withdrawal by Subject|4|||
28039570|NCT02406027|54697767|FG005|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
28039571|NCT02406027|54697768|FG006|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
28039572|NCT02406027|54697762|FG000|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
28039573|NCT02406027|54697763|FG001|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
28039574|NCT02406027|54697764|FG002|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
28039575|NCT02406027|54697765|FG003|Open-label Phase (Period 2)|Study Terminated by Sponsor|11|||
28039576|NCT02406027|54697766|FG004|Open-label Phase (Period 2)|Study Terminated by Sponsor|7|||
28039577|NCT02406027|54697767|FG005|Open-label Phase (Period 2)|Study Terminated by Sponsor|24|||
28039578|NCT02406027|54697768|FG006|Open-label Phase (Period 2)|Study Terminated by Sponsor|19|||
28039579|NCT02406027|54697762|FG000|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
28039580|NCT02406027|54697763|FG001|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
28039581|NCT02406027|54697764|FG002|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
28039582|NCT02406027|54697765|FG003|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
28039583|NCT02406027|54697766|FG004|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
28039584|NCT02406027|54697767|FG005|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1|||
28039585|NCT02406027|54697768|FG006|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
28039586|NCT02406027|54697762|FG000|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
28039587|NCT02406027|54697763|FG001|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
28039588|NCT02406027|54697764|FG002|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
28039589|NCT02406027|54697765|FG003|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
28039590|NCT02406027|54697766|FG004|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1|||
28039591|NCT02406027|54697767|FG005|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
28039592|NCT02406027|54697768|FG006|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
28039593|NCT02354651|54697784|FG000|Overall Study|Withdrawal by Subject|2|||
28039594|NCT02354651|54697784|FG000|Overall Study|Physician Decision|1|||
28039595|NCT02278120|54697793|FG000|Overall Study|Progressive disease|122|||
28039596|NCT02278120|54697794|FG001|Overall Study|Progressive disease|174|||
28039597|NCT02278120|54697793|FG000|Overall Study|Patient/guardian decision|14|||
28039598|NCT02278120|54697794|FG001|Overall Study|Patient/guardian decision|8|||
28039599|NCT02278120|54697793|FG000|Overall Study|Adverse Event|12|||
28039600|NCT02278120|54697794|FG001|Overall Study|Adverse Event|10|||
28039601|NCT02278120|54697793|FG000|Overall Study|Physician Decision|8|||
28039602|NCT02278120|54697794|FG001|Overall Study|Physician Decision|19|||
28039603|NCT02278120|54697793|FG000|Overall Study|Death|3|||
28039604|NCT02278120|54697794|FG001|Overall Study|Death|3|||
28039605|NCT02278120|54697793|FG000|Overall Study|Lost to Follow-up|2|||
28039606|NCT02278120|54697794|FG001|Overall Study|Lost to Follow-up|0|||
28039607|NCT02278120|54697793|FG000|Overall Study|Protocol Violation|0|||
28039608|NCT02278120|54697794|FG001|Overall Study|Protocol Violation|2|||
28039609|NCT02255357|54697802|FG000|Overall Study|Physician Decision|10|||
28039610|NCT02255357|54697803|FG001|Overall Study|Physician Decision|24|||
28039611|NCT02211131|54697811|FG000|Overall Study|Death|26|||
28039612|NCT02211131|54697812|FG001|Overall Study|Death|16|||
28039613|NCT02211131|54697811|FG000|Overall Study|Lost to Follow-up|4|||
28039614|NCT02211131|54697812|FG001|Overall Study|Lost to Follow-up|3|||
28039615|NCT02211131|54697811|FG000|Overall Study|Decision by Sponsor|1|||
28039616|NCT02211131|54697812|FG001|Overall Study|Decision by Sponsor|1|||
28039617|NCT02211131|54697811|FG000|Overall Study|Withdrawal by Subject|3|||
28039618|NCT02211131|54697812|FG001|Overall Study|Withdrawal by Subject|8|||
28039619|NCT02155647|54697827|FG000|Overall Study|Still on Treatment|26|||
28039620|NCT02155647|54697828|FG001|Overall Study|Still on Treatment|26|||
28039621|NCT02155647|54697827|FG000|Overall Study|Off-Treatment, but follow up ongoing|15|||
28039622|NCT02155647|54697828|FG001|Overall Study|Off-Treatment, but follow up ongoing|26|||
28039623|NCT02134587|54697838|FG000|Overall Study|Did not completed all meetings|30|||
28039624|NCT01752920|54697855|FG000|Overall Study|Adverse Event|1|||
28039625|NCT01752920|54697856|FG001|Overall Study|Adverse Event|0|||
28039626|NCT01752920|54697857|FG002|Overall Study|Adverse Event|5|||
28039627|NCT01752920|54697858|FG003|Overall Study|Adverse Event|10|||
28039628|NCT01752920|54697855|FG000|Overall Study|Clinical Disease Progression|6|||
28039629|NCT01752920|54697856|FG001|Overall Study|Clinical Disease Progression|4|||
28039630|NCT01752920|54697857|FG002|Overall Study|Clinical Disease Progression|1|||
28039631|NCT01752920|54697858|FG003|Overall Study|Clinical Disease Progression|13|||
28039632|NCT01752920|54697855|FG000|Overall Study|Physician Decision|1|||
28039633|NCT01752920|54697856|FG001|Overall Study|Physician Decision|0|||
28039634|NCT01752920|54697857|FG002|Overall Study|Physician Decision|0|||
28039635|NCT01752920|54697858|FG003|Overall Study|Physician Decision|3|||
28039636|NCT01752920|54697855|FG000|Overall Study|Radiographic Disease Progression|20|||
28039637|NCT01752920|54697856|FG001|Overall Study|Radiographic Disease Progression|7|||
28039638|NCT01752920|54697857|FG002|Overall Study|Radiographic Disease Progression|12|||
28039639|NCT01752920|54697858|FG003|Overall Study|Radiographic Disease Progression|29|||
28039640|NCT01752920|54697855|FG000|Overall Study|Study Terminated by Sponsor|0|||
28039641|NCT01752920|54697856|FG001|Overall Study|Study Terminated by Sponsor|0|||
28039642|NCT01752920|54697857|FG002|Overall Study|Study Terminated by Sponsor|0|||
28039643|NCT01752920|54697858|FG003|Overall Study|Study Terminated by Sponsor|1|||
28039644|NCT01752920|54697855|FG000|Overall Study|Withdrawal by Subject|0|||
28039645|NCT01752920|54697856|FG001|Overall Study|Withdrawal by Subject|1|||
28039646|NCT01752920|54697857|FG002|Overall Study|Withdrawal by Subject|0|||
28039647|NCT01752920|54697858|FG003|Overall Study|Withdrawal by Subject|1|||
28039648|NCT01752920|54697855|FG000|Overall Study|Lack of clinical benefit|1|||
28039649|NCT01752920|54697856|FG001|Overall Study|Lack of clinical benefit|1|||
28039650|NCT01752920|54697857|FG002|Overall Study|Lack of clinical benefit|1|||
28039651|NCT01752920|54697858|FG003|Overall Study|Lack of clinical benefit|1|||
28039652|NCT00976963|54697872|FG000|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|2|||
28039653|NCT00976963|54697873|FG001|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|0|||
28039654|NCT00976963|54697872|FG000|Overall Study|administrative error|1|||
28039655|NCT00976963|54697873|FG001|Overall Study|administrative error|0|||
28039656|NCT00976963|54697872|FG000|Overall Study|allergic reaction due to previously unknown allergy|1|||
28039657|NCT00976963|54697873|FG001|Overall Study|allergic reaction due to previously unknown allergy|0|||
28039658|NCT00423735|54697890|FG000|Overall Study|Ineligible / No protocol treatment|8|||
28039659|NCT00423735|54697891|FG001|Overall Study|Ineligible / No protocol treatment|6|||
28039660|NCT00423735|54697892|FG002|Overall Study|Ineligible / No protocol treatment|0|||
28039661|NCT00626327|54697905|FG000|Overall Study|Withdrawal by Subject|21|||
28039662|NCT00626327|54697906|FG001|Overall Study|Withdrawal by Subject|29|||
27939855|NCT01081912|54596203|FG002|Conversion/Titration|Withdrawal by Subject|0|||
27939856|NCT01081912|54596201|FG000|Conversion/Titration|Non-Compliance|47|||
27939857|NCT01081912|54596202|FG001|Conversion/Titration|Non-Compliance|0|||
28039663|NCT00626327|54697907|FG002|Overall Study|Withdrawal by Subject|30|||
28039664|NCT00626327|54697905|FG000|Overall Study|Adverse Event|1|||
28039665|NCT00626327|54697906|FG001|Overall Study|Adverse Event|0|||
28039666|NCT00626327|54697907|FG002|Overall Study|Adverse Event|0|||
28039667|NCT00626327|54697905|FG000|Overall Study|Lost to Follow-up|24|||
28039668|NCT00626327|54697906|FG001|Overall Study|Lost to Follow-up|21|||
28039669|NCT00626327|54697907|FG002|Overall Study|Lost to Follow-up|23|||
28039670|NCT00626327|54697905|FG000|Overall Study|Inappropriate enrollment|4|||
28039671|NCT00626327|54697906|FG001|Overall Study|Inappropriate enrollment|5|||
28039672|NCT00626327|54697907|FG002|Overall Study|Inappropriate enrollment|3|||
28039673|NCT00626327|54697905|FG000|Overall Study|Administrative Reason|2|||
28039674|NCT00626327|54697906|FG001|Overall Study|Administrative Reason|0|||
28039675|NCT00626327|54697907|FG002|Overall Study|Administrative Reason|6|||
28039676|NCT00626327|54697905|FG000|Overall Study|Protocol Violation|26|||
28039677|NCT00626327|54697906|FG001|Overall Study|Protocol Violation|4|||
28039678|NCT00626327|54697907|FG002|Overall Study|Protocol Violation|26|||
28039679|NCT00357994|54697925|FG000|Overall Study|Adverse Event|1|||
27810080|NCT01859702|54265780|FG000|Overall Study|Protocol deviation|3|||
28039680|NCT00357994|54697926|FG001|Overall Study|Adverse Event|2|||
28039681|NCT00357994|54697925|FG000|Overall Study|Lack of Efficacy|0|||
28039682|NCT00357994|54697926|FG001|Overall Study|Lack of Efficacy|1|||
28039683|NCT00357994|54697925|FG000|Overall Study|Protocol Violation|1|||
28039684|NCT00357994|54697926|FG001|Overall Study|Protocol Violation|0|||
28039685|NCT00423657|54697934|FG000|Overall Study|Withdrew consent|10|||
28039686|NCT00423657|54697935|FG001|Overall Study|Withdrew consent|8|||
28039687|NCT00423657|54697934|FG000|Overall Study|Non-compliance|0|||
28039688|NCT00423657|54697935|FG001|Overall Study|Non-compliance|1|||
28039689|NCT00423657|54697934|FG000|Overall Study|Other|15|||
28039690|NCT00423657|54697935|FG001|Overall Study|Other|16|||
28039691|NCT00423657|54697934|FG000|Overall Study|Request of sponsor/investigator|1|||
28039692|NCT00423657|54697935|FG001|Overall Study|Request of sponsor/investigator|0|||
28039693|NCT00367432|54697941|FG000|First Period (16 Weeks)|Adverse Event|6|||
28039694|NCT00367432|54697942|FG001|First Period (16 Weeks)|Adverse Event|0|||
28039695|NCT00367432|54697941|FG000|First Period (16 Weeks)|Lack of Efficacy|24|||
28039696|NCT00367432|54697942|FG001|First Period (16 Weeks)|Lack of Efficacy|0|||
28039697|NCT00367432|54697941|FG000|First Period (16 Weeks)|Withdrawal by Subject|6|||
28039698|NCT00367432|54697942|FG001|First Period (16 Weeks)|Withdrawal by Subject|0|||
28039699|NCT00367432|54697941|FG000|First Period (16 Weeks)|Other Reason|2|||
28039700|NCT00367432|54697942|FG001|First Period (16 Weeks)|Other Reason|0|||
28039701|NCT00367432|54697941|FG000|Second Period (up to 54 Months)|Adverse Event|14|||
28039702|NCT00367432|54697942|FG001|Second Period (up to 54 Months)|Adverse Event|3|||
28039703|NCT00367432|54697941|FG000|Second Period (up to 54 Months)|Lack of Efficacy|59|||
28039704|NCT00367432|54697942|FG001|Second Period (up to 54 Months)|Lack of Efficacy|5|||
28039705|NCT00367432|54697941|FG000|Second Period (up to 54 Months)|Lost to Follow-up|0|||
28039706|NCT00367432|54697942|FG001|Second Period (up to 54 Months)|Lost to Follow-up|1|||
28039707|NCT00367432|54697941|FG000|Second Period (up to 54 Months)|Withdrawal by Subject|8|||
28039708|NCT00367432|54697942|FG001|Second Period (up to 54 Months)|Withdrawal by Subject|5|||
27810081|NCT01859702|54265780|FG000|Overall Study|Adverse Event|2|||
28039709|NCT00367432|54697941|FG000|Second Period (up to 54 Months)|Other Reason|6|||
27810082|NCT01835132|54265784|FG000|Initial Phase|Insufficient Therapeutic Response|2|||
27810083|NCT01747551|54265790|FG000|Overall Study|Progressive Disease|24|||
27810084|NCT01747551|54265791|FG001|Overall Study|Progressive Disease|17|||
27810085|NCT01747551|54265790|FG000|Overall Study|Death|3|||
27810086|NCT01747551|54265791|FG001|Overall Study|Death|1|||
27810087|NCT01747551|54265790|FG000|Overall Study|Adverse Event|7|||
28039710|NCT00367432|54697942|FG001|Second Period (up to 54 Months)|Other Reason|2|||
28039711|NCT00623363|54697948|FG000|Overall Study|Adverse Event|2|||
28039712|NCT00623363|54697949|FG001|Overall Study|Adverse Event|2|||
28039713|NCT00423267|54697958|FG000|Period A|Withdrawal by Subject|0|||
28039714|NCT00423267|54697959|FG001|Period A|Withdrawal by Subject|1|||
28039715|NCT00423267|54697958|FG000|Period A|Non-compliance with protocol|1|||
27810088|NCT01747551|54265791|FG001|Overall Study|Adverse Event|1|||
27810089|NCT01747551|54265790|FG000|Overall Study|Prolonged Treatment Delay|2|||
28039716|NCT00423267|54697959|FG001|Period A|Non-compliance with protocol|0|||
28039717|NCT00423267|54697958|FG000|Period A|Administrative|1|||
28039718|NCT00423267|54697959|FG001|Period A|Administrative|0|||
28039719|NCT00626093|54697967|FG000|Overall Study|Lost to Follow-up|5|||
28039720|NCT00626093|54697967|FG000|Overall Study|Death|1|||
28039721|NCT00626093|54697967|FG000|Overall Study|Physician Decision|4|||
27810090|NCT01747551|54265791|FG001|Overall Study|Prolonged Treatment Delay|0|||
27810091|NCT01747551|54265790|FG000|Overall Study|Withdrawal by Subject|3|||
28039722|NCT00626093|54697967|FG000|Overall Study|Withdrawal by Subject|6|||
27810092|NCT01747551|54265791|FG001|Overall Study|Withdrawal by Subject|1|||
27810093|NCT01747551|54265790|FG000|Overall Study|Physician Decision|2|||
27810094|NCT01747551|54265791|FG001|Overall Study|Physician Decision|1|||
27810095|NCT01747551|54265790|FG000|Overall Study|Other|2|||
27810096|NCT01747551|54265791|FG001|Overall Study|Other|0|||
27810097|NCT01736397|54265799|FG000|Overall Study|Lack of Efficacy|1|||
28039723|NCT00626093|54697967|FG000|Overall Study|Protocol Violation|1|||
28039724|NCT00626093|54697967|FG000|Overall Study|One of the required devices not implante|6|||
28039725|NCT00357760|54697973|FG000|Overall Study|Disease progression|44|||
28039726|NCT00357760|54697974|FG001|Overall Study|Disease progression|17|||
28039727|NCT00357760|54697973|FG000|Overall Study|Adverse Event|10|||
28039728|NCT00357760|54697974|FG001|Overall Study|Adverse Event|7|||
28039729|NCT00357760|54697973|FG000|Overall Study|Death|0|||
28039730|NCT00357760|54697974|FG001|Overall Study|Death|3|||
28039731|NCT00357760|54697973|FG000|Overall Study|Alternative therapy|1|||
28039732|NCT00357760|54697974|FG001|Overall Study|Alternative therapy|0|||
28039733|NCT00357760|54697973|FG000|Overall Study|Withdrawal by Subject|0|||
28039734|NCT00357760|54697974|FG001|Overall Study|Withdrawal by Subject|2|||
28039735|NCT00357760|54697973|FG000|Overall Study|Never started treatment|2|||
28039736|NCT00357760|54697974|FG001|Overall Study|Never started treatment|1|||
28039737|NCT00357760|54697973|FG000|Overall Study|Ineligible|0|||
28039738|NCT00357760|54697974|FG001|Overall Study|Ineligible|2|||
28039739|NCT00357760|54697973|FG000|Overall Study|Physician Decision|2|||
28039740|NCT00357760|54697974|FG001|Overall Study|Physician Decision|1|||
28039741|NCT00357760|54697973|FG000|Overall Study|Protocol Violation|0|||
28039742|NCT00357760|54697974|FG001|Overall Study|Protocol Violation|1|||
28039743|NCT00357760|54697973|FG000|Overall Study|To receive hospice care|0|||
28039744|NCT00357760|54697974|FG001|Overall Study|To receive hospice care|1|||
28039745|NCT00622739|54697982|FG000|Overall Study|Physician Decision|1|||
28039746|NCT00622739|54697983|FG001|Overall Study|Physician Decision|0|||
27810098|NCT01736397|54265800|FG001|Overall Study|Lack of Efficacy|11|||
27810099|NCT01736397|54265799|FG000|Overall Study|Withdrawal by Subject|6|||
27810100|NCT01736397|54265800|FG001|Overall Study|Withdrawal by Subject|5|||
27810101|NCT01736397|54265799|FG000|Overall Study|Lost to Follow-up|0|||
27810102|NCT01736397|54265800|FG001|Overall Study|Lost to Follow-up|1|||
27810103|NCT01736397|54265799|FG000|Overall Study|Adverse Event|6|||
27810104|NCT01736397|54265800|FG001|Overall Study|Adverse Event|3|||
27810105|NCT01736397|54265799|FG000|Overall Study|Not stated|1|||
27810106|NCT01736397|54265800|FG001|Overall Study|Not stated|4|||
27810107|NCT01859390|54265808|FG000|Overall Study|Insufficient Sputum Collected|1|||
27810108|NCT01859390|54265809|FG001|Overall Study|Insufficient Sputum Collected|3|||
27810109|NCT01859390|54265808|FG000|Overall Study|Sample Missing Collection Date|0|||
27810110|NCT01859390|54265809|FG001|Overall Study|Sample Missing Collection Date|1|||
27810111|NCT01859390|54265808|FG000|Overall Study|Tube Cracked|0|||
27810112|NCT01859390|54265809|FG001|Overall Study|Tube Cracked|2|||
27810113|NCT01859390|54265808|FG000|Overall Study|Shipment Error|0|||
27810114|NCT01859390|54265809|FG001|Overall Study|Shipment Error|1|||
27810115|NCT01858766|54265834|FG000|Overall Study|Randomized but Never Treated|0|||
27810116|NCT01858766|54265835|FG001|Overall Study|Randomized but Never Treated|0|||
27810117|NCT01858766|54265836|FG002|Overall Study|Randomized but Never Treated|0|||
27810118|NCT01858766|54265837|FG003|Overall Study|Randomized but Never Treated|0|||
27810119|NCT01858766|54265838|FG004|Overall Study|Randomized but Never Treated|0|||
27810120|NCT01858766|54265839|FG005|Overall Study|Randomized but Never Treated|1|||
28039747|NCT00622739|54697982|FG000|Overall Study|Adverse Event|1|||
28039748|NCT00622739|54697983|FG001|Overall Study|Adverse Event|2|||
28039749|NCT00622739|54697982|FG000|Overall Study|Lack of Efficacy|0|||
28039750|NCT00622739|54697983|FG001|Overall Study|Lack of Efficacy|2|||
28039751|NCT00622739|54697982|FG000|Overall Study|Withdrawal by Subject|0|||
28039752|NCT00622739|54697983|FG001|Overall Study|Withdrawal by Subject|1|||
28039753|NCT00622739|54697982|FG000|Overall Study|Lost to Follow-up|0|||
28039754|NCT00622739|54697983|FG001|Overall Study|Lost to Follow-up|1|||
28039755|NCT00435825|54697995|FG000|Overall Study|Abnormality of Laboratory Test|0|||
28039756|NCT00435825|54697996|FG001|Overall Study|Abnormality of Laboratory Test|1|||
28039757|NCT00435825|54697997|FG002|Overall Study|Abnormality of Laboratory Test|0|||
28039758|NCT00435825|54697998|FG003|Overall Study|Abnormality of Laboratory Test|0|||
28039759|NCT00435825|54697995|FG000|Overall Study|Insufficient Therapeutic Response|3|||
28039760|NCT00435825|54697996|FG001|Overall Study|Insufficient Therapeutic Response|1|||
28039761|NCT00435825|54697997|FG002|Overall Study|Insufficient Therapeutic Response|0|||
28039762|NCT00435825|54697998|FG003|Overall Study|Insufficient Therapeutic Response|3|||
28039763|NCT00435825|54697995|FG000|Overall Study|Other Protocol Violation|1|||
28039764|NCT00435825|54697996|FG001|Overall Study|Other Protocol Violation|0|||
28039765|NCT00435825|54697997|FG002|Overall Study|Other Protocol Violation|0|||
28039766|NCT00435825|54697998|FG003|Overall Study|Other Protocol Violation|0|||
27810121|NCT01858766|54265840|FG006|Overall Study|Randomized but Never Treated|0|||
27810122|NCT01858766|54265841|FG007|Overall Study|Randomized but Never Treated|0|||
27810123|NCT01858766|54265842|FG008|Overall Study|Randomized but Never Treated|0|||
27810124|NCT01858766|54265843|FG009|Overall Study|Randomized but Never Treated|0|||
27810125|NCT01858766|54265844|FG010|Overall Study|Randomized but Never Treated|0|||
27810126|NCT01858766|54265845|FG011|Overall Study|Randomized but Never Treated|0|||
27810127|NCT01858766|54265846|FG012|Overall Study|Randomized but Never Treated|0|||
27810128|NCT01858766|54265847|FG013|Overall Study|Randomized but Never Treated|0|||
27810129|NCT01858766|54265848|FG014|Overall Study|Randomized but Never Treated|0|||
27810130|NCT01858766|54265849|FG015|Overall Study|Randomized but Never Treated|0|||
27810131|NCT01858766|54265850|FG016|Overall Study|Randomized but Never Treated|0|||
27810132|NCT01858766|54265851|FG017|Overall Study|Randomized but Never Treated|1|||
27810133|NCT01858766|54265852|FG018|Overall Study|Randomized but Never Treated|0|||
27810134|NCT01858766|54265834|FG000|Overall Study|Death|0|||
27810135|NCT01858766|54265835|FG001|Overall Study|Death|0|||
27810136|NCT01858766|54265836|FG002|Overall Study|Death|1|||
27810137|NCT01858766|54265837|FG003|Overall Study|Death|0|||
27810138|NCT01858766|54265838|FG004|Overall Study|Death|0|||
27810139|NCT01858766|54265839|FG005|Overall Study|Death|0|||
27810140|NCT01858766|54265840|FG006|Overall Study|Death|0|||
27810141|NCT01858766|54265841|FG007|Overall Study|Death|0|||
27810142|NCT01858766|54265842|FG008|Overall Study|Death|0|||
27810143|NCT01858766|54265843|FG009|Overall Study|Death|0|||
27810144|NCT01858766|54265844|FG010|Overall Study|Death|0|||
27810145|NCT01858766|54265845|FG011|Overall Study|Death|0|||
27810146|NCT01858766|54265846|FG012|Overall Study|Death|0|||
27810147|NCT01858766|54265847|FG013|Overall Study|Death|0|||
27810148|NCT01858766|54265848|FG014|Overall Study|Death|0|||
27810149|NCT01858766|54265849|FG015|Overall Study|Death|0|||
27810150|NCT01858766|54265850|FG016|Overall Study|Death|0|||
27810151|NCT01858766|54265851|FG017|Overall Study|Death|0|||
27810152|NCT01858766|54265852|FG018|Overall Study|Death|0|||
28039767|NCT00435825|54697995|FG000|Overall Study|Refused treatment|2|||
28039768|NCT00435825|54697996|FG001|Overall Study|Refused treatment|0|||
28039769|NCT00435825|54697997|FG002|Overall Study|Refused treatment|0|||
28039770|NCT00435825|54697998|FG003|Overall Study|Refused treatment|5|||
27810153|NCT01858766|54265834|FG000|Overall Study|Lack of Efficacy|1|||
28039771|NCT00435825|54697995|FG000|Overall Study|Failure to return|5|||
28039772|NCT00435825|54697996|FG001|Overall Study|Failure to return|0|||
28039773|NCT00435825|54697997|FG002|Overall Study|Failure to return|4|||
28039774|NCT00435825|54697998|FG003|Overall Study|Failure to return|0|||
28039775|NCT00435825|54697995|FG000|Overall Study|Did not receive study drug|1|||
27810154|NCT01858766|54265835|FG001|Overall Study|Lack of Efficacy|0|||
27810155|NCT01858766|54265836|FG002|Overall Study|Lack of Efficacy|0|||
27810156|NCT01858766|54265837|FG003|Overall Study|Lack of Efficacy|0|||
27810157|NCT01858766|54265838|FG004|Overall Study|Lack of Efficacy|1|||
27810158|NCT01858766|54265839|FG005|Overall Study|Lack of Efficacy|2|||
27810159|NCT01858766|54265840|FG006|Overall Study|Lack of Efficacy|0|||
27810160|NCT01858766|54265841|FG007|Overall Study|Lack of Efficacy|0|||
27810161|NCT01858766|54265842|FG008|Overall Study|Lack of Efficacy|0|||
27810162|NCT01858766|54265843|FG009|Overall Study|Lack of Efficacy|0|||
27810163|NCT01858766|54265844|FG010|Overall Study|Lack of Efficacy|0|||
27810164|NCT01858766|54265845|FG011|Overall Study|Lack of Efficacy|3|||
27810165|NCT01858766|54265846|FG012|Overall Study|Lack of Efficacy|5|||
27810166|NCT01858766|54265847|FG013|Overall Study|Lack of Efficacy|3|||
27810167|NCT01858766|54265848|FG014|Overall Study|Lack of Efficacy|5|||
27810168|NCT01858766|54265849|FG015|Overall Study|Lack of Efficacy|5|||
27810169|NCT01858766|54265850|FG016|Overall Study|Lack of Efficacy|2|||
27810170|NCT01858766|54265851|FG017|Overall Study|Lack of Efficacy|3|||
27810171|NCT01858766|54265852|FG018|Overall Study|Lack of Efficacy|3|||
27810172|NCT01858766|54265834|FG000|Overall Study|Lost to Follow-up|0|||
27810173|NCT01858766|54265835|FG001|Overall Study|Lost to Follow-up|0|||
27847898|NCT01361568|54340599|FG000|Overall Study|Physician Decision|0|||
28039776|NCT00435825|54697996|FG001|Overall Study|Did not receive study drug|0|||
28039777|NCT00435825|54697997|FG002|Overall Study|Did not receive study drug|2|||
28039778|NCT00435825|54697998|FG003|Overall Study|Did not receive study drug|0|||
28039779|NCT00435825|54697995|FG000|Overall Study|Did not enter follow-up|0|||
28039780|NCT00435825|54697996|FG001|Overall Study|Did not enter follow-up|4|||
28039781|NCT00435825|54697997|FG002|Overall Study|Did not enter follow-up|1|||
28039782|NCT00435825|54697998|FG003|Overall Study|Did not enter follow-up|3|||
27810174|NCT01858766|54265836|FG002|Overall Study|Lost to Follow-up|0|||
27810175|NCT01858766|54265837|FG003|Overall Study|Lost to Follow-up|0|||
27810176|NCT01858766|54265838|FG004|Overall Study|Lost to Follow-up|0|||
27810177|NCT01858766|54265839|FG005|Overall Study|Lost to Follow-up|1|||
27810178|NCT01858766|54265840|FG006|Overall Study|Lost to Follow-up|0|||
27810179|NCT01858766|54265841|FG007|Overall Study|Lost to Follow-up|2|||
27810180|NCT01858766|54265842|FG008|Overall Study|Lost to Follow-up|0|||
27810181|NCT01858766|54265843|FG009|Overall Study|Lost to Follow-up|0|||
27810182|NCT01858766|54265844|FG010|Overall Study|Lost to Follow-up|0|||
27810183|NCT01858766|54265845|FG011|Overall Study|Lost to Follow-up|1|||
27810184|NCT01858766|54265846|FG012|Overall Study|Lost to Follow-up|0|||
27810185|NCT01858766|54265847|FG013|Overall Study|Lost to Follow-up|0|||
27810186|NCT01858766|54265848|FG014|Overall Study|Lost to Follow-up|3|||
27810187|NCT01858766|54265849|FG015|Overall Study|Lost to Follow-up|1|||
27810188|NCT01858766|54265850|FG016|Overall Study|Lost to Follow-up|1|||
27810189|NCT01858766|54265851|FG017|Overall Study|Lost to Follow-up|0|||
27810190|NCT01858766|54265852|FG018|Overall Study|Lost to Follow-up|1|||
27810191|NCT01858766|54265834|FG000|Overall Study|Withdrew Consent|0|||
27810192|NCT01858766|54265835|FG001|Overall Study|Withdrew Consent|0|||
27810193|NCT01858766|54265836|FG002|Overall Study|Withdrew Consent|0|||
27810194|NCT01858766|54265837|FG003|Overall Study|Withdrew Consent|0|||
27810195|NCT01858766|54265838|FG004|Overall Study|Withdrew Consent|0|||
27810196|NCT01858766|54265839|FG005|Overall Study|Withdrew Consent|0|||
27810197|NCT01858766|54265840|FG006|Overall Study|Withdrew Consent|0|||
28039783|NCT00435825|54697995|FG000|Overall Study|Did not complete full follow-up period|6|||
28039784|NCT00435825|54697996|FG001|Overall Study|Did not complete full follow-up period|6|||
28039785|NCT00435825|54697997|FG002|Overall Study|Did not complete full follow-up period|4|||
28039786|NCT00435825|54697998|FG003|Overall Study|Did not complete full follow-up period|5|||
28039787|NCT00574145|54698010|FG000|Overall Study|Withdrawal by Subject|2|||
28039788|NCT00574145|54698011|FG001|Overall Study|Withdrawal by Subject|1|||
28039789|NCT00423189|54698020|FG000|Overall Study|Death|0|||
28039790|NCT00423189|54698021|FG001|Overall Study|Death|1|||
28039791|NCT00423189|54698022|FG002|Overall Study|Death|0|||
28039792|NCT00422799|54698035|FG000|Overall Study|Withdrawal by Subject|6|||
28039793|NCT00422799|54698035|FG000|Overall Study|Adverse Event|7|||
28039794|NCT00435045|54698041|FG000|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
28039795|NCT00435045|54698042|FG001|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
28039796|NCT00435045|54698041|FG000|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
28039797|NCT00435045|54698042|FG001|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
28039798|NCT00435045|54698041|FG000|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2|||
28039799|NCT00435045|54698042|FG001|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1|||
28039800|NCT00435045|54698041|FG000|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1|||
28039801|NCT00435045|54698042|FG001|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0|||
28039802|NCT00435045|54698041|FG000|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0|||
28039803|NCT00435045|54698042|FG001|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1|||
28039804|NCT00435045|54698041|FG000|Weeks 9-12 / 20mg Dose Level|Adverse Event|4|||
28039805|NCT00435045|54698042|FG001|Weeks 9-12 / 20mg Dose Level|Adverse Event|3|||
28039806|NCT00435045|54698041|FG000|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
28039807|NCT00435045|54698042|FG001|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
28039808|NCT00435045|54698041|FG000|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0|||
28039809|NCT00435045|54698042|FG001|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1|||
28039810|NCT00435045|54698041|FG000|Weeks 13-16 / 40mg Dose Level|Adverse Event|3|||
28039811|NCT00435045|54698042|FG001|Weeks 13-16 / 40mg Dose Level|Adverse Event|2|||
28039812|NCT00435045|54698041|FG000|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1|||
28039813|NCT00435045|54698042|FG001|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0|||
28039814|NCT00435045|54698041|FG000|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1|||
28039815|NCT00435045|54698042|FG001|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0|||
28039816|NCT00441129|54698050|FG000|Overall Study|Withdrawal by Subject|6|||
28039817|NCT00441129|54698051|FG001|Overall Study|Withdrawal by Subject|14|||
28039818|NCT00622505|54698059|FG000|Overall Study|Adverse Event|9|||
28039819|NCT00622505|54698060|FG001|Overall Study|Adverse Event|7|||
28039820|NCT00622505|54698059|FG000|Overall Study|Abnormal Laboratory Value(s)|3|||
28039821|NCT00622505|54698060|FG001|Overall Study|Abnormal Laboratory Value(s)|5|||
28039822|NCT00622505|54698059|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
28039823|NCT00622505|54698060|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
28039824|NCT00622505|54698059|FG000|Overall Study|Withdrawal by Subject|12|||
27810198|NCT01858766|54265841|FG007|Overall Study|Withdrew Consent|0|||
27810199|NCT01858766|54265842|FG008|Overall Study|Withdrew Consent|0|||
27810200|NCT01858766|54265843|FG009|Overall Study|Withdrew Consent|0|||
27810201|NCT01858766|54265844|FG010|Overall Study|Withdrew Consent|0|||
27810202|NCT01858766|54265845|FG011|Overall Study|Withdrew Consent|1|||
27810203|NCT01858766|54265846|FG012|Overall Study|Withdrew Consent|0|||
27810204|NCT01858766|54265847|FG013|Overall Study|Withdrew Consent|0|||
27810205|NCT01858766|54265848|FG014|Overall Study|Withdrew Consent|0|||
27810206|NCT01858766|54265849|FG015|Overall Study|Withdrew Consent|0|||
27810207|NCT01858766|54265850|FG016|Overall Study|Withdrew Consent|0|||
27810208|NCT01858766|54265851|FG017|Overall Study|Withdrew Consent|0|||
27939858|NCT01081912|54596203|FG002|Conversion/Titration|Non-Compliance|0|||
27939859|NCT01081912|54596201|FG000|Maintenance Treatment|Adverse Event|0|||
28039825|NCT00622505|54698060|FG001|Overall Study|Withdrawal by Subject|5|||
28039826|NCT00622505|54698059|FG000|Overall Study|Administrative Problems|2|||
28039827|NCT00622505|54698060|FG001|Overall Study|Administrative Problems|4|||
28039828|NCT00622505|54698059|FG000|Overall Study|Death|2|||
28039829|NCT00622505|54698060|FG001|Overall Study|Death|2|||
27810209|NCT01858766|54265852|FG018|Overall Study|Withdrew Consent|0|||
27810210|NCT01734993|54265885|FG000|Overall Study|Adverse Event|1|||
27810211|NCT01734993|54265885|FG000|Overall Study|Lack of Efficacy|1|||
27810212|NCT01745367|54265892|FG000|Overall Study|Death|1|||
27810213|NCT01745367|54265893|FG001|Overall Study|Death|0|||
27810214|NCT01745367|54265892|FG000|Overall Study|Withdrawal by Subject|1|||
27810215|NCT01745367|54265893|FG001|Overall Study|Withdrawal by Subject|2|||
27810216|NCT01745367|54265892|FG000|Overall Study|Termination of The Study by The Sponsor|6|||
27810217|NCT01745367|54265893|FG001|Overall Study|Termination of The Study by The Sponsor|18|||
27810218|NCT01745367|54265892|FG000|Overall Study|Other Reasons Unspecified|0|||
28039830|NCT00350272|54698068|FG000|Blinded 12 Week Treatment|Adverse Event|1|||
28039831|NCT00350272|54698069|FG001|Blinded 12 Week Treatment|Adverse Event|0|||
28039832|NCT00350272|54698068|FG000|Blinded 12 Week Treatment|Death|1|||
28039833|NCT00350272|54698069|FG001|Blinded 12 Week Treatment|Death|0|||
28039834|NCT00350272|54698068|FG000|Blinded 12 Week Treatment|Lost to Follow-up|2|||
28039835|NCT00350272|54698069|FG001|Blinded 12 Week Treatment|Lost to Follow-up|0|||
27847899|NCT01361568|54340600|FG001|Overall Study|Physician Decision|0|||
27847900|NCT01361568|54340601|FG002|Overall Study|Physician Decision|0|||
27847901|NCT01361568|54340602|FG003|Overall Study|Physician Decision|0|||
27847902|NCT01361568|54340603|FG004|Overall Study|Physician Decision|0|||
27847903|NCT01361568|54340604|FG005|Overall Study|Physician Decision|1|||
27847904|NCT01361568|54340599|FG000|Overall Study|Withdrawal by Subject|2|||
28039836|NCT00350272|54698068|FG000|Blinded 12 Week Treatment|Withdrawal by Subject|3|||
28039837|NCT00350272|54698069|FG001|Blinded 12 Week Treatment|Withdrawal by Subject|0|||
28039838|NCT00350272|54698068|FG000|Blinded 12 Week Treatment|Physician Decision|2|||
28039839|NCT00350272|54698069|FG001|Blinded 12 Week Treatment|Physician Decision|1|||
28039840|NCT00350272|54698068|FG000|Blinded 12 Week Treatment|Sponsor decision|0|||
28039841|NCT00350272|54698069|FG001|Blinded 12 Week Treatment|Sponsor decision|1|||
28039842|NCT00350272|54698068|FG000|Open-Label 84 Week Treatment|Adverse Event|2|||
27810219|NCT01745367|54265893|FG001|Overall Study|Other Reasons Unspecified|2|||
27810220|NCT01733121|54265901|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|2|||
27810221|NCT01733121|54265902|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
27810222|NCT01733121|54265901|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
27810223|NCT01733121|54265902|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
27810224|NCT01733121|54265901|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
27810225|NCT01733121|54265902|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3|||
27810226|NCT01733121|54265901|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
27810227|NCT01733121|54265902|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
27810228|NCT01744977|54265912|FG000|Overall Study|Withdrawal by Subject|1|||
27810229|NCT01744977|54265913|FG001|Overall Study|Withdrawal by Subject|2|||
27847905|NCT01361568|54340600|FG001|Overall Study|Withdrawal by Subject|1|||
27810230|NCT01744977|54265912|FG000|Overall Study|Death|2|||
27810231|NCT01744977|54265913|FG001|Overall Study|Death|3|||
27810232|NCT01744977|54265912|FG000|Overall Study|Lost to Follow-up|2|||
27810233|NCT01744977|54265913|FG001|Overall Study|Lost to Follow-up|0|||
27810234|NCT01744977|54265912|FG000|Overall Study|No longer meets inclusion|6|||
27810235|NCT01744977|54265913|FG001|Overall Study|No longer meets inclusion|0|||
27810236|NCT01383928|54265922|FG000|Overall Study|Initiation of ASCT|2|||
27810237|NCT01383928|54265923|FG001|Overall Study|Initiation of ASCT|1|||
27810238|NCT01383928|54265924|FG002|Overall Study|Initiation of ASCT|18|||
27810239|NCT01383928|54265922|FG000|Overall Study|Adverse Event|1|||
27810240|NCT01383928|54265923|FG001|Overall Study|Adverse Event|2|||
27810241|NCT01383928|54265924|FG002|Overall Study|Adverse Event|8|||
27810242|NCT01383928|54265922|FG000|Overall Study|Other|1|||
27810243|NCT01383928|54265923|FG001|Overall Study|Other|3|||
27810244|NCT01383928|54265924|FG002|Overall Study|Other|4|||
27810245|NCT01383928|54265922|FG000|Overall Study|Progressive Disease|1|||
27810246|NCT01383928|54265923|FG001|Overall Study|Progressive Disease|1|||
27810247|NCT01383928|54265924|FG002|Overall Study|Progressive Disease|5|||
27810248|NCT01383928|54265922|FG000|Overall Study|Withdrawal by Subject|0|||
27847906|NCT01361568|54340601|FG002|Overall Study|Withdrawal by Subject|0|||
27847907|NCT01361568|54340602|FG003|Overall Study|Withdrawal by Subject|0|||
27847908|NCT01361568|54340603|FG004|Overall Study|Withdrawal by Subject|0|||
27847909|NCT01361568|54340604|FG005|Overall Study|Withdrawal by Subject|1|||
27847910|NCT03084367|54340619|FG000|Overall Study|Lost to Follow-up|32|||
27847911|NCT03084367|54340619|FG000|Overall Study|Withdrawal by Subject|4|||
27847912|NCT03084367|54340619|FG000|Overall Study|Other|1|||
27847913|NCT01454570|54340632|FG000|Overall Study|Withdrawal by Subject|2|||
27939860|NCT01081912|54596202|FG001|Maintenance Treatment|Adverse Event|2|||
27939861|NCT01081912|54596203|FG002|Maintenance Treatment|Adverse Event|12|||
28039843|NCT00350272|54698069|FG001|Open-Label 84 Week Treatment|Adverse Event|1|||
28039844|NCT00350272|54698068|FG000|Open-Label 84 Week Treatment|Lost to Follow-up|3|||
27810249|NCT01383928|54265923|FG001|Overall Study|Withdrawal by Subject|0|||
27810250|NCT01383928|54265924|FG002|Overall Study|Withdrawal by Subject|4|||
27810251|NCT01383928|54265922|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
27810252|NCT01383928|54265923|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
27810253|NCT01383928|54265924|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
27847914|NCT01454570|54340632|FG000|Overall Study|Screen Failure|7|||
28039845|NCT00350272|54698069|FG001|Open-Label 84 Week Treatment|Lost to Follow-up|2|||
28039846|NCT00350272|54698068|FG000|Open-Label 84 Week Treatment|Withdrawal by Subject|1|||
28039847|NCT00350272|54698069|FG001|Open-Label 84 Week Treatment|Withdrawal by Subject|2|||
28039848|NCT00350272|54698068|FG000|Open-Label 84 Week Treatment|Physician Decision|1|||
28039849|NCT00350272|54698069|FG001|Open-Label 84 Week Treatment|Physician Decision|2|||
28039850|NCT00350272|54698068|FG000|Open-Label 84 Week Treatment|Sponsor decision|2|||
28039851|NCT00350272|54698069|FG001|Open-Label 84 Week Treatment|Sponsor decision|1|||
28039852|NCT00357370|54698080|FG000|Cohort 2|Lack of Efficacy|0|||
28039853|NCT00357370|54698081|FG001|Cohort 2|Lack of Efficacy|2|||
28039854|NCT00357370|54698082|FG002|Cohort 2|Lack of Efficacy|1|||
28039855|NCT00357370|54698080|FG000|Cohort 2|Adverse Event|1|||
28039856|NCT00357370|54698081|FG001|Cohort 2|Adverse Event|1|||
28039857|NCT00357370|54698082|FG002|Cohort 2|Adverse Event|1|||
28039858|NCT00357370|54698080|FG000|Cohort 2|Lost to Follow-up|0|||
28039859|NCT00357370|54698081|FG001|Cohort 2|Lost to Follow-up|1|||
28039860|NCT00357370|54698082|FG002|Cohort 2|Lost to Follow-up|0|||
28039861|NCT00357370|54698080|FG000|Cohort 2|non-compliance, not met criteria, etc|1|||
28039862|NCT00357370|54698081|FG001|Cohort 2|non-compliance, not met criteria, etc|1|||
28039863|NCT00357370|54698082|FG002|Cohort 2|non-compliance, not met criteria, etc|0|||
28039864|NCT00357370|54698080|FG000|Cohort 2|Withdrawal by Subject|0|||
28039865|NCT00357370|54698081|FG001|Cohort 2|Withdrawal by Subject|2|||
28039866|NCT00357370|54698082|FG002|Cohort 2|Withdrawal by Subject|0|||
28039867|NCT00574847|54698092|FG000|Overall Study|Adverse Event|2|||
28039868|NCT00574847|54698093|FG001|Overall Study|Adverse Event|0|||
28039869|NCT00574847|54698092|FG000|Overall Study|Death|1|||
28039870|NCT00574847|54698093|FG001|Overall Study|Death|0|||
28039871|NCT00574847|54698092|FG000|Overall Study|Withdrawal by Subject|2|||
28039872|NCT00574847|54698093|FG001|Overall Study|Withdrawal by Subject|2|||
28039873|NCT00574847|54698092|FG000|Overall Study|Physician Decision|1|||
28039874|NCT00574847|54698093|FG001|Overall Study|Physician Decision|0|||
28039875|NCT00574847|54698092|FG000|Overall Study|Did not receive medication (declined)|2|||
28039876|NCT00574847|54698093|FG001|Overall Study|Did not receive medication (declined)|5|||
28039877|NCT00348790|54698099|FG000|Completed Treatment|Withdrawal by Subject|4|||
28039878|NCT00348790|54698099|FG000|Completed Treatment|Disease progression|14|||
28039879|NCT00348790|54698099|FG000|Completed Treatment|Adverse Event|4|||
28039880|NCT00348790|54698099|FG000|Completed Treatment|Required surgery|2|||
28039881|NCT00348790|54698099|FG000|Completed Treatment|Unable to travel to study site|1|||
28039882|NCT00360490|54698106|FG000|Overall Study|Adverse Event|4|||
28039883|NCT00360490|54698107|FG001|Overall Study|Adverse Event|2|||
28039884|NCT00360490|54698106|FG000|Overall Study|Lost to Follow-up|2|||
28039885|NCT00360490|54698107|FG001|Overall Study|Lost to Follow-up|1|||
28039886|NCT00360490|54698106|FG000|Overall Study|Physician Decision|2|||
28039887|NCT00360490|54698107|FG001|Overall Study|Physician Decision|1|||
28039888|NCT00360490|54698106|FG000|Overall Study|Protocol Violation|0|||
28039889|NCT00360490|54698107|FG001|Overall Study|Protocol Violation|4|||
28039890|NCT00360490|54698106|FG000|Overall Study|Withdrawal by Subject|1|||
28039891|NCT00360490|54698107|FG001|Overall Study|Withdrawal by Subject|3|||
28039892|NCT00624377|54698113|FG000|Overall Study|Lost to Follow-up|355|||
28039893|NCT00624377|54698113|FG000|Overall Study|Withdrawal by Subject|100|||
28039894|NCT00624377|54698113|FG000|Overall Study|Adverse Event|14|||
28039895|NCT00624377|54698113|FG000|Overall Study|Other|91|||
28039896|NCT00624377|54698113|FG000|Overall Study|Non-evaluable population|84|||
28039897|NCT00624065|54698119|FG000|Overall Study|Adverse Event|5|||
28039898|NCT00624065|54698120|FG001|Overall Study|Adverse Event|6|||
28039899|NCT00624065|54698119|FG000|Overall Study|Lost to Follow-up|4|||
28039900|NCT00624065|54698120|FG001|Overall Study|Lost to Follow-up|1|||
28039901|NCT00624065|54698119|FG000|Overall Study|Consent withdrawn|6|||
28039902|NCT00624065|54698120|FG001|Overall Study|Consent withdrawn|5|||
28039903|NCT00624065|54698119|FG000|Overall Study|Lack of Efficacy|0|||
28039904|NCT00624065|54698120|FG001|Overall Study|Lack of Efficacy|3|||
28039905|NCT00624065|54698119|FG000|Overall Study|Met protocol-defined stopping criteria|4|||
28039906|NCT00624065|54698120|FG001|Overall Study|Met protocol-defined stopping criteria|9|||
28039907|NCT00360412|54698128|FG000|Overall Study|Adverse Event|37|||
28039908|NCT00360412|54698129|FG001|Overall Study|Adverse Event|65|||
27939862|NCT01081912|54596201|FG000|Maintenance Treatment|Lack of Efficacy|0|||
27939863|NCT01081912|54596202|FG001|Maintenance Treatment|Lack of Efficacy|14|||
28039909|NCT00360412|54698128|FG000|Overall Study|Protocol Violation|2|||
28039910|NCT00360412|54698129|FG001|Overall Study|Protocol Violation|5|||
28039911|NCT00360412|54698128|FG000|Overall Study|Patient withdrew consent|27|||
28039912|NCT00360412|54698129|FG001|Overall Study|Patient withdrew consent|52|||
28039913|NCT00360412|54698128|FG000|Overall Study|Lack of therapeutic efficacy|46|||
28039914|NCT00360412|54698129|FG001|Overall Study|Lack of therapeutic efficacy|61|||
28039915|NCT00360412|54698128|FG000|Overall Study|Physician Decision|2|||
28039916|NCT00360412|54698129|FG001|Overall Study|Physician Decision|4|||
28039917|NCT00360412|54698128|FG000|Overall Study|Other|5|||
28039918|NCT00360412|54698129|FG001|Overall Study|Other|6|||
28039919|NCT00360412|54698128|FG000|Overall Study|Study termination by Sponsor|214|||
28039920|NCT00360412|54698129|FG001|Overall Study|Study termination by Sponsor|469|||
28039921|NCT00623831|54698137|FG000|Overall Study|Withdrawal by Subject|1|||
28039922|NCT00623831|54698138|FG001|Overall Study|Withdrawal by Subject|0|||
28039923|NCT00623831|54698137|FG000|Overall Study|Progressive Disease|0|||
28039924|NCT00623831|54698138|FG001|Overall Study|Progressive Disease|1|||
28039925|NCT00360334|54698149|FG000|Overall Study|Adverse Event|7|||
28039926|NCT00360334|54698150|FG001|Overall Study|Adverse Event|4|||
28039927|NCT00360334|54698149|FG000|Overall Study|Protocol Violation|1|||
28039928|NCT00360334|54698150|FG001|Overall Study|Protocol Violation|1|||
28039929|NCT00360334|54698149|FG000|Overall Study|Physician Decision|2|||
28039930|NCT00360334|54698150|FG001|Overall Study|Physician Decision|3|||
28039931|NCT00360334|54698149|FG000|Overall Study|Lack of Efficacy|0|||
28039932|NCT00360334|54698150|FG001|Overall Study|Lack of Efficacy|1|||
28039933|NCT00360334|54698149|FG000|Overall Study|Entry criterion not met|1|||
28039934|NCT00360334|54698150|FG001|Overall Study|Entry criterion not met|2|||
28039935|NCT00360334|54698149|FG000|Overall Study|Subject decision|8|||
28039936|NCT00360334|54698150|FG001|Overall Study|Subject decision|2|||
28039937|NCT00422097|54698162|FG000|Dose Level 2|Still on treatment|0|||
28039938|NCT00422097|54698163|FG001|Dose Level 2|Still on treatment|1|||
28039939|NCT00422097|54698164|FG002|Dose Level 2|Still on treatment|0|||
28039940|NCT00422097|54698165|FG003|Dose Level 2|Still on treatment|0|||
28039941|NCT00422097|54698166|FG004|Dose Level 2|Still on treatment|0|||
27810254|NCT01382602|54265936|FG000|Overall Study|Protocol Violation|0|||
28039942|NCT00422097|54698167|FG005|Dose Level 2|Still on treatment|0|||
28039943|NCT00422097|54698168|FG006|Dose Level 2|Still on treatment|0|||
28039944|NCT00422097|54698169|FG007|Dose Level 2|Still on treatment|0|||
27810255|NCT01382602|54265937|FG001|Overall Study|Protocol Violation|3|||
27810256|NCT01382602|54265936|FG000|Overall Study|Withdrawal by Subject|0|||
27810257|NCT01382602|54265937|FG001|Overall Study|Withdrawal by Subject|1|||
27810258|NCT04801420|54265946|FG000|Overall Study|Other|1|||
27810259|NCT04801420|54265947|FG001|Overall Study|Other|2|||
27810260|NCT04801420|54265948|FG002|Overall Study|Other|1|||
27810261|NCT04801420|54265946|FG000|Overall Study|Lost to Follow-up|7|||
27810262|NCT04801420|54265947|FG001|Overall Study|Lost to Follow-up|9|||
27810263|NCT04801420|54265948|FG002|Overall Study|Lost to Follow-up|10|||
27810264|NCT04801420|54265946|FG000|Overall Study|Moved from study area|0|||
27810265|NCT04801420|54265947|FG001|Overall Study|Moved from study area|1|||
27810266|NCT04801420|54265948|FG002|Overall Study|Moved from study area|1|||
27810267|NCT04801420|54265946|FG000|Overall Study|Withdrawal by Subject|5|||
27810268|NCT04801420|54265947|FG001|Overall Study|Withdrawal by Subject|1|||
27810269|NCT04801420|54265948|FG002|Overall Study|Withdrawal by Subject|4|||
27810270|NCT04801420|54265946|FG000|Overall Study|Individual stopping criteria reached|0|||
27810271|NCT04801420|54265947|FG001|Overall Study|Individual stopping criteria reached|1|||
27810272|NCT04801420|54265948|FG002|Overall Study|Individual stopping criteria reached|0|||
27810273|NCT04801420|54265946|FG000|Overall Study|Ongoing in the study|195|||
27810274|NCT04801420|54265947|FG001|Overall Study|Ongoing in the study|195|||
27810275|NCT04801420|54265948|FG002|Overall Study|Ongoing in the study|192|||
27810276|NCT04294472|54265963|FG000|Overall Study|Adverse Event|0|||
27810277|NCT04294472|54265964|FG001|Overall Study|Adverse Event|1|||
27810278|NCT04294472|54265965|FG002|Overall Study|Adverse Event|1|||
27810279|NCT04294472|54265963|FG000|Overall Study|Randomized but not treated|0|||
27810280|NCT04294472|54265964|FG001|Overall Study|Randomized but not treated|1|||
27810281|NCT04294472|54265965|FG002|Overall Study|Randomized but not treated|1|||
27810282|NCT04233918|54265975|FG000|Part C (Extension Period)|Ongoing in study|0|||
27810283|NCT04233918|54265976|FG001|Part C (Extension Period)|Ongoing in study|0|||
27810284|NCT04233918|54265977|FG002|Part C (Extension Period)|Ongoing in study|15|||
27810285|NCT04060251|54265989|FG000|Overall Study|Study terminated due to low enrollment.|7|||
27810286|NCT04060251|54265990|FG001|Overall Study|Study terminated due to low enrollment.|5|||
27810287|NCT04060251|54265991|FG002|Overall Study|Study terminated due to low enrollment.|7|||
27810288|NCT04060251|54265989|FG000|Overall Study|Adverse Event|1|||
27810289|NCT04060251|54265990|FG001|Overall Study|Adverse Event|1|||
27810290|NCT04060251|54265991|FG002|Overall Study|Adverse Event|0|||
27810291|NCT04048876|54266003|FG000|Placebo Controlled Phase|Withdrawal by Subject|1|||
27810292|NCT04048876|54266004|FG001|Placebo Controlled Phase|Withdrawal by Subject|2|||
27810293|NCT04048876|54266005|FG002|Placebo Controlled Phase|Withdrawal by Subject|0|||
27810294|NCT04048876|54266006|FG003|Placebo Controlled Phase|Withdrawal by Subject|1|||
28039945|NCT00348556|54698193|FG000|Overall Study|Adverse Event|1|||
28039946|NCT00434967|54698201|FG000|Overall Study|Adverse Event|2|||
27810295|NCT04048876|54266003|FG000|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
27810296|NCT04048876|54266004|FG001|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
27810297|NCT04048876|54266005|FG002|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
27810298|NCT04048876|54266006|FG003|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
27810299|NCT04048876|54266003|FG000|Placebo Controlled Phase|Adverse Event|0|||
27810300|NCT04048876|54266004|FG001|Placebo Controlled Phase|Adverse Event|1|||
27810301|NCT04048876|54266005|FG002|Placebo Controlled Phase|Adverse Event|0|||
27810302|NCT04048876|54266006|FG003|Placebo Controlled Phase|Adverse Event|0|||
27810303|NCT04048876|54266003|FG000|Active Treatment Phase|Study Terminated by Sponsor|2|||
28039947|NCT00434967|54698202|FG001|Overall Study|Adverse Event|4|||
27810304|NCT04048876|54266004|FG001|Active Treatment Phase|Study Terminated by Sponsor|0|||
27810305|NCT04048876|54266005|FG002|Active Treatment Phase|Study Terminated by Sponsor|3|||
27810306|NCT04048876|54266006|FG003|Active Treatment Phase|Study Terminated by Sponsor|2|||
27810307|NCT03921424|54266033|FG000|Overall Study|Lost to Follow-up|0|||
27810308|NCT03921424|54266034|FG001|Overall Study|Lost to Follow-up|1|||
27810309|NCT03921424|54266033|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
27810310|NCT03921424|54266034|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
27810311|NCT03852628|54266057|FG000|Overall Study|Lost to Follow-up|7|||
27810312|NCT03852628|54266058|FG001|Overall Study|Lost to Follow-up|6|||
28039948|NCT00434967|54698203|FG002|Overall Study|Adverse Event|3|||
28039949|NCT00434967|54698204|FG003|Overall Study|Adverse Event|3|||
28039950|NCT00434967|54698201|FG000|Overall Study|Lost to Follow-up|0|||
28039951|NCT00434967|54698202|FG001|Overall Study|Lost to Follow-up|0|||
28039952|NCT00434967|54698203|FG002|Overall Study|Lost to Follow-up|1|||
28039953|NCT00434967|54698204|FG003|Overall Study|Lost to Follow-up|0|||
28039954|NCT00434967|54698201|FG000|Overall Study|Withdrawal by Subject|2|||
28039955|NCT00434967|54698202|FG001|Overall Study|Withdrawal by Subject|2|||
28039956|NCT00434967|54698203|FG002|Overall Study|Withdrawal by Subject|4|||
28039957|NCT00434967|54698204|FG003|Overall Study|Withdrawal by Subject|6|||
28039958|NCT00434967|54698201|FG000|Overall Study|Randomized in error|0|||
28039959|NCT00434967|54698202|FG001|Overall Study|Randomized in error|0|||
28039960|NCT00434967|54698203|FG002|Overall Study|Randomized in error|0|||
28039961|NCT00434967|54698204|FG003|Overall Study|Randomized in error|1|||
28039962|NCT00434967|54698201|FG000|Overall Study|Protocol Violation|0|||
28039963|NCT00434967|54698202|FG001|Overall Study|Protocol Violation|1|||
28039964|NCT00434967|54698203|FG002|Overall Study|Protocol Violation|0|||
28039965|NCT00434967|54698204|FG003|Overall Study|Protocol Violation|1|||
28039966|NCT00434967|54698201|FG000|Overall Study|Physician Decision|1|||
27847915|NCT01494350|54340645|FG000|Overall Study|Worsening of lesion|1|||
27847916|NCT03281629|54340655|FG000|Overall Study|The two participants dropped out due to COVID-19 lockdown.|2|||
27847917|NCT03281629|54340656|FG001|Overall Study|The two participants dropped out due to COVID-19 lockdown.|0|||
27847918|NCT03281629|54340655|FG000|Overall Study|Death|0|||
27847919|NCT03281629|54340656|FG001|Overall Study|Death|1|||
27847920|NCT03281629|54340655|FG000|Overall Study|Participant's schedule change and cannot participate in the study|0|||
27847921|NCT03281629|54340656|FG001|Overall Study|Participant's schedule change and cannot participate in the study|1|||
27939864|NCT01081912|54596203|FG002|Maintenance Treatment|Lack of Efficacy|64|||
27939865|NCT01081912|54596201|FG000|Maintenance Treatment|Lost to Follow-up|0|||
28039967|NCT00434967|54698202|FG001|Overall Study|Physician Decision|1|||
28039968|NCT00434967|54698203|FG002|Overall Study|Physician Decision|1|||
27810313|NCT03852628|54266057|FG000|Overall Study|Lack of Efficacy|6|||
28039969|NCT00434967|54698204|FG003|Overall Study|Physician Decision|0|||
28039970|NCT00434967|54698201|FG000|Overall Study|Patient Disposition Challenges|2|||
28039971|NCT00434967|54698202|FG001|Overall Study|Patient Disposition Challenges|0|||
27810314|NCT03852628|54266058|FG001|Overall Study|Lack of Efficacy|6|||
27810315|NCT03602976|54266064|FG000|Overall Study|Withdrawal by Subject|1|||
27810316|NCT03474107|54266073|FG000|Overall Study|Adverse Event|42|||
27810317|NCT03474107|54266074|FG001|Overall Study|Adverse Event|46|||
27810318|NCT03474107|54266073|FG000|Overall Study|Death|2|||
27810319|NCT03474107|54266074|FG001|Overall Study|Death|2|||
27810320|NCT03474107|54266073|FG000|Overall Study|Lost to Follow-up|0|||
27810321|NCT03474107|54266074|FG001|Overall Study|Lost to Follow-up|1|||
27810322|NCT03474107|54266073|FG000|Overall Study|Progressive Disease|177|||
27810323|NCT03474107|54266074|FG001|Overall Study|Progressive Disease|180|||
27810324|NCT03474107|54266073|FG000|Overall Study|Protocol Violation|1|||
27810325|NCT03474107|54266074|FG001|Overall Study|Protocol Violation|1|||
28039972|NCT00434967|54698203|FG002|Overall Study|Patient Disposition Challenges|0|||
28039973|NCT00434967|54698204|FG003|Overall Study|Patient Disposition Challenges|3|||
28039974|NCT00356590|54698214|FG000|Overall Study|Adverse Event|54|||
28039975|NCT00356590|54698214|FG000|Overall Study|Death|10|||
28039976|NCT00356590|54698214|FG000|Overall Study|Lost to Follow-up|35|||
28039977|NCT00356590|54698214|FG000|Overall Study|Physician Decision|46|||
28039978|NCT00356590|54698214|FG000|Overall Study|Withdrawal by Subject|41|||
28039979|NCT00356590|54698214|FG000|Overall Study|Completed month 12 only|2|||
28039980|NCT00356590|54698214|FG000|Overall Study|Protocol issues|6|||
28039981|NCT00356590|54698214|FG000|Overall Study|Response status|28|||
28039982|NCT00356590|54698214|FG000|Overall Study|Other|52|||
28039983|NCT00356278|54698221|FG000|Overall Study|Withdrawal by Subject|25|||
28039984|NCT00356278|54698222|FG001|Overall Study|Withdrawal by Subject|15|||
28039985|NCT00356278|54698223|FG002|Overall Study|Withdrawal by Subject|19|||
28039986|NCT00356200|54698233|FG000|Cohort 1: 10 ug/ml|Lack of Efficacy|1|||
27810326|NCT03474107|54266073|FG000|Overall Study|Withdrawal by Subject|15|||
27810327|NCT03474107|54266074|FG001|Overall Study|Withdrawal by Subject|27|||
27810328|NCT03474107|54266073|FG000|Overall Study|Physician Decision|7|||
27810329|NCT03474107|54266074|FG001|Overall Study|Physician Decision|22|||
27810330|NCT03474107|54266073|FG000|Overall Study|Miscellaneous|1|||
27810331|NCT03474107|54266074|FG001|Overall Study|Miscellaneous|6|||
27810332|NCT03278106|54266089|FG000|Overall Study|No protocol treatment|1|||
28039987|NCT00356200|54698234|FG001|Cohort 1: 10 ug/ml|Lack of Efficacy|0|||
28039988|NCT00356200|54698233|FG000|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0|||
28039989|NCT00356200|54698234|FG001|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2|||
28039990|NCT00356122|54698246|FG000|TREATMENT|Lack of Efficacy|26|||
28039991|NCT00356122|54698246|FG000|TREATMENT|Adverse Event|10|||
28039992|NCT00356122|54698246|FG000|TREATMENT|Subject's request|4|||
27810333|NCT03214198|54266093|FG000|Overall Study|Case Report Forms Uncollected|18|||
27810334|NCT03214198|54266093|FG000|Overall Study|Protocol Deviation|18|||
28039993|NCT00356122|54698246|FG000|TREATMENT|Other|4|||
28039994|NCT00356122|54698246|FG000|TREATMENT|Did not receive study medication|1|||
28039995|NCT00356122|54698246|FG000|FOLLOW-UP|Death|37|||
28039996|NCT00356122|54698246|FG000|FOLLOW-UP|Lost to Follow-up|2|||
28039997|NCT00356122|54698246|FG000|FOLLOW-UP|Other|2|||
28039998|NCT00347932|54698252|FG000|Overall Study|Adverse Event|4|||
28039999|NCT00347932|54698253|FG001|Overall Study|Adverse Event|5|||
28040000|NCT00347932|54698252|FG000|Overall Study|Lack of Efficacy|3|||
28040001|NCT00347932|54698253|FG001|Overall Study|Lack of Efficacy|14|||
28040002|NCT00347932|54698252|FG000|Overall Study|Lost to Follow-up|10|||
28040003|NCT00347932|54698253|FG001|Overall Study|Lost to Follow-up|9|||
28040004|NCT00347932|54698252|FG000|Overall Study|Withdrawal by Subject|10|||
28040005|NCT00347932|54698253|FG001|Overall Study|Withdrawal by Subject|16|||
28040006|NCT00347932|54698252|FG000|Overall Study|Did not meet inclusion criteria|4|||
28040007|NCT00347932|54698253|FG001|Overall Study|Did not meet inclusion criteria|8|||
28040008|NCT00528996|54698264|FG000|Overall Study|Other reasons than listing|6|||
28040009|NCT00528996|54698265|FG001|Overall Study|Other reasons than listing|7|||
28040010|NCT00528996|54698266|FG002|Overall Study|Other reasons than listing|14|||
28040011|NCT00528996|54698267|FG003|Overall Study|Other reasons than listing|11|||
28040012|NCT00528996|54698268|FG004|Overall Study|Other reasons than listing|5|||
28040013|NCT00528996|54698264|FG000|Overall Study|Refused continue medication|16|||
28040014|NCT00528996|54698265|FG001|Overall Study|Refused continue medication|0|||
28040015|NCT00528996|54698266|FG002|Overall Study|Refused continue medication|3|||
28040016|NCT00528996|54698267|FG003|Overall Study|Refused continue medication|3|||
28040017|NCT00528996|54698268|FG004|Overall Study|Refused continue medication|6|||
28040018|NCT00528996|54698264|FG000|Overall Study|Lost to Follow-up|2|||
28040019|NCT00528996|54698265|FG001|Overall Study|Lost to Follow-up|0|||
28040020|NCT00528996|54698266|FG002|Overall Study|Lost to Follow-up|4|||
28040021|NCT00528996|54698267|FG003|Overall Study|Lost to Follow-up|1|||
28040022|NCT00528996|54698268|FG004|Overall Study|Lost to Follow-up|3|||
28040023|NCT00528996|54698264|FG000|Overall Study|Protocol Violation|1|||
28040024|NCT00528996|54698265|FG001|Overall Study|Protocol Violation|2|||
28040025|NCT00528996|54698266|FG002|Overall Study|Protocol Violation|3|||
28040026|NCT00528996|54698267|FG003|Overall Study|Protocol Violation|3|||
28040027|NCT00528996|54698268|FG004|Overall Study|Protocol Violation|2|||
28040028|NCT00528996|54698264|FG000|Overall Study|Lack of Efficacy|7|||
27939866|NCT01081912|54596202|FG001|Maintenance Treatment|Lost to Follow-up|1|||
27939867|NCT01081912|54596203|FG002|Maintenance Treatment|Lost to Follow-up|0|||
27939868|NCT01081912|54596201|FG000|Maintenance Treatment|Physician Decision|0|||
27939869|NCT01081912|54596202|FG001|Maintenance Treatment|Physician Decision|0|||
27939870|NCT01081912|54596203|FG002|Maintenance Treatment|Physician Decision|1|||
27939871|NCT01081912|54596201|FG000|Maintenance Treatment|Protocol Violation|0|||
27939872|NCT01081912|54596202|FG001|Maintenance Treatment|Protocol Violation|1|||
28040029|NCT00528996|54698265|FG001|Overall Study|Lack of Efficacy|2|||
27810343|NCT03052608|54266118|FG000|Treatment Phase|Adverse Event|10|||
27810344|NCT03052608|54266119|FG001|Treatment Phase|Adverse Event|12|||
27810345|NCT03052608|54266118|FG000|Treatment Phase|Death|6|||
27810346|NCT03052608|54266119|FG001|Treatment Phase|Death|4|||
27810347|NCT03052608|54266118|FG000|Treatment Phase|Withdrawal by Subject|4|||
27810348|NCT03052608|54266119|FG001|Treatment Phase|Withdrawal by Subject|12|||
27810349|NCT03052608|54266118|FG000|Treatment Phase|Global Deterioration of Health Status|0|||
27810350|NCT03052608|54266119|FG001|Treatment Phase|Global Deterioration of Health Status|3|||
27810351|NCT03052608|54266118|FG000|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|0|||
27810352|NCT03052608|54266119|FG001|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|1|||
27810353|NCT03052608|54266118|FG000|Treatment Phase|Subject didn't receive study treatment.|0|||
27810354|NCT03052608|54266119|FG001|Treatment Phase|Subject didn't receive study treatment.|1|||
27810355|NCT03052608|54266118|FG000|Treatment Phase|Ongoing|103|||
27810356|NCT03052608|54266119|FG001|Treatment Phase|Ongoing|31|||
27810357|NCT03052608|54266118|FG000|Long-Term Follow-up Phase|Death|23|||
27810358|NCT03052608|54266119|FG001|Long-Term Follow-up Phase|Death|28|||
27810359|NCT03052608|54266118|FG000|Long-Term Follow-up Phase|Lost to Follow-up|0|||
27831258|NCT01813019|54307655|FG001|Overall Study|Protocol Deviation|1|||
28040030|NCT00528996|54698266|FG002|Overall Study|Lack of Efficacy|1|||
28040031|NCT00528996|54698267|FG003|Overall Study|Lack of Efficacy|3|||
28040032|NCT00528996|54698268|FG004|Overall Study|Lack of Efficacy|3|||
28040033|NCT00528996|54698264|FG000|Overall Study|Adverse Event|32|||
28040034|NCT00528996|54698265|FG001|Overall Study|Adverse Event|13|||
28040035|NCT00528996|54698266|FG002|Overall Study|Adverse Event|18|||
28040036|NCT00528996|54698267|FG003|Overall Study|Adverse Event|29|||
28040037|NCT00528996|54698268|FG004|Overall Study|Adverse Event|18|||
28040038|NCT00359788|54698285|FG000|Overall Study|Adverse Event|11|||
28040039|NCT00359788|54698286|FG001|Overall Study|Adverse Event|10|||
28040040|NCT00359788|54698285|FG000|Overall Study|Lack of Efficacy|1|||
28040041|NCT00359788|54698286|FG001|Overall Study|Lack of Efficacy|2|||
28040042|NCT00359788|54698285|FG000|Overall Study|Lost to Follow-up|3|||
28040043|NCT00359788|54698286|FG001|Overall Study|Lost to Follow-up|2|||
28040044|NCT00359788|54698285|FG000|Overall Study|Withdrawal by Subject|4|||
28040045|NCT00359788|54698286|FG001|Overall Study|Withdrawal by Subject|1|||
28040046|NCT00359788|54698285|FG000|Overall Study|Protocol Violation|4|||
28040047|NCT00359788|54698286|FG001|Overall Study|Protocol Violation|2|||
28040048|NCT03878160|54698295|FG000|Overall Study|Lost to Follow-up|1|||
28040049|NCT03878160|54698296|FG001|Overall Study|Lost to Follow-up|1|||
28040050|NCT03878160|54698297|FG002|Overall Study|Lost to Follow-up|1|||
28040051|NCT03878160|54698295|FG000|Overall Study|Did not meet eligibility criteria, withdrawn by PI|1|||
28040052|NCT03878160|54698296|FG001|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
28040053|NCT03878160|54698297|FG002|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
28040054|NCT00623597|54698307|FG000|Overall Study|Failed to return|1|||
28040055|NCT00623597|54698308|FG001|Overall Study|Failed to return|0|||
28040056|NCT00347776|54698319|FG000|1.5 Month Follow-up|Death|2|||
28040057|NCT00347776|54698320|FG001|1.5 Month Follow-up|Death|0|||
28040058|NCT00347776|54698321|FG002|1.5 Month Follow-up|Death|0|||
28040059|NCT00347776|54698319|FG000|1.5 Month Follow-up|reached the endpoint|12|||
28040060|NCT00347776|54698320|FG001|1.5 Month Follow-up|reached the endpoint|8|||
28040061|NCT00347776|54698321|FG002|1.5 Month Follow-up|reached the endpoint|12|||
28040062|NCT00347776|54698319|FG000|6 Month Follow-up|Death|2|||
28040063|NCT00347776|54698320|FG001|6 Month Follow-up|Death|1|||
28040064|NCT00347776|54698321|FG002|6 Month Follow-up|Death|3|||
28040065|NCT00347776|54698319|FG000|6 Month Follow-up|reached endpont|20|||
28040066|NCT00347776|54698320|FG001|6 Month Follow-up|reached endpont|12|||
28040067|NCT00347776|54698321|FG002|6 Month Follow-up|reached endpont|15|||
28040068|NCT00347776|54698319|FG000|12 Month Follow-up|Lost to Follow-up|7|||
28040069|NCT00347776|54698320|FG001|12 Month Follow-up|Lost to Follow-up|6|||
28040070|NCT00347776|54698321|FG002|12 Month Follow-up|Lost to Follow-up|6|||
28040071|NCT00347776|54698319|FG000|12 Month Follow-up|Death|3|||
28040072|NCT00347776|54698320|FG001|12 Month Follow-up|Death|4|||
28040073|NCT00347776|54698321|FG002|12 Month Follow-up|Death|4|||
28040074|NCT00347776|54698319|FG000|12 Month Follow-up|Reached endpoint|13|||
28040075|NCT00347776|54698320|FG001|12 Month Follow-up|Reached endpoint|6|||
28040076|NCT00347776|54698321|FG002|12 Month Follow-up|Reached endpoint|9|||
28040077|NCT03829228|54698329|FG000|Overall Study|Protocol Violation|1|||
28040078|NCT00529542|54698335|FG000|Overall Study|Withdrawal by Subject|1|||
28040079|NCT00529542|54698336|FG001|Overall Study|Withdrawal by Subject|0|||
28040080|NCT00529542|54698335|FG000|Overall Study|Lost to Follow-up|0|||
28040081|NCT00529542|54698336|FG001|Overall Study|Lost to Follow-up|1|||
28040082|NCT00621959|54698344|FG000|Overall Study|Adverse Event|4|||
28040083|NCT00621959|54698345|FG001|Overall Study|Adverse Event|2|||
28040084|NCT00621959|54698344|FG000|Overall Study|Lack of Efficacy|1|||
28040085|NCT00621959|54698345|FG001|Overall Study|Lack of Efficacy|1|||
28040086|NCT00621959|54698344|FG000|Overall Study|Lost to Follow-up|0|||
28040087|NCT00621959|54698345|FG001|Overall Study|Lost to Follow-up|2|||
28040088|NCT00621959|54698344|FG000|Overall Study|Withdrawal by Subject|1|||
28040089|NCT00621959|54698345|FG001|Overall Study|Withdrawal by Subject|1|||
28040090|NCT00621959|54698344|FG000|Overall Study|Other|1|||
28040091|NCT00621959|54698345|FG001|Overall Study|Other|3|||
28040092|NCT03877224|54698353|FG000|Overall Study|Death|3|||
28040093|NCT03877224|54698354|FG001|Overall Study|Death|2|||
28040094|NCT03877224|54698353|FG000|Overall Study|Withdrawal by Subject|1|||
28040095|NCT03877224|54698354|FG001|Overall Study|Withdrawal by Subject|6|||
28040096|NCT03877224|54698353|FG000|Overall Study|Participant is alive, just unable to come for visits|1|||
28040097|NCT03877224|54698354|FG001|Overall Study|Participant is alive, just unable to come for visits|0|||
28040098|NCT00528606|54698362|FG000|Overall Study|Withdrew consent|4|||
28040099|NCT00528606|54698363|FG001|Overall Study|Withdrew consent|3|||
28040100|NCT00528606|54698362|FG000|Overall Study|Lost to Follow-up|4|||
28040101|NCT00528606|54698363|FG001|Overall Study|Lost to Follow-up|1|||
28040102|NCT00528606|54698362|FG000|Overall Study|Adverse Event|3|||
28040103|NCT00528606|54698363|FG001|Overall Study|Adverse Event|0|||
28040104|NCT00528606|54698362|FG000|Overall Study|Other|2|||
28040105|NCT00528606|54698363|FG001|Overall Study|Other|0|||
28040106|NCT00621257|54698374|FG000|Overall Study|Lost to Follow-up|4|||
28040107|NCT00621257|54698375|FG001|Overall Study|Lost to Follow-up|0|||
27810360|NCT03052608|54266119|FG001|Long-Term Follow-up Phase|Lost to Follow-up|2|||
27810361|NCT03052608|54266118|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|4|||
27810362|NCT03052608|54266119|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|18|||
28040108|NCT00621257|54698376|FG002|Overall Study|Lost to Follow-up|2|||
28040109|NCT00621257|54698377|FG003|Overall Study|Lost to Follow-up|4|||
28040110|NCT00621257|54698378|FG004|Overall Study|Lost to Follow-up|7|||
28040111|NCT00621257|54698374|FG000|Overall Study|Adverse Event|0|||
28040112|NCT00621257|54698375|FG001|Overall Study|Adverse Event|1|||
28040113|NCT00621257|54698376|FG002|Overall Study|Adverse Event|1|||
28040114|NCT00621257|54698377|FG003|Overall Study|Adverse Event|0|||
28040115|NCT00621257|54698378|FG004|Overall Study|Adverse Event|0|||
28040116|NCT00621257|54698374|FG000|Overall Study|Physician Decision|0|||
28040117|NCT00621257|54698375|FG001|Overall Study|Physician Decision|2|||
28040118|NCT00621257|54698376|FG002|Overall Study|Physician Decision|0|||
28040119|NCT00621257|54698377|FG003|Overall Study|Physician Decision|1|||
28040120|NCT00621257|54698378|FG004|Overall Study|Physician Decision|1|||
28040121|NCT00621257|54698374|FG000|Overall Study|Withdrawal by Subject|0|||
28040122|NCT00621257|54698375|FG001|Overall Study|Withdrawal by Subject|0|||
28040123|NCT00621257|54698376|FG002|Overall Study|Withdrawal by Subject|0|||
28040124|NCT00621257|54698377|FG003|Overall Study|Withdrawal by Subject|1|||
28040125|NCT00621257|54698378|FG004|Overall Study|Withdrawal by Subject|1|||
28040126|NCT00528840|54698390|FG000|Overall Study|Lost to Follow-up|10|||
28040127|NCT00528840|54698390|FG000|Overall Study|Adverse Event|1|||
28040128|NCT00528840|54698390|FG000|Overall Study|Withdrawal by Subject|17|||
28040129|NCT00528840|54698390|FG000|Overall Study|Death|2|||
28040130|NCT00528840|54698390|FG000|Overall Study|Administrative Reasons|1|||
27810363|NCT03052608|54266118|FG000|Long-Term Follow-up Phase|Ongoing|122|||
27810364|NCT03052608|54266119|FG001|Long-Term Follow-up Phase|Ongoing|99|||
27810365|NCT02914639|54266127|FG000|Overall Study|Withdrawal by Subject|0|||
27810366|NCT02914639|54266128|FG001|Overall Study|Withdrawal by Subject|2|||
27810367|NCT02865018|54266135|FG000|Overall Study|Withdrawal by Subject|1|||
27810368|NCT02704208|54266150|FG000|Overall Study|Lost to Follow-up|42|||
27810369|NCT02704208|54266151|FG001|Overall Study|Lost to Follow-up|37|||
27810370|NCT02618408|54266160|FG000|Overall Study|Withdrawal by Subject|1|||
27810371|NCT02618408|54266161|FG001|Overall Study|Withdrawal by Subject|0|||
27810372|NCT02618408|54266162|FG002|Overall Study|Withdrawal by Subject|4|||
27810373|NCT02618408|54266160|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
27810374|NCT02618408|54266161|FG001|Overall Study|Withdrawal By Parent/Guardian|3|||
27810375|NCT02618408|54266162|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
28040131|NCT00528840|54698390|FG000|Overall Study|Other|2|||
28040132|NCT00528528|54698398|FG000|Overall Study|Lost to Follow-up|0|||
28040133|NCT00528528|54698399|FG001|Overall Study|Lost to Follow-up|0|||
28040134|NCT00528528|54698400|FG002|Overall Study|Lost to Follow-up|1|||
28040135|NCT00528528|54698401|FG003|Overall Study|Lost to Follow-up|1|||
28040136|NCT00528528|54698398|FG000|Overall Study|Ineligible to continue the trial|0|||
28040137|NCT00528528|54698399|FG001|Overall Study|Ineligible to continue the trial|0|||
28040138|NCT00528528|54698400|FG002|Overall Study|Ineligible to continue the trial|0|||
28040139|NCT00528528|54698401|FG003|Overall Study|Ineligible to continue the trial|1|||
28040140|NCT00528528|54698398|FG000|Overall Study|Other|0|||
28040141|NCT00528528|54698399|FG001|Overall Study|Other|1|||
28040142|NCT00528528|54698400|FG002|Overall Study|Other|0|||
28040143|NCT00528528|54698401|FG003|Overall Study|Other|0|||
28040144|NCT00528528|54698398|FG000|Overall Study|Withdrawal by Subject|3|||
28040145|NCT00528528|54698399|FG001|Overall Study|Withdrawal by Subject|2|||
28040146|NCT00528528|54698400|FG002|Overall Study|Withdrawal by Subject|1|||
28040147|NCT00528528|54698401|FG003|Overall Study|Withdrawal by Subject|1|||
28040148|NCT00528528|54698398|FG000|Overall Study|Ongoing participant|0|||
28040149|NCT00528528|54698399|FG001|Overall Study|Ongoing participant|0|||
28040150|NCT00528528|54698400|FG002|Overall Study|Ongoing participant|1|||
28040151|NCT00528528|54698401|FG003|Overall Study|Ongoing participant|0|||
28040152|NCT00620555|54698413|FG000|Overall Study|Adverse Event|4|||
28040153|NCT00620555|54698413|FG000|Overall Study|Protocol Violation|2|||
28040154|NCT00620555|54698413|FG000|Overall Study|Lack of Efficacy|12|||
28040155|NCT00620555|54698413|FG000|Overall Study|Withdrawal by Subject|1|||
28040156|NCT00620555|54698413|FG000|Overall Study|Choice of other treatment|1|||
28040157|NCT00620555|54698413|FG000|Overall Study|Visit failure against planned|1|||
28040158|NCT00529386|54698417|FG000|Overall Study|Lost to Follow-up|1|||
28040159|NCT03875118|54698423|FG000|Overall Study|Withdrawal by Subject|4|||
28040160|NCT03875118|54698424|FG001|Overall Study|Withdrawal by Subject|4|||
28040161|NCT00529308|54698432|FG000|Overall Study|Withdrawal by Subject|1|||
28040162|NCT00529308|54698433|FG001|Overall Study|Withdrawal by Subject|1|||
28040163|NCT03875508|54698439|FG000|Overall Study|Adverse Event|1|||
28040164|NCT03875508|54698439|FG000|Overall Study|Lost to Follow-up|8|||
28040165|NCT03875508|54698439|FG000|Overall Study|Lack of Efficacy|1|||
27810376|NCT02618408|54266160|FG000|Overall Study|Lost to Follow-up|4|||
28040166|NCT03875508|54698439|FG000|Overall Study|Other, not specified|2|||
27810377|NCT02618408|54266161|FG001|Overall Study|Lost to Follow-up|2|||
28040167|NCT00620321|54698445|FG000|Overall Study|Adverse Event|1|||
28040168|NCT00620321|54698446|FG001|Overall Study|Adverse Event|1|||
28040169|NCT00620321|54698445|FG000|Overall Study|Death|1|||
28040170|NCT00620321|54698446|FG001|Overall Study|Death|1|||
28040171|NCT00620321|54698445|FG000|Overall Study|Physician Decision|0|||
28040172|NCT00620321|54698446|FG001|Overall Study|Physician Decision|7|||
28040173|NCT00620321|54698445|FG000|Overall Study|Progressive Disease|5|||
27810378|NCT02618408|54266162|FG002|Overall Study|Lost to Follow-up|6|||
28040174|NCT00620321|54698446|FG001|Overall Study|Progressive Disease|5|||
28040175|NCT00620321|54698445|FG000|Overall Study|Sponsor Decision|0|||
28040176|NCT00620321|54698446|FG001|Overall Study|Sponsor Decision|1|||
28040177|NCT00620321|54698445|FG000|Overall Study|Withdrawal by Subject|1|||
28040178|NCT00620321|54698446|FG001|Overall Study|Withdrawal by Subject|1|||
28040179|NCT00621023|54698452|FG000|Overall Study|Death|5|||
28040180|NCT00621023|54698452|FG000|Overall Study|Follow up discontinued|1|||
28040181|NCT00528372|54698465|FG000|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2|||
28040182|NCT00528372|54698466|FG001|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
28040183|NCT00528372|54698467|FG002|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
28040184|NCT00528372|54698468|FG003|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
28040185|NCT00528372|54698469|FG004|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
28040186|NCT00528372|54698470|FG005|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
28040187|NCT00528372|54698471|FG006|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
28040188|NCT00528372|54698472|FG007|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
27810379|NCT02618408|54266160|FG000|Overall Study|Adverse Event|4|||
28040189|NCT00528372|54698473|FG008|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
28040190|NCT00528372|54698465|FG000|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
28040191|NCT00528372|54698466|FG001|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
27810380|NCT02618408|54266161|FG001|Overall Study|Adverse Event|0|||
27810381|NCT02618408|54266162|FG002|Overall Study|Adverse Event|10|||
27810382|NCT02618408|54266160|FG000|Overall Study|Physician Decision|1|||
27810383|NCT02618408|54266161|FG001|Overall Study|Physician Decision|1|||
27810384|NCT02618408|54266162|FG002|Overall Study|Physician Decision|2|||
27810385|NCT02618408|54266160|FG000|Overall Study|Protocol Violation|1|||
27810386|NCT02618408|54266161|FG001|Overall Study|Protocol Violation|1|||
27810387|NCT02618408|54266162|FG002|Overall Study|Protocol Violation|2|||
27810388|NCT02618408|54266160|FG000|Overall Study|Other, Multiple Categories|0|||
27810389|NCT02618408|54266161|FG001|Overall Study|Other, Multiple Categories|0|||
27810390|NCT02618408|54266162|FG002|Overall Study|Other, Multiple Categories|4|||
27810391|NCT02553460|54266173|FG000|Overall Study|Death|3|||
27810392|NCT02553460|54266173|FG000|Overall Study|Withdrawal by Subject|1|||
27810393|NCT02553460|54266173|FG000|Overall Study|Development of unacceptable toxicity during treatment|1|||
27810394|NCT02553460|54266173|FG000|Overall Study|Relapse or Transplant|14|||
27810395|NCT02553460|54266173|FG000|Overall Study|No response to treatment|2|||
27810396|NCT02553460|54266173|FG000|Overall Study|Still on therapy|7|||
27810397|NCT02553460|54266173|FG000|Overall Study|CAR T cells|1|||
27810398|NCT02157883|54266186|FG000|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1|||
27810399|NCT02157883|54266186|FG000|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3|||
27810400|NCT02157883|54266186|FG000|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15|||
27810401|NCT02157883|54266186|FG000|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1|||
27810402|NCT02157883|54266186|FG000|Part B: Day 19 to End Part B (AZD9291)|Death|3|||
27810403|NCT02071290|54266195|FG000|Overall Study|Death|1|||
27810404|NCT02071290|54266196|FG001|Overall Study|Death|0|||
27810405|NCT02071290|54266195|FG000|Overall Study|Withdrawal by Subject|0|||
27810406|NCT02071290|54266196|FG001|Overall Study|Withdrawal by Subject|1|||
27810407|NCT02071290|54266195|FG000|Overall Study|Protocol Violation|3|||
27810408|NCT02071290|54266196|FG001|Overall Study|Protocol Violation|5|||
27810409|NCT02071290|54266195|FG000|Overall Study|Physician Decision|0|||
27810410|NCT02071290|54266196|FG001|Overall Study|Physician Decision|1|||
27810411|NCT02066181|54266204|FG000|Overall Study|Withdrawal by Subject|1|||
27810412|NCT02066181|54266205|FG001|Overall Study|Withdrawal by Subject|1|||
27810413|NCT01972217|54266218|FG000|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
27810414|NCT01972217|54266219|FG001|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1|||
27810415|NCT01972217|54266220|FG002|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
27810416|NCT01972217|54266221|FG003|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
27810417|NCT01972217|54266218|FG000|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1|||
27810418|NCT01972217|54266219|FG001|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9|||
27810419|NCT01972217|54266220|FG002|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
27810420|NCT01972217|54266221|FG003|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
27810421|NCT01972217|54266218|FG000|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
27810422|NCT01972217|54266219|FG001|Part A: Open-label Safety Run-in Period|Adverse Event|1|||
27810423|NCT01972217|54266220|FG002|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
27810424|NCT01972217|54266221|FG003|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
27810425|NCT01972217|54266218|FG000|Part A: Open-label Safety Run-in Period|Death|0|||
27810426|NCT01972217|54266219|FG001|Part A: Open-label Safety Run-in Period|Death|1|||
27810427|NCT01972217|54266220|FG002|Part A: Open-label Safety Run-in Period|Death|0|||
27810428|NCT01972217|54266221|FG003|Part A: Open-label Safety Run-in Period|Death|0|||
28040192|NCT00528372|54698467|FG002|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
28040193|NCT00528372|54698468|FG003|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6|||
27810429|NCT01972217|54266218|FG000|Part B Double-blind, Randomised Period|Death|0|||
27847922|NCT00218543|54340662|FG000|Overall Study|Lost to Follow-up|8|||
27847923|NCT00218543|54340662|FG000|Overall Study|relocated|1|||
28040194|NCT00528372|54698469|FG004|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
28040195|NCT00528372|54698470|FG005|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
28040196|NCT00528372|54698471|FG006|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
28040197|NCT00528372|54698472|FG007|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
28040198|NCT00528372|54698473|FG008|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
28040199|NCT00528372|54698465|FG000|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
28040200|NCT00528372|54698466|FG001|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
28040201|NCT00528372|54698467|FG002|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7|||
28040202|NCT00528372|54698468|FG003|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
28040203|NCT00528372|54698469|FG004|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
28040204|NCT00528372|54698470|FG005|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
28040205|NCT00528372|54698471|FG006|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
28040206|NCT00528372|54698472|FG007|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
28040207|NCT00528372|54698473|FG008|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
28040208|NCT00528372|54698465|FG000|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5|||
28040209|NCT00528372|54698466|FG001|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
28040210|NCT00528372|54698467|FG002|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
27810430|NCT01972217|54266219|FG001|Part B Double-blind, Randomised Period|Death|0|||
28040211|NCT00528372|54698468|FG003|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
28040212|NCT00528372|54698469|FG004|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
28040213|NCT00528372|54698470|FG005|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
28040214|NCT00528372|54698471|FG006|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
28040215|NCT00528372|54698472|FG007|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
28040216|NCT00528372|54698473|FG008|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
28040217|NCT00528372|54698465|FG000|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
28040218|NCT00528372|54698466|FG001|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
28040219|NCT00528372|54698467|FG002|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
28040220|NCT00528372|54698468|FG003|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2|||
28040221|NCT00528372|54698469|FG004|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
28040222|NCT00528372|54698470|FG005|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1|||
28040223|NCT00528372|54698471|FG006|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
28040224|NCT00528372|54698472|FG007|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
28040225|NCT00528372|54698473|FG008|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
28040226|NCT00528372|54698465|FG000|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
28040227|NCT00528372|54698466|FG001|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
28040228|NCT00528372|54698467|FG002|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
28040229|NCT00528372|54698468|FG003|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
28040230|NCT00528372|54698469|FG004|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
28040231|NCT00528372|54698470|FG005|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
28040232|NCT00528372|54698471|FG006|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
28040233|NCT00528372|54698472|FG007|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
28040234|NCT00528372|54698473|FG008|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
28040235|NCT00528372|54698465|FG000|Short-term (ST) Period (Day 1-Week 24)|Other|3|||
28040236|NCT00528372|54698466|FG001|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
27810431|NCT01972217|54266220|FG002|Part B Double-blind, Randomised Period|Death|43|||
27810432|NCT01972217|54266221|FG003|Part B Double-blind, Randomised Period|Death|44|||
27810433|NCT01972217|54266218|FG000|Part B Double-blind, Randomised Period|Reason not recorded|0|||
27810434|NCT01972217|54266219|FG001|Part B Double-blind, Randomised Period|Reason not recorded|0|||
27810435|NCT01972217|54266220|FG002|Part B Double-blind, Randomised Period|Reason not recorded|1|||
27810436|NCT01972217|54266221|FG003|Part B Double-blind, Randomised Period|Reason not recorded|0|||
27810437|NCT01972217|54266218|FG000|Part B Double-blind, Randomised Period|Screen failure|0|||
27810438|NCT01972217|54266219|FG001|Part B Double-blind, Randomised Period|Screen failure|0|||
27810439|NCT01972217|54266220|FG002|Part B Double-blind, Randomised Period|Screen failure|0|||
27810440|NCT01972217|54266221|FG003|Part B Double-blind, Randomised Period|Screen failure|1|||
27810441|NCT01972217|54266218|FG000|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
27810442|NCT01972217|54266219|FG001|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
27810443|NCT01972217|54266220|FG002|Part B Double-blind, Randomised Period|Lost to Follow-up|2|||
27810444|NCT01972217|54266221|FG003|Part B Double-blind, Randomised Period|Lost to Follow-up|1|||
27810445|NCT01972217|54266218|FG000|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
27810446|NCT01972217|54266219|FG001|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
27810447|NCT01972217|54266220|FG002|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
27810448|NCT01972217|54266221|FG003|Part B Double-blind, Randomised Period|Withdrawal by Subject|1|||
27939873|NCT01081912|54596203|FG002|Maintenance Treatment|Protocol Violation|2|||
27810449|NCT01970865|54266250|FG000|Overall Study|Death|3|||
27810450|NCT01970865|54266251|FG001|Overall Study|Death|1|||
27810451|NCT01970865|54266252|FG002|Overall Study|Death|3|||
28040237|NCT00528372|54698467|FG002|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
28040238|NCT00528372|54698468|FG003|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
28040239|NCT00528372|54698469|FG004|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
28040240|NCT00528372|54698470|FG005|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
28040241|NCT00528372|54698471|FG006|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
28040242|NCT00528372|54698472|FG007|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
28040243|NCT00528372|54698473|FG008|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
28040244|NCT00528372|54698465|FG000|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
28040245|NCT00528372|54698466|FG001|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
27810452|NCT01970865|54266253|FG003|Overall Study|Death|4|||
27810453|NCT01970865|54266254|FG004|Overall Study|Death|6|||
28040246|NCT00528372|54698467|FG002|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1|||
28040247|NCT00528372|54698468|FG003|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
28040248|NCT00528372|54698469|FG004|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
28040249|NCT00528372|54698470|FG005|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
28040250|NCT00528372|54698471|FG006|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2|||
28040251|NCT00528372|54698472|FG007|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
28040252|NCT00528372|54698473|FG008|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
28040253|NCT00528372|54698465|FG000|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
28040254|NCT00528372|54698466|FG001|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
28040255|NCT00528372|54698467|FG002|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
28040256|NCT00528372|54698468|FG003|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
28040257|NCT00528372|54698469|FG004|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2|||
28040258|NCT00528372|54698470|FG005|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
28040259|NCT00528372|54698471|FG006|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4|||
28040260|NCT00528372|54698472|FG007|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
28040261|NCT00528372|54698473|FG008|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
28040262|NCT00528372|54698465|FG000|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
28040263|NCT00528372|54698466|FG001|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
28040264|NCT00528372|54698467|FG002|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
28040265|NCT00528372|54698468|FG003|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
28040266|NCT00528372|54698469|FG004|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7|||
28040267|NCT00528372|54698470|FG005|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0|||
28040268|NCT00528372|54698471|FG006|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
28040269|NCT00528372|54698472|FG007|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2|||
28040270|NCT00528372|54698473|FG008|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
28040271|NCT00528372|54698465|FG000|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
28040272|NCT00528372|54698466|FG001|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
28040273|NCT00528372|54698467|FG002|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
28040274|NCT00528372|54698468|FG003|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
28040275|NCT00528372|54698469|FG004|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0|||
28040276|NCT00528372|54698470|FG005|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4|||
28040277|NCT00528372|54698471|FG006|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
28040278|NCT00528372|54698472|FG007|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
28040279|NCT00528372|54698473|FG008|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
28040280|NCT00528372|54698465|FG000|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
28040281|NCT00528372|54698466|FG001|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
28040282|NCT00528372|54698467|FG002|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
28040283|NCT00528372|54698468|FG003|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
28040284|NCT00528372|54698469|FG004|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
28040285|NCT00528372|54698470|FG005|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
27810454|NCT01970865|54266255|FG005|Overall Study|Death|3|||
27810455|NCT01970865|54266256|FG006|Overall Study|Death|1|||
27810456|NCT01970865|54266257|FG007|Overall Study|Death|3|||
27810457|NCT01970865|54266258|FG008|Overall Study|Death|2|||
27810458|NCT01970865|54266259|FG009|Overall Study|Death|1|||
27810459|NCT01970865|54266260|FG010|Overall Study|Death|1|||
27810460|NCT01970865|54266261|FG011|Overall Study|Death|4|||
27810461|NCT01970865|54266262|FG012|Overall Study|Death|14|||
27810462|NCT01970865|54266263|FG013|Overall Study|Death|19|||
27810463|NCT01970865|54266264|FG014|Overall Study|Death|15|||
27810464|NCT01970865|54266265|FG015|Overall Study|Death|10|||
27810465|NCT01970865|54266266|FG016|Overall Study|Death|1|||
27810466|NCT01970865|54266250|FG000|Overall Study|Lost to Follow-up|0|||
27810467|NCT01970865|54266251|FG001|Overall Study|Lost to Follow-up|0|||
27810468|NCT01970865|54266252|FG002|Overall Study|Lost to Follow-up|0|||
27810469|NCT01970865|54266253|FG003|Overall Study|Lost to Follow-up|1|||
27810470|NCT01970865|54266254|FG004|Overall Study|Lost to Follow-up|1|||
27810471|NCT01970865|54266255|FG005|Overall Study|Lost to Follow-up|0|||
27810472|NCT01970865|54266256|FG006|Overall Study|Lost to Follow-up|0|||
27810473|NCT01970865|54266257|FG007|Overall Study|Lost to Follow-up|0|||
27810474|NCT01970865|54266258|FG008|Overall Study|Lost to Follow-up|0|||
28040286|NCT00528372|54698471|FG006|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
28040287|NCT00528372|54698472|FG007|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
28040288|NCT00528372|54698473|FG008|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
28040289|NCT00528372|54698465|FG000|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
28040290|NCT00528372|54698466|FG001|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
28040291|NCT00528372|54698467|FG002|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
28040292|NCT00528372|54698468|FG003|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
28040293|NCT00528372|54698469|FG004|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2|||
28040294|NCT00528372|54698470|FG005|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1|||
28040295|NCT00528372|54698471|FG006|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
28040296|NCT00528372|54698472|FG007|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
28040297|NCT00528372|54698473|FG008|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
28040298|NCT00528372|54698465|FG000|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
28040299|NCT00528372|54698466|FG001|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
28040300|NCT00528372|54698467|FG002|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
28040301|NCT00528372|54698468|FG003|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
27810475|NCT01970865|54266259|FG009|Overall Study|Lost to Follow-up|0|||
27810476|NCT01970865|54266260|FG010|Overall Study|Lost to Follow-up|0|||
27810477|NCT01970865|54266261|FG011|Overall Study|Lost to Follow-up|0|||
27810478|NCT01970865|54266262|FG012|Overall Study|Lost to Follow-up|1|||
27810479|NCT01970865|54266263|FG013|Overall Study|Lost to Follow-up|0|||
27810480|NCT01970865|54266264|FG014|Overall Study|Lost to Follow-up|0|||
27810481|NCT01970865|54266265|FG015|Overall Study|Lost to Follow-up|0|||
27810482|NCT01970865|54266266|FG016|Overall Study|Lost to Follow-up|0|||
27810483|NCT01970865|54266250|FG000|Overall Study|Withdrawal by Subject|0|||
27810484|NCT01970865|54266251|FG001|Overall Study|Withdrawal by Subject|0|||
27810485|NCT01970865|54266252|FG002|Overall Study|Withdrawal by Subject|0|||
27810486|NCT01970865|54266253|FG003|Overall Study|Withdrawal by Subject|1|||
27810487|NCT01970865|54266254|FG004|Overall Study|Withdrawal by Subject|2|||
27810488|NCT01970865|54266255|FG005|Overall Study|Withdrawal by Subject|0|||
27810489|NCT01970865|54266256|FG006|Overall Study|Withdrawal by Subject|0|||
27810490|NCT01970865|54266257|FG007|Overall Study|Withdrawal by Subject|0|||
27810491|NCT01970865|54266258|FG008|Overall Study|Withdrawal by Subject|0|||
27810492|NCT01970865|54266259|FG009|Overall Study|Withdrawal by Subject|0|||
27810493|NCT01970865|54266260|FG010|Overall Study|Withdrawal by Subject|0|||
27810494|NCT01970865|54266261|FG011|Overall Study|Withdrawal by Subject|1|||
27810495|NCT01970865|54266262|FG012|Overall Study|Withdrawal by Subject|2|||
27810496|NCT01970865|54266263|FG013|Overall Study|Withdrawal by Subject|5|||
27810497|NCT01970865|54266264|FG014|Overall Study|Withdrawal by Subject|2|||
27810498|NCT01970865|54266265|FG015|Overall Study|Withdrawal by Subject|7|||
27810499|NCT01970865|54266266|FG016|Overall Study|Withdrawal by Subject|0|||
27810500|NCT01970865|54266250|FG000|Overall Study|Other|0|||
27810501|NCT01970865|54266251|FG001|Overall Study|Other|0|||
27810502|NCT01970865|54266252|FG002|Overall Study|Other|0|||
27810503|NCT01970865|54266253|FG003|Overall Study|Other|1|||
27810504|NCT01970865|54266254|FG004|Overall Study|Other|0|||
27810505|NCT01970865|54266255|FG005|Overall Study|Other|0|||
27810506|NCT01970865|54266256|FG006|Overall Study|Other|0|||
27810507|NCT01970865|54266257|FG007|Overall Study|Other|0|||
27810508|NCT01970865|54266258|FG008|Overall Study|Other|0|||
27810509|NCT01970865|54266259|FG009|Overall Study|Other|0|||
27810510|NCT01970865|54266260|FG010|Overall Study|Other|0|||
27810511|NCT01970865|54266261|FG011|Overall Study|Other|0|||
27810512|NCT01970865|54266262|FG012|Overall Study|Other|0|||
27810513|NCT01970865|54266263|FG013|Overall Study|Other|1|||
27810514|NCT01970865|54266264|FG014|Overall Study|Other|0|||
27939874|NCT01081912|54596201|FG000|Maintenance Treatment|Withdrawal by Subject|0|||
27810515|NCT01970865|54266265|FG015|Overall Study|Other|1|||
27810516|NCT01970865|54266266|FG016|Overall Study|Other|0|||
27810517|NCT01970865|54266250|FG000|Overall Study|Study ongoing|0|||
27810518|NCT01970865|54266251|FG001|Overall Study|Study ongoing|2|||
27810519|NCT01970865|54266252|FG002|Overall Study|Study ongoing|0|||
27810520|NCT01970865|54266253|FG003|Overall Study|Study ongoing|6|||
27810521|NCT01970865|54266254|FG004|Overall Study|Study ongoing|8|||
27810522|NCT01970865|54266255|FG005|Overall Study|Study ongoing|0|||
27810523|NCT01970865|54266256|FG006|Overall Study|Study ongoing|2|||
27810524|NCT01970865|54266257|FG007|Overall Study|Study ongoing|0|||
27810525|NCT01970865|54266258|FG008|Overall Study|Study ongoing|1|||
27810526|NCT01970865|54266259|FG009|Overall Study|Study ongoing|3|||
28040302|NCT00528372|54698469|FG004|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
28040303|NCT00528372|54698470|FG005|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
28040304|NCT00528372|54698471|FG006|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
27810527|NCT01970865|54266260|FG010|Overall Study|Study ongoing|29|||
27810528|NCT01970865|54266261|FG011|Overall Study|Study ongoing|22|||
27810529|NCT01970865|54266262|FG012|Overall Study|Study ongoing|43|||
27810530|NCT01970865|54266263|FG013|Overall Study|Study ongoing|41|||
28040305|NCT00528372|54698472|FG007|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
28040306|NCT00528372|54698473|FG008|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
28040307|NCT00528372|54698465|FG000|Long-term (LT) Period (Weeks 24-102)|Other|2|||
28040308|NCT00528372|54698466|FG001|Long-term (LT) Period (Weeks 24-102)|Other|2|||
28040309|NCT00528372|54698467|FG002|Long-term (LT) Period (Weeks 24-102)|Other|1|||
28040310|NCT00528372|54698468|FG003|Long-term (LT) Period (Weeks 24-102)|Other|2|||
28040311|NCT00528372|54698469|FG004|Long-term (LT) Period (Weeks 24-102)|Other|3|||
28040312|NCT00528372|54698470|FG005|Long-term (LT) Period (Weeks 24-102)|Other|0|||
28040313|NCT00528372|54698471|FG006|Long-term (LT) Period (Weeks 24-102)|Other|3|||
28040314|NCT00528372|54698472|FG007|Long-term (LT) Period (Weeks 24-102)|Other|1|||
28040315|NCT00528372|54698473|FG008|Long-term (LT) Period (Weeks 24-102)|Other|0|||
28040316|NCT00527982|54698521|FG000|Overall Study|Physician Decision|1|||
28040317|NCT00527982|54698522|FG001|Overall Study|Physician Decision|0|||
28040318|NCT00527904|54698528|FG000|Overall Study|Adverse Event|45|||
28040319|NCT00527904|54698528|FG000|Overall Study|Withdrawal by Subject|21|||
28040320|NCT00527904|54698528|FG000|Overall Study|Lost to Follow-up|8|||
28040321|NCT00527904|54698528|FG000|Overall Study|misc|22|||
28040322|NCT00619619|54698540|FG000|Overall Study|Physician Decision|0|||
28040323|NCT00619619|54698541|FG001|Overall Study|Physician Decision|0|||
27810531|NCT01970865|54266264|FG014|Overall Study|Study ongoing|29|||
27810532|NCT01970865|54266265|FG015|Overall Study|Study ongoing|29|||
27810533|NCT01970865|54266266|FG016|Overall Study|Study ongoing|2|||
27810534|NCT01711541|54266341|FG000|Overall Study|Cancel prior to treatment|0|||
27810535|NCT01711541|54266342|FG001|Overall Study|Cancel prior to treatment|0|||
27810536|NCT01711541|54266343|FG002|Overall Study|Cancel prior to treatment|0|||
27810537|NCT01711541|54266344|FG003|Overall Study|Cancel prior to treatment|1|||
27810538|NCT01711541|54266345|FG004|Overall Study|Cancel prior to treatment|0|||
27810539|NCT01711541|54266341|FG000|Overall Study|Ineligible|0|||
27810540|NCT01711541|54266342|FG001|Overall Study|Ineligible|1|||
27810541|NCT01711541|54266343|FG002|Overall Study|Ineligible|0|||
27810542|NCT01711541|54266344|FG003|Overall Study|Ineligible|0|||
27810543|NCT01711541|54266345|FG004|Overall Study|Ineligible|0|||
27810544|NCT01382446|54266381|FG000|Overall Study|Withdrawal by Subject|0|||
27810545|NCT01382446|54266382|FG001|Overall Study|Withdrawal by Subject|1|||
27810546|NCT01382446|54266381|FG000|Overall Study|Removal from Mechanical Ventilation|3|||
27810547|NCT01382446|54266382|FG001|Overall Study|Removal from Mechanical Ventilation|3|||
27810548|NCT01382212|54266388|FG000|Overall Study|Kidney transplant|1|||
27810549|NCT01382212|54266388|FG000|Overall Study|Withdrew consent|1|||
27810550|NCT01381900|54266395|FG000|Overall Study|Subject meets glycemic withdrawal crit.|2|||
27810551|NCT01381900|54266396|FG001|Overall Study|Subject meets glycemic withdrawal crit.|0|||
27810552|NCT01381900|54266397|FG002|Overall Study|Subject meets glycemic withdrawal crit.|0|||
27810553|NCT01381900|54266395|FG000|Overall Study|Adverse Event|4|||
27810554|NCT01381900|54266396|FG001|Overall Study|Adverse Event|6|||
27810555|NCT01381900|54266397|FG002|Overall Study|Adverse Event|7|||
27810556|NCT01381900|54266395|FG000|Overall Study|Noncompliance with study drug|0|||
27810557|NCT01381900|54266396|FG001|Overall Study|Noncompliance with study drug|0|||
27810558|NCT01381900|54266397|FG002|Overall Study|Noncompliance with study drug|1|||
27810559|NCT01381900|54266395|FG000|Overall Study|Physician Decision|0|||
27810560|NCT01381900|54266396|FG001|Overall Study|Physician Decision|1|||
27810561|NCT01381900|54266397|FG002|Overall Study|Physician Decision|1|||
27810562|NCT01381900|54266395|FG000|Overall Study|Protocol Violation|0|||
27810563|NCT01381900|54266396|FG001|Overall Study|Protocol Violation|1|||
27810564|NCT01381900|54266397|FG002|Overall Study|Protocol Violation|1|||
27810565|NCT01381900|54266395|FG000|Overall Study|Withdrawal by Subject|0|||
27810566|NCT01381900|54266396|FG001|Overall Study|Withdrawal by Subject|0|||
27810567|NCT01381900|54266397|FG002|Overall Study|Withdrawal by Subject|1|||
27810568|NCT01381900|54266395|FG000|Overall Study|Early withdraw|3|||
27810569|NCT01381900|54266396|FG001|Overall Study|Early withdraw|1|||
27810570|NCT01381900|54266397|FG002|Overall Study|Early withdraw|1|||
27810571|NCT01744665|54266405|FG000|Monitoring Phase|Adverse Event|4|||
27810572|NCT01744665|54266405|FG000|Monitoring Phase|Abnormal laboratory value(s)|1|||
28040324|NCT00619619|54698542|FG002|Overall Study|Physician Decision|1|||
28040325|NCT00619619|54698543|FG003|Overall Study|Physician Decision|0|||
27810573|NCT01744665|54266405|FG000|Monitoring Phase|Unsatisfactory therapeutic effect|7|||
27810574|NCT01744665|54266405|FG000|Monitoring Phase|Withdrawal by Subject|5|||
27810575|NCT01744665|54266405|FG000|Monitoring Phase|Did not achieve MR4.5|1|||
27810576|NCT01744665|54266405|FG000|Consolidation Phase|Adverse Event|2|||
27810577|NCT01744665|54266405|FG000|Consolidation Phase|Unsatisfactory therapeutic effect|4|||
28040326|NCT00619619|54698544|FG004|Overall Study|Physician Decision|0|||
28040327|NCT00619619|54698545|FG005|Overall Study|Physician Decision|0|||
28040328|NCT00619619|54698546|FG006|Overall Study|Physician Decision|0|||
28040329|NCT00619619|54698547|FG007|Overall Study|Physician Decision|0|||
28040330|NCT00619619|54698540|FG000|Overall Study|Protocol Violation|0|||
28040331|NCT00619619|54698541|FG001|Overall Study|Protocol Violation|0|||
28040332|NCT00619619|54698542|FG002|Overall Study|Protocol Violation|0|||
28040333|NCT00619619|54698543|FG003|Overall Study|Protocol Violation|1|||
28040334|NCT00619619|54698544|FG004|Overall Study|Protocol Violation|0|||
28040335|NCT00619619|54698545|FG005|Overall Study|Protocol Violation|0|||
28040336|NCT00619619|54698546|FG006|Overall Study|Protocol Violation|1|||
28040337|NCT00619619|54698547|FG007|Overall Study|Protocol Violation|1|||
28040338|NCT00619619|54698540|FG000|Overall Study|Adverse Event|0|||
28040339|NCT00619619|54698541|FG001|Overall Study|Adverse Event|0|||
28040340|NCT00619619|54698542|FG002|Overall Study|Adverse Event|0|||
28040341|NCT00619619|54698543|FG003|Overall Study|Adverse Event|0|||
28040342|NCT00619619|54698544|FG004|Overall Study|Adverse Event|2|||
28040343|NCT00619619|54698545|FG005|Overall Study|Adverse Event|0|||
28040344|NCT00619619|54698546|FG006|Overall Study|Adverse Event|0|||
28040345|NCT00619619|54698547|FG007|Overall Study|Adverse Event|2|||
28040346|NCT00527826|54698570|FG000|Overall Study|Adverse Event|10|||
28040347|NCT00527826|54698571|FG001|Overall Study|Adverse Event|10|||
28040348|NCT00527826|54698570|FG000|Overall Study|Lost to Follow-up|3|||
28040349|NCT00527826|54698571|FG001|Overall Study|Lost to Follow-up|2|||
28040350|NCT00527826|54698570|FG000|Overall Study|Withdrawal by Subject|5|||
28040351|NCT00527826|54698571|FG001|Overall Study|Withdrawal by Subject|8|||
28040352|NCT00527826|54698570|FG000|Overall Study|Inclusion Criteria Not Met|3|||
28040353|NCT00527826|54698571|FG001|Overall Study|Inclusion Criteria Not Met|3|||
28040354|NCT00527826|54698570|FG000|Overall Study|Alpha-1 Antitrypsin Deficiency|0|||
28040355|NCT00527826|54698571|FG001|Overall Study|Alpha-1 Antitrypsin Deficiency|1|||
28040356|NCT00527826|54698570|FG000|Overall Study|Additional Intake of Viani forte|0|||
28040357|NCT00527826|54698571|FG001|Overall Study|Additional Intake of Viani forte|1|||
28040358|NCT00527826|54698570|FG000|Overall Study|Participant moved away|0|||
28040359|NCT00527826|54698571|FG001|Overall Study|Participant moved away|1|||
28040360|NCT00527748|54698589|FG000|Overall Study|Other|3|||
28040361|NCT00619385|54698596|FG000|Overall Study|Adverse Event|0|||
28040362|NCT00619385|54698597|FG001|Overall Study|Adverse Event|0|||
28040363|NCT00619385|54698598|FG002|Overall Study|Adverse Event|3|||
28040364|NCT00619385|54698596|FG000|Overall Study|Other|1|||
28040365|NCT00619385|54698597|FG001|Overall Study|Other|2|||
28040366|NCT00619385|54698598|FG002|Overall Study|Other|1|||
28040367|NCT00619307|54698611|FG000|Overall Study|Adverse Event|0|||
28040368|NCT00619307|54698612|FG001|Overall Study|Adverse Event|1|||
28040369|NCT00619307|54698611|FG000|Overall Study|Lost to Follow-up|0|||
28040370|NCT00619307|54698612|FG001|Overall Study|Lost to Follow-up|1|||
28040371|NCT00619307|54698611|FG000|Overall Study|Protocol Violation|3|||
28040372|NCT00619307|54698612|FG001|Overall Study|Protocol Violation|0|||
28040373|NCT00619307|54698611|FG000|Overall Study|Withdrew consent|1|||
28040374|NCT00619307|54698612|FG001|Overall Study|Withdrew consent|0|||
28040375|NCT00619307|54698611|FG000|Overall Study|Severe migraine|0|||
28040376|NCT00619307|54698612|FG001|Overall Study|Severe migraine|1|||
28040377|NCT00619307|54698611|FG000|Overall Study|MS attack plus steroids|0|||
28040378|NCT00619307|54698612|FG001|Overall Study|MS attack plus steroids|1|||
28040379|NCT00619229|54698620|FG000|Overall Study|Withdrawal by Subject|1|||
28040380|NCT00619229|54698621|FG001|Overall Study|Withdrawal by Subject|1|||
28040381|NCT00619229|54698620|FG000|Overall Study|Lost to Follow-up|1|||
28040382|NCT00619229|54698621|FG001|Overall Study|Lost to Follow-up|0|||
28040383|NCT00619229|54698620|FG000|Overall Study|Termination of the Study by the Sponsor|1|||
28040384|NCT00619229|54698621|FG001|Overall Study|Termination of the Study by the Sponsor|1|||
28040385|NCT00619229|54698620|FG000|Overall Study|Investigator planned Cataract Operation|1|||
28040386|NCT00619229|54698621|FG001|Overall Study|Investigator planned Cataract Operation|0|||
28040387|NCT00619151|54698629|FG000|Overall Study|Study terminated prior to followup|1|||
28040388|NCT00619151|54698630|FG001|Overall Study|Study terminated prior to followup|0|||
28040389|NCT00618995|54698636|FG000|Period 1|Adverse Event|0|||
28040390|NCT00618995|54698637|FG001|Period 1|Adverse Event|0|||
28040391|NCT00618995|54698638|FG002|Period 1|Adverse Event|1|||
28040392|NCT00618995|54698639|FG003|Period 1|Adverse Event|0|||
28040393|NCT00618995|54698636|FG000|Period 1|Protocol Violation|0|||
28040394|NCT00618995|54698637|FG001|Period 1|Protocol Violation|1|||
28040395|NCT00618995|54698638|FG002|Period 1|Protocol Violation|1|||
28040396|NCT00618995|54698639|FG003|Period 1|Protocol Violation|0|||
28040397|NCT00618995|54698636|FG000|Period 2|Protocol Violation|0|||
28040398|NCT00618995|54698637|FG001|Period 2|Protocol Violation|0|||
28040399|NCT00618995|54698638|FG002|Period 2|Protocol Violation|1|||
28040400|NCT00618995|54698639|FG003|Period 2|Protocol Violation|0|||
28040401|NCT00618995|54698636|FG000|Period 4|Adverse Event|1|||
28040402|NCT00618995|54698637|FG001|Period 4|Adverse Event|0|||
28040403|NCT00618995|54698638|FG002|Period 4|Adverse Event|0|||
28040404|NCT00618995|54698639|FG003|Period 4|Adverse Event|0|||
28040405|NCT03685344|54698653|FG000|Overall Study|Withdrawal by Subject|1|||
28040406|NCT03685344|54698654|FG001|Overall Study|Withdrawal by Subject|1|||
28040407|NCT03685344|54698655|FG002|Overall Study|Withdrawal by Subject|2|||
28040408|NCT03685344|54698656|FG003|Overall Study|Withdrawal by Subject|0|||
28040409|NCT03685344|54698653|FG000|Overall Study|Physician Decision|1|||
28040410|NCT03685344|54698654|FG001|Overall Study|Physician Decision|1|||
28040411|NCT03685344|54698655|FG002|Overall Study|Physician Decision|5|||
28040412|NCT03685344|54698656|FG003|Overall Study|Physician Decision|0|||
28040413|NCT03685344|54698653|FG000|Overall Study|Death|1|||
28040414|NCT03685344|54698654|FG001|Overall Study|Death|1|||
28040415|NCT03685344|54698655|FG002|Overall Study|Death|0|||
28040416|NCT03685344|54698656|FG003|Overall Study|Death|0|||
28040417|NCT00520572|54698672|FG000|Overall Study|Adverse Event|9|||
28040418|NCT00520572|54698673|FG001|Overall Study|Adverse Event|3|||
28040419|NCT00520572|54698674|FG002|Overall Study|Adverse Event|6|||
28040420|NCT00520572|54698675|FG003|Overall Study|Adverse Event|9|||
28040421|NCT00520572|54698676|FG004|Overall Study|Adverse Event|7|||
28040422|NCT00520572|54698677|FG005|Overall Study|Adverse Event|2|||
28040423|NCT00520572|54698672|FG000|Overall Study|Withdrawal by Subject|0|||
28040424|NCT00520572|54698673|FG001|Overall Study|Withdrawal by Subject|9|||
28040425|NCT00520572|54698674|FG002|Overall Study|Withdrawal by Subject|5|||
28040426|NCT00520572|54698675|FG003|Overall Study|Withdrawal by Subject|2|||
28040427|NCT00520572|54698676|FG004|Overall Study|Withdrawal by Subject|2|||
28040428|NCT00520572|54698677|FG005|Overall Study|Withdrawal by Subject|0|||
28040429|NCT00520572|54698672|FG000|Overall Study|Protocol Violation|0|||
28040430|NCT00520572|54698673|FG001|Overall Study|Protocol Violation|0|||
28040431|NCT00520572|54698674|FG002|Overall Study|Protocol Violation|1|||
28040432|NCT00520572|54698675|FG003|Overall Study|Protocol Violation|0|||
28040433|NCT00520572|54698676|FG004|Overall Study|Protocol Violation|0|||
28040434|NCT00520572|54698677|FG005|Overall Study|Protocol Violation|0|||
28040435|NCT00520572|54698672|FG000|Overall Study|Lack of Efficacy|1|||
28040436|NCT00520572|54698673|FG001|Overall Study|Lack of Efficacy|1|||
28040437|NCT00520572|54698674|FG002|Overall Study|Lack of Efficacy|1|||
28040438|NCT00520572|54698675|FG003|Overall Study|Lack of Efficacy|2|||
28040439|NCT00520572|54698676|FG004|Overall Study|Lack of Efficacy|1|||
28040440|NCT00520572|54698677|FG005|Overall Study|Lack of Efficacy|0|||
28040441|NCT00520572|54698672|FG000|Overall Study|Lost to Follow-up|0|||
28040442|NCT00520572|54698673|FG001|Overall Study|Lost to Follow-up|0|||
28040443|NCT00520572|54698674|FG002|Overall Study|Lost to Follow-up|0|||
28040444|NCT00520572|54698675|FG003|Overall Study|Lost to Follow-up|0|||
28040445|NCT00520572|54698676|FG004|Overall Study|Lost to Follow-up|1|||
28040446|NCT00520572|54698677|FG005|Overall Study|Lost to Follow-up|0|||
28040447|NCT00520572|54698672|FG000|Overall Study|Incorrect enrollment|1|||
28040448|NCT00520572|54698673|FG001|Overall Study|Incorrect enrollment|0|||
28040449|NCT00520572|54698674|FG002|Overall Study|Incorrect enrollment|1|||
28040450|NCT00520572|54698675|FG003|Overall Study|Incorrect enrollment|0|||
28040451|NCT00520572|54698676|FG004|Overall Study|Incorrect enrollment|1|||
28040452|NCT00520572|54698677|FG005|Overall Study|Incorrect enrollment|0|||
28040453|NCT00520572|54698672|FG000|Overall Study|Oral corticotherapy for acute urticaria|0|||
28040454|NCT00520572|54698673|FG001|Overall Study|Oral corticotherapy for acute urticaria|1|||
28040455|NCT00520572|54698674|FG002|Overall Study|Oral corticotherapy for acute urticaria|0|||
28040456|NCT00520572|54698675|FG003|Overall Study|Oral corticotherapy for acute urticaria|0|||
28040457|NCT00520572|54698676|FG004|Overall Study|Oral corticotherapy for acute urticaria|0|||
28040458|NCT00520572|54698677|FG005|Overall Study|Oral corticotherapy for acute urticaria|0|||
28040459|NCT00520572|54698672|FG000|Overall Study|Long break in taking Medication|0|||
28040460|NCT00520572|54698673|FG001|Overall Study|Long break in taking Medication|0|||
28040461|NCT00520572|54698674|FG002|Overall Study|Long break in taking Medication|0|||
28040462|NCT00520572|54698675|FG003|Overall Study|Long break in taking Medication|1|||
28040463|NCT00520572|54698676|FG004|Overall Study|Long break in taking Medication|0|||
28040464|NCT00520572|54698677|FG005|Overall Study|Long break in taking Medication|0|||
28040465|NCT00520572|54698672|FG000|Overall Study|Did not receive Treatment|1|||
28040466|NCT00520572|54698673|FG001|Overall Study|Did not receive Treatment|0|||
28040467|NCT00520572|54698674|FG002|Overall Study|Did not receive Treatment|1|||
28040468|NCT00520572|54698675|FG003|Overall Study|Did not receive Treatment|0|||
28040469|NCT00520572|54698676|FG004|Overall Study|Did not receive Treatment|0|||
28040470|NCT00520572|54698677|FG005|Overall Study|Did not receive Treatment|0|||
28040471|NCT00573833|54698691|FG000|Overall Study|Not Treated|2|||
28040472|NCT00520494|54698695|FG000|Overall Study|Withdrawal by Subject|1|||
28040473|NCT00527514|54698699|FG000|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1|||
28040474|NCT00527514|54698699|FG000|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2|||
28040475|NCT00527514|54698699|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1|||
28040476|NCT00527514|54698699|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1|||
28040477|NCT00527514|54698699|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1|||
28040478|NCT00527514|54698699|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1|||
28040479|NCT00527514|54698699|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1|||
28040480|NCT00618449|54698712|FG000|Overall Study|Lost to Follow-up|98|||
28040481|NCT00618449|54698713|FG001|Overall Study|Lost to Follow-up|110|||
28040482|NCT03684642|54698722|FG000|Overall Study|Adverse Event|6|||
28040483|NCT03684642|54698723|FG001|Overall Study|Adverse Event|15|||
28040484|NCT03684642|54698724|FG002|Overall Study|Adverse Event|11|||
28040485|NCT03684642|54698722|FG000|Overall Study|Withdrawal by Subject|35|||
28040486|NCT03684642|54698723|FG001|Overall Study|Withdrawal by Subject|53|||
28040487|NCT03684642|54698724|FG002|Overall Study|Withdrawal by Subject|23|||
28040488|NCT03684642|54698722|FG000|Overall Study|Lack of Efficacy|0|||
28040489|NCT03684642|54698723|FG001|Overall Study|Lack of Efficacy|0|||
28040490|NCT03684642|54698724|FG002|Overall Study|Lack of Efficacy|1|||
28040491|NCT03684642|54698722|FG000|Overall Study|Poor compliance to protocol|0|||
28040492|NCT03684642|54698723|FG001|Overall Study|Poor compliance to protocol|4|||
28040493|NCT03684642|54698724|FG002|Overall Study|Poor compliance to protocol|1|||
28040494|NCT03684642|54698722|FG000|Overall Study|Other than specified|62|||
28040495|NCT03684642|54698723|FG001|Overall Study|Other than specified|60|||
28040496|NCT03684642|54698724|FG002|Overall Study|Other than specified|67|||
28040497|NCT03684642|54698722|FG000|Overall Study|Randomized and not treated|0|||
28040498|NCT03684642|54698723|FG001|Overall Study|Randomized and not treated|0|||
28040499|NCT03684642|54698724|FG002|Overall Study|Randomized and not treated|1|||
28040500|NCT03684642|54698722|FG000|Overall Study|Missing completion status but alive at last contact|0|||
28040501|NCT03684642|54698723|FG001|Overall Study|Missing completion status but alive at last contact|1|||
28040502|NCT03684642|54698724|FG002|Overall Study|Missing completion status but alive at last contact|2|||
28040503|NCT00519636|54698736|FG000|Treatment Period 1|Adverse Event|1|||
28040504|NCT00519636|54698737|FG001|Treatment Period 1|Adverse Event|0|||
28040505|NCT00519636|54698738|FG002|Treatment Period 1|Adverse Event|1|||
28040506|NCT00519636|54698739|FG003|Treatment Period 1|Adverse Event|0|||
28040507|NCT00519636|54698736|FG000|Treatment Period 1|Sponsor request due to missed visit|1|||
28040508|NCT00519636|54698737|FG001|Treatment Period 1|Sponsor request due to missed visit|0|||
28040509|NCT00519636|54698738|FG002|Treatment Period 1|Sponsor request due to missed visit|0|||
28040510|NCT00519636|54698739|FG003|Treatment Period 1|Sponsor request due to missed visit|0|||
28040511|NCT00519636|54698736|FG000|Washout Period|Adverse Event|2|||
28040512|NCT00519636|54698737|FG001|Washout Period|Adverse Event|1|||
28040513|NCT00519636|54698738|FG002|Washout Period|Adverse Event|1|||
28040514|NCT00519636|54698739|FG003|Washout Period|Adverse Event|0|||
28040515|NCT00519636|54698736|FG000|Washout Period|Lost to Follow-up|1|||
28040516|NCT00519636|54698737|FG001|Washout Period|Lost to Follow-up|0|||
28040517|NCT00519636|54698738|FG002|Washout Period|Lost to Follow-up|0|||
28040518|NCT00519636|54698739|FG003|Washout Period|Lost to Follow-up|0|||
28040519|NCT00519636|54698736|FG000|Washout Period|Protocol Violation|0|||
28040520|NCT00519636|54698737|FG001|Washout Period|Protocol Violation|0|||
28040521|NCT00519636|54698738|FG002|Washout Period|Protocol Violation|1|||
28040522|NCT00519636|54698739|FG003|Washout Period|Protocol Violation|2|||
28040523|NCT00519636|54698736|FG000|Washout Period|Withdrawal by Subject|1|||
28040524|NCT00519636|54698737|FG001|Washout Period|Withdrawal by Subject|0|||
28040525|NCT00519636|54698738|FG002|Washout Period|Withdrawal by Subject|1|||
28040526|NCT00519636|54698739|FG003|Washout Period|Withdrawal by Subject|0|||
28040527|NCT00519636|54698736|FG000|Washout Period|Failed to meet continuation criteria|14|||
28040528|NCT00519636|54698737|FG001|Washout Period|Failed to meet continuation criteria|11|||
28040529|NCT00519636|54698738|FG002|Washout Period|Failed to meet continuation criteria|9|||
28040530|NCT00519636|54698739|FG003|Washout Period|Failed to meet continuation criteria|3|||
28040531|NCT00519636|54698736|FG000|Washout Period|Out of pollen area > 48 hours|1|||
28040532|NCT00519636|54698737|FG001|Washout Period|Out of pollen area > 48 hours|0|||
28040533|NCT00519636|54698738|FG002|Washout Period|Out of pollen area > 48 hours|0|||
28040534|NCT00519636|54698739|FG003|Washout Period|Out of pollen area > 48 hours|0|||
28040535|NCT00519636|54698736|FG000|Washout Period|Participating in study at another site|1|||
28040536|NCT00519636|54698737|FG001|Washout Period|Participating in study at another site|0|||
28040537|NCT00519636|54698738|FG002|Washout Period|Participating in study at another site|0|||
28040538|NCT00519636|54698739|FG003|Washout Period|Participating in study at another site|0|||
28040539|NCT00519636|54698736|FG000|Washout Period|Non-compliant|0|||
28040540|NCT00519636|54698737|FG001|Washout Period|Non-compliant|1|||
28040541|NCT00519636|54698738|FG002|Washout Period|Non-compliant|0|||
28040542|NCT00519636|54698739|FG003|Washout Period|Non-compliant|0|||
28040543|NCT00519636|54698736|FG000|Washout Period|Per doctors request|0|||
28040544|NCT00519636|54698737|FG001|Washout Period|Per doctors request|1|||
28040545|NCT00519636|54698738|FG002|Washout Period|Per doctors request|0|||
28040546|NCT00519636|54698739|FG003|Washout Period|Per doctors request|0|||
28040547|NCT00519636|54698736|FG000|Washout Period|Subject randomized in error|0|||
28040548|NCT00519636|54698737|FG001|Washout Period|Subject randomized in error|0|||
28040549|NCT00519636|54698738|FG002|Washout Period|Subject randomized in error|1|||
28040550|NCT00519636|54698739|FG003|Washout Period|Subject randomized in error|0|||
28040551|NCT00519636|54698736|FG000|Washout Period|Prohibited medications|0|||
27810578|NCT01744665|54266405|FG000|Consolidation Phase|Withdrawal by Subject|4|||
27810579|NCT01744665|54266405|FG000|Consolidation Phase|Administrative problems|9|||
27810580|NCT01744665|54266405|FG000|Re-initiation Phase|Administrative problems|10|||
27810581|NCT01744665|54266405|FG000|Re-initiation Phase|Adverse Event|1|||
27810582|NCT01744665|54266405|FG000|Re-initiation Phase|No longer required treatment|1|||
27810583|NCT01744665|54266405|FG000|Re-initiation Phase|Withdrawal by Subject|1|||
27810584|NCT01744197|54266414|FG000|Overall Study|Received 1 patch|2|||
27810585|NCT01744197|54266415|FG001|Overall Study|Received 1 patch|1|||
28040552|NCT00519636|54698737|FG001|Washout Period|Prohibited medications|0|||
27810586|NCT01744197|54266414|FG000|Overall Study|No patch received|2|||
27810587|NCT01744197|54266415|FG001|Overall Study|No patch received|2|||
27810588|NCT01732107|54266421|FG000|Overall Study|Adverse Event|2|||
27810589|NCT01732107|54266421|FG000|Overall Study|Disease Progression|8|||
27810590|NCT01732107|54266421|FG000|Overall Study|Physician Decision|1|||
27810591|NCT01732107|54266421|FG000|Overall Study|Withdrawal by Subject|2|||
27810592|NCT01743027|54266429|FG000|Overall Study|Adverse Event|2|||
27810593|NCT01743027|54266430|FG001|Overall Study|Adverse Event|0|||
27810594|NCT01743027|54266431|FG002|Overall Study|Adverse Event|0|||
27810595|NCT01743027|54266432|FG003|Overall Study|Adverse Event|0|||
27810596|NCT01743027|54266429|FG000|Overall Study|Lost to Follow-up|0|||
27810597|NCT01743027|54266430|FG001|Overall Study|Lost to Follow-up|0|||
27810598|NCT01743027|54266431|FG002|Overall Study|Lost to Follow-up|2|||
28040553|NCT00519636|54698738|FG002|Washout Period|Prohibited medications|1|||
28040554|NCT00519636|54698739|FG003|Washout Period|Prohibited medications|0|||
28040555|NCT00519636|54698736|FG000|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
28040556|NCT00519636|54698737|FG001|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
28040557|NCT00519636|54698738|FG002|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
28040558|NCT00519636|54698739|FG003|Treatment Period 2|Failed To Meet Continuation Criteria|1|||
28040559|NCT00519636|54698736|FG000|Treatment Period 2|Subject randomized in error|0|||
28040560|NCT00519636|54698737|FG001|Treatment Period 2|Subject randomized in error|1|||
28040561|NCT00519636|54698738|FG002|Treatment Period 2|Subject randomized in error|0|||
28040562|NCT00519636|54698739|FG003|Treatment Period 2|Subject randomized in error|0|||
28040563|NCT00519636|54698736|FG000|Treatment Period 2|Per doctors request|0|||
28040564|NCT00519636|54698737|FG001|Treatment Period 2|Per doctors request|0|||
28040565|NCT00519636|54698738|FG002|Treatment Period 2|Per doctors request|1|||
28040566|NCT00519636|54698739|FG003|Treatment Period 2|Per doctors request|0|||
28040567|NCT00519636|54698736|FG000|Treatment Period 2|Subject misrandomized|0|||
28040568|NCT00519636|54698737|FG001|Treatment Period 2|Subject misrandomized|0|||
28040569|NCT00519636|54698738|FG002|Treatment Period 2|Subject misrandomized|0|||
28040570|NCT00519636|54698739|FG003|Treatment Period 2|Subject misrandomized|1|||
28040571|NCT00519636|54698736|FG000|Post Study Period|Subject randomized in error|0|||
28040572|NCT00519636|54698737|FG001|Post Study Period|Subject randomized in error|0|||
28040573|NCT00519636|54698738|FG002|Post Study Period|Subject randomized in error|0|||
28040574|NCT00519636|54698739|FG003|Post Study Period|Subject randomized in error|1|||
28040575|NCT00618371|54698753|FG000|Overall Study|Withdrawal by Subject|2|||
28040576|NCT00526890|54698758|FG000|Overall Study|Adverse Event|2|||
28040577|NCT03864900|54698764|FG000|Overall Study|Withdrawal by Subject|1|||
28040578|NCT03864900|54698765|FG001|Overall Study|Withdrawal by Subject|1|||
28040579|NCT03864900|54698764|FG000|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|2|||
28040580|NCT03864900|54698765|FG001|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|5|||
28040581|NCT00526656|54698771|FG000|Overall Study|Death|1|||
28040582|NCT00526656|54698771|FG000|Overall Study|Refused surgery|1|||
28040583|NCT00617903|54698778|FG000|Overall Study|Withdrawal by Subject|2|||
28040584|NCT00617903|54698779|FG001|Overall Study|Withdrawal by Subject|3|||
28040585|NCT00617903|54698778|FG000|Overall Study|Lost to Follow-up|1|||
28040586|NCT00617903|54698779|FG001|Overall Study|Lost to Follow-up|1|||
28040587|NCT00617903|54698778|FG000|Overall Study|Lack of Efficacy|0|||
28040588|NCT00617903|54698779|FG001|Overall Study|Lack of Efficacy|1|||
28040589|NCT00617903|54698778|FG000|Overall Study|Adverse Event|0|||
28040590|NCT00617903|54698779|FG001|Overall Study|Adverse Event|1|||
28040591|NCT00617903|54698778|FG000|Overall Study|noncompliance|0|||
28040592|NCT00617903|54698779|FG001|Overall Study|noncompliance|1|||
28040593|NCT00526110|54698787|FG000|Overall Study|Adverse Event|2|||
27810599|NCT01743027|54266432|FG003|Overall Study|Lost to Follow-up|0|||
27810600|NCT01743027|54266429|FG000|Overall Study|Progressive Disease|1|||
27810601|NCT01743027|54266430|FG001|Overall Study|Progressive Disease|4|||
27847924|NCT00218543|54340662|FG000|Overall Study|Withdrawal by Subject|1|||
27939875|NCT01081912|54596202|FG001|Maintenance Treatment|Withdrawal by Subject|5|||
28040594|NCT00526110|54698788|FG001|Overall Study|Adverse Event|9|||
28040595|NCT00526110|54698787|FG000|Overall Study|Disease Progression|0|||
28040596|NCT00526110|54698788|FG001|Overall Study|Disease Progression|19|||
27810602|NCT01743027|54266431|FG002|Overall Study|Progressive Disease|3|||
27810603|NCT01743027|54266432|FG003|Overall Study|Progressive Disease|0|||
27939876|NCT01081912|54596203|FG002|Maintenance Treatment|Withdrawal by Subject|5|||
28040597|NCT00526110|54698787|FG000|Overall Study|Maximal Response|0|||
28040598|NCT00526110|54698788|FG001|Overall Study|Maximal Response|6|||
28040599|NCT00526110|54698787|FG000|Overall Study|Withdrawal by Subject|0|||
28040600|NCT00526110|54698788|FG001|Overall Study|Withdrawal by Subject|2|||
28040601|NCT00526110|54698787|FG000|Overall Study|Poor Tolerance|0|||
28040602|NCT00526110|54698788|FG001|Overall Study|Poor Tolerance|5|||
28040603|NCT00512148|54698794|FG000|Primay Study Period|Withdrawal by Subject|1|||
28040604|NCT00511836|54698802|FG000|Double-blind Period|Lost to Follow-up|1|||
28040605|NCT00511836|54698803|FG001|Double-blind Period|Lost to Follow-up|0|||
28040606|NCT00573755|54698812|FG000|Overall Study|Still receiving treatment|1|||
28040607|NCT00573755|54698813|FG001|Overall Study|Still receiving treatment|0|||
28040608|NCT00524316|54698819|FG000|Overall Study|Withdrawal by Subject|2|||
28040609|NCT00524316|54698819|FG000|Overall Study|Adverse Event|7|||
28040610|NCT00524316|54698819|FG000|Overall Study|Disease Progression|7|||
28040611|NCT03861936|54698836|FG000|Overall Study|Withdrawal by Subject|4|||
28040612|NCT03861936|54698837|FG001|Overall Study|Withdrawal by Subject|1|||
28040613|NCT03861936|54698838|FG002|Overall Study|Withdrawal by Subject|3|||
28040614|NCT03861936|54698836|FG000|Overall Study|Lost to Follow-up|5|||
28040615|NCT03861936|54698837|FG001|Overall Study|Lost to Follow-up|3|||
28040616|NCT03861936|54698838|FG002|Overall Study|Lost to Follow-up|3|||
28040617|NCT03861936|54698836|FG000|Overall Study|Physician Decision|0|||
28040618|NCT03861936|54698837|FG001|Overall Study|Physician Decision|1|||
28040619|NCT03861936|54698838|FG002|Overall Study|Physician Decision|0|||
28040620|NCT03861936|54698836|FG000|Overall Study|Protocol Deviation|0|||
28040621|NCT03861936|54698837|FG001|Overall Study|Protocol Deviation|0|||
28040622|NCT03861936|54698838|FG002|Overall Study|Protocol Deviation|1|||
28040623|NCT03861936|54698836|FG000|Overall Study|Reason not Specified|5|||
28040624|NCT03861936|54698837|FG001|Overall Study|Reason not Specified|5|||
28040625|NCT03861936|54698838|FG002|Overall Study|Reason not Specified|3|||
28040626|NCT00434577|54698851|FG000|Months 0-3|Serious Adverse Event|0|||
28040627|NCT00434577|54698852|FG001|Months 0-3|Serious Adverse Event|0|||
28040628|NCT00434577|54698853|FG002|Months 0-3|Serious Adverse Event|1|||
28040629|NCT00434577|54698854|FG003|Months 0-3|Serious Adverse Event|0|||
28040630|NCT00434577|54698855|FG004|Months 0-3|Serious Adverse Event|0|||
28040631|NCT00434577|54698851|FG000|Months 0-3|Adverse Event|0|||
28040632|NCT00434577|54698852|FG001|Months 0-3|Adverse Event|1|||
28040633|NCT00434577|54698853|FG002|Months 0-3|Adverse Event|1|||
28040634|NCT00434577|54698854|FG003|Months 0-3|Adverse Event|0|||
28040635|NCT00434577|54698855|FG004|Months 0-3|Adverse Event|0|||
28040636|NCT00434577|54698851|FG000|Months 0-3|Lost to Follow-up|0|||
28040637|NCT00434577|54698852|FG001|Months 0-3|Lost to Follow-up|0|||
28040638|NCT00434577|54698853|FG002|Months 0-3|Lost to Follow-up|0|||
28040639|NCT00434577|54698854|FG003|Months 0-3|Lost to Follow-up|0|||
28040640|NCT00434577|54698855|FG004|Months 0-3|Lost to Follow-up|2|||
28040641|NCT00434577|54698851|FG000|Months 0-3|Protocol Violation|1|||
28040642|NCT00434577|54698852|FG001|Months 0-3|Protocol Violation|0|||
28040643|NCT00434577|54698853|FG002|Months 0-3|Protocol Violation|1|||
28040644|NCT00434577|54698854|FG003|Months 0-3|Protocol Violation|0|||
28040645|NCT00434577|54698855|FG004|Months 0-3|Protocol Violation|0|||
28040646|NCT00434577|54698851|FG000|Months 0-3|Withdrawal by Subject|2|||
28040647|NCT00434577|54698852|FG001|Months 0-3|Withdrawal by Subject|1|||
28040648|NCT00434577|54698853|FG002|Months 0-3|Withdrawal by Subject|1|||
28040649|NCT00434577|54698854|FG003|Months 0-3|Withdrawal by Subject|1|||
28040650|NCT00434577|54698855|FG004|Months 0-3|Withdrawal by Subject|1|||
28040651|NCT00434421|54698867|FG000|Overall Study|Withdrawal by Subject|1|||
28040652|NCT00434421|54698867|FG000|Overall Study|Non-compliance with study treatment|1|||
28040653|NCT00421707|54698873|FG000|Period 1: Treatment Period 1|Withdrawal by Subject|1|||
28040654|NCT00421707|54698874|FG001|Period 1: Treatment Period 1|Withdrawal by Subject|5|||
28040655|NCT00421707|54698873|FG000|Period 1: Treatment Period 1|Adverse Event|7|||
28040656|NCT00421707|54698874|FG001|Period 1: Treatment Period 1|Adverse Event|2|||
28040657|NCT00421707|54698873|FG000|Period 1: Treatment Period 1|Lost to Follow-up|2|||
28040658|NCT00421707|54698874|FG001|Period 1: Treatment Period 1|Lost to Follow-up|2|||
28040659|NCT00421707|54698873|FG000|Period 1: Treatment Period 1|Protocol Violation|1|||
28040660|NCT00421707|54698874|FG001|Period 1: Treatment Period 1|Protocol Violation|0|||
28040661|NCT00421707|54698873|FG000|Period 2: Washout|Adverse Event|1|||
28040662|NCT00421707|54698874|FG001|Period 2: Washout|Adverse Event|1|||
28040663|NCT00421707|54698873|FG000|Period 2: Washout|Withdrawal by Subject|0|||
28040664|NCT00421707|54698874|FG001|Period 2: Washout|Withdrawal by Subject|1|||
28040665|NCT00421707|54698873|FG000|Period 2: Washout|Lost to Follow-up|0|||
28040666|NCT00421707|54698874|FG001|Period 2: Washout|Lost to Follow-up|1|||
28040667|NCT00421707|54698873|FG000|Period 2: Washout|Other: Pregnancy|0|||
28040668|NCT00421707|54698874|FG001|Period 2: Washout|Other: Pregnancy|1|||
28040669|NCT00421707|54698873|FG000|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
28040670|NCT00421707|54698874|FG001|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
28040671|NCT00421707|54698873|FG000|Period 3:Treatment Period 2|Protocol Violation|1|||
28040672|NCT00421707|54698874|FG001|Period 3:Treatment Period 2|Protocol Violation|0|||
28040673|NCT00421707|54698873|FG000|Period 3:Treatment Period 2|Adverse Event|0|||
28040674|NCT00421707|54698874|FG001|Period 3:Treatment Period 2|Adverse Event|2|||
28040675|NCT00518622|54698900|FG000|Overall Study|Lost to Follow-up|0|||
28040676|NCT00518622|54698901|FG001|Overall Study|Lost to Follow-up|0|||
28040677|NCT00518622|54698902|FG002|Overall Study|Lost to Follow-up|1|||
28040678|NCT00518622|54698903|FG003|Overall Study|Lost to Follow-up|0|||
28040679|NCT00518622|54698904|FG004|Overall Study|Lost to Follow-up|0|||
28040680|NCT00518622|54698905|FG005|Overall Study|Lost to Follow-up|0|||
28040681|NCT00518622|54698906|FG006|Overall Study|Lost to Follow-up|0|||
28040682|NCT00518622|54698907|FG007|Overall Study|Lost to Follow-up|0|||
28040683|NCT00518622|54698900|FG000|Overall Study|Study medication taken incorrectly|0|||
28040684|NCT00518622|54698901|FG001|Overall Study|Study medication taken incorrectly|1|||
28040685|NCT00518622|54698902|FG002|Overall Study|Study medication taken incorrectly|0|||
28040686|NCT00518622|54698903|FG003|Overall Study|Study medication taken incorrectly|0|||
28040687|NCT00518622|54698904|FG004|Overall Study|Study medication taken incorrectly|0|||
28040688|NCT00518622|54698905|FG005|Overall Study|Study medication taken incorrectly|0|||
28040689|NCT00518622|54698906|FG006|Overall Study|Study medication taken incorrectly|0|||
28040690|NCT00518622|54698907|FG007|Overall Study|Study medication taken incorrectly|0|||
28040691|NCT03783078|54698925|FG000|Overall Study|Participants Ongoing|29|||
28040692|NCT03783078|54698925|FG000|Overall Study|Death|26|||
28040693|NCT00517296|54698931|FG000|Overall Study|Withdrawal by Subject|1|||
28040694|NCT00517296|54698932|FG001|Overall Study|Withdrawal by Subject|0|||
28040695|NCT00516906|54698940|FG000|Overall Study|Final Dressing Removal Data not captured|6|||
28040696|NCT00516906|54698941|FG001|Overall Study|Final Dressing Removal Data not captured|2|||
28040697|NCT00523848|54698947|FG000|Overall Study|Adverse Event|11|||
28040698|NCT00523848|54698947|FG000|Overall Study|Withdrawal by Subject|2|||
28040699|NCT00523848|54698947|FG000|Overall Study|NOT TREATED (Became ineligible)|2|||
28040700|NCT00523848|54698947|FG000|Overall Study|Disease Progression|5|||
28040701|NCT00523848|54698947|FG000|Overall Study|Other, unspecified|4|||
28040702|NCT00617669|54698953|FG000|Overall Study|Withdrawal by Subject|71|||
28040703|NCT00617669|54698954|FG001|Overall Study|Withdrawal by Subject|77|||
28040704|NCT00617669|54698953|FG000|Overall Study|Lost to Follow-up|3|||
28040705|NCT00617669|54698954|FG001|Overall Study|Lost to Follow-up|2|||
28040706|NCT00617669|54698953|FG000|Overall Study|Adverse Event|87|||
28040707|NCT00617669|54698954|FG001|Overall Study|Adverse Event|76|||
28040708|NCT00617669|54698953|FG000|Overall Study|Protocol Violation|2|||
28040709|NCT00617669|54698954|FG001|Overall Study|Protocol Violation|3|||
28040710|NCT00617669|54698953|FG000|Overall Study|Reason not otherwise captured, eg; death|265|||
28040711|NCT00617669|54698954|FG001|Overall Study|Reason not otherwise captured, eg; death|290|||
28040712|NCT00617669|54698953|FG000|Overall Study|Patients randomized but not treated|2|||
28040713|NCT00617669|54698954|FG001|Overall Study|Patients randomized but not treated|3|||
28040714|NCT03682848|54698960|FG000|Overall Study|Withdrawal by Subject|2|||
28040715|NCT03682848|54698960|FG000|Overall Study|Site closed|5|||
28040716|NCT03682848|54698960|FG000|Overall Study|Protocol Deviation|1|||
28040717|NCT03682848|54698960|FG000|Overall Study|Adverse Event|1|||
28040718|NCT00510510|54698967|FG000|Overall Study|Adverse Event|4|||
28040719|NCT00510510|54698968|FG001|Overall Study|Adverse Event|3|||
28040720|NCT00510510|54698969|FG002|Overall Study|Adverse Event|6|||
28040721|NCT00510510|54698967|FG000|Overall Study|Lack of Efficacy|0|||
28040722|NCT00510510|54698968|FG001|Overall Study|Lack of Efficacy|1|||
28040723|NCT00510510|54698969|FG002|Overall Study|Lack of Efficacy|1|||
28040724|NCT00510510|54698967|FG000|Overall Study|Subjects no longer requires study drug|0|||
28040725|NCT00510510|54698968|FG001|Overall Study|Subjects no longer requires study drug|0|||
28040726|NCT00510510|54698969|FG002|Overall Study|Subjects no longer requires study drug|2|||
28040727|NCT00510510|54698967|FG000|Overall Study|Withdrawal by Subject|1|||
28040728|NCT00510510|54698968|FG001|Overall Study|Withdrawal by Subject|2|||
28040729|NCT00510510|54698969|FG002|Overall Study|Withdrawal by Subject|3|||
28040730|NCT00510510|54698967|FG000|Overall Study|Lost to Follow-up|0|||
28040731|NCT00510510|54698968|FG001|Overall Study|Lost to Follow-up|0|||
28040732|NCT00510510|54698969|FG002|Overall Study|Lost to Follow-up|1|||
28040733|NCT00510510|54698967|FG000|Overall Study|Protocol Violation|0|||
28040734|NCT00510510|54698968|FG001|Overall Study|Protocol Violation|3|||
28040735|NCT00510510|54698969|FG002|Overall Study|Protocol Violation|4|||
28040736|NCT00617591|54698977|FG000|Overall Study|Withdrew consent during Induction|4|||
28040737|NCT00617591|54698977|FG000|Overall Study|Withdrew consent during Maintenance|6|||
28040738|NCT00510276|54698984|FG000|Acute Double-Blind Phase|Adverse Event|21|||
28040739|NCT00510276|54698985|FG001|Acute Double-Blind Phase|Adverse Event|6|||
28040740|NCT00510276|54698984|FG000|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
28040741|NCT00510276|54698985|FG001|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
28040742|NCT00510276|54698984|FG000|Acute Double-Blind Phase|Lack of Efficacy|3|||
28040743|NCT00510276|54698985|FG001|Acute Double-Blind Phase|Lack of Efficacy|4|||
28040744|NCT00510276|54698984|FG000|Acute Double-Blind Phase|Lost to Follow-up|48|||
28040745|NCT00510276|54698985|FG001|Acute Double-Blind Phase|Lost to Follow-up|49|||
28040746|NCT00510276|54698984|FG000|Acute Double-Blind Phase|Physician Decision|0|||
28040747|NCT00510276|54698985|FG001|Acute Double-Blind Phase|Physician Decision|3|||
28040748|NCT00510276|54698984|FG000|Acute Double-Blind Phase|Protocol Violation|4|||
28040749|NCT00510276|54698985|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
28040750|NCT00510276|54698984|FG000|Acute Double-Blind Phase|Sponsor Decision|2|||
28040751|NCT00510276|54698985|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
28040752|NCT00510276|54698984|FG000|Acute Double-Blind Phase|Subject Decision|26|||
28040753|NCT00510276|54698985|FG001|Acute Double-Blind Phase|Subject Decision|28|||
28040754|NCT00510276|54698984|FG000|Extension Open-Label Phase|Adverse Event|9|||
28040755|NCT00510276|54698985|FG001|Extension Open-Label Phase|Adverse Event|18|||
28040756|NCT00510276|54698984|FG000|Extension Open-Label Phase|Lack of Efficacy|2|||
28040757|NCT00510276|54698985|FG001|Extension Open-Label Phase|Lack of Efficacy|7|||
28040758|NCT00510276|54698984|FG000|Extension Open-Label Phase|Lost to Follow-up|12|||
28040759|NCT00510276|54698985|FG001|Extension Open-Label Phase|Lost to Follow-up|10|||
28040760|NCT00510276|54698984|FG000|Extension Open-Label Phase|Physician Decision|2|||
28040761|NCT00510276|54698985|FG001|Extension Open-Label Phase|Physician Decision|3|||
28040762|NCT00510276|54698984|FG000|Extension Open-Label Phase|Protocol Violation|0|||
28040763|NCT00510276|54698985|FG001|Extension Open-Label Phase|Protocol Violation|1|||
28040764|NCT00510276|54698984|FG000|Extension Open-Label Phase|Sponsor Decision|1|||
28040765|NCT00510276|54698985|FG001|Extension Open-Label Phase|Sponsor Decision|0|||
28040766|NCT00510276|54698984|FG000|Extension Open-Label Phase|Subject Decision|7|||
28040767|NCT00510276|54698985|FG001|Extension Open-Label Phase|Subject Decision|9|||
28040768|NCT00616655|54699001|FG000|Overall Study|Adverse Event|10|||
28040769|NCT00616655|54699002|FG001|Overall Study|Adverse Event|7|||
28040770|NCT00616655|54699003|FG002|Overall Study|Adverse Event|12|||
28040771|NCT00616655|54699001|FG000|Overall Study|Lack of Efficacy|5|||
28040772|NCT00616655|54699002|FG001|Overall Study|Lack of Efficacy|5|||
28040773|NCT00616655|54699003|FG002|Overall Study|Lack of Efficacy|5|||
28040774|NCT00616655|54699001|FG000|Overall Study|Lost to Follow-up|3|||
28040775|NCT00616655|54699002|FG001|Overall Study|Lost to Follow-up|12|||
28040776|NCT00616655|54699003|FG002|Overall Study|Lost to Follow-up|10|||
28040777|NCT00616655|54699001|FG000|Overall Study|Protocol Violation|2|||
28040778|NCT00616655|54699002|FG001|Overall Study|Protocol Violation|4|||
28040779|NCT00616655|54699003|FG002|Overall Study|Protocol Violation|3|||
28040780|NCT00616655|54699001|FG000|Overall Study|Withdrawal by Subject|9|||
28040781|NCT00616655|54699002|FG001|Overall Study|Withdrawal by Subject|7|||
28040782|NCT00616655|54699003|FG002|Overall Study|Withdrawal by Subject|11|||
28040783|NCT00616655|54699001|FG000|Overall Study|Does not meet in/ex criteria|0|||
28040784|NCT00616655|54699002|FG001|Overall Study|Does not meet in/ex criteria|0|||
28040785|NCT00616655|54699003|FG002|Overall Study|Does not meet in/ex criteria|2|||
28040786|NCT00616655|54699001|FG000|Overall Study|Other|6|||
28040787|NCT00616655|54699002|FG001|Overall Study|Other|6|||
28040788|NCT00616655|54699003|FG002|Overall Study|Other|5|||
28040789|NCT00510198|54699013|FG000|Overall Study|Withdrawal by Subject|5|||
28040790|NCT00510198|54699014|FG001|Overall Study|Withdrawal by Subject|4|||
28040791|NCT00516048|54699024|FG000|Overall Study|Death|0|||
28040792|NCT00516048|54699025|FG001|Overall Study|Death|0|||
28040793|NCT00516048|54699026|FG002|Overall Study|Death|1|||
28040794|NCT00516048|54699024|FG000|Overall Study|Subject Decision|0|||
28040795|NCT00516048|54699025|FG001|Overall Study|Subject Decision|2|||
28040796|NCT00516048|54699026|FG002|Overall Study|Subject Decision|0|||
28040797|NCT00617357|54699034|FG000|Overall Study|Lost to Follow-up|7|||
28040798|NCT00617357|54699034|FG000|Overall Study|Death|5|||
28040799|NCT00617357|54699034|FG000|Overall Study|insurance concerns|2|||
28040800|NCT00617357|54699034|FG000|Overall Study|Withdrawal by Subject|1|||
28040801|NCT00617357|54699034|FG000|Overall Study|Physician Decision|1|||
28040802|NCT00420927|54699046|FG000|Period 1|Adverse Event|19|||
28040803|NCT00420927|54699047|FG001|Period 1|Adverse Event|15|||
28040804|NCT00420927|54699048|FG002|Period 1|Adverse Event|0|||
28040805|NCT00420927|54699049|FG003|Period 1|Adverse Event|0|||
27810604|NCT01743027|54266429|FG000|Overall Study|Protocol Violation|1|||
28040806|NCT00420927|54699050|FG004|Period 1|Adverse Event|0|||
28040807|NCT00420927|54699051|FG005|Period 1|Adverse Event|0|||
28040808|NCT00420927|54699052|FG006|Period 1|Adverse Event|0|||
28040809|NCT00420927|54699046|FG000|Period 1|Withdrawal by Subject|7|||
28040810|NCT00420927|54699047|FG001|Period 1|Withdrawal by Subject|12|||
28040811|NCT00420927|54699048|FG002|Period 1|Withdrawal by Subject|0|||
28040812|NCT00420927|54699049|FG003|Period 1|Withdrawal by Subject|0|||
28040813|NCT00420927|54699050|FG004|Period 1|Withdrawal by Subject|0|||
28040814|NCT00420927|54699051|FG005|Period 1|Withdrawal by Subject|0|||
28040815|NCT00420927|54699052|FG006|Period 1|Withdrawal by Subject|0|||
28040816|NCT00420927|54699046|FG000|Period 1|Lost to Follow-up|8|||
28040817|NCT00420927|54699047|FG001|Period 1|Lost to Follow-up|6|||
28040818|NCT00420927|54699048|FG002|Period 1|Lost to Follow-up|0|||
28040819|NCT00420927|54699049|FG003|Period 1|Lost to Follow-up|0|||
28040820|NCT00420927|54699050|FG004|Period 1|Lost to Follow-up|0|||
28040821|NCT00420927|54699051|FG005|Period 1|Lost to Follow-up|0|||
28040822|NCT00420927|54699052|FG006|Period 1|Lost to Follow-up|0|||
28040823|NCT00420927|54699046|FG000|Period 1|Lack of efficacy/Loss of efficacy|1|||
28040824|NCT00420927|54699047|FG001|Period 1|Lack of efficacy/Loss of efficacy|6|||
28040825|NCT00420927|54699048|FG002|Period 1|Lack of efficacy/Loss of efficacy|0|||
28040826|NCT00420927|54699049|FG003|Period 1|Lack of efficacy/Loss of efficacy|0|||
28040827|NCT00420927|54699050|FG004|Period 1|Lack of efficacy/Loss of efficacy|0|||
28040828|NCT00420927|54699051|FG005|Period 1|Lack of efficacy/Loss of efficacy|0|||
28040829|NCT00420927|54699052|FG006|Period 1|Lack of efficacy/Loss of efficacy|0|||
28040830|NCT00420927|54699046|FG000|Period 1|Death|2|||
28040831|NCT00420927|54699047|FG001|Period 1|Death|0|||
28040832|NCT00420927|54699048|FG002|Period 1|Death|0|||
28040833|NCT00420927|54699049|FG003|Period 1|Death|0|||
28040834|NCT00420927|54699050|FG004|Period 1|Death|0|||
28040835|NCT00420927|54699051|FG005|Period 1|Death|0|||
28040836|NCT00420927|54699052|FG006|Period 1|Death|0|||
28040837|NCT00420927|54699046|FG000|Period 1|Subject moved/relocated|0|||
28040838|NCT00420927|54699047|FG001|Period 1|Subject moved/relocated|2|||
28040839|NCT00420927|54699048|FG002|Period 1|Subject moved/relocated|0|||
28040840|NCT00420927|54699049|FG003|Period 1|Subject moved/relocated|0|||
28040841|NCT00420927|54699050|FG004|Period 1|Subject moved/relocated|0|||
28040842|NCT00420927|54699051|FG005|Period 1|Subject moved/relocated|0|||
28040843|NCT00420927|54699052|FG006|Period 1|Subject moved/relocated|0|||
28040844|NCT00420927|54699046|FG000|Period 1|Noncompliant with study drug|1|||
28040845|NCT00420927|54699047|FG001|Period 1|Noncompliant with study drug|1|||
28040846|NCT00420927|54699048|FG002|Period 1|Noncompliant with study drug|0|||
28040847|NCT00420927|54699049|FG003|Period 1|Noncompliant with study drug|0|||
28040848|NCT00420927|54699050|FG004|Period 1|Noncompliant with study drug|0|||
28040849|NCT00420927|54699051|FG005|Period 1|Noncompliant with study drug|0|||
28040850|NCT00420927|54699052|FG006|Period 1|Noncompliant with study drug|0|||
28040851|NCT00420927|54699046|FG000|Period 1|Randomization error|1|||
28040852|NCT00420927|54699047|FG001|Period 1|Randomization error|0|||
28040853|NCT00420927|54699048|FG002|Period 1|Randomization error|0|||
28040854|NCT00420927|54699049|FG003|Period 1|Randomization error|0|||
28040855|NCT00420927|54699050|FG004|Period 1|Randomization error|0|||
28040856|NCT00420927|54699051|FG005|Period 1|Randomization error|0|||
28040857|NCT00420927|54699052|FG006|Period 1|Randomization error|0|||
28040858|NCT00420927|54699046|FG000|Period 1|Suspected tuberculosis/positive test|1|||
28040859|NCT00420927|54699047|FG001|Period 1|Suspected tuberculosis/positive test|1|||
28040860|NCT00420927|54699048|FG002|Period 1|Suspected tuberculosis/positive test|0|||
28040861|NCT00420927|54699049|FG003|Period 1|Suspected tuberculosis/positive test|0|||
28040862|NCT00420927|54699050|FG004|Period 1|Suspected tuberculosis/positive test|0|||
28040863|NCT00420927|54699051|FG005|Period 1|Suspected tuberculosis/positive test|0|||
28040864|NCT00420927|54699052|FG006|Period 1|Suspected tuberculosis/positive test|0|||
28040865|NCT00420927|54699046|FG000|Period 1|Study site closure|0|||
28040866|NCT00420927|54699047|FG001|Period 1|Study site closure|1|||
28040867|NCT00420927|54699048|FG002|Period 1|Study site closure|0|||
28040868|NCT00420927|54699049|FG003|Period 1|Study site closure|0|||
28040869|NCT00420927|54699050|FG004|Period 1|Study site closure|0|||
27810605|NCT01743027|54266430|FG001|Overall Study|Protocol Violation|1|||
27810606|NCT01743027|54266431|FG002|Overall Study|Protocol Violation|1|||
28040870|NCT00420927|54699051|FG005|Period 1|Study site closure|0|||
28040871|NCT00420927|54699052|FG006|Period 1|Study site closure|0|||
28040872|NCT00420927|54699046|FG000|Period 1|Subject received new diagnosis|0|||
27810607|NCT01743027|54266432|FG003|Overall Study|Protocol Violation|0|||
28040873|NCT00420927|54699047|FG001|Period 1|Subject received new diagnosis|2|||
28040874|NCT00420927|54699048|FG002|Period 1|Subject received new diagnosis|0|||
28040875|NCT00420927|54699049|FG003|Period 1|Subject received new diagnosis|0|||
27810608|NCT01743027|54266429|FG000|Overall Study|Withdrawal by Subject|1|||
28040876|NCT00420927|54699050|FG004|Period 1|Subject received new diagnosis|0|||
28040877|NCT00420927|54699051|FG005|Period 1|Subject received new diagnosis|0|||
28040878|NCT00420927|54699052|FG006|Period 1|Subject received new diagnosis|0|||
28040879|NCT00420927|54699046|FG000|Period 1|Received wrong treatment/incorrect dose|0|||
28040880|NCT00420927|54699047|FG001|Period 1|Received wrong treatment/incorrect dose|1|||
28040881|NCT00420927|54699048|FG002|Period 1|Received wrong treatment/incorrect dose|0|||
28040882|NCT00420927|54699049|FG003|Period 1|Received wrong treatment/incorrect dose|0|||
28040883|NCT00420927|54699050|FG004|Period 1|Received wrong treatment/incorrect dose|0|||
28040884|NCT00420927|54699051|FG005|Period 1|Received wrong treatment/incorrect dose|0|||
28040885|NCT00420927|54699052|FG006|Period 1|Received wrong treatment/incorrect dose|0|||
28040886|NCT00420927|54699046|FG000|Period 1|Failed to meet entry criteria|8|||
28040887|NCT00420927|54699047|FG001|Period 1|Failed to meet entry criteria|7|||
27810609|NCT01743027|54266430|FG001|Overall Study|Withdrawal by Subject|0|||
27810610|NCT01743027|54266431|FG002|Overall Study|Withdrawal by Subject|3|||
27810611|NCT01743027|54266432|FG003|Overall Study|Withdrawal by Subject|1|||
28040888|NCT00420927|54699048|FG002|Period 1|Failed to meet entry criteria|0|||
28040889|NCT00420927|54699049|FG003|Period 1|Failed to meet entry criteria|0|||
28040890|NCT00420927|54699050|FG004|Period 1|Failed to meet entry criteria|0|||
28040891|NCT00420927|54699051|FG005|Period 1|Failed to meet entry criteria|0|||
27810612|NCT01380730|54266450|FG000|Overall Study|Death|0|||
27810613|NCT01380730|54266451|FG001|Overall Study|Death|0|||
27810614|NCT01380730|54266452|FG002|Overall Study|Death|0|||
27810615|NCT01380730|54266453|FG003|Overall Study|Death|0|||
27810616|NCT01380730|54266454|FG004|Overall Study|Death|1|||
27810617|NCT01380730|54266455|FG005|Overall Study|Death|0|||
27810618|NCT01380730|54266456|FG006|Overall Study|Death|0|||
28040892|NCT00420927|54699052|FG006|Period 1|Failed to meet entry criteria|0|||
28040893|NCT00420927|54699046|FG000|Period 1|Took prohibited medication|1|||
28040894|NCT00420927|54699047|FG001|Period 1|Took prohibited medication|3|||
28040895|NCT00420927|54699048|FG002|Period 1|Took prohibited medication|0|||
28040896|NCT00420927|54699049|FG003|Period 1|Took prohibited medication|0|||
28040897|NCT00420927|54699050|FG004|Period 1|Took prohibited medication|0|||
28040898|NCT00420927|54699051|FG005|Period 1|Took prohibited medication|0|||
28040899|NCT00420927|54699052|FG006|Period 1|Took prohibited medication|0|||
28040900|NCT00420927|54699046|FG000|Period 2|Adverse Event|0|||
28040901|NCT00420927|54699047|FG001|Period 2|Adverse Event|0|||
28040902|NCT00420927|54699048|FG002|Period 2|Adverse Event|7|||
28040903|NCT00420927|54699049|FG003|Period 2|Adverse Event|3|||
28040904|NCT00420927|54699050|FG004|Period 2|Adverse Event|17|||
28040905|NCT00420927|54699051|FG005|Period 2|Adverse Event|6|||
28040906|NCT00420927|54699052|FG006|Period 2|Adverse Event|20|||
28040907|NCT00420927|54699046|FG000|Period 2|Withdrawal by Subject|0|||
28040908|NCT00420927|54699047|FG001|Period 2|Withdrawal by Subject|0|||
28040909|NCT00420927|54699048|FG002|Period 2|Withdrawal by Subject|1|||
28040910|NCT00420927|54699049|FG003|Period 2|Withdrawal by Subject|3|||
28040911|NCT00420927|54699050|FG004|Period 2|Withdrawal by Subject|11|||
28040912|NCT00420927|54699051|FG005|Period 2|Withdrawal by Subject|2|||
28040913|NCT00420927|54699052|FG006|Period 2|Withdrawal by Subject|12|||
28040914|NCT00420927|54699046|FG000|Period 2|Lost to Follow-up|0|||
28040915|NCT00420927|54699047|FG001|Period 2|Lost to Follow-up|0|||
28040916|NCT00420927|54699048|FG002|Period 2|Lost to Follow-up|2|||
28040917|NCT00420927|54699049|FG003|Period 2|Lost to Follow-up|2|||
28040918|NCT00420927|54699050|FG004|Period 2|Lost to Follow-up|6|||
28040919|NCT00420927|54699051|FG005|Period 2|Lost to Follow-up|3|||
28040920|NCT00420927|54699052|FG006|Period 2|Lost to Follow-up|9|||
28040921|NCT00420927|54699046|FG000|Period 2|Lack of efficacy/Loss of efficacy|0|||
28040922|NCT00420927|54699047|FG001|Period 2|Lack of efficacy/Loss of efficacy|0|||
28040923|NCT00420927|54699048|FG002|Period 2|Lack of efficacy/Loss of efficacy|2|||
28040924|NCT00420927|54699049|FG003|Period 2|Lack of efficacy/Loss of efficacy|1|||
28040925|NCT00420927|54699050|FG004|Period 2|Lack of efficacy/Loss of efficacy|6|||
28040926|NCT00420927|54699051|FG005|Period 2|Lack of efficacy/Loss of efficacy|2|||
28040927|NCT00420927|54699052|FG006|Period 2|Lack of efficacy/Loss of efficacy|6|||
28040928|NCT00420927|54699046|FG000|Period 2|Received wrong treatment/incorrect dose|0|||
28040929|NCT00420927|54699047|FG001|Period 2|Received wrong treatment/incorrect dose|0|||
28040930|NCT00420927|54699048|FG002|Period 2|Received wrong treatment/incorrect dose|0|||
28040931|NCT00420927|54699049|FG003|Period 2|Received wrong treatment/incorrect dose|0|||
28040932|NCT00420927|54699050|FG004|Period 2|Received wrong treatment/incorrect dose|0|||
27939877|NCT01081912|54596201|FG000|Maintenance Treatment|Non-Compliance|0|||
27939878|NCT01081912|54596202|FG001|Maintenance Treatment|Non-Compliance|4|||
28040933|NCT00420927|54699051|FG005|Period 2|Received wrong treatment/incorrect dose|0|||
28040934|NCT00420927|54699052|FG006|Period 2|Received wrong treatment/incorrect dose|1|||
28040935|NCT00420927|54699046|FG000|Period 2|Subject unable to find transportation|0|||
28040936|NCT00420927|54699047|FG001|Period 2|Subject unable to find transportation|0|||
28040937|NCT00420927|54699048|FG002|Period 2|Subject unable to find transportation|0|||
28040938|NCT00420927|54699049|FG003|Period 2|Subject unable to find transportation|0|||
28040939|NCT00420927|54699050|FG004|Period 2|Subject unable to find transportation|0|||
27810619|NCT01380730|54266457|FG007|Overall Study|Death|0|||
27810620|NCT01395784|54266475|FG000|Overall Study|Lost to Follow-up|7|||
27939879|NCT01081912|54596203|FG002|Maintenance Treatment|Non-Compliance|7|||
28040940|NCT00420927|54699051|FG005|Period 2|Subject unable to find transportation|0|||
28040941|NCT00420927|54699052|FG006|Period 2|Subject unable to find transportation|1|||
28040942|NCT00420927|54699046|FG000|Period 2|Physician Decision|0|||
28040943|NCT00420927|54699047|FG001|Period 2|Physician Decision|0|||
28040944|NCT00420927|54699048|FG002|Period 2|Physician Decision|0|||
28040945|NCT00420927|54699049|FG003|Period 2|Physician Decision|0|||
28040946|NCT00420927|54699050|FG004|Period 2|Physician Decision|1|||
28040947|NCT00420927|54699051|FG005|Period 2|Physician Decision|1|||
28040948|NCT00420927|54699052|FG006|Period 2|Physician Decision|0|||
28040949|NCT00420927|54699046|FG000|Period 2|Sponsor decision|0|||
28040950|NCT00420927|54699047|FG001|Period 2|Sponsor decision|0|||
28040951|NCT00420927|54699048|FG002|Period 2|Sponsor decision|1|||
28040952|NCT00420927|54699049|FG003|Period 2|Sponsor decision|0|||
28040953|NCT00420927|54699050|FG004|Period 2|Sponsor decision|0|||
28040954|NCT00420927|54699051|FG005|Period 2|Sponsor decision|0|||
28040955|NCT00420927|54699052|FG006|Period 2|Sponsor decision|1|||
28040956|NCT00420927|54699046|FG000|Period 2|Randomization error|0|||
28040957|NCT00420927|54699047|FG001|Period 2|Randomization error|0|||
28040958|NCT00420927|54699048|FG002|Period 2|Randomization error|0|||
28040959|NCT00420927|54699049|FG003|Period 2|Randomization error|0|||
28040960|NCT00420927|54699050|FG004|Period 2|Randomization error|1|||
28040961|NCT00420927|54699051|FG005|Period 2|Randomization error|1|||
28040962|NCT00420927|54699052|FG006|Period 2|Randomization error|0|||
28040963|NCT00420927|54699046|FG000|Period 2|Noncompliant with study drug|0|||
28040964|NCT00420927|54699047|FG001|Period 2|Noncompliant with study drug|0|||
28040965|NCT00420927|54699048|FG002|Period 2|Noncompliant with study drug|0|||
28040966|NCT00420927|54699049|FG003|Period 2|Noncompliant with study drug|1|||
28040967|NCT00420927|54699050|FG004|Period 2|Noncompliant with study drug|0|||
28040968|NCT00420927|54699051|FG005|Period 2|Noncompliant with study drug|0|||
28040969|NCT00420927|54699052|FG006|Period 2|Noncompliant with study drug|2|||
28040970|NCT00420927|54699046|FG000|Period 2|Methotrexate intolerance|0|||
28040971|NCT00420927|54699047|FG001|Period 2|Methotrexate intolerance|0|||
28040972|NCT00420927|54699048|FG002|Period 2|Methotrexate intolerance|0|||
28040973|NCT00420927|54699049|FG003|Period 2|Methotrexate intolerance|0|||
28040974|NCT00420927|54699050|FG004|Period 2|Methotrexate intolerance|0|||
28040975|NCT00420927|54699051|FG005|Period 2|Methotrexate intolerance|0|||
28040976|NCT00420927|54699052|FG006|Period 2|Methotrexate intolerance|1|||
28040977|NCT00420927|54699046|FG000|Period 2|Took prohibited medication|0|||
28040978|NCT00420927|54699047|FG001|Period 2|Took prohibited medication|0|||
28040979|NCT00420927|54699048|FG002|Period 2|Took prohibited medication|0|||
28040980|NCT00420927|54699049|FG003|Period 2|Took prohibited medication|0|||
28040981|NCT00420927|54699050|FG004|Period 2|Took prohibited medication|1|||
28040982|NCT00420927|54699051|FG005|Period 2|Took prohibited medication|0|||
28040983|NCT00420927|54699052|FG006|Period 2|Took prohibited medication|0|||
28040984|NCT00573443|54699069|FG000|Double-Blind Phase|Lost to Follow-up|1|||
28040985|NCT00573443|54699070|FG001|Double-Blind Phase|Lost to Follow-up|3|||
27810621|NCT01395784|54266475|FG000|Overall Study|Withdrawal by Subject|3|||
27810622|NCT01395784|54266475|FG000|Overall Study|Physician Decision|5|||
27810623|NCT01380184|54266479|FG000|Part 1 (19 Days)|Adverse Event|1|||
27810624|NCT01380184|54266479|FG000|Part 2|Adverse Event|5|||
27810625|NCT01380184|54266479|FG000|Part 2|Disease Progression|8|||
27810626|NCT01380184|54266479|FG000|Part 2|Lost to Follow-up|1|||
27810627|NCT01395394|54266486|FG000|Baseline Study Visit|Protocol Violation|1|||
28040986|NCT00573443|54699071|FG002|Double-Blind Phase|Lost to Follow-up|2|||
28040987|NCT00573443|54699069|FG000|Double-Blind Phase|Exacerbation of MS symptoms|1|||
28040988|NCT00573443|54699070|FG001|Double-Blind Phase|Exacerbation of MS symptoms|0|||
28040989|NCT00573443|54699071|FG002|Double-Blind Phase|Exacerbation of MS symptoms|1|||
28040990|NCT00573443|54699069|FG000|Double-Blind Phase|Adverse Event|1|||
28040991|NCT00573443|54699070|FG001|Double-Blind Phase|Adverse Event|5|||
28040992|NCT00573443|54699071|FG002|Double-Blind Phase|Adverse Event|0|||
27810628|NCT01395394|54266487|FG001|Baseline Study Visit|Protocol Violation|0|||
27810629|NCT01395394|54266488|FG002|Baseline Study Visit|Protocol Violation|0|||
27810630|NCT01395316|54266496|FG000|Overall Study|Lost to Follow-up|2|||
27939880|NCT01081912|54596201|FG000|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
28040993|NCT00573443|54699069|FG000|Double-Blind Phase|Serious Adverse Event (AE)|2|||
28040994|NCT00573443|54699070|FG001|Double-Blind Phase|Serious Adverse Event (AE)|3|||
28040995|NCT00573443|54699071|FG002|Double-Blind Phase|Serious Adverse Event (AE)|1|||
28040996|NCT00573443|54699069|FG000|Double-Blind Phase|Medication refusal due to AE|2|||
28040997|NCT00573443|54699070|FG001|Double-Blind Phase|Medication refusal due to AE|2|||
28040998|NCT00573443|54699071|FG002|Double-Blind Phase|Medication refusal due to AE|0|||
28040999|NCT00573443|54699069|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
28041000|NCT00573443|54699070|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
28041001|NCT00573443|54699071|FG002|Double-Blind Phase|Withdrawal by Subject|7|||
28041002|NCT00573443|54699069|FG000|Double-Blind Phase|Protocol Violation|0|||
28041003|NCT00573443|54699070|FG001|Double-Blind Phase|Protocol Violation|2|||
27810631|NCT01395316|54266496|FG000|Overall Study|poor MRI quality|1|||
27939881|NCT01081912|54596202|FG001|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
28041004|NCT00573443|54699071|FG002|Double-Blind Phase|Protocol Violation|1|||
28041005|NCT00573443|54699069|FG000|Double-Blind Phase|Other|0|||
28041006|NCT00573443|54699070|FG001|Double-Blind Phase|Other|2|||
28041007|NCT00573443|54699071|FG002|Double-Blind Phase|Other|3|||
28041008|NCT00573443|54699069|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
28041009|NCT00573443|54699070|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
28041010|NCT00573443|54699071|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
27810632|NCT01742091|54266506|FG000|Overall Study|Adverse Event|0|||
27810633|NCT01742091|54266507|FG001|Overall Study|Adverse Event|0|||
27810634|NCT01742091|54266508|FG002|Overall Study|Adverse Event|0|||
27810635|NCT01742091|54266509|FG003|Overall Study|Adverse Event|0|||
27810636|NCT01742091|54266510|FG004|Overall Study|Adverse Event|1|||
27810637|NCT01742091|54266511|FG005|Overall Study|Adverse Event|0|||
28041011|NCT00573443|54699069|FG000|Open-Label Extension Phase|Exacerbation of MS symptoms|2|||
28041012|NCT00573443|54699070|FG001|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
28041013|NCT00573443|54699071|FG002|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
28041014|NCT00573443|54699069|FG000|Open-Label Extension Phase|Adverse Event|3|||
28041015|NCT00573443|54699070|FG001|Open-Label Extension Phase|Adverse Event|0|||
28041016|NCT00573443|54699071|FG002|Open-Label Extension Phase|Adverse Event|0|||
28041017|NCT00573443|54699069|FG000|Open-Label Extension Phase|Serious Adverse Event|5|||
27810638|NCT01742091|54266506|FG000|Overall Study|Physician Decision|0|||
27810639|NCT01742091|54266507|FG001|Overall Study|Physician Decision|0|||
27810640|NCT01742091|54266508|FG002|Overall Study|Physician Decision|0|||
28041018|NCT00573443|54699070|FG001|Open-Label Extension Phase|Serious Adverse Event|0|||
28041019|NCT00573443|54699071|FG002|Open-Label Extension Phase|Serious Adverse Event|0|||
28041020|NCT00573443|54699069|FG000|Open-Label Extension Phase|Withdrawal by Subject|3|||
28041021|NCT00573443|54699070|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
28041022|NCT00573443|54699071|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
28041023|NCT00573443|54699069|FG000|Open-Label Extension Phase|Protocol Violation|2|||
27810641|NCT01742091|54266509|FG003|Overall Study|Physician Decision|0|||
27810642|NCT01742091|54266510|FG004|Overall Study|Physician Decision|0|||
27810643|NCT01742091|54266511|FG005|Overall Study|Physician Decision|1|||
27810644|NCT01742091|54266506|FG000|Overall Study|Withdrawal by Subject|0|||
27810645|NCT01742091|54266507|FG001|Overall Study|Withdrawal by Subject|0|||
27810646|NCT01742091|54266508|FG002|Overall Study|Withdrawal by Subject|0|||
27810647|NCT01742091|54266509|FG003|Overall Study|Withdrawal by Subject|1|||
27810648|NCT01742091|54266510|FG004|Overall Study|Withdrawal by Subject|0|||
27810649|NCT01742091|54266511|FG005|Overall Study|Withdrawal by Subject|0|||
27810650|NCT01742091|54266506|FG000|Overall Study|Lost to Follow-up|0|||
27810651|NCT01742091|54266507|FG001|Overall Study|Lost to Follow-up|0|||
27810652|NCT01742091|54266508|FG002|Overall Study|Lost to Follow-up|0|||
27810653|NCT01742091|54266509|FG003|Overall Study|Lost to Follow-up|0|||
27810654|NCT01742091|54266510|FG004|Overall Study|Lost to Follow-up|0|||
27810655|NCT01742091|54266511|FG005|Overall Study|Lost to Follow-up|1|||
27810656|NCT01731951|54266531|FG000|Overall Study|Documented Disease Progression|1|||
27810657|NCT01731951|54266532|FG001|Overall Study|Documented Disease Progression|0|||
27810658|NCT01731951|54266533|FG002|Overall Study|Documented Disease Progression|0|||
27810659|NCT01731951|54266534|FG003|Overall Study|Documented Disease Progression|0|||
27810660|NCT01731951|54266535|FG004|Overall Study|Documented Disease Progression|0|||
28041024|NCT00573443|54699070|FG001|Open-Label Extension Phase|Protocol Violation|0|||
28041025|NCT00573443|54699071|FG002|Open-Label Extension Phase|Protocol Violation|0|||
28041026|NCT00573443|54699069|FG000|Open-Label Extension Phase|Other|2|||
28041027|NCT00573443|54699070|FG001|Open-Label Extension Phase|Other|0|||
28041028|NCT00573443|54699071|FG002|Open-Label Extension Phase|Other|0|||
28041029|NCT00420849|54699093|FG000|Overall Study|Lack of Efficacy|154|||
28041030|NCT00420849|54699093|FG000|Overall Study|Adverse Event|107|||
28041031|NCT00420849|54699093|FG000|Overall Study|Withdrawal by Subject|28|||
28041032|NCT00420849|54699093|FG000|Overall Study|Death|18|||
28041033|NCT00420849|54699093|FG000|Overall Study|Other|14|||
28041034|NCT00420849|54699093|FG000|Overall Study|Transplant|8|||
28041035|NCT00420849|54699093|FG000|Overall Study|Protocol Violation|1|||
28041036|NCT00420849|54699093|FG000|Overall Study|Lost to Follow-up|1|||
27810661|NCT01731951|54266536|FG005|Overall Study|Documented Disease Progression|0|||
27810662|NCT01731951|54266531|FG000|Overall Study|Lost to Follow-up|2|||
28041037|NCT00617279|54699102|FG000|Overall Study|Study terminated by Sponsor|10|||
28041038|NCT00617279|54699103|FG001|Overall Study|Study terminated by Sponsor|15|||
28041039|NCT00617279|54699102|FG000|Overall Study|Graft abandonment|2|||
28041040|NCT00617279|54699103|FG001|Overall Study|Graft abandonment|0|||
28041041|NCT00617279|54699102|FG000|Overall Study|Lost to Follow-up|1|||
27810663|NCT01731951|54266532|FG001|Overall Study|Lost to Follow-up|0|||
27810664|NCT01731951|54266533|FG002|Overall Study|Lost to Follow-up|0|||
27810665|NCT01731951|54266534|FG003|Overall Study|Lost to Follow-up|1|||
27810666|NCT01731951|54266535|FG004|Overall Study|Lost to Follow-up|3|||
27810667|NCT01731951|54266536|FG005|Overall Study|Lost to Follow-up|1|||
27810668|NCT01731951|54266531|FG000|Overall Study|Withdrawal of Consent|1|||
28041042|NCT00617279|54699103|FG001|Overall Study|Lost to Follow-up|0|||
28041043|NCT00617279|54699102|FG000|Overall Study|Death|1|||
28041044|NCT00617279|54699103|FG001|Overall Study|Death|2|||
28041045|NCT00420381|54699109|FG000|Overall Study|Protocol Violation|1|||
28041046|NCT00617201|54699115|FG000|Overall Study|Lost to Follow-up|9|||
28041047|NCT00617201|54699116|FG001|Overall Study|Lost to Follow-up|13|||
28041048|NCT00420303|54699126|FG000|Overall Study|Serious Adverse Event|1|||
28041049|NCT00420303|54699127|FG001|Overall Study|Serious Adverse Event|0|||
28041050|NCT00420303|54699126|FG000|Overall Study|Lack of Efficacy|0|||
28041051|NCT00420303|54699127|FG001|Overall Study|Lack of Efficacy|3|||
28041052|NCT00420303|54699126|FG000|Overall Study|Physician Decision|0|||
28041053|NCT00420303|54699127|FG001|Overall Study|Physician Decision|1|||
28041054|NCT00617123|54699135|FG000|Referral Screening Period|Did Not Meet Protocol Eligibility|36|||
28041055|NCT00617123|54699136|FG001|Referral Screening Period|Did Not Meet Protocol Eligibility|24|||
28041056|NCT00617123|54699135|FG000|Referral Screening Period|Did Not Wish To Continue|3|||
28041057|NCT00617123|54699136|FG001|Referral Screening Period|Did Not Wish To Continue|1|||
28041058|NCT00617123|54699135|FG000|Referral Screening Period|Adverse Event|0|||
28041059|NCT00617123|54699136|FG001|Referral Screening Period|Adverse Event|1|||
28041060|NCT00617123|54699135|FG000|Study Treatment Period|Withdrawal by Subject|8|||
28041061|NCT00617123|54699136|FG001|Study Treatment Period|Withdrawal by Subject|12|||
28041062|NCT00617123|54699135|FG000|Study Treatment Period|Adverse Event|7|||
28041063|NCT00617123|54699136|FG001|Study Treatment Period|Adverse Event|3|||
28041064|NCT00617123|54699135|FG000|Study Treatment Period|Did Not Meet Protocol Eligibility|2|||
28041065|NCT00617123|54699136|FG001|Study Treatment Period|Did Not Meet Protocol Eligibility|0|||
28041066|NCT00617123|54699135|FG000|Study Treatment Period|Noncompliance with Protocol|0|||
28041067|NCT00617123|54699136|FG001|Study Treatment Period|Noncompliance with Protocol|1|||
28041068|NCT00419757|54699144|FG000|Overall Study|Adverse Event|1|||
28041069|NCT00419757|54699145|FG001|Overall Study|Adverse Event|4|||
28041070|NCT00419757|54699144|FG000|Overall Study|Lost to Follow-up|1|||
28041071|NCT00419757|54699145|FG001|Overall Study|Lost to Follow-up|4|||
28041072|NCT00419757|54699144|FG000|Overall Study|Withdrawal by Subject|7|||
28041073|NCT00419757|54699145|FG001|Overall Study|Withdrawal by Subject|1|||
28041074|NCT00419757|54699144|FG000|Overall Study|Protocol Violation|2|||
28041075|NCT00419757|54699145|FG001|Overall Study|Protocol Violation|3|||
28041076|NCT00419757|54699144|FG000|Overall Study|Study specific discontinuation criteria|4|||
28041077|NCT00419757|54699145|FG001|Overall Study|Study specific discontinuation criteria|8|||
28041078|NCT00419757|54699144|FG000|Overall Study|Multiple reasons|3|||
28041079|NCT00419757|54699145|FG001|Overall Study|Multiple reasons|1|||
28041080|NCT00434109|54699153|FG000|Overall Study|Physician Decision|9|||
28041081|NCT00434109|54699153|FG000|Overall Study|Adverse Event|5|||
28041082|NCT00434109|54699153|FG000|Overall Study|Protocol Violation|1|||
28041083|NCT00434109|54699153|FG000|Overall Study|had embolism, did not receive sunitinib|3|||
28041084|NCT00433329|54699157|FG000|Overall Study|Adverse Event|9|||
28041085|NCT00433329|54699157|FG000|Overall Study|Death|4|||
28041086|NCT00433329|54699157|FG000|Overall Study|Withdrew consent|3|||
28041087|NCT00433329|54699157|FG000|Overall Study|Discontinued sildenafil|2|||
27810669|NCT01731951|54266532|FG001|Overall Study|Withdrawal of Consent|0|||
27810670|NCT01731951|54266533|FG002|Overall Study|Withdrawal of Consent|0|||
27810671|NCT01731951|54266534|FG003|Overall Study|Withdrawal of Consent|0|||
28041088|NCT00433329|54699157|FG000|Overall Study|Moved out of state|1|||
28041089|NCT00433329|54699157|FG000|Overall Study|Lost to Follow-up|1|||
28041090|NCT00433329|54699157|FG000|Overall Study|Physician Decision|1|||
28041091|NCT00616421|54699164|FG000|Overall Study|Withdrawal by Subject|9|||
28041092|NCT00616421|54699165|FG001|Overall Study|Withdrawal by Subject|11|||
28041093|NCT00616421|54699166|FG002|Overall Study|Withdrawal by Subject|8|||
28041094|NCT00616421|54699164|FG000|Overall Study|Lost to Follow-up|12|||
28041095|NCT00616421|54699165|FG001|Overall Study|Lost to Follow-up|26|||
28041096|NCT00616421|54699166|FG002|Overall Study|Lost to Follow-up|30|||
28041097|NCT00616421|54699164|FG000|Overall Study|Inappropriate enrollment|3|||
28041098|NCT00616421|54699165|FG001|Overall Study|Inappropriate enrollment|0|||
28041099|NCT00616421|54699166|FG002|Overall Study|Inappropriate enrollment|1|||
28041100|NCT00616421|54699164|FG000|Overall Study|Administrative reason|1|||
28041101|NCT00616421|54699165|FG001|Overall Study|Administrative reason|0|||
28041102|NCT00616421|54699166|FG002|Overall Study|Administrative reason|0|||
27810672|NCT01731951|54266535|FG004|Overall Study|Withdrawal of Consent|0|||
27810673|NCT01731951|54266536|FG005|Overall Study|Withdrawal of Consent|2|||
27810674|NCT01731951|54266531|FG000|Overall Study|Death|13|||
27810675|NCT01731951|54266532|FG001|Overall Study|Death|15|||
27810676|NCT01731951|54266533|FG002|Overall Study|Death|9|||
27810677|NCT01731951|54266534|FG003|Overall Study|Death|8|||
27810678|NCT01731951|54266535|FG004|Overall Study|Death|9|||
28041103|NCT00616421|54699164|FG000|Overall Study|Protocol Violation|0|||
28041104|NCT00616421|54699165|FG001|Overall Study|Protocol Violation|1|||
28041105|NCT00616421|54699166|FG002|Overall Study|Protocol Violation|2|||
28041106|NCT00616421|54699164|FG000|Overall Study|Unable to classify|1|||
27810679|NCT01731951|54266536|FG005|Overall Study|Death|6|||
27810680|NCT01731171|54266556|FG000|Overall Study|Withdrawal by Subject|4|||
27810681|NCT01731171|54266557|FG001|Overall Study|Withdrawal by Subject|1|||
28041107|NCT00616421|54699165|FG001|Overall Study|Unable to classify|0|||
28041108|NCT00616421|54699166|FG002|Overall Study|Unable to classify|0|||
28041109|NCT00433017|54699190|FG000|Overall Study|Adverse Event|5|||
28041110|NCT00433017|54699191|FG001|Overall Study|Adverse Event|3|||
28041111|NCT00433017|54699190|FG000|Overall Study|Withdrawal by Subject|4|||
28041112|NCT00433017|54699191|FG001|Overall Study|Withdrawal by Subject|5|||
28041113|NCT00433017|54699190|FG000|Overall Study|Lost to Follow-up|3|||
28041114|NCT00433017|54699191|FG001|Overall Study|Lost to Follow-up|4|||
28041115|NCT00433017|54699190|FG000|Overall Study|Administrative problems|80|||
28041116|NCT00433017|54699191|FG001|Overall Study|Administrative problems|86|||
28041117|NCT00433017|54699190|FG000|Overall Study|Protocol Violation|1|||
28041118|NCT00433017|54699191|FG001|Overall Study|Protocol Violation|0|||
28041119|NCT00433017|54699190|FG000|Overall Study|Death|2|||
28041120|NCT00433017|54699191|FG001|Overall Study|Death|2|||
28041121|NCT00433017|54699190|FG000|Overall Study|Subject no longer requires study drug|1|||
28041122|NCT00433017|54699191|FG001|Overall Study|Subject no longer requires study drug|1|||
28041123|NCT00615719|54699223|FG000|Overall Study|Physician Decision|5|||
28041124|NCT00418665|54699230|FG000|Treatment Period|Ineligibility determined|1|||
28041125|NCT00418665|54699231|FG001|Treatment Period|Ineligibility determined|1|||
28041126|NCT00418665|54699232|FG002|Treatment Period|Ineligibility determined|0|||
28041127|NCT00418665|54699230|FG000|Treatment Period|Adverse Event|2|||
28041128|NCT00418665|54699231|FG001|Treatment Period|Adverse Event|2|||
28041129|NCT00418665|54699232|FG002|Treatment Period|Adverse Event|0|||
28041130|NCT00418665|54699230|FG000|Treatment Period|Withdrawal by Subject|0|||
28041131|NCT00418665|54699231|FG001|Treatment Period|Withdrawal by Subject|3|||
28041132|NCT00418665|54699232|FG002|Treatment Period|Withdrawal by Subject|1|||
28041133|NCT00418665|54699230|FG000|Treatment Period|Requirement for alternative therapy|1|||
28041134|NCT00418665|54699231|FG001|Treatment Period|Requirement for alternative therapy|0|||
28041135|NCT00418665|54699232|FG002|Treatment Period|Requirement for alternative therapy|0|||
28041136|NCT00418665|54699230|FG000|Treatment Period|Physician Decision|1|||
28041137|NCT00418665|54699231|FG001|Treatment Period|Physician Decision|0|||
28041138|NCT00418665|54699232|FG002|Treatment Period|Physician Decision|3|||
28041139|NCT00418665|54699230|FG000|Treatment Extension|Adverse Event|1|||
28041140|NCT00418665|54699231|FG001|Treatment Extension|Adverse Event|0|||
28041141|NCT00418665|54699232|FG002|Treatment Extension|Adverse Event|0|||
28041142|NCT00418665|54699230|FG000|Treatment Extension|Withdrawal by Subject|1|||
28041143|NCT00418665|54699231|FG001|Treatment Extension|Withdrawal by Subject|0|||
28041144|NCT00418665|54699232|FG002|Treatment Extension|Withdrawal by Subject|0|||
28041145|NCT00418665|54699230|FG000|Treatment Extension|Requirement for alternative therapy|2|||
28041146|NCT00418665|54699231|FG001|Treatment Extension|Requirement for alternative therapy|2|||
28041147|NCT00418665|54699232|FG002|Treatment Extension|Requirement for alternative therapy|0|||
28041148|NCT00418665|54699230|FG000|Treatment Extension|Physician Decision|2|||
28041149|NCT00418665|54699231|FG001|Treatment Extension|Physician Decision|2|||
28041150|NCT00418665|54699232|FG002|Treatment Extension|Physician Decision|1|||
28041151|NCT00418665|54699230|FG000|Treatment Extension|Death|0|||
28041152|NCT00418665|54699231|FG001|Treatment Extension|Death|0|||
28041153|NCT00418665|54699232|FG002|Treatment Extension|Death|1|||
28076994|NCT00094458|54731727|FG005|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
28076995|NCT00094458|54731722|FG000|Study Extension: Week 30 Through Week 50|Other|1|||
28076996|NCT00094458|54731723|FG001|Study Extension: Week 30 Through Week 50|Other|2|||
28076997|NCT00094458|54731724|FG002|Study Extension: Week 30 Through Week 50|Other|3|||
28076998|NCT00094458|54731725|FG003|Study Extension: Week 30 Through Week 50|Other|0|||
28076999|NCT00094458|54731726|FG004|Study Extension: Week 30 Through Week 50|Other|0|||
28077000|NCT00094458|54731727|FG005|Study Extension: Week 30 Through Week 50|Other|0|||
27810682|NCT01731171|54266556|FG000|Overall Study|Lost to Follow-up|3|||
27810683|NCT01731171|54266557|FG001|Overall Study|Lost to Follow-up|2|||
27810684|NCT01731171|54266556|FG000|Overall Study|Moved out of Area|0|||
27810685|NCT01731171|54266557|FG001|Overall Study|Moved out of Area|2|||
27810686|NCT01731171|54266556|FG000|Overall Study|Terminated for Lack of Adherence|0|||
27810687|NCT01731171|54266557|FG001|Overall Study|Terminated for Lack of Adherence|1|||
27810688|NCT01731171|54266556|FG000|Overall Study|Terminated for Safety Reasons|0|||
28077001|NCT00094458|54731722|FG000|OLE: Open-Label Extension|Adverse Event|0|||
28077002|NCT00094458|54731723|FG001|OLE: Open-Label Extension|Adverse Event|0|||
28077003|NCT00094458|54731724|FG002|OLE: Open-Label Extension|Adverse Event|0|||
28077004|NCT00094458|54731725|FG003|OLE: Open-Label Extension|Adverse Event|0|||
28077005|NCT00094458|54731726|FG004|OLE: Open-Label Extension|Adverse Event|3|||
28077006|NCT00094458|54731727|FG005|OLE: Open-Label Extension|Adverse Event|4|||
28077007|NCT00094458|54731722|FG000|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
27810689|NCT01731171|54266557|FG001|Overall Study|Terminated for Safety Reasons|1|||
27810690|NCT01741701|54266565|FG000|Overall Study|Adverse Event|5|||
28077008|NCT00094458|54731723|FG001|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
28077009|NCT00094458|54731724|FG002|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
27810691|NCT01741701|54266566|FG001|Overall Study|Adverse Event|1|||
27810692|NCT01741701|54266565|FG000|Overall Study|Withdrawal by Subject|0|||
27810693|NCT01741701|54266566|FG001|Overall Study|Withdrawal by Subject|1|||
27810694|NCT01741545|54266574|FG000|Treatment Period|Lack of Efficacy|0|||
27810695|NCT01741545|54266575|FG001|Treatment Period|Lack of Efficacy|1|||
28041154|NCT00432237|54699244|FG000|Overall Study|Adverse Event|0|||
27810696|NCT01741545|54266574|FG000|Treatment Period|Adverse event, non-fatal|1|||
27810697|NCT01741545|54266575|FG001|Treatment Period|Adverse event, non-fatal|3|||
27810698|NCT01741545|54266574|FG000|Follow-up Period (24 Weeks)|Other than specified|0|||
27810699|NCT01741545|54266575|FG001|Follow-up Period (24 Weeks)|Other than specified|1|||
27810700|NCT01741545|54266574|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
27810701|NCT01741545|54266575|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
27810702|NCT01884350|54266583|FG000|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17|||
27810703|NCT01884350|54266584|FG001|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20|||
27810704|NCT01884350|54266585|FG002|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0|||
27810705|NCT01884350|54266583|FG000|Primary Efficacy Analysis Set (24 Weeks)|Death|6|||
27810706|NCT01884350|54266584|FG001|Primary Efficacy Analysis Set (24 Weeks)|Death|4|||
28041155|NCT00432237|54699245|FG001|Overall Study|Adverse Event|0|||
28041156|NCT00432237|54699246|FG002|Overall Study|Adverse Event|0|||
28041157|NCT00432237|54699247|FG003|Overall Study|Adverse Event|1|||
28041158|NCT00432237|54699244|FG000|Overall Study|Lack of Efficacy|0|||
28041159|NCT00432237|54699245|FG001|Overall Study|Lack of Efficacy|0|||
28041160|NCT00432237|54699246|FG002|Overall Study|Lack of Efficacy|0|||
28041161|NCT00432237|54699247|FG003|Overall Study|Lack of Efficacy|1|||
28041162|NCT00432237|54699244|FG000|Overall Study|Lost to Follow-up|10|||
28041163|NCT00432237|54699245|FG001|Overall Study|Lost to Follow-up|10|||
28041164|NCT00432237|54699246|FG002|Overall Study|Lost to Follow-up|18|||
28041165|NCT00432237|54699247|FG003|Overall Study|Lost to Follow-up|18|||
28041166|NCT00432237|54699244|FG000|Overall Study|Physician Decision|1|||
28041167|NCT00432237|54699245|FG001|Overall Study|Physician Decision|3|||
28041168|NCT00432237|54699246|FG002|Overall Study|Physician Decision|2|||
28041169|NCT00432237|54699247|FG003|Overall Study|Physician Decision|1|||
28041170|NCT00432237|54699244|FG000|Overall Study|Pregnancy|0|||
28041171|NCT00432237|54699245|FG001|Overall Study|Pregnancy|1|||
28041172|NCT00432237|54699246|FG002|Overall Study|Pregnancy|0|||
28041173|NCT00432237|54699247|FG003|Overall Study|Pregnancy|0|||
28041174|NCT00432237|54699244|FG000|Overall Study|Protocol Violation|13|||
28041175|NCT00432237|54699245|FG001|Overall Study|Protocol Violation|10|||
28041176|NCT00432237|54699246|FG002|Overall Study|Protocol Violation|11|||
28041177|NCT00432237|54699247|FG003|Overall Study|Protocol Violation|8|||
28041178|NCT00432237|54699244|FG000|Overall Study|Withdrawal by Subject|5|||
28041179|NCT00432237|54699245|FG001|Overall Study|Withdrawal by Subject|6|||
28041180|NCT00432237|54699246|FG002|Overall Study|Withdrawal by Subject|9|||
28041181|NCT00432237|54699247|FG003|Overall Study|Withdrawal by Subject|11|||
28041182|NCT00432237|54699244|FG000|Overall Study|Lack of Qualifying Event|38|||
28041183|NCT00432237|54699245|FG001|Overall Study|Lack of Qualifying Event|71|||
28041184|NCT00432237|54699246|FG002|Overall Study|Lack of Qualifying Event|69|||
28041185|NCT00432237|54699247|FG003|Overall Study|Lack of Qualifying Event|84|||
28041186|NCT00531284|54699274|FG000|Overall Study|Progressive Disease|1|||
28041187|NCT00531284|54699275|FG001|Overall Study|Progressive Disease|3|||
28041188|NCT00531284|54699276|FG002|Overall Study|Progressive Disease|5|||
28041189|NCT00531284|54699277|FG003|Overall Study|Progressive Disease|42|||
28041190|NCT00531284|54699278|FG004|Overall Study|Progressive Disease|4|||
28041191|NCT00531284|54699279|FG005|Overall Study|Progressive Disease|4|||
28041192|NCT00531284|54699280|FG006|Overall Study|Progressive Disease|3|||
28041193|NCT00531284|54699281|FG007|Overall Study|Progressive Disease|8|||
28041194|NCT00531284|54699282|FG008|Overall Study|Progressive Disease|6|||
28041195|NCT00531284|54699283|FG009|Overall Study|Progressive Disease|3|||
28041196|NCT00531284|54699284|FG010|Overall Study|Progressive Disease|3|||
28041197|NCT00531284|54699285|FG011|Overall Study|Progressive Disease|14|||
28041198|NCT00531284|54699286|FG012|Overall Study|Progressive Disease|2|||
28041199|NCT00531284|54699287|FG013|Overall Study|Progressive Disease|1|||
28041200|NCT00531284|54699288|FG014|Overall Study|Progressive Disease|2|||
28041201|NCT00531284|54699289|FG015|Overall Study|Progressive Disease|11|||
28041202|NCT00531284|54699290|FG016|Overall Study|Progressive Disease|5|||
28041203|NCT00531284|54699274|FG000|Overall Study|Adverse Event|0|||
28041204|NCT00531284|54699275|FG001|Overall Study|Adverse Event|1|||
28041205|NCT00531284|54699276|FG002|Overall Study|Adverse Event|1|||
28041206|NCT00531284|54699277|FG003|Overall Study|Adverse Event|7|||
28041207|NCT00531284|54699278|FG004|Overall Study|Adverse Event|0|||
28041208|NCT00531284|54699279|FG005|Overall Study|Adverse Event|2|||
28041209|NCT00531284|54699280|FG006|Overall Study|Adverse Event|3|||
28041210|NCT00531284|54699281|FG007|Overall Study|Adverse Event|2|||
28041211|NCT00531284|54699282|FG008|Overall Study|Adverse Event|3|||
27810707|NCT01884350|54266585|FG002|Primary Efficacy Analysis Set (24 Weeks)|Death|0|||
27810708|NCT01884350|54266583|FG000|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
28041212|NCT00531284|54699283|FG009|Overall Study|Adverse Event|0|||
28041213|NCT00531284|54699284|FG010|Overall Study|Adverse Event|0|||
28041214|NCT00531284|54699285|FG011|Overall Study|Adverse Event|5|||
28041215|NCT00531284|54699286|FG012|Overall Study|Adverse Event|0|||
27810709|NCT01884350|54266584|FG001|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1|||
27810710|NCT01884350|54266585|FG002|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
27810711|NCT01884350|54266583|FG000|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7|||
27810712|NCT01884350|54266584|FG001|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6|||
27810713|NCT01884350|54266585|FG002|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0|||
27810714|NCT01884350|54266583|FG000|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15|||
27810715|NCT01884350|54266584|FG001|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11|||
27810716|NCT01884350|54266585|FG002|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0|||
27810717|NCT01884350|54266583|FG000|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
27810718|NCT01884350|54266584|FG001|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2|||
27810719|NCT01884350|54266585|FG002|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
27810720|NCT01884350|54266583|FG000|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2|||
27810721|NCT01884350|54266584|FG001|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5|||
27810722|NCT01884350|54266585|FG002|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0|||
27810723|NCT01884350|54266583|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2|||
27810724|NCT01884350|54266584|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
27810725|NCT01884350|54266585|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
27810726|NCT01884350|54266583|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
27810727|NCT01884350|54266584|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
27810728|NCT01884350|54266585|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0|||
27810729|NCT01884350|54266583|FG000|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
27810730|NCT01884350|54266584|FG001|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
27810731|NCT01884350|54266585|FG002|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0|||
27810732|NCT01884350|54266583|FG000|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
27810733|NCT01884350|54266584|FG001|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
27810734|NCT01884350|54266585|FG002|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0|||
27810735|NCT01884350|54266583|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21|||
27810736|NCT01884350|54266584|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0|||
27810737|NCT01884350|54266585|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2|||
27810738|NCT01884350|54266583|FG000|Primary Efficacy Analysis Set (48 Weeks)|Death|7|||
27810739|NCT01884350|54266584|FG001|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
27810740|NCT01884350|54266585|FG002|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
27810741|NCT01884350|54266583|FG000|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
27810742|NCT01884350|54266584|FG001|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0|||
27810743|NCT01884350|54266585|FG002|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
27810744|NCT01884350|54266583|FG000|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17|||
27810745|NCT01884350|54266584|FG001|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6|||
27810746|NCT01884350|54266585|FG002|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3|||
27810747|NCT01884350|54266583|FG000|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17|||
27810748|NCT01884350|54266584|FG001|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3|||
27810749|NCT01884350|54266585|FG002|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0|||
27810750|NCT01884350|54266583|FG000|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3|||
27810751|NCT01884350|54266584|FG001|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0|||
27810752|NCT01884350|54266585|FG002|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2|||
27810753|NCT01884350|54266583|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4|||
27810754|NCT01884350|54266584|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
27810755|NCT01884350|54266585|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
27810756|NCT01884350|54266583|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3|||
27810757|NCT01884350|54266584|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
27810758|NCT01884350|54266585|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
27810759|NCT01884350|54266583|FG000|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4|||
27810760|NCT01884350|54266584|FG001|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1|||
27810761|NCT01884350|54266585|FG002|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0|||
27810762|NCT01884350|54266583|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1|||
27810763|NCT01884350|54266584|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
27810764|NCT01884350|54266585|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
27810765|NCT01884350|54266583|FG000|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2|||
27810766|NCT01884350|54266584|FG001|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
27810767|NCT01884350|54266585|FG002|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
27810768|NCT01614795|54266599|FG000|Overall Study|Adverse Event|0|||
28041216|NCT00531284|54699287|FG013|Overall Study|Adverse Event|1|||
27810769|NCT01614795|54266600|FG001|Overall Study|Adverse Event|0|||
28041217|NCT00531284|54699288|FG014|Overall Study|Adverse Event|1|||
28041218|NCT00531284|54699289|FG015|Overall Study|Adverse Event|0|||
28041219|NCT00531284|54699290|FG016|Overall Study|Adverse Event|2|||
27810770|NCT01614795|54266601|FG002|Overall Study|Adverse Event|1|||
27810771|NCT01614795|54266602|FG003|Overall Study|Adverse Event|1|||
28041220|NCT00531284|54699274|FG000|Overall Study|Withdrawal by Subject|1|||
28041221|NCT00531284|54699275|FG001|Overall Study|Withdrawal by Subject|0|||
28041222|NCT00531284|54699276|FG002|Overall Study|Withdrawal by Subject|0|||
28041223|NCT00531284|54699277|FG003|Overall Study|Withdrawal by Subject|4|||
28041224|NCT00531284|54699278|FG004|Overall Study|Withdrawal by Subject|0|||
28041225|NCT00531284|54699279|FG005|Overall Study|Withdrawal by Subject|0|||
28041226|NCT00531284|54699280|FG006|Overall Study|Withdrawal by Subject|0|||
28041227|NCT00531284|54699281|FG007|Overall Study|Withdrawal by Subject|0|||
28041228|NCT00531284|54699282|FG008|Overall Study|Withdrawal by Subject|0|||
28041229|NCT00531284|54699283|FG009|Overall Study|Withdrawal by Subject|0|||
28041230|NCT00531284|54699284|FG010|Overall Study|Withdrawal by Subject|0|||
28041231|NCT00531284|54699285|FG011|Overall Study|Withdrawal by Subject|3|||
27810772|NCT01614795|54266599|FG000|Overall Study|Lack of Efficacy|10|||
27810773|NCT01614795|54266600|FG001|Overall Study|Lack of Efficacy|10|||
28041232|NCT00531284|54699286|FG012|Overall Study|Withdrawal by Subject|0|||
28041233|NCT00531284|54699287|FG013|Overall Study|Withdrawal by Subject|1|||
28041234|NCT00531284|54699288|FG014|Overall Study|Withdrawal by Subject|0|||
28041235|NCT00531284|54699289|FG015|Overall Study|Withdrawal by Subject|1|||
28041236|NCT00531284|54699290|FG016|Overall Study|Withdrawal by Subject|1|||
28041237|NCT00531284|54699274|FG000|Overall Study|Other|1|||
28041238|NCT00531284|54699275|FG001|Overall Study|Other|0|||
28041239|NCT00531284|54699276|FG002|Overall Study|Other|0|||
28041240|NCT00531284|54699277|FG003|Overall Study|Other|10|||
28041241|NCT00531284|54699278|FG004|Overall Study|Other|2|||
28041242|NCT00531284|54699279|FG005|Overall Study|Other|1|||
28041243|NCT00531284|54699280|FG006|Overall Study|Other|0|||
28041244|NCT00531284|54699281|FG007|Overall Study|Other|0|||
28041245|NCT00531284|54699282|FG008|Overall Study|Other|2|||
28041246|NCT00531284|54699283|FG009|Overall Study|Other|1|||
28041247|NCT00531284|54699284|FG010|Overall Study|Other|0|||
28041248|NCT00531284|54699285|FG011|Overall Study|Other|2|||
28041249|NCT00531284|54699286|FG012|Overall Study|Other|0|||
28041250|NCT00531284|54699287|FG013|Overall Study|Other|0|||
28041251|NCT00531284|54699288|FG014|Overall Study|Other|1|||
28041252|NCT00531284|54699289|FG015|Overall Study|Other|0|||
28041253|NCT00531284|54699290|FG016|Overall Study|Other|0|||
28041254|NCT00531206|54699346|FG000|Overall Study|Adverse Event related|5|||
28041255|NCT00531206|54699346|FG000|Overall Study|Lack of Efficacy|2|||
28041256|NCT00531206|54699346|FG000|Overall Study|Lost to Follow-up|5|||
28041257|NCT00531206|54699346|FG000|Overall Study|including non-related adverse events|8|||
28041258|NCT00530816|54699353|FG000|Overall Study|Progressive Disease|16|||
28041259|NCT00530816|54699354|FG001|Overall Study|Progressive Disease|24|||
28041260|NCT00530816|54699355|FG002|Overall Study|Progressive Disease|24|||
28041261|NCT00530816|54699353|FG000|Overall Study|Adverse Event|6|||
28041262|NCT00530816|54699354|FG001|Overall Study|Adverse Event|13|||
28041263|NCT00530816|54699355|FG002|Overall Study|Adverse Event|7|||
28041264|NCT00530816|54699353|FG000|Overall Study|Other|3|||
28041265|NCT00530816|54699354|FG001|Overall Study|Other|3|||
28041266|NCT00530816|54699355|FG002|Overall Study|Other|4|||
28041267|NCT00530816|54699353|FG000|Overall Study|Withdrawal by Subject|1|||
28041268|NCT00530816|54699354|FG001|Overall Study|Withdrawal by Subject|2|||
28041269|NCT00530816|54699355|FG002|Overall Study|Withdrawal by Subject|6|||
28041270|NCT00615017|54699369|FG000|Overall Study|Adverse Event|0|||
28041271|NCT00615017|54699370|FG001|Overall Study|Adverse Event|1|||
28041272|NCT00615017|54699371|FG002|Overall Study|Adverse Event|2|||
27810774|NCT01614795|54266601|FG002|Overall Study|Lack of Efficacy|9|||
27810775|NCT01614795|54266602|FG003|Overall Study|Lack of Efficacy|8|||
27810776|NCT01614795|54266599|FG000|Overall Study|Physician Decision|1|||
27810777|NCT01614795|54266600|FG001|Overall Study|Physician Decision|0|||
27810778|NCT01614795|54266601|FG002|Overall Study|Physician Decision|1|||
28041273|NCT00615017|54699372|FG003|Overall Study|Adverse Event|0|||
28041274|NCT00615017|54699373|FG004|Overall Study|Adverse Event|0|||
28041275|NCT00615017|54699374|FG005|Overall Study|Adverse Event|1|||
28041276|NCT00615017|54699369|FG000|Overall Study|Death|0|||
28041277|NCT00615017|54699370|FG001|Overall Study|Death|0|||
28041278|NCT00615017|54699371|FG002|Overall Study|Death|2|||
27810779|NCT01614795|54266602|FG003|Overall Study|Physician Decision|1|||
27810780|NCT01614795|54266599|FG000|Overall Study|Withdrawal by Subject|0|||
28041279|NCT00615017|54699372|FG003|Overall Study|Death|0|||
28041280|NCT00615017|54699373|FG004|Overall Study|Death|1|||
28041281|NCT00615017|54699374|FG005|Overall Study|Death|1|||
28041282|NCT00615017|54699369|FG000|Overall Study|Sepsis resolved|0|||
28041283|NCT00615017|54699370|FG001|Overall Study|Sepsis resolved|0|||
28041284|NCT00615017|54699371|FG002|Overall Study|Sepsis resolved|1|||
28041285|NCT00615017|54699372|FG003|Overall Study|Sepsis resolved|0|||
28041286|NCT00615017|54699373|FG004|Overall Study|Sepsis resolved|0|||
28041287|NCT00615017|54699374|FG005|Overall Study|Sepsis resolved|0|||
28041288|NCT00615017|54699369|FG000|Overall Study|Transferred out of Intensive Care Unit|0|||
28041289|NCT00615017|54699370|FG001|Overall Study|Transferred out of Intensive Care Unit|0|||
28041290|NCT00615017|54699371|FG002|Overall Study|Transferred out of Intensive Care Unit|0|||
28041291|NCT00615017|54699372|FG003|Overall Study|Transferred out of Intensive Care Unit|1|||
28041292|NCT00615017|54699373|FG004|Overall Study|Transferred out of Intensive Care Unit|0|||
28041293|NCT00615017|54699374|FG005|Overall Study|Transferred out of Intensive Care Unit|0|||
28041294|NCT00615017|54699369|FG000|Overall Study|Physician discontinued drug|0|||
28041295|NCT00615017|54699370|FG001|Overall Study|Physician discontinued drug|0|||
28041296|NCT00615017|54699371|FG002|Overall Study|Physician discontinued drug|0|||
28041297|NCT00615017|54699372|FG003|Overall Study|Physician discontinued drug|0|||
27810781|NCT01614795|54266600|FG001|Overall Study|Withdrawal by Subject|1|||
27810782|NCT01614795|54266601|FG002|Overall Study|Withdrawal by Subject|0|||
27810783|NCT01614795|54266602|FG003|Overall Study|Withdrawal by Subject|2|||
27810784|NCT01614795|54266599|FG000|Overall Study|Ineligible|0|||
28041298|NCT00615017|54699373|FG004|Overall Study|Physician discontinued drug|0|||
28041299|NCT00615017|54699374|FG005|Overall Study|Physician discontinued drug|1|||
28041300|NCT00614939|54699390|FG000|Overall Study|Withdrawal by Subject|10|||
28041301|NCT00614939|54699391|FG001|Overall Study|Withdrawal by Subject|17|||
28041302|NCT00614939|54699390|FG000|Overall Study|Study specific discontinuation criteris|13|||
28041303|NCT00614939|54699391|FG001|Overall Study|Study specific discontinuation criteris|16|||
28041304|NCT00614939|54699390|FG000|Overall Study|Adverse Event|2|||
28041305|NCT00614939|54699391|FG001|Overall Study|Adverse Event|5|||
28041306|NCT00614939|54699390|FG000|Overall Study|Incorrect enrollment|1|||
28041307|NCT00614939|54699391|FG001|Overall Study|Incorrect enrollment|2|||
28041308|NCT00614939|54699390|FG000|Overall Study|Death|4|||
28041309|NCT00614939|54699391|FG001|Overall Study|Death|3|||
28041310|NCT00614939|54699390|FG000|Overall Study|Poor/non-compliance|4|||
28041311|NCT00614939|54699391|FG001|Overall Study|Poor/non-compliance|0|||
28041312|NCT00614939|54699390|FG000|Overall Study|Hospitalized due to kidney transplant|1|||
28041313|NCT00614939|54699391|FG001|Overall Study|Hospitalized due to kidney transplant|0|||
28041314|NCT00530504|54699397|FG000|Overall Study|Death|54|||
28041315|NCT00530504|54699397|FG000|Overall Study|Lost to Follow-up|26|||
28041316|NCT00530504|54699397|FG000|Overall Study|Withdrawal by Subject|39|||
28041317|NCT00530504|54699397|FG000|Overall Study|Exited study due to other reasons|33|||
28041318|NCT05159362|54699404|FG000|Field Testing (4 Weeks)|Withdrawal by Subject|1|||
28041319|NCT05159362|54699405|FG001|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
28041320|NCT05159362|54699406|FG002|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
28041321|NCT04975191|54699421|FG000|Overall Study|Protocol Violation|1|||
28041322|NCT04975191|54699422|FG001|Overall Study|Protocol Violation|2|||
28041323|NCT04975191|54699423|FG002|Overall Study|Protocol Violation|2|||
28041324|NCT04975191|54699424|FG003|Overall Study|Protocol Violation|2|||
28041325|NCT04975191|54699421|FG000|Overall Study|Lost to Follow-up|13|||
28041326|NCT04975191|54699422|FG001|Overall Study|Lost to Follow-up|3|||
28041327|NCT04975191|54699423|FG002|Overall Study|Lost to Follow-up|8|||
28041328|NCT04975191|54699424|FG003|Overall Study|Lost to Follow-up|8|||
28041329|NCT04492020|54699450|FG000|Overall Study|Adverse Event|1|||
28041330|NCT04492020|54699451|FG001|Overall Study|Adverse Event|3|||
27810785|NCT01614795|54266600|FG001|Overall Study|Ineligible|1|||
27810786|NCT01614795|54266601|FG002|Overall Study|Ineligible|0|||
27810787|NCT01614795|54266602|FG003|Overall Study|Ineligible|0|||
27810788|NCT01834586|54266613|FG000|Overall Study|Adverse Event|1|||
27810789|NCT01614249|54266619|FG000|Overall Study|Lost to Follow-up|11|||
27810790|NCT01614249|54266620|FG001|Overall Study|Lost to Follow-up|23|||
27810791|NCT01597778|54266628|FG000|Overall Study|Death|7|||
27810792|NCT01597778|54266629|FG001|Overall Study|Death|10|||
27810793|NCT01597778|54266628|FG000|Overall Study|Withdrawal by Subject|3|||
27810794|NCT01597778|54266629|FG001|Overall Study|Withdrawal by Subject|4|||
27810795|NCT01597778|54266628|FG000|Overall Study|Adverse Event|1|||
27810796|NCT01597778|54266629|FG001|Overall Study|Adverse Event|1|||
27810797|NCT01597778|54266628|FG000|Overall Study|Protocol Violation|1|||
27810798|NCT01597778|54266629|FG001|Overall Study|Protocol Violation|11|||
27810799|NCT01597778|54266628|FG000|Overall Study|Transplanted off protocol|2|||
28041331|NCT04492020|54699450|FG000|Overall Study|Withdrawal by Subject|4|||
28041332|NCT04492020|54699451|FG001|Overall Study|Withdrawal by Subject|3|||
28041333|NCT04492020|54699450|FG000|Overall Study|Lost to Follow-up|4|||
28041334|NCT04492020|54699451|FG001|Overall Study|Lost to Follow-up|3|||
28041335|NCT04492020|54699450|FG000|Overall Study|Protocol Violation|5|||
27810800|NCT01597778|54266629|FG001|Overall Study|Transplanted off protocol|3|||
27810801|NCT01614093|54266635|FG000|Overall Study|Withdrawal by Subject|1|||
27810802|NCT01834274|54266642|FG000|Overall Study|Study Termination|41|||
27810803|NCT01834274|54266643|FG001|Overall Study|Study Termination|38|||
27810804|NCT01834274|54266642|FG000|Overall Study|Withdrawal by Subject|1|||
28041336|NCT04492020|54699451|FG001|Overall Study|Protocol Violation|2|||
28041337|NCT04492020|54699450|FG000|Overall Study|Lack of Qualifying Event|25|||
27810805|NCT01834274|54266643|FG001|Overall Study|Withdrawal by Subject|1|||
27810806|NCT01834274|54266642|FG000|Overall Study|Lost to Follow-up|3|||
28041338|NCT04492020|54699451|FG001|Overall Study|Lack of Qualifying Event|27|||
28041339|NCT04492020|54699450|FG000|Overall Study|Non-compliance with Study Drug|2|||
28041340|NCT04492020|54699451|FG001|Overall Study|Non-compliance with Study Drug|1|||
28041341|NCT04382911|54699457|FG000|Overall Study|unable to be imaged prior to surgery|2|||
28041342|NCT04072575|54699465|FG000|Overall Study|Physician Decision|1|||
28041343|NCT04072575|54699465|FG000|Overall Study|Adverse Event|7|||
28041344|NCT04072575|54699465|FG000|Overall Study|Withdrawal by Subject|14|||
28041345|NCT04072575|54699465|FG000|Overall Study|Other|2|||
28041346|NCT03956056|54699469|FG000|Overall Study|Cannot make vaccine due to lack of tissue variants|2|||
28041347|NCT03956056|54699469|FG000|Overall Study|Lack of Efficacy|1|||
28041348|NCT03911869|54699475|FG000|Safety Lead-in Phase|Death|7|||
28041349|NCT03911869|54699476|FG001|Safety Lead-in Phase|Death|0|||
28041350|NCT03911869|54699477|FG002|Safety Lead-in Phase|Death|0|||
28041351|NCT03911869|54699475|FG000|Safety Lead-in Phase|Study termination by sponsor|2|||
28041352|NCT03911869|54699476|FG001|Safety Lead-in Phase|Study termination by sponsor|0|||
28041353|NCT03911869|54699477|FG002|Safety Lead-in Phase|Study termination by sponsor|0|||
28041354|NCT03911869|54699475|FG000|Safety Lead-in Phase|Other|1|||
28041355|NCT03911869|54699476|FG001|Safety Lead-in Phase|Other|0|||
28041356|NCT03911869|54699477|FG002|Safety Lead-in Phase|Other|0|||
28041357|NCT03911869|54699475|FG000|Phase 2|Death|0|||
28041358|NCT03911869|54699476|FG001|Phase 2|Death|3|||
28041359|NCT03911869|54699477|FG002|Phase 2|Death|0|||
28041360|NCT03897088|54699486|FG000|Overall Study|Withdrawal by Subject|12|||
28041361|NCT03897088|54699487|FG001|Overall Study|Withdrawal by Subject|12|||
28041362|NCT03897088|54699486|FG000|Overall Study|Lost to Follow-up|7|||
28041363|NCT03897088|54699487|FG001|Overall Study|Lost to Follow-up|15|||
28041364|NCT03897088|54699486|FG000|Overall Study|Sponsor Decision|1|||
28041365|NCT03897088|54699487|FG001|Overall Study|Sponsor Decision|2|||
28041366|NCT03897088|54699486|FG000|Overall Study|COVID-19|2|||
28041367|NCT03897088|54699487|FG001|Overall Study|COVID-19|0|||
28041368|NCT03897088|54699486|FG000|Overall Study|Other|3|||
28041369|NCT03897088|54699487|FG001|Overall Study|Other|0|||
28041370|NCT03897088|54699486|FG000|Overall Study|Non-compliance with Study Drug|1|||
28041371|NCT03897088|54699487|FG001|Overall Study|Non-compliance with Study Drug|1|||
28041372|NCT03897088|54699486|FG000|Overall Study|Pregnancy|0|||
28041373|NCT03897088|54699487|FG001|Overall Study|Pregnancy|1|||
28041374|NCT03700684|54699515|FG000|Overall Study|COVID-19|0|||
28041375|NCT03700684|54699516|FG001|Overall Study|COVID-19|0|||
28041376|NCT03700684|54699517|FG002|Overall Study|COVID-19|2|||
28041377|NCT03659136|54699527|FG000|Overall Study|Not treated|2|||
28041378|NCT03659136|54699528|FG001|Overall Study|Not treated|0|||
28041379|NCT03659136|54699527|FG000|Overall Study|Covid-19 related|1|||
28041380|NCT03659136|54699528|FG001|Overall Study|Covid-19 related|1|||
28041381|NCT03659136|54699527|FG000|Overall Study|Withdrawal by Subject|1|||
28041382|NCT03659136|54699528|FG001|Overall Study|Withdrawal by Subject|6|||
28041383|NCT03659136|54699527|FG000|Overall Study|Adverse Event|4|||
28041384|NCT03659136|54699528|FG001|Overall Study|Adverse Event|6|||
28041385|NCT03659136|54699527|FG000|Overall Study|Progressive disease|37|||
28041386|NCT03659136|54699528|FG001|Overall Study|Progressive disease|31|||
28041387|NCT03659136|54699527|FG000|Overall Study|Study closure|2|||
28041388|NCT03659136|54699528|FG001|Overall Study|Study closure|2|||
28041389|NCT03659136|54699527|FG000|Overall Study|Sponsor decision/recommendation|3|||
28041390|NCT03659136|54699528|FG001|Overall Study|Sponsor decision/recommendation|2|||
28041391|NCT03659136|54699527|FG000|Overall Study|Switched to other drug/therapy|2|||
28041392|NCT03659136|54699528|FG001|Overall Study|Switched to other drug/therapy|2|||
28041393|NCT03659136|54699527|FG000|Overall Study|Lack of clinical benefit|0|||
28041394|NCT03659136|54699528|FG001|Overall Study|Lack of clinical benefit|1|||
28041395|NCT03390036|54699563|FG000|Overall Study|Lost to Follow-up|1|||
28041396|NCT03390036|54699564|FG001|Overall Study|Lost to Follow-up|0|||
28041397|NCT03390036|54699565|FG002|Overall Study|Lost to Follow-up|0|||
28041398|NCT03390036|54699563|FG000|Overall Study|Lack of Efficacy|1|||
28041399|NCT03390036|54699564|FG001|Overall Study|Lack of Efficacy|0|||
28041400|NCT03390036|54699565|FG002|Overall Study|Lack of Efficacy|0|||
28041401|NCT03366844|54699590|FG000|Overall Study|Physician Decision|1|||
28041402|NCT03366844|54699590|FG000|Overall Study|Unevaluable for co-primary endpoint (did not complete all required biopsies)|5|||
28041403|NCT03341936|54699596|FG000|Overall Study|Ineligible|1|||
28041404|NCT03341936|54699596|FG000|Overall Study|Disease Progression|2|||
28041405|NCT03341936|54699596|FG000|Overall Study|Withdrew Consent|4|||
28041406|NCT03341936|54699596|FG000|Overall Study|Non-Compliance|1|||
28041407|NCT03341936|54699596|FG000|Overall Study|Physician Decision|1|||
28041408|NCT03341936|54699596|FG000|Overall Study|Withdrawal by Subject|1|||
28041409|NCT03341936|54699596|FG000|Overall Study|Other|1|||
28041410|NCT03284203|54699600|FG000|Overall Study|Lost to Follow-up|3|||
28041411|NCT03233724|54699619|FG000|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
28041412|NCT03233724|54699620|FG001|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
28077010|NCT00094458|54731725|FG003|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
28041413|NCT03233724|54699621|FG002|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
28041414|NCT03233724|54699622|FG003|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
28041415|NCT03233724|54699623|FG004|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|1|||
28041416|NCT03233724|54699619|FG000|Phase I Dose Escalation|Best interest of participant|1|||
28041417|NCT03233724|54699620|FG001|Phase I Dose Escalation|Best interest of participant|1|||
28041418|NCT03233724|54699621|FG002|Phase I Dose Escalation|Best interest of participant|1|||
28041419|NCT03233724|54699622|FG003|Phase I Dose Escalation|Best interest of participant|0|||
28041420|NCT03233724|54699623|FG004|Phase I Dose Escalation|Best interest of participant|0|||
28041421|NCT03233724|54699619|FG000|Phase I Dose Escalation|Physician Decision|0|||
28041422|NCT03233724|54699620|FG001|Phase I Dose Escalation|Physician Decision|0|||
28041423|NCT03233724|54699621|FG002|Phase I Dose Escalation|Physician Decision|1|||
28041424|NCT03233724|54699622|FG003|Phase I Dose Escalation|Physician Decision|0|||
28041425|NCT03233724|54699623|FG004|Phase I Dose Escalation|Physician Decision|0|||
28041426|NCT03233724|54699619|FG000|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
28041427|NCT03233724|54699620|FG001|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
28041428|NCT03233724|54699621|FG002|Phase I Dose Escalation|Delay >3 weeks on treatment|1|||
28041429|NCT03233724|54699622|FG003|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
28041430|NCT03233724|54699623|FG004|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
28041431|NCT03026283|54699637|FG000|CCTA Diagnosis|CCTA not performed as planned|9|||
28041432|NCT03026283|54699638|FG001|CCTA Diagnosis|CCTA not performed as planned|0|||
28041433|NCT03026283|54699639|FG002|CCTA Diagnosis|CCTA not performed as planned|0|||
28041434|NCT03026283|54699640|FG003|CCTA Diagnosis|CCTA not performed as planned|0|||
28041435|NCT03026283|54699641|FG004|CCTA Diagnosis|CCTA not performed as planned|0|||
28041436|NCT03026283|54699642|FG005|CCTA Diagnosis|CCTA not performed as planned|0|||
28041437|NCT03026283|54699643|FG006|CCTA Diagnosis|CCTA not performed as planned|0|||
28041438|NCT03026283|54699644|FG007|CCTA Diagnosis|CCTA not performed as planned|0|||
28041439|NCT03026283|54699637|FG000|CCTA Diagnosis|Withdrawal by Subject|5|||
28041440|NCT03026283|54699638|FG001|CCTA Diagnosis|Withdrawal by Subject|0|||
28041441|NCT03026283|54699639|FG002|CCTA Diagnosis|Withdrawal by Subject|0|||
28041442|NCT03026283|54699640|FG003|CCTA Diagnosis|Withdrawal by Subject|0|||
28041443|NCT03026283|54699641|FG004|CCTA Diagnosis|Withdrawal by Subject|0|||
28041444|NCT03026283|54699642|FG005|CCTA Diagnosis|Withdrawal by Subject|0|||
28041445|NCT03026283|54699643|FG006|CCTA Diagnosis|Withdrawal by Subject|0|||
28041446|NCT03026283|54699644|FG007|CCTA Diagnosis|Withdrawal by Subject|0|||
28041447|NCT03026283|54699637|FG000|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
28041448|NCT03026283|54699638|FG001|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3|||
28041449|NCT03026283|54699639|FG002|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
28041450|NCT03026283|54699640|FG003|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
28041451|NCT03026283|54699641|FG004|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
28041452|NCT03026283|54699642|FG005|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
28041453|NCT03026283|54699643|FG006|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
28041454|NCT03026283|54699644|FG007|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
28041455|NCT03026283|54699637|FG000|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
28041456|NCT03026283|54699638|FG001|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
28041457|NCT03026283|54699639|FG002|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15|||
28041458|NCT03026283|54699640|FG003|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
28041459|NCT03026283|54699641|FG004|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
28041460|NCT03026283|54699642|FG005|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
28041461|NCT03026283|54699643|FG006|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
28041462|NCT03026283|54699644|FG007|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
28041463|NCT03026283|54699637|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
28041464|NCT03026283|54699638|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
28041465|NCT03026283|54699639|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
28041466|NCT03026283|54699640|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8|||
28041467|NCT03026283|54699641|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11|||
28041468|NCT03026283|54699642|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
28041469|NCT03026283|54699643|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
28041470|NCT03026283|54699644|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
28041471|NCT03026283|54699637|FG000|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
28041472|NCT03026283|54699638|FG001|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
28041473|NCT03026283|54699639|FG002|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
28041474|NCT03026283|54699640|FG003|Optimal Care/Stress Test/ICA|Lost to Follow-up|9|||
28041475|NCT03026283|54699641|FG004|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
28041476|NCT03026283|54699642|FG005|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
28041477|NCT03026283|54699643|FG006|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
28041478|NCT03026283|54699644|FG007|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
28041479|NCT03026283|54699637|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
28041480|NCT03026283|54699638|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
28041481|NCT03026283|54699639|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
28041482|NCT03026283|54699640|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2|||
28041483|NCT03026283|54699641|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
28041484|NCT03026283|54699642|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7|||
28041485|NCT03026283|54699643|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
28041486|NCT03026283|54699644|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
28041487|NCT03026283|54699637|FG000|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
28041488|NCT03026283|54699638|FG001|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
28041489|NCT03026283|54699639|FG002|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
28041490|NCT03026283|54699640|FG003|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1|||
28041491|NCT03026283|54699641|FG004|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
28041492|NCT03026283|54699642|FG005|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
28041493|NCT03026283|54699643|FG006|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
28041494|NCT03026283|54699644|FG007|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
28041495|NCT03026283|54699637|FG000|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
28041496|NCT03026283|54699638|FG001|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
28041497|NCT03026283|54699639|FG002|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
28041498|NCT03026283|54699640|FG003|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
28041499|NCT03026283|54699641|FG004|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25|||
28041500|NCT03026283|54699642|FG005|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19|||
28041501|NCT03026283|54699643|FG006|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
28041502|NCT03026283|54699644|FG007|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
28041503|NCT02701283|54699678|FG000|Overall Study|Death|25|||
28041504|NCT02701283|54699679|FG001|Overall Study|Death|29|||
28041505|NCT02701283|54699680|FG002|Overall Study|Death|19|||
28041506|NCT02701283|54699678|FG000|Overall Study|Lost to Follow-up|3|||
28041507|NCT02701283|54699679|FG001|Overall Study|Lost to Follow-up|8|||
28041508|NCT02701283|54699680|FG002|Overall Study|Lost to Follow-up|1|||
28041509|NCT02701283|54699678|FG000|Overall Study|Withdrawal by Subject|12|||
28041510|NCT02701283|54699679|FG001|Overall Study|Withdrawal by Subject|41|||
28041511|NCT02701283|54699680|FG002|Overall Study|Withdrawal by Subject|1|||
28041512|NCT02701283|54699678|FG000|Overall Study|Missed 2-year visit|22|||
28041513|NCT02701283|54699679|FG001|Overall Study|Missed 2-year visit|27|||
28041514|NCT02701283|54699680|FG002|Overall Study|Missed 2-year visit|0|||
28041515|NCT02701283|54699678|FG000|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|7|||
28041516|NCT02701283|54699679|FG001|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|57|||
28041517|NCT02701283|54699680|FG002|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|0|||
28041518|NCT02166463|54699727|FG000|Overall Study|Lost to Follow-up|0|||
28041519|NCT02166463|54699728|FG001|Overall Study|Lost to Follow-up|1|||
28041520|NCT02166463|54699727|FG000|Overall Study|Physician Decision|10|||
28041521|NCT02166463|54699728|FG001|Overall Study|Physician Decision|10|||
28041522|NCT02166463|54699727|FG000|Overall Study|Ineligible|11|||
28041523|NCT02166463|54699728|FG001|Overall Study|Ineligible|2|||
28041524|NCT02166463|54699727|FG000|Overall Study|Progressive Disease|9|||
28041525|NCT02166463|54699728|FG001|Overall Study|Progressive Disease|6|||
28041526|NCT02166463|54699727|FG000|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
28041527|NCT02166463|54699728|FG001|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
28041528|NCT02166463|54699727|FG000|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|1|||
28041529|NCT02166463|54699728|FG001|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|0|||
27810807|NCT01834274|54266643|FG001|Overall Study|Lost to Follow-up|1|||
27810808|NCT01834274|54266642|FG000|Overall Study|Other|2|||
27810809|NCT01834274|54266643|FG001|Overall Study|Other|1|||
28041530|NCT02166463|54699727|FG000|Overall Study|Refusal of further protocol therapy|5|||
28041531|NCT02166463|54699728|FG001|Overall Study|Refusal of further protocol therapy|6|||
27810810|NCT01739595|54266652|FG000|Overall Study|Adverse Event|3|||
27810811|NCT01739595|54266653|FG001|Overall Study|Adverse Event|0|||
27810812|NCT01739595|54266654|FG002|Overall Study|Adverse Event|0|||
27810813|NCT01739595|54266652|FG000|Overall Study|Lost to Follow-up|2|||
27810814|NCT01739595|54266653|FG001|Overall Study|Lost to Follow-up|0|||
27810815|NCT01739595|54266654|FG002|Overall Study|Lost to Follow-up|0|||
27810816|NCT01739595|54266652|FG000|Overall Study|Withdrawal by Subject|2|||
27810817|NCT01739595|54266653|FG001|Overall Study|Withdrawal by Subject|1|||
28041532|NCT01994954|54699745|FG000|Overall Study|Death|1|||
28041533|NCT01994954|54699746|FG001|Overall Study|Death|0|||
27810818|NCT01739595|54266654|FG002|Overall Study|Withdrawal by Subject|2|||
27810819|NCT01739595|54266652|FG000|Overall Study|Eligibility issue|3|||
28041534|NCT01994954|54699745|FG000|Overall Study|Withdrawal by Subject|9|||
28041535|NCT01994954|54699746|FG001|Overall Study|Withdrawal by Subject|14|||
28041536|NCT01994954|54699745|FG000|Overall Study|Physician Decision|2|||
28041537|NCT01994954|54699746|FG001|Overall Study|Physician Decision|2|||
28041538|NCT01994954|54699745|FG000|Overall Study|Lost to Follow-up|8|||
28041539|NCT01994954|54699746|FG001|Overall Study|Lost to Follow-up|10|||
28041540|NCT01994954|54699745|FG000|Overall Study|6 Month Follow-up Not Complete|5|||
28041541|NCT01994954|54699746|FG001|Overall Study|6 Month Follow-up Not Complete|4|||
28041542|NCT01902173|54699764|FG000|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1|||
28041543|NCT01902173|54699765|FG001|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
28041544|NCT01902173|54699766|FG002|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
28041545|NCT01902173|54699767|FG003|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
28041546|NCT01902173|54699768|FG004|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
28041547|NCT01902173|54699769|FG005|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
28041548|NCT01902173|54699764|FG000|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2|||
28041549|NCT01902173|54699765|FG001|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
28041550|NCT01902173|54699766|FG002|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
28041551|NCT01902173|54699767|FG003|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
28041552|NCT01902173|54699768|FG004|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
28041553|NCT01902173|54699769|FG005|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
28041554|NCT01902173|54699764|FG000|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
28041555|NCT01902173|54699765|FG001|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5|||
28041556|NCT01902173|54699766|FG002|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
28041557|NCT01902173|54699767|FG003|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
28041558|NCT01902173|54699768|FG004|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
28041559|NCT01902173|54699769|FG005|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
28041560|NCT01902173|54699764|FG000|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
28041561|NCT01902173|54699765|FG001|Phase 1 Doublet Regimen Cohort 2|Ineligible|1|||
28041562|NCT01902173|54699766|FG002|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
28041563|NCT01902173|54699767|FG003|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
28041564|NCT01902173|54699768|FG004|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
28041565|NCT01902173|54699769|FG005|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
28041566|NCT01902173|54699764|FG000|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
28041567|NCT01902173|54699765|FG001|Phase 1 Doublet Regimen Cohort 2|No treated|3|||
28041568|NCT01902173|54699766|FG002|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
28041569|NCT01902173|54699767|FG003|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
28041570|NCT01902173|54699768|FG004|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
28041571|NCT01902173|54699769|FG005|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
28041572|NCT01902173|54699764|FG000|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
28041573|NCT01902173|54699765|FG001|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
28041574|NCT01902173|54699766|FG002|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3|||
28041575|NCT01902173|54699767|FG003|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
28041576|NCT01902173|54699768|FG004|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
28041577|NCT01902173|54699769|FG005|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
28041578|NCT01902173|54699764|FG000|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
28041579|NCT01902173|54699765|FG001|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
28041580|NCT01902173|54699766|FG002|Phase 1 Triplet Regimen Cohort 1|Ineligible|1|||
28041581|NCT01902173|54699767|FG003|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
28041582|NCT01902173|54699768|FG004|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
28041583|NCT01902173|54699769|FG005|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
28041584|NCT01902173|54699764|FG000|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
28041585|NCT01902173|54699765|FG001|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
28041586|NCT01902173|54699766|FG002|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
28041587|NCT01902173|54699767|FG003|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1|||
28041588|NCT01902173|54699768|FG004|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
28041589|NCT01902173|54699769|FG005|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
28041590|NCT01902173|54699764|FG000|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
28041591|NCT01902173|54699765|FG001|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
28041592|NCT01902173|54699766|FG002|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
28041593|NCT01902173|54699767|FG003|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2|||
28041594|NCT01902173|54699768|FG004|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
28041595|NCT01902173|54699769|FG005|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
28041596|NCT01902173|54699764|FG000|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
28041597|NCT01902173|54699765|FG001|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
28041598|NCT01902173|54699766|FG002|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
28041599|NCT01902173|54699767|FG003|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
28041600|NCT01902173|54699768|FG004|Phase 1 Triplet Regimen Cohort 3|Ongoing|1|||
28041601|NCT01902173|54699769|FG005|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
28041602|NCT01902173|54699764|FG000|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
28041603|NCT01902173|54699765|FG001|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
28041604|NCT01902173|54699766|FG002|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
28041605|NCT01902173|54699767|FG003|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
28041606|NCT01902173|54699768|FG004|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2|||
28041607|NCT01902173|54699769|FG005|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
28041608|NCT01902173|54699764|FG000|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
28041609|NCT01902173|54699765|FG001|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
28041610|NCT01902173|54699766|FG002|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
27810820|NCT01739595|54266653|FG001|Overall Study|Eligibility issue|0|||
28041611|NCT01902173|54699767|FG003|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
28041612|NCT01902173|54699768|FG004|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
28041613|NCT01902173|54699769|FG005|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1|||
28041614|NCT01902173|54699764|FG000|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
28041615|NCT01902173|54699765|FG001|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
28041616|NCT01902173|54699766|FG002|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
28041617|NCT01902173|54699767|FG003|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
28041618|NCT01902173|54699768|FG004|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
28041619|NCT01902173|54699769|FG005|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3|||
28041620|NCT01902173|54699764|FG000|Phase 1 Triplet Regimen Cohort 4|Death|0|||
28041621|NCT01902173|54699765|FG001|Phase 1 Triplet Regimen Cohort 4|Death|0|||
28041622|NCT01902173|54699766|FG002|Phase 1 Triplet Regimen Cohort 4|Death|0|||
28041623|NCT01902173|54699767|FG003|Phase 1 Triplet Regimen Cohort 4|Death|0|||
28041624|NCT01902173|54699768|FG004|Phase 1 Triplet Regimen Cohort 4|Death|0|||
28041625|NCT01902173|54699769|FG005|Phase 1 Triplet Regimen Cohort 4|Death|1|||
28041626|NCT01772472|54699809|FG000|Overall Study|Death|56|||
28041627|NCT01772472|54699810|FG001|Overall Study|Death|42|||
28041628|NCT01772472|54699809|FG000|Overall Study|Physician Decision|1|||
28041629|NCT01772472|54699810|FG001|Overall Study|Physician Decision|3|||
28041630|NCT01772472|54699809|FG000|Overall Study|Other|5|||
28041631|NCT01772472|54699810|FG001|Overall Study|Other|5|||
28041632|NCT01772472|54699809|FG000|Overall Study|Lost to Follow-up|12|||
28041633|NCT01772472|54699810|FG001|Overall Study|Lost to Follow-up|8|||
28041634|NCT01772472|54699809|FG000|Overall Study|Withdrawal by Subject|72|||
28041635|NCT01772472|54699810|FG001|Overall Study|Withdrawal by Subject|50|||
28041636|NCT01772472|54699809|FG000|Overall Study|Ongoing|597|||
28041637|NCT01772472|54699810|FG001|Overall Study|Ongoing|635|||
28041638|NCT01522976|54699819|FG000|Overall Study|Ineligible|4|||
28041639|NCT01522976|54699820|FG001|Overall Study|Ineligible|0|||
27810821|NCT01739595|54266654|FG002|Overall Study|Eligibility issue|0|||
27810822|NCT01739595|54266652|FG000|Overall Study|Protocol Violation|1|||
27810823|NCT01739595|54266653|FG001|Overall Study|Protocol Violation|0|||
27810824|NCT01739595|54266654|FG002|Overall Study|Protocol Violation|0|||
27810825|NCT01739595|54266652|FG000|Overall Study|Lab assessment|1|||
27810826|NCT01739595|54266653|FG001|Overall Study|Lab assessment|0|||
27810827|NCT01739595|54266654|FG002|Overall Study|Lab assessment|0|||
27810828|NCT01739595|54266652|FG000|Overall Study|Drug discrepancy|1|||
27810829|NCT01739595|54266653|FG001|Overall Study|Drug discrepancy|0|||
27810830|NCT01739595|54266654|FG002|Overall Study|Drug discrepancy|0|||
27810831|NCT01833494|54266661|FG000|Overall Study|Adverse Event|24|||
27810832|NCT01833494|54266661|FG000|Overall Study|Physician Decision|6|||
28041640|NCT01522976|54699821|FG002|Overall Study|Ineligible|1|||
28041641|NCT01522976|54699819|FG000|Overall Study|Death|7|||
28041642|NCT01522976|54699820|FG001|Overall Study|Death|6|||
28041643|NCT01522976|54699821|FG002|Overall Study|Death|2|||
28041644|NCT01522976|54699819|FG000|Overall Study|Still on treatment|9|||
28041645|NCT01522976|54699820|FG001|Overall Study|Still on treatment|9|||
27810833|NCT01833494|54266661|FG000|Overall Study|Withdrawal by Subject|6|||
27810834|NCT01833494|54266661|FG000|Overall Study|Decrease in serum phosphorus|4|||
27810835|NCT01833494|54266661|FG000|Overall Study|Decrease in serum calcium|4|||
27810836|NCT01833494|54266661|FG000|Overall Study|Increase in serum ferritin|1|||
27810837|NCT01738971|54266668|FG000|Overall Study|Lost to Follow-up|19|||
27810838|NCT01738971|54266669|FG001|Overall Study|Lost to Follow-up|30|||
27810839|NCT01738971|54266670|FG002|Overall Study|Lost to Follow-up|17|||
27810840|NCT01738581|54266680|FG000|Overall Study|Lost to Follow-up|1|||
27810841|NCT01738581|54266681|FG001|Overall Study|Lost to Follow-up|0|||
28041646|NCT01522976|54699821|FG002|Overall Study|Still on treatment|6|||
28041647|NCT01522976|54699819|FG000|Overall Study|Disease progression|28|||
27810842|NCT01738503|54266693|FG000|Induction/Stabilization (Days -14 to -1)|Other|35|||
27810843|NCT01738503|54266694|FG001|Induction/Stabilization (Days -14 to -1)|Other|0|||
28041648|NCT01522976|54699820|FG001|Overall Study|Disease progression|30|||
28041649|NCT01522976|54699821|FG002|Overall Study|Disease progression|25|||
28041650|NCT01522976|54699819|FG000|Overall Study|Adverse Event|17|||
28041651|NCT01522976|54699820|FG001|Overall Study|Adverse Event|7|||
28041652|NCT01522976|54699821|FG002|Overall Study|Adverse Event|18|||
28041653|NCT01522976|54699819|FG000|Overall Study|Refusal unrelated to adverse event|10|||
28041654|NCT01522976|54699820|FG001|Overall Study|Refusal unrelated to adverse event|13|||
28041655|NCT01522976|54699821|FG002|Overall Study|Refusal unrelated to adverse event|14|||
28041656|NCT01522976|54699819|FG000|Overall Study|Not protocol specified|22|||
28041657|NCT01522976|54699820|FG001|Overall Study|Not protocol specified|27|||
28041658|NCT01522976|54699821|FG002|Overall Study|Not protocol specified|27|||
28041659|NCT00861705|54699873|FG000|Overall Study|Never Began Treatment|7|||
28041660|NCT00861705|54699874|FG001|Overall Study|Never Began Treatment|3|||
28041661|NCT00861705|54699875|FG002|Overall Study|Never Began Treatment|0|||
28041662|NCT00861705|54699876|FG003|Overall Study|Never Began Treatment|1|||
28041663|NCT00380367|54699901|FG000|Overall Study|Lost to Follow-up|1|||
28041664|NCT00380367|54699901|FG000|Overall Study|Withdrawal by Subject|1|||
28041665|NCT00531050|54699911|FG000|Part 1: Period 1|Adverse Event|0|||
28041666|NCT00531050|54699912|FG001|Part 1: Period 1|Adverse Event|1|||
28041667|NCT00531050|54699913|FG002|Part 1: Period 1|Adverse Event|0|||
28041668|NCT00531050|54699914|FG003|Part 1: Period 1|Adverse Event|0|||
28041669|NCT00531050|54699915|FG004|Part 1: Period 1|Adverse Event|0|||
28041670|NCT00531050|54699916|FG005|Part 1: Period 1|Adverse Event|0|||
28041671|NCT00531050|54699911|FG000|Part 1: Period 1|Protocol Deviation|0|||
28041672|NCT00531050|54699912|FG001|Part 1: Period 1|Protocol Deviation|0|||
28041673|NCT00531050|54699913|FG002|Part 1: Period 1|Protocol Deviation|0|||
28041674|NCT00531050|54699914|FG003|Part 1: Period 1|Protocol Deviation|1|||
28041675|NCT00531050|54699915|FG004|Part 1: Period 1|Protocol Deviation|0|||
28041676|NCT00531050|54699916|FG005|Part 1: Period 1|Protocol Deviation|0|||
28041677|NCT00531050|54699911|FG000|Part 1: Period 3|Adverse Event|1|||
28041678|NCT00531050|54699912|FG001|Part 1: Period 3|Adverse Event|0|||
28041679|NCT00531050|54699913|FG002|Part 1: Period 3|Adverse Event|0|||
28041680|NCT00531050|54699914|FG003|Part 1: Period 3|Adverse Event|0|||
28041681|NCT00531050|54699915|FG004|Part 1: Period 3|Adverse Event|0|||
28041682|NCT00531050|54699916|FG005|Part 1: Period 3|Adverse Event|0|||
28041683|NCT00531050|54699911|FG000|Part 2: Period 1|Adverse Event|0|||
28041684|NCT00531050|54699912|FG001|Part 2: Period 1|Adverse Event|0|||
28041685|NCT00531050|54699913|FG002|Part 2: Period 1|Adverse Event|0|||
28041686|NCT00531050|54699914|FG003|Part 2: Period 1|Adverse Event|0|||
28041687|NCT00531050|54699915|FG004|Part 2: Period 1|Adverse Event|0|||
28041688|NCT00531050|54699916|FG005|Part 2: Period 1|Adverse Event|1|||
28041689|NCT00531050|54699911|FG000|Part 2: Period 3|Abnormal test procedure|1|||
28041690|NCT00531050|54699912|FG001|Part 2: Period 3|Abnormal test procedure|0|||
28041691|NCT00531050|54699913|FG002|Part 2: Period 3|Abnormal test procedure|0|||
28041692|NCT00531050|54699914|FG003|Part 2: Period 3|Abnormal test procedure|0|||
28041693|NCT00531050|54699915|FG004|Part 2: Period 3|Abnormal test procedure|0|||
28041694|NCT00531050|54699916|FG005|Part 2: Period 3|Abnormal test procedure|1|||
28041695|NCT00530348|54699935|FG000|Overall Study|Adverse Event|5|||
28041696|NCT00530348|54699936|FG001|Overall Study|Adverse Event|1|||
28041697|NCT00530348|54699935|FG000|Overall Study|Death|0|||
28041698|NCT00530348|54699936|FG001|Overall Study|Death|1|||
28041699|NCT00530348|54699935|FG000|Overall Study|Lack of Efficacy|2|||
28041700|NCT00530348|54699936|FG001|Overall Study|Lack of Efficacy|0|||
28041701|NCT00530348|54699935|FG000|Overall Study|Lost to Follow-up|0|||
28041702|NCT00530348|54699936|FG001|Overall Study|Lost to Follow-up|2|||
28041703|NCT00530348|54699935|FG000|Overall Study|Physician Decision|1|||
28041704|NCT00530348|54699936|FG001|Overall Study|Physician Decision|2|||
28041705|NCT00530348|54699935|FG000|Overall Study|Pregnancy|1|||
28041706|NCT00530348|54699936|FG001|Overall Study|Pregnancy|0|||
28041707|NCT00530348|54699935|FG000|Overall Study|Withdrawal by Subject|12|||
28041708|NCT00530348|54699936|FG001|Overall Study|Withdrawal by Subject|12|||
28041709|NCT00530348|54699935|FG000|Overall Study|Randomised in error|1|||
28041710|NCT00530348|54699936|FG001|Overall Study|Randomised in error|0|||
28041711|NCT00530348|54699935|FG000|Overall Study|Noncompliance with inclusion criterion 3|0|||
28041712|NCT00530348|54699936|FG001|Overall Study|Noncompliance with inclusion criterion 3|1|||
28041713|NCT03886220|54699944|FG000|Treatment Period|Discontinued study drug during the treatment period|5|||
28041714|NCT03886220|54699945|FG001|Treatment Period|Discontinued study drug during the treatment period|12|||
28041715|NCT03886220|54699944|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
28041716|NCT03886220|54699945|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
28041717|NCT03886220|54699944|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
28041718|NCT03886220|54699945|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
28041719|NCT00530270|54699953|FG000|Overall Study|Protocol Violation|1|||
28041720|NCT00530270|54699954|FG001|Overall Study|Protocol Violation|0|||
28041721|NCT03885596|54699964|FG000|Overall Study|Withdrawal by Subject|2|||
27810844|NCT01738503|54266695|FG002|Induction/Stabilization (Days -14 to -1)|Other|0|||
28041722|NCT03885596|54699965|FG001|Overall Study|Withdrawal by Subject|1|||
28041723|NCT03885596|54699966|FG002|Overall Study|Withdrawal by Subject|0|||
28041724|NCT03885596|54699967|FG003|Overall Study|Withdrawal by Subject|0|||
28041725|NCT00529100|54699983|FG000|Overall Study|Adverse Event|0|||
28041726|NCT00529100|54699984|FG001|Overall Study|Adverse Event|5|||
28041727|NCT00529100|54699983|FG000|Overall Study|Protocol Violation|0|||
28041728|NCT00529100|54699984|FG001|Overall Study|Protocol Violation|1|||
28041729|NCT00529100|54699983|FG000|Overall Study|Progressive Disease|0|||
28041730|NCT00529100|54699984|FG001|Overall Study|Progressive Disease|1|||
28041731|NCT00529100|54699983|FG000|Overall Study|Withdrawal by Subject|0|||
28041732|NCT00529100|54699984|FG001|Overall Study|Withdrawal by Subject|1|||
28041733|NCT00529100|54699983|FG000|Overall Study|Participant Ineligibility|0|||
28041734|NCT00529100|54699984|FG001|Overall Study|Participant Ineligibility|1|||
28041735|NCT03878108|54699996|FG000|Overall Study|Adverse Event|1|||
28041736|NCT03878108|54699997|FG001|Overall Study|Adverse Event|0|||
28041737|NCT00529958|54700006|FG000|2-Year Follow-up|Lost to Follow-up|1|||
28041738|NCT00529958|54700007|FG001|2-Year Follow-up|Lost to Follow-up|2|||
28041739|NCT00529958|54700008|FG002|2-Year Follow-up|Lost to Follow-up|2|||
28041740|NCT00529958|54700006|FG000|2-Year Follow-up|Withdrawal by Subject|3|||
28041741|NCT00529958|54700007|FG001|2-Year Follow-up|Withdrawal by Subject|0|||
28041742|NCT00529958|54700008|FG002|2-Year Follow-up|Withdrawal by Subject|0|||
28041743|NCT00529958|54700006|FG000|5-Year Follow-up|Lost to Follow-up|2|||
28041744|NCT00529958|54700007|FG001|5-Year Follow-up|Lost to Follow-up|3|||
28041745|NCT00529958|54700008|FG002|5-Year Follow-up|Lost to Follow-up|1|||
28041746|NCT00529958|54700006|FG000|5-Year Follow-up|Withdrawal by Subject|1|||
28041747|NCT00529958|54700007|FG001|5-Year Follow-up|Withdrawal by Subject|0|||
28041748|NCT00529958|54700008|FG002|5-Year Follow-up|Withdrawal by Subject|0|||
28041749|NCT00529802|54700016|FG000|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3|||
28041750|NCT00529802|54700016|FG000|Evaluable for Primary Endpoint|Worsening performance status|2|||
28041751|NCT00529802|54700016|FG000|Evaluable for Primary Endpoint|Adverse Event|2|||
28041752|NCT00529802|54700016|FG000|Evaluable for Primary Endpoint|Death|1|||
28041753|NCT00529802|54700016|FG000|Evaluable for Primary Endpoint|Lack of Efficacy|1|||
28041754|NCT00529802|54700016|FG000|Evaluable for Primary Endpoint|Lost to Follow-up|1|||
28041755|NCT00529802|54700016|FG000|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2|||
28041756|NCT00528866|54700022|FG000|Overall Study|Protocol Violation|6|||
28041757|NCT00614393|54700032|FG000|Overall Study|Adverse Event|20|||
28041758|NCT00614393|54700033|FG001|Overall Study|Adverse Event|2|||
28041759|NCT00614393|54700034|FG002|Overall Study|Adverse Event|3|||
28041760|NCT00614393|54700035|FG003|Overall Study|Adverse Event|13|||
28041761|NCT00614393|54700036|FG004|Overall Study|Adverse Event|21|||
28041762|NCT00614393|54700032|FG000|Overall Study|Lost to Follow-up|0|||
28041763|NCT00614393|54700033|FG001|Overall Study|Lost to Follow-up|0|||
28041764|NCT00614393|54700034|FG002|Overall Study|Lost to Follow-up|0|||
28041765|NCT00614393|54700035|FG003|Overall Study|Lost to Follow-up|1|||
28041766|NCT00614393|54700036|FG004|Overall Study|Lost to Follow-up|2|||
28041767|NCT00614393|54700032|FG000|Overall Study|Physician Decision|17|||
28041768|NCT00614393|54700033|FG001|Overall Study|Physician Decision|0|||
28041769|NCT00614393|54700034|FG002|Overall Study|Physician Decision|1|||
28041770|NCT00614393|54700035|FG003|Overall Study|Physician Decision|8|||
28041771|NCT00614393|54700036|FG004|Overall Study|Physician Decision|9|||
28041772|NCT00614393|54700032|FG000|Overall Study|Progressive Disease|118|||
28041773|NCT00614393|54700033|FG001|Overall Study|Progressive Disease|5|||
28041774|NCT00614393|54700034|FG002|Overall Study|Progressive Disease|5|||
28041775|NCT00614393|54700035|FG003|Overall Study|Progressive Disease|138|||
28041776|NCT00614393|54700036|FG004|Overall Study|Progressive Disease|130|||
28041777|NCT00614393|54700032|FG000|Overall Study|Protocol Violation|1|||
28041778|NCT00614393|54700033|FG001|Overall Study|Protocol Violation|0|||
28041779|NCT00614393|54700034|FG002|Overall Study|Protocol Violation|0|||
28041780|NCT00614393|54700035|FG003|Overall Study|Protocol Violation|0|||
28041781|NCT00614393|54700036|FG004|Overall Study|Protocol Violation|0|||
28041782|NCT00614393|54700032|FG000|Overall Study|Terminated by Sponsor|0|||
28041783|NCT00614393|54700033|FG001|Overall Study|Terminated by Sponsor|0|||
28041784|NCT00614393|54700034|FG002|Overall Study|Terminated by Sponsor|0|||
28041785|NCT00614393|54700035|FG003|Overall Study|Terminated by Sponsor|0|||
28041786|NCT00614393|54700036|FG004|Overall Study|Terminated by Sponsor|1|||
28041787|NCT00614393|54700032|FG000|Overall Study|Withdrawal by Subject|20|||
28041788|NCT00614393|54700033|FG001|Overall Study|Withdrawal by Subject|1|||
28041789|NCT00614393|54700034|FG002|Overall Study|Withdrawal by Subject|1|||
28041790|NCT00614393|54700035|FG003|Overall Study|Withdrawal by Subject|16|||
28041791|NCT00614393|54700036|FG004|Overall Study|Withdrawal by Subject|13|||
28041792|NCT00614393|54700032|FG000|Overall Study|Other|4|||
28041793|NCT00614393|54700033|FG001|Overall Study|Other|0|||
28041794|NCT00614393|54700034|FG002|Overall Study|Other|0|||
28041795|NCT00614393|54700035|FG003|Overall Study|Other|4|||
28041796|NCT00614393|54700036|FG004|Overall Study|Other|2|||
28041797|NCT00614393|54700032|FG000|Overall Study|Not Treated|0|||
28041798|NCT00614393|54700033|FG001|Overall Study|Not Treated|0|||
28041799|NCT00614393|54700034|FG002|Overall Study|Not Treated|0|||
28041800|NCT00614393|54700035|FG003|Overall Study|Not Treated|0|||
28041801|NCT00614393|54700036|FG004|Overall Study|Not Treated|2|||
28041802|NCT00612677|54700048|FG000|Overall Study|study closed before treatment started|1|||
28041803|NCT00613925|54700054|FG000|Overall Study|1 did not tolerate outpatient biopsy|0|||
28041804|NCT00613925|54700055|FG001|Overall Study|1 did not tolerate outpatient biopsy|1|||
28041805|NCT00613301|54700061|FG000|Overall Study|Adverse Event|49|||
28041806|NCT00613301|54700061|FG000|Overall Study|Lost to Follow-up|88|||
28041807|NCT00613301|54700061|FG000|Overall Study|Withdrawal by Subject|5|||
28041808|NCT00613301|54700061|FG000|Overall Study|Death|6|||
28041809|NCT00613301|54700061|FG000|Overall Study|Lack of Efficacy|13|||
28041810|NCT00613301|54700061|FG000|Overall Study|Physician Decision|2|||
28041811|NCT00613301|54700061|FG000|Overall Study|No data was collected|53|||
28041812|NCT00613301|54700061|FG000|Overall Study|Irregularly enrolled patients|12|||
28041813|NCT00609947|54700066|FG000|Overall Study|Death|1|||
28041814|NCT00609869|54700071|FG000|Overall Study|Withdrawn, ischemic stroke|1|||
28041815|NCT00609869|54700071|FG000|Overall Study|Severe hematologic toxicity|1|||
28041816|NCT00609869|54700071|FG000|Overall Study|Withdrawal by Subject|1|||
28041817|NCT00609869|54700071|FG000|Overall Study|Seizures|1|||
28041818|NCT00609869|54700071|FG000|Overall Study|Severe tumor flare reaction|1|||
28041819|NCT00609869|54700071|FG000|Overall Study|Hepatitis B infection|1|||
28041820|NCT00609869|54700071|FG000|Overall Study|Rituximab reaction prior to lenalidomide|1|||
28041821|NCT00609869|54700071|FG000|Overall Study|Mantle cell: not evaluable|4|||
28041822|NCT00529568|54700077|FG000|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5|||
28041823|NCT00529568|54700078|FG001|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
28041824|NCT00529568|54700079|FG002|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
28041825|NCT00529568|54700077|FG000|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12|||
28041826|NCT00529568|54700078|FG001|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
28041827|NCT00529568|54700079|FG002|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
28041828|NCT00529568|54700077|FG000|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5|||
28041829|NCT00529568|54700078|FG001|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
28041830|NCT00529568|54700079|FG002|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
28041831|NCT00529568|54700077|FG000|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8|||
28041832|NCT00529568|54700078|FG001|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
28041833|NCT00529568|54700079|FG002|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
28041834|NCT00529568|54700077|FG000|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13|||
28041835|NCT00529568|54700078|FG001|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
28041836|NCT00529568|54700079|FG002|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
28041837|NCT00529568|54700077|FG000|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3|||
28041838|NCT00529568|54700078|FG001|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
28041839|NCT00529568|54700079|FG002|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
28041840|NCT00529568|54700077|FG000|Double-bilnd Antiviral Treatment Phase|Adverse Event|0|||
28041841|NCT00529568|54700078|FG001|Double-bilnd Antiviral Treatment Phase|Adverse Event|10|||
28041842|NCT00529568|54700079|FG002|Double-bilnd Antiviral Treatment Phase|Adverse Event|27|||
28041843|NCT00529568|54700077|FG000|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
28041844|NCT00529568|54700078|FG001|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1|||
28041845|NCT00529568|54700079|FG002|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
28041846|NCT00529568|54700077|FG000|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0|||
28041847|NCT00529568|54700078|FG001|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15|||
28041848|NCT00529568|54700079|FG002|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48|||
28041849|NCT00529568|54700077|FG000|Double-bilnd Antiviral Treatment Phase|Physician Decision|0|||
28041850|NCT00529568|54700078|FG001|Double-bilnd Antiviral Treatment Phase|Physician Decision|5|||
28041851|NCT00529568|54700079|FG002|Double-bilnd Antiviral Treatment Phase|Physician Decision|8|||
28041852|NCT00529568|54700077|FG000|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0|||
28041853|NCT00529568|54700078|FG001|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17|||
28041854|NCT00529568|54700079|FG002|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19|||
28041855|NCT00611975|54700090|FG000|Overall Study|Withdrawal by Subject|3|||
28041856|NCT00611975|54700091|FG001|Overall Study|Withdrawal by Subject|7|||
28041857|NCT00611975|54700090|FG000|Overall Study|Pregnancy|2|||
28041858|NCT00611975|54700091|FG001|Overall Study|Pregnancy|1|||
28041859|NCT00573131|54700099|FG000|Overall Study|Withdrawal by Subject|10|||
28041860|NCT00573131|54700100|FG001|Overall Study|Withdrawal by Subject|8|||
28041861|NCT00521144|54700111|FG000|Overall Study|Not Treated|0|||
28041862|NCT00521144|54700112|FG001|Overall Study|Not Treated|0|||
28041863|NCT00521144|54700113|FG002|Overall Study|Not Treated|0|||
28041864|NCT00521144|54700114|FG003|Overall Study|Not Treated|1|||
28041865|NCT00521144|54700115|FG004|Overall Study|Not Treated|0|||
28041866|NCT00521144|54700111|FG000|Overall Study|Adverse Event|0|||
28041867|NCT00521144|54700112|FG001|Overall Study|Adverse Event|1|||
28041868|NCT00521144|54700113|FG002|Overall Study|Adverse Event|0|||
28041869|NCT00521144|54700114|FG003|Overall Study|Adverse Event|0|||
28041870|NCT00521144|54700115|FG004|Overall Study|Adverse Event|1|||
28041871|NCT00521144|54700111|FG000|Overall Study|Progressive Disease|4|||
28041872|NCT00521144|54700112|FG001|Overall Study|Progressive Disease|2|||
28041873|NCT00521144|54700113|FG002|Overall Study|Progressive Disease|2|||
28041874|NCT00521144|54700114|FG003|Overall Study|Progressive Disease|0|||
28041875|NCT00521144|54700115|FG004|Overall Study|Progressive Disease|6|||
28041876|NCT00520676|54700129|FG000|Overall Study|Death|84|||
28041877|NCT00520676|54700130|FG001|Overall Study|Death|81|||
28041878|NCT00520676|54700129|FG000|Overall Study|Lost to Follow-up|6|||
28041879|NCT00520676|54700130|FG001|Overall Study|Lost to Follow-up|10|||
28041880|NCT00520676|54700129|FG000|Overall Study|Physician Decision|4|||
28041881|NCT00520676|54700130|FG001|Overall Study|Physician Decision|1|||
28041882|NCT00520676|54700129|FG000|Overall Study|Withdrawal by Subject|7|||
28041883|NCT00520676|54700130|FG001|Overall Study|Withdrawal by Subject|11|||
28041884|NCT00610649|54700147|FG000|Overall Study|Adverse Event|1|||
28041885|NCT00610649|54700148|FG001|Overall Study|Adverse Event|0|||
28041886|NCT00610649|54700149|FG002|Overall Study|Adverse Event|0|||
28041887|NCT00610649|54700150|FG003|Overall Study|Adverse Event|0|||
28041888|NCT00610649|54700151|FG004|Overall Study|Adverse Event|0|||
28041889|NCT00610649|54700152|FG005|Overall Study|Adverse Event|0|||
28041890|NCT00610649|54700153|FG006|Overall Study|Adverse Event|0|||
28041891|NCT00610649|54700154|FG007|Overall Study|Adverse Event|0|||
28041892|NCT00610649|54700155|FG008|Overall Study|Adverse Event|0|||
28041893|NCT00610649|54700156|FG009|Overall Study|Adverse Event|0|||
28041894|NCT00610649|54700157|FG010|Overall Study|Adverse Event|1|||
28041895|NCT00610649|54700147|FG000|Overall Study|Family Emergency|0|||
28041896|NCT00610649|54700148|FG001|Overall Study|Family Emergency|1|||
28041897|NCT00610649|54700149|FG002|Overall Study|Family Emergency|0|||
28041898|NCT00610649|54700150|FG003|Overall Study|Family Emergency|0|||
28041899|NCT00610649|54700151|FG004|Overall Study|Family Emergency|0|||
28041900|NCT00610649|54700152|FG005|Overall Study|Family Emergency|0|||
28041901|NCT00610649|54700153|FG006|Overall Study|Family Emergency|0|||
28041902|NCT00610649|54700154|FG007|Overall Study|Family Emergency|0|||
28041903|NCT00610649|54700155|FG008|Overall Study|Family Emergency|0|||
28041904|NCT00610649|54700156|FG009|Overall Study|Family Emergency|0|||
28041905|NCT00610649|54700157|FG010|Overall Study|Family Emergency|0|||
28041906|NCT00610649|54700147|FG000|Overall Study|Withdrawal by Subject|0|||
28041907|NCT00610649|54700148|FG001|Overall Study|Withdrawal by Subject|0|||
28041908|NCT00610649|54700149|FG002|Overall Study|Withdrawal by Subject|0|||
28041909|NCT00610649|54700150|FG003|Overall Study|Withdrawal by Subject|0|||
28041910|NCT00610649|54700151|FG004|Overall Study|Withdrawal by Subject|0|||
28041911|NCT00610649|54700152|FG005|Overall Study|Withdrawal by Subject|0|||
28041912|NCT00610649|54700153|FG006|Overall Study|Withdrawal by Subject|0|||
28041913|NCT00610649|54700154|FG007|Overall Study|Withdrawal by Subject|0|||
28041914|NCT00610649|54700155|FG008|Overall Study|Withdrawal by Subject|0|||
28041915|NCT00610649|54700156|FG009|Overall Study|Withdrawal by Subject|1|||
28041916|NCT00610649|54700157|FG010|Overall Study|Withdrawal by Subject|0|||
28041917|NCT00608543|54700181|FG000|Overall Study|Adverse Event|4|||
27810845|NCT01738503|54266696|FG003|Induction/Stabilization (Days -14 to -1)|Other|0|||
27810846|NCT01738503|54266697|FG004|Induction/Stabilization (Days -14 to -1)|Other|0|||
27810847|NCT01738503|54266698|FG005|Induction/Stabilization (Days -14 to -1)|Other|0|||
27810848|NCT01738503|54266699|FG006|Induction/Stabilization (Days -14 to -1)|Other|0|||
27810849|NCT01738503|54266693|FG000|Treatment Period|Adverse Event|0|||
27810850|NCT01738503|54266694|FG001|Treatment Period|Adverse Event|1|||
27810851|NCT01738503|54266695|FG002|Treatment Period|Adverse Event|0|||
27810852|NCT01738503|54266696|FG003|Treatment Period|Adverse Event|1|||
27810853|NCT01738503|54266697|FG004|Treatment Period|Adverse Event|2|||
27810854|NCT01738503|54266698|FG005|Treatment Period|Adverse Event|2|||
27810855|NCT01738503|54266699|FG006|Treatment Period|Adverse Event|2|||
27810856|NCT01738503|54266693|FG000|Treatment Period|Lost to Follow-up|0|||
28041918|NCT00520130|54700188|FG000|Overall Study|Disease progression on study|4|||
28105675|NCT03694353|54763227|FG000|Overall Study|Withdrawal by Subject|1|||
28105676|NCT03694353|54763227|FG000|Overall Study|Subject received <= 40 mg/day for > 32 weeks|1|||
28105677|NCT04521777|54763231|FG000|Overall Study|Death|2|||
28105678|NCT04521777|54763231|FG000|Overall Study|Withdrawal by Subject|2|||
28105679|NCT03700671|54763237|FG000|Overall Study|Lack of Efficacy|1|||
28105680|NCT03700671|54763238|FG001|Overall Study|Lack of Efficacy|2|||
28105681|NCT04764669|54763250|FG000|Overall Study|Adverse Event|1|||
28105682|NCT04764669|54763251|FG001|Overall Study|Adverse Event|0|||
28105683|NCT04764669|54763252|FG002|Overall Study|Adverse Event|1|||
28105684|NCT04764669|54763253|FG003|Overall Study|Adverse Event|0|||
28105685|NCT04764669|54763250|FG000|Overall Study|Subject Choice|0|||
28105686|NCT04764669|54763251|FG001|Overall Study|Subject Choice|0|||
28041919|NCT00520130|54700189|FG001|Overall Study|Disease progression on study|0|||
28041920|NCT00520130|54700188|FG000|Overall Study|Physician Decision|1|||
28041921|NCT00520130|54700189|FG001|Overall Study|Physician Decision|1|||
28041922|NCT00519896|54700199|FG000|Overall Study|Protocol Violation|1|||
28041923|NCT00519896|54700199|FG000|Overall Study|Adverse Event|1|||
28041924|NCT00527618|54700212|FG000|Week 1-12 (First Intervention)|Lost to Follow-up|3|||
28041925|NCT00527618|54700213|FG001|Week 1-12 (First Intervention)|Lost to Follow-up|1|||
28041926|NCT00527618|54700212|FG000|Week 1-12 (First Intervention)|Adverse Event|0|||
28041927|NCT00527618|54700213|FG001|Week 1-12 (First Intervention)|Adverse Event|1|||
28105687|NCT04764669|54763252|FG002|Overall Study|Subject Choice|1|||
28105688|NCT04764669|54763253|FG003|Overall Study|Subject Choice|0|||
28105689|NCT04764669|54763250|FG000|Overall Study|Withdrawal by Subject|2|||
28041928|NCT00527618|54700212|FG000|Week 13-14 (Washout)|Lost to Follow-up|1|||
28041929|NCT00527618|54700213|FG001|Week 13-14 (Washout)|Lost to Follow-up|0|||
28041930|NCT00527618|54700212|FG000|Week 15-18 (Second Intervention)|Lost to Follow-up|0|||
28041931|NCT00527618|54700213|FG001|Week 15-18 (Second Intervention)|Lost to Follow-up|1|||
28041932|NCT00527618|54700212|FG000|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0|||
28041933|NCT00527618|54700213|FG001|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1|||
28041934|NCT00527618|54700212|FG000|Week 15-18 (Second Intervention)|Withdrawal by Subject|0|||
28041935|NCT00527618|54700213|FG001|Week 15-18 (Second Intervention)|Withdrawal by Subject|1|||
28041936|NCT00527072|54700220|FG000|Overall Study|Adverse Event|13|||
28041937|NCT00527072|54700220|FG000|Overall Study|Lack of Efficacy|11|||
28041938|NCT00527072|54700220|FG000|Overall Study|Lost to Follow-up|3|||
28041939|NCT00527072|54700220|FG000|Overall Study|Protocol Violation|2|||
28041940|NCT00527072|54700220|FG000|Overall Study|Withdrawal by Subject|7|||
28041941|NCT00526994|54700228|FG000|Overall Study|Lost to Follow-up|98|||
28041942|NCT00526994|54700229|FG001|Overall Study|Lost to Follow-up|108|||
28041943|NCT00526994|54700230|FG002|Overall Study|Lost to Follow-up|96|||
28041944|NCT00526994|54700228|FG000|Overall Study|Death|4|||
28041945|NCT00526994|54700229|FG001|Overall Study|Death|3|||
28041946|NCT00526994|54700230|FG002|Overall Study|Death|3|||
28041947|NCT00526994|54700228|FG000|Overall Study|Withdrawal by Subject|2|||
28041948|NCT00526994|54700229|FG001|Overall Study|Withdrawal by Subject|7|||
28041949|NCT00526994|54700230|FG002|Overall Study|Withdrawal by Subject|5|||
28041950|NCT00526994|54700228|FG000|Overall Study|incarcerated, impaired, incomplete|4|||
28041951|NCT00526994|54700229|FG001|Overall Study|incarcerated, impaired, incomplete|3|||
28041952|NCT00526994|54700230|FG002|Overall Study|incarcerated, impaired, incomplete|3|||
28041953|NCT00519428|54700241|FG000|Overall Study|Adverse Event|5|||
28041954|NCT00519428|54700242|FG001|Overall Study|Adverse Event|2|||
28041955|NCT00519428|54700243|FG002|Overall Study|Adverse Event|10|||
28041956|NCT00519428|54700241|FG000|Overall Study|Lost to Follow-up|7|||
28041957|NCT00519428|54700242|FG001|Overall Study|Lost to Follow-up|7|||
28041958|NCT00519428|54700243|FG002|Overall Study|Lost to Follow-up|6|||
28041959|NCT00519428|54700241|FG000|Overall Study|Withdrawal by Subject|8|||
28041960|NCT00519428|54700242|FG001|Overall Study|Withdrawal by Subject|3|||
28041961|NCT00519428|54700243|FG002|Overall Study|Withdrawal by Subject|7|||
28041962|NCT00519428|54700241|FG000|Overall Study|unstated|1|||
28041963|NCT00519428|54700242|FG001|Overall Study|unstated|3|||
28041964|NCT00519428|54700243|FG002|Overall Study|unstated|2|||
28041965|NCT00432159|54700259|FG000|Overall Study|Death|0|||
28041966|NCT00432159|54700260|FG001|Overall Study|Death|1|||
28041967|NCT00432159|54700261|FG002|Overall Study|Death|0|||
28041968|NCT00432159|54700262|FG003|Overall Study|Death|0|||
28041969|NCT00432159|54700263|FG004|Overall Study|Death|0|||
28041970|NCT00432159|54700259|FG000|Overall Study|Failure|9|||
28041971|NCT00432159|54700260|FG001|Overall Study|Failure|5|||
28041972|NCT00432159|54700261|FG002|Overall Study|Failure|3|||
28041973|NCT00432159|54700262|FG003|Overall Study|Failure|2|||
28041974|NCT00432159|54700263|FG004|Overall Study|Failure|3|||
28041975|NCT00432159|54700259|FG000|Overall Study|Missing NDI and/or neuro. assessment|13|||
28105690|NCT04764669|54763251|FG001|Overall Study|Withdrawal by Subject|0|||
28105691|NCT04764669|54763252|FG002|Overall Study|Withdrawal by Subject|0|||
28105692|NCT04764669|54763253|FG003|Overall Study|Withdrawal by Subject|0|||
28041976|NCT00432159|54700260|FG001|Overall Study|Missing NDI and/or neuro. assessment|24|||
28041977|NCT00432159|54700261|FG002|Overall Study|Missing NDI and/or neuro. assessment|1|||
28041978|NCT00432159|54700262|FG003|Overall Study|Missing NDI and/or neuro. assessment|3|||
28041979|NCT00432159|54700263|FG004|Overall Study|Missing NDI and/or neuro. assessment|7|||
28041980|NCT00519194|54700275|FG000|Overall Study|Withdrawal by Subject|9|||
28041981|NCT00519194|54700275|FG000|Overall Study|Death|9|||
28041982|NCT00519194|54700275|FG000|Overall Study|Lost to Follow-up|3|||
28041983|NCT00431847|54700283|FG000|Overall Study|completion of less than two study visits|6|||
28041984|NCT00431847|54700284|FG001|Overall Study|completion of less than two study visits|3|||
28041985|NCT00431847|54700285|FG002|Overall Study|completion of less than two study visits|4|||
28041986|NCT00431847|54700286|FG003|Overall Study|completion of less than two study visits|14|||
28041987|NCT00431847|54700287|FG004|Overall Study|completion of less than two study visits|0|||
28041988|NCT00431847|54700283|FG000|Overall Study|Protocol Violation|0|||
28041989|NCT00431847|54700284|FG001|Overall Study|Protocol Violation|0|||
28041990|NCT00431847|54700285|FG002|Overall Study|Protocol Violation|0|||
28041991|NCT00431847|54700286|FG003|Overall Study|Protocol Violation|0|||
28041992|NCT00431847|54700287|FG004|Overall Study|Protocol Violation|1|||
28041993|NCT00431067|54700297|FG000|Overall Study|Other Adverse Event|9|||
28041994|NCT00431067|54700297|FG000|Overall Study|Progressive disease|30|||
28041995|NCT00431067|54700297|FG000|Overall Study|Non-compliance,lost to follow-up|2|||
28041996|NCT00430989|54700303|FG000|Overall Study|Lost to Follow-up|2|||
28041997|NCT00430989|54700304|FG001|Overall Study|Lost to Follow-up|3|||
28041998|NCT00430989|54700303|FG000|Overall Study|Withdrawal by Subject|15|||
28041999|NCT00430989|54700304|FG001|Overall Study|Withdrawal by Subject|14|||
28042000|NCT00430989|54700303|FG000|Overall Study|Protocol Violation|30|||
28042001|NCT00430989|54700304|FG001|Overall Study|Protocol Violation|37|||
28042002|NCT00430989|54700303|FG000|Overall Study|Not eligible|13|||
28042003|NCT00430989|54700304|FG001|Overall Study|Not eligible|6|||
28042004|NCT00430755|54700312|FG000|Overall Study|Withdrawal by Subject|53|||
28042005|NCT00518882|54700318|FG000|Double-Blind, Week 0-26|Adverse Event|23|||
28042006|NCT00518882|54700319|FG001|Double-Blind, Week 0-26|Adverse Event|31|||
28042007|NCT00518882|54700318|FG000|Double-Blind, Week 0-26|Lack of Efficacy|1|||
28042008|NCT00518882|54700319|FG001|Double-Blind, Week 0-26|Lack of Efficacy|0|||
28042009|NCT00518882|54700318|FG000|Double-Blind, Week 0-26|Protocol Violation|4|||
28042010|NCT00518882|54700319|FG001|Double-Blind, Week 0-26|Protocol Violation|3|||
28042011|NCT00518882|54700318|FG000|Double-Blind, Week 0-26|Withdrawal criteria|1|||
28042012|NCT00518882|54700319|FG001|Double-Blind, Week 0-26|Withdrawal criteria|1|||
28042013|NCT00518882|54700318|FG000|Double-Blind, Week 0-26|Lost to follow up|2|||
28042014|NCT00518882|54700319|FG001|Double-Blind, Week 0-26|Lost to follow up|1|||
28042015|NCT00518882|54700318|FG000|Double-Blind, Week 0-26|Subject decision|1|||
28042016|NCT00518882|54700319|FG001|Double-Blind, Week 0-26|Subject decision|1|||
28042017|NCT00518882|54700318|FG000|Double-Blind, Week 0-26|Withdrawal of consent|1|||
28042018|NCT00518882|54700319|FG001|Double-Blind, Week 0-26|Withdrawal of consent|3|||
28042019|NCT00518882|54700318|FG000|Double-Blind, Week 0-26|Loss of trust|0|||
28042020|NCT00518882|54700319|FG001|Double-Blind, Week 0-26|Loss of trust|1|||
28042021|NCT00518882|54700318|FG000|Double-Blind, Week 0-26|Fear of hypoglycaemia|0|||
28042022|NCT00518882|54700319|FG001|Double-Blind, Week 0-26|Fear of hypoglycaemia|1|||
28042023|NCT00518882|54700318|FG000|Double-Blind, Week 0-26|Hypoglycaemia|0|||
28042024|NCT00518882|54700319|FG001|Double-Blind, Week 0-26|Hypoglycaemia|2|||
28042025|NCT00518882|54700318|FG000|Double-Blind, Week 0-26|Mutual consent|0|||
28042026|NCT00518882|54700319|FG001|Double-Blind, Week 0-26|Mutual consent|1|||
28042027|NCT00518882|54700318|FG000|Open-Label Extension, Week 26-78|Adverse Event|3|||
28042028|NCT00518882|54700319|FG001|Open-Label Extension, Week 26-78|Adverse Event|9|||
28042029|NCT00518882|54700318|FG000|Open-Label Extension, Week 26-78|Lack of Efficacy|6|||
28042030|NCT00518882|54700319|FG001|Open-Label Extension, Week 26-78|Lack of Efficacy|5|||
28042031|NCT00518882|54700318|FG000|Open-Label Extension, Week 26-78|Protocol Violation|3|||
28042032|NCT00518882|54700319|FG001|Open-Label Extension, Week 26-78|Protocol Violation|4|||
28042033|NCT00518882|54700318|FG000|Open-Label Extension, Week 26-78|Withdrawel criteria|1|||
28042034|NCT00518882|54700319|FG001|Open-Label Extension, Week 26-78|Withdrawel criteria|2|||
28042035|NCT00518882|54700318|FG000|Open-Label Extension, Week 26-78|Hypoglycaemia|0|||
28042036|NCT00518882|54700319|FG001|Open-Label Extension, Week 26-78|Hypoglycaemia|1|||
28042037|NCT00518882|54700318|FG000|Open-Label Extension, Week 26-78|Lost to follow up|1|||
28042038|NCT00518882|54700319|FG001|Open-Label Extension, Week 26-78|Lost to follow up|1|||
28042039|NCT00518882|54700318|FG000|Open-Label Extension, Week 26-78|Consent withdrawn|2|||
28042040|NCT00518882|54700319|FG001|Open-Label Extension, Week 26-78|Consent withdrawn|1|||
28042041|NCT00518882|54700318|FG000|Open-Label Extension, Week 26-78|Change in treatment|1|||
28042042|NCT00518882|54700319|FG001|Open-Label Extension, Week 26-78|Change in treatment|1|||
28042043|NCT00518882|54700318|FG000|Open-Label Extension, Week 26-78|Creatine increased|1|||
28042044|NCT00518882|54700319|FG001|Open-Label Extension, Week 26-78|Creatine increased|0|||
28042045|NCT00518882|54700318|FG000|Open-Label Extension, Week 26-78|Decreased kidney function|1|||
28042046|NCT00518882|54700319|FG001|Open-Label Extension, Week 26-78|Decreased kidney function|0|||
28042047|NCT00518882|54700318|FG000|Open-Label Extension, Week 26-78|Exclusion criteria|2|||
28042048|NCT00518882|54700319|FG001|Open-Label Extension, Week 26-78|Exclusion criteria|0|||
28042049|NCT00518882|54700318|FG000|Open-Label Extension, Week 26-78|Subject decision|2|||
28042050|NCT00518882|54700319|FG001|Open-Label Extension, Week 26-78|Subject decision|0|||
28042051|NCT00518882|54700318|FG000|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18|||
28042052|NCT00518882|54700319|FG001|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25|||
28042053|NCT00518336|54700327|FG000|Year 7|Lost to Follow-up|2|||
28042054|NCT00518336|54700328|FG001|Year 7|Lost to Follow-up|0|||
28042055|NCT00518336|54700327|FG000|Year 7|Could not attend in time|0|||
28042056|NCT00518336|54700328|FG001|Year 7|Could not attend in time|3|||
28042057|NCT00518336|54700327|FG000|Year 8|Lost to Follow-up|1|||
28042058|NCT00518336|54700328|FG001|Year 8|Lost to Follow-up|1|||
28042059|NCT00518336|54700327|FG000|Year 8|Could not attend in time|0|||
28042060|NCT00518336|54700328|FG001|Year 8|Could not attend in time|1|||
28042061|NCT00518336|54700327|FG000|Year 9|Migrated/moved from study area|1|||
28042062|NCT00518336|54700328|FG001|Year 9|Migrated/moved from study area|1|||
28042063|NCT00518336|54700327|FG000|Year 9|Lost to Follow-up|3|||
28042064|NCT00518336|54700328|FG001|Year 9|Lost to Follow-up|0|||
28042065|NCT00518336|54700327|FG000|Year 9|Personal reasons|1|||
28042066|NCT00518336|54700328|FG001|Year 9|Personal reasons|0|||
28042067|NCT00518180|54700337|FG000|Overall Study|Withdrawal by Subject|29|||
28042068|NCT00518180|54700338|FG001|Overall Study|Withdrawal by Subject|30|||
28042069|NCT00518180|54700339|FG002|Overall Study|Withdrawal by Subject|42|||
28042070|NCT00518180|54700337|FG000|Overall Study|Lost to Follow-up|30|||
28042071|NCT00518180|54700338|FG001|Overall Study|Lost to Follow-up|28|||
28042072|NCT00518180|54700339|FG002|Overall Study|Lost to Follow-up|34|||
28042073|NCT00518180|54700337|FG000|Overall Study|Administrative reason|0|||
28042074|NCT00518180|54700338|FG001|Overall Study|Administrative reason|2|||
28042075|NCT00518180|54700339|FG002|Overall Study|Administrative reason|2|||
28042076|NCT00518180|54700337|FG000|Overall Study|Protocol Violation|5|||
28042077|NCT00518180|54700338|FG001|Overall Study|Protocol Violation|7|||
28042078|NCT00518180|54700339|FG002|Overall Study|Protocol Violation|4|||
28042079|NCT00518180|54700337|FG000|Overall Study|Unable to classify|0|||
28042080|NCT00518180|54700338|FG001|Overall Study|Unable to classify|2|||
28042081|NCT00518180|54700339|FG002|Overall Study|Unable to classify|0|||
28042082|NCT00518180|54700337|FG000|Overall Study|Adverse Event|1|||
28042083|NCT00518180|54700338|FG001|Overall Study|Adverse Event|0|||
28042084|NCT00518180|54700339|FG002|Overall Study|Adverse Event|0|||
28042085|NCT00525902|54700356|FG000|Overall Study|Lack of Efficacy|1|||
28042086|NCT00525824|54700364|FG000|Overall Study|Adverse Event|7|||
28042087|NCT00525824|54700365|FG001|Overall Study|Adverse Event|11|||
28042088|NCT00525824|54700366|FG002|Overall Study|Adverse Event|6|||
28042089|NCT00525824|54700367|FG003|Overall Study|Adverse Event|7|||
28042090|NCT00525824|54700364|FG000|Overall Study|Withdrawal by Subject|5|||
28042091|NCT00525824|54700365|FG001|Overall Study|Withdrawal by Subject|9|||
28042092|NCT00525824|54700366|FG002|Overall Study|Withdrawal by Subject|3|||
28042093|NCT00525824|54700367|FG003|Overall Study|Withdrawal by Subject|4|||
28042094|NCT00525824|54700364|FG000|Overall Study|Lost to Follow-up|4|||
28042095|NCT00525824|54700365|FG001|Overall Study|Lost to Follow-up|2|||
28042096|NCT00525824|54700366|FG002|Overall Study|Lost to Follow-up|4|||
28042097|NCT00525824|54700367|FG003|Overall Study|Lost to Follow-up|0|||
28042098|NCT00525824|54700364|FG000|Overall Study|Incorrect enrolment/mis-randomisation|1|||
28042099|NCT00525824|54700365|FG001|Overall Study|Incorrect enrolment/mis-randomisation|2|||
28042100|NCT00525824|54700366|FG002|Overall Study|Incorrect enrolment/mis-randomisation|1|||
28042101|NCT00525824|54700367|FG003|Overall Study|Incorrect enrolment/mis-randomisation|2|||
28042102|NCT00525824|54700364|FG000|Overall Study|Severe non-compliance|0|||
28042103|NCT00525824|54700365|FG001|Overall Study|Severe non-compliance|1|||
28042104|NCT00525824|54700366|FG002|Overall Study|Severe non-compliance|1|||
28042105|NCT00525824|54700367|FG003|Overall Study|Severe non-compliance|1|||
28042106|NCT00525824|54700364|FG000|Overall Study|Safety reasons|1|||
28042107|NCT00525824|54700365|FG001|Overall Study|Safety reasons|0|||
28042108|NCT00525824|54700366|FG002|Overall Study|Safety reasons|1|||
28042109|NCT00525824|54700367|FG003|Overall Study|Safety reasons|0|||
28042110|NCT00525824|54700364|FG000|Overall Study|Other|1|||
28042111|NCT00525824|54700365|FG001|Overall Study|Other|3|||
28042112|NCT00525824|54700366|FG002|Overall Study|Other|3|||
28042113|NCT00525824|54700367|FG003|Overall Study|Other|1|||
28042114|NCT00525590|54700381|FG000|Overall Study|Adverse Event|3|||
28042115|NCT00525590|54700381|FG000|Overall Study|Physician Decision|3|||
28042116|NCT00525590|54700381|FG000|Overall Study|Withdrawal by Subject|16|||
28042117|NCT00525590|54700381|FG000|Overall Study|Lost to Follow-up|1|||
28042118|NCT00525590|54700381|FG000|Overall Study|Death|9|||
28042119|NCT00525590|54700381|FG000|Overall Study|Other|13|||
28042120|NCT00430677|54700388|FG000|Short-term Period|Death|1|||
28042121|NCT00430677|54700389|FG001|Short-term Period|Death|1|||
28042122|NCT00430677|54700390|FG002|Short-term Period|Death|5|||
28042123|NCT00430677|54700388|FG000|Short-term Period|Adverse Event|15|||
28042124|NCT00430677|54700389|FG001|Short-term Period|Adverse Event|13|||
28042125|NCT00430677|54700390|FG002|Short-term Period|Adverse Event|9|||
28042126|NCT00430677|54700388|FG000|Short-term Period|Lack of Efficacy|5|||
28042127|NCT00430677|54700389|FG001|Short-term Period|Lack of Efficacy|6|||
28042128|NCT00430677|54700390|FG002|Short-term Period|Lack of Efficacy|4|||
28042129|NCT00430677|54700388|FG000|Short-term Period|Withdrawal by Subject|1|||
28042130|NCT00430677|54700389|FG001|Short-term Period|Withdrawal by Subject|1|||
28042131|NCT00430677|54700390|FG002|Short-term Period|Withdrawal by Subject|2|||
28042132|NCT00430677|54700388|FG000|Short-term Period|Participant no longer met study criteria|1|||
28042133|NCT00430677|54700389|FG001|Short-term Period|Participant no longer met study criteria|1|||
28042134|NCT00430677|54700390|FG002|Short-term Period|Participant no longer met study criteria|2|||
28042135|NCT00430677|54700388|FG000|Short-term Period|Poor compliance/ noncompliance|0|||
28042136|NCT00430677|54700389|FG001|Short-term Period|Poor compliance/ noncompliance|1|||
28042137|NCT00430677|54700390|FG002|Short-term Period|Poor compliance/ noncompliance|0|||
28042138|NCT00430677|54700388|FG000|Short-term Period|Pregnancy|0|||
28042139|NCT00430677|54700389|FG001|Short-term Period|Pregnancy|2|||
28042140|NCT00430677|54700390|FG002|Short-term Period|Pregnancy|0|||
28042141|NCT00430677|54700388|FG000|Long-term Extension Period|Death|1|||
28042142|NCT00430677|54700389|FG001|Long-term Extension Period|Death|0|||
28042143|NCT00430677|54700390|FG002|Long-term Extension Period|Death|0|||
28042144|NCT00430677|54700388|FG000|Long-term Extension Period|Adverse Event|3|||
28042145|NCT00430677|54700389|FG001|Long-term Extension Period|Adverse Event|2|||
28042146|NCT00430677|54700390|FG002|Long-term Extension Period|Adverse Event|5|||
28042147|NCT00430677|54700388|FG000|Long-term Extension Period|Lack of Efficacy|5|||
28042148|NCT00430677|54700389|FG001|Long-term Extension Period|Lack of Efficacy|3|||
28042149|NCT00430677|54700390|FG002|Long-term Extension Period|Lack of Efficacy|8|||
28042150|NCT00430677|54700388|FG000|Long-term Extension Period|Lost to Follow-up|1|||
28042151|NCT00430677|54700389|FG001|Long-term Extension Period|Lost to Follow-up|1|||
28042152|NCT00430677|54700390|FG002|Long-term Extension Period|Lost to Follow-up|1|||
27847925|NCT00218543|54340662|FG000|Overall Study|Physician Decision|3|||
27847926|NCT00218543|54340662|FG000|Overall Study|Adverse Event|2|||
27847927|NCT00216671|54340677|FG000|Overall Study|Adverse Event|4|||
27847928|NCT00216671|54340678|FG001|Overall Study|Adverse Event|9|||
27847929|NCT00216671|54340677|FG000|Overall Study|Pregnancy|0|||
27847930|NCT00216671|54340678|FG001|Overall Study|Pregnancy|1|||
27847931|NCT00216671|54340677|FG000|Overall Study|Withdrawal by Subject|4|||
27847932|NCT00216671|54340678|FG001|Overall Study|Withdrawal by Subject|2|||
27847933|NCT00216671|54340677|FG000|Overall Study|Refused Injections|3|||
27847934|NCT00216671|54340678|FG001|Overall Study|Refused Injections|13|||
27847935|NCT00216671|54340677|FG000|Overall Study|No Need to Continue Medication|1|||
27847936|NCT00216671|54340678|FG001|Overall Study|No Need to Continue Medication|1|||
27847937|NCT00216671|54340677|FG000|Overall Study|Insufficient Response|9|||
27847938|NCT00216671|54340678|FG001|Overall Study|Insufficient Response|4|||
27847939|NCT00216671|54340677|FG000|Overall Study|Lost to Follow-up|3|||
27847940|NCT00216671|54340678|FG001|Overall Study|Lost to Follow-up|5|||
28042153|NCT00430677|54700388|FG000|Long-term Extension Period|Withdrawal by Subject|5|||
28042154|NCT00430677|54700389|FG001|Long-term Extension Period|Withdrawal by Subject|1|||
28042155|NCT00430677|54700390|FG002|Long-term Extension Period|Withdrawal by Subject|2|||
28042156|NCT00430677|54700388|FG000|Long-term Extension Period|Pregnancy|1|||
28042157|NCT00430677|54700389|FG001|Long-term Extension Period|Pregnancy|1|||
28042158|NCT00430677|54700390|FG002|Long-term Extension Period|Pregnancy|0|||
28042159|NCT00430677|54700388|FG000|Long-term Extension Period|Administrative reason by sponsor|41|||
28042160|NCT00430677|54700389|FG001|Long-term Extension Period|Administrative reason by sponsor|49|||
28042161|NCT00430677|54700390|FG002|Long-term Extension Period|Administrative reason by sponsor|46|||
28042162|NCT00430677|54700388|FG000|Long-term Extension Period|Other|2|||
28042163|NCT00430677|54700389|FG001|Long-term Extension Period|Other|1|||
28042164|NCT00430677|54700390|FG002|Long-term Extension Period|Other|1|||
28042165|NCT00430677|54700388|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
28042166|NCT00430677|54700389|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
28042167|NCT00430677|54700390|FG002|Long-term Extension Period|Poor compliance/noncompliance|0|||
28042168|NCT00525512|54700418|FG000|Double-Blind Phase|Adverse Event|48|||
28042169|NCT00525512|54700419|FG001|Double-Blind Phase|Adverse Event|28|||
28042170|NCT00525512|54700420|FG002|Double-Blind Phase|Adverse Event|0|||
28042171|NCT00525512|54700421|FG003|Double-Blind Phase|Adverse Event|0|||
28042172|NCT00525512|54700418|FG000|Double-Blind Phase|Protocol Violation|3|||
28042173|NCT00525512|54700419|FG001|Double-Blind Phase|Protocol Violation|1|||
28042174|NCT00525512|54700420|FG002|Double-Blind Phase|Protocol Violation|0|||
28042175|NCT00525512|54700421|FG003|Double-Blind Phase|Protocol Violation|0|||
28042176|NCT00525512|54700418|FG000|Double-Blind Phase|Lost to Follow-up|3|||
28042177|NCT00525512|54700419|FG001|Double-Blind Phase|Lost to Follow-up|7|||
28042178|NCT00525512|54700420|FG002|Double-Blind Phase|Lost to Follow-up|0|||
28042179|NCT00525512|54700421|FG003|Double-Blind Phase|Lost to Follow-up|0|||
28042180|NCT00525512|54700418|FG000|Double-Blind Phase|Withdrawal by Subject|17|||
28042181|NCT00525512|54700419|FG001|Double-Blind Phase|Withdrawal by Subject|12|||
28042182|NCT00525512|54700420|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
28042183|NCT00525512|54700421|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
28042184|NCT00525512|54700418|FG000|Double-Blind Phase|Lack of Efficacy|13|||
28042185|NCT00525512|54700419|FG001|Double-Blind Phase|Lack of Efficacy|5|||
28042186|NCT00525512|54700420|FG002|Double-Blind Phase|Lack of Efficacy|0|||
28042187|NCT00525512|54700421|FG003|Double-Blind Phase|Lack of Efficacy|0|||
28042188|NCT00525512|54700418|FG000|Double-Blind Phase|Other reason (not specified)|12|||
28042189|NCT00525512|54700419|FG001|Double-Blind Phase|Other reason (not specified)|13|||
28042190|NCT00525512|54700420|FG002|Double-Blind Phase|Other reason (not specified)|0|||
28042191|NCT00525512|54700421|FG003|Double-Blind Phase|Other reason (not specified)|0|||
28042192|NCT00525512|54700418|FG000|Open-Label Phase|Adverse Event|0|||
28042193|NCT00525512|54700419|FG001|Open-Label Phase|Adverse Event|0|||
28042194|NCT00525512|54700420|FG002|Open-Label Phase|Adverse Event|1|||
28042195|NCT00525512|54700421|FG003|Open-Label Phase|Adverse Event|0|||
28042196|NCT00525512|54700418|FG000|Open-Label Phase|Lost to Follow-up|0|||
28042197|NCT00525512|54700419|FG001|Open-Label Phase|Lost to Follow-up|0|||
28042198|NCT00525512|54700420|FG002|Open-Label Phase|Lost to Follow-up|1|||
28042199|NCT00525512|54700421|FG003|Open-Label Phase|Lost to Follow-up|0|||
28042200|NCT00525512|54700418|FG000|Open-Label Phase|Other reason (not specified)|0|||
28042201|NCT00525512|54700419|FG001|Open-Label Phase|Other reason (not specified)|0|||
28042202|NCT00525512|54700420|FG002|Open-Label Phase|Other reason (not specified)|4|||
28042203|NCT00525512|54700421|FG003|Open-Label Phase|Other reason (not specified)|5|||
28042204|NCT00517634|54700433|FG000|Second Treatment Period|Withdrawal by Subject|0|||
28042205|NCT00517634|54700434|FG001|Second Treatment Period|Withdrawal by Subject|0|||
28042206|NCT00517634|54700435|FG002|Second Treatment Period|Withdrawal by Subject|0|||
28042207|NCT00517634|54700436|FG003|Second Treatment Period|Withdrawal by Subject|0|||
28042208|NCT00517634|54700437|FG004|Second Treatment Period|Withdrawal by Subject|1|||
28042209|NCT00517634|54700438|FG005|Second Treatment Period|Withdrawal by Subject|0|||
28042210|NCT03683576|54700450|FG000|Overall Study|Withdrawal by Subject|2|||
28042211|NCT03683576|54700451|FG001|Overall Study|Withdrawal by Subject|0|||
28042212|NCT03683576|54700452|FG002|Overall Study|Withdrawal by Subject|8|||
28042213|NCT03683576|54700453|FG003|Overall Study|Withdrawal by Subject|3|||
28042214|NCT03683576|54700450|FG000|Overall Study|Adverse Event|3|||
28042215|NCT03683576|54700451|FG001|Overall Study|Adverse Event|0|||
28042216|NCT03683576|54700452|FG002|Overall Study|Adverse Event|0|||
28042217|NCT03683576|54700453|FG003|Overall Study|Adverse Event|4|||
28042218|NCT03683576|54700450|FG000|Overall Study|Lack of Efficacy|1|||
28042219|NCT03683576|54700451|FG001|Overall Study|Lack of Efficacy|0|||
28042220|NCT03683576|54700452|FG002|Overall Study|Lack of Efficacy|1|||
28042221|NCT03683576|54700453|FG003|Overall Study|Lack of Efficacy|1|||
28042222|NCT03683576|54700450|FG000|Overall Study|Lost to Follow-up|0|||
28042223|NCT03683576|54700451|FG001|Overall Study|Lost to Follow-up|1|||
28042224|NCT03683576|54700452|FG002|Overall Study|Lost to Follow-up|2|||
28042225|NCT03683576|54700453|FG003|Overall Study|Lost to Follow-up|0|||
28042226|NCT03683576|54700450|FG000|Overall Study|Other, Not Specified|0|||
28042227|NCT03683576|54700451|FG001|Overall Study|Other, Not Specified|2|||
28042228|NCT03683576|54700452|FG002|Overall Study|Other, Not Specified|0|||
28042229|NCT03683576|54700453|FG003|Overall Study|Other, Not Specified|0|||
28042230|NCT03683576|54700450|FG000|Overall Study|Protocol Violation|0|||
28042231|NCT03683576|54700451|FG001|Overall Study|Protocol Violation|1|||
28042232|NCT03683576|54700452|FG002|Overall Study|Protocol Violation|1|||
28042233|NCT03683576|54700453|FG003|Overall Study|Protocol Violation|0|||
28042234|NCT03863834|54700463|FG000|Overall Study|Lost to Follow-up|3|||
28042235|NCT00430521|54700475|FG000|Overall Study|Adverse Event|0|||
28042236|NCT00430521|54700476|FG001|Overall Study|Adverse Event|0|||
28042237|NCT00430521|54700477|FG002|Overall Study|Adverse Event|0|||
28042238|NCT00430521|54700478|FG003|Overall Study|Adverse Event|0|||
28042239|NCT00430521|54700479|FG004|Overall Study|Adverse Event|0|||
28042240|NCT00430521|54700480|FG005|Overall Study|Adverse Event|2|||
28042241|NCT00430521|54700481|FG006|Overall Study|Adverse Event|1|||
28042242|NCT00430521|54700482|FG007|Overall Study|Adverse Event|0|||
28042243|NCT00430521|54700475|FG000|Overall Study|Lost to Follow-up|7|||
28042244|NCT00430521|54700476|FG001|Overall Study|Lost to Follow-up|8|||
28042245|NCT00430521|54700477|FG002|Overall Study|Lost to Follow-up|3|||
28042246|NCT00430521|54700478|FG003|Overall Study|Lost to Follow-up|5|||
28042247|NCT00430521|54700479|FG004|Overall Study|Lost to Follow-up|5|||
28042248|NCT00430521|54700480|FG005|Overall Study|Lost to Follow-up|2|||
28042249|NCT00430521|54700481|FG006|Overall Study|Lost to Follow-up|8|||
28042250|NCT00430521|54700482|FG007|Overall Study|Lost to Follow-up|10|||
28042251|NCT00430521|54700475|FG000|Overall Study|Pregnancy|0|||
28042252|NCT00430521|54700476|FG001|Overall Study|Pregnancy|0|||
28042253|NCT00430521|54700477|FG002|Overall Study|Pregnancy|0|||
28042254|NCT00430521|54700478|FG003|Overall Study|Pregnancy|0|||
28042255|NCT00430521|54700479|FG004|Overall Study|Pregnancy|0|||
28042256|NCT00430521|54700480|FG005|Overall Study|Pregnancy|0|||
28042257|NCT00430521|54700481|FG006|Overall Study|Pregnancy|1|||
28042258|NCT00430521|54700482|FG007|Overall Study|Pregnancy|0|||
28042259|NCT00430521|54700475|FG000|Overall Study|Vaccine Expired|0|||
28042260|NCT00430521|54700476|FG001|Overall Study|Vaccine Expired|0|||
28042261|NCT00430521|54700477|FG002|Overall Study|Vaccine Expired|0|||
28042262|NCT00430521|54700478|FG003|Overall Study|Vaccine Expired|0|||
28042263|NCT00430521|54700479|FG004|Overall Study|Vaccine Expired|0|||
28042264|NCT00430521|54700480|FG005|Overall Study|Vaccine Expired|1|||
28042265|NCT00430521|54700481|FG006|Overall Study|Vaccine Expired|0|||
28105693|NCT04439253|54763263|FG000|Overall Study|Adverse Event|1|||
28105694|NCT04439253|54763263|FG000|Overall Study|Disease progression|2|||
28105695|NCT04439253|54763263|FG000|Overall Study|Complicating disease|1|||
28105696|NCT04438785|54763269|FG000|Overall Study|change of weight, give up intervention|2|||
27810857|NCT01738503|54266694|FG001|Treatment Period|Lost to Follow-up|0|||
27810858|NCT01738503|54266695|FG002|Treatment Period|Lost to Follow-up|3|||
28042266|NCT00430521|54700482|FG007|Overall Study|Vaccine Expired|0|||
27810859|NCT01738503|54266696|FG003|Treatment Period|Lost to Follow-up|4|||
27810860|NCT01738503|54266697|FG004|Treatment Period|Lost to Follow-up|1|||
28042267|NCT00430521|54700475|FG000|Overall Study|Protocol Violation|1|||
27810861|NCT01738503|54266698|FG005|Treatment Period|Lost to Follow-up|1|||
28042268|NCT00430521|54700476|FG001|Overall Study|Protocol Violation|0|||
28042269|NCT00430521|54700477|FG002|Overall Study|Protocol Violation|0|||
28042270|NCT00430521|54700478|FG003|Overall Study|Protocol Violation|0|||
28042271|NCT00430521|54700479|FG004|Overall Study|Protocol Violation|0|||
28042272|NCT00430521|54700480|FG005|Overall Study|Protocol Violation|0|||
28042273|NCT00430521|54700481|FG006|Overall Study|Protocol Violation|0|||
28042274|NCT00430521|54700482|FG007|Overall Study|Protocol Violation|0|||
28042275|NCT00430521|54700475|FG000|Overall Study|Withdrawal by Subject|3|||
28042276|NCT00430521|54700476|FG001|Overall Study|Withdrawal by Subject|1|||
28042277|NCT00430521|54700477|FG002|Overall Study|Withdrawal by Subject|0|||
28042278|NCT00430521|54700478|FG003|Overall Study|Withdrawal by Subject|3|||
28042279|NCT00430521|54700479|FG004|Overall Study|Withdrawal by Subject|0|||
28042280|NCT00430521|54700480|FG005|Overall Study|Withdrawal by Subject|0|||
28042281|NCT00430521|54700481|FG006|Overall Study|Withdrawal by Subject|0|||
28042282|NCT00430521|54700482|FG007|Overall Study|Withdrawal by Subject|2|||
28042283|NCT00429663|54700515|FG000|Overall Study|Lost to Follow-up|24|||
28042284|NCT00429663|54700516|FG001|Overall Study|Lost to Follow-up|31|||
28042285|NCT00429663|54700515|FG000|Overall Study|Physician Decision|6|||
28042286|NCT00429663|54700516|FG001|Overall Study|Physician Decision|3|||
27810862|NCT01738503|54266699|FG006|Treatment Period|Lost to Follow-up|5|||
27810863|NCT01738503|54266693|FG000|Treatment Period|Withdrawal by Subject|0|||
27810864|NCT01738503|54266694|FG001|Treatment Period|Withdrawal by Subject|1|||
27810865|NCT01738503|54266695|FG002|Treatment Period|Withdrawal by Subject|0|||
27810866|NCT01738503|54266696|FG003|Treatment Period|Withdrawal by Subject|1|||
28042287|NCT00429663|54700515|FG000|Overall Study|Withdrawal by Subject|2|||
28042288|NCT00429663|54700516|FG001|Overall Study|Withdrawal by Subject|5|||
28042289|NCT00429663|54700515|FG000|Overall Study|Death|4|||
28042290|NCT00429663|54700516|FG001|Overall Study|Death|0|||
28042291|NCT00429585|54700524|FG000|Overall Study|Death|1|||
28042292|NCT00429585|54700525|FG001|Overall Study|Death|0|||
28042293|NCT00429585|54700524|FG000|Overall Study|Lost to Follow-up|27|||
28042294|NCT00429585|54700525|FG001|Overall Study|Lost to Follow-up|20|||
28042295|NCT00429585|54700524|FG000|Overall Study|Physician Decision|2|||
28042296|NCT00429585|54700525|FG001|Overall Study|Physician Decision|0|||
28042297|NCT00440271|54700533|FG000|Overall Study|Protocol Violation|1|||
28042298|NCT00440271|54700534|FG001|Overall Study|Protocol Violation|1|||
28042299|NCT00440271|54700533|FG000|Overall Study|Adverse Event|0|||
28042300|NCT00440271|54700534|FG001|Overall Study|Adverse Event|1|||
28042301|NCT00440271|54700533|FG000|Overall Study|Lost to Follow-up|1|||
28042302|NCT00440271|54700534|FG001|Overall Study|Lost to Follow-up|0|||
28042303|NCT00440271|54700533|FG000|Overall Study|Withdrawal by Subject|0|||
28042304|NCT00440271|54700534|FG001|Overall Study|Withdrawal by Subject|2|||
28042305|NCT00440271|54700533|FG000|Overall Study|Lack of Efficacy|0|||
28042306|NCT00440271|54700534|FG001|Overall Study|Lack of Efficacy|1|||
28042307|NCT00440271|54700533|FG000|Overall Study|Due to closure of trial|8|||
28042308|NCT00440271|54700534|FG001|Overall Study|Due to closure of trial|10|||
28042309|NCT00440271|54700533|FG000|Overall Study|Other|2|||
28042310|NCT00440271|54700534|FG001|Overall Study|Other|0|||
28042311|NCT00346216|54700543|FG000|Overall Study|Other|181|||
28042312|NCT00346216|54700544|FG001|Overall Study|Other|231|||
28042313|NCT00346216|54700545|FG002|Overall Study|Other|205|||
28042314|NCT00346216|54700543|FG000|Overall Study|No longer willing to participate|600|||
28042315|NCT00346216|54700544|FG001|Overall Study|No longer willing to participate|606|||
28042316|NCT00346216|54700545|FG002|Overall Study|No longer willing to participate|585|||
28042317|NCT00346216|54700543|FG000|Overall Study|Withdrawal by Subject|661|||
28042318|NCT00346216|54700544|FG001|Overall Study|Withdrawal by Subject|692|||
28042319|NCT00346216|54700545|FG002|Overall Study|Withdrawal by Subject|651|||
28042320|NCT00346216|54700543|FG000|Overall Study|Lost to Follow-up|611|||
28042321|NCT00346216|54700544|FG001|Overall Study|Lost to Follow-up|588|||
28042322|NCT00346216|54700545|FG002|Overall Study|Lost to Follow-up|542|||
27810867|NCT01738503|54266697|FG004|Treatment Period|Withdrawal by Subject|1|||
27810868|NCT01738503|54266698|FG005|Treatment Period|Withdrawal by Subject|1|||
27810869|NCT01738503|54266699|FG006|Treatment Period|Withdrawal by Subject|1|||
27810870|NCT01738503|54266693|FG000|Treatment Period|Protocol Violation|0|||
27810871|NCT01738503|54266694|FG001|Treatment Period|Protocol Violation|3|||
27810872|NCT01738503|54266695|FG002|Treatment Period|Protocol Violation|1|||
27810873|NCT01738503|54266696|FG003|Treatment Period|Protocol Violation|0|||
27810874|NCT01738503|54266697|FG004|Treatment Period|Protocol Violation|4|||
27810875|NCT01738503|54266698|FG005|Treatment Period|Protocol Violation|2|||
27810876|NCT01738503|54266699|FG006|Treatment Period|Protocol Violation|0|||
28042323|NCT00346216|54700543|FG000|Overall Study|Physician Decision|80|||
28042324|NCT00346216|54700544|FG001|Overall Study|Physician Decision|76|||
28042325|NCT00346216|54700545|FG002|Overall Study|Physician Decision|59|||
28042326|NCT00346216|54700543|FG000|Overall Study|Does not meet entrance criteria|13|||
27810877|NCT01738503|54266693|FG000|Treatment Period|Other|0|||
27810878|NCT01738503|54266694|FG001|Treatment Period|Other|0|||
27810879|NCT01738503|54266695|FG002|Treatment Period|Other|1|||
28042327|NCT00346216|54700544|FG001|Overall Study|Does not meet entrance criteria|10|||
28042328|NCT00346216|54700545|FG002|Overall Study|Does not meet entrance criteria|8|||
28042329|NCT00346216|54700543|FG000|Overall Study|Death|189|||
28042330|NCT00346216|54700544|FG001|Overall Study|Death|192|||
28042331|NCT00346216|54700545|FG002|Overall Study|Death|228|||
28042332|NCT00346216|54700543|FG000|Overall Study|Study terminated by sponsor|11|||
28042333|NCT00346216|54700544|FG001|Overall Study|Study terminated by sponsor|4|||
28042334|NCT00346216|54700545|FG002|Overall Study|Study terminated by sponsor|8|||
28042335|NCT00346216|54700543|FG000|Overall Study|Missing Subject Summary Status|62|||
28042336|NCT00346216|54700544|FG001|Overall Study|Missing Subject Summary Status|61|||
28042337|NCT00346216|54700545|FG002|Overall Study|Missing Subject Summary Status|62|||
27810880|NCT01738503|54266696|FG003|Treatment Period|Other|0|||
27810881|NCT01738503|54266697|FG004|Treatment Period|Other|0|||
28042338|NCT00417963|54700553|FG000|Overall Study|Lost to Follow-up|3|||
28042339|NCT00417963|54700553|FG000|Overall Study|Withdrawal by Subject|18|||
28042340|NCT00417963|54700553|FG000|Overall Study|Death|17|||
28042341|NCT00417963|54700553|FG000|Overall Study|Study device could not be deployed|3|||
28042342|NCT00429273|54700565|FG000|Overall Study|Lost to Follow-up|1|||
27810882|NCT01738503|54266698|FG005|Treatment Period|Other|0|||
27810883|NCT01738503|54266699|FG006|Treatment Period|Other|0|||
27810884|NCT01738503|54266693|FG000|PET Imaging Sub-study|Adverse Event|0|||
27810885|NCT01738503|54266694|FG001|PET Imaging Sub-study|Adverse Event|0|||
27810886|NCT01738503|54266695|FG002|PET Imaging Sub-study|Adverse Event|0|||
27810887|NCT01738503|54266696|FG003|PET Imaging Sub-study|Adverse Event|0|||
27810888|NCT01738503|54266697|FG004|PET Imaging Sub-study|Adverse Event|0|||
27810889|NCT01738503|54266698|FG005|PET Imaging Sub-study|Adverse Event|1|||
27810890|NCT01738503|54266699|FG006|PET Imaging Sub-study|Adverse Event|0|||
27810891|NCT01738503|54266693|FG000|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
27810892|NCT01738503|54266694|FG001|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
27810893|NCT01738503|54266695|FG002|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
27810894|NCT01738503|54266696|FG003|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
27810895|NCT01738503|54266697|FG004|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
27810896|NCT01738503|54266698|FG005|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
27810897|NCT01738503|54266699|FG006|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
27810898|NCT01738191|54266723|FG000|Overall Study|Withdrawal by Subject|4|||
27810899|NCT01738191|54266724|FG001|Overall Study|Withdrawal by Subject|1|||
27810900|NCT01737879|54266730|FG000|Overall Study|Death|1|||
27810901|NCT01737879|54266730|FG000|Overall Study|Sponsor decision|40|||
27810902|NCT01879683|54266734|FG000|Overall Study|Did not Complete 4-week Follow-up Visit|1|||
27810903|NCT01605825|54266740|FG000|Overall Study|Adverse Event|4|||
27810904|NCT01605825|54266741|FG001|Overall Study|Adverse Event|2|||
27810905|NCT01605825|54266740|FG000|Overall Study|Withdrawal by Subject|0|||
27810906|NCT01605825|54266741|FG001|Overall Study|Withdrawal by Subject|1|||
27810907|NCT01605825|54266740|FG000|Overall Study|Non-Compliance -Investigational Drug|3|||
27810908|NCT01605825|54266741|FG001|Overall Study|Non-Compliance -Investigational Drug|0|||
27810909|NCT01605825|54266740|FG000|Overall Study|Non-Compliance with Protocol|3|||
27810910|NCT01605825|54266741|FG001|Overall Study|Non-Compliance with Protocol|0|||
27810911|NCT01727505|54266747|FG000|First 24 Hours|Adverse Event|0|||
27810912|NCT01727505|54266748|FG001|First 24 Hours|Adverse Event|1|||
27810913|NCT01727505|54266747|FG000|Second 24 Hours|Missing data|0|||
27810914|NCT01727505|54266748|FG001|Second 24 Hours|Missing data|1|||
27810915|NCT01726803|54266756|FG000|Overall Study|Lost to Follow-up|6|||
27810916|NCT01726803|54266757|FG001|Overall Study|Lost to Follow-up|1|||
27810917|NCT01726803|54266756|FG000|Overall Study|Withdrawal by Subject|1|||
27810918|NCT01726803|54266757|FG001|Overall Study|Withdrawal by Subject|0|||
28042343|NCT00429273|54700566|FG001|Overall Study|Lost to Follow-up|2|||
28042344|NCT00429273|54700567|FG002|Overall Study|Lost to Follow-up|2|||
28042345|NCT00429273|54700565|FG000|Overall Study|Physician Decision|6|||
28042346|NCT00429273|54700566|FG001|Overall Study|Physician Decision|5|||
28042347|NCT00429273|54700567|FG002|Overall Study|Physician Decision|5|||
28042348|NCT00429273|54700565|FG000|Overall Study|Adverse Event|1|||
28042349|NCT00429273|54700566|FG001|Overall Study|Adverse Event|1|||
28042350|NCT00429273|54700567|FG002|Overall Study|Adverse Event|2|||
28042351|NCT00359632|54700577|FG000|Overall Study|Death|2|||
28042352|NCT00359632|54700578|FG001|Overall Study|Death|0|||
28042353|NCT00359632|54700577|FG000|Overall Study|Adverse Event|1|||
28042354|NCT00359632|54700578|FG001|Overall Study|Adverse Event|0|||
28042355|NCT00359632|54700577|FG000|Overall Study|Non-compliance with visit schedule|1|||
28042356|NCT00359632|54700578|FG001|Overall Study|Non-compliance with visit schedule|0|||
27810919|NCT01726335|54266763|FG000|Overall Study|Lost to Follow-up|2|||
27810920|NCT01726335|54266763|FG000|Overall Study|Withdrawal by Subject|15|||
27810921|NCT01726335|54266763|FG000|Overall Study|Adverse Event|4|||
27810922|NCT01726335|54266763|FG000|Overall Study|Lost to Follow-up|2|||
27810923|NCT01726335|54266763|FG000|Overall Study|Exacerbation of psychotic symptoms|1|||
27847941|NCT00216671|54340677|FG000|Overall Study|Non compliant|2|||
27847942|NCT00216671|54340678|FG001|Overall Study|Non compliant|2|||
27847943|NCT00216671|54340677|FG000|Overall Study|Ineligible|0|||
28042357|NCT00417885|54700584|FG000|Overall Study|Adverse Event|1|||
28042358|NCT00417885|54700584|FG000|Overall Study|Objective Progression or Relapse|3|||
28042359|NCT00417885|54700584|FG000|Overall Study|Transferred to Another Sunitinib Study|2|||
28042360|NCT04488770|54700601|FG000|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
28042361|NCT04488770|54700602|FG001|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
28042362|NCT04488770|54700603|FG002|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
28042363|NCT04488770|54700604|FG003|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|1|||
27810924|NCT01877421|54266799|FG000|Phase 2|Lost to Follow-up|0|||
28042364|NCT04488770|54700605|FG004|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
28042365|NCT04488770|54700606|FG005|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
28042366|NCT04488770|54700607|FG006|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
27847944|NCT00216671|54340678|FG001|Overall Study|Ineligible|2|||
28042367|NCT04488770|54700608|FG007|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
28042368|NCT04488770|54700609|FG008|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
28042369|NCT04488770|54700610|FG009|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
28042370|NCT04488770|54700611|FG010|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
28042371|NCT04488770|54700612|FG011|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
28042372|NCT04488770|54700613|FG012|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
28042373|NCT04488770|54700601|FG000|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|1|||
28042374|NCT04488770|54700602|FG001|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
28042375|NCT04488770|54700603|FG002|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
28042376|NCT04488770|54700604|FG003|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
28042377|NCT04488770|54700605|FG004|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
28042378|NCT04488770|54700606|FG005|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
28042379|NCT04488770|54700607|FG006|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
28042380|NCT04488770|54700608|FG007|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
28042381|NCT04488770|54700609|FG008|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
28042382|NCT04488770|54700610|FG009|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
28042383|NCT04488770|54700611|FG010|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
28042384|NCT04488770|54700612|FG011|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
28042385|NCT04488770|54700613|FG012|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
28042386|NCT04488770|54700601|FG000|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
28042387|NCT04488770|54700602|FG001|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
28042388|NCT04488770|54700603|FG002|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
28042389|NCT04488770|54700604|FG003|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
28042390|NCT04488770|54700605|FG004|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
28042391|NCT04488770|54700606|FG005|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
28042392|NCT04488770|54700607|FG006|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
28042393|NCT04488770|54700608|FG007|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
28042394|NCT04488770|54700609|FG008|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
28042395|NCT04488770|54700610|FG009|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
28042396|NCT04488770|54700611|FG010|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
28042397|NCT04488770|54700612|FG011|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
28042398|NCT04488770|54700613|FG012|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
28042399|NCT04488770|54700601|FG000|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
28042400|NCT04488770|54700602|FG001|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
28042401|NCT04488770|54700603|FG002|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
28042402|NCT04488770|54700604|FG003|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
28042403|NCT04488770|54700605|FG004|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|1|||
28042404|NCT04488770|54700606|FG005|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
27810925|NCT01877421|54266800|FG001|Phase 2|Lost to Follow-up|0|||
27810926|NCT01877421|54266801|FG002|Phase 2|Lost to Follow-up|0|||
27810927|NCT01877421|54266802|FG003|Phase 2|Lost to Follow-up|0|||
27810928|NCT01877421|54266803|FG004|Phase 2|Lost to Follow-up|0|||
27810929|NCT01877421|54266804|FG005|Phase 2|Lost to Follow-up|0|||
27810930|NCT01877421|54266805|FG006|Phase 2|Lost to Follow-up|1|||
27810931|NCT01877421|54266806|FG007|Phase 2|Lost to Follow-up|0|||
27810932|NCT01877421|54266807|FG008|Phase 2|Lost to Follow-up|0|||
27810933|NCT01877421|54266808|FG009|Phase 2|Lost to Follow-up|0|||
27810934|NCT01877421|54266809|FG010|Phase 2|Lost to Follow-up|0|||
27810935|NCT01877421|54266810|FG011|Phase 2|Lost to Follow-up|0|||
27810936|NCT01877421|54266811|FG012|Phase 2|Lost to Follow-up|0|||
28042405|NCT04488770|54700607|FG006|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
28042406|NCT04488770|54700608|FG007|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
28042407|NCT04488770|54700609|FG008|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
28042408|NCT04488770|54700610|FG009|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
27847945|NCT00216671|54340677|FG000|Overall Study|Physician Decision|1|||
27847946|NCT00216671|54340678|FG001|Overall Study|Physician Decision|1|||
27810937|NCT01877421|54266812|FG013|Phase 2|Lost to Follow-up|0|||
27810938|NCT01877421|54266813|FG014|Phase 2|Lost to Follow-up|0|||
27810939|NCT01877421|54266814|FG015|Phase 2|Lost to Follow-up|0|||
27810940|NCT01877421|54266815|FG016|Phase 2|Lost to Follow-up|0|||
27810941|NCT01877421|54266816|FG017|Phase 2|Lost to Follow-up|0|||
27810942|NCT01877421|54266799|FG000|Phase 2|Withdrawal by Subject|0|||
27810943|NCT01877421|54266800|FG001|Phase 2|Withdrawal by Subject|0|||
27810944|NCT01877421|54266801|FG002|Phase 2|Withdrawal by Subject|0|||
27810945|NCT01877421|54266802|FG003|Phase 2|Withdrawal by Subject|0|||
27810946|NCT01877421|54266803|FG004|Phase 2|Withdrawal by Subject|0|||
27810947|NCT01877421|54266804|FG005|Phase 2|Withdrawal by Subject|0|||
27810948|NCT01877421|54266805|FG006|Phase 2|Withdrawal by Subject|0|||
27810949|NCT01877421|54266806|FG007|Phase 2|Withdrawal by Subject|0|||
27810950|NCT01877421|54266807|FG008|Phase 2|Withdrawal by Subject|1|||
27810951|NCT01877421|54266808|FG009|Phase 2|Withdrawal by Subject|0|||
27810952|NCT01877421|54266809|FG010|Phase 2|Withdrawal by Subject|1|||
27810953|NCT01877421|54266810|FG011|Phase 2|Withdrawal by Subject|0|||
27810954|NCT01877421|54266811|FG012|Phase 2|Withdrawal by Subject|1|||
27810955|NCT01877421|54266812|FG013|Phase 2|Withdrawal by Subject|0|||
27810956|NCT01877421|54266813|FG014|Phase 2|Withdrawal by Subject|0|||
27810957|NCT01877421|54266814|FG015|Phase 2|Withdrawal by Subject|1|||
27810958|NCT01877421|54266815|FG016|Phase 2|Withdrawal by Subject|0|||
27810959|NCT01877421|54266816|FG017|Phase 2|Withdrawal by Subject|0|||
27810960|NCT01877421|54266799|FG000|Phase 2|Protocol Violation|0|||
27810961|NCT01877421|54266800|FG001|Phase 2|Protocol Violation|0|||
28042409|NCT04488770|54700611|FG010|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
28042410|NCT04488770|54700612|FG011|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
28042411|NCT04488770|54700613|FG012|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
28042412|NCT00525044|54700659|FG000|Overall Study|Lost to Follow-up|0|||
28042413|NCT00525044|54700660|FG001|Overall Study|Lost to Follow-up|1|||
28042414|NCT00355342|54700668|FG000|Overall Study|Adverse Event|13|||
28042415|NCT00355342|54700669|FG001|Overall Study|Adverse Event|15|||
28042416|NCT00355342|54700668|FG000|Overall Study|Lost to Follow-up|4|||
28042417|NCT00355342|54700669|FG001|Overall Study|Lost to Follow-up|2|||
28042418|NCT00355342|54700668|FG000|Overall Study|Withdrawal by Subject|14|||
28042419|NCT00355342|54700669|FG001|Overall Study|Withdrawal by Subject|11|||
28042420|NCT00355342|54700668|FG000|Overall Study|Sponsor terminated study|2|||
28042421|NCT00355342|54700669|FG001|Overall Study|Sponsor terminated study|2|||
28042422|NCT00355342|54700668|FG000|Overall Study|Overcompliant-PI discretion|1|||
28042423|NCT00355342|54700669|FG001|Overall Study|Overcompliant-PI discretion|0|||
28042424|NCT00355342|54700668|FG000|Overall Study|Use of prohibited medication|1|||
28042425|NCT00355342|54700669|FG001|Overall Study|Use of prohibited medication|0|||
28042426|NCT00355342|54700668|FG000|Overall Study|COPD exacerbation|1|||
28042427|NCT00355342|54700669|FG001|Overall Study|COPD exacerbation|1|||
28042428|NCT00355342|54700668|FG000|Overall Study|Dispensed wrong study drug kit|1|||
28042429|NCT00355342|54700669|FG001|Overall Study|Dispensed wrong study drug kit|0|||
28042430|NCT00355342|54700668|FG000|Overall Study|Non-compliance with Dexa scans|1|||
28042431|NCT00355342|54700669|FG001|Overall Study|Non-compliance with Dexa scans|0|||
28042432|NCT00355342|54700668|FG000|Overall Study|Withdrawal by participant and physician|1|||
28042433|NCT00355342|54700669|FG001|Overall Study|Withdrawal by participant and physician|0|||
28042434|NCT00355342|54700668|FG000|Overall Study|Participant relocated|0|||
28042435|NCT00355342|54700669|FG001|Overall Study|Participant relocated|1|||
28042436|NCT00355342|54700668|FG000|Overall Study|Participant discontinued study drug|0|||
28042437|NCT00355342|54700669|FG001|Overall Study|Participant discontinued study drug|1|||
28042438|NCT00355342|54700668|FG000|Overall Study|Study management|0|||
28042439|NCT00355342|54700669|FG001|Overall Study|Study management|1|||
28042440|NCT00355342|54700668|FG000|Overall Study|Protocol Violation|0|||
28042441|NCT00355342|54700669|FG001|Overall Study|Protocol Violation|1|||
28042442|NCT00355342|54700668|FG000|Overall Study|Use of protocol excluded medication|0|||
28042443|NCT00355342|54700669|FG001|Overall Study|Use of protocol excluded medication|1|||
28042444|NCT01573754|54700677|FG000|Overall Study|Noncompliance or remission not achieved|3|||
28042445|NCT01573754|54700678|FG001|Overall Study|Noncompliance or remission not achieved|15|||
28042446|NCT00355264|54700684|FG000|Extension (Variable Duration)|Adverse Event|1|||
28042447|NCT00355264|54700684|FG000|Extension (Variable Duration)|Withdrew Consent|1|||
28042448|NCT00355030|54700695|FG000|Study Period 1 Treatment|Adverse Event|1|||
28042449|NCT00355030|54700696|FG001|Study Period 1 Treatment|Adverse Event|1|||
28042450|NCT00355030|54700695|FG000|Study Period 1 Treatment|Lost to Follow-up|3|||
28042451|NCT00355030|54700696|FG001|Study Period 1 Treatment|Lost to Follow-up|0|||
27810962|NCT01877421|54266801|FG002|Phase 2|Protocol Violation|0|||
27810963|NCT01877421|54266802|FG003|Phase 2|Protocol Violation|0|||
27810964|NCT01877421|54266803|FG004|Phase 2|Protocol Violation|0|||
27810965|NCT01877421|54266804|FG005|Phase 2|Protocol Violation|0|||
28042452|NCT00355030|54700695|FG000|Study Period 1 Treatment|Withdrawal by Subject|4|||
28042453|NCT00355030|54700696|FG001|Study Period 1 Treatment|Withdrawal by Subject|1|||
28042454|NCT00355030|54700695|FG000|Study Period 1 Treatment|Parent/Caregiver Decision|1|||
27810966|NCT01877421|54266805|FG006|Phase 2|Protocol Violation|0|||
27810967|NCT01877421|54266806|FG007|Phase 2|Protocol Violation|0|||
27810968|NCT01877421|54266807|FG008|Phase 2|Protocol Violation|0|||
27810969|NCT01877421|54266808|FG009|Phase 2|Protocol Violation|0|||
27810970|NCT01877421|54266809|FG010|Phase 2|Protocol Violation|1|||
28042455|NCT00355030|54700696|FG001|Study Period 1 Treatment|Parent/Caregiver Decision|2|||
28042456|NCT00355030|54700695|FG000|Study Period 1 Treatment|Physician Decision|0|||
28042457|NCT00355030|54700696|FG001|Study Period 1 Treatment|Physician Decision|1|||
28042458|NCT00355030|54700695|FG000|Study Period 1 Treatment|Sponsor Decision|34|||
28042459|NCT00355030|54700696|FG001|Study Period 1 Treatment|Sponsor Decision|32|||
28042460|NCT00355030|54700695|FG000|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0|||
28042461|NCT00355030|54700696|FG001|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1|||
28042462|NCT00355030|54700695|FG000|Study Period 1 Treatment|Other|2|||
28042463|NCT00355030|54700696|FG001|Study Period 1 Treatment|Other|6|||
28042464|NCT00355030|54700695|FG000|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0|||
28042465|NCT00355030|54700696|FG001|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1|||
28042466|NCT00355030|54700695|FG000|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
28042467|NCT00355030|54700696|FG001|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
28042468|NCT00354172|54700702|FG000|Overall Study|Did not receive transplant|1|||
28042469|NCT00345592|54700708|FG000|Overall Study|Death|14|||
28042470|NCT00345592|54700709|FG001|Overall Study|Death|16|||
28042471|NCT00345592|54700708|FG000|Overall Study|Withdrawal by Subject|11|||
28042472|NCT00345592|54700709|FG001|Overall Study|Withdrawal by Subject|8|||
28042473|NCT00353704|54700717|FG000|Overall Study|Protocol Violation|3|||
28042474|NCT00353704|54700718|FG001|Overall Study|Protocol Violation|1|||
28042475|NCT00512252|54700727|FG000|Overall Study|Lost to Follow-up|0|||
28042476|NCT00512252|54700728|FG001|Overall Study|Lost to Follow-up|0|||
28042477|NCT00512252|54700729|FG002|Overall Study|Lost to Follow-up|1|||
28042478|NCT00512252|54700727|FG000|Overall Study|Protocol Violation|0|||
28042479|NCT00512252|54700728|FG001|Overall Study|Protocol Violation|0|||
28042480|NCT00512252|54700729|FG002|Overall Study|Protocol Violation|1|||
28042481|NCT00512252|54700727|FG000|Overall Study|Death|0|||
28042482|NCT00512252|54700728|FG001|Overall Study|Death|0|||
28042483|NCT00512252|54700729|FG002|Overall Study|Death|1|||
28042484|NCT00516386|54700744|FG000|Overall Study|not interested in the study|4|||
28042485|NCT00516386|54700744|FG000|Overall Study|Lost to Follow-up|2|||
28042486|NCT00524420|54700750|FG000|Overall Study|Lack of Efficacy|1|||
28042487|NCT00524420|54700751|FG001|Overall Study|Lack of Efficacy|0|||
28042488|NCT00512096|54700759|FG000|Overall Study|Adverse Event|2|||
28042489|NCT00512096|54700759|FG000|Overall Study|Withdrawal by Subject|2|||
28042490|NCT00512096|54700759|FG000|Overall Study|Lack of Efficacy|3|||
28042491|NCT00524030|54700765|FG000|Overall Study|Lack of Efficacy|10|||
28042492|NCT00524030|54700766|FG001|Overall Study|Lack of Efficacy|24|||
28042493|NCT00524030|54700765|FG000|Overall Study|Lost to Follow-up|0|||
28042494|NCT00524030|54700766|FG001|Overall Study|Lost to Follow-up|2|||
28042495|NCT00524030|54700765|FG000|Overall Study|Withdrawal by Subject|3|||
28042496|NCT00524030|54700766|FG001|Overall Study|Withdrawal by Subject|8|||
28042497|NCT00524030|54700765|FG000|Overall Study|Noncompliance/Investigator discretion|0|||
28042498|NCT00524030|54700766|FG001|Overall Study|Noncompliance/Investigator discretion|2|||
28042499|NCT00524030|54700765|FG000|Overall Study|Protocol Violation|0|||
27810971|NCT01877421|54266810|FG011|Phase 2|Protocol Violation|0|||
27810972|NCT01877421|54266811|FG012|Phase 2|Protocol Violation|0|||
27810973|NCT01877421|54266812|FG013|Phase 2|Protocol Violation|0|||
27810974|NCT01877421|54266813|FG014|Phase 2|Protocol Violation|0|||
27810975|NCT01877421|54266814|FG015|Phase 2|Protocol Violation|0|||
27810976|NCT01877421|54266815|FG016|Phase 2|Protocol Violation|0|||
27810977|NCT01877421|54266816|FG017|Phase 2|Protocol Violation|0|||
27847947|NCT00216671|54340677|FG000|Overall Study|Protocol Violation|3|||
27847948|NCT00216671|54340678|FG001|Overall Study|Protocol Violation|5|||
28042500|NCT00524030|54700766|FG001|Overall Study|Protocol Violation|1|||
28042501|NCT00524030|54700765|FG000|Overall Study|Pregnancy|1|||
28042502|NCT00524030|54700766|FG001|Overall Study|Pregnancy|0|||
28042503|NCT00524030|54700765|FG000|Overall Study|Adverse Event|3|||
28042504|NCT00524030|54700766|FG001|Overall Study|Adverse Event|21|||
28042505|NCT00524030|54700765|FG000|Overall Study|Death|0|||
28042506|NCT00524030|54700766|FG001|Overall Study|Death|1|||
28042507|NCT00523718|54700775|FG000|Overall Study|Withdrawal by Subject|1|||
28042508|NCT00523718|54700776|FG001|Overall Study|Withdrawal by Subject|0|||
28042509|NCT00523718|54700775|FG000|Overall Study|Protocol Violation|2|||
28042510|NCT00523718|54700776|FG001|Overall Study|Protocol Violation|0|||
28042511|NCT00523640|54700782|FG000|Overall Study|Death|1|||
28042512|NCT00345358|54700790|FG000|Primary Vaccination Phase|Other|0|||
27847949|NCT00216671|54340677|FG000|Overall Study|Relapse|1|||
27847950|NCT00216671|54340678|FG001|Overall Study|Relapse|0|||
28042513|NCT00345358|54700791|FG001|Primary Vaccination Phase|Other|1|||
28042514|NCT00345358|54700792|FG002|Primary Vaccination Phase|Other|1|||
28042515|NCT00345358|54700793|FG003|Primary Vaccination Phase|Other|0|||
28042516|NCT00345358|54700790|FG000|Primary Vaccination Phase|Adverse event, non-fatal|3|||
28042517|NCT00345358|54700791|FG001|Primary Vaccination Phase|Adverse event, non-fatal|1|||
28042518|NCT00345358|54700792|FG002|Primary Vaccination Phase|Adverse event, non-fatal|1|||
27810978|NCT01726023|54266898|FG000|Overall Study|Death|1|||
27810979|NCT01726023|54266899|FG001|Overall Study|Death|1|||
27810980|NCT01726023|54266898|FG000|Overall Study|Lost to Follow-up|5|||
28042519|NCT00345358|54700793|FG003|Primary Vaccination Phase|Adverse event, non-fatal|0|||
28042520|NCT00345358|54700790|FG000|Primary Vaccination Phase|Withdrawal by Subject|1|||
28042521|NCT00345358|54700791|FG001|Primary Vaccination Phase|Withdrawal by Subject|2|||
28042522|NCT00345358|54700792|FG002|Primary Vaccination Phase|Withdrawal by Subject|4|||
28042523|NCT00345358|54700793|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
28042524|NCT00345358|54700790|FG000|Primary Vaccination Phase|Lost to Follow-up|1|||
28042525|NCT00345358|54700791|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
28042526|NCT00345358|54700792|FG002|Primary Vaccination Phase|Lost to Follow-up|2|||
28042527|NCT00345358|54700793|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
28042528|NCT00345358|54700790|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
28042529|NCT00345358|54700791|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
28042530|NCT00345358|54700792|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
28042531|NCT00345358|54700793|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
28042532|NCT00345358|54700790|FG000|Booster Vaccination Phase|Lost to Follow-up|3|||
28042533|NCT00345358|54700791|FG001|Booster Vaccination Phase|Lost to Follow-up|0|||
28042534|NCT00345358|54700792|FG002|Booster Vaccination Phase|Lost to Follow-up|0|||
28042535|NCT00345358|54700793|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
28042536|NCT03869684|54700806|FG000|Overall Study|Adverse Event|0|||
28042537|NCT03869684|54700807|FG001|Overall Study|Adverse Event|3|||
28042538|NCT03869684|54700808|FG002|Overall Study|Adverse Event|1|||
28042539|NCT03869684|54700806|FG000|Overall Study|Withdrawal by Subject|1|||
28042540|NCT03869684|54700807|FG001|Overall Study|Withdrawal by Subject|0|||
28042541|NCT03869684|54700808|FG002|Overall Study|Withdrawal by Subject|0|||
28042542|NCT03869684|54700806|FG000|Overall Study|Lost to Follow-up|1|||
28042543|NCT03869684|54700807|FG001|Overall Study|Lost to Follow-up|0|||
28042544|NCT03869684|54700808|FG002|Overall Study|Lost to Follow-up|0|||
28042545|NCT03869684|54700806|FG000|Overall Study|Study prematurely terminated by sponsor|0|||
28042546|NCT03869684|54700807|FG001|Overall Study|Study prematurely terminated by sponsor|0|||
28042547|NCT03869684|54700808|FG002|Overall Study|Study prematurely terminated by sponsor|2|||
28042548|NCT00516074|54700818|FG000|Overall Study|Adverse Event|0|||
28042549|NCT00516074|54700819|FG001|Overall Study|Adverse Event|1|||
28042550|NCT00516074|54700818|FG000|Overall Study|Subject Decision|4|||
28042551|NCT00516074|54700819|FG001|Overall Study|Subject Decision|2|||
28042552|NCT00516074|54700818|FG000|Overall Study|Loss of Glucose Control|2|||
28042553|NCT00516074|54700819|FG001|Overall Study|Loss of Glucose Control|0|||
28042554|NCT00515294|54700829|FG000|Overall Study|Lost to Follow-up|3|||
28042555|NCT00515294|54700830|FG001|Overall Study|Lost to Follow-up|2|||
28042556|NCT00515294|54700831|FG002|Overall Study|Lost to Follow-up|3|||
28042557|NCT00515294|54700832|FG003|Overall Study|Lost to Follow-up|1|||
28042558|NCT00515294|54700829|FG000|Overall Study|Driver simulator problems|1|||
27810981|NCT01726023|54266899|FG001|Overall Study|Lost to Follow-up|10|||
27810982|NCT01726023|54266898|FG000|Overall Study|Other Eligibility criteria|7|||
27810983|NCT01726023|54266899|FG001|Overall Study|Other Eligibility criteria|7|||
27810984|NCT01726023|54266898|FG000|Overall Study|Withdrawal by Subject|16|||
27810985|NCT01726023|54266899|FG001|Overall Study|Withdrawal by Subject|8|||
27810986|NCT01877265|54266912|FG000|Treatment Period 1|Sponsor Decision|0|||
27810987|NCT01877265|54266913|FG001|Treatment Period 1|Sponsor Decision|0|||
27810988|NCT01877265|54266914|FG002|Treatment Period 1|Sponsor Decision|1|||
27810989|NCT01877265|54266915|FG003|Treatment Period 1|Sponsor Decision|0|||
27810990|NCT01877265|54266916|FG004|Treatment Period 1|Sponsor Decision|0|||
27810991|NCT01877265|54266917|FG005|Treatment Period 1|Sponsor Decision|0|||
27810992|NCT01877265|54266912|FG000|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
27810993|NCT01877265|54266913|FG001|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
27847951|NCT00216671|54340677|FG000|Overall Study|Investigator Illness|0|||
28042559|NCT00515294|54700830|FG001|Overall Study|Driver simulator problems|1|||
28042560|NCT00515294|54700831|FG002|Overall Study|Driver simulator problems|1|||
28042561|NCT00515294|54700832|FG003|Overall Study|Driver simulator problems|3|||
28042562|NCT00515294|54700829|FG000|Overall Study|Caffeine amount inaccurate|5|||
28042563|NCT00515294|54700830|FG001|Overall Study|Caffeine amount inaccurate|0|||
28042564|NCT00515294|54700831|FG002|Overall Study|Caffeine amount inaccurate|7|||
28042565|NCT00515294|54700832|FG003|Overall Study|Caffeine amount inaccurate|0|||
28042566|NCT00345046|54700845|FG000|Overall Study|Protocol Violation|1|||
28042567|NCT00345046|54700846|FG001|Overall Study|Protocol Violation|1|||
28042568|NCT00345046|54700847|FG002|Overall Study|Protocol Violation|2|||
28042569|NCT00515216|54700855|FG000|Overall Study|Withdrawal by Subject|1|||
28042570|NCT01004978|54700862|FG000|Overall Study|Disease progression|31|||
28042571|NCT01004978|54700863|FG001|Overall Study|Disease progression|48|||
28042572|NCT01004978|54700862|FG000|Overall Study|Adverse Event|42|||
28042573|NCT01004978|54700863|FG001|Overall Study|Adverse Event|22|||
28042574|NCT01004978|54700862|FG000|Overall Study|Death|3|||
28042575|NCT01004978|54700863|FG001|Overall Study|Death|2|||
28042576|NCT01004978|54700862|FG000|Overall Study|Withdrawal by Subject|16|||
28042577|NCT01004978|54700863|FG001|Overall Study|Withdrawal by Subject|16|||
28042578|NCT01004978|54700862|FG000|Overall Study|Alternative therapy|4|||
27810994|NCT01877265|54266914|FG002|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
28042579|NCT01004978|54700863|FG001|Overall Study|Alternative therapy|8|||
28042580|NCT01004978|54700862|FG000|Overall Study|Physician Decision|6|||
28042581|NCT01004978|54700863|FG001|Overall Study|Physician Decision|3|||
28042582|NCT01004978|54700862|FG000|Overall Study|Other complicating disease|2|||
28042583|NCT01004978|54700863|FG001|Overall Study|Other complicating disease|2|||
28042584|NCT01004978|54700862|FG000|Overall Study|Protocol Violation|2|||
28042585|NCT01004978|54700863|FG001|Overall Study|Protocol Violation|3|||
28042586|NCT01004978|54700862|FG000|Overall Study|Non-compliance|3|||
28042587|NCT01004978|54700863|FG001|Overall Study|Non-compliance|2|||
28042588|NCT01004978|54700862|FG000|Overall Study|Ineligible|1|||
28042589|NCT01004978|54700863|FG001|Overall Study|Ineligible|0|||
28042590|NCT01004978|54700862|FG000|Overall Study|Unblinded|0|||
28042591|NCT01004978|54700863|FG001|Overall Study|Unblinded|1|||
28042592|NCT01004978|54700862|FG000|Overall Study|Performance status worsening|0|||
28042593|NCT01004978|54700863|FG001|Overall Study|Performance status worsening|1|||
28042594|NCT01004978|54700862|FG000|Overall Study|Never started treatment|8|||
28042595|NCT01004978|54700863|FG001|Overall Study|Never started treatment|9|||
28042596|NCT00522626|54700869|FG000|Overall Study|Lost to Follow-up|7|||
28042597|NCT00440193|54700875|FG000|Treatment Period|Adverse Event|74|||
28042598|NCT00440193|54700876|FG001|Treatment Period|Adverse Event|67|||
28042599|NCT00440193|54700875|FG000|Treatment Period|Death|19|||
28042600|NCT00440193|54700876|FG001|Treatment Period|Death|22|||
28042601|NCT00440193|54700875|FG000|Treatment Period|Lack of Efficacy|0|||
28042602|NCT00440193|54700876|FG001|Treatment Period|Lack of Efficacy|1|||
28042603|NCT00440193|54700875|FG000|Treatment Period|Lost to Follow-up|12|||
28042604|NCT00440193|54700876|FG001|Treatment Period|Lost to Follow-up|18|||
28042605|NCT00440193|54700875|FG000|Treatment Period|Physician Decision|3|||
28042606|NCT00440193|54700876|FG001|Treatment Period|Physician Decision|6|||
28042607|NCT00440193|54700875|FG000|Treatment Period|Protocol Violation|16|||
28042608|NCT00440193|54700876|FG001|Treatment Period|Protocol Violation|19|||
28042609|NCT00440193|54700875|FG000|Treatment Period|Withdrawal by Subject|36|||
28042610|NCT00440193|54700876|FG001|Treatment Period|Withdrawal by Subject|77|||
28042611|NCT00440193|54700875|FG000|Treatment Period|Clinical endpoint reached|28|||
28042612|NCT00440193|54700876|FG001|Treatment Period|Clinical endpoint reached|25|||
28042613|NCT00440193|54700875|FG000|Treatment Period|Study terminated by sponsor|102|||
28042614|NCT00440193|54700876|FG001|Treatment Period|Study terminated by sponsor|94|||
28042615|NCT00440193|54700875|FG000|Treatment Period|Protocol driven decision point|2|||
28042616|NCT00440193|54700876|FG001|Treatment Period|Protocol driven decision point|2|||
28042617|NCT00440193|54700875|FG000|Treatment Period|Switch to commercial drug|0|||
28042618|NCT00440193|54700876|FG001|Treatment Period|Switch to commercial drug|2|||
28042619|NCT00440193|54700875|FG000|Treatment Period|Technical problems|1|||
28042620|NCT00440193|54700876|FG001|Treatment Period|Technical problems|1|||
28042621|NCT00440193|54700875|FG000|Treatment Period|Participant convenience|5|||
28042622|NCT00440193|54700876|FG001|Treatment Period|Participant convenience|2|||
28042623|NCT00440193|54700875|FG000|Treatment Period|Participant did not receive treatment|7|||
28042624|NCT00440193|54700876|FG001|Treatment Period|Participant did not receive treatment|13|||
28042625|NCT00440193|54700875|FG000|Treatment Period|Site closed by investigator|0|||
28042626|NCT00440193|54700876|FG001|Treatment Period|Site closed by investigator|2|||
28042627|NCT00440193|54700875|FG000|Observational Period|Adverse Event|2|||
28042628|NCT00440193|54700876|FG001|Observational Period|Adverse Event|2|||
27810995|NCT01877265|54266915|FG003|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
27810996|NCT01877265|54266916|FG004|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
27810997|NCT01877265|54266917|FG005|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1|||
27810998|NCT01877265|54266912|FG000|Treatment Period 3|Lost to Follow-up|1|||
27810999|NCT01877265|54266913|FG001|Treatment Period 3|Lost to Follow-up|0|||
27811000|NCT01877265|54266914|FG002|Treatment Period 3|Lost to Follow-up|0|||
27811001|NCT01877265|54266915|FG003|Treatment Period 3|Lost to Follow-up|0|||
27811002|NCT01877265|54266916|FG004|Treatment Period 3|Lost to Follow-up|0|||
27811003|NCT01877265|54266917|FG005|Treatment Period 3|Lost to Follow-up|0|||
27811004|NCT01877187|54266928|FG000|Overall Study|Death|2|||
27811005|NCT01877187|54266928|FG000|Overall Study|Withdrawal by Subject|4|||
27811006|NCT01877187|54266928|FG000|Overall Study|Lost to Follow-up|3|||
27811007|NCT01877187|54266928|FG000|Overall Study|Declining clinical status|11|||
28042629|NCT00440193|54700875|FG000|Observational Period|Death|15|||
28042630|NCT00440193|54700876|FG001|Observational Period|Death|20|||
28042631|NCT00440193|54700875|FG000|Observational Period|Lost to Follow-up|12|||
28042632|NCT00440193|54700876|FG001|Observational Period|Lost to Follow-up|8|||
28042633|NCT00440193|54700875|FG000|Observational Period|Protocol Violation|1|||
28042634|NCT00440193|54700876|FG001|Observational Period|Protocol Violation|0|||
28042635|NCT00440193|54700875|FG000|Observational Period|Withdrawal by Subject|11|||
28042636|NCT00440193|54700876|FG001|Observational Period|Withdrawal by Subject|8|||
28042637|NCT00440193|54700875|FG000|Observational Period|Physician Decision|1|||
28042638|NCT00440193|54700876|FG001|Observational Period|Physician Decision|0|||
28042639|NCT00440193|54700875|FG000|Observational Period|Clinical endpoint reached|1|||
28042640|NCT00440193|54700876|FG001|Observational Period|Clinical endpoint reached|0|||
28042641|NCT00440193|54700875|FG000|Observational Period|Participant convenience|2|||
28042642|NCT00440193|54700876|FG001|Observational Period|Participant convenience|0|||
28042643|NCT00511472|54700884|FG000|Overall Study|Clinical Adverse Event|1|||
28042644|NCT00511472|54700885|FG001|Overall Study|Clinical Adverse Event|2|||
28042645|NCT00511472|54700884|FG000|Overall Study|Laboratory Adverse Event|0|||
28042646|NCT00511472|54700885|FG001|Overall Study|Laboratory Adverse Event|2|||
28042647|NCT00511472|54700884|FG000|Overall Study|Not reported|2|||
28042648|NCT00511472|54700885|FG001|Overall Study|Not reported|2|||
28042649|NCT00514904|54700902|FG000|Overall Study|Withdrawal by Subject|3|||
28042650|NCT00514904|54700903|FG001|Overall Study|Withdrawal by Subject|2|||
28042651|NCT00514904|54700902|FG000|Overall Study|Lost to Follow-up|21|||
28042652|NCT00514904|54700903|FG001|Overall Study|Lost to Follow-up|3|||
28042653|NCT00440115|54700912|FG000|Overall Study|Death|7|||
28042654|NCT00440115|54700913|FG001|Overall Study|Death|9|||
28042655|NCT00440115|54700914|FG002|Overall Study|Death|5|||
28042656|NCT00440115|54700912|FG000|Overall Study|Incarceration|0|||
28042657|NCT00440115|54700913|FG001|Overall Study|Incarceration|2|||
28042658|NCT00440115|54700914|FG002|Overall Study|Incarceration|1|||
28042659|NCT00440037|54700922|FG000|Overall Study|Withdrawal by Subject|6|||
28042660|NCT00440037|54700922|FG000|Overall Study|Administrative decision|3|||
28042661|NCT00417027|54700929|FG000|Overall Study|Protocol Violation|0|||
28042662|NCT00417027|54700930|FG001|Overall Study|Protocol Violation|5|||
28042663|NCT00417027|54700931|FG002|Overall Study|Protocol Violation|5|||
28042664|NCT00416949|54700939|FG000|Overall Study|Patients refused to participate|5|||
28042665|NCT00416715|54700943|FG000|Overall Study|Not evaluable for joint aches|7|||
28042666|NCT00416715|54700943|FG000|Overall Study|Vitamin D levels not evaluable|8|||
28042667|NCT00406029|54700955|FG000|Overall Study|Adverse Event|12|||
28042668|NCT00406029|54700956|FG001|Overall Study|Adverse Event|2|||
28042669|NCT00406029|54700957|FG002|Overall Study|Adverse Event|5|||
28042670|NCT00406029|54700958|FG003|Overall Study|Adverse Event|10|||
28042671|NCT00406029|54700959|FG004|Overall Study|Adverse Event|7|||
28042672|NCT00406029|54700955|FG000|Overall Study|Withdrawal by Subject|3|||
28042673|NCT00406029|54700956|FG001|Overall Study|Withdrawal by Subject|4|||
28042674|NCT00406029|54700957|FG002|Overall Study|Withdrawal by Subject|2|||
28042675|NCT00406029|54700958|FG003|Overall Study|Withdrawal by Subject|2|||
28042676|NCT00406029|54700959|FG004|Overall Study|Withdrawal by Subject|0|||
28042677|NCT00406029|54700955|FG000|Overall Study|Protocol Violation|1|||
28042678|NCT00406029|54700956|FG001|Overall Study|Protocol Violation|2|||
28042679|NCT00406029|54700957|FG002|Overall Study|Protocol Violation|0|||
28042680|NCT00406029|54700958|FG003|Overall Study|Protocol Violation|2|||
28042681|NCT00406029|54700959|FG004|Overall Study|Protocol Violation|0|||
28042682|NCT00406029|54700955|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
28042683|NCT00406029|54700956|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
28042684|NCT00406029|54700957|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
28042685|NCT00406029|54700958|FG003|Overall Study|Did Not Meet Eligibility Criteria|0|||
28042686|NCT00406029|54700959|FG004|Overall Study|Did Not Meet Eligibility Criteria|0|||
28042687|NCT00406029|54700955|FG000|Overall Study|Randomized in Error|0|||
28042688|NCT00406029|54700956|FG001|Overall Study|Randomized in Error|0|||
28042689|NCT00406029|54700957|FG002|Overall Study|Randomized in Error|2|||
28042690|NCT00406029|54700958|FG003|Overall Study|Randomized in Error|3|||
28042691|NCT00406029|54700959|FG004|Overall Study|Randomized in Error|1|||
28042692|NCT00514514|54700974|FG000|Pre-phase|Death|10|||
28042693|NCT00514514|54700975|FG001|Pre-phase|Death|0|||
28042694|NCT00514514|54700976|FG002|Pre-phase|Death|0|||
28042695|NCT00514514|54700974|FG000|Pre-phase|administrative problems|2|||
28042696|NCT00514514|54700975|FG001|Pre-phase|administrative problems|0|||
28042697|NCT00514514|54700976|FG002|Pre-phase|administrative problems|0|||
28042698|NCT00514514|54700974|FG000|Pre-phase|Protocol Violation|6|||
28042699|NCT00514514|54700975|FG001|Pre-phase|Protocol Violation|0|||
28042700|NCT00514514|54700976|FG002|Pre-phase|Protocol Violation|0|||
28042701|NCT00514514|54700974|FG000|Pre-phase|condition no longer requires study drug|7|||
28042702|NCT00514514|54700975|FG001|Pre-phase|condition no longer requires study drug|0|||
28042703|NCT00514514|54700976|FG002|Pre-phase|condition no longer requires study drug|0|||
28042704|NCT00514514|54700974|FG000|Pre-phase|abnormal test procedure results|15|||
28042705|NCT00514514|54700975|FG001|Pre-phase|abnormal test procedure results|0|||
28042706|NCT00514514|54700976|FG002|Pre-phase|abnormal test procedure results|0|||
28042707|NCT00514514|54700974|FG000|Pre-phase|Lost to Follow-up|2|||
28042708|NCT00514514|54700975|FG001|Pre-phase|Lost to Follow-up|0|||
28042709|NCT00514514|54700976|FG002|Pre-phase|Lost to Follow-up|0|||
28042710|NCT00514514|54700974|FG000|Pre-phase|abnormal lab values|23|||
28042711|NCT00514514|54700975|FG001|Pre-phase|abnormal lab values|0|||
28042712|NCT00514514|54700976|FG002|Pre-phase|abnormal lab values|0|||
28042713|NCT00514514|54700974|FG000|Pre-phase|Lack of Efficacy|35|||
28042714|NCT00514514|54700975|FG001|Pre-phase|Lack of Efficacy|0|||
28042715|NCT00514514|54700976|FG002|Pre-phase|Lack of Efficacy|0|||
28042716|NCT00514514|54700974|FG000|Pre-phase|Adverse Event|137|||
28042717|NCT00514514|54700975|FG001|Pre-phase|Adverse Event|0|||
28042718|NCT00514514|54700976|FG002|Pre-phase|Adverse Event|0|||
28042719|NCT00514514|54700974|FG000|Pre-phase|Withdrawal by Subject|66|||
28042720|NCT00514514|54700975|FG001|Pre-phase|Withdrawal by Subject|0|||
28042721|NCT00514514|54700976|FG002|Pre-phase|Withdrawal by Subject|0|||
28042722|NCT00514514|54700974|FG000|Randomized - 9 Month|Death|3|||
28042723|NCT00514514|54700975|FG001|Randomized - 9 Month|Death|2|||
28042724|NCT00514514|54700976|FG002|Randomized - 9 Month|Death|2|||
28042725|NCT00514514|54700974|FG000|Randomized - 9 Month|Administrative problems|1|||
28042726|NCT00514514|54700975|FG001|Randomized - 9 Month|Administrative problems|1|||
28042727|NCT00514514|54700976|FG002|Randomized - 9 Month|Administrative problems|2|||
28042728|NCT00514514|54700974|FG000|Randomized - 9 Month|Withdrawal by Subject|7|||
28042729|NCT00514514|54700975|FG001|Randomized - 9 Month|Withdrawal by Subject|7|||
28042730|NCT00514514|54700976|FG002|Randomized - 9 Month|Withdrawal by Subject|5|||
28042731|NCT00514514|54700974|FG000|Randomized - 9 Month|Protocol Violation|1|||
28042732|NCT00514514|54700975|FG001|Randomized - 9 Month|Protocol Violation|1|||
28042733|NCT00514514|54700976|FG002|Randomized - 9 Month|Protocol Violation|0|||
28042734|NCT00514514|54700974|FG000|Randomized - 9 Month|Lack of Efficacy|2|||
28042735|NCT00514514|54700975|FG001|Randomized - 9 Month|Lack of Efficacy|3|||
28042736|NCT00514514|54700976|FG002|Randomized - 9 Month|Lack of Efficacy|1|||
28042737|NCT00514514|54700974|FG000|Randomized - 9 Month|Abnormal laboratory values|0|||
28042738|NCT00514514|54700975|FG001|Randomized - 9 Month|Abnormal laboratory values|3|||
28042739|NCT00514514|54700976|FG002|Randomized - 9 Month|Abnormal laboratory values|1|||
28042740|NCT00514514|54700974|FG000|Randomized - 9 Month|Adverse Event|25|||
28042741|NCT00514514|54700975|FG001|Randomized - 9 Month|Adverse Event|44|||
28042742|NCT00514514|54700976|FG002|Randomized - 9 Month|Adverse Event|27|||
28042743|NCT00514514|54700974|FG000|Extension - 4 Years|Withdrawal by Subject|5|||
28042744|NCT00514514|54700975|FG001|Extension - 4 Years|Withdrawal by Subject|2|||
28042745|NCT00514514|54700976|FG002|Extension - 4 Years|Withdrawal by Subject|2|||
28042746|NCT00514514|54700974|FG000|Extension - 4 Years|Lost to Follow-up|12|||
28042747|NCT00514514|54700975|FG001|Extension - 4 Years|Lost to Follow-up|10|||
28042748|NCT00514514|54700976|FG002|Extension - 4 Years|Lost to Follow-up|9|||
28042749|NCT00514514|54700974|FG000|Extension - 4 Years|Administrative problems|3|||
28042750|NCT00514514|54700975|FG001|Extension - 4 Years|Administrative problems|1|||
28042751|NCT00514514|54700976|FG002|Extension - 4 Years|Administrative problems|1|||
28042752|NCT00514514|54700974|FG000|Extension - 4 Years|Death|8|||
28042753|NCT00514514|54700975|FG001|Extension - 4 Years|Death|3|||
28042754|NCT00514514|54700976|FG002|Extension - 4 Years|Death|6|||
28042755|NCT00514514|54700974|FG000|Extension - 4 Years|Adverse Event|9|||
28042756|NCT00514514|54700975|FG001|Extension - 4 Years|Adverse Event|6|||
28042757|NCT00514514|54700976|FG002|Extension - 4 Years|Adverse Event|3|||
28042758|NCT00405639|54700986|FG000|Overall Study|Withdrawal by Subject|1|||
28042759|NCT00405639|54700987|FG001|Overall Study|Withdrawal by Subject|0|||
28042760|NCT00405639|54700986|FG000|Overall Study|Adverse Event|1|||
28042761|NCT00405639|54700987|FG001|Overall Study|Adverse Event|0|||
28042762|NCT00405639|54700986|FG000|Overall Study|Seizure prior to receiving BNP|1|||
28042763|NCT00405639|54700987|FG001|Overall Study|Seizure prior to receiving BNP|0|||
28042764|NCT00439725|54700995|FG000|Treatment Period|Withdrawal by Subject|22|||
28042765|NCT00439725|54700996|FG001|Treatment Period|Withdrawal by Subject|19|||
28042766|NCT00439725|54700995|FG000|Treatment Period|Study terminated by sponsor|156|||
28042767|NCT00439725|54700996|FG001|Treatment Period|Study terminated by sponsor|148|||
28042768|NCT00439725|54700995|FG000|Treatment Period|Site closed by investigator|1|||
28042769|NCT00439725|54700996|FG001|Treatment Period|Site closed by investigator|2|||
28042770|NCT00439725|54700995|FG000|Treatment Period|Adverse Event|39|||
28042771|NCT00439725|54700996|FG001|Treatment Period|Adverse Event|18|||
28042772|NCT00439725|54700995|FG000|Treatment Period|Physician Decision|1|||
28042773|NCT00439725|54700996|FG001|Treatment Period|Physician Decision|1|||
28042774|NCT00439725|54700995|FG000|Treatment Period|Protocol Violation|2|||
28042775|NCT00439725|54700996|FG001|Treatment Period|Protocol Violation|1|||
28042776|NCT00439725|54700995|FG000|Treatment Period|Clinical endpoint reached|6|||
28042777|NCT00439725|54700996|FG001|Treatment Period|Clinical endpoint reached|50|||
28042778|NCT00439725|54700995|FG000|Treatment Period|Technical problems|1|||
28042779|NCT00439725|54700996|FG001|Treatment Period|Technical problems|0|||
27811008|NCT01877187|54266928|FG000|Overall Study|Liver transplant|2|||
28042780|NCT00439725|54700995|FG000|Treatment Period|Lost to Follow-up|1|||
28042781|NCT00439725|54700996|FG001|Treatment Period|Lost to Follow-up|1|||
28042782|NCT00439725|54700995|FG000|Treatment Period|Participant convenience|1|||
28042783|NCT00439725|54700996|FG001|Treatment Period|Participant convenience|0|||
28042784|NCT00439725|54700995|FG000|Treatment Period|Protocol driven decision point|1|||
28042785|NCT00439725|54700996|FG001|Treatment Period|Protocol driven decision point|1|||
28042786|NCT00439725|54700995|FG000|Treatment Period|Death|1|||
28042787|NCT00439725|54700996|FG001|Treatment Period|Death|1|||
28042788|NCT00439725|54700995|FG000|Treatment Period|Participant did not receive treatment|4|||
28042789|NCT00439725|54700996|FG001|Treatment Period|Participant did not receive treatment|4|||
28042790|NCT00439725|54700995|FG000|Observational Period|Withdrawal by Subject|2|||
28042791|NCT00439725|54700996|FG001|Observational Period|Withdrawal by Subject|2|||
28042792|NCT00439725|54700995|FG000|Observational Period|Lost to Follow-up|0|||
28042793|NCT00439725|54700996|FG001|Observational Period|Lost to Follow-up|1|||
28042794|NCT00439725|54700995|FG000|Observational Period|Death|0|||
28042795|NCT00439725|54700996|FG001|Observational Period|Death|2|||
28042796|NCT00439725|54700995|FG000|Observational Period|Study termination by sponsor|1|||
28042797|NCT00439725|54700996|FG001|Observational Period|Study termination by sponsor|1|||
28042798|NCT00439725|54700995|FG000|Observational Period|Clinical endpoint reached|3|||
28042799|NCT00439725|54700996|FG001|Observational Period|Clinical endpoint reached|1|||
28042800|NCT00439725|54700995|FG000|Observational Period|Technical problems|1|||
28042801|NCT00439725|54700996|FG001|Observational Period|Technical problems|0|||
28042802|NCT00439725|54700995|FG000|Observational Period|Participant convenience|1|||
28042803|NCT00439725|54700996|FG001|Observational Period|Participant convenience|0|||
27811009|NCT01858532|54266939|FG000|Overall Study|Adverse Event|58|||
27811010|NCT01858532|54266940|FG001|Overall Study|Adverse Event|50|||
27811011|NCT01858532|54266941|FG002|Overall Study|Adverse Event|23|||
27811012|NCT01858532|54266942|FG003|Overall Study|Adverse Event|28|||
28042804|NCT00521586|54701004|FG000|Initial Vaccination (Year 0)|Subject request|8|||
28042805|NCT00521586|54701005|FG001|Initial Vaccination (Year 0)|Subject request|11|||
28042806|NCT00521586|54701004|FG000|Initial Vaccination (Year 0)|Lost to Follow-up|5|||
28042807|NCT00521586|54701005|FG001|Initial Vaccination (Year 0)|Lost to Follow-up|10|||
28042808|NCT00521586|54701004|FG000|Initial Vaccination (Year 0)|Protocol Violation|2|||
28042809|NCT00521586|54701005|FG001|Initial Vaccination (Year 0)|Protocol Violation|5|||
28042810|NCT00521586|54701004|FG000|Initial Vaccination (Year 0)|Other, unspecified|3|||
28042811|NCT00521586|54701005|FG001|Initial Vaccination (Year 0)|Other, unspecified|1|||
28042812|NCT00521586|54701004|FG000|Initial Vaccination (Year 0)|Investigator request|2|||
28042813|NCT00521586|54701005|FG001|Initial Vaccination (Year 0)|Investigator request|0|||
28042814|NCT00521586|54701004|FG000|Initial Vaccination (Year 0)|Adverse Event|0|||
28042815|NCT00521586|54701005|FG001|Initial Vaccination (Year 0)|Adverse Event|1|||
28042816|NCT00521586|54701004|FG000|Initial Vaccination (Year 0)|Death|1|||
28042817|NCT00521586|54701005|FG001|Initial Vaccination (Year 0)|Death|0|||
28042818|NCT00521586|54701004|FG000|Initial Vaccination (Year 0)|Failed to return|0|||
28042819|NCT00521586|54701005|FG001|Initial Vaccination (Year 0)|Failed to return|1|||
28042820|NCT00521586|54701004|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5|||
28042821|NCT00521586|54701005|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1|||
28042822|NCT00521586|54701004|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Death|5|||
28042823|NCT00521586|54701005|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Death|2|||
28042824|NCT00521586|54701004|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7|||
28042825|NCT00521586|54701005|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3|||
28042826|NCT00521586|54701004|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
28042827|NCT00521586|54701005|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
28042828|NCT00521586|54701004|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55|||
28042829|NCT00521586|54701005|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56|||
28042830|NCT00521586|54701004|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Other|22|||
28042831|NCT00521586|54701005|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Other|26|||
28042832|NCT00521586|54701004|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18|||
28042833|NCT00521586|54701005|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22|||
28042834|NCT00521586|54701004|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54|||
28042835|NCT00521586|54701005|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57|||
28042836|NCT00521586|54701004|FG000|Revaccination With 13vPnC (Year 5)|Subject request|0|||
28042837|NCT00521586|54701005|FG001|Revaccination With 13vPnC (Year 5)|Subject request|1|||
28042838|NCT00521586|54701004|FG000|Revaccination With 13vPnC (Year 5)|Failed to return|1|||
28042839|NCT00521586|54701005|FG001|Revaccination With 13vPnC (Year 5)|Failed to return|4|||
28042840|NCT00521586|54701004|FG000|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2|||
28042841|NCT00521586|54701005|FG001|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7|||
28042842|NCT00515502|54701023|FG000|Treatment Period 1|Adverse Event|0|||
28042843|NCT00515502|54701024|FG001|Treatment Period 1|Adverse Event|0|||
28042844|NCT00515502|54701025|FG002|Treatment Period 1|Adverse Event|0|||
28042845|NCT00515502|54701026|FG003|Treatment Period 1|Adverse Event|0|||
28042846|NCT00515502|54701027|FG004|Treatment Period 1|Adverse Event|0|||
28042847|NCT00515502|54701028|FG005|Treatment Period 1|Adverse Event|0|||
28042848|NCT00515502|54701029|FG006|Treatment Period 1|Adverse Event|1|||
28042849|NCT00515502|54701030|FG007|Treatment Period 1|Adverse Event|0|||
28042850|NCT00515502|54701031|FG008|Treatment Period 1|Adverse Event|1|||
28042851|NCT00515502|54701032|FG009|Treatment Period 1|Adverse Event|0|||
27811013|NCT01858532|54266939|FG000|Overall Study|Withdrew consent|71|||
28042852|NCT00515502|54701033|FG010|Treatment Period 1|Adverse Event|0|||
28042853|NCT00515502|54701034|FG011|Treatment Period 1|Adverse Event|1|||
28042854|NCT00515502|54701023|FG000|Treatment Period 2|Adverse Event|0|||
28042855|NCT00515502|54701024|FG001|Treatment Period 2|Adverse Event|1|||
28042856|NCT00515502|54701025|FG002|Treatment Period 2|Adverse Event|0|||
28042857|NCT00515502|54701026|FG003|Treatment Period 2|Adverse Event|0|||
28042858|NCT00515502|54701027|FG004|Treatment Period 2|Adverse Event|0|||
28042859|NCT00515502|54701028|FG005|Treatment Period 2|Adverse Event|0|||
28042860|NCT00515502|54701029|FG006|Treatment Period 2|Adverse Event|0|||
28042861|NCT00515502|54701030|FG007|Treatment Period 2|Adverse Event|0|||
28042862|NCT00515502|54701031|FG008|Treatment Period 2|Adverse Event|0|||
28042863|NCT00515502|54701032|FG009|Treatment Period 2|Adverse Event|0|||
28042864|NCT00515502|54701033|FG010|Treatment Period 2|Adverse Event|0|||
28042865|NCT00515502|54701034|FG011|Treatment Period 2|Adverse Event|0|||
28042866|NCT00439647|54701053|FG000|Overall Study|Withdrawal by Subject|25|||
28042867|NCT00439647|54701054|FG001|Overall Study|Withdrawal by Subject|22|||
28042868|NCT00439647|54701053|FG000|Overall Study|Death|15|||
28042869|NCT00439647|54701054|FG001|Overall Study|Death|18|||
28042870|NCT00439647|54701053|FG000|Overall Study|Adverse Event|11|||
28042871|NCT00439647|54701054|FG001|Overall Study|Adverse Event|11|||
28042872|NCT00439647|54701053|FG000|Overall Study|Lost to Follow-up|4|||
28042873|NCT00439647|54701054|FG001|Overall Study|Lost to Follow-up|12|||
28042874|NCT00439647|54701053|FG000|Overall Study|Protocol Violation|3|||
28042875|NCT00439647|54701054|FG001|Overall Study|Protocol Violation|4|||
28042876|NCT00439647|54701053|FG000|Overall Study|Lack of Efficacy|0|||
28042877|NCT00439647|54701054|FG001|Overall Study|Lack of Efficacy|4|||
28042878|NCT00515112|54701062|FG000|Overall Study|Death|0|||
28042879|NCT00515112|54701063|FG001|Overall Study|Death|1|||
28042880|NCT00515112|54701062|FG000|Overall Study|The study was terminated|3|||
28042881|NCT00515112|54701063|FG001|Overall Study|The study was terminated|2|||
28042882|NCT00404547|54701071|FG000|Overall Study|Adverse Event|39|||
28042883|NCT00404547|54701072|FG001|Overall Study|Adverse Event|6|||
28042884|NCT00404547|54701071|FG000|Overall Study|Withdrawal by Subject|19|||
28042885|NCT00404547|54701072|FG001|Overall Study|Withdrawal by Subject|2|||
28042886|NCT00404547|54701071|FG000|Overall Study|Protocol Violation|0|||
28042887|NCT00404547|54701072|FG001|Overall Study|Protocol Violation|1|||
28042888|NCT00404547|54701071|FG000|Overall Study|Lost to Follow-up|20|||
28042889|NCT00404547|54701072|FG001|Overall Study|Lost to Follow-up|9|||
28042890|NCT00404547|54701071|FG000|Overall Study|Lack of compliance|5|||
28042891|NCT00404547|54701072|FG001|Overall Study|Lack of compliance|1|||
28042892|NCT00404547|54701071|FG000|Overall Study|Other|4|||
28042893|NCT00404547|54701072|FG001|Overall Study|Other|0|||
28042894|NCT00404547|54701071|FG000|Overall Study|Reason not stated|3|||
28042895|NCT00404547|54701072|FG001|Overall Study|Reason not stated|6|||
28042896|NCT00515034|54701082|FG000|Overall Study|Adverse Event|2|||
28042897|NCT00515034|54701083|FG001|Overall Study|Adverse Event|0|||
28042898|NCT00515034|54701084|FG002|Overall Study|Adverse Event|1|||
28042899|NCT00515034|54701085|FG003|Overall Study|Adverse Event|0|||
27811014|NCT01858532|54266940|FG001|Overall Study|Withdrew consent|93|||
27811015|NCT01858532|54266941|FG002|Overall Study|Withdrew consent|46|||
27811016|NCT01858532|54266942|FG003|Overall Study|Withdrew consent|27|||
27811017|NCT01858532|54266939|FG000|Overall Study|Lost to Follow-up|17|||
27811018|NCT01858532|54266940|FG001|Overall Study|Lost to Follow-up|26|||
27811019|NCT01858532|54266941|FG002|Overall Study|Lost to Follow-up|11|||
27811020|NCT01858532|54266942|FG003|Overall Study|Lost to Follow-up|14|||
27811021|NCT01858532|54266939|FG000|Overall Study|Deterioration of medical status|3|||
27811022|NCT01858532|54266940|FG001|Overall Study|Deterioration of medical status|4|||
27811023|NCT01858532|54266941|FG002|Overall Study|Deterioration of medical status|3|||
27811024|NCT01858532|54266942|FG003|Overall Study|Deterioration of medical status|7|||
27811025|NCT01858532|54266939|FG000|Overall Study|Investigator request|3|||
27811026|NCT01858532|54266940|FG001|Overall Study|Investigator request|4|||
27811027|NCT01858532|54266941|FG002|Overall Study|Investigator request|2|||
27811028|NCT01858532|54266942|FG003|Overall Study|Investigator request|6|||
27811029|NCT01858532|54266939|FG000|Overall Study|Other, not specified|29|||
27811030|NCT01858532|54266940|FG001|Overall Study|Other, not specified|15|||
27811031|NCT01858532|54266941|FG002|Overall Study|Other, not specified|13|||
27939882|NCT01081912|54596203|FG002|Maintenance Treatment|Withdrawal by Medical Monitor|1|||
28042900|NCT00515034|54701082|FG000|Overall Study|Death|4|||
28042901|NCT00515034|54701083|FG001|Overall Study|Death|2|||
28042902|NCT00515034|54701084|FG002|Overall Study|Death|1|||
28042903|NCT00515034|54701085|FG003|Overall Study|Death|3|||
28042904|NCT00515034|54701082|FG000|Overall Study|Withdrawal by Subject|1|||
28042905|NCT00515034|54701083|FG001|Overall Study|Withdrawal by Subject|0|||
27811032|NCT01858532|54266942|FG003|Overall Study|Other, not specified|11|||
28042906|NCT00515034|54701084|FG002|Overall Study|Withdrawal by Subject|3|||
28042907|NCT00515034|54701085|FG003|Overall Study|Withdrawal by Subject|0|||
28042908|NCT00515034|54701082|FG000|Overall Study|Physician Decision|0|||
28042909|NCT00515034|54701083|FG001|Overall Study|Physician Decision|0|||
27811033|NCT01883492|54266954|FG000|Overall Study|Lost to Follow-up|3|||
28042910|NCT00515034|54701084|FG002|Overall Study|Physician Decision|1|||
28042911|NCT00515034|54701085|FG003|Overall Study|Physician Decision|1|||
27811034|NCT01883492|54266955|FG001|Overall Study|Lost to Follow-up|4|||
27811035|NCT01883492|54266954|FG000|Overall Study|Surgery on contra-lateral hip|0|||
27811036|NCT01883492|54266955|FG001|Overall Study|Surgery on contra-lateral hip|1|||
27811037|NCT01883492|54266954|FG000|Overall Study|Poor X-ray quality|7|||
27811038|NCT01883492|54266955|FG001|Overall Study|Poor X-ray quality|4|||
27811039|NCT01883492|54266954|FG000|Overall Study|Withdrawal by Subject|1|||
27811040|NCT01883492|54266955|FG001|Overall Study|Withdrawal by Subject|0|||
27811041|NCT01883492|54266954|FG000|Overall Study|inappropriate implant used|1|||
27811042|NCT01883492|54266955|FG001|Overall Study|inappropriate implant used|1|||
27811043|NCT01883492|54266954|FG000|Overall Study|bone anatomy did not meet study criteria|1|||
27811044|NCT01883492|54266955|FG001|Overall Study|bone anatomy did not meet study criteria|1|||
27811045|NCT01832480|54266963|FG000|Overall Study|Lost to Follow-up|33|||
27811046|NCT01832480|54266964|FG001|Overall Study|Lost to Follow-up|30|||
27811047|NCT01832480|54266963|FG000|Overall Study|Withdrawal by Subject|0|||
27811048|NCT01832480|54266964|FG001|Overall Study|Withdrawal by Subject|2|||
27811049|NCT01832480|54266963|FG000|Overall Study|post randomization ineligible|8|||
27811050|NCT01832480|54266964|FG001|Overall Study|post randomization ineligible|10|||
27811051|NCT01858376|54266970|FG000|Overall Study|Dropped d/t lab work not fitting criter|4|||
27811052|NCT01831856|54266976|FG000|Overall Study|Adverse Event|5|||
27811053|NCT01831856|54266977|FG001|Overall Study|Adverse Event|8|||
27811054|NCT01831856|54266976|FG000|Overall Study|Lack of Efficacy|13|||
27811055|NCT01831856|54266977|FG001|Overall Study|Lack of Efficacy|11|||
27811056|NCT01831856|54266976|FG000|Overall Study|Unsuccessful Electrical Cardioversion|16|||
27811057|NCT01831856|54266977|FG001|Overall Study|Unsuccessful Electrical Cardioversion|18|||
27811058|NCT01831544|54266983|FG000|Overall Study|Death|1|||
27811059|NCT01831544|54266983|FG000|Overall Study|Still on original MVAD device|2|||
27811060|NCT01857206|54266989|FG000|Overall Study|ADMINISTRATIVE REASON|0|||
27811061|NCT01857206|54266990|FG001|Overall Study|ADMINISTRATIVE REASON|1|||
27811062|NCT01857206|54266989|FG000|Overall Study|Lost to Follow-up|9|||
27811063|NCT01857206|54266990|FG001|Overall Study|Lost to Follow-up|6|||
27811064|NCT01857206|54266989|FG000|Overall Study|Unclassified|3|||
27811065|NCT01857206|54266990|FG001|Overall Study|Unclassified|3|||
27811066|NCT01857206|54266989|FG000|Overall Study|Withdrawal by Subject|1|||
27811067|NCT01857206|54266990|FG001|Overall Study|Withdrawal by Subject|0|||
27811068|NCT01882088|54267000|FG000|Overall Study|Intolerance of esophageal manometry|1|||
27811069|NCT01882088|54267000|FG000|Overall Study|no possibility to place the catheter|1|||
27811070|NCT01882088|54267000|FG000|Overall Study|Protocol Violation|1|||
27811071|NCT01882088|54267000|FG000|Overall Study|inadequate pH-impedance tracings|2|||
27811072|NCT01881776|54267007|FG000|Overall Study|Lost to Follow-up|1|||
27811073|NCT01881776|54267008|FG001|Overall Study|Lost to Follow-up|2|||
27811074|NCT01881776|54267009|FG002|Overall Study|Lost to Follow-up|1|||
27811075|NCT01881776|54267007|FG000|Overall Study|Protocol Violation|0|||
27811076|NCT01881776|54267008|FG001|Overall Study|Protocol Violation|2|||
27811077|NCT01881776|54267009|FG002|Overall Study|Protocol Violation|1|||
27811078|NCT01708161|54267023|FG000|Overall Study|Adverse Event|1|||
27811079|NCT01708161|54267024|FG001|Overall Study|Adverse Event|3|||
27811080|NCT01708161|54267025|FG002|Overall Study|Adverse Event|4|||
27811081|NCT01708161|54267026|FG003|Overall Study|Adverse Event|2|||
27811082|NCT01708161|54267027|FG004|Overall Study|Adverse Event|3|||
27811083|NCT01708161|54267028|FG005|Overall Study|Adverse Event|0|||
27811084|NCT01708161|54267023|FG000|Overall Study|Death|0|||
27811085|NCT01708161|54267024|FG001|Overall Study|Death|0|||
27811086|NCT01708161|54267025|FG002|Overall Study|Death|0|||
27811087|NCT01708161|54267026|FG003|Overall Study|Death|1|||
27811088|NCT01708161|54267027|FG004|Overall Study|Death|0|||
27811089|NCT01708161|54267028|FG005|Overall Study|Death|1|||
27811090|NCT01708161|54267023|FG000|Overall Study|Withdrawal by Subject|0|||
27811091|NCT01708161|54267024|FG001|Overall Study|Withdrawal by Subject|1|||
27811092|NCT01708161|54267025|FG002|Overall Study|Withdrawal by Subject|1|||
27811093|NCT01708161|54267026|FG003|Overall Study|Withdrawal by Subject|0|||
28042912|NCT00515034|54701082|FG000|Overall Study|Other|1|||
28042913|NCT00515034|54701083|FG001|Overall Study|Other|0|||
28042914|NCT00515034|54701084|FG002|Overall Study|Other|2|||
28042915|NCT00515034|54701085|FG003|Overall Study|Other|1|||
28042916|NCT00404235|54701097|FG000|Overall Study|Withdrawal by Subject|1|||
28042917|NCT00404235|54701098|FG001|Overall Study|Withdrawal by Subject|2|||
28042918|NCT00404079|54701106|FG000|Overall Study|Lost to follow up, adverse event etc|22|||
27811094|NCT01708161|54267027|FG004|Overall Study|Withdrawal by Subject|0|||
27847952|NCT00216671|54340678|FG001|Overall Study|Investigator Illness|1|||
27939883|NCT01038609|54596215|FG000|Overall Study|Adverse Event|0|||
28042919|NCT00404079|54701107|FG001|Overall Study|Lost to follow up, adverse event etc|20|||
27811095|NCT01708161|54267028|FG005|Overall Study|Withdrawal by Subject|0|||
27811096|NCT01708161|54267023|FG000|Overall Study|Administrative problems|0|||
27811097|NCT01708161|54267024|FG001|Overall Study|Administrative problems|1|||
27811098|NCT01708161|54267025|FG002|Overall Study|Administrative problems|0|||
27811099|NCT01708161|54267026|FG003|Overall Study|Administrative problems|0|||
28042920|NCT00403845|54701113|FG000|Treatment Period 1|Subject withdrew consent|1|||
28042921|NCT00403845|54701114|FG001|Treatment Period 1|Subject withdrew consent|0|||
28042922|NCT00403845|54701115|FG002|Treatment Period 1|Subject withdrew consent|0|||
28042923|NCT00403845|54701116|FG003|Treatment Period 1|Subject withdrew consent|0|||
28042924|NCT00403845|54701113|FG000|Treatment Period 1|Subject no longer needs study drug|0|||
28042925|NCT00403845|54701114|FG001|Treatment Period 1|Subject no longer needs study drug|0|||
28042926|NCT00403845|54701115|FG002|Treatment Period 1|Subject no longer needs study drug|0|||
28042927|NCT00403845|54701116|FG003|Treatment Period 1|Subject no longer needs study drug|1|||
28042928|NCT00403845|54701113|FG000|Treatment Period 2|Subject withdrew consent|1|||
28042929|NCT00403845|54701114|FG001|Treatment Period 2|Subject withdrew consent|0|||
28042930|NCT00403845|54701115|FG002|Treatment Period 2|Subject withdrew consent|0|||
28042931|NCT00403845|54701116|FG003|Treatment Period 2|Subject withdrew consent|0|||
28042932|NCT00403845|54701113|FG000|Treatment Period 3|Subject withdrew consent|0|||
28042933|NCT00403845|54701114|FG001|Treatment Period 3|Subject withdrew consent|0|||
28042934|NCT00403845|54701115|FG002|Treatment Period 3|Subject withdrew consent|0|||
28042935|NCT00403845|54701116|FG003|Treatment Period 3|Subject withdrew consent|1|||
27811100|NCT01708161|54267027|FG004|Overall Study|Administrative problems|0|||
27811101|NCT01708161|54267028|FG005|Overall Study|Administrative problems|0|||
27811102|NCT01708161|54267023|FG000|Overall Study|Disease progression|3|||
27811103|NCT01708161|54267024|FG001|Overall Study|Disease progression|5|||
27811104|NCT01708161|54267025|FG002|Overall Study|Disease progression|5|||
27811105|NCT01708161|54267026|FG003|Overall Study|Disease progression|13|||
27811106|NCT01708161|54267027|FG004|Overall Study|Disease progression|3|||
27811107|NCT01708161|54267028|FG005|Overall Study|Disease progression|0|||
27811108|NCT01707693|54267044|FG000|Overall Study Allocation|Withdrawal by Subject|9|||
27811109|NCT01707693|54267045|FG001|Overall Study Allocation|Withdrawal by Subject|5|||
27811110|NCT01707693|54267044|FG000|Overall Study Allocation|Protocol Violation|4|||
27811111|NCT01707693|54267045|FG001|Overall Study Allocation|Protocol Violation|3|||
27811112|NCT01707693|54267044|FG000|Time 3 Measures @ 6 Mth|Lost to Follow-up|0|||
27811113|NCT01707693|54267045|FG001|Time 3 Measures @ 6 Mth|Lost to Follow-up|3|||
27811114|NCT01707693|54267044|FG000|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0|||
27811115|NCT01707693|54267045|FG001|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2|||
27811116|NCT01722669|54267058|FG000|Overall Study|Withdrawal by Subject|0|||
27811117|NCT01722669|54267059|FG001|Overall Study|Withdrawal by Subject|0|||
27811118|NCT01722669|54267060|FG002|Overall Study|Withdrawal by Subject|0|||
27811119|NCT01722669|54267061|FG003|Overall Study|Withdrawal by Subject|0|||
27811120|NCT01722669|54267062|FG004|Overall Study|Withdrawal by Subject|0|||
27811121|NCT01722669|54267063|FG005|Overall Study|Withdrawal by Subject|2|||
27811122|NCT01707147|54267083|FG000|Overall Study|Administered Trajenta prior to contract|5|||
27811123|NCT01707147|54267083|FG000|Overall Study|Patients who have not taken Trajenta|1|||
27811124|NCT01707147|54267083|FG000|Overall Study|Follow-up failure|17|||
27811125|NCT01707147|54267083|FG000|Overall Study|Violated inclusion/exclusion criteria|77|||
27811126|NCT01876251|54267090|FG000|Overall Study|Clinical progression|1|||
27811127|NCT01876251|54267091|FG001|Overall Study|Clinical progression|0|||
27811128|NCT01876251|54267092|FG002|Overall Study|Clinical progression|0|||
27811129|NCT01876251|54267090|FG000|Overall Study|Death|2|||
27811130|NCT01876251|54267091|FG001|Overall Study|Death|0|||
27811131|NCT01876251|54267092|FG002|Overall Study|Death|1|||
27811132|NCT01876251|54267090|FG000|Overall Study|Participant started new treatment|1|||
27811133|NCT01876251|54267091|FG001|Overall Study|Participant started new treatment|0|||
27811134|NCT01876251|54267092|FG002|Overall Study|Participant started new treatment|1|||
27811135|NCT01876251|54267090|FG000|Overall Study|Participant refused further follow-up|0|||
27811136|NCT01876251|54267091|FG001|Overall Study|Participant refused further follow-up|0|||
27811137|NCT01876251|54267092|FG002|Overall Study|Participant refused further follow-up|1|||
27811138|NCT01876251|54267090|FG000|Overall Study|Study terminated|1|||
27811139|NCT01876251|54267091|FG001|Overall Study|Study terminated|0|||
27811140|NCT01876251|54267092|FG002|Overall Study|Study terminated|0|||
27811141|NCT01876251|54267090|FG000|Overall Study|Objective progression or relapse|10|||
27811142|NCT01876251|54267091|FG001|Overall Study|Objective progression or relapse|3|||
27811143|NCT01876251|54267092|FG002|Overall Study|Objective progression or relapse|8|||
27811144|NCT01875471|54267103|FG000|Overall Study|Adverse Event|0|||
28042936|NCT00403845|54701113|FG000|Treatment Period 3|Adverse Event|0|||
28042937|NCT00403845|54701114|FG001|Treatment Period 3|Adverse Event|0|||
28042938|NCT00403845|54701115|FG002|Treatment Period 3|Adverse Event|0|||
28042939|NCT00403845|54701116|FG003|Treatment Period 3|Adverse Event|1|||
27811145|NCT01875471|54267104|FG001|Overall Study|Adverse Event|1|||
27811146|NCT01875471|54267103|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
27847953|NCT00216671|54340677|FG000|Overall Study|Patient Moved|0|||
28042940|NCT00509262|54701128|FG000|Overall Study|Adverse Event|16|||
27811147|NCT01875471|54267104|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
27811148|NCT01875237|54267112|FG000|Overall Study|GVDH before DLI|1|||
27811149|NCT01875237|54267113|FG001|Overall Study|GVDH before DLI|0|||
27811150|NCT01875237|54267112|FG000|Overall Study|DLI cells could not be produced|1|||
27811151|NCT01875237|54267113|FG001|Overall Study|DLI cells could not be produced|0|||
28042941|NCT00509262|54701129|FG001|Overall Study|Adverse Event|18|||
28042942|NCT00509262|54701128|FG000|Overall Study|Other|2|||
28042943|NCT00509262|54701129|FG001|Overall Study|Other|2|||
28042944|NCT00509262|54701128|FG000|Overall Study|Lack of Efficacy|1|||
28042945|NCT00509262|54701129|FG001|Overall Study|Lack of Efficacy|0|||
28042946|NCT00509262|54701128|FG000|Overall Study|Lost to Follow-up|1|||
28042947|NCT00509262|54701129|FG001|Overall Study|Lost to Follow-up|6|||
28042948|NCT00509262|54701128|FG000|Overall Study|Physician Decision|1|||
28042949|NCT00509262|54701129|FG001|Overall Study|Physician Decision|3|||
28042950|NCT00509262|54701128|FG000|Overall Study|Protocol Violation|2|||
28042951|NCT00509262|54701129|FG001|Overall Study|Protocol Violation|2|||
28042952|NCT00509262|54701128|FG000|Overall Study|Withdrawal by Subject|24|||
28042953|NCT00509262|54701129|FG001|Overall Study|Withdrawal by Subject|11|||
28042954|NCT00607997|54701139|FG000|Overall Study|Lack of Efficacy|6|||
28042955|NCT00607997|54701140|FG001|Overall Study|Lack of Efficacy|20|||
28042956|NCT00607997|54701141|FG002|Overall Study|Lack of Efficacy|14|||
28042957|NCT00607997|54701142|FG003|Overall Study|Lack of Efficacy|10|||
28042958|NCT00607997|54701139|FG000|Overall Study|Death|8|||
28042959|NCT00607997|54701140|FG001|Overall Study|Death|5|||
28042960|NCT00607997|54701141|FG002|Overall Study|Death|2|||
28042961|NCT00607997|54701142|FG003|Overall Study|Death|5|||
28042962|NCT00607997|54701139|FG000|Overall Study|Adverse Event|3|||
28042963|NCT00607997|54701140|FG001|Overall Study|Adverse Event|1|||
28042964|NCT00607997|54701141|FG002|Overall Study|Adverse Event|2|||
28042965|NCT00607997|54701142|FG003|Overall Study|Adverse Event|0|||
28042966|NCT00607997|54701139|FG000|Overall Study|Physician Decision|4|||
28042967|NCT00607997|54701140|FG001|Overall Study|Physician Decision|1|||
28042968|NCT00607997|54701141|FG002|Overall Study|Physician Decision|0|||
28042969|NCT00607997|54701142|FG003|Overall Study|Physician Decision|0|||
28042970|NCT00607997|54701139|FG000|Overall Study|Relapse, recurrent illness|4|||
28042971|NCT00607997|54701140|FG001|Overall Study|Relapse, recurrent illness|0|||
28042972|NCT00607997|54701141|FG002|Overall Study|Relapse, recurrent illness|2|||
28042973|NCT00607997|54701142|FG003|Overall Study|Relapse, recurrent illness|0|||
28042974|NCT00607997|54701139|FG000|Overall Study|Other without explanation|2|||
28042975|NCT00607997|54701140|FG001|Overall Study|Other without explanation|0|||
28042976|NCT00607997|54701141|FG002|Overall Study|Other without explanation|4|||
28042977|NCT00607997|54701142|FG003|Overall Study|Other without explanation|1|||
28042978|NCT00509106|54701159|FG000|Overall Study|Adverse Event|3|||
28042979|NCT00509106|54701160|FG001|Overall Study|Adverse Event|2|||
28042980|NCT00509106|54701159|FG000|Overall Study|Noncompliance|0|||
28042981|NCT00509106|54701160|FG001|Overall Study|Noncompliance|1|||
28042982|NCT00509106|54701159|FG000|Overall Study|At the request of sponsor/investigator|1|||
28042983|NCT00509106|54701160|FG001|Overall Study|At the request of sponsor/investigator|2|||
28042984|NCT00509106|54701159|FG000|Overall Study|Withdrew consent|4|||
28042985|NCT00509106|54701160|FG001|Overall Study|Withdrew consent|8|||
28042986|NCT00509106|54701159|FG000|Overall Study|Lost to Follow-up|16|||
28042987|NCT00509106|54701160|FG001|Overall Study|Lost to Follow-up|10|||
28042988|NCT00509106|54701159|FG000|Overall Study|Other|1|||
28042989|NCT00509106|54701160|FG001|Overall Study|Other|0|||
28042990|NCT00509106|54701159|FG000|Overall Study|Death|6|||
28042991|NCT00509106|54701160|FG001|Overall Study|Death|6|||
28042992|NCT00607919|54701168|FG000|Acute Phase|Adverse Event|9|||
28042993|NCT00607919|54701169|FG001|Acute Phase|Adverse Event|2|||
28042994|NCT00607919|54701168|FG000|Acute Phase|Entry Criteria Not Met|1|||
28042995|NCT00607919|54701169|FG001|Acute Phase|Entry Criteria Not Met|1|||
28042996|NCT00607919|54701168|FG000|Acute Phase|Lack of Efficacy|1|||
28042997|NCT00607919|54701169|FG001|Acute Phase|Lack of Efficacy|2|||
28042998|NCT00607919|54701168|FG000|Acute Phase|Lost to Follow-up|9|||
28042999|NCT00607919|54701169|FG001|Acute Phase|Lost to Follow-up|3|||
28043000|NCT00607919|54701168|FG000|Acute Phase|Parent/Caregiver Decision|6|||
28043001|NCT00607919|54701169|FG001|Acute Phase|Parent/Caregiver Decision|4|||
28043002|NCT00607919|54701168|FG000|Acute Phase|Protocol Violation|5|||
28043003|NCT00607919|54701169|FG001|Acute Phase|Protocol Violation|1|||
28043004|NCT00607919|54701168|FG000|Acute Phase|Withdrawal by Subject|3|||
28043005|NCT00607919|54701169|FG001|Acute Phase|Withdrawal by Subject|3|||
28043006|NCT00607919|54701168|FG000|Open-Label Phase|Adverse Event|1|||
27939884|NCT01038609|54596216|FG001|Overall Study|Adverse Event|0|||
27939885|NCT01038609|54596217|FG002|Overall Study|Adverse Event|1|||
27939886|NCT01038609|54596218|FG003|Overall Study|Adverse Event|0|||
28043007|NCT00607919|54701169|FG001|Open-Label Phase|Adverse Event|5|||
28043008|NCT00607919|54701168|FG000|Open-Label Phase|Lost to Follow-up|4|||
28043009|NCT00607919|54701169|FG001|Open-Label Phase|Lost to Follow-up|1|||
28043010|NCT00607919|54701168|FG000|Open-Label Phase|Protocol Violation|2|||
28043011|NCT00607919|54701169|FG001|Open-Label Phase|Protocol Violation|2|||
28043012|NCT00607919|54701168|FG000|Open-Label Phase|Withdrawal by Subject|2|||
28043013|NCT00607919|54701169|FG001|Open-Label Phase|Withdrawal by Subject|2|||
28043014|NCT00607919|54701168|FG000|Open-Label Phase|Parent/Caregiver Decision|1|||
28043015|NCT00607919|54701169|FG001|Open-Label Phase|Parent/Caregiver Decision|2|||
28043016|NCT00344968|54701180|FG000|Overall Study|Adverse Event|5|||
28043017|NCT00344968|54701181|FG001|Overall Study|Adverse Event|4|||
28043018|NCT00344968|54701182|FG002|Overall Study|Adverse Event|15|||
28043019|NCT00344968|54701180|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
28043020|NCT00344968|54701181|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
28043021|NCT00344968|54701182|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
28043022|NCT00344968|54701180|FG000|Overall Study|Protocol Violation|2|||
28043023|NCT00344968|54701181|FG001|Overall Study|Protocol Violation|2|||
28043024|NCT00344968|54701182|FG002|Overall Study|Protocol Violation|5|||
28043025|NCT00344968|54701180|FG000|Overall Study|Withdrawal by Subject|14|||
28043026|NCT00344968|54701181|FG001|Overall Study|Withdrawal by Subject|31|||
28043027|NCT00344968|54701182|FG002|Overall Study|Withdrawal by Subject|27|||
28043028|NCT00344968|54701180|FG000|Overall Study|Lost to Follow-up|24|||
28043029|NCT00344968|54701181|FG001|Overall Study|Lost to Follow-up|37|||
28043030|NCT00344968|54701182|FG002|Overall Study|Lost to Follow-up|37|||
28043031|NCT00344968|54701180|FG000|Overall Study|Death|11|||
28043032|NCT00344968|54701181|FG001|Overall Study|Death|27|||
28043033|NCT00344968|54701182|FG002|Overall Study|Death|31|||
28043034|NCT00344968|54701180|FG000|Overall Study|Other|0|||
28043035|NCT00344968|54701181|FG001|Overall Study|Other|1|||
28043036|NCT00344968|54701182|FG002|Overall Study|Other|0|||
28043037|NCT00509028|54701193|FG000|Overall Study|Adverse Event|2|||
28043038|NCT00509028|54701194|FG001|Overall Study|Adverse Event|0|||
28043039|NCT00509028|54701193|FG000|Overall Study|Withdrawal by Subject|4|||
28043040|NCT00509028|54701194|FG001|Overall Study|Withdrawal by Subject|3|||
28043041|NCT00509028|54701193|FG000|Overall Study|Lost to Follow-up|0|||
28043042|NCT00509028|54701194|FG001|Overall Study|Lost to Follow-up|1|||
28043043|NCT00509028|54701193|FG000|Overall Study|Protocol Violation|4|||
28043044|NCT00509028|54701194|FG001|Overall Study|Protocol Violation|2|||
28043045|NCT00509028|54701193|FG000|Overall Study|Non-compliance|2|||
28043046|NCT00509028|54701194|FG001|Overall Study|Non-compliance|1|||
28043047|NCT00352846|54701202|FG000|Overall Study|Disease progression|0|||
28043048|NCT00352846|54701203|FG001|Overall Study|Disease progression|2|||
28043049|NCT00352846|54701202|FG000|Overall Study|Withdrawal by Subject|3|||
28043050|NCT00352846|54701203|FG001|Overall Study|Withdrawal by Subject|8|||
28043051|NCT00352846|54701202|FG000|Overall Study|Ineligible|3|||
28043052|NCT00352846|54701203|FG001|Overall Study|Ineligible|2|||
28043053|NCT00352846|54701202|FG000|Overall Study|Non-compliance|2|||
28043054|NCT00352846|54701203|FG001|Overall Study|Non-compliance|0|||
28043055|NCT00352846|54701202|FG000|Overall Study|Death|0|||
27811152|NCT01874535|54267123|FG000|Overall Study|Lost to Follow-up|10|||
27811153|NCT01874535|54267124|FG001|Overall Study|Lost to Follow-up|9|||
28043056|NCT00352846|54701203|FG001|Overall Study|Death|1|||
28043057|NCT00508872|54701209|FG000|Overall Study|Lost to Follow-up|1|||
28043058|NCT00508872|54701209|FG000|Overall Study|Physician Decision|1|||
28043059|NCT00508482|54701216|FG000|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9|||
28043060|NCT00508482|54701217|FG001|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7|||
28043061|NCT00508482|54701218|FG002|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4|||
28043062|NCT00508482|54701216|FG000|Over 4 Weeks of Treatment|Lost to Follow-up|12|||
28043063|NCT00508482|54701217|FG001|Over 4 Weeks of Treatment|Lost to Follow-up|10|||
28043064|NCT00508482|54701218|FG002|Over 4 Weeks of Treatment|Lost to Follow-up|16|||
28043065|NCT00508482|54701216|FG000|at the 4th Week of Follow-up|Lost to Follow-up|20|||
28043066|NCT00508482|54701217|FG001|at the 4th Week of Follow-up|Lost to Follow-up|6|||
28043067|NCT00508482|54701218|FG002|at the 4th Week of Follow-up|Lost to Follow-up|1|||
28043068|NCT00344500|54701229|FG000|Overall Study|Adverse Event|6|||
28043069|NCT00344500|54701230|FG001|Overall Study|Adverse Event|2|||
28043070|NCT00344500|54701231|FG002|Overall Study|Adverse Event|0|||
28043071|NCT00344500|54701229|FG000|Overall Study|Lost to Follow-up|5|||
28043072|NCT00344500|54701230|FG001|Overall Study|Lost to Follow-up|13|||
28043073|NCT00344500|54701231|FG002|Overall Study|Lost to Follow-up|1|||
28043074|NCT00344500|54701229|FG000|Overall Study|Withdrawal by Subject|7|||
28043075|NCT00344500|54701230|FG001|Overall Study|Withdrawal by Subject|10|||
27811154|NCT01874535|54267123|FG000|Overall Study|incomplete symptom resolution|45|||
27847954|NCT00216671|54340678|FG001|Overall Study|Patient Moved|1|||
28043076|NCT00344500|54701231|FG002|Overall Study|Withdrawal by Subject|0|||
28043077|NCT00344500|54701229|FG000|Overall Study|Protocol Violation|4|||
28043078|NCT00344500|54701230|FG001|Overall Study|Protocol Violation|7|||
28043079|NCT00344500|54701231|FG002|Overall Study|Protocol Violation|1|||
28043080|NCT00344500|54701229|FG000|Overall Study|Not Noted|1|||
28043081|NCT00344500|54701230|FG001|Overall Study|Not Noted|3|||
28043082|NCT00344500|54701231|FG002|Overall Study|Not Noted|0|||
28043083|NCT00344032|54701240|FG000|Overall Study|Adverse Event|0|||
28043084|NCT00344032|54701241|FG001|Overall Study|Adverse Event|1|||
28043085|NCT00344032|54701240|FG000|Overall Study|Withdrawal by Subject|6|||
28043086|NCT00344032|54701241|FG001|Overall Study|Withdrawal by Subject|2|||
28043087|NCT00344032|54701240|FG000|Overall Study|Lost to Follow-up|4|||
28043088|NCT00344032|54701241|FG001|Overall Study|Lost to Follow-up|6|||
28043089|NCT00344032|54701240|FG000|Overall Study|Physician Decision|4|||
28043090|NCT00344032|54701241|FG001|Overall Study|Physician Decision|1|||
28043091|NCT00607373|54701249|FG000|Treatment Period|Adverse Event|0|||
28043092|NCT00607373|54701250|FG001|Treatment Period|Adverse Event|4|||
28043093|NCT00607373|54701249|FG000|Treatment Period|Physician Decision|0|||
28043094|NCT00607373|54701250|FG001|Treatment Period|Physician Decision|1|||
28043095|NCT00607373|54701249|FG000|Treatment Period|Withdrawal by Subject|0|||
28043096|NCT00607373|54701250|FG001|Treatment Period|Withdrawal by Subject|1|||
28043097|NCT00607373|54701249|FG000|Follow-up Period|Other|0|||
28043098|NCT00607373|54701250|FG001|Follow-up Period|Other|1|||
28043099|NCT00607373|54701249|FG000|Follow-up Period|Protocol Violation|0|||
28043100|NCT00607373|54701250|FG001|Follow-up Period|Protocol Violation|1|||
28043101|NCT00607373|54701249|FG000|Follow-up Period|Withdrawal by Subject|1|||
28043102|NCT00607373|54701250|FG001|Follow-up Period|Withdrawal by Subject|3|||
28043103|NCT00508404|54701256|FG000|Overall Study|Ongoing at Data Cut-off|12|||
28043104|NCT00508404|54701256|FG000|Overall Study|Adverse Event|2|||
28043105|NCT00508404|54701256|FG000|Overall Study|Death|16|||
28043106|NCT00508404|54701256|FG000|Overall Study|Physician Decision|2|||
28043107|NCT00508404|54701256|FG000|Overall Study|Withdrawal by Subject|3|||
28043108|NCT00508404|54701256|FG000|Overall Study|Protocol-specified Criteria|2|||
28043109|NCT00508404|54701256|FG000|Overall Study|Lost to Follow-up|2|||
28043110|NCT00508404|54701256|FG000|Overall Study|Other - Not Specified|3|||
28043111|NCT00352690|54701263|FG000|Overall Study|Determined to be ineligible|2|||
28043112|NCT00352690|54701264|FG001|Overall Study|Determined to be ineligible|0|||
28043113|NCT00609245|54701270|FG000|Overall Study|Adverse Event|1|||
28043114|NCT00343642|54701279|FG000|Overall Study|Lost to Follow-up|0|||
28043115|NCT00343642|54701280|FG001|Overall Study|Lost to Follow-up|1|||
28043116|NCT00343642|54701281|FG002|Overall Study|Lost to Follow-up|0|||
28043117|NCT00343642|54701279|FG000|Overall Study|Pregnancy|1|||
28043118|NCT00343642|54701280|FG001|Overall Study|Pregnancy|0|||
28043119|NCT00343642|54701281|FG002|Overall Study|Pregnancy|2|||
28043120|NCT00343642|54701279|FG000|Overall Study|Withdrawal by Subject|2|||
28043121|NCT00343642|54701280|FG001|Overall Study|Withdrawal by Subject|3|||
28043122|NCT00343642|54701281|FG002|Overall Study|Withdrawal by Subject|4|||
28043123|NCT00343642|54701279|FG000|Overall Study|Adverse Event|0|||
28043124|NCT00343642|54701280|FG001|Overall Study|Adverse Event|0|||
28043125|NCT00343642|54701281|FG002|Overall Study|Adverse Event|1|||
28043126|NCT00343642|54701279|FG000|Overall Study|Flare up|6|||
28043127|NCT00343642|54701280|FG001|Overall Study|Flare up|4|||
28043128|NCT00343642|54701281|FG002|Overall Study|Flare up|0|||
28043129|NCT00609167|54701294|FG000|Overall Study|Withdrawal by Subject|1|||
28043130|NCT00609167|54701295|FG001|Overall Study|Withdrawal by Subject|0|||
28043131|NCT00609167|54701294|FG000|Overall Study|Lack of Efficacy|1|||
28043132|NCT00609167|54701295|FG001|Overall Study|Lack of Efficacy|0|||
28043133|NCT00609167|54701294|FG000|Overall Study|Adverse Event|5|||
28043134|NCT00609167|54701295|FG001|Overall Study|Adverse Event|1|||
28043135|NCT00609167|54701294|FG000|Overall Study|Disease Progression|1|||
28043136|NCT00609167|54701295|FG001|Overall Study|Disease Progression|0|||
28043137|NCT00609167|54701294|FG000|Overall Study|Stem Cell Transplant|0|||
28043138|NCT00609167|54701295|FG001|Overall Study|Stem Cell Transplant|6|||
28043139|NCT00606281|54701303|FG000|Overall Study|Adverse Event|11|||
28043140|NCT00606281|54701304|FG001|Overall Study|Adverse Event|12|||
28043141|NCT00606281|54701303|FG000|Overall Study|Death|1|||
28043142|NCT00606281|54701304|FG001|Overall Study|Death|0|||
28043143|NCT00606281|54701303|FG000|Overall Study|Lack of Efficacy|28|||
28043144|NCT00606281|54701304|FG001|Overall Study|Lack of Efficacy|35|||
28043145|NCT00606281|54701303|FG000|Overall Study|Physician Decision|0|||
28043146|NCT00606281|54701304|FG001|Overall Study|Physician Decision|1|||
28043147|NCT00606281|54701303|FG000|Overall Study|Protocol Violation|3|||
28043148|NCT00606281|54701304|FG001|Overall Study|Protocol Violation|3|||
28043149|NCT00606281|54701303|FG000|Overall Study|Withdrawal by Subject|11|||
28043150|NCT00606281|54701304|FG001|Overall Study|Withdrawal by Subject|13|||
28043151|NCT00606281|54701303|FG000|Overall Study|Progression to depressive phase|1|||
28043152|NCT00606281|54701304|FG001|Overall Study|Progression to depressive phase|1|||
28043153|NCT00606281|54701303|FG000|Overall Study|Change of residence or other commitments|1|||
28043154|NCT00606281|54701304|FG001|Overall Study|Change of residence or other commitments|1|||
28043155|NCT00506142|54701312|FG000|Overall Study|Adverse Event|8|||
28043156|NCT00506142|54701313|FG001|Overall Study|Adverse Event|7|||
28043157|NCT00506142|54701312|FG000|Overall Study|Lack of Efficacy|21|||
28043158|NCT00506142|54701313|FG001|Overall Study|Lack of Efficacy|7|||
28043159|NCT00506142|54701312|FG000|Overall Study|Withdrawal by Subject|4|||
28043160|NCT00506142|54701313|FG001|Overall Study|Withdrawal by Subject|5|||
28043161|NCT00506142|54701312|FG000|Overall Study|Physician Decision|1|||
28043162|NCT00506142|54701313|FG001|Overall Study|Physician Decision|0|||
28043163|NCT00506142|54701312|FG000|Overall Study|New health condition|1|||
28043164|NCT00506142|54701313|FG001|Overall Study|New health condition|0|||
28043165|NCT00514020|54701319|FG000|Overall Study|Adverse Event|6|||
28043166|NCT00514020|54701319|FG000|Overall Study|Withdrawal by Subject|3|||
28043167|NCT00514020|54701319|FG000|Overall Study|Physician Decision|1|||
28043168|NCT00514020|54701319|FG000|Overall Study|disease progression|9|||
28043169|NCT00514020|54701319|FG000|Overall Study|other complicating disease|2|||
28043170|NCT00514020|54701319|FG000|Overall Study|patient went to radiation treatment|1|||
28043171|NCT00514020|54701319|FG000|Overall Study|"patients moved to the no tx group"|6|||
28043172|NCT00513708|54701326|FG000|Overall Study|Lost to Follow-up|4|||
28043173|NCT00513708|54701327|FG001|Overall Study|Lost to Follow-up|4|||
28043174|NCT00513708|54701328|FG002|Overall Study|Lost to Follow-up|4|||
28043175|NCT00513474|54701338|FG000|Overall Study|Death|6|||
28043176|NCT00513474|54701339|FG001|Overall Study|Death|9|||
28043177|NCT00513474|54701338|FG000|Overall Study|Participant Withdrew Consent|1|||
28043178|NCT00513474|54701339|FG001|Overall Study|Participant Withdrew Consent|0|||
28043179|NCT00505752|54701349|FG000|Overall Study|Adverse Event|1|||
28043180|NCT00505752|54701350|FG001|Overall Study|Adverse Event|0|||
28043181|NCT00505752|54701351|FG002|Overall Study|Adverse Event|1|||
28043182|NCT00505752|54701352|FG003|Overall Study|Adverse Event|0|||
28043183|NCT00505752|54701349|FG000|Overall Study|Lost to Follow-up|1|||
28043184|NCT00505752|54701350|FG001|Overall Study|Lost to Follow-up|0|||
28043185|NCT00505752|54701351|FG002|Overall Study|Lost to Follow-up|0|||
28043186|NCT00505752|54701352|FG003|Overall Study|Lost to Follow-up|0|||
28043187|NCT00505752|54701349|FG000|Overall Study|Lack of ovarian response|1|||
28043188|NCT00505752|54701350|FG001|Overall Study|Lack of ovarian response|3|||
28043189|NCT00505752|54701351|FG002|Overall Study|Lack of ovarian response|0|||
28043190|NCT00505752|54701352|FG003|Overall Study|Lack of ovarian response|0|||
28043191|NCT00505752|54701349|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
28043192|NCT00505752|54701350|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
28043193|NCT00505752|54701351|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
28043194|NCT00505752|54701352|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
28043195|NCT00505752|54701349|FG000|Overall Study|No oocytes retrieved|0|||
28043196|NCT00505752|54701350|FG001|Overall Study|No oocytes retrieved|2|||
28043197|NCT00505752|54701351|FG002|Overall Study|No oocytes retrieved|0|||
28043198|NCT00505752|54701352|FG003|Overall Study|No oocytes retrieved|1|||
28043199|NCT00505752|54701349|FG000|Overall Study|No Fertilization|1|||
27811155|NCT01874535|54267124|FG001|Overall Study|incomplete symptom resolution|35|||
27811156|NCT01722045|54267130|FG000|Overall Study|Adverse Event|8|||
27811157|NCT01722045|54267130|FG000|Overall Study|Death|3|||
27811158|NCT01722045|54267130|FG000|Overall Study|Withdrawal by Subject|8|||
27811159|NCT01722045|54267130|FG000|Overall Study|Lost to Follow-up|4|||
28043200|NCT00505752|54701350|FG001|Overall Study|No Fertilization|1|||
28043201|NCT00505752|54701351|FG002|Overall Study|No Fertilization|2|||
28043202|NCT00505752|54701352|FG003|Overall Study|No Fertilization|1|||
28043203|NCT00505752|54701349|FG000|Overall Study|All embryos/blastocysts discarded|0|||
27811160|NCT01722045|54267130|FG000|Overall Study|Protocol Deviation|1|||
27811161|NCT01722045|54267130|FG000|Overall Study|Physician Decision|3|||
27811162|NCT01722045|54267130|FG000|Overall Study|Relocation (did not wish to transfer)|1|||
28043204|NCT00505752|54701350|FG001|Overall Study|All embryos/blastocysts discarded|0|||
28043205|NCT00505752|54701351|FG002|Overall Study|All embryos/blastocysts discarded|1|||
28043206|NCT00505752|54701352|FG003|Overall Study|All embryos/blastocysts discarded|1|||
28043207|NCT00505752|54701349|FG000|Overall Study|Other|1|||
28043208|NCT00505752|54701350|FG001|Overall Study|Other|2|||
28043209|NCT00505752|54701351|FG002|Overall Study|Other|1|||
28043210|NCT00505752|54701352|FG003|Overall Study|Other|2|||
28043211|NCT03601637|54701364|FG000|Overall Study|Withdrawal of Consent (not due to adverse event)|0|||
28043212|NCT03601637|54701365|FG001|Overall Study|Withdrawal of Consent (not due to adverse event)|1|||
28043213|NCT03601637|54701364|FG000|Overall Study|Adverse Event|1|||
28043214|NCT03601637|54701365|FG001|Overall Study|Adverse Event|1|||
28043215|NCT03601637|54701364|FG000|Overall Study|Other|0|||
28043216|NCT03601637|54701365|FG001|Overall Study|Other|1|||
28043217|NCT00343252|54701380|FG000|6 Months (All Treated Participants)|Adverse Event|17|||
28043218|NCT00343252|54701381|FG001|6 Months (All Treated Participants)|Adverse Event|11|||
28043219|NCT00343252|54701380|FG000|6 Months (All Treated Participants)|Death|0|||
28043220|NCT00343252|54701381|FG001|6 Months (All Treated Participants)|Death|2|||
28043221|NCT00343252|54701380|FG000|6 Months (All Treated Participants)|Entry Criteria Not Met|10|||
28043222|NCT00343252|54701381|FG001|6 Months (All Treated Participants)|Entry Criteria Not Met|8|||
28043223|NCT00343252|54701380|FG000|6 Months (All Treated Participants)|Lack of Efficacy|0|||
28043224|NCT00343252|54701381|FG001|6 Months (All Treated Participants)|Lack of Efficacy|1|||
28043225|NCT00343252|54701380|FG000|6 Months (All Treated Participants)|Lost to Follow-up|0|||
27811163|NCT01721109|54267134|FG000|Overall Study|Lack of Efficacy|1|||
27811164|NCT01721109|54267134|FG000|Overall Study|Non- Compliance with Study Drug|3|||
28043226|NCT00343252|54701381|FG001|6 Months (All Treated Participants)|Lost to Follow-up|4|||
28043227|NCT00343252|54701380|FG000|6 Months (All Treated Participants)|Physician Decision|1|||
28043228|NCT00343252|54701381|FG001|6 Months (All Treated Participants)|Physician Decision|3|||
28043229|NCT00343252|54701380|FG000|6 Months (All Treated Participants)|Protocol Violation|2|||
28043230|NCT00343252|54701381|FG001|6 Months (All Treated Participants)|Protocol Violation|2|||
28043231|NCT00343252|54701380|FG000|6 Months (All Treated Participants)|Sponsor Decision|7|||
28043232|NCT00343252|54701381|FG001|6 Months (All Treated Participants)|Sponsor Decision|4|||
28043233|NCT00343252|54701380|FG000|6 Months (All Treated Participants)|Withdrawal by Subject|19|||
28043234|NCT00343252|54701381|FG001|6 Months (All Treated Participants)|Withdrawal by Subject|9|||
28043235|NCT00343252|54701380|FG000|12 Months (All Treated Participants)|Adverse Event|22|||
28043236|NCT00343252|54701381|FG001|12 Months (All Treated Participants)|Adverse Event|20|||
28043237|NCT00343252|54701380|FG000|12 Months (All Treated Participants)|Death|3|||
28043238|NCT00343252|54701381|FG001|12 Months (All Treated Participants)|Death|3|||
28043239|NCT00343252|54701380|FG000|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
28043240|NCT00343252|54701381|FG001|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
28043241|NCT00343252|54701380|FG000|12 Months (All Treated Participants)|Lack of Efficacy|1|||
28043242|NCT00343252|54701381|FG001|12 Months (All Treated Participants)|Lack of Efficacy|1|||
28043243|NCT00343252|54701380|FG000|12 Months (All Treated Participants)|Lost to Follow-up|1|||
28043244|NCT00343252|54701381|FG001|12 Months (All Treated Participants)|Lost to Follow-up|5|||
28043245|NCT00343252|54701380|FG000|12 Months (All Treated Participants)|Physician Decision|4|||
28043246|NCT00343252|54701381|FG001|12 Months (All Treated Participants)|Physician Decision|5|||
28043247|NCT00343252|54701380|FG000|12 Months (All Treated Participants)|Protocol Violation|3|||
28043248|NCT00343252|54701381|FG001|12 Months (All Treated Participants)|Protocol Violation|2|||
28043249|NCT00343252|54701380|FG000|12 Months (All Treated Participants)|Sponsor Decision|9|||
28043250|NCT00343252|54701381|FG001|12 Months (All Treated Participants)|Sponsor Decision|6|||
28043251|NCT00343252|54701380|FG000|12 Months (All Treated Participants)|Withdrawal by Subject|33|||
28043252|NCT00343252|54701381|FG001|12 Months (All Treated Participants)|Withdrawal by Subject|17|||
28043253|NCT00343252|54701380|FG000|18 Months (All Treated Participants)|Adverse Event|31|||
28043254|NCT00343252|54701381|FG001|18 Months (All Treated Participants)|Adverse Event|23|||
28043255|NCT00343252|54701380|FG000|18 Months (All Treated Participants)|Death|4|||
28043256|NCT00343252|54701381|FG001|18 Months (All Treated Participants)|Death|5|||
28043257|NCT00343252|54701380|FG000|18 Months (All Treated Participants)|Entry Criteria Not Met|11|||
28043258|NCT00343252|54701381|FG001|18 Months (All Treated Participants)|Entry Criteria Not Met|10|||
28043259|NCT00343252|54701380|FG000|18 Months (All Treated Participants)|Lack of Efficacy|1|||
28043260|NCT00343252|54701381|FG001|18 Months (All Treated Participants)|Lack of Efficacy|1|||
28043261|NCT00343252|54701380|FG000|18 Months (All Treated Participants)|Lost to Follow-up|3|||
28043262|NCT00343252|54701381|FG001|18 Months (All Treated Participants)|Lost to Follow-up|7|||
28043263|NCT00343252|54701380|FG000|18 Months (All Treated Participants)|Physician Decision|4|||
28043264|NCT00343252|54701381|FG001|18 Months (All Treated Participants)|Physician Decision|7|||
28043265|NCT00343252|54701380|FG000|18 Months (All Treated Participants)|Protocol Violation|3|||
28043266|NCT00343252|54701381|FG001|18 Months (All Treated Participants)|Protocol Violation|3|||
28043267|NCT00343252|54701380|FG000|18 Months (All Treated Participants)|Sponsor Decision|8|||
28043268|NCT00343252|54701381|FG001|18 Months (All Treated Participants)|Sponsor Decision|5|||
28043269|NCT00343252|54701380|FG000|18 Months (All Treated Participants)|Withdrawal by Subject|36|||
28043270|NCT00343252|54701381|FG001|18 Months (All Treated Participants)|Withdrawal by Subject|20|||
28043271|NCT00342628|54701390|FG000|Overall Study|Withdrawal by Subject|19|||
28043272|NCT00342628|54701391|FG001|Overall Study|Withdrawal by Subject|19|||
28043273|NCT00342628|54701392|FG002|Overall Study|Withdrawal by Subject|18|||
28043274|NCT00342628|54701390|FG000|Overall Study|Death|1|||
28043275|NCT00342628|54701391|FG001|Overall Study|Death|1|||
28043276|NCT00342628|54701392|FG002|Overall Study|Death|0|||
28043277|NCT00342628|54701390|FG000|Overall Study|moved residence|0|||
28043278|NCT00342628|54701391|FG001|Overall Study|moved residence|1|||
28043279|NCT00342628|54701392|FG002|Overall Study|moved residence|1|||
28043280|NCT00505284|54701405|FG000|Overall Study|Adverse Event|3|||
28043281|NCT00505284|54701406|FG001|Overall Study|Adverse Event|7|||
28043282|NCT00505284|54701407|FG002|Overall Study|Adverse Event|9|||
28043283|NCT00505284|54701408|FG003|Overall Study|Adverse Event|14|||
28043284|NCT00505284|54701409|FG004|Overall Study|Adverse Event|22|||
28043285|NCT00505284|54701405|FG000|Overall Study|Protocol Violation|0|||
28043286|NCT00505284|54701406|FG001|Overall Study|Protocol Violation|1|||
28043287|NCT00505284|54701407|FG002|Overall Study|Protocol Violation|1|||
28043288|NCT00505284|54701408|FG003|Overall Study|Protocol Violation|0|||
28043289|NCT00505284|54701409|FG004|Overall Study|Protocol Violation|0|||
28043290|NCT00505284|54701405|FG000|Overall Study|Withdrawal by Subject|2|||
27939887|NCT01038609|54596219|FG004|Overall Study|Adverse Event|0|||
28043291|NCT00505284|54701406|FG001|Overall Study|Withdrawal by Subject|6|||
28043292|NCT00505284|54701407|FG002|Overall Study|Withdrawal by Subject|1|||
28043293|NCT00505284|54701408|FG003|Overall Study|Withdrawal by Subject|0|||
28043294|NCT00505284|54701409|FG004|Overall Study|Withdrawal by Subject|6|||
28043295|NCT00505284|54701405|FG000|Overall Study|Lack of Efficacy|0|||
28043296|NCT00505284|54701406|FG001|Overall Study|Lack of Efficacy|1|||
28043297|NCT00505284|54701407|FG002|Overall Study|Lack of Efficacy|1|||
28043298|NCT00505284|54701408|FG003|Overall Study|Lack of Efficacy|1|||
28043299|NCT00505284|54701409|FG004|Overall Study|Lack of Efficacy|1|||
28043300|NCT00505284|54701405|FG000|Overall Study|Physician Decision|0|||
28043301|NCT00505284|54701406|FG001|Overall Study|Physician Decision|1|||
28043302|NCT00505284|54701407|FG002|Overall Study|Physician Decision|0|||
28043303|NCT00505284|54701408|FG003|Overall Study|Physician Decision|0|||
28043304|NCT00505284|54701409|FG004|Overall Study|Physician Decision|0|||
28043305|NCT00505284|54701405|FG000|Overall Study|Other|5|||
28043306|NCT00505284|54701406|FG001|Overall Study|Other|0|||
28043307|NCT00505284|54701407|FG002|Overall Study|Other|0|||
28043308|NCT00505284|54701408|FG003|Overall Study|Other|4|||
28043309|NCT00505284|54701409|FG004|Overall Study|Other|4|||
28043310|NCT00337168|54701421|FG000|Overall Study|Death|5|||
28043311|NCT00337168|54701421|FG000|Overall Study|Not protocol specified|2|||
28043312|NCT00337168|54701421|FG000|Overall Study|Did not start therapy|1|||
28043313|NCT00606905|54701428|FG000|Overall Study|No Pregnancy|9|||
28043314|NCT00606905|54701429|FG001|Overall Study|No Pregnancy|6|||
28043315|NCT00606905|54701428|FG000|Overall Study|Non-Index Pregnancy|1|||
28043316|NCT00606905|54701429|FG001|Overall Study|Non-Index Pregnancy|4|||
28043317|NCT00606905|54701428|FG000|Overall Study|Withdrew|5|||
28043318|NCT00606905|54701429|FG001|Overall Study|Withdrew|5|||
28043319|NCT00606593|54701435|FG000|Overall Study|Adverse Event|0|||
28043320|NCT00606593|54701436|FG001|Overall Study|Adverse Event|0|||
28043321|NCT00606593|54701437|FG002|Overall Study|Adverse Event|0|||
28043322|NCT00606593|54701438|FG003|Overall Study|Adverse Event|1|||
28043323|NCT00606593|54701439|FG004|Overall Study|Adverse Event|1|||
28043324|NCT00606593|54701440|FG005|Overall Study|Adverse Event|0|||
28043325|NCT00606593|54701441|FG006|Overall Study|Adverse Event|1|||
28043326|NCT00606593|54701442|FG007|Overall Study|Adverse Event|2|||
28043327|NCT00606593|54701443|FG008|Overall Study|Adverse Event|1|||
28043328|NCT00606593|54701444|FG009|Overall Study|Adverse Event|0|||
28043329|NCT00606593|54701435|FG000|Overall Study|Withdrawal of consent|1|||
28043330|NCT00606593|54701436|FG001|Overall Study|Withdrawal of consent|0|||
28043331|NCT00606593|54701437|FG002|Overall Study|Withdrawal of consent|1|||
28043332|NCT00606593|54701438|FG003|Overall Study|Withdrawal of consent|0|||
28043333|NCT00606593|54701439|FG004|Overall Study|Withdrawal of consent|0|||
28043334|NCT00606593|54701440|FG005|Overall Study|Withdrawal of consent|0|||
28043335|NCT00606593|54701441|FG006|Overall Study|Withdrawal of consent|0|||
28043336|NCT00606593|54701442|FG007|Overall Study|Withdrawal of consent|0|||
28043337|NCT00606593|54701443|FG008|Overall Study|Withdrawal of consent|0|||
28043338|NCT00606593|54701444|FG009|Overall Study|Withdrawal of consent|0|||
28043339|NCT00606593|54701435|FG000|Overall Study|Administrative/Other|0|||
28043340|NCT00606593|54701436|FG001|Overall Study|Administrative/Other|0|||
28043341|NCT00606593|54701437|FG002|Overall Study|Administrative/Other|1|||
28043342|NCT00606593|54701438|FG003|Overall Study|Administrative/Other|0|||
28043343|NCT00606593|54701439|FG004|Overall Study|Administrative/Other|0|||
28043344|NCT00606593|54701440|FG005|Overall Study|Administrative/Other|0|||
28043345|NCT00606593|54701441|FG006|Overall Study|Administrative/Other|0|||
28043346|NCT00606593|54701442|FG007|Overall Study|Administrative/Other|0|||
28043347|NCT00606593|54701443|FG008|Overall Study|Administrative/Other|0|||
28043348|NCT00606593|54701444|FG009|Overall Study|Administrative/Other|0|||
28043349|NCT00605267|54701459|FG000|Overall Study|Adverse Event|0|||
28043350|NCT00605267|54701460|FG001|Overall Study|Adverse Event|1|||
28043351|NCT00605267|54701459|FG000|Overall Study|Lack of Efficacy|1|||
28043352|NCT00605267|54701460|FG001|Overall Study|Lack of Efficacy|5|||
28043353|NCT00605267|54701459|FG000|Overall Study|Withdrawal by Subject|2|||
28043354|NCT00605267|54701460|FG001|Overall Study|Withdrawal by Subject|3|||
28043355|NCT00605813|54701466|FG000|Overall Study|Protocol Violation|25|||
28043356|NCT00604721|54701479|FG000|Overall Study|Physician Decision|1|||
28043357|NCT00604721|54701479|FG000|Overall Study|Withdrawal by Subject|1|||
28043358|NCT00605657|54701484|FG000|Overall Study|Adverse Event|1|||
28043359|NCT00605657|54701484|FG000|Overall Study|Protocol Violation|1|||
28043360|NCT00604565|54701490|FG000|Overall Study|Study terminated|0|||
28043361|NCT00604565|54701491|FG001|Overall Study|Study terminated|3|||
28043362|NCT00605345|54701499|FG000|Overall Study|Withdrawal by Subject|1|||
28043363|NCT00605345|54701500|FG001|Overall Study|Withdrawal by Subject|0|||
28043364|NCT00605345|54701499|FG000|Overall Study|Adverse Event|0|||
28043365|NCT00605345|54701500|FG001|Overall Study|Adverse Event|1|||
28043366|NCT00605345|54701499|FG000|Overall Study|Protocol Violation|0|||
28043367|NCT00605345|54701500|FG001|Overall Study|Protocol Violation|2|||
28043368|NCT00604175|54701509|FG000|Entry Through Week 28|Death|2|||
28043369|NCT00604175|54701510|FG001|Entry Through Week 28|Death|0|||
28043370|NCT00604175|54701511|FG002|Entry Through Week 28|Death|0|||
28043371|NCT00604175|54701509|FG000|Entry Through Week 28|Withdrawal by Subject|1|||
28043372|NCT00604175|54701510|FG001|Entry Through Week 28|Withdrawal by Subject|0|||
28043373|NCT00604175|54701511|FG002|Entry Through Week 28|Withdrawal by Subject|0|||
28043374|NCT00604175|54701509|FG000|Entry Through Week 28|Lost to Follow-up|4|||
28043375|NCT00604175|54701510|FG001|Entry Through Week 28|Lost to Follow-up|3|||
28043376|NCT00604175|54701511|FG002|Entry Through Week 28|Lost to Follow-up|0|||
28043377|NCT00604175|54701509|FG000|Entry Through Week 28|Ineligible|1|||
28043378|NCT00604175|54701510|FG001|Entry Through Week 28|Ineligible|0|||
28043379|NCT00604175|54701511|FG002|Entry Through Week 28|Ineligible|0|||
28043380|NCT00604175|54701509|FG000|Entry Through Week 28|Did not start intervention|2|||
28043381|NCT00604175|54701510|FG001|Entry Through Week 28|Did not start intervention|0|||
28043382|NCT00604175|54701511|FG002|Entry Through Week 28|Did not start intervention|1|||
28043383|NCT00604175|54701509|FG000|Week 29 Through Week 72|Death|0|||
28043384|NCT00604175|54701510|FG001|Week 29 Through Week 72|Death|0|||
28043385|NCT00604175|54701511|FG002|Week 29 Through Week 72|Death|1|||
28043386|NCT00604175|54701509|FG000|Week 29 Through Week 72|Lost to Follow-up|12|||
28043387|NCT00604175|54701510|FG001|Week 29 Through Week 72|Lost to Follow-up|6|||
28043388|NCT00604175|54701511|FG002|Week 29 Through Week 72|Lost to Follow-up|2|||
28043389|NCT00604175|54701509|FG000|Week 29 Through Week 72|Site closure|0|||
28043390|NCT00604175|54701510|FG001|Week 29 Through Week 72|Site closure|1|||
28043391|NCT00604175|54701511|FG002|Week 29 Through Week 72|Site closure|0|||
28043392|NCT00604175|54701509|FG000|Week 29 Through Week 72|Non-adherence to study requirements|0|||
28043393|NCT00604175|54701510|FG001|Week 29 Through Week 72|Non-adherence to study requirements|0|||
28043394|NCT00604175|54701511|FG002|Week 29 Through Week 72|Non-adherence to study requirements|1|||
28043395|NCT00605189|54701546|FG000|Overall Study|Adverse Event|1|||
28043396|NCT00605189|54701547|FG001|Overall Study|Adverse Event|0|||
28043397|NCT00605189|54701548|FG002|Overall Study|Adverse Event|0|||
28043398|NCT00605189|54701546|FG000|Overall Study|Other|2|||
28043399|NCT00605189|54701547|FG001|Overall Study|Other|2|||
28043400|NCT00605189|54701548|FG002|Overall Study|Other|0|||
28043401|NCT00340834|54701561|FG000|Core Phase of Study|Adverse Event|26|||
28043402|NCT00340834|54701562|FG001|Core Phase of Study|Adverse Event|9|||
28043403|NCT00340834|54701563|FG002|Core Phase of Study|Adverse Event|9|||
28043404|NCT00340834|54701564|FG003|Core Phase of Study|Adverse Event|0|||
28043405|NCT00340834|54701565|FG004|Core Phase of Study|Adverse Event|0|||
28043406|NCT00340834|54701561|FG000|Core Phase of Study|Withdrawal by Subject|11|||
28043407|NCT00340834|54701562|FG001|Core Phase of Study|Withdrawal by Subject|9|||
28043408|NCT00340834|54701563|FG002|Core Phase of Study|Withdrawal by Subject|16|||
28043409|NCT00340834|54701564|FG003|Core Phase of Study|Withdrawal by Subject|0|||
28043410|NCT00340834|54701565|FG004|Core Phase of Study|Withdrawal by Subject|0|||
28043411|NCT00340834|54701561|FG000|Core Phase of Study|Administrative Problems|6|||
28043412|NCT00340834|54701562|FG001|Core Phase of Study|Administrative Problems|2|||
28043413|NCT00340834|54701563|FG002|Core Phase of Study|Administrative Problems|7|||
28043414|NCT00340834|54701564|FG003|Core Phase of Study|Administrative Problems|0|||
28043415|NCT00340834|54701565|FG004|Core Phase of Study|Administrative Problems|0|||
28043416|NCT00340834|54701561|FG000|Core Phase of Study|Lack of Efficacy|3|||
28043417|NCT00340834|54701562|FG001|Core Phase of Study|Lack of Efficacy|3|||
28043418|NCT00340834|54701563|FG002|Core Phase of Study|Lack of Efficacy|7|||
28043419|NCT00340834|54701564|FG003|Core Phase of Study|Lack of Efficacy|0|||
28043420|NCT00340834|54701565|FG004|Core Phase of Study|Lack of Efficacy|0|||
28043421|NCT00340834|54701561|FG000|Core Phase of Study|Abnormal laboratory value(s)|4|||
28043422|NCT00340834|54701562|FG001|Core Phase of Study|Abnormal laboratory value(s)|6|||
28043423|NCT00340834|54701563|FG002|Core Phase of Study|Abnormal laboratory value(s)|1|||
28043424|NCT00340834|54701564|FG003|Core Phase of Study|Abnormal laboratory value(s)|0|||
28043425|NCT00340834|54701565|FG004|Core Phase of Study|Abnormal laboratory value(s)|0|||
28043426|NCT00340834|54701561|FG000|Core Phase of Study|Abnormal test procedure result(s)|4|||
28043427|NCT00340834|54701562|FG001|Core Phase of Study|Abnormal test procedure result(s)|3|||
28043428|NCT00340834|54701563|FG002|Core Phase of Study|Abnormal test procedure result(s)|3|||
28043429|NCT00340834|54701564|FG003|Core Phase of Study|Abnormal test procedure result(s)|0|||
28043430|NCT00340834|54701565|FG004|Core Phase of Study|Abnormal test procedure result(s)|0|||
28043431|NCT00340834|54701561|FG000|Core Phase of Study|Lost to Follow-up|1|||
28043432|NCT00340834|54701562|FG001|Core Phase of Study|Lost to Follow-up|1|||
28043433|NCT00340834|54701563|FG002|Core Phase of Study|Lost to Follow-up|4|||
28043434|NCT00340834|54701564|FG003|Core Phase of Study|Lost to Follow-up|0|||
28043435|NCT00340834|54701565|FG004|Core Phase of Study|Lost to Follow-up|0|||
28043436|NCT00340834|54701561|FG000|Core Phase of Study|Death|2|||
28043437|NCT00340834|54701562|FG001|Core Phase of Study|Death|0|||
28043438|NCT00340834|54701563|FG002|Core Phase of Study|Death|0|||
28043439|NCT00340834|54701564|FG003|Core Phase of Study|Death|0|||
28043440|NCT00340834|54701565|FG004|Core Phase of Study|Death|0|||
28043441|NCT00340834|54701561|FG000|Core Phase of Study|Protocol Violation|0|||
28043442|NCT00340834|54701562|FG001|Core Phase of Study|Protocol Violation|0|||
28043443|NCT00340834|54701563|FG002|Core Phase of Study|Protocol Violation|2|||
28043444|NCT00340834|54701564|FG003|Core Phase of Study|Protocol Violation|0|||
28043445|NCT00340834|54701565|FG004|Core Phase of Study|Protocol Violation|0|||
28043446|NCT00340834|54701561|FG000|Extension Phase of Study|Subject did not receive study drug|0|||
28043447|NCT00340834|54701562|FG001|Extension Phase of Study|Subject did not receive study drug|1|||
28043448|NCT00340834|54701563|FG002|Extension Phase of Study|Subject did not receive study drug|0|||
28043449|NCT00340834|54701564|FG003|Extension Phase of Study|Subject did not receive study drug|2|||
28043450|NCT00340834|54701565|FG004|Extension Phase of Study|Subject did not receive study drug|0|||
28043451|NCT00340834|54701561|FG000|Extension Phase of Study|Subject withdrew consent|26|||
28043452|NCT00340834|54701562|FG001|Extension Phase of Study|Subject withdrew consent|31|||
28043453|NCT00340834|54701563|FG002|Extension Phase of Study|Subject withdrew consent|0|||
28043454|NCT00340834|54701564|FG003|Extension Phase of Study|Subject withdrew consent|12|||
28043455|NCT00340834|54701565|FG004|Extension Phase of Study|Subject withdrew consent|15|||
28043456|NCT00340834|54701561|FG000|Extension Phase of Study|Adverse Event|21|||
28043457|NCT00340834|54701562|FG001|Extension Phase of Study|Adverse Event|22|||
28043458|NCT00340834|54701563|FG002|Extension Phase of Study|Adverse Event|0|||
28043459|NCT00340834|54701564|FG003|Extension Phase of Study|Adverse Event|19|||
28043460|NCT00340834|54701565|FG004|Extension Phase of Study|Adverse Event|7|||
28043461|NCT00340834|54701561|FG000|Extension Phase of Study|Abnormal laboratory value(s)|14|||
28043462|NCT00340834|54701562|FG001|Extension Phase of Study|Abnormal laboratory value(s)|13|||
28043463|NCT00340834|54701563|FG002|Extension Phase of Study|Abnormal laboratory value(s)|0|||
28043464|NCT00340834|54701564|FG003|Extension Phase of Study|Abnormal laboratory value(s)|13|||
28043465|NCT00340834|54701565|FG004|Extension Phase of Study|Abnormal laboratory value(s)|4|||
28043466|NCT00340834|54701561|FG000|Extension Phase of Study|Unsatisfactory therapeutic effect|13|||
28043467|NCT00340834|54701562|FG001|Extension Phase of Study|Unsatisfactory therapeutic effect|7|||
28043468|NCT00340834|54701563|FG002|Extension Phase of Study|Unsatisfactory therapeutic effect|0|||
28043469|NCT00340834|54701564|FG003|Extension Phase of Study|Unsatisfactory therapeutic effect|4|||
28043470|NCT00340834|54701565|FG004|Extension Phase of Study|Unsatisfactory therapeutic effect|9|||
28043471|NCT00340834|54701561|FG000|Extension Phase of Study|Lost to Follow-up|1|||
28043472|NCT00340834|54701562|FG001|Extension Phase of Study|Lost to Follow-up|1|||
28043473|NCT00340834|54701563|FG002|Extension Phase of Study|Lost to Follow-up|0|||
28043474|NCT00340834|54701564|FG003|Extension Phase of Study|Lost to Follow-up|2|||
28043475|NCT00340834|54701565|FG004|Extension Phase of Study|Lost to Follow-up|3|||
28043476|NCT00340834|54701561|FG000|Extension Phase of Study|Subject no longer requires study drug|4|||
28043477|NCT00340834|54701562|FG001|Extension Phase of Study|Subject no longer requires study drug|0|||
28043478|NCT00340834|54701563|FG002|Extension Phase of Study|Subject no longer requires study drug|0|||
28043479|NCT00340834|54701564|FG003|Extension Phase of Study|Subject no longer requires study drug|0|||
28043480|NCT00340834|54701565|FG004|Extension Phase of Study|Subject no longer requires study drug|2|||
28043481|NCT00340834|54701561|FG000|Extension Phase of Study|Administrative problems|3|||
28043482|NCT00340834|54701562|FG001|Extension Phase of Study|Administrative problems|0|||
28043483|NCT00340834|54701563|FG002|Extension Phase of Study|Administrative problems|0|||
28043484|NCT00340834|54701564|FG003|Extension Phase of Study|Administrative problems|1|||
28043485|NCT00340834|54701565|FG004|Extension Phase of Study|Administrative problems|1|||
28043486|NCT00340834|54701561|FG000|Extension Phase of Study|Abnormal test procedure result(s)|0|||
28043487|NCT00340834|54701562|FG001|Extension Phase of Study|Abnormal test procedure result(s)|1|||
28043488|NCT00340834|54701563|FG002|Extension Phase of Study|Abnormal test procedure result(s)|0|||
28043489|NCT00340834|54701564|FG003|Extension Phase of Study|Abnormal test procedure result(s)|0|||
28043490|NCT00340834|54701565|FG004|Extension Phase of Study|Abnormal test procedure result(s)|2|||
28043491|NCT00340834|54701561|FG000|Extension Phase of Study|Protocol Violation|3|||
28043492|NCT00340834|54701562|FG001|Extension Phase of Study|Protocol Violation|0|||
28043493|NCT00340834|54701563|FG002|Extension Phase of Study|Protocol Violation|0|||
28043494|NCT00340834|54701564|FG003|Extension Phase of Study|Protocol Violation|0|||
28043495|NCT00340834|54701565|FG004|Extension Phase of Study|Protocol Violation|0|||
28043496|NCT00340834|54701561|FG000|Extension Phase of Study|Death|0|||
28043497|NCT00340834|54701562|FG001|Extension Phase of Study|Death|0|||
28043498|NCT00340834|54701563|FG002|Extension Phase of Study|Death|0|||
28043499|NCT00340834|54701564|FG003|Extension Phase of Study|Death|0|||
28043500|NCT00340834|54701565|FG004|Extension Phase of Study|Death|1|||
28043501|NCT00603941|54701578|FG000|Overall Study|Disease progression|6|||
28043502|NCT00603941|54701579|FG001|Overall Study|Disease progression|7|||
28043503|NCT00603941|54701580|FG002|Overall Study|Disease progression|1|||
28043504|NCT00603941|54701578|FG000|Overall Study|Adverse Event|1|||
27811165|NCT01721109|54267134|FG000|Overall Study|Withdrew Consent|1|||
28043505|NCT00603941|54701579|FG001|Overall Study|Adverse Event|0|||
28043506|NCT00603941|54701580|FG002|Overall Study|Adverse Event|1|||
28043507|NCT00603941|54701578|FG000|Overall Study|Physician Decision|0|||
28043508|NCT00603941|54701579|FG001|Overall Study|Physician Decision|1|||
28043509|NCT00603941|54701580|FG002|Overall Study|Physician Decision|0|||
28043510|NCT00603941|54701578|FG000|Overall Study|Withdrawal by Subject|0|||
28043511|NCT00603941|54701579|FG001|Overall Study|Withdrawal by Subject|2|||
28043512|NCT00603941|54701580|FG002|Overall Study|Withdrawal by Subject|0|||
28043513|NCT00340678|54701593|FG000|Overall Study|Lost to Follow-up|1|||
28043514|NCT00340678|54701594|FG001|Overall Study|Lost to Follow-up|0|||
28043515|NCT00340678|54701595|FG002|Overall Study|Lost to Follow-up|0|||
28043516|NCT00340678|54701596|FG003|Overall Study|Lost to Follow-up|0|||
28043517|NCT00336544|54701606|FG000|Overall Study|Lack of Efficacy|8|||
28043518|NCT00336544|54701607|FG001|Overall Study|Lack of Efficacy|5|||
28043519|NCT00336544|54701606|FG000|Overall Study|Adverse Event|4|||
28043520|NCT00336544|54701607|FG001|Overall Study|Adverse Event|9|||
28043521|NCT00336544|54701606|FG000|Overall Study|Withdrawal by Subject|4|||
28043522|NCT00336544|54701607|FG001|Overall Study|Withdrawal by Subject|3|||
28043523|NCT00336544|54701606|FG000|Overall Study|Other|3|||
28043524|NCT00336544|54701607|FG001|Overall Study|Other|5|||
28043525|NCT00605033|54701615|FG000|Overall Study|Adverse Event|2|||
28043526|NCT00605033|54701616|FG001|Overall Study|Adverse Event|2|||
28043527|NCT00605033|54701615|FG000|Overall Study|Lost to Follow-up|1|||
28043528|NCT00605033|54701616|FG001|Overall Study|Lost to Follow-up|1|||
28043529|NCT00605033|54701615|FG000|Overall Study|Withdrawal by Subject|3|||
28043530|NCT00605033|54701616|FG001|Overall Study|Withdrawal by Subject|4|||
28043531|NCT00605033|54701615|FG000|Overall Study|Protocol Violation|1|||
28043532|NCT00605033|54701616|FG001|Overall Study|Protocol Violation|1|||
28043533|NCT00339040|54701624|FG000|Stage I|Not able to attend clinic|1|||
28043534|NCT00339040|54701625|FG001|Stage I|Not able to attend clinic|0|||
28043535|NCT00339040|54701624|FG000|Stage I|Protocol Violation|1|||
28043536|NCT00339040|54701625|FG001|Stage I|Protocol Violation|1|||
28043537|NCT00339040|54701624|FG000|Stage II|Lost to Follow-up|3|||
28043538|NCT00339040|54701625|FG001|Stage II|Lost to Follow-up|0|||
28043539|NCT00339040|54701624|FG000|Stage II|Withdrawal by Subject|1|||
28043540|NCT00339040|54701625|FG001|Stage II|Withdrawal by Subject|2|||
28043541|NCT00339040|54701624|FG000|Stage II|Protocol Violation|3|||
28043542|NCT00339040|54701625|FG001|Stage II|Protocol Violation|0|||
28043543|NCT00339040|54701624|FG000|Stage II|Not able to attend clinic|1|||
28043544|NCT00339040|54701625|FG001|Stage II|Not able to attend clinic|0|||
28043545|NCT00339040|54701624|FG000|Stage II|Site closing|2|||
28043546|NCT00339040|54701625|FG001|Stage II|Site closing|0|||
28043547|NCT00338962|54701635|FG000|Overall Study|Lost to Follow-up|3|||
28043548|NCT00338962|54701636|FG001|Overall Study|Lost to Follow-up|3|||
28043549|NCT00338962|54701637|FG002|Overall Study|Lost to Follow-up|2|||
28043550|NCT00338962|54701638|FG003|Overall Study|Lost to Follow-up|3|||
28043551|NCT00338962|54701635|FG000|Overall Study|Withdrawal by Subject|1|||
28043552|NCT00338962|54701636|FG001|Overall Study|Withdrawal by Subject|0|||
28043553|NCT00338962|54701637|FG002|Overall Study|Withdrawal by Subject|0|||
28043554|NCT00338962|54701638|FG003|Overall Study|Withdrawal by Subject|0|||
28043555|NCT00338962|54701635|FG000|Overall Study|No Transportation|2|||
27811166|NCT01721109|54267134|FG000|Overall Study|Lost to Follow-up|2|||
27811167|NCT01874145|54267140|FG000|Core Period|Non-compliance|1|||
27811168|NCT01874145|54267141|FG001|Core Period|Non-compliance|0|||
27811169|NCT01874145|54267140|FG000|Core Period|Protocol Violation|1|||
27811170|NCT01874145|54267141|FG001|Core Period|Protocol Violation|1|||
27811171|NCT01874145|54267140|FG000|Core Period|Physician Decision|1|||
27811172|NCT01874145|54267141|FG001|Core Period|Physician Decision|1|||
27811173|NCT01874145|54267140|FG000|Core Period|Adverse Event|0|||
27811174|NCT01874145|54267141|FG001|Core Period|Adverse Event|1|||
27811175|NCT01874145|54267140|FG000|Core Period|Withdrawal by Subject|0|||
27811176|NCT01874145|54267141|FG001|Core Period|Withdrawal by Subject|4|||
27811177|NCT01874145|54267140|FG000|Extension Period|Adverse Event|3|||
27811178|NCT01874145|54267141|FG001|Extension Period|Adverse Event|2|||
27811179|NCT01874145|54267140|FG000|Extension Period|Withdrawal by Subject|2|||
27811180|NCT01874145|54267141|FG001|Extension Period|Withdrawal by Subject|1|||
27811181|NCT01874145|54267140|FG000|Extension Period|Lost to Follow-up|1|||
27811182|NCT01874145|54267141|FG001|Extension Period|Lost to Follow-up|1|||
27811183|NCT01720797|54267153|FG000|Overall Study|Withdrawal by Subject|3|||
28043556|NCT00338962|54701636|FG001|Overall Study|No Transportation|0|||
28043557|NCT00338962|54701637|FG002|Overall Study|No Transportation|0|||
28043558|NCT00338962|54701638|FG003|Overall Study|No Transportation|0|||
28043559|NCT00338962|54701635|FG000|Overall Study|Time Constraint|2|||
28043560|NCT00338962|54701636|FG001|Overall Study|Time Constraint|0|||
28043561|NCT00338962|54701637|FG002|Overall Study|Time Constraint|0|||
28043562|NCT00338962|54701638|FG003|Overall Study|Time Constraint|0|||
28043563|NCT00338962|54701635|FG000|Overall Study|Moved|0|||
28043564|NCT00338962|54701636|FG001|Overall Study|Moved|1|||
28043565|NCT00338962|54701637|FG002|Overall Study|Moved|0|||
28043566|NCT00338962|54701638|FG003|Overall Study|Moved|0|||
28043567|NCT00338962|54701635|FG000|Overall Study|Adverse Event|0|||
28043568|NCT00338962|54701636|FG001|Overall Study|Adverse Event|0|||
28043569|NCT00338962|54701637|FG002|Overall Study|Adverse Event|2|||
28043570|NCT00338962|54701638|FG003|Overall Study|Adverse Event|0|||
28043571|NCT00338962|54701635|FG000|Overall Study|Poor Compliance|0|||
27811184|NCT01720797|54267154|FG001|Overall Study|Withdrawal by Subject|0|||
28043572|NCT00338962|54701636|FG001|Overall Study|Poor Compliance|0|||
28043573|NCT00338962|54701637|FG002|Overall Study|Poor Compliance|2|||
28043574|NCT00338962|54701638|FG003|Overall Study|Poor Compliance|0|||
28043575|NCT00568061|54701650|FG000|Overall Study|Inclusion / exclusion criteria|5|||
28043576|NCT00568061|54701651|FG001|Overall Study|Inclusion / exclusion criteria|1|||
28043577|NCT00568061|54701650|FG000|Overall Study|Adverse Event|0|||
28043578|NCT00568061|54701651|FG001|Overall Study|Adverse Event|1|||
28043579|NCT00338884|54701658|FG000|Overall Study|Objective Disease Progression or Relapse|44|||
28043580|NCT00338884|54701658|FG000|Overall Study|Adverse Event|14|||
28043581|NCT00338884|54701658|FG000|Overall Study|Death|8|||
28043582|NCT00338884|54701658|FG000|Overall Study|Other|4|||
28043583|NCT00338884|54701658|FG000|Overall Study|Global Deterioration of Health Status|3|||
28043584|NCT00338884|54701658|FG000|Overall Study|Withdrawal by Subject|3|||
28043585|NCT00338884|54701658|FG000|Overall Study|Lost to Follow-up|1|||
28043586|NCT00338884|54701658|FG000|Overall Study|Randomized But Did Not Receive Treatment|1|||
28043587|NCT00338806|54701664|FG000|Acute Phase|Withdrawal by Subject|0|||
28043588|NCT00338806|54701665|FG001|Acute Phase|Withdrawal by Subject|1|||
28043589|NCT00338806|54701664|FG000|Follow-up|Lost to Follow-up|1|||
28043590|NCT00338806|54701665|FG001|Follow-up|Lost to Follow-up|3|||
28043591|NCT03038100|54701675|FG000|Overall Study|Death|289|||
28043592|NCT03038100|54701676|FG001|Overall Study|Death|272|||
28043593|NCT03038100|54701675|FG000|Overall Study|Lost to Follow-up|9|||
28043594|NCT03038100|54701676|FG001|Overall Study|Lost to Follow-up|10|||
28043595|NCT03038100|54701675|FG000|Overall Study|Protocol Deviation|1|||
28043596|NCT03038100|54701676|FG001|Overall Study|Protocol Deviation|4|||
28043597|NCT03038100|54701675|FG000|Overall Study|Withdrawal by Subject|45|||
28043598|NCT03038100|54701676|FG001|Overall Study|Withdrawal by Subject|51|||
28043599|NCT03038100|54701675|FG000|Overall Study|Study Terminated By Sponsor|305|||
28043600|NCT03038100|54701676|FG001|Overall Study|Study Terminated By Sponsor|311|||
28043601|NCT03038100|54701675|FG000|Overall Study|Physician Decision|1|||
28043602|NCT03038100|54701676|FG001|Overall Study|Physician Decision|3|||
28043603|NCT00338728|54701683|FG000|Overall Study|Screen Failure|14|||
28043604|NCT00336856|54701687|FG000|Overall Study|Withdrawal by Subject|3|||
28043605|NCT00336856|54701687|FG000|Overall Study|Found ineligible at time of analysis|1|||
28043606|NCT00566501|54701693|FG000|Overall Study|Adverse Event|68|||
28043607|NCT00566501|54701694|FG001|Overall Study|Adverse Event|59|||
28043608|NCT00566501|54701693|FG000|Overall Study|Medication Non-compliance|5|||
28043609|NCT00566501|54701694|FG001|Overall Study|Medication Non-compliance|0|||
28043610|NCT00566501|54701693|FG000|Overall Study|Protocol Violation|2|||
28043611|NCT00566501|54701694|FG001|Overall Study|Protocol Violation|2|||
28043612|NCT00566501|54701693|FG000|Overall Study|Request of Investigator or Sponsor|6|||
28043613|NCT00566501|54701694|FG001|Overall Study|Request of Investigator or Sponsor|7|||
28043614|NCT00566501|54701693|FG000|Overall Study|Withdrawal by Subject|33|||
28043615|NCT00566501|54701694|FG001|Overall Study|Withdrawal by Subject|30|||
28043616|NCT00566501|54701693|FG000|Overall Study|Lack of Efficacy|8|||
28043617|NCT00566501|54701694|FG001|Overall Study|Lack of Efficacy|3|||
28043618|NCT00566501|54701693|FG000|Overall Study|Other|25|||
28043619|NCT00566501|54701694|FG001|Overall Study|Other|21|||
28043620|NCT00504894|54701703|FG000|Overall Study|fMRI technical problems|1|||
28043621|NCT00504894|54701704|FG001|Overall Study|fMRI technical problems|1|||
28043622|NCT00504894|54701705|FG002|Overall Study|fMRI technical problems|0|||
28043623|NCT00504894|54701703|FG000|Overall Study|Withdrawal by Subject|0|||
28043624|NCT00504894|54701704|FG001|Overall Study|Withdrawal by Subject|1|||
28043625|NCT00504894|54701705|FG002|Overall Study|Withdrawal by Subject|0|||
28043626|NCT00504894|54701703|FG000|Overall Study|Infusion technical problems|0|||
28043627|NCT00504894|54701704|FG001|Overall Study|Infusion technical problems|1|||
28043628|NCT00504894|54701705|FG002|Overall Study|Infusion technical problems|0|||
28043629|NCT00504894|54701703|FG000|Overall Study|poor subject data|2|||
28043630|NCT00504894|54701704|FG001|Overall Study|poor subject data|0|||
28043631|NCT00504894|54701705|FG002|Overall Study|poor subject data|0|||
28105697|NCT04438785|54763270|FG001|Overall Study|change of weight, give up intervention|10|||
27811185|NCT01831466|54267172|FG000|Overall Study|Protocol Violation|1|||
28043632|NCT00513240|54701715|FG000|Overall Study|Did not have intended surgery|3|||
28043633|NCT00513240|54701716|FG001|Overall Study|Did not have intended surgery|0|||
28043634|NCT00513240|54701715|FG000|Overall Study|Death|3|||
28043635|NCT00513240|54701716|FG001|Overall Study|Death|3|||
28043636|NCT00513240|54701715|FG000|Overall Study|Withdrawal by Subject|7|||
28043637|NCT00513240|54701716|FG001|Overall Study|Withdrawal by Subject|4|||
28043638|NCT00504426|54701729|FG000|Overall Study|Adverse Event|0|||
28043639|NCT00504426|54701730|FG001|Overall Study|Adverse Event|0|||
28043640|NCT00504426|54701731|FG002|Overall Study|Adverse Event|2|||
28043641|NCT00504426|54701732|FG003|Overall Study|Adverse Event|0|||
28043642|NCT00504426|54701729|FG000|Overall Study|Protocol Violation|1|||
28043643|NCT00504426|54701730|FG001|Overall Study|Protocol Violation|1|||
28043644|NCT00504426|54701731|FG002|Overall Study|Protocol Violation|2|||
28043645|NCT00504426|54701732|FG003|Overall Study|Protocol Violation|0|||
28043646|NCT00504426|54701729|FG000|Overall Study|Withdrawal by Subject|2|||
28043647|NCT00504426|54701730|FG001|Overall Study|Withdrawal by Subject|0|||
28043648|NCT00504426|54701731|FG002|Overall Study|Withdrawal by Subject|0|||
28043649|NCT00504426|54701732|FG003|Overall Study|Withdrawal by Subject|0|||
28043650|NCT00504348|54701745|FG000|Overall Study|Adverse Event|3|||
28043651|NCT00504348|54701745|FG000|Overall Study|Lack of Efficacy|4|||
28043652|NCT00504348|54701745|FG000|Overall Study|Physician Decision|1|||
28043653|NCT00507546|54701751|FG000|Overall Study|Withdrawal by Subject|1|||
28043654|NCT00507546|54701752|FG001|Overall Study|Withdrawal by Subject|0|||
28043655|NCT00507546|54701751|FG000|Overall Study|Protocol Violation|1|||
28043656|NCT00507546|54701752|FG001|Overall Study|Protocol Violation|0|||
28043657|NCT00507546|54701751|FG000|Overall Study|Physician Decision|0|||
28043658|NCT00507546|54701752|FG001|Overall Study|Physician Decision|1|||
28043659|NCT00567593|54701760|FG000|Overall Study|Adverse Event|1|||
28043660|NCT00567593|54701760|FG000|Overall Study|Physician Decision|1|||
28043661|NCT00335764|54701769|FG000|Overall Study|wrong histology|1|||
28043662|NCT00335764|54701770|FG001|Overall Study|wrong histology|0|||
28043663|NCT00335764|54701771|FG002|Overall Study|wrong histology|0|||
28043664|NCT00335764|54701772|FG003|Overall Study|wrong histology|0|||
28043665|NCT00335764|54701773|FG004|Overall Study|wrong histology|1|||
28043666|NCT00567359|54701809|FG000|Overall Study|Withdrawal by Subject|1|||
28043667|NCT00492726|54701815|FG000|Overall Study|Adverse Event|10|||
28043668|NCT00492726|54701816|FG001|Overall Study|Adverse Event|6|||
28043669|NCT00492726|54701815|FG000|Overall Study|Death|7|||
28043670|NCT00492726|54701816|FG001|Overall Study|Death|2|||
28043671|NCT00492726|54701815|FG000|Overall Study|Lack of Efficacy|0|||
28043672|NCT00492726|54701816|FG001|Overall Study|Lack of Efficacy|2|||
28043673|NCT00492726|54701815|FG000|Overall Study|Lost to Follow-up|27|||
28043674|NCT00492726|54701816|FG001|Overall Study|Lost to Follow-up|19|||
28043675|NCT00492726|54701815|FG000|Overall Study|Physician Decision|0|||
28043676|NCT00492726|54701816|FG001|Overall Study|Physician Decision|1|||
28043677|NCT00492726|54701815|FG000|Overall Study|Withdrawal by Subject|6|||
28043678|NCT00492726|54701816|FG001|Overall Study|Withdrawal by Subject|3|||
28043679|NCT00492726|54701815|FG000|Overall Study|Non compliant with study medication|0|||
28043680|NCT00492726|54701816|FG001|Overall Study|Non compliant with study medication|3|||
28043681|NCT00309946|54701822|FG000|Overall Study|Withdrawal by Subject|1|||
28043682|NCT00492648|54701828|FG000|Month 30 (109671 Study)|Protocol Violation|0|||
28043683|NCT00492648|54701829|FG001|Month 30 (109671 Study)|Protocol Violation|1|||
28043684|NCT00506922|54701840|FG000|Overall Study|Physician Decision|0|||
28043685|NCT00506922|54701841|FG001|Overall Study|Physician Decision|0|||
28043686|NCT00506922|54701842|FG002|Overall Study|Physician Decision|0|||
28043687|NCT00506922|54701843|FG003|Overall Study|Physician Decision|2|||
28043688|NCT00506922|54701844|FG004|Overall Study|Physician Decision|0|||
28043689|NCT00506922|54701840|FG000|Overall Study|Withdrawal by Subject|0|||
28043690|NCT00506922|54701841|FG001|Overall Study|Withdrawal by Subject|0|||
28043691|NCT00506922|54701842|FG002|Overall Study|Withdrawal by Subject|0|||
28043692|NCT00506922|54701843|FG003|Overall Study|Withdrawal by Subject|0|||
28043693|NCT00506922|54701844|FG004|Overall Study|Withdrawal by Subject|1|||
28043694|NCT00492024|54701854|FG000|Treatment|Adverse Event|3|||
28043695|NCT00492024|54701855|FG001|Treatment|Adverse Event|1|||
28043696|NCT00492024|54701854|FG000|Treatment|Lack of Efficacy|21|||
28043697|NCT00492024|54701855|FG001|Treatment|Lack of Efficacy|20|||
28043698|NCT00492024|54701854|FG000|Treatment|Lost to Follow-up|3|||
28043699|NCT00492024|54701855|FG001|Treatment|Lost to Follow-up|1|||
28043700|NCT00492024|54701854|FG000|Treatment|Withdrawal by Subject|2|||
28043701|NCT00492024|54701855|FG001|Treatment|Withdrawal by Subject|0|||
28043702|NCT00492024|54701854|FG000|Follow up|Lack of Efficacy|0|||
28043703|NCT00492024|54701855|FG001|Follow up|Lack of Efficacy|1|||
28043704|NCT00492024|54701854|FG000|Follow up|Lost to Follow-up|1|||
28043705|NCT00492024|54701855|FG001|Follow up|Lost to Follow-up|1|||
28043706|NCT00491556|54701863|FG000|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1|||
28043707|NCT00491556|54701864|FG001|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0|||
28043708|NCT00491556|54701863|FG000|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1|||
28043709|NCT00491556|54701864|FG001|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0|||
28043710|NCT00491556|54701863|FG000|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1|||
28043711|NCT00491556|54701864|FG001|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0|||
28043712|NCT00491556|54701863|FG000|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2|||
28043713|NCT00491556|54701864|FG001|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0|||
28043714|NCT00491556|54701863|FG000|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11|||
28043715|NCT00491556|54701864|FG001|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0|||
28043716|NCT00491556|54701863|FG000|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2|||
28043717|NCT00491556|54701864|FG001|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0|||
28043718|NCT00491556|54701863|FG000|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2|||
28043719|NCT00491556|54701864|FG001|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0|||
28043720|NCT00491556|54701863|FG000|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3|||
28043721|NCT00491556|54701864|FG001|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0|||
28043722|NCT00491556|54701863|FG000|Entry-Week (WK) 48: EXP/Standard Care|Other|3|||
28043723|NCT00491556|54701864|FG001|Entry-Week (WK) 48: EXP/Standard Care|Other|0|||
28043724|NCT00491556|54701863|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
28043725|NCT00491556|54701864|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
28043726|NCT00491556|54701863|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2|||
28043727|NCT00491556|54701864|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0|||
28043728|NCT00491556|54701863|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2|||
28043729|NCT00491556|54701864|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1|||
28043730|NCT00491556|54701863|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5|||
28043731|NCT00491556|54701864|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0|||
28043732|NCT00491556|54701863|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2|||
28043733|NCT00491556|54701864|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0|||
28043734|NCT00491556|54701863|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5|||
28043735|NCT00491556|54701864|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0|||
28043736|NCT00491556|54701863|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2|||
28043737|NCT00491556|54701864|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0|||
28043738|NCT00491556|54701863|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2|||
28043739|NCT00491556|54701864|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0|||
28043740|NCT00491556|54701863|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2|||
28043741|NCT00491556|54701864|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0|||
28043742|NCT00491556|54701863|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0|||
28043743|NCT00491556|54701864|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1|||
28043744|NCT00491556|54701863|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0|||
28043745|NCT00491556|54701864|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1|||
28043746|NCT00506454|54701880|FG000|Overall Study|Withdrawal by Subject|1|||
28043747|NCT00506454|54701881|FG001|Overall Study|Withdrawal by Subject|1|||
28043748|NCT00485472|54701889|FG000|Overall Study|Adverse Event|8|||
28043749|NCT00485472|54701890|FG001|Overall Study|Adverse Event|5|||
28043750|NCT00485472|54701889|FG000|Overall Study|Lack of Efficacy|5|||
28043751|NCT00485472|54701890|FG001|Overall Study|Lack of Efficacy|4|||
28043752|NCT00485472|54701889|FG000|Overall Study|Withdrawal by Subject|1|||
28043753|NCT00485472|54701890|FG001|Overall Study|Withdrawal by Subject|0|||
28043754|NCT00485472|54701889|FG000|Overall Study|Protocol Violation|0|||
28043755|NCT00485472|54701890|FG001|Overall Study|Protocol Violation|1|||
28043756|NCT00485472|54701889|FG000|Overall Study|Other|2|||
28043757|NCT00485472|54701890|FG001|Overall Study|Other|1|||
28043758|NCT00485472|54701889|FG000|Overall Study|Lost to Follow-up|0|||
28043759|NCT00485472|54701890|FG001|Overall Study|Lost to Follow-up|1|||
28043760|NCT00491400|54701898|FG000|Overall Study|Withdrawal by Subject|5|||
28043761|NCT00491400|54701899|FG001|Overall Study|Withdrawal by Subject|4|||
28043762|NCT00491322|54701909|FG000|Overall Study|Protocol Violation|1|||
28043763|NCT00491322|54701910|FG001|Overall Study|Protocol Violation|0|||
28043764|NCT00491322|54701909|FG000|Overall Study|Pregnancy|0|||
28043765|NCT00491322|54701910|FG001|Overall Study|Pregnancy|1|||
28043766|NCT00502320|54701918|FG000|Overall Study|Lost to Follow-up|1|||
28043767|NCT00502320|54701919|FG001|Overall Study|Lost to Follow-up|1|||
28043768|NCT00502320|54701918|FG000|Overall Study|Withdrew Consent|1|||
28043769|NCT00502320|54701919|FG001|Overall Study|Withdrew Consent|0|||
28043770|NCT00502320|54701918|FG000|Overall Study|No longer met criteria|1|||
28043771|NCT00502320|54701919|FG001|Overall Study|No longer met criteria|0|||
28043772|NCT00502320|54701918|FG000|Overall Study|Screen Failure|0|||
28043773|NCT00502320|54701919|FG001|Overall Study|Screen Failure|1|||
27811186|NCT01831466|54267173|FG001|Overall Study|Protocol Violation|1|||
27811187|NCT01831466|54267174|FG002|Overall Study|Protocol Violation|2|||
27811188|NCT01831466|54267175|FG003|Overall Study|Protocol Violation|0|||
27811189|NCT01831466|54267176|FG004|Overall Study|Protocol Violation|0|||
27811190|NCT01831466|54267177|FG005|Overall Study|Protocol Violation|1|||
27811191|NCT01831466|54267178|FG006|Overall Study|Protocol Violation|0|||
27811192|NCT01831466|54267179|FG007|Overall Study|Protocol Violation|0|||
27811193|NCT01831466|54267180|FG008|Overall Study|Protocol Violation|0|||
27811194|NCT01831466|54267181|FG009|Overall Study|Protocol Violation|0|||
27811195|NCT01831466|54267182|FG010|Overall Study|Protocol Violation|0|||
27811196|NCT01831466|54267183|FG011|Overall Study|Protocol Violation|0|||
27811197|NCT01831466|54267172|FG000|Overall Study|Other|2|||
28043774|NCT00502320|54701918|FG000|Overall Study|Adverse Event|3|||
28043775|NCT00502320|54701919|FG001|Overall Study|Adverse Event|5|||
28043776|NCT02567825|54701927|FG000|Overall Study|No follow-up post-randomization|5|||
28043777|NCT02567825|54701928|FG001|Overall Study|No follow-up post-randomization|1|||
28043778|NCT02567825|54701927|FG000|Overall Study|Follow-up less than 23 months|16|||
28043779|NCT02567825|54701928|FG001|Overall Study|Follow-up less than 23 months|20|||
28043780|NCT00490776|54701934|FG000|Overall Study|Withdrawal by Subject|1|||
28043781|NCT00490776|54701934|FG000|Overall Study|Administrative Problems|1|||
28043782|NCT00490776|54701934|FG000|Overall Study|Death|1|||
28043783|NCT00490776|54701934|FG000|Overall Study|New Cancer Therapy|1|||
28043784|NCT00490776|54701934|FG000|Overall Study|Disease Progression|5|||
28043785|NCT00566735|54701940|FG000|Overall Study|Withdrawal by Subject|0|||
27811198|NCT01831466|54267173|FG001|Overall Study|Other|3|||
27811199|NCT01831466|54267174|FG002|Overall Study|Other|2|||
27811200|NCT01831466|54267175|FG003|Overall Study|Other|2|||
27811201|NCT01831466|54267176|FG004|Overall Study|Other|2|||
27811202|NCT01831466|54267177|FG005|Overall Study|Other|1|||
27811203|NCT01831466|54267178|FG006|Overall Study|Other|0|||
27811204|NCT01831466|54267179|FG007|Overall Study|Other|0|||
27811205|NCT01831466|54267180|FG008|Overall Study|Other|0|||
27811206|NCT01831466|54267181|FG009|Overall Study|Other|0|||
27811207|NCT01831466|54267182|FG010|Overall Study|Other|0|||
27811208|NCT01831466|54267183|FG011|Overall Study|Other|0|||
27811209|NCT01831466|54267172|FG000|Overall Study|Non-compliance with study treatment|2|||
27811210|NCT01831466|54267173|FG001|Overall Study|Non-compliance with study treatment|1|||
27811211|NCT01831466|54267174|FG002|Overall Study|Non-compliance with study treatment|1|||
27811212|NCT01831466|54267175|FG003|Overall Study|Non-compliance with study treatment|0|||
27811213|NCT01831466|54267176|FG004|Overall Study|Non-compliance with study treatment|0|||
28043786|NCT00566735|54701941|FG001|Overall Study|Withdrawal by Subject|1|||
28043787|NCT00566735|54701940|FG000|Overall Study|Refused neuropsychological testing|2|||
28043788|NCT00566735|54701941|FG001|Overall Study|Refused neuropsychological testing|5|||
28043789|NCT00566735|54701940|FG000|Overall Study|Switched into a manic episode|0|||
28043790|NCT00566735|54701941|FG001|Overall Study|Switched into a manic episode|1|||
28043791|NCT00566111|54701949|FG000|Overall Study|Adverse Event|0|||
28043792|NCT00566111|54701950|FG001|Overall Study|Adverse Event|2|||
28043793|NCT00514046|54701965|FG000|Overall Study|transferred to another protocol|2|||
28043794|NCT00514046|54701966|FG001|Overall Study|transferred to another protocol|1|||
28043795|NCT00514046|54701967|FG002|Overall Study|transferred to another protocol|3|||
28043796|NCT00514046|54701968|FG003|Overall Study|transferred to another protocol|0|||
28043797|NCT00514046|54701969|FG004|Overall Study|transferred to another protocol|1|||
28043798|NCT00514046|54701970|FG005|Overall Study|transferred to another protocol|0|||
28043799|NCT00514046|54701971|FG006|Overall Study|transferred to another protocol|0|||
28043800|NCT00514046|54701972|FG007|Overall Study|transferred to another protocol|0|||
28043801|NCT00514046|54701973|FG008|Overall Study|transferred to another protocol|0|||
28043802|NCT00514046|54701965|FG000|Overall Study|Getting vandetanib via the REMS program|1|||
28043803|NCT00514046|54701966|FG001|Overall Study|Getting vandetanib via the REMS program|0|||
28043804|NCT00514046|54701967|FG002|Overall Study|Getting vandetanib via the REMS program|0|||
28043805|NCT00514046|54701968|FG003|Overall Study|Getting vandetanib via the REMS program|0|||
28043806|NCT00514046|54701969|FG004|Overall Study|Getting vandetanib via the REMS program|0|||
27811214|NCT01831466|54267177|FG005|Overall Study|Non-compliance with study treatment|1|||
27811215|NCT01831466|54267178|FG006|Overall Study|Non-compliance with study treatment|0|||
27811216|NCT01831466|54267179|FG007|Overall Study|Non-compliance with study treatment|0|||
27811217|NCT01831466|54267180|FG008|Overall Study|Non-compliance with study treatment|0|||
27811218|NCT01831466|54267181|FG009|Overall Study|Non-compliance with study treatment|0|||
27811219|NCT01831466|54267182|FG010|Overall Study|Non-compliance with study treatment|0|||
27811220|NCT01831466|54267183|FG011|Overall Study|Non-compliance with study treatment|0|||
27811221|NCT01831466|54267172|FG000|Overall Study|Death|0|||
27811222|NCT01831466|54267173|FG001|Overall Study|Death|1|||
27811223|NCT01831466|54267174|FG002|Overall Study|Death|0|||
27811224|NCT01831466|54267175|FG003|Overall Study|Death|0|||
27811225|NCT01831466|54267176|FG004|Overall Study|Death|0|||
27811226|NCT01831466|54267177|FG005|Overall Study|Death|0|||
27811227|NCT01831466|54267178|FG006|Overall Study|Death|0|||
27811228|NCT01831466|54267179|FG007|Overall Study|Death|0|||
27811229|NCT01831466|54267180|FG008|Overall Study|Death|0|||
27811230|NCT01831466|54267181|FG009|Overall Study|Death|0|||
27811231|NCT01831466|54267182|FG010|Overall Study|Death|0|||
27811232|NCT01831466|54267183|FG011|Overall Study|Death|0|||
27811233|NCT01831466|54267172|FG000|Overall Study|Withdrawal by Subject|6|||
27811234|NCT01831466|54267173|FG001|Overall Study|Withdrawal by Subject|3|||
27811235|NCT01831466|54267174|FG002|Overall Study|Withdrawal by Subject|3|||
27811236|NCT01831466|54267175|FG003|Overall Study|Withdrawal by Subject|3|||
27811237|NCT01831466|54267176|FG004|Overall Study|Withdrawal by Subject|3|||
27811238|NCT01831466|54267177|FG005|Overall Study|Withdrawal by Subject|5|||
27811239|NCT01831466|54267178|FG006|Overall Study|Withdrawal by Subject|0|||
27811240|NCT01831466|54267179|FG007|Overall Study|Withdrawal by Subject|0|||
27811241|NCT01831466|54267180|FG008|Overall Study|Withdrawal by Subject|0|||
27811242|NCT01831466|54267181|FG009|Overall Study|Withdrawal by Subject|1|||
27811243|NCT01831466|54267182|FG010|Overall Study|Withdrawal by Subject|0|||
27939888|NCT01038609|54596215|FG000|Overall Study|Dosing Error|0|||
28043807|NCT00514046|54701970|FG005|Overall Study|Getting vandetanib via the REMS program|0|||
28043808|NCT00514046|54701971|FG006|Overall Study|Getting vandetanib via the REMS program|0|||
28043809|NCT00514046|54701972|FG007|Overall Study|Getting vandetanib via the REMS program|1|||
28043810|NCT00514046|54701973|FG008|Overall Study|Getting vandetanib via the REMS program|1|||
27811244|NCT01831466|54267183|FG011|Overall Study|Withdrawal by Subject|1|||
27811245|NCT01831466|54267172|FG000|Overall Study|Lost to Follow-up|0|||
27811246|NCT01831466|54267173|FG001|Overall Study|Lost to Follow-up|1|||
28043811|NCT00514046|54701965|FG000|Overall Study|Disease progression on study|0|||
28043812|NCT00514046|54701966|FG001|Overall Study|Disease progression on study|0|||
28043813|NCT00514046|54701967|FG002|Overall Study|Disease progression on study|2|||
28043814|NCT00514046|54701968|FG003|Overall Study|Disease progression on study|0|||
28043815|NCT00514046|54701969|FG004|Overall Study|Disease progression on study|0|||
28043816|NCT00514046|54701970|FG005|Overall Study|Disease progression on study|1|||
28043817|NCT00514046|54701971|FG006|Overall Study|Disease progression on study|0|||
28043818|NCT00514046|54701972|FG007|Overall Study|Disease progression on study|0|||
28043819|NCT00514046|54701973|FG008|Overall Study|Disease progression on study|0|||
28043820|NCT00564629|54701997|FG000|Overall Study|Vomited within 2 hours of receiving drug|15|||
28043821|NCT00564629|54701998|FG001|Overall Study|Vomited within 2 hours of receiving drug|9|||
28043822|NCT00564395|54702004|FG000|First Intervention (10 Days)|Withdrawal by Subject|1|||
28043823|NCT00564395|54702005|FG001|First Intervention (10 Days)|Withdrawal by Subject|0|||
28043824|NCT00564395|54702004|FG000|First Intervention (10 Days)|Trouble with the CGM tracing|1|||
28043825|NCT00564395|54702005|FG001|First Intervention (10 Days)|Trouble with the CGM tracing|2|||
28043826|NCT00502242|54702013|FG000|Overall Study|Lack of Efficacy|1|||
28043827|NCT00502242|54702014|FG001|Overall Study|Lack of Efficacy|11|||
28043828|NCT00502242|54702013|FG000|Overall Study|Adverse Event|31|||
28043829|NCT00502242|54702014|FG001|Overall Study|Adverse Event|20|||
28043830|NCT00502242|54702013|FG000|Overall Study|Physician Decision|2|||
28043831|NCT00502242|54702014|FG001|Overall Study|Physician Decision|3|||
28043832|NCT00502242|54702013|FG000|Overall Study|Other - Unspecified|8|||
28043833|NCT00502242|54702014|FG001|Overall Study|Other - Unspecified|14|||
28043834|NCT00502242|54702013|FG000|Overall Study|Protocol Violation|3|||
28043835|NCT00502242|54702014|FG001|Overall Study|Protocol Violation|1|||
28043836|NCT00502242|54702013|FG000|Overall Study|Withdrawal by Subject|6|||
28043837|NCT00502242|54702014|FG001|Overall Study|Withdrawal by Subject|7|||
28043838|NCT03972137|54702024|FG000|Overall Study|Lost to Follow-up|2|||
28043839|NCT03972137|54702024|FG000|Overall Study|Withdrawal by Subject|4|||
28043840|NCT00490698|54702040|FG000|Overall Study|Withdrawal by Subject|1|||
28043841|NCT00490698|54702040|FG000|Overall Study|Disease Progression|7|||
28043842|NCT00490698|54702040|FG000|Overall Study|Physician Decision|2|||
28043843|NCT03855228|54702048|FG000|Overall Study|Adverse Event|2|||
28043844|NCT03855228|54702049|FG001|Overall Study|Adverse Event|4|||
27811247|NCT01831466|54267174|FG002|Overall Study|Lost to Follow-up|4|||
27811248|NCT01831466|54267175|FG003|Overall Study|Lost to Follow-up|2|||
27811249|NCT01831466|54267176|FG004|Overall Study|Lost to Follow-up|0|||
27811250|NCT01831466|54267177|FG005|Overall Study|Lost to Follow-up|3|||
27811251|NCT01831466|54267178|FG006|Overall Study|Lost to Follow-up|0|||
27811252|NCT01831466|54267179|FG007|Overall Study|Lost to Follow-up|0|||
28043845|NCT03855228|54702050|FG002|Overall Study|Adverse Event|4|||
28043846|NCT03855228|54702051|FG003|Overall Study|Adverse Event|8|||
28043847|NCT03855228|54702048|FG000|Overall Study|Treatment Failure|1|||
28043848|NCT03855228|54702049|FG001|Overall Study|Treatment Failure|2|||
28043849|NCT03855228|54702050|FG002|Overall Study|Treatment Failure|1|||
28043850|NCT03855228|54702051|FG003|Overall Study|Treatment Failure|8|||
28043851|NCT03855228|54702048|FG000|Overall Study|Lost to Follow-up|0|||
28043852|NCT03855228|54702049|FG001|Overall Study|Lost to Follow-up|0|||
28043853|NCT03855228|54702050|FG002|Overall Study|Lost to Follow-up|0|||
28043854|NCT03855228|54702051|FG003|Overall Study|Lost to Follow-up|1|||
28043855|NCT03855228|54702048|FG000|Overall Study|Protocol Violation|0|||
28043856|NCT03855228|54702049|FG001|Overall Study|Protocol Violation|1|||
28043857|NCT03855228|54702050|FG002|Overall Study|Protocol Violation|2|||
28043858|NCT03855228|54702051|FG003|Overall Study|Protocol Violation|1|||
28043859|NCT03855228|54702048|FG000|Overall Study|Did Not Meet Entry Requirements|0|||
28043860|NCT03855228|54702049|FG001|Overall Study|Did Not Meet Entry Requirements|2|||
28043861|NCT03855228|54702050|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
28043862|NCT03855228|54702051|FG003|Overall Study|Did Not Meet Entry Requirements|1|||
28043863|NCT00511238|54702063|FG000|Overall Study|Adverse Event|13|||
28043864|NCT00511238|54702064|FG001|Overall Study|Adverse Event|33|||
28105698|NCT04741503|54763278|FG000|Initial Enrollment|Failed to meet screening criteria|0|||
27811253|NCT01831466|54267180|FG008|Overall Study|Lost to Follow-up|0|||
27811254|NCT01831466|54267181|FG009|Overall Study|Lost to Follow-up|1|||
27811255|NCT01831466|54267182|FG010|Overall Study|Lost to Follow-up|0|||
28043865|NCT00511238|54702063|FG000|Overall Study|Withdrawal by Subject|2|||
28043866|NCT00511238|54702064|FG001|Overall Study|Withdrawal by Subject|22|||
28043867|NCT00511238|54702063|FG000|Overall Study|Progressive Disease|23|||
28043868|NCT00511238|54702064|FG001|Overall Study|Progressive Disease|157|||
28043869|NCT00511238|54702063|FG000|Overall Study|various reasons|4|||
28043870|NCT00511238|54702064|FG001|Overall Study|various reasons|14|||
28043871|NCT00513500|54702082|FG000|Overall Study|Lost to Follow-up|35|||
28043872|NCT00513500|54702083|FG001|Overall Study|Lost to Follow-up|39|||
28043873|NCT00513500|54702082|FG000|Overall Study|Death|2|||
28043874|NCT00513500|54702083|FG001|Overall Study|Death|1|||
28043875|NCT00513500|54702082|FG000|Overall Study|Hospitalized|4|||
28043876|NCT00513500|54702083|FG001|Overall Study|Hospitalized|14|||
27811256|NCT01831466|54267183|FG011|Overall Study|Lost to Follow-up|1|||
28043877|NCT03969719|54702092|FG000|Overall Study|Other reasons not specified|1|||
28043878|NCT03969719|54702093|FG001|Overall Study|Other reasons not specified|1|||
28043879|NCT03969719|54702094|FG002|Overall Study|Other reasons not specified|3|||
28043880|NCT03969719|54702092|FG000|Overall Study|Withdrawal by Subject|2|||
28043881|NCT03969719|54702093|FG001|Overall Study|Withdrawal by Subject|3|||
28043882|NCT03969719|54702094|FG002|Overall Study|Withdrawal by Subject|2|||
28043883|NCT03969719|54702092|FG000|Overall Study|Protocol Violation|1|||
28043884|NCT03969719|54702093|FG001|Overall Study|Protocol Violation|2|||
28043885|NCT03969719|54702094|FG002|Overall Study|Protocol Violation|0|||
28043886|NCT03969719|54702092|FG000|Overall Study|Adverse Event|0|||
28043887|NCT03969719|54702093|FG001|Overall Study|Adverse Event|2|||
28043888|NCT03969719|54702094|FG002|Overall Study|Adverse Event|0|||
28043889|NCT03969719|54702092|FG000|Overall Study|Lost to Follow-up|0|||
28043890|NCT03969719|54702093|FG001|Overall Study|Lost to Follow-up|1|||
28043891|NCT03969719|54702094|FG002|Overall Study|Lost to Follow-up|0|||
28043892|NCT00511004|54702105|FG000|Overall Study|Lost to Follow-up|0|||
28043893|NCT00511004|54702106|FG001|Overall Study|Lost to Follow-up|0|||
28043894|NCT00511004|54702107|FG002|Overall Study|Lost to Follow-up|4|||
28043895|NCT02877134|54702134|FG000|Main Study (Parts I,II): Up to Week 38|Death|0|||
28043896|NCT02877134|54702135|FG001|Main Study (Parts I,II): Up to Week 38|Death|1|||
28043897|NCT02877134|54702136|FG002|Main Study (Parts I,II): Up to Week 38|Death|0|||
28043898|NCT02877134|54702137|FG003|Main Study (Parts I,II): Up to Week 38|Death|0|||
28043899|NCT02877134|54702138|FG004|Main Study (Parts I,II): Up to Week 38|Death|0|||
28043900|NCT02877134|54702139|FG005|Main Study (Parts I,II): Up to Week 38|Death|1|||
28043901|NCT02877134|54702140|FG006|Main Study (Parts I,II): Up to Week 38|Death|0|||
28043902|NCT02877134|54702141|FG007|Main Study (Parts I,II): Up to Week 38|Death|0|||
28043903|NCT02877134|54702142|FG008|Main Study (Parts I,II): Up to Week 38|Death|0|||
28043904|NCT02877134|54702143|FG009|Main Study (Parts I,II): Up to Week 38|Death|0|||
28043905|NCT02877134|54702144|FG010|Main Study (Parts I,II): Up to Week 38|Death|0|||
28043906|NCT02877134|54702145|FG011|Main Study (Parts I,II): Up to Week 38|Death|0|||
28043907|NCT02877134|54702134|FG000|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
28043908|NCT02877134|54702135|FG001|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|4|||
28043909|NCT02877134|54702136|FG002|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
28043910|NCT02877134|54702137|FG003|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
28043911|NCT02877134|54702138|FG004|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
28043912|NCT02877134|54702139|FG005|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
28043913|NCT02877134|54702140|FG006|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
28043914|NCT02877134|54702141|FG007|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
28043915|NCT02877134|54702142|FG008|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
28043916|NCT02877134|54702143|FG009|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
28043917|NCT02877134|54702144|FG010|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
28043918|NCT02877134|54702145|FG011|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
28043919|NCT02877134|54702134|FG000|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|13|||
28043920|NCT02877134|54702135|FG001|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|19|||
28043921|NCT02877134|54702136|FG002|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|5|||
28043922|NCT02877134|54702137|FG003|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|8|||
28043923|NCT02877134|54702138|FG004|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|3|||
28043924|NCT02877134|54702139|FG005|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|6|||
28043925|NCT02877134|54702140|FG006|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|2|||
28043926|NCT02877134|54702141|FG007|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
28043927|NCT02877134|54702142|FG008|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
28043928|NCT02877134|54702143|FG009|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
28043929|NCT02877134|54702144|FG010|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
28043930|NCT02877134|54702145|FG011|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
28043931|NCT02877134|54702134|FG000|Main Study (Parts I,II): Up to Week 38|Other|1|||
28043932|NCT02877134|54702135|FG001|Main Study (Parts I,II): Up to Week 38|Other|1|||
28043933|NCT02877134|54702136|FG002|Main Study (Parts I,II): Up to Week 38|Other|3|||
28043934|NCT02877134|54702137|FG003|Main Study (Parts I,II): Up to Week 38|Other|6|||
28043935|NCT02877134|54702138|FG004|Main Study (Parts I,II): Up to Week 38|Other|4|||
28043936|NCT02877134|54702139|FG005|Main Study (Parts I,II): Up to Week 38|Other|3|||
28043937|NCT02877134|54702140|FG006|Main Study (Parts I,II): Up to Week 38|Other|2|||
28043938|NCT02877134|54702141|FG007|Main Study (Parts I,II): Up to Week 38|Other|0|||
28043939|NCT02877134|54702142|FG008|Main Study (Parts I,II): Up to Week 38|Other|0|||
28043940|NCT02877134|54702143|FG009|Main Study (Parts I,II): Up to Week 38|Other|0|||
28043941|NCT02877134|54702144|FG010|Main Study (Parts I,II): Up to Week 38|Other|0|||
28043942|NCT02877134|54702145|FG011|Main Study (Parts I,II): Up to Week 38|Other|0|||
28043943|NCT02877134|54702134|FG000|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
28043944|NCT02877134|54702135|FG001|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
28043945|NCT02877134|54702136|FG002|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
28043946|NCT02877134|54702137|FG003|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
28043947|NCT02877134|54702138|FG004|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
28043948|NCT02877134|54702139|FG005|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
28043949|NCT02877134|54702140|FG006|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
28043950|NCT02877134|54702141|FG007|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
28043951|NCT02877134|54702142|FG008|Part II LTE Phase: From Week 24-88|Lost to Follow-up|1|||
28043952|NCT02877134|54702143|FG009|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
28043953|NCT02877134|54702144|FG010|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
28043954|NCT02877134|54702145|FG011|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
28043955|NCT02877134|54702134|FG000|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
28043956|NCT02877134|54702135|FG001|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
28043957|NCT02877134|54702136|FG002|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
28043958|NCT02877134|54702137|FG003|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
28043959|NCT02877134|54702138|FG004|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
28043960|NCT02877134|54702139|FG005|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
28043961|NCT02877134|54702140|FG006|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
28043962|NCT02877134|54702141|FG007|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|1|||
28043963|NCT02877134|54702142|FG008|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|2|||
28043964|NCT02877134|54702143|FG009|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
28043965|NCT02877134|54702144|FG010|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|9|||
28043966|NCT02877134|54702145|FG011|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
28043967|NCT02877134|54702134|FG000|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
28043968|NCT02877134|54702135|FG001|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
28043969|NCT02877134|54702136|FG002|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
27811257|NCT01831466|54267172|FG000|Overall Study|Lack of Efficacy|5|||
27811258|NCT01831466|54267173|FG001|Overall Study|Lack of Efficacy|8|||
27811259|NCT01831466|54267174|FG002|Overall Study|Lack of Efficacy|7|||
27811260|NCT01831466|54267175|FG003|Overall Study|Lack of Efficacy|6|||
27811261|NCT01831466|54267176|FG004|Overall Study|Lack of Efficacy|9|||
27811262|NCT01831466|54267177|FG005|Overall Study|Lack of Efficacy|8|||
27811263|NCT01831466|54267178|FG006|Overall Study|Lack of Efficacy|1|||
27811264|NCT01831466|54267179|FG007|Overall Study|Lack of Efficacy|1|||
27811265|NCT01831466|54267180|FG008|Overall Study|Lack of Efficacy|2|||
27811266|NCT01831466|54267181|FG009|Overall Study|Lack of Efficacy|2|||
27811267|NCT01831466|54267182|FG010|Overall Study|Lack of Efficacy|2|||
27811268|NCT01831466|54267183|FG011|Overall Study|Lack of Efficacy|0|||
28043970|NCT02877134|54702137|FG003|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
28043971|NCT02877134|54702138|FG004|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
28043972|NCT02877134|54702139|FG005|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
28043973|NCT02877134|54702140|FG006|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
28043974|NCT02877134|54702141|FG007|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
28043975|NCT02877134|54702142|FG008|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
28043976|NCT02877134|54702143|FG009|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
28043977|NCT02877134|54702144|FG010|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
28043978|NCT02877134|54702145|FG011|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
28043979|NCT02877134|54702134|FG000|Part II LTE Phase: From Week 24-88|Other|0|||
28043980|NCT02877134|54702135|FG001|Part II LTE Phase: From Week 24-88|Other|0|||
28043981|NCT02877134|54702136|FG002|Part II LTE Phase: From Week 24-88|Other|0|||
28043982|NCT02877134|54702137|FG003|Part II LTE Phase: From Week 24-88|Other|0|||
28043983|NCT02877134|54702138|FG004|Part II LTE Phase: From Week 24-88|Other|0|||
28043984|NCT02877134|54702139|FG005|Part II LTE Phase: From Week 24-88|Other|0|||
28043985|NCT02877134|54702140|FG006|Part II LTE Phase: From Week 24-88|Other|0|||
28043986|NCT02877134|54702141|FG007|Part II LTE Phase: From Week 24-88|Other|0|||
28043987|NCT02877134|54702142|FG008|Part II LTE Phase: From Week 24-88|Other|0|||
28043988|NCT02877134|54702143|FG009|Part II LTE Phase: From Week 24-88|Other|3|||
28043989|NCT02877134|54702144|FG010|Part II LTE Phase: From Week 24-88|Other|1|||
28043990|NCT02877134|54702145|FG011|Part II LTE Phase: From Week 24-88|Other|1|||
28043991|NCT00563381|54702171|FG000|Overall Study|Adverse Event|264|||
28043992|NCT00563381|54702172|FG001|Overall Study|Adverse Event|292|||
28043993|NCT00563381|54702171|FG000|Overall Study|Protocol Violation|66|||
28043994|NCT00563381|54702172|FG001|Overall Study|Protocol Violation|74|||
28043995|NCT00563381|54702171|FG000|Overall Study|Lost to Follow-up|7|||
28043996|NCT00563381|54702172|FG001|Overall Study|Lost to Follow-up|15|||
28043997|NCT00563381|54702171|FG000|Overall Study|Withdrawal by Subject|192|||
28043998|NCT00563381|54702172|FG001|Overall Study|Withdrawal by Subject|209|||
28043999|NCT00563381|54702171|FG000|Overall Study|Lack of Efficacy|32|||
28044000|NCT00563381|54702172|FG001|Overall Study|Lack of Efficacy|24|||
28044001|NCT00563381|54702171|FG000|Overall Study|Individual different reasons|24|||
27811269|NCT01831466|54267172|FG000|Overall Study|Adverse Event|0|||
27811270|NCT01831466|54267173|FG001|Overall Study|Adverse Event|0|||
27811271|NCT01831466|54267174|FG002|Overall Study|Adverse Event|4|||
28044002|NCT00563381|54702172|FG001|Overall Study|Individual different reasons|34|||
28044003|NCT00512798|54702180|FG000|Overall Study|Death|0|||
28044004|NCT00512798|54702181|FG001|Overall Study|Death|3|||
28044005|NCT00512798|54702180|FG000|Overall Study|Adverse Event|2|||
28044006|NCT00512798|54702181|FG001|Overall Study|Adverse Event|4|||
28044007|NCT00512798|54702180|FG000|Overall Study|Progression of disease|14|||
28044008|NCT00512798|54702181|FG001|Overall Study|Progression of disease|20|||
28044009|NCT00512798|54702180|FG000|Overall Study|Withdrawal by Subject|3|||
28044010|NCT00512798|54702181|FG001|Overall Study|Withdrawal by Subject|0|||
28044011|NCT00565721|54702188|FG000|Overall Study|Screen Failure|2|||
28044012|NCT00565721|54702188|FG000|Overall Study|Lost to Follow-up|6|||
28044013|NCT00565721|54702188|FG000|Overall Study|Technical Problems|1|||
28044014|NCT00565721|54702188|FG000|Overall Study|Physician Decision|2|||
28044015|NCT00565721|54702188|FG000|Overall Study|Other reasons|6|||
28044016|NCT00561977|54702210|FG000|Overall Study|Withdrawal by Subject|0|||
28044017|NCT00561977|54702211|FG001|Overall Study|Withdrawal by Subject|2|||
28044018|NCT00561977|54702212|FG002|Overall Study|Withdrawal by Subject|1|||
28044019|NCT00561977|54702210|FG000|Overall Study|Pregnancy|0|||
28044020|NCT00561977|54702211|FG001|Overall Study|Pregnancy|1|||
28044021|NCT00561977|54702212|FG002|Overall Study|Pregnancy|1|||
28044022|NCT00561821|54702224|FG000|Overall Study|Not treated|0|||
28044023|NCT00561821|54702225|FG001|Overall Study|Not treated|0|||
28044024|NCT00561821|54702226|FG002|Overall Study|Not treated|1|||
28044025|NCT00561821|54702227|FG003|Overall Study|Not treated|0|||
28044026|NCT00561821|54702224|FG000|Overall Study|Withdrawal by Subject|0|||
28044027|NCT00561821|54702225|FG001|Overall Study|Withdrawal by Subject|1|||
28044028|NCT00561821|54702226|FG002|Overall Study|Withdrawal by Subject|0|||
28044029|NCT00561821|54702227|FG003|Overall Study|Withdrawal by Subject|2|||
28044030|NCT00561821|54702224|FG000|Overall Study|Reasons not related to trial|2|||
28044031|NCT00561821|54702225|FG001|Overall Study|Reasons not related to trial|1|||
28044032|NCT00561821|54702226|FG002|Overall Study|Reasons not related to trial|0|||
28044033|NCT00561821|54702227|FG003|Overall Study|Reasons not related to trial|0|||
28044034|NCT00561821|54702224|FG000|Overall Study|Other (reason not specified)|1|||
28044035|NCT00561821|54702225|FG001|Overall Study|Other (reason not specified)|1|||
28044036|NCT00561821|54702226|FG002|Overall Study|Other (reason not specified)|0|||
28044037|NCT00561821|54702227|FG003|Overall Study|Other (reason not specified)|0|||
28044038|NCT00561821|54702224|FG000|Overall Study|Adverse Event|2|||
28044039|NCT00561821|54702225|FG001|Overall Study|Adverse Event|3|||
28044040|NCT00561821|54702226|FG002|Overall Study|Adverse Event|1|||
28044041|NCT00561821|54702227|FG003|Overall Study|Adverse Event|1|||
28044042|NCT00558701|54702239|FG000|Overall Study|Protocol Deviations|1|||
28044043|NCT00558701|54702240|FG001|Overall Study|Protocol Deviations|4|||
28044044|NCT03684044|54702248|FG000|Overall Study|Adverse Event|3|||
28044045|NCT03684044|54702249|FG001|Overall Study|Adverse Event|0|||
28044046|NCT03684044|54702248|FG000|Overall Study|Death|4|||
28044047|NCT03684044|54702249|FG001|Overall Study|Death|7|||
28044048|NCT03684044|54702248|FG000|Overall Study|Lost to Follow-up|3|||
28044049|NCT03684044|54702249|FG001|Overall Study|Lost to Follow-up|2|||
28044050|NCT03684044|54702248|FG000|Overall Study|Patient Not Available|0|||
28044051|NCT03684044|54702249|FG001|Overall Study|Patient Not Available|2|||
28044052|NCT03684044|54702248|FG000|Overall Study|Physician Decision|1|||
28044053|NCT03684044|54702249|FG001|Overall Study|Physician Decision|0|||
28044054|NCT03684044|54702248|FG000|Overall Study|Withdrawal by Subject|11|||
28044055|NCT03684044|54702249|FG001|Overall Study|Withdrawal by Subject|9|||
28044056|NCT00510692|54702257|FG000|Overall Study|Adverse Event|1|||
28044057|NCT00510692|54702258|FG001|Overall Study|Adverse Event|3|||
28044058|NCT00510692|54702257|FG000|Overall Study|Withdrawal by Subject|1|||
28044059|NCT00510692|54702258|FG001|Overall Study|Withdrawal by Subject|0|||
28044060|NCT00335452|54702270|FG000|Overall Study|Death|156|||
28044061|NCT00335452|54702271|FG001|Overall Study|Death|144|||
28044062|NCT00335452|54702272|FG002|Overall Study|Death|158|||
28044063|NCT00335452|54702273|FG003|Overall Study|Death|129|||
28044064|NCT00335452|54702270|FG000|Overall Study|Lost to Follow-up|2|||
28044065|NCT00335452|54702271|FG001|Overall Study|Lost to Follow-up|3|||
28044066|NCT00335452|54702272|FG002|Overall Study|Lost to Follow-up|1|||
28044067|NCT00335452|54702273|FG003|Overall Study|Lost to Follow-up|2|||
28044068|NCT00522548|54702290|FG000|Overall Study|Adverse Event|2|||
28044069|NCT00522548|54702291|FG001|Overall Study|Adverse Event|2|||
28044070|NCT00522548|54702290|FG000|Overall Study|Withdrawal by Subject|0|||
28044071|NCT00522548|54702291|FG001|Overall Study|Withdrawal by Subject|2|||
28044072|NCT00522392|54702299|FG000|Overall Study|Disease progression|0|||
28044073|NCT00522392|54702300|FG001|Overall Study|Disease progression|3|||
28044074|NCT00522392|54702299|FG000|Overall Study|Adverse Event|7|||
28044075|NCT00522392|54702300|FG001|Overall Study|Adverse Event|7|||
28044076|NCT00522392|54702299|FG000|Overall Study|Withdrawal by Subject|1|||
28044077|NCT00522392|54702300|FG001|Overall Study|Withdrawal by Subject|1|||
28044078|NCT00522392|54702299|FG000|Overall Study|Physician Decision|0|||
28044079|NCT00522392|54702300|FG001|Overall Study|Physician Decision|1|||
28044080|NCT00522392|54702299|FG000|Overall Study|Non-compliance|0|||
28044081|NCT00522392|54702300|FG001|Overall Study|Non-compliance|1|||
28044082|NCT00309244|54702308|FG000|Overall Study|Adverse Event|29|||
28044083|NCT00309244|54702309|FG001|Overall Study|Adverse Event|12|||
28044084|NCT00309244|54702308|FG000|Overall Study|Lost to Follow-up|6|||
28044085|NCT00309244|54702309|FG001|Overall Study|Lost to Follow-up|22|||
28044086|NCT00309244|54702308|FG000|Overall Study|Physician Decision|5|||
28044087|NCT00309244|54702309|FG001|Overall Study|Physician Decision|8|||
28044088|NCT00309244|54702308|FG000|Overall Study|Protocol Violation|6|||
28044089|NCT00309244|54702309|FG001|Overall Study|Protocol Violation|3|||
28044090|NCT00309244|54702308|FG000|Overall Study|Withdrawal by Subject|50|||
28044091|NCT00309244|54702309|FG001|Overall Study|Withdrawal by Subject|32|||
28044092|NCT00309244|54702308|FG000|Overall Study|Various|7|||
28044093|NCT00309244|54702309|FG001|Overall Study|Various|7|||
28044094|NCT00309244|54702308|FG000|Overall Study|Randomized but not dosed|11|||
28044095|NCT00309244|54702309|FG001|Overall Study|Randomized but not dosed|12|||
28044096|NCT00309244|54702308|FG000|Overall Study|Death|4|||
28044097|NCT00309244|54702309|FG001|Overall Study|Death|1|||
28044098|NCT00483756|54702318|FG000|Overall Study|Death|2|||
28044099|NCT00483756|54702319|FG001|Overall Study|Death|0|||
28044100|NCT00483756|54702320|FG002|Overall Study|Death|1|||
28044101|NCT00483756|54702318|FG000|Overall Study|Adverse Event|19|||
28044102|NCT00483756|54702319|FG001|Overall Study|Adverse Event|38|||
28044103|NCT00483756|54702320|FG002|Overall Study|Adverse Event|40|||
28044104|NCT00483756|54702318|FG000|Overall Study|Lack of Efficacy|1|||
28044105|NCT00483756|54702319|FG001|Overall Study|Lack of Efficacy|0|||
28044106|NCT00483756|54702320|FG002|Overall Study|Lack of Efficacy|0|||
28044107|NCT00483756|54702318|FG000|Overall Study|Lost to Follow-up|3|||
28044108|NCT00483756|54702319|FG001|Overall Study|Lost to Follow-up|1|||
28044109|NCT00483756|54702320|FG002|Overall Study|Lost to Follow-up|0|||
28044110|NCT00483756|54702318|FG000|Overall Study|Withdrawal by Subject|5|||
28044111|NCT00483756|54702319|FG001|Overall Study|Withdrawal by Subject|3|||
28044112|NCT00483756|54702320|FG002|Overall Study|Withdrawal by Subject|4|||
28044113|NCT00483756|54702318|FG000|Overall Study|Other|2|||
28044114|NCT00483756|54702319|FG001|Overall Study|Other|4|||
28044115|NCT00483756|54702320|FG002|Overall Study|Other|3|||
28044116|NCT00483756|54702318|FG000|Overall Study|Randomized, Not Treated|1|||
28044117|NCT00483756|54702319|FG001|Overall Study|Randomized, Not Treated|4|||
28044118|NCT00483756|54702320|FG002|Overall Study|Randomized, Not Treated|4|||
28044119|NCT00309166|54702330|FG000|Overall Study|Adverse event, non-fatal|1|||
28044120|NCT00309166|54702331|FG001|Overall Study|Adverse event, non-fatal|0|||
28044121|NCT00309166|54702330|FG000|Overall Study|Withdrawal by Subject|4|||
28044122|NCT00309166|54702331|FG001|Overall Study|Withdrawal by Subject|3|||
28044123|NCT00501852|54702337|FG000|Overall Study|Adverse Event|3|||
28044124|NCT00501852|54702337|FG000|Overall Study|Withdrawal by Subject|2|||
28044125|NCT00482274|54702351|FG000|Overall Study|Adverse Event|1|||
28044126|NCT00490542|54702357|FG000|Overall Study|Lost to Follow-up|3|||
28044127|NCT00490542|54702358|FG001|Overall Study|Lost to Follow-up|0|||
28044128|NCT00490542|54702357|FG000|Overall Study|Adverse Event|3|||
28044129|NCT00490542|54702358|FG001|Overall Study|Adverse Event|3|||
28044130|NCT00490542|54702357|FG000|Overall Study|Lack of Efficacy|1|||
28044131|NCT00490542|54702358|FG001|Overall Study|Lack of Efficacy|1|||
28044132|NCT00501540|54702364|FG000|Overall Study|Death|5|||
28044133|NCT00322348|54702370|FG000|Overall Study|Adverse Event|0|||
28044134|NCT00322348|54702371|FG001|Overall Study|Adverse Event|1|||
28044135|NCT00322348|54702370|FG000|Overall Study|Withdrawal by Subject|1|||
28044136|NCT00322348|54702371|FG001|Overall Study|Withdrawal by Subject|4|||
28044137|NCT00322348|54702370|FG000|Overall Study|Lost to Follow-up|1|||
28044138|NCT00322348|54702371|FG001|Overall Study|Lost to Follow-up|0|||
28044139|NCT00322348|54702370|FG000|Overall Study|Death|0|||
28044140|NCT00322348|54702371|FG001|Overall Study|Death|2|||
28044141|NCT00322348|54702370|FG000|Overall Study|Disease Progression|30|||
28044142|NCT00322348|54702371|FG001|Overall Study|Disease Progression|25|||
28044143|NCT00322348|54702370|FG000|Overall Study|Reasons not specified|5|||
28044144|NCT00322348|54702371|FG001|Overall Study|Reasons not specified|1|||
28044145|NCT00501228|54702377|FG000|Overall Study|Withdrawal by Subject|1|||
28044146|NCT00308620|54702384|FG000|Overall Study|Death|1|||
28044147|NCT00308620|54702385|FG001|Overall Study|Death|1|||
28044148|NCT00308620|54702386|FG002|Overall Study|Death|0|||
28044149|NCT00308620|54702384|FG000|Overall Study|Lost to Follow-up|0|||
28044150|NCT00308620|54702385|FG001|Overall Study|Lost to Follow-up|0|||
28044151|NCT00308620|54702386|FG002|Overall Study|Lost to Follow-up|1|||
28044152|NCT00492752|54702396|FG000|Double Blind Treatment|Death|13|||
28044153|NCT00492752|54702397|FG001|Double Blind Treatment|Death|0|||
28044154|NCT00492752|54702398|FG002|Double Blind Treatment|Death|2|||
28044155|NCT00492752|54702399|FG003|Double Blind Treatment|Death|0|||
28044156|NCT00492752|54702396|FG000|Double Blind Treatment|Adverse Event|1|||
28044157|NCT00492752|54702397|FG001|Double Blind Treatment|Adverse Event|0|||
28044158|NCT00492752|54702398|FG002|Double Blind Treatment|Adverse Event|0|||
28044159|NCT00492752|54702399|FG003|Double Blind Treatment|Adverse Event|0|||
28044160|NCT00492752|54702396|FG000|Double Blind Treatment|Protocol Violation|0|||
28044161|NCT00492752|54702397|FG001|Double Blind Treatment|Protocol Violation|0|||
28044162|NCT00492752|54702398|FG002|Double Blind Treatment|Protocol Violation|1|||
28044163|NCT00492752|54702399|FG003|Double Blind Treatment|Protocol Violation|0|||
28044164|NCT00492752|54702396|FG000|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
28044165|NCT00492752|54702397|FG001|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
28044166|NCT00492752|54702398|FG002|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
28044167|NCT00492752|54702399|FG003|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
28044168|NCT00492752|54702396|FG000|Follow-up and/or Open Label Sorafenib|Death|75|||
28044169|NCT00492752|54702397|FG001|Follow-up and/or Open Label Sorafenib|Death|5|||
28044170|NCT00492752|54702398|FG002|Follow-up and/or Open Label Sorafenib|Death|45|||
28044171|NCT00492752|54702399|FG003|Follow-up and/or Open Label Sorafenib|Death|1|||
28044172|NCT00492752|54702396|FG000|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8|||
28044173|NCT00492752|54702397|FG001|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1|||
28044174|NCT00492752|54702398|FG002|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2|||
28044175|NCT00492752|54702399|FG003|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0|||
28044176|NCT00492752|54702396|FG000|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2|||
28044177|NCT00492752|54702397|FG001|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1|||
28044178|NCT00492752|54702398|FG002|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
28044179|NCT00492752|54702399|FG003|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
28044180|NCT00492752|54702396|FG000|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
28044181|NCT00492752|54702397|FG001|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1|||
28044182|NCT00492752|54702398|FG002|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
28044183|NCT00492752|54702399|FG003|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2|||
28044184|NCT00492752|54702396|FG000|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
28044185|NCT00492752|54702397|FG001|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
28044186|NCT00492752|54702398|FG002|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
28044187|NCT00492752|54702399|FG003|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1|||
28044188|NCT00492752|54702396|FG000|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
28044189|NCT00492752|54702397|FG001|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6|||
28044190|NCT00492752|54702398|FG002|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
28044191|NCT00492752|54702399|FG003|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
28044192|NCT00492752|54702396|FG000|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1|||
28044193|NCT00492752|54702397|FG001|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
28044194|NCT00492752|54702398|FG002|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
28044195|NCT00492752|54702399|FG003|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
28044196|NCT00308308|54702408|FG000|Overall Study|Adverse Event|17|||
28044197|NCT00308308|54702409|FG001|Overall Study|Adverse Event|2|||
28044198|NCT00308308|54702408|FG000|Overall Study|Lost to Follow-up|5|||
28044199|NCT00308308|54702409|FG001|Overall Study|Lost to Follow-up|5|||
28044200|NCT00308308|54702408|FG000|Overall Study|Physician Decision|15|||
28044201|NCT00308308|54702409|FG001|Overall Study|Physician Decision|7|||
28044202|NCT00308308|54702408|FG000|Overall Study|Protocol Violation|3|||
28044203|NCT00308308|54702409|FG001|Overall Study|Protocol Violation|14|||
28044204|NCT00308308|54702408|FG000|Overall Study|Withdrawal by Subject|47|||
28044205|NCT00308308|54702409|FG001|Overall Study|Withdrawal by Subject|19|||
28044206|NCT00308308|54702408|FG000|Overall Study|Various|7|||
28044207|NCT00308308|54702409|FG001|Overall Study|Various|5|||
28044208|NCT00308308|54702408|FG000|Overall Study|Randomized but not dosed|8|||
28044209|NCT00308308|54702409|FG001|Overall Study|Randomized but not dosed|16|||
28044210|NCT00308308|54702408|FG000|Overall Study|Other|1|||
28044211|NCT00308308|54702409|FG001|Overall Study|Other|0|||
28044212|NCT00505934|54702415|FG000|Overall Study|Adverse Event|1|||
28044213|NCT00505934|54702415|FG000|Overall Study|Other: Unable to obtain IV & PK samples|1|||
28044214|NCT00505934|54702415|FG000|Overall Study|Other: IV dose needed to be changed|1|||
28044215|NCT00505778|54702421|FG000|Overall Study|Adverse Event|2|||
28044216|NCT00505778|54702422|FG001|Overall Study|Adverse Event|7|||
28044217|NCT00505778|54702421|FG000|Overall Study|Physician Decision|8|||
28044218|NCT00505778|54702422|FG001|Overall Study|Physician Decision|14|||
28044219|NCT00505778|54702421|FG000|Overall Study|Lost to Follow-up|17|||
28044220|NCT00505778|54702422|FG001|Overall Study|Lost to Follow-up|23|||
28044221|NCT00505778|54702421|FG000|Overall Study|Unable to Meet Protocol Criteria|4|||
28044222|NCT00505778|54702422|FG001|Overall Study|Unable to Meet Protocol Criteria|1|||
28044223|NCT00505778|54702421|FG000|Overall Study|Protocol Violation|7|||
28044224|NCT00505778|54702422|FG001|Overall Study|Protocol Violation|9|||
28044225|NCT00505778|54702421|FG000|Overall Study|Withdrawal by Subject|29|||
28044226|NCT00505778|54702422|FG001|Overall Study|Withdrawal by Subject|14|||
28044227|NCT00505778|54702421|FG000|Overall Study|Relapse|65|||
28044228|NCT00505778|54702422|FG001|Overall Study|Relapse|65|||
28044229|NCT00505778|54702421|FG000|Overall Study|Took No Study Drug|2|||
28044230|NCT00505778|54702422|FG001|Overall Study|Took No Study Drug|2|||
28044231|NCT00308074|54702428|FG000|Overall Study|Withdrawal by Subject|1|||
28044232|NCT00500760|54702434|FG000|Overall Study|Death|32|||
28044233|NCT00500760|54702435|FG001|Overall Study|Death|15|||
28044234|NCT00500760|54702434|FG000|Overall Study|Withdrawal by Subject|5|||
28044235|NCT00500760|54702435|FG001|Overall Study|Withdrawal by Subject|7|||
28044236|NCT00500760|54702434|FG000|Overall Study|Administrative decision|2|||
28044237|NCT00500760|54702435|FG001|Overall Study|Administrative decision|0|||
28044238|NCT00500760|54702434|FG000|Overall Study|Lost to Follow-up|3|||
28044239|NCT00500760|54702435|FG001|Overall Study|Lost to Follow-up|0|||
28044240|NCT00500760|54702434|FG000|Overall Study|Other|1|||
28044241|NCT00500760|54702435|FG001|Overall Study|Other|2|||
28044242|NCT00505622|54702444|FG000|Overall Study|Adverse Event|5|||
28044243|NCT00505622|54702445|FG001|Overall Study|Adverse Event|6|||
28044244|NCT00505622|54702446|FG002|Overall Study|Adverse Event|4|||
28044245|NCT00505622|54702444|FG000|Overall Study|Protocol Violation|1|||
28044246|NCT00505622|54702445|FG001|Overall Study|Protocol Violation|1|||
28044247|NCT00505622|54702446|FG002|Overall Study|Protocol Violation|0|||
28044248|NCT00505622|54702444|FG000|Overall Study|Withdrawal by Subject|0|||
28044249|NCT00505622|54702445|FG001|Overall Study|Withdrawal by Subject|3|||
28044250|NCT00505622|54702446|FG002|Overall Study|Withdrawal by Subject|2|||
28044251|NCT00505622|54702444|FG000|Overall Study|Study termination by sponsor|115|||
28044252|NCT00505622|54702445|FG001|Overall Study|Study termination by sponsor|98|||
28044253|NCT00505622|54702446|FG002|Overall Study|Study termination by sponsor|90|||
28044254|NCT03851094|54702456|FG000|Overall Study|Withdrawal by Subject|0|||
28044255|NCT03851094|54702457|FG001|Overall Study|Withdrawal by Subject|1|||
28044256|NCT03851094|54702456|FG000|Overall Study|Participant lost device|0|||
28044257|NCT03851094|54702457|FG001|Overall Study|Participant lost device|1|||
28044258|NCT03851094|54702456|FG000|Overall Study|Participant returned device|0|||
28044259|NCT03851094|54702457|FG001|Overall Study|Participant returned device|2|||
28044260|NCT00505076|54702468|FG000|Overall Study|Adverse Event|1|||
28044261|NCT00505076|54702469|FG001|Overall Study|Adverse Event|0|||
28044262|NCT00505076|54702470|FG002|Overall Study|Adverse Event|1|||
28044263|NCT00505076|54702468|FG000|Overall Study|Protocol Violation|2|||
28044264|NCT00505076|54702469|FG001|Overall Study|Protocol Violation|1|||
28044265|NCT00505076|54702470|FG002|Overall Study|Protocol Violation|2|||
28044266|NCT00505076|54702468|FG000|Overall Study|Withdrawal by Subject|0|||
28044267|NCT00505076|54702469|FG001|Overall Study|Withdrawal by Subject|1|||
28044268|NCT00505076|54702470|FG002|Overall Study|Withdrawal by Subject|2|||
28044269|NCT00307684|54702478|FG000|Open Label Phase|Lack of Efficacy|0|||
28044270|NCT00307684|54702479|FG001|Open Label Phase|Lack of Efficacy|0|||
28044271|NCT00307684|54702480|FG002|Open Label Phase|Lack of Efficacy|3|||
28044272|NCT00307684|54702478|FG000|Open Label Phase|Adverse Event|0|||
28044273|NCT00307684|54702479|FG001|Open Label Phase|Adverse Event|0|||
28044274|NCT00307684|54702480|FG002|Open Label Phase|Adverse Event|16|||
28044275|NCT00307684|54702478|FG000|Open Label Phase|Withdrawal by Subject|0|||
28044276|NCT00307684|54702479|FG001|Open Label Phase|Withdrawal by Subject|0|||
27811272|NCT01831466|54267175|FG003|Overall Study|Adverse Event|6|||
27811273|NCT01831466|54267176|FG004|Overall Study|Adverse Event|3|||
28044277|NCT00307684|54702480|FG002|Open Label Phase|Withdrawal by Subject|15|||
28044278|NCT00307684|54702478|FG000|Open Label Phase|Lost to Follow-up|0|||
28044279|NCT00307684|54702479|FG001|Open Label Phase|Lost to Follow-up|0|||
28044280|NCT00307684|54702480|FG002|Open Label Phase|Lost to Follow-up|11|||
27847955|NCT00216671|54340677|FG000|Overall Study|Ineligible, no efficacy data|2|||
27847956|NCT00216671|54340678|FG001|Overall Study|Ineligible, no efficacy data|2|||
27847957|NCT00216671|54340677|FG000|Overall Study|Insufficient Response Adverse Event|2|||
27847958|NCT00216671|54340678|FG001|Overall Study|Insufficient Response Adverse Event|1|||
27847959|NCT00216203|54340684|FG000|Overall Study|Withdrawal by Subject|2|||
27847960|NCT02644668|54340719|FG000|Overall Study|Adverse Event|2|||
27847961|NCT02644668|54340720|FG001|Overall Study|Adverse Event|0|||
27811274|NCT01831466|54267177|FG005|Overall Study|Adverse Event|7|||
27811275|NCT01831466|54267178|FG006|Overall Study|Adverse Event|0|||
27811276|NCT01831466|54267179|FG007|Overall Study|Adverse Event|1|||
27811277|NCT01831466|54267180|FG008|Overall Study|Adverse Event|1|||
27811278|NCT01831466|54267181|FG009|Overall Study|Adverse Event|1|||
27811279|NCT01831466|54267182|FG010|Overall Study|Adverse Event|0|||
27811280|NCT01831466|54267183|FG011|Overall Study|Adverse Event|2|||
27811281|NCT01881620|54267203|FG000|Overall Study|Protocol Violation|4|||
27811282|NCT01830920|54267212|FG000|Overall Study|Adverse Event|1|||
27847962|NCT02644668|54340721|FG002|Overall Study|Adverse Event|1|||
27811283|NCT01830920|54267213|FG001|Overall Study|Adverse Event|0|||
27811284|NCT01830920|54267214|FG002|Overall Study|Adverse Event|1|||
27811285|NCT01830920|54267215|FG003|Overall Study|Adverse Event|0|||
27847963|NCT02644668|54340719|FG000|Overall Study|Protocol Violation|0|||
27847964|NCT02644668|54340720|FG001|Overall Study|Protocol Violation|0|||
28044281|NCT00307684|54702478|FG000|Open Label Phase|non compliance|0|||
28044282|NCT00307684|54702479|FG001|Open Label Phase|non compliance|0|||
28044283|NCT00307684|54702480|FG002|Open Label Phase|non compliance|5|||
27811286|NCT01830920|54267216|FG004|Overall Study|Adverse Event|0|||
28044284|NCT00307684|54702478|FG000|Open Label Phase|other|0|||
28044285|NCT00307684|54702479|FG001|Open Label Phase|other|0|||
28044286|NCT00307684|54702480|FG002|Open Label Phase|other|6|||
28044287|NCT00307684|54702478|FG000|Double Blind Phase|Lack of Efficacy|2|||
28044288|NCT00307684|54702479|FG001|Double Blind Phase|Lack of Efficacy|5|||
28044289|NCT00307684|54702480|FG002|Double Blind Phase|Lack of Efficacy|0|||
28044290|NCT00489918|54702493|FG000|Overall Study|Withdrawal by Subject|2|||
28044291|NCT00489918|54702494|FG001|Overall Study|Withdrawal by Subject|1|||
28044292|NCT00489918|54702495|FG002|Overall Study|Withdrawal by Subject|1|||
28044293|NCT00489918|54702496|FG003|Overall Study|Withdrawal by Subject|0|||
28044294|NCT00489918|54702497|FG004|Overall Study|Withdrawal by Subject|1|||
28044295|NCT00489918|54702493|FG000|Overall Study|Adverse Event|0|||
28044296|NCT00489918|54702494|FG001|Overall Study|Adverse Event|1|||
28044297|NCT00489918|54702495|FG002|Overall Study|Adverse Event|1|||
28044298|NCT00489918|54702496|FG003|Overall Study|Adverse Event|0|||
28044299|NCT00489918|54702497|FG004|Overall Study|Adverse Event|0|||
28044300|NCT00489918|54702493|FG000|Overall Study|Lost to Follow-up|0|||
28044301|NCT00489918|54702494|FG001|Overall Study|Lost to Follow-up|0|||
28044302|NCT00489918|54702495|FG002|Overall Study|Lost to Follow-up|1|||
28044303|NCT00489918|54702496|FG003|Overall Study|Lost to Follow-up|1|||
28044304|NCT00489918|54702497|FG004|Overall Study|Lost to Follow-up|0|||
28044305|NCT00489918|54702493|FG000|Overall Study|Physician Decision|0|||
28044306|NCT00489918|54702494|FG001|Overall Study|Physician Decision|0|||
28044307|NCT00489918|54702495|FG002|Overall Study|Physician Decision|1|||
28044308|NCT00489918|54702496|FG003|Overall Study|Physician Decision|0|||
28044309|NCT00489918|54702497|FG004|Overall Study|Physician Decision|0|||
28044310|NCT00307294|54702509|FG000|Overall Study|Withdrawal by Subject|1|||
28044311|NCT03963401|54702520|FG000|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
28044312|NCT03963401|54702521|FG001|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
28044313|NCT03963401|54702522|FG002|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
28044314|NCT03963401|54702523|FG003|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
28044315|NCT03963401|54702524|FG004|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
28044316|NCT03963401|54702525|FG005|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
28044317|NCT03963401|54702520|FG000|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
28044318|NCT03963401|54702521|FG001|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
28044319|NCT03963401|54702522|FG002|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
28044320|NCT03963401|54702523|FG003|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
28044321|NCT03963401|54702524|FG004|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
28044322|NCT03963401|54702525|FG005|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
28044323|NCT03963401|54702520|FG000|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
28044324|NCT03963401|54702521|FG001|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
28044325|NCT03963401|54702522|FG002|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
28044326|NCT03963401|54702523|FG003|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
28044327|NCT03963401|54702524|FG004|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
28044328|NCT03963401|54702525|FG005|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|0|||
28044329|NCT03963401|54702520|FG000|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
28044330|NCT03963401|54702521|FG001|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|1|||
28044331|NCT03963401|54702522|FG002|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
28044332|NCT03963401|54702523|FG003|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
28044333|NCT03963401|54702524|FG004|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
28044334|NCT03963401|54702525|FG005|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
28044335|NCT03963401|54702520|FG000|Extension Period (Week 17 - Week 52)|Adverse Event|6|||
28044336|NCT03963401|54702521|FG001|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
28044337|NCT03963401|54702522|FG002|Extension Period (Week 17 - Week 52)|Adverse Event|2|||
28044338|NCT03963401|54702523|FG003|Extension Period (Week 17 - Week 52)|Adverse Event|0|||
28044339|NCT03963401|54702524|FG004|Extension Period (Week 17 - Week 52)|Adverse Event|4|||
28044340|NCT03963401|54702525|FG005|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
28044341|NCT03963401|54702520|FG000|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
28044342|NCT03963401|54702521|FG001|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
28044343|NCT03963401|54702522|FG002|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
28044344|NCT03963401|54702523|FG003|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
28044345|NCT03963401|54702524|FG004|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
28044346|NCT03963401|54702525|FG005|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
28044347|NCT03963401|54702520|FG000|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
28044348|NCT03963401|54702521|FG001|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
28044349|NCT03963401|54702522|FG002|Extension Period (Week 17 - Week 52)|Lost to Follow-up|1|||
28044350|NCT03963401|54702523|FG003|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
28044351|NCT03963401|54702524|FG004|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
28044352|NCT03963401|54702525|FG005|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
28044353|NCT03963401|54702520|FG000|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|1|||
28044354|NCT03963401|54702521|FG001|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
28044355|NCT03963401|54702522|FG002|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
28044356|NCT03963401|54702523|FG003|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
28044357|NCT03963401|54702524|FG004|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
28044358|NCT03963401|54702525|FG005|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
28044359|NCT03963401|54702520|FG000|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|4|||
27811287|NCT01830920|54267212|FG000|Overall Study|Withdrawal by Subject|2|||
27811288|NCT01830920|54267213|FG001|Overall Study|Withdrawal by Subject|2|||
27811289|NCT01830920|54267214|FG002|Overall Study|Withdrawal by Subject|1|||
27811290|NCT01830920|54267215|FG003|Overall Study|Withdrawal by Subject|7|||
27811291|NCT01830920|54267216|FG004|Overall Study|Withdrawal by Subject|1|||
27811292|NCT01830920|54267212|FG000|Overall Study|Death|3|||
27811293|NCT01830920|54267213|FG001|Overall Study|Death|3|||
27811294|NCT01830920|54267214|FG002|Overall Study|Death|5|||
27811295|NCT01830920|54267215|FG003|Overall Study|Death|4|||
27811296|NCT01830920|54267216|FG004|Overall Study|Death|4|||
27811297|NCT01830920|54267212|FG000|Overall Study|Other|15|||
27811298|NCT01830920|54267213|FG001|Overall Study|Other|1|||
27811299|NCT01830920|54267214|FG002|Overall Study|Other|1|||
27811300|NCT01830920|54267215|FG003|Overall Study|Other|5|||
27811301|NCT01830920|54267216|FG004|Overall Study|Other|3|||
27811302|NCT01881230|54267231|FG000|Overall Study|Death|2|||
27811303|NCT01881230|54267232|FG001|Overall Study|Death|0|||
27811304|NCT01881230|54267233|FG002|Overall Study|Death|1|||
27811305|NCT01881230|54267231|FG000|Overall Study|Adverse Event|9|||
27811306|NCT01881230|54267232|FG001|Overall Study|Adverse Event|13|||
27811307|NCT01881230|54267233|FG002|Overall Study|Adverse Event|12|||
27811308|NCT01881230|54267231|FG000|Overall Study|Progressive Disease|31|||
27847965|NCT02644668|54340721|FG002|Overall Study|Protocol Violation|1|||
28044360|NCT03963401|54702521|FG001|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
28044361|NCT03963401|54702522|FG002|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
28044362|NCT03963401|54702523|FG003|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
28044363|NCT03963401|54702524|FG004|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
27847966|NCT02644668|54340719|FG000|Overall Study|Withdrawal by Subject|0|||
27847967|NCT02644668|54340720|FG001|Overall Study|Withdrawal by Subject|0|||
28044364|NCT03963401|54702525|FG005|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
28044365|NCT03963401|54702520|FG000|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|1|||
28044366|NCT03963401|54702521|FG001|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
28044367|NCT03963401|54702522|FG002|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
28044368|NCT03963401|54702523|FG003|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
28044369|NCT03963401|54702524|FG004|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
28044370|NCT03963401|54702525|FG005|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
28044371|NCT03963401|54702520|FG000|Extension Period (Week 17 - Week 52)|Other|1|||
28044372|NCT03963401|54702521|FG001|Extension Period (Week 17 - Week 52)|Other|1|||
28044373|NCT03963401|54702522|FG002|Extension Period (Week 17 - Week 52)|Other|0|||
28044374|NCT03963401|54702523|FG003|Extension Period (Week 17 - Week 52)|Other|1|||
28044375|NCT03963401|54702524|FG004|Extension Period (Week 17 - Week 52)|Other|1|||
28044376|NCT03963401|54702525|FG005|Extension Period (Week 17 - Week 52)|Other|1|||
28044377|NCT00334282|54702545|FG000|Overall Study|Lost to Follow-up|11|||
28044378|NCT00334282|54702546|FG001|Overall Study|Lost to Follow-up|5|||
28044379|NCT00334282|54702545|FG000|Overall Study|Withdrawal by Subject|17|||
28044380|NCT00334282|54702546|FG001|Overall Study|Withdrawal by Subject|3|||
28044381|NCT00334282|54702545|FG000|Overall Study|Death|194|||
28044382|NCT00334282|54702546|FG001|Overall Study|Death|100|||
28044383|NCT00306670|54702558|FG000|Overall Study|patients recruited; Genentech, the st|0|||
28044384|NCT00306670|54702559|FG001|Overall Study|patients recruited; Genentech, the st|2|||
28044385|NCT00306592|54702565|FG000|Overall Study|Adverse Event|8|||
28044386|NCT00306592|54702566|FG001|Overall Study|Adverse Event|15|||
28044387|NCT00306592|54702565|FG000|Overall Study|Lost to Follow-up|1|||
28044388|NCT00306592|54702566|FG001|Overall Study|Lost to Follow-up|0|||
28044389|NCT00306592|54702565|FG000|Overall Study|Noncompliance|0|||
27811309|NCT01881230|54267232|FG001|Overall Study|Progressive Disease|35|||
27811310|NCT01881230|54267233|FG002|Overall Study|Progressive Disease|36|||
27811311|NCT01881230|54267231|FG000|Overall Study|Symptomatic Deterioration|3|||
27811312|NCT01881230|54267232|FG001|Overall Study|Symptomatic Deterioration|3|||
27811313|NCT01881230|54267233|FG002|Overall Study|Symptomatic Deterioration|1|||
27811314|NCT01881230|54267231|FG000|Overall Study|Withdrawal by Subject|6|||
27811315|NCT01881230|54267232|FG001|Overall Study|Withdrawal by Subject|4|||
27847968|NCT02644668|54340721|FG002|Overall Study|Withdrawal by Subject|1|||
27811316|NCT01881230|54267233|FG002|Overall Study|Withdrawal by Subject|6|||
27847969|NCT02644356|54340740|FG000|Overall Study|Withdrawal by Subject|2|||
28044390|NCT00306592|54702566|FG001|Overall Study|Noncompliance|2|||
28044391|NCT00306592|54702565|FG000|Overall Study|Persistent Antibodies|6|||
28044392|NCT00306592|54702566|FG001|Overall Study|Persistent Antibodies|3|||
27811317|NCT01881230|54267231|FG000|Overall Study|Physician Decision|4|||
27811318|NCT01881230|54267232|FG001|Overall Study|Physician Decision|3|||
27811319|NCT01881230|54267233|FG002|Overall Study|Physician Decision|6|||
27811320|NCT01881230|54267231|FG000|Overall Study|Non-Compliance with Study Drug|1|||
27811321|NCT01881230|54267232|FG001|Overall Study|Non-Compliance with Study Drug|2|||
27811322|NCT01881230|54267233|FG002|Overall Study|Non-Compliance with Study Drug|0|||
27811323|NCT01881230|54267231|FG000|Overall Study|Given Commercially Available Drug|0|||
27811324|NCT01881230|54267232|FG001|Overall Study|Given Commercially Available Drug|0|||
27811325|NCT01881230|54267233|FG002|Overall Study|Given Commercially Available Drug|2|||
27811326|NCT01881230|54267231|FG000|Overall Study|Protocol Violation|1|||
27811327|NCT01881230|54267232|FG001|Overall Study|Protocol Violation|1|||
27811328|NCT01881230|54267233|FG002|Overall Study|Protocol Violation|0|||
27811329|NCT01881230|54267231|FG000|Overall Study|Miscellaneous|3|||
27811330|NCT01881230|54267232|FG001|Overall Study|Miscellaneous|3|||
27811331|NCT01881230|54267233|FG002|Overall Study|Miscellaneous|0|||
27811332|NCT01881230|54267231|FG000|Overall Study|Untreated: Other|0|||
27811333|NCT01881230|54267232|FG001|Overall Study|Untreated: Other|0|||
27811334|NCT01881230|54267233|FG002|Overall Study|Untreated: Other|1|||
27811335|NCT01881230|54267231|FG000|Overall Study|Untreated: Death|0|||
27811336|NCT01881230|54267232|FG001|Overall Study|Untreated: Death|0|||
27811337|NCT01881230|54267233|FG002|Overall Study|Untreated: Death|1|||
27811338|NCT01881230|54267231|FG000|Overall Study|Untreated: Withdrawal Before Study Start|1|||
27811339|NCT01881230|54267232|FG001|Overall Study|Untreated: Withdrawal Before Study Start|0|||
27811340|NCT01881230|54267233|FG002|Overall Study|Untreated: Withdrawal Before Study Start|0|||
27811341|NCT01856582|54267241|FG000|Overall Study|Died prior to Boost infusion|1|||
27811342|NCT01829360|54267249|FG000|Overall Study|Protocol Violation|0|||
27811343|NCT01829360|54267250|FG001|Overall Study|Protocol Violation|0|||
27811344|NCT01829360|54267251|FG002|Overall Study|Protocol Violation|1|||
28044393|NCT00306592|54702565|FG000|Overall Study|Voluntary|10|||
28044394|NCT00306592|54702566|FG001|Overall Study|Voluntary|6|||
28044395|NCT00306592|54702565|FG000|Overall Study|Other|5|||
28044396|NCT00306592|54702566|FG001|Overall Study|Other|10|||
28044397|NCT00306592|54702565|FG000|Overall Study|Other|1|||
27847970|NCT01494038|54340781|FG000|Overall Study|Protocol Violation|1|||
27847971|NCT01494038|54340782|FG001|Overall Study|Protocol Violation|1|||
27847972|NCT01494038|54340781|FG000|Overall Study|Lost to Follow-up|18|||
28044398|NCT00306592|54702566|FG001|Overall Study|Other|2|||
27811345|NCT01829360|54267252|FG003|Overall Study|Protocol Violation|0|||
28044399|NCT00306592|54702565|FG000|Overall Study|48-week Treatment Period Ongoing|0|||
28044400|NCT00306592|54702566|FG001|Overall Study|48-week Treatment Period Ongoing|20|||
28044401|NCT00321646|54702570|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
28044402|NCT00321646|54702570|FG000|Neoadjuvant Chemotherapy|Adverse Event|2|||
28044403|NCT00321646|54702570|FG000|Neoadjuvant Chemotherapy|Disease progression|1|||
28044404|NCT00403767|54702576|FG000|Overall Study|Adverse Event|993|||
28044405|NCT00403767|54702577|FG001|Overall Study|Adverse Event|919|||
28044406|NCT00403767|54702576|FG000|Overall Study|Non-compliant with study medication|134|||
28044407|NCT00403767|54702577|FG001|Overall Study|Non-compliant with study medication|164|||
28044408|NCT00403767|54702576|FG000|Overall Study|Consent withdrawn|671|||
28044409|NCT00403767|54702577|FG001|Overall Study|Consent withdrawn|673|||
28044410|NCT00403767|54702576|FG000|Overall Study|Investigator dec./not protocol-related|191|||
28044411|NCT00403767|54702577|FG001|Overall Study|Investigator dec./not protocol-related|178|||
28044412|NCT00403767|54702576|FG000|Overall Study|Lost to Follow-up|6|||
28044413|NCT00403767|54702577|FG001|Overall Study|Lost to Follow-up|8|||
28044414|NCT00403767|54702576|FG000|Overall Study|Protocol Violation|142|||
28044415|NCT00403767|54702577|FG001|Overall Study|Protocol Violation|124|||
28044416|NCT00403767|54702576|FG000|Overall Study|Clinical efficacy endpoint reached|300|||
28044417|NCT00403767|54702577|FG001|Overall Study|Clinical efficacy endpoint reached|332|||
28044418|NCT00403767|54702576|FG000|Overall Study|Study terminated by sponsor|82|||
28044419|NCT00403767|54702577|FG001|Overall Study|Study terminated by sponsor|69|||
28044420|NCT00403767|54702576|FG000|Overall Study|Missing/incomplete data|1|||
27811346|NCT01856114|54267268|FG000|Overall Study|Withdrawal by Subject|1|||
27811347|NCT01856114|54267269|FG001|Overall Study|Withdrawal by Subject|0|||
27811348|NCT01856114|54267268|FG000|Overall Study|Adverse Event|1|||
27811349|NCT01856114|54267269|FG001|Overall Study|Adverse Event|0|||
27811350|NCT01855958|54267277|FG000|Overall Study|Withdrawal by Subject|1|||
27847973|NCT01494038|54340782|FG001|Overall Study|Lost to Follow-up|20|||
28044421|NCT00403767|54702577|FG001|Overall Study|Missing/incomplete data|1|||
28044422|NCT00492284|54702587|FG000|Overall Study|Adverse Event|0|||
28044423|NCT00492284|54702588|FG001|Overall Study|Adverse Event|1|||
28044424|NCT00492284|54702589|FG002|Overall Study|Adverse Event|1|||
28044425|NCT00492284|54702590|FG003|Overall Study|Adverse Event|2|||
27811351|NCT01855958|54267278|FG001|Overall Study|Withdrawal by Subject|0|||
27811352|NCT01855412|54267289|FG000|Overall Study|Death|77|||
27939889|NCT01038609|54596216|FG001|Overall Study|Dosing Error|0|||
28044426|NCT00492284|54702587|FG000|Overall Study|Lost to Follow-up|0|||
28044427|NCT00492284|54702588|FG001|Overall Study|Lost to Follow-up|0|||
28044428|NCT00492284|54702589|FG002|Overall Study|Lost to Follow-up|3|||
28044429|NCT00492284|54702590|FG003|Overall Study|Lost to Follow-up|1|||
28044430|NCT00492284|54702587|FG000|Overall Study|Death|0|||
28044431|NCT00492284|54702588|FG001|Overall Study|Death|3|||
28044432|NCT00492284|54702589|FG002|Overall Study|Death|2|||
28044433|NCT00492284|54702590|FG003|Overall Study|Death|5|||
28044434|NCT00492284|54702587|FG000|Overall Study|Withdrawal by Subject|1|||
28044435|NCT00492284|54702588|FG001|Overall Study|Withdrawal by Subject|0|||
28044436|NCT00492284|54702589|FG002|Overall Study|Withdrawal by Subject|0|||
28044437|NCT00492284|54702590|FG003|Overall Study|Withdrawal by Subject|2|||
28044438|NCT00510458|54702600|FG000|Overall Study|5 year not evaluable/missed|21|||
28044439|NCT00510458|54702600|FG000|Overall Study|Death|1|||
28044440|NCT00510458|54702600|FG000|Overall Study|Terminated|14|||
28044441|NCT00510458|54702600|FG000|Overall Study|Lost to Follow-up|6|||
28044442|NCT00510458|54702600|FG000|Overall Study|Withdrawal by Subject|3|||
28044443|NCT00510458|54702600|FG000|Overall Study|Revision|2|||
28044444|NCT00414765|54702607|FG000|Overall Study|Adverse Event|5|||
28044445|NCT00414765|54702608|FG001|Overall Study|Adverse Event|9|||
28044446|NCT00414765|54702607|FG000|Overall Study|Withdrawal by Subject|1|||
28044447|NCT00414765|54702608|FG001|Overall Study|Withdrawal by Subject|1|||
28044448|NCT00414765|54702607|FG000|Overall Study|Disease Progression|0|||
28044449|NCT00414765|54702608|FG001|Overall Study|Disease Progression|1|||
28044450|NCT00500682|54702616|FG000|Overall Study|Adverse Event|37|||
28044451|NCT00500682|54702617|FG001|Overall Study|Adverse Event|29|||
28044452|NCT00500682|54702616|FG000|Overall Study|Death|25|||
28044453|NCT00500682|54702617|FG001|Overall Study|Death|16|||
28044454|NCT00500682|54702616|FG000|Overall Study|Lost to Follow-up|11|||
28044455|NCT00500682|54702617|FG001|Overall Study|Lost to Follow-up|11|||
28044456|NCT00500682|54702616|FG000|Overall Study|Physician Decision|6|||
28044457|NCT00500682|54702617|FG001|Overall Study|Physician Decision|10|||
28044458|NCT00500682|54702616|FG000|Overall Study|Pregnancy|2|||
28044459|NCT00500682|54702617|FG001|Overall Study|Pregnancy|0|||
28044460|NCT00500682|54702616|FG000|Overall Study|Protocol Violation|1|||
28044461|NCT00500682|54702617|FG001|Overall Study|Protocol Violation|3|||
28044462|NCT00500682|54702616|FG000|Overall Study|Withdrawal by Subject|80|||
28044463|NCT00500682|54702617|FG001|Overall Study|Withdrawal by Subject|74|||
28044464|NCT00500682|54702616|FG000|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
28044465|NCT00500682|54702617|FG001|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
28044466|NCT00500370|54702625|FG000|Overall Study|Adverse Event|9|||
28044467|NCT00500370|54702626|FG001|Overall Study|Adverse Event|3|||
28044468|NCT00500370|54702625|FG000|Overall Study|Lost to Follow-up|10|||
28044469|NCT00500370|54702626|FG001|Overall Study|Lost to Follow-up|10|||
28044470|NCT00500370|54702625|FG000|Overall Study|Protocol Violation|2|||
28044471|NCT00500370|54702626|FG001|Overall Study|Protocol Violation|4|||
28044472|NCT00500370|54702625|FG000|Overall Study|Sponsor Decision|2|||
28044473|NCT00500370|54702626|FG001|Overall Study|Sponsor Decision|0|||
28044474|NCT00500370|54702625|FG000|Overall Study|Subject Decision|10|||
28044475|NCT00500370|54702626|FG001|Overall Study|Subject Decision|17|||
28044476|NCT00320788|54702637|FG000|Overall Study|Adverse Event|0|||
28044477|NCT00320788|54702638|FG001|Overall Study|Adverse Event|0|||
28044478|NCT00320788|54702639|FG002|Overall Study|Adverse Event|0|||
28044479|NCT00320788|54702640|FG003|Overall Study|Adverse Event|1|||
28044480|NCT00320788|54702641|FG004|Overall Study|Adverse Event|0|||
28044481|NCT00320788|54702637|FG000|Overall Study|Death|0|||
28044482|NCT00320788|54702638|FG001|Overall Study|Death|0|||
28044483|NCT00320788|54702639|FG002|Overall Study|Death|1|||
28044484|NCT00320788|54702640|FG003|Overall Study|Death|0|||
28044485|NCT00320788|54702641|FG004|Overall Study|Death|1|||
28044486|NCT00320788|54702637|FG000|Overall Study|Lost to Follow-up|0|||
28044487|NCT00320788|54702638|FG001|Overall Study|Lost to Follow-up|2|||
28044488|NCT00320788|54702639|FG002|Overall Study|Lost to Follow-up|1|||
28044489|NCT00320788|54702640|FG003|Overall Study|Lost to Follow-up|0|||
28044490|NCT00320788|54702641|FG004|Overall Study|Lost to Follow-up|0|||
28044491|NCT00320788|54702637|FG000|Overall Study|Decision by the Sponsor|1|||
28044492|NCT00320788|54702638|FG001|Overall Study|Decision by the Sponsor|1|||
28044493|NCT00320788|54702639|FG002|Overall Study|Decision by the Sponsor|0|||
28044494|NCT00320788|54702640|FG003|Overall Study|Decision by the Sponsor|0|||
28044495|NCT00320788|54702641|FG004|Overall Study|Decision by the Sponsor|1|||
28044496|NCT00320788|54702637|FG000|Overall Study|Other|1|||
28044497|NCT00320788|54702638|FG001|Overall Study|Other|2|||
28044498|NCT00320788|54702639|FG002|Overall Study|Other|1|||
28044499|NCT00320788|54702640|FG003|Overall Study|Other|1|||
28044500|NCT00320788|54702641|FG004|Overall Study|Other|1|||
28044501|NCT00320788|54702637|FG000|Overall Study|Physician Decision|1|||
28044502|NCT00320788|54702638|FG001|Overall Study|Physician Decision|1|||
28044503|NCT00320788|54702639|FG002|Overall Study|Physician Decision|0|||
28044504|NCT00320788|54702640|FG003|Overall Study|Physician Decision|0|||
28044505|NCT00320788|54702641|FG004|Overall Study|Physician Decision|0|||
28044506|NCT00320788|54702637|FG000|Overall Study|Protocol Violation|0|||
28044507|NCT00320788|54702638|FG001|Overall Study|Protocol Violation|0|||
28044508|NCT00320788|54702639|FG002|Overall Study|Protocol Violation|0|||
28044509|NCT00320788|54702640|FG003|Overall Study|Protocol Violation|0|||
28044510|NCT00320788|54702641|FG004|Overall Study|Protocol Violation|1|||
28044511|NCT00320788|54702637|FG000|Overall Study|Withdrawal by Subject|3|||
28044512|NCT00320788|54702638|FG001|Overall Study|Withdrawal by Subject|0|||
28044513|NCT00320788|54702639|FG002|Overall Study|Withdrawal by Subject|0|||
28044514|NCT00320788|54702640|FG003|Overall Study|Withdrawal by Subject|3|||
28044515|NCT00320788|54702641|FG004|Overall Study|Withdrawal by Subject|1|||
28044516|NCT00503984|54702661|FG000|Overall Study|Protocol Violation|0|||
28044517|NCT00503984|54702662|FG001|Overall Study|Protocol Violation|1|||
28044518|NCT00503984|54702663|FG002|Overall Study|Protocol Violation|0|||
28044519|NCT00503984|54702664|FG003|Overall Study|Protocol Violation|0|||
28044520|NCT00503984|54702665|FG004|Overall Study|Protocol Violation|0|||
28044521|NCT00503984|54702666|FG005|Overall Study|Protocol Violation|0|||
28044522|NCT00503984|54702661|FG000|Overall Study|Adverse Event|0|||
28044523|NCT00503984|54702662|FG001|Overall Study|Adverse Event|1|||
28044524|NCT00503984|54702663|FG002|Overall Study|Adverse Event|0|||
28044525|NCT00503984|54702664|FG003|Overall Study|Adverse Event|0|||
28044526|NCT00503984|54702665|FG004|Overall Study|Adverse Event|0|||
28044527|NCT00503984|54702666|FG005|Overall Study|Adverse Event|0|||
28044528|NCT00503984|54702661|FG000|Overall Study|Death|0|||
28044529|NCT00503984|54702662|FG001|Overall Study|Death|0|||
28044530|NCT00503984|54702663|FG002|Overall Study|Death|0|||
28044531|NCT00503984|54702664|FG003|Overall Study|Death|0|||
28044532|NCT00503984|54702665|FG004|Overall Study|Death|1|||
28044533|NCT00503984|54702666|FG005|Overall Study|Death|0|||
28044534|NCT00565409|54702690|FG000|Period 1 Open Label|Adverse Event|17|||
28044535|NCT00565409|54702691|FG001|Period 1 Open Label|Adverse Event|0|||
28044536|NCT00565409|54702692|FG002|Period 1 Open Label|Adverse Event|0|||
28044537|NCT00565409|54702693|FG003|Period 1 Open Label|Adverse Event|0|||
28044538|NCT00565409|54702690|FG000|Period 1 Open Label|Death|2|||
28044539|NCT00565409|54702691|FG001|Period 1 Open Label|Death|0|||
28044540|NCT00565409|54702692|FG002|Period 1 Open Label|Death|0|||
28044541|NCT00565409|54702693|FG003|Period 1 Open Label|Death|0|||
28044542|NCT00565409|54702690|FG000|Period 1 Open Label|Lost to Follow-up|1|||
28044543|NCT00565409|54702691|FG001|Period 1 Open Label|Lost to Follow-up|0|||
28044544|NCT00565409|54702692|FG002|Period 1 Open Label|Lost to Follow-up|0|||
28044545|NCT00565409|54702693|FG003|Period 1 Open Label|Lost to Follow-up|0|||
28044546|NCT00565409|54702690|FG000|Period 1 Open Label|Other|21|||
28044547|NCT00565409|54702691|FG001|Period 1 Open Label|Other|0|||
28044548|NCT00565409|54702692|FG002|Period 1 Open Label|Other|0|||
28044549|NCT00565409|54702693|FG003|Period 1 Open Label|Other|0|||
28044550|NCT00565409|54702690|FG000|Period 1 Open Label|Protocol Violation|14|||
28044551|NCT00565409|54702691|FG001|Period 1 Open Label|Protocol Violation|0|||
28044552|NCT00565409|54702692|FG002|Period 1 Open Label|Protocol Violation|0|||
28044553|NCT00565409|54702693|FG003|Period 1 Open Label|Protocol Violation|0|||
28044554|NCT00565409|54702690|FG000|Period 1 Open Label|Unsatisfactory Response-Efficacy|22|||
28044555|NCT00565409|54702691|FG001|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
28044556|NCT00565409|54702692|FG002|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
28044557|NCT00565409|54702693|FG003|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
28044558|NCT00565409|54702690|FG000|Period 1 Open Label|no conclusion of participation record|1|||
28044559|NCT00565409|54702691|FG001|Period 1 Open Label|no conclusion of participation record|0|||
28044560|NCT00565409|54702692|FG002|Period 1 Open Label|no conclusion of participation record|0|||
28044561|NCT00565409|54702693|FG003|Period 1 Open Label|no conclusion of participation record|0|||
28044562|NCT00565409|54702690|FG000|After Period 1, Prior to Period 2|did not meet criteria|152|||
28044563|NCT00565409|54702691|FG001|After Period 1, Prior to Period 2|did not meet criteria|0|||
28044564|NCT00565409|54702692|FG002|After Period 1, Prior to Period 2|did not meet criteria|0|||
28044565|NCT00565409|54702693|FG003|After Period 1, Prior to Period 2|did not meet criteria|0|||
28044566|NCT00565409|54702690|FG000|Period 2 Double-Blind|Adverse Event|0|||
28044567|NCT00565409|54702691|FG001|Period 2 Double-Blind|Adverse Event|7|||
28044568|NCT00565409|54702692|FG002|Period 2 Double-Blind|Adverse Event|4|||
28044569|NCT00565409|54702693|FG003|Period 2 Double-Blind|Adverse Event|5|||
28044570|NCT00565409|54702690|FG000|Period 2 Double-Blind|Death|0|||
28044571|NCT00565409|54702691|FG001|Period 2 Double-Blind|Death|2|||
28044572|NCT00565409|54702692|FG002|Period 2 Double-Blind|Death|0|||
28044573|NCT00565409|54702693|FG003|Period 2 Double-Blind|Death|0|||
28044574|NCT00565409|54702690|FG000|Period 2 Double-Blind|Protocol Violation|0|||
28044575|NCT00565409|54702691|FG001|Period 2 Double-Blind|Protocol Violation|4|||
28044576|NCT00565409|54702692|FG002|Period 2 Double-Blind|Protocol Violation|6|||
28044577|NCT00565409|54702693|FG003|Period 2 Double-Blind|Protocol Violation|2|||
28044578|NCT00565409|54702690|FG000|Period 2 Double-Blind|Lost to Follow-up|0|||
28044579|NCT00565409|54702691|FG001|Period 2 Double-Blind|Lost to Follow-up|0|||
28044580|NCT00565409|54702692|FG002|Period 2 Double-Blind|Lost to Follow-up|1|||
28044581|NCT00565409|54702693|FG003|Period 2 Double-Blind|Lost to Follow-up|0|||
28044582|NCT00565409|54702690|FG000|Period 2 Double-Blind|Other|0|||
28044583|NCT00565409|54702691|FG001|Period 2 Double-Blind|Other|4|||
28044584|NCT00565409|54702692|FG002|Period 2 Double-Blind|Other|5|||
28044585|NCT00565409|54702693|FG003|Period 2 Double-Blind|Other|9|||
28044586|NCT00565409|54702690|FG000|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0|||
28044587|NCT00565409|54702691|FG001|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4|||
28044588|NCT00565409|54702692|FG002|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11|||
28044589|NCT00565409|54702693|FG003|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43|||
28044590|NCT00394251|54702705|FG000|Overall Study|Adverse Event|7|||
28044591|NCT00394251|54702706|FG001|Overall Study|Adverse Event|5|||
28044592|NCT00394251|54702705|FG000|Overall Study|Unacceptable Toxicity|20|||
28044593|NCT00394251|54702706|FG001|Overall Study|Unacceptable Toxicity|18|||
28044594|NCT00394251|54702705|FG000|Overall Study|Physician Decision|1|||
28044595|NCT00394251|54702706|FG001|Overall Study|Physician Decision|1|||
28044596|NCT00394251|54702705|FG000|Overall Study|Protocol Violation|0|||
28044597|NCT00394251|54702706|FG001|Overall Study|Protocol Violation|1|||
28044598|NCT00394251|54702705|FG000|Overall Study|Withdrawal by Subject|7|||
28044599|NCT00394251|54702706|FG001|Overall Study|Withdrawal by Subject|11|||
28044600|NCT00394251|54702705|FG000|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
28044601|NCT00394251|54702706|FG001|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
28044602|NCT00394095|54702718|FG000|Overall Study|Adverse Event|1|||
28044603|NCT00394095|54702719|FG001|Overall Study|Adverse Event|0|||
28044604|NCT00503906|54702726|FG000|Overall Study|Withdrawal by Subject|1|||
28044605|NCT00305110|54702731|FG000|Overall Study|Missing data|29|||
28044606|NCT00491894|54702735|FG000|Overall Study|Adverse Event|14|||
28044607|NCT00491894|54702735|FG000|Overall Study|Withdrawal by Subject|5|||
28044608|NCT00491894|54702735|FG000|Overall Study|Death|3|||
28044609|NCT00491894|54702735|FG000|Overall Study|Lost to Follow-up|3|||
28044610|NCT00491894|54702735|FG000|Overall Study|Lack of Efficacy|2|||
28044611|NCT00491894|54702735|FG000|Overall Study|Other-Failed to meet any criteria|2|||
28044612|NCT00491894|54702735|FG000|Overall Study|Physician Decision|2|||
28044613|NCT00491894|54702735|FG000|Overall Study|Protocol Violation|2|||
28044614|NCT00491894|54702735|FG000|Overall Study|Other-Intake of prohibited medication|1|||
28044615|NCT00491504|54702743|FG000|Overall Study|Adverse Event|0|||
28044616|NCT00491504|54702744|FG001|Overall Study|Adverse Event|1|||
28044617|NCT00491504|54702745|FG002|Overall Study|Adverse Event|0|||
28044618|NCT00491504|54702746|FG003|Overall Study|Adverse Event|0|||
28044619|NCT00491504|54702743|FG000|Overall Study|Withdrawal by Subject|0|||
28044620|NCT00491504|54702744|FG001|Overall Study|Withdrawal by Subject|0|||
28044621|NCT00491504|54702745|FG002|Overall Study|Withdrawal by Subject|1|||
28044622|NCT00491504|54702746|FG003|Overall Study|Withdrawal by Subject|2|||
28044623|NCT00491504|54702743|FG000|Overall Study|Protocol Violation|0|||
28044624|NCT00491504|54702744|FG001|Overall Study|Protocol Violation|0|||
28044625|NCT00491504|54702745|FG002|Overall Study|Protocol Violation|3|||
28044626|NCT00491504|54702746|FG003|Overall Study|Protocol Violation|2|||
28044627|NCT00500292|54702757|FG000|Overall Study|Adverse Event|3|||
28044628|NCT00500292|54702758|FG001|Overall Study|Adverse Event|6|||
28044629|NCT00500292|54702759|FG002|Overall Study|Adverse Event|4|||
28044630|NCT00500292|54702757|FG000|Overall Study|Condition under investigation worsened|21|||
28044631|NCT00500292|54702758|FG001|Overall Study|Condition under investigation worsened|23|||
28044632|NCT00500292|54702759|FG002|Overall Study|Condition under investigation worsened|19|||
28044633|NCT00500292|54702757|FG000|Overall Study|Withdrawal by Subject|0|||
28044634|NCT00500292|54702758|FG001|Overall Study|Withdrawal by Subject|1|||
28044635|NCT00500292|54702759|FG002|Overall Study|Withdrawal by Subject|0|||
28044636|NCT00500292|54702757|FG000|Overall Study|Other|1|||
28044637|NCT00500292|54702758|FG001|Overall Study|Other|1|||
28044638|NCT00500292|54702759|FG002|Overall Study|Other|4|||
28044639|NCT00499746|54702767|FG000|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7|||
28044640|NCT00499746|54702767|FG000|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3|||
28044641|NCT00499746|54702767|FG000|Phase 1(6-9 One Day Sessions)|Investigator decision|1|||
28044642|NCT00499746|54702767|FG000|Phase 1(6-9 One Day Sessions)|Unable to determine|1|||
28044643|NCT00489216|54702781|FG000|Overall Study|Adverse Event|1|||
28044644|NCT00499590|54702788|FG000|Overall Study|Study Terminated|112|||
28044645|NCT00499590|54702789|FG001|Overall Study|Study Terminated|112|||
28044646|NCT00499590|54702790|FG002|Overall Study|Study Terminated|112|||
28044647|NCT00499590|54702788|FG000|Overall Study|Not treated|1|||
28044648|NCT00499590|54702789|FG001|Overall Study|Not treated|0|||
28044649|NCT00499590|54702790|FG002|Overall Study|Not treated|1|||
28044650|NCT00510146|54702801|FG000|Double-Blind Treatment|Adverse Event|30|||
28044651|NCT00510146|54702802|FG001|Double-Blind Treatment|Adverse Event|13|||
28044652|NCT00510146|54702801|FG000|Double-Blind Treatment|Lack of Efficacy|6|||
28044653|NCT00510146|54702802|FG001|Double-Blind Treatment|Lack of Efficacy|13|||
28044654|NCT00510146|54702801|FG000|Double-Blind Treatment|Lost to Follow-up|3|||
28044655|NCT00510146|54702802|FG001|Double-Blind Treatment|Lost to Follow-up|7|||
28044656|NCT00510146|54702801|FG000|Double-Blind Treatment|Physician Decision|6|||
28044657|NCT00510146|54702802|FG001|Double-Blind Treatment|Physician Decision|0|||
28044658|NCT00510146|54702801|FG000|Double-Blind Treatment|Protocol Violation|1|||
28044659|NCT00510146|54702802|FG001|Double-Blind Treatment|Protocol Violation|2|||
28044660|NCT00510146|54702801|FG000|Double-Blind Treatment|Withdrawal by Subject|27|||
28044661|NCT00510146|54702802|FG001|Double-Blind Treatment|Withdrawal by Subject|13|||
28044662|NCT00510146|54702801|FG000|Double-Blind Treatment|Clinical Relapse|0|||
28044663|NCT00510146|54702802|FG001|Double-Blind Treatment|Clinical Relapse|1|||
28044664|NCT00510146|54702801|FG000|Double-Blind Treatment|Entry Criteria Not Met|3|||
28044665|NCT00510146|54702802|FG001|Double-Blind Treatment|Entry Criteria Not Met|0|||
28044666|NCT00510146|54702801|FG000|Open-Label Treatment|Adverse Event|22|||
28044667|NCT00510146|54702802|FG001|Open-Label Treatment|Adverse Event|8|||
28044668|NCT00510146|54702801|FG000|Open-Label Treatment|Death|1|||
28044669|NCT00510146|54702802|FG001|Open-Label Treatment|Death|1|||
28044670|NCT00510146|54702801|FG000|Open-Label Treatment|Lack of Efficacy|4|||
28044671|NCT00510146|54702802|FG001|Open-Label Treatment|Lack of Efficacy|0|||
28044672|NCT00510146|54702801|FG000|Open-Label Treatment|Lost to Follow-up|10|||
28044673|NCT00510146|54702802|FG001|Open-Label Treatment|Lost to Follow-up|1|||
28044674|NCT00510146|54702801|FG000|Open-Label Treatment|Physician Decision|3|||
28044675|NCT00510146|54702802|FG001|Open-Label Treatment|Physician Decision|1|||
28044676|NCT00510146|54702801|FG000|Open-Label Treatment|Protocol Violation|4|||
28044677|NCT00510146|54702802|FG001|Open-Label Treatment|Protocol Violation|2|||
28044678|NCT00510146|54702801|FG000|Open-Label Treatment|Withdrawal by Subject|24|||
28044679|NCT00510146|54702802|FG001|Open-Label Treatment|Withdrawal by Subject|12|||
28044680|NCT00510146|54702801|FG000|Open-Label Treatment|Clinical Relapse|1|||
28044681|NCT00510146|54702802|FG001|Open-Label Treatment|Clinical Relapse|1|||
28044682|NCT00510146|54702801|FG000|Open-Label Treatment|Sponsor Decision|2|||
28044683|NCT00510146|54702802|FG001|Open-Label Treatment|Sponsor Decision|0|||
28044684|NCT00480636|54702810|FG000|Overall Study|Death|12|||
28044685|NCT00480636|54702810|FG000|Overall Study|Lost to Follow-up|4|||
28044686|NCT00480636|54702810|FG000|Overall Study|Other|2|||
28044687|NCT00480636|54702810|FG000|Overall Study|Lost to follow-up; subsequently died|1|||
28044688|NCT00499122|54702814|FG000|Overall Study|Withdrawal by Subject|2|||
28044689|NCT00393939|54702821|FG000|Overall Study|Protocol Violation|1|||
28044690|NCT00393939|54702822|FG001|Overall Study|Protocol Violation|1|||
28044691|NCT00393939|54702821|FG000|Overall Study|Lost to Follow-up|2|||
28044692|NCT00393939|54702822|FG001|Overall Study|Lost to Follow-up|4|||
28044693|NCT00393939|54702821|FG000|Overall Study|Death|10|||
28044694|NCT00393939|54702822|FG001|Overall Study|Death|4|||
28044695|NCT00393939|54702821|FG000|Overall Study|Sponsor|5|||
28044696|NCT00393939|54702822|FG001|Overall Study|Sponsor|13|||
28044697|NCT00393939|54702821|FG000|Overall Study|Objective progression or relapse|239|||
28044698|NCT00393939|54702822|FG001|Overall Study|Objective progression or relapse|223|||
28044699|NCT00393939|54702821|FG000|Overall Study|Withdrawal by Subject|2|||
28044700|NCT00393939|54702822|FG001|Overall Study|Withdrawal by Subject|7|||
28044701|NCT00393939|54702821|FG000|Overall Study|Other|37|||
28044702|NCT00393939|54702822|FG001|Overall Study|Other|45|||
28044703|NCT00488982|54702828|FG000|Course 1|Physician Decision|0|||
28044704|NCT00488982|54702829|FG001|Course 1|Physician Decision|2|||
28044705|NCT00488982|54702830|FG002|Course 1|Physician Decision|4|||
28044706|NCT00488982|54702828|FG000|Course 1|Withdrawal by Subject|0|||
28044707|NCT00488982|54702829|FG001|Course 1|Withdrawal by Subject|8|||
28044708|NCT00488982|54702830|FG002|Course 1|Withdrawal by Subject|2|||
28044709|NCT00488982|54702828|FG000|Course 1|nonprotocol therapy|0|||
28044710|NCT00488982|54702829|FG001|Course 1|nonprotocol therapy|2|||
28044711|NCT00488982|54702830|FG002|Course 1|nonprotocol therapy|2|||
28044712|NCT00488982|54702828|FG000|Course 1|Adverse Event|0|||
28044713|NCT00488982|54702829|FG001|Course 1|Adverse Event|0|||
28044714|NCT00488982|54702830|FG002|Course 1|Adverse Event|6|||
28044715|NCT00488826|54702847|FG000|Overall Study|Withdrawal by Subject|40|||
28044716|NCT00488826|54702848|FG001|Overall Study|Withdrawal by Subject|35|||
28044717|NCT00488826|54702849|FG002|Overall Study|Withdrawal by Subject|19|||
28044718|NCT00488826|54702847|FG000|Overall Study|Protocol Violation|0|||
28044719|NCT00488826|54702848|FG001|Overall Study|Protocol Violation|0|||
28044720|NCT00488826|54702849|FG002|Overall Study|Protocol Violation|2|||
28044721|NCT00488826|54702847|FG000|Overall Study|Adverse Event|9|||
28044722|NCT00488826|54702848|FG001|Overall Study|Adverse Event|15|||
28044723|NCT00488826|54702849|FG002|Overall Study|Adverse Event|4|||
28044724|NCT00488826|54702847|FG000|Overall Study|Lost to Follow-up|5|||
28044725|NCT00488826|54702848|FG001|Overall Study|Lost to Follow-up|1|||
28044726|NCT00488826|54702849|FG002|Overall Study|Lost to Follow-up|0|||
28044727|NCT00488826|54702847|FG000|Overall Study|Protocol Deviations|2|||
28044728|NCT00488826|54702848|FG001|Overall Study|Protocol Deviations|1|||
28044729|NCT00488826|54702849|FG002|Overall Study|Protocol Deviations|1|||
28044730|NCT00393861|54702857|FG000|Overall Study|Adverse Event|2|||
28044731|NCT00393861|54702857|FG000|Overall Study|Disease Progression|24|||
28044732|NCT00480324|54702863|FG000|Overall Study|Adverse Event|1|||
28044733|NCT00480324|54702864|FG001|Overall Study|Adverse Event|1|||
28044734|NCT00480324|54702863|FG000|Overall Study|Protocol Violation|0|||
28044735|NCT00480324|54702864|FG001|Overall Study|Protocol Violation|1|||
28044736|NCT00480324|54702863|FG000|Overall Study|Withdrawal by Subject|14|||
28044737|NCT00480324|54702864|FG001|Overall Study|Withdrawal by Subject|5|||
28044738|NCT00480324|54702863|FG000|Overall Study|Lost to Follow-up|17|||
28044739|NCT00480324|54702864|FG001|Overall Study|Lost to Follow-up|8|||
28044740|NCT00480324|54702863|FG000|Overall Study|Subject's mother pregnant|0|||
28044741|NCT00480324|54702864|FG001|Overall Study|Subject's mother pregnant|1|||
28044742|NCT00488592|54702870|FG000|Overall Study|Withdrawal by Subject|1|||
28044743|NCT00488592|54702870|FG000|Overall Study|Disease progression|1|||
28044744|NCT00488592|54702870|FG000|Overall Study|Enrolled but not treated|1|||
28044745|NCT00488514|54702874|FG000|Overall Study|Adverse Event|41|||
28044746|NCT00488514|54702874|FG000|Overall Study|Lost to Follow-up|44|||
28044747|NCT00488514|54702874|FG000|Overall Study|Protocol Violation|32|||
28044748|NCT00488514|54702874|FG000|Overall Study|Withdrawal by Subject|106|||
28044749|NCT00488514|54702874|FG000|Overall Study|Lack of Efficacy|28|||
28044750|NCT00488514|54702874|FG000|Overall Study|Did not meet criteria for treatment|30|||
28044751|NCT00488514|54702874|FG000|Overall Study|Postive drug screen|1|||
28044752|NCT00488514|54702874|FG000|Overall Study|Withdrawn per medical monitor decision|2|||
28044753|NCT00488514|54702874|FG000|Overall Study|Investigator decision|1|||
28044754|NCT00488514|54702874|FG000|Overall Study|Participant had too few migraines|5|||
28044755|NCT00488514|54702874|FG000|Overall Study|Increase in number of migraines|2|||
28044756|NCT00488514|54702874|FG000|Overall Study|Increased use of concomitant medication|1|||
28044757|NCT00320710|54702898|FG000|Overall Study|Disease progression|24|||
28044758|NCT00320710|54702899|FG001|Overall Study|Disease progression|19|||
28044759|NCT00320710|54702900|FG002|Overall Study|Disease progression|2|||
28044760|NCT00320710|54702898|FG000|Overall Study|Death|10|||
28044761|NCT00320710|54702899|FG001|Overall Study|Death|7|||
28044762|NCT00320710|54702900|FG002|Overall Study|Death|1|||
28044763|NCT00320710|54702898|FG000|Overall Study|Administrative problems|1|||
28044764|NCT00320710|54702899|FG001|Overall Study|Administrative problems|2|||
28044765|NCT00320710|54702900|FG002|Overall Study|Administrative problems|0|||
28044766|NCT00320710|54702898|FG000|Overall Study|Withdrawal by Subject|20|||
28044767|NCT00320710|54702899|FG001|Overall Study|Withdrawal by Subject|26|||
28044768|NCT00320710|54702900|FG002|Overall Study|Withdrawal by Subject|1|||
28044769|NCT00320710|54702898|FG000|Overall Study|Protocol Violation|6|||
28044770|NCT00320710|54702899|FG001|Overall Study|Protocol Violation|5|||
28044771|NCT00320710|54702900|FG002|Overall Study|Protocol Violation|0|||
28044772|NCT00320710|54702898|FG000|Overall Study|Abnormal test procedure result(s)|2|||
28044773|NCT00320710|54702899|FG001|Overall Study|Abnormal test procedure result(s)|0|||
28044774|NCT00320710|54702900|FG002|Overall Study|Abnormal test procedure result(s)|0|||
28044775|NCT00320710|54702898|FG000|Overall Study|Abnormal laboratory value(s)|12|||
28044776|NCT00320710|54702899|FG001|Overall Study|Abnormal laboratory value(s)|3|||
28044777|NCT00320710|54702900|FG002|Overall Study|Abnormal laboratory value(s)|0|||
28044778|NCT00320710|54702898|FG000|Overall Study|Adverse Event|18|||
28044779|NCT00320710|54702899|FG001|Overall Study|Adverse Event|14|||
28044780|NCT00320710|54702900|FG002|Overall Study|Adverse Event|1|||
28044781|NCT00320710|54702898|FG000|Overall Study|Lost to Follow-up|1|||
28044782|NCT00320710|54702899|FG001|Overall Study|Lost to Follow-up|0|||
28044783|NCT00320710|54702900|FG002|Overall Study|Lost to Follow-up|0|||
28044784|NCT00320398|54702909|FG000|Overall Study|Adverse Event|1|||
28044785|NCT00320398|54702910|FG001|Overall Study|Adverse Event|4|||
28044786|NCT00320398|54702909|FG000|Overall Study|Other|1|||
28044787|NCT00320398|54702910|FG001|Overall Study|Other|0|||
28044788|NCT00498186|54702917|FG000|Overall Study|Protocol Violation|10|||
28044789|NCT00498186|54702917|FG000|Overall Study|Lack of Efficacy|31|||
28044790|NCT00498186|54702917|FG000|Overall Study|Adverse Event|89|||
28044791|NCT00498186|54702917|FG000|Overall Study|Unsatisfactory compliance of subject|12|||
28044792|NCT00498186|54702917|FG000|Overall Study|Withdrawal by Subject|18|||
28044793|NCT00498186|54702917|FG000|Overall Study|Lost to Follow-up|3|||
28044794|NCT00498186|54702917|FG000|Overall Study|Other|10|||
28044795|NCT00333970|54702923|FG000|Overall Study|Withdrawal by Subject|13|||
28044796|NCT00333970|54702924|FG001|Overall Study|Withdrawal by Subject|7|||
28044797|NCT00477594|54702932|FG000|Year 1 and Year 2|Adverse Event|4|||
28044798|NCT00477594|54702933|FG001|Year 1 and Year 2|Adverse Event|2|||
28044799|NCT00477594|54702932|FG000|Year 1 and Year 2|Physician Decision|2|||
28044800|NCT00477594|54702933|FG001|Year 1 and Year 2|Physician Decision|1|||
28044801|NCT00477594|54702932|FG000|Year 1 and Year 2|Withdrawal by Subject|2|||
28044802|NCT00477594|54702933|FG001|Year 1 and Year 2|Withdrawal by Subject|1|||
28044803|NCT00477594|54702932|FG000|Year 1 and Year 2|Other|1|||
28044804|NCT00477594|54702933|FG001|Year 1 and Year 2|Other|0|||
28044805|NCT00477594|54702932|FG000|Year 3|Adverse Event|1|||
28044806|NCT00477594|54702933|FG001|Year 3|Adverse Event|0|||
28044807|NCT00477594|54702932|FG000|Year 3|Withdrawal by Subject|1|||
28044808|NCT00477594|54702933|FG001|Year 3|Withdrawal by Subject|0|||
28044809|NCT00477594|54702932|FG000|Follow-up Period|Withdrawal by Subject|2|||
28044810|NCT00477594|54702933|FG001|Follow-up Period|Withdrawal by Subject|1|||
28044811|NCT00477594|54702932|FG000|Follow-up Period|Other|1|||
28044812|NCT00477594|54702933|FG001|Follow-up Period|Other|0|||
28044813|NCT00475722|54702941|FG000|Overall Study|Withdrawal by Subject|12|||
28044814|NCT00475722|54702942|FG001|Overall Study|Withdrawal by Subject|12|||
28044815|NCT00475722|54702941|FG000|Overall Study|Protocol Violation|3|||
28044816|NCT00475722|54702942|FG001|Overall Study|Protocol Violation|0|||
28044817|NCT00304954|54702952|FG000|Overall Study|Withdrawal by Subject|0|||
28044818|NCT00304954|54702953|FG001|Overall Study|Withdrawal by Subject|0|||
28044819|NCT00304954|54702954|FG002|Overall Study|Withdrawal by Subject|1|||
28044820|NCT00304954|54702955|FG003|Overall Study|Withdrawal by Subject|0|||
28044821|NCT00304954|54702952|FG000|Overall Study|Adverse Event|1|||
28044822|NCT00304954|54702953|FG001|Overall Study|Adverse Event|0|||
28044823|NCT00304954|54702954|FG002|Overall Study|Adverse Event|0|||
28044824|NCT00304954|54702955|FG003|Overall Study|Adverse Event|0|||
28044825|NCT00475176|54702973|FG000|Overall Study|Adverse Event|2|||
28044826|NCT00475176|54702973|FG000|Overall Study|Withdrawal by Subject|1|||
28044827|NCT00475176|54702973|FG000|Overall Study|Protocol Violation|1|||
28044828|NCT00414609|54702979|FG000|Core Study|Adverse Event|9|||
28044829|NCT00414609|54702980|FG001|Core Study|Adverse Event|11|||
28044830|NCT00414609|54702981|FG002|Core Study|Adverse Event|0|||
28044831|NCT00414609|54702979|FG000|Core Study|Abnormal laboratory values|0|||
28044832|NCT00414609|54702980|FG001|Core Study|Abnormal laboratory values|1|||
28044833|NCT00414609|54702981|FG002|Core Study|Abnormal laboratory values|0|||
28044834|NCT00414609|54702979|FG000|Core Study|Abnormal test procedure results|1|||
28044835|NCT00414609|54702980|FG001|Core Study|Abnormal test procedure results|1|||
28044836|NCT00414609|54702981|FG002|Core Study|Abnormal test procedure results|0|||
28044837|NCT00414609|54702979|FG000|Core Study|Protocol deviation|0|||
28044838|NCT00414609|54702980|FG001|Core Study|Protocol deviation|1|||
28044839|NCT00414609|54702981|FG002|Core Study|Protocol deviation|0|||
28044840|NCT00414609|54702979|FG000|Core Study|Patient withdrew consent|10|||
28044841|NCT00414609|54702980|FG001|Core Study|Patient withdrew consent|11|||
28044842|NCT00414609|54702981|FG002|Core Study|Patient withdrew consent|0|||
28044843|NCT00414609|54702979|FG000|Core Study|Lost to Follow-up|7|||
28044844|NCT00414609|54702980|FG001|Core Study|Lost to Follow-up|4|||
28044845|NCT00414609|54702981|FG002|Core Study|Lost to Follow-up|0|||
28044846|NCT00414609|54702979|FG000|Core Study|Administrative problems|0|||
28044847|NCT00414609|54702980|FG001|Core Study|Administrative problems|2|||
28044848|NCT00414609|54702981|FG002|Core Study|Administrative problems|0|||
28044849|NCT00414609|54702979|FG000|Core Study|Death|7|||
28044850|NCT00414609|54702980|FG001|Core Study|Death|14|||
28044851|NCT00414609|54702981|FG002|Core Study|Death|0|||
28044852|NCT00414609|54702979|FG000|Extension Study|Adverse Event|0|||
28044853|NCT00414609|54702980|FG001|Extension Study|Adverse Event|0|||
28044854|NCT00414609|54702981|FG002|Extension Study|Adverse Event|14|||
28044855|NCT00414609|54702979|FG000|Extension Study|Unsatisfactory therapeutic effect|0|||
28044856|NCT00414609|54702980|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
28044857|NCT00414609|54702981|FG002|Extension Study|Unsatisfactory therapeutic effect|2|||
28044858|NCT00414609|54702979|FG000|Extension Study|Withdrawal by Subject|0|||
28044859|NCT00414609|54702980|FG001|Extension Study|Withdrawal by Subject|0|||
28044860|NCT00414609|54702981|FG002|Extension Study|Withdrawal by Subject|13|||
28044861|NCT00414609|54702979|FG000|Extension Study|Lost to Follow-up|0|||
28044862|NCT00414609|54702980|FG001|Extension Study|Lost to Follow-up|0|||
28044863|NCT00414609|54702981|FG002|Extension Study|Lost to Follow-up|10|||
28044864|NCT00414609|54702979|FG000|Extension Study|Administrative problems|0|||
28044865|NCT00414609|54702980|FG001|Extension Study|Administrative problems|0|||
28044866|NCT00414609|54702981|FG002|Extension Study|Administrative problems|1|||
28044867|NCT00414609|54702979|FG000|Extension Study|Death|0|||
28044868|NCT00414609|54702980|FG001|Extension Study|Death|0|||
28044869|NCT00414609|54702981|FG002|Extension Study|Death|17|||
28044870|NCT00393705|54702992|FG000|Overall Study|Adverse Event|0|||
28044871|NCT00393705|54702993|FG001|Overall Study|Adverse Event|2|||
28044872|NCT00393705|54702992|FG000|Overall Study|Death|0|||
28044873|NCT00393705|54702993|FG001|Overall Study|Death|1|||
28044874|NCT00393705|54702992|FG000|Overall Study|Lost to Follow-up|2|||
28044875|NCT00393705|54702993|FG001|Overall Study|Lost to Follow-up|2|||
28044876|NCT00393705|54702992|FG000|Overall Study|Entry Criteria Not Met|10|||
28044877|NCT00393705|54702993|FG001|Overall Study|Entry Criteria Not Met|10|||
28044878|NCT00393705|54702992|FG000|Overall Study|Protocol Violation|4|||
28044879|NCT00393705|54702993|FG001|Overall Study|Protocol Violation|3|||
28044880|NCT00393705|54702992|FG000|Overall Study|Withdrawal by Subject|5|||
28044881|NCT00393705|54702993|FG001|Overall Study|Withdrawal by Subject|3|||
28044882|NCT00393705|54702992|FG000|Overall Study|Physician Decision|2|||
28044883|NCT00393705|54702993|FG001|Overall Study|Physician Decision|2|||
28044884|NCT00303628|54703001|FG000|Overall Study|Disease progression|0|||
28044885|NCT00303628|54703002|FG001|Overall Study|Disease progression|1|||
28044886|NCT00303628|54703001|FG000|Overall Study|Adverse Event|26|||
28044887|NCT00303628|54703002|FG001|Overall Study|Adverse Event|36|||
28044888|NCT00303628|54703001|FG000|Overall Study|Death|0|||
28044889|NCT00303628|54703002|FG001|Overall Study|Death|1|||
28044890|NCT00303628|54703001|FG000|Overall Study|Withdrawal by Subject|11|||
28044891|NCT00303628|54703002|FG001|Overall Study|Withdrawal by Subject|20|||
28044892|NCT00303628|54703001|FG000|Overall Study|Alternative therapy|2|||
28044893|NCT00303628|54703002|FG001|Overall Study|Alternative therapy|0|||
28044894|NCT00303628|54703001|FG000|Overall Study|Other complicating disease|0|||
28044895|NCT00303628|54703002|FG001|Overall Study|Other complicating disease|1|||
28044896|NCT00303628|54703001|FG000|Overall Study|Not start protocol therapy|3|||
28044897|NCT00303628|54703002|FG001|Overall Study|Not start protocol therapy|5|||
28044898|NCT00303628|54703001|FG000|Overall Study|Other|8|||
28044899|NCT00303628|54703002|FG001|Overall Study|Other|9|||
28044900|NCT00414453|54703008|FG000|Overall Study|Abnormal lab work|16|||
28044901|NCT00332488|54703021|FG000|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8|||
28044902|NCT00332488|54703022|FG001|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2|||
28044903|NCT00332488|54703023|FG002|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6|||
28044904|NCT00332488|54703021|FG000|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13|||
28044905|NCT00332488|54703022|FG001|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2|||
28044906|NCT00332488|54703023|FG002|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10|||
28044907|NCT00332488|54703021|FG000|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21|||
28044908|NCT00332488|54703022|FG001|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10|||
28044909|NCT00332488|54703023|FG002|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20|||
28044910|NCT00332488|54703021|FG000|Initial Treatment Phase (Weeks 0 - 12)|Various|4|||
28044911|NCT00332488|54703022|FG001|Initial Treatment Phase (Weeks 0 - 12)|Various|0|||
28044912|NCT00332488|54703023|FG002|Initial Treatment Phase (Weeks 0 - 12)|Various|20|||
28044913|NCT00332488|54703021|FG000|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1|||
28044914|NCT00332488|54703022|FG001|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3|||
28044915|NCT00332488|54703023|FG002|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0|||
28044916|NCT00332488|54703021|FG000|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3|||
28044917|NCT00332488|54703022|FG001|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1|||
28044918|NCT00332488|54703023|FG002|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0|||
28044919|NCT00332488|54703021|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
28044920|NCT00332488|54703022|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
28044921|NCT00332488|54703023|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3|||
28044922|NCT00332488|54703021|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
28044923|NCT00332488|54703022|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
28044924|NCT00332488|54703023|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1|||
28044925|NCT00332488|54703021|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
28044926|NCT00332488|54703022|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
28044927|NCT00332488|54703023|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3|||
28044928|NCT00332488|54703021|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
28044929|NCT00332488|54703022|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
28044930|NCT00332488|54703023|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1|||
28044931|NCT00332488|54703021|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
28044932|NCT00332488|54703022|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
28044933|NCT00332488|54703023|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8|||
28044934|NCT00332488|54703021|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
28044935|NCT00332488|54703022|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
28044936|NCT00332488|54703023|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Various|5|||
28044937|NCT00332332|54703033|FG000|Overall Study|Adverse Event|13|||
28044938|NCT00332332|54703033|FG000|Overall Study|Death|1|||
28044939|NCT00332332|54703033|FG000|Overall Study|Withdrawal by Subject|8|||
28044940|NCT00332332|54703033|FG000|Overall Study|Physician Decision|1|||
28044941|NCT00332332|54703033|FG000|Overall Study|Lost to Follow-up|3|||
28044942|NCT00332332|54703033|FG000|Overall Study|Protocol deviation|4|||
28044943|NCT00332332|54703033|FG000|Overall Study|Noncompliance|2|||
28044944|NCT00332332|54703033|FG000|Overall Study|Disease progression|2|||
28044945|NCT00332332|54703033|FG000|Overall Study|Other|18|||
28044946|NCT00332332|54703033|FG000|Overall Study|Did not receive study treatment|16|||
28044947|NCT00392925|54703041|FG000|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11|||
28044948|NCT00392925|54703042|FG001|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
28044949|NCT00392925|54703043|FG002|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
28044950|NCT00392925|54703044|FG003|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
28044951|NCT00392925|54703041|FG000|4 Week Lead-In Period - Non-Randomized|Adverse Event|5|||
28044952|NCT00392925|54703042|FG001|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
28044953|NCT00392925|54703043|FG002|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
28044954|NCT00392925|54703044|FG003|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
28044955|NCT00392925|54703041|FG000|4 Week Lead-In Period - Non-Randomized|Physician Decision|1|||
28044956|NCT00392925|54703042|FG001|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
28044957|NCT00392925|54703043|FG002|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
28044958|NCT00392925|54703044|FG003|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
28044959|NCT00392925|54703041|FG000|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5|||
28044960|NCT00392925|54703042|FG001|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
28044961|NCT00392925|54703043|FG002|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
28044962|NCT00392925|54703044|FG003|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
28044963|NCT00392925|54703041|FG000|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16|||
28044964|NCT00392925|54703042|FG001|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
28044965|NCT00392925|54703043|FG002|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
28044966|NCT00392925|54703044|FG003|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
28044967|NCT00392925|54703041|FG000|Randomization to Treatment Group Period|Withdrawal by Subject|0|||
28044968|NCT00392925|54703042|FG001|Randomization to Treatment Group Period|Withdrawal by Subject|2|||
28044969|NCT00392925|54703043|FG002|Randomization to Treatment Group Period|Withdrawal by Subject|6|||
28044970|NCT00392925|54703044|FG003|Randomization to Treatment Group Period|Withdrawal by Subject|8|||
28044971|NCT00392925|54703041|FG000|Randomization to Treatment Group Period|Adverse Event|0|||
28044972|NCT00392925|54703042|FG001|Randomization to Treatment Group Period|Adverse Event|3|||
28044973|NCT00392925|54703043|FG002|Randomization to Treatment Group Period|Adverse Event|3|||
28044974|NCT00392925|54703044|FG003|Randomization to Treatment Group Period|Adverse Event|5|||
28044975|NCT00392925|54703041|FG000|Randomization to Treatment Group Period|Protocol Violation|0|||
28044976|NCT00392925|54703042|FG001|Randomization to Treatment Group Period|Protocol Violation|0|||
28044977|NCT00392925|54703043|FG002|Randomization to Treatment Group Period|Protocol Violation|2|||
28044978|NCT00392925|54703044|FG003|Randomization to Treatment Group Period|Protocol Violation|1|||
28044979|NCT00392925|54703041|FG000|Randomization to Treatment Group Period|Lost to Follow-up|0|||
28044980|NCT00392925|54703042|FG001|Randomization to Treatment Group Period|Lost to Follow-up|3|||
28044981|NCT00392925|54703043|FG002|Randomization to Treatment Group Period|Lost to Follow-up|8|||
28044982|NCT00392925|54703044|FG003|Randomization to Treatment Group Period|Lost to Follow-up|4|||
28044983|NCT00474786|54703062|FG000|Overall Study|Not Meeting Study Criteria|0|||
28044984|NCT00474786|54703063|FG001|Overall Study|Not Meeting Study Criteria|1|||
28044985|NCT00474786|54703062|FG000|Overall Study|Investigator Request|2|||
28044986|NCT00474786|54703063|FG001|Overall Study|Investigator Request|1|||
28044987|NCT00474786|54703062|FG000|Overall Study|Death|189|||
28044988|NCT00474786|54703063|FG001|Overall Study|Death|170|||
28044989|NCT00474786|54703062|FG000|Overall Study|Discontinuation of Study by Sponsor|42|||
28044990|NCT00474786|54703063|FG001|Overall Study|Discontinuation of Study by Sponsor|59|||
27811353|NCT01855412|54267290|FG001|Overall Study|Death|123|||
27811354|NCT01855412|54267291|FG002|Overall Study|Death|30|||
27811355|NCT01855412|54267289|FG000|Overall Study|Lost to Follow-up|28|||
27811356|NCT01855412|54267290|FG001|Overall Study|Lost to Follow-up|46|||
27811357|NCT01855412|54267291|FG002|Overall Study|Lost to Follow-up|15|||
28044991|NCT00474786|54703062|FG000|Overall Study|Lost to Follow-up|4|||
28044992|NCT00474786|54703063|FG001|Overall Study|Lost to Follow-up|7|||
28044993|NCT00474786|54703062|FG000|Overall Study|Protocol Violation|2|||
28044994|NCT00474786|54703063|FG001|Overall Study|Protocol Violation|0|||
28044995|NCT00474786|54703062|FG000|Overall Study|Withdrawal by Subject|15|||
28044996|NCT00474786|54703063|FG001|Overall Study|Withdrawal by Subject|15|||
28044997|NCT00474786|54703062|FG000|Overall Study|Other|5|||
28044998|NCT00474786|54703063|FG001|Overall Study|Other|0|||
28044999|NCT00392769|54703069|FG000|Overall Study|Clinical Deterioration|9|||
28045000|NCT00392769|54703069|FG000|Overall Study|Adverse Event|1|||
28045001|NCT00319696|54703073|FG000|Overall Study|Adverse Event|36|||
28045002|NCT00319696|54703073|FG000|Overall Study|withdrawal of consent|14|||
28045003|NCT00319696|54703073|FG000|Overall Study|administrative|7|||
28045004|NCT00319696|54703073|FG000|Overall Study|Lost to Follow-up|3|||
28045005|NCT00474630|54703085|FG000|Overall Study|Adverse Event|98|||
28045006|NCT00474630|54703086|FG001|Overall Study|Adverse Event|26|||
28045007|NCT00474630|54703085|FG000|Overall Study|Lost to Follow-up|22|||
28045008|NCT00474630|54703086|FG001|Overall Study|Lost to Follow-up|15|||
28045009|NCT00474630|54703085|FG000|Overall Study|Withdrawal by Subject|21|||
28045010|NCT00474630|54703086|FG001|Overall Study|Withdrawal by Subject|15|||
28045011|NCT00474630|54703085|FG000|Overall Study|Protocol Violation|3|||
28045012|NCT00474630|54703086|FG001|Overall Study|Protocol Violation|4|||
28045013|NCT00474630|54703085|FG000|Overall Study|Lack of Efficacy|5|||
28045014|NCT00474630|54703086|FG001|Overall Study|Lack of Efficacy|6|||
28045015|NCT00474630|54703085|FG000|Overall Study|Drug noncompliance, other|11|||
28045016|NCT00474630|54703086|FG001|Overall Study|Drug noncompliance, other|4|||
28045017|NCT00392379|54703095|FG000|Overall Study|Withdrawal by Subject|17|||
28045018|NCT00392379|54703096|FG001|Overall Study|Withdrawal by Subject|28|||
27811358|NCT01855412|54267289|FG000|Overall Study|Withdrawal by Subject|77|||
27811359|NCT01855412|54267290|FG001|Overall Study|Withdrawal by Subject|123|||
27811360|NCT01855412|54267291|FG002|Overall Study|Withdrawal by Subject|24|||
27811361|NCT01855412|54267289|FG000|Overall Study|Physician Decision|25|||
27811362|NCT01855412|54267290|FG001|Overall Study|Physician Decision|31|||
27811363|NCT01855412|54267291|FG002|Overall Study|Physician Decision|3|||
28045019|NCT00392379|54703095|FG000|Overall Study|Lost to Follow-up|4|||
28045020|NCT00392379|54703096|FG001|Overall Study|Lost to Follow-up|9|||
28045021|NCT00392379|54703095|FG000|Overall Study|Adverse Event|1|||
28045022|NCT00392379|54703096|FG001|Overall Study|Adverse Event|1|||
28045023|NCT00497874|54703104|FG000|Overall Study|Withdrawal by Subject|48|||
27811364|NCT01855412|54267289|FG000|Overall Study|Site Closure|4|||
28045024|NCT00497874|54703105|FG001|Overall Study|Withdrawal by Subject|17|||
28045025|NCT00497874|54703104|FG000|Overall Study|Illness|8|||
28045026|NCT00497874|54703105|FG001|Overall Study|Illness|4|||
28045027|NCT00497874|54703104|FG000|Overall Study|Death|2|||
28045028|NCT00497874|54703105|FG001|Overall Study|Death|4|||
28045029|NCT00497874|54703104|FG000|Overall Study|Unable to contact|52|||
28045030|NCT00497874|54703105|FG001|Overall Study|Unable to contact|67|||
28045031|NCT00497874|54703104|FG000|Overall Study|Unable to schedule|37|||
28045032|NCT00497874|54703105|FG001|Overall Study|Unable to schedule|24|||
28045033|NCT00403455|54703113|FG000|Overall Study|Withdrawal by Subject|1|||
28045034|NCT00318370|54703117|FG000|Period 1|Lack of Efficacy|5|||
28045035|NCT00318370|54703118|FG001|Period 1|Lack of Efficacy|0|||
28045036|NCT00318370|54703119|FG002|Period 1|Lack of Efficacy|0|||
28045037|NCT00318370|54703117|FG000|Period 1|Physician Decision|1|||
28045038|NCT00318370|54703118|FG001|Period 1|Physician Decision|0|||
28045039|NCT00318370|54703119|FG002|Period 1|Physician Decision|0|||
28045040|NCT00318370|54703117|FG000|Period 1|Withdrawal by Subject|1|||
28045041|NCT00318370|54703118|FG001|Period 1|Withdrawal by Subject|0|||
28045042|NCT00318370|54703119|FG002|Period 1|Withdrawal by Subject|0|||
28045043|NCT00318370|54703117|FG000|Period 2|Adverse Event|0|||
28045044|NCT00318370|54703118|FG001|Period 2|Adverse Event|3|||
28045045|NCT00318370|54703119|FG002|Period 2|Adverse Event|0|||
28045046|NCT00318370|54703117|FG000|Period 2|Lack of Efficacy|0|||
28045047|NCT00318370|54703118|FG001|Period 2|Lack of Efficacy|5|||
28045048|NCT00318370|54703119|FG002|Period 2|Lack of Efficacy|0|||
28045049|NCT00318370|54703117|FG000|Period 2|Physician Decision|0|||
28045050|NCT00318370|54703118|FG001|Period 2|Physician Decision|1|||
28045051|NCT00318370|54703119|FG002|Period 2|Physician Decision|0|||
28045052|NCT00318370|54703117|FG000|Period 2|Withdrawal by Subject|0|||
28045053|NCT00318370|54703118|FG001|Period 2|Withdrawal by Subject|1|||
28045054|NCT00318370|54703119|FG002|Period 2|Withdrawal by Subject|0|||
28045055|NCT00318370|54703117|FG000|Period 2|Other|0|||
28045056|NCT00318370|54703118|FG001|Period 2|Other|1|||
28045057|NCT00318370|54703119|FG002|Period 2|Other|0|||
28045058|NCT00318370|54703117|FG000|Period 3|Adverse Event|0|||
28045059|NCT00318370|54703118|FG001|Period 3|Adverse Event|0|||
28045060|NCT00318370|54703119|FG002|Period 3|Adverse Event|1|||
28045061|NCT00318370|54703117|FG000|Period 3|Lack of Efficacy|0|||
28045062|NCT00318370|54703118|FG001|Period 3|Lack of Efficacy|0|||
28045063|NCT00318370|54703119|FG002|Period 3|Lack of Efficacy|24|||
28045064|NCT00318370|54703117|FG000|Period 3|Death|0|||
28045065|NCT00318370|54703118|FG001|Period 3|Death|0|||
28045066|NCT00318370|54703119|FG002|Period 3|Death|1|||
28045067|NCT00318370|54703117|FG000|Period 3|Physician Decision|0|||
28045068|NCT00318370|54703118|FG001|Period 3|Physician Decision|0|||
28045069|NCT00318370|54703119|FG002|Period 3|Physician Decision|1|||
28045070|NCT00318370|54703117|FG000|Period 3|Withdrawal by Subject|0|||
28045071|NCT00318370|54703118|FG001|Period 3|Withdrawal by Subject|0|||
28045072|NCT00318370|54703119|FG002|Period 3|Withdrawal by Subject|3|||
28045073|NCT00318370|54703117|FG000|Period 3|Other|0|||
28045074|NCT00318370|54703118|FG001|Period 3|Other|0|||
28045075|NCT00318370|54703119|FG002|Period 3|Other|3|||
28045076|NCT00510068|54703127|FG000|Double-blind Period|Disease progression|98|||
27811365|NCT01855412|54267290|FG001|Overall Study|Site Closure|18|||
27811366|NCT01855412|54267291|FG002|Overall Study|Site Closure|1|||
27811367|NCT01855412|54267289|FG000|Overall Study|Reason not Specified|1|||
27811368|NCT01855412|54267290|FG001|Overall Study|Reason not Specified|2|||
27811369|NCT01855412|54267291|FG002|Overall Study|Reason not Specified|3|||
27811370|NCT01614470|54267307|FG000|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
27811371|NCT01614470|54267308|FG001|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
27811372|NCT01614470|54267309|FG002|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
27811373|NCT01614470|54267307|FG000|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
27811374|NCT01614470|54267308|FG001|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
27811375|NCT01614470|54267309|FG002|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0|||
28045077|NCT00510068|54703128|FG001|Double-blind Period|Disease progression|169|||
27811376|NCT01880528|54267320|FG000|Overall Study|Other|1|||
28045078|NCT00510068|54703127|FG000|Double-blind Period|Final primary analysis|52|||
28045079|NCT00510068|54703128|FG001|Double-blind Period|Final primary analysis|18|||
28045080|NCT00510068|54703127|FG000|Double-blind Period|Adverse Event|37|||
28045081|NCT00510068|54703128|FG001|Double-blind Period|Adverse Event|7|||
28045082|NCT00510068|54703127|FG000|Double-blind Period|Withdrawal by Subject|8|||
28045083|NCT00510068|54703128|FG001|Double-blind Period|Withdrawal by Subject|6|||
28045084|NCT00510068|54703127|FG000|Double-blind Period|Death|4|||
28045085|NCT00510068|54703128|FG001|Double-blind Period|Death|3|||
28045086|NCT00510068|54703127|FG000|Double-blind Period|Abnormal test result (s)|1|||
28045087|NCT00510068|54703128|FG001|Double-blind Period|Abnormal test result (s)|0|||
28045088|NCT00510068|54703127|FG000|Double-blind Period|Lost to Follow-up|1|||
28045089|NCT00510068|54703128|FG001|Double-blind Period|Lost to Follow-up|0|||
28045090|NCT00510068|54703127|FG000|Double-blind Period|Protocol Violation|6|||
28045091|NCT00510068|54703128|FG001|Double-blind Period|Protocol Violation|0|||
28045092|NCT00510068|54703127|FG000|Open-label Period|Disease Progression|124|||
28045093|NCT00510068|54703128|FG001|Open-label Period|Disease Progression|0|||
28045094|NCT00510068|54703127|FG000|Open-label Period|Adverse Event|46|||
28045095|NCT00510068|54703128|FG001|Open-label Period|Adverse Event|0|||
28045096|NCT00510068|54703127|FG000|Open-label Period|Withdrawal by Subject|21|||
28045097|NCT00510068|54703128|FG001|Open-label Period|Withdrawal by Subject|0|||
28045098|NCT00510068|54703127|FG000|Open-label Period|Administrative problems|17|||
28045099|NCT00510068|54703128|FG001|Open-label Period|Administrative problems|0|||
27811377|NCT01880528|54267321|FG001|Overall Study|Other|1|||
27811378|NCT01854944|54267330|FG000|Overall Study|Withdrawal by Subject|0|||
27811379|NCT01854944|54267331|FG001|Overall Study|Withdrawal by Subject|0|||
27811380|NCT01854944|54267332|FG002|Overall Study|Withdrawal by Subject|1|||
27811381|NCT01829048|54267359|FG000|Overall Study|Withdrawal by Subject|0|||
27811382|NCT01829048|54267360|FG001|Overall Study|Withdrawal by Subject|0|||
27811383|NCT01829048|54267361|FG002|Overall Study|Withdrawal by Subject|0|||
27811384|NCT01829048|54267362|FG003|Overall Study|Withdrawal by Subject|2|||
27811385|NCT01829048|54267363|FG004|Overall Study|Withdrawal by Subject|0|||
27811386|NCT01854710|54267376|FG000|Overall Study|Withdrawal by Subject|2|||
27811387|NCT01854710|54267377|FG001|Overall Study|Withdrawal by Subject|1|||
27811388|NCT01854710|54267378|FG002|Overall Study|Withdrawal by Subject|0|||
27811389|NCT01854710|54267379|FG003|Overall Study|Withdrawal by Subject|0|||
27811390|NCT01854710|54267380|FG004|Overall Study|Withdrawal by Subject|0|||
27811391|NCT01854710|54267381|FG005|Overall Study|Withdrawal by Subject|0|||
27811392|NCT01854710|54267376|FG000|Overall Study|CRI procedural error|2|||
27811393|NCT01854710|54267377|FG001|Overall Study|CRI procedural error|2|||
28045100|NCT00510068|54703127|FG000|Open-label Period|Death|7|||
28045101|NCT00510068|54703128|FG001|Open-label Period|Death|0|||
28045102|NCT00510068|54703127|FG000|Open-label Period|New cancer therapy|7|||
28045103|NCT00510068|54703128|FG001|Open-label Period|New cancer therapy|0|||
28045104|NCT00510068|54703127|FG000|Open-label Period|Protocol Violation|2|||
28045105|NCT00510068|54703128|FG001|Open-label Period|Protocol Violation|0|||
28045106|NCT00510068|54703127|FG000|Open-label Period|Abnormal laboratory value (s)|1|||
28045107|NCT00510068|54703128|FG001|Open-label Period|Abnormal laboratory value (s)|0|||
28045108|NCT00509600|54703136|FG000|Overall Study|Adverse Event|1|||
28045109|NCT00402987|54703144|FG000|Overall Study|Lack of Efficacy|0|||
28045110|NCT00402987|54703145|FG001|Overall Study|Lack of Efficacy|0|||
28045111|NCT00402987|54703146|FG002|Overall Study|Lack of Efficacy|1|||
28045112|NCT00402987|54703147|FG003|Overall Study|Lack of Efficacy|0|||
28045113|NCT00501644|54703171|FG000|Overall Study|Adverse Event|4|||
28045114|NCT00501644|54703171|FG000|Overall Study|Withdrawal by Subject|1|||
28045115|NCT00497796|54703177|FG000|Overall Study|Adverse event (not related)|9|||
28045116|NCT00497796|54703178|FG001|Overall Study|Adverse event (not related)|9|||
28045117|NCT00497796|54703177|FG000|Overall Study|Adverse event (related)|5|||
27811394|NCT01854710|54267378|FG002|Overall Study|CRI procedural error|2|||
28045118|NCT00497796|54703178|FG001|Overall Study|Adverse event (related)|4|||
28045119|NCT00497796|54703177|FG000|Overall Study|CMV infection or disease treatment|30|||
28045120|NCT00497796|54703178|FG001|Overall Study|CMV infection or disease treatment|4|||
28045121|NCT00497796|54703177|FG000|Overall Study|Consent withdrawn|10|||
28045122|NCT00497796|54703178|FG001|Overall Study|Consent withdrawn|3|||
28045123|NCT00497796|54703177|FG000|Overall Study|Investigator/sponsor discretion|31|||
28045124|NCT00497796|54703178|FG001|Overall Study|Investigator/sponsor discretion|34|||
28045125|NCT00497796|54703177|FG000|Overall Study|Lost to Follow-up|0|||
28045126|NCT00497796|54703178|FG001|Overall Study|Lost to Follow-up|1|||
28045127|NCT00497796|54703177|FG000|Overall Study|Not applicable (randomized not treated)|0|||
28045128|NCT00497796|54703178|FG001|Overall Study|Not applicable (randomized not treated)|4|||
28045129|NCT00496782|54703186|FG000|Overall Study|Protocol Violation|1|||
28045130|NCT00496782|54703187|FG001|Overall Study|Protocol Violation|2|||
28045131|NCT00402831|54703195|FG000|Overall Study|Lost to Follow-up|1|||
28045132|NCT00402831|54703196|FG001|Overall Study|Lost to Follow-up|2|||
28045133|NCT00402831|54703195|FG000|Overall Study|Non-compliance with protocol|0|||
28045134|NCT00402831|54703196|FG001|Overall Study|Non-compliance with protocol|1|||
28045135|NCT00496626|54703206|FG000|Overall Study|Lost to Follow-up|0|||
27811395|NCT01854710|54267379|FG003|Overall Study|CRI procedural error|2|||
27811396|NCT01854710|54267380|FG004|Overall Study|CRI procedural error|2|||
27811397|NCT01854710|54267381|FG005|Overall Study|CRI procedural error|2|||
27811398|NCT01828034|54267395|FG000|Overall Study|Withdrawal by Subject|0|||
27811399|NCT01828034|54267396|FG001|Overall Study|Withdrawal by Subject|0|||
28045136|NCT00496626|54703207|FG001|Overall Study|Lost to Follow-up|1|||
28045137|NCT00496626|54703206|FG000|Overall Study|Protocol Violation|1|||
28045138|NCT00496626|54703207|FG001|Overall Study|Protocol Violation|0|||
28045139|NCT00496626|54703206|FG000|Overall Study|Withdrawal by Subject|5|||
28045140|NCT00496626|54703207|FG001|Overall Study|Withdrawal by Subject|4|||
28045141|NCT00496626|54703206|FG000|Overall Study|Relocated|0|||
28045142|NCT00496626|54703207|FG001|Overall Study|Relocated|1|||
28045143|NCT00471822|54703217|FG000|Overall Study|Protocol Violation|2|||
28045144|NCT00471276|54703221|FG000|Overall Study|Death|2|||
28045145|NCT00471276|54703221|FG000|Overall Study|Adverse Event|16|||
28045146|NCT00471276|54703221|FG000|Overall Study|Protocol Violation|1|||
28045147|NCT00471276|54703221|FG000|Overall Study|Objective progression or relapse|54|||
28045148|NCT00471276|54703221|FG000|Overall Study|Global deterioration of health status|1|||
28045149|NCT00471276|54703221|FG000|Overall Study|Other|3|||
28045150|NCT00471276|54703221|FG000|Overall Study|Refused treatment|6|||
28045151|NCT00470262|54703227|FG000|Overall Study|Withdrawal by Subject|2|||
28045152|NCT00470262|54703228|FG001|Overall Study|Withdrawal by Subject|0|||
28045153|NCT00496470|54703237|FG000|Overall Study|Adverse Event|8|||
28045154|NCT00496470|54703238|FG001|Overall Study|Adverse Event|10|||
28045155|NCT00496470|54703237|FG000|Overall Study|Withdrawal by Subject|5|||
28045156|NCT00496470|54703238|FG001|Overall Study|Withdrawal by Subject|12|||
28045157|NCT00496470|54703237|FG000|Overall Study|Incorrectly enrolled|13|||
28045158|NCT00496470|54703238|FG001|Overall Study|Incorrectly enrolled|5|||
28045159|NCT00496470|54703237|FG000|Overall Study|Other reason|0|||
28045160|NCT00496470|54703238|FG001|Overall Study|Other reason|2|||
28045161|NCT00496080|54703244|FG000|Overall Study|Lost to Follow-up|9|||
28045162|NCT00496080|54703244|FG000|Overall Study|Surgical re-intervention|7|||
28045163|NCT00496080|54703244|FG000|Overall Study|Withdrawal by Subject|5|||
28045164|NCT00496080|54703244|FG000|Overall Study|Physician Decision|6|||
28045165|NCT00487578|54703251|FG000|Overall Study|Adverse Event|1|||
28045166|NCT00487578|54703252|FG001|Overall Study|Adverse Event|2|||
28045167|NCT00487578|54703251|FG000|Overall Study|Lack of Efficacy|0|||
28045168|NCT00487578|54703252|FG001|Overall Study|Lack of Efficacy|1|||
28045169|NCT00487578|54703251|FG000|Overall Study|Lost to Follow-up|0|||
28045170|NCT00487578|54703252|FG001|Overall Study|Lost to Follow-up|1|||
28045171|NCT00495612|54703260|FG000|Overall Study|Lost to Follow-up|1|||
28045172|NCT00495612|54703261|FG001|Overall Study|Lost to Follow-up|0|||
28045173|NCT00495612|54703260|FG000|Overall Study|Subject's Decision to Withdraw|3|||
28045174|NCT00495612|54703261|FG001|Overall Study|Subject's Decision to Withdraw|0|||
28045175|NCT00487188|54703269|FG000|Induction Phase|Abnormality of Laboratory Test|0|||
28045176|NCT00487188|54703270|FG001|Induction Phase|Abnormality of Laboratory Test|1|||
28045177|NCT00487188|54703271|FG002|Induction Phase|Abnormality of Laboratory Test|0|||
28045178|NCT00487188|54703269|FG000|Induction Phase|Adverse Event|5|||
28045179|NCT00487188|54703270|FG001|Induction Phase|Adverse Event|0|||
28045180|NCT00487188|54703271|FG002|Induction Phase|Adverse Event|0|||
28045181|NCT00487188|54703269|FG000|Induction Phase|Lack of Efficacy|0|||
28045182|NCT00487188|54703270|FG001|Induction Phase|Lack of Efficacy|1|||
28045183|NCT00487188|54703271|FG002|Induction Phase|Lack of Efficacy|0|||
28045184|NCT00487188|54703269|FG000|Induction Phase|Protocol Violation|1|||
28045185|NCT00487188|54703270|FG001|Induction Phase|Protocol Violation|0|||
28045186|NCT00487188|54703271|FG002|Induction Phase|Protocol Violation|0|||
28045187|NCT00487188|54703269|FG000|Induction Phase|Refused Treatment|1|||
28045188|NCT00487188|54703270|FG001|Induction Phase|Refused Treatment|2|||
28045189|NCT00487188|54703271|FG002|Induction Phase|Refused Treatment|0|||
28045190|NCT00487188|54703269|FG000|Induction Phase|Lost to Follow-up|2|||
28045191|NCT00487188|54703270|FG001|Induction Phase|Lost to Follow-up|2|||
28045192|NCT00487188|54703271|FG002|Induction Phase|Lost to Follow-up|0|||
28045193|NCT00487188|54703269|FG000|Induction Phase|Administrative|0|||
28045194|NCT00487188|54703270|FG001|Induction Phase|Administrative|1|||
28045195|NCT00487188|54703271|FG002|Induction Phase|Administrative|0|||
28045196|NCT00487188|54703269|FG000|Maintenance Phase|Adverse Event|1|||
28045197|NCT00487188|54703270|FG001|Maintenance Phase|Adverse Event|0|||
28045198|NCT00487188|54703271|FG002|Maintenance Phase|Adverse Event|0|||
28045199|NCT00487188|54703269|FG000|Maintenance Phase|Death|1|||
28045200|NCT00487188|54703270|FG001|Maintenance Phase|Death|0|||
28045201|NCT00487188|54703271|FG002|Maintenance Phase|Death|0|||
28045202|NCT00487188|54703269|FG000|Maintenance Phase|Lost to Follow-up|1|||
28045203|NCT00487188|54703270|FG001|Maintenance Phase|Lost to Follow-up|0|||
28045204|NCT00487188|54703271|FG002|Maintenance Phase|Lost to Follow-up|0|||
28045205|NCT00487188|54703269|FG000|Maintenance Phase|Administrative|0|||
28045206|NCT00487188|54703270|FG001|Maintenance Phase|Administrative|0|||
28045207|NCT00487188|54703271|FG002|Maintenance Phase|Administrative|1|||
28045208|NCT00509366|54703292|FG000|Overall Study|Not Treated (Screen Failure)|1|||
28045209|NCT00509366|54703293|FG001|Overall Study|Not Treated (Screen Failure)|1|||
28045210|NCT00509366|54703294|FG002|Overall Study|Not Treated (Screen Failure)|1|||
28045211|NCT00509366|54703295|FG003|Overall Study|Not Treated (Screen Failure)|0|||
28045212|NCT00509366|54703296|FG004|Overall Study|Not Treated (Screen Failure)|0|||
28045213|NCT00500318|54703308|FG000|Overall Study|Adverse Event|3|||
28045214|NCT00500318|54703309|FG001|Overall Study|Adverse Event|8|||
28045215|NCT00500318|54703308|FG000|Overall Study|Protocol Violation|1|||
28045216|NCT00500318|54703309|FG001|Overall Study|Protocol Violation|3|||
28045217|NCT00500318|54703308|FG000|Overall Study|Withdrawal by Subject|1|||
28045218|NCT00500318|54703309|FG001|Overall Study|Withdrawal by Subject|2|||
28045219|NCT00500318|54703308|FG000|Overall Study|Lack of Efficacy|0|||
28045220|NCT00500318|54703309|FG001|Overall Study|Lack of Efficacy|3|||
28045221|NCT00500318|54703308|FG000|Overall Study|Other Reason|0|||
28045222|NCT00500318|54703309|FG001|Overall Study|Other Reason|1|||
28045223|NCT00508820|54703317|FG000|Overall Study|Adverse Event|6|||
28045224|NCT00508820|54703318|FG001|Overall Study|Adverse Event|10|||
28045225|NCT00508820|54703317|FG000|Overall Study|Death|6|||
28045226|NCT00508820|54703318|FG001|Overall Study|Death|8|||
28045227|NCT00508820|54703317|FG000|Overall Study|Lost to Follow-up|1|||
28045228|NCT00508820|54703318|FG001|Overall Study|Lost to Follow-up|1|||
28045229|NCT00508820|54703317|FG000|Overall Study|Physician Decision|8|||
28045230|NCT00508820|54703318|FG001|Overall Study|Physician Decision|2|||
28045231|NCT00508820|54703317|FG000|Overall Study|Pregnancy|0|||
28045232|NCT00508820|54703318|FG001|Overall Study|Pregnancy|2|||
28045233|NCT00508820|54703317|FG000|Overall Study|Protocol Violation|2|||
28045234|NCT00508820|54703318|FG001|Overall Study|Protocol Violation|0|||
28045235|NCT00508820|54703317|FG000|Overall Study|Withdrawal by Subject|10|||
28045236|NCT00508820|54703318|FG001|Overall Study|Withdrawal by Subject|12|||
28045237|NCT00508820|54703317|FG000|Overall Study|Other|11|||
28045238|NCT00508820|54703318|FG001|Overall Study|Other|2|||
28045239|NCT00508820|54703317|FG000|Overall Study|Noncompliance|1|||
28045240|NCT00508820|54703318|FG001|Overall Study|Noncompliance|0|||
28045241|NCT00508820|54703317|FG000|Overall Study|Requirement for alternative therapy|7|||
28045242|NCT00508820|54703318|FG001|Overall Study|Requirement for alternative therapy|15|||
28045243|NCT00508820|54703317|FG000|Overall Study|Protocol-specified Criteria|3|||
28045244|NCT00508820|54703318|FG001|Overall Study|Protocol-specified Criteria|12|||
28045245|NCT00499694|54703324|FG000|Overall Study|Patient never received treatment.|1|||
28045246|NCT00486954|54703333|FG000|Pilot Part|Adverse Event|4|||
28045247|NCT00486954|54703334|FG001|Pilot Part|Adverse Event|0|||
28045248|NCT00486954|54703335|FG002|Pilot Part|Adverse Event|5|||
28045249|NCT00486954|54703336|FG003|Pilot Part|Adverse Event|0|||
28045250|NCT00486954|54703337|FG004|Pilot Part|Adverse Event|0|||
28045251|NCT00486954|54703333|FG000|Pilot Part|Disease Progression|2|||
28045252|NCT00486954|54703334|FG001|Pilot Part|Disease Progression|0|||
28045253|NCT00486954|54703335|FG002|Pilot Part|Disease Progression|1|||
28045254|NCT00486954|54703336|FG003|Pilot Part|Disease Progression|0|||
28045255|NCT00486954|54703337|FG004|Pilot Part|Disease Progression|0|||
28045256|NCT00486954|54703333|FG000|Randomized Part|Lost to Follow-up|0|||
28045257|NCT00486954|54703334|FG001|Randomized Part|Lost to Follow-up|0|||
28045258|NCT00486954|54703335|FG002|Randomized Part|Lost to Follow-up|0|||
28045259|NCT00486954|54703336|FG003|Randomized Part|Lost to Follow-up|0|||
28045260|NCT00486954|54703337|FG004|Randomized Part|Lost to Follow-up|1|||
28045261|NCT00486954|54703333|FG000|Randomized Part|Withdrawal by Subject|0|||
28045262|NCT00486954|54703334|FG001|Randomized Part|Withdrawal by Subject|0|||
28045263|NCT00486954|54703335|FG002|Randomized Part|Withdrawal by Subject|0|||
28045264|NCT00486954|54703336|FG003|Randomized Part|Withdrawal by Subject|1|||
28045265|NCT00486954|54703337|FG004|Randomized Part|Withdrawal by Subject|0|||
28045266|NCT00486954|54703333|FG000|Randomized Part|Sponsor Terminated Study|0|||
28045267|NCT00486954|54703334|FG001|Randomized Part|Sponsor Terminated Study|0|||
28045268|NCT00486954|54703335|FG002|Randomized Part|Sponsor Terminated Study|0|||
28045269|NCT00486954|54703336|FG003|Randomized Part|Sponsor Terminated Study|19|||
28045270|NCT00486954|54703337|FG004|Randomized Part|Sponsor Terminated Study|13|||
28045271|NCT00494676|54703347|FG000|Allocation|Withdrawal by Subject|2|||
28045272|NCT00494676|54703348|FG001|Allocation|Withdrawal by Subject|4|||
28045273|NCT00494676|54703347|FG000|First Intervention|Withdrawal by Subject|1|||
28045274|NCT00494676|54703348|FG001|First Intervention|Withdrawal by Subject|3|||
28045275|NCT00494676|54703347|FG000|Second Intervention|Withdrawal by Subject|1|||
28045276|NCT00494676|54703348|FG001|Second Intervention|Withdrawal by Subject|1|||
28045277|NCT00486720|54703356|FG000|Overall Study|Adverse Event|1|||
28045278|NCT00486720|54703357|FG001|Overall Study|Adverse Event|2|||
28045279|NCT00486720|54703356|FG000|Overall Study|Lack of Efficacy|4|||
28045280|NCT00486720|54703357|FG001|Overall Study|Lack of Efficacy|6|||
28045281|NCT00486720|54703356|FG000|Overall Study|Physician Decision|1|||
28045282|NCT00486720|54703357|FG001|Overall Study|Physician Decision|2|||
28045283|NCT00486720|54703356|FG000|Overall Study|Protocol Violation|1|||
28045284|NCT00486720|54703357|FG001|Overall Study|Protocol Violation|0|||
28045285|NCT00486720|54703356|FG000|Overall Study|Withdrawal by Subject|3|||
28045286|NCT00486720|54703357|FG001|Overall Study|Withdrawal by Subject|1|||
28045287|NCT00486720|54703356|FG000|Overall Study|Progressive Disease|0|||
27939890|NCT01038609|54596217|FG002|Overall Study|Dosing Error|0|||
28045288|NCT00486720|54703357|FG001|Overall Study|Progressive Disease|1|||
28045289|NCT00486330|54703363|FG000|Overall Study|Adverse Event|2|||
28045290|NCT00486252|54703367|FG000|Overall Study|Adverse Event|7|||
28045291|NCT00486252|54703367|FG000|Overall Study|Lack of Efficacy|9|||
28045292|NCT00486252|54703367|FG000|Overall Study|Lost to Follow-up|24|||
28045293|NCT00486252|54703367|FG000|Overall Study|Other|18|||
28045294|NCT00494442|54703375|FG000|Overall Study|Death|1|||
28045295|NCT00494442|54703376|FG001|Overall Study|Death|1|||
28045296|NCT00494442|54703375|FG000|Overall Study|Lack of Efficacy|16|||
28045297|NCT00494442|54703376|FG001|Overall Study|Lack of Efficacy|10|||
28045298|NCT00494442|54703375|FG000|Overall Study|Adverse Event|0|||
28045299|NCT00494442|54703376|FG001|Overall Study|Adverse Event|2|||
28045300|NCT00494442|54703375|FG000|Overall Study|Physician Decision|0|||
28045301|NCT00494442|54703376|FG001|Overall Study|Physician Decision|1|||
28045302|NCT00494442|54703375|FG000|Overall Study|Non-compliance|0|||
28045303|NCT00494442|54703376|FG001|Overall Study|Non-compliance|1|||
28045304|NCT00494442|54703375|FG000|Overall Study|Intercurrent illness|0|||
28045305|NCT00494442|54703376|FG001|Overall Study|Intercurrent illness|1|||
28045306|NCT03851016|54703384|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
28045307|NCT03851016|54703385|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
28045308|NCT00493974|54703393|FG000|Overall Study|Death|1|||
28045309|NCT00493974|54703394|FG001|Overall Study|Death|2|||
28045310|NCT00493974|54703393|FG000|Overall Study|Withdrawal by Subject|8|||
28045311|NCT00493974|54703394|FG001|Overall Study|Withdrawal by Subject|6|||
28045312|NCT00493974|54703393|FG000|Overall Study|Lost to Follow-up|4|||
28045313|NCT00493974|54703394|FG001|Overall Study|Lost to Follow-up|6|||
28045314|NCT00469092|54703402|FG000|Overall Study|Adverse Event|5|||
28045315|NCT00469092|54703403|FG001|Overall Study|Adverse Event|4|||
28045316|NCT00469092|54703402|FG000|Overall Study|Lack of Efficacy|1|||
28045317|NCT00469092|54703403|FG001|Overall Study|Lack of Efficacy|0|||
28045318|NCT00469092|54703402|FG000|Overall Study|Lost to Follow-up|1|||
28045319|NCT00469092|54703403|FG001|Overall Study|Lost to Follow-up|2|||
28045320|NCT00469092|54703402|FG000|Overall Study|Protocol Violation|3|||
28045321|NCT00469092|54703403|FG001|Overall Study|Protocol Violation|3|||
28045322|NCT00469092|54703402|FG000|Overall Study|Withdrawal by Subject|4|||
28045323|NCT00469092|54703403|FG001|Overall Study|Withdrawal by Subject|4|||
28045324|NCT00469092|54703402|FG000|Overall Study|Withdrawal Criteria|3|||
28045325|NCT00469092|54703403|FG001|Overall Study|Withdrawal Criteria|4|||
28045326|NCT00469092|54703402|FG000|Overall Study|Incorrectly Randomised|4|||
28045327|NCT00469092|54703403|FG001|Overall Study|Incorrectly Randomised|3|||
28045328|NCT00469092|54703402|FG000|Overall Study|Contraindication metformin/glimepiride|1|||
28045329|NCT00469092|54703403|FG001|Overall Study|Contraindication metformin/glimepiride|0|||
28045330|NCT00469092|54703402|FG000|Overall Study|Use of lipid lowering drug|1|||
28045331|NCT00469092|54703403|FG001|Overall Study|Use of lipid lowering drug|0|||
27811400|NCT01828034|54267397|FG002|Overall Study|Withdrawal by Subject|0|||
28045332|NCT00469092|54703402|FG000|Overall Study|Hypoglycaemic Episodes|1|||
28045333|NCT00469092|54703403|FG001|Overall Study|Hypoglycaemic Episodes|1|||
28045334|NCT00469092|54703402|FG000|Overall Study|Abnormal lab value|1|||
28045335|NCT00469092|54703403|FG001|Overall Study|Abnormal lab value|0|||
28045336|NCT00469092|54703402|FG000|Overall Study|Use of Corticosteroid|1|||
28045337|NCT00469092|54703403|FG001|Overall Study|Use of Corticosteroid|0|||
28045338|NCT00499616|54703413|FG000|Overall Study|Death|1|||
28045339|NCT00499616|54703414|FG001|Overall Study|Death|5|||
28045340|NCT00499616|54703415|FG002|Overall Study|Death|3|||
28045341|NCT00499616|54703416|FG003|Overall Study|Death|1|||
28045342|NCT00499616|54703413|FG000|Overall Study|Lack of Efficacy|5|||
28045343|NCT00499616|54703414|FG001|Overall Study|Lack of Efficacy|0|||
28045344|NCT00499616|54703415|FG002|Overall Study|Lack of Efficacy|19|||
28045345|NCT00499616|54703416|FG003|Overall Study|Lack of Efficacy|0|||
28045346|NCT00499616|54703413|FG000|Overall Study|Lost to Follow-up|0|||
28045347|NCT00499616|54703414|FG001|Overall Study|Lost to Follow-up|0|||
28045348|NCT00499616|54703415|FG002|Overall Study|Lost to Follow-up|1|||
28045349|NCT00499616|54703416|FG003|Overall Study|Lost to Follow-up|0|||
28045350|NCT00499616|54703413|FG000|Overall Study|Physician Decision|6|||
28045351|NCT00499616|54703414|FG001|Overall Study|Physician Decision|16|||
28045352|NCT00499616|54703415|FG002|Overall Study|Physician Decision|9|||
27811401|NCT01828034|54267398|FG003|Overall Study|Withdrawal by Subject|1|||
27811402|NCT01853696|54267407|FG000|Overall Study|Withdrawal by Subject|1|||
27811403|NCT01853696|54267408|FG001|Overall Study|Withdrawal by Subject|1|||
27811404|NCT01853696|54267407|FG000|Overall Study|Lost to Follow-up|5|||
27811405|NCT01853696|54267408|FG001|Overall Study|Lost to Follow-up|4|||
27811406|NCT01871805|54267420|FG000|Phase I|Death|7|||
27811407|NCT01871805|54267421|FG001|Phase I|Death|4|||
27811408|NCT01871805|54267422|FG002|Phase I|Death|6|||
27811409|NCT01871805|54267423|FG003|Phase I|Death|2|||
28045353|NCT00499616|54703416|FG003|Overall Study|Physician Decision|0|||
28045354|NCT00499616|54703413|FG000|Overall Study|Withdrawal by Subject|1|||
28045355|NCT00499616|54703414|FG001|Overall Study|Withdrawal by Subject|0|||
28045356|NCT00499616|54703415|FG002|Overall Study|Withdrawal by Subject|1|||
28045357|NCT00499616|54703416|FG003|Overall Study|Withdrawal by Subject|0|||
28045358|NCT00499616|54703413|FG000|Overall Study|Ineligible|1|||
28045359|NCT00499616|54703414|FG001|Overall Study|Ineligible|2|||
28045360|NCT00499616|54703415|FG002|Overall Study|Ineligible|0|||
28045361|NCT00499616|54703416|FG003|Overall Study|Ineligible|15|||
28045362|NCT00499616|54703413|FG000|Overall Study|Not evaluable|0|||
28045363|NCT00499616|54703414|FG001|Overall Study|Not evaluable|0|||
28045364|NCT00499616|54703415|FG002|Overall Study|Not evaluable|0|||
28045365|NCT00499616|54703416|FG003|Overall Study|Not evaluable|41|||
28045366|NCT00499616|54703413|FG000|Overall Study|Patient/Parent Refusal|1|||
28045367|NCT00499616|54703414|FG001|Overall Study|Patient/Parent Refusal|5|||
28045368|NCT00499616|54703415|FG002|Overall Study|Patient/Parent Refusal|3|||
28045369|NCT00499616|54703416|FG003|Overall Study|Patient/Parent Refusal|0|||
28045370|NCT00402597|54703434|FG000|Overall Study|Death|15|||
28045371|NCT00402597|54703435|FG001|Overall Study|Death|7|||
28045372|NCT00402597|54703436|FG002|Overall Study|Death|6|||
28045373|NCT00402597|54703437|FG003|Overall Study|Death|4|||
28045374|NCT00402597|54703438|FG004|Overall Study|Death|6|||
28045375|NCT00402597|54703434|FG000|Overall Study|Adverse Event|81|||
28045376|NCT00402597|54703435|FG001|Overall Study|Adverse Event|18|||
28045377|NCT00402597|54703436|FG002|Overall Study|Adverse Event|106|||
28045378|NCT00402597|54703437|FG003|Overall Study|Adverse Event|39|||
28045379|NCT00402597|54703438|FG004|Overall Study|Adverse Event|71|||
28045380|NCT00402597|54703434|FG000|Overall Study|Lost to Follow-up|8|||
28045381|NCT00402597|54703435|FG001|Overall Study|Lost to Follow-up|1|||
28045382|NCT00402597|54703436|FG002|Overall Study|Lost to Follow-up|8|||
28045383|NCT00402597|54703437|FG003|Overall Study|Lost to Follow-up|2|||
28045384|NCT00402597|54703438|FG004|Overall Study|Lost to Follow-up|3|||
28045385|NCT00402597|54703434|FG000|Overall Study|Withdrawal by Subject|57|||
28045386|NCT00402597|54703435|FG001|Overall Study|Withdrawal by Subject|16|||
28045387|NCT00402597|54703436|FG002|Overall Study|Withdrawal by Subject|65|||
28045388|NCT00402597|54703437|FG003|Overall Study|Withdrawal by Subject|15|||
28045389|NCT00402597|54703438|FG004|Overall Study|Withdrawal by Subject|24|||
28045390|NCT00402597|54703434|FG000|Overall Study|reason not specified|30|||
28045391|NCT00402597|54703435|FG001|Overall Study|reason not specified|4|||
28045392|NCT00402597|54703436|FG002|Overall Study|reason not specified|27|||
28045393|NCT00402597|54703437|FG003|Overall Study|reason not specified|14|||
28045394|NCT00402597|54703438|FG004|Overall Study|reason not specified|20|||
28045395|NCT00402363|54703454|FG000|Overall Study|Adverse Event|9|||
28045396|NCT00402363|54703455|FG001|Overall Study|Adverse Event|14|||
28045397|NCT00402363|54703456|FG002|Overall Study|Adverse Event|2|||
28045398|NCT00402363|54703457|FG003|Overall Study|Adverse Event|2|||
28045399|NCT00402363|54703454|FG000|Overall Study|Withdrew Consent|10|||
28045400|NCT00402363|54703455|FG001|Overall Study|Withdrew Consent|5|||
28045401|NCT00402363|54703456|FG002|Overall Study|Withdrew Consent|2|||
28045402|NCT00402363|54703457|FG003|Overall Study|Withdrew Consent|1|||
28045403|NCT00402363|54703454|FG000|Overall Study|Protocol Violation|3|||
28045404|NCT00402363|54703455|FG001|Overall Study|Protocol Violation|5|||
28045405|NCT00402363|54703456|FG002|Overall Study|Protocol Violation|0|||
28045406|NCT00402363|54703457|FG003|Overall Study|Protocol Violation|3|||
28045407|NCT00402363|54703454|FG000|Overall Study|Lost to Follow-up|5|||
28045408|NCT00402363|54703455|FG001|Overall Study|Lost to Follow-up|4|||
28045409|NCT00402363|54703456|FG002|Overall Study|Lost to Follow-up|0|||
28045410|NCT00402363|54703457|FG003|Overall Study|Lost to Follow-up|2|||
28045411|NCT00402363|54703454|FG000|Overall Study|"Captured as Other"|6|||
28045412|NCT00402363|54703455|FG001|Overall Study|"Captured as Other"|2|||
28045413|NCT00402363|54703456|FG002|Overall Study|"Captured as Other"|2|||
28045414|NCT00402363|54703457|FG003|Overall Study|"Captured as Other"|2|||
28045415|NCT00469014|54703477|FG000|Initial Phase Randomization|Disease Progression|0|||
28045416|NCT00469014|54703478|FG001|Initial Phase Randomization|Disease Progression|1|||
28045417|NCT00469014|54703479|FG002|Initial Phase Randomization|Disease Progression|1|||
28045418|NCT00469014|54703480|FG003|Initial Phase Randomization|Disease Progression|0|||
28045419|NCT00469014|54703477|FG000|Initial Phase Randomization|No Response|1|||
28045420|NCT00469014|54703478|FG001|Initial Phase Randomization|No Response|0|||
28045421|NCT00469014|54703479|FG002|Initial Phase Randomization|No Response|0|||
28045422|NCT00469014|54703480|FG003|Initial Phase Randomization|No Response|1|||
28045423|NCT00469014|54703477|FG000|Adaptive Randomization|Not Evaluable|1|||
28045424|NCT00469014|54703478|FG001|Adaptive Randomization|Not Evaluable|0|||
28045425|NCT00469014|54703479|FG002|Adaptive Randomization|Not Evaluable|0|||
28045426|NCT00469014|54703480|FG003|Adaptive Randomization|Not Evaluable|1|||
28045427|NCT00469014|54703477|FG000|Adaptive Randomization|No Response|0|||
28045428|NCT00469014|54703478|FG001|Adaptive Randomization|No Response|1|||
28045429|NCT00469014|54703479|FG002|Adaptive Randomization|No Response|0|||
28045430|NCT00469014|54703480|FG003|Adaptive Randomization|No Response|0|||
28045431|NCT00469014|54703477|FG000|Adaptive Randomization|Death|0|||
28045432|NCT00469014|54703478|FG001|Adaptive Randomization|Death|0|||
28045433|NCT00469014|54703479|FG002|Adaptive Randomization|Death|1|||
27811410|NCT01871805|54267424|FG004|Phase I|Death|9|||
27811411|NCT01871805|54267425|FG005|Phase I|Death|0|||
28045434|NCT00469014|54703480|FG003|Adaptive Randomization|Death|0|||
28045435|NCT00493038|54703492|FG000|Treatment|Adverse Event|8|||
28045436|NCT00493038|54703493|FG001|Treatment|Adverse Event|4|||
28045437|NCT00493038|54703492|FG000|Treatment|Lost to Follow-up|5|||
28045438|NCT00493038|54703493|FG001|Treatment|Lost to Follow-up|3|||
28045439|NCT00493038|54703492|FG000|Treatment|Withdrawal by Subject|11|||
28045440|NCT00493038|54703493|FG001|Treatment|Withdrawal by Subject|12|||
28045441|NCT00493038|54703492|FG000|Treatment|Other|0|||
28045442|NCT00493038|54703493|FG001|Treatment|Other|1|||
28045443|NCT00493038|54703492|FG000|Follow-up|Lost to Follow-up|1|||
28045444|NCT00493038|54703493|FG001|Follow-up|Lost to Follow-up|0|||
28045445|NCT00392223|54703501|FG000|Overall Study|Adverse Event|5|||
27811412|NCT01871805|54267420|FG000|Phase I|Alive in Survival Follow-up|0|||
28045446|NCT00392223|54703502|FG001|Overall Study|Adverse Event|4|||
28045447|NCT00392223|54703501|FG000|Overall Study|Lost to Follow-up|1|||
28045448|NCT00392223|54703502|FG001|Overall Study|Lost to Follow-up|4|||
28045449|NCT00392223|54703501|FG000|Overall Study|Protocol Violation|0|||
28045450|NCT00392223|54703502|FG001|Overall Study|Protocol Violation|3|||
28045451|NCT00392223|54703501|FG000|Overall Study|Withdrawal by Subject|3|||
28045452|NCT00392223|54703502|FG001|Overall Study|Withdrawal by Subject|2|||
28045453|NCT00402285|54703511|FG000|Overall Study|insufficient RNA quality|7|||
28045454|NCT00402285|54703512|FG001|Overall Study|insufficient RNA quality|6|||
28045455|NCT00402285|54703513|FG002|Overall Study|insufficient RNA quality|2|||
28045456|NCT00413283|54703523|FG000|Overall Study|Withdrawal by Subject|1|||
28045457|NCT00413283|54703524|FG001|Overall Study|Withdrawal by Subject|0|||
28045458|NCT00413283|54703525|FG002|Overall Study|Withdrawal by Subject|0|||
28045459|NCT00413283|54703526|FG003|Overall Study|Withdrawal by Subject|1|||
28045460|NCT00413283|54703523|FG000|Overall Study|Death|0|||
28045461|NCT00413283|54703524|FG001|Overall Study|Death|0|||
28045462|NCT00413283|54703525|FG002|Overall Study|Death|1|||
28045463|NCT00413283|54703526|FG003|Overall Study|Death|1|||
28045464|NCT00413283|54703523|FG000|Overall Study|Adverse Event|0|||
28045465|NCT00413283|54703524|FG001|Overall Study|Adverse Event|0|||
28045466|NCT00413283|54703525|FG002|Overall Study|Adverse Event|0|||
28045467|NCT00413283|54703526|FG003|Overall Study|Adverse Event|1|||
28045468|NCT00413283|54703523|FG000|Overall Study|Ineligibility determined|0|||
28045469|NCT00413283|54703524|FG001|Overall Study|Ineligibility determined|0|||
28045470|NCT00413283|54703525|FG002|Overall Study|Ineligibility determined|0|||
28045471|NCT00413283|54703526|FG003|Overall Study|Ineligibility determined|1|||
28045472|NCT00413283|54703523|FG000|Overall Study|Protocol deviation|0|||
28045473|NCT00413283|54703524|FG001|Overall Study|Protocol deviation|1|||
28045474|NCT00413283|54703525|FG002|Overall Study|Protocol deviation|0|||
28045475|NCT00413283|54703526|FG003|Overall Study|Protocol deviation|0|||
28045476|NCT00413283|54703523|FG000|Overall Study|Requirement for alternative therapy|0|||
28045477|NCT00413283|54703524|FG001|Overall Study|Requirement for alternative therapy|2|||
28045478|NCT00413283|54703525|FG002|Overall Study|Requirement for alternative therapy|0|||
28045479|NCT00413283|54703526|FG003|Overall Study|Requirement for alternative therapy|0|||
28045480|NCT00413283|54703523|FG000|Overall Study|Other|0|||
28045481|NCT00413283|54703524|FG001|Overall Study|Other|0|||
28045482|NCT00413283|54703525|FG002|Overall Study|Other|1|||
28045483|NCT00413283|54703526|FG003|Overall Study|Other|0|||
28045484|NCT00402051|54703538|FG000|Overall Study|Progressive Disease|13|||
28045485|NCT00402051|54703539|FG001|Overall Study|Progressive Disease|20|||
28045486|NCT00402051|54703538|FG000|Overall Study|Adverse Event|11|||
28045487|NCT00402051|54703539|FG001|Overall Study|Adverse Event|4|||
28045488|NCT00402051|54703538|FG000|Overall Study|Physician Decision|7|||
28045489|NCT00402051|54703539|FG001|Overall Study|Physician Decision|3|||
28045490|NCT00402051|54703538|FG000|Overall Study|Withdrawal by Subject|3|||
28045491|NCT00402051|54703539|FG001|Overall Study|Withdrawal by Subject|3|||
28045492|NCT00402051|54703538|FG000|Overall Study|Death - Related to Study Drug|1|||
28045493|NCT00402051|54703539|FG001|Overall Study|Death - Related to Study Drug|2|||
28045494|NCT00402051|54703538|FG000|Overall Study|Death Due to Study Disease|2|||
28045495|NCT00402051|54703539|FG001|Overall Study|Death Due to Study Disease|1|||
28045496|NCT00402051|54703538|FG000|Overall Study|Death Due to Adverse Event|0|||
28045497|NCT00402051|54703539|FG001|Overall Study|Death Due to Adverse Event|2|||
28045498|NCT00402051|54703538|FG000|Overall Study|Lost to Follow-up|1|||
28045499|NCT00402051|54703539|FG001|Overall Study|Lost to Follow-up|0|||
28045500|NCT00468858|54703548|FG000|Overall Study|Adverse Event|0|||
28045501|NCT00468858|54703549|FG001|Overall Study|Adverse Event|1|||
28045502|NCT00468858|54703550|FG002|Overall Study|Adverse Event|0|||
28045503|NCT00468858|54703548|FG000|Overall Study|Withdrawal by Subject|7|||
28045504|NCT00468858|54703549|FG001|Overall Study|Withdrawal by Subject|4|||
28045505|NCT00468858|54703550|FG002|Overall Study|Withdrawal by Subject|5|||
28045506|NCT00468858|54703548|FG000|Overall Study|Relocation|1|||
28045507|NCT00468858|54703549|FG001|Overall Study|Relocation|3|||
27939891|NCT01038609|54596218|FG003|Overall Study|Dosing Error|1|||
28045508|NCT00468858|54703550|FG002|Overall Study|Relocation|3|||
28045509|NCT00468858|54703548|FG000|Overall Study|Lost to Follow-up|1|||
28045510|NCT00468858|54703549|FG001|Overall Study|Lost to Follow-up|2|||
28045511|NCT00468858|54703550|FG002|Overall Study|Lost to Follow-up|5|||
28045512|NCT00468858|54703548|FG000|Overall Study|Other|0|||
28045513|NCT00468858|54703549|FG001|Overall Study|Other|0|||
28045514|NCT00468858|54703550|FG002|Overall Study|Other|1|||
28045515|NCT00401973|54703615|FG000|Overall Study|Adverse Event|2|||
28045516|NCT00401973|54703616|FG001|Overall Study|Adverse Event|8|||
28045517|NCT00401973|54703617|FG002|Overall Study|Adverse Event|4|||
28045518|NCT00401973|54703615|FG000|Overall Study|Clinical Relapse|0|||
28045519|NCT00401973|54703616|FG001|Overall Study|Clinical Relapse|1|||
28045520|NCT00401973|54703617|FG002|Overall Study|Clinical Relapse|1|||
28045521|NCT00401973|54703615|FG000|Overall Study|Lack of Efficacy|0|||
28045522|NCT00401973|54703616|FG001|Overall Study|Lack of Efficacy|0|||
28045523|NCT00401973|54703617|FG002|Overall Study|Lack of Efficacy|3|||
28045524|NCT00401973|54703615|FG000|Overall Study|Lost to Follow-up|2|||
28045525|NCT00401973|54703616|FG001|Overall Study|Lost to Follow-up|2|||
28045526|NCT00401973|54703617|FG002|Overall Study|Lost to Follow-up|2|||
28045527|NCT00401973|54703615|FG000|Overall Study|Physician Decision|2|||
28045528|NCT00401973|54703616|FG001|Overall Study|Physician Decision|0|||
28045529|NCT00401973|54703617|FG002|Overall Study|Physician Decision|1|||
28045530|NCT00401973|54703615|FG000|Overall Study|Protocol Violation|1|||
28045531|NCT00401973|54703616|FG001|Overall Study|Protocol Violation|2|||
28045532|NCT00401973|54703617|FG002|Overall Study|Protocol Violation|3|||
28045533|NCT00401973|54703615|FG000|Overall Study|Sponsor Decision|0|||
28045534|NCT00401973|54703616|FG001|Overall Study|Sponsor Decision|1|||
28045535|NCT00401973|54703617|FG002|Overall Study|Sponsor Decision|0|||
28045536|NCT00401973|54703615|FG000|Overall Study|Withdrawal by Subject|4|||
28045537|NCT00401973|54703616|FG001|Overall Study|Withdrawal by Subject|12|||
28045538|NCT00401973|54703617|FG002|Overall Study|Withdrawal by Subject|9|||
28045539|NCT00401193|54703630|FG000|Overall Study|Adverse Event|1|||
28045540|NCT00401193|54703631|FG001|Overall Study|Adverse Event|3|||
28045541|NCT00401193|54703632|FG002|Overall Study|Adverse Event|1|||
28045542|NCT00401193|54703630|FG000|Overall Study|Protocol Violation|3|||
28045543|NCT00401193|54703631|FG001|Overall Study|Protocol Violation|1|||
28045544|NCT00401193|54703632|FG002|Overall Study|Protocol Violation|1|||
28045545|NCT00401193|54703630|FG000|Overall Study|Lost to Follow-up|6|||
28045546|NCT00401193|54703631|FG001|Overall Study|Lost to Follow-up|5|||
28045547|NCT00401193|54703632|FG002|Overall Study|Lost to Follow-up|1|||
28045548|NCT00401193|54703630|FG000|Overall Study|Withdrawal by Subject|2|||
28045549|NCT00401193|54703631|FG001|Overall Study|Withdrawal by Subject|0|||
28045550|NCT00401193|54703632|FG002|Overall Study|Withdrawal by Subject|1|||
28045551|NCT00401193|54703630|FG000|Overall Study|Other Event|3|||
28045552|NCT00401193|54703631|FG001|Overall Study|Other Event|2|||
28045553|NCT00401193|54703632|FG002|Overall Study|Other Event|2|||
28045554|NCT00400569|54703641|FG000|Overall Study|Death|1|||
28045555|NCT00413049|54703650|FG000|Overall Study|Adverse Event|10|||
28045556|NCT00413049|54703651|FG001|Overall Study|Adverse Event|8|||
28045557|NCT00413049|54703650|FG000|Overall Study|Withdrawal by Subject|7|||
28045558|NCT00413049|54703651|FG001|Overall Study|Withdrawal by Subject|5|||
28045559|NCT00413049|54703650|FG000|Overall Study|Lost to Follow-up|2|||
28045560|NCT00413049|54703651|FG001|Overall Study|Lost to Follow-up|3|||
28045561|NCT00413049|54703650|FG000|Overall Study|Protocol Violation|3|||
28045562|NCT00413049|54703651|FG001|Overall Study|Protocol Violation|1|||
28045563|NCT00413049|54703650|FG000|Overall Study|Subject no longer requires study drug|0|||
28045564|NCT00413049|54703651|FG001|Overall Study|Subject no longer requires study drug|1|||
28045565|NCT00413049|54703650|FG000|Overall Study|Abnormal laboratory value(s)|1|||
28045566|NCT00413049|54703651|FG001|Overall Study|Abnormal laboratory value(s)|0|||
28045567|NCT00413049|54703650|FG000|Overall Study|Lack of Efficacy|1|||
28045568|NCT00413049|54703651|FG001|Overall Study|Lack of Efficacy|0|||
28045569|NCT00454194|54703659|FG000|Overall Study|Adverse Event|7|||
28045570|NCT00454194|54703660|FG001|Overall Study|Adverse Event|2|||
28045571|NCT00454194|54703659|FG000|Overall Study|Withdrawal by Subject|12|||
28045572|NCT00454194|54703660|FG001|Overall Study|Withdrawal by Subject|8|||
28045573|NCT00454194|54703659|FG000|Overall Study|Other Medical Problems|1|||
28045574|NCT00454194|54703660|FG001|Overall Study|Other Medical Problems|2|||
28045575|NCT00454194|54703659|FG000|Overall Study|Other Unspecified Reason|2|||
28045576|NCT00454194|54703660|FG001|Overall Study|Other Unspecified Reason|2|||
28045577|NCT00412971|54703668|FG000|Overall Study|Lost to Follow-up|17|||
28045578|NCT00412971|54703669|FG001|Overall Study|Lost to Follow-up|9|||
28045579|NCT00412971|54703668|FG000|Overall Study|Protocol Violation|13|||
28045580|NCT00412971|54703669|FG001|Overall Study|Protocol Violation|1|||
28045581|NCT00303472|54703682|FG000|Treatment Period|Adverse Event|0|||
28045582|NCT00303472|54703683|FG001|Treatment Period|Adverse Event|0|||
28045583|NCT00303472|54703684|FG002|Treatment Period|Adverse Event|0|||
28045584|NCT00303472|54703685|FG003|Treatment Period|Adverse Event|0|||
28045585|NCT00303472|54703686|FG004|Treatment Period|Adverse Event|1|||
28045586|NCT00303472|54703687|FG005|Treatment Period|Adverse Event|0|||
28045587|NCT00303472|54703688|FG006|Treatment Period|Adverse Event|0|||
28045588|NCT00303472|54703682|FG000|Treatment Period|Death|0|||
28045589|NCT00303472|54703683|FG001|Treatment Period|Death|0|||
28045590|NCT00303472|54703684|FG002|Treatment Period|Death|0|||
28045591|NCT00303472|54703685|FG003|Treatment Period|Death|1|||
28045592|NCT00303472|54703686|FG004|Treatment Period|Death|0|||
28045593|NCT00303472|54703687|FG005|Treatment Period|Death|0|||
28045594|NCT00303472|54703688|FG006|Treatment Period|Death|1|||
28045595|NCT00303472|54703682|FG000|Treatment Period|Withdrawal by Subject|0|||
28045596|NCT00303472|54703683|FG001|Treatment Period|Withdrawal by Subject|0|||
28045597|NCT00303472|54703684|FG002|Treatment Period|Withdrawal by Subject|0|||
28045598|NCT00303472|54703685|FG003|Treatment Period|Withdrawal by Subject|1|||
28045599|NCT00303472|54703686|FG004|Treatment Period|Withdrawal by Subject|0|||
28045600|NCT00303472|54703687|FG005|Treatment Period|Withdrawal by Subject|1|||
28045601|NCT00303472|54703688|FG006|Treatment Period|Withdrawal by Subject|0|||
28045602|NCT00303472|54703682|FG000|Treatment Period|Other|0|||
28045603|NCT00303472|54703683|FG001|Treatment Period|Other|0|||
28045604|NCT00303472|54703684|FG002|Treatment Period|Other|0|||
28045605|NCT00303472|54703685|FG003|Treatment Period|Other|0|||
28045606|NCT00303472|54703686|FG004|Treatment Period|Other|1|||
28045607|NCT00303472|54703687|FG005|Treatment Period|Other|0|||
28045608|NCT00303472|54703688|FG006|Treatment Period|Other|1|||
28045609|NCT00303472|54703682|FG000|Treatment Period|Disease Progression (to AML)|0|||
28045610|NCT00303472|54703683|FG001|Treatment Period|Disease Progression (to AML)|0|||
28045611|NCT00303472|54703684|FG002|Treatment Period|Disease Progression (to AML)|0|||
28045612|NCT00303472|54703685|FG003|Treatment Period|Disease Progression (to AML)|0|||
28045613|NCT00303472|54703686|FG004|Treatment Period|Disease Progression (to AML)|1|||
28045614|NCT00303472|54703687|FG005|Treatment Period|Disease Progression (to AML)|0|||
28045615|NCT00303472|54703688|FG006|Treatment Period|Disease Progression (to AML)|0|||
28045616|NCT00303472|54703682|FG000|Treatment Extension (Optional)|Adverse Event|1|||
28045617|NCT00303472|54703683|FG001|Treatment Extension (Optional)|Adverse Event|0|||
28045618|NCT00303472|54703684|FG002|Treatment Extension (Optional)|Adverse Event|1|||
28045619|NCT00303472|54703685|FG003|Treatment Extension (Optional)|Adverse Event|0|||
28045620|NCT00303472|54703686|FG004|Treatment Extension (Optional)|Adverse Event|0|||
28045621|NCT00303472|54703687|FG005|Treatment Extension (Optional)|Adverse Event|0|||
28045622|NCT00303472|54703688|FG006|Treatment Extension (Optional)|Adverse Event|0|||
28045623|NCT00303472|54703682|FG000|Treatment Extension (Optional)|Death|2|||
28045624|NCT00303472|54703683|FG001|Treatment Extension (Optional)|Death|0|||
28045625|NCT00303472|54703684|FG002|Treatment Extension (Optional)|Death|1|||
28045626|NCT00303472|54703685|FG003|Treatment Extension (Optional)|Death|0|||
28045627|NCT00303472|54703686|FG004|Treatment Extension (Optional)|Death|0|||
28045628|NCT00303472|54703687|FG005|Treatment Extension (Optional)|Death|0|||
28045629|NCT00303472|54703688|FG006|Treatment Extension (Optional)|Death|0|||
28045630|NCT00303472|54703682|FG000|Treatment Extension (Optional)|Lost to Follow-up|0|||
28045631|NCT00303472|54703683|FG001|Treatment Extension (Optional)|Lost to Follow-up|0|||
28045632|NCT00303472|54703684|FG002|Treatment Extension (Optional)|Lost to Follow-up|0|||
28045633|NCT00303472|54703685|FG003|Treatment Extension (Optional)|Lost to Follow-up|1|||
28045634|NCT00303472|54703686|FG004|Treatment Extension (Optional)|Lost to Follow-up|0|||
28045635|NCT00303472|54703687|FG005|Treatment Extension (Optional)|Lost to Follow-up|0|||
28045636|NCT00303472|54703688|FG006|Treatment Extension (Optional)|Lost to Follow-up|0|||
28045637|NCT00303472|54703682|FG000|Treatment Extension (Optional)|Physician Decision|0|||
28045638|NCT00303472|54703683|FG001|Treatment Extension (Optional)|Physician Decision|4|||
28045639|NCT00303472|54703684|FG002|Treatment Extension (Optional)|Physician Decision|2|||
28045640|NCT00303472|54703685|FG003|Treatment Extension (Optional)|Physician Decision|3|||
28045641|NCT00303472|54703686|FG004|Treatment Extension (Optional)|Physician Decision|2|||
28045642|NCT00303472|54703687|FG005|Treatment Extension (Optional)|Physician Decision|0|||
28045643|NCT00303472|54703688|FG006|Treatment Extension (Optional)|Physician Decision|0|||
28045644|NCT00303472|54703682|FG000|Treatment Extension (Optional)|Withdrawal by Subject|1|||
28045645|NCT00303472|54703683|FG001|Treatment Extension (Optional)|Withdrawal by Subject|0|||
28045646|NCT00303472|54703684|FG002|Treatment Extension (Optional)|Withdrawal by Subject|1|||
28045647|NCT00303472|54703685|FG003|Treatment Extension (Optional)|Withdrawal by Subject|2|||
28045648|NCT00303472|54703686|FG004|Treatment Extension (Optional)|Withdrawal by Subject|1|||
28045649|NCT00303472|54703687|FG005|Treatment Extension (Optional)|Withdrawal by Subject|0|||
28045650|NCT00303472|54703688|FG006|Treatment Extension (Optional)|Withdrawal by Subject|0|||
28045651|NCT00303472|54703682|FG000|Treatment Extension (Optional)|Other|0|||
28045652|NCT00303472|54703683|FG001|Treatment Extension (Optional)|Other|2|||
28045653|NCT00303472|54703684|FG002|Treatment Extension (Optional)|Other|4|||
28045654|NCT00303472|54703685|FG003|Treatment Extension (Optional)|Other|2|||
28045655|NCT00303472|54703686|FG004|Treatment Extension (Optional)|Other|1|||
28045656|NCT00303472|54703687|FG005|Treatment Extension (Optional)|Other|0|||
28045657|NCT00303472|54703688|FG006|Treatment Extension (Optional)|Other|0|||
28045658|NCT00303472|54703682|FG000|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
28045659|NCT00303472|54703683|FG001|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
28045660|NCT00303472|54703684|FG002|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
28045661|NCT00303472|54703685|FG003|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
28045662|NCT00303472|54703686|FG004|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
28045663|NCT00303472|54703687|FG005|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
28045664|NCT00303472|54703688|FG006|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
28045665|NCT00468546|54703706|FG000|Week 24 Analysis|Lack of Efficacy|83|||
28045666|NCT00468546|54703707|FG001|Week 24 Analysis|Lack of Efficacy|37|||
28045667|NCT00468546|54703706|FG000|Week 24 Analysis|Refused treatment|5|||
28045668|NCT00468546|54703707|FG001|Week 24 Analysis|Refused treatment|5|||
28045669|NCT00468546|54703706|FG000|Week 24 Analysis|Adverse Event|1|||
28045670|NCT00468546|54703707|FG001|Week 24 Analysis|Adverse Event|8|||
28045671|NCT00468546|54703706|FG000|Week 24 Analysis|Failure to return|3|||
28045672|NCT00468546|54703707|FG001|Week 24 Analysis|Failure to return|4|||
28045673|NCT00468546|54703706|FG000|Week 24 Analysis|Rescue therapy|2|||
28045674|NCT00468546|54703707|FG001|Week 24 Analysis|Rescue therapy|0|||
28045675|NCT00468546|54703706|FG000|Week 24 Analysis|Incorrect diagnosis and treatment|0|||
28045676|NCT00468546|54703707|FG001|Week 24 Analysis|Incorrect diagnosis and treatment|1|||
28045677|NCT00468546|54703706|FG000|Week 24 Analysis|Due to clinical hold|1|||
28045678|NCT00468546|54703707|FG001|Week 24 Analysis|Due to clinical hold|0|||
28045679|NCT00468546|54703706|FG000|Week 24 Analysis|Went onto rescue therapy|1|||
28045680|NCT00468546|54703707|FG001|Week 24 Analysis|Went onto rescue therapy|0|||
28045681|NCT00468546|54703706|FG000|Week 24 Analysis|Participant unblinded (clinical hold)|1|||
28045682|NCT00468546|54703707|FG001|Week 24 Analysis|Participant unblinded (clinical hold)|0|||
28045683|NCT00468546|54703706|FG000|Week 24 to Week 104 Analysis|Adverse Event|2|||
28045684|NCT00468546|54703707|FG001|Week 24 to Week 104 Analysis|Adverse Event|5|||
28045685|NCT00468546|54703706|FG000|Week 24 to Week 104 Analysis|Death|1|||
28045686|NCT00468546|54703707|FG001|Week 24 to Week 104 Analysis|Death|0|||
28045687|NCT00468546|54703706|FG000|Week 24 to Week 104 Analysis|Lack of Efficacy|3|||
28045688|NCT00468546|54703707|FG001|Week 24 to Week 104 Analysis|Lack of Efficacy|12|||
28045689|NCT00468546|54703706|FG000|Week 24 to Week 104 Analysis|Protocol Violation|0|||
27811413|NCT01871805|54267421|FG001|Phase I|Alive in Survival Follow-up|2|||
27811414|NCT01871805|54267422|FG002|Phase I|Alive in Survival Follow-up|4|||
27811415|NCT01871805|54267423|FG003|Phase I|Alive in Survival Follow-up|5|||
27811416|NCT01871805|54267424|FG004|Phase I|Alive in Survival Follow-up|4|||
27811417|NCT01871805|54267425|FG005|Phase I|Alive in Survival Follow-up|0|||
27811418|NCT01871805|54267420|FG000|Phase I|Lost to Follow-up|0|||
27811419|NCT01871805|54267421|FG001|Phase I|Lost to Follow-up|1|||
27811420|NCT01871805|54267422|FG002|Phase I|Lost to Follow-up|3|||
27847974|NCT01494038|54340781|FG000|Overall Study|Withdrawal by Subject|44|||
27847975|NCT01494038|54340782|FG001|Overall Study|Withdrawal by Subject|34|||
28045690|NCT00468546|54703707|FG001|Week 24 to Week 104 Analysis|Protocol Violation|2|||
28045691|NCT00468546|54703706|FG000|Week 24 to Week 104 Analysis|Refused treatment|4|||
28045692|NCT00468546|54703707|FG001|Week 24 to Week 104 Analysis|Refused treatment|7|||
28045693|NCT00468546|54703706|FG000|Week 24 to Week 104 Analysis|Failure to return|1|||
28045694|NCT00468546|54703707|FG001|Week 24 to Week 104 Analysis|Failure to return|2|||
28045695|NCT00468546|54703706|FG000|Week 24 to Week 104 Analysis|Movement into re-treatment study|77|||
28045696|NCT00468546|54703707|FG001|Week 24 to Week 104 Analysis|Movement into re-treatment study|183|||
28045697|NCT00468546|54703706|FG000|Week 24 to Week 104 Analysis|Other|17|||
28045698|NCT00468546|54703707|FG001|Week 24 to Week 104 Analysis|Other|14|||
28045699|NCT00303316|54703715|FG000|Overall Study|Protocol Violation|1|||
28045700|NCT00303316|54703716|FG001|Overall Study|Protocol Violation|0|||
28045701|NCT00303316|54703715|FG000|Overall Study|Lost to Follow-up|0|||
28045702|NCT00303316|54703716|FG001|Overall Study|Lost to Follow-up|1|||
28045703|NCT00303316|54703715|FG000|Overall Study|Withdrawal by Subject|1|||
28045704|NCT00303316|54703716|FG001|Overall Study|Withdrawal by Subject|2|||
28045705|NCT00468312|54703724|FG000|Overall Study|Adverse Event|2|||
28045706|NCT00468312|54703725|FG001|Overall Study|Adverse Event|1|||
28045707|NCT00468312|54703724|FG000|Overall Study|Lack of Efficacy|0|||
28045708|NCT00468312|54703725|FG001|Overall Study|Lack of Efficacy|1|||
28045709|NCT00468312|54703724|FG000|Overall Study|Withdrawal by Subject|0|||
28045710|NCT00468312|54703725|FG001|Overall Study|Withdrawal by Subject|1|||
28045711|NCT00468312|54703724|FG000|Overall Study|Protocol Violation|2|||
28045712|NCT00468312|54703725|FG001|Overall Study|Protocol Violation|1|||
28045713|NCT00468312|54703724|FG000|Overall Study|Did not meet protocol eligibility|0|||
28045714|NCT00468312|54703725|FG001|Overall Study|Did not meet protocol eligibility|1|||
28045715|NCT00331864|54703733|FG000|Overall Study|Adverse Event|30|||
28045716|NCT00331864|54703734|FG001|Overall Study|Adverse Event|1|||
28045717|NCT00331864|54703733|FG000|Overall Study|Lack of Efficacy|4|||
28045718|NCT00331864|54703734|FG001|Overall Study|Lack of Efficacy|0|||
28045719|NCT00331864|54703733|FG000|Overall Study|Protocol Violation|3|||
28045720|NCT00331864|54703734|FG001|Overall Study|Protocol Violation|0|||
28045721|NCT00331864|54703733|FG000|Overall Study|Withdrawal by Subject|10|||
28045722|NCT00331864|54703734|FG001|Overall Study|Withdrawal by Subject|0|||
28045723|NCT00331864|54703733|FG000|Overall Study|Lost to Follow-up|4|||
28045724|NCT00331864|54703734|FG001|Overall Study|Lost to Follow-up|3|||
28045725|NCT00331864|54703733|FG000|Overall Study|Administrative Problems|1|||
28045726|NCT00331864|54703734|FG001|Overall Study|Administrative Problems|0|||
27811421|NCT01871805|54267423|FG003|Phase I|Lost to Follow-up|0|||
27811422|NCT01871805|54267424|FG004|Phase I|Lost to Follow-up|0|||
27811423|NCT01871805|54267425|FG005|Phase I|Lost to Follow-up|0|||
28045727|NCT00331864|54703733|FG000|Overall Study|Death|6|||
28045728|NCT00331864|54703734|FG001|Overall Study|Death|0|||
28045729|NCT00331630|54703740|FG000|Evaluated for and Completed SOC Surgery|Progressive Disease|1|||
28045730|NCT00331630|54703740|FG000|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1|||
28045731|NCT00331630|54703740|FG000|Follow up for 5 Years|Death|5|||
28045732|NCT00331630|54703740|FG000|Follow up for 5 Years|Data collection was stopped|24|||
28045733|NCT00331552|54703746|FG000|Period 3: Phase II|Neurological Symptoms|1|||
28045734|NCT00331552|54703747|FG001|Period 3: Phase II|Neurological Symptoms|0|||
27811424|NCT01871805|54267420|FG000|Phase II|Death|0|||
27811425|NCT01871805|54267421|FG001|Phase II|Death|0|||
28045735|NCT00331552|54703746|FG000|Period 3: Phase II|Severe Nausea|1|||
28045736|NCT00331552|54703747|FG001|Period 3: Phase II|Severe Nausea|0|||
28045737|NCT00317356|54703762|FG000|Overall Study|Adverse Event|0|||
28045738|NCT00317356|54703763|FG001|Overall Study|Adverse Event|0|||
28045739|NCT00317356|54703764|FG002|Overall Study|Adverse Event|1|||
28045740|NCT00317356|54703765|FG003|Overall Study|Adverse Event|0|||
28045741|NCT00317356|54703762|FG000|Overall Study|Lack of Efficacy|1|||
28045742|NCT00317356|54703763|FG001|Overall Study|Lack of Efficacy|1|||
28045743|NCT00317356|54703764|FG002|Overall Study|Lack of Efficacy|0|||
28045744|NCT00317356|54703765|FG003|Overall Study|Lack of Efficacy|3|||
28045745|NCT00317356|54703762|FG000|Overall Study|Physician Decision|0|||
28045746|NCT00317356|54703763|FG001|Overall Study|Physician Decision|1|||
28045747|NCT00317356|54703764|FG002|Overall Study|Physician Decision|0|||
28045748|NCT00317356|54703765|FG003|Overall Study|Physician Decision|0|||
28045749|NCT00331006|54703775|FG000|Screening Phase|Withdrawal by Subject|1|||
28045750|NCT00331006|54703775|FG000|Screening Phase|enrollment halted|1|||
28045751|NCT00331006|54703775|FG000|Screening Phase|Lost to Follow-up|1|||
28045752|NCT00331006|54703775|FG000|Screening Phase|Ineligible for treatment phase|4|||
28045753|NCT00331006|54703775|FG000|Treatment Phase|Withdrawal by Subject|1|||
28045754|NCT00331006|54703775|FG000|Follow-Up Phase I|Lost to Follow-up|1|||
28045755|NCT00331006|54703775|FG000|Follow-Up Phase II|Lost to Follow-up|3|||
28045756|NCT00302458|54703779|FG000|Overall Study|Lost to Follow-up|1|||
28045757|NCT00302458|54703779|FG000|Overall Study|Ineligible after screening|1|||
28045758|NCT00302458|54703779|FG000|Overall Study|Withdrawal by Subject|1|||
28045759|NCT00391053|54703791|FG000|Overall Study|Serious Adverse Events|1|||
28045760|NCT00391053|54703792|FG001|Overall Study|Serious Adverse Events|0|||
28045761|NCT00391053|54703793|FG002|Overall Study|Serious Adverse Events|1|||
28045762|NCT00391053|54703794|FG003|Overall Study|Serious Adverse Events|4|||
28045763|NCT00391053|54703791|FG000|Overall Study|Protocol Violation|2|||
28045764|NCT00391053|54703792|FG001|Overall Study|Protocol Violation|0|||
28045765|NCT00391053|54703793|FG002|Overall Study|Protocol Violation|0|||
28045766|NCT00391053|54703794|FG003|Overall Study|Protocol Violation|0|||
28045767|NCT00391053|54703791|FG000|Overall Study|Lost to Follow-up|1|||
28045768|NCT00391053|54703792|FG001|Overall Study|Lost to Follow-up|0|||
28045769|NCT00391053|54703793|FG002|Overall Study|Lost to Follow-up|0|||
28045770|NCT00391053|54703794|FG003|Overall Study|Lost to Follow-up|5|||
28045771|NCT00391053|54703791|FG000|Overall Study|Withdrawal by Subject|5|||
28045772|NCT00391053|54703792|FG001|Overall Study|Withdrawal by Subject|1|||
28045773|NCT00391053|54703793|FG002|Overall Study|Withdrawal by Subject|1|||
28045774|NCT00391053|54703794|FG003|Overall Study|Withdrawal by Subject|1|||
28045775|NCT00317044|54703807|FG000|Overall Study|Protocol Violation|28|||
28045776|NCT00317044|54703808|FG001|Overall Study|Protocol Violation|22|||
28045777|NCT00317044|54703809|FG002|Overall Study|Protocol Violation|20|||
28045778|NCT00317044|54703807|FG000|Overall Study|Adverse Event|4|||
28045779|NCT00317044|54703808|FG001|Overall Study|Adverse Event|7|||
28045780|NCT00317044|54703809|FG002|Overall Study|Adverse Event|4|||
28045781|NCT00317044|54703807|FG000|Overall Study|Withdrawal by Subject|10|||
28045782|NCT00317044|54703808|FG001|Overall Study|Withdrawal by Subject|7|||
28045783|NCT00317044|54703809|FG002|Overall Study|Withdrawal by Subject|12|||
28045784|NCT00317044|54703807|FG000|Overall Study|Lost to Follow-up|0|||
28045785|NCT00317044|54703808|FG001|Overall Study|Lost to Follow-up|2|||
28045786|NCT00317044|54703809|FG002|Overall Study|Lost to Follow-up|3|||
28045787|NCT00317044|54703807|FG000|Overall Study|Multiple Reasons|6|||
28045788|NCT00317044|54703808|FG001|Overall Study|Multiple Reasons|2|||
28045789|NCT00317044|54703809|FG002|Overall Study|Multiple Reasons|6|||
28045790|NCT00301834|54703817|FG000|Overall Study|Death|1|||
28045791|NCT00301366|54703824|FG000|Overall Study|Adverse Event|1|||
28045792|NCT00330928|54703828|FG000|Overall Study|Lost to Follow-up|6|||
28045793|NCT00330928|54703828|FG000|Overall Study|Physician Decision|9|||
28045794|NCT00330928|54703828|FG000|Overall Study|Death|1|||
28045795|NCT00330928|54703828|FG000|Overall Study|IVUS could not be performed.|1|||
28045796|NCT00330616|54703832|FG000|Overall Study|Adverse Event|13|||
28045797|NCT00330616|54703832|FG000|Overall Study|Lack of Efficacy|1|||
27939892|NCT01038609|54596219|FG004|Overall Study|Dosing Error|1|||
27811426|NCT01871805|54267422|FG002|Phase II|Death|0|||
28045798|NCT00330616|54703832|FG000|Overall Study|Lost to Follow-up|2|||
28045799|NCT00330616|54703832|FG000|Overall Study|Withdrawal by Subject|4|||
28045800|NCT00330616|54703832|FG000|Overall Study|Other|1|||
28045801|NCT00466440|54703839|FG000|Overall Study|Adverse Event|0|||
28045802|NCT00466440|54703840|FG001|Overall Study|Adverse Event|3|||
28045803|NCT00466440|54703841|FG002|Overall Study|Adverse Event|1|||
28045804|NCT00466440|54703839|FG000|Overall Study|Death|1|||
28045805|NCT00466440|54703840|FG001|Overall Study|Death|1|||
28045806|NCT00466440|54703841|FG002|Overall Study|Death|0|||
28045807|NCT00466440|54703839|FG000|Overall Study|Progressive disease|13|||
28045808|NCT00466440|54703840|FG001|Overall Study|Progressive disease|5|||
28045809|NCT00466440|54703841|FG002|Overall Study|Progressive disease|4|||
28045810|NCT00466440|54703839|FG000|Overall Study|Lost to Follow-up|0|||
28045811|NCT00466440|54703840|FG001|Overall Study|Lost to Follow-up|1|||
28045812|NCT00466440|54703841|FG002|Overall Study|Lost to Follow-up|0|||
28045813|NCT00466440|54703839|FG000|Overall Study|Physician Decision|0|||
28045814|NCT00466440|54703840|FG001|Overall Study|Physician Decision|1|||
28045815|NCT00466440|54703841|FG002|Overall Study|Physician Decision|2|||
28045816|NCT00466440|54703839|FG000|Overall Study|Protocol entry criteria not met|0|||
28045817|NCT00466440|54703840|FG001|Overall Study|Protocol entry criteria not met|0|||
28045818|NCT00466440|54703841|FG002|Overall Study|Protocol entry criteria not met|4|||
28045819|NCT00466440|54703839|FG000|Overall Study|Withdrawal by Subject|0|||
28045820|NCT00466440|54703840|FG001|Overall Study|Withdrawal by Subject|1|||
28045821|NCT00466440|54703841|FG002|Overall Study|Withdrawal by Subject|0|||
28045822|NCT00466440|54703839|FG000|Overall Study|Sponsor decision|0|||
28045823|NCT00466440|54703840|FG001|Overall Study|Sponsor decision|0|||
28045824|NCT00466440|54703841|FG002|Overall Study|Sponsor decision|1|||
28045825|NCT00465972|54703860|FG000|Overall Study|Withdrawal by Subject|2|||
28045826|NCT00465972|54703861|FG001|Overall Study|Withdrawal by Subject|1|||
28045827|NCT00465894|54703871|FG000|Treatment For 12 Weeks|Lost to Follow-up|4|||
28045828|NCT00465894|54703872|FG001|Treatment For 12 Weeks|Lost to Follow-up|1|||
28045829|NCT00465894|54703871|FG000|Treatment For 12 Weeks|Family Issues|1|||
28045830|NCT00465894|54703872|FG001|Treatment For 12 Weeks|Family Issues|1|||
28045831|NCT00465894|54703871|FG000|Treatment For 12 Weeks|Withdrawal by Subject|0|||
28045832|NCT00465894|54703872|FG001|Treatment For 12 Weeks|Withdrawal by Subject|1|||
28045833|NCT00330460|54703896|FG000|Overall Study|Physician Decision|1|||
28045834|NCT00330460|54703897|FG001|Overall Study|Physician Decision|0|||
28045835|NCT00330460|54703896|FG000|Overall Study|Adverse Event|10|||
28045836|NCT00330460|54703897|FG001|Overall Study|Adverse Event|8|||
28045837|NCT00330460|54703896|FG000|Overall Study|Withdrawal by Subject|18|||
28045838|NCT00330460|54703897|FG001|Overall Study|Withdrawal by Subject|17|||
28045839|NCT00330460|54703896|FG000|Overall Study|Death|1|||
28045840|NCT00330460|54703897|FG001|Overall Study|Death|1|||
28045841|NCT00330460|54703896|FG000|Overall Study|Ineligibility determined|1|||
28045842|NCT00330460|54703897|FG001|Overall Study|Ineligibility determined|3|||
28045843|NCT00330460|54703896|FG000|Overall Study|Lost to Follow-up|8|||
28045844|NCT00330460|54703897|FG001|Overall Study|Lost to Follow-up|3|||
28045845|NCT00330460|54703896|FG000|Overall Study|Noncompliance|2|||
28045846|NCT00330460|54703897|FG001|Overall Study|Noncompliance|1|||
28045847|NCT00330460|54703896|FG000|Overall Study|Other|1|||
28045848|NCT00330460|54703897|FG001|Overall Study|Other|0|||
28045849|NCT00454116|54703906|FG000|Overall Study|Adverse Event|5|||
28045850|NCT00454116|54703907|FG001|Overall Study|Adverse Event|11|||
28045851|NCT00454116|54703908|FG002|Overall Study|Adverse Event|9|||
28045852|NCT00454116|54703906|FG000|Overall Study|Condition under investigation worsened|17|||
28045853|NCT00454116|54703907|FG001|Overall Study|Condition under investigation worsened|13|||
28045854|NCT00454116|54703908|FG002|Overall Study|Condition under investigation worsened|18|||
28045855|NCT00454116|54703906|FG000|Overall Study|Withdrawal by Subject|3|||
28045856|NCT00454116|54703907|FG001|Overall Study|Withdrawal by Subject|3|||
28045857|NCT00454116|54703908|FG002|Overall Study|Withdrawal by Subject|1|||
28045858|NCT00454116|54703906|FG000|Overall Study|Other|2|||
28045859|NCT00454116|54703907|FG001|Overall Study|Other|2|||
28045860|NCT00454116|54703908|FG002|Overall Study|Other|0|||
28045861|NCT00465816|54703919|FG000|Overall Study|Lost to Follow-up|0|||
28045862|NCT00465816|54703920|FG001|Overall Study|Lost to Follow-up|0|||
28045863|NCT00465816|54703921|FG002|Overall Study|Lost to Follow-up|2|||
28045864|NCT00465738|54703932|FG000|Overall Study|Lost to Follow-up|2|||
28045865|NCT00465738|54703933|FG001|Overall Study|Lost to Follow-up|0|||
28045866|NCT00465738|54703932|FG000|Overall Study|Adverse Event|0|||
28045867|NCT00465738|54703933|FG001|Overall Study|Adverse Event|1|||
28045868|NCT00465738|54703932|FG000|Overall Study|Withdrawal by Subject|2|||
28045869|NCT00465738|54703933|FG001|Overall Study|Withdrawal by Subject|0|||
28045870|NCT00465738|54703932|FG000|Overall Study|Other|2|||
28045871|NCT00465738|54703933|FG001|Overall Study|Other|5|||
28045872|NCT00400179|54703941|FG000|Overall Study|Adverse Event|2|||
28045873|NCT00400179|54703942|FG001|Overall Study|Adverse Event|2|||
28045874|NCT00400179|54703941|FG000|Overall Study|Death|1|||
28045875|NCT00400179|54703942|FG001|Overall Study|Death|2|||
28045876|NCT00400179|54703941|FG000|Overall Study|Withdrew Consent|1|||
28045877|NCT00400179|54703942|FG001|Overall Study|Withdrew Consent|5|||
28045878|NCT00400179|54703941|FG000|Overall Study|Disease progression|1|||
28045879|NCT00400179|54703942|FG001|Overall Study|Disease progression|1|||
28045880|NCT00400179|54703941|FG000|Overall Study|Intercurrent illness|0|||
28045881|NCT00400179|54703942|FG001|Overall Study|Intercurrent illness|1|||
28045882|NCT00400179|54703941|FG000|Overall Study|Investigator judgment|0|||
28045883|NCT00400179|54703942|FG001|Overall Study|Investigator judgment|1|||
28045884|NCT00400179|54703941|FG000|Overall Study|Randomization error/patient ineligible|1|||
28045885|NCT00400179|54703942|FG001|Overall Study|Randomization error/patient ineligible|6|||
28045886|NCT00465270|54703950|FG000|Overall Study|Death|7|||
28045887|NCT00465270|54703951|FG001|Overall Study|Death|11|||
28045888|NCT00465270|54703950|FG000|Overall Study|Withdrawal by Subject|34|||
28045889|NCT00465270|54703951|FG001|Overall Study|Withdrawal by Subject|78|||
28045890|NCT00465270|54703950|FG000|Overall Study|Lost to Follow-up|60|||
28045891|NCT00465270|54703951|FG001|Overall Study|Lost to Follow-up|67|||
28045892|NCT00465270|54703950|FG000|Overall Study|Investigator request|3|||
28045893|NCT00465270|54703951|FG001|Overall Study|Investigator request|4|||
28045894|NCT00464568|54703957|FG000|Overall Study|Adverse Event|2|||
28045895|NCT00464490|54703976|FG000|Overall Study|Physician Decision|11|||
28045896|NCT00464490|54703977|FG001|Overall Study|Physician Decision|11|||
28045897|NCT03849300|54703987|FG000|Overall Study|move out to different area|1|||
28045898|NCT03849300|54703988|FG001|Overall Study|move out to different area|3|||
28045899|NCT03849300|54703989|FG002|Overall Study|move out to different area|1|||
28045900|NCT03849300|54703990|FG003|Overall Study|move out to different area|4|||
28045901|NCT03849300|54703987|FG000|Overall Study|scheduling/transportation conflict|4|||
28045902|NCT03849300|54703988|FG001|Overall Study|scheduling/transportation conflict|4|||
28045903|NCT03849300|54703989|FG002|Overall Study|scheduling/transportation conflict|3|||
28045904|NCT03849300|54703990|FG003|Overall Study|scheduling/transportation conflict|2|||
28045905|NCT00412893|54704004|FG000|Overall Study|Adverse Event|31|||
28045906|NCT00412893|54704005|FG001|Overall Study|Adverse Event|53|||
28045907|NCT00412893|54704004|FG000|Overall Study|Death|17|||
28045908|NCT00412893|54704005|FG001|Overall Study|Death|21|||
28045909|NCT00412893|54704004|FG000|Overall Study|Insufficient Therapeutic Response|39|||
28045910|NCT00412893|54704005|FG001|Overall Study|Insufficient Therapeutic Response|23|||
28045911|NCT00412893|54704004|FG000|Overall Study|Lost to Follow-up|2|||
28045912|NCT00412893|54704005|FG001|Overall Study|Lost to Follow-up|1|||
28045913|NCT00412893|54704004|FG000|Overall Study|Violation of Selection at Entry|17|||
28045914|NCT00412893|54704005|FG001|Overall Study|Violation of Selection at Entry|10|||
28045915|NCT00412893|54704004|FG000|Overall Study|Other Protocol Violation|10|||
28045916|NCT00412893|54704005|FG001|Overall Study|Other Protocol Violation|6|||
28045917|NCT00412893|54704004|FG000|Overall Study|Did Not Cooperate|12|||
28045918|NCT00412893|54704005|FG001|Overall Study|Did Not Cooperate|9|||
28045919|NCT00412893|54704004|FG000|Overall Study|Administrative Reason|12|||
28045920|NCT00412893|54704005|FG001|Overall Study|Administrative Reason|15|||
28045921|NCT00412893|54704004|FG000|Overall Study|Randomized but Never Received Study Drug|5|||
28045922|NCT00412893|54704005|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
28045923|NCT00412737|54704013|FG000|Overall Study|Death|1|||
28045924|NCT00412737|54704014|FG001|Overall Study|Death|0|||
28045925|NCT00412737|54704013|FG000|Overall Study|Adverse Event|3|||
28045926|NCT00412737|54704014|FG001|Overall Study|Adverse Event|2|||
28045927|NCT00412737|54704013|FG000|Overall Study|Refused Treatment|6|||
28045928|NCT00412737|54704014|FG001|Overall Study|Refused Treatment|2|||
28045929|NCT00412737|54704013|FG000|Overall Study|Failure to Return|6|||
28045930|NCT00412737|54704014|FG001|Overall Study|Failure to Return|2|||
28045931|NCT00508742|54704022|FG000|Period 1: Infant Series|Adverse Event|5|||
28045932|NCT00508742|54704023|FG001|Period 1: Infant Series|Adverse Event|4|||
28045933|NCT00508742|54704022|FG000|Period 1: Infant Series|Protocol Violation|1|||
28045934|NCT00508742|54704023|FG001|Period 1: Infant Series|Protocol Violation|0|||
28045935|NCT00508742|54704022|FG000|Period 1: Infant Series|Parent/Legal Guardian Request|31|||
28045936|NCT00508742|54704023|FG001|Period 1: Infant Series|Parent/Legal Guardian Request|40|||
28045937|NCT00508742|54704022|FG000|Period 1: Infant Series|Physician Decision|1|||
28045938|NCT00508742|54704023|FG001|Period 1: Infant Series|Physician Decision|0|||
28045939|NCT00508742|54704022|FG000|Period 1: Infant Series|Other|4|||
28045940|NCT00508742|54704023|FG001|Period 1: Infant Series|Other|1|||
28045941|NCT00508742|54704022|FG000|Period 2: After Infant Series|Adverse Event|2|||
28045942|NCT00508742|54704023|FG001|Period 2: After Infant Series|Adverse Event|6|||
28045943|NCT00508742|54704022|FG000|Period 2: After Infant Series|Lost to Follow-up|1|||
28045944|NCT00508742|54704023|FG001|Period 2: After Infant Series|Lost to Follow-up|1|||
28045945|NCT00508742|54704022|FG000|Period 2: After Infant Series|Protocol Violation|1|||
28045946|NCT00508742|54704023|FG001|Period 2: After Infant Series|Protocol Violation|0|||
28045947|NCT00508742|54704022|FG000|Period 2: After Infant Series|Parent/Legal Guardian Request|0|||
28045948|NCT00508742|54704023|FG001|Period 2: After Infant Series|Parent/Legal Guardian Request|3|||
28045949|NCT00508742|54704022|FG000|Period 2: After Infant Series|Failed to Return|1|||
28045950|NCT00508742|54704023|FG001|Period 2: After Infant Series|Failed to Return|0|||
28045951|NCT00508742|54704022|FG000|Period 2: After Infant Series|Other|2|||
28045952|NCT00508742|54704023|FG001|Period 2: After Infant Series|Other|1|||
28045953|NCT00508742|54704022|FG000|Period 3: Toddler Dose|Adverse Event|1|||
28045954|NCT00508742|54704023|FG001|Period 3: Toddler Dose|Adverse Event|0|||
28045955|NCT00508742|54704022|FG000|Period 3: Toddler Dose|Lost to Follow-up|2|||
28045956|NCT00508742|54704023|FG001|Period 3: Toddler Dose|Lost to Follow-up|3|||
28045957|NCT00508742|54704022|FG000|Period 3: Toddler Dose|Parent/Legal Guardian Request|17|||
28045958|NCT00508742|54704023|FG001|Period 3: Toddler Dose|Parent/Legal Guardian Request|8|||
28045959|NCT00508742|54704022|FG000|Period 3: Toddler Dose|Other|5|||
28045960|NCT00508742|54704023|FG001|Period 3: Toddler Dose|Other|4|||
28045961|NCT00508274|54704044|FG000|Overall Study|Adverse Event|5|||
28045962|NCT00508274|54704044|FG000|Overall Study|Death|7|||
28045963|NCT00508274|54704044|FG000|Overall Study|Disease progression|32|||
28045964|NCT00508274|54704044|FG000|Overall Study|Withdrawal by Subject|1|||
28045965|NCT00508274|54704044|FG000|Overall Study|Subject received new anti-cancer chemotherapy/traditional Chinese medicine|2|||
28045966|NCT00508274|54704044|FG000|Overall Study|Missing|3|||
28045967|NCT00499460|54704050|FG000|Intervention 1 (30 Days)|Withdrawal by Subject|1|||
28045968|NCT00499460|54704051|FG001|Intervention 1 (30 Days)|Withdrawal by Subject|0|||
28045969|NCT00499460|54704050|FG000|Intervention 1 (30 Days)|Fainting upon Blood Draw|1|||
28045970|NCT00499460|54704051|FG001|Intervention 1 (30 Days)|Fainting upon Blood Draw|0|||
28045971|NCT00499460|54704050|FG000|Intervention 2 (30 Days)|Withdrawal by Subject|0|||
28045972|NCT00499460|54704051|FG001|Intervention 2 (30 Days)|Withdrawal by Subject|1|||
28045973|NCT00412113|54704069|FG000|Overall Study|Adverse Event|11|||
28045974|NCT00412113|54704070|FG001|Overall Study|Adverse Event|15|||
28045975|NCT00412113|54704069|FG000|Overall Study|did not receive treatment|1|||
28045976|NCT00412113|54704070|FG001|Overall Study|did not receive treatment|0|||
28045977|NCT00411645|54704078|FG000|Overall Study|Consent Withdrawn|13|||
28045978|NCT00411645|54704079|FG001|Overall Study|Consent Withdrawn|22|||
28045979|NCT00411645|54704078|FG000|Overall Study|Death|56|||
28045980|NCT00411645|54704079|FG001|Overall Study|Death|135|||
28045981|NCT00411645|54704078|FG000|Overall Study|Investigator/Sponsor Decision|10|||
28045982|NCT00411645|54704079|FG001|Overall Study|Investigator/Sponsor Decision|7|||
28045983|NCT00411645|54704078|FG000|Overall Study|Lost to Follow-up|2|||
28045984|NCT00411645|54704079|FG001|Overall Study|Lost to Follow-up|0|||
28045985|NCT00490724|54704089|FG000|Period I|Physician Decision|0|||
28045986|NCT00490724|54704090|FG001|Period I|Physician Decision|0|||
28045987|NCT00490724|54704091|FG002|Period I|Physician Decision|1|||
28045988|NCT00490724|54704089|FG000|Period II|Treatment Discontinuation|3|||
28045989|NCT00490724|54704090|FG001|Period II|Treatment Discontinuation|1|||
28045990|NCT00490724|54704091|FG002|Period II|Treatment Discontinuation|3|||
28045991|NCT03835221|54704099|FG000|Methafilcon A|Withdrawal by Subject|1|||
28045992|NCT00398073|54704107|FG000|Overall Study|Withdrawal by Subject|1|||
28045993|NCT00398073|54704108|FG001|Overall Study|Withdrawal by Subject|0|||
28045994|NCT00490646|54704116|FG000|Overall Study|Still on trastuzumab monotherapy|1|||
28045995|NCT00490646|54704117|FG001|Overall Study|Still on trastuzumab monotherapy|1|||
28045996|NCT00490646|54704116|FG000|Overall Study|Never Treated (had an adverse event)|1|||
28045997|NCT00490646|54704117|FG001|Overall Study|Never Treated (had an adverse event)|0|||
28045998|NCT00490646|54704116|FG000|Overall Study|Never Treated (withdrew consent)|0|||
28045999|NCT00490646|54704117|FG001|Overall Study|Never Treated (withdrew consent)|1|||
28046000|NCT00388947|54704123|FG000|Overall Study|Protocol Violation|47|||
28046001|NCT00490568|54704127|FG000|Overall Study|Adverse Event|116|||
28046002|NCT00490568|54704127|FG000|Overall Study|Lost to Follow-up|13|||
28046003|NCT00490568|54704127|FG000|Overall Study|Protocol Violation|45|||
28046004|NCT00490568|54704127|FG000|Overall Study|Withdrawal by Subject|135|||
28046005|NCT00490568|54704127|FG000|Overall Study|Still in the study at termination|974|||
28046006|NCT00490568|54704127|FG000|Overall Study|Other|1|||
28046007|NCT00490568|54704127|FG000|Overall Study|Exclusion criteria met|1|||
28046008|NCT00490568|54704127|FG000|Overall Study|Caregiver related|20|||
28046009|NCT00490568|54704127|FG000|Overall Study|Abnormal ECG|25|||
28046010|NCT00490568|54704127|FG000|Overall Study|Participant refused follow-up|9|||
28046011|NCT00490568|54704127|FG000|Overall Study|Legal representative withdrew consent|1|||
28046012|NCT00490568|54704127|FG000|Overall Study|Disease progression|4|||
28046013|NCT00490568|54704127|FG000|Overall Study|Unmet inclusion-exclusion criteria|5|||
28046014|NCT00490568|54704127|FG000|Overall Study|Investigator decision|3|||
28046015|NCT00490568|54704127|FG000|Overall Study|Non-Compliance|7|||
28046016|NCT00490568|54704127|FG000|Overall Study|Efficacy related|3|||
28046017|NCT00490568|54704127|FG000|Overall Study|Participant died|1|||
28046018|NCT00490568|54704127|FG000|Overall Study|Participant withdrawal due to surgery|1|||
28046019|NCT00561353|54704142|FG000|Overall Study|Subject reached a virologic endpoint|2|||
28046020|NCT00561353|54704143|FG001|Overall Study|Subject reached a virologic endpoint|1|||
28046021|NCT00561353|54704144|FG002|Overall Study|Subject reached a virologic endpoint|1|||
28046022|NCT00561353|54704145|FG003|Overall Study|Subject reached a virologic endpoint|4|||
28046023|NCT00561353|54704146|FG004|Overall Study|Subject reached a virologic endpoint|1|||
28046024|NCT00561353|54704147|FG005|Overall Study|Subject reached a virologic endpoint|3|||
28046025|NCT00561353|54704148|FG006|Overall Study|Subject reached a virologic endpoint|4|||
28046026|NCT00561353|54704149|FG007|Overall Study|Subject reached a virologic endpoint|4|||
28046027|NCT00561353|54704150|FG008|Overall Study|Subject reached a virologic endpoint|5|||
28046028|NCT00561353|54704151|FG009|Overall Study|Subject reached a virologic endpoint|0|||
28046029|NCT00561353|54704142|FG000|Overall Study|Subject ineligible to continue the trial|0|||
28046030|NCT00561353|54704143|FG001|Overall Study|Subject ineligible to continue the trial|0|||
28046031|NCT00561353|54704144|FG002|Overall Study|Subject ineligible to continue the trial|0|||
28046032|NCT00561353|54704145|FG003|Overall Study|Subject ineligible to continue the trial|0|||
28046033|NCT00561353|54704146|FG004|Overall Study|Subject ineligible to continue the trial|0|||
28046034|NCT00561353|54704147|FG005|Overall Study|Subject ineligible to continue the trial|1|||
28046035|NCT00561353|54704148|FG006|Overall Study|Subject ineligible to continue the trial|1|||
28046036|NCT00561353|54704149|FG007|Overall Study|Subject ineligible to continue the trial|0|||
28046037|NCT00561353|54704150|FG008|Overall Study|Subject ineligible to continue the trial|2|||
28046038|NCT00561353|54704151|FG009|Overall Study|Subject ineligible to continue the trial|1|||
28046039|NCT00561353|54704142|FG000|Overall Study|Other|1|||
28046040|NCT00561353|54704143|FG001|Overall Study|Other|0|||
28046041|NCT00561353|54704144|FG002|Overall Study|Other|1|||
28046042|NCT00561353|54704145|FG003|Overall Study|Other|0|||
28046043|NCT00561353|54704146|FG004|Overall Study|Other|0|||
28046044|NCT00561353|54704147|FG005|Overall Study|Other|2|||
28046045|NCT00561353|54704148|FG006|Overall Study|Other|0|||
28046046|NCT00561353|54704149|FG007|Overall Study|Other|0|||
28046047|NCT00561353|54704150|FG008|Overall Study|Other|0|||
28046048|NCT00561353|54704151|FG009|Overall Study|Other|0|||
28046049|NCT00561353|54704142|FG000|Overall Study|Adverse Event|0|||
28046050|NCT00561353|54704143|FG001|Overall Study|Adverse Event|0|||
27811427|NCT01871805|54267423|FG003|Phase II|Death|0|||
27811428|NCT01871805|54267424|FG004|Phase II|Death|0|||
28046051|NCT00561353|54704144|FG002|Overall Study|Adverse Event|0|||
28046052|NCT00561353|54704145|FG003|Overall Study|Adverse Event|2|||
28046053|NCT00561353|54704146|FG004|Overall Study|Adverse Event|0|||
28046054|NCT00561353|54704147|FG005|Overall Study|Adverse Event|0|||
28046055|NCT00561353|54704148|FG006|Overall Study|Adverse Event|1|||
28046056|NCT00561353|54704149|FG007|Overall Study|Adverse Event|0|||
28046057|NCT00561353|54704150|FG008|Overall Study|Adverse Event|0|||
28046058|NCT00561353|54704151|FG009|Overall Study|Adverse Event|1|||
28046059|NCT00561353|54704142|FG000|Overall Study|Lost to Follow-up|2|||
28046060|NCT00561353|54704143|FG001|Overall Study|Lost to Follow-up|0|||
28046061|NCT00561353|54704144|FG002|Overall Study|Lost to Follow-up|1|||
28046062|NCT00561353|54704145|FG003|Overall Study|Lost to Follow-up|0|||
28046063|NCT00561353|54704146|FG004|Overall Study|Lost to Follow-up|0|||
28046064|NCT00561353|54704147|FG005|Overall Study|Lost to Follow-up|0|||
28046065|NCT00561353|54704148|FG006|Overall Study|Lost to Follow-up|0|||
28046066|NCT00561353|54704149|FG007|Overall Study|Lost to Follow-up|0|||
28046067|NCT00561353|54704150|FG008|Overall Study|Lost to Follow-up|0|||
28046068|NCT00561353|54704151|FG009|Overall Study|Lost to Follow-up|0|||
28046069|NCT00561353|54704142|FG000|Overall Study|Withdrawal by Subject|0|||
28046070|NCT00561353|54704143|FG001|Overall Study|Withdrawal by Subject|2|||
28046071|NCT00561353|54704144|FG002|Overall Study|Withdrawal by Subject|0|||
28046072|NCT00561353|54704145|FG003|Overall Study|Withdrawal by Subject|0|||
28046073|NCT00561353|54704146|FG004|Overall Study|Withdrawal by Subject|0|||
28046074|NCT00561353|54704147|FG005|Overall Study|Withdrawal by Subject|0|||
28046075|NCT00561353|54704148|FG006|Overall Study|Withdrawal by Subject|0|||
28046076|NCT00561353|54704149|FG007|Overall Study|Withdrawal by Subject|0|||
28046077|NCT00561353|54704150|FG008|Overall Study|Withdrawal by Subject|0|||
28046078|NCT00561353|54704151|FG009|Overall Study|Withdrawal by Subject|0|||
28046079|NCT00560885|54704218|FG000|Overall Study|Death|7|||
28046080|NCT00560885|54704218|FG000|Overall Study|Withdrawal by Subject|1|||
28046081|NCT00397215|54704226|FG000|Month 0 (Day 0)|Adverse Event|0|||
28046082|NCT00397215|54704227|FG001|Month 0 (Day 0)|Adverse Event|1|||
28046083|NCT00397215|54704228|FG002|Month 0 (Day 0)|Adverse Event|0|||
27811429|NCT01871805|54267425|FG005|Phase II|Death|45|||
27811430|NCT01871805|54267420|FG000|Phase II|Alive in Survival Follow-up|0|||
27811431|NCT01871805|54267421|FG001|Phase II|Alive in Survival Follow-up|0|||
27811432|NCT01871805|54267422|FG002|Phase II|Alive in Survival Follow-up|0|||
27811433|NCT01871805|54267423|FG003|Phase II|Alive in Survival Follow-up|0|||
27811434|NCT01871805|54267424|FG004|Phase II|Alive in Survival Follow-up|0|||
27811435|NCT01871805|54267425|FG005|Phase II|Alive in Survival Follow-up|29|||
27811436|NCT01871805|54267420|FG000|Phase II|Lost to Follow-up|0|||
28046084|NCT00397215|54704229|FG003|Month 0 (Day 0)|Adverse Event|0|||
28046085|NCT00397215|54704226|FG000|Month 0 (Day 0)|Withdrawal by Subject|3|||
28046086|NCT00397215|54704227|FG001|Month 0 (Day 0)|Withdrawal by Subject|3|||
28046087|NCT00397215|54704228|FG002|Month 0 (Day 0)|Withdrawal by Subject|3|||
28046088|NCT00397215|54704229|FG003|Month 0 (Day 0)|Withdrawal by Subject|1|||
28046089|NCT00397215|54704226|FG000|Month 0 (Day 0)|Other|4|||
28046090|NCT00397215|54704227|FG001|Month 0 (Day 0)|Other|1|||
28046091|NCT00397215|54704228|FG002|Month 0 (Day 0)|Other|3|||
28046092|NCT00397215|54704229|FG003|Month 0 (Day 0)|Other|3|||
28046093|NCT00397215|54704226|FG000|Month 6 (Day 180)|Adverse Event|0|||
28046094|NCT00397215|54704227|FG001|Month 6 (Day 180)|Adverse Event|3|||
28046095|NCT00397215|54704228|FG002|Month 6 (Day 180)|Adverse Event|2|||
28046096|NCT00397215|54704229|FG003|Month 6 (Day 180)|Adverse Event|0|||
27811437|NCT01871805|54267421|FG001|Phase II|Lost to Follow-up|0|||
27811438|NCT01871805|54267422|FG002|Phase II|Lost to Follow-up|0|||
27811439|NCT01871805|54267423|FG003|Phase II|Lost to Follow-up|0|||
27811440|NCT01871805|54267424|FG004|Phase II|Lost to Follow-up|0|||
28046097|NCT00397215|54704226|FG000|Month 6 (Day 180)|Other|2|||
28046098|NCT00397215|54704227|FG001|Month 6 (Day 180)|Other|0|||
27811441|NCT01871805|54267425|FG005|Phase II|Lost to Follow-up|13|||
28046099|NCT00397215|54704228|FG002|Month 6 (Day 180)|Other|3|||
28046100|NCT00397215|54704229|FG003|Month 6 (Day 180)|Other|0|||
28046101|NCT00556439|54704246|FG000|Study Entry to Week 12|Lack of Efficacy|5|||
28046102|NCT00556439|54704247|FG001|Study Entry to Week 12|Lack of Efficacy|0|||
28046103|NCT00556439|54704248|FG002|Study Entry to Week 12|Lack of Efficacy|6|||
28046104|NCT00556439|54704249|FG003|Study Entry to Week 12|Lack of Efficacy|0|||
28046105|NCT00556439|54704246|FG000|Study Entry to Week 12|Physician Decision|1|||
28046106|NCT00556439|54704247|FG001|Study Entry to Week 12|Physician Decision|0|||
28046107|NCT00556439|54704248|FG002|Study Entry to Week 12|Physician Decision|0|||
28046108|NCT00556439|54704249|FG003|Study Entry to Week 12|Physician Decision|0|||
28046109|NCT00556439|54704246|FG000|Study Entry to Week 12|Withdrawal by Subject|1|||
28046110|NCT00556439|54704247|FG001|Study Entry to Week 12|Withdrawal by Subject|0|||
28046111|NCT00556439|54704248|FG002|Study Entry to Week 12|Withdrawal by Subject|1|||
28046112|NCT00556439|54704249|FG003|Study Entry to Week 12|Withdrawal by Subject|0|||
28046113|NCT00556439|54704246|FG000|Study Entry to Week 12|Recurrent infection|1|||
28046114|NCT00556439|54704247|FG001|Study Entry to Week 12|Recurrent infection|0|||
28046115|NCT00556439|54704248|FG002|Study Entry to Week 12|Recurrent infection|0|||
28046116|NCT00556439|54704249|FG003|Study Entry to Week 12|Recurrent infection|0|||
28046117|NCT00556439|54704246|FG000|Study Entry to Week 12|Malignancy|0|||
28046118|NCT00556439|54704247|FG001|Study Entry to Week 12|Malignancy|0|||
28046119|NCT00556439|54704248|FG002|Study Entry to Week 12|Malignancy|1|||
28046120|NCT00556439|54704249|FG003|Study Entry to Week 12|Malignancy|0|||
28046121|NCT00556439|54704246|FG000|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1|||
28046122|NCT00556439|54704247|FG001|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3|||
28046123|NCT00556439|54704248|FG002|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
27811442|NCT01719861|54267456|FG000|Cycle 1|Death|4|||
27811443|NCT01719861|54267456|FG000|Cycle 2|Death|1|||
27811444|NCT01853618|54267466|FG000|Overall Study|Bile duct stent blockage/progressive dis|1|||
28046124|NCT00556439|54704249|FG003|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
28046125|NCT00556439|54704246|FG000|After Week 12 (Randomized Study Period)|Physician Decision|1|||
28046126|NCT00556439|54704247|FG001|After Week 12 (Randomized Study Period)|Physician Decision|0|||
28046127|NCT00556439|54704248|FG002|After Week 12 (Randomized Study Period)|Physician Decision|0|||
28046128|NCT00556439|54704249|FG003|After Week 12 (Randomized Study Period)|Physician Decision|0|||
28046129|NCT00556439|54704246|FG000|After Week 12 (Randomized Study Period)|Malignancy|0|||
28046130|NCT00556439|54704247|FG001|After Week 12 (Randomized Study Period)|Malignancy|1|||
28046131|NCT00556439|54704248|FG002|After Week 12 (Randomized Study Period)|Malignancy|0|||
28046132|NCT00556439|54704249|FG003|After Week 12 (Randomized Study Period)|Malignancy|1|||
28046133|NCT00556439|54704246|FG000|After Week 12 (Randomized Study Period)|Severe infection|1|||
28046134|NCT00556439|54704247|FG001|After Week 12 (Randomized Study Period)|Severe infection|0|||
28046135|NCT00556439|54704248|FG002|After Week 12 (Randomized Study Period)|Severe infection|0|||
28046136|NCT00556439|54704249|FG003|After Week 12 (Randomized Study Period)|Severe infection|0|||
28046137|NCT00387465|54704262|FG000|Overall Study|Withdrawal by Subject|0|||
28046138|NCT00387465|54704263|FG001|Overall Study|Withdrawal by Subject|1|||
28046139|NCT00387465|54704264|FG002|Overall Study|Withdrawal by Subject|0|||
28046140|NCT00387153|54704281|FG000|Overall Study|Adverse Event|1|||
28046141|NCT00387153|54704281|FG000|Overall Study|Disease Progression|3|||
28046142|NCT00387153|54704281|FG000|Overall Study|Lack of Response|4|||
28046143|NCT00386607|54704285|FG000|Core|Adverse Event|40|||
28046144|NCT00386607|54704286|FG001|Core|Adverse Event|0|||
27811445|NCT01853618|54267467|FG001|Overall Study|Bile duct stent blockage/progressive dis|0|||
27811446|NCT01853618|54267468|FG002|Overall Study|Bile duct stent blockage/progressive dis|0|||
27811447|NCT01853618|54267469|FG003|Overall Study|Bile duct stent blockage/progressive dis|0|||
27811448|NCT01853618|54267470|FG004|Overall Study|Bile duct stent blockage/progressive dis|0|||
27811449|NCT01853618|54267466|FG000|Overall Study|Progressive disease|1|||
27811450|NCT01853618|54267467|FG001|Overall Study|Progressive disease|1|||
27811451|NCT01853618|54267468|FG002|Overall Study|Progressive disease|1|||
27811452|NCT01853618|54267469|FG003|Overall Study|Progressive disease|1|||
27811453|NCT01853618|54267470|FG004|Overall Study|Progressive disease|2|||
27811454|NCT01853618|54267466|FG000|Overall Study|Physician Decision|0|||
27811455|NCT01853618|54267467|FG001|Overall Study|Physician Decision|1|||
27811456|NCT01853618|54267468|FG002|Overall Study|Physician Decision|1|||
27811457|NCT01853618|54267469|FG003|Overall Study|Physician Decision|0|||
27847976|NCT01494038|54340781|FG000|Overall Study|Not able to get to clinic|21|||
27847977|NCT01494038|54340782|FG001|Overall Study|Not able to get to clinic|15|||
28046145|NCT00386607|54704285|FG000|Core|Abnormal laboratory value(s)|3|||
28046146|NCT00386607|54704286|FG001|Core|Abnormal laboratory value(s)|0|||
28046147|NCT00386607|54704285|FG000|Core|Unsatisfactory therapeutic effect|23|||
28046148|NCT00386607|54704286|FG001|Core|Unsatisfactory therapeutic effect|0|||
28046149|NCT00386607|54704285|FG000|Core|Condition no longer requires study drug|4|||
28046150|NCT00386607|54704286|FG001|Core|Condition no longer requires study drug|0|||
28046151|NCT00386607|54704285|FG000|Core|Patient withdrew consent|15|||
28046152|NCT00386607|54704286|FG001|Core|Patient withdrew consent|0|||
28046153|NCT00386607|54704285|FG000|Core|Lost to Follow-up|23|||
27811458|NCT01853618|54267470|FG004|Overall Study|Physician Decision|0|||
28046154|NCT00386607|54704286|FG001|Core|Lost to Follow-up|0|||
27811459|NCT01853618|54267466|FG000|Overall Study|Refused further treatment|0|||
27847978|NCT01494038|54340781|FG000|Overall Study|Not willing to adhere to reqs|2|||
28046155|NCT00386607|54704285|FG000|Core|Administrative problems|1|||
28046156|NCT00386607|54704286|FG001|Core|Administrative problems|0|||
28046157|NCT00386607|54704285|FG000|Core|Protocol Deviation|6|||
28046158|NCT00386607|54704286|FG001|Core|Protocol Deviation|0|||
28046159|NCT00386607|54704285|FG000|Extension|Adverse Event|0|||
28046160|NCT00386607|54704286|FG001|Extension|Adverse Event|6|||
28046161|NCT00386607|54704285|FG000|Extension|Abnormal laboratory value(s)|0|||
28046162|NCT00386607|54704286|FG001|Extension|Abnormal laboratory value(s)|1|||
28046163|NCT00386607|54704285|FG000|Extension|Administrative problems|0|||
28046164|NCT00386607|54704286|FG001|Extension|Administrative problems|1|||
28046165|NCT00386607|54704285|FG000|Extension|Lost to Follow-up|0|||
28046166|NCT00386607|54704286|FG001|Extension|Lost to Follow-up|3|||
28046167|NCT00386607|54704285|FG000|Extension|Patient withdrew consent|0|||
28046168|NCT00386607|54704286|FG001|Extension|Patient withdrew consent|5|||
28046169|NCT00386607|54704285|FG000|Extension|Unsatisfactory therapeutic effect|0|||
28046170|NCT00386607|54704286|FG001|Extension|Unsatisfactory therapeutic effect|1|||
28046171|NCT00410163|54704300|FG000|Treatment and Follow-up Phase (2 Years)|Adverse Event|4|||
28046172|NCT00410163|54704301|FG001|Treatment and Follow-up Phase (2 Years)|Adverse Event|2|||
28046173|NCT00410163|54704300|FG000|Treatment and Follow-up Phase (2 Years)|Death|1|||
28046174|NCT00410163|54704301|FG001|Treatment and Follow-up Phase (2 Years)|Death|1|||
28046175|NCT00410163|54704300|FG000|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2|||
28046176|NCT00410163|54704301|FG001|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1|||
28046177|NCT00410163|54704300|FG000|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0|||
28046178|NCT00410163|54704301|FG001|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4|||
28046179|NCT00410163|54704300|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2|||
28046180|NCT00410163|54704301|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1|||
28046181|NCT00410163|54704300|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1|||
28046182|NCT00410163|54704301|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0|||
28046183|NCT00410163|54704300|FG000|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
28046184|NCT00410163|54704301|FG001|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
28046185|NCT00410163|54704300|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1|||
28046186|NCT00410163|54704301|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0|||
28046187|NCT00410163|54704300|FG000|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0|||
28046188|NCT00410163|54704301|FG001|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1|||
28046189|NCT00410163|54704300|FG000|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3|||
28046190|NCT00410163|54704301|FG001|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1|||
28046191|NCT00410163|54704300|FG000|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
28046192|NCT00410163|54704301|FG001|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
28046193|NCT00410163|54704300|FG000|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1|||
28046194|NCT00410163|54704301|FG001|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0|||
28046195|NCT00410163|54704300|FG000|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4|||
28046196|NCT00410163|54704301|FG001|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8|||
28046197|NCT00410163|54704300|FG000|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1|||
28046198|NCT00410163|54704301|FG001|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0|||
28046199|NCT00409617|54704337|FG000|Overall Study|Adverse Event|57|||
28046200|NCT00409617|54704337|FG000|Overall Study|Lack of Efficacy|54|||
28046201|NCT00409617|54704337|FG000|Overall Study|Lost to Follow-up|2|||
28046202|NCT00409617|54704337|FG000|Overall Study|Protocol Violation|24|||
28046203|NCT00409617|54704337|FG000|Overall Study|Withdrawal by Subject|8|||
28046204|NCT00409617|54704337|FG000|Overall Study|Administrative reasons|1|||
28046205|NCT00409617|54704337|FG000|Overall Study|Not described|14|||
28046206|NCT00300274|54704344|FG000|Overall Study|Withdrawal by Subject|12|||
28046207|NCT00300274|54704345|FG001|Overall Study|Withdrawal by Subject|3|||
28046208|NCT00300274|54704346|FG002|Overall Study|Withdrawal by Subject|14|||
28046209|NCT00300274|54704344|FG000|Overall Study|Lost to Follow-up|3|||
28046210|NCT00300274|54704345|FG001|Overall Study|Lost to Follow-up|4|||
28046211|NCT00300274|54704346|FG002|Overall Study|Lost to Follow-up|5|||
28046212|NCT00300274|54704344|FG000|Overall Study|Death|31|||
28046213|NCT00300274|54704345|FG001|Overall Study|Death|20|||
28046214|NCT00300274|54704346|FG002|Overall Study|Death|25|||
28046215|NCT00300274|54704344|FG000|Overall Study|Re-transplant|0|||
28046216|NCT00300274|54704345|FG001|Overall Study|Re-transplant|0|||
28046217|NCT00300274|54704346|FG002|Overall Study|Re-transplant|1|||
28046218|NCT00299728|54704356|FG000|Overall Study|Lost to Follow-up|0|||
28046219|NCT00299728|54704357|FG001|Overall Study|Lost to Follow-up|1|||
28046220|NCT00299728|54704356|FG000|Overall Study|Withdrawal by Subject|0|||
28046221|NCT00299728|54704357|FG001|Overall Study|Withdrawal by Subject|1|||
28046222|NCT00299728|54704356|FG000|Overall Study|Progressive disease|0|||
28046223|NCT00299728|54704357|FG001|Overall Study|Progressive disease|1|||
28046224|NCT00396591|54704363|FG000|Overall Study|Disease Progression|13|||
28046225|NCT00396591|54704363|FG000|Overall Study|Adverse Event|2|||
28046226|NCT00396591|54704363|FG000|Overall Study|Participant request|1|||
28046227|NCT00316264|54704370|FG000|Overall Study|Lost to Follow-up|0|||
28046228|NCT00316264|54704371|FG001|Overall Study|Lost to Follow-up|1|||
28046229|NCT00316264|54704372|FG002|Overall Study|Lost to Follow-up|0|||
28046230|NCT00316264|54704370|FG000|Overall Study|Withdrawal of Consent|3|||
28046231|NCT00316264|54704371|FG001|Overall Study|Withdrawal of Consent|5|||
28046232|NCT00316264|54704372|FG002|Overall Study|Withdrawal of Consent|6|||
28046233|NCT00316264|54704370|FG000|Overall Study|Death|2|||
28046234|NCT00316264|54704371|FG001|Overall Study|Death|0|||
28046235|NCT00316264|54704372|FG002|Overall Study|Death|0|||
28046236|NCT00316264|54704370|FG000|Overall Study|Other|1|||
28046237|NCT00316264|54704371|FG001|Overall Study|Other|1|||
28046238|NCT00316264|54704372|FG002|Overall Study|Other|0|||
28046239|NCT00385827|54704383|FG000|Part 1|Adverse Event|1|||
28046240|NCT00385827|54704384|FG001|Part 1|Adverse Event|0|||
28046241|NCT00385827|54704385|FG002|Part 1|Adverse Event|0|||
28046242|NCT00385827|54704383|FG000|Part 1|Death|2|||
28046243|NCT00385827|54704384|FG001|Part 1|Death|0|||
28046244|NCT00385827|54704385|FG002|Part 1|Death|0|||
28046245|NCT00385827|54704383|FG000|Part 1|Lack of Efficacy|5|||
28046246|NCT00385827|54704384|FG001|Part 1|Lack of Efficacy|0|||
28046247|NCT00385827|54704385|FG002|Part 1|Lack of Efficacy|0|||
28046248|NCT00385827|54704383|FG000|Part 1|Other|1|||
28046249|NCT00385827|54704384|FG001|Part 1|Other|0|||
28046250|NCT00385827|54704385|FG002|Part 1|Other|0|||
28046251|NCT00385827|54704383|FG000|Part 2|Adverse Event|0|||
28046252|NCT00385827|54704384|FG001|Part 2|Adverse Event|6|||
28046253|NCT00385827|54704385|FG002|Part 2|Adverse Event|10|||
28046254|NCT00385827|54704383|FG000|Part 2|Death|0|||
28046255|NCT00385827|54704384|FG001|Part 2|Death|0|||
28046256|NCT00385827|54704385|FG002|Part 2|Death|2|||
28046257|NCT00385827|54704383|FG000|Part 2|Lack of Efficacy|0|||
28046258|NCT00385827|54704384|FG001|Part 2|Lack of Efficacy|14|||
28046259|NCT00385827|54704385|FG002|Part 2|Lack of Efficacy|13|||
28046260|NCT00385827|54704383|FG000|Part 2|Randomized but not treated|0|||
28046261|NCT00385827|54704384|FG001|Part 2|Randomized but not treated|2|||
28046262|NCT00385827|54704385|FG002|Part 2|Randomized but not treated|2|||
28046263|NCT00385827|54704383|FG000|Part 2|Other|0|||
28046264|NCT00385827|54704384|FG001|Part 2|Other|11|||
28046265|NCT00385827|54704385|FG002|Part 2|Other|21|||
28046266|NCT00498602|54704402|FG000|Overall Study|Death|0|||
28046267|NCT00498602|54704403|FG001|Overall Study|Death|0|||
28046268|NCT00498602|54704404|FG002|Overall Study|Death|0|||
28046269|NCT00498602|54704405|FG003|Overall Study|Death|0|||
28046270|NCT00498602|54704406|FG004|Overall Study|Death|0|||
28046271|NCT00498602|54704407|FG005|Overall Study|Death|1|||
28046272|NCT00498602|54704408|FG006|Overall Study|Death|0|||
28046273|NCT00498602|54704402|FG000|Overall Study|Lack of Efficacy|1|||
28046274|NCT00498602|54704403|FG001|Overall Study|Lack of Efficacy|0|||
28046275|NCT00498602|54704404|FG002|Overall Study|Lack of Efficacy|0|||
28046276|NCT00498602|54704405|FG003|Overall Study|Lack of Efficacy|0|||
28046277|NCT00498602|54704406|FG004|Overall Study|Lack of Efficacy|0|||
28046278|NCT00498602|54704407|FG005|Overall Study|Lack of Efficacy|0|||
28046279|NCT00498602|54704408|FG006|Overall Study|Lack of Efficacy|0|||
28046280|NCT00498602|54704402|FG000|Overall Study|Lost to Follow-up|0|||
28046281|NCT00498602|54704403|FG001|Overall Study|Lost to Follow-up|2|||
28046282|NCT00498602|54704404|FG002|Overall Study|Lost to Follow-up|0|||
28046283|NCT00498602|54704405|FG003|Overall Study|Lost to Follow-up|2|||
28046284|NCT00498602|54704406|FG004|Overall Study|Lost to Follow-up|0|||
28046285|NCT00498602|54704407|FG005|Overall Study|Lost to Follow-up|0|||
28046286|NCT00498602|54704408|FG006|Overall Study|Lost to Follow-up|0|||
28046287|NCT00498602|54704402|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
28046288|NCT00498602|54704403|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
28046289|NCT00498602|54704404|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
28046290|NCT00498602|54704405|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
28046291|NCT00498602|54704406|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
28046292|NCT00498602|54704407|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
28046293|NCT00498602|54704408|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
28046294|NCT00498602|54704402|FG000|Overall Study|AE not related to Study Drug|1|||
28046295|NCT00498602|54704403|FG001|Overall Study|AE not related to Study Drug|3|||
28046296|NCT00498602|54704404|FG002|Overall Study|AE not related to Study Drug|0|||
28046297|NCT00498602|54704405|FG003|Overall Study|AE not related to Study Drug|0|||
28046298|NCT00498602|54704406|FG004|Overall Study|AE not related to Study Drug|2|||
28046299|NCT00498602|54704407|FG005|Overall Study|AE not related to Study Drug|2|||
28046300|NCT00498602|54704408|FG006|Overall Study|AE not related to Study Drug|1|||
28046301|NCT00498602|54704402|FG000|Overall Study|Caregiver Request|2|||
28046302|NCT00498602|54704403|FG001|Overall Study|Caregiver Request|2|||
28046303|NCT00498602|54704404|FG002|Overall Study|Caregiver Request|2|||
28046304|NCT00498602|54704405|FG003|Overall Study|Caregiver Request|0|||
28046305|NCT00498602|54704406|FG004|Overall Study|Caregiver Request|1|||
28046306|NCT00498602|54704407|FG005|Overall Study|Caregiver Request|2|||
28046307|NCT00498602|54704408|FG006|Overall Study|Caregiver Request|0|||
28046308|NCT00498602|54704402|FG000|Overall Study|Investigator Request|0|||
28046309|NCT00498602|54704403|FG001|Overall Study|Investigator Request|0|||
28046310|NCT00498602|54704404|FG002|Overall Study|Investigator Request|1|||
28046311|NCT00498602|54704405|FG003|Overall Study|Investigator Request|0|||
28046312|NCT00498602|54704406|FG004|Overall Study|Investigator Request|0|||
28046313|NCT00498602|54704407|FG005|Overall Study|Investigator Request|0|||
28046314|NCT00498602|54704408|FG006|Overall Study|Investigator Request|0|||
28046315|NCT00498602|54704402|FG000|Overall Study|Subject Request|3|||
28046316|NCT00498602|54704403|FG001|Overall Study|Subject Request|0|||
28046317|NCT00498602|54704404|FG002|Overall Study|Subject Request|1|||
28046318|NCT00498602|54704405|FG003|Overall Study|Subject Request|1|||
28046319|NCT00498602|54704406|FG004|Overall Study|Subject Request|1|||
28046320|NCT00498602|54704407|FG005|Overall Study|Subject Request|4|||
28046321|NCT00498602|54704408|FG006|Overall Study|Subject Request|1|||
28046322|NCT00498602|54704402|FG000|Overall Study|Other|2|||
28046323|NCT00498602|54704403|FG001|Overall Study|Other|3|||
28046324|NCT00498602|54704404|FG002|Overall Study|Other|1|||
28046325|NCT00498602|54704405|FG003|Overall Study|Other|0|||
28046326|NCT00498602|54704406|FG004|Overall Study|Other|0|||
28046327|NCT00498602|54704407|FG005|Overall Study|Other|3|||
28046328|NCT00498602|54704408|FG006|Overall Study|Other|0|||
28046329|NCT00507728|54704427|FG000|Randomization to Month 3|Lost to Follow-up|15|||
28046330|NCT00507728|54704428|FG001|Randomization to Month 3|Lost to Follow-up|14|||
28046331|NCT00507728|54704429|FG002|Randomization to Month 3|Lost to Follow-up|20|||
28046332|NCT00507728|54704427|FG000|From 3 Months to 6 Months|Lost to Follow-up|6|||
28046333|NCT00507728|54704428|FG001|From 3 Months to 6 Months|Lost to Follow-up|10|||
28046334|NCT00507728|54704429|FG002|From 3 Months to 6 Months|Lost to Follow-up|9|||
28046335|NCT00498368|54704445|FG000|Overall Study|Withdrawal by Subject|3|||
28046336|NCT00498368|54704446|FG001|Overall Study|Withdrawal by Subject|2|||
28046337|NCT00385671|54704455|FG000|Overall Study|Adverse Event|14|||
28046338|NCT00385671|54704456|FG001|Overall Study|Adverse Event|27|||
28046339|NCT00385671|54704457|FG002|Overall Study|Adverse Event|18|||
28046340|NCT00385671|54704455|FG000|Overall Study|Lack of Efficacy|5|||
28046341|NCT00385671|54704456|FG001|Overall Study|Lack of Efficacy|9|||
28046342|NCT00385671|54704457|FG002|Overall Study|Lack of Efficacy|5|||
28046343|NCT00385671|54704455|FG000|Overall Study|Lost to Follow-up|6|||
28046344|NCT00385671|54704456|FG001|Overall Study|Lost to Follow-up|6|||
28046345|NCT00385671|54704457|FG002|Overall Study|Lost to Follow-up|5|||
28046346|NCT00385671|54704455|FG000|Overall Study|Physician Decision|2|||
28046347|NCT00385671|54704456|FG001|Overall Study|Physician Decision|1|||
28046348|NCT00385671|54704457|FG002|Overall Study|Physician Decision|2|||
28046349|NCT00385671|54704455|FG000|Overall Study|Protocol Violation|5|||
28046350|NCT00385671|54704456|FG001|Overall Study|Protocol Violation|2|||
28046351|NCT00385671|54704457|FG002|Overall Study|Protocol Violation|1|||
28046352|NCT00385671|54704455|FG000|Overall Study|Sponsor Decision|2|||
28046353|NCT00385671|54704456|FG001|Overall Study|Sponsor Decision|2|||
28046354|NCT00385671|54704457|FG002|Overall Study|Sponsor Decision|1|||
28046355|NCT00385671|54704455|FG000|Overall Study|Withdrawal by Subject|4|||
28046356|NCT00385671|54704456|FG001|Overall Study|Withdrawal by Subject|4|||
28046357|NCT00385671|54704457|FG002|Overall Study|Withdrawal by Subject|4|||
28046358|NCT00497198|54704469|FG000|Overall Study|Adverse Event|4|||
28046359|NCT00497198|54704470|FG001|Overall Study|Adverse Event|2|||
28046360|NCT00497198|54704469|FG000|Overall Study|Physician Decision|1|||
28046361|NCT00497198|54704470|FG001|Overall Study|Physician Decision|2|||
28046362|NCT00497198|54704469|FG000|Overall Study|Withdrawal by Subject|0|||
28046363|NCT00497198|54704470|FG001|Overall Study|Withdrawal by Subject|1|||
27939893|NCT01038609|54596215|FG000|Overall Study|Death in the Family|1|||
28046364|NCT00496964|54704478|FG000|Overall Study|Withdrawal by Subject|0|||
28046365|NCT00496964|54704479|FG001|Overall Study|Withdrawal by Subject|1|||
28046366|NCT00490490|54704487|FG000|Completed Assessment for TTP|Withdrawal by Subject|1|||
28046367|NCT00490490|54704487|FG000|Completed Assessment for TTP|Lost to Follow-up|2|||
28046368|NCT00385593|54704493|FG000|Overall Study|Adverse Event|3|||
28046369|NCT00385593|54704494|FG001|Overall Study|Adverse Event|2|||
28046370|NCT00385593|54704493|FG000|Overall Study|Withdrawal by Subject|17|||
28046371|NCT00385593|54704494|FG001|Overall Study|Withdrawal by Subject|7|||
28046372|NCT00385593|54704493|FG000|Overall Study|Lost to Follow-up|12|||
28046373|NCT00385593|54704494|FG001|Overall Study|Lost to Follow-up|8|||
28046374|NCT00385593|54704493|FG000|Overall Study|Protocol Violation|7|||
28046375|NCT00385593|54704494|FG001|Overall Study|Protocol Violation|4|||
28046376|NCT00385593|54704493|FG000|Overall Study|Several reasons|17|||
28046377|NCT00385593|54704494|FG001|Overall Study|Several reasons|15|||
28046378|NCT00385593|54704493|FG000|Overall Study|Incorrect inclusion|2|||
28046379|NCT00385593|54704494|FG001|Overall Study|Incorrect inclusion|0|||
28046380|NCT00385593|54704493|FG000|Overall Study|Incorrect randomization|0|||
28046381|NCT00385593|54704494|FG001|Overall Study|Incorrect randomization|1|||
28046382|NCT00495794|54704502|FG000|Overall Study|Pharmacist did not activate patient|522|||
28046383|NCT00495794|54704503|FG001|Overall Study|Pharmacist did not activate patient|0|||
28046384|NCT00495170|54704509|FG000|Overall Study|Lost to Follow-up|9|||
28046385|NCT00495170|54704509|FG000|Overall Study|Withdrawal by Subject|3|||
28046386|NCT00495170|54704509|FG000|Overall Study|Inappropriate staging|8|||
28046387|NCT03853148|54704517|FG000|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
28046388|NCT03853148|54704518|FG001|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
28046389|NCT03853148|54704519|FG002|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
28046390|NCT03853148|54704520|FG003|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
28046391|NCT00385203|54704532|FG000|Overall Study|Adverse Event|5|||
28046392|NCT00385203|54704533|FG001|Overall Study|Adverse Event|4|||
28046393|NCT00385203|54704532|FG000|Overall Study|Death|1|||
28046394|NCT00385203|54704533|FG001|Overall Study|Death|0|||
28046395|NCT00385203|54704532|FG000|Overall Study|Condition under investigation worsened|18|||
28046396|NCT00385203|54704533|FG001|Overall Study|Condition under investigation worsened|3|||
28046397|NCT00385203|54704532|FG000|Overall Study|Incorrect enrollment|2|||
28046398|NCT00385203|54704533|FG001|Overall Study|Incorrect enrollment|0|||
28046399|NCT00408993|54704542|FG000|Overall Study|Adverse Event|15|||
28046400|NCT00408993|54704543|FG001|Overall Study|Adverse Event|4|||
28046401|NCT00408993|54704542|FG000|Overall Study|Protocol Violation|1|||
28046402|NCT00408993|54704543|FG001|Overall Study|Protocol Violation|6|||
28046403|NCT00408993|54704542|FG000|Overall Study|Lack of Efficacy|1|||
28046404|NCT00408993|54704543|FG001|Overall Study|Lack of Efficacy|4|||
28046405|NCT00408993|54704542|FG000|Overall Study|Withdrawal by Subject|2|||
28046406|NCT00408993|54704543|FG001|Overall Study|Withdrawal by Subject|3|||
28046407|NCT00395967|54704553|FG000|Treatment Period|Failed Mobilization|1|||
28046408|NCT00395967|54704553|FG000|Follow-up Period|Death|1|||
28046409|NCT00395967|54704553|FG000|Follow-up Period|Lost to Follow-up|1|||
28046410|NCT00395733|54704559|FG000|Period 2|Withdrawal by Subject|1|||
28046411|NCT00395733|54704560|FG001|Period 2|Withdrawal by Subject|2|||
28046412|NCT00395733|54704559|FG000|Period 2|Protocol Violation|0|||
28046413|NCT00395733|54704560|FG001|Period 2|Protocol Violation|1|||
28046414|NCT00395733|54704559|FG000|Period 2|Adverse Event|0|||
28046415|NCT00395733|54704560|FG001|Period 2|Adverse Event|2|||
28046416|NCT00395733|54704559|FG000|Period 2|Technical problems|1|||
28046417|NCT00395733|54704560|FG001|Period 2|Technical problems|0|||
28046418|NCT00395343|54704568|FG000|Overall Study|Adverse Event|13|||
28046419|NCT00395343|54704569|FG001|Overall Study|Adverse Event|5|||
28046420|NCT00395343|54704568|FG000|Overall Study|Lack of Efficacy|0|||
28046421|NCT00395343|54704569|FG001|Overall Study|Lack of Efficacy|1|||
27847979|NCT01494038|54340782|FG001|Overall Study|Not willing to adhere to reqs|9|||
27847980|NCT01494038|54340781|FG000|Overall Study|Death|2|||
27847981|NCT01494038|54340782|FG001|Overall Study|Death|4|||
27847982|NCT02640612|54340819|FG000|Overall Study|Adverse Event|6|||
27847983|NCT02640612|54340820|FG001|Overall Study|Adverse Event|7|||
27847984|NCT02640612|54340821|FG002|Overall Study|Adverse Event|2|||
27847985|NCT02640612|54340819|FG000|Overall Study|Death|1|||
27847986|NCT02640612|54340820|FG001|Overall Study|Death|0|||
27847987|NCT02640612|54340821|FG002|Overall Study|Death|0|||
27847988|NCT02640612|54340819|FG000|Overall Study|Withdrawal by Subject|10|||
27847989|NCT02640612|54340820|FG001|Overall Study|Withdrawal by Subject|3|||
27847990|NCT02640612|54340821|FG002|Overall Study|Withdrawal by Subject|3|||
27847991|NCT02640612|54340819|FG000|Overall Study|Lost to Follow-up|4|||
27847992|NCT02640612|54340820|FG001|Overall Study|Lost to Follow-up|1|||
27847993|NCT02640612|54340821|FG002|Overall Study|Lost to Follow-up|1|||
27847994|NCT02640612|54340819|FG000|Overall Study|Protocol Violation|0|||
27847995|NCT02640612|54340820|FG001|Overall Study|Protocol Violation|2|||
27847996|NCT02640612|54340821|FG002|Overall Study|Protocol Violation|0|||
27847997|NCT02640612|54340819|FG000|Overall Study|Lack of Efficacy|1|||
27847998|NCT02640612|54340820|FG001|Overall Study|Lack of Efficacy|1|||
27847999|NCT02640612|54340821|FG002|Overall Study|Lack of Efficacy|0|||
27848000|NCT00639769|54340829|FG000|Overall Study|Death|2|||
27848001|NCT00639769|54340829|FG000|Overall Study|Adverse Event|7|||
28046422|NCT00395343|54704568|FG000|Overall Study|Lost to Follow-up|4|||
28046423|NCT00395343|54704569|FG001|Overall Study|Lost to Follow-up|4|||
28046424|NCT00395343|54704568|FG000|Overall Study|Physician Decision|2|||
28046425|NCT00395343|54704569|FG001|Overall Study|Physician Decision|4|||
28046426|NCT00395343|54704568|FG000|Overall Study|Protocol Violation|6|||
28046427|NCT00395343|54704569|FG001|Overall Study|Protocol Violation|8|||
28046428|NCT00395343|54704568|FG000|Overall Study|Withdrawal by Subject|11|||
27848002|NCT00639769|54340829|FG000|Overall Study|Lack of Efficacy|1|||
27848003|NCT00639769|54340829|FG000|Overall Study|Disease progression|26|||
27848004|NCT00639769|54340829|FG000|Overall Study|Withdrawal by Subject|4|||
27848005|NCT00639457|54340835|FG000|Overall Study|Withdrawal by Subject|2|||
27848006|NCT00639457|54340836|FG001|Overall Study|Withdrawal by Subject|3|||
27848007|NCT00639379|54340842|FG000|Period 1 - 2 Weeks|Lost to Follow-up|2|||
27848008|NCT00639379|54340843|FG001|Period 1 - 2 Weeks|Lost to Follow-up|0|||
27848009|NCT00639379|54340842|FG000|Period 1 - 2 Weeks|lens issue|3|||
27848010|NCT00639379|54340843|FG001|Period 1 - 2 Weeks|lens issue|0|||
27848011|NCT00639223|54340851|FG000|Overall Study|Lost to Follow-up|0|||
27848012|NCT00639223|54340852|FG001|Overall Study|Lost to Follow-up|2|||
27848013|NCT00638989|54340861|FG000|Overall Study|Lost to Follow-up|0|||
27848014|NCT00638989|54340862|FG001|Overall Study|Lost to Follow-up|0|||
27848015|NCT00638989|54340863|FG002|Overall Study|Lost to Follow-up|1|||
27848016|NCT00637273|54340884|FG000|Overall Study|Adverse Event|11|||
27848017|NCT00637273|54340885|FG001|Overall Study|Adverse Event|5|||
27848018|NCT00637273|54340886|FG002|Overall Study|Adverse Event|7|||
27848019|NCT00637273|54340884|FG000|Overall Study|Lost to Follow-up|8|||
27848020|NCT00637273|54340885|FG001|Overall Study|Lost to Follow-up|9|||
27848021|NCT00637273|54340886|FG002|Overall Study|Lost to Follow-up|13|||
27848022|NCT00637273|54340884|FG000|Overall Study|Protocol Violation|2|||
27848023|NCT00637273|54340885|FG001|Overall Study|Protocol Violation|4|||
27848024|NCT00637273|54340886|FG002|Overall Study|Protocol Violation|1|||
27848025|NCT00637273|54340884|FG000|Overall Study|Withdrawal of Consent|18|||
27848026|NCT00637273|54340885|FG001|Overall Study|Withdrawal of Consent|6|||
27848027|NCT00637273|54340886|FG002|Overall Study|Withdrawal of Consent|18|||
27848028|NCT00637273|54340884|FG000|Overall Study|Investigator Decision|1|||
27848029|NCT00637273|54340885|FG001|Overall Study|Investigator Decision|3|||
27848030|NCT00637273|54340886|FG002|Overall Study|Investigator Decision|1|||
27848031|NCT00637273|54340884|FG000|Overall Study|Administrative|2|||
27848032|NCT00637273|54340885|FG001|Overall Study|Administrative|0|||
27848033|NCT00637273|54340886|FG002|Overall Study|Administrative|0|||
27848034|NCT00637273|54340884|FG000|Overall Study|Loss of Glucose Control|1|||
27848035|NCT00637273|54340885|FG001|Overall Study|Loss of Glucose Control|1|||
27848036|NCT00637273|54340886|FG002|Overall Study|Loss of Glucose Control|1|||
27848037|NCT00988351|54340896|FG000|Overall Study|Withdrawal by Subject|8|||
27848038|NCT00988351|54340897|FG001|Overall Study|Withdrawal by Subject|0|||
27848039|NCT00988351|54340896|FG000|Overall Study|Lost to Follow-up|6|||
27848040|NCT00988351|54340897|FG001|Overall Study|Lost to Follow-up|9|||
27848041|NCT00988351|54340896|FG000|Overall Study|not using CPAP|5|||
27848042|NCT00988351|54340897|FG001|Overall Study|not using CPAP|3|||
27848043|NCT00988117|54340903|FG000|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1|||
27848044|NCT00988117|54340903|FG000|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2|||
27848045|NCT00637195|54340910|FG000|Overall Study|Lost to Follow-up|1|||
27848046|NCT00637195|54340911|FG001|Overall Study|Lost to Follow-up|0|||
27848047|NCT00637195|54340910|FG000|Overall Study|Other|2|||
27848048|NCT00637195|54340911|FG001|Overall Study|Other|0|||
27848049|NCT00637195|54340910|FG000|Overall Study|Withdrawal by Subject|0|||
27848050|NCT00637195|54340911|FG001|Overall Study|Withdrawal by Subject|1|||
27848051|NCT00636961|54340929|FG000|Period 1|Administrative problems|1|||
27848052|NCT00636961|54340930|FG001|Period 1|Administrative problems|1|||
27848053|NCT00636961|54340929|FG000|Period 2|Adverse Event|1|||
27848054|NCT00636961|54340930|FG001|Period 2|Adverse Event|0|||
27848055|NCT00635089|54340945|FG000|Overall Study|Adverse Event|7|||
27848056|NCT00635089|54340945|FG000|Overall Study|Lack of Efficacy|28|||
27848057|NCT00635089|54340945|FG000|Overall Study|Protocol Deviation|4|||
27848058|NCT00635089|54340945|FG000|Overall Study|Lost to Follow-up|8|||
28046429|NCT00395343|54704569|FG001|Overall Study|Withdrawal by Subject|12|||
28046430|NCT00395343|54704568|FG000|Overall Study|Other|5|||
28046431|NCT00395343|54704569|FG001|Overall Study|Other|2|||
28046432|NCT00560573|54704575|FG000|Overall Study|Death|4|||
28046433|NCT00560573|54704576|FG001|Overall Study|Death|1|||
28046434|NCT00560573|54704577|FG002|Overall Study|Death|4|||
28046435|NCT00560573|54704578|FG003|Overall Study|Death|5|||
28046436|NCT00560573|54704579|FG004|Overall Study|Death|1|||
28046437|NCT00560573|54704580|FG005|Overall Study|Death|10|||
28046438|NCT00560573|54704575|FG000|Overall Study|Lost to Follow-up|0|||
28046439|NCT00560573|54704576|FG001|Overall Study|Lost to Follow-up|0|||
28046440|NCT00560573|54704577|FG002|Overall Study|Lost to Follow-up|0|||
28046441|NCT00560573|54704578|FG003|Overall Study|Lost to Follow-up|1|||
28046442|NCT00560573|54704579|FG004|Overall Study|Lost to Follow-up|1|||
28046443|NCT00560573|54704580|FG005|Overall Study|Lost to Follow-up|0|||
27848059|NCT00635089|54340945|FG000|Overall Study|Other|31|||
27848060|NCT01493414|54340962|FG000|Overall Study|Adverse Event|405|||
27848061|NCT01493414|54340962|FG000|Overall Study|Disease progression|204|||
27848062|NCT01493414|54340962|FG000|Overall Study|Death|101|||
27848063|NCT01493414|54340962|FG000|Overall Study|Physician Decision|93|||
27848064|NCT01493414|54340962|FG000|Overall Study|Withdrawal by Subject|79|||
27848065|NCT01493414|54340962|FG000|Overall Study|Protocol deviation|27|||
27848066|NCT01493414|54340962|FG000|Overall Study|Administrative problems|25|||
27848067|NCT01493414|54340962|FG000|Overall Study|Lost to Follow-up|16|||
27848068|NCT00634543|54340972|FG000|Overall Study|Other|1|||
27848069|NCT00634543|54340973|FG001|Overall Study|Other|2|||
28046444|NCT00560573|54704575|FG000|Overall Study|Withdrawal by Subject|0|||
28046445|NCT00560573|54704576|FG001|Overall Study|Withdrawal by Subject|0|||
27811460|NCT01853618|54267467|FG001|Overall Study|Refused further treatment|0|||
27811461|NCT01853618|54267468|FG002|Overall Study|Refused further treatment|0|||
27811462|NCT01853618|54267469|FG003|Overall Study|Refused further treatment|0|||
27811463|NCT01853618|54267470|FG004|Overall Study|Refused further treatment|1|||
27811464|NCT01853462|54267485|FG000|Overall Study|Withdrawal by Subject|1|||
27811465|NCT01853462|54267486|FG001|Overall Study|Withdrawal by Subject|1|||
27811466|NCT01719783|54267496|FG000|Dose 2|Physician Decision|1|||
28046446|NCT00560573|54704577|FG002|Overall Study|Withdrawal by Subject|0|||
28046447|NCT00560573|54704578|FG003|Overall Study|Withdrawal by Subject|1|||
28046448|NCT00560573|54704579|FG004|Overall Study|Withdrawal by Subject|1|||
27811467|NCT01719783|54267497|FG001|Dose 2|Physician Decision|0|||
27811468|NCT01853384|54267525|FG000|Randomized|Adverse Event|5|||
27811469|NCT01853384|54267526|FG001|Randomized|Adverse Event|3|||
27811470|NCT01853384|54267525|FG000|Randomized|Death|1|||
27811471|NCT01853384|54267526|FG001|Randomized|Death|2|||
27811472|NCT01853384|54267525|FG000|Randomized|Lost to Follow-up|1|||
27811473|NCT01853384|54267526|FG001|Randomized|Lost to Follow-up|1|||
27811474|NCT01853384|54267525|FG000|Randomized|Withdrawal by Subject|5|||
27811475|NCT01853384|54267526|FG001|Randomized|Withdrawal by Subject|3|||
27811476|NCT01853384|54267525|FG000|Randomized|Sponsor Decision|47|||
27811477|NCT01853384|54267526|FG001|Randomized|Sponsor Decision|34|||
27811478|NCT01853384|54267525|FG000|Randomized|Other|3|||
27811479|NCT01853384|54267526|FG001|Randomized|Other|3|||
27811480|NCT01853384|54267525|FG000|Completed Follow up Visit 1|Early Termination|13|||
27811481|NCT01853384|54267526|FG001|Completed Follow up Visit 1|Early Termination|9|||
27811482|NCT01853384|54267525|FG000|Completed Follow up Visit 1|Withdrawal by Subject|1|||
27811483|NCT01853384|54267526|FG001|Completed Follow up Visit 1|Withdrawal by Subject|0|||
27811484|NCT01853384|54267525|FG000|Completed Follow up Visit 2|Adverse Event|1|||
27811485|NCT01853384|54267526|FG001|Completed Follow up Visit 2|Adverse Event|0|||
27811486|NCT01853384|54267525|FG000|Completed Follow up Visit 2|Withdrawal by Subject|1|||
27811487|NCT01853384|54267526|FG001|Completed Follow up Visit 2|Withdrawal by Subject|2|||
27811488|NCT01853384|54267525|FG000|Completed Follow up Visit 2|Death|1|||
27811489|NCT01853384|54267526|FG001|Completed Follow up Visit 2|Death|0|||
27811490|NCT01853384|54267525|FG000|Completed Follow up Visit 2|Lost to Follow-up|0|||
27811491|NCT01853384|54267526|FG001|Completed Follow up Visit 2|Lost to Follow-up|1|||
27811492|NCT01878890|54267536|FG000|Overall Study|Protocol Violation|0|||
27811493|NCT01878890|54267537|FG001|Overall Study|Protocol Violation|1|||
27811494|NCT01878890|54267538|FG002|Overall Study|Protocol Violation|0|||
27811495|NCT01878890|54267539|FG003|Overall Study|Protocol Violation|0|||
27811496|NCT01827332|54267552|FG000|Overall Study|Lost to Follow-up|2|||
27811497|NCT01827332|54267553|FG001|Overall Study|Lost to Follow-up|1|||
27811498|NCT01719003|54267567|FG000|Overall Study|Non compliant with protocol|1|||
27811499|NCT01719003|54267568|FG001|Overall Study|Non compliant with protocol|1|||
27811500|NCT01719003|54267569|FG002|Overall Study|Non compliant with protocol|0|||
27811501|NCT01719003|54267570|FG003|Overall Study|Non compliant with protocol|1|||
27811502|NCT01719003|54267571|FG004|Overall Study|Non compliant with protocol|2|||
27811503|NCT01719003|54267572|FG005|Overall Study|Non compliant with protocol|1|||
27811504|NCT01719003|54267573|FG006|Overall Study|Non compliant with protocol|2|||
28046449|NCT00560573|54704580|FG005|Overall Study|Withdrawal by Subject|0|||
28046450|NCT00560573|54704575|FG000|Overall Study|Other|2|||
27811505|NCT01719003|54267574|FG007|Overall Study|Non compliant with protocol|3|||
27811506|NCT01719003|54267575|FG008|Overall Study|Non compliant with protocol|0|||
27811507|NCT01719003|54267567|FG000|Overall Study|Adverse Event|6|||
27811508|NCT01719003|54267568|FG001|Overall Study|Adverse Event|5|||
27811509|NCT01719003|54267569|FG002|Overall Study|Adverse Event|4|||
27811510|NCT01719003|54267570|FG003|Overall Study|Adverse Event|3|||
27811511|NCT01719003|54267571|FG004|Overall Study|Adverse Event|4|||
27811512|NCT01719003|54267572|FG005|Overall Study|Adverse Event|3|||
27811513|NCT01719003|54267573|FG006|Overall Study|Adverse Event|6|||
27811514|NCT01719003|54267574|FG007|Overall Study|Adverse Event|5|||
28046451|NCT00560573|54704576|FG001|Overall Study|Other|2|||
27811515|NCT01719003|54267575|FG008|Overall Study|Adverse Event|0|||
27811516|NCT01719003|54267567|FG000|Overall Study|Lost to Follow-up|0|||
27811517|NCT01719003|54267568|FG001|Overall Study|Lost to Follow-up|6|||
28046452|NCT00560573|54704577|FG002|Overall Study|Other|2|||
28046453|NCT00560573|54704578|FG003|Overall Study|Other|3|||
28046454|NCT00560573|54704579|FG004|Overall Study|Other|3|||
28046455|NCT00560573|54704580|FG005|Overall Study|Other|3|||
28046456|NCT00560573|54704575|FG000|Overall Study|Enrolled, not treated|0|||
28046457|NCT00560573|54704576|FG001|Overall Study|Enrolled, not treated|0|||
28046458|NCT00560573|54704577|FG002|Overall Study|Enrolled, not treated|0|||
28046459|NCT00560573|54704578|FG003|Overall Study|Enrolled, not treated|0|||
28046460|NCT00560573|54704579|FG004|Overall Study|Enrolled, not treated|1|||
28046461|NCT00560573|54704580|FG005|Overall Study|Enrolled, not treated|0|||
28046462|NCT03961529|54704613|FG000|Overall Study|Adverse Event|13|||
28046463|NCT03961529|54704614|FG001|Overall Study|Adverse Event|5|||
28046464|NCT03961529|54704615|FG002|Overall Study|Adverse Event|2|||
28046465|NCT03961529|54704613|FG000|Overall Study|Withdrawal by Subject|17|||
28046466|NCT03961529|54704614|FG001|Overall Study|Withdrawal by Subject|2|||
28046467|NCT03961529|54704615|FG002|Overall Study|Withdrawal by Subject|1|||
28046468|NCT03961529|54704613|FG000|Overall Study|Withdrawal by parent/guardian|0|||
28046469|NCT03961529|54704614|FG001|Overall Study|Withdrawal by parent/guardian|7|||
28046470|NCT03961529|54704615|FG002|Overall Study|Withdrawal by parent/guardian|0|||
28046471|NCT03961529|54704613|FG000|Overall Study|Physician Decision|2|||
28046472|NCT03961529|54704614|FG001|Overall Study|Physician Decision|1|||
28046473|NCT03961529|54704615|FG002|Overall Study|Physician Decision|1|||
28046474|NCT03961529|54704613|FG000|Overall Study|Lost to Follow-up|2|||
28046475|NCT03961529|54704614|FG001|Overall Study|Lost to Follow-up|1|||
28046476|NCT03961529|54704615|FG002|Overall Study|Lost to Follow-up|0|||
28046477|NCT03961529|54704613|FG000|Overall Study|Lack of Efficacy|2|||
28046478|NCT03961529|54704614|FG001|Overall Study|Lack of Efficacy|0|||
28046479|NCT03961529|54704615|FG002|Overall Study|Lack of Efficacy|1|||
28046480|NCT03961529|54704613|FG000|Overall Study|Other|6|||
28046481|NCT03961529|54704614|FG001|Overall Study|Other|1|||
28046482|NCT03961529|54704615|FG002|Overall Study|Other|0|||
28046483|NCT00494780|54704625|FG000|Overall Study|Adverse Event|1|||
27811518|NCT01719003|54267569|FG002|Overall Study|Lost to Follow-up|7|||
28046484|NCT00494780|54704626|FG001|Overall Study|Adverse Event|0|||
28046485|NCT00494780|54704625|FG000|Overall Study|Withdrew before Dosed|0|||
28046486|NCT00494780|54704626|FG001|Overall Study|Withdrew before Dosed|1|||
28046487|NCT00494780|54704625|FG000|Overall Study|Progression of Study Disease|7|||
28046488|NCT00494780|54704626|FG001|Overall Study|Progression of Study Disease|8|||
28046489|NCT00494780|54704625|FG000|Overall Study|New Treatment|2|||
28046490|NCT00494780|54704626|FG001|Overall Study|New Treatment|2|||
28046491|NCT00494780|54704625|FG000|Overall Study|Non-compliance|1|||
28046492|NCT00494780|54704626|FG001|Overall Study|Non-compliance|0|||
28046493|NCT00494780|54704625|FG000|Overall Study|Residual Tumour Mass|0|||
28046494|NCT00494780|54704626|FG001|Overall Study|Residual Tumour Mass|1|||
28046495|NCT00494780|54704625|FG000|Overall Study|Insurance Issues|0|||
28046496|NCT00494780|54704626|FG001|Overall Study|Insurance Issues|1|||
28046497|NCT00490022|54704636|FG000|Overall Study|Adverse Event|0|||
28046498|NCT00490022|54704637|FG001|Overall Study|Adverse Event|2|||
28046499|NCT00490022|54704636|FG000|Overall Study|Withdrawal by Subject|1|||
28046500|NCT00490022|54704637|FG001|Overall Study|Withdrawal by Subject|0|||
28046501|NCT00490022|54704636|FG000|Overall Study|Subject failed to disclose concommitant|0|||
28046502|NCT00490022|54704637|FG001|Overall Study|Subject failed to disclose concommitant|1|||
28046503|NCT00493454|54704643|FG000|Overall Study|Withdrawal by Subject|1|||
28046504|NCT00493220|54704653|FG000|Third Intervention|Withdrawal by Subject|1|||
28046505|NCT00493220|54704654|FG001|Third Intervention|Withdrawal by Subject|0|||
28046506|NCT00493220|54704655|FG002|Third Intervention|Withdrawal by Subject|0|||
28046507|NCT00493220|54704656|FG003|Third Intervention|Withdrawal by Subject|0|||
28046508|NCT00493220|54704657|FG004|Third Intervention|Withdrawal by Subject|0|||
28046509|NCT00493220|54704658|FG005|Third Intervention|Withdrawal by Subject|0|||
28046510|NCT00394953|54704670|FG000|First Treatment Period|Adverse Event|1|||
28046511|NCT00394953|54704671|FG001|First Treatment Period|Adverse Event|2|||
28046512|NCT00394953|54704670|FG000|First Treatment Period|Death|6|||
28046513|NCT00394953|54704671|FG001|First Treatment Period|Death|7|||
28046514|NCT00394953|54704670|FG000|First Treatment Period|Lack of Efficacy|1|||
28046515|NCT00394953|54704671|FG001|First Treatment Period|Lack of Efficacy|1|||
28046516|NCT00394953|54704670|FG000|First Treatment Period|Withdrawal by Subject|6|||
28046517|NCT00394953|54704671|FG001|First Treatment Period|Withdrawal by Subject|3|||
28046518|NCT00394953|54704670|FG000|First Treatment Period|Lost to Follow-up|0|||
28046519|NCT00394953|54704671|FG001|First Treatment Period|Lost to Follow-up|1|||
28046520|NCT00394953|54704670|FG000|First Treatment Period|Renal transplant|11|||
27811519|NCT01719003|54267570|FG003|Overall Study|Lost to Follow-up|2|||
27811520|NCT01719003|54267571|FG004|Overall Study|Lost to Follow-up|3|||
28046521|NCT00394953|54704671|FG001|First Treatment Period|Renal transplant|7|||
27811521|NCT01719003|54267572|FG005|Overall Study|Lost to Follow-up|4|||
28046522|NCT00394953|54704670|FG000|First Treatment Period|Not defined|4|||
28046523|NCT00394953|54704671|FG001|First Treatment Period|Not defined|1|||
28046524|NCT00394953|54704670|FG000|Second Treatment Period|Adverse Event|2|||
28046525|NCT00394953|54704671|FG001|Second Treatment Period|Adverse Event|5|||
28046526|NCT00394953|54704670|FG000|Second Treatment Period|Death|8|||
28046527|NCT00394953|54704671|FG001|Second Treatment Period|Death|4|||
28046528|NCT00394953|54704670|FG000|Second Treatment Period|Lack of Efficacy|9|||
28046529|NCT00394953|54704671|FG001|Second Treatment Period|Lack of Efficacy|47|||
28046530|NCT00394953|54704670|FG000|Second Treatment Period|Withdrawal by Subject|3|||
28046531|NCT00394953|54704671|FG001|Second Treatment Period|Withdrawal by Subject|3|||
28046532|NCT00394953|54704670|FG000|Second Treatment Period|Lost to Follow-up|0|||
28046533|NCT00394953|54704671|FG001|Second Treatment Period|Lost to Follow-up|1|||
28046534|NCT00394953|54704670|FG000|Second Treatment Period|Renal transplant|4|||
28046535|NCT00394953|54704671|FG001|Second Treatment Period|Renal transplant|6|||
28046536|NCT00394953|54704670|FG000|Second Treatment Period|Not defined|3|||
28046537|NCT00394953|54704671|FG001|Second Treatment Period|Not defined|8|||
28046538|NCT00485732|54704679|FG000|Overall Study|Protocol Violation|1|||
28046539|NCT00485732|54704680|FG001|Overall Study|Protocol Violation|3|||
28046540|NCT00485732|54704679|FG000|Overall Study|Withdrawal by Subject|5|||
28046541|NCT00485732|54704680|FG001|Overall Study|Withdrawal by Subject|4|||
28046542|NCT00485732|54704679|FG000|Overall Study|Lost to Follow-up|2|||
28046543|NCT00485732|54704680|FG001|Overall Study|Lost to Follow-up|2|||
28046544|NCT00489554|54704686|FG000|Overall Study|Adverse Event|2|||
28046545|NCT00489554|54704686|FG000|Overall Study|Withdrawal by Subject|1|||
28046546|NCT00489554|54704686|FG000|Overall Study|Lost to Follow-up|1|||
28046547|NCT00408681|54704690|FG000|Overall Study|Lack of Efficacy|2|||
28046548|NCT00408681|54704690|FG000|Overall Study|Adverse Event|7|||
28046549|NCT00560417|54704697|FG000|Overall Study|Adverse Event|3|||
28046550|NCT00560417|54704698|FG001|Overall Study|Adverse Event|2|||
28046551|NCT00560417|54704697|FG000|Overall Study|Entry Criteria Not Met|1|||
28046552|NCT00560417|54704698|FG001|Overall Study|Entry Criteria Not Met|0|||
28046553|NCT00560417|54704697|FG000|Overall Study|Lost to Follow-up|0|||
28046554|NCT00560417|54704698|FG001|Overall Study|Lost to Follow-up|1|||
28046555|NCT00560417|54704697|FG000|Overall Study|Physician Decision|2|||
28046556|NCT00560417|54704698|FG001|Overall Study|Physician Decision|6|||
28046557|NCT00560417|54704697|FG000|Overall Study|Protocol Violation|6|||
28046558|NCT00560417|54704698|FG001|Overall Study|Protocol Violation|5|||
28046559|NCT00560417|54704697|FG000|Overall Study|Sponsor Decision|2|||
28046560|NCT00560417|54704698|FG001|Overall Study|Sponsor Decision|0|||
28046561|NCT00560417|54704697|FG000|Overall Study|Withdrawal by Subject|3|||
28046562|NCT00560417|54704698|FG001|Overall Study|Withdrawal by Subject|3|||
28046563|NCT03968159|54704711|FG000|Overall Study|Adverse Event|4|||
28046564|NCT03968159|54704712|FG001|Overall Study|Adverse Event|4|||
28046565|NCT03968159|54704711|FG000|Overall Study|Lost to Follow-up|1|||
28046566|NCT03968159|54704712|FG001|Overall Study|Lost to Follow-up|1|||
28046567|NCT03968159|54704711|FG000|Overall Study|Use of prohibited medication|0|||
28046568|NCT03968159|54704712|FG001|Overall Study|Use of prohibited medication|1|||
28046569|NCT03968159|54704711|FG000|Overall Study|Protocol Violation|2|||
28046570|NCT03968159|54704712|FG001|Overall Study|Protocol Violation|2|||
28046571|NCT03968159|54704711|FG000|Overall Study|Withdrawal by Subject|4|||
28046572|NCT03968159|54704712|FG001|Overall Study|Withdrawal by Subject|6|||
28046573|NCT03968159|54704711|FG000|Overall Study|Lack of Efficacy|0|||
28046574|NCT03968159|54704712|FG001|Overall Study|Lack of Efficacy|1|||
28046575|NCT03968159|54704711|FG000|Overall Study|Not further specified|2|||
28046576|NCT03968159|54704712|FG001|Overall Study|Not further specified|0|||
28046577|NCT03966911|54704720|FG000|Overall Study|Adverse Event|1|||
28046578|NCT03966911|54704721|FG001|Overall Study|Adverse Event|1|||
28046579|NCT03966911|54704720|FG000|Overall Study|Withdrawal by Subject|8|||
28046580|NCT03966911|54704721|FG001|Overall Study|Withdrawal by Subject|2|||
28046581|NCT03966911|54704720|FG000|Overall Study|Unable to complete study visits due to COVID-19|0|||
28046582|NCT03966911|54704721|FG001|Overall Study|Unable to complete study visits due to COVID-19|13|||
27811522|NCT01719003|54267573|FG006|Overall Study|Lost to Follow-up|3|||
27811523|NCT01719003|54267574|FG007|Overall Study|Lost to Follow-up|2|||
27811524|NCT01719003|54267575|FG008|Overall Study|Lost to Follow-up|2|||
27811525|NCT01719003|54267567|FG000|Overall Study|Refusal to continue, not due to AE|2|||
27811526|NCT01719003|54267568|FG001|Overall Study|Refusal to continue, not due to AE|5|||
27811527|NCT01719003|54267569|FG002|Overall Study|Refusal to continue, not due to AE|4|||
27811528|NCT01719003|54267570|FG003|Overall Study|Refusal to continue, not due to AE|4|||
27811529|NCT01719003|54267571|FG004|Overall Study|Refusal to continue, not due to AE|4|||
27811530|NCT01719003|54267572|FG005|Overall Study|Refusal to continue, not due to AE|3|||
27939894|NCT01038609|54596216|FG001|Overall Study|Death in the Family|0|||
27848070|NCT00634543|54340972|FG000|Overall Study|Protocol Violation|3|||
28046583|NCT03966365|54704731|FG000|Overall Study|Protocol Violation|1|||
28046584|NCT03966365|54704732|FG001|Overall Study|Protocol Violation|0|||
28046585|NCT00375219|54704741|FG000|Overall Study|Failure to achieve a response|16|||
28046586|NCT00375219|54704742|FG001|Overall Study|Failure to achieve a response|2|||
28046587|NCT00375219|54704743|FG002|Overall Study|Failure to achieve a response|0|||
28046588|NCT00375219|54704741|FG000|Overall Study|Adverse Event|8|||
28046589|NCT00375219|54704742|FG001|Overall Study|Adverse Event|2|||
28046590|NCT00375219|54704743|FG002|Overall Study|Adverse Event|1|||
28046591|NCT00375219|54704741|FG000|Overall Study|Protocol Violation|1|||
28046592|NCT00375219|54704742|FG001|Overall Study|Protocol Violation|0|||
28046593|NCT00375219|54704743|FG002|Overall Study|Protocol Violation|1|||
28046594|NCT00375219|54704741|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|5|||
28046595|NCT00375219|54704742|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|3|||
28046596|NCT00375219|54704743|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|0|||
28046597|NCT00375219|54704741|FG000|Overall Study|Lost to Follow-up|1|||
28046598|NCT00375219|54704742|FG001|Overall Study|Lost to Follow-up|1|||
28046599|NCT00375219|54704743|FG002|Overall Study|Lost to Follow-up|0|||
28046600|NCT00375219|54704741|FG000|Overall Study|Disease progression|18|||
28046601|NCT00375219|54704742|FG001|Overall Study|Disease progression|9|||
28046602|NCT00375219|54704743|FG002|Overall Study|Disease progression|12|||
28046603|NCT00375219|54704741|FG000|Overall Study|Death|4|||
28046604|NCT00375219|54704742|FG001|Overall Study|Death|3|||
28046605|NCT00375219|54704743|FG002|Overall Study|Death|7|||
28046606|NCT00375219|54704741|FG000|Overall Study|Hematologic resistance|1|||
28046607|NCT00375219|54704742|FG001|Overall Study|Hematologic resistance|0|||
28046608|NCT00375219|54704743|FG002|Overall Study|Hematologic resistance|0|||
28046609|NCT00375219|54704741|FG000|Overall Study|Specific tyrosine kinase inhibitor avail|1|||
28046610|NCT00375219|54704742|FG001|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
28046611|NCT00375219|54704743|FG002|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
28046612|NCT00375219|54704741|FG000|Overall Study|Allograft|2|||
28046613|NCT00375219|54704742|FG001|Overall Study|Allograft|0|||
28046614|NCT00375219|54704743|FG002|Overall Study|Allograft|0|||
28046615|NCT00375219|54704741|FG000|Overall Study|Cord blood transplantation|1|||
28046616|NCT00375219|54704742|FG001|Overall Study|Cord blood transplantation|0|||
28046617|NCT00375219|54704743|FG002|Overall Study|Cord blood transplantation|0|||
28046618|NCT00375219|54704741|FG000|Overall Study|Withdrawal by Subject|1|||
28046619|NCT00375219|54704742|FG001|Overall Study|Withdrawal by Subject|0|||
28046620|NCT00375219|54704743|FG002|Overall Study|Withdrawal by Subject|0|||
28046621|NCT03965351|54704752|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
28046622|NCT03965351|54704753|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
28046623|NCT03965351|54704752|FG000|Second Intervention (4 Weeks)|Adverse Event|0|||
28046624|NCT03965351|54704753|FG001|Second Intervention (4 Weeks)|Adverse Event|1|||
28046625|NCT00554801|54704761|FG000|Overall Study|left area before completion|5|||
28046626|NCT00554801|54704762|FG001|Overall Study|left area before completion|0|||
28046627|NCT00554801|54704761|FG000|Overall Study|Withdrawal by Subject|14|||
28046628|NCT00554801|54704762|FG001|Overall Study|Withdrawal by Subject|0|||
28046629|NCT00374907|54704772|FG000|12-Week Short-term Period|Subject Withdrew Consent|3|||
28046630|NCT00374907|54704773|FG001|12-Week Short-term Period|Subject Withdrew Consent|1|||
28046631|NCT00374907|54704772|FG000|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8|||
28046632|NCT00374907|54704773|FG001|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9|||
28046633|NCT00374907|54704772|FG000|116-Week Short-term + Long-term Period|Lack of Efficacy|4|||
28046634|NCT00374907|54704773|FG001|116-Week Short-term + Long-term Period|Lack of Efficacy|2|||
28046635|NCT00374907|54704772|FG000|116-Week Short-term + Long-term Period|Adverse Event|0|||
28046636|NCT00374907|54704773|FG001|116-Week Short-term + Long-term Period|Adverse Event|2|||
28046637|NCT00374907|54704772|FG000|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
28046638|NCT00374907|54704773|FG001|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
28046639|NCT00374127|54704781|FG000|Overall Study|Did not inhale during smoking procedure.|3|||
28046640|NCT00374127|54704781|FG000|Overall Study|Blood could not be drawn.|2|||
28046641|NCT00374127|54704781|FG000|Overall Study|Protocol Violation|5|||
28046642|NCT00374127|54704781|FG000|Overall Study|Pregnancy|1|||
28046643|NCT00553787|54704794|FG000|Overall Study|Adverse Event|34|||
28046644|NCT00553787|54704795|FG001|Overall Study|Adverse Event|21|||
28046645|NCT00553787|54704796|FG002|Overall Study|Adverse Event|67|||
28046646|NCT00553787|54704794|FG000|Overall Study|Lost to Follow-up|132|||
28046647|NCT00553787|54704795|FG001|Overall Study|Lost to Follow-up|44|||
28046648|NCT00553787|54704796|FG002|Overall Study|Lost to Follow-up|78|||
28046649|NCT00553787|54704794|FG000|Overall Study|Withdrawal by Subject|151|||
28046650|NCT00553787|54704795|FG001|Overall Study|Withdrawal by Subject|40|||
28046651|NCT00553787|54704796|FG002|Overall Study|Withdrawal by Subject|83|||
28046652|NCT00553787|54704794|FG000|Overall Study|Lack of Efficacy|31|||
28046653|NCT00553787|54704795|FG001|Overall Study|Lack of Efficacy|1|||
28046654|NCT00553787|54704796|FG002|Overall Study|Lack of Efficacy|3|||
28046655|NCT00553787|54704794|FG000|Overall Study|Pregnancy|0|||
27848071|NCT00634543|54340973|FG001|Overall Study|Protocol Violation|3|||
28046656|NCT00553787|54704795|FG001|Overall Study|Pregnancy|1|||
28046657|NCT00553787|54704796|FG002|Overall Study|Pregnancy|2|||
28046658|NCT00553787|54704794|FG000|Overall Study|non compliance|4|||
28046659|NCT00553787|54704795|FG001|Overall Study|non compliance|0|||
28046660|NCT00553787|54704796|FG002|Overall Study|non compliance|11|||
28046661|NCT00553787|54704794|FG000|Overall Study|Requirement for restricted medication|8|||
28046662|NCT00553787|54704795|FG001|Overall Study|Requirement for restricted medication|7|||
28046663|NCT00553787|54704796|FG002|Overall Study|Requirement for restricted medication|5|||
28046664|NCT00553787|54704794|FG000|Overall Study|Other|18|||
28046665|NCT00553787|54704795|FG001|Overall Study|Other|10|||
28046666|NCT00553787|54704796|FG002|Overall Study|Other|13|||
28046667|NCT00407745|54704806|FG000|Overall Study|Lack of Efficacy|1|||
28046668|NCT00407745|54704807|FG001|Overall Study|Lack of Efficacy|2|||
28046669|NCT00407745|54704806|FG000|Overall Study|Withdrawal by Subject|3|||
28046670|NCT00407745|54704807|FG001|Overall Study|Withdrawal by Subject|3|||
28046671|NCT00407745|54704806|FG000|Overall Study|Protocol Violation|5|||
28046672|NCT00407745|54704807|FG001|Overall Study|Protocol Violation|3|||
27811531|NCT01719003|54267573|FG006|Overall Study|Refusal to continue, not due to AE|8|||
28046673|NCT00407745|54704806|FG000|Overall Study|Adverse Event|8|||
28046674|NCT00407745|54704807|FG001|Overall Study|Adverse Event|8|||
28046675|NCT00407745|54704806|FG000|Overall Study|Other|2|||
28046676|NCT00407745|54704807|FG001|Overall Study|Other|0|||
28046677|NCT00407745|54704806|FG000|Overall Study|Randomized, unknown if treated|0|||
28046678|NCT00407745|54704807|FG001|Overall Study|Randomized, unknown if treated|1|||
27811532|NCT01719003|54267574|FG007|Overall Study|Refusal to continue, not due to AE|7|||
27811533|NCT01719003|54267575|FG008|Overall Study|Refusal to continue, not due to AE|1|||
27811534|NCT01719003|54267567|FG000|Overall Study|Reason other than those specified|0|||
27811535|NCT01719003|54267568|FG001|Overall Study|Reason other than those specified|0|||
27811536|NCT01719003|54267569|FG002|Overall Study|Reason other than those specified|2|||
27811537|NCT01719003|54267570|FG003|Overall Study|Reason other than those specified|3|||
28046679|NCT03958955|54704813|FG000|Overall Study|Adverse Event|1|||
28046680|NCT00464334|54704830|FG000|Overall Study|Adverse Event|0|||
28046681|NCT00464334|54704831|FG001|Overall Study|Adverse Event|0|||
28046682|NCT00464334|54704832|FG002|Overall Study|Adverse Event|0|||
28046683|NCT00464334|54704833|FG003|Overall Study|Adverse Event|1|||
28046684|NCT00464334|54704834|FG004|Overall Study|Adverse Event|1|||
28046685|NCT00464334|54704835|FG005|Overall Study|Adverse Event|1|||
28046686|NCT00464334|54704836|FG006|Overall Study|Adverse Event|0|||
28046687|NCT00464334|54704837|FG007|Overall Study|Adverse Event|0|||
28046688|NCT00464334|54704838|FG008|Overall Study|Adverse Event|2|||
28046689|NCT00464334|54704839|FG009|Overall Study|Adverse Event|1|||
28046690|NCT00464334|54704840|FG010|Overall Study|Adverse Event|2|||
28046691|NCT00464334|54704830|FG000|Overall Study|Lack of Efficacy|0|||
28046692|NCT00464334|54704831|FG001|Overall Study|Lack of Efficacy|1|||
28046693|NCT00464334|54704832|FG002|Overall Study|Lack of Efficacy|0|||
28046694|NCT00464334|54704833|FG003|Overall Study|Lack of Efficacy|0|||
28046695|NCT00464334|54704834|FG004|Overall Study|Lack of Efficacy|0|||
28046696|NCT00464334|54704835|FG005|Overall Study|Lack of Efficacy|0|||
28046697|NCT00464334|54704836|FG006|Overall Study|Lack of Efficacy|0|||
28046698|NCT00464334|54704837|FG007|Overall Study|Lack of Efficacy|0|||
28046699|NCT00464334|54704838|FG008|Overall Study|Lack of Efficacy|0|||
28046700|NCT00464334|54704839|FG009|Overall Study|Lack of Efficacy|0|||
28046701|NCT00464334|54704840|FG010|Overall Study|Lack of Efficacy|0|||
28046702|NCT00464334|54704830|FG000|Overall Study|Lost to Follow-up|0|||
28046703|NCT00464334|54704831|FG001|Overall Study|Lost to Follow-up|0|||
28046704|NCT00464334|54704832|FG002|Overall Study|Lost to Follow-up|1|||
28046705|NCT00464334|54704833|FG003|Overall Study|Lost to Follow-up|0|||
28046706|NCT00464334|54704834|FG004|Overall Study|Lost to Follow-up|1|||
28046707|NCT00464334|54704835|FG005|Overall Study|Lost to Follow-up|0|||
28046708|NCT00464334|54704836|FG006|Overall Study|Lost to Follow-up|1|||
28046709|NCT00464334|54704837|FG007|Overall Study|Lost to Follow-up|0|||
28046710|NCT00464334|54704838|FG008|Overall Study|Lost to Follow-up|0|||
27811538|NCT01719003|54267571|FG004|Overall Study|Reason other than those specified|4|||
27811539|NCT01719003|54267572|FG005|Overall Study|Reason other than those specified|1|||
27811540|NCT01719003|54267573|FG006|Overall Study|Reason other than those specified|0|||
27811541|NCT01719003|54267574|FG007|Overall Study|Reason other than those specified|3|||
27811542|NCT01719003|54267575|FG008|Overall Study|Reason other than those specified|1|||
27811543|NCT01719003|54267567|FG000|Overall Study|Lack of Efficacy|0|||
27811544|NCT01719003|54267568|FG001|Overall Study|Lack of Efficacy|0|||
27811545|NCT01719003|54267569|FG002|Overall Study|Lack of Efficacy|0|||
27811546|NCT01719003|54267570|FG003|Overall Study|Lack of Efficacy|0|||
27939895|NCT01038609|54596217|FG002|Overall Study|Death in the Family|0|||
28046711|NCT00464334|54704839|FG009|Overall Study|Lost to Follow-up|0|||
28046712|NCT00464334|54704840|FG010|Overall Study|Lost to Follow-up|2|||
28046713|NCT00464334|54704830|FG000|Overall Study|Progressive Disease|0|||
27811547|NCT01719003|54267571|FG004|Overall Study|Lack of Efficacy|0|||
27811548|NCT01719003|54267572|FG005|Overall Study|Lack of Efficacy|0|||
27811549|NCT01719003|54267573|FG006|Overall Study|Lack of Efficacy|1|||
28046714|NCT00464334|54704831|FG001|Overall Study|Progressive Disease|0|||
28046715|NCT00464334|54704832|FG002|Overall Study|Progressive Disease|0|||
28046716|NCT00464334|54704833|FG003|Overall Study|Progressive Disease|0|||
28046717|NCT00464334|54704834|FG004|Overall Study|Progressive Disease|0|||
28046718|NCT00464334|54704835|FG005|Overall Study|Progressive Disease|1|||
28046719|NCT00464334|54704836|FG006|Overall Study|Progressive Disease|0|||
28046720|NCT00464334|54704837|FG007|Overall Study|Progressive Disease|0|||
28046721|NCT00464334|54704838|FG008|Overall Study|Progressive Disease|1|||
28046722|NCT00464334|54704839|FG009|Overall Study|Progressive Disease|0|||
28046723|NCT00464334|54704840|FG010|Overall Study|Progressive Disease|0|||
27848072|NCT00634543|54340972|FG000|Overall Study|Adverse Event|11|||
27848073|NCT00634543|54340973|FG001|Overall Study|Adverse Event|11|||
27848074|NCT00634543|54340972|FG000|Overall Study|Withdrawal by Subject|4|||
27848075|NCT00634543|54340973|FG001|Overall Study|Withdrawal by Subject|4|||
27848076|NCT00634543|54340972|FG000|Overall Study|Lost to Follow-up|0|||
27848077|NCT00634543|54340973|FG001|Overall Study|Lost to Follow-up|1|||
28046724|NCT00464334|54704830|FG000|Overall Study|Study Terminated by Sponsor|0|||
28046725|NCT00464334|54704831|FG001|Overall Study|Study Terminated by Sponsor|0|||
28046726|NCT00464334|54704832|FG002|Overall Study|Study Terminated by Sponsor|0|||
28046727|NCT00464334|54704833|FG003|Overall Study|Study Terminated by Sponsor|1|||
28046728|NCT00464334|54704834|FG004|Overall Study|Study Terminated by Sponsor|0|||
28046729|NCT00464334|54704835|FG005|Overall Study|Study Terminated by Sponsor|0|||
28046730|NCT00464334|54704836|FG006|Overall Study|Study Terminated by Sponsor|0|||
28046731|NCT00464334|54704837|FG007|Overall Study|Study Terminated by Sponsor|0|||
28046732|NCT00464334|54704838|FG008|Overall Study|Study Terminated by Sponsor|0|||
28046733|NCT00464334|54704839|FG009|Overall Study|Study Terminated by Sponsor|0|||
28046734|NCT00464334|54704840|FG010|Overall Study|Study Terminated by Sponsor|0|||
28046735|NCT00464334|54704830|FG000|Overall Study|Withdrawal by Subject|1|||
28046736|NCT00464334|54704831|FG001|Overall Study|Withdrawal by Subject|7|||
28046737|NCT00464334|54704832|FG002|Overall Study|Withdrawal by Subject|4|||
28046738|NCT00464334|54704833|FG003|Overall Study|Withdrawal by Subject|2|||
28046739|NCT00464334|54704834|FG004|Overall Study|Withdrawal by Subject|2|||
28046740|NCT00464334|54704835|FG005|Overall Study|Withdrawal by Subject|2|||
28046741|NCT00464334|54704836|FG006|Overall Study|Withdrawal by Subject|2|||
28046742|NCT00464334|54704837|FG007|Overall Study|Withdrawal by Subject|1|||
28046743|NCT00464334|54704838|FG008|Overall Study|Withdrawal by Subject|3|||
28046744|NCT00464334|54704839|FG009|Overall Study|Withdrawal by Subject|0|||
28046745|NCT00464334|54704840|FG010|Overall Study|Withdrawal by Subject|0|||
28046746|NCT00299494|54704881|FG000|Overall Study|Withdrawal by Subject|0|||
28046747|NCT00299494|54704882|FG001|Overall Study|Withdrawal by Subject|0|||
28046748|NCT00299494|54704883|FG002|Overall Study|Withdrawal by Subject|0|||
28046749|NCT00299494|54704884|FG003|Overall Study|Withdrawal by Subject|3|||
28046750|NCT00299494|54704885|FG004|Overall Study|Withdrawal by Subject|1|||
28046751|NCT00299494|54704886|FG005|Overall Study|Withdrawal by Subject|4|||
28046752|NCT00299494|54704881|FG000|Overall Study|Physician Decision|0|||
28046753|NCT00299494|54704882|FG001|Overall Study|Physician Decision|0|||
28046754|NCT00299494|54704883|FG002|Overall Study|Physician Decision|0|||
28046755|NCT00299494|54704884|FG003|Overall Study|Physician Decision|0|||
28046756|NCT00299494|54704885|FG004|Overall Study|Physician Decision|1|||
28046757|NCT00299494|54704886|FG005|Overall Study|Physician Decision|0|||
28046758|NCT00299494|54704881|FG000|Overall Study|Death|3|||
28046759|NCT00299494|54704882|FG001|Overall Study|Death|1|||
28046760|NCT00299494|54704883|FG002|Overall Study|Death|4|||
28046761|NCT00299494|54704884|FG003|Overall Study|Death|6|||
28046762|NCT00299494|54704885|FG004|Overall Study|Death|18|||
28046763|NCT00299494|54704886|FG005|Overall Study|Death|19|||
28046764|NCT00299494|54704881|FG000|Overall Study|Lost to Follow-up|0|||
28046765|NCT00299494|54704882|FG001|Overall Study|Lost to Follow-up|0|||
28046766|NCT00299494|54704883|FG002|Overall Study|Lost to Follow-up|0|||
28046767|NCT00299494|54704884|FG003|Overall Study|Lost to Follow-up|0|||
27811550|NCT01719003|54267574|FG007|Overall Study|Lack of Efficacy|0|||
27811551|NCT01719003|54267575|FG008|Overall Study|Lack of Efficacy|0|||
27811552|NCT01853228|54267594|FG000|Phase 1|Lack of Efficacy|8|||
27811553|NCT01853228|54267595|FG001|Phase 1|Lack of Efficacy|0|||
27811554|NCT01853228|54267594|FG000|Phase 1|Other|1|||
27811555|NCT01853228|54267595|FG001|Phase 1|Other|0|||
27811556|NCT01853228|54267594|FG000|Phase 2|Physician Decision|0|||
27811557|NCT01853228|54267595|FG001|Phase 2|Physician Decision|1|||
27848078|NCT00985465|54340981|FG000|Overall Study|Withdrawal by Subject|1|||
27848079|NCT00985465|54340982|FG001|Overall Study|Withdrawal by Subject|2|||
27848080|NCT00985465|54340981|FG000|Overall Study|Considered to be part of the other group|0|||
27848081|NCT00985465|54340982|FG001|Overall Study|Considered to be part of the other group|1|||
27848082|NCT01049919|54340991|FG000|Overall Study|Met study endpoint (major amputation, death)|36|||
27848083|NCT01049919|54340992|FG001|Overall Study|Met study endpoint (major amputation, death)|16|||
27848084|NCT01049919|54340991|FG000|Overall Study|Withdrawal by Subject|5|||
27848085|NCT01049919|54340992|FG001|Overall Study|Withdrawal by Subject|0|||
27848086|NCT01049919|54340991|FG000|Overall Study|Lost to Follow-up|6|||
28046768|NCT00299494|54704885|FG004|Overall Study|Lost to Follow-up|3|||
28046769|NCT00299494|54704886|FG005|Overall Study|Lost to Follow-up|1|||
28046770|NCT00299494|54704881|FG000|Overall Study|Other - Unspecified|0|||
28046771|NCT00299494|54704882|FG001|Overall Study|Other - Unspecified|0|||
28046772|NCT00299494|54704883|FG002|Overall Study|Other - Unspecified|0|||
28046773|NCT00299494|54704884|FG003|Overall Study|Other - Unspecified|0|||
28046774|NCT00299494|54704885|FG004|Overall Study|Other - Unspecified|3|||
28046775|NCT00299494|54704886|FG005|Overall Study|Other - Unspecified|1|||
28046776|NCT00299494|54704881|FG000|Overall Study|Other - site closure|0|||
27811558|NCT01853228|54267594|FG000|Phase 2|Proceed To Transplant|0|||
27811559|NCT01853228|54267595|FG001|Phase 2|Proceed To Transplant|3|||
28046777|NCT00299494|54704882|FG001|Overall Study|Other - site closure|0|||
28046778|NCT00299494|54704883|FG002|Overall Study|Other - site closure|0|||
28046779|NCT00299494|54704884|FG003|Overall Study|Other - site closure|1|||
28046780|NCT00299494|54704885|FG004|Overall Study|Other - site closure|1|||
28046781|NCT00299494|54704886|FG005|Overall Study|Other - site closure|1|||
28046782|NCT00453180|54704913|FG000|Overall Study|Lost to Follow-up|2|||
28046783|NCT00453180|54704914|FG001|Overall Study|Lost to Follow-up|1|||
27811560|NCT01853228|54267594|FG000|Phase 2|Lack of Efficacy|0|||
27811561|NCT01853228|54267595|FG001|Phase 2|Lack of Efficacy|4|||
27811562|NCT01705587|54267602|FG000|Overall Study|Withdrawal by Subject|0|||
27811563|NCT01705587|54267603|FG001|Overall Study|Withdrawal by Subject|1|||
27811564|NCT01718535|54267619|FG000|Overall Study|Bidirectional Sequencing not possible|1|||
27811565|NCT01718535|54267620|FG001|Overall Study|Bidirectional Sequencing not possible|0|||
27811566|NCT01718535|54267621|FG002|Overall Study|Bidirectional Sequencing not possible|0|||
27811567|NCT01718535|54267622|FG003|Overall Study|Bidirectional Sequencing not possible|1|||
27811568|NCT01718535|54267623|FG004|Overall Study|Bidirectional Sequencing not possible|0|||
27811569|NCT01718535|54267624|FG005|Overall Study|Bidirectional Sequencing not possible|0|||
27811570|NCT01718535|54267625|FG006|Overall Study|Bidirectional Sequencing not possible|0|||
27811571|NCT01718535|54267626|FG007|Overall Study|Bidirectional Sequencing not possible|0|||
27811572|NCT01718535|54267627|FG008|Overall Study|Bidirectional Sequencing not possible|0|||
27811573|NCT01718535|54267628|FG009|Overall Study|Bidirectional Sequencing not possible|0|||
27811574|NCT01717989|54267650|FG000|Overall Study|Ineligibility determined|6|||
27811575|NCT01717989|54267650|FG000|Overall Study|Protocol deviation|6|||
27811576|NCT01717989|54267650|FG000|Overall Study|Withdrawal by Subject|11|||
27811577|NCT01717989|54267650|FG000|Overall Study|Physician Decision|2|||
27811578|NCT01717989|54267650|FG000|Overall Study|Lost to Follow-up|11|||
27811579|NCT01717989|54267650|FG000|Overall Study|Death|439|||
27811580|NCT01717989|54267650|FG000|Overall Study|Protocol-specified criteria|551|||
27811581|NCT01717989|54267650|FG000|Overall Study|Other|40|||
27811582|NCT01705509|54267669|FG000|Inclusion CPET|Screen Failure|5|||
27811583|NCT01705509|54267669|FG000|Inclusion CPET|Withdrawal by Subject|2|||
27811584|NCT01705509|54267669|FG000|CPET w/ Ranexa|Screen Failure|2|||
27811585|NCT01853072|54267675|FG000|Overall Study|Adverse event prior to treatment|0|||
27811586|NCT01853072|54267676|FG001|Overall Study|Adverse event prior to treatment|1|||
27811587|NCT01853072|54267675|FG000|Overall Study|Adverse Event|0|||
27811588|NCT01853072|54267676|FG001|Overall Study|Adverse Event|3|||
27811589|NCT01853072|54267675|FG000|Overall Study|Death|1|||
27811590|NCT01853072|54267676|FG001|Overall Study|Death|4|||
27811591|NCT01853072|54267675|FG000|Overall Study|Lost to Follow-up|0|||
27811592|NCT01853072|54267676|FG001|Overall Study|Lost to Follow-up|3|||
27811593|NCT01853072|54267675|FG000|Overall Study|Non-compliance with study drug|0|||
27811594|NCT01853072|54267676|FG001|Overall Study|Non-compliance with study drug|1|||
27811595|NCT01853072|54267675|FG000|Overall Study|Physician Decision|1|||
27811596|NCT01853072|54267676|FG001|Overall Study|Physician Decision|1|||
27811597|NCT01853072|54267675|FG000|Overall Study|Withdrawal by Subject|1|||
27811598|NCT01853072|54267676|FG001|Overall Study|Withdrawal by Subject|2|||
27811599|NCT01853072|54267675|FG000|Overall Study|Reason not specified|9|||
27811600|NCT01853072|54267676|FG001|Overall Study|Reason not specified|6|||
27811601|NCT01877720|54267684|FG000|Overall Study|Adverse Event|1|||
27811602|NCT01877720|54267685|FG001|Overall Study|Adverse Event|0|||
27811603|NCT01870869|54267695|FG000|Overall Study|Implanted with nonstudy device|1|||
27811604|NCT01870869|54267696|FG001|Overall Study|Implanted with nonstudy device|3|||
27811605|NCT01870869|54267697|FG002|Overall Study|Implanted with nonstudy device|14|||
27811606|NCT01870869|54267698|FG003|Overall Study|Implanted with nonstudy device|4|||
27811607|NCT01870869|54267695|FG000|Overall Study|Death|0|||
27811608|NCT01870869|54267696|FG001|Overall Study|Death|0|||
27811609|NCT01870869|54267697|FG002|Overall Study|Death|7|||
27811610|NCT01870869|54267698|FG003|Overall Study|Death|1|||
27811611|NCT01870869|54267695|FG000|Overall Study|Subject choice|6|||
27811612|NCT01870869|54267696|FG001|Overall Study|Subject choice|2|||
28046784|NCT00453180|54704913|FG000|Overall Study|Adverse Event|1|||
28046785|NCT00453180|54704914|FG001|Overall Study|Adverse Event|2|||
27811613|NCT01870869|54267697|FG002|Overall Study|Subject choice|22|||
27811614|NCT01870869|54267698|FG003|Overall Study|Subject choice|8|||
27811615|NCT01870869|54267695|FG000|Overall Study|Lost to Follow-up|10|||
27811616|NCT01870869|54267696|FG001|Overall Study|Lost to Follow-up|2|||
28046786|NCT00464178|54704920|FG000|Overall Study|Protocol Violation|1|||
28046787|NCT00464178|54704920|FG000|Overall Study|Withdrawal by Subject|1|||
27811617|NCT01870869|54267697|FG002|Overall Study|Lost to Follow-up|25|||
27811618|NCT01870869|54267698|FG003|Overall Study|Lost to Follow-up|3|||
27811619|NCT01870869|54267695|FG000|Overall Study|Reason not Specified|1|||
27811620|NCT01870869|54267696|FG001|Overall Study|Reason not Specified|2|||
27811621|NCT01870869|54267697|FG002|Overall Study|Reason not Specified|20|||
27811622|NCT01870869|54267698|FG003|Overall Study|Reason not Specified|4|||
28046788|NCT00560105|54704927|FG000|Overall Study|musculoskeletal chest discomfort with us|1|||
28046789|NCT00560105|54704928|FG001|Overall Study|musculoskeletal chest discomfort with us|2|||
28046790|NCT00467610|54704934|FG000|Overall Study|Withdrawal by Subject|1|||
28046791|NCT00316186|54704938|FG000|Overall Study|Adverse Event|6|||
28046792|NCT00316186|54704938|FG000|Overall Study|Disease Progression|4|||
28046793|NCT00316186|54704938|FG000|Overall Study|Lost to Follow-up|1|||
28046794|NCT00316186|54704938|FG000|Overall Study|Other|1|||
28046795|NCT00453102|54704942|FG000|Overall Study|Withdrawal by Subject|2|||
28046796|NCT00299182|54704953|FG000|Overall Study|Withdrawal by Subject|0|||
28046797|NCT00299182|54704954|FG001|Overall Study|Withdrawal by Subject|0|||
28046798|NCT00299182|54704955|FG002|Overall Study|Withdrawal by Subject|1|||
28046799|NCT00299182|54704956|FG003|Overall Study|Withdrawal by Subject|0|||
28046800|NCT00299182|54704957|FG004|Overall Study|Withdrawal by Subject|1|||
28046801|NCT00299182|54704958|FG005|Overall Study|Withdrawal by Subject|2|||
28046802|NCT00299182|54704959|FG006|Overall Study|Withdrawal by Subject|0|||
28046803|NCT00299182|54704953|FG000|Overall Study|Chemotherapy Changed|0|||
28046804|NCT00299182|54704954|FG001|Overall Study|Chemotherapy Changed|0|||
28046805|NCT00299182|54704955|FG002|Overall Study|Chemotherapy Changed|1|||
28046806|NCT00299182|54704956|FG003|Overall Study|Chemotherapy Changed|0|||
28046807|NCT00299182|54704957|FG004|Overall Study|Chemotherapy Changed|1|||
28046808|NCT00299182|54704958|FG005|Overall Study|Chemotherapy Changed|0|||
28046809|NCT00299182|54704959|FG006|Overall Study|Chemotherapy Changed|1|||
28046810|NCT00299182|54704953|FG000|Overall Study|Adverse Event|0|||
28046811|NCT00299182|54704954|FG001|Overall Study|Adverse Event|0|||
28046812|NCT00299182|54704955|FG002|Overall Study|Adverse Event|0|||
28046813|NCT00299182|54704956|FG003|Overall Study|Adverse Event|0|||
28046814|NCT00299182|54704957|FG004|Overall Study|Adverse Event|0|||
28046815|NCT00299182|54704958|FG005|Overall Study|Adverse Event|1|||
28046816|NCT00299182|54704959|FG006|Overall Study|Adverse Event|0|||
28046817|NCT00299182|54704953|FG000|Overall Study|Not Eligible|0|||
28046818|NCT00299182|54704954|FG001|Overall Study|Not Eligible|0|||
28046819|NCT00299182|54704955|FG002|Overall Study|Not Eligible|0|||
28046820|NCT00299182|54704956|FG003|Overall Study|Not Eligible|0|||
28046821|NCT00299182|54704957|FG004|Overall Study|Not Eligible|1|||
28046822|NCT00299182|54704958|FG005|Overall Study|Not Eligible|0|||
28046823|NCT00299182|54704959|FG006|Overall Study|Not Eligible|0|||
28046824|NCT00467142|54704977|FG000|Overall Study|Withdrawal by Subject|1|||
28046825|NCT00467142|54704977|FG000|Overall Study|Adverse Event|1|||
28046826|NCT00467142|54704977|FG000|Overall Study|Protocol Violation|1|||
28046827|NCT00553475|54704984|FG000|Overall Study|Adverse Event|7|||
28046828|NCT00553475|54704985|FG001|Overall Study|Adverse Event|17|||
28046829|NCT00553475|54704986|FG002|Overall Study|Adverse Event|13|||
28046830|NCT00553475|54704984|FG000|Overall Study|Lack of Efficacy|7|||
28046831|NCT00553475|54704985|FG001|Overall Study|Lack of Efficacy|1|||
28046832|NCT00553475|54704986|FG002|Overall Study|Lack of Efficacy|0|||
28046833|NCT00553475|54704984|FG000|Overall Study|Withdrawal by Subject|1|||
28046834|NCT00553475|54704985|FG001|Overall Study|Withdrawal by Subject|1|||
28046835|NCT00553475|54704986|FG002|Overall Study|Withdrawal by Subject|0|||
28046836|NCT00553475|54704984|FG000|Overall Study|Physician Decision|1|||
28046837|NCT00553475|54704985|FG001|Overall Study|Physician Decision|0|||
28046838|NCT00553475|54704986|FG002|Overall Study|Physician Decision|0|||
28046839|NCT00553475|54704984|FG000|Overall Study|Due to moving|0|||
28046840|NCT00553475|54704985|FG001|Overall Study|Due to moving|1|||
28046841|NCT00553475|54704986|FG002|Overall Study|Due to moving|0|||
28046842|NCT00329602|54704998|FG000|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119|||
28046843|NCT00329602|54704999|FG001|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99|||
28046844|NCT00329602|54705000|FG002|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0|||
28046845|NCT00329602|54704998|FG000|40-Week Open-Label Treatment Phase|Adverse Event|0|||
28046846|NCT00329602|54704999|FG001|40-Week Open-Label Treatment Phase|Adverse Event|0|||
28046847|NCT00329602|54705000|FG002|40-Week Open-Label Treatment Phase|Adverse Event|20|||
28046848|NCT00329602|54704998|FG000|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
28046849|NCT00329602|54704999|FG001|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
28046850|NCT00329602|54705000|FG002|40-Week Open-Label Treatment Phase|Lost to Follow-up|1|||
28046851|NCT00329602|54704998|FG000|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
28046852|NCT00329602|54704999|FG001|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
27811623|NCT01870869|54267695|FG000|Overall Study|Not evaluable|10|||
27811624|NCT01870869|54267696|FG001|Overall Study|Not evaluable|5|||
28046853|NCT00329602|54705000|FG002|40-Week Open-Label Treatment Phase|Protocol Violation|2|||
28046854|NCT00329602|54704998|FG000|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
28046855|NCT00329602|54704999|FG001|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
28046856|NCT00329602|54705000|FG002|40-Week Open-Label Treatment Phase|Lack of Efficacy|9|||
28046857|NCT00329602|54704998|FG000|40-Week Open-Label Treatment Phase|Captured as Other|0|||
28046858|NCT00329602|54704999|FG001|40-Week Open-Label Treatment Phase|Captured as Other|0|||
28046859|NCT00329602|54705000|FG002|40-Week Open-Label Treatment Phase|Captured as Other|4|||
28046860|NCT00463866|54705018|FG000|Overall Study|Adverse Event|70|||
28046861|NCT00463866|54705019|FG001|Overall Study|Adverse Event|93|||
28046862|NCT00463866|54705018|FG000|Overall Study|Withdrawal by Subject|81|||
28046863|NCT00463866|54705019|FG001|Overall Study|Withdrawal by Subject|79|||
28046864|NCT00463866|54705018|FG000|Overall Study|Lost to Follow-up|46|||
28046865|NCT00463866|54705019|FG001|Overall Study|Lost to Follow-up|55|||
28046866|NCT00463866|54705018|FG000|Overall Study|Incorrect Enrolment|64|||
28046867|NCT00463866|54705019|FG001|Overall Study|Incorrect Enrolment|66|||
28046868|NCT00463866|54705018|FG000|Overall Study|Severe Non-Compliance to Protocol|25|||
28046869|NCT00463866|54705019|FG001|Overall Study|Severe Non-Compliance to Protocol|21|||
28046870|NCT00463866|54705018|FG000|Overall Study|Safety Reason|1|||
28046871|NCT00463866|54705019|FG001|Overall Study|Safety Reason|3|||
28046872|NCT00463866|54705018|FG000|Overall Study|Mis-Randomization of subject|0|||
28046873|NCT00463866|54705019|FG001|Overall Study|Mis-Randomization of subject|1|||
28046874|NCT00463866|54705018|FG000|Overall Study|Other|22|||
28046875|NCT00463866|54705019|FG001|Overall Study|Other|22|||
28046876|NCT00313846|54705027|FG000|Overall Study|Withdrawal by Subject|2|||
28046877|NCT00313846|54705028|FG001|Overall Study|Withdrawal by Subject|0|||
28046878|NCT00313846|54705027|FG000|Overall Study|Adverse Event|1|||
28046879|NCT00313846|54705028|FG001|Overall Study|Adverse Event|8|||
28046880|NCT00313846|54705027|FG000|Overall Study|Administrative|2|||
28046881|NCT00313846|54705028|FG001|Overall Study|Administrative|3|||
28046882|NCT00551135|54705039|FG000|Overall Study|Adverse Event|1|||
28046883|NCT00551135|54705040|FG001|Overall Study|Adverse Event|0|||
28046884|NCT00551135|54705041|FG002|Overall Study|Adverse Event|1|||
28046885|NCT00551135|54705042|FG003|Overall Study|Adverse Event|1|||
28046886|NCT00551135|54705039|FG000|Overall Study|Lost to Follow-up|0|||
28046887|NCT00551135|54705040|FG001|Overall Study|Lost to Follow-up|0|||
28046888|NCT00551135|54705041|FG002|Overall Study|Lost to Follow-up|0|||
28046889|NCT00551135|54705042|FG003|Overall Study|Lost to Follow-up|1|||
28046890|NCT00551135|54705039|FG000|Overall Study|Other|3|||
28046891|NCT00551135|54705040|FG001|Overall Study|Other|2|||
27811625|NCT01870869|54267697|FG002|Overall Study|Not evaluable|42|||
27811626|NCT01870869|54267698|FG003|Overall Study|Not evaluable|10|||
27811627|NCT01877408|54267710|FG000|Overall Study|Lost to Follow-up|0|||
27811628|NCT01877408|54267711|FG001|Overall Study|Lost to Follow-up|2|||
27811629|NCT01717287|54267720|FG000|Overall Study|Lost to Follow-up|0|||
27811630|NCT01717287|54267721|FG001|Overall Study|Lost to Follow-up|2|||
27811631|NCT01717287|54267720|FG000|Overall Study|Protocol Violation|0|||
27811632|NCT01717287|54267721|FG001|Overall Study|Protocol Violation|1|||
27811633|NCT01827254|54267727|FG000|Overall Study|Death|10|||
27848087|NCT01049919|54340992|FG001|Overall Study|Lost to Follow-up|1|||
27848088|NCT01049919|54340991|FG000|Overall Study|Physician Decision|2|||
27848089|NCT01049919|54340992|FG001|Overall Study|Physician Decision|0|||
27848090|NCT01049919|54340991|FG000|Overall Study|Received 2nd treatment via compassionate use|1|||
27848091|NCT01049919|54340992|FG001|Overall Study|Received 2nd treatment via compassionate use|0|||
27848092|NCT01049919|54340991|FG000|Overall Study|Early study termination by sponsor.|2|||
27848093|NCT01049919|54340992|FG001|Overall Study|Early study termination by sponsor.|0|||
27848094|NCT01049373|54341000|FG000|Overall Study|Protocol Violation|9|||
27848095|NCT01049373|54341001|FG001|Overall Study|Protocol Violation|9|||
27848096|NCT01049373|54341000|FG000|Overall Study|Withdrawal by Subject|8|||
27848097|NCT01049373|54341001|FG001|Overall Study|Withdrawal by Subject|5|||
27848098|NCT01049373|54341000|FG000|Overall Study|Adverse Event|3|||
27848099|NCT01049373|54341001|FG001|Overall Study|Adverse Event|3|||
27848100|NCT01049373|54341000|FG000|Overall Study|Lost to Follow-up|9|||
27848101|NCT01049373|54341001|FG001|Overall Study|Lost to Follow-up|4|||
27848102|NCT01049373|54341000|FG000|Overall Study|no evaluable study values|9|||
27848103|NCT01049373|54341001|FG001|Overall Study|no evaluable study values|21|||
27848104|NCT01049373|54341000|FG000|Overall Study|Other|1|||
27848105|NCT01049373|54341001|FG001|Overall Study|Other|1|||
27848106|NCT01049373|54341000|FG000|Overall Study|Non-cooperation|0|||
28046892|NCT00551135|54705041|FG002|Overall Study|Other|1|||
28046893|NCT00551135|54705042|FG003|Overall Study|Other|2|||
28046894|NCT00551135|54705039|FG000|Overall Study|Withdrawal by Subject|1|||
28046895|NCT00551135|54705040|FG001|Overall Study|Withdrawal by Subject|0|||
27811634|NCT01827254|54267727|FG000|Overall Study|Case report form not completed|4|||
28046896|NCT00551135|54705041|FG002|Overall Study|Withdrawal by Subject|3|||
28046897|NCT00551135|54705042|FG003|Overall Study|Withdrawal by Subject|1|||
27811635|NCT01827254|54267727|FG000|Overall Study|Invalidated centre|3|||
27811636|NCT01827254|54267727|FG000|Overall Study|Discontinued prior initiation: sunitinib|1|||
27848107|NCT01049373|54341001|FG001|Overall Study|Non-cooperation|1|||
28046898|NCT00299104|54705055|FG000|Treatment Period|Adverse Event|14|||
28046899|NCT00299104|54705056|FG001|Treatment Period|Adverse Event|9|||
28046900|NCT00299104|54705057|FG002|Treatment Period|Adverse Event|7|||
27811637|NCT01827254|54267727|FG000|Overall Study|Did not complete re-challenge|1|||
28046901|NCT00299104|54705055|FG000|Treatment Period|Death|1|||
28046902|NCT00299104|54705056|FG001|Treatment Period|Death|1|||
28046903|NCT00299104|54705057|FG002|Treatment Period|Death|1|||
28046904|NCT00299104|54705055|FG000|Treatment Period|Insufficient therapeutic response|34|||
28046905|NCT00299104|54705056|FG001|Treatment Period|Insufficient therapeutic response|13|||
28046906|NCT00299104|54705057|FG002|Treatment Period|Insufficient therapeutic response|8|||
28046907|NCT00299104|54705055|FG000|Treatment Period|Failure to return|9|||
28046908|NCT00299104|54705056|FG001|Treatment Period|Failure to return|8|||
28046909|NCT00299104|54705057|FG002|Treatment Period|Failure to return|8|||
28046910|NCT00299104|54705055|FG000|Treatment Period|Violation of selection criteria|1|||
28046911|NCT00299104|54705056|FG001|Treatment Period|Violation of selection criteria|2|||
28046912|NCT00299104|54705057|FG002|Treatment Period|Violation of selection criteria|0|||
28046913|NCT00299104|54705055|FG000|Treatment Period|Protocol Violation|1|||
28046914|NCT00299104|54705056|FG001|Treatment Period|Protocol Violation|1|||
28046915|NCT00299104|54705057|FG002|Treatment Period|Protocol Violation|0|||
28046916|NCT00299104|54705055|FG000|Treatment Period|Refused treatment|9|||
28046917|NCT00299104|54705056|FG001|Treatment Period|Refused treatment|2|||
28046918|NCT00299104|54705057|FG002|Treatment Period|Refused treatment|2|||
28046919|NCT00299104|54705055|FG000|Treatment Period|Withdrew consent|14|||
28046920|NCT00299104|54705056|FG001|Treatment Period|Withdrew consent|19|||
28046921|NCT00299104|54705057|FG002|Treatment Period|Withdrew consent|9|||
28046922|NCT00299104|54705055|FG000|Treatment Period|Administrative reasons|106|||
27811638|NCT01827254|54267727|FG000|Overall Study|Disease progression|36|||
28046923|NCT00299104|54705056|FG001|Treatment Period|Administrative reasons|120|||
28046924|NCT00299104|54705057|FG002|Treatment Period|Administrative reasons|137|||
28046925|NCT00299104|54705055|FG000|Safety Follow-Up (SFU) Period|Death|3|||
28046926|NCT00299104|54705056|FG001|Safety Follow-Up (SFU) Period|Death|2|||
28046927|NCT00299104|54705057|FG002|Safety Follow-Up (SFU) Period|Death|1|||
28046928|NCT00299104|54705055|FG000|Safety Follow-Up (SFU) Period|Lost to Follow-up|9|||
28046929|NCT00299104|54705056|FG001|Safety Follow-Up (SFU) Period|Lost to Follow-up|11|||
28046930|NCT00299104|54705057|FG002|Safety Follow-Up (SFU) Period|Lost to Follow-up|20|||
28046931|NCT00299104|54705055|FG000|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16|||
28046932|NCT00299104|54705056|FG001|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21|||
28046933|NCT00299104|54705057|FG002|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11|||
28046934|NCT00299104|54705055|FG000|Safety Follow-Up (SFU) Period|Administrative reasons|27|||
28046935|NCT00299104|54705056|FG001|Safety Follow-Up (SFU) Period|Administrative reasons|7|||
28046936|NCT00299104|54705057|FG002|Safety Follow-Up (SFU) Period|Administrative reasons|5|||
28046937|NCT00299104|54705055|FG000|Extended Safety Follow-Up (ESFU) Period|Death|0|||
28046938|NCT00299104|54705056|FG001|Extended Safety Follow-Up (ESFU) Period|Death|1|||
27811639|NCT01827254|54267727|FG000|Overall Study|Intolerance to treatment|4|||
27811640|NCT01824602|54267739|FG000|Overall Study|Withdrawal by Subject|0|||
27811641|NCT01824602|54267740|FG001|Overall Study|Withdrawal by Subject|0|||
27811642|NCT01824602|54267741|FG002|Overall Study|Withdrawal by Subject|1|||
27811643|NCT01824602|54267742|FG003|Overall Study|Withdrawal by Subject|2|||
27811644|NCT01824602|54267739|FG000|Overall Study|Patient non-compliance|0|||
27811645|NCT01824602|54267740|FG001|Overall Study|Patient non-compliance|0|||
27811646|NCT01824602|54267741|FG002|Overall Study|Patient non-compliance|1|||
27811647|NCT01824602|54267742|FG003|Overall Study|Patient non-compliance|0|||
27811648|NCT01824602|54267739|FG000|Overall Study|Adverse Event|1|||
27811649|NCT01824602|54267740|FG001|Overall Study|Adverse Event|0|||
27811650|NCT01824602|54267741|FG002|Overall Study|Adverse Event|2|||
27811651|NCT01824602|54267742|FG003|Overall Study|Adverse Event|2|||
27811652|NCT01824602|54267739|FG000|Overall Study|Treatment failure|0|||
27811653|NCT01824602|54267740|FG001|Overall Study|Treatment failure|0|||
27811654|NCT01824602|54267741|FG002|Overall Study|Treatment failure|0|||
27811655|NCT01824602|54267742|FG003|Overall Study|Treatment failure|1|||
28046939|NCT00299104|54705057|FG002|Extended Safety Follow-Up (ESFU) Period|Death|0|||
28046940|NCT00299104|54705055|FG000|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
28046941|NCT00299104|54705056|FG001|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
28046942|NCT00299104|54705057|FG002|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
28046943|NCT00299104|54705055|FG000|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2|||
28046944|NCT00299104|54705056|FG001|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4|||
27811656|NCT01704651|54267754|FG000|Overall Study|Pre-op withdrawal by subject|1|||
27811657|NCT01704651|54267755|FG001|Overall Study|Pre-op withdrawal by subject|1|||
27811658|NCT01704651|54267754|FG000|Overall Study|Pre-op change in treatment plan|1|||
28046945|NCT00299104|54705057|FG002|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8|||
28046946|NCT00299104|54705055|FG000|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1|||
28046947|NCT00299104|54705056|FG001|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
28046948|NCT00299104|54705057|FG002|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
28046949|NCT00313612|54705067|FG000|Overall Study|Patient never received treatment|0|||
28046950|NCT00313612|54705068|FG001|Overall Study|Patient never received treatment|1|||
28046951|NCT00507416|54705077|FG000|Overall Study|Adverse Event|58|||
28046952|NCT00507416|54705078|FG001|Overall Study|Adverse Event|67|||
28046953|NCT00507416|54705079|FG002|Overall Study|Adverse Event|65|||
28046954|NCT00507416|54705077|FG000|Overall Study|Protocol Violation|1|||
28046955|NCT00507416|54705078|FG001|Overall Study|Protocol Violation|2|||
28046956|NCT00507416|54705079|FG002|Overall Study|Protocol Violation|0|||
28046957|NCT00507416|54705077|FG000|Overall Study|Lack ofEfficacy / Physician Decision|7|||
28046958|NCT00507416|54705078|FG001|Overall Study|Lack ofEfficacy / Physician Decision|7|||
28046959|NCT00507416|54705079|FG002|Overall Study|Lack ofEfficacy / Physician Decision|8|||
28046960|NCT00507416|54705077|FG000|Overall Study|Progressive Disease|20|||
28046961|NCT00507416|54705078|FG001|Overall Study|Progressive Disease|10|||
28046962|NCT00507416|54705079|FG002|Overall Study|Progressive Disease|13|||
28046963|NCT00507416|54705077|FG000|Overall Study|Patient declined further treatment|18|||
28046964|NCT00507416|54705078|FG001|Overall Study|Patient declined further treatment|14|||
28046965|NCT00507416|54705079|FG002|Overall Study|Patient declined further treatment|11|||
28046966|NCT00507416|54705077|FG000|Overall Study|Other|11|||
28046967|NCT00507416|54705078|FG001|Overall Study|Other|16|||
28046968|NCT00507416|54705079|FG002|Overall Study|Other|13|||
28046969|NCT00507416|54705077|FG000|Overall Study|Did not Receive Study Treatment|3|||
28046970|NCT00507416|54705078|FG001|Overall Study|Did not Receive Study Treatment|9|||
28046971|NCT00507416|54705079|FG002|Overall Study|Did not Receive Study Treatment|4|||
28046972|NCT00489476|54705091|FG000|Overall Study|Lost to Follow-up|0|||
28046973|NCT00489476|54705092|FG001|Overall Study|Lost to Follow-up|1|||
28046974|NCT00489476|54705093|FG002|Overall Study|Lost to Follow-up|0|||
28046975|NCT00489476|54705094|FG003|Overall Study|Lost to Follow-up|0|||
28046976|NCT00550745|54705106|FG000|Overall Study|Death|20|||
27811659|NCT01704651|54267755|FG001|Overall Study|Pre-op change in treatment plan|4|||
28046977|NCT00550745|54705107|FG001|Overall Study|Death|16|||
28046978|NCT00550745|54705106|FG000|Overall Study|Lost to Follow-up|45|||
28046979|NCT00550745|54705107|FG001|Overall Study|Lost to Follow-up|30|||
28046980|NCT00550745|54705106|FG000|Overall Study|Physician Decision|0|||
28046981|NCT00550745|54705107|FG001|Overall Study|Physician Decision|2|||
28046982|NCT00550745|54705106|FG000|Overall Study|Protocol Violation|4|||
28046983|NCT00550745|54705107|FG001|Overall Study|Protocol Violation|2|||
28046984|NCT00550745|54705106|FG000|Overall Study|Withdrawal by Subject|17|||
28046985|NCT00550745|54705107|FG001|Overall Study|Withdrawal by Subject|10|||
28046986|NCT00550745|54705106|FG000|Overall Study|Screen failure|1|||
28046987|NCT00550745|54705107|FG001|Overall Study|Screen failure|0|||
28046988|NCT00452790|54705115|FG000|Infant Series|Clinical hold - consent withdrawn|118|||
28046989|NCT00452790|54705116|FG001|Infant Series|Clinical hold - consent withdrawn|123|||
28046990|NCT00452790|54705115|FG000|Infant Series|Parent/legal guardian request|8|||
28046991|NCT00452790|54705116|FG001|Infant Series|Parent/legal guardian request|6|||
28046992|NCT00452790|54705115|FG000|Infant Series|Failed to return|4|||
28046993|NCT00452790|54705116|FG001|Infant Series|Failed to return|1|||
28046994|NCT00452790|54705115|FG000|Infant Series|Protocol Violation|1|||
27811660|NCT01704651|54267754|FG000|Overall Study|Nasogastric tube placement in surgery|1|||
27811661|NCT01704651|54267755|FG001|Overall Study|Nasogastric tube placement in surgery|1|||
27811662|NCT01704651|54267754|FG000|Overall Study|Post-op did not have laparotomy|2|||
27811663|NCT01704651|54267755|FG001|Overall Study|Post-op did not have laparotomy|1|||
27811664|NCT01876706|54267761|FG000|Overall Study|BPH Intervention|9|||
27811665|NCT01876706|54267761|FG000|Overall Study|Lost to Follow-up|7|||
28046995|NCT00452790|54705116|FG001|Infant Series|Protocol Violation|3|||
28046996|NCT00452790|54705115|FG000|Infant Series|Lost to Follow-up|2|||
28046997|NCT00452790|54705116|FG001|Infant Series|Lost to Follow-up|2|||
28046998|NCT00452790|54705115|FG000|Infant Series|Adverse Event|1|||
28046999|NCT00452790|54705116|FG001|Infant Series|Adverse Event|2|||
28047000|NCT00452790|54705115|FG000|Infant Series|Other reasons|1|||
28047001|NCT00452790|54705116|FG001|Infant Series|Other reasons|2|||
28047002|NCT00452790|54705115|FG000|Infant Series|Investigator request|0|||
28047003|NCT00452790|54705116|FG001|Infant Series|Investigator request|1|||
28047004|NCT00452790|54705115|FG000|Infant Series|Death|0|||
28047005|NCT00452790|54705116|FG001|Infant Series|Death|1|||
28047006|NCT00452790|54705115|FG000|After Infant Series|Investigator request|10|||
28047007|NCT00452790|54705116|FG001|After Infant Series|Investigator request|10|||
27811666|NCT01876706|54267761|FG000|Overall Study|Withdrawals|6|||
28047008|NCT00452790|54705115|FG000|After Infant Series|Adverse Event|4|||
28047009|NCT00452790|54705116|FG001|After Infant Series|Adverse Event|1|||
28047010|NCT00452790|54705115|FG000|After Infant Series|Parent/legal guardian request|1|||
27811667|NCT01876706|54267761|FG000|Overall Study|Death|3|||
27811668|NCT01876082|54267767|FG000|Overall Study|Withdrawal by Subject|0|||
27811669|NCT01876082|54267768|FG001|Overall Study|Withdrawal by Subject|2|||
27811670|NCT01876082|54267767|FG000|Overall Study|Protocol Violation|1|||
27811671|NCT01876082|54267768|FG001|Overall Study|Protocol Violation|0|||
27811672|NCT01876082|54267767|FG000|Overall Study|Adverse Event|1|||
28047011|NCT00452790|54705116|FG001|After Infant Series|Parent/legal guardian request|3|||
28047012|NCT00452790|54705115|FG000|After Infant Series|Lost to Follow-up|4|||
28047013|NCT00452790|54705116|FG001|After Infant Series|Lost to Follow-up|0|||
28047014|NCT00452790|54705115|FG000|After Infant Series|Failed to return|1|||
28047015|NCT00452790|54705116|FG001|After Infant Series|Failed to return|0|||
28047016|NCT00452790|54705115|FG000|After Infant Series|Other reasons|1|||
28047017|NCT00452790|54705116|FG001|After Infant Series|Other reasons|0|||
28047018|NCT00452790|54705115|FG000|Toddler Dose|Failed to return|0|||
27811673|NCT01876082|54267768|FG001|Overall Study|Adverse Event|1|||
27811674|NCT01876082|54267767|FG000|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|0|||
27811675|NCT01876082|54267768|FG001|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|1|||
27811676|NCT01704495|54267778|FG000|Subjects Randomized|Other Reason|3|||
27811677|NCT01704495|54267779|FG001|Subjects Randomized|Other Reason|2|||
27811678|NCT01704495|54267780|FG002|Subjects Randomized|Other Reason|3|||
28047019|NCT00452790|54705116|FG001|Toddler Dose|Failed to return|1|||
28047020|NCT00452790|54705115|FG000|Toddler Dose|Parent/legal guardian request|0|||
28047021|NCT00452790|54705116|FG001|Toddler Dose|Parent/legal guardian request|1|||
28047022|NCT00463788|54705128|FG000|Overall Study|Progressive Disease|86|||
28047023|NCT00463788|54705129|FG001|Overall Study|Progressive Disease|42|||
28047024|NCT00463788|54705128|FG000|Overall Study|Adverse Event|6|||
28047025|NCT00463788|54705129|FG001|Overall Study|Adverse Event|2|||
28047026|NCT00463788|54705128|FG000|Overall Study|Withdrawal by Subject|6|||
28047027|NCT00463788|54705129|FG001|Overall Study|Withdrawal by Subject|2|||
28047028|NCT00463788|54705128|FG000|Overall Study|Death|4|||
28047029|NCT00463788|54705129|FG001|Overall Study|Death|3|||
28047030|NCT00463788|54705128|FG000|Overall Study|Symptomatic Deterioration|2|||
28047031|NCT00463788|54705129|FG001|Overall Study|Symptomatic Deterioration|3|||
28047032|NCT00463788|54705128|FG000|Overall Study|Lost to Follow-up|1|||
28047033|NCT00463788|54705129|FG001|Overall Study|Lost to Follow-up|0|||
28047034|NCT00463788|54705128|FG000|Overall Study|Protocol Violation|0|||
28047035|NCT00463788|54705129|FG001|Overall Study|Protocol Violation|1|||
28047036|NCT00463788|54705128|FG000|Overall Study|Other|3|||
28047037|NCT00463788|54705129|FG001|Overall Study|Other|0|||
27811679|NCT01704495|54267781|FG003|Subjects Randomized|Other Reason|2|||
27811680|NCT01704495|54267778|FG000|Subjects Randomized|Discontinuation criteria met|4|||
27811681|NCT01704495|54267779|FG001|Subjects Randomized|Discontinuation criteria met|2|||
27811682|NCT01704495|54267780|FG002|Subjects Randomized|Discontinuation criteria met|2|||
27811683|NCT01704495|54267781|FG003|Subjects Randomized|Discontinuation criteria met|0|||
27811684|NCT01704495|54267778|FG000|Subjects Randomized|Adverse Event|8|||
27811685|NCT01704495|54267779|FG001|Subjects Randomized|Adverse Event|2|||
27811686|NCT01704495|54267780|FG002|Subjects Randomized|Adverse Event|0|||
27811687|NCT01704495|54267781|FG003|Subjects Randomized|Adverse Event|7|||
27811688|NCT01704495|54267778|FG000|Subjects Randomized|Withdrawal by Subject|5|||
27811689|NCT01704495|54267779|FG001|Subjects Randomized|Withdrawal by Subject|5|||
27811690|NCT01704495|54267780|FG002|Subjects Randomized|Withdrawal by Subject|5|||
27848108|NCT00985231|54341011|FG000|Overall Study|ineligible|1|||
27848109|NCT00985231|54341012|FG001|Overall Study|ineligible|0|||
27848110|NCT00985231|54341011|FG000|Overall Study|Protocol Violation|1|||
27848111|NCT00985231|54341012|FG001|Overall Study|Protocol Violation|0|||
27848112|NCT00985231|54341011|FG000|Overall Study|Withdrawal by Subject|1|||
27848113|NCT00985231|54341012|FG001|Overall Study|Withdrawal by Subject|0|||
27848114|NCT00985231|54341011|FG000|Overall Study|Lost to Follow-up|0|||
27848115|NCT00985231|54341012|FG001|Overall Study|Lost to Follow-up|1|||
27848116|NCT00985231|54341011|FG000|Overall Study|Study related symptoms & complaints|0|||
27848117|NCT00985231|54341012|FG001|Overall Study|Study related symptoms & complaints|2|||
28047038|NCT00463788|54705128|FG000|Overall Study|Randomized but not treated|1|||
28047039|NCT00463788|54705129|FG001|Overall Study|Randomized but not treated|1|||
28047040|NCT00548249|54705141|FG000|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3|||
28047041|NCT00548249|54705142|FG001|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
28047042|NCT00548249|54705143|FG002|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
28047043|NCT00548249|54705144|FG003|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2|||
28047044|NCT00548249|54705145|FG004|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
28047045|NCT00548249|54705141|FG000|Overall Study|Transferrin Saturation (TSAT) <20%|5|||
27811691|NCT01704495|54267781|FG003|Subjects Randomized|Withdrawal by Subject|5|||
27811692|NCT01704495|54267778|FG000|Subjects Randomized|Protocol Violation|1|||
27811693|NCT01704495|54267779|FG001|Subjects Randomized|Protocol Violation|1|||
28047046|NCT00548249|54705142|FG001|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
28047047|NCT00548249|54705143|FG002|Overall Study|Transferrin Saturation (TSAT) <20%|3|||
27848118|NCT01048671|54341032|FG000|Overall Study|Protocol Violation|0|||
27848119|NCT01048671|54341033|FG001|Overall Study|Protocol Violation|1|||
27811694|NCT01704495|54267780|FG002|Subjects Randomized|Protocol Violation|2|||
27811695|NCT01704495|54267781|FG003|Subjects Randomized|Protocol Violation|0|||
27811696|NCT01704495|54267778|FG000|Subjects Randomized|Eligibility criteria not fulfilled|1|||
27811697|NCT01704495|54267779|FG001|Subjects Randomized|Eligibility criteria not fulfilled|3|||
27811698|NCT01704495|54267780|FG002|Subjects Randomized|Eligibility criteria not fulfilled|4|||
27811699|NCT01704495|54267781|FG003|Subjects Randomized|Eligibility criteria not fulfilled|3|||
28047048|NCT00548249|54705144|FG003|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
28047049|NCT00548249|54705145|FG004|Overall Study|Transferrin Saturation (TSAT) <20%|2|||
28047050|NCT00548249|54705141|FG000|Overall Study|Protocol Violation|1|||
28047051|NCT00548249|54705142|FG001|Overall Study|Protocol Violation|1|||
28047052|NCT00548249|54705143|FG002|Overall Study|Protocol Violation|4|||
28047053|NCT00548249|54705144|FG003|Overall Study|Protocol Violation|0|||
28047054|NCT00548249|54705145|FG004|Overall Study|Protocol Violation|3|||
28047055|NCT00548249|54705141|FG000|Overall Study|Miscellaneous|2|||
28047056|NCT00548249|54705142|FG001|Overall Study|Miscellaneous|3|||
28047057|NCT00548249|54705143|FG002|Overall Study|Miscellaneous|2|||
28047058|NCT00548249|54705144|FG003|Overall Study|Miscellaneous|0|||
28047059|NCT00548249|54705145|FG004|Overall Study|Miscellaneous|2|||
28047060|NCT00548249|54705141|FG000|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
28047061|NCT00548249|54705142|FG001|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
27811700|NCT01704495|54267778|FG000|Optional Safety Extension|Adverse Event|0|||
28047062|NCT00548249|54705143|FG002|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2|||
28047063|NCT00548249|54705144|FG003|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1|||
28047064|NCT00548249|54705145|FG004|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4|||
28047065|NCT00548249|54705141|FG000|Overall Study|Adverse Event|2|||
28047066|NCT00548249|54705142|FG001|Overall Study|Adverse Event|2|||
28047067|NCT00548249|54705143|FG002|Overall Study|Adverse Event|0|||
28047068|NCT00548249|54705144|FG003|Overall Study|Adverse Event|1|||
28047069|NCT00548249|54705145|FG004|Overall Study|Adverse Event|1|||
28047070|NCT00548249|54705141|FG000|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
28047071|NCT00548249|54705142|FG001|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
28047072|NCT00548249|54705143|FG002|Overall Study|Post-dialysis high TSAT or low UIBC|1|||
28047073|NCT00548249|54705144|FG003|Overall Study|Post-dialysis high TSAT or low UIBC|3|||
28047074|NCT00548249|54705145|FG004|Overall Study|Post-dialysis high TSAT or low UIBC|2|||
28047075|NCT00548249|54705141|FG000|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
28047076|NCT00548249|54705142|FG001|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
28047077|NCT00548249|54705143|FG002|Overall Study|Erythropoietin (ESA)Dose Change Required|1|||
28047078|NCT00548249|54705144|FG003|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
28047079|NCT00548249|54705145|FG004|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
28047080|NCT00548249|54705141|FG000|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
28047081|NCT00548249|54705142|FG001|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
28047082|NCT00548249|54705143|FG002|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
28047083|NCT00548249|54705144|FG003|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
28047084|NCT00548249|54705145|FG004|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0|||
28047085|NCT00548249|54705141|FG000|Overall Study|Prolonged hospitalization|0|||
28047086|NCT00548249|54705142|FG001|Overall Study|Prolonged hospitalization|0|||
28047087|NCT00548249|54705143|FG002|Overall Study|Prolonged hospitalization|2|||
28047088|NCT00548249|54705144|FG003|Overall Study|Prolonged hospitalization|1|||
28047089|NCT00548249|54705145|FG004|Overall Study|Prolonged hospitalization|0|||
28047090|NCT00548249|54705141|FG000|Overall Study|Withdrawal by Subject|2|||
27811701|NCT01704495|54267779|FG001|Optional Safety Extension|Adverse Event|4|||
27811702|NCT01704495|54267780|FG002|Optional Safety Extension|Adverse Event|0|||
27811703|NCT01704495|54267781|FG003|Optional Safety Extension|Adverse Event|1|||
27811704|NCT01704495|54267778|FG000|Optional Safety Extension|Other reason|27|||
27811705|NCT01704495|54267779|FG001|Optional Safety Extension|Other reason|29|||
27811706|NCT01704495|54267780|FG002|Optional Safety Extension|Other reason|30|||
27811707|NCT01704495|54267781|FG003|Optional Safety Extension|Other reason|28|||
27811708|NCT01704495|54267778|FG000|Optional Safety Extension|Withdrawal by Subject|2|||
27811709|NCT01704495|54267779|FG001|Optional Safety Extension|Withdrawal by Subject|0|||
27811710|NCT01704495|54267780|FG002|Optional Safety Extension|Withdrawal by Subject|1|||
27848120|NCT01048671|54341034|FG002|Overall Study|Protocol Violation|1|||
27848121|NCT01360866|54341046|FG000|Overall Study|Lost to Follow-up|11|||
28047091|NCT00548249|54705142|FG001|Overall Study|Withdrawal by Subject|0|||
28047092|NCT00548249|54705143|FG002|Overall Study|Withdrawal by Subject|0|||
28047093|NCT00548249|54705144|FG003|Overall Study|Withdrawal by Subject|0|||
28047094|NCT00548249|54705145|FG004|Overall Study|Withdrawal by Subject|0|||
28047095|NCT00548249|54705141|FG000|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
27811711|NCT01704495|54267781|FG003|Optional Safety Extension|Withdrawal by Subject|2|||
27811712|NCT01716663|54267791|FG000|Overall Study|Withdrawn prior to procedure|4|||
28047096|NCT00548249|54705142|FG001|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
28047097|NCT00548249|54705143|FG002|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
28047098|NCT00548249|54705144|FG003|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
28047099|NCT00548249|54705145|FG004|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
28047100|NCT00548249|54705141|FG000|Overall Study|Sponsor's request|0|||
28047101|NCT00548249|54705142|FG001|Overall Study|Sponsor's request|0|||
28047102|NCT00548249|54705143|FG002|Overall Study|Sponsor's request|0|||
28047103|NCT00548249|54705144|FG003|Overall Study|Sponsor's request|1|||
28047104|NCT00548249|54705145|FG004|Overall Study|Sponsor's request|0|||
28047105|NCT00463476|54705159|FG000|Overall Study|Withdrawal by Subject|1|||
28047106|NCT00463476|54705160|FG001|Overall Study|Withdrawal by Subject|2|||
28047107|NCT00463476|54705159|FG000|Overall Study|Lost to Follow-up|1|||
28047108|NCT00463476|54705160|FG001|Overall Study|Lost to Follow-up|1|||
28047109|NCT03839940|54705168|FG000|Overall Study|Withdrawal by Subject|3|||
28047110|NCT03839940|54705169|FG001|Overall Study|Withdrawal by Subject|0|||
28047111|NCT03839940|54705168|FG000|Overall Study|Protocol Violation|0|||
28047112|NCT03839940|54705169|FG001|Overall Study|Protocol Violation|1|||
28047113|NCT03839940|54705168|FG000|Overall Study|No Post-Baseline Pain Score Data|1|||
28047114|NCT03839940|54705169|FG001|Overall Study|No Post-Baseline Pain Score Data|1|||
28047115|NCT03839628|54705177|FG000|Overall Study|Withdrawal by Subject|1|||
28047116|NCT00462462|54705183|FG000|Overall Study|Physician Decision|0|||
28047117|NCT00462462|54705184|FG001|Overall Study|Physician Decision|1|||
28047118|NCT00462384|54705192|FG000|Overall Study|Adverse Event|2|||
28047119|NCT00462384|54705192|FG000|Overall Study|Death|2|||
28047120|NCT00462384|54705192|FG000|Overall Study|Withdrawal by Subject|1|||
28047121|NCT00462384|54705192|FG000|Overall Study|Other|4|||
28047122|NCT00452400|54705201|FG000|Overall Study|Adverse Event|1|||
28047123|NCT00452400|54705202|FG001|Overall Study|Adverse Event|1|||
28047124|NCT00452400|54705203|FG002|Overall Study|Adverse Event|5|||
28047125|NCT00452400|54705204|FG003|Overall Study|Adverse Event|0|||
28047126|NCT00452400|54705205|FG004|Overall Study|Adverse Event|2|||
28047127|NCT00452400|54705201|FG000|Overall Study|Protocol Violation|0|||
28047128|NCT00452400|54705202|FG001|Overall Study|Protocol Violation|0|||
28047129|NCT00452400|54705203|FG002|Overall Study|Protocol Violation|1|||
28047130|NCT00452400|54705204|FG003|Overall Study|Protocol Violation|0|||
28047131|NCT00452400|54705205|FG004|Overall Study|Protocol Violation|0|||
28047132|NCT00452400|54705201|FG000|Overall Study|Lost to Follow-up|1|||
28047133|NCT00452400|54705202|FG001|Overall Study|Lost to Follow-up|0|||
28047134|NCT00452400|54705203|FG002|Overall Study|Lost to Follow-up|0|||
28047135|NCT00452400|54705204|FG003|Overall Study|Lost to Follow-up|0|||
28047136|NCT00452400|54705205|FG004|Overall Study|Lost to Follow-up|0|||
28047137|NCT00452400|54705201|FG000|Overall Study|Withdrawal by Subject|1|||
28047138|NCT00452400|54705202|FG001|Overall Study|Withdrawal by Subject|0|||
28047139|NCT00452400|54705203|FG002|Overall Study|Withdrawal by Subject|1|||
28047140|NCT00452400|54705204|FG003|Overall Study|Withdrawal by Subject|0|||
28047141|NCT00452400|54705205|FG004|Overall Study|Withdrawal by Subject|0|||
28047142|NCT00452400|54705201|FG000|Overall Study|Lack of Efficacy|2|||
28047143|NCT00452400|54705202|FG001|Overall Study|Lack of Efficacy|0|||
28047144|NCT00452400|54705203|FG002|Overall Study|Lack of Efficacy|0|||
28047145|NCT00452400|54705204|FG003|Overall Study|Lack of Efficacy|0|||
28047146|NCT00452400|54705205|FG004|Overall Study|Lack of Efficacy|0|||
28047147|NCT00452400|54705201|FG000|Overall Study|Other reasons not listed above|0|||
28047148|NCT00452400|54705202|FG001|Overall Study|Other reasons not listed above|0|||
28047149|NCT00452400|54705203|FG002|Overall Study|Other reasons not listed above|0|||
28047150|NCT00452400|54705204|FG003|Overall Study|Other reasons not listed above|1|||
28047151|NCT00452400|54705205|FG004|Overall Study|Other reasons not listed above|1|||
28047152|NCT00462306|54705219|FG000|Overall Study|insufficient data|0|||
28047153|NCT00462306|54705220|FG001|Overall Study|insufficient data|13|||
28047154|NCT00461682|54705228|FG000|Overall Study|Protocol Violation|1|||
28047155|NCT00443430|54705236|FG000|Overall Study|Lack of Efficacy|3|||
28047156|NCT00443430|54705237|FG001|Overall Study|Lack of Efficacy|3|||
28047157|NCT00443430|54705236|FG000|Overall Study|Adverse Event|1|||
28047158|NCT00443430|54705237|FG001|Overall Study|Adverse Event|1|||
28047159|NCT00460746|54705243|FG000|Overall Study|Adverse Event|1|||
28047160|NCT00460746|54705243|FG000|Overall Study|Lost to Follow-up|1|||
27811713|NCT01716663|54267791|FG000|Overall Study|Treated with non-study catheter|2|||
28047161|NCT00443118|54705250|FG000|Overall Study|unknown primary outcome|3|||
28047162|NCT00443118|54705251|FG001|Overall Study|unknown primary outcome|1|||
28047163|NCT00443118|54705252|FG002|Overall Study|unknown primary outcome|0|||
28047164|NCT00443118|54705250|FG000|Overall Study|Withdrawal by Subject|1|||
28047165|NCT00443118|54705251|FG001|Overall Study|Withdrawal by Subject|0|||
28047166|NCT00443118|54705252|FG002|Overall Study|Withdrawal by Subject|0|||
28047167|NCT00460434|54705280|FG000|Overall Study|Lost to Follow-up|3|||
28047168|NCT00460434|54705281|FG001|Overall Study|Lost to Follow-up|7|||
28047169|NCT00373425|54705292|FG000|Overall Study|Relapse of NSCLC|116|||
28047170|NCT00373425|54705293|FG001|Overall Study|Relapse of NSCLC|104|||
28047171|NCT00373425|54705294|FG002|Overall Study|Relapse of NSCLC|19|||
28047172|NCT00373425|54705295|FG003|Overall Study|Relapse of NSCLC|2|||
28047173|NCT00373425|54705296|FG004|Overall Study|Relapse of NSCLC|26|||
28047174|NCT00373425|54705292|FG000|Overall Study|Adverse Event|191|||
28047175|NCT00373425|54705293|FG001|Overall Study|Adverse Event|22|||
28047176|NCT00373425|54705294|FG002|Overall Study|Adverse Event|59|||
28047177|NCT00373425|54705295|FG003|Overall Study|Adverse Event|0|||
28047178|NCT00373425|54705296|FG004|Overall Study|Adverse Event|34|||
28047179|NCT00373425|54705292|FG000|Overall Study|Patient request|35|||
28047180|NCT00373425|54705293|FG001|Overall Study|Patient request|18|||
28047181|NCT00373425|54705294|FG002|Overall Study|Patient request|43|||
28047182|NCT00373425|54705295|FG003|Overall Study|Patient request|6|||
28047183|NCT00373425|54705296|FG004|Overall Study|Patient request|7|||
28047184|NCT00373425|54705292|FG000|Overall Study|Medical/ethical/noncompliance reason|21|||
28047185|NCT00373425|54705293|FG001|Overall Study|Medical/ethical/noncompliance reason|9|||
28047186|NCT00373425|54705294|FG002|Overall Study|Medical/ethical/noncompliance reason|10|||
28047187|NCT00373425|54705295|FG003|Overall Study|Medical/ethical/noncompliance reason|2|||
28047188|NCT00373425|54705296|FG004|Overall Study|Medical/ethical/noncompliance reason|5|||
28047189|NCT00373425|54705292|FG000|Overall Study|Death|7|||
28047190|NCT00373425|54705293|FG001|Overall Study|Death|0|||
28047191|NCT00373425|54705294|FG002|Overall Study|Death|3|||
28047192|NCT00373425|54705295|FG003|Overall Study|Death|1|||
28047193|NCT00373425|54705296|FG004|Overall Study|Death|0|||
28047194|NCT00459342|54705305|FG000|Overall Study|Not eligible|1|||
28047195|NCT00443040|54705312|FG000|Overall Study|Withdrawal by Subject|1|||
28047196|NCT00443040|54705313|FG001|Overall Study|Withdrawal by Subject|0|||
28047197|NCT00443040|54705314|FG002|Overall Study|Withdrawal by Subject|0|||
28047198|NCT00443040|54705312|FG000|Overall Study|Converted to an open laparotomy|3|||
28047199|NCT00443040|54705313|FG001|Overall Study|Converted to an open laparotomy|0|||
28047200|NCT00443040|54705314|FG002|Overall Study|Converted to an open laparotomy|1|||
28047201|NCT00442962|54705322|FG000|Overall Study|Pregnancy|1|||
28047202|NCT00442962|54705322|FG000|Overall Study|Lost to Follow-up|7|||
28047203|NCT00313300|54705331|FG000|Randomized in Phase A (26 Weeks)|Adverse Event|19|||
28047204|NCT00313300|54705332|FG001|Randomized in Phase A (26 Weeks)|Adverse Event|14|||
28047205|NCT00313300|54705333|FG002|Randomized in Phase A (26 Weeks)|Adverse Event|17|||
28047206|NCT00313300|54705334|FG003|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
28047207|NCT00313300|54705335|FG004|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
28047208|NCT00313300|54705331|FG000|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20|||
28047209|NCT00313300|54705332|FG001|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12|||
28047210|NCT00313300|54705333|FG002|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13|||
28047211|NCT00313300|54705334|FG003|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
28047212|NCT00313300|54705335|FG004|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
28047213|NCT00313300|54705331|FG000|Randomized in Phase A (26 Weeks)|Death|3|||
28047214|NCT00313300|54705332|FG001|Randomized in Phase A (26 Weeks)|Death|4|||
28047215|NCT00313300|54705333|FG002|Randomized in Phase A (26 Weeks)|Death|0|||
28047216|NCT00313300|54705334|FG003|Randomized in Phase A (26 Weeks)|Death|0|||
28047217|NCT00313300|54705335|FG004|Randomized in Phase A (26 Weeks)|Death|0|||
28047218|NCT00313300|54705331|FG000|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
28047219|NCT00313300|54705332|FG001|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
28047220|NCT00313300|54705333|FG002|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2|||
28047221|NCT00313300|54705334|FG003|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
28047222|NCT00313300|54705335|FG004|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
28047223|NCT00313300|54705331|FG000|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3|||
28047224|NCT00313300|54705332|FG001|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2|||
28047225|NCT00313300|54705333|FG002|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1|||
28047226|NCT00313300|54705334|FG003|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
28047227|NCT00313300|54705335|FG004|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
28047228|NCT00313300|54705331|FG000|Randomized in Phase A (26 Weeks)|no longer meets criteria|4|||
28047229|NCT00313300|54705332|FG001|Randomized in Phase A (26 Weeks)|no longer meets criteria|3|||
28047230|NCT00313300|54705333|FG002|Randomized in Phase A (26 Weeks)|no longer meets criteria|2|||
28047231|NCT00313300|54705334|FG003|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
28047232|NCT00313300|54705335|FG004|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
28047233|NCT00313300|54705331|FG000|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1|||
28047234|NCT00313300|54705332|FG001|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
28047235|NCT00313300|54705333|FG002|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
28047236|NCT00313300|54705334|FG003|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
28047237|NCT00313300|54705335|FG004|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
28047238|NCT00313300|54705331|FG000|Randomized in Phase B (26 Weeks)|Adverse Event|34|||
28047239|NCT00313300|54705332|FG001|Randomized in Phase B (26 Weeks)|Adverse Event|9|||
28047240|NCT00313300|54705333|FG002|Randomized in Phase B (26 Weeks)|Adverse Event|12|||
28047241|NCT00313300|54705334|FG003|Randomized in Phase B (26 Weeks)|Adverse Event|23|||
28047242|NCT00313300|54705335|FG004|Randomized in Phase B (26 Weeks)|Adverse Event|19|||
28047243|NCT00313300|54705331|FG000|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35|||
28047244|NCT00313300|54705332|FG001|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14|||
28047245|NCT00313300|54705333|FG002|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
28047246|NCT00313300|54705334|FG003|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15|||
28047247|NCT00313300|54705335|FG004|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
28047248|NCT00313300|54705331|FG000|Randomized in Phase B (26 Weeks)|Death|5|||
28047249|NCT00313300|54705332|FG001|Randomized in Phase B (26 Weeks)|Death|3|||
28047250|NCT00313300|54705333|FG002|Randomized in Phase B (26 Weeks)|Death|1|||
28047251|NCT00313300|54705334|FG003|Randomized in Phase B (26 Weeks)|Death|0|||
28047252|NCT00313300|54705335|FG004|Randomized in Phase B (26 Weeks)|Death|1|||
28047253|NCT00313300|54705331|FG000|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5|||
28047254|NCT00313300|54705332|FG001|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
28047255|NCT00313300|54705333|FG002|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
28047256|NCT00313300|54705334|FG003|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
28047257|NCT00313300|54705335|FG004|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
28047258|NCT00313300|54705331|FG000|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
28047259|NCT00313300|54705332|FG001|Randomized in Phase B (26 Weeks)|poor/non-compliance|1|||
28047260|NCT00313300|54705333|FG002|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
28047261|NCT00313300|54705334|FG003|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
28047262|NCT00313300|54705335|FG004|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
28047263|NCT00313300|54705331|FG000|Randomized in Phase B (26 Weeks)|no longer meets criteria|9|||
28047264|NCT00313300|54705332|FG001|Randomized in Phase B (26 Weeks)|no longer meets criteria|3|||
28047265|NCT00313300|54705333|FG002|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
28047266|NCT00313300|54705334|FG003|Randomized in Phase B (26 Weeks)|no longer meets criteria|0|||
28047267|NCT00313300|54705335|FG004|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
28047268|NCT00313300|54705331|FG000|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2|||
28047269|NCT00313300|54705332|FG001|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1|||
28047270|NCT00313300|54705333|FG002|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0|||
28047271|NCT00313300|54705334|FG003|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193|||
28047272|NCT00313300|54705335|FG004|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164|||
28047273|NCT00313300|54705331|FG000|Randomized in Phase B (26 Weeks)|non-specified|1|||
28047274|NCT00313300|54705332|FG001|Randomized in Phase B (26 Weeks)|non-specified|0|||
28047275|NCT00313300|54705333|FG002|Randomized in Phase B (26 Weeks)|non-specified|0|||
28047276|NCT00313300|54705334|FG003|Randomized in Phase B (26 Weeks)|non-specified|0|||
28047277|NCT00313300|54705335|FG004|Randomized in Phase B (26 Weeks)|non-specified|0|||
28047278|NCT00313300|54705331|FG000|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
28047279|NCT00313300|54705332|FG001|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
28047280|NCT00313300|54705333|FG002|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2|||
28047281|NCT00313300|54705334|FG003|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
28047282|NCT00313300|54705335|FG004|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
28047283|NCT00313300|54705331|FG000|Follow-Up(30days)-Randomized Phase A|Death|0|||
28047284|NCT00313300|54705332|FG001|Follow-Up(30days)-Randomized Phase A|Death|1|||
28047285|NCT00313300|54705333|FG002|Follow-Up(30days)-Randomized Phase A|Death|0|||
28047286|NCT00313300|54705334|FG003|Follow-Up(30days)-Randomized Phase A|Death|0|||
28047287|NCT00313300|54705335|FG004|Follow-Up(30days)-Randomized Phase A|Death|0|||
28047288|NCT00313300|54705331|FG000|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
28047289|NCT00313300|54705332|FG001|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0|||
28047290|NCT00313300|54705333|FG002|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2|||
28047291|NCT00313300|54705334|FG003|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
28047292|NCT00313300|54705335|FG004|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
28047293|NCT00313300|54705331|FG000|Follow-Up(30days)-Randomized Phase B|Death|1|||
28047294|NCT00313300|54705332|FG001|Follow-Up(30days)-Randomized Phase B|Death|0|||
28047295|NCT00313300|54705333|FG002|Follow-Up(30days)-Randomized Phase B|Death|0|||
28047296|NCT00313300|54705334|FG003|Follow-Up(30days)-Randomized Phase B|Death|0|||
28047297|NCT00313300|54705335|FG004|Follow-Up(30days)-Randomized Phase B|Death|0|||
28047298|NCT00313300|54705331|FG000|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
28047299|NCT00313300|54705332|FG001|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
28047300|NCT00313300|54705333|FG002|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
28047301|NCT00313300|54705334|FG003|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2|||
28047302|NCT00313300|54705335|FG004|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1|||
28047303|NCT00313300|54705331|FG000|Follow-Up(30days)-Randomized Phase B|missing end of study status|1|||
28047304|NCT00313300|54705332|FG001|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
28047305|NCT00313300|54705333|FG002|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
28047306|NCT00313300|54705334|FG003|Follow-Up(30days)-Randomized Phase B|missing end of study status|2|||
28047307|NCT00313300|54705335|FG004|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
28047308|NCT00459186|54705353|FG000|Single Agent RAD001|Withdrawal by Subject|1|||
28047309|NCT00459186|54705353|FG000|PET Imaging and Assessment|Adverse Event|3|||
28047310|NCT00328510|54705359|FG000|Overall Study|Gag disorder, could not use frame|4|||
28047311|NCT00328510|54705360|FG001|Overall Study|Gag disorder, could not use frame|0|||
28047312|NCT00328510|54705359|FG000|Overall Study|Dentition problems, could not use frame|1|||
28047313|NCT00328510|54705360|FG001|Overall Study|Dentition problems, could not use frame|0|||
28047314|NCT00328510|54705359|FG000|Overall Study|Withdrawal by Subject|4|||
28047315|NCT00328510|54705360|FG001|Overall Study|Withdrawal by Subject|2|||
28047316|NCT00328510|54705359|FG000|Overall Study|Severe kyphosis, could not use mask|0|||
28047317|NCT00328510|54705360|FG001|Overall Study|Severe kyphosis, could not use mask|1|||
28047318|NCT00328510|54705359|FG000|Overall Study|Treatment changed to a single fraction|1|||
28047319|NCT00328510|54705360|FG001|Overall Study|Treatment changed to a single fraction|1|||
28047320|NCT00313144|54705366|FG000|Overall Study|Discontinue Aralast ≥4 consecutive doses|12|||
28047321|NCT00313144|54705366|FG000|Overall Study|Death|7|||
28047322|NCT00313144|54705366|FG000|Overall Study|Lost to Follow-up|5|||
28047323|NCT00313144|54705366|FG000|Overall Study|Withdrawal by Subject|4|||
28047324|NCT00313144|54705366|FG000|Overall Study|Terminated by sponsor/ homecare provider|4|||
28047325|NCT00313144|54705366|FG000|Overall Study|Physician Decision|4|||
28047326|NCT00313144|54705366|FG000|Overall Study|Adverse event - transient|5|||
28047327|NCT00313144|54705366|FG000|Overall Study|Liver transplant|1|||
28047328|NCT00313144|54705366|FG000|Overall Study|Insurance (homecare provider) change|1|||
28047329|NCT00313144|54705366|FG000|Overall Study|Change to different product|1|||
28047330|NCT00313144|54705366|FG000|Overall Study|Due to termination of the study|66|||
28047331|NCT00459108|54705379|FG000|Overall Study|Withdrawal by Subject|5|||
28047332|NCT00459108|54705379|FG000|Overall Study|Adverse Event|3|||
28047333|NCT00459108|54705379|FG000|Overall Study|Death|2|||
28047334|NCT00459108|54705379|FG000|Overall Study|Progression|1|||
28047335|NCT00458484|54705391|FG000|Overall Study|Not eligible b/c prior radiation history|0|||
28047336|NCT00458484|54705392|FG001|Overall Study|Not eligible b/c prior radiation history|0|||
28047337|NCT00458484|54705393|FG002|Overall Study|Not eligible b/c prior radiation history|0|||
28047338|NCT00458484|54705394|FG003|Overall Study|Not eligible b/c prior radiation history|0|||
28047339|NCT00458484|54705395|FG004|Overall Study|Not eligible b/c prior radiation history|0|||
28047340|NCT00458484|54705396|FG005|Overall Study|Not eligible b/c prior radiation history|1|||
28047341|NCT00458484|54705397|FG006|Overall Study|Not eligible b/c prior radiation history|0|||
28047342|NCT00328198|54705422|FG000|Treatment|Adverse Event|21|||
28047343|NCT00328198|54705422|FG000|Treatment|Death|1|||
28047344|NCT00328198|54705422|FG000|Treatment|Physician Decision|5|||
28047345|NCT00328198|54705422|FG000|Treatment|Withdrawal by Subject|5|||
28047346|NCT00328198|54705422|FG000|Treatment|Evidence of disease progression|2|||
28047347|NCT00328198|54705422|FG000|Treatment|Non-compliance|1|||
28047348|NCT00328198|54705422|FG000|Treatment|Confirmed complete response, MRD -|3|||
28047349|NCT00328198|54705422|FG000|Follow-up|Lost to Follow-up|4|||
28047350|NCT00328198|54705422|FG000|Follow-up|Death|31|||
28047351|NCT00450450|54705428|FG000|Overall Study|Death|1|||
28047352|NCT00450450|54705429|FG001|Overall Study|Death|3|||
28047353|NCT00450450|54705428|FG000|Overall Study|Relapse|2|||
28047354|NCT00450450|54705429|FG001|Overall Study|Relapse|0|||
28047355|NCT00450450|54705428|FG000|Overall Study|Missing Data|2|||
28047356|NCT00450450|54705429|FG001|Overall Study|Missing Data|0|||
28047357|NCT00442572|54705437|FG000|Overall Study|Relapse|8|||
28047358|NCT00442572|54705438|FG001|Overall Study|Relapse|1|||
28047359|NCT00442572|54705437|FG000|Overall Study|Lost to Follow-up|0|||
28047360|NCT00442572|54705438|FG001|Overall Study|Lost to Follow-up|1|||
28047361|NCT00442572|54705437|FG000|Overall Study|Withdrawal by Subject|0|||
28047362|NCT00442572|54705438|FG001|Overall Study|Withdrawal by Subject|1|||
28047363|NCT00442416|54705447|FG000|Overall Study|Adverse Event|4|||
28047364|NCT00442416|54705448|FG001|Overall Study|Adverse Event|1|||
27811714|NCT01716585|54267797|FG000|Double-blind Treatment|Did Not Receive Study Drug|4|||
27811715|NCT01716585|54267798|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
27811716|NCT01716585|54267797|FG000|Double-blind Treatment|Adverse Event|2|||
27811717|NCT01716585|54267798|FG001|Double-blind Treatment|Adverse Event|1|||
27811718|NCT01716585|54267797|FG000|Double-blind Treatment|Withdrawal by Subject|3|||
27811719|NCT01716585|54267798|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
27811720|NCT01716585|54267797|FG000|Double-blind Treatment|Lost to Follow-up|2|||
27811721|NCT01716585|54267798|FG001|Double-blind Treatment|Lost to Follow-up|0|||
28047365|NCT00442416|54705447|FG000|Overall Study|Death|1|||
28047366|NCT00442416|54705448|FG001|Overall Study|Death|0|||
28047367|NCT00442416|54705447|FG000|Overall Study|Lack of Efficacy|2|||
28047368|NCT00442416|54705448|FG001|Overall Study|Lack of Efficacy|0|||
28047369|NCT00442416|54705447|FG000|Overall Study|Protocol Violation|2|||
28047370|NCT00442416|54705448|FG001|Overall Study|Protocol Violation|3|||
28047371|NCT00442416|54705447|FG000|Overall Study|Withdrew consent|1|||
28047372|NCT00442416|54705448|FG001|Overall Study|Withdrew consent|2|||
28047373|NCT00442416|54705447|FG000|Overall Study|Administrative/Other|27|||
27811722|NCT01716585|54267797|FG000|Double-blind Treatment|Subject Noncompliant|1|||
28047374|NCT00442416|54705448|FG001|Overall Study|Administrative/Other|33|||
28047375|NCT00441792|54705456|FG000|Overall Study|Lost to Follow-up|0|||
28047376|NCT00441792|54705457|FG001|Overall Study|Lost to Follow-up|2|||
28047377|NCT00312208|54705465|FG000|Overall Study|Adverse Event|97|||
28047378|NCT00312208|54705466|FG001|Overall Study|Adverse Event|61|||
28047379|NCT00312208|54705465|FG000|Overall Study|Protocol Violation|5|||
28047380|NCT00312208|54705466|FG001|Overall Study|Protocol Violation|3|||
28047381|NCT00312208|54705465|FG000|Overall Study|Death|2|||
28047382|NCT00312208|54705466|FG001|Overall Study|Death|1|||
28047383|NCT00312208|54705465|FG000|Overall Study|Lack of Efficacy|7|||
28047384|NCT00312208|54705466|FG001|Overall Study|Lack of Efficacy|4|||
28047385|NCT00312208|54705465|FG000|Overall Study|Lost to Follow-up|3|||
28047386|NCT00312208|54705466|FG001|Overall Study|Lost to Follow-up|5|||
28047387|NCT00312208|54705465|FG000|Overall Study|Withdrawal by Subject|53|||
28047388|NCT00312208|54705466|FG001|Overall Study|Withdrawal by Subject|42|||
28047389|NCT00312208|54705465|FG000|Overall Study|Other|5|||
28047390|NCT00312208|54705466|FG001|Overall Study|Other|7|||
28047391|NCT00297778|54705474|FG000|Overall Study|Adverse Event|16|||
28047392|NCT00297778|54705475|FG001|Overall Study|Adverse Event|10|||
28047393|NCT00297778|54705474|FG000|Overall Study|Withdrawal by Subject|1|||
28047394|NCT00297778|54705475|FG001|Overall Study|Withdrawal by Subject|5|||
28047395|NCT00297778|54705474|FG000|Overall Study|Lack of Efficacy|2|||
28047396|NCT00297778|54705475|FG001|Overall Study|Lack of Efficacy|1|||
28047397|NCT00297778|54705474|FG000|Overall Study|Non-compliant with trial protocol|0|||
28047398|NCT00297778|54705475|FG001|Overall Study|Non-compliant with trial protocol|3|||
28047399|NCT00297778|54705474|FG000|Overall Study|Other|0|||
28047400|NCT00297778|54705475|FG001|Overall Study|Other|1|||
28047401|NCT03848832|54705484|FG000|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
28047402|NCT03848832|54705485|FG001|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
28047403|NCT03848832|54705486|FG002|Overall Study|Withdrawal of Consent Due To Covid-19|1|||
28047404|NCT03848832|54705484|FG000|Overall Study|Withdrawal by Subject|0|||
28047405|NCT03848832|54705485|FG001|Overall Study|Withdrawal by Subject|0|||
28047406|NCT03848832|54705486|FG002|Overall Study|Withdrawal by Subject|1|||
28047407|NCT03848832|54705484|FG000|Overall Study|Withdrawal (Covid-19)|0|||
28047408|NCT03848832|54705485|FG001|Overall Study|Withdrawal (Covid-19)|2|||
28047409|NCT03848832|54705486|FG002|Overall Study|Withdrawal (Covid-19)|0|||
28047410|NCT03848832|54705484|FG000|Overall Study|Physician Decision|2|||
28047411|NCT03848832|54705485|FG001|Overall Study|Physician Decision|1|||
28047412|NCT03848832|54705486|FG002|Overall Study|Physician Decision|3|||
28047413|NCT03848832|54705484|FG000|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
28047414|NCT03848832|54705485|FG001|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
28047415|NCT03848832|54705486|FG002|Overall Study|Sponsor Decision - Covid-19 Precaution|1|||
28047416|NCT03848832|54705484|FG000|Overall Study|Adverse Event|1|||
28047417|NCT03848832|54705485|FG001|Overall Study|Adverse Event|0|||
28047418|NCT03848832|54705486|FG002|Overall Study|Adverse Event|0|||
28047419|NCT00450372|54705496|FG000|Overall Study|Physician Decision|1|||
28047420|NCT00327340|54705505|FG000|Overall Study|Withdrawal by Subject|1|||
28047421|NCT00327340|54705506|FG001|Overall Study|Withdrawal by Subject|5|||
28047422|NCT00327340|54705505|FG000|Overall Study|Physician Decision|1|||
28047423|NCT00327340|54705506|FG001|Overall Study|Physician Decision|1|||
28047424|NCT00327340|54705505|FG000|Overall Study|Disease Progression|10|||
28047425|NCT00327340|54705506|FG001|Overall Study|Disease Progression|19|||
28047426|NCT00327340|54705505|FG000|Overall Study|Symptomatic Disease|0|||
28047427|NCT00327340|54705506|FG001|Overall Study|Symptomatic Disease|2|||
28047428|NCT00327340|54705505|FG000|Overall Study|Adverse Event|3|||
28047429|NCT00327340|54705506|FG001|Overall Study|Adverse Event|3|||
28047430|NCT00548093|54705516|FG000|Overall Study|Death|33|||
27811723|NCT01716585|54267798|FG001|Double-blind Treatment|Subject Noncompliant|0|||
27811724|NCT01716585|54267797|FG000|Double-blind Treatment|Other|1|||
27811725|NCT01716585|54267798|FG001|Double-blind Treatment|Other|0|||
27811726|NCT01716585|54267797|FG000|Open-label Treatment|Adverse Event|0|||
27811727|NCT01716585|54267798|FG001|Open-label Treatment|Adverse Event|2|||
27811728|NCT01716585|54267797|FG000|Open-label Treatment|Virologic Failure|0|||
27848122|NCT01360866|54341047|FG001|Overall Study|Lost to Follow-up|28|||
28047431|NCT00548093|54705517|FG001|Overall Study|Death|13|||
28047432|NCT00548093|54705516|FG000|Overall Study|Lost to Follow-up|3|||
28047433|NCT00548093|54705517|FG001|Overall Study|Lost to Follow-up|1|||
28047434|NCT00548093|54705516|FG000|Overall Study|Objective progression or relapse|1|||
28047435|NCT00548093|54705517|FG001|Overall Study|Objective progression or relapse|1|||
27811729|NCT01716585|54267798|FG001|Open-label Treatment|Virologic Failure|2|||
27811730|NCT01716585|54267797|FG000|Open-label Treatment|Withdrawal by Subject|0|||
28047436|NCT00548093|54705516|FG000|Overall Study|Other|11|||
28047437|NCT00548093|54705517|FG001|Overall Study|Other|1|||
28047438|NCT00548093|54705516|FG000|Overall Study|Withdrawal by Subject|1|||
28047439|NCT00548093|54705517|FG001|Overall Study|Withdrawal by Subject|0|||
28047440|NCT00548093|54705516|FG000|Overall Study|Completed post-treatment follow-up|1|||
28047441|NCT00548093|54705517|FG001|Overall Study|Completed post-treatment follow-up|0|||
28047442|NCT00450216|54705528|FG000|Overall Study|Adverse Event|38|||
27848123|NCT01360866|54341048|FG002|Overall Study|Lost to Follow-up|41|||
28047443|NCT00450216|54705529|FG001|Overall Study|Adverse Event|23|||
28047444|NCT00450216|54705528|FG000|Overall Study|Withdrawal by Subject|48|||
28047445|NCT00450216|54705529|FG001|Overall Study|Withdrawal by Subject|26|||
28047446|NCT00450216|54705528|FG000|Overall Study|Lost to Follow-up|16|||
28047447|NCT00450216|54705529|FG001|Overall Study|Lost to Follow-up|9|||
28047448|NCT00450216|54705528|FG000|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
28047449|NCT00450216|54705529|FG001|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
28047450|NCT00450216|54705528|FG000|Overall Study|misc|21|||
28047451|NCT00450216|54705529|FG001|Overall Study|misc|20|||
28047452|NCT00441480|54705537|FG000|Overall Study|Protocol Violation|1|||
28047453|NCT00441480|54705538|FG001|Overall Study|Protocol Violation|1|||
28047454|NCT00441480|54705537|FG000|Overall Study|Withdrawal by Subject|2|||
28047455|NCT00441480|54705538|FG001|Overall Study|Withdrawal by Subject|3|||
28047456|NCT00547703|54705546|FG000|Overall Study|Lost to Follow-up|1|||
28047457|NCT00547703|54705547|FG001|Overall Study|Lost to Follow-up|0|||
28047458|NCT00297232|54705553|FG000|Overall Study|Lack of Efficacy|7|||
28047459|NCT00297232|54705553|FG000|Overall Study|Lost to Follow-up|10|||
28047460|NCT00297232|54705553|FG000|Overall Study|Adverse Event|63|||
28047461|NCT00297232|54705553|FG000|Overall Study|Voluntary Withdrawal|120|||
28047462|NCT00297232|54705553|FG000|Overall Study|Subject was Noncompliant|9|||
28047463|NCT00297232|54705553|FG000|Overall Study|Death|9|||
28047464|NCT00297232|54705553|FG000|Overall Study|Anti-natalizumab Positive|8|||
28047465|NCT00297232|54705553|FG000|Overall Study|Switched to Commercial Tysabri|22|||
28047466|NCT00297232|54705553|FG000|Overall Study|Disease Progression|8|||
28047467|NCT00297232|54705553|FG000|Overall Study|Fear of PML|10|||
28047468|NCT00297232|54705553|FG000|Overall Study|Anti-JCV Antibody Positive|13|||
28047469|NCT00297232|54705553|FG000|Overall Study|Miscellaneous|5|||
28047470|NCT00297232|54705553|FG000|Overall Study|Sponsor Decision|34|||
28047471|NCT00297232|54705553|FG000|Overall Study|Subject Relocated|7|||
28047472|NCT00297232|54705553|FG000|Overall Study|Subject Withdrew Consent|37|||
28047473|NCT00297232|54705553|FG000|Overall Study|Persistently Positive Antibodies|11|||
28047474|NCT00297232|54705553|FG000|Overall Study|Investigator Withdrew From Program|19|||
28047475|NCT00297232|54705553|FG000|Overall Study|Did Not Enroll to Week 264|34|||
28047476|NCT00297232|54705553|FG000|Overall Study|Did Not Enroll to Week 480|17|||
28047477|NCT00297232|54705553|FG000|Overall Study|No data available after Week 264|161|||
28047478|NCT00297232|54705553|FG000|Overall Study|Other|1|||
28047479|NCT00449670|54705569|FG000|Primary Phase (Study no.109630)|Serious Adverse Event|1|||
28047480|NCT00449670|54705570|FG001|Primary Phase (Study no.109630)|Serious Adverse Event|0|||
28047481|NCT00449670|54705569|FG000|Primary Phase (Study no.109630)|Non-serious adverse event|4|||
28047482|NCT00449670|54705570|FG001|Primary Phase (Study no.109630)|Non-serious adverse event|0|||
28047483|NCT00449670|54705569|FG000|Primary Phase (Study no.109630)|Withdrawal by Subject|4|||
28047484|NCT00449670|54705570|FG001|Primary Phase (Study no.109630)|Withdrawal by Subject|1|||
28047485|NCT00449670|54705569|FG000|Primary Phase (Study no.109630)|Lost to Follow-up|5|||
28047486|NCT00449670|54705570|FG001|Primary Phase (Study no.109630)|Lost to Follow-up|1|||
28047487|NCT00449670|54705569|FG000|Booster Phase (Study no.109873)|Migrated/moved from study area|0|||
28047488|NCT00449670|54705570|FG001|Booster Phase (Study no.109873)|Migrated/moved from study area|1|||
28047489|NCT00449670|54705569|FG000|Booster Phase (Study no.109873)|Other|0|||
28047490|NCT00449670|54705570|FG001|Booster Phase (Study no.109873)|Other|2|||
28047491|NCT00296374|54705586|FG000|Overall Study|Adverse Event|14|||
28047492|NCT00296374|54705587|FG001|Overall Study|Adverse Event|10|||
28047493|NCT00296374|54705588|FG002|Overall Study|Adverse Event|7|||
28047494|NCT00296374|54705586|FG000|Overall Study|Withdrawal by Subject|3|||
28047495|NCT00296374|54705587|FG001|Overall Study|Withdrawal by Subject|5|||
28047496|NCT00296374|54705588|FG002|Overall Study|Withdrawal by Subject|11|||
28047497|NCT00296374|54705586|FG000|Overall Study|Incorrect enrollment|3|||
28047498|NCT00296374|54705587|FG001|Overall Study|Incorrect enrollment|3|||
28047499|NCT00296374|54705588|FG002|Overall Study|Incorrect enrollment|4|||
28047500|NCT00296374|54705586|FG000|Overall Study|Protocol Violation|1|||
28047501|NCT00296374|54705587|FG001|Overall Study|Protocol Violation|2|||
28047502|NCT00296374|54705588|FG002|Overall Study|Protocol Violation|3|||
28047503|NCT00296374|54705586|FG000|Overall Study|Lost to Follow-up|3|||
27811731|NCT01716585|54267798|FG001|Open-label Treatment|Withdrawal by Subject|3|||
28047504|NCT00296374|54705587|FG001|Overall Study|Lost to Follow-up|1|||
28047505|NCT00296374|54705588|FG002|Overall Study|Lost to Follow-up|1|||
28047506|NCT00296374|54705586|FG000|Overall Study|Relocated to another state|1|||
28047507|NCT00296374|54705587|FG001|Overall Study|Relocated to another state|0|||
28047508|NCT00296374|54705588|FG002|Overall Study|Relocated to another state|0|||
28047509|NCT00296374|54705586|FG000|Overall Study|Stopped drug before end of study visit|0|||
28047510|NCT00296374|54705587|FG001|Overall Study|Stopped drug before end of study visit|1|||
28047511|NCT00296374|54705588|FG002|Overall Study|Stopped drug before end of study visit|0|||
28047512|NCT00296374|54705586|FG000|Overall Study|Nephrologist introduced ACE|0|||
28047513|NCT00296374|54705587|FG001|Overall Study|Nephrologist introduced ACE|1|||
27939896|NCT01038609|54596218|FG003|Overall Study|Death in the Family|0|||
28047514|NCT00296374|54705588|FG002|Overall Study|Nephrologist introduced ACE|0|||
28047515|NCT00296374|54705586|FG000|Overall Study|Pregnancy|0|||
28047516|NCT00296374|54705587|FG001|Overall Study|Pregnancy|0|||
28047517|NCT00296374|54705588|FG002|Overall Study|Pregnancy|2|||
28047518|NCT00296374|54705586|FG000|Overall Study|Other|0|||
28047519|NCT00296374|54705587|FG001|Overall Study|Other|0|||
28047520|NCT00296374|54705588|FG002|Overall Study|Other|1|||
28047521|NCT00326950|54705611|FG000|Overall Study|Progressive Disease|1|||
28047522|NCT00548717|54705617|FG000|Overall Study|Death|5|||
28047523|NCT00548717|54705618|FG001|Overall Study|Death|2|||
28047524|NCT00548717|54705617|FG000|Overall Study|Relapse|3|||
28047525|NCT00548717|54705618|FG001|Overall Study|Relapse|0|||
28047526|NCT00548717|54705617|FG000|Overall Study|Alternative treatment for GVHD|1|||
28047527|NCT00548717|54705618|FG001|Overall Study|Alternative treatment for GVHD|0|||
28047528|NCT00441168|54705629|FG000|Treatment Period|Death|3|||
28047529|NCT00441168|54705630|FG001|Treatment Period|Death|0|||
28047530|NCT00441168|54705629|FG000|Treatment Period|Adverse Event|1|||
28047531|NCT00441168|54705630|FG001|Treatment Period|Adverse Event|2|||
28047532|NCT00441168|54705629|FG000|Treatment Period|Progressive Disease|0|||
28047533|NCT00441168|54705630|FG001|Treatment Period|Progressive Disease|2|||
28047534|NCT00441168|54705629|FG000|Treatment Period|Protocol Violation|0|||
28047535|NCT00441168|54705630|FG001|Treatment Period|Protocol Violation|1|||
28047536|NCT00441168|54705629|FG000|Treatment Period|Lost to Follow-up|0|||
28047537|NCT00441168|54705630|FG001|Treatment Period|Lost to Follow-up|1|||
28047538|NCT00441168|54705629|FG000|Treatment Period|Withdrawal by Subject|3|||
28047539|NCT00441168|54705630|FG001|Treatment Period|Withdrawal by Subject|0|||
28047540|NCT00441168|54705629|FG000|Treatment Period|qualified for stem-cell transplantation|3|||
28047541|NCT00441168|54705630|FG001|Treatment Period|qualified for stem-cell transplantation|0|||
27939897|NCT01038609|54596219|FG004|Overall Study|Death in the Family|0|||
27939898|NCT01038609|54596215|FG000|Overall Study|Refusal of Blood Draws|0|||
27939899|NCT01038609|54596216|FG001|Overall Study|Refusal of Blood Draws|1|||
27939900|NCT01038609|54596217|FG002|Overall Study|Refusal of Blood Draws|0|||
28047542|NCT00441168|54705629|FG000|Treatment Period|refractory disease|1|||
28047543|NCT00441168|54705630|FG001|Treatment Period|refractory disease|0|||
28047544|NCT00441168|54705629|FG000|Follow-up Period|Death|3|||
28047545|NCT00441168|54705630|FG001|Follow-up Period|Death|0|||
28047546|NCT00441168|54705629|FG000|Follow-up Period|Lost to Follow-up|5|||
28047547|NCT00441168|54705630|FG001|Follow-up Period|Lost to Follow-up|6|||
28047548|NCT00441168|54705629|FG000|Follow-up Period|Withdrawal by Subject|3|||
28047549|NCT00441168|54705630|FG001|Follow-up Period|Withdrawal by Subject|0|||
28047550|NCT00441168|54705629|FG000|Follow-up Period|Other|1|||
28047551|NCT00441168|54705630|FG001|Follow-up Period|Other|3|||
28047552|NCT00296140|54705638|FG000|Overall Study|Lost to Follow-up|1|||
28047553|NCT00296140|54705639|FG001|Overall Study|Lost to Follow-up|0|||
28047554|NCT00296140|54705638|FG000|Overall Study|Withdrawal by Subject|1|||
28047555|NCT00296140|54705639|FG001|Overall Study|Withdrawal by Subject|0|||
28047556|NCT00296140|54705638|FG000|Overall Study|Discharge to Nursing Home|1|||
28047557|NCT00296140|54705639|FG001|Overall Study|Discharge to Nursing Home|0|||
28047558|NCT03958331|54705648|FG000|Overall Study|Withdrawal by Subject|3|||
28047559|NCT03958331|54705649|FG001|Overall Study|Withdrawal by Subject|1|||
28047560|NCT03958331|54705650|FG002|Overall Study|Withdrawal by Subject|5|||
28047561|NCT03958331|54705648|FG000|Overall Study|Weaned from medicine|2|||
28047562|NCT03958331|54705649|FG001|Overall Study|Weaned from medicine|0|||
28047563|NCT03958331|54705650|FG002|Overall Study|Weaned from medicine|0|||
28047564|NCT03958331|54705648|FG000|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|2|||
28047565|NCT03958331|54705649|FG001|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|1|||
28047566|NCT03958331|54705650|FG002|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|12|||
28047567|NCT03956615|54705656|FG000|Overall Study|No multiple myeloma confirmed|2|||
28047568|NCT03956615|54705656|FG000|Overall Study|Assessment of membrane-expressed ideotypic paraprotein not possible due to low CD38 signals|1|||
28047569|NCT03956615|54705656|FG000|Overall Study|No expression of ideotypic paraprotein on membrane|2|||
28047570|NCT03956615|54705656|FG000|Overall Study|Not selected for sdAb generation, due to limitation of total number to 3|2|||
28047571|NCT03956225|54705662|FG000|Overall Study|Lack of Efficacy|1|||
28047572|NCT03956225|54705663|FG001|Overall Study|Lack of Efficacy|1|||
28047573|NCT03956225|54705662|FG000|Overall Study|Lost to Follow-up|0|||
28047574|NCT03956225|54705663|FG001|Overall Study|Lost to Follow-up|1|||
28047575|NCT03956225|54705662|FG000|Overall Study|Withdrawal by Subject|2|||
28047576|NCT03956225|54705663|FG001|Overall Study|Withdrawal by Subject|1|||
28047577|NCT03956225|54705662|FG000|Overall Study|Other Reasons|2|||
28047578|NCT03956225|54705663|FG001|Overall Study|Other Reasons|1|||
28047579|NCT00457626|54705672|FG000|Overall Study|Adverse Event|3|||
28047580|NCT00457626|54705672|FG000|Overall Study|Administrative Problems|2|||
28047581|NCT00457626|54705672|FG000|Overall Study|Participant's Condition No Longer Requires Study Drug|1|||
28047582|NCT00373113|54705678|FG000|Overall Study|Death|1|||
28047583|NCT00373113|54705679|FG001|Overall Study|Death|7|||
28047584|NCT00373113|54705678|FG000|Overall Study|Adverse Event|38|||
28047585|NCT00373113|54705679|FG001|Overall Study|Adverse Event|24|||
27939901|NCT01038609|54596218|FG003|Overall Study|Refusal of Blood Draws|0|||
28047586|NCT00373113|54705678|FG000|Overall Study|Study terminated by sponsor|9|||
28047587|NCT00373113|54705679|FG001|Overall Study|Study terminated by sponsor|1|||
28047588|NCT00373113|54705678|FG000|Overall Study|Global deterioration of health status|10|||
28047589|NCT00373113|54705679|FG001|Overall Study|Global deterioration of health status|7|||
28047590|NCT00373113|54705678|FG000|Overall Study|Lost to Follow-up|1|||
28047591|NCT00373113|54705679|FG001|Overall Study|Lost to Follow-up|3|||
28047592|NCT00373113|54705678|FG000|Overall Study|Objective progression or relapse|150|||
28047593|NCT00373113|54705679|FG001|Overall Study|Objective progression or relapse|169|||
28047594|NCT00373113|54705678|FG000|Overall Study|Other|14|||
28047595|NCT00373113|54705679|FG001|Overall Study|Other|17|||
28047596|NCT00373113|54705678|FG000|Overall Study|Protocol Violation|5|||
28047597|NCT00373113|54705679|FG001|Overall Study|Protocol Violation|1|||
28047598|NCT00373113|54705678|FG000|Overall Study|Withdrawal by Subject|10|||
28047599|NCT00373113|54705679|FG001|Overall Study|Withdrawal by Subject|15|||
28047600|NCT00407511|54705685|FG000|Overall Study|Adverse Event|9|||
28047601|NCT00407511|54705685|FG000|Overall Study|Lost to Follow-up|4|||
28047602|NCT00407511|54705685|FG000|Overall Study|Other|5|||
28047603|NCT00407511|54705685|FG000|Overall Study|Withdrawal by Subject|4|||
28047604|NCT00384189|54705693|FG000|Overall Study|Reason Not Specified|50|||
28047605|NCT00384189|54705694|FG001|Overall Study|Reason Not Specified|57|||
28047606|NCT00384189|54705695|FG002|Overall Study|Reason Not Specified|58|||
28047607|NCT00384189|54705696|FG003|Overall Study|Reason Not Specified|40|||
28047608|NCT00326716|54705708|FG000|Pre-Natal Mothers|Discontinued ATV Before Delivery|1|||
28047609|NCT00326716|54705709|FG001|Pre-Natal Mothers|Discontinued ATV Before Delivery|2|||
28047610|NCT00326716|54705710|FG002|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
28047611|NCT00326716|54705711|FG003|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
28047612|NCT00548405|54705744|FG000|Overall Study|Adverse Event|6|||
28047613|NCT00548405|54705745|FG001|Overall Study|Adverse Event|2|||
28047614|NCT00548405|54705746|FG002|Overall Study|Adverse Event|0|||
28047615|NCT00548405|54705744|FG000|Overall Study|Lack of Efficacy|6|||
28047616|NCT00548405|54705745|FG001|Overall Study|Lack of Efficacy|0|||
28047617|NCT00548405|54705746|FG002|Overall Study|Lack of Efficacy|0|||
28047618|NCT00548405|54705744|FG000|Overall Study|Physician Decision|3|||
28047619|NCT00548405|54705745|FG001|Overall Study|Physician Decision|4|||
28047620|NCT00548405|54705746|FG002|Overall Study|Physician Decision|1|||
28047621|NCT00548405|54705744|FG000|Overall Study|Pregnancy|1|||
28047622|NCT00548405|54705745|FG001|Overall Study|Pregnancy|0|||
28047623|NCT00548405|54705746|FG002|Overall Study|Pregnancy|0|||
28047624|NCT00548405|54705744|FG000|Overall Study|Protocol Violation|1|||
28047625|NCT00548405|54705745|FG001|Overall Study|Protocol Violation|0|||
28047626|NCT00548405|54705746|FG002|Overall Study|Protocol Violation|0|||
28047627|NCT00548405|54705744|FG000|Overall Study|Withdrawal by Subject|36|||
28047628|NCT00548405|54705745|FG001|Overall Study|Withdrawal by Subject|12|||
28047629|NCT00548405|54705746|FG002|Overall Study|Withdrawal by Subject|5|||
28047630|NCT00548405|54705744|FG000|Overall Study|Lost to Follow-up|1|||
28047631|NCT00548405|54705745|FG001|Overall Study|Lost to Follow-up|1|||
28047632|NCT00548405|54705746|FG002|Overall Study|Lost to Follow-up|2|||
28047633|NCT00548405|54705744|FG000|Overall Study|Death|0|||
28047634|NCT00548405|54705745|FG001|Overall Study|Death|1|||
28047635|NCT00548405|54705746|FG002|Overall Study|Death|1|||
28047636|NCT00548405|54705744|FG000|Overall Study|Sponsor decision|1|||
28047637|NCT00548405|54705745|FG001|Overall Study|Sponsor decision|0|||
28047638|NCT00548405|54705746|FG002|Overall Study|Sponsor decision|0|||
28047639|NCT00548405|54705744|FG000|Overall Study|Randomized but not treated|1|||
28047640|NCT00548405|54705745|FG001|Overall Study|Randomized but not treated|0|||
28047641|NCT00548405|54705746|FG002|Overall Study|Randomized but not treated|0|||
28047642|NCT00295750|54705758|FG000|Overall Study|Adverse Event|19|||
28047643|NCT00295750|54705759|FG001|Overall Study|Adverse Event|15|||
28047644|NCT00295750|54705760|FG002|Overall Study|Adverse Event|12|||
28047645|NCT00295750|54705758|FG000|Overall Study|Lack of Efficacy|1|||
28047646|NCT00295750|54705759|FG001|Overall Study|Lack of Efficacy|1|||
28047647|NCT00295750|54705760|FG002|Overall Study|Lack of Efficacy|0|||
28047648|NCT00295750|54705758|FG000|Overall Study|Lost to Follow-up|1|||
28047649|NCT00295750|54705759|FG001|Overall Study|Lost to Follow-up|4|||
28047650|NCT00295750|54705760|FG002|Overall Study|Lost to Follow-up|1|||
28047651|NCT00295750|54705758|FG000|Overall Study|Taking prohibited therapy|2|||
28047652|NCT00295750|54705759|FG001|Overall Study|Taking prohibited therapy|3|||
28047653|NCT00295750|54705760|FG002|Overall Study|Taking prohibited therapy|2|||
28047654|NCT00295750|54705758|FG000|Overall Study|Administrative errors|2|||
28047655|NCT00295750|54705759|FG001|Overall Study|Administrative errors|4|||
28047656|NCT00295750|54705760|FG002|Overall Study|Administrative errors|5|||
28047657|NCT00295750|54705758|FG000|Overall Study|Trial drug errors|1|||
28047658|NCT00295750|54705759|FG001|Overall Study|Trial drug errors|1|||
28047659|NCT00295750|54705760|FG002|Overall Study|Trial drug errors|0|||
28047660|NCT00295750|54705758|FG000|Overall Study|Disease progression|2|||
28047661|NCT00295750|54705759|FG001|Overall Study|Disease progression|1|||
28047662|NCT00295750|54705760|FG002|Overall Study|Disease progression|0|||
28047663|NCT00295750|54705758|FG000|Overall Study|Personal reasons|0|||
28047664|NCT00295750|54705759|FG001|Overall Study|Personal reasons|1|||
28047665|NCT00295750|54705760|FG002|Overall Study|Personal reasons|0|||
28047666|NCT00295750|54705758|FG000|Overall Study|Randomized but never received trial drug|4|||
28047667|NCT00295750|54705759|FG001|Overall Study|Randomized but never received trial drug|3|||
28047668|NCT00295750|54705760|FG002|Overall Study|Randomized but never received trial drug|3|||
28047669|NCT00295750|54705758|FG000|Overall Study|Withdrawal by Subject|9|||
28047670|NCT00295750|54705759|FG001|Overall Study|Withdrawal by Subject|4|||
28047671|NCT00295750|54705760|FG002|Overall Study|Withdrawal by Subject|7|||
28047672|NCT00295750|54705758|FG000|Overall Study|Protocol Violation|2|||
28047673|NCT00295750|54705759|FG001|Overall Study|Protocol Violation|4|||
28047674|NCT00295750|54705760|FG002|Overall Study|Protocol Violation|2|||
28047675|NCT03948581|54705770|FG000|Overall Study|Lost to Follow-up|0|||
27811732|NCT01852292|54267807|FG000|Overall Study|Untreated - did not receive study drug|3|||
28047676|NCT03948581|54705771|FG001|Overall Study|Lost to Follow-up|1|||
28047677|NCT00548327|54705779|FG000|Overall Study|Adverse Event|0|||
28047678|NCT00548327|54705780|FG001|Overall Study|Adverse Event|1|||
28047679|NCT03953183|54705802|FG000|Overall Study|Physician Decision|0|||
28047680|NCT03953183|54705803|FG001|Overall Study|Physician Decision|1|||
28047681|NCT03953183|54705802|FG000|Overall Study|Withdrawal by Subject|0|||
28047682|NCT03953183|54705803|FG001|Overall Study|Withdrawal by Subject|1|||
27848124|NCT01360866|54341049|FG003|Overall Study|Lost to Follow-up|0|||
27848125|NCT01360866|54341046|FG000|Overall Study|Adverse Event|56|||
27848126|NCT01360866|54341047|FG001|Overall Study|Adverse Event|61|||
27848127|NCT01360866|54341048|FG002|Overall Study|Adverse Event|134|||
27848128|NCT01360866|54341049|FG003|Overall Study|Adverse Event|6|||
27848129|NCT01360866|54341046|FG000|Overall Study|Paticipant met withdrawal criteria|11|||
27848130|NCT01360866|54341047|FG001|Overall Study|Paticipant met withdrawal criteria|28|||
27848131|NCT01360866|54341048|FG002|Overall Study|Paticipant met withdrawal criteria|54|||
27848132|NCT01360866|54341049|FG003|Overall Study|Paticipant met withdrawal criteria|0|||
27848133|NCT01360866|54341046|FG000|Overall Study|Withdrawn by Investigator|9|||
27848134|NCT01360866|54341047|FG001|Overall Study|Withdrawn by Investigator|8|||
27848135|NCT01360866|54341048|FG002|Overall Study|Withdrawn by Investigator|31|||
27848136|NCT01360866|54341049|FG003|Overall Study|Withdrawn by Investigator|2|||
27848137|NCT01360866|54341046|FG000|Overall Study|Withdrawal by participant|79|||
27848138|NCT01360866|54341047|FG001|Overall Study|Withdrawal by participant|89|||
27848139|NCT01360866|54341048|FG002|Overall Study|Withdrawal by participant|168|||
27848140|NCT01360866|54341049|FG003|Overall Study|Withdrawal by participant|8|||
27848141|NCT01360866|54341046|FG000|Overall Study|Protocol Deviation|25|||
27848142|NCT01360866|54341047|FG001|Overall Study|Protocol Deviation|33|||
27848143|NCT01360866|54341048|FG002|Overall Study|Protocol Deviation|61|||
27848144|NCT01360866|54341049|FG003|Overall Study|Protocol Deviation|2|||
27848145|NCT01360866|54341046|FG000|Overall Study|Lack of Efficacy|30|||
27848146|NCT01360866|54341047|FG001|Overall Study|Lack of Efficacy|40|||
27848147|NCT01360866|54341048|FG002|Overall Study|Lack of Efficacy|30|||
27848148|NCT01360866|54341049|FG003|Overall Study|Lack of Efficacy|4|||
27848149|NCT00985153|54341063|FG000|Overall Study|Lost to Follow-up|16|||
27848150|NCT00985153|54341064|FG001|Overall Study|Lost to Follow-up|19|||
27848151|NCT00985153|54341065|FG002|Overall Study|Lost to Follow-up|17|||
27848152|NCT00985153|54341066|FG003|Overall Study|Lost to Follow-up|20|||
27848153|NCT00985153|54341063|FG000|Overall Study|Protocol Violation|3|||
28047683|NCT00406653|54705813|FG000|Induction Period|Adverse Event|1|||
28047684|NCT00406653|54705814|FG001|Induction Period|Adverse Event|10|||
28047685|NCT00406653|54705815|FG002|Induction Period|Adverse Event|4|||
28047686|NCT00406653|54705816|FG003|Induction Period|Adverse Event|11|||
28047687|NCT00406653|54705817|FG004|Induction Period|Adverse Event|0|||
28047688|NCT00406653|54705818|FG005|Induction Period|Adverse Event|0|||
28047689|NCT00406653|54705819|FG006|Induction Period|Adverse Event|0|||
28047690|NCT00406653|54705813|FG000|Induction Period|Lack of Efficacy|11|||
28047691|NCT00406653|54705814|FG001|Induction Period|Lack of Efficacy|14|||
27811733|NCT01852292|54267808|FG001|Overall Study|Untreated - did not receive study drug|1|||
27811734|NCT01852292|54267807|FG000|Overall Study|Death|9|||
27811735|NCT01852292|54267808|FG001|Overall Study|Death|8|||
27811736|NCT01852292|54267807|FG000|Overall Study|Patient/guardian decision|8|||
27811737|NCT01852292|54267808|FG001|Overall Study|Patient/guardian decision|4|||
27811738|NCT01852292|54267807|FG000|Overall Study|Adverse Event|8|||
27811739|NCT01852292|54267808|FG001|Overall Study|Adverse Event|11|||
27811740|NCT01852292|54267807|FG000|Overall Study|Physician Decision|6|||
27811741|NCT01852292|54267808|FG001|Overall Study|Physician Decision|2|||
27811742|NCT01852292|54267807|FG000|Overall Study|Protocol Violation|2|||
27811743|NCT01852292|54267808|FG001|Overall Study|Protocol Violation|0|||
27811744|NCT01852292|54267807|FG000|Overall Study|Non-compliance with study treatment|1|||
27848154|NCT00985153|54341064|FG001|Overall Study|Protocol Violation|2|||
27848155|NCT00985153|54341065|FG002|Overall Study|Protocol Violation|4|||
28047692|NCT00406653|54705815|FG002|Induction Period|Lack of Efficacy|8|||
27811745|NCT01852292|54267808|FG001|Overall Study|Non-compliance with study treatment|0|||
27848156|NCT00985153|54341066|FG003|Overall Study|Protocol Violation|3|||
28047693|NCT00406653|54705816|FG003|Induction Period|Lack of Efficacy|10|||
27848157|NCT00985153|54341063|FG000|Overall Study|Withdrawal by Subject|6|||
28047694|NCT00406653|54705817|FG004|Induction Period|Lack of Efficacy|0|||
28047695|NCT00406653|54705818|FG005|Induction Period|Lack of Efficacy|0|||
28047696|NCT00406653|54705819|FG006|Induction Period|Lack of Efficacy|0|||
27811746|NCT01852292|54267807|FG000|Overall Study|Study terminated by Sponsor|0|||
28047697|NCT00406653|54705813|FG000|Induction Period|Lost to Follow-up|0|||
28047698|NCT00406653|54705814|FG001|Induction Period|Lost to Follow-up|2|||
28047699|NCT00406653|54705815|FG002|Induction Period|Lost to Follow-up|0|||
28047700|NCT00406653|54705816|FG003|Induction Period|Lost to Follow-up|0|||
28047701|NCT00406653|54705817|FG004|Induction Period|Lost to Follow-up|0|||
28047702|NCT00406653|54705818|FG005|Induction Period|Lost to Follow-up|0|||
28047703|NCT00406653|54705819|FG006|Induction Period|Lost to Follow-up|0|||
27811747|NCT01852292|54267808|FG001|Overall Study|Study terminated by Sponsor|1|||
27811748|NCT01852292|54267807|FG000|Overall Study|Progressive disease|42|||
27811749|NCT01852292|54267808|FG001|Overall Study|Progressive disease|52|||
27811750|NCT01715805|54267814|FG000|Placebo + ADT Lead-in Period|Adverse Event|41|||
27811751|NCT01715805|54267815|FG001|Placebo + ADT Lead-in Period|Adverse Event|0|||
27811752|NCT01715805|54267816|FG002|Placebo + ADT Lead-in Period|Adverse Event|0|||
27811753|NCT01715805|54267817|FG003|Placebo + ADT Lead-in Period|Adverse Event|0|||
27811754|NCT01715805|54267814|FG000|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6|||
27811755|NCT01715805|54267815|FG001|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
27811756|NCT01715805|54267816|FG002|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
27811757|NCT01715805|54267817|FG003|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
27811758|NCT01715805|54267814|FG000|Placebo + ADT Lead-in Period|Protocol Violation|74|||
27811759|NCT01715805|54267815|FG001|Placebo + ADT Lead-in Period|Protocol Violation|0|||
27811760|NCT01715805|54267816|FG002|Placebo + ADT Lead-in Period|Protocol Violation|0|||
27811761|NCT01715805|54267817|FG003|Placebo + ADT Lead-in Period|Protocol Violation|0|||
27811762|NCT01715805|54267814|FG000|Placebo + ADT Lead-in Period|Withdrawal of Consent|49|||
27811763|NCT01715805|54267815|FG001|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
27811764|NCT01715805|54267816|FG002|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
27811765|NCT01715805|54267817|FG003|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
27811766|NCT01715805|54267814|FG000|Placebo + ADT Lead-in Period|Lost to Follow-up|34|||
27811767|NCT01715805|54267815|FG001|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
27811768|NCT01715805|54267816|FG002|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
27811769|NCT01715805|54267817|FG003|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
27811770|NCT01715805|54267814|FG000|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1|||
27811771|NCT01715805|54267815|FG001|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
27811772|NCT01715805|54267816|FG002|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
27811773|NCT01715805|54267817|FG003|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
27811774|NCT01715805|54267814|FG000|Placebo + ADT Lead-in Period|Other Reason Not Specified|10|||
27811775|NCT01715805|54267815|FG001|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
27811776|NCT01715805|54267816|FG002|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
27811777|NCT01715805|54267817|FG003|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
27811778|NCT01715805|54267814|FG000|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
27811779|NCT01715805|54267815|FG001|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
27811780|NCT01715805|54267816|FG002|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
27811781|NCT01715805|54267817|FG003|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1|||
27811782|NCT01715805|54267814|FG000|Double-Blind or Continued Treatment|Adverse Event|0|||
27811783|NCT01715805|54267815|FG001|Double-Blind or Continued Treatment|Adverse Event|3|||
27811784|NCT01715805|54267816|FG002|Double-Blind or Continued Treatment|Adverse Event|23|||
27811785|NCT01715805|54267817|FG003|Double-Blind or Continued Treatment|Adverse Event|2|||
27811786|NCT01715805|54267814|FG000|Double-Blind or Continued Treatment|Protocol Violation|0|||
27811787|NCT01715805|54267815|FG001|Double-Blind or Continued Treatment|Protocol Violation|14|||
27811788|NCT01715805|54267816|FG002|Double-Blind or Continued Treatment|Protocol Violation|12|||
27811789|NCT01715805|54267817|FG003|Double-Blind or Continued Treatment|Protocol Violation|19|||
27811790|NCT01715805|54267814|FG000|Double-Blind or Continued Treatment|Withdrawal of consent|0|||
27811791|NCT01715805|54267815|FG001|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
27811792|NCT01715805|54267816|FG002|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
27811793|NCT01715805|54267817|FG003|Double-Blind or Continued Treatment|Withdrawal of consent|13|||
27811794|NCT01715805|54267814|FG000|Double-Blind or Continued Treatment|Lost to Follow-up|0|||
27811795|NCT01715805|54267815|FG001|Double-Blind or Continued Treatment|Lost to Follow-up|7|||
27939902|NCT01038609|54596219|FG004|Overall Study|Refusal of Blood Draws|0|||
27939903|NCT02357134|54596235|FG000|Overall Study|Lost to Follow-up|1|||
27811796|NCT01715805|54267816|FG002|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
27811797|NCT01715805|54267817|FG003|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
27811798|NCT01715805|54267814|FG000|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
27811799|NCT01715805|54267815|FG001|Double-Blind or Continued Treatment|Other Reason Not Specified|1|||
27939904|NCT02357134|54596236|FG001|Overall Study|Lost to Follow-up|0|||
28047704|NCT00406653|54705813|FG000|Induction Period|Withdrawal of Consent|2|||
28047705|NCT00406653|54705814|FG001|Induction Period|Withdrawal of Consent|5|||
28047706|NCT00406653|54705815|FG002|Induction Period|Withdrawal of Consent|1|||
28047707|NCT00406653|54705816|FG003|Induction Period|Withdrawal of Consent|2|||
28047708|NCT00406653|54705817|FG004|Induction Period|Withdrawal of Consent|0|||
28047709|NCT00406653|54705818|FG005|Induction Period|Withdrawal of Consent|0|||
28047710|NCT00406653|54705819|FG006|Induction Period|Withdrawal of Consent|0|||
28047711|NCT00406653|54705813|FG000|Induction Period|Subject No Longer Meets Study Criteria|0|||
28047712|NCT00406653|54705814|FG001|Induction Period|Subject No Longer Meets Study Criteria|0|||
28047713|NCT00406653|54705815|FG002|Induction Period|Subject No Longer Meets Study Criteria|0|||
28047714|NCT00406653|54705816|FG003|Induction Period|Subject No Longer Meets Study Criteria|2|||
27811800|NCT01715805|54267816|FG002|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
27811801|NCT01715805|54267817|FG003|Double-Blind or Continued Treatment|Other Reason Not Specified|3|||
27811802|NCT01715805|54267814|FG000|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
27811803|NCT01715805|54267815|FG001|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3|||
28047715|NCT00406653|54705817|FG004|Induction Period|Subject No Longer Meets Study Criteria|0|||
28047716|NCT00406653|54705818|FG005|Induction Period|Subject No Longer Meets Study Criteria|0|||
28047717|NCT00406653|54705819|FG006|Induction Period|Subject No Longer Meets Study Criteria|0|||
28047718|NCT00406653|54705813|FG000|Induction Period|Pregnancy|1|||
28047719|NCT00406653|54705814|FG001|Induction Period|Pregnancy|0|||
28047720|NCT00406653|54705815|FG002|Induction Period|Pregnancy|0|||
28047721|NCT00406653|54705816|FG003|Induction Period|Pregnancy|0|||
28047722|NCT00406653|54705817|FG004|Induction Period|Pregnancy|0|||
28047723|NCT00406653|54705818|FG005|Induction Period|Pregnancy|0|||
28047724|NCT00406653|54705819|FG006|Induction Period|Pregnancy|0|||
28047725|NCT00406653|54705813|FG000|Induction Period|Declined participation but followup done|0|||
28047726|NCT00406653|54705814|FG001|Induction Period|Declined participation but followup done|2|||
28047727|NCT00406653|54705815|FG002|Induction Period|Declined participation but followup done|1|||
28047728|NCT00406653|54705816|FG003|Induction Period|Declined participation but followup done|1|||
28047729|NCT00406653|54705817|FG004|Induction Period|Declined participation but followup done|0|||
28047730|NCT00406653|54705818|FG005|Induction Period|Declined participation but followup done|0|||
28047731|NCT00406653|54705819|FG006|Induction Period|Declined participation but followup done|0|||
28047732|NCT00406653|54705813|FG000|Induction Period|Given prohibited drug|0|||
28047733|NCT00406653|54705814|FG001|Induction Period|Given prohibited drug|1|||
28047734|NCT00406653|54705815|FG002|Induction Period|Given prohibited drug|2|||
28047735|NCT00406653|54705816|FG003|Induction Period|Given prohibited drug|0|||
28047736|NCT00406653|54705817|FG004|Induction Period|Given prohibited drug|0|||
28047737|NCT00406653|54705818|FG005|Induction Period|Given prohibited drug|0|||
28047738|NCT00406653|54705819|FG006|Induction Period|Given prohibited drug|0|||
28047739|NCT00406653|54705813|FG000|Induction Period|Incarcerated|0|||
28047740|NCT00406653|54705814|FG001|Induction Period|Incarcerated|0|||
28047741|NCT00406653|54705815|FG002|Induction Period|Incarcerated|1|||
28047742|NCT00406653|54705816|FG003|Induction Period|Incarcerated|0|||
28047743|NCT00406653|54705817|FG004|Induction Period|Incarcerated|0|||
28047744|NCT00406653|54705818|FG005|Induction Period|Incarcerated|0|||
28047745|NCT00406653|54705819|FG006|Induction Period|Incarcerated|0|||
28047746|NCT00406653|54705813|FG000|Induction Period|Patient relocated|0|||
28047747|NCT00406653|54705814|FG001|Induction Period|Patient relocated|0|||
28047748|NCT00406653|54705815|FG002|Induction Period|Patient relocated|1|||
28047749|NCT00406653|54705816|FG003|Induction Period|Patient relocated|0|||
28047750|NCT00406653|54705817|FG004|Induction Period|Patient relocated|0|||
28047751|NCT00406653|54705818|FG005|Induction Period|Patient relocated|0|||
28047752|NCT00406653|54705819|FG006|Induction Period|Patient relocated|0|||
28047753|NCT00406653|54705813|FG000|Maintenance Period|Adverse Event|0|||
27811804|NCT01715805|54267816|FG002|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
27811805|NCT01715805|54267817|FG003|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
27811806|NCT01852214|54267825|FG000|Period 1|Adverse Event|1|||
27811807|NCT01852214|54267826|FG001|Period 1|Adverse Event|2|||
27811808|NCT01852214|54267825|FG000|Period 1|Withdrawal by Subject|0|||
27811809|NCT01852214|54267826|FG001|Period 1|Withdrawal by Subject|1|||
27811810|NCT01852214|54267825|FG000|Washout Period|Withdrawal by Subject|0|||
27811811|NCT01852214|54267826|FG001|Washout Period|Withdrawal by Subject|1|||
27811812|NCT01393990|54267851|FG000|Overall Study|Adverse Event|0|||
27811813|NCT01393990|54267852|FG001|Overall Study|Adverse Event|0|||
27811814|NCT01393990|54267853|FG002|Overall Study|Adverse Event|0|||
27811815|NCT01393990|54267854|FG003|Overall Study|Adverse Event|0|||
27939905|NCT02357134|54596237|FG002|Overall Study|Lost to Follow-up|0|||
28047754|NCT00406653|54705814|FG001|Maintenance Period|Adverse Event|0|||
28047755|NCT00406653|54705815|FG002|Maintenance Period|Adverse Event|0|||
28047756|NCT00406653|54705816|FG003|Maintenance Period|Adverse Event|0|||
28047757|NCT00406653|54705817|FG004|Maintenance Period|Adverse Event|1|||
27811816|NCT01393990|54267855|FG004|Overall Study|Adverse Event|0|||
27811817|NCT01393990|54267856|FG005|Overall Study|Adverse Event|0|||
27811818|NCT01393990|54267857|FG006|Overall Study|Adverse Event|0|||
28047758|NCT00406653|54705818|FG005|Maintenance Period|Adverse Event|1|||
28047759|NCT00406653|54705819|FG006|Maintenance Period|Adverse Event|0|||
28047760|NCT00406653|54705813|FG000|Maintenance Period|Lack of Efficacy|0|||
28047761|NCT00406653|54705814|FG001|Maintenance Period|Lack of Efficacy|0|||
28047762|NCT00406653|54705815|FG002|Maintenance Period|Lack of Efficacy|0|||
28047763|NCT00406653|54705816|FG003|Maintenance Period|Lack of Efficacy|0|||
28047764|NCT00406653|54705817|FG004|Maintenance Period|Lack of Efficacy|20|||
28047765|NCT00406653|54705818|FG005|Maintenance Period|Lack of Efficacy|26|||
28047766|NCT00406653|54705819|FG006|Maintenance Period|Lack of Efficacy|0|||
28047767|NCT00406653|54705813|FG000|Maintenance Period|Lost to Follow-up|0|||
28047768|NCT00406653|54705814|FG001|Maintenance Period|Lost to Follow-up|0|||
28047769|NCT00406653|54705815|FG002|Maintenance Period|Lost to Follow-up|0|||
28047770|NCT00406653|54705816|FG003|Maintenance Period|Lost to Follow-up|0|||
28047771|NCT00406653|54705817|FG004|Maintenance Period|Lost to Follow-up|2|||
28047772|NCT00406653|54705818|FG005|Maintenance Period|Lost to Follow-up|1|||
28047773|NCT00406653|54705819|FG006|Maintenance Period|Lost to Follow-up|0|||
28047774|NCT00406653|54705813|FG000|Maintenance Period|Withdrawal of Consent|0|||
28047775|NCT00406653|54705814|FG001|Maintenance Period|Withdrawal of Consent|0|||
28047776|NCT00406653|54705815|FG002|Maintenance Period|Withdrawal of Consent|0|||
28047777|NCT00406653|54705816|FG003|Maintenance Period|Withdrawal of Consent|0|||
28047778|NCT00406653|54705817|FG004|Maintenance Period|Withdrawal of Consent|2|||
28047779|NCT00406653|54705818|FG005|Maintenance Period|Withdrawal of Consent|0|||
28047780|NCT00406653|54705819|FG006|Maintenance Period|Withdrawal of Consent|0|||
28047781|NCT00406653|54705813|FG000|Maintenance Period|Pregnancy|0|||
28047782|NCT00406653|54705814|FG001|Maintenance Period|Pregnancy|0|||
28047783|NCT00406653|54705815|FG002|Maintenance Period|Pregnancy|0|||
28047784|NCT00406653|54705816|FG003|Maintenance Period|Pregnancy|0|||
28047785|NCT00406653|54705817|FG004|Maintenance Period|Pregnancy|0|||
28047786|NCT00406653|54705818|FG005|Maintenance Period|Pregnancy|1|||
28047787|NCT00406653|54705819|FG006|Maintenance Period|Pregnancy|0|||
28047788|NCT00406653|54705813|FG000|Maintenance Period|Administrative Reason By Sponsor|0|||
28047789|NCT00406653|54705814|FG001|Maintenance Period|Administrative Reason By Sponsor|0|||
28047790|NCT00406653|54705815|FG002|Maintenance Period|Administrative Reason By Sponsor|0|||
28047791|NCT00406653|54705816|FG003|Maintenance Period|Administrative Reason By Sponsor|0|||
28047792|NCT00406653|54705817|FG004|Maintenance Period|Administrative Reason By Sponsor|4|||
28047793|NCT00406653|54705818|FG005|Maintenance Period|Administrative Reason By Sponsor|7|||
28047794|NCT00406653|54705819|FG006|Maintenance Period|Administrative Reason By Sponsor|0|||
28047795|NCT00406653|54705813|FG000|Maintenance Period|Error in disease score evaluation|0|||
28047796|NCT00406653|54705814|FG001|Maintenance Period|Error in disease score evaluation|0|||
28047797|NCT00406653|54705815|FG002|Maintenance Period|Error in disease score evaluation|0|||
28047798|NCT00406653|54705816|FG003|Maintenance Period|Error in disease score evaluation|0|||
28047799|NCT00406653|54705817|FG004|Maintenance Period|Error in disease score evaluation|1|||
28047800|NCT00406653|54705818|FG005|Maintenance Period|Error in disease score evaluation|0|||
28047801|NCT00406653|54705819|FG006|Maintenance Period|Error in disease score evaluation|0|||
28047802|NCT00406653|54705813|FG000|Open-Label Period|Death|0|||
28047803|NCT00406653|54705814|FG001|Open-Label Period|Death|0|||
28047804|NCT00406653|54705815|FG002|Open-Label Period|Death|0|||
28047805|NCT00406653|54705816|FG003|Open-Label Period|Death|0|||
28047806|NCT00406653|54705817|FG004|Open-Label Period|Death|0|||
28047807|NCT00406653|54705818|FG005|Open-Label Period|Death|0|||
28047808|NCT00406653|54705819|FG006|Open-Label Period|Death|1|||
28047809|NCT00406653|54705813|FG000|Open-Label Period|Adverse Event|0|||
28047810|NCT00406653|54705814|FG001|Open-Label Period|Adverse Event|0|||
28047811|NCT00406653|54705815|FG002|Open-Label Period|Adverse Event|0|||
28047812|NCT00406653|54705816|FG003|Open-Label Period|Adverse Event|0|||
28047813|NCT00406653|54705817|FG004|Open-Label Period|Adverse Event|0|||
28047814|NCT00406653|54705818|FG005|Open-Label Period|Adverse Event|0|||
28047815|NCT00406653|54705819|FG006|Open-Label Period|Adverse Event|18|||
28047816|NCT00406653|54705813|FG000|Open-Label Period|Lack of Efficacy|0|||
28047817|NCT00406653|54705814|FG001|Open-Label Period|Lack of Efficacy|0|||
28047818|NCT00406653|54705815|FG002|Open-Label Period|Lack of Efficacy|0|||
28047819|NCT00406653|54705816|FG003|Open-Label Period|Lack of Efficacy|0|||
28047820|NCT00406653|54705817|FG004|Open-Label Period|Lack of Efficacy|0|||
27811819|NCT01393990|54267858|FG007|Overall Study|Adverse Event|0|||
27811820|NCT01393990|54267859|FG008|Overall Study|Adverse Event|0|||
28047821|NCT00406653|54705818|FG005|Open-Label Period|Lack of Efficacy|0|||
28047822|NCT00406653|54705819|FG006|Open-Label Period|Lack of Efficacy|160|||
28047823|NCT00406653|54705813|FG000|Open-Label Period|Lost to Follow-up|0|||
28047824|NCT00406653|54705814|FG001|Open-Label Period|Lost to Follow-up|0|||
28047825|NCT00406653|54705815|FG002|Open-Label Period|Lost to Follow-up|0|||
27811821|NCT01393990|54267860|FG009|Overall Study|Adverse Event|0|||
28047826|NCT00406653|54705816|FG003|Open-Label Period|Lost to Follow-up|0|||
28047827|NCT00406653|54705817|FG004|Open-Label Period|Lost to Follow-up|0|||
28047828|NCT00406653|54705818|FG005|Open-Label Period|Lost to Follow-up|0|||
28047829|NCT00406653|54705819|FG006|Open-Label Period|Lost to Follow-up|6|||
28047830|NCT00406653|54705813|FG000|Open-Label Period|Withdrawal of Consent|0|||
28047831|NCT00406653|54705814|FG001|Open-Label Period|Withdrawal of Consent|0|||
28047832|NCT00406653|54705815|FG002|Open-Label Period|Withdrawal of Consent|0|||
28047833|NCT00406653|54705816|FG003|Open-Label Period|Withdrawal of Consent|0|||
28047834|NCT00406653|54705817|FG004|Open-Label Period|Withdrawal of Consent|0|||
28047835|NCT00406653|54705818|FG005|Open-Label Period|Withdrawal of Consent|0|||
28047836|NCT00406653|54705819|FG006|Open-Label Period|Withdrawal of Consent|11|||
28047837|NCT00406653|54705813|FG000|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
28047838|NCT00406653|54705814|FG001|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
28047839|NCT00406653|54705815|FG002|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
28047840|NCT00406653|54705816|FG003|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
28047841|NCT00406653|54705817|FG004|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
28047842|NCT00406653|54705818|FG005|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
28047843|NCT00406653|54705819|FG006|Open-Label Period|Subject No Longer Meets Study Criteria|1|||
28047844|NCT00406653|54705813|FG000|Open-Label Period|Pregnancy|0|||
28047845|NCT00406653|54705814|FG001|Open-Label Period|Pregnancy|0|||
28047846|NCT00406653|54705815|FG002|Open-Label Period|Pregnancy|0|||
28047847|NCT00406653|54705816|FG003|Open-Label Period|Pregnancy|0|||
28047848|NCT00406653|54705817|FG004|Open-Label Period|Pregnancy|0|||
28047849|NCT00406653|54705818|FG005|Open-Label Period|Pregnancy|0|||
28047850|NCT00406653|54705819|FG006|Open-Label Period|Pregnancy|2|||
28047851|NCT00406653|54705813|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
28047852|NCT00406653|54705814|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
28047853|NCT00406653|54705815|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
28047854|NCT00406653|54705816|FG003|Open-Label Period|Administrative Reason By Sponsor|0|||
28047855|NCT00406653|54705817|FG004|Open-Label Period|Administrative Reason By Sponsor|0|||
28047856|NCT00406653|54705818|FG005|Open-Label Period|Administrative Reason By Sponsor|0|||
28047857|NCT00406653|54705819|FG006|Open-Label Period|Administrative Reason By Sponsor|115|||
28047858|NCT00406653|54705813|FG000|Open-Label Period|Declined participation but followup done|0|||
28047859|NCT00406653|54705814|FG001|Open-Label Period|Declined participation but followup done|0|||
28047860|NCT00406653|54705815|FG002|Open-Label Period|Declined participation but followup done|0|||
28047861|NCT00406653|54705816|FG003|Open-Label Period|Declined participation but followup done|0|||
28047862|NCT00406653|54705817|FG004|Open-Label Period|Declined participation but followup done|0|||
28047863|NCT00406653|54705818|FG005|Open-Label Period|Declined participation but followup done|0|||
28047864|NCT00406653|54705819|FG006|Open-Label Period|Declined participation but followup done|8|||
28047865|NCT00406653|54705813|FG000|Open-Label Period|Discontinued by Sponsor|0|||
28047866|NCT00406653|54705814|FG001|Open-Label Period|Discontinued by Sponsor|0|||
28047867|NCT00406653|54705815|FG002|Open-Label Period|Discontinued by Sponsor|0|||
28047868|NCT00406653|54705816|FG003|Open-Label Period|Discontinued by Sponsor|0|||
28047869|NCT00406653|54705817|FG004|Open-Label Period|Discontinued by Sponsor|0|||
28047870|NCT00406653|54705818|FG005|Open-Label Period|Discontinued by Sponsor|0|||
28047871|NCT00406653|54705819|FG006|Open-Label Period|Discontinued by Sponsor|1|||
28047872|NCT00406653|54705813|FG000|Open-Label Period|Refused followup|0|||
28047873|NCT00406653|54705814|FG001|Open-Label Period|Refused followup|0|||
28047874|NCT00406653|54705815|FG002|Open-Label Period|Refused followup|0|||
28047875|NCT00406653|54705816|FG003|Open-Label Period|Refused followup|0|||
28047876|NCT00406653|54705817|FG004|Open-Label Period|Refused followup|0|||
28047877|NCT00406653|54705818|FG005|Open-Label Period|Refused followup|0|||
28047878|NCT00406653|54705819|FG006|Open-Label Period|Refused followup|1|||
28047879|NCT00547157|54705841|FG000|Overall Study|Other|1|||
28047880|NCT00547157|54705842|FG001|Overall Study|Other|0|||
28047881|NCT00547157|54705841|FG000|Overall Study|Death|38|||
28047882|NCT00547157|54705842|FG001|Overall Study|Death|18|||
28047883|NCT00547157|54705841|FG000|Overall Study|Withdrawal by Subject|3|||
28047884|NCT00547157|54705842|FG001|Overall Study|Withdrawal by Subject|1|||
28047885|NCT00547157|54705841|FG000|Overall Study|Administrative decision|3|||
28047886|NCT00547157|54705842|FG001|Overall Study|Administrative decision|2|||
28047887|NCT00547157|54705841|FG000|Overall Study|Lost to Follow-up|4|||
27811822|NCT01393990|54267861|FG010|Overall Study|Adverse Event|0|||
27811823|NCT01393990|54267862|FG011|Overall Study|Adverse Event|0|||
28047888|NCT00547157|54705842|FG001|Overall Study|Lost to Follow-up|2|||
28047889|NCT00384033|54705852|FG000|Overall Study|Adverse Event|10|||
28047890|NCT00384033|54705853|FG001|Overall Study|Adverse Event|8|||
28047891|NCT00384033|54705854|FG002|Overall Study|Adverse Event|11|||
28047892|NCT00384033|54705855|FG003|Overall Study|Adverse Event|20|||
28047893|NCT00384033|54705852|FG000|Overall Study|Failed to return|1|||
28047894|NCT00384033|54705853|FG001|Overall Study|Failed to return|3|||
28047895|NCT00384033|54705854|FG002|Overall Study|Failed to return|2|||
28047896|NCT00384033|54705855|FG003|Overall Study|Failed to return|2|||
28047897|NCT00384033|54705852|FG000|Overall Study|Physician Decision|1|||
28047898|NCT00384033|54705853|FG001|Overall Study|Physician Decision|0|||
28047899|NCT00384033|54705854|FG002|Overall Study|Physician Decision|0|||
28047900|NCT00384033|54705855|FG003|Overall Study|Physician Decision|0|||
27811824|NCT01393990|54267863|FG012|Overall Study|Adverse Event|0|||
28047901|NCT00384033|54705852|FG000|Overall Study|Lost to Follow-up|6|||
28047902|NCT00384033|54705853|FG001|Overall Study|Lost to Follow-up|12|||
28047903|NCT00384033|54705854|FG002|Overall Study|Lost to Follow-up|7|||
28047904|NCT00384033|54705855|FG003|Overall Study|Lost to Follow-up|7|||
28047905|NCT00384033|54705852|FG000|Overall Study|Other|2|||
28047906|NCT00384033|54705853|FG001|Overall Study|Other|0|||
28047907|NCT00384033|54705854|FG002|Overall Study|Other|0|||
28047908|NCT00384033|54705855|FG003|Overall Study|Other|0|||
28047909|NCT00384033|54705852|FG000|Overall Study|Protocol Violation|5|||
28047910|NCT00384033|54705853|FG001|Overall Study|Protocol Violation|0|||
28047911|NCT00384033|54705854|FG002|Overall Study|Protocol Violation|5|||
28047912|NCT00384033|54705855|FG003|Overall Study|Protocol Violation|6|||
28047913|NCT00384033|54705852|FG000|Overall Study|Withdrawal by Subject|6|||
28047914|NCT00384033|54705853|FG001|Overall Study|Withdrawal by Subject|2|||
28047915|NCT00384033|54705854|FG002|Overall Study|Withdrawal by Subject|5|||
28047916|NCT00384033|54705855|FG003|Overall Study|Withdrawal by Subject|2|||
28047917|NCT00384033|54705852|FG000|Overall Study|Lack of Efficacy|7|||
28047918|NCT00384033|54705853|FG001|Overall Study|Lack of Efficacy|3|||
28047919|NCT00384033|54705854|FG002|Overall Study|Lack of Efficacy|3|||
28047920|NCT00384033|54705855|FG003|Overall Study|Lack of Efficacy|1|||
28047921|NCT00384033|54705852|FG000|Overall Study|Randomized but not treated|3|||
28047922|NCT00384033|54705853|FG001|Overall Study|Randomized but not treated|7|||
28047923|NCT00384033|54705854|FG002|Overall Study|Randomized but not treated|10|||
28047924|NCT00384033|54705855|FG003|Overall Study|Randomized but not treated|2|||
28047925|NCT00546377|54705865|FG000|Overall Study|Deemed ineligible|1|||
28047926|NCT00546377|54705865|FG000|Overall Study|Adverse Event|6|||
28047927|NCT00545753|54705872|FG000|Overall Study|Withdrawal by Subject|0|||
28047928|NCT00545753|54705873|FG001|Overall Study|Withdrawal by Subject|1|||
28047929|NCT00545753|54705874|FG002|Overall Study|Withdrawal by Subject|10|||
28047930|NCT00545753|54705872|FG000|Overall Study|Lost to Follow-up|13|||
28047931|NCT00545753|54705873|FG001|Overall Study|Lost to Follow-up|3|||
28047932|NCT00545753|54705874|FG002|Overall Study|Lost to Follow-up|12|||
28047933|NCT00545753|54705872|FG000|Overall Study|Protocol Violation|3|||
28047934|NCT00545753|54705873|FG001|Overall Study|Protocol Violation|1|||
28047935|NCT00545753|54705874|FG002|Overall Study|Protocol Violation|4|||
28047936|NCT00406419|54705886|FG000|Overall Study|Death|3|||
28047937|NCT00406419|54705887|FG001|Overall Study|Death|1|||
28047938|NCT00406419|54705888|FG002|Overall Study|Death|4|||
28047939|NCT00406419|54705886|FG000|Overall Study|Protocol Violation|6|||
28047940|NCT00406419|54705887|FG001|Overall Study|Protocol Violation|2|||
28047941|NCT00406419|54705888|FG002|Overall Study|Protocol Violation|5|||
28047942|NCT00406419|54705886|FG000|Overall Study|Study Terminated by Sponsor|260|||
28047943|NCT00406419|54705887|FG001|Overall Study|Study Terminated by Sponsor|288|||
28047944|NCT00406419|54705888|FG002|Overall Study|Study Terminated by Sponsor|282|||
28047945|NCT00406419|54705886|FG000|Overall Study|Withdrawal by Subject|17|||
28047946|NCT00406419|54705887|FG001|Overall Study|Withdrawal by Subject|24|||
28047947|NCT00406419|54705888|FG002|Overall Study|Withdrawal by Subject|26|||
28047948|NCT00406419|54705886|FG000|Overall Study|Lack of Efficacy|12|||
28047949|NCT00406419|54705887|FG001|Overall Study|Lack of Efficacy|1|||
28047950|NCT00406419|54705888|FG002|Overall Study|Lack of Efficacy|6|||
28047951|NCT00406419|54705886|FG000|Overall Study|Non-Compliance with Study Drug|5|||
28047952|NCT00406419|54705887|FG001|Overall Study|Non-Compliance with Study Drug|6|||
28047953|NCT00406419|54705888|FG002|Overall Study|Non-Compliance with Study Drug|3|||
28047954|NCT00406419|54705886|FG000|Overall Study|Adverse Event|10|||
28047955|NCT00406419|54705887|FG001|Overall Study|Adverse Event|12|||
27811825|NCT01393990|54267864|FG013|Overall Study|Adverse Event|0|||
27811826|NCT01393990|54267865|FG014|Overall Study|Adverse Event|1|||
27811827|NCT01393990|54267866|FG015|Overall Study|Adverse Event|1|||
27811828|NCT01393990|54267867|FG016|Overall Study|Adverse Event|0|||
27811829|NCT01393990|54267868|FG017|Overall Study|Adverse Event|0|||
27811830|NCT01393990|54267851|FG000|Overall Study|Progressive Disease|1|||
27811831|NCT01393990|54267852|FG001|Overall Study|Progressive Disease|0|||
28047956|NCT00406419|54705888|FG002|Overall Study|Adverse Event|16|||
28047957|NCT00406419|54705886|FG000|Overall Study|Lost to Follow-up|11|||
28047958|NCT00406419|54705887|FG001|Overall Study|Lost to Follow-up|10|||
28047959|NCT00406419|54705888|FG002|Overall Study|Lost to Follow-up|5|||
28047960|NCT00325468|54705901|FG000|Overall Study|Adverse Event|1|||
28047961|NCT00325468|54705902|FG001|Overall Study|Adverse Event|1|||
28047962|NCT00325468|54705903|FG002|Overall Study|Adverse Event|0|||
28047963|NCT00325468|54705904|FG003|Overall Study|Adverse Event|5|||
28047964|NCT00325468|54705905|FG004|Overall Study|Adverse Event|1|||
28047965|NCT00325468|54705901|FG000|Overall Study|Death|2|||
28047966|NCT00325468|54705902|FG001|Overall Study|Death|0|||
27811832|NCT01393990|54267853|FG002|Overall Study|Progressive Disease|0|||
27811833|NCT01393990|54267854|FG003|Overall Study|Progressive Disease|1|||
28047967|NCT00325468|54705903|FG002|Overall Study|Death|2|||
28047968|NCT00325468|54705904|FG003|Overall Study|Death|4|||
28047969|NCT00325468|54705905|FG004|Overall Study|Death|0|||
28047970|NCT00325468|54705901|FG000|Overall Study|Lost to Follow-up|0|||
28047971|NCT00325468|54705902|FG001|Overall Study|Lost to Follow-up|0|||
27811834|NCT01393990|54267855|FG004|Overall Study|Progressive Disease|1|||
28047972|NCT00325468|54705903|FG002|Overall Study|Lost to Follow-up|1|||
28047973|NCT00325468|54705904|FG003|Overall Study|Lost to Follow-up|2|||
28047974|NCT00325468|54705905|FG004|Overall Study|Lost to Follow-up|2|||
28047975|NCT00325468|54705901|FG000|Overall Study|Physician Decision|1|||
28047976|NCT00325468|54705902|FG001|Overall Study|Physician Decision|1|||
28047977|NCT00325468|54705903|FG002|Overall Study|Physician Decision|0|||
28047978|NCT00325468|54705904|FG003|Overall Study|Physician Decision|1|||
28047979|NCT00325468|54705905|FG004|Overall Study|Physician Decision|0|||
28047980|NCT00325468|54705901|FG000|Overall Study|Withdrawal by Subject|3|||
28047981|NCT00325468|54705902|FG001|Overall Study|Withdrawal by Subject|1|||
28047982|NCT00325468|54705903|FG002|Overall Study|Withdrawal by Subject|0|||
28047983|NCT00325468|54705904|FG003|Overall Study|Withdrawal by Subject|14|||
28047984|NCT00325468|54705905|FG004|Overall Study|Withdrawal by Subject|4|||
28047985|NCT00325468|54705901|FG000|Overall Study|site closure etc|4|||
28047986|NCT00325468|54705902|FG001|Overall Study|site closure etc|2|||
28047987|NCT00325468|54705903|FG002|Overall Study|site closure etc|1|||
28047988|NCT00325468|54705904|FG003|Overall Study|site closure etc|8|||
28047989|NCT00325468|54705905|FG004|Overall Study|site closure etc|1|||
28047990|NCT03833661|54705918|FG000|Overall Study|Treatment ongoing|9|||
28047991|NCT00311584|54705924|FG000|Overall Study|Death|1|||
28047992|NCT00311584|54705925|FG001|Overall Study|Death|0|||
28047993|NCT00311584|54705924|FG000|Overall Study|Lack of Efficacy|12|||
28047994|NCT00311584|54705925|FG001|Overall Study|Lack of Efficacy|15|||
28047995|NCT00311584|54705924|FG000|Overall Study|Physician Decision|4|||
28047996|NCT00311584|54705925|FG001|Overall Study|Physician Decision|5|||
28047997|NCT00311584|54705924|FG000|Overall Study|Withdrawal by Subject|1|||
28047998|NCT00311584|54705925|FG001|Overall Study|Withdrawal by Subject|1|||
28047999|NCT00311584|54705924|FG000|Overall Study|ineligible|2|||
28048000|NCT00311584|54705925|FG001|Overall Study|ineligible|2|||
28048001|NCT00383331|54705933|FG000|Overall Study|Protocol Violation|0|||
28048002|NCT00383331|54705934|FG001|Overall Study|Protocol Violation|1|||
28048003|NCT03934541|54705944|FG000|Overall Study|Study Terminated by Sponsor|0|||
28048004|NCT03934541|54705945|FG001|Overall Study|Study Terminated by Sponsor|1|||
28048005|NCT03934541|54705946|FG002|Overall Study|Study Terminated by Sponsor|0|||
28048006|NCT03934541|54705947|FG003|Overall Study|Study Terminated by Sponsor|0|||
28048007|NCT00325234|54705959|FG000|Overall Study|Adverse Event|10|||
28048008|NCT00325234|54705960|FG001|Overall Study|Adverse Event|7|||
28048009|NCT00325234|54705959|FG000|Overall Study|Death due to Study Disease|1|||
28048010|NCT00325234|54705960|FG001|Overall Study|Death due to Study Disease|0|||
28048011|NCT00325234|54705959|FG000|Overall Study|Entry Criteria Not Met|1|||
28048012|NCT00325234|54705960|FG001|Overall Study|Entry Criteria Not Met|2|||
28048013|NCT00325234|54705959|FG000|Overall Study|Subject Decision|6|||
28048014|NCT00325234|54705960|FG001|Overall Study|Subject Decision|8|||
28048015|NCT00325234|54705959|FG000|Overall Study|Physician Decision|17|||
28048016|NCT00325234|54705960|FG001|Overall Study|Physician Decision|12|||
28048017|NCT00325234|54705959|FG000|Overall Study|Progressive Disease|34|||
28048018|NCT00325234|54705960|FG001|Overall Study|Progressive Disease|37|||
28048019|NCT00366249|54705970|FG000|Overall Study|Adverse Event|53|||
28048020|NCT00366249|54705971|FG001|Overall Study|Adverse Event|28|||
28048021|NCT00366249|54705970|FG000|Overall Study|Death|0|||
28048022|NCT00366249|54705971|FG001|Overall Study|Death|1|||
28048023|NCT00366249|54705970|FG000|Overall Study|Physician Decision|5|||
28048024|NCT00366249|54705971|FG001|Overall Study|Physician Decision|2|||
28048025|NCT00366249|54705970|FG000|Overall Study|Lost to Follow-up|2|||
28048026|NCT00366249|54705971|FG001|Overall Study|Lost to Follow-up|0|||
28048027|NCT00366249|54705970|FG000|Overall Study|Protocol Violation|1|||
28048028|NCT00366249|54705971|FG001|Overall Study|Protocol Violation|2|||
28048029|NCT00366249|54705970|FG000|Overall Study|Withdrawal by Subject|18|||
28048030|NCT00366249|54705971|FG001|Overall Study|Withdrawal by Subject|4|||
28048031|NCT00366249|54705970|FG000|Overall Study|Lack of Efficacy|21|||
28048032|NCT00366249|54705971|FG001|Overall Study|Lack of Efficacy|21|||
28048033|NCT00366249|54705970|FG000|Overall Study|Most due to osteomylitis status|31|||
28048034|NCT00366249|54705971|FG001|Overall Study|Most due to osteomylitis status|20|||
28048035|NCT00325156|54705977|FG000|Overall Study|Protocol Violation|8|||
28048036|NCT00325156|54705977|FG000|Overall Study|Lost to follow-up (complete vaccination)|41|||
28048037|NCT00325156|54705977|FG000|Overall Study|Migrated/moved from study area|12|||
28048038|NCT00325156|54705977|FG000|Overall Study|Adverse event, non-fatal|3|||
28048039|NCT00325156|54705977|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|16|||
28048040|NCT00325156|54705977|FG000|Overall Study|Other|1|||
28048041|NCT00325156|54705977|FG000|Overall Study|Withdrawal by Subject|31|||
28048042|NCT03927911|54705987|FG000|Overall Study|problems with eDiary|0|||
28048043|NCT03927911|54705988|FG001|Overall Study|problems with eDiary|1|||
28048044|NCT03927911|54705989|FG002|Overall Study|problems with eDiary|0|||
28048045|NCT03927911|54705990|FG003|Overall Study|problems with eDiary|1|||
28048046|NCT03927911|54705991|FG004|Overall Study|problems with eDiary|0|||
28048047|NCT03927911|54705992|FG005|Overall Study|problems with eDiary|4|||
28048048|NCT03927911|54705987|FG000|Overall Study|Adverse Event|0|||
28048049|NCT03927911|54705988|FG001|Overall Study|Adverse Event|0|||
28048050|NCT03927911|54705989|FG002|Overall Study|Adverse Event|0|||
28048051|NCT03927911|54705990|FG003|Overall Study|Adverse Event|0|||
28048052|NCT03927911|54705991|FG004|Overall Study|Adverse Event|0|||
28048053|NCT03927911|54705992|FG005|Overall Study|Adverse Event|1|||
28048054|NCT03927911|54705987|FG000|Overall Study|not treated -study terminated by sponsor|0|||
28048055|NCT03927911|54705988|FG001|Overall Study|not treated -study terminated by sponsor|1|||
28048056|NCT03927911|54705989|FG002|Overall Study|not treated -study terminated by sponsor|0|||
28048057|NCT03927911|54705990|FG003|Overall Study|not treated -study terminated by sponsor|0|||
28048058|NCT03927911|54705991|FG004|Overall Study|not treated -study terminated by sponsor|0|||
28048059|NCT03927911|54705992|FG005|Overall Study|not treated -study terminated by sponsor|0|||
28048060|NCT03927911|54705987|FG000|Overall Study|Surgery cancelled|0|||
28048061|NCT03927911|54705988|FG001|Overall Study|Surgery cancelled|0|||
28048062|NCT03927911|54705989|FG002|Overall Study|Surgery cancelled|0|||
28048063|NCT03927911|54705990|FG003|Overall Study|Surgery cancelled|1|||
28048064|NCT03927911|54705991|FG004|Overall Study|Surgery cancelled|0|||
28048065|NCT03927911|54705992|FG005|Overall Study|Surgery cancelled|1|||
28048066|NCT03927911|54705987|FG000|Overall Study|Protocol Violation|0|||
28048067|NCT03927911|54705988|FG001|Overall Study|Protocol Violation|0|||
28048068|NCT03927911|54705989|FG002|Overall Study|Protocol Violation|0|||
28048069|NCT03927911|54705990|FG003|Overall Study|Protocol Violation|0|||
28048070|NCT03927911|54705991|FG004|Overall Study|Protocol Violation|0|||
28048071|NCT03927911|54705992|FG005|Overall Study|Protocol Violation|1|||
28048072|NCT00383019|54706008|FG000|Overall Study|Adverse Event|5|||
28048073|NCT00383019|54706009|FG001|Overall Study|Adverse Event|1|||
28048074|NCT00383019|54706008|FG000|Overall Study|Withdrawal by Subject|0|||
28048075|NCT00383019|54706009|FG001|Overall Study|Withdrawal by Subject|1|||
28048076|NCT00310804|54706017|FG000|Overall Study|Lost to Follow-up|2|||
28048077|NCT00310804|54706018|FG001|Overall Study|Lost to Follow-up|0|||
28048078|NCT00310804|54706017|FG000|Overall Study|Withdrawal by Subject|3|||
28048079|NCT00310804|54706018|FG001|Overall Study|Withdrawal by Subject|0|||
28048080|NCT03826186|54706040|FG000|Overall Study|Protocol Violation|2|||
28048081|NCT03826186|54706041|FG001|Overall Study|Protocol Violation|0|||
28048082|NCT03826186|54706040|FG000|Overall Study|Withdrawal by Subject|1|||
28048083|NCT03826186|54706041|FG001|Overall Study|Withdrawal by Subject|0|||
28048084|NCT00382863|54706049|FG000|Overall Study|Death|9|||
28048085|NCT00382863|54706050|FG001|Overall Study|Death|9|||
28048086|NCT00382863|54706049|FG000|Overall Study|Lost to Follow-up|1|||
28048087|NCT00382863|54706050|FG001|Overall Study|Lost to Follow-up|2|||
28048088|NCT00382863|54706049|FG000|Overall Study|Withdrawal by Subject|5|||
28048089|NCT00382863|54706050|FG001|Overall Study|Withdrawal by Subject|25|||
28048090|NCT03933449|54706058|FG000|Overall Study|Adverse Event|6|||
28048091|NCT03933449|54706059|FG001|Overall Study|Adverse Event|4|||
28048092|NCT03933449|54706058|FG000|Overall Study|Death|55|||
28048093|NCT03933449|54706059|FG001|Overall Study|Death|57|||
28048094|NCT03933449|54706058|FG000|Overall Study|Sponsor Decision|1|||
28048095|NCT03933449|54706059|FG001|Overall Study|Sponsor Decision|0|||
28048096|NCT00290758|54706082|FG000|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1|||
28048097|NCT00290758|54706083|FG001|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2|||
28048098|NCT00290758|54706082|FG000|Pre-Intervention rFNA Through Follow-Up|ConMeds|1|||
28048099|NCT00290758|54706083|FG001|Pre-Intervention rFNA Through Follow-Up|ConMeds|0|||
28048100|NCT00290758|54706082|FG000|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3|||
28048101|NCT00290758|54706083|FG001|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1|||
28048102|NCT00290758|54706082|FG000|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
28048103|NCT00290758|54706083|FG001|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
28048104|NCT00290758|54706082|FG000|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0|||
28048105|NCT00290758|54706083|FG001|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5|||
28048106|NCT00290758|54706082|FG000|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1|||
28048107|NCT00290758|54706083|FG001|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0|||
28048108|NCT00290758|54706082|FG000|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0|||
28048109|NCT00290758|54706083|FG001|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1|||
28048110|NCT00290758|54706082|FG000|Post Intervention rFNA|<4000 Epithelial Cells|6|||
28048111|NCT00290758|54706083|FG001|Post Intervention rFNA|<4000 Epithelial Cells|5|||
28048112|NCT00372567|54706096|FG000|Phase 3 Study|Adverse Event|5|||
28048113|NCT00372567|54706097|FG001|Phase 3 Study|Adverse Event|1|||
28048114|NCT00372567|54706098|FG002|Phase 3 Study|Adverse Event|1|||
27939906|NCT02357134|54596238|FG003|Overall Study|Lost to Follow-up|0|||
28048115|NCT00372567|54706096|FG000|Phase 3 Study|Death|1|||
28048116|NCT00372567|54706097|FG001|Phase 3 Study|Death|1|||
28048117|NCT00372567|54706098|FG002|Phase 3 Study|Death|0|||
28048118|NCT00372567|54706096|FG000|Phase 3 Study|Protocol Violation|0|||
28048119|NCT00372567|54706097|FG001|Phase 3 Study|Protocol Violation|0|||
28048120|NCT00372567|54706098|FG002|Phase 3 Study|Protocol Violation|1|||
28048121|NCT00372567|54706096|FG000|Phase 3 Study|Objective progression or relapse|10|||
28048122|NCT00372567|54706097|FG001|Phase 3 Study|Objective progression or relapse|13|||
28048123|NCT00372567|54706098|FG002|Phase 3 Study|Objective progression or relapse|4|||
28048124|NCT00372567|54706096|FG000|Phase 3 Study|Global deterioration of health status|0|||
28048125|NCT00372567|54706097|FG001|Phase 3 Study|Global deterioration of health status|1|||
28048126|NCT00372567|54706098|FG002|Phase 3 Study|Global deterioration of health status|0|||
28048127|NCT00372567|54706096|FG000|Phase 3 Study|Other|2|||
28048128|NCT00372567|54706097|FG001|Phase 3 Study|Other|2|||
28048129|NCT00372567|54706098|FG002|Phase 3 Study|Other|1|||
28048130|NCT00372567|54706096|FG000|Phase 3 Study|study terminated by sponsor|13|||
28048131|NCT00372567|54706097|FG001|Phase 3 Study|study terminated by sponsor|8|||
28048132|NCT00372567|54706098|FG002|Phase 3 Study|study terminated by sponsor|5|||
28048133|NCT00365547|54706106|FG000|Overall Study|Insurance did not cover Avastin|1|||
28048134|NCT00365547|54706106|FG000|Overall Study|Screen failure|1|||
28048135|NCT00365547|54706106|FG000|Overall Study|Withdrawal by Subject|1|||
28048136|NCT00545441|54706115|FG000|Overall Study|Fistula draining at 6 months|2|||
28048137|NCT00545441|54706116|FG001|Overall Study|Fistula draining at 6 months|4|||
28048138|NCT00545441|54706115|FG000|Overall Study|Lost to Follow-up|9|||
28048139|NCT00545441|54706116|FG001|Overall Study|Lost to Follow-up|5|||
28048140|NCT00545441|54706115|FG000|Overall Study|Technical failure|0|||
28048141|NCT00545441|54706116|FG001|Overall Study|Technical failure|1|||
28048142|NCT00545441|54706115|FG000|Overall Study|Withdrawal by Subject|1|||
28048143|NCT00545441|54706116|FG001|Overall Study|Withdrawal by Subject|1|||
28048144|NCT00545441|54706115|FG000|Overall Study|Persistence or recurrence of fistula|5|||
28048145|NCT00545441|54706116|FG001|Overall Study|Persistence or recurrence of fistula|2|||
28048146|NCT00545441|54706115|FG000|Overall Study|Patients were not treated|1|||
28048147|NCT00545441|54706116|FG001|Overall Study|Patients were not treated|3|||
28048148|NCT00294658|54706124|FG000|Overall Study|Death|0|||
28048149|NCT00294658|54706125|FG001|Overall Study|Death|1|||
28048150|NCT00294658|54706124|FG000|Overall Study|Lost to Follow-up|4|||
28048151|NCT00294658|54706125|FG001|Overall Study|Lost to Follow-up|0|||
28048152|NCT00294658|54706124|FG000|Overall Study|Physician Decision|1|||
28048153|NCT00294658|54706125|FG001|Overall Study|Physician Decision|2|||
28048154|NCT00294658|54706124|FG000|Overall Study|Pregnancy|0|||
28048155|NCT00294658|54706125|FG001|Overall Study|Pregnancy|1|||
28048156|NCT00294658|54706124|FG000|Overall Study|Withdrawal by Subject|0|||
28048157|NCT00294658|54706125|FG001|Overall Study|Withdrawal by Subject|4|||
28048158|NCT00294658|54706124|FG000|Overall Study|Found to have invasive thymoma|1|||
28048159|NCT00294658|54706125|FG001|Overall Study|Found to have invasive thymoma|0|||
28048160|NCT00294658|54706124|FG000|Overall Study|Patient and family were not satisfied|0|||
28048161|NCT00294658|54706125|FG001|Overall Study|Patient and family were not satisfied|1|||
28048162|NCT03923933|54706133|FG000|Overall Study|Lost to Follow-up|1|||
28048163|NCT03923933|54706134|FG001|Overall Study|Lost to Follow-up|0|||
28048164|NCT03923933|54706133|FG000|Overall Study|Withdrawal by Subject|0|||
28048165|NCT03923933|54706134|FG001|Overall Study|Withdrawal by Subject|1|||
28048166|NCT00372489|54706140|FG000|Overall Study|Adverse Event|18|||
28048167|NCT00372489|54706140|FG000|Overall Study|Lack of Efficacy|1|||
28048168|NCT00372489|54706140|FG000|Overall Study|Lost to Follow-up|3|||
28048169|NCT00372489|54706140|FG000|Overall Study|Physician Decision|3|||
28048170|NCT00372489|54706140|FG000|Overall Study|Withdrawal by Subject|5|||
28048171|NCT00372489|54706140|FG000|Overall Study|Patient Relocation|2|||
28048172|NCT00372489|54706140|FG000|Overall Study|Renal transplant|6|||
28048173|NCT00372489|54706140|FG000|Overall Study|Sponsor Decision to Terminate Study|41|||
28048174|NCT00372411|54706147|FG000|Overall Study|Withdrawal by Subject|3|||
28048175|NCT00372411|54706148|FG001|Overall Study|Withdrawal by Subject|4|||
28048176|NCT00372411|54706149|FG002|Overall Study|Withdrawal by Subject|1|||
28048177|NCT00372411|54706147|FG000|Overall Study|Death|0|||
28048178|NCT00372411|54706148|FG001|Overall Study|Death|2|||
28048179|NCT00372411|54706149|FG002|Overall Study|Death|1|||
28048180|NCT00372411|54706147|FG000|Overall Study|Lost to Follow-up|1|||
28048181|NCT00372411|54706148|FG001|Overall Study|Lost to Follow-up|1|||
28048182|NCT00372411|54706149|FG002|Overall Study|Lost to Follow-up|1|||
28048183|NCT00372411|54706147|FG000|Overall Study|Adverse Event|1|||
28048184|NCT00372411|54706148|FG001|Overall Study|Adverse Event|1|||
28048185|NCT00372411|54706149|FG002|Overall Study|Adverse Event|0|||
28048186|NCT00372255|54706159|FG000|Overall Study|Withdrawn for other reasons|2|||
27811835|NCT01393990|54267856|FG005|Overall Study|Progressive Disease|1|||
28048187|NCT00372255|54706160|FG001|Overall Study|Withdrawn for other reasons|1|||
28048188|NCT00274456|54706171|FG000|Overall Study|Still on treatment|2|||
28048189|NCT00274456|54706172|FG001|Overall Study|Still on treatment|3|||
28048190|NCT00274456|54706173|FG002|Overall Study|Still on treatment|5|||
28048191|NCT00274456|54706174|FG003|Overall Study|Still on treatment|1|||
28048192|NCT00274456|54706171|FG000|Overall Study|Unacceptable toxicity|10|||
28048193|NCT00274456|54706172|FG001|Overall Study|Unacceptable toxicity|5|||
28048194|NCT00274456|54706173|FG002|Overall Study|Unacceptable toxicity|12|||
28048195|NCT00274456|54706174|FG003|Overall Study|Unacceptable toxicity|16|||
28048196|NCT00274456|54706171|FG000|Overall Study|Adverse Event|0|||
28048197|NCT00274456|54706172|FG001|Overall Study|Adverse Event|1|||
28048198|NCT00274456|54706173|FG002|Overall Study|Adverse Event|2|||
28048199|NCT00274456|54706174|FG003|Overall Study|Adverse Event|2|||
28048200|NCT00274456|54706171|FG000|Overall Study|Physician Decision|7|||
28048201|NCT00274456|54706172|FG001|Overall Study|Physician Decision|5|||
28048202|NCT00274456|54706173|FG002|Overall Study|Physician Decision|6|||
28048203|NCT00274456|54706174|FG003|Overall Study|Physician Decision|13|||
28048204|NCT00274456|54706171|FG000|Overall Study|Lost to Follow-up|0|||
28048205|NCT00274456|54706172|FG001|Overall Study|Lost to Follow-up|0|||
28048206|NCT00274456|54706173|FG002|Overall Study|Lost to Follow-up|1|||
28048207|NCT00274456|54706174|FG003|Overall Study|Lost to Follow-up|0|||
28048208|NCT00274456|54706171|FG000|Overall Study|Withdrawal by Subject|18|||
28048209|NCT00274456|54706172|FG001|Overall Study|Withdrawal by Subject|13|||
28048210|NCT00274456|54706173|FG002|Overall Study|Withdrawal by Subject|9|||
28048211|NCT00274456|54706174|FG003|Overall Study|Withdrawal by Subject|13|||
28048212|NCT00364923|54706184|FG000|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4|||
28048213|NCT00364923|54706184|FG000|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24|||
28048214|NCT00381849|54706190|FG000|Wash Out|Withdrawal by Subject|0|||
28048215|NCT00381849|54706191|FG001|Wash Out|Withdrawal by Subject|1|||
28048216|NCT00273052|54706199|FG000|Overall Study|Withdrawal by Subject|16|||
28048217|NCT00273052|54706200|FG001|Overall Study|Withdrawal by Subject|19|||
28048218|NCT00273052|54706199|FG000|Overall Study|Adverse Event|21|||
28048219|NCT00273052|54706200|FG001|Overall Study|Adverse Event|19|||
28048220|NCT00273052|54706199|FG000|Overall Study|Protocol Violation|14|||
28048221|NCT00273052|54706200|FG001|Overall Study|Protocol Violation|18|||
28048222|NCT00273052|54706199|FG000|Overall Study|Lost to Follow-up|7|||
28048223|NCT00273052|54706200|FG001|Overall Study|Lost to Follow-up|25|||
28048224|NCT00273052|54706199|FG000|Overall Study|Lack of Efficacy|6|||
28048225|NCT00273052|54706200|FG001|Overall Study|Lack of Efficacy|4|||
28048226|NCT00273052|54706199|FG000|Overall Study|Non-Compliance|3|||
28048227|NCT00273052|54706200|FG001|Overall Study|Non-Compliance|1|||
28048228|NCT00273052|54706199|FG000|Overall Study|Other|2|||
28048229|NCT00273052|54706200|FG001|Overall Study|Other|0|||
28048230|NCT00273052|54706199|FG000|Overall Study|Worsening serum lipid levels|0|||
28048231|NCT00273052|54706200|FG001|Overall Study|Worsening serum lipid levels|2|||
28048232|NCT00290290|54706208|FG000|Overall Study|Death|3|||
28048233|NCT00290290|54706209|FG001|Overall Study|Death|4|||
28048234|NCT00290290|54706208|FG000|Overall Study|Withdrawal by Subject|2|||
28048235|NCT00290290|54706209|FG001|Overall Study|Withdrawal by Subject|2|||
28048236|NCT00290290|54706208|FG000|Overall Study|Underwent clean surgical procedure|13|||
28048237|NCT00290290|54706209|FG001|Overall Study|Underwent clean surgical procedure|12|||
28048238|NCT00272038|54706215|FG000|Overall Study|withdrew before they received 2 cycles|7|||
28048239|NCT00271024|54706224|FG000|Overall Study|Lost Interest|3|||
28048240|NCT00271024|54706225|FG001|Overall Study|Lost Interest|4|||
28048241|NCT00271024|54706226|FG002|Overall Study|Lost Interest|2|||
28048242|NCT00271024|54706227|FG003|Overall Study|Lost Interest|3|||
28048243|NCT00271024|54706224|FG000|Overall Study|Unknown/Unspecified|11|||
28048244|NCT00271024|54706225|FG001|Overall Study|Unknown/Unspecified|11|||
28048245|NCT00271024|54706226|FG002|Overall Study|Unknown/Unspecified|8|||
28048246|NCT00271024|54706227|FG003|Overall Study|Unknown/Unspecified|4|||
28048247|NCT00271024|54706224|FG000|Overall Study|Protocol Violation|1|||
28048248|NCT00271024|54706225|FG001|Overall Study|Protocol Violation|6|||
28048249|NCT00271024|54706226|FG002|Overall Study|Protocol Violation|5|||
28048250|NCT00271024|54706227|FG003|Overall Study|Protocol Violation|11|||
28048251|NCT00271024|54706224|FG000|Overall Study|Unpleasant Reaction To Tablet|1|||
28048252|NCT00271024|54706225|FG001|Overall Study|Unpleasant Reaction To Tablet|3|||
28048253|NCT00271024|54706226|FG002|Overall Study|Unpleasant Reaction To Tablet|4|||
28048254|NCT00271024|54706227|FG003|Overall Study|Unpleasant Reaction To Tablet|2|||
28048255|NCT00271024|54706224|FG000|Overall Study|Time Commitment, Scheduling, or Travel|6|||
28048256|NCT00271024|54706225|FG001|Overall Study|Time Commitment, Scheduling, or Travel|2|||
28048257|NCT00271024|54706226|FG002|Overall Study|Time Commitment, Scheduling, or Travel|4|||
28048258|NCT00271024|54706227|FG003|Overall Study|Time Commitment, Scheduling, or Travel|4|||
28048259|NCT00381693|54706237|FG000|Overall Study|Death|1|||
28048260|NCT00381693|54706237|FG000|Overall Study|Adverse Event|4|||
28048261|NCT00381693|54706237|FG000|Overall Study|Patient Choice|1|||
28048262|NCT00381693|54706237|FG000|Overall Study|Progression|2|||
28048263|NCT00545363|54706243|FG000|Overall Study|Adverse Event|6|||
28048264|NCT00545363|54706244|FG001|Overall Study|Adverse Event|7|||
28048265|NCT00545363|54706243|FG000|Overall Study|Withdrawal by Subject|6|||
28048266|NCT00545363|54706244|FG001|Overall Study|Withdrawal by Subject|5|||
28048267|NCT00545363|54706243|FG000|Overall Study|Non-compliance|3|||
28048268|NCT00545363|54706244|FG001|Overall Study|Non-compliance|1|||
28048269|NCT00545363|54706243|FG000|Overall Study|Did not meet entry criteria|1|||
28048270|NCT00545363|54706244|FG001|Overall Study|Did not meet entry criteria|1|||
28048271|NCT00545363|54706243|FG000|Overall Study|Lost to Follow-up|2|||
28048272|NCT00545363|54706244|FG001|Overall Study|Lost to Follow-up|0|||
28048273|NCT00545363|54706243|FG000|Overall Study|Other|1|||
28048274|NCT00545363|54706244|FG001|Overall Study|Other|1|||
28048275|NCT00457392|54706252|FG000|Overall Study|Objective Progression or Relapse|229|||
28048276|NCT00457392|54706253|FG001|Overall Study|Objective Progression or Relapse|296|||
28048277|NCT00457392|54706252|FG000|Overall Study|Death|106|||
28048278|NCT00457392|54706253|FG001|Overall Study|Death|106|||
28048279|NCT00457392|54706252|FG000|Overall Study|Adverse Event|84|||
28048280|NCT00457392|54706253|FG001|Overall Study|Adverse Event|41|||
28048281|NCT00457392|54706252|FG000|Overall Study|Global Deterioration of Health Status|22|||
28048282|NCT00457392|54706253|FG001|Overall Study|Global Deterioration of Health Status|8|||
28048283|NCT00457392|54706252|FG000|Overall Study|Withdrawal by Subject|14|||
28048284|NCT00457392|54706253|FG001|Overall Study|Withdrawal by Subject|8|||
28048285|NCT00457392|54706252|FG000|Overall Study|Lost to Follow-up|6|||
28048286|NCT00457392|54706253|FG001|Overall Study|Lost to Follow-up|7|||
28048287|NCT00457392|54706252|FG000|Overall Study|Protocol Violation|4|||
28048288|NCT00457392|54706253|FG001|Overall Study|Protocol Violation|3|||
28048289|NCT00457392|54706252|FG000|Overall Study|Other|7|||
28048290|NCT00457392|54706253|FG001|Overall Study|Other|4|||
28048291|NCT00457392|54706252|FG000|Overall Study|Study Terminated by Sponsor|1|||
28048292|NCT00457392|54706253|FG001|Overall Study|Study Terminated by Sponsor|4|||
28048293|NCT00457392|54706252|FG000|Overall Study|Randomized, Not Treated|7|||
28048294|NCT00457392|54706253|FG001|Overall Study|Randomized, Not Treated|3|||
28048295|NCT00545051|54706261|FG000|Overall Study|Adverse Event|7|||
28048296|NCT00545051|54706262|FG001|Overall Study|Adverse Event|3|||
28048297|NCT00545051|54706261|FG000|Overall Study|Death|1|||
28048298|NCT00545051|54706262|FG001|Overall Study|Death|0|||
28048299|NCT00545051|54706261|FG000|Overall Study|Violation of inclusion/exclusion|0|||
28048300|NCT00545051|54706262|FG001|Overall Study|Violation of inclusion/exclusion|2|||
28048301|NCT00545051|54706261|FG000|Overall Study|Protocol Violation|1|||
28048302|NCT00545051|54706262|FG001|Overall Study|Protocol Violation|0|||
28048303|NCT00545051|54706261|FG000|Overall Study|Withdrawal by Subject|0|||
28048304|NCT00545051|54706262|FG001|Overall Study|Withdrawal by Subject|1|||
28048305|NCT00545051|54706261|FG000|Overall Study|Administrative reasons|0|||
28048306|NCT00545051|54706262|FG001|Overall Study|Administrative reasons|1|||
28048307|NCT00381615|54706272|FG000|Overall Study|Withdrawal by Subject|1|||
28048308|NCT00381615|54706273|FG001|Overall Study|Withdrawal by Subject|3|||
28048309|NCT00381615|54706274|FG002|Overall Study|Withdrawal by Subject|0|||
28048310|NCT00381615|54706275|FG003|Overall Study|Withdrawal by Subject|1|||
28048311|NCT00381615|54706272|FG000|Overall Study|Lost to Follow-up|3|||
28048312|NCT00381615|54706273|FG001|Overall Study|Lost to Follow-up|2|||
28048313|NCT00381615|54706274|FG002|Overall Study|Lost to Follow-up|0|||
28048314|NCT00381615|54706275|FG003|Overall Study|Lost to Follow-up|1|||
28048315|NCT00381615|54706272|FG000|Overall Study|Protocol Violation|0|||
28048316|NCT00381615|54706273|FG001|Overall Study|Protocol Violation|0|||
28048317|NCT00381615|54706274|FG002|Overall Study|Protocol Violation|1|||
28048318|NCT00381615|54706275|FG003|Overall Study|Protocol Violation|0|||
28048319|NCT00371865|54706289|FG000|Overall Study|Lack of Efficacy|0|||
28048320|NCT00371865|54706290|FG001|Overall Study|Lack of Efficacy|2|||
28048321|NCT00371865|54706289|FG000|Overall Study|Protocol Violation|3|||
28048322|NCT00371865|54706290|FG001|Overall Study|Protocol Violation|2|||
28048323|NCT00371865|54706289|FG000|Overall Study|Withdrawal by Subject|12|||
28048324|NCT00371865|54706290|FG001|Overall Study|Withdrawal by Subject|10|||
28048325|NCT00364845|54706298|FG000|Overall Study|Adverse Event|1|||
28048326|NCT00364845|54706299|FG001|Overall Study|Adverse Event|0|||
28048327|NCT00364845|54706298|FG000|Overall Study|Withdrawal by Subject|2|||
28048328|NCT00364845|54706299|FG001|Overall Study|Withdrawal by Subject|1|||
28048329|NCT00364845|54706298|FG000|Overall Study|Physician Decision|8|||
28048330|NCT00364845|54706299|FG001|Overall Study|Physician Decision|8|||
28048331|NCT00364845|54706298|FG000|Overall Study|Lost to Follow-up|0|||
28048332|NCT00364845|54706299|FG001|Overall Study|Lost to Follow-up|1|||
28048333|NCT00364845|54706298|FG000|Overall Study|Death|0|||
28048334|NCT00364845|54706299|FG001|Overall Study|Death|1|||
28048335|NCT00293722|54706305|FG000|Overall Study|Other|427|||
28048336|NCT00381303|54706311|FG000|Overall Study|Lost to Follow-up|25|||
28048337|NCT00381303|54706312|FG001|Overall Study|Lost to Follow-up|9|||
28048338|NCT00381303|54706311|FG000|Overall Study|AE/HIV-related event|22|||
28048339|NCT00381303|54706312|FG001|Overall Study|AE/HIV-related event|6|||
28048340|NCT00381303|54706311|FG000|Overall Study|Non-Adherence|13|||
28048341|NCT00381303|54706312|FG001|Overall Study|Non-Adherence|6|||
28048342|NCT00381303|54706311|FG000|Overall Study|Withdrawal by Subject|13|||
28048343|NCT00381303|54706312|FG001|Overall Study|Withdrawal by Subject|6|||
28048344|NCT00381303|54706311|FG000|Overall Study|Virologic failure|6|||
28048345|NCT00381303|54706312|FG001|Overall Study|Virologic failure|4|||
28048346|NCT00381303|54706311|FG000|Overall Study|Ineligible to continue the trial|2|||
28048347|NCT00381303|54706312|FG001|Overall Study|Ineligible to continue the trial|1|||
28048348|NCT00381303|54706311|FG000|Overall Study|Pregnancy|2|||
28048349|NCT00381303|54706312|FG001|Overall Study|Pregnancy|0|||
28048350|NCT00381303|54706311|FG000|Overall Study|Physician Decision|1|||
28048351|NCT00381303|54706312|FG001|Overall Study|Physician Decision|0|||
28048352|NCT00381303|54706311|FG000|Overall Study|Physician's decision to close the site|3|||
28048353|NCT00381303|54706312|FG001|Overall Study|Physician's decision to close the site|1|||
28048354|NCT00381303|54706311|FG000|Overall Study|Subject moved out of state|2|||
28048355|NCT00381303|54706312|FG001|Overall Study|Subject moved out of state|0|||
28048356|NCT00381303|54706311|FG000|Overall Study|Subject taking too many different meds|1|||
28048357|NCT00381303|54706312|FG001|Overall Study|Subject taking too many different meds|0|||
28048358|NCT00381303|54706311|FG000|Overall Study|No virologic response by week 12|1|||
28048359|NCT00381303|54706312|FG001|Overall Study|No virologic response by week 12|0|||
28048360|NCT00381303|54706311|FG000|Overall Study|Subject was too busy for appointments|1|||
27811836|NCT01393990|54267857|FG006|Overall Study|Progressive Disease|1|||
27811837|NCT01393990|54267858|FG007|Overall Study|Progressive Disease|1|||
27811838|NCT01393990|54267859|FG008|Overall Study|Progressive Disease|3|||
27811839|NCT01393990|54267860|FG009|Overall Study|Progressive Disease|1|||
27811840|NCT01393990|54267861|FG010|Overall Study|Progressive Disease|0|||
27811841|NCT01393990|54267862|FG011|Overall Study|Progressive Disease|0|||
28048361|NCT00381303|54706312|FG001|Overall Study|Subject was too busy for appointments|0|||
28048362|NCT00381303|54706311|FG000|Overall Study|Subject did not continue visits|1|||
28048363|NCT00381303|54706312|FG001|Overall Study|Subject did not continue visits|0|||
28048364|NCT00381303|54706311|FG000|Overall Study|Subject primary physician's decision|1|||
28048365|NCT00381303|54706312|FG001|Overall Study|Subject primary physician's decision|0|||
28048366|NCT00448812|54706332|FG000|Year 2|Missed visit but remained in study|4|||
28048367|NCT00448812|54706333|FG001|Year 2|Missed visit but remained in study|1|||
28048368|NCT00448812|54706332|FG000|Year 3|Withdrawal by Subject|1|||
28048369|NCT00448812|54706333|FG001|Year 3|Withdrawal by Subject|3|||
28048370|NCT00448812|54706332|FG000|Year 3|Lost to Follow-up|1|||
28048371|NCT00448812|54706333|FG001|Year 3|Lost to Follow-up|0|||
28048372|NCT00448812|54706332|FG000|Year 3|Missed visit but remained in study|2|||
28048373|NCT00448812|54706333|FG001|Year 3|Missed visit but remained in study|0|||
28048374|NCT00448812|54706332|FG000|Year 5|Missed visit but remained in study|1|||
28048375|NCT00448812|54706333|FG001|Year 5|Missed visit but remained in study|0|||
28048376|NCT00364689|54706354|FG000|Overall Study|Lost to Follow-up|1|||
28048377|NCT00545129|54706362|FG000|Overall Study|Lack of Efficacy|2|||
28048378|NCT00545129|54706363|FG001|Overall Study|Lack of Efficacy|5|||
28048379|NCT00545129|54706362|FG000|Overall Study|Death|2|||
28048380|NCT00545129|54706363|FG001|Overall Study|Death|1|||
28048381|NCT00545129|54706362|FG000|Overall Study|Adverse Event|1|||
28048382|NCT00545129|54706363|FG001|Overall Study|Adverse Event|1|||
28048383|NCT00545129|54706362|FG000|Overall Study|Rollover to Study A4091029 (NCT00830180)|9|||
28048384|NCT00545129|54706363|FG001|Overall Study|Rollover to Study A4091029 (NCT00830180)|14|||
28048385|NCT00545129|54706362|FG000|Overall Study|Other|3|||
28048386|NCT00545129|54706363|FG001|Overall Study|Other|3|||
28048387|NCT00364611|54706371|FG000|Overall Study|Did not receive study medication|0|||
28048388|NCT00364611|54706372|FG001|Overall Study|Did not receive study medication|1|||
28048389|NCT00364611|54706371|FG000|Overall Study|Adverse Event|7|||
28048390|NCT00364611|54706372|FG001|Overall Study|Adverse Event|4|||
28048391|NCT00364611|54706371|FG000|Overall Study|Participant's Request|3|||
28048392|NCT00364611|54706372|FG001|Overall Study|Participant's Request|4|||
28048393|NCT00364611|54706371|FG000|Overall Study|Disease Progression|38|||
28048394|NCT00364611|54706372|FG001|Overall Study|Disease Progression|8|||
28048395|NCT00364611|54706371|FG000|Overall Study|Investigator decision|2|||
28048396|NCT00364611|54706372|FG001|Overall Study|Investigator decision|2|||
28048397|NCT00364611|54706371|FG000|Overall Study|Found Ineligible|1|||
28048398|NCT00364611|54706372|FG001|Overall Study|Found Ineligible|0|||
28048399|NCT00364611|54706371|FG000|Overall Study|Presumed CR on Study|0|||
28048400|NCT00364611|54706372|FG001|Overall Study|Presumed CR on Study|1|||
28048401|NCT00364611|54706371|FG000|Overall Study|Receiving Liver Ablation|0|||
28048402|NCT00364611|54706372|FG001|Overall Study|Receiving Liver Ablation|1|||
28048403|NCT00364533|54706383|FG000|Overall Study|Adverse Event|8|||
28048404|NCT00364533|54706384|FG001|Overall Study|Adverse Event|7|||
28048405|NCT00364533|54706385|FG002|Overall Study|Adverse Event|15|||
28048406|NCT00364533|54706386|FG003|Overall Study|Adverse Event|5|||
28048407|NCT00364533|54706387|FG004|Overall Study|Adverse Event|2|||
27811842|NCT01393990|54267863|FG012|Overall Study|Progressive Disease|0|||
27811843|NCT01393990|54267864|FG013|Overall Study|Progressive Disease|1|||
27811844|NCT01393990|54267865|FG014|Overall Study|Progressive Disease|6|||
27811845|NCT01393990|54267866|FG015|Overall Study|Progressive Disease|1|||
27811846|NCT01393990|54267867|FG016|Overall Study|Progressive Disease|0|||
27811847|NCT01393990|54267868|FG017|Overall Study|Progressive Disease|0|||
28048408|NCT00364533|54706383|FG000|Overall Study|Withdrawal by Subject|4|||
28048409|NCT00364533|54706384|FG001|Overall Study|Withdrawal by Subject|8|||
28048410|NCT00364533|54706385|FG002|Overall Study|Withdrawal by Subject|6|||
28048411|NCT00364533|54706386|FG003|Overall Study|Withdrawal by Subject|6|||
28048412|NCT00364533|54706387|FG004|Overall Study|Withdrawal by Subject|6|||
28048413|NCT00364533|54706383|FG000|Overall Study|Lack of Efficacy|22|||
28048414|NCT00364533|54706384|FG001|Overall Study|Lack of Efficacy|22|||
28048415|NCT00364533|54706385|FG002|Overall Study|Lack of Efficacy|21|||
28048416|NCT00364533|54706386|FG003|Overall Study|Lack of Efficacy|17|||
27811848|NCT01393990|54267851|FG000|Overall Study|Death|0|||
27811849|NCT01393990|54267852|FG001|Overall Study|Death|0|||
27811850|NCT01393990|54267853|FG002|Overall Study|Death|0|||
27811851|NCT01393990|54267854|FG003|Overall Study|Death|0|||
27811852|NCT01393990|54267855|FG004|Overall Study|Death|1|||
27811853|NCT01393990|54267856|FG005|Overall Study|Death|0|||
28048417|NCT00364533|54706387|FG004|Overall Study|Lack of Efficacy|42|||
27811854|NCT01393990|54267857|FG006|Overall Study|Death|0|||
27811855|NCT01393990|54267858|FG007|Overall Study|Death|0|||
27811856|NCT01393990|54267859|FG008|Overall Study|Death|0|||
27811857|NCT01393990|54267860|FG009|Overall Study|Death|0|||
27811858|NCT01393990|54267861|FG010|Overall Study|Death|0|||
27811859|NCT01393990|54267862|FG011|Overall Study|Death|0|||
27811860|NCT01393990|54267863|FG012|Overall Study|Death|0|||
27811861|NCT01393990|54267864|FG013|Overall Study|Death|1|||
27811862|NCT01393990|54267865|FG014|Overall Study|Death|1|||
27811863|NCT01393990|54267866|FG015|Overall Study|Death|0|||
27811864|NCT01393990|54267867|FG016|Overall Study|Death|0|||
27811865|NCT01393990|54267868|FG017|Overall Study|Death|0|||
27811866|NCT01393990|54267851|FG000|Overall Study|Withdrawal by Subject|0|||
28048418|NCT00364533|54706383|FG000|Overall Study|Subject discharged from hospital|4|||
28048419|NCT00364533|54706384|FG001|Overall Study|Subject discharged from hospital|1|||
28048420|NCT00364533|54706385|FG002|Overall Study|Subject discharged from hospital|2|||
28048421|NCT00364533|54706386|FG003|Overall Study|Subject discharged from hospital|3|||
28048422|NCT00364533|54706387|FG004|Overall Study|Subject discharged from hospital|1|||
28048423|NCT00364533|54706383|FG000|Overall Study|Variations in drug compliance|2|||
28048424|NCT00364533|54706384|FG001|Overall Study|Variations in drug compliance|1|||
28048425|NCT00364533|54706385|FG002|Overall Study|Variations in drug compliance|1|||
28048426|NCT00364533|54706386|FG003|Overall Study|Variations in drug compliance|0|||
28048427|NCT00364533|54706387|FG004|Overall Study|Variations in drug compliance|0|||
28048428|NCT00364533|54706383|FG000|Overall Study|Non-compliance|1|||
28048429|NCT00364533|54706384|FG001|Overall Study|Non-compliance|0|||
28048430|NCT00364533|54706385|FG002|Overall Study|Non-compliance|0|||
28048431|NCT00364533|54706386|FG003|Overall Study|Non-compliance|0|||
28048432|NCT00364533|54706387|FG004|Overall Study|Non-compliance|0|||
28048433|NCT00364533|54706383|FG000|Overall Study|Protocol Violation|1|||
28048434|NCT00364533|54706384|FG001|Overall Study|Protocol Violation|1|||
28048435|NCT00364533|54706385|FG002|Overall Study|Protocol Violation|0|||
28048436|NCT00364533|54706386|FG003|Overall Study|Protocol Violation|0|||
28048437|NCT00364533|54706387|FG004|Overall Study|Protocol Violation|0|||
28048438|NCT04006847|54706399|FG000|Overall Study|Product issue|1|||
28048439|NCT00544817|54706403|FG000|Combined Modality|Lack of Efficacy|2|||
28048440|NCT00544817|54706403|FG000|Combined Modality|Worsening Neurologic Symptoms|2|||
28048441|NCT00544817|54706403|FG000|Combined Modality|Adverse Event|2|||
28048442|NCT00544817|54706403|FG000|Combined Modality|Intercurrent Illness - Pneumonia|1|||
28048443|NCT00544817|54706403|FG000|No Treatment Interval|Lack of Efficacy|8|||
28048444|NCT00544817|54706403|FG000|No Treatment Interval|Physician Decision|3|||
28048445|NCT00544817|54706403|FG000|No Treatment Interval|Adverse Event|1|||
28048446|NCT00544817|54706403|FG000|Follow-up Systemic Therapy|Lack of Efficacy|15|||
28048447|NCT00544817|54706403|FG000|Follow-up Systemic Therapy|Physician Decision|3|||
28048448|NCT00544817|54706403|FG000|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1|||
28048449|NCT00289978|54706410|FG000|Overall Study|Withdrawal by Subject|31|||
28048450|NCT00289978|54706411|FG001|Overall Study|Withdrawal by Subject|17|||
27811867|NCT01393990|54267852|FG001|Overall Study|Withdrawal by Subject|0|||
27811868|NCT01393990|54267853|FG002|Overall Study|Withdrawal by Subject|0|||
27811869|NCT01393990|54267854|FG003|Overall Study|Withdrawal by Subject|0|||
27811870|NCT01393990|54267855|FG004|Overall Study|Withdrawal by Subject|0|||
27811871|NCT01393990|54267856|FG005|Overall Study|Withdrawal by Subject|0|||
27811872|NCT01393990|54267857|FG006|Overall Study|Withdrawal by Subject|0|||
27811873|NCT01393990|54267858|FG007|Overall Study|Withdrawal by Subject|0|||
27811874|NCT01393990|54267859|FG008|Overall Study|Withdrawal by Subject|0|||
27811875|NCT01393990|54267860|FG009|Overall Study|Withdrawal by Subject|0|||
27811876|NCT01393990|54267861|FG010|Overall Study|Withdrawal by Subject|0|||
27811877|NCT01393990|54267862|FG011|Overall Study|Withdrawal by Subject|0|||
27811878|NCT01393990|54267863|FG012|Overall Study|Withdrawal by Subject|0|||
27811879|NCT01393990|54267864|FG013|Overall Study|Withdrawal by Subject|0|||
27811880|NCT01393990|54267865|FG014|Overall Study|Withdrawal by Subject|1|||
27811881|NCT01393990|54267866|FG015|Overall Study|Withdrawal by Subject|1|||
27811882|NCT01393990|54267867|FG016|Overall Study|Withdrawal by Subject|0|||
28048451|NCT00289978|54706412|FG002|Overall Study|Withdrawal by Subject|28|||
28048452|NCT00289978|54706410|FG000|Overall Study|Adverse Event|22|||
28048453|NCT00289978|54706411|FG001|Overall Study|Adverse Event|13|||
28048454|NCT00289978|54706412|FG002|Overall Study|Adverse Event|18|||
28048455|NCT00289978|54706410|FG000|Overall Study|Lack of Efficacy|13|||
28048456|NCT00289978|54706411|FG001|Overall Study|Lack of Efficacy|6|||
27811883|NCT01393990|54267868|FG017|Overall Study|Withdrawal by Subject|0|||
27811884|NCT00210184|54267917|FG000|Overall Study|The medical record was lost for these patients: no clinical data is available|2|||
27811885|NCT00210106|54267921|FG000|Overall Study|Death|1|||
27811886|NCT00210106|54267921|FG000|Overall Study|Protocol Violation|13|||
27811887|NCT01851590|54267929|FG000|Overall Study|Withdrawal by Subject|0|||
27811888|NCT01851590|54267930|FG001|Overall Study|Withdrawal by Subject|0|||
27811889|NCT01851590|54267931|FG002|Overall Study|Withdrawal by Subject|1|||
27811890|NCT01851590|54267929|FG000|Overall Study|Adverse Event|0|||
27811891|NCT01851590|54267930|FG001|Overall Study|Adverse Event|0|||
27811892|NCT01851590|54267931|FG002|Overall Study|Adverse Event|2|||
27811893|NCT01851590|54267929|FG000|Overall Study|Lack of Efficacy|0|||
27811894|NCT01851590|54267930|FG001|Overall Study|Lack of Efficacy|1|||
27811895|NCT01851590|54267931|FG002|Overall Study|Lack of Efficacy|0|||
27811896|NCT01852058|54267946|FG000|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1|||
27811897|NCT01852058|54267947|FG001|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
27811898|NCT01852058|54267948|FG002|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
27811899|NCT01852058|54267949|FG003|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
27811900|NCT01852058|54267950|FG004|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
27811901|NCT01852058|54267951|FG005|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
27811902|NCT01852058|54267952|FG006|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
27811903|NCT01852058|54267953|FG007|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
27811904|NCT01852058|54267954|FG008|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
27811905|NCT01852058|54267955|FG009|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
27811906|NCT01852058|54267956|FG010|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
27811907|NCT01852058|54267957|FG011|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
27811908|NCT01852058|54267946|FG000|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
27811909|NCT01852058|54267947|FG001|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
27811910|NCT01852058|54267948|FG002|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
27811911|NCT01852058|54267949|FG003|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
27811912|NCT01852058|54267950|FG004|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1|||
27939907|NCT00745420|54596248|FG000|Overall Study|Ineligible|1|||
28048457|NCT00289978|54706412|FG002|Overall Study|Lack of Efficacy|25|||
28048458|NCT00289978|54706410|FG000|Overall Study|Abnormal laboratory value(s)|20|||
28048459|NCT00289978|54706411|FG001|Overall Study|Abnormal laboratory value(s)|9|||
28048460|NCT00289978|54706412|FG002|Overall Study|Abnormal laboratory value(s)|1|||
28048461|NCT00289978|54706410|FG000|Overall Study|Lost to Follow-up|3|||
28048462|NCT00289978|54706411|FG001|Overall Study|Lost to Follow-up|5|||
28048463|NCT00289978|54706412|FG002|Overall Study|Lost to Follow-up|7|||
28048464|NCT00289978|54706410|FG000|Overall Study|Protocol Violation|5|||
28048465|NCT00289978|54706411|FG001|Overall Study|Protocol Violation|5|||
28048466|NCT00289978|54706412|FG002|Overall Study|Protocol Violation|4|||
28048467|NCT00289978|54706410|FG000|Overall Study|Abnormal test procedure result(s)|2|||
28048468|NCT00289978|54706411|FG001|Overall Study|Abnormal test procedure result(s)|1|||
28048469|NCT00289978|54706412|FG002|Overall Study|Abnormal test procedure result(s)|1|||
28048470|NCT00289978|54706410|FG000|Overall Study|Death|1|||
28048471|NCT00289978|54706411|FG001|Overall Study|Death|0|||
28048472|NCT00289978|54706412|FG002|Overall Study|Death|2|||
28048473|NCT00543803|54706420|FG000|Overall Study|Adverse Event|14|||
28048474|NCT00543803|54706420|FG000|Overall Study|Lack of Efficacy|22|||
28048475|NCT00543803|54706420|FG000|Overall Study|Lost to Follow-up|20|||
28048476|NCT00543803|54706420|FG000|Overall Study|Other|86|||
28048477|NCT00542321|54706428|FG000|Overall Study|Death|0|||
28048478|NCT00542321|54706429|FG001|Overall Study|Death|1|||
28048479|NCT00289900|54706441|FG000|Overall Study|Adverse Event|28|||
28048480|NCT00289900|54706442|FG001|Overall Study|Adverse Event|40|||
28048481|NCT00289900|54706443|FG002|Overall Study|Adverse Event|13|||
28048482|NCT00289900|54706444|FG003|Overall Study|Adverse Event|19|||
28048483|NCT00289900|54706445|FG004|Overall Study|Adverse Event|20|||
28048484|NCT00289900|54706446|FG005|Overall Study|Adverse Event|33|||
28048485|NCT00289900|54706441|FG000|Overall Study|Lost to Follow-up|7|||
28048486|NCT00289900|54706442|FG001|Overall Study|Lost to Follow-up|7|||
28048487|NCT00289900|54706443|FG002|Overall Study|Lost to Follow-up|8|||
28048488|NCT00289900|54706444|FG003|Overall Study|Lost to Follow-up|8|||
28048489|NCT00289900|54706445|FG004|Overall Study|Lost to Follow-up|4|||
28048490|NCT00289900|54706446|FG005|Overall Study|Lost to Follow-up|8|||
28048491|NCT00289900|54706441|FG000|Overall Study|Participant had flushing|18|||
28048492|NCT00289900|54706442|FG001|Overall Study|Participant had flushing|42|||
28048493|NCT00289900|54706443|FG002|Overall Study|Participant had flushing|1|||
28048494|NCT00289900|54706444|FG003|Overall Study|Participant had flushing|2|||
28048495|NCT00289900|54706445|FG004|Overall Study|Participant had flushing|0|||
28048496|NCT00289900|54706446|FG005|Overall Study|Participant had flushing|4|||
28048497|NCT00289900|54706441|FG000|Overall Study|Other|0|||
28048498|NCT00289900|54706442|FG001|Overall Study|Other|0|||
28048499|NCT00289900|54706443|FG002|Overall Study|Other|0|||
28048500|NCT00289900|54706444|FG003|Overall Study|Other|5|||
28048501|NCT00289900|54706445|FG004|Overall Study|Other|1|||
27811913|NCT01852058|54267951|FG005|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
27811914|NCT01852058|54267952|FG006|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
27811915|NCT01852058|54267953|FG007|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
27811916|NCT01852058|54267954|FG008|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
27811917|NCT01852058|54267955|FG009|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
28048502|NCT00289900|54706446|FG005|Overall Study|Other|0|||
28048503|NCT00289900|54706441|FG000|Overall Study|Participant moved|1|||
28048504|NCT00289900|54706442|FG001|Overall Study|Participant moved|0|||
28048505|NCT00289900|54706443|FG002|Overall Study|Participant moved|0|||
28048506|NCT00289900|54706444|FG003|Overall Study|Participant moved|1|||
28048507|NCT00289900|54706445|FG004|Overall Study|Participant moved|1|||
28048508|NCT00289900|54706446|FG005|Overall Study|Participant moved|1|||
28048509|NCT00289900|54706441|FG000|Overall Study|Withdrawal by Subject|10|||
28048510|NCT00289900|54706442|FG001|Overall Study|Withdrawal by Subject|21|||
28048511|NCT00289900|54706443|FG002|Overall Study|Withdrawal by Subject|8|||
28048512|NCT00289900|54706444|FG003|Overall Study|Withdrawal by Subject|18|||
28048513|NCT00289900|54706445|FG004|Overall Study|Withdrawal by Subject|12|||
28048514|NCT00289900|54706446|FG005|Overall Study|Withdrawal by Subject|11|||
28048515|NCT00289900|54706441|FG000|Overall Study|Protocol Violation|3|||
28048516|NCT00289900|54706442|FG001|Overall Study|Protocol Violation|9|||
28048517|NCT00289900|54706443|FG002|Overall Study|Protocol Violation|2|||
28048518|NCT00289900|54706444|FG003|Overall Study|Protocol Violation|6|||
28048519|NCT00289900|54706445|FG004|Overall Study|Protocol Violation|7|||
28048520|NCT00289900|54706446|FG005|Overall Study|Protocol Violation|4|||
28048521|NCT00289900|54706441|FG000|Overall Study|site terminated|1|||
28048522|NCT00289900|54706442|FG001|Overall Study|site terminated|0|||
28048523|NCT00289900|54706443|FG002|Overall Study|site terminated|1|||
28048524|NCT00289900|54706444|FG003|Overall Study|site terminated|0|||
28048525|NCT00289900|54706445|FG004|Overall Study|site terminated|0|||
28048526|NCT00289900|54706446|FG005|Overall Study|site terminated|0|||
28048527|NCT00289900|54706441|FG000|Overall Study|Not treated|0|||
28048528|NCT00289900|54706442|FG001|Overall Study|Not treated|1|||
28048529|NCT00289900|54706443|FG002|Overall Study|Not treated|0|||
28048530|NCT00289900|54706444|FG003|Overall Study|Not treated|0|||
28048531|NCT00289900|54706445|FG004|Overall Study|Not treated|0|||
27811918|NCT01852058|54267956|FG010|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
27811919|NCT01852058|54267957|FG011|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
27811920|NCT01852058|54267946|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
27811921|NCT01852058|54267947|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
27811922|NCT01852058|54267948|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
27811923|NCT01852058|54267949|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
27811924|NCT01852058|54267950|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
27811925|NCT01852058|54267951|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
27811926|NCT01852058|54267952|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
27811927|NCT01852058|54267953|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
27811928|NCT01852058|54267954|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
27811929|NCT01852058|54267955|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
27811930|NCT01852058|54267956|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
27811931|NCT01852058|54267957|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
27811932|NCT01852058|54267946|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
27811933|NCT01852058|54267947|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
27811934|NCT01852058|54267948|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
27811935|NCT01852058|54267949|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
27811936|NCT01852058|54267950|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1|||
27811937|NCT01852058|54267951|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
27811938|NCT01852058|54267952|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
27811939|NCT01852058|54267953|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
27811940|NCT01852058|54267954|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
27939908|NCT02853370|54596252|FG000|Overall Study|Physician Decision|1|||
28048532|NCT00289900|54706446|FG005|Overall Study|Not treated|0|||
28048533|NCT00543725|54706465|FG000|Overall Study|Adverse Event|18|||
28048534|NCT00543725|54706466|FG001|Overall Study|Adverse Event|27|||
28048535|NCT00543725|54706465|FG000|Overall Study|Sponsor's Decision|0|||
28048536|NCT00543725|54706466|FG001|Overall Study|Sponsor's Decision|1|||
28048537|NCT00543725|54706465|FG000|Overall Study|Subject Non-Compliant|4|||
28048538|NCT00543725|54706466|FG001|Overall Study|Subject Non-Compliant|4|||
28048539|NCT00543725|54706465|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
28048540|NCT00543725|54706466|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
28048541|NCT00543725|54706465|FG000|Overall Study|Subject Reached A Virologic Endpoint|22|||
28048542|NCT00543725|54706466|FG001|Overall Study|Subject Reached A Virologic Endpoint|14|||
28048543|NCT00543725|54706465|FG000|Overall Study|Protocol Violation|0|||
28048544|NCT00543725|54706466|FG001|Overall Study|Protocol Violation|1|||
28048545|NCT00543725|54706465|FG000|Overall Study|Withdrawal by Subject|4|||
28048546|NCT00543725|54706466|FG001|Overall Study|Withdrawal by Subject|13|||
28048547|NCT00543725|54706465|FG000|Overall Study|Lost to Follow-up|15|||
28048548|NCT00543725|54706466|FG001|Overall Study|Lost to Follow-up|11|||
28048549|NCT00543725|54706465|FG000|Overall Study|Other|3|||
28048550|NCT00543725|54706466|FG001|Overall Study|Other|3|||
28048551|NCT00269152|54706474|FG000|Overall Study|Adverse Event|9|||
28048552|NCT00269152|54706475|FG001|Overall Study|Adverse Event|3|||
28048553|NCT00269152|54706474|FG000|Overall Study|Withdrawal by Subject|7|||
28048554|NCT00269152|54706475|FG001|Overall Study|Withdrawal by Subject|3|||
28048555|NCT00269152|54706474|FG000|Overall Study|Physician Decision|2|||
28048556|NCT00269152|54706475|FG001|Overall Study|Physician Decision|3|||
28048557|NCT00269152|54706474|FG000|Overall Study|Protocol Violation|0|||
28048558|NCT00269152|54706475|FG001|Overall Study|Protocol Violation|1|||
28048559|NCT00379899|54706483|FG000|Overall Study|Adverse Event|7|||
28048560|NCT00379899|54706484|FG001|Overall Study|Adverse Event|3|||
28048561|NCT00379899|54706483|FG000|Overall Study|Death|10|||
28048562|NCT00379899|54706484|FG001|Overall Study|Death|10|||
28048563|NCT00379899|54706483|FG000|Overall Study|Lost to Follow-up|2|||
28048564|NCT00379899|54706484|FG001|Overall Study|Lost to Follow-up|4|||
28048565|NCT00379899|54706483|FG000|Overall Study|Physician Decision|3|||
28048566|NCT00379899|54706484|FG001|Overall Study|Physician Decision|4|||
28048567|NCT00379899|54706483|FG000|Overall Study|Withdrawal by Subject|5|||
28048568|NCT00379899|54706484|FG001|Overall Study|Withdrawal by Subject|5|||
28048569|NCT00379899|54706483|FG000|Overall Study|Ineligibility determined|0|||
28048570|NCT00379899|54706484|FG001|Overall Study|Ineligibility determined|1|||
28048571|NCT00379899|54706483|FG000|Overall Study|Noncompliance|1|||
28048572|NCT00379899|54706484|FG001|Overall Study|Noncompliance|1|||
28048573|NCT00379899|54706483|FG000|Overall Study|Parathyroidectomy|0|||
28048574|NCT00379899|54706484|FG001|Overall Study|Parathyroidectomy|2|||
28048575|NCT00379899|54706483|FG000|Overall Study|Renal transplantation|5|||
28048576|NCT00379899|54706484|FG001|Overall Study|Renal transplantation|4|||
28048577|NCT00379899|54706483|FG000|Overall Study|Coronary artery bypass graft|1|||
28048578|NCT00379899|54706484|FG001|Overall Study|Coronary artery bypass graft|1|||
28048579|NCT00379899|54706483|FG000|Overall Study|Other protocol-specified criteria|3|||
28048580|NCT00379899|54706484|FG001|Overall Study|Other protocol-specified criteria|4|||
28048581|NCT00379899|54706483|FG000|Overall Study|Other|3|||
28048582|NCT00379899|54706484|FG001|Overall Study|Other|1|||
28048583|NCT00371787|54706492|FG000|Overall Study|Withdrawal by Subject|3|||
28048584|NCT00371787|54706493|FG001|Overall Study|Withdrawal by Subject|1|||
28048585|NCT00363129|54706501|FG000|Overall Study|Withdrawal by Subject|11|||
28048586|NCT00363129|54706502|FG001|Overall Study|Withdrawal by Subject|18|||
28048587|NCT00363129|54706501|FG000|Overall Study|Adverse Event|8|||
28048588|NCT00363129|54706502|FG001|Overall Study|Adverse Event|3|||
28048589|NCT00363129|54706501|FG000|Overall Study|Alternate Treatment|2|||
28048590|NCT00363129|54706502|FG001|Overall Study|Alternate Treatment|4|||
28048591|NCT00363129|54706501|FG000|Overall Study|Other Medical Problems|2|||
28048592|NCT00363129|54706502|FG001|Overall Study|Other Medical Problems|4|||
28048593|NCT00363129|54706501|FG000|Overall Study|Death|0|||
28048594|NCT00363129|54706502|FG001|Overall Study|Death|1|||
28048595|NCT00363129|54706501|FG000|Overall Study|Other Reasons|6|||
28048596|NCT00363129|54706502|FG001|Overall Study|Other Reasons|3|||
28048597|NCT00268996|54706510|FG000|Overall Study|Adverse Event|11|||
28048598|NCT00268996|54706511|FG001|Overall Study|Adverse Event|7|||
28048599|NCT00268996|54706510|FG000|Overall Study|Lost to Follow-up|3|||
28048600|NCT00268996|54706511|FG001|Overall Study|Lost to Follow-up|1|||
28048601|NCT00268996|54706510|FG000|Overall Study|Withdrawal by Subject|5|||
28048602|NCT00268996|54706511|FG001|Overall Study|Withdrawal by Subject|11|||
28048603|NCT00268996|54706510|FG000|Overall Study|Non-compliance|1|||
28048604|NCT00268996|54706511|FG001|Overall Study|Non-compliance|0|||
28048605|NCT00268996|54706510|FG000|Overall Study|Other|1|||
28048606|NCT00268996|54706511|FG001|Overall Study|Other|1|||
28048607|NCT00371397|54706519|FG000|Session 1|Withdrawal by Subject|1|||
28048608|NCT00371397|54706520|FG001|Session 1|Withdrawal by Subject|0|||
28048609|NCT00371397|54706521|FG002|Session 1|Withdrawal by Subject|0|||
28048610|NCT00371397|54706522|FG003|Session 1|Withdrawal by Subject|0|||
28048611|NCT00371397|54706523|FG004|Session 1|Withdrawal by Subject|0|||
28048612|NCT00371397|54706524|FG005|Session 1|Withdrawal by Subject|0|||
28048613|NCT00371397|54706525|FG006|Session 1|Withdrawal by Subject|0|||
28048614|NCT00371397|54706526|FG007|Session 1|Withdrawal by Subject|1|||
28048615|NCT00371397|54706527|FG008|Session 1|Withdrawal by Subject|0|||
28048616|NCT00371397|54706528|FG009|Session 1|Withdrawal by Subject|0|||
28048617|NCT00371397|54706529|FG010|Session 1|Withdrawal by Subject|0|||
28048618|NCT00371397|54706530|FG011|Session 1|Withdrawal by Subject|0|||
28048619|NCT00379587|54706536|FG000|Overall Study|Lost to Follow-up|2|||
28048620|NCT00289276|54706542|FG000|Second Part of FAST Study (Expansion)|Death|0|||
28048621|NCT00289276|54706543|FG001|Second Part of FAST Study (Expansion)|Death|2|||
28048622|NCT00289276|54706542|FG000|Second Part of FAST Study (Expansion)|Lost to Follow-up|0|||
28048623|NCT00289276|54706543|FG001|Second Part of FAST Study (Expansion)|Lost to Follow-up|1|||
28048624|NCT00289198|54706551|FG000|Overall Study|Adverse Event|0|||
28048625|NCT00289198|54706552|FG001|Overall Study|Adverse Event|2|||
28048626|NCT00289198|54706551|FG000|Overall Study|Protocol Violation|2|||
28048627|NCT00289198|54706552|FG001|Overall Study|Protocol Violation|1|||
27811941|NCT01852058|54267955|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
27811942|NCT01852058|54267956|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
27811943|NCT01852058|54267957|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
27811944|NCT01852058|54267946|FG000|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
27811945|NCT01852058|54267947|FG001|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
27811946|NCT01852058|54267948|FG002|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
27811947|NCT01852058|54267949|FG003|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
27811948|NCT01852058|54267950|FG004|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3|||
27811949|NCT01852058|54267951|FG005|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1|||
27811950|NCT01852058|54267952|FG006|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
27811951|NCT01852058|54267953|FG007|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
27811952|NCT01852058|54267954|FG008|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
27811953|NCT01852058|54267955|FG009|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
27811954|NCT01852058|54267956|FG010|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
27811955|NCT01852058|54267957|FG011|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
27811956|NCT01852058|54267946|FG000|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
27811957|NCT01852058|54267947|FG001|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
27811958|NCT01852058|54267948|FG002|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
27811959|NCT01852058|54267949|FG003|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1|||
27811960|NCT01852058|54267950|FG004|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
27811961|NCT01852058|54267951|FG005|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
27811962|NCT01852058|54267952|FG006|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
27811963|NCT01852058|54267953|FG007|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
27811964|NCT01852058|54267954|FG008|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
27811965|NCT01852058|54267955|FG009|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
27811966|NCT01852058|54267956|FG010|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
27811967|NCT01852058|54267957|FG011|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
27811968|NCT01852058|54267946|FG000|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
27811969|NCT01852058|54267947|FG001|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
27811970|NCT01852058|54267948|FG002|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
27811971|NCT01852058|54267949|FG003|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
27811972|NCT01852058|54267950|FG004|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1|||
27811973|NCT01852058|54267951|FG005|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7|||
27811974|NCT01852058|54267952|FG006|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
27811975|NCT01852058|54267953|FG007|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
27811976|NCT01852058|54267954|FG008|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
27811977|NCT01852058|54267955|FG009|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
27811978|NCT01852058|54267956|FG010|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
27811979|NCT01852058|54267957|FG011|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
27811980|NCT01852058|54267946|FG000|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
27811981|NCT01852058|54267947|FG001|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
27811982|NCT01852058|54267948|FG002|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
27811983|NCT01852058|54267949|FG003|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
27811984|NCT01852058|54267950|FG004|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
27811985|NCT01852058|54267951|FG005|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
27811986|NCT01852058|54267952|FG006|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
27811987|NCT01852058|54267953|FG007|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1|||
27811988|NCT01852058|54267954|FG008|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
27811989|NCT01852058|54267955|FG009|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
27811990|NCT01852058|54267956|FG010|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
27811991|NCT01852058|54267957|FG011|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
27811992|NCT01852058|54267946|FG000|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
27811993|NCT01852058|54267947|FG001|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
27811994|NCT01852058|54267948|FG002|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
28048628|NCT00289198|54706551|FG000|Overall Study|Withdrawal by Subject|4|||
28048629|NCT00289198|54706552|FG001|Overall Study|Withdrawal by Subject|1|||
27811995|NCT01852058|54267949|FG003|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
27811996|NCT01852058|54267950|FG004|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
27811997|NCT01852058|54267951|FG005|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
27811998|NCT01852058|54267952|FG006|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
27811999|NCT01852058|54267953|FG007|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
27812000|NCT01852058|54267954|FG008|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1|||
27812001|NCT01852058|54267955|FG009|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
28048630|NCT00289198|54706551|FG000|Overall Study|Lack of Efficacy|2|||
28048631|NCT00289198|54706552|FG001|Overall Study|Lack of Efficacy|0|||
28048632|NCT00289198|54706551|FG000|Overall Study|Other: Low compliance|0|||
28048633|NCT00289198|54706552|FG001|Overall Study|Other: Low compliance|1|||
28048634|NCT00289198|54706551|FG000|Overall Study|Other: Physician's decision|0|||
28048635|NCT00289198|54706552|FG001|Overall Study|Other: Physician's decision|1|||
27812002|NCT01852058|54267956|FG010|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
27812003|NCT01852058|54267957|FG011|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
27812004|NCT00218296|54267994|FG000|Overall Study|Lost to Follow-up|9|||
27812005|NCT00218296|54267995|FG001|Overall Study|Lost to Follow-up|7|||
27812006|NCT00218296|54267994|FG000|Overall Study|Withdrawal by Subject|36|||
27812007|NCT00218296|54267995|FG001|Overall Study|Withdrawal by Subject|47|||
27812008|NCT00218296|54267994|FG000|Overall Study|Randomized but did not enter treatment|66|||
27812009|NCT00218296|54267995|FG001|Overall Study|Randomized but did not enter treatment|67|||
27812010|NCT00217672|54268003|FG000|Allocation|Ineligible|2|||
27812011|NCT00217672|54268004|FG001|Allocation|Ineligible|0|||
27812012|NCT00217672|54268003|FG000|Treatment|disease progression|33|||
27812013|NCT00217672|54268004|FG001|Treatment|disease progression|4|||
27812014|NCT00217672|54268003|FG000|Treatment|Adverse Event|18|||
27812015|NCT00217672|54268004|FG001|Treatment|Adverse Event|2|||
27812016|NCT00217672|54268003|FG000|Treatment|reqd treatment not permitted by protocol|6|||
27812017|NCT00217672|54268004|FG001|Treatment|reqd treatment not permitted by protocol|0|||
27812018|NCT00217672|54268003|FG000|Treatment|Physician Decision|6|||
27812019|NCT00217672|54268004|FG001|Treatment|Physician Decision|0|||
27812020|NCT00217672|54268003|FG000|Treatment|insurance issues|1|||
27812021|NCT00217672|54268004|FG001|Treatment|insurance issues|1|||
27812022|NCT00217672|54268003|FG000|Treatment|Death|2|||
27812023|NCT00217672|54268004|FG001|Treatment|Death|0|||
27812024|NCT00217672|54268003|FG000|Treatment|secondary malignancy|1|||
27812025|NCT00217672|54268004|FG001|Treatment|secondary malignancy|0|||
27812026|NCT00217672|54268003|FG000|Follow-up|Withdrawal by Subject|4|||
27812027|NCT00217672|54268004|FG001|Follow-up|Withdrawal by Subject|0|||
27812028|NCT00217672|54268003|FG000|Follow-up|Lost to Follow-up|1|||
27812029|NCT00217672|54268004|FG001|Follow-up|Lost to Follow-up|0|||
27812030|NCT00216736|54268010|FG000|Overall Study|Lost to Follow-up|1|||
27812031|NCT00216736|54268011|FG001|Overall Study|Lost to Follow-up|1|||
27812032|NCT01850030|54268019|FG000|Overall Study|Adverse Event|64|||
27812033|NCT01850030|54268020|FG001|Overall Study|Adverse Event|82|||
27812034|NCT01850030|54268019|FG000|Overall Study|Lack of Efficacy|3|||
27812035|NCT01850030|54268020|FG001|Overall Study|Lack of Efficacy|1|||
27812036|NCT01850030|54268019|FG000|Overall Study|Lost to Follow-up|5|||
27812037|NCT01850030|54268020|FG001|Overall Study|Lost to Follow-up|5|||
27812038|NCT01850030|54268019|FG000|Overall Study|Withdrawal by Subject|3|||
27812039|NCT01850030|54268020|FG001|Overall Study|Withdrawal by Subject|4|||
27812040|NCT01850030|54268019|FG000|Overall Study|Protocol Violation|24|||
27812041|NCT01850030|54268020|FG001|Overall Study|Protocol Violation|28|||
27812042|NCT01850030|54268019|FG000|Overall Study|pregnancy not confirmed at visit 4|248|||
27812043|NCT01850030|54268020|FG001|Overall Study|pregnancy not confirmed at visit 4|249|||
27812044|NCT00215644|54268028|FG000|Overall Study|Disease Progression|28|||
27812045|NCT00215644|54268029|FG001|Overall Study|Disease Progression|10|||
27812046|NCT00215644|54268028|FG000|Overall Study|Adverse Event|2|||
27812047|NCT00215644|54268029|FG001|Overall Study|Adverse Event|9|||
27812048|NCT00215644|54268028|FG000|Overall Study|Death|1|||
27812049|NCT00215644|54268029|FG001|Overall Study|Death|2|||
27812050|NCT00215644|54268028|FG000|Overall Study|Withdrawal by Subject|1|||
28048636|NCT00289198|54706551|FG000|Overall Study|Other: Unable to attend on schedule|2|||
28048637|NCT00289198|54706552|FG001|Overall Study|Other: Unable to attend on schedule|1|||
28048638|NCT00289198|54706551|FG000|Overall Study|Other: Miscalculation of the visit date|21|||
28048639|NCT00289198|54706552|FG001|Overall Study|Other: Miscalculation of the visit date|22|||
27812051|NCT00215644|54268029|FG001|Overall Study|Withdrawal by Subject|0|||
27812052|NCT00215644|54268028|FG000|Overall Study|Other|3|||
27812053|NCT00215644|54268029|FG001|Overall Study|Other|15|||
27812054|NCT00215644|54268028|FG000|Overall Study|Randomized but Not Treated|1|||
27812055|NCT00215644|54268029|FG001|Overall Study|Randomized but Not Treated|0|||
27812056|NCT01870401|54268037|FG000|Overall Study|Death|48|||
27812057|NCT01870401|54268038|FG001|Overall Study|Death|24|||
27939909|NCT02853370|54596252|FG000|Overall Study|Lack of Efficacy|2|||
28048640|NCT00289198|54706551|FG000|Overall Study|Other: Impossible to come on visit|0|||
27812058|NCT01870401|54268037|FG000|Overall Study|Withdrawal by Subject|39|||
28048641|NCT00289198|54706552|FG001|Overall Study|Other: Impossible to come on visit|1|||
28048642|NCT00363051|54706561|FG000|Overall Study|Adminstrative problems|1|||
28048643|NCT00363051|54706562|FG001|Overall Study|Adminstrative problems|1|||
28048644|NCT00363051|54706561|FG000|Overall Study|Adverse Event|21|||
28048645|NCT00363051|54706562|FG001|Overall Study|Adverse Event|12|||
28048646|NCT00363051|54706561|FG000|Overall Study|New Cancer Therapy|2|||
28048647|NCT00363051|54706562|FG001|Overall Study|New Cancer Therapy|1|||
28048648|NCT00363051|54706561|FG000|Overall Study|Withdrawal by Subject|11|||
28048649|NCT00363051|54706562|FG001|Overall Study|Withdrawal by Subject|3|||
28048650|NCT00363051|54706561|FG000|Overall Study|Lost to Follow-up|0|||
28048651|NCT00363051|54706562|FG001|Overall Study|Lost to Follow-up|1|||
28048652|NCT00363051|54706561|FG000|Overall Study|Protocol Violation|0|||
28048653|NCT00363051|54706562|FG001|Overall Study|Protocol Violation|2|||
28048654|NCT00363051|54706561|FG000|Overall Study|Death|3|||
28048655|NCT00363051|54706562|FG001|Overall Study|Death|2|||
28048656|NCT00379353|54706572|FG000|Overall Study|Hospitalization|3|||
28048657|NCT00379353|54706573|FG001|Overall Study|Hospitalization|3|||
28048658|NCT00379353|54706572|FG000|Overall Study|Withdrawal by Subject|5|||
28048659|NCT00379353|54706573|FG001|Overall Study|Withdrawal by Subject|2|||
28048660|NCT00379353|54706572|FG000|Overall Study|Death|1|||
28048661|NCT00379353|54706573|FG001|Overall Study|Death|0|||
28048662|NCT00379353|54706572|FG000|Overall Study|Cardiac Tamponade|1|||
28048663|NCT00379353|54706573|FG001|Overall Study|Cardiac Tamponade|0|||
28048664|NCT00379353|54706572|FG000|Overall Study|Non-compliance|1|||
28048665|NCT00379353|54706573|FG001|Overall Study|Non-compliance|0|||
28048666|NCT00379353|54706572|FG000|Overall Study|Conflicting drug treatment|0|||
28048667|NCT00379353|54706573|FG001|Overall Study|Conflicting drug treatment|1|||
28048668|NCT00378573|54706589|FG000|Treatment Period|Adverse Event|9|||
28048669|NCT00378573|54706589|FG000|Treatment Period|Physician Decision|1|||
28048670|NCT00378573|54706589|FG000|Treatment Period|Withdrawal by Subject|2|||
28048671|NCT00378573|54706589|FG000|Treatment Period|Disease Progression|4|||
28048672|NCT00378573|54706589|FG000|Treatment Period|Sponsor decision to close study|1|||
28048673|NCT00378573|54706589|FG000|Follow-up|Death|12|||
28048674|NCT00378573|54706589|FG000|Follow-up|Lost to Follow-up|1|||
28048675|NCT00378573|54706589|FG000|Follow-up|Withdrawal by Subject|1|||
28048676|NCT03831945|54706595|FG000|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
28048677|NCT03831945|54706596|FG001|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
28048678|NCT03831945|54706595|FG000|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
28048679|NCT03831945|54706596|FG001|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
28048680|NCT03831945|54706595|FG000|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|2|||
28048681|NCT03831945|54706596|FG001|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|1|||
28048682|NCT00457002|54706604|FG000|Overall Study|Death|40|||
28048683|NCT00457002|54706605|FG001|Overall Study|Death|47|||
28048684|NCT00457002|54706604|FG000|Overall Study|Adverse Event|284|||
28048685|NCT00457002|54706605|FG001|Overall Study|Adverse Event|260|||
28048686|NCT00457002|54706604|FG000|Overall Study|Withdrawal by Subject|299|||
28048687|NCT00457002|54706605|FG001|Overall Study|Withdrawal by Subject|271|||
28048688|NCT00457002|54706604|FG000|Overall Study|Lost to Follow-up|72|||
28048689|NCT00457002|54706605|FG001|Overall Study|Lost to Follow-up|71|||
28048690|NCT00457002|54706604|FG000|Overall Study|Poor/Non-compliance|46|||
28048691|NCT00457002|54706605|FG001|Overall Study|Poor/Non-compliance|33|||
28048692|NCT00457002|54706604|FG000|Overall Study|No longer met criteria|41|||
28048693|NCT00457002|54706605|FG001|Overall Study|No longer met criteria|37|||
28048694|NCT00457002|54706604|FG000|Overall Study|Administrative reason by Sponsor|1|||
28048695|NCT00457002|54706605|FG001|Overall Study|Administrative reason by Sponsor|0|||
27812059|NCT01870401|54268038|FG001|Overall Study|Withdrawal by Subject|26|||
27812060|NCT01870401|54268037|FG000|Overall Study|Lost to Follow-up|19|||
27812061|NCT01870401|54268038|FG001|Overall Study|Lost to Follow-up|14|||
27812062|NCT01870401|54268037|FG000|Overall Study|Other|9|||
27812063|NCT01870401|54268038|FG001|Overall Study|Other|7|||
27812064|NCT01870401|54268037|FG000|Overall Study|On-going in the Study|35|||
27812065|NCT01870401|54268038|FG001|Overall Study|On-going in the Study|25|||
27812066|NCT00213148|54268050|FG000|Cycle 1 (1 Month)|Lost to Follow-up|1|||
28048696|NCT00457002|54706604|FG000|Overall Study|non-specified|29|||
28048697|NCT00457002|54706605|FG001|Overall Study|non-specified|38|||
28048698|NCT00457002|54706604|FG000|Overall Study|treated for 1 day; missing status/reason|1|||
28048699|NCT00457002|54706605|FG001|Overall Study|treated for 1 day; missing status/reason|0|||
28048700|NCT00362115|54706618|FG000|Overall Study|Adverse Event|0|||
27812067|NCT00213148|54268051|FG001|Cycle 1 (1 Month)|Lost to Follow-up|0|||
27812068|NCT00213148|54268052|FG002|Cycle 1 (1 Month)|Lost to Follow-up|2|||
27812069|NCT00213148|54268053|FG003|Cycle 1 (1 Month)|Lost to Follow-up|2|||
27812070|NCT00213148|54268054|FG004|Cycle 1 (1 Month)|Lost to Follow-up|1|||
27812071|NCT00213148|54268050|FG000|Cycle 1 (1 Month)|Adverse Event|0|||
28048701|NCT00362115|54706619|FG001|Overall Study|Adverse Event|1|||
28048702|NCT00362115|54706620|FG002|Overall Study|Adverse Event|1|||
28048703|NCT00362115|54706621|FG003|Overall Study|Adverse Event|1|||
28048704|NCT00362115|54706622|FG004|Overall Study|Adverse Event|2|||
28048705|NCT00362115|54706623|FG005|Overall Study|Adverse Event|2|||
28048706|NCT00362115|54706624|FG006|Overall Study|Adverse Event|1|||
28048707|NCT00362115|54706618|FG000|Overall Study|Protocol Violation|0|||
28048708|NCT00362115|54706619|FG001|Overall Study|Protocol Violation|0|||
28048709|NCT00362115|54706620|FG002|Overall Study|Protocol Violation|0|||
28048710|NCT00362115|54706621|FG003|Overall Study|Protocol Violation|0|||
28048711|NCT00362115|54706622|FG004|Overall Study|Protocol Violation|0|||
28048712|NCT00362115|54706623|FG005|Overall Study|Protocol Violation|1|||
28048713|NCT00362115|54706624|FG006|Overall Study|Protocol Violation|0|||
28048714|NCT00362115|54706618|FG000|Overall Study|Lost to Follow-up|0|||
28048715|NCT00362115|54706619|FG001|Overall Study|Lost to Follow-up|1|||
28048716|NCT00362115|54706620|FG002|Overall Study|Lost to Follow-up|0|||
28048717|NCT00362115|54706621|FG003|Overall Study|Lost to Follow-up|0|||
28048718|NCT00362115|54706622|FG004|Overall Study|Lost to Follow-up|2|||
28048719|NCT00362115|54706623|FG005|Overall Study|Lost to Follow-up|0|||
28048720|NCT00362115|54706624|FG006|Overall Study|Lost to Follow-up|1|||
28048721|NCT00362115|54706618|FG000|Overall Study|Withdrawal by Subject|1|||
28048722|NCT00362115|54706619|FG001|Overall Study|Withdrawal by Subject|3|||
28048723|NCT00362115|54706620|FG002|Overall Study|Withdrawal by Subject|1|||
28048724|NCT00362115|54706621|FG003|Overall Study|Withdrawal by Subject|0|||
28048725|NCT00362115|54706622|FG004|Overall Study|Withdrawal by Subject|1|||
28048726|NCT00362115|54706623|FG005|Overall Study|Withdrawal by Subject|3|||
28048727|NCT00362115|54706624|FG006|Overall Study|Withdrawal by Subject|4|||
28048728|NCT00362115|54706618|FG000|Overall Study|Lack of Efficacy|1|||
28048729|NCT00362115|54706619|FG001|Overall Study|Lack of Efficacy|0|||
28048730|NCT00362115|54706620|FG002|Overall Study|Lack of Efficacy|5|||
28048731|NCT00362115|54706621|FG003|Overall Study|Lack of Efficacy|2|||
28048732|NCT00362115|54706622|FG004|Overall Study|Lack of Efficacy|2|||
28048733|NCT00362115|54706623|FG005|Overall Study|Lack of Efficacy|0|||
28048734|NCT00362115|54706624|FG006|Overall Study|Lack of Efficacy|3|||
28048735|NCT00362115|54706618|FG000|Overall Study|Physician Decision|0|||
28048736|NCT00362115|54706619|FG001|Overall Study|Physician Decision|0|||
28048737|NCT00362115|54706620|FG002|Overall Study|Physician Decision|0|||
28048738|NCT00362115|54706621|FG003|Overall Study|Physician Decision|0|||
28048739|NCT00362115|54706622|FG004|Overall Study|Physician Decision|0|||
28048740|NCT00362115|54706623|FG005|Overall Study|Physician Decision|0|||
28048741|NCT00362115|54706624|FG006|Overall Study|Physician Decision|3|||
28048742|NCT00362115|54706618|FG000|Overall Study|Other|0|||
28048743|NCT00362115|54706619|FG001|Overall Study|Other|1|||
28048744|NCT00362115|54706620|FG002|Overall Study|Other|0|||
28048745|NCT00362115|54706621|FG003|Overall Study|Other|1|||
28048746|NCT00362115|54706622|FG004|Overall Study|Other|0|||
28048747|NCT00362115|54706623|FG005|Overall Study|Other|1|||
28048748|NCT00362115|54706624|FG006|Overall Study|Other|0|||
28048749|NCT00485264|54706646|FG000|Overall Study|Enrolled But Not Given Treatment|0|||
28048750|NCT00485264|54706647|FG001|Overall Study|Enrolled But Not Given Treatment|0|||
28048751|NCT00485264|54706648|FG002|Overall Study|Enrolled But Not Given Treatment|0|||
28048752|NCT00485264|54706649|FG003|Overall Study|Enrolled But Not Given Treatment|0|||
28048753|NCT00485264|54706650|FG004|Overall Study|Enrolled But Not Given Treatment|1|||
28048754|NCT00485264|54706651|FG005|Overall Study|Enrolled But Not Given Treatment|0|||
28048755|NCT00485264|54706646|FG000|Overall Study|Death|1|||
28048756|NCT00485264|54706647|FG001|Overall Study|Death|0|||
28048757|NCT00485264|54706648|FG002|Overall Study|Death|0|||
28048758|NCT00485264|54706649|FG003|Overall Study|Death|0|||
28048759|NCT00485264|54706650|FG004|Overall Study|Death|1|||
28048760|NCT00485264|54706651|FG005|Overall Study|Death|0|||
28048761|NCT00485264|54706646|FG000|Overall Study|Adverse Event|1|||
28048762|NCT00485264|54706647|FG001|Overall Study|Adverse Event|0|||
28048763|NCT00485264|54706648|FG002|Overall Study|Adverse Event|2|||
28048764|NCT00485264|54706649|FG003|Overall Study|Adverse Event|3|||
28048765|NCT00485264|54706650|FG004|Overall Study|Adverse Event|1|||
28048766|NCT00485264|54706651|FG005|Overall Study|Adverse Event|3|||
28048767|NCT00485264|54706646|FG000|Overall Study|Pregnancy|4|||
28048768|NCT00485264|54706647|FG001|Overall Study|Pregnancy|0|||
28048769|NCT00485264|54706648|FG002|Overall Study|Pregnancy|0|||
28048770|NCT00485264|54706649|FG003|Overall Study|Pregnancy|0|||
28048771|NCT00485264|54706650|FG004|Overall Study|Pregnancy|0|||
28048772|NCT00485264|54706651|FG005|Overall Study|Pregnancy|0|||
28048773|NCT00485264|54706646|FG000|Overall Study|Disallowed Medication|0|||
28048774|NCT00485264|54706647|FG001|Overall Study|Disallowed Medication|0|||
28048775|NCT00485264|54706648|FG002|Overall Study|Disallowed Medication|0|||
28048776|NCT00485264|54706649|FG003|Overall Study|Disallowed Medication|0|||
28048777|NCT00485264|54706650|FG004|Overall Study|Disallowed Medication|0|||
28048778|NCT00485264|54706651|FG005|Overall Study|Disallowed Medication|1|||
28048779|NCT00485264|54706646|FG000|Overall Study|Number/Volume/Timing of Study Meds|2|||
28048780|NCT00485264|54706647|FG001|Overall Study|Number/Volume/Timing of Study Meds|1|||
28048781|NCT00485264|54706648|FG002|Overall Study|Number/Volume/Timing of Study Meds|1|||
28048782|NCT00485264|54706649|FG003|Overall Study|Number/Volume/Timing of Study Meds|0|||
28048783|NCT00485264|54706650|FG004|Overall Study|Number/Volume/Timing of Study Meds|0|||
28048784|NCT00485264|54706651|FG005|Overall Study|Number/Volume/Timing of Study Meds|0|||
28048785|NCT00485264|54706646|FG000|Overall Study|Lack of Efficacy|0|||
28048786|NCT00485264|54706647|FG001|Overall Study|Lack of Efficacy|1|||
28048787|NCT00485264|54706648|FG002|Overall Study|Lack of Efficacy|0|||
28048788|NCT00485264|54706649|FG003|Overall Study|Lack of Efficacy|0|||
28048789|NCT00485264|54706650|FG004|Overall Study|Lack of Efficacy|0|||
28048790|NCT00485264|54706651|FG005|Overall Study|Lack of Efficacy|0|||
28048791|NCT00485264|54706646|FG000|Overall Study|Guardian Consent Withdrawn|1|||
28048792|NCT00485264|54706647|FG001|Overall Study|Guardian Consent Withdrawn|0|||
28048793|NCT00485264|54706648|FG002|Overall Study|Guardian Consent Withdrawn|0|||
28048794|NCT00485264|54706649|FG003|Overall Study|Guardian Consent Withdrawn|0|||
28048795|NCT00485264|54706650|FG004|Overall Study|Guardian Consent Withdrawn|1|||
28048796|NCT00485264|54706651|FG005|Overall Study|Guardian Consent Withdrawn|0|||
28048797|NCT00485264|54706646|FG000|Overall Study|Physician Decision|0|||
28048798|NCT00485264|54706647|FG001|Overall Study|Physician Decision|2|||
28048799|NCT00485264|54706648|FG002|Overall Study|Physician Decision|0|||
28048800|NCT00485264|54706649|FG003|Overall Study|Physician Decision|0|||
28048801|NCT00485264|54706650|FG004|Overall Study|Physician Decision|0|||
28048802|NCT00485264|54706651|FG005|Overall Study|Physician Decision|0|||
28048803|NCT00485264|54706646|FG000|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
28048804|NCT00485264|54706647|FG001|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
28048805|NCT00485264|54706648|FG002|Overall Study|Intolerance/Unable to Tolerate Dose|1|||
28048806|NCT00485264|54706649|FG003|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
28048807|NCT00485264|54706650|FG004|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
28048808|NCT00485264|54706651|FG005|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
28048809|NCT00485264|54706646|FG000|Overall Study|Not Able to Attend Clinic|5|||
28048810|NCT00485264|54706647|FG001|Overall Study|Not Able to Attend Clinic|0|||
28048811|NCT00485264|54706648|FG002|Overall Study|Not Able to Attend Clinic|0|||
28048812|NCT00485264|54706649|FG003|Overall Study|Not Able to Attend Clinic|1|||
28048813|NCT00485264|54706650|FG004|Overall Study|Not Able to Attend Clinic|1|||
28048814|NCT00485264|54706651|FG005|Overall Study|Not Able to Attend Clinic|2|||
28048815|NCT00485264|54706646|FG000|Overall Study|Non-Compliant|17|||
28048816|NCT00485264|54706647|FG001|Overall Study|Non-Compliant|2|||
28048817|NCT00485264|54706648|FG002|Overall Study|Non-Compliant|1|||
28048818|NCT00485264|54706649|FG003|Overall Study|Non-Compliant|0|||
28048819|NCT00485264|54706650|FG004|Overall Study|Non-Compliant|1|||
28048820|NCT00485264|54706651|FG005|Overall Study|Non-Compliant|0|||
28048821|NCT00485264|54706646|FG000|Overall Study|Lost to Follow-up|2|||
28048822|NCT00485264|54706647|FG001|Overall Study|Lost to Follow-up|1|||
28048823|NCT00485264|54706648|FG002|Overall Study|Lost to Follow-up|1|||
28048824|NCT00485264|54706649|FG003|Overall Study|Lost to Follow-up|0|||
28048825|NCT00485264|54706650|FG004|Overall Study|Lost to Follow-up|0|||
27812072|NCT00213148|54268051|FG001|Cycle 1 (1 Month)|Adverse Event|0|||
27812073|NCT00213148|54268052|FG002|Cycle 1 (1 Month)|Adverse Event|1|||
27812074|NCT00213148|54268053|FG003|Cycle 1 (1 Month)|Adverse Event|0|||
27812075|NCT00213148|54268054|FG004|Cycle 1 (1 Month)|Adverse Event|0|||
27812076|NCT00213148|54268050|FG000|Cycle 1 (1 Month)|Lack of Efficacy|4|||
27812077|NCT00213148|54268051|FG001|Cycle 1 (1 Month)|Lack of Efficacy|0|||
27812078|NCT00213148|54268052|FG002|Cycle 1 (1 Month)|Lack of Efficacy|8|||
27812079|NCT00213148|54268053|FG003|Cycle 1 (1 Month)|Lack of Efficacy|5|||
27812080|NCT00213148|54268054|FG004|Cycle 1 (1 Month)|Lack of Efficacy|8|||
27812081|NCT00213148|54268050|FG000|Cycle 1 (1 Month)|Protocol Violation|1|||
27812082|NCT00213148|54268051|FG001|Cycle 1 (1 Month)|Protocol Violation|0|||
27812083|NCT00213148|54268052|FG002|Cycle 1 (1 Month)|Protocol Violation|1|||
28048826|NCT00485264|54706651|FG005|Overall Study|Lost to Follow-up|1|||
28048827|NCT00485264|54706646|FG000|Overall Study|Other Reason|3|||
28048828|NCT00485264|54706647|FG001|Overall Study|Other Reason|0|||
28048829|NCT00485264|54706648|FG002|Overall Study|Other Reason|0|||
28048830|NCT00485264|54706649|FG003|Overall Study|Other Reason|0|||
28048831|NCT00485264|54706650|FG004|Overall Study|Other Reason|0|||
27812084|NCT00213148|54268053|FG003|Cycle 1 (1 Month)|Protocol Violation|0|||
27848158|NCT00985153|54341064|FG001|Overall Study|Withdrawal by Subject|11|||
28048832|NCT00485264|54706651|FG005|Overall Study|Other Reason|0|||
28048833|NCT00293254|54706672|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
28048834|NCT00293254|54706673|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
28048835|NCT00293254|54706672|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|2|||
28048836|NCT00293254|54706673|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
28048837|NCT00293254|54706672|FG000|Primary Study - Double-Blind Week 0-48|Death|5|||
27812085|NCT00213148|54268054|FG004|Cycle 1 (1 Month)|Protocol Violation|0|||
28048838|NCT00293254|54706673|FG001|Primary Study - Double-Blind Week 0-48|Death|2|||
28048839|NCT00293254|54706672|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
28048840|NCT00293254|54706673|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
28048841|NCT00293254|54706672|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3|||
28048842|NCT00293254|54706673|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
28048843|NCT00293254|54706672|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5|||
28048844|NCT00293254|54706673|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
28048845|NCT00293254|54706672|FG000|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1|||
28048846|NCT00293254|54706673|FG001|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0|||
28048847|NCT00293254|54706672|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35|||
28048848|NCT00293254|54706673|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57|||
28048849|NCT00293254|54706672|FG000|Extension - Double-Blind Week 49-156|Adverse Event|4|||
28048850|NCT00293254|54706673|FG001|Extension - Double-Blind Week 49-156|Adverse Event|1|||
28048851|NCT00293254|54706672|FG000|Extension - Double-Blind Week 49-156|Death|4|||
28048852|NCT00293254|54706673|FG001|Extension - Double-Blind Week 49-156|Death|1|||
28048853|NCT00293254|54706672|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|3|||
28048854|NCT00293254|54706673|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|4|||
28048855|NCT00293254|54706672|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
28048856|NCT00293254|54706673|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
28048857|NCT00293254|54706672|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12|||
28048858|NCT00293254|54706673|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8|||
28048859|NCT00293254|54706672|FG000|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6|||
28048860|NCT00293254|54706673|FG001|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3|||
28048861|NCT00293254|54706672|FG000|Extension - Double-Blind Week 49-156|Other Reason|10|||
28048862|NCT00293254|54706673|FG001|Extension - Double-Blind Week 49-156|Other Reason|2|||
28048863|NCT00293254|54706672|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
28048864|NCT00293254|54706673|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7|||
28048865|NCT00293254|54706672|FG000|Extension - Open-Label Week 157-240|Adverse Event|2|||
28048866|NCT00293254|54706673|FG001|Extension - Open-Label Week 157-240|Adverse Event|1|||
28048867|NCT00293254|54706672|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|1|||
28048868|NCT00293254|54706673|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
28048869|NCT00293254|54706672|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
28048870|NCT00293254|54706673|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|0|||
28048871|NCT00293254|54706672|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|2|||
28048872|NCT00293254|54706673|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
28048873|NCT00293254|54706672|FG000|Extension - Open-Label Week 157-240|Other Reason|4|||
28048874|NCT00293254|54706673|FG001|Extension - Open-Label Week 157-240|Other Reason|0|||
28048875|NCT00293254|54706672|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|4|||
28048876|NCT00293254|54706673|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|7|||
28048877|NCT00293254|54706672|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16|||
28048878|NCT00293254|54706673|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14|||
28048879|NCT00293254|54706672|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6|||
28048880|NCT00293254|54706673|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3|||
28048881|NCT00293254|54706672|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3|||
28048882|NCT00293254|54706673|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0|||
28048883|NCT00293254|54706672|FG000|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
28048884|NCT00293254|54706673|FG001|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
28048885|NCT00293254|54706672|FG000|Open-Label Post Virologic Failure Phase|Other Reason|1|||
28048886|NCT00293254|54706673|FG001|Open-Label Post Virologic Failure Phase|Other Reason|2|||
28048887|NCT00456846|54706687|FG000|Overall Study|Adverse Event|2|||
28048888|NCT00456846|54706688|FG001|Overall Study|Adverse Event|15|||
28048889|NCT00456846|54706687|FG000|Overall Study|Physician Decision|11|||
28048890|NCT00456846|54706688|FG001|Overall Study|Physician Decision|6|||
28048891|NCT00456846|54706687|FG000|Overall Study|Protocol Deviation|2|||
28048892|NCT00456846|54706688|FG001|Overall Study|Protocol Deviation|0|||
28048893|NCT00456846|54706687|FG000|Overall Study|Participant Discretion|1|||
28048894|NCT00456846|54706688|FG001|Overall Study|Participant Discretion|5|||
28048895|NCT00456846|54706687|FG000|Overall Study|Other|0|||
28048896|NCT00456846|54706688|FG001|Overall Study|Other|2|||
28048897|NCT00448344|54706696|FG000|Overall Study|Lost to Follow-up|20|||
27939910|NCT02853370|54596252|FG000|Overall Study|Death|1|||
28048898|NCT00448344|54706697|FG001|Overall Study|Lost to Follow-up|22|||
27939911|NCT02853370|54596252|FG000|Overall Study|Adverse Event|4|||
28048899|NCT00448344|54706696|FG000|Overall Study|Withdrawal by Subject|6|||
28048900|NCT00448344|54706697|FG001|Overall Study|Withdrawal by Subject|8|||
28048901|NCT00448344|54706696|FG000|Overall Study|Death|3|||
27939912|NCT02853370|54596252|FG000|Overall Study|Withdrawal by Subject|3|||
27939913|NCT01879072|54596257|FG000|Overall Study|Withdrawal by Subject|121|||
28048902|NCT00448344|54706697|FG001|Overall Study|Death|4|||
28048903|NCT00448344|54706696|FG000|Overall Study|Physician Decision|1|||
28048904|NCT00448344|54706697|FG001|Overall Study|Physician Decision|2|||
28048905|NCT00484094|54706703|FG000|Overall Study|Discontinued|39|||
28048906|NCT00484094|54706703|FG000|Overall Study|Other|3|||
28048907|NCT00447876|54706709|FG000|Overall Study|Withdrawal by Subject|1|||
28048908|NCT00447876|54706710|FG001|Overall Study|Withdrawal by Subject|4|||
28048909|NCT00447876|54706709|FG000|Overall Study|Lost to Follow-up|1|||
28048910|NCT00447876|54706710|FG001|Overall Study|Lost to Follow-up|0|||
28048911|NCT00447876|54706709|FG000|Overall Study|Deterioration of symptomology|1|||
28048912|NCT00447876|54706710|FG001|Overall Study|Deterioration of symptomology|0|||
28048913|NCT00456612|54706716|FG000|Overall Study|Withdrawal by Subject|3|||
28048914|NCT00456300|54706721|FG000|Overall Study|Adverse Event|1|||
28048915|NCT00456300|54706722|FG001|Overall Study|Adverse Event|0|||
28048916|NCT00267748|54706733|FG000|Non-randomized Period|Progressive disease|10|||
28048917|NCT00267748|54706734|FG001|Non-randomized Period|Progressive disease|0|||
28048918|NCT00267748|54706735|FG002|Non-randomized Period|Progressive disease|0|||
28048919|NCT00267748|54706733|FG000|Non-randomized Period|Adverse Event|8|||
28048920|NCT00267748|54706734|FG001|Non-randomized Period|Adverse Event|0|||
28048921|NCT00267748|54706735|FG002|Non-randomized Period|Adverse Event|0|||
28048922|NCT00267748|54706733|FG000|Non-randomized Period|Death|1|||
28048923|NCT00267748|54706734|FG001|Non-randomized Period|Death|0|||
28048924|NCT00267748|54706735|FG002|Non-randomized Period|Death|0|||
28048925|NCT00267748|54706733|FG000|Non-randomized Period|Participant not willing to participate|1|||
28048926|NCT00267748|54706734|FG001|Non-randomized Period|Participant not willing to participate|0|||
28048927|NCT00267748|54706735|FG002|Non-randomized Period|Participant not willing to participate|0|||
28048928|NCT00267748|54706733|FG000|Non-randomized Period|Other|3|||
28048929|NCT00267748|54706734|FG001|Non-randomized Period|Other|0|||
28048930|NCT00267748|54706735|FG002|Non-randomized Period|Other|0|||
28048931|NCT00267748|54706733|FG000|Randomized Period|Death|0|||
28048932|NCT00267748|54706734|FG001|Randomized Period|Death|2|||
28048933|NCT00267748|54706735|FG002|Randomized Period|Death|3|||
28048934|NCT00267748|54706733|FG000|Randomized Period|Adverse Event|0|||
28048935|NCT00267748|54706734|FG001|Randomized Period|Adverse Event|23|||
28048936|NCT00267748|54706735|FG002|Randomized Period|Adverse Event|25|||
28048937|NCT00267748|54706733|FG000|Randomized Period|Global deterioration of health status|0|||
28048938|NCT00267748|54706734|FG001|Randomized Period|Global deterioration of health status|6|||
28048939|NCT00267748|54706735|FG002|Randomized Period|Global deterioration of health status|7|||
28048940|NCT00267748|54706733|FG000|Randomized Period|Lost to Follow-up|0|||
28048941|NCT00267748|54706734|FG001|Randomized Period|Lost to Follow-up|1|||
28048942|NCT00267748|54706735|FG002|Randomized Period|Lost to Follow-up|0|||
28048943|NCT00267748|54706733|FG000|Randomized Period|Objective progression or relapse|0|||
28048944|NCT00267748|54706734|FG001|Randomized Period|Objective progression or relapse|77|||
28048945|NCT00267748|54706735|FG002|Randomized Period|Objective progression or relapse|86|||
28048946|NCT00267748|54706733|FG000|Randomized Period|Withdrawal by Subject|0|||
28048947|NCT00267748|54706734|FG001|Randomized Period|Withdrawal by Subject|9|||
28048948|NCT00267748|54706735|FG002|Randomized Period|Withdrawal by Subject|2|||
28048949|NCT00267748|54706733|FG000|Randomized Period|Other|0|||
28048950|NCT00267748|54706734|FG001|Randomized Period|Other|9|||
28048951|NCT00267748|54706735|FG002|Randomized Period|Other|6|||
28048952|NCT00267748|54706733|FG000|Randomized Period|randomized but not treated|0|||
28048953|NCT00267748|54706734|FG001|Randomized Period|randomized but not treated|0|||
28048954|NCT00267748|54706735|FG002|Randomized Period|randomized but not treated|3|||
28048955|NCT00267202|54706744|FG000|Overall Study|Unsatisfactory therapeutic effect|21|||
28048956|NCT00267202|54706745|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
28048957|NCT00267202|54706744|FG000|Overall Study|Withdrawal by Subject|12|||
28048958|NCT00267202|54706745|FG001|Overall Study|Withdrawal by Subject|15|||
28048959|NCT00267202|54706744|FG000|Overall Study|Adverse Event|13|||
28048960|NCT00267202|54706745|FG001|Overall Study|Adverse Event|7|||
28048961|NCT00267202|54706744|FG000|Overall Study|Protocol Violation|2|||
28048962|NCT00267202|54706745|FG001|Overall Study|Protocol Violation|3|||
28048963|NCT00267202|54706744|FG000|Overall Study|Administrative problems|2|||
28048964|NCT00267202|54706745|FG001|Overall Study|Administrative problems|1|||
28048965|NCT00267202|54706744|FG000|Overall Study|Lost to Follow-up|3|||
28048966|NCT00267202|54706745|FG001|Overall Study|Lost to Follow-up|0|||
28048967|NCT00267046|54706754|FG000|Overall Study|Disease progression|4|||
28048968|NCT00267046|54706755|FG001|Overall Study|Disease progression|2|||
28048969|NCT00267046|54706754|FG000|Overall Study|Chemotoxicity|2|||
28048970|NCT00267046|54706755|FG001|Overall Study|Chemotoxicity|0|||
28048971|NCT00267046|54706754|FG000|Overall Study|Open-label palifermin|2|||
28048972|NCT00267046|54706755|FG001|Overall Study|Open-label palifermin|7|||
27939914|NCT01879072|54596257|FG000|Overall Study|Not Transplanted|30|||
28048973|NCT00267046|54706754|FG000|Overall Study|Surgery|3|||
28048974|NCT00267046|54706755|FG001|Overall Study|Surgery|1|||
28048975|NCT00267046|54706754|FG000|Overall Study|Withdrawal by Subject|1|||
28048976|NCT00267046|54706755|FG001|Overall Study|Withdrawal by Subject|0|||
28048977|NCT00267046|54706754|FG000|Overall Study|Radiation|0|||
28048978|NCT00267046|54706755|FG001|Overall Study|Radiation|1|||
28048979|NCT00441090|54706766|FG000|Overall Study|Adverse Event|0|||
28048980|NCT00441090|54706767|FG001|Overall Study|Adverse Event|1|||
28048981|NCT00441090|54706768|FG002|Overall Study|Adverse Event|1|||
28048982|NCT00441090|54706769|FG003|Overall Study|Adverse Event|0|||
28048983|NCT00441090|54706770|FG004|Overall Study|Adverse Event|0|||
28048984|NCT00441090|54706766|FG000|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
28048985|NCT00441090|54706767|FG001|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
28048986|NCT00441090|54706768|FG002|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
28048987|NCT00441090|54706769|FG003|Overall Study|Platelet increase;more than 500,000 mm^3|2|||
28048988|NCT00441090|54706770|FG004|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
28048989|NCT00441090|54706766|FG000|Overall Study|Withdrawal by Subject|1|||
28048990|NCT00441090|54706767|FG001|Overall Study|Withdrawal by Subject|0|||
28048991|NCT00441090|54706768|FG002|Overall Study|Withdrawal by Subject|1|||
28048992|NCT00441090|54706769|FG003|Overall Study|Withdrawal by Subject|0|||
28048993|NCT00441090|54706770|FG004|Overall Study|Withdrawal by Subject|0|||
28048994|NCT00441090|54706766|FG000|Overall Study|Lack of Efficacy|1|||
28048995|NCT00441090|54706767|FG001|Overall Study|Lack of Efficacy|0|||
28048996|NCT00441090|54706768|FG002|Overall Study|Lack of Efficacy|0|||
28048997|NCT00441090|54706769|FG003|Overall Study|Lack of Efficacy|0|||
28048998|NCT00441090|54706770|FG004|Overall Study|Lack of Efficacy|0|||
28048999|NCT00441012|54706784|FG000|Overall Study|Adverse Event|0|||
28049000|NCT00441012|54706785|FG001|Overall Study|Adverse Event|1|||
28049001|NCT00441012|54706784|FG000|Overall Study|Lost to Follow-up|3|||
28049002|NCT00441012|54706785|FG001|Overall Study|Lost to Follow-up|3|||
28049003|NCT00441012|54706784|FG000|Overall Study|Protocol Violation|10|||
28049004|NCT00441012|54706785|FG001|Overall Study|Protocol Violation|9|||
28049005|NCT00441012|54706784|FG000|Overall Study|Withdrawal by Subject|4|||
28049006|NCT00441012|54706785|FG001|Overall Study|Withdrawal by Subject|0|||
28049007|NCT00441012|54706784|FG000|Overall Study|Subject Randomized but Not Vaccinated|1|||
28049008|NCT00441012|54706785|FG001|Overall Study|Subject Randomized but Not Vaccinated|0|||
28049009|NCT00286468|54706794|FG000|Overall Study|Hyperglycemic Rescue|28|||
28049010|NCT00286468|54706795|FG001|Overall Study|Hyperglycemic Rescue|30|||
28049011|NCT00286468|54706796|FG002|Overall Study|Hyperglycemic Rescue|31|||
28049012|NCT00286468|54706794|FG000|Overall Study|Adverse Event|2|||
28049013|NCT00286468|54706795|FG001|Overall Study|Adverse Event|6|||
28049014|NCT00286468|54706796|FG002|Overall Study|Adverse Event|4|||
28049015|NCT00286468|54706794|FG000|Overall Study|Protocol Violation|0|||
28049016|NCT00286468|54706795|FG001|Overall Study|Protocol Violation|3|||
28049017|NCT00286468|54706796|FG002|Overall Study|Protocol Violation|1|||
28049018|NCT00286468|54706794|FG000|Overall Study|Lost to Follow-up|1|||
28049019|NCT00286468|54706795|FG001|Overall Study|Lost to Follow-up|1|||
28049020|NCT00286468|54706796|FG002|Overall Study|Lost to Follow-up|2|||
28049021|NCT00286468|54706794|FG000|Overall Study|Withdrawal by Subject|3|||
28049022|NCT00286468|54706795|FG001|Overall Study|Withdrawal by Subject|8|||
28049023|NCT00286468|54706796|FG002|Overall Study|Withdrawal by Subject|11|||
28049024|NCT00286468|54706794|FG000|Overall Study|Physician Decision|3|||
28049025|NCT00286468|54706795|FG001|Overall Study|Physician Decision|2|||
28049026|NCT00286468|54706796|FG002|Overall Study|Physician Decision|1|||
28049027|NCT00507026|54706807|FG000|Overall Study|Lack of Efficacy|6|||
28049028|NCT00507026|54706808|FG001|Overall Study|Lack of Efficacy|4|||
28049029|NCT00507026|54706809|FG002|Overall Study|Lack of Efficacy|21|||
27848159|NCT00985153|54341065|FG002|Overall Study|Withdrawal by Subject|11|||
27848160|NCT00985153|54341066|FG003|Overall Study|Withdrawal by Subject|10|||
27848161|NCT00985153|54341063|FG000|Overall Study|Missed One or More Bleeds|7|||
27848162|NCT00985153|54341064|FG001|Overall Study|Missed One or More Bleeds|7|||
27848163|NCT00985153|54341065|FG002|Overall Study|Missed One or More Bleeds|8|||
27848164|NCT00985153|54341066|FG003|Overall Study|Missed One or More Bleeds|10|||
27848165|NCT00985153|54341063|FG000|Overall Study|Incomplete Safety Follow-up|3|||
27848166|NCT00985153|54341064|FG001|Overall Study|Incomplete Safety Follow-up|5|||
28049030|NCT00507026|54706807|FG000|Overall Study|Withdrawal by Subject|2|||
28049031|NCT00507026|54706808|FG001|Overall Study|Withdrawal by Subject|0|||
27848167|NCT00985153|54341065|FG002|Overall Study|Incomplete Safety Follow-up|4|||
27848168|NCT00985153|54341066|FG003|Overall Study|Incomplete Safety Follow-up|4|||
27848169|NCT01047345|54341078|FG000|Base Study|Adverse Event|3|||
28049032|NCT00507026|54706809|FG002|Overall Study|Withdrawal by Subject|0|||
28049033|NCT00507026|54706807|FG000|Overall Study|Investigator Decision|1|||
28049034|NCT00507026|54706808|FG001|Overall Study|Investigator Decision|0|||
28049035|NCT00507026|54706809|FG002|Overall Study|Investigator Decision|0|||
28049036|NCT00507026|54706807|FG000|Overall Study|Adverse Event|2|||
28049037|NCT00507026|54706808|FG001|Overall Study|Adverse Event|0|||
28049038|NCT00507026|54706809|FG002|Overall Study|Adverse Event|0|||
28049039|NCT00507026|54706807|FG000|Overall Study|Protocol Violation|1|||
28049040|NCT00507026|54706808|FG001|Overall Study|Protocol Violation|0|||
28049041|NCT00507026|54706809|FG002|Overall Study|Protocol Violation|0|||
28049042|NCT00507026|54706807|FG000|Overall Study|Other|1|||
28049043|NCT00507026|54706808|FG001|Overall Study|Other|0|||
28049044|NCT00507026|54706809|FG002|Overall Study|Other|0|||
28049045|NCT00446550|54706819|FG000|Overall Study|Adverse Event|1|||
28049046|NCT00446550|54706820|FG001|Overall Study|Adverse Event|0|||
28049047|NCT03847974|54706827|FG000|Overall Study|relocated out of region|3|||
28049048|NCT03847974|54706827|FG000|Overall Study|Withdrawal by Subject|2|||
28049049|NCT03847974|54706827|FG000|Overall Study|Adverse Event|1|||
28049050|NCT00506948|54706831|FG000|Overall Study|Death|4|||
28049051|NCT00506948|54706831|FG000|Overall Study|Adverse Event|5|||
28049052|NCT00506948|54706831|FG000|Overall Study|Physician Decision|1|||
28049053|NCT00286234|54706839|FG000|Overall Study|Protocol Violation|1|||
28049054|NCT00286234|54706840|FG001|Overall Study|Protocol Violation|2|||
28049055|NCT00286234|54706841|FG002|Overall Study|Protocol Violation|0|||
28049056|NCT00286234|54706842|FG003|Overall Study|Protocol Violation|1|||
28049057|NCT00286234|54706839|FG000|Overall Study|Physician Decision|1|||
28049058|NCT00286234|54706840|FG001|Overall Study|Physician Decision|0|||
28049059|NCT00286234|54706841|FG002|Overall Study|Physician Decision|0|||
28049060|NCT00286234|54706842|FG003|Overall Study|Physician Decision|1|||
28049061|NCT00286234|54706839|FG000|Overall Study|Adverse Event|0|||
28049062|NCT00286234|54706840|FG001|Overall Study|Adverse Event|0|||
28049063|NCT00286234|54706841|FG002|Overall Study|Adverse Event|0|||
28049064|NCT00286234|54706842|FG003|Overall Study|Adverse Event|1|||
28049065|NCT00286234|54706839|FG000|Overall Study|Adverse Event|0|||
28049066|NCT00286234|54706840|FG001|Overall Study|Adverse Event|0|||
28049067|NCT00286234|54706841|FG002|Overall Study|Adverse Event|0|||
28049068|NCT00286234|54706842|FG003|Overall Study|Adverse Event|1|||
28049069|NCT00445848|54706852|FG000|Overall Study|Adverse Event|14|||
28049070|NCT00445848|54706852|FG000|Overall Study|Withdrawal by Subject|4|||
28049071|NCT00445848|54706852|FG000|Overall Study|Progression|62|||
28049072|NCT00445848|54706852|FG000|Overall Study|Other-Not protocol specified|5|||
28049073|NCT00286156|54706859|FG000|Overall Study|Missed 12 month visit|0|||
28049074|NCT00286156|54706860|FG001|Overall Study|Missed 12 month visit|0|||
28049075|NCT00286156|54706861|FG002|Overall Study|Missed 12 month visit|1|||
28049076|NCT00286156|54706859|FG000|Overall Study|AE: pulmonary embolus|0|||
28049077|NCT00286156|54706860|FG001|Overall Study|AE: pulmonary embolus|1|||
28049078|NCT00286156|54706861|FG002|Overall Study|AE: pulmonary embolus|0|||
28049079|NCT00286156|54706859|FG000|Overall Study|AE: nephrotic-range proteinuruia|1|||
28049080|NCT00286156|54706860|FG001|Overall Study|AE: nephrotic-range proteinuruia|0|||
28049081|NCT00286156|54706861|FG002|Overall Study|AE: nephrotic-range proteinuruia|0|||
28049082|NCT00286156|54706859|FG000|Overall Study|AE: pneumonia|1|||
28049083|NCT00286156|54706860|FG001|Overall Study|AE: pneumonia|0|||
28049084|NCT00286156|54706861|FG002|Overall Study|AE: pneumonia|0|||
28049085|NCT00455520|54706871|FG000|Open Label Tapentadol Extended Release|Withdrawal by Subject|24|||
28049086|NCT00455520|54706872|FG001|Open Label Tapentadol Extended Release|Withdrawal by Subject|0|||
28049087|NCT00455520|54706871|FG000|Open Label Tapentadol Extended Release|Lost to Follow-up|3|||
28049088|NCT00455520|54706872|FG001|Open Label Tapentadol Extended Release|Lost to Follow-up|0|||
28049089|NCT00455520|54706871|FG000|Open Label Tapentadol Extended Release|Adverse Event|100|||
28049090|NCT00455520|54706872|FG001|Open Label Tapentadol Extended Release|Adverse Event|0|||
28049091|NCT00455520|54706871|FG000|Open Label Tapentadol Extended Release|Lack of Efficacy|23|||
28049092|NCT00455520|54706872|FG001|Open Label Tapentadol Extended Release|Lack of Efficacy|0|||
28049093|NCT00455520|54706871|FG000|Open Label Tapentadol Extended Release|Study drug non-compliant|13|||
28049094|NCT00455520|54706872|FG001|Open Label Tapentadol Extended Release|Study drug non-compliant|0|||
28049095|NCT00455520|54706871|FG000|Open Label Tapentadol Extended Release|All other|33|||
28049096|NCT00455520|54706872|FG001|Open Label Tapentadol Extended Release|All other|0|||
28049097|NCT00455520|54706871|FG000|Double Blind Tapentadol ER vs Placebo|Adverse Event|29|||
28049098|NCT00455520|54706872|FG001|Double Blind Tapentadol ER vs Placebo|Adverse Event|15|||
28049099|NCT00455520|54706871|FG000|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8|||
28049100|NCT00455520|54706872|FG001|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29|||
28049101|NCT00455520|54706871|FG000|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15|||
28049102|NCT00455520|54706872|FG001|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7|||
28049103|NCT00455520|54706871|FG000|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
28049104|NCT00455520|54706872|FG001|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
28049105|NCT00455520|54706871|FG000|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4|||
28049106|NCT00455520|54706872|FG001|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2|||
27812086|NCT00213148|54268050|FG000|Cycle 1 (1 Month)|Other|3|||
27812087|NCT00213148|54268051|FG001|Cycle 1 (1 Month)|Other|0|||
28049107|NCT00455520|54706871|FG000|Double Blind Tapentadol ER vs Placebo|All other|4|||
28049108|NCT00455520|54706872|FG001|Double Blind Tapentadol ER vs Placebo|All other|6|||
28049109|NCT00440700|54706881|FG000|Overall Study|Withdrawal by Subject|8|||
28049110|NCT00440700|54706882|FG001|Overall Study|Withdrawal by Subject|8|||
28049111|NCT00440700|54706883|FG002|Overall Study|Withdrawal by Subject|4|||
28049112|NCT00284050|54706894|FG000|Overall Study|Adverse Event|1|||
27812088|NCT00213148|54268052|FG002|Cycle 1 (1 Month)|Other|2|||
28049113|NCT00284050|54706895|FG001|Overall Study|Adverse Event|1|||
28049114|NCT00284050|54706896|FG002|Overall Study|Adverse Event|1|||
28049115|NCT00284050|54706894|FG000|Overall Study|Lack of Efficacy|0|||
28049116|NCT00284050|54706895|FG001|Overall Study|Lack of Efficacy|1|||
28049117|NCT00284050|54706896|FG002|Overall Study|Lack of Efficacy|3|||
28049118|NCT00284050|54706894|FG000|Overall Study|Protocol Violation|0|||
28049119|NCT00284050|54706895|FG001|Overall Study|Protocol Violation|1|||
28049120|NCT00284050|54706896|FG002|Overall Study|Protocol Violation|2|||
28049121|NCT00284050|54706894|FG000|Overall Study|Withdrawal by Subject|2|||
28049122|NCT00284050|54706895|FG001|Overall Study|Withdrawal by Subject|2|||
28049123|NCT00284050|54706896|FG002|Overall Study|Withdrawal by Subject|2|||
28049124|NCT00284050|54706894|FG000|Overall Study|Lost to Follow-up|1|||
28049125|NCT00284050|54706895|FG001|Overall Study|Lost to Follow-up|0|||
28049126|NCT00284050|54706896|FG002|Overall Study|Lost to Follow-up|1|||
28049127|NCT00284050|54706894|FG000|Overall Study|Death|1|||
28049128|NCT00284050|54706895|FG001|Overall Study|Death|0|||
28049129|NCT00284050|54706896|FG002|Overall Study|Death|0|||
28049130|NCT00293020|54706904|FG000|Overall Study|Withdrawal by Subject|34|||
28049131|NCT00293020|54706904|FG000|Overall Study|Adverse Event|30|||
28049132|NCT00293020|54706904|FG000|Overall Study|Death|32|||
28049133|NCT00293020|54706904|FG000|Overall Study|Lack of Efficacy|12|||
28049134|NCT00293020|54706904|FG000|Overall Study|Lost to Follow-up|4|||
28049135|NCT00293020|54706904|FG000|Overall Study|Protocol Violation|6|||
28049136|NCT00293020|54706904|FG000|Overall Study|Physician Decision|21|||
28049137|NCT00293020|54706904|FG000|Overall Study|Other Reason|22|||
28049138|NCT00293020|54706904|FG000|Overall Study|No dose taken|1|||
28049139|NCT00377637|54706912|FG000|Induction Phase|Adverse Event|12|||
28049140|NCT00377637|54706913|FG001|Induction Phase|Adverse Event|21|||
28049141|NCT00377637|54706914|FG002|Induction Phase|Adverse Event|0|||
28049142|NCT00377637|54706915|FG003|Induction Phase|Adverse Event|0|||
28049143|NCT00377637|54706912|FG000|Induction Phase|Deterioration/serum creatinine|2|||
28049144|NCT00377637|54706913|FG001|Induction Phase|Deterioration/serum creatinine|0|||
28049145|NCT00377637|54706914|FG002|Induction Phase|Deterioration/serum creatinine|0|||
28049146|NCT00377637|54706915|FG003|Induction Phase|Deterioration/serum creatinine|0|||
28049147|NCT00377637|54706912|FG000|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
28049148|NCT00377637|54706913|FG001|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1|||
28049149|NCT00377637|54706914|FG002|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
28049150|NCT00377637|54706915|FG003|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
28049151|NCT00377637|54706912|FG000|Induction Phase|Lost to Follow-up|2|||
28049152|NCT00377637|54706913|FG001|Induction Phase|Lost to Follow-up|1|||
28049153|NCT00377637|54706914|FG002|Induction Phase|Lost to Follow-up|0|||
28049154|NCT00377637|54706915|FG003|Induction Phase|Lost to Follow-up|0|||
28049155|NCT00377637|54706912|FG000|Induction Phase|Death|1|||
28049156|NCT00377637|54706913|FG001|Induction Phase|Death|3|||
28049157|NCT00377637|54706914|FG002|Induction Phase|Death|0|||
28049158|NCT00377637|54706915|FG003|Induction Phase|Death|0|||
28049159|NCT00377637|54706912|FG000|Induction Phase|Withdrawal by Subject|5|||
28049160|NCT00377637|54706913|FG001|Induction Phase|Withdrawal by Subject|6|||
28049161|NCT00377637|54706914|FG002|Induction Phase|Withdrawal by Subject|0|||
28049162|NCT00377637|54706915|FG003|Induction Phase|Withdrawal by Subject|0|||
28049163|NCT00377637|54706912|FG000|Induction Phase|Physician Decision|3|||
28049164|NCT00377637|54706913|FG001|Induction Phase|Physician Decision|1|||
28049165|NCT00377637|54706914|FG002|Induction Phase|Physician Decision|0|||
28049166|NCT00377637|54706915|FG003|Induction Phase|Physician Decision|0|||
28049167|NCT00377637|54706912|FG000|Induction Phase|Sponsor decision|1|||
28049168|NCT00377637|54706913|FG001|Induction Phase|Sponsor decision|2|||
28049169|NCT00377637|54706914|FG002|Induction Phase|Sponsor decision|0|||
28049170|NCT00377637|54706915|FG003|Induction Phase|Sponsor decision|0|||
28049171|NCT00377637|54706912|FG000|Induction Phase|Non-Compliance|1|||
28049172|NCT00377637|54706913|FG001|Induction Phase|Non-Compliance|0|||
28049173|NCT00377637|54706914|FG002|Induction Phase|Non-Compliance|0|||
28049174|NCT00377637|54706915|FG003|Induction Phase|Non-Compliance|0|||
28049175|NCT00377637|54706912|FG000|Induction Phase|Reason for withdrawal is not noted|2|||
28049176|NCT00377637|54706913|FG001|Induction Phase|Reason for withdrawal is not noted|0|||
28049177|NCT00377637|54706914|FG002|Induction Phase|Reason for withdrawal is not noted|0|||
28049178|NCT00377637|54706915|FG003|Induction Phase|Reason for withdrawal is not noted|0|||
28049179|NCT00377637|54706912|FG000|Maintenance Phase|Adverse Event|0|||
28049180|NCT00377637|54706913|FG001|Maintenance Phase|Adverse Event|0|||
28049181|NCT00377637|54706914|FG002|Maintenance Phase|Adverse Event|29|||
28049182|NCT00377637|54706915|FG003|Maintenance Phase|Adverse Event|43|||
28049183|NCT00377637|54706912|FG000|Maintenance Phase|Physician Decision|0|||
28049184|NCT00377637|54706913|FG001|Maintenance Phase|Physician Decision|0|||
28049185|NCT00377637|54706914|FG002|Maintenance Phase|Physician Decision|5|||
28049186|NCT00377637|54706915|FG003|Maintenance Phase|Physician Decision|4|||
28049187|NCT00377637|54706912|FG000|Maintenance Phase|Lost to Follow-up|0|||
28049188|NCT00377637|54706913|FG001|Maintenance Phase|Lost to Follow-up|0|||
28049189|NCT00377637|54706914|FG002|Maintenance Phase|Lost to Follow-up|3|||
28049190|NCT00377637|54706915|FG003|Maintenance Phase|Lost to Follow-up|1|||
28049191|NCT00377637|54706912|FG000|Maintenance Phase|Withdrawal by Subject|0|||
28049192|NCT00377637|54706913|FG001|Maintenance Phase|Withdrawal by Subject|0|||
28049193|NCT00377637|54706914|FG002|Maintenance Phase|Withdrawal by Subject|3|||
28049194|NCT00377637|54706915|FG003|Maintenance Phase|Withdrawal by Subject|3|||
28049195|NCT00377637|54706912|FG000|Maintenance Phase|Sponsor decision|0|||
28049196|NCT00377637|54706913|FG001|Maintenance Phase|Sponsor decision|0|||
28049197|NCT00377637|54706914|FG002|Maintenance Phase|Sponsor decision|2|||
28049198|NCT00377637|54706915|FG003|Maintenance Phase|Sponsor decision|3|||
28049199|NCT00377637|54706912|FG000|Maintenance Phase|Non-compliance|0|||
28049200|NCT00377637|54706913|FG001|Maintenance Phase|Non-compliance|0|||
28049201|NCT00377637|54706914|FG002|Maintenance Phase|Non-compliance|1|||
28049202|NCT00377637|54706915|FG003|Maintenance Phase|Non-compliance|1|||
28049203|NCT00377637|54706912|FG000|Maintenance Phase|Study medication stopped > 14 days|0|||
28049204|NCT00377637|54706913|FG001|Maintenance Phase|Study medication stopped > 14 days|0|||
28049205|NCT00377637|54706914|FG002|Maintenance Phase|Study medication stopped > 14 days|0|||
28049206|NCT00377637|54706915|FG003|Maintenance Phase|Study medication stopped > 14 days|1|||
28049207|NCT00377637|54706912|FG000|Maintenance Phase|Death|0|||
28049208|NCT00377637|54706913|FG001|Maintenance Phase|Death|0|||
28049209|NCT00377637|54706914|FG002|Maintenance Phase|Death|0|||
28049210|NCT00377637|54706915|FG003|Maintenance Phase|Death|1|||
28049211|NCT00377403|54706931|FG000|Overall Study|Unable to contact for telephone intervie|4|||
28049212|NCT00377403|54706932|FG001|Overall Study|Unable to contact for telephone intervie|7|||
28049213|NCT00370149|54706940|FG000|Overall Study|Physician Decision|16|||
28049214|NCT00370149|54706941|FG001|Overall Study|Physician Decision|16|||
28049215|NCT00370149|54706940|FG000|Overall Study|Protocol Violation|1|||
28049216|NCT00370149|54706941|FG001|Overall Study|Protocol Violation|0|||
28049217|NCT00370149|54706940|FG000|Overall Study|Catheter inserted in wrong vessel-|2|||
28049218|NCT00370149|54706941|FG001|Overall Study|Catheter inserted in wrong vessel-|1|||
28049219|NCT00370149|54706940|FG000|Overall Study|Pre-existing infection|0|||
28049220|NCT00370149|54706941|FG001|Overall Study|Pre-existing infection|1|||
28049221|NCT00370149|54706940|FG000|Overall Study|Antibiotic coated dressing placed|0|||
28049222|NCT00370149|54706941|FG001|Overall Study|Antibiotic coated dressing placed|1|||
28049223|NCT00292942|54706954|FG000|Overall Study|Withdrawal by Subject|0|||
28049224|NCT00292942|54706955|FG001|Overall Study|Withdrawal by Subject|0|||
28049225|NCT00292942|54706956|FG002|Overall Study|Withdrawal by Subject|1|||
28049226|NCT00292942|54706957|FG003|Overall Study|Withdrawal by Subject|0|||
28049227|NCT00292942|54706954|FG000|Overall Study|Adverse Event|0|||
28049228|NCT00292942|54706955|FG001|Overall Study|Adverse Event|0|||
28049229|NCT00292942|54706956|FG002|Overall Study|Adverse Event|0|||
28049230|NCT00292942|54706957|FG003|Overall Study|Adverse Event|1|||
28049231|NCT00483938|54706977|FG000|Overall Study|Protocol Violation|0|||
28049232|NCT00483938|54706978|FG001|Overall Study|Protocol Violation|0|||
28049233|NCT00483938|54706979|FG002|Overall Study|Protocol Violation|0|||
28049234|NCT00483938|54706980|FG003|Overall Study|Protocol Violation|0|||
28049235|NCT00483938|54706981|FG004|Overall Study|Protocol Violation|0|||
28049236|NCT00483938|54706982|FG005|Overall Study|Protocol Violation|0|||
28049237|NCT00483938|54706983|FG006|Overall Study|Protocol Violation|3|||
28049238|NCT00483938|54706977|FG000|Overall Study|Withdrawal by Subject|1|||
28049239|NCT00483938|54706978|FG001|Overall Study|Withdrawal by Subject|6|||
28049240|NCT00483938|54706979|FG002|Overall Study|Withdrawal by Subject|0|||
28049241|NCT00483938|54706980|FG003|Overall Study|Withdrawal by Subject|0|||
28049242|NCT00483938|54706981|FG004|Overall Study|Withdrawal by Subject|1|||
28049243|NCT00483938|54706982|FG005|Overall Study|Withdrawal by Subject|3|||
28049244|NCT00483938|54706983|FG006|Overall Study|Withdrawal by Subject|2|||
28049245|NCT00483938|54706977|FG000|Overall Study|Lost to Follow-up|1|||
28049246|NCT00483938|54706978|FG001|Overall Study|Lost to Follow-up|2|||
28049247|NCT00483938|54706979|FG002|Overall Study|Lost to Follow-up|0|||
28049248|NCT00483938|54706980|FG003|Overall Study|Lost to Follow-up|2|||
28049249|NCT00483938|54706981|FG004|Overall Study|Lost to Follow-up|1|||
28049250|NCT00483938|54706982|FG005|Overall Study|Lost to Follow-up|1|||
28049251|NCT00483938|54706983|FG006|Overall Study|Lost to Follow-up|3|||
28049252|NCT00483938|54706977|FG000|Overall Study|Death|0|||
28049253|NCT00483938|54706978|FG001|Overall Study|Death|2|||
28049254|NCT00483938|54706979|FG002|Overall Study|Death|0|||
28049255|NCT00483938|54706980|FG003|Overall Study|Death|0|||
28049256|NCT00483938|54706981|FG004|Overall Study|Death|0|||
28049257|NCT00483938|54706982|FG005|Overall Study|Death|0|||
28049258|NCT00483938|54706983|FG006|Overall Study|Death|0|||
28049259|NCT00483938|54706977|FG000|Overall Study|Other|3|||
27939915|NCT00954538|54596263|FG000|Part III|Withdrawal by Subject|0|||
28049260|NCT00483938|54706978|FG001|Overall Study|Other|9|||
28049261|NCT00483938|54706979|FG002|Overall Study|Other|0|||
28049262|NCT00483938|54706980|FG003|Overall Study|Other|4|||
28049263|NCT00483938|54706981|FG004|Overall Study|Other|0|||
28049264|NCT00483938|54706982|FG005|Overall Study|Other|4|||
28049265|NCT00483938|54706983|FG006|Overall Study|Other|32|||
28049266|NCT00370071|54707002|FG000|Overall Study|Withdrawal by Subject|2|||
28049267|NCT00369915|54707008|FG000|Overall Study|expected side effects|2|||
28049268|NCT00369915|54707009|FG001|Overall Study|expected side effects|1|||
28049269|NCT00369915|54707008|FG000|Overall Study|Withdrawal by Subject|4|||
28049270|NCT00369915|54707009|FG001|Overall Study|Withdrawal by Subject|1|||
28049271|NCT00369915|54707008|FG000|Overall Study|W/drawl by investigators|0|||
28049272|NCT00369915|54707009|FG001|Overall Study|W/drawl by investigators|1|||
28049273|NCT00369681|54707015|FG000|Overall Study|Death|1|||
28049274|NCT00266812|54707021|FG000|Overall Study|Disease Progression|9|||
28049275|NCT00266812|54707022|FG001|Overall Study|Disease Progression|3|||
28049276|NCT00266812|54707021|FG000|Overall Study|Death|5|||
28049277|NCT00266812|54707022|FG001|Overall Study|Death|4|||
28049278|NCT00266812|54707021|FG000|Overall Study|Adverse Event|3|||
28049279|NCT00266812|54707022|FG001|Overall Study|Adverse Event|1|||
28049280|NCT00266812|54707021|FG000|Overall Study|Protocol Violation|0|||
28049281|NCT00266812|54707022|FG001|Overall Study|Protocol Violation|1|||
28049282|NCT00266812|54707021|FG000|Overall Study|Withdrawal by Subject|0|||
28049283|NCT00266812|54707022|FG001|Overall Study|Withdrawal by Subject|2|||
28049284|NCT00266812|54707021|FG000|Overall Study|Discontinued before starting study drug|4|||
28049285|NCT00266812|54707022|FG001|Overall Study|Discontinued before starting study drug|0|||
28049286|NCT00488774|54707032|FG000|Overall Study|Withdrawal of consent|2|||
28049287|NCT00488774|54707033|FG001|Overall Study|Withdrawal of consent|2|||
28049288|NCT00488774|54707034|FG002|Overall Study|Withdrawal of consent|2|||
28049289|NCT00488774|54707035|FG003|Overall Study|Withdrawal of consent|0|||
28049290|NCT00488774|54707032|FG000|Overall Study|Other|6|||
28049291|NCT00488774|54707033|FG001|Overall Study|Other|3|||
28049292|NCT00488774|54707034|FG002|Overall Study|Other|2|||
28049293|NCT00488774|54707035|FG003|Overall Study|Other|2|||
28049294|NCT00488774|54707032|FG000|Overall Study|Lost to Follow-up|0|||
28049295|NCT00488774|54707033|FG001|Overall Study|Lost to Follow-up|0|||
28049296|NCT00488774|54707034|FG002|Overall Study|Lost to Follow-up|1|||
28049297|NCT00488774|54707035|FG003|Overall Study|Lost to Follow-up|1|||
28049298|NCT00361569|54707050|FG000|Overall Study|Protocol Violation|3|||
28049299|NCT00361569|54707051|FG001|Overall Study|Protocol Violation|2|||
28049300|NCT00361569|54707052|FG002|Overall Study|Protocol Violation|4|||
28049301|NCT00361569|54707053|FG003|Overall Study|Protocol Violation|2|||
28049302|NCT00361569|54707050|FG000|Overall Study|Withdrawal by Subject|2|||
28049303|NCT00361569|54707051|FG001|Overall Study|Withdrawal by Subject|1|||
28049304|NCT00361569|54707052|FG002|Overall Study|Withdrawal by Subject|9|||
28049305|NCT00361569|54707053|FG003|Overall Study|Withdrawal by Subject|14|||
28049306|NCT00361569|54707050|FG000|Overall Study|Adverse Event|3|||
28049307|NCT00361569|54707051|FG001|Overall Study|Adverse Event|5|||
28049308|NCT00361569|54707052|FG002|Overall Study|Adverse Event|2|||
28049309|NCT00361569|54707053|FG003|Overall Study|Adverse Event|2|||
28049310|NCT00361569|54707050|FG000|Overall Study|Lost to Follow-up|2|||
28049311|NCT00361569|54707051|FG001|Overall Study|Lost to Follow-up|3|||
28049312|NCT00361569|54707052|FG002|Overall Study|Lost to Follow-up|3|||
28049313|NCT00361569|54707053|FG003|Overall Study|Lost to Follow-up|2|||
28049314|NCT00361569|54707050|FG000|Overall Study|Not specified by investigator|2|||
28049315|NCT00361569|54707051|FG001|Overall Study|Not specified by investigator|0|||
28049316|NCT00361569|54707052|FG002|Overall Study|Not specified by investigator|0|||
28049317|NCT00361569|54707053|FG003|Overall Study|Not specified by investigator|1|||
28049318|NCT00488618|54707065|FG000|Overall Study|Adverse Event|13|||
28049319|NCT00488618|54707066|FG001|Overall Study|Adverse Event|17|||
28049320|NCT00488618|54707065|FG000|Overall Study|Insufficient Therapeutic Response|18|||
28049321|NCT00488618|54707066|FG001|Overall Study|Insufficient Therapeutic Response|11|||
28049322|NCT00488618|54707065|FG000|Overall Study|Protocol Violation|0|||
28049323|NCT00488618|54707066|FG001|Overall Study|Protocol Violation|2|||
28049324|NCT00488618|54707065|FG000|Overall Study|Withdrawal of Consent|15|||
28049325|NCT00488618|54707066|FG001|Overall Study|Withdrawal of Consent|13|||
28049326|NCT00488618|54707065|FG000|Overall Study|Lost to Follow-up|1|||
28049327|NCT00488618|54707066|FG001|Overall Study|Lost to Follow-up|0|||
28049328|NCT00266656|54707074|FG000|Overall Study|Death|1|||
28049329|NCT00266656|54707075|FG001|Overall Study|Death|0|||
28049330|NCT00266656|54707074|FG000|Overall Study|Lost to Follow-up|4|||
28049331|NCT00266656|54707075|FG001|Overall Study|Lost to Follow-up|1|||
28049332|NCT00266656|54707074|FG000|Overall Study|Withdrawal by Subject|4|||
28049333|NCT00266656|54707075|FG001|Overall Study|Withdrawal by Subject|2|||
28049334|NCT00266656|54707074|FG000|Overall Study|Did Not Reach Final Height|4|||
28049335|NCT00266656|54707075|FG001|Overall Study|Did Not Reach Final Height|8|||
28049336|NCT00266656|54707074|FG000|Overall Study|Parent/Caregiver Decision|1|||
28049337|NCT00266656|54707075|FG001|Overall Study|Parent/Caregiver Decision|2|||
28049338|NCT00483704|54707084|FG000|Randomization|Withdrawal by Subject|19|||
28049339|NCT00483704|54707085|FG001|Randomization|Withdrawal by Subject|28|||
28049340|NCT00483704|54707086|FG002|Randomization|Withdrawal by Subject|18|||
28049341|NCT00483704|54707084|FG000|Randomization|Protocol Violation|14|||
28049342|NCT00483704|54707085|FG001|Randomization|Protocol Violation|25|||
27939916|NCT00954538|54596264|FG001|Part III|Withdrawal by Subject|0|||
28049343|NCT00483704|54707086|FG002|Randomization|Protocol Violation|22|||
28049344|NCT00483704|54707084|FG000|Randomization|Lost to Follow-up|14|||
27939917|NCT00954538|54596265|FG002|Part III|Withdrawal by Subject|0|||
28049345|NCT00483704|54707085|FG001|Randomization|Lost to Follow-up|14|||
28049346|NCT00483704|54707086|FG002|Randomization|Lost to Follow-up|19|||
28049347|NCT00483704|54707084|FG000|Randomization|Pregnancy|1|||
28049348|NCT00483704|54707085|FG001|Randomization|Pregnancy|0|||
28049349|NCT00483704|54707086|FG002|Randomization|Pregnancy|0|||
28049350|NCT00483704|54707084|FG000|Randomization|Physician Decision|2|||
28049351|NCT00483704|54707085|FG001|Randomization|Physician Decision|4|||
28049352|NCT00483704|54707086|FG002|Randomization|Physician Decision|0|||
28049353|NCT00483704|54707084|FG000|Randomization|Progressive disease|0|||
28049354|NCT00483704|54707085|FG001|Randomization|Progressive disease|0|||
28049355|NCT00483704|54707086|FG002|Randomization|Progressive disease|1|||
28049356|NCT00483704|54707084|FG000|Randomization|Lack of qualifying migraines|21|||
28049357|NCT00483704|54707085|FG001|Randomization|Lack of qualifying migraines|25|||
28049358|NCT00483704|54707086|FG002|Randomization|Lack of qualifying migraines|31|||
28049359|NCT00483704|54707084|FG000|Treatment|Lack of qualifying migraines|101|||
28049360|NCT00483704|54707085|FG001|Treatment|Lack of qualifying migraines|99|||
28049361|NCT00483704|54707086|FG002|Treatment|Lack of qualifying migraines|116|||
28049362|NCT00483704|54707084|FG000|Treatment|Adverse Event|3|||
28049363|NCT00483704|54707085|FG001|Treatment|Adverse Event|5|||
28049364|NCT00483704|54707086|FG002|Treatment|Adverse Event|4|||
28049365|NCT00483704|54707084|FG000|Treatment|Withdrawal by Subject|16|||
28049366|NCT00483704|54707085|FG001|Treatment|Withdrawal by Subject|12|||
28049367|NCT00483704|54707086|FG002|Treatment|Withdrawal by Subject|21|||
28049368|NCT00483704|54707084|FG000|Treatment|Protocol Violation|6|||
28049369|NCT00483704|54707085|FG001|Treatment|Protocol Violation|3|||
28049370|NCT00483704|54707086|FG002|Treatment|Protocol Violation|5|||
28049371|NCT00483704|54707084|FG000|Treatment|Lost to Follow-up|2|||
28049372|NCT00483704|54707085|FG001|Treatment|Lost to Follow-up|7|||
28049373|NCT00483704|54707086|FG002|Treatment|Lost to Follow-up|5|||
28049374|NCT00483704|54707084|FG000|Treatment|Lack of Efficacy|1|||
28049375|NCT00483704|54707085|FG001|Treatment|Lack of Efficacy|1|||
28049376|NCT00483704|54707086|FG002|Treatment|Lack of Efficacy|1|||
28049377|NCT00483704|54707084|FG000|Treatment|Pregnancy|0|||
28049378|NCT00483704|54707085|FG001|Treatment|Pregnancy|1|||
28049379|NCT00483704|54707086|FG002|Treatment|Pregnancy|0|||
28049380|NCT00483704|54707084|FG000|Treatment|Physician Decision|0|||
28049381|NCT00483704|54707085|FG001|Treatment|Physician Decision|1|||
28049382|NCT00483704|54707086|FG002|Treatment|Physician Decision|4|||
28049383|NCT00483548|54707099|FG000|Overall Study|Randomized; not treated with study drug|1|||
28049384|NCT00483548|54707100|FG001|Overall Study|Randomized; not treated with study drug|3|||
28049385|NCT00483548|54707099|FG000|Overall Study|Adverse Event|25|||
28049386|NCT00483548|54707100|FG001|Overall Study|Adverse Event|14|||
28049387|NCT00483548|54707099|FG000|Overall Study|Laboratory abnormality|1|||
28049388|NCT00483548|54707100|FG001|Overall Study|Laboratory abnormality|2|||
28049389|NCT00483548|54707099|FG000|Overall Study|Lack of Efficacy|4|||
28049390|NCT00483548|54707100|FG001|Overall Study|Lack of Efficacy|8|||
28049391|NCT00483548|54707099|FG000|Overall Study|Protocol Violation|11|||
28049392|NCT00483548|54707100|FG001|Overall Study|Protocol Violation|7|||
28049393|NCT00483548|54707099|FG000|Overall Study|Pregnancy|1|||
28049394|NCT00483548|54707100|FG001|Overall Study|Pregnancy|0|||
28049395|NCT00483548|54707099|FG000|Overall Study|Protocol required discontinuation|6|||
28049396|NCT00483548|54707100|FG001|Overall Study|Protocol required discontinuation|6|||
28049397|NCT00483548|54707099|FG000|Overall Study|Unable to comply with protocol schedule|1|||
28049398|NCT00483548|54707100|FG001|Overall Study|Unable to comply with protocol schedule|0|||
28049399|NCT00483548|54707099|FG000|Overall Study|Non-compliance with medication|2|||
28049400|NCT00483548|54707100|FG001|Overall Study|Non-compliance with medication|0|||
28049401|NCT00483548|54707099|FG000|Overall Study|Lost to Follow-up|3|||
28049402|NCT00483548|54707100|FG001|Overall Study|Lost to Follow-up|4|||
28049403|NCT00483548|54707099|FG000|Overall Study|Withdrawal by Subject|5|||
28049404|NCT00483548|54707100|FG001|Overall Study|Withdrawal by Subject|2|||
28049405|NCT00445770|54707109|FG000|Overall Study|Adverse Event|9|||
28049406|NCT00445770|54707110|FG001|Overall Study|Adverse Event|15|||
28049407|NCT00445770|54707111|FG002|Overall Study|Adverse Event|19|||
28049408|NCT00445770|54707109|FG000|Overall Study|Lack of Efficacy|38|||
28049409|NCT00445770|54707110|FG001|Overall Study|Lack of Efficacy|13|||
28049410|NCT00445770|54707111|FG002|Overall Study|Lack of Efficacy|6|||
28049411|NCT00445770|54707109|FG000|Overall Study|Lost to Follow-up|0|||
28049412|NCT00445770|54707110|FG001|Overall Study|Lost to Follow-up|2|||
28049413|NCT00445770|54707111|FG002|Overall Study|Lost to Follow-up|0|||
28049414|NCT00445770|54707109|FG000|Overall Study|Other|6|||
28049415|NCT00445770|54707110|FG001|Overall Study|Other|5|||
28049416|NCT00445770|54707111|FG002|Overall Study|Other|6|||
28049417|NCT00266032|54707124|FG000|Treatment|Adverse Event|42|||
28049418|NCT00266032|54707125|FG001|Treatment|Adverse Event|26|||
28049419|NCT00266032|54707126|FG002|Treatment|Adverse Event|10|||
28049420|NCT00266032|54707124|FG000|Treatment|Lost to Follow-up|19|||
28049421|NCT00266032|54707125|FG001|Treatment|Lost to Follow-up|4|||
28049422|NCT00266032|54707126|FG002|Treatment|Lost to Follow-up|2|||
28049423|NCT00266032|54707124|FG000|Treatment|Pregnancy|3|||
28049424|NCT00266032|54707125|FG001|Treatment|Pregnancy|2|||
28049425|NCT00266032|54707126|FG002|Treatment|Pregnancy|2|||
28049426|NCT00266032|54707124|FG000|Treatment|Protocol Violation|6|||
28049427|NCT00266032|54707125|FG001|Treatment|Protocol Violation|14|||
28049428|NCT00266032|54707126|FG002|Treatment|Protocol Violation|13|||
28049429|NCT00266032|54707124|FG000|Treatment|Withdrawal by Subject|28|||
28049430|NCT00266032|54707125|FG001|Treatment|Withdrawal by Subject|13|||
28049431|NCT00266032|54707126|FG002|Treatment|Withdrawal by Subject|12|||
28049432|NCT00266032|54707124|FG000|Treatment|patient moved/wish for pregnancy/no need|13|||
28049433|NCT00266032|54707125|FG001|Treatment|patient moved/wish for pregnancy/no need|5|||
28049434|NCT00266032|54707126|FG002|Treatment|patient moved/wish for pregnancy/no need|8|||
28049435|NCT00266032|54707124|FG000|Open-label Safety Extension|Adverse Event|5|||
28049436|NCT00266032|54707125|FG001|Open-label Safety Extension|Adverse Event|0|||
28049437|NCT00266032|54707126|FG002|Open-label Safety Extension|Adverse Event|4|||
28049438|NCT00266032|54707124|FG000|Open-label Safety Extension|Lost to Follow-up|2|||
28049439|NCT00266032|54707125|FG001|Open-label Safety Extension|Lost to Follow-up|5|||
28049440|NCT00266032|54707126|FG002|Open-label Safety Extension|Lost to Follow-up|4|||
28049441|NCT00266032|54707124|FG000|Open-label Safety Extension|Pregnancy|4|||
28049442|NCT00266032|54707125|FG001|Open-label Safety Extension|Pregnancy|1|||
28049443|NCT00266032|54707126|FG002|Open-label Safety Extension|Pregnancy|2|||
28049444|NCT00266032|54707124|FG000|Open-label Safety Extension|Protocol Violation|1|||
28049445|NCT00266032|54707125|FG001|Open-label Safety Extension|Protocol Violation|3|||
28049446|NCT00266032|54707126|FG002|Open-label Safety Extension|Protocol Violation|2|||
28049447|NCT00266032|54707124|FG000|Open-label Safety Extension|Withdrawal by Subject|19|||
28049448|NCT00266032|54707125|FG001|Open-label Safety Extension|Withdrawal by Subject|3|||
28049449|NCT00266032|54707126|FG002|Open-label Safety Extension|Withdrawal by Subject|12|||
28049450|NCT00266032|54707124|FG000|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10|||
28049451|NCT00266032|54707125|FG001|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2|||
28049452|NCT00266032|54707126|FG002|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1|||
28049453|NCT00483002|54707134|FG000|Overall Study|Adverse Event|68|||
28049454|NCT00483002|54707134|FG000|Overall Study|Lack of Efficacy|555|||
28049455|NCT00483002|54707134|FG000|Overall Study|Lost to Follow-up|962|||
28049456|NCT00483002|54707134|FG000|Overall Study|Other|2|||
28049457|NCT00483002|54707134|FG000|Overall Study|Other|967|||
28049458|NCT00482612|54707142|FG000|In-treatment Period|No study medication administered|0|||
28049459|NCT00482612|54707143|FG001|In-treatment Period|No study medication administered|0|||
28049460|NCT00482612|54707144|FG002|In-treatment Period|No study medication administered|1|||
28049461|NCT00482612|54707145|FG003|In-treatment Period|No study medication administered|0|||
28049462|NCT00482612|54707142|FG000|Follow-up Period|Other|4|||
28049463|NCT00482612|54707143|FG001|Follow-up Period|Other|2|||
28049464|NCT00482612|54707144|FG002|Follow-up Period|Other|1|||
28049465|NCT00482612|54707145|FG003|Follow-up Period|Other|2|||
28049466|NCT00482612|54707142|FG000|Follow-up Period|Lack of compliance|0|||
28049467|NCT00482612|54707143|FG001|Follow-up Period|Lack of compliance|0|||
28049468|NCT00482612|54707144|FG002|Follow-up Period|Lack of compliance|1|||
28049469|NCT00482612|54707145|FG003|Follow-up Period|Lack of compliance|0|||
28049470|NCT00482612|54707142|FG000|Follow-up Period|Lost to Follow-up|0|||
28049471|NCT00482612|54707143|FG001|Follow-up Period|Lost to Follow-up|4|||
28049472|NCT00482612|54707144|FG002|Follow-up Period|Lost to Follow-up|2|||
28049473|NCT00482612|54707145|FG003|Follow-up Period|Lost to Follow-up|1|||
28049474|NCT00482612|54707142|FG000|Follow-up Period|Adverse Event|4|||
28049475|NCT00482612|54707143|FG001|Follow-up Period|Adverse Event|7|||
28049476|NCT00482612|54707144|FG002|Follow-up Period|Adverse Event|9|||
28049477|NCT00482612|54707145|FG003|Follow-up Period|Adverse Event|0|||
28049478|NCT00482612|54707142|FG000|Follow-up Period|Lack of Efficacy|2|||
28049479|NCT00482612|54707143|FG001|Follow-up Period|Lack of Efficacy|0|||
28049480|NCT00482612|54707144|FG002|Follow-up Period|Lack of Efficacy|1|||
28049481|NCT00482612|54707145|FG003|Follow-up Period|Lack of Efficacy|0|||
28049482|NCT00482612|54707142|FG000|Follow-up Period|Withdrawal by Subject|3|||
28049483|NCT00482612|54707143|FG001|Follow-up Period|Withdrawal by Subject|5|||
28049484|NCT00482612|54707144|FG002|Follow-up Period|Withdrawal by Subject|7|||
28049485|NCT00482612|54707145|FG003|Follow-up Period|Withdrawal by Subject|2|||
27812089|NCT00213148|54268053|FG003|Cycle 1 (1 Month)|Other|2|||
27812090|NCT00213148|54268054|FG004|Cycle 1 (1 Month)|Other|7|||
27812091|NCT00213148|54268050|FG000|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
27812092|NCT00213148|54268051|FG001|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
27812093|NCT00213148|54268052|FG002|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
27812094|NCT00213148|54268053|FG003|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1|||
27812095|NCT00213148|54268054|FG004|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
28049486|NCT00482612|54707142|FG000|Follow-up Period|Reasons not related to trial|1|||
28049487|NCT00482612|54707143|FG001|Follow-up Period|Reasons not related to trial|0|||
27812096|NCT00213148|54268050|FG000|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
27939918|NCT00954538|54596266|FG003|Part III|Withdrawal by Subject|0|||
28049488|NCT00482612|54707144|FG002|Follow-up Period|Reasons not related to trial|1|||
27812097|NCT00213148|54268051|FG001|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
28049489|NCT00482612|54707145|FG003|Follow-up Period|Reasons not related to trial|3|||
28049490|NCT00282568|54707159|FG000|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2|||
28049491|NCT00282568|54707159|FG000|Pharmacokinetic Treatment Period|Enrolled erroneously|1|||
28049492|NCT00282568|54707159|FG000|Extended Treatment Period|Adverse Event|17|||
28049493|NCT00282568|54707159|FG000|Extended Treatment Period|Non-compliance|4|||
28049494|NCT00282568|54707159|FG000|Extended Treatment Period|Physician Decision|1|||
28049495|NCT00282568|54707159|FG000|Extended Treatment Period|Lost to Follow-up|2|||
28049496|NCT00265564|54707165|FG000|Overall Study|Lost to Follow-up|5|||
28049497|NCT00265564|54707166|FG001|Overall Study|Lost to Follow-up|7|||
28049498|NCT00265564|54707165|FG000|Overall Study|met exclusion criteria|5|||
28049499|NCT00265564|54707166|FG001|Overall Study|met exclusion criteria|2|||
28049500|NCT00376623|54707175|FG000|Overall Study|Progressive disease|35|||
28049501|NCT00376623|54707176|FG001|Overall Study|Progressive disease|22|||
28049502|NCT00376623|54707177|FG002|Overall Study|Progressive disease|17|||
28049503|NCT00376623|54707175|FG000|Overall Study|Lost to Follow-up|0|||
28049504|NCT00376623|54707176|FG001|Overall Study|Lost to Follow-up|1|||
28049505|NCT00376623|54707177|FG002|Overall Study|Lost to Follow-up|0|||
28049506|NCT00376623|54707175|FG000|Overall Study|Adverse Event other than Dose Limiting Toxicity|6|||
28049507|NCT00376623|54707176|FG001|Overall Study|Adverse Event other than Dose Limiting Toxicity|1|||
28049508|NCT00376623|54707177|FG002|Overall Study|Adverse Event other than Dose Limiting Toxicity|2|||
28049509|NCT00376623|54707175|FG000|Overall Study|Not treated with BI 2536|1|||
28049510|NCT00376623|54707176|FG001|Overall Study|Not treated with BI 2536|0|||
28049511|NCT00376623|54707177|FG002|Overall Study|Not treated with BI 2536|0|||
28049512|NCT00376623|54707175|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
28049513|NCT00376623|54707176|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
28049514|NCT00376623|54707177|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
28049515|NCT00376623|54707175|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|1|||
28049516|NCT00376623|54707176|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
28049517|NCT00376623|54707177|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
28049518|NCT00376623|54707175|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|2|||
28049519|NCT00376623|54707176|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
27812098|NCT00213148|54268052|FG002|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
27812099|NCT00213148|54268053|FG003|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
27812100|NCT00213148|54268054|FG004|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1|||
27812101|NCT00213148|54268050|FG000|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15|||
27812102|NCT00213148|54268051|FG001|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0|||
27812103|NCT00213148|54268052|FG002|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
27812104|NCT00213148|54268053|FG003|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8|||
27812105|NCT00213148|54268054|FG004|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
27812106|NCT00213148|54268050|FG000|Cycle 2 (1 Month)|Lost to Follow-up|0|||
27812107|NCT00213148|54268051|FG001|Cycle 2 (1 Month)|Lost to Follow-up|0|||
27812108|NCT00213148|54268052|FG002|Cycle 2 (1 Month)|Lost to Follow-up|2|||
27812109|NCT00213148|54268053|FG003|Cycle 2 (1 Month)|Lost to Follow-up|2|||
27812110|NCT00213148|54268054|FG004|Cycle 2 (1 Month)|Lost to Follow-up|1|||
27812111|NCT00213148|54268050|FG000|Cycle 2 (1 Month)|Lack of Efficacy|1|||
27812112|NCT00213148|54268051|FG001|Cycle 2 (1 Month)|Lack of Efficacy|3|||
27812113|NCT00213148|54268052|FG002|Cycle 2 (1 Month)|Lack of Efficacy|7|||
27812114|NCT00213148|54268053|FG003|Cycle 2 (1 Month)|Lack of Efficacy|6|||
27812115|NCT00213148|54268054|FG004|Cycle 2 (1 Month)|Lack of Efficacy|16|||
27812116|NCT00213148|54268050|FG000|Cycle 2 (1 Month)|Other|2|||
27812117|NCT00213148|54268051|FG001|Cycle 2 (1 Month)|Other|1|||
27812118|NCT00213148|54268052|FG002|Cycle 2 (1 Month)|Other|2|||
27812119|NCT00213148|54268053|FG003|Cycle 2 (1 Month)|Other|8|||
27812120|NCT00213148|54268054|FG004|Cycle 2 (1 Month)|Other|7|||
27812121|NCT00213148|54268050|FG000|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
27812122|NCT00213148|54268051|FG001|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1|||
27812123|NCT00213148|54268052|FG002|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
27812124|NCT00213148|54268053|FG003|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
27812125|NCT00213148|54268054|FG004|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
27812126|NCT00213148|54268050|FG000|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1|||
27812127|NCT00213148|54268051|FG001|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
27812128|NCT00213148|54268052|FG002|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
27812129|NCT00213148|54268053|FG003|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
27812130|NCT00213148|54268054|FG004|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
27939919|NCT00954538|54596267|FG004|Part III|Withdrawal by Subject|1|||
28049520|NCT00376623|54707177|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
28077011|NCT00094458|54731726|FG004|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
27812131|NCT00213148|54268050|FG000|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10|||
27812132|NCT00213148|54268051|FG001|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1|||
27812133|NCT00213148|54268052|FG002|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
27812134|NCT00213148|54268053|FG003|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
27812135|NCT00213148|54268054|FG004|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6|||
27812136|NCT00213148|54268050|FG000|Cycle 3 (1 Month)|Lost to Follow-up|0|||
27812137|NCT00213148|54268051|FG001|Cycle 3 (1 Month)|Lost to Follow-up|2|||
27812138|NCT00213148|54268052|FG002|Cycle 3 (1 Month)|Lost to Follow-up|0|||
27812139|NCT00213148|54268053|FG003|Cycle 3 (1 Month)|Lost to Follow-up|0|||
27812140|NCT00213148|54268054|FG004|Cycle 3 (1 Month)|Lost to Follow-up|1|||
28049521|NCT00376623|54707175|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
28049522|NCT00376623|54707176|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536|1|||
28049523|NCT00376623|54707177|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
28049524|NCT00376623|54707175|FG000|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
28049525|NCT00376623|54707176|FG001|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
28049526|NCT00376623|54707177|FG002|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
28049527|NCT00376623|54707175|FG000|Overall Study|Participant's decision to stop treatment with BI 2536|2|||
28049528|NCT00376623|54707176|FG001|Overall Study|Participant's decision to stop treatment with BI 2536|0|||
28049529|NCT00376623|54707177|FG002|Overall Study|Participant's decision to stop treatment with BI 2536|1|||
28049530|NCT00376623|54707175|FG000|Overall Study|Increase of tumour markers|0|||
28049531|NCT00376623|54707176|FG001|Overall Study|Increase of tumour markers|1|||
28049532|NCT00376623|54707177|FG002|Overall Study|Increase of tumour markers|0|||
28049533|NCT00376623|54707175|FG000|Overall Study|Bone metastasis|1|||
28049534|NCT00376623|54707176|FG001|Overall Study|Bone metastasis|0|||
28049535|NCT00376623|54707177|FG002|Overall Study|Bone metastasis|0|||
28049536|NCT00445692|54707191|FG000|Overall Study|Adverse Event|11|||
28049537|NCT00445692|54707191|FG000|Overall Study|Lack of Efficacy|5|||
28049538|NCT03824236|54707200|FG000|Overall Study|Lost to Follow-up|0|||
28049539|NCT03824236|54707201|FG001|Overall Study|Lost to Follow-up|0|||
28049540|NCT03824236|54707202|FG002|Overall Study|Lost to Follow-up|1|||
28049541|NCT00282412|54707210|FG000|Overall Study|Death|2|||
28049542|NCT00282334|54707216|FG000|Overall Study|Withdrawal by Subject|8|||
28049543|NCT00282334|54707217|FG001|Overall Study|Withdrawal by Subject|5|||
28049544|NCT00282256|54707223|FG000|Pharmacokinetic Treatment Period|Poor venous access|1|||
28049545|NCT00282256|54707223|FG000|Extension Treatment Period|Adverse Event|2|||
28049546|NCT00265330|54707227|FG000|Overall Study|Adverse Event|41|||
28049547|NCT00265330|54707227|FG000|Overall Study|Lost to Follow-up|8|||
28049548|NCT00265330|54707227|FG000|Overall Study|Withdrawal by Subject|34|||
28049549|NCT00265330|54707227|FG000|Overall Study|Patient Wanted to Start Psychotherapy|1|||
28049550|NCT00265330|54707227|FG000|Overall Study|Lack of Efficacy|4|||
28049551|NCT00265330|54707227|FG000|Overall Study|Family Scheduling Conflicts|1|||
28049552|NCT00265330|54707227|FG000|Overall Study|Began Taking Formulary Geodon|1|||
28049553|NCT00265330|54707227|FG000|Overall Study|Discharged from Unit for Long Term Care|1|||
28049554|NCT00265330|54707227|FG000|Overall Study|Site Closed by Sponsor|1|||
28049555|NCT00265330|54707227|FG000|Overall Study|Principal Investigators Request|1|||
28049556|NCT00265330|54707227|FG000|Overall Study|Withdrew Consent|1|||
28049557|NCT00265330|54707227|FG000|Overall Study|Protocol Violation|1|||
28049558|NCT00292318|54707233|FG000|Overall Study|Study terminated by officials|2|||
28049559|NCT00292318|54707234|FG001|Overall Study|Study terminated by officials|1|||
28049560|NCT00281632|54707240|FG000|Overall Study|Adverse Event|7|||
28049561|NCT00281632|54707240|FG000|Overall Study|Withdrawal by Subject|2|||
28049562|NCT00281632|54707240|FG000|Overall Study|Disease Progression|22|||
28049563|NCT00281632|54707240|FG000|Overall Study|Death|1|||
28049564|NCT00281632|54707240|FG000|Overall Study|Physician Decision|1|||
28049565|NCT00281632|54707240|FG000|Overall Study|Ongoing|3|||
28049566|NCT00543569|54707256|FG000|Overall Study|Death|2|||
28049567|NCT00543569|54707257|FG001|Overall Study|Death|2|||
28049568|NCT00543569|54707258|FG002|Overall Study|Death|3|||
28049569|NCT00543569|54707259|FG003|Overall Study|Death|1|||
28049570|NCT00543569|54707256|FG000|Overall Study|Lost to Follow-up|0|||
28049571|NCT00543569|54707257|FG001|Overall Study|Lost to Follow-up|0|||
28049572|NCT00543569|54707258|FG002|Overall Study|Lost to Follow-up|1|||
28049573|NCT00543569|54707259|FG003|Overall Study|Lost to Follow-up|1|||
28049574|NCT00543569|54707256|FG000|Overall Study|Miscellaneous Reasons|7|||
28049575|NCT00543569|54707257|FG001|Overall Study|Miscellaneous Reasons|3|||
28049576|NCT00543569|54707258|FG002|Overall Study|Miscellaneous Reasons|11|||
28049577|NCT00543569|54707259|FG003|Overall Study|Miscellaneous Reasons|4|||
28049578|NCT00543569|54707256|FG000|Overall Study|Randomized but never received study drug|3|||
27812141|NCT00213148|54268050|FG000|Cycle 3 (1 Month)|Other|0|||
27812142|NCT00213148|54268051|FG001|Cycle 3 (1 Month)|Other|0|||
27812143|NCT00213148|54268052|FG002|Cycle 3 (1 Month)|Other|1|||
28049579|NCT00543569|54707257|FG001|Overall Study|Randomized but never received study drug|3|||
28049580|NCT00543569|54707258|FG002|Overall Study|Randomized but never received study drug|5|||
28049581|NCT00543569|54707259|FG003|Overall Study|Randomized but never received study drug|3|||
28049582|NCT00445458|54707273|FG000|Overall Study|Disease Progression|3|||
28049583|NCT00445458|54707274|FG001|Overall Study|Disease Progression|4|||
28049584|NCT00445458|54707275|FG002|Overall Study|Disease Progression|54|||
28049585|NCT00445458|54707276|FG003|Overall Study|Disease Progression|27|||
28049586|NCT00445458|54707273|FG000|Overall Study|Withdrawal by Subject|0|||
28049587|NCT00445458|54707274|FG001|Overall Study|Withdrawal by Subject|0|||
28049588|NCT00445458|54707275|FG002|Overall Study|Withdrawal by Subject|7|||
28049589|NCT00445458|54707276|FG003|Overall Study|Withdrawal by Subject|0|||
28049590|NCT00445458|54707273|FG000|Overall Study|Adverse Event|0|||
28049591|NCT00445458|54707274|FG001|Overall Study|Adverse Event|0|||
28049592|NCT00445458|54707275|FG002|Overall Study|Adverse Event|3|||
28049593|NCT00445458|54707276|FG003|Overall Study|Adverse Event|0|||
28049594|NCT00445458|54707273|FG000|Overall Study|Death|0|||
28049595|NCT00445458|54707274|FG001|Overall Study|Death|1|||
28049596|NCT00445458|54707275|FG002|Overall Study|Death|2|||
28049597|NCT00445458|54707276|FG003|Overall Study|Death|0|||
28049598|NCT00445458|54707273|FG000|Overall Study|Physician Decision|0|||
28049599|NCT00445458|54707274|FG001|Overall Study|Physician Decision|0|||
28049600|NCT00445458|54707275|FG002|Overall Study|Physician Decision|1|||
28049601|NCT00445458|54707276|FG003|Overall Study|Physician Decision|1|||
28049602|NCT00445458|54707273|FG000|Overall Study|Surgery|0|||
28049603|NCT00445458|54707274|FG001|Overall Study|Surgery|0|||
28049604|NCT00445458|54707275|FG002|Overall Study|Surgery|1|||
28049605|NCT00445458|54707276|FG003|Overall Study|Surgery|0|||
28049606|NCT03914417|54707289|FG000|Overall Study|Withdrawal by Subject|2|||
28049607|NCT00541385|54707295|FG000|Overall Study|Adverse Event|6|||
28049608|NCT00541385|54707296|FG001|Overall Study|Adverse Event|3|||
28049609|NCT00541385|54707295|FG000|Overall Study|Withdrawal by Subject|2|||
28049610|NCT00541385|54707296|FG001|Overall Study|Withdrawal by Subject|2|||
28049611|NCT00541385|54707295|FG000|Overall Study|Lost to Follow-up|6|||
28049612|NCT00541385|54707296|FG001|Overall Study|Lost to Follow-up|1|||
28049613|NCT00541385|54707295|FG000|Overall Study|Parasite reappearance/malaria|67|||
28049614|NCT00541385|54707296|FG001|Overall Study|Parasite reappearance/malaria|32|||
28049615|NCT00265096|54707305|FG000|Overall Study|Adverse Event|14|||
28049616|NCT00265096|54707306|FG001|Overall Study|Adverse Event|18|||
28049617|NCT00265096|54707307|FG002|Overall Study|Adverse Event|18|||
28049618|NCT00265096|54707305|FG000|Overall Study|Lost to Follow-up|2|||
28049619|NCT00265096|54707306|FG001|Overall Study|Lost to Follow-up|5|||
28049620|NCT00265096|54707307|FG002|Overall Study|Lost to Follow-up|3|||
28049621|NCT00265096|54707305|FG000|Overall Study|Death|0|||
28049622|NCT00265096|54707306|FG001|Overall Study|Death|1|||
28049623|NCT00265096|54707307|FG002|Overall Study|Death|2|||
28049624|NCT00265096|54707305|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
28049625|NCT00265096|54707306|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
28049626|NCT00265096|54707307|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
28049627|NCT00265096|54707305|FG000|Overall Study|Other|11|||
28049628|NCT00265096|54707306|FG001|Overall Study|Other|19|||
28049629|NCT00265096|54707307|FG002|Overall Study|Other|10|||
28049630|NCT02201108|54707319|FG000|Double-blind Period (up to Week 96)|Adverse Event|0|||
28049631|NCT02201108|54707320|FG001|Double-blind Period (up to Week 96)|Adverse Event|6|||
28049632|NCT02201108|54707319|FG000|Double-blind Period (up to Week 96)|Lack of Efficacy|2|||
28049633|NCT02201108|54707320|FG001|Double-blind Period (up to Week 96)|Lack of Efficacy|1|||
28049634|NCT02201108|54707319|FG000|Double-blind Period (up to Week 96)|Withdrawal by Subject|2|||
28049635|NCT02201108|54707320|FG001|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
27812144|NCT00213148|54268053|FG003|Cycle 3 (1 Month)|Other|1|||
27812145|NCT00213148|54268054|FG004|Cycle 3 (1 Month)|Other|0|||
27812146|NCT01704261|54268076|FG000|Overall Study|Withdrawal by Subject|12|||
27812147|NCT01704261|54268077|FG001|Overall Study|Withdrawal by Subject|15|||
27812148|NCT01704261|54268076|FG000|Overall Study|Lost to Follow-up|1|||
27812149|NCT01704261|54268077|FG001|Overall Study|Lost to Follow-up|0|||
27812150|NCT01715571|54268083|FG000|Overall Study|Lost to Follow-up|8|||
27812151|NCT00212758|54268087|FG000|Standard Therapy of GH (12 Months)|Adverse Event|1|||
27812152|NCT00212758|54268088|FG001|Standard Therapy of GH (12 Months)|Adverse Event|0|||
27812153|NCT00212758|54268087|FG000|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
27812154|NCT00212758|54268088|FG001|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
27812155|NCT01824290|54268096|FG000|Period 1: Double Blind|Entry Criteria Not Met|1|||
27939920|NCT00954538|54596268|FG005|Part III|Withdrawal by Subject|0|||
27939921|NCT00943852|54596277|FG000|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
28049636|NCT02201108|54707319|FG000|Open Label Period (up to Week 192)|Lack of Efficacy|10|||
28049637|NCT02201108|54707320|FG001|Open Label Period (up to Week 192)|Lack of Efficacy|14|||
28049638|NCT02201108|54707319|FG000|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
28049639|NCT02201108|54707320|FG001|Open Label Period (up to Week 192)|Poor compliance to protocol|1|||
28049640|NCT02201108|54707319|FG000|Open Label Period (up to Week 192)|Other reason|4|||
28049641|NCT02201108|54707320|FG001|Open Label Period (up to Week 192)|Other reason|7|||
28049642|NCT02201108|54707319|FG000|Open Label Period (up to Week 192)|Adverse Event|7|||
28049643|NCT02201108|54707320|FG001|Open Label Period (up to Week 192)|Adverse Event|5|||
27943477|NCT00929110|54600374|FG001|Overall Study|Patient inability to use the device|1|||
27812156|NCT01824290|54268097|FG001|Period 1: Double Blind|Entry Criteria Not Met|0|||
27812157|NCT01824290|54268098|FG002|Period 1: Double Blind|Entry Criteria Not Met|0|||
27812158|NCT01824290|54268099|FG003|Period 1: Double Blind|Entry Criteria Not Met|0|||
27812159|NCT01824290|54268096|FG000|Period 1: Double Blind|Parent/Caregiver Decision|1|||
27812160|NCT01824290|54268097|FG001|Period 1: Double Blind|Parent/Caregiver Decision|1|||
27812161|NCT01824290|54268098|FG002|Period 1: Double Blind|Parent/Caregiver Decision|0|||
27812162|NCT01824290|54268099|FG003|Period 1: Double Blind|Parent/Caregiver Decision|0|||
27812163|NCT01824290|54268096|FG000|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
27812164|NCT01824290|54268097|FG001|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
28049644|NCT00281320|54707341|FG000|Overall Study|Adverse Event|12|||
28049645|NCT00281320|54707342|FG001|Overall Study|Adverse Event|9|||
28049646|NCT00281320|54707341|FG000|Overall Study|Lack of Efficacy|4|||
28049647|NCT00281320|54707342|FG001|Overall Study|Lack of Efficacy|3|||
28049648|NCT00281320|54707341|FG000|Overall Study|Withdrawal by Subject|5|||
28049649|NCT00281320|54707342|FG001|Overall Study|Withdrawal by Subject|6|||
28049650|NCT00281320|54707341|FG000|Overall Study|Lost to Follow-up|1|||
28049651|NCT00281320|54707342|FG001|Overall Study|Lost to Follow-up|2|||
28049652|NCT00281320|54707341|FG000|Overall Study|Other|3|||
28049653|NCT00281320|54707342|FG001|Overall Study|Other|1|||
28049654|NCT00541307|54707354|FG000|Overall Study|Death|5|||
28049655|NCT00541307|54707354|FG000|Overall Study|Physician Decision|3|||
28049656|NCT00541307|54707354|FG000|Overall Study|Withdrawal by Subject|6|||
28049657|NCT00541307|54707354|FG000|Overall Study|Lost to Follow-up|4|||
28049658|NCT00541307|54707354|FG000|Overall Study|Subject returned early (outside window)|1|||
28049659|NCT00541307|54707354|FG000|Overall Study|Surgical Bypass|5|||
28049660|NCT00541229|54707364|FG000|Treatment Period I (Week 1)|Physician Decision|0|||
28049661|NCT00541229|54707365|FG001|Treatment Period I (Week 1)|Physician Decision|0|||
28049662|NCT00541229|54707366|FG002|Treatment Period I (Week 1)|Physician Decision|1|||
28049663|NCT00541229|54707367|FG003|Treatment Period I (Week 1)|Physician Decision|0|||
27812165|NCT01824290|54268098|FG002|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
27812166|NCT01824290|54268099|FG003|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
27812167|NCT01824290|54268096|FG000|Period 2: Open-Label Treatment|Adverse Event|0|||
27812168|NCT01824290|54268097|FG001|Period 2: Open-Label Treatment|Adverse Event|0|||
27812169|NCT01824290|54268098|FG002|Period 2: Open-Label Treatment|Adverse Event|0|||
27812170|NCT01824290|54268099|FG003|Period 2: Open-Label Treatment|Adverse Event|1|||
27812171|NCT01824290|54268096|FG000|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
27812172|NCT01824290|54268097|FG001|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
27812173|NCT01824290|54268098|FG002|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
27812174|NCT01824290|54268099|FG003|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
27812175|NCT01824290|54268096|FG000|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
27812176|NCT01824290|54268097|FG001|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
27812177|NCT01824290|54268098|FG002|Period 2: Open-Label Treatment|Withdrawal by Subject|2|||
28049664|NCT00541229|54707368|FG004|Treatment Period I (Week 1)|Physician Decision|0|||
28049665|NCT00541229|54707369|FG005|Treatment Period I (Week 1)|Physician Decision|0|||
28049666|NCT00541229|54707364|FG000|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
28049667|NCT00541229|54707365|FG001|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
28049668|NCT00541229|54707366|FG002|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
27812178|NCT01824290|54268099|FG003|Period 2: Open-Label Treatment|Withdrawal by Subject|1|||
27812179|NCT01715415|54268113|FG000|Double-blind Treatment|Did Not Receive Study Drug|0|||
27812180|NCT01715415|54268114|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
27812181|NCT01715415|54268113|FG000|Double-blind Treatment|Adverse Event|3|||
27812182|NCT01715415|54268114|FG001|Double-blind Treatment|Adverse Event|0|||
27812183|NCT01715415|54268113|FG000|Double-blind Treatment|Withdrawal by Subject|1|||
27812184|NCT01715415|54268114|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
27812185|NCT01715415|54268113|FG000|Double-blind Treatment|Other|1|||
27812186|NCT01715415|54268114|FG001|Double-blind Treatment|Other|0|||
27812187|NCT01715415|54268113|FG000|Open-label Treatment|Adverse Event|0|||
27812188|NCT01715415|54268114|FG001|Open-label Treatment|Adverse Event|1|||
27812189|NCT01715415|54268113|FG000|Open-label Treatment|Subject Noncompliant|0|||
28049669|NCT00541229|54707367|FG003|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
27812190|NCT01715415|54268114|FG001|Open-label Treatment|Subject Noncompliant|1|||
27812191|NCT00211510|54268123|FG000|Overall Study|Physician Decision|3|||
27812192|NCT00211510|54268124|FG001|Overall Study|Physician Decision|1|||
27812193|NCT00211510|54268123|FG000|Overall Study|Withdrawal by Subject|3|||
27812194|NCT00211510|54268124|FG001|Overall Study|Withdrawal by Subject|1|||
27812195|NCT01869777|54268133|FG000|Overall Study|Excluded from the analysis, ineligible|1|||
27812196|NCT01714947|54268137|FG000|Part B|Progressive Disease|3|||
27812197|NCT01869699|54268143|FG000|Overall Study|Withdrawal by Subject|1|||
27812198|NCT01869699|54268144|FG001|Overall Study|Withdrawal by Subject|0|||
28049670|NCT00541229|54707368|FG004|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
28049671|NCT00541229|54707369|FG005|Treatment Period I (Week 1)|Withdrawal by Subject|1|||
28049672|NCT00541229|54707364|FG000|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
27939922|NCT00943852|54596278|FG001|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
27939923|NCT00943852|54596279|FG002|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
27939924|NCT00943852|54596280|FG003|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1|||
27939925|NCT00943852|54596281|FG004|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
27939926|NCT00943852|54596282|FG005|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
27939927|NCT00943852|54596283|FG006|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
27939928|NCT00943852|54596284|FG007|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
27939929|NCT00943852|54596285|FG008|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
27939930|NCT00943852|54596286|FG009|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
27939931|NCT00943852|54596277|FG000|Washout Period After Period 2 Treatment|Trial stopped early|0|||
28049673|NCT00541229|54707365|FG001|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
28049674|NCT00541229|54707366|FG002|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
28049675|NCT00541229|54707367|FG003|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
28049676|NCT00541229|54707368|FG004|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
28049677|NCT00541229|54707369|FG005|Treatment Period I (Week 1)|Protocol Specified Criteria|1|||
28049678|NCT00541229|54707364|FG000|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
28049679|NCT00541229|54707365|FG001|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
28049680|NCT00541229|54707366|FG002|Treatment Period I (Week 1)|Study Terminated by Sponsor|2|||
28049681|NCT00541229|54707367|FG003|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
28049682|NCT00541229|54707368|FG004|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
28049683|NCT00541229|54707369|FG005|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
28049684|NCT00541229|54707364|FG000|Washout Period I (Week 2-5)|Adverse Event|1|||
28049685|NCT00541229|54707365|FG001|Washout Period I (Week 2-5)|Adverse Event|0|||
28049686|NCT00541229|54707366|FG002|Washout Period I (Week 2-5)|Adverse Event|1|||
28049687|NCT00541229|54707367|FG003|Washout Period I (Week 2-5)|Adverse Event|0|||
28049688|NCT00541229|54707368|FG004|Washout Period I (Week 2-5)|Adverse Event|0|||
28049689|NCT00541229|54707369|FG005|Washout Period I (Week 2-5)|Adverse Event|0|||
28049690|NCT00541229|54707364|FG000|Washout Period I (Week 2-5)|Physician Decision|0|||
28049691|NCT00541229|54707365|FG001|Washout Period I (Week 2-5)|Physician Decision|0|||
28049692|NCT00541229|54707366|FG002|Washout Period I (Week 2-5)|Physician Decision|0|||
28049693|NCT00541229|54707367|FG003|Washout Period I (Week 2-5)|Physician Decision|1|||
28049694|NCT00541229|54707368|FG004|Washout Period I (Week 2-5)|Physician Decision|0|||
28049695|NCT00541229|54707369|FG005|Washout Period I (Week 2-5)|Physician Decision|0|||
28049696|NCT00541229|54707364|FG000|Washout Period I (Week 2-5)|Protocol Violation|0|||
28049697|NCT00541229|54707365|FG001|Washout Period I (Week 2-5)|Protocol Violation|0|||
28049698|NCT00541229|54707366|FG002|Washout Period I (Week 2-5)|Protocol Violation|0|||
28049699|NCT00541229|54707367|FG003|Washout Period I (Week 2-5)|Protocol Violation|0|||
28049700|NCT00541229|54707368|FG004|Washout Period I (Week 2-5)|Protocol Violation|0|||
28049701|NCT00541229|54707369|FG005|Washout Period I (Week 2-5)|Protocol Violation|1|||
28049702|NCT00541229|54707364|FG000|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
28049703|NCT00541229|54707365|FG001|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2|||
28049704|NCT00541229|54707366|FG002|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
28049705|NCT00541229|54707367|FG003|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
28049706|NCT00541229|54707368|FG004|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1|||
28049707|NCT00541229|54707369|FG005|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4|||
28049708|NCT00541229|54707364|FG000|Treatment Period II (Week 6)|Protocol Violation|0|||
28049709|NCT00541229|54707365|FG001|Treatment Period II (Week 6)|Protocol Violation|0|||
28049710|NCT00541229|54707366|FG002|Treatment Period II (Week 6)|Protocol Violation|0|||
28049711|NCT00541229|54707367|FG003|Treatment Period II (Week 6)|Protocol Violation|0|||
28049712|NCT00541229|54707368|FG004|Treatment Period II (Week 6)|Protocol Violation|1|||
28049713|NCT00541229|54707369|FG005|Treatment Period II (Week 6)|Protocol Violation|1|||
28049714|NCT00541229|54707364|FG000|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
28049715|NCT00541229|54707365|FG001|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
28049716|NCT00541229|54707366|FG002|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
28049717|NCT00541229|54707367|FG003|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
28049718|NCT00541229|54707368|FG004|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
28049719|NCT00541229|54707369|FG005|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
28049720|NCT00541229|54707364|FG000|Washout Period II (Week 7-10)|Protocol Violation|1|||
28049721|NCT00541229|54707365|FG001|Washout Period II (Week 7-10)|Protocol Violation|0|||
28049722|NCT00541229|54707366|FG002|Washout Period II (Week 7-10)|Protocol Violation|0|||
28049723|NCT00541229|54707367|FG003|Washout Period II (Week 7-10)|Protocol Violation|0|||
28049724|NCT00541229|54707368|FG004|Washout Period II (Week 7-10)|Protocol Violation|0|||
28049725|NCT00541229|54707369|FG005|Washout Period II (Week 7-10)|Protocol Violation|0|||
28049726|NCT00541229|54707364|FG000|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
27848170|NCT01047345|54341079|FG001|Base Study|Adverse Event|0|||
27848171|NCT01047345|54341080|FG002|Base Study|Adverse Event|0|||
28049727|NCT00541229|54707365|FG001|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
28049728|NCT00541229|54707366|FG002|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
28049729|NCT00541229|54707367|FG003|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
28049730|NCT00541229|54707368|FG004|Washout Period II (Week 7-10)|Withdrawal by Subject|1|||
28049731|NCT00541229|54707369|FG005|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
28049732|NCT00541229|54707364|FG000|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
28049733|NCT00541229|54707365|FG001|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
28049734|NCT00541229|54707366|FG002|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2|||
28049735|NCT00541229|54707367|FG003|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
28049736|NCT00541229|54707368|FG004|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
28049737|NCT00541229|54707369|FG005|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
28049738|NCT00541229|54707364|FG000|Treatment Period III (Week 11)|Adverse Event|0|||
28049739|NCT00541229|54707365|FG001|Treatment Period III (Week 11)|Adverse Event|0|||
28049740|NCT00541229|54707366|FG002|Treatment Period III (Week 11)|Adverse Event|0|||
28049741|NCT00541229|54707367|FG003|Treatment Period III (Week 11)|Adverse Event|0|||
28049742|NCT00541229|54707368|FG004|Treatment Period III (Week 11)|Adverse Event|1|||
28049743|NCT00541229|54707369|FG005|Treatment Period III (Week 11)|Adverse Event|0|||
28049744|NCT00541229|54707364|FG000|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
28049745|NCT00541229|54707365|FG001|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
28049746|NCT00541229|54707366|FG002|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
28049747|NCT00541229|54707367|FG003|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
28049748|NCT00541229|54707368|FG004|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
28049749|NCT00541229|54707369|FG005|Treatment Period III (Week 11)|Protocol Specified Criteria|1|||
28049750|NCT00541229|54707364|FG000|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
28049751|NCT00541229|54707365|FG001|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
28049752|NCT00541229|54707366|FG002|Treatment Period III (Week 11)|Study Terminated by Sponsor|1|||
28049753|NCT00541229|54707367|FG003|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
28049754|NCT00541229|54707368|FG004|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
28049755|NCT00541229|54707369|FG005|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
28049756|NCT00481988|54707379|FG000|Overall Study|Withdrawal by Subject|1|||
28049757|NCT00481988|54707380|FG001|Overall Study|Withdrawal by Subject|1|||
28049758|NCT00481832|54707397|FG000|Enrollment|Physician Decision|8|||
28049759|NCT00481832|54707397|FG000|Enrollment|Unable to collect enough stem cells|2|||
28049760|NCT00481832|54707397|FG000|Inter-transplant Period|Adverse Event|4|||
28049761|NCT00481832|54707397|FG000|Inter-transplant Period|Death|3|||
28049762|NCT00481832|54707397|FG000|Inter-transplant Period|Physician Decision|4|||
28049763|NCT00481832|54707397|FG000|Inter-transplant Period|Disease relapse|11|||
28049764|NCT00481832|54707397|FG000|Inter-transplant Period|Lack of allogeneic donor|5|||
28049765|NCT00481676|54707403|FG000|Overall Study|Adverse Event|0|||
28049766|NCT00481676|54707404|FG001|Overall Study|Adverse Event|1|||
28049767|NCT00481676|54707403|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
28049768|NCT00481676|54707404|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
28049769|NCT00481676|54707403|FG000|Overall Study|Administrative problem|1|||
28049770|NCT00481676|54707404|FG001|Overall Study|Administrative problem|0|||
28049771|NCT00542789|54707412|FG000|Overall Study|Adverse Event|18|||
28049772|NCT00542789|54707413|FG001|Overall Study|Adverse Event|17|||
28049773|NCT00542789|54707412|FG000|Overall Study|Withdrawal by Subject|7|||
28049774|NCT00542789|54707413|FG001|Overall Study|Withdrawal by Subject|3|||
28049775|NCT00542789|54707412|FG000|Overall Study|Protocol Violation|8|||
28049776|NCT00542789|54707413|FG001|Overall Study|Protocol Violation|1|||
28049777|NCT00542789|54707412|FG000|Overall Study|Recurrence of Gastric Ulcer|8|||
28049778|NCT00542789|54707413|FG001|Overall Study|Recurrence of Gastric Ulcer|57|||
28049779|NCT00464672|54707421|FG000|Overall Study|withdrawal of consent|0|||
28049780|NCT00464672|54707422|FG001|Overall Study|withdrawal of consent|0|||
28049781|NCT00464672|54707423|FG002|Overall Study|withdrawal of consent|0|||
28049782|NCT00464672|54707424|FG003|Overall Study|withdrawal of consent|1|||
28049783|NCT00464672|54707425|FG004|Overall Study|withdrawal of consent|9|||
28049784|NCT00464672|54707426|FG005|Overall Study|withdrawal of consent|4|||
28049785|NCT00464672|54707421|FG000|Overall Study|Lost to Follow-up|25|||
28049786|NCT00464672|54707422|FG001|Overall Study|Lost to Follow-up|10|||
28049787|NCT00464672|54707423|FG002|Overall Study|Lost to Follow-up|0|||
28049788|NCT00464672|54707424|FG003|Overall Study|Lost to Follow-up|0|||
28049789|NCT00464672|54707425|FG004|Overall Study|Lost to Follow-up|1|||
28049790|NCT00464672|54707426|FG005|Overall Study|Lost to Follow-up|0|||
27812199|NCT01714635|54268153|FG000|Overall Study|Discontinued|1|||
28049791|NCT00473876|54707456|FG000|Overall Study|Lost to Follow-up|3|||
28049792|NCT00473876|54707457|FG001|Overall Study|Lost to Follow-up|1|||
27812200|NCT01714635|54268154|FG001|Overall Study|Discontinued|0|||
28049793|NCT00463580|54707467|FG000|Overall Study|Lost to Follow-up|1|||
28049794|NCT00463580|54707468|FG001|Overall Study|Lost to Follow-up|0|||
28049795|NCT00463580|54707467|FG000|Overall Study|Schedule conflict|2|||
28049796|NCT00463580|54707468|FG001|Overall Study|Schedule conflict|0|||
28049797|NCT00463580|54707467|FG000|Overall Study|Medical/psychiatric complications|0|||
28049798|NCT00463580|54707468|FG001|Overall Study|Medical/psychiatric complications|2|||
28049799|NCT00540449|54707482|FG000|Overall Study|Adverse Event|12|||
28049800|NCT00540449|54707483|FG001|Overall Study|Adverse Event|32|||
28049801|NCT00540449|54707482|FG000|Overall Study|Sponsor's Decision|1|||
28049802|NCT00540449|54707483|FG001|Overall Study|Sponsor's Decision|1|||
28049803|NCT00540449|54707482|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
28049804|NCT00540449|54707483|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
28049805|NCT00540449|54707482|FG000|Overall Study|Lost to Follow-up|19|||
28049806|NCT00540449|54707483|FG001|Overall Study|Lost to Follow-up|17|||
28049807|NCT00540449|54707482|FG000|Overall Study|Subject Non-Compliant|7|||
28049808|NCT00540449|54707483|FG001|Overall Study|Subject Non-Compliant|5|||
28049809|NCT00540449|54707482|FG000|Overall Study|Subject Reached A Virologic Endpoint|32|||
28049810|NCT00540449|54707483|FG001|Overall Study|Subject Reached A Virologic Endpoint|8|||
28049811|NCT00540449|54707482|FG000|Overall Study|Withdrawal by Subject|10|||
28049812|NCT00540449|54707483|FG001|Overall Study|Withdrawal by Subject|10|||
28049813|NCT00540449|54707482|FG000|Overall Study|Other|1|||
28049814|NCT00540449|54707483|FG001|Overall Study|Other|4|||
28049815|NCT03911843|54707491|FG000|Overall Study|Adverse Event|2|||
28049816|NCT03911843|54707492|FG001|Overall Study|Adverse Event|0|||
28049817|NCT03911843|54707491|FG000|Overall Study|Protocol Violation|2|||
28049818|NCT03911843|54707492|FG001|Overall Study|Protocol Violation|0|||
28049819|NCT03911843|54707491|FG000|Overall Study|Lost to Follow-up|0|||
28049820|NCT03911843|54707492|FG001|Overall Study|Lost to Follow-up|1|||
28049821|NCT00361335|54707503|FG000|IV Period: Baseline to E0|Adverse Event|9|||
28049822|NCT00361335|54707504|FG001|IV Period: Baseline to E0|Adverse Event|4|||
28049823|NCT00361335|54707505|FG002|IV Period: Baseline to E0|Adverse Event|5|||
28049824|NCT00361335|54707506|FG003|IV Period: Baseline to E0|Adverse Event|9|||
28049825|NCT00361335|54707507|FG004|IV Period: Baseline to E0|Adverse Event|8|||
28049826|NCT00361335|54707508|FG005|IV Period: Baseline to E0|Adverse Event|0|||
28049827|NCT00361335|54707509|FG006|IV Period: Baseline to E0|Adverse Event|0|||
28049828|NCT00361335|54707503|FG000|IV Period: Baseline to E0|Lost to Follow-up|1|||
28049829|NCT00361335|54707504|FG001|IV Period: Baseline to E0|Lost to Follow-up|0|||
28049830|NCT00361335|54707505|FG002|IV Period: Baseline to E0|Lost to Follow-up|0|||
28049831|NCT00361335|54707506|FG003|IV Period: Baseline to E0|Lost to Follow-up|2|||
28049832|NCT00361335|54707507|FG004|IV Period: Baseline to E0|Lost to Follow-up|2|||
28049833|NCT00361335|54707508|FG005|IV Period: Baseline to E0|Lost to Follow-up|0|||
28049834|NCT00361335|54707509|FG006|IV Period: Baseline to E0|Lost to Follow-up|0|||
28049835|NCT00361335|54707503|FG000|IV Period: Baseline to E0|Death|1|||
28049836|NCT00361335|54707504|FG001|IV Period: Baseline to E0|Death|1|||
28049837|NCT00361335|54707505|FG002|IV Period: Baseline to E0|Death|1|||
28049838|NCT00361335|54707506|FG003|IV Period: Baseline to E0|Death|1|||
28049839|NCT00361335|54707507|FG004|IV Period: Baseline to E0|Death|0|||
28049840|NCT00361335|54707508|FG005|IV Period: Baseline to E0|Death|0|||
28049841|NCT00361335|54707509|FG006|IV Period: Baseline to E0|Death|0|||
28049842|NCT00361335|54707503|FG000|IV Period: Baseline to E0|Discontinued oral study agent|2|||
28049843|NCT00361335|54707504|FG001|IV Period: Baseline to E0|Discontinued oral study agent|1|||
28049844|NCT00361335|54707505|FG002|IV Period: Baseline to E0|Discontinued oral study agent|1|||
28049845|NCT00361335|54707506|FG003|IV Period: Baseline to E0|Discontinued oral study agent|1|||
28049846|NCT00361335|54707507|FG004|IV Period: Baseline to E0|Discontinued oral study agent|2|||
27848172|NCT01047345|54341078|FG000|Base Study|Lost to Follow-up|4|||
28049847|NCT00361335|54707508|FG005|IV Period: Baseline to E0|Discontinued oral study agent|0|||
28049848|NCT00361335|54707509|FG006|IV Period: Baseline to E0|Discontinued oral study agent|0|||
28049849|NCT00361335|54707503|FG000|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
28049850|NCT00361335|54707504|FG001|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
28049851|NCT00361335|54707505|FG002|IV Period: Baseline to E0|Protocol-prohibited medications|1|||
28049852|NCT00361335|54707506|FG003|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
28049853|NCT00361335|54707507|FG004|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
28049854|NCT00361335|54707508|FG005|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
28049855|NCT00361335|54707509|FG006|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
28049856|NCT00361335|54707503|FG000|IV Period: Baseline to E0|Worsening of RA|0|||
28049857|NCT00361335|54707504|FG001|IV Period: Baseline to E0|Worsening of RA|5|||
28049858|NCT00361335|54707505|FG002|IV Period: Baseline to E0|Worsening of RA|1|||
28049859|NCT00361335|54707506|FG003|IV Period: Baseline to E0|Worsening of RA|4|||
28049860|NCT00361335|54707507|FG004|IV Period: Baseline to E0|Worsening of RA|2|||
28049861|NCT00361335|54707508|FG005|IV Period: Baseline to E0|Worsening of RA|0|||
28049862|NCT00361335|54707509|FG006|IV Period: Baseline to E0|Worsening of RA|0|||
27812201|NCT01714635|54268155|FG002|Overall Study|Discontinued|2|||
27812202|NCT01714635|54268153|FG000|Overall Study|Missed 6-month exam|1|||
27812203|NCT01714635|54268154|FG001|Overall Study|Missed 6-month exam|0|||
28049863|NCT00361335|54707503|FG000|IV Period: Baseline to E0|Other|2|||
28049864|NCT00361335|54707504|FG001|IV Period: Baseline to E0|Other|9|||
28049865|NCT00361335|54707505|FG002|IV Period: Baseline to E0|Other|9|||
28049866|NCT00361335|54707506|FG003|IV Period: Baseline to E0|Other|3|||
28049867|NCT00361335|54707507|FG004|IV Period: Baseline to E0|Other|2|||
28049868|NCT00361335|54707508|FG005|IV Period: Baseline to E0|Other|0|||
28049869|NCT00361335|54707509|FG006|IV Period: Baseline to E0|Other|0|||
28049870|NCT00361335|54707503|FG000|IV Period: Baseline to E0|Lack of Efficacy|5|||
28049871|NCT00361335|54707504|FG001|IV Period: Baseline to E0|Lack of Efficacy|9|||
28049872|NCT00361335|54707505|FG002|IV Period: Baseline to E0|Lack of Efficacy|3|||
28049873|NCT00361335|54707506|FG003|IV Period: Baseline to E0|Lack of Efficacy|7|||
28049874|NCT00361335|54707507|FG004|IV Period: Baseline to E0|Lack of Efficacy|8|||
28049875|NCT00361335|54707508|FG005|IV Period: Baseline to E0|Lack of Efficacy|0|||
28049876|NCT00361335|54707509|FG006|IV Period: Baseline to E0|Lack of Efficacy|0|||
28049877|NCT00361335|54707503|FG000|SC Period: Week E0 to Week E24|Adverse Event|0|||
28049878|NCT00361335|54707504|FG001|SC Period: Week E0 to Week E24|Adverse Event|2|||
28049879|NCT00361335|54707505|FG002|SC Period: Week E0 to Week E24|Adverse Event|1|||
28049880|NCT00361335|54707506|FG003|SC Period: Week E0 to Week E24|Adverse Event|2|||
28049881|NCT00361335|54707507|FG004|SC Period: Week E0 to Week E24|Adverse Event|0|||
28049882|NCT00361335|54707508|FG005|SC Period: Week E0 to Week E24|Adverse Event|0|||
28049883|NCT00361335|54707509|FG006|SC Period: Week E0 to Week E24|Adverse Event|2|||
28049884|NCT00361335|54707503|FG000|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
28049885|NCT00361335|54707504|FG001|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
28049886|NCT00361335|54707505|FG002|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
28049887|NCT00361335|54707506|FG003|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
28049888|NCT00361335|54707507|FG004|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
28049889|NCT00361335|54707508|FG005|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
28049890|NCT00361335|54707509|FG006|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
28049891|NCT00361335|54707503|FG000|SC Period: Week E0 to Week E24|Death|0|||
28049892|NCT00361335|54707504|FG001|SC Period: Week E0 to Week E24|Death|0|||
28049893|NCT00361335|54707505|FG002|SC Period: Week E0 to Week E24|Death|0|||
28049894|NCT00361335|54707506|FG003|SC Period: Week E0 to Week E24|Death|0|||
28049895|NCT00361335|54707507|FG004|SC Period: Week E0 to Week E24|Death|0|||
28049896|NCT00361335|54707508|FG005|SC Period: Week E0 to Week E24|Death|0|||
28049897|NCT00361335|54707509|FG006|SC Period: Week E0 to Week E24|Death|1|||
28049898|NCT00361335|54707503|FG000|SC Period: Week E0 to Week E24|Worsening of RA|0|||
28049899|NCT00361335|54707504|FG001|SC Period: Week E0 to Week E24|Worsening of RA|1|||
28049900|NCT00361335|54707505|FG002|SC Period: Week E0 to Week E24|Worsening of RA|1|||
28049901|NCT00361335|54707506|FG003|SC Period: Week E0 to Week E24|Worsening of RA|1|||
28049902|NCT00361335|54707507|FG004|SC Period: Week E0 to Week E24|Worsening of RA|0|||
27848173|NCT01047345|54341079|FG001|Base Study|Lost to Follow-up|1|||
27848174|NCT01047345|54341080|FG002|Base Study|Lost to Follow-up|0|||
27848175|NCT01047345|54341078|FG000|Base Study|Protocol Violation|3|||
27848176|NCT01047345|54341079|FG001|Base Study|Protocol Violation|1|||
27848177|NCT01047345|54341080|FG002|Base Study|Protocol Violation|0|||
27848178|NCT01047345|54341078|FG000|Base Study|Withdrawal by Subject|12|||
27812204|NCT01714635|54268155|FG002|Overall Study|Missed 6-month exam|0|||
27812205|NCT01849874|54268165|FG000|Overall Study|Death|34|||
27812206|NCT01849874|54268166|FG001|Overall Study|Death|16|||
27812207|NCT01849874|54268165|FG000|Overall Study|Withdrawal by Subject|4|||
27848179|NCT01047345|54341079|FG001|Base Study|Withdrawal by Subject|4|||
27848180|NCT01047345|54341080|FG002|Base Study|Withdrawal by Subject|0|||
27848181|NCT01047345|54341078|FG000|Extension|Withdrawal by Subject|0|||
27848182|NCT01047345|54341079|FG001|Extension|Withdrawal by Subject|0|||
27848183|NCT01047345|54341080|FG002|Extension|Withdrawal by Subject|1|||
27848184|NCT01047345|54341078|FG000|Extension|Lost to Follow-up|0|||
28049903|NCT00361335|54707508|FG005|SC Period: Week E0 to Week E24|Worsening of RA|0|||
28049904|NCT00361335|54707509|FG006|SC Period: Week E0 to Week E24|Worsening of RA|0|||
28049905|NCT00361335|54707503|FG000|SC Period: Week E0 to Week E24|Other|1|||
27812208|NCT01849874|54268166|FG001|Overall Study|Withdrawal by Subject|8|||
27812209|NCT01849874|54268165|FG000|Overall Study|Lost to Follow-up|0|||
27812210|NCT01849874|54268166|FG001|Overall Study|Lost to Follow-up|1|||
27812211|NCT01849874|54268165|FG000|Overall Study|Randomized but Never Treated|1|||
27812212|NCT01849874|54268166|FG001|Overall Study|Randomized but Never Treated|8|||
27812213|NCT01849874|54268165|FG000|Overall Study|Ongoing|162|||
27812214|NCT01849874|54268166|FG001|Overall Study|Ongoing|69|||
27812215|NCT01713933|54268172|FG000|Overall Study|Lost to Follow-up|2|||
27812216|NCT01713933|54268172|FG000|Overall Study|Withdrawal by Subject|3|||
27812217|NCT01713933|54268172|FG000|Overall Study|Excluded from analysis as a BMI outlier|1|||
27848185|NCT01047345|54341079|FG001|Extension|Lost to Follow-up|0|||
28049906|NCT00361335|54707504|FG001|SC Period: Week E0 to Week E24|Other|0|||
28049907|NCT00361335|54707505|FG002|SC Period: Week E0 to Week E24|Other|0|||
27812218|NCT01868997|54268178|FG000|Overall Study|Adverse Event|2|||
27812219|NCT01868997|54268179|FG001|Overall Study|Adverse Event|5|||
27848186|NCT01047345|54341080|FG002|Extension|Lost to Follow-up|5|||
28049908|NCT00361335|54707506|FG003|SC Period: Week E0 to Week E24|Other|1|||
28049909|NCT00361335|54707507|FG004|SC Period: Week E0 to Week E24|Other|0|||
28049910|NCT00361335|54707508|FG005|SC Period: Week E0 to Week E24|Other|1|||
28049911|NCT00361335|54707509|FG006|SC Period: Week E0 to Week E24|Other|2|||
28049912|NCT00361335|54707503|FG000|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
28049913|NCT00361335|54707504|FG001|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
28049914|NCT00361335|54707505|FG002|SC Period: Week E0 to Week E24|Lack of Efficacy|2|||
28049915|NCT00361335|54707506|FG003|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
28049916|NCT00361335|54707507|FG004|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
28049917|NCT00361335|54707508|FG005|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
28049918|NCT00361335|54707509|FG006|SC Period: Week E0 to Week E24|Lack of Efficacy|3|||
28049919|NCT00264550|54707529|FG000|Overall Study|Death|0|||
28049920|NCT00264550|54707530|FG001|Overall Study|Death|3|||
28049921|NCT00264550|54707531|FG002|Overall Study|Death|0|||
28049922|NCT00264550|54707532|FG003|Overall Study|Death|0|||
28049923|NCT00264550|54707529|FG000|Overall Study|Lost to Follow-up|3|||
28049924|NCT00264550|54707530|FG001|Overall Study|Lost to Follow-up|1|||
28049925|NCT00264550|54707531|FG002|Overall Study|Lost to Follow-up|1|||
28049926|NCT00264550|54707532|FG003|Overall Study|Lost to Follow-up|1|||
28049927|NCT00264550|54707529|FG000|Overall Study|Adverse Event|23|||
28049928|NCT00264550|54707530|FG001|Overall Study|Adverse Event|18|||
28049929|NCT00264550|54707531|FG002|Overall Study|Adverse Event|9|||
28049930|NCT00264550|54707532|FG003|Overall Study|Adverse Event|14|||
28049931|NCT00264550|54707529|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
28049932|NCT00264550|54707530|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
28049933|NCT00264550|54707531|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
28049934|NCT00264550|54707532|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
28049935|NCT00264550|54707529|FG000|Overall Study|Discontinued oral study agent|0|||
28049936|NCT00264550|54707530|FG001|Overall Study|Discontinued oral study agent|1|||
28049937|NCT00264550|54707531|FG002|Overall Study|Discontinued oral study agent|0|||
28049938|NCT00264550|54707532|FG003|Overall Study|Discontinued oral study agent|0|||
28049939|NCT00264550|54707529|FG000|Overall Study|Other|13|||
27812220|NCT01868997|54268178|FG000|Overall Study|Lack of Efficacy|2|||
28049940|NCT00264550|54707530|FG001|Overall Study|Other|7|||
28049941|NCT00264550|54707531|FG002|Overall Study|Other|3|||
28049942|NCT00264550|54707532|FG003|Overall Study|Other|9|||
28049943|NCT00541931|54707544|FG000|Overall Study|Adverse Event|1|||
28049944|NCT00541931|54707545|FG001|Overall Study|Adverse Event|0|||
28049945|NCT00541931|54707544|FG000|Overall Study|Lost to Follow-up|3|||
28049946|NCT00541931|54707545|FG001|Overall Study|Lost to Follow-up|3|||
28049947|NCT00541931|54707544|FG000|Overall Study|Withdrawal by Subject|1|||
28049948|NCT00541931|54707545|FG001|Overall Study|Withdrawal by Subject|0|||
28049949|NCT00541931|54707544|FG000|Overall Study|Transportation Issue|0|||
28049950|NCT00541931|54707545|FG001|Overall Study|Transportation Issue|1|||
28049951|NCT00368979|54707555|FG000|Overall Study|Adverse Event|9|||
28049952|NCT00368979|54707556|FG001|Overall Study|Adverse Event|16|||
28049953|NCT00368979|54707555|FG000|Overall Study|Lack of Efficacy|5|||
28049954|NCT00368979|54707556|FG001|Overall Study|Lack of Efficacy|3|||
28049955|NCT00368979|54707555|FG000|Overall Study|Other|3|||
28049956|NCT00368979|54707556|FG001|Overall Study|Other|1|||
27812221|NCT01868997|54268179|FG001|Overall Study|Lack of Efficacy|0|||
27812222|NCT01868997|54268178|FG000|Overall Study|Other|3|||
27812223|NCT01868997|54268179|FG001|Overall Study|Other|1|||
27812224|NCT01875848|54268187|FG000|Overall Study|Withdrawal by Subject|2|||
27812225|NCT01875848|54268188|FG001|Overall Study|Withdrawal by Subject|0|||
27812226|NCT04191382|54268197|FG000|Overall Study|Withdrawal by Subject|1|||
27812227|NCT04191382|54268198|FG001|Overall Study|Withdrawal by Subject|0|||
27812228|NCT04191382|54268199|FG002|Overall Study|Withdrawal by Subject|0|||
27812229|NCT01703091|54268209|FG000|Overall Study|Adverse Event|5|||
27812230|NCT01703091|54268210|FG001|Overall Study|Adverse Event|3|||
27812231|NCT01703091|54268209|FG000|Overall Study|Physician Decision|2|||
27812232|NCT01703091|54268210|FG001|Overall Study|Physician Decision|1|||
27812233|NCT01703091|54268209|FG000|Overall Study|Withdrawal by Subject|1|||
27812234|NCT01703091|54268210|FG001|Overall Study|Withdrawal by Subject|0|||
27812235|NCT01703091|54268209|FG000|Overall Study|Sponsor Decision|1|||
27812236|NCT01703091|54268210|FG001|Overall Study|Sponsor Decision|0|||
28049957|NCT00368979|54707555|FG000|Overall Study|Lost to Follow-up|1|||
28049958|NCT00368979|54707556|FG001|Overall Study|Lost to Follow-up|0|||
28049959|NCT00368979|54707555|FG000|Overall Study|Protocol Violation|2|||
28049960|NCT00368979|54707556|FG001|Overall Study|Protocol Violation|1|||
27812237|NCT01712685|54268216|FG000|Overall Study|pt declined to participate before trmt|1|||
27812238|NCT01867671|54268222|FG000|Overall Study|Adverse Event|5|||
27812239|NCT01867671|54268223|FG001|Overall Study|Adverse Event|3|||
27812240|NCT01867671|54268222|FG000|Overall Study|Anaphylaxis|0|||
27812241|NCT01867671|54268223|FG001|Overall Study|Anaphylaxis|1|||
28049961|NCT00368979|54707555|FG000|Overall Study|Withdrawal by Subject|5|||
28049962|NCT00368979|54707556|FG001|Overall Study|Withdrawal by Subject|9|||
28049963|NCT00264238|54707562|FG000|Overall Study|Protocol Violation|1|||
28049964|NCT00540293|54707568|FG000|Overall Study|Adverse event related to study drug|10|||
28049965|NCT00540293|54707568|FG000|Overall Study|Adverse event not related to study drug|7|||
28049966|NCT00540293|54707568|FG000|Overall Study|Withdrawal by Subject|6|||
28049967|NCT00540293|54707568|FG000|Overall Study|Protocol violation, & subject schedule|12|||
28049968|NCT00375609|54707581|FG000|Overall Study|Did not receive treatment|1|||
28049969|NCT00375609|54707582|FG001|Overall Study|Did not receive treatment|0|||
28049970|NCT00375609|54707583|FG002|Overall Study|Did not receive treatment|0|||
28049971|NCT00375609|54707581|FG000|Overall Study|Adverse Event|0|||
28049972|NCT00375609|54707582|FG001|Overall Study|Adverse Event|3|||
28049973|NCT00375609|54707583|FG002|Overall Study|Adverse Event|0|||
28049974|NCT00375609|54707581|FG000|Overall Study|Lost to Follow-up|1|||
28049975|NCT00375609|54707582|FG001|Overall Study|Lost to Follow-up|0|||
28049976|NCT00375609|54707583|FG002|Overall Study|Lost to Follow-up|0|||
28049977|NCT00375609|54707581|FG000|Overall Study|Physician Decision|0|||
28049978|NCT00375609|54707582|FG001|Overall Study|Physician Decision|0|||
28049979|NCT00375609|54707583|FG002|Overall Study|Physician Decision|1|||
28049980|NCT00375609|54707581|FG000|Overall Study|Withdrawal by Subject|1|||
28049981|NCT00375609|54707582|FG001|Overall Study|Withdrawal by Subject|4|||
28049982|NCT00375609|54707583|FG002|Overall Study|Withdrawal by Subject|0|||
28049983|NCT00375609|54707581|FG000|Overall Study|Neurologist Wanted Pt to start Plavix|1|||
28049984|NCT00375609|54707582|FG001|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
28049985|NCT00375609|54707583|FG002|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
28049986|NCT00359073|54707622|FG000|Overall Study|Withdrawal by Subject|1|||
28049987|NCT00359073|54707623|FG001|Overall Study|Withdrawal by Subject|1|||
28049988|NCT00359073|54707622|FG000|Overall Study|Eligibility criteria no longer met|3|||
28049989|NCT00359073|54707623|FG001|Overall Study|Eligibility criteria no longer met|0|||
28049990|NCT00359073|54707622|FG000|Overall Study|developed RV16 antibody|0|||
28049991|NCT00359073|54707623|FG001|Overall Study|developed RV16 antibody|1|||
28049992|NCT03918239|54707633|FG000|Overall Study|Lost to Follow-up|3|||
28049993|NCT03918239|54707634|FG001|Overall Study|Lost to Follow-up|1|||
28049994|NCT03918239|54707633|FG000|Overall Study|Pregnancy|0|||
28049995|NCT03918239|54707634|FG001|Overall Study|Pregnancy|2|||
28049996|NCT03918239|54707633|FG000|Overall Study|Withdrawal by Subject|3|||
28049997|NCT03918239|54707634|FG001|Overall Study|Withdrawal by Subject|3|||
28049998|NCT03918239|54707633|FG000|Overall Study|positive urine drug screening results|4|||
28049999|NCT03918239|54707634|FG001|Overall Study|positive urine drug screening results|1|||
28050000|NCT00368745|54707642|FG000|Double-blind Treatment Period|Adverse Event|6|||
28050001|NCT00368745|54707643|FG001|Double-blind Treatment Period|Adverse Event|6|||
28050002|NCT00368745|54707642|FG000|Double-blind Treatment Period|Lack of Efficacy|7|||
28050003|NCT00368745|54707643|FG001|Double-blind Treatment Period|Lack of Efficacy|16|||
28050004|NCT00368745|54707642|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
28050005|NCT00368745|54707643|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
28050006|NCT00368745|54707642|FG000|Double-blind Treatment Period|Withdrawal by Subject|5|||
28050007|NCT00368745|54707643|FG001|Double-blind Treatment Period|Withdrawal by Subject|3|||
28050008|NCT00368745|54707642|FG000|Double-blind Treatment Period|Other|7|||
28050009|NCT00368745|54707643|FG001|Double-blind Treatment Period|Other|6|||
28050010|NCT00454818|54707657|FG000|Phase I: Open-label Dose-escalation|Received heart transplant|1|||
28050011|NCT00454818|54707658|FG001|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
28050012|NCT00454818|54707659|FG002|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
28050013|NCT00454818|54707660|FG003|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
28050014|NCT00454818|54707661|FG004|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
28050015|NCT00454818|54707657|FG000|Phase I: Open-label Dose-escalation|Death|0|||
28050016|NCT00454818|54707658|FG001|Phase I: Open-label Dose-escalation|Death|1|||
28050017|NCT00454818|54707659|FG002|Phase I: Open-label Dose-escalation|Death|0|||
28050018|NCT00454818|54707660|FG003|Phase I: Open-label Dose-escalation|Death|0|||
28050019|NCT00454818|54707661|FG004|Phase I: Open-label Dose-escalation|Death|0|||
28050020|NCT00454818|54707657|FG000|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
28050021|NCT00454818|54707658|FG001|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
28050022|NCT00454818|54707659|FG002|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
28050023|NCT00454818|54707660|FG003|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
28050024|NCT00454818|54707661|FG004|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
28050025|NCT00454818|54707657|FG000|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
28050026|NCT00454818|54707658|FG001|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
28050027|NCT00454818|54707659|FG002|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
28050028|NCT00454818|54707660|FG003|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
28050029|NCT00454818|54707661|FG004|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
28050030|NCT00454818|54707657|FG000|Phase 2: Randomized Double-blind|Death|0|||
28050031|NCT00454818|54707658|FG001|Phase 2: Randomized Double-blind|Death|1|||
28050032|NCT00454818|54707659|FG002|Phase 2: Randomized Double-blind|Death|0|||
28050033|NCT00454818|54707660|FG003|Phase 2: Randomized Double-blind|Death|0|||
28050034|NCT00454818|54707661|FG004|Phase 2: Randomized Double-blind|Death|1|||
28050035|NCT00454818|54707657|FG000|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
28050036|NCT00454818|54707658|FG001|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
28050037|NCT00454818|54707659|FG002|Phase 2: Randomized Double-blind|Received a heart transplant|2|||
28050038|NCT00454818|54707660|FG003|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
28050039|NCT00454818|54707661|FG004|Phase 2: Randomized Double-blind|Received a heart transplant|1|||
28050040|NCT00454818|54707657|FG000|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
28050041|NCT00454818|54707658|FG001|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
28050042|NCT00454818|54707659|FG002|Phase 2: Randomized Double-blind|Received left ventricular assist device|1|||
28050043|NCT00454818|54707660|FG003|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
28050044|NCT00454818|54707661|FG004|Phase 2: Randomized Double-blind|Received left ventricular assist device|2|||
28050045|NCT00445224|54707680|FG000|Specific Exercises|Withdrawal by Subject|3|||
28050046|NCT00445224|54707681|FG001|Specific Exercises|Withdrawal by Subject|3|||
28050047|NCT00445224|54707680|FG000|Specific Exercises|Withdrawal by Subject|1|||
28050048|NCT00445224|54707681|FG001|Specific Exercises|Withdrawal by Subject|0|||
28050049|NCT00358917|54707698|FG000|Overall Study|Adverse Event|14|||
28050050|NCT00358917|54707699|FG001|Overall Study|Adverse Event|21|||
28050051|NCT00358917|54707698|FG000|Overall Study|Withdrawal by Subject|5|||
28050052|NCT00358917|54707699|FG001|Overall Study|Withdrawal by Subject|7|||
28050053|NCT00358917|54707698|FG000|Overall Study|Lost to Follow-up|20|||
28050054|NCT00358917|54707699|FG001|Overall Study|Lost to Follow-up|17|||
28050055|NCT00358917|54707698|FG000|Overall Study|Noncompliance|12|||
28050056|NCT00358917|54707699|FG001|Overall Study|Noncompliance|11|||
28050057|NCT00358917|54707698|FG000|Overall Study|Death|2|||
28050058|NCT00358917|54707699|FG001|Overall Study|Death|3|||
28050059|NCT00358917|54707698|FG000|Overall Study|Virologic failure|11|||
28050060|NCT00358917|54707699|FG001|Overall Study|Virologic failure|8|||
28050061|NCT00358917|54707698|FG000|Overall Study|Unable to Continue Participation|2|||
28050062|NCT00358917|54707699|FG001|Overall Study|Unable to Continue Participation|2|||
28050063|NCT00264004|54707711|FG000|Overall Study|Adverse Event|2|||
28050064|NCT00264004|54707712|FG001|Overall Study|Adverse Event|3|||
28050065|NCT00264004|54707713|FG002|Overall Study|Adverse Event|6|||
28050066|NCT00264004|54707714|FG003|Overall Study|Adverse Event|4|||
28050067|NCT00264004|54707711|FG000|Overall Study|Withdrawal by Subject|0|||
28050068|NCT00264004|54707712|FG001|Overall Study|Withdrawal by Subject|1|||
28050069|NCT00264004|54707713|FG002|Overall Study|Withdrawal by Subject|2|||
28050070|NCT00264004|54707714|FG003|Overall Study|Withdrawal by Subject|2|||
28050071|NCT00264004|54707711|FG000|Overall Study|Other|2|||
28050072|NCT00264004|54707712|FG001|Overall Study|Other|2|||
28050073|NCT00264004|54707713|FG002|Overall Study|Other|0|||
28050074|NCT00264004|54707714|FG003|Overall Study|Other|3|||
28050075|NCT00264004|54707711|FG000|Overall Study|Development study specific disc. crit.|1|||
28050076|NCT00264004|54707712|FG001|Overall Study|Development study specific disc. crit.|0|||
28050077|NCT00264004|54707713|FG002|Overall Study|Development study specific disc. crit.|1|||
28050078|NCT00264004|54707714|FG003|Overall Study|Development study specific disc. crit.|0|||
28050079|NCT00264004|54707711|FG000|Overall Study|Cond. under inv. worsened|9|||
28050080|NCT00264004|54707712|FG001|Overall Study|Cond. under inv. worsened|5|||
28050081|NCT00264004|54707713|FG002|Overall Study|Cond. under inv. worsened|3|||
28050082|NCT00264004|54707714|FG003|Overall Study|Cond. under inv. worsened|4|||
28050083|NCT00264004|54707711|FG000|Overall Study|Not treated|3|||
28050084|NCT00264004|54707712|FG001|Overall Study|Not treated|0|||
28050085|NCT00264004|54707713|FG002|Overall Study|Not treated|2|||
28050086|NCT00264004|54707714|FG003|Overall Study|Not treated|2|||
28050087|NCT00368355|54707726|FG000|Overall Study|Adverse Event|1|||
28050088|NCT00368355|54707727|FG001|Overall Study|Adverse Event|0|||
28050089|NCT00368355|54707726|FG000|Overall Study|Death|2|||
28050090|NCT00368355|54707727|FG001|Overall Study|Death|4|||
28050091|NCT00368355|54707726|FG000|Overall Study|Relapse|6|||
28050092|NCT00368355|54707727|FG001|Overall Study|Relapse|10|||
28050093|NCT00368355|54707726|FG000|Overall Study|Subsequent transplant|0|||
28050094|NCT00368355|54707727|FG001|Overall Study|Subsequent transplant|3|||
28050095|NCT00368355|54707726|FG000|Overall Study|Treatment - hematopoietic cell product|2|||
28050096|NCT00368355|54707727|FG001|Overall Study|Treatment - hematopoietic cell product|0|||
28050097|NCT00445146|54707733|FG000|Overall Study|Withdrew Consent|29|||
28050098|NCT00445146|54707733|FG000|Overall Study|Lack of Efficacy|28|||
28050099|NCT00445146|54707733|FG000|Overall Study|Investigator's Discretion|22|||
28050100|NCT00445146|54707733|FG000|Overall Study|Adverse Event|13|||
28050101|NCT00445146|54707733|FG000|Overall Study|Lost to Follow-up|13|||
28050102|NCT00445146|54707733|FG000|Overall Study|Death|9|||
28050103|NCT00445146|54707733|FG000|Overall Study|Protocol Violation|4|||
28050104|NCT00445146|54707733|FG000|Overall Study|Pregnancy|1|||
28050105|NCT00368277|54707739|FG000|Overall Study|Adverse Event|33|||
28050106|NCT00368277|54707740|FG001|Overall Study|Adverse Event|49|||
28050107|NCT00368277|54707739|FG000|Overall Study|Death|2|||
28050108|NCT00368277|54707740|FG001|Overall Study|Death|1|||
28050109|NCT00368277|54707739|FG000|Overall Study|Unsatisfactory therapeutic effect|31|||
28050110|NCT00368277|54707740|FG001|Overall Study|Unsatisfactory therapeutic effect|24|||
28050111|NCT00368277|54707739|FG000|Overall Study|Protocol deviation|7|||
28050112|NCT00368277|54707740|FG001|Overall Study|Protocol deviation|0|||
28050113|NCT00368277|54707739|FG000|Overall Study|Patient withdrew consent|32|||
28050114|NCT00368277|54707740|FG001|Overall Study|Patient withdrew consent|28|||
28050115|NCT00368277|54707739|FG000|Overall Study|Lost to Follow-up|8|||
28050116|NCT00368277|54707740|FG001|Overall Study|Lost to Follow-up|6|||
28050117|NCT00280150|54707750|FG000|Overall Study|Adverse Event|0|||
28050118|NCT00280150|54707751|FG001|Overall Study|Adverse Event|1|||
28050119|NCT00280150|54707752|FG002|Overall Study|Adverse Event|2|||
28050120|NCT00280150|54707753|FG003|Overall Study|Adverse Event|3|||
28050121|NCT00280150|54707750|FG000|Overall Study|Lack of Efficacy|0|||
28050122|NCT00280150|54707751|FG001|Overall Study|Lack of Efficacy|0|||
28050123|NCT00280150|54707752|FG002|Overall Study|Lack of Efficacy|0|||
28050124|NCT00280150|54707753|FG003|Overall Study|Lack of Efficacy|3|||
28050125|NCT00280150|54707750|FG000|Overall Study|Physician Decision|0|||
28050126|NCT00280150|54707751|FG001|Overall Study|Physician Decision|0|||
28050127|NCT00280150|54707752|FG002|Overall Study|Physician Decision|0|||
28050128|NCT00280150|54707753|FG003|Overall Study|Physician Decision|1|||
28050129|NCT00280150|54707750|FG000|Overall Study|Protocol Violation|0|||
28050130|NCT00280150|54707751|FG001|Overall Study|Protocol Violation|0|||
28050131|NCT00280150|54707752|FG002|Overall Study|Protocol Violation|0|||
28050132|NCT00280150|54707753|FG003|Overall Study|Protocol Violation|1|||
28050133|NCT00280150|54707750|FG000|Overall Study|Withdrawal by Subject|0|||
28050134|NCT00280150|54707751|FG001|Overall Study|Withdrawal by Subject|0|||
28050135|NCT00280150|54707752|FG002|Overall Study|Withdrawal by Subject|0|||
28050136|NCT00280150|54707753|FG003|Overall Study|Withdrawal by Subject|1|||
28050137|NCT00280150|54707750|FG000|Overall Study|Did not get consolidation therapy|3|||
28050138|NCT00280150|54707751|FG001|Overall Study|Did not get consolidation therapy|0|||
28050139|NCT00280150|54707752|FG002|Overall Study|Did not get consolidation therapy|3|||
28050140|NCT00280150|54707753|FG003|Overall Study|Did not get consolidation therapy|0|||
28050141|NCT00280150|54707750|FG000|Overall Study|Declining Performance Status|0|||
28050142|NCT00280150|54707751|FG001|Overall Study|Declining Performance Status|0|||
28050143|NCT00280150|54707752|FG002|Overall Study|Declining Performance Status|0|||
28050144|NCT00280150|54707753|FG003|Overall Study|Declining Performance Status|1|||
28050145|NCT00279916|54707766|FG000|Overall Study|Withdrawal by Subject|4|||
28050146|NCT00279916|54707767|FG001|Overall Study|Withdrawal by Subject|3|||
28050147|NCT00279916|54707766|FG000|Overall Study|Lost to Follow-up|3|||
28050148|NCT00279916|54707767|FG001|Overall Study|Lost to Follow-up|2|||
28050149|NCT00358527|54707775|FG000|Overall Study|Adverse Event|4|||
28050150|NCT00358527|54707776|FG001|Overall Study|Adverse Event|0|||
28050151|NCT00358527|54707775|FG000|Overall Study|Withdrawal by Subject|1|||
28050152|NCT00358527|54707776|FG001|Overall Study|Withdrawal by Subject|1|||
28050153|NCT00358527|54707775|FG000|Overall Study|Non-compliance with protocol|6|||
28050154|NCT00358527|54707776|FG001|Overall Study|Non-compliance with protocol|1|||
28050155|NCT00358527|54707775|FG000|Overall Study|Administrative|2|||
28050156|NCT00358527|54707776|FG001|Overall Study|Administrative|1|||
28050157|NCT00251758|54707785|FG000|Overall Study|Adverse Event|7|||
28050158|NCT00251758|54707786|FG001|Overall Study|Adverse Event|9|||
28050159|NCT00251758|54707787|FG002|Overall Study|Adverse Event|11|||
28050160|NCT00251758|54707785|FG000|Overall Study|Lost to Follow-up|4|||
28050161|NCT00251758|54707786|FG001|Overall Study|Lost to Follow-up|2|||
28050162|NCT00251758|54707787|FG002|Overall Study|Lost to Follow-up|5|||
28050163|NCT00251758|54707785|FG000|Overall Study|Withdrawal by Subject|13|||
28050164|NCT00251758|54707786|FG001|Overall Study|Withdrawal by Subject|7|||
28050165|NCT00251758|54707787|FG002|Overall Study|Withdrawal by Subject|3|||
28050166|NCT00251758|54707785|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
28050167|NCT00251758|54707786|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
28050168|NCT00251758|54707787|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
28050169|NCT00251758|54707785|FG000|Overall Study|Lack of Efficacy|3|||
28050170|NCT00251758|54707786|FG001|Overall Study|Lack of Efficacy|0|||
28050171|NCT00251758|54707787|FG002|Overall Study|Lack of Efficacy|0|||
28050172|NCT00251758|54707785|FG000|Overall Study|Noncompliant|0|||
28050173|NCT00251758|54707786|FG001|Overall Study|Noncompliant|2|||
28050174|NCT00251758|54707787|FG002|Overall Study|Noncompliant|2|||
28050175|NCT00251758|54707785|FG000|Overall Study|Pregnancy|0|||
28050176|NCT00251758|54707786|FG001|Overall Study|Pregnancy|1|||
28050177|NCT00251758|54707787|FG002|Overall Study|Pregnancy|0|||
28050178|NCT00251758|54707785|FG000|Overall Study|Per Subject Request|0|||
28050179|NCT00251758|54707786|FG001|Overall Study|Per Subject Request|0|||
28050180|NCT00251758|54707787|FG002|Overall Study|Per Subject Request|1|||
28050181|NCT00251758|54707785|FG000|Overall Study|Per Investigator Request|1|||
28050182|NCT00251758|54707786|FG001|Overall Study|Per Investigator Request|0|||
28050183|NCT00251758|54707787|FG002|Overall Study|Per Investigator Request|0|||
28050184|NCT00279214|54707797|FG000|Overall Study|Physician Decision|3|||
28050185|NCT00279214|54707798|FG001|Overall Study|Physician Decision|2|||
28050186|NCT00262834|54707806|FG000|Overall Study|Surgery delayed/tissue not collected|1|||
28050187|NCT00262834|54707807|FG001|Overall Study|Surgery delayed/tissue not collected|4|||
28050188|NCT00541775|54707820|FG000|Overall Study|Adverse Event|3|||
28050189|NCT00541775|54707821|FG001|Overall Study|Adverse Event|2|||
28050190|NCT00541775|54707822|FG002|Overall Study|Adverse Event|1|||
28050191|NCT00541775|54707820|FG000|Overall Study|Lack of Efficacy|0|||
28050192|NCT00541775|54707821|FG001|Overall Study|Lack of Efficacy|0|||
28050193|NCT00541775|54707822|FG002|Overall Study|Lack of Efficacy|3|||
28050194|NCT00541775|54707820|FG000|Overall Study|Lost to Follow-up|0|||
28050195|NCT00541775|54707821|FG001|Overall Study|Lost to Follow-up|0|||
28050196|NCT00541775|54707822|FG002|Overall Study|Lost to Follow-up|2|||
28050197|NCT00541775|54707820|FG000|Overall Study|Protocol Violation|1|||
28050198|NCT00541775|54707821|FG001|Overall Study|Protocol Violation|0|||
28050199|NCT00541775|54707822|FG002|Overall Study|Protocol Violation|0|||
28050200|NCT00541775|54707820|FG000|Overall Study|Withdrawal by Subject and Other|5|||
28050201|NCT00541775|54707821|FG001|Overall Study|Withdrawal by Subject and Other|0|||
28050202|NCT00541775|54707822|FG002|Overall Study|Withdrawal by Subject and Other|2|||
28050203|NCT00539513|54707832|FG000|Overall Study|Withdrawal by Subject|2|||
28050204|NCT00539513|54707833|FG001|Overall Study|Withdrawal by Subject|1|||
28050205|NCT00539513|54707832|FG000|Overall Study|Lost to Follow-up|0|||
28050206|NCT00539513|54707833|FG001|Overall Study|Lost to Follow-up|1|||
28050207|NCT02969915|54707843|FG000|Overall Study|Death|104|||
28050208|NCT02969915|54707844|FG001|Overall Study|Death|125|||
28050209|NCT02969915|54707843|FG000|Overall Study|Lost to Follow-up|108|||
28050210|NCT02969915|54707844|FG001|Overall Study|Lost to Follow-up|112|||
28050211|NCT02969915|54707843|FG000|Overall Study|Censored due to COVID-19|481|||
28050212|NCT02969915|54707844|FG001|Overall Study|Censored due to COVID-19|471|||
28050213|NCT00454584|54707853|FG000|Controlled Period|Adverse Event|5|||
28050214|NCT00454584|54707854|FG001|Controlled Period|Adverse Event|2|||
28050215|NCT00454584|54707855|FG002|Controlled Period|Adverse Event|1|||
28050216|NCT00454584|54707856|FG003|Controlled Period|Adverse Event|0|||
28050217|NCT00454584|54707857|FG004|Controlled Period|Adverse Event|0|||
28050218|NCT00454584|54707858|FG005|Controlled Period|Adverse Event|0|||
28050219|NCT00454584|54707853|FG000|Controlled Period|Lost to Follow-up|1|||
28050220|NCT00454584|54707854|FG001|Controlled Period|Lost to Follow-up|2|||
28050221|NCT00454584|54707855|FG002|Controlled Period|Lost to Follow-up|2|||
28050222|NCT00454584|54707856|FG003|Controlled Period|Lost to Follow-up|0|||
28050223|NCT00454584|54707857|FG004|Controlled Period|Lost to Follow-up|0|||
28050224|NCT00454584|54707858|FG005|Controlled Period|Lost to Follow-up|0|||
28050225|NCT00454584|54707853|FG000|Controlled Period|Other|5|||
28050226|NCT00454584|54707854|FG001|Controlled Period|Other|4|||
28050227|NCT00454584|54707855|FG002|Controlled Period|Other|2|||
28050228|NCT00454584|54707856|FG003|Controlled Period|Other|0|||
28050229|NCT00454584|54707857|FG004|Controlled Period|Other|0|||
28050230|NCT00454584|54707858|FG005|Controlled Period|Other|0|||
28050231|NCT00454584|54707853|FG000|After Controlled Period|Adverse Event|0|||
28050232|NCT00454584|54707854|FG001|After Controlled Period|Adverse Event|0|||
28050233|NCT00454584|54707855|FG002|After Controlled Period|Adverse Event|0|||
28050234|NCT00454584|54707856|FG003|After Controlled Period|Adverse Event|9|||
28050235|NCT00454584|54707857|FG004|After Controlled Period|Adverse Event|3|||
28050236|NCT00454584|54707858|FG005|After Controlled Period|Adverse Event|9|||
28050237|NCT00454584|54707853|FG000|After Controlled Period|Lack of Efficacy|0|||
28050238|NCT00454584|54707854|FG001|After Controlled Period|Lack of Efficacy|0|||
28050239|NCT00454584|54707855|FG002|After Controlled Period|Lack of Efficacy|0|||
28050240|NCT00454584|54707856|FG003|After Controlled Period|Lack of Efficacy|1|||
28050241|NCT00454584|54707857|FG004|After Controlled Period|Lack of Efficacy|0|||
28050242|NCT00454584|54707858|FG005|After Controlled Period|Lack of Efficacy|0|||
28050243|NCT00454584|54707853|FG000|After Controlled Period|Lost to Follow-up|0|||
28050244|NCT00454584|54707854|FG001|After Controlled Period|Lost to Follow-up|0|||
28050245|NCT00454584|54707855|FG002|After Controlled Period|Lost to Follow-up|0|||
28050246|NCT00454584|54707856|FG003|After Controlled Period|Lost to Follow-up|2|||
28050247|NCT00454584|54707857|FG004|After Controlled Period|Lost to Follow-up|4|||
28050248|NCT00454584|54707858|FG005|After Controlled Period|Lost to Follow-up|6|||
28050249|NCT00454584|54707853|FG000|After Controlled Period|Other|0|||
28050250|NCT00454584|54707854|FG001|After Controlled Period|Other|0|||
28050251|NCT00454584|54707855|FG002|After Controlled Period|Other|0|||
28050252|NCT00454584|54707856|FG003|After Controlled Period|Other|1|||
28050253|NCT00454584|54707857|FG004|After Controlled Period|Other|0|||
28050254|NCT00454584|54707858|FG005|After Controlled Period|Other|0|||
28050255|NCT00454584|54707853|FG000|After Controlled Period|Other|0|||
28050256|NCT00454584|54707854|FG001|After Controlled Period|Other|0|||
28050257|NCT00454584|54707855|FG002|After Controlled Period|Other|0|||
28050258|NCT00454584|54707856|FG003|After Controlled Period|Other|13|||
28050259|NCT00454584|54707857|FG004|After Controlled Period|Other|5|||
28050260|NCT00454584|54707858|FG005|After Controlled Period|Other|17|||
28050261|NCT00445068|54707872|FG000|Overall Study|Disease progression|26|||
28050262|NCT00445068|54707872|FG000|Overall Study|Adverse Event|5|||
28050263|NCT00445068|54707872|FG000|Overall Study|Abnormal laboratory value|2|||
28050264|NCT00445068|54707872|FG000|Overall Study|Withdrawal by Subject|2|||
28050265|NCT00445068|54707872|FG000|Overall Study|Death|1|||
28050266|NCT00539279|54707878|FG000|Treatment|Withdrawal by Subject|10|||
28050267|NCT00539279|54707879|FG001|Treatment|Withdrawal by Subject|8|||
28050268|NCT00539279|54707878|FG000|Treatment|Death|1|||
28050269|NCT00539279|54707879|FG001|Treatment|Death|0|||
28050270|NCT00539279|54707878|FG000|Post-Treatment Assessment|Lost to Follow-up|12|||
28050271|NCT00539279|54707879|FG001|Post-Treatment Assessment|Lost to Follow-up|9|||
28050272|NCT00539279|54707878|FG000|6-Month Follow-Up Assessment|Lost to Follow-up|1|||
28050273|NCT00539279|54707879|FG001|6-Month Follow-Up Assessment|Lost to Follow-up|7|||
28050274|NCT00444912|54707887|FG000|Overall Study|Death|1|||
28050275|NCT00444912|54707888|FG001|Overall Study|Death|2|||
28050276|NCT00444912|54707887|FG000|Overall Study|Lost to Follow-up|1|||
28050277|NCT00444912|54707888|FG001|Overall Study|Lost to Follow-up|0|||
28050278|NCT00444912|54707887|FG000|Overall Study|Participant Failed Mobilization|1|||
28050279|NCT00444912|54707888|FG001|Overall Study|Participant Failed Mobilization|0|||
28050280|NCT00538733|54707894|FG000|Overall Study|Adverse Event|8|||
28050281|NCT00538733|54707894|FG000|Overall Study|Death|1|||
28050282|NCT00538733|54707894|FG000|Overall Study|declined to participate|2|||
28050283|NCT00538733|54707894|FG000|Overall Study|still on therapy|1|||
28050284|NCT00444678|54707901|FG000|Overall Study|Toxicity|11|||
28050285|NCT00444678|54707901|FG000|Overall Study|Disease Progression|12|||
28050286|NCT00444678|54707901|FG000|Overall Study|Death|3|||
28050287|NCT00444678|54707901|FG000|Overall Study|Physician Decision|3|||
28050288|NCT00444678|54707901|FG000|Overall Study|Withdrawal by Subject|2|||
28050289|NCT00358449|54707908|FG000|Overall Study|Adverse Event|1|||
28050290|NCT00358449|54707909|FG001|Overall Study|Adverse Event|0|||
28050291|NCT00358449|54707910|FG002|Overall Study|Adverse Event|1|||
28050292|NCT00358449|54707908|FG000|Overall Study|Lost to Follow-up|1|||
28050293|NCT00358449|54707909|FG001|Overall Study|Lost to Follow-up|0|||
28050294|NCT00358449|54707910|FG002|Overall Study|Lost to Follow-up|0|||
28050295|NCT00358449|54707908|FG000|Overall Study|Withdrawal by Subject|2|||
28050296|NCT00358449|54707909|FG001|Overall Study|Withdrawal by Subject|0|||
28050297|NCT00358449|54707910|FG002|Overall Study|Withdrawal by Subject|0|||
28050298|NCT00358449|54707908|FG000|Overall Study|Lack of Efficacy|0|||
28050299|NCT00358449|54707909|FG001|Overall Study|Lack of Efficacy|1|||
28050300|NCT00358449|54707910|FG002|Overall Study|Lack of Efficacy|0|||
28050301|NCT00358449|54707908|FG000|Overall Study|Steriod Inhaler was Increased|0|||
28050302|NCT00358449|54707909|FG001|Overall Study|Steriod Inhaler was Increased|0|||
28050303|NCT00358449|54707910|FG002|Overall Study|Steriod Inhaler was Increased|1|||
28050304|NCT00539981|54707922|FG000|Overall Study|Adverse events (AE)|3|||
28050305|NCT00539981|54707923|FG001|Overall Study|Adverse events (AE)|3|||
28050306|NCT00539981|54707922|FG000|Overall Study|Lost to Follow-up|260|||
28050307|NCT00539981|54707923|FG001|Overall Study|Lost to Follow-up|251|||
28050308|NCT00539981|54707922|FG000|Overall Study|Withdrew consent|22|||
28050309|NCT00539981|54707923|FG001|Overall Study|Withdrew consent|14|||
28050310|NCT00539981|54707922|FG000|Overall Study|Death|1|||
28050311|NCT00539981|54707923|FG001|Overall Study|Death|1|||
28050312|NCT00539981|54707922|FG000|Overall Study|Other reason-unspecified|9|||
28050313|NCT00539981|54707923|FG001|Overall Study|Other reason-unspecified|13|||
28050314|NCT00367341|54707934|FG000|Overall Study|Physician Decision|1|||
28050315|NCT00367341|54707935|FG001|Overall Study|Physician Decision|0|||
28050316|NCT00367341|54707934|FG000|Overall Study|Protocol Violation|1|||
28050317|NCT00367341|54707935|FG001|Overall Study|Protocol Violation|0|||
28050318|NCT00440466|54707944|FG000|Overall Study|Death|3|||
28050319|NCT00440466|54707945|FG001|Overall Study|Death|2|||
28050320|NCT00440466|54707946|FG002|Overall Study|Death|9|||
28050321|NCT00440466|54707944|FG000|Overall Study|Adverse Event|3|||
28050322|NCT00440466|54707945|FG001|Overall Study|Adverse Event|4|||
27812242|NCT01867671|54268222|FG000|Overall Study|Inability to reach 3 mg peanut/placebo|2|||
27812243|NCT01867671|54268223|FG001|Overall Study|Inability to reach 3 mg peanut/placebo|0|||
27812244|NCT01867671|54268222|FG000|Overall Study|Lost to Follow-up|0|||
28050323|NCT00440466|54707946|FG002|Overall Study|Adverse Event|11|||
28050324|NCT00440466|54707944|FG000|Overall Study|Lost to Follow-up|1|||
28050325|NCT00440466|54707945|FG001|Overall Study|Lost to Follow-up|0|||
28050326|NCT00440466|54707946|FG002|Overall Study|Lost to Follow-up|2|||
28050327|NCT00440466|54707944|FG000|Overall Study|Physician Decision|2|||
28050328|NCT00440466|54707945|FG001|Overall Study|Physician Decision|0|||
28050329|NCT00440466|54707946|FG002|Overall Study|Physician Decision|1|||
28050330|NCT00440466|54707944|FG000|Overall Study|Protocol Violation|2|||
27812245|NCT01867671|54268223|FG001|Overall Study|Lost to Follow-up|1|||
27812246|NCT01867671|54268222|FG000|Overall Study|Non-compliance with Study Drug|1|||
27812247|NCT01867671|54268223|FG001|Overall Study|Non-compliance with Study Drug|2|||
27939932|NCT00943852|54596278|FG001|Washout Period After Period 2 Treatment|Trial stopped early|0|||
28050331|NCT00440466|54707945|FG001|Overall Study|Protocol Violation|0|||
28050332|NCT00440466|54707946|FG002|Overall Study|Protocol Violation|4|||
28050333|NCT00440466|54707944|FG000|Overall Study|Withdrawal by Subject|2|||
28050334|NCT00440466|54707945|FG001|Overall Study|Withdrawal by Subject|5|||
28050335|NCT00440466|54707946|FG002|Overall Study|Withdrawal by Subject|9|||
28050336|NCT00440466|54707944|FG000|Overall Study|Began Dialysis|0|||
28050337|NCT00440466|54707945|FG001|Overall Study|Began Dialysis|0|||
28050338|NCT00440466|54707946|FG002|Overall Study|Began Dialysis|1|||
28050339|NCT00440466|54707944|FG000|Overall Study|Met Hemoglobin Withdrawal Criteria|0|||
28050340|NCT00440466|54707945|FG001|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
28050341|NCT00440466|54707946|FG002|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
28050342|NCT00537485|54707978|FG000|Overall Study|Adverse Event|10|||
28050343|NCT00537485|54707979|FG001|Overall Study|Adverse Event|5|||
28050344|NCT00537485|54707978|FG000|Overall Study|Withdrawal by Subject|3|||
28050345|NCT00537485|54707979|FG001|Overall Study|Withdrawal by Subject|2|||
28050346|NCT00537485|54707978|FG000|Overall Study|Withdrawal by Subject|1|||
28050347|NCT00537485|54707979|FG001|Overall Study|Withdrawal by Subject|3|||
28050348|NCT00537485|54707978|FG000|Overall Study|Physician Decision|1|||
28050349|NCT00537485|54707979|FG001|Overall Study|Physician Decision|0|||
28050350|NCT00616967|54707987|FG000|Overall Study|Withdrawal by Subject|0|||
28050351|NCT00616967|54707988|FG001|Overall Study|Withdrawal by Subject|0|||
28050352|NCT00616967|54707989|FG002|Overall Study|Withdrawal by Subject|1|||
28050353|NCT00537329|54708007|FG000|Overall Study|Death|10|||
28050354|NCT00537329|54708007|FG000|Overall Study|Adverse Event|3|||
28050355|NCT00537329|54708007|FG000|Overall Study|Lack of Efficacy|2|||
28050356|NCT00537329|54708007|FG000|Overall Study|Lost to Follow-up|6|||
28050357|NCT00537329|54708007|FG000|Overall Study|Withdrawal by Subject|4|||
28050358|NCT00537329|54708007|FG000|Overall Study|Other|1|||
28050359|NCT03897179|54708011|FG000|Overall Study|Withdrawal by Subject|1|||
28050360|NCT03905135|54708017|FG000|Dose Escalation|Adverse Event|1|||
28050361|NCT03905135|54708018|FG001|Dose Escalation|Adverse Event|1|||
28050362|NCT03905135|54708017|FG000|Dose Escalation|Progressive disease|3|||
28050363|NCT03905135|54708018|FG001|Dose Escalation|Progressive disease|1|||
28050364|NCT03905135|54708017|FG000|Dose Escalation|Intercurrent illness|1|||
28050365|NCT03905135|54708018|FG001|Dose Escalation|Intercurrent illness|0|||
28050366|NCT00357903|54708028|FG000|Overall Study|Adverse Event|87|||
28050367|NCT00357903|54708029|FG001|Overall Study|Adverse Event|4|||
28050368|NCT00357903|54708028|FG000|Overall Study|Death|33|||
28050369|NCT00357903|54708029|FG001|Overall Study|Death|0|||
28050370|NCT00357903|54708028|FG000|Overall Study|Lost to Follow-up|23|||
28050371|NCT00357903|54708029|FG001|Overall Study|Lost to Follow-up|4|||
28050372|NCT00357903|54708028|FG000|Overall Study|Physician Decision|39|||
28050373|NCT00357903|54708029|FG001|Overall Study|Physician Decision|5|||
28050374|NCT00357903|54708028|FG000|Overall Study|Withdrawal by Subject|57|||
28050375|NCT00357903|54708029|FG001|Overall Study|Withdrawal by Subject|7|||
28050376|NCT00357903|54708028|FG000|Overall Study|Completed month 12 only|0|||
28050377|NCT00357903|54708029|FG001|Overall Study|Completed month 12 only|1|||
28050378|NCT00357903|54708028|FG000|Overall Study|Protocol issues|14|||
28050379|NCT00357903|54708029|FG001|Overall Study|Protocol issues|3|||
28050380|NCT00357903|54708028|FG000|Overall Study|Response status|61|||
28050381|NCT00357903|54708029|FG001|Overall Study|Response status|9|||
28050382|NCT00357903|54708028|FG000|Overall Study|Other|49|||
28050383|NCT00357903|54708029|FG001|Overall Study|Other|10|||
28050384|NCT00348933|54708036|FG000|Overall Study|Withdrawal by Subject|10|||
28050385|NCT00348933|54708036|FG000|Overall Study|Lost to Follow-up|6|||
28050386|NCT00348933|54708036|FG000|Overall Study|Protocol Violation|2|||
28050387|NCT00348933|54708036|FG000|Overall Study|Adverse Event|7|||
28050388|NCT03896477|54708044|FG000|Overall Study|Met Ineligibility Criteria During the Study|1|||
28050389|NCT03896477|54708045|FG001|Overall Study|Met Ineligibility Criteria During the Study|1|||
28050390|NCT03896477|54708046|FG002|Overall Study|Met Ineligibility Criteria During the Study|2|||
28050391|NCT03896477|54708044|FG000|Overall Study|Parent Requested Withdrawal|8|||
28050392|NCT03896477|54708045|FG001|Overall Study|Parent Requested Withdrawal|12|||
28050393|NCT03896477|54708046|FG002|Overall Study|Parent Requested Withdrawal|9|||
28050394|NCT03896477|54708044|FG000|Overall Study|Adverse Event|0|||
28050395|NCT03896477|54708045|FG001|Overall Study|Adverse Event|0|||
28050396|NCT03896477|54708046|FG002|Overall Study|Adverse Event|1|||
28050397|NCT03896477|54708044|FG000|Overall Study|Death|1|||
28050398|NCT03896477|54708045|FG001|Overall Study|Death|0|||
28050399|NCT03896477|54708046|FG002|Overall Study|Death|0|||
28050400|NCT03896477|54708044|FG000|Overall Study|Other|5|||
28050401|NCT03896477|54708045|FG001|Overall Study|Other|6|||
28050402|NCT03896477|54708046|FG002|Overall Study|Other|7|||
28050403|NCT03896477|54708044|FG000|Overall Study|Lost to Follow-up|2|||
28050404|NCT03896477|54708045|FG001|Overall Study|Lost to Follow-up|1|||
27812248|NCT01867671|54268222|FG000|Overall Study|Withdrawal by Subject|21|||
28050405|NCT03896477|54708046|FG002|Overall Study|Lost to Follow-up|1|||
28050406|NCT00444600|54708061|FG000|Overall Study|Death|7|||
28050407|NCT00444600|54708062|FG001|Overall Study|Death|5|||
28050408|NCT00444600|54708063|FG002|Overall Study|Death|3|||
28050409|NCT00444600|54708064|FG003|Overall Study|Death|2|||
28050410|NCT00444600|54708061|FG000|Overall Study|Dropped|11|||
28050411|NCT00444600|54708062|FG001|Overall Study|Dropped|11|||
28050412|NCT00444600|54708063|FG002|Overall Study|Dropped|7|||
27848187|NCT01046877|54341088|FG000|Overall Study|Exited voluntarily before tube extrusion|7|||
27848188|NCT01046877|54341088|FG000|Overall Study|Exited voluntarily after tube extrusion|11|||
27812249|NCT01867671|54268223|FG001|Overall Study|Withdrawal by Subject|21|||
27812250|NCT01702311|54268231|FG000|Overall Study|Withdrawal by Subject|3|||
27812251|NCT01702311|54268232|FG001|Overall Study|Withdrawal by Subject|2|||
27812252|NCT01702311|54268231|FG000|Overall Study|Discharge less than 24 hours|10|||
27812253|NCT01702311|54268232|FG001|Overall Study|Discharge less than 24 hours|7|||
27812254|NCT01702311|54268231|FG000|Overall Study|Physician Decision|3|||
27812255|NCT01702311|54268232|FG001|Overall Study|Physician Decision|4|||
27812256|NCT01712061|54268248|FG000|Overall Study|Adverse Event|4|||
27812257|NCT01712061|54268249|FG001|Overall Study|Adverse Event|9|||
27848189|NCT00984061|54341092|FG000|Clarithromycin Alone|Protocol Violation|1|||
27848190|NCT01046643|54341101|FG000|First Period Treatment or Placebo|Withdrawal by Subject|0|||
27812258|NCT01712061|54268250|FG002|Overall Study|Adverse Event|5|||
27812259|NCT01712061|54268248|FG000|Overall Study|Death|0|||
28050413|NCT00444600|54708064|FG003|Overall Study|Dropped|7|||
28050414|NCT00444600|54708061|FG000|Overall Study|Missed visit|1|||
28050415|NCT00444600|54708062|FG001|Overall Study|Missed visit|0|||
28050416|NCT00444600|54708063|FG002|Overall Study|Missed visit|0|||
28050417|NCT00444600|54708064|FG003|Overall Study|Missed visit|1|||
28050418|NCT00537095|54708082|FG000|Overall Study|surgery|1|||
28050419|NCT00537095|54708083|FG001|Overall Study|surgery|0|||
28050420|NCT00537095|54708082|FG000|Overall Study|Adverse Event|24|||
28050421|NCT00537095|54708083|FG001|Overall Study|Adverse Event|4|||
28050422|NCT00537095|54708082|FG000|Overall Study|disease progression|21|||
28050423|NCT00537095|54708083|FG001|Overall Study|disease progression|48|||
28050424|NCT00537095|54708082|FG000|Overall Study|Death|3|||
28050425|NCT00537095|54708083|FG001|Overall Study|Death|1|||
27812260|NCT01712061|54268249|FG001|Overall Study|Death|0|||
27812261|NCT01712061|54268250|FG002|Overall Study|Death|1|||
27812262|NCT01712061|54268248|FG000|Overall Study|Lost to Follow-up|1|||
27812263|NCT01712061|54268249|FG001|Overall Study|Lost to Follow-up|0|||
27812264|NCT01712061|54268250|FG002|Overall Study|Lost to Follow-up|1|||
27848191|NCT01046643|54341102|FG001|First Period Treatment or Placebo|Withdrawal by Subject|1|||
27848192|NCT01046643|54341103|FG002|First Period Treatment or Placebo|Withdrawal by Subject|0|||
27848193|NCT01046643|54341104|FG003|First Period Treatment or Placebo|Withdrawal by Subject|0|||
28050426|NCT00537095|54708082|FG000|Overall Study|Withdrawal by Subject|2|||
28050427|NCT00537095|54708083|FG001|Overall Study|Withdrawal by Subject|2|||
28050428|NCT00537095|54708082|FG000|Overall Study|subjective disease progression|0|||
28050429|NCT00537095|54708083|FG001|Overall Study|subjective disease progression|1|||
28050430|NCT00537095|54708082|FG000|Overall Study|Incorrect enrolment|0|||
28050431|NCT00537095|54708083|FG001|Overall Study|Incorrect enrolment|1|||
28050432|NCT00443898|54708093|FG000|Overall Study|Adverse Event|0|||
28050433|NCT00443898|54708094|FG001|Overall Study|Adverse Event|0|||
28050434|NCT00443898|54708095|FG002|Overall Study|Adverse Event|1|||
28050435|NCT00443898|54708096|FG003|Overall Study|Adverse Event|1|||
28050436|NCT00443898|54708093|FG000|Overall Study|Lack of Efficacy|2|||
28050437|NCT00443898|54708094|FG001|Overall Study|Lack of Efficacy|3|||
28050438|NCT00443898|54708095|FG002|Overall Study|Lack of Efficacy|3|||
27848194|NCT00983905|54341114|FG000|Theophylline Alone|Adverse Event|1|||
27848195|NCT00983905|54341114|FG000|Colchicine Alone|Adverse Event|2|||
27848196|NCT01046565|54341121|FG000|Overall Study|Adverse Event|2|||
27848197|NCT01046565|54341121|FG000|Overall Study|Withdrawal by Subject|7|||
27848198|NCT00983827|54341130|FG000|Overall Study|Withdrawal by Subject|1|||
28050439|NCT00443898|54708096|FG003|Overall Study|Lack of Efficacy|1|||
28050440|NCT00443898|54708093|FG000|Overall Study|Protocol Violation|1|||
28050441|NCT00443898|54708094|FG001|Overall Study|Protocol Violation|1|||
28050442|NCT00443898|54708095|FG002|Overall Study|Protocol Violation|1|||
27812265|NCT01712061|54268248|FG000|Overall Study|Did Not Meet Entrance Criteria|4|||
27812266|NCT01712061|54268249|FG001|Overall Study|Did Not Meet Entrance Criteria|6|||
27812267|NCT01712061|54268250|FG002|Overall Study|Did Not Meet Entrance Criteria|3|||
27812268|NCT01712061|54268248|FG000|Overall Study|Medication Error Without Associated AE|0|||
27812269|NCT01712061|54268249|FG001|Overall Study|Medication Error Without Associated AE|1|||
28050443|NCT00443898|54708096|FG003|Overall Study|Protocol Violation|0|||
27848199|NCT00983749|54341136|FG000|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1|||
28050444|NCT00443898|54708093|FG000|Overall Study|Withdrawal by Subject|11|||
28050445|NCT00443898|54708094|FG001|Overall Study|Withdrawal by Subject|10|||
28050446|NCT00443898|54708095|FG002|Overall Study|Withdrawal by Subject|10|||
28050447|NCT00443898|54708096|FG003|Overall Study|Withdrawal by Subject|6|||
28050448|NCT00443898|54708093|FG000|Overall Study|Lost to Follow-up|10|||
28050449|NCT00443898|54708094|FG001|Overall Study|Lost to Follow-up|10|||
28050450|NCT00443898|54708095|FG002|Overall Study|Lost to Follow-up|14|||
28050451|NCT00443898|54708096|FG003|Overall Study|Lost to Follow-up|10|||
28050452|NCT00443898|54708093|FG000|Overall Study|Death|0|||
28050453|NCT00443898|54708094|FG001|Overall Study|Death|1|||
28050454|NCT00443898|54708095|FG002|Overall Study|Death|0|||
28050455|NCT00443898|54708096|FG003|Overall Study|Death|0|||
28050456|NCT00537017|54708106|FG000|Treatment Phase|Adverse Event|19|||
28050457|NCT00537017|54708106|FG000|Treatment Phase|Withdrawal by Subject|13|||
28050458|NCT00537017|54708106|FG000|Treatment Phase|Protocol Violation|2|||
28050459|NCT00537017|54708106|FG000|Follow-up Phase|Withdrawal by Subject|9|||
28050460|NCT00348309|54708113|FG000|Overall Study|Adverse Event|56|||
28050461|NCT00348309|54708114|FG001|Overall Study|Adverse Event|28|||
28050462|NCT00348309|54708115|FG002|Overall Study|Adverse Event|63|||
28050463|NCT00348309|54708113|FG000|Overall Study|Lost to Follow-up|6|||
28050464|NCT00348309|54708114|FG001|Overall Study|Lost to Follow-up|7|||
28050465|NCT00348309|54708115|FG002|Overall Study|Lost to Follow-up|4|||
28050466|NCT00348309|54708113|FG000|Overall Study|Protocol Violation|7|||
28050467|NCT00348309|54708114|FG001|Overall Study|Protocol Violation|12|||
28050468|NCT00348309|54708115|FG002|Overall Study|Protocol Violation|7|||
28050469|NCT00348309|54708113|FG000|Overall Study|Withdrawal by Subject|33|||
28050470|NCT00348309|54708114|FG001|Overall Study|Withdrawal by Subject|37|||
28050471|NCT00348309|54708115|FG002|Overall Study|Withdrawal by Subject|40|||
28050472|NCT00348309|54708113|FG000|Overall Study|Non-compliance|8|||
28050473|NCT00348309|54708114|FG001|Overall Study|Non-compliance|6|||
28050474|NCT00348309|54708115|FG002|Overall Study|Non-compliance|8|||
28050475|NCT00348309|54708113|FG000|Overall Study|Death of caregiver|1|||
28050476|NCT00348309|54708114|FG001|Overall Study|Death of caregiver|0|||
28050477|NCT00348309|54708115|FG002|Overall Study|Death of caregiver|1|||
28050478|NCT00348309|54708113|FG000|Overall Study|Lack of insight, dementia|1|||
28050479|NCT00348309|54708114|FG001|Overall Study|Lack of insight, dementia|0|||
28050480|NCT00348309|54708115|FG002|Overall Study|Lack of insight, dementia|0|||
28050481|NCT00348309|54708113|FG000|Overall Study|Wrong bottle allocated|1|||
28050482|NCT00348309|54708114|FG001|Overall Study|Wrong bottle allocated|0|||
28050483|NCT00348309|54708115|FG002|Overall Study|Wrong bottle allocated|0|||
28050484|NCT00348309|54708113|FG000|Overall Study|Caregiver sick|1|||
28050485|NCT00348309|54708114|FG001|Overall Study|Caregiver sick|0|||
28050486|NCT00348309|54708115|FG002|Overall Study|Caregiver sick|0|||
28050487|NCT00348309|54708113|FG000|Overall Study|Use of prohibited medication|5|||
28050488|NCT00348309|54708114|FG001|Overall Study|Use of prohibited medication|2|||
28050489|NCT00348309|54708115|FG002|Overall Study|Use of prohibited medication|2|||
28050490|NCT00348309|54708113|FG000|Overall Study|Caregiver withdrawal|3|||
28050491|NCT00348309|54708114|FG001|Overall Study|Caregiver withdrawal|0|||
28050492|NCT00348309|54708115|FG002|Overall Study|Caregiver withdrawal|7|||
28050493|NCT00348309|54708113|FG000|Overall Study|Unable to complete ET visit|1|||
28050494|NCT00348309|54708114|FG001|Overall Study|Unable to complete ET visit|0|||
28050495|NCT00348309|54708115|FG002|Overall Study|Unable to complete ET visit|0|||
28050496|NCT00348309|54708113|FG000|Overall Study|PI closing medical practice|1|||
28050497|NCT00348309|54708114|FG001|Overall Study|PI closing medical practice|0|||
28050498|NCT00348309|54708115|FG002|Overall Study|PI closing medical practice|0|||
28050499|NCT00348309|54708113|FG000|Overall Study|Principal investigator's decision|1|||
28050500|NCT00348309|54708114|FG001|Overall Study|Principal investigator's decision|0|||
28050501|NCT00348309|54708115|FG002|Overall Study|Principal investigator's decision|0|||
28050502|NCT00348309|54708113|FG000|Overall Study|No disponibility of medication|1|||
28050503|NCT00348309|54708114|FG001|Overall Study|No disponibility of medication|0|||
28050504|NCT00348309|54708115|FG002|Overall Study|No disponibility of medication|0|||
28050505|NCT00348309|54708113|FG000|Overall Study|Worsened neurodegenerative disease|1|||
28050506|NCT00348309|54708114|FG001|Overall Study|Worsened neurodegenerative disease|0|||
28050507|NCT00348309|54708115|FG002|Overall Study|Worsened neurodegenerative disease|0|||
28050508|NCT00348309|54708113|FG000|Overall Study|Cognitive and behaviour worsening|2|||
28050509|NCT00348309|54708114|FG001|Overall Study|Cognitive and behaviour worsening|0|||
28050510|NCT00348309|54708115|FG002|Overall Study|Cognitive and behaviour worsening|0|||
28050511|NCT00348309|54708113|FG000|Overall Study|Worsening of alzheimer|1|||
28050512|NCT00348309|54708114|FG001|Overall Study|Worsening of alzheimer|0|||
28050513|NCT00348309|54708115|FG002|Overall Study|Worsening of alzheimer|1|||
28050514|NCT00348309|54708113|FG000|Overall Study|Did not appear in time for Visit 3|1|||
28050515|NCT00348309|54708114|FG001|Overall Study|Did not appear in time for Visit 3|0|||
28050516|NCT00348309|54708115|FG002|Overall Study|Did not appear in time for Visit 3|0|||
28050517|NCT00348309|54708113|FG000|Overall Study|Participant died|2|||
28050518|NCT00348309|54708114|FG001|Overall Study|Participant died|1|||
28050519|NCT00348309|54708115|FG002|Overall Study|Participant died|1|||
28050520|NCT00348309|54708113|FG000|Overall Study|Decision of sponsor|1|||
28050521|NCT00348309|54708114|FG001|Overall Study|Decision of sponsor|0|||
28050522|NCT00348309|54708115|FG002|Overall Study|Decision of sponsor|0|||
28050523|NCT00348309|54708113|FG000|Overall Study|Ineffectiveness of treatment|0|||
28050524|NCT00348309|54708114|FG001|Overall Study|Ineffectiveness of treatment|1|||
28050525|NCT00348309|54708115|FG002|Overall Study|Ineffectiveness of treatment|0|||
28050526|NCT00348309|54708113|FG000|Overall Study|A foul of exclusion criteria|0|||
28050527|NCT00348309|54708114|FG001|Overall Study|A foul of exclusion criteria|1|||
28050528|NCT00348309|54708115|FG002|Overall Study|A foul of exclusion criteria|0|||
28050529|NCT00348309|54708113|FG000|Overall Study|Participant was hospitalized|0|||
28050530|NCT00348309|54708114|FG001|Overall Study|Participant was hospitalized|1|||
28050531|NCT00348309|54708115|FG002|Overall Study|Participant was hospitalized|0|||
28050532|NCT00348309|54708113|FG000|Overall Study|Sponsor refuseal|0|||
28050533|NCT00348309|54708114|FG001|Overall Study|Sponsor refuseal|1|||
28050534|NCT00348309|54708115|FG002|Overall Study|Sponsor refuseal|1|||
28050535|NCT00348309|54708113|FG000|Overall Study|Forgot often medication|0|||
28050536|NCT00348309|54708114|FG001|Overall Study|Forgot often medication|1|||
28050537|NCT00348309|54708115|FG002|Overall Study|Forgot often medication|0|||
28050538|NCT00348309|54708113|FG000|Overall Study|Medical Monitor decision|0|||
28050539|NCT00348309|54708114|FG001|Overall Study|Medical Monitor decision|0|||
28050540|NCT00348309|54708115|FG002|Overall Study|Medical Monitor decision|1|||
28050541|NCT00348309|54708113|FG000|Overall Study|Increased dose of Aricept|0|||
28050542|NCT00348309|54708114|FG001|Overall Study|Increased dose of Aricept|0|||
28050543|NCT00348309|54708115|FG002|Overall Study|Increased dose of Aricept|1|||
28050544|NCT00348309|54708113|FG000|Overall Study|Site closure|0|||
28050545|NCT00348309|54708114|FG001|Overall Study|Site closure|0|||
28050546|NCT00348309|54708115|FG002|Overall Study|Site closure|1|||
28050547|NCT00348309|54708113|FG000|Overall Study|Adverse event not attended|0|||
28050548|NCT00348309|54708114|FG001|Overall Study|Adverse event not attended|0|||
28050549|NCT00348309|54708115|FG002|Overall Study|Adverse event not attended|1|||
28050550|NCT00348309|54708113|FG000|Overall Study|ECG abnormal|0|||
28050551|NCT00348309|54708114|FG001|Overall Study|ECG abnormal|0|||
28050552|NCT00348309|54708115|FG002|Overall Study|ECG abnormal|2|||
28050553|NCT00348309|54708113|FG000|Overall Study|Cardiologist recommendations|0|||
28050554|NCT00348309|54708114|FG001|Overall Study|Cardiologist recommendations|0|||
28050555|NCT00348309|54708115|FG002|Overall Study|Cardiologist recommendations|1|||
28050556|NCT00348309|54708113|FG000|Overall Study|HCV career|0|||
28050557|NCT00348309|54708114|FG001|Overall Study|HCV career|0|||
28050558|NCT00348309|54708115|FG002|Overall Study|HCV career|1|||
28050559|NCT00440310|54708126|FG000|Overall Study|Lost to Follow-up|4|||
28050560|NCT00440310|54708127|FG001|Overall Study|Lost to Follow-up|5|||
28050561|NCT00440310|54708126|FG000|Overall Study|Protocol Violation|0|||
28050562|NCT00440310|54708127|FG001|Overall Study|Protocol Violation|1|||
28050563|NCT00440310|54708126|FG000|Overall Study|Withdrawal by Subject|15|||
28050564|NCT00440310|54708127|FG001|Overall Study|Withdrawal by Subject|14|||
28050565|NCT00440310|54708126|FG000|Overall Study|No Reply at EOS|7|||
28050566|NCT00440310|54708127|FG001|Overall Study|No Reply at EOS|7|||
28050567|NCT00440310|54708126|FG000|Overall Study|Other|1|||
27812270|NCT01712061|54268250|FG002|Overall Study|Medication Error Without Associated AE|0|||
27812271|NCT01712061|54268248|FG000|Overall Study|Withdrawal by Subject|1|||
27812272|NCT01712061|54268249|FG001|Overall Study|Withdrawal by Subject|7|||
27812273|NCT01712061|54268250|FG002|Overall Study|Withdrawal by Subject|1|||
27812274|NCT01712061|54268248|FG000|Overall Study|Other|0|||
27812275|NCT01712061|54268249|FG001|Overall Study|Other|3|||
27812276|NCT01712061|54268250|FG002|Overall Study|Other|0|||
27812277|NCT03592186|54268261|FG000|Overall Study|Withdrawal by Subject|1|||
27812278|NCT03592186|54268262|FG001|Overall Study|Withdrawal by Subject|0|||
27812279|NCT03592186|54268261|FG000|Overall Study|Lost to Follow-up|16|||
27812280|NCT03592186|54268262|FG001|Overall Study|Lost to Follow-up|11|||
27812281|NCT03598114|54268270|FG000|Overall Study|Staff turnover/left the program|3|||
27812282|NCT03598114|54268271|FG001|Overall Study|Staff turnover/left the program|39|||
27812283|NCT01711983|54268298|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|32|||
28050568|NCT00440310|54708127|FG001|Overall Study|Other|0|||
28050569|NCT00440310|54708126|FG000|Overall Study|Status Unknown|1|||
28050570|NCT00440310|54708127|FG001|Overall Study|Status Unknown|3|||
27812284|NCT01711983|54268298|FG000|6-Month Closure Evaluation|Technical Failure (No Test Device)|26|||
27812285|NCT01711983|54268298|FG000|36-Month Closure Evaluation|Test Device Removal|2|||
27812286|NCT01711983|54268298|FG000|36-Month Closure Evaluation|Missed Echocardiograph|62|||
28050571|NCT00440232|54708135|FG000|Overall Study|Lost to Follow-up|1|||
28050572|NCT00440232|54708136|FG001|Overall Study|Lost to Follow-up|1|||
28050573|NCT00440232|54708135|FG000|Overall Study|Unable to treat within allowed time|0|||
28050574|NCT00440232|54708136|FG001|Overall Study|Unable to treat within allowed time|1|||
28050575|NCT00440232|54708135|FG000|Overall Study|Onset of headache within 4 hours of fast|2|||
28050576|NCT00440232|54708136|FG001|Overall Study|Onset of headache within 4 hours of fast|2|||
28050577|NCT00356889|54708142|FG000|Overall Study|Protocol Violation|2|||
28050578|NCT00356889|54708142|FG000|Overall Study|Adverse Event|1|||
28050579|NCT00356811|54708147|FG000|Overall Study|Death|35|||
28050580|NCT00356811|54708147|FG000|Overall Study|Lost to Follow-up|2|||
27812287|NCT01874288|54268312|FG000|Overall Study|Withdrawal by Subject|1|||
27812288|NCT01874288|54268313|FG001|Overall Study|Withdrawal by Subject|0|||
27812289|NCT01874288|54268314|FG002|Overall Study|Withdrawal by Subject|2|||
27812290|NCT01874288|54268315|FG003|Overall Study|Withdrawal by Subject|1|||
27812291|NCT01874288|54268316|FG004|Overall Study|Withdrawal by Subject|1|||
27812292|NCT01874288|54268312|FG000|Overall Study|Physician Decision|0|||
27812293|NCT01874288|54268313|FG001|Overall Study|Physician Decision|0|||
27812294|NCT01874288|54268314|FG002|Overall Study|Physician Decision|0|||
27812295|NCT01874288|54268315|FG003|Overall Study|Physician Decision|1|||
27812296|NCT01874288|54268316|FG004|Overall Study|Physician Decision|0|||
27812297|NCT01874288|54268312|FG000|Overall Study|Progressive disease|2|||
27812298|NCT01874288|54268313|FG001|Overall Study|Progressive disease|0|||
27812299|NCT01874288|54268314|FG002|Overall Study|Progressive disease|3|||
27848200|NCT00983749|54341137|FG001|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3|||
27848201|NCT01046253|54341145|FG000|Second Intervention|Adverse Event|0|||
27848202|NCT01046253|54341146|FG001|Second Intervention|Adverse Event|1|||
28050581|NCT00356811|54708147|FG000|Overall Study|Withdrawal by Subject|6|||
28050582|NCT00356811|54708147|FG000|Overall Study|Participant Could Not Make a Checkup|1|||
28050583|NCT00356811|54708147|FG000|Overall Study|Study Is Terminating|3|||
28050584|NCT00356811|54708147|FG000|Overall Study|Site Closed during Follow-up|2|||
28050585|NCT00439218|54708152|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
28050586|NCT00535223|54708171|FG000|Overall Study|Withdrawal by Subject|4|||
28050587|NCT00535223|54708172|FG001|Overall Study|Withdrawal by Subject|1|||
28050588|NCT00536939|54708178|FG000|Overall Study|Withdrawal by Subject|1|||
28050589|NCT00536939|54708179|FG001|Overall Study|Withdrawal by Subject|0|||
28050590|NCT00536939|54708178|FG000|Overall Study|Other Complicating Disease|1|||
28050591|NCT00536939|54708179|FG001|Overall Study|Other Complicating Disease|0|||
28050592|NCT00347919|54708187|FG000|Overall Study|Lost to Follow-up|11|||
28050593|NCT00347919|54708188|FG001|Overall Study|Lost to Follow-up|13|||
28050594|NCT00347919|54708189|FG002|Overall Study|Lost to Follow-up|0|||
28050595|NCT00347919|54708187|FG000|Overall Study|Withdrawal by Subject|6|||
28050596|NCT00347919|54708188|FG001|Overall Study|Withdrawal by Subject|8|||
28050597|NCT00347919|54708189|FG002|Overall Study|Withdrawal by Subject|0|||
28050598|NCT00347919|54708187|FG000|Overall Study|Physician Decision|1|||
28050599|NCT00347919|54708188|FG001|Overall Study|Physician Decision|1|||
28050600|NCT00347919|54708189|FG002|Overall Study|Physician Decision|0|||
28050601|NCT00347919|54708187|FG000|Overall Study|Sponsor terminated study|15|||
28050602|NCT00347919|54708188|FG001|Overall Study|Sponsor terminated study|10|||
28050603|NCT00347919|54708189|FG002|Overall Study|Sponsor terminated study|16|||
28050604|NCT00347919|54708187|FG000|Overall Study|Death|35|||
28050605|NCT00347919|54708188|FG001|Overall Study|Death|42|||
28050606|NCT00347919|54708189|FG002|Overall Study|Death|19|||
28050607|NCT00347919|54708187|FG000|Overall Study|Par. Started Other Treatment|1|||
28050608|NCT00347919|54708188|FG001|Overall Study|Par. Started Other Treatment|1|||
28050609|NCT00347919|54708189|FG002|Overall Study|Par. Started Other Treatment|1|||
28050610|NCT00347919|54708187|FG000|Overall Study|Missing|2|||
28050611|NCT00347919|54708188|FG001|Overall Study|Missing|1|||
28050612|NCT00347919|54708189|FG002|Overall Study|Missing|2|||
28050613|NCT00439140|54708202|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
28050614|NCT00439140|54708203|FG001|Treatment Cycle 1|Lost to Follow-up|1|||
28050615|NCT00439140|54708204|FG002|Treatment Cycle 1|Lost to Follow-up|1|||
28050616|NCT00439140|54708202|FG000|Treatment Cycle 1|Personal reasons|0|||
28050617|NCT00439140|54708203|FG001|Treatment Cycle 1|Personal reasons|2|||
28050618|NCT00439140|54708204|FG002|Treatment Cycle 1|Personal reasons|0|||
28050619|NCT00439140|54708202|FG000|Treatment Cycle 1|Withdrawal by Subject|0|||
28050620|NCT00439140|54708203|FG001|Treatment Cycle 1|Withdrawal by Subject|1|||
28050621|NCT00439140|54708204|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
28050622|NCT00439140|54708202|FG000|Treatment Cycle 2|Withdrawal by Subject|1|||
28050623|NCT00439140|54708203|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
28050624|NCT00439140|54708204|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
28050625|NCT00439140|54708202|FG000|Treatment Cycle 2|Lost to Follow-up|1|||
28050626|NCT00439140|54708203|FG001|Treatment Cycle 2|Lost to Follow-up|1|||
28050627|NCT00439140|54708204|FG002|Treatment Cycle 2|Lost to Follow-up|0|||
28050628|NCT00356421|54708214|FG000|Overall Study|Lack of Efficacy|3|||
28050629|NCT00356421|54708215|FG001|Overall Study|Lack of Efficacy|0|||
28050630|NCT00356421|54708214|FG000|Overall Study|Withdrawal by Subject|9|||
28050631|NCT00356421|54708215|FG001|Overall Study|Withdrawal by Subject|2|||
27812300|NCT01874288|54268315|FG003|Overall Study|Progressive disease|5|||
27812301|NCT01874288|54268316|FG004|Overall Study|Progressive disease|1|||
28050632|NCT00356421|54708214|FG000|Overall Study|Related to study drug|15|||
28050633|NCT00356421|54708215|FG001|Overall Study|Related to study drug|12|||
28050634|NCT00356421|54708214|FG000|Overall Study|Not related to study drug|5|||
28050635|NCT00356421|54708215|FG001|Overall Study|Not related to study drug|3|||
28050636|NCT00443820|54708225|FG000|Overall Study|Adverse Event|1|||
27812302|NCT01874054|54268345|FG000|Overall Study|Withdrawal by Subject|3|||
27812303|NCT01874054|54268345|FG000|Overall Study|Study Termination by Sponsor|42|||
27812304|NCT01874054|54268345|FG000|Overall Study|Lost to Follow-up|5|||
28050637|NCT00443820|54708226|FG001|Overall Study|Adverse Event|1|||
28050638|NCT00443820|54708227|FG002|Overall Study|Adverse Event|0|||
28050639|NCT00443820|54708228|FG003|Overall Study|Adverse Event|0|||
28050640|NCT00443820|54708225|FG000|Overall Study|Lack of Efficacy|3|||
28050641|NCT00443820|54708226|FG001|Overall Study|Lack of Efficacy|2|||
28050642|NCT00443820|54708227|FG002|Overall Study|Lack of Efficacy|1|||
28050643|NCT00443820|54708228|FG003|Overall Study|Lack of Efficacy|1|||
28050644|NCT00443820|54708225|FG000|Overall Study|Protocol Violation|2|||
28050645|NCT00443820|54708226|FG001|Overall Study|Protocol Violation|1|||
28050646|NCT00443820|54708227|FG002|Overall Study|Protocol Violation|2|||
28050647|NCT00443820|54708228|FG003|Overall Study|Protocol Violation|1|||
28050648|NCT00443820|54708225|FG000|Overall Study|Withdrawal by Subject|6|||
28050649|NCT00443820|54708226|FG001|Overall Study|Withdrawal by Subject|7|||
28050650|NCT00443820|54708227|FG002|Overall Study|Withdrawal by Subject|8|||
28050651|NCT00443820|54708228|FG003|Overall Study|Withdrawal by Subject|9|||
28050652|NCT00443820|54708225|FG000|Overall Study|Lost to Follow-up|9|||
28050653|NCT00443820|54708226|FG001|Overall Study|Lost to Follow-up|8|||
28050654|NCT00443820|54708227|FG002|Overall Study|Lost to Follow-up|6|||
28050655|NCT00443820|54708228|FG003|Overall Study|Lost to Follow-up|5|||
28050656|NCT00443820|54708225|FG000|Overall Study|Administrative problems|0|||
28050657|NCT00443820|54708226|FG001|Overall Study|Administrative problems|0|||
28050658|NCT00443820|54708227|FG002|Overall Study|Administrative problems|0|||
28050659|NCT00443820|54708228|FG003|Overall Study|Administrative problems|1|||
28050660|NCT00443820|54708225|FG000|Overall Study|Death|0|||
28050661|NCT00443820|54708226|FG001|Overall Study|Death|0|||
28050662|NCT00443820|54708227|FG002|Overall Study|Death|1|||
28050663|NCT00443820|54708228|FG003|Overall Study|Death|0|||
28050664|NCT00438672|54708240|FG000|Overall Study|Lost to Follow-up|7|||
28050665|NCT00438672|54708241|FG001|Overall Study|Lost to Follow-up|9|||
28050666|NCT00438360|54708249|FG000|Overall Study|Adverse Event|6|||
28050667|NCT00438360|54708250|FG001|Overall Study|Adverse Event|1|||
28050668|NCT00438360|54708249|FG000|Overall Study|Lack of Efficacy|42|||
28050669|NCT00438360|54708250|FG001|Overall Study|Lack of Efficacy|27|||
28050670|NCT00438360|54708249|FG000|Overall Study|Other|24|||
28050671|NCT00438360|54708250|FG001|Overall Study|Other|15|||
28050672|NCT00536471|54708260|FG000|Overall Study|Lost to Follow-up|48|||
28050673|NCT00536471|54708261|FG001|Overall Study|Lost to Follow-up|23|||
28050674|NCT00536471|54708262|FG002|Overall Study|Lost to Follow-up|48|||
28050675|NCT00536471|54708263|FG003|Overall Study|Lost to Follow-up|22|||
28050676|NCT00536471|54708260|FG000|Overall Study|Adverse Event|32|||
28050677|NCT00536471|54708261|FG001|Overall Study|Adverse Event|16|||
28050678|NCT00536471|54708262|FG002|Overall Study|Adverse Event|28|||
28050679|NCT00536471|54708263|FG003|Overall Study|Adverse Event|13|||
28050680|NCT00536471|54708260|FG000|Overall Study|Withdrawal by Subject|40|||
28050681|NCT00536471|54708261|FG001|Overall Study|Withdrawal by Subject|24|||
28050682|NCT00536471|54708262|FG002|Overall Study|Withdrawal by Subject|43|||
28050683|NCT00536471|54708263|FG003|Overall Study|Withdrawal by Subject|21|||
28050684|NCT00536471|54708260|FG000|Overall Study|Lack of Efficacy|17|||
28050685|NCT00536471|54708261|FG001|Overall Study|Lack of Efficacy|18|||
28050686|NCT00536471|54708262|FG002|Overall Study|Lack of Efficacy|11|||
28050687|NCT00536471|54708263|FG003|Overall Study|Lack of Efficacy|9|||
28050688|NCT00536471|54708260|FG000|Overall Study|Protocol Violation|8|||
27812305|NCT01874054|54268345|FG000|Overall Study|Death|5|||
27812306|NCT01873742|54268351|FG000|Overall Study|Lost to Follow-up|68|||
27812307|NCT01873742|54268352|FG001|Overall Study|Lost to Follow-up|76|||
27812308|NCT01873586|54268358|FG000|Overall Study|Lost to Follow-up|3|||
27812309|NCT01849562|54268368|FG000|Overall Study|Lost to Follow-up|1|||
27812310|NCT01849562|54268369|FG001|Overall Study|Lost to Follow-up|0|||
27812311|NCT01849562|54268370|FG002|Overall Study|Lost to Follow-up|0|||
27812312|NCT01849562|54268368|FG000|Overall Study|Non-compliance with Study Drug|1|||
27812313|NCT01849562|54268369|FG001|Overall Study|Non-compliance with Study Drug|0|||
27812314|NCT01849562|54268370|FG002|Overall Study|Non-compliance with Study Drug|0|||
27812315|NCT04027348|54268406|FG000|Overall Study|Adverse Event|2|||
27812316|NCT04196686|54268419|FG000|First Treatment (4 Minutes)|Withdrawal by Subject|0|||
27812317|NCT04196686|54268420|FG001|First Treatment (4 Minutes)|Withdrawal by Subject|3|||
28050689|NCT00536471|54708261|FG001|Overall Study|Protocol Violation|1|||
28050690|NCT00536471|54708262|FG002|Overall Study|Protocol Violation|2|||
28050691|NCT00536471|54708263|FG003|Overall Study|Protocol Violation|3|||
28050692|NCT00536471|54708260|FG000|Overall Study|Physician Decision|11|||
28050693|NCT00536471|54708261|FG001|Overall Study|Physician Decision|1|||
28050694|NCT00536471|54708262|FG002|Overall Study|Physician Decision|3|||
28050695|NCT00536471|54708263|FG003|Overall Study|Physician Decision|2|||
27812318|NCT01611974|54268429|FG000|Overall Study|Death|10|||
27812319|NCT01611974|54268430|FG001|Overall Study|Death|12|||
27812320|NCT01611974|54268431|FG002|Overall Study|Death|10|||
28050696|NCT00536471|54708260|FG000|Overall Study|Death|0|||
28050697|NCT00536471|54708261|FG001|Overall Study|Death|0|||
28050698|NCT00536471|54708262|FG002|Overall Study|Death|1|||
28050699|NCT00536471|54708263|FG003|Overall Study|Death|2|||
28050700|NCT00536471|54708260|FG000|Overall Study|Sponsor Decision|0|||
28050701|NCT00536471|54708261|FG001|Overall Study|Sponsor Decision|1|||
28050702|NCT00536471|54708262|FG002|Overall Study|Sponsor Decision|3|||
28050703|NCT00536471|54708263|FG003|Overall Study|Sponsor Decision|2|||
28050704|NCT00359619|54708287|FG000|Overall Study|Adverse Event|0|||
28050705|NCT00359619|54708288|FG001|Overall Study|Adverse Event|0|||
28050706|NCT00359619|54708289|FG002|Overall Study|Adverse Event|1|||
28050707|NCT00359619|54708290|FG003|Overall Study|Adverse Event|0|||
28050708|NCT00359619|54708291|FG004|Overall Study|Adverse Event|0|||
28050709|NCT00359619|54708292|FG005|Overall Study|Adverse Event|0|||
28050710|NCT00359619|54708293|FG006|Overall Study|Adverse Event|1|||
28050711|NCT00359619|54708287|FG000|Overall Study|Withdrawal by Subject|3|||
28050712|NCT00359619|54708288|FG001|Overall Study|Withdrawal by Subject|1|||
28050713|NCT00359619|54708289|FG002|Overall Study|Withdrawal by Subject|4|||
28050714|NCT00359619|54708290|FG003|Overall Study|Withdrawal by Subject|2|||
28050715|NCT00359619|54708291|FG004|Overall Study|Withdrawal by Subject|2|||
27812321|NCT01611974|54268429|FG000|Overall Study|Lost to Follow-up|0|||
27812322|NCT01611974|54268430|FG001|Overall Study|Lost to Follow-up|1|||
27812323|NCT01611974|54268431|FG002|Overall Study|Lost to Follow-up|0|||
27812324|NCT01611974|54268429|FG000|Overall Study|Physician Decision|5|||
27812325|NCT01611974|54268430|FG001|Overall Study|Physician Decision|1|||
27812326|NCT01611974|54268431|FG002|Overall Study|Physician Decision|2|||
27812327|NCT01611974|54268429|FG000|Overall Study|Withdrawal by Subject|0|||
27812328|NCT01611974|54268430|FG001|Overall Study|Withdrawal by Subject|1|||
27812329|NCT01611974|54268431|FG002|Overall Study|Withdrawal by Subject|4|||
27812330|NCT01848938|54268441|FG000|Overall Study|Lost to Follow-up|1|||
27812331|NCT01848938|54268442|FG001|Overall Study|Lost to Follow-up|1|||
27812332|NCT01871870|54268448|FG000|Overall Study|Hardware issues|7|||
27812333|NCT01871870|54268448|FG000|Overall Study|hyperglycemia|2|||
27812334|NCT01871558|54268461|FG000|Overall Study|Other reason|0|||
27812335|NCT01871558|54268462|FG001|Overall Study|Other reason|1|||
27812336|NCT01871558|54268461|FG000|Overall Study|antidiabetic drug prematurely stopped|1|||
27812337|NCT01871558|54268462|FG001|Overall Study|antidiabetic drug prematurely stopped|1|||
27812338|NCT01871558|54268461|FG000|Overall Study|Withdrawal by Subject|2|||
27812339|NCT01871558|54268462|FG001|Overall Study|Withdrawal by Subject|0|||
27812340|NCT01711359|54268471|FG000|Treatment Period|Withdrawal by Subject|18|||
27812341|NCT01711359|54268472|FG001|Treatment Period|Withdrawal by Subject|7|||
27812342|NCT01711359|54268473|FG002|Treatment Period|Withdrawal by Subject|13|||
27812343|NCT01711359|54268471|FG000|Treatment Period|Lack of Efficacy|13|||
27812344|NCT01711359|54268472|FG001|Treatment Period|Lack of Efficacy|2|||
27812345|NCT01711359|54268473|FG002|Treatment Period|Lack of Efficacy|2|||
27812346|NCT01711359|54268471|FG000|Treatment Period|Adverse Event|8|||
27812347|NCT01711359|54268472|FG001|Treatment Period|Adverse Event|10|||
27812348|NCT01711359|54268473|FG002|Treatment Period|Adverse Event|24|||
27812349|NCT01711359|54268471|FG000|Treatment Period|Physician Decision|4|||
27812350|NCT01711359|54268472|FG001|Treatment Period|Physician Decision|3|||
27812351|NCT01711359|54268473|FG002|Treatment Period|Physician Decision|2|||
27812352|NCT01711359|54268471|FG000|Treatment Period|Death|3|||
27812353|NCT01711359|54268472|FG001|Treatment Period|Death|0|||
27812354|NCT01711359|54268473|FG002|Treatment Period|Death|0|||
27812355|NCT01711359|54268471|FG000|Treatment Period|Entry Criteria Not Met|1|||
27812356|NCT01711359|54268472|FG001|Treatment Period|Entry Criteria Not Met|0|||
27812357|NCT01711359|54268473|FG002|Treatment Period|Entry Criteria Not Met|0|||
27812358|NCT01711359|54268471|FG000|Treatment Period|Sponsor Decision|1|||
27812359|NCT01711359|54268472|FG001|Treatment Period|Sponsor Decision|0|||
27812360|NCT01711359|54268473|FG002|Treatment Period|Sponsor Decision|0|||
27812361|NCT01711359|54268471|FG000|Treatment Period|Lost to Follow-up|1|||
27812362|NCT01711359|54268472|FG001|Treatment Period|Lost to Follow-up|1|||
27812363|NCT01711359|54268473|FG002|Treatment Period|Lost to Follow-up|1|||
27812364|NCT01711359|54268471|FG000|Treatment Period|Randomized, Not Treated|3|||
27812365|NCT01711359|54268472|FG001|Treatment Period|Randomized, Not Treated|1|||
27812366|NCT01711359|54268473|FG002|Treatment Period|Randomized, Not Treated|0|||
27812367|NCT01710657|54268500|FG000|Overall Study|Lost to Follow-up|2|||
27848203|NCT01046253|54341145|FG000|Second Intervention|Protocol Violation|0|||
28050716|NCT00359619|54708292|FG005|Overall Study|Withdrawal by Subject|0|||
28050717|NCT00359619|54708293|FG006|Overall Study|Withdrawal by Subject|3|||
28050718|NCT00359619|54708287|FG000|Overall Study|Other|1|||
28050719|NCT00359619|54708288|FG001|Overall Study|Other|0|||
27812368|NCT01710657|54268501|FG001|Overall Study|Lost to Follow-up|0|||
27812369|NCT01710657|54268502|FG002|Overall Study|Lost to Follow-up|1|||
27812370|NCT01710657|54268500|FG000|Overall Study|Protocol Violation|2|||
28050720|NCT00359619|54708289|FG002|Overall Study|Other|0|||
28050721|NCT00359619|54708290|FG003|Overall Study|Other|0|||
27812371|NCT01710657|54268501|FG001|Overall Study|Protocol Violation|2|||
27812372|NCT01710657|54268502|FG002|Overall Study|Protocol Violation|0|||
27812373|NCT01710657|54268500|FG000|Overall Study|Adverse Event|14|||
27812374|NCT01710657|54268501|FG001|Overall Study|Adverse Event|8|||
27812375|NCT01710657|54268502|FG002|Overall Study|Adverse Event|28|||
27812376|NCT01710657|54268500|FG000|Overall Study|Withdrawal by Subject|0|||
27812377|NCT01710657|54268501|FG001|Overall Study|Withdrawal by Subject|1|||
28050722|NCT00359619|54708291|FG004|Overall Study|Other|0|||
28050723|NCT00359619|54708292|FG005|Overall Study|Other|0|||
28050724|NCT00359619|54708293|FG006|Overall Study|Other|0|||
28050725|NCT00359619|54708287|FG000|Overall Study|Lost to Follow-up|4|||
28050726|NCT00359619|54708288|FG001|Overall Study|Lost to Follow-up|4|||
28050727|NCT00359619|54708289|FG002|Overall Study|Lost to Follow-up|2|||
28050728|NCT00359619|54708290|FG003|Overall Study|Lost to Follow-up|1|||
28050729|NCT00359619|54708291|FG004|Overall Study|Lost to Follow-up|1|||
28050730|NCT00359619|54708292|FG005|Overall Study|Lost to Follow-up|5|||
28050731|NCT00359619|54708293|FG006|Overall Study|Lost to Follow-up|0|||
28050732|NCT00437658|54708312|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
28050733|NCT00437658|54708313|FG001|Treatment Period (24 Weeks)|Adverse Event|7|||
28050734|NCT00437658|54708314|FG002|Treatment Period (24 Weeks)|Adverse Event|14|||
28050735|NCT00437658|54708312|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
28050736|NCT00437658|54708313|FG001|Treatment Period (24 Weeks)|Non-compliance|1|||
28050737|NCT00437658|54708314|FG002|Treatment Period (24 Weeks)|Non-compliance|4|||
28050738|NCT00437658|54708312|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|9|||
28050739|NCT00437658|54708313|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
28050740|NCT00437658|54708314|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
28050741|NCT00437658|54708312|FG000|Treatment Period (24 Weeks)|Lack of Efficacy|4|||
28050742|NCT00437658|54708313|FG001|Treatment Period (24 Weeks)|Lack of Efficacy|2|||
28050743|NCT00437658|54708314|FG002|Treatment Period (24 Weeks)|Lack of Efficacy|3|||
28050744|NCT00437658|54708312|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
28050745|NCT00437658|54708313|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|4|||
28050746|NCT00437658|54708314|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
28050747|NCT00437658|54708312|FG000|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5|||
28050748|NCT00437658|54708313|FG001|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
28050749|NCT00437658|54708314|FG002|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
28050750|NCT00437658|54708312|FG000|Post-treatment Period (24 Weeks)|Adverse Event|1|||
28050751|NCT00437658|54708313|FG001|Post-treatment Period (24 Weeks)|Adverse Event|0|||
28050752|NCT00437658|54708314|FG002|Post-treatment Period (24 Weeks)|Adverse Event|1|||
28050753|NCT00437658|54708312|FG000|Post-treatment Period (24 Weeks)|Non-compliance|3|||
28050754|NCT00437658|54708313|FG001|Post-treatment Period (24 Weeks)|Non-compliance|0|||
28050755|NCT00437658|54708314|FG002|Post-treatment Period (24 Weeks)|Non-compliance|1|||
28050756|NCT00437658|54708312|FG000|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12|||
28050757|NCT00437658|54708313|FG001|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6|||
28050758|NCT00437658|54708314|FG002|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8|||
28050759|NCT00437658|54708312|FG000|Post-treatment Period (24 Weeks)|Lack of Efficacy|0|||
28050760|NCT00437658|54708313|FG001|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
28050761|NCT00437658|54708314|FG002|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
28050762|NCT00437658|54708312|FG000|Post-treatment Period (24 Weeks)|Lost to Follow-up|5|||
28050763|NCT00437658|54708313|FG001|Post-treatment Period (24 Weeks)|Lost to Follow-up|0|||
28050764|NCT00437658|54708314|FG002|Post-treatment Period (24 Weeks)|Lost to Follow-up|1|||
28050765|NCT00437658|54708312|FG000|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3|||
28050766|NCT00437658|54708313|FG001|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
28050767|NCT00437658|54708314|FG002|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
28050768|NCT03828747|54708324|FG000|Double-Blind Treatment Period|Adverse Event|6|||
28050769|NCT03828747|54708325|FG001|Double-Blind Treatment Period|Adverse Event|6|||
28050770|NCT03828747|54708324|FG000|Double-Blind Treatment Period|Death|1|||
28050771|NCT03828747|54708325|FG001|Double-Blind Treatment Period|Death|2|||
28050772|NCT03828747|54708324|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
28050773|NCT03828747|54708325|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
28050774|NCT03828747|54708324|FG000|Double-Blind Treatment Period|Withdrawal by Subject|19|||
28050775|NCT03828747|54708325|FG001|Double-Blind Treatment Period|Withdrawal by Subject|21|||
28050776|NCT03828747|54708324|FG000|Double-Blind Treatment Period|Physician Decision|0|||
28050777|NCT03828747|54708325|FG001|Double-Blind Treatment Period|Physician Decision|3|||
28050778|NCT03828747|54708324|FG000|Double-Blind Treatment Period|Various reasons|5|||
28050779|NCT03828747|54708325|FG001|Double-Blind Treatment Period|Various reasons|3|||
28050780|NCT03828747|54708324|FG000|Open-Label Extension|Continuing on Study|77|||
28050781|NCT03828747|54708325|FG001|Open-Label Extension|Continuing on Study|72|||
28050782|NCT03828747|54708324|FG000|Open-Label Extension|Adverse Event|3|||
28050783|NCT03828747|54708325|FG001|Open-Label Extension|Adverse Event|4|||
28050784|NCT03828747|54708324|FG000|Open-Label Extension|Death|0|||
28050785|NCT03828747|54708325|FG001|Open-Label Extension|Death|2|||
28050786|NCT03828747|54708324|FG000|Open-Label Extension|Lost to Follow-up|4|||
28050787|NCT03828747|54708325|FG001|Open-Label Extension|Lost to Follow-up|0|||
28050788|NCT03828747|54708324|FG000|Open-Label Extension|Withdrawal by Subject|19|||
28050789|NCT03828747|54708325|FG001|Open-Label Extension|Withdrawal by Subject|16|||
28050790|NCT03828747|54708324|FG000|Open-Label Extension|Various reasons|1|||
28050791|NCT03828747|54708325|FG001|Open-Label Extension|Various reasons|1|||
28050792|NCT00356265|54708335|FG000|Overall Study|Withdrawal by Subject|0|||
28050793|NCT00356265|54708336|FG001|Overall Study|Withdrawal by Subject|0|||
28050794|NCT00356265|54708337|FG002|Overall Study|Withdrawal by Subject|1|||
28050795|NCT00535145|54708346|FG000|Phase I|Adverse Event|3|||
28050796|NCT00535145|54708346|FG000|Phase I|Lost to Follow-up|7|||
28050797|NCT00535145|54708346|FG000|Phase I|Withdrawal by Subject|6|||
28050798|NCT00535145|54708346|FG000|Phase I|(eligibility)|8|||
28050799|NCT00535145|54708346|FG000|Phase I|(protocol violation)|1|||
28050800|NCT00535145|54708346|FG000|Phase I|(PI decision)|1|||
28050801|NCT00535145|54708346|FG000|Phase I|(diagnosis)|3|||
28050802|NCT00535145|54708346|FG000|Phase II|Adverse Event|2|||
28050803|NCT00535145|54708346|FG000|Phase II|Lack of Efficacy|1|||
28050804|NCT00535145|54708346|FG000|Phase II|Lost to Follow-up|5|||
28050805|NCT00535145|54708346|FG000|Phase II|Withdrawal by Subject|5|||
28050806|NCT00535145|54708346|FG000|Phase II|Subject non-compliance|2|||
28050807|NCT00437268|54708356|FG000|Overall Study|Adverse Event|1|||
28050808|NCT00437268|54708357|FG001|Overall Study|Adverse Event|1|||
28050809|NCT00437268|54708356|FG000|Overall Study|Withdrawal by Subject|2|||
28050810|NCT00437268|54708357|FG001|Overall Study|Withdrawal by Subject|2|||
28050811|NCT00437268|54708356|FG000|Overall Study|Progressive disease|9|||
28050812|NCT00437268|54708357|FG001|Overall Study|Progressive disease|9|||
28050813|NCT00437268|54708356|FG000|Overall Study|Physician Decision|1|||
28050814|NCT00437268|54708357|FG001|Overall Study|Physician Decision|0|||
28050815|NCT00437268|54708356|FG000|Overall Study|Death|0|||
28050816|NCT00437268|54708357|FG001|Overall Study|Death|1|||
28050817|NCT00437034|54708365|FG000|Overall Study|Adverse Event|1|||
28050818|NCT00437034|54708365|FG000|Overall Study|Disease progression during treatment|5|||
28050819|NCT00337467|54708369|FG000|Overall Study|Adverse Event|3|||
28050820|NCT00337467|54708369|FG000|Overall Study|Subject Withdrew Consent|2|||
28050821|NCT00337467|54708369|FG000|Overall Study|Pregnancy|1|||
28050822|NCT00337467|54708369|FG000|Overall Study|Lost to Follow-up|2|||
28050823|NCT00337467|54708369|FG000|Overall Study|Subject No Longer Met Study Criteria|2|||
28050824|NCT00337077|54708379|FG000|Overall Study|Progressive disease|25|||
28050825|NCT00337077|54708380|FG001|Overall Study|Progressive disease|37|||
28050826|NCT00337077|54708381|FG002|Overall Study|Progressive disease|19|||
28050827|NCT00337077|54708379|FG000|Overall Study|Adverse Event|7|||
28050828|NCT00337077|54708380|FG001|Overall Study|Adverse Event|7|||
28050829|NCT00337077|54708381|FG002|Overall Study|Adverse Event|1|||
28050830|NCT00337077|54708379|FG000|Overall Study|Death|0|||
28050831|NCT00337077|54708380|FG001|Overall Study|Death|1|||
28050832|NCT00337077|54708381|FG002|Overall Study|Death|0|||
28050833|NCT00337077|54708379|FG000|Overall Study|Withdrawal by Subject|7|||
28050834|NCT00337077|54708380|FG001|Overall Study|Withdrawal by Subject|2|||
28050835|NCT00337077|54708381|FG002|Overall Study|Withdrawal by Subject|2|||
28050836|NCT00337077|54708379|FG000|Overall Study|Alternative therapy|1|||
28050837|NCT00337077|54708380|FG001|Overall Study|Alternative therapy|0|||
28050838|NCT00337077|54708381|FG002|Overall Study|Alternative therapy|0|||
28050839|NCT00337077|54708379|FG000|Overall Study|Physician Decision|1|||
28050840|NCT00337077|54708380|FG001|Overall Study|Physician Decision|4|||
28050841|NCT00337077|54708381|FG002|Overall Study|Physician Decision|2|||
28050842|NCT00337077|54708379|FG000|Overall Study|Never started treatment|1|||
28050843|NCT00337077|54708380|FG001|Overall Study|Never started treatment|1|||
28050844|NCT00337077|54708381|FG002|Overall Study|Never started treatment|0|||
28050845|NCT00337077|54708379|FG000|Overall Study|Ineligible|1|||
28050846|NCT00337077|54708380|FG001|Overall Study|Ineligible|1|||
28050847|NCT00337077|54708381|FG002|Overall Study|Ineligible|1|||
28050848|NCT00428220|54708387|FG000|Overall Study|Participant died|8|||
28050849|NCT00428220|54708387|FG000|Overall Study|Global deterioration of health status|7|||
28050850|NCT00428220|54708387|FG000|Overall Study|Lost to Follow-up|4|||
28050851|NCT00428220|54708387|FG000|Overall Study|Objective progression or relapse|123|||
28050852|NCT00428220|54708387|FG000|Overall Study|Participant refused continued treatment|7|||
28050853|NCT00428220|54708387|FG000|Overall Study|Adverse Event|51|||
28050854|NCT00428220|54708387|FG000|Overall Study|Other|23|||
28050855|NCT00345579|54708417|FG000|Overall Study|Adverse Event|9|||
28050856|NCT00345579|54708418|FG001|Overall Study|Adverse Event|6|||
28050857|NCT00345579|54708417|FG000|Overall Study|Protocol Violation|14|||
28050858|NCT00345579|54708418|FG001|Overall Study|Protocol Violation|5|||
28050859|NCT00345579|54708417|FG000|Overall Study|Withdrawal by Subject|50|||
28050860|NCT00345579|54708418|FG001|Overall Study|Withdrawal by Subject|17|||
28050861|NCT00345579|54708417|FG000|Overall Study|Lost to Follow-up|82|||
28050862|NCT00345579|54708418|FG001|Overall Study|Lost to Follow-up|36|||
28050863|NCT00345579|54708417|FG000|Overall Study|Other|9|||
28050864|NCT00345579|54708418|FG001|Overall Study|Other|1|||
28050865|NCT00335829|54708425|FG000|Overall Study|Withdrawal by Subject|1|||
28050866|NCT00335829|54708425|FG000|Overall Study|Lost to Follow-up|1|||
28050867|NCT00335829|54708425|FG000|Overall Study|Adverse Event|1|||
28050868|NCT00344019|54708432|FG000|Overall Study|did not meet final inclusion criteria|0|||
28050869|NCT00344019|54708433|FG001|Overall Study|did not meet final inclusion criteria|0|||
28050870|NCT00344019|54708434|FG002|Overall Study|did not meet final inclusion criteria|74|||
28050871|NCT00535847|54708448|FG000|Overall Study|Adverse Event|5|||
28050872|NCT00535847|54708449|FG001|Overall Study|Adverse Event|3|||
28050873|NCT00535847|54708450|FG002|Overall Study|Adverse Event|2|||
28050874|NCT00535847|54708448|FG000|Overall Study|Non compliance|1|||
28050875|NCT00535847|54708449|FG001|Overall Study|Non compliance|1|||
28050876|NCT00535847|54708450|FG002|Overall Study|Non compliance|0|||
28050877|NCT00535847|54708448|FG000|Overall Study|Protocol-defined Virologic Stopping Rule|16|||
28050878|NCT00535847|54708449|FG001|Overall Study|Protocol-defined Virologic Stopping Rule|10|||
28050879|NCT00535847|54708450|FG002|Overall Study|Protocol-defined Virologic Stopping Rule|0|||
28050880|NCT00334893|54708464|FG000|Overall Study|Not Treated|1|||
28050881|NCT00334893|54708465|FG001|Overall Study|Not Treated|0|||
28050882|NCT00334737|54708476|FG000|Hospital Phase|Death|1|||
28050883|NCT00334737|54708477|FG001|Hospital Phase|Death|2|||
28050884|NCT00334737|54708478|FG002|Hospital Phase|Death|3|||
28050885|NCT00334737|54708476|FG000|Hospital Phase|Withdrawal by Subject|0|||
28050886|NCT00334737|54708477|FG001|Hospital Phase|Withdrawal by Subject|0|||
28050887|NCT00334737|54708478|FG002|Hospital Phase|Withdrawal by Subject|1|||
28050888|NCT00334737|54708476|FG000|Hospital Phase|Did not receive study drug|1|||
28050889|NCT00334737|54708477|FG001|Hospital Phase|Did not receive study drug|0|||
28050890|NCT00334737|54708478|FG002|Hospital Phase|Did not receive study drug|0|||
28050891|NCT00334737|54708476|FG000|Follow up Phase|Lost to Follow-up|5|||
28050892|NCT00334737|54708477|FG001|Follow up Phase|Lost to Follow-up|3|||
28050893|NCT00334737|54708478|FG002|Follow up Phase|Lost to Follow-up|6|||
28050894|NCT00427908|54708490|FG000|Primary Phase|Lost to Follow-up|4|||
28050895|NCT00427908|54708491|FG001|Primary Phase|Lost to Follow-up|0|||
28050896|NCT00427908|54708492|FG002|Primary Phase|Lost to Follow-up|2|||
28050897|NCT00427908|54708493|FG003|Primary Phase|Lost to Follow-up|0|||
28050898|NCT00427908|54708490|FG000|Primary Phase|Withdrawal by Subject|1|||
28050899|NCT00427908|54708491|FG001|Primary Phase|Withdrawal by Subject|2|||
28050900|NCT00427908|54708492|FG002|Primary Phase|Withdrawal by Subject|1|||
28050901|NCT00427908|54708493|FG003|Primary Phase|Withdrawal by Subject|0|||
28050902|NCT00427908|54708490|FG000|Primary Phase|Adverse Event|0|||
28050903|NCT00427908|54708491|FG001|Primary Phase|Adverse Event|1|||
28050904|NCT00427908|54708492|FG002|Primary Phase|Adverse Event|0|||
28050905|NCT00427908|54708493|FG003|Primary Phase|Adverse Event|0|||
28050906|NCT00334113|54708530|FG000|Overall Study|Lost to Follow-up|2|||
28050907|NCT00334113|54708531|FG001|Overall Study|Lost to Follow-up|2|||
28050908|NCT00334113|54708530|FG000|Overall Study|Withdrawal by Subject|0|||
28050909|NCT00334113|54708531|FG001|Overall Study|Withdrawal by Subject|1|||
28050910|NCT00416598|54708537|FG000|Induction & Intensification|Adverse Event|38|||
28050911|NCT00416598|54708537|FG000|Induction & Intensification|Death|32|||
28050912|NCT00416598|54708537|FG000|Induction & Intensification|Withdrawal by Subject|46|||
28050913|NCT00416598|54708537|FG000|Induction & Intensification|Alternative Treatment|135|||
28050914|NCT00416598|54708537|FG000|Induction & Intensification|Physician discretion/other medical issue|45|||
28050915|NCT00416598|54708537|FG000|Induction & Intensification|Relapse/progression|29|||
28050916|NCT00416598|54708537|FG000|Induction & Intensification|Failed induction|87|||
28050917|NCT00416598|54708537|FG000|Decitabine Maintenance|Adverse Event|5|||
28050918|NCT00416598|54708537|FG000|Decitabine Maintenance|Withdrawal by Subject|18|||
28050919|NCT00416598|54708537|FG000|Decitabine Maintenance|Progression/relapse|38|||
28050920|NCT00416598|54708537|FG000|Decitabine Maintenance|Alternative treatment|2|||
28050921|NCT00416598|54708537|FG000|Decitabine Maintenance|Physician discretion/other medical issue|9|||
28050922|NCT00534599|54708543|FG000|Overall Study|Adverse Event|25|||
28050923|NCT00534599|54708544|FG001|Overall Study|Adverse Event|4|||
28050924|NCT00534599|54708543|FG000|Overall Study|Incorrect enrollment|2|||
28050925|NCT00534599|54708544|FG001|Overall Study|Incorrect enrollment|1|||
28050926|NCT00534599|54708543|FG000|Overall Study|Mis-randomization|2|||
28050927|NCT00534599|54708544|FG001|Overall Study|Mis-randomization|2|||
28050928|NCT00534599|54708543|FG000|Overall Study|Developed study-specific d/c criteria|5|||
28050929|NCT00534599|54708544|FG001|Overall Study|Developed study-specific d/c criteria|0|||
28050930|NCT00534599|54708543|FG000|Overall Study|Lack of Efficacy|0|||
28050931|NCT00534599|54708544|FG001|Overall Study|Lack of Efficacy|1|||
28050932|NCT00534599|54708543|FG000|Overall Study|Generalized anxiety disorder worsened|0|||
28050933|NCT00534599|54708544|FG001|Overall Study|Generalized anxiety disorder worsened|1|||
28050934|NCT00534599|54708543|FG000|Overall Study|Protocol Violation|1|||
28050935|NCT00534599|54708544|FG001|Overall Study|Protocol Violation|3|||
28050936|NCT00534599|54708543|FG000|Overall Study|Lost to Follow-up|11|||
28050937|NCT00534599|54708544|FG001|Overall Study|Lost to Follow-up|14|||
28050938|NCT00534599|54708543|FG000|Overall Study|Withdrawal by Subject|4|||
28050939|NCT00534599|54708544|FG001|Overall Study|Withdrawal by Subject|6|||
28050940|NCT00534599|54708543|FG000|Overall Study|Other|7|||
28050941|NCT00534599|54708544|FG001|Overall Study|Other|0|||
28050942|NCT03892889|54708567|FG000|Overall Study|Adverse Event|17|||
28050943|NCT03892889|54708567|FG000|Overall Study|Lack of Efficacy|1|||
28050944|NCT03892889|54708567|FG000|Overall Study|Lost to Follow-up|46|||
28050945|NCT03892889|54708567|FG000|Overall Study|Non-compliance with study drug|22|||
28050946|NCT03892889|54708567|FG000|Overall Study|Pregnancy|1|||
28050947|NCT03892889|54708567|FG000|Overall Study|Protocol Deviation|3|||
28050948|NCT03892889|54708567|FG000|Overall Study|Withdrawal by Subject|50|||
28050949|NCT03892889|54708567|FG000|Overall Study|Withdrawal by Caregiver|1|||
28050950|NCT03892889|54708567|FG000|Overall Study|Study Terminated by Sponsor|50|||
28050951|NCT03892889|54708567|FG000|Overall Study|Physician Decision|8|||
28050952|NCT03892889|54708567|FG000|Overall Study|Reason not Specified|5|||
28050953|NCT00473330|54708574|FG000|Core Study|Adverse Event|4|||
28050954|NCT00473330|54708575|FG001|Core Study|Adverse Event|4|||
28050955|NCT00473330|54708576|FG002|Core Study|Adverse Event|1|||
28050956|NCT00473330|54708574|FG000|Core Study|Death|6|||
28050957|NCT00473330|54708575|FG001|Core Study|Death|4|||
28050958|NCT00473330|54708576|FG002|Core Study|Death|4|||
28050959|NCT00473330|54708574|FG000|Core Study|Lost to Follow-up|5|||
28050960|NCT00473330|54708575|FG001|Core Study|Lost to Follow-up|5|||
28050961|NCT00473330|54708576|FG002|Core Study|Lost to Follow-up|10|||
28050962|NCT00473330|54708574|FG000|Core Study|Physician Decision|2|||
28050963|NCT00473330|54708575|FG001|Core Study|Physician Decision|1|||
28050964|NCT00473330|54708576|FG002|Core Study|Physician Decision|3|||
28050965|NCT00473330|54708574|FG000|Core Study|Subject Non-compliance|1|||
28050966|NCT00473330|54708575|FG001|Core Study|Subject Non-compliance|2|||
28050967|NCT00473330|54708576|FG002|Core Study|Subject Non-compliance|1|||
28050968|NCT00473330|54708574|FG000|Core Study|Subject Required Other Therapy|0|||
28050969|NCT00473330|54708575|FG001|Core Study|Subject Required Other Therapy|1|||
28050970|NCT00473330|54708576|FG002|Core Study|Subject Required Other Therapy|3|||
28050971|NCT00473330|54708574|FG000|Core Study|Subject's Decision|9|||
28050972|NCT00473330|54708575|FG001|Core Study|Subject's Decision|8|||
28050973|NCT00473330|54708576|FG002|Core Study|Subject's Decision|19|||
28050974|NCT00473330|54708574|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
28050975|NCT00473330|54708575|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
28050976|NCT00473330|54708576|FG002|Open-label Extension Through Month 48|Adverse Event|2|||
28050977|NCT00473330|54708574|FG000|Open-label Extension Through Month 48|Death|2|||
28050978|NCT00473330|54708575|FG001|Open-label Extension Through Month 48|Death|0|||
28050979|NCT00473330|54708576|FG002|Open-label Extension Through Month 48|Death|0|||
28050980|NCT00473330|54708574|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
28050981|NCT00473330|54708575|FG001|Open-label Extension Through Month 48|Lost to Follow-up|0|||
28050982|NCT00473330|54708576|FG002|Open-label Extension Through Month 48|Lost to Follow-up|2|||
28050983|NCT00473330|54708574|FG000|Open-label Extension Through Month 48|Physician's Decision|2|||
28050984|NCT00473330|54708575|FG001|Open-label Extension Through Month 48|Physician's Decision|1|||
28050985|NCT00473330|54708576|FG002|Open-label Extension Through Month 48|Physician's Decision|3|||
28050986|NCT00473330|54708574|FG000|Open-label Extension Through Month 48|Subject's Decision|1|||
28050987|NCT00473330|54708575|FG001|Open-label Extension Through Month 48|Subject's Decision|3|||
28050988|NCT00473330|54708576|FG002|Open-label Extension Through Month 48|Subject's Decision|3|||
28050989|NCT00473330|54708574|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18|||
28050990|NCT00473330|54708575|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15|||
28050991|NCT00473330|54708576|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16|||
28050992|NCT00473330|54708574|FG000|Open-label Extension Through Month 48|Subject Non-compliance|2|||
28050993|NCT00473330|54708575|FG001|Open-label Extension Through Month 48|Subject Non-compliance|1|||
28050994|NCT00473330|54708576|FG002|Open-label Extension Through Month 48|Subject Non-compliance|0|||
28050995|NCT00473330|54708574|FG000|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
28050996|NCT00473330|54708575|FG001|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
28050997|NCT00473330|54708576|FG002|Open-label Extension Through Month 48|Subject Required Other Therapy|1|||
28050998|NCT00473330|54708574|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
28050999|NCT00473330|54708575|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
28051000|NCT00473330|54708576|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
28051001|NCT00473330|54708574|FG000|Open-label Extension Through Month 60|Death|2|||
27812378|NCT01710657|54268502|FG002|Overall Study|Withdrawal by Subject|2|||
27812379|NCT01710657|54268500|FG000|Overall Study|Lack of Efficacy|0|||
27812380|NCT01710657|54268501|FG001|Overall Study|Lack of Efficacy|1|||
27812381|NCT01710657|54268502|FG002|Overall Study|Lack of Efficacy|1|||
27812382|NCT01701063|54268513|FG000|Overall Study|Lost to Follow-up|0|||
27812383|NCT01701063|54268514|FG001|Overall Study|Lost to Follow-up|1|||
27812384|NCT01701063|54268515|FG002|Overall Study|Lost to Follow-up|0|||
27812385|NCT01701063|54268513|FG000|Overall Study|Withdrawal by Subject|0|||
27812386|NCT01701063|54268514|FG001|Overall Study|Withdrawal by Subject|0|||
28051002|NCT00473330|54708575|FG001|Open-label Extension Through Month 60|Death|2|||
27812387|NCT01701063|54268515|FG002|Overall Study|Withdrawal by Subject|1|||
27812388|NCT01701063|54268513|FG000|Overall Study|Other|0|||
27812389|NCT01701063|54268514|FG001|Overall Study|Other|0|||
28051003|NCT00473330|54708576|FG002|Open-label Extension Through Month 60|Death|1|||
28051004|NCT00473330|54708574|FG000|Open-label Extension Through Month 60|Lost to Follow-up|3|||
28051005|NCT00473330|54708575|FG001|Open-label Extension Through Month 60|Lost to Follow-up|0|||
28051006|NCT00473330|54708576|FG002|Open-label Extension Through Month 60|Lost to Follow-up|4|||
27812390|NCT01701063|54268515|FG002|Overall Study|Other|1|||
27812391|NCT01700985|54268526|FG000|Overall Study|Incarcerated|0|||
27812392|NCT01700985|54268527|FG001|Overall Study|Incarcerated|1|||
28051007|NCT00473330|54708574|FG000|Open-label Extension Through Month 60|Physician's Decision|2|||
28051008|NCT00473330|54708575|FG001|Open-label Extension Through Month 60|Physician's Decision|1|||
28051009|NCT00473330|54708576|FG002|Open-label Extension Through Month 60|Physician's Decision|3|||
28051010|NCT00473330|54708574|FG000|Open-label Extension Through Month 60|Subject's Decision|1|||
28051011|NCT00473330|54708575|FG001|Open-label Extension Through Month 60|Subject's Decision|3|||
28051012|NCT00473330|54708576|FG002|Open-label Extension Through Month 60|Subject's Decision|4|||
28051013|NCT00473330|54708574|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77|||
28051014|NCT00473330|54708575|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71|||
28051015|NCT00473330|54708576|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62|||
28051016|NCT00473330|54708574|FG000|Open-label Extension Through Month 60|Subject Non-compliance|2|||
28051017|NCT00473330|54708575|FG001|Open-label Extension Through Month 60|Subject Non-compliance|1|||
28051018|NCT00473330|54708576|FG002|Open-label Extension Through Month 60|Subject Non-compliance|0|||
28051019|NCT00473330|54708574|FG000|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
28051020|NCT00473330|54708575|FG001|Open-label Extension Through Month 60|Subject Required Other Therapy|0|||
28051021|NCT00473330|54708576|FG002|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
28051022|NCT00416520|54708606|FG000|Open-label Period|Adverse Event|28|||
28051023|NCT00416520|54708607|FG001|Open-label Period|Adverse Event|10|||
28051024|NCT00416520|54708608|FG002|Open-label Period|Adverse Event|0|||
28051025|NCT00416520|54708609|FG003|Open-label Period|Adverse Event|0|||
28051026|NCT00416520|54708606|FG000|Open-label Period|Death|2|||
28051027|NCT00416520|54708607|FG001|Open-label Period|Death|1|||
28051028|NCT00416520|54708608|FG002|Open-label Period|Death|0|||
28051029|NCT00416520|54708609|FG003|Open-label Period|Death|0|||
28051030|NCT00416520|54708606|FG000|Open-label Period|Lack of Efficacy|8|||
28051031|NCT00416520|54708607|FG001|Open-label Period|Lack of Efficacy|1|||
28051032|NCT00416520|54708608|FG002|Open-label Period|Lack of Efficacy|0|||
28051033|NCT00416520|54708609|FG003|Open-label Period|Lack of Efficacy|0|||
28051034|NCT00416520|54708606|FG000|Open-label Period|Protocol Violation|3|||
28051035|NCT00416520|54708607|FG001|Open-label Period|Protocol Violation|3|||
28051036|NCT00416520|54708608|FG002|Open-label Period|Protocol Violation|0|||
28051037|NCT00416520|54708609|FG003|Open-label Period|Protocol Violation|0|||
28051038|NCT00416520|54708606|FG000|Open-label Period|Withdrawal by Subject|16|||
28051039|NCT00416520|54708607|FG001|Open-label Period|Withdrawal by Subject|5|||
28051040|NCT00416520|54708608|FG002|Open-label Period|Withdrawal by Subject|0|||
28051041|NCT00416520|54708609|FG003|Open-label Period|Withdrawal by Subject|0|||
28051042|NCT00416520|54708606|FG000|Open-label Period|Other Reasons|3|||
28051043|NCT00416520|54708607|FG001|Open-label Period|Other Reasons|12|||
28051044|NCT00416520|54708608|FG002|Open-label Period|Other Reasons|0|||
28051045|NCT00416520|54708609|FG003|Open-label Period|Other Reasons|0|||
28051046|NCT00416520|54708606|FG000|Placebo-controlled Withdrawal Period|Adverse Event|0|||
28051047|NCT00416520|54708607|FG001|Placebo-controlled Withdrawal Period|Adverse Event|0|||
28051048|NCT00416520|54708608|FG002|Placebo-controlled Withdrawal Period|Adverse Event|0|||
28051049|NCT00416520|54708609|FG003|Placebo-controlled Withdrawal Period|Adverse Event|1|||
28051050|NCT00416520|54708606|FG000|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
28051051|NCT00416520|54708607|FG001|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
28051052|NCT00416520|54708608|FG002|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
28051053|NCT00416520|54708609|FG003|Placebo-controlled Withdrawal Period|Lack of Efficacy|3|||
28051054|NCT00416520|54708606|FG000|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
28051055|NCT00416520|54708607|FG001|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
28051056|NCT00416520|54708608|FG002|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
28051057|NCT00416520|54708609|FG003|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
28051058|NCT00533429|54708621|FG000|Overall Study|Adverse Event|3|||
28051059|NCT00533429|54708622|FG001|Overall Study|Adverse Event|1|||
28051060|NCT00533429|54708621|FG000|Overall Study|Death|1|||
28051061|NCT00533429|54708622|FG001|Overall Study|Death|0|||
28051062|NCT00533429|54708621|FG000|Overall Study|Withdrawal by Subject|2|||
28051063|NCT00533429|54708622|FG001|Overall Study|Withdrawal by Subject|0|||
28051064|NCT00533429|54708621|FG000|Overall Study|Progressive Disease|12|||
28051065|NCT00533429|54708622|FG001|Overall Study|Progressive Disease|13|||
28051066|NCT00533429|54708621|FG000|Overall Study|Symptomatic deterioration|1|||
28051067|NCT00533429|54708622|FG001|Overall Study|Symptomatic deterioration|2|||
28051068|NCT00533273|54708632|FG000|Double-blind|Withdrew consent|0|||
28051069|NCT00533273|54708633|FG001|Double-blind|Withdrew consent|2|||
28051070|NCT00533273|54708632|FG000|Open-label|Withdrawal by Subject|6|||
28051071|NCT00533273|54708633|FG001|Open-label|Withdrawal by Subject|0|||
28051072|NCT03891641|54708641|FG000|Overall Study|Study Stoppage Due to COVID-19|2|||
28051073|NCT03891641|54708642|FG001|Overall Study|Study Stoppage Due to COVID-19|2|||
28051074|NCT00339183|54708650|FG000|Overall Study|Adverse Event|5|||
28051075|NCT00339183|54708651|FG001|Overall Study|Adverse Event|3|||
28051076|NCT00339183|54708650|FG000|Overall Study|Withdrawal by Subject|16|||
28051077|NCT00339183|54708651|FG001|Overall Study|Withdrawal by Subject|19|||
28051078|NCT00339183|54708650|FG000|Overall Study|Physician Decision|2|||
28051079|NCT00339183|54708651|FG001|Overall Study|Physician Decision|4|||
28051080|NCT00339183|54708650|FG000|Overall Study|Lost to Follow-up|17|||
28051081|NCT00339183|54708651|FG001|Overall Study|Lost to Follow-up|17|||
28051082|NCT00339183|54708650|FG000|Overall Study|Protocol-specified criteria|12|||
28051083|NCT00339183|54708651|FG001|Overall Study|Protocol-specified criteria|8|||
28051084|NCT00339183|54708650|FG000|Overall Study|Missing reason|3|||
28051085|NCT00339183|54708651|FG001|Overall Study|Missing reason|1|||
28051086|NCT00339183|54708650|FG000|Overall Study|Other|46|||
28051087|NCT00339183|54708651|FG001|Overall Study|Other|40|||
28051088|NCT00339183|54708650|FG000|Overall Study|Ongoing|20|||
28051089|NCT00339183|54708651|FG001|Overall Study|Ongoing|13|||
28051090|NCT00333801|54708663|FG000|Overall Study|Moved to another state|5|||
28051091|NCT00333801|54708664|FG001|Overall Study|Moved to another state|3|||
28051092|NCT00333801|54708663|FG000|Overall Study|Lost to Follow-up|2|||
28051093|NCT00333801|54708664|FG001|Overall Study|Lost to Follow-up|0|||
28051094|NCT00333801|54708663|FG000|Overall Study|Incarcerated|1|||
28051095|NCT00333801|54708664|FG001|Overall Study|Incarcerated|2|||
28051096|NCT00333801|54708663|FG000|Overall Study|Withdrawal by Subject|0|||
28051097|NCT00333801|54708664|FG001|Overall Study|Withdrawal by Subject|1|||
28051098|NCT00532883|54708674|FG000|Overall Study|Adverse Event|1|||
28051099|NCT00532883|54708675|FG001|Overall Study|Adverse Event|0|||
28051100|NCT00532883|54708676|FG002|Overall Study|Adverse Event|0|||
28051101|NCT00532883|54708677|FG003|Overall Study|Adverse Event|1|||
28051102|NCT00532883|54708674|FG000|Overall Study|Lost to Follow-up|1|||
28051103|NCT00532883|54708675|FG001|Overall Study|Lost to Follow-up|1|||
28051104|NCT00532883|54708676|FG002|Overall Study|Lost to Follow-up|1|||
28051105|NCT00532883|54708677|FG003|Overall Study|Lost to Follow-up|0|||
28051106|NCT00532883|54708674|FG000|Overall Study|Withdrawal by Subject|0|||
28051107|NCT00532883|54708675|FG001|Overall Study|Withdrawal by Subject|1|||
28051108|NCT00532883|54708676|FG002|Overall Study|Withdrawal by Subject|1|||
28051109|NCT00532883|54708677|FG003|Overall Study|Withdrawal by Subject|0|||
28051110|NCT00532883|54708674|FG000|Overall Study|Subject was Nonadherent|0|||
28051111|NCT00532883|54708675|FG001|Overall Study|Subject was Nonadherent|1|||
28051112|NCT00532883|54708676|FG002|Overall Study|Subject was Nonadherent|1|||
28051113|NCT00532883|54708677|FG003|Overall Study|Subject was Nonadherent|0|||
28051114|NCT00532883|54708674|FG000|Overall Study|Early Study Termination|4|||
28051115|NCT00532883|54708675|FG001|Overall Study|Early Study Termination|4|||
28051116|NCT00532883|54708676|FG002|Overall Study|Early Study Termination|1|||
28051117|NCT00532883|54708677|FG003|Overall Study|Early Study Termination|4|||
28051118|NCT00354159|54708689|FG000|Randomized Study Period|Withdrawal by Subject|5|||
28051119|NCT00354159|54708690|FG001|Randomized Study Period|Withdrawal by Subject|3|||
28051120|NCT00354159|54708689|FG000|Randomized Study Period|Physician Decision|6|||
28051121|NCT00354159|54708690|FG001|Randomized Study Period|Physician Decision|10|||
28051122|NCT00354159|54708689|FG000|Randomized Study Period|Lost to Follow-up|4|||
28051123|NCT00354159|54708690|FG001|Randomized Study Period|Lost to Follow-up|0|||
28051124|NCT00354159|54708689|FG000|Randomized Study Period|Death|7|||
28051125|NCT00354159|54708690|FG001|Randomized Study Period|Death|9|||
28051126|NCT00354159|54708689|FG000|Long-term Follow-up|Withdrawal by Subject|9|||
28051127|NCT00354159|54708690|FG001|Long-term Follow-up|Withdrawal by Subject|9|||
28051128|NCT00354159|54708689|FG000|Long-term Follow-up|Physician Decision|127|||
28051129|NCT00354159|54708690|FG001|Long-term Follow-up|Physician Decision|122|||
28051130|NCT00354159|54708689|FG000|Long-term Follow-up|Lost to Follow-up|1|||
28051131|NCT00354159|54708690|FG001|Long-term Follow-up|Lost to Follow-up|0|||
28051132|NCT00354159|54708689|FG000|Long-term Follow-up|Death|14|||
28051133|NCT00354159|54708690|FG001|Long-term Follow-up|Death|11|||
28051134|NCT00354159|54708689|FG000|Long-term Follow-up|Study Closed|29|||
28051135|NCT00354159|54708690|FG001|Long-term Follow-up|Study Closed|34|||
28051136|NCT00338949|54708705|FG000|Subject Screening|Screen failures|11|||
28051137|NCT00338949|54708706|FG001|Subject Screening|Screen failures|11|||
28051138|NCT00338949|54708705|FG000|Randomization|Withdrawal by Subject|1|||
28051139|NCT00338949|54708706|FG001|Randomization|Withdrawal by Subject|0|||
28051140|NCT00338949|54708705|FG000|Randomization|Adverse Event|0|||
28051141|NCT00338949|54708706|FG001|Randomization|Adverse Event|5|||
28051142|NCT00332709|54708714|FG000|Overall Study|Adverse Event|11|||
28051143|NCT00332709|54708715|FG001|Overall Study|Adverse Event|14|||
28051144|NCT00332709|54708714|FG000|Overall Study|Withdrawal by Subject|2|||
28051145|NCT00332709|54708715|FG001|Overall Study|Withdrawal by Subject|3|||
28051146|NCT00332709|54708714|FG000|Overall Study|Lost to Follow-up|2|||
28051147|NCT00332709|54708715|FG001|Overall Study|Lost to Follow-up|0|||
28051148|NCT00332709|54708714|FG000|Overall Study|Administrative Problems|0|||
28051149|NCT00332709|54708715|FG001|Overall Study|Administrative Problems|3|||
28051150|NCT00332709|54708714|FG000|Overall Study|Abnormal test procedure result|1|||
28051151|NCT00332709|54708715|FG001|Overall Study|Abnormal test procedure result|0|||
28051152|NCT00332241|54708723|FG000|Overall Study|Lack of Efficacy|6|||
28051153|NCT00332241|54708724|FG001|Overall Study|Lack of Efficacy|1|||
28051154|NCT00332241|54708723|FG000|Overall Study|Adverse Event|3|||
28051155|NCT00332241|54708724|FG001|Overall Study|Adverse Event|5|||
28051156|NCT00332241|54708723|FG000|Overall Study|Withdrawal by Subject|2|||
28051157|NCT00332241|54708724|FG001|Overall Study|Withdrawal by Subject|1|||
28051158|NCT00332241|54708723|FG000|Overall Study|Lost to Follow-up|4|||
28051159|NCT00332241|54708724|FG001|Overall Study|Lost to Follow-up|1|||
28051160|NCT00337935|54708732|FG000|Overall Study|Adverse Event|2|||
28051161|NCT00337935|54708733|FG001|Overall Study|Adverse Event|5|||
28051162|NCT00337935|54708732|FG000|Overall Study|Death|2|||
28051163|NCT00337935|54708733|FG001|Overall Study|Death|8|||
28051164|NCT00337935|54708732|FG000|Overall Study|Physician Decision|1|||
28051165|NCT00337935|54708733|FG001|Overall Study|Physician Decision|1|||
28051166|NCT00337935|54708732|FG000|Overall Study|Lost to Follow-up|0|||
28051167|NCT00337935|54708733|FG001|Overall Study|Lost to Follow-up|1|||
28051168|NCT00337935|54708732|FG000|Overall Study|Protocol Violation|4|||
28051169|NCT00337935|54708733|FG001|Overall Study|Protocol Violation|3|||
28051170|NCT00337935|54708732|FG000|Overall Study|Withdrawal by Subject|1|||
28051171|NCT00337935|54708733|FG001|Overall Study|Withdrawal by Subject|7|||
28051172|NCT00337935|54708732|FG000|Overall Study|Other|0|||
28051173|NCT00337935|54708733|FG001|Overall Study|Other|1|||
28051174|NCT00337935|54708732|FG000|Overall Study|Lack of Efficacy|0|||
28051175|NCT00337935|54708733|FG001|Overall Study|Lack of Efficacy|1|||
28051176|NCT00337779|54708742|FG000|Overall Study|Withdrawal by Subject|10|||
28051177|NCT00337779|54708743|FG001|Overall Study|Withdrawal by Subject|12|||
28051178|NCT00337779|54708742|FG000|Overall Study|Sponsor decision|1|||
28051179|NCT00337779|54708743|FG001|Overall Study|Sponsor decision|1|||
28051180|NCT00337779|54708742|FG000|Overall Study|Physician Decision|3|||
28051181|NCT00337779|54708743|FG001|Overall Study|Physician Decision|6|||
28051182|NCT00337779|54708742|FG000|Overall Study|Protocol Violation|1|||
28051183|NCT00337779|54708743|FG001|Overall Study|Protocol Violation|1|||
28051184|NCT00337779|54708742|FG000|Overall Study|Lost to Follow-up|6|||
28051185|NCT00337779|54708743|FG001|Overall Study|Lost to Follow-up|5|||
28051186|NCT00337779|54708742|FG000|Overall Study|Adverse Event|28|||
28051187|NCT00337779|54708743|FG001|Overall Study|Adverse Event|51|||
28051188|NCT00337779|54708742|FG000|Overall Study|Pregnancy|3|||
28051189|NCT00337779|54708743|FG001|Overall Study|Pregnancy|2|||
28051190|NCT00337779|54708742|FG000|Overall Study|Death|0|||
28051191|NCT00337779|54708743|FG001|Overall Study|Death|1|||
28051192|NCT00352755|54708749|FG000|Overall Study|Physician Decision|1|||
28051193|NCT00352755|54708749|FG000|Overall Study|Adverse Event|1|||
28051194|NCT00533897|54708756|FG000|Lead-in (LI) Period 1|Adverse Event|1|||
28051195|NCT00533897|54708757|FG001|Lead-in (LI) Period 1|Adverse Event|0|||
28051196|NCT00533897|54708758|FG002|Lead-in (LI) Period 1|Adverse Event|0|||
28051197|NCT00533897|54708759|FG003|Lead-in (LI) Period 1|Adverse Event|0|||
28051198|NCT00533897|54708760|FG004|Lead-in (LI) Period 1|Adverse Event|0|||
28051199|NCT00533897|54708761|FG005|Lead-in (LI) Period 1|Adverse Event|0|||
28051200|NCT00533897|54708762|FG006|Lead-in (LI) Period 1|Adverse Event|0|||
28051201|NCT00533897|54708763|FG007|Lead-in (LI) Period 1|Adverse Event|0|||
28051202|NCT00533897|54708756|FG000|Lead-in (LI) Period 1|Participant Withdrew Consent|2|||
28051203|NCT00533897|54708757|FG001|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
28051204|NCT00533897|54708758|FG002|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
28051205|NCT00533897|54708759|FG003|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
28051206|NCT00533897|54708760|FG004|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
28051207|NCT00533897|54708761|FG005|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
28051208|NCT00533897|54708762|FG006|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
28051209|NCT00533897|54708763|FG007|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
28051210|NCT00533897|54708756|FG000|Lead-in (LI) Period 1|Lost to Follow-up|1|||
27939933|NCT00943852|54596279|FG002|Washout Period After Period 2 Treatment|Trial stopped early|0|||
28051211|NCT00533897|54708757|FG001|Lead-in (LI) Period 1|Lost to Follow-up|0|||
28051212|NCT00533897|54708758|FG002|Lead-in (LI) Period 1|Lost to Follow-up|0|||
28051213|NCT00533897|54708759|FG003|Lead-in (LI) Period 1|Lost to Follow-up|0|||
28051214|NCT00533897|54708760|FG004|Lead-in (LI) Period 1|Lost to Follow-up|0|||
28051215|NCT00533897|54708761|FG005|Lead-in (LI) Period 1|Lost to Follow-up|0|||
28051216|NCT00533897|54708762|FG006|Lead-in (LI) Period 1|Lost to Follow-up|0|||
27939934|NCT00943852|54596280|FG003|Washout Period After Period 2 Treatment|Trial stopped early|0|||
28051217|NCT00533897|54708763|FG007|Lead-in (LI) Period 1|Lost to Follow-up|0|||
28051218|NCT00533897|54708756|FG000|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2|||
28051219|NCT00533897|54708757|FG001|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
28051220|NCT00533897|54708758|FG002|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
28051221|NCT00533897|54708759|FG003|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
28051222|NCT00533897|54708760|FG004|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
28051223|NCT00533897|54708761|FG005|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
28051224|NCT00533897|54708762|FG006|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
28051225|NCT00533897|54708763|FG007|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
28051226|NCT00533897|54708756|FG000|Lead-in (LI) Period 1|Lack of Efficacy|3|||
28051227|NCT00533897|54708757|FG001|Lead-in (LI) Period 1|Lack of Efficacy|0|||
28051228|NCT00533897|54708758|FG002|Lead-in (LI) Period 1|Lack of Efficacy|0|||
28051229|NCT00533897|54708759|FG003|Lead-in (LI) Period 1|Lack of Efficacy|0|||
28051230|NCT00533897|54708760|FG004|Lead-in (LI) Period 1|Lack of Efficacy|0|||
28051231|NCT00533897|54708761|FG005|Lead-in (LI) Period 1|Lack of Efficacy|0|||
28051232|NCT00533897|54708762|FG006|Lead-in (LI) Period 1|Lack of Efficacy|0|||
28051233|NCT00533897|54708763|FG007|Lead-in (LI) Period 1|Lack of Efficacy|0|||
28051234|NCT00533897|54708756|FG000|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1|||
28051235|NCT00533897|54708757|FG001|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
28051236|NCT00533897|54708758|FG002|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
28051237|NCT00533897|54708759|FG003|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
28051238|NCT00533897|54708760|FG004|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
28051239|NCT00533897|54708761|FG005|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
28051240|NCT00533897|54708762|FG006|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
28051241|NCT00533897|54708763|FG007|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
28051242|NCT00533897|54708756|FG000|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
28051243|NCT00533897|54708757|FG001|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1|||
28051244|NCT00533897|54708758|FG002|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2|||
28051245|NCT00533897|54708759|FG003|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
28051246|NCT00533897|54708760|FG004|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
28051247|NCT00533897|54708761|FG005|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
28051248|NCT00533897|54708762|FG006|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
28051249|NCT00533897|54708763|FG007|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
28051250|NCT00533897|54708756|FG000|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
28051251|NCT00533897|54708757|FG001|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
28051252|NCT00533897|54708758|FG002|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1|||
28051253|NCT00533897|54708759|FG003|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
28051254|NCT00533897|54708760|FG004|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
28051255|NCT00533897|54708761|FG005|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
28051256|NCT00533897|54708762|FG006|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
28051257|NCT00533897|54708763|FG007|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
28051258|NCT00533897|54708756|FG000|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
28051259|NCT00533897|54708757|FG001|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
28051260|NCT00533897|54708758|FG002|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
28051261|NCT00533897|54708759|FG003|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
28051262|NCT00533897|54708760|FG004|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
28051263|NCT00533897|54708761|FG005|Re-introduction (RI) Period 3|Participant Withdrew Consent|1|||
28051264|NCT00533897|54708762|FG006|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
28051265|NCT00533897|54708763|FG007|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
28051266|NCT00533897|54708756|FG000|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
28051267|NCT00533897|54708757|FG001|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
28051268|NCT00533897|54708758|FG002|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
28051269|NCT00533897|54708759|FG003|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
28051270|NCT00533897|54708760|FG004|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
28051271|NCT00533897|54708761|FG005|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1|||
28051272|NCT00533897|54708762|FG006|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
28051273|NCT00533897|54708763|FG007|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
28051274|NCT00533897|54708756|FG000|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
28051275|NCT00533897|54708757|FG001|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
28051276|NCT00533897|54708758|FG002|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
28051277|NCT00533897|54708759|FG003|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
28051278|NCT00533897|54708760|FG004|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
28051279|NCT00533897|54708761|FG005|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
28051280|NCT00533897|54708762|FG006|Long Term Extension (LTE)|Participant Withdrew Consent|2|||
28051281|NCT00533897|54708763|FG007|Long Term Extension (LTE)|Participant Withdrew Consent|5|||
28051282|NCT00533897|54708756|FG000|Long Term Extension (LTE)|Death|0|||
28051283|NCT00533897|54708757|FG001|Long Term Extension (LTE)|Death|0|||
28051284|NCT00533897|54708758|FG002|Long Term Extension (LTE)|Death|0|||
28051285|NCT00533897|54708759|FG003|Long Term Extension (LTE)|Death|0|||
28051286|NCT00533897|54708760|FG004|Long Term Extension (LTE)|Death|0|||
28051287|NCT00533897|54708761|FG005|Long Term Extension (LTE)|Death|0|||
28051288|NCT00533897|54708762|FG006|Long Term Extension (LTE)|Death|1|||
28051289|NCT00533897|54708763|FG007|Long Term Extension (LTE)|Death|3|||
28051290|NCT00533897|54708756|FG000|Long Term Extension (LTE)|Lack of Efficacy|0|||
28051291|NCT00533897|54708757|FG001|Long Term Extension (LTE)|Lack of Efficacy|0|||
28051292|NCT00533897|54708758|FG002|Long Term Extension (LTE)|Lack of Efficacy|0|||
28051293|NCT00533897|54708759|FG003|Long Term Extension (LTE)|Lack of Efficacy|0|||
28051294|NCT00533897|54708760|FG004|Long Term Extension (LTE)|Lack of Efficacy|0|||
28051295|NCT00533897|54708761|FG005|Long Term Extension (LTE)|Lack of Efficacy|0|||
28051296|NCT00533897|54708762|FG006|Long Term Extension (LTE)|Lack of Efficacy|5|||
28051297|NCT00533897|54708763|FG007|Long Term Extension (LTE)|Lack of Efficacy|3|||
28051298|NCT00533897|54708756|FG000|Long Term Extension (LTE)|Poor/Non-compliance|0|||
28051299|NCT00533897|54708757|FG001|Long Term Extension (LTE)|Poor/Non-compliance|0|||
28051300|NCT00533897|54708758|FG002|Long Term Extension (LTE)|Poor/Non-compliance|0|||
28051301|NCT00533897|54708759|FG003|Long Term Extension (LTE)|Poor/Non-compliance|0|||
28051302|NCT00533897|54708760|FG004|Long Term Extension (LTE)|Poor/Non-compliance|0|||
28051303|NCT00533897|54708761|FG005|Long Term Extension (LTE)|Poor/Non-compliance|0|||
28051304|NCT00533897|54708762|FG006|Long Term Extension (LTE)|Poor/Non-compliance|1|||
28051305|NCT00533897|54708763|FG007|Long Term Extension (LTE)|Poor/Non-compliance|0|||
28051306|NCT00533897|54708756|FG000|Long Term Extension (LTE)|Adverse Event|0|||
28051307|NCT00533897|54708757|FG001|Long Term Extension (LTE)|Adverse Event|0|||
28051308|NCT00533897|54708758|FG002|Long Term Extension (LTE)|Adverse Event|0|||
28051309|NCT00533897|54708759|FG003|Long Term Extension (LTE)|Adverse Event|0|||
28051310|NCT00533897|54708760|FG004|Long Term Extension (LTE)|Adverse Event|0|||
28051311|NCT00533897|54708761|FG005|Long Term Extension (LTE)|Adverse Event|0|||
28051312|NCT00533897|54708762|FG006|Long Term Extension (LTE)|Adverse Event|2|||
28051313|NCT00533897|54708763|FG007|Long Term Extension (LTE)|Adverse Event|5|||
28051314|NCT00533897|54708756|FG000|Long Term Extension (LTE)|Pregnancy|0|||
28051315|NCT00533897|54708757|FG001|Long Term Extension (LTE)|Pregnancy|0|||
28051316|NCT00533897|54708758|FG002|Long Term Extension (LTE)|Pregnancy|0|||
28051317|NCT00533897|54708759|FG003|Long Term Extension (LTE)|Pregnancy|0|||
28051318|NCT00533897|54708760|FG004|Long Term Extension (LTE)|Pregnancy|0|||
28051319|NCT00533897|54708761|FG005|Long Term Extension (LTE)|Pregnancy|0|||
28051320|NCT00533897|54708762|FG006|Long Term Extension (LTE)|Pregnancy|0|||
28051321|NCT00533897|54708763|FG007|Long Term Extension (LTE)|Pregnancy|2|||
28051322|NCT00533897|54708756|FG000|Long Term Extension (LTE)|Lost to Follow-up|0|||
28051323|NCT00533897|54708757|FG001|Long Term Extension (LTE)|Lost to Follow-up|0|||
28051324|NCT00533897|54708758|FG002|Long Term Extension (LTE)|Lost to Follow-up|0|||
28051325|NCT00533897|54708759|FG003|Long Term Extension (LTE)|Lost to Follow-up|0|||
28051326|NCT00533897|54708760|FG004|Long Term Extension (LTE)|Lost to Follow-up|0|||
28051327|NCT00533897|54708761|FG005|Long Term Extension (LTE)|Lost to Follow-up|0|||
28051328|NCT00533897|54708762|FG006|Long Term Extension (LTE)|Lost to Follow-up|1|||
28051329|NCT00533897|54708763|FG007|Long Term Extension (LTE)|Lost to Follow-up|1|||
28051330|NCT00533897|54708756|FG000|Long Term Extension (LTE)|Other|0|||
28051331|NCT00533897|54708757|FG001|Long Term Extension (LTE)|Other|0|||
28051332|NCT00533897|54708758|FG002|Long Term Extension (LTE)|Other|0|||
28051333|NCT00533897|54708759|FG003|Long Term Extension (LTE)|Other|0|||
28051334|NCT00533897|54708760|FG004|Long Term Extension (LTE)|Other|0|||
28051335|NCT00533897|54708761|FG005|Long Term Extension (LTE)|Other|0|||
28051336|NCT00533897|54708762|FG006|Long Term Extension (LTE)|Other|1|||
28051337|NCT00533897|54708763|FG007|Long Term Extension (LTE)|Other|6|||
28051338|NCT00426660|54708794|FG000|Overall Study|Death|14|||
28051339|NCT00426660|54708794|FG000|Overall Study|Adverse Event|23|||
28051340|NCT00426660|54708794|FG000|Overall Study|Insufficient Clinical Response|22|||
28051341|NCT00426660|54708794|FG000|Overall Study|Lost to Follow-up|15|||
28051342|NCT00426660|54708794|FG000|Overall Study|Other|23|||
28051343|NCT00426660|54708794|FG000|Overall Study|Withdrawal by Subject|18|||
28051344|NCT00426660|54708794|FG000|Overall Study|Protocol Violation|1|||
28051345|NCT00426660|54708794|FG000|Overall Study|Enrolled Not Treated|15|||
28051346|NCT00426270|54708798|FG000|Overall Study|Incorrectly Enrolled in the Study|1|||
28051347|NCT00426270|54708798|FG000|Overall Study|Adverse Event|5|||
28051348|NCT00330681|54708804|FG000|Overall Study|Adverse Event|3|||
28051349|NCT00330681|54708805|FG001|Overall Study|Adverse Event|6|||
28051350|NCT00330681|54708804|FG000|Overall Study|Protocol Violation|0|||
28051351|NCT00330681|54708805|FG001|Overall Study|Protocol Violation|1|||
28051352|NCT00330681|54708804|FG000|Overall Study|Withdrawal by Subject|5|||
28051353|NCT00330681|54708805|FG001|Overall Study|Withdrawal by Subject|5|||
28051354|NCT00330681|54708804|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
28051355|NCT00330681|54708805|FG001|Overall Study|Tracheotomy due to worsening of ALS|2|||
28051356|NCT00329901|54708814|FG000|Overall Study|Withdrawal by Subject|4|||
28051357|NCT00329901|54708815|FG001|Overall Study|Withdrawal by Subject|3|||
28051358|NCT00329901|54708816|FG002|Overall Study|Withdrawal by Subject|2|||
28051359|NCT00329901|54708814|FG000|Overall Study|Lost to Follow-up|2|||
28051360|NCT00329901|54708815|FG001|Overall Study|Lost to Follow-up|0|||
28051361|NCT00329901|54708816|FG002|Overall Study|Lost to Follow-up|1|||
28051362|NCT00329901|54708814|FG000|Overall Study|Protocol Violation|1|||
28051363|NCT00329901|54708815|FG001|Overall Study|Protocol Violation|0|||
28051364|NCT00329901|54708816|FG002|Overall Study|Protocol Violation|1|||
28051365|NCT00329901|54708814|FG000|Overall Study|Unable to classify|2|||
28051366|NCT00329901|54708815|FG001|Overall Study|Unable to classify|2|||
28051367|NCT00329901|54708816|FG002|Overall Study|Unable to classify|0|||
28051368|NCT00436956|54708828|FG000|Overall Study|Not evaluable|1|||
28051369|NCT00436956|54708829|FG001|Overall Study|Not evaluable|0|||
28051370|NCT00329745|54708838|FG000|Overall Study|Protocol Violation|1|||
28051371|NCT00329745|54708839|FG001|Overall Study|Protocol Violation|0|||
28051372|NCT00329745|54708838|FG000|Overall Study|Withdrawal by Subject|0|||
28051373|NCT00329745|54708839|FG001|Overall Study|Withdrawal by Subject|1|||
28051374|NCT00329745|54708838|FG000|Overall Study|Lost to Follow-up|86|||
28051375|NCT00329745|54708839|FG001|Overall Study|Lost to Follow-up|101|||
28051376|NCT00436644|54708845|FG000|Overall Study|Adverse Event|2|||
28051377|NCT00436644|54708845|FG000|Overall Study|Death|1|||
28051378|NCT00324987|54708851|FG000|Overall Study|Adverse Event|2|||
28051379|NCT00324987|54708852|FG001|Overall Study|Adverse Event|1|||
28051380|NCT00324987|54708851|FG000|Overall Study|Withdrawal by Subject|1|||
28051381|NCT00324987|54708852|FG001|Overall Study|Withdrawal by Subject|1|||
28051382|NCT00324987|54708851|FG000|Overall Study|Progression|1|||
28051383|NCT00324987|54708852|FG001|Overall Study|Progression|1|||
28051384|NCT00324987|54708851|FG000|Overall Study|symptomatic deterioration, toxicity, etc|2|||
28051385|NCT00324987|54708852|FG001|Overall Study|symptomatic deterioration, toxicity, etc|3|||
28051386|NCT00324675|54708860|FG000|Overall Study|Adverse Event|1|||
28051387|NCT00324675|54708861|FG001|Overall Study|Adverse Event|0|||
28051388|NCT00436566|54708867|FG000|Overall Study|Withdrawal by Subject|2|||
28051389|NCT00436566|54708867|FG000|Overall Study|Protocol Violation|1|||
28051390|NCT00352365|54708871|FG000|Induction Therapy|Adverse Event|7|||
28051391|NCT00352365|54708871|FG000|Induction Therapy|Progression/Relapse|8|||
28051392|NCT00352365|54708871|FG000|Induction Therapy|Death|7|||
28051393|NCT00352365|54708871|FG000|Induction Therapy|Not protocol specified|1|||
28051394|NCT00352365|54708871|FG000|Induction Therapy|Not eligible|3|||
28051395|NCT00352365|54708871|FG000|Induction Therapy|Death before starting protocol therapy|1|||
28051396|NCT00352365|54708871|FG000|Maintenance Therapy|Progression/Relapse|3|||
28051397|NCT00352365|54708871|FG000|Maintenance Therapy|Death|2|||
28051398|NCT00352365|54708871|FG000|Maintenance Therapy|Not protocol specified|3|||
28051399|NCT00352365|54708871|FG000|Maintenance Therapy|Not eligible|4|||
28051400|NCT00532493|54708881|FG000|Overall Study|Death|1|||
28051401|NCT00532493|54708882|FG001|Overall Study|Death|1|||
28051402|NCT00532493|54708881|FG000|Overall Study|Lost to Follow-up|10|||
28051403|NCT00532493|54708882|FG001|Overall Study|Lost to Follow-up|7|||
28051404|NCT00532493|54708881|FG000|Overall Study|Withdrawal by Subject|7|||
28051405|NCT00532493|54708882|FG001|Overall Study|Withdrawal by Subject|9|||
28051406|NCT00532493|54708881|FG000|Overall Study|Physician Decision|1|||
28051407|NCT00532493|54708882|FG001|Overall Study|Physician Decision|6|||
28051408|NCT00532493|54708881|FG000|Overall Study|Adverse Event|6|||
28051409|NCT00532493|54708882|FG001|Overall Study|Adverse Event|5|||
28051410|NCT00532493|54708881|FG000|Overall Study|Protocol Deviation|1|||
28051411|NCT00532493|54708882|FG001|Overall Study|Protocol Deviation|0|||
28051412|NCT00532493|54708881|FG000|Overall Study|Subject Moved Away|3|||
28051413|NCT00532493|54708882|FG001|Overall Study|Subject Moved Away|1|||
28051414|NCT00532493|54708881|FG000|Overall Study|Contraindicative Medication|1|||
28051415|NCT00532493|54708882|FG001|Overall Study|Contraindicative Medication|0|||
28051416|NCT00533507|54708890|FG000|Overall Study|Withdrawal by Subject|1|||
28051417|NCT03886493|54708894|FG000|Overall Study|Adverse Event|1|||
28051418|NCT00352053|54708900|FG000|Double-Blind Phase (Through Week 48)|Virologic Failure|14|||
28051419|NCT00352053|54708901|FG001|Double-Blind Phase (Through Week 48)|Virologic Failure|10|||
28051420|NCT00352053|54708900|FG000|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
28051421|NCT00352053|54708901|FG001|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
28051422|NCT00352053|54708900|FG000|Double-Blind Phase (Through Week 48)|Adverse Event|1|||
28051423|NCT00352053|54708901|FG001|Double-Blind Phase (Through Week 48)|Adverse Event|0|||
28051424|NCT00352053|54708900|FG000|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0|||
28051425|NCT00352053|54708901|FG001|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1|||
28051426|NCT00352053|54708900|FG000|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1|||
28051427|NCT00352053|54708901|FG001|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0|||
28051428|NCT00352053|54708900|FG000|First Extension Phase (Weeks 48-144)|Physician Decision|9|||
28051429|NCT00352053|54708901|FG001|First Extension Phase (Weeks 48-144)|Physician Decision|13|||
28051430|NCT00352053|54708900|FG000|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1|||
28051431|NCT00352053|54708901|FG001|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4|||
28051432|NCT00352053|54708900|FG000|First Extension Phase (Weeks 48-144)|Pregnancy|1|||
28051433|NCT00352053|54708901|FG001|First Extension Phase (Weeks 48-144)|Pregnancy|0|||
28051434|NCT00352053|54708900|FG000|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1|||
28051435|NCT00352053|54708901|FG001|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0|||
28051436|NCT00352053|54708900|FG000|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
28051437|NCT00352053|54708901|FG001|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
28051438|NCT00352053|54708900|FG000|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
28051439|NCT00352053|54708901|FG001|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
28051440|NCT00352053|54708900|FG000|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
28051441|NCT00352053|54708901|FG001|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
28051442|NCT00352053|54708900|FG000|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0|||
28051443|NCT00352053|54708901|FG001|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1|||
28051444|NCT00351819|54708917|FG000|Overall Study|Lost to Follow-up|4|||
28051445|NCT00351819|54708918|FG001|Overall Study|Lost to Follow-up|4|||
28051446|NCT00351819|54708917|FG000|Overall Study|Withdrawal by Subject|0|||
28051447|NCT00351819|54708918|FG001|Overall Study|Withdrawal by Subject|4|||
28051448|NCT00351819|54708917|FG000|Overall Study|Elevated PSA|1|||
28051449|NCT00351819|54708918|FG001|Overall Study|Elevated PSA|1|||
28051450|NCT00351819|54708917|FG000|Overall Study|Traumatic ankle fracture|1|||
28051451|NCT00351819|54708918|FG001|Overall Study|Traumatic ankle fracture|0|||
28051452|NCT00351819|54708917|FG000|Overall Study|Unprofessional behavior|1|||
28051453|NCT00351819|54708918|FG001|Overall Study|Unprofessional behavior|0|||
28051454|NCT00351819|54708917|FG000|Overall Study|Non-compliance|0|||
28051455|NCT00351819|54708918|FG001|Overall Study|Non-compliance|1|||
28051456|NCT00351819|54708917|FG000|Overall Study|Incarcerated|0|||
28051457|NCT00351819|54708918|FG001|Overall Study|Incarcerated|1|||
28051458|NCT00351819|54708917|FG000|Overall Study|Enrolled in another trial|0|||
28051459|NCT00351819|54708918|FG001|Overall Study|Enrolled in another trial|1|||
28051460|NCT00351351|54708926|FG000|Overall Study|surgical access pbs; device issues|9|||
28051461|NCT00351351|54708927|FG001|Overall Study|surgical access pbs; device issues|4|||
28051462|NCT00323115|54708933|FG000|Vaccine Administration|Adverse Event|1|||
28051463|NCT00323115|54708933|FG000|Adjuvant Therapy & Survival Follow-Up|Death|8|||
28051464|NCT00322881|54708942|FG000|Overall Study|Death|2|||
28051465|NCT00322881|54708942|FG000|Overall Study|Adverse Event|1|||
28051466|NCT00322881|54708942|FG000|Overall Study|Disease Progression|2|||
28051467|NCT00415194|54708948|FG000|Overall Study|Adverse Event|37|||
28051468|NCT00415194|54708949|FG001|Overall Study|Adverse Event|32|||
28051469|NCT00415194|54708948|FG000|Overall Study|Entry Criteria Not Met|4|||
28051470|NCT00415194|54708949|FG001|Overall Study|Entry Criteria Not Met|8|||
28051471|NCT00415194|54708948|FG000|Overall Study|Lost to Follow-up|1|||
28051472|NCT00415194|54708949|FG001|Overall Study|Lost to Follow-up|0|||
28051473|NCT00415194|54708948|FG000|Overall Study|Physician Decision|10|||
28051474|NCT00415194|54708949|FG001|Overall Study|Physician Decision|16|||
28051475|NCT00415194|54708948|FG000|Overall Study|Progressive Disease|180|||
28051476|NCT00415194|54708949|FG001|Overall Study|Progressive Disease|217|||
28051477|NCT00415194|54708948|FG000|Overall Study|Protocol Violation|4|||
28051478|NCT00415194|54708949|FG001|Overall Study|Protocol Violation|2|||
28051479|NCT00415194|54708948|FG000|Overall Study|Withdrawal by Subject|28|||
27812393|NCT01710501|54268536|FG000|Overall Study|Lost to Follow-up|2|||
27812394|NCT01710501|54268537|FG001|Overall Study|Lost to Follow-up|0|||
27812395|NCT01710501|54268538|FG002|Overall Study|Lost to Follow-up|0|||
27812396|NCT01700829|54268548|FG000|Overall Study|Withdrawal by Subject|1|||
27812397|NCT01700829|54268549|FG001|Overall Study|Withdrawal by Subject|1|||
27812398|NCT01710345|54268558|FG000|Overall Study|Adverse Event|0|||
27812399|NCT01710345|54268559|FG001|Overall Study|Adverse Event|2|||
27812400|NCT01710345|54268560|FG002|Overall Study|Adverse Event|0|||
27812401|NCT01710345|54268558|FG000|Overall Study|Lack of Efficacy|2|||
27812402|NCT01710345|54268559|FG001|Overall Study|Lack of Efficacy|3|||
27812403|NCT01710345|54268560|FG002|Overall Study|Lack of Efficacy|1|||
27812404|NCT01710345|54268558|FG000|Overall Study|Drug Dosing Error|1|||
27812405|NCT01710345|54268559|FG001|Overall Study|Drug Dosing Error|0|||
27812406|NCT01710345|54268560|FG002|Overall Study|Drug Dosing Error|0|||
27812407|NCT01710033|54268576|FG000|Stage 2|Adverse Event|0|||
27812408|NCT01710033|54268577|FG001|Stage 2|Adverse Event|0|||
27812409|NCT01710033|54268578|FG002|Stage 2|Adverse Event|0|||
28051480|NCT00415194|54708949|FG001|Overall Study|Withdrawal by Subject|21|||
28051481|NCT00415194|54708948|FG000|Overall Study|Death Due to Study Disease|26|||
28051482|NCT00415194|54708949|FG001|Overall Study|Death Due to Study Disease|29|||
28051483|NCT00415194|54708948|FG000|Overall Study|Death Due to Study Drug Related AE|11|||
28051484|NCT00415194|54708949|FG001|Overall Study|Death Due to Study Drug Related AE|1|||
28051485|NCT00415194|54708948|FG000|Overall Study|Death Due to Procedural Related AE|0|||
28051486|NCT00415194|54708949|FG001|Overall Study|Death Due to Procedural Related AE|1|||
28051487|NCT00415194|54708948|FG000|Overall Study|Death Due to AE (Other Causes)|27|||
28051488|NCT00415194|54708949|FG001|Overall Study|Death Due to AE (Other Causes)|15|||
28051489|NCT00436332|54708955|FG000|Overall Study|Adverse Event|9|||
28051490|NCT00436332|54708955|FG000|Overall Study|Withdrawal by Subject|2|||
28051491|NCT00436332|54708955|FG000|Overall Study|Progression|59|||
27812410|NCT01710033|54268579|FG003|Stage 2|Adverse Event|0|||
27812411|NCT01710033|54268580|FG004|Stage 2|Adverse Event|1|||
27812412|NCT01822496|54268597|FG000|Overall Study|Protocol Violation|2|||
27812413|NCT01822496|54268598|FG001|Overall Study|Protocol Violation|2|||
27812414|NCT01822496|54268599|FG002|Overall Study|Protocol Violation|0|||
27812415|NCT01822496|54268600|FG003|Overall Study|Protocol Violation|1|||
27812416|NCT01822496|54268597|FG000|Overall Study|Withdrawal by Subject|0|||
27812417|NCT01822496|54268598|FG001|Overall Study|Withdrawal by Subject|0|||
27812418|NCT01822496|54268599|FG002|Overall Study|Withdrawal by Subject|0|||
27812419|NCT01822496|54268600|FG003|Overall Study|Withdrawal by Subject|3|||
27812420|NCT01867047|54268612|FG000|Overall Study|Lost to Follow-up|3|||
27812421|NCT01867047|54268613|FG001|Overall Study|Lost to Follow-up|3|||
27812422|NCT01867047|54268612|FG000|Overall Study|Withdrawal by Subject|2|||
27812423|NCT01867047|54268613|FG001|Overall Study|Withdrawal by Subject|0|||
28051492|NCT00436332|54708955|FG000|Overall Study|Death|2|||
28051493|NCT00436332|54708955|FG000|Overall Study|Not Protocol Specified|6|||
28051494|NCT00436332|54708955|FG000|Overall Study|Ineligible|2|||
28051495|NCT00436332|54708955|FG000|Overall Study|Never Received Treatment|3|||
28051496|NCT00532259|54708959|FG000|Overall Study|Withdrawal by Subject|2|||
28051497|NCT00532259|54708959|FG000|Overall Study|Adverse Event|1|||
28051498|NCT00532259|54708959|FG000|Overall Study|Death|1|||
28051499|NCT00532259|54708959|FG000|Overall Study|Lack of Efficacy|21|||
28051500|NCT00532259|54708959|FG000|Overall Study|Lost to Follow-up|3|||
28051501|NCT00532259|54708959|FG000|Overall Study|Physician Decision|3|||
28051502|NCT00532259|54708959|FG000|Overall Study|Protocol Violation|1|||
28051503|NCT00322491|54708966|FG000|Overall Study|Adverse Event|1|||
28051504|NCT00322491|54708967|FG001|Overall Study|Adverse Event|0|||
28051505|NCT00322491|54708966|FG000|Overall Study|Death|1|||
28051506|NCT00322491|54708967|FG001|Overall Study|Death|2|||
28051507|NCT00322023|54708977|FG000|Overall Study|various|0|||
28051508|NCT00322023|54708978|FG001|Overall Study|various|2|||
28051509|NCT00322023|54708979|FG002|Overall Study|various|6|||
28051510|NCT00414960|54708989|FG000|Overall Study|Adverse Event|4|||
28051511|NCT00414960|54708990|FG001|Overall Study|Adverse Event|0|||
28051512|NCT00414960|54708989|FG000|Overall Study|Withdrawal by Subject|3|||
28051513|NCT00414960|54708990|FG001|Overall Study|Withdrawal by Subject|0|||
28051514|NCT00414960|54708989|FG000|Overall Study|Physician Decision|0|||
28051515|NCT00414960|54708990|FG001|Overall Study|Physician Decision|1|||
28051516|NCT00321789|54708998|FG000|Overall Study|Lost to Follow-up|4|||
28051517|NCT00321789|54708999|FG001|Overall Study|Lost to Follow-up|7|||
28051518|NCT00321789|54708998|FG000|Overall Study|Withdrawal by Subject|6|||
28051519|NCT00321789|54708999|FG001|Overall Study|Withdrawal by Subject|6|||
28051520|NCT00321789|54708998|FG000|Overall Study|Protocol Violation|5|||
28051521|NCT00321789|54708999|FG001|Overall Study|Protocol Violation|3|||
28051522|NCT00414726|54709007|FG000|Overall Study|Withdrawal by Subject|0|||
28051523|NCT00414726|54709008|FG001|Overall Study|Withdrawal by Subject|1|||
28051524|NCT00531947|54709016|FG000|Overall Study|Adverse Event|5|||
28051525|NCT00531947|54709017|FG001|Overall Study|Adverse Event|10|||
28051526|NCT00531947|54709016|FG000|Overall Study|Lost to Follow-up|12|||
28051527|NCT00531947|54709017|FG001|Overall Study|Lost to Follow-up|9|||
28051528|NCT00531947|54709016|FG000|Overall Study|Withdrawal by Subject|14|||
28051529|NCT00531947|54709017|FG001|Overall Study|Withdrawal by Subject|19|||
28051530|NCT00531947|54709016|FG000|Overall Study|Protocol Violation|2|||
28051531|NCT00531947|54709017|FG001|Overall Study|Protocol Violation|1|||
28051532|NCT00531947|54709016|FG000|Overall Study|Non-Compliance|4|||
28051533|NCT00531947|54709017|FG001|Overall Study|Non-Compliance|7|||
27812424|NCT01867047|54268612|FG000|Overall Study|Physician Decision|2|||
27812425|NCT01867047|54268613|FG001|Overall Study|Physician Decision|0|||
27812426|NCT01867047|54268612|FG000|Overall Study|surgery not indicated in protocol|1|||
28051534|NCT00531947|54709016|FG000|Overall Study|Other (e.g., Lack of Efficacy)|5|||
28051535|NCT00531947|54709017|FG001|Overall Study|Other (e.g., Lack of Efficacy)|5|||
28051536|NCT00530855|54709023|FG000|Overall Study|Lack of Efficacy|20|||
28051537|NCT00530855|54709023|FG000|Overall Study|Withdrawal by Subject|30|||
28051538|NCT00530855|54709023|FG000|Overall Study|Fatal Serious AE|3|||
28051539|NCT00530855|54709023|FG000|Overall Study|Non Fatal Serious AE|7|||
28051540|NCT00530855|54709023|FG000|Overall Study|Non Fatal Non Serious AE|12|||
28051541|NCT00530855|54709023|FG000|Overall Study|Protocol Violation|3|||
28051542|NCT00530855|54709023|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
28051543|NCT00530855|54709023|FG000|Overall Study|Lost to Follow-up|9|||
28051544|NCT00530855|54709023|FG000|Overall Study|Other reason for premature termination|17|||
28051545|NCT00530777|54709029|FG000|Overall Study|Lost to Follow-up|0|||
28051546|NCT00530777|54709030|FG001|Overall Study|Lost to Follow-up|1|||
28051547|NCT00530777|54709029|FG000|Overall Study|Death|1|||
28051548|NCT00530777|54709030|FG001|Overall Study|Death|2|||
28051549|NCT00530777|54709029|FG000|Overall Study|Physician Decision|1|||
28051550|NCT00530777|54709030|FG001|Overall Study|Physician Decision|0|||
28051551|NCT00530777|54709029|FG000|Overall Study|Withdrawal by Subject|0|||
28051552|NCT00530777|54709030|FG001|Overall Study|Withdrawal by Subject|1|||
28051553|NCT00530777|54709029|FG000|Overall Study|Unable to adhere to visit schedule|5|||
28051554|NCT00530777|54709030|FG001|Overall Study|Unable to adhere to visit schedule|1|||
28051555|NCT03882047|54709039|FG000|Overall Study|Adverse Event|0|||
28051556|NCT03882047|54709040|FG001|Overall Study|Adverse Event|2|||
28051557|NCT03882047|54709041|FG002|Overall Study|Adverse Event|2|||
27812427|NCT01867047|54268613|FG001|Overall Study|surgery not indicated in protocol|2|||
27812428|NCT01821560|54268625|FG000|Overall Study|Lost to Follow-up|5|||
28051558|NCT03882047|54709039|FG000|Overall Study|Treatment Failure|3|||
28051559|NCT03882047|54709040|FG001|Overall Study|Treatment Failure|3|||
28051560|NCT03882047|54709041|FG002|Overall Study|Treatment Failure|12|||
28051561|NCT03882047|54709039|FG000|Overall Study|Lost to Follow-up|0|||
28051562|NCT03882047|54709040|FG001|Overall Study|Lost to Follow-up|1|||
28051563|NCT03882047|54709041|FG002|Overall Study|Lost to Follow-up|0|||
28051564|NCT03882047|54709039|FG000|Overall Study|Did Not Wish to Continue|1|||
28051565|NCT03882047|54709040|FG001|Overall Study|Did Not Wish to Continue|4|||
28051566|NCT03882047|54709041|FG002|Overall Study|Did Not Wish to Continue|1|||
28051567|NCT03882047|54709039|FG000|Overall Study|Noncompliance With Protocol|2|||
28051568|NCT03882047|54709040|FG001|Overall Study|Noncompliance With Protocol|0|||
28051569|NCT03882047|54709041|FG002|Overall Study|Noncompliance With Protocol|0|||
28051570|NCT03882047|54709039|FG000|Overall Study|Did Not Meet Eligibility|0|||
28051571|NCT03882047|54709040|FG001|Overall Study|Did Not Meet Eligibility|0|||
28051572|NCT03882047|54709041|FG002|Overall Study|Did Not Meet Eligibility|1|||
28051573|NCT00530621|54709051|FG000|Overall Study|Adverse Event|11|||
28051574|NCT00530621|54709052|FG001|Overall Study|Adverse Event|8|||
28051575|NCT00530621|54709051|FG000|Overall Study|Physician Decision|2|||
28051576|NCT00530621|54709052|FG001|Overall Study|Physician Decision|4|||
28051577|NCT00530621|54709051|FG000|Overall Study|Progressive Disease (PD)|47|||
28051578|NCT00530621|54709052|FG001|Overall Study|Progressive Disease (PD)|40|||
28051579|NCT00530621|54709051|FG000|Overall Study|Sponsor Decision|12|||
28051580|NCT00530621|54709052|FG001|Overall Study|Sponsor Decision|15|||
28051581|NCT00530621|54709051|FG000|Overall Study|Subject Decision|4|||
28051582|NCT00530621|54709052|FG001|Overall Study|Subject Decision|7|||
28051583|NCT00530621|54709051|FG000|Overall Study|Death|3|||
28051584|NCT00530621|54709052|FG001|Overall Study|Death|6|||
27812429|NCT01821560|54268626|FG001|Overall Study|Lost to Follow-up|5|||
27812430|NCT01821560|54268625|FG000|Overall Study|Withdrawal by Subject|1|||
27812431|NCT01821560|54268626|FG001|Overall Study|Withdrawal by Subject|1|||
27812432|NCT01821560|54268625|FG000|Overall Study|Protocol Violation|0|||
27812433|NCT01821560|54268626|FG001|Overall Study|Protocol Violation|1|||
27812434|NCT01871402|54268634|FG000|Overall Study|Lost to Follow-up|1|||
27812435|NCT01871402|54268635|FG001|Overall Study|Lost to Follow-up|0|||
27812436|NCT01871402|54268634|FG000|Overall Study|Withdrawal by Subject|0|||
27812437|NCT01871402|54268635|FG001|Overall Study|Withdrawal by Subject|2|||
27812438|NCT01871402|54268634|FG000|Overall Study|Non-compliance|0|||
27812439|NCT01871402|54268635|FG001|Overall Study|Non-compliance|1|||
27812440|NCT01846442|54268654|FG000|Overall Study|Adverse Event|2|||
27812441|NCT01846442|54268655|FG001|Overall Study|Adverse Event|4|||
27812442|NCT01846442|54268656|FG002|Overall Study|Adverse Event|2|||
27812443|NCT01846442|54268657|FG003|Overall Study|Adverse Event|1|||
27812444|NCT01846442|54268654|FG000|Overall Study|Lost to Follow-up|0|||
27812445|NCT01846442|54268655|FG001|Overall Study|Lost to Follow-up|0|||
27812446|NCT01846442|54268656|FG002|Overall Study|Lost to Follow-up|1|||
27812447|NCT01846442|54268657|FG003|Overall Study|Lost to Follow-up|0|||
27812448|NCT01846442|54268654|FG000|Overall Study|Withdrawal by Subject|3|||
27812449|NCT01846442|54268655|FG001|Overall Study|Withdrawal by Subject|2|||
27812450|NCT01846442|54268656|FG002|Overall Study|Withdrawal by Subject|0|||
27812451|NCT01846442|54268657|FG003|Overall Study|Withdrawal by Subject|1|||
27812452|NCT01846442|54268654|FG000|Overall Study|Left the city/Lost medication|1|||
27812453|NCT01846442|54268655|FG001|Overall Study|Left the city/Lost medication|0|||
27812454|NCT01846442|54268656|FG002|Overall Study|Left the city/Lost medication|1|||
27812455|NCT01846442|54268657|FG003|Overall Study|Left the city/Lost medication|1|||
27812456|NCT01709721|54268670|FG000|Open Label Phase|Withdrawal by Subject|0|||
27812457|NCT01709721|54268671|FG001|Open Label Phase|Withdrawal by Subject|0|||
27812458|NCT01709721|54268672|FG002|Open Label Phase|Withdrawal by Subject|5|||
27812459|NCT01709721|54268670|FG000|Open Label Phase|Adverse Event|0|||
27812460|NCT01709721|54268671|FG001|Open Label Phase|Adverse Event|0|||
27812461|NCT01709721|54268672|FG002|Open Label Phase|Adverse Event|8|||
27812462|NCT01709721|54268670|FG000|Open Label Phase|Non-compliance With Study Drug|0|||
27812463|NCT01709721|54268671|FG001|Open Label Phase|Non-compliance With Study Drug|0|||
28051585|NCT00530621|54709051|FG000|Overall Study|Not Treated Due to PD Prior to Dosing|1|||
28051586|NCT00530621|54709052|FG001|Overall Study|Not Treated Due to PD Prior to Dosing|0|||
28051587|NCT00531479|54709064|FG000|Overall Study|Death|68|||
27812464|NCT01709721|54268672|FG002|Open Label Phase|Non-compliance With Study Drug|3|||
27812465|NCT01709721|54268670|FG000|Open Label Phase|Investigator Decision|0|||
27812466|NCT01709721|54268671|FG001|Open Label Phase|Investigator Decision|0|||
28051588|NCT00531479|54709065|FG001|Overall Study|Death|71|||
28051589|NCT00531479|54709064|FG000|Overall Study|Lost to Follow-up|0|||
28051590|NCT00531479|54709065|FG001|Overall Study|Lost to Follow-up|2|||
28051591|NCT00531479|54709064|FG000|Overall Study|Other|0|||
28051592|NCT00531479|54709065|FG001|Overall Study|Other|1|||
27812467|NCT01709721|54268672|FG002|Open Label Phase|Investigator Decision|1|||
27812468|NCT01709721|54268670|FG000|Open Label Phase|Sponsor Decision|0|||
27812469|NCT01709721|54268671|FG001|Open Label Phase|Sponsor Decision|0|||
27812470|NCT01709721|54268672|FG002|Open Label Phase|Sponsor Decision|2|||
27812471|NCT01709721|54268670|FG000|Open Label Phase|Protocol Violation|0|||
28051593|NCT00531479|54709064|FG000|Overall Study|Withdrawal by Subject|6|||
28051594|NCT00531479|54709065|FG001|Overall Study|Withdrawal by Subject|6|||
28051595|NCT00531479|54709064|FG000|Overall Study|Did not receive treatment|2|||
28051596|NCT00531479|54709065|FG001|Overall Study|Did not receive treatment|3|||
28051597|NCT00530075|54709071|FG000|Overall Study|Adverse Event|1|||
28051598|NCT00530075|54709071|FG000|Overall Study|Death|1|||
28051599|NCT00530075|54709071|FG000|Overall Study|Lack of Efficacy|3|||
28051600|NCT00530075|54709071|FG000|Overall Study|Protocol Violation|1|||
28051601|NCT00530075|54709071|FG000|Overall Study|Withdrawal by Subject|1|||
28051602|NCT00531011|54709077|FG000|Overall Study|Withdrawal by Subject|2|||
28051603|NCT00531011|54709078|FG001|Overall Study|Withdrawal by Subject|4|||
28051604|NCT00531011|54709077|FG000|Overall Study|Death|1|||
28051605|NCT00531011|54709078|FG001|Overall Study|Death|0|||
28051606|NCT00531011|54709077|FG000|Overall Study|Lost to Follow-up|1|||
28051607|NCT00531011|54709078|FG001|Overall Study|Lost to Follow-up|0|||
28051608|NCT00531011|54709077|FG000|Overall Study|Physician Decision|0|||
28051609|NCT00531011|54709078|FG001|Overall Study|Physician Decision|3|||
28051610|NCT00529217|54709084|FG000|Overall Study|Lack of Efficacy|2|||
28051611|NCT00529217|54709084|FG000|Overall Study|Unable to adhere to study schedule|2|||
28051612|NCT00471146|54709091|FG000|Overall Study|Adverse Event|32|||
28051613|NCT00471146|54709092|FG001|Overall Study|Adverse Event|33|||
28051614|NCT00471146|54709091|FG000|Overall Study|Withdrawal by Subject|14|||
28051615|NCT00471146|54709092|FG001|Overall Study|Withdrawal by Subject|11|||
28051616|NCT00471146|54709091|FG000|Overall Study|Death|11|||
28051617|NCT00471146|54709092|FG001|Overall Study|Death|12|||
28051618|NCT00471146|54709091|FG000|Overall Study|Lost to Follow-up|4|||
28051619|NCT00471146|54709092|FG001|Overall Study|Lost to Follow-up|2|||
28051620|NCT00471146|54709091|FG000|Overall Study|Protocol Violation|2|||
28051621|NCT00471146|54709092|FG001|Overall Study|Protocol Violation|2|||
28051622|NCT00471146|54709091|FG000|Overall Study|Objective progression or relapse|84|||
28051623|NCT00471146|54709092|FG001|Overall Study|Objective progression or relapse|87|||
28051624|NCT00471146|54709091|FG000|Overall Study|Global deterioration of health status|12|||
28051625|NCT00471146|54709092|FG001|Overall Study|Global deterioration of health status|14|||
28051626|NCT00471146|54709091|FG000|Overall Study|Randomized but not treated|9|||
28051627|NCT00471146|54709092|FG001|Overall Study|Randomized but not treated|8|||
28051628|NCT00471146|54709091|FG000|Overall Study|Other|4|||
28051629|NCT00471146|54709092|FG001|Overall Study|Other|5|||
28051630|NCT00469898|54709098|FG000|Overall Study|Adverse Event|7|||
27812472|NCT01709721|54268671|FG001|Open Label Phase|Protocol Violation|0|||
27812473|NCT01709721|54268672|FG002|Open Label Phase|Protocol Violation|1|||
27812474|NCT01709721|54268670|FG000|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
27812475|NCT01709721|54268671|FG001|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
27812476|NCT01709721|54268672|FG002|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|1|||
27812477|NCT01709721|54268670|FG000|Open Label Phase|Inadequate Pain Control|0|||
27812478|NCT01709721|54268671|FG001|Open Label Phase|Inadequate Pain Control|0|||
27812479|NCT01709721|54268672|FG002|Open Label Phase|Inadequate Pain Control|37|||
27812480|NCT01709721|54268670|FG000|Open Label Phase|Other, Specify in text field in database|0|||
27812481|NCT01709721|54268671|FG001|Open Label Phase|Other, Specify in text field in database|0|||
27812482|NCT01709721|54268672|FG002|Open Label Phase|Other, Specify in text field in database|14|||
28051631|NCT00469898|54709098|FG000|Overall Study|Withdrawal by Subject|4|||
28051632|NCT00469898|54709098|FG000|Overall Study|Death|4|||
28051633|NCT00469898|54709098|FG000|Overall Study|Disease progression|9|||
28051634|NCT00469898|54709098|FG000|Overall Study|Decreased performance status|1|||
28051635|NCT00529763|54709105|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
28051636|NCT00529763|54709106|FG001|Overall Study|Adverse Event Unrelated to Study Drug|5|||
28051637|NCT00529763|54709107|FG002|Overall Study|Adverse Event Unrelated to Study Drug|3|||
28051638|NCT00529763|54709105|FG000|Overall Study|Death|1|||
28051639|NCT00529763|54709106|FG001|Overall Study|Death|1|||
28051640|NCT00529763|54709107|FG002|Overall Study|Death|1|||
28051641|NCT00529763|54709105|FG000|Overall Study|Disease Progression|10|||
28051642|NCT00529763|54709106|FG001|Overall Study|Disease Progression|16|||
28051643|NCT00529763|54709107|FG002|Overall Study|Disease Progression|11|||
28051644|NCT00529763|54709105|FG000|Overall Study|Lost to Follow-up|1|||
27812483|NCT01709721|54268670|FG000|Randomized Phase|Adverse Event|0|||
27812484|NCT01709721|54268671|FG001|Randomized Phase|Adverse Event|1|||
27812485|NCT01709721|54268672|FG002|Randomized Phase|Adverse Event|0|||
28051645|NCT00529763|54709106|FG001|Overall Study|Lost to Follow-up|2|||
28051646|NCT00529763|54709107|FG002|Overall Study|Lost to Follow-up|3|||
27812486|NCT01709721|54268670|FG000|Randomized Phase|Lost to Follow-up|1|||
28051647|NCT00529763|54709105|FG000|Overall Study|Stem Cell Transplant|0|||
28051648|NCT00529763|54709106|FG001|Overall Study|Stem Cell Transplant|3|||
28051649|NCT00529763|54709107|FG002|Overall Study|Stem Cell Transplant|1|||
28051650|NCT00529763|54709105|FG000|Overall Study|Study Drug Toxicity|3|||
28051651|NCT00529763|54709106|FG001|Overall Study|Study Drug Toxicity|6|||
28051652|NCT00529763|54709107|FG002|Overall Study|Study Drug Toxicity|4|||
28051653|NCT00529763|54709105|FG000|Overall Study|Participant Withdrew Consent|2|||
28051654|NCT00529763|54709106|FG001|Overall Study|Participant Withdrew Consent|3|||
28051655|NCT00529763|54709107|FG002|Overall Study|Participant Withdrew Consent|4|||
28051656|NCT00529763|54709105|FG000|Overall Study|Other reasons|2|||
28051657|NCT00529763|54709106|FG001|Overall Study|Other reasons|0|||
28051658|NCT00529763|54709107|FG002|Overall Study|Other reasons|2|||
28051659|NCT00529763|54709105|FG000|Overall Study|Participant request to discontinue treatment|1|||
28051660|NCT00529763|54709106|FG001|Overall Study|Participant request to discontinue treatment|1|||
28051661|NCT00529763|54709107|FG002|Overall Study|Participant request to discontinue treatment|3|||
28051662|NCT00486902|54709122|FG000|Overall Study|Withdrawal by Subject|1|||
28051663|NCT00486902|54709123|FG001|Overall Study|Withdrawal by Subject|2|||
28051664|NCT00486902|54709122|FG000|Overall Study|decision for postpartum tubal ligation|3|||
28051665|NCT00486902|54709123|FG001|Overall Study|decision for postpartum tubal ligation|1|||
28051666|NCT00486902|54709122|FG000|Overall Study|spinal anesthetic protocal violation|1|||
28051667|NCT00486902|54709123|FG001|Overall Study|spinal anesthetic protocal violation|1|||
28051668|NCT00486902|54709122|FG000|Overall Study|Did not meet inclusion criteria|1|||
28051669|NCT00486902|54709123|FG001|Overall Study|Did not meet inclusion criteria|0|||
28051670|NCT00486902|54709122|FG000|Overall Study|No toradol due to hemmorhage or allergy|3|||
28051671|NCT00486902|54709123|FG001|Overall Study|No toradol due to hemmorhage or allergy|1|||
28051672|NCT03687827|54709129|FG000|Treatment Period 1|Death|0|||
28051673|NCT03687827|54709130|FG001|Treatment Period 1|Death|1|||
28051674|NCT03687827|54709129|FG000|Treatment Period 1|Lost to Follow-up|2|||
28051675|NCT03687827|54709130|FG001|Treatment Period 1|Lost to Follow-up|2|||
28051676|NCT03687827|54709129|FG000|Treatment Period 1|Physician Decision|5|||
28051677|NCT03687827|54709130|FG001|Treatment Period 1|Physician Decision|2|||
28051678|NCT03687827|54709129|FG000|Treatment Period 1|Withdrawal by Subject|7|||
28051679|NCT03687827|54709130|FG001|Treatment Period 1|Withdrawal by Subject|3|||
28051680|NCT03687827|54709129|FG000|Treatment Period 2|Physician Decision|4|||
28051681|NCT03687827|54709130|FG001|Treatment Period 2|Physician Decision|1|||
28051682|NCT03687827|54709129|FG000|Treatment Period 2|Withdrawal by Subject|1|||
28051683|NCT03687827|54709130|FG001|Treatment Period 2|Withdrawal by Subject|2|||
28051684|NCT00529529|54709139|FG000|Overall Study|Adverse Event|12|||
28051685|NCT00529529|54709140|FG001|Overall Study|Adverse Event|17|||
28051686|NCT00529529|54709141|FG002|Overall Study|Adverse Event|8|||
28051687|NCT00529529|54709139|FG000|Overall Study|Subject withdrew consent|12|||
28051688|NCT00529529|54709140|FG001|Overall Study|Subject withdrew consent|9|||
28051689|NCT00529529|54709141|FG002|Overall Study|Subject withdrew consent|12|||
28051690|NCT00529529|54709139|FG000|Overall Study|Protocol deviation|8|||
28051691|NCT00529529|54709140|FG001|Overall Study|Protocol deviation|12|||
28051692|NCT00529529|54709141|FG002|Overall Study|Protocol deviation|5|||
28051693|NCT00529529|54709139|FG000|Overall Study|Lost to Follow-up|5|||
28051694|NCT00529529|54709140|FG001|Overall Study|Lost to Follow-up|3|||
28051695|NCT00529529|54709141|FG002|Overall Study|Lost to Follow-up|1|||
28051696|NCT00529529|54709139|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
28051697|NCT00529529|54709140|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
28051698|NCT00529529|54709141|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
28051699|NCT00529529|54709139|FG000|Overall Study|Death|2|||
28051700|NCT00529529|54709140|FG001|Overall Study|Death|0|||
28051701|NCT00529529|54709141|FG002|Overall Study|Death|0|||
28051702|NCT00529529|54709139|FG000|Overall Study|Abnormal test procedure result(s)|1|||
28051703|NCT00529529|54709140|FG001|Overall Study|Abnormal test procedure result(s)|0|||
28051704|NCT00529529|54709141|FG002|Overall Study|Abnormal test procedure result(s)|0|||
28051705|NCT00529529|54709139|FG000|Overall Study|Administrative problems|1|||
28051706|NCT00529529|54709140|FG001|Overall Study|Administrative problems|0|||
28051707|NCT00529529|54709141|FG002|Overall Study|Administrative problems|3|||
28051708|NCT05655377|54709149|FG000|Overall Study|Withdrawal by Subject|2|||
28051709|NCT00486434|54709155|FG000|Overall Study|Withdrawal by Subject|34|||
28051710|NCT00486434|54709156|FG001|Overall Study|Withdrawal by Subject|39|||
28051711|NCT00486434|54709155|FG000|Overall Study|Adverse Event|118|||
28051712|NCT00486434|54709156|FG001|Overall Study|Adverse Event|44|||
28051713|NCT00486434|54709155|FG000|Overall Study|Protocol Violation|22|||
28051714|NCT00486434|54709156|FG001|Overall Study|Protocol Violation|21|||
28051715|NCT00486434|54709155|FG000|Overall Study|Lack of Efficacy|12|||
27848204|NCT01046253|54341146|FG001|Second Intervention|Protocol Violation|1|||
28051716|NCT00486434|54709156|FG001|Overall Study|Lack of Efficacy|19|||
28051717|NCT00486434|54709155|FG000|Overall Study|Lost to Follow-up|2|||
27848205|NCT00983515|54341152|FG000|Ritonavir Alone|liver panel out of range|6|||
28051718|NCT00486434|54709156|FG001|Overall Study|Lost to Follow-up|3|||
28051719|NCT00486434|54709155|FG000|Overall Study|Death|1|||
28051720|NCT00486434|54709156|FG001|Overall Study|Death|2|||
27939935|NCT00943852|54596281|FG004|Washout Period After Period 2 Treatment|Trial stopped early|0|||
28051721|NCT00486434|54709155|FG000|Overall Study|Personal reasons|5|||
28051722|NCT00486434|54709156|FG001|Overall Study|Personal reasons|6|||
28051723|NCT00424632|54709165|FG000|Overall Study|Death|0|||
28051724|NCT00424632|54709166|FG001|Overall Study|Death|0|||
28051725|NCT00424632|54709167|FG002|Overall Study|Death|0|||
28051726|NCT00424632|54709168|FG003|Overall Study|Death|0|||
28051727|NCT00424632|54709169|FG004|Overall Study|Death|0|||
28051728|NCT00424632|54709170|FG005|Overall Study|Death|2|||
28051729|NCT00424632|54709171|FG006|Overall Study|Death|0|||
28051730|NCT00424632|54709172|FG007|Overall Study|Death|0|||
28051731|NCT00424632|54709173|FG008|Overall Study|Death|0|||
28051732|NCT00424632|54709174|FG009|Overall Study|Death|0|||
28051733|NCT00424632|54709165|FG000|Overall Study|Adverse Event|0|||
28051734|NCT00424632|54709166|FG001|Overall Study|Adverse Event|0|||
28051735|NCT00424632|54709167|FG002|Overall Study|Adverse Event|0|||
28051736|NCT00424632|54709168|FG003|Overall Study|Adverse Event|0|||
28051737|NCT00424632|54709169|FG004|Overall Study|Adverse Event|0|||
28051738|NCT00424632|54709170|FG005|Overall Study|Adverse Event|0|||
28051739|NCT00424632|54709171|FG006|Overall Study|Adverse Event|0|||
28051740|NCT00424632|54709172|FG007|Overall Study|Adverse Event|0|||
28051741|NCT00424632|54709173|FG008|Overall Study|Adverse Event|3|||
28051742|NCT00424632|54709174|FG009|Overall Study|Adverse Event|2|||
28051743|NCT00424632|54709165|FG000|Overall Study|Global deterioration of health status|0|||
28051744|NCT00424632|54709166|FG001|Overall Study|Global deterioration of health status|0|||
28051745|NCT00424632|54709167|FG002|Overall Study|Global deterioration of health status|0|||
28051746|NCT00424632|54709168|FG003|Overall Study|Global deterioration of health status|1|||
28051747|NCT00424632|54709169|FG004|Overall Study|Global deterioration of health status|1|||
28051748|NCT00424632|54709170|FG005|Overall Study|Global deterioration of health status|0|||
28051749|NCT00424632|54709171|FG006|Overall Study|Global deterioration of health status|0|||
28051750|NCT00424632|54709172|FG007|Overall Study|Global deterioration of health status|0|||
28051751|NCT00424632|54709173|FG008|Overall Study|Global deterioration of health status|0|||
28051752|NCT00424632|54709174|FG009|Overall Study|Global deterioration of health status|0|||
28051753|NCT00424632|54709165|FG000|Overall Study|Objective progression or relapse|1|||
28051754|NCT00424632|54709166|FG001|Overall Study|Objective progression or relapse|1|||
28051755|NCT00424632|54709167|FG002|Overall Study|Objective progression or relapse|1|||
28051756|NCT00424632|54709168|FG003|Overall Study|Objective progression or relapse|2|||
28051757|NCT00424632|54709169|FG004|Overall Study|Objective progression or relapse|2|||
28051758|NCT00424632|54709170|FG005|Overall Study|Objective progression or relapse|13|||
28051759|NCT00424632|54709171|FG006|Overall Study|Objective progression or relapse|7|||
28051760|NCT00424632|54709172|FG007|Overall Study|Objective progression or relapse|3|||
28051761|NCT00424632|54709173|FG008|Overall Study|Objective progression or relapse|12|||
28051762|NCT00424632|54709174|FG009|Overall Study|Objective progression or relapse|4|||
28051763|NCT00424632|54709165|FG000|Overall Study|Other|0|||
28051764|NCT00424632|54709166|FG001|Overall Study|Other|0|||
28051765|NCT00424632|54709167|FG002|Overall Study|Other|0|||
28051766|NCT00424632|54709168|FG003|Overall Study|Other|1|||
28051767|NCT00424632|54709169|FG004|Overall Study|Other|0|||
28051768|NCT00424632|54709170|FG005|Overall Study|Other|0|||
28051769|NCT00424632|54709171|FG006|Overall Study|Other|0|||
28051770|NCT00424632|54709172|FG007|Overall Study|Other|0|||
28051771|NCT00424632|54709173|FG008|Overall Study|Other|1|||
28051772|NCT00424632|54709174|FG009|Overall Study|Other|0|||
28051773|NCT00529451|54709209|FG000|Overall Study|Subject withdrew consent|16|||
28051774|NCT00529451|54709210|FG001|Overall Study|Subject withdrew consent|21|||
27812487|NCT01709721|54268671|FG001|Randomized Phase|Lost to Follow-up|0|||
27812488|NCT01709721|54268672|FG002|Randomized Phase|Lost to Follow-up|0|||
27812489|NCT01709721|54268670|FG000|Randomized Phase|Inadequate Pain Control|1|||
27812490|NCT01709721|54268671|FG001|Randomized Phase|Inadequate Pain Control|2|||
27812491|NCT01709721|54268672|FG002|Randomized Phase|Inadequate Pain Control|0|||
27812492|NCT01709721|54268670|FG000|Randomized Phase|Other, Specify text field in database|1|||
27812493|NCT01709721|54268671|FG001|Randomized Phase|Other, Specify text field in database|3|||
27812494|NCT01709721|54268672|FG002|Randomized Phase|Other, Specify text field in database|0|||
27812495|NCT01866657|54268682|FG000|Overall Study|Surgery canceled|2|||
27812496|NCT01866657|54268683|FG001|Overall Study|Surgery canceled|0|||
28051775|NCT00529451|54709211|FG002|Overall Study|Subject withdrew consent|13|||
28051776|NCT00529451|54709212|FG003|Overall Study|Subject withdrew consent|12|||
28051777|NCT00529451|54709209|FG000|Overall Study|Adverse Event|9|||
27812497|NCT01700205|54268691|FG000|Overall Study|Withdrawal by Subject|13|||
28051778|NCT00529451|54709210|FG001|Overall Study|Adverse Event|16|||
28051779|NCT00529451|54709211|FG002|Overall Study|Adverse Event|14|||
28051780|NCT00529451|54709212|FG003|Overall Study|Adverse Event|8|||
28051781|NCT00529451|54709209|FG000|Overall Study|Unsatisfactory therapeutic response|6|||
28051782|NCT00529451|54709210|FG001|Overall Study|Unsatisfactory therapeutic response|2|||
28051783|NCT00529451|54709211|FG002|Overall Study|Unsatisfactory therapeutic response|5|||
28051784|NCT00529451|54709212|FG003|Overall Study|Unsatisfactory therapeutic response|4|||
28051785|NCT00529451|54709209|FG000|Overall Study|Lost to Follow-up|4|||
28051786|NCT00529451|54709210|FG001|Overall Study|Lost to Follow-up|7|||
28051787|NCT00529451|54709211|FG002|Overall Study|Lost to Follow-up|4|||
28051788|NCT00529451|54709212|FG003|Overall Study|Lost to Follow-up|4|||
28051789|NCT00529451|54709209|FG000|Overall Study|Protocol deviation|1|||
28051790|NCT00529451|54709210|FG001|Overall Study|Protocol deviation|1|||
27812498|NCT01700205|54268692|FG001|Overall Study|Withdrawal by Subject|13|||
28051791|NCT00529451|54709211|FG002|Overall Study|Protocol deviation|4|||
28051792|NCT00529451|54709212|FG003|Overall Study|Protocol deviation|1|||
28051793|NCT00529451|54709209|FG000|Overall Study|Administrative problems|1|||
28051794|NCT00529451|54709210|FG001|Overall Study|Administrative problems|1|||
28051795|NCT00529451|54709211|FG002|Overall Study|Administrative problems|0|||
28051796|NCT00529451|54709212|FG003|Overall Study|Administrative problems|2|||
28051797|NCT03876743|54709229|FG000|Overall Study|Lost to Follow-up|6|||
28051798|NCT03876743|54709230|FG001|Overall Study|Lost to Follow-up|4|||
28051799|NCT03876743|54709231|FG002|Overall Study|Lost to Follow-up|4|||
28051800|NCT03876743|54709232|FG003|Overall Study|Lost to Follow-up|7|||
28051801|NCT00486278|54709246|FG000|Overall Study|Adverse Event|5|||
28051802|NCT00486278|54709246|FG000|Overall Study|Withdrawal by Subject|2|||
28051803|NCT00486278|54709246|FG000|Overall Study|Physician Decision|2|||
28051804|NCT00321711|54709265|FG000|Part A|Adverse Event|3|||
28051805|NCT00321711|54709266|FG001|Part A|Adverse Event|3|||
28051806|NCT00321711|54709267|FG002|Part A|Adverse Event|2|||
28051807|NCT00321711|54709268|FG003|Part A|Adverse Event|0|||
28051808|NCT00321711|54709269|FG004|Part A|Adverse Event|0|||
28051809|NCT00321711|54709265|FG000|Part A|Withdrawal by Subject|1|||
28051810|NCT00321711|54709266|FG001|Part A|Withdrawal by Subject|1|||
28051811|NCT00321711|54709267|FG002|Part A|Withdrawal by Subject|1|||
28051812|NCT00321711|54709268|FG003|Part A|Withdrawal by Subject|0|||
28051813|NCT00321711|54709269|FG004|Part A|Withdrawal by Subject|0|||
28051814|NCT00321711|54709265|FG000|Part A|Disease progression|0|||
28051815|NCT00321711|54709266|FG001|Part A|Disease progression|1|||
28051816|NCT00321711|54709267|FG002|Part A|Disease progression|0|||
28051817|NCT00321711|54709268|FG003|Part A|Disease progression|0|||
28051818|NCT00321711|54709269|FG004|Part A|Disease progression|0|||
28051819|NCT00321711|54709265|FG000|Part A|Requirement for alternative therapy|0|||
28051820|NCT00321711|54709266|FG001|Part A|Requirement for alternative therapy|2|||
28051821|NCT00321711|54709267|FG002|Part A|Requirement for alternative therapy|1|||
28051822|NCT00321711|54709268|FG003|Part A|Requirement for alternative therapy|0|||
28051823|NCT00321711|54709269|FG004|Part A|Requirement for alternative therapy|0|||
28051824|NCT00321711|54709265|FG000|Part A|Physician Decision|0|||
28051825|NCT00321711|54709266|FG001|Part A|Physician Decision|1|||
28051826|NCT00321711|54709267|FG002|Part A|Physician Decision|3|||
28051827|NCT00321711|54709268|FG003|Part A|Physician Decision|0|||
28051828|NCT00321711|54709269|FG004|Part A|Physician Decision|0|||
28051829|NCT00321711|54709265|FG000|Part A|Other|1|||
28051830|NCT00321711|54709266|FG001|Part A|Other|2|||
28051831|NCT00321711|54709267|FG002|Part A|Other|3|||
28051832|NCT00321711|54709268|FG003|Part A|Other|0|||
28051833|NCT00321711|54709269|FG004|Part A|Other|0|||
28051834|NCT00321711|54709265|FG000|Part A|Protocol deviation|0|||
28051835|NCT00321711|54709266|FG001|Part A|Protocol deviation|0|||
28051836|NCT00321711|54709267|FG002|Part A|Protocol deviation|1|||
28051837|NCT00321711|54709268|FG003|Part A|Protocol deviation|0|||
28051838|NCT00321711|54709269|FG004|Part A|Protocol deviation|0|||
28051839|NCT00321711|54709265|FG000|Part B|Noncompliance|0|||
28051840|NCT00321711|54709266|FG001|Part B|Noncompliance|0|||
28051841|NCT00321711|54709267|FG002|Part B|Noncompliance|0|||
28051842|NCT00321711|54709268|FG003|Part B|Noncompliance|0|||
28051843|NCT00321711|54709269|FG004|Part B|Noncompliance|1|||
28051844|NCT00321711|54709265|FG000|Part B|Adverse Event|0|||
28051845|NCT00321711|54709266|FG001|Part B|Adverse Event|0|||
28051846|NCT00321711|54709267|FG002|Part B|Adverse Event|0|||
28051847|NCT00321711|54709268|FG003|Part B|Adverse Event|2|||
28051848|NCT00321711|54709269|FG004|Part B|Adverse Event|1|||
28051849|NCT00321711|54709265|FG000|Part B|Disease progression|0|||
28051850|NCT00321711|54709266|FG001|Part B|Disease progression|0|||
28051851|NCT00321711|54709267|FG002|Part B|Disease progression|0|||
28051852|NCT00321711|54709268|FG003|Part B|Disease progression|1|||
28051853|NCT00321711|54709269|FG004|Part B|Disease progression|0|||
28051854|NCT00321711|54709265|FG000|Part B|Physician Decision|0|||
28051855|NCT00321711|54709266|FG001|Part B|Physician Decision|0|||
28105699|NCT04741503|54763279|FG001|Initial Enrollment|Failed to meet screening criteria|0|||
27848206|NCT00983515|54341152|FG000|Colchicine With Ritonavir|Lost to Follow-up|1|||
28051856|NCT00321711|54709267|FG002|Part B|Physician Decision|0|||
28051857|NCT00321711|54709268|FG003|Part B|Physician Decision|1|||
28051858|NCT00321711|54709269|FG004|Part B|Physician Decision|2|||
28051859|NCT00321711|54709265|FG000|Part B|Death|0|||
28051860|NCT00321711|54709266|FG001|Part B|Death|0|||
28051861|NCT00321711|54709267|FG002|Part B|Death|0|||
28051862|NCT00321711|54709268|FG003|Part B|Death|2|||
28051863|NCT00321711|54709269|FG004|Part B|Death|1|||
28051864|NCT00486044|54709283|FG000|Overall Study|Withdrawal by Subject|2|||
28051865|NCT00486044|54709284|FG001|Overall Study|Withdrawal by Subject|1|||
28051866|NCT00486044|54709283|FG000|Overall Study|Adverse Event|0|||
28051867|NCT00486044|54709284|FG001|Overall Study|Adverse Event|1|||
28051868|NCT00486044|54709283|FG000|Overall Study|Lost to Follow-up|0|||
28051869|NCT00486044|54709284|FG001|Overall Study|Lost to Follow-up|1|||
28051870|NCT00351273|54709293|FG000|Overall Study|Lost to Follow-up|1|||
28051871|NCT00351273|54709294|FG001|Overall Study|Lost to Follow-up|2|||
28051872|NCT00351273|54709295|FG002|Overall Study|Lost to Follow-up|5|||
28051873|NCT00327717|54709310|FG000|Overall Study|Adverse Event|6|||
28051874|NCT00327717|54709311|FG001|Overall Study|Adverse Event|6|||
28051875|NCT00327717|54709310|FG000|Overall Study|Lack of Efficacy|0|||
28051876|NCT00327717|54709311|FG001|Overall Study|Lack of Efficacy|1|||
28051877|NCT00327717|54709310|FG000|Overall Study|Withdrawal by Subject|3|||
28051878|NCT00327717|54709311|FG001|Overall Study|Withdrawal by Subject|7|||
28051879|NCT00463346|54709319|FG000|Overall Study|Withdrawal by Subject|3|||
28051880|NCT00463346|54709320|FG001|Overall Study|Withdrawal by Subject|3|||
28051881|NCT00462488|54709330|FG000|Overall Study|Protocol Violation|1|||
28051882|NCT00462488|54709331|FG001|Overall Study|Protocol Violation|0|||
28051883|NCT00462488|54709330|FG000|Overall Study|Lack of Efficacy|19|||
28051884|NCT00462488|54709331|FG001|Overall Study|Lack of Efficacy|17|||
28051885|NCT00454142|54709337|FG000|Overall Study|Withdrawal by Subject|1|||
28051886|NCT00424476|54709346|FG000|Overall Study|Withdrawal by Subject|7|||
28051887|NCT00424476|54709347|FG001|Overall Study|Withdrawal by Subject|6|||
28051888|NCT00424476|54709348|FG002|Overall Study|Withdrawal by Subject|3|||
28051889|NCT00424476|54709346|FG000|Overall Study|Adverse Event|19|||
28051890|NCT00424476|54709347|FG001|Overall Study|Adverse Event|16|||
28051891|NCT00424476|54709348|FG002|Overall Study|Adverse Event|15|||
28051892|NCT00424476|54709346|FG000|Overall Study|Lack of Efficacy|16|||
28051893|NCT00424476|54709347|FG001|Overall Study|Lack of Efficacy|12|||
28051894|NCT00424476|54709348|FG002|Overall Study|Lack of Efficacy|12|||
28051895|NCT00424476|54709346|FG000|Overall Study|Lack of Compliance|1|||
28051896|NCT00424476|54709347|FG001|Overall Study|Lack of Compliance|1|||
28051897|NCT00424476|54709348|FG002|Overall Study|Lack of Compliance|1|||
28051898|NCT00424476|54709346|FG000|Overall Study|Lost to Follow-up|4|||
28051899|NCT00424476|54709347|FG001|Overall Study|Lost to Follow-up|6|||
28051900|NCT00424476|54709348|FG002|Overall Study|Lost to Follow-up|3|||
28051901|NCT00424476|54709346|FG000|Overall Study|Protocol Violation|7|||
28051902|NCT00424476|54709347|FG001|Overall Study|Protocol Violation|2|||
28051903|NCT00424476|54709348|FG002|Overall Study|Protocol Violation|3|||
28051904|NCT00424476|54709346|FG000|Overall Study|Physician Decision|3|||
28051905|NCT00424476|54709347|FG001|Overall Study|Physician Decision|2|||
28051906|NCT00424476|54709348|FG002|Overall Study|Physician Decision|3|||
28051907|NCT00424476|54709346|FG000|Overall Study|Other|4|||
28051908|NCT00424476|54709347|FG001|Overall Study|Other|3|||
28051909|NCT00424476|54709348|FG002|Overall Study|Other|9|||
28051910|NCT00453986|54709361|FG000|Overall Study|Lost to Follow-up|6|||
28051911|NCT00453986|54709362|FG001|Overall Study|Lost to Follow-up|5|||
28051912|NCT00453986|54709363|FG002|Overall Study|Lost to Follow-up|6|||
28051913|NCT00453986|54709364|FG003|Overall Study|Lost to Follow-up|2|||
28051914|NCT00453986|54709365|FG004|Overall Study|Lost to Follow-up|0|||
28051915|NCT00435942|54709383|FG000|Overall Study|Death|17|||
28051916|NCT00435942|54709384|FG001|Overall Study|Death|10|||
28051917|NCT00435942|54709383|FG000|Overall Study|Withdrawal by Subject|2|||
28051918|NCT00435942|54709384|FG001|Overall Study|Withdrawal by Subject|0|||
28051919|NCT00435942|54709383|FG000|Overall Study|Lost to Follow-up|0|||
28051920|NCT00435942|54709384|FG001|Overall Study|Lost to Follow-up|16|||
28051921|NCT00435942|54709383|FG000|Overall Study|Conversion to Open Repair|1|||
28051922|NCT00435942|54709384|FG001|Overall Study|Conversion to Open Repair|0|||
28051923|NCT00435942|54709383|FG000|Overall Study|Technical Failure|3|||
28051924|NCT00435942|54709384|FG001|Overall Study|Technical Failure|0|||
28051925|NCT00435942|54709383|FG000|Overall Study|Other|0|||
28051926|NCT00435942|54709384|FG001|Overall Study|Other|1|||
28051927|NCT00453362|54709390|FG000|Overall Study|Adverse Event|5|||
28051928|NCT00453362|54709390|FG000|Overall Study|Death|7|||
28051929|NCT00453362|54709390|FG000|Overall Study|Physician Decision|2|||
28051930|NCT00453362|54709390|FG000|Overall Study|Withdrawal by Subject|3|||
28051931|NCT00453362|54709390|FG000|Overall Study|Progression of disease|56|||
28051932|NCT00453362|54709390|FG000|Overall Study|Screening Failure|14|||
28051933|NCT00424398|54709409|FG000|Overall Study|Withdrawal by Subject|2|||
28051934|NCT00424398|54709410|FG001|Overall Study|Withdrawal by Subject|1|||
28051935|NCT00424398|54709411|FG002|Overall Study|Withdrawal by Subject|0|||
28051936|NCT00424398|54709409|FG000|Overall Study|Subject met exclusion criteria|1|||
28051937|NCT00424398|54709410|FG001|Overall Study|Subject met exclusion criteria|0|||
28051938|NCT00424398|54709411|FG002|Overall Study|Subject met exclusion criteria|0|||
28051939|NCT00461786|54709419|FG000|Overall Study|Entry Criteria Not Met|2|||
28051940|NCT00461786|54709419|FG000|Overall Study|Inevaluable (Never Treated)|1|||
28051941|NCT00435162|54709426|FG000|Period 2 (2 Weeks)|Adverse Event|0|||
28051942|NCT00435162|54709427|FG001|Period 2 (2 Weeks)|Adverse Event|1|||
28051943|NCT00435162|54709428|FG002|Period 2 (2 Weeks)|Adverse Event|0|||
28051944|NCT00435162|54709429|FG003|Period 2 (2 Weeks)|Adverse Event|0|||
28051945|NCT00435162|54709430|FG004|Period 2 (2 Weeks)|Adverse Event|0|||
28051946|NCT00435162|54709431|FG005|Period 2 (2 Weeks)|Adverse Event|0|||
28051947|NCT03836664|54709446|FG000|Overall Study|Didn't complete forms and lost drug|3|||
28051948|NCT03836664|54709447|FG001|Overall Study|Didn't complete forms and lost drug|3|||
28051949|NCT00350727|54709460|FG000|Phase I: Dose Escalation|Adverse Event|4|||
28051950|NCT00350727|54709461|FG001|Phase I: Dose Escalation|Adverse Event|0|||
28051951|NCT00350727|54709462|FG002|Phase I: Dose Escalation|Adverse Event|0|||
28051952|NCT00350727|54709460|FG000|Phase I: Dose Escalation|Lack of Efficacy|25|||
28051953|NCT00350727|54709461|FG001|Phase I: Dose Escalation|Lack of Efficacy|0|||
28051954|NCT00350727|54709462|FG002|Phase I: Dose Escalation|Lack of Efficacy|0|||
28051955|NCT00350727|54709460|FG000|Phase I: Dose Escalation|Death|1|||
28051956|NCT00350727|54709461|FG001|Phase I: Dose Escalation|Death|0|||
28051957|NCT00350727|54709462|FG002|Phase I: Dose Escalation|Death|0|||
28051958|NCT00350727|54709460|FG000|Phase I: Dose Escalation|Physician Decision|1|||
28051959|NCT00350727|54709461|FG001|Phase I: Dose Escalation|Physician Decision|0|||
28051960|NCT00350727|54709462|FG002|Phase I: Dose Escalation|Physician Decision|0|||
28051961|NCT00350727|54709460|FG000|Phase I: Dose Escalation|Transition to Extension Phase|3|||
28051962|NCT00350727|54709461|FG001|Phase I: Dose Escalation|Transition to Extension Phase|0|||
28051963|NCT00350727|54709462|FG002|Phase I: Dose Escalation|Transition to Extension Phase|0|||
28051964|NCT00350727|54709460|FG000|Phase II|Disease Progression|0|||
28051965|NCT00350727|54709461|FG001|Phase II|Disease Progression|15|||
28051966|NCT00350727|54709462|FG002|Phase II|Disease Progression|16|||
28051967|NCT00350727|54709460|FG000|Phase II|Clinical Deterioration|0|||
28051968|NCT00350727|54709461|FG001|Phase II|Clinical Deterioration|1|||
28051969|NCT00350727|54709462|FG002|Phase II|Clinical Deterioration|0|||
28051970|NCT00350727|54709460|FG000|Phase II|Withdrawal by Subject|0|||
28051971|NCT00350727|54709461|FG001|Phase II|Withdrawal by Subject|2|||
28051972|NCT00350727|54709462|FG002|Phase II|Withdrawal by Subject|1|||
28051973|NCT00350727|54709460|FG000|Phase II|Adverse Event|0|||
28051974|NCT00350727|54709461|FG001|Phase II|Adverse Event|1|||
28051975|NCT00350727|54709462|FG002|Phase II|Adverse Event|1|||
28051976|NCT00350727|54709460|FG000|Phase II|Death|0|||
28051977|NCT00350727|54709461|FG001|Phase II|Death|0|||
28051978|NCT00350727|54709462|FG002|Phase II|Death|2|||
28051979|NCT00350727|54709460|FG000|Phase II|Sponsor Terminated Study|0|||
28051980|NCT00350727|54709461|FG001|Phase II|Sponsor Terminated Study|0|||
28051981|NCT00350727|54709462|FG002|Phase II|Sponsor Terminated Study|1|||
28051982|NCT00350727|54709460|FG000|Phase II|Enrolled in Rollover Study|0|||
28051983|NCT00350727|54709461|FG001|Phase II|Enrolled in Rollover Study|0|||
28051984|NCT00350727|54709462|FG002|Phase II|Enrolled in Rollover Study|1|||
28051985|NCT00434304|54709481|FG000|Overall Study|Adverse Event|14|||
28051986|NCT00434304|54709481|FG000|Overall Study|Lack of Efficacy|2|||
28051987|NCT00434304|54709481|FG000|Overall Study|Withdrawal by Subject|4|||
28051988|NCT00424008|54709488|FG000|Overall Study|Adverse Event|8|||
28051989|NCT00424008|54709489|FG001|Overall Study|Adverse Event|6|||
28051990|NCT00424008|54709488|FG000|Overall Study|Lack of Efficacy|40|||
28051991|NCT00424008|54709489|FG001|Overall Study|Lack of Efficacy|34|||
28051992|NCT00424008|54709488|FG000|Overall Study|Lost to Follow-up|1|||
28051993|NCT00424008|54709489|FG001|Overall Study|Lost to Follow-up|2|||
28051994|NCT00424008|54709488|FG000|Overall Study|Withdrawal by Subject|5|||
28051995|NCT00424008|54709489|FG001|Overall Study|Withdrawal by Subject|8|||
28051996|NCT00424008|54709488|FG000|Overall Study|Noncompliance with protocol|13|||
28051997|NCT00424008|54709489|FG001|Overall Study|Noncompliance with protocol|7|||
28051998|NCT00424008|54709488|FG000|Overall Study|Did not meet protocol eligibility|16|||
28051999|NCT00424008|54709489|FG001|Overall Study|Did not meet protocol eligibility|21|||
28052000|NCT00424008|54709488|FG000|Overall Study|Administrative|266|||
28052001|NCT00424008|54709489|FG001|Overall Study|Administrative|257|||
28052002|NCT00423930|54709496|FG000|Overall Study|Withdrawal by Subject|2|||
28052003|NCT00423852|54709500|FG000|Overall Study|Removed pior to the high-dose portion|3|||
28052004|NCT00461708|54709506|FG000|Overall Study|Adverse Event|17|||
28052005|NCT00461708|54709507|FG001|Overall Study|Adverse Event|7|||
28052006|NCT00461708|54709506|FG000|Overall Study|Lack of Efficacy|68|||
28052007|NCT00461708|54709507|FG001|Overall Study|Lack of Efficacy|20|||
28052008|NCT00461708|54709506|FG000|Overall Study|Physician Decision|10|||
28052009|NCT00461708|54709507|FG001|Overall Study|Physician Decision|4|||
28052010|NCT00461708|54709506|FG000|Overall Study|Withdrawal by Subject|8|||
28052011|NCT00461708|54709507|FG001|Overall Study|Withdrawal by Subject|2|||
28052012|NCT00461708|54709506|FG000|Overall Study|Other|4|||
28052013|NCT00461708|54709507|FG001|Overall Study|Other|4|||
28052014|NCT00461708|54709506|FG000|Overall Study|Death|8|||
28052015|NCT00461708|54709507|FG001|Overall Study|Death|1|||
28052016|NCT00327171|54709518|FG000|Overall Study|Did not receive study medication|3|||
28052017|NCT00327171|54709519|FG001|Overall Study|Did not receive study medication|0|||
28052018|NCT00327171|54709518|FG000|Overall Study|Adverse Event|23|||
28052019|NCT00327171|54709519|FG001|Overall Study|Adverse Event|23|||
28052020|NCT00327171|54709518|FG000|Overall Study|Disease progression/lack of efficacy|68|||
28052021|NCT00327171|54709519|FG001|Overall Study|Disease progression/lack of efficacy|69|||
28052022|NCT00327171|54709518|FG000|Overall Study|Investigator/participant request|1|||
28052023|NCT00327171|54709519|FG001|Overall Study|Investigator/participant request|8|||
28052024|NCT00327171|54709518|FG000|Overall Study|Clinical progression|12|||
28052025|NCT00327171|54709519|FG001|Overall Study|Clinical progression|8|||
28052026|NCT00327171|54709518|FG000|Overall Study|Undisclosed history of ischemia|0|||
28052027|NCT00327171|54709519|FG001|Overall Study|Undisclosed history of ischemia|1|||
28052028|NCT00327171|54709518|FG000|Overall Study|Other|1|||
28052029|NCT00327171|54709519|FG001|Overall Study|Other|0|||
28052030|NCT00461630|54709527|FG000|Overall Study|Death|798|||
28052031|NCT00461630|54709528|FG001|Overall Study|Death|732|||
28052032|NCT00461630|54709527|FG000|Overall Study|Lost to Follow-up|108|||
28052033|NCT00461630|54709528|FG001|Overall Study|Lost to Follow-up|95|||
28052034|NCT00461552|54709536|FG000|Overall Study|Drug Dispensing error|0|||
28052035|NCT00461552|54709537|FG001|Overall Study|Drug Dispensing error|2|||
28052036|NCT00453206|54709543|FG000|Overall Study|Death|1|||
28052037|NCT03850496|54709550|FG000|Overall Study|Withdrawal by Subject|1|||
28052038|NCT03850496|54709551|FG001|Overall Study|Withdrawal by Subject|0|||
28052039|NCT03850496|54709552|FG002|Overall Study|Withdrawal by Subject|0|||
28052040|NCT03850496|54709550|FG000|Overall Study|Lost to Follow-up|0|||
28052041|NCT03850496|54709551|FG001|Overall Study|Lost to Follow-up|1|||
28052042|NCT03850496|54709552|FG002|Overall Study|Lost to Follow-up|4|||
28052043|NCT00327015|54709564|FG000|Overall Study|Lack of Efficacy|18|||
28052044|NCT00327015|54709565|FG001|Overall Study|Lack of Efficacy|18|||
28052045|NCT00327015|54709566|FG002|Overall Study|Lack of Efficacy|35|||
28052046|NCT00327015|54709567|FG003|Overall Study|Lack of Efficacy|29|||
28052047|NCT00327015|54709564|FG000|Overall Study|Withdrawal of Consent by Subject|20|||
28052048|NCT00327015|54709565|FG001|Overall Study|Withdrawal of Consent by Subject|24|||
28052049|NCT00327015|54709566|FG002|Overall Study|Withdrawal of Consent by Subject|28|||
28052050|NCT00327015|54709567|FG003|Overall Study|Withdrawal of Consent by Subject|25|||
28052051|NCT00327015|54709564|FG000|Overall Study|Lost to Follow-up|22|||
28052052|NCT00327015|54709565|FG001|Overall Study|Lost to Follow-up|23|||
28052053|NCT00327015|54709566|FG002|Overall Study|Lost to Follow-up|29|||
28052054|NCT00327015|54709567|FG003|Overall Study|Lost to Follow-up|22|||
28052055|NCT00327015|54709564|FG000|Overall Study|Adverse Event|14|||
28052056|NCT00327015|54709565|FG001|Overall Study|Adverse Event|10|||
28052057|NCT00327015|54709566|FG002|Overall Study|Adverse Event|14|||
28052058|NCT00327015|54709567|FG003|Overall Study|Adverse Event|14|||
28052059|NCT00327015|54709564|FG000|Overall Study|Subject no longer meets study criteria|4|||
28052060|NCT00327015|54709565|FG001|Overall Study|Subject no longer meets study criteria|2|||
28052061|NCT00327015|54709566|FG002|Overall Study|Subject no longer meets study criteria|8|||
28052062|NCT00327015|54709567|FG003|Overall Study|Subject no longer meets study criteria|7|||
28052063|NCT00327015|54709564|FG000|Overall Study|Poor/Noncompliance|11|||
28052064|NCT00327015|54709565|FG001|Overall Study|Poor/Noncompliance|8|||
28052065|NCT00327015|54709566|FG002|Overall Study|Poor/Noncompliance|4|||
28052066|NCT00327015|54709567|FG003|Overall Study|Poor/Noncompliance|5|||
28052067|NCT00327015|54709564|FG000|Overall Study|Physician Decision|0|||
28052068|NCT00327015|54709565|FG001|Overall Study|Physician Decision|1|||
28052069|NCT00327015|54709566|FG002|Overall Study|Physician Decision|3|||
28052070|NCT00327015|54709567|FG003|Overall Study|Physician Decision|2|||
28052071|NCT00327015|54709564|FG000|Overall Study|Death|1|||
28052072|NCT00327015|54709565|FG001|Overall Study|Death|2|||
28052073|NCT00327015|54709566|FG002|Overall Study|Death|2|||
28052074|NCT00327015|54709567|FG003|Overall Study|Death|3|||
28052075|NCT00327015|54709564|FG000|Overall Study|Pregnancy|0|||
28052076|NCT00327015|54709565|FG001|Overall Study|Pregnancy|2|||
28052077|NCT00327015|54709566|FG002|Overall Study|Pregnancy|1|||
28052078|NCT00327015|54709567|FG003|Overall Study|Pregnancy|1|||
28052079|NCT00327015|54709564|FG000|Overall Study|Administrative Reason by Sponsor|1|||
28052080|NCT00327015|54709565|FG001|Overall Study|Administrative Reason by Sponsor|2|||
28052081|NCT00327015|54709566|FG002|Overall Study|Administrative Reason by Sponsor|2|||
28052082|NCT00327015|54709567|FG003|Overall Study|Administrative Reason by Sponsor|1|||
28052083|NCT00434148|54709579|FG000|Overall Study|Adverse Event|18|||
28052084|NCT00434148|54709580|FG001|Overall Study|Adverse Event|18|||
28052085|NCT00434148|54709579|FG000|Overall Study|Lack of Efficacy|25|||
28052086|NCT00434148|54709580|FG001|Overall Study|Lack of Efficacy|28|||
28052087|NCT00434148|54709579|FG000|Overall Study|Withdrawal by Subject|15|||
28052088|NCT00434148|54709580|FG001|Overall Study|Withdrawal by Subject|15|||
28052089|NCT00434148|54709579|FG000|Overall Study|Protocol Violation|4|||
28052090|NCT00434148|54709580|FG001|Overall Study|Protocol Violation|0|||
28052091|NCT00434148|54709579|FG000|Overall Study|Administrative problems|6|||
28052092|NCT00434148|54709580|FG001|Overall Study|Administrative problems|10|||
28052093|NCT00434148|54709579|FG000|Overall Study|Lost to Follow-up|0|||
28052094|NCT00434148|54709580|FG001|Overall Study|Lost to Follow-up|1|||
28052095|NCT00434148|54709579|FG000|Overall Study|Condition no longer requires study drug|1|||
28052096|NCT00434148|54709580|FG001|Overall Study|Condition no longer requires study drug|0|||
28052097|NCT00434148|54709579|FG000|Overall Study|Abnormal test procedure result|0|||
28052098|NCT00434148|54709580|FG001|Overall Study|Abnormal test procedure result|1|||
28052099|NCT00468728|54709588|FG000|Treatment|criteria for mITT population|4|||
28052100|NCT00468728|54709589|FG001|Treatment|criteria for mITT population|11|||
28052101|NCT00468728|54709588|FG000|Follow-up|mITT failure|34|||
28052102|NCT00468728|54709589|FG001|Follow-up|mITT failure|31|||
28052103|NCT00433914|54709599|FG000|Overall Study|Withdrawal by Subject|0|||
28052104|NCT00433914|54709600|FG001|Overall Study|Withdrawal by Subject|2|||
28052105|NCT00433914|54709599|FG000|Overall Study|Lost to Follow-up|0|||
28052106|NCT00433914|54709600|FG001|Overall Study|Lost to Follow-up|1|||
28052107|NCT00468650|54709606|FG000|Overall Study|Lost to Follow-up|4|||
28052108|NCT00468650|54709606|FG000|Overall Study|Withdrawal by Subject|2|||
28052109|NCT00468650|54709606|FG000|Overall Study|Protocol Violation|1|||
28052110|NCT00423150|54709611|FG000|Overall Study|Adverse Event|11|||
28052111|NCT00423150|54709611|FG000|Overall Study|Progression of disease being studied|69|||
28052112|NCT00423150|54709611|FG000|Overall Study|Withdrawal by Subject|1|||
28052113|NCT00423150|54709611|FG000|Overall Study|Non-compliance with protocol|1|||
28052114|NCT00423150|54709611|FG000|Overall Study|Administrative|4|||
28052115|NCT00433836|54709617|FG000|Overall Study|Adverse Event|7|||
28052116|NCT00433836|54709618|FG001|Overall Study|Adverse Event|0|||
28052117|NCT00433836|54709617|FG000|Overall Study|Lost to Follow-up|3|||
28052118|NCT00433836|54709618|FG001|Overall Study|Lost to Follow-up|0|||
28052119|NCT00433836|54709617|FG000|Overall Study|Withdrawal by Subject|2|||
28052120|NCT00433836|54709618|FG001|Overall Study|Withdrawal by Subject|1|||
28052121|NCT00433836|54709617|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
28052122|NCT00433836|54709618|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
28052123|NCT00433836|54709617|FG000|Overall Study|Protocol Violation|0|||
28052124|NCT00433836|54709618|FG001|Overall Study|Protocol Violation|2|||
28052125|NCT00433836|54709617|FG000|Overall Study|Condition no longer requires study drug|0|||
28052126|NCT00433836|54709618|FG001|Overall Study|Condition no longer requires study drug|1|||
28052127|NCT00433836|54709617|FG000|Overall Study|Abnormal laboratory values|0|||
28052128|NCT00433836|54709618|FG001|Overall Study|Abnormal laboratory values|1|||
28052129|NCT00433446|54709624|FG000|Overall Study|Adverse Event|4|||
28052130|NCT00433446|54709624|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
28052131|NCT00433446|54709624|FG000|Overall Study|Progression|44|||
28052132|NCT00433446|54709624|FG000|Overall Study|Other - Not Protocol specified|3|||
28052133|NCT00433446|54709624|FG000|Overall Study|Ineligible|9|||
28052134|NCT00468104|54709628|FG000|First Intervention|Protocol Violation|2|||
28052135|NCT00468104|54709629|FG001|First Intervention|Protocol Violation|1|||
28052136|NCT00468104|54709628|FG000|First Intervention|bleeding at chest tube site--first dose|1|||
28052137|NCT00468104|54709629|FG001|First Intervention|bleeding at chest tube site--first dose|0|||
28052138|NCT00468104|54709628|FG000|First Intervention|died within 3 weeks|1|||
28052139|NCT00468104|54709629|FG001|First Intervention|died within 3 weeks|0|||
28052140|NCT00468104|54709628|FG000|First Intervention|malposition/blocked chest tube tube|2|||
28052141|NCT00468104|54709629|FG001|First Intervention|malposition/blocked chest tube tube|0|||
28052142|NCT00468104|54709628|FG000|First Intervention|large lung mass with minimal effusion|1|||
28052143|NCT00468104|54709629|FG001|First Intervention|large lung mass with minimal effusion|0|||
28052144|NCT00468104|54709628|FG000|First Intervention|associated prolonged pneumothorax|1|||
28052145|NCT00468104|54709629|FG001|First Intervention|associated prolonged pneumothorax|0|||
28052146|NCT00468104|54709628|FG000|First Intervention|trapped lung|1|||
28052147|NCT00468104|54709629|FG001|First Intervention|trapped lung|0|||
28052148|NCT00468104|54709628|FG000|Second Intervention|Withdrawal by Subject|5|||
28052149|NCT00468104|54709629|FG001|Second Intervention|Withdrawal by Subject|2|||
28052150|NCT00468104|54709628|FG000|Second Intervention|discarded for malposition of chest tube|0|||
28052151|NCT00468104|54709629|FG001|Second Intervention|discarded for malposition of chest tube|2|||
28052152|NCT00326625|54709640|FG000|Overall Study|Adverse Event|20|||
28052153|NCT00326625|54709641|FG001|Overall Study|Adverse Event|9|||
28052154|NCT00326625|54709640|FG000|Overall Study|Withdrawal by Subject|15|||
28052155|NCT00326625|54709641|FG001|Overall Study|Withdrawal by Subject|12|||
28052156|NCT00326625|54709640|FG000|Overall Study|Death|18|||
28052157|NCT00326625|54709641|FG001|Overall Study|Death|16|||
28052158|NCT00326625|54709640|FG000|Overall Study|Lost to Follow-up|1|||
28052159|NCT00326625|54709641|FG001|Overall Study|Lost to Follow-up|0|||
28052160|NCT00326625|54709640|FG000|Overall Study|prescheduled medical intervention|0|||
28052161|NCT00326625|54709641|FG001|Overall Study|prescheduled medical intervention|1|||
28052162|NCT00433290|54709649|FG000|Overall Study|Adverse Event|24|||
28052163|NCT00433290|54709650|FG001|Overall Study|Adverse Event|7|||
28052164|NCT00433290|54709649|FG000|Overall Study|Lack of Efficacy|1|||
28052165|NCT00433290|54709650|FG001|Overall Study|Lack of Efficacy|5|||
28052166|NCT00433290|54709649|FG000|Overall Study|Withdrawal by Subject|4|||
28052167|NCT00433290|54709650|FG001|Overall Study|Withdrawal by Subject|2|||
28052168|NCT00433290|54709649|FG000|Overall Study|Protocol Violation|3|||
28052169|NCT00433290|54709650|FG001|Overall Study|Protocol Violation|2|||
28052170|NCT00433290|54709649|FG000|Overall Study|Physician Decision|2|||
28052171|NCT00433290|54709650|FG001|Overall Study|Physician Decision|0|||
28052172|NCT00433290|54709649|FG000|Overall Study|Entry Criteria Not Met|0|||
28052173|NCT00433290|54709650|FG001|Overall Study|Entry Criteria Not Met|1|||
28052174|NCT00433290|54709649|FG000|Overall Study|Lost to Follow-up|1|||
28052175|NCT00433290|54709650|FG001|Overall Study|Lost to Follow-up|0|||
28052176|NCT00467870|54709662|FG000|Overall Study|Adverse Event|13|||
28052177|NCT00467870|54709663|FG001|Overall Study|Adverse Event|9|||
28052178|NCT00467870|54709664|FG002|Overall Study|Adverse Event|1|||
28052179|NCT00467870|54709665|FG003|Overall Study|Adverse Event|15|||
28052180|NCT00467870|54709666|FG004|Overall Study|Adverse Event|15|||
28052181|NCT00467870|54709667|FG005|Overall Study|Adverse Event|1|||
28052182|NCT00467870|54709662|FG000|Overall Study|Protocol Violation|2|||
28052183|NCT00467870|54709663|FG001|Overall Study|Protocol Violation|1|||
28052184|NCT00467870|54709664|FG002|Overall Study|Protocol Violation|1|||
28052185|NCT00467870|54709665|FG003|Overall Study|Protocol Violation|2|||
28052186|NCT00467870|54709666|FG004|Overall Study|Protocol Violation|0|||
28052187|NCT00467870|54709667|FG005|Overall Study|Protocol Violation|0|||
28052188|NCT00467870|54709662|FG000|Overall Study|Withdrawal by Subject|14|||
28052189|NCT00467870|54709663|FG001|Overall Study|Withdrawal by Subject|21|||
28052190|NCT00467870|54709664|FG002|Overall Study|Withdrawal by Subject|0|||
28052191|NCT00467870|54709665|FG003|Overall Study|Withdrawal by Subject|9|||
28052192|NCT00467870|54709666|FG004|Overall Study|Withdrawal by Subject|10|||
28052193|NCT00467870|54709667|FG005|Overall Study|Withdrawal by Subject|1|||
28052194|NCT00467870|54709662|FG000|Overall Study|Lost to Follow-up|5|||
28052195|NCT00467870|54709663|FG001|Overall Study|Lost to Follow-up|3|||
28052196|NCT00467870|54709664|FG002|Overall Study|Lost to Follow-up|1|||
28052197|NCT00467870|54709665|FG003|Overall Study|Lost to Follow-up|1|||
28052198|NCT00467870|54709666|FG004|Overall Study|Lost to Follow-up|3|||
28052199|NCT00467870|54709667|FG005|Overall Study|Lost to Follow-up|0|||
28052200|NCT00467870|54709662|FG000|Overall Study|Subject Non-compliance|3|||
28052201|NCT00467870|54709663|FG001|Overall Study|Subject Non-compliance|4|||
28052202|NCT00467870|54709664|FG002|Overall Study|Subject Non-compliance|0|||
28052203|NCT00467870|54709665|FG003|Overall Study|Subject Non-compliance|1|||
28052204|NCT00467870|54709666|FG004|Overall Study|Subject Non-compliance|5|||
28052205|NCT00467870|54709667|FG005|Overall Study|Subject Non-compliance|0|||
28052206|NCT00467870|54709662|FG000|Overall Study|Other/Unknown|8|||
28052207|NCT00467870|54709663|FG001|Overall Study|Other/Unknown|5|||
28052208|NCT00467870|54709664|FG002|Overall Study|Other/Unknown|1|||
28052209|NCT00467870|54709665|FG003|Overall Study|Other/Unknown|5|||
28052210|NCT00467870|54709666|FG004|Overall Study|Other/Unknown|4|||
28052211|NCT00467870|54709667|FG005|Overall Study|Other/Unknown|0|||
28052212|NCT00467558|54709679|FG000|Overall Study|Lost to Follow-up|2|||
28052213|NCT00467558|54709680|FG001|Overall Study|Lost to Follow-up|0|||
28052214|NCT00422292|54709690|FG000|Overall Study|Serious adverse events|1|||
27812499|NCT01700205|54268691|FG000|Overall Study|Protocol Violation|2|||
27812500|NCT01700205|54268692|FG001|Overall Study|Protocol Violation|2|||
27812501|NCT01700049|54268698|FG000|Overall Study|Withdrawal by Subject|1|||
27812502|NCT01699815|54268705|FG000|Overall Study|Protocol Violation|4|||
27812503|NCT01699815|54268706|FG001|Overall Study|Protocol Violation|7|||
27812504|NCT01699815|54268705|FG000|Overall Study|record could not be located|1|||
27812505|NCT01699815|54268706|FG001|Overall Study|record could not be located|0|||
27812506|NCT01699815|54268705|FG000|Overall Study|Adverse Event|0|||
27812507|NCT01699815|54268706|FG001|Overall Study|Adverse Event|1|||
27812508|NCT01866423|54268712|FG000|Overall Study|Lack of Efficacy|3|||
27812509|NCT01866423|54268712|FG000|Overall Study|Sponsor Decision|1|||
27812510|NCT01846208|54268719|FG000|Overall Study|Withdrew prior to treatment|1|||
27812511|NCT01846208|54268720|FG001|Overall Study|Withdrew prior to treatment|1|||
27812512|NCT01846208|54268721|FG002|Overall Study|Withdrew prior to treatment|1|||
27812513|NCT01846208|54268719|FG000|Overall Study|Dosing Symptoms|1|||
28052215|NCT00422292|54709691|FG001|Overall Study|Serious adverse events|4|||
28052216|NCT00422292|54709692|FG002|Overall Study|Serious adverse events|0|||
28052217|NCT00422292|54709693|FG003|Overall Study|Serious adverse events|0|||
28052218|NCT00422292|54709690|FG000|Overall Study|Adverse Event|1|||
28052219|NCT00422292|54709691|FG001|Overall Study|Adverse Event|0|||
28052220|NCT00422292|54709692|FG002|Overall Study|Adverse Event|1|||
28052221|NCT00422292|54709693|FG003|Overall Study|Adverse Event|0|||
28052222|NCT00422292|54709690|FG000|Overall Study|Protocol Violation|4|||
28052223|NCT00422292|54709691|FG001|Overall Study|Protocol Violation|25|||
28052224|NCT00422292|54709692|FG002|Overall Study|Protocol Violation|8|||
28052225|NCT00422292|54709693|FG003|Overall Study|Protocol Violation|5|||
28052226|NCT00422292|54709690|FG000|Overall Study|Lost to Follow-up|6|||
28052227|NCT00422292|54709691|FG001|Overall Study|Lost to Follow-up|12|||
28052228|NCT00422292|54709692|FG002|Overall Study|Lost to Follow-up|6|||
28052229|NCT00422292|54709693|FG003|Overall Study|Lost to Follow-up|6|||
27812514|NCT01846208|54268720|FG001|Overall Study|Dosing Symptoms|2|||
27848207|NCT00982735|54341159|FG000|Overall Study|Lost to Follow-up|6|||
28052230|NCT00422292|54709690|FG000|Overall Study|Withdrawal by Subject|6|||
28052231|NCT00422292|54709691|FG001|Overall Study|Withdrawal by Subject|25|||
28052232|NCT00422292|54709692|FG002|Overall Study|Withdrawal by Subject|7|||
28052233|NCT00422292|54709693|FG003|Overall Study|Withdrawal by Subject|13|||
28105700|NCT04741503|54763280|FG002|Initial Enrollment|Failed to meet screening criteria|767|||
28105701|NCT04741503|54763278|FG000|Initial Enrollment|Overquotas removed|0|||
27848208|NCT00982735|54341159|FG000|Overall Study|Patient ineligible for trial|224|||
28052234|NCT00452348|54709705|FG000|Overall Study|Adverse Event|6|||
28052235|NCT00452348|54709706|FG001|Overall Study|Adverse Event|9|||
28052236|NCT00452348|54709705|FG000|Overall Study|Lack of Efficacy|10|||
27812515|NCT01846208|54268721|FG002|Overall Study|Dosing Symptoms|6|||
27812516|NCT01846208|54268719|FG000|Overall Study|Withdrawal by Subject|5|||
28052237|NCT00452348|54709706|FG001|Overall Study|Lack of Efficacy|9|||
28052238|NCT00452348|54709705|FG000|Overall Study|Lost to Follow-up|14|||
28052239|NCT00452348|54709706|FG001|Overall Study|Lost to Follow-up|8|||
28052240|NCT00452348|54709705|FG000|Overall Study|Protocol Violation|22|||
28052241|NCT00452348|54709706|FG001|Overall Study|Protocol Violation|28|||
28052242|NCT00452348|54709705|FG000|Overall Study|Withdrawal by Subject|18|||
28052243|NCT00452348|54709706|FG001|Overall Study|Withdrawal by Subject|21|||
28052244|NCT00452348|54709705|FG000|Overall Study|Other|9|||
28052245|NCT00452348|54709706|FG001|Overall Study|Other|9|||
28052246|NCT00452114|54709714|FG000|Overall Study|Physician Decision|3|||
28052247|NCT00452114|54709715|FG001|Overall Study|Physician Decision|3|||
28052248|NCT00320541|54709723|FG000|Overall Study|Adverse Event|21|||
28052249|NCT00320541|54709724|FG001|Overall Study|Adverse Event|19|||
28052250|NCT00320541|54709723|FG000|Overall Study|Protocol Violation|0|||
28052251|NCT00320541|54709724|FG001|Overall Study|Protocol Violation|1|||
28052252|NCT00320541|54709723|FG000|Overall Study|Withdrawal by Subject|12|||
28052253|NCT00320541|54709724|FG001|Overall Study|Withdrawal by Subject|16|||
28052254|NCT00320541|54709723|FG000|Overall Study|Physician Decision|9|||
28052255|NCT00320541|54709724|FG001|Overall Study|Physician Decision|13|||
28052256|NCT00320541|54709723|FG000|Overall Study|Other|3|||
28052257|NCT00320541|54709724|FG001|Overall Study|Other|4|||
28052258|NCT00320541|54709723|FG000|Overall Study|Sponsor Decision|2|||
28052259|NCT00320541|54709724|FG001|Overall Study|Sponsor Decision|1|||
28052260|NCT00320541|54709723|FG000|Overall Study|Death due to Study Disease|1|||
28052261|NCT00320541|54709724|FG001|Overall Study|Death due to Study Disease|3|||
28052262|NCT00320541|54709723|FG000|Overall Study|Death due to Adverse Event(s)|1|||
28052263|NCT00320541|54709724|FG001|Overall Study|Death due to Adverse Event(s)|0|||
28052264|NCT00320541|54709723|FG000|Overall Study|Protocol Entry Criterion Not Met|1|||
28052265|NCT00320541|54709724|FG001|Overall Study|Protocol Entry Criterion Not Met|0|||
28052266|NCT00320385|54709732|FG000|Overall Study|Lost to Follow-up|7|||
28052267|NCT00320385|54709733|FG001|Overall Study|Lost to Follow-up|10|||
28052268|NCT00320385|54709732|FG000|Overall Study|Withdrawal by Subject|6|||
28052269|NCT00320385|54709733|FG001|Overall Study|Withdrawal by Subject|7|||
28052270|NCT00320385|54709732|FG000|Overall Study|Sponsor Terminated Study|2|||
28052271|NCT00320385|54709733|FG001|Overall Study|Sponsor Terminated Study|1|||
28052272|NCT00320385|54709732|FG000|Overall Study|Investigator Decision|0|||
28052273|NCT00320385|54709733|FG001|Overall Study|Investigator Decision|1|||
28052274|NCT00320385|54709732|FG000|Overall Study|Death|1|||
28052275|NCT00320385|54709733|FG001|Overall Study|Death|2|||
28052276|NCT00320385|54709732|FG000|Overall Study|Serious Adverse Event|1|||
28052277|NCT00320385|54709733|FG001|Overall Study|Serious Adverse Event|0|||
28052278|NCT00320385|54709732|FG000|Overall Study|Withdrew Consent|1|||
27848209|NCT01361178|54341165|FG000|Overall Study|Death|13|||
27848210|NCT01361178|54341166|FG001|Overall Study|Death|0|||
27848211|NCT00981799|54341176|FG000|Overall Study|Adverse Event|1|||
27848212|NCT00981799|54341177|FG001|Overall Study|Adverse Event|1|||
27848213|NCT00981799|54341178|FG002|Overall Study|Adverse Event|0|||
28052279|NCT00320385|54709733|FG001|Overall Study|Withdrew Consent|0|||
28052280|NCT00320385|54709732|FG000|Overall Study|Adverse Event|0|||
28052281|NCT00320385|54709733|FG001|Overall Study|Adverse Event|1|||
28052282|NCT00326001|54709741|FG000|Overall Study|Adverse Event|4|||
28052283|NCT00326001|54709742|FG001|Overall Study|Adverse Event|5|||
28052284|NCT00326001|54709741|FG000|Overall Study|Physician Decision|3|||
27812517|NCT01846208|54268720|FG001|Overall Study|Withdrawal by Subject|0|||
27812518|NCT01846208|54268721|FG002|Overall Study|Withdrawal by Subject|0|||
27812519|NCT01846208|54268719|FG000|Overall Study|Non-compliance|1|||
27812520|NCT01846208|54268720|FG001|Overall Study|Non-compliance|1|||
27812521|NCT01846208|54268721|FG002|Overall Study|Non-compliance|0|||
27812522|NCT01846208|54268719|FG000|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1|||
27812523|NCT01846208|54268720|FG001|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
28052285|NCT00326001|54709742|FG001|Overall Study|Physician Decision|3|||
28052286|NCT00309777|54709752|FG000|Overall Study|Adverse Event|13|||
28052287|NCT00309777|54709753|FG001|Overall Study|Adverse Event|2|||
28052288|NCT00309777|54709754|FG002|Overall Study|Adverse Event|8|||
28052289|NCT00309777|54709755|FG003|Overall Study|Adverse Event|1|||
28052290|NCT00309777|54709752|FG000|Overall Study|Protocol Violation|4|||
28052291|NCT00309777|54709753|FG001|Overall Study|Protocol Violation|1|||
28052292|NCT00309777|54709754|FG002|Overall Study|Protocol Violation|3|||
27812524|NCT01846208|54268721|FG002|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
27812525|NCT01846208|54268719|FG000|Overall Study|Refused SU OFC|0|||
28052293|NCT00309777|54709755|FG003|Overall Study|Protocol Violation|1|||
28052294|NCT00309777|54709752|FG000|Overall Study|Withdrawal by Subject|6|||
28052295|NCT00309777|54709753|FG001|Overall Study|Withdrawal by Subject|5|||
28052296|NCT00309777|54709754|FG002|Overall Study|Withdrawal by Subject|7|||
28052297|NCT00309777|54709755|FG003|Overall Study|Withdrawal by Subject|2|||
28052298|NCT00309777|54709752|FG000|Overall Study|Lost to Follow-up|0|||
27812526|NCT01846208|54268720|FG001|Overall Study|Refused SU OFC|0|||
27848214|NCT00981799|54341179|FG003|Overall Study|Adverse Event|0|||
28052299|NCT00309777|54709753|FG001|Overall Study|Lost to Follow-up|0|||
27812527|NCT01846208|54268721|FG002|Overall Study|Refused SU OFC|1|||
27812528|NCT01845974|54268731|FG000|Overall Study|screen failure|1|||
27812529|NCT01845974|54268732|FG001|Overall Study|screen failure|0|||
27812530|NCT01865487|54268744|FG000|Overall Study|Lost to Follow-up|0|||
27812531|NCT01865487|54268745|FG001|Overall Study|Lost to Follow-up|0|||
27812532|NCT01865487|54268746|FG002|Overall Study|Lost to Follow-up|0|||
27812533|NCT01865487|54268747|FG003|Overall Study|Lost to Follow-up|1|||
27812534|NCT01865487|54268748|FG004|Overall Study|Lost to Follow-up|0|||
27812535|NCT01865487|54268749|FG005|Overall Study|Lost to Follow-up|0|||
27812536|NCT01865487|54268750|FG006|Overall Study|Lost to Follow-up|1|||
27812537|NCT01865487|54268751|FG007|Overall Study|Lost to Follow-up|0|||
27812538|NCT01865487|54268752|FG008|Overall Study|Lost to Follow-up|0|||
27812539|NCT01865487|54268753|FG009|Overall Study|Lost to Follow-up|0|||
27812540|NCT01865487|54268744|FG000|Overall Study|Withdrawal by Subject|0|||
27812541|NCT01865487|54268745|FG001|Overall Study|Withdrawal by Subject|0|||
27812542|NCT01865487|54268746|FG002|Overall Study|Withdrawal by Subject|0|||
27812543|NCT01865487|54268747|FG003|Overall Study|Withdrawal by Subject|0|||
27812544|NCT01865487|54268748|FG004|Overall Study|Withdrawal by Subject|1|||
27812545|NCT01865487|54268749|FG005|Overall Study|Withdrawal by Subject|0|||
27812546|NCT01865487|54268750|FG006|Overall Study|Withdrawal by Subject|0|||
27812547|NCT01865487|54268751|FG007|Overall Study|Withdrawal by Subject|0|||
27812548|NCT01865487|54268752|FG008|Overall Study|Withdrawal by Subject|0|||
27812549|NCT01865487|54268753|FG009|Overall Study|Withdrawal by Subject|0|||
27812550|NCT01699503|54268783|FG000|Overall Study|Death|31|||
27812551|NCT01699503|54268784|FG001|Overall Study|Death|40|||
27812552|NCT01699503|54268783|FG000|Overall Study|Withdrawal by Subject|65|||
27812553|NCT01699503|54268784|FG001|Overall Study|Withdrawal by Subject|57|||
27812554|NCT01699503|54268783|FG000|Overall Study|Lost to Follow-up|121|||
27812555|NCT01699503|54268784|FG001|Overall Study|Lost to Follow-up|117|||
27812556|NCT01699503|54268783|FG000|Overall Study|Excluded due to quality|783|||
27812557|NCT01699503|54268784|FG001|Overall Study|Excluded due to quality|791|||
27812558|NCT01709409|54268792|FG000|Overall Study|Protocol Violation|1|||
27812559|NCT01709409|54268793|FG001|Overall Study|Protocol Violation|0|||
27812560|NCT01698879|54268802|FG000|Overall Study|Withdrawal by Subject|1|||
27812561|NCT01698879|54268803|FG001|Overall Study|Withdrawal by Subject|0|||
27812562|NCT01698879|54268804|FG002|Overall Study|Withdrawal by Subject|0|||
27812563|NCT01698801|54268843|FG000|Treatment Phase|Adverse Event|4|||
27812564|NCT01698801|54268843|FG000|Treatment Phase|Protocol Violation|1|||
27812565|NCT01698801|54268843|FG000|Treatment Phase|Other|4|||
27812566|NCT01698801|54268843|FG000|Treatment Phase|Withdrawal by Subject|1|||
27812567|NCT01698801|54268843|FG000|Treatment Phase|Disease progression|1|||
27812568|NCT01698801|54268843|FG000|Follow Up Phase|Withdrawal by Subject|1|||
27812569|NCT01698801|54268843|FG000|Follow Up Phase|Death|4|||
27812570|NCT01682811|54268855|FG000|Part 2 Dose Level 1|Withdrawal by Subject|0|||
27812571|NCT01682811|54268856|FG001|Part 2 Dose Level 1|Withdrawal by Subject|0|||
27812572|NCT01682811|54268857|FG002|Part 2 Dose Level 1|Withdrawal by Subject|0|||
27812573|NCT01682811|54268858|FG003|Part 2 Dose Level 1|Withdrawal by Subject|0|||
27812574|NCT01682811|54268859|FG004|Part 2 Dose Level 1|Withdrawal by Subject|1|||
27812575|NCT01682811|54268860|FG005|Part 2 Dose Level 1|Withdrawal by Subject|0|||
27812576|NCT01682811|54268861|FG006|Part 2 Dose Level 1|Withdrawal by Subject|0|||
27812577|NCT01682811|54268855|FG000|Part 2 Dose Level 1|Protocol Violation|0|||
27812578|NCT01682811|54268856|FG001|Part 2 Dose Level 1|Protocol Violation|0|||
27812579|NCT01682811|54268857|FG002|Part 2 Dose Level 1|Protocol Violation|0|||
27812580|NCT01682811|54268858|FG003|Part 2 Dose Level 1|Protocol Violation|0|||
27812581|NCT01682811|54268859|FG004|Part 2 Dose Level 1|Protocol Violation|4|||
27812582|NCT01682811|54268860|FG005|Part 2 Dose Level 1|Protocol Violation|0|||
27812583|NCT01682811|54268861|FG006|Part 2 Dose Level 1|Protocol Violation|0|||
27812584|NCT01682811|54268855|FG000|Part 2 Dose Level 1|Lost to Follow-up|0|||
27812585|NCT01682811|54268856|FG001|Part 2 Dose Level 1|Lost to Follow-up|0|||
27812586|NCT01682811|54268857|FG002|Part 2 Dose Level 1|Lost to Follow-up|0|||
27812587|NCT01682811|54268858|FG003|Part 2 Dose Level 1|Lost to Follow-up|0|||
27848215|NCT00981175|54341193|FG000|Primary Dose Vaccination|Adverse Event|1|||
27848216|NCT00981175|54341194|FG001|Primary Dose Vaccination|Adverse Event|0|||
27812588|NCT01682811|54268859|FG004|Part 2 Dose Level 1|Lost to Follow-up|6|||
27848217|NCT00981175|54341193|FG000|Primary Dose Vaccination|Protocol Violation|0|||
27848218|NCT00981175|54341194|FG001|Primary Dose Vaccination|Protocol Violation|1|||
28105702|NCT04741503|54763279|FG001|Initial Enrollment|Overquotas removed|0|||
27812589|NCT01682811|54268860|FG005|Part 2 Dose Level 1|Lost to Follow-up|0|||
27812590|NCT01682811|54268861|FG006|Part 2 Dose Level 1|Lost to Follow-up|0|||
27812591|NCT01682811|54268855|FG000|Part 2 Dose Level 2|Lost to Follow-up|0|||
27812592|NCT01682811|54268856|FG001|Part 2 Dose Level 2|Lost to Follow-up|0|||
27812593|NCT01682811|54268857|FG002|Part 2 Dose Level 2|Lost to Follow-up|0|||
27812594|NCT01682811|54268858|FG003|Part 2 Dose Level 2|Lost to Follow-up|0|||
27812595|NCT01682811|54268859|FG004|Part 2 Dose Level 2|Lost to Follow-up|0|||
27812596|NCT01682811|54268860|FG005|Part 2 Dose Level 2|Lost to Follow-up|3|||
27812597|NCT01682811|54268861|FG006|Part 2 Dose Level 2|Lost to Follow-up|0|||
27812598|NCT01682031|54268882|FG000|Overall Study|Withdrawal by Subject|0|||
28052300|NCT00309777|54709754|FG002|Overall Study|Lost to Follow-up|1|||
28052301|NCT00309777|54709755|FG003|Overall Study|Lost to Follow-up|0|||
28052302|NCT00309777|54709752|FG000|Overall Study|Death|0|||
28052303|NCT00309777|54709753|FG001|Overall Study|Death|1|||
28052304|NCT00309777|54709754|FG002|Overall Study|Death|0|||
28052305|NCT00309777|54709755|FG003|Overall Study|Death|0|||
28052306|NCT00309387|54709767|FG000|Overall Study|Death|72|||
28052307|NCT00309387|54709768|FG001|Overall Study|Death|73|||
28052308|NCT00309387|54709767|FG000|Overall Study|Lost to Follow-up|70|||
28052309|NCT00309387|54709768|FG001|Overall Study|Lost to Follow-up|86|||
28052310|NCT00325143|54709775|FG000|Overall Study|Lost to follow-up(complete vacc. course)|13|||
28052311|NCT00325143|54709775|FG000|Overall Study|Migrated/moved from study area|1|||
28052312|NCT00325143|54709775|FG000|Overall Study|Lost to follow-up(incompl. vacc. course)|4|||
28052313|NCT00325143|54709775|FG000|Overall Study|Withdrawal by Subject|8|||
28052314|NCT00319839|54709779|FG000|Overall Study|Adverse Event|5|||
28052315|NCT00319839|54709779|FG000|Overall Study|Withdrawal by Subject|1|||
28052316|NCT00319449|54709785|FG000|Overall Study|Subject did not wish to continue|1|||
28052317|NCT00319449|54709786|FG001|Overall Study|Subject did not wish to continue|0|||
28052318|NCT00319449|54709785|FG000|Overall Study|Noncompliance with the protocol|1|||
28052319|NCT00319449|54709786|FG001|Overall Study|Noncompliance with the protocol|0|||
28052320|NCT00308997|54709794|FG000|Overall Study|Subject feigned clinical data|0|||
28052321|NCT00308997|54709795|FG001|Overall Study|Subject feigned clinical data|1|||
28052322|NCT00308997|54709794|FG000|Overall Study|Unable to tolerate intervention|1|||
28052323|NCT00308997|54709795|FG001|Overall Study|Unable to tolerate intervention|0|||
28052324|NCT00308685|54709803|FG000|Overall Study|Lost to Follow-up|1|||
28052325|NCT00308685|54709804|FG001|Overall Study|Lost to Follow-up|0|||
28052326|NCT00308685|54709803|FG000|Overall Study|Need to administer prohibited medication|1|||
28052327|NCT00308685|54709804|FG001|Overall Study|Need to administer prohibited medication|2|||
28052328|NCT00308685|54709803|FG000|Overall Study|Other than specified|1|||
28052329|NCT00308685|54709804|FG001|Overall Study|Other than specified|3|||
28052330|NCT00317109|54709812|FG000|Overall Study|Withdrawal by Subject|2|||
28052331|NCT00317109|54709813|FG001|Overall Study|Withdrawal by Subject|0|||
28052332|NCT00317109|54709812|FG000|Overall Study|Migated/moved from study area|1|||
28052333|NCT00317109|54709813|FG001|Overall Study|Migated/moved from study area|0|||
28052334|NCT00316719|54709821|FG000|Overall Study|Adverse Event|0|||
28052335|NCT00316719|54709822|FG001|Overall Study|Adverse Event|6|||
28052336|NCT00316719|54709821|FG000|Overall Study|Consent withdrawn|2|||
28052337|NCT00316719|54709822|FG001|Overall Study|Consent withdrawn|0|||
28052338|NCT00422058|54709834|FG000|Double-Blind, Week 0-20|Adverse Event|3|||
28052339|NCT00422058|54709835|FG001|Double-Blind, Week 0-20|Adverse Event|4|||
28052340|NCT00422058|54709836|FG002|Double-Blind, Week 0-20|Adverse Event|5|||
28052341|NCT00422058|54709837|FG003|Double-Blind, Week 0-20|Adverse Event|9|||
28052342|NCT00422058|54709838|FG004|Double-Blind, Week 0-20|Adverse Event|5|||
28052343|NCT00422058|54709839|FG005|Double-Blind, Week 0-20|Adverse Event|3|||
28052344|NCT00422058|54709834|FG000|Double-Blind, Week 0-20|Protocol Violation|3|||
28052345|NCT00422058|54709835|FG001|Double-Blind, Week 0-20|Protocol Violation|2|||
28052346|NCT00422058|54709836|FG002|Double-Blind, Week 0-20|Protocol Violation|2|||
28052347|NCT00422058|54709837|FG003|Double-Blind, Week 0-20|Protocol Violation|3|||
28052348|NCT00422058|54709838|FG004|Double-Blind, Week 0-20|Protocol Violation|2|||
28052349|NCT00422058|54709839|FG005|Double-Blind, Week 0-20|Protocol Violation|2|||
28052350|NCT00422058|54709834|FG000|Double-Blind, Week 0-20|Lack of Efficacy|2|||
28052351|NCT00422058|54709835|FG001|Double-Blind, Week 0-20|Lack of Efficacy|1|||
28052352|NCT00422058|54709836|FG002|Double-Blind, Week 0-20|Lack of Efficacy|1|||
28052353|NCT00422058|54709837|FG003|Double-Blind, Week 0-20|Lack of Efficacy|0|||
28052354|NCT00422058|54709838|FG004|Double-Blind, Week 0-20|Lack of Efficacy|0|||
28052355|NCT00422058|54709839|FG005|Double-Blind, Week 0-20|Lack of Efficacy|1|||
27848219|NCT00981175|54341193|FG000|Primary Dose Vaccination|Lost to Follow-up|2|||
27848220|NCT00981175|54341194|FG001|Primary Dose Vaccination|Lost to Follow-up|1|||
27848221|NCT00981175|54341193|FG000|Booster Dose Vaccination|Lost to Follow-up|2|||
27848222|NCT00981175|54341194|FG001|Booster Dose Vaccination|Lost to Follow-up|3|||
27848223|NCT00981019|54341207|FG000|Overall Study|Did not respond|65|||
27848224|NCT00981019|54341207|FG000|Overall Study|Did not match target population|94|||
27848225|NCT00981019|54341207|FG000|Overall Study|Inadvertent exclusion|239|||
27848226|NCT00981019|54341207|FG000|Overall Study|Hit the survey after closure|79|||
27848227|NCT01045161|54341214|FG000|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8|||
27848228|NCT01045161|54341215|FG001|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12|||
27848229|NCT01045161|54341216|FG002|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6|||
28052356|NCT00422058|54709834|FG000|Double-Blind, Week 0-20|Other|11|||
28052357|NCT00422058|54709835|FG001|Double-Blind, Week 0-20|Other|3|||
27848230|NCT01045161|54341214|FG000|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4|||
28052358|NCT00422058|54709836|FG002|Double-Blind, Week 0-20|Other|8|||
28052359|NCT00422058|54709837|FG003|Double-Blind, Week 0-20|Other|8|||
27848231|NCT01045161|54341215|FG001|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3|||
28052360|NCT00422058|54709838|FG004|Double-Blind, Week 0-20|Other|4|||
28052361|NCT00422058|54709839|FG005|Double-Blind, Week 0-20|Other|10|||
28052362|NCT00422058|54709834|FG000|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
28052363|NCT00422058|54709835|FG001|Open-Label Extension, Week 20-104|Not giving consent for extension|17|||
28052364|NCT00422058|54709836|FG002|Open-Label Extension, Week 20-104|Not giving consent for extension|15|||
28052365|NCT00422058|54709837|FG003|Open-Label Extension, Week 20-104|Not giving consent for extension|8|||
28052366|NCT00422058|54709838|FG004|Open-Label Extension, Week 20-104|Not giving consent for extension|10|||
28052367|NCT00422058|54709839|FG005|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
28052368|NCT00422058|54709834|FG000|Open-Label Extension, Week 20-104|Adverse Event|3|||
28052369|NCT00422058|54709835|FG001|Open-Label Extension, Week 20-104|Adverse Event|4|||
28052370|NCT00422058|54709836|FG002|Open-Label Extension, Week 20-104|Adverse Event|7|||
28052371|NCT00422058|54709837|FG003|Open-Label Extension, Week 20-104|Adverse Event|4|||
28052372|NCT00422058|54709838|FG004|Open-Label Extension, Week 20-104|Adverse Event|4|||
28052373|NCT00422058|54709839|FG005|Open-Label Extension, Week 20-104|Adverse Event|0|||
28052374|NCT00422058|54709834|FG000|Open-Label Extension, Week 20-104|Protocol Violation|1|||
28052375|NCT00422058|54709835|FG001|Open-Label Extension, Week 20-104|Protocol Violation|2|||
28052376|NCT00422058|54709836|FG002|Open-Label Extension, Week 20-104|Protocol Violation|3|||
28052377|NCT00422058|54709837|FG003|Open-Label Extension, Week 20-104|Protocol Violation|1|||
28052378|NCT00422058|54709838|FG004|Open-Label Extension, Week 20-104|Protocol Violation|5|||
28052379|NCT00422058|54709839|FG005|Open-Label Extension, Week 20-104|Protocol Violation|3|||
28052380|NCT00422058|54709834|FG000|Open-Label Extension, Week 20-104|Lack of Efficacy|3|||
28052381|NCT00422058|54709835|FG001|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
28052382|NCT00422058|54709836|FG002|Open-Label Extension, Week 20-104|Lack of Efficacy|5|||
28052383|NCT00422058|54709837|FG003|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
28052384|NCT00422058|54709838|FG004|Open-Label Extension, Week 20-104|Lack of Efficacy|0|||
28052385|NCT00422058|54709839|FG005|Open-Label Extension, Week 20-104|Lack of Efficacy|1|||
28052386|NCT00422058|54709834|FG000|Open-Label Extension, Week 20-104|Other|13|||
28052387|NCT00422058|54709835|FG001|Open-Label Extension, Week 20-104|Other|14|||
28052388|NCT00422058|54709836|FG002|Open-Label Extension, Week 20-104|Other|6|||
28052389|NCT00422058|54709837|FG003|Open-Label Extension, Week 20-104|Other|13|||
28052390|NCT00422058|54709838|FG004|Open-Label Extension, Week 20-104|Other|16|||
28052391|NCT00422058|54709839|FG005|Open-Label Extension, Week 20-104|Other|18|||
28052392|NCT00413244|54709863|FG000|Overall Study|Withdrawal by Subject|10|||
28052393|NCT00413244|54709864|FG001|Overall Study|Withdrawal by Subject|1|||
28052394|NCT00420420|54709892|FG000|Overall Study|Adverse Event|5|||
28052395|NCT00420420|54709893|FG001|Overall Study|Adverse Event|3|||
28052396|NCT00420420|54709892|FG000|Overall Study|Protocol Violation|1|||
28052397|NCT00420420|54709893|FG001|Overall Study|Protocol Violation|1|||
28052398|NCT00420420|54709892|FG000|Overall Study|Withdrawal by Subject|1|||
28052399|NCT00420420|54709893|FG001|Overall Study|Withdrawal by Subject|0|||
28052400|NCT00420420|54709892|FG000|Overall Study|sponsor decision (abnormal ECG @ screen)|1|||
28052401|NCT00420420|54709893|FG001|Overall Study|sponsor decision (abnormal ECG @ screen)|0|||
28052402|NCT00420342|54709902|FG000|Overall Study|Lost to Follow-up|1|||
28052403|NCT00420342|54709903|FG001|Overall Study|Lost to Follow-up|0|||
28052404|NCT00420342|54709904|FG002|Overall Study|Lost to Follow-up|1|||
28052405|NCT00420342|54709902|FG000|Overall Study|Withdrawal by Subject|0|||
28052406|NCT00420342|54709903|FG001|Overall Study|Withdrawal by Subject|2|||
28052407|NCT00420342|54709904|FG002|Overall Study|Withdrawal by Subject|0|||
28052408|NCT00432744|54709914|FG000|Months 0-6|Withdrawal by Subject|4|||
28052409|NCT00432744|54709915|FG001|Months 0-6|Withdrawal by Subject|4|||
28052410|NCT00432744|54709914|FG000|Months 0-6|Too disabled to score|1|||
28052411|NCT00432744|54709915|FG001|Months 0-6|Too disabled to score|0|||
28052412|NCT00432744|54709914|FG000|Months 7 - 12|Withdrawal by Subject|1|||
28052413|NCT00432744|54709915|FG001|Months 7 - 12|Withdrawal by Subject|0|||
28052414|NCT00432744|54709914|FG000|Months 7 - 12|Too disabled to score|0|||
28052415|NCT00432744|54709915|FG001|Months 7 - 12|Too disabled to score|1|||
28052416|NCT00432666|54709923|FG000|Main Period|Adverse Event|1|||
28052417|NCT00432666|54709924|FG001|Main Period|Adverse Event|1|||
28052418|NCT00432666|54709923|FG000|Main Period|Consent Withdrawn|1|||
28052419|NCT00432666|54709924|FG001|Main Period|Consent Withdrawn|0|||
28052420|NCT00432666|54709923|FG000|Open-Label Extension Period|Withdrawal Criteria Occurred|1|||
28052421|NCT00432666|54709924|FG001|Open-Label Extension Period|Withdrawal Criteria Occurred|0|||
28052422|NCT00432666|54709923|FG000|Open-Label Extension Period|Lack of Efficacy|6|||
27939936|NCT00943852|54596282|FG005|Washout Period After Period 2 Treatment|Trial stopped early|1|||
27939937|NCT00943852|54596283|FG006|Washout Period After Period 2 Treatment|Trial stopped early|0|||
28052423|NCT00432666|54709924|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
28052424|NCT00432666|54709923|FG000|Open-Label Extension Period|Adverse Event|5|||
28052425|NCT00432666|54709924|FG001|Open-Label Extension Period|Adverse Event|0|||
28052426|NCT00432666|54709923|FG000|Open-Label Extension Period|Consent withdrawn|10|||
28052427|NCT00432666|54709924|FG001|Open-Label Extension Period|Consent withdrawn|0|||
28052428|NCT00432666|54709923|FG000|Open-Label Extension Period|Physician Decision|3|||
28052429|NCT00432666|54709924|FG001|Open-Label Extension Period|Physician Decision|0|||
28052430|NCT00451958|54709934|FG000|CS21A (NCT00451958)|Adverse Event|21|||
28052431|NCT00451958|54709935|FG001|CS21A (NCT00451958)|Adverse Event|34|||
28052432|NCT00451958|54709936|FG002|CS21A (NCT00451958)|Adverse Event|14|||
28052433|NCT00451958|54709937|FG003|CS21A (NCT00451958)|Adverse Event|17|||
28052434|NCT00451958|54709938|FG004|CS21A (NCT00451958)|Adverse Event|0|||
28052435|NCT00451958|54709934|FG000|CS21A (NCT00451958)|Lost to Follow-up|6|||
28052436|NCT00451958|54709935|FG001|CS21A (NCT00451958)|Lost to Follow-up|5|||
28052437|NCT00451958|54709936|FG002|CS21A (NCT00451958)|Lost to Follow-up|1|||
28052438|NCT00451958|54709937|FG003|CS21A (NCT00451958)|Lost to Follow-up|1|||
28052439|NCT00451958|54709938|FG004|CS21A (NCT00451958)|Lost to Follow-up|0|||
28052440|NCT00451958|54709934|FG000|CS21A (NCT00451958)|Protocol Violation|1|||
28052441|NCT00451958|54709935|FG001|CS21A (NCT00451958)|Protocol Violation|3|||
28052442|NCT00451958|54709936|FG002|CS21A (NCT00451958)|Protocol Violation|2|||
28052443|NCT00451958|54709937|FG003|CS21A (NCT00451958)|Protocol Violation|0|||
28052444|NCT00451958|54709938|FG004|CS21A (NCT00451958)|Protocol Violation|0|||
28052445|NCT00451958|54709934|FG000|CS21A (NCT00451958)|Physician Decision|2|||
28052446|NCT00451958|54709935|FG001|CS21A (NCT00451958)|Physician Decision|4|||
28052447|NCT00451958|54709936|FG002|CS21A (NCT00451958)|Physician Decision|4|||
28052448|NCT00451958|54709937|FG003|CS21A (NCT00451958)|Physician Decision|4|||
28052449|NCT00451958|54709938|FG004|CS21A (NCT00451958)|Physician Decision|0|||
28052450|NCT00451958|54709934|FG000|CS21A (NCT00451958)|Withdrawal by Subject|7|||
28052451|NCT00451958|54709935|FG001|CS21A (NCT00451958)|Withdrawal by Subject|4|||
28052452|NCT00451958|54709936|FG002|CS21A (NCT00451958)|Withdrawal by Subject|4|||
28052453|NCT00451958|54709937|FG003|CS21A (NCT00451958)|Withdrawal by Subject|3|||
28052454|NCT00451958|54709938|FG004|CS21A (NCT00451958)|Withdrawal by Subject|0|||
28052455|NCT00451958|54709934|FG000|CS21A (NCT00451958)|Miscellaneous reasons|28|||
28052456|NCT00451958|54709935|FG001|CS21A (NCT00451958)|Miscellaneous reasons|27|||
28052457|NCT00451958|54709936|FG002|CS21A (NCT00451958)|Miscellaneous reasons|17|||
28052458|NCT00451958|54709937|FG003|CS21A (NCT00451958)|Miscellaneous reasons|14|||
28052459|NCT00451958|54709938|FG004|CS21A (NCT00451958)|Miscellaneous reasons|0|||
28052460|NCT00432276|54709954|FG000|Overall Study|Hyperglycemic Rescue|44|||
28052461|NCT00432276|54709955|FG001|Overall Study|Hyperglycemic Rescue|87|||
28052462|NCT00432276|54709954|FG000|Overall Study|Adverse Event|13|||
28052463|NCT00432276|54709955|FG001|Overall Study|Adverse Event|16|||
28052464|NCT00432276|54709954|FG000|Overall Study|Protocol Violation|25|||
28052465|NCT00432276|54709955|FG001|Overall Study|Protocol Violation|20|||
28052466|NCT00432276|54709954|FG000|Overall Study|Lost to Follow-up|6|||
28052467|NCT00432276|54709955|FG001|Overall Study|Lost to Follow-up|2|||
28052468|NCT00432276|54709954|FG000|Overall Study|Withdrawal by Subject|25|||
28052469|NCT00432276|54709955|FG001|Overall Study|Withdrawal by Subject|20|||
28052470|NCT00432276|54709954|FG000|Overall Study|Physician Decision|6|||
28052471|NCT00432276|54709955|FG001|Overall Study|Physician Decision|8|||
28052472|NCT00432276|54709954|FG000|Overall Study|Other|2|||
28052473|NCT00432276|54709955|FG001|Overall Study|Other|3|||
28052474|NCT00413010|54709963|FG000|Overall Study|Adverse Event|8|||
28052475|NCT00413010|54709964|FG001|Overall Study|Adverse Event|4|||
28052476|NCT00413010|54709963|FG000|Overall Study|Laboratory abnormality|0|||
28052477|NCT00413010|54709964|FG001|Overall Study|Laboratory abnormality|2|||
28052478|NCT00413010|54709963|FG000|Overall Study|Lack of Efficacy|0|||
28052479|NCT00413010|54709964|FG001|Overall Study|Lack of Efficacy|3|||
28052480|NCT00413010|54709963|FG000|Overall Study|Lost to Follow-up|3|||
28052481|NCT00413010|54709964|FG001|Overall Study|Lost to Follow-up|0|||
28052482|NCT00413010|54709963|FG000|Overall Study|Withdrawal by Subject|7|||
28052483|NCT00413010|54709964|FG001|Overall Study|Withdrawal by Subject|2|||
28052484|NCT00413010|54709963|FG000|Overall Study|Due to termination of the study|54|||
28052485|NCT00413010|54709964|FG001|Overall Study|Due to termination of the study|52|||
28052486|NCT00459290|54709970|FG000|Overall Study|Adverse Event|3|||
28052487|NCT00459290|54709970|FG000|Overall Study|Ineligible|2|||
28052488|NCT00443534|54709981|FG000|Overall Study|Lack of Efficacy|67|||
28052489|NCT00443534|54709981|FG000|Overall Study|Adverse Event|16|||
28052490|NCT00443534|54709981|FG000|Overall Study|Death|9|||
28105703|NCT04741503|54763280|FG002|Initial Enrollment|Overquotas removed|186|||
28052491|NCT00443534|54709981|FG000|Overall Study|Withdrawal by Subject|8|||
28052492|NCT00443534|54709981|FG000|Overall Study|Study Terminated by Sponsor|12|||
28052493|NCT00443534|54709981|FG000|Overall Study|Other|10|||
28052494|NCT00443534|54709981|FG000|Overall Study|Enrolled, Not Treated|1|||
28052495|NCT00419952|54709987|FG000|Overall Study|Adverse Event|8|||
28052496|NCT00419952|54709988|FG001|Overall Study|Adverse Event|10|||
28052497|NCT00419952|54709987|FG000|Overall Study|Withdrawal by Subject|44|||
28052498|NCT00419952|54709988|FG001|Overall Study|Withdrawal by Subject|43|||
28052499|NCT00419952|54709987|FG000|Overall Study|Lost to Follow-up|43|||
28052500|NCT00419952|54709988|FG001|Overall Study|Lost to Follow-up|34|||
28105704|NCT04741503|54763278|FG000|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|23|||
28052501|NCT00419952|54709987|FG000|Overall Study|Protocol Violation|32|||
28159974|NCT02737475|54830022|FG000|Overall Study|Participant withdrew consent|0|||
28052502|NCT00419952|54709988|FG001|Overall Study|Protocol Violation|24|||
28052503|NCT00419952|54709987|FG000|Overall Study|Pregnancy|4|||
28052504|NCT00419952|54709988|FG001|Overall Study|Pregnancy|2|||
28052505|NCT00419952|54709987|FG000|Overall Study|Physician Decision|1|||
28052506|NCT00419952|54709988|FG001|Overall Study|Physician Decision|3|||
28052507|NCT00419952|54709987|FG000|Overall Study|Incorrectly enrolled|10|||
28052508|NCT00419952|54709988|FG001|Overall Study|Incorrectly enrolled|3|||
28052509|NCT00419952|54709987|FG000|Overall Study|Intake of prohibited medication|2|||
28052510|NCT00419952|54709988|FG001|Overall Study|Intake of prohibited medication|2|||
28052511|NCT00419952|54709987|FG000|Overall Study|Occurence of 2 or more exacerbations|2|||
28052512|NCT00419952|54709988|FG001|Overall Study|Occurence of 2 or more exacerbations|0|||
28052513|NCT00419952|54709987|FG000|Overall Study|Diary or medication non-compliance|2|||
28052514|NCT00419952|54709988|FG001|Overall Study|Diary or medication non-compliance|4|||
28052515|NCT00419952|54709987|FG000|Overall Study|Abnormal ECG|1|||
28052516|NCT00419952|54709988|FG001|Overall Study|Abnormal ECG|0|||
28052517|NCT00443456|54709994|FG000|Overall Study|Adverse Event|16|||
28052518|NCT00443456|54709994|FG000|Overall Study|Move|1|||
28052519|NCT00443456|54709994|FG000|Overall Study|Withdrawal by Subject|1|||
28052520|NCT00419562|54710004|FG000|Overall Study|Lost to Follow-up|12|||
28052521|NCT00419562|54710005|FG001|Overall Study|Lost to Follow-up|13|||
28052522|NCT00419562|54710004|FG000|Overall Study|Withdrawal by Subject|20|||
28052523|NCT00419562|54710005|FG001|Overall Study|Withdrawal by Subject|18|||
28052524|NCT00419562|54710004|FG000|Overall Study|Participant Institutionalized|1|||
28052525|NCT00419562|54710005|FG001|Overall Study|Participant Institutionalized|0|||
28052526|NCT00432042|54710014|FG000|Overall Study|Protocol Violation|2|||
28052527|NCT00432042|54710015|FG001|Overall Study|Protocol Violation|0|||
28052528|NCT00432042|54710016|FG002|Overall Study|Protocol Violation|0|||
28052529|NCT00432042|54710014|FG000|Overall Study|Withdrawal by Subject|0|||
28052530|NCT00432042|54710015|FG001|Overall Study|Withdrawal by Subject|0|||
28052531|NCT00432042|54710016|FG002|Overall Study|Withdrawal by Subject|2|||
28052532|NCT00432042|54710014|FG000|Overall Study|Lost to Follow-up|5|||
28052533|NCT00432042|54710015|FG001|Overall Study|Lost to Follow-up|1|||
28052534|NCT00432042|54710016|FG002|Overall Study|Lost to Follow-up|0|||
28052535|NCT00308139|54710026|FG000|Overall Study|Adverse Event|20|||
28052536|NCT00308139|54710027|FG001|Overall Study|Adverse Event|14|||
28052537|NCT00308139|54710026|FG000|Overall Study|Lost to Follow-up|13|||
28052538|NCT00308139|54710027|FG001|Overall Study|Lost to Follow-up|8|||
28052539|NCT00308139|54710026|FG000|Overall Study|Protocol Violation|3|||
28052540|NCT00308139|54710027|FG001|Overall Study|Protocol Violation|2|||
28052541|NCT00308139|54710026|FG000|Overall Study|Withdrawal of Consent|40|||
28052542|NCT00308139|54710027|FG001|Overall Study|Withdrawal of Consent|42|||
28052543|NCT00308139|54710026|FG000|Overall Study|Investigator Decision|11|||
28052544|NCT00308139|54710027|FG001|Overall Study|Investigator Decision|10|||
28052545|NCT00308139|54710026|FG000|Overall Study|Loss of Glucose Control|5|||
28052546|NCT00308139|54710027|FG001|Overall Study|Loss of Glucose Control|7|||
28052547|NCT00308139|54710026|FG000|Overall Study|Administrative|1|||
28052548|NCT00308139|54710027|FG001|Overall Study|Administrative|4|||
28052549|NCT00308139|54710026|FG000|Overall Study|Other|1|||
28052550|NCT00308139|54710027|FG001|Overall Study|Other|0|||
28052551|NCT00459134|54710055|FG000|Overall Study|Physician Decision|1|||
28052552|NCT00459134|54710056|FG001|Overall Study|Physician Decision|1|||
28052553|NCT00459134|54710055|FG000|Overall Study|Withdrawal by Subject|8|||
28052554|NCT00459134|54710056|FG001|Overall Study|Withdrawal by Subject|7|||
28052555|NCT00459134|54710055|FG000|Overall Study|Lost to Follow-up|6|||
28052556|NCT00459134|54710056|FG001|Overall Study|Lost to Follow-up|7|||
28052557|NCT00459134|54710055|FG000|Overall Study|Surgery|1|||
28052558|NCT00459134|54710056|FG001|Overall Study|Surgery|2|||
28052559|NCT00459134|54710055|FG000|Overall Study|Toxicity|4|||
28052560|NCT00459134|54710056|FG001|Overall Study|Toxicity|5|||
28052561|NCT00459134|54710055|FG000|Overall Study|Progression|1|||
28052562|NCT00459134|54710056|FG001|Overall Study|Progression|0|||
28052563|NCT00459134|54710055|FG000|Overall Study|Multiple Reasons|2|||
28052564|NCT00459134|54710056|FG001|Overall Study|Multiple Reasons|3|||
28052565|NCT00459056|54710064|FG000|First Intervention (First Three Months)|Lost to Follow-up|1|||
28052566|NCT00459056|54710065|FG001|First Intervention (First Three Months)|Lost to Follow-up|1|||
28052567|NCT00431964|54710073|FG000|Overall Study|Adverse Event|1|||
28052568|NCT00431964|54710074|FG001|Overall Study|Adverse Event|0|||
28052569|NCT00431964|54710073|FG000|Overall Study|Lost to Follow-up|1|||
28052570|NCT00431964|54710074|FG001|Overall Study|Lost to Follow-up|2|||
28052571|NCT00431964|54710073|FG000|Overall Study|Physician Decision|2|||
28052572|NCT00431964|54710074|FG001|Overall Study|Physician Decision|2|||
28052573|NCT00431964|54710073|FG000|Overall Study|Withdrawal by Subject|2|||
28052574|NCT00431964|54710074|FG001|Overall Study|Withdrawal by Subject|1|||
28052575|NCT00431964|54710073|FG000|Overall Study|Parental Consent Withdrawn|0|||
28052576|NCT00431964|54710074|FG001|Overall Study|Parental Consent Withdrawn|2|||
28052577|NCT00431964|54710073|FG000|Overall Study|Due to Unstable Health|0|||
27848232|NCT01045161|54341216|FG002|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8|||
28052578|NCT00431964|54710074|FG001|Overall Study|Due to Unstable Health|1|||
28052579|NCT00412854|54710082|FG000|Overall Study|Withdrawn due to adverse events|1|||
28052580|NCT00412854|54710083|FG001|Overall Study|Withdrawn due to adverse events|5|||
28052581|NCT00412854|54710082|FG000|Overall Study|Withdrawn for other reasons|13|||
28052582|NCT00412854|54710083|FG001|Overall Study|Withdrawn for other reasons|11|||
28052583|NCT00431496|54710089|FG000|Overall Study|Adverse Event|3|||
28052584|NCT00431496|54710089|FG000|Overall Study|Lost to Follow-up|1|||
28052585|NCT00431496|54710089|FG000|Overall Study|Withdrawal by Subject|2|||
28052586|NCT00431496|54710089|FG000|Overall Study|Protocol-specified criteria|5|||
28052587|NCT00316173|54710095|FG000|Run-in Phase|Adverse Event|1|||
28052588|NCT00316173|54710096|FG001|Run-in Phase|Adverse Event|0|||
28052589|NCT00316173|54710095|FG000|Run-in Phase|Protocol Violation|1|||
28052590|NCT00316173|54710096|FG001|Run-in Phase|Protocol Violation|0|||
28052591|NCT00316173|54710095|FG000|Run-in Phase|Study Follow-up Stopped|5|||
28052592|NCT00316173|54710096|FG001|Run-in Phase|Study Follow-up Stopped|0|||
28052593|NCT00316173|54710095|FG000|Treatment Phase|Adverse Event|0|||
28052594|NCT00316173|54710096|FG001|Treatment Phase|Adverse Event|1|||
28052595|NCT00316173|54710095|FG000|Treatment Phase|Lack of Efficacy|0|||
28052596|NCT00316173|54710096|FG001|Treatment Phase|Lack of Efficacy|3|||
28052597|NCT00316173|54710095|FG000|Treatment Phase|Lost to Follow-up|0|||
28052598|NCT00316173|54710096|FG001|Treatment Phase|Lost to Follow-up|3|||
28052599|NCT00316173|54710095|FG000|Treatment Phase|Withdrawal by Subject|0|||
28052600|NCT00316173|54710096|FG001|Treatment Phase|Withdrawal by Subject|1|||
28052601|NCT00316173|54710095|FG000|Treatment Phase|Study Follow-up Stopped|0|||
28052602|NCT00316173|54710096|FG001|Treatment Phase|Study Follow-up Stopped|34|||
28052603|NCT00412542|54710103|FG000|Overall Study|Withdrawal by Subject|0|||
28052604|NCT00412542|54710104|FG001|Overall Study|Withdrawal by Subject|2|||
28052605|NCT00412542|54710103|FG000|Overall Study|Not Eligible|0|||
28052606|NCT00412542|54710104|FG001|Overall Study|Not Eligible|1|||
28052607|NCT00316017|54710111|FG000|Overall Study|Protocol Violation|11|||
28052608|NCT00316017|54710112|FG001|Overall Study|Protocol Violation|13|||
28052609|NCT00316017|54710113|FG002|Overall Study|Protocol Violation|19|||
28052610|NCT00451178|54710123|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
28052611|NCT00451178|54710124|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
28052612|NCT00451178|54710123|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4|||
28052613|NCT00451178|54710124|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3|||
28052614|NCT00451178|54710123|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2|||
28052615|NCT00451178|54710124|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1|||
28052616|NCT00451178|54710123|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1|||
28052617|NCT00451178|54710124|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2|||
28052618|NCT00451178|54710123|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Death|4|||
28052619|NCT00451178|54710124|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Death|3|||
28052620|NCT00451178|54710123|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1|||
28052621|NCT00451178|54710124|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2|||
28052622|NCT00451178|54710123|FG000|Prior to Maintenance Therapy|Physician Decision|2|||
28052623|NCT00451178|54710124|FG001|Prior to Maintenance Therapy|Physician Decision|0|||
28052624|NCT00451178|54710123|FG000|Prior to Maintenance Therapy|PD|2|||
28052625|NCT00451178|54710124|FG001|Prior to Maintenance Therapy|PD|0|||
28052626|NCT00451178|54710123|FG000|Maintenance Therapy (up to 3 Years)|Adverse Event|4|||
28052627|NCT00451178|54710124|FG001|Maintenance Therapy (up to 3 Years)|Adverse Event|0|||
28052628|NCT00451178|54710123|FG000|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5|||
28052629|NCT00451178|54710124|FG001|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0|||
28052630|NCT00451178|54710123|FG000|Maintenance Therapy (up to 3 Years)|Physician Decision|1|||
28052631|NCT00451178|54710124|FG001|Maintenance Therapy (up to 3 Years)|Physician Decision|0|||
28052632|NCT00451178|54710123|FG000|Maintenance Therapy (up to 3 Years)|Death|1|||
28052633|NCT00451178|54710124|FG001|Maintenance Therapy (up to 3 Years)|Death|0|||
28052634|NCT00451178|54710123|FG000|Maintenance Therapy (up to 3 Years)|PD|10|||
28052635|NCT00451178|54710124|FG001|Maintenance Therapy (up to 3 Years)|PD|0|||
28052636|NCT00451178|54710123|FG000|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9|||
28052637|NCT00451178|54710124|FG001|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0|||
28052638|NCT00451178|54710123|FG000|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6|||
28052639|NCT00451178|54710124|FG001|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26|||
28052640|NCT00450866|54710134|FG000|Overall Study|Adverse Event|0|||
28052641|NCT00450866|54710135|FG001|Overall Study|Adverse Event|1|||
28052642|NCT00450866|54710134|FG000|Overall Study|Withdrawal by Subject|5|||
28052643|NCT00450866|54710135|FG001|Overall Study|Withdrawal by Subject|2|||
28052644|NCT00450866|54710134|FG000|Overall Study|Death|1|||
27812599|NCT01682031|54268883|FG001|Overall Study|Withdrawal by Subject|1|||
28052645|NCT00450866|54710135|FG001|Overall Study|Death|0|||
28052646|NCT00450866|54710134|FG000|Overall Study|Physician Decision|1|||
28052647|NCT00450866|54710135|FG001|Overall Study|Physician Decision|0|||
28052648|NCT00442598|54710144|FG000|Overall Study|Adverse Event|1|||
28052649|NCT00442598|54710145|FG001|Overall Study|Adverse Event|0|||
28052650|NCT00442598|54710146|FG002|Overall Study|Adverse Event|0|||
28052651|NCT00442598|54710144|FG000|Overall Study|Tumor progression|3|||
28052652|NCT00442598|54710145|FG001|Overall Study|Tumor progression|4|||
28052653|NCT00442598|54710146|FG002|Overall Study|Tumor progression|0|||
28052654|NCT00442598|54710144|FG000|Overall Study|Clinical deterioration|1|||
28052655|NCT00442598|54710145|FG001|Overall Study|Clinical deterioration|2|||
28052656|NCT00442598|54710146|FG002|Overall Study|Clinical deterioration|0|||
28052657|NCT00442598|54710144|FG000|Overall Study|CA125 progression|0|||
28052658|NCT00442598|54710145|FG001|Overall Study|CA125 progression|1|||
28052659|NCT00442598|54710146|FG002|Overall Study|CA125 progression|0|||
28052660|NCT00442598|54710144|FG000|Overall Study|Reduced creatinine clearance|1|||
28052661|NCT00442598|54710145|FG001|Overall Study|Reduced creatinine clearance|0|||
28052662|NCT00442598|54710146|FG002|Overall Study|Reduced creatinine clearance|0|||
28052663|NCT00442598|54710144|FG000|Overall Study|Death|0|||
28052664|NCT00442598|54710145|FG001|Overall Study|Death|1|||
28052665|NCT00442598|54710146|FG002|Overall Study|Death|0|||
28052666|NCT00442286|54710156|FG000|Overall Study|Death|2|||
28052667|NCT00442286|54710157|FG001|Overall Study|Death|2|||
28052668|NCT00442286|54710156|FG000|Overall Study|Lost to Follow-up|1|||
28052669|NCT00442286|54710157|FG001|Overall Study|Lost to Follow-up|0|||
28052670|NCT00442286|54710156|FG000|Overall Study|Withdrawal by Subject|2|||
28052671|NCT00442286|54710157|FG001|Overall Study|Withdrawal by Subject|0|||
28052672|NCT00442286|54710156|FG000|Overall Study|System explanted|1|||
28052673|NCT00442286|54710157|FG001|Overall Study|System explanted|0|||
28052674|NCT00442286|54710156|FG000|Overall Study|Patient Injury|1|||
28052675|NCT00442286|54710157|FG001|Overall Study|Patient Injury|0|||
27812600|NCT01682031|54268882|FG000|Overall Study|Adverse Event|0|||
27812601|NCT01682031|54268883|FG001|Overall Study|Adverse Event|2|||
27812602|NCT01682031|54268882|FG000|Overall Study|MRI results indicate increased nodul|0|||
27812603|NCT01682031|54268883|FG001|Overall Study|MRI results indicate increased nodul|1|||
27812604|NCT01682031|54268882|FG000|Overall Study|Patient could not swallow tablets|1|||
27812605|NCT01682031|54268883|FG001|Overall Study|Patient could not swallow tablets|0|||
27812606|NCT01682031|54268882|FG000|Overall Study|Patient stopped selenium on his own|0|||
27812607|NCT01682031|54268883|FG001|Overall Study|Patient stopped selenium on his own|1|||
27812608|NCT01567527|54268904|FG000|Conversion Phase.|Protocol deviation|3|||
27812609|NCT01567527|54268905|FG001|Conversion Phase.|Protocol deviation|0|||
27812610|NCT01567527|54268906|FG002|Conversion Phase.|Protocol deviation|0|||
27812611|NCT01567527|54268907|FG003|Conversion Phase.|Protocol deviation|0|||
27812612|NCT01567527|54268908|FG004|Conversion Phase.|Protocol deviation|0|||
27812613|NCT01567527|54268904|FG000|Conversion Phase.|Met withdrawal criteria|10|||
28052676|NCT00441974|54710165|FG000|Overall Study|Adverse Event|6|||
28052677|NCT00441974|54710165|FG000|Overall Study|Consent Withdrawn|35|||
28052678|NCT00441974|54710165|FG000|Overall Study|Lost to Follow-up|80|||
28052679|NCT00441974|54710165|FG000|Overall Study|Protocol Violation|7|||
28052680|NCT00441584|54710172|FG000|Overall Study|Lack of Efficacy|79|||
28052681|NCT00441584|54710172|FG000|Overall Study|Withdrawal by Subject|8|||
28052682|NCT00441584|54710172|FG000|Overall Study|Adverse Event|6|||
28052683|NCT00441584|54710172|FG000|Overall Study|Protocol Violation|5|||
28052684|NCT00441584|54710172|FG000|Overall Study|Lost to Follow-up|4|||
28052685|NCT00441584|54710172|FG000|Overall Study|Failure to meet eligibility criteria|3|||
28052686|NCT00430716|54710179|FG000|Double Blind Phase|Death|1|||
28052687|NCT00430716|54710180|FG001|Double Blind Phase|Death|0|||
28052688|NCT00430716|54710181|FG002|Double Blind Phase|Death|0|||
28052689|NCT00430716|54710179|FG000|Double Blind Phase|No longer willing to participate|2|||
28052690|NCT00430716|54710180|FG001|Double Blind Phase|No longer willing to participate|1|||
28052691|NCT00430716|54710181|FG002|Double Blind Phase|No longer willing to participate|1|||
28052692|NCT00430716|54710179|FG000|Double Blind Phase|Other|0|||
28052693|NCT00430716|54710180|FG001|Double Blind Phase|Other|2|||
28052694|NCT00430716|54710181|FG002|Double Blind Phase|Other|0|||
28052695|NCT00430716|54710179|FG000|Double Blind Phase|Study terminated by sponsor|1|||
28052696|NCT00430716|54710180|FG001|Double Blind Phase|Study terminated by sponsor|1|||
28052697|NCT00430716|54710181|FG002|Double Blind Phase|Study terminated by sponsor|2|||
28052698|NCT00430716|54710179|FG000|Double Blind Phase|Adverse Event|1|||
28052699|NCT00430716|54710180|FG001|Double Blind Phase|Adverse Event|1|||
28052700|NCT00430716|54710181|FG002|Double Blind Phase|Adverse Event|3|||
28052701|NCT00430716|54710179|FG000|Double Blind Phase|Not treated|1|||
28052702|NCT00430716|54710180|FG001|Double Blind Phase|Not treated|0|||
28052703|NCT00430716|54710181|FG002|Double Blind Phase|Not treated|0|||
27812614|NCT01567527|54268905|FG001|Conversion Phase.|Met withdrawal criteria|0|||
28052704|NCT00430716|54710179|FG000|Open Label Phase|Lost to Follow-up|1|||
28052705|NCT00430716|54710180|FG001|Open Label Phase|Lost to Follow-up|0|||
28052706|NCT00430716|54710181|FG002|Open Label Phase|Lost to Follow-up|1|||
28052707|NCT00430716|54710179|FG000|Open Label Phase|No longer willing to participate|0|||
28052708|NCT00430716|54710180|FG001|Open Label Phase|No longer willing to participate|1|||
28052709|NCT00430716|54710181|FG002|Open Label Phase|No longer willing to participate|1|||
28052710|NCT00430716|54710179|FG000|Open Label Phase|Other|3|||
28052711|NCT00430716|54710180|FG001|Open Label Phase|Other|1|||
27812615|NCT01567527|54268906|FG002|Conversion Phase.|Met withdrawal criteria|0|||
27812616|NCT01567527|54268907|FG003|Conversion Phase.|Met withdrawal criteria|0|||
27812617|NCT01567527|54268908|FG004|Conversion Phase.|Met withdrawal criteria|0|||
28052712|NCT00430716|54710181|FG002|Open Label Phase|Other|1|||
28052713|NCT00430716|54710179|FG000|Open Label Phase|Protocol Violation|1|||
28052714|NCT00430716|54710180|FG001|Open Label Phase|Protocol Violation|0|||
28052715|NCT00430716|54710181|FG002|Open Label Phase|Protocol Violation|0|||
28052716|NCT00430716|54710179|FG000|Open Label Phase|Study terminated by sponsor|4|||
28052717|NCT00430716|54710180|FG001|Open Label Phase|Study terminated by sponsor|5|||
28052718|NCT00430716|54710181|FG002|Open Label Phase|Study terminated by sponsor|4|||
28052719|NCT00441272|54710191|FG000|Overall Study|Study terminated prior to enrollment|25|||
28052720|NCT00441272|54710192|FG001|Overall Study|Study terminated prior to enrollment|25|||
28052721|NCT00430638|54710200|FG000|Overall Study|Adverse Event|15|||
28052722|NCT00430638|54710201|FG001|Overall Study|Adverse Event|15|||
28052723|NCT00430638|54710200|FG000|Overall Study|Uncontrolled blood pressure|48|||
28052724|NCT00430638|54710201|FG001|Overall Study|Uncontrolled blood pressure|13|||
28052725|NCT00430638|54710200|FG000|Overall Study|Lost to Follow-up|1|||
28052726|NCT00430638|54710201|FG001|Overall Study|Lost to Follow-up|7|||
28052727|NCT00430638|54710200|FG000|Overall Study|Protocol Violation|6|||
28052728|NCT00430638|54710201|FG001|Overall Study|Protocol Violation|4|||
28052729|NCT00430638|54710200|FG000|Overall Study|Withdrawal by Subject|4|||
28052730|NCT00430638|54710201|FG001|Overall Study|Withdrawal by Subject|6|||
28052731|NCT00430638|54710200|FG000|Overall Study|Non-compliant|2|||
28052732|NCT00430638|54710201|FG001|Overall Study|Non-compliant|1|||
28052733|NCT00430638|54710200|FG000|Overall Study|Other|2|||
28052734|NCT00430638|54710201|FG001|Overall Study|Other|2|||
28052735|NCT00430482|54710213|FG000|Completed Treatment|Insufficient Treatment|7|||
28052736|NCT00430482|54710214|FG001|Completed Treatment|Insufficient Treatment|11|||
28052737|NCT00449930|54710222|FG000|Overall Study|Adverse Event|9|||
28052738|NCT00449930|54710223|FG001|Overall Study|Adverse Event|19|||
28052739|NCT00449930|54710222|FG000|Overall Study|Trial Terminated ( Site Closed)|1|||
28052740|NCT00449930|54710223|FG001|Overall Study|Trial Terminated ( Site Closed)|0|||
28052741|NCT00449930|54710222|FG000|Overall Study|Lack of Efficacy|10|||
28052742|NCT00449930|54710223|FG001|Overall Study|Lack of Efficacy|1|||
28052743|NCT00449930|54710222|FG000|Overall Study|Lost to Follow-up|9|||
28052744|NCT00449930|54710223|FG001|Overall Study|Lost to Follow-up|14|||
28052745|NCT00449930|54710222|FG000|Overall Study|Physician Decision|1|||
28052746|NCT00449930|54710223|FG001|Overall Study|Physician Decision|2|||
28052747|NCT00449930|54710222|FG000|Overall Study|Protocol Violation|14|||
28052748|NCT00449930|54710223|FG001|Overall Study|Protocol Violation|15|||
28052749|NCT00449930|54710222|FG000|Overall Study|Withdrawal by Subject|16|||
28052750|NCT00449930|54710223|FG001|Overall Study|Withdrawal by Subject|23|||
28052751|NCT00449930|54710222|FG000|Overall Study|Glycemic discontinuation criteria|1|||
28052752|NCT00449930|54710223|FG001|Overall Study|Glycemic discontinuation criteria|1|||
28052753|NCT00449696|54710231|FG000|Overall Study|Other Treatment Required|6|||
28052754|NCT00449696|54710232|FG001|Overall Study|Other Treatment Required|1|||
28052755|NCT00449696|54710231|FG000|Overall Study|Withdrawal by Subject|5|||
28052756|NCT00449696|54710232|FG001|Overall Study|Withdrawal by Subject|5|||
28052757|NCT00449696|54710231|FG000|Overall Study|Lost to Follow-up|2|||
28052758|NCT00449696|54710232|FG001|Overall Study|Lost to Follow-up|3|||
28052759|NCT00449696|54710231|FG000|Overall Study|Others|7|||
28052760|NCT00449696|54710232|FG001|Overall Study|Others|0|||
28052761|NCT00441116|54710240|FG000|Overall Study|Adverse Event|1|||
28052762|NCT00441116|54710241|FG001|Overall Study|Adverse Event|1|||
28052763|NCT00441116|54710240|FG000|Overall Study|Withdrawal by Subject|1|||
28052764|NCT00441116|54710241|FG001|Overall Study|Withdrawal by Subject|0|||
28052765|NCT00441116|54710240|FG000|Overall Study|Did not meet Eligibility Criteria|1|||
28052766|NCT00441116|54710241|FG001|Overall Study|Did not meet Eligibility Criteria|1|||
28052767|NCT00430248|54710250|FG000|Overall Study|Adverse Event|49|||
28052768|NCT00430248|54710251|FG001|Overall Study|Adverse Event|61|||
28052769|NCT00430248|54710252|FG002|Overall Study|Adverse Event|64|||
28052770|NCT00430248|54710250|FG000|Overall Study|Protocol Violation|10|||
28052771|NCT00430248|54710251|FG001|Overall Study|Protocol Violation|2|||
28052772|NCT00430248|54710252|FG002|Overall Study|Protocol Violation|4|||
28052773|NCT00430248|54710250|FG000|Overall Study|Personal Reasons|12|||
28052774|NCT00430248|54710251|FG001|Overall Study|Personal Reasons|24|||
28052775|NCT00430248|54710252|FG002|Overall Study|Personal Reasons|9|||
28052776|NCT00430248|54710250|FG000|Overall Study|Lost to Follow-up|28|||
28052777|NCT00430248|54710251|FG001|Overall Study|Lost to Follow-up|33|||
28052778|NCT00430248|54710252|FG002|Overall Study|Lost to Follow-up|28|||
28052779|NCT00430248|54710250|FG000|Overall Study|Therapeutic Failure|1|||
28052780|NCT00430248|54710251|FG001|Overall Study|Therapeutic Failure|1|||
28052781|NCT00430248|54710252|FG002|Overall Study|Therapeutic Failure|1|||
28052782|NCT00430248|54710250|FG000|Overall Study|Withdrawal by Subject|14|||
28052783|NCT00430248|54710251|FG001|Overall Study|Withdrawal by Subject|20|||
28052784|NCT00430248|54710252|FG002|Overall Study|Withdrawal by Subject|16|||
28052785|NCT00430248|54710250|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
28052786|NCT00430248|54710251|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
27812618|NCT01567527|54268904|FG000|Conversion Phase.|Withdrawal by Subject|32|||
27939938|NCT00943852|54596284|FG007|Washout Period After Period 2 Treatment|Trial stopped early|0|||
28052787|NCT00430248|54710252|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
28052788|NCT00430248|54710250|FG000|Overall Study|Gout Flare|3|||
28052789|NCT00430248|54710251|FG001|Overall Study|Gout Flare|7|||
28052790|NCT00430248|54710252|FG002|Overall Study|Gout Flare|2|||
28052791|NCT00430248|54710250|FG000|Overall Study|Reason Not Specified|8|||
28052792|NCT00430248|54710251|FG001|Overall Study|Reason Not Specified|8|||
28052793|NCT00430248|54710252|FG002|Overall Study|Reason Not Specified|11|||
28052794|NCT00449540|54710262|FG000|Pretreatment Phase|No migraine experienced|66|||
28052795|NCT00449540|54710263|FG001|Pretreatment Phase|No migraine experienced|0|||
28052796|NCT00449540|54710264|FG002|Pretreatment Phase|No migraine experienced|0|||
28052797|NCT00449540|54710262|FG000|Treatment Phase|did not experience or treat migraine|0|||
28052798|NCT00449540|54710263|FG001|Treatment Phase|did not experience or treat migraine|20|||
28052799|NCT00449540|54710264|FG002|Treatment Phase|did not experience or treat migraine|17|||
28052800|NCT00411762|54710272|FG000|Overall Study|Withdrawal by Subject|5|||
28052801|NCT00429858|54710276|FG000|Overall Study|Withdrawal by Subject|1|||
28052802|NCT00429858|54710276|FG000|Overall Study|Study Termination|1|||
28052803|NCT00449150|54710284|FG000|Overall Study|Adverse Event|11|||
28052804|NCT00449150|54710285|FG001|Overall Study|Adverse Event|18|||
28052805|NCT00449150|54710286|FG002|Overall Study|Adverse Event|9|||
28052806|NCT00449150|54710284|FG000|Overall Study|Lack of Efficacy|1|||
28052807|NCT00449150|54710285|FG001|Overall Study|Lack of Efficacy|2|||
28052808|NCT00449150|54710286|FG002|Overall Study|Lack of Efficacy|2|||
28052809|NCT00449150|54710284|FG000|Overall Study|Other|16|||
28052810|NCT00449150|54710285|FG001|Overall Study|Other|13|||
28052811|NCT00449150|54710286|FG002|Overall Study|Other|14|||
28052812|NCT00449150|54710284|FG000|Overall Study|Withdrawal by Subject|17|||
28052813|NCT00449150|54710285|FG001|Overall Study|Withdrawal by Subject|18|||
28052814|NCT00449150|54710286|FG002|Overall Study|Withdrawal by Subject|21|||
28052815|NCT00449150|54710284|FG000|Overall Study|Protocol Violation|1|||
28052816|NCT00449150|54710285|FG001|Overall Study|Protocol Violation|2|||
27812619|NCT01567527|54268905|FG001|Conversion Phase.|Withdrawal by Subject|0|||
27812620|NCT01567527|54268906|FG002|Conversion Phase.|Withdrawal by Subject|0|||
27812621|NCT01567527|54268907|FG003|Conversion Phase.|Withdrawal by Subject|0|||
27812622|NCT01567527|54268908|FG004|Conversion Phase.|Withdrawal by Subject|0|||
27812623|NCT01567527|54268904|FG000|Conversion Phase.|Lost to Follow-up|16|||
27812624|NCT01567527|54268905|FG001|Conversion Phase.|Lost to Follow-up|0|||
27812625|NCT01567527|54268906|FG002|Conversion Phase.|Lost to Follow-up|0|||
28052817|NCT00449150|54710286|FG002|Overall Study|Protocol Violation|1|||
28052818|NCT00428844|54710300|FG000|Completed Study Drug Treatment|Adverse Event|2|||
28052819|NCT00428844|54710301|FG001|Completed Study Drug Treatment|Adverse Event|4|||
27812626|NCT01567527|54268907|FG003|Conversion Phase.|Lost to Follow-up|0|||
27812627|NCT01567527|54268908|FG004|Conversion Phase.|Lost to Follow-up|0|||
27812628|NCT01567527|54268904|FG000|Conversion Phase.|Lack of Efficacy|2|||
28052820|NCT00428844|54710302|FG002|Completed Study Drug Treatment|Adverse Event|4|||
27939939|NCT00943852|54596285|FG008|Washout Period After Period 2 Treatment|Trial stopped early|0|||
27939940|NCT00943852|54596286|FG009|Washout Period After Period 2 Treatment|Trial stopped early|0|||
28052821|NCT00428844|54710300|FG000|Completed Study Drug Treatment|Protocol Violation|0|||
28052822|NCT00428844|54710301|FG001|Completed Study Drug Treatment|Protocol Violation|1|||
28052823|NCT00428844|54710302|FG002|Completed Study Drug Treatment|Protocol Violation|1|||
28052824|NCT00428844|54710300|FG000|Completed Study Drug Treatment|Withdrawal by Subject|0|||
28052825|NCT00428844|54710301|FG001|Completed Study Drug Treatment|Withdrawal by Subject|1|||
28052826|NCT00428844|54710302|FG002|Completed Study Drug Treatment|Withdrawal by Subject|1|||
28052827|NCT00428844|54710300|FG000|Completed Study Drug Treatment|Randomized Not Treated|0|||
28052828|NCT00428844|54710301|FG001|Completed Study Drug Treatment|Randomized Not Treated|0|||
28052829|NCT00428844|54710302|FG002|Completed Study Drug Treatment|Randomized Not Treated|1|||
28052830|NCT00428844|54710300|FG000|Completed Test of Cure (TOC) Visit|Adverse Event|0|||
28052831|NCT00428844|54710301|FG001|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
28052832|NCT00428844|54710302|FG002|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
28052833|NCT00428844|54710300|FG000|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
28052834|NCT00428844|54710301|FG001|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
28052835|NCT00428844|54710302|FG002|Completed Test of Cure (TOC) Visit|Protocol Violation|1|||
28052836|NCT00428844|54710300|FG000|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1|||
28052837|NCT00428844|54710301|FG001|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
28052838|NCT00428844|54710302|FG002|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
27812629|NCT01567527|54268905|FG001|Conversion Phase.|Lack of Efficacy|0|||
28052839|NCT00428844|54710300|FG000|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2|||
28052840|NCT00428844|54710301|FG001|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
28052841|NCT00428844|54710302|FG002|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
28052842|NCT00428844|54710300|FG000|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
28052843|NCT00428844|54710301|FG001|Completed Test of Cure (TOC) Visit|Microbiologic failure|1|||
27812630|NCT01567527|54268906|FG002|Conversion Phase.|Lack of Efficacy|0|||
27812631|NCT01567527|54268907|FG003|Conversion Phase.|Lack of Efficacy|0|||
27812632|NCT01567527|54268908|FG004|Conversion Phase.|Lack of Efficacy|0|||
28052844|NCT00428844|54710302|FG002|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
28052845|NCT00457418|54710310|FG000|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2|||
28052846|NCT00457418|54710310|FG000|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1|||
28052847|NCT00457418|54710310|FG000|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2|||
28052848|NCT00457418|54710310|FG000|Post PK Maintenance|Adverse Event|10|||
28052849|NCT00457418|54710310|FG000|Post PK Maintenance|Progression of Disease|6|||
28052850|NCT00457418|54710310|FG000|Post PK Maintenance|Withdrawal by Subject|11|||
28052851|NCT00457418|54710310|FG000|Post PK Maintenance|Lost to Follow-up|1|||
28052852|NCT00449072|54710316|FG000|Overall Study|Adverse Event|3|||
28052853|NCT00449072|54710317|FG001|Overall Study|Adverse Event|1|||
28052854|NCT00449072|54710316|FG000|Overall Study|Protocol Violation|14|||
28052855|NCT00449072|54710317|FG001|Overall Study|Protocol Violation|12|||
28052856|NCT00449072|54710316|FG000|Overall Study|Lost to Follow-up|5|||
27812633|NCT01567527|54268904|FG000|Conversion Phase.|Adverse Event|33|||
27812634|NCT01567527|54268905|FG001|Conversion Phase.|Adverse Event|0|||
27812635|NCT01567527|54268906|FG002|Conversion Phase.|Adverse Event|0|||
27812636|NCT01567527|54268907|FG003|Conversion Phase.|Adverse Event|0|||
27812637|NCT01567527|54268908|FG004|Conversion Phase.|Adverse Event|0|||
27812638|NCT01567527|54268904|FG000|Conversion Phase.|Withdrawn by the investigator|3|||
27812639|NCT01567527|54268905|FG001|Conversion Phase.|Withdrawn by the investigator|0|||
27812640|NCT01567527|54268906|FG002|Conversion Phase.|Withdrawn by the investigator|0|||
27812641|NCT01567527|54268907|FG003|Conversion Phase.|Withdrawn by the investigator|0|||
27812642|NCT01567527|54268908|FG004|Conversion Phase.|Withdrawn by the investigator|0|||
27812643|NCT01567527|54268904|FG000|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
27812644|NCT01567527|54268905|FG001|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41|||
27812645|NCT01567527|54268906|FG002|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
27812646|NCT01567527|54268907|FG003|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
27812647|NCT01567527|54268908|FG004|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
27812648|NCT01567527|54268904|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
27812649|NCT01567527|54268905|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45|||
28052857|NCT00449072|54710317|FG001|Overall Study|Lost to Follow-up|7|||
28052858|NCT00449072|54710316|FG000|Overall Study|Withdrawal by Subject|11|||
28052859|NCT00449072|54710317|FG001|Overall Study|Withdrawal by Subject|8|||
28052860|NCT00449072|54710316|FG000|Overall Study|Lack of Efficacy|1|||
28052861|NCT00449072|54710317|FG001|Overall Study|Lack of Efficacy|1|||
28052862|NCT00449072|54710316|FG000|Overall Study|Physician Decision|1|||
28052863|NCT00449072|54710317|FG001|Overall Study|Physician Decision|0|||
28052864|NCT00449072|54710316|FG000|Overall Study|Not treated|0|||
28052865|NCT00449072|54710317|FG001|Overall Study|Not treated|1|||
28052866|NCT00449072|54710316|FG000|Overall Study|Excluded medication|0|||
28052867|NCT00449072|54710317|FG001|Overall Study|Excluded medication|2|||
28052868|NCT00449072|54710316|FG000|Overall Study|Non-compliance|2|||
28052869|NCT00449072|54710317|FG001|Overall Study|Non-compliance|5|||
28052870|NCT00449072|54710316|FG000|Overall Study|Sponsor decision|1|||
28052871|NCT00449072|54710317|FG001|Overall Study|Sponsor decision|3|||
28052872|NCT00449072|54710316|FG000|Overall Study|Relocation|3|||
28052873|NCT00449072|54710317|FG001|Overall Study|Relocation|2|||
27812650|NCT01567527|54268906|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
28052874|NCT00428610|54710326|FG000|Overall Study|Death Due to Adverse Event|3|||
28052875|NCT00428610|54710327|FG001|Overall Study|Death Due to Adverse Event|0|||
28052876|NCT00428610|54710328|FG002|Overall Study|Death Due to Adverse Event|5|||
28052877|NCT00428610|54710326|FG000|Overall Study|Death Due to Progressive Disease|0|||
28052878|NCT00428610|54710327|FG001|Overall Study|Death Due to Progressive Disease|0|||
28052879|NCT00428610|54710328|FG002|Overall Study|Death Due to Progressive Disease|2|||
28052880|NCT00428610|54710326|FG000|Overall Study|Adverse Event|2|||
28052881|NCT00428610|54710327|FG001|Overall Study|Adverse Event|3|||
28052882|NCT00428610|54710328|FG002|Overall Study|Adverse Event|2|||
28052883|NCT00428610|54710326|FG000|Overall Study|Investigator Decision|2|||
28052884|NCT00428610|54710327|FG001|Overall Study|Investigator Decision|1|||
27812651|NCT01567527|54268907|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
27812652|NCT01567527|54268908|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
27812653|NCT01567527|54268904|FG000|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
27812654|NCT01567527|54268905|FG001|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44|||
27812655|NCT01567527|54268906|FG002|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
27812656|NCT01567527|54268907|FG003|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
28052885|NCT00428610|54710328|FG002|Overall Study|Investigator Decision|1|||
28052886|NCT00428610|54710326|FG000|Overall Study|Progressive Disease|42|||
28052887|NCT00428610|54710327|FG001|Overall Study|Progressive Disease|14|||
28052888|NCT00428610|54710328|FG002|Overall Study|Progressive Disease|22|||
28052889|NCT00428610|54710326|FG000|Overall Study|Withdrawal by Subject|4|||
28052890|NCT00428610|54710327|FG001|Overall Study|Withdrawal by Subject|0|||
28052891|NCT00428610|54710328|FG002|Overall Study|Withdrawal by Subject|0|||
28052892|NCT00419094|54710338|FG000|Overall Study|Adverse Event|3|||
28052893|NCT00419094|54710339|FG001|Overall Study|Adverse Event|7|||
27812657|NCT01567527|54268908|FG004|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
27812658|NCT01567527|54268904|FG000|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
27812659|NCT01567527|54268905|FG001|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12|||
27812660|NCT01567527|54268906|FG002|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
27812661|NCT01567527|54268907|FG003|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
27812662|NCT01567527|54268908|FG004|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
27812663|NCT01567527|54268904|FG000|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
27812664|NCT01567527|54268905|FG001|Oral Aripiprazole Stabilization Phase.|Adverse Event|63|||
27812665|NCT01567527|54268906|FG002|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
27812666|NCT01567527|54268907|FG003|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
27812667|NCT01567527|54268908|FG004|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
27812668|NCT01567527|54268904|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
27812669|NCT01567527|54268905|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2|||
27812670|NCT01567527|54268906|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
27812671|NCT01567527|54268907|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
27812672|NCT01567527|54268908|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
27812673|NCT01567527|54268904|FG000|IM Depot Stabilization.|Protocol deviation|0|||
27812674|NCT01567527|54268905|FG001|IM Depot Stabilization.|Protocol deviation|0|||
27812675|NCT01567527|54268906|FG002|IM Depot Stabilization.|Protocol deviation|5|||
27812676|NCT01567527|54268907|FG003|IM Depot Stabilization.|Protocol deviation|0|||
27812677|NCT01567527|54268908|FG004|IM Depot Stabilization.|Protocol deviation|0|||
27812678|NCT01567527|54268904|FG000|IM Depot Stabilization.|Met withdrawal criteria|0|||
27812679|NCT01567527|54268905|FG001|IM Depot Stabilization.|Met withdrawal criteria|0|||
27812680|NCT01567527|54268906|FG002|IM Depot Stabilization.|Met withdrawal criteria|26|||
27812681|NCT01567527|54268907|FG003|IM Depot Stabilization.|Met withdrawal criteria|0|||
27812682|NCT01567527|54268908|FG004|IM Depot Stabilization.|Met withdrawal criteria|0|||
27812683|NCT01567527|54268904|FG000|IM Depot Stabilization.|Withdrawal by Subject|0|||
27812684|NCT01567527|54268905|FG001|IM Depot Stabilization.|Withdrawal by Subject|0|||
27812685|NCT01567527|54268906|FG002|IM Depot Stabilization.|Withdrawal by Subject|56|||
27812686|NCT01567527|54268907|FG003|IM Depot Stabilization.|Withdrawal by Subject|0|||
27812687|NCT01567527|54268908|FG004|IM Depot Stabilization.|Withdrawal by Subject|0|||
27812688|NCT01567527|54268904|FG000|IM Depot Stabilization.|Sponsor discontinued study|0|||
27812689|NCT01567527|54268905|FG001|IM Depot Stabilization.|Sponsor discontinued study|0|||
27812690|NCT01567527|54268906|FG002|IM Depot Stabilization.|Sponsor discontinued study|1|||
27812691|NCT01567527|54268907|FG003|IM Depot Stabilization.|Sponsor discontinued study|0|||
27812692|NCT01567527|54268908|FG004|IM Depot Stabilization.|Sponsor discontinued study|0|||
27812693|NCT01567527|54268904|FG000|IM Depot Stabilization.|Lost to Follow-up|0|||
27812694|NCT01567527|54268905|FG001|IM Depot Stabilization.|Lost to Follow-up|0|||
27812695|NCT01567527|54268906|FG002|IM Depot Stabilization.|Lost to Follow-up|21|||
27812696|NCT01567527|54268907|FG003|IM Depot Stabilization.|Lost to Follow-up|0|||
27812697|NCT01567527|54268908|FG004|IM Depot Stabilization.|Lost to Follow-up|0|||
27812698|NCT01567527|54268904|FG000|IM Depot Stabilization.|Lack of Efficacy|0|||
27812699|NCT01567527|54268905|FG001|IM Depot Stabilization.|Lack of Efficacy|0|||
27812700|NCT01567527|54268906|FG002|IM Depot Stabilization.|Lack of Efficacy|7|||
27812701|NCT01567527|54268907|FG003|IM Depot Stabilization.|Lack of Efficacy|0|||
28052894|NCT00419094|54710338|FG000|Overall Study|Lack of Efficacy|1|||
28052895|NCT00419094|54710339|FG001|Overall Study|Lack of Efficacy|0|||
28052896|NCT00419094|54710338|FG000|Overall Study|Lost to Follow-up|0|||
28052897|NCT00419094|54710339|FG001|Overall Study|Lost to Follow-up|2|||
28052898|NCT00419094|54710338|FG000|Overall Study|Protocol Violation|1|||
28052899|NCT00419094|54710339|FG001|Overall Study|Protocol Violation|14|||
28052900|NCT00419094|54710338|FG000|Overall Study|Withdrawal of consent|1|||
28052901|NCT00419094|54710339|FG001|Overall Study|Withdrawal of consent|5|||
27812702|NCT01567527|54268908|FG004|IM Depot Stabilization.|Lack of Efficacy|0|||
28052902|NCT00419094|54710338|FG000|Overall Study|Other: Error determining exit criteria|1|||
28052903|NCT00419094|54710339|FG001|Overall Study|Other: Error determining exit criteria|0|||
28052904|NCT00419094|54710338|FG000|Overall Study|Other: Patient non-compliant|0|||
28052905|NCT00419094|54710339|FG001|Overall Study|Other: Patient non-compliant|1|||
28052906|NCT00419094|54710338|FG000|Overall Study|Other: No contact for extended period|0|||
28052907|NCT00419094|54710339|FG001|Overall Study|Other: No contact for extended period|1|||
28052908|NCT00448916|54710349|FG000|Overall Study|Adverse Event|2|||
28052909|NCT00448916|54710350|FG001|Overall Study|Adverse Event|2|||
28052910|NCT00448916|54710351|FG002|Overall Study|Adverse Event|3|||
28052911|NCT00448916|54710352|FG003|Overall Study|Adverse Event|2|||
28052912|NCT00448916|54710349|FG000|Overall Study|Lack of Efficacy|1|||
28052913|NCT00448916|54710350|FG001|Overall Study|Lack of Efficacy|0|||
28052914|NCT00448916|54710351|FG002|Overall Study|Lack of Efficacy|2|||
27812703|NCT01567527|54268904|FG000|IM Depot Stabilization.|Adverse Event|0|||
28052915|NCT00448916|54710352|FG003|Overall Study|Lack of Efficacy|1|||
28052916|NCT00448916|54710349|FG000|Overall Study|Withdrawal by Subject|3|||
28052917|NCT00448916|54710350|FG001|Overall Study|Withdrawal by Subject|3|||
28052918|NCT00448916|54710351|FG002|Overall Study|Withdrawal by Subject|1|||
28052919|NCT00448916|54710352|FG003|Overall Study|Withdrawal by Subject|1|||
28052920|NCT00448916|54710349|FG000|Overall Study|Other|1|||
28052921|NCT00448916|54710350|FG001|Overall Study|Other|0|||
28052922|NCT00448916|54710351|FG002|Overall Study|Other|0|||
28052923|NCT00448916|54710352|FG003|Overall Study|Other|0|||
28052924|NCT00448916|54710349|FG000|Overall Study|Lost to Follow-up|0|||
28052925|NCT00448916|54710350|FG001|Overall Study|Lost to Follow-up|1|||
28052926|NCT00448916|54710351|FG002|Overall Study|Lost to Follow-up|0|||
28052927|NCT00448916|54710352|FG003|Overall Study|Lost to Follow-up|1|||
28052928|NCT00448916|54710349|FG000|Overall Study|Protocol Violation|0|||
28052929|NCT00448916|54710350|FG001|Overall Study|Protocol Violation|0|||
28052930|NCT00448916|54710351|FG002|Overall Study|Protocol Violation|0|||
28052931|NCT00448916|54710352|FG003|Overall Study|Protocol Violation|1|||
28052932|NCT00418938|54710366|FG000|Overall Study|Reimbursement|1|||
28052933|NCT00418938|54710367|FG001|Overall Study|Reimbursement|0|||
28052934|NCT00418938|54710366|FG000|Overall Study|Administrative decision|3|||
28052935|NCT00418938|54710367|FG001|Overall Study|Administrative decision|3|||
28052936|NCT00418938|54710366|FG000|Overall Study|Withdrawal by Subject|16|||
28052937|NCT00418938|54710367|FG001|Overall Study|Withdrawal by Subject|15|||
28052938|NCT00418938|54710366|FG000|Overall Study|Lost to Follow-up|1|||
28052939|NCT00418938|54710367|FG001|Overall Study|Lost to Follow-up|3|||
28052940|NCT00418938|54710366|FG000|Overall Study|Adverse Event|1|||
28052941|NCT00418938|54710367|FG001|Overall Study|Adverse Event|1|||
28052942|NCT00418938|54710366|FG000|Overall Study|On-going|1|||
28052943|NCT00418938|54710367|FG001|Overall Study|On-going|1|||
28052944|NCT00418938|54710366|FG000|Overall Study|Ineligibility Determined|1|||
28052945|NCT00418938|54710367|FG001|Overall Study|Ineligibility Determined|0|||
28052946|NCT00448760|54710373|FG000|Overall Study|Death|3|||
28052947|NCT00418314|54710379|FG000|Overall Study|Withdrawal by Subject|1|||
28052948|NCT00418314|54710380|FG001|Overall Study|Withdrawal by Subject|2|||
28052949|NCT00448448|54710388|FG000|Overall Study|Withdrawal by Subject|13|||
28052950|NCT00448448|54710389|FG001|Overall Study|Withdrawal by Subject|2|||
28052951|NCT00448448|54710388|FG000|Overall Study|On protocol when study ended|83|||
28052952|NCT00448448|54710389|FG001|Overall Study|On protocol when study ended|36|||
28052953|NCT00448448|54710388|FG000|Overall Study|Lost to Follow-up|2|||
28052954|NCT00448448|54710389|FG001|Overall Study|Lost to Follow-up|1|||
28052955|NCT00448448|54710388|FG000|Overall Study|Wrong diagnosis (n=3) or other|2|||
28052956|NCT00448448|54710389|FG001|Overall Study|Wrong diagnosis (n=3) or other|1|||
28052957|NCT00448448|54710388|FG000|Overall Study|Signed consent lost|0|||
28052958|NCT00448448|54710389|FG001|Overall Study|Signed consent lost|1|||
28052959|NCT00405912|54710398|FG000|Overall Study|Withdrawal by Subject|12|||
28052960|NCT00405912|54710399|FG001|Overall Study|Withdrawal by Subject|11|||
28052961|NCT00405912|54710400|FG002|Overall Study|Withdrawal by Subject|12|||
28052962|NCT00405912|54710398|FG000|Overall Study|Lost to Follow-up|4|||
28052963|NCT00405912|54710399|FG001|Overall Study|Lost to Follow-up|8|||
28052964|NCT00405912|54710400|FG002|Overall Study|Lost to Follow-up|4|||
28052965|NCT00448136|54710410|FG000|Overall Study|Death|3|||
28052966|NCT00448136|54710411|FG001|Overall Study|Death|8|||
28052967|NCT00448136|54710410|FG000|Overall Study|Investigator's decision (progression)|1|||
28052968|NCT00448136|54710411|FG001|Overall Study|Investigator's decision (progression)|0|||
27812704|NCT01567527|54268905|FG001|IM Depot Stabilization.|Adverse Event|0|||
27812705|NCT01567527|54268906|FG002|IM Depot Stabilization.|Adverse Event|37|||
27812706|NCT01567527|54268907|FG003|IM Depot Stabilization.|Adverse Event|0|||
27812707|NCT01567527|54268908|FG004|IM Depot Stabilization.|Adverse Event|0|||
27812708|NCT01567527|54268904|FG000|IM Depot Stabilization.|Withdrawn by the investigator|0|||
27812709|NCT01567527|54268905|FG001|IM Depot Stabilization.|Withdrawn by the investigator|0|||
28052969|NCT00447902|54710419|FG000|Overall Study|Adverse Event|0|||
28052970|NCT00447902|54710420|FG001|Overall Study|Adverse Event|3|||
28052971|NCT00447902|54710419|FG000|Overall Study|Protocol Violation|1|||
28052972|NCT00447902|54710420|FG001|Overall Study|Protocol Violation|0|||
28052973|NCT00447902|54710419|FG000|Overall Study|Withdrawal by Subject|0|||
28052974|NCT00447902|54710420|FG001|Overall Study|Withdrawal by Subject|1|||
28052975|NCT00447902|54710419|FG000|Overall Study|included patients who discontinued|1|||
28052976|NCT00447902|54710420|FG001|Overall Study|included patients who discontinued|1|||
28052977|NCT00447902|54710419|FG000|Overall Study|Lack of Efficacy|2|||
28052978|NCT00447902|54710420|FG001|Overall Study|Lack of Efficacy|1|||
28052979|NCT00307437|54710429|FG000|Controlled Period|Adverse Event|7|||
28052980|NCT00307437|54710430|FG001|Controlled Period|Adverse Event|2|||
28052981|NCT00307437|54710431|FG002|Controlled Period|Adverse Event|5|||
28052982|NCT00307437|54710432|FG003|Controlled Period|Adverse Event|0|||
28052983|NCT00307437|54710433|FG004|Controlled Period|Adverse Event|0|||
28052984|NCT00307437|54710434|FG005|Controlled Period|Adverse Event|0|||
28052985|NCT00307437|54710435|FG006|Controlled Period|Adverse Event|0|||
28052986|NCT00307437|54710429|FG000|Controlled Period|Death|0|||
28052987|NCT00307437|54710430|FG001|Controlled Period|Death|0|||
28052988|NCT00307437|54710431|FG002|Controlled Period|Death|1|||
28052989|NCT00307437|54710432|FG003|Controlled Period|Death|0|||
28052990|NCT00307437|54710433|FG004|Controlled Period|Death|0|||
28052991|NCT00307437|54710434|FG005|Controlled Period|Death|0|||
28052992|NCT00307437|54710435|FG006|Controlled Period|Death|0|||
28052993|NCT00307437|54710429|FG000|Controlled Period|Lack of Efficacy|2|||
28052994|NCT00307437|54710430|FG001|Controlled Period|Lack of Efficacy|0|||
28052995|NCT00307437|54710431|FG002|Controlled Period|Lack of Efficacy|0|||
28052996|NCT00307437|54710432|FG003|Controlled Period|Lack of Efficacy|0|||
28052997|NCT00307437|54710433|FG004|Controlled Period|Lack of Efficacy|0|||
28052998|NCT00307437|54710434|FG005|Controlled Period|Lack of Efficacy|0|||
28052999|NCT00307437|54710435|FG006|Controlled Period|Lack of Efficacy|0|||
28053000|NCT00307437|54710429|FG000|Controlled Period|Lost to Follow-up|2|||
28053001|NCT00307437|54710430|FG001|Controlled Period|Lost to Follow-up|3|||
28053002|NCT00307437|54710431|FG002|Controlled Period|Lost to Follow-up|0|||
28053003|NCT00307437|54710432|FG003|Controlled Period|Lost to Follow-up|0|||
28053004|NCT00307437|54710433|FG004|Controlled Period|Lost to Follow-up|0|||
28053005|NCT00307437|54710434|FG005|Controlled Period|Lost to Follow-up|0|||
28053006|NCT00307437|54710435|FG006|Controlled Period|Lost to Follow-up|0|||
28053007|NCT00307437|54710429|FG000|Controlled Period|Other|5|||
28053008|NCT00307437|54710430|FG001|Controlled Period|Other|1|||
28053009|NCT00307437|54710431|FG002|Controlled Period|Other|3|||
28053010|NCT00307437|54710432|FG003|Controlled Period|Other|0|||
28053011|NCT00307437|54710433|FG004|Controlled Period|Other|0|||
28053012|NCT00307437|54710434|FG005|Controlled Period|Other|0|||
28053013|NCT00307437|54710435|FG006|Controlled Period|Other|0|||
28053014|NCT00307437|54710429|FG000|After Controlled Period|Adverse Event|0|||
28053015|NCT00307437|54710430|FG001|After Controlled Period|Adverse Event|0|||
28053016|NCT00307437|54710431|FG002|After Controlled Period|Adverse Event|0|||
28053017|NCT00307437|54710432|FG003|After Controlled Period|Adverse Event|18|||
28053018|NCT00307437|54710433|FG004|After Controlled Period|Adverse Event|16|||
28053019|NCT00307437|54710434|FG005|After Controlled Period|Adverse Event|31|||
28053020|NCT00307437|54710435|FG006|After Controlled Period|Adverse Event|40|||
28053021|NCT00307437|54710429|FG000|After Controlled Period|Death|0|||
28053022|NCT00307437|54710430|FG001|After Controlled Period|Death|0|||
28053023|NCT00307437|54710431|FG002|After Controlled Period|Death|0|||
28053024|NCT00307437|54710432|FG003|After Controlled Period|Death|3|||
28053025|NCT00307437|54710433|FG004|After Controlled Period|Death|1|||
28053026|NCT00307437|54710434|FG005|After Controlled Period|Death|1|||
28053027|NCT00307437|54710435|FG006|After Controlled Period|Death|3|||
28053028|NCT00307437|54710429|FG000|After Controlled Period|Lack of Efficacy|0|||
28053029|NCT00307437|54710430|FG001|After Controlled Period|Lack of Efficacy|0|||
28053030|NCT00307437|54710431|FG002|After Controlled Period|Lack of Efficacy|0|||
28053031|NCT00307437|54710432|FG003|After Controlled Period|Lack of Efficacy|15|||
28053032|NCT00307437|54710433|FG004|After Controlled Period|Lack of Efficacy|17|||
28053033|NCT00307437|54710434|FG005|After Controlled Period|Lack of Efficacy|37|||
28053034|NCT00307437|54710435|FG006|After Controlled Period|Lack of Efficacy|24|||
28053035|NCT00307437|54710429|FG000|After Controlled Period|Lost to Follow-up|0|||
28053036|NCT00307437|54710430|FG001|After Controlled Period|Lost to Follow-up|0|||
28053037|NCT00307437|54710431|FG002|After Controlled Period|Lost to Follow-up|0|||
28053038|NCT00307437|54710432|FG003|After Controlled Period|Lost to Follow-up|7|||
28053039|NCT00307437|54710433|FG004|After Controlled Period|Lost to Follow-up|12|||
28053040|NCT00307437|54710434|FG005|After Controlled Period|Lost to Follow-up|13|||
28053041|NCT00307437|54710435|FG006|After Controlled Period|Lost to Follow-up|18|||
28053042|NCT00307437|54710429|FG000|After Controlled Period|Other|0|||
28053043|NCT00307437|54710430|FG001|After Controlled Period|Other|0|||
28053044|NCT00307437|54710431|FG002|After Controlled Period|Other|0|||
28053045|NCT00307437|54710432|FG003|After Controlled Period|Other|15|||
28053046|NCT00307437|54710433|FG004|After Controlled Period|Other|9|||
28053047|NCT00307437|54710434|FG005|After Controlled Period|Other|40|||
28053048|NCT00307437|54710435|FG006|After Controlled Period|Other|28|||
28053049|NCT00440726|54710460|FG000|Phase 1|Dose-Limiting Toxicity|0|||
27812710|NCT01567527|54268906|FG002|IM Depot Stabilization.|Withdrawn by the investigator|6|||
27812711|NCT01567527|54268907|FG003|IM Depot Stabilization.|Withdrawn by the investigator|0|||
27812712|NCT01567527|54268908|FG004|IM Depot Stabilization.|Withdrawn by the investigator|0|||
27812713|NCT01567527|54268904|FG000|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
27812714|NCT01567527|54268905|FG001|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
27812715|NCT01567527|54268906|FG002|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
27812716|NCT01567527|54268907|FG003|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
27812717|NCT01567527|54268908|FG004|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
27812718|NCT01567527|54268904|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
27812719|NCT01567527|54268905|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
27812720|NCT01567527|54268906|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
27812721|NCT01567527|54268907|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16|||
27812722|NCT01567527|54268908|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33|||
27812723|NCT01567527|54268904|FG000|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
28053050|NCT00440726|54710461|FG001|Phase 1|Dose-Limiting Toxicity|1|||
28053051|NCT00440726|54710462|FG002|Phase 1|Dose-Limiting Toxicity|0|||
28053052|NCT00440726|54710460|FG000|Phase 1|Physician Decision|1|||
28053053|NCT00440726|54710461|FG001|Phase 1|Physician Decision|0|||
28053054|NCT00440726|54710462|FG002|Phase 1|Physician Decision|0|||
28053055|NCT00440726|54710460|FG000|Phase 2|Death|0|||
28053056|NCT00440726|54710461|FG001|Phase 2|Death|0|||
28053057|NCT00440726|54710462|FG002|Phase 2|Death|1|||
28053058|NCT00440726|54710460|FG000|Phase 2|Adverse Event|0|||
28053059|NCT00440726|54710461|FG001|Phase 2|Adverse Event|0|||
28053060|NCT00440726|54710462|FG002|Phase 2|Adverse Event|1|||
28053061|NCT00447590|54710473|FG000|Overall Study|Withdrawal by Subject|26|||
28053062|NCT00447590|54710473|FG000|Overall Study|Lost to Follow-up|24|||
28053063|NCT00447590|54710473|FG000|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10|||
28053064|NCT00447278|54710479|FG000|Period II (6 Month Open-Label)|Adverse Event|7|||
28053065|NCT00447278|54710480|FG001|Period II (6 Month Open-Label)|Adverse Event|3|||
28053066|NCT00447278|54710479|FG000|Period II (6 Month Open-Label)|Lost to Follow-up|0|||
28053067|NCT00447278|54710480|FG001|Period II (6 Month Open-Label)|Lost to Follow-up|4|||
28053068|NCT00447278|54710479|FG000|Period II (6 Month Open-Label)|Protocol Violation|10|||
28053069|NCT00447278|54710480|FG001|Period II (6 Month Open-Label)|Protocol Violation|7|||
28053070|NCT00447278|54710479|FG000|Period II (6 Month Open-Label)|Withdrawal by Subject|1|||
28053071|NCT00447278|54710480|FG001|Period II (6 Month Open-Label)|Withdrawal by Subject|3|||
28053072|NCT00447278|54710479|FG000|Period II (6 Month Open-Label)|Physician Decision|4|||
28053073|NCT00447278|54710480|FG001|Period II (6 Month Open-Label)|Physician Decision|1|||
28053074|NCT00447278|54710479|FG000|Period II (6 Month Open-Label)|Lack of Efficacy|11|||
28053075|NCT00447278|54710480|FG001|Period II (6 Month Open-Label)|Lack of Efficacy|1|||
28053076|NCT00447278|54710479|FG000|Period II (6 Month Open-Label)|Parent/Guardian Decision|9|||
28053077|NCT00447278|54710480|FG001|Period II (6 Month Open-Label)|Parent/Guardian Decision|10|||
28053078|NCT00447278|54710479|FG000|Period III (Optional 6 Month Extension)|Adverse Event|2|||
28053079|NCT00447278|54710480|FG001|Period III (Optional 6 Month Extension)|Adverse Event|2|||
28053080|NCT00447278|54710479|FG000|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
28053081|NCT00447278|54710480|FG001|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
28053082|NCT00447278|54710479|FG000|Period III (Optional 6 Month Extension)|Protocol Violation|6|||
28053083|NCT00447278|54710480|FG001|Period III (Optional 6 Month Extension)|Protocol Violation|1|||
28053084|NCT00447278|54710479|FG000|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4|||
28053085|NCT00447278|54710480|FG001|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1|||
28053086|NCT00447278|54710479|FG000|Period III (Optional 6 Month Extension)|Physician Decision|1|||
28053087|NCT00447278|54710480|FG001|Period III (Optional 6 Month Extension)|Physician Decision|1|||
28053088|NCT00447278|54710479|FG000|Period III (Optional 6 Month Extension)|Lack of Efficacy|4|||
28053089|NCT00447278|54710480|FG001|Period III (Optional 6 Month Extension)|Lack of Efficacy|0|||
28053090|NCT00447278|54710479|FG000|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11|||
28053091|NCT00447278|54710480|FG001|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8|||
28053092|NCT00446966|54710489|FG000|Overall Study|Lost to Follow-up|10|||
28053093|NCT00446966|54710490|FG001|Overall Study|Lost to Follow-up|7|||
28053094|NCT00446654|54710498|FG000|Overall Study|Withdrawal by Subject|1|||
28053095|NCT00446654|54710499|FG001|Overall Study|Withdrawal by Subject|0|||
28053096|NCT00446654|54710498|FG000|Overall Study|Adverse Event|1|||
28053097|NCT00446654|54710499|FG001|Overall Study|Adverse Event|0|||
28053098|NCT00405756|54710508|FG000|Double-blind Treatment|Ongoing in Double-blind Treatment|45|||
28053099|NCT00405756|54710509|FG001|Double-blind Treatment|Ongoing in Double-blind Treatment|24|||
28053100|NCT00405756|54710510|FG002|Double-blind Treatment|Ongoing in Double-blind Treatment|18|||
28053101|NCT00405756|54710508|FG000|Double-blind Treatment|Adverse Event|31|||
28053102|NCT00405756|54710509|FG001|Double-blind Treatment|Adverse Event|27|||
28053103|NCT00405756|54710510|FG002|Double-blind Treatment|Adverse Event|12|||
28053104|NCT00405756|54710508|FG000|Double-blind Treatment|Disease Progression|47|||
28053105|NCT00405756|54710509|FG001|Double-blind Treatment|Disease Progression|81|||
28053106|NCT00405756|54710510|FG002|Double-blind Treatment|Disease Progression|102|||
28053107|NCT00405756|54710508|FG000|Double-blind Treatment|Lack of Efficacy|1|||
28053108|NCT00405756|54710509|FG001|Double-blind Treatment|Lack of Efficacy|4|||
28053109|NCT00405756|54710510|FG002|Double-blind Treatment|Lack of Efficacy|2|||
28053110|NCT00405756|54710508|FG000|Double-blind Treatment|Withdrawal by Subject|15|||
28053111|NCT00405756|54710509|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
28053112|NCT00405756|54710510|FG002|Double-blind Treatment|Withdrawal by Subject|10|||
28053113|NCT00405756|54710508|FG000|Double-blind Treatment|Lost to Follow-up|1|||
28053114|NCT00405756|54710509|FG001|Double-blind Treatment|Lost to Follow-up|0|||
28053115|NCT00405756|54710510|FG002|Double-blind Treatment|Lost to Follow-up|0|||
28053116|NCT00405756|54710508|FG000|Double-blind Treatment|Death|4|||
28053117|NCT00405756|54710509|FG001|Double-blind Treatment|Death|4|||
28053118|NCT00405756|54710510|FG002|Double-blind Treatment|Death|4|||
28053119|NCT00405756|54710508|FG000|Double-blind Treatment|Protocol Violation|1|||
28053120|NCT00405756|54710509|FG001|Double-blind Treatment|Protocol Violation|0|||
28053121|NCT00405756|54710510|FG002|Double-blind Treatment|Protocol Violation|2|||
28053122|NCT00405756|54710508|FG000|Double-blind Treatment|Other|7|||
28053123|NCT00405756|54710509|FG001|Double-blind Treatment|Other|4|||
28053124|NCT00405756|54710510|FG002|Double-blind Treatment|Other|4|||
28053125|NCT00405756|54710508|FG000|Open-label Extension|Ongoing in Open Label Period|7|||
28053126|NCT00405756|54710509|FG001|Open-label Extension|Ongoing in Open Label Period|15|||
28053127|NCT00405756|54710510|FG002|Open-label Extension|Ongoing in Open Label Period|25|||
28053128|NCT00405756|54710508|FG000|Open-label Extension|Adverse Event|1|||
28053129|NCT00405756|54710509|FG001|Open-label Extension|Adverse Event|3|||
28053130|NCT00405756|54710510|FG002|Open-label Extension|Adverse Event|7|||
28053131|NCT00405756|54710508|FG000|Open-label Extension|Disease Progression|8|||
28053132|NCT00405756|54710509|FG001|Open-label Extension|Disease Progression|23|||
28053133|NCT00405756|54710510|FG002|Open-label Extension|Disease Progression|26|||
28053134|NCT00405756|54710508|FG000|Open-label Extension|Withdrawal by Subject|2|||
28053135|NCT00405756|54710509|FG001|Open-label Extension|Withdrawal by Subject|3|||
28053136|NCT00405756|54710510|FG002|Open-label Extension|Withdrawal by Subject|3|||
28053137|NCT00405756|54710508|FG000|Open-label Extension|Death|1|||
28053138|NCT00405756|54710509|FG001|Open-label Extension|Death|2|||
28053139|NCT00405756|54710510|FG002|Open-label Extension|Death|4|||
28053140|NCT00405756|54710508|FG000|Open-label Extension|Other|0|||
28053141|NCT00405756|54710509|FG001|Open-label Extension|Other|1|||
28053142|NCT00405756|54710510|FG002|Open-label Extension|Other|7|||
28053143|NCT00405756|54710508|FG000|Follow-up|Ongoing in Follow-up Period|52|||
28053144|NCT00405756|54710509|FG001|Follow-up|Ongoing in Follow-up Period|51|||
28053145|NCT00405756|54710510|FG002|Follow-up|Ongoing in Follow-up Period|60|||
28053146|NCT00405756|54710508|FG000|Follow-up|Death|21|||
28053147|NCT00405756|54710509|FG001|Follow-up|Death|31|||
28053148|NCT00405756|54710510|FG002|Follow-up|Death|24|||
28053149|NCT00405756|54710508|FG000|Follow-up|Lost to Follow-up|2|||
28053150|NCT00405756|54710509|FG001|Follow-up|Lost to Follow-up|8|||
28053151|NCT00405756|54710510|FG002|Follow-up|Lost to Follow-up|4|||
28053152|NCT00456092|54710521|FG000|Extension Phase|Grade 2 or Greater AE|2|||
28053153|NCT00456092|54710522|FG001|Extension Phase|Grade 2 or Greater AE|2|||
28053154|NCT00456092|54710523|FG002|Extension Phase|Grade 2 or Greater AE|0|||
28053155|NCT00456092|54710524|FG003|Extension Phase|Grade 2 or Greater AE|0|||
28053156|NCT00456092|54710525|FG004|Extension Phase|Grade 2 or Greater AE|2|||
28053157|NCT00456092|54710521|FG000|Extension Phase|Flare of Psoriatic Arthritis|1|||
28053158|NCT00456092|54710522|FG001|Extension Phase|Flare of Psoriatic Arthritis|0|||
28053159|NCT00456092|54710523|FG002|Extension Phase|Flare of Psoriatic Arthritis|0|||
28053160|NCT00456092|54710524|FG003|Extension Phase|Flare of Psoriatic Arthritis|0|||
28053161|NCT00456092|54710525|FG004|Extension Phase|Flare of Psoriatic Arthritis|1|||
28053162|NCT00456092|54710521|FG000|Extension Phase|Worsening / Not Responding to Study Drug|3|||
28053163|NCT00456092|54710522|FG001|Extension Phase|Worsening / Not Responding to Study Drug|1|||
28053164|NCT00456092|54710523|FG002|Extension Phase|Worsening / Not Responding to Study Drug|0|||
28053165|NCT00456092|54710524|FG003|Extension Phase|Worsening / Not Responding to Study Drug|0|||
28053166|NCT00456092|54710525|FG004|Extension Phase|Worsening / Not Responding to Study Drug|2|||
28053167|NCT00456092|54710521|FG000|Extension Phase|Withdrew Consent|2|||
28053168|NCT00456092|54710522|FG001|Extension Phase|Withdrew Consent|0|||
28053169|NCT00456092|54710523|FG002|Extension Phase|Withdrew Consent|0|||
28053170|NCT00456092|54710524|FG003|Extension Phase|Withdrew Consent|0|||
28053171|NCT00456092|54710525|FG004|Extension Phase|Withdrew Consent|0|||
28053172|NCT00456092|54710521|FG000|Extension Phase|Lost to Follow-up|1|||
28053173|NCT00456092|54710522|FG001|Extension Phase|Lost to Follow-up|1|||
28053174|NCT00456092|54710523|FG002|Extension Phase|Lost to Follow-up|0|||
28053175|NCT00456092|54710524|FG003|Extension Phase|Lost to Follow-up|0|||
28053176|NCT00456092|54710525|FG004|Extension Phase|Lost to Follow-up|1|||
28053177|NCT00456092|54710521|FG000|Extension Phase|Other|2|||
28053178|NCT00456092|54710522|FG001|Extension Phase|Other|0|||
28053179|NCT00456092|54710523|FG002|Extension Phase|Other|0|||
28053180|NCT00456092|54710524|FG003|Extension Phase|Other|1|||
28053181|NCT00456092|54710525|FG004|Extension Phase|Other|1|||
28053182|NCT00456092|54710521|FG000|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3|||
28053183|NCT00456092|54710522|FG001|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4|||
28053184|NCT00456092|54710523|FG002|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2|||
28053185|NCT00456092|54710524|FG003|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
28053186|NCT00456092|54710525|FG004|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
28053187|NCT00456092|54710521|FG000|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1|||
28053188|NCT00456092|54710522|FG001|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2|||
28053189|NCT00456092|54710523|FG002|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
27812724|NCT01567527|54268905|FG001|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
27812725|NCT01567527|54268906|FG002|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
27939941|NCT00943852|54596277|FG000|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
28053190|NCT00456092|54710524|FG003|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
28053191|NCT00456092|54710525|FG004|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
28053192|NCT00456092|54710521|FG000|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2|||
28053193|NCT00456092|54710522|FG001|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
28053194|NCT00456092|54710523|FG002|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
28053195|NCT00456092|54710524|FG003|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
28053196|NCT00456092|54710525|FG004|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
28053197|NCT00456092|54710521|FG000|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
28053198|NCT00456092|54710522|FG001|Treatment Phase (12 Weeks)|Flare of Psoriasis|1|||
28053199|NCT00456092|54710523|FG002|Treatment Phase (12 Weeks)|Flare of Psoriasis|2|||
28053200|NCT00456092|54710524|FG003|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
28053201|NCT00456092|54710525|FG004|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
28053202|NCT00456092|54710521|FG000|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
28053203|NCT00456092|54710522|FG001|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
28053204|NCT00456092|54710523|FG002|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
28053205|NCT00456092|54710524|FG003|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
28053206|NCT00456092|54710525|FG004|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
28053207|NCT00456092|54710521|FG000|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
28053208|NCT00456092|54710522|FG001|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2|||
28053209|NCT00456092|54710523|FG002|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7|||
28053210|NCT00456092|54710524|FG003|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
28053211|NCT00456092|54710525|FG004|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
28053212|NCT00456092|54710521|FG000|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
28053213|NCT00456092|54710522|FG001|Treatment Phase (12 Weeks)|Withdrew Consent|1|||
28053214|NCT00456092|54710523|FG002|Treatment Phase (12 Weeks)|Withdrew Consent|2|||
28053215|NCT00456092|54710524|FG003|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
28053216|NCT00456092|54710525|FG004|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
28053217|NCT00456092|54710521|FG000|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
28053218|NCT00456092|54710522|FG001|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
28053219|NCT00456092|54710523|FG002|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
27812726|NCT01567527|54268907|FG003|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4|||
27812727|NCT01567527|54268908|FG004|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7|||
27812728|NCT01567527|54268904|FG000|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
27812729|NCT01567527|54268905|FG001|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
27812730|NCT01567527|54268906|FG002|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
27812731|NCT01567527|54268907|FG003|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7|||
27812732|NCT01567527|54268908|FG004|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1|||
27812733|NCT01567527|54268904|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
27812734|NCT01567527|54268905|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
27812735|NCT01567527|54268906|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
27812736|NCT01567527|54268907|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13|||
27812737|NCT01567527|54268908|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10|||
27812738|NCT01567527|54268904|FG000|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
27812739|NCT01567527|54268905|FG001|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
28053220|NCT00456092|54710524|FG003|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
27812740|NCT01567527|54268906|FG002|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
27812741|NCT01567527|54268907|FG003|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1|||
27812742|NCT01567527|54268908|FG004|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3|||
27812743|NCT01567527|54268904|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
28053221|NCT00456092|54710525|FG004|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
28053222|NCT00456092|54710521|FG000|Treatment Phase (12 Weeks)|Other|1|||
28053223|NCT00456092|54710522|FG001|Treatment Phase (12 Weeks)|Other|0|||
28053224|NCT00456092|54710523|FG002|Treatment Phase (12 Weeks)|Other|1|||
28053225|NCT00456092|54710524|FG003|Treatment Phase (12 Weeks)|Other|0|||
28053226|NCT00456092|54710525|FG004|Treatment Phase (12 Weeks)|Other|0|||
28053227|NCT00411450|54710539|FG000|Overall Study|Ongoing at time of data cut-off.|3|||
28053228|NCT00404820|54710547|FG000|Overall Study|Adverse Event|4|||
28053229|NCT00404820|54710548|FG001|Overall Study|Adverse Event|16|||
28053230|NCT00404820|54710547|FG000|Overall Study|Withdrawal by Subject|5|||
28053231|NCT00404820|54710548|FG001|Overall Study|Withdrawal by Subject|3|||
28053232|NCT00404820|54710547|FG000|Overall Study|Lost to Follow-up|7|||
28053233|NCT00404820|54710548|FG001|Overall Study|Lost to Follow-up|3|||
28053234|NCT00404820|54710547|FG000|Overall Study|Administrative problems|2|||
28053235|NCT00404820|54710548|FG001|Overall Study|Administrative problems|0|||
28053236|NCT00404820|54710547|FG000|Overall Study|Death|1|||
28053237|NCT00404820|54710548|FG001|Overall Study|Death|0|||
28053238|NCT00404820|54710547|FG000|Overall Study|Other|0|||
28053239|NCT00404820|54710548|FG001|Overall Study|Other|2|||
28053240|NCT00417612|54710556|FG000|Overall Study|Errant diagnosis|0|||
28053241|NCT00417612|54710557|FG001|Overall Study|Errant diagnosis|1|||
28053242|NCT00417612|54710556|FG000|Overall Study|Adverse Event|2|||
28053243|NCT00417612|54710557|FG001|Overall Study|Adverse Event|0|||
28053244|NCT00417612|54710556|FG000|Overall Study|Protocol Violation|0|||
28053245|NCT00417612|54710557|FG001|Overall Study|Protocol Violation|2|||
28053246|NCT00417612|54710556|FG000|Overall Study|Lost to Follow-up|1|||
28053247|NCT00417612|54710557|FG001|Overall Study|Lost to Follow-up|0|||
28053248|NCT00446030|54710567|FG000|TREATMENT (up to 52 Weeks)|Adverse Event|29|||
28053249|NCT00446030|54710568|FG001|TREATMENT (up to 52 Weeks)|Adverse Event|8|||
28053250|NCT00446030|54710567|FG000|TREATMENT (up to 52 Weeks)|Subject Request|9|||
28053251|NCT00446030|54710568|FG001|TREATMENT (up to 52 Weeks)|Subject Request|1|||
28053252|NCT00446030|54710567|FG000|TREATMENT (up to 52 Weeks)|Poor compliance|1|||
28053253|NCT00446030|54710568|FG001|TREATMENT (up to 52 Weeks)|Poor compliance|0|||
28053254|NCT00446030|54710567|FG000|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1|||
28053255|NCT00446030|54710568|FG001|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0|||
28053256|NCT00446030|54710567|FG000|TREATMENT (up to 52 Weeks)|Protocol Violation|1|||
28053257|NCT00446030|54710568|FG001|TREATMENT (up to 52 Weeks)|Protocol Violation|0|||
28053258|NCT00446030|54710567|FG000|TREATMENT (up to 52 Weeks)|Physician Decision|1|||
28053259|NCT00446030|54710568|FG001|TREATMENT (up to 52 Weeks)|Physician Decision|0|||
28053260|NCT00446030|54710567|FG000|TREATMENT (up to 52 Weeks)|Patient concern|1|||
28053261|NCT00446030|54710568|FG001|TREATMENT (up to 52 Weeks)|Patient concern|0|||
28053262|NCT00446030|54710567|FG000|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1|||
28053263|NCT00446030|54710568|FG001|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0|||
28053264|NCT00446030|54710567|FG000|FOLLOW-UP (up to 2-years)|Subject's request|9|||
28053265|NCT00446030|54710568|FG001|FOLLOW-UP (up to 2-years)|Subject's request|4|||
28053266|NCT00446030|54710567|FG000|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5|||
28053267|NCT00446030|54710568|FG001|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0|||
28053268|NCT00446030|54710567|FG000|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4|||
28053269|NCT00446030|54710568|FG001|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0|||
28053270|NCT00446030|54710567|FG000|FOLLOW-UP (up to 2-years)|Death|2|||
28053271|NCT00446030|54710568|FG001|FOLLOW-UP (up to 2-years)|Death|2|||
28053272|NCT00446030|54710567|FG000|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3|||
28053273|NCT00446030|54710568|FG001|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2|||
28053274|NCT00446030|54710567|FG000|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2|||
28053275|NCT00446030|54710568|FG001|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0|||
28053276|NCT00446030|54710567|FG000|FOLLOW-UP (up to 2-years)|Per physician discretion|2|||
28053277|NCT00446030|54710568|FG001|FOLLOW-UP (up to 2-years)|Per physician discretion|0|||
28053278|NCT00446030|54710567|FG000|FOLLOW-UP (up to 2-years)|Protocol Violation|1|||
28053279|NCT00446030|54710568|FG001|FOLLOW-UP (up to 2-years)|Protocol Violation|0|||
28053280|NCT00446030|54710567|FG000|FOLLOW-UP (up to 2-years)|Patient concern|1|||
28053281|NCT00446030|54710568|FG001|FOLLOW-UP (up to 2-years)|Patient concern|0|||
27812744|NCT01567527|54268905|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
27812745|NCT01567527|54268906|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
27812746|NCT01567527|54268907|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19|||
28053282|NCT00446030|54710567|FG000|FOLLOW-UP (up to 2-years)|Right axilla wound|1|||
28053283|NCT00446030|54710568|FG001|FOLLOW-UP (up to 2-years)|Right axilla wound|0|||
28053284|NCT00446030|54710567|FG000|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0|||
28053285|NCT00446030|54710568|FG001|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1|||
28053286|NCT00411216|54710576|FG000|Overall Study|Ten participants were entered into the c|0|||
28053287|NCT00411216|54710577|FG001|Overall Study|Ten participants were entered into the c|2|||
28053288|NCT00410514|54710586|FG000|Overall Study|Adverse Event|2|||
28053289|NCT00410514|54710587|FG001|Overall Study|Adverse Event|2|||
28053290|NCT00410514|54710588|FG002|Overall Study|Adverse Event|2|||
28053291|NCT00410514|54710586|FG000|Overall Study|Protocol Violation|0|||
28053292|NCT00410514|54710587|FG001|Overall Study|Protocol Violation|1|||
27812747|NCT01567527|54268908|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35|||
27812748|NCT01567527|54268904|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
27812749|NCT01567527|54268905|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
27812750|NCT01567527|54268906|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
27812751|NCT01567527|54268907|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8|||
27812752|NCT01567527|54268908|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5|||
27812753|NCT01818752|54268919|FG000|Overall Study|Adverse Event|64|||
27812754|NCT01818752|54268920|FG001|Overall Study|Adverse Event|74|||
27812755|NCT01818752|54268919|FG000|Overall Study|Death|14|||
28053293|NCT00410514|54710588|FG002|Overall Study|Protocol Violation|1|||
28053294|NCT00410514|54710586|FG000|Overall Study|Lost to Follow-up|0|||
28053295|NCT00410514|54710587|FG001|Overall Study|Lost to Follow-up|0|||
28053296|NCT00410514|54710588|FG002|Overall Study|Lost to Follow-up|2|||
28053297|NCT00410514|54710586|FG000|Overall Study|Non-compliant with study procedures|0|||
28053298|NCT00410514|54710587|FG001|Overall Study|Non-compliant with study procedures|0|||
27812756|NCT01818752|54268920|FG001|Overall Study|Death|18|||
27812757|NCT01818752|54268919|FG000|Overall Study|Non-compliance|16|||
27812758|NCT01818752|54268920|FG001|Overall Study|Non-compliance|20|||
27812759|NCT01818752|54268919|FG000|Overall Study|Withdrawal by Subject|15|||
27812760|NCT01818752|54268920|FG001|Overall Study|Withdrawal by Subject|14|||
27812761|NCT01818752|54268919|FG000|Overall Study|Physician Decision|9|||
27812762|NCT01818752|54268920|FG001|Overall Study|Physician Decision|8|||
27812763|NCT01818752|54268919|FG000|Overall Study|Disease Progression|54|||
27812764|NCT01818752|54268920|FG001|Overall Study|Disease Progression|48|||
27812765|NCT01818752|54268919|FG000|Overall Study|Other|7|||
27812766|NCT01818752|54268920|FG001|Overall Study|Other|8|||
27812767|NCT01818752|54268919|FG000|Overall Study|Continuing Treatment|1|||
27812768|NCT01818752|54268920|FG001|Overall Study|Continuing Treatment|4|||
27812769|NCT01818752|54268919|FG000|Overall Study|Randomized but not Dosed|7|||
27812770|NCT01818752|54268920|FG001|Overall Study|Randomized but not Dosed|4|||
27812771|NCT01845818|54268928|FG000|Overall Study|Withdrawal by Subject|0|||
27812772|NCT01845818|54268929|FG001|Overall Study|Withdrawal by Subject|1|||
27812773|NCT01845818|54268928|FG000|Overall Study|Lost to Follow-up|7|||
27812774|NCT01845818|54268929|FG001|Overall Study|Lost to Follow-up|5|||
27812775|NCT01845818|54268928|FG000|Overall Study|Administrative Reasons|3|||
27812776|NCT01845818|54268929|FG001|Overall Study|Administrative Reasons|1|||
27812777|NCT01845818|54268928|FG000|Overall Study|Serious Adverse Event|1|||
27812778|NCT01845818|54268929|FG001|Overall Study|Serious Adverse Event|1|||
27812779|NCT01845818|54268928|FG000|Overall Study|Other|25|||
28053299|NCT00410514|54710588|FG002|Overall Study|Non-compliant with study procedures|2|||
28053300|NCT03847610|54710596|FG000|Overall Study|Withdrawal by Subject|1|||
28053301|NCT03843632|54710604|FG000|Overall Study|Withdrawal by Subject|1|||
28053302|NCT03843632|54710605|FG001|Overall Study|Withdrawal by Subject|0|||
28053303|NCT03843632|54710606|FG002|Overall Study|Withdrawal by Subject|0|||
27812780|NCT01845818|54268929|FG001|Overall Study|Other|8|||
27812781|NCT01845818|54268928|FG000|Overall Study|Did Not Receive Any Dose of Adalimumab|5|||
27812782|NCT01845818|54268929|FG001|Overall Study|Did Not Receive Any Dose of Adalimumab|0|||
27812783|NCT01845818|54268928|FG000|Overall Study|No Follow-Up Data Available|4|||
27812784|NCT01845818|54268929|FG001|Overall Study|No Follow-Up Data Available|1|||
27812785|NCT01362608|54268939|FG000|Overall Study|Protocol Violation|0|||
27812786|NCT01362608|54268940|FG001|Overall Study|Protocol Violation|1|||
27812787|NCT01362608|54268939|FG000|Overall Study|Lost to Follow-up|3|||
28053304|NCT03843632|54710607|FG003|Overall Study|Withdrawal by Subject|0|||
28053305|NCT00455858|54710617|FG000|Overall Study|Lost to Follow-up|2|||
28053306|NCT00455858|54710617|FG000|Overall Study|Protocol Violation|1|||
28053307|NCT00455858|54710617|FG000|Overall Study|Lack of Efficacy|1|||
28053308|NCT00455858|54710617|FG000|Overall Study|Well controlled FPG without insulin|1|||
28053309|NCT00455858|54710617|FG000|Overall Study|Withdrawal|1|||
28053310|NCT00439556|54710624|FG000|Overall Study|Patient was taken off study for non-comp|0|||
28053311|NCT00439556|54710625|FG001|Overall Study|Patient was taken off study for non-comp|1|||
28053312|NCT00439556|54710626|FG002|Overall Study|Patient was taken off study for non-comp|0|||
28053313|NCT00410202|54710638|FG000|On-Treatment|Continuing treatment|69|||
28053314|NCT00410202|54710639|FG001|On-Treatment|Continuing treatment|71|||
28053315|NCT00410202|54710640|FG002|On-Treatment|Continuing treatment|66|||
28053316|NCT00410202|54710638|FG000|On-Treatment|Adverse Event|1|||
28053317|NCT00410202|54710639|FG001|On-Treatment|Adverse Event|3|||
28053318|NCT00410202|54710640|FG002|On-Treatment|Adverse Event|2|||
28053319|NCT00410202|54710638|FG000|On-Treatment|Death|1|||
28053320|NCT00410202|54710639|FG001|On-Treatment|Death|0|||
28053321|NCT00410202|54710640|FG002|On-Treatment|Death|0|||
28053322|NCT00410202|54710638|FG000|On-Treatment|Lost to Follow-up|1|||
28053323|NCT00410202|54710639|FG001|On-Treatment|Lost to Follow-up|0|||
28053324|NCT00410202|54710640|FG002|On-Treatment|Lost to Follow-up|1|||
28053325|NCT00410202|54710638|FG000|On-Treatment|Lack of Efficacy|1|||
28053326|NCT00410202|54710639|FG001|On-Treatment|Lack of Efficacy|4|||
28053327|NCT00410202|54710640|FG002|On-Treatment|Lack of Efficacy|0|||
28053328|NCT00410202|54710638|FG000|On-Treatment|Withdrawal by Subject|2|||
28053329|NCT00410202|54710639|FG001|On-Treatment|Withdrawal by Subject|1|||
28053330|NCT00410202|54710640|FG002|On-Treatment|Withdrawal by Subject|1|||
28053331|NCT00410202|54710638|FG000|On-Treatment|Other Reason|0|||
28053332|NCT00410202|54710639|FG001|On-Treatment|Other Reason|0|||
28053333|NCT00410202|54710640|FG002|On-Treatment|Other Reason|1|||
28053334|NCT00410202|54710638|FG000|Off-treatment Follow up|Continuing off-treatment follow up|10|||
28053335|NCT00410202|54710639|FG001|Off-treatment Follow up|Continuing off-treatment follow up|8|||
28053336|NCT00410202|54710640|FG002|Off-treatment Follow up|Continuing off-treatment follow up|11|||
27812788|NCT01362608|54268940|FG001|Overall Study|Lost to Follow-up|1|||
27812789|NCT01362608|54268939|FG000|Overall Study|Withdrawal by Subject|1|||
27812790|NCT01362608|54268940|FG001|Overall Study|Withdrawal by Subject|2|||
27812791|NCT01362608|54268939|FG000|Overall Study|Lack of Efficacy|0|||
27812792|NCT01362608|54268940|FG001|Overall Study|Lack of Efficacy|2|||
27812793|NCT01362608|54268939|FG000|Overall Study|Adverse Event|0|||
27812794|NCT01362608|54268940|FG001|Overall Study|Adverse Event|2|||
28053337|NCT00410202|54710638|FG000|Off-treatment Follow up|Follow up not required per protocol|3|||
28053338|NCT00410202|54710639|FG001|Off-treatment Follow up|Follow up not required per protocol|0|||
28053339|NCT00410202|54710640|FG002|Off-treatment Follow up|Follow up not required per protocol|1|||
28053340|NCT00410202|54710638|FG000|Off-treatment Follow up|Lost to Follow-up|1|||
28053341|NCT00410202|54710639|FG001|Off-treatment Follow up|Lost to Follow-up|0|||
28053342|NCT00410202|54710640|FG002|Off-treatment Follow up|Lost to Follow-up|0|||
28053343|NCT00445328|54710651|FG000|Overall Study|Death|0|||
28053344|NCT00445328|54710652|FG001|Overall Study|Death|1|||
28053345|NCT00445328|54710651|FG000|Overall Study|Adverse Event|0|||
28053346|NCT00445328|54710652|FG001|Overall Study|Adverse Event|3|||
28053347|NCT00445328|54710651|FG000|Overall Study|Other|0|||
28053348|NCT00445328|54710652|FG001|Overall Study|Other|2|||
28053349|NCT00445328|54710651|FG000|Overall Study|Withdrawal by Subject|2|||
28053350|NCT00445328|54710652|FG001|Overall Study|Withdrawal by Subject|0|||
28053351|NCT00445328|54710651|FG000|Overall Study|Protocol Violation|1|||
28053352|NCT00445328|54710652|FG001|Overall Study|Protocol Violation|0|||
28053353|NCT00455312|54710660|FG000|Overall Study|Death|0|||
28053354|NCT00455312|54710661|FG001|Overall Study|Death|1|||
28053355|NCT00444626|54710667|FG000|Initial Treatment Period|Withdrawal by Subject|2|||
28053356|NCT00444626|54710667|FG000|Initial Treatment Period|Adverse Event|1|||
28053357|NCT00444626|54710667|FG000|Initial Treatment Period|Lost to Follow-up|9|||
28053358|NCT00404352|54710694|FG000|Double Blind (up to 24 Month)|Adverse Event|5|||
28053359|NCT00404352|54710695|FG001|Double Blind (up to 24 Month)|Adverse Event|4|||
28053360|NCT00404352|54710696|FG002|Double Blind (up to 24 Month)|Adverse Event|6|||
28053361|NCT00404352|54710697|FG003|Double Blind (up to 24 Month)|Adverse Event|0|||
28053362|NCT00404352|54710698|FG004|Double Blind (up to 24 Month)|Adverse Event|0|||
28053363|NCT00404352|54710699|FG005|Double Blind (up to 24 Month)|Adverse Event|0|||
28053364|NCT00404352|54710700|FG006|Double Blind (up to 24 Month)|Adverse Event|0|||
28053365|NCT00404352|54710701|FG007|Double Blind (up to 24 Month)|Adverse Event|0|||
28053366|NCT00404352|54710702|FG008|Double Blind (up to 24 Month)|Adverse Event|0|||
28053367|NCT00404352|54710694|FG000|Double Blind (up to 24 Month)|Pregnancy|0|||
28053368|NCT00404352|54710695|FG001|Double Blind (up to 24 Month)|Pregnancy|0|||
28053369|NCT00404352|54710696|FG002|Double Blind (up to 24 Month)|Pregnancy|2|||
27812795|NCT01871090|54268948|FG000|Overall Study|Interrogation not done in Emergency Room|1|||
27812796|NCT01871090|54268949|FG001|Overall Study|Interrogation not done in Emergency Room|22|||
27812797|NCT01871090|54268948|FG000|Overall Study|Interrogation not completed correctly|1|||
27812798|NCT01871090|54268949|FG001|Overall Study|Interrogation not completed correctly|0|||
27812799|NCT01871090|54268948|FG000|Overall Study|Subject Non-Compliance|0|||
27812800|NCT01871090|54268949|FG001|Overall Study|Subject Non-Compliance|1|||
27812801|NCT01818596|54268957|FG000|Overall Study|Enrolled but Not Treated|4|||
27812802|NCT01818596|54268958|FG001|Overall Study|Enrolled but Not Treated|0|||
27812803|NCT01818596|54268957|FG000|Overall Study|Adverse Event|7|||
27812804|NCT01818596|54268958|FG001|Overall Study|Adverse Event|0|||
27812805|NCT01818596|54268957|FG000|Overall Study|Death|3|||
27812806|NCT01818596|54268958|FG001|Overall Study|Death|0|||
27812807|NCT01818596|54268957|FG000|Overall Study|Investigator's Discretion|4|||
27812808|NCT01818596|54268958|FG001|Overall Study|Investigator's Discretion|0|||
27812809|NCT01818596|54268957|FG000|Overall Study|Protocol Violation|1|||
27812810|NCT01818596|54268958|FG001|Overall Study|Protocol Violation|0|||
27812811|NCT01818596|54268957|FG000|Overall Study|Withdrew Consent|5|||
27812812|NCT01818596|54268958|FG001|Overall Study|Withdrew Consent|0|||
27812813|NCT01818596|54268957|FG000|Overall Study|Lost to Follow-up|7|||
27812814|NCT01818596|54268958|FG001|Overall Study|Lost to Follow-up|0|||
27812815|NCT04577794|54268971|FG000|Overall Study|Adverse Event|1|||
27812816|NCT04577794|54268972|FG001|Overall Study|Adverse Event|1|||
27812817|NCT01594281|54268989|FG000|Interventional Core Phase|Protocol Deviation|1|||
27812818|NCT01594281|54268990|FG001|Interventional Core Phase|Protocol Deviation|0|||
27812819|NCT01594281|54268991|FG002|Interventional Core Phase|Protocol Deviation|0|||
27812820|NCT01594281|54268989|FG000|Interventional Core Phase|Subject Withdrew Consent|0|||
27812821|NCT01594281|54268990|FG001|Interventional Core Phase|Subject Withdrew Consent|1|||
27939942|NCT00943852|54596278|FG001|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
27939943|NCT00943852|54596279|FG002|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
28053370|NCT00404352|54710697|FG003|Double Blind (up to 24 Month)|Pregnancy|0|||
28053371|NCT00404352|54710698|FG004|Double Blind (up to 24 Month)|Pregnancy|0|||
28053372|NCT00404352|54710699|FG005|Double Blind (up to 24 Month)|Pregnancy|0|||
28053373|NCT00404352|54710700|FG006|Double Blind (up to 24 Month)|Pregnancy|0|||
28053374|NCT00404352|54710701|FG007|Double Blind (up to 24 Month)|Pregnancy|0|||
28053375|NCT00404352|54710702|FG008|Double Blind (up to 24 Month)|Pregnancy|0|||
28053376|NCT00404352|54710694|FG000|Double Blind (up to 24 Month)|Death|0|||
28053377|NCT00404352|54710695|FG001|Double Blind (up to 24 Month)|Death|0|||
27812822|NCT01594281|54268991|FG002|Interventional Core Phase|Subject Withdrew Consent|1|||
27812823|NCT01594281|54268989|FG000|Interventional Core Phase|Death|1|||
27812824|NCT01594281|54268990|FG001|Interventional Core Phase|Death|1|||
27812825|NCT01594281|54268991|FG002|Interventional Core Phase|Death|2|||
27812826|NCT01594281|54268989|FG000|Interventional Core Phase|Lost to Follow-up|1|||
27812827|NCT01594281|54268990|FG001|Interventional Core Phase|Lost to Follow-up|4|||
27812828|NCT01594281|54268991|FG002|Interventional Core Phase|Lost to Follow-up|1|||
27812829|NCT01594281|54268989|FG000|Interventional Core Phase|Adverse Event|4|||
27812830|NCT01594281|54268990|FG001|Interventional Core Phase|Adverse Event|4|||
27812831|NCT01594281|54268991|FG002|Interventional Core Phase|Adverse Event|4|||
27812832|NCT01594281|54268989|FG000|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
27812833|NCT01594281|54268990|FG001|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
27812834|NCT01594281|54268991|FG002|Non-Interventional Follow Up Phase|Lost to Follow-up|0|||
27812835|NCT01594281|54268989|FG000|Non-Interventional Follow Up Phase|Administrative Problems|0|||
27812836|NCT01594281|54268990|FG001|Non-Interventional Follow Up Phase|Administrative Problems|0|||
27812837|NCT01594281|54268991|FG002|Non-Interventional Follow Up Phase|Administrative Problems|1|||
27812838|NCT01594281|54268989|FG000|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
28053378|NCT00404352|54710696|FG002|Double Blind (up to 24 Month)|Death|1|||
28053379|NCT00404352|54710697|FG003|Double Blind (up to 24 Month)|Death|0|||
28053380|NCT00404352|54710698|FG004|Double Blind (up to 24 Month)|Death|0|||
28053381|NCT00404352|54710699|FG005|Double Blind (up to 24 Month)|Death|0|||
28053382|NCT00404352|54710700|FG006|Double Blind (up to 24 Month)|Death|0|||
28053383|NCT00404352|54710701|FG007|Double Blind (up to 24 Month)|Death|0|||
28053384|NCT00404352|54710702|FG008|Double Blind (up to 24 Month)|Death|0|||
28053385|NCT00404352|54710694|FG000|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
28053386|NCT00404352|54710695|FG001|Double Blind (up to 24 Month)|Lost to Follow-up|2|||
28053387|NCT00404352|54710696|FG002|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
28053388|NCT00404352|54710697|FG003|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
28053389|NCT00404352|54710698|FG004|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
28053390|NCT00404352|54710699|FG005|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
28053391|NCT00404352|54710700|FG006|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
28053392|NCT00404352|54710701|FG007|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
28053393|NCT00404352|54710702|FG008|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
28053394|NCT00404352|54710694|FG000|Double Blind (up to 24 Month)|Withdrawal by Subject|11|||
28053395|NCT00404352|54710695|FG001|Double Blind (up to 24 Month)|Withdrawal by Subject|8|||
28053396|NCT00404352|54710696|FG002|Double Blind (up to 24 Month)|Withdrawal by Subject|7|||
28053397|NCT00404352|54710697|FG003|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
28053398|NCT00404352|54710698|FG004|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
28053399|NCT00404352|54710699|FG005|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
28053400|NCT00404352|54710700|FG006|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
28053401|NCT00404352|54710701|FG007|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
28053402|NCT00404352|54710702|FG008|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
28053403|NCT00404352|54710694|FG000|Double Blind (up to 24 Month)|Disease progression|3|||
28053404|NCT00404352|54710695|FG001|Double Blind (up to 24 Month)|Disease progression|0|||
28053405|NCT00404352|54710696|FG002|Double Blind (up to 24 Month)|Disease progression|2|||
28053406|NCT00404352|54710697|FG003|Double Blind (up to 24 Month)|Disease progression|0|||
28053407|NCT00404352|54710698|FG004|Double Blind (up to 24 Month)|Disease progression|0|||
28053408|NCT00404352|54710699|FG005|Double Blind (up to 24 Month)|Disease progression|0|||
28053409|NCT00404352|54710700|FG006|Double Blind (up to 24 Month)|Disease progression|0|||
28053410|NCT00404352|54710701|FG007|Double Blind (up to 24 Month)|Disease progression|0|||
28053411|NCT00404352|54710702|FG008|Double Blind (up to 24 Month)|Disease progression|0|||
28053412|NCT00404352|54710694|FG000|Double Blind (up to 24 Month)|Poor compliance|1|||
28053413|NCT00404352|54710695|FG001|Double Blind (up to 24 Month)|Poor compliance|0|||
28053414|NCT00404352|54710696|FG002|Double Blind (up to 24 Month)|Poor compliance|0|||
28053415|NCT00404352|54710697|FG003|Double Blind (up to 24 Month)|Poor compliance|0|||
28053416|NCT00404352|54710698|FG004|Double Blind (up to 24 Month)|Poor compliance|0|||
28053417|NCT00404352|54710699|FG005|Double Blind (up to 24 Month)|Poor compliance|0|||
28053418|NCT00404352|54710700|FG006|Double Blind (up to 24 Month)|Poor compliance|0|||
28053419|NCT00404352|54710701|FG007|Double Blind (up to 24 Month)|Poor compliance|0|||
28053420|NCT00404352|54710702|FG008|Double Blind (up to 24 Month)|Poor compliance|0|||
28053421|NCT00404352|54710694|FG000|Double Blind (up to 24 Month)|Switched to open label phase|31|||
28053422|NCT00404352|54710695|FG001|Double Blind (up to 24 Month)|Switched to open label phase|30|||
28053423|NCT00404352|54710696|FG002|Double Blind (up to 24 Month)|Switched to open label phase|59|||
28053424|NCT00404352|54710697|FG003|Double Blind (up to 24 Month)|Switched to open label phase|0|||
28053425|NCT00404352|54710698|FG004|Double Blind (up to 24 Month)|Switched to open label phase|0|||
27848233|NCT01045161|54341214|FG000|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6|||
28053426|NCT00404352|54710699|FG005|Double Blind (up to 24 Month)|Switched to open label phase|0|||
28053427|NCT00404352|54710700|FG006|Double Blind (up to 24 Month)|Switched to open label phase|0|||
28053428|NCT00404352|54710701|FG007|Double Blind (up to 24 Month)|Switched to open label phase|0|||
28053429|NCT00404352|54710702|FG008|Double Blind (up to 24 Month)|Switched to open label phase|0|||
28053430|NCT00404352|54710694|FG000|Double Blind (up to 24 Month)|Randomized but not treated|0|||
28053431|NCT00404352|54710695|FG001|Double Blind (up to 24 Month)|Randomized but not treated|2|||
28053432|NCT00404352|54710696|FG002|Double Blind (up to 24 Month)|Randomized but not treated|0|||
28053433|NCT00404352|54710697|FG003|Double Blind (up to 24 Month)|Randomized but not treated|0|||
28053434|NCT00404352|54710698|FG004|Double Blind (up to 24 Month)|Randomized but not treated|0|||
28053435|NCT00404352|54710699|FG005|Double Blind (up to 24 Month)|Randomized but not treated|0|||
28053436|NCT00404352|54710700|FG006|Double Blind (up to 24 Month)|Randomized but not treated|0|||
28053437|NCT00404352|54710701|FG007|Double Blind (up to 24 Month)|Randomized but not treated|0|||
28053438|NCT00404352|54710702|FG008|Double Blind (up to 24 Month)|Randomized but not treated|0|||
28053439|NCT00404352|54710694|FG000|Double Blind (up to 24 Month)|Physician Decision|0|||
28053440|NCT00404352|54710695|FG001|Double Blind (up to 24 Month)|Physician Decision|0|||
28053441|NCT00404352|54710696|FG002|Double Blind (up to 24 Month)|Physician Decision|1|||
28053442|NCT00404352|54710697|FG003|Double Blind (up to 24 Month)|Physician Decision|0|||
28053443|NCT00404352|54710698|FG004|Double Blind (up to 24 Month)|Physician Decision|0|||
28053444|NCT00404352|54710699|FG005|Double Blind (up to 24 Month)|Physician Decision|0|||
28053445|NCT00404352|54710700|FG006|Double Blind (up to 24 Month)|Physician Decision|0|||
28053446|NCT00404352|54710701|FG007|Double Blind (up to 24 Month)|Physician Decision|0|||
28053447|NCT00404352|54710702|FG008|Double Blind (up to 24 Month)|Physician Decision|0|||
28053448|NCT00404352|54710694|FG000|Double Blind (up to 24 Month)|Other|0|||
28053449|NCT00404352|54710695|FG001|Double Blind (up to 24 Month)|Other|1|||
28053450|NCT00404352|54710696|FG002|Double Blind (up to 24 Month)|Other|0|||
28053451|NCT00404352|54710697|FG003|Double Blind (up to 24 Month)|Other|0|||
28053452|NCT00404352|54710698|FG004|Double Blind (up to 24 Month)|Other|0|||
28053453|NCT00404352|54710699|FG005|Double Blind (up to 24 Month)|Other|0|||
28053454|NCT00404352|54710700|FG006|Double Blind (up to 24 Month)|Other|0|||
28053455|NCT00404352|54710701|FG007|Double Blind (up to 24 Month)|Other|0|||
28053456|NCT00404352|54710702|FG008|Double Blind (up to 24 Month)|Other|0|||
28053457|NCT00404352|54710694|FG000|Open Label (up to 24 Month)|Adverse Event|0|||
28053458|NCT00404352|54710695|FG001|Open Label (up to 24 Month)|Adverse Event|0|||
28053459|NCT00404352|54710696|FG002|Open Label (up to 24 Month)|Adverse Event|0|||
28053460|NCT00404352|54710697|FG003|Open Label (up to 24 Month)|Adverse Event|2|||
28053461|NCT00404352|54710698|FG004|Open Label (up to 24 Month)|Adverse Event|1|||
28053462|NCT00404352|54710699|FG005|Open Label (up to 24 Month)|Adverse Event|1|||
28053463|NCT00404352|54710700|FG006|Open Label (up to 24 Month)|Adverse Event|0|||
28053464|NCT00404352|54710701|FG007|Open Label (up to 24 Month)|Adverse Event|0|||
28053465|NCT00404352|54710702|FG008|Open Label (up to 24 Month)|Adverse Event|0|||
27812839|NCT01594281|54268990|FG001|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0|||
27812840|NCT01594281|54268991|FG002|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
27812841|NCT01566981|54269004|FG000|Overall Study|Lost to Follow-up|5|||
27812842|NCT01566981|54269005|FG001|Overall Study|Lost to Follow-up|8|||
27812843|NCT01870778|54269015|FG000|Overall Study|Withdrawal by Subject|8|||
27812844|NCT01870778|54269016|FG001|Overall Study|Withdrawal by Subject|7|||
27939944|NCT00943852|54596280|FG003|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
28053466|NCT00404352|54710694|FG000|Open Label (up to 24 Month)|Pregnancy|0|||
28053467|NCT00404352|54710695|FG001|Open Label (up to 24 Month)|Pregnancy|0|||
28053468|NCT00404352|54710696|FG002|Open Label (up to 24 Month)|Pregnancy|0|||
28053469|NCT00404352|54710697|FG003|Open Label (up to 24 Month)|Pregnancy|0|||
28053470|NCT00404352|54710698|FG004|Open Label (up to 24 Month)|Pregnancy|0|||
28053471|NCT00404352|54710699|FG005|Open Label (up to 24 Month)|Pregnancy|1|||
28053472|NCT00404352|54710700|FG006|Open Label (up to 24 Month)|Pregnancy|0|||
28053473|NCT00404352|54710701|FG007|Open Label (up to 24 Month)|Pregnancy|0|||
28053474|NCT00404352|54710702|FG008|Open Label (up to 24 Month)|Pregnancy|0|||
28053475|NCT00404352|54710694|FG000|Open Label (up to 24 Month)|Lost to Follow-up|0|||
28053476|NCT00404352|54710695|FG001|Open Label (up to 24 Month)|Lost to Follow-up|0|||
28053477|NCT00404352|54710696|FG002|Open Label (up to 24 Month)|Lost to Follow-up|0|||
28053478|NCT00404352|54710697|FG003|Open Label (up to 24 Month)|Lost to Follow-up|0|||
28053479|NCT00404352|54710698|FG004|Open Label (up to 24 Month)|Lost to Follow-up|1|||
28053480|NCT00404352|54710699|FG005|Open Label (up to 24 Month)|Lost to Follow-up|0|||
28053481|NCT00404352|54710700|FG006|Open Label (up to 24 Month)|Lost to Follow-up|0|||
28053482|NCT00404352|54710701|FG007|Open Label (up to 24 Month)|Lost to Follow-up|0|||
28053483|NCT00404352|54710702|FG008|Open Label (up to 24 Month)|Lost to Follow-up|0|||
28053484|NCT00404352|54710694|FG000|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
28053485|NCT00404352|54710695|FG001|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
28053486|NCT00404352|54710696|FG002|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
28053487|NCT00404352|54710697|FG003|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
28053488|NCT00404352|54710698|FG004|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
28053489|NCT00404352|54710699|FG005|Open Label (up to 24 Month)|Withdrawal by Subject|5|||
28053490|NCT00404352|54710700|FG006|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
28053491|NCT00404352|54710701|FG007|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
28053492|NCT00404352|54710702|FG008|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
28053493|NCT00404352|54710694|FG000|Open Label (up to 24 Month)|Disease progression|0|||
28053494|NCT00404352|54710695|FG001|Open Label (up to 24 Month)|Disease progression|0|||
28053495|NCT00404352|54710696|FG002|Open Label (up to 24 Month)|Disease progression|0|||
28053496|NCT00404352|54710697|FG003|Open Label (up to 24 Month)|Disease progression|1|||
28053497|NCT00404352|54710698|FG004|Open Label (up to 24 Month)|Disease progression|0|||
28053498|NCT00404352|54710699|FG005|Open Label (up to 24 Month)|Disease progression|0|||
28053499|NCT00404352|54710700|FG006|Open Label (up to 24 Month)|Disease progression|0|||
28053500|NCT00404352|54710701|FG007|Open Label (up to 24 Month)|Disease progression|0|||
28053501|NCT00404352|54710702|FG008|Open Label (up to 24 Month)|Disease progression|0|||
28053502|NCT00404352|54710694|FG000|Open Label Extension (up to 36 Months)|Adverse Event|0|||
28053503|NCT00404352|54710695|FG001|Open Label Extension (up to 36 Months)|Adverse Event|0|||
28053504|NCT00404352|54710696|FG002|Open Label Extension (up to 36 Months)|Adverse Event|0|||
28053505|NCT00404352|54710697|FG003|Open Label Extension (up to 36 Months)|Adverse Event|0|||
28053506|NCT00404352|54710698|FG004|Open Label Extension (up to 36 Months)|Adverse Event|0|||
28053507|NCT00404352|54710699|FG005|Open Label Extension (up to 36 Months)|Adverse Event|0|||
28053508|NCT00404352|54710700|FG006|Open Label Extension (up to 36 Months)|Adverse Event|1|||
28053509|NCT00404352|54710701|FG007|Open Label Extension (up to 36 Months)|Adverse Event|1|||
28053510|NCT00404352|54710702|FG008|Open Label Extension (up to 36 Months)|Adverse Event|0|||
28053511|NCT00404352|54710694|FG000|Open Label Extension (up to 36 Months)|Other|0|||
28053512|NCT00404352|54710695|FG001|Open Label Extension (up to 36 Months)|Other|0|||
28053513|NCT00404352|54710696|FG002|Open Label Extension (up to 36 Months)|Other|0|||
28053514|NCT00404352|54710697|FG003|Open Label Extension (up to 36 Months)|Other|0|||
28053515|NCT00404352|54710698|FG004|Open Label Extension (up to 36 Months)|Other|0|||
28053516|NCT00404352|54710699|FG005|Open Label Extension (up to 36 Months)|Other|0|||
28053517|NCT00404352|54710700|FG006|Open Label Extension (up to 36 Months)|Other|0|||
28053518|NCT00404352|54710701|FG007|Open Label Extension (up to 36 Months)|Other|0|||
28053519|NCT00404352|54710702|FG008|Open Label Extension (up to 36 Months)|Other|2|||
28053520|NCT00439244|54710722|FG000|Overall Study|Adverse Event|5|||
28053521|NCT00439244|54710723|FG001|Overall Study|Adverse Event|2|||
28053522|NCT00439244|54710724|FG002|Overall Study|Adverse Event|3|||
28053523|NCT00439244|54710722|FG000|Overall Study|Withdrawal by Subject|3|||
28053524|NCT00439244|54710723|FG001|Overall Study|Withdrawal by Subject|1|||
28053525|NCT00439244|54710724|FG002|Overall Study|Withdrawal by Subject|2|||
28053526|NCT00439244|54710722|FG000|Overall Study|Lost to Follow-up|2|||
28053527|NCT00439244|54710723|FG001|Overall Study|Lost to Follow-up|1|||
28053528|NCT00439244|54710724|FG002|Overall Study|Lost to Follow-up|2|||
28053529|NCT00439244|54710722|FG000|Overall Study|Death|0|||
28053530|NCT00439244|54710723|FG001|Overall Study|Death|1|||
28053531|NCT00439244|54710724|FG002|Overall Study|Death|0|||
28053532|NCT00439244|54710722|FG000|Overall Study|Protocol Violation|0|||
28053533|NCT00439244|54710723|FG001|Overall Study|Protocol Violation|1|||
28053534|NCT00439244|54710724|FG002|Overall Study|Protocol Violation|0|||
28053535|NCT00439244|54710722|FG000|Overall Study|Administrative problems|1|||
28053536|NCT00439244|54710723|FG001|Overall Study|Administrative problems|0|||
28053537|NCT00439244|54710724|FG002|Overall Study|Administrative problems|0|||
28053538|NCT00438464|54710743|FG000|Overall Study|Terminated Early|14|||
28053539|NCT00438464|54710744|FG001|Overall Study|Terminated Early|5|||
28053540|NCT00438464|54710743|FG000|Overall Study|Incomplete data submission|0|||
28053541|NCT00438464|54710744|FG001|Overall Study|Incomplete data submission|2|||
28053542|NCT00437294|54710764|FG000|Overall Study|Adverse Event|5|||
28053543|NCT00437294|54710765|FG001|Overall Study|Adverse Event|4|||
28053544|NCT00437294|54710764|FG000|Overall Study|Death|5|||
28053545|NCT00437294|54710765|FG001|Overall Study|Death|2|||
28053546|NCT00437294|54710764|FG000|Overall Study|Physician Decision|0|||
28053547|NCT00437294|54710765|FG001|Overall Study|Physician Decision|3|||
28053548|NCT00437294|54710764|FG000|Overall Study|Withdrawal by Subject|5|||
28053549|NCT00437294|54710765|FG001|Overall Study|Withdrawal by Subject|0|||
28053550|NCT00437294|54710764|FG000|Overall Study|Progressive Disease|19|||
28053551|NCT00437294|54710765|FG001|Overall Study|Progressive Disease|23|||
28053552|NCT00437294|54710764|FG000|Overall Study|Sponsor Decision|8|||
28053553|NCT00437294|54710765|FG001|Overall Study|Sponsor Decision|9|||
28053554|NCT00437294|54710764|FG000|Overall Study|Protocol Violation|0|||
28053555|NCT00437294|54710765|FG001|Overall Study|Protocol Violation|1|||
28053556|NCT00437294|54710764|FG000|Overall Study|Entry criteria not met|1|||
28053557|NCT00437294|54710765|FG001|Overall Study|Entry criteria not met|1|||
28053558|NCT00436982|54710779|FG000|Overall Study|Withdrawal by Subject|3|||
28053559|NCT00436982|54710780|FG001|Overall Study|Withdrawal by Subject|1|||
28053560|NCT00436982|54710779|FG000|Overall Study|Did not receive allocated intervention|0|||
28053561|NCT00436982|54710780|FG001|Overall Study|Did not receive allocated intervention|1|||
28053562|NCT00436982|54710779|FG000|Overall Study|no RSA data|1|||
28053563|NCT00436982|54710780|FG001|Overall Study|no RSA data|2|||
28053564|NCT00443846|54710792|FG000|Overall Study|Withdrawn due to intercurrent disease|1|||
28053565|NCT00443846|54710793|FG001|Overall Study|Withdrawn due to intercurrent disease|0|||
28053566|NCT00443846|54710792|FG000|Overall Study|Not vaccinated, no blood sample drawn|1|||
28053567|NCT00443846|54710793|FG001|Overall Study|Not vaccinated, no blood sample drawn|0|||
28053568|NCT00443846|54710792|FG000|Overall Study|Adverse Event|0|||
28053569|NCT00443846|54710793|FG001|Overall Study|Adverse Event|1|||
28053570|NCT00443846|54710792|FG000|Overall Study|Personal reason|8|||
28053571|NCT00443846|54710793|FG001|Overall Study|Personal reason|3|||
28053572|NCT00443846|54710792|FG000|Overall Study|Lost to Follow-up|1|||
28053573|NCT00443846|54710793|FG001|Overall Study|Lost to Follow-up|2|||
28053574|NCT00436826|54710801|FG000|Double Blind Period (DBP)|Adverse Event|2|||
28053575|NCT00436826|54710802|FG001|Double Blind Period (DBP)|Adverse Event|0|||
28053576|NCT00436826|54710803|FG002|Double Blind Period (DBP)|Adverse Event|0|||
28053577|NCT00436826|54710804|FG003|Double Blind Period (DBP)|Adverse Event|0|||
28053578|NCT00436826|54710805|FG004|Double Blind Period (DBP)|Adverse Event|0|||
28053579|NCT00436826|54710806|FG005|Double Blind Period (DBP)|Adverse Event|0|||
28053580|NCT00436826|54710801|FG000|Double Blind Period (DBP)|Protocol Violation|1|||
28053581|NCT00436826|54710802|FG001|Double Blind Period (DBP)|Protocol Violation|0|||
28053582|NCT00436826|54710803|FG002|Double Blind Period (DBP)|Protocol Violation|0|||
28053583|NCT00436826|54710804|FG003|Double Blind Period (DBP)|Protocol Violation|0|||
28053584|NCT00436826|54710805|FG004|Double Blind Period (DBP)|Protocol Violation|0|||
28053585|NCT00436826|54710806|FG005|Double Blind Period (DBP)|Protocol Violation|0|||
28053586|NCT00436826|54710801|FG000|Double Blind Period (DBP)|Other|10|||
28053587|NCT00436826|54710802|FG001|Double Blind Period (DBP)|Other|11|||
28053588|NCT00436826|54710803|FG002|Double Blind Period (DBP)|Other|0|||
28053589|NCT00436826|54710804|FG003|Double Blind Period (DBP)|Other|0|||
28053590|NCT00436826|54710805|FG004|Double Blind Period (DBP)|Other|0|||
28053591|NCT00436826|54710806|FG005|Double Blind Period (DBP)|Other|0|||
28053592|NCT00436826|54710801|FG000|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
28053593|NCT00436826|54710802|FG001|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
28053594|NCT00436826|54710803|FG002|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
28053595|NCT00436826|54710804|FG003|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1|||
28053596|NCT00436826|54710805|FG004|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
28053597|NCT00436826|54710806|FG005|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
28053598|NCT00436826|54710801|FG000|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
28053599|NCT00436826|54710802|FG001|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
28053600|NCT00436826|54710803|FG002|Ext. Period (With Cladribine Treatment)|Other un-specified|46|||
28053601|NCT00436826|54710804|FG003|Ext. Period (With Cladribine Treatment)|Other un-specified|25|||
28053602|NCT00436826|54710805|FG004|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
28053603|NCT00436826|54710806|FG005|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
28053604|NCT00436826|54710801|FG000|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
28053605|NCT00436826|54710802|FG001|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
28053606|NCT00436826|54710803|FG002|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
28053607|NCT00436826|54710804|FG003|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
28053608|NCT00436826|54710805|FG004|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51|||
28053609|NCT00436826|54710806|FG005|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7|||
28053610|NCT00410124|54710824|FG000|Core Phase Double Blind (15 Months)|Adverse Event|36|||
28053611|NCT00410124|54710825|FG001|Core Phase Double Blind (15 Months)|Adverse Event|2|||
28053612|NCT00410124|54710824|FG000|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1|||
27812845|NCT01870778|54269015|FG000|Overall Study|Lost to Follow-up|0|||
28053613|NCT00410124|54710825|FG001|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0|||
27812846|NCT01870778|54269016|FG001|Overall Study|Lost to Follow-up|2|||
27812847|NCT01818284|54269029|FG000|Overall Study|Not eligible due to White Blood Counts|4|||
27812848|NCT01818284|54269030|FG001|Overall Study|Not eligible due to White Blood Counts|4|||
27812849|NCT01818284|54269029|FG000|Overall Study|Death|0|||
27812850|NCT01818284|54269030|FG001|Overall Study|Death|2|||
27812851|NCT01610492|54269066|FG000|Overall Study|Adverse Event|1|||
27812852|NCT01610492|54269066|FG000|Overall Study|Lack of Efficacy|3|||
27812853|NCT01610492|54269066|FG000|Overall Study|Other: Reached stopping criteria|1|||
27812854|NCT01610492|54269066|FG000|Overall Study|Other:Treatment stopped due to remission|1|||
27812855|NCT01817582|54269073|FG000|Overall Study|Withdrawal by Subject|0|||
27812856|NCT01817582|54269074|FG001|Overall Study|Withdrawal by Subject|1|||
27812857|NCT01817582|54269075|FG002|Overall Study|Withdrawal by Subject|0|||
27812858|NCT01817582|54269073|FG000|Overall Study|Participant revealed masked treatment|1|||
27812859|NCT01817582|54269074|FG001|Overall Study|Participant revealed masked treatment|0|||
27812860|NCT01817582|54269075|FG002|Overall Study|Participant revealed masked treatment|0|||
27812861|NCT01817582|54269073|FG000|Overall Study|Randomized but exclusion criteria met|1|||
27812862|NCT01817582|54269074|FG001|Overall Study|Randomized but exclusion criteria met|0|||
27812863|NCT01817582|54269075|FG002|Overall Study|Randomized but exclusion criteria met|0|||
27812864|NCT01594125|54269088|FG000|Overall Study|Withdrawal by Subject|1|||
28053614|NCT00410124|54710824|FG000|Core Phase Double Blind (15 Months)|Protocol Violation|2|||
28053615|NCT00410124|54710825|FG001|Core Phase Double Blind (15 Months)|Protocol Violation|1|||
27812865|NCT01594125|54269089|FG001|Overall Study|Withdrawal by Subject|0|||
27812866|NCT01594125|54269090|FG002|Overall Study|Withdrawal by Subject|0|||
27812867|NCT01594125|54269091|FG003|Overall Study|Withdrawal by Subject|1|||
27812868|NCT01594125|54269092|FG004|Overall Study|Withdrawal by Subject|0|||
28053616|NCT00410124|54710824|FG000|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13|||
28053617|NCT00410124|54710825|FG001|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2|||
28053618|NCT00410124|54710824|FG000|Core Phase Double Blind (15 Months)|Lost to Follow-up|4|||
28053619|NCT00410124|54710825|FG001|Core Phase Double Blind (15 Months)|Lost to Follow-up|0|||
28053620|NCT00410124|54710824|FG000|Core Phase Double Blind (15 Months)|Administrative Problems|2|||
28053621|NCT00410124|54710825|FG001|Core Phase Double Blind (15 Months)|Administrative Problems|0|||
28053622|NCT00410124|54710824|FG000|Core Phase Double Blind (15 Months)|Death|7|||
28053623|NCT00410124|54710825|FG001|Core Phase Double Blind (15 Months)|Death|4|||
28053624|NCT00410124|54710824|FG000|Core Phase Double Blind (15 Months)|Disease Progression|137|||
28053625|NCT00410124|54710825|FG001|Core Phase Double Blind (15 Months)|Disease Progression|124|||
28053626|NCT00410124|54710824|FG000|Extension Phase - Open Label (45 Months)|Adverse Event|7|||
28053627|NCT00410124|54710825|FG001|Extension Phase - Open Label (45 Months)|Adverse Event|19|||
28053628|NCT00410124|54710824|FG000|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0|||
28053629|NCT00410124|54710825|FG001|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1|||
28053630|NCT00410124|54710824|FG000|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0|||
28053631|NCT00410124|54710825|FG001|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1|||
28053632|NCT00410124|54710824|FG000|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
28053633|NCT00410124|54710825|FG001|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
28053634|NCT00410124|54710824|FG000|Extension Phase - Open Label (45 Months)|Death|2|||
28053635|NCT00410124|54710825|FG001|Extension Phase - Open Label (45 Months)|Death|10|||
28053636|NCT00410124|54710824|FG000|Extension Phase - Open Label (45 Months)|Disease Progression|56|||
28053637|NCT00410124|54710825|FG001|Extension Phase - Open Label (45 Months)|Disease Progression|78|||
28053638|NCT00410124|54710824|FG000|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1|||
28053639|NCT00410124|54710825|FG001|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0|||
28053640|NCT00410124|54710824|FG000|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0|||
28053641|NCT00410124|54710825|FG001|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1|||
28053642|NCT00410046|54710835|FG000|Overall Study|Adverse Event|3|||
28053643|NCT00410046|54710835|FG000|Overall Study|Withdrawal by Subject|1|||
28053644|NCT00410046|54710835|FG000|Overall Study|Lost to Follow-up|1|||
28053645|NCT00416624|54710844|FG000|Overall Study|Withdrawal by Subject|1|||
28053646|NCT00416624|54710845|FG001|Overall Study|Withdrawal by Subject|6|||
28053647|NCT00416624|54710846|FG002|Overall Study|Withdrawal by Subject|4|||
28053648|NCT00416624|54710847|FG003|Overall Study|Withdrawal by Subject|9|||
28053649|NCT00416624|54710844|FG000|Overall Study|Death|4|||
28053650|NCT00416624|54710845|FG001|Overall Study|Death|7|||
28053651|NCT00416624|54710846|FG002|Overall Study|Death|7|||
28053652|NCT00416624|54710847|FG003|Overall Study|Death|1|||
28053653|NCT00416624|54710844|FG000|Overall Study|Adverse Event|8|||
28053654|NCT00416624|54710845|FG001|Overall Study|Adverse Event|3|||
28053655|NCT00416624|54710846|FG002|Overall Study|Adverse Event|2|||
28053656|NCT00416624|54710847|FG003|Overall Study|Adverse Event|2|||
28053657|NCT00416624|54710844|FG000|Overall Study|Other|8|||
28053658|NCT00416624|54710845|FG001|Overall Study|Other|11|||
28053659|NCT00416624|54710846|FG002|Overall Study|Other|5|||
28053660|NCT00416624|54710847|FG003|Overall Study|Other|5|||
28053661|NCT00416624|54710844|FG000|Overall Study|Cancel|1|||
28053662|NCT00416624|54710845|FG001|Overall Study|Cancel|0|||
28053663|NCT00416624|54710846|FG002|Overall Study|Cancel|0|||
28053664|NCT00416624|54710847|FG003|Overall Study|Cancel|0|||
28053665|NCT00262600|54710860|FG000|Overall Study|Lost to Follow-up|17|||
28053666|NCT00262600|54710861|FG001|Overall Study|Lost to Follow-up|31|||
28053667|NCT00262600|54710862|FG002|Overall Study|Lost to Follow-up|41|||
28053668|NCT00262600|54710860|FG000|Overall Study|Withdrawal by Subject|128|||
28053669|NCT00262600|54710861|FG001|Overall Study|Withdrawal by Subject|145|||
28053670|NCT00262600|54710862|FG002|Overall Study|Withdrawal by Subject|139|||
28053671|NCT00262600|54710860|FG000|Overall Study|Not Treated|32|||
28053672|NCT00262600|54710861|FG001|Overall Study|Not Treated|17|||
28053673|NCT00262600|54710862|FG002|Overall Study|Not Treated|24|||
28053674|NCT00262600|54710860|FG000|Overall Study|Other|58|||
28053675|NCT00262600|54710861|FG001|Overall Study|Other|59|||
28053676|NCT00262600|54710862|FG002|Overall Study|Other|62|||
28053677|NCT00409578|54710874|FG000|Overall Study|Adverse Event|27|||
28053678|NCT00409578|54710875|FG001|Overall Study|Adverse Event|37|||
28053679|NCT00409578|54710876|FG002|Overall Study|Adverse Event|25|||
28053680|NCT00409578|54710877|FG003|Overall Study|Adverse Event|33|||
28053681|NCT00409578|54710874|FG000|Overall Study|Abnormal laboratory value(s)|2|||
28053682|NCT00409578|54710875|FG001|Overall Study|Abnormal laboratory value(s)|2|||
28053683|NCT00409578|54710876|FG002|Overall Study|Abnormal laboratory value(s)|2|||
28053684|NCT00409578|54710877|FG003|Overall Study|Abnormal laboratory value(s)|4|||
28053685|NCT00409578|54710874|FG000|Overall Study|Lack of Efficacy|0|||
28053686|NCT00409578|54710875|FG001|Overall Study|Lack of Efficacy|0|||
28053687|NCT00409578|54710876|FG002|Overall Study|Lack of Efficacy|0|||
28053688|NCT00409578|54710877|FG003|Overall Study|Lack of Efficacy|2|||
28159975|NCT02737475|54830023|FG001|Overall Study|Participant withdrew consent|0|||
28053689|NCT00409578|54710874|FG000|Overall Study|Subject no longer requires study drug|0|||
28053690|NCT00409578|54710875|FG001|Overall Study|Subject no longer requires study drug|0|||
28053691|NCT00409578|54710876|FG002|Overall Study|Subject no longer requires study drug|0|||
28053692|NCT00409578|54710877|FG003|Overall Study|Subject no longer requires study drug|1|||
28053693|NCT00409578|54710874|FG000|Overall Study|Withdrawal by Subject|8|||
28053694|NCT00409578|54710875|FG001|Overall Study|Withdrawal by Subject|15|||
27812869|NCT01594125|54269088|FG000|Overall Study|Progressive Disease|3|||
27812870|NCT01594125|54269089|FG001|Overall Study|Progressive Disease|12|||
27812871|NCT01594125|54269090|FG002|Overall Study|Progressive Disease|3|||
27812872|NCT01594125|54269091|FG003|Overall Study|Progressive Disease|3|||
27812873|NCT01594125|54269092|FG004|Overall Study|Progressive Disease|7|||
28053695|NCT00409578|54710876|FG002|Overall Study|Withdrawal by Subject|16|||
28053696|NCT00409578|54710877|FG003|Overall Study|Withdrawal by Subject|17|||
28053697|NCT00409578|54710874|FG000|Overall Study|Lost to Follow-up|2|||
28053698|NCT00409578|54710875|FG001|Overall Study|Lost to Follow-up|0|||
28053699|NCT00409578|54710876|FG002|Overall Study|Lost to Follow-up|2|||
28053700|NCT00409578|54710877|FG003|Overall Study|Lost to Follow-up|2|||
28053701|NCT00409578|54710874|FG000|Overall Study|Administrative problems|8|||
28053702|NCT00409578|54710875|FG001|Overall Study|Administrative problems|9|||
28053703|NCT00409578|54710876|FG002|Overall Study|Administrative problems|2|||
28053704|NCT00409578|54710877|FG003|Overall Study|Administrative problems|4|||
28053705|NCT00409578|54710874|FG000|Overall Study|Death|2|||
28053706|NCT00409578|54710875|FG001|Overall Study|Death|4|||
28053707|NCT00409578|54710876|FG002|Overall Study|Death|4|||
28053708|NCT00409578|54710877|FG003|Overall Study|Death|2|||
28053709|NCT00409578|54710874|FG000|Overall Study|Protocol Violation|3|||
28053710|NCT00409578|54710875|FG001|Overall Study|Protocol Violation|2|||
28053711|NCT00409578|54710876|FG002|Overall Study|Protocol Violation|3|||
28053712|NCT00409578|54710877|FG003|Overall Study|Protocol Violation|1|||
28053713|NCT00409578|54710874|FG000|Overall Study|Missing|0|||
28053714|NCT00409578|54710875|FG001|Overall Study|Missing|1|||
28053715|NCT00409578|54710876|FG002|Overall Study|Missing|0|||
28053716|NCT00409578|54710877|FG003|Overall Study|Missing|1|||
28053717|NCT00428090|54710891|FG000|Overall Study|Adverse Event|10|||
28053718|NCT00428090|54710892|FG001|Overall Study|Adverse Event|8|||
28053719|NCT00428090|54710893|FG002|Overall Study|Adverse Event|10|||
28053720|NCT00428090|54710894|FG003|Overall Study|Adverse Event|11|||
28053721|NCT00428090|54710891|FG000|Overall Study|Lost to Follow-up|3|||
28053722|NCT00428090|54710892|FG001|Overall Study|Lost to Follow-up|6|||
28053723|NCT00428090|54710893|FG002|Overall Study|Lost to Follow-up|1|||
28053724|NCT00428090|54710894|FG003|Overall Study|Lost to Follow-up|4|||
28053725|NCT00428090|54710891|FG000|Overall Study|Protocol Violation|3|||
28053726|NCT00428090|54710892|FG001|Overall Study|Protocol Violation|1|||
28053727|NCT00428090|54710893|FG002|Overall Study|Protocol Violation|3|||
28053728|NCT00428090|54710894|FG003|Overall Study|Protocol Violation|3|||
28053729|NCT00428090|54710891|FG000|Overall Study|Withdrawal by Subject|10|||
28053730|NCT00428090|54710892|FG001|Overall Study|Withdrawal by Subject|12|||
28053731|NCT00428090|54710893|FG002|Overall Study|Withdrawal by Subject|15|||
28053732|NCT00428090|54710894|FG003|Overall Study|Withdrawal by Subject|5|||
28053733|NCT00428090|54710891|FG000|Overall Study|Sponsor terminated study|0|||
28053734|NCT00428090|54710892|FG001|Overall Study|Sponsor terminated study|1|||
28053735|NCT00428090|54710893|FG002|Overall Study|Sponsor terminated study|0|||
28053736|NCT00428090|54710894|FG003|Overall Study|Sponsor terminated study|0|||
28053737|NCT00428090|54710891|FG000|Overall Study|Non-compliance|4|||
28053738|NCT00428090|54710892|FG001|Overall Study|Non-compliance|0|||
28053739|NCT00428090|54710893|FG002|Overall Study|Non-compliance|1|||
28053740|NCT00428090|54710894|FG003|Overall Study|Non-compliance|3|||
27812874|NCT01870076|54269108|FG000|Overall Study|Withdrawal by Subject|1|||
27812875|NCT01870076|54269109|FG001|Overall Study|Withdrawal by Subject|0|||
27812876|NCT01870076|54269110|FG002|Overall Study|Withdrawal by Subject|1|||
27812877|NCT01870076|54269111|FG003|Overall Study|Withdrawal by Subject|0|||
27812878|NCT01592721|54269121|FG000|Long-term Follow-up|Death|1|||
27939945|NCT00943852|54596281|FG004|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
28053741|NCT00428090|54710891|FG000|Overall Study|Par. did not returned to visit|1|||
28053742|NCT00428090|54710892|FG001|Overall Study|Par. did not returned to visit|0|||
28053743|NCT00428090|54710893|FG002|Overall Study|Par. did not returned to visit|0|||
28053744|NCT00428090|54710894|FG003|Overall Study|Par. did not returned to visit|1|||
28053745|NCT00428090|54710891|FG000|Overall Study|Follow-Up visit not possible|1|||
28053746|NCT00428090|54710892|FG001|Overall Study|Follow-Up visit not possible|0|||
28053747|NCT00428090|54710893|FG002|Overall Study|Follow-Up visit not possible|0|||
28053748|NCT00428090|54710894|FG003|Overall Study|Follow-Up visit not possible|0|||
28053749|NCT00428090|54710891|FG000|Overall Study|Prohibited medication used for SAE|1|||
28053750|NCT00428090|54710892|FG001|Overall Study|Prohibited medication used for SAE|0|||
28053751|NCT00428090|54710893|FG002|Overall Study|Prohibited medication used for SAE|0|||
27812879|NCT01613378|54269125|FG000|Overall Study|Lack of Efficacy|13|||
27812880|NCT01613378|54269125|FG000|Overall Study|Adverse Event|11|||
27812881|NCT01613378|54269125|FG000|Overall Study|Withdrawal by Subject|8|||
28053752|NCT00428090|54710894|FG003|Overall Study|Prohibited medication used for SAE|0|||
27812882|NCT01613378|54269125|FG000|Overall Study|Death|2|||
27812883|NCT01613378|54269125|FG000|Overall Study|Lost to Follow-up|1|||
27812884|NCT01613378|54269125|FG000|Overall Study|Other Reason|4|||
27812885|NCT01592409|54269131|FG000|Overall Study|Withdrawal by Subject|0|||
27812886|NCT01592409|54269132|FG001|Overall Study|Withdrawal by Subject|1|||
27812887|NCT01697319|54269151|FG000|Primary Phase|Withdrawal by Subject|1|||
27812888|NCT01697319|54269151|FG000|Extension Phase|Terminated by Sponsor|15|||
27812889|NCT01566435|54269166|FG000|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1|||
27812890|NCT01696929|54269174|FG000|Overall Study|Physician Decision|1|||
27812891|NCT01696773|54269184|FG000|Days 15-27, Washout|Adverse Event|1|||
27812892|NCT01696773|54269185|FG001|Days 15-27, Washout|Adverse Event|0|||
27812893|NCT01696695|54269191|FG000|Overall Study|Disease progression|373|||
27812894|NCT01696695|54269191|FG000|Overall Study|Death|29|||
27812895|NCT01696695|54269191|FG000|Overall Study|Adverse Event|74|||
27812896|NCT01696695|54269191|FG000|Overall Study|Withdrawal by Subject|92|||
27812897|NCT01696695|54269191|FG000|Overall Study|Lost to Follow-up|48|||
27812898|NCT01696695|54269191|FG000|Overall Study|Other|74|||
27939946|NCT00943852|54596282|FG005|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
28053753|NCT00428090|54710891|FG000|Overall Study|Death of par.|1|||
28053754|NCT00428090|54710892|FG001|Overall Study|Death of par.|0|||
28053755|NCT00428090|54710893|FG002|Overall Study|Death of par.|1|||
28053756|NCT00428090|54710894|FG003|Overall Study|Death of par.|0|||
28053757|NCT00428090|54710891|FG000|Overall Study|Visit 7 exceed the visit window|0|||
28053758|NCT00428090|54710892|FG001|Overall Study|Visit 7 exceed the visit window|1|||
28053759|NCT00428090|54710893|FG002|Overall Study|Visit 7 exceed the visit window|0|||
28053760|NCT00428090|54710894|FG003|Overall Study|Visit 7 exceed the visit window|0|||
28053761|NCT00428090|54710891|FG000|Overall Study|Medical monitor terminated par.|0|||
28053762|NCT00428090|54710892|FG001|Overall Study|Medical monitor terminated par.|1|||
28053763|NCT00428090|54710893|FG002|Overall Study|Medical monitor terminated par.|0|||
28053764|NCT00428090|54710894|FG003|Overall Study|Medical monitor terminated par.|0|||
28053765|NCT00428090|54710891|FG000|Overall Study|Mental status of par. was|0|||
28053766|NCT00428090|54710892|FG001|Overall Study|Mental status of par. was|1|||
28053767|NCT00428090|54710893|FG002|Overall Study|Mental status of par. was|0|||
28053768|NCT00428090|54710894|FG003|Overall Study|Mental status of par. was|0|||
28053769|NCT00428090|54710891|FG000|Overall Study|Worsening of AD|0|||
28053770|NCT00428090|54710892|FG001|Overall Study|Worsening of AD|0|||
28053771|NCT00428090|54710893|FG002|Overall Study|Worsening of AD|1|||
28053772|NCT00428090|54710894|FG003|Overall Study|Worsening of AD|0|||
28053773|NCT00428090|54710891|FG000|Overall Study|Excluded for concerning QTc value|0|||
28053774|NCT00428090|54710892|FG001|Overall Study|Excluded for concerning QTc value|0|||
28053775|NCT00428090|54710893|FG002|Overall Study|Excluded for concerning QTc value|1|||
28053776|NCT00428090|54710894|FG003|Overall Study|Excluded for concerning QTc value|0|||
28053777|NCT00428090|54710891|FG000|Overall Study|Insufficient AD documentation|0|||
28053778|NCT00428090|54710892|FG001|Overall Study|Insufficient AD documentation|0|||
27812899|NCT01696695|54269191|FG000|Overall Study|Major Protocol Violation|192|||
28053779|NCT00428090|54710893|FG002|Overall Study|Insufficient AD documentation|1|||
28053780|NCT00428090|54710894|FG003|Overall Study|Insufficient AD documentation|0|||
28053781|NCT00428090|54710891|FG000|Overall Study|High MMSE scores|0|||
28053782|NCT00428090|54710892|FG001|Overall Study|High MMSE scores|0|||
28053783|NCT00428090|54710893|FG002|Overall Study|High MMSE scores|1|||
28053784|NCT00428090|54710894|FG003|Overall Study|High MMSE scores|0|||
28053785|NCT00428090|54710891|FG000|Overall Study|Deterioration of cognitive status|0|||
28053786|NCT00428090|54710892|FG001|Overall Study|Deterioration of cognitive status|0|||
28053787|NCT00428090|54710893|FG002|Overall Study|Deterioration of cognitive status|1|||
28053788|NCT00428090|54710894|FG003|Overall Study|Deterioration of cognitive status|0|||
28053789|NCT00428090|54710891|FG000|Overall Study|Serious adverse event|0|||
28053790|NCT00428090|54710892|FG001|Overall Study|Serious adverse event|0|||
28053791|NCT00428090|54710893|FG002|Overall Study|Serious adverse event|1|||
28053792|NCT00428090|54710894|FG003|Overall Study|Serious adverse event|0|||
28053793|NCT00428090|54710891|FG000|Overall Study|Excluded for heart insufficiency|0|||
28053794|NCT00428090|54710892|FG001|Overall Study|Excluded for heart insufficiency|0|||
28053795|NCT00428090|54710893|FG002|Overall Study|Excluded for heart insufficiency|1|||
28053796|NCT00428090|54710894|FG003|Overall Study|Excluded for heart insufficiency|0|||
28053797|NCT00428090|54710891|FG000|Overall Study|Raised Creatinine Value|0|||
28053798|NCT00428090|54710892|FG001|Overall Study|Raised Creatinine Value|0|||
28053799|NCT00428090|54710893|FG002|Overall Study|Raised Creatinine Value|0|||
28053800|NCT00428090|54710894|FG003|Overall Study|Raised Creatinine Value|1|||
28053801|NCT00416312|54710912|FG000|Overall Study|tumors not visible on imaging|2|||
28053802|NCT00436436|54710916|FG000|Overall Study|Progression|4|||
28053803|NCT00436436|54710916|FG000|Overall Study|Adverse Event|2|||
27812900|NCT01565889|54269210|FG000|Part A|Withdrawal by Subject|1|||
27812901|NCT01565889|54269211|FG001|Part A|Withdrawal by Subject|0|||
27812902|NCT01565889|54269212|FG002|Part A|Withdrawal by Subject|0|||
27812903|NCT01565889|54269213|FG003|Part A|Withdrawal by Subject|0|||
28053804|NCT00436436|54710916|FG000|Overall Study|Death|6|||
28053805|NCT00262522|54710924|FG000|Study Start Through 8 Weeks|Adverse Event|1|||
28053806|NCT00262522|54710925|FG001|Study Start Through 8 Weeks|Adverse Event|2|||
28053807|NCT00262522|54710926|FG002|Study Start Through 8 Weeks|Adverse Event|3|||
28053808|NCT00262522|54710927|FG003|Study Start Through 8 Weeks|Adverse Event|1|||
28053809|NCT00262522|54710924|FG000|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
28053810|NCT00262522|54710925|FG001|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
28053811|NCT00262522|54710926|FG002|Study Start Through 8 Weeks|Withdrawal by Subject|3|||
28053812|NCT00262522|54710927|FG003|Study Start Through 8 Weeks|Withdrawal by Subject|0|||
28053813|NCT00262522|54710924|FG000|Study Start Through 8 Weeks|Lost to Follow-up|1|||
28053814|NCT00262522|54710925|FG001|Study Start Through 8 Weeks|Lost to Follow-up|2|||
28053815|NCT00262522|54710926|FG002|Study Start Through 8 Weeks|Lost to Follow-up|3|||
28053816|NCT00262522|54710927|FG003|Study Start Through 8 Weeks|Lost to Follow-up|2|||
28053817|NCT00262522|54710924|FG000|Study Start Through 8 Weeks|Noncompliance|0|||
28053818|NCT00262522|54710925|FG001|Study Start Through 8 Weeks|Noncompliance|0|||
28053819|NCT00262522|54710926|FG002|Study Start Through 8 Weeks|Noncompliance|2|||
28053820|NCT00262522|54710927|FG003|Study Start Through 8 Weeks|Noncompliance|2|||
28053821|NCT00262522|54710924|FG000|Study Start Through 8 Weeks|Death|1|||
28053822|NCT00262522|54710925|FG001|Study Start Through 8 Weeks|Death|0|||
28053823|NCT00262522|54710926|FG002|Study Start Through 8 Weeks|Death|0|||
28053824|NCT00262522|54710927|FG003|Study Start Through 8 Weeks|Death|0|||
28053825|NCT00262522|54710924|FG000|Study Start Through 48 Weeks|Adverse Event|16|||
28053826|NCT00262522|54710925|FG001|Study Start Through 48 Weeks|Adverse Event|0|||
28053827|NCT00262522|54710926|FG002|Study Start Through 48 Weeks|Adverse Event|10|||
28053828|NCT00262522|54710927|FG003|Study Start Through 48 Weeks|Adverse Event|0|||
28053829|NCT00262522|54710924|FG000|Study Start Through 48 Weeks|Withdrawal by Subject|10|||
28053830|NCT00262522|54710925|FG001|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
28053831|NCT00262522|54710926|FG002|Study Start Through 48 Weeks|Withdrawal by Subject|11|||
28053832|NCT00262522|54710927|FG003|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
28053833|NCT00262522|54710924|FG000|Study Start Through 48 Weeks|Lost to Follow-up|8|||
28053834|NCT00262522|54710925|FG001|Study Start Through 48 Weeks|Lost to Follow-up|0|||
28053835|NCT00262522|54710926|FG002|Study Start Through 48 Weeks|Lost to Follow-up|14|||
28053836|NCT00262522|54710927|FG003|Study Start Through 48 Weeks|Lost to Follow-up|0|||
28053837|NCT00262522|54710924|FG000|Study Start Through 48 Weeks|Noncompliance|3|||
28053838|NCT00262522|54710925|FG001|Study Start Through 48 Weeks|Noncompliance|0|||
28053839|NCT00262522|54710926|FG002|Study Start Through 48 Weeks|Noncompliance|8|||
28053840|NCT00262522|54710927|FG003|Study Start Through 48 Weeks|Noncompliance|0|||
28053841|NCT00262522|54710924|FG000|Study Start Through 48 Weeks|Death|2|||
28053842|NCT00262522|54710925|FG001|Study Start Through 48 Weeks|Death|0|||
28053843|NCT00262522|54710926|FG002|Study Start Through 48 Weeks|Death|1|||
28053844|NCT00262522|54710927|FG003|Study Start Through 48 Weeks|Death|0|||
28053845|NCT00262522|54710924|FG000|Study Start Through 48 Weeks|Virologic failure|2|||
28053846|NCT00262522|54710925|FG001|Study Start Through 48 Weeks|Virologic failure|0|||
28053847|NCT00262522|54710926|FG002|Study Start Through 48 Weeks|Virologic failure|4|||
28053848|NCT00262522|54710927|FG003|Study Start Through 48 Weeks|Virologic failure|0|||
28053849|NCT00262522|54710924|FG000|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8|||
28053850|NCT00262522|54710925|FG001|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
28053851|NCT00262522|54710926|FG002|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7|||
28053852|NCT00262522|54710927|FG003|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
28053853|NCT00262522|54710924|FG000|Study Start Through 96 Weeks|Adverse Event|20|||
28053854|NCT00262522|54710925|FG001|Study Start Through 96 Weeks|Adverse Event|0|||
28053855|NCT00262522|54710926|FG002|Study Start Through 96 Weeks|Adverse Event|16|||
28053856|NCT00262522|54710927|FG003|Study Start Through 96 Weeks|Adverse Event|0|||
28053857|NCT00262522|54710924|FG000|Study Start Through 96 Weeks|Withdrawal by Subject|15|||
28053858|NCT00262522|54710925|FG001|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
28053859|NCT00262522|54710926|FG002|Study Start Through 96 Weeks|Withdrawal by Subject|13|||
28053860|NCT00262522|54710927|FG003|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
28053861|NCT00262522|54710924|FG000|Study Start Through 96 Weeks|Lost to Follow-up|19|||
28053862|NCT00262522|54710925|FG001|Study Start Through 96 Weeks|Lost to Follow-up|0|||
28053863|NCT00262522|54710926|FG002|Study Start Through 96 Weeks|Lost to Follow-up|18|||
28053864|NCT00262522|54710927|FG003|Study Start Through 96 Weeks|Lost to Follow-up|0|||
28053865|NCT00262522|54710924|FG000|Study Start Through 96 Weeks|Noncompliance|6|||
28053866|NCT00262522|54710925|FG001|Study Start Through 96 Weeks|Noncompliance|0|||
28053867|NCT00262522|54710926|FG002|Study Start Through 96 Weeks|Noncompliance|11|||
28053868|NCT00262522|54710927|FG003|Study Start Through 96 Weeks|Noncompliance|0|||
28053869|NCT00262522|54710924|FG000|Study Start Through 96 Weeks|Death|2|||
28053870|NCT00262522|54710925|FG001|Study Start Through 96 Weeks|Death|0|||
28053871|NCT00262522|54710926|FG002|Study Start Through 96 Weeks|Death|2|||
28053872|NCT00262522|54710927|FG003|Study Start Through 96 Weeks|Death|0|||
28159976|NCT02737475|54830024|FG002|Overall Study|Participant withdrew consent|0|||
28053873|NCT00262522|54710924|FG000|Study Start Through 96 Weeks|Virologic failure|5|||
28053874|NCT00262522|54710925|FG001|Study Start Through 96 Weeks|Virologic failure|0|||
28053875|NCT00262522|54710926|FG002|Study Start Through 96 Weeks|Virologic failure|8|||
28053876|NCT00262522|54710927|FG003|Study Start Through 96 Weeks|Virologic failure|0|||
28053877|NCT00262522|54710924|FG000|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10|||
28053878|NCT00262522|54710925|FG001|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
28053879|NCT00262522|54710926|FG002|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9|||
28053880|NCT00262522|54710927|FG003|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
28053881|NCT00436280|54710935|FG000|Period 1: Induction|Adverse Event|8|||
28053882|NCT00436280|54710935|FG000|Period 1: Induction|Progressive Disease|12|||
28053883|NCT00436280|54710935|FG000|Period 1: Induction|Stable Disease|6|||
28053884|NCT00436280|54710935|FG000|Period 1: Induction|Withdrawal by Subject|1|||
28053885|NCT00436280|54710935|FG000|Period 1: Induction|Death|1|||
28053886|NCT00436280|54710935|FG000|Period 2: Consolidation|Adverse Event|1|||
28053887|NCT00436280|54710935|FG000|Period 2: Consolidation|Progressive Disease|10|||
28053888|NCT00436280|54710935|FG000|Period 2: Consolidation|Stable Disease|1|||
28053889|NCT00436280|54710935|FG000|Period 2: Consolidation|Physician Decision|2|||
28053890|NCT00436280|54710935|FG000|Period 2: Consolidation|Withdrawal by Subject|2|||
28053891|NCT00436280|54710935|FG000|Period 2: Consolidation|Death|1|||
28053892|NCT00436280|54710935|FG000|Period 3: Maintenance|Adverse Event|6|||
27812904|NCT01565889|54269214|FG004|Part A|Withdrawal by Subject|0|||
27812905|NCT01565889|54269215|FG005|Part A|Withdrawal by Subject|0|||
27812906|NCT01565889|54269210|FG000|Part B|Withdrawal by Subject|0|||
27812907|NCT01565889|54269211|FG001|Part B|Withdrawal by Subject|0|||
27812908|NCT01565889|54269212|FG002|Part B|Withdrawal by Subject|0|||
27812909|NCT01565889|54269213|FG003|Part B|Withdrawal by Subject|0|||
27812910|NCT01565889|54269214|FG004|Part B|Withdrawal by Subject|0|||
27812911|NCT01565889|54269215|FG005|Part B|Withdrawal by Subject|1|||
27812912|NCT01565889|54269210|FG000|Part B|Lack of Efficacy|0|||
27812913|NCT01565889|54269211|FG001|Part B|Lack of Efficacy|0|||
27812914|NCT01565889|54269212|FG002|Part B|Lack of Efficacy|0|||
27812915|NCT01565889|54269213|FG003|Part B|Lack of Efficacy|0|||
27812916|NCT01565889|54269214|FG004|Part B|Lack of Efficacy|0|||
27812917|NCT01565889|54269215|FG005|Part B|Lack of Efficacy|2|||
27812918|NCT01565889|54269210|FG000|Part B|Lost to Follow-up|0|||
27812919|NCT01565889|54269211|FG001|Part B|Lost to Follow-up|0|||
27812920|NCT01565889|54269212|FG002|Part B|Lost to Follow-up|0|||
27812921|NCT01565889|54269213|FG003|Part B|Lost to Follow-up|0|||
27812922|NCT01565889|54269214|FG004|Part B|Lost to Follow-up|0|||
27812923|NCT01565889|54269215|FG005|Part B|Lost to Follow-up|1|||
27812924|NCT01696071|54269230|FG000|Treatment Period 2: 4 Weeks|Adverse Event|1|||
27812925|NCT01696071|54269231|FG001|Treatment Period 2: 4 Weeks|Adverse Event|0|||
27812926|NCT01591863|54269242|FG000|Overall Study|Adverse Event|3|||
27812927|NCT01591863|54269242|FG000|Overall Study|Withdrawal by Subject|1|||
27812928|NCT01591863|54269242|FG000|Overall Study|recurrence|9|||
27812929|NCT01591863|54269242|FG000|Overall Study|Lack of Efficacy|1|||
27812930|NCT01591785|54269248|FG000|Overall Study|worsening condition|1|||
27812931|NCT01591785|54269249|FG001|Overall Study|worsening condition|2|||
27812932|NCT01591785|54269248|FG000|Overall Study|Protocol Violation|2|||
27812933|NCT01591785|54269249|FG001|Overall Study|Protocol Violation|0|||
27812934|NCT01591785|54269248|FG000|Overall Study|Lost to Follow-up|1|||
27812935|NCT01591785|54269249|FG001|Overall Study|Lost to Follow-up|0|||
27812936|NCT01695993|54269258|FG000|Overall Study|Lost to Follow-up|2|||
27812937|NCT01695993|54269259|FG001|Overall Study|Lost to Follow-up|1|||
27812938|NCT01695993|54269260|FG002|Overall Study|Lost to Follow-up|3|||
27812939|NCT01695993|54269258|FG000|Overall Study|Withdrawal by Subject|2|||
27812940|NCT01695993|54269259|FG001|Overall Study|Withdrawal by Subject|2|||
27812941|NCT01695993|54269260|FG002|Overall Study|Withdrawal by Subject|2|||
27812942|NCT01695993|54269258|FG000|Overall Study|To ill to continue|1|||
27812943|NCT01695993|54269259|FG001|Overall Study|To ill to continue|2|||
27812944|NCT01695993|54269260|FG002|Overall Study|To ill to continue|0|||
27848234|NCT01045161|54341215|FG001|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3|||
27848235|NCT01045161|54341216|FG002|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2|||
28053893|NCT00436280|54710935|FG000|Period 3: Maintenance|Progressive Disease|12|||
28053894|NCT00394836|54710941|FG000|Teatment or Follow-up Phase|Adverse Event|0|||
28053895|NCT00394836|54710942|FG001|Teatment or Follow-up Phase|Adverse Event|2|||
27812945|NCT01695993|54269258|FG000|Overall Study|Changed Medical Facility|0|||
27812946|NCT01695993|54269259|FG001|Overall Study|Changed Medical Facility|0|||
27812947|NCT01695993|54269260|FG002|Overall Study|Changed Medical Facility|1|||
27812948|NCT01565343|54269271|FG000|Overall Study|Administrative decision/technical issues|1|||
27812949|NCT01565343|54269272|FG001|Overall Study|Administrative decision/technical issues|0|||
27812950|NCT01565343|54269273|FG002|Overall Study|Administrative decision/technical issues|0|||
27812951|NCT01695135|54269298|FG000|Double-blind Treatment Phase|Progressive disease|50|||
27812952|NCT01695135|54269299|FG001|Double-blind Treatment Phase|Progressive disease|110|||
27812953|NCT01695135|54269300|FG002|Double-blind Treatment Phase|Progressive disease|0|||
27812954|NCT01695135|54269301|FG003|Double-blind Treatment Phase|Progressive disease|0|||
27812955|NCT01695135|54269298|FG000|Double-blind Treatment Phase|Withdrawal by Subject|6|||
27812956|NCT01695135|54269299|FG001|Double-blind Treatment Phase|Withdrawal by Subject|14|||
27812957|NCT01695135|54269300|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
27812958|NCT01695135|54269301|FG003|Double-blind Treatment Phase|Withdrawal by Subject|0|||
27812959|NCT01695135|54269298|FG000|Double-blind Treatment Phase|Adverse Event|7|||
27812960|NCT01695135|54269299|FG001|Double-blind Treatment Phase|Adverse Event|7|||
27812961|NCT01695135|54269300|FG002|Double-blind Treatment Phase|Adverse Event|0|||
27812962|NCT01695135|54269301|FG003|Double-blind Treatment Phase|Adverse Event|0|||
27812963|NCT01695135|54269298|FG000|Double-blind Treatment Phase|Other|1|||
27812964|NCT01695135|54269299|FG001|Double-blind Treatment Phase|Other|3|||
27812965|NCT01695135|54269300|FG002|Double-blind Treatment Phase|Other|0|||
27812966|NCT01695135|54269301|FG003|Double-blind Treatment Phase|Other|0|||
27812967|NCT01695135|54269298|FG000|Double-blind Treatment Phase|Physician Decision|6|||
27812968|NCT01695135|54269299|FG001|Double-blind Treatment Phase|Physician Decision|3|||
27812969|NCT01695135|54269300|FG002|Double-blind Treatment Phase|Physician Decision|0|||
27812970|NCT01695135|54269301|FG003|Double-blind Treatment Phase|Physician Decision|0|||
27812971|NCT01695135|54269298|FG000|Double-blind Treatment Phase|Death|1|||
27812972|NCT01695135|54269299|FG001|Double-blind Treatment Phase|Death|1|||
27812973|NCT01695135|54269300|FG002|Double-blind Treatment Phase|Death|0|||
27812974|NCT01695135|54269301|FG003|Double-blind Treatment Phase|Death|0|||
27812975|NCT01695135|54269298|FG000|Double-blind Treatment Phase|Noncompliance with study drug|0|||
27812976|NCT01695135|54269299|FG001|Double-blind Treatment Phase|Noncompliance with study drug|1|||
27812977|NCT01695135|54269300|FG002|Double-blind Treatment Phase|Noncompliance with study drug|0|||
27812978|NCT01695135|54269301|FG003|Double-blind Treatment Phase|Noncompliance with study drug|0|||
27812979|NCT01695135|54269298|FG000|Open Label Extension Treatment Phase|Progressive disease|0|||
27812980|NCT01695135|54269299|FG001|Open Label Extension Treatment Phase|Progressive disease|0|||
27812981|NCT01695135|54269300|FG002|Open Label Extension Treatment Phase|Progressive disease|13|||
27812982|NCT01695135|54269301|FG003|Open Label Extension Treatment Phase|Progressive disease|22|||
27812983|NCT01695135|54269298|FG000|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
27812984|NCT01695135|54269299|FG001|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
27812985|NCT01695135|54269300|FG002|Open Label Extension Treatment Phase|Withdrawal by Subject|6|||
27812986|NCT01695135|54269301|FG003|Open Label Extension Treatment Phase|Withdrawal by Subject|16|||
27812987|NCT01695135|54269298|FG000|Open Label Extension Treatment Phase|Adverse Event|0|||
27812988|NCT01695135|54269299|FG001|Open Label Extension Treatment Phase|Adverse Event|0|||
27812989|NCT01695135|54269300|FG002|Open Label Extension Treatment Phase|Adverse Event|11|||
28053896|NCT00394836|54710941|FG000|Teatment or Follow-up Phase|Protocol Violation|0|||
28053897|NCT00394836|54710942|FG001|Teatment or Follow-up Phase|Protocol Violation|2|||
28053898|NCT00394836|54710941|FG000|Teatment or Follow-up Phase|Disease Progression|27|||
28053899|NCT00394836|54710942|FG001|Teatment or Follow-up Phase|Disease Progression|60|||
28053900|NCT00394836|54710941|FG000|Teatment or Follow-up Phase|Patient Refusal|1|||
28053901|NCT00394836|54710942|FG001|Teatment or Follow-up Phase|Patient Refusal|2|||
28053902|NCT00394836|54710941|FG000|Teatment or Follow-up Phase|Death|0|||
28053903|NCT00394836|54710942|FG001|Teatment or Follow-up Phase|Death|1|||
28053904|NCT00394836|54710941|FG000|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0|||
28053905|NCT00394836|54710942|FG001|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1|||
28053906|NCT00394836|54710941|FG000|Teatment or Follow-up Phase|Started alternative treatment|0|||
28053907|NCT00394836|54710942|FG001|Teatment or Follow-up Phase|Started alternative treatment|6|||
28053908|NCT00394836|54710941|FG000|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0|||
28053909|NCT00394836|54710942|FG001|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1|||
28053910|NCT00394836|54710941|FG000|Teatment or Follow-up Phase|Physician Decision|0|||
28053911|NCT00394836|54710942|FG001|Teatment or Follow-up Phase|Physician Decision|1|||
28053912|NCT00394836|54710941|FG000|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0|||
28053913|NCT00394836|54710942|FG001|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1|||
28053914|NCT00394836|54710941|FG000|Teatment or Follow-up Phase|Non compliance|0|||
28053915|NCT00394836|54710942|FG001|Teatment or Follow-up Phase|Non compliance|1|||
28053916|NCT00394836|54710941|FG000|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0|||
28053917|NCT00394836|54710942|FG001|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1|||
28053918|NCT00394836|54710941|FG000|Extended Follow-up Phase (2-5 Years)|Death|0|||
28053919|NCT00394836|54710942|FG001|Extended Follow-up Phase (2-5 Years)|Death|1|||
28053920|NCT00394836|54710941|FG000|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13|||
28053921|NCT00394836|54710942|FG001|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41|||
28053922|NCT00394836|54710941|FG000|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7|||
28053923|NCT00394836|54710942|FG001|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10|||
28053924|NCT00250588|54710953|FG000|Overall Study|Withdrawal by Subject|3|||
28053925|NCT00250588|54710954|FG001|Overall Study|Withdrawal by Subject|6|||
28053926|NCT00250588|54710955|FG002|Overall Study|Withdrawal by Subject|0|||
28053927|NCT00250588|54710953|FG000|Overall Study|Lost to Follow-up|6|||
28053928|NCT00250588|54710954|FG001|Overall Study|Lost to Follow-up|13|||
28053929|NCT00250588|54710955|FG002|Overall Study|Lost to Follow-up|13|||
28053930|NCT00416078|54710965|FG000|Overall Study|Death|3|||
28053931|NCT00416078|54710966|FG001|Overall Study|Death|4|||
28053932|NCT00416078|54710965|FG000|Overall Study|Withdrawal by Subject|3|||
28053933|NCT00416078|54710966|FG001|Overall Study|Withdrawal by Subject|2|||
28053934|NCT00416078|54710965|FG000|Overall Study|Physician Decision|1|||
28053935|NCT00416078|54710966|FG001|Overall Study|Physician Decision|0|||
28053936|NCT00416078|54710965|FG000|Overall Study|Lost to Follow-up|4|||
28053937|NCT00416078|54710966|FG001|Overall Study|Lost to Follow-up|2|||
28053938|NCT00394524|54710974|FG000|Overall Study|Protocol Violation|2|||
28053939|NCT00394524|54710975|FG001|Overall Study|Protocol Violation|3|||
28053940|NCT00394524|54710974|FG000|Overall Study|Death|1|||
27812990|NCT01695135|54269301|FG003|Open Label Extension Treatment Phase|Adverse Event|16|||
27812991|NCT01695135|54269298|FG000|Open Label Extension Treatment Phase|Other|0|||
27812992|NCT01695135|54269299|FG001|Open Label Extension Treatment Phase|Other|0|||
27812993|NCT01695135|54269300|FG002|Open Label Extension Treatment Phase|Other|4|||
27812994|NCT01695135|54269301|FG003|Open Label Extension Treatment Phase|Other|7|||
27812995|NCT01695135|54269298|FG000|Open Label Extension Treatment Phase|Physician Decision|0|||
27812996|NCT01695135|54269299|FG001|Open Label Extension Treatment Phase|Physician Decision|0|||
27812997|NCT01695135|54269300|FG002|Open Label Extension Treatment Phase|Physician Decision|4|||
27812998|NCT01695135|54269301|FG003|Open Label Extension Treatment Phase|Physician Decision|1|||
27812999|NCT01695135|54269298|FG000|Open Label Extension Treatment Phase|Death|0|||
27813000|NCT01695135|54269299|FG001|Open Label Extension Treatment Phase|Death|0|||
27813001|NCT01695135|54269300|FG002|Open Label Extension Treatment Phase|Death|2|||
27813002|NCT01695135|54269301|FG003|Open Label Extension Treatment Phase|Death|7|||
27813003|NCT01695135|54269298|FG000|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
27813004|NCT01695135|54269299|FG001|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
27813005|NCT01695135|54269300|FG002|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
27813006|NCT01695135|54269301|FG003|Open Label Extension Treatment Phase|Noncompliance with study drug|1|||
27813007|NCT01610414|54269311|FG000|Study Start - Month 13|Serious Adverse Event|65|||
27813008|NCT01610414|54269312|FG001|Study Start - Month 13|Serious Adverse Event|67|||
27813009|NCT01610414|54269311|FG000|Study Start - Month 13|Adverse Event|14|||
27813010|NCT01610414|54269312|FG001|Study Start - Month 13|Adverse Event|14|||
27848236|NCT01045161|54341214|FG000|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4|||
28053941|NCT00394524|54710975|FG001|Overall Study|Death|0|||
28053942|NCT00394524|54710974|FG000|Overall Study|Withdrawal by Subject|0|||
28053943|NCT00394524|54710975|FG001|Overall Study|Withdrawal by Subject|1|||
28053944|NCT00409344|54710985|FG000|Overall Study|no enrollment|0|||
28053945|NCT00409344|54710986|FG001|Overall Study|no enrollment|0|||
28053946|NCT00415610|54710995|FG000|Overall Study|Death|3|||
28053947|NCT00415610|54710996|FG001|Overall Study|Death|2|||
28053948|NCT00415610|54710997|FG002|Overall Study|Death|5|||
28053949|NCT00394212|54711007|FG000|Overall Study|Lost to Follow-up|3|||
28053950|NCT00394212|54711008|FG001|Overall Study|Lost to Follow-up|0|||
28053951|NCT00394212|54711007|FG000|Overall Study|Withdrawal by Subject|4|||
28053952|NCT00394212|54711008|FG001|Overall Study|Withdrawal by Subject|1|||
28053953|NCT00250432|54711016|FG000|Overall Study|Adverse Event|25|||
28053954|NCT00250432|54711017|FG001|Overall Study|Adverse Event|29|||
28053955|NCT00250432|54711016|FG000|Overall Study|Lack of Efficacy|2|||
28053956|NCT00250432|54711017|FG001|Overall Study|Lack of Efficacy|1|||
28053957|NCT00250432|54711016|FG000|Overall Study|Lost to Follow-up|6|||
28053958|NCT00250432|54711017|FG001|Overall Study|Lost to Follow-up|5|||
28053959|NCT00250432|54711016|FG000|Overall Study|Patient Moved|0|||
28053960|NCT00250432|54711017|FG001|Overall Study|Patient Moved|1|||
28053961|NCT00250432|54711016|FG000|Overall Study|Protocol Violation|0|||
28053962|NCT00250432|54711017|FG001|Overall Study|Protocol Violation|3|||
28053963|NCT00250432|54711016|FG000|Overall Study|Withdrawal by Subject|6|||
28053964|NCT00250432|54711017|FG001|Overall Study|Withdrawal by Subject|2|||
28053965|NCT00250432|54711016|FG000|Overall Study|Pt died out of posttherapy report period|6|||
28053966|NCT00250432|54711017|FG001|Overall Study|Pt died out of posttherapy report period|5|||
28053967|NCT00250432|54711016|FG000|Overall Study|Pt was considered untreatable|0|||
28053968|NCT00250432|54711017|FG001|Overall Study|Pt was considered untreatable|1|||
28053969|NCT00250276|54711027|FG000|Overall Study|Serious Adverse Event|0|||
28053970|NCT00250276|54711028|FG001|Overall Study|Serious Adverse Event|0|||
27813011|NCT01610414|54269311|FG000|Study Start - Month 13|Protocol Violation|3|||
27813012|NCT01610414|54269312|FG001|Study Start - Month 13|Protocol Violation|1|||
27848237|NCT01045161|54341215|FG001|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1|||
28053971|NCT00250276|54711029|FG002|Overall Study|Serious Adverse Event|1|||
28053972|NCT00250276|54711030|FG003|Overall Study|Serious Adverse Event|0|||
28053973|NCT00250276|54711027|FG000|Overall Study|Non-serious Adverse Event|2|||
28053974|NCT00250276|54711028|FG001|Overall Study|Non-serious Adverse Event|0|||
28053975|NCT00250276|54711029|FG002|Overall Study|Non-serious Adverse Event|0|||
28053976|NCT00250276|54711030|FG003|Overall Study|Non-serious Adverse Event|2|||
27813013|NCT01610414|54269311|FG000|Study Start - Month 13|Withdrawal by Subject|23|||
27813014|NCT01610414|54269312|FG001|Study Start - Month 13|Withdrawal by Subject|30|||
27813015|NCT01610414|54269311|FG000|Study Start - Month 13|Migrated/moved from study area|2|||
27813016|NCT01610414|54269312|FG001|Study Start - Month 13|Migrated/moved from study area|4|||
27813017|NCT01610414|54269311|FG000|Study Start - Month 13|Lost to Follow-up|4|||
27813018|NCT01610414|54269312|FG001|Study Start - Month 13|Lost to Follow-up|6|||
27813019|NCT01610414|54269311|FG000|Study Start - Month 13|Suspected HZ episode|1|||
27813020|NCT01610414|54269312|FG001|Study Start - Month 13|Suspected HZ episode|3|||
27813021|NCT01610414|54269311|FG000|Study Start - Month 13|Other reasons for withdrawal|3|||
27813022|NCT01610414|54269312|FG001|Study Start - Month 13|Other reasons for withdrawal|4|||
27813023|NCT01610414|54269311|FG000|Month 13 - Month 25|Serious Adverse Event|35|||
27813024|NCT01610414|54269312|FG001|Month 13 - Month 25|Serious Adverse Event|38|||
27813025|NCT01610414|54269311|FG000|Month 13 - Month 25|Adverse Event|8|||
27813026|NCT01610414|54269312|FG001|Month 13 - Month 25|Adverse Event|4|||
27813027|NCT01610414|54269311|FG000|Month 13 - Month 25|Withdrawal by Subject|7|||
27813028|NCT01610414|54269312|FG001|Month 13 - Month 25|Withdrawal by Subject|8|||
27813029|NCT01610414|54269311|FG000|Month 13 - Month 25|Migrated/moved from study area|4|||
27813030|NCT01610414|54269312|FG001|Month 13 - Month 25|Migrated/moved from study area|2|||
27813031|NCT01610414|54269311|FG000|Month 13 - Month 25|Protocol Violation|0|||
27813032|NCT01610414|54269312|FG001|Month 13 - Month 25|Protocol Violation|2|||
27813033|NCT01610414|54269311|FG000|Month 13 - Month 25|Lost to Follow-up|5|||
27813034|NCT01610414|54269312|FG001|Month 13 - Month 25|Lost to Follow-up|9|||
27813035|NCT01610414|54269311|FG000|Month 13 - Month 25|Other reasons for withdrawal|6|||
27813036|NCT01610414|54269312|FG001|Month 13 - Month 25|Other reasons for withdrawal|7|||
27813037|NCT01610414|54269311|FG000|After Month 25|Study end not reached|48|||
27813038|NCT01610414|54269312|FG001|After Month 25|Study end not reached|53|||
27813039|NCT01564407|54269340|FG000|Overall Study|Lost to Follow-up|0|||
27813040|NCT01564407|54269341|FG001|Overall Study|Lost to Follow-up|1|||
27813041|NCT01564407|54269342|FG002|Overall Study|Lost to Follow-up|0|||
27813042|NCT01564407|54269343|FG003|Overall Study|Lost to Follow-up|0|||
27813043|NCT01564407|54269344|FG004|Overall Study|Lost to Follow-up|0|||
28053977|NCT00250276|54711027|FG000|Overall Study|Protocol Violation|0|||
28053978|NCT00250276|54711028|FG001|Overall Study|Protocol Violation|1|||
28053979|NCT00250276|54711029|FG002|Overall Study|Protocol Violation|0|||
28053980|NCT00250276|54711030|FG003|Overall Study|Protocol Violation|0|||
28053981|NCT00250276|54711027|FG000|Overall Study|Withdrawal by Subject|1|||
28053982|NCT00250276|54711028|FG001|Overall Study|Withdrawal by Subject|2|||
28053983|NCT00250276|54711029|FG002|Overall Study|Withdrawal by Subject|3|||
28053984|NCT00250276|54711030|FG003|Overall Study|Withdrawal by Subject|2|||
28053985|NCT00250276|54711027|FG000|Overall Study|Migrated/moved from study area|3|||
28053986|NCT00250276|54711028|FG001|Overall Study|Migrated/moved from study area|0|||
28053987|NCT00250276|54711029|FG002|Overall Study|Migrated/moved from study area|2|||
28053988|NCT00250276|54711030|FG003|Overall Study|Migrated/moved from study area|7|||
28053989|NCT00250276|54711027|FG000|Overall Study|Lost to Follow-up|11|||
28053990|NCT00250276|54711028|FG001|Overall Study|Lost to Follow-up|18|||
28053991|NCT00250276|54711029|FG002|Overall Study|Lost to Follow-up|13|||
28053992|NCT00250276|54711030|FG003|Overall Study|Lost to Follow-up|8|||
28053993|NCT00249808|54711045|FG000|Overall Study|Other|27|||
28053994|NCT00249808|54711045|FG000|Overall Study|Protocol Violation|3|||
28053995|NCT00249808|54711045|FG000|Overall Study|Lost to Follow-up|8|||
28053996|NCT00249808|54711045|FG000|Overall Study|Adverse Event|81|||
28053997|NCT00249808|54711045|FG000|Overall Study|Lack of Efficacy|52|||
28053998|NCT00249808|54711045|FG000|Overall Study|Did Not Provide Post-Baseline Data|11|||
28053999|NCT00278512|54711051|FG000|Overall Study|Death|1|||
28054000|NCT00278512|54711052|FG001|Overall Study|Death|0|||
28054001|NCT00427934|54711062|FG000|Overall Study|Adverse Event|1|||
28054002|NCT00427934|54711063|FG001|Overall Study|Adverse Event|0|||
28054003|NCT00427934|54711064|FG002|Overall Study|Adverse Event|5|||
28054004|NCT00427934|54711065|FG003|Overall Study|Adverse Event|4|||
28054005|NCT00427934|54711062|FG000|Overall Study|Lack of Efficacy|0|||
28054006|NCT00427934|54711063|FG001|Overall Study|Lack of Efficacy|0|||
28054007|NCT00427934|54711064|FG002|Overall Study|Lack of Efficacy|5|||
28054008|NCT00427934|54711065|FG003|Overall Study|Lack of Efficacy|2|||
28054009|NCT00427934|54711062|FG000|Overall Study|Randomized But Did Not Receive Treatment|0|||
28054010|NCT00427934|54711063|FG001|Overall Study|Randomized But Did Not Receive Treatment|0|||
27813044|NCT01564407|54269340|FG000|Overall Study|Withdrawal by Subject|0|||
27813045|NCT01564407|54269341|FG001|Overall Study|Withdrawal by Subject|1|||
27848238|NCT01045161|54341216|FG002|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6|||
28054011|NCT00427934|54711064|FG002|Overall Study|Randomized But Did Not Receive Treatment|1|||
28054012|NCT00427934|54711065|FG003|Overall Study|Randomized But Did Not Receive Treatment|1|||
28054013|NCT00427934|54711062|FG000|Overall Study|Other|0|||
28054014|NCT00427934|54711063|FG001|Overall Study|Other|0|||
28054015|NCT00427934|54711064|FG002|Overall Study|Other|11|||
28054016|NCT00427934|54711065|FG003|Overall Study|Other|5|||
27813046|NCT01564407|54269342|FG002|Overall Study|Withdrawal by Subject|0|||
27813047|NCT01564407|54269343|FG003|Overall Study|Withdrawal by Subject|0|||
27813048|NCT01564407|54269344|FG004|Overall Study|Withdrawal by Subject|0|||
28054017|NCT00427934|54711062|FG000|Overall Study|Withdrawal by Subject|0|||
28054018|NCT00427934|54711063|FG001|Overall Study|Withdrawal by Subject|0|||
28054019|NCT00427934|54711064|FG002|Overall Study|Withdrawal by Subject|1|||
28054020|NCT00427934|54711065|FG003|Overall Study|Withdrawal by Subject|3|||
28054021|NCT00435188|54711079|FG000|Overall Study|Death|1|||
28054022|NCT00435188|54711080|FG001|Overall Study|Death|6|||
28054023|NCT00435188|54711079|FG000|Overall Study|Withdrawal by Subject|16|||
28054024|NCT00435188|54711080|FG001|Overall Study|Withdrawal by Subject|11|||
28054025|NCT00435188|54711079|FG000|Overall Study|Lost to Follow-up|5|||
28054026|NCT00435188|54711080|FG001|Overall Study|Lost to Follow-up|6|||
28054027|NCT00427778|54711088|FG000|First Intervention (4 Weeks)|no longer interested|1|||
28054028|NCT00427778|54711089|FG001|First Intervention (4 Weeks)|no longer interested|0|||
28054029|NCT00427778|54711088|FG000|First Intervention (4 Weeks)|Not successfully fitted with ring|2|||
28054030|NCT00427778|54711089|FG001|First Intervention (4 Weeks)|Not successfully fitted with ring|0|||
28054031|NCT00427778|54711088|FG000|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0|||
28054032|NCT00427778|54711089|FG001|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1|||
28054033|NCT00427778|54711088|FG000|First Intervention (4 Weeks)|anxious about using ring|1|||
28054034|NCT00427778|54711089|FG001|First Intervention (4 Weeks)|anxious about using ring|0|||
28054035|NCT00427700|54711110|FG000|Overall Study|Lost to Follow-up|2|||
28054036|NCT00427700|54711111|FG001|Overall Study|Lost to Follow-up|5|||
28054037|NCT00427700|54711110|FG000|Overall Study|no induction of menses|1|||
28054038|NCT00427700|54711111|FG001|Overall Study|no induction of menses|4|||
28054039|NCT00427700|54711110|FG000|Overall Study|Pregnancy|0|||
28054040|NCT00427700|54711111|FG001|Overall Study|Pregnancy|2|||
28054041|NCT00409188|54711120|FG000|Overall Study|Ongoing at data cut-off|383|||
28054042|NCT00409188|54711121|FG001|Overall Study|Ongoing at data cut-off|175|||
28054043|NCT00434954|54711129|FG000|Overall Study|Adverse Event|17|||
28054044|NCT00434954|54711130|FG001|Overall Study|Adverse Event|2|||
28054045|NCT00434954|54711129|FG000|Overall Study|Entry criteria not met|14|||
28054046|NCT00434954|54711130|FG001|Overall Study|Entry criteria not met|16|||
28054047|NCT00434954|54711129|FG000|Overall Study|Lost to Follow-up|0|||
27813049|NCT01564407|54269340|FG000|Overall Study|funding lost, study ended|0|||
27813050|NCT01564407|54269341|FG001|Overall Study|funding lost, study ended|0|||
27813051|NCT01564407|54269342|FG002|Overall Study|funding lost, study ended|0|||
27813052|NCT01564407|54269343|FG003|Overall Study|funding lost, study ended|1|||
27813053|NCT01564407|54269344|FG004|Overall Study|funding lost, study ended|0|||
27813054|NCT01590771|54269367|FG000|Overall Study|Other Protocol Specified Criteria|5|||
27813055|NCT01590771|54269368|FG001|Overall Study|Other Protocol Specified Criteria|14|||
27813056|NCT01590771|54269367|FG000|Overall Study|Withdrawal by Subject|8|||
27813057|NCT01590771|54269368|FG001|Overall Study|Withdrawal by Subject|15|||
27813058|NCT01590771|54269367|FG000|Overall Study|Protocol Violation|1|||
27813059|NCT01590771|54269368|FG001|Overall Study|Protocol Violation|2|||
27813060|NCT01590771|54269367|FG000|Overall Study|Lost to Follow-up|1|||
27813061|NCT01590771|54269368|FG001|Overall Study|Lost to Follow-up|1|||
27813062|NCT01590771|54269367|FG000|Overall Study|Lack of Efficacy|1|||
27813063|NCT01590771|54269368|FG001|Overall Study|Lack of Efficacy|0|||
27813064|NCT01590771|54269367|FG000|Overall Study|Adverse Event|3|||
27813065|NCT01590771|54269368|FG001|Overall Study|Adverse Event|7|||
27813066|NCT01563237|54269374|FG000|Overall Study|Lost to Follow-up|6|||
27813067|NCT01563237|54269375|FG001|Overall Study|Lost to Follow-up|0|||
27813068|NCT01563237|54269374|FG000|Overall Study|Withdrawal by Subject|1|||
27813069|NCT01563237|54269375|FG001|Overall Study|Withdrawal by Subject|0|||
27813070|NCT01563237|54269374|FG000|Overall Study|Adverse Event|1|||
27813071|NCT01563237|54269375|FG001|Overall Study|Adverse Event|0|||
27813072|NCT01563237|54269374|FG000|Overall Study|Medical Reasons|1|||
27813073|NCT01563237|54269375|FG001|Overall Study|Medical Reasons|0|||
27813074|NCT01563237|54269374|FG000|Overall Study|Death|1|||
27813075|NCT01563237|54269375|FG001|Overall Study|Death|0|||
27813076|NCT01694433|54269391|FG000|Overall Study|Adverse Event|7|||
27813077|NCT01694433|54269392|FG001|Overall Study|Adverse Event|0|||
27813078|NCT01694433|54269391|FG000|Overall Study|Physician Decision|1|||
27813079|NCT01694433|54269392|FG001|Overall Study|Physician Decision|0|||
28054048|NCT00434954|54711130|FG001|Overall Study|Lost to Follow-up|1|||
28054049|NCT00434954|54711129|FG000|Overall Study|Physician Decision|6|||
28054050|NCT00434954|54711130|FG001|Overall Study|Physician Decision|3|||
28054051|NCT00434954|54711129|FG000|Overall Study|Protocol Violation|36|||
28054052|NCT00434954|54711130|FG001|Overall Study|Protocol Violation|27|||
28054053|NCT00434954|54711129|FG000|Overall Study|Sponsor decision|1|||
28054054|NCT00434954|54711130|FG001|Overall Study|Sponsor decision|0|||
27813080|NCT01694433|54269391|FG000|Overall Study|Withdrawal by Subject|3|||
27813081|NCT01694433|54269392|FG001|Overall Study|Withdrawal by Subject|4|||
27813082|NCT01694121|54269400|FG000|Overall Study|Participant used false ID, was withdrawn|1|||
27813083|NCT01694121|54269401|FG001|Overall Study|Participant used false ID, was withdrawn|0|||
27813084|NCT01562613|54269407|FG000|Overall Study|Lost to Follow-up|2|||
27813085|NCT01562613|54269407|FG000|Overall Study|Withdrawal by Subject|2|||
27813086|NCT01693185|54269413|FG000|Overall Study|diagnostic procedure after colonoscopy|0|||
27813087|NCT01693185|54269414|FG001|Overall Study|diagnostic procedure after colonoscopy|6|||
27813088|NCT01693029|54269429|FG000|Overall Study|Withdrawal by Subject|15|||
27813089|NCT01693029|54269430|FG001|Overall Study|Withdrawal by Subject|22|||
27813090|NCT01693029|54269429|FG000|Overall Study|Kidney transplantation|7|||
28054055|NCT00434954|54711129|FG000|Overall Study|Subject decision|8|||
28054056|NCT00434954|54711130|FG001|Overall Study|Subject decision|22|||
28054057|NCT00276484|54711138|FG000|Overall Study|Adverse Event|4|||
28054058|NCT00276484|54711139|FG001|Overall Study|Adverse Event|7|||
28054059|NCT00276484|54711138|FG000|Overall Study|Lost to Follow-up|1|||
28054060|NCT00276484|54711139|FG001|Overall Study|Lost to Follow-up|1|||
28054061|NCT00276484|54711138|FG000|Overall Study|Protocol Violation|0|||
28054062|NCT00276484|54711139|FG001|Overall Study|Protocol Violation|1|||
28054063|NCT00276484|54711138|FG000|Overall Study|Withdrawal by Subject|4|||
28054064|NCT00276484|54711139|FG001|Overall Study|Withdrawal by Subject|3|||
28054065|NCT00276484|54711138|FG000|Overall Study|Could not take time off work|0|||
28054066|NCT00276484|54711139|FG001|Overall Study|Could not take time off work|1|||
28054067|NCT00426842|54711145|FG000|Overall Study|Lost to Follow-up|1|||
28054068|NCT00434876|54711153|FG000|Overall Study|Lost to Follow-up|1|||
28054069|NCT00434876|54711154|FG001|Overall Study|Lost to Follow-up|1|||
28054070|NCT00276094|54711163|FG000|Overall Study|Adverse Event|15|||
28054071|NCT00276094|54711164|FG001|Overall Study|Adverse Event|13|||
28054072|NCT00276094|54711165|FG002|Overall Study|Adverse Event|11|||
28054073|NCT00276094|54711163|FG000|Overall Study|Withdrawal by Subject|14|||
28054074|NCT00276094|54711164|FG001|Overall Study|Withdrawal by Subject|14|||
28054075|NCT00276094|54711165|FG002|Overall Study|Withdrawal by Subject|12|||
28054076|NCT00276094|54711163|FG000|Overall Study|Protocol Violation|16|||
28054077|NCT00276094|54711164|FG001|Overall Study|Protocol Violation|7|||
28054078|NCT00276094|54711165|FG002|Overall Study|Protocol Violation|10|||
28054079|NCT00276094|54711163|FG000|Overall Study|Lost to Follow-up|8|||
28054080|NCT00276094|54711164|FG001|Overall Study|Lost to Follow-up|6|||
28054081|NCT00276094|54711165|FG002|Overall Study|Lost to Follow-up|4|||
28054082|NCT00276094|54711163|FG000|Overall Study|Other-Subject moved out of country|1|||
28054083|NCT00276094|54711164|FG001|Overall Study|Other-Subject moved out of country|0|||
28054084|NCT00276094|54711165|FG002|Overall Study|Other-Subject moved out of country|0|||
28054085|NCT00276094|54711163|FG000|Overall Study|Other-Scheduled gastroplasty|1|||
28054086|NCT00276094|54711164|FG001|Overall Study|Other-Scheduled gastroplasty|0|||
28054087|NCT00276094|54711165|FG002|Overall Study|Other-Scheduled gastroplasty|0|||
28054088|NCT00276094|54711163|FG000|Overall Study|Other-Lack of efficacy|1|||
28054089|NCT00276094|54711164|FG001|Overall Study|Other-Lack of efficacy|0|||
28054090|NCT00276094|54711165|FG002|Overall Study|Other-Lack of efficacy|0|||
28054091|NCT00276094|54711163|FG000|Overall Study|Other-Refused follow-up visit|1|||
28054092|NCT00276094|54711164|FG001|Overall Study|Other-Refused follow-up visit|0|||
28054093|NCT00276094|54711165|FG002|Overall Study|Other-Refused follow-up visit|0|||
28054094|NCT00276094|54711163|FG000|Overall Study|Other-Repeat safety labs-exclusionary|0|||
28054095|NCT00276094|54711164|FG001|Overall Study|Other-Repeat safety labs-exclusionary|1|||
28054096|NCT00276094|54711165|FG002|Overall Study|Other-Repeat safety labs-exclusionary|0|||
28054097|NCT00276094|54711163|FG000|Overall Study|Other-Relocation|0|||
28054098|NCT00276094|54711164|FG001|Overall Study|Other-Relocation|1|||
28054099|NCT00276094|54711165|FG002|Overall Study|Other-Relocation|0|||
28054100|NCT00276094|54711163|FG000|Overall Study|Other-Study medication lost|0|||
28054101|NCT00276094|54711164|FG001|Overall Study|Other-Study medication lost|0|||
28054102|NCT00276094|54711165|FG002|Overall Study|Other-Study medication lost|1|||
28054103|NCT00276016|54711179|FG000|Intervention 1|Withdrawal by Subject|0|||
28054104|NCT00276016|54711180|FG001|Intervention 1|Withdrawal by Subject|1|||
28054105|NCT00276016|54711181|FG002|Intervention 1|Withdrawal by Subject|0|||
28054106|NCT00276016|54711182|FG003|Intervention 1|Withdrawal by Subject|0|||
28054107|NCT00276016|54711183|FG004|Intervention 1|Withdrawal by Subject|0|||
28054108|NCT00276016|54711184|FG005|Intervention 1|Withdrawal by Subject|0|||
28054109|NCT00434642|54711195|FG000|Blinded Treatment Phase|Adverse Event|12|||
28054110|NCT00434642|54711196|FG001|Blinded Treatment Phase|Adverse Event|58|||
28054111|NCT00434642|54711195|FG000|Blinded Treatment Phase|Clinical Disease Progression|4|||
28054112|NCT00434642|54711196|FG001|Blinded Treatment Phase|Clinical Disease Progression|5|||
28054113|NCT00434642|54711195|FG000|Blinded Treatment Phase|Disease Progression Per RECIST|168|||
28054114|NCT00434642|54711196|FG001|Blinded Treatment Phase|Disease Progression Per RECIST|109|||
28054115|NCT00434642|54711195|FG000|Blinded Treatment Phase|Physician Decision|19|||
28054116|NCT00434642|54711196|FG001|Blinded Treatment Phase|Physician Decision|27|||
28054117|NCT00434642|54711195|FG000|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3|||
28054118|NCT00434642|54711196|FG001|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0|||
28105705|NCT04741503|54763279|FG001|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|17|||
28105706|NCT04741503|54763280|FG002|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|0|||
28054119|NCT00434642|54711195|FG000|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32|||
28054120|NCT00434642|54711196|FG001|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29|||
28054121|NCT00434642|54711195|FG000|Blinded Treatment Phase|Did not Receive Treatment|4|||
28054122|NCT00434642|54711196|FG001|Blinded Treatment Phase|Did not Receive Treatment|1|||
28054123|NCT00434642|54711195|FG000|Open-label Treatment Phase|Adverse Event|0|||
28054124|NCT00434642|54711196|FG001|Open-label Treatment Phase|Adverse Event|5|||
28054125|NCT00434642|54711195|FG000|Open-label Treatment Phase|Disease Progression Per RECIST|0|||
28054126|NCT00434642|54711196|FG001|Open-label Treatment Phase|Disease Progression Per RECIST|6|||
28054127|NCT00434330|54711208|FG000|Overall Study|Adverse Event|0|||
28054128|NCT00434330|54711209|FG001|Overall Study|Adverse Event|0|||
28054129|NCT00434330|54711210|FG002|Overall Study|Adverse Event|1|||
28054130|NCT00434330|54711211|FG003|Overall Study|Adverse Event|0|||
28054131|NCT00434330|54711212|FG004|Overall Study|Adverse Event|0|||
28054132|NCT00434330|54711213|FG005|Overall Study|Adverse Event|0|||
28054133|NCT00434330|54711208|FG000|Overall Study|Death|1|||
28054134|NCT00434330|54711209|FG001|Overall Study|Death|0|||
28054135|NCT00434330|54711210|FG002|Overall Study|Death|0|||
28054136|NCT00434330|54711211|FG003|Overall Study|Death|0|||
28054137|NCT00434330|54711212|FG004|Overall Study|Death|1|||
28054138|NCT00434330|54711213|FG005|Overall Study|Death|1|||
28054139|NCT00434330|54711208|FG000|Overall Study|Withdrawal by Subject|0|||
28054140|NCT00434330|54711209|FG001|Overall Study|Withdrawal by Subject|0|||
28054141|NCT00434330|54711210|FG002|Overall Study|Withdrawal by Subject|1|||
28054142|NCT00434330|54711211|FG003|Overall Study|Withdrawal by Subject|1|||
28054143|NCT00434330|54711212|FG004|Overall Study|Withdrawal by Subject|0|||
28054144|NCT00434330|54711213|FG005|Overall Study|Withdrawal by Subject|0|||
28054145|NCT00434330|54711208|FG000|Overall Study|Renal transplant|0|||
28054146|NCT00434330|54711209|FG001|Overall Study|Renal transplant|0|||
28054147|NCT00434330|54711210|FG002|Overall Study|Renal transplant|0|||
28054148|NCT00434330|54711211|FG003|Overall Study|Renal transplant|1|||
28054149|NCT00434330|54711212|FG004|Overall Study|Renal transplant|0|||
28054150|NCT00434330|54711213|FG005|Overall Study|Renal transplant|0|||
28054151|NCT00434330|54711208|FG000|Overall Study|Subject Not Compliant With Study|0|||
28054152|NCT00434330|54711209|FG001|Overall Study|Subject Not Compliant With Study|0|||
28054153|NCT00434330|54711210|FG002|Overall Study|Subject Not Compliant With Study|1|||
28054154|NCT00434330|54711211|FG003|Overall Study|Subject Not Compliant With Study|0|||
28054155|NCT00434330|54711212|FG004|Overall Study|Subject Not Compliant With Study|0|||
28054156|NCT00434330|54711213|FG005|Overall Study|Subject Not Compliant With Study|0|||
28054157|NCT00426764|54711227|FG000|Overall Study|Protocol Violation|1|||
28054158|NCT00426764|54711227|FG000|Overall Study|Withdrawal by Subject|4|||
28054159|NCT00426764|54711227|FG000|Overall Study|Physician Decision|6|||
28054160|NCT00426764|54711227|FG000|Overall Study|Compassionate Use|1|||
28054161|NCT00426764|54711227|FG000|Overall Study|Progressive Disease|83|||
28054162|NCT00426764|54711227|FG000|Overall Study|Adverse Event|24|||
28054163|NCT00426764|54711227|FG000|Overall Study|Other|1|||
28054164|NCT00426764|54711227|FG000|Overall Study|Death|1|||
28054165|NCT00426764|54711227|FG000|Overall Study|Other Reasons (Miscellaneous)|10|||
28054166|NCT00434252|54711239|FG000|Overall Study|Lack of Efficacy|50|||
28054167|NCT00434252|54711240|FG001|Overall Study|Lack of Efficacy|100|||
28054168|NCT00434252|54711239|FG000|Overall Study|Adverse Event|6|||
28054169|NCT00434252|54711240|FG001|Overall Study|Adverse Event|13|||
28054170|NCT00434252|54711239|FG000|Overall Study|Death|1|||
28054171|NCT00434252|54711240|FG001|Overall Study|Death|2|||
28054172|NCT00434252|54711239|FG000|Overall Study|Lost to Follow-up|0|||
28054173|NCT00434252|54711240|FG001|Overall Study|Lost to Follow-up|1|||
28054174|NCT00434252|54711239|FG000|Overall Study|Physician Decision|4|||
28054175|NCT00434252|54711240|FG001|Overall Study|Physician Decision|8|||
28054176|NCT00434252|54711239|FG000|Overall Study|Withdrawal by Subject|3|||
28054177|NCT00434252|54711240|FG001|Overall Study|Withdrawal by Subject|7|||
28054178|NCT00425750|54711246|FG000|Overall Study|Death|1|||
28054179|NCT00425750|54711246|FG000|Overall Study|Withdrawal by Subject|3|||
28054180|NCT00425750|54711246|FG000|Overall Study|Adverse Event|3|||
28054181|NCT00425750|54711246|FG000|Overall Study|Progression of disease|18|||
28054182|NCT00414908|54711252|FG000|Overall Study|Protocol Violation|1|||
28054183|NCT00414908|54711253|FG001|Overall Study|Protocol Violation|1|||
28054184|NCT00242710|54711265|FG000|Core Study (up to Year 1)|Adverse Event|30|||
28054185|NCT00242710|54711266|FG001|Core Study (up to Year 1)|Adverse Event|25|||
28054186|NCT00242710|54711267|FG002|Core Study (up to Year 1)|Adverse Event|23|||
28054187|NCT00242710|54711268|FG003|Core Study (up to Year 1)|Adverse Event|14|||
28054188|NCT00242710|54711265|FG000|Core Study (up to Year 1)|Death|0|||
28054189|NCT00242710|54711266|FG001|Core Study (up to Year 1)|Death|0|||
28054190|NCT00242710|54711267|FG002|Core Study (up to Year 1)|Death|1|||
28105707|NCT04734873|54763289|FG000|Overall Study|Lost to Follow-up|1|||
28054191|NCT00242710|54711268|FG003|Core Study (up to Year 1)|Death|0|||
28054192|NCT00242710|54711265|FG000|Core Study (up to Year 1)|Physician Decision|0|||
28054193|NCT00242710|54711266|FG001|Core Study (up to Year 1)|Physician Decision|1|||
28054194|NCT00242710|54711267|FG002|Core Study (up to Year 1)|Physician Decision|0|||
28054195|NCT00242710|54711268|FG003|Core Study (up to Year 1)|Physician Decision|1|||
28054196|NCT00242710|54711265|FG000|Core Study (up to Year 1)|Lost to Follow-up|8|||
28054197|NCT00242710|54711266|FG001|Core Study (up to Year 1)|Lost to Follow-up|8|||
28054198|NCT00242710|54711267|FG002|Core Study (up to Year 1)|Lost to Follow-up|7|||
28054199|NCT00242710|54711268|FG003|Core Study (up to Year 1)|Lost to Follow-up|3|||
28054200|NCT00242710|54711265|FG000|Core Study (up to Year 1)|Other|6|||
28054201|NCT00242710|54711266|FG001|Core Study (up to Year 1)|Other|1|||
28054202|NCT00242710|54711267|FG002|Core Study (up to Year 1)|Other|0|||
28054203|NCT00242710|54711268|FG003|Core Study (up to Year 1)|Other|2|||
28054204|NCT00242710|54711265|FG000|Core Study (up to Year 1)|Protocol Violation|2|||
28054205|NCT00242710|54711266|FG001|Core Study (up to Year 1)|Protocol Violation|9|||
28054206|NCT00242710|54711267|FG002|Core Study (up to Year 1)|Protocol Violation|1|||
28054207|NCT00242710|54711268|FG003|Core Study (up to Year 1)|Protocol Violation|3|||
28054208|NCT00242710|54711265|FG000|Core Study (up to Year 1)|Withdrawal by Subject|27|||
28054209|NCT00242710|54711266|FG001|Core Study (up to Year 1)|Withdrawal by Subject|16|||
28054210|NCT00242710|54711267|FG002|Core Study (up to Year 1)|Withdrawal by Subject|15|||
28054211|NCT00242710|54711268|FG003|Core Study (up to Year 1)|Withdrawal by Subject|6|||
28054212|NCT00242710|54711265|FG000|Core Study (up to Year 1)|Lack of Efficacy|1|||
28054213|NCT00242710|54711266|FG001|Core Study (up to Year 1)|Lack of Efficacy|0|||
28054214|NCT00242710|54711267|FG002|Core Study (up to Year 1)|Lack of Efficacy|0|||
28054215|NCT00242710|54711268|FG003|Core Study (up to Year 1)|Lack of Efficacy|0|||
28054216|NCT00242710|54711265|FG000|Core Study (up to Year 1)|Randomized but not Treated|12|||
28054217|NCT00242710|54711266|FG001|Core Study (up to Year 1)|Randomized but not Treated|4|||
28054218|NCT00242710|54711267|FG002|Core Study (up to Year 1)|Randomized but not Treated|4|||
28054219|NCT00242710|54711268|FG003|Core Study (up to Year 1)|Randomized but not Treated|2|||
28054220|NCT00242710|54711265|FG000|Period Between Core Study and Extension|Adverse Event|2|||
28054221|NCT00242710|54711266|FG001|Period Between Core Study and Extension|Adverse Event|3|||
28054222|NCT00242710|54711267|FG002|Period Between Core Study and Extension|Adverse Event|5|||
28054223|NCT00242710|54711268|FG003|Period Between Core Study and Extension|Adverse Event|2|||
28054224|NCT00242710|54711265|FG000|Period Between Core Study and Extension|Physician Decision|1|||
28054225|NCT00242710|54711266|FG001|Period Between Core Study and Extension|Physician Decision|1|||
28054226|NCT00242710|54711267|FG002|Period Between Core Study and Extension|Physician Decision|0|||
28054227|NCT00242710|54711268|FG003|Period Between Core Study and Extension|Physician Decision|0|||
28054228|NCT00242710|54711265|FG000|Period Between Core Study and Extension|Other|24|||
28054229|NCT00242710|54711266|FG001|Period Between Core Study and Extension|Other|24|||
28054230|NCT00242710|54711267|FG002|Period Between Core Study and Extension|Other|9|||
28054231|NCT00242710|54711268|FG003|Period Between Core Study and Extension|Other|11|||
28054232|NCT00242710|54711265|FG000|Period Between Core Study and Extension|Extension not Available|17|||
28054233|NCT00242710|54711266|FG001|Period Between Core Study and Extension|Extension not Available|21|||
28054234|NCT00242710|54711267|FG002|Period Between Core Study and Extension|Extension not Available|8|||
28054235|NCT00242710|54711268|FG003|Period Between Core Study and Extension|Extension not Available|7|||
28054236|NCT00242710|54711265|FG000|Period Between Core Study and Extension|Protocol Violation|0|||
28054237|NCT00242710|54711266|FG001|Period Between Core Study and Extension|Protocol Violation|0|||
28054238|NCT00242710|54711267|FG002|Period Between Core Study and Extension|Protocol Violation|2|||
28054239|NCT00242710|54711268|FG003|Period Between Core Study and Extension|Protocol Violation|1|||
28054240|NCT00242710|54711265|FG000|Period Between Core Study and Extension|Withdrawal by Subject|75|||
28054241|NCT00242710|54711266|FG001|Period Between Core Study and Extension|Withdrawal by Subject|63|||
28054242|NCT00242710|54711267|FG002|Period Between Core Study and Extension|Withdrawal by Subject|24|||
28054243|NCT00242710|54711268|FG003|Period Between Core Study and Extension|Withdrawal by Subject|28|||
28054244|NCT00242710|54711265|FG000|Study Extension (up to Year 2)|Adverse Event|7|||
28054245|NCT00242710|54711266|FG001|Study Extension (up to Year 2)|Adverse Event|9|||
28054246|NCT00242710|54711267|FG002|Study Extension (up to Year 2)|Adverse Event|2|||
28054247|NCT00242710|54711268|FG003|Study Extension (up to Year 2)|Adverse Event|4|||
28054248|NCT00242710|54711265|FG000|Study Extension (up to Year 2)|Death|0|||
28054249|NCT00242710|54711266|FG001|Study Extension (up to Year 2)|Death|0|||
28054250|NCT00242710|54711267|FG002|Study Extension (up to Year 2)|Death|0|||
28054251|NCT00242710|54711268|FG003|Study Extension (up to Year 2)|Death|1|||
28054252|NCT00242710|54711265|FG000|Study Extension (up to Year 2)|Lost to Follow-up|7|||
28054253|NCT00242710|54711266|FG001|Study Extension (up to Year 2)|Lost to Follow-up|7|||
28054254|NCT00242710|54711267|FG002|Study Extension (up to Year 2)|Lost to Follow-up|5|||
28054255|NCT00242710|54711268|FG003|Study Extension (up to Year 2)|Lost to Follow-up|0|||
28054256|NCT00242710|54711265|FG000|Study Extension (up to Year 2)|Other|3|||
28054257|NCT00242710|54711266|FG001|Study Extension (up to Year 2)|Other|5|||
28054258|NCT00242710|54711267|FG002|Study Extension (up to Year 2)|Other|4|||
28054259|NCT00242710|54711268|FG003|Study Extension (up to Year 2)|Other|3|||
28054260|NCT00242710|54711265|FG000|Study Extension (up to Year 2)|Protocol Violation|0|||
28054261|NCT00242710|54711266|FG001|Study Extension (up to Year 2)|Protocol Violation|2|||
28054262|NCT00242710|54711267|FG002|Study Extension (up to Year 2)|Protocol Violation|0|||
28054263|NCT00242710|54711268|FG003|Study Extension (up to Year 2)|Protocol Violation|1|||
28105708|NCT04734873|54763290|FG001|Overall Study|Lost to Follow-up|3|||
28105709|NCT04734873|54763291|FG002|Overall Study|Lost to Follow-up|2|||
28054264|NCT00242710|54711265|FG000|Study Extension (up to Year 2)|Withdrawal by Subject|10|||
28054265|NCT00242710|54711266|FG001|Study Extension (up to Year 2)|Withdrawal by Subject|6|||
28054266|NCT00242710|54711267|FG002|Study Extension (up to Year 2)|Withdrawal by Subject|4|||
28054267|NCT00242710|54711268|FG003|Study Extension (up to Year 2)|Withdrawal by Subject|1|||
28054268|NCT00408876|54711282|FG000|Overall Study|Adverse Event|9|||
28054269|NCT00408876|54711283|FG001|Overall Study|Adverse Event|17|||
28054270|NCT00408876|54711284|FG002|Overall Study|Adverse Event|27|||
28054271|NCT00408876|54711285|FG003|Overall Study|Adverse Event|10|||
28054272|NCT00408876|54711282|FG000|Overall Study|Withdrawal by Subject|3|||
28054273|NCT00408876|54711283|FG001|Overall Study|Withdrawal by Subject|6|||
28054274|NCT00408876|54711284|FG002|Overall Study|Withdrawal by Subject|6|||
28054275|NCT00408876|54711285|FG003|Overall Study|Withdrawal by Subject|14|||
28054276|NCT00408876|54711282|FG000|Overall Study|Lack of Efficacy|2|||
28054277|NCT00408876|54711283|FG001|Overall Study|Lack of Efficacy|4|||
28054278|NCT00408876|54711284|FG002|Overall Study|Lack of Efficacy|5|||
28054279|NCT00408876|54711285|FG003|Overall Study|Lack of Efficacy|6|||
28054280|NCT00408876|54711282|FG000|Overall Study|Lost to Follow-up|1|||
28054281|NCT00408876|54711283|FG001|Overall Study|Lost to Follow-up|6|||
28054282|NCT00408876|54711284|FG002|Overall Study|Lost to Follow-up|5|||
28054283|NCT00408876|54711285|FG003|Overall Study|Lost to Follow-up|2|||
28054284|NCT00408876|54711282|FG000|Overall Study|Protocol Violation|0|||
28054285|NCT00408876|54711283|FG001|Overall Study|Protocol Violation|3|||
28054286|NCT00408876|54711284|FG002|Overall Study|Protocol Violation|4|||
28054287|NCT00408876|54711285|FG003|Overall Study|Protocol Violation|3|||
28054288|NCT00408876|54711282|FG000|Overall Study|Physician Decision|1|||
28054289|NCT00408876|54711283|FG001|Overall Study|Physician Decision|0|||
28054290|NCT00408876|54711284|FG002|Overall Study|Physician Decision|3|||
28054291|NCT00408876|54711285|FG003|Overall Study|Physician Decision|0|||
28054292|NCT00240994|54711295|FG000|Overall Study|Lost to Follow-up|1|||
28054293|NCT00240994|54711295|FG000|Overall Study|Protocol Violation|1|||
28054294|NCT00240994|54711295|FG000|Overall Study|Graft failure|1|||
28054295|NCT00239590|54711299|FG000|Randomized|Lost to Follow-up|0|||
28054296|NCT00239590|54711300|FG001|Randomized|Lost to Follow-up|1|||
28054297|NCT00239590|54711299|FG000|Randomized|Withdrawal by Subject|0|||
28054298|NCT00239590|54711300|FG001|Randomized|Withdrawal by Subject|1|||
28054299|NCT00239590|54711299|FG000|Completed Study Protocol|Adverse Event|1|||
28054300|NCT00239590|54711300|FG001|Completed Study Protocol|Adverse Event|1|||
28054301|NCT00239590|54711299|FG000|Completed Study Protocol|Withdrawal by Subject|0|||
28054302|NCT00239590|54711300|FG001|Completed Study Protocol|Withdrawal by Subject|1|||
28054303|NCT00433160|54711310|FG000|52-Week Double-Blind (DB) Period|Adverse Event|6|||
28054304|NCT00433160|54711311|FG001|52-Week Double-Blind (DB) Period|Adverse Event|2|||
28054305|NCT00433160|54711310|FG000|52-Week Double-Blind (DB) Period|Death|0|||
28054306|NCT00433160|54711311|FG001|52-Week Double-Blind (DB) Period|Death|0|||
28054307|NCT00433160|54711310|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
28054308|NCT00433160|54711311|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
28054309|NCT00433160|54711310|FG000|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0|||
28054310|NCT00433160|54711311|FG001|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1|||
28054311|NCT00433160|54711310|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
28054312|NCT00433160|54711311|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|2|||
28054313|NCT00433160|54711310|FG000|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6|||
28054314|NCT00433160|54711311|FG001|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1|||
28054315|NCT00433160|54711310|FG000|52-Week Double-Blind (DB) Period|Physician Decision|4|||
28054316|NCT00433160|54711311|FG001|52-Week Double-Blind (DB) Period|Physician Decision|2|||
28054317|NCT00433160|54711310|FG000|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
28054318|NCT00433160|54711311|FG001|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
28054319|NCT00433160|54711310|FG000|52-Week Double-Blind (DB) Period|Lack of Efficacy|1|||
28054320|NCT00433160|54711311|FG001|52-Week Double-Blind (DB) Period|Lack of Efficacy|2|||
28105710|NCT04734873|54763289|FG000|Overall Study|Randomized but not dosed|1|||
28105711|NCT04734873|54763290|FG001|Overall Study|Randomized but not dosed|0|||
28054321|NCT00433160|54711310|FG000|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3|||
28054322|NCT00433160|54711311|FG001|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1|||
28054323|NCT00433160|54711310|FG000|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1|||
28054324|NCT00433160|54711311|FG001|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2|||
28054325|NCT00433160|54711310|FG000|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2|||
27943478|NCT00929110|54600375|FG002|Overall Study|Patient inability to use the device|0|||
28054326|NCT00433160|54711311|FG001|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0|||
28105712|NCT04734873|54763291|FG002|Overall Study|Randomized but not dosed|1|||
28054327|NCT00433160|54711310|FG000|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0|||
28054328|NCT00433160|54711311|FG001|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1|||
28054329|NCT00433160|54711310|FG000|104 Weeks, 28-Week OL Period|Adverse Event|2|||
28054330|NCT00433160|54711311|FG001|104 Weeks, 28-Week OL Period|Adverse Event|0|||
28054331|NCT00433160|54711310|FG000|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8|||
28054332|NCT00433160|54711311|FG001|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2|||
28054333|NCT00433160|54711310|FG000|104 Weeks, 28-Week OL Period|Physician Decision|0|||
28054334|NCT00433160|54711311|FG001|104 Weeks, 28-Week OL Period|Physician Decision|1|||
28054335|NCT00239356|54711323|FG000|Overall Study|Lack of Efficacy|1|||
28054336|NCT00239356|54711324|FG001|Overall Study|Lack of Efficacy|0|||
28054337|NCT00239356|54711323|FG000|Overall Study|Adverse Event|6|||
28054338|NCT00239356|54711324|FG001|Overall Study|Adverse Event|0|||
28054339|NCT00239356|54711323|FG000|Overall Study|Withdrawal by Subject|15|||
28054340|NCT00239356|54711324|FG001|Overall Study|Withdrawal by Subject|6|||
28054341|NCT00239356|54711323|FG000|Overall Study|Lost to Follow-up|3|||
28054342|NCT00239356|54711324|FG001|Overall Study|Lost to Follow-up|0|||
28054343|NCT00239356|54711323|FG000|Overall Study|poor/non-compliance|2|||
28054344|NCT00239356|54711324|FG001|Overall Study|poor/non-compliance|0|||
28054345|NCT00239356|54711323|FG000|Overall Study|Pregnancy|1|||
28054346|NCT00239356|54711324|FG001|Overall Study|Pregnancy|0|||
28054347|NCT00239356|54711323|FG000|Overall Study|Administrative reason|0|||
28054348|NCT00239356|54711324|FG001|Overall Study|Administrative reason|1|||
28054349|NCT00239356|54711323|FG000|Overall Study|Drug available on market|11|||
28054350|NCT00239356|54711324|FG001|Overall Study|Drug available on market|2|||
28054351|NCT00393510|54711332|FG000|Overall Study|Physician Decision|3|||
28054352|NCT00393510|54711333|FG001|Overall Study|Physician Decision|9|||
28054353|NCT00425438|54711341|FG000|Overall Study|Termination by Sponsor|25|||
28054354|NCT00425438|54711342|FG001|Overall Study|Termination by Sponsor|27|||
28054355|NCT00275002|54711350|FG000|Overall Study|Death|1|||
28054356|NCT00275002|54711351|FG001|Overall Study|Death|0|||
28054357|NCT00275002|54711350|FG000|Overall Study|Disease progression|21|||
28054358|NCT00275002|54711351|FG001|Overall Study|Disease progression|15|||
28054359|NCT00275002|54711350|FG000|Overall Study|Adverse Event|0|||
28054360|NCT00275002|54711351|FG001|Overall Study|Adverse Event|1|||
28054361|NCT00433004|54711359|FG000|Overall Study|Lost to Follow-up|5|||
28054362|NCT00433004|54711360|FG001|Overall Study|Lost to Follow-up|7|||
28054363|NCT00238264|54711366|FG000|Overall Study|Death|7|||
28054364|NCT00238264|54711366|FG000|Overall Study|Lost to Follow-up|18|||
28054365|NCT00238264|54711366|FG000|Overall Study|Withdrawal by Subject|4|||
28054366|NCT00238264|54711366|FG000|Overall Study|Ineligible|7|||
28054367|NCT00414596|54711370|FG000|Overall Study|Protocol Violation|2|||
28054368|NCT00393042|54711374|FG000|First Intervention|Withdrawal by Subject|1|||
28054369|NCT00393042|54711375|FG001|First Intervention|Withdrawal by Subject|2|||
28054370|NCT00393042|54711374|FG000|First Intervention|Lost to Follow-up|3|||
28054371|NCT00393042|54711375|FG001|First Intervention|Lost to Follow-up|3|||
28054372|NCT00393042|54711374|FG000|First Intervention|Protocol Violation|1|||
28054373|NCT00393042|54711375|FG001|First Intervention|Protocol Violation|0|||
28054374|NCT00393042|54711374|FG000|First Intervention|Adverse Event|0|||
28054375|NCT00393042|54711375|FG001|First Intervention|Adverse Event|1|||
28054376|NCT00393042|54711374|FG000|Second Intervetion|Adverse Event|0|||
28054377|NCT00393042|54711375|FG001|Second Intervetion|Adverse Event|3|||
28054378|NCT00393042|54711374|FG000|Second Intervetion|Withdrawal by Subject|0|||
28054379|NCT00393042|54711375|FG001|Second Intervetion|Withdrawal by Subject|2|||
28054380|NCT00393042|54711374|FG000|Second Intervetion|Lack of Efficacy|1|||
28054381|NCT00393042|54711375|FG001|Second Intervetion|Lack of Efficacy|0|||
28054382|NCT00393042|54711374|FG000|Second Intervetion|Lost to Follow-up|0|||
28054383|NCT00393042|54711375|FG001|Second Intervetion|Lost to Follow-up|2|||
28054384|NCT00393042|54711374|FG000|Second Intervetion|Protocol Violation|1|||
28054385|NCT00393042|54711375|FG001|Second Intervetion|Protocol Violation|1|||
28054386|NCT00392808|54711433|FG000|Overall Study|Lost to Follow-up|3|||
28054387|NCT00392808|54711434|FG001|Overall Study|Lost to Follow-up|2|||
28054388|NCT00392808|54711435|FG002|Overall Study|Lost to Follow-up|1|||
28054389|NCT00392808|54711436|FG003|Overall Study|Lost to Follow-up|2|||
28054390|NCT00392808|54711433|FG000|Overall Study|Unable to withdraw blood|3|||
28054391|NCT00392808|54711434|FG001|Overall Study|Unable to withdraw blood|1|||
28054392|NCT00392808|54711435|FG002|Overall Study|Unable to withdraw blood|1|||
28054393|NCT00392808|54711436|FG003|Overall Study|Unable to withdraw blood|2|||
28054394|NCT00274846|54711455|FG000|Overall Study|Did not receive adequate NK cells|1|||
28054395|NCT00237796|54711462|FG000|Overall Study|Baseline and one other ILSS required|10|||
28054396|NCT00237796|54711463|FG001|Overall Study|Baseline and one other ILSS required|5|||
28054397|NCT00414440|54711472|FG000|Core Period|Withdrawal by Subject|70|||
28054398|NCT00414440|54711473|FG001|Core Period|Withdrawal by Subject|32|||
28054399|NCT00414440|54711472|FG000|Extension Period|Lost to Follow-up|44|||
28054400|NCT00414440|54711473|FG001|Extension Period|Lost to Follow-up|52|||
28054401|NCT00414440|54711472|FG000|Extension Period|Did not consent to continue follow up|61|||
28054402|NCT00414440|54711473|FG001|Extension Period|Did not consent to continue follow up|54|||
28054403|NCT00414440|54711472|FG000|Extension Period|Other|1|||
28054404|NCT00414440|54711473|FG001|Extension Period|Other|1|||
28054405|NCT00414440|54711472|FG000|Extension Period|Administrative|16|||
28054406|NCT00414440|54711473|FG001|Extension Period|Administrative|16|||
28054407|NCT00414440|54711472|FG000|Extension Period|Death|1|||
28054408|NCT00414440|54711473|FG001|Extension Period|Death|2|||
28054409|NCT00414440|54711472|FG000|Extension Period|Withdrawal by Subject|9|||
28054410|NCT00414440|54711473|FG001|Extension Period|Withdrawal by Subject|7|||
28054411|NCT00414440|54711472|FG000|Extension Period|Not included in follow up period|18|||
28054412|NCT00414440|54711473|FG001|Extension Period|Not included in follow up period|8|||
28054413|NCT00209560|54711481|FG000|Overall Study|Lack of Efficacy|1|||
28054414|NCT00209560|54711482|FG001|Overall Study|Lack of Efficacy|0|||
28054415|NCT00236080|54711493|FG000|Overall Study|Adverse Event|0|||
28054416|NCT00236080|54711494|FG001|Overall Study|Adverse Event|0|||
28054417|NCT00236080|54711495|FG002|Overall Study|Adverse Event|3|||
28054418|NCT00236080|54711496|FG003|Overall Study|Adverse Event|1|||
28054419|NCT00236080|54711497|FG004|Overall Study|Adverse Event|0|||
28054420|NCT00236080|54711493|FG000|Overall Study|Lost to Follow-up|0|||
28054421|NCT00236080|54711494|FG001|Overall Study|Lost to Follow-up|1|||
28054422|NCT00236080|54711495|FG002|Overall Study|Lost to Follow-up|0|||
28054423|NCT00236080|54711496|FG003|Overall Study|Lost to Follow-up|0|||
28054424|NCT00236080|54711497|FG004|Overall Study|Lost to Follow-up|0|||
28054425|NCT00236080|54711493|FG000|Overall Study|Physician Decision|1|||
28054426|NCT00236080|54711494|FG001|Overall Study|Physician Decision|0|||
28054427|NCT00236080|54711495|FG002|Overall Study|Physician Decision|1|||
28054428|NCT00236080|54711496|FG003|Overall Study|Physician Decision|1|||
28054429|NCT00236080|54711497|FG004|Overall Study|Physician Decision|1|||
28054430|NCT00236080|54711493|FG000|Overall Study|Withdrawal by Subject|1|||
28054431|NCT00236080|54711494|FG001|Overall Study|Withdrawal by Subject|0|||
28054432|NCT00236080|54711495|FG002|Overall Study|Withdrawal by Subject|0|||
28054433|NCT00236080|54711496|FG003|Overall Study|Withdrawal by Subject|0|||
28054434|NCT00236080|54711497|FG004|Overall Study|Withdrawal by Subject|0|||
28054435|NCT00236080|54711493|FG000|Overall Study|Miscellaneous|0|||
28054436|NCT00236080|54711494|FG001|Overall Study|Miscellaneous|0|||
28054437|NCT00236080|54711495|FG002|Overall Study|Miscellaneous|1|||
28054438|NCT00236080|54711496|FG003|Overall Study|Miscellaneous|0|||
28054439|NCT00236080|54711497|FG004|Overall Study|Miscellaneous|0|||
28054440|NCT00432380|54711512|FG000|Overall Study|Migrated/moved from study area|3|||
28054441|NCT00432380|54711513|FG001|Overall Study|Migrated/moved from study area|4|||
28054442|NCT00432380|54711514|FG002|Overall Study|Migrated/moved from study area|1|||
28054443|NCT00432380|54711512|FG000|Overall Study|Adverse Event|1|||
28054444|NCT00432380|54711513|FG001|Overall Study|Adverse Event|0|||
28054445|NCT00432380|54711514|FG002|Overall Study|Adverse Event|0|||
28054446|NCT00234052|54711523|FG000|Treatment|Withdrawal by Subject|3|||
28054447|NCT00234052|54711523|FG000|Treatment|Adverse Event|5|||
28054448|NCT00234052|54711523|FG000|Treatment|Death|2|||
28054449|NCT00234052|54711523|FG000|Treatment|Progressive Disease|11|||
28054450|NCT00234052|54711523|FG000|Follow-up for 5 Years|Death|41|||
28054451|NCT00234052|54711523|FG000|Follow-up for 5 Years|Lost to Follow-up|1|||
28054452|NCT00234052|54711523|FG000|Follow-up for 5 Years|Other|7|||
28054453|NCT00408408|54711533|FG000|Overall Study|No follow up data|2|||
28054454|NCT00408408|54711534|FG001|Overall Study|No follow up data|3|||
28054455|NCT00408408|54711535|FG002|Overall Study|No follow up data|0|||
28054456|NCT00408408|54711536|FG003|Overall Study|No follow up data|7|||
28054457|NCT00408408|54711537|FG004|Overall Study|No follow up data|5|||
28054458|NCT00408408|54711538|FG005|Overall Study|No follow up data|3|||
28054459|NCT00414050|54711556|FG000|Overall Study|Adverse Event|1|||
28054460|NCT00414050|54711557|FG001|Overall Study|Adverse Event|1|||
28054461|NCT00414050|54711558|FG002|Overall Study|Adverse Event|1|||
28054462|NCT00414050|54711559|FG003|Overall Study|Adverse Event|1|||
28054463|NCT00414050|54711556|FG000|Overall Study|Lost to Follow-up|2|||
28054464|NCT00414050|54711557|FG001|Overall Study|Lost to Follow-up|2|||
28054465|NCT00414050|54711558|FG002|Overall Study|Lost to Follow-up|1|||
28054466|NCT00414050|54711559|FG003|Overall Study|Lost to Follow-up|1|||
28054467|NCT00414050|54711556|FG000|Overall Study|Withdrawal by Subject|5|||
28054468|NCT00414050|54711557|FG001|Overall Study|Withdrawal by Subject|3|||
28054469|NCT00414050|54711558|FG002|Overall Study|Withdrawal by Subject|2|||
28054470|NCT00414050|54711559|FG003|Overall Study|Withdrawal by Subject|4|||
28054471|NCT00414050|54711556|FG000|Overall Study|Subject discontinued for other reason|1|||
28054472|NCT00414050|54711557|FG001|Overall Study|Subject discontinued for other reason|2|||
28054473|NCT00414050|54711558|FG002|Overall Study|Subject discontinued for other reason|2|||
28054474|NCT00414050|54711559|FG003|Overall Study|Subject discontinued for other reason|1|||
28054475|NCT00414050|54711556|FG000|Overall Study|Subject Moved|0|||
28054476|NCT00414050|54711557|FG001|Overall Study|Subject Moved|0|||
28054477|NCT00414050|54711558|FG002|Overall Study|Subject Moved|0|||
28054478|NCT00414050|54711559|FG003|Overall Study|Subject Moved|1|||
28054479|NCT00413972|54711573|FG000|Overall Study|Adverse Event|2|||
28054480|NCT00413972|54711574|FG001|Overall Study|Adverse Event|1|||
28054481|NCT00413972|54711575|FG002|Overall Study|Adverse Event|0|||
28054482|NCT00413972|54711576|FG003|Overall Study|Adverse Event|0|||
28054483|NCT00413972|54711573|FG000|Overall Study|Lost to Follow-up|1|||
28054484|NCT00413972|54711574|FG001|Overall Study|Lost to Follow-up|2|||
28054485|NCT00413972|54711575|FG002|Overall Study|Lost to Follow-up|1|||
28054486|NCT00413972|54711576|FG003|Overall Study|Lost to Follow-up|0|||
28054487|NCT00413972|54711573|FG000|Overall Study|Withdrawal by Subject|4|||
28054488|NCT00413972|54711574|FG001|Overall Study|Withdrawal by Subject|5|||
28054489|NCT00413972|54711575|FG002|Overall Study|Withdrawal by Subject|7|||
28054490|NCT00413972|54711576|FG003|Overall Study|Withdrawal by Subject|2|||
28054491|NCT00413972|54711573|FG000|Overall Study|Protocol Violation|0|||
28054492|NCT00413972|54711574|FG001|Overall Study|Protocol Violation|0|||
28054493|NCT00413972|54711575|FG002|Overall Study|Protocol Violation|2|||
28054494|NCT00413972|54711576|FG003|Overall Study|Protocol Violation|0|||
28054495|NCT00413972|54711573|FG000|Overall Study|Other|0|||
28054496|NCT00413972|54711574|FG001|Overall Study|Other|0|||
28054497|NCT00413972|54711575|FG002|Overall Study|Other|0|||
28054498|NCT00413972|54711576|FG003|Overall Study|Other|1|||
28054499|NCT00259012|54711588|FG000|Overall Study|Adverse Event|0|||
27813091|NCT01693029|54269430|FG001|Overall Study|Kidney transplantation|7|||
27813092|NCT01693029|54269429|FG000|Overall Study|Bindinging anti-EPO antibodies|6|||
27813093|NCT01693029|54269430|FG001|Overall Study|Bindinging anti-EPO antibodies|2|||
28054500|NCT00259012|54711589|FG001|Overall Study|Adverse Event|1|||
28054501|NCT00259012|54711588|FG000|Overall Study|Withdrawal by Subject|1|||
28054502|NCT00259012|54711589|FG001|Overall Study|Withdrawal by Subject|0|||
28054503|NCT00259012|54711588|FG000|Overall Study|Physician Decision|0|||
28054504|NCT00259012|54711589|FG001|Overall Study|Physician Decision|1|||
28054505|NCT00259012|54711588|FG000|Overall Study|Lost to Follow-up|0|||
28054506|NCT00259012|54711589|FG001|Overall Study|Lost to Follow-up|1|||
28054507|NCT00259012|54711588|FG000|Overall Study|Protocol Violation|1|||
27813094|NCT01693029|54269429|FG000|Overall Study|Protocol Violation|6|||
27813095|NCT01693029|54269430|FG001|Overall Study|Protocol Violation|7|||
28054508|NCT00259012|54711589|FG001|Overall Study|Protocol Violation|1|||
28054509|NCT00209170|54711597|FG000|Overall Study|Adverse Event|0|||
28054510|NCT00209170|54711598|FG001|Overall Study|Adverse Event|1|||
28054511|NCT00209170|54711597|FG000|Overall Study|Withdrawal by Subject|2|||
27813096|NCT01693029|54269429|FG000|Overall Study|Change in dialysis modality|2|||
28054512|NCT00209170|54711598|FG001|Overall Study|Withdrawal by Subject|1|||
28054513|NCT00209170|54711597|FG000|Overall Study|Lack of Efficacy|0|||
28054514|NCT00209170|54711598|FG001|Overall Study|Lack of Efficacy|1|||
28054515|NCT00413894|54711604|FG000|Overall Study|Withdrawal by Subject|10|||
28054516|NCT00413894|54711604|FG000|Overall Study|Administrative Reasons|1|||
28054517|NCT00413894|54711604|FG000|Overall Study|Hb <10 grams/deciliter|12|||
28054518|NCT00413894|54711604|FG000|Overall Study|Adverse Event|28|||
28054519|NCT00413894|54711604|FG000|Overall Study|Protocol Violation|11|||
28054520|NCT00413894|54711604|FG000|Overall Study|Other|18|||
28054521|NCT00407550|54711613|FG000|Overall Study|Adverse Event|0|||
28054522|NCT00407550|54711614|FG001|Overall Study|Adverse Event|1|||
28054523|NCT00407550|54711613|FG000|Overall Study|Withdrawal by Subject|0|||
28054524|NCT00407550|54711614|FG001|Overall Study|Withdrawal by Subject|2|||
28054525|NCT00407550|54711613|FG000|Overall Study|Death|1|||
28054526|NCT00407550|54711614|FG001|Overall Study|Death|0|||
28054527|NCT00407550|54711613|FG000|Overall Study|Insurance or Other medical condition|2|||
28054528|NCT00407550|54711614|FG001|Overall Study|Insurance or Other medical condition|1|||
28054529|NCT00209092|54711622|FG000|Overall Study|Progression of disease|7|||
28054530|NCT00209092|54711623|FG001|Overall Study|Progression of disease|1|||
28054531|NCT00209092|54711622|FG000|Overall Study|Adverse Event|0|||
28054532|NCT00209092|54711623|FG001|Overall Study|Adverse Event|1|||
28054533|NCT00209092|54711622|FG000|Overall Study|Withdrawal by Subject|1|||
28054534|NCT00209092|54711623|FG001|Overall Study|Withdrawal by Subject|0|||
28054535|NCT00403494|54711631|FG000|Overall Study|Adverse Event|10|||
28054536|NCT00403494|54711632|FG001|Overall Study|Adverse Event|8|||
28054537|NCT00403494|54711631|FG000|Overall Study|Withdrew Consent|3|||
28054538|NCT00403494|54711632|FG001|Overall Study|Withdrew Consent|2|||
28054539|NCT00403494|54711631|FG000|Overall Study|Inappropriately enrolled|0|||
28054540|NCT00403494|54711632|FG001|Overall Study|Inappropriately enrolled|1|||
28054541|NCT00403494|54711631|FG000|Overall Study|Lost to Follow-up|0|||
28054542|NCT00403494|54711632|FG001|Overall Study|Lost to Follow-up|2|||
28054543|NCT00403494|54711631|FG000|Overall Study|Protocol noncompliance|0|||
28054544|NCT00403494|54711632|FG001|Overall Study|Protocol noncompliance|1|||
28054545|NCT00403494|54711631|FG000|Overall Study|Death|1|||
28054546|NCT00403494|54711632|FG001|Overall Study|Death|0|||
28054547|NCT00403494|54711631|FG000|Overall Study|Sponsor Request|1|||
28054548|NCT00403494|54711632|FG001|Overall Study|Sponsor Request|0|||
28054549|NCT00403260|54711642|FG000|Overall Study|Adverse Event|5|||
28054550|NCT00403260|54711643|FG001|Overall Study|Adverse Event|4|||
28054551|NCT00403260|54711642|FG000|Overall Study|Withdrawal by Subject|5|||
28054552|NCT00403260|54711643|FG001|Overall Study|Withdrawal by Subject|6|||
28054553|NCT00403260|54711642|FG000|Overall Study|Lost to Follow-up|49|||
28054554|NCT00403260|54711643|FG001|Overall Study|Lost to Follow-up|25|||
28054555|NCT00403260|54711642|FG000|Overall Study|Re-appearance of P. falciparum|34|||
28054556|NCT00403260|54711643|FG001|Overall Study|Re-appearance of P. falciparum|25|||
28054557|NCT00403260|54711642|FG000|Overall Study|P. vivax infection|26|||
28054558|NCT00403260|54711643|FG001|Overall Study|P. vivax infection|4|||
28054559|NCT00403260|54711642|FG000|Overall Study|Mixed infection with P. vivax|2|||
28054560|NCT00403260|54711643|FG001|Overall Study|Mixed infection with P. vivax|0|||
28054561|NCT00403260|54711642|FG000|Overall Study|Mixed infection with P. falciparum|1|||
28054562|NCT00403260|54711643|FG001|Overall Study|Mixed infection with P. falciparum|0|||
28054563|NCT00403260|54711642|FG000|Overall Study|P. vivax infection at screening|1|||
28054564|NCT00403260|54711643|FG001|Overall Study|P. vivax infection at screening|0|||
28054565|NCT00403260|54711642|FG000|Overall Study|P. ovale infection|1|||
28054566|NCT00403260|54711643|FG001|Overall Study|P. ovale infection|0|||
28054567|NCT00403260|54711642|FG000|Overall Study|Gametocyte re-appearance|1|||
28054568|NCT00403260|54711643|FG001|Overall Study|Gametocyte re-appearance|1|||
28054569|NCT00403260|54711642|FG000|Overall Study|Withdrawn from study accidentally|0|||
28054570|NCT00403260|54711643|FG001|Overall Study|Withdrawn from study accidentally|1|||
28054571|NCT00406848|54711651|FG000|Overall Study|Withdrawal by Subject|27|||
28054572|NCT00406848|54711652|FG001|Overall Study|Withdrawal by Subject|22|||
28054573|NCT00406848|54711651|FG000|Overall Study|Adverse Event|38|||
28054574|NCT00406848|54711652|FG001|Overall Study|Adverse Event|7|||
28054575|NCT00406848|54711651|FG000|Overall Study|Lack of Efficacy|9|||
28054576|NCT00406848|54711652|FG001|Overall Study|Lack of Efficacy|14|||
28054577|NCT00406848|54711651|FG000|Overall Study|Protocol Violation|10|||
28054578|NCT00406848|54711652|FG001|Overall Study|Protocol Violation|6|||
28054579|NCT00406848|54711651|FG000|Overall Study|Lost to Follow-up|6|||
28054580|NCT00406848|54711652|FG001|Overall Study|Lost to Follow-up|2|||
28054581|NCT00406848|54711651|FG000|Overall Study|Physician Decision|2|||
28054582|NCT00406848|54711652|FG001|Overall Study|Physician Decision|2|||
28054583|NCT00406848|54711651|FG000|Overall Study|Sponsor Decision|1|||
28054584|NCT00406848|54711652|FG001|Overall Study|Sponsor Decision|1|||
28054585|NCT00406692|54711661|FG000|Overall Study|Withdrawal by Subject|4|||
28054586|NCT00406692|54711661|FG000|Overall Study|Physician Decision|1|||
28054587|NCT00406692|54711661|FG000|Overall Study|Adverse Event|1|||
28054588|NCT00406692|54711661|FG000|Overall Study|Lack of Efficacy|1|||
28054589|NCT00315705|54711667|FG000|Phase 1|Refused further treatment|1|||
28054590|NCT00315705|54711667|FG000|Phase 1|Failure to achieve response|8|||
28054591|NCT00315705|54711667|FG000|Phase 1|Disease relapse|4|||
28054592|NCT00315705|54711667|FG000|Phase 1|Scheduled for transplant|9|||
28054593|NCT00315705|54711667|FG000|Phase 1|Death|3|||
28054594|NCT00315705|54711667|FG000|Phase 2|Physician Decision|4|||
28054595|NCT00315705|54711667|FG000|Phase 2|Adverse Event|1|||
28054596|NCT00315705|54711667|FG000|Phase 2|Failure to achieve response|3|||
28054597|NCT00315705|54711667|FG000|Phase 2|Disease relapse|1|||
28054598|NCT00315705|54711667|FG000|Phase 2|Scheduled for transplant|8|||
28054599|NCT00315705|54711667|FG000|Phase 2|Other|1|||
28054600|NCT00315705|54711667|FG000|Phase 2|Death|7|||
27813097|NCT01693029|54269430|FG001|Overall Study|Change in dialysis modality|1|||
28054601|NCT00307125|54711686|FG000|Screening Phase|Adverse Event|1|||
28054602|NCT00307125|54711687|FG001|Screening Phase|Adverse Event|0|||
28054603|NCT00307125|54711688|FG002|Screening Phase|Adverse Event|0|||
28054604|NCT00307125|54711686|FG000|Screening Phase|Protocol Violation|27|||
28054605|NCT00307125|54711687|FG001|Screening Phase|Protocol Violation|0|||
28054606|NCT00307125|54711688|FG002|Screening Phase|Protocol Violation|0|||
28054607|NCT00307125|54711686|FG000|Screening Phase|Lost to Follow-up|87|||
28054608|NCT00307125|54711687|FG001|Screening Phase|Lost to Follow-up|0|||
28054609|NCT00307125|54711688|FG002|Screening Phase|Lost to Follow-up|0|||
28054610|NCT00307125|54711686|FG000|Screening Phase|Death|10|||
28054611|NCT00307125|54711687|FG001|Screening Phase|Death|0|||
28054612|NCT00307125|54711688|FG002|Screening Phase|Death|0|||
28054613|NCT00307125|54711686|FG000|Screening Phase|Withdrawal by Subject|77|||
28054614|NCT00307125|54711687|FG001|Screening Phase|Withdrawal by Subject|0|||
28054615|NCT00307125|54711688|FG002|Screening Phase|Withdrawal by Subject|0|||
28054616|NCT00307125|54711686|FG000|Screening Phase|Physician Decision|26|||
28054617|NCT00307125|54711687|FG001|Screening Phase|Physician Decision|0|||
28054618|NCT00307125|54711688|FG002|Screening Phase|Physician Decision|0|||
28054619|NCT00307125|54711686|FG000|Screening Phase|Sponsor Decision|4|||
27813098|NCT01693029|54269429|FG000|Overall Study|Physician Decision|0|||
27813099|NCT01693029|54269430|FG001|Overall Study|Physician Decision|2|||
27813100|NCT01693029|54269429|FG000|Overall Study|Lost to Follow-up|0|||
27813101|NCT01693029|54269430|FG001|Overall Study|Lost to Follow-up|1|||
27813102|NCT01693029|54269429|FG000|Overall Study|Adverse Event|1|||
27813103|NCT01693029|54269430|FG001|Overall Study|Adverse Event|6|||
27813104|NCT01693029|54269429|FG000|Overall Study|Death|5|||
27813105|NCT01693029|54269430|FG001|Overall Study|Death|8|||
27813106|NCT01693029|54269429|FG000|Overall Study|Non-compliance|2|||
28054620|NCT00307125|54711687|FG001|Screening Phase|Sponsor Decision|0|||
28054621|NCT00307125|54711688|FG002|Screening Phase|Sponsor Decision|0|||
28054622|NCT00307125|54711686|FG000|Screening Phase|Study Terminated|17|||
27813107|NCT01693029|54269430|FG001|Overall Study|Non-compliance|1|||
27813108|NCT01589445|54269436|FG000|001 (Pioglitazone) -3 Months|Protocol Violation|1|||
27813109|NCT01589445|54269436|FG000|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1|||
27813110|NCT01589445|54269436|FG000|001 (Pioglitazone) -3 Months|Lost to Follow-up|2|||
28054623|NCT00307125|54711687|FG001|Screening Phase|Study Terminated|0|||
28054624|NCT00307125|54711688|FG002|Screening Phase|Study Terminated|0|||
28054625|NCT00307125|54711686|FG000|Screening Phase|Graft Loss|3|||
28054626|NCT00307125|54711687|FG001|Screening Phase|Graft Loss|0|||
28054627|NCT00307125|54711688|FG002|Screening Phase|Graft Loss|0|||
28054628|NCT00307125|54711686|FG000|Screening Phase|Graft Failure|8|||
28054629|NCT00307125|54711687|FG001|Screening Phase|Graft Failure|0|||
28054630|NCT00307125|54711688|FG002|Screening Phase|Graft Failure|0|||
28054631|NCT00307125|54711686|FG000|Screening Phase|Follow-up period ended on Dec 31, 2011|83|||
28054632|NCT00307125|54711687|FG001|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
28054633|NCT00307125|54711688|FG002|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
28054634|NCT00307125|54711686|FG000|Screening Phase|Scheduling issues/Non-compliance|55|||
28054635|NCT00307125|54711687|FG001|Screening Phase|Scheduling issues/Non-compliance|0|||
28054636|NCT00307125|54711688|FG002|Screening Phase|Scheduling issues/Non-compliance|0|||
28054637|NCT00307125|54711686|FG000|Screening Phase|Moved or transferred facilities|34|||
28054638|NCT00307125|54711687|FG001|Screening Phase|Moved or transferred facilities|0|||
28054639|NCT00307125|54711688|FG002|Screening Phase|Moved or transferred facilities|0|||
28054640|NCT00307125|54711686|FG000|Screening Phase|Received Pancreas Transplant|8|||
28054641|NCT00307125|54711687|FG001|Screening Phase|Received Pancreas Transplant|0|||
27813111|NCT01589445|54269436|FG000|001 (Pioglitazone) -3 Months|Lack of Efficacy|1|||
27813112|NCT01589445|54269436|FG000|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2|||
27813113|NCT01589445|54269436|FG000|002 (Metformin)-3 Months|Lack of Efficacy|1|||
27813114|NCT01589445|54269436|FG000|002 (Metformin)-3 Months|Lost to Follow-up|2|||
27813115|NCT01589445|54269436|FG000|002 (Metformin)-3 Months|Protocol Violation|2|||
27813116|NCT01589445|54269436|FG000|002 (Metformin)-3 Months|Adverse Event|2|||
27813117|NCT01589445|54269436|FG000|002 (Metformin)-3 Months|Husbands of female patients refrained|2|||
27813118|NCT01588509|54269446|FG000|Overall Study|Lost to Follow-up|1|||
28054642|NCT00307125|54711688|FG002|Screening Phase|Received Pancreas Transplant|0|||
28054643|NCT00307125|54711686|FG000|Screening Phase|Ineligible for pilot|4|||
28054644|NCT00307125|54711687|FG001|Screening Phase|Ineligible for pilot|0|||
28054645|NCT00307125|54711688|FG002|Screening Phase|Ineligible for pilot|0|||
28054646|NCT00307125|54711686|FG000|Screening Phase|Try to get pregnant|1|||
28054647|NCT00307125|54711687|FG001|Screening Phase|Try to get pregnant|0|||
28054648|NCT00307125|54711688|FG002|Screening Phase|Try to get pregnant|0|||
28054649|NCT00307125|54711686|FG000|Screening Phase|Developed acute leukemia|1|||
27813119|NCT01588509|54269447|FG001|Overall Study|Lost to Follow-up|0|||
27813120|NCT01588353|54269456|FG000|Step2|Withdrawal by Subject|0|||
27813121|NCT01588353|54269457|FG001|Step2|Withdrawal by Subject|1|||
27813122|NCT01588353|54269458|FG002|Step2|Withdrawal by Subject|0|||
27813123|NCT01588353|54269456|FG000|Step3|Adverse Event|0|||
27813124|NCT01588353|54269457|FG001|Step3|Adverse Event|0|||
27813125|NCT01588353|54269458|FG002|Step3|Adverse Event|2|||
27813126|NCT01588197|54269467|FG000|Overall Study|Lack of Efficacy|0|||
27813127|NCT01588197|54269468|FG001|Overall Study|Lack of Efficacy|1|||
28054650|NCT00307125|54711687|FG001|Screening Phase|Developed acute leukemia|0|||
28054651|NCT00307125|54711688|FG002|Screening Phase|Developed acute leukemia|0|||
28054652|NCT00307125|54711686|FG000|Screening Phase|Metastatic colon cancer|1|||
28054653|NCT00307125|54711687|FG001|Screening Phase|Metastatic colon cancer|0|||
28054654|NCT00307125|54711688|FG002|Screening Phase|Metastatic colon cancer|0|||
28054655|NCT00307125|54711686|FG000|Screening Phase|Malignancy|1|||
28054656|NCT00307125|54711687|FG001|Screening Phase|Malignancy|0|||
28054657|NCT00307125|54711688|FG002|Screening Phase|Malignancy|0|||
28054658|NCT00307125|54711686|FG000|Screening Phase|PAK|1|||
28054659|NCT00307125|54711687|FG001|Screening Phase|PAK|0|||
28054660|NCT00307125|54711688|FG002|Screening Phase|PAK|0|||
28054661|NCT00307125|54711686|FG000|Screening Phase|Ineligible|1|||
28054662|NCT00307125|54711687|FG001|Screening Phase|Ineligible|0|||
28054663|NCT00307125|54711688|FG002|Screening Phase|Ineligible|0|||
28054664|NCT00307125|54711686|FG000|Screening Phase|Screen Error|1|||
28054665|NCT00307125|54711687|FG001|Screening Phase|Screen Error|0|||
28054666|NCT00307125|54711688|FG002|Screening Phase|Screen Error|0|||
28054667|NCT00307125|54711686|FG000|Screening Phase|Sample of Anti-HLA Ab was not obtained|1|||
28054668|NCT00307125|54711687|FG001|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
27813128|NCT01588197|54269467|FG000|Overall Study|No MRI|1|||
27813129|NCT01588197|54269468|FG001|Overall Study|No MRI|0|||
28054669|NCT00307125|54711688|FG002|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
28054670|NCT00307125|54711686|FG000|Screening Phase|AMR and treated with rituximab|1|||
28054671|NCT00307125|54711687|FG001|Screening Phase|AMR and treated with rituximab|0|||
28054672|NCT00307125|54711688|FG002|Screening Phase|AMR and treated with rituximab|0|||
28054673|NCT00307125|54711686|FG000|Screening Phase|Coronary artery bypass|1|||
28054674|NCT00307125|54711687|FG001|Screening Phase|Coronary artery bypass|0|||
28054675|NCT00307125|54711688|FG002|Screening Phase|Coronary artery bypass|0|||
28054676|NCT00307125|54711686|FG000|Pilot Phase|Lost to Follow-up|0|||
28054677|NCT00307125|54711687|FG001|Pilot Phase|Lost to Follow-up|1|||
28054678|NCT00307125|54711688|FG002|Pilot Phase|Lost to Follow-up|0|||
27813130|NCT01561989|54269476|FG000|Overall Study|accural target not met.|5|||
28054679|NCT00307125|54711686|FG000|Pilot Phase|Withdrawal by Subject|0|||
28054680|NCT00307125|54711687|FG001|Pilot Phase|Withdrawal by Subject|1|||
28054681|NCT00307125|54711688|FG002|Pilot Phase|Withdrawal by Subject|1|||
27813131|NCT01561989|54269477|FG001|Overall Study|accural target not met.|6|||
27813132|NCT01587885|54269492|FG000|Treatment Period 1|Failure to Return|0|||
27813133|NCT01587885|54269493|FG001|Treatment Period 1|Failure to Return|1|||
27813134|NCT01587885|54269492|FG000|Treatment Period 1|Protocol Violation|0|||
27813135|NCT01587885|54269493|FG001|Treatment Period 1|Protocol Violation|2|||
27813136|NCT01587651|54269503|FG000|Overall Study|Adverse Event|0|||
27813137|NCT01587651|54269504|FG001|Overall Study|Adverse Event|1|||
27813138|NCT01587651|54269505|FG002|Overall Study|Adverse Event|0|||
27813139|NCT01587651|54269503|FG000|Overall Study|Protocol Violation|0|||
27813140|NCT01587651|54269504|FG001|Overall Study|Protocol Violation|1|||
27813141|NCT01587651|54269505|FG002|Overall Study|Protocol Violation|1|||
27813142|NCT01587651|54269503|FG000|Overall Study|Withdrawal by Subject|0|||
27813143|NCT01587651|54269504|FG001|Overall Study|Withdrawal by Subject|1|||
27813144|NCT01587651|54269505|FG002|Overall Study|Withdrawal by Subject|0|||
27813145|NCT01691859|54269527|FG000|Overall Study|Adverse Event|19|||
27813146|NCT01691859|54269527|FG000|Overall Study|Lack of Efficacy|11|||
27813147|NCT01691859|54269527|FG000|Overall Study|Protocol Violation|4|||
27813148|NCT01691859|54269527|FG000|Overall Study|Product commercially available|221|||
27813149|NCT01691859|54269527|FG000|Overall Study|Study closed/terminated|50|||
27813150|NCT01691859|54269527|FG000|Overall Study|Lost to Follow-up|5|||
27813151|NCT01691859|54269527|FG000|Overall Study|Physician Decision|6|||
27813152|NCT01691859|54269527|FG000|Overall Study|Withdrawal by Subject|31|||
27813153|NCT01691781|54269571|FG000|Overall Study|Withdrawal by Subject|4|||
27813154|NCT01691781|54269572|FG001|Overall Study|Withdrawal by Subject|3|||
27813155|NCT01691781|54269571|FG000|Overall Study|Physician Decision|1|||
27813156|NCT01691781|54269572|FG001|Overall Study|Physician Decision|1|||
28054682|NCT00307047|54711700|FG000|Overall Study|Lost to Follow-up|35|||
28054683|NCT00307047|54711701|FG001|Overall Study|Lost to Follow-up|24|||
28054684|NCT00307047|54711700|FG000|Overall Study|Withdrawal by Subject|6|||
28054685|NCT00307047|54711701|FG001|Overall Study|Withdrawal by Subject|6|||
28054686|NCT00307047|54711700|FG000|Overall Study|Physician Decision|1|||
28054687|NCT00307047|54711701|FG001|Overall Study|Physician Decision|2|||
28054688|NCT00307047|54711700|FG000|Overall Study|Lost to follow-up for other reasons|0|||
28054689|NCT00307047|54711701|FG001|Overall Study|Lost to follow-up for other reasons|1|||
28054690|NCT00307047|54711700|FG000|Overall Study|All death, all MI, all Revascularization|27|||
28054691|NCT00307047|54711701|FG001|Overall Study|All death, all MI, all Revascularization|16|||
28054692|NCT00306891|54711711|FG000|Part A|Withdrawal by Subject|1|||
28054693|NCT00306891|54711712|FG001|Part A|Withdrawal by Subject|1|||
28054694|NCT00306891|54711713|FG002|Part A|Withdrawal by Subject|0|||
28054695|NCT00306891|54711714|FG003|Part A|Withdrawal by Subject|0|||
28054696|NCT00306891|54711711|FG000|Part A|Condition under investigation worsened|2|||
28054697|NCT00306891|54711712|FG001|Part A|Condition under investigation worsened|2|||
28054698|NCT00306891|54711713|FG002|Part A|Condition under investigation worsened|0|||
28054699|NCT00306891|54711714|FG003|Part A|Condition under investigation worsened|0|||
28054700|NCT00306891|54711711|FG000|Part A|Incorrect enrol/entry crit not fulfilled|0|||
28054701|NCT00306891|54711712|FG001|Part A|Incorrect enrol/entry crit not fulfilled|1|||
28054702|NCT00306891|54711713|FG002|Part A|Incorrect enrol/entry crit not fulfilled|0|||
28054703|NCT00306891|54711714|FG003|Part A|Incorrect enrol/entry crit not fulfilled|0|||
28054704|NCT00306891|54711711|FG000|Part A|Partial bowel obstruction|1|||
28054705|NCT00306891|54711712|FG001|Part A|Partial bowel obstruction|0|||
27813157|NCT01691781|54269571|FG000|Overall Study|Protocol Violation|2|||
27813158|NCT01691781|54269572|FG001|Overall Study|Protocol Violation|2|||
27813159|NCT01691781|54269571|FG000|Overall Study|Adverse Event|0|||
27813160|NCT01691781|54269572|FG001|Overall Study|Adverse Event|1|||
27813161|NCT01561755|54269580|FG000|Overall Study|Lost to Follow-up|0|||
28054706|NCT00306891|54711713|FG002|Part A|Partial bowel obstruction|0|||
28054707|NCT00306891|54711714|FG003|Part A|Partial bowel obstruction|0|||
28054708|NCT00306891|54711711|FG000|Part A|Reaccumul. of ascites following drainage|0|||
28054709|NCT00306891|54711712|FG001|Part A|Reaccumul. of ascites following drainage|1|||
28054710|NCT00306891|54711713|FG002|Part A|Reaccumul. of ascites following drainage|0|||
28054711|NCT00306891|54711714|FG003|Part A|Reaccumul. of ascites following drainage|0|||
28054712|NCT00306891|54711711|FG000|Part A|Suspicion of second malignancy|0|||
28054713|NCT00306891|54711712|FG001|Part A|Suspicion of second malignancy|1|||
28054714|NCT00306891|54711713|FG002|Part A|Suspicion of second malignancy|0|||
28054715|NCT00306891|54711714|FG003|Part A|Suspicion of second malignancy|0|||
28054716|NCT00306891|54711711|FG000|Part A|QTC interval outwith elig. criteria|1|||
28054717|NCT00306891|54711712|FG001|Part A|QTC interval outwith elig. criteria|0|||
28054718|NCT00306891|54711713|FG002|Part A|QTC interval outwith elig. criteria|0|||
28054719|NCT00306891|54711714|FG003|Part A|QTC interval outwith elig. criteria|0|||
28054720|NCT00306891|54711711|FG000|Part B|Death|0|||
28054721|NCT00306891|54711712|FG001|Part B|Death|0|||
28054722|NCT00306891|54711713|FG002|Part B|Death|1|||
28054723|NCT00306891|54711714|FG003|Part B|Death|2|||
28054724|NCT00306891|54711711|FG000|Part B|Adverse Event|0|||
28054725|NCT00306891|54711712|FG001|Part B|Adverse Event|0|||
28054726|NCT00306891|54711713|FG002|Part B|Adverse Event|5|||
28054727|NCT00306891|54711714|FG003|Part B|Adverse Event|5|||
28054728|NCT00306891|54711711|FG000|Part B|Withdrawal by Subject|0|||
28054729|NCT00306891|54711712|FG001|Part B|Withdrawal by Subject|0|||
28054730|NCT00306891|54711713|FG002|Part B|Withdrawal by Subject|3|||
28054731|NCT00306891|54711714|FG003|Part B|Withdrawal by Subject|1|||
27813162|NCT01561755|54269581|FG001|Overall Study|Lost to Follow-up|1|||
27813163|NCT01585155|54269601|FG000|Overall Study|Adverse Event|1|||
27813164|NCT01585155|54269601|FG000|Overall Study|Lack of Efficacy|2|||
27813165|NCT01585155|54269601|FG000|Overall Study|Worsening ulcerative colitis|2|||
27813166|NCT01560507|54269608|FG000|Overall Study|Lost to Follow-up|3|||
27813167|NCT01560507|54269609|FG001|Overall Study|Lost to Follow-up|1|||
27813168|NCT01560507|54269610|FG002|Overall Study|Lost to Follow-up|2|||
28054732|NCT00306891|54711711|FG000|Part B|Condition under investigation worsened|0|||
28054733|NCT00306891|54711712|FG001|Part B|Condition under investigation worsened|0|||
28054734|NCT00306891|54711713|FG002|Part B|Condition under investigation worsened|2|||
28054735|NCT00306891|54711714|FG003|Part B|Condition under investigation worsened|8|||
28054736|NCT00306891|54711711|FG000|Part B|Development of study specific disc crit.|0|||
28054737|NCT00306891|54711712|FG001|Part B|Development of study specific disc crit.|0|||
28054738|NCT00306891|54711713|FG002|Part B|Development of study specific disc crit.|0|||
28054739|NCT00306891|54711714|FG003|Part B|Development of study specific disc crit.|1|||
28054740|NCT00314145|54711727|FG000|Overall Study|Withdrawal by Subject|8|||
28054741|NCT00314145|54711728|FG001|Overall Study|Withdrawal by Subject|10|||
28054742|NCT00314145|54711727|FG000|Overall Study|Lost to Follow-up|5|||
28054743|NCT00314145|54711728|FG001|Overall Study|Lost to Follow-up|12|||
28054744|NCT00314145|54711727|FG000|Overall Study|Physician Decision|3|||
28054745|NCT00314145|54711728|FG001|Overall Study|Physician Decision|4|||
28054746|NCT00314145|54711727|FG000|Overall Study|Adverse Event|0|||
28054747|NCT00314145|54711728|FG001|Overall Study|Adverse Event|3|||
28054748|NCT00314145|54711727|FG000|Overall Study|Protocol Violation|3|||
28054749|NCT00314145|54711728|FG001|Overall Study|Protocol Violation|0|||
28054750|NCT00314145|54711727|FG000|Overall Study|Sponsor Decision|2|||
28054751|NCT00314145|54711728|FG001|Overall Study|Sponsor Decision|0|||
28054752|NCT00313911|54711737|FG000|Overall Study|Serious adverse event|6|||
28054753|NCT00313911|54711738|FG001|Overall Study|Serious adverse event|1|||
28054754|NCT00313911|54711737|FG000|Overall Study|Adverse Event|2|||
28054755|NCT00313911|54711738|FG001|Overall Study|Adverse Event|3|||
28054756|NCT00313911|54711737|FG000|Overall Study|Protocol Violation|19|||
28054757|NCT00313911|54711738|FG001|Overall Study|Protocol Violation|10|||
28054758|NCT00313911|54711737|FG000|Overall Study|Lost to Follow-up|27|||
28054759|NCT00313911|54711738|FG001|Overall Study|Lost to Follow-up|14|||
28054760|NCT00313911|54711737|FG000|Overall Study|Withdrawal by Subject|39|||
27813169|NCT01560507|54269608|FG000|Overall Study|Withdrawal by Subject|1|||
27813170|NCT01560507|54269609|FG001|Overall Study|Withdrawal by Subject|1|||
28054761|NCT00313911|54711738|FG001|Overall Study|Withdrawal by Subject|12|||
28054762|NCT00313911|54711737|FG000|Overall Study|Did not meet age criteria|1|||
28054763|NCT00313911|54711738|FG001|Overall Study|Did not meet age criteria|1|||
27848239|NCT01045161|54341214|FG000|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
28054764|NCT00391872|54711746|FG000|Overall Study|Protocol Violation|7|||
28054765|NCT00391872|54711747|FG001|Overall Study|Protocol Violation|2|||
28054766|NCT00391872|54711746|FG000|Overall Study|Withdrawal by Subject|296|||
28054767|NCT00391872|54711747|FG001|Overall Study|Withdrawal by Subject|249|||
28054768|NCT00391872|54711746|FG000|Overall Study|Reason unknown|2|||
28054769|NCT00391872|54711747|FG001|Overall Study|Reason unknown|4|||
27813171|NCT01560507|54269610|FG002|Overall Study|Withdrawal by Subject|0|||
27813172|NCT01584843|54269625|FG000|First Treatment Period|Adverse Event|0|||
28054770|NCT00391872|54711746|FG000|Overall Study|Lost to Follow-up|2|||
28054771|NCT00391872|54711747|FG001|Overall Study|Lost to Follow-up|0|||
28054772|NCT00391170|54711755|FG000|Overall Study|Withdrawal by Subject|1|||
28054773|NCT00391170|54711756|FG001|Overall Study|Withdrawal by Subject|0|||
28054774|NCT00391170|54711755|FG000|Overall Study|Adverse Event|3|||
28054775|NCT00391170|54711756|FG001|Overall Study|Adverse Event|2|||
28054776|NCT00391170|54711755|FG000|Overall Study|Physician Decision|2|||
28054777|NCT00391170|54711756|FG001|Overall Study|Physician Decision|2|||
28054778|NCT00402324|54711764|FG000|Overall Study|Lost to Follow-up|11|||
28054779|NCT00402324|54711765|FG001|Overall Study|Lost to Follow-up|11|||
28054780|NCT00402324|54711764|FG000|Overall Study|Protocol Entry Criteria Not Met|5|||
28054781|NCT00402324|54711765|FG001|Overall Study|Protocol Entry Criteria Not Met|4|||
28054782|NCT00402324|54711764|FG000|Overall Study|Protocol Violation|8|||
28054783|NCT00402324|54711765|FG001|Overall Study|Protocol Violation|7|||
28054784|NCT00402324|54711764|FG000|Overall Study|Withdrawal by Subject|5|||
28054785|NCT00402324|54711765|FG001|Overall Study|Withdrawal by Subject|2|||
28054786|NCT00402324|54711764|FG000|Overall Study|Physician Decision|2|||
28054787|NCT00402324|54711765|FG001|Overall Study|Physician Decision|4|||
28054788|NCT00402324|54711764|FG000|Overall Study|Sponsor Decision|4|||
28054789|NCT00402324|54711765|FG001|Overall Study|Sponsor Decision|5|||
28054790|NCT00402324|54711764|FG000|Overall Study|Lack of Efficacy|1|||
28054791|NCT00402324|54711765|FG001|Overall Study|Lack of Efficacy|4|||
28054792|NCT00402324|54711764|FG000|Overall Study|Adverse Event|6|||
28054793|NCT00402324|54711765|FG001|Overall Study|Adverse Event|4|||
28054794|NCT00402324|54711764|FG000|Overall Study|Death|1|||
28054795|NCT00402324|54711765|FG001|Overall Study|Death|0|||
28054796|NCT00294723|54711774|FG000|Double-Blind Period 52 Weeks|Adverse Event|18|||
28054797|NCT00294723|54711775|FG001|Double-Blind Period 52 Weeks|Adverse Event|25|||
27813173|NCT01584843|54269626|FG001|First Treatment Period|Adverse Event|0|||
27813174|NCT01584843|54269627|FG002|First Treatment Period|Adverse Event|1|||
28054798|NCT00294723|54711776|FG002|Double-Blind Period 52 Weeks|Adverse Event|15|||
28054799|NCT00294723|54711774|FG000|Double-Blind Period 52 Weeks|Lack of Efficacy|9|||
28054800|NCT00294723|54711775|FG001|Double-Blind Period 52 Weeks|Lack of Efficacy|15|||
28054801|NCT00294723|54711776|FG002|Double-Blind Period 52 Weeks|Lack of Efficacy|25|||
28054802|NCT00294723|54711774|FG000|Double-Blind Period 52 Weeks|Protocol Violation|11|||
28054803|NCT00294723|54711775|FG001|Double-Blind Period 52 Weeks|Protocol Violation|11|||
28054804|NCT00294723|54711776|FG002|Double-Blind Period 52 Weeks|Protocol Violation|5|||
28054805|NCT00294723|54711774|FG000|Double-Blind Period 52 Weeks|Not specified in study report|36|||
28054806|NCT00294723|54711775|FG001|Double-Blind Period 52 Weeks|Not specified in study report|38|||
28054807|NCT00294723|54711776|FG002|Double-Blind Period 52 Weeks|Not specified in study report|51|||
28054808|NCT00294723|54711774|FG000|Open-Label Extension 52 Weeks|Adverse Event|5|||
28054809|NCT00294723|54711775|FG001|Open-Label Extension 52 Weeks|Adverse Event|5|||
28054810|NCT00294723|54711776|FG002|Open-Label Extension 52 Weeks|Adverse Event|2|||
28054811|NCT00294723|54711774|FG000|Open-Label Extension 52 Weeks|Lack of Efficacy|12|||
28054812|NCT00294723|54711775|FG001|Open-Label Extension 52 Weeks|Lack of Efficacy|15|||
28054813|NCT00294723|54711776|FG002|Open-Label Extension 52 Weeks|Lack of Efficacy|21|||
28054814|NCT00294723|54711774|FG000|Open-Label Extension 52 Weeks|Protocol Violation|4|||
28054815|NCT00294723|54711775|FG001|Open-Label Extension 52 Weeks|Protocol Violation|3|||
28054816|NCT00294723|54711776|FG002|Open-Label Extension 52 Weeks|Protocol Violation|3|||
28054817|NCT00294723|54711774|FG000|Open-Label Extension 52 Weeks|Not specified in study report|19|||
28054818|NCT00294723|54711775|FG001|Open-Label Extension 52 Weeks|Not specified in study report|16|||
28054819|NCT00294723|54711776|FG002|Open-Label Extension 52 Weeks|Not specified in study report|14|||
28054820|NCT00294723|54711774|FG000|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
28054821|NCT00294723|54711775|FG001|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
28054822|NCT00294723|54711776|FG002|Additional Open-Label Extension 91 Weeks|Adverse Event|0|||
28054823|NCT00294723|54711774|FG000|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24|||
28054824|NCT00294723|54711775|FG001|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14|||
28054825|NCT00294723|54711776|FG002|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16|||
28054826|NCT00294723|54711774|FG000|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
28054827|NCT00294723|54711775|FG001|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
28054828|NCT00294723|54711776|FG002|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
28054829|NCT00294723|54711774|FG000|Additional Open-Label Extension 91 Weeks|Not specified in study report|2|||
28054830|NCT00294723|54711775|FG001|Additional Open-Label Extension 91 Weeks|Not specified in study report|5|||
28054831|NCT00294723|54711776|FG002|Additional Open-Label Extension 91 Weeks|Not specified in study report|3|||
28054832|NCT00402246|54711789|FG000|Overall Study|Death|62|||
28054833|NCT00402246|54711790|FG001|Overall Study|Death|58|||
28054834|NCT00402246|54711789|FG000|Overall Study|Lost to Follow-up|20|||
27813175|NCT01584843|54269628|FG003|First Treatment Period|Adverse Event|0|||
28054835|NCT00402246|54711790|FG001|Overall Study|Lost to Follow-up|28|||
28054836|NCT00402246|54711789|FG000|Overall Study|Withdrawal by Subject|72|||
28054837|NCT00402246|54711790|FG001|Overall Study|Withdrawal by Subject|87|||
27848240|NCT01045161|54341215|FG001|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
28054838|NCT00402246|54711789|FG000|Overall Study|Physician Decision|24|||
28054839|NCT00402246|54711790|FG001|Overall Study|Physician Decision|26|||
28054840|NCT00402246|54711789|FG000|Overall Study|Protocol Violation|25|||
28054841|NCT00402246|54711790|FG001|Overall Study|Protocol Violation|24|||
28054842|NCT00402246|54711789|FG000|Overall Study|Missed Final Visit|1|||
28054843|NCT00402246|54711790|FG001|Overall Study|Missed Final Visit|2|||
28054844|NCT00402246|54711789|FG000|Overall Study|Insurance Issues|2|||
28054845|NCT00402246|54711790|FG001|Overall Study|Insurance Issues|1|||
28054846|NCT00402246|54711789|FG000|Overall Study|Heart Transplant|0|||
28054847|NCT00402246|54711790|FG001|Overall Study|Heart Transplant|1|||
28054848|NCT00402246|54711789|FG000|Overall Study|Patient's device explanted|6|||
28054849|NCT00402246|54711790|FG001|Overall Study|Patient's device explanted|2|||
28054850|NCT00402246|54711789|FG000|Overall Study|Center Closure|5|||
28054851|NCT00402246|54711790|FG001|Overall Study|Center Closure|3|||
28054852|NCT00402246|54711789|FG000|Overall Study|Deterioriating Condition|3|||
28054853|NCT00402246|54711790|FG001|Overall Study|Deterioriating Condition|2|||
28054854|NCT00375492|54711800|FG000|Overall Study|Adverse Event|4|||
28054855|NCT00375492|54711801|FG001|Overall Study|Adverse Event|5|||
28054856|NCT00375492|54711800|FG000|Overall Study|Entry Criteria Not Met|0|||
28054857|NCT00375492|54711801|FG001|Overall Study|Entry Criteria Not Met|1|||
28054858|NCT00375492|54711800|FG000|Overall Study|Loss of Glucose Control|0|||
28054859|NCT00375492|54711801|FG001|Overall Study|Loss of Glucose Control|1|||
28054860|NCT00375492|54711800|FG000|Overall Study|Lost to Follow-up|10|||
28054861|NCT00375492|54711801|FG001|Overall Study|Lost to Follow-up|5|||
28054862|NCT00375492|54711800|FG000|Overall Study|Physician Decision|0|||
28054863|NCT00375492|54711801|FG001|Overall Study|Physician Decision|4|||
28054864|NCT00375492|54711800|FG000|Overall Study|Protocol Violation|6|||
28054865|NCT00375492|54711801|FG001|Overall Study|Protocol Violation|3|||
28054866|NCT00375492|54711800|FG000|Overall Study|Sponsor Decision|0|||
28054867|NCT00375492|54711801|FG001|Overall Study|Sponsor Decision|1|||
28054868|NCT00375492|54711800|FG000|Overall Study|Withdrawal by Subject|6|||
28054869|NCT00375492|54711801|FG001|Overall Study|Withdrawal by Subject|6|||
28054870|NCT00306189|54711811|FG000|Overall Study|Physician Decision|0|||
28054871|NCT00306189|54711812|FG001|Overall Study|Physician Decision|0|||
28054872|NCT00306189|54711813|FG002|Overall Study|Physician Decision|0|||
28054873|NCT00306189|54711814|FG003|Overall Study|Physician Decision|1|||
28054874|NCT00306189|54711811|FG000|Overall Study|Adverse Event|3|||
28054875|NCT00306189|54711812|FG001|Overall Study|Adverse Event|3|||
28054876|NCT00306189|54711813|FG002|Overall Study|Adverse Event|2|||
28054877|NCT00306189|54711814|FG003|Overall Study|Adverse Event|2|||
28054878|NCT00306189|54711811|FG000|Overall Study|Withdrawal by Subject|4|||
28054879|NCT00306189|54711812|FG001|Overall Study|Withdrawal by Subject|2|||
28054880|NCT00306189|54711813|FG002|Overall Study|Withdrawal by Subject|8|||
28054881|NCT00306189|54711814|FG003|Overall Study|Withdrawal by Subject|1|||
28054882|NCT00306189|54711811|FG000|Overall Study|Ineligibility determined|1|||
28054883|NCT00306189|54711812|FG001|Overall Study|Ineligibility determined|1|||
28054884|NCT00306189|54711813|FG002|Overall Study|Ineligibility determined|1|||
28054885|NCT00306189|54711814|FG003|Overall Study|Ineligibility determined|1|||
28054886|NCT00306189|54711811|FG000|Overall Study|Other|1|||
28054887|NCT00306189|54711812|FG001|Overall Study|Other|0|||
28054888|NCT00306189|54711813|FG002|Overall Study|Other|0|||
28054889|NCT00306189|54711814|FG003|Overall Study|Other|0|||
28054890|NCT00312897|54711826|FG000|Overall Study|Adverse Event|1|||
28054891|NCT00312897|54711827|FG001|Overall Study|Adverse Event|0|||
28054892|NCT00312897|54711826|FG000|Overall Study|Lost to Follow-up|2|||
28054893|NCT00312897|54711827|FG001|Overall Study|Lost to Follow-up|0|||
28054894|NCT00312897|54711826|FG000|Overall Study|Physician Decision|1|||
28054895|NCT00312897|54711827|FG001|Overall Study|Physician Decision|0|||
28054896|NCT00312897|54711826|FG000|Overall Study|Withdrawal by Subject|1|||
28054897|NCT00312897|54711827|FG001|Overall Study|Withdrawal by Subject|3|||
28054898|NCT00312897|54711826|FG000|Overall Study|Pregnancy|1|||
28054899|NCT00312897|54711827|FG001|Overall Study|Pregnancy|0|||
28054900|NCT00312897|54711826|FG000|Overall Study|discontinued prior to getting treatment|0|||
28054901|NCT00312897|54711827|FG001|Overall Study|discontinued prior to getting treatment|3|||
28054902|NCT00312663|54711836|FG000|Immunization Phase|Adverse Event|0|||
28054903|NCT00312663|54711837|FG001|Immunization Phase|Adverse Event|1|||
28054904|NCT00312663|54711838|FG002|Immunization Phase|Adverse Event|0|||
28054905|NCT00294645|54711849|FG000|Overall Study|Death|10|||
28054906|NCT00294645|54711850|FG001|Overall Study|Death|18|||
28054907|NCT00294645|54711849|FG000|Overall Study|Lost to Follow-up|1|||
28054908|NCT00294645|54711850|FG001|Overall Study|Lost to Follow-up|10|||
28054909|NCT00294645|54711849|FG000|Overall Study|Withdrawal by Subject|18|||
28054910|NCT00294645|54711850|FG001|Overall Study|Withdrawal by Subject|34|||
28054911|NCT00294645|54711849|FG000|Overall Study|Physician Decision|15|||
28054912|NCT00294645|54711850|FG001|Overall Study|Physician Decision|20|||
28054913|NCT00294645|54711849|FG000|Overall Study|Other|4|||
28054914|NCT00294645|54711850|FG001|Overall Study|Other|10|||
28054915|NCT00305877|54711858|FG000|Overall Study|Lack of Efficacy|6|||
28054916|NCT00305877|54711859|FG001|Overall Study|Lack of Efficacy|9|||
28054917|NCT00305877|54711858|FG000|Overall Study|Adverse Event|9|||
28054918|NCT00305877|54711859|FG001|Overall Study|Adverse Event|14|||
28054919|NCT00305877|54711858|FG000|Overall Study|Death|0|||
28054920|NCT00305877|54711859|FG001|Overall Study|Death|1|||
28054921|NCT00305877|54711858|FG000|Overall Study|Withdrawal by Subject|4|||
28054922|NCT00305877|54711859|FG001|Overall Study|Withdrawal by Subject|2|||
28054923|NCT00305877|54711858|FG000|Overall Study|Physician Decision|1|||
28054924|NCT00305877|54711859|FG001|Overall Study|Physician Decision|1|||
28054925|NCT00305877|54711858|FG000|Overall Study|Never start treatment|2|||
28054926|NCT00305877|54711859|FG001|Overall Study|Never start treatment|5|||
28054927|NCT00305877|54711858|FG000|Overall Study|Ineligible|2|||
28054928|NCT00305877|54711859|FG001|Overall Study|Ineligible|1|||
28054929|NCT00305877|54711858|FG000|Overall Study|Transportation issue with daily RT|0|||
28054930|NCT00305877|54711859|FG001|Overall Study|Transportation issue with daily RT|1|||
28054931|NCT00312195|54711867|FG000|Overall Study|Adverse Event|4|||
28054932|NCT00312195|54711868|FG001|Overall Study|Adverse Event|6|||
28054933|NCT00312195|54711867|FG000|Overall Study|Lost to Follow-up|1|||
28054934|NCT00312195|54711868|FG001|Overall Study|Lost to Follow-up|0|||
28054935|NCT00312195|54711867|FG000|Overall Study|Protocol Violation|1|||
28054936|NCT00312195|54711868|FG001|Overall Study|Protocol Violation|0|||
28054937|NCT00305253|54711878|FG000|Overall Study|Withdrawal by Subject|0|||
28054938|NCT00305253|54711879|FG001|Overall Study|Withdrawal by Subject|1|||
28054939|NCT00293709|54711885|FG000|Overall Study|Other|47|||
28054940|NCT00311181|54711889|FG000|Overall Study|Final DFTs were not obtained|96|||
28054941|NCT00293397|54711893|FG000|Overall Study|Death|2|||
28054942|NCT00290745|54711898|FG000|Overall Study|Withdrawal by Subject|4|||
28054943|NCT00290745|54711898|FG000|Overall Study|Physician Decision|2|||
28054944|NCT00290745|54711898|FG000|Overall Study|Surgery after 3 months for progression|3|||
28054945|NCT00290745|54711898|FG000|Overall Study|Baseline MRI not available|3|||
28054946|NCT00402168|54711904|FG000|Randomized|Lost to Follow-up|1|||
28054947|NCT00402168|54711905|FG001|Randomized|Lost to Follow-up|0|||
28054948|NCT00402168|54711904|FG000|Randomized|Withdrawal by Subject|0|||
28054949|NCT00402168|54711905|FG001|Randomized|Withdrawal by Subject|1|||
28054950|NCT00402168|54711904|FG000|Treatment (up to 12 Months)|Death|0|||
28054951|NCT00402168|54711905|FG001|Treatment (up to 12 Months)|Death|1|||
28054952|NCT00402168|54711904|FG000|Treatment (up to 12 Months)|Lack of Efficacy|2|||
28054953|NCT00402168|54711905|FG001|Treatment (up to 12 Months)|Lack of Efficacy|0|||
28054954|NCT00402168|54711904|FG000|Treatment (up to 12 Months)|non-specified|0|||
28054955|NCT00402168|54711905|FG001|Treatment (up to 12 Months)|non-specified|1|||
28054956|NCT00402168|54711904|FG000|Long Term (LT)|Adverse Event|1|||
28054957|NCT00402168|54711905|FG001|Long Term (LT)|Adverse Event|5|||
28054958|NCT00402168|54711904|FG000|Long Term (LT)|Withdrawal by Subject|4|||
28054959|NCT00402168|54711905|FG001|Long Term (LT)|Withdrawal by Subject|7|||
28054960|NCT00402168|54711904|FG000|Long Term (LT)|Pregnancy|0|||
28054961|NCT00402168|54711905|FG001|Long Term (LT)|Pregnancy|1|||
28054962|NCT00402168|54711904|FG000|Long Term (LT)|Lost to Follow-up|1|||
28054963|NCT00402168|54711905|FG001|Long Term (LT)|Lost to Follow-up|0|||
28054964|NCT00402168|54711904|FG000|Long Term (LT)|Death|4|||
27813176|NCT01584843|54269629|FG004|First Treatment Period|Adverse Event|0|||
28054965|NCT00402168|54711905|FG001|Long Term (LT)|Death|0|||
28054966|NCT00402168|54711904|FG000|Long Term (LT)|Lack of Efficacy|0|||
28054967|NCT00402168|54711905|FG001|Long Term (LT)|Lack of Efficacy|2|||
28054968|NCT00402168|54711904|FG000|Long Term (LT)|non-specified|1|||
28054969|NCT00402168|54711905|FG001|Long Term (LT)|non-specified|2|||
28054970|NCT00402168|54711904|FG000|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2|||
28054971|NCT00402168|54711905|FG001|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0|||
27813177|NCT01584843|54269630|FG005|First Treatment Period|Adverse Event|0|||
28054972|NCT00402168|54711904|FG000|Switched From CNI to Belatacept in LT|Adverse Event|4|||
27813178|NCT01584843|54269625|FG000|First Treatment Period|Protocol Violation|0|||
27813179|NCT01584843|54269626|FG001|First Treatment Period|Protocol Violation|0|||
28054973|NCT00402168|54711905|FG001|Switched From CNI to Belatacept in LT|Adverse Event|0|||
28054974|NCT00290589|54711921|FG000|Overall Study|Lost to Follow-up|2|||
28054975|NCT00290589|54711922|FG001|Overall Study|Lost to Follow-up|2|||
28054976|NCT00290511|54711928|FG000|Overall Study|Adverse Event|1|||
28054977|NCT00290511|54711928|FG000|Overall Study|Death|1|||
28054978|NCT00290511|54711928|FG000|Overall Study|Physician Decision|1|||
28054979|NCT00290511|54711928|FG000|Overall Study|Withdrawal by Subject|1|||
28054980|NCT00290433|54711932|FG000|Overall Study|Disease Progression|13|||
28054981|NCT00290433|54711932|FG000|Overall Study|Adverse Event|14|||
28054982|NCT00290433|54711932|FG000|Overall Study|Withdrawal by Subject|1|||
28054983|NCT00290433|54711932|FG000|Overall Study|Non-Compliance|1|||
28054984|NCT00290433|54711932|FG000|Overall Study|Congestive Heart Failure|1|||
28054985|NCT00290433|54711932|FG000|Overall Study|Transplant in CR|5|||
28054986|NCT00290433|54711932|FG000|Overall Study|Unrelated Infection/Death|1|||
28054987|NCT00304083|54711938|FG000|Overall Study|Withdrawal by Subject|4|||
28054988|NCT00304083|54711939|FG001|Overall Study|Withdrawal by Subject|2|||
28054989|NCT00304083|54711938|FG000|Overall Study|Physician Decision|8|||
28054990|NCT00304083|54711939|FG001|Overall Study|Physician Decision|3|||
28054991|NCT00304083|54711938|FG000|Overall Study|Disease Progression|5|||
28054992|NCT00304083|54711939|FG001|Overall Study|Disease Progression|1|||
28054993|NCT00304083|54711938|FG000|Overall Study|Other|5|||
28054994|NCT00304083|54711939|FG001|Overall Study|Other|2|||
28054995|NCT00293241|54711947|FG000|Overall Study|Lost to Follow-up|9|||
28054996|NCT00293241|54711948|FG001|Overall Study|Lost to Follow-up|16|||
28054997|NCT00293241|54711947|FG000|Overall Study|Physician Decision|23|||
28054998|NCT00293241|54711948|FG001|Overall Study|Physician Decision|17|||
28054999|NCT00293241|54711947|FG000|Overall Study|Withdrawal by Subject|4|||
28055000|NCT00293241|54711948|FG001|Overall Study|Withdrawal by Subject|8|||
28055001|NCT00391092|54711959|FG000|Overall Study|Death|78|||
28055002|NCT00391092|54711960|FG001|Overall Study|Death|81|||
28055003|NCT00391092|54711959|FG000|Overall Study|Lost to Follow-up|13|||
28055004|NCT00391092|54711960|FG001|Overall Study|Lost to Follow-up|18|||
28055005|NCT00391092|54711959|FG000|Overall Study|Alive on treatment|29|||
28055006|NCT00391092|54711960|FG001|Overall Study|Alive on treatment|33|||
28055007|NCT00391092|54711959|FG000|Overall Study|Alive in follow-up|88|||
28055008|NCT00391092|54711960|FG001|Overall Study|Alive in follow-up|84|||
28055009|NCT00374868|54711966|FG000|Overall Study|Adverse Event|12|||
28055010|NCT00374868|54711966|FG000|Overall Study|Progressive Disease|7|||
28055011|NCT00374868|54711966|FG000|Overall Study|Physician Decision|13|||
28055012|NCT00374868|54711966|FG000|Overall Study|Lost to Follow-up|1|||
28055013|NCT00374868|54711966|FG000|Overall Study|Death|2|||
28055014|NCT00374868|54711966|FG000|Overall Study|Other - Not Specified|1|||
28055015|NCT00374556|54711972|FG000|Overall Study|Lost to Follow-up|1|||
28055016|NCT00374556|54711973|FG001|Overall Study|Lost to Follow-up|0|||
28055017|NCT00374556|54711972|FG000|Overall Study|Removed at baseline due to medical cond|0|||
28055018|NCT00374556|54711973|FG001|Overall Study|Removed at baseline due to medical cond|1|||
28055019|NCT00290355|54711981|FG000|Overall Study|Serious adverse event|7|||
28055020|NCT00290355|54711982|FG001|Overall Study|Serious adverse event|4|||
28055021|NCT00290355|54711981|FG000|Overall Study|Study product reactogenicity|1|||
28055022|NCT00290355|54711982|FG001|Overall Study|Study product reactogenicity|0|||
28055023|NCT00290355|54711981|FG000|Overall Study|Protocol Violation|1|||
28055024|NCT00290355|54711982|FG001|Overall Study|Protocol Violation|0|||
28055025|NCT00290355|54711981|FG000|Overall Study|Withdrawal by Subject|2|||
28055026|NCT00290355|54711982|FG001|Overall Study|Withdrawal by Subject|0|||
28055027|NCT00290355|54711981|FG000|Overall Study|Migrated / moved from the study area|1|||
28055028|NCT00290355|54711982|FG001|Overall Study|Migrated / moved from the study area|0|||
28055029|NCT00290355|54711981|FG000|Overall Study|Lost to Follow-up|3|||
28055030|NCT00290355|54711982|FG001|Overall Study|Lost to Follow-up|1|||
28055031|NCT00290355|54711981|FG000|Overall Study|Other|2|||
28055032|NCT00290355|54711982|FG001|Overall Study|Other|0|||
28055033|NCT00374322|54711990|FG000|Overall Study|Lost to Follow-up|92|||
28055034|NCT00374322|54711991|FG001|Overall Study|Lost to Follow-up|90|||
28055035|NCT00374322|54711990|FG000|Overall Study|Protocol Violation|8|||
28055036|NCT00374322|54711991|FG001|Overall Study|Protocol Violation|3|||
28055037|NCT00374322|54711990|FG000|Overall Study|Withdrawal by Subject|235|||
28055038|NCT00374322|54711991|FG001|Overall Study|Withdrawal by Subject|167|||
28055039|NCT00374322|54711990|FG000|Overall Study|Sponsor Terminated Study|866|||
28055040|NCT00374322|54711991|FG001|Overall Study|Sponsor Terminated Study|990|||
28055041|NCT00374322|54711990|FG000|Overall Study|Physician Decision|36|||
28055042|NCT00374322|54711991|FG001|Overall Study|Physician Decision|32|||
28055043|NCT00374322|54711990|FG000|Overall Study|Par. Consented to Survival FU Only|3|||
28055044|NCT00374322|54711991|FG001|Overall Study|Par. Consented to Survival FU Only|1|||
28055045|NCT00374322|54711990|FG000|Overall Study|Sponsor Decision|2|||
28055046|NCT00374322|54711991|FG001|Overall Study|Sponsor Decision|3|||
28055047|NCT00374322|54711990|FG000|Overall Study|FU by a Non-Principal Investigator (PI)|2|||
28055048|NCT00374322|54711991|FG001|Overall Study|FU by a Non-Principal Investigator (PI)|3|||
28055049|NCT00374322|54711990|FG000|Overall Study|Seen in FU by a Non-Primary Investigator|1|||
28055050|NCT00374322|54711991|FG001|Overall Study|Seen in FU by a Non-Primary Investigator|0|||
28055051|NCT00374322|54711990|FG000|Overall Study|Severe Toxicity|1|||
28055052|NCT00374322|54711991|FG001|Overall Study|Severe Toxicity|0|||
28055053|NCT00374322|54711990|FG000|Overall Study|Site Closed|2|||
28055054|NCT00374322|54711991|FG001|Overall Study|Site Closed|2|||
28055055|NCT00374322|54711990|FG000|Overall Study|Participant Changed Physician|1|||
28055056|NCT00374322|54711991|FG001|Overall Study|Participant Changed Physician|0|||
28055057|NCT00374322|54711990|FG000|Overall Study|Started Another Chemotherapy Regimen|0|||
28055058|NCT00374322|54711991|FG001|Overall Study|Started Another Chemotherapy Regimen|1|||
28055059|NCT00374322|54711990|FG000|Overall Study|Noncompliance with Study Requirements|0|||
28055060|NCT00374322|54711991|FG001|Overall Study|Noncompliance with Study Requirements|1|||
28055061|NCT00374322|54711990|FG000|Overall Study|Withdrew Consent During Follow-up|0|||
28055062|NCT00374322|54711991|FG001|Overall Study|Withdrew Consent During Follow-up|5|||
28055063|NCT00374322|54711990|FG000|Overall Study|Did Not Receive Study Medication|8|||
28055064|NCT00374322|54711991|FG001|Overall Study|Did Not Receive Study Medication|6|||
28055065|NCT00303459|54712000|FG000|Overall Study|Death|33|||
28055066|NCT00303459|54712001|FG001|Overall Study|Death|44|||
28055067|NCT00303459|54712000|FG000|Overall Study|Withdrawal of consent|32|||
28055068|NCT00303459|54712001|FG001|Overall Study|Withdrawal of consent|26|||
28055069|NCT00303459|54712000|FG000|Overall Study|Lost to Follow-up|5|||
28055070|NCT00303459|54712001|FG001|Overall Study|Lost to Follow-up|4|||
28055071|NCT00303459|54712000|FG000|Overall Study|Administrative reason|7|||
28055072|NCT00303459|54712001|FG001|Overall Study|Administrative reason|7|||
28055073|NCT00303459|54712000|FG000|Overall Study|Decision by the investigator|5|||
28055074|NCT00303459|54712001|FG001|Overall Study|Decision by the investigator|7|||
28055075|NCT00303459|54712000|FG000|Overall Study|Lung transplantation|1|||
28055076|NCT00303459|54712001|FG001|Overall Study|Lung transplantation|1|||
28055077|NCT00289887|54712010|FG000|Overall Study|Adverse Event|3|||
28055078|NCT00289887|54712011|FG001|Overall Study|Adverse Event|3|||
28055079|NCT00289887|54712010|FG000|Overall Study|Lack of Efficacy|3|||
28055080|NCT00289887|54712011|FG001|Overall Study|Lack of Efficacy|11|||
28055081|NCT00289887|54712010|FG000|Overall Study|Lost to Follow-up|3|||
28055082|NCT00289887|54712011|FG001|Overall Study|Lost to Follow-up|3|||
28055083|NCT00289887|54712010|FG000|Overall Study|Protocol Violation|3|||
28055084|NCT00289887|54712011|FG001|Overall Study|Protocol Violation|1|||
28055085|NCT00289887|54712010|FG000|Overall Study|Withdrawal by Subject|3|||
28055086|NCT00289887|54712011|FG001|Overall Study|Withdrawal by Subject|8|||
28055087|NCT00289887|54712010|FG000|Overall Study|Other|7|||
28055088|NCT00289887|54712011|FG001|Overall Study|Other|3|||
28055089|NCT00303069|54712021|FG000|Overall Study|Lost to Follow-up|1|||
28055090|NCT00303069|54712022|FG001|Overall Study|Lost to Follow-up|0|||
28055091|NCT00303069|54712023|FG002|Overall Study|Lost to Follow-up|0|||
28055092|NCT00303069|54712024|FG003|Overall Study|Lost to Follow-up|2|||
28055093|NCT00303069|54712021|FG000|Overall Study|subject moved|1|||
28055094|NCT00303069|54712022|FG001|Overall Study|subject moved|0|||
28055095|NCT00303069|54712023|FG002|Overall Study|subject moved|0|||
28055096|NCT00303069|54712024|FG003|Overall Study|subject moved|0|||
28055097|NCT00303069|54712021|FG000|Overall Study|Recruitment into Army Reserves|0|||
28055098|NCT00303069|54712022|FG001|Overall Study|Recruitment into Army Reserves|0|||
28055099|NCT00303069|54712023|FG002|Overall Study|Recruitment into Army Reserves|1|||
28055100|NCT00303069|54712024|FG003|Overall Study|Recruitment into Army Reserves|0|||
28055101|NCT00401544|54712038|FG000|Overall Study|Adverse Event|5|||
28055102|NCT00401544|54712039|FG001|Overall Study|Adverse Event|1|||
28055103|NCT00401544|54712040|FG002|Overall Study|Adverse Event|1|||
28055104|NCT00401544|54712041|FG003|Overall Study|Adverse Event|1|||
28055105|NCT00401544|54712038|FG000|Overall Study|Death|3|||
28055106|NCT00401544|54712039|FG001|Overall Study|Death|6|||
28055107|NCT00401544|54712040|FG002|Overall Study|Death|2|||
28055108|NCT00401544|54712041|FG003|Overall Study|Death|5|||
28055109|NCT00401544|54712038|FG000|Overall Study|Lost to Follow-up|2|||
28055110|NCT00401544|54712039|FG001|Overall Study|Lost to Follow-up|0|||
28055111|NCT00401544|54712040|FG002|Overall Study|Lost to Follow-up|1|||
28055112|NCT00401544|54712041|FG003|Overall Study|Lost to Follow-up|1|||
28055113|NCT00401544|54712038|FG000|Overall Study|Withdrawal by Subject|7|||
28055114|NCT00401544|54712039|FG001|Overall Study|Withdrawal by Subject|6|||
28055115|NCT00401544|54712040|FG002|Overall Study|Withdrawal by Subject|6|||
28105713|NCT04435665|54763303|FG000|Overall Study|Lost to Follow-up|0|||
27848241|NCT01045161|54341216|FG002|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
27848242|NCT01045161|54341214|FG000|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
27943479|NCT01147068|54600390|FG000|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
28055116|NCT00401544|54712041|FG003|Overall Study|Withdrawal by Subject|5|||
28055117|NCT00401544|54712038|FG000|Overall Study|Physician Decision|1|||
28055118|NCT00401544|54712039|FG001|Overall Study|Physician Decision|3|||
28055119|NCT00401544|54712040|FG002|Overall Study|Physician Decision|0|||
28055120|NCT00401544|54712041|FG003|Overall Study|Physician Decision|0|||
28055121|NCT00401544|54712038|FG000|Overall Study|Ineligibility determined|0|||
28055122|NCT00401544|54712039|FG001|Overall Study|Ineligibility determined|1|||
28055123|NCT00401544|54712040|FG002|Overall Study|Ineligibility determined|0|||
28055124|NCT00401544|54712041|FG003|Overall Study|Ineligibility determined|2|||
28055125|NCT00401544|54712038|FG000|Overall Study|Disease progression|0|||
28055126|NCT00401544|54712039|FG001|Overall Study|Disease progression|1|||
28055127|NCT00401544|54712040|FG002|Overall Study|Disease progression|0|||
28055128|NCT00401544|54712041|FG003|Overall Study|Disease progression|0|||
28055129|NCT00401544|54712038|FG000|Overall Study|Other|0|||
28055130|NCT00401544|54712039|FG001|Overall Study|Other|0|||
28055131|NCT00401544|54712040|FG002|Overall Study|Other|2|||
28055132|NCT00401544|54712041|FG003|Overall Study|Other|2|||
28055133|NCT00289731|54712059|FG000|Overall Study|Adverse Event|1|||
28055134|NCT00289731|54712060|FG001|Overall Study|Adverse Event|2|||
28055135|NCT00289731|54712061|FG002|Overall Study|Adverse Event|2|||
28055136|NCT00289731|54712059|FG000|Overall Study|Other|1|||
28055137|NCT00289731|54712060|FG001|Overall Study|Other|0|||
28055138|NCT00289731|54712061|FG002|Overall Study|Other|0|||
28055139|NCT00289185|54712073|FG000|Overall Study|Withdrawal by Subject|4|||
28055140|NCT00289185|54712074|FG001|Overall Study|Withdrawal by Subject|8|||
28055141|NCT00289185|54712073|FG000|Overall Study|Lost to Follow-up|23|||
28055142|NCT00289185|54712074|FG001|Overall Study|Lost to Follow-up|17|||
28055143|NCT00289185|54712073|FG000|Overall Study|Death|1|||
28055144|NCT00289185|54712074|FG001|Overall Study|Death|1|||
28055145|NCT00292461|54712083|FG000|Overall Study|Adverse Event|4|||
28055146|NCT00292461|54712084|FG001|Overall Study|Adverse Event|2|||
28055147|NCT00292461|54712083|FG000|Overall Study|Lack of Efficacy|1|||
28055148|NCT00292461|54712084|FG001|Overall Study|Lack of Efficacy|0|||
28055149|NCT00292461|54712083|FG000|Overall Study|Withdrawal by Subject|0|||
28055150|NCT00292461|54712084|FG001|Overall Study|Withdrawal by Subject|1|||
28055151|NCT00292461|54712083|FG000|Overall Study|Protocol Violation|4|||
28055152|NCT00292461|54712084|FG001|Overall Study|Protocol Violation|3|||
28055153|NCT00292461|54712083|FG000|Overall Study|Lost to Follow-up|1|||
28055154|NCT00292461|54712084|FG001|Overall Study|Lost to Follow-up|0|||
28055155|NCT00288639|54712090|FG000|Overall Study|Adverse Event|5|||
28055156|NCT00288639|54712090|FG000|Overall Study|Lack of Efficacy|4|||
28055157|NCT00288639|54712090|FG000|Overall Study|Withdrawal by Subject|2|||
28055158|NCT00288639|54712090|FG000|Overall Study|Other|1|||
28055159|NCT00390858|54712096|FG000|Overall Study|Adverse Event|6|||
28055160|NCT00390858|54712097|FG001|Overall Study|Adverse Event|2|||
28055161|NCT00390858|54712096|FG000|Overall Study|Lack of Efficacy|0|||
28055162|NCT00390858|54712097|FG001|Overall Study|Lack of Efficacy|1|||
28055163|NCT00390858|54712096|FG000|Overall Study|Withdrawal by Subject|3|||
28055164|NCT00390858|54712097|FG001|Overall Study|Withdrawal by Subject|4|||
28055165|NCT00390780|54712105|FG000|Overall Study|Not completed|10|||
28055166|NCT00390780|54712106|FG001|Overall Study|Not completed|4|||
28055167|NCT00390780|54712105|FG000|Overall Study|Protocol Violation|6|||
28055168|NCT00390780|54712106|FG001|Overall Study|Protocol Violation|4|||
28055169|NCT00390780|54712105|FG000|Overall Study|Lost to Follow-up|3|||
28055170|NCT00390780|54712106|FG001|Overall Study|Lost to Follow-up|6|||
28055171|NCT00390780|54712105|FG000|Overall Study|Adverse Event|2|||
28055172|NCT00390780|54712106|FG001|Overall Study|Adverse Event|3|||
28055173|NCT00390780|54712105|FG000|Overall Study|Death|1|||
28055174|NCT00390780|54712106|FG001|Overall Study|Death|3|||
28055175|NCT00390780|54712105|FG000|Overall Study|Withdrawal by Subject|1|||
28055176|NCT00390780|54712106|FG001|Overall Study|Withdrawal by Subject|2|||
28055177|NCT00390780|54712105|FG000|Overall Study|Inclusion criteria not satisfied|0|||
28055178|NCT00390780|54712106|FG001|Overall Study|Inclusion criteria not satisfied|2|||
28055179|NCT00390780|54712105|FG000|Overall Study|Lost to follow up and other reasons|0|||
28055180|NCT00390780|54712106|FG001|Overall Study|Lost to follow up and other reasons|1|||
28055181|NCT00390780|54712105|FG000|Overall Study|Investigator decision, SAE, other reason|0|||
28055182|NCT00390780|54712106|FG001|Overall Study|Investigator decision, SAE, other reason|1|||
28055183|NCT00390780|54712105|FG000|Overall Study|SAE, death|0|||
28055184|NCT00390780|54712106|FG001|Overall Study|SAE, death|1|||
28055185|NCT00390546|54712114|FG000|Overall Study|Renal impairment|1|||
28055186|NCT00390546|54712115|FG001|Overall Study|Renal impairment|0|||
28055187|NCT00390546|54712114|FG000|Overall Study|Physician Decision|5|||
28055188|NCT00390546|54712115|FG001|Overall Study|Physician Decision|5|||
28055189|NCT00390468|54712122|FG000|Overall Study|Protocol Violation|2|||
28055190|NCT00390468|54712122|FG000|Overall Study|Lack of Efficacy|1|||
28055191|NCT00400764|54712131|FG000|Phase Ib|Adverse Event|1|||
28055192|NCT00400764|54712132|FG001|Phase Ib|Adverse Event|0|||
28055193|NCT00400764|54712133|FG002|Phase Ib|Adverse Event|0|||
28055194|NCT00400764|54712134|FG003|Phase Ib|Adverse Event|0|||
28055195|NCT00400764|54712135|FG004|Phase Ib|Adverse Event|0|||
28055196|NCT00400764|54712131|FG000|Phase Ib|Death|1|||
28055197|NCT00400764|54712132|FG001|Phase Ib|Death|0|||
28055198|NCT00400764|54712133|FG002|Phase Ib|Death|0|||
28055199|NCT00400764|54712134|FG003|Phase Ib|Death|0|||
28055200|NCT00400764|54712135|FG004|Phase Ib|Death|0|||
28055201|NCT00400764|54712131|FG000|Phase Ib|Disease Progression|4|||
28055202|NCT00400764|54712132|FG001|Phase Ib|Disease Progression|4|||
28055203|NCT00400764|54712133|FG002|Phase Ib|Disease Progression|0|||
28055204|NCT00400764|54712134|FG003|Phase Ib|Disease Progression|0|||
28055205|NCT00400764|54712135|FG004|Phase Ib|Disease Progression|0|||
28055206|NCT00400764|54712131|FG000|Phase II|Death|0|||
28055207|NCT00400764|54712132|FG001|Phase II|Death|0|||
28055208|NCT00400764|54712133|FG002|Phase II|Death|1|||
28055209|NCT00400764|54712134|FG003|Phase II|Death|2|||
28055210|NCT00400764|54712135|FG004|Phase II|Death|0|||
28055211|NCT00400764|54712131|FG000|Phase II|Lost to Follow-up|0|||
28055212|NCT00400764|54712132|FG001|Phase II|Lost to Follow-up|0|||
28055213|NCT00400764|54712133|FG002|Phase II|Lost to Follow-up|1|||
28055214|NCT00400764|54712134|FG003|Phase II|Lost to Follow-up|0|||
28055215|NCT00400764|54712135|FG004|Phase II|Lost to Follow-up|0|||
28055216|NCT00400764|54712131|FG000|Phase II|Physician Decision|0|||
28055217|NCT00400764|54712132|FG001|Phase II|Physician Decision|0|||
28055218|NCT00400764|54712133|FG002|Phase II|Physician Decision|1|||
28055219|NCT00400764|54712134|FG003|Phase II|Physician Decision|1|||
28055220|NCT00400764|54712135|FG004|Phase II|Physician Decision|0|||
28055221|NCT00400764|54712131|FG000|Phase II|Sponsor's decision to terminate|0|||
28055222|NCT00400764|54712132|FG001|Phase II|Sponsor's decision to terminate|0|||
28055223|NCT00400764|54712133|FG002|Phase II|Sponsor's decision to terminate|18|||
28055224|NCT00400764|54712134|FG003|Phase II|Sponsor's decision to terminate|22|||
28055225|NCT00400764|54712135|FG004|Phase II|Sponsor's decision to terminate|11|||
28055226|NCT00400764|54712131|FG000|Phase II|Patient began new, non-protocol, therapy|0|||
28055227|NCT00400764|54712132|FG001|Phase II|Patient began new, non-protocol, therapy|0|||
28055228|NCT00400764|54712133|FG002|Phase II|Patient began new, non-protocol, therapy|1|||
28055229|NCT00400764|54712134|FG003|Phase II|Patient began new, non-protocol, therapy|0|||
28055230|NCT00400764|54712135|FG004|Phase II|Patient began new, non-protocol, therapy|0|||
28055231|NCT00400764|54712131|FG000|Phase II|Withdrawal by Subject|0|||
28055232|NCT00400764|54712132|FG001|Phase II|Withdrawal by Subject|0|||
28055233|NCT00400764|54712133|FG002|Phase II|Withdrawal by Subject|1|||
28055234|NCT00400764|54712134|FG003|Phase II|Withdrawal by Subject|1|||
28055235|NCT00400764|54712135|FG004|Phase II|Withdrawal by Subject|0|||
28055236|NCT00302211|54712155|FG000|Double Blind Period (New Patients)|Withdrawal by Subject|2|||
28055237|NCT00302211|54712156|FG001|Double Blind Period (New Patients)|Withdrawal by Subject|1|||
28055238|NCT00302211|54712157|FG002|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
28055239|NCT00302211|54712158|FG003|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
28055240|NCT00302211|54712159|FG004|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
28055241|NCT00302211|54712155|FG000|Double Blind Period (New Patients)|Adverse Event|0|||
28055242|NCT00302211|54712156|FG001|Double Blind Period (New Patients)|Adverse Event|0|||
28055243|NCT00302211|54712157|FG002|Double Blind Period (New Patients)|Adverse Event|3|||
28055244|NCT00302211|54712158|FG003|Double Blind Period (New Patients)|Adverse Event|0|||
28055245|NCT00302211|54712159|FG004|Double Blind Period (New Patients)|Adverse Event|0|||
28055246|NCT00302211|54712155|FG000|Double Blind Period (New Patients)|Investigator's judgement|1|||
28055247|NCT00302211|54712156|FG001|Double Blind Period (New Patients)|Investigator's judgement|0|||
28055248|NCT00302211|54712157|FG002|Double Blind Period (New Patients)|Investigator's judgement|0|||
28055249|NCT00302211|54712158|FG003|Double Blind Period (New Patients)|Investigator's judgement|0|||
28055250|NCT00302211|54712159|FG004|Double Blind Period (New Patients)|Investigator's judgement|0|||
28055251|NCT00302211|54712155|FG000|Double Blind Period (New Patients)|Disease progression|0|||
28055252|NCT00302211|54712156|FG001|Double Blind Period (New Patients)|Disease progression|1|||
28055253|NCT00302211|54712157|FG002|Double Blind Period (New Patients)|Disease progression|1|||
28055254|NCT00302211|54712158|FG003|Double Blind Period (New Patients)|Disease progression|0|||
28055255|NCT00302211|54712159|FG004|Double Blind Period (New Patients)|Disease progression|0|||
28055256|NCT00302211|54712155|FG000|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
28055257|NCT00302211|54712156|FG001|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
28055258|NCT00302211|54712157|FG002|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
28055259|NCT00302211|54712158|FG003|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
28055260|NCT00302211|54712159|FG004|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
28055261|NCT00302211|54712155|FG000|Open Label-Patients From Double-Blind|Adverse Event|0|||
28055262|NCT00302211|54712156|FG001|Open Label-Patients From Double-Blind|Adverse Event|0|||
28055263|NCT00302211|54712157|FG002|Open Label-Patients From Double-Blind|Adverse Event|0|||
28055264|NCT00302211|54712158|FG003|Open Label-Patients From Double-Blind|Adverse Event|1|||
28055265|NCT00302211|54712159|FG004|Open Label-Patients From Double-Blind|Adverse Event|0|||
28055266|NCT00302211|54712155|FG000|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
28055267|NCT00302211|54712156|FG001|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
28055268|NCT00302211|54712157|FG002|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
28055269|NCT00302211|54712158|FG003|Open Label-Patients From Double-Blind|Investigator's judgement|1|||
28055270|NCT00302211|54712159|FG004|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
28055271|NCT00302211|54712155|FG000|Open Label-Patients From Double-Blind|Disease progression|0|||
28055272|NCT00302211|54712156|FG001|Open Label-Patients From Double-Blind|Disease progression|0|||
28055273|NCT00302211|54712157|FG002|Open Label-Patients From Double-Blind|Disease progression|0|||
28055274|NCT00302211|54712158|FG003|Open Label-Patients From Double-Blind|Disease progression|1|||
28055275|NCT00302211|54712159|FG004|Open Label-Patients From Double-Blind|Disease progression|2|||
28055276|NCT00302211|54712155|FG000|Open Label-Patients From Double-Blind|Death|0|||
28055277|NCT00302211|54712156|FG001|Open Label-Patients From Double-Blind|Death|0|||
28055278|NCT00302211|54712157|FG002|Open Label-Patients From Double-Blind|Death|0|||
28055279|NCT00302211|54712158|FG003|Open Label-Patients From Double-Blind|Death|1|||
28055280|NCT00302211|54712159|FG004|Open Label-Patients From Double-Blind|Death|1|||
28055281|NCT00302211|54712155|FG000|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
28055282|NCT00302211|54712156|FG001|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
28055283|NCT00302211|54712157|FG002|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
28055284|NCT00302211|54712158|FG003|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
28055285|NCT00302211|54712159|FG004|Open Label-Patients From Double-Blind|Lost to Follow-up|1|||
28055286|NCT00302211|54712155|FG000|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
28055287|NCT00302211|54712156|FG001|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
28055288|NCT00302211|54712157|FG002|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
28055289|NCT00302211|54712158|FG003|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
28055290|NCT00302211|54712159|FG004|Open Label-Patients From Double-Blind|PH requiring lung transplant|1|||
28055291|NCT00302211|54712155|FG000|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
28055292|NCT00302211|54712156|FG001|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
28055293|NCT00302211|54712157|FG002|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
28055294|NCT00302211|54712158|FG003|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1|||
28055295|NCT00302211|54712159|FG004|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
28055296|NCT00288015|54712171|FG000|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1|||
28055297|NCT00288015|54712171|FG000|Bevacizumab Treatment Cycles 1-2|Physician Decision|1|||
28055298|NCT00288015|54712171|FG000|First Response Assessment|Withdrawal by Subject|1|||
28055299|NCT00288015|54712171|FG000|First Response Assessment|Death|1|||
28055300|NCT00288015|54712171|FG000|First Response Assessment|Physician Decision|2|||
28055301|NCT00288015|54712171|FG000|Continued Bevacizumab Cycle 3+|Disease progressed|7|||
28055302|NCT00288015|54712171|FG000|Follow up for Survival x 2 Years|Death|13|||
28055303|NCT00288015|54712171|FG000|Follow up for Survival x 2 Years|Lost to Follow-up|4|||
28055304|NCT00288015|54712171|FG000|Follow up for Survival x 2 Years|Other|9|||
28055305|NCT00389064|54712177|FG000|Overall Study|Adverse Event|11|||
28055306|NCT00389064|54712178|FG001|Overall Study|Adverse Event|3|||
28055307|NCT00389064|54712177|FG000|Overall Study|Lack of Efficacy|3|||
28055308|NCT00389064|54712178|FG001|Overall Study|Lack of Efficacy|14|||
28055309|NCT00389064|54712177|FG000|Overall Study|Withdrawal by Subject|17|||
28055310|NCT00389064|54712178|FG001|Overall Study|Withdrawal by Subject|27|||
28055311|NCT00389064|54712177|FG000|Overall Study|Physician Decision|2|||
28055312|NCT00389064|54712178|FG001|Overall Study|Physician Decision|2|||
28055313|NCT00389064|54712177|FG000|Overall Study|Lost to Follow-up|1|||
28055314|NCT00389064|54712178|FG001|Overall Study|Lost to Follow-up|2|||
28055315|NCT00389064|54712177|FG000|Overall Study|Protocol Violation|2|||
28055316|NCT00389064|54712178|FG001|Overall Study|Protocol Violation|0|||
28055317|NCT00389064|54712177|FG000|Overall Study|Multiple Reasons|9|||
28055318|NCT00389064|54712178|FG001|Overall Study|Multiple Reasons|11|||
28055319|NCT00388674|54712186|FG000|Initial Treatment|Administrative Reason by Sponsor|241|||
28055320|NCT00388674|54712187|FG001|Initial Treatment|Administrative Reason by Sponsor|158|||
27813180|NCT01584843|54269627|FG002|First Treatment Period|Protocol Violation|0|||
27813181|NCT01584843|54269628|FG003|First Treatment Period|Protocol Violation|0|||
27813182|NCT01584843|54269629|FG004|First Treatment Period|Protocol Violation|0|||
27813183|NCT01584843|54269630|FG005|First Treatment Period|Protocol Violation|1|||
27813184|NCT01584843|54269625|FG000|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
27813185|NCT01584843|54269626|FG001|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
27813186|NCT01584843|54269627|FG002|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
27813187|NCT01584843|54269628|FG003|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
27813188|NCT01584843|54269629|FG004|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
27813189|NCT01584843|54269630|FG005|First Treatment Period|Met Protocol-defined Stopping Criteria|1|||
27813190|NCT01584843|54269625|FG000|Second Treatment Period|Withdrawal by Subject|0|||
27813191|NCT01584843|54269626|FG001|Second Treatment Period|Withdrawal by Subject|0|||
27813192|NCT01584843|54269627|FG002|Second Treatment Period|Withdrawal by Subject|0|||
27813193|NCT01584843|54269628|FG003|Second Treatment Period|Withdrawal by Subject|0|||
27813194|NCT01584843|54269629|FG004|Second Treatment Period|Withdrawal by Subject|0|||
27848243|NCT01045161|54341215|FG001|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4|||
27943480|NCT01147068|54600391|FG001|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
28105714|NCT04435665|54763304|FG001|Overall Study|Lost to Follow-up|0|||
27813195|NCT01584843|54269630|FG005|Second Treatment Period|Withdrawal by Subject|1|||
28055321|NCT00388674|54712186|FG000|Initial Treatment|Adverse Event|22|||
28055322|NCT00388674|54712187|FG001|Initial Treatment|Adverse Event|87|||
28055323|NCT00388674|54712186|FG000|Initial Treatment|Death|215|||
28055324|NCT00388674|54712187|FG001|Initial Treatment|Death|216|||
28055325|NCT00388674|54712186|FG000|Initial Treatment|Non-HCC HBV Disease Progression|11|||
28055326|NCT00388674|54712187|FG001|Initial Treatment|Non-HCC HBV Disease Progression|17|||
28055327|NCT00388674|54712186|FG000|Initial Treatment|HCC|12|||
27813196|NCT01560429|54269648|FG000|Overall Study|Protocol Violation|3|||
27813197|NCT01560429|54269649|FG001|Overall Study|Protocol Violation|6|||
27813198|NCT01582971|54269659|FG000|Overall Study|Death|2|||
27813199|NCT01582971|54269660|FG001|Overall Study|Death|1|||
27813200|NCT01582971|54269659|FG000|Overall Study|Lost to Follow-up|18|||
27813201|NCT01582971|54269660|FG001|Overall Study|Lost to Follow-up|21|||
28055328|NCT00388674|54712187|FG001|Initial Treatment|HCC|20|||
28055329|NCT00388674|54712186|FG000|Initial Treatment|Lost to Follow-up|526|||
28055330|NCT00388674|54712187|FG001|Initial Treatment|Lost to Follow-up|624|||
28055331|NCT00388674|54712186|FG000|Initial Treatment|Malignancy (Non-HCC)|7|||
28055332|NCT00388674|54712187|FG001|Initial Treatment|Malignancy (Non-HCC)|3|||
28055333|NCT00388674|54712186|FG000|Initial Treatment|Never Treated with Study Medication|1|||
28055334|NCT00388674|54712187|FG001|Initial Treatment|Never Treated with Study Medication|7|||
28055335|NCT00388674|54712186|FG000|Initial Treatment|Non-Study related Comorbidities|3|||
28055336|NCT00388674|54712187|FG001|Initial Treatment|Non-Study related Comorbidities|4|||
28055337|NCT00388674|54712186|FG000|Initial Treatment|Not Defined|125|||
28055338|NCT00388674|54712187|FG001|Initial Treatment|Not Defined|172|||
28055339|NCT00388674|54712186|FG000|Initial Treatment|Partial or inadequate Treatment|112|||
28055340|NCT00388674|54712187|FG001|Initial Treatment|Partial or inadequate Treatment|472|||
28055341|NCT00388674|54712186|FG000|Initial Treatment|Pregnancy|26|||
28055342|NCT00388674|54712187|FG001|Initial Treatment|Pregnancy|16|||
28055343|NCT00388674|54712186|FG000|Initial Treatment|Study Drug Toxicity|5|||
28055344|NCT00388674|54712187|FG001|Initial Treatment|Study Drug Toxicity|92|||
28055345|NCT00388674|54712186|FG000|Initial Treatment|Participant Request|501|||
28055346|NCT00388674|54712187|FG001|Initial Treatment|Participant Request|673|||
28055347|NCT00388674|54712186|FG000|Initial Treatment|No Off-Treatment Status Data|11|||
28055348|NCT00388674|54712187|FG001|Initial Treatment|No Off-Treatment Status Data|13|||
28055349|NCT00388674|54712186|FG000|Initial Treatment|Not Reported|10|||
28055350|NCT00388674|54712187|FG001|Initial Treatment|Not Reported|12|||
28055351|NCT00388674|54712186|FG000|End of Study|Administrative Reason By Sponsor|299|||
28055352|NCT00388674|54712187|FG001|End of Study|Administrative Reason By Sponsor|253|||
28055353|NCT00388674|54712186|FG000|End of Study|Death|239|||
28055354|NCT00388674|54712187|FG001|End of Study|Death|262|||
28055355|NCT00388674|54712186|FG000|End of Study|HBV Disease Progression (Non-HCC)|3|||
28055356|NCT00388674|54712187|FG001|End of Study|HBV Disease Progression (Non-HCC)|9|||
28055357|NCT00388674|54712186|FG000|End of Study|HCC|8|||
28055358|NCT00388674|54712187|FG001|End of Study|HCC|7|||
28055359|NCT00388674|54712186|FG000|End of Study|Lost to Follow-up|587|||
28055360|NCT00388674|54712187|FG001|End of Study|Lost to Follow-up|715|||
28055361|NCT00388674|54712186|FG000|End of Study|Malignancy (Non-HCC)|1|||
28055362|NCT00388674|54712187|FG001|End of Study|Malignancy (Non-HCC)|1|||
28055363|NCT00388674|54712186|FG000|End of Study|Non-Study Related Comorbidities|3|||
28055364|NCT00388674|54712187|FG001|End of Study|Non-Study Related Comorbidities|4|||
28055365|NCT00388674|54712186|FG000|End of Study|Not Defined|135|||
28055366|NCT00388674|54712187|FG001|End of Study|Not Defined|214|||
28055367|NCT00388674|54712186|FG000|End of Study|Participant Withdrew Consent|437|||
28055368|NCT00388674|54712187|FG001|End of Study|Participant Withdrew Consent|673|||
27813202|NCT01582971|54269659|FG000|Overall Study|Withdrawal by Subject|4|||
27813203|NCT01582971|54269660|FG001|Overall Study|Withdrawal by Subject|2|||
28055369|NCT00388674|54712186|FG000|End of Study|No Off-Treatment Status Data|22|||
28055370|NCT00388674|54712187|FG001|End of Study|No Off-Treatment Status Data|30|||
28055371|NCT00388674|54712186|FG000|End of Study|Not Reported|0|||
28055372|NCT00388674|54712187|FG001|End of Study|Not Reported|1|||
28055373|NCT00388362|54712193|FG000|Enrolled|Ineligible|1|||
28055374|NCT00388362|54712193|FG000|Enrolled|Adverse Event|9|||
28055375|NCT00388362|54712193|FG000|Enrolled|Death|1|||
28055376|NCT00388362|54712193|FG000|Enrolled|Loss insurance|1|||
28055377|NCT00388362|54712193|FG000|Enrolled|Withdrawal by Subject|1|||
28055378|NCT00388362|54712193|FG000|Remained on Study Median of 514 Days|Death|2|||
28055379|NCT00387894|54712197|FG000|Overall Study|Withdrawal by Subject|1|||
28055380|NCT00387426|54712201|FG000|Overall Study|Lack of Response|7|||
27813204|NCT01582971|54269659|FG000|Overall Study|Other|15|||
28055381|NCT00387426|54712201|FG000|Overall Study|Toxicities|4|||
28055382|NCT00387426|54712201|FG000|Overall Study|Disease Progression|3|||
28055383|NCT00387348|54712208|FG000|Overall Study|Death|1|||
28055384|NCT00387348|54712209|FG001|Overall Study|Death|1|||
28055385|NCT00387348|54712210|FG002|Overall Study|Death|0|||
28055386|NCT00387348|54712208|FG000|Overall Study|Physician Decision|1|||
28055387|NCT00387348|54712209|FG001|Overall Study|Physician Decision|0|||
28055388|NCT00387348|54712210|FG002|Overall Study|Physician Decision|1|||
27813205|NCT01582971|54269660|FG001|Overall Study|Other|13|||
27813206|NCT01690299|54269675|FG000|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
27813207|NCT01690299|54269676|FG001|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
27813208|NCT01690299|54269677|FG002|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1|||
27813209|NCT01690299|54269678|FG003|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
27813210|NCT01690299|54269679|FG004|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
27813211|NCT01690299|54269680|FG005|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
28055389|NCT00387348|54712208|FG000|Overall Study|Withdrawal by Subject|0|||
28055390|NCT00387348|54712209|FG001|Overall Study|Withdrawal by Subject|2|||
28055391|NCT00387348|54712210|FG002|Overall Study|Withdrawal by Subject|2|||
28055392|NCT00387348|54712208|FG000|Overall Study|Adverse Event|1|||
28055393|NCT00387348|54712209|FG001|Overall Study|Adverse Event|0|||
28055394|NCT00387348|54712210|FG002|Overall Study|Adverse Event|1|||
28055395|NCT00413660|54712230|FG000|Up To Week 12|Adverse Event|1|||
28055396|NCT00413660|54712231|FG001|Up To Week 12|Adverse Event|3|||
28055397|NCT00413660|54712232|FG002|Up To Week 12|Adverse Event|1|||
28055398|NCT00413660|54712233|FG003|Up To Week 12|Adverse Event|4|||
28055399|NCT00413660|54712234|FG004|Up To Week 12|Adverse Event|6|||
28055400|NCT00413660|54712235|FG005|Up To Week 12|Adverse Event|4|||
28055401|NCT00413660|54712236|FG006|Up To Week 12|Adverse Event|1|||
28055402|NCT00413660|54712237|FG007|Up To Week 12|Adverse Event|0|||
28055403|NCT00413660|54712238|FG008|Up To Week 12|Adverse Event|0|||
28055404|NCT00413660|54712239|FG009|Up To Week 12|Adverse Event|0|||
28055405|NCT00413660|54712240|FG010|Up To Week 12|Adverse Event|0|||
28055406|NCT00413660|54712230|FG000|Up To Week 12|Lack of Efficacy|2|||
28055407|NCT00413660|54712231|FG001|Up To Week 12|Lack of Efficacy|0|||
28055408|NCT00413660|54712232|FG002|Up To Week 12|Lack of Efficacy|0|||
28055409|NCT00413660|54712233|FG003|Up To Week 12|Lack of Efficacy|0|||
28055410|NCT00413660|54712234|FG004|Up To Week 12|Lack of Efficacy|0|||
28055411|NCT00413660|54712235|FG005|Up To Week 12|Lack of Efficacy|0|||
28055412|NCT00413660|54712236|FG006|Up To Week 12|Lack of Efficacy|5|||
28055413|NCT00413660|54712237|FG007|Up To Week 12|Lack of Efficacy|0|||
28055414|NCT00413660|54712238|FG008|Up To Week 12|Lack of Efficacy|0|||
28055415|NCT00413660|54712239|FG009|Up To Week 12|Lack of Efficacy|0|||
28055416|NCT00413660|54712240|FG010|Up To Week 12|Lack of Efficacy|0|||
28055417|NCT00413660|54712230|FG000|Up To Week 12|Lost to Follow-up|0|||
28055418|NCT00413660|54712231|FG001|Up To Week 12|Lost to Follow-up|1|||
28055419|NCT00413660|54712232|FG002|Up To Week 12|Lost to Follow-up|0|||
28055420|NCT00413660|54712233|FG003|Up To Week 12|Lost to Follow-up|0|||
28055421|NCT00413660|54712234|FG004|Up To Week 12|Lost to Follow-up|1|||
28055422|NCT00413660|54712235|FG005|Up To Week 12|Lost to Follow-up|0|||
28055423|NCT00413660|54712236|FG006|Up To Week 12|Lost to Follow-up|0|||
28055424|NCT00413660|54712237|FG007|Up To Week 12|Lost to Follow-up|0|||
28055425|NCT00413660|54712238|FG008|Up To Week 12|Lost to Follow-up|0|||
28055426|NCT00413660|54712239|FG009|Up To Week 12|Lost to Follow-up|0|||
28055427|NCT00413660|54712240|FG010|Up To Week 12|Lost to Follow-up|0|||
27813212|NCT01690299|54269675|FG000|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4|||
28055428|NCT00413660|54712230|FG000|Up To Week 12|Withdrawal by Subject|0|||
28055429|NCT00413660|54712231|FG001|Up To Week 12|Withdrawal by Subject|2|||
28055430|NCT00413660|54712232|FG002|Up To Week 12|Withdrawal by Subject|0|||
28055431|NCT00413660|54712233|FG003|Up To Week 12|Withdrawal by Subject|2|||
28055432|NCT00413660|54712234|FG004|Up To Week 12|Withdrawal by Subject|0|||
28055433|NCT00413660|54712235|FG005|Up To Week 12|Withdrawal by Subject|2|||
27813213|NCT01690299|54269676|FG001|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
28055434|NCT00413660|54712236|FG006|Up To Week 12|Withdrawal by Subject|2|||
28055435|NCT00413660|54712237|FG007|Up To Week 12|Withdrawal by Subject|0|||
28055436|NCT00413660|54712238|FG008|Up To Week 12|Withdrawal by Subject|0|||
28055437|NCT00413660|54712239|FG009|Up To Week 12|Withdrawal by Subject|0|||
28055438|NCT00413660|54712240|FG010|Up To Week 12|Withdrawal by Subject|0|||
28055439|NCT00413660|54712230|FG000|Up To Week 12|Randomized, Not Treated|1|||
28055440|NCT00413660|54712231|FG001|Up To Week 12|Randomized, Not Treated|0|||
28055441|NCT00413660|54712232|FG002|Up To Week 12|Randomized, Not Treated|0|||
28055442|NCT00413660|54712233|FG003|Up To Week 12|Randomized, Not Treated|1|||
28055443|NCT00413660|54712234|FG004|Up To Week 12|Randomized, Not Treated|0|||
28055444|NCT00413660|54712235|FG005|Up To Week 12|Randomized, Not Treated|0|||
28055445|NCT00413660|54712236|FG006|Up To Week 12|Randomized, Not Treated|0|||
28055446|NCT00413660|54712237|FG007|Up To Week 12|Randomized, Not Treated|0|||
28055447|NCT00413660|54712238|FG008|Up To Week 12|Randomized, Not Treated|0|||
28055448|NCT00413660|54712239|FG009|Up To Week 12|Randomized, Not Treated|0|||
28055449|NCT00413660|54712240|FG010|Up To Week 12|Randomized, Not Treated|0|||
28055450|NCT00413660|54712230|FG000|Up To Week 12|Other|3|||
28055451|NCT00413660|54712231|FG001|Up To Week 12|Other|1|||
28055452|NCT00413660|54712232|FG002|Up To Week 12|Other|6|||
28055453|NCT00413660|54712233|FG003|Up To Week 12|Other|1|||
28055454|NCT00413660|54712234|FG004|Up To Week 12|Other|2|||
28055455|NCT00413660|54712235|FG005|Up To Week 12|Other|4|||
28055456|NCT00413660|54712236|FG006|Up To Week 12|Other|3|||
28055457|NCT00413660|54712237|FG007|Up To Week 12|Other|0|||
28055458|NCT00413660|54712238|FG008|Up To Week 12|Other|0|||
28055459|NCT00413660|54712239|FG009|Up To Week 12|Other|0|||
28055460|NCT00413660|54712240|FG010|Up To Week 12|Other|0|||
28055461|NCT00413660|54712230|FG000|Post Week 12|Adverse Event|2|||
28055462|NCT00413660|54712231|FG001|Post Week 12|Adverse Event|0|||
28055463|NCT00413660|54712232|FG002|Post Week 12|Adverse Event|2|||
28055464|NCT00413660|54712233|FG003|Post Week 12|Adverse Event|1|||
28055465|NCT00413660|54712234|FG004|Post Week 12|Adverse Event|4|||
28055466|NCT00413660|54712235|FG005|Post Week 12|Adverse Event|2|||
28055467|NCT00413660|54712236|FG006|Post Week 12|Adverse Event|2|||
28055468|NCT00413660|54712237|FG007|Post Week 12|Adverse Event|0|||
28055469|NCT00413660|54712238|FG008|Post Week 12|Adverse Event|0|||
28055470|NCT00413660|54712239|FG009|Post Week 12|Adverse Event|0|||
28055471|NCT00413660|54712240|FG010|Post Week 12|Adverse Event|0|||
28055472|NCT00413660|54712230|FG000|Post Week 12|Lack of Efficacy|0|||
28055473|NCT00413660|54712231|FG001|Post Week 12|Lack of Efficacy|0|||
28055474|NCT00413660|54712232|FG002|Post Week 12|Lack of Efficacy|1|||
28055475|NCT00413660|54712233|FG003|Post Week 12|Lack of Efficacy|0|||
28055476|NCT00413660|54712234|FG004|Post Week 12|Lack of Efficacy|0|||
28055477|NCT00413660|54712235|FG005|Post Week 12|Lack of Efficacy|0|||
28055478|NCT00413660|54712236|FG006|Post Week 12|Lack of Efficacy|0|||
28055479|NCT00413660|54712237|FG007|Post Week 12|Lack of Efficacy|0|||
28055480|NCT00413660|54712238|FG008|Post Week 12|Lack of Efficacy|0|||
28055481|NCT00413660|54712239|FG009|Post Week 12|Lack of Efficacy|1|||
28055482|NCT00413660|54712240|FG010|Post Week 12|Lack of Efficacy|0|||
28055483|NCT00413660|54712230|FG000|Post Week 12|Lost to Follow-up|0|||
28055484|NCT00413660|54712231|FG001|Post Week 12|Lost to Follow-up|1|||
28055485|NCT00413660|54712232|FG002|Post Week 12|Lost to Follow-up|1|||
28055486|NCT00413660|54712233|FG003|Post Week 12|Lost to Follow-up|0|||
28055487|NCT00413660|54712234|FG004|Post Week 12|Lost to Follow-up|0|||
28055488|NCT00413660|54712235|FG005|Post Week 12|Lost to Follow-up|0|||
28055489|NCT00413660|54712236|FG006|Post Week 12|Lost to Follow-up|0|||
28055490|NCT00413660|54712237|FG007|Post Week 12|Lost to Follow-up|0|||
28055491|NCT00413660|54712238|FG008|Post Week 12|Lost to Follow-up|0|||
28055492|NCT00413660|54712239|FG009|Post Week 12|Lost to Follow-up|0|||
28055493|NCT00413660|54712240|FG010|Post Week 12|Lost to Follow-up|0|||
28055494|NCT00413660|54712230|FG000|Post Week 12|Withdrawal by Subject|0|||
28055495|NCT00413660|54712231|FG001|Post Week 12|Withdrawal by Subject|1|||
28055496|NCT00413660|54712232|FG002|Post Week 12|Withdrawal by Subject|1|||
28055497|NCT00413660|54712233|FG003|Post Week 12|Withdrawal by Subject|0|||
28055498|NCT00413660|54712234|FG004|Post Week 12|Withdrawal by Subject|1|||
28055499|NCT00413660|54712235|FG005|Post Week 12|Withdrawal by Subject|0|||
28055500|NCT00413660|54712236|FG006|Post Week 12|Withdrawal by Subject|0|||
28055501|NCT00413660|54712237|FG007|Post Week 12|Withdrawal by Subject|0|||
28055502|NCT00413660|54712238|FG008|Post Week 12|Withdrawal by Subject|0|||
28055503|NCT00413660|54712239|FG009|Post Week 12|Withdrawal by Subject|0|||
28055504|NCT00413660|54712240|FG010|Post Week 12|Withdrawal by Subject|1|||
28055505|NCT00413660|54712230|FG000|Post Week 12|Other|1|||
28055506|NCT00413660|54712231|FG001|Post Week 12|Other|2|||
28055507|NCT00413660|54712232|FG002|Post Week 12|Other|3|||
28055508|NCT00413660|54712233|FG003|Post Week 12|Other|0|||
28055509|NCT00413660|54712234|FG004|Post Week 12|Other|1|||
28055510|NCT00413660|54712235|FG005|Post Week 12|Other|1|||
28055511|NCT00413660|54712236|FG006|Post Week 12|Other|1|||
28055512|NCT00413660|54712237|FG007|Post Week 12|Other|0|||
28055513|NCT00413660|54712238|FG008|Post Week 12|Other|0|||
28055514|NCT00413660|54712239|FG009|Post Week 12|Other|0|||
28055515|NCT00413660|54712240|FG010|Post Week 12|Other|0|||
28055516|NCT00431834|54712274|FG000|Overall Study|Withdrawal by Subject|7|||
28055517|NCT00431834|54712274|FG000|Overall Study|Death|3|||
28055518|NCT00431834|54712274|FG000|Overall Study|Missed Endpoint Visit|2|||
28055519|NCT00431834|54712274|FG000|Overall Study|Lost to Follow-up|1|||
28055520|NCT00431444|54712283|FG000|Overall Study|Protocol Violation|1|||
28055521|NCT00431444|54712284|FG001|Overall Study|Protocol Violation|4|||
28055522|NCT00431444|54712283|FG000|Overall Study|Adverse Event|2|||
28055523|NCT00431444|54712284|FG001|Overall Study|Adverse Event|1|||
28055524|NCT00431444|54712283|FG000|Overall Study|Withdrawal by Subject|1|||
28055525|NCT00431444|54712284|FG001|Overall Study|Withdrawal by Subject|1|||
28055526|NCT00431444|54712283|FG000|Overall Study|Lost to Follow-up|1|||
28055527|NCT00431444|54712284|FG001|Overall Study|Lost to Follow-up|0|||
28055528|NCT00431444|54712283|FG000|Overall Study|Administrative Problems|0|||
28055529|NCT00431444|54712284|FG001|Overall Study|Administrative Problems|1|||
28055530|NCT00430352|54712290|FG000|Overall Study|Disease progression|58|||
28055531|NCT00430352|54712290|FG000|Overall Study|Withdrawal by Subject|11|||
28055532|NCT00430352|54712290|FG000|Overall Study|Adverse Event|16|||
28055533|NCT00430352|54712290|FG000|Overall Study|Death|5|||
28055534|NCT00430352|54712290|FG000|Overall Study|Other|48|||
28055535|NCT00287469|54712296|FG000|Overall Study|serious adverse event|1|||
27813214|NCT01690299|54269677|FG002|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
27813215|NCT01690299|54269678|FG003|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
28055536|NCT00287469|54712297|FG001|Overall Study|serious adverse event|6|||
28055537|NCT00287469|54712296|FG000|Overall Study|Adverse Event|1|||
28055538|NCT00287469|54712297|FG001|Overall Study|Adverse Event|1|||
28055539|NCT00287469|54712296|FG000|Overall Study|moved from area|144|||
28055540|NCT00287469|54712297|FG001|Overall Study|moved from area|138|||
28055541|NCT00287469|54712296|FG000|Overall Study|Lost to Follow-up|74|||
28055542|NCT00287469|54712297|FG001|Overall Study|Lost to Follow-up|69|||
28055543|NCT00429572|54712305|FG000|Overall Study|Disease progression|1|||
27813216|NCT01690299|54269679|FG004|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
27813217|NCT01690299|54269680|FG005|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
28055544|NCT00287079|54712311|FG000|Overall Study|Qualifying relapse|12|||
28055545|NCT00287079|54712312|FG001|Overall Study|Qualifying relapse|1|||
28055546|NCT00287079|54712311|FG000|Overall Study|Non-qualifying relapse|1|||
28055547|NCT00287079|54712312|FG001|Overall Study|Non-qualifying relapse|0|||
28055548|NCT00287079|54712311|FG000|Overall Study|Adverse Event|5|||
28055549|NCT00287079|54712312|FG001|Overall Study|Adverse Event|0|||
28055550|NCT00287079|54712311|FG000|Overall Study|Protocol Violation|1|||
28055551|NCT00287079|54712312|FG001|Overall Study|Protocol Violation|0|||
28055552|NCT00287079|54712311|FG000|Overall Study|Other|3|||
28055553|NCT00287079|54712312|FG001|Overall Study|Other|0|||
28055554|NCT00429494|54712318|FG000|Overall Study|Withdrawal by Subject|9|||
28055555|NCT00429494|54712318|FG000|Overall Study|Death|6|||
28055556|NCT00429416|54712322|FG000|Overall Study|Death|1|||
28055557|NCT00429182|54712326|FG000|Overall Study|Not evaluable, Disease Progression|2|||
28055558|NCT00429182|54712326|FG000|Overall Study|Not eligible|5|||
28055559|NCT00429104|54712330|FG000|Overall Study|Protocol Violation|1|||
28055560|NCT00429026|54712334|FG000|Overall Study|Inevaluable for response.|40|||
28055561|NCT00301821|54712338|FG000|Overall Study|Ineligible|25|||
28055562|NCT00301821|54712338|FG000|Overall Study|Cancel|1|||
28055563|NCT00372996|54712344|FG000|Overall Study|Death|11|||
28055564|NCT00372996|54712345|FG001|Overall Study|Death|4|||
28055565|NCT00372996|54712346|FG002|Overall Study|Death|8|||
28055566|NCT00372996|54712347|FG003|Overall Study|Death|7|||
28055567|NCT00372996|54712344|FG000|Overall Study|Lost to Follow-up|0|||
28055568|NCT00372996|54712345|FG001|Overall Study|Lost to Follow-up|2|||
28055569|NCT00372996|54712346|FG002|Overall Study|Lost to Follow-up|0|||
28055570|NCT00372996|54712347|FG003|Overall Study|Lost to Follow-up|1|||
28055571|NCT00372996|54712344|FG000|Overall Study|Withdrawal by Subject|12|||
28055572|NCT00372996|54712345|FG001|Overall Study|Withdrawal by Subject|6|||
28055573|NCT00372996|54712346|FG002|Overall Study|Withdrawal by Subject|9|||
28055574|NCT00372996|54712347|FG003|Overall Study|Withdrawal by Subject|5|||
28055575|NCT00372996|54712344|FG000|Overall Study|Study Terminated by Sponsor|4|||
28055576|NCT00372996|54712345|FG001|Overall Study|Study Terminated by Sponsor|0|||
28055577|NCT00372996|54712346|FG002|Overall Study|Study Terminated by Sponsor|4|||
28055578|NCT00372996|54712347|FG003|Overall Study|Study Terminated by Sponsor|0|||
28055579|NCT00372996|54712344|FG000|Overall Study|Other|10|||
28055580|NCT00372996|54712345|FG001|Overall Study|Other|2|||
28055581|NCT00372996|54712346|FG002|Overall Study|Other|7|||
28055582|NCT00372996|54712347|FG003|Overall Study|Other|7|||
28055583|NCT00399516|54712357|FG000|Overall Study|Lost to Follow-up|2|||
28055584|NCT00399360|54712365|FG000|Overall Study|Lost to Follow-up|2|||
28055585|NCT00399360|54712366|FG001|Overall Study|Lost to Follow-up|1|||
28055586|NCT00399360|54712367|FG002|Overall Study|Lost to Follow-up|2|||
28055587|NCT00399360|54712368|FG003|Overall Study|Lost to Follow-up|4|||
28055588|NCT00399360|54712365|FG000|Overall Study|Adverse Event|0|||
28055589|NCT00399360|54712366|FG001|Overall Study|Adverse Event|0|||
28055590|NCT00399360|54712367|FG002|Overall Study|Adverse Event|1|||
28055591|NCT00399360|54712368|FG003|Overall Study|Adverse Event|0|||
28055592|NCT00399360|54712365|FG000|Overall Study|Withdrawal by Subject|0|||
28055593|NCT00399360|54712366|FG001|Overall Study|Withdrawal by Subject|2|||
28055594|NCT00399360|54712367|FG002|Overall Study|Withdrawal by Subject|0|||
28055595|NCT00399360|54712368|FG003|Overall Study|Withdrawal by Subject|2|||
28055596|NCT00428948|54712385|FG000|Overall Study|Lost to Follow-up|15|||
28055597|NCT00428948|54712386|FG001|Overall Study|Lost to Follow-up|8|||
28055598|NCT00428948|54712385|FG000|Overall Study|Adverse Event|148|||
28055599|NCT00428948|54712386|FG001|Overall Study|Adverse Event|24|||
28055600|NCT00428948|54712385|FG000|Overall Study|Subject Met Withdrawal Criteria|4|||
28055601|NCT00428948|54712386|FG001|Overall Study|Subject Met Withdrawal Criteria|0|||
28055602|NCT00428948|54712385|FG000|Overall Study|Investigator Withdrew Subject|3|||
28055603|NCT00428948|54712386|FG001|Overall Study|Investigator Withdrew Subject|4|||
28055604|NCT00428948|54712385|FG000|Overall Study|Subject Withdrew Consent|50|||
28055605|NCT00428948|54712386|FG001|Overall Study|Subject Withdrew Consent|30|||
28055606|NCT00428948|54712385|FG000|Overall Study|Protocol Deviation|1|||
28055607|NCT00428948|54712386|FG001|Overall Study|Protocol Deviation|1|||
28055608|NCT00428792|54712394|FG000|Overall Study|Lack of Efficacy|1|||
28055609|NCT00428792|54712395|FG001|Overall Study|Lack of Efficacy|3|||
28055610|NCT00428792|54712394|FG000|Overall Study|Lost to Follow-up|0|||
28055611|NCT00428792|54712395|FG001|Overall Study|Lost to Follow-up|1|||
28055612|NCT00300885|54712403|FG000|Treatment|Adverse Event|134|||
28055613|NCT00300885|54712404|FG001|Treatment|Adverse Event|82|||
28055614|NCT00300885|54712403|FG000|Treatment|Death|20|||
28055615|NCT00300885|54712404|FG001|Treatment|Death|7|||
28055616|NCT00300885|54712403|FG000|Treatment|Lack of Efficacy|1|||
28055617|NCT00300885|54712404|FG001|Treatment|Lack of Efficacy|1|||
28055618|NCT00300885|54712403|FG000|Treatment|Lost to Follow-up|3|||
27813218|NCT01690299|54269675|FG000|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1|||
27813219|NCT01690299|54269676|FG001|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3|||
27813220|NCT01690299|54269677|FG002|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
27813221|NCT01690299|54269678|FG003|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
28055619|NCT00300885|54712404|FG001|Treatment|Lost to Follow-up|2|||
28055620|NCT00300885|54712403|FG000|Treatment|Physician Decision|4|||
28055621|NCT00300885|54712404|FG001|Treatment|Physician Decision|5|||
28055622|NCT00300885|54712403|FG000|Treatment|Protocol Violation|11|||
28055623|NCT00300885|54712404|FG001|Treatment|Protocol Violation|11|||
28055624|NCT00300885|54712403|FG000|Treatment|Withdrawal by Subject|26|||
28055625|NCT00300885|54712404|FG001|Treatment|Withdrawal by Subject|23|||
28105715|NCT04435665|54763305|FG002|Overall Study|Lost to Follow-up|0|||
28055626|NCT00300885|54712403|FG000|Treatment|Disease progression|171|||
28055627|NCT00300885|54712404|FG001|Treatment|Disease progression|238|||
28055628|NCT00300885|54712403|FG000|Treatment|Random code broken (subject died)|0|||
28055629|NCT00300885|54712404|FG001|Treatment|Random code broken (subject died)|1|||
28055630|NCT00300885|54712403|FG000|Treatment|Non-compliant with study medication|3|||
28055631|NCT00300885|54712404|FG001|Treatment|Non-compliant with study medication|4|||
28055632|NCT00300885|54712403|FG000|Follow-up|Death|141|||
28055633|NCT00300885|54712404|FG001|Follow-up|Death|163|||
28055634|NCT00300885|54712403|FG000|Follow-up|Lost to Follow-up|11|||
28055635|NCT00300885|54712404|FG001|Follow-up|Lost to Follow-up|7|||
28055636|NCT00300885|54712403|FG000|Follow-up|Withdrawal by Subject|26|||
28055637|NCT00300885|54712404|FG001|Follow-up|Withdrawal by Subject|25|||
28055638|NCT00386334|54712412|FG000|Double Blind Period|Adverse Event|9|||
28055639|NCT00386334|54712413|FG001|Double Blind Period|Adverse Event|14|||
28055640|NCT00386334|54712412|FG000|Double Blind Period|Protocol Violation|1|||
28055641|NCT00386334|54712413|FG001|Double Blind Period|Protocol Violation|1|||
28055642|NCT00386334|54712412|FG000|Double Blind Period|Withdrawal by Subject|9|||
28055643|NCT00386334|54712413|FG001|Double Blind Period|Withdrawal by Subject|13|||
28055644|NCT00386334|54712412|FG000|Double Blind Period|Lack of Efficacy|20|||
28055645|NCT00386334|54712413|FG001|Double Blind Period|Lack of Efficacy|11|||
28055646|NCT00386334|54712412|FG000|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4|||
28055647|NCT00386334|54712413|FG001|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5|||
28055648|NCT00386334|54712412|FG000|Double Blind Period|Other|3|||
28055649|NCT00386334|54712413|FG001|Double Blind Period|Other|3|||
28055650|NCT00386334|54712412|FG000|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3|||
28055651|NCT00386334|54712413|FG001|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1|||
28055652|NCT00428714|54712430|FG000|Overall Study|Progressive Disease|28|||
28055653|NCT00428714|54712431|FG001|Overall Study|Progressive Disease|36|||
28055654|NCT00428714|54712430|FG000|Overall Study|Withdrawal by Subject|0|||
28055655|NCT00428714|54712431|FG001|Overall Study|Withdrawal by Subject|3|||
28055656|NCT00428714|54712430|FG000|Overall Study|Adverse Event|0|||
28055657|NCT00428714|54712431|FG001|Overall Study|Adverse Event|2|||
28055658|NCT00428714|54712430|FG000|Overall Study|Physician Decision|1|||
28055659|NCT00428714|54712431|FG001|Overall Study|Physician Decision|1|||
28055660|NCT00428714|54712430|FG000|Overall Study|Death due to Progressive Disease (PD)|1|||
28055661|NCT00428714|54712431|FG001|Overall Study|Death due to Progressive Disease (PD)|0|||
28055662|NCT00428714|54712430|FG000|Overall Study|Death due to other then PD|1|||
28055663|NCT00428714|54712431|FG001|Overall Study|Death due to other then PD|0|||
28055664|NCT00292227|54712440|FG000|Patch Period|Adverse Event|1|||
28055665|NCT00292227|54712441|FG001|Patch Period|Adverse Event|0|||
28055666|NCT00292227|54712442|FG002|Patch Period|Adverse Event|2|||
28055667|NCT00292227|54712440|FG000|Patch Period|Withdrawal by Subject|0|||
28055668|NCT00292227|54712441|FG001|Patch Period|Withdrawal by Subject|0|||
28055669|NCT00292227|54712442|FG002|Patch Period|Withdrawal by Subject|1|||
28055670|NCT00386100|54712452|FG000|Overall Study|Did not receive study medication|6|||
28055671|NCT00386100|54712453|FG001|Overall Study|Did not receive study medication|4|||
28055672|NCT00386100|54712452|FG000|Overall Study|Adverse Event|15|||
28055673|NCT00386100|54712453|FG001|Overall Study|Adverse Event|25|||
28055674|NCT00386100|54712452|FG000|Overall Study|Death|0|||
28055675|NCT00386100|54712453|FG001|Overall Study|Death|1|||
28055676|NCT00386100|54712452|FG000|Overall Study|Insufficient therapeutic effect|30|||
28055677|NCT00386100|54712453|FG001|Overall Study|Insufficient therapeutic effect|6|||
28055678|NCT00386100|54712452|FG000|Overall Study|Lost to Follow-up|29|||
28055679|NCT00386100|54712453|FG001|Overall Study|Lost to Follow-up|29|||
28055680|NCT00386100|54712452|FG000|Overall Study|Non-compliance|18|||
28055681|NCT00386100|54712453|FG001|Overall Study|Non-compliance|19|||
28055682|NCT00386100|54712452|FG000|Overall Study|Protocol Violation|5|||
28055683|NCT00386100|54712453|FG001|Overall Study|Protocol Violation|3|||
28055684|NCT00386100|54712452|FG000|Overall Study|Withdrawal by Subject|32|||
28055685|NCT00386100|54712453|FG001|Overall Study|Withdrawal by Subject|31|||
28055686|NCT00386100|54712452|FG000|Overall Study|Bone mass density (BMD) loss >6%|4|||
28055687|NCT00386100|54712453|FG001|Overall Study|Bone mass density (BMD) loss >6%|4|||
28055688|NCT00386100|54712452|FG000|Overall Study|BMD <2.5|1|||
28055689|NCT00386100|54712453|FG001|Overall Study|BMD <2.5|0|||
28055690|NCT00386100|54712452|FG000|Overall Study|Consecutive elevated Hba1C|1|||
28055691|NCT00386100|54712453|FG001|Overall Study|Consecutive elevated Hba1C|0|||
28055692|NCT00386100|54712452|FG000|Overall Study|Visit 11 DXA showed excessive bone loss|0|||
28055693|NCT00386100|54712453|FG001|Overall Study|Visit 11 DXA showed excessive bone loss|1|||
28055694|NCT00386100|54712452|FG000|Overall Study|Laboratory findings|1|||
28055695|NCT00386100|54712453|FG001|Overall Study|Laboratory findings|0|||
28105716|NCT04435665|54763306|FG003|Overall Study|Lost to Follow-up|1|||
28055696|NCT00386100|54712452|FG000|Overall Study|Participant's concern due to CPK levels|1|||
28055697|NCT00386100|54712453|FG001|Overall Study|Participant's concern due to CPK levels|0|||
28055698|NCT00386100|54712452|FG000|Overall Study|Participant moving out of state|2|||
28055699|NCT00386100|54712453|FG001|Overall Study|Participant moving out of state|0|||
28055700|NCT00386100|54712452|FG000|Overall Study|Excessive bone loss vs. baseline value|0|||
28055701|NCT00386100|54712453|FG001|Overall Study|Excessive bone loss vs. baseline value|1|||
28055702|NCT00386100|54712452|FG000|Overall Study|Didn't meet entry criteria|1|||
28055703|NCT00386100|54712453|FG001|Overall Study|Didn't meet entry criteria|1|||
28055704|NCT00386100|54712452|FG000|Overall Study|Participant's PCP wanted to stop drug|1|||
28055705|NCT00386100|54712453|FG001|Overall Study|Participant's PCP wanted to stop drug|0|||
28055706|NCT00386100|54712452|FG000|Overall Study|Osteoporosis findings on Visit 2 DXA|0|||
28055707|NCT00386100|54712453|FG001|Overall Study|Osteoporosis findings on Visit 2 DXA|1|||
28055708|NCT00386100|54712452|FG000|Overall Study|Bad metabolic control & patient security|1|||
28055709|NCT00386100|54712453|FG001|Overall Study|Bad metabolic control & patient security|0|||
28055710|NCT00386100|54712452|FG000|Overall Study|Bone loss by DXA bone scan|1|||
28055711|NCT00386100|54712453|FG001|Overall Study|Bone loss by DXA bone scan|0|||
28055712|NCT00386100|54712452|FG000|Overall Study|DBP 93 mmHg at randomization|1|||
28055713|NCT00386100|54712453|FG001|Overall Study|DBP 93 mmHg at randomization|0|||
28055714|NCT00386100|54712452|FG000|Overall Study|7.6% bone loss|1|||
28055715|NCT00386100|54712453|FG001|Overall Study|7.6% bone loss|0|||
28055716|NCT00386100|54712452|FG000|Overall Study|Osteoporosis|0|||
28055717|NCT00386100|54712453|FG001|Overall Study|Osteoporosis|1|||
28055718|NCT00386100|54712452|FG000|Overall Study|Positive pregnancy test|1|||
28055719|NCT00386100|54712453|FG001|Overall Study|Positive pregnancy test|3|||
28055720|NCT00386100|54712452|FG000|Overall Study|Out of country for 5 months|1|||
28055721|NCT00386100|54712453|FG001|Overall Study|Out of country for 5 months|0|||
28055722|NCT00386100|54712452|FG000|Overall Study|Hb1Ac >8%|0|||
28055723|NCT00386100|54712453|FG001|Overall Study|Hb1Ac >8%|1|||
28055724|NCT00386100|54712452|FG000|Overall Study|Participant randomized in error|1|||
28055725|NCT00386100|54712453|FG001|Overall Study|Participant randomized in error|0|||
28055726|NCT00300495|54712461|FG000|Overall Study|Protocol Violation|4|||
28055727|NCT00300495|54712462|FG001|Overall Study|Protocol Violation|1|||
28055728|NCT00386022|54712470|FG000|Plus Estrogen|Lost to Follow-up|2|||
28055729|NCT00386022|54712471|FG001|Plus Estrogen|Lost to Follow-up|0|||
28055730|NCT00386022|54712470|FG000|Plus Estrogen|Adverse Event|0|||
28055731|NCT00386022|54712471|FG001|Plus Estrogen|Adverse Event|1|||
28055732|NCT00286455|54712482|FG000|Overall Study|Hyperglycemia rescue|19|||
28055733|NCT00286455|54712483|FG001|Overall Study|Hyperglycemia rescue|13|||
28055734|NCT00286455|54712484|FG002|Overall Study|Hyperglycemia rescue|10|||
28055735|NCT00286455|54712482|FG000|Overall Study|Adverse Event|1|||
28055736|NCT00286455|54712483|FG001|Overall Study|Adverse Event|3|||
28055737|NCT00286455|54712484|FG002|Overall Study|Adverse Event|2|||
28055738|NCT00286455|54712482|FG000|Overall Study|Lost to Follow-up|0|||
28055739|NCT00286455|54712483|FG001|Overall Study|Lost to Follow-up|3|||
28055740|NCT00286455|54712484|FG002|Overall Study|Lost to Follow-up|3|||
28055741|NCT00286455|54712482|FG000|Overall Study|Physician Decision|3|||
28055742|NCT00286455|54712483|FG001|Overall Study|Physician Decision|0|||
28055743|NCT00286455|54712484|FG002|Overall Study|Physician Decision|2|||
28055744|NCT00286455|54712482|FG000|Overall Study|Protocol Violation|1|||
28055745|NCT00286455|54712483|FG001|Overall Study|Protocol Violation|1|||
28055746|NCT00286455|54712484|FG002|Overall Study|Protocol Violation|0|||
28055747|NCT00286455|54712482|FG000|Overall Study|Participant Non-compliance|1|||
28055748|NCT00286455|54712483|FG001|Overall Study|Participant Non-compliance|0|||
28055749|NCT00286455|54712484|FG002|Overall Study|Participant Non-compliance|0|||
28055750|NCT00286455|54712482|FG000|Overall Study|Withdrawal by Subject|0|||
28055751|NCT00286455|54712483|FG001|Overall Study|Withdrawal by Subject|8|||
28055752|NCT00286455|54712484|FG002|Overall Study|Withdrawal by Subject|7|||
28055753|NCT00385944|54712494|FG000|1st Maintenance Dose Period|Physician Decision|1|||
28055754|NCT00385944|54712495|FG001|1st Maintenance Dose Period|Physician Decision|0|||
28055755|NCT00385944|54712496|FG002|1st Maintenance Dose Period|Physician Decision|0|||
28055756|NCT00385944|54712494|FG000|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
28055757|NCT00385944|54712495|FG001|1st Maintenance Dose Period|Entry Criteria Exclusion|1|||
28055758|NCT00385944|54712496|FG002|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
28055759|NCT00385944|54712494|FG000|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3|||
27939947|NCT00943852|54596283|FG006|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1|||
28055760|NCT00385944|54712495|FG001|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
28105717|NCT04428411|54763316|FG000|Overall Study|Lost to Follow-up|114|||
28055761|NCT00385944|54712496|FG002|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
28055762|NCT00385944|54712494|FG000|2nd Maintenance Dose Period|Invalid PD Data|2|||
28055763|NCT00385944|54712495|FG001|2nd Maintenance Dose Period|Invalid PD Data|3|||
28055764|NCT00385944|54712496|FG002|2nd Maintenance Dose Period|Invalid PD Data|0|||
28055765|NCT00286221|54712515|FG000|Overall Study|Protocol Violation|2|||
28055766|NCT00286221|54712516|FG001|Overall Study|Protocol Violation|1|||
28055767|NCT00286221|54712517|FG002|Overall Study|Protocol Violation|6|||
28055768|NCT00286221|54712518|FG003|Overall Study|Protocol Violation|4|||
28055769|NCT00286221|54712515|FG000|Overall Study|Unanticipated Neurosurgical Complication|6|||
28055770|NCT00286221|54712516|FG001|Overall Study|Unanticipated Neurosurgical Complication|3|||
28055771|NCT00286221|54712517|FG002|Overall Study|Unanticipated Neurosurgical Complication|3|||
27813222|NCT01690299|54269679|FG004|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
27813223|NCT01690299|54269680|FG005|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
27813224|NCT01690299|54269675|FG000|Placebo-controlled Phase (Weeks 0-16)|Other|2|||
27813225|NCT01690299|54269676|FG001|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
27813226|NCT01690299|54269677|FG002|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
27813227|NCT01690299|54269678|FG003|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
27813228|NCT01690299|54269679|FG004|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
27813229|NCT01690299|54269680|FG005|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
28055772|NCT00286221|54712518|FG003|Overall Study|Unanticipated Neurosurgical Complication|2|||
28055773|NCT00286221|54712515|FG000|Overall Study|Inability to trigger PCA|2|||
28055774|NCT00286221|54712516|FG001|Overall Study|Inability to trigger PCA|0|||
28055775|NCT00286221|54712517|FG002|Overall Study|Inability to trigger PCA|0|||
28055776|NCT00286221|54712518|FG003|Overall Study|Inability to trigger PCA|0|||
28055777|NCT00286221|54712515|FG000|Overall Study|Unrecognized exclusion criteria met|0|||
28055778|NCT00286221|54712516|FG001|Overall Study|Unrecognized exclusion criteria met|1|||
28055779|NCT00286221|54712517|FG002|Overall Study|Unrecognized exclusion criteria met|0|||
28055780|NCT00286221|54712518|FG003|Overall Study|Unrecognized exclusion criteria met|0|||
28055781|NCT00285207|54712530|FG000|Overall Study|Lost to Follow-up|3|||
28055782|NCT00285207|54712531|FG001|Overall Study|Lost to Follow-up|2|||
28055783|NCT00285207|54712530|FG000|Overall Study|Withdrawal by Subject|5|||
28055784|NCT00285207|54712531|FG001|Overall Study|Withdrawal by Subject|2|||
28055785|NCT00285207|54712530|FG000|Overall Study|Pregnancy|1|||
28055786|NCT00285207|54712531|FG001|Overall Study|Pregnancy|1|||
28055787|NCT00285207|54712530|FG000|Overall Study|non-compliance|0|||
28055788|NCT00285207|54712531|FG001|Overall Study|non-compliance|1|||
28055789|NCT00398112|54712537|FG000|Overall Study|Adverse Event|4|||
28055790|NCT00398112|54712537|FG000|Overall Study|Disease progression|9|||
28055791|NCT00398112|54712537|FG000|Overall Study|Alternative treatment|1|||
28055792|NCT00398112|54712537|FG000|Overall Study|Withdrawal by Subject|3|||
28055793|NCT00398112|54712537|FG000|Overall Study|Death|1|||
28055794|NCT00424346|54712545|FG000|Core Study|Adverse Event|5|||
28055795|NCT00424346|54712546|FG001|Core Study|Adverse Event|3|||
28055796|NCT00424346|54712547|FG002|Core Study|Adverse Event|1|||
28055797|NCT00424346|54712548|FG003|Core Study|Adverse Event|1|||
28055798|NCT00424346|54712545|FG000|Core Study|Abnormal Laboratory Values|0|||
28055799|NCT00424346|54712546|FG001|Core Study|Abnormal Laboratory Values|1|||
28055800|NCT00424346|54712547|FG002|Core Study|Abnormal Laboratory Values|0|||
28055801|NCT00424346|54712548|FG003|Core Study|Abnormal Laboratory Values|0|||
28055802|NCT00424346|54712545|FG000|Core Study|Lack of Efficacy|1|||
28055803|NCT00424346|54712546|FG001|Core Study|Lack of Efficacy|3|||
28055804|NCT00424346|54712547|FG002|Core Study|Lack of Efficacy|0|||
28055805|NCT00424346|54712548|FG003|Core Study|Lack of Efficacy|4|||
28055806|NCT00424346|54712545|FG000|Core Study|Withdrawal by Subject|1|||
28055807|NCT00424346|54712546|FG001|Core Study|Withdrawal by Subject|0|||
28055808|NCT00424346|54712547|FG002|Core Study|Withdrawal by Subject|0|||
28055809|NCT00424346|54712548|FG003|Core Study|Withdrawal by Subject|2|||
28055810|NCT00424346|54712545|FG000|Core Study|Lost to Follow-up|1|||
28055811|NCT00424346|54712546|FG001|Core Study|Lost to Follow-up|1|||
28055812|NCT00424346|54712547|FG002|Core Study|Lost to Follow-up|0|||
28055813|NCT00424346|54712548|FG003|Core Study|Lost to Follow-up|0|||
28055814|NCT00424346|54712545|FG000|Core Study|Administrative Problems|1|||
28055815|NCT00424346|54712546|FG001|Core Study|Administrative Problems|0|||
27813230|NCT01690299|54269675|FG000|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
27813231|NCT01690299|54269676|FG001|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
28055816|NCT00424346|54712547|FG002|Core Study|Administrative Problems|1|||
28055817|NCT00424346|54712548|FG003|Core Study|Administrative Problems|0|||
28055818|NCT00424346|54712545|FG000|Core Study|Protocol Violation|0|||
28055819|NCT00424346|54712546|FG001|Core Study|Protocol Violation|0|||
28055820|NCT00424346|54712547|FG002|Core Study|Protocol Violation|2|||
28055821|NCT00424346|54712548|FG003|Core Study|Protocol Violation|0|||
28055822|NCT00424346|54712545|FG000|Extension Phase|Adverse Event|0|||
28055823|NCT00424346|54712546|FG001|Extension Phase|Adverse Event|9|||
28055824|NCT00424346|54712547|FG002|Extension Phase|Adverse Event|5|||
28055825|NCT00424346|54712548|FG003|Extension Phase|Adverse Event|4|||
28055826|NCT00424346|54712545|FG000|Extension Phase|Lack of Efficacy|0|||
28055827|NCT00424346|54712546|FG001|Extension Phase|Lack of Efficacy|16|||
28055828|NCT00424346|54712547|FG002|Extension Phase|Lack of Efficacy|14|||
28055829|NCT00424346|54712548|FG003|Extension Phase|Lack of Efficacy|11|||
28055830|NCT00424346|54712545|FG000|Extension Phase|Withdrawal by Subject|0|||
28055831|NCT00424346|54712546|FG001|Extension Phase|Withdrawal by Subject|5|||
28055832|NCT00424346|54712547|FG002|Extension Phase|Withdrawal by Subject|3|||
28055833|NCT00424346|54712548|FG003|Extension Phase|Withdrawal by Subject|4|||
28055834|NCT00424346|54712545|FG000|Extension Phase|Lost to Follow-up|0|||
28055835|NCT00424346|54712546|FG001|Extension Phase|Lost to Follow-up|2|||
28055836|NCT00424346|54712547|FG002|Extension Phase|Lost to Follow-up|0|||
28055837|NCT00424346|54712548|FG003|Extension Phase|Lost to Follow-up|0|||
28055838|NCT00424346|54712545|FG000|Extension Phase|Administrative Problems|0|||
28055839|NCT00424346|54712546|FG001|Extension Phase|Administrative Problems|69|||
28055840|NCT00424346|54712547|FG002|Extension Phase|Administrative Problems|32|||
28055841|NCT00424346|54712548|FG003|Extension Phase|Administrative Problems|35|||
28055842|NCT00424346|54712545|FG000|Extension Phase|Death|0|||
28055843|NCT00424346|54712546|FG001|Extension Phase|Death|0|||
28055844|NCT00424346|54712547|FG002|Extension Phase|Death|0|||
28055845|NCT00424346|54712548|FG003|Extension Phase|Death|1|||
28055846|NCT00424346|54712545|FG000|Extension Phase|Protocol Violation|0|||
28055847|NCT00424346|54712546|FG001|Extension Phase|Protocol Violation|1|||
28055848|NCT00424346|54712547|FG002|Extension Phase|Protocol Violation|1|||
28055849|NCT00424346|54712548|FG003|Extension Phase|Protocol Violation|0|||
28055850|NCT00283959|54712561|FG000|Extension Period|Low Compliance|1|||
28055851|NCT00372528|54712565|FG000|Overall Study|Lack of Efficacy|1|||
28055852|NCT00372528|54712565|FG000|Overall Study|Adverse Event|1|||
28055853|NCT00372528|54712565|FG000|Overall Study|Study Terminated by Sponsor|18|||
28055854|NCT00372528|54712565|FG000|Overall Study|Other|1|||
28055855|NCT00283803|54712569|FG000|Overall Study|Physician Decision|9|||
28055856|NCT00283803|54712569|FG000|Overall Study|Withdrawal by Subject|4|||
28055857|NCT00397488|54712573|FG000|Overall Study|Withdrawal by Subject|3|||
28055858|NCT00397488|54712573|FG000|Overall Study|Adverse Event|3|||
28055859|NCT00397488|54712573|FG000|Overall Study|Death|1|||
28055860|NCT00424190|54712579|FG000|Overall Study|Withdrew consent|3|||
28055861|NCT00424190|54712580|FG001|Overall Study|Withdrew consent|4|||
28055862|NCT00424190|54712579|FG000|Overall Study|Death|3|||
28055863|NCT00424190|54712580|FG001|Overall Study|Death|0|||
28055864|NCT00424190|54712579|FG000|Overall Study|Noncompliance|1|||
27813232|NCT01690299|54269677|FG002|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
27813233|NCT01690299|54269678|FG003|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
27813234|NCT01690299|54269679|FG004|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4|||
28055865|NCT00424190|54712580|FG001|Overall Study|Noncompliance|2|||
28055866|NCT00424190|54712579|FG000|Overall Study|Request of sponsor or investigator|0|||
28055867|NCT00424190|54712580|FG001|Overall Study|Request of sponsor or investigator|2|||
28055868|NCT00424190|54712579|FG000|Overall Study|Diagnosis of osteomyelitis|0|||
28055869|NCT00424190|54712580|FG001|Overall Study|Diagnosis of osteomyelitis|1|||
28055870|NCT00424190|54712579|FG000|Overall Study|Other|15|||
27813235|NCT01690299|54269680|FG005|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
28055871|NCT00424190|54712580|FG001|Overall Study|Other|21|||
28055872|NCT00428246|54712589|FG000|Overall Study|Withdrawal by Subject|0|||
28055873|NCT00428246|54712590|FG001|Overall Study|Withdrawal by Subject|0|||
28055874|NCT00428246|54712591|FG002|Overall Study|Withdrawal by Subject|1|||
28055875|NCT00428246|54712589|FG000|Overall Study|Adverse Event|1|||
28055876|NCT00428246|54712590|FG001|Overall Study|Adverse Event|0|||
28055877|NCT00428246|54712591|FG002|Overall Study|Adverse Event|0|||
28055878|NCT00274287|54712599|FG000|Overall Study|Withdrawal by Subject|1|||
28055879|NCT00274287|54712599|FG000|Overall Study|subject non-compliance|1|||
28055880|NCT00423800|54712606|FG000|Overall Study|Protocol Violation|0|||
28055881|NCT00423800|54712607|FG001|Overall Study|Protocol Violation|1|||
28055882|NCT00405548|54712616|FG000|Overall Study|Cognitive Memory problems on study day|1|||
28055883|NCT00405548|54712617|FG001|Overall Study|Cognitive Memory problems on study day|0|||
28055884|NCT00405548|54712616|FG000|Overall Study|Amyloidosis on study echo-exclusionary|0|||
28055885|NCT00405548|54712617|FG001|Overall Study|Amyloidosis on study echo-exclusionary|1|||
28055886|NCT00405548|54712616|FG000|Overall Study|Unable to self-administer shots|1|||
28055887|NCT00405548|54712617|FG001|Overall Study|Unable to self-administer shots|0|||
28055888|NCT00405548|54712616|FG000|Overall Study|Venous access failed during study day|1|||
28055889|NCT00405548|54712617|FG001|Overall Study|Venous access failed during study day|0|||
28055890|NCT00405548|54712616|FG000|Overall Study|Withdrawal by Subject|1|||
28055891|NCT00405548|54712617|FG001|Overall Study|Withdrawal by Subject|0|||
28055892|NCT00405392|54712625|FG000|Overall Study|Adverse Event|15|||
28055893|NCT00405392|54712626|FG001|Overall Study|Adverse Event|14|||
28055894|NCT00405392|54712625|FG000|Overall Study|Did not meet Eligibility criteria|7|||
27813236|NCT01690299|54269675|FG000|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
28055895|NCT00405392|54712626|FG001|Overall Study|Did not meet Eligibility criteria|2|||
28055896|NCT00405392|54712625|FG000|Overall Study|Withdrawal by Subject|4|||
28055897|NCT00405392|54712626|FG001|Overall Study|Withdrawal by Subject|3|||
28055898|NCT00405392|54712625|FG000|Overall Study|Lost to Follow-up|1|||
28055899|NCT00405392|54712626|FG001|Overall Study|Lost to Follow-up|2|||
28055900|NCT00405392|54712625|FG000|Overall Study|Data missing|2|||
28055901|NCT00405392|54712626|FG001|Overall Study|Data missing|0|||
28055902|NCT00405392|54712625|FG000|Overall Study|Non-compliance|0|||
28055903|NCT00405392|54712626|FG001|Overall Study|Non-compliance|1|||
28055904|NCT00405392|54712625|FG000|Overall Study|Other|1|||
28055905|NCT00405392|54712626|FG001|Overall Study|Other|5|||
28055906|NCT00282243|54712632|FG000|Pharmacokinetic Treatment Period|Adverse Event|3|||
28055907|NCT00282243|54712632|FG000|Pharmacokinetic Treatment Period|Withdrawal by Subject|2|||
28055908|NCT00282243|54712632|FG000|Extension Treatment Period|Adverse Event|15|||
28055909|NCT00282243|54712632|FG000|Extension Treatment Period|Withdrawal by Subject|4|||
28055910|NCT00282243|54712632|FG000|Extension Treatment Period|Non-compliance|2|||
28055911|NCT00282243|54712632|FG000|Extension Treatment Period|Physician Decision|1|||
28055912|NCT00272961|54712641|FG000|Placebo Run-in Phase: Up to Week 2|Physician Decision|1|||
28055913|NCT00272961|54712642|FG001|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
28055914|NCT00272961|54712643|FG002|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
28055915|NCT00272961|54712644|FG003|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
28055916|NCT00272961|54712645|FG004|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
28055917|NCT00272961|54712641|FG000|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1|||
27813237|NCT01690299|54269676|FG001|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
27813238|NCT01690299|54269677|FG002|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
28055918|NCT00272961|54712642|FG001|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
28055919|NCT00272961|54712643|FG002|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
28055920|NCT00272961|54712644|FG003|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
28055921|NCT00272961|54712645|FG004|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
28055922|NCT00272961|54712641|FG000|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5|||
28055923|NCT00272961|54712642|FG001|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
28055924|NCT00272961|54712643|FG002|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
28055925|NCT00272961|54712644|FG003|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
28055926|NCT00272961|54712645|FG004|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
28055927|NCT00272961|54712641|FG000|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2|||
28055928|NCT00272961|54712642|FG001|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
28055929|NCT00272961|54712643|FG002|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
28055930|NCT00272961|54712644|FG003|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
28055931|NCT00272961|54712645|FG004|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
28055932|NCT00272961|54712641|FG000|Placebo Run-in Phase: Up to Week 2|Other|2|||
28055933|NCT00272961|54712642|FG001|Placebo Run-in Phase: Up to Week 2|Other|0|||
28055934|NCT00272961|54712643|FG002|Placebo Run-in Phase: Up to Week 2|Other|0|||
28055935|NCT00272961|54712644|FG003|Placebo Run-in Phase: Up to Week 2|Other|0|||
28055936|NCT00272961|54712645|FG004|Placebo Run-in Phase: Up to Week 2|Other|0|||
28055937|NCT00272961|54712641|FG000|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
28055938|NCT00272961|54712642|FG001|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
28055939|NCT00272961|54712643|FG002|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
28055940|NCT00272961|54712644|FG003|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
28055941|NCT00272961|54712645|FG004|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2|||
28055942|NCT00272961|54712641|FG000|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
28055943|NCT00272961|54712642|FG001|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
28055944|NCT00272961|54712643|FG002|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
28055945|NCT00272961|54712644|FG003|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
28055946|NCT00272961|54712645|FG004|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
28055947|NCT00272961|54712641|FG000|Treatment Phase: Week 3 Up to Week 12|Other|1|||
28055948|NCT00272961|54712642|FG001|Treatment Phase: Week 3 Up to Week 12|Other|3|||
28055949|NCT00272961|54712643|FG002|Treatment Phase: Week 3 Up to Week 12|Other|3|||
28055950|NCT00272961|54712644|FG003|Treatment Phase: Week 3 Up to Week 12|Other|2|||
28055951|NCT00272961|54712645|FG004|Treatment Phase: Week 3 Up to Week 12|Other|2|||
28055952|NCT00282087|54712657|FG000|Overall Study|Death|1|||
28055953|NCT00404924|54712664|FG000|Overall Study|Adverse Event|75|||
28055954|NCT00404924|54712665|FG001|Overall Study|Adverse Event|16|||
28055955|NCT00404924|54712664|FG000|Overall Study|Condition under investigation worsened|475|||
28055956|NCT00404924|54712665|FG001|Overall Study|Condition under investigation worsened|264|||
28055957|NCT00404924|54712664|FG000|Overall Study|Lost to Follow-up|1|||
28055958|NCT00404924|54712665|FG001|Overall Study|Lost to Follow-up|1|||
28055959|NCT00404924|54712664|FG000|Overall Study|Withdrawal by Subject|26|||
28055960|NCT00404924|54712665|FG001|Overall Study|Withdrawal by Subject|13|||
28055961|NCT00404924|54712664|FG000|Overall Study|Other|25|||
28055962|NCT00404924|54712665|FG001|Overall Study|Other|11|||
28055963|NCT00404924|54712664|FG000|Overall Study|Randomised but not received treatment|1|||
28055964|NCT00404924|54712665|FG001|Overall Study|Randomised but not received treatment|1|||
28055965|NCT00281697|54712673|FG000|Overall Study|> 60 days since last dose of study drug|4|||
28055966|NCT00281697|54712674|FG001|Overall Study|> 60 days since last dose of study drug|4|||
28055967|NCT00281697|54712673|FG000|Overall Study|Adverse Event|54|||
28055968|NCT00281697|54712674|FG001|Overall Study|Adverse Event|15|||
28055969|NCT00281697|54712673|FG000|Overall Study|Death|8|||
27813239|NCT01690299|54269678|FG003|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9|||
28055970|NCT00281697|54712674|FG001|Overall Study|Death|3|||
28055971|NCT00281697|54712673|FG000|Overall Study|Disease progression|279|||
28055972|NCT00281697|54712674|FG001|Overall Study|Disease progression|149|||
28055973|NCT00281697|54712673|FG000|Overall Study|Other|5|||
28055974|NCT00281697|54712674|FG001|Overall Study|Other|6|||
28055975|NCT00281697|54712673|FG000|Overall Study|Physician's decision to withdraw|15|||
27813240|NCT01690299|54269679|FG004|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10|||
27813241|NCT01690299|54269680|FG005|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8|||
27813242|NCT01690299|54269675|FG000|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
27813243|NCT01690299|54269676|FG001|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
27813244|NCT01690299|54269677|FG002|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
27813245|NCT01690299|54269678|FG003|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
27813246|NCT01690299|54269679|FG004|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
27813247|NCT01690299|54269680|FG005|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
27813248|NCT01690299|54269675|FG000|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
27813249|NCT01690299|54269676|FG001|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
27813250|NCT01690299|54269677|FG002|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
27813251|NCT01690299|54269678|FG003|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8|||
27813252|NCT01690299|54269679|FG004|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5|||
27813253|NCT01690299|54269680|FG005|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11|||
27813254|NCT01690299|54269675|FG000|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
27813255|NCT01690299|54269676|FG001|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
28055976|NCT00281697|54712674|FG001|Overall Study|Physician's decision to withdraw|12|||
28055977|NCT00281697|54712673|FG000|Overall Study|Subject/guardian's decision to withdraw|33|||
28055978|NCT00281697|54712674|FG001|Overall Study|Subject/guardian's decision to withdraw|6|||
28055979|NCT00281697|54712673|FG000|Overall Study|Did not receive study drug|3|||
28055980|NCT00281697|54712674|FG001|Overall Study|Did not receive study drug|2|||
28055981|NCT00271947|54712680|FG000|Overall Study|Lost to Follow-up|1|||
28055982|NCT00232180|54712686|FG000|Double-blind (DB) Phase|Death|186|||
28055983|NCT00232180|54712687|FG001|Double-blind (DB) Phase|Death|222|||
28055984|NCT00232180|54712688|FG002|Double-blind (DB) Phase|Death|0|||
28055985|NCT00232180|54712686|FG000|Double-blind (DB) Phase|Lost to Follow-up|34|||
28055986|NCT00232180|54712687|FG001|Double-blind (DB) Phase|Lost to Follow-up|28|||
28055987|NCT00232180|54712688|FG002|Double-blind (DB) Phase|Lost to Follow-up|0|||
28055988|NCT00232180|54712686|FG000|Double-blind (DB) Phase|Withdrawal by Subject|131|||
28055989|NCT00232180|54712687|FG001|Double-blind (DB) Phase|Withdrawal by Subject|148|||
28055990|NCT00232180|54712688|FG002|Double-blind (DB) Phase|Withdrawal by Subject|0|||
28055991|NCT00232180|54712686|FG000|Double-blind (DB) Phase|Protocol Violation|28|||
28055992|NCT00232180|54712687|FG001|Double-blind (DB) Phase|Protocol Violation|21|||
28055993|NCT00232180|54712688|FG002|Double-blind (DB) Phase|Protocol Violation|0|||
28055994|NCT00232180|54712686|FG000|Double-blind (DB) Phase|Adverse Event|83|||
28055995|NCT00232180|54712687|FG001|Double-blind (DB) Phase|Adverse Event|100|||
28055996|NCT00232180|54712688|FG002|Double-blind (DB) Phase|Adverse Event|0|||
28055997|NCT00232180|54712686|FG000|Double-blind (DB) Phase|Other|70|||
28055998|NCT00232180|54712687|FG001|Double-blind (DB) Phase|Other|75|||
28055999|NCT00232180|54712688|FG002|Double-blind (DB) Phase|Other|0|||
28056000|NCT00232180|54712686|FG000|Double-blind (DB) Phase|Randomized but not treated|3|||
28056001|NCT00232180|54712687|FG001|Double-blind (DB) Phase|Randomized but not treated|4|||
28056002|NCT00232180|54712688|FG002|Double-blind (DB) Phase|Randomized but not treated|0|||
28056003|NCT00232180|54712686|FG000|Double-blind (DB) Phase|Laboratory abnormality|6|||
28056004|NCT00232180|54712687|FG001|Double-blind (DB) Phase|Laboratory abnormality|7|||
28056005|NCT00232180|54712688|FG002|Double-blind (DB) Phase|Laboratory abnormality|0|||
28056006|NCT00232180|54712686|FG000|Open Label Phase|Death|0|||
28056007|NCT00232180|54712687|FG001|Open Label Phase|Death|0|||
28056008|NCT00232180|54712688|FG002|Open Label Phase|Death|48|||
28056009|NCT00232180|54712686|FG000|Open Label Phase|Lost to Follow-up|0|||
28056010|NCT00232180|54712687|FG001|Open Label Phase|Lost to Follow-up|0|||
28056011|NCT00232180|54712688|FG002|Open Label Phase|Lost to Follow-up|5|||
28056012|NCT00232180|54712686|FG000|Open Label Phase|Protocol Violation|0|||
28056013|NCT00232180|54712687|FG001|Open Label Phase|Protocol Violation|0|||
28056014|NCT00232180|54712688|FG002|Open Label Phase|Protocol Violation|3|||
28056015|NCT00232180|54712686|FG000|Open Label Phase|Study terminated by sponsor|0|||
28056016|NCT00232180|54712687|FG001|Open Label Phase|Study terminated by sponsor|0|||
28056017|NCT00232180|54712688|FG002|Open Label Phase|Study terminated by sponsor|3|||
28056018|NCT00232180|54712686|FG000|Open Label Phase|Withdrawal by Subject|0|||
28056019|NCT00232180|54712687|FG001|Open Label Phase|Withdrawal by Subject|0|||
28056020|NCT00232180|54712688|FG002|Open Label Phase|Withdrawal by Subject|37|||
28056021|NCT00232180|54712686|FG000|Open Label Phase|Other|0|||
28056022|NCT00232180|54712687|FG001|Open Label Phase|Other|0|||
28056023|NCT00232180|54712688|FG002|Open Label Phase|Other|16|||
28056024|NCT00232180|54712686|FG000|Open Label Phase|Adverse Event|0|||
28056025|NCT00232180|54712687|FG001|Open Label Phase|Adverse Event|0|||
28056026|NCT00232180|54712688|FG002|Open Label Phase|Adverse Event|25|||
28056027|NCT00232180|54712686|FG000|Open Label Phase|Laboratory abnormality|0|||
28056028|NCT00232180|54712687|FG001|Open Label Phase|Laboratory abnormality|0|||
28056029|NCT00232180|54712688|FG002|Open Label Phase|Laboratory abnormality|10|||
28056030|NCT00232180|54712686|FG000|Open Label Phase|Randomized but not treated|0|||
28056031|NCT00232180|54712687|FG001|Open Label Phase|Randomized but not treated|0|||
28056032|NCT00232180|54712688|FG002|Open Label Phase|Randomized but not treated|1|||
28056033|NCT00280917|54712701|FG000|Overall Study|Adverse Event|1|||
28056034|NCT00280917|54712702|FG001|Overall Study|Adverse Event|1|||
28056035|NCT00280917|54712703|FG002|Overall Study|Adverse Event|4|||
28056036|NCT00280917|54712704|FG003|Overall Study|Adverse Event|1|||
28056037|NCT00280917|54712701|FG000|Overall Study|Change Therapy|1|||
28056038|NCT00280917|54712702|FG001|Overall Study|Change Therapy|2|||
28056039|NCT00280917|54712703|FG002|Overall Study|Change Therapy|0|||
28056040|NCT00280917|54712704|FG003|Overall Study|Change Therapy|0|||
28056041|NCT00280917|54712701|FG000|Overall Study|Withdrawal by Subject|0|||
28056042|NCT00280917|54712702|FG001|Overall Study|Withdrawal by Subject|2|||
28056043|NCT00280917|54712703|FG002|Overall Study|Withdrawal by Subject|0|||
28056044|NCT00280917|54712704|FG003|Overall Study|Withdrawal by Subject|1|||
28056045|NCT00280917|54712701|FG000|Overall Study|Noncompliance|0|||
28056046|NCT00280917|54712702|FG001|Overall Study|Noncompliance|1|||
28056047|NCT00280917|54712703|FG002|Overall Study|Noncompliance|2|||
28056048|NCT00280917|54712704|FG003|Overall Study|Noncompliance|0|||
28056049|NCT00280683|54712716|FG000|Overall Study|Withdrawal by Subject|1|||
28056050|NCT00280683|54712717|FG001|Overall Study|Withdrawal by Subject|2|||
28056051|NCT00280683|54712716|FG000|Overall Study|Adverse Event|1|||
28056052|NCT00280683|54712717|FG001|Overall Study|Adverse Event|1|||
28056053|NCT00270855|54712727|FG000|Overall Study|Withdrawal by Subject|8|||
28056054|NCT00270855|54712728|FG001|Overall Study|Withdrawal by Subject|8|||
28056055|NCT00404768|54712740|FG000|Part A and B|Withdrawn due to labor progression|1|||
28056056|NCT00404768|54712741|FG001|Part A and B|Withdrawn due to labor progression|0|||
28056057|NCT00404768|54712742|FG002|Part A and B|Withdrawn due to labor progression|0|||
28056058|NCT00404768|54712743|FG003|Part A and B|Withdrawn due to labor progression|0|||
28056059|NCT00404768|54712740|FG000|Part A and B|Withdrawn as delivery imminemnt|0|||
28056060|NCT00404768|54712741|FG001|Part A and B|Withdrawn as delivery imminemnt|1|||
28056061|NCT00404768|54712742|FG002|Part A and B|Withdrawn as delivery imminemnt|0|||
28056062|NCT00404768|54712743|FG003|Part A and B|Withdrawn as delivery imminemnt|0|||
28056063|NCT00404768|54712740|FG000|Part C|Adverse Event|0|||
28056064|NCT00404768|54712741|FG001|Part C|Adverse Event|0|||
28056065|NCT00404768|54712742|FG002|Part C|Adverse Event|0|||
28056066|NCT00404768|54712743|FG003|Part C|Adverse Event|3|||
28056067|NCT00404768|54712740|FG000|Part C|Lost to Follow-up|0|||
28056068|NCT00404768|54712741|FG001|Part C|Lost to Follow-up|0|||
28056069|NCT00404768|54712742|FG002|Part C|Lost to Follow-up|3|||
28056070|NCT00404768|54712743|FG003|Part C|Lost to Follow-up|1|||
28056071|NCT00404768|54712740|FG000|Part C|Withdrawal by Subject|0|||
28056072|NCT00404768|54712741|FG001|Part C|Withdrawal by Subject|0|||
28056073|NCT00404768|54712742|FG002|Part C|Withdrawal by Subject|2|||
28056074|NCT00404768|54712743|FG003|Part C|Withdrawal by Subject|1|||
28056075|NCT00404768|54712740|FG000|Part C|Early withdrawal from study medication|0|||
28056076|NCT00404768|54712741|FG001|Part C|Early withdrawal from study medication|0|||
28056077|NCT00404768|54712742|FG002|Part C|Early withdrawal from study medication|1|||
28056078|NCT00404768|54712743|FG003|Part C|Early withdrawal from study medication|0|||
28056079|NCT00404768|54712740|FG000|Part C|Participant did not respond to therapy|0|||
28056080|NCT00404768|54712741|FG001|Part C|Participant did not respond to therapy|0|||
28056081|NCT00404768|54712742|FG002|Part C|Participant did not respond to therapy|1|||
28056082|NCT00404768|54712743|FG003|Part C|Participant did not respond to therapy|1|||
28056083|NCT00404768|54712740|FG000|Part C|Physician withdrew the study medication|0|||
28056084|NCT00404768|54712741|FG001|Part C|Physician withdrew the study medication|0|||
28056085|NCT00404768|54712742|FG002|Part C|Physician withdrew the study medication|1|||
28056086|NCT00404768|54712743|FG003|Part C|Physician withdrew the study medication|0|||
28056087|NCT00404768|54712740|FG000|Part C|Participant delivered baby|0|||
28056088|NCT00404768|54712741|FG001|Part C|Participant delivered baby|0|||
28056089|NCT00404768|54712742|FG002|Part C|Participant delivered baby|0|||
28056090|NCT00404768|54712743|FG003|Part C|Participant delivered baby|1|||
28056091|NCT00404768|54712740|FG000|Part C|Unsatisfactory uterine response to IP|0|||
27848244|NCT01045161|54341216|FG002|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
28056092|NCT00404768|54712741|FG001|Part C|Unsatisfactory uterine response to IP|0|||
28056093|NCT00404768|54712742|FG002|Part C|Unsatisfactory uterine response to IP|0|||
28056094|NCT00404768|54712743|FG003|Part C|Unsatisfactory uterine response to IP|1|||
28056095|NCT00404768|54712740|FG000|Part C|Active labor|0|||
28056096|NCT00404768|54712741|FG001|Part C|Active labor|0|||
28056097|NCT00404768|54712742|FG002|Part C|Active labor|0|||
28056098|NCT00404768|54712743|FG003|Part C|Active labor|1|||
28056099|NCT00404768|54712740|FG000|Part C|Lack of Efficacy|0|||
28056100|NCT00404768|54712741|FG001|Part C|Lack of Efficacy|0|||
28056101|NCT00404768|54712742|FG002|Part C|Lack of Efficacy|0|||
28056102|NCT00404768|54712743|FG003|Part C|Lack of Efficacy|2|||
28056103|NCT00404768|54712740|FG000|Part C|Treatment failure|0|||
28056104|NCT00404768|54712741|FG001|Part C|Treatment failure|0|||
28056105|NCT00404768|54712742|FG002|Part C|Treatment failure|0|||
28056106|NCT00404768|54712743|FG003|Part C|Treatment failure|1|||
28056107|NCT00404768|54712740|FG000|Part C|Investigator discretion|0|||
28056108|NCT00404768|54712741|FG001|Part C|Investigator discretion|0|||
28056109|NCT00404768|54712742|FG002|Part C|Investigator discretion|0|||
28056110|NCT00404768|54712743|FG003|Part C|Investigator discretion|1|||
28056111|NCT00404768|54712740|FG000|Part C|Researcher suspended study medication|0|||
28056112|NCT00404768|54712741|FG001|Part C|Researcher suspended study medication|0|||
28056113|NCT00404768|54712742|FG002|Part C|Researcher suspended study medication|0|||
28056114|NCT00404768|54712743|FG003|Part C|Researcher suspended study medication|1|||
28056115|NCT00270231|54712758|FG000|First Intervention|Lost to Follow-up|1|||
28056116|NCT00270231|54712759|FG001|First Intervention|Lost to Follow-up|1|||
28056117|NCT00270231|54712758|FG000|Washout Period|Lost to Follow-up|1|||
27813256|NCT01690299|54269677|FG002|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
28056118|NCT00270231|54712759|FG001|Washout Period|Lost to Follow-up|0|||
28056119|NCT00270231|54712758|FG000|Second Intervention|Lost to Follow-up|0|||
28056120|NCT00270231|54712759|FG001|Second Intervention|Lost to Follow-up|1|||
28056121|NCT00258856|54712769|FG000|Overall Study|Lost to Follow-up|1|||
28056122|NCT00258856|54712770|FG001|Overall Study|Lost to Follow-up|0|||
28056123|NCT00258856|54712771|FG002|Overall Study|Lost to Follow-up|2|||
28056124|NCT00258856|54712772|FG003|Overall Study|Lost to Follow-up|0|||
28056125|NCT00258856|54712769|FG000|Overall Study|Non-compliance|2|||
28056126|NCT00258856|54712770|FG001|Overall Study|Non-compliance|0|||
28056127|NCT00258856|54712771|FG002|Overall Study|Non-compliance|0|||
28056128|NCT00258856|54712772|FG003|Overall Study|Non-compliance|1|||
28056129|NCT00269919|54712782|FG000|Overall Study|Other|26|||
28056130|NCT00269919|54712782|FG000|Overall Study|Started but not treated|1|||
28056131|NCT00258154|54712789|FG000|Overall Study|Adverse Event|1|||
28056132|NCT00258154|54712790|FG001|Overall Study|Adverse Event|0|||
28056133|NCT00258154|54712789|FG000|Overall Study|Lost to Follow-up|0|||
28056134|NCT00258154|54712790|FG001|Overall Study|Lost to Follow-up|1|||
28056135|NCT00258154|54712789|FG000|Overall Study|Protocol Violation|2|||
28056136|NCT00258154|54712790|FG001|Overall Study|Protocol Violation|1|||
28056137|NCT00258154|54712789|FG000|Overall Study|Withdrawal by Subject|3|||
28056138|NCT00258154|54712790|FG001|Overall Study|Withdrawal by Subject|4|||
28056139|NCT00258154|54712789|FG000|Overall Study|Patient Moved|3|||
28056140|NCT00258154|54712790|FG001|Overall Study|Patient Moved|1|||
28056141|NCT00257920|54712798|FG000|Period: Washout Period of Two Weeks|Lost to Follow-up|0|||
28056142|NCT00257920|54712799|FG001|Period: Washout Period of Two Weeks|Lost to Follow-up|1|||
28056143|NCT00257920|54712798|FG000|Period: Second Intervention|Other|2|||
28056144|NCT00257920|54712799|FG001|Period: Second Intervention|Other|1|||
28056145|NCT00268983|54712808|FG000|Overall Study|Death|3|||
28056146|NCT00268983|54712809|FG001|Overall Study|Death|0|||
28056147|NCT00257608|54712817|FG000|Chemotherapy Phase|Adverse Event|138|||
28056148|NCT00257608|54712818|FG001|Chemotherapy Phase|Adverse Event|0|||
28056149|NCT00257608|54712819|FG002|Chemotherapy Phase|Adverse Event|0|||
28056150|NCT00257608|54712817|FG000|Chemotherapy Phase|Disease progression|139|||
28056151|NCT00257608|54712818|FG001|Chemotherapy Phase|Disease progression|0|||
28056152|NCT00257608|54712819|FG002|Chemotherapy Phase|Disease progression|0|||
28056153|NCT00257608|54712817|FG000|Chemotherapy Phase|Unwillingness or inability to comply|6|||
28056154|NCT00257608|54712818|FG001|Chemotherapy Phase|Unwillingness or inability to comply|0|||
28056155|NCT00257608|54712819|FG002|Chemotherapy Phase|Unwillingness or inability to comply|0|||
28056156|NCT00257608|54712817|FG000|Chemotherapy Phase|Need for concomitant/ancillary therapy|27|||
28056157|NCT00257608|54712818|FG001|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
28056158|NCT00257608|54712819|FG002|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
28056159|NCT00257608|54712817|FG000|Chemotherapy Phase|Patient's decision to discontinue|35|||
28056160|NCT00257608|54712818|FG001|Chemotherapy Phase|Patient's decision to discontinue|0|||
28056161|NCT00257608|54712819|FG002|Chemotherapy Phase|Patient's decision to discontinue|0|||
28056162|NCT00257608|54712817|FG000|Chemotherapy Phase|Unrelated intercurrent illness|3|||
28056163|NCT00257608|54712818|FG001|Chemotherapy Phase|Unrelated intercurrent illness|0|||
28056164|NCT00257608|54712819|FG002|Chemotherapy Phase|Unrelated intercurrent illness|0|||
28056165|NCT00257608|54712817|FG000|Chemotherapy Phase|Physician Decision|28|||
28056166|NCT00257608|54712818|FG001|Chemotherapy Phase|Physician Decision|0|||
28056167|NCT00257608|54712819|FG002|Chemotherapy Phase|Physician Decision|0|||
28056168|NCT00257608|54712817|FG000|Post Chemotherapy Phase|Adverse Event|0|||
28056169|NCT00257608|54712818|FG001|Post Chemotherapy Phase|Adverse Event|34|||
28056170|NCT00257608|54712819|FG002|Post Chemotherapy Phase|Adverse Event|38|||
28056171|NCT00257608|54712817|FG000|Post Chemotherapy Phase|Disease progression|0|||
28056172|NCT00257608|54712818|FG001|Post Chemotherapy Phase|Disease progression|204|||
27939948|NCT00943852|54596284|FG007|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
27813257|NCT01690299|54269678|FG003|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
28056173|NCT00257608|54712819|FG002|Post Chemotherapy Phase|Disease progression|168|||
28056174|NCT00257608|54712817|FG000|Post Chemotherapy Phase|Unwillingness or inability to comply|0|||
28056175|NCT00257608|54712818|FG001|Post Chemotherapy Phase|Unwillingness or inability to comply|4|||
28056176|NCT00257608|54712819|FG002|Post Chemotherapy Phase|Unwillingness or inability to comply|5|||
28056177|NCT00257608|54712817|FG000|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
28056178|NCT00257608|54712818|FG001|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
28056179|NCT00257608|54712819|FG002|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
28056180|NCT00257608|54712817|FG000|Post Chemotherapy Phase|Patient's decision to discontinue|0|||
28056181|NCT00257608|54712818|FG001|Post Chemotherapy Phase|Patient's decision to discontinue|4|||
28056182|NCT00257608|54712819|FG002|Post Chemotherapy Phase|Patient's decision to discontinue|8|||
28056183|NCT00257608|54712817|FG000|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
28056184|NCT00257608|54712818|FG001|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
28056185|NCT00257608|54712819|FG002|Post Chemotherapy Phase|Unrelated intercurrent illness|1|||
28056186|NCT00257608|54712817|FG000|Post Chemotherapy Phase|Lost to Follow-up|0|||
28056187|NCT00257608|54712818|FG001|Post Chemotherapy Phase|Lost to Follow-up|0|||
28056188|NCT00257608|54712819|FG002|Post Chemotherapy Phase|Lost to Follow-up|1|||
28056189|NCT00257608|54712817|FG000|Post Chemotherapy Phase|Physician Decision|0|||
28056190|NCT00257608|54712818|FG001|Post Chemotherapy Phase|Physician Decision|8|||
28056191|NCT00257608|54712819|FG002|Post Chemotherapy Phase|Physician Decision|11|||
28056192|NCT00257608|54712817|FG000|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
28056193|NCT00257608|54712818|FG001|Post Chemotherapy Phase|Sponsor's decision to terminate study|1|||
28056194|NCT00257608|54712819|FG002|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
28056195|NCT00257608|54712817|FG000|Post Chemotherapy Phase|Not treated|0|||
28056196|NCT00257608|54712818|FG001|Post Chemotherapy Phase|Not treated|4|||
28056197|NCT00257608|54712819|FG002|Post Chemotherapy Phase|Not treated|7|||
28056198|NCT00231478|54712834|FG000|Overall Study|Protocol Violation|3|||
28056199|NCT00231478|54712835|FG001|Overall Study|Protocol Violation|2|||
28056200|NCT00231478|54712834|FG000|Overall Study|Refused Treatment|1|||
28056201|NCT00231478|54712835|FG001|Overall Study|Refused Treatment|1|||
28056202|NCT00231478|54712834|FG000|Overall Study|Withdrawal by Subject|1|||
28056203|NCT00231478|54712835|FG001|Overall Study|Withdrawal by Subject|0|||
28056204|NCT00231478|54712834|FG000|Overall Study|Adverse Event|0|||
28056205|NCT00231478|54712835|FG001|Overall Study|Adverse Event|1|||
28056206|NCT00231478|54712834|FG000|Overall Study|Administrative|3|||
28056207|NCT00231478|54712835|FG001|Overall Study|Administrative|2|||
28056208|NCT00413192|54712845|FG000|Overall Study|Disease progression|26|||
28056209|NCT00413192|54712846|FG001|Overall Study|Disease progression|31|||
28056210|NCT00413192|54712847|FG002|Overall Study|Disease progression|16|||
28056211|NCT00413192|54712848|FG003|Overall Study|Disease progression|25|||
28056212|NCT00413192|54712845|FG000|Overall Study|Toxicity|3|||
28056213|NCT00413192|54712846|FG001|Overall Study|Toxicity|2|||
28056214|NCT00413192|54712847|FG002|Overall Study|Toxicity|2|||
28056215|NCT00413192|54712848|FG003|Overall Study|Toxicity|2|||
28056216|NCT00413192|54712845|FG000|Overall Study|Withdrawal by Subject|3|||
28056217|NCT00413192|54712846|FG001|Overall Study|Withdrawal by Subject|5|||
28056218|NCT00413192|54712847|FG002|Overall Study|Withdrawal by Subject|0|||
28056219|NCT00413192|54712848|FG003|Overall Study|Withdrawal by Subject|1|||
28056220|NCT00413192|54712845|FG000|Overall Study|Intercurrent illness|0|||
28056221|NCT00413192|54712846|FG001|Overall Study|Intercurrent illness|0|||
28056222|NCT00413192|54712847|FG002|Overall Study|Intercurrent illness|0|||
28056223|NCT00413192|54712848|FG003|Overall Study|Intercurrent illness|1|||
28056224|NCT00413192|54712845|FG000|Overall Study|Intercurrent death|0|||
28056225|NCT00413192|54712846|FG001|Overall Study|Intercurrent death|1|||
28056226|NCT00413192|54712847|FG002|Overall Study|Intercurrent death|0|||
28056227|NCT00413192|54712848|FG003|Overall Study|Intercurrent death|0|||
28056228|NCT00413192|54712845|FG000|Overall Study|Other|5|||
28056229|NCT00413192|54712846|FG001|Overall Study|Other|1|||
28056230|NCT00413192|54712847|FG002|Overall Study|Other|1|||
28056231|NCT00413192|54712848|FG003|Overall Study|Other|2|||
28056232|NCT00413192|54712845|FG000|Overall Study|Not treated|0|||
28056233|NCT00413192|54712846|FG001|Overall Study|Not treated|0|||
28056234|NCT00413192|54712847|FG002|Overall Study|Not treated|0|||
28056235|NCT00413192|54712848|FG003|Overall Study|Not treated|1|||
28056236|NCT00207142|54712861|FG000|Induction Phase|Adverse Event|9|||
28056237|NCT00207142|54712862|FG001|Induction Phase|Adverse Event|0|||
28056238|NCT00207142|54712863|FG002|Induction Phase|Adverse Event|0|||
28056239|NCT00207142|54712864|FG003|Induction Phase|Adverse Event|0|||
28056240|NCT00207142|54712861|FG000|Induction Phase|Death|1|||
28056241|NCT00207142|54712862|FG001|Induction Phase|Death|0|||
28056242|NCT00207142|54712863|FG002|Induction Phase|Death|0|||
28056243|NCT00207142|54712864|FG003|Induction Phase|Death|0|||
28056244|NCT00207142|54712861|FG000|Induction Phase|Lack of Efficacy|1|||
28056245|NCT00207142|54712862|FG001|Induction Phase|Lack of Efficacy|0|||
28056246|NCT00207142|54712863|FG002|Induction Phase|Lack of Efficacy|0|||
28056247|NCT00207142|54712864|FG003|Induction Phase|Lack of Efficacy|0|||
28056248|NCT00207142|54712861|FG000|Induction Phase|Lost to Follow-up|5|||
28056249|NCT00207142|54712862|FG001|Induction Phase|Lost to Follow-up|0|||
28056250|NCT00207142|54712863|FG002|Induction Phase|Lost to Follow-up|0|||
28056251|NCT00207142|54712864|FG003|Induction Phase|Lost to Follow-up|0|||
28056252|NCT00207142|54712861|FG000|Induction Phase|Physician Decision|2|||
28056253|NCT00207142|54712862|FG001|Induction Phase|Physician Decision|0|||
28056254|NCT00207142|54712863|FG002|Induction Phase|Physician Decision|0|||
28056255|NCT00207142|54712864|FG003|Induction Phase|Physician Decision|0|||
28056256|NCT00207142|54712861|FG000|Induction Phase|Poor/noncompliance|2|||
28056257|NCT00207142|54712862|FG001|Induction Phase|Poor/noncompliance|0|||
28056258|NCT00207142|54712863|FG002|Induction Phase|Poor/noncompliance|0|||
28056259|NCT00207142|54712864|FG003|Induction Phase|Poor/noncompliance|0|||
28056260|NCT00207142|54712861|FG000|Induction Phase|Pregnancy|1|||
28056261|NCT00207142|54712862|FG001|Induction Phase|Pregnancy|0|||
28056262|NCT00207142|54712863|FG002|Induction Phase|Pregnancy|0|||
28056263|NCT00207142|54712864|FG003|Induction Phase|Pregnancy|0|||
28056264|NCT00207142|54712861|FG000|Induction Phase|Subject no longer meets study criteria|3|||
28056265|NCT00207142|54712862|FG001|Induction Phase|Subject no longer meets study criteria|0|||
28056266|NCT00207142|54712863|FG002|Induction Phase|Subject no longer meets study criteria|0|||
28056267|NCT00207142|54712864|FG003|Induction Phase|Subject no longer meets study criteria|0|||
28056268|NCT00207142|54712861|FG000|Induction Phase|Withdrawal by Subject|4|||
28056269|NCT00207142|54712862|FG001|Induction Phase|Withdrawal by Subject|0|||
28056270|NCT00207142|54712863|FG002|Induction Phase|Withdrawal by Subject|0|||
28056271|NCT00207142|54712864|FG003|Induction Phase|Withdrawal by Subject|0|||
28056272|NCT00207142|54712861|FG000|Induction Phase|Incarceration|1|||
28056273|NCT00207142|54712862|FG001|Induction Phase|Incarceration|0|||
28056274|NCT00207142|54712863|FG002|Induction Phase|Incarceration|0|||
28056275|NCT00207142|54712864|FG003|Induction Phase|Incarceration|0|||
28056276|NCT00207142|54712861|FG000|Induction Phase|Missing lab data|1|||
28056277|NCT00207142|54712862|FG001|Induction Phase|Missing lab data|0|||
28056278|NCT00207142|54712863|FG002|Induction Phase|Missing lab data|0|||
28056279|NCT00207142|54712864|FG003|Induction Phase|Missing lab data|0|||
28056280|NCT00207142|54712861|FG000|Maintenance Phase/Rescue Phase|Adverse Event|0|||
28105718|NCT04422561|54763325|FG000|Overall Study|Lost to Follow-up|25|||
28056281|NCT00207142|54712862|FG001|Maintenance Phase/Rescue Phase|Adverse Event|1|||
28056282|NCT00207142|54712863|FG002|Maintenance Phase/Rescue Phase|Adverse Event|4|||
28056283|NCT00207142|54712864|FG003|Maintenance Phase/Rescue Phase|Adverse Event|1|||
28056284|NCT00207142|54712861|FG000|Maintenance Phase/Rescue Phase|Lost to Follow-up|0|||
28056285|NCT00207142|54712862|FG001|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
28056286|NCT00207142|54712863|FG002|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
28056287|NCT00207142|54712864|FG003|Maintenance Phase/Rescue Phase|Lost to Follow-up|2|||
28056288|NCT00207142|54712861|FG000|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
28056289|NCT00207142|54712862|FG001|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
27813258|NCT01690299|54269679|FG004|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13|||
27813259|NCT01690299|54269680|FG005|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
27813260|NCT01690299|54269675|FG000|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
27813261|NCT01690299|54269676|FG001|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
27813262|NCT01690299|54269677|FG002|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
27813263|NCT01690299|54269678|FG003|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
27813264|NCT01690299|54269679|FG004|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
27813265|NCT01690299|54269680|FG005|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1|||
28056290|NCT00207142|54712863|FG002|Maintenance Phase/Rescue Phase|RTV intake impossible|1|||
28056291|NCT00207142|54712864|FG003|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
28056292|NCT00207142|54712861|FG000|Maintenance Phase/Rescue Phase|Poor/noncompliance|0|||
28056293|NCT00207142|54712862|FG001|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
28056294|NCT00207142|54712863|FG002|Maintenance Phase/Rescue Phase|Poor/noncompliance|2|||
28056295|NCT00207142|54712864|FG003|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
27848245|NCT01045161|54341214|FG000|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
28056296|NCT00207142|54712861|FG000|Maintenance Phase/Rescue Phase|Pregnancy|0|||
28056297|NCT00207142|54712862|FG001|Maintenance Phase/Rescue Phase|Pregnancy|2|||
28056298|NCT00207142|54712863|FG002|Maintenance Phase/Rescue Phase|Pregnancy|2|||
28056299|NCT00207142|54712864|FG003|Maintenance Phase/Rescue Phase|Pregnancy|0|||
28056300|NCT00207142|54712861|FG000|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
28056301|NCT00207142|54712862|FG001|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
28056302|NCT00207142|54712863|FG002|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1|||
28056303|NCT00207142|54712864|FG003|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
28056304|NCT00207142|54712861|FG000|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0|||
28056305|NCT00207142|54712862|FG001|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
28056306|NCT00207142|54712863|FG002|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
28056307|NCT00207142|54712864|FG003|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1|||
28056308|NCT00207142|54712861|FG000|Maintenance Phase/Rescue Phase|Death|0|||
28056309|NCT00207142|54712862|FG001|Maintenance Phase/Rescue Phase|Death|0|||
28056310|NCT00207142|54712863|FG002|Maintenance Phase/Rescue Phase|Death|0|||
28056311|NCT00207142|54712864|FG003|Maintenance Phase/Rescue Phase|Death|1|||
28056312|NCT00207142|54712861|FG000|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
28056313|NCT00207142|54712862|FG001|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
28056314|NCT00207142|54712863|FG002|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
28056315|NCT00207142|54712864|FG003|Maintenance Phase/Rescue Phase|Lack of Efficacy|1|||
28056316|NCT00268905|54712882|FG000|Overall Study|Adverse Event|3|||
28056317|NCT00268905|54712883|FG001|Overall Study|Adverse Event|0|||
28056318|NCT00268905|54712884|FG002|Overall Study|Adverse Event|4|||
28056319|NCT00268905|54712882|FG000|Overall Study|Lost to Follow-up|0|||
28056320|NCT00268905|54712883|FG001|Overall Study|Lost to Follow-up|1|||
28056321|NCT00268905|54712884|FG002|Overall Study|Lost to Follow-up|0|||
28056322|NCT00268905|54712882|FG000|Overall Study|Withdrawal by Subject|0|||
28056323|NCT00268905|54712883|FG001|Overall Study|Withdrawal by Subject|0|||
28056324|NCT00268905|54712884|FG002|Overall Study|Withdrawal by Subject|3|||
28056325|NCT00268905|54712882|FG000|Overall Study|Progressive Disease|28|||
28056326|NCT00268905|54712883|FG001|Overall Study|Progressive Disease|4|||
28056327|NCT00268905|54712884|FG002|Overall Study|Progressive Disease|3|||
28056328|NCT00268905|54712882|FG000|Overall Study|Physician Decision|3|||
28056329|NCT00268905|54712883|FG001|Overall Study|Physician Decision|0|||
28056330|NCT00268905|54712884|FG002|Overall Study|Physician Decision|1|||
28056331|NCT00268905|54712882|FG000|Overall Study|Clinical Progression|9|||
28056332|NCT00268905|54712883|FG001|Overall Study|Clinical Progression|4|||
28056333|NCT00268905|54712884|FG002|Overall Study|Clinical Progression|1|||
28056334|NCT00206518|54712894|FG000|Overall Study|Lack of Efficacy|6|||
28056335|NCT00206518|54712895|FG001|Overall Study|Lack of Efficacy|4|||
28056336|NCT00206518|54712894|FG000|Overall Study|Adverse Event|2|||
28056337|NCT00206518|54712895|FG001|Overall Study|Adverse Event|1|||
28056338|NCT00206518|54712894|FG000|Overall Study|Physician Decision|1|||
28056339|NCT00206518|54712895|FG001|Overall Study|Physician Decision|0|||
28056340|NCT00206518|54712894|FG000|Overall Study|Protocol Violation|1|||
28056341|NCT00206518|54712895|FG001|Overall Study|Protocol Violation|1|||
28056342|NCT00423722|54712903|FG000|Overall Study|Death|4|||
28056343|NCT00423722|54712904|FG001|Overall Study|Death|4|||
28056344|NCT00423722|54712903|FG000|Overall Study|Declined to participate|2|||
28056345|NCT00423722|54712904|FG001|Overall Study|Declined to participate|3|||
27848246|NCT01045161|54341215|FG001|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
28056346|NCT00423722|54712903|FG000|Overall Study|Unable to complete questionnaires|4|||
28056347|NCT00423722|54712904|FG001|Overall Study|Unable to complete questionnaires|4|||
28056348|NCT00423722|54712903|FG000|Overall Study|Withdrawal by Subject|4|||
28056349|NCT00423722|54712904|FG001|Overall Study|Withdrawal by Subject|2|||
28056350|NCT00206440|54712918|FG000|Overall Study|Protocol Violation|1|||
28056351|NCT00206440|54712919|FG001|Overall Study|Protocol Violation|2|||
28056352|NCT00206440|54712918|FG000|Overall Study|Adverse Event|4|||
28056353|NCT00206440|54712919|FG001|Overall Study|Adverse Event|2|||
28056354|NCT00268437|54712925|FG000|Overall Study|Ineligible|1|||
28056355|NCT00423488|54712932|FG000|Overall Study|No evidence of study drug intake|2|||
28056356|NCT00423488|54712933|FG001|Overall Study|No evidence of study drug intake|1|||
28056357|NCT00423488|54712932|FG000|Overall Study|No post baseline data|3|||
28056358|NCT00423488|54712933|FG001|Overall Study|No post baseline data|0|||
28056359|NCT00404066|54712939|FG000|Overall Study|Withdrawal by Subject - Pre-treatment|1|||
28056360|NCT00404066|54712939|FG000|Overall Study|Withdrawal by Subject - Adverse event|2|||
28056361|NCT00423332|54712945|FG000|Overall Study|Adverse Event|6|||
28056362|NCT00423332|54712946|FG001|Overall Study|Adverse Event|2|||
28056363|NCT00423332|54712945|FG000|Overall Study|Withdrawal by Subject|1|||
28056364|NCT00423332|54712946|FG001|Overall Study|Withdrawal by Subject|0|||
28056365|NCT00423332|54712945|FG000|Overall Study|Condition under investigation worsened|1|||
28056366|NCT00423332|54712946|FG001|Overall Study|Condition under investigation worsened|1|||
28056367|NCT00423332|54712945|FG000|Overall Study|Progressive at Week 6|0|||
28056368|NCT00423332|54712946|FG001|Overall Study|Progressive at Week 6|1|||
28056369|NCT00423332|54712945|FG000|Overall Study|Unblinded before 12 weeks|1|||
28056370|NCT00423332|54712946|FG001|Overall Study|Unblinded before 12 weeks|3|||
28056371|NCT00413036|54712953|FG000|Overall Study|Adverse Event|44|||
28056372|NCT00413036|54712953|FG000|Overall Study|Lack of Efficacy|129|||
28056373|NCT00413036|54712953|FG000|Overall Study|Withdrawal by Subject|7|||
28056374|NCT00413036|54712953|FG000|Overall Study|Death|9|||
28056375|NCT00413036|54712953|FG000|Overall Study|Other|26|||
28056376|NCT00413036|54712953|FG000|Overall Study|Missing|2|||
28056377|NCT00412958|54712961|FG000|Overall Study|Withdrawal by Subject|3|||
28056378|NCT00412958|54712962|FG001|Overall Study|Withdrawal by Subject|0|||
28056379|NCT00412958|54712963|FG002|Overall Study|Withdrawal by Subject|0|||
28056380|NCT00412958|54712964|FG003|Overall Study|Withdrawal by Subject|1|||
28056381|NCT00412958|54712961|FG000|Overall Study|Adverse Event|0|||
28056382|NCT00412958|54712962|FG001|Overall Study|Adverse Event|1|||
28056383|NCT00412958|54712963|FG002|Overall Study|Adverse Event|0|||
28056384|NCT00412958|54712964|FG003|Overall Study|Adverse Event|0|||
28056385|NCT00412958|54712961|FG000|Overall Study|Lost to Follow-up|0|||
28056386|NCT00412958|54712962|FG001|Overall Study|Lost to Follow-up|1|||
28056387|NCT00412958|54712963|FG002|Overall Study|Lost to Follow-up|0|||
28056388|NCT00412958|54712964|FG003|Overall Study|Lost to Follow-up|0|||
28056389|NCT00412958|54712961|FG000|Overall Study|Death|0|||
28056390|NCT00412958|54712962|FG001|Overall Study|Death|1|||
28056391|NCT00412958|54712963|FG002|Overall Study|Death|0|||
28056392|NCT00412958|54712964|FG003|Overall Study|Death|0|||
28056393|NCT00412958|54712961|FG000|Overall Study|Transport issue|0|||
28056394|NCT00412958|54712962|FG001|Overall Study|Transport issue|1|||
28056395|NCT00412958|54712963|FG002|Overall Study|Transport issue|0|||
28056396|NCT00412958|54712964|FG003|Overall Study|Transport issue|0|||
28056397|NCT00423176|54712976|FG000|Overall Study|Adverse Event|4|||
28056398|NCT00423176|54712977|FG001|Overall Study|Adverse Event|6|||
28056399|NCT00423176|54712976|FG000|Overall Study|Treatment Failure|1|||
28056400|NCT00423176|54712977|FG001|Overall Study|Treatment Failure|6|||
28056401|NCT00423176|54712976|FG000|Overall Study|Lost to Follow-up|4|||
28056402|NCT00423176|54712977|FG001|Overall Study|Lost to Follow-up|7|||
28056403|NCT00423176|54712976|FG000|Overall Study|Withdrawal by Subject|4|||
27813266|NCT01690143|54269709|FG000|Overall Study|Withdrawal by Subject|1|||
27813267|NCT01559259|54269732|FG000|Overall Study|Withdrawal by Subject|0|||
28056404|NCT00423176|54712977|FG001|Overall Study|Withdrawal by Subject|3|||
28056405|NCT00423176|54712976|FG000|Overall Study|Protocol Violation|1|||
28056406|NCT00423176|54712977|FG001|Overall Study|Protocol Violation|3|||
28056407|NCT00423176|54712976|FG000|Overall Study|Did not meet protocol eligibility|2|||
28056408|NCT00423176|54712977|FG001|Overall Study|Did not meet protocol eligibility|4|||
28056409|NCT00412880|54712983|FG000|Overall Study|Withdrew, overdose of study treatment|1|||
28056410|NCT00412880|54712983|FG000|Overall Study|Consent withdrawn|1|||
28056411|NCT00412880|54712983|FG000|Overall Study|Adverse Event|1|||
28056412|NCT00412880|54712983|FG000|Overall Study|Progressive disease|20|||
28056413|NCT00268203|54712987|FG000|Overall Study|Lost to Follow-up|92|||
28056414|NCT00268203|54712987|FG000|Overall Study|Withdrawal by Subject|9|||
28056415|NCT00268203|54712987|FG000|Overall Study|Received Other NHL Therapy|7|||
28056416|NCT00268203|54712987|FG000|Overall Study|Progressive Disease|359|||
28056417|NCT00268203|54712987|FG000|Overall Study|Death|84|||
28056418|NCT00268203|54712987|FG000|Overall Study|Reason Not Specified|34|||
28056419|NCT00268203|54712987|FG000|Overall Study|Completed 2 Years of Follow-up|62|||
28056420|NCT00384930|54712996|FG000|Overall Study|Adverse Event|5|||
28056421|NCT00384930|54712997|FG001|Overall Study|Adverse Event|4|||
27813268|NCT01559259|54269733|FG001|Overall Study|Withdrawal by Subject|0|||
28056422|NCT00384930|54712998|FG002|Overall Study|Adverse Event|12|||
28056423|NCT00384930|54712999|FG003|Overall Study|Adverse Event|11|||
28056424|NCT00384930|54713000|FG004|Overall Study|Adverse Event|14|||
28056425|NCT00384930|54712996|FG000|Overall Study|Entry Criteria Not Met|2|||
28056426|NCT00384930|54712997|FG001|Overall Study|Entry Criteria Not Met|6|||
28056427|NCT00384930|54712998|FG002|Overall Study|Entry Criteria Not Met|7|||
28056428|NCT00384930|54712999|FG003|Overall Study|Entry Criteria Not Met|8|||
28056429|NCT00384930|54713000|FG004|Overall Study|Entry Criteria Not Met|4|||
27813269|NCT01559259|54269734|FG002|Overall Study|Withdrawal by Subject|0|||
27813270|NCT01559259|54269735|FG003|Overall Study|Withdrawal by Subject|1|||
28056430|NCT00384930|54712996|FG000|Overall Study|Lack of Efficacy|1|||
28056431|NCT00384930|54712997|FG001|Overall Study|Lack of Efficacy|1|||
28056432|NCT00384930|54712998|FG002|Overall Study|Lack of Efficacy|2|||
28056433|NCT00384930|54712999|FG003|Overall Study|Lack of Efficacy|1|||
28056434|NCT00384930|54713000|FG004|Overall Study|Lack of Efficacy|2|||
28056435|NCT00384930|54712996|FG000|Overall Study|Lost to Follow-up|5|||
28056436|NCT00384930|54712997|FG001|Overall Study|Lost to Follow-up|3|||
28056437|NCT00384930|54712998|FG002|Overall Study|Lost to Follow-up|0|||
28056438|NCT00384930|54712999|FG003|Overall Study|Lost to Follow-up|4|||
28056439|NCT00384930|54713000|FG004|Overall Study|Lost to Follow-up|6|||
28056440|NCT00384930|54712996|FG000|Overall Study|Physician Decision|0|||
28056441|NCT00384930|54712997|FG001|Overall Study|Physician Decision|1|||
28056442|NCT00384930|54712998|FG002|Overall Study|Physician Decision|1|||
28056443|NCT00384930|54712999|FG003|Overall Study|Physician Decision|0|||
28056444|NCT00384930|54713000|FG004|Overall Study|Physician Decision|1|||
28056445|NCT00384930|54712996|FG000|Overall Study|Protocol Violation|1|||
28056446|NCT00384930|54712997|FG001|Overall Study|Protocol Violation|0|||
28056447|NCT00384930|54712998|FG002|Overall Study|Protocol Violation|1|||
28056448|NCT00384930|54712999|FG003|Overall Study|Protocol Violation|6|||
28056449|NCT00384930|54713000|FG004|Overall Study|Protocol Violation|4|||
28056450|NCT00384930|54712996|FG000|Overall Study|Sponsor Decision|3|||
28056451|NCT00384930|54712997|FG001|Overall Study|Sponsor Decision|4|||
28056452|NCT00384930|54712998|FG002|Overall Study|Sponsor Decision|0|||
28056453|NCT00384930|54712999|FG003|Overall Study|Sponsor Decision|5|||
28056454|NCT00384930|54713000|FG004|Overall Study|Sponsor Decision|0|||
28056455|NCT00384930|54712996|FG000|Overall Study|Withdrawal by Subject|9|||
28056456|NCT00384930|54712997|FG001|Overall Study|Withdrawal by Subject|7|||
28056457|NCT00384930|54712998|FG002|Overall Study|Withdrawal by Subject|7|||
28056458|NCT00384930|54712999|FG003|Overall Study|Withdrawal by Subject|6|||
28056459|NCT00384930|54713000|FG004|Overall Study|Withdrawal by Subject|16|||
28056460|NCT00384930|54712996|FG000|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
28056461|NCT00384930|54712997|FG001|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
28056462|NCT00384930|54712998|FG002|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
28056463|NCT00384930|54712999|FG003|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
28056464|NCT00384930|54713000|FG004|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
28056465|NCT00423098|54713017|FG000|Overall Study|Adverse Event|1|||
28056466|NCT00423098|54713018|FG001|Overall Study|Adverse Event|2|||
28056467|NCT00423098|54713017|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
28056468|NCT00423098|54713018|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
28056469|NCT00423098|54713017|FG000|Overall Study|Administrative problems|0|||
28056470|NCT00423098|54713018|FG001|Overall Study|Administrative problems|1|||
28056471|NCT00423098|54713017|FG000|Overall Study|Death|2|||
28056472|NCT00423098|54713018|FG001|Overall Study|Death|0|||
28056473|NCT00750698|54713035|FG000|Overall Study|Withdrawal by Subject|1|||
28056474|NCT00750698|54713036|FG001|Overall Study|Withdrawal by Subject|0|||
28056475|NCT00750698|54713035|FG000|Overall Study|Progressive disease|5|||
28056476|NCT00750698|54713036|FG001|Overall Study|Progressive disease|2|||
28056477|NCT00411788|54713042|FG000|Overall Study|Protocol Violation|1|||
28056478|NCT00411788|54713042|FG000|Overall Study|Adverse Event|1|||
28056479|NCT00422942|54713046|FG000|Overall Study|Study terminated by Sponsor|3|||
28056480|NCT00422162|54713052|FG000|Overall Study|Adverse Event|11|||
28056481|NCT00422162|54713053|FG001|Overall Study|Adverse Event|9|||
28056482|NCT00422162|54713052|FG000|Overall Study|Lack of Efficacy|4|||
27813271|NCT01559259|54269736|FG004|Overall Study|Withdrawal by Subject|0|||
27813272|NCT01559259|54269732|FG000|Overall Study|Adverse Event|0|||
27813273|NCT01559259|54269733|FG001|Overall Study|Adverse Event|1|||
28056483|NCT00422162|54713053|FG001|Overall Study|Lack of Efficacy|10|||
28056484|NCT00422162|54713052|FG000|Overall Study|Withdrawal by Subject|7|||
28056485|NCT00422162|54713053|FG001|Overall Study|Withdrawal by Subject|6|||
28056486|NCT00422162|54713052|FG000|Overall Study|Lost to Follow-up|1|||
28056487|NCT00422162|54713053|FG001|Overall Study|Lost to Follow-up|2|||
28056488|NCT00422162|54713052|FG000|Overall Study|Non-Compliant with Protocol|1|||
28056489|NCT00422162|54713053|FG001|Overall Study|Non-Compliant with Protocol|1|||
28056490|NCT00422162|54713052|FG000|Overall Study|Other|0|||
28056491|NCT00422162|54713053|FG001|Overall Study|Other|1|||
28056492|NCT00422162|54713052|FG000|Overall Study|Didn't Receive Treatment|0|||
28056493|NCT00422162|54713053|FG001|Overall Study|Didn't Receive Treatment|1|||
27813274|NCT01559259|54269734|FG002|Overall Study|Adverse Event|1|||
27813275|NCT01559259|54269735|FG003|Overall Study|Adverse Event|0|||
27813276|NCT01559259|54269736|FG004|Overall Study|Adverse Event|0|||
27813277|NCT01670500|54269760|FG000|Overall Study|Withdrawal by Subject|1|||
27813278|NCT01670500|54269761|FG001|Overall Study|Withdrawal by Subject|0|||
28056494|NCT00411632|54713069|FG000|Overall Study|Death|1|||
28056495|NCT00422084|54713075|FG000|Overall Study|Adverse Event|21|||
28056496|NCT00422084|54713076|FG001|Overall Study|Adverse Event|7|||
28056497|NCT00422084|54713075|FG000|Overall Study|Withdrawal by Subject|12|||
28056498|NCT00422084|54713076|FG001|Overall Study|Withdrawal by Subject|9|||
28056499|NCT00422084|54713075|FG000|Overall Study|Lost to Follow-up|14|||
28056500|NCT00422084|54713076|FG001|Overall Study|Lost to Follow-up|9|||
28056501|NCT00422084|54713075|FG000|Overall Study|Protocol Violation|4|||
28056502|NCT00422084|54713076|FG001|Overall Study|Protocol Violation|1|||
28056503|NCT00422084|54713075|FG000|Overall Study|Lack of Efficacy|40|||
28056504|NCT00422084|54713076|FG001|Overall Study|Lack of Efficacy|42|||
28056505|NCT00422084|54713075|FG000|Overall Study|P. vivax infection|3|||
28056506|NCT00422084|54713076|FG001|Overall Study|P. vivax infection|6|||
28056507|NCT00422084|54713075|FG000|Overall Study|Cyesis|1|||
28056508|NCT00422084|54713076|FG001|Overall Study|Cyesis|0|||
28056509|NCT00422084|54713075|FG000|Overall Study|Withdrawn from study accidentally|1|||
28056510|NCT00422084|54713076|FG001|Overall Study|Withdrawn from study accidentally|0|||
28056511|NCT00422084|54713075|FG000|Overall Study|Non-compliance|1|||
28056512|NCT00422084|54713076|FG001|Overall Study|Non-compliance|0|||
28056513|NCT00422084|54713075|FG000|Overall Study|Re-location|0|||
28056514|NCT00422084|54713076|FG001|Overall Study|Re-location|1|||
28056515|NCT00422084|54713075|FG000|Overall Study|Not defined|1|||
28056516|NCT00422084|54713076|FG001|Overall Study|Not defined|1|||
28056517|NCT00421928|54713085|FG000|Overall Study|Adverse Event|61|||
28056518|NCT00421928|54713086|FG001|Overall Study|Adverse Event|140|||
28056519|NCT00421928|54713087|FG002|Overall Study|Adverse Event|22|||
28056520|NCT00421928|54713085|FG000|Overall Study|Lost to Follow-up|5|||
28056521|NCT00421928|54713086|FG001|Overall Study|Lost to Follow-up|0|||
28056522|NCT00421928|54713087|FG002|Overall Study|Lost to Follow-up|3|||
28056523|NCT00421928|54713085|FG000|Overall Study|Withdrawal by Subject|50|||
28056524|NCT00421928|54713086|FG001|Overall Study|Withdrawal by Subject|48|||
28056525|NCT00421928|54713087|FG002|Overall Study|Withdrawal by Subject|43|||
28056526|NCT00421928|54713085|FG000|Overall Study|Lack of Efficacy|15|||
28056527|NCT00421928|54713086|FG001|Overall Study|Lack of Efficacy|7|||
28056528|NCT00421928|54713087|FG002|Overall Study|Lack of Efficacy|35|||
28056529|NCT00421928|54713085|FG000|Overall Study|Study drug non-compliant|6|||
28056530|NCT00421928|54713086|FG001|Overall Study|Study drug non-compliant|7|||
28056531|NCT00421928|54713087|FG002|Overall Study|Study drug non-compliant|4|||
28056532|NCT00421928|54713085|FG000|Overall Study|All other|26|||
28056533|NCT00421928|54713086|FG001|Overall Study|All other|21|||
28056534|NCT00421928|54713087|FG002|Overall Study|All other|27|||
28056535|NCT00421928|54713085|FG000|Overall Study|Death|0|||
28056536|NCT00421928|54713086|FG001|Overall Study|Death|1|||
28056537|NCT00421928|54713087|FG002|Overall Study|Death|0|||
28056538|NCT00383292|54713098|FG000|Overall Study|Adverse Event|4|||
28056539|NCT00383292|54713099|FG001|Overall Study|Adverse Event|1|||
27813279|NCT02400736|54269769|FG000|Overall Study|Lost to Follow-up|6|||
27813280|NCT02400736|54269770|FG001|Overall Study|Lost to Follow-up|6|||
27813281|NCT02400736|54269769|FG000|Overall Study|Withdrawal by Subject|2|||
28056540|NCT00383292|54713100|FG002|Overall Study|Adverse Event|2|||
28056541|NCT00383292|54713098|FG000|Overall Study|Death|3|||
28056542|NCT00383292|54713099|FG001|Overall Study|Death|3|||
28056543|NCT00383292|54713100|FG002|Overall Study|Death|3|||
28056544|NCT00383292|54713098|FG000|Overall Study|Physician Decision|4|||
28056545|NCT00383292|54713099|FG001|Overall Study|Physician Decision|0|||
28056546|NCT00383292|54713100|FG002|Overall Study|Physician Decision|1|||
27813282|NCT02400736|54269770|FG001|Overall Study|Withdrawal by Subject|1|||
27813283|NCT02400736|54269769|FG000|Overall Study|Moved from the area|3|||
28056547|NCT00383292|54713098|FG000|Overall Study|Withdrawal by Subject|3|||
28105719|NCT04422561|54763326|FG001|Overall Study|Lost to Follow-up|11|||
28056548|NCT00383292|54713099|FG001|Overall Study|Withdrawal by Subject|2|||
28056549|NCT00383292|54713100|FG002|Overall Study|Withdrawal by Subject|2|||
28056550|NCT00383292|54713098|FG000|Overall Study|Other|1|||
28056551|NCT00383292|54713099|FG001|Overall Study|Other|0|||
28056552|NCT00383292|54713100|FG002|Overall Study|Other|0|||
28056553|NCT00372060|54713111|FG000|Period I - Double-blind (Weeks 0-12)|Adverse Event|2|||
28056554|NCT00372060|54713112|FG001|Period I - Double-blind (Weeks 0-12)|Adverse Event|0|||
28056555|NCT00372060|54713111|FG000|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0|||
28056556|NCT00372060|54713112|FG001|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1|||
28056557|NCT00372060|54713111|FG000|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1|||
28056558|NCT00372060|54713112|FG001|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0|||
28056559|NCT00372060|54713111|FG000|Period II - Open-label (Weeks 12-52)|Adverse Event|3|||
28056560|NCT00372060|54713112|FG001|Period II - Open-label (Weeks 12-52)|Adverse Event|0|||
28056561|NCT00372060|54713111|FG000|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9|||
28056562|NCT00372060|54713112|FG001|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8|||
28056563|NCT00372060|54713111|FG000|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2|||
28056564|NCT00372060|54713112|FG001|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0|||
28056565|NCT00421304|54713124|FG000|Overall Study|Lost to Follow-up|5|||
28056566|NCT00421304|54713125|FG001|Overall Study|Lost to Follow-up|2|||
28056567|NCT00421304|54713126|FG002|Overall Study|Lost to Follow-up|5|||
28056568|NCT00421304|54713124|FG000|Overall Study|Withdrawal by Subject|2|||
28056569|NCT00421304|54713125|FG001|Overall Study|Withdrawal by Subject|2|||
28056570|NCT00421304|54713126|FG002|Overall Study|Withdrawal by Subject|2|||
28056571|NCT00421304|54713124|FG000|Overall Study|Mistakenly randomized, chose not to participate in study|1|||
28056572|NCT00421304|54713125|FG001|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
28056573|NCT00421304|54713126|FG002|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
28056574|NCT00421304|54713124|FG000|Overall Study|Did not attend Day 360 visit|0|||
28056575|NCT00421304|54713125|FG001|Overall Study|Did not attend Day 360 visit|0|||
28056576|NCT00421304|54713126|FG002|Overall Study|Did not attend Day 360 visit|1|||
28056577|NCT00396630|54713138|FG000|Overall Study|Lost to Follow-up|1|||
28056578|NCT00396630|54713139|FG001|Overall Study|Lost to Follow-up|1|||
28056579|NCT00396630|54713138|FG000|Overall Study|Withdrawal by Subject|1|||
28056580|NCT00396630|54713139|FG001|Overall Study|Withdrawal by Subject|1|||
28056581|NCT00396630|54713138|FG000|Overall Study|Not vaccinated at Visit 3|3|||
28056582|NCT00396630|54713139|FG001|Overall Study|Not vaccinated at Visit 3|3|||
28056583|NCT00396318|54713146|FG000|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5|||
28056584|NCT00396162|54713152|FG000|Overall Study|Withdrawal by Subject|2|||
28056585|NCT00396162|54713153|FG001|Overall Study|Withdrawal by Subject|3|||
28056586|NCT00381888|54713163|FG000|Overall Study|Death|1|||
28056587|NCT00381888|54713163|FG000|Overall Study|Withdrawal by Subject|1|||
28056588|NCT00381888|54713163|FG000|Overall Study|Physician Decision|1|||
28056589|NCT00381888|54713163|FG000|Overall Study|Protocol Violation|9|||
28056590|NCT00381888|54713163|FG000|Overall Study|Had laparoscopic surgery|2|||
28056591|NCT00381888|54713163|FG000|Overall Study|Surgery was cancelled|2|||
28056592|NCT00381888|54713163|FG000|Overall Study|Adverse Event|1|||
28056593|NCT00267969|54713170|FG000|Controlled Period|Adverse Event|6|||
28056594|NCT00267969|54713171|FG001|Controlled Period|Adverse Event|0|||
28056595|NCT00267969|54713172|FG002|Controlled Period|Adverse Event|2|||
28056596|NCT00267969|54713173|FG003|Controlled Period|Adverse Event|0|||
27813284|NCT02400736|54269770|FG001|Overall Study|Moved from the area|1|||
28056597|NCT00267969|54713174|FG004|Controlled Period|Adverse Event|0|||
28056598|NCT00267969|54713175|FG005|Controlled Period|Adverse Event|0|||
28056599|NCT00267969|54713176|FG006|Controlled Period|Adverse Event|0|||
28056600|NCT00267969|54713170|FG000|Controlled Period|Lack of Efficacy|3|||
28056601|NCT00267969|54713171|FG001|Controlled Period|Lack of Efficacy|0|||
28056602|NCT00267969|54713172|FG002|Controlled Period|Lack of Efficacy|1|||
28056603|NCT00267969|54713173|FG003|Controlled Period|Lack of Efficacy|0|||
28056604|NCT00267969|54713174|FG004|Controlled Period|Lack of Efficacy|0|||
28056605|NCT00267969|54713175|FG005|Controlled Period|Lack of Efficacy|0|||
28056606|NCT00267969|54713176|FG006|Controlled Period|Lack of Efficacy|0|||
28056607|NCT00267969|54713170|FG000|Controlled Period|Lost to Follow-up|1|||
28056608|NCT00267969|54713171|FG001|Controlled Period|Lost to Follow-up|0|||
28056609|NCT00267969|54713172|FG002|Controlled Period|Lost to Follow-up|1|||
28056610|NCT00267969|54713173|FG003|Controlled Period|Lost to Follow-up|0|||
27813285|NCT01689519|54269782|FG000|Intent to Treat|Death|157|||
28056611|NCT00267969|54713174|FG004|Controlled Period|Lost to Follow-up|0|||
28056612|NCT00267969|54713175|FG005|Controlled Period|Lost to Follow-up|0|||
28056613|NCT00267969|54713176|FG006|Controlled Period|Lost to Follow-up|0|||
28056614|NCT00267969|54713170|FG000|Controlled Period|Randomized but not treated|0|||
28056615|NCT00267969|54713171|FG001|Controlled Period|Randomized but not treated|0|||
28056616|NCT00267969|54713172|FG002|Controlled Period|Randomized but not treated|1|||
28056617|NCT00267969|54713173|FG003|Controlled Period|Randomized but not treated|0|||
28056618|NCT00267969|54713174|FG004|Controlled Period|Randomized but not treated|0|||
28056619|NCT00267969|54713175|FG005|Controlled Period|Randomized but not treated|0|||
28056620|NCT00267969|54713176|FG006|Controlled Period|Randomized but not treated|0|||
28056621|NCT00267969|54713170|FG000|Controlled Period|Other|2|||
28056622|NCT00267969|54713171|FG001|Controlled Period|Other|1|||
28056623|NCT00267969|54713172|FG002|Controlled Period|Other|6|||
28056624|NCT00267969|54713173|FG003|Controlled Period|Other|0|||
28056625|NCT00267969|54713174|FG004|Controlled Period|Other|0|||
28056626|NCT00267969|54713175|FG005|Controlled Period|Other|0|||
28056627|NCT00267969|54713176|FG006|Controlled Period|Other|0|||
28056628|NCT00267969|54713170|FG000|After Controlled Period|Adverse Event|0|||
28056629|NCT00267969|54713171|FG001|After Controlled Period|Adverse Event|0|||
28056630|NCT00267969|54713172|FG002|After Controlled Period|Adverse Event|0|||
28056631|NCT00267969|54713173|FG003|After Controlled Period|Adverse Event|7|||
28056632|NCT00267969|54713174|FG004|After Controlled Period|Adverse Event|8|||
28056633|NCT00267969|54713175|FG005|After Controlled Period|Adverse Event|23|||
28056634|NCT00267969|54713176|FG006|After Controlled Period|Adverse Event|21|||
28056635|NCT00267969|54713170|FG000|After Controlled Period|Death|0|||
28056636|NCT00267969|54713171|FG001|After Controlled Period|Death|0|||
28056637|NCT00267969|54713172|FG002|After Controlled Period|Death|0|||
28056638|NCT00267969|54713173|FG003|After Controlled Period|Death|1|||
28056639|NCT00267969|54713174|FG004|After Controlled Period|Death|2|||
28056640|NCT00267969|54713175|FG005|After Controlled Period|Death|0|||
28056641|NCT00267969|54713176|FG006|After Controlled Period|Death|1|||
28056642|NCT00267969|54713170|FG000|After Controlled Period|Lack of Efficacy|0|||
28056643|NCT00267969|54713171|FG001|After Controlled Period|Lack of Efficacy|0|||
28056644|NCT00267969|54713172|FG002|After Controlled Period|Lack of Efficacy|0|||
28056645|NCT00267969|54713173|FG003|After Controlled Period|Lack of Efficacy|10|||
28056646|NCT00267969|54713174|FG004|After Controlled Period|Lack of Efficacy|6|||
28056647|NCT00267969|54713175|FG005|After Controlled Period|Lack of Efficacy|28|||
28056648|NCT00267969|54713176|FG006|After Controlled Period|Lack of Efficacy|15|||
28056649|NCT00267969|54713170|FG000|After Controlled Period|Lost to Follow-up|0|||
28056650|NCT00267969|54713171|FG001|After Controlled Period|Lost to Follow-up|0|||
28056651|NCT00267969|54713172|FG002|After Controlled Period|Lost to Follow-up|0|||
28056652|NCT00267969|54713173|FG003|After Controlled Period|Lost to Follow-up|5|||
28056653|NCT00267969|54713174|FG004|After Controlled Period|Lost to Follow-up|8|||
28056654|NCT00267969|54713175|FG005|After Controlled Period|Lost to Follow-up|9|||
28056655|NCT00267969|54713176|FG006|After Controlled Period|Lost to Follow-up|10|||
28056656|NCT00267969|54713170|FG000|After Controlled Period|Other|0|||
28056657|NCT00267969|54713171|FG001|After Controlled Period|Other|0|||
28056658|NCT00267969|54713172|FG002|After Controlled Period|Other|0|||
28056659|NCT00267969|54713173|FG003|After Controlled Period|Other|13|||
28056660|NCT00267969|54713174|FG004|After Controlled Period|Other|11|||
28056661|NCT00267969|54713175|FG005|After Controlled Period|Other|22|||
28056662|NCT00267969|54713176|FG006|After Controlled Period|Other|25|||
28056663|NCT00280293|54713196|FG000|Overall Study|Protocol Violation|3|||
28056664|NCT00280293|54713197|FG001|Overall Study|Protocol Violation|0|||
28056665|NCT00280293|54713196|FG000|Overall Study|Physician Decision|5|||
28056666|NCT00280293|54713197|FG001|Overall Study|Physician Decision|4|||
28056667|NCT00280293|54713196|FG000|Overall Study|Lost to Follow-up|14|||
28056668|NCT00280293|54713197|FG001|Overall Study|Lost to Follow-up|12|||
27813286|NCT01689519|54269783|FG001|Intent to Treat|Death|167|||
28056669|NCT00280293|54713196|FG000|Overall Study|Withdrawal by Subject|3|||
28056670|NCT00280293|54713197|FG001|Overall Study|Withdrawal by Subject|5|||
28056671|NCT00280293|54713196|FG000|Overall Study|Incarceration/Legal Reasons|1|||
28056672|NCT00280293|54713197|FG001|Overall Study|Incarceration/Legal Reasons|1|||
28056673|NCT00280293|54713196|FG000|Overall Study|Adverse Event|0|||
28056674|NCT00280293|54713197|FG001|Overall Study|Adverse Event|1|||
28056675|NCT00421148|54713223|FG000|Overall Study|Lost to Follow-up|0|||
28056676|NCT00421148|54713224|FG001|Overall Study|Lost to Follow-up|0|||
28056677|NCT00421148|54713225|FG002|Overall Study|Lost to Follow-up|0|||
28056678|NCT00421148|54713226|FG003|Overall Study|Lost to Follow-up|0|||
28056679|NCT00421148|54713227|FG004|Overall Study|Lost to Follow-up|0|||
28056680|NCT00421148|54713228|FG005|Overall Study|Lost to Follow-up|0|||
28056681|NCT00421148|54713229|FG006|Overall Study|Lost to Follow-up|0|||
28056682|NCT00421148|54713230|FG007|Overall Study|Lost to Follow-up|0|||
28056683|NCT00421148|54713231|FG008|Overall Study|Lost to Follow-up|0|||
28056684|NCT00421148|54713232|FG009|Overall Study|Lost to Follow-up|0|||
28056685|NCT00421148|54713233|FG010|Overall Study|Lost to Follow-up|0|||
28056686|NCT00421148|54713234|FG011|Overall Study|Lost to Follow-up|0|||
28056687|NCT00421148|54713235|FG012|Overall Study|Lost to Follow-up|0|||
28056688|NCT00421148|54713236|FG013|Overall Study|Lost to Follow-up|0|||
28056689|NCT00421148|54713237|FG014|Overall Study|Lost to Follow-up|0|||
28056690|NCT00421148|54713238|FG015|Overall Study|Lost to Follow-up|0|||
28056691|NCT00421148|54713239|FG016|Overall Study|Lost to Follow-up|0|||
28056692|NCT00421148|54713240|FG017|Overall Study|Lost to Follow-up|1|||
28056693|NCT00421148|54713241|FG018|Overall Study|Lost to Follow-up|0|||
28056694|NCT00421148|54713242|FG019|Overall Study|Lost to Follow-up|0|||
28056695|NCT00421148|54713223|FG000|Overall Study|Withdrawal by Subject|0|||
28056696|NCT00421148|54713224|FG001|Overall Study|Withdrawal by Subject|0|||
28056697|NCT00421148|54713225|FG002|Overall Study|Withdrawal by Subject|0|||
28056698|NCT00421148|54713226|FG003|Overall Study|Withdrawal by Subject|0|||
28056699|NCT00421148|54713227|FG004|Overall Study|Withdrawal by Subject|0|||
28056700|NCT00421148|54713228|FG005|Overall Study|Withdrawal by Subject|0|||
28056701|NCT00421148|54713229|FG006|Overall Study|Withdrawal by Subject|0|||
28056702|NCT00421148|54713230|FG007|Overall Study|Withdrawal by Subject|0|||
28056703|NCT00421148|54713231|FG008|Overall Study|Withdrawal by Subject|0|||
28056704|NCT00421148|54713232|FG009|Overall Study|Withdrawal by Subject|0|||
28056705|NCT00421148|54713233|FG010|Overall Study|Withdrawal by Subject|0|||
28056706|NCT00421148|54713234|FG011|Overall Study|Withdrawal by Subject|0|||
28056707|NCT00421148|54713235|FG012|Overall Study|Withdrawal by Subject|0|||
28056708|NCT00421148|54713236|FG013|Overall Study|Withdrawal by Subject|0|||
28056709|NCT00421148|54713237|FG014|Overall Study|Withdrawal by Subject|0|||
28056710|NCT00421148|54713238|FG015|Overall Study|Withdrawal by Subject|0|||
28056711|NCT00421148|54713239|FG016|Overall Study|Withdrawal by Subject|0|||
28056712|NCT00421148|54713240|FG017|Overall Study|Withdrawal by Subject|1|||
28056713|NCT00421148|54713241|FG018|Overall Study|Withdrawal by Subject|0|||
28056714|NCT00421148|54713242|FG019|Overall Study|Withdrawal by Subject|0|||
28056715|NCT00421148|54713223|FG000|Overall Study|Protocol Violation|0|||
28056716|NCT00421148|54713224|FG001|Overall Study|Protocol Violation|0|||
28056717|NCT00421148|54713225|FG002|Overall Study|Protocol Violation|0|||
28056718|NCT00421148|54713226|FG003|Overall Study|Protocol Violation|0|||
28056719|NCT00421148|54713227|FG004|Overall Study|Protocol Violation|0|||
28056720|NCT00421148|54713228|FG005|Overall Study|Protocol Violation|1|||
28056721|NCT00421148|54713229|FG006|Overall Study|Protocol Violation|0|||
28056722|NCT00421148|54713230|FG007|Overall Study|Protocol Violation|0|||
28056723|NCT00421148|54713231|FG008|Overall Study|Protocol Violation|0|||
28056724|NCT00421148|54713232|FG009|Overall Study|Protocol Violation|0|||
28056725|NCT00421148|54713233|FG010|Overall Study|Protocol Violation|0|||
28056726|NCT00421148|54713234|FG011|Overall Study|Protocol Violation|0|||
28056727|NCT00421148|54713235|FG012|Overall Study|Protocol Violation|0|||
28056728|NCT00421148|54713236|FG013|Overall Study|Protocol Violation|0|||
28056729|NCT00421148|54713237|FG014|Overall Study|Protocol Violation|0|||
28056730|NCT00421148|54713238|FG015|Overall Study|Protocol Violation|0|||
28056731|NCT00421148|54713239|FG016|Overall Study|Protocol Violation|0|||
28056732|NCT00421148|54713240|FG017|Overall Study|Protocol Violation|0|||
28056733|NCT00421148|54713241|FG018|Overall Study|Protocol Violation|1|||
28056734|NCT00421148|54713242|FG019|Overall Study|Protocol Violation|0|||
28056735|NCT00403754|54713284|FG000|Core Treatment Period 1|Withdrawal by Subject|0|||
28056736|NCT00403754|54713285|FG001|Core Treatment Period 1|Withdrawal by Subject|1|||
28056737|NCT00403754|54713286|FG002|Core Treatment Period 1|Withdrawal by Subject|0|||
28056738|NCT00403754|54713287|FG003|Core Treatment Period 1|Withdrawal by Subject|0|||
28056739|NCT00403754|54713284|FG000|Core Treatment Period 2|Lack of Efficacy|0|||
28056740|NCT00403754|54713285|FG001|Core Treatment Period 2|Lack of Efficacy|0|||
28056741|NCT00403754|54713286|FG002|Core Treatment Period 2|Lack of Efficacy|1|||
28056742|NCT00403754|54713287|FG003|Core Treatment Period 2|Lack of Efficacy|0|||
28056743|NCT00280059|54713301|FG000|Efficacy Assessment Phase|Death|2|||
28056744|NCT00280059|54713302|FG001|Efficacy Assessment Phase|Death|0|||
28056745|NCT00280059|54713301|FG000|Efficacy Assessment Phase|Adverse Event|33|||
28056746|NCT00280059|54713302|FG001|Efficacy Assessment Phase|Adverse Event|31|||
28056747|NCT00280059|54713301|FG000|Efficacy Assessment Phase|Laboratory abnormaility|1|||
28056748|NCT00280059|54713302|FG001|Efficacy Assessment Phase|Laboratory abnormaility|0|||
28056749|NCT00280059|54713301|FG000|Efficacy Assessment Phase|Lack of Efficacy|19|||
28056750|NCT00280059|54713302|FG001|Efficacy Assessment Phase|Lack of Efficacy|3|||
28056751|NCT00280059|54713301|FG000|Efficacy Assessment Phase|Lost to Follow-up|6|||
28056752|NCT00280059|54713302|FG001|Efficacy Assessment Phase|Lost to Follow-up|13|||
28056753|NCT00280059|54713301|FG000|Efficacy Assessment Phase|Other|7|||
28056754|NCT00280059|54713302|FG001|Efficacy Assessment Phase|Other|8|||
28056755|NCT00280059|54713301|FG000|Efficacy Assessment Phase|Withdrawal by Subject|26|||
28056756|NCT00280059|54713302|FG001|Efficacy Assessment Phase|Withdrawal by Subject|25|||
28056757|NCT00403130|54713316|FG000|2 Years From Start of Treatment|Not Eligible|3|||
28056758|NCT00403130|54713316|FG000|2 Years From Start of Treatment|Lost to Follow up|1|||
28056759|NCT00403130|54713316|FG000|2 Years From Start of Treatment|Withdrawal by Subject|1|||
28105720|NCT01369498|54763336|FG000|Overall Study|Lack of Efficacy|9|||
28056760|NCT00403130|54713316|FG000|Survival Follow-up up to 6 Years|Lost to Follow-up|10|||
28056761|NCT00402740|54713320|FG000|Overall Study|Withdrawal by Subject|18|||
28056762|NCT00402740|54713320|FG000|Overall Study|Death|50|||
28056763|NCT00402740|54713320|FG000|Overall Study|Lost to Follow-up|6|||
28056764|NCT00402740|54713320|FG000|Overall Study|No stent. Completed FU at 30 days.|5|||
28056765|NCT00402740|54713320|FG000|Overall Study|Subject disposition unknown.|1|||
28056766|NCT00420290|54713330|FG000|Overall Study|Adverse Event|3|||
28056767|NCT00420290|54713331|FG001|Overall Study|Adverse Event|1|||
28056768|NCT00420290|54713330|FG000|Overall Study|Withdrawal by Subject|0|||
28056769|NCT00420290|54713331|FG001|Overall Study|Withdrawal by Subject|2|||
28056770|NCT00420290|54713330|FG000|Overall Study|did not meet inclusion/exclusion|1|||
28056771|NCT00420290|54713331|FG001|Overall Study|did not meet inclusion/exclusion|1|||
28056772|NCT00267189|54713339|FG000|Overall Study|Patient withdrew consent|1|||
28056773|NCT00267189|54713340|FG001|Overall Study|Patient withdrew consent|1|||
28056774|NCT00267189|54713339|FG000|Overall Study|Death|1|||
28056775|NCT00267189|54713340|FG001|Overall Study|Death|0|||
28056776|NCT00267189|54713339|FG000|Overall Study|Missing|3|||
28056777|NCT00267189|54713340|FG001|Overall Study|Missing|0|||
28056778|NCT03834350|54713346|FG000|Overall Study|Withdrawal by Subject|1|||
28056779|NCT00402116|54713354|FG000|Overall Study|Jaw infection after surgery-other|1|||
28056780|NCT00402116|54713355|FG001|Overall Study|Jaw infection after surgery-other|0|||
28056781|NCT00402116|54713356|FG002|Overall Study|Jaw infection after surgery-other|0|||
28056782|NCT00402116|54713354|FG000|Overall Study|Withdrawal by Subject|1|||
28056783|NCT00402116|54713355|FG001|Overall Study|Withdrawal by Subject|0|||
28056784|NCT00402116|54713356|FG002|Overall Study|Withdrawal by Subject|5|||
28056785|NCT00402116|54713354|FG000|Overall Study|Treatment completed per protocol|1|||
28056786|NCT00402116|54713355|FG001|Overall Study|Treatment completed per protocol|1|||
28056787|NCT00402116|54713356|FG002|Overall Study|Treatment completed per protocol|2|||
28056788|NCT00402116|54713354|FG000|Overall Study|other complicating disease|0|||
28056789|NCT00402116|54713355|FG001|Overall Study|other complicating disease|0|||
28056790|NCT00402116|54713356|FG002|Overall Study|other complicating disease|2|||
28056791|NCT00402116|54713354|FG000|Overall Study|Disease Progression|0|||
28056792|NCT00402116|54713355|FG001|Overall Study|Disease Progression|4|||
28056793|NCT00402116|54713356|FG002|Overall Study|Disease Progression|38|||
28056794|NCT00402116|54713354|FG000|Overall Study|mistaken thrombocytopenia|0|||
28056795|NCT00402116|54713355|FG001|Overall Study|mistaken thrombocytopenia|0|||
28056796|NCT00402116|54713356|FG002|Overall Study|mistaken thrombocytopenia|1|||
28056797|NCT00402116|54713354|FG000|Overall Study|decline related hyponatremia/tumor|0|||
28056798|NCT00402116|54713355|FG001|Overall Study|decline related hyponatremia/tumor|0|||
28056799|NCT00402116|54713356|FG002|Overall Study|decline related hyponatremia/tumor|1|||
28056800|NCT00402116|54713354|FG000|Overall Study|Adverse Event|0|||
28056801|NCT00402116|54713355|FG001|Overall Study|Adverse Event|1|||
28056802|NCT00402116|54713356|FG002|Overall Study|Adverse Event|6|||
28056803|NCT00401960|54713386|FG000|Overall Study|Lost to Follow-up|3|||
28056804|NCT00401960|54713387|FG001|Overall Study|Lost to Follow-up|0|||
28056805|NCT00401960|54713386|FG000|Overall Study|Death|2|||
28056806|NCT00401960|54713387|FG001|Overall Study|Death|0|||
28056807|NCT00401726|54713397|FG000|Overall Study|Adverse Event|34|||
28056808|NCT00401726|54713398|FG001|Overall Study|Adverse Event|45|||
28056809|NCT00401726|54713397|FG000|Overall Study|Death|0|||
28056810|NCT00401726|54713398|FG001|Overall Study|Death|3|||
28056811|NCT00401726|54713397|FG000|Overall Study|Sponsor Request|0|||
28056812|NCT00401726|54713398|FG001|Overall Study|Sponsor Request|1|||
28056813|NCT00401726|54713397|FG000|Overall Study|Physician Decision|3|||
28056814|NCT00401726|54713398|FG001|Overall Study|Physician Decision|6|||
28056815|NCT00401726|54713397|FG000|Overall Study|Lost to Follow-up|23|||
28056816|NCT00401726|54713398|FG001|Overall Study|Lost to Follow-up|20|||
28056817|NCT00401726|54713397|FG000|Overall Study|Protocol Violation|6|||
28056818|NCT00401726|54713398|FG001|Overall Study|Protocol Violation|3|||
28056819|NCT00401726|54713397|FG000|Overall Study|Withdrawal by Subject|18|||
28056820|NCT00401726|54713398|FG001|Overall Study|Withdrawal by Subject|24|||
28056821|NCT00401726|54713397|FG000|Overall Study|Lack of Efficacy|4|||
28056822|NCT00401726|54713398|FG001|Overall Study|Lack of Efficacy|6|||
28056823|NCT00401726|54713397|FG000|Overall Study|Protocol Deviation|9|||
28056824|NCT00401726|54713398|FG001|Overall Study|Protocol Deviation|4|||
28056825|NCT00371826|54713407|FG000|Core Phase (12 Months)|Adverse Event|15|||
28056826|NCT00371826|54713408|FG001|Core Phase (12 Months)|Adverse Event|4|||
28056827|NCT00371826|54713409|FG002|Core Phase (12 Months)|Adverse Event|9|||
28056828|NCT00371826|54713407|FG000|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
28056829|NCT00371826|54713408|FG001|Core Phase (12 Months)|Abnormal test procedure result(s)|0|||
28056830|NCT00371826|54713409|FG002|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
28056831|NCT00371826|54713407|FG000|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6|||
28056832|NCT00371826|54713408|FG001|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3|||
28105721|NCT01369498|54763337|FG001|Overall Study|Lack of Efficacy|9|||
28056833|NCT00371826|54713409|FG002|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2|||
28056834|NCT00371826|54713407|FG000|Core Phase (12 Months)|Protocol Violation|1|||
28056835|NCT00371826|54713408|FG001|Core Phase (12 Months)|Protocol Violation|0|||
28056836|NCT00371826|54713409|FG002|Core Phase (12 Months)|Protocol Violation|1|||
28056837|NCT00371826|54713407|FG000|Core Phase (12 Months)|Subject withdrew consent|0|||
28056838|NCT00371826|54713408|FG001|Core Phase (12 Months)|Subject withdrew consent|0|||
28056839|NCT00371826|54713409|FG002|Core Phase (12 Months)|Subject withdrew consent|3|||
28056840|NCT00371826|54713407|FG000|Core Phase (12 Months)|Administrative problems|1|||
28056841|NCT00371826|54713408|FG001|Core Phase (12 Months)|Administrative problems|0|||
28056842|NCT00371826|54713409|FG002|Core Phase (12 Months)|Administrative problems|8|||
28056843|NCT00371826|54713407|FG000|Core Phase (12 Months)|Graft Loss|0|||
28056844|NCT00371826|54713408|FG001|Core Phase (12 Months)|Graft Loss|1|||
28056845|NCT00371826|54713409|FG002|Core Phase (12 Months)|Graft Loss|0|||
28056846|NCT00371826|54713407|FG000|Extension Phase (24 Months)|Adverse Event|4|||
28056847|NCT00371826|54713408|FG001|Extension Phase (24 Months)|Adverse Event|5|||
28056848|NCT00371826|54713409|FG002|Extension Phase (24 Months)|Adverse Event|0|||
28056849|NCT00371826|54713407|FG000|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
28056850|NCT00371826|54713408|FG001|Extension Phase (24 Months)|Abnormal test procedure result(s)|1|||
28056851|NCT00371826|54713409|FG002|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
28056852|NCT00371826|54713407|FG000|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
28056853|NCT00371826|54713408|FG001|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2|||
28056854|NCT00371826|54713409|FG002|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
28056855|NCT00371826|54713407|FG000|Extension Phase (24 Months)|Subject withdrew consent|1|||
28056856|NCT00371826|54713408|FG001|Extension Phase (24 Months)|Subject withdrew consent|2|||
28056857|NCT00371826|54713409|FG002|Extension Phase (24 Months)|Subject withdrew consent|0|||
28056858|NCT00371826|54713407|FG000|Extension Phase (24 Months)|Administrative problems|0|||
28056859|NCT00371826|54713408|FG001|Extension Phase (24 Months)|Administrative problems|0|||
28056860|NCT00371826|54713409|FG002|Extension Phase (24 Months)|Administrative problems|2|||
28056861|NCT00396084|54713423|FG000|Overall Study|Adverse Event|0|||
28056862|NCT00396084|54713424|FG001|Overall Study|Adverse Event|0|||
28056863|NCT00396084|54713425|FG002|Overall Study|Adverse Event|0|||
28056864|NCT00396084|54713426|FG003|Overall Study|Adverse Event|0|||
28056865|NCT00396084|54713427|FG004|Overall Study|Adverse Event|1|||
28056866|NCT00396084|54713428|FG005|Overall Study|Adverse Event|2|||
28056867|NCT00396084|54713423|FG000|Overall Study|Withdrawal by Subject|0|||
28056868|NCT00396084|54713424|FG001|Overall Study|Withdrawal by Subject|0|||
28056869|NCT00396084|54713425|FG002|Overall Study|Withdrawal by Subject|0|||
28056870|NCT00396084|54713426|FG003|Overall Study|Withdrawal by Subject|1|||
28056871|NCT00396084|54713427|FG004|Overall Study|Withdrawal by Subject|0|||
28056872|NCT00396084|54713428|FG005|Overall Study|Withdrawal by Subject|0|||
28056873|NCT00395850|54713450|FG000|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6|||
28056874|NCT00395850|54713451|FG001|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
28056875|NCT00395850|54713452|FG002|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
28056876|NCT00395850|54713453|FG003|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
28056877|NCT00395850|54713450|FG000|Pre-randomization Baseline/Induction|Withdrawal by Subject|4|||
28056878|NCT00395850|54713451|FG001|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
28056879|NCT00395850|54713452|FG002|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
28056880|NCT00395850|54713453|FG003|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
28056881|NCT00395850|54713450|FG000|Pre-randomization Baseline/Induction|Inconsistent attendance|1|||
28056882|NCT00395850|54713451|FG001|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
28056883|NCT00395850|54713452|FG002|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
28056884|NCT00395850|54713453|FG003|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
28056885|NCT00395850|54713450|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
28056886|NCT00395850|54713451|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
28056887|NCT00395850|54713452|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6|||
28056888|NCT00395850|54713453|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4|||
28056889|NCT00395850|54713450|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1|||
28056890|NCT00395850|54713451|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
28056891|NCT00395850|54713452|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
28056892|NCT00395850|54713453|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
27813287|NCT01689519|54269782|FG000|Intent to Treat|Lost to Follow-up|4|||
28105722|NCT01369498|54763338|FG002|Overall Study|Lack of Efficacy|1|||
27813288|NCT01689519|54269783|FG001|Intent to Treat|Lost to Follow-up|8|||
28056893|NCT00395850|54713450|FG000|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1|||
28056894|NCT00395850|54713451|FG001|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
28056895|NCT00395850|54713452|FG002|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
28056896|NCT00395850|54713453|FG003|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
28056897|NCT00395850|54713450|FG000|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1|||
28056898|NCT00395850|54713451|FG001|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
28056899|NCT00395850|54713452|FG002|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
28056900|NCT00395850|54713453|FG003|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
28056901|NCT00420212|54713466|FG000|Overall Study|Adverse Event|22|||
28056902|NCT00420212|54713467|FG001|Overall Study|Adverse Event|40|||
28056903|NCT00420212|54713468|FG002|Overall Study|Adverse Event|36|||
28056904|NCT00420212|54713466|FG000|Overall Study|Lost to Follow-up|9|||
28056905|NCT00420212|54713467|FG001|Overall Study|Lost to Follow-up|11|||
28056906|NCT00420212|54713468|FG002|Overall Study|Lost to Follow-up|11|||
28056907|NCT00420212|54713466|FG000|Overall Study|Withdrawal by Subject|31|||
28056908|NCT00420212|54713467|FG001|Overall Study|Withdrawal by Subject|22|||
28056909|NCT00420212|54713468|FG002|Overall Study|Withdrawal by Subject|19|||
28056910|NCT00420212|54713466|FG000|Overall Study|Physician Decision|4|||
28056911|NCT00420212|54713467|FG001|Overall Study|Physician Decision|4|||
28056912|NCT00420212|54713468|FG002|Overall Study|Physician Decision|3|||
28056913|NCT00420212|54713466|FG000|Overall Study|Protocol Violation|4|||
28056914|NCT00420212|54713467|FG001|Overall Study|Protocol Violation|4|||
28056915|NCT00420212|54713468|FG002|Overall Study|Protocol Violation|8|||
28056916|NCT00420212|54713466|FG000|Overall Study|Death|0|||
28056917|NCT00420212|54713467|FG001|Overall Study|Death|0|||
28056918|NCT00420212|54713468|FG002|Overall Study|Death|1|||
28056919|NCT00420212|54713466|FG000|Overall Study|Other-Unspecified|21|||
28056920|NCT00420212|54713467|FG001|Overall Study|Other-Unspecified|14|||
28056921|NCT00420212|54713468|FG002|Overall Study|Other-Unspecified|18|||
28056922|NCT00401258|54713479|FG000|Overall Study|Adverse Event|7|||
28056923|NCT00380874|54713485|FG000|Overall Study|Adverse Event|7|||
28056924|NCT00380874|54713486|FG001|Overall Study|Adverse Event|7|||
28056925|NCT00380874|54713485|FG000|Overall Study|Death|1|||
28056926|NCT00380874|54713486|FG001|Overall Study|Death|0|||
28056927|NCT00380874|54713485|FG000|Overall Study|Withdrawal by Subject|2|||
28056928|NCT00380874|54713486|FG001|Overall Study|Withdrawal by Subject|1|||
28056929|NCT00380874|54713485|FG000|Overall Study|Not related to study drug|3|||
28056930|NCT00380874|54713486|FG001|Overall Study|Not related to study drug|2|||
28056931|NCT00420056|54713492|FG000|Overall Study|Objective progression or relapse|17|||
28056932|NCT00411554|54713498|FG000|Overall Study|Adverse Event|2|||
28056933|NCT00411554|54713499|FG001|Overall Study|Adverse Event|4|||
28056934|NCT00411554|54713498|FG000|Overall Study|Lack of Efficacy|2|||
28056935|NCT00411554|54713499|FG001|Overall Study|Lack of Efficacy|5|||
28056936|NCT00411554|54713498|FG000|Overall Study|Withdrawal by Subject|3|||
28056937|NCT00411554|54713499|FG001|Overall Study|Withdrawal by Subject|0|||
28056938|NCT00411554|54713498|FG000|Overall Study|Patient Moved|1|||
28056939|NCT00411554|54713499|FG001|Overall Study|Patient Moved|0|||
28056940|NCT00400712|54713507|FG000|Overall Study|Death|1|||
28056941|NCT00400712|54713508|FG001|Overall Study|Death|0|||
28056942|NCT00400712|54713507|FG000|Overall Study|Withdrawal by Subject|11|||
28056943|NCT00400712|54713508|FG001|Overall Study|Withdrawal by Subject|12|||
28056944|NCT00400712|54713507|FG000|Overall Study|Physician Decision|5|||
28056945|NCT00400712|54713508|FG001|Overall Study|Physician Decision|4|||
27939949|NCT00943852|54596285|FG008|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
27939950|NCT00943852|54596286|FG009|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
28056946|NCT00380718|54713516|FG000|Overall Study|Adverse Event|1|||
28056947|NCT00380718|54713516|FG000|Overall Study|Death after 30-day post-therapy followup|17|||
28056948|NCT00380250|54713522|FG000|Overall Study|Withdrawal by Subject|39|||
28056949|NCT00380250|54713523|FG001|Overall Study|Withdrawal by Subject|28|||
28056950|NCT00380250|54713522|FG000|Overall Study|Adverse Event|20|||
28056951|NCT00380250|54713523|FG001|Overall Study|Adverse Event|9|||
28056952|NCT00380250|54713522|FG000|Overall Study|Lack of Efficacy|10|||
28056953|NCT00380250|54713523|FG001|Overall Study|Lack of Efficacy|8|||
28056954|NCT00380250|54713522|FG000|Overall Study|Protocol Violation|15|||
28056955|NCT00380250|54713523|FG001|Overall Study|Protocol Violation|5|||
28056956|NCT00380250|54713522|FG000|Overall Study|Lost to Follow-up|14|||
28056957|NCT00380250|54713523|FG001|Overall Study|Lost to Follow-up|5|||
28056958|NCT00380250|54713522|FG000|Overall Study|Physician Decision|1|||
28105723|NCT01369498|54763339|FG003|Overall Study|Lack of Efficacy|3|||
27813289|NCT01689519|54269782|FG000|Intent to Treat|Other|2|||
28056959|NCT00380250|54713523|FG001|Overall Study|Physician Decision|0|||
28056960|NCT00400400|54713531|FG000|Overall Study|Adverse Event|9|||
28056961|NCT00400400|54713532|FG001|Overall Study|Adverse Event|8|||
28056962|NCT00400400|54713531|FG000|Overall Study|Protocol Violation|2|||
28056963|NCT00400400|54713532|FG001|Overall Study|Protocol Violation|0|||
28056964|NCT00400400|54713531|FG000|Overall Study|Withdrawal by Subject|1|||
28056965|NCT00400400|54713532|FG001|Overall Study|Withdrawal by Subject|3|||
28056966|NCT00400400|54713531|FG000|Overall Study|Administrative Problem|1|||
28056967|NCT00400400|54713532|FG001|Overall Study|Administrative Problem|0|||
28056968|NCT00400400|54713531|FG000|Overall Study|Lost to Follow-up|0|||
28056969|NCT00400400|54713532|FG001|Overall Study|Lost to Follow-up|1|||
28056970|NCT00400400|54713531|FG000|Overall Study|Did not receive study drug|1|||
28056971|NCT00400400|54713532|FG001|Overall Study|Did not receive study drug|3|||
28056972|NCT00395694|54713540|FG000|Escalation Phase + Maintenance Phase|Adverse Event|1|||
28056973|NCT00395694|54713541|FG001|Escalation Phase + Maintenance Phase|Adverse Event|2|||
28056974|NCT00395694|54713540|FG000|Continuation Phase|Adverse Event|1|||
27813290|NCT01689519|54269783|FG001|Intent to Treat|Other|4|||
28056975|NCT00395694|54713541|FG001|Continuation Phase|Adverse Event|0|||
28056976|NCT00395694|54713540|FG000|Continuation Phase|Lack of Efficacy|12|||
28056977|NCT00395694|54713541|FG001|Continuation Phase|Lack of Efficacy|11|||
28056978|NCT00395694|54713540|FG000|Continuation Phase|Withdrawal Due to Wishes of Family|1|||
28056979|NCT00395694|54713541|FG001|Continuation Phase|Withdrawal Due to Wishes of Family|0|||
28056980|NCT00395694|54713540|FG000|Continuation Phase|Poor Compliance|1|||
28056981|NCT00395694|54713541|FG001|Continuation Phase|Poor Compliance|0|||
27813291|NCT01689519|54269782|FG000|Intent to Treat|Physician Decision|4|||
27848247|NCT01045161|54341216|FG002|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2|||
27848248|NCT01045161|54341214|FG000|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10|||
27848249|NCT01045161|54341215|FG001|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7|||
28056982|NCT00395694|54713540|FG000|Continuation Phase|Withdrawal by Subject|0|||
27813292|NCT01689519|54269783|FG001|Intent to Treat|Physician Decision|1|||
27813293|NCT01689519|54269782|FG000|Intent to Treat|Study terminated by Spon6sor|59|||
27813294|NCT01689519|54269783|FG001|Intent to Treat|Study terminated by Spon6sor|48|||
27813295|NCT01689519|54269782|FG000|Intent to Treat|Withdrawal by Subject|21|||
27813296|NCT01689519|54269783|FG001|Intent to Treat|Withdrawal by Subject|20|||
27813297|NCT01689519|54269782|FG000|Safety Population|Death|158|||
27813298|NCT01689519|54269783|FG001|Safety Population|Death|165|||
27813299|NCT01689519|54269782|FG000|Safety Population|Lost to Follow-up|4|||
27813300|NCT01689519|54269783|FG001|Safety Population|Lost to Follow-up|8|||
27813301|NCT01689519|54269782|FG000|Safety Population|Other|2|||
27813302|NCT01689519|54269783|FG001|Safety Population|Other|4|||
27813303|NCT01689519|54269782|FG000|Safety Population|Physician Decision|4|||
27813304|NCT01689519|54269783|FG001|Safety Population|Physician Decision|1|||
27813305|NCT01689519|54269782|FG000|Safety Population|Study Terminated By Sponsor|60|||
27813306|NCT01689519|54269783|FG001|Safety Population|Study Terminated By Sponsor|47|||
27813307|NCT01689519|54269782|FG000|Safety Population|Withdrawal by Subject|20|||
27813308|NCT01689519|54269783|FG001|Safety Population|Withdrawal by Subject|20|||
27813309|NCT01689363|54269789|FG000|Overall Study|Protocol Violation|0|||
27813310|NCT01689363|54269790|FG001|Overall Study|Protocol Violation|1|||
27813311|NCT01689363|54269791|FG002|Overall Study|Protocol Violation|0|||
27813312|NCT01689363|54269792|FG003|Overall Study|Protocol Violation|0|||
27813313|NCT01689363|54269793|FG004|Overall Study|Protocol Violation|0|||
27813314|NCT01689363|54269794|FG005|Overall Study|Protocol Violation|0|||
27813315|NCT01689363|54269795|FG006|Overall Study|Protocol Violation|0|||
27813316|NCT01689363|54269796|FG007|Overall Study|Protocol Violation|0|||
27813317|NCT01558635|54269812|FG000|Overall Study|Death|1|||
27813318|NCT01558635|54269812|FG000|Overall Study|Withdrawal by Subject|2|||
27813319|NCT01558635|54269812|FG000|Overall Study|Physician Decision|1|||
27813320|NCT01558635|54269812|FG000|Overall Study|Subject received other treatment|1|||
27813321|NCT01558635|54269812|FG000|Overall Study|Reveal XT was explanted|1|||
27813322|NCT00089986|54269826|FG000|Overall Study|Adverse Event|6|||
27813323|NCT00089986|54269827|FG001|Overall Study|Adverse Event|9|||
27813324|NCT00089986|54269828|FG002|Overall Study|Adverse Event|6|||
28056983|NCT00395694|54713541|FG001|Continuation Phase|Withdrawal by Subject|2|||
27813325|NCT00089986|54269826|FG000|Overall Study|Lost to Follow-up|3|||
27813326|NCT00089986|54269827|FG001|Overall Study|Lost to Follow-up|1|||
28056984|NCT00419744|54713553|FG000|Overall Study|Adverse Event|39|||
28056985|NCT00419744|54713554|FG001|Overall Study|Adverse Event|40|||
28056986|NCT00419744|54713555|FG002|Overall Study|Adverse Event|50|||
28056987|NCT00419744|54713553|FG000|Overall Study|Withdrawal by Subject|45|||
27813327|NCT00089986|54269828|FG002|Overall Study|Lost to Follow-up|1|||
27813328|NCT00089986|54269826|FG000|Overall Study|Protocol Violation|0|||
27813329|NCT00089986|54269827|FG001|Overall Study|Protocol Violation|1|||
27813330|NCT00089986|54269828|FG002|Overall Study|Protocol Violation|0|||
27813331|NCT00089986|54269826|FG000|Overall Study|Patient transferred to another hospital|2|||
27813332|NCT00089986|54269827|FG001|Overall Study|Patient transferred to another hospital|1|||
27813333|NCT00089986|54269828|FG002|Overall Study|Patient transferred to another hospital|0|||
27813334|NCT00089986|54269826|FG000|Overall Study|Subject withdrew but agreed follow up|1|||
27813335|NCT00089986|54269827|FG001|Overall Study|Subject withdrew but agreed follow up|2|||
27813336|NCT00089986|54269828|FG002|Overall Study|Subject withdrew but agreed follow up|0|||
27813337|NCT00089986|54269826|FG000|Overall Study|Hemohlobin stopping rule|0|||
27813338|NCT00089986|54269827|FG001|Overall Study|Hemohlobin stopping rule|1|||
27813339|NCT00089986|54269828|FG002|Overall Study|Hemohlobin stopping rule|0|||
27813340|NCT00089986|54269826|FG000|Overall Study|Investigator decision to withdrew|0|||
28056988|NCT00419744|54713554|FG001|Overall Study|Withdrawal by Subject|49|||
28056989|NCT00419744|54713555|FG002|Overall Study|Withdrawal by Subject|52|||
28056990|NCT00419744|54713553|FG000|Overall Study|Lost to Follow-up|8|||
28056991|NCT00419744|54713554|FG001|Overall Study|Lost to Follow-up|10|||
28056992|NCT00419744|54713555|FG002|Overall Study|Lost to Follow-up|6|||
28056993|NCT00419744|54713553|FG000|Overall Study|Protocol Violation|4|||
28056994|NCT00419744|54713554|FG001|Overall Study|Protocol Violation|7|||
28056995|NCT00419744|54713555|FG002|Overall Study|Protocol Violation|8|||
28056996|NCT00419744|54713553|FG000|Overall Study|Randomized in error|9|||
28056997|NCT00419744|54713554|FG001|Overall Study|Randomized in error|6|||
28056998|NCT00419744|54713555|FG002|Overall Study|Randomized in error|7|||
28056999|NCT00419744|54713553|FG000|Overall Study|Moving out of state|2|||
28057000|NCT00419744|54713554|FG001|Overall Study|Moving out of state|0|||
28057001|NCT00419744|54713555|FG002|Overall Study|Moving out of state|1|||
28057002|NCT00419744|54713553|FG000|Overall Study|Physician Decision|10|||
28057003|NCT00419744|54713554|FG001|Overall Study|Physician Decision|5|||
28057004|NCT00419744|54713555|FG002|Overall Study|Physician Decision|6|||
28057005|NCT00419744|54713553|FG000|Overall Study|Spirometry mouthpiece issues|0|||
28057006|NCT00419744|54713554|FG001|Overall Study|Spirometry mouthpiece issues|1|||
28057007|NCT00419744|54713555|FG002|Overall Study|Spirometry mouthpiece issues|2|||
28057008|NCT00419744|54713553|FG000|Overall Study|Incorrect medication kit dispensed|0|||
28057009|NCT00419744|54713554|FG001|Overall Study|Incorrect medication kit dispensed|0|||
28057010|NCT00419744|54713555|FG002|Overall Study|Incorrect medication kit dispensed|1|||
28057011|NCT00395538|54713566|FG000|Overall Study|Did not re-consent to revised protocol|1|||
28057012|NCT00395538|54713567|FG001|Overall Study|Did not re-consent to revised protocol|10|||
28057013|NCT00395538|54713568|FG002|Overall Study|Did not re-consent to revised protocol|0|||
28057014|NCT00395538|54713566|FG000|Overall Study|FDA partial hold on PTH|0|||
28057015|NCT00395538|54713567|FG001|Overall Study|FDA partial hold on PTH|0|||
28057016|NCT00395538|54713568|FG002|Overall Study|FDA partial hold on PTH|11|||
28057017|NCT00395538|54713566|FG000|Overall Study|Failed screening|0|||
28057018|NCT00395538|54713567|FG001|Overall Study|Failed screening|0|||
28057019|NCT00395538|54713568|FG002|Overall Study|Failed screening|4|||
28057020|NCT00395538|54713566|FG000|Overall Study|Switch to Natpara|0|||
28057021|NCT00395538|54713567|FG001|Overall Study|Switch to Natpara|0|||
27813341|NCT00089986|54269827|FG001|Overall Study|Investigator decision to withdrew|1|||
27813342|NCT00089986|54269828|FG002|Overall Study|Investigator decision to withdrew|0|||
27813343|NCT00089986|54269826|FG000|Overall Study|Enrollment in another study|0|||
27813344|NCT00089986|54269827|FG001|Overall Study|Enrollment in another study|1|||
27813345|NCT00089986|54269828|FG002|Overall Study|Enrollment in another study|0|||
27813346|NCT00089986|54269826|FG000|Overall Study|Family decision|0|||
27813347|NCT00089986|54269827|FG001|Overall Study|Family decision|1|||
28057022|NCT00395538|54713568|FG002|Overall Study|Switch to Natpara|3|||
27813348|NCT00089986|54269828|FG002|Overall Study|Family decision|0|||
27813349|NCT00089986|54269826|FG000|Overall Study|Do not resuscitate (DNR)|0|||
27813350|NCT00089986|54269827|FG001|Overall Study|Do not resuscitate (DNR)|0|||
27813351|NCT00089986|54269828|FG002|Overall Study|Do not resuscitate (DNR)|1|||
27813352|NCT00089986|54269826|FG000|Overall Study|Withdrawal by Subject|3|||
27939951|NCT00943852|54596277|FG000|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
27939952|NCT00943852|54596278|FG001|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
27939953|NCT00943852|54596279|FG002|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
28057023|NCT00395538|54713566|FG000|Overall Study|Adverse Event|1|||
28057024|NCT00395538|54713567|FG001|Overall Study|Adverse Event|0|||
28057025|NCT00395538|54713568|FG002|Overall Study|Adverse Event|2|||
28057026|NCT00395538|54713566|FG000|Overall Study|DXA or QCT z-score or t-score<-2|0|||
28057027|NCT00395538|54713567|FG001|Overall Study|DXA or QCT z-score or t-score<-2|2|||
28057028|NCT00395538|54713568|FG002|Overall Study|DXA or QCT z-score or t-score<-2|0|||
28057029|NCT00395538|54713566|FG000|Overall Study|Non-compliance with study protocol|0|||
28057030|NCT00395538|54713567|FG001|Overall Study|Non-compliance with study protocol|1|||
27813353|NCT00089986|54269827|FG001|Overall Study|Withdrawal by Subject|6|||
27813354|NCT00089986|54269828|FG002|Overall Study|Withdrawal by Subject|2|||
28057031|NCT00395538|54713568|FG002|Overall Study|Non-compliance with study protocol|0|||
27813355|NCT01689207|54269851|FG000|Overall Study|Adverse Event|0|||
28057032|NCT00395538|54713566|FG000|Overall Study|PTH resistance|0|||
28057033|NCT00395538|54713567|FG001|Overall Study|PTH resistance|0|||
28057034|NCT00395538|54713568|FG002|Overall Study|PTH resistance|1|||
28057035|NCT00395538|54713566|FG000|Overall Study|Pregnancy|1|||
28057036|NCT00395538|54713567|FG001|Overall Study|Pregnancy|0|||
28057037|NCT00395538|54713568|FG002|Overall Study|Pregnancy|0|||
28057038|NCT00395538|54713566|FG000|Overall Study|Partial recovery of parathyroid function|0|||
28057039|NCT00395538|54713567|FG001|Overall Study|Partial recovery of parathyroid function|0|||
28057040|NCT00395538|54713568|FG002|Overall Study|Partial recovery of parathyroid function|1|||
28057041|NCT00395538|54713566|FG000|Overall Study|Participant elected to discontinue|0|||
28057042|NCT00395538|54713567|FG001|Overall Study|Participant elected to discontinue|0|||
28057043|NCT00395538|54713568|FG002|Overall Study|Participant elected to discontinue|1|||
28057044|NCT00395460|54713578|FG000|Overall Study|Withdrawal by Subject|1|||
28057045|NCT00395460|54713579|FG001|Overall Study|Withdrawal by Subject|0|||
28057046|NCT00395304|54713585|FG000|Treatment Period 1|Withdrawal by Subject|0|||
28057047|NCT00395304|54713586|FG001|Treatment Period 1|Withdrawal by Subject|3|||
28057048|NCT00395304|54713587|FG002|Treatment Period 1|Withdrawal by Subject|0|||
28057049|NCT00395304|54713588|FG003|Treatment Period 1|Withdrawal by Subject|2|||
28057050|NCT00395304|54713589|FG004|Treatment Period 1|Withdrawal by Subject|1|||
28057051|NCT00395304|54713590|FG005|Treatment Period 1|Withdrawal by Subject|1|||
28057052|NCT00395304|54713585|FG000|Treatment Period 1|Lost to Follow-up|1|||
28057053|NCT00395304|54713586|FG001|Treatment Period 1|Lost to Follow-up|0|||
28057054|NCT00395304|54713587|FG002|Treatment Period 1|Lost to Follow-up|0|||
28057055|NCT00395304|54713588|FG003|Treatment Period 1|Lost to Follow-up|1|||
28057056|NCT00395304|54713589|FG004|Treatment Period 1|Lost to Follow-up|0|||
28057057|NCT00395304|54713590|FG005|Treatment Period 1|Lost to Follow-up|1|||
28057058|NCT00395304|54713585|FG000|Treatment Period 1|Physician Decision|0|||
28057059|NCT00395304|54713586|FG001|Treatment Period 1|Physician Decision|1|||
28057060|NCT00395304|54713587|FG002|Treatment Period 1|Physician Decision|0|||
28057061|NCT00395304|54713588|FG003|Treatment Period 1|Physician Decision|0|||
28057062|NCT00395304|54713589|FG004|Treatment Period 1|Physician Decision|0|||
28057063|NCT00395304|54713590|FG005|Treatment Period 1|Physician Decision|0|||
28057064|NCT00395304|54713585|FG000|Treatment Period 2|Withdrawal by Subject|0|||
28057065|NCT00395304|54713586|FG001|Treatment Period 2|Withdrawal by Subject|0|||
28057066|NCT00395304|54713587|FG002|Treatment Period 2|Withdrawal by Subject|0|||
28057067|NCT00395304|54713588|FG003|Treatment Period 2|Withdrawal by Subject|1|||
28057068|NCT00395304|54713589|FG004|Treatment Period 2|Withdrawal by Subject|0|||
28057069|NCT00395304|54713590|FG005|Treatment Period 2|Withdrawal by Subject|2|||
28057070|NCT00395304|54713585|FG000|Treatment Period 2|Lost to Follow-up|0|||
28057071|NCT00395304|54713586|FG001|Treatment Period 2|Lost to Follow-up|3|||
28057072|NCT00395304|54713587|FG002|Treatment Period 2|Lost to Follow-up|0|||
28057073|NCT00395304|54713588|FG003|Treatment Period 2|Lost to Follow-up|0|||
28057074|NCT00395304|54713589|FG004|Treatment Period 2|Lost to Follow-up|0|||
28057075|NCT00395304|54713590|FG005|Treatment Period 2|Lost to Follow-up|0|||
28057076|NCT00395304|54713585|FG000|Treatment Period 2|Physician Decision|0|||
28057077|NCT00395304|54713586|FG001|Treatment Period 2|Physician Decision|0|||
28057078|NCT00395304|54713587|FG002|Treatment Period 2|Physician Decision|1|||
28057079|NCT00395304|54713588|FG003|Treatment Period 2|Physician Decision|0|||
28057080|NCT00395304|54713589|FG004|Treatment Period 2|Physician Decision|0|||
28057081|NCT00395304|54713590|FG005|Treatment Period 2|Physician Decision|0|||
28057082|NCT00395304|54713585|FG000|Treatment Period 2|Other|0|||
27939954|NCT00943852|54596280|FG003|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
27939955|NCT00943852|54596281|FG004|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
27939956|NCT00943852|54596282|FG005|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
27939957|NCT00943852|54596283|FG006|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
27939958|NCT00943852|54596284|FG007|Washout Period After Period 4 Treatment|Not taking medication per protocol|1|||
27939959|NCT00943852|54596285|FG008|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
27939960|NCT00943852|54596286|FG009|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
27939961|NCT00943852|54596277|FG000|Washout Period After Period 4 Treatment|Trial stopped early|1|||
27939962|NCT00943852|54596278|FG001|Washout Period After Period 4 Treatment|Trial stopped early|0|||
27939963|NCT00943852|54596279|FG002|Washout Period After Period 4 Treatment|Trial stopped early|1|||
27939964|NCT00943852|54596280|FG003|Washout Period After Period 4 Treatment|Trial stopped early|1|||
27939965|NCT00943852|54596281|FG004|Washout Period After Period 4 Treatment|Trial stopped early|0|||
27939966|NCT00943852|54596282|FG005|Washout Period After Period 4 Treatment|Trial stopped early|0|||
27939967|NCT00943852|54596283|FG006|Washout Period After Period 4 Treatment|Trial stopped early|1|||
27939968|NCT00943852|54596284|FG007|Washout Period After Period 4 Treatment|Trial stopped early|0|||
28057083|NCT00395304|54713586|FG001|Treatment Period 2|Other|1|||
28057084|NCT00395304|54713587|FG002|Treatment Period 2|Other|0|||
28057085|NCT00395304|54713588|FG003|Treatment Period 2|Other|0|||
28057086|NCT00395304|54713589|FG004|Treatment Period 2|Other|0|||
28057087|NCT00395304|54713590|FG005|Treatment Period 2|Other|0|||
27813356|NCT01689207|54269852|FG001|Overall Study|Adverse Event|1|||
27813357|NCT01689207|54269853|FG002|Overall Study|Adverse Event|0|||
27813358|NCT01689207|54269854|FG003|Overall Study|Adverse Event|0|||
28057088|NCT00395304|54713585|FG000|Treatment Period 3|Withdrawal by Subject|0|||
27813359|NCT01689207|54269855|FG004|Overall Study|Adverse Event|2|||
27813360|NCT01689207|54269856|FG005|Overall Study|Adverse Event|1|||
27939969|NCT00943852|54596285|FG008|Washout Period After Period 4 Treatment|Trial stopped early|0|||
27939970|NCT00943852|54596286|FG009|Washout Period After Period 4 Treatment|Trial stopped early|0|||
27939971|NCT00952276|54596301|FG000|Overall Study|Withdrawal by Subject|1|||
27939972|NCT00952276|54596302|FG001|Overall Study|Withdrawal by Subject|0|||
27939973|NCT00952276|54596303|FG002|Overall Study|Withdrawal by Subject|0|||
27939974|NCT00952276|54596304|FG003|Overall Study|Withdrawal by Subject|1|||
27939975|NCT00952276|54596305|FG004|Overall Study|Withdrawal by Subject|0|||
28057089|NCT00395304|54713586|FG001|Treatment Period 3|Withdrawal by Subject|0|||
28057090|NCT00395304|54713587|FG002|Treatment Period 3|Withdrawal by Subject|0|||
28057091|NCT00395304|54713588|FG003|Treatment Period 3|Withdrawal by Subject|1|||
28057092|NCT00395304|54713589|FG004|Treatment Period 3|Withdrawal by Subject|0|||
28057093|NCT00395304|54713590|FG005|Treatment Period 3|Withdrawal by Subject|1|||
27939976|NCT00943384|54596317|FG000|Overall Study|Dispositioned prior to treatment|23|||
27939977|NCT00943384|54596317|FG000|Overall Study|Treated off protocol-protocol violation|5|||
27939978|NCT00943384|54596317|FG000|Overall Study|Lost to Follow-up|16|||
28057094|NCT00395304|54713585|FG000|Treatment Period 3|Lost to Follow-up|1|||
28057095|NCT00395304|54713586|FG001|Treatment Period 3|Lost to Follow-up|1|||
28057096|NCT00395304|54713587|FG002|Treatment Period 3|Lost to Follow-up|0|||
28057097|NCT00395304|54713588|FG003|Treatment Period 3|Lost to Follow-up|0|||
28057098|NCT00395304|54713589|FG004|Treatment Period 3|Lost to Follow-up|0|||
28057099|NCT00395304|54713590|FG005|Treatment Period 3|Lost to Follow-up|0|||
28057100|NCT00395304|54713585|FG000|Treatment Period 3|Physician Decision|0|||
28057101|NCT00395304|54713586|FG001|Treatment Period 3|Physician Decision|1|||
28057102|NCT00395304|54713587|FG002|Treatment Period 3|Physician Decision|0|||
27939979|NCT00943384|54596317|FG000|Overall Study|Withdrawal by Subject|5|||
27939980|NCT00943306|54596321|FG000|Overall Study|Physician Decision|1|||
27939981|NCT00943306|54596321|FG000|Overall Study|Death|1|||
27939982|NCT00943306|54596321|FG000|Overall Study|Sponsor decision due to non-compliance|1|||
27939983|NCT01198002|54596328|FG000|Treatment Period 1 (Weeks 0-52)|Adverse Event|18|||
27939984|NCT01198002|54596329|FG001|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
27939985|NCT01198002|54596330|FG002|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
27939986|NCT01198002|54596328|FG000|Treatment Period 1 (Weeks 0-52)|Death|2|||
27939987|NCT01198002|54596329|FG001|Treatment Period 1 (Weeks 0-52)|Death|0|||
27939988|NCT01198002|54596330|FG002|Treatment Period 1 (Weeks 0-52)|Death|1|||
27939989|NCT01198002|54596328|FG000|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10|||
27939990|NCT01198002|54596329|FG001|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9|||
27939991|NCT01198002|54596330|FG002|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6|||
28057103|NCT00395304|54713588|FG003|Treatment Period 3|Physician Decision|0|||
28057104|NCT00395304|54713589|FG004|Treatment Period 3|Physician Decision|0|||
28057105|NCT00395304|54713590|FG005|Treatment Period 3|Physician Decision|0|||
28057106|NCT00395304|54713585|FG000|Treatment Period 3|Other|0|||
28057107|NCT00395304|54713586|FG001|Treatment Period 3|Other|0|||
28057108|NCT00395304|54713587|FG002|Treatment Period 3|Other|0|||
27939992|NCT01198002|54596328|FG000|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1|||
27939993|NCT01198002|54596329|FG001|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
27939994|NCT01198002|54596330|FG002|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
27939995|NCT01198002|54596328|FG000|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
27939996|NCT01198002|54596329|FG001|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2|||
27939997|NCT01198002|54596330|FG002|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
27939998|NCT01198002|54596328|FG000|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16|||
27939999|NCT01198002|54596329|FG001|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21|||
27940000|NCT01198002|54596330|FG002|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12|||
27940001|NCT01198002|54596328|FG000|Treatment Period 1 (Weeks 0-52)|Physician Decision|1|||
27940002|NCT01198002|54596329|FG001|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
27813361|NCT01689207|54269857|FG006|Overall Study|Adverse Event|0|||
28057109|NCT00395304|54713588|FG003|Treatment Period 3|Other|1|||
28057110|NCT00395304|54713589|FG004|Treatment Period 3|Other|0|||
28057111|NCT00395304|54713590|FG005|Treatment Period 3|Other|0|||
28057112|NCT00395226|54713599|FG000|Overall Study|Adverse Event|4|||
27813362|NCT01689207|54269858|FG007|Overall Study|Adverse Event|0|||
28057113|NCT00395226|54713600|FG001|Overall Study|Adverse Event|3|||
28057114|NCT00395226|54713599|FG000|Overall Study|Withdrawal by Subject|0|||
28057115|NCT00395226|54713600|FG001|Overall Study|Withdrawal by Subject|1|||
27940003|NCT01198002|54596330|FG002|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
27940004|NCT01198002|54596328|FG000|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14|||
28057116|NCT00395226|54713599|FG000|Overall Study|Lost to Follow-up|0|||
28057117|NCT00395226|54713600|FG001|Overall Study|Lost to Follow-up|1|||
28057118|NCT00394914|54713608|FG000|Treatment Period|Adverse Event|0|||
28057119|NCT00394914|54713609|FG001|Treatment Period|Adverse Event|3|||
28057120|NCT00394914|54713610|FG002|Treatment Period|Adverse Event|1|||
28057121|NCT00394914|54713608|FG000|Treatment Period|Lost to Follow-up|0|||
28057122|NCT00394914|54713609|FG001|Treatment Period|Lost to Follow-up|1|||
28057123|NCT00394914|54713610|FG002|Treatment Period|Lost to Follow-up|0|||
28057124|NCT00394914|54713608|FG000|Treatment Period|Withdrawal by Subject|0|||
28057125|NCT00394914|54713609|FG001|Treatment Period|Withdrawal by Subject|2|||
28057126|NCT00394914|54713610|FG002|Treatment Period|Withdrawal by Subject|2|||
28057127|NCT00394914|54713608|FG000|Treatment Period|Noncompliance with protocol|0|||
28057128|NCT00394914|54713609|FG001|Treatment Period|Noncompliance with protocol|3|||
28057129|NCT00394914|54713610|FG002|Treatment Period|Noncompliance with protocol|2|||
28057130|NCT00394914|54713608|FG000|Treatment Period|Did not meet protocol eligibility|0|||
28057131|NCT00394914|54713609|FG001|Treatment Period|Did not meet protocol eligibility|1|||
28057132|NCT00394914|54713610|FG002|Treatment Period|Did not meet protocol eligibility|1|||
28057133|NCT00366444|54713618|FG000|Overall Study|Withdrawal by Subject|1|||
28057134|NCT00366444|54713619|FG001|Overall Study|Withdrawal by Subject|1|||
28057135|NCT00366444|54713618|FG000|Overall Study|Lack of Efficacy|0|||
28057136|NCT00366444|54713619|FG001|Overall Study|Lack of Efficacy|1|||
28057137|NCT00365976|54713627|FG000|Overall Study|Withdrawal by Subject|1|||
28057138|NCT00365976|54713628|FG001|Overall Study|Withdrawal by Subject|5|||
28057139|NCT00379236|54713636|FG000|Double-blind|Adverse Event|11|||
28057140|NCT00379236|54713637|FG001|Double-blind|Adverse Event|6|||
28057141|NCT00379236|54713638|FG002|Double-blind|Adverse Event|0|||
28057142|NCT00379236|54713636|FG000|Double-blind|Protocol Violation|3|||
28057143|NCT00379236|54713637|FG001|Double-blind|Protocol Violation|3|||
28057144|NCT00379236|54713638|FG002|Double-blind|Protocol Violation|0|||
28057145|NCT00379236|54713636|FG000|Double-blind|Withdrawal by Subject|12|||
28057146|NCT00379236|54713637|FG001|Double-blind|Withdrawal by Subject|13|||
28057147|NCT00379236|54713638|FG002|Double-blind|Withdrawal by Subject|0|||
28057148|NCT00379236|54713636|FG000|Double-blind|Lost to Follow-up|4|||
28057149|NCT00379236|54713637|FG001|Double-blind|Lost to Follow-up|3|||
28057150|NCT00379236|54713638|FG002|Double-blind|Lost to Follow-up|0|||
28057151|NCT00379236|54713636|FG000|Double-blind|Use of exclusionary medication|1|||
28057152|NCT00379236|54713637|FG001|Double-blind|Use of exclusionary medication|2|||
28057153|NCT00379236|54713638|FG002|Double-blind|Use of exclusionary medication|0|||
28057154|NCT00379236|54713636|FG000|Double-blind|Other|3|||
28057155|NCT00379236|54713637|FG001|Double-blind|Other|7|||
28057156|NCT00379236|54713638|FG002|Double-blind|Other|0|||
28057157|NCT00379236|54713636|FG000|Double-blind|Data could not be retrieved|2|||
28057158|NCT00379236|54713637|FG001|Double-blind|Data could not be retrieved|2|||
28057159|NCT00379236|54713638|FG002|Double-blind|Data could not be retrieved|0|||
28057160|NCT00379236|54713636|FG000|Open-label Extension|Adverse Event|0|||
28057161|NCT00379236|54713637|FG001|Open-label Extension|Adverse Event|0|||
28057162|NCT00379236|54713638|FG002|Open-label Extension|Adverse Event|13|||
28057163|NCT00379236|54713636|FG000|Open-label Extension|Protocol Violation|0|||
28057164|NCT00379236|54713637|FG001|Open-label Extension|Protocol Violation|0|||
28057165|NCT00379236|54713638|FG002|Open-label Extension|Protocol Violation|7|||
28057166|NCT00379236|54713636|FG000|Open-label Extension|Withdrawal by Subject|0|||
28057167|NCT00379236|54713637|FG001|Open-label Extension|Withdrawal by Subject|0|||
28057168|NCT00379236|54713638|FG002|Open-label Extension|Withdrawal by Subject|13|||
28057169|NCT00379236|54713636|FG000|Open-label Extension|Lost to Follow-up|0|||
28057170|NCT00379236|54713637|FG001|Open-label Extension|Lost to Follow-up|0|||
28057171|NCT00379236|54713638|FG002|Open-label Extension|Lost to Follow-up|12|||
28057172|NCT00379236|54713636|FG000|Open-label Extension|Use of exclusionary medication|0|||
28057173|NCT00379236|54713637|FG001|Open-label Extension|Use of exclusionary medication|0|||
28057174|NCT00379236|54713638|FG002|Open-label Extension|Use of exclusionary medication|3|||
28057175|NCT00379236|54713636|FG000|Open-label Extension|Other|0|||
28057176|NCT00379236|54713637|FG001|Open-label Extension|Other|0|||
28057177|NCT00379236|54713638|FG002|Open-label Extension|Other|7|||
28057178|NCT00379080|54713653|FG000|Overall Study|Withdrawal by Subject|0|||
28057179|NCT00379080|54713654|FG001|Overall Study|Withdrawal by Subject|4|||
28057180|NCT00379080|54713655|FG002|Overall Study|Withdrawal by Subject|0|||
28057181|NCT00378534|54713680|FG000|Overall Study|Participants did not receive transplant|3|||
27813363|NCT01689207|54269859|FG008|Overall Study|Adverse Event|1|||
27813364|NCT01689207|54269860|FG009|Overall Study|Adverse Event|0|||
27813365|NCT01689207|54269861|FG010|Overall Study|Adverse Event|0|||
28057182|NCT00378534|54713681|FG001|Overall Study|Participants did not receive transplant|0|||
28057183|NCT00377676|54713688|FG000|Overall Study|Adverse Event|498|||
28057184|NCT00377676|54713689|FG001|Overall Study|Adverse Event|107|||
28057185|NCT00377676|54713688|FG000|Overall Study|Protocol Violation|33|||
28057186|NCT00377676|54713689|FG001|Overall Study|Protocol Violation|27|||
28057187|NCT00377676|54713688|FG000|Overall Study|Death|5|||
28057188|NCT00377676|54713689|FG001|Overall Study|Death|2|||
28057189|NCT00377676|54713688|FG000|Overall Study|Withdrawal by Subject|187|||
28057190|NCT00377676|54713689|FG001|Overall Study|Withdrawal by Subject|72|||
28057191|NCT00377676|54713688|FG000|Overall Study|Lost to Follow-up|120|||
28057192|NCT00377676|54713689|FG001|Overall Study|Lost to Follow-up|56|||
28057193|NCT00377676|54713688|FG000|Overall Study|Other|118|||
28057194|NCT00377676|54713689|FG001|Overall Study|Other|58|||
28057195|NCT00377520|54713695|FG000|Overall Study|Ineligible (Prior radiation)|1|||
28057196|NCT00377364|54713701|FG000|Overall Study|Lost to Follow-up|1|||
28057197|NCT00377364|54713702|FG001|Overall Study|Lost to Follow-up|0|||
28057198|NCT00377364|54713701|FG000|Overall Study|Withdrawal by Subject|1|||
28057199|NCT00377364|54713702|FG001|Overall Study|Withdrawal by Subject|0|||
28057200|NCT03831282|54713710|FG000|Overall Study|Could not place sensor|1|||
28057201|NCT00365508|54713716|FG000|Overall Study|Lost to Follow-up|139|||
28057202|NCT00365508|54713717|FG001|Overall Study|Lost to Follow-up|154|||
28057203|NCT00365352|54713726|FG000|Overall Study|Adverse Event|6|||
28057204|NCT00365352|54713727|FG001|Overall Study|Adverse Event|7|||
28057205|NCT00365352|54713728|FG002|Overall Study|Adverse Event|8|||
28057206|NCT00365352|54713726|FG000|Overall Study|Participant Withdrew Consent|8|||
28057207|NCT00365352|54713727|FG001|Overall Study|Participant Withdrew Consent|3|||
28057208|NCT00365352|54713728|FG002|Overall Study|Participant Withdrew Consent|4|||
28057209|NCT00365352|54713726|FG000|Overall Study|Lack of Efficacy|3|||
28057210|NCT00365352|54713727|FG001|Overall Study|Lack of Efficacy|0|||
28057211|NCT00365352|54713728|FG002|Overall Study|Lack of Efficacy|0|||
28057212|NCT00365352|54713726|FG000|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
28057213|NCT00365352|54713727|FG001|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
28057214|NCT00365352|54713728|FG002|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2|||
28057215|NCT00365352|54713726|FG000|Overall Study|Non-Compliance (after Randomization)|1|||
28057216|NCT00365352|54713727|FG001|Overall Study|Non-Compliance (after Randomization)|0|||
28057217|NCT00365352|54713728|FG002|Overall Study|Non-Compliance (after Randomization)|1|||
28057218|NCT00365352|54713726|FG000|Overall Study|Lost to Follow-up|1|||
28057219|NCT00365352|54713727|FG001|Overall Study|Lost to Follow-up|1|||
28057220|NCT00365352|54713728|FG002|Overall Study|Lost to Follow-up|0|||
28057221|NCT00365352|54713726|FG000|Overall Study|Withdrawal of Participant by Sponsor|1|||
28057222|NCT00365352|54713727|FG001|Overall Study|Withdrawal of Participant by Sponsor|0|||
28057223|NCT00365352|54713728|FG002|Overall Study|Withdrawal of Participant by Sponsor|0|||
28057224|NCT00376506|54713741|FG000|Overall Study|Death|0|||
28057225|NCT00376506|54713742|FG001|Overall Study|Death|2|||
28057226|NCT00410384|54713754|FG000|Overall Study|Withdrawal by Subject|28|||
27813366|NCT00089284|54269896|FG000|Overall Study|Adverse event before starting treatment|0|||
27813367|NCT00089284|54269897|FG001|Overall Study|Adverse event before starting treatment|0|||
28057227|NCT00410384|54713755|FG001|Overall Study|Withdrawal by Subject|17|||
28057228|NCT00410384|54713756|FG002|Overall Study|Withdrawal by Subject|20|||
28057229|NCT00410384|54713754|FG000|Overall Study|Adverse Event|23|||
28057230|NCT00410384|54713755|FG001|Overall Study|Adverse Event|18|||
28057231|NCT00410384|54713756|FG002|Overall Study|Adverse Event|23|||
28057232|NCT00410384|54713754|FG000|Overall Study|Lack of Efficacy|20|||
28057233|NCT00410384|54713755|FG001|Overall Study|Lack of Efficacy|12|||
28057234|NCT00410384|54713756|FG002|Overall Study|Lack of Efficacy|17|||
28057235|NCT00410384|54713754|FG000|Overall Study|Lack of Compliance|2|||
28057236|NCT00410384|54713755|FG001|Overall Study|Lack of Compliance|2|||
28057237|NCT00410384|54713756|FG002|Overall Study|Lack of Compliance|2|||
28057238|NCT00410384|54713754|FG000|Overall Study|Lost to Follow-up|4|||
28057239|NCT00410384|54713755|FG001|Overall Study|Lost to Follow-up|6|||
28057240|NCT00410384|54713756|FG002|Overall Study|Lost to Follow-up|6|||
28057241|NCT00410384|54713754|FG000|Overall Study|Protocol Violation|6|||
28057242|NCT00410384|54713755|FG001|Overall Study|Protocol Violation|6|||
28057243|NCT00410384|54713756|FG002|Overall Study|Protocol Violation|6|||
28057244|NCT00410384|54713754|FG000|Overall Study|Physician Decision|3|||
28057245|NCT00410384|54713755|FG001|Overall Study|Physician Decision|3|||
28057246|NCT00410384|54713756|FG002|Overall Study|Physician Decision|4|||
28057247|NCT00410384|54713754|FG000|Overall Study|Other|3|||
28057248|NCT00410384|54713755|FG001|Overall Study|Other|8|||
28057249|NCT00410384|54713756|FG002|Overall Study|Other|4|||
28057250|NCT00370032|54713766|FG000|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0|||
28057251|NCT00370032|54713767|FG001|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1|||
28057252|NCT00370032|54713766|FG000|Washout Period|Withdrawal by Subject|0|||
28057253|NCT00370032|54713767|FG001|Washout Period|Withdrawal by Subject|1|||
28057254|NCT00370032|54713766|FG000|Washout Period|Lost to Follow-up|0|||
28057255|NCT00370032|54713767|FG001|Washout Period|Lost to Follow-up|1|||
28057256|NCT00370032|54713766|FG000|Washout Period|Adverse Event|1|||
28057257|NCT00370032|54713767|FG001|Washout Period|Adverse Event|0|||
28057258|NCT00370032|54713766|FG000|Follow-up Period|Withdrawal by Subject|1|||
28057259|NCT00370032|54713767|FG001|Follow-up Period|Withdrawal by Subject|0|||
28057260|NCT00410072|54713784|FG000|Day 1 to Week 48|Adverse Event|1|||
28057261|NCT00410072|54713785|FG001|Day 1 to Week 48|Adverse Event|2|||
28057262|NCT00410072|54713784|FG000|Day 1 to Week 48|Lost to Follow-up|5|||
28057263|NCT00410072|54713785|FG001|Day 1 to Week 48|Lost to Follow-up|2|||
28057264|NCT00410072|54713784|FG000|Day 1 to Week 48|Other|0|||
28057265|NCT00410072|54713785|FG001|Day 1 to Week 48|Other|1|||
28057266|NCT00410072|54713784|FG000|Day 1 to Week 48|poor compliance/noncompliance|0|||
28057267|NCT00410072|54713785|FG001|Day 1 to Week 48|poor compliance/noncompliance|3|||
28057268|NCT00410072|54713784|FG000|Day 1 to Week 48|Pregnancy|0|||
28057269|NCT00410072|54713785|FG001|Day 1 to Week 48|Pregnancy|2|||
28057270|NCT00410072|54713784|FG000|Day 1 to Week 48|Withdrawal by Subject|0|||
28057271|NCT00410072|54713785|FG001|Day 1 to Week 48|Withdrawal by Subject|2|||
28057272|NCT00410072|54713784|FG000|After Week 48 to Week 96|Adverse Event|1|||
28057273|NCT00410072|54713785|FG001|After Week 48 to Week 96|Adverse Event|2|||
28057274|NCT00410072|54713784|FG000|After Week 48 to Week 96|Death|0|||
28057275|NCT00410072|54713785|FG001|After Week 48 to Week 96|Death|1|||
28057276|NCT00410072|54713784|FG000|After Week 48 to Week 96|Lack of Efficacy|1|||
28057277|NCT00410072|54713785|FG001|After Week 48 to Week 96|Lack of Efficacy|0|||
28057278|NCT00410072|54713784|FG000|After Week 48 to Week 96|Lost to Follow-up|2|||
28057279|NCT00410072|54713785|FG001|After Week 48 to Week 96|Lost to Follow-up|4|||
28057280|NCT00410072|54713784|FG000|After Week 48 to Week 96|Other|2|||
28057281|NCT00410072|54713785|FG001|After Week 48 to Week 96|Other|0|||
28057282|NCT00410072|54713784|FG000|After Week 48 to Week 96|Poor compliance/noncompliance|0|||
28057283|NCT00410072|54713785|FG001|After Week 48 to Week 96|Poor compliance/noncompliance|1|||
28057284|NCT00410072|54713784|FG000|After Week 48 to Week 96|Pregnancy|0|||
28057285|NCT00410072|54713785|FG001|After Week 48 to Week 96|Pregnancy|2|||
27813368|NCT00089284|54269898|FG002|Overall Study|Adverse event before starting treatment|0|||
27813369|NCT00089284|54269899|FG003|Overall Study|Adverse event before starting treatment|0|||
27813370|NCT00089284|54269900|FG004|Overall Study|Adverse event before starting treatment|0|||
27813371|NCT00089284|54269901|FG005|Overall Study|Adverse event before starting treatment|0|||
27813372|NCT00089284|54269902|FG006|Overall Study|Adverse event before starting treatment|1|||
27813373|NCT01688973|54269926|FG000|Overall Study|Ineligible|2|||
27813374|NCT01688973|54269927|FG001|Overall Study|Ineligible|3|||
27813375|NCT00087646|54269938|FG000|Overall Study|Adverse Event|37|||
27813376|NCT00087646|54269939|FG001|Overall Study|Adverse Event|6|||
27813377|NCT00087646|54269940|FG002|Overall Study|Adverse Event|18|||
27813378|NCT00087646|54269941|FG003|Overall Study|Adverse Event|20|||
27813379|NCT00087646|54269938|FG000|Overall Study|Death|0|||
28105724|NCT01369498|54763336|FG000|Overall Study|Adverse Event|1|||
28105725|NCT01369498|54763337|FG001|Overall Study|Adverse Event|2|||
28105726|NCT01369498|54763338|FG002|Overall Study|Adverse Event|0|||
27813380|NCT00087646|54269939|FG001|Overall Study|Death|1|||
27813381|NCT00087646|54269940|FG002|Overall Study|Death|0|||
27813382|NCT00087646|54269941|FG003|Overall Study|Death|0|||
27813383|NCT00087646|54269938|FG000|Overall Study|Withdrawal by Subject|6|||
27813384|NCT00087646|54269939|FG001|Overall Study|Withdrawal by Subject|1|||
27813385|NCT00087646|54269940|FG002|Overall Study|Withdrawal by Subject|2|||
27813386|NCT00087646|54269941|FG003|Overall Study|Withdrawal by Subject|2|||
27940005|NCT01198002|54596329|FG001|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
28057286|NCT00410072|54713784|FG000|After Week 48 to Week 96|Withdrawal by Subject|0|||
27813387|NCT00087646|54269938|FG000|Overall Study|Insufficient therapeutic response|64|||
27813388|NCT00087646|54269939|FG001|Overall Study|Insufficient therapeutic response|24|||
28057287|NCT00410072|54713785|FG001|After Week 48 to Week 96|Withdrawal by Subject|1|||
27813389|NCT00087646|54269940|FG002|Overall Study|Insufficient therapeutic response|38|||
27813390|NCT00087646|54269941|FG003|Overall Study|Insufficient therapeutic response|51|||
27813391|NCT00087646|54269938|FG000|Overall Study|Refused Treatment/Did Not Cooperate|13|||
27813392|NCT00087646|54269939|FG001|Overall Study|Refused Treatment/Did Not Cooperate|6|||
28057288|NCT00409838|54713793|FG000|Short-term Period|Adverse Event|0|||
28057289|NCT00409838|54713794|FG001|Short-term Period|Adverse Event|1|||
28057290|NCT00409838|54713793|FG000|Short-term Period|Lost to Follow-up|0|||
27813393|NCT00087646|54269940|FG002|Overall Study|Refused Treatment/Did Not Cooperate|4|||
27813394|NCT00087646|54269941|FG003|Overall Study|Refused Treatment/Did Not Cooperate|5|||
27813395|NCT00087646|54269938|FG000|Overall Study|Failure to Return|5|||
27813396|NCT00087646|54269939|FG001|Overall Study|Failure to Return|2|||
27813397|NCT00087646|54269940|FG002|Overall Study|Failure to Return|2|||
27813398|NCT00087646|54269941|FG003|Overall Study|Failure to Return|3|||
27813399|NCT00087646|54269938|FG000|Overall Study|Administrative/Other|6|||
27813400|NCT00087646|54269939|FG001|Overall Study|Administrative/Other|1|||
27813401|NCT00087646|54269940|FG002|Overall Study|Administrative/Other|1|||
27813402|NCT00087646|54269941|FG003|Overall Study|Administrative/Other|2|||
27813403|NCT00087646|54269938|FG000|Overall Study|Other Protocol Violation|3|||
27813404|NCT00087646|54269939|FG001|Overall Study|Other Protocol Violation|1|||
27813405|NCT00087646|54269940|FG002|Overall Study|Other Protocol Violation|0|||
27813406|NCT00087646|54269941|FG003|Overall Study|Other Protocol Violation|0|||
27813407|NCT00087646|54269938|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
27813408|NCT00087646|54269939|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
27813409|NCT00087646|54269940|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
27813410|NCT00087646|54269941|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
27813411|NCT00087568|54269958|FG000|Overall Study|Adverse Event|4|||
27813412|NCT00087568|54269959|FG001|Overall Study|Adverse Event|0|||
27813413|NCT00087568|54269958|FG000|Overall Study|Withdrawal by Subject|1|||
27813414|NCT00087568|54269959|FG001|Overall Study|Withdrawal by Subject|1|||
27813415|NCT00087568|54269958|FG000|Overall Study|Lost to Follow-up|1|||
27813416|NCT00087568|54269959|FG001|Overall Study|Lost to Follow-up|0|||
27813417|NCT00087568|54269958|FG000|Overall Study|Lack of Efficacy|24|||
27813418|NCT00087568|54269959|FG001|Overall Study|Lack of Efficacy|1|||
27813419|NCT00085540|54269967|FG000|Overall Study|Withdrawal by Subject|0|||
27813420|NCT00085540|54269968|FG001|Overall Study|Withdrawal by Subject|1|||
27813421|NCT00085540|54269967|FG000|Overall Study|Protocol Violation|0|||
27813422|NCT00085540|54269968|FG001|Overall Study|Protocol Violation|1|||
27813423|NCT01688739|54269984|FG000|Overall Study|Administrative Decision|1|||
27813424|NCT01688739|54269985|FG001|Overall Study|Administrative Decision|0|||
27813425|NCT01688739|54269986|FG002|Overall Study|Administrative Decision|0|||
27813426|NCT01688739|54269987|FG003|Overall Study|Administrative Decision|0|||
27813427|NCT01688739|54269988|FG004|Overall Study|Administrative Decision|0|||
27813428|NCT01688739|54269989|FG005|Overall Study|Administrative Decision|0|||
27813429|NCT01688739|54269990|FG006|Overall Study|Administrative Decision|0|||
27813430|NCT01688739|54269991|FG007|Overall Study|Administrative Decision|0|||
27813431|NCT01688739|54269992|FG008|Overall Study|Administrative Decision|0|||
27813432|NCT01688739|54269993|FG009|Overall Study|Administrative Decision|0|||
27813433|NCT00084838|54270023|FG000|Overall Study|Death|1|||
27813434|NCT00084838|54270023|FG000|Overall Study|Adverse Event|2|||
27813435|NCT00084838|54270023|FG000|Overall Study|Withdrawal by Subject|1|||
27813436|NCT00084838|54270023|FG000|Overall Study|Progressive Disease|4|||
27813437|NCT00084838|54270023|FG000|Overall Study|Pt Non-Compliance|1|||
27813438|NCT00084838|54270023|FG000|Overall Study|Ineligible|4|||
27813439|NCT01558089|54270029|FG000|Overall Study|Adverse Event|1|||
27813440|NCT01558089|54270029|FG000|Overall Study|Lack of Efficacy|1|||
27813441|NCT01558089|54270029|FG000|Overall Study|Lost to Follow-up|5|||
27813442|NCT01558089|54270029|FG000|Overall Study|Withdrawal by Subject|6|||
27813443|NCT01581021|54270035|FG000|Overall Study|Lost to Follow-up|4|||
27813444|NCT01581021|54270036|FG001|Overall Study|Lost to Follow-up|6|||
27813445|NCT01581021|54270035|FG000|Overall Study|More than 2 hooks in thoracic|3|||
27813446|NCT01581021|54270036|FG001|Overall Study|More than 2 hooks in thoracic|0|||
27813447|NCT01581021|54270035|FG000|Overall Study|Neuromuscular|2|||
27813448|NCT01581021|54270036|FG001|Overall Study|Neuromuscular|1|||
27813449|NCT01581021|54270035|FG000|Overall Study|Not Randomized|1|||
27813450|NCT01581021|54270036|FG001|Overall Study|Not Randomized|2|||
27813451|NCT01581021|54270035|FG000|Overall Study|Lenke 6 Classification|0|||
27813452|NCT01581021|54270036|FG001|Overall Study|Lenke 6 Classification|1|||
27813453|NCT01581021|54270035|FG000|Overall Study|Lack of Efficacy|0|||
27813454|NCT01581021|54270036|FG001|Overall Study|Lack of Efficacy|1|||
27813455|NCT00084682|54270042|FG000|Overall Study|Withdrawal by Subject|1|||
27813456|NCT01556997|54270050|FG000|Overall Study|Adverse Event|10|||
27813457|NCT01556997|54270051|FG001|Overall Study|Adverse Event|12|||
27813458|NCT01556997|54270052|FG002|Overall Study|Adverse Event|12|||
27813459|NCT01556997|54270050|FG000|Overall Study|Lost to Follow-up|6|||
27813460|NCT01556997|54270051|FG001|Overall Study|Lost to Follow-up|6|||
27813461|NCT01556997|54270052|FG002|Overall Study|Lost to Follow-up|4|||
27813462|NCT01556997|54270050|FG000|Overall Study|Physician Decision|1|||
27813463|NCT01556997|54270051|FG001|Overall Study|Physician Decision|1|||
27813464|NCT01556997|54270052|FG002|Overall Study|Physician Decision|1|||
27813465|NCT01556997|54270050|FG000|Overall Study|Withdrawal by Subject|7|||
27813466|NCT01556997|54270051|FG001|Overall Study|Withdrawal by Subject|6|||
27813467|NCT01556997|54270052|FG002|Overall Study|Withdrawal by Subject|8|||
27813468|NCT01556997|54270050|FG000|Overall Study|Other|2|||
27813469|NCT01556997|54270051|FG001|Overall Study|Other|3|||
27813470|NCT01556997|54270052|FG002|Overall Study|Other|7|||
27813471|NCT00082888|54270063|FG000|Overall Study|Ineligible|1|||
27813472|NCT00082888|54270064|FG001|Overall Study|Ineligible|0|||
27813473|NCT00082888|54270065|FG002|Overall Study|Ineligible|0|||
27813474|NCT00082810|54270074|FG000|Overall Study|Adverse Event|3|||
27813475|NCT00082810|54270074|FG000|Overall Study|Progressive disease|24|||
27813476|NCT00082810|54270074|FG000|Overall Study|Withdrawal by Subject|4|||
27813477|NCT01577745|54270085|FG000|Overall Study|Withdrawal by Subject|0|||
27813478|NCT01577745|54270086|FG001|Overall Study|Withdrawal by Subject|1|||
27813479|NCT01577745|54270087|FG002|Overall Study|Withdrawal by Subject|0|||
27813480|NCT01577745|54270088|FG003|Overall Study|Withdrawal by Subject|3|||
27813481|NCT01577745|54270089|FG004|Overall Study|Withdrawal by Subject|2|||
27813482|NCT01577745|54270090|FG005|Overall Study|Withdrawal by Subject|0|||
27813483|NCT01577745|54270085|FG000|Overall Study|Death|3|||
27813484|NCT01577745|54270086|FG001|Overall Study|Death|2|||
27813485|NCT01577745|54270087|FG002|Overall Study|Death|2|||
27813486|NCT01577745|54270088|FG003|Overall Study|Death|1|||
27813487|NCT01577745|54270089|FG004|Overall Study|Death|1|||
27813488|NCT01577745|54270090|FG005|Overall Study|Death|3|||
27813489|NCT01577745|54270085|FG000|Overall Study|Physician Decision|0|||
27813490|NCT01577745|54270086|FG001|Overall Study|Physician Decision|0|||
27813491|NCT01577745|54270087|FG002|Overall Study|Physician Decision|0|||
27813492|NCT01577745|54270088|FG003|Overall Study|Physician Decision|1|||
27813493|NCT01577745|54270089|FG004|Overall Study|Physician Decision|1|||
27813494|NCT01577745|54270090|FG005|Overall Study|Physician Decision|0|||
27813495|NCT01577745|54270085|FG000|Overall Study|Lost to Follow-up|0|||
27813496|NCT01577745|54270086|FG001|Overall Study|Lost to Follow-up|0|||
27813497|NCT01577745|54270087|FG002|Overall Study|Lost to Follow-up|0|||
27813498|NCT01577745|54270088|FG003|Overall Study|Lost to Follow-up|0|||
27813499|NCT01577745|54270089|FG004|Overall Study|Lost to Follow-up|0|||
27813500|NCT01577745|54270090|FG005|Overall Study|Lost to Follow-up|1|||
27813501|NCT01577745|54270085|FG000|Overall Study|Alternative Therapy|0|||
27813502|NCT01577745|54270086|FG001|Overall Study|Alternative Therapy|0|||
27813503|NCT01577745|54270087|FG002|Overall Study|Alternative Therapy|0|||
27813504|NCT01577745|54270088|FG003|Overall Study|Alternative Therapy|1|||
27813505|NCT01577745|54270089|FG004|Overall Study|Alternative Therapy|1|||
27813506|NCT01577745|54270090|FG005|Overall Study|Alternative Therapy|0|||
27813507|NCT01688037|54270112|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
27813508|NCT01688037|54270113|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
27813509|NCT01688037|54270114|FG002|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
27813510|NCT01688037|54270112|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|1|||
27813511|NCT01688037|54270113|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
27813512|NCT01688037|54270114|FG002|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
27813513|NCT01688037|54270112|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4|||
27813514|NCT01688037|54270113|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0|||
27813515|NCT01688037|54270114|FG002|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
27813516|NCT01688037|54270112|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
27813517|NCT01688037|54270113|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
27813518|NCT01688037|54270114|FG002|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
27813519|NCT01688037|54270112|FG000|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
27813520|NCT01688037|54270113|FG001|Double-Blind Period (Week 0 to 6)|Physician Decision|1|||
27813521|NCT01688037|54270114|FG002|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
27813522|NCT01688037|54270112|FG000|Open-Label Period (Week 6 to 12)|Adverse Event|4|||
27813523|NCT01688037|54270113|FG001|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
27813524|NCT01688037|54270114|FG002|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
27813525|NCT01688037|54270112|FG000|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
27813526|NCT01688037|54270113|FG001|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
27813527|NCT01688037|54270114|FG002|Open-Label Period (Week 6 to 12)|Non-compliance|2|||
27813528|NCT01688037|54270112|FG000|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1|||
27813529|NCT01688037|54270113|FG001|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2|||
27813530|NCT01688037|54270114|FG002|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0|||
27813531|NCT01688037|54270112|FG000|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
27813532|NCT01688037|54270113|FG001|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
27813533|NCT01688037|54270114|FG002|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1|||
27813534|NCT01688037|54270112|FG000|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
27813535|NCT01688037|54270113|FG001|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1|||
27813536|NCT01688037|54270114|FG002|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
28057291|NCT00409838|54713794|FG001|Short-term Period|Lost to Follow-up|1|||
27813537|NCT01610336|54270147|FG000|Overall Study|Progressive Disease|4|||
27813538|NCT01610336|54270148|FG001|Overall Study|Progressive Disease|6|||
27813539|NCT01610336|54270149|FG002|Overall Study|Progressive Disease|6|||
27813540|NCT01610336|54270150|FG003|Overall Study|Progressive Disease|5|||
27813541|NCT01610336|54270151|FG004|Overall Study|Progressive Disease|3|||
27813542|NCT01610336|54270152|FG005|Overall Study|Progressive Disease|10|||
27813543|NCT01610336|54270153|FG006|Overall Study|Progressive Disease|1|||
27813544|NCT01610336|54270154|FG007|Overall Study|Progressive Disease|6|||
27813545|NCT01610336|54270155|FG008|Overall Study|Progressive Disease|6|||
27813546|NCT01610336|54270156|FG009|Overall Study|Progressive Disease|40|||
28057292|NCT00409838|54713793|FG000|Short-term Period|Withdrawal by Subject|2|||
28057293|NCT00409838|54713794|FG001|Short-term Period|Withdrawal by Subject|3|||
28057294|NCT00409838|54713793|FG000|Short-term Period|Never Treated|1|||
28057295|NCT00409838|54713794|FG001|Short-term Period|Never Treated|0|||
28057296|NCT00409838|54713793|FG000|Long-term Extension Period|Adverse Event|10|||
28057297|NCT00409838|54713794|FG001|Long-term Extension Period|Adverse Event|0|||
28057298|NCT00409838|54713793|FG000|Long-term Extension Period|Death|1|||
28057299|NCT00409838|54713794|FG001|Long-term Extension Period|Death|0|||
28057300|NCT00409838|54713793|FG000|Long-term Extension Period|Lack of Efficacy|2|||
28057301|NCT00409838|54713794|FG001|Long-term Extension Period|Lack of Efficacy|0|||
28057302|NCT00409838|54713793|FG000|Long-term Extension Period|Withdrawal by Subject|3|||
28057303|NCT00409838|54713794|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
28057304|NCT00409838|54713793|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
28057305|NCT00409838|54713794|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
28057306|NCT00409838|54713793|FG000|Long-term Extension Period|Pregnancy|1|||
28057307|NCT00409838|54713794|FG001|Long-term Extension Period|Pregnancy|0|||
28057308|NCT00399542|54713819|FG000|Overall Study|Adverse Event|18|||
28057309|NCT00399542|54713820|FG001|Overall Study|Adverse Event|15|||
28057310|NCT00399542|54713819|FG000|Overall Study|Protocol Violation|13|||
28057311|NCT00399542|54713820|FG001|Overall Study|Protocol Violation|3|||
28057312|NCT00399542|54713819|FG000|Overall Study|Withdrawal by Subject|28|||
28057313|NCT00399542|54713820|FG001|Overall Study|Withdrawal by Subject|10|||
28057314|NCT00399542|54713819|FG000|Overall Study|Lack of Efficacy|18|||
28057315|NCT00399542|54713820|FG001|Overall Study|Lack of Efficacy|8|||
28057316|NCT00399542|54713819|FG000|Overall Study|Lost to Follow-up|6|||
28057317|NCT00399542|54713820|FG001|Overall Study|Lost to Follow-up|6|||
28057318|NCT00399542|54713819|FG000|Overall Study|Other|1|||
28057319|NCT00399542|54713820|FG001|Overall Study|Other|0|||
27813547|NCT01610336|54270157|FG010|Overall Study|Progressive Disease|36|||
27813548|NCT01610336|54270147|FG000|Overall Study|Adverse Event|0|||
27813549|NCT01610336|54270148|FG001|Overall Study|Adverse Event|0|||
27813550|NCT01610336|54270149|FG002|Overall Study|Adverse Event|0|||
27813551|NCT01610336|54270150|FG003|Overall Study|Adverse Event|1|||
27813552|NCT01610336|54270151|FG004|Overall Study|Adverse Event|1|||
27813553|NCT01610336|54270152|FG005|Overall Study|Adverse Event|1|||
27813554|NCT01610336|54270153|FG006|Overall Study|Adverse Event|0|||
27813555|NCT01610336|54270154|FG007|Overall Study|Adverse Event|0|||
27813556|NCT01610336|54270155|FG008|Overall Study|Adverse Event|2|||
27813557|NCT01610336|54270156|FG009|Overall Study|Adverse Event|8|||
27813558|NCT01610336|54270157|FG010|Overall Study|Adverse Event|6|||
27813559|NCT01610336|54270147|FG000|Overall Study|Subject/Guardian decision|1|||
27813560|NCT01610336|54270148|FG001|Overall Study|Subject/Guardian decision|1|||
28057320|NCT00399542|54713819|FG000|Overall Study|Physician Decision|0|||
28057321|NCT00399542|54713820|FG001|Overall Study|Physician Decision|1|||
28057322|NCT00409682|54713829|FG000|Open-label Induction Period|Adverse Event|1|||
28057323|NCT00409682|54713830|FG001|Open-label Induction Period|Adverse Event|0|||
28057324|NCT00409682|54713831|FG002|Open-label Induction Period|Adverse Event|0|||
28057325|NCT00409682|54713829|FG000|Open-label Induction Period|Lack of Efficacy|1|||
28057326|NCT00409682|54713830|FG001|Open-label Induction Period|Lack of Efficacy|0|||
28057327|NCT00409682|54713831|FG002|Open-label Induction Period|Lack of Efficacy|0|||
28057328|NCT00409682|54713829|FG000|Open-label Induction Period|Protocol Violation|1|||
28057329|NCT00409682|54713830|FG001|Open-label Induction Period|Protocol Violation|0|||
28057330|NCT00409682|54713831|FG002|Open-label Induction Period|Protocol Violation|0|||
28057331|NCT00409682|54713829|FG000|Open-label Induction Period|Subject did not satisfy entry criteria|1|||
27813561|NCT01610336|54270149|FG002|Overall Study|Subject/Guardian decision|0|||
27813562|NCT01610336|54270150|FG003|Overall Study|Subject/Guardian decision|1|||
27813563|NCT01610336|54270151|FG004|Overall Study|Subject/Guardian decision|0|||
27813564|NCT01610336|54270152|FG005|Overall Study|Subject/Guardian decision|0|||
27813565|NCT01610336|54270153|FG006|Overall Study|Subject/Guardian decision|0|||
27813566|NCT01610336|54270154|FG007|Overall Study|Subject/Guardian decision|1|||
27813567|NCT01610336|54270155|FG008|Overall Study|Subject/Guardian decision|0|||
28057332|NCT00409682|54713830|FG001|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
28077012|NCT00094458|54731727|FG005|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
27813568|NCT01610336|54270156|FG009|Overall Study|Subject/Guardian decision|2|||
27813569|NCT01610336|54270157|FG010|Overall Study|Subject/Guardian decision|2|||
27813570|NCT01610336|54270147|FG000|Overall Study|Death|0|||
27813571|NCT01610336|54270148|FG001|Overall Study|Death|0|||
27813572|NCT01610336|54270149|FG002|Overall Study|Death|0|||
27813573|NCT01610336|54270150|FG003|Overall Study|Death|0|||
27813574|NCT01610336|54270151|FG004|Overall Study|Death|0|||
27813575|NCT01610336|54270152|FG005|Overall Study|Death|1|||
27813576|NCT01610336|54270153|FG006|Overall Study|Death|3|||
27813577|NCT01610336|54270154|FG007|Overall Study|Death|0|||
27813578|NCT01610336|54270155|FG008|Overall Study|Death|0|||
27813579|NCT01610336|54270156|FG009|Overall Study|Death|1|||
27813580|NCT01610336|54270157|FG010|Overall Study|Death|2|||
27813581|NCT01610336|54270147|FG000|Overall Study|Non-Compliance with study treatment|0|||
27813582|NCT01610336|54270148|FG001|Overall Study|Non-Compliance with study treatment|0|||
27813583|NCT01610336|54270149|FG002|Overall Study|Non-Compliance with study treatment|0|||
27813584|NCT01610336|54270150|FG003|Overall Study|Non-Compliance with study treatment|0|||
27813585|NCT01610336|54270151|FG004|Overall Study|Non-Compliance with study treatment|0|||
27813586|NCT01610336|54270152|FG005|Overall Study|Non-Compliance with study treatment|0|||
27813587|NCT01610336|54270153|FG006|Overall Study|Non-Compliance with study treatment|0|||
27813588|NCT01610336|54270154|FG007|Overall Study|Non-Compliance with study treatment|0|||
27813589|NCT01610336|54270155|FG008|Overall Study|Non-Compliance with study treatment|0|||
27813590|NCT01610336|54270156|FG009|Overall Study|Non-Compliance with study treatment|1|||
27813591|NCT01610336|54270157|FG010|Overall Study|Non-Compliance with study treatment|0|||
27813592|NCT01610336|54270147|FG000|Overall Study|Physician Decision|0|||
27813593|NCT01610336|54270148|FG001|Overall Study|Physician Decision|0|||
27813594|NCT01610336|54270149|FG002|Overall Study|Physician Decision|0|||
27813595|NCT01610336|54270150|FG003|Overall Study|Physician Decision|0|||
27813596|NCT01610336|54270151|FG004|Overall Study|Physician Decision|0|||
27813597|NCT01610336|54270152|FG005|Overall Study|Physician Decision|0|||
27813598|NCT01610336|54270153|FG006|Overall Study|Physician Decision|1|||
27813599|NCT01610336|54270154|FG007|Overall Study|Physician Decision|0|||
27813600|NCT01610336|54270155|FG008|Overall Study|Physician Decision|0|||
27813601|NCT01610336|54270156|FG009|Overall Study|Physician Decision|0|||
27813602|NCT01610336|54270157|FG010|Overall Study|Physician Decision|0|||
27813603|NCT01610336|54270147|FG000|Overall Study|Protocol Deviation|0|||
27813604|NCT01610336|54270148|FG001|Overall Study|Protocol Deviation|0|||
27813605|NCT01610336|54270149|FG002|Overall Study|Protocol Deviation|0|||
27813606|NCT01610336|54270150|FG003|Overall Study|Protocol Deviation|0|||
27813607|NCT01610336|54270151|FG004|Overall Study|Protocol Deviation|0|||
27813608|NCT01610336|54270152|FG005|Overall Study|Protocol Deviation|0|||
27813609|NCT01610336|54270153|FG006|Overall Study|Protocol Deviation|0|||
27813610|NCT01610336|54270154|FG007|Overall Study|Protocol Deviation|0|||
27813611|NCT01610336|54270155|FG008|Overall Study|Protocol Deviation|0|||
27813612|NCT01610336|54270156|FG009|Overall Study|Protocol Deviation|1|||
27813613|NCT01610336|54270157|FG010|Overall Study|Protocol Deviation|0|||
27813614|NCT01610336|54270147|FG000|Overall Study|Transfer to another trial|0|||
27813615|NCT01610336|54270148|FG001|Overall Study|Transfer to another trial|0|||
27813616|NCT01610336|54270149|FG002|Overall Study|Transfer to another trial|0|||
27813617|NCT01610336|54270150|FG003|Overall Study|Transfer to another trial|0|||
27813618|NCT01610336|54270151|FG004|Overall Study|Transfer to another trial|0|||
28057333|NCT00409682|54713831|FG002|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
28057334|NCT00409682|54713829|FG000|EOW Double-blind Maintenance Period|Adverse Event|0|||
28057335|NCT00409682|54713830|FG001|EOW Double-blind Maintenance Period|Adverse Event|10|||
28057336|NCT00409682|54713831|FG002|EOW Double-blind Maintenance Period|Adverse Event|12|||
28057337|NCT00409682|54713829|FG000|EOW Double-blind Maintenance Period|Lack of Efficacy|0|||
28057338|NCT00409682|54713830|FG001|EOW Double-blind Maintenance Period|Lack of Efficacy|18|||
28057339|NCT00409682|54713831|FG002|EOW Double-blind Maintenance Period|Lack of Efficacy|11|||
28057340|NCT00409682|54713829|FG000|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
28057341|NCT00409682|54713830|FG001|EOW Double-blind Maintenance Period|Lost to Follow-up|1|||
28057342|NCT00409682|54713831|FG002|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
28057343|NCT00409682|54713829|FG000|EOW Double-blind Maintenance Period|Withdrawal by Subject|0|||
28057344|NCT00409682|54713830|FG001|EOW Double-blind Maintenance Period|Withdrawal by Subject|4|||
28057345|NCT00409682|54713831|FG002|EOW Double-blind Maintenance Period|Withdrawal by Subject|2|||
27813619|NCT01610336|54270152|FG005|Overall Study|Transfer to another trial|0|||
27813620|NCT01610336|54270153|FG006|Overall Study|Transfer to another trial|0|||
27813621|NCT01610336|54270154|FG007|Overall Study|Transfer to another trial|0|||
27813622|NCT01610336|54270155|FG008|Overall Study|Transfer to another trial|0|||
27813623|NCT01610336|54270156|FG009|Overall Study|Transfer to another trial|0|||
27813624|NCT01610336|54270157|FG010|Overall Study|Transfer to another trial|1|||
27813625|NCT01613222|54270185|FG000|Overall Study|Physician Decision|1|||
27813626|NCT01613222|54270185|FG000|Overall Study|Unable to place arterial line|1|||
27813627|NCT01613222|54270185|FG000|Overall Study|Reused disposable sensors|10|||
27813628|NCT01612676|54270232|FG000|Overall Study|Adverse Event|2|||
27813629|NCT01612676|54270233|FG001|Overall Study|Adverse Event|3|||
27813630|NCT01612676|54270234|FG002|Overall Study|Adverse Event|1|||
27813631|NCT01612676|54270235|FG003|Overall Study|Adverse Event|3|||
27813632|NCT01612676|54270232|FG000|Overall Study|Protocol Violation|0|||
27813633|NCT01612676|54270233|FG001|Overall Study|Protocol Violation|1|||
27813634|NCT01612676|54270234|FG002|Overall Study|Protocol Violation|0|||
27813635|NCT01612676|54270235|FG003|Overall Study|Protocol Violation|0|||
27813636|NCT01869764|54270249|FG000|Overall Study|Withdrawal by Subject|0|||
27813637|NCT01869764|54270250|FG001|Overall Study|Withdrawal by Subject|2|||
27813638|NCT01842620|54270256|FG000|Period 1|Withdrawal by Subject|1|||
27813639|NCT01842620|54270257|FG001|Period 1|Withdrawal by Subject|0|||
27813640|NCT01931839|54270283|FG000|Overall Study|Death|0|||
27813641|NCT01931839|54270284|FG001|Overall Study|Death|1|||
27813642|NCT01931839|54270285|FG002|Overall Study|Death|2|||
27813643|NCT01931839|54270286|FG003|Overall Study|Death|0|||
27813644|NCT01931839|54270287|FG004|Overall Study|Death|0|||
27813645|NCT01931839|54270288|FG005|Overall Study|Death|0|||
27813646|NCT01931839|54270289|FG006|Overall Study|Death|0|||
27813647|NCT01931839|54270283|FG000|Overall Study|Physician Decision|1|||
27813648|NCT01931839|54270284|FG001|Overall Study|Physician Decision|0|||
27813649|NCT01931839|54270285|FG002|Overall Study|Physician Decision|1|||
27813650|NCT01931839|54270286|FG003|Overall Study|Physician Decision|0|||
27813651|NCT01931839|54270287|FG004|Overall Study|Physician Decision|0|||
27813652|NCT01931839|54270288|FG005|Overall Study|Physician Decision|0|||
27813653|NCT01931839|54270289|FG006|Overall Study|Physician Decision|1|||
27813654|NCT01931839|54270283|FG000|Overall Study|Withdrawal of consent|0|||
27813655|NCT01931839|54270284|FG001|Overall Study|Withdrawal of consent|0|||
27813656|NCT01931839|54270285|FG002|Overall Study|Withdrawal of consent|0|||
27813657|NCT01931839|54270286|FG003|Overall Study|Withdrawal of consent|0|||
27813658|NCT01931839|54270287|FG004|Overall Study|Withdrawal of consent|1|||
27813659|NCT01931839|54270288|FG005|Overall Study|Withdrawal of consent|0|||
27813660|NCT01931839|54270289|FG006|Overall Study|Withdrawal of consent|0|||
27813661|NCT01931839|54270283|FG000|Overall Study|Adverse Event|9|||
27813662|NCT01931839|54270284|FG001|Overall Study|Adverse Event|4|||
27813663|NCT01931839|54270285|FG002|Overall Study|Adverse Event|1|||
27813664|NCT01931839|54270286|FG003|Overall Study|Adverse Event|3|||
27813665|NCT01931839|54270287|FG004|Overall Study|Adverse Event|0|||
27813666|NCT01931839|54270288|FG005|Overall Study|Adverse Event|0|||
27813667|NCT01931839|54270289|FG006|Overall Study|Adverse Event|1|||
27813668|NCT01931839|54270283|FG000|Overall Study|Withdrawal of consent (not due to AE)|11|||
27813669|NCT01931839|54270284|FG001|Overall Study|Withdrawal of consent (not due to AE)|8|||
27813670|NCT01931839|54270285|FG002|Overall Study|Withdrawal of consent (not due to AE)|13|||
27813671|NCT01931839|54270286|FG003|Overall Study|Withdrawal of consent (not due to AE)|3|||
27813672|NCT01931839|54270287|FG004|Overall Study|Withdrawal of consent (not due to AE)|0|||
27813673|NCT01931839|54270288|FG005|Overall Study|Withdrawal of consent (not due to AE)|2|||
27813674|NCT01931839|54270289|FG006|Overall Study|Withdrawal of consent (not due to AE)|2|||
27813675|NCT01931839|54270283|FG000|Overall Study|Other non-compliance|15|||
27813676|NCT01931839|54270284|FG001|Overall Study|Other non-compliance|9|||
27813677|NCT01931839|54270285|FG002|Overall Study|Other non-compliance|12|||
27813678|NCT01931839|54270286|FG003|Overall Study|Other non-compliance|3|||
27813679|NCT01931839|54270287|FG004|Overall Study|Other non-compliance|0|||
27813680|NCT01931839|54270288|FG005|Overall Study|Other non-compliance|3|||
27813681|NCT01931839|54270289|FG006|Overall Study|Other non-compliance|0|||
27813682|NCT01931839|54270283|FG000|Overall Study|Lost to Follow-up|1|||
27813683|NCT01931839|54270284|FG001|Overall Study|Lost to Follow-up|2|||
27813684|NCT01931839|54270285|FG002|Overall Study|Lost to Follow-up|4|||
27813685|NCT01931839|54270286|FG003|Overall Study|Lost to Follow-up|5|||
27813686|NCT01931839|54270287|FG004|Overall Study|Lost to Follow-up|0|||
27813687|NCT01931839|54270288|FG005|Overall Study|Lost to Follow-up|0|||
27813688|NCT01931839|54270289|FG006|Overall Study|Lost to Follow-up|0|||
27813689|NCT01931839|54270283|FG000|Overall Study|Other|4|||
27813690|NCT01931839|54270284|FG001|Overall Study|Other|2|||
27813691|NCT01931839|54270285|FG002|Overall Study|Other|6|||
27813692|NCT01931839|54270286|FG003|Overall Study|Other|0|||
27813693|NCT01931839|54270287|FG004|Overall Study|Other|0|||
27813694|NCT01931839|54270288|FG005|Overall Study|Other|0|||
27813695|NCT01931839|54270289|FG006|Overall Study|Other|0|||
27813696|NCT01842308|54270314|FG000|Overall Study|Withdrawal by Subject|0|||
27813697|NCT01842308|54270315|FG001|Overall Study|Withdrawal by Subject|0|||
27813698|NCT01842308|54270316|FG002|Overall Study|Withdrawal by Subject|0|||
27813699|NCT01842308|54270317|FG003|Overall Study|Withdrawal by Subject|0|||
27813700|NCT01842308|54270318|FG004|Overall Study|Withdrawal by Subject|1|||
27813701|NCT01931059|54270333|FG000|Day 1|Pregnancy|0|||
27813702|NCT01931059|54270334|FG001|Day 1|Pregnancy|1|||
27813703|NCT01931059|54270333|FG000|Day3|Lost to Follow-up|1|||
27813704|NCT01931059|54270334|FG001|Day3|Lost to Follow-up|0|||
27813705|NCT01841762|54270346|FG000|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51|||
27813706|NCT01841762|54270346|FG000|Treatment Period|Adverse Event|16|||
27813707|NCT01841762|54270346|FG000|Treatment Period|Death|1|||
27813708|NCT01841762|54270346|FG000|Treatment Period|Withdrawal by Subject|7|||
27813709|NCT01841762|54270346|FG000|Treatment Period|Lost to Follow-up|1|||
27813710|NCT01841762|54270346|FG000|Treatment Period|Physician Decision|2|||
27813711|NCT01841762|54270346|FG000|Treatment Period|Other, including non-compliance|5|||
27813712|NCT01841762|54270346|FG000|Post-Treatment Safety Follow-Up Period|Death|1|||
27813713|NCT01841762|54270346|FG000|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7|||
27813714|NCT01841762|54270346|FG000|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6|||
27813715|NCT01841762|54270346|FG000|Post-Treatment Safety Follow-Up Period|Other, administrative error|1|||
27813716|NCT01841060|54270363|FG000|Overall Study|Protocol Violation|10|||
27813717|NCT01814696|54270369|FG000|Overall Study|Withdrawal by Subject|1|||
27813718|NCT01814696|54270370|FG001|Overall Study|Withdrawal by Subject|0|||
27813719|NCT01814696|54270369|FG000|Overall Study|Randomized to wrong group|1|||
27813720|NCT01814696|54270370|FG001|Overall Study|Randomized to wrong group|0|||
27848250|NCT01045161|54341216|FG002|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9|||
27848251|NCT01045161|54341214|FG000|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
27848252|NCT01045161|54341215|FG001|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
27848253|NCT01045161|54341216|FG002|Part B - 40 Additional Weeks Open Label|Adverse Event|7|||
27848254|NCT01045161|54341214|FG000|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3|||
27848255|NCT01045161|54341215|FG001|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
27848256|NCT01045161|54341216|FG002|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
27848257|NCT01045161|54341214|FG000|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
27848258|NCT01045161|54341215|FG001|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5|||
27848259|NCT01045161|54341216|FG002|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
27848260|NCT01045161|54341214|FG000|Part B - 40 Additional Weeks Open Label|Other Reason|4|||
27848261|NCT01045161|54341215|FG001|Part B - 40 Additional Weeks Open Label|Other Reason|2|||
27848262|NCT01045161|54341216|FG002|Part B - 40 Additional Weeks Open Label|Other Reason|1|||
28057346|NCT00409682|54713829|FG000|EOW Double-blind Maintenance Period|Protocol Violation|0|||
28057347|NCT00409682|54713830|FG001|EOW Double-blind Maintenance Period|Protocol Violation|4|||
28057348|NCT00409682|54713831|FG002|EOW Double-blind Maintenance Period|Protocol Violation|1|||
28057349|NCT00409682|54713829|FG000|EOW Double-blind Maintenance Period|Non-compliance|0|||
28057350|NCT00409682|54713830|FG001|EOW Double-blind Maintenance Period|Non-compliance|0|||
28057351|NCT00409682|54713831|FG002|EOW Double-blind Maintenance Period|Non-compliance|1|||
28057352|NCT00398216|54713843|FG000|Overall Study|Adverse Event|4|||
28057353|NCT00398216|54713844|FG001|Overall Study|Adverse Event|2|||
28057354|NCT00398216|54713845|FG002|Overall Study|Adverse Event|5|||
28057355|NCT00398216|54713846|FG003|Overall Study|Adverse Event|7|||
28057356|NCT00398216|54713847|FG004|Overall Study|Adverse Event|2|||
28057357|NCT00398216|54713843|FG000|Overall Study|Protocol Violation|2|||
28057358|NCT00398216|54713844|FG001|Overall Study|Protocol Violation|4|||
28057359|NCT00398216|54713845|FG002|Overall Study|Protocol Violation|5|||
28057360|NCT00398216|54713846|FG003|Overall Study|Protocol Violation|7|||
28057361|NCT00398216|54713847|FG004|Overall Study|Protocol Violation|5|||
28057362|NCT00398216|54713843|FG000|Overall Study|Lost to Follow-up|1|||
28057363|NCT00398216|54713844|FG001|Overall Study|Lost to Follow-up|6|||
28057364|NCT00398216|54713845|FG002|Overall Study|Lost to Follow-up|4|||
28057365|NCT00398216|54713846|FG003|Overall Study|Lost to Follow-up|4|||
28057366|NCT00398216|54713847|FG004|Overall Study|Lost to Follow-up|1|||
27848263|NCT01045161|54341214|FG000|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
27848264|NCT01045161|54341215|FG001|Part B - 40 Additional Weeks Open Label|Protocol Violation|6|||
28057367|NCT00398216|54713843|FG000|Overall Study|Death|0|||
28057368|NCT00398216|54713844|FG001|Overall Study|Death|3|||
28057369|NCT00398216|54713845|FG002|Overall Study|Death|0|||
28057370|NCT00398216|54713846|FG003|Overall Study|Death|0|||
28057371|NCT00398216|54713847|FG004|Overall Study|Death|0|||
28057372|NCT00398216|54713843|FG000|Overall Study|Withdrawal by Subject|1|||
28057373|NCT00398216|54713844|FG001|Overall Study|Withdrawal by Subject|0|||
28057374|NCT00398216|54713845|FG002|Overall Study|Withdrawal by Subject|3|||
28057375|NCT00398216|54713846|FG003|Overall Study|Withdrawal by Subject|1|||
28057376|NCT00398216|54713847|FG004|Overall Study|Withdrawal by Subject|2|||
27848265|NCT01045161|54341216|FG002|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
28057377|NCT00398216|54713843|FG000|Overall Study|administrative reasons|3|||
28057378|NCT00398216|54713844|FG001|Overall Study|administrative reasons|4|||
28057379|NCT00398216|54713845|FG002|Overall Study|administrative reasons|4|||
28057380|NCT00398216|54713846|FG003|Overall Study|administrative reasons|3|||
28057381|NCT00398216|54713847|FG004|Overall Study|administrative reasons|3|||
28057382|NCT00398216|54713843|FG000|Overall Study|entrance criteria|0|||
27813721|NCT01970371|54270379|FG000|Overall Study|Death|8|||
28057383|NCT00398216|54713844|FG001|Overall Study|entrance criteria|0|||
27848266|NCT01045161|54341214|FG000|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5|||
27848267|NCT01045161|54341215|FG001|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1|||
27848268|NCT01045161|54341216|FG002|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6|||
27848269|NCT00633217|54341235|FG000|Overall Study|Adverse Event|5|||
27848270|NCT00633217|54341236|FG001|Overall Study|Adverse Event|9|||
27848271|NCT00633217|54341235|FG000|Overall Study|Lack of Efficacy|0|||
27848272|NCT00633217|54341236|FG001|Overall Study|Lack of Efficacy|2|||
27848273|NCT00633217|54341235|FG000|Overall Study|Protocol Violation|3|||
27848274|NCT00633217|54341236|FG001|Overall Study|Protocol Violation|7|||
27848275|NCT00633217|54341235|FG000|Overall Study|Lost to Follow-up|2|||
27848276|NCT00633217|54341236|FG001|Overall Study|Lost to Follow-up|2|||
27848277|NCT00633217|54341235|FG000|Overall Study|Investigator Discretion|2|||
27848278|NCT00633217|54341236|FG001|Overall Study|Investigator Discretion|0|||
27848279|NCT00633217|54341235|FG000|Overall Study|Withdrew Consent|3|||
27848280|NCT00633217|54341236|FG001|Overall Study|Withdrew Consent|3|||
27848281|NCT01673490|54341242|FG000|Overall Study|Lost to Follow-up|1|||
27848282|NCT01673490|54341242|FG000|Overall Study|Adverse Event|3|||
27848283|NCT01673490|54341242|FG000|Overall Study|Withdrawal by Subject|3|||
27848284|NCT00215657|54341254|FG000|Overall Study|Adverse Event|5|||
27848285|NCT00215657|54341255|FG001|Overall Study|Adverse Event|1|||
27848286|NCT00215657|54341256|FG002|Overall Study|Adverse Event|3|||
27848287|NCT00215657|54341257|FG003|Overall Study|Adverse Event|0|||
27848288|NCT00215657|54341258|FG004|Overall Study|Adverse Event|3|||
27848289|NCT00215657|54341259|FG005|Overall Study|Adverse Event|1|||
27848290|NCT00215657|54341260|FG006|Overall Study|Adverse Event|0|||
27848291|NCT00215657|54341261|FG007|Overall Study|Adverse Event|3|||
27848292|NCT00215657|54341254|FG000|Overall Study|Withdrawal by Subject|6|||
27848293|NCT00215657|54341255|FG001|Overall Study|Withdrawal by Subject|3|||
27813722|NCT01970371|54270380|FG001|Overall Study|Death|13|||
27813723|NCT01970371|54270381|FG002|Overall Study|Death|12|||
27813724|NCT01970371|54270379|FG000|Overall Study|Lost to Follow-up|0|||
27813725|NCT01970371|54270380|FG001|Overall Study|Lost to Follow-up|0|||
27813726|NCT01970371|54270381|FG002|Overall Study|Lost to Follow-up|1|||
27813727|NCT01868594|54270402|FG000|Overall Study|Do not meet inclusion criteria|4|||
27813728|NCT01868594|54270403|FG001|Overall Study|Do not meet inclusion criteria|3|||
27813729|NCT01616953|54270413|FG000|Overall Study|Lost to Follow-up|1|||
27813730|NCT01616953|54270414|FG001|Overall Study|Lost to Follow-up|0|||
27813731|NCT01616953|54270413|FG000|Overall Study|lack of bone and soft tissue|1|||
27813732|NCT01616953|54270414|FG001|Overall Study|lack of bone and soft tissue|0|||
27813733|NCT01867658|54270420|FG000|Overall Study|Withdrawal by Subject|6|||
27813734|NCT01867658|54270420|FG000|Overall Study|Death|2|||
27813735|NCT01867658|54270420|FG000|Overall Study|Subject could not be contacted|1|||
27813736|NCT01867580|54270426|FG000|Overall Study|Withdrawal by Subject|2|||
27813737|NCT01867580|54270427|FG001|Overall Study|Withdrawal by Subject|3|||
27813738|NCT01867580|54270426|FG000|Overall Study|Physician Decision|17|||
27813739|NCT01867580|54270427|FG001|Overall Study|Physician Decision|12|||
27813740|NCT01867580|54270426|FG000|Overall Study|Lost to Follow-up|3|||
27813741|NCT01867580|54270427|FG001|Overall Study|Lost to Follow-up|5|||
27813742|NCT01867580|54270426|FG000|Overall Study|Sponsor terminated study|1|||
27813743|NCT01867580|54270427|FG001|Overall Study|Sponsor terminated study|0|||
27813744|NCT01867580|54270426|FG000|Overall Study|Missed follow-up assessment|2|||
27813745|NCT01867580|54270427|FG001|Overall Study|Missed follow-up assessment|1|||
27813746|NCT01867580|54270426|FG000|Overall Study|Interruption to therapy|3|||
27813747|NCT01867580|54270427|FG001|Overall Study|Interruption to therapy|0|||
27813748|NCT01867580|54270426|FG000|Overall Study|Osteomyelitis|0|||
27813749|NCT01867580|54270427|FG001|Overall Study|Osteomyelitis|1|||
27813750|NCT01867580|54270426|FG000|Overall Study|Continuation of therapy|0|||
27813751|NCT01867580|54270427|FG001|Overall Study|Continuation of therapy|1|||
27813752|NCT01867580|54270426|FG000|Overall Study|Wound recurrence|0|||
27813753|NCT01867580|54270427|FG001|Overall Study|Wound recurrence|1|||
27813754|NCT01839656|54270441|FG000|Overall Study|Withdrawal by Subject|1|||
27813755|NCT01839656|54270442|FG001|Overall Study|Withdrawal by Subject|1|||
27813756|NCT01839656|54270441|FG000|Overall Study|Adverse event, serious fatal|1|||
27813757|NCT01839656|54270442|FG001|Overall Study|Adverse event, serious fatal|4|||
27813758|NCT01839656|54270441|FG000|Overall Study|Early study closure|0|||
27813759|NCT01839656|54270442|FG001|Overall Study|Early study closure|11|||
27813760|NCT01839656|54270441|FG000|Overall Study|Adverse Event|1|||
27813761|NCT01839656|54270442|FG001|Overall Study|Adverse Event|0|||
27813762|NCT01839188|54270448|FG000|Overall Study|Withdrawal by Subject|1|||
27813763|NCT01838876|54270457|FG000|Overall Study|Adverse Event|49|||
27848294|NCT00215657|54341256|FG002|Overall Study|Withdrawal by Subject|3|||
27813764|NCT01838876|54270457|FG000|Overall Study|Insufficient Therapeutic Response|10|||
27813765|NCT01838876|54270457|FG000|Overall Study|Protocol Violation|34|||
27813766|NCT01838876|54270457|FG000|Overall Study|Withdrawal of Consent|33|||
27813767|NCT01838876|54270457|FG000|Overall Study|Lost to Follow-up|21|||
27813768|NCT01838876|54270457|FG000|Overall Study|Study or Site Terminated by Sponsor|1|||
27848295|NCT00215657|54341257|FG003|Overall Study|Withdrawal by Subject|1|||
27813769|NCT01838876|54270457|FG000|Overall Study|Reason not Specified|7|||
27813770|NCT01838876|54270457|FG000|Overall Study|Did not meet eligibility criteria|78|||
27813771|NCT01838642|54270472|FG000|Overall Study|Died on study|1|||
27813772|NCT01611194|54270479|FG000|Overall Study|Lost to Follow-up|0|||
27813773|NCT01611194|54270480|FG001|Overall Study|Lost to Follow-up|1|||
27813774|NCT01611194|54270479|FG000|Overall Study|Withdrawal by Subject|0|||
27813775|NCT01611194|54270480|FG001|Overall Study|Withdrawal by Subject|1|||
27813776|NCT01611194|54270479|FG000|Overall Study|drug use|0|||
27813777|NCT01611194|54270480|FG001|Overall Study|drug use|1|||
27813778|NCT01813058|54270488|FG000|Overall Study|Withdrawal by Subject|5|||
27813779|NCT01813058|54270489|FG001|Overall Study|Withdrawal by Subject|4|||
27813780|NCT01867424|54270497|FG000|Overall Study|Patient noncompliance|2|||
27813781|NCT01867424|54270498|FG001|Overall Study|Patient noncompliance|1|||
27813782|NCT01811732|54270506|FG000|Overall Study|Lost to Follow-up|24|||
27813783|NCT01811732|54270507|FG001|Overall Study|Lost to Follow-up|30|||
27813784|NCT01811732|54270506|FG000|Overall Study|Withdrawal by Subject|16|||
27813785|NCT01811732|54270507|FG001|Overall Study|Withdrawal by Subject|10|||
27813786|NCT01811732|54270506|FG000|Overall Study|Adverse Event|3|||
27813787|NCT01811732|54270507|FG001|Overall Study|Adverse Event|9|||
27813788|NCT01811732|54270506|FG000|Overall Study|Lack of Efficacy|3|||
27813789|NCT01811732|54270507|FG001|Overall Study|Lack of Efficacy|1|||
27813790|NCT01811732|54270506|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
27813791|NCT01811732|54270507|FG001|Overall Study|Non-compliance with study drug/procedure|3|||
27813792|NCT01811732|54270506|FG000|Overall Study|Physician Decision|2|||
27813793|NCT01811732|54270507|FG001|Overall Study|Physician Decision|0|||
27813794|NCT01811732|54270506|FG000|Overall Study|Death|1|||
27813795|NCT01811732|54270507|FG001|Overall Study|Death|1|||
27813796|NCT01811732|54270506|FG000|Overall Study|Insufficient venous access|0|||
27813797|NCT01811732|54270507|FG001|Overall Study|Insufficient venous access|1|||
27813798|NCT01811732|54270506|FG000|Overall Study|Protocol Violation|0|||
27813799|NCT01811732|54270507|FG001|Overall Study|Protocol Violation|1|||
27813800|NCT01811732|54270506|FG000|Overall Study|Subject incarcerated|1|||
27813801|NCT01811732|54270507|FG001|Overall Study|Subject incarcerated|2|||
27813802|NCT01811732|54270506|FG000|Overall Study|Admitted to another facility|1|||
27813803|NCT01811732|54270507|FG001|Overall Study|Admitted to another facility|0|||
27813804|NCT01811732|54270506|FG000|Overall Study|Correct study drug not available on site|1|||
27813805|NCT01811732|54270507|FG001|Overall Study|Correct study drug not available on site|0|||
27813806|NCT01836458|54270518|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
27813807|NCT01836458|54270519|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
27813808|NCT01836458|54270520|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
27813809|NCT01836458|54270521|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
27813810|NCT01811186|54270533|FG000|Overall Study|Adverse Event|54|||
27813811|NCT01811186|54270534|FG001|Overall Study|Adverse Event|38|||
27813812|NCT01811186|54270533|FG000|Overall Study|Protocol Violation|5|||
27813813|NCT01811186|54270534|FG001|Overall Study|Protocol Violation|6|||
27813814|NCT01811186|54270533|FG000|Overall Study|Withdrawal by Subject|5|||
27813815|NCT01811186|54270534|FG001|Overall Study|Withdrawal by Subject|10|||
27813816|NCT01811186|54270533|FG000|Overall Study|Lack of Efficacy|3|||
27813817|NCT01811186|54270534|FG001|Overall Study|Lack of Efficacy|6|||
27813818|NCT01811186|54270533|FG000|Overall Study|Lost to Follow-up|4|||
27813819|NCT01811186|54270534|FG001|Overall Study|Lost to Follow-up|2|||
27813820|NCT01866098|54270547|FG000|Overall Study|Lost to Follow-up|11|||
27813821|NCT01866098|54270548|FG001|Overall Study|Lost to Follow-up|18|||
27813822|NCT01866098|54270549|FG002|Overall Study|Lost to Follow-up|13|||
28057384|NCT00398216|54713845|FG002|Overall Study|entrance criteria|0|||
28057385|NCT00398216|54713846|FG003|Overall Study|entrance criteria|0|||
28057386|NCT00398216|54713847|FG004|Overall Study|entrance criteria|2|||
28057387|NCT00398138|54713859|FG000|Overall Study|Adverse Event|2|||
28057388|NCT00397982|54713863|FG000|Overall Study|Withdrawal by Subject|1|||
28057389|NCT00397982|54713863|FG000|Overall Study|Adverse Event|1|||
28057390|NCT00397982|54713863|FG000|Overall Study|noncompliance|1|||
28057391|NCT00397982|54713863|FG000|Overall Study|Unrelated health issues|1|||
28057392|NCT00408902|54713868|FG000|Overall Study|Lack of Efficacy|7|||
27813823|NCT01866098|54270547|FG000|Overall Study|Physician Decision|0|||
27813824|NCT01866098|54270548|FG001|Overall Study|Physician Decision|1|||
27813825|NCT01866098|54270549|FG002|Overall Study|Physician Decision|2|||
27813826|NCT01866098|54270547|FG000|Overall Study|Adverse Event|1|||
27813827|NCT01866098|54270548|FG001|Overall Study|Adverse Event|5|||
27813828|NCT01866098|54270549|FG002|Overall Study|Adverse Event|4|||
27813829|NCT01866098|54270547|FG000|Overall Study|Protocol Violation|1|||
27813830|NCT01866098|54270548|FG001|Overall Study|Protocol Violation|0|||
27813831|NCT01866098|54270549|FG002|Overall Study|Protocol Violation|0|||
27813832|NCT01866098|54270547|FG000|Overall Study|Withdrawal by Subject|1|||
27813833|NCT01866098|54270548|FG001|Overall Study|Withdrawal by Subject|2|||
27813834|NCT01866098|54270549|FG002|Overall Study|Withdrawal by Subject|0|||
27813835|NCT01866098|54270547|FG000|Overall Study|Unrelated Hospitalization|2|||
27813836|NCT01866098|54270548|FG001|Overall Study|Unrelated Hospitalization|0|||
28057393|NCT00408902|54713868|FG000|Overall Study|Adverse Event|3|||
27813837|NCT01866098|54270549|FG002|Overall Study|Unrelated Hospitalization|1|||
27813838|NCT01866098|54270547|FG000|Overall Study|Non-compliance|1|||
27813839|NCT01866098|54270548|FG001|Overall Study|Non-compliance|0|||
27813840|NCT01866098|54270549|FG002|Overall Study|Non-compliance|1|||
28057394|NCT00397514|54713873|FG000|Overall Study|Withdrawal by Subject|1|||
28057395|NCT00397514|54713873|FG000|Overall Study|Pacing wire malfunction|1|||
28057396|NCT00397514|54713873|FG000|Overall Study|Not able to capture & pace LV intraoper.|4|||
28057397|NCT00397514|54713873|FG000|Overall Study|early extubation|2|||
28057398|NCT00397514|54713873|FG000|Overall Study|poor echocardiographic windows|1|||
28057399|NCT00397046|54713887|FG000|Overall Study|Disease Progression|3|||
28057400|NCT00397046|54713888|FG001|Overall Study|Disease Progression|3|||
28057401|NCT00397046|54713889|FG002|Overall Study|Disease Progression|10|||
28057402|NCT00397046|54713890|FG003|Overall Study|Disease Progression|5|||
28057403|NCT00396812|54713901|FG000|Overall Study|Physician Decision|1|||
28057404|NCT00396656|54713905|FG000|First Treatment Period|Withdrawal by Subject|0|||
28057405|NCT00396656|54713906|FG001|First Treatment Period|Withdrawal by Subject|2|||
28057406|NCT00396656|54713905|FG000|Second Treatment Period|Adverse Event|0|||
28057407|NCT00396656|54713906|FG001|Second Treatment Period|Adverse Event|1|||
28057408|NCT00408434|54713919|FG000|Overall Study|Adverse Event|0|||
28057409|NCT00408434|54713920|FG001|Overall Study|Adverse Event|0|||
28057410|NCT00408434|54713921|FG002|Overall Study|Adverse Event|1|||
28057411|NCT00408434|54713922|FG003|Overall Study|Adverse Event|0|||
28057412|NCT00408434|54713923|FG004|Overall Study|Adverse Event|0|||
28057413|NCT00408434|54713924|FG005|Overall Study|Adverse Event|0|||
28057414|NCT00408434|54713925|FG006|Overall Study|Adverse Event|0|||
28057415|NCT00408434|54713919|FG000|Overall Study|Progressive disease|6|||
28057416|NCT00408434|54713920|FG001|Overall Study|Progressive disease|3|||
28057417|NCT00408434|54713921|FG002|Overall Study|Progressive disease|4|||
28057418|NCT00408434|54713922|FG003|Overall Study|Progressive disease|3|||
28057419|NCT00408434|54713923|FG004|Overall Study|Progressive disease|3|||
28057420|NCT00408434|54713924|FG005|Overall Study|Progressive disease|1|||
28057421|NCT00408434|54713925|FG006|Overall Study|Progressive disease|4|||
28057422|NCT00408434|54713919|FG000|Overall Study|Other|0|||
28057423|NCT00408434|54713920|FG001|Overall Study|Other|0|||
28057424|NCT00408434|54713921|FG002|Overall Study|Other|1|||
28057425|NCT00408434|54713922|FG003|Overall Study|Other|0|||
28057426|NCT00408434|54713923|FG004|Overall Study|Other|2|||
28057427|NCT00408434|54713924|FG005|Overall Study|Other|1|||
28057428|NCT00408434|54713925|FG006|Overall Study|Other|0|||
28057429|NCT00408434|54713919|FG000|Overall Study|Terminated by Investigator|0|||
28057430|NCT00408434|54713920|FG001|Overall Study|Terminated by Investigator|0|||
28057431|NCT00408434|54713921|FG002|Overall Study|Terminated by Investigator|0|||
28057432|NCT00408434|54713922|FG003|Overall Study|Terminated by Investigator|0|||
28057433|NCT00408434|54713923|FG004|Overall Study|Terminated by Investigator|1|||
28057434|NCT00408434|54713924|FG005|Overall Study|Terminated by Investigator|1|||
28057435|NCT00408434|54713925|FG006|Overall Study|Terminated by Investigator|0|||
28057436|NCT00418886|54713944|FG000|Overall Study|discontinue treatment survival follow up|90|||
28057437|NCT00418886|54713945|FG001|Overall Study|discontinue treatment survival follow up|91|||
28057438|NCT00418886|54713944|FG000|Overall Study|Death|122|||
28057439|NCT00418886|54713945|FG001|Overall Study|Death|147|||
28057440|NCT00418886|54713944|FG000|Overall Study|Withdrawal by Subject|9|||
27813841|NCT01866098|54270547|FG000|Overall Study|Pregnancy|2|||
27813842|NCT01866098|54270548|FG001|Overall Study|Pregnancy|0|||
28057441|NCT00418886|54713945|FG001|Overall Study|Withdrawal by Subject|10|||
27813843|NCT01866098|54270549|FG002|Overall Study|Pregnancy|0|||
27813844|NCT01866098|54270547|FG000|Overall Study|Death|0|||
27813845|NCT01866098|54270548|FG001|Overall Study|Death|1|||
28057442|NCT00418886|54713944|FG000|Overall Study|Lost to Follow-up|4|||
28057443|NCT00418886|54713945|FG001|Overall Study|Lost to Follow-up|6|||
28057444|NCT00418886|54713944|FG000|Overall Study|withdrawn due to other reason|1|||
28057445|NCT00418886|54713945|FG001|Overall Study|withdrawn due to other reason|0|||
28057446|NCT00418886|54713944|FG000|Overall Study|randomised but no treatment received|0|||
28057447|NCT00418886|54713945|FG001|Overall Study|randomised but no treatment received|1|||
28057448|NCT00418184|54713953|FG000|Double-blind Phase|Withdrawal by Subject|22|||
28057449|NCT00418184|54713954|FG001|Double-blind Phase|Withdrawal by Subject|9|||
28057450|NCT00418184|54713953|FG000|Double-blind Phase|Adverse Event|2|||
28057451|NCT00418184|54713954|FG001|Double-blind Phase|Adverse Event|1|||
28057452|NCT00418184|54713953|FG000|Double-blind Phase|Poor compliance|3|||
28057453|NCT00418184|54713954|FG001|Double-blind Phase|Poor compliance|1|||
28057454|NCT00407030|54713963|FG000|Main Period - 8 to 20 Weeks|Adverse Event|2|||
28057455|NCT00407030|54713964|FG001|Main Period - 8 to 20 Weeks|Adverse Event|1|||
28057456|NCT00407030|54713965|FG002|Main Period - 8 to 20 Weeks|Adverse Event|0|||
28057457|NCT00407030|54713963|FG000|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
27813846|NCT01866098|54270549|FG002|Overall Study|Death|0|||
27813847|NCT01865552|54270563|FG000|Period 1|Adverse Event|1|||
27813848|NCT01865552|54270564|FG001|Period 1|Adverse Event|0|||
27813849|NCT01865552|54270565|FG002|Period 1|Adverse Event|0|||
27813850|NCT01865552|54270566|FG003|Period 1|Adverse Event|1|||
27813851|NCT01865552|54270567|FG004|Period 1|Adverse Event|1|||
27813852|NCT01865552|54270568|FG005|Period 1|Adverse Event|1|||
27813853|NCT01865552|54270563|FG000|Period 1|Pathological lab|0|||
27813854|NCT01865552|54270564|FG001|Period 1|Pathological lab|0|||
27813855|NCT01865552|54270565|FG002|Period 1|Pathological lab|0|||
27813856|NCT01865552|54270566|FG003|Period 1|Pathological lab|0|||
27813857|NCT01865552|54270567|FG004|Period 1|Pathological lab|1|||
27813858|NCT01865552|54270568|FG005|Period 1|Pathological lab|0|||
28057458|NCT00407030|54713964|FG001|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
28057459|NCT00407030|54713965|FG002|Main Period - 8 to 20 Weeks|Lack of Efficacy|3|||
28057460|NCT00407030|54713963|FG000|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
28057461|NCT00407030|54713964|FG001|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
28057462|NCT00407030|54713965|FG002|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
28057463|NCT00407030|54713963|FG000|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
28057464|NCT00407030|54713964|FG001|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
28057465|NCT00407030|54713965|FG002|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
28057466|NCT00407030|54713963|FG000|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
28057467|NCT00407030|54713964|FG001|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
28057468|NCT00407030|54713965|FG002|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1|||
28057469|NCT00407030|54713963|FG000|Main Period - 8 to 20 Weeks|Patient Decision|1|||
28057470|NCT00407030|54713964|FG001|Main Period - 8 to 20 Weeks|Patient Decision|0|||
27813859|NCT01865552|54270563|FG000|Period 1|Other|0|||
27813860|NCT01865552|54270564|FG001|Period 1|Other|0|||
27813861|NCT01865552|54270565|FG002|Period 1|Other|0|||
27813862|NCT01865552|54270566|FG003|Period 1|Other|0|||
28057471|NCT00407030|54713965|FG002|Main Period - 8 to 20 Weeks|Patient Decision|0|||
28057472|NCT00407030|54713963|FG000|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
28057473|NCT00407030|54713964|FG001|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5|||
28057474|NCT00407030|54713965|FG002|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
28057475|NCT00407030|54713963|FG000|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
28057476|NCT00407030|54713964|FG001|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
27813863|NCT01865552|54270567|FG004|Period 1|Other|1|||
27813864|NCT01865552|54270568|FG005|Period 1|Other|0|||
27813865|NCT01809314|54270582|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
27813866|NCT01809314|54270582|FG000|Overall Study|Adverse Event|6|||
27813867|NCT01809314|54270582|FG000|Overall Study|Insufficient Therapeutic Response|14|||
27813868|NCT01809314|54270582|FG000|Overall Study|Lost to Follow-up|724|||
27813869|NCT01803464|54270590|FG000|Overall Study|Incomplete data|0|||
28057477|NCT00407030|54713965|FG002|Extension Period - up to 68 Weeks|Lack of Efficacy|0|||
27813870|NCT01803464|54270591|FG001|Overall Study|Incomplete data|0|||
27813871|NCT01803464|54270592|FG002|Overall Study|Incomplete data|4|||
27813872|NCT01803464|54270593|FG003|Overall Study|Incomplete data|0|||
27813873|NCT01803464|54270590|FG000|Overall Study|Withdrawal by Subject|1|||
27813874|NCT01803464|54270591|FG001|Overall Study|Withdrawal by Subject|0|||
27813875|NCT01803464|54270592|FG002|Overall Study|Withdrawal by Subject|0|||
27813876|NCT01803464|54270593|FG003|Overall Study|Withdrawal by Subject|0|||
27813877|NCT01808690|54270609|FG000|Overall Study|Withdrawal by Subject|1|||
27813878|NCT01808690|54270610|FG001|Overall Study|Withdrawal by Subject|2|||
27813879|NCT01363297|54270621|FG000|Overall Study|Other|0|||
27813880|NCT01363297|54270622|FG001|Overall Study|Other|0|||
27813881|NCT01363297|54270623|FG002|Overall Study|Other|0|||
27813882|NCT01363297|54270624|FG003|Overall Study|Other|0|||
27813883|NCT01363297|54270625|FG004|Overall Study|Other|1|||
27813884|NCT01363297|54270621|FG000|Overall Study|Death|3|||
27813885|NCT01363297|54270622|FG001|Overall Study|Death|6|||
27813886|NCT01363297|54270623|FG002|Overall Study|Death|6|||
27813887|NCT01363297|54270624|FG003|Overall Study|Death|10|||
27813888|NCT01363297|54270625|FG004|Overall Study|Death|30|||
27813889|NCT01908907|54270644|FG000|Overall Study|Physician Decision|1|||
27813890|NCT01908907|54270645|FG001|Overall Study|Physician Decision|0|||
27813891|NCT01908907|54270644|FG000|Overall Study|Protocol Violation|1|||
27813892|NCT01908907|54270645|FG001|Overall Study|Protocol Violation|0|||
27813893|NCT01808612|54270658|FG000|Treatment Period|Adverse Event|8|||
27813894|NCT01808612|54270659|FG001|Treatment Period|Adverse Event|4|||
27813895|NCT01808612|54270660|FG002|Treatment Period|Adverse Event|3|||
27813896|NCT01808612|54270658|FG000|Treatment Period|Lost to Follow-up|2|||
27813897|NCT01808612|54270659|FG001|Treatment Period|Lost to Follow-up|2|||
27813898|NCT01808612|54270660|FG002|Treatment Period|Lost to Follow-up|1|||
27813899|NCT01808612|54270658|FG000|Treatment Period|Protocol Violation|1|||
27813900|NCT01808612|54270659|FG001|Treatment Period|Protocol Violation|0|||
27813901|NCT01808612|54270660|FG002|Treatment Period|Protocol Violation|0|||
27813902|NCT01808612|54270658|FG000|Treatment Period|Withdrawal by Subject|1|||
27813903|NCT01808612|54270659|FG001|Treatment Period|Withdrawal by Subject|0|||
27813904|NCT01808612|54270660|FG002|Treatment Period|Withdrawal by Subject|4|||
27813905|NCT01808612|54270658|FG000|Treatment Period|Physician Decision|1|||
27813906|NCT01808612|54270659|FG001|Treatment Period|Physician Decision|0|||
27813907|NCT01808612|54270660|FG002|Treatment Period|Physician Decision|4|||
27813908|NCT01808612|54270658|FG000|Treatment Period|Sponsor Decision|1|||
27813909|NCT01808612|54270659|FG001|Treatment Period|Sponsor Decision|0|||
27813910|NCT01808612|54270660|FG002|Treatment Period|Sponsor Decision|0|||
27813911|NCT01808612|54270658|FG000|Treatment Period|Lack of Efficacy|1|||
27813912|NCT01808612|54270659|FG001|Treatment Period|Lack of Efficacy|1|||
27813913|NCT01808612|54270660|FG002|Treatment Period|Lack of Efficacy|2|||
27813914|NCT01808612|54270658|FG000|Discontinuation Period|Adverse Event|1|||
27813915|NCT01808612|54270659|FG001|Discontinuation Period|Adverse Event|0|||
27813916|NCT01808612|54270660|FG002|Discontinuation Period|Adverse Event|0|||
27813917|NCT01808612|54270658|FG000|Discontinuation Period|Physician Decision|1|||
27813918|NCT01808612|54270659|FG001|Discontinuation Period|Physician Decision|0|||
27813919|NCT01808612|54270660|FG002|Discontinuation Period|Physician Decision|0|||
27813920|NCT01808612|54270658|FG000|Discontinuation Period|Lost to Follow-up|0|||
28057478|NCT00407030|54713963|FG000|Extension Period - up to 68 Weeks|Adverse Event|1|||
28057479|NCT00407030|54713964|FG001|Extension Period - up to 68 Weeks|Adverse Event|0|||
28057480|NCT00407030|54713965|FG002|Extension Period - up to 68 Weeks|Adverse Event|0|||
28057481|NCT00407030|54713963|FG000|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
28057482|NCT00407030|54713964|FG001|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
28057483|NCT00407030|54713965|FG002|Extension Period - up to 68 Weeks|Consent Withdrawn|0|||
28057484|NCT00407030|54713963|FG000|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
28057485|NCT00407030|54713964|FG001|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
28057486|NCT00407030|54713965|FG002|Extension Period - up to 68 Weeks|Lost to Follow-up|0|||
28057487|NCT00407030|54713963|FG000|Extension Period - up to 68 Weeks|Patient Decision|1|||
27813921|NCT01808612|54270659|FG001|Discontinuation Period|Lost to Follow-up|1|||
27813922|NCT01808612|54270660|FG002|Discontinuation Period|Lost to Follow-up|0|||
27813923|NCT01908829|54270674|FG000|Overall Study|Adverse Event|13|||
27813924|NCT01908829|54270675|FG001|Overall Study|Adverse Event|11|||
27813925|NCT01908829|54270676|FG002|Overall Study|Adverse Event|13|||
27813926|NCT01908829|54270674|FG000|Overall Study|Lost to Follow-up|4|||
27813927|NCT01908829|54270675|FG001|Overall Study|Lost to Follow-up|2|||
27813928|NCT01908829|54270676|FG002|Overall Study|Lost to Follow-up|1|||
27813929|NCT01908829|54270674|FG000|Overall Study|Randomized no double-blind drug received|1|||
27813930|NCT01908829|54270675|FG001|Overall Study|Randomized no double-blind drug received|0|||
27813931|NCT01908829|54270676|FG002|Overall Study|Randomized no double-blind drug received|1|||
27813932|NCT01908829|54270674|FG000|Overall Study|Discontinued (no EoT page)|2|||
27813933|NCT01908829|54270675|FG001|Overall Study|Discontinued (no EoT page)|0|||
27813934|NCT01908829|54270676|FG002|Overall Study|Discontinued (no EoT page)|0|||
28057488|NCT00407030|54713964|FG001|Extension Period - up to 68 Weeks|Patient Decision|2|||
28057489|NCT00407030|54713965|FG002|Extension Period - up to 68 Weeks|Patient Decision|0|||
28057490|NCT00407030|54713963|FG000|Extension Period - up to 68 Weeks|Physician Decision|1|||
27813935|NCT01908829|54270674|FG000|Overall Study|Miscellaneous|0|||
27813936|NCT01908829|54270675|FG001|Overall Study|Miscellaneous|2|||
27813937|NCT01908829|54270676|FG002|Overall Study|Miscellaneous|0|||
27813938|NCT01908829|54270674|FG000|Overall Study|Protocol Violation|2|||
27813939|NCT01908829|54270675|FG001|Overall Study|Protocol Violation|2|||
27813940|NCT01908829|54270676|FG002|Overall Study|Protocol Violation|0|||
27813941|NCT01908829|54270674|FG000|Overall Study|Lack of Efficacy|1|||
28057491|NCT00407030|54713964|FG001|Extension Period - up to 68 Weeks|Physician Decision|2|||
28057492|NCT00407030|54713965|FG002|Extension Period - up to 68 Weeks|Physician Decision|0|||
28057493|NCT00406718|54713978|FG000|Overall Study|Withdrawal by Subject|2|||
28057494|NCT00406718|54713979|FG001|Overall Study|Withdrawal by Subject|9|||
28057495|NCT00406718|54713980|FG002|Overall Study|Withdrawal by Subject|4|||
28057496|NCT00406718|54713978|FG000|Overall Study|Lost to Follow-up|2|||
28057497|NCT00406718|54713979|FG001|Overall Study|Lost to Follow-up|5|||
28057498|NCT00406718|54713980|FG002|Overall Study|Lost to Follow-up|4|||
28057499|NCT00406640|54713992|FG000|Acute Phase|Adverse Event|18|||
28057500|NCT00406640|54713993|FG001|Acute Phase|Adverse Event|13|||
28057501|NCT00406640|54713992|FG000|Acute Phase|Failed to Return|5|||
28057502|NCT00406640|54713993|FG001|Acute Phase|Failed to Return|1|||
28057503|NCT00406640|54713992|FG000|Acute Phase|Physician Decision|0|||
28057504|NCT00406640|54713993|FG001|Acute Phase|Physician Decision|1|||
28057505|NCT00406640|54713992|FG000|Acute Phase|Lost to Follow-up|7|||
28057506|NCT00406640|54713993|FG001|Acute Phase|Lost to Follow-up|4|||
28057507|NCT00406640|54713992|FG000|Acute Phase|Protocol deviation|4|||
28057508|NCT00406640|54713993|FG001|Acute Phase|Protocol deviation|10|||
28057509|NCT00406640|54713992|FG000|Acute Phase|Protocol Violation|3|||
28057510|NCT00406640|54713993|FG001|Acute Phase|Protocol Violation|2|||
28057511|NCT00406640|54713992|FG000|Acute Phase|Withdrawal by Subject|11|||
28057512|NCT00406640|54713993|FG001|Acute Phase|Withdrawal by Subject|9|||
28057513|NCT00406640|54713992|FG000|Acute Phase|Lack of Efficacy|3|||
28057514|NCT00406640|54713993|FG001|Acute Phase|Lack of Efficacy|3|||
28057515|NCT00406640|54713992|FG000|DB Continuation Phase for Responders|Adverse Event|11|||
28057516|NCT00406640|54713993|FG001|DB Continuation Phase for Responders|Adverse Event|11|||
28057517|NCT00406640|54713992|FG000|DB Continuation Phase for Responders|Death|1|||
28057518|NCT00406640|54713993|FG001|DB Continuation Phase for Responders|Death|0|||
28057519|NCT00406640|54713992|FG000|DB Continuation Phase for Responders|Failed to Return|0|||
28057520|NCT00406640|54713993|FG001|DB Continuation Phase for Responders|Failed to Return|2|||
28057521|NCT00406640|54713992|FG000|DB Continuation Phase for Responders|Physician Decision|2|||
28057522|NCT00406640|54713993|FG001|DB Continuation Phase for Responders|Physician Decision|3|||
28057523|NCT00406640|54713992|FG000|DB Continuation Phase for Responders|Lost to Follow-up|1|||
28057524|NCT00406640|54713993|FG001|DB Continuation Phase for Responders|Lost to Follow-up|7|||
28057525|NCT00406640|54713992|FG000|DB Continuation Phase for Responders|non-compliance|7|||
28057526|NCT00406640|54713993|FG001|DB Continuation Phase for Responders|non-compliance|5|||
28057527|NCT00406640|54713992|FG000|DB Continuation Phase for Responders|Protocol Violation|2|||
28057528|NCT00406640|54713993|FG001|DB Continuation Phase for Responders|Protocol Violation|2|||
28057529|NCT00406640|54713992|FG000|DB Continuation Phase for Responders|Withdrawal by Subject|8|||
28057530|NCT00406640|54713993|FG001|DB Continuation Phase for Responders|Withdrawal by Subject|6|||
28057531|NCT00406640|54713992|FG000|DB Continuation Phase for Responders|Lack of Efficacy|1|||
28057532|NCT00406640|54713993|FG001|DB Continuation Phase for Responders|Lack of Efficacy|1|||
28057533|NCT00406640|54713992|FG000|OL Extension Phase for Non-Responders|Adverse Event|6|||
28057534|NCT00406640|54713993|FG001|OL Extension Phase for Non-Responders|Adverse Event|6|||
28057535|NCT00406640|54713992|FG000|OL Extension Phase for Non-Responders|Failed to Return|1|||
28057536|NCT00406640|54713993|FG001|OL Extension Phase for Non-Responders|Failed to Return|0|||
28057537|NCT00406640|54713992|FG000|OL Extension Phase for Non-Responders|Physician Decision|1|||
28057538|NCT00406640|54713993|FG001|OL Extension Phase for Non-Responders|Physician Decision|0|||
28057539|NCT00406640|54713992|FG000|OL Extension Phase for Non-Responders|Lost to Follow-up|2|||
28057540|NCT00406640|54713993|FG001|OL Extension Phase for Non-Responders|Lost to Follow-up|3|||
28057541|NCT00406640|54713992|FG000|OL Extension Phase for Non-Responders|non-compliance|3|||
28057542|NCT00406640|54713993|FG001|OL Extension Phase for Non-Responders|non-compliance|2|||
28057543|NCT00406640|54713992|FG000|OL Extension Phase for Non-Responders|Withdrawal by Subject|3|||
27813942|NCT01908829|54270675|FG001|Overall Study|Lack of Efficacy|3|||
27848296|NCT00215657|54341258|FG004|Overall Study|Withdrawal by Subject|6|||
27848297|NCT00215657|54341259|FG005|Overall Study|Withdrawal by Subject|1|||
27848298|NCT00215657|54341260|FG006|Overall Study|Withdrawal by Subject|10|||
27848299|NCT00215657|54341261|FG007|Overall Study|Withdrawal by Subject|3|||
28057544|NCT00406640|54713993|FG001|OL Extension Phase for Non-Responders|Withdrawal by Subject|6|||
28057545|NCT00406640|54713992|FG000|OL Extension Phase for Non-Responders|Lack of Efficacy|6|||
27813943|NCT01908829|54270676|FG002|Overall Study|Lack of Efficacy|2|||
27813944|NCT01908829|54270674|FG000|Overall Study|Withdrawal by Subject|26|||
27813945|NCT01908829|54270675|FG001|Overall Study|Withdrawal by Subject|29|||
27813946|NCT01908829|54270676|FG002|Overall Study|Withdrawal by Subject|22|||
27813947|NCT01773122|54270688|FG000|Overall Study|Due to amended age eligibility criteria|3|||
27813948|NCT01773122|54270689|FG001|Overall Study|Due to amended age eligibility criteria|1|||
27813949|NCT01773122|54270690|FG002|Overall Study|Due to amended age eligibility criteria|0|||
27813950|NCT01773122|54270691|FG003|Overall Study|Due to amended age eligibility criteria|1|||
27813951|NCT01808534|54270701|FG000|Overall Study|Disease progression|3|||
27813952|NCT01808534|54270701|FG000|Overall Study|Physician Decision|1|||
27813953|NCT01808222|54270705|FG000|Overall Study|mpMR scan was not performed|1|||
27813954|NCT01772576|54270709|FG000|Overall Study|Death|15|||
27813955|NCT01772576|54270709|FG000|Overall Study|Protocol Violation|1|||
27813956|NCT01772576|54270709|FG000|Overall Study|Lost to Follow-up|3|||
27813957|NCT01772576|54270709|FG000|Overall Study|Study device not used|3|||
27813958|NCT01772576|54270709|FG000|Overall Study|Adverse Event|6|||
27813959|NCT01772576|54270709|FG000|Overall Study|Withdrawal by Subject|6|||
27813960|NCT01802216|54270736|FG000|4 Month Visit|Participant did not show to visit|3|||
27813961|NCT01802216|54270737|FG001|4 Month Visit|Participant did not show to visit|4|||
27813962|NCT01802216|54270736|FG000|8 Month Visit|Participant did not show to visit|3|||
27813963|NCT01802216|54270737|FG001|8 Month Visit|Participant did not show to visit|5|||
27813964|NCT01802216|54270736|FG000|12 Month Visit|Participant did not show to visit|3|||
27813965|NCT01802216|54270737|FG001|12 Month Visit|Participant did not show to visit|4|||
28057546|NCT00406640|54713993|FG001|OL Extension Phase for Non-Responders|Lack of Efficacy|7|||
28057547|NCT00394706|54714013|FG000|Overall Study|Withdrawal by Subject|2|||
28057548|NCT00394706|54714014|FG001|Overall Study|Withdrawal by Subject|0|||
28057549|NCT00394706|54714015|FG002|Overall Study|Withdrawal by Subject|1|||
28057550|NCT00394706|54714016|FG003|Overall Study|Withdrawal by Subject|0|||
28057551|NCT00394706|54714017|FG004|Overall Study|Withdrawal by Subject|0|||
28057552|NCT00394706|54714018|FG005|Overall Study|Withdrawal by Subject|2|||
28057553|NCT00394706|54714019|FG006|Overall Study|Withdrawal by Subject|1|||
28057554|NCT00394706|54714020|FG007|Overall Study|Withdrawal by Subject|0|||
28057555|NCT00394706|54714013|FG000|Overall Study|Lost to Follow-up|2|||
28057556|NCT00394706|54714014|FG001|Overall Study|Lost to Follow-up|2|||
28057557|NCT00394706|54714015|FG002|Overall Study|Lost to Follow-up|8|||
28057558|NCT00394706|54714016|FG003|Overall Study|Lost to Follow-up|1|||
28057559|NCT00394706|54714017|FG004|Overall Study|Lost to Follow-up|2|||
28057560|NCT00394706|54714018|FG005|Overall Study|Lost to Follow-up|5|||
28057561|NCT00394706|54714019|FG006|Overall Study|Lost to Follow-up|2|||
28057562|NCT00394706|54714020|FG007|Overall Study|Lost to Follow-up|0|||
28057563|NCT00394472|54714036|FG000|Overall Study|Protocol Violation|1|||
28057564|NCT00394472|54714037|FG001|Overall Study|Protocol Violation|3|||
28057565|NCT00394472|54714036|FG000|Overall Study|incorrect enrolment|4|||
28057566|NCT00394472|54714037|FG001|Overall Study|incorrect enrolment|2|||
28057567|NCT00394472|54714036|FG000|Overall Study|Adverse Event|4|||
28057568|NCT00394472|54714037|FG001|Overall Study|Adverse Event|2|||
28057569|NCT00394472|54714036|FG000|Overall Study|Withdrawal by Subject|0|||
28057570|NCT00394472|54714037|FG001|Overall Study|Withdrawal by Subject|2|||
28057571|NCT00394472|54714036|FG000|Overall Study|Physician Decision|0|||
28057572|NCT00394472|54714037|FG001|Overall Study|Physician Decision|1|||
28057573|NCT00394472|54714036|FG000|Overall Study|Lost to Follow-up|0|||
28057574|NCT00394472|54714037|FG001|Overall Study|Lost to Follow-up|1|||
28057575|NCT00419120|54714043|FG000|Long Term Follow up Period|study ongoing|10|||
28057576|NCT00395642|54714047|FG000|Overall Study|Death|4|||
28057577|NCT00395642|54714047|FG000|Overall Study|Lost to Follow-up|1|||
27813966|NCT01808144|54270745|FG000|Overall Study|Death|1|||
27813967|NCT01808144|54270746|FG001|Overall Study|Death|0|||
28057578|NCT00395642|54714047|FG000|Overall Study|Physician Decision|7|||
28057579|NCT00395642|54714047|FG000|Overall Study|Withdrawal by Subject|1|||
28057580|NCT00395486|54714053|FG000|Overall Study|Adverse Event|1|||
28057581|NCT00395486|54714054|FG001|Overall Study|Adverse Event|2|||
28057582|NCT00395486|54714053|FG000|Overall Study|Withdrawal by Subject|5|||
28057583|NCT00395486|54714054|FG001|Overall Study|Withdrawal by Subject|2|||
28057584|NCT00395486|54714053|FG000|Overall Study|Lost to Follow-up|0|||
27813968|NCT01808144|54270745|FG000|Overall Study|Withdrawal by Subject|16|||
27813969|NCT01808144|54270746|FG001|Overall Study|Withdrawal by Subject|23|||
27813970|NCT01808144|54270745|FG000|Overall Study|Lost to Follow-up|6|||
27813971|NCT01808144|54270746|FG001|Overall Study|Lost to Follow-up|3|||
27813972|NCT01808144|54270745|FG000|Overall Study|Protocol Violation|6|||
27813973|NCT01808144|54270746|FG001|Overall Study|Protocol Violation|6|||
27813974|NCT01808144|54270745|FG000|Overall Study|Gout flare|0|||
27813975|NCT01808144|54270746|FG001|Overall Study|Gout flare|1|||
27813976|NCT01808144|54270745|FG000|Overall Study|Adverse Event|11|||
27813977|NCT01808144|54270746|FG001|Overall Study|Adverse Event|15|||
27813978|NCT01801982|54270752|FG000|Overall Study|Lost to Follow-up|1|||
27813979|NCT01808066|54270765|FG000|Overall Study|Withdrawal by Subject|15|||
27813980|NCT01604343|54270773|FG000|Prior to W52 Administration(Through W52)|Lost to Follow-up|5|||
27813981|NCT01604343|54270774|FG001|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
27813982|NCT01604343|54270775|FG002|Prior to W52 Administration(Through W52)|Lost to Follow-up|4|||
27813983|NCT01604343|54270776|FG003|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
27813984|NCT01604343|54270777|FG004|Prior to W52 Administration(Through W52)|Lost to Follow-up|3|||
27813985|NCT01604343|54270773|FG000|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19|||
27813986|NCT01604343|54270774|FG001|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
27813987|NCT01604343|54270775|FG002|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12|||
27813988|NCT01604343|54270776|FG003|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
27813989|NCT01604343|54270777|FG004|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16|||
27813990|NCT01604343|54270773|FG000|Prior to W52 Administration(Through W52)|Adverse Event|25|||
27813991|NCT01604343|54270774|FG001|Prior to W52 Administration(Through W52)|Adverse Event|0|||
27813992|NCT01604343|54270775|FG002|Prior to W52 Administration(Through W52)|Adverse Event|41|||
27813993|NCT01604343|54270776|FG003|Prior to W52 Administration(Through W52)|Adverse Event|0|||
27813994|NCT01604343|54270777|FG004|Prior to W52 Administration(Through W52)|Adverse Event|42|||
28057585|NCT00395486|54714054|FG001|Overall Study|Lost to Follow-up|1|||
28057586|NCT00395018|54714060|FG000|On-Treatment|Death|4|||
28057587|NCT00395018|54714060|FG000|On-Treatment|Other Reason|2|||
28057588|NCT00395018|54714060|FG000|On-Treatment|Poor/non-compliance|2|||
28057589|NCT00395018|54714060|FG000|On-Treatment|Subject no longer meets study criteria|2|||
28057590|NCT00395018|54714060|FG000|Off-Treatment Follow-up|Followup no longer required per protocol|1|||
28057591|NCT00395018|54714060|FG000|Off-Treatment Follow-up|Lost to Follow-up|2|||
28057592|NCT00395018|54714060|FG000|Off-Treatment Follow-up|Poor/non-compliance|1|||
28057593|NCT00375518|54714066|FG000|Overall Study|Withdrawal by Subject|2|||
28057594|NCT00375518|54714067|FG001|Overall Study|Withdrawal by Subject|10|||
28057595|NCT00375518|54714066|FG000|Overall Study|Patient Not Treated|6|||
28057596|NCT00375518|54714067|FG001|Overall Study|Patient Not Treated|6|||
28057597|NCT00375518|54714066|FG000|Overall Study|Death|0|||
28057598|NCT00375518|54714067|FG001|Overall Study|Death|1|||
28057599|NCT00256750|54714076|FG000|Transplanted Pre-Treatment|Withdrawal by Subject|3|||
28057600|NCT00256750|54714077|FG001|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
28057601|NCT00256750|54714078|FG002|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
28057602|NCT00256750|54714076|FG000|Transplanted Pre-Treatment|Other|2|||
28057603|NCT00256750|54714077|FG001|Transplanted Pre-Treatment|Other|0|||
28057604|NCT00256750|54714078|FG002|Transplanted Pre-Treatment|Other|0|||
28057605|NCT00256750|54714076|FG000|Transplanted Pre-Treatment|Death|1|||
28057606|NCT00256750|54714077|FG001|Transplanted Pre-Treatment|Death|0|||
28057607|NCT00256750|54714078|FG002|Transplanted Pre-Treatment|Death|0|||
28057608|NCT00256750|54714076|FG000|Post-Transplant Treated (12 Months)|Adverse Event|20|||
28057609|NCT00256750|54714077|FG001|Post-Transplant Treated (12 Months)|Adverse Event|12|||
28057610|NCT00256750|54714078|FG002|Post-Transplant Treated (12 Months)|Adverse Event|8|||
28057611|NCT00256750|54714076|FG000|Post-Transplant Treated (12 Months)|Death|3|||
28057612|NCT00256750|54714077|FG001|Post-Transplant Treated (12 Months)|Death|2|||
28057613|NCT00256750|54714078|FG002|Post-Transplant Treated (12 Months)|Death|4|||
27813995|NCT01604343|54270773|FG000|Prior to W52 Administration(Through W52)|Death|5|||
27813996|NCT01604343|54270774|FG001|Prior to W52 Administration(Through W52)|Death|0|||
27813997|NCT01604343|54270775|FG002|Prior to W52 Administration(Through W52)|Death|2|||
27813998|NCT01604343|54270776|FG003|Prior to W52 Administration(Through W52)|Death|0|||
27813999|NCT01604343|54270777|FG004|Prior to W52 Administration(Through W52)|Death|4|||
27848300|NCT00215657|54341254|FG000|Overall Study|Insuff prostate specific antigen resp|3|||
28057614|NCT00256750|54714076|FG000|Post-Transplant Treated (12 Months)|Lack of Efficacy|10|||
28057615|NCT00256750|54714077|FG001|Post-Transplant Treated (12 Months)|Lack of Efficacy|22|||
27814000|NCT01604343|54270773|FG000|Prior to W52 Administration(Through W52)|Lack of Efficacy|24|||
27848301|NCT00215657|54341255|FG001|Overall Study|Insuff prostate specific antigen resp|2|||
27848302|NCT00215657|54341256|FG002|Overall Study|Insuff prostate specific antigen resp|2|||
28057616|NCT00256750|54714078|FG002|Post-Transplant Treated (12 Months)|Lack of Efficacy|27|||
28057617|NCT00256750|54714076|FG000|Post-Transplant Treated (12 Months)|Lost to Follow-up|1|||
28057618|NCT00256750|54714077|FG001|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
28057619|NCT00256750|54714078|FG002|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
28057620|NCT00256750|54714076|FG000|Post-Transplant Treated (12 Months)|Other|5|||
27814001|NCT01604343|54270774|FG001|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
27814002|NCT01604343|54270775|FG002|Prior to W52 Administration(Through W52)|Lack of Efficacy|5|||
27814003|NCT01604343|54270776|FG003|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
27814004|NCT01604343|54270777|FG004|Prior to W52 Administration(Through W52)|Lack of Efficacy|14|||
27814005|NCT01604343|54270773|FG000|Prior to W52 Administration(Through W52)|Physician Decision|4|||
27814006|NCT01604343|54270774|FG001|Prior to W52 Administration(Through W52)|Physician Decision|0|||
27814007|NCT01604343|54270775|FG002|Prior to W52 Administration(Through W52)|Physician Decision|1|||
27814008|NCT01604343|54270776|FG003|Prior to W52 Administration(Through W52)|Physician Decision|0|||
27814009|NCT01604343|54270777|FG004|Prior to W52 Administration(Through W52)|Physician Decision|2|||
27814010|NCT01604343|54270773|FG000|Prior to W52 Administration(Through W52)|Pregnancy|1|||
27814011|NCT01604343|54270774|FG001|Prior to W52 Administration(Through W52)|Pregnancy|0|||
28057621|NCT00256750|54714077|FG001|Post-Transplant Treated (12 Months)|Other|4|||
28057622|NCT00256750|54714078|FG002|Post-Transplant Treated (12 Months)|Other|2|||
28057623|NCT00256750|54714076|FG000|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0|||
28057624|NCT00256750|54714077|FG001|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3|||
28057625|NCT00256750|54714078|FG002|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5|||
28057626|NCT00256750|54714076|FG000|Post-Transplant Treated (12 Months)|Protocol Violation|2|||
28057627|NCT00256750|54714077|FG001|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
28057628|NCT00256750|54714078|FG002|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
28057629|NCT00256750|54714076|FG000|Post-Transplant Treated (24 Months)|Adverse Event|7|||
28057630|NCT00256750|54714077|FG001|Post-Transplant Treated (24 Months)|Adverse Event|3|||
28057631|NCT00256750|54714078|FG002|Post-Transplant Treated (24 Months)|Adverse Event|6|||
28057632|NCT00256750|54714076|FG000|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5|||
28057633|NCT00256750|54714077|FG001|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1|||
28057634|NCT00256750|54714078|FG002|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0|||
28057635|NCT00256750|54714076|FG000|Post-Transplant Treated (24 Months)|Death|3|||
28057636|NCT00256750|54714077|FG001|Post-Transplant Treated (24 Months)|Death|0|||
28057637|NCT00256750|54714078|FG002|Post-Transplant Treated (24 Months)|Death|0|||
28057638|NCT00256750|54714076|FG000|Post-Transplant Treated (24 Months)|Lack of Efficacy|4|||
28057639|NCT00256750|54714077|FG001|Post-Transplant Treated (24 Months)|Lack of Efficacy|3|||
28057640|NCT00256750|54714078|FG002|Post-Transplant Treated (24 Months)|Lack of Efficacy|2|||
28057641|NCT00256750|54714076|FG000|Post-Transplant Treated (24 Months)|Other|2|||
28057642|NCT00256750|54714077|FG001|Post-Transplant Treated (24 Months)|Other|0|||
28057643|NCT00256750|54714078|FG002|Post-Transplant Treated (24 Months)|Other|1|||
28057644|NCT00256750|54714076|FG000|Post-Transplant Treated (36 Months)|Adverse Event|5|||
28057645|NCT00256750|54714077|FG001|Post-Transplant Treated (36 Months)|Adverse Event|1|||
28057646|NCT00256750|54714078|FG002|Post-Transplant Treated (36 Months)|Adverse Event|2|||
28057647|NCT00256750|54714076|FG000|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
28057648|NCT00256750|54714077|FG001|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0|||
28057649|NCT00256750|54714078|FG002|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
28057650|NCT00256750|54714076|FG000|Post-Transplant Treated (36 Months)|Death|0|||
28057651|NCT00256750|54714077|FG001|Post-Transplant Treated (36 Months)|Death|2|||
28057652|NCT00256750|54714078|FG002|Post-Transplant Treated (36 Months)|Death|1|||
28057653|NCT00256750|54714076|FG000|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
27814012|NCT01604343|54270775|FG002|Prior to W52 Administration(Through W52)|Pregnancy|1|||
27814013|NCT01604343|54270776|FG003|Prior to W52 Administration(Through W52)|Pregnancy|0|||
27814014|NCT01604343|54270777|FG004|Prior to W52 Administration(Through W52)|Pregnancy|0|||
27814015|NCT01604343|54270773|FG000|Prior to W52 Administration(Through W52)|Other|15|||
27814016|NCT01604343|54270774|FG001|Prior to W52 Administration(Through W52)|Other|0|||
27814017|NCT01604343|54270775|FG002|Prior to W52 Administration(Through W52)|Other|10|||
27814018|NCT01604343|54270776|FG003|Prior to W52 Administration(Through W52)|Other|0|||
27814019|NCT01604343|54270777|FG004|Prior to W52 Administration(Through W52)|Other|6|||
27814020|NCT01604343|54270773|FG000|Week 52 to Week 104|Lost to Follow-up|0|||
27814021|NCT01604343|54270774|FG001|Week 52 to Week 104|Lost to Follow-up|2|||
27814022|NCT01604343|54270775|FG002|Week 52 to Week 104|Lost to Follow-up|4|||
27814023|NCT01604343|54270776|FG003|Week 52 to Week 104|Lost to Follow-up|2|||
27814024|NCT01604343|54270777|FG004|Week 52 to Week 104|Lost to Follow-up|1|||
27814025|NCT01604343|54270773|FG000|Week 52 to Week 104|Withdrawal by Subject|0|||
27814026|NCT01604343|54270774|FG001|Week 52 to Week 104|Withdrawal by Subject|7|||
27814027|NCT01604343|54270775|FG002|Week 52 to Week 104|Withdrawal by Subject|12|||
27814028|NCT01604343|54270776|FG003|Week 52 to Week 104|Withdrawal by Subject|8|||
28057654|NCT00256750|54714077|FG001|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
28057655|NCT00256750|54714078|FG002|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1|||
28057656|NCT00256750|54714076|FG000|Post-Transplant Treated (36 Months)|Lack of Efficacy|4|||
28057657|NCT00256750|54714077|FG001|Post-Transplant Treated (36 Months)|Lack of Efficacy|1|||
28057658|NCT00256750|54714078|FG002|Post-Transplant Treated (36 Months)|Lack of Efficacy|0|||
27814029|NCT01604343|54270777|FG004|Week 52 to Week 104|Withdrawal by Subject|4|||
27814030|NCT01604343|54270773|FG000|Week 52 to Week 104|Adverse Event|0|||
27814031|NCT01604343|54270774|FG001|Week 52 to Week 104|Adverse Event|12|||
27814032|NCT01604343|54270775|FG002|Week 52 to Week 104|Adverse Event|26|||
27814033|NCT01604343|54270776|FG003|Week 52 to Week 104|Adverse Event|21|||
27814034|NCT01604343|54270777|FG004|Week 52 to Week 104|Adverse Event|27|||
27814035|NCT01604343|54270773|FG000|Week 52 to Week 104|Death|0|||
27814036|NCT01604343|54270774|FG001|Week 52 to Week 104|Death|4|||
27814037|NCT01604343|54270775|FG002|Week 52 to Week 104|Death|2|||
27814038|NCT01604343|54270776|FG003|Week 52 to Week 104|Death|5|||
27814039|NCT01604343|54270777|FG004|Week 52 to Week 104|Death|0|||
27814040|NCT01604343|54270773|FG000|Week 52 to Week 104|Lack of Efficacy|0|||
27814041|NCT01604343|54270774|FG001|Week 52 to Week 104|Lack of Efficacy|6|||
27814042|NCT01604343|54270775|FG002|Week 52 to Week 104|Lack of Efficacy|11|||
27814043|NCT01604343|54270776|FG003|Week 52 to Week 104|Lack of Efficacy|2|||
27814044|NCT01604343|54270777|FG004|Week 52 to Week 104|Lack of Efficacy|3|||
27814045|NCT01604343|54270773|FG000|Week 52 to Week 104|Physician Decision|0|||
27814046|NCT01604343|54270774|FG001|Week 52 to Week 104|Physician Decision|1|||
27814047|NCT01604343|54270775|FG002|Week 52 to Week 104|Physician Decision|0|||
28057659|NCT00256750|54714076|FG000|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
28057660|NCT00256750|54714077|FG001|Post-Transplant Treated (36 Months)|Protocol Violation|1|||
28057661|NCT00256750|54714078|FG002|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
28057662|NCT00256750|54714076|FG000|Post-Transplant Treated (36 Months)|Other|0|||
28057663|NCT00256750|54714077|FG001|Post-Transplant Treated (36 Months)|Other|1|||
28057664|NCT00256750|54714078|FG002|Post-Transplant Treated (36 Months)|Other|1|||
28057665|NCT00256750|54714076|FG000|Long Term Extension (LTE; 84 Months)|Adverse Event|13|||
28057666|NCT00256750|54714077|FG001|Long Term Extension (LTE; 84 Months)|Adverse Event|11|||
28057667|NCT00256750|54714078|FG002|Long Term Extension (LTE; 84 Months)|Adverse Event|14|||
28057668|NCT00256750|54714076|FG000|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5|||
28057669|NCT00256750|54714077|FG001|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4|||
28057670|NCT00256750|54714078|FG002|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1|||
28057671|NCT00256750|54714076|FG000|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4|||
28057672|NCT00256750|54714077|FG001|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
28057673|NCT00256750|54714078|FG002|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
28057674|NCT00256750|54714076|FG000|Long Term Extension (LTE; 84 Months)|Death|9|||
28057675|NCT00256750|54714077|FG001|Long Term Extension (LTE; 84 Months)|Death|4|||
28057676|NCT00256750|54714078|FG002|Long Term Extension (LTE; 84 Months)|Death|4|||
28057677|NCT00256750|54714076|FG000|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6|||
28057678|NCT00256750|54714077|FG001|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3|||
28057679|NCT00256750|54714078|FG002|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0|||
28057680|NCT00256750|54714076|FG000|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4|||
28057681|NCT00256750|54714077|FG001|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
28057682|NCT00256750|54714078|FG002|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
28057683|NCT00256750|54714076|FG000|Long Term Extension (LTE; 84 Months)|Pregnancy|0|||
28057684|NCT00256750|54714077|FG001|Long Term Extension (LTE; 84 Months)|Pregnancy|1|||
28057685|NCT00256750|54714078|FG002|Long Term Extension (LTE; 84 Months)|Pregnancy|2|||
28057686|NCT00256750|54714076|FG000|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
28057687|NCT00256750|54714077|FG001|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
28057688|NCT00256750|54714078|FG002|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0|||
28057689|NCT00256750|54714076|FG000|Long Term Extension (LTE; 84 Months)|Other|5|||
28057690|NCT00256750|54714077|FG001|Long Term Extension (LTE; 84 Months)|Other|4|||
28057691|NCT00256750|54714078|FG002|Long Term Extension (LTE; 84 Months)|Other|5|||
27814048|NCT01604343|54270776|FG003|Week 52 to Week 104|Physician Decision|0|||
27814049|NCT01604343|54270777|FG004|Week 52 to Week 104|Physician Decision|2|||
27814050|NCT01604343|54270773|FG000|Week 52 to Week 104|Pregnancy|0|||
27814051|NCT01604343|54270774|FG001|Week 52 to Week 104|Pregnancy|0|||
27814052|NCT01604343|54270775|FG002|Week 52 to Week 104|Pregnancy|1|||
27814053|NCT01604343|54270776|FG003|Week 52 to Week 104|Pregnancy|2|||
27848303|NCT00215657|54341257|FG003|Overall Study|Insuff prostate specific antigen resp|2|||
28057692|NCT00279201|54714089|FG000|Initiation|Death|1|||
28057693|NCT00279201|54714090|FG001|Initiation|Death|5|||
28057694|NCT00279201|54714091|FG002|Initiation|Death|0|||
27848304|NCT00215657|54341258|FG004|Overall Study|Insuff prostate specific antigen resp|1|||
28057695|NCT00279201|54714092|FG003|Initiation|Death|0|||
28057696|NCT00279201|54714093|FG004|Initiation|Death|0|||
28057697|NCT00279201|54714094|FG005|Initiation|Death|0|||
28057698|NCT00279201|54714089|FG000|Initiation|Adverse Event|6|||
28057699|NCT00279201|54714090|FG001|Initiation|Adverse Event|15|||
28057700|NCT00279201|54714091|FG002|Initiation|Adverse Event|0|||
28057701|NCT00279201|54714092|FG003|Initiation|Adverse Event|0|||
27848305|NCT00215657|54341259|FG005|Overall Study|Insuff prostate specific antigen resp|2|||
27814054|NCT01604343|54270777|FG004|Week 52 to Week 104|Pregnancy|1|||
27814055|NCT01604343|54270773|FG000|Week 52 to Week 104|Other|0|||
27814056|NCT01604343|54270774|FG001|Week 52 to Week 104|Other|11|||
27814057|NCT01604343|54270775|FG002|Week 52 to Week 104|Other|11|||
27814058|NCT01604343|54270776|FG003|Week 52 to Week 104|Other|6|||
28057702|NCT00279201|54714093|FG004|Initiation|Adverse Event|0|||
28057703|NCT00279201|54714094|FG005|Initiation|Adverse Event|0|||
28057704|NCT00279201|54714089|FG000|Initiation|Lost to Follow-up|42|||
28057705|NCT00279201|54714090|FG001|Initiation|Lost to Follow-up|41|||
28057706|NCT00279201|54714091|FG002|Initiation|Lost to Follow-up|0|||
28057707|NCT00279201|54714092|FG003|Initiation|Lost to Follow-up|0|||
28057708|NCT00279201|54714093|FG004|Initiation|Lost to Follow-up|0|||
27814059|NCT01604343|54270777|FG004|Week 52 to Week 104|Other|3|||
27814060|NCT01604343|54270773|FG000|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3|||
27814061|NCT01604343|54270774|FG001|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
28057709|NCT00279201|54714094|FG005|Initiation|Lost to Follow-up|0|||
28057710|NCT00279201|54714089|FG000|Initiation|Entry Criteria Exclusion|7|||
28057711|NCT00279201|54714090|FG001|Initiation|Entry Criteria Exclusion|9|||
28057712|NCT00279201|54714091|FG002|Initiation|Entry Criteria Exclusion|0|||
28057713|NCT00279201|54714092|FG003|Initiation|Entry Criteria Exclusion|0|||
28057714|NCT00279201|54714093|FG004|Initiation|Entry Criteria Exclusion|0|||
28057715|NCT00279201|54714094|FG005|Initiation|Entry Criteria Exclusion|0|||
28057716|NCT00279201|54714089|FG000|Initiation|Protocol Violation|9|||
28057717|NCT00279201|54714090|FG001|Initiation|Protocol Violation|10|||
28057718|NCT00279201|54714091|FG002|Initiation|Protocol Violation|0|||
28057719|NCT00279201|54714092|FG003|Initiation|Protocol Violation|0|||
28057720|NCT00279201|54714093|FG004|Initiation|Protocol Violation|0|||
28057721|NCT00279201|54714094|FG005|Initiation|Protocol Violation|0|||
28057722|NCT00279201|54714089|FG000|Initiation|Withdrawal by Subject|35|||
28057723|NCT00279201|54714090|FG001|Initiation|Withdrawal by Subject|41|||
28057724|NCT00279201|54714091|FG002|Initiation|Withdrawal by Subject|0|||
28057725|NCT00279201|54714092|FG003|Initiation|Withdrawal by Subject|0|||
28057726|NCT00279201|54714093|FG004|Initiation|Withdrawal by Subject|0|||
28057727|NCT00279201|54714094|FG005|Initiation|Withdrawal by Subject|0|||
28057728|NCT00279201|54714089|FG000|Initiation|Physician Decision|15|||
28057729|NCT00279201|54714090|FG001|Initiation|Physician Decision|18|||
28057730|NCT00279201|54714091|FG002|Initiation|Physician Decision|0|||
28057731|NCT00279201|54714092|FG003|Initiation|Physician Decision|0|||
28057732|NCT00279201|54714093|FG004|Initiation|Physician Decision|0|||
28057733|NCT00279201|54714094|FG005|Initiation|Physician Decision|0|||
28057734|NCT00279201|54714089|FG000|Initiation|Sponsor Decision|13|||
27814062|NCT01604343|54270775|FG002|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2|||
27814063|NCT01604343|54270776|FG003|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
27814064|NCT01604343|54270777|FG004|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
27814065|NCT01604343|54270773|FG000|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12|||
27814066|NCT01604343|54270774|FG001|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4|||
27814067|NCT01604343|54270775|FG002|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11|||
27814068|NCT01604343|54270776|FG003|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3|||
27814069|NCT01604343|54270777|FG004|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14|||
27814070|NCT01604343|54270773|FG000|Safety Follow-up Period (Week 104-120)|Other|15|||
27814071|NCT01604343|54270774|FG001|Safety Follow-up Period (Week 104-120)|Other|2|||
27814072|NCT01604343|54270775|FG002|Safety Follow-up Period (Week 104-120)|Other|20|||
27814073|NCT01604343|54270776|FG003|Safety Follow-up Period (Week 104-120)|Other|6|||
27814074|NCT01604343|54270777|FG004|Safety Follow-up Period (Week 104-120)|Other|14|||
27814075|NCT01801436|54270787|FG000|Overall Study|Withdrawal by Subject|3|||
27814076|NCT01801436|54270787|FG000|Overall Study|Adverse Event|2|||
27814077|NCT01801436|54270787|FG000|Overall Study|Progressive disease|4|||
27814078|NCT01771250|54270791|FG000|Period 1|Met exclusion criteria|1|||
27814079|NCT01771250|54270792|FG001|Period 1|Met exclusion criteria|0|||
27814080|NCT01770860|54270798|FG000|Overall Study|Withdrawal by Subject|4|||
27814081|NCT01770860|54270798|FG000|Overall Study|Lost to Follow-up|1|||
28057735|NCT00279201|54714090|FG001|Initiation|Sponsor Decision|5|||
28057736|NCT00279201|54714091|FG002|Initiation|Sponsor Decision|0|||
28057737|NCT00279201|54714092|FG003|Initiation|Sponsor Decision|0|||
28057738|NCT00279201|54714093|FG004|Initiation|Sponsor Decision|0|||
28057739|NCT00279201|54714094|FG005|Initiation|Sponsor Decision|0|||
28057740|NCT00279201|54714089|FG000|Initiation|Discontinuation Oral Antihyperglycemics|0|||
28057741|NCT00279201|54714090|FG001|Initiation|Discontinuation Oral Antihyperglycemics|1|||
28057742|NCT00279201|54714091|FG002|Initiation|Discontinuation Oral Antihyperglycemics|0|||
28057743|NCT00279201|54714092|FG003|Initiation|Discontinuation Oral Antihyperglycemics|0|||
27814082|NCT01770860|54270798|FG000|Overall Study|Administrative decision made by the PI|1|||
27814083|NCT01603875|54270809|FG000|Overall Study|Preexisting rabies antibody|3|||
27940006|NCT01198002|54596330|FG002|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
27814084|NCT01603875|54270810|FG001|Overall Study|Preexisting rabies antibody|4|||
27814085|NCT01603875|54270811|FG002|Overall Study|Preexisting rabies antibody|3|||
27814086|NCT01603875|54270809|FG000|Overall Study|Lost to Follow-up|4|||
28057744|NCT00279201|54714093|FG004|Initiation|Discontinuation Oral Antihyperglycemics|0|||
28057745|NCT00279201|54714094|FG005|Initiation|Discontinuation Oral Antihyperglycemics|0|||
28057746|NCT00279201|54714089|FG000|Maintenance|Lack of Efficacy|32|||
28057747|NCT00279201|54714090|FG001|Maintenance|Lack of Efficacy|30|||
28057748|NCT00279201|54714091|FG002|Maintenance|Lack of Efficacy|0|||
28057749|NCT00279201|54714092|FG003|Maintenance|Lack of Efficacy|0|||
28057750|NCT00279201|54714093|FG004|Maintenance|Lack of Efficacy|0|||
28057751|NCT00279201|54714094|FG005|Maintenance|Lack of Efficacy|0|||
28057752|NCT00279201|54714089|FG000|Maintenance|Discontinuation Antihyperglycemic Drugs|3|||
28057753|NCT00279201|54714090|FG001|Maintenance|Discontinuation Antihyperglycemic Drugs|2|||
28057754|NCT00279201|54714091|FG002|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
28057755|NCT00279201|54714092|FG003|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
28057756|NCT00279201|54714093|FG004|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
28057757|NCT00279201|54714094|FG005|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
28057758|NCT00279201|54714089|FG000|Maintenance|Adverse Event|4|||
28057759|NCT00279201|54714090|FG001|Maintenance|Adverse Event|4|||
28057760|NCT00279201|54714091|FG002|Maintenance|Adverse Event|0|||
28057761|NCT00279201|54714092|FG003|Maintenance|Adverse Event|0|||
28057762|NCT00279201|54714093|FG004|Maintenance|Adverse Event|0|||
28057763|NCT00279201|54714094|FG005|Maintenance|Adverse Event|0|||
28057764|NCT00279201|54714089|FG000|Maintenance|Death|4|||
28057765|NCT00279201|54714090|FG001|Maintenance|Death|4|||
28057766|NCT00279201|54714091|FG002|Maintenance|Death|0|||
28057767|NCT00279201|54714092|FG003|Maintenance|Death|0|||
28057768|NCT00279201|54714093|FG004|Maintenance|Death|0|||
28057769|NCT00279201|54714094|FG005|Maintenance|Death|0|||
28057770|NCT00279201|54714089|FG000|Maintenance|Lost to Follow-up|17|||
28057771|NCT00279201|54714090|FG001|Maintenance|Lost to Follow-up|13|||
28057772|NCT00279201|54714091|FG002|Maintenance|Lost to Follow-up|0|||
27814087|NCT01603875|54270810|FG001|Overall Study|Lost to Follow-up|3|||
27814088|NCT01603875|54270811|FG002|Overall Study|Lost to Follow-up|6|||
27814089|NCT01603875|54270809|FG000|Overall Study|Protocol Violation|0|||
27814090|NCT01603875|54270810|FG001|Overall Study|Protocol Violation|1|||
27814091|NCT01603875|54270811|FG002|Overall Study|Protocol Violation|0|||
28057773|NCT00279201|54714092|FG003|Maintenance|Lost to Follow-up|0|||
28057774|NCT00279201|54714093|FG004|Maintenance|Lost to Follow-up|0|||
27814092|NCT01770392|54270819|FG000|Washout Period of at Least 14 Days|Adverse Event|1|||
27814093|NCT01603641|54270829|FG000|Overall Study|Did not Receive Treatment|3|||
27940007|NCT01198002|54596328|FG000|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213|||
28057775|NCT00279201|54714094|FG005|Maintenance|Lost to Follow-up|0|||
28057776|NCT00279201|54714089|FG000|Maintenance|Entry Criteria Exclusion|1|||
28057777|NCT00279201|54714090|FG001|Maintenance|Entry Criteria Exclusion|4|||
28057778|NCT00279201|54714091|FG002|Maintenance|Entry Criteria Exclusion|0|||
28057779|NCT00279201|54714092|FG003|Maintenance|Entry Criteria Exclusion|0|||
28057780|NCT00279201|54714093|FG004|Maintenance|Entry Criteria Exclusion|0|||
28057781|NCT00279201|54714094|FG005|Maintenance|Entry Criteria Exclusion|0|||
28057782|NCT00279201|54714089|FG000|Maintenance|Protocol Violation|16|||
28057783|NCT00279201|54714090|FG001|Maintenance|Protocol Violation|24|||
28057784|NCT00279201|54714091|FG002|Maintenance|Protocol Violation|0|||
28057785|NCT00279201|54714092|FG003|Maintenance|Protocol Violation|0|||
28057786|NCT00279201|54714093|FG004|Maintenance|Protocol Violation|0|||
28057787|NCT00279201|54714094|FG005|Maintenance|Protocol Violation|0|||
28057788|NCT00279201|54714089|FG000|Maintenance|Withdrawal by Subject|18|||
28057789|NCT00279201|54714090|FG001|Maintenance|Withdrawal by Subject|18|||
28057790|NCT00279201|54714091|FG002|Maintenance|Withdrawal by Subject|0|||
28057791|NCT00279201|54714092|FG003|Maintenance|Withdrawal by Subject|0|||
28057792|NCT00279201|54714093|FG004|Maintenance|Withdrawal by Subject|0|||
28057793|NCT00279201|54714094|FG005|Maintenance|Withdrawal by Subject|0|||
28057794|NCT00279201|54714089|FG000|Maintenance|Physician Decision|9|||
28057795|NCT00279201|54714090|FG001|Maintenance|Physician Decision|9|||
28057796|NCT00279201|54714091|FG002|Maintenance|Physician Decision|0|||
28057797|NCT00279201|54714092|FG003|Maintenance|Physician Decision|0|||
28057798|NCT00279201|54714093|FG004|Maintenance|Physician Decision|0|||
28057799|NCT00279201|54714094|FG005|Maintenance|Physician Decision|0|||
28057800|NCT00279201|54714089|FG000|Maintenance|Sponsor Decision|4|||
28057801|NCT00279201|54714090|FG001|Maintenance|Sponsor Decision|0|||
28057802|NCT00279201|54714091|FG002|Maintenance|Sponsor Decision|0|||
28057803|NCT00279201|54714092|FG003|Maintenance|Sponsor Decision|0|||
28057804|NCT00279201|54714093|FG004|Maintenance|Sponsor Decision|0|||
28057805|NCT00279201|54714094|FG005|Maintenance|Sponsor Decision|0|||
28057806|NCT00279201|54714089|FG000|Maintenance|HbA1c>7.5%|123|||
28057807|NCT00279201|54714090|FG001|Maintenance|HbA1c>7.5%|126|||
28057808|NCT00279201|54714091|FG002|Maintenance|HbA1c>7.5%|0|||
28057809|NCT00279201|54714092|FG003|Maintenance|HbA1c>7.5%|0|||
27814094|NCT01603641|54270829|FG000|Overall Study|Adverse Event|1|||
27814095|NCT01603641|54270829|FG000|Overall Study|Lack of Efficacy|1|||
27814096|NCT01603641|54270829|FG000|Overall Study|Lost to Follow-up|6|||
27814097|NCT01603641|54270829|FG000|Overall Study|Personal Reasons|18|||
27814098|NCT01603641|54270829|FG000|Overall Study|Other Miscellaneous Reasons|6|||
27814099|NCT01556763|54270836|FG000|Overall Study|Withdrawal by Subject|0|||
27814100|NCT01556763|54270837|FG001|Overall Study|Withdrawal by Subject|1|||
27814101|NCT01556763|54270838|FG002|Overall Study|Withdrawal by Subject|0|||
27814102|NCT01576575|54270848|FG000|Buprenorphine Control|Withdrawal by Subject|3|||
27814103|NCT01576575|54270848|FG000|Buprenorphine + Rifampin|Withdrawal by Subject|3|||
27814104|NCT01576575|54270848|FG000|Buprenorphine + Grapefruit|Withdrawal by Subject|1|||
27814105|NCT01555983|54270858|FG000|Overall Study|Withdrawal by Subject|1|||
28057810|NCT00279201|54714093|FG004|Maintenance|HbA1c>7.5%|0|||
28057811|NCT00279201|54714094|FG005|Maintenance|HbA1c>7.5%|0|||
28057812|NCT00279201|54714089|FG000|Intensification Addendum|Withdrawal by Subject|0|||
28057813|NCT00279201|54714090|FG001|Intensification Addendum|Withdrawal by Subject|0|||
28057814|NCT00279201|54714091|FG002|Intensification Addendum|Withdrawal by Subject|12|||
28057815|NCT00279201|54714092|FG003|Intensification Addendum|Withdrawal by Subject|14|||
28057816|NCT00279201|54714093|FG004|Intensification Addendum|Withdrawal by Subject|9|||
28057817|NCT00279201|54714094|FG005|Intensification Addendum|Withdrawal by Subject|18|||
28057818|NCT00279201|54714089|FG000|Intensification Addendum|Lost to Follow-up|0|||
28057819|NCT00279201|54714090|FG001|Intensification Addendum|Lost to Follow-up|0|||
28057820|NCT00279201|54714091|FG002|Intensification Addendum|Lost to Follow-up|4|||
28057821|NCT00279201|54714092|FG003|Intensification Addendum|Lost to Follow-up|6|||
28057822|NCT00279201|54714093|FG004|Intensification Addendum|Lost to Follow-up|7|||
28057823|NCT00279201|54714094|FG005|Intensification Addendum|Lost to Follow-up|7|||
28057824|NCT00279201|54714089|FG000|Intensification Addendum|Protocol Violation|0|||
28057825|NCT00279201|54714090|FG001|Intensification Addendum|Protocol Violation|0|||
28057826|NCT00279201|54714091|FG002|Intensification Addendum|Protocol Violation|2|||
28057827|NCT00279201|54714092|FG003|Intensification Addendum|Protocol Violation|2|||
28057828|NCT00279201|54714093|FG004|Intensification Addendum|Protocol Violation|6|||
28057829|NCT00279201|54714094|FG005|Intensification Addendum|Protocol Violation|6|||
28057830|NCT00279201|54714089|FG000|Intensification Addendum|Adverse Event|0|||
28057831|NCT00279201|54714090|FG001|Intensification Addendum|Adverse Event|0|||
28057832|NCT00279201|54714091|FG002|Intensification Addendum|Adverse Event|0|||
28057833|NCT00279201|54714092|FG003|Intensification Addendum|Adverse Event|4|||
28057834|NCT00279201|54714093|FG004|Intensification Addendum|Adverse Event|1|||
28057835|NCT00279201|54714094|FG005|Intensification Addendum|Adverse Event|3|||
28057836|NCT00279201|54714089|FG000|Intensification Addendum|Physician Decision|0|||
28057837|NCT00279201|54714090|FG001|Intensification Addendum|Physician Decision|0|||
28057838|NCT00279201|54714091|FG002|Intensification Addendum|Physician Decision|4|||
28057839|NCT00279201|54714092|FG003|Intensification Addendum|Physician Decision|1|||
28057840|NCT00279201|54714093|FG004|Intensification Addendum|Physician Decision|3|||
27814106|NCT01555983|54270859|FG001|Overall Study|Withdrawal by Subject|0|||
28057841|NCT00279201|54714094|FG005|Intensification Addendum|Physician Decision|2|||
28057842|NCT00279201|54714089|FG000|Intensification Addendum|Sponsor Decision|0|||
28057843|NCT00279201|54714090|FG001|Intensification Addendum|Sponsor Decision|0|||
28057844|NCT00279201|54714091|FG002|Intensification Addendum|Sponsor Decision|0|||
28057845|NCT00279201|54714092|FG003|Intensification Addendum|Sponsor Decision|0|||
28057846|NCT00279201|54714093|FG004|Intensification Addendum|Sponsor Decision|1|||
28057847|NCT00279201|54714094|FG005|Intensification Addendum|Sponsor Decision|1|||
28057848|NCT00279201|54714089|FG000|Intensification Addendum|Entry Criteria Exclusion|0|||
28057849|NCT00279201|54714090|FG001|Intensification Addendum|Entry Criteria Exclusion|0|||
28057850|NCT00279201|54714091|FG002|Intensification Addendum|Entry Criteria Exclusion|1|||
27814107|NCT01555983|54270860|FG002|Overall Study|Withdrawal by Subject|0|||
27848306|NCT00215657|54341260|FG006|Overall Study|Insuff prostate specific antigen resp|3|||
27848307|NCT00215657|54341261|FG007|Overall Study|Insuff prostate specific antigen resp|2|||
28057851|NCT00279201|54714092|FG003|Intensification Addendum|Entry Criteria Exclusion|0|||
28057852|NCT00279201|54714093|FG004|Intensification Addendum|Entry Criteria Exclusion|0|||
28057853|NCT00279201|54714094|FG005|Intensification Addendum|Entry Criteria Exclusion|0|||
28057854|NCT00279201|54714089|FG000|Intensification Addendum|Lack of Efficacy|0|||
28057855|NCT00279201|54714090|FG001|Intensification Addendum|Lack of Efficacy|0|||
28057856|NCT00279201|54714091|FG002|Intensification Addendum|Lack of Efficacy|0|||
27814108|NCT01555983|54270861|FG003|Overall Study|Withdrawal by Subject|0|||
27814109|NCT01555983|54270862|FG004|Overall Study|Withdrawal by Subject|1|||
27814110|NCT01555983|54270863|FG005|Overall Study|Withdrawal by Subject|1|||
27814111|NCT01576341|54270871|FG000|Overall Study|Withdrawal by Subject|24|||
27814112|NCT01576341|54270871|FG000|Overall Study|Adverse Event|10|||
27814113|NCT01576341|54270871|FG000|Overall Study|Death|21|||
27814114|NCT01576341|54270871|FG000|Overall Study|Physician Decision|2|||
27814115|NCT01576341|54270871|FG000|Overall Study|Lost to Follow-up|2|||
27814116|NCT01576341|54270871|FG000|Overall Study|Kidney transplantation|10|||
27814117|NCT01576341|54270871|FG000|Overall Study|Protocol Violation|12|||
27814118|NCT01576341|54270871|FG000|Overall Study|Other|12|||
27814119|NCT01892722|54270880|FG000|Overall Study|Protocol deviation|0|||
27814120|NCT01892722|54270881|FG001|Overall Study|Protocol deviation|1|||
27814121|NCT01892722|54270880|FG000|Overall Study|Administrative problems|0|||
27814122|NCT01892722|54270881|FG001|Overall Study|Administrative problems|1|||
27814123|NCT01892722|54270880|FG000|Overall Study|Patient/guardian decision|0|||
27814124|NCT01892722|54270881|FG001|Overall Study|Patient/guardian decision|2|||
27814125|NCT01892722|54270880|FG000|Overall Study|Physician Decision|1|||
27814126|NCT01892722|54270881|FG001|Overall Study|Physician Decision|2|||
27814127|NCT01892722|54270880|FG000|Overall Study|Adverse Event|3|||
27814128|NCT01892722|54270881|FG001|Overall Study|Adverse Event|2|||
27814129|NCT01892722|54270880|FG000|Overall Study|Lack of Efficacy|0|||
27814130|NCT01892722|54270881|FG001|Overall Study|Lack of Efficacy|7|||
27814131|NCT01892722|54270880|FG000|Overall Study|Withdrawal by Subject|3|||
27814132|NCT01892722|54270881|FG001|Overall Study|Withdrawal by Subject|5|||
27814133|NCT01687413|54270898|FG000|Overall Study|Withdrawal by Subject|0|||
27814134|NCT01687413|54270899|FG001|Overall Study|Withdrawal by Subject|2|||
27814135|NCT01687413|54270898|FG000|Overall Study|Not eligible|0|||
27814136|NCT01687413|54270899|FG001|Overall Study|Not eligible|2|||
27814137|NCT01687413|54270898|FG000|Overall Study|Patient withdrew before completing all radiotherapy|1|||
27814138|NCT01687413|54270899|FG001|Overall Study|Patient withdrew before completing all radiotherapy|0|||
27814139|NCT01555671|54270925|FG000|Overall Study|Physician Decision|20|||
27814140|NCT01555671|54270926|FG001|Overall Study|Physician Decision|25|||
27814141|NCT01801358|54270940|FG000|Overall Study|Adverse Event|0|||
27814142|NCT01801358|54270941|FG001|Overall Study|Adverse Event|2|||
27814143|NCT01801358|54270942|FG002|Overall Study|Adverse Event|1|||
27814144|NCT01801358|54270943|FG003|Overall Study|Adverse Event|0|||
27814145|NCT01801358|54270944|FG004|Overall Study|Adverse Event|0|||
27814146|NCT01801358|54270945|FG005|Overall Study|Adverse Event|1|||
27814147|NCT01801358|54270940|FG000|Overall Study|Physician Decision|0|||
27814148|NCT01801358|54270941|FG001|Overall Study|Physician Decision|0|||
27814149|NCT01801358|54270942|FG002|Overall Study|Physician Decision|1|||
28057857|NCT00279201|54714092|FG003|Intensification Addendum|Lack of Efficacy|1|||
28057858|NCT00279201|54714093|FG004|Intensification Addendum|Lack of Efficacy|1|||
28057859|NCT00279201|54714094|FG005|Intensification Addendum|Lack of Efficacy|0|||
28057860|NCT00279201|54714089|FG000|Intensification Addendum|Death|0|||
28057861|NCT00279201|54714090|FG001|Intensification Addendum|Death|0|||
28057862|NCT00279201|54714091|FG002|Intensification Addendum|Death|0|||
28057863|NCT00279201|54714092|FG003|Intensification Addendum|Death|0|||
28057864|NCT00279201|54714093|FG004|Intensification Addendum|Death|1|||
28057865|NCT00279201|54714094|FG005|Intensification Addendum|Death|0|||
28057866|NCT00203476|54714130|FG000|Overall Study|Lost to Follow-up|1|||
27814150|NCT01801358|54270943|FG003|Overall Study|Physician Decision|0|||
28057867|NCT00203476|54714131|FG001|Overall Study|Lost to Follow-up|0|||
28057868|NCT00203476|54714132|FG002|Overall Study|Lost to Follow-up|0|||
28057869|NCT00203476|54714130|FG000|Overall Study|Withdrawal by Subject|0|||
28057870|NCT00203476|54714131|FG001|Overall Study|Withdrawal by Subject|1|||
27814151|NCT01801358|54270944|FG004|Overall Study|Physician Decision|0|||
27814152|NCT01801358|54270945|FG005|Overall Study|Physician Decision|0|||
27814153|NCT01801358|54270940|FG000|Overall Study|Progressive Disease|6|||
27814154|NCT01801358|54270941|FG001|Overall Study|Progressive Disease|4|||
27814155|NCT01801358|54270942|FG002|Overall Study|Progressive Disease|4|||
27814156|NCT01801358|54270943|FG003|Overall Study|Progressive Disease|5|||
27814157|NCT01801358|54270944|FG004|Overall Study|Progressive Disease|6|||
27814158|NCT01801358|54270945|FG005|Overall Study|Progressive Disease|5|||
28057871|NCT00203476|54714132|FG002|Overall Study|Withdrawal by Subject|0|||
28057872|NCT00203242|54714140|FG000|Overall Study|Lost to Follow-up|1|||
28057873|NCT00200356|54714146|FG000|Overall Study|Lack of Efficacy|3|||
28057874|NCT00200356|54714147|FG001|Overall Study|Lack of Efficacy|3|||
28057875|NCT00200356|54714146|FG000|Overall Study|Protocol Violation|4|||
28057876|NCT00200356|54714147|FG001|Overall Study|Protocol Violation|4|||
28057877|NCT00200356|54714146|FG000|Overall Study|Nontreatment|1|||
28057878|NCT00200356|54714147|FG001|Overall Study|Nontreatment|0|||
28057879|NCT00227344|54714155|FG000|Overall Study|study terminated early|12|||
28057880|NCT00227344|54714156|FG001|Overall Study|study terminated early|5|||
28057881|NCT00227266|54714165|FG000|Overall Study|Withdrawal by Subject|0|||
28057882|NCT00227266|54714166|FG001|Overall Study|Withdrawal by Subject|0|||
28057883|NCT00227266|54714167|FG002|Overall Study|Withdrawal by Subject|1|||
28057884|NCT00227266|54714165|FG000|Overall Study|Protocol Violation|1|||
28057885|NCT00227266|54714166|FG001|Overall Study|Protocol Violation|0|||
28057886|NCT00227266|54714167|FG002|Overall Study|Protocol Violation|1|||
28057887|NCT00227266|54714165|FG000|Overall Study|Excessive weight gain|0|||
28057888|NCT00227266|54714166|FG001|Overall Study|Excessive weight gain|0|||
28057889|NCT00227266|54714167|FG002|Overall Study|Excessive weight gain|2|||
28057890|NCT00256282|54714178|FG000|Overall Study|Disease progression, relapse during acti|12|||
28057891|NCT00256282|54714178|FG000|Overall Study|Adverse Event|3|||
27814159|NCT01801358|54270940|FG000|Overall Study|Withdrawal by Subject|0|||
27814160|NCT01801358|54270941|FG001|Overall Study|Withdrawal by Subject|0|||
27814161|NCT01801358|54270942|FG002|Overall Study|Withdrawal by Subject|0|||
27814162|NCT01801358|54270943|FG003|Overall Study|Withdrawal by Subject|1|||
27814163|NCT01801358|54270944|FG004|Overall Study|Withdrawal by Subject|0|||
27814164|NCT01801358|54270945|FG005|Overall Study|Withdrawal by Subject|2|||
27814165|NCT01807598|54270980|FG000|Overall Study|Withdrawal by Subject|4|||
27814166|NCT01807598|54270980|FG000|Overall Study|Adverse Event|1|||
27814167|NCT01807598|54270980|FG000|Overall Study|Other Physician Decision|1|||
27814168|NCT01801280|54270988|FG000|Period 1|Withdrawal by Subject|0|||
27848308|NCT00215657|54341254|FG000|Overall Study|Insufficient testosterone response|5|||
27848309|NCT00215657|54341255|FG001|Overall Study|Insufficient testosterone response|4|||
27848310|NCT00215657|54341256|FG002|Overall Study|Insufficient testosterone response|1|||
28057892|NCT00256282|54714178|FG000|Overall Study|Physician Decision|1|||
28057893|NCT00266877|54714185|FG000|Overall Study|Death|1|||
28057894|NCT00266877|54714186|FG001|Overall Study|Death|1|||
27814169|NCT01801280|54270989|FG001|Period 1|Withdrawal by Subject|1|||
27814170|NCT01801280|54270990|FG002|Period 1|Withdrawal by Subject|0|||
27814171|NCT01801280|54270991|FG003|Period 1|Withdrawal by Subject|0|||
27814172|NCT01801280|54270988|FG000|Period 2|Withdrawal by Subject|1|||
27814173|NCT01801280|54270989|FG001|Period 2|Withdrawal by Subject|0|||
27814174|NCT01801280|54270990|FG002|Period 2|Withdrawal by Subject|0|||
27814175|NCT01801280|54270991|FG003|Period 2|Withdrawal by Subject|0|||
27814176|NCT01801280|54270988|FG000|Period 4|Protocol Violation|0|||
27814177|NCT01801280|54270989|FG001|Period 4|Protocol Violation|0|||
27814178|NCT01801280|54270990|FG002|Period 4|Protocol Violation|1|||
27814179|NCT01801280|54270991|FG003|Period 4|Protocol Violation|0|||
27814180|NCT01769456|54271001|FG000|Overall Study|Lost to Follow-up|19|||
27814181|NCT01769456|54271001|FG000|Overall Study|Withdrawal by Subject|3|||
27814182|NCT01769456|54271001|FG000|Overall Study|Did not receive PCC intervention|6|||
27814183|NCT01769456|54271001|FG000|Overall Study|Moved out of the area|3|||
27814184|NCT01769456|54271001|FG000|Overall Study|No wk 0 visit w/in 30 days of screening|5|||
27814185|NCT01769456|54271001|FG000|Overall Study|Parental request to youth to withdraw|1|||
27814186|NCT01769378|54271008|FG000|Overall Study|Adverse Event|10|||
27814187|NCT01769378|54271009|FG001|Overall Study|Adverse Event|0|||
27814188|NCT01769378|54271008|FG000|Overall Study|Entry criteria not met|1|||
27814189|NCT01769378|54271009|FG001|Overall Study|Entry criteria not met|0|||
27814190|NCT01769378|54271008|FG000|Overall Study|Protocol Violation|1|||
27814191|NCT01769378|54271009|FG001|Overall Study|Protocol Violation|1|||
27814192|NCT01769378|54271008|FG000|Overall Study|Withdrawal by Subject|10|||
27814193|NCT01769378|54271009|FG001|Overall Study|Withdrawal by Subject|3|||
27814194|NCT01769378|54271008|FG000|Overall Study|Sponsor Decision|1|||
28057895|NCT00266877|54714187|FG002|Overall Study|Death|1|||
28057896|NCT00266877|54714185|FG000|Overall Study|Adverse Event|6|||
28057897|NCT00266877|54714186|FG001|Overall Study|Adverse Event|4|||
27814195|NCT01769378|54271009|FG001|Overall Study|Sponsor Decision|0|||
28057898|NCT00266877|54714187|FG002|Overall Study|Adverse Event|1|||
28057899|NCT00266877|54714185|FG000|Overall Study|Physician Decision|2|||
28057900|NCT00266877|54714186|FG001|Overall Study|Physician Decision|1|||
28057901|NCT00266877|54714187|FG002|Overall Study|Physician Decision|1|||
27814196|NCT01769378|54271008|FG000|Overall Study|Lost to Follow-up|2|||
27814197|NCT01769378|54271009|FG001|Overall Study|Lost to Follow-up|0|||
27814198|NCT01807520|54271018|FG000|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
27848311|NCT00215657|54341257|FG003|Overall Study|Insufficient testosterone response|12|||
28057902|NCT00266877|54714185|FG000|Overall Study|Withdrawal by Subject|3|||
27814199|NCT01807520|54271019|FG001|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1|||
28105727|NCT01369498|54763339|FG003|Overall Study|Adverse Event|1|||
27814200|NCT01807520|54271020|FG002|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3|||
27814201|NCT01807520|54271021|FG003|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
27814202|NCT01807520|54271022|FG004|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
27814203|NCT01807520|54271023|FG005|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
27814204|NCT01807520|54271024|FG006|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
27814205|NCT01807520|54271018|FG000|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
27814206|NCT01807520|54271019|FG001|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
27814207|NCT01807520|54271020|FG002|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
27814208|NCT01807520|54271021|FG003|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
27814209|NCT01807520|54271022|FG004|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
27814210|NCT01807520|54271023|FG005|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
27814211|NCT01807520|54271024|FG006|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
27814212|NCT01807520|54271018|FG000|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
27814213|NCT01807520|54271019|FG001|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
27814214|NCT01807520|54271020|FG002|Treatment Period 1 (0-16 Weeks)|Physician Decision|1|||
27814215|NCT01807520|54271021|FG003|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
27814216|NCT01807520|54271022|FG004|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
27814217|NCT01807520|54271023|FG005|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
27814218|NCT01807520|54271024|FG006|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
27814219|NCT01807520|54271018|FG000|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1|||
27814220|NCT01807520|54271019|FG001|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
27814221|NCT01807520|54271020|FG002|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
27814222|NCT01807520|54271021|FG003|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
27814223|NCT01807520|54271022|FG004|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
27814224|NCT01807520|54271023|FG005|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
27814225|NCT01807520|54271024|FG006|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
27814226|NCT01807520|54271018|FG000|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
27814227|NCT01807520|54271019|FG001|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
27814228|NCT01807520|54271020|FG002|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2|||
27814229|NCT01807520|54271021|FG003|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
27814230|NCT01807520|54271022|FG004|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
27814231|NCT01807520|54271023|FG005|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
27814232|NCT01807520|54271024|FG006|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
27814233|NCT01807520|54271018|FG000|Treatment Period 1 (0-16 Weeks)|Adverse Event|2|||
27814234|NCT01807520|54271019|FG001|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
27814235|NCT01807520|54271020|FG002|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
27814236|NCT01807520|54271021|FG003|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
27814237|NCT01807520|54271022|FG004|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
27814238|NCT01807520|54271023|FG005|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
27814239|NCT01807520|54271024|FG006|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
27814240|NCT01807520|54271018|FG000|Treatment Period 2 (16-132 Weeks)|Study terminated|7|||
27814241|NCT01807520|54271019|FG001|Treatment Period 2 (16-132 Weeks)|Study terminated|4|||
27814242|NCT01807520|54271020|FG002|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
27814243|NCT01807520|54271021|FG003|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
27814244|NCT01807520|54271022|FG004|Treatment Period 2 (16-132 Weeks)|Study terminated|2|||
27814245|NCT01807520|54271023|FG005|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
27814246|NCT01807520|54271024|FG006|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
27814247|NCT01807520|54271018|FG000|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
27814248|NCT01807520|54271019|FG001|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
27814249|NCT01807520|54271020|FG002|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
27814250|NCT01807520|54271021|FG003|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1|||
27814251|NCT01807520|54271022|FG004|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
27814252|NCT01807520|54271023|FG005|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
27814253|NCT01807520|54271024|FG006|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
27814254|NCT01807520|54271018|FG000|Treatment Period 2 (16-132 Weeks)|Pregnancy|1|||
27814255|NCT01807520|54271019|FG001|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
27814256|NCT01807520|54271020|FG002|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
27814257|NCT01807520|54271021|FG003|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
27814258|NCT01807520|54271022|FG004|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
27814259|NCT01807520|54271023|FG005|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
27814260|NCT01807520|54271024|FG006|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
27814261|NCT01807520|54271018|FG000|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
28057903|NCT00266877|54714186|FG001|Overall Study|Withdrawal by Subject|1|||
28057904|NCT00266877|54714187|FG002|Overall Study|Withdrawal by Subject|1|||
27814262|NCT01807520|54271019|FG001|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2|||
27814263|NCT01807520|54271020|FG002|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
27814264|NCT01807520|54271021|FG003|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
27814265|NCT01807520|54271022|FG004|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
27814266|NCT01807520|54271023|FG005|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
27814267|NCT01807520|54271024|FG006|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
27814268|NCT01807520|54271018|FG000|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4|||
27814269|NCT01807520|54271019|FG001|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
27814270|NCT01807520|54271020|FG002|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
27814271|NCT01807520|54271021|FG003|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1|||
27814272|NCT01807520|54271022|FG004|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
27814273|NCT01807520|54271023|FG005|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
27814274|NCT01807520|54271024|FG006|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
27814275|NCT01807520|54271018|FG000|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5|||
27814276|NCT01807520|54271019|FG001|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3|||
27814277|NCT01807520|54271020|FG002|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
27814278|NCT01807520|54271021|FG003|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
27814279|NCT01807520|54271022|FG004|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1|||
27814280|NCT01807520|54271023|FG005|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
27814281|NCT01807520|54271024|FG006|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
27814282|NCT01807520|54271018|FG000|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
27814283|NCT01807520|54271019|FG001|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
27814284|NCT01807520|54271020|FG002|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
27814285|NCT01807520|54271021|FG003|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
27814286|NCT01807520|54271022|FG004|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
27814287|NCT01807520|54271023|FG005|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
27814288|NCT01807520|54271024|FG006|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
27814289|NCT01807520|54271018|FG000|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5|||
27814290|NCT01807520|54271019|FG001|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6|||
27814291|NCT01807520|54271020|FG002|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
27814292|NCT01807520|54271021|FG003|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
27814293|NCT01807520|54271022|FG004|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
27814294|NCT01807520|54271023|FG005|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
27814295|NCT01807520|54271024|FG006|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
27814296|NCT01807520|54271018|FG000|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
27814297|NCT01807520|54271019|FG001|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
27814298|NCT01807520|54271020|FG002|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
27814299|NCT01807520|54271021|FG003|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
27814300|NCT01807520|54271022|FG004|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
27814301|NCT01807520|54271023|FG005|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1|||
27814302|NCT01807520|54271024|FG006|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
27814303|NCT01807520|54271018|FG000|Follow-up Period (132-140 Weeks)|Study terminated|0|||
27814304|NCT01807520|54271019|FG001|Follow-up Period (132-140 Weeks)|Study terminated|0|||
27814305|NCT01807520|54271020|FG002|Follow-up Period (132-140 Weeks)|Study terminated|0|||
27814306|NCT01807520|54271021|FG003|Follow-up Period (132-140 Weeks)|Study terminated|0|||
27814307|NCT01807520|54271022|FG004|Follow-up Period (132-140 Weeks)|Study terminated|0|||
27814308|NCT01807520|54271023|FG005|Follow-up Period (132-140 Weeks)|Study terminated|1|||
27814309|NCT01807520|54271024|FG006|Follow-up Period (132-140 Weeks)|Study terminated|0|||
27814310|NCT01807520|54271018|FG000|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
27814311|NCT01807520|54271019|FG001|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
27814312|NCT01807520|54271020|FG002|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
27814313|NCT01807520|54271021|FG003|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
27814314|NCT01807520|54271022|FG004|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
27814315|NCT01807520|54271023|FG005|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2|||
28057905|NCT00266877|54714185|FG000|Overall Study|Disease Progression|72|||
28057906|NCT00266877|54714186|FG001|Overall Study|Disease Progression|37|||
28057907|NCT00266877|54714187|FG002|Overall Study|Disease Progression|23|||
28057908|NCT00266877|54714185|FG000|Overall Study|Symptomatic Deterioration|6|||
28057909|NCT00266877|54714186|FG001|Overall Study|Symptomatic Deterioration|3|||
28057910|NCT00266877|54714187|FG002|Overall Study|Symptomatic Deterioration|1|||
28057911|NCT00266877|54714185|FG000|Overall Study|Hospitalization|1|||
28057912|NCT00266877|54714186|FG001|Overall Study|Hospitalization|0|||
27814316|NCT01807520|54271024|FG006|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1|||
27814317|NCT01806896|54271037|FG000|Overall Study|Adverse Event|2|||
27814318|NCT01806896|54271038|FG001|Overall Study|Adverse Event|0|||
27814319|NCT01806896|54271037|FG000|Overall Study|Other|1|||
27814320|NCT01806896|54271038|FG001|Overall Study|Other|0|||
27814321|NCT01768676|54271046|FG000|Overall Study|Adverse Event|3|||
27814322|NCT01768676|54271047|FG001|Overall Study|Adverse Event|3|||
27814323|NCT01768676|54271046|FG000|Overall Study|Lost to Follow-up|13|||
27814324|NCT01768676|54271047|FG001|Overall Study|Lost to Follow-up|16|||
27814325|NCT01768676|54271046|FG000|Overall Study|Protocol Violation|1|||
28057913|NCT00266877|54714187|FG002|Overall Study|Hospitalization|0|||
28057914|NCT00266877|54714185|FG000|Overall Study|Concomitant Radiotherapy|0|||
28057915|NCT00266877|54714186|FG001|Overall Study|Concomitant Radiotherapy|1|||
28057916|NCT00266877|54714187|FG002|Overall Study|Concomitant Radiotherapy|0|||
28057917|NCT00256204|54714199|FG000|Overall Study|Adverse Event|10|||
28057918|NCT00256204|54714200|FG001|Overall Study|Adverse Event|14|||
28057919|NCT00256204|54714201|FG002|Overall Study|Adverse Event|16|||
28057920|NCT00256204|54714202|FG003|Overall Study|Adverse Event|14|||
28057921|NCT00256204|54714199|FG000|Overall Study|Death|0|||
28057922|NCT00256204|54714200|FG001|Overall Study|Death|1|||
27814326|NCT01768676|54271047|FG001|Overall Study|Protocol Violation|1|||
27814327|NCT01768676|54271046|FG000|Overall Study|Physician Decision|4|||
28057923|NCT00256204|54714201|FG002|Overall Study|Death|0|||
28057924|NCT00256204|54714202|FG003|Overall Study|Death|0|||
28057925|NCT00256204|54714199|FG000|Overall Study|Lost to Follow-up|1|||
28057926|NCT00256204|54714200|FG001|Overall Study|Lost to Follow-up|1|||
27814328|NCT01768676|54271047|FG001|Overall Study|Physician Decision|1|||
27814329|NCT01768676|54271046|FG000|Overall Study|Withdrawal by Subject|3|||
28057927|NCT00256204|54714201|FG002|Overall Study|Lost to Follow-up|1|||
28057928|NCT00256204|54714202|FG003|Overall Study|Lost to Follow-up|2|||
27814330|NCT01768676|54271047|FG001|Overall Study|Withdrawal by Subject|10|||
27814331|NCT01555125|54271056|FG000|Induction Period|Lost to Follow-up|0|||
28057929|NCT00256204|54714199|FG000|Overall Study|Protocol Violation|1|||
28057930|NCT00256204|54714200|FG001|Overall Study|Protocol Violation|0|||
28057931|NCT00256204|54714201|FG002|Overall Study|Protocol Violation|2|||
28057932|NCT00256204|54714202|FG003|Overall Study|Protocol Violation|1|||
28057933|NCT00256204|54714199|FG000|Overall Study|Physician Decision|0|||
27814332|NCT01555125|54271057|FG001|Induction Period|Lost to Follow-up|2|||
27814333|NCT01555125|54271058|FG002|Induction Period|Lost to Follow-up|0|||
27814334|NCT01555125|54271059|FG003|Induction Period|Lost to Follow-up|0|||
27940008|NCT01198002|54596329|FG001|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216|||
27940009|NCT01198002|54596330|FG002|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224|||
28057934|NCT00256204|54714200|FG001|Overall Study|Physician Decision|0|||
28057935|NCT00256204|54714201|FG002|Overall Study|Physician Decision|1|||
28057936|NCT00256204|54714202|FG003|Overall Study|Physician Decision|2|||
28057937|NCT00256204|54714199|FG000|Overall Study|Withdrawal by Subject|17|||
28057938|NCT00256204|54714200|FG001|Overall Study|Withdrawal by Subject|6|||
28057939|NCT00256204|54714201|FG002|Overall Study|Withdrawal by Subject|7|||
28057940|NCT00256204|54714202|FG003|Overall Study|Withdrawal by Subject|5|||
28057941|NCT00256204|54714199|FG000|Overall Study|Need for additional prohibited treatment|38|||
28057942|NCT00256204|54714200|FG001|Overall Study|Need for additional prohibited treatment|28|||
28057943|NCT00256204|54714201|FG002|Overall Study|Need for additional prohibited treatment|27|||
28057944|NCT00256204|54714202|FG003|Overall Study|Need for additional prohibited treatment|25|||
28057945|NCT00256126|54714217|FG000|Overall Study|Adverse Event|1|||
28057946|NCT00256126|54714218|FG001|Overall Study|Adverse Event|0|||
28057947|NCT00256126|54714217|FG000|Overall Study|Other|1|||
28057948|NCT00256126|54714218|FG001|Overall Study|Other|2|||
28057949|NCT00278889|54714227|FG000|Overall Study|Withdrawal by Subject|0|||
28057950|NCT00278889|54714228|FG001|Overall Study|Withdrawal by Subject|5|||
28057951|NCT00278889|54714229|FG002|Overall Study|Withdrawal by Subject|3|||
28057952|NCT00278889|54714227|FG000|Overall Study|Lost to Follow-up|1|||
28057953|NCT00278889|54714228|FG001|Overall Study|Lost to Follow-up|1|||
28057954|NCT00278889|54714229|FG002|Overall Study|Lost to Follow-up|0|||
28057955|NCT00278889|54714227|FG000|Overall Study|Death|24|||
28057956|NCT00278889|54714228|FG001|Overall Study|Death|21|||
28057957|NCT00278889|54714229|FG002|Overall Study|Death|17|||
28057958|NCT00278109|54714237|FG000|Overall Study|Adverse Event|3|||
28057959|NCT00278109|54714237|FG000|Overall Study|social circumstances|1|||
28057960|NCT00296517|54714243|FG000|Dose Level 2 - Week 2|Adverse Event|1|||
28057961|NCT00296517|54714244|FG001|Dose Level 2 - Week 2|Adverse Event|5|||
28057962|NCT00296517|54714243|FG000|Dose Level 2 - Week 2|Withdrawal by Subject|1|||
28057963|NCT00296517|54714244|FG001|Dose Level 2 - Week 2|Withdrawal by Subject|0|||
28057964|NCT00296517|54714243|FG000|Dose Level 3 - Weeks 3-12|Adverse Event|30|||
28057965|NCT00296517|54714244|FG001|Dose Level 3 - Weeks 3-12|Adverse Event|34|||
28057966|NCT00296517|54714243|FG000|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3|||
28057967|NCT00296517|54714244|FG001|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6|||
28057968|NCT00296517|54714243|FG000|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3|||
28057969|NCT00296517|54714244|FG001|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2|||
28057970|NCT00296517|54714243|FG000|Dose Level 3 - Weeks 3-12|Protocol Violation|1|||
28057971|NCT00296517|54714244|FG001|Dose Level 3 - Weeks 3-12|Protocol Violation|0|||
27814335|NCT01555125|54271060|FG004|Induction Period|Lost to Follow-up|0|||
27848312|NCT00215657|54341258|FG004|Overall Study|Insufficient testosterone response|8|||
28057972|NCT00296517|54714243|FG000|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7|||
28057973|NCT00296517|54714244|FG001|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18|||
28057974|NCT00296517|54714243|FG000|Dose Level 3 - Weeks 3-12|Non - Compliance|1|||
28057975|NCT00296517|54714244|FG001|Dose Level 3 - Weeks 3-12|Non - Compliance|0|||
28057976|NCT00296517|54714243|FG000|Dose Level 3 - Weeks 3-12|Other|0|||
28057977|NCT00296517|54714244|FG001|Dose Level 3 - Weeks 3-12|Other|2|||
28057978|NCT00224770|54714253|FG000|Overall Study|Lost to Follow-up|4|||
28057979|NCT00224770|54714254|FG001|Overall Study|Lost to Follow-up|2|||
28057980|NCT00224770|54714255|FG002|Overall Study|Lost to Follow-up|0|||
27814336|NCT01555125|54271056|FG000|Induction Period|Adverse Event|0|||
28057981|NCT00266409|54714268|FG000|Overall Study|Lack of Efficacy|2|||
28057982|NCT00266409|54714269|FG001|Overall Study|Lack of Efficacy|6|||
28057983|NCT00266409|54714270|FG002|Overall Study|Lack of Efficacy|1|||
28057984|NCT00266409|54714271|FG003|Overall Study|Lack of Efficacy|2|||
28057985|NCT00266409|54714268|FG000|Overall Study|Adverse Event|7|||
28057986|NCT00266409|54714269|FG001|Overall Study|Adverse Event|2|||
28057987|NCT00266409|54714270|FG002|Overall Study|Adverse Event|1|||
28057988|NCT00266409|54714271|FG003|Overall Study|Adverse Event|1|||
28057989|NCT00266409|54714268|FG000|Overall Study|Lost to Follow-up|18|||
28057990|NCT00266409|54714269|FG001|Overall Study|Lost to Follow-up|21|||
28057991|NCT00266409|54714270|FG002|Overall Study|Lost to Follow-up|6|||
28057992|NCT00266409|54714271|FG003|Overall Study|Lost to Follow-up|8|||
28057993|NCT00266409|54714268|FG000|Overall Study|Withdrawal by Subject|6|||
28057994|NCT00266409|54714269|FG001|Overall Study|Withdrawal by Subject|10|||
28057995|NCT00266409|54714270|FG002|Overall Study|Withdrawal by Subject|3|||
28057996|NCT00266409|54714271|FG003|Overall Study|Withdrawal by Subject|9|||
28057997|NCT00266409|54714268|FG000|Overall Study|Protocol Violation|5|||
28057998|NCT00266409|54714269|FG001|Overall Study|Protocol Violation|3|||
28057999|NCT00266409|54714270|FG002|Overall Study|Protocol Violation|4|||
27814337|NCT01555125|54271057|FG001|Induction Period|Adverse Event|1|||
27814338|NCT01555125|54271058|FG002|Induction Period|Adverse Event|0|||
27814339|NCT01555125|54271059|FG003|Induction Period|Adverse Event|0|||
27814340|NCT01555125|54271060|FG004|Induction Period|Adverse Event|1|||
27814341|NCT01555125|54271056|FG000|Induction Period|Subject / guardian decision|0|||
27814342|NCT01555125|54271057|FG001|Induction Period|Subject / guardian decision|0|||
27814343|NCT01555125|54271058|FG002|Induction Period|Subject / guardian decision|0|||
27814344|NCT01555125|54271059|FG003|Induction Period|Subject / guardian decision|0|||
27814345|NCT01555125|54271060|FG004|Induction Period|Subject / guardian decision|2|||
27814346|NCT01555125|54271056|FG000|Induction Period|Death|1|||
27814347|NCT01555125|54271057|FG001|Induction Period|Death|0|||
27814348|NCT01555125|54271058|FG002|Induction Period|Death|0|||
27814349|NCT01555125|54271059|FG003|Induction Period|Death|0|||
27814350|NCT01555125|54271060|FG004|Induction Period|Death|0|||
27814351|NCT01555125|54271056|FG000|Maintenance Period|Adverse Event|1|||
27814352|NCT01555125|54271057|FG001|Maintenance Period|Adverse Event|1|||
27814353|NCT01555125|54271058|FG002|Maintenance Period|Adverse Event|0|||
27814354|NCT01555125|54271059|FG003|Maintenance Period|Adverse Event|0|||
27814355|NCT01555125|54271060|FG004|Maintenance Period|Adverse Event|0|||
27814356|NCT01555125|54271056|FG000|Maintenance Period|Subject / guardian decision|1|||
27814357|NCT01555125|54271057|FG001|Maintenance Period|Subject / guardian decision|2|||
27814358|NCT01555125|54271058|FG002|Maintenance Period|Subject / guardian decision|0|||
27814359|NCT01555125|54271059|FG003|Maintenance Period|Subject / guardian decision|0|||
27814360|NCT01555125|54271060|FG004|Maintenance Period|Subject / guardian decision|0|||
27814361|NCT01555125|54271056|FG000|Maintenance Period|Lost to Follow-up|2|||
27814362|NCT01555125|54271057|FG001|Maintenance Period|Lost to Follow-up|0|||
27814363|NCT01555125|54271058|FG002|Maintenance Period|Lost to Follow-up|0|||
27814364|NCT01555125|54271059|FG003|Maintenance Period|Lost to Follow-up|1|||
27814365|NCT01555125|54271060|FG004|Maintenance Period|Lost to Follow-up|0|||
27814366|NCT01555125|54271056|FG000|Maintenance Period|Lack of Efficacy|6|||
27814367|NCT01555125|54271057|FG001|Maintenance Period|Lack of Efficacy|1|||
27814368|NCT01555125|54271058|FG002|Maintenance Period|Lack of Efficacy|3|||
27814369|NCT01555125|54271059|FG003|Maintenance Period|Lack of Efficacy|0|||
27814370|NCT01555125|54271060|FG004|Maintenance Period|Lack of Efficacy|0|||
27814371|NCT01555125|54271056|FG000|Maintenance Period|Physician Decision|0|||
27814372|NCT01555125|54271057|FG001|Maintenance Period|Physician Decision|0|||
28058000|NCT00266409|54714271|FG003|Overall Study|Protocol Violation|2|||
27814373|NCT01555125|54271058|FG002|Maintenance Period|Physician Decision|1|||
28058001|NCT00266409|54714268|FG000|Overall Study|Other|7|||
27814374|NCT01555125|54271059|FG003|Maintenance Period|Physician Decision|0|||
27814375|NCT01555125|54271060|FG004|Maintenance Period|Physician Decision|0|||
27814376|NCT01555125|54271056|FG000|Maintenance Period|Death|0|||
27814377|NCT01555125|54271057|FG001|Maintenance Period|Death|0|||
27814378|NCT01555125|54271058|FG002|Maintenance Period|Death|0|||
27814379|NCT01555125|54271059|FG003|Maintenance Period|Death|1|||
27814380|NCT01555125|54271060|FG004|Maintenance Period|Death|0|||
28058002|NCT00266409|54714269|FG001|Overall Study|Other|4|||
27814381|NCT01555125|54271056|FG000|Extension|Adverse Event|1|||
28058003|NCT00266409|54714270|FG002|Overall Study|Other|2|||
28058004|NCT00266409|54714271|FG003|Overall Study|Other|0|||
28058005|NCT00277095|54714281|FG000|Overall Study|Death|2|||
28058006|NCT00277095|54714281|FG000|Overall Study|Explanted|7|||
28058007|NCT00277095|54714281|FG000|Overall Study|Lost to Follow-up|2|||
28058008|NCT00277095|54714281|FG000|Overall Study|Missed Follow-up|9|||
28058009|NCT00277095|54714281|FG000|Overall Study|Physician Decision|1|||
28058010|NCT00265785|54714285|FG000|Overall Study|Adverse Event|4|||
28058011|NCT00265785|54714285|FG000|Overall Study|Withdrawal by Subject|3|||
28058012|NCT00265785|54714285|FG000|Overall Study|Progression/Relapse|15|||
28058013|NCT00265785|54714285|FG000|Overall Study|Not protocol specified|2|||
28058014|NCT00265785|54714285|FG000|Overall Study|Ineligible|1|||
28058015|NCT00265785|54714285|FG000|Overall Study|Did not receive protocol treatment|2|||
28058016|NCT00276159|54714289|FG000|Overall Study|Did not receive all 24 doses of 852A|6|||
28058017|NCT00265395|54714295|FG000|Overall Study|Adverse Event|3|||
28058018|NCT00265395|54714296|FG001|Overall Study|Adverse Event|6|||
28058019|NCT00265395|54714295|FG000|Overall Study|Lost to Follow-up|2|||
28058020|NCT00265395|54714296|FG001|Overall Study|Lost to Follow-up|1|||
28058021|NCT00265395|54714295|FG000|Overall Study|Withdrawal by Subject|1|||
28058022|NCT00265395|54714296|FG001|Overall Study|Withdrawal by Subject|6|||
28058023|NCT00265395|54714295|FG000|Overall Study|Protocol Violation|2|||
28058024|NCT00265395|54714296|FG001|Overall Study|Protocol Violation|2|||
28058025|NCT00265395|54714295|FG000|Overall Study|Lack of Efficacy|0|||
28058026|NCT00265395|54714296|FG001|Overall Study|Lack of Efficacy|1|||
28058027|NCT00265395|54714295|FG000|Overall Study|Administrative|0|||
28058028|NCT00265395|54714296|FG001|Overall Study|Administrative|1|||
28058029|NCT00195442|54714301|FG000|Overall Study|Less than expected therapeutic effect|38|||
28058030|NCT00195442|54714301|FG000|Overall Study|Lost to Follow-up|27|||
28058031|NCT00195442|54714301|FG000|Overall Study|Switch to other Factor VIII preparation|23|||
28058032|NCT00195442|54714301|FG000|Overall Study|Intermittent product shortage|21|||
28058033|NCT00195442|54714301|FG000|Overall Study|Death|7|||
28058034|NCT00195442|54714301|FG000|Overall Study|No reason specified|4|||
28058035|NCT00195442|54714301|FG000|Overall Study|Poor cooperation|2|||
28058036|NCT00195442|54714301|FG000|Overall Study|Other|14|||
28058037|NCT00275301|54714305|FG000|Overall Study|Adverse Event|5|||
28058038|NCT00251745|54714312|FG000|Overall Study|Adverse Event|7|||
28058039|NCT00251745|54714313|FG001|Overall Study|Adverse Event|9|||
28058040|NCT00251745|54714314|FG002|Overall Study|Adverse Event|11|||
28058041|NCT00251745|54714312|FG000|Overall Study|Lost to Follow-up|4|||
28058042|NCT00251745|54714313|FG001|Overall Study|Lost to Follow-up|2|||
28058043|NCT00251745|54714314|FG002|Overall Study|Lost to Follow-up|5|||
28058044|NCT00251745|54714312|FG000|Overall Study|Withdrawal by Subject|13|||
28058045|NCT00251745|54714313|FG001|Overall Study|Withdrawal by Subject|7|||
28058046|NCT00251745|54714314|FG002|Overall Study|Withdrawal by Subject|3|||
28058047|NCT00251745|54714312|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
28058048|NCT00251745|54714313|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
28058049|NCT00251745|54714314|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
28058050|NCT00251745|54714312|FG000|Overall Study|Lack of Efficacy|3|||
28058051|NCT00251745|54714313|FG001|Overall Study|Lack of Efficacy|0|||
28058052|NCT00251745|54714314|FG002|Overall Study|Lack of Efficacy|0|||
28058053|NCT00251745|54714312|FG000|Overall Study|Noncompliant|0|||
28058054|NCT00251745|54714313|FG001|Overall Study|Noncompliant|2|||
28058055|NCT00251745|54714314|FG002|Overall Study|Noncompliant|2|||
28058056|NCT00251745|54714312|FG000|Overall Study|Pregnancy|0|||
28058057|NCT00251745|54714313|FG001|Overall Study|Pregnancy|1|||
28058058|NCT00251745|54714314|FG002|Overall Study|Pregnancy|0|||
28058059|NCT00251745|54714312|FG000|Overall Study|Per Subject Request|0|||
28058060|NCT00251745|54714313|FG001|Overall Study|Per Subject Request|0|||
28058061|NCT00251745|54714314|FG002|Overall Study|Per Subject Request|1|||
28058062|NCT00251745|54714312|FG000|Overall Study|Per Investigator Request|1|||
28058063|NCT00251745|54714313|FG001|Overall Study|Per Investigator Request|0|||
28058064|NCT00251745|54714314|FG002|Overall Study|Per Investigator Request|0|||
28058065|NCT00255190|54714324|FG000|Overall Study|Adverse Event|17|||
28058066|NCT00255190|54714325|FG001|Overall Study|Adverse Event|36|||
28058067|NCT00255190|54714324|FG000|Overall Study|Protocol Violation|2|||
28058068|NCT00255190|54714325|FG001|Overall Study|Protocol Violation|2|||
28058069|NCT00255190|54714324|FG000|Overall Study|Lost to Follow-up|10|||
28058070|NCT00255190|54714325|FG001|Overall Study|Lost to Follow-up|27|||
28058071|NCT00255190|54714324|FG000|Overall Study|Withdrew Consent|17|||
28058072|NCT00255190|54714325|FG001|Overall Study|Withdrew Consent|48|||
28058073|NCT00255190|54714324|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
28058074|NCT00255190|54714325|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
28058075|NCT00255190|54714324|FG000|Overall Study|Erosive esophagitis not healed|0|||
27814382|NCT01555125|54271057|FG001|Extension|Adverse Event|2|||
27814383|NCT01555125|54271058|FG002|Extension|Adverse Event|1|||
28058076|NCT00255190|54714325|FG001|Overall Study|Erosive esophagitis not healed|20|||
28058077|NCT00255190|54714324|FG000|Overall Study|Various|4|||
28058078|NCT00255190|54714325|FG001|Overall Study|Various|23|||
28058079|NCT00359424|54714333|FG000|Overall Study|Death|99|||
28058080|NCT00359424|54714334|FG001|Overall Study|Death|58|||
28058081|NCT00359424|54714333|FG000|Overall Study|Lost to Follow-up|19|||
28058082|NCT00359424|54714334|FG001|Overall Study|Lost to Follow-up|7|||
28058083|NCT00359424|54714333|FG000|Overall Study|Withdrawal by Subject|10|||
28058084|NCT00359424|54714334|FG001|Overall Study|Withdrawal by Subject|2|||
28058085|NCT00359424|54714333|FG000|Overall Study|follow up not conducted|2|||
28058086|NCT00359424|54714334|FG001|Overall Study|follow up not conducted|0|||
28058087|NCT00255034|54714342|FG000|Overall Study|Withdrawal by Subject|15|||
28058088|NCT00255034|54714343|FG001|Overall Study|Withdrawal by Subject|38|||
28058089|NCT00254566|54714351|FG000|Overall Study|Death|1|||
28058090|NCT00254566|54714352|FG001|Overall Study|Death|0|||
28058091|NCT00254566|54714351|FG000|Overall Study|Adverse Event|5|||
28058092|NCT00254566|54714352|FG001|Overall Study|Adverse Event|4|||
28058093|NCT00254566|54714351|FG000|Overall Study|Lack of Efficacy|12|||
28058094|NCT00254566|54714352|FG001|Overall Study|Lack of Efficacy|9|||
28058095|NCT00254566|54714351|FG000|Overall Study|Other|1|||
27814384|NCT01555125|54271059|FG003|Extension|Adverse Event|1|||
28058096|NCT00254566|54714352|FG001|Overall Study|Other|5|||
28058097|NCT00254566|54714351|FG000|Overall Study|Withdrawal by Subject|5|||
28058098|NCT00254566|54714352|FG001|Overall Study|Withdrawal by Subject|6|||
28058099|NCT00254566|54714351|FG000|Overall Study|Lost to Follow-up|7|||
28058100|NCT00254566|54714352|FG001|Overall Study|Lost to Follow-up|2|||
27814385|NCT01555125|54271060|FG004|Extension|Adverse Event|0|||
27814386|NCT01555125|54271056|FG000|Extension|Protocol deviation|1|||
27814387|NCT01555125|54271057|FG001|Extension|Protocol deviation|0|||
27814388|NCT01555125|54271058|FG002|Extension|Protocol deviation|0|||
27814389|NCT01555125|54271059|FG003|Extension|Protocol deviation|0|||
27814390|NCT01555125|54271060|FG004|Extension|Protocol deviation|0|||
27814391|NCT01555125|54271056|FG000|Extension|Lack of Efficacy|7|||
27814392|NCT01555125|54271057|FG001|Extension|Lack of Efficacy|6|||
27814393|NCT01555125|54271058|FG002|Extension|Lack of Efficacy|3|||
27814394|NCT01555125|54271059|FG003|Extension|Lack of Efficacy|0|||
27814395|NCT01555125|54271060|FG004|Extension|Lack of Efficacy|0|||
27814396|NCT01555125|54271056|FG000|Extension|Lost to Follow-up|2|||
27814397|NCT01555125|54271057|FG001|Extension|Lost to Follow-up|1|||
27814398|NCT01555125|54271058|FG002|Extension|Lost to Follow-up|2|||
27814399|NCT01555125|54271059|FG003|Extension|Lost to Follow-up|0|||
27814400|NCT01555125|54271060|FG004|Extension|Lost to Follow-up|0|||
27814401|NCT01555125|54271056|FG000|Extension|Study terminated by sponsor|32|||
27814402|NCT01555125|54271057|FG001|Extension|Study terminated by sponsor|33|||
27814403|NCT01555125|54271058|FG002|Extension|Study terminated by sponsor|16|||
27814404|NCT01555125|54271059|FG003|Extension|Study terminated by sponsor|20|||
27814405|NCT01555125|54271060|FG004|Extension|Study terminated by sponsor|0|||
27814406|NCT01555125|54271056|FG000|Extension|Subject/guardian decision|1|||
27814407|NCT01555125|54271057|FG001|Extension|Subject/guardian decision|9|||
27814408|NCT01555125|54271058|FG002|Extension|Subject/guardian decision|1|||
27814409|NCT01555125|54271059|FG003|Extension|Subject/guardian decision|0|||
27814410|NCT01555125|54271060|FG004|Extension|Subject/guardian decision|0|||
27814411|NCT01555125|54271056|FG000|Extension|Technical Problems|1|||
27814412|NCT01555125|54271057|FG001|Extension|Technical Problems|0|||
27814413|NCT01555125|54271058|FG002|Extension|Technical Problems|0|||
27814414|NCT01555125|54271059|FG003|Extension|Technical Problems|1|||
27814415|NCT01555125|54271060|FG004|Extension|Technical Problems|0|||
27814416|NCT01555125|54271056|FG000|Follow-Up Period|Lost to Follow-up|1|||
27814417|NCT01555125|54271057|FG001|Follow-Up Period|Lost to Follow-up|0|||
27940010|NCT01198002|54596328|FG000|Treatment Period 2 (Weeks 52-100)|Adverse Event|2|||
27940011|NCT01198002|54596329|FG001|Treatment Period 2 (Weeks 52-100)|Adverse Event|0|||
27940012|NCT01198002|54596330|FG002|Treatment Period 2 (Weeks 52-100)|Adverse Event|1|||
28058101|NCT00358956|54714358|FG000|Overall Study|Adverse Event|3|||
28058102|NCT00358956|54714358|FG000|Overall Study|condition under investigation worsened|4|||
28058103|NCT00358956|54714358|FG000|Overall Study|Withdrawal by Subject|1|||
28058104|NCT03830892|54714364|FG000|Overall Study|Physician Decision|2|||
28058105|NCT03830892|54714365|FG001|Overall Study|Physician Decision|3|||
28058106|NCT03830892|54714364|FG000|Overall Study|Study terminated due to COVID|4|||
28058107|NCT03830892|54714365|FG001|Overall Study|Study terminated due to COVID|0|||
27814418|NCT01555125|54271058|FG002|Follow-Up Period|Lost to Follow-up|0|||
27814419|NCT01555125|54271059|FG003|Follow-Up Period|Lost to Follow-up|0|||
27814420|NCT01555125|54271060|FG004|Follow-Up Period|Lost to Follow-up|0|||
27814421|NCT01555125|54271056|FG000|Follow-Up Period|Subject / guardian decision|3|||
27814422|NCT01555125|54271057|FG001|Follow-Up Period|Subject / guardian decision|1|||
27814423|NCT01555125|54271058|FG002|Follow-Up Period|Subject / guardian decision|1|||
27814424|NCT01555125|54271059|FG003|Follow-Up Period|Subject / guardian decision|1|||
27814425|NCT01555125|54271060|FG004|Follow-Up Period|Subject / guardian decision|0|||
27814426|NCT01768286|54271079|FG000|Overall Study|Randomized But Not Treated|0|||
27814427|NCT01768286|54271080|FG001|Overall Study|Randomized But Not Treated|0|||
27814428|NCT01768286|54271081|FG002|Overall Study|Randomized But Not Treated|1|||
28058108|NCT03830892|54714364|FG000|Overall Study|Protocol Violation|0|||
28058109|NCT03830892|54714365|FG001|Overall Study|Protocol Violation|1|||
28058110|NCT03830892|54714364|FG000|Overall Study|Withdrawal by Subject|0|||
28058111|NCT03830892|54714365|FG001|Overall Study|Withdrawal by Subject|2|||
28058112|NCT00253630|54714371|FG000|Overall Study|ineligible|2|||
28058113|NCT00358644|54714375|FG000|Overall Study|Progressive Disease|21|||
28058114|NCT00358644|54714375|FG000|Overall Study|Adverse Event|7|||
27814429|NCT01768286|54271082|FG003|Overall Study|Randomized But Not Treated|0|||
27814430|NCT01768286|54271079|FG000|Overall Study|Lack of Efficacy|7|||
28058115|NCT00358644|54714375|FG000|Overall Study|Death|11|||
28058116|NCT00358644|54714375|FG000|Overall Study|Withdrawal by Subject|4|||
28058117|NCT00358644|54714375|FG000|Overall Study|Physician Decision|6|||
28058118|NCT00358644|54714375|FG000|Overall Study|Patient not eligible for study|1|||
28058119|NCT00364182|54714382|FG000|First Intervention|Secondary prophylaxis|1|||
27814431|NCT01768286|54271080|FG001|Overall Study|Lack of Efficacy|4|||
28058120|NCT00364182|54714383|FG001|First Intervention|Secondary prophylaxis|0|||
28058121|NCT00364182|54714384|FG002|First Intervention|Secondary prophylaxis|0|||
28058122|NCT00364182|54714382|FG000|First Intervention|Withdrawal by Subject|2|||
28058123|NCT00364182|54714383|FG001|First Intervention|Withdrawal by Subject|0|||
28058124|NCT00364182|54714384|FG002|First Intervention|Withdrawal by Subject|0|||
28058125|NCT00364182|54714382|FG000|Second Intervention|non-compliance|0|||
28058126|NCT00364182|54714383|FG001|Second Intervention|non-compliance|1|||
28058127|NCT00364182|54714384|FG002|Second Intervention|non-compliance|1|||
28058128|NCT00364182|54714382|FG000|Second Intervention|Protocol Violation|0|||
28058129|NCT00364182|54714383|FG001|Second Intervention|Protocol Violation|1|||
28058130|NCT00364182|54714384|FG002|Second Intervention|Protocol Violation|0|||
28058131|NCT00364182|54714382|FG000|Second Intervention|Adverse Event|0|||
28058132|NCT00364182|54714383|FG001|Second Intervention|Adverse Event|0|||
28058133|NCT00364182|54714384|FG002|Second Intervention|Adverse Event|1|||
27814432|NCT01768286|54271081|FG002|Overall Study|Lack of Efficacy|0|||
28058134|NCT00364182|54714382|FG000|Third Intervention|non-compliance|0|||
28058135|NCT00364182|54714383|FG001|Third Intervention|non-compliance|1|||
28058136|NCT00364182|54714384|FG002|Third Intervention|non-compliance|0|||
28058137|NCT00364182|54714382|FG000|Third Intervention|Lost to Follow-up|0|||
28058138|NCT00364182|54714383|FG001|Third Intervention|Lost to Follow-up|0|||
28058139|NCT00364182|54714384|FG002|Third Intervention|Lost to Follow-up|1|||
28058140|NCT00369486|54714399|FG000|4-Week Visit|Missed visit|2|||
28058141|NCT00369486|54714400|FG001|4-Week Visit|Missed visit|2|||
28058142|NCT00369486|54714401|FG002|4-Week Visit|Missed visit|0|||
28058143|NCT00369486|54714402|FG003|4-Week Visit|Missed visit|2|||
28058144|NCT00369486|54714403|FG004|4-Week Visit|Missed visit|1|||
28058145|NCT00369486|54714399|FG000|4-Week Visit|Dropped|0|||
28058146|NCT00369486|54714400|FG001|4-Week Visit|Dropped|0|||
28058147|NCT00369486|54714401|FG002|4-Week Visit|Dropped|1|||
28058148|NCT00369486|54714402|FG003|4-Week Visit|Dropped|0|||
28058149|NCT00369486|54714403|FG004|4-Week Visit|Dropped|0|||
28058150|NCT00369486|54714399|FG000|8-Week Visit|Missed visit|0|||
28058151|NCT00369486|54714400|FG001|8-Week Visit|Missed visit|1|||
28058152|NCT00369486|54714401|FG002|8-Week Visit|Missed visit|0|||
28058153|NCT00369486|54714402|FG003|8-Week Visit|Missed visit|0|||
28058154|NCT00369486|54714403|FG004|8-Week Visit|Missed visit|1|||
28058155|NCT00369486|54714399|FG000|8-Week Visit|Dropped|0|||
28058156|NCT00369486|54714400|FG001|8-Week Visit|Dropped|0|||
28058157|NCT00369486|54714401|FG002|8-Week Visit|Dropped|0|||
28058158|NCT00369486|54714402|FG003|8-Week Visit|Dropped|1|||
28058159|NCT00369486|54714403|FG004|8-Week Visit|Dropped|0|||
28058160|NCT00369486|54714399|FG000|17-Week Visit|Missed visit|0|||
28058161|NCT00369486|54714400|FG001|17-Week Visit|Missed visit|0|||
28058162|NCT00369486|54714401|FG002|17-Week Visit|Missed visit|1|||
28058163|NCT00369486|54714402|FG003|17-Week Visit|Missed visit|1|||
28058164|NCT00369486|54714403|FG004|17-Week Visit|Missed visit|1|||
28058165|NCT00369486|54714399|FG000|34-Week Visit|Dropped|0|||
28058166|NCT00369486|54714400|FG001|34-Week Visit|Dropped|1|||
28058167|NCT00369486|54714401|FG002|34-Week Visit|Dropped|1|||
28058168|NCT00369486|54714402|FG003|34-Week Visit|Dropped|3|||
28058169|NCT00369486|54714403|FG004|34-Week Visit|Dropped|3|||
28058170|NCT00363480|54714415|FG000|Overall Study|Criteria for treatment period not fulfil|1|||
28058171|NCT00363480|54714415|FG000|Overall Study|Adverse Event|4|||
28058172|NCT00363480|54714415|FG000|Overall Study|Lost to Follow-up|5|||
27814433|NCT01768286|54271082|FG003|Overall Study|Lack of Efficacy|1|||
28058173|NCT00363480|54714415|FG000|Overall Study|Withdrawal by Subject|5|||
28058174|NCT00363480|54714415|FG000|Overall Study|Non-compliance of subject|1|||
27814434|NCT01768286|54271079|FG000|Overall Study|Withdrew Consent|0|||
28058175|NCT00363480|54714415|FG000|Overall Study|Participant discontinued on its own|1|||
28058176|NCT00363246|54714419|FG000|Overall Study|Death|40|||
28058177|NCT00363246|54714419|FG000|Overall Study|Withdrawal by Subject|19|||
28058178|NCT00363246|54714419|FG000|Overall Study|Lost to Follow-up|14|||
28058179|NCT00363246|54714419|FG000|Overall Study|Bad health|6|||
28058180|NCT00363246|54714419|FG000|Overall Study|Stopped using wheelchair|11|||
28058181|NCT00363246|54714419|FG000|Overall Study|Subject expressed security concerns|2|||
28058182|NCT00363246|54714419|FG000|Overall Study|Eligibility changed due to Hospice move|5|||
28058183|NCT00223990|54714426|FG000|Overall Study|Moved from area|2|||
28058184|NCT00223990|54714427|FG001|Overall Study|Moved from area|1|||
28058185|NCT00223990|54714426|FG000|Overall Study|Withdrawal by Subject|4|||
28058186|NCT00223990|54714427|FG001|Overall Study|Withdrawal by Subject|8|||
28058187|NCT00223990|54714426|FG000|Overall Study|Lost to Follow-up|1|||
28058188|NCT00223990|54714427|FG001|Overall Study|Lost to Follow-up|0|||
28058189|NCT00221104|54714435|FG000|Overall Study|Adverse Event|1|||
28058190|NCT00221104|54714436|FG001|Overall Study|Adverse Event|0|||
28058191|NCT00221104|54714435|FG000|Overall Study|Physician Decision|1|||
28058192|NCT00221104|54714436|FG001|Overall Study|Physician Decision|0|||
28058193|NCT00221104|54714435|FG000|Overall Study|Protocol Violation|2|||
28058194|NCT00221104|54714436|FG001|Overall Study|Protocol Violation|0|||
28058195|NCT00221104|54714435|FG000|Overall Study|Withdrawal by Subject|42|||
28058196|NCT00221104|54714436|FG001|Overall Study|Withdrawal by Subject|29|||
28058197|NCT00221104|54714435|FG000|Overall Study|Others|37|||
28058198|NCT00221104|54714436|FG001|Overall Study|Others|47|||
28058199|NCT00189202|54714444|FG000|Overall Study|Physician Decision|5|||
28058200|NCT00187486|54714448|FG000|Overall Study|Protocol Violation|1|||
28058201|NCT00220636|54714452|FG000|Overall Study|Withdrawal by Subject|4|||
28058202|NCT00362232|54714459|FG000|Treatment (12 +/- 2 Days)|Adverse Event|62|||
28058203|NCT00362232|54714460|FG001|Treatment (12 +/- 2 Days)|Adverse Event|56|||
28058204|NCT00362232|54714459|FG000|Treatment (12 +/- 2 Days)|Death|1|||
28058205|NCT00362232|54714460|FG001|Treatment (12 +/- 2 Days)|Death|3|||
28058206|NCT00362232|54714459|FG000|Treatment (12 +/- 2 Days)|Lost to Follow-up|3|||
28058207|NCT00362232|54714460|FG001|Treatment (12 +/- 2 Days)|Lost to Follow-up|1|||
28058208|NCT00362232|54714459|FG000|Treatment (12 +/- 2 Days)|Physician Decision|2|||
28058209|NCT00362232|54714460|FG001|Treatment (12 +/- 2 Days)|Physician Decision|5|||
28058210|NCT00362232|54714459|FG000|Treatment (12 +/- 2 Days)|Protocol Violation|22|||
28058211|NCT00362232|54714460|FG001|Treatment (12 +/- 2 Days)|Protocol Violation|21|||
28058212|NCT00362232|54714459|FG000|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49|||
28058213|NCT00362232|54714460|FG001|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47|||
28058214|NCT00362232|54714459|FG000|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9|||
27814435|NCT01768286|54271080|FG001|Overall Study|Withdrew Consent|0|||
27814436|NCT01768286|54271081|FG002|Overall Study|Withdrew Consent|1|||
27814437|NCT01768286|54271082|FG003|Overall Study|Withdrew Consent|0|||
27814438|NCT01800968|54271094|FG000|Overall Study|Death|23|||
28058215|NCT00362232|54714460|FG001|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0|||
28058216|NCT00362232|54714459|FG000|Treatment (12 +/- 2 Days)|Technical Problems|1|||
28058217|NCT00362232|54714460|FG001|Treatment (12 +/- 2 Days)|Technical Problems|0|||
28058218|NCT00362232|54714459|FG000|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10|||
28058219|NCT00362232|54714460|FG001|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18|||
28058220|NCT00362232|54714459|FG000|Follow-up (30 (+ 5) Days)|Adverse Event|2|||
28058221|NCT00362232|54714460|FG001|Follow-up (30 (+ 5) Days)|Adverse Event|3|||
28058222|NCT00362232|54714459|FG000|Follow-up (30 (+ 5) Days)|Death|1|||
27814439|NCT01800968|54271095|FG001|Overall Study|Death|16|||
27814440|NCT01800968|54271094|FG000|Overall Study|Lost to Follow-up|5|||
27814441|NCT01800968|54271095|FG001|Overall Study|Lost to Follow-up|7|||
27814442|NCT01800968|54271094|FG000|Overall Study|Withdrawal by Subject|7|||
27814443|NCT01800968|54271095|FG001|Overall Study|Withdrawal by Subject|9|||
27814444|NCT01800968|54271094|FG000|Overall Study|Physician Decision|1|||
28058223|NCT00362232|54714460|FG001|Follow-up (30 (+ 5) Days)|Death|1|||
28058224|NCT00362232|54714459|FG000|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27|||
27814445|NCT01800968|54271095|FG001|Overall Study|Physician Decision|0|||
27814446|NCT01799720|54271104|FG000|Overall Study|Withdrawal by Subject|3|||
27814447|NCT01799720|54271105|FG001|Overall Study|Withdrawal by Subject|0|||
27814448|NCT01799720|54271106|FG002|Overall Study|Withdrawal by Subject|0|||
27814449|NCT01799720|54271104|FG000|Overall Study|Protocol Violation|0|||
27814450|NCT01799720|54271105|FG001|Overall Study|Protocol Violation|1|||
27814451|NCT01799720|54271106|FG002|Overall Study|Protocol Violation|0|||
27814452|NCT01799720|54271104|FG000|Overall Study|Pregnancy|0|||
27814453|NCT01799720|54271105|FG001|Overall Study|Pregnancy|0|||
27814454|NCT01799720|54271106|FG002|Overall Study|Pregnancy|1|||
27814455|NCT01687257|54271116|FG000|Overall Study|Efficacy Failure|6|||
28058225|NCT00362232|54714460|FG001|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28|||
28058226|NCT00362232|54714459|FG000|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8|||
28058227|NCT00362232|54714460|FG001|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7|||
28058228|NCT00219544|54714466|FG000|Single Blind Treatment Period|Lack of Efficacy|5|||
28058229|NCT00219544|54714467|FG001|Single Blind Treatment Period|Lack of Efficacy|0|||
28058230|NCT00219544|54714466|FG000|Single Blind Treatment Period|Adverse Event|9|||
28058231|NCT00219544|54714467|FG001|Single Blind Treatment Period|Adverse Event|0|||
28058232|NCT00219544|54714466|FG000|Single Blind Treatment Period|Protocol Violation|4|||
28058233|NCT00219544|54714467|FG001|Single Blind Treatment Period|Protocol Violation|0|||
28058234|NCT00219544|54714466|FG000|Single Blind Treatment Period|Lost to Follow-up|2|||
28058235|NCT00219544|54714467|FG001|Single Blind Treatment Period|Lost to Follow-up|0|||
28058236|NCT00219544|54714466|FG000|Single Blind Treatment Period|Investigator decision to withdraw|1|||
28058237|NCT00219544|54714467|FG001|Single Blind Treatment Period|Investigator decision to withdraw|0|||
28058238|NCT00219544|54714466|FG000|Single Blind Treatment Period|Withdrawal by Subject|1|||
28058239|NCT00219544|54714467|FG001|Single Blind Treatment Period|Withdrawal by Subject|0|||
28058240|NCT00357552|54714475|FG000|Screening|Did not meet eligibility criteria|84|||
28058241|NCT00357552|54714475|FG000|Weeks 0 to 24|Death|1|||
28058242|NCT00357552|54714475|FG000|Weeks 24 to 104|Death|3|||
28058243|NCT00357552|54714475|FG000|Weeks 24 to 104|Not able to get to clinic|2|||
28058244|NCT00187096|54714486|FG000|Overall Study|unacceptable toxicity|0|||
28058245|NCT00187096|54714487|FG001|Overall Study|unacceptable toxicity|0|||
28058246|NCT00187096|54714488|FG002|Overall Study|unacceptable toxicity|1|||
28058247|NCT00357396|54714498|FG000|Overall Study|Adverse Event|1|||
28058248|NCT00357396|54714499|FG001|Overall Study|Adverse Event|0|||
28058249|NCT00186628|54714504|FG000|Overall Study|Death|2|||
28058250|NCT00186628|54714504|FG000|Overall Study|Withdrawal by subject (before treatment)|1|||
28058251|NCT00368550|54714512|FG000|Overall Study|Adverse Event|7|||
28058252|NCT00368550|54714513|FG001|Overall Study|Adverse Event|4|||
28058253|NCT00368550|54714512|FG000|Overall Study|Lack of Efficacy|4|||
28058254|NCT00368550|54714513|FG001|Overall Study|Lack of Efficacy|9|||
28058255|NCT00368550|54714512|FG000|Overall Study|Withdrawal by Subject|17|||
28058256|NCT00368550|54714513|FG001|Overall Study|Withdrawal by Subject|10|||
28058257|NCT00368472|54714519|FG000|Overall Study|Adverse Event|22|||
28058258|NCT00368472|54714519|FG000|Overall Study|Medication non-compliance|4|||
28058259|NCT00368472|54714519|FG000|Overall Study|Protocol Violation|2|||
28058260|NCT00368472|54714519|FG000|Overall Study|Request of Investigator or Sponsor|3|||
28058261|NCT00368472|54714519|FG000|Overall Study|Withdrawal by Subject|40|||
28058262|NCT00368472|54714519|FG000|Overall Study|Diary non-compliance|1|||
28058263|NCT00368472|54714519|FG000|Overall Study|Other|32|||
27814456|NCT01687257|54271117|FG001|Overall Study|Efficacy Failure|0|||
27848313|NCT00215657|54341259|FG005|Overall Study|Insufficient testosterone response|12|||
28058264|NCT00368472|54714519|FG000|Overall Study|Missing Final Disposition Date|1|||
28058265|NCT00357006|54714526|FG000|Overall Study|Lost to Follow-up|1|||
28058266|NCT00357006|54714527|FG001|Overall Study|Lost to Follow-up|2|||
28058267|NCT00357006|54714528|FG002|Overall Study|Lost to Follow-up|1|||
28058268|NCT00357006|54714526|FG000|Overall Study|Withdrawal by Subject|1|||
28058269|NCT00357006|54714527|FG001|Overall Study|Withdrawal by Subject|3|||
27814457|NCT01687257|54271118|FG002|Overall Study|Efficacy Failure|5|||
28058270|NCT00357006|54714528|FG002|Overall Study|Withdrawal by Subject|2|||
28058271|NCT00165646|54714539|FG000|Overall Study|Adverse Event|1|||
28058272|NCT00165646|54714540|FG001|Overall Study|Adverse Event|1|||
28058273|NCT00165646|54714541|FG002|Overall Study|Adverse Event|1|||
27814458|NCT01687257|54271116|FG000|Overall Study|Subject Withdrew Consent|1|||
28058274|NCT00165646|54714539|FG000|Overall Study|Lack of Efficacy|1|||
27814459|NCT01687257|54271117|FG001|Overall Study|Subject Withdrew Consent|1|||
28058275|NCT00165646|54714540|FG001|Overall Study|Lack of Efficacy|2|||
28058276|NCT00165646|54714541|FG002|Overall Study|Lack of Efficacy|0|||
28058277|NCT00165646|54714539|FG000|Overall Study|Withdrawal by Subject|0|||
27814460|NCT01687257|54271118|FG002|Overall Study|Subject Withdrew Consent|1|||
27814461|NCT01687257|54271116|FG000|Overall Study|Adverse Event|1|||
28058278|NCT00165646|54714540|FG001|Overall Study|Withdrawal by Subject|2|||
27814462|NCT01687257|54271117|FG001|Overall Study|Adverse Event|0|||
27814463|NCT01687257|54271118|FG002|Overall Study|Adverse Event|0|||
27814464|NCT01687257|54271116|FG000|Overall Study|Investigator's Discretion|0|||
27814465|NCT01687257|54271117|FG001|Overall Study|Investigator's Discretion|3|||
27814466|NCT01687257|54271118|FG002|Overall Study|Investigator's Discretion|0|||
28058279|NCT00165646|54714541|FG002|Overall Study|Withdrawal by Subject|1|||
28058280|NCT00165646|54714539|FG000|Overall Study|Physician Decision|2|||
28058281|NCT00165646|54714540|FG001|Overall Study|Physician Decision|0|||
28058282|NCT00165646|54714541|FG002|Overall Study|Physician Decision|2|||
28058283|NCT00165646|54714539|FG000|Overall Study|Protocol Violation|1|||
28058284|NCT00165646|54714540|FG001|Overall Study|Protocol Violation|0|||
28058285|NCT00165646|54714541|FG002|Overall Study|Protocol Violation|0|||
28058286|NCT00367770|54714549|FG000|Overall Study|Adverse Event|1|||
28058287|NCT00367770|54714549|FG000|Overall Study|Withdrawal by Subject|1|||
28058288|NCT00185614|54714553|FG000|Inter-treatment Period|Physician Decision|1|||
28058289|NCT00185614|54714553|FG000|Inter-treatment Period|Relapse|2|||
27814467|NCT01806740|54271132|FG000|Overall Study|Withdrawal by Subject|4|||
27814468|NCT01806740|54271132|FG000|Overall Study|Physician Decision|1|||
28058290|NCT00185614|54714553|FG000|Inter-treatment Period|Lack of allogenic donor|1|||
28058291|NCT00162370|54714557|FG000|Efficacy Population|Lost to Follow-up|51|||
28058292|NCT00361842|54714566|FG000|Overall Study|Withdrawal by Subject|2|||
28058293|NCT00361842|54714567|FG001|Overall Study|Withdrawal by Subject|3|||
28058294|NCT00361842|54714566|FG000|Overall Study|Death|2|||
28058295|NCT00361842|54714567|FG001|Overall Study|Death|1|||
28058296|NCT00361842|54714566|FG000|Overall Study|Disease progression|19|||
28058297|NCT00361842|54714567|FG001|Overall Study|Disease progression|20|||
28058298|NCT00361842|54714566|FG000|Overall Study|Adverse Event|2|||
27814469|NCT01806740|54271132|FG000|Overall Study|Patient's refusal of treatment|1|||
28058299|NCT00361842|54714567|FG001|Overall Study|Adverse Event|3|||
28058300|NCT00361842|54714566|FG000|Overall Study|Occurrence of unacceptable toxicity|1|||
28058301|NCT00361842|54714567|FG001|Overall Study|Occurrence of unacceptable toxicity|5|||
28058302|NCT00361842|54714566|FG000|Overall Study|Other|1|||
28058303|NCT00361842|54714567|FG001|Overall Study|Other|0|||
28058304|NCT00361842|54714566|FG000|Overall Study|Other|0|||
28058305|NCT00361842|54714567|FG001|Overall Study|Other|2|||
28058306|NCT00361296|54714575|FG000|Overall Study|Physician Decision|1|||
27814470|NCT01687101|54271139|FG000|Overall Study|Lost to Follow-up|7|||
27814471|NCT01968967|54271145|FG000|Treatment Period|Other|22|||
27814472|NCT01968967|54271146|FG001|Treatment Period|Other|22|||
27814473|NCT01968967|54271147|FG002|Treatment Period|Other|0|||
27814474|NCT01968967|54271148|FG003|Treatment Period|Other|0|||
27814475|NCT01968967|54271149|FG004|Treatment Period|Other|0|||
27814476|NCT01968967|54271145|FG000|Treatment Period|Withdrawal by Subject|71|||
27814477|NCT01968967|54271146|FG001|Treatment Period|Withdrawal by Subject|61|||
27814478|NCT01968967|54271147|FG002|Treatment Period|Withdrawal by Subject|0|||
27814479|NCT01968967|54271148|FG003|Treatment Period|Withdrawal by Subject|0|||
27814480|NCT01968967|54271149|FG004|Treatment Period|Withdrawal by Subject|0|||
27814481|NCT01968967|54271145|FG000|Treatment Period|Did Not Meet Entrance Criteria|2|||
27814482|NCT01968967|54271146|FG001|Treatment Period|Did Not Meet Entrance Criteria|3|||
27814483|NCT01968967|54271147|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
27814484|NCT01968967|54271148|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
28058307|NCT00361296|54714575|FG000|Overall Study|Lack of Efficacy|2|||
28058308|NCT00356148|54714581|FG000|Overall Study|Reoperation within 30 days|2|||
28058309|NCT00356148|54714582|FG001|Overall Study|Reoperation within 30 days|1|||
28058310|NCT00361218|54714589|FG000|Overall Study|Lost to Follow-up|11|||
28058311|NCT00361218|54714589|FG000|Overall Study|Personal Reasons|7|||
28058312|NCT00361218|54714589|FG000|Overall Study|terminated / withdrawn due to toxicity /|5|||
28058313|NCT00367458|54714595|FG000|First Intervention - 8 Weeks|Adverse Event|2|||
27814485|NCT01968967|54271149|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
27814486|NCT01968967|54271145|FG000|Treatment Period|Lost to Follow-up|26|||
27814487|NCT01968967|54271146|FG001|Treatment Period|Lost to Follow-up|31|||
27848314|NCT00215657|54341260|FG006|Overall Study|Insufficient testosterone response|4|||
28058314|NCT00367458|54714596|FG001|First Intervention - 8 Weeks|Adverse Event|0|||
28058315|NCT00162136|54714608|FG000|Overall Study|Adverse Event|1|||
28058316|NCT00162136|54714608|FG000|Overall Study|Death|1|||
27814488|NCT01968967|54271147|FG002|Treatment Period|Lost to Follow-up|0|||
27814489|NCT01968967|54271148|FG003|Treatment Period|Lost to Follow-up|0|||
27814490|NCT01968967|54271149|FG004|Treatment Period|Lost to Follow-up|0|||
27814491|NCT01968967|54271145|FG000|Treatment Period|Protocol Violation|1|||
27814492|NCT01968967|54271146|FG001|Treatment Period|Protocol Violation|2|||
27814493|NCT01968967|54271147|FG002|Treatment Period|Protocol Violation|0|||
27814494|NCT01968967|54271148|FG003|Treatment Period|Protocol Violation|0|||
27814495|NCT01968967|54271149|FG004|Treatment Period|Protocol Violation|0|||
27814496|NCT01968967|54271145|FG000|Treatment Period|Adverse Event|9|||
27814497|NCT01968967|54271146|FG001|Treatment Period|Adverse Event|8|||
27814498|NCT01968967|54271147|FG002|Treatment Period|Adverse Event|0|||
27814499|NCT01968967|54271148|FG003|Treatment Period|Adverse Event|0|||
27814500|NCT01968967|54271149|FG004|Treatment Period|Adverse Event|0|||
27814501|NCT01968967|54271145|FG000|Treatment Period|Death|9|||
27814502|NCT01968967|54271146|FG001|Treatment Period|Death|2|||
27814503|NCT01968967|54271147|FG002|Treatment Period|Death|0|||
27814504|NCT01968967|54271148|FG003|Treatment Period|Death|0|||
27814505|NCT01968967|54271149|FG004|Treatment Period|Death|0|||
27814506|NCT01968967|54271145|FG000|Treatment Period|Randomized Not Treated|6|||
27814507|NCT01968967|54271146|FG001|Treatment Period|Randomized Not Treated|5|||
27814508|NCT01968967|54271147|FG002|Treatment Period|Randomized Not Treated|0|||
27814509|NCT01968967|54271148|FG003|Treatment Period|Randomized Not Treated|0|||
27814510|NCT01968967|54271149|FG004|Treatment Period|Randomized Not Treated|0|||
27814511|NCT01968967|54271145|FG000|Extension Period|Withdrew Consent|0|||
27814512|NCT01968967|54271146|FG001|Extension Period|Withdrew Consent|0|||
27814513|NCT01968967|54271147|FG002|Extension Period|Withdrew Consent|2|||
27814514|NCT01968967|54271148|FG003|Extension Period|Withdrew Consent|0|||
27814515|NCT01968967|54271149|FG004|Extension Period|Withdrew Consent|5|||
27814516|NCT01554579|54271165|FG000|Overall Study|Adverse Event|6|||
27814517|NCT01554579|54271166|FG001|Overall Study|Adverse Event|25|||
27814518|NCT01554579|54271165|FG000|Overall Study|Lack of Efficacy|2|||
27814519|NCT01554579|54271166|FG001|Overall Study|Lack of Efficacy|1|||
27814520|NCT01554579|54271165|FG000|Overall Study|Withdrawal by Subject|2|||
27814521|NCT01554579|54271166|FG001|Overall Study|Withdrawal by Subject|1|||
27814522|NCT01806662|54271173|FG000|First Intervention (Weeks 0-16)|Withdrawal by Subject|4|||
27814523|NCT01806662|54271174|FG001|First Intervention (Weeks 0-16)|Withdrawal by Subject|0|||
27814524|NCT01806662|54271173|FG000|First Intervention (Weeks 0-16)|Adverse Event|0|||
27814525|NCT01806662|54271174|FG001|First Intervention (Weeks 0-16)|Adverse Event|1|||
27814526|NCT01806662|54271173|FG000|Second Intervention (Weeks 16-32)|Lack of Efficacy|2|||
27814527|NCT01806662|54271174|FG001|Second Intervention (Weeks 16-32)|Lack of Efficacy|3|||
27814528|NCT01806662|54271173|FG000|Second Intervention (Weeks 16-32)|Lost to Follow-up|0|||
27814529|NCT01806662|54271174|FG001|Second Intervention (Weeks 16-32)|Lost to Follow-up|1|||
27814530|NCT01930123|54271182|FG000|Overall Study|Adverse Event|1|||
27814531|NCT01930123|54271183|FG001|Overall Study|Adverse Event|0|||
27814532|NCT01930123|54271182|FG000|Overall Study|Physician Decision|21|||
27814533|NCT01930123|54271183|FG001|Overall Study|Physician Decision|8|||
27814534|NCT01930123|54271182|FG000|Overall Study|Withdrawal by Subject|1|||
28058317|NCT00162136|54714608|FG000|Overall Study|Disease Progression/Relapse|23|||
28058318|NCT00162136|54714608|FG000|Overall Study|Investigator Request|5|||
28058319|NCT00162136|54714608|FG000|Overall Study|Study Drug Toxicity|4|||
28058320|NCT00162136|54714608|FG000|Overall Study|Withdrawal by Subject|1|||
28058321|NCT00252694|54714634|FG000|Overall Study|Withdrawal by Subject|83|||
28058322|NCT00252694|54714635|FG001|Overall Study|Withdrawal by Subject|91|||
28058323|NCT00252694|54714634|FG000|Overall Study|Death|36|||
28058324|NCT00252694|54714635|FG001|Overall Study|Death|34|||
28058325|NCT00252694|54714634|FG000|Overall Study|Mostly Lost to Follow Up|8|||
28058326|NCT00252694|54714635|FG001|Overall Study|Mostly Lost to Follow Up|13|||
28058327|NCT00252694|54714634|FG000|Overall Study|Patient Moving|17|||
28058328|NCT00252694|54714635|FG001|Overall Study|Patient Moving|16|||
28058329|NCT00185458|54714641|FG000|Contraception Phase|Adverse Event|37|||
28058330|NCT00185458|54714641|FG000|Contraception Phase|Lost to Follow-up|10|||
27814535|NCT01930123|54271183|FG001|Overall Study|Withdrawal by Subject|0|||
27814536|NCT01930045|54271189|FG000|Pause (up to 37 Days)|Withdrawal by Subject|0|||
27814537|NCT01930045|54271190|FG001|Pause (up to 37 Days)|Withdrawal by Subject|0|||
28058331|NCT00185458|54714641|FG000|Contraception Phase|Protocol Violation|2|||
27814538|NCT01930045|54271191|FG002|Pause (up to 37 Days)|Withdrawal by Subject|0|||
27814539|NCT01930045|54271192|FG003|Pause (up to 37 Days)|Withdrawal by Subject|0|||
27814540|NCT01930045|54271193|FG004|Pause (up to 37 Days)|Withdrawal by Subject|0|||
28058332|NCT00185458|54714641|FG000|Contraception Phase|Physician Decision|2|||
28058333|NCT00185458|54714641|FG000|Contraception Phase|Withdrawal by Subject|7|||
28058334|NCT00185458|54714641|FG000|HRT Phase|Adverse Event|18|||
28058335|NCT00185458|54714641|FG000|HRT Phase|Lost to Follow-up|4|||
27814541|NCT01930045|54271194|FG005|Pause (up to 37 Days)|Withdrawal by Subject|1|||
27814542|NCT01930045|54271189|FG000|Pause (up to 37 Days)|Protocol Violation|0|||
27814543|NCT01930045|54271190|FG001|Pause (up to 37 Days)|Protocol Violation|0|||
28058336|NCT00185458|54714641|FG000|HRT Phase|Protocol Violation|2|||
28058337|NCT00185458|54714641|FG000|HRT Phase|Withdrawal by Subject|3|||
28058338|NCT00185380|54714656|FG000|Overall Study|Adverse Event|41|||
28058339|NCT00185380|54714657|FG001|Overall Study|Adverse Event|43|||
28058340|NCT00185380|54714658|FG002|Overall Study|Adverse Event|48|||
28058341|NCT00185380|54714656|FG000|Overall Study|Lost to Follow-up|0|||
28058342|NCT00185380|54714657|FG001|Overall Study|Lost to Follow-up|4|||
28058343|NCT00185380|54714658|FG002|Overall Study|Lost to Follow-up|3|||
28058344|NCT00185380|54714656|FG000|Overall Study|Pregnancy|1|||
28058345|NCT00185380|54714657|FG001|Overall Study|Pregnancy|4|||
28058346|NCT00185380|54714658|FG002|Overall Study|Pregnancy|0|||
28058347|NCT00185380|54714656|FG000|Overall Study|Protocol Violation|2|||
28058348|NCT00185380|54714657|FG001|Overall Study|Protocol Violation|2|||
28058349|NCT00185380|54714658|FG002|Overall Study|Protocol Violation|1|||
28058350|NCT00185380|54714656|FG000|Overall Study|Withdrawal by Subject|1|||
28058351|NCT00185380|54714657|FG001|Overall Study|Withdrawal by Subject|2|||
28058352|NCT00185380|54714658|FG002|Overall Study|Withdrawal by Subject|0|||
28058353|NCT00185380|54714656|FG000|Overall Study|Failed insertion|1|||
28058354|NCT00185380|54714657|FG001|Overall Study|Failed insertion|1|||
28058355|NCT00185380|54714658|FG002|Overall Study|Failed insertion|2|||
28058356|NCT00185380|54714656|FG000|Overall Study|Planned pregnancy|9|||
28058357|NCT00185380|54714657|FG001|Overall Study|Planned pregnancy|12|||
28058358|NCT00185380|54714658|FG002|Overall Study|Planned pregnancy|12|||
28058359|NCT00185380|54714656|FG000|Overall Study|No need for contraception|3|||
28058360|NCT00185380|54714657|FG001|Overall Study|No need for contraception|3|||
28058361|NCT00185380|54714658|FG002|Overall Study|No need for contraception|3|||
28058362|NCT00185380|54714656|FG000|Overall Study|Could not attend visits|2|||
28058363|NCT00185380|54714657|FG001|Overall Study|Could not attend visits|0|||
28058364|NCT00185380|54714658|FG002|Overall Study|Could not attend visits|4|||
28058365|NCT00185380|54714656|FG000|Overall Study|personal reason|6|||
28058366|NCT00185380|54714657|FG001|Overall Study|personal reason|1|||
28058367|NCT00185380|54714658|FG002|Overall Study|personal reason|1|||
28058368|NCT00160654|54714666|FG000|Overall Study|Adverse Event|14|||
28058369|NCT00160654|54714666|FG000|Overall Study|Lack of Efficacy|4|||
28058370|NCT00160654|54714666|FG000|Overall Study|Lost to Follow-up|2|||
28058371|NCT00160654|54714666|FG000|Overall Study|Intake of expired drug|7|||
28058372|NCT00160654|54714666|FG000|Overall Study|Psychological trauma|1|||
28058373|NCT00160654|54714666|FG000|Overall Study|Sponsor decision|1|||
28058374|NCT00160654|54714666|FG000|Overall Study|Patient met exclusion criteria|1|||
28058375|NCT00160654|54714666|FG000|Overall Study|Patient decision|1|||
28058376|NCT00160654|54714666|FG000|Overall Study|Poor compliance, dilantin toxicity|1|||
28058377|NCT00160654|54714666|FG000|Overall Study|Met exclusion criteria|1|||
28058378|NCT00366678|54714672|FG000|Infant Series|Withdrawal by Subject|8|||
28058379|NCT00366678|54714673|FG001|Infant Series|Withdrawal by Subject|6|||
28058380|NCT00366678|54714674|FG002|Infant Series|Withdrawal by Subject|0|||
28058381|NCT00366678|54714672|FG000|Infant Series|Protocol Violation|4|||
28058382|NCT00366678|54714673|FG001|Infant Series|Protocol Violation|3|||
28058383|NCT00366678|54714674|FG002|Infant Series|Protocol Violation|0|||
28058384|NCT00366678|54714672|FG000|Infant Series|Failed to return|1|||
28058385|NCT00366678|54714673|FG001|Infant Series|Failed to return|1|||
28058386|NCT00366678|54714674|FG002|Infant Series|Failed to return|0|||
28058387|NCT00366678|54714672|FG000|Infant Series|Adverse Event|1|||
28058388|NCT00366678|54714673|FG001|Infant Series|Adverse Event|0|||
28058389|NCT00366678|54714674|FG002|Infant Series|Adverse Event|0|||
28058390|NCT00366678|54714672|FG000|After Infant|Withdrawal by Subject|8|||
28058391|NCT00366678|54714673|FG001|After Infant|Withdrawal by Subject|4|||
28058392|NCT00366678|54714674|FG002|After Infant|Withdrawal by Subject|0|||
28058393|NCT00366678|54714672|FG000|After Infant|Lost to Follow-up|2|||
28058394|NCT00366678|54714673|FG001|After Infant|Lost to Follow-up|1|||
28058395|NCT00366678|54714674|FG002|After Infant|Lost to Follow-up|0|||
28058396|NCT00366678|54714672|FG000|After Infant|Failed to return|5|||
28058397|NCT00366678|54714673|FG001|After Infant|Failed to return|5|||
28058398|NCT00366678|54714674|FG002|After Infant|Failed to return|0|||
28058399|NCT00366678|54714672|FG000|After Infant|Adverse Event|1|||
28058400|NCT00366678|54714673|FG001|After Infant|Adverse Event|0|||
28058401|NCT00366678|54714674|FG002|After Infant|Adverse Event|0|||
28058402|NCT00366678|54714672|FG000|After Infant|Protocol Violation|1|||
28058403|NCT00366678|54714673|FG001|After Infant|Protocol Violation|0|||
28058404|NCT00366678|54714674|FG002|After Infant|Protocol Violation|0|||
28058405|NCT00366678|54714672|FG000|Toddler Dose|Protocol Violation|2|||
28058406|NCT00366678|54714673|FG001|Toddler Dose|Protocol Violation|1|||
28058407|NCT00366678|54714674|FG002|Toddler Dose|Protocol Violation|0|||
28058408|NCT00366678|54714672|FG000|Toddler Dose|Failed to return|1|||
28058409|NCT00366678|54714673|FG001|Toddler Dose|Failed to return|0|||
28058410|NCT00366678|54714674|FG002|Toddler Dose|Failed to return|0|||
28058411|NCT00366678|54714672|FG000|Toddler Dose|Withdrawal by Subject|1|||
28058412|NCT00366678|54714673|FG001|Toddler Dose|Withdrawal by Subject|0|||
28058413|NCT00366678|54714674|FG002|Toddler Dose|Withdrawal by Subject|0|||
28058414|NCT00366678|54714672|FG000|Toddler Dose|protocol deviation|1|||
28058415|NCT00366678|54714673|FG001|Toddler Dose|protocol deviation|0|||
28058416|NCT00366678|54714674|FG002|Toddler Dose|protocol deviation|0|||
28058417|NCT00355368|54714721|FG000|Overall Study|Protocol Violation|8|||
27814544|NCT01930045|54271191|FG002|Pause (up to 37 Days)|Protocol Violation|0|||
27814545|NCT01930045|54271192|FG003|Pause (up to 37 Days)|Protocol Violation|0|||
27814546|NCT01930045|54271193|FG004|Pause (up to 37 Days)|Protocol Violation|0|||
27814547|NCT01930045|54271194|FG005|Pause (up to 37 Days)|Protocol Violation|1|||
27814548|NCT01929343|54271209|FG000|Overall Study|Physician Decision|0|||
27814549|NCT01929343|54271210|FG001|Overall Study|Physician Decision|2|||
27814550|NCT01929343|54271211|FG002|Overall Study|Physician Decision|0|||
27814551|NCT01929343|54271209|FG000|Overall Study|Withdrawal by Subject|1|||
27814552|NCT01929343|54271210|FG001|Overall Study|Withdrawal by Subject|0|||
27814553|NCT01929343|54271211|FG002|Overall Study|Withdrawal by Subject|0|||
28058418|NCT00355368|54714722|FG001|Overall Study|Protocol Violation|7|||
28058419|NCT00355368|54714721|FG000|Overall Study|cardiac arrest prior to intubation|2|||
28058420|NCT00355368|54714722|FG001|Overall Study|cardiac arrest prior to intubation|2|||
28058421|NCT00360282|54714728|FG000|Washout 1-3 Weeks|Lost to Follow-up|0|||
28058422|NCT00360282|54714729|FG001|Washout 1-3 Weeks|Lost to Follow-up|0|||
28058423|NCT00360282|54714730|FG002|Washout 1-3 Weeks|Lost to Follow-up|1|||
28058424|NCT00360282|54714731|FG003|Washout 1-3 Weeks|Lost to Follow-up|0|||
28058425|NCT00360282|54714728|FG000|Second Intervention|Adverse Event|0|||
28058426|NCT00360282|54714729|FG001|Second Intervention|Adverse Event|1|||
28058427|NCT00360282|54714730|FG002|Second Intervention|Adverse Event|0|||
28058428|NCT00360282|54714731|FG003|Second Intervention|Adverse Event|0|||
28058429|NCT00373958|54714741|FG000|Infant Series|Withdrawal by Subject|13|||
28058430|NCT00373958|54714742|FG001|Infant Series|Withdrawal by Subject|15|||
28058431|NCT00373958|54714741|FG000|Infant Series|Failed to return|8|||
28058432|NCT00373958|54714742|FG001|Infant Series|Failed to return|13|||
28058433|NCT00373958|54714741|FG000|Infant Series|Lost to Follow-up|6|||
28058434|NCT00373958|54714742|FG001|Infant Series|Lost to Follow-up|5|||
28058435|NCT00373958|54714741|FG000|Infant Series|Protocol Violation|3|||
28058436|NCT00373958|54714742|FG001|Infant Series|Protocol Violation|7|||
28058437|NCT00373958|54714741|FG000|Infant Series|Lost Kaiser coverage|4|||
28058438|NCT00373958|54714742|FG001|Infant Series|Lost Kaiser coverage|0|||
28058439|NCT00373958|54714741|FG000|Infant Series|Child relocated|1|||
28058440|NCT00373958|54714742|FG001|Infant Series|Child relocated|0|||
28058441|NCT00373958|54714741|FG000|Infant Series|Consent was not received|1|||
28058442|NCT00373958|54714742|FG001|Infant Series|Consent was not received|0|||
28058443|NCT00373958|54714741|FG000|Infant Series|Adverse Event|3|||
28058444|NCT00373958|54714742|FG001|Infant Series|Adverse Event|1|||
28058445|NCT00373958|54714741|FG000|Infant Series|Physician Decision|1|||
28058446|NCT00373958|54714742|FG001|Infant Series|Physician Decision|1|||
28058447|NCT00373958|54714741|FG000|Toddler Dose|Lost to Follow-up|5|||
28058448|NCT00373958|54714742|FG001|Toddler Dose|Lost to Follow-up|8|||
27814554|NCT01968811|54271219|FG000|Overall Study|Protocol Violation|4|||
27814555|NCT01968811|54271219|FG000|Overall Study|post op.ref. of subject to other hospita|1|||
28058449|NCT00373958|54714741|FG000|Toddler Dose|Withdrawal by Subject|2|||
28058450|NCT00373958|54714742|FG001|Toddler Dose|Withdrawal by Subject|2|||
28058451|NCT00373958|54714741|FG000|Toddler Dose|Failed to return|1|||
28058452|NCT00373958|54714742|FG001|Toddler Dose|Failed to return|2|||
28058453|NCT00373958|54714741|FG000|Toddler Dose|Protocol Violation|0|||
28058454|NCT00373958|54714742|FG001|Toddler Dose|Protocol Violation|1|||
28058455|NCT00373958|54714741|FG000|Toddler Dose|Withdrawn after infant series|22|||
28058456|NCT00373958|54714742|FG001|Toddler Dose|Withdrawn after infant series|25|||
28058457|NCT00373880|54714771|FG000|Overall Study|Physician Decision|3|||
28058458|NCT00373880|54714771|FG000|Overall Study|Arrested|1|||
27814556|NCT01806584|54271225|FG000|Overall Study|Adverse Event|2|||
27814557|NCT01806584|54271226|FG001|Overall Study|Adverse Event|1|||
27814558|NCT01806584|54271225|FG000|Overall Study|Death|1|||
27814559|NCT01806584|54271226|FG001|Overall Study|Death|0|||
27814560|NCT01806584|54271225|FG000|Overall Study|Lost to Follow-up|0|||
27814561|NCT01806584|54271226|FG001|Overall Study|Lost to Follow-up|2|||
27814562|NCT01806584|54271225|FG000|Overall Study|Study terminated by sponsor|9|||
27848315|NCT00215657|54341261|FG007|Overall Study|Insufficient testosterone response|7|||
27940013|NCT01198002|54596328|FG000|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3|||
28058459|NCT00373880|54714771|FG000|Overall Study|Protocol Violation|14|||
28058460|NCT00184600|54714786|FG000|Overall Study|Adverse Event|9|||
28058461|NCT00184600|54714787|FG001|Overall Study|Adverse Event|0|||
28058462|NCT00184600|54714788|FG002|Overall Study|Adverse Event|5|||
28058463|NCT00184600|54714786|FG000|Overall Study|Death|3|||
28058464|NCT00184600|54714787|FG001|Overall Study|Death|9|||
28058465|NCT00184600|54714788|FG002|Overall Study|Death|7|||
28058466|NCT00184600|54714786|FG000|Overall Study|Lack of Efficacy|3|||
28058467|NCT00184600|54714787|FG001|Overall Study|Lack of Efficacy|1|||
28058468|NCT00184600|54714788|FG002|Overall Study|Lack of Efficacy|3|||
28058469|NCT00184600|54714786|FG000|Overall Study|Lost to Follow-up|4|||
28058470|NCT00184600|54714787|FG001|Overall Study|Lost to Follow-up|6|||
28058471|NCT00184600|54714788|FG002|Overall Study|Lost to Follow-up|1|||
28058472|NCT00184600|54714786|FG000|Overall Study|Protocol Violation|2|||
27814563|NCT01806584|54271226|FG001|Overall Study|Study terminated by sponsor|14|||
27814564|NCT01806584|54271225|FG000|Overall Study|Withdrawal by Subject|1|||
28058473|NCT00184600|54714787|FG001|Overall Study|Protocol Violation|2|||
27814565|NCT01806584|54271226|FG001|Overall Study|Withdrawal by Subject|1|||
27814566|NCT01806584|54271225|FG000|Overall Study|Other unspecified|1|||
27814567|NCT01806584|54271226|FG001|Overall Study|Other unspecified|0|||
27814568|NCT01798706|54271234|FG000|Overall Study|Adverse Event|15|||
27814569|NCT01798706|54271235|FG001|Overall Study|Adverse Event|10|||
28058474|NCT00184600|54714788|FG002|Overall Study|Protocol Violation|3|||
28058475|NCT00184600|54714786|FG000|Overall Study|Withdrawal by Subject|20|||
28058476|NCT00184600|54714787|FG001|Overall Study|Withdrawal by Subject|28|||
28058477|NCT00184600|54714788|FG002|Overall Study|Withdrawal by Subject|12|||
28058478|NCT00184600|54714786|FG000|Overall Study|Unclassified|4|||
28058479|NCT00184600|54714787|FG001|Overall Study|Unclassified|5|||
28058480|NCT00184600|54714788|FG002|Overall Study|Unclassified|3|||
28058481|NCT00265317|54714800|FG000|Lead-In|Objective progression or relapse|6|||
28058482|NCT00265317|54714801|FG001|Lead-In|Objective progression or relapse|11|||
28058483|NCT00265317|54714802|FG002|Lead-In|Objective progression or relapse|0|||
28058484|NCT00265317|54714803|FG003|Lead-In|Objective progression or relapse|0|||
28058485|NCT00265317|54714800|FG000|Lead-In|Adverse Event|2|||
28058486|NCT00265317|54714801|FG001|Lead-In|Adverse Event|1|||
28058487|NCT00265317|54714802|FG002|Lead-In|Adverse Event|0|||
28058488|NCT00265317|54714803|FG003|Lead-In|Adverse Event|0|||
28058489|NCT00265317|54714800|FG000|Lead-In|Death|3|||
28058490|NCT00265317|54714801|FG001|Lead-In|Death|5|||
28058491|NCT00265317|54714802|FG002|Lead-In|Death|0|||
28058492|NCT00265317|54714803|FG003|Lead-In|Death|0|||
28058493|NCT00265317|54714800|FG000|Lead-In|Withdrawal/other than adverse event|1|||
28058494|NCT00265317|54714801|FG001|Lead-In|Withdrawal/other than adverse event|0|||
27814570|NCT01798706|54271234|FG000|Overall Study|Lack of Efficacy|0|||
28058495|NCT00265317|54714802|FG002|Lead-In|Withdrawal/other than adverse event|0|||
28058496|NCT00265317|54714803|FG003|Lead-In|Withdrawal/other than adverse event|0|||
27814571|NCT01798706|54271235|FG001|Overall Study|Lack of Efficacy|2|||
27814572|NCT01798706|54271234|FG000|Overall Study|Poor compliance to protocol|1|||
27814573|NCT01798706|54271235|FG001|Overall Study|Poor compliance to protocol|0|||
28058497|NCT00265317|54714800|FG000|Phase 2|Objective progression or relapse|0|||
28058498|NCT00265317|54714801|FG001|Phase 2|Objective progression or relapse|0|||
27814574|NCT01798706|54271234|FG000|Overall Study|Other than specified above|5|||
27814575|NCT01798706|54271235|FG001|Overall Study|Other than specified above|9|||
27814576|NCT01767194|54271243|FG000|Overall Study|Adverse Event|1|||
27814577|NCT01767194|54271244|FG001|Overall Study|Adverse Event|1|||
28058499|NCT00265317|54714802|FG002|Phase 2|Objective progression or relapse|37|||
28058500|NCT00265317|54714803|FG003|Phase 2|Objective progression or relapse|38|||
28058501|NCT00265317|54714800|FG000|Phase 2|Global deterioration of health status|0|||
28058502|NCT00265317|54714801|FG001|Phase 2|Global deterioration of health status|0|||
28058503|NCT00265317|54714802|FG002|Phase 2|Global deterioration of health status|3|||
28058504|NCT00265317|54714803|FG003|Phase 2|Global deterioration of health status|0|||
28058505|NCT00265317|54714800|FG000|Phase 2|Adverse Event|0|||
28058506|NCT00265317|54714801|FG001|Phase 2|Adverse Event|0|||
27814578|NCT01767194|54271243|FG000|Overall Study|Death|0|||
28058507|NCT00265317|54714802|FG002|Phase 2|Adverse Event|7|||
27814579|NCT01767194|54271244|FG001|Overall Study|Death|1|||
27814580|NCT01767194|54271243|FG000|Overall Study|Lack of Efficacy|12|||
27814581|NCT01767194|54271244|FG001|Overall Study|Lack of Efficacy|11|||
27814582|NCT01767194|54271243|FG000|Overall Study|Physician Decision|2|||
27814583|NCT01767194|54271244|FG001|Overall Study|Physician Decision|23|||
27814584|NCT01767194|54271243|FG000|Overall Study|Withdrawal by Subject|0|||
27814585|NCT01767194|54271244|FG001|Overall Study|Withdrawal by Subject|1|||
27814586|NCT01767194|54271243|FG000|Overall Study|Ineligible|1|||
27814587|NCT01767194|54271244|FG001|Overall Study|Ineligible|1|||
27814588|NCT01767194|54271243|FG000|Overall Study|Refusal by patient/parent|2|||
27814589|NCT01767194|54271244|FG001|Overall Study|Refusal by patient/parent|4|||
27814590|NCT01767194|54271243|FG000|Overall Study|Criteria not met on time for next cycle|0|||
27814591|NCT01767194|54271244|FG001|Overall Study|Criteria not met on time for next cycle|1|||
27814592|NCT01575873|54271255|FG000|Overall Study|Withdrawal by Subject|15|||
27814593|NCT01575873|54271256|FG001|Overall Study|Withdrawal by Subject|20|||
27814594|NCT01575873|54271257|FG002|Overall Study|Withdrawal by Subject|34|||
27814595|NCT01575873|54271258|FG003|Overall Study|Withdrawal by Subject|34|||
27940014|NCT01198002|54596329|FG001|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
28058508|NCT00265317|54714803|FG003|Phase 2|Adverse Event|5|||
28058509|NCT00265317|54714800|FG000|Phase 2|Death|0|||
27940015|NCT01198002|54596330|FG002|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
27940016|NCT01198002|54596328|FG000|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1|||
27940017|NCT01198002|54596329|FG001|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
27940018|NCT01198002|54596330|FG002|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
27940019|NCT01198002|54596328|FG000|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
27940020|NCT01198002|54596329|FG001|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2|||
27940021|NCT01198002|54596330|FG002|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
27940022|NCT01198002|54596328|FG000|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
27940023|NCT01198002|54596329|FG001|Treatment Period 2 (Weeks 52-100)|Physician Decision|0|||
27940024|NCT01198002|54596330|FG002|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
27940025|NCT01198002|54596328|FG000|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62|||
27940026|NCT01198002|54596329|FG001|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70|||
27940027|NCT01198002|54596330|FG002|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75|||
27940028|NCT01197534|54596363|FG000|Overall Study|Not reported|16|||
27940029|NCT01197534|54596364|FG001|Overall Study|Not reported|10|||
27940030|NCT01197534|54596365|FG002|Overall Study|Not reported|16|||
27940031|NCT01197534|54596363|FG000|Overall Study|Enrolment in long term extension|57|||
27940032|NCT01197534|54596364|FG001|Overall Study|Enrolment in long term extension|66|||
27940033|NCT01197534|54596365|FG002|Overall Study|Enrolment in long term extension|119|||
27940034|NCT01197534|54596363|FG000|Overall Study|Severe non-compliance to protocol|3|||
27940035|NCT01197534|54596364|FG001|Overall Study|Severe non-compliance to protocol|4|||
27940036|NCT01197534|54596365|FG002|Overall Study|Severe non-compliance to protocol|1|||
27940037|NCT01197534|54596363|FG000|Overall Study|Lack of therapeutic response|9|||
27940038|NCT01197534|54596364|FG001|Overall Study|Lack of therapeutic response|4|||
27940039|NCT01197534|54596365|FG002|Overall Study|Lack of therapeutic response|9|||
27940040|NCT01197534|54596363|FG000|Overall Study|Dev. of study specific discont. criteria|13|||
28058510|NCT00265317|54714801|FG001|Phase 2|Death|0|||
28058511|NCT00265317|54714802|FG002|Phase 2|Death|12|||
28058512|NCT00265317|54714803|FG003|Phase 2|Death|15|||
28058513|NCT00265317|54714800|FG000|Phase 2|Protocol Violation|0|||
28058514|NCT00265317|54714801|FG001|Phase 2|Protocol Violation|0|||
28058515|NCT00265317|54714802|FG002|Phase 2|Protocol Violation|1|||
28058516|NCT00265317|54714803|FG003|Phase 2|Protocol Violation|4|||
28058517|NCT00265317|54714800|FG000|Phase 2|Lost to Follow-up|0|||
28058518|NCT00265317|54714801|FG001|Phase 2|Lost to Follow-up|0|||
28058519|NCT00265317|54714802|FG002|Phase 2|Lost to Follow-up|0|||
28058520|NCT00265317|54714803|FG003|Phase 2|Lost to Follow-up|1|||
28058521|NCT00265317|54714800|FG000|Phase 2|Withdrawal/other than adverse event|0|||
28058522|NCT00265317|54714801|FG001|Phase 2|Withdrawal/other than adverse event|0|||
28058523|NCT00265317|54714802|FG002|Phase 2|Withdrawal/other than adverse event|2|||
27814596|NCT01575873|54271255|FG000|Overall Study|Adverse Event|7|||
27814597|NCT01575873|54271256|FG001|Overall Study|Adverse Event|7|||
27814598|NCT01575873|54271257|FG002|Overall Study|Adverse Event|9|||
27814599|NCT01575873|54271258|FG003|Overall Study|Adverse Event|12|||
27814600|NCT01575873|54271255|FG000|Overall Study|Lost to Follow-up|1|||
27940041|NCT01197534|54596364|FG001|Overall Study|Dev. of study specific discont. criteria|6|||
27940042|NCT01197534|54596365|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
27940043|NCT01197534|54596363|FG000|Overall Study|Lost to Follow-up|1|||
28058524|NCT00265317|54714803|FG003|Phase 2|Withdrawal/other than adverse event|1|||
28058525|NCT00265317|54714800|FG000|Phase 2|Study terminated by sponsor|0|||
28058526|NCT00265317|54714801|FG001|Phase 2|Study terminated by sponsor|0|||
28058527|NCT00265317|54714802|FG002|Phase 2|Study terminated by sponsor|1|||
28058528|NCT00265317|54714803|FG003|Phase 2|Study terminated by sponsor|0|||
28058529|NCT00265317|54714800|FG000|Phase 2|Other|0|||
28058530|NCT00265317|54714801|FG001|Phase 2|Other|0|||
28058531|NCT00265317|54714802|FG002|Phase 2|Other|1|||
28058532|NCT00265317|54714803|FG003|Phase 2|Other|1|||
28058533|NCT00373490|54714824|FG000|Overall Study|Adverse Event|0|||
28058534|NCT00373490|54714825|FG001|Overall Study|Adverse Event|1|||
28058535|NCT00373490|54714824|FG000|Overall Study|Lack of Efficacy|9|||
28058536|NCT00373490|54714825|FG001|Overall Study|Lack of Efficacy|4|||
28058537|NCT00373490|54714824|FG000|Overall Study|Withdrawal by Subject|0|||
28058538|NCT00373490|54714825|FG001|Overall Study|Withdrawal by Subject|1|||
28058539|NCT00251589|54714835|FG000|Overall Study|Adverse Event|5|||
28058540|NCT00251589|54714836|FG001|Overall Study|Adverse Event|1|||
28058541|NCT00251589|54714837|FG002|Overall Study|Adverse Event|2|||
28058542|NCT00251589|54714838|FG003|Overall Study|Adverse Event|1|||
28058543|NCT00251589|54714835|FG000|Overall Study|Withdrawal by Subject|1|||
28058544|NCT00251589|54714836|FG001|Overall Study|Withdrawal by Subject|1|||
28058545|NCT00251589|54714837|FG002|Overall Study|Withdrawal by Subject|0|||
28058546|NCT00251589|54714838|FG003|Overall Study|Withdrawal by Subject|0|||
28058547|NCT00251589|54714835|FG000|Overall Study|Discontinued due to progressive disease|9|||
28058548|NCT00251589|54714836|FG001|Overall Study|Discontinued due to progressive disease|1|||
28058549|NCT00251589|54714837|FG002|Overall Study|Discontinued due to progressive disease|0|||
28058550|NCT00251589|54714838|FG003|Overall Study|Discontinued due to progressive disease|1|||
28058551|NCT00265239|54714850|FG000|Overall Study|Adverse Event|2|||
28058552|NCT00265239|54714851|FG001|Overall Study|Adverse Event|1|||
28058553|NCT00350298|54714859|FG000|Overall Study|Death|7|||
28058554|NCT00350298|54714860|FG001|Overall Study|Death|8|||
28058555|NCT00350298|54714859|FG000|Overall Study|Lost to Follow-up|1|||
28058556|NCT00350298|54714860|FG001|Overall Study|Lost to Follow-up|2|||
28058557|NCT00350298|54714859|FG000|Overall Study|Withdrawal by Subject|1|||
28058558|NCT00350298|54714860|FG001|Overall Study|Withdrawal by Subject|3|||
28058559|NCT00159874|54714873|FG000|Overall Study|Adverse Event|2|||
28058560|NCT00159874|54714874|FG001|Overall Study|Adverse Event|2|||
28058561|NCT00159874|54714875|FG002|Overall Study|Adverse Event|5|||
28058562|NCT00159874|54714876|FG003|Overall Study|Adverse Event|1|||
28058563|NCT00159874|54714877|FG004|Overall Study|Adverse Event|1|||
28058564|NCT00159874|54714878|FG005|Overall Study|Adverse Event|2|||
28058565|NCT00159874|54714879|FG006|Overall Study|Adverse Event|0|||
28058566|NCT00159874|54714873|FG000|Overall Study|Does Not Meet Entrance Criteria|1|||
28058567|NCT00159874|54714874|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
28058568|NCT00159874|54714875|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
28058569|NCT00159874|54714876|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
28058570|NCT00159874|54714877|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
28058571|NCT00159874|54714878|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
28058572|NCT00159874|54714879|FG006|Overall Study|Does Not Meet Entrance Criteria|0|||
28058573|NCT00159874|54714873|FG000|Overall Study|Lack of Efficacy|2|||
28058574|NCT00159874|54714874|FG001|Overall Study|Lack of Efficacy|0|||
28058575|NCT00159874|54714875|FG002|Overall Study|Lack of Efficacy|1|||
27814601|NCT01575873|54271256|FG001|Overall Study|Lost to Follow-up|3|||
27814602|NCT01575873|54271257|FG002|Overall Study|Lost to Follow-up|13|||
28058576|NCT00159874|54714876|FG003|Overall Study|Lack of Efficacy|1|||
28058577|NCT00159874|54714877|FG004|Overall Study|Lack of Efficacy|0|||
27814603|NCT01575873|54271258|FG003|Overall Study|Lost to Follow-up|5|||
28058578|NCT00159874|54714878|FG005|Overall Study|Lack of Efficacy|3|||
28058579|NCT00159874|54714879|FG006|Overall Study|Lack of Efficacy|0|||
28058580|NCT00159874|54714873|FG000|Overall Study|Lost to Follow-up|1|||
28058581|NCT00159874|54714874|FG001|Overall Study|Lost to Follow-up|0|||
28058582|NCT00159874|54714875|FG002|Overall Study|Lost to Follow-up|3|||
28058583|NCT00159874|54714876|FG003|Overall Study|Lost to Follow-up|0|||
28058584|NCT00159874|54714877|FG004|Overall Study|Lost to Follow-up|1|||
28058585|NCT00159874|54714878|FG005|Overall Study|Lost to Follow-up|2|||
28058586|NCT00159874|54714879|FG006|Overall Study|Lost to Follow-up|1|||
28058587|NCT00159874|54714873|FG000|Overall Study|Other|8|||
28058588|NCT00159874|54714874|FG001|Overall Study|Other|8|||
28058589|NCT00159874|54714875|FG002|Overall Study|Other|8|||
28058590|NCT00159874|54714876|FG003|Overall Study|Other|0|||
28058591|NCT00159874|54714877|FG004|Overall Study|Other|2|||
28058592|NCT00159874|54714878|FG005|Overall Study|Other|1|||
28058593|NCT00159874|54714879|FG006|Overall Study|Other|3|||
28058594|NCT00159874|54714873|FG000|Overall Study|Protocol Violation|0|||
28058595|NCT00159874|54714874|FG001|Overall Study|Protocol Violation|5|||
28058596|NCT00159874|54714875|FG002|Overall Study|Protocol Violation|2|||
28058597|NCT00159874|54714876|FG003|Overall Study|Protocol Violation|0|||
28058598|NCT00159874|54714877|FG004|Overall Study|Protocol Violation|0|||
28058599|NCT00159874|54714878|FG005|Overall Study|Protocol Violation|0|||
28058600|NCT00159874|54714879|FG006|Overall Study|Protocol Violation|0|||
28058601|NCT00159874|54714873|FG000|Overall Study|Death|3|||
28058602|NCT00159874|54714874|FG001|Overall Study|Death|8|||
28058603|NCT00159874|54714875|FG002|Overall Study|Death|15|||
28058604|NCT00159874|54714876|FG003|Overall Study|Death|0|||
28058605|NCT00159874|54714877|FG004|Overall Study|Death|1|||
28058606|NCT00159874|54714878|FG005|Overall Study|Death|2|||
28058607|NCT00159874|54714879|FG006|Overall Study|Death|0|||
28058608|NCT00159874|54714873|FG000|Overall Study|Withdrawal by Subject|2|||
28058609|NCT00159874|54714874|FG001|Overall Study|Withdrawal by Subject|6|||
28058610|NCT00159874|54714875|FG002|Overall Study|Withdrawal by Subject|8|||
28058611|NCT00159874|54714876|FG003|Overall Study|Withdrawal by Subject|4|||
28058612|NCT00159874|54714877|FG004|Overall Study|Withdrawal by Subject|3|||
28058613|NCT00159874|54714878|FG005|Overall Study|Withdrawal by Subject|2|||
28058614|NCT00159874|54714879|FG006|Overall Study|Withdrawal by Subject|1|||
28058615|NCT00159874|54714873|FG000|Overall Study|Pregnancy|1|||
28058616|NCT00159874|54714874|FG001|Overall Study|Pregnancy|1|||
28058617|NCT00159874|54714875|FG002|Overall Study|Pregnancy|0|||
28058618|NCT00159874|54714876|FG003|Overall Study|Pregnancy|0|||
28058619|NCT00159874|54714877|FG004|Overall Study|Pregnancy|0|||
28058620|NCT00159874|54714878|FG005|Overall Study|Pregnancy|0|||
28058621|NCT00159874|54714879|FG006|Overall Study|Pregnancy|0|||
28058622|NCT00349908|54714897|FG000|Overall Study|Withdrawal by Subject|0|||
28058623|NCT00349908|54714898|FG001|Overall Study|Withdrawal by Subject|4|||
28058624|NCT00184054|54714905|FG000|Overall Study|Adverse Event|1|||
28058625|NCT00183430|54714911|FG000|Overall Study|Adverse Event|1|||
28058626|NCT00183430|54714912|FG001|Overall Study|Adverse Event|0|||
28058627|NCT00183430|54714911|FG000|Overall Study|Lost to Follow-up|3|||
28058628|NCT00183430|54714912|FG001|Overall Study|Lost to Follow-up|0|||
28058629|NCT00183430|54714911|FG000|Overall Study|did not meet inclusion criteria|1|||
28058630|NCT00183430|54714912|FG001|Overall Study|did not meet inclusion criteria|0|||
28058631|NCT00183430|54714911|FG000|Overall Study|Withdrawal by Subject|1|||
28058632|NCT00183430|54714912|FG001|Overall Study|Withdrawal by Subject|0|||
28058633|NCT00183274|54714918|FG000|Phase 1: Open-Label|Adverse Event|31|||
28058634|NCT00183274|54714919|FG001|Phase 1: Open-Label|Adverse Event|0|||
28058635|NCT00183274|54714920|FG002|Phase 1: Open-Label|Adverse Event|0|||
28058636|NCT00183274|54714921|FG003|Phase 1: Open-Label|Adverse Event|0|||
28058637|NCT00183274|54714922|FG004|Phase 1: Open-Label|Adverse Event|0|||
28058638|NCT00183274|54714923|FG005|Phase 1: Open-Label|Adverse Event|0|||
28058639|NCT00183274|54714918|FG000|Phase 1: Open-Label|Lack of Efficacy|13|||
28058640|NCT00183274|54714919|FG001|Phase 1: Open-Label|Lack of Efficacy|0|||
28058641|NCT00183274|54714920|FG002|Phase 1: Open-Label|Lack of Efficacy|0|||
28058642|NCT00183274|54714921|FG003|Phase 1: Open-Label|Lack of Efficacy|0|||
28058643|NCT00183274|54714922|FG004|Phase 1: Open-Label|Lack of Efficacy|0|||
28058644|NCT00183274|54714923|FG005|Phase 1: Open-Label|Lack of Efficacy|0|||
28058645|NCT00183274|54714918|FG000|Phase 1: Open-Label|Protocol Violation|11|||
28058646|NCT00183274|54714919|FG001|Phase 1: Open-Label|Protocol Violation|0|||
28058647|NCT00183274|54714920|FG002|Phase 1: Open-Label|Protocol Violation|0|||
28058648|NCT00183274|54714921|FG003|Phase 1: Open-Label|Protocol Violation|0|||
28058649|NCT00183274|54714922|FG004|Phase 1: Open-Label|Protocol Violation|0|||
28058650|NCT00183274|54714923|FG005|Phase 1: Open-Label|Protocol Violation|0|||
28058651|NCT00183274|54714918|FG000|Phase 1: Open-Label|Withdrawal by Subject|13|||
28058652|NCT00183274|54714919|FG001|Phase 1: Open-Label|Withdrawal by Subject|0|||
28058653|NCT00183274|54714920|FG002|Phase 1: Open-Label|Withdrawal by Subject|0|||
28058654|NCT00183274|54714921|FG003|Phase 1: Open-Label|Withdrawal by Subject|0|||
28058655|NCT00183274|54714922|FG004|Phase 1: Open-Label|Withdrawal by Subject|0|||
28058656|NCT00183274|54714923|FG005|Phase 1: Open-Label|Withdrawal by Subject|0|||
28058657|NCT00183274|54714918|FG000|Phase 1: Open-Label|Lost to Follow-up|33|||
27940044|NCT01197534|54596364|FG001|Overall Study|Lost to Follow-up|4|||
27940045|NCT01197534|54596365|FG002|Overall Study|Lost to Follow-up|2|||
27940046|NCT01197534|54596363|FG000|Overall Study|Adverse Event|35|||
28058658|NCT00183274|54714919|FG001|Phase 1: Open-Label|Lost to Follow-up|0|||
28058659|NCT00183274|54714920|FG002|Phase 1: Open-Label|Lost to Follow-up|0|||
28058660|NCT00183274|54714921|FG003|Phase 1: Open-Label|Lost to Follow-up|0|||
28058661|NCT00183274|54714922|FG004|Phase 1: Open-Label|Lost to Follow-up|0|||
28058662|NCT00183274|54714923|FG005|Phase 1: Open-Label|Lost to Follow-up|0|||
28058663|NCT00183274|54714918|FG000|Phase 1: Open-Label|Other|9|||
28058664|NCT00183274|54714919|FG001|Phase 1: Open-Label|Other|0|||
28058665|NCT00183274|54714920|FG002|Phase 1: Open-Label|Other|0|||
28058666|NCT00183274|54714921|FG003|Phase 1: Open-Label|Other|0|||
28058667|NCT00183274|54714922|FG004|Phase 1: Open-Label|Other|0|||
28058668|NCT00183274|54714923|FG005|Phase 1: Open-Label|Other|0|||
28058669|NCT00183274|54714918|FG000|Phase 2: Double-Blind|Relapsed|0|||
27940047|NCT01197534|54596364|FG001|Overall Study|Adverse Event|36|||
27940048|NCT01197534|54596365|FG002|Overall Study|Adverse Event|24|||
27940049|NCT01197378|54596376|FG000|Overall Study|Adverse Event|3|||
27940050|NCT01197378|54596376|FG000|Overall Study|Withdrawal by Subject|1|||
27940051|NCT01197378|54596376|FG000|Overall Study|Physician Decision|1|||
28058670|NCT00183274|54714919|FG001|Phase 2: Double-Blind|Relapsed|8|||
28058671|NCT00183274|54714920|FG002|Phase 2: Double-Blind|Relapsed|29|||
28058672|NCT00183274|54714921|FG003|Phase 2: Double-Blind|Relapsed|0|||
28058673|NCT00183274|54714922|FG004|Phase 2: Double-Blind|Relapsed|0|||
28058674|NCT00183274|54714923|FG005|Phase 2: Double-Blind|Relapsed|0|||
28058675|NCT00183274|54714918|FG000|Phase 2: Double-Blind|Withdrawal by Subject|0|||
28058676|NCT00183274|54714919|FG001|Phase 2: Double-Blind|Withdrawal by Subject|18|||
28058677|NCT00183274|54714920|FG002|Phase 2: Double-Blind|Withdrawal by Subject|14|||
28058678|NCT00183274|54714921|FG003|Phase 2: Double-Blind|Withdrawal by Subject|0|||
28058679|NCT00183274|54714922|FG004|Phase 2: Double-Blind|Withdrawal by Subject|0|||
28058680|NCT00183274|54714923|FG005|Phase 2: Double-Blind|Withdrawal by Subject|0|||
28058681|NCT00183274|54714918|FG000|Phase 3: Double-Blind|Withdrawal by Subject|0|||
28058682|NCT00183274|54714919|FG001|Phase 3: Double-Blind|Withdrawal by Subject|0|||
28058683|NCT00183274|54714920|FG002|Phase 3: Double-Blind|Withdrawal by Subject|0|||
28058684|NCT00183274|54714921|FG003|Phase 3: Double-Blind|Withdrawal by Subject|1|||
28058685|NCT00183274|54714922|FG004|Phase 3: Double-Blind|Withdrawal by Subject|9|||
28058686|NCT00183274|54714923|FG005|Phase 3: Double-Blind|Withdrawal by Subject|2|||
28058687|NCT00183274|54714918|FG000|Phase 3: Double-Blind|Relapsed|0|||
28058688|NCT00183274|54714919|FG001|Phase 3: Double-Blind|Relapsed|0|||
28058689|NCT00183274|54714920|FG002|Phase 3: Double-Blind|Relapsed|0|||
28058690|NCT00183274|54714921|FG003|Phase 3: Double-Blind|Relapsed|1|||
28058691|NCT00183274|54714922|FG004|Phase 3: Double-Blind|Relapsed|11|||
28058692|NCT00183274|54714923|FG005|Phase 3: Double-Blind|Relapsed|2|||
28058693|NCT00183196|54714941|FG000|Overall Study|Withdrawal by Subject|18|||
28058694|NCT00183196|54714942|FG001|Overall Study|Withdrawal by Subject|11|||
28058695|NCT00183196|54714943|FG002|Overall Study|Withdrawal by Subject|13|||
28058696|NCT00183196|54714941|FG000|Overall Study|Adverse Event|1|||
28058697|NCT00183196|54714942|FG001|Overall Study|Adverse Event|2|||
28058698|NCT00183196|54714943|FG002|Overall Study|Adverse Event|2|||
28058699|NCT00183196|54714941|FG000|Overall Study|Legal event|1|||
28058700|NCT00183196|54714942|FG001|Overall Study|Legal event|1|||
28058701|NCT00183196|54714943|FG002|Overall Study|Legal event|1|||
28058702|NCT00183196|54714941|FG000|Overall Study|Required more intensive care|0|||
28058703|NCT00183196|54714942|FG001|Overall Study|Required more intensive care|1|||
28058704|NCT00183196|54714943|FG002|Overall Study|Required more intensive care|2|||
28058705|NCT00349752|54714953|FG000|Overall Study|Adverse Event|8|||
28058706|NCT00349752|54714954|FG001|Overall Study|Adverse Event|12|||
28058707|NCT00349752|54714953|FG000|Overall Study|Lack of Efficacy|37|||
28058708|NCT00349752|54714954|FG001|Overall Study|Lack of Efficacy|42|||
28058709|NCT00349752|54714953|FG000|Overall Study|Lost to Follow-up|4|||
28058710|NCT00349752|54714954|FG001|Overall Study|Lost to Follow-up|2|||
28058711|NCT00349752|54714953|FG000|Overall Study|Personal reasons|6|||
28058712|NCT00349752|54714954|FG001|Overall Study|Personal reasons|5|||
27940052|NCT01197378|54596376|FG000|Overall Study|Other|2|||
27940053|NCT01197300|54596382|FG000|Overall Study|Lost to Follow-up|0|||
27940054|NCT01197300|54596383|FG001|Overall Study|Lost to Follow-up|1|||
28058713|NCT00349752|54714953|FG000|Overall Study|Other: Required exclusionary medication|0|||
28058714|NCT00349752|54714954|FG001|Overall Study|Other: Required exclusionary medication|1|||
28058715|NCT00349752|54714953|FG000|Overall Study|Other: Non compliance|0|||
28058716|NCT00349752|54714954|FG001|Overall Study|Other: Non compliance|1|||
28058717|NCT00349752|54714953|FG000|Overall Study|Other: Patient stopped steroids|0|||
28058718|NCT00349752|54714954|FG001|Overall Study|Other: Patient stopped steroids|1|||
28058719|NCT00349752|54714953|FG000|Overall Study|Other: Patient's steroid use|1|||
28058720|NCT00349752|54714954|FG001|Overall Study|Other: Patient's steroid use|0|||
28058721|NCT00349752|54714953|FG000|Overall Study|Other: Ineligible|1|||
28058722|NCT00349752|54714954|FG001|Overall Study|Other: Ineligible|0|||
28058723|NCT00349752|54714953|FG000|Overall Study|Other: Inadvertently unblinded|1|||
28058724|NCT00349752|54714954|FG001|Overall Study|Other: Inadvertently unblinded|0|||
28058725|NCT00349752|54714953|FG000|Overall Study|Other:History of squamous cell carcinoma|1|||
28058726|NCT00349752|54714954|FG001|Overall Study|Other:History of squamous cell carcinoma|0|||
28058727|NCT00174460|54714962|FG000|Overall Study|Withdrawal by Subject|0|||
28058728|NCT00174460|54714963|FG001|Overall Study|Withdrawal by Subject|1|||
28058729|NCT00348816|54714970|FG000|Overall Study|Noncompliance with radiation treatment|1|||
28058730|NCT00265083|54714979|FG000|Overall Study|Adverse Event|5|||
28058731|NCT00265083|54714980|FG001|Overall Study|Adverse Event|13|||
28058732|NCT00265083|54714981|FG002|Overall Study|Adverse Event|15|||
28058733|NCT00265083|54714979|FG000|Overall Study|Lost to Follow-up|3|||
28058734|NCT00265083|54714980|FG001|Overall Study|Lost to Follow-up|4|||
28058735|NCT00265083|54714981|FG002|Overall Study|Lost to Follow-up|4|||
28058736|NCT00265083|54714979|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
28058737|NCT00265083|54714980|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
28058738|NCT00265083|54714981|FG002|Overall Study|Unsatisfactory therapeutic effect|14|||
28058739|NCT00265083|54714979|FG000|Overall Study|Other|1|||
28058740|NCT00265083|54714980|FG001|Overall Study|Other|12|||
28058741|NCT00265083|54714981|FG002|Overall Study|Other|9|||
28058742|NCT00264849|54714992|FG000|Overall Study|Adverse Event|7|||
28058743|NCT00264849|54714993|FG001|Overall Study|Adverse Event|2|||
28058744|NCT00264849|54714992|FG000|Overall Study|Withdrawal by Subject|7|||
28058745|NCT00264849|54714993|FG001|Overall Study|Withdrawal by Subject|11|||
28058746|NCT00264849|54714992|FG000|Overall Study|Protocol Violation|5|||
28058747|NCT00264849|54714993|FG001|Overall Study|Protocol Violation|3|||
28058748|NCT00264849|54714992|FG000|Overall Study|Lack of Efficacy|1|||
28058749|NCT00264849|54714993|FG001|Overall Study|Lack of Efficacy|6|||
28058750|NCT00264849|54714992|FG000|Overall Study|Lost to Follow-up|0|||
28058751|NCT00264849|54714993|FG001|Overall Study|Lost to Follow-up|2|||
28058752|NCT00264849|54714992|FG000|Overall Study|Death|0|||
28058753|NCT00264849|54714993|FG001|Overall Study|Death|1|||
28058754|NCT00264849|54714992|FG000|Overall Study|Administrative Problems|2|||
28058755|NCT00264849|54714993|FG001|Overall Study|Administrative Problems|0|||
28058756|NCT00211809|54714999|FG000|Overall Study|Lack of Efficacy|1|||
28058757|NCT00211809|54714999|FG000|Overall Study|Lost to Follow-up|2|||
28058758|NCT00211809|54714999|FG000|Overall Study|Pregnancy|1|||
28058759|NCT00211809|54714999|FG000|Overall Study|side effects|2|||
28058760|NCT00129766|54715007|FG000|Overall Study|Death|3|||
28058761|NCT00129766|54715008|FG001|Overall Study|Death|8|||
28058762|NCT00129766|54715007|FG000|Overall Study|Withdrawal of consent|31|||
28058763|NCT00129766|54715008|FG001|Overall Study|Withdrawal of consent|30|||
28058764|NCT00129766|54715007|FG000|Overall Study|Lost to Follow-up|26|||
28058765|NCT00129766|54715008|FG001|Overall Study|Lost to Follow-up|21|||
28058766|NCT00150592|54715017|FG000|Overall Study|Adverse Event|4|||
28058767|NCT00150592|54715018|FG001|Overall Study|Adverse Event|1|||
28058768|NCT00150592|54715017|FG000|Overall Study|Protocol Violation|1|||
28058769|NCT00150592|54715018|FG001|Overall Study|Protocol Violation|0|||
28058770|NCT00150592|54715017|FG000|Overall Study|Withdrawal by Subject|1|||
28058771|NCT00150592|54715018|FG001|Overall Study|Withdrawal by Subject|2|||
28058772|NCT00150592|54715017|FG000|Overall Study|Non-compliance|1|||
28058773|NCT00150592|54715018|FG001|Overall Study|Non-compliance|0|||
28058774|NCT00149890|54715026|FG000|Overall Study|Adverse Event|1|||
28058775|NCT00149890|54715027|FG001|Overall Study|Adverse Event|8|||
28058776|NCT00149890|54715026|FG000|Overall Study|Lack of Efficacy|8|||
28058777|NCT00149890|54715027|FG001|Overall Study|Lack of Efficacy|9|||
28058778|NCT00149890|54715026|FG000|Overall Study|Protocol Violation|1|||
28058779|NCT00149890|54715027|FG001|Overall Study|Protocol Violation|0|||
28058780|NCT00149890|54715026|FG000|Overall Study|Lost to Follow-up|1|||
28058781|NCT00149890|54715027|FG001|Overall Study|Lost to Follow-up|0|||
27848316|NCT00215657|54341254|FG000|Overall Study|Other|3|||
28058782|NCT00149890|54715026|FG000|Overall Study|Graft Loss|2|||
28058783|NCT00149890|54715027|FG001|Overall Study|Graft Loss|1|||
28058784|NCT00174382|54715033|FG000|Overall Study|Death|2|||
28058785|NCT00174382|54715033|FG000|Overall Study|Adverse Event|19|||
28058786|NCT00174382|54715033|FG000|Overall Study|Withdrawal by Subject|6|||
28058787|NCT00174382|54715033|FG000|Overall Study|Protocol Violation|3|||
28058788|NCT00174382|54715033|FG000|Overall Study|Arrived early for last visit in error|1|||
28058789|NCT00174382|54715033|FG000|Overall Study|Subject felt pill not effective enough|1|||
28058790|NCT00174382|54715033|FG000|Overall Study|Lost to Follow-up|1|||
28058791|NCT00355134|54715042|FG000|Core Phase|Withdrawal by Subject|35|||
28058792|NCT00355134|54715043|FG001|Core Phase|Withdrawal by Subject|24|||
28058793|NCT00355134|54715044|FG002|Core Phase|Withdrawal by Subject|35|||
28058794|NCT00355134|54715045|FG003|Core Phase|Withdrawal by Subject|0|||
28058795|NCT00355134|54715046|FG004|Core Phase|Withdrawal by Subject|0|||
28058796|NCT00355134|54715042|FG000|Core Phase|Adverse Event|28|||
28058797|NCT00355134|54715043|FG001|Core Phase|Adverse Event|22|||
28058798|NCT00355134|54715044|FG002|Core Phase|Adverse Event|16|||
28058799|NCT00355134|54715045|FG003|Core Phase|Adverse Event|0|||
28058800|NCT00355134|54715046|FG004|Core Phase|Adverse Event|0|||
28058801|NCT00355134|54715042|FG000|Core Phase|Lost to Follow-up|17|||
28058802|NCT00355134|54715043|FG001|Core Phase|Lost to Follow-up|13|||
28058803|NCT00355134|54715044|FG002|Core Phase|Lost to Follow-up|21|||
28058804|NCT00355134|54715045|FG003|Core Phase|Lost to Follow-up|0|||
28058805|NCT00355134|54715046|FG004|Core Phase|Lost to Follow-up|0|||
28058806|NCT00355134|54715042|FG000|Core Phase|Abnormal laboratory value(s)|19|||
28058807|NCT00355134|54715043|FG001|Core Phase|Abnormal laboratory value(s)|14|||
28058808|NCT00355134|54715044|FG002|Core Phase|Abnormal laboratory value(s)|2|||
28058809|NCT00355134|54715045|FG003|Core Phase|Abnormal laboratory value(s)|0|||
28058810|NCT00355134|54715046|FG004|Core Phase|Abnormal laboratory value(s)|0|||
28058811|NCT00355134|54715042|FG000|Core Phase|Unsatisfactory therapeutic effect|10|||
28058812|NCT00355134|54715043|FG001|Core Phase|Unsatisfactory therapeutic effect|6|||
28058813|NCT00355134|54715044|FG002|Core Phase|Unsatisfactory therapeutic effect|17|||
28058814|NCT00355134|54715045|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
28058815|NCT00355134|54715046|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
28058816|NCT00355134|54715042|FG000|Core Phase|Administrative problems|5|||
28058817|NCT00355134|54715043|FG001|Core Phase|Administrative problems|3|||
28058818|NCT00355134|54715044|FG002|Core Phase|Administrative problems|5|||
28058819|NCT00355134|54715045|FG003|Core Phase|Administrative problems|0|||
28058820|NCT00355134|54715046|FG004|Core Phase|Administrative problems|0|||
28058821|NCT00355134|54715042|FG000|Core Phase|Protocol Violation|3|||
28058822|NCT00355134|54715043|FG001|Core Phase|Protocol Violation|2|||
28058823|NCT00355134|54715044|FG002|Core Phase|Protocol Violation|2|||
28058824|NCT00355134|54715045|FG003|Core Phase|Protocol Violation|0|||
28058825|NCT00355134|54715046|FG004|Core Phase|Protocol Violation|0|||
28058826|NCT00355134|54715042|FG000|Core Phase|Abnormal test procedure result(s)|1|||
28058827|NCT00355134|54715043|FG001|Core Phase|Abnormal test procedure result(s)|2|||
28058828|NCT00355134|54715044|FG002|Core Phase|Abnormal test procedure result(s)|1|||
28058829|NCT00355134|54715045|FG003|Core Phase|Abnormal test procedure result(s)|0|||
28058830|NCT00355134|54715046|FG004|Core Phase|Abnormal test procedure result(s)|0|||
28058831|NCT00355134|54715042|FG000|Core Phase|Condition no longer requires study drug|1|||
28058832|NCT00355134|54715043|FG001|Core Phase|Condition no longer requires study drug|0|||
28058833|NCT00355134|54715044|FG002|Core Phase|Condition no longer requires study drug|1|||
28058834|NCT00355134|54715045|FG003|Core Phase|Condition no longer requires study drug|0|||
28058835|NCT00355134|54715046|FG004|Core Phase|Condition no longer requires study drug|0|||
28058836|NCT00355134|54715042|FG000|Extension Phase|Withdrawal by Subject|7|||
28058837|NCT00355134|54715043|FG001|Extension Phase|Withdrawal by Subject|11|||
28058838|NCT00355134|54715044|FG002|Extension Phase|Withdrawal by Subject|0|||
28058839|NCT00355134|54715045|FG003|Extension Phase|Withdrawal by Subject|7|||
28058840|NCT00355134|54715046|FG004|Extension Phase|Withdrawal by Subject|5|||
28058841|NCT00355134|54715042|FG000|Extension Phase|Adverse Event|13|||
28058842|NCT00355134|54715043|FG001|Extension Phase|Adverse Event|9|||
28058843|NCT00355134|54715044|FG002|Extension Phase|Adverse Event|0|||
28058844|NCT00355134|54715045|FG003|Extension Phase|Adverse Event|3|||
28058845|NCT00355134|54715046|FG004|Extension Phase|Adverse Event|5|||
28058846|NCT00355134|54715042|FG000|Extension Phase|Lost to Follow-up|2|||
27814604|NCT01575873|54271255|FG000|Overall Study|Death|3|||
27814605|NCT01575873|54271256|FG001|Overall Study|Death|2|||
27814606|NCT01575873|54271257|FG002|Overall Study|Death|8|||
27814607|NCT01575873|54271258|FG003|Overall Study|Death|9|||
27814608|NCT01575873|54271255|FG000|Overall Study|Noncompliance|1|||
28058847|NCT00355134|54715043|FG001|Extension Phase|Lost to Follow-up|6|||
28058848|NCT00355134|54715044|FG002|Extension Phase|Lost to Follow-up|0|||
28058849|NCT00355134|54715045|FG003|Extension Phase|Lost to Follow-up|2|||
28058850|NCT00355134|54715046|FG004|Extension Phase|Lost to Follow-up|4|||
28058851|NCT00355134|54715042|FG000|Extension Phase|Abnormal laboratory value(s)|4|||
28058852|NCT00355134|54715043|FG001|Extension Phase|Abnormal laboratory value(s)|2|||
28058853|NCT00355134|54715044|FG002|Extension Phase|Abnormal laboratory value(s)|0|||
28058854|NCT00355134|54715045|FG003|Extension Phase|Abnormal laboratory value(s)|2|||
27814609|NCT01575873|54271256|FG001|Overall Study|Noncompliance|2|||
28058855|NCT00355134|54715046|FG004|Extension Phase|Abnormal laboratory value(s)|2|||
28058856|NCT00355134|54715042|FG000|Extension Phase|Administrative problems|2|||
28058857|NCT00355134|54715043|FG001|Extension Phase|Administrative problems|4|||
28058858|NCT00355134|54715044|FG002|Extension Phase|Administrative problems|0|||
28058859|NCT00355134|54715045|FG003|Extension Phase|Administrative problems|1|||
28058860|NCT00355134|54715046|FG004|Extension Phase|Administrative problems|1|||
28058861|NCT00355134|54715042|FG000|Extension Phase|Unsatisfactory therapeutic effect|3|||
28058862|NCT00355134|54715043|FG001|Extension Phase|Unsatisfactory therapeutic effect|4|||
28058863|NCT00355134|54715044|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
28058864|NCT00355134|54715045|FG003|Extension Phase|Unsatisfactory therapeutic effect|0|||
28058865|NCT00355134|54715046|FG004|Extension Phase|Unsatisfactory therapeutic effect|1|||
28058866|NCT00355134|54715042|FG000|Extension Phase|Abnormal test procedure result(s)|0|||
28058867|NCT00355134|54715043|FG001|Extension Phase|Abnormal test procedure result(s)|1|||
28058868|NCT00355134|54715044|FG002|Extension Phase|Abnormal test procedure result(s)|0|||
28058869|NCT00355134|54715045|FG003|Extension Phase|Abnormal test procedure result(s)|0|||
28058870|NCT00355134|54715046|FG004|Extension Phase|Abnormal test procedure result(s)|1|||
28058871|NCT00355134|54715042|FG000|Extension Phase|Protocol Violation|0|||
28058872|NCT00355134|54715043|FG001|Extension Phase|Protocol Violation|0|||
28058873|NCT00355134|54715044|FG002|Extension Phase|Protocol Violation|0|||
28058874|NCT00355134|54715045|FG003|Extension Phase|Protocol Violation|1|||
28058875|NCT00355134|54715046|FG004|Extension Phase|Protocol Violation|0|||
28058876|NCT00171730|54715056|FG000|Overall Study|Adverse Event|3|||
28058877|NCT00171730|54715056|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
28058878|NCT00171730|54715056|FG000|Overall Study|Unsatisfactory Therapeutic Effect|8|||
28058879|NCT00171730|54715056|FG000|Overall Study|Withdrawal by Subject|3|||
28058880|NCT00355056|54715068|FG000|Randomization Period|Early Termination|4|||
28058881|NCT00355056|54715069|FG001|Randomization Period|Early Termination|6|||
28058882|NCT00348348|54715085|FG000|Overall Study|Adverse event - unrelated to study drug|0|||
28058883|NCT00348348|54715086|FG001|Overall Study|Adverse event - unrelated to study drug|1|||
28058884|NCT00348348|54715085|FG000|Overall Study|Lack of Efficacy|1|||
28058885|NCT00348348|54715086|FG001|Overall Study|Lack of Efficacy|1|||
28058886|NCT00348348|54715085|FG000|Overall Study|Lost to Follow-up|8|||
28058887|NCT00348348|54715086|FG001|Overall Study|Lost to Follow-up|10|||
28058888|NCT00348348|54715085|FG000|Overall Study|Withdrawal by Subject|4|||
28058889|NCT00348348|54715086|FG001|Overall Study|Withdrawal by Subject|1|||
28058890|NCT00348348|54715085|FG000|Overall Study|Other|7|||
28058891|NCT00348348|54715086|FG001|Overall Study|Other|4|||
28058892|NCT00348348|54715085|FG000|Overall Study|Dissallowed Meds - unrelated to study|1|||
28058893|NCT00348348|54715086|FG001|Overall Study|Dissallowed Meds - unrelated to study|3|||
28058894|NCT00348348|54715085|FG000|Overall Study|Dissallowed Meds - unlikley related|1|||
28058895|NCT00348348|54715086|FG001|Overall Study|Dissallowed Meds - unlikley related|1|||
28058896|NCT00348348|54715085|FG000|Overall Study|Dissallowed Meds - possibly releated|1|||
28058897|NCT00348348|54715086|FG001|Overall Study|Dissallowed Meds - possibly releated|1|||
28058898|NCT00348348|54715085|FG000|Overall Study|Worsening of BC - Unrelated to study|0|||
28058899|NCT00348348|54715086|FG001|Overall Study|Worsening of BC - Unrelated to study|3|||
28058900|NCT00348348|54715085|FG000|Overall Study|Worsening of BC - Unlikely related|1|||
28058901|NCT00348348|54715086|FG001|Overall Study|Worsening of BC - Unlikely related|2|||
28058902|NCT00348348|54715085|FG000|Overall Study|Adverse event probably related to study|1|||
28058903|NCT00348348|54715086|FG001|Overall Study|Adverse event probably related to study|0|||
28058904|NCT00347958|54715092|FG000|Overall Study|Adverse Event|1|||
28058905|NCT00347958|54715092|FG000|Overall Study|Protocol Violation|2|||
28058906|NCT00347958|54715092|FG000|Overall Study|Withdrawal by Subject|1|||
28058907|NCT00354744|54715096|FG000|Overall Study|Adverse Event|2|||
28058908|NCT00354744|54715096|FG000|Overall Study|Death|2|||
28058909|NCT00354744|54715096|FG000|Overall Study|Lack of Efficacy|11|||
28058910|NCT00354744|54715096|FG000|Overall Study|Lost to Follow-up|2|||
28058911|NCT00354744|54715096|FG000|Overall Study|Physician Decision|11|||
28058912|NCT00354744|54715096|FG000|Overall Study|Withdrawal by Subject|14|||
28058913|NCT00373256|54715104|FG000|Overall Study|Adverse Event (AE)|1|||
28058914|NCT00373256|54715105|FG001|Overall Study|Adverse Event (AE)|5|||
28058915|NCT00373256|54715104|FG000|Overall Study|Lost to Follow-up|2|||
28058916|NCT00373256|54715105|FG001|Overall Study|Lost to Follow-up|1|||
28058917|NCT00373256|54715104|FG000|Overall Study|Death|9|||
28058918|NCT00373256|54715105|FG001|Overall Study|Death|8|||
28058919|NCT00373256|54715104|FG000|Overall Study|Objective Progression or Relapse|111|||
27814610|NCT01575873|54271257|FG002|Overall Study|Noncompliance|4|||
28058920|NCT00373256|54715105|FG001|Overall Study|Objective Progression or Relapse|104|||
28058921|NCT00373256|54715104|FG000|Overall Study|Refused Treatment-Reason Other Than AE|4|||
28058922|NCT00373256|54715105|FG001|Overall Study|Refused Treatment-Reason Other Than AE|7|||
28058923|NCT00373256|54715104|FG000|Overall Study|Other|73|||
28058924|NCT00373256|54715105|FG001|Overall Study|Other|107|||
28058925|NCT00373256|54715104|FG000|Overall Study|Protocol Violation|0|||
28058926|NCT00373256|54715105|FG001|Overall Study|Protocol Violation|2|||
28058927|NCT00373256|54715104|FG000|Overall Study|Study Terminated by Sponsor|41|||
28058928|NCT00373256|54715105|FG001|Overall Study|Study Terminated by Sponsor|13|||
28058929|NCT00394082|54715111|FG000|Overall Study|Unacceptable toxicity|15|||
28058930|NCT00394082|54715111|FG000|Overall Study|Adverse Event|4|||
28058931|NCT00394082|54715111|FG000|Overall Study|Physician Decision|4|||
28058932|NCT00394082|54715111|FG000|Overall Study|Withdrawal by Subject|2|||
28058933|NCT00394082|54715111|FG000|Overall Study|Other|1|||
28058934|NCT00393848|54715119|FG000|Overall Study|Surgical schedule|0|||
28058935|NCT00393848|54715120|FG001|Overall Study|Surgical schedule|0|||
28058936|NCT00393848|54715121|FG002|Overall Study|Surgical schedule|0|||
28058937|NCT00393848|54715122|FG003|Overall Study|Surgical schedule|1|||
28058938|NCT00393848|54715119|FG000|Overall Study|Personal reasons|0|||
28058939|NCT00393848|54715120|FG001|Overall Study|Personal reasons|0|||
28058940|NCT00393848|54715121|FG002|Overall Study|Personal reasons|2|||
28058941|NCT00393848|54715122|FG003|Overall Study|Personal reasons|0|||
28058942|NCT00393458|54715137|FG000|Overall Study|Adverse Event|35|||
28058943|NCT00393458|54715138|FG001|Overall Study|Adverse Event|24|||
28058944|NCT00393458|54715139|FG002|Overall Study|Adverse Event|40|||
28058945|NCT00393458|54715140|FG003|Overall Study|Adverse Event|35|||
28058946|NCT00393458|54715137|FG000|Overall Study|Subject withdrew consent|27|||
28058947|NCT00393458|54715138|FG001|Overall Study|Subject withdrew consent|40|||
28058948|NCT00393458|54715139|FG002|Overall Study|Subject withdrew consent|33|||
28058949|NCT00393458|54715140|FG003|Overall Study|Subject withdrew consent|50|||
28058950|NCT00393458|54715137|FG000|Overall Study|Unsatisfactory therapeutic effect|12|||
28058951|NCT00393458|54715138|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
28058952|NCT00393458|54715139|FG002|Overall Study|Unsatisfactory therapeutic effect|12|||
28058953|NCT00393458|54715140|FG003|Overall Study|Unsatisfactory therapeutic effect|30|||
28058954|NCT00393458|54715137|FG000|Overall Study|Protocol deviation|11|||
28058955|NCT00393458|54715138|FG001|Overall Study|Protocol deviation|11|||
28058956|NCT00393458|54715139|FG002|Overall Study|Protocol deviation|11|||
28058957|NCT00393458|54715140|FG003|Overall Study|Protocol deviation|10|||
28058958|NCT00393458|54715137|FG000|Overall Study|Administrative problems|7|||
28058959|NCT00393458|54715138|FG001|Overall Study|Administrative problems|8|||
28058960|NCT00393458|54715139|FG002|Overall Study|Administrative problems|5|||
28058961|NCT00393458|54715140|FG003|Overall Study|Administrative problems|2|||
28058962|NCT00393458|54715137|FG000|Overall Study|Lost to Follow-up|5|||
28058963|NCT00393458|54715138|FG001|Overall Study|Lost to Follow-up|6|||
28058964|NCT00393458|54715139|FG002|Overall Study|Lost to Follow-up|5|||
28058965|NCT00393458|54715140|FG003|Overall Study|Lost to Follow-up|3|||
28058966|NCT00393458|54715137|FG000|Overall Study|Abnormal laboratory value(s)|1|||
28058967|NCT00393458|54715138|FG001|Overall Study|Abnormal laboratory value(s)|1|||
28058968|NCT00393458|54715139|FG002|Overall Study|Abnormal laboratory value(s)|0|||
28058969|NCT00393458|54715140|FG003|Overall Study|Abnormal laboratory value(s)|0|||
28058970|NCT00393458|54715137|FG000|Overall Study|Death|1|||
28058971|NCT00393458|54715138|FG001|Overall Study|Death|1|||
28058972|NCT00393458|54715139|FG002|Overall Study|Death|5|||
28058973|NCT00393458|54715140|FG003|Overall Study|Death|5|||
28058974|NCT00393458|54715137|FG000|Overall Study|Abnormal test procedure result(s)|0|||
28058975|NCT00393458|54715138|FG001|Overall Study|Abnormal test procedure result(s)|1|||
28058976|NCT00393458|54715139|FG002|Overall Study|Abnormal test procedure result(s)|1|||
28058977|NCT00393458|54715140|FG003|Overall Study|Abnormal test procedure result(s)|2|||
28058978|NCT00393458|54715137|FG000|Overall Study|Subject no longer requires study drug|0|||
28058979|NCT00393458|54715138|FG001|Overall Study|Subject no longer requires study drug|1|||
28058980|NCT00393458|54715139|FG002|Overall Study|Subject no longer requires study drug|0|||
28058981|NCT00393458|54715140|FG003|Overall Study|Subject no longer requires study drug|0|||
28058982|NCT00417482|54715153|FG000|Phase B 1st 16 Weeks|Lack of Efficacy|14|||
28058983|NCT00417482|54715154|FG001|Phase B 1st 16 Weeks|Lack of Efficacy|8|||
28058984|NCT00417482|54715155|FG002|Phase B 1st 16 Weeks|Lack of Efficacy|24|||
28058985|NCT00417482|54715153|FG000|Phase B 1st 16 Weeks|Adverse Event|2|||
27814611|NCT01575873|54271258|FG003|Overall Study|Noncompliance|3|||
27814612|NCT01575873|54271255|FG000|Overall Study|Administrative decision|1|||
28058986|NCT00417482|54715154|FG001|Phase B 1st 16 Weeks|Adverse Event|0|||
28058987|NCT00417482|54715155|FG002|Phase B 1st 16 Weeks|Adverse Event|1|||
28058988|NCT00417482|54715153|FG000|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
28058989|NCT00417482|54715154|FG001|Phase B 1st 16 Weeks|Moved, Unclear reasons|3|||
28058990|NCT00417482|54715155|FG002|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
28058991|NCT00417482|54715153|FG000|Phase B 1st 16 Weeks|Death|1|||
28058992|NCT00417482|54715154|FG001|Phase B 1st 16 Weeks|Death|0|||
28058993|NCT00417482|54715155|FG002|Phase B 1st 16 Weeks|Death|0|||
28058994|NCT00417482|54715153|FG000|Phase B 2nd 16 Weeks|Lack of Efficacy|1|||
28058995|NCT00417482|54715154|FG001|Phase B 2nd 16 Weeks|Lack of Efficacy|12|||
28058996|NCT00417482|54715155|FG002|Phase B 2nd 16 Weeks|Lack of Efficacy|2|||
28058997|NCT00417482|54715153|FG000|Phase B 2nd 16 Weeks|Adverse Event|0|||
28058998|NCT00417482|54715154|FG001|Phase B 2nd 16 Weeks|Adverse Event|0|||
28058999|NCT00417482|54715155|FG002|Phase B 2nd 16 Weeks|Adverse Event|1|||
28059000|NCT00417482|54715153|FG000|Phase B 2nd 16 Weeks|Moved; unclear reason|1|||
28059001|NCT00417482|54715154|FG001|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
28059002|NCT00417482|54715155|FG002|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
28059003|NCT00417482|54715153|FG000|Phase B 2nd 16 Weeks|Death|1|||
28059004|NCT00417482|54715154|FG001|Phase B 2nd 16 Weeks|Death|1|||
28059005|NCT00417482|54715155|FG002|Phase B 2nd 16 Weeks|Death|0|||
28059006|NCT00417248|54715169|FG000|Overall Study|Study Terminated|6|||
28059007|NCT00417248|54715169|FG000|Overall Study|Death|1|||
28059008|NCT00417248|54715169|FG000|Overall Study|Lack of Efficacy|1|||
28059009|NCT00392288|54715177|FG000|Overall Study|Adverse Event|17|||
28059010|NCT00392288|54715178|FG001|Overall Study|Adverse Event|7|||
28059011|NCT00392288|54715179|FG002|Overall Study|Adverse Event|8|||
28059012|NCT00392288|54715177|FG000|Overall Study|Lack of Efficacy|8|||
28059013|NCT00392288|54715178|FG001|Overall Study|Lack of Efficacy|5|||
28059014|NCT00392288|54715179|FG002|Overall Study|Lack of Efficacy|3|||
28059015|NCT00392288|54715177|FG000|Overall Study|Protocol Violation|1|||
28059016|NCT00392288|54715178|FG001|Overall Study|Protocol Violation|3|||
28059017|NCT00392288|54715179|FG002|Overall Study|Protocol Violation|1|||
28059018|NCT00392288|54715177|FG000|Overall Study|Lost to Follow-up|1|||
28059019|NCT00392288|54715178|FG001|Overall Study|Lost to Follow-up|1|||
28059020|NCT00392288|54715179|FG002|Overall Study|Lost to Follow-up|1|||
28059021|NCT00392288|54715177|FG000|Overall Study|Withdrawal by Subject|1|||
28059022|NCT00392288|54715178|FG001|Overall Study|Withdrawal by Subject|0|||
28059023|NCT00392288|54715179|FG002|Overall Study|Withdrawal by Subject|2|||
28059024|NCT00392288|54715177|FG000|Overall Study|Parent/legal guardian withdrawal|1|||
28059025|NCT00392288|54715178|FG001|Overall Study|Parent/legal guardian withdrawal|2|||
28059026|NCT00392288|54715179|FG002|Overall Study|Parent/legal guardian withdrawal|1|||
28059027|NCT00392288|54715177|FG000|Overall Study|Other|3|||
28059028|NCT00392288|54715178|FG001|Overall Study|Other|4|||
28059029|NCT00392288|54715179|FG002|Overall Study|Other|1|||
28059030|NCT00417170|54715189|FG000|Overall Study|Adverse Event|1|||
28059031|NCT00417170|54715190|FG001|Overall Study|Adverse Event|1|||
28059032|NCT00417170|54715189|FG000|Overall Study|Withdrawal by Subject|1|||
28059033|NCT00417170|54715190|FG001|Overall Study|Withdrawal by Subject|1|||
28059034|NCT00417170|54715189|FG000|Overall Study|Lost to Follow-up|0|||
28059035|NCT00417170|54715190|FG001|Overall Study|Lost to Follow-up|1|||
28059036|NCT00392990|54715198|FG000|Treatment on Study|Adverse Event|3|||
28059037|NCT00392990|54715199|FG001|Treatment on Study|Adverse Event|1|||
28059038|NCT00392990|54715198|FG000|Follow up for 2 Years|Death|4|||
28059039|NCT00392990|54715199|FG001|Follow up for 2 Years|Death|0|||
28059040|NCT00249873|54715207|FG000|Overall Study|Not treated|7|||
28059041|NCT00249873|54715208|FG001|Overall Study|Not treated|8|||
28059042|NCT00249873|54715207|FG000|Overall Study|Significant thrombocytopenia|9|||
28059043|NCT00249873|54715208|FG001|Overall Study|Significant thrombocytopenia|8|||
28059044|NCT00249873|54715207|FG000|Overall Study|Severe allergic reaction|8|||
28059045|NCT00249873|54715208|FG001|Overall Study|Severe allergic reaction|1|||
28059046|NCT00249873|54715207|FG000|Overall Study|Serious haemorrhagic Adverse Event|74|||
28059047|NCT00249873|54715208|FG001|Overall Study|Serious haemorrhagic Adverse Event|30|||
28059048|NCT00249873|54715207|FG000|Overall Study|Other Serious Adverse Event|86|||
28059049|NCT00249873|54715208|FG001|Overall Study|Other Serious Adverse Event|97|||
28059050|NCT00249873|54715207|FG000|Overall Study|Qualifying condition not present|20|||
28059051|NCT00249873|54715208|FG001|Overall Study|Qualifying condition not present|23|||
28059052|NCT00249873|54715207|FG000|Overall Study|Contraindication to oral anticoagulant|4|||
28059053|NCT00249873|54715208|FG001|Overall Study|Contraindication to oral anticoagulant|8|||
28059054|NCT00249873|54715207|FG000|Overall Study|Withdrawal by Subject|504|||
28059055|NCT00249873|54715208|FG001|Overall Study|Withdrawal by Subject|466|||
28059056|NCT00249873|54715207|FG000|Overall Study|Lost to Follow-up|4|||
28059057|NCT00249873|54715208|FG001|Overall Study|Lost to Follow-up|7|||
28059058|NCT00249873|54715207|FG000|Overall Study|Minor bleeding|99|||
28059059|NCT00249873|54715208|FG001|Overall Study|Minor bleeding|37|||
28059060|NCT00249873|54715207|FG000|Overall Study|Non-compliance|41|||
28059061|NCT00249873|54715208|FG001|Overall Study|Non-compliance|46|||
28059062|NCT00249873|54715207|FG000|Overall Study|Other non serious Adverse Event|112|||
28059063|NCT00249873|54715208|FG001|Overall Study|Other non serious Adverse Event|108|||
28059064|NCT00249873|54715207|FG000|Overall Study|Other contraindicated medication|1|||
28059065|NCT00249873|54715208|FG001|Overall Study|Other contraindicated medication|0|||
28059066|NCT00249873|54715207|FG000|Overall Study|Patient not wish to continue after May08|3|||
28059067|NCT00249873|54715208|FG001|Overall Study|Patient not wish to continue after May08|4|||
28059068|NCT00249873|54715207|FG000|Overall Study|Physician withdrew consent|59|||
28059069|NCT00249873|54715208|FG001|Overall Study|Physician withdrew consent|60|||
28059070|NCT00249873|54715207|FG000|Overall Study|Open label clopidogrel required|31|||
28059071|NCT00249873|54715208|FG001|Overall Study|Open label clopidogrel required|42|||
28059072|NCT00249873|54715207|FG000|Overall Study|Angiotensin II receptor blocker required|1|||
28059073|NCT00249873|54715208|FG001|Overall Study|Angiotensin II receptor blocker required|0|||
28059074|NCT00249873|54715207|FG000|Overall Study|Oral anticoagulant required|159|||
28059075|NCT00249873|54715208|FG001|Overall Study|Oral anticoagulant required|157|||
27814613|NCT01575873|54271256|FG001|Overall Study|Administrative decision|1|||
27814614|NCT01575873|54271257|FG002|Overall Study|Administrative decision|1|||
27814615|NCT01575873|54271258|FG003|Overall Study|Administrative decision|0|||
28059076|NCT00249873|54715207|FG000|Overall Study|Study drug intolerance|5|||
28059077|NCT00249873|54715208|FG001|Overall Study|Study drug intolerance|0|||
28059078|NCT00249873|54715207|FG000|Overall Study|Surgery/ procedure|9|||
28059079|NCT00249873|54715208|FG001|Overall Study|Surgery/ procedure|9|||
28059080|NCT00249873|54715207|FG000|Overall Study|Event related to cardiac condition|12|||
28059081|NCT00249873|54715208|FG001|Overall Study|Event related to cardiac condition|21|||
28059082|NCT00249873|54715207|FG000|Overall Study|Thromboembolic/outcome event|82|||
28059083|NCT00249873|54715208|FG001|Overall Study|Thromboembolic/outcome event|122|||
28059084|NCT00392210|54715216|FG000|First Voiding Trial|Physician Decision|2|||
28059085|NCT00392210|54715217|FG001|First Voiding Trial|Physician Decision|2|||
28059086|NCT00391976|54715226|FG000|Overall Study|Adverse Event|0|||
28059087|NCT00391976|54715227|FG001|Overall Study|Adverse Event|0|||
28059088|NCT00391976|54715228|FG002|Overall Study|Adverse Event|1|||
28059089|NCT00391976|54715226|FG000|Overall Study|Withdrawal of consent|0|||
28059090|NCT00391976|54715227|FG001|Overall Study|Withdrawal of consent|1|||
28059091|NCT00391976|54715228|FG002|Overall Study|Withdrawal of consent|1|||
28059092|NCT00391976|54715226|FG000|Overall Study|Lost to Follow-up|1|||
28059093|NCT00391976|54715227|FG001|Overall Study|Lost to Follow-up|2|||
28059094|NCT00391976|54715228|FG002|Overall Study|Lost to Follow-up|0|||
28059095|NCT00391976|54715226|FG000|Overall Study|Inappropriate enrollment|1|||
28059096|NCT00391976|54715227|FG001|Overall Study|Inappropriate enrollment|1|||
28059097|NCT00391976|54715228|FG002|Overall Study|Inappropriate enrollment|0|||
28059098|NCT00391976|54715226|FG000|Overall Study|Protocol deviation/violation|4|||
28059099|NCT00391976|54715227|FG001|Overall Study|Protocol deviation/violation|2|||
28059100|NCT00391976|54715228|FG002|Overall Study|Protocol deviation/violation|1|||
28059101|NCT00391976|54715226|FG000|Overall Study|Recurrence/no eradication of infection|21|||
28059102|NCT00391976|54715227|FG001|Overall Study|Recurrence/no eradication of infection|19|||
28059103|NCT00391976|54715228|FG002|Overall Study|Recurrence/no eradication of infection|0|||
28059104|NCT00391976|54715226|FG000|Overall Study|Unable to classify|0|||
28059105|NCT00391976|54715227|FG001|Overall Study|Unable to classify|0|||
28059106|NCT00391976|54715228|FG002|Overall Study|Unable to classify|1|||
28059107|NCT00391976|54715226|FG000|Overall Study|Positive P. aeruginosa antibody test|0|||
28059108|NCT00391976|54715227|FG001|Overall Study|Positive P. aeruginosa antibody test|0|||
28059109|NCT00391976|54715228|FG002|Overall Study|Positive P. aeruginosa antibody test|31|||
28059110|NCT00391898|54715240|FG000|Overall Study|Adverse Event|3|||
28059111|NCT00391898|54715241|FG001|Overall Study|Adverse Event|0|||
28059112|NCT00391898|54715240|FG000|Overall Study|Other|8|||
28059113|NCT00391898|54715241|FG001|Overall Study|Other|10|||
28059114|NCT00391586|54715247|FG000|Overall Study|Progressive disease|13|||
28059115|NCT00391586|54715247|FG000|Overall Study|Adverse Event|5|||
27814616|NCT01575873|54271255|FG000|Overall Study|Protocol deviation|0|||
27814617|NCT01575873|54271256|FG001|Overall Study|Protocol deviation|1|||
27814618|NCT01575873|54271257|FG002|Overall Study|Protocol deviation|0|||
27814619|NCT01575873|54271258|FG003|Overall Study|Protocol deviation|1|||
27814620|NCT01575873|54271255|FG000|Overall Study|Requirement for Alternative Therapy|0|||
27814621|NCT01575873|54271256|FG001|Overall Study|Requirement for Alternative Therapy|0|||
27814622|NCT01575873|54271257|FG002|Overall Study|Requirement for Alternative Therapy|1|||
27814623|NCT01575873|54271258|FG003|Overall Study|Requirement for Alternative Therapy|1|||
27814624|NCT01575873|54271255|FG000|Overall Study|Other|0|||
27814625|NCT01575873|54271256|FG001|Overall Study|Other|0|||
27814626|NCT01575873|54271257|FG002|Overall Study|Other|4|||
28059116|NCT00391586|54715247|FG000|Overall Study|Physician Decision|2|||
28059117|NCT00391586|54715247|FG000|Overall Study|Death|4|||
28059118|NCT00391430|54715254|FG000|Overall Study|Withdrawal by Subject|3|||
28059119|NCT00391430|54715255|FG001|Overall Study|Withdrawal by Subject|0|||
28059120|NCT00391430|54715256|FG002|Overall Study|Withdrawal by Subject|12|||
28059121|NCT00391274|54715266|FG000|Overall Study|Death Due to Study Disease|55|||
28059122|NCT00391274|54715267|FG001|Overall Study|Death Due to Study Disease|45|||
28059123|NCT00391274|54715266|FG000|Overall Study|Lost to Follow-up|0|||
28059124|NCT00391274|54715267|FG001|Overall Study|Lost to Follow-up|3|||
28059125|NCT00391274|54715266|FG000|Overall Study|Physician Decision|4|||
28059126|NCT00391274|54715267|FG001|Overall Study|Physician Decision|2|||
28059127|NCT00391274|54715266|FG000|Overall Study|Withdrawal by Subject|0|||
28059128|NCT00391274|54715267|FG001|Overall Study|Withdrawal by Subject|3|||
28059129|NCT00391274|54715266|FG000|Overall Study|Death Due to Adverse Event|1|||
28059130|NCT00391274|54715267|FG001|Overall Study|Death Due to Adverse Event|3|||
28059131|NCT00391274|54715266|FG000|Overall Study|Death Due to Indeterminate Cause|1|||
28059132|NCT00391274|54715267|FG001|Overall Study|Death Due to Indeterminate Cause|0|||
28059133|NCT00391274|54715266|FG000|Overall Study|Death Not Study Related|0|||
28059134|NCT00391274|54715267|FG001|Overall Study|Death Not Study Related|1|||
28059135|NCT00391118|54715276|FG000|Overall Study|Adverse Event|3|||
28059136|NCT00391118|54715277|FG001|Overall Study|Adverse Event|10|||
28059137|NCT00391118|54715278|FG002|Overall Study|Adverse Event|7|||
28059138|NCT00391118|54715276|FG000|Overall Study|Lost to Follow-up|0|||
28059139|NCT00391118|54715277|FG001|Overall Study|Lost to Follow-up|2|||
28059140|NCT00391118|54715278|FG002|Overall Study|Lost to Follow-up|3|||
28059141|NCT00391118|54715276|FG000|Overall Study|Withdrawal by Subject|0|||
28059142|NCT00391118|54715277|FG001|Overall Study|Withdrawal by Subject|9|||
28059143|NCT00391118|54715278|FG002|Overall Study|Withdrawal by Subject|1|||
28059144|NCT00391118|54715276|FG000|Overall Study|Death|0|||
28059145|NCT00391118|54715277|FG001|Overall Study|Death|1|||
28059146|NCT00391118|54715278|FG002|Overall Study|Death|0|||
28059147|NCT00391118|54715276|FG000|Overall Study|Physician Decision|0|||
28059148|NCT00391118|54715277|FG001|Overall Study|Physician Decision|3|||
27814627|NCT01575873|54271258|FG003|Overall Study|Other|2|||
27814628|NCT01575561|54271266|FG000|Overall Study|Adverse Event|9|||
27814629|NCT01575561|54271266|FG000|Overall Study|Lack of Efficacy|8|||
27814630|NCT01575561|54271266|FG000|Overall Study|Lost to Follow-up|6|||
28059149|NCT00391118|54715278|FG002|Overall Study|Physician Decision|0|||
28059150|NCT00391118|54715276|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
28059151|NCT00391118|54715277|FG001|Overall Study|Protocol Entry Criteria Not Met|3|||
28059152|NCT00391118|54715278|FG002|Overall Study|Protocol Entry Criteria Not Met|1|||
28059153|NCT00391118|54715276|FG000|Overall Study|Progressive Disease|7|||
28059154|NCT00391118|54715277|FG001|Overall Study|Progressive Disease|26|||
27814631|NCT01575561|54271266|FG000|Overall Study|Protocol Violation|4|||
27814632|NCT01575561|54271266|FG000|Overall Study|Withdrawal by Subject|11|||
28059155|NCT00391118|54715278|FG002|Overall Study|Progressive Disease|43|||
28059156|NCT00391118|54715276|FG000|Overall Study|Sponsor Decision|0|||
28059157|NCT00391118|54715277|FG001|Overall Study|Sponsor Decision|1|||
28059158|NCT00391118|54715278|FG002|Overall Study|Sponsor Decision|3|||
28059159|NCT00391118|54715276|FG000|Overall Study|Protocol Violation|1|||
28059160|NCT00391118|54715277|FG001|Overall Study|Protocol Violation|0|||
28059161|NCT00391118|54715278|FG002|Overall Study|Protocol Violation|0|||
28059162|NCT00390884|54715291|FG000|Overall Study|Withdrawal by Subject|2|||
28059163|NCT00390884|54715292|FG001|Overall Study|Withdrawal by Subject|2|||
28059164|NCT00365846|54715298|FG000|Overall Study|Lost to Follow-up|1|||
28059165|NCT00264537|54715308|FG000|Overall Study|Death|0|||
28059166|NCT00264537|54715309|FG001|Overall Study|Death|3|||
28059167|NCT00264537|54715310|FG002|Overall Study|Death|3|||
28059168|NCT00264537|54715311|FG003|Overall Study|Death|2|||
28059169|NCT00264537|54715308|FG000|Overall Study|Lost to Follow-up|3|||
28059170|NCT00264537|54715309|FG001|Overall Study|Lost to Follow-up|4|||
28059171|NCT00264537|54715310|FG002|Overall Study|Lost to Follow-up|7|||
28059172|NCT00264537|54715311|FG003|Overall Study|Lost to Follow-up|6|||
28059173|NCT00264537|54715308|FG000|Overall Study|Adverse Event|21|||
28059174|NCT00264537|54715309|FG001|Overall Study|Adverse Event|32|||
28059175|NCT00264537|54715310|FG002|Overall Study|Adverse Event|24|||
28059176|NCT00264537|54715311|FG003|Overall Study|Adverse Event|34|||
28059177|NCT00264537|54715308|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
28059178|NCT00264537|54715309|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
28059179|NCT00264537|54715310|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
28059180|NCT00264537|54715311|FG003|Overall Study|Unsatisfactory therapeutic effect|7|||
28059181|NCT00264537|54715308|FG000|Overall Study|Other|21|||
28059182|NCT00264537|54715309|FG001|Overall Study|Other|11|||
28059183|NCT00264537|54715310|FG002|Overall Study|Other|10|||
28059184|NCT00264537|54715311|FG003|Overall Study|Other|11|||
28059185|NCT00264537|54715308|FG000|Overall Study|Not treated|0|||
28059186|NCT00264537|54715309|FG001|Overall Study|Not treated|2|||
28059187|NCT00264537|54715310|FG002|Overall Study|Not treated|1|||
28059188|NCT00264537|54715311|FG003|Overall Study|Not treated|0|||
28059189|NCT00371462|54715325|FG000|Overall Study|Withdrawal by Subject|1|||
28059190|NCT00371462|54715326|FG001|Overall Study|Withdrawal by Subject|0|||
28059191|NCT00371462|54715325|FG000|Overall Study|Other|7|||
28059192|NCT00371462|54715326|FG001|Overall Study|Other|8|||
28059193|NCT00371150|54715334|FG000|Overall Study|Lost to Follow-up|3|||
28059194|NCT00371150|54715335|FG001|Overall Study|Lost to Follow-up|2|||
28059195|NCT00264303|54715347|FG000|Overall Study|Adverse Event|4|||
28059196|NCT00264303|54715348|FG001|Overall Study|Adverse Event|3|||
28059197|NCT00264303|54715347|FG000|Overall Study|Lack of Efficacy|10|||
28059198|NCT00264303|54715348|FG001|Overall Study|Lack of Efficacy|13|||
28059199|NCT00264303|54715347|FG000|Overall Study|Lost to Follow-up|3|||
28059200|NCT00264303|54715348|FG001|Overall Study|Lost to Follow-up|3|||
28059201|NCT00264303|54715347|FG000|Overall Study|Withdrawal by Subject|2|||
28059202|NCT00264303|54715348|FG001|Overall Study|Withdrawal by Subject|3|||
28059203|NCT00264303|54715347|FG000|Overall Study|Various reasons listed in study report|6|||
28059204|NCT00264303|54715348|FG001|Overall Study|Various reasons listed in study report|7|||
28059205|NCT00370682|54715357|FG000|Overall Study|Moved from area|0|||
28059206|NCT00370682|54715358|FG001|Overall Study|Moved from area|2|||
28059207|NCT00370682|54715359|FG002|Overall Study|Moved from area|0|||
28059208|NCT00370682|54715357|FG000|Overall Study|Lost to Follow-up|0|||
28059209|NCT00370682|54715358|FG001|Overall Study|Lost to Follow-up|1|||
28059210|NCT00370682|54715359|FG002|Overall Study|Lost to Follow-up|1|||
28059211|NCT00264147|54715376|FG000|Treatment I Period|Adverse Event|3|||
28059212|NCT00264147|54715377|FG001|Treatment I Period|Adverse Event|6|||
28059213|NCT00264147|54715378|FG002|Treatment I Period|Adverse Event|3|||
28059214|NCT00264147|54715379|FG003|Treatment I Period|Adverse Event|5|||
28059215|NCT00264147|54715380|FG004|Treatment I Period|Adverse Event|7|||
28059216|NCT00264147|54715381|FG005|Treatment I Period|Adverse Event|0|||
28059217|NCT00264147|54715376|FG000|Treatment I Period|Laboratory Adverse Event|0|||
28059218|NCT00264147|54715377|FG001|Treatment I Period|Laboratory Adverse Event|0|||
28059219|NCT00264147|54715378|FG002|Treatment I Period|Laboratory Adverse Event|0|||
28059220|NCT00264147|54715379|FG003|Treatment I Period|Laboratory Adverse Event|1|||
28059221|NCT00264147|54715380|FG004|Treatment I Period|Laboratory Adverse Event|0|||
28059222|NCT00264147|54715381|FG005|Treatment I Period|Laboratory Adverse Event|0|||
28059223|NCT00264147|54715376|FG000|Treatment I Period|Lack of Efficacy|6|||
28059224|NCT00264147|54715377|FG001|Treatment I Period|Lack of Efficacy|2|||
28059225|NCT00264147|54715378|FG002|Treatment I Period|Lack of Efficacy|8|||
28059226|NCT00264147|54715379|FG003|Treatment I Period|Lack of Efficacy|0|||
28059227|NCT00264147|54715380|FG004|Treatment I Period|Lack of Efficacy|1|||
28059228|NCT00264147|54715381|FG005|Treatment I Period|Lack of Efficacy|0|||
28059229|NCT00264147|54715376|FG000|Treatment I Period|Lost to Follow-up|1|||
28059230|NCT00264147|54715377|FG001|Treatment I Period|Lost to Follow-up|0|||
28059231|NCT00264147|54715378|FG002|Treatment I Period|Lost to Follow-up|0|||
28059232|NCT00264147|54715379|FG003|Treatment I Period|Lost to Follow-up|1|||
28059233|NCT00264147|54715380|FG004|Treatment I Period|Lost to Follow-up|1|||
28059234|NCT00264147|54715381|FG005|Treatment I Period|Lost to Follow-up|0|||
28059235|NCT00264147|54715376|FG000|Treatment I Period|Protocol Violation|2|||
28059236|NCT00264147|54715377|FG001|Treatment I Period|Protocol Violation|2|||
28059237|NCT00264147|54715378|FG002|Treatment I Period|Protocol Violation|0|||
28059238|NCT00264147|54715379|FG003|Treatment I Period|Protocol Violation|0|||
28059239|NCT00264147|54715380|FG004|Treatment I Period|Protocol Violation|0|||
28059240|NCT00264147|54715381|FG005|Treatment I Period|Protocol Violation|0|||
28059241|NCT00264147|54715376|FG000|Treatment I Period|Withdrawal by Subject|2|||
28059242|NCT00264147|54715377|FG001|Treatment I Period|Withdrawal by Subject|0|||
28059243|NCT00264147|54715378|FG002|Treatment I Period|Withdrawal by Subject|0|||
28059244|NCT00264147|54715379|FG003|Treatment I Period|Withdrawal by Subject|2|||
28059245|NCT00264147|54715380|FG004|Treatment I Period|Withdrawal by Subject|2|||
28059246|NCT00264147|54715381|FG005|Treatment I Period|Withdrawal by Subject|0|||
28059247|NCT00264147|54715376|FG000|Treatment I Period|Patient out of town for an extended time|0|||
28059248|NCT00264147|54715377|FG001|Treatment I Period|Patient out of town for an extended time|1|||
28059249|NCT00264147|54715378|FG002|Treatment I Period|Patient out of town for an extended time|0|||
28059250|NCT00264147|54715379|FG003|Treatment I Period|Patient out of town for an extended time|0|||
28059251|NCT00264147|54715380|FG004|Treatment I Period|Patient out of town for an extended time|0|||
28059252|NCT00264147|54715381|FG005|Treatment I Period|Patient out of town for an extended time|0|||
28059253|NCT00264147|54715376|FG000|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
28059254|NCT00264147|54715377|FG001|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
28059255|NCT00264147|54715378|FG002|Treatment I Period|Unblinded due to Serious Adverse Event|1|||
28059256|NCT00264147|54715379|FG003|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
28059257|NCT00264147|54715380|FG004|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
28059258|NCT00264147|54715381|FG005|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
28059259|NCT00264147|54715376|FG000|Treatment I Period|Reassigned to Treatment II Period|84|||
28059260|NCT00264147|54715377|FG001|Treatment I Period|Reassigned to Treatment II Period|72|||
28059261|NCT00264147|54715378|FG002|Treatment I Period|Reassigned to Treatment II Period|65|||
28059262|NCT00264147|54715379|FG003|Treatment I Period|Reassigned to Treatment II Period|63|||
28059263|NCT00264147|54715380|FG004|Treatment I Period|Reassigned to Treatment II Period|45|||
28059264|NCT00264147|54715381|FG005|Treatment I Period|Reassigned to Treatment II Period|0|||
28059265|NCT00264147|54715376|FG000|Treatment II Period|Adverse Event|0|||
28059266|NCT00264147|54715377|FG001|Treatment II Period|Adverse Event|0|||
28059267|NCT00264147|54715378|FG002|Treatment II Period|Adverse Event|0|||
28059268|NCT00264147|54715379|FG003|Treatment II Period|Adverse Event|0|||
28059269|NCT00264147|54715380|FG004|Treatment II Period|Adverse Event|9|||
28059270|NCT00264147|54715381|FG005|Treatment II Period|Adverse Event|9|||
28059271|NCT00264147|54715376|FG000|Treatment II Period|Laboratory Adverse Event|0|||
28059272|NCT00264147|54715377|FG001|Treatment II Period|Laboratory Adverse Event|0|||
28059273|NCT00264147|54715378|FG002|Treatment II Period|Laboratory Adverse Event|0|||
28059274|NCT00264147|54715379|FG003|Treatment II Period|Laboratory Adverse Event|0|||
28059275|NCT00264147|54715380|FG004|Treatment II Period|Laboratory Adverse Event|0|||
28059276|NCT00264147|54715381|FG005|Treatment II Period|Laboratory Adverse Event|1|||
28059277|NCT00264147|54715376|FG000|Treatment II Period|Lack of Efficacy|0|||
28059278|NCT00264147|54715377|FG001|Treatment II Period|Lack of Efficacy|0|||
28059279|NCT00264147|54715378|FG002|Treatment II Period|Lack of Efficacy|0|||
28059280|NCT00264147|54715379|FG003|Treatment II Period|Lack of Efficacy|0|||
28059281|NCT00264147|54715380|FG004|Treatment II Period|Lack of Efficacy|20|||
28059282|NCT00264147|54715381|FG005|Treatment II Period|Lack of Efficacy|19|||
28059283|NCT00264147|54715376|FG000|Treatment II Period|Lost to Follow-up|0|||
28059284|NCT00264147|54715377|FG001|Treatment II Period|Lost to Follow-up|0|||
28059285|NCT00264147|54715378|FG002|Treatment II Period|Lost to Follow-up|0|||
28059286|NCT00264147|54715379|FG003|Treatment II Period|Lost to Follow-up|0|||
28059287|NCT00264147|54715380|FG004|Treatment II Period|Lost to Follow-up|1|||
28059288|NCT00264147|54715381|FG005|Treatment II Period|Lost to Follow-up|1|||
28059289|NCT00264147|54715376|FG000|Treatment II Period|Withdrawal by Subject|0|||
28059290|NCT00264147|54715377|FG001|Treatment II Period|Withdrawal by Subject|0|||
28059291|NCT00264147|54715378|FG002|Treatment II Period|Withdrawal by Subject|0|||
28059292|NCT00264147|54715379|FG003|Treatment II Period|Withdrawal by Subject|0|||
28059293|NCT00264147|54715380|FG004|Treatment II Period|Withdrawal by Subject|3|||
28059294|NCT00264147|54715381|FG005|Treatment II Period|Withdrawal by Subject|2|||
28059295|NCT00264147|54715376|FG000|Treatment II Period|Pre-scheduled total hip replacement|0|||
28059296|NCT00264147|54715377|FG001|Treatment II Period|Pre-scheduled total hip replacement|0|||
28059297|NCT00264147|54715378|FG002|Treatment II Period|Pre-scheduled total hip replacement|0|||
28059298|NCT00264147|54715379|FG003|Treatment II Period|Pre-scheduled total hip replacement|0|||
28059299|NCT00264147|54715380|FG004|Treatment II Period|Pre-scheduled total hip replacement|0|||
28059300|NCT00264147|54715381|FG005|Treatment II Period|Pre-scheduled total hip replacement|1|||
28059301|NCT00263757|54715397|FG000|Overall Study|Withdrawal by Subject|5|||
28059302|NCT00263757|54715398|FG001|Overall Study|Withdrawal by Subject|4|||
28059303|NCT00263757|54715397|FG000|Overall Study|Screen failure|0|||
28059304|NCT00263757|54715398|FG001|Overall Study|Screen failure|1|||
28059305|NCT00263757|54715397|FG000|Overall Study|Adverse Event|3|||
28059306|NCT00263757|54715398|FG001|Overall Study|Adverse Event|3|||
28059307|NCT00263211|54715406|FG000|Overall Study|Death|1|||
28059308|NCT00263211|54715407|FG001|Overall Study|Death|0|||
28059309|NCT00263211|54715406|FG000|Overall Study|Withdrawal by Subject|3|||
28059310|NCT00263211|54715407|FG001|Overall Study|Withdrawal by Subject|0|||
28059311|NCT00263211|54715406|FG000|Overall Study|Protocol Violation|1|||
28059312|NCT00263211|54715407|FG001|Overall Study|Protocol Violation|0|||
28059313|NCT00263211|54715406|FG000|Overall Study|Disease Progression|0|||
28059314|NCT00263211|54715407|FG001|Overall Study|Disease Progression|1|||
28059315|NCT00248625|54715418|FG000|Overall Study|Withdrawal by Subject|0|||
28059316|NCT00248625|54715419|FG001|Overall Study|Withdrawal by Subject|2|||
28059317|NCT00262821|54715427|FG000|Overall Study|Ineligible - wrong stage|0|||
28059318|NCT00262821|54715428|FG001|Overall Study|Ineligible - wrong stage|3|||
28059319|NCT00262821|54715427|FG000|Overall Study|Ineligible - wrong cell type|2|||
28059320|NCT00262821|54715428|FG001|Overall Study|Ineligible - wrong cell type|2|||
28059321|NCT00262821|54715427|FG000|Overall Study|Ineligible - wrong primary|0|||
28059322|NCT00262821|54715428|FG001|Overall Study|Ineligible - wrong primary|1|||
28059323|NCT00262821|54715427|FG000|Overall Study|Ineligible - inadequate pathology|1|||
28059324|NCT00262821|54715428|FG001|Overall Study|Ineligible - inadequate pathology|3|||
28059325|NCT00262821|54715427|FG000|Overall Study|Ineligible - elevated creatinine|0|||
28059326|NCT00262821|54715428|FG001|Overall Study|Ineligible - elevated creatinine|2|||
28059327|NCT00262821|54715427|FG000|Overall Study|Ineligible - required test not done|1|||
28059328|NCT00262821|54715428|FG001|Overall Study|Ineligible - required test not done|4|||
28059329|NCT00262821|54715427|FG000|Overall Study|Inevaluable - inadequate data|0|||
28059330|NCT00262821|54715428|FG001|Overall Study|Inevaluable - inadequate data|4|||
28059331|NCT00262743|54715436|FG000|Overall Study|Adverse Event|0|||
28059332|NCT00262743|54715437|FG001|Overall Study|Adverse Event|9|||
28059333|NCT00262743|54715436|FG000|Overall Study|Disease progression|0|||
28059334|NCT00262743|54715437|FG001|Overall Study|Disease progression|3|||
28059335|NCT00262119|54715444|FG000|Overall Study|Lost to Follow-up|38|||
28059336|NCT00262119|54715445|FG001|Overall Study|Lost to Follow-up|51|||
28059337|NCT00262119|54715446|FG002|Overall Study|Lost to Follow-up|42|||
28059338|NCT00262119|54715444|FG000|Overall Study|Death|20|||
28059339|NCT00262119|54715445|FG001|Overall Study|Death|19|||
28059340|NCT00262119|54715446|FG002|Overall Study|Death|16|||
28059341|NCT00170950|54715456|FG000|Overall Study|Death|236|||
28059342|NCT00170950|54715457|FG001|Overall Study|Death|274|||
28059343|NCT00170950|54715456|FG000|Overall Study|Withdrawal by Subject|496|||
28059344|NCT00170950|54715457|FG001|Overall Study|Withdrawal by Subject|498|||
28059345|NCT00170950|54715456|FG000|Overall Study|Lost to Follow-up|134|||
28059346|NCT00170950|54715457|FG001|Overall Study|Lost to Follow-up|115|||
28059347|NCT00170950|54715456|FG000|Overall Study|Missing|2|||
28059348|NCT00170950|54715457|FG001|Overall Study|Missing|1|||
28059349|NCT00170950|54715456|FG000|Overall Study|Termination Data Not Recorded|17|||
28059350|NCT00170950|54715457|FG001|Overall Study|Termination Data Not Recorded|22|||
28059351|NCT00239577|54715467|FG000|Primary Phase|Adverse Event|0|||
28059352|NCT00239577|54715468|FG001|Primary Phase|Adverse Event|0|||
28059353|NCT00239577|54715469|FG002|Primary Phase|Adverse Event|1|||
28059354|NCT00239577|54715470|FG003|Primary Phase|Adverse Event|0|||
28059355|NCT00239577|54715467|FG000|Primary Phase|Other|5|||
28059356|NCT00239577|54715468|FG001|Primary Phase|Other|3|||
28059357|NCT00239577|54715469|FG002|Primary Phase|Other|2|||
28059358|NCT00239577|54715470|FG003|Primary Phase|Other|0|||
28059359|NCT00262041|54715486|FG000|Overall Study|Withdrawal by Subject|0|||
28059360|NCT00262041|54715487|FG001|Overall Study|Withdrawal by Subject|3|||
28059361|NCT00262041|54715488|FG002|Overall Study|Withdrawal by Subject|1|||
28059362|NCT00262041|54715486|FG000|Overall Study|Lost to Follow-up|1|||
28059363|NCT00262041|54715487|FG001|Overall Study|Lost to Follow-up|1|||
28059364|NCT00262041|54715488|FG002|Overall Study|Lost to Follow-up|5|||
28059365|NCT00262041|54715486|FG000|Overall Study|Unable to classify|1|||
28059366|NCT00262041|54715487|FG001|Overall Study|Unable to classify|0|||
28059367|NCT00262041|54715488|FG002|Overall Study|Unable to classify|0|||
28059368|NCT00208767|54715504|FG000|Overall Study|Adverse Event|9|||
28059369|NCT00208767|54715505|FG001|Overall Study|Adverse Event|1|||
28059370|NCT00208767|54715504|FG000|Overall Study|Withdrawal by Subject|14|||
28059371|NCT00208767|54715505|FG001|Overall Study|Withdrawal by Subject|3|||
28059372|NCT00208767|54715504|FG000|Overall Study|Death|1|||
28059373|NCT00208767|54715505|FG001|Overall Study|Death|0|||
28059374|NCT00208767|54715504|FG000|Overall Study|Lost to Follow-up|3|||
28059375|NCT00208767|54715505|FG001|Overall Study|Lost to Follow-up|3|||
28059376|NCT00390806|54715513|FG000|Overall Study|Lost to Follow-up|7|||
28059377|NCT00390806|54715514|FG001|Overall Study|Lost to Follow-up|6|||
28059378|NCT00390806|54715513|FG000|Overall Study|Protocol Violation|2|||
28059379|NCT00390806|54715514|FG001|Overall Study|Protocol Violation|2|||
28059380|NCT00390806|54715513|FG000|Overall Study|Withdrawal by Subject|12|||
28059381|NCT00390806|54715514|FG001|Overall Study|Withdrawal by Subject|15|||
28059382|NCT00390806|54715513|FG000|Overall Study|Investigator Decision|4|||
28059383|NCT00390806|54715514|FG001|Overall Study|Investigator Decision|6|||
28059384|NCT00390806|54715513|FG000|Overall Study|Death|1|||
28059385|NCT00390806|54715514|FG001|Overall Study|Death|0|||
28059386|NCT00390806|54715513|FG000|Overall Study|Physician Decision|0|||
28059387|NCT00390806|54715514|FG001|Overall Study|Physician Decision|1|||
28059388|NCT00390806|54715513|FG000|Overall Study|Ongoing|4|||
28059389|NCT00390806|54715514|FG001|Overall Study|Ongoing|2|||
28059390|NCT00390572|54715522|FG000|Overall Study|Lost to Follow-up|8|||
28059391|NCT00390572|54715523|FG001|Overall Study|Lost to Follow-up|4|||
28059392|NCT00390572|54715522|FG000|Overall Study|health condition|0|||
28059393|NCT00390572|54715523|FG001|Overall Study|health condition|1|||
28059394|NCT00390416|54715533|FG000|Overall Study|Withdrawal by Subject|1|||
28059395|NCT00390416|54715533|FG000|Overall Study|Not treated|3|||
28059396|NCT00261495|54715539|FG000|Titration Phase (Weeks 0 to 4)|Adverse Event|28|||
28059397|NCT00261495|54715540|FG001|Titration Phase (Weeks 0 to 4)|Adverse Event|36|||
28059398|NCT00261495|54715539|FG000|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6|||
28059399|NCT00261495|54715540|FG001|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11|||
28059400|NCT00261495|54715539|FG000|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
28059401|NCT00261495|54715540|FG001|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
28059402|NCT00261495|54715539|FG000|Titration Phase (Weeks 0 to 4)|Physician Decision|3|||
28059403|NCT00261495|54715540|FG001|Titration Phase (Weeks 0 to 4)|Physician Decision|1|||
28059404|NCT00261495|54715539|FG000|Titration Phase (Weeks 0 to 4)|Non-compliance|2|||
28059405|NCT00261495|54715540|FG001|Titration Phase (Weeks 0 to 4)|Non-compliance|5|||
28059406|NCT00261495|54715539|FG000|Titration Phase (Weeks 0 to 4)|Protocol Violation|1|||
28059407|NCT00261495|54715540|FG001|Titration Phase (Weeks 0 to 4)|Protocol Violation|4|||
28059408|NCT00261495|54715539|FG000|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29|||
28059409|NCT00261495|54715540|FG001|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20|||
28059410|NCT00261495|54715539|FG000|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14|||
28059411|NCT00261495|54715540|FG001|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10|||
28059412|NCT00261495|54715539|FG000|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6|||
28059413|NCT00261495|54715540|FG001|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5|||
28059414|NCT00261495|54715539|FG000|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1|||
28059415|NCT00261495|54715540|FG001|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5|||
28059416|NCT00261495|54715539|FG000|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5|||
28059417|NCT00261495|54715540|FG001|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2|||
28059418|NCT00261495|54715539|FG000|Maintenance Phase (Weeks 4 to 24)|Other|6|||
28059419|NCT00261495|54715540|FG001|Maintenance Phase (Weeks 4 to 24)|Other|5|||
28059420|NCT00261495|54715539|FG000|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
28059421|NCT00261495|54715540|FG001|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
28059422|NCT00261495|54715539|FG000|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2|||
28059423|NCT00261495|54715540|FG001|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0|||
28059424|NCT00261495|54715539|FG000|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2|||
28059425|NCT00261495|54715540|FG001|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0|||
28059426|NCT00261495|54715539|FG000|Extension Phase (Weeks 24 to 52)|Other|4|||
28059427|NCT00261495|54715540|FG001|Extension Phase (Weeks 24 to 52)|Other|2|||
28059428|NCT00261495|54715539|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|4|||
28059429|NCT00261495|54715540|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
28059430|NCT00261495|54715539|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
28059431|NCT00261495|54715540|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
28059432|NCT00261495|54715539|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
28059433|NCT00261495|54715540|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
28059434|NCT00261495|54715539|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance|1|||
28059435|NCT00261495|54715540|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance|0|||
28059436|NCT00261495|54715539|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
28059437|NCT00261495|54715540|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
28059438|NCT00168844|54715549|FG000|Overall Study|Adverse Event|31|||
28059439|NCT00168844|54715550|FG001|Overall Study|Adverse Event|32|||
28059440|NCT00168844|54715551|FG002|Overall Study|Adverse Event|48|||
28059441|NCT00168844|54715549|FG000|Overall Study|Lost to Follow-up|4|||
28059442|NCT00168844|54715550|FG001|Overall Study|Lost to Follow-up|5|||
28059443|NCT00168844|54715551|FG002|Overall Study|Lost to Follow-up|11|||
28059444|NCT00168844|54715549|FG000|Overall Study|Withdrawal by Subject|12|||
28059445|NCT00168844|54715550|FG001|Overall Study|Withdrawal by Subject|9|||
27940055|NCT01197300|54596382|FG000|Overall Study|Protocol Violation|0|||
27940056|NCT01197300|54596383|FG001|Overall Study|Protocol Violation|1|||
27940057|NCT01196988|54596398|FG000|Overall Study|Adverse Event|1|||
27940058|NCT01196988|54596399|FG001|Overall Study|Adverse Event|2|||
27940059|NCT01196988|54596400|FG002|Overall Study|Adverse Event|0|||
27940060|NCT01196988|54596401|FG003|Overall Study|Adverse Event|0|||
27940061|NCT01196988|54596398|FG000|Overall Study|Withdrawal by Subject|5|||
28059446|NCT00168844|54715551|FG002|Overall Study|Withdrawal by Subject|19|||
28059447|NCT00168844|54715549|FG000|Overall Study|Protocol Violation|2|||
28059448|NCT00168844|54715550|FG001|Overall Study|Protocol Violation|2|||
28059449|NCT00168844|54715551|FG002|Overall Study|Protocol Violation|4|||
28059450|NCT00168844|54715549|FG000|Overall Study|Other|6|||
28059451|NCT00168844|54715550|FG001|Overall Study|Other|7|||
28059452|NCT00168844|54715551|FG002|Overall Study|Other|9|||
28059453|NCT00365456|54715559|FG000|Trial Period I (12 Months)|Adverse Event|84|||
28059454|NCT00365456|54715560|FG001|Trial Period I (12 Months)|Adverse Event|0|||
28059455|NCT00365456|54715559|FG000|Trial Period I (12 Months)|Non-compliance|3|||
28059456|NCT00365456|54715560|FG001|Trial Period I (12 Months)|Non-compliance|0|||
28059457|NCT00365456|54715559|FG000|Trial Period I (12 Months)|Withdrawal by Subject|27|||
28059458|NCT00365456|54715560|FG001|Trial Period I (12 Months)|Withdrawal by Subject|0|||
28059459|NCT00365456|54715559|FG000|Trial Period I (12 Months)|Other|11|||
28059460|NCT00365456|54715560|FG001|Trial Period I (12 Months)|Other|0|||
27814633|NCT01575561|54271266|FG000|Overall Study|administration|1|||
27814634|NCT01609790|54271273|FG000|Overall Study|Protocol Violation|1|||
27814635|NCT01609790|54271274|FG001|Overall Study|Protocol Violation|7|||
27814636|NCT01609790|54271275|FG002|Overall Study|Protocol Violation|8|||
27814637|NCT01767116|54271285|FG000|Overall Study|Lost to Follow-up|2|||
27814638|NCT01767116|54271286|FG001|Overall Study|Lost to Follow-up|2|||
28059461|NCT00365456|54715559|FG000|Trial Period II (12 Months)|Adverse Event|0|||
28059462|NCT00365456|54715560|FG001|Trial Period II (12 Months)|Adverse Event|6|||
28059463|NCT00365456|54715559|FG000|Trial Period II (12 Months)|Non-compliance|0|||
28059464|NCT00365456|54715560|FG001|Trial Period II (12 Months)|Non-compliance|2|||
28059465|NCT00365456|54715559|FG000|Trial Period II (12 Months)|Withdrawal by Subject|0|||
28059466|NCT00365456|54715560|FG001|Trial Period II (12 Months)|Withdrawal by Subject|5|||
28059467|NCT00365456|54715559|FG000|Trial Period II (12 Months)|Other|0|||
28059468|NCT00365456|54715560|FG001|Trial Period II (12 Months)|Other|1|||
28059469|NCT00365456|54715559|FG000|Trial Period III (12 Months)|Adverse Event|13|||
28059470|NCT00365456|54715560|FG001|Trial Period III (12 Months)|Adverse Event|3|||
28059471|NCT00365456|54715559|FG000|Trial Period III (12 Months)|Withdrawal by Subject|4|||
28059472|NCT00365456|54715560|FG001|Trial Period III (12 Months)|Withdrawal by Subject|1|||
28059473|NCT00365456|54715559|FG000|Trial Period III (12 Months)|Other|1|||
28059474|NCT00365456|54715560|FG001|Trial Period III (12 Months)|Other|1|||
28059475|NCT00147238|54715566|FG000|Overall Study|Inevaluable|8|||
28059476|NCT00206427|54715570|FG000|Overall Study|Adverse Event|2|||
28059477|NCT00146848|54715577|FG000|Pre-randomization|Death|19|||
28059478|NCT00146848|54715578|FG001|Pre-randomization|Death|0|||
28059479|NCT00146848|54715579|FG002|Pre-randomization|Death|0|||
28059480|NCT00146848|54715577|FG000|Pre-randomization|Lost to Follow-up|70|||
28059481|NCT00146848|54715578|FG001|Pre-randomization|Lost to Follow-up|0|||
28059482|NCT00146848|54715579|FG002|Pre-randomization|Lost to Follow-up|0|||
28059483|NCT00146848|54715577|FG000|Pre-randomization|Physician Decision|8|||
28059484|NCT00146848|54715578|FG001|Pre-randomization|Physician Decision|0|||
28059485|NCT00146848|54715579|FG002|Pre-randomization|Physician Decision|0|||
28059486|NCT00146848|54715577|FG000|Pre-randomization|Protocol Violation|172|||
28059487|NCT00146848|54715578|FG001|Pre-randomization|Protocol Violation|0|||
28059488|NCT00146848|54715579|FG002|Pre-randomization|Protocol Violation|0|||
28059489|NCT00146848|54715577|FG000|Pre-randomization|Withdrawal by Subject|40|||
28059490|NCT00146848|54715578|FG001|Pre-randomization|Withdrawal by Subject|0|||
28059491|NCT00146848|54715579|FG002|Pre-randomization|Withdrawal by Subject|0|||
28059492|NCT00146848|54715577|FG000|Post-randomization|Lost to Follow-up|12|||
28059493|NCT00146848|54715578|FG001|Post-randomization|Lost to Follow-up|15|||
28059494|NCT00146848|54715579|FG002|Post-randomization|Lost to Follow-up|12|||
28059495|NCT00146848|54715577|FG000|Post-randomization|Withdrawn|26|||
28059496|NCT00146848|54715578|FG001|Post-randomization|Withdrawn|32|||
28059497|NCT00146848|54715579|FG002|Post-randomization|Withdrawn|27|||
28059498|NCT00205881|54715587|FG000|Overall Study|Withdrawal by Subject|16|||
28059499|NCT00365378|54715594|FG000|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11|||
28059500|NCT00365378|54715595|FG001|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7|||
28059501|NCT00365378|54715596|FG002|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
28059502|NCT00365378|54715594|FG000|Vaccination (Day 1 to Month 7)|Adverse Event|4|||
28059503|NCT00365378|54715595|FG001|Vaccination (Day 1 to Month 7)|Adverse Event|5|||
28059504|NCT00365378|54715596|FG002|Vaccination (Day 1 to Month 7)|Adverse Event|0|||
28059505|NCT00365378|54715594|FG000|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88|||
28059506|NCT00365378|54715595|FG001|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75|||
28059507|NCT00365378|54715596|FG002|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0|||
28059508|NCT00365378|54715594|FG000|Vaccination (Day 1 to Month 7)|Pregnancy|19|||
28059509|NCT00365378|54715595|FG001|Vaccination (Day 1 to Month 7)|Pregnancy|14|||
28059510|NCT00365378|54715596|FG002|Vaccination (Day 1 to Month 7)|Pregnancy|0|||
28059511|NCT00365378|54715594|FG000|Vaccination (Day 1 to Month 7)|Protocol Violation|22|||
28059512|NCT00365378|54715595|FG001|Vaccination (Day 1 to Month 7)|Protocol Violation|13|||
28059513|NCT00365378|54715596|FG002|Vaccination (Day 1 to Month 7)|Protocol Violation|0|||
28059514|NCT00365378|54715594|FG000|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50|||
28059515|NCT00365378|54715595|FG001|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44|||
28059516|NCT00365378|54715596|FG002|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0|||
28059517|NCT00365378|54715594|FG000|Vaccination (Day 1 to Month 7)|Other|17|||
28059518|NCT00365378|54715595|FG001|Vaccination (Day 1 to Month 7)|Other|9|||
28059519|NCT00365378|54715596|FG002|Vaccination (Day 1 to Month 7)|Other|0|||
28059520|NCT00365378|54715594|FG000|Follow-up (Month 7 Though Month 48)|Moved|6|||
28059521|NCT00365378|54715595|FG001|Follow-up (Month 7 Though Month 48)|Moved|5|||
28059522|NCT00365378|54715596|FG002|Follow-up (Month 7 Though Month 48)|Moved|0|||
28059523|NCT00365378|54715594|FG000|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67|||
28059524|NCT00365378|54715595|FG001|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69|||
28059525|NCT00365378|54715596|FG002|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0|||
28059526|NCT00365378|54715594|FG000|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
28059527|NCT00365378|54715595|FG001|Follow-up (Month 7 Though Month 48)|Pregnancy|1|||
28059528|NCT00365378|54715596|FG002|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
28059529|NCT00365378|54715594|FG000|Follow-up (Month 7 Though Month 48)|Protocol Violation|1|||
28059530|NCT00365378|54715595|FG001|Follow-up (Month 7 Though Month 48)|Protocol Violation|2|||
28059531|NCT00365378|54715596|FG002|Follow-up (Month 7 Though Month 48)|Protocol Violation|0|||
28059532|NCT00365378|54715594|FG000|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73|||
28059533|NCT00365378|54715595|FG001|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104|||
28059534|NCT00365378|54715596|FG002|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0|||
28059535|NCT00365378|54715594|FG000|Follow-up (Month 7 Though Month 48)|Other|11|||
28059536|NCT00365378|54715595|FG001|Follow-up (Month 7 Though Month 48)|Other|21|||
28059537|NCT00365378|54715596|FG002|Follow-up (Month 7 Though Month 48)|Other|0|||
28059538|NCT00365378|54715594|FG000|Extension|Adverse Event|0|||
28059539|NCT00365378|54715595|FG001|Extension|Adverse Event|0|||
28059540|NCT00365378|54715596|FG002|Extension|Adverse Event|1|||
28059541|NCT00365378|54715594|FG000|Extension|Moved|0|||
28059542|NCT00365378|54715595|FG001|Extension|Moved|0|||
28059543|NCT00365378|54715596|FG002|Extension|Moved|8|||
28059544|NCT00365378|54715594|FG000|Extension|Lost to Follow-up|0|||
28059545|NCT00365378|54715595|FG001|Extension|Lost to Follow-up|0|||
28059546|NCT00365378|54715596|FG002|Extension|Lost to Follow-up|57|||
28059547|NCT00365378|54715594|FG000|Extension|Protocol Violation|0|||
28059548|NCT00365378|54715595|FG001|Extension|Protocol Violation|0|||
28059549|NCT00365378|54715596|FG002|Extension|Protocol Violation|2|||
28059550|NCT00365378|54715594|FG000|Extension|Withdrawal by Subject|0|||
28059551|NCT00365378|54715595|FG001|Extension|Withdrawal by Subject|0|||
28059552|NCT00365378|54715596|FG002|Extension|Withdrawal by Subject|98|||
28059553|NCT00365378|54715594|FG000|Extension|Other|0|||
28059554|NCT00365378|54715595|FG001|Extension|Other|0|||
28059555|NCT00365378|54715596|FG002|Extension|Other|31|||
28059556|NCT00389324|54715603|FG000|Run-In Phase|Adverse Event|1|||
28059557|NCT00389324|54715603|FG000|Run-In Phase|Lost to Follow-up|1|||
27814639|NCT01574703|54271296|FG000|Overall Study|Adverse Event|0|||
28059558|NCT00389324|54715603|FG000|Run-In Phase|Withdrawal by Subject|1|||
28059559|NCT00389324|54715603|FG000|Subcutaneous Phase|Adverse Event|2|||
28059560|NCT00389324|54715603|FG000|Subcutaneous Phase|Non-compliance with study medication|2|||
28059561|NCT00389324|54715603|FG000|Subcutaneous Phase|Withdrawal by Subject|2|||
28059562|NCT00389324|54715603|FG000|Subcutaneous Phase|Lost to Follow-up|1|||
28059563|NCT00365300|54715612|FG000|Open-label Phase|Adverse Event|4|||
28059564|NCT00365300|54715613|FG001|Open-label Phase|Adverse Event|0|||
28059565|NCT00365300|54715612|FG000|Open-label Phase|Failed to Return|1|||
28059566|NCT00365300|54715613|FG001|Open-label Phase|Failed to Return|0|||
28059567|NCT00365300|54715612|FG000|Open-label Phase|Physician Decision|1|||
28059568|NCT00365300|54715613|FG001|Open-label Phase|Physician Decision|0|||
28059569|NCT00365300|54715612|FG000|Open-label Phase|Noncompliance|9|||
28059570|NCT00365300|54715613|FG001|Open-label Phase|Noncompliance|0|||
28059571|NCT00365300|54715612|FG000|Open-label Phase|Parent/Legal Guardian Request|4|||
28059572|NCT00365300|54715613|FG001|Open-label Phase|Parent/Legal Guardian Request|0|||
28059573|NCT00365300|54715612|FG000|Open-label Phase|Protocol Violation|1|||
28059574|NCT00365300|54715613|FG001|Open-label Phase|Protocol Violation|0|||
28059575|NCT00365300|54715612|FG000|Open-label Phase|Lack of Efficacy|1|||
28059576|NCT00365300|54715613|FG001|Open-label Phase|Lack of Efficacy|0|||
28059577|NCT00365300|54715612|FG000|Open-label Phase|Patient skipped open label phase|1|||
28059578|NCT00365300|54715613|FG001|Open-label Phase|Patient skipped open label phase|0|||
28059579|NCT00365300|54715612|FG000|Double-blind Phase|Failed to return|1|||
28059580|NCT00365300|54715613|FG001|Double-blind Phase|Failed to return|0|||
28059581|NCT00365300|54715612|FG000|Double-blind Phase|Noncompliance|1|||
28059582|NCT00365300|54715613|FG001|Double-blind Phase|Noncompliance|1|||
28059583|NCT00365300|54715612|FG000|Double-blind Phase|Withdrawal by Subject|0|||
28059584|NCT00365300|54715613|FG001|Double-blind Phase|Withdrawal by Subject|1|||
28059585|NCT00365300|54715612|FG000|Double-blind Phase|Protocol Violation|3|||
28059586|NCT00365300|54715613|FG001|Double-blind Phase|Protocol Violation|1|||
28059587|NCT00365300|54715612|FG000|Double-blind Phase|Lack of Efficacy|6|||
28059588|NCT00365300|54715613|FG001|Double-blind Phase|Lack of Efficacy|6|||
28059589|NCT00370292|54715624|FG000|Overall Study|Disease Progression|4|||
28059590|NCT00370292|54715624|FG000|Overall Study|Adverse Event|7|||
28059591|NCT00370292|54715624|FG000|Overall Study|Physician Decision|2|||
28059592|NCT00369824|54715641|FG000|Overall Study|Adverse Event|0|||
28059593|NCT00369824|54715642|FG001|Overall Study|Adverse Event|2|||
28059594|NCT00369824|54715643|FG002|Overall Study|Adverse Event|0|||
28059595|NCT00369824|54715644|FG003|Overall Study|Adverse Event|0|||
28059596|NCT00369824|54715645|FG004|Overall Study|Adverse Event|1|||
28059597|NCT00369824|54715646|FG005|Overall Study|Adverse Event|0|||
28059598|NCT00369824|54715641|FG000|Overall Study|Protocol Violation|0|||
28059599|NCT00369824|54715642|FG001|Overall Study|Protocol Violation|1|||
28059600|NCT00369824|54715643|FG002|Overall Study|Protocol Violation|0|||
28059601|NCT00369824|54715644|FG003|Overall Study|Protocol Violation|1|||
28059602|NCT00369824|54715645|FG004|Overall Study|Protocol Violation|1|||
28059603|NCT00369824|54715646|FG005|Overall Study|Protocol Violation|0|||
28059604|NCT00369824|54715641|FG000|Overall Study|Withdrawal by Subject|9|||
28059605|NCT00369824|54715642|FG001|Overall Study|Withdrawal by Subject|5|||
28059606|NCT00369824|54715643|FG002|Overall Study|Withdrawal by Subject|5|||
28059607|NCT00369824|54715644|FG003|Overall Study|Withdrawal by Subject|4|||
28059608|NCT00369824|54715645|FG004|Overall Study|Withdrawal by Subject|6|||
28059609|NCT00369824|54715646|FG005|Overall Study|Withdrawal by Subject|2|||
28059610|NCT00369824|54715641|FG000|Overall Study|Lost to Follow-up|6|||
28059611|NCT00369824|54715642|FG001|Overall Study|Lost to Follow-up|11|||
28059612|NCT00369824|54715643|FG002|Overall Study|Lost to Follow-up|7|||
28059613|NCT00369824|54715644|FG003|Overall Study|Lost to Follow-up|8|||
28059614|NCT00369824|54715645|FG004|Overall Study|Lost to Follow-up|9|||
28059615|NCT00369824|54715646|FG005|Overall Study|Lost to Follow-up|6|||
28059616|NCT00369824|54715641|FG000|Overall Study|Other|0|||
28059617|NCT00369824|54715642|FG001|Overall Study|Other|0|||
28059618|NCT00369824|54715643|FG002|Overall Study|Other|0|||
28059619|NCT00369824|54715644|FG003|Overall Study|Other|2|||
28059620|NCT00369824|54715645|FG004|Overall Study|Other|1|||
27814640|NCT01574703|54271297|FG001|Overall Study|Adverse Event|2|||
27814641|NCT01574703|54271298|FG002|Overall Study|Adverse Event|1|||
27814642|NCT01574703|54271299|FG003|Overall Study|Adverse Event|1|||
27814643|NCT01574703|54271296|FG000|Overall Study|Protocol Violation|0|||
27814644|NCT01574703|54271297|FG001|Overall Study|Protocol Violation|0|||
27814645|NCT01574703|54271298|FG002|Overall Study|Protocol Violation|0|||
27814646|NCT01574703|54271299|FG003|Overall Study|Protocol Violation|1|||
27814647|NCT01574703|54271296|FG000|Overall Study|Unspecified Reason|27|||
28059621|NCT00369824|54715646|FG005|Overall Study|Other|3|||
27814648|NCT01574703|54271297|FG001|Overall Study|Unspecified Reason|15|||
27814649|NCT01574703|54271298|FG002|Overall Study|Unspecified Reason|20|||
27814650|NCT01574703|54271299|FG003|Overall Study|Unspecified Reason|16|||
27814651|NCT01574703|54271296|FG000|Overall Study|Withdrawal by Subject|53|||
28059622|NCT00369668|54715663|FG000|Overall Study|Lack of Efficacy|4|||
28059623|NCT00369668|54715664|FG001|Overall Study|Lack of Efficacy|5|||
28059624|NCT00369668|54715665|FG002|Overall Study|Lack of Efficacy|7|||
28059625|NCT00388154|54715676|FG000|Overall Study|Withdrawal by Subject|1|||
28059626|NCT00387764|54715680|FG000|Overall Study|Adverse Event|12|||
28059627|NCT00387764|54715680|FG000|Overall Study|Withdrawal by Subject|8|||
28059628|NCT00387764|54715680|FG000|Overall Study|Sponsor Terminated Study|1|||
28059629|NCT00387764|54715680|FG000|Overall Study|Physician Decision|1|||
28059630|NCT00387764|54715680|FG000|Overall Study|Other|2|||
27848317|NCT00215657|54341255|FG001|Overall Study|Other|1|||
27814652|NCT01574703|54271297|FG001|Overall Study|Withdrawal by Subject|52|||
27814653|NCT01574703|54271298|FG002|Overall Study|Withdrawal by Subject|36|||
27814654|NCT01574703|54271299|FG003|Overall Study|Withdrawal by Subject|61|||
27814655|NCT01574703|54271296|FG000|Overall Study|Met Withdrawal Criteria|0|||
27814656|NCT01574703|54271297|FG001|Overall Study|Met Withdrawal Criteria|1|||
27814657|NCT01574703|54271298|FG002|Overall Study|Met Withdrawal Criteria|1|||
27848318|NCT00215657|54341256|FG002|Overall Study|Other|2|||
27848319|NCT00215657|54341257|FG003|Overall Study|Other|3|||
27848320|NCT00215657|54341258|FG004|Overall Study|Other|5|||
27848321|NCT00215657|54341259|FG005|Overall Study|Other|4|||
27848322|NCT00215657|54341260|FG006|Overall Study|Other|6|||
27848323|NCT00215657|54341261|FG007|Overall Study|Other|1|||
27848324|NCT00633061|54341281|FG000|Overall Study|Study closed|86|||
27848325|NCT00633061|54341282|FG001|Overall Study|Study closed|0|||
27848326|NCT00632827|54341290|FG000|Overall Study|Excluded after GVD (Not evaluable)|2|||
27848327|NCT00632827|54341290|FG000|Overall Study|Death|2|||
27848328|NCT00632827|54341290|FG000|Overall Study|Adverse Event|5|||
27848329|NCT00632827|54341290|FG000|Overall Study|Lost to Follow-up|1|||
27848330|NCT00214019|54341295|FG000|Overall Study|Lost to Follow-up|11|||
28059631|NCT00387764|54715680|FG000|Overall Study|Death|7|||
28059632|NCT00386360|54715686|FG000|Overall Study|Adverse Event|4|||
28059633|NCT00386360|54715687|FG001|Overall Study|Adverse Event|2|||
28059634|NCT00386360|54715686|FG000|Overall Study|Physician Decision|2|||
27814658|NCT01574703|54271299|FG003|Overall Study|Met Withdrawal Criteria|0|||
27814659|NCT01574703|54271296|FG000|Overall Study|Lost to Follow-up|43|||
27814660|NCT01574703|54271297|FG001|Overall Study|Lost to Follow-up|41|||
27814661|NCT01574703|54271298|FG002|Overall Study|Lost to Follow-up|46|||
27814662|NCT01574703|54271299|FG003|Overall Study|Lost to Follow-up|35|||
27814663|NCT01574703|54271296|FG000|Overall Study|Death|2|||
27814664|NCT01574703|54271297|FG001|Overall Study|Death|1|||
27814665|NCT01574703|54271298|FG002|Overall Study|Death|1|||
27814666|NCT01574703|54271299|FG003|Overall Study|Death|0|||
27814667|NCT01686633|54271312|FG000|Overall Study|Lack of Efficacy|33|||
28059635|NCT00386360|54715687|FG001|Overall Study|Physician Decision|2|||
28059636|NCT00386360|54715686|FG000|Overall Study|Lost to Follow-up|0|||
27814668|NCT01686633|54271313|FG001|Overall Study|Lack of Efficacy|13|||
28059637|NCT00386360|54715687|FG001|Overall Study|Lost to Follow-up|2|||
28059638|NCT00386360|54715686|FG000|Overall Study|Protocol Violation|0|||
27814669|NCT01686633|54271314|FG002|Overall Study|Lack of Efficacy|11|||
27814670|NCT01686633|54271312|FG000|Overall Study|Withdrawal by Subject|8|||
27814671|NCT01686633|54271313|FG001|Overall Study|Withdrawal by Subject|8|||
27848331|NCT00214019|54341295|FG000|Overall Study|Withdrawal by Subject|2|||
27848332|NCT00214019|54341295|FG000|Overall Study|Screen Failed prior to randomization|17|||
27848333|NCT00210119|54341302|FG000|Overall Study|Protocol Violation|1|||
27814672|NCT01686633|54271314|FG002|Overall Study|Withdrawal by Subject|5|||
28059639|NCT00386360|54715687|FG001|Overall Study|Protocol Violation|3|||
28059640|NCT00386360|54715686|FG000|Overall Study|Withdrawal by Subject|3|||
28059641|NCT00386360|54715687|FG001|Overall Study|Withdrawal by Subject|6|||
28059642|NCT00386360|54715686|FG000|Overall Study|Did not take any study medication|0|||
28059643|NCT00386360|54715687|FG001|Overall Study|Did not take any study medication|2|||
28059644|NCT00369278|54715695|FG000|Overall Study|Adverse Event|14|||
28059645|NCT00369278|54715696|FG001|Overall Study|Adverse Event|11|||
28059646|NCT00369278|54715695|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
28059647|NCT00369278|54715696|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
28059648|NCT00369278|54715695|FG000|Overall Study|Protocol Violation|2|||
28059649|NCT00369278|54715696|FG001|Overall Study|Protocol Violation|1|||
28059650|NCT00369278|54715695|FG000|Overall Study|Withdrawal by Subject|2|||
28059651|NCT00369278|54715696|FG001|Overall Study|Withdrawal by Subject|2|||
28059652|NCT00369278|54715695|FG000|Overall Study|Lost to Follow-up|1|||
28059653|NCT00369278|54715696|FG001|Overall Study|Lost to Follow-up|0|||
28059654|NCT00369278|54715695|FG000|Overall Study|Graft loss|1|||
28059655|NCT00369278|54715696|FG001|Overall Study|Graft loss|2|||
28059656|NCT00529373|54715704|FG000|Base Study|Adverse Event|525|||
28059657|NCT00529373|54715705|FG001|Base Study|Adverse Event|470|||
28059658|NCT00529373|54715704|FG000|Base Study|Lack of Efficacy|16|||
28059659|NCT00529373|54715705|FG001|Base Study|Lack of Efficacy|75|||
28059660|NCT00529373|54715704|FG000|Base Study|Lost to Follow-up|221|||
28059661|NCT00529373|54715705|FG001|Base Study|Lost to Follow-up|208|||
28059662|NCT00529373|54715704|FG000|Base Study|Other Protocol Specified Criteria|19|||
28059663|NCT00529373|54715705|FG001|Base Study|Other Protocol Specified Criteria|20|||
28059664|NCT00529373|54715704|FG000|Base Study|Physician Decision|60|||
28059665|NCT00529373|54715705|FG001|Base Study|Physician Decision|52|||
28059666|NCT00529373|54715704|FG000|Base Study|Protocol Violation|48|||
28059667|NCT00529373|54715705|FG001|Base Study|Protocol Violation|38|||
28059668|NCT00529373|54715704|FG000|Base Study|Withdrawal by Subject|1062|||
28059669|NCT00529373|54715705|FG001|Base Study|Withdrawal by Subject|967|||
28059670|NCT00529373|54715704|FG000|Base Study|Did not continue into Extension|1795|||
28059671|NCT00529373|54715705|FG001|Base Study|Did not continue into Extension|2238|||
28059672|NCT00529373|54715704|FG000|First Extension Study|Adverse Event|162|||
28059673|NCT00529373|54715705|FG001|First Extension Study|Adverse Event|142|||
28059674|NCT00529373|54715704|FG000|First Extension Study|Lack of Efficacy|65|||
28059675|NCT00529373|54715705|FG001|First Extension Study|Lack of Efficacy|427|||
28059676|NCT00529373|54715704|FG000|First Extension Study|Lost to Follow-up|41|||
28059677|NCT00529373|54715705|FG001|First Extension Study|Lost to Follow-up|37|||
28059678|NCT00529373|54715704|FG000|First Extension Study|Other|27|||
28059679|NCT00529373|54715705|FG001|First Extension Study|Other|47|||
28059680|NCT00529373|54715704|FG000|First Extension Study|Physician Decision|50|||
28059681|NCT00529373|54715705|FG001|First Extension Study|Physician Decision|45|||
28059682|NCT00529373|54715704|FG000|First Extension Study|Protocol Violation|16|||
28059683|NCT00529373|54715705|FG001|First Extension Study|Protocol Violation|13|||
28059684|NCT00529373|54715704|FG000|First Extension Study|Withdrawal by Subject|296|||
28059685|NCT00529373|54715705|FG001|First Extension Study|Withdrawal by Subject|287|||
28059686|NCT00529373|54715704|FG000|First Extension Study|Disposition record non-existing|0|||
28059687|NCT00529373|54715705|FG001|First Extension Study|Disposition record non-existing|1|||
28059688|NCT00529373|54715704|FG000|First Extension Study|Discontinued after 5 years completion|208|||
28059689|NCT00529373|54715705|FG001|First Extension Study|Discontinued after 5 years completion|346|||
28059690|NCT00529373|54715704|FG000|First Extension Study|Did not cont. into 2nd Ext (verified)|256|||
28059691|NCT00529373|54715705|FG001|First Extension Study|Did not cont. into 2nd Ext (verified)|281|||
28059692|NCT00529373|54715704|FG000|First Extension Study|Did not cont. into 2nd Ext (unknown)|32|||
28059693|NCT00529373|54715705|FG001|First Extension Study|Did not cont. into 2nd Ext (unknown)|25|||
28059694|NCT00529373|54715704|FG000|Second Extension Study|Adverse Event|101|||
28059695|NCT00529373|54715705|FG001|Second Extension Study|Adverse Event|51|||
28059696|NCT00529373|54715704|FG000|Second Extension Study|Lack of Efficacy|7|||
28059697|NCT00529373|54715705|FG001|Second Extension Study|Lack of Efficacy|15|||
28059698|NCT00529373|54715704|FG000|Second Extension Study|Lost to Follow-up|18|||
28059699|NCT00529373|54715705|FG001|Second Extension Study|Lost to Follow-up|12|||
28059700|NCT00529373|54715704|FG000|Second Extension Study|Other|7|||
28059701|NCT00529373|54715705|FG001|Second Extension Study|Other|12|||
28059702|NCT00529373|54715704|FG000|Second Extension Study|Physician Decision|63|||
28059703|NCT00529373|54715705|FG001|Second Extension Study|Physician Decision|26|||
28059704|NCT00529373|54715704|FG000|Second Extension Study|Protocol Violation|2|||
28059705|NCT00529373|54715705|FG001|Second Extension Study|Protocol Violation|1|||
28059706|NCT00529373|54715704|FG000|Second Extension Study|Withdrawal by Subject|97|||
27814673|NCT01686633|54271312|FG000|Overall Study|Physician Decision|3|||
27814674|NCT01686633|54271313|FG001|Overall Study|Physician Decision|4|||
27814675|NCT01686633|54271314|FG002|Overall Study|Physician Decision|4|||
27814676|NCT01686633|54271312|FG000|Overall Study|Adverse Event|4|||
27814677|NCT01686633|54271313|FG001|Overall Study|Adverse Event|3|||
27814678|NCT01686633|54271314|FG002|Overall Study|Adverse Event|3|||
27814679|NCT01686633|54271312|FG000|Overall Study|Protocol Violation|2|||
28059707|NCT00529373|54715705|FG001|Second Extension Study|Withdrawal by Subject|75|||
28059708|NCT00529373|54715704|FG000|Second Extension Study|Status Missing|5|||
28059709|NCT00529373|54715705|FG001|Second Extension Study|Status Missing|5|||
28059710|NCT00369122|54715719|FG000|Overall Study|Ineligible|10|||
28059711|NCT00369122|54715719|FG000|Overall Study|No protocol treatment|1|||
28059712|NCT03687125|54715725|FG000|Overall Study|Progressive Disease|2|||
28059713|NCT03687125|54715726|FG001|Overall Study|Progressive Disease|1|||
28059714|NCT03687125|54715725|FG000|Overall Study|Protocol Violation|1|||
28059715|NCT03687125|54715726|FG001|Overall Study|Protocol Violation|0|||
28059716|NCT03872843|54715736|FG000|Overall Study|Lost to Follow-up|5|||
28059717|NCT03872843|54715737|FG001|Overall Study|Lost to Follow-up|7|||
28059718|NCT00146770|54715745|FG000|Overall Study|Adverse Event|2|||
28059719|NCT00146770|54715746|FG001|Overall Study|Adverse Event|0|||
27814680|NCT01686633|54271313|FG001|Overall Study|Protocol Violation|3|||
27814681|NCT01686633|54271314|FG002|Overall Study|Protocol Violation|0|||
27814682|NCT01686633|54271312|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
28059720|NCT00146770|54715745|FG000|Overall Study|Pregnancy|1|||
28059721|NCT00146770|54715746|FG001|Overall Study|Pregnancy|0|||
28059722|NCT00146770|54715745|FG000|Overall Study|Withdrawal by Subject|2|||
28059723|NCT00146770|54715746|FG001|Overall Study|Withdrawal by Subject|0|||
28059724|NCT03874013|54715754|FG000|Overall Study|Adverse Event|0|||
27814683|NCT01686633|54271313|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
27814684|NCT01686633|54271314|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
27814685|NCT01686633|54271312|FG000|Overall Study|Lost to Follow-up|0|||
27814686|NCT01686633|54271313|FG001|Overall Study|Lost to Follow-up|1|||
27814687|NCT01686633|54271314|FG002|Overall Study|Lost to Follow-up|1|||
27940062|NCT01196988|54596399|FG001|Overall Study|Withdrawal by Subject|1|||
28059725|NCT03874013|54715755|FG001|Overall Study|Adverse Event|1|||
28059726|NCT00168064|54715763|FG000|Overall Study|Adverse Event|26|||
28059727|NCT00168064|54715764|FG001|Overall Study|Adverse Event|22|||
28059728|NCT00168064|54715763|FG000|Overall Study|Withdrawal by Subject|3|||
28059729|NCT00168064|54715764|FG001|Overall Study|Withdrawal by Subject|4|||
28059730|NCT00168064|54715763|FG000|Overall Study|Lack of Efficacy|4|||
28059731|NCT00168064|54715764|FG001|Overall Study|Lack of Efficacy|4|||
28059732|NCT00168064|54715763|FG000|Overall Study|Lost to Follow-up|4|||
28059733|NCT00168064|54715764|FG001|Overall Study|Lost to Follow-up|3|||
28059734|NCT00168064|54715763|FG000|Overall Study|Non-compliance|2|||
28059735|NCT00168064|54715764|FG001|Overall Study|Non-compliance|3|||
28059736|NCT00168064|54715763|FG000|Overall Study|Concurrent Illness|4|||
27940063|NCT01196988|54596400|FG002|Overall Study|Withdrawal by Subject|4|||
27940064|NCT01196988|54596401|FG003|Overall Study|Withdrawal by Subject|0|||
27940065|NCT01196988|54596398|FG000|Overall Study|Lost to Follow-up|16|||
27940066|NCT01196988|54596399|FG001|Overall Study|Lost to Follow-up|29|||
27940067|NCT01196988|54596400|FG002|Overall Study|Lost to Follow-up|21|||
27940068|NCT01196988|54596401|FG003|Overall Study|Lost to Follow-up|1|||
27940069|NCT01196988|54596398|FG000|Overall Study|Other|2|||
27940070|NCT01196988|54596399|FG001|Overall Study|Other|0|||
27940071|NCT01196988|54596400|FG002|Overall Study|Other|0|||
27940072|NCT01196988|54596401|FG003|Overall Study|Other|0|||
27814698|NCT01685697|54271335|FG000|Overall Study|Protocol Violation|3|||
27814699|NCT01685697|54271336|FG001|Overall Study|Protocol Violation|3|||
28059737|NCT00168064|54715764|FG001|Overall Study|Concurrent Illness|3|||
28059738|NCT00168064|54715763|FG000|Overall Study|Subject's Best interest|2|||
28059739|NCT00168064|54715764|FG001|Overall Study|Subject's Best interest|2|||
28059740|NCT00168064|54715763|FG000|Overall Study|Various|4|||
28059741|NCT00168064|54715764|FG001|Overall Study|Various|3|||
28059742|NCT00166114|54715774|FG000|Overall Study|Protocol Violation|2|||
28059743|NCT00166114|54715775|FG001|Overall Study|Protocol Violation|1|||
28059744|NCT00166114|54715774|FG000|Overall Study|Withdrawal by Subject|10|||
28059745|NCT00166114|54715775|FG001|Overall Study|Withdrawal by Subject|4|||
28059746|NCT00166114|54715774|FG000|Overall Study|Adverse Event|2|||
28059747|NCT00166114|54715775|FG001|Overall Study|Adverse Event|1|||
28059748|NCT03686969|54715783|FG000|Overall Study|Study terminated|1|||
28059749|NCT03686969|54715784|FG001|Overall Study|Study terminated|0|||
28059750|NCT00145600|54715794|FG000|Overall Study|Death|1|||
28059751|NCT00145600|54715795|FG001|Overall Study|Death|2|||
28059752|NCT00145600|54715796|FG002|Overall Study|Death|2|||
28059753|NCT00145600|54715797|FG003|Overall Study|Death|6|||
28059754|NCT00145600|54715794|FG000|Overall Study|Ineligible|3|||
28059755|NCT00145600|54715795|FG001|Overall Study|Ineligible|0|||
28059756|NCT00145600|54715796|FG002|Overall Study|Ineligible|1|||
28059757|NCT00145600|54715797|FG003|Overall Study|Ineligible|5|||
28059758|NCT00145600|54715794|FG000|Overall Study|Lost to Follow-up|2|||
28059759|NCT00145600|54715795|FG001|Overall Study|Lost to Follow-up|6|||
28059760|NCT00145600|54715796|FG002|Overall Study|Lost to Follow-up|2|||
28059761|NCT00145600|54715797|FG003|Overall Study|Lost to Follow-up|4|||
28059762|NCT00145600|54715794|FG000|Overall Study|Noncompliance|1|||
28059763|NCT00145600|54715795|FG001|Overall Study|Noncompliance|0|||
28059764|NCT00145600|54715796|FG002|Overall Study|Noncompliance|0|||
28059765|NCT00145600|54715797|FG003|Overall Study|Noncompliance|0|||
28059766|NCT00145600|54715794|FG000|Overall Study|Withdrawal by Subject|1|||
28059767|NCT00145600|54715795|FG001|Overall Study|Withdrawal by Subject|2|||
28059768|NCT00145600|54715796|FG002|Overall Study|Withdrawal by Subject|0|||
28059769|NCT00145600|54715797|FG003|Overall Study|Withdrawal by Subject|1|||
28059770|NCT00129376|54715821|FG000|Overall Study|Adverse Event|1|||
27814700|NCT02395120|54271347|FG000|Overall Study|Missed follow-up dental exam|57|||
28059771|NCT00129376|54715821|FG000|Overall Study|Lack of Efficacy|1|||
27814701|NCT02395120|54271348|FG001|Overall Study|Missed follow-up dental exam|62|||
27940073|NCT01196052|54596412|FG000|Overall Study|Adverse Event|9|||
28059772|NCT00129220|54715828|FG000|Study Period II|Adverse Event|9|||
28059773|NCT00129220|54715829|FG001|Study Period II|Adverse Event|5|||
28059774|NCT00129220|54715830|FG002|Study Period II|Adverse Event|7|||
28059775|NCT00129220|54715828|FG000|Study Period II|Lack of Efficacy|15|||
28059776|NCT00129220|54715829|FG001|Study Period II|Lack of Efficacy|1|||
28059777|NCT00129220|54715830|FG002|Study Period II|Lack of Efficacy|28|||
28059778|NCT00129220|54715828|FG000|Study Period II|Entry Criteria Not Met|2|||
28059779|NCT00129220|54715829|FG001|Study Period II|Entry Criteria Not Met|0|||
28059780|NCT00129220|54715830|FG002|Study Period II|Entry Criteria Not Met|2|||
28059781|NCT00129220|54715828|FG000|Study Period II|Protocol Violation|4|||
28059782|NCT00129220|54715829|FG001|Study Period II|Protocol Violation|2|||
28059783|NCT00129220|54715830|FG002|Study Period II|Protocol Violation|1|||
28059784|NCT00129220|54715828|FG000|Study Period II|Physician Decision|0|||
28059785|NCT00129220|54715829|FG001|Study Period II|Physician Decision|1|||
28059786|NCT00129220|54715830|FG002|Study Period II|Physician Decision|0|||
28059787|NCT00129220|54715828|FG000|Study Period II|Withdrawal by Subject|1|||
28059788|NCT00129220|54715829|FG001|Study Period II|Withdrawal by Subject|3|||
28059789|NCT00129220|54715830|FG002|Study Period II|Withdrawal by Subject|4|||
28059790|NCT00129220|54715828|FG000|Study Period II|Reason Not Specified|2|||
28059791|NCT00129220|54715829|FG001|Study Period II|Reason Not Specified|0|||
28059792|NCT00129220|54715830|FG002|Study Period II|Reason Not Specified|5|||
28059793|NCT00129220|54715828|FG000|Study Period III|Adverse Event|1|||
28059794|NCT00129220|54715829|FG001|Study Period III|Adverse Event|0|||
28059795|NCT00129220|54715830|FG002|Study Period III|Adverse Event|3|||
28059796|NCT00129220|54715828|FG000|Study Period III|Protocol Violation|1|||
28059797|NCT00129220|54715829|FG001|Study Period III|Protocol Violation|1|||
28059798|NCT00129220|54715830|FG002|Study Period III|Protocol Violation|2|||
28059799|NCT00129220|54715828|FG000|Study Period III|Withdrawal by Subject|1|||
28059800|NCT00129220|54715829|FG001|Study Period III|Withdrawal by Subject|0|||
28059801|NCT00129220|54715830|FG002|Study Period III|Withdrawal by Subject|3|||
28059802|NCT00129220|54715828|FG000|Study Period III|Sponsor Decision|1|||
28059803|NCT00129220|54715829|FG001|Study Period III|Sponsor Decision|0|||
28059804|NCT00129220|54715830|FG002|Study Period III|Sponsor Decision|0|||
28059805|NCT00129220|54715828|FG000|Study Period III|Reason Not Specified|9|||
28059806|NCT00129220|54715829|FG001|Study Period III|Reason Not Specified|0|||
28059807|NCT00129220|54715830|FG002|Study Period III|Reason Not Specified|2|||
28059808|NCT00128830|54715850|FG000|Overall Study|Adverse Event|10|||
27940074|NCT01196052|54596412|FG000|Overall Study|Lost to Follow-up|1|||
27814702|NCT02395120|54271349|FG002|Overall Study|Missed follow-up dental exam|6|||
27814703|NCT02395120|54271350|FG003|Overall Study|Missed follow-up dental exam|6|||
27814704|NCT02395120|54271351|FG004|Overall Study|Missed follow-up dental exam|51|||
27814705|NCT01685229|54271365|FG000|Overall Study|Subjects missing Study Exit form|3|||
27814706|NCT01685229|54271366|FG001|Overall Study|Subjects missing Study Exit form|1|||
27814707|NCT01685229|54271365|FG000|Overall Study|Lost to Follow-up|16|||
27814708|NCT01685229|54271366|FG001|Overall Study|Lost to Follow-up|10|||
27814709|NCT01685229|54271365|FG000|Overall Study|Withdrawal by Subject|6|||
27814710|NCT01685229|54271366|FG001|Overall Study|Withdrawal by Subject|5|||
27814711|NCT01685229|54271365|FG000|Overall Study|Death|1|||
27814712|NCT01685229|54271366|FG001|Overall Study|Death|0|||
27814713|NCT01551693|54271377|FG000|Overall Study|Disease Progression|1|||
27814714|NCT01551693|54271378|FG001|Overall Study|Disease Progression|0|||
27814715|NCT01551693|54271377|FG000|Overall Study|Adverse Event|0|||
27814716|NCT01551693|54271378|FG001|Overall Study|Adverse Event|1|||
27814717|NCT01551693|54271377|FG000|Overall Study|Withdrawal by Subject|0|||
27814718|NCT01551693|54271378|FG001|Overall Study|Withdrawal by Subject|1|||
27814719|NCT01574157|54271386|FG000|Overall Study|Withdrawal by Subject|4|||
27814720|NCT01574157|54271387|FG001|Overall Study|Withdrawal by Subject|5|||
27814721|NCT01574157|54271386|FG000|Overall Study|Lost to Follow-up|0|||
27814722|NCT01574157|54271387|FG001|Overall Study|Lost to Follow-up|3|||
27814723|NCT01574079|54271399|FG000|Overall Study|Physician Decision|0|||
27814724|NCT01574079|54271400|FG001|Overall Study|Physician Decision|2|||
27814725|NCT01574079|54271399|FG000|Overall Study|Lost to Follow-up|1|||
27814726|NCT01574079|54271400|FG001|Overall Study|Lost to Follow-up|0|||
28059809|NCT00128830|54715850|FG000|Overall Study|Withdrawal by Subject|14|||
28059810|NCT00128830|54715850|FG000|Overall Study|Lost to Follow-up|4|||
28059811|NCT00128830|54715850|FG000|Overall Study|Reached a virologic endpoint|29|||
28059812|NCT00128830|54715850|FG000|Overall Study|Non-compliant|4|||
27814727|NCT01573767|54271410|FG000|Overall Study|Adverse Event|0|||
27814728|NCT01573767|54271411|FG001|Overall Study|Adverse Event|1|||
27814729|NCT01573767|54271412|FG002|Overall Study|Adverse Event|0|||
27814730|NCT01573767|54271413|FG003|Overall Study|Adverse Event|1|||
28059813|NCT00128830|54715850|FG000|Overall Study|Discontinued or ineligible for study|2|||
28059814|NCT00128830|54715850|FG000|Overall Study|Other|9|||
28059815|NCT03686033|54715856|FG000|Treatment Period 2 (1 Day)|Adverse Event|0|||
28059816|NCT03686033|54715857|FG001|Treatment Period 2 (1 Day)|Adverse Event|0|||
27814731|NCT01573767|54271410|FG000|Overall Study|Lack of Efficacy|18|||
27814732|NCT01573767|54271411|FG001|Overall Study|Lack of Efficacy|15|||
27814733|NCT01573767|54271412|FG002|Overall Study|Lack of Efficacy|12|||
27814734|NCT01573767|54271413|FG003|Overall Study|Lack of Efficacy|17|||
27814735|NCT01573767|54271410|FG000|Overall Study|Protocol Violation|3|||
27814736|NCT01573767|54271411|FG001|Overall Study|Protocol Violation|1|||
27814737|NCT01573767|54271412|FG002|Overall Study|Protocol Violation|1|||
27814738|NCT01573767|54271413|FG003|Overall Study|Protocol Violation|3|||
27814739|NCT01573767|54271410|FG000|Overall Study|Lost to Follow-up|0|||
27814740|NCT01573767|54271411|FG001|Overall Study|Lost to Follow-up|1|||
27814741|NCT01573767|54271412|FG002|Overall Study|Lost to Follow-up|1|||
27814742|NCT01573767|54271413|FG003|Overall Study|Lost to Follow-up|1|||
27814743|NCT01573767|54271410|FG000|Overall Study|Physician Decision|1|||
27814744|NCT01573767|54271411|FG001|Overall Study|Physician Decision|2|||
27814745|NCT01573767|54271412|FG002|Overall Study|Physician Decision|0|||
27814746|NCT01573767|54271413|FG003|Overall Study|Physician Decision|2|||
27814747|NCT01573767|54271410|FG000|Overall Study|Withdrawal by Subject|0|||
27814748|NCT01573767|54271411|FG001|Overall Study|Withdrawal by Subject|1|||
27814749|NCT01573767|54271412|FG002|Overall Study|Withdrawal by Subject|0|||
27814750|NCT01573767|54271413|FG003|Overall Study|Withdrawal by Subject|0|||
27814751|NCT01551303|54271425|FG000|Overall Study|failed awareness check on vision test|4|||
27814752|NCT01551303|54271426|FG001|Overall Study|failed awareness check on vision test|7|||
27814753|NCT00638404|54271434|FG000|Overall Study|Physician Decision|8|||
27814754|NCT00638404|54271435|FG001|Overall Study|Physician Decision|0|||
27814755|NCT01550757|54271449|FG000|Overall Study|Lost to Follow-up|21|||
27814756|NCT01550757|54271450|FG001|Overall Study|Lost to Follow-up|14|||
27814757|NCT01550757|54271451|FG002|Overall Study|Lost to Follow-up|42|||
27814758|NCT01550757|54271452|FG003|Overall Study|Lost to Follow-up|53|||
27814759|NCT01550757|54271449|FG000|Overall Study|Withdrawal by Subject|2|||
27814760|NCT01550757|54271450|FG001|Overall Study|Withdrawal by Subject|0|||
27814761|NCT01550757|54271451|FG002|Overall Study|Withdrawal by Subject|3|||
28059817|NCT03686033|54715858|FG002|Treatment Period 2 (1 Day)|Adverse Event|0|||
27814762|NCT01550757|54271452|FG003|Overall Study|Withdrawal by Subject|1|||
27814763|NCT01685073|54271464|FG000|Overall Study|Lost to Follow-up|6|||
27814764|NCT01685073|54271465|FG001|Overall Study|Lost to Follow-up|8|||
27814765|NCT01685073|54271464|FG000|Overall Study|Withdrawal by Subject|24|||
27814766|NCT01685073|54271465|FG001|Overall Study|Withdrawal by Subject|24|||
27814767|NCT01572909|54271473|FG000|Overall Study|Adverse Event|7|||
27814768|NCT01572909|54271474|FG001|Overall Study|Adverse Event|2|||
27848334|NCT00210119|54341302|FG000|Overall Study|Withdrawal by Subject|1|||
28059818|NCT03686033|54715859|FG003|Treatment Period 2 (1 Day)|Adverse Event|0|||
28059819|NCT03686033|54715860|FG004|Treatment Period 2 (1 Day)|Adverse Event|1|||
28059820|NCT03686033|54715861|FG005|Treatment Period 2 (1 Day)|Adverse Event|0|||
28059821|NCT00128206|54715877|FG000|Overall Study|Lost to Follow-up|137|||
28059822|NCT00128206|54715878|FG001|Overall Study|Lost to Follow-up|118|||
28059823|NCT00128206|54715877|FG000|Overall Study|Adverse Event|0|||
28059824|NCT00128206|54715878|FG001|Overall Study|Adverse Event|2|||
27848335|NCT01044459|54341308|FG000|Overall Study|Withdrawal by Subject|21|||
28059825|NCT03685643|54715886|FG000|Overall Study|Lost to Follow-up|14|||
28059826|NCT03685643|54715887|FG001|Overall Study|Lost to Follow-up|22|||
28059827|NCT03823378|54715899|FG000|Overall Study|Adverse Event|2|||
28059828|NCT03823378|54715900|FG001|Overall Study|Adverse Event|2|||
28059829|NCT03823378|54715901|FG002|Overall Study|Adverse Event|0|||
28059830|NCT03823378|54715902|FG003|Overall Study|Adverse Event|0|||
28059831|NCT03823378|54715903|FG004|Overall Study|Adverse Event|0|||
28059832|NCT03823378|54715904|FG005|Overall Study|Adverse Event|0|||
28059833|NCT03823378|54715899|FG000|Overall Study|Lost to Follow-up|0|||
27814769|NCT01572909|54271473|FG000|Overall Study|Death|3|||
27814770|NCT01572909|54271474|FG001|Overall Study|Death|1|||
27814771|NCT01572909|54271473|FG000|Overall Study|Lost to Follow-up|8|||
27814772|NCT01572909|54271474|FG001|Overall Study|Lost to Follow-up|7|||
27814773|NCT01572909|54271473|FG000|Overall Study|Physician Decision|1|||
27814774|NCT01572909|54271474|FG001|Overall Study|Physician Decision|1|||
28059834|NCT03823378|54715900|FG001|Overall Study|Lost to Follow-up|1|||
27814775|NCT01572909|54271473|FG000|Overall Study|Technical Issues|1|||
27814776|NCT01572909|54271474|FG001|Overall Study|Technical Issues|0|||
27848336|NCT01044459|54341309|FG001|Overall Study|Withdrawal by Subject|28|||
27848337|NCT01044459|54341308|FG000|Overall Study|Terminated by Sponsor|22|||
28059835|NCT03823378|54715901|FG002|Overall Study|Lost to Follow-up|0|||
28059836|NCT03823378|54715902|FG003|Overall Study|Lost to Follow-up|0|||
28059837|NCT03823378|54715903|FG004|Overall Study|Lost to Follow-up|1|||
28059838|NCT03823378|54715904|FG005|Overall Study|Lost to Follow-up|0|||
28059839|NCT03823378|54715899|FG000|Overall Study|Withdrawal by Subject|0|||
28059840|NCT03823378|54715900|FG001|Overall Study|Withdrawal by Subject|1|||
27814777|NCT01572909|54271473|FG000|Overall Study|Withdrawal by Subject|12|||
27814778|NCT01572909|54271474|FG001|Overall Study|Withdrawal by Subject|11|||
27814779|NCT01572909|54271473|FG000|Overall Study|Infarct, comorbidity, Pt refusal of exam|0|||
28059841|NCT03823378|54715901|FG002|Overall Study|Withdrawal by Subject|4|||
28059842|NCT03823378|54715902|FG003|Overall Study|Withdrawal by Subject|2|||
28059843|NCT03823378|54715903|FG004|Overall Study|Withdrawal by Subject|0|||
28059844|NCT03823378|54715904|FG005|Overall Study|Withdrawal by Subject|1|||
28059845|NCT03823378|54715899|FG000|Overall Study|Other, not specified|19|||
28059846|NCT03823378|54715900|FG001|Overall Study|Other, not specified|12|||
28059847|NCT03823378|54715901|FG002|Overall Study|Other, not specified|6|||
28059848|NCT03823378|54715902|FG003|Overall Study|Other, not specified|8|||
28059849|NCT03823378|54715903|FG004|Overall Study|Other, not specified|17|||
28059850|NCT03823378|54715904|FG005|Overall Study|Other, not specified|7|||
28059851|NCT00142792|54715921|FG000|Overall Study|Death|0|||
28059852|NCT00142792|54715922|FG001|Overall Study|Death|0|||
28059853|NCT00142792|54715923|FG002|Overall Study|Death|1|||
28059854|NCT00142792|54715921|FG000|Overall Study|Withdrawal by Subject|3|||
28059855|NCT00142792|54715922|FG001|Overall Study|Withdrawal by Subject|2|||
28059856|NCT00142792|54715923|FG002|Overall Study|Withdrawal by Subject|3|||
28059857|NCT00142792|54715921|FG000|Overall Study|Lost to Follow-up|8|||
28059858|NCT00142792|54715922|FG001|Overall Study|Lost to Follow-up|11|||
28059859|NCT00142792|54715923|FG002|Overall Study|Lost to Follow-up|7|||
28059860|NCT00142792|54715921|FG000|Overall Study|No category|1|||
28059861|NCT00142792|54715922|FG001|Overall Study|No category|2|||
28059862|NCT00142792|54715923|FG002|Overall Study|No category|1|||
28059863|NCT00141778|54715934|FG000|Randomization Prior to Study Med|Withdrawal by Subject|5|||
28059864|NCT00141778|54715935|FG001|Randomization Prior to Study Med|Withdrawal by Subject|2|||
28059865|NCT00141778|54715936|FG002|Randomization Prior to Study Med|Withdrawal by Subject|6|||
28059866|NCT00141778|54715934|FG000|Started Study Medication|Met safety criteria for discontinuation|2|||
28059867|NCT00141778|54715935|FG001|Started Study Medication|Met safety criteria for discontinuation|4|||
28059868|NCT00141778|54715936|FG002|Started Study Medication|Met safety criteria for discontinuation|3|||
28059869|NCT00141778|54715934|FG000|Started Study Medication|Withdrawal by Subject|0|||
28059870|NCT00141778|54715935|FG001|Started Study Medication|Withdrawal by Subject|2|||
28059871|NCT00141778|54715936|FG002|Started Study Medication|Withdrawal by Subject|0|||
28059872|NCT00141778|54715934|FG000|Started Study Medication|Difficulty Swallowing|0|||
28059873|NCT00141778|54715935|FG001|Started Study Medication|Difficulty Swallowing|1|||
28059874|NCT00141778|54715936|FG002|Started Study Medication|Difficulty Swallowing|0|||
28059875|NCT00141778|54715934|FG000|Started Study Medication|Chest Discomfort|0|||
28059876|NCT00141778|54715935|FG001|Started Study Medication|Chest Discomfort|0|||
28059877|NCT00141778|54715936|FG002|Started Study Medication|Chest Discomfort|1|||
28059878|NCT00127660|54715948|FG000|Overall Study|Protocol Violation|3|||
28059879|NCT00127660|54715949|FG001|Overall Study|Protocol Violation|3|||
28059880|NCT00127660|54715950|FG002|Overall Study|Protocol Violation|5|||
28059881|NCT00127660|54715951|FG003|Overall Study|Protocol Violation|0|||
28059882|NCT03817528|54715961|FG000|Overall Study|Withdrawal by Subject|1|||
28059883|NCT03817528|54715961|FG000|Overall Study|Adverse Event|2|||
28059884|NCT00115336|54715967|FG000|Overall Study|Hospital discharge before study drug|0|||
28059885|NCT00115336|54715968|FG001|Overall Study|Hospital discharge before study drug|1|||
28059886|NCT00205803|54715978|FG000|Infant Series|Lost to Follow-up|10|||
28059887|NCT00205803|54715979|FG001|Infant Series|Lost to Follow-up|4|||
28059888|NCT00205803|54715978|FG000|Infant Series|Withdrawal by Subject|2|||
28059889|NCT00205803|54715979|FG001|Infant Series|Withdrawal by Subject|5|||
28059890|NCT00205803|54715978|FG000|Infant Series|Physician Decision|3|||
28059891|NCT00205803|54715979|FG001|Infant Series|Physician Decision|1|||
28059892|NCT00205803|54715978|FG000|Infant Series|Protocol Violation|1|||
28059893|NCT00205803|54715979|FG001|Infant Series|Protocol Violation|0|||
28059894|NCT00205803|54715978|FG000|Infant Series|Lost Kaiser coverage|0|||
28059895|NCT00205803|54715979|FG001|Infant Series|Lost Kaiser coverage|1|||
28059896|NCT00205803|54715978|FG000|Infant Series|Non-compliant|1|||
28059897|NCT00205803|54715979|FG001|Infant Series|Non-compliant|0|||
28059898|NCT00205803|54715978|FG000|Infant Series|Sponsor request|1|||
28059899|NCT00205803|54715979|FG001|Infant Series|Sponsor request|0|||
28059900|NCT00205803|54715978|FG000|After Infant Series|Adverse Event|1|||
28059901|NCT00205803|54715979|FG001|After Infant Series|Adverse Event|1|||
28059902|NCT00205803|54715978|FG000|After Infant Series|Protocol Violation|1|||
28059903|NCT00205803|54715979|FG001|After Infant Series|Protocol Violation|1|||
28059904|NCT00205803|54715978|FG000|After Infant Series|Lost to Follow-up|2|||
28059905|NCT00205803|54715979|FG001|After Infant Series|Lost to Follow-up|1|||
28059906|NCT00205803|54715978|FG000|After Infant Series|Physician Decision|3|||
28059907|NCT00205803|54715979|FG001|After Infant Series|Physician Decision|2|||
28059908|NCT00205803|54715978|FG000|After Infant Series|Withdrawal by Subject|1|||
28059909|NCT00205803|54715979|FG001|After Infant Series|Withdrawal by Subject|4|||
28059910|NCT00205803|54715978|FG000|After Infant Series|Other|10|||
28059911|NCT00205803|54715979|FG001|After Infant Series|Other|4|||
28059912|NCT00205803|54715978|FG000|Toddler Dose|Lost to Follow-up|2|||
28059913|NCT00205803|54715979|FG001|Toddler Dose|Lost to Follow-up|3|||
28059914|NCT00127192|54716008|FG000|Overall Study|Adverse Event|0|||
28059915|NCT00127192|54716009|FG001|Overall Study|Adverse Event|1|||
28059916|NCT00127192|54716010|FG002|Overall Study|Adverse Event|1|||
28059917|NCT00127192|54716011|FG003|Overall Study|Adverse Event|1|||
28059918|NCT00127192|54716012|FG004|Overall Study|Adverse Event|0|||
28059919|NCT00127192|54716008|FG000|Overall Study|Lack of Efficacy|2|||
28059920|NCT00127192|54716009|FG001|Overall Study|Lack of Efficacy|0|||
28059921|NCT00127192|54716010|FG002|Overall Study|Lack of Efficacy|0|||
28059922|NCT00127192|54716011|FG003|Overall Study|Lack of Efficacy|0|||
28059923|NCT00127192|54716012|FG004|Overall Study|Lack of Efficacy|2|||
28059924|NCT00127192|54716008|FG000|Overall Study|Withdrawal by Subject|0|||
28059925|NCT00127192|54716009|FG001|Overall Study|Withdrawal by Subject|0|||
28059926|NCT00127192|54716010|FG002|Overall Study|Withdrawal by Subject|1|||
28059927|NCT00127192|54716011|FG003|Overall Study|Withdrawal by Subject|0|||
28059928|NCT00127192|54716012|FG004|Overall Study|Withdrawal by Subject|3|||
28059929|NCT00127192|54716008|FG000|Overall Study|Adverse event in pre-treatment period|1|||
28059930|NCT00127192|54716009|FG001|Overall Study|Adverse event in pre-treatment period|0|||
28059931|NCT00127192|54716010|FG002|Overall Study|Adverse event in pre-treatment period|0|||
28059932|NCT00127192|54716011|FG003|Overall Study|Adverse event in pre-treatment period|0|||
28059933|NCT00127192|54716012|FG004|Overall Study|Adverse event in pre-treatment period|0|||
28059934|NCT00205179|54716026|FG000|Overall Study|Death|0|||
28059935|NCT00205179|54716027|FG001|Overall Study|Death|2|||
28059936|NCT00205179|54716026|FG000|Overall Study|Physician Decision|1|||
28059937|NCT00205179|54716027|FG001|Overall Study|Physician Decision|1|||
28059938|NCT00205179|54716026|FG000|Overall Study|Adverse Event|1|||
28059939|NCT00205179|54716027|FG001|Overall Study|Adverse Event|1|||
28059940|NCT00127036|54716036|FG000|Overall Study|Insufficient Data for Analysis|6|||
28059941|NCT00127036|54716037|FG001|Overall Study|Insufficient Data for Analysis|11|||
28059942|NCT00127036|54716036|FG000|Overall Study|Screen Failure|2|||
28059943|NCT00127036|54716037|FG001|Overall Study|Screen Failure|0|||
28059944|NCT00259857|54716045|FG000|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1|||
28059945|NCT00259857|54716046|FG001|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2|||
28059946|NCT00259857|54716045|FG000|24 Months Treatment|Lost to Follow-up|0|||
28059947|NCT00259857|54716046|FG001|24 Months Treatment|Lost to Follow-up|3|||
28059948|NCT00203307|54716054|FG000|First Intervention|Adverse Event|2|||
28059949|NCT00203307|54716055|FG001|First Intervention|Adverse Event|0|||
28059950|NCT00126568|54716061|FG000|Overall Study|Death|2|||
28059951|NCT00114634|54716066|FG000|Overall Study|failure to return forms|3|||
28059952|NCT00202839|54716074|FG000|Overall Study|Adverse Event|1|||
28059953|NCT00202839|54716075|FG001|Overall Study|Adverse Event|5|||
28059954|NCT00202839|54716074|FG000|Overall Study|Physician Decision|12|||
28059955|NCT00202839|54716075|FG001|Overall Study|Physician Decision|0|||
28059956|NCT00202839|54716074|FG000|Overall Study|Withdrawal by Subject|6|||
28059957|NCT00202839|54716075|FG001|Overall Study|Withdrawal by Subject|2|||
28059958|NCT00202839|54716074|FG000|Overall Study|Protocol Violation|2|||
28059959|NCT00202839|54716075|FG001|Overall Study|Protocol Violation|1|||
28059960|NCT00202839|54716074|FG000|Overall Study|Lost to Follow-up|3|||
28059961|NCT00202839|54716075|FG001|Overall Study|Lost to Follow-up|2|||
28059962|NCT00201201|54716083|FG000|Overall Study|Death|0|||
28059963|NCT00201201|54716084|FG001|Overall Study|Death|2|||
28059964|NCT00201201|54716083|FG000|Overall Study|Withdrawal by Subject|5|||
28059965|NCT00201201|54716084|FG001|Overall Study|Withdrawal by Subject|5|||
28059966|NCT00126490|54716090|FG000|Overall Study|Stopped after 1 infusion (fall/injury)|1|||
28059967|NCT00346632|54716096|FG000|Overall Study|Progressive Disease|2|||
28059968|NCT00346632|54716097|FG001|Overall Study|Progressive Disease|2|||
28059969|NCT00346632|54716098|FG002|Overall Study|Progressive Disease|4|||
28059970|NCT00346632|54716099|FG003|Overall Study|Progressive Disease|3|||
28059971|NCT00346632|54716100|FG004|Overall Study|Progressive Disease|3|||
28059972|NCT00346632|54716101|FG005|Overall Study|Progressive Disease|1|||
28059973|NCT00346632|54716102|FG006|Overall Study|Progressive Disease|2|||
28059974|NCT00346632|54716103|FG007|Overall Study|Progressive Disease|2|||
28059975|NCT00346632|54716104|FG008|Overall Study|Progressive Disease|2|||
28059976|NCT00346632|54716105|FG009|Overall Study|Progressive Disease|2|||
28059977|NCT00346632|54716096|FG000|Overall Study|Adverse Event|0|||
28059978|NCT00346632|54716097|FG001|Overall Study|Adverse Event|0|||
28059979|NCT00346632|54716098|FG002|Overall Study|Adverse Event|0|||
28059980|NCT00346632|54716099|FG003|Overall Study|Adverse Event|0|||
28059981|NCT00346632|54716100|FG004|Overall Study|Adverse Event|1|||
28059982|NCT00346632|54716101|FG005|Overall Study|Adverse Event|1|||
28059983|NCT00346632|54716102|FG006|Overall Study|Adverse Event|1|||
28059984|NCT00346632|54716103|FG007|Overall Study|Adverse Event|0|||
28059985|NCT00346632|54716104|FG008|Overall Study|Adverse Event|0|||
28059986|NCT00346632|54716105|FG009|Overall Study|Adverse Event|0|||
28059987|NCT00346632|54716096|FG000|Overall Study|Death|0|||
28059988|NCT00346632|54716097|FG001|Overall Study|Death|0|||
28059989|NCT00346632|54716098|FG002|Overall Study|Death|1|||
28059990|NCT00346632|54716099|FG003|Overall Study|Death|0|||
28059991|NCT00346632|54716100|FG004|Overall Study|Death|0|||
28059992|NCT00346632|54716101|FG005|Overall Study|Death|0|||
28059993|NCT00346632|54716102|FG006|Overall Study|Death|0|||
28059994|NCT00346632|54716103|FG007|Overall Study|Death|0|||
28059995|NCT00346632|54716104|FG008|Overall Study|Death|0|||
28059996|NCT00346632|54716105|FG009|Overall Study|Death|0|||
28059997|NCT00346632|54716096|FG000|Overall Study|Protocol Violation|0|||
28059998|NCT00346632|54716097|FG001|Overall Study|Protocol Violation|0|||
28059999|NCT00346632|54716098|FG002|Overall Study|Protocol Violation|0|||
28060000|NCT00346632|54716099|FG003|Overall Study|Protocol Violation|0|||
28060001|NCT00346632|54716100|FG004|Overall Study|Protocol Violation|0|||
28060002|NCT00346632|54716101|FG005|Overall Study|Protocol Violation|0|||
28060003|NCT00346632|54716102|FG006|Overall Study|Protocol Violation|1|||
28060004|NCT00346632|54716103|FG007|Overall Study|Protocol Violation|0|||
28060005|NCT00346632|54716104|FG008|Overall Study|Protocol Violation|0|||
28060006|NCT00346632|54716105|FG009|Overall Study|Protocol Violation|0|||
28060007|NCT00346632|54716096|FG000|Overall Study|Withdrawal by Subject|0|||
28060008|NCT00346632|54716097|FG001|Overall Study|Withdrawal by Subject|0|||
28060009|NCT00346632|54716098|FG002|Overall Study|Withdrawal by Subject|0|||
28060010|NCT00346632|54716099|FG003|Overall Study|Withdrawal by Subject|0|||
28060011|NCT00346632|54716100|FG004|Overall Study|Withdrawal by Subject|0|||
28060012|NCT00346632|54716101|FG005|Overall Study|Withdrawal by Subject|0|||
28060013|NCT00346632|54716102|FG006|Overall Study|Withdrawal by Subject|1|||
28060014|NCT00346632|54716103|FG007|Overall Study|Withdrawal by Subject|0|||
28060015|NCT00346632|54716104|FG008|Overall Study|Withdrawal by Subject|0|||
28060016|NCT00346632|54716105|FG009|Overall Study|Withdrawal by Subject|0|||
28060017|NCT00346632|54716096|FG000|Overall Study|Switched to alternative treatment|0|||
28060018|NCT00346632|54716097|FG001|Overall Study|Switched to alternative treatment|0|||
28060019|NCT00346632|54716098|FG002|Overall Study|Switched to alternative treatment|1|||
28060020|NCT00346632|54716099|FG003|Overall Study|Switched to alternative treatment|0|||
28060021|NCT00346632|54716100|FG004|Overall Study|Switched to alternative treatment|0|||
28060022|NCT00346632|54716101|FG005|Overall Study|Switched to alternative treatment|0|||
28060023|NCT00346632|54716102|FG006|Overall Study|Switched to alternative treatment|0|||
28060024|NCT00346632|54716103|FG007|Overall Study|Switched to alternative treatment|0|||
28060025|NCT00346632|54716104|FG008|Overall Study|Switched to alternative treatment|0|||
28060026|NCT00346632|54716105|FG009|Overall Study|Switched to alternative treatment|0|||
28060027|NCT00346632|54716096|FG000|Overall Study|Not Stated|1|||
28060028|NCT00346632|54716097|FG001|Overall Study|Not Stated|1|||
28060029|NCT00346632|54716098|FG002|Overall Study|Not Stated|0|||
28060030|NCT00346632|54716099|FG003|Overall Study|Not Stated|0|||
28060031|NCT00346632|54716100|FG004|Overall Study|Not Stated|0|||
28060032|NCT00346632|54716101|FG005|Overall Study|Not Stated|0|||
28060033|NCT00346632|54716102|FG006|Overall Study|Not Stated|0|||
28060034|NCT00346632|54716103|FG007|Overall Study|Not Stated|2|||
28060035|NCT00346632|54716104|FG008|Overall Study|Not Stated|2|||
28060036|NCT00346632|54716105|FG009|Overall Study|Not Stated|1|||
28060037|NCT00200967|54716169|FG000|First Treatment Period|Withdrawal by Subject|5|||
28060038|NCT00200967|54716170|FG001|First Treatment Period|Withdrawal by Subject|1|||
28060039|NCT00200967|54716169|FG000|First Treatment Period|Pregnancy|1|||
28060040|NCT00200967|54716170|FG001|First Treatment Period|Pregnancy|0|||
28060041|NCT00200967|54716169|FG000|Wash-out Period|Lost to Follow-up|0|||
28060042|NCT00200967|54716170|FG001|Wash-out Period|Lost to Follow-up|1|||
28060043|NCT00200967|54716169|FG000|Second Treatment Period|Withdrawal by Subject|1|||
28060044|NCT00200967|54716170|FG001|Second Treatment Period|Withdrawal by Subject|2|||
28060045|NCT00200967|54716169|FG000|Run-out Period|Lost to Follow-up|1|||
28060046|NCT00200967|54716170|FG001|Run-out Period|Lost to Follow-up|0|||
27814780|NCT01572909|54271474|FG001|Overall Study|Infarct, comorbidity, Pt refusal of exam|3|||
27814781|NCT01572675|54271484|FG000|Overall Study|End of prescribed treatment|140|||
27814782|NCT01572675|54271485|FG001|Overall Study|End of prescribed treatment|118|||
28060047|NCT00354432|54716180|FG000|Overall Study|Adverse Event|3|||
27814783|NCT01572675|54271484|FG000|Overall Study|Recovery|16|||
28060048|NCT00354432|54716181|FG001|Overall Study|Adverse Event|1|||
27814784|NCT01572675|54271485|FG001|Overall Study|Recovery|23|||
27814785|NCT01572675|54271484|FG000|Overall Study|Lack of Efficacy|31|||
27814786|NCT01572675|54271485|FG001|Overall Study|Lack of Efficacy|31|||
28060049|NCT00354432|54716182|FG002|Overall Study|Adverse Event|5|||
28060050|NCT00354432|54716183|FG003|Overall Study|Adverse Event|5|||
28060051|NCT00354432|54716180|FG000|Overall Study|Off/Toxicity|3|||
28060052|NCT00354432|54716181|FG001|Overall Study|Off/Toxicity|7|||
28060053|NCT00354432|54716182|FG002|Overall Study|Off/Toxicity|5|||
28060054|NCT00354432|54716183|FG003|Overall Study|Off/Toxicity|5|||
28060055|NCT00140140|54716196|FG000|Overall Study|Unacceptable toxicity|1|||
28060056|NCT00140140|54716197|FG001|Overall Study|Unacceptable toxicity|1|||
28060057|NCT00140140|54716198|FG002|Overall Study|Unacceptable toxicity|2|||
28060058|NCT00140140|54716196|FG000|Overall Study|Physician Decision|1|||
28060059|NCT00140140|54716197|FG001|Overall Study|Physician Decision|1|||
28060060|NCT00140140|54716198|FG002|Overall Study|Physician Decision|0|||
28060061|NCT00346398|54716207|FG000|Overall Study|Lost to Follow-up|3|||
28060062|NCT00346398|54716208|FG001|Overall Study|Lost to Follow-up|0|||
28060063|NCT00346398|54716207|FG000|Overall Study|Withdrawal by Subject|0|||
28060064|NCT00346398|54716208|FG001|Overall Study|Withdrawal by Subject|2|||
28060065|NCT00346164|54716218|FG000|Overall Study|Adverse Event|0|||
28060066|NCT00346164|54716219|FG001|Overall Study|Adverse Event|0|||
28060067|NCT00346164|54716220|FG002|Overall Study|Adverse Event|0|||
28060068|NCT00346164|54716221|FG003|Overall Study|Adverse Event|1|||
28060069|NCT00346164|54716218|FG000|Overall Study|Lack of Efficacy|0|||
28060070|NCT00346164|54716219|FG001|Overall Study|Lack of Efficacy|1|||
28060071|NCT00346164|54716220|FG002|Overall Study|Lack of Efficacy|7|||
28060072|NCT00346164|54716221|FG003|Overall Study|Lack of Efficacy|25|||
28060073|NCT00346164|54716218|FG000|Overall Study|Physician Decision|0|||
28060074|NCT00346164|54716219|FG001|Overall Study|Physician Decision|1|||
28060075|NCT00346164|54716220|FG002|Overall Study|Physician Decision|2|||
28060076|NCT00346164|54716221|FG003|Overall Study|Physician Decision|27|||
28060077|NCT00346164|54716218|FG000|Overall Study|Protocol Violation|6|||
28060078|NCT00346164|54716219|FG001|Overall Study|Protocol Violation|2|||
27814787|NCT01572675|54271484|FG000|Overall Study|Intolerance|6|||
27814788|NCT01572675|54271485|FG001|Overall Study|Intolerance|5|||
27814789|NCT01572675|54271484|FG000|Overall Study|Improved symptoms|8|||
27814790|NCT01572675|54271485|FG001|Overall Study|Improved symptoms|2|||
27814791|NCT01572675|54271484|FG000|Overall Study|Surgical intervention|3|||
27814792|NCT01572675|54271485|FG001|Overall Study|Surgical intervention|6|||
27814793|NCT01572675|54271484|FG000|Overall Study|Withdrawal by Subject|5|||
28060079|NCT00346164|54716220|FG002|Overall Study|Protocol Violation|10|||
27814794|NCT01572675|54271485|FG001|Overall Study|Withdrawal by Subject|1|||
27814795|NCT01572675|54271484|FG000|Overall Study|Physician Decision|2|||
27814796|NCT01572675|54271485|FG001|Overall Study|Physician Decision|2|||
28060080|NCT00346164|54716221|FG003|Overall Study|Protocol Violation|4|||
28060081|NCT00346164|54716218|FG000|Overall Study|Withdrawal by Subject|0|||
28060082|NCT00346164|54716219|FG001|Overall Study|Withdrawal by Subject|0|||
28060083|NCT00346164|54716220|FG002|Overall Study|Withdrawal by Subject|2|||
28060084|NCT00346164|54716221|FG003|Overall Study|Withdrawal by Subject|0|||
28060085|NCT00346164|54716218|FG000|Overall Study|Ineligible|11|||
28060086|NCT00346164|54716219|FG001|Overall Study|Ineligible|2|||
28060087|NCT00346164|54716220|FG002|Overall Study|Ineligible|2|||
28060088|NCT00346164|54716221|FG003|Overall Study|Ineligible|23|||
28060089|NCT00346164|54716218|FG000|Overall Study|Refusal of further protocol therapy|0|||
28060090|NCT00346164|54716219|FG001|Overall Study|Refusal of further protocol therapy|1|||
28060091|NCT00346164|54716220|FG002|Overall Study|Refusal of further protocol therapy|3|||
28060092|NCT00346164|54716221|FG003|Overall Study|Refusal of further protocol therapy|15|||
28060093|NCT00346164|54716218|FG000|Overall Study|Inability to start week 16 tx on time|0|||
28060094|NCT00346164|54716219|FG001|Overall Study|Inability to start week 16 tx on time|0|||
28060095|NCT00346164|54716220|FG002|Overall Study|Inability to start week 16 tx on time|0|||
28060096|NCT00346164|54716221|FG003|Overall Study|Inability to start week 16 tx on time|11|||
28060097|NCT00114244|54716249|FG000|Overall Study|Adverse Event|2|||
28060098|NCT00114244|54716250|FG001|Overall Study|Adverse Event|5|||
28060099|NCT00114244|54716249|FG000|Overall Study|Withdrawal by Subject|0|||
28060100|NCT00114244|54716250|FG001|Overall Study|Withdrawal by Subject|2|||
28060101|NCT00138658|54716256|FG000|Overall Study|Adverse Event|23|||
28060102|NCT00138658|54716256|FG000|Overall Study|Death|1|||
28060103|NCT00138658|54716256|FG000|Overall Study|Disease Progression|21|||
28060104|NCT00138658|54716256|FG000|Overall Study|Physician Decision|11|||
28060105|NCT00138658|54716256|FG000|Overall Study|Withdrawal by Subject|5|||
28060106|NCT00337662|54716265|FG000|Study Period II|Lost to Follow-up|0|||
28060107|NCT00337662|54716266|FG001|Study Period II|Lost to Follow-up|0|||
27814797|NCT01572675|54271484|FG000|Overall Study|Death unrelated to coxibs|1|||
27814798|NCT01572675|54271485|FG001|Overall Study|Death unrelated to coxibs|1|||
28060108|NCT00337662|54716267|FG002|Study Period II|Lost to Follow-up|0|||
28060109|NCT00337662|54716268|FG003|Study Period II|Lost to Follow-up|35|||
28060110|NCT00337662|54716265|FG000|Study Period II|Withdrawal by Subject|0|||
28060111|NCT00337662|54716266|FG001|Study Period II|Withdrawal by Subject|0|||
28060112|NCT00337662|54716267|FG002|Study Period II|Withdrawal by Subject|0|||
28060113|NCT00337662|54716268|FG003|Study Period II|Withdrawal by Subject|20|||
28060114|NCT00337662|54716265|FG000|Study Period II|Adverse Event|0|||
28060115|NCT00337662|54716266|FG001|Study Period II|Adverse Event|0|||
27814799|NCT01572675|54271484|FG000|Overall Study|Other disease detected|1|||
28060116|NCT00337662|54716267|FG002|Study Period II|Adverse Event|0|||
28060117|NCT00337662|54716268|FG003|Study Period II|Adverse Event|16|||
28060118|NCT00337662|54716265|FG000|Study Period II|Physician Decision|0|||
28060119|NCT00337662|54716266|FG001|Study Period II|Physician Decision|0|||
28060120|NCT00337662|54716267|FG002|Study Period II|Physician Decision|0|||
28060121|NCT00337662|54716268|FG003|Study Period II|Physician Decision|13|||
28060122|NCT00337662|54716265|FG000|Study Period II|Entry Criteria Not Met|0|||
28060123|NCT00337662|54716266|FG001|Study Period II|Entry Criteria Not Met|0|||
28060124|NCT00337662|54716267|FG002|Study Period II|Entry Criteria Not Met|0|||
28060125|NCT00337662|54716268|FG003|Study Period II|Entry Criteria Not Met|6|||
28060126|NCT00337662|54716265|FG000|Study Period II|Protocol Violation|0|||
28060127|NCT00337662|54716266|FG001|Study Period II|Protocol Violation|0|||
28060128|NCT00337662|54716267|FG002|Study Period II|Protocol Violation|0|||
28060129|NCT00337662|54716268|FG003|Study Period II|Protocol Violation|6|||
28060130|NCT00337662|54716265|FG000|Study Period II|Lack of Efficacy|0|||
28060131|NCT00337662|54716266|FG001|Study Period II|Lack of Efficacy|0|||
28060132|NCT00337662|54716267|FG002|Study Period II|Lack of Efficacy|0|||
28060133|NCT00337662|54716268|FG003|Study Period II|Lack of Efficacy|7|||
28060134|NCT00337662|54716265|FG000|Study Period II|Sponsor Decision|0|||
28060135|NCT00337662|54716266|FG001|Study Period II|Sponsor Decision|0|||
28060136|NCT00337662|54716267|FG002|Study Period II|Sponsor Decision|0|||
28060137|NCT00337662|54716268|FG003|Study Period II|Sponsor Decision|2|||
28060138|NCT00337662|54716265|FG000|Study Period II|Parent/Caregiver Decision|0|||
28060139|NCT00337662|54716266|FG001|Study Period II|Parent/Caregiver Decision|0|||
28060140|NCT00337662|54716267|FG002|Study Period II|Parent/Caregiver Decision|0|||
28060141|NCT00337662|54716268|FG003|Study Period II|Parent/Caregiver Decision|1|||
28060142|NCT00337662|54716265|FG000|Study Period III|Lost to Follow-up|14|||
28060143|NCT00337662|54716266|FG001|Study Period III|Lost to Follow-up|16|||
28060144|NCT00337662|54716267|FG002|Study Period III|Lost to Follow-up|14|||
28060145|NCT00337662|54716268|FG003|Study Period III|Lost to Follow-up|0|||
28060146|NCT00337662|54716265|FG000|Study Period III|Withdrawal by Subject|18|||
28060147|NCT00337662|54716266|FG001|Study Period III|Withdrawal by Subject|14|||
28060148|NCT00337662|54716267|FG002|Study Period III|Withdrawal by Subject|12|||
28060149|NCT00337662|54716268|FG003|Study Period III|Withdrawal by Subject|0|||
28060150|NCT00337662|54716265|FG000|Study Period III|Adverse Event|9|||
28060151|NCT00337662|54716266|FG001|Study Period III|Adverse Event|10|||
28060152|NCT00337662|54716267|FG002|Study Period III|Adverse Event|8|||
28060153|NCT00337662|54716268|FG003|Study Period III|Adverse Event|0|||
28060154|NCT00337662|54716265|FG000|Study Period III|Protocol Violation|3|||
28060155|NCT00337662|54716266|FG001|Study Period III|Protocol Violation|8|||
28060156|NCT00337662|54716267|FG002|Study Period III|Protocol Violation|2|||
28060157|NCT00337662|54716268|FG003|Study Period III|Protocol Violation|0|||
28060158|NCT00337662|54716265|FG000|Study Period III|Physician Decision|6|||
28060159|NCT00337662|54716266|FG001|Study Period III|Physician Decision|5|||
28060160|NCT00337662|54716267|FG002|Study Period III|Physician Decision|0|||
28060161|NCT00337662|54716268|FG003|Study Period III|Physician Decision|0|||
28060162|NCT00337662|54716265|FG000|Study Period III|Entry Criteria Not Met|4|||
28060163|NCT00337662|54716266|FG001|Study Period III|Entry Criteria Not Met|1|||
28060164|NCT00337662|54716267|FG002|Study Period III|Entry Criteria Not Met|3|||
28060165|NCT00337662|54716268|FG003|Study Period III|Entry Criteria Not Met|0|||
28060166|NCT00337662|54716265|FG000|Study Period III|Lack of Efficacy|4|||
28060167|NCT00337662|54716266|FG001|Study Period III|Lack of Efficacy|4|||
28060168|NCT00337662|54716267|FG002|Study Period III|Lack of Efficacy|2|||
28060169|NCT00337662|54716268|FG003|Study Period III|Lack of Efficacy|0|||
28060170|NCT00337662|54716265|FG000|Study Period III|Parent/Caregiver Decision|0|||
28060171|NCT00337662|54716266|FG001|Study Period III|Parent/Caregiver Decision|0|||
28060172|NCT00337662|54716267|FG002|Study Period III|Parent/Caregiver Decision|2|||
28060173|NCT00337662|54716268|FG003|Study Period III|Parent/Caregiver Decision|0|||
28060174|NCT00337662|54716265|FG000|Study Period III|Sponsor Decision|1|||
28060175|NCT00337662|54716266|FG001|Study Period III|Sponsor Decision|0|||
28060176|NCT00337662|54716267|FG002|Study Period III|Sponsor Decision|1|||
28060177|NCT00337662|54716268|FG003|Study Period III|Sponsor Decision|0|||
28060178|NCT00337662|54716265|FG000|Study Period III|Clinical Relapse|1|||
28060179|NCT00337662|54716266|FG001|Study Period III|Clinical Relapse|0|||
28060180|NCT00337662|54716267|FG002|Study Period III|Clinical Relapse|0|||
28060181|NCT00337662|54716268|FG003|Study Period III|Clinical Relapse|0|||
28060182|NCT00138424|54716283|FG000|Overall Study|Physician Decision|0|||
28060183|NCT00138424|54716284|FG001|Overall Study|Physician Decision|1|||
28060184|NCT00138424|54716285|FG002|Overall Study|Physician Decision|0|||
28060185|NCT00138424|54716286|FG003|Overall Study|Physician Decision|0|||
28060186|NCT00368966|54716300|FG000|Infant Series|Withdrawal by Subject|11|||
28060187|NCT00368966|54716301|FG001|Infant Series|Withdrawal by Subject|6|||
28060188|NCT00368966|54716300|FG000|Infant Series|Protocol Violation|2|||
28060189|NCT00368966|54716301|FG001|Infant Series|Protocol Violation|1|||
28060190|NCT00368966|54716300|FG000|Infant Series|Lost to Follow-up|2|||
28060191|NCT00368966|54716301|FG001|Infant Series|Lost to Follow-up|0|||
28060192|NCT00368966|54716300|FG000|Infant Series|Randomization error|0|||
28060193|NCT00368966|54716301|FG001|Infant Series|Randomization error|1|||
28060194|NCT00368966|54716300|FG000|Infant Series|Failed to meet eligibility criteria|0|||
28060195|NCT00368966|54716301|FG001|Infant Series|Failed to meet eligibility criteria|1|||
28060196|NCT00368966|54716300|FG000|Infant Series|Adverse Event|0|||
28060197|NCT00368966|54716301|FG001|Infant Series|Adverse Event|1|||
28060198|NCT00368966|54716300|FG000|Infant Series|Failed to return|1|||
28060199|NCT00368966|54716301|FG001|Infant Series|Failed to return|0|||
28060200|NCT00368966|54716300|FG000|After Infant|Failed to return|3|||
28060201|NCT00368966|54716301|FG001|After Infant|Failed to return|1|||
28060202|NCT00368966|54716300|FG000|After Infant|Adverse Event|1|||
28060203|NCT00368966|54716301|FG001|After Infant|Adverse Event|2|||
28060204|NCT00368966|54716300|FG000|After Infant|Withdrawal by Subject|1|||
28060205|NCT00368966|54716301|FG001|After Infant|Withdrawal by Subject|1|||
28060206|NCT00368966|54716300|FG000|After Infant|Death|1|||
28060207|NCT00368966|54716301|FG001|After Infant|Death|0|||
28060208|NCT00368966|54716300|FG000|After Infant|Lost to Follow-up|0|||
28060209|NCT00368966|54716301|FG001|After Infant|Lost to Follow-up|1|||
28060210|NCT00368966|54716300|FG000|Toddler Dose|Withdrawal by Subject|1|||
28060211|NCT00368966|54716301|FG001|Toddler Dose|Withdrawal by Subject|1|||
28060212|NCT00368966|54716300|FG000|Toddler Dose|Lost to Follow-up|0|||
28060213|NCT00368966|54716301|FG001|Toddler Dose|Lost to Follow-up|2|||
28060214|NCT00114166|54716334|FG000|Overall Study|Wrong primary|0|||
28060215|NCT00114166|54716335|FG001|Overall Study|Wrong primary|1|||
28060216|NCT00125242|54716345|FG000|Overall Study|did not qualify|7|||
28060217|NCT00125242|54716346|FG001|Overall Study|did not qualify|2|||
28060218|NCT00337428|54716353|FG000|Overall Study|Withdrawal by Subject|1|||
28060219|NCT00337428|54716354|FG001|Overall Study|Withdrawal by Subject|2|||
28060220|NCT00337428|54716353|FG000|Overall Study|Lack of Time|1|||
28060221|NCT00337428|54716354|FG001|Overall Study|Lack of Time|1|||
28060222|NCT00337428|54716353|FG000|Overall Study|Unwilling to Continue|1|||
28060223|NCT00337428|54716354|FG001|Overall Study|Unwilling to Continue|0|||
28060224|NCT00337428|54716353|FG000|Overall Study|Anorexia|1|||
28060225|NCT00337428|54716354|FG001|Overall Study|Anorexia|0|||
28060226|NCT00235989|54716364|FG000|Core Treatment Period (CT)|Lost to Follow-up|0|||
28060227|NCT00235989|54716365|FG001|Core Treatment Period (CT)|Lost to Follow-up|0|||
28060228|NCT00235989|54716366|FG002|Core Treatment Period (CT)|Lost to Follow-up|0|||
27814800|NCT01572675|54271485|FG001|Overall Study|Other disease detected|1|||
27814801|NCT01572675|54271484|FG000|Overall Study|Unknown reason|1|||
27814802|NCT01572675|54271485|FG001|Overall Study|Unknown reason|1|||
27814803|NCT01572675|54271484|FG000|Overall Study|Rheumatologist new evaluation|0|||
28060229|NCT00235989|54716367|FG003|Core Treatment Period (CT)|Lost to Follow-up|0|||
28060230|NCT00235989|54716368|FG004|Core Treatment Period (CT)|Lost to Follow-up|0|||
28060231|NCT00235989|54716369|FG005|Core Treatment Period (CT)|Lost to Follow-up|2|||
28060232|NCT00235989|54716364|FG000|Extension Treatment Period (ET)|Adverse Event|3|||
28060233|NCT00235989|54716365|FG001|Extension Treatment Period (ET)|Adverse Event|0|||
28060234|NCT00235989|54716366|FG002|Extension Treatment Period (ET)|Adverse Event|2|||
28060235|NCT00235989|54716367|FG003|Extension Treatment Period (ET)|Adverse Event|0|||
28060236|NCT00235989|54716368|FG004|Extension Treatment Period (ET)|Adverse Event|0|||
27814804|NCT01572675|54271485|FG001|Overall Study|Rheumatologist new evaluation|1|||
27814805|NCT01572675|54271484|FG000|Overall Study|Missing data|1|||
27814806|NCT01572675|54271485|FG001|Overall Study|Missing data|4|||
27814807|NCT01572675|54271484|FG000|Overall Study|Lost to Follow-up|22|||
28060237|NCT00235989|54716369|FG005|Extension Treatment Period (ET)|Adverse Event|0|||
28060238|NCT00235989|54716364|FG000|Extension Treatment Period (ET)|Lost to Follow-up|2|||
28060239|NCT00235989|54716365|FG001|Extension Treatment Period (ET)|Lost to Follow-up|0|||
28060240|NCT00235989|54716366|FG002|Extension Treatment Period (ET)|Lost to Follow-up|1|||
28060241|NCT00235989|54716367|FG003|Extension Treatment Period (ET)|Lost to Follow-up|0|||
28060242|NCT00235989|54716368|FG004|Extension Treatment Period (ET)|Lost to Follow-up|0|||
28060243|NCT00235989|54716369|FG005|Extension Treatment Period (ET)|Lost to Follow-up|0|||
28060244|NCT00235989|54716364|FG000|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
28060245|NCT00235989|54716365|FG001|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
28060246|NCT00235989|54716366|FG002|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
28060247|NCT00235989|54716367|FG003|Extension Treatment Period (ET)|Withdrawal by Subject|4|||
28060248|NCT00235989|54716368|FG004|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
28060249|NCT00235989|54716369|FG005|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
28060250|NCT00235989|54716364|FG000|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
28060251|NCT00235989|54716365|FG001|Extension Treatment Period (ET)|´Other´ not further itemized|3|||
28060252|NCT00235989|54716366|FG002|Extension Treatment Period (ET)|´Other´ not further itemized|1|||
28060253|NCT00235989|54716367|FG003|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
28060254|NCT00235989|54716368|FG004|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
28060255|NCT00235989|54716369|FG005|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
28060256|NCT00113386|54716381|FG000|Overall Study|Withdrawal by Subject|1|||
28060257|NCT00113386|54716382|FG001|Overall Study|Withdrawal by Subject|0|||
28060258|NCT00113386|54716381|FG000|Overall Study|Physician Decision|0|||
28060259|NCT00113386|54716382|FG001|Overall Study|Physician Decision|1|||
28060260|NCT00113386|54716381|FG000|Overall Study|Toxicity|3|||
28060261|NCT00113386|54716382|FG001|Overall Study|Toxicity|0|||
28060262|NCT00113386|54716381|FG000|Overall Study|Ineligible|1|||
28060263|NCT00113386|54716382|FG001|Overall Study|Ineligible|2|||
28060264|NCT00113386|54716381|FG000|Overall Study|Unknown - Lost to Follow-Up|2|||
28060265|NCT00113386|54716382|FG001|Overall Study|Unknown - Lost to Follow-Up|1|||
28060266|NCT00353262|54716388|FG000|Overall Study|Adverse Event|8|||
28060267|NCT00353262|54716388|FG000|Overall Study|Withdrawal by Subject|2|||
28060268|NCT00353262|54716388|FG000|Overall Study|Insufficient Therapeutic Response|13|||
28060269|NCT00353262|54716388|FG000|Overall Study|Progression|1|||
28060270|NCT00353262|54716388|FG000|Overall Study|Surgery|4|||
28060271|NCT00353262|54716388|FG000|Overall Study|Break from Chemotherapy|1|||
28060272|NCT00337272|54716394|FG000|Screening Period (Pre-randomization)|Withdrawal by Subject|2|||
28060273|NCT00337272|54716395|FG001|Screening Period (Pre-randomization)|Withdrawal by Subject|0|||
28060274|NCT00337272|54716394|FG000|Screening Period (Pre-randomization)|Non-compliance|1|||
28060275|NCT00337272|54716395|FG001|Screening Period (Pre-randomization)|Non-compliance|0|||
28060276|NCT00337272|54716394|FG000|Screening Period (Pre-randomization)|Screen failure|3|||
28060277|NCT00337272|54716395|FG001|Screening Period (Pre-randomization)|Screen failure|0|||
28060278|NCT00337272|54716394|FG000|Treatment Period|Non-compliance|1|||
28060279|NCT00337272|54716395|FG001|Treatment Period|Non-compliance|1|||
28060280|NCT00337272|54716394|FG000|Treatment Period|Withdrawal by Subject|0|||
28060281|NCT00337272|54716395|FG001|Treatment Period|Withdrawal by Subject|1|||
28060282|NCT00337272|54716394|FG000|Withdrawal Period|Non-compliance|0|||
28060283|NCT00337272|54716395|FG001|Withdrawal Period|Non-compliance|1|||
28060284|NCT00125164|54716405|FG000|Overall Study|Adverse Event|0|||
28060285|NCT00125164|54716406|FG001|Overall Study|Adverse Event|0|||
28060286|NCT00125164|54716407|FG002|Overall Study|Adverse Event|2|||
28060287|NCT00125164|54716408|FG003|Overall Study|Adverse Event|4|||
28060288|NCT00125164|54716405|FG000|Overall Study|Lost to Follow-up|0|||
28060289|NCT00125164|54716406|FG001|Overall Study|Lost to Follow-up|0|||
28060290|NCT00125164|54716407|FG002|Overall Study|Lost to Follow-up|1|||
28060291|NCT00125164|54716408|FG003|Overall Study|Lost to Follow-up|1|||
28060292|NCT00125164|54716405|FG000|Overall Study|Withdrawal by Subject|2|||
28060293|NCT00125164|54716406|FG001|Overall Study|Withdrawal by Subject|0|||
28060294|NCT00125164|54716407|FG002|Overall Study|Withdrawal by Subject|1|||
28060295|NCT00125164|54716408|FG003|Overall Study|Withdrawal by Subject|1|||
28060296|NCT00136318|54716420|FG000|Overall Study|Adverse Event|5|||
28060297|NCT00136318|54716421|FG001|Overall Study|Adverse Event|5|||
28060298|NCT00136318|54716420|FG000|Overall Study|Withdrawal by Subject|2|||
28060299|NCT00136318|54716421|FG001|Overall Study|Withdrawal by Subject|2|||
27814808|NCT01572675|54271485|FG001|Overall Study|Lost to Follow-up|27|||
27814809|NCT05065983|54271504|FG000|Overall Study|Lost to Follow-up|2|||
27814810|NCT04797650|54271511|FG000|Overall Study|Reason Not Specified|5|||
28060300|NCT00136084|54716430|FG000|Overall Study|Death|12|||
28060301|NCT00136084|54716431|FG001|Overall Study|Death|5|||
28060302|NCT00136084|54716430|FG000|Overall Study|Unacceptable toxicity|8|||
28060303|NCT00136084|54716431|FG001|Overall Study|Unacceptable toxicity|11|||
28060304|NCT00136084|54716430|FG000|Overall Study|Relapse|20|||
28060305|NCT00136084|54716431|FG001|Overall Study|Relapse|23|||
28060306|NCT00136084|54716430|FG000|Overall Study|Lost to Follow-up|2|||
28060307|NCT00136084|54716431|FG001|Overall Study|Lost to Follow-up|0|||
27814811|NCT04797650|54271512|FG001|Overall Study|Reason Not Specified|12|||
27814812|NCT04797650|54271513|FG002|Overall Study|Reason Not Specified|5|||
28060308|NCT00136084|54716430|FG000|Overall Study|No Response|1|||
28060309|NCT00136084|54716431|FG001|Overall Study|No Response|2|||
27814813|NCT04797650|54271511|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|1|||
28060310|NCT00136084|54716430|FG000|Overall Study|Withdrawal by Subject|5|||
28060311|NCT00136084|54716431|FG001|Overall Study|Withdrawal by Subject|1|||
28060312|NCT00364832|54716452|FG000|Core Period|Early Withdrawals|2|||
28060313|NCT00364832|54716453|FG001|Core Period|Early Withdrawals|2|||
28060314|NCT00364832|54716454|FG002|Core Period|Early Withdrawals|1|||
28060315|NCT00364832|54716455|FG003|Core Period|Early Withdrawals|1|||
28060316|NCT00364832|54716456|FG004|Core Period|Early Withdrawals|0|||
27814814|NCT04797650|54271512|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|7|||
27814815|NCT04797650|54271513|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|0|||
27814816|NCT04797650|54271511|FG000|Overall Study|Lack of Efficacy|1|||
27814817|NCT04797650|54271512|FG001|Overall Study|Lack of Efficacy|0|||
27814818|NCT04797650|54271513|FG002|Overall Study|Lack of Efficacy|1|||
27814819|NCT04797650|54271511|FG000|Overall Study|Non-compliance with Study Drug|0|||
28060317|NCT00364832|54716457|FG005|Core Period|Early Withdrawals|0|||
28060318|NCT00364832|54716458|FG006|Core Period|Early Withdrawals|4|||
28060319|NCT00364832|54716459|FG007|Core Period|Early Withdrawals|1|||
28060320|NCT00364832|54716460|FG008|Core Period|Early Withdrawals|0|||
28060321|NCT00364832|54716461|FG009|Core Period|Early Withdrawals|0|||
28060322|NCT00364832|54716462|FG010|Core Period|Early Withdrawals|0|||
28060323|NCT00364832|54716463|FG011|Core Period|Early Withdrawals|0|||
28060324|NCT00364832|54716452|FG000|Extension Year 1|Early Withdrawals|0|||
28060325|NCT00364832|54716453|FG001|Extension Year 1|Early Withdrawals|0|||
28060326|NCT00364832|54716454|FG002|Extension Year 1|Early Withdrawals|0|||
28060327|NCT00364832|54716455|FG003|Extension Year 1|Early Withdrawals|0|||
28060328|NCT00364832|54716456|FG004|Extension Year 1|Early Withdrawals|0|||
28060329|NCT00364832|54716457|FG005|Extension Year 1|Early Withdrawals|0|||
28060330|NCT00364832|54716458|FG006|Extension Year 1|Early Withdrawals|0|||
27814820|NCT04797650|54271512|FG001|Overall Study|Non-compliance with Study Drug|0|||
28060331|NCT00364832|54716459|FG007|Extension Year 1|Early Withdrawals|0|||
28060332|NCT00364832|54716460|FG008|Extension Year 1|Early Withdrawals|0|||
28060333|NCT00364832|54716461|FG009|Extension Year 1|Early Withdrawals|4|||
28060334|NCT00364832|54716462|FG010|Extension Year 1|Early Withdrawals|2|||
28060335|NCT00364832|54716463|FG011|Extension Year 1|Early Withdrawals|10|||
28060336|NCT00364832|54716452|FG000|Extension Year 2|Early Withdrawals|0|||
28060337|NCT00364832|54716453|FG001|Extension Year 2|Early Withdrawals|0|||
28060338|NCT00364832|54716454|FG002|Extension Year 2|Early Withdrawals|0|||
28060339|NCT00364832|54716455|FG003|Extension Year 2|Early Withdrawals|0|||
28060340|NCT00364832|54716456|FG004|Extension Year 2|Early Withdrawals|0|||
28060341|NCT00364832|54716457|FG005|Extension Year 2|Early Withdrawals|0|||
28060342|NCT00364832|54716458|FG006|Extension Year 2|Early Withdrawals|0|||
28060343|NCT00364832|54716459|FG007|Extension Year 2|Early Withdrawals|0|||
28060344|NCT00364832|54716460|FG008|Extension Year 2|Early Withdrawals|0|||
28060345|NCT00364832|54716461|FG009|Extension Year 2|Early Withdrawals|5|||
28060346|NCT00364832|54716462|FG010|Extension Year 2|Early Withdrawals|5|||
28060347|NCT00364832|54716463|FG011|Extension Year 2|Early Withdrawals|3|||
28060348|NCT00235755|54716483|FG000|4-Week Titration Phase|Adverse Event|6|||
28060349|NCT00235755|54716484|FG001|4-Week Titration Phase|Adverse Event|14|||
28060350|NCT00235755|54716485|FG002|4-Week Titration Phase|Adverse Event|20|||
28060351|NCT00235755|54716483|FG000|4-Week Titration Phase|Lost to Follow-up|0|||
28060352|NCT00235755|54716484|FG001|4-Week Titration Phase|Lost to Follow-up|1|||
28060353|NCT00235755|54716485|FG002|4-Week Titration Phase|Lost to Follow-up|1|||
28060354|NCT00235755|54716483|FG000|4-Week Titration Phase|Protocol Violation|2|||
28060355|NCT00235755|54716484|FG001|4-Week Titration Phase|Protocol Violation|2|||
28060356|NCT00235755|54716485|FG002|4-Week Titration Phase|Protocol Violation|1|||
28060357|NCT00235755|54716483|FG000|4-Week Titration Phase|Withdrawal by Subject|1|||
28060358|NCT00235755|54716484|FG001|4-Week Titration Phase|Withdrawal by Subject|2|||
28060359|NCT00235755|54716485|FG002|4-Week Titration Phase|Withdrawal by Subject|3|||
28060360|NCT00235755|54716483|FG000|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
28060361|NCT00235755|54716484|FG001|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
28060362|NCT00235755|54716485|FG002|4-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
28060363|NCT00235755|54716483|FG000|4-Week Titration Phase|Randomization Occurred in Error|1|||
28060364|NCT00235755|54716484|FG001|4-Week Titration Phase|Randomization Occurred in Error|0|||
28060365|NCT00235755|54716485|FG002|4-Week Titration Phase|Randomization Occurred in Error|0|||
28060366|NCT00235755|54716483|FG000|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1|||
28060367|NCT00235755|54716484|FG001|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
28060368|NCT00235755|54716485|FG002|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
28060369|NCT00235755|54716483|FG000|12-Week Maintenance Phase|Adverse Event|8|||
28060370|NCT00235755|54716484|FG001|12-Week Maintenance Phase|Adverse Event|12|||
28060371|NCT00235755|54716485|FG002|12-Week Maintenance Phase|Adverse Event|26|||
28060372|NCT00235755|54716483|FG000|12-Week Maintenance Phase|Lost to Follow-up|2|||
28060373|NCT00235755|54716484|FG001|12-Week Maintenance Phase|Lost to Follow-up|3|||
28060374|NCT00235755|54716485|FG002|12-Week Maintenance Phase|Lost to Follow-up|0|||
27814821|NCT04797650|54271513|FG002|Overall Study|Non-compliance with Study Drug|2|||
27814822|NCT04797650|54271511|FG000|Overall Study|Lost to Follow-up|4|||
27814823|NCT04797650|54271512|FG001|Overall Study|Lost to Follow-up|6|||
28060375|NCT00235755|54716483|FG000|12-Week Maintenance Phase|Lack of Efficacy|5|||
27814824|NCT04797650|54271513|FG002|Overall Study|Lost to Follow-up|1|||
28060376|NCT00235755|54716484|FG001|12-Week Maintenance Phase|Lack of Efficacy|0|||
28060377|NCT00235755|54716485|FG002|12-Week Maintenance Phase|Lack of Efficacy|0|||
28060378|NCT00235755|54716483|FG000|12-Week Maintenance Phase|Protocol Violation|0|||
28060379|NCT00235755|54716484|FG001|12-Week Maintenance Phase|Protocol Violation|4|||
28060380|NCT00235755|54716485|FG002|12-Week Maintenance Phase|Protocol Violation|2|||
28060381|NCT00235755|54716483|FG000|12-Week Maintenance Phase|Withdrawal by Subject|0|||
28060382|NCT00235755|54716484|FG001|12-Week Maintenance Phase|Withdrawal by Subject|8|||
28060383|NCT00235755|54716485|FG002|12-Week Maintenance Phase|Withdrawal by Subject|3|||
28060384|NCT00235755|54716483|FG000|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1|||
28060385|NCT00235755|54716484|FG001|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
28060386|NCT00235755|54716485|FG002|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
28060387|NCT00337194|54716510|FG000|Overall Study|Adverse Event|5|||
28060388|NCT00337194|54716511|FG001|Overall Study|Adverse Event|1|||
28060389|NCT00337194|54716510|FG000|Overall Study|Death|2|||
28060390|NCT00337194|54716511|FG001|Overall Study|Death|0|||
28060391|NCT00337194|54716510|FG000|Overall Study|Withdrawal by Subject|1|||
28060392|NCT00337194|54716511|FG001|Overall Study|Withdrawal by Subject|0|||
28060393|NCT00337194|54716510|FG000|Overall Study|Disease progression|1|||
28060394|NCT00337194|54716511|FG001|Overall Study|Disease progression|2|||
28060395|NCT00337194|54716510|FG000|Overall Study|Subsequent non-protocol therapy|3|||
28060396|NCT00337194|54716511|FG001|Overall Study|Subsequent non-protocol therapy|1|||
28060397|NCT03826914|54716521|FG000|Overall Study|Withdrawal by Subject|1|||
28060398|NCT03826914|54716522|FG001|Overall Study|Withdrawal by Subject|1|||
28060399|NCT00385736|54716533|FG000|Efficacy Analysis Set - Induction|Adverse Event|5|||
28060400|NCT00385736|54716534|FG001|Efficacy Analysis Set - Induction|Adverse Event|6|||
28060401|NCT00385736|54716535|FG002|Efficacy Analysis Set - Induction|Adverse Event|4|||
28060402|NCT00385736|54716533|FG000|Efficacy Analysis Set - Induction|Withdrawal by Subject|0|||
28060403|NCT00385736|54716534|FG001|Efficacy Analysis Set - Induction|Withdrawal by Subject|2|||
28060404|NCT00385736|54716535|FG002|Efficacy Analysis Set - Induction|Withdrawal by Subject|1|||
28060405|NCT00385736|54716533|FG000|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
28060406|NCT00385736|54716534|FG001|Efficacy Analysis Set - Induction|Lost to Follow-up|2|||
28060407|NCT00385736|54716535|FG002|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
28060408|NCT00385736|54716533|FG000|Efficacy Analysis Set - Induction|Lack of Efficacy|4|||
28060409|NCT00385736|54716534|FG001|Efficacy Analysis Set - Induction|Lack of Efficacy|2|||
28060410|NCT00385736|54716535|FG002|Efficacy Analysis Set - Induction|Lack of Efficacy|1|||
28060411|NCT00385736|54716533|FG000|Efficacy Analysis Set - Induction|Protocol Violation|0|||
28060412|NCT00385736|54716534|FG001|Efficacy Analysis Set - Induction|Protocol Violation|0|||
28060413|NCT00385736|54716535|FG002|Efficacy Analysis Set - Induction|Protocol Violation|2|||
28060414|NCT00385736|54716533|FG000|Efficacy Analysis Set - Induction|Other|0|||
28060415|NCT00385736|54716534|FG001|Efficacy Analysis Set - Induction|Other|0|||
28060416|NCT00385736|54716535|FG002|Efficacy Analysis Set - Induction|Other|1|||
28060417|NCT00385736|54716533|FG000|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
28060418|NCT00385736|54716534|FG001|Efficacy Analysis Set - Maintenance|Adverse Event|15|||
28060419|NCT00385736|54716535|FG002|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
28060420|NCT00385736|54716533|FG000|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
28060421|NCT00385736|54716534|FG001|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
28060422|NCT00385736|54716535|FG002|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14|||
28060423|NCT00385736|54716533|FG000|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0|||
28060424|NCT00385736|54716534|FG001|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
28060425|NCT00385736|54716535|FG002|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
28060426|NCT00385736|54716533|FG000|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38|||
28060427|NCT00385736|54716534|FG001|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16|||
28060428|NCT00385736|54716535|FG002|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31|||
28060429|NCT00385736|54716533|FG000|Efficacy Analysis Set - Maintenance|Protocol Violation|2|||
28060430|NCT00385736|54716534|FG001|Efficacy Analysis Set - Maintenance|Protocol Violation|1|||
28060431|NCT00385736|54716535|FG002|Efficacy Analysis Set - Maintenance|Protocol Violation|6|||
28060432|NCT00385736|54716533|FG000|Efficacy Analysis Set - Maintenance|Other|0|||
28060433|NCT00385736|54716534|FG001|Efficacy Analysis Set - Maintenance|Other|4|||
28060434|NCT00385736|54716535|FG002|Efficacy Analysis Set - Maintenance|Other|4|||
28060435|NCT00385736|54716533|FG000|Safety Analysis Set|Adverse Event|23|||
28060436|NCT00385736|54716534|FG001|Safety Analysis Set|Adverse Event|15|||
28060437|NCT00385736|54716535|FG002|Safety Analysis Set|Adverse Event|23|||
28060438|NCT00385736|54716533|FG000|Safety Analysis Set|Withdrawal by Subject|6|||
28060439|NCT00385736|54716534|FG001|Safety Analysis Set|Withdrawal by Subject|6|||
28060440|NCT00385736|54716535|FG002|Safety Analysis Set|Withdrawal by Subject|14|||
28060441|NCT00385736|54716533|FG000|Safety Analysis Set|Lost to Follow-up|0|||
28060442|NCT00385736|54716534|FG001|Safety Analysis Set|Lost to Follow-up|2|||
28060443|NCT00385736|54716535|FG002|Safety Analysis Set|Lost to Follow-up|2|||
28060444|NCT00385736|54716533|FG000|Safety Analysis Set|Lack of Efficacy|38|||
28060445|NCT00385736|54716534|FG001|Safety Analysis Set|Lack of Efficacy|16|||
28060446|NCT00385736|54716535|FG002|Safety Analysis Set|Lack of Efficacy|31|||
28060447|NCT00385736|54716533|FG000|Safety Analysis Set|Protocol Violation|2|||
28060448|NCT00385736|54716534|FG001|Safety Analysis Set|Protocol Violation|1|||
28060449|NCT00385736|54716535|FG002|Safety Analysis Set|Protocol Violation|6|||
28060450|NCT00385736|54716533|FG000|Safety Analysis Set|Other|1|||
28060451|NCT00385736|54716534|FG001|Safety Analysis Set|Other|4|||
28060452|NCT00385736|54716535|FG002|Safety Analysis Set|Other|4|||
28060453|NCT00195819|54716546|FG000|Double-Blind|Withdrawal by Subject|1|||
28060454|NCT00195819|54716547|FG001|Double-Blind|Withdrawal by Subject|0|||
28060455|NCT00195819|54716546|FG000|Double-Blind|Moved|1|||
28060456|NCT00195819|54716547|FG001|Double-Blind|Moved|0|||
28060457|NCT00195819|54716546|FG000|Open-label|Adverse Event|0|||
28060458|NCT00195819|54716547|FG001|Open-label|Adverse Event|9|||
28060459|NCT00195819|54716546|FG000|Open-label|Lack of Efficacy|0|||
28060460|NCT00195819|54716547|FG001|Open-label|Lack of Efficacy|2|||
28060461|NCT00195819|54716546|FG000|Open-label|Pregnancy|0|||
28060462|NCT00195819|54716547|FG001|Open-label|Pregnancy|1|||
28060463|NCT00195819|54716546|FG000|Open-label|Protocol Violation|0|||
28060464|NCT00195819|54716547|FG001|Open-label|Protocol Violation|2|||
28060465|NCT00195819|54716546|FG000|Open-label|Moved|0|||
28060466|NCT00195819|54716547|FG001|Open-label|Moved|1|||
28060467|NCT00195819|54716546|FG000|Open-label|Withdrawal by Subject|0|||
28060468|NCT00195819|54716547|FG001|Open-label|Withdrawal by Subject|5|||
28060469|NCT00527735|54716562|FG000|Overall Study|Disease progression|47|||
28060470|NCT00527735|54716563|FG001|Overall Study|Disease progression|61|||
28060471|NCT00527735|54716564|FG002|Overall Study|Disease progression|53|||
28060472|NCT00527735|54716562|FG000|Overall Study|Death|23|||
28060473|NCT00527735|54716563|FG001|Overall Study|Death|13|||
28060474|NCT00527735|54716564|FG002|Overall Study|Death|15|||
28060475|NCT00527735|54716562|FG000|Overall Study|Completed treatment in treatment phase|14|||
28060476|NCT00527735|54716563|FG001|Overall Study|Completed treatment in treatment phase|13|||
28060477|NCT00527735|54716564|FG002|Overall Study|Completed treatment in treatment phase|18|||
28060478|NCT00527735|54716562|FG000|Overall Study|Adverse Event|10|||
28060479|NCT00527735|54716563|FG001|Overall Study|Adverse Event|6|||
28060480|NCT00527735|54716564|FG002|Overall Study|Adverse Event|7|||
28060481|NCT00527735|54716562|FG000|Overall Study|Not identified|5|||
28060482|NCT00527735|54716563|FG001|Overall Study|Not identified|5|||
28060483|NCT00527735|54716564|FG002|Overall Study|Not identified|5|||
28060484|NCT00527735|54716562|FG000|Overall Study|Withdrawal by Subject|5|||
28060485|NCT00527735|54716563|FG001|Overall Study|Withdrawal by Subject|4|||
28060486|NCT00527735|54716564|FG002|Overall Study|Withdrawal by Subject|3|||
28060487|NCT00527735|54716562|FG000|Overall Study|No longer met study criteria|2|||
28060488|NCT00527735|54716563|FG001|Overall Study|No longer met study criteria|2|||
28060489|NCT00527735|54716564|FG002|Overall Study|No longer met study criteria|1|||
28060490|NCT00527735|54716562|FG000|Overall Study|Lost to Follow-up|0|||
28060491|NCT00527735|54716563|FG001|Overall Study|Lost to Follow-up|0|||
28060492|NCT00527735|54716564|FG002|Overall Study|Lost to Follow-up|3|||
28060493|NCT00527735|54716562|FG000|Overall Study|Poor compliance or noncompliance|0|||
28060494|NCT00527735|54716563|FG001|Overall Study|Poor compliance or noncompliance|1|||
28060495|NCT00527735|54716564|FG002|Overall Study|Poor compliance or noncompliance|1|||
28060496|NCT00527735|54716562|FG000|Overall Study|Completed treatment during maintenance|2|||
27814825|NCT04705597|54271525|FG000|Overall Study|Death|16|||
27940075|NCT01196052|54596412|FG000|Overall Study|Noncompliance to Protocol Requirements|2|||
27814826|NCT04705597|54271526|FG001|Overall Study|Death|9|||
28060497|NCT00527735|54716563|FG001|Overall Study|Completed treatment during maintenance|2|||
28060498|NCT00527735|54716564|FG002|Overall Study|Completed treatment during maintenance|1|||
28060499|NCT00336492|54716587|FG000|Overall Study|Adverse Event|4|||
28060500|NCT00336492|54716588|FG001|Overall Study|Adverse Event|3|||
28060501|NCT00336492|54716589|FG002|Overall Study|Adverse Event|6|||
28060502|NCT00336492|54716587|FG000|Overall Study|Lack of Efficacy|6|||
28060503|NCT00336492|54716588|FG001|Overall Study|Lack of Efficacy|1|||
28060504|NCT00336492|54716589|FG002|Overall Study|Lack of Efficacy|4|||
28060505|NCT00336492|54716587|FG000|Overall Study|Other|5|||
28060506|NCT00336492|54716588|FG001|Overall Study|Other|0|||
28060507|NCT00336492|54716589|FG002|Overall Study|Other|1|||
28060508|NCT00194025|54716597|FG000|Overall Study|Adverse Event|1|||
28060509|NCT00194025|54716597|FG000|Overall Study|non-adherence with study medication|4|||
28060510|NCT00368108|54716604|FG000|Overall Study|Adverse Event|38|||
28060511|NCT00368108|54716605|FG001|Overall Study|Adverse Event|26|||
28060512|NCT00368108|54716606|FG002|Overall Study|Adverse Event|44|||
28060513|NCT00368108|54716604|FG000|Overall Study|Abnormal Laboratory Value|0|||
28060514|NCT00368108|54716605|FG001|Overall Study|Abnormal Laboratory Value|0|||
28060515|NCT00368108|54716606|FG002|Overall Study|Abnormal Laboratory Value|3|||
28060516|NCT00368108|54716604|FG000|Overall Study|Protocol Violation|5|||
28060517|NCT00368108|54716605|FG001|Overall Study|Protocol Violation|9|||
28060518|NCT00368108|54716606|FG002|Overall Study|Protocol Violation|9|||
28060519|NCT00368108|54716604|FG000|Overall Study|Withdrawal by Subject|9|||
28060520|NCT00368108|54716605|FG001|Overall Study|Withdrawal by Subject|3|||
28060521|NCT00368108|54716606|FG002|Overall Study|Withdrawal by Subject|5|||
28060522|NCT00368108|54716604|FG000|Overall Study|Lack of Efficacy|7|||
28060523|NCT00368108|54716605|FG001|Overall Study|Lack of Efficacy|8|||
28060524|NCT00368108|54716606|FG002|Overall Study|Lack of Efficacy|5|||
28060525|NCT00368108|54716604|FG000|Overall Study|Physician Decision|2|||
28060526|NCT00368108|54716605|FG001|Overall Study|Physician Decision|0|||
28060527|NCT00368108|54716606|FG002|Overall Study|Physician Decision|1|||
28060528|NCT00368108|54716604|FG000|Overall Study|Other|3|||
28060529|NCT00368108|54716605|FG001|Overall Study|Other|7|||
28060530|NCT00368108|54716606|FG002|Overall Study|Other|1|||
28060531|NCT00364130|54716616|FG000|Intervention Period|Lost to Follow-up|4|||
28060532|NCT00364130|54716617|FG001|Intervention Period|Lost to Follow-up|3|||
28060533|NCT00364130|54716616|FG000|Intervention Period|Pregnancy|1|||
28060534|NCT00364130|54716617|FG001|Intervention Period|Pregnancy|0|||
28060535|NCT00364130|54716616|FG000|Intervention Period|Withdrawal by Subject|4|||
28060536|NCT00364130|54716617|FG001|Intervention Period|Withdrawal by Subject|5|||
28060537|NCT00364130|54716616|FG000|Post Intervention Follow-up Period|Lost to Follow-up|5|||
28060538|NCT00364130|54716617|FG001|Post Intervention Follow-up Period|Lost to Follow-up|11|||
28060539|NCT00521339|54716625|FG000|Treatment Phase|Adverse Event|2|||
28060540|NCT00521339|54716626|FG001|Treatment Phase|Adverse Event|0|||
28060541|NCT00521339|54716627|FG002|Treatment Phase|Adverse Event|0|||
28060542|NCT00521339|54716625|FG000|Treatment Phase|Intolerability to study drug|2|||
28060543|NCT00521339|54716626|FG001|Treatment Phase|Intolerability to study drug|0|||
28060544|NCT00521339|54716627|FG002|Treatment Phase|Intolerability to study drug|0|||
28060545|NCT00521339|54716625|FG000|Treatment Phase|Lack of Efficacy|3|||
28060546|NCT00521339|54716626|FG001|Treatment Phase|Lack of Efficacy|0|||
28060547|NCT00521339|54716627|FG002|Treatment Phase|Lack of Efficacy|0|||
28060548|NCT00521339|54716625|FG000|Treatment Phase|Withdrawal by Subject|3|||
28060549|NCT00521339|54716626|FG001|Treatment Phase|Withdrawal by Subject|0|||
28060550|NCT00521339|54716627|FG002|Treatment Phase|Withdrawal by Subject|0|||
28060551|NCT00521339|54716625|FG000|Treatment Phase|Lost to Follow-up|1|||
28060552|NCT00521339|54716626|FG001|Treatment Phase|Lost to Follow-up|0|||
28060553|NCT00521339|54716627|FG002|Treatment Phase|Lost to Follow-up|0|||
28060554|NCT00521339|54716625|FG000|Treatment Phase|Protocol Violation|1|||
28060555|NCT00521339|54716626|FG001|Treatment Phase|Protocol Violation|0|||
28060556|NCT00521339|54716627|FG002|Treatment Phase|Protocol Violation|0|||
28060557|NCT00521339|54716625|FG000|Treatment Extension Phase|Withdrawal by Subject|0|||
28060558|NCT00521339|54716626|FG001|Treatment Extension Phase|Withdrawal by Subject|0|||
28060559|NCT00521339|54716627|FG002|Treatment Extension Phase|Withdrawal by Subject|2|||
28060560|NCT00521339|54716625|FG000|Treatment Extension Phase|Death|0|||
28060561|NCT00521339|54716626|FG001|Treatment Extension Phase|Death|0|||
28060562|NCT00521339|54716627|FG002|Treatment Extension Phase|Death|1|||
28060563|NCT00363896|54716650|FG000|Overall Study|Withdrawal by Subject|29|||
28060564|NCT00363896|54716651|FG001|Overall Study|Withdrawal by Subject|16|||
27814827|NCT04705597|54271525|FG000|Overall Study|Lost to Follow-up|1|||
27814828|NCT04705597|54271526|FG001|Overall Study|Lost to Follow-up|0|||
27814829|NCT04705597|54271525|FG000|Overall Study|Withdrawal by Subject|1|||
27814830|NCT04705597|54271526|FG001|Overall Study|Withdrawal by Subject|2|||
27814831|NCT04534114|54271540|FG000|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
28060565|NCT00363896|54716650|FG000|Overall Study|Adverse Event|24|||
28060566|NCT00363896|54716651|FG001|Overall Study|Adverse Event|13|||
28060567|NCT00363896|54716650|FG000|Overall Study|COPD exacerbation|13|||
28060568|NCT00363896|54716651|FG001|Overall Study|COPD exacerbation|7|||
28060569|NCT00363896|54716650|FG000|Overall Study|Lack of Efficacy|12|||
28060570|NCT00363896|54716651|FG001|Overall Study|Lack of Efficacy|8|||
28060571|NCT00363896|54716650|FG000|Overall Study|Protocol Violation|6|||
27814832|NCT04534114|54271541|FG001|Main Treatment Period|COVID-19 pandemic: Participant decision|1|||
28060572|NCT00363896|54716651|FG001|Overall Study|Protocol Violation|1|||
28060573|NCT00363896|54716650|FG000|Overall Study|Lost to Follow-up|3|||
28060574|NCT00363896|54716651|FG001|Overall Study|Lost to Follow-up|0|||
28060575|NCT00363896|54716650|FG000|Overall Study|Non-fulfilment of entry criteria|1|||
28060576|NCT00363896|54716651|FG001|Overall Study|Non-fulfilment of entry criteria|0|||
28060577|NCT00363896|54716650|FG000|Overall Study|Other|1|||
28060578|NCT00363896|54716651|FG001|Overall Study|Other|2|||
28060579|NCT00527423|54716660|FG000|Overall Study|Protocol Violation|1|||
28060580|NCT00527423|54716660|FG000|Overall Study|Adverse Event|5|||
28060581|NCT00527423|54716660|FG000|Overall Study|Physician Decision|4|||
28060582|NCT00527423|54716660|FG000|Overall Study|Withdrawal by Subject|10|||
28060583|NCT00527423|54716660|FG000|Overall Study|Lost to Follow-up|4|||
28060584|NCT00527423|54716660|FG000|Overall Study|OTHER|4|||
28060585|NCT00527423|54716660|FG000|Overall Study|Death|9|||
28060586|NCT00527111|54716668|FG000|Overall Study|Adverse Event|14|||
28060587|NCT00527111|54716669|FG001|Overall Study|Adverse Event|13|||
28060588|NCT00527111|54716668|FG000|Overall Study|Death|0|||
28060589|NCT00527111|54716669|FG001|Overall Study|Death|1|||
28060590|NCT00527111|54716668|FG000|Overall Study|Investigator Request|2|||
28060591|NCT00527111|54716669|FG001|Overall Study|Investigator Request|1|||
28060592|NCT00527111|54716668|FG000|Overall Study|Patient Request|2|||
28060593|NCT00527111|54716669|FG001|Overall Study|Patient Request|5|||
28060594|NCT00527111|54716668|FG000|Overall Study|Other|2|||
28060595|NCT00527111|54716669|FG001|Overall Study|Other|2|||
27814833|NCT04534114|54271542|FG002|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
28060596|NCT00336024|54716677|FG000|Overall Study|Death|2|||
28060597|NCT00336024|54716678|FG001|Overall Study|Death|1|||
28060598|NCT00336024|54716677|FG000|Overall Study|Physician Decision|4|||
28060599|NCT00336024|54716678|FG001|Overall Study|Physician Decision|1|||
28060600|NCT00336024|54716677|FG000|Overall Study|Protocol Violation|1|||
27814834|NCT04534114|54271543|FG003|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
28060601|NCT00336024|54716678|FG001|Overall Study|Protocol Violation|0|||
28060602|NCT00336024|54716677|FG000|Overall Study|Withdrawal by Subject|1|||
28060603|NCT00336024|54716678|FG001|Overall Study|Withdrawal by Subject|2|||
28060604|NCT00336024|54716677|FG000|Overall Study|Failure to fulfill consolidation|1|||
28060605|NCT00336024|54716678|FG001|Overall Study|Failure to fulfill consolidation|1|||
28060606|NCT00336024|54716677|FG000|Overall Study|Progressive Disease|4|||
28060607|NCT00336024|54716678|FG001|Overall Study|Progressive Disease|7|||
28060608|NCT00336024|54716677|FG000|Overall Study|Ineligible|7|||
28060609|NCT00336024|54716678|FG001|Overall Study|Ineligible|7|||
28060610|NCT00384956|54716684|FG000|Overall Study|Ineligible (acute myeloid leukemia)|3|||
28060611|NCT00367640|54716692|FG000|Overall Study|Adverse Event|3|||
28060612|NCT00367640|54716693|FG001|Overall Study|Adverse Event|6|||
28060613|NCT00367640|54716694|FG002|Overall Study|Adverse Event|8|||
28060614|NCT00367640|54716695|FG003|Overall Study|Adverse Event|0|||
28060615|NCT00367640|54716692|FG000|Overall Study|Withdrawal by Subject|8|||
28060616|NCT00367640|54716693|FG001|Overall Study|Withdrawal by Subject|11|||
28060617|NCT00367640|54716694|FG002|Overall Study|Withdrawal by Subject|8|||
28060618|NCT00367640|54716695|FG003|Overall Study|Withdrawal by Subject|6|||
28060619|NCT00367640|54716692|FG000|Overall Study|Any other reason not above-mentioned|7|||
28060620|NCT00367640|54716693|FG001|Overall Study|Any other reason not above-mentioned|5|||
28060621|NCT00367640|54716694|FG002|Overall Study|Any other reason not above-mentioned|3|||
28060622|NCT00367640|54716695|FG003|Overall Study|Any other reason not above-mentioned|4|||
28060623|NCT00367484|54716705|FG000|Overall Study|Adverse Event|7|||
28060624|NCT00367484|54716705|FG000|Overall Study|Withdrew informed consent|5|||
28060625|NCT00367484|54716705|FG000|Overall Study|Travel to USA|1|||
28060626|NCT00367484|54716705|FG000|Overall Study|Lost to Follow-up|1|||
28060627|NCT00367484|54716705|FG000|Overall Study|Protocol Violation|1|||
28060628|NCT00367484|54716705|FG000|Overall Study|The choice of the patient|1|||
28060629|NCT00367484|54716705|FG000|Overall Study|Lack of Efficacy|1|||
28060630|NCT00526799|54716711|FG000|Overall Study|Withdrawal by Subject|1|||
28060631|NCT00526799|54716712|FG001|Overall Study|Withdrawal by Subject|0|||
28060632|NCT00526799|54716711|FG000|Overall Study|Intercurrent Complicating Disease|0|||
28060633|NCT00526799|54716712|FG001|Overall Study|Intercurrent Complicating Disease|1|||
28060634|NCT00526331|54716718|FG000|Overall Study|Sponsor Termination|55|||
28060635|NCT00520481|54716724|FG000|Overall Study|Adverse Event|4|||
28060636|NCT00520481|54716725|FG001|Overall Study|Adverse Event|1|||
28060637|NCT00520481|54716724|FG000|Overall Study|Withdrawal by Subject|3|||
28060638|NCT00520481|54716725|FG001|Overall Study|Withdrawal by Subject|0|||
28060639|NCT00520403|54716733|FG000|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6|||
28060640|NCT00520403|54716733|FG000|Bevacizumab + IFN/Vinblastine|Adverse Event|4|||
28060641|NCT00520403|54716733|FG000|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4|||
28060642|NCT00520403|54716733|FG000|Bevacizumab + IFN/Vinblastine|Death|2|||
28060643|NCT00520403|54716733|FG000|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1|||
28060644|NCT00520403|54716733|FG000|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1|||
28060645|NCT00520403|54716733|FG000|Bevacizumab Monotherapy|Radiological progression of cancer|1|||
28060646|NCT00520403|54716733|FG000|Bevacizumab Monotherapy|Symptomatic progression of cancer|1|||
28060647|NCT00520013|54716740|FG000|Overall Study|Withdrawal by Subject|0|||
28060648|NCT00520013|54716741|FG001|Overall Study|Withdrawal by Subject|0|||
28060649|NCT00520013|54716742|FG002|Overall Study|Withdrawal by Subject|1|||
28060650|NCT00520013|54716740|FG000|Overall Study|Adverse Event|2|||
28060651|NCT00520013|54716741|FG001|Overall Study|Adverse Event|10|||
28060652|NCT00520013|54716742|FG002|Overall Study|Adverse Event|7|||
28060653|NCT00520013|54716740|FG000|Overall Study|Progressive Disease|7|||
28060654|NCT00520013|54716741|FG001|Overall Study|Progressive Disease|3|||
28060655|NCT00520013|54716742|FG002|Overall Study|Progressive Disease|0|||
28060656|NCT00520013|54716740|FG000|Overall Study|Clinical Progression|3|||
28060657|NCT00520013|54716741|FG001|Overall Study|Clinical Progression|1|||
28060658|NCT00520013|54716742|FG002|Overall Study|Clinical Progression|0|||
28060659|NCT00520013|54716740|FG000|Overall Study|Death|0|||
28060660|NCT00520013|54716741|FG001|Overall Study|Death|1|||
28060661|NCT00520013|54716742|FG002|Overall Study|Death|0|||
28060662|NCT00520013|54716740|FG000|Overall Study|Physician Decision|0|||
28060663|NCT00520013|54716741|FG001|Overall Study|Physician Decision|0|||
28060664|NCT00520013|54716742|FG002|Overall Study|Physician Decision|3|||
28060665|NCT00519779|54716750|FG000|Overall Study|Withdrawal by Subject|0|||
28060666|NCT00519779|54716751|FG001|Overall Study|Withdrawal by Subject|1|||
28060667|NCT00526097|54716759|FG000|Overall Study|Adverse Event|6|||
28060668|NCT00526097|54716760|FG001|Overall Study|Adverse Event|44|||
28060669|NCT00526097|54716759|FG000|Overall Study|Protocol Violation|4|||
28060670|NCT00526097|54716760|FG001|Overall Study|Protocol Violation|10|||
28060671|NCT00526097|54716759|FG000|Overall Study|Withdrawal by Subject|3|||
28060672|NCT00526097|54716760|FG001|Overall Study|Withdrawal by Subject|1|||
28060673|NCT00526097|54716759|FG000|Overall Study|Other|2|||
28060674|NCT00526097|54716760|FG001|Overall Study|Other|1|||
28060675|NCT00525785|54716766|FG000|Overall Study|Withdrawal by Subject|1|||
28060676|NCT00525785|54716766|FG000|Overall Study|Lack of Efficacy|1|||
28060677|NCT00525785|54716766|FG000|Overall Study|Physician Decision|1|||
28060678|NCT00525161|54716770|FG000|Overall Study|Adverse Event|1|||
28060679|NCT00524771|54716776|FG000|Overall Study|Protocol Violation|220|||
28060680|NCT00524771|54716777|FG001|Overall Study|Protocol Violation|585|||
28060681|NCT00135694|54716787|FG000|Overall Study|Adverse Event|17|||
28060682|NCT00135694|54716788|FG001|Overall Study|Adverse Event|4|||
28060683|NCT00135694|54716789|FG002|Overall Study|Adverse Event|0|||
28060684|NCT00135694|54716787|FG000|Overall Study|Death|14|||
28060685|NCT00135694|54716788|FG001|Overall Study|Death|1|||
28060686|NCT00135694|54716789|FG002|Overall Study|Death|2|||
28060687|NCT00135694|54716787|FG000|Overall Study|Lost to Follow-up|8|||
28060688|NCT00135694|54716788|FG001|Overall Study|Lost to Follow-up|7|||
28060689|NCT00135694|54716789|FG002|Overall Study|Lost to Follow-up|1|||
28060690|NCT00135694|54716787|FG000|Overall Study|Withdrawal by Subject|41|||
28060691|NCT00135694|54716788|FG001|Overall Study|Withdrawal by Subject|7|||
28060692|NCT00135694|54716789|FG002|Overall Study|Withdrawal by Subject|4|||
28060693|NCT00135694|54716787|FG000|Overall Study|Protocol Violation|19|||
28060694|NCT00135694|54716788|FG001|Overall Study|Protocol Violation|1|||
28060695|NCT00135694|54716789|FG002|Overall Study|Protocol Violation|0|||
28060696|NCT00135694|54716787|FG000|Overall Study|Hepatitis C related reasons|39|||
28060697|NCT00135694|54716788|FG001|Overall Study|Hepatitis C related reasons|1|||
28060698|NCT00135694|54716789|FG002|Overall Study|Hepatitis C related reasons|0|||
28060699|NCT00135694|54716787|FG000|Overall Study|Ineligible for Random assignment|42|||
28060700|NCT00135694|54716788|FG001|Overall Study|Ineligible for Random assignment|0|||
28060701|NCT00135694|54716789|FG002|Overall Study|Ineligible for Random assignment|0|||
28060702|NCT00524459|54716797|FG000|Overall Study|Withdrawal by Subject|1|||
28060703|NCT00524459|54716797|FG000|Overall Study|Other|1|||
28060704|NCT00519623|54716801|FG000|Overall Study|Adverse Event|1|||
28060705|NCT00519077|54716805|FG000|Overall Study|Death|6|||
28060706|NCT00519077|54716805|FG000|Overall Study|Other|2|||
28060707|NCT00124618|54716809|FG000|Overall Study|Ineligible|1|||
28060708|NCT00124462|54716815|FG000|Overall Study|Lost to Follow-up|3|||
28060709|NCT00124462|54716816|FG001|Overall Study|Lost to Follow-up|3|||
28060710|NCT00124462|54716815|FG000|Overall Study|Physician Decision|3|||
28060711|NCT00124462|54716816|FG001|Overall Study|Physician Decision|4|||
28060712|NCT00124462|54716815|FG000|Overall Study|Withdrawal by Subject|4|||
28060713|NCT00124462|54716816|FG001|Overall Study|Withdrawal by Subject|5|||
28060714|NCT00124462|54716815|FG000|Overall Study|Device fitting, n=2, other hlth issues|1|||
28060715|NCT00124462|54716816|FG001|Overall Study|Device fitting, n=2, other hlth issues|1|||
28060716|NCT00124072|54716826|FG000|Overall Study|Lost to Follow-up for Mortality|0|||
28060717|NCT00124072|54716827|FG001|Overall Study|Lost to Follow-up for Mortality|3|||
28060718|NCT00124072|54716828|FG002|Overall Study|Lost to Follow-up for Mortality|2|||
28060719|NCT00124072|54716829|FG003|Overall Study|Lost to Follow-up for Mortality|2|||
28060720|NCT00124072|54716826|FG000|Overall Study|Lost to Follow-up for Morbidity|15|||
28060721|NCT00124072|54716827|FG001|Overall Study|Lost to Follow-up for Morbidity|25|||
28060722|NCT00124072|54716828|FG002|Overall Study|Lost to Follow-up for Morbidity|19|||
28060723|NCT00124072|54716829|FG003|Overall Study|Lost to Follow-up for Morbidity|18|||
28060724|NCT00124072|54716826|FG000|Overall Study|Death|499|||
28060725|NCT00124072|54716827|FG001|Overall Study|Death|484|||
28060726|NCT00124072|54716828|FG002|Overall Study|Death|471|||
28060727|NCT00124072|54716829|FG003|Overall Study|Death|480|||
28060728|NCT00362648|54716843|FG000|Overall Study|Adverse Event|12|||
28060729|NCT00362648|54716844|FG001|Overall Study|Adverse Event|21|||
28060730|NCT00362648|54716845|FG002|Overall Study|Adverse Event|1|||
28060731|NCT00362648|54716846|FG003|Overall Study|Adverse Event|0|||
28060732|NCT00362648|54716843|FG000|Overall Study|Lost to Follow-up|62|||
28060733|NCT00362648|54716844|FG001|Overall Study|Lost to Follow-up|69|||
28060734|NCT00362648|54716845|FG002|Overall Study|Lost to Follow-up|4|||
28060735|NCT00362648|54716846|FG003|Overall Study|Lost to Follow-up|3|||
28060736|NCT00362648|54716843|FG000|Overall Study|Protocol Violation|4|||
28060737|NCT00362648|54716844|FG001|Overall Study|Protocol Violation|2|||
28060738|NCT00362648|54716845|FG002|Overall Study|Protocol Violation|2|||
28060739|NCT00362648|54716846|FG003|Overall Study|Protocol Violation|2|||
28060740|NCT00362648|54716843|FG000|Overall Study|Withdrawal by Subject|48|||
28060741|NCT00362648|54716844|FG001|Overall Study|Withdrawal by Subject|42|||
28060742|NCT00362648|54716845|FG002|Overall Study|Withdrawal by Subject|2|||
28060743|NCT00362648|54716846|FG003|Overall Study|Withdrawal by Subject|6|||
28060744|NCT00524303|54716863|FG000|Overall Study|Lost to Follow-up|6|||
28060745|NCT00524303|54716864|FG001|Overall Study|Lost to Follow-up|0|||
28060746|NCT00524303|54716865|FG002|Overall Study|Lost to Follow-up|3|||
28060747|NCT00524303|54716863|FG000|Overall Study|Protocol Violation|0|||
28060748|NCT00524303|54716864|FG001|Overall Study|Protocol Violation|1|||
28060749|NCT00524303|54716865|FG002|Overall Study|Protocol Violation|1|||
28060750|NCT00524303|54716863|FG000|Overall Study|Withdrawal by Subject|3|||
28060751|NCT00524303|54716864|FG001|Overall Study|Withdrawal by Subject|0|||
28060752|NCT00524303|54716865|FG002|Overall Study|Withdrawal by Subject|4|||
28060753|NCT00524303|54716863|FG000|Overall Study|Death|0|||
28060754|NCT00524303|54716864|FG001|Overall Study|Death|2|||
28060755|NCT00524303|54716865|FG002|Overall Study|Death|3|||
28060756|NCT00524303|54716863|FG000|Overall Study|Adverse Event|1|||
28060757|NCT00524303|54716864|FG001|Overall Study|Adverse Event|2|||
28060758|NCT00524303|54716865|FG002|Overall Study|Adverse Event|3|||
28060759|NCT00524303|54716863|FG000|Overall Study|Did not Complete Study Dosing|1|||
28060760|NCT00524303|54716864|FG001|Overall Study|Did not Complete Study Dosing|0|||
28060761|NCT00524303|54716865|FG002|Overall Study|Did not Complete Study Dosing|0|||
28060762|NCT00524303|54716863|FG000|Overall Study|Worsening Peripheral Neuropathy|1|||
28060763|NCT00524303|54716864|FG001|Overall Study|Worsening Peripheral Neuropathy|0|||
28060764|NCT00524303|54716865|FG002|Overall Study|Worsening Peripheral Neuropathy|0|||
28060765|NCT00524303|54716863|FG000|Overall Study|Disease Progression|0|||
28060766|NCT00524303|54716864|FG001|Overall Study|Disease Progression|4|||
28060767|NCT00524303|54716865|FG002|Overall Study|Disease Progression|1|||
28060768|NCT00524303|54716863|FG000|Overall Study|Disease Recurrence|0|||
28060769|NCT00524303|54716864|FG001|Overall Study|Disease Recurrence|1|||
28060770|NCT00524303|54716865|FG002|Overall Study|Disease Recurrence|0|||
28060771|NCT00524303|54716863|FG000|Overall Study|Sponsor Request|0|||
28060772|NCT00524303|54716864|FG001|Overall Study|Sponsor Request|0|||
28060773|NCT00524303|54716865|FG002|Overall Study|Sponsor Request|1|||
27848338|NCT01044459|54341309|FG001|Overall Study|Terminated by Sponsor|21|||
28060774|NCT00524303|54716863|FG000|Overall Study|Physician Decision|0|||
28060775|NCT00524303|54716864|FG001|Overall Study|Physician Decision|0|||
28060776|NCT00524303|54716865|FG002|Overall Study|Physician Decision|1|||
27814835|NCT04534114|54271540|FG000|Main Treatment Period|COVID-19 pandemic: Death|0|||
27814836|NCT04534114|54271541|FG001|Main Treatment Period|COVID-19 pandemic: Death|1|||
27814837|NCT04534114|54271542|FG002|Main Treatment Period|COVID-19 pandemic: Death|0|||
28060777|NCT00524303|54716863|FG000|Overall Study|Completed 5 years|0|||
28060778|NCT00524303|54716864|FG001|Overall Study|Completed 5 years|0|||
28060779|NCT00524303|54716865|FG002|Overall Study|Completed 5 years|1|||
28060780|NCT00335556|54716882|FG000|Overall Study|Death|0|||
28060781|NCT00335556|54716883|FG001|Overall Study|Death|5|||
28060782|NCT00335556|54716884|FG002|Overall Study|Death|0|||
28060783|NCT00335556|54716885|FG003|Overall Study|Death|0|||
28060784|NCT00335556|54716886|FG004|Overall Study|Death|1|||
28060785|NCT00335556|54716887|FG005|Overall Study|Death|0|||
28060786|NCT00335556|54716882|FG000|Overall Study|Lack of Efficacy|0|||
28060787|NCT00335556|54716883|FG001|Overall Study|Lack of Efficacy|19|||
28060788|NCT00335556|54716884|FG002|Overall Study|Lack of Efficacy|3|||
28060789|NCT00335556|54716885|FG003|Overall Study|Lack of Efficacy|3|||
28060790|NCT00335556|54716886|FG004|Overall Study|Lack of Efficacy|0|||
28060791|NCT00335556|54716887|FG005|Overall Study|Lack of Efficacy|1|||
28060792|NCT00335556|54716882|FG000|Overall Study|Physician Decision|0|||
28060793|NCT00335556|54716883|FG001|Overall Study|Physician Decision|6|||
28060794|NCT00335556|54716884|FG002|Overall Study|Physician Decision|2|||
28060795|NCT00335556|54716885|FG003|Overall Study|Physician Decision|1|||
28060796|NCT00335556|54716886|FG004|Overall Study|Physician Decision|0|||
28060797|NCT00335556|54716887|FG005|Overall Study|Physician Decision|0|||
27814838|NCT04534114|54271543|FG003|Main Treatment Period|COVID-19 pandemic: Death|2|||
27814839|NCT04534114|54271540|FG000|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
27814840|NCT04534114|54271541|FG001|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
27814841|NCT04534114|54271542|FG002|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
27814842|NCT04534114|54271543|FG003|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
27814843|NCT04534114|54271540|FG000|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
27814844|NCT04534114|54271541|FG001|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
27814845|NCT04534114|54271542|FG002|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
27814846|NCT04534114|54271543|FG003|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
27814847|NCT04534114|54271540|FG000|Main Treatment Period|Physician Decision|0|||
27814848|NCT04534114|54271541|FG001|Main Treatment Period|Physician Decision|0|||
27814849|NCT04534114|54271542|FG002|Main Treatment Period|Physician Decision|0|||
27814850|NCT04534114|54271543|FG003|Main Treatment Period|Physician Decision|1|||
27814851|NCT04534114|54271540|FG000|Main Treatment Period|Death|1|||
27814852|NCT04534114|54271541|FG001|Main Treatment Period|Death|0|||
27814853|NCT04534114|54271542|FG002|Main Treatment Period|Death|0|||
27814854|NCT04534114|54271543|FG003|Main Treatment Period|Death|1|||
27814855|NCT04534114|54271540|FG000|Main Treatment Period|Other reason|1|||
27814856|NCT04534114|54271541|FG001|Main Treatment Period|Other reason|1|||
27814857|NCT04534114|54271542|FG002|Main Treatment Period|Other reason|0|||
27814858|NCT04534114|54271543|FG003|Main Treatment Period|Other reason|0|||
27814859|NCT04534114|54271540|FG000|Main Treatment Period|Participant decision|1|||
27814860|NCT04534114|54271541|FG001|Main Treatment Period|Participant decision|3|||
27814861|NCT04534114|54271542|FG002|Main Treatment Period|Participant decision|3|||
27814862|NCT04534114|54271543|FG003|Main Treatment Period|Participant decision|1|||
27814863|NCT04534114|54271540|FG000|Main Treatment Period|Protocol-specified withdrawal criterion met|2|||
27814864|NCT04534114|54271541|FG001|Main Treatment Period|Protocol-specified withdrawal criterion met|1|||
27814865|NCT04534114|54271542|FG002|Main Treatment Period|Protocol-specified withdrawal criterion met|4|||
27814866|NCT04534114|54271543|FG003|Main Treatment Period|Protocol-specified withdrawal criterion met|6|||
27848339|NCT01044459|54341308|FG000|Overall Study|Adverse Event|22|||
27848340|NCT01044459|54341309|FG001|Overall Study|Adverse Event|20|||
28060798|NCT00335556|54716882|FG000|Overall Study|Ineligible|2|||
28060799|NCT00335556|54716883|FG001|Overall Study|Ineligible|0|||
28060800|NCT00335556|54716884|FG002|Overall Study|Ineligible|0|||
28060801|NCT00335556|54716885|FG003|Overall Study|Ineligible|0|||
28060802|NCT00335556|54716886|FG004|Overall Study|Ineligible|0|||
28060803|NCT00335556|54716887|FG005|Overall Study|Ineligible|0|||
28060804|NCT00335556|54716882|FG000|Overall Study|Refusal of further protocol therapy|0|||
28060805|NCT00335556|54716883|FG001|Overall Study|Refusal of further protocol therapy|4|||
27814867|NCT04534114|54271540|FG000|Main Treatment Period|Adverse Event|4|||
27814868|NCT04534114|54271541|FG001|Main Treatment Period|Adverse Event|2|||
27814869|NCT04534114|54271542|FG002|Main Treatment Period|Adverse Event|1|||
27814870|NCT04534114|54271543|FG003|Main Treatment Period|Adverse Event|2|||
27814871|NCT04534114|54271540|FG000|Extension Treatment Period|COVID-19 pandemic: Death|0|||
27814872|NCT04534114|54271541|FG001|Extension Treatment Period|COVID-19 pandemic: Death|0|||
27814873|NCT04534114|54271542|FG002|Extension Treatment Period|COVID-19 pandemic: Death|0|||
27814874|NCT04534114|54271543|FG003|Extension Treatment Period|COVID-19 pandemic: Death|1|||
27814875|NCT04534114|54271540|FG000|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
27814876|NCT04534114|54271541|FG001|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
27814877|NCT04534114|54271542|FG002|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
27814878|NCT04534114|54271543|FG003|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
27814879|NCT04534114|54271540|FG000|Extension Treatment Period|Other reason|0|||
27814880|NCT04534114|54271541|FG001|Extension Treatment Period|Other reason|1|||
27814881|NCT04534114|54271542|FG002|Extension Treatment Period|Other reason|0|||
27814882|NCT04534114|54271543|FG003|Extension Treatment Period|Other reason|0|||
27814883|NCT04534114|54271540|FG000|Extension Treatment Period|Death|0|||
27814884|NCT04534114|54271541|FG001|Extension Treatment Period|Death|0|||
27814885|NCT04534114|54271542|FG002|Extension Treatment Period|Death|1|||
28060806|NCT00335556|54716884|FG002|Overall Study|Refusal of further protocol therapy|0|||
28060807|NCT00335556|54716885|FG003|Overall Study|Refusal of further protocol therapy|1|||
28060808|NCT00335556|54716886|FG004|Overall Study|Refusal of further protocol therapy|0|||
27848341|NCT01044459|54341308|FG000|Overall Study|Lack of Efficacy|23|||
28060809|NCT00335556|54716887|FG005|Overall Study|Refusal of further protocol therapy|0|||
28060810|NCT00518687|54716908|FG000|Overall Study|Adverse Event|201|||
28060811|NCT00518687|54716909|FG001|Overall Study|Adverse Event|177|||
28060812|NCT00518687|54716908|FG000|Overall Study|Lost to Follow-up|144|||
28060813|NCT00518687|54716909|FG001|Overall Study|Lost to Follow-up|155|||
28060814|NCT00518687|54716908|FG000|Overall Study|Physician Decision|42|||
28060815|NCT00518687|54716909|FG001|Overall Study|Physician Decision|48|||
28060816|NCT00518687|54716908|FG000|Overall Study|Progressive disease|2|||
28060817|NCT00518687|54716909|FG001|Overall Study|Progressive disease|2|||
28060818|NCT00518687|54716908|FG000|Overall Study|Protocol Violation|8|||
28060819|NCT00518687|54716909|FG001|Overall Study|Protocol Violation|10|||
28060820|NCT00518687|54716908|FG000|Overall Study|Study terminated by sponsor|930|||
28060821|NCT00518687|54716909|FG001|Overall Study|Study terminated by sponsor|918|||
28060822|NCT00518687|54716908|FG000|Overall Study|Withdrawal by Subject|110|||
28060823|NCT00518687|54716909|FG001|Overall Study|Withdrawal by Subject|110|||
28060824|NCT00134056|54716917|FG000|Randomization|Not eligible for assigned treatment|22|||
28060825|NCT00134056|54716918|FG001|Randomization|Not eligible for assigned treatment|20|||
28060826|NCT00134056|54716917|FG000|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
28060827|NCT00134056|54716918|FG001|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
28060828|NCT00134056|54716917|FG000|Eligible for Protocol Assigned Treatment|Adverse Event|81|||
28060829|NCT00134056|54716918|FG001|Eligible for Protocol Assigned Treatment|Adverse Event|67|||
28060830|NCT00134056|54716917|FG000|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20|||
28060831|NCT00134056|54716918|FG001|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21|||
28060832|NCT00134056|54716917|FG000|Eligible for Protocol Assigned Treatment|Other|55|||
28060833|NCT00134056|54716918|FG001|Eligible for Protocol Assigned Treatment|Other|56|||
28060834|NCT00518531|54716929|FG000|Treatment Period 1|Adverse Event|5|||
28060835|NCT00518531|54716930|FG001|Treatment Period 1|Adverse Event|0|||
28060836|NCT00518531|54716929|FG000|Treatment Period 1|Lost to Follow-up|5|||
28060837|NCT00518531|54716930|FG001|Treatment Period 1|Lost to Follow-up|3|||
28060838|NCT00518531|54716929|FG000|Treatment Period 1|Physician Decision|1|||
28060839|NCT00518531|54716930|FG001|Treatment Period 1|Physician Decision|0|||
28060840|NCT00518531|54716929|FG000|Treatment Period 1|Protocol Violation|2|||
28060841|NCT00518531|54716930|FG001|Treatment Period 1|Protocol Violation|0|||
28060842|NCT00518531|54716929|FG000|Treatment Period 1|Withdrawal by Subject|4|||
28060843|NCT00518531|54716930|FG001|Treatment Period 1|Withdrawal by Subject|6|||
28060844|NCT00518531|54716929|FG000|Treatment Period 1|Early crossover|1|||
28060845|NCT00518531|54716930|FG001|Treatment Period 1|Early crossover|3|||
28060846|NCT00518531|54716929|FG000|Treatment Period 2|Withdrawal by Subject|0|||
28060847|NCT00518531|54716930|FG001|Treatment Period 2|Withdrawal by Subject|8|||
28060848|NCT00518531|54716929|FG000|Treatment Period 2|Complete out of scheduled visit window|1|||
28060849|NCT00518531|54716930|FG001|Treatment Period 2|Complete out of scheduled visit window|2|||
28060850|NCT00518531|54716929|FG000|Treatment Period 2|Adverse Event|1|||
28060851|NCT00518531|54716930|FG001|Treatment Period 2|Adverse Event|7|||
28060852|NCT00518531|54716929|FG000|Treatment Period 2|Protocol-specified criteria|0|||
28060853|NCT00518531|54716930|FG001|Treatment Period 2|Protocol-specified criteria|1|||
28060854|NCT00518531|54716929|FG000|Treatment Period 2|Non-compliance|1|||
28060855|NCT00518531|54716930|FG001|Treatment Period 2|Non-compliance|2|||
28060856|NCT00351468|54716938|FG000|Overall Study|Adverse Event|42|||
27814886|NCT04534114|54271543|FG003|Extension Treatment Period|Death|2|||
27814887|NCT04534114|54271540|FG000|Extension Treatment Period|Adverse Event|0|||
28060857|NCT00351468|54716938|FG000|Overall Study|Withdrawal by Subject|39|||
28060858|NCT00351468|54716938|FG000|Overall Study|Various -follow up w clinical team|39|||
28060859|NCT00351468|54716938|FG000|Overall Study|Lack of Efficacy|32|||
28060860|NCT00351468|54716938|FG000|Overall Study|Non-compliance|8|||
28060861|NCT00351468|54716938|FG000|Overall Study|Lost to Follow-up|4|||
28060862|NCT00351468|54716938|FG000|Overall Study|Protocol Violation|3|||
28060863|NCT00523991|54716945|FG000|Overall Study|Adverse Event|6|||
28060864|NCT00523991|54716946|FG001|Overall Study|Adverse Event|5|||
28060865|NCT00523991|54716945|FG000|Overall Study|Protocol Violation|1|||
28060866|NCT00523991|54716946|FG001|Overall Study|Protocol Violation|4|||
28060867|NCT00523991|54716945|FG000|Overall Study|Lost to Follow-up|4|||
28060868|NCT00523991|54716946|FG001|Overall Study|Lost to Follow-up|1|||
28060869|NCT00523991|54716945|FG000|Overall Study|Withdrawal by Subject|7|||
28060870|NCT00523991|54716946|FG001|Overall Study|Withdrawal by Subject|17|||
28060871|NCT00523991|54716945|FG000|Overall Study|Other reason (not specified)|3|||
28060872|NCT00523991|54716946|FG001|Overall Study|Other reason (not specified)|0|||
28060873|NCT00350844|54716952|FG000|Overall Study|Lost to Follow-up|1|||
28060874|NCT00345540|54716956|FG000|Overall Study|Withdrawal by Subject|1|||
28060875|NCT00335322|54716963|FG000|Overall Study|Randomised but withdrew prior to ART sta|1|||
28060876|NCT00335322|54716964|FG001|Overall Study|Randomised but withdrew prior to ART sta|2|||
28060877|NCT00335322|54716965|FG002|Overall Study|Randomised but withdrew prior to ART sta|2|||
28060878|NCT00523367|54716976|FG000|Overall Study|19 screen failures|19|||
28060879|NCT00523367|54716976|FG000|Overall Study|4 Withdrawn by PI|4|||
28060880|NCT03755765|54716983|FG000|Overall Study|Withdrawal by Subject|2|||
28060881|NCT03755765|54716984|FG001|Overall Study|Withdrawal by Subject|4|||
28060882|NCT03755765|54716985|FG002|Overall Study|Withdrawal by Subject|4|||
28060883|NCT00344448|54716993|FG000|Screening|Withdrawal by Subject|0|||
28060884|NCT00344448|54716994|FG001|Screening|Withdrawal by Subject|1|||
28060885|NCT00344448|54716993|FG000|Double Blind, Placebo Controlled|Withdrawal by Subject|1|||
28060886|NCT00344448|54716994|FG001|Double Blind, Placebo Controlled|Withdrawal by Subject|0|||
28060887|NCT00344448|54716993|FG000|Double Blind, Placebo Controlled|Study terminated|1|||
28060888|NCT00344448|54716994|FG001|Double Blind, Placebo Controlled|Study terminated|0|||
28060889|NCT00344448|54716993|FG000|Open Label|Withdrawal by Subject|1|||
28060890|NCT00344448|54716994|FG001|Open Label|Withdrawal by Subject|1|||
28060891|NCT00344448|54716993|FG000|Open Label|Study terminated|1|||
28060892|NCT00344448|54716994|FG001|Open Label|Study terminated|0|||
28060893|NCT00324168|54717002|FG000|Overall Study|Lost to Follow-up|19|||
28060894|NCT00324168|54717003|FG001|Overall Study|Lost to Follow-up|18|||
28060895|NCT00324168|54717002|FG000|Overall Study|Death|3|||
28060896|NCT00324168|54717003|FG001|Overall Study|Death|3|||
28060897|NCT00324168|54717002|FG000|Overall Study|Patient did not visit in f/u window|6|||
28060898|NCT00324168|54717003|FG001|Overall Study|Patient did not visit in f/u window|9|||
28060899|NCT00517829|54717011|FG000|Overall Study|Adverse Event|22|||
28060900|NCT00517829|54717012|FG001|Overall Study|Adverse Event|34|||
28060901|NCT00517829|54717011|FG000|Overall Study|Disease Progression|39|||
28060902|NCT00517829|54717012|FG001|Overall Study|Disease Progression|32|||
28060903|NCT00517829|54717011|FG000|Overall Study|Patient Request|6|||
28060904|NCT00517829|54717012|FG001|Overall Study|Patient Request|5|||
28060905|NCT00517829|54717011|FG000|Overall Study|Investigator Request|5|||
28060906|NCT00517829|54717012|FG001|Overall Study|Investigator Request|3|||
28060907|NCT00517829|54717011|FG000|Overall Study|Other|3|||
28060908|NCT00517829|54717012|FG001|Overall Study|Other|1|||
28060909|NCT00343512|54717018|FG000|Overall Study|Withdrawal by Subject|2|||
28060910|NCT00334542|54717023|FG000|Overall Study|Adverse Event|3|||
28060911|NCT00334542|54717023|FG000|Overall Study|Withdrawal by Subject|1|||
28060912|NCT00334542|54717023|FG000|Overall Study|New cancer diagnosis|1|||
28060913|NCT00112294|54717030|FG000|Overall Study|Still on study|5|||
28060914|NCT00112294|54717031|FG001|Overall Study|Still on study|0|||
28060915|NCT00235443|54717043|FG000|Overall Study|Adverse Event|4|||
28060916|NCT00235443|54717044|FG001|Overall Study|Adverse Event|12|||
28060917|NCT00235443|54717045|FG002|Overall Study|Adverse Event|17|||
27814888|NCT04534114|54271541|FG001|Extension Treatment Period|Adverse Event|1|||
27814889|NCT04534114|54271542|FG002|Extension Treatment Period|Adverse Event|0|||
27814890|NCT04534114|54271543|FG003|Extension Treatment Period|Adverse Event|1|||
28060918|NCT00235443|54717046|FG003|Overall Study|Adverse Event|44|||
28060919|NCT00235443|54717047|FG004|Overall Study|Adverse Event|10|||
28060920|NCT00235443|54717048|FG005|Overall Study|Adverse Event|15|||
28060921|NCT00235443|54717043|FG000|Overall Study|Lack of Efficacy|0|||
28060922|NCT00235443|54717044|FG001|Overall Study|Lack of Efficacy|1|||
28060923|NCT00235443|54717045|FG002|Overall Study|Lack of Efficacy|5|||
28060924|NCT00235443|54717046|FG003|Overall Study|Lack of Efficacy|12|||
28060925|NCT00235443|54717047|FG004|Overall Study|Lack of Efficacy|2|||
28060926|NCT00235443|54717048|FG005|Overall Study|Lack of Efficacy|9|||
28060927|NCT00235443|54717043|FG000|Overall Study|Withdrawal by Subject|3|||
28060928|NCT00235443|54717044|FG001|Overall Study|Withdrawal by Subject|9|||
28060929|NCT00235443|54717045|FG002|Overall Study|Withdrawal by Subject|25|||
28060930|NCT00235443|54717046|FG003|Overall Study|Withdrawal by Subject|24|||
28060931|NCT00235443|54717047|FG004|Overall Study|Withdrawal by Subject|10|||
28060932|NCT00235443|54717048|FG005|Overall Study|Withdrawal by Subject|12|||
28060933|NCT00235443|54717043|FG000|Overall Study|Lost to Follow-up|0|||
28060934|NCT00235443|54717044|FG001|Overall Study|Lost to Follow-up|8|||
28060935|NCT00235443|54717045|FG002|Overall Study|Lost to Follow-up|6|||
28060936|NCT00235443|54717046|FG003|Overall Study|Lost to Follow-up|6|||
28060937|NCT00235443|54717047|FG004|Overall Study|Lost to Follow-up|4|||
28060938|NCT00235443|54717048|FG005|Overall Study|Lost to Follow-up|3|||
28060939|NCT00235443|54717043|FG000|Overall Study|Unsatisfactory compliance|0|||
28060940|NCT00235443|54717044|FG001|Overall Study|Unsatisfactory compliance|2|||
28060941|NCT00235443|54717045|FG002|Overall Study|Unsatisfactory compliance|3|||
28060942|NCT00235443|54717046|FG003|Overall Study|Unsatisfactory compliance|4|||
28060943|NCT00235443|54717047|FG004|Overall Study|Unsatisfactory compliance|1|||
28060944|NCT00235443|54717048|FG005|Overall Study|Unsatisfactory compliance|0|||
28060945|NCT00235443|54717043|FG000|Overall Study|Other reasons for premature termination|1|||
28060946|NCT00235443|54717044|FG001|Overall Study|Other reasons for premature termination|6|||
28060947|NCT00235443|54717045|FG002|Overall Study|Other reasons for premature termination|6|||
28060948|NCT00235443|54717046|FG003|Overall Study|Other reasons for premature termination|7|||
28060949|NCT00235443|54717047|FG004|Overall Study|Other reasons for premature termination|3|||
28060950|NCT00235443|54717048|FG005|Overall Study|Other reasons for premature termination|6|||
28060951|NCT00234039|54717064|FG000|Overall Study|Adverse Event|2|||
28060952|NCT00234039|54717064|FG000|Overall Study|Progression/relapse|34|||
28060953|NCT00234039|54717064|FG000|Overall Study|Other - Not Protocol Specified|3|||
28060954|NCT00234039|54717064|FG000|Overall Study|Ineligible|9|||
28060955|NCT00234039|54717064|FG000|Overall Study|No Protocol Treatment Received|2|||
28060956|NCT00323622|54717076|FG000|Overall Study|Other|30|||
28060957|NCT00323622|54717077|FG001|Overall Study|Other|91|||
28060958|NCT00323622|54717078|FG002|Overall Study|Other|4|||
28060959|NCT00323622|54717079|FG003|Overall Study|Other|12|||
28060960|NCT00323622|54717080|FG004|Overall Study|Other|32|||
28060961|NCT00323622|54717081|FG005|Overall Study|Other|74|||
28060962|NCT00323622|54717082|FG006|Overall Study|Other|5|||
28060963|NCT00323622|54717083|FG007|Overall Study|Other|13|||
28060964|NCT00323622|54717076|FG000|Overall Study|Death|1|||
28060965|NCT00323622|54717077|FG001|Overall Study|Death|1|||
28060966|NCT00323622|54717078|FG002|Overall Study|Death|0|||
28060967|NCT00323622|54717079|FG003|Overall Study|Death|0|||
28060968|NCT00323622|54717080|FG004|Overall Study|Death|7|||
28060969|NCT00323622|54717081|FG005|Overall Study|Death|0|||
28060970|NCT00323622|54717082|FG006|Overall Study|Death|0|||
28060971|NCT00323622|54717083|FG007|Overall Study|Death|2|||
28060972|NCT00189423|54717111|FG000|Overall Study|Death|746|||
28060973|NCT00189423|54717112|FG001|Overall Study|Death|747|||
28060974|NCT00189423|54717111|FG000|Overall Study|Withdrawal by Subject|9|||
28060975|NCT00189423|54717112|FG001|Overall Study|Withdrawal by Subject|9|||
28060976|NCT00189423|54717111|FG000|Overall Study|Lost to Follow-up|10|||
28060977|NCT00189423|54717112|FG001|Overall Study|Lost to Follow-up|10|||
28060978|NCT00323310|54717118|FG000|Overall Study|Withdrawal by Subject|1|||
28060979|NCT00323310|54717118|FG000|Overall Study|a parent refused blood draw|1|||
28060980|NCT00323310|54717118|FG000|Overall Study|did not complete the 24-hr f-up visit|1|||
28060981|NCT00186537|54717125|FG000|Overall Study|Withdrawal by Subject|4|||
28060982|NCT00186537|54717126|FG001|Overall Study|Withdrawal by Subject|0|||
28060983|NCT00186537|54717127|FG002|Overall Study|Withdrawal by Subject|3|||
28060984|NCT00186537|54717125|FG000|Overall Study|ALT > 1.5 x ULN|3|||
28060985|NCT00186537|54717126|FG001|Overall Study|ALT > 1.5 x ULN|0|||
28060986|NCT00186537|54717127|FG002|Overall Study|ALT > 1.5 x ULN|0|||
28060987|NCT00517751|54717135|FG000|Overall Study|Death|3|||
28060988|NCT00517751|54717135|FG000|Overall Study|Withdrawal by Subject|37|||
28060989|NCT00517751|54717135|FG000|Overall Study|Lost to Follow-up|4|||
28060990|NCT00517751|54717135|FG000|Overall Study|patient not over due|6|||
28060991|NCT00517751|54717135|FG000|Overall Study|Patient not due for visit|76|||
28060992|NCT00517751|54717135|FG000|Overall Study|Missing|3|||
28060993|NCT00322842|54717141|FG000|Overall Study|Withdrawal by Subject|0|||
28060994|NCT00322842|54717142|FG001|Overall Study|Withdrawal by Subject|1|||
28060995|NCT00322842|54717141|FG000|Overall Study|Lost to Follow-up|0|||
28060996|NCT00322842|54717142|FG001|Overall Study|Lost to Follow-up|1|||
28060997|NCT00322842|54717141|FG000|Overall Study|Refused transplant|1|||
28060998|NCT00322842|54717142|FG001|Overall Study|Refused transplant|0|||
28060999|NCT00322842|54717141|FG000|Overall Study|Death|1|||
28061000|NCT00322842|54717142|FG001|Overall Study|Death|0|||
27848342|NCT01044459|54341309|FG001|Overall Study|Lack of Efficacy|12|||
28061001|NCT00255723|54717151|FG000|Overall Study|Adverse Event|1|||
28061002|NCT00255723|54717152|FG001|Overall Study|Adverse Event|1|||
28061003|NCT00255723|54717151|FG000|Overall Study|Death|0|||
28061004|NCT00255723|54717152|FG001|Overall Study|Death|1|||
28061005|NCT00255723|54717151|FG000|Overall Study|Response Data Not Available|1|||
28061006|NCT00255723|54717152|FG001|Overall Study|Response Data Not Available|0|||
28061007|NCT00132808|54717161|FG000|Stratum I|Adverse Event|2|||
28061008|NCT00132808|54717162|FG001|Stratum I|Adverse Event|1|||
28061009|NCT00132808|54717163|FG002|Stratum I|Adverse Event|0|||
28061010|NCT00132808|54717161|FG000|Stratum I|Lost to Follow-up|3|||
28061011|NCT00132808|54717162|FG001|Stratum I|Lost to Follow-up|4|||
28061012|NCT00132808|54717163|FG002|Stratum I|Lost to Follow-up|1|||
28061013|NCT00132808|54717161|FG000|Stratum I|Withdrawal by Subject|4|||
28061014|NCT00132808|54717162|FG001|Stratum I|Withdrawal by Subject|7|||
28061015|NCT00132808|54717163|FG002|Stratum I|Withdrawal by Subject|3|||
28061016|NCT00132808|54717161|FG000|Stratum I|Abnormal test procedure result (s)|0|||
28061017|NCT00132808|54717162|FG001|Stratum I|Abnormal test procedure result (s)|0|||
28061018|NCT00132808|54717163|FG002|Stratum I|Abnormal test procedure result (s)|1|||
28061019|NCT00132808|54717161|FG000|Stratum II|Adverse Event|1|||
28061020|NCT00132808|54717162|FG001|Stratum II|Adverse Event|2|||
28061021|NCT00132808|54717163|FG002|Stratum II|Adverse Event|1|||
28061022|NCT00132808|54717161|FG000|Stratum II|Death|1|||
28061023|NCT00132808|54717162|FG001|Stratum II|Death|0|||
28061024|NCT00132808|54717163|FG002|Stratum II|Death|0|||
28061025|NCT00132808|54717161|FG000|Stratum II|Lost to Follow-up|2|||
28061026|NCT00132808|54717162|FG001|Stratum II|Lost to Follow-up|2|||
28061027|NCT00132808|54717163|FG002|Stratum II|Lost to Follow-up|1|||
28061028|NCT00132808|54717161|FG000|Stratum II|Protocol Violation|0|||
28061029|NCT00132808|54717162|FG001|Stratum II|Protocol Violation|2|||
28061030|NCT00132808|54717163|FG002|Stratum II|Protocol Violation|1|||
28061031|NCT00132808|54717161|FG000|Stratum II|Withdrawal by Subject|4|||
28061032|NCT00132808|54717162|FG001|Stratum II|Withdrawal by Subject|9|||
28061033|NCT00132808|54717163|FG002|Stratum II|Withdrawal by Subject|6|||
28061034|NCT00517361|54717171|FG000|Overall Study|Death|6|||
28061035|NCT00517361|54717171|FG000|Overall Study|The study was terminated|5|||
28061036|NCT00516893|54717175|FG000|Overall Study|Lost to Follow-up|4|||
28061037|NCT00516893|54717175|FG000|Overall Study|Adverse Event|3|||
28061038|NCT00516893|54717175|FG000|Overall Study|Withdrawal by Subject|2|||
28061039|NCT00516893|54717175|FG000|Overall Study|Noncompliance|2|||
28061040|NCT00516893|54717175|FG000|Overall Study|Death|1|||
28061041|NCT00516893|54717175|FG000|Overall Study|Persistent Antibodies per Protocol|6|||
28061042|NCT00516893|54717175|FG000|Overall Study|Relocated|1|||
28061043|NCT00516893|54717175|FG000|Overall Study|Pregnancy|1|||
28061044|NCT00516893|54717175|FG000|Overall Study|Received Medication From Another Study|1|||
28061045|NCT00522431|54717179|FG000|Overall Study|Adverse Event|5|||
28061046|NCT00522431|54717179|FG000|Overall Study|Protocol Violation|2|||
28061047|NCT00522431|54717179|FG000|Overall Study|Withdrawal by Subject|2|||
28061048|NCT00522431|54717179|FG000|Overall Study|Subject non-compliance|1|||
28061049|NCT00522431|54717179|FG000|Overall Study|Other/unknown|1|||
28061050|NCT00185211|54717185|FG000|Placebo-controlled Study (92012)|Adverse Event|8|||
28061051|NCT00185211|54717186|FG001|Placebo-controlled Study (92012)|Adverse Event|0|||
28061052|NCT00185211|54717185|FG000|Placebo-controlled Study (92012)|Lost to Follow-up|3|||
28061053|NCT00185211|54717186|FG001|Placebo-controlled Study (92012)|Lost to Follow-up|2|||
28061054|NCT00185211|54717185|FG000|Placebo-controlled Study (92012)|Withdrawal by Subject|9|||
28061055|NCT00185211|54717186|FG001|Placebo-controlled Study (92012)|Withdrawal by Subject|7|||
28061056|NCT00185211|54717185|FG000|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0|||
28061057|NCT00185211|54717186|FG001|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1|||
28061058|NCT00185211|54717185|FG000|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1|||
28061059|NCT00185211|54717186|FG001|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0|||
28061060|NCT00185211|54717185|FG000|Follow-up Study (91031 - This Study)|Adverse Event|5|||
28061061|NCT00185211|54717186|FG001|Follow-up Study (91031 - This Study)|Adverse Event|6|||
28061062|NCT00185211|54717185|FG000|Follow-up Study (91031 - This Study)|Lack of Efficacy|1|||
28061063|NCT00185211|54717186|FG001|Follow-up Study (91031 - This Study)|Lack of Efficacy|0|||
28061064|NCT00185211|54717185|FG000|Follow-up Study (91031 - This Study)|Lost to Follow-up|6|||
28061065|NCT00185211|54717186|FG001|Follow-up Study (91031 - This Study)|Lost to Follow-up|4|||
28061066|NCT00185211|54717185|FG000|Follow-up Study (91031 - This Study)|Physician Decision|1|||
28061067|NCT00185211|54717186|FG001|Follow-up Study (91031 - This Study)|Physician Decision|0|||
28061068|NCT00185211|54717185|FG000|Follow-up Study (91031 - This Study)|Pregnancy|0|||
28061069|NCT00185211|54717186|FG001|Follow-up Study (91031 - This Study)|Pregnancy|1|||
28061070|NCT00185211|54717185|FG000|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13|||
27848343|NCT01044459|54341308|FG000|Overall Study|Protocol Violation|11|||
27848344|NCT01044459|54341309|FG001|Overall Study|Protocol Violation|16|||
28061071|NCT00185211|54717186|FG001|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21|||
28061072|NCT00185211|54717185|FG000|Follow-up Study (91031 - This Study)|other disease modif. treatment|0|||
28061073|NCT00185211|54717186|FG001|Follow-up Study (91031 - This Study)|other disease modif. treatment|2|||
28061074|NCT00516737|54717195|FG000|Overall Study|Lost to Follow-up|2|||
28061075|NCT00516737|54717196|FG001|Overall Study|Lost to Follow-up|0|||
28061076|NCT00516737|54717195|FG000|Overall Study|Physician Decision|0|||
28061077|NCT00516737|54717196|FG001|Overall Study|Physician Decision|1|||
28061078|NCT00516737|54717195|FG000|Overall Study|Withdrawal by Subject|0|||
28061079|NCT00516737|54717196|FG001|Overall Study|Withdrawal by Subject|1|||
28061080|NCT00516737|54717195|FG000|Overall Study|Lack of Qualifying Event|9|||
28061081|NCT00516737|54717196|FG001|Overall Study|Lack of Qualifying Event|6|||
28061082|NCT00132730|54717206|FG000|Period II - 12-week Treatment (Base)|Clinical adverse experience|11|||
28061083|NCT00132730|54717207|FG001|Period II - 12-week Treatment (Base)|Clinical adverse experience|4|||
28061084|NCT00132730|54717208|FG002|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
28061085|NCT00132730|54717209|FG003|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
28061086|NCT00132730|54717210|FG004|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
28061087|NCT00132730|54717211|FG005|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
28061088|NCT00132730|54717206|FG000|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
28061089|NCT00132730|54717207|FG001|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
28061090|NCT00132730|54717208|FG002|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
28061091|NCT00132730|54717209|FG003|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
28061092|NCT00132730|54717210|FG004|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
28061093|NCT00132730|54717211|FG005|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
28061094|NCT00132730|54717206|FG000|Period II - 12-week Treatment (Base)|Other reasons|11|||
28061095|NCT00132730|54717207|FG001|Period II - 12-week Treatment (Base)|Other reasons|10|||
27814891|NCT04534114|54271540|FG000|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
27814892|NCT04534114|54271541|FG001|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
27814893|NCT04534114|54271542|FG002|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|0|||
27814894|NCT04534114|54271543|FG003|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|1|||
27814895|NCT04474366|54271564|FG000|Overall Study|Lost to Follow-up|2|||
27814896|NCT04474366|54271565|FG001|Overall Study|Lost to Follow-up|5|||
27814897|NCT04422431|54271571|FG000|Treatment Period (48 Weeks)|Adverse Event|3|||
27814898|NCT04422431|54271571|FG000|Treatment Period (48 Weeks)|Withdrawal by Subject|1|||
27814899|NCT04422431|54271571|FG000|Treatment Period (48 Weeks)|Other than specified|1|||
27814900|NCT04422431|54271571|FG000|Extension Period (48 Weeks)|ongoing in the Extension Period|25|||
27814901|NCT04115488|54271582|FG000|Overall Study|Adverse Event|8|||
27814902|NCT04115488|54271583|FG001|Overall Study|Adverse Event|4|||
27814903|NCT04115488|54271582|FG000|Overall Study|Withdrawal by Subject|3|||
27814904|NCT04115488|54271583|FG001|Overall Study|Withdrawal by Subject|6|||
27814905|NCT04115488|54271582|FG000|Overall Study|Investigator/ Sponsor Decision|2|||
27814906|NCT04115488|54271583|FG001|Overall Study|Investigator/ Sponsor Decision|0|||
27814907|NCT04115488|54271582|FG000|Overall Study|Patient 's location change|1|||
27814908|NCT04115488|54271583|FG001|Overall Study|Patient 's location change|0|||
27814909|NCT04115488|54271582|FG000|Overall Study|Due to COVID-19 restrictions at site|0|||
27814910|NCT04115488|54271583|FG001|Overall Study|Due to COVID-19 restrictions at site|1|||
27814911|NCT04080752|54271607|FG000|Overall Study|Adverse Event|2|||
27814912|NCT04080752|54271608|FG001|Overall Study|Adverse Event|3|||
27814913|NCT04080752|54271607|FG000|Overall Study|Lack of Efficacy|1|||
27814914|NCT04080752|54271608|FG001|Overall Study|Lack of Efficacy|0|||
27814915|NCT04080752|54271607|FG000|Overall Study|Lost to Follow-up|1|||
27814916|NCT04080752|54271608|FG001|Overall Study|Lost to Follow-up|0|||
27814917|NCT04080752|54271607|FG000|Overall Study|Pregnancy|0|||
27814918|NCT04080752|54271608|FG001|Overall Study|Pregnancy|1|||
27814919|NCT04080752|54271607|FG000|Overall Study|Withdrawal by Subject|7|||
27814920|NCT04080752|54271608|FG001|Overall Study|Withdrawal by Subject|0|||
27814921|NCT04080752|54271607|FG000|Overall Study|Non-Compliance with Study Drug|0|||
27814922|NCT04080752|54271608|FG001|Overall Study|Non-Compliance with Study Drug|1|||
27814923|NCT04080752|54271607|FG000|Overall Study|Other|2|||
27814924|NCT04080752|54271608|FG001|Overall Study|Other|1|||
28061096|NCT00132730|54717208|FG002|Period II - 12-week Treatment (Base)|Other reasons|9|||
28061097|NCT00132730|54717209|FG003|Period II - 12-week Treatment (Base)|Other reasons|13|||
28061098|NCT00132730|54717210|FG004|Period II - 12-week Treatment (Base)|Other reasons|0|||
28061099|NCT00132730|54717211|FG005|Period II - 12-week Treatment (Base)|Other reasons|0|||
28061100|NCT00132730|54717206|FG000|Period III - Blinded Extension (EXT1)|Site terminated|0|||
28061101|NCT00132730|54717207|FG001|Period III - Blinded Extension (EXT1)|Site terminated|0|||
28061102|NCT00132730|54717208|FG002|Period III - Blinded Extension (EXT1)|Site terminated|57|||
28061103|NCT00132730|54717209|FG003|Period III - Blinded Extension (EXT1)|Site terminated|20|||
28061104|NCT00132730|54717210|FG004|Period III - Blinded Extension (EXT1)|Site terminated|0|||
28061105|NCT00132730|54717211|FG005|Period III - Blinded Extension (EXT1)|Site terminated|0|||
28061106|NCT00132730|54717206|FG000|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
28061107|NCT00132730|54717207|FG001|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
27814925|NCT03968419|54271618|FG000|Treatment Period|Adverse Event|0|||
27814926|NCT03968419|54271619|FG001|Treatment Period|Adverse Event|0|||
27814927|NCT03968419|54271620|FG002|Treatment Period|Adverse Event|1|||
27814928|NCT03968419|54271618|FG000|Safety Follow-up Period|Death|3|||
27814929|NCT03968419|54271619|FG001|Safety Follow-up Period|Death|2|||
27814930|NCT03968419|54271620|FG002|Safety Follow-up Period|Death|1|||
27814931|NCT03968419|54271618|FG000|Safety Follow-up Period|Subject Decision|2|||
27814932|NCT03968419|54271619|FG001|Safety Follow-up Period|Subject Decision|1|||
27814933|NCT03968419|54271620|FG002|Safety Follow-up Period|Subject Decision|0|||
28061108|NCT00132730|54717208|FG002|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11|||
28061109|NCT00132730|54717209|FG003|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1|||
28061110|NCT00132730|54717210|FG004|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
28061111|NCT00132730|54717211|FG005|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
28061112|NCT00132730|54717206|FG000|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
28061113|NCT00132730|54717207|FG001|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
28061114|NCT00132730|54717208|FG002|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
28061115|NCT00132730|54717209|FG003|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1|||
28061116|NCT00132730|54717210|FG004|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
28061117|NCT00132730|54717211|FG005|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
28061118|NCT00132730|54717206|FG000|Period III - Blinded Extension (EXT1)|Other reasons|0|||
28061119|NCT00132730|54717207|FG001|Period III - Blinded Extension (EXT1)|Other reasons|0|||
28061120|NCT00132730|54717208|FG002|Period III - Blinded Extension (EXT1)|Other reasons|14|||
28061121|NCT00132730|54717209|FG003|Period III - Blinded Extension (EXT1)|Other reasons|3|||
28061122|NCT00132730|54717210|FG004|Period III - Blinded Extension (EXT1)|Other reasons|0|||
28061123|NCT00132730|54717211|FG005|Period III - Blinded Extension (EXT1)|Other reasons|0|||
27814934|NCT03816332|54271640|FG000|Nivolumab, Tacrolimus, and Prednisone|Did not receive Nivolumab|2|||
27814935|NCT03816332|54271640|FG000|Nivolumab, Tacrolimus, and Prednisone|Death|2|||
27814936|NCT03784846|54271649|FG000|Pre-COVID Study|Lost to Follow-up|3|||
28061124|NCT00132730|54717206|FG000|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
28061125|NCT00132730|54717207|FG001|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
28061126|NCT00132730|54717208|FG002|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
28061127|NCT00132730|54717209|FG003|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
28061128|NCT00132730|54717210|FG004|Period IV - Open-label Extension (EXT2)|Site terminated|169|||
28061129|NCT00132730|54717211|FG005|Period IV - Open-label Extension (EXT2)|Site terminated|68|||
28061130|NCT00132730|54717206|FG000|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
28061131|NCT00132730|54717207|FG001|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
28061132|NCT00132730|54717208|FG002|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
28061133|NCT00132730|54717209|FG003|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
28061134|NCT00132730|54717210|FG004|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3|||
28061135|NCT00132730|54717211|FG005|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
28061136|NCT00132730|54717206|FG000|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
28061137|NCT00132730|54717207|FG001|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
28061138|NCT00132730|54717208|FG002|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
28061139|NCT00132730|54717209|FG003|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
28061140|NCT00132730|54717210|FG004|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1|||
28061141|NCT00132730|54717211|FG005|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
28061142|NCT00132730|54717206|FG000|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
28061143|NCT00132730|54717207|FG001|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
28061144|NCT00132730|54717208|FG002|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
28061145|NCT00132730|54717209|FG003|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
28061146|NCT00132730|54717210|FG004|Period IV - Open-label Extension (EXT2)|Other reasons|6|||
28061147|NCT00132730|54717211|FG005|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
28061148|NCT00132730|54717206|FG000|Period V - Open-label Extension (EXT2)|Site terminated|0|||
28061149|NCT00132730|54717207|FG001|Period V - Open-label Extension (EXT2)|Site terminated|0|||
28061150|NCT00132730|54717208|FG002|Period V - Open-label Extension (EXT2)|Site terminated|0|||
28061151|NCT00132730|54717209|FG003|Period V - Open-label Extension (EXT2)|Site terminated|0|||
28061152|NCT00132730|54717210|FG004|Period V - Open-label Extension (EXT2)|Site terminated|7|||
28061153|NCT00132730|54717211|FG005|Period V - Open-label Extension (EXT2)|Site terminated|2|||
28061154|NCT00232557|54717227|FG000|Overall Study|Lost to Follow-up|3|||
28061155|NCT00232557|54717228|FG001|Overall Study|Lost to Follow-up|5|||
28061156|NCT00522275|54717234|FG000|Overall Study|Adverse Event|35|||
28061157|NCT00522275|54717234|FG000|Overall Study|Lack of Efficacy|80|||
28061158|NCT00522275|54717234|FG000|Overall Study|Subject withdrew consent|16|||
28061159|NCT00522275|54717234|FG000|Overall Study|Protocol deviation|1|||
28061160|NCT00522275|54717234|FG000|Overall Study|Unsatisfactory compliance|11|||
28061161|NCT00522275|54717234|FG000|Overall Study|Lost to Follow-up|8|||
28061162|NCT00522275|54717234|FG000|Overall Study|Other: Subject wants to become pregnant|2|||
28061163|NCT00522275|54717234|FG000|Overall Study|Other: Subject is pregnant|2|||
28061164|NCT00522275|54717234|FG000|Overall Study|Other: Subject relocated|2|||
28061165|NCT00522275|54717234|FG000|Overall Study|Other: Subject arrested|1|||
27814937|NCT03784846|54271650|FG001|Pre-COVID Study|Lost to Follow-up|3|||
27814938|NCT03784846|54271651|FG002|Pre-COVID Study|Lost to Follow-up|2|||
28061166|NCT00522275|54717234|FG000|Overall Study|Other: Site / clinic closed|4|||
28061167|NCT00522275|54717234|FG000|Overall Study|Other: Travel to / from site difficulty|3|||
28061168|NCT00522275|54717234|FG000|Overall Study|Other: Sponsor request|2|||
28061169|NCT00522275|54717234|FG000|Overall Study|Other: Subject ran out of medication|1|||
28061170|NCT00522275|54717234|FG000|Overall Study|Other: Subject had surgery for epilepsy|2|||
28061171|NCT00522041|54717240|FG000|Overall Study|Adverse Event|9|||
28061172|NCT00522041|54717241|FG001|Overall Study|Adverse Event|3|||
28061173|NCT00522041|54717240|FG000|Overall Study|Protocol Violation|2|||
28061174|NCT00522041|54717241|FG001|Overall Study|Protocol Violation|0|||
28061175|NCT00522041|54717240|FG000|Overall Study|Lost to Follow-up|1|||
28061176|NCT00522041|54717241|FG001|Overall Study|Lost to Follow-up|4|||
28061177|NCT00522041|54717240|FG000|Overall Study|Voluntary withdrawal|5|||
28061178|NCT00522041|54717241|FG001|Overall Study|Voluntary withdrawal|4|||
28061179|NCT00522041|54717240|FG000|Overall Study|Did not receive treatment|0|||
28061180|NCT00522041|54717241|FG001|Overall Study|Did not receive treatment|1|||
28061181|NCT00122980|54717250|FG000|Overall Study|Death|0|||
28061182|NCT00122980|54717251|FG001|Overall Study|Death|1|||
28061183|NCT00122980|54717250|FG000|Overall Study|Physician Decision|2|||
28061184|NCT00122980|54717251|FG001|Overall Study|Physician Decision|0|||
28061185|NCT00122980|54717250|FG000|Overall Study|Protocol Violation|5|||
28061186|NCT00122980|54717251|FG001|Overall Study|Protocol Violation|1|||
28061187|NCT00122980|54717250|FG000|Overall Study|Withdrawal by Subject|2|||
28061188|NCT00122980|54717251|FG001|Overall Study|Withdrawal by Subject|3|||
28061189|NCT00122980|54717250|FG000|Overall Study|Adjudicated stroke (study endpoint)|7|||
28061190|NCT00122980|54717251|FG001|Overall Study|Adjudicated stroke (study endpoint)|0|||
28061191|NCT00122980|54717250|FG000|Overall Study|Study termination|27|||
28061192|NCT00122980|54717251|FG001|Overall Study|Study termination|35|||
28061193|NCT03868631|54717259|FG000|Baseline to Week 6|Adverse Event|0|||
28061194|NCT03868631|54717260|FG001|Baseline to Week 6|Adverse Event|3|||
28061195|NCT03868631|54717259|FG000|Baseline to Week 6|Protocol Violation|1|||
28061196|NCT03868631|54717260|FG001|Baseline to Week 6|Protocol Violation|1|||
28061197|NCT03868631|54717259|FG000|Baseline to Week 6|Withdrawal by Subject|3|||
28061198|NCT03868631|54717260|FG001|Baseline to Week 6|Withdrawal by Subject|0|||
28061199|NCT03868631|54717259|FG000|Week 6 to Week 12 (Study Completion)|Adverse Event|2|||
28061200|NCT03868631|54717260|FG001|Week 6 to Week 12 (Study Completion)|Adverse Event|0|||
28061201|NCT03868631|54717259|FG000|Week 6 to Week 12 (Study Completion)|Protocol Violation|1|||
28061202|NCT03868631|54717260|FG001|Week 6 to Week 12 (Study Completion)|Protocol Violation|0|||
28061203|NCT03868631|54717259|FG000|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
28061204|NCT03868631|54717260|FG001|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
28061205|NCT00340704|54717275|FG000|PK Study|Adverse Event|0|||
28061206|NCT00340704|54717276|FG001|PK Study|Adverse Event|1|||
28061207|NCT00340704|54717277|FG002|PK Study|Adverse Event|0|||
28061208|NCT00340704|54717278|FG003|PK Study|Adverse Event|0|||
28061209|NCT00340704|54717279|FG004|PK Study|Adverse Event|0|||
28061210|NCT00340704|54717280|FG005|PK Study|Adverse Event|0|||
28061211|NCT00340704|54717281|FG006|PK Study|Adverse Event|0|||
28061212|NCT00340704|54717282|FG007|PK Study|Adverse Event|0|||
28061213|NCT00340704|54717283|FG008|PK Study|Adverse Event|0|||
28061214|NCT00340704|54717275|FG000|PK Study|Not treated|0|||
28061215|NCT00340704|54717276|FG001|PK Study|Not treated|0|||
28061216|NCT00340704|54717277|FG002|PK Study|Not treated|1|||
28061217|NCT00340704|54717278|FG003|PK Study|Not treated|0|||
28061218|NCT00340704|54717279|FG004|PK Study|Not treated|0|||
28061219|NCT00340704|54717280|FG005|PK Study|Not treated|0|||
28061220|NCT00340704|54717281|FG006|PK Study|Not treated|0|||
28061221|NCT00340704|54717282|FG007|PK Study|Not treated|0|||
28061222|NCT00340704|54717283|FG008|PK Study|Not treated|0|||
28061223|NCT00340704|54717275|FG000|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
28061224|NCT00340704|54717276|FG001|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
28061225|NCT00340704|54717277|FG002|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
28061226|NCT00340704|54717278|FG003|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2|||
28061227|NCT00340704|54717279|FG004|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4|||
28061228|NCT00340704|54717280|FG005|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
28061229|NCT00340704|54717281|FG006|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
28061230|NCT00340704|54717282|FG007|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
28061231|NCT00340704|54717283|FG008|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
28061232|NCT00340704|54717275|FG000|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
28061233|NCT00340704|54717276|FG001|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
27814939|NCT03784846|54271649|FG000|Pre-COVID Study|Withdrawal by Subject|1|||
27814940|NCT03784846|54271650|FG001|Pre-COVID Study|Withdrawal by Subject|2|||
27814941|NCT03784846|54271651|FG002|Pre-COVID Study|Withdrawal by Subject|1|||
27814942|NCT03784846|54271649|FG000|Pre-COVID Study|Discontinued by Researchers|7|||
27814943|NCT03784846|54271650|FG001|Pre-COVID Study|Discontinued by Researchers|6|||
27814944|NCT03784846|54271651|FG002|Pre-COVID Study|Discontinued by Researchers|2|||
27814945|NCT03784846|54271649|FG000|Post-COVID Study|Lost to Follow-up|3|||
27814946|NCT03784846|54271650|FG001|Post-COVID Study|Lost to Follow-up|5|||
27814947|NCT03784846|54271651|FG002|Post-COVID Study|Lost to Follow-up|1|||
28061234|NCT00340704|54717277|FG002|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
28061235|NCT00340704|54717278|FG003|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
28061236|NCT00340704|54717279|FG004|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
28061237|NCT00340704|54717280|FG005|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1|||
28061238|NCT00340704|54717281|FG006|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
28061239|NCT00340704|54717282|FG007|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
28061240|NCT00340704|54717283|FG008|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
28061241|NCT00340704|54717275|FG000|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
28061242|NCT00340704|54717276|FG001|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
28061243|NCT00340704|54717277|FG002|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
28061244|NCT00340704|54717278|FG003|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
28061245|NCT00340704|54717279|FG004|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1|||
28061246|NCT00340704|54717280|FG005|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3|||
28061247|NCT00340704|54717281|FG006|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
28061248|NCT00340704|54717282|FG007|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
28061249|NCT00340704|54717283|FG008|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
28061250|NCT00340704|54717275|FG000|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
28061251|NCT00340704|54717276|FG001|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
28061252|NCT00340704|54717277|FG002|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
28061253|NCT00340704|54717278|FG003|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
28061254|NCT00340704|54717279|FG004|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
28061255|NCT00340704|54717280|FG005|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3|||
28061256|NCT00340704|54717281|FG006|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53|||
28061257|NCT00340704|54717282|FG007|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11|||
28061258|NCT00340704|54717283|FG008|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28|||
28061259|NCT00132496|54717311|FG000|Overall Study|Withdrawal by Subject|1|||
28061260|NCT00132496|54717312|FG001|Overall Study|Withdrawal by Subject|2|||
28061261|NCT00132496|54717311|FG000|Overall Study|Physician Decision|1|||
28061262|NCT00132496|54717312|FG001|Overall Study|Physician Decision|0|||
28061263|NCT00231777|54717320|FG000|Overall Study|Lost to Follow-up|3|||
28061264|NCT00231777|54717321|FG001|Overall Study|Lost to Follow-up|0|||
28061265|NCT00231777|54717320|FG000|Overall Study|Other|3|||
28061266|NCT00231777|54717321|FG001|Overall Study|Other|2|||
28061267|NCT00231465|54717327|FG000|Overall Study|Completed only one cycle|1|||
28061268|NCT00231465|54717327|FG000|Overall Study|Did not have follow up CT scans|1|||
28061269|NCT00254397|54717335|FG000|Overall Study|Disease Progression|4|||
28061270|NCT00254397|54717336|FG001|Overall Study|Disease Progression|1|||
28061271|NCT00254397|54717337|FG002|Overall Study|Disease Progression|16|||
28061272|NCT00254397|54717338|FG003|Overall Study|Disease Progression|23|||
28061273|NCT00254397|54717335|FG000|Overall Study|Non-Compliant|0|||
28061274|NCT00254397|54717336|FG001|Overall Study|Non-Compliant|0|||
28061275|NCT00254397|54717337|FG002|Overall Study|Non-Compliant|0|||
28061276|NCT00254397|54717338|FG003|Overall Study|Non-Compliant|1|||
28061277|NCT00254397|54717335|FG000|Overall Study|Adverse Event|2|||
28061278|NCT00254397|54717336|FG001|Overall Study|Adverse Event|0|||
28061279|NCT00254397|54717337|FG002|Overall Study|Adverse Event|3|||
27814948|NCT03784846|54271649|FG000|Post-COVID Study|Withdrawal by Subject|1|||
27814949|NCT03784846|54271650|FG001|Post-COVID Study|Withdrawal by Subject|2|||
27814950|NCT03784846|54271651|FG002|Post-COVID Study|Withdrawal by Subject|0|||
28061280|NCT00254397|54717338|FG003|Overall Study|Adverse Event|1|||
28061281|NCT00254163|54717349|FG000|Overall Study|Adverse Event|29|||
28061282|NCT00254163|54717350|FG001|Overall Study|Adverse Event|26|||
28061283|NCT00254163|54717349|FG000|Overall Study|Patient request/withdrew consent|6|||
28061284|NCT00254163|54717350|FG001|Overall Study|Patient request/withdrew consent|4|||
28061285|NCT00254163|54717349|FG000|Overall Study|Investigator request|1|||
28061286|NCT00254163|54717350|FG001|Overall Study|Investigator request|3|||
28061287|NCT00254163|54717349|FG000|Overall Study|Failed entry|1|||
28061288|NCT00254163|54717350|FG001|Overall Study|Failed entry|3|||
28061289|NCT00254163|54717349|FG000|Overall Study|Progressive disease|0|||
28061290|NCT00254163|54717350|FG001|Overall Study|Progressive disease|1|||
28061291|NCT00254163|54717349|FG000|Overall Study|Death|0|||
28061292|NCT00254163|54717350|FG001|Overall Study|Death|1|||
28061293|NCT00254163|54717349|FG000|Overall Study|Other|8|||
28061294|NCT00254163|54717350|FG001|Overall Study|Other|8|||
28061295|NCT03869333|54717360|FG000|Overall Study|Lost to Follow-up|1|||
28061296|NCT03869333|54717361|FG001|Overall Study|Lost to Follow-up|0|||
28061297|NCT03869333|54717362|FG002|Overall Study|Lost to Follow-up|0|||
28061298|NCT03869333|54717363|FG003|Overall Study|Lost to Follow-up|0|||
28061299|NCT03869333|54717360|FG000|Overall Study|Pregnancy|1|||
28061300|NCT03869333|54717361|FG001|Overall Study|Pregnancy|0|||
28061301|NCT03869333|54717362|FG002|Overall Study|Pregnancy|0|||
28061302|NCT03869333|54717363|FG003|Overall Study|Pregnancy|0|||
28061303|NCT03869333|54717360|FG000|Overall Study|Physician Decision|0|||
28061304|NCT03869333|54717361|FG001|Overall Study|Physician Decision|1|||
28061305|NCT03869333|54717362|FG002|Overall Study|Physician Decision|0|||
28061306|NCT03869333|54717363|FG003|Overall Study|Physician Decision|0|||
28061307|NCT00110890|54717375|FG000|Overall Study|Adverse Event|30|||
28061308|NCT00110890|54717376|FG001|Overall Study|Adverse Event|7|||
28061309|NCT00110890|54717375|FG000|Overall Study|Death|16|||
28061310|NCT00110890|54717376|FG001|Overall Study|Death|9|||
28061311|NCT00110890|54717375|FG000|Overall Study|Lost to Follow-up|3|||
28061312|NCT00110890|54717376|FG001|Overall Study|Lost to Follow-up|1|||
28061313|NCT00110890|54717375|FG000|Overall Study|Physician Decision|4|||
28061314|NCT00110890|54717376|FG001|Overall Study|Physician Decision|5|||
28061315|NCT00110890|54717375|FG000|Overall Study|Withdrawal by Subject|17|||
28061316|NCT00110890|54717376|FG001|Overall Study|Withdrawal by Subject|5|||
28061317|NCT00110890|54717375|FG000|Overall Study|Protocol Deviation|1|||
28061318|NCT00110890|54717376|FG001|Overall Study|Protocol Deviation|0|||
28061319|NCT00110890|54717375|FG000|Overall Study|Noncompliance|10|||
28061320|NCT00110890|54717376|FG001|Overall Study|Noncompliance|0|||
28061321|NCT00110890|54717375|FG000|Overall Study|Kidney Transplant|16|||
28061322|NCT00110890|54717376|FG001|Overall Study|Kidney Transplant|12|||
28061323|NCT00110890|54717375|FG000|Overall Study|Invest. Product Commercially Available|217|||
28061324|NCT00110890|54717376|FG001|Overall Study|Invest. Product Commercially Available|110|||
28061325|NCT00110890|54717375|FG000|Overall Study|Other|34|||
28061326|NCT00110890|54717376|FG001|Overall Study|Other|23|||
28061327|NCT00110890|54717375|FG000|Overall Study|Ineligibility determined|3|||
28061328|NCT00110890|54717376|FG001|Overall Study|Ineligibility determined|0|||
28061329|NCT00110890|54717375|FG000|Overall Study|Requirement for alternative therapy|0|||
28061330|NCT00110890|54717376|FG001|Overall Study|Requirement for alternative therapy|1|||
28061331|NCT00110890|54717375|FG000|Overall Study|Disease progression|0|||
28061332|NCT00110890|54717376|FG001|Overall Study|Disease progression|1|||
28061333|NCT00110890|54717375|FG000|Overall Study|Parathyroidectomy|0|||
28061334|NCT00110890|54717376|FG001|Overall Study|Parathyroidectomy|1|||
28061335|NCT00110890|54717375|FG000|Overall Study|Did not enter follow-up phase|10|||
28061336|NCT00110890|54717376|FG001|Overall Study|Did not enter follow-up phase|4|||
28061337|NCT00182637|54717382|FG000|Overall Study|Adverse Event|2|||
28061338|NCT00182637|54717382|FG000|Overall Study|Disease Progression|1|||
28061339|NCT00182325|54717389|FG000|Overall Study|Lost to Follow-up|7|||
27814951|NCT03756350|54271659|FG000|Overall Study|Lost to Follow-up|1|||
27814952|NCT03648996|54271681|FG000|Overall Study|Withdrawal by Subject|0|||
27814953|NCT03648996|54271682|FG001|Overall Study|Withdrawal by Subject|2|||
28061340|NCT00182325|54717390|FG001|Overall Study|Lost to Follow-up|7|||
28061341|NCT00182325|54717389|FG000|Overall Study|Miscarriage|5|||
28061342|NCT00182325|54717390|FG001|Overall Study|Miscarriage|3|||
28061343|NCT00182325|54717389|FG000|Overall Study|Did not complete survey|22|||
28061344|NCT00182325|54717390|FG001|Overall Study|Did not complete survey|43|||
28061345|NCT00122278|54717398|FG000|Overall Study|Lost to Follow-up|2|||
28061346|NCT00122278|54717399|FG001|Overall Study|Lost to Follow-up|0|||
28061347|NCT00182091|54717409|FG000|Overall Study|Withdrawal by Subject|1|||
28061348|NCT00182091|54717410|FG001|Overall Study|Withdrawal by Subject|0|||
28061349|NCT00182091|54717411|FG002|Overall Study|Withdrawal by Subject|0|||
28061350|NCT00182091|54717412|FG003|Overall Study|Withdrawal by Subject|0|||
28061351|NCT00181155|54717420|FG000|Overall Study|Physician Decision|1|||
28061352|NCT00181155|54717421|FG001|Overall Study|Physician Decision|0|||
28061353|NCT00181155|54717420|FG000|Overall Study|Withdrawal by Subject|1|||
28061354|NCT00181155|54717421|FG001|Overall Study|Withdrawal by Subject|0|||
28061355|NCT00322452|54717430|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
28061356|NCT00322452|54717431|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
28061357|NCT00322452|54717430|FG000|Overall Study|Lost to Follow-up|5|||
28061358|NCT00322452|54717431|FG001|Overall Study|Lost to Follow-up|2|||
28061359|NCT00322452|54717430|FG000|Overall Study|Withdrawal by Subject|19|||
28061360|NCT00322452|54717431|FG001|Overall Study|Withdrawal by Subject|46|||
28061361|NCT00322452|54717430|FG000|Overall Study|Death|223|||
28061362|NCT00322452|54717431|FG001|Overall Study|Death|227|||
28061363|NCT00110812|54717440|FG000|Main Study|Death|0|||
28061364|NCT00110812|54717441|FG001|Main Study|Death|0|||
28061365|NCT00110812|54717442|FG002|Main Study|Death|2|||
28061366|NCT00110812|54717440|FG000|Main Study|Withdrawal by Subject|0|||
28061367|NCT00110812|54717441|FG001|Main Study|Withdrawal by Subject|0|||
28061368|NCT00110812|54717442|FG002|Main Study|Withdrawal by Subject|1|||
28061369|NCT00110812|54717440|FG000|Main Study|Lost to Follow-up|8|||
28061370|NCT00110812|54717441|FG001|Main Study|Lost to Follow-up|11|||
28061371|NCT00110812|54717442|FG002|Main Study|Lost to Follow-up|10|||
28061372|NCT00110812|54717440|FG000|Extended Follow-up|Death|1|||
28061373|NCT00110812|54717441|FG001|Extended Follow-up|Death|0|||
28061374|NCT00110812|54717442|FG002|Extended Follow-up|Death|3|||
28061375|NCT00110812|54717440|FG000|Extended Follow-up|Withdrawal by Subject|0|||
28061376|NCT00110812|54717441|FG001|Extended Follow-up|Withdrawal by Subject|1|||
27814954|NCT03648996|54271683|FG002|Overall Study|Withdrawal by Subject|2|||
27814955|NCT03648996|54271681|FG000|Overall Study|Physician Decision|2|||
28061377|NCT00110812|54717442|FG002|Extended Follow-up|Withdrawal by Subject|0|||
27814956|NCT03648996|54271682|FG001|Overall Study|Physician Decision|0|||
28061378|NCT00110812|54717440|FG000|Extended Follow-up|Lost to Follow-up|1|||
28061379|NCT00110812|54717441|FG001|Extended Follow-up|Lost to Follow-up|3|||
28061380|NCT00110812|54717442|FG002|Extended Follow-up|Lost to Follow-up|1|||
28061381|NCT00516269|54717457|FG000|Overall Study|Adverse Event|2|||
28061382|NCT00516269|54717458|FG001|Overall Study|Adverse Event|1|||
28061383|NCT00516269|54717457|FG000|Overall Study|Lost to Follow-up|0|||
28061384|NCT00516269|54717458|FG001|Overall Study|Lost to Follow-up|1|||
28061385|NCT00516269|54717457|FG000|Overall Study|Protocol Violation|0|||
27814957|NCT03648996|54271683|FG002|Overall Study|Physician Decision|0|||
27814958|NCT03562767|54271701|FG000|Overall Study|Physician Decision|2|||
27814959|NCT03562767|54271702|FG001|Overall Study|Physician Decision|0|||
27814960|NCT03562767|54271703|FG002|Overall Study|Physician Decision|0|||
27814961|NCT03562767|54271701|FG000|Overall Study|Logistic Reason|1|||
27814962|NCT03562767|54271702|FG001|Overall Study|Logistic Reason|3|||
27814963|NCT03562767|54271703|FG002|Overall Study|Logistic Reason|0|||
27814964|NCT03483961|54271725|FG000|Overall Study|Lost to Follow-up|7|||
27814965|NCT03483961|54271726|FG001|Overall Study|Lost to Follow-up|6|||
27814966|NCT03483961|54271727|FG002|Overall Study|Lost to Follow-up|6|||
27814967|NCT03483961|54271728|FG003|Overall Study|Lost to Follow-up|6|||
27814968|NCT03483961|54271729|FG004|Overall Study|Lost to Follow-up|6|||
27814969|NCT03483961|54271730|FG005|Overall Study|Lost to Follow-up|4|||
27814970|NCT03483961|54271731|FG006|Overall Study|Lost to Follow-up|4|||
27814971|NCT03483961|54271732|FG007|Overall Study|Lost to Follow-up|11|||
27848345|NCT01044459|54341308|FG000|Overall Study|Other Reason|7|||
28061386|NCT00516269|54717458|FG001|Overall Study|Protocol Violation|1|||
28061387|NCT00229203|54717466|FG000|Overall Study|Progressive disease|18|||
28061388|NCT00229203|54717467|FG001|Overall Study|Progressive disease|9|||
28061389|NCT00229203|54717466|FG000|Overall Study|Toxicity|6|||
28061390|NCT00229203|54717467|FG001|Overall Study|Toxicity|1|||
28061391|NCT00229203|54717466|FG000|Overall Study|Death|4|||
28061392|NCT00229203|54717467|FG001|Overall Study|Death|2|||
28061393|NCT00229203|54717466|FG000|Overall Study|Other|3|||
28061394|NCT00229203|54717467|FG001|Overall Study|Other|3|||
28061395|NCT00229203|54717466|FG000|Overall Study|Withdrawal by Subject|1|||
28061396|NCT00229203|54717467|FG001|Overall Study|Withdrawal by Subject|4|||
27814972|NCT03483961|54271733|FG008|Overall Study|Lost to Follow-up|1|||
27814973|NCT03483961|54271734|FG009|Overall Study|Lost to Follow-up|0|||
27814974|NCT03483961|54271725|FG000|Overall Study|Withdrawal by Subject|3|||
27814975|NCT03483961|54271726|FG001|Overall Study|Withdrawal by Subject|4|||
27814976|NCT03483961|54271727|FG002|Overall Study|Withdrawal by Subject|5|||
28061397|NCT00228813|54717473|FG000|Overall Study|Death|4|||
28061398|NCT00322374|54717480|FG000|Starting Dose|Physician Decision|2|||
27814977|NCT03483961|54271728|FG003|Overall Study|Withdrawal by Subject|3|||
27814978|NCT03483961|54271729|FG004|Overall Study|Withdrawal by Subject|4|||
27814979|NCT03483961|54271730|FG005|Overall Study|Withdrawal by Subject|2|||
27814980|NCT03483961|54271731|FG006|Overall Study|Withdrawal by Subject|1|||
27814981|NCT03483961|54271732|FG007|Overall Study|Withdrawal by Subject|2|||
27814982|NCT03483961|54271733|FG008|Overall Study|Withdrawal by Subject|1|||
27814983|NCT03483961|54271734|FG009|Overall Study|Withdrawal by Subject|0|||
27814984|NCT03483961|54271725|FG000|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|1|||
27814985|NCT03483961|54271726|FG001|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
27814986|NCT03483961|54271727|FG002|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
27814987|NCT03483961|54271728|FG003|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
28061399|NCT00322374|54717481|FG001|Starting Dose|Physician Decision|0|||
27814988|NCT03483961|54271729|FG004|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
27814989|NCT03483961|54271730|FG005|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
28061400|NCT00322374|54717482|FG002|Starting Dose|Physician Decision|0|||
28061401|NCT00322374|54717483|FG003|Starting Dose|Physician Decision|0|||
28061402|NCT00322374|54717480|FG000|Starting Dose|Study Drug Toxicity|4|||
28061403|NCT00322374|54717481|FG001|Starting Dose|Study Drug Toxicity|0|||
28061404|NCT00322374|54717482|FG002|Starting Dose|Study Drug Toxicity|0|||
28061405|NCT00322374|54717483|FG003|Starting Dose|Study Drug Toxicity|0|||
28061406|NCT00322374|54717480|FG000|First Escalation|Documented Disease Progression|0|||
28061407|NCT00322374|54717481|FG001|First Escalation|Documented Disease Progression|6|||
28061408|NCT00322374|54717482|FG002|First Escalation|Documented Disease Progression|0|||
28061409|NCT00322374|54717483|FG003|First Escalation|Documented Disease Progression|0|||
28061410|NCT00322374|54717480|FG000|First Escalation|Physician Decision|0|||
28061411|NCT00322374|54717481|FG001|First Escalation|Physician Decision|12|||
28061412|NCT00322374|54717482|FG002|First Escalation|Physician Decision|0|||
28061413|NCT00322374|54717483|FG003|First Escalation|Physician Decision|0|||
28061414|NCT00322374|54717480|FG000|First Escalation|Study Drug Toxicity|0|||
28061415|NCT00322374|54717481|FG001|First Escalation|Study Drug Toxicity|11|||
28061416|NCT00322374|54717482|FG002|First Escalation|Study Drug Toxicity|0|||
28061417|NCT00322374|54717483|FG003|First Escalation|Study Drug Toxicity|0|||
28061418|NCT00322374|54717480|FG000|First Escalation|Participant Request|0|||
28061419|NCT00322374|54717481|FG001|First Escalation|Participant Request|1|||
28061420|NCT00322374|54717482|FG002|First Escalation|Participant Request|0|||
28061421|NCT00322374|54717483|FG003|First Escalation|Participant Request|0|||
28061422|NCT00322374|54717480|FG000|Second Escalation|Physician Decision|0|||
28061423|NCT00322374|54717481|FG001|Second Escalation|Physician Decision|0|||
28061424|NCT00322374|54717482|FG002|Second Escalation|Physician Decision|5|||
28061425|NCT00322374|54717483|FG003|Second Escalation|Physician Decision|0|||
28061426|NCT00322374|54717480|FG000|Second Escalation|Study Drug Toxicity|0|||
27814990|NCT03483961|54271731|FG006|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
27814991|NCT03483961|54271732|FG007|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
28061427|NCT00322374|54717481|FG001|Second Escalation|Study Drug Toxicity|0|||
28061428|NCT00322374|54717482|FG002|Second Escalation|Study Drug Toxicity|1|||
28061429|NCT00322374|54717483|FG003|Second Escalation|Study Drug Toxicity|0|||
28061430|NCT00174447|54717496|FG000|Overall Study|Adverse Event|19|||
28061431|NCT00174447|54717496|FG000|Overall Study|Withdrawal by Subject|15|||
28061432|NCT00174447|54717496|FG000|Overall Study|Protocol Violation|1|||
28061433|NCT00174447|54717496|FG000|Overall Study|Lack of Efficacy|1|||
28061434|NCT00174447|54717496|FG000|Overall Study|Administrative reason/Other|2|||
28061435|NCT00321984|54717503|FG000|Overall Study|Adverse Event|9|||
28061436|NCT00321984|54717504|FG001|Overall Study|Adverse Event|6|||
28061437|NCT00321984|54717505|FG002|Overall Study|Adverse Event|8|||
28061438|NCT00321984|54717503|FG000|Overall Study|Protocol Violation|0|||
28061439|NCT00321984|54717504|FG001|Overall Study|Protocol Violation|1|||
28061440|NCT00321984|54717505|FG002|Overall Study|Protocol Violation|1|||
28061441|NCT00321984|54717503|FG000|Overall Study|Lost to Follow-up|2|||
28061442|NCT00321984|54717504|FG001|Overall Study|Lost to Follow-up|4|||
28061443|NCT00321984|54717505|FG002|Overall Study|Lost to Follow-up|2|||
28061444|NCT00321984|54717503|FG000|Overall Study|Withdrawal by Subject|8|||
28061445|NCT00321984|54717504|FG001|Overall Study|Withdrawal by Subject|6|||
28061446|NCT00321984|54717505|FG002|Overall Study|Withdrawal by Subject|5|||
28061447|NCT00321984|54717503|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|3|||
28061448|NCT00321984|54717504|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
28061449|NCT00321984|54717505|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
28061450|NCT00321984|54717503|FG000|Overall Study|Lack of Efficacy|3|||
28061451|NCT00321984|54717504|FG001|Overall Study|Lack of Efficacy|1|||
28061452|NCT00321984|54717505|FG002|Overall Study|Lack of Efficacy|3|||
28061453|NCT00321984|54717503|FG000|Overall Study|Noncompliant|0|||
28061454|NCT00321984|54717504|FG001|Overall Study|Noncompliant|0|||
28061455|NCT00321984|54717505|FG002|Overall Study|Noncompliant|2|||
28061456|NCT00321984|54717503|FG000|Overall Study|Pregnancy|0|||
28061457|NCT00321984|54717504|FG001|Overall Study|Pregnancy|1|||
28061458|NCT00321984|54717505|FG002|Overall Study|Pregnancy|0|||
28061459|NCT00321984|54717503|FG000|Overall Study|Per Subject Request|1|||
28061460|NCT00321984|54717504|FG001|Overall Study|Per Subject Request|0|||
28061461|NCT00321984|54717505|FG002|Overall Study|Per Subject Request|0|||
28061462|NCT00321984|54717503|FG000|Overall Study|Per Investigator Request|1|||
28061463|NCT00321984|54717504|FG001|Overall Study|Per Investigator Request|0|||
28061464|NCT00321984|54717505|FG002|Overall Study|Per Investigator Request|0|||
28061465|NCT00321984|54717503|FG000|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
28061466|NCT00321984|54717504|FG001|Overall Study|Per Sponsor Due to High Baseline Gastrin|1|||
28061467|NCT00321984|54717505|FG002|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
28061468|NCT00515099|54717515|FG000|Overall Study|Lost to Follow-up|0|||
28061469|NCT00515099|54717516|FG001|Overall Study|Lost to Follow-up|4|||
28061470|NCT00515099|54717515|FG000|Overall Study|Withdrawal by Subject|2|||
28061471|NCT00515099|54717516|FG001|Overall Study|Withdrawal by Subject|0|||
28061472|NCT00515099|54717515|FG000|Overall Study|IRB Recommendation|1|||
28061473|NCT00515099|54717516|FG001|Overall Study|IRB Recommendation|0|||
28061474|NCT00110266|54717522|FG000|Overall Study|Adverse Event|27|||
28061475|NCT00110266|54717522|FG000|Overall Study|Abnormal laboratory value|15|||
28061476|NCT00110266|54717522|FG000|Overall Study|Withdrawal by Subject|16|||
28061477|NCT00110266|54717522|FG000|Overall Study|Death|17|||
28061478|NCT00110266|54717522|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
28061479|NCT00110266|54717522|FG000|Overall Study|Participant condition no longer requires study drug|1|||
28061480|NCT00174291|54717529|FG000|Overall Study|Lost to Follow-up|1|||
28061481|NCT00174291|54717530|FG001|Overall Study|Lost to Follow-up|1|||
28061482|NCT00174291|54717529|FG000|Overall Study|Protocol Violation|0|||
28061483|NCT00174291|54717530|FG001|Overall Study|Protocol Violation|2|||
28061484|NCT00174291|54717529|FG000|Overall Study|Study terminated by sponsor|1|||
28061485|NCT00174291|54717530|FG001|Overall Study|Study terminated by sponsor|0|||
28061486|NCT00174291|54717529|FG000|Overall Study|Withdrawal by Subject|3|||
28061487|NCT00174291|54717530|FG001|Overall Study|Withdrawal by Subject|3|||
28061488|NCT00366548|54717538|FG000|Infant Series|Adverse Event|1|||
28061489|NCT00366548|54717539|FG001|Infant Series|Adverse Event|3|||
28061490|NCT00366548|54717538|FG000|Infant Series|Protocol Violation|0|||
28061491|NCT00366548|54717539|FG001|Infant Series|Protocol Violation|1|||
28061492|NCT00366548|54717538|FG000|Infant Series|Withdrawal by Subject|3|||
28061493|NCT00366548|54717539|FG001|Infant Series|Withdrawal by Subject|1|||
28061494|NCT00366548|54717538|FG000|After Infant Series|Withdrawal by Subject|3|||
28061495|NCT00366548|54717539|FG001|After Infant Series|Withdrawal by Subject|1|||
28061496|NCT00366548|54717538|FG000|After Infant Series|Adverse Event|2|||
28061497|NCT00366548|54717539|FG001|After Infant Series|Adverse Event|0|||
28061498|NCT00366548|54717538|FG000|After Infant Series|Lost to Follow-up|1|||
28061499|NCT00366548|54717539|FG001|After Infant Series|Lost to Follow-up|0|||
28061500|NCT00252057|54717565|FG000|Overall Study|Withdrawal by Subject|2|||
28061501|NCT00252057|54717566|FG001|Overall Study|Withdrawal by Subject|5|||
28061502|NCT00252057|54717565|FG000|Overall Study|Death|1|||
28061503|NCT00252057|54717566|FG001|Overall Study|Death|2|||
28061504|NCT00252057|54717565|FG000|Overall Study|Participant previously enrolled|0|||
28061505|NCT00252057|54717566|FG001|Overall Study|Participant previously enrolled|1|||
28061506|NCT00132028|54717572|FG000|Overall Study|Adverse Event|7|||
28061507|NCT00132028|54717572|FG000|Overall Study|Death|2|||
28061508|NCT00132028|54717572|FG000|Overall Study|Lack of Efficacy|11|||
28061509|NCT00132028|54717572|FG000|Overall Study|Withdrawal by Subject|2|||
28061510|NCT00132028|54717572|FG000|Overall Study|not eligible|2|||
28061511|NCT00132028|54717572|FG000|Overall Study|Physician Decision|3|||
28061512|NCT00131248|54717576|FG000|Intervention 1 (3-day Course)|Withdrawal by Subject|1|||
28061513|NCT00131248|54717577|FG001|Intervention 1 (3-day Course)|Withdrawal by Subject|0|||
28061514|NCT00362414|54717583|FG000|Overall Study|Death|2|||
28061515|NCT00362414|54717583|FG000|Overall Study|Adverse Event|1|||
28061516|NCT00096382|54717592|FG000|Overall Study|Not treated|1|||
28061517|NCT00096382|54717593|FG001|Overall Study|Not treated|0|||
28061518|NCT00096382|54717592|FG000|Overall Study|Death during treatment|1|||
28061519|NCT00096382|54717593|FG001|Overall Study|Death during treatment|0|||
28061520|NCT00359294|54717604|FG000|Overall Study|Progressive disease|1|||
28061521|NCT00359294|54717605|FG001|Overall Study|Progressive disease|1|||
28061522|NCT00359294|54717606|FG002|Overall Study|Progressive disease|2|||
28061523|NCT00359294|54717607|FG003|Overall Study|Progressive disease|3|||
28061524|NCT00359294|54717608|FG004|Overall Study|Progressive disease|2|||
28061525|NCT00359294|54717604|FG000|Overall Study|Withdrawal by Subject|0|||
28061526|NCT00359294|54717605|FG001|Overall Study|Withdrawal by Subject|0|||
28061527|NCT00359294|54717606|FG002|Overall Study|Withdrawal by Subject|0|||
28061528|NCT00359294|54717607|FG003|Overall Study|Withdrawal by Subject|0|||
28061529|NCT00359294|54717608|FG004|Overall Study|Withdrawal by Subject|1|||
28061530|NCT00359294|54717604|FG000|Overall Study|Not treated|0|||
28061531|NCT00359294|54717605|FG001|Overall Study|Not treated|0|||
28061532|NCT00359294|54717606|FG002|Overall Study|Not treated|0|||
28061533|NCT00359294|54717607|FG003|Overall Study|Not treated|1|||
28061534|NCT00359294|54717608|FG004|Overall Study|Not treated|0|||
28061535|NCT00359294|54717604|FG000|Overall Study|Physician Decision|0|||
28061536|NCT00359294|54717605|FG001|Overall Study|Physician Decision|0|||
28061537|NCT00359294|54717606|FG002|Overall Study|Physician Decision|1|||
28061538|NCT00359294|54717607|FG003|Overall Study|Physician Decision|0|||
28061539|NCT00359294|54717608|FG004|Overall Study|Physician Decision|0|||
28061540|NCT00384332|54717618|FG000|Overall Study|Lost to Follow-up|4|||
28061541|NCT00384332|54717619|FG001|Overall Study|Lost to Follow-up|0|||
28061542|NCT00096226|54717627|FG000|Overall Study|Ineligible|2|||
28061543|NCT00096226|54717627|FG000|Overall Study|Protocol treatment not started|1|||
28061544|NCT00105508|54717633|FG000|Overall Study|Prephase Dropout|1|||
28061545|NCT00105508|54717634|FG001|Overall Study|Prephase Dropout|0|||
28061546|NCT00105508|54717633|FG000|Overall Study|Adverse Event|16|||
28061547|NCT00105508|54717634|FG001|Overall Study|Adverse Event|19|||
28061548|NCT00105508|54717633|FG000|Overall Study|Insufficient Efficacy|1|||
28061549|NCT00105508|54717634|FG001|Overall Study|Insufficient Efficacy|0|||
28061550|NCT00105508|54717633|FG000|Overall Study|Withdrawal by Subject|10|||
28061551|NCT00105508|54717634|FG001|Overall Study|Withdrawal by Subject|6|||
28061552|NCT00105508|54717633|FG000|Overall Study|Lost to Follow-up|3|||
28061553|NCT00105508|54717634|FG001|Overall Study|Lost to Follow-up|0|||
28061554|NCT00105508|54717633|FG000|Overall Study|Protocol Violation|1|||
28061555|NCT00105508|54717634|FG001|Overall Study|Protocol Violation|2|||
28061556|NCT00105508|54717633|FG000|Overall Study|Other|8|||
28061557|NCT00105508|54717634|FG001|Overall Study|Other|9|||
28061558|NCT00105196|54717642|FG000|Overall Study|Lack of Efficacy|2|||
28061559|NCT00105196|54717643|FG001|Overall Study|Lack of Efficacy|3|||
28061560|NCT00105196|54717642|FG000|Overall Study|Adverse Event|11|||
28061561|NCT00105196|54717643|FG001|Overall Study|Adverse Event|3|||
28061562|NCT00105196|54717642|FG000|Overall Study|Withdrawal by Subject|6|||
28061563|NCT00105196|54717643|FG001|Overall Study|Withdrawal by Subject|6|||
28061564|NCT00105196|54717642|FG000|Overall Study|Lost to Follow-up|3|||
28061565|NCT00105196|54717643|FG001|Overall Study|Lost to Follow-up|2|||
28061566|NCT00105196|54717642|FG000|Overall Study|Poor/noncompliance|3|||
28061567|NCT00105196|54717643|FG001|Overall Study|Poor/noncompliance|4|||
28061568|NCT00105196|54717642|FG000|Overall Study|Protocol Violation|5|||
28061569|NCT00105196|54717643|FG001|Overall Study|Protocol Violation|2|||
28061570|NCT00105196|54717642|FG000|Overall Study|pending surgery|0|||
28061571|NCT00105196|54717643|FG001|Overall Study|pending surgery|1|||
28061572|NCT00105196|54717642|FG000|Overall Study|marijuana use|0|||
28061573|NCT00105196|54717643|FG001|Overall Study|marijuana use|1|||
28061574|NCT00105196|54717642|FG000|Overall Study|Subject became unblinded|0|||
28061575|NCT00105196|54717643|FG001|Overall Study|Subject became unblinded|1|||
28061576|NCT03820024|54717651|FG000|Overall Study|Physician Decision|1|||
28061577|NCT03820024|54717652|FG001|Overall Study|Physician Decision|2|||
28061578|NCT03819634|54717658|FG000|Overall Study|Physician Decision|2|||
28061579|NCT00104572|54717665|FG000|Overall Study|Withdrawal by Subject|3|||
28061580|NCT00104572|54717666|FG001|Overall Study|Withdrawal by Subject|3|||
28061581|NCT00104572|54717667|FG002|Overall Study|Withdrawal by Subject|0|||
28061582|NCT00514943|54717677|FG000|Stage 1|Progressive disease|4|||
28061583|NCT00514943|54717678|FG001|Stage 1|Progressive disease|8|||
28061584|NCT00514943|54717677|FG000|Stage 1|Other Adverse Event|16|||
28061585|NCT00514943|54717678|FG001|Stage 1|Other Adverse Event|6|||
28061586|NCT00514943|54717677|FG000|Stage 1|Not treated|1|||
28061587|NCT00514943|54717678|FG001|Stage 1|Not treated|2|||
28061588|NCT00514943|54717677|FG000|Stage 1|Patient refused to continue study meds|8|||
28061589|NCT00514943|54717678|FG001|Stage 1|Patient refused to continue study meds|3|||
28061590|NCT00514943|54717677|FG000|Stage 1|Other than stated above|1|||
28061591|NCT00514943|54717678|FG001|Stage 1|Other than stated above|7|||
28061592|NCT00514943|54717677|FG000|Stage 2|Progressive disease|27|||
28061593|NCT00514943|54717678|FG001|Stage 2|Progressive disease|24|||
28061594|NCT00514943|54717677|FG000|Stage 2|Other Adverse Event|3|||
28061595|NCT00514943|54717678|FG001|Stage 2|Other Adverse Event|10|||
28061596|NCT00514943|54717677|FG000|Stage 2|Patient refused to continue study meds|2|||
28061597|NCT00514943|54717678|FG001|Stage 2|Patient refused to continue study meds|0|||
28061598|NCT00514943|54717677|FG000|Stage 2|Other than stated above|0|||
28061599|NCT00514943|54717678|FG001|Stage 2|Other than stated above|2|||
28061600|NCT03864653|54717699|FG000|Overall Study|Withdrawal by Subject|1|||
28061601|NCT00103402|54717705|FG000|Overall Study|Adverse Event|3|||
28061602|NCT00103402|54717706|FG001|Overall Study|Adverse Event|4|||
28061603|NCT00103402|54717705|FG000|Overall Study|Lost to Follow-up|8|||
28061604|NCT00103402|54717706|FG001|Overall Study|Lost to Follow-up|7|||
28061605|NCT00103402|54717705|FG000|Overall Study|Dissatisfied/No longer interested|6|||
28061606|NCT00103402|54717706|FG001|Overall Study|Dissatisfied/No longer interested|6|||
28061607|NCT00103402|54717705|FG000|Overall Study|Personal constraints/Other|5|||
28061608|NCT00103402|54717706|FG001|Overall Study|Personal constraints/Other|0|||
28061609|NCT03864341|54717712|FG000|Overall Study|Withdrawal by Subject|1|||
28061610|NCT01739309|54717716|FG000|Overall Study|On study treatment|3|||
28061611|NCT00095836|54717722|FG000|Overall Study|Lost to Follow-up|1|||
28061612|NCT00095836|54717722|FG000|Overall Study|Adverse Event|1|||
28061613|NCT00095836|54717722|FG000|Overall Study|Death|2|||
28061614|NCT00168831|54717729|FG000|Overall Study|Adverse Event|36|||
28061615|NCT00168831|54717730|FG001|Overall Study|Adverse Event|47|||
28061616|NCT00168831|54717731|FG002|Overall Study|Adverse Event|74|||
28061617|NCT00168831|54717729|FG000|Overall Study|Lost to Follow-up|5|||
28061618|NCT00168831|54717730|FG001|Overall Study|Lost to Follow-up|6|||
28061619|NCT00168831|54717731|FG002|Overall Study|Lost to Follow-up|4|||
28061620|NCT00168831|54717729|FG000|Overall Study|Withdrawal by Subject|7|||
28061621|NCT00168831|54717730|FG001|Overall Study|Withdrawal by Subject|14|||
28061622|NCT00168831|54717731|FG002|Overall Study|Withdrawal by Subject|19|||
28061623|NCT00168831|54717729|FG000|Overall Study|Protocol Violation|6|||
28061624|NCT00168831|54717730|FG001|Overall Study|Protocol Violation|11|||
28061625|NCT00168831|54717731|FG002|Overall Study|Protocol Violation|11|||
28061626|NCT00168831|54717729|FG000|Overall Study|Other|6|||
28061627|NCT00168831|54717730|FG001|Overall Study|Other|3|||
28061628|NCT00168831|54717731|FG002|Overall Study|Other|6|||
28061629|NCT00103012|54717742|FG000|Overall Study|Withdrawal by Subject|2|||
28061630|NCT00103012|54717743|FG001|Overall Study|Withdrawal by Subject|1|||
28061631|NCT00103012|54717744|FG002|Overall Study|Withdrawal by Subject|2|||
28061632|NCT00103012|54717742|FG000|Overall Study|Pregnancy|1|||
28061633|NCT00103012|54717743|FG001|Overall Study|Pregnancy|0|||
28061634|NCT00103012|54717744|FG002|Overall Study|Pregnancy|0|||
28061635|NCT00103012|54717742|FG000|Overall Study|Adverse Event|0|||
28061636|NCT00103012|54717743|FG001|Overall Study|Adverse Event|0|||
28061637|NCT00103012|54717744|FG002|Overall Study|Adverse Event|1|||
28061638|NCT00103012|54717742|FG000|Overall Study|Subject non-compliant with medications|0|||
28061639|NCT00103012|54717743|FG001|Overall Study|Subject non-compliant with medications|0|||
28061640|NCT00103012|54717744|FG002|Overall Study|Subject non-compliant with medications|1|||
28061641|NCT00512135|54717752|FG000|Overall Study|Not Treated|5|||
28061642|NCT00512135|54717752|FG000|Overall Study|Lack of Efficacy|2|||
28061643|NCT00512135|54717752|FG000|Overall Study|Adverse Event|6|||
28061644|NCT00512135|54717752|FG000|Overall Study|Withdrawal by Subject|22|||
28061645|NCT00512135|54717752|FG000|Overall Study|Lost to Follow-up|27|||
28061646|NCT00512135|54717752|FG000|Overall Study|Other|22|||
28061647|NCT00251979|54717759|FG000|Overall Study|Protocol Violation|3|||
28061648|NCT00251979|54717760|FG001|Overall Study|Protocol Violation|5|||
28061649|NCT00251979|54717759|FG000|Overall Study|Adverse Event|11|||
28061650|NCT00251979|54717760|FG001|Overall Study|Adverse Event|17|||
28061651|NCT00251979|54717759|FG000|Overall Study|Withdrawal by Subject|13|||
28061652|NCT00251979|54717760|FG001|Overall Study|Withdrawal by Subject|7|||
28061653|NCT00251979|54717759|FG000|Overall Study|Lost to Follow-up|8|||
28061654|NCT00251979|54717760|FG001|Overall Study|Lost to Follow-up|6|||
28061655|NCT00251979|54717759|FG000|Overall Study|Death|3|||
28061656|NCT00251979|54717760|FG001|Overall Study|Death|5|||
28061657|NCT00511901|54717768|FG000|Overall Study|Withdrawal by Subject|1|||
28061658|NCT00511901|54717769|FG001|Overall Study|Withdrawal by Subject|3|||
28061659|NCT03862625|54717777|FG000|Overall Study|Lost to Follow-up|0|||
28061660|NCT03862625|54717778|FG001|Overall Study|Lost to Follow-up|1|||
28061661|NCT00163215|54717784|FG000|Overall Study|Lack of Efficacy|3|||
28061662|NCT00163215|54717784|FG000|Overall Study|Withdrawal by Subject|5|||
28061663|NCT00163215|54717784|FG000|Overall Study|Other|7|||
28061664|NCT00228423|54717790|FG000|Overall Study|Adverse Event|2|||
28061665|NCT00228423|54717791|FG001|Overall Study|Adverse Event|5|||
28061666|NCT00228423|54717790|FG000|Overall Study|Withdrawal by Subject|7|||
28061667|NCT00228423|54717791|FG001|Overall Study|Withdrawal by Subject|3|||
28061668|NCT00228423|54717790|FG000|Overall Study|Protocol Violation|1|||
28061669|NCT00228423|54717791|FG001|Overall Study|Protocol Violation|3|||
28061670|NCT00228423|54717790|FG000|Overall Study|Physician Decision|0|||
28061671|NCT00228423|54717791|FG001|Overall Study|Physician Decision|1|||
28061672|NCT00511667|54717799|FG000|Overall Study|Adverse Event|1|||
28061673|NCT00511667|54717800|FG001|Overall Study|Adverse Event|0|||
28061674|NCT00511667|54717799|FG000|Overall Study|Protocol Violation|1|||
28061675|NCT00511667|54717800|FG001|Overall Study|Protocol Violation|1|||
28061676|NCT00511667|54717799|FG000|Overall Study|Withdrawal by Subject|2|||
28061677|NCT00511667|54717800|FG001|Overall Study|Withdrawal by Subject|0|||
28061678|NCT00511667|54717799|FG000|Overall Study|Site terminated|6|||
28061679|NCT00511667|54717800|FG001|Overall Study|Site terminated|1|||
28061680|NCT00511667|54717799|FG000|Overall Study|Other|2|||
28061681|NCT00511667|54717800|FG001|Overall Study|Other|1|||
27814992|NCT03483961|54271733|FG008|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
27814993|NCT03483961|54271734|FG009|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
28061682|NCT00227877|54717816|FG000|Pre-visit Assessment|Technical difficulties|7|||
28061683|NCT00227877|54717817|FG001|Pre-visit Assessment|Technical difficulties|3|||
28061684|NCT00227877|54717818|FG002|Pre-visit Assessment|Technical difficulties|0|||
28061685|NCT00227877|54717819|FG003|Pre-visit Assessment|Technical difficulties|0|||
28061686|NCT00227877|54717816|FG000|Post-visit Checklist|Lost to Follow-up|24|||
28061687|NCT00227877|54717817|FG001|Post-visit Checklist|Lost to Follow-up|13|||
28061688|NCT00227877|54717818|FG002|Post-visit Checklist|Lost to Follow-up|1|||
28061689|NCT00227877|54717819|FG003|Post-visit Checklist|Lost to Follow-up|0|||
28061690|NCT00227877|54717816|FG000|3-months Follow-up|Completed late|135|||
28061691|NCT00227877|54717817|FG001|3-months Follow-up|Completed late|128|||
27814994|NCT03483961|54271725|FG000|Overall Study|Adverse Event|0|||
28061692|NCT00227877|54717818|FG002|3-months Follow-up|Completed late|34|||
28061693|NCT00227877|54717819|FG003|3-months Follow-up|Completed late|8|||
28061694|NCT00227877|54717816|FG000|3-months Follow-up|Lost to Follow-up|178|||
28061695|NCT00227877|54717817|FG001|3-months Follow-up|Lost to Follow-up|139|||
28061696|NCT00227877|54717818|FG002|3-months Follow-up|Lost to Follow-up|18|||
28061697|NCT00227877|54717819|FG003|3-months Follow-up|Lost to Follow-up|13|||
28061698|NCT00227877|54717816|FG000|12-months Follow-up|Completed late|78|||
28061699|NCT00227877|54717817|FG001|12-months Follow-up|Completed late|74|||
28061700|NCT00227877|54717818|FG002|12-months Follow-up|Completed late|1|||
28061701|NCT00227877|54717819|FG003|12-months Follow-up|Completed late|0|||
28061702|NCT00227877|54717816|FG000|12-months Follow-up|Lost to Follow-up|232|||
28061703|NCT00227877|54717817|FG001|12-months Follow-up|Lost to Follow-up|189|||
28061704|NCT00227877|54717818|FG002|12-months Follow-up|Lost to Follow-up|30|||
28061705|NCT00227877|54717819|FG003|12-months Follow-up|Lost to Follow-up|26|||
28061706|NCT00513695|54717831|FG000|Overall Study|Discontinued therapy|2|||
28061707|NCT00513695|54717831|FG000|Overall Study|Progression prior to surgery|3|||
28061708|NCT00162981|54717837|FG000|Overall Study|Adverse Event|2|||
28061709|NCT00162981|54717838|FG001|Overall Study|Adverse Event|5|||
28061710|NCT00162981|54717837|FG000|Overall Study|Withdrawal by Subject|1|||
28061711|NCT00162981|54717838|FG001|Overall Study|Withdrawal by Subject|1|||
28061712|NCT00162981|54717837|FG000|Overall Study|Physician Decision|1|||
28061713|NCT00162981|54717838|FG001|Overall Study|Physician Decision|0|||
28061714|NCT00511433|54717846|FG000|Overall Study|Adverse Event|5|||
28061715|NCT00511433|54717847|FG001|Overall Study|Adverse Event|0|||
28061716|NCT00511433|54717846|FG000|Overall Study|Other Reason|1|||
28061717|NCT00511433|54717847|FG001|Overall Study|Other Reason|1|||
28061718|NCT00099268|54717857|FG000|Overall Study|Withdrawal by Subject|46|||
28061719|NCT00099268|54717858|FG001|Overall Study|Withdrawal by Subject|28|||
28061720|NCT00099268|54717857|FG000|Overall Study|Adverse Event|19|||
28061721|NCT00099268|54717858|FG001|Overall Study|Adverse Event|19|||
28061722|NCT00099268|54717857|FG000|Overall Study|Protocol Violation|9|||
28061723|NCT00099268|54717858|FG001|Overall Study|Protocol Violation|8|||
28061724|NCT00099268|54717857|FG000|Overall Study|Lost to Follow-up|6|||
28061725|NCT00099268|54717858|FG001|Overall Study|Lost to Follow-up|4|||
28061726|NCT00099268|54717857|FG000|Overall Study|Lack of Efficacy|5|||
28061727|NCT00099268|54717858|FG001|Overall Study|Lack of Efficacy|18|||
28061728|NCT00099268|54717857|FG000|Overall Study|Administrative problems|4|||
28061729|NCT00099268|54717858|FG001|Overall Study|Administrative problems|4|||
28061730|NCT00099268|54717857|FG000|Overall Study|Death|3|||
28061731|NCT00099268|54717858|FG001|Overall Study|Death|1|||
28061732|NCT00511355|54717866|FG000|Overall Study|Adverse Event|4|||
28061733|NCT00511355|54717867|FG001|Overall Study|Adverse Event|4|||
28061734|NCT00511355|54717866|FG000|Overall Study|Pregnancy Wish|1|||
28061735|NCT00511355|54717867|FG001|Overall Study|Pregnancy Wish|0|||
27814995|NCT03483961|54271726|FG001|Overall Study|Adverse Event|0|||
27814996|NCT03483961|54271727|FG002|Overall Study|Adverse Event|1|||
27814997|NCT03483961|54271728|FG003|Overall Study|Adverse Event|0|||
28061736|NCT00511355|54717866|FG000|Overall Study|Lost to Follow-up|2|||
28061737|NCT00511355|54717867|FG001|Overall Study|Lost to Follow-up|1|||
28061738|NCT00511355|54717866|FG000|Overall Study|Other Reason|0|||
28061739|NCT00511355|54717867|FG001|Overall Study|Other Reason|1|||
28061740|NCT00511355|54717866|FG000|Overall Study|Pre-treatment (serious) adverse event|0|||
28061741|NCT00511355|54717867|FG001|Overall Study|Pre-treatment (serious) adverse event|1|||
28061742|NCT00511355|54717866|FG000|Overall Study|Withdrawal of informed consent|0|||
28061743|NCT00511355|54717867|FG001|Overall Study|Withdrawal of informed consent|1|||
28061744|NCT00511355|54717866|FG000|Overall Study|Other reason pre-treatment|0|||
28061745|NCT00511355|54717867|FG001|Overall Study|Other reason pre-treatment|1|||
28061746|NCT00095212|54717877|FG000|Overall Study|Withdrawal by Subject|1|||
28061747|NCT00095212|54717878|FG001|Overall Study|Withdrawal by Subject|3|||
28061748|NCT00120874|54717886|FG000|Overall Study|Death|0|||
28061749|NCT00120874|54717887|FG001|Overall Study|Death|1|||
28061750|NCT00120406|54717895|FG000|Overall Study|Death|9|||
28061751|NCT00120406|54717896|FG001|Overall Study|Death|4|||
28061752|NCT00120406|54717895|FG000|Overall Study|Withdrawal by Subject|5|||
28061753|NCT00120406|54717896|FG001|Overall Study|Withdrawal by Subject|7|||
28061754|NCT00120406|54717895|FG000|Overall Study|Lost to Follow-up|5|||
28061755|NCT00120406|54717896|FG001|Overall Study|Lost to Follow-up|2|||
28061756|NCT00120406|54717895|FG000|Overall Study|received non-study stent|0|||
28061757|NCT00120406|54717896|FG001|Overall Study|received non-study stent|2|||
28061758|NCT00120406|54717895|FG000|Overall Study|patient moved but has not withdrawn|0|||
28061759|NCT00120406|54717896|FG001|Overall Study|patient moved but has not withdrawn|1|||
28061760|NCT00120250|54717902|FG000|Overall Study|Lost to Follow-up|1|||
28061761|NCT00120250|54717903|FG001|Overall Study|Lost to Follow-up|1|||
28061762|NCT00120250|54717902|FG000|Overall Study|Protocol Violation|0|||
28061763|NCT00120250|54717903|FG001|Overall Study|Protocol Violation|1|||
28061764|NCT00511199|54717912|FG000|Overall Study|Unacceptable Vaginal Bleeding|63|||
28061765|NCT00511199|54717913|FG001|Overall Study|Unacceptable Vaginal Bleeding|4|||
28061766|NCT00511199|54717912|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|227|||
28061767|NCT00511199|54717913|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|52|||
28061768|NCT00511199|54717912|FG000|Overall Study|Withdrawal of Informed Consent|19|||
28061769|NCT00511199|54717913|FG001|Overall Study|Withdrawal of Informed Consent|4|||
28061770|NCT00511199|54717912|FG000|Overall Study|Pregnancy|6|||
28061771|NCT00511199|54717913|FG001|Overall Study|Pregnancy|3|||
28061772|NCT00511199|54717912|FG000|Overall Study|Pregnancy Wish|16|||
28061773|NCT00511199|54717913|FG001|Overall Study|Pregnancy Wish|8|||
28061774|NCT00511199|54717912|FG000|Overall Study|Lost to Follow-up|40|||
28061775|NCT00511199|54717913|FG001|Overall Study|Lost to Follow-up|17|||
28061776|NCT00511199|54717912|FG000|Overall Study|Other Reason|78|||
28061777|NCT00511199|54717913|FG001|Overall Study|Other Reason|37|||
28061778|NCT00384176|54717924|FG000|Overall Study|Death|239|||
28061779|NCT00384176|54717925|FG001|Overall Study|Death|247|||
28061780|NCT00384176|54717926|FG002|Overall Study|Death|105|||
28061781|NCT00384176|54717924|FG000|Overall Study|Withdrawal by Subject|52|||
28061782|NCT00384176|54717925|FG001|Overall Study|Withdrawal by Subject|48|||
28061783|NCT00384176|54717926|FG002|Overall Study|Withdrawal by Subject|22|||
28061784|NCT00384176|54717924|FG000|Overall Study|Lost to Follow-up|16|||
28061785|NCT00384176|54717925|FG001|Overall Study|Lost to Follow-up|18|||
28061786|NCT00384176|54717926|FG002|Overall Study|Lost to Follow-up|4|||
28061787|NCT00384176|54717924|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|2|||
28061788|NCT00384176|54717925|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|3|||
28061789|NCT00384176|54717926|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|0|||
28061790|NCT00384176|54717924|FG000|Overall Study|Longer QTC as Visit 1|1|||
28061791|NCT00384176|54717925|FG001|Overall Study|Longer QTC as Visit 1|0|||
28061792|NCT00384176|54717926|FG002|Overall Study|Longer QTC as Visit 1|0|||
28061793|NCT00384176|54717924|FG000|Overall Study|Toxicity of treatment|1|||
28061794|NCT00384176|54717925|FG001|Overall Study|Toxicity of treatment|0|||
28061795|NCT00384176|54717926|FG002|Overall Study|Toxicity of treatment|0|||
28061796|NCT00384176|54717924|FG000|Overall Study|Did not receive study treatment|0|||
28061797|NCT00384176|54717925|FG001|Overall Study|Did not receive study treatment|1|||
28061798|NCT00384176|54717926|FG002|Overall Study|Did not receive study treatment|1|||
28061799|NCT00384176|54717924|FG000|Overall Study|Physician Decision|0|||
28061800|NCT00384176|54717925|FG001|Overall Study|Physician Decision|2|||
27940076|NCT01196052|54596412|FG000|Overall Study|Reason not Specified|5|||
27940077|NCT01196052|54596412|FG000|Overall Study|Withdrawal by Subject|6|||
27940078|NCT01195662|54596419|FG000|Double Blind Treatment Period|Adverse Event|4|||
27940079|NCT01195662|54596420|FG001|Double Blind Treatment Period|Adverse Event|1|||
27940080|NCT01195662|54596421|FG002|Double Blind Treatment Period|Adverse Event|2|||
27940081|NCT01195662|54596419|FG000|Double Blind Treatment Period|Withdrawal by Subject|6|||
28061801|NCT00384176|54717926|FG002|Overall Study|Physician Decision|0|||
28061802|NCT00384176|54717924|FG000|Overall Study|Liver metastases, colon resec. planned|1|||
28061803|NCT00384176|54717925|FG001|Overall Study|Liver metastases, colon resec. planned|0|||
28061804|NCT00384176|54717926|FG002|Overall Study|Liver metastases, colon resec. planned|0|||
28061805|NCT00513305|54717936|FG000|Overall Study|Adverse Event|6|||
28061806|NCT00513305|54717937|FG001|Overall Study|Adverse Event|2|||
28061807|NCT00513305|54717936|FG000|Overall Study|Death (through Consolidation Treatment)|2|||
28061808|NCT00513305|54717937|FG001|Overall Study|Death (through Consolidation Treatment)|2|||
28061809|NCT00513305|54717936|FG000|Overall Study|Lack of Efficacy|8|||
28061810|NCT00513305|54717937|FG001|Overall Study|Lack of Efficacy|13|||
28061811|NCT00513305|54717936|FG000|Overall Study|Withdrawal by Subject|1|||
28061812|NCT00513305|54717937|FG001|Overall Study|Withdrawal by Subject|2|||
28061813|NCT00513305|54717936|FG000|Overall Study|Disease progression|8|||
28061814|NCT00513305|54717937|FG001|Overall Study|Disease progression|5|||
28061815|NCT00513305|54717936|FG000|Overall Study|Eligible for stem cell transplant|1|||
28061816|NCT00513305|54717937|FG001|Overall Study|Eligible for stem cell transplant|0|||
28061817|NCT00513305|54717936|FG000|Overall Study|Hematologic counts did not recover|1|||
28061818|NCT00513305|54717937|FG001|Overall Study|Hematologic counts did not recover|0|||
28061819|NCT00513305|54717936|FG000|Overall Study|Physician Decision|1|||
28061820|NCT00513305|54717937|FG001|Overall Study|Physician Decision|0|||
28061821|NCT00513305|54717936|FG000|Overall Study|Persistent hypocellularity|0|||
28061822|NCT00513305|54717937|FG001|Overall Study|Persistent hypocellularity|1|||
28061823|NCT00513305|54717936|FG000|Overall Study|Sponsor Decision|0|||
28061824|NCT00513305|54717937|FG001|Overall Study|Sponsor Decision|2|||
28061825|NCT00513071|54717943|FG000|Overall Study|Adverse Event|1|||
28061826|NCT00513071|54717943|FG000|Overall Study|Withdrawal by Subject|1|||
28061827|NCT00513071|54717943|FG000|Overall Study|Physician Decision|3|||
28061828|NCT00510887|54717947|FG000|Overall Study|Lost to Follow-up|1|||
28061829|NCT00358826|54717955|FG000|Core Study|Adverse Event|1|||
28061830|NCT00358826|54717956|FG001|Core Study|Adverse Event|3|||
28061831|NCT00358826|54717957|FG002|Core Study|Adverse Event|1|||
28061832|NCT00358826|54717958|FG003|Core Study|Adverse Event|1|||
28061833|NCT00358826|54717959|FG004|Core Study|Adverse Event|0|||
28061834|NCT00358826|54717960|FG005|Core Study|Adverse Event|0|||
28061835|NCT00358826|54717961|FG006|Core Study|Adverse Event|0|||
28061836|NCT00358826|54717962|FG007|Core Study|Adverse Event|0|||
28061837|NCT00358826|54717955|FG000|Core Study|Withdrawal by Subject|2|||
28061838|NCT00358826|54717956|FG001|Core Study|Withdrawal by Subject|2|||
28061839|NCT00358826|54717957|FG002|Core Study|Withdrawal by Subject|0|||
28061840|NCT00358826|54717958|FG003|Core Study|Withdrawal by Subject|0|||
28061841|NCT00358826|54717959|FG004|Core Study|Withdrawal by Subject|0|||
27848346|NCT01044459|54341309|FG001|Overall Study|Other Reason|14|||
27940082|NCT01195662|54596420|FG001|Double Blind Treatment Period|Withdrawal by Subject|4|||
27940083|NCT01195662|54596421|FG002|Double Blind Treatment Period|Withdrawal by Subject|4|||
28061842|NCT00358826|54717960|FG005|Core Study|Withdrawal by Subject|0|||
28061843|NCT00358826|54717961|FG006|Core Study|Withdrawal by Subject|0|||
28061844|NCT00358826|54717962|FG007|Core Study|Withdrawal by Subject|0|||
28061845|NCT00358826|54717955|FG000|Core Study|Lost to Follow-up|0|||
28061846|NCT00358826|54717956|FG001|Core Study|Lost to Follow-up|0|||
28061847|NCT00358826|54717957|FG002|Core Study|Lost to Follow-up|0|||
28061848|NCT00358826|54717958|FG003|Core Study|Lost to Follow-up|1|||
28061849|NCT00358826|54717959|FG004|Core Study|Lost to Follow-up|0|||
28061850|NCT00358826|54717960|FG005|Core Study|Lost to Follow-up|0|||
28061851|NCT00358826|54717961|FG006|Core Study|Lost to Follow-up|0|||
28061852|NCT00358826|54717962|FG007|Core Study|Lost to Follow-up|0|||
28061853|NCT00358826|54717955|FG000|Core Study|Physician Decision|0|||
28061854|NCT00358826|54717956|FG001|Core Study|Physician Decision|0|||
28061855|NCT00358826|54717957|FG002|Core Study|Physician Decision|1|||
28061856|NCT00358826|54717958|FG003|Core Study|Physician Decision|0|||
28061857|NCT00358826|54717959|FG004|Core Study|Physician Decision|0|||
28061858|NCT00358826|54717960|FG005|Core Study|Physician Decision|0|||
28061859|NCT00358826|54717961|FG006|Core Study|Physician Decision|0|||
28061860|NCT00358826|54717962|FG007|Core Study|Physician Decision|0|||
28061861|NCT00358826|54717955|FG000|MDCT Substudy|Adverse Event|0|||
28061862|NCT00358826|54717956|FG001|MDCT Substudy|Adverse Event|0|||
28061863|NCT00358826|54717957|FG002|MDCT Substudy|Adverse Event|0|||
28061864|NCT00358826|54717958|FG003|MDCT Substudy|Adverse Event|0|||
28061865|NCT00358826|54717959|FG004|MDCT Substudy|Adverse Event|1|||
28061866|NCT00358826|54717960|FG005|MDCT Substudy|Adverse Event|0|||
28061867|NCT00358826|54717961|FG006|MDCT Substudy|Adverse Event|0|||
28061868|NCT00358826|54717962|FG007|MDCT Substudy|Adverse Event|0|||
28061869|NCT00358826|54717955|FG000|MDCT Substudy|Lost to Follow-up|0|||
28061870|NCT00358826|54717956|FG001|MDCT Substudy|Lost to Follow-up|0|||
28061871|NCT00358826|54717957|FG002|MDCT Substudy|Lost to Follow-up|0|||
28061872|NCT00358826|54717958|FG003|MDCT Substudy|Lost to Follow-up|0|||
28061873|NCT00358826|54717959|FG004|MDCT Substudy|Lost to Follow-up|0|||
28061874|NCT00358826|54717960|FG005|MDCT Substudy|Lost to Follow-up|1|||
28061875|NCT00358826|54717961|FG006|MDCT Substudy|Lost to Follow-up|0|||
28061876|NCT00358826|54717962|FG007|MDCT Substudy|Lost to Follow-up|0|||
28061877|NCT00358826|54717955|FG000|MDCT Substudy|Withdrawal by Subject|0|||
28061878|NCT00358826|54717956|FG001|MDCT Substudy|Withdrawal by Subject|0|||
28061879|NCT00358826|54717957|FG002|MDCT Substudy|Withdrawal by Subject|0|||
28061880|NCT00358826|54717958|FG003|MDCT Substudy|Withdrawal by Subject|0|||
28061881|NCT00358826|54717959|FG004|MDCT Substudy|Withdrawal by Subject|0|||
28061882|NCT00358826|54717960|FG005|MDCT Substudy|Withdrawal by Subject|1|||
28061883|NCT00358826|54717961|FG006|MDCT Substudy|Withdrawal by Subject|0|||
28061884|NCT00358826|54717962|FG007|MDCT Substudy|Withdrawal by Subject|0|||
28061885|NCT00510653|54717976|FG000|Overall Study|Withdrawal by Subject|8|||
28061886|NCT00510653|54717976|FG000|Overall Study|Monetary|3|||
28061887|NCT00362336|54717983|FG000|Overall Study|Serious Adverse Event|1|||
28061888|NCT00362336|54717984|FG001|Overall Study|Serious Adverse Event|0|||
28061889|NCT00362336|54717985|FG002|Overall Study|Serious Adverse Event|1|||
28061890|NCT00362336|54717983|FG000|Overall Study|Protocol Violation|0|||
28061891|NCT00362336|54717984|FG001|Overall Study|Protocol Violation|0|||
28061892|NCT00362336|54717985|FG002|Overall Study|Protocol Violation|1|||
28061893|NCT00362336|54717983|FG000|Overall Study|Lost to Follow-up|6|||
28061894|NCT00362336|54717984|FG001|Overall Study|Lost to Follow-up|4|||
28061895|NCT00362336|54717985|FG002|Overall Study|Lost to Follow-up|0|||
28061896|NCT00362336|54717983|FG000|Overall Study|Withdrawal by Subject|3|||
28061897|NCT00362336|54717984|FG001|Overall Study|Withdrawal by Subject|3|||
28061898|NCT00362336|54717985|FG002|Overall Study|Withdrawal by Subject|1|||
28061899|NCT00506285|54718002|FG000|3 Week Screening Phase|Withdrawal by Subject|17|||
28061900|NCT00506285|54718003|FG001|3 Week Screening Phase|Withdrawal by Subject|10|||
28061901|NCT00506285|54718002|FG000|Double Blind Cross-Over Phase|Withdrawal by Subject|4|||
28061902|NCT00506285|54718003|FG001|Double Blind Cross-Over Phase|Withdrawal by Subject|3|||
28061903|NCT00506285|54718002|FG000|Double Blind Cross-Over Phase|Lost to Follow-up|5|||
28061904|NCT00506285|54718003|FG001|Double Blind Cross-Over Phase|Lost to Follow-up|2|||
28061905|NCT00506285|54718002|FG000|6-month Open Label Phase|Lost to Follow-up|1|||
28061906|NCT00506285|54718003|FG001|6-month Open Label Phase|Lost to Follow-up|7|||
28061907|NCT00506285|54718002|FG000|6-month Open Label Phase|Withdrawal by Subject|9|||
27848347|NCT01044459|54341308|FG000|Overall Study|COPD exacerbation|9|||
27848348|NCT01044459|54341309|FG001|Overall Study|COPD exacerbation|8|||
27848349|NCT01044459|54341308|FG000|Overall Study|Lost to Follow-up|18|||
28061908|NCT00506285|54718003|FG001|6-month Open Label Phase|Withdrawal by Subject|5|||
28061909|NCT00506129|54718011|FG000|Overall Study|Disease Progression/Relapse|15|||
28061910|NCT00506129|54718011|FG000|Overall Study|Death|7|||
28061911|NCT00358670|54718017|FG000|Overall Study|Adverse Event|26|||
28061912|NCT00358670|54718018|FG001|Overall Study|Adverse Event|29|||
28061913|NCT00358670|54718017|FG000|Overall Study|Lack of Efficacy|20|||
28061914|NCT00358670|54718018|FG001|Overall Study|Lack of Efficacy|23|||
28061915|NCT00358670|54718017|FG000|Overall Study|Protocol Violation|6|||
28061916|NCT00358670|54718018|FG001|Overall Study|Protocol Violation|9|||
28061917|NCT00358670|54718017|FG000|Overall Study|Lost to Follow-up|4|||
28061918|NCT00358670|54718018|FG001|Overall Study|Lost to Follow-up|5|||
28061919|NCT00358670|54718017|FG000|Overall Study|Withdrawal by Subject|13|||
28061920|NCT00358670|54718018|FG001|Overall Study|Withdrawal by Subject|24|||
28061921|NCT00358670|54718017|FG000|Overall Study|Protocol Defined Clinical Event|0|||
28061922|NCT00358670|54718018|FG001|Overall Study|Protocol Defined Clinical Event|1|||
28061923|NCT00358670|54718017|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
28061924|NCT00358670|54718018|FG001|Overall Study|Did Not Meet Protocol Eligibility|3|||
28061925|NCT00358670|54718017|FG000|Overall Study|Administrative|153|||
28061926|NCT00358670|54718018|FG001|Overall Study|Administrative|125|||
28061927|NCT00505661|54718024|FG000|Overall Study|Not Eligible|4|||
28061928|NCT00383786|54718030|FG000|Overall Study|Protocol Violation|2|||
28061929|NCT00383786|54718031|FG001|Overall Study|Protocol Violation|6|||
28061930|NCT00383786|54718030|FG000|Overall Study|Withdrawal by Subject|2|||
28061931|NCT00383786|54718031|FG001|Overall Study|Withdrawal by Subject|5|||
28061932|NCT00383786|54718030|FG000|Overall Study|Physician Decision|0|||
28061933|NCT00383786|54718031|FG001|Overall Study|Physician Decision|1|||
28061934|NCT00383708|54718037|FG000|Enrolment Through Start Treatment|Withdrawal by Subject|1|||
28061935|NCT00383708|54718037|FG000|Enrolment Through Start Treatment|Did not meet entry criteria|32|||
28061936|NCT00383708|54718037|FG000|Run-in Period|Protocol Violation|4|||
28061937|NCT00383708|54718037|FG000|Run-in Period|Adverse Event|2|||
28061938|NCT00383708|54718037|FG000|Run-in Period|Claustrophobia|1|||
28061939|NCT00383708|54718037|FG000|Co-administration Period|Adverse Event|5|||
28061940|NCT00504881|54718044|FG000|Overall Study|Lack of Efficacy|1|||
28061941|NCT00504881|54718045|FG001|Overall Study|Lack of Efficacy|5|||
28061942|NCT00504881|54718044|FG000|Overall Study|Lost to Follow-up|0|||
28061943|NCT00504881|54718045|FG001|Overall Study|Lost to Follow-up|2|||
28061944|NCT00504881|54718044|FG000|Overall Study|Withdrawal by Subject|1|||
28061945|NCT00504881|54718045|FG001|Overall Study|Withdrawal by Subject|4|||
28061946|NCT00504881|54718044|FG000|Overall Study|Non-Compliance|1|||
28061947|NCT00504881|54718045|FG001|Overall Study|Non-Compliance|0|||
28061948|NCT00504881|54718044|FG000|Overall Study|No Birth Control|0|||
28061949|NCT00504881|54718045|FG001|Overall Study|No Birth Control|1|||
28061950|NCT00504881|54718044|FG000|Overall Study|Safety Visit not performed|0|||
28061951|NCT00504881|54718045|FG001|Overall Study|Safety Visit not performed|1|||
28061952|NCT00504881|54718044|FG000|Overall Study|AE, serious fatal|0|||
28061953|NCT00504881|54718045|FG001|Overall Study|AE, serious fatal|1|||
28061954|NCT00504881|54718044|FG000|Overall Study|SAE, non-fatal|2|||
28061955|NCT00504881|54718045|FG001|Overall Study|SAE, non-fatal|6|||
28061956|NCT00504881|54718044|FG000|Overall Study|AE, non-serious non-fatal|4|||
28061957|NCT00504881|54718045|FG001|Overall Study|AE, non-serious non-fatal|14|||
28061958|NCT00504881|54718044|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
28061959|NCT00504881|54718045|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2|||
28061960|NCT00504881|54718044|FG000|Overall Study|AE of unknown type|1|||
28061961|NCT00504881|54718045|FG001|Overall Study|AE of unknown type|0|||
28061962|NCT00504725|54718055|FG000|Overall Study|Protocol Violation|1|||
28061963|NCT00504725|54718056|FG001|Overall Study|Protocol Violation|0|||
28061964|NCT00383240|54718066|FG000|Overall Study|Adverse Event|4|||
28061965|NCT00383240|54718067|FG001|Overall Study|Adverse Event|6|||
28061966|NCT00383240|54718068|FG002|Overall Study|Adverse Event|9|||
28061967|NCT00383240|54718069|FG003|Overall Study|Adverse Event|7|||
28061968|NCT00383240|54718066|FG000|Overall Study|Treatment Failure|8|||
28061969|NCT00383240|54718067|FG001|Overall Study|Treatment Failure|13|||
28061970|NCT00383240|54718068|FG002|Overall Study|Treatment Failure|47|||
28061971|NCT00383240|54718069|FG003|Overall Study|Treatment Failure|46|||
28061972|NCT00383240|54718066|FG000|Overall Study|Lost to Follow-up|3|||
28061973|NCT00383240|54718067|FG001|Overall Study|Lost to Follow-up|0|||
28061974|NCT00383240|54718068|FG002|Overall Study|Lost to Follow-up|0|||
28061975|NCT00383240|54718069|FG003|Overall Study|Lost to Follow-up|2|||
28061976|NCT00383240|54718066|FG000|Overall Study|Withdrawal by subject, reasons unrelated|6|||
28061977|NCT00383240|54718067|FG001|Overall Study|Withdrawal by subject, reasons unrelated|3|||
28061978|NCT00383240|54718068|FG002|Overall Study|Withdrawal by subject, reasons unrelated|8|||
28061979|NCT00383240|54718069|FG003|Overall Study|Withdrawal by subject, reasons unrelated|8|||
28061980|NCT00383240|54718066|FG000|Overall Study|Withdrawal by subjects, reasons related|0|||
28061981|NCT00383240|54718067|FG001|Overall Study|Withdrawal by subjects, reasons related|1|||
28061982|NCT00383240|54718068|FG002|Overall Study|Withdrawal by subjects, reasons related|3|||
27848350|NCT01044459|54341309|FG001|Overall Study|Lost to Follow-up|12|||
28061983|NCT00383240|54718069|FG003|Overall Study|Withdrawal by subjects, reasons related|5|||
28061984|NCT00383240|54718066|FG000|Overall Study|Protocol Violation|4|||
28061985|NCT00383240|54718067|FG001|Overall Study|Protocol Violation|5|||
28061986|NCT00383240|54718068|FG002|Overall Study|Protocol Violation|9|||
28061987|NCT00383240|54718069|FG003|Overall Study|Protocol Violation|6|||
28061988|NCT00383240|54718066|FG000|Overall Study|Did not meet protocol eligibility|9|||
28061989|NCT00383240|54718067|FG001|Overall Study|Did not meet protocol eligibility|4|||
28061990|NCT00383240|54718068|FG002|Overall Study|Did not meet protocol eligibility|9|||
28061991|NCT00383240|54718069|FG003|Overall Study|Did not meet protocol eligibility|3|||
28061992|NCT00383240|54718066|FG000|Overall Study|Administrative|1|||
28061993|NCT00383240|54718067|FG001|Overall Study|Administrative|1|||
28061994|NCT00383240|54718068|FG002|Overall Study|Administrative|0|||
28061995|NCT00383240|54718069|FG003|Overall Study|Administrative|0|||
28061996|NCT00362180|54718089|FG000|Treated Period|Withdrawal by Subject|1|||
28061997|NCT00362180|54718090|FG001|Treated Period|Withdrawal by Subject|0|||
28061998|NCT00362180|54718091|FG002|Treated Period|Withdrawal by Subject|0|||
28061999|NCT00362180|54718092|FG003|Treated Period|Withdrawal by Subject|0|||
28062000|NCT00362180|54718093|FG004|Treated Period|Withdrawal by Subject|0|||
28062001|NCT00362180|54718094|FG005|Treated Period|Withdrawal by Subject|0|||
28062002|NCT00362180|54718095|FG006|Treated Period|Withdrawal by Subject|0|||
28062003|NCT00362180|54718096|FG007|Treated Period|Withdrawal by Subject|0|||
28062004|NCT00362180|54718097|FG008|Treated Period|Withdrawal by Subject|0|||
28062005|NCT00362180|54718089|FG000|Treated Period|Adverse Event|0|||
28062006|NCT00362180|54718090|FG001|Treated Period|Adverse Event|0|||
28062007|NCT00362180|54718091|FG002|Treated Period|Adverse Event|0|||
28062008|NCT00362180|54718092|FG003|Treated Period|Adverse Event|0|||
28062009|NCT00362180|54718093|FG004|Treated Period|Adverse Event|0|||
28062010|NCT00362180|54718094|FG005|Treated Period|Adverse Event|1|||
28062011|NCT00362180|54718095|FG006|Treated Period|Adverse Event|0|||
28062012|NCT00362180|54718096|FG007|Treated Period|Adverse Event|1|||
28062013|NCT00362180|54718097|FG008|Treated Period|Adverse Event|0|||
28062014|NCT00383162|54718115|FG000|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3|||
28062015|NCT00383162|54718116|FG001|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4|||
28062016|NCT00383162|54718115|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|8|||
28062017|NCT00383162|54718116|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
28062018|NCT00383162|54718115|FG000|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4|||
28062019|NCT00383162|54718116|FG001|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2|||
28062020|NCT00383162|54718115|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2|||
28062021|NCT00383162|54718116|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0|||
28062022|NCT00383162|54718115|FG000|Migraine Attack 1 (Period 1)|Non-compliant|3|||
28062023|NCT00383162|54718116|FG001|Migraine Attack 1 (Period 1)|Non-compliant|0|||
28062024|NCT00383162|54718115|FG000|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1|||
28062025|NCT00383162|54718116|FG001|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3|||
28062026|NCT00383162|54718115|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
28062027|NCT00383162|54718116|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
28062028|NCT00383162|54718115|FG000|Migraine Attack 2 (Period 2)|Adverse Event|1|||
28062029|NCT00383162|54718116|FG001|Migraine Attack 2 (Period 2)|Adverse Event|0|||
28062030|NCT00383162|54718115|FG000|Migraine Attack 2 (Period 2)|Unknown reason|0|||
28062031|NCT00383162|54718116|FG001|Migraine Attack 2 (Period 2)|Unknown reason|3|||
28062032|NCT00358436|54718124|FG000|Overall Study|Adverse Event|29|||
28062033|NCT00358436|54718125|FG001|Overall Study|Adverse Event|13|||
28062034|NCT00358436|54718124|FG000|Overall Study|Lack of Efficacy|34|||
28062035|NCT00358436|54718125|FG001|Overall Study|Lack of Efficacy|36|||
28062036|NCT00358436|54718124|FG000|Overall Study|Lost to Follow-up|11|||
28062037|NCT00358436|54718125|FG001|Overall Study|Lost to Follow-up|6|||
28062038|NCT00358436|54718124|FG000|Overall Study|Protocol Violation|8|||
28062039|NCT00358436|54718125|FG001|Overall Study|Protocol Violation|3|||
28062040|NCT00358436|54718124|FG000|Overall Study|Withdrawal by Subject|40|||
28062041|NCT00358436|54718125|FG001|Overall Study|Withdrawal by Subject|17|||
28062042|NCT00358436|54718124|FG000|Overall Study|Non-fulfilment of inclusion/exclusion|4|||
28062043|NCT00358436|54718125|FG001|Overall Study|Non-fulfilment of inclusion/exclusion|0|||
28062044|NCT00358436|54718124|FG000|Overall Study|COPD exacerbation|22|||
28062045|NCT00358436|54718125|FG001|Overall Study|COPD exacerbation|10|||
28062046|NCT00358436|54718124|FG000|Overall Study|Other|6|||
28062047|NCT00358436|54718125|FG001|Overall Study|Other|1|||
28062048|NCT00383084|54718135|FG000|Overall Study|Withdrawal by Subject|12|||
28062049|NCT00383084|54718136|FG001|Overall Study|Withdrawal by Subject|10|||
28062050|NCT00361634|54718142|FG000|Overall Study|Lost to Follow-up|1|||
28062051|NCT00361634|54718142|FG000|Overall Study|Withdrawal by Subject|1|||
28062052|NCT00357968|54718148|FG000|First Maintenance Dose Phase|Not a PCI patient|47|||
28062053|NCT00357968|54718149|FG001|First Maintenance Dose Phase|Not a PCI patient|42|||
28062054|NCT00357968|54718148|FG000|First Maintenance Dose Phase|Withdrawal by Subject|1|||
28062055|NCT00357968|54718149|FG001|First Maintenance Dose Phase|Withdrawal by Subject|2|||
28062056|NCT00357656|54718172|FG000|Overall Study|Other, No surgery performed|0|||
28062057|NCT00357656|54718173|FG001|Overall Study|Other, No surgery performed|3|||
28062058|NCT00357500|54718191|FG000|Overall Study|Adverse Event|3|||
28062059|NCT00357500|54718191|FG000|Overall Study|Withdrawal by Subject|5|||
28062060|NCT00357500|54718191|FG000|Overall Study|Progressive Disease|65|||
28062061|NCT00357500|54718191|FG000|Overall Study|Not Started Protocol Therapy|4|||
28062062|NCT00357110|54718197|FG000|Overall Study|Early study termination|5|||
28062063|NCT00357110|54718198|FG001|Overall Study|Early study termination|5|||
28062064|NCT00098722|54718207|FG000|Double Blind Phase|Adverse Event|7|||
28062065|NCT00098722|54718208|FG001|Double Blind Phase|Adverse Event|7|||
28062066|NCT00098722|54718209|FG002|Double Blind Phase|Adverse Event|3|||
28062067|NCT00098722|54718210|FG003|Double Blind Phase|Adverse Event|0|||
28062068|NCT00098722|54718211|FG004|Double Blind Phase|Adverse Event|0|||
28062069|NCT00098722|54718212|FG005|Double Blind Phase|Adverse Event|0|||
28062070|NCT00098722|54718213|FG006|Double Blind Phase|Adverse Event|0|||
28062071|NCT00098722|54718207|FG000|Double Blind Phase|Death|2|||
28062072|NCT00098722|54718208|FG001|Double Blind Phase|Death|5|||
28062073|NCT00098722|54718209|FG002|Double Blind Phase|Death|0|||
28062074|NCT00098722|54718210|FG003|Double Blind Phase|Death|0|||
28062075|NCT00098722|54718211|FG004|Double Blind Phase|Death|0|||
28062076|NCT00098722|54718212|FG005|Double Blind Phase|Death|0|||
28062077|NCT00098722|54718213|FG006|Double Blind Phase|Death|0|||
27940084|NCT01195662|54596419|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
27940085|NCT01195662|54596420|FG001|Double Blind Treatment Period|Lost to Follow-up|2|||
27940086|NCT01195662|54596421|FG002|Double Blind Treatment Period|Lost to Follow-up|3|||
27940087|NCT01195662|54596419|FG000|Double Blind Treatment Period|Administrative reason|2|||
28062078|NCT00098722|54718207|FG000|Double Blind Phase|Lack of Efficacy|21|||
27814998|NCT03483961|54271729|FG004|Overall Study|Adverse Event|0|||
27814999|NCT03483961|54271730|FG005|Overall Study|Adverse Event|0|||
27815000|NCT03483961|54271731|FG006|Overall Study|Adverse Event|0|||
27815001|NCT03483961|54271732|FG007|Overall Study|Adverse Event|0|||
27815002|NCT03483961|54271733|FG008|Overall Study|Adverse Event|0|||
28062079|NCT00098722|54718208|FG001|Double Blind Phase|Lack of Efficacy|23|||
27815003|NCT03483961|54271734|FG009|Overall Study|Adverse Event|0|||
27940088|NCT01195662|54596420|FG001|Double Blind Treatment Period|Administrative reason|1|||
28062080|NCT00098722|54718209|FG002|Double Blind Phase|Lack of Efficacy|15|||
28062081|NCT00098722|54718210|FG003|Double Blind Phase|Lack of Efficacy|0|||
28062082|NCT00098722|54718211|FG004|Double Blind Phase|Lack of Efficacy|0|||
27815004|NCT03459807|54271761|FG000|Overall Study|Withdrawal due to transplant|0|||
28062083|NCT00098722|54718212|FG005|Double Blind Phase|Lack of Efficacy|0|||
28062084|NCT00098722|54718213|FG006|Double Blind Phase|Lack of Efficacy|0|||
27815005|NCT03459807|54271762|FG001|Overall Study|Withdrawal due to transplant|1|||
28062085|NCT00098722|54718207|FG000|Double Blind Phase|Participant defaulted|16|||
28062086|NCT00098722|54718208|FG001|Double Blind Phase|Participant defaulted|11|||
28062087|NCT00098722|54718209|FG002|Double Blind Phase|Participant defaulted|9|||
28062088|NCT00098722|54718210|FG003|Double Blind Phase|Participant defaulted|0|||
28062089|NCT00098722|54718211|FG004|Double Blind Phase|Participant defaulted|0|||
28062090|NCT00098722|54718212|FG005|Double Blind Phase|Participant defaulted|0|||
28062091|NCT00098722|54718213|FG006|Double Blind Phase|Participant defaulted|0|||
28062092|NCT00098722|54718207|FG000|Double Blind Phase|Pregnancy|1|||
28062093|NCT00098722|54718208|FG001|Double Blind Phase|Pregnancy|0|||
28062094|NCT00098722|54718209|FG002|Double Blind Phase|Pregnancy|0|||
28062095|NCT00098722|54718210|FG003|Double Blind Phase|Pregnancy|0|||
28062096|NCT00098722|54718211|FG004|Double Blind Phase|Pregnancy|0|||
28062097|NCT00098722|54718212|FG005|Double Blind Phase|Pregnancy|0|||
28062098|NCT00098722|54718213|FG006|Double Blind Phase|Pregnancy|0|||
28062099|NCT00098722|54718207|FG000|Double Blind Phase|Randomized, not treated|4|||
28062100|NCT00098722|54718208|FG001|Double Blind Phase|Randomized, not treated|3|||
28062101|NCT00098722|54718209|FG002|Double Blind Phase|Randomized, not treated|3|||
28062102|NCT00098722|54718210|FG003|Double Blind Phase|Randomized, not treated|0|||
28062103|NCT00098722|54718211|FG004|Double Blind Phase|Randomized, not treated|0|||
28062104|NCT00098722|54718212|FG005|Double Blind Phase|Randomized, not treated|0|||
28062105|NCT00098722|54718213|FG006|Double Blind Phase|Randomized, not treated|0|||
28062106|NCT00098722|54718207|FG000|Double Blind Phase|Ongoing at cut-off date|128|||
28062107|NCT00098722|54718208|FG001|Double Blind Phase|Ongoing at cut-off date|137|||
28062108|NCT00098722|54718209|FG002|Double Blind Phase|Ongoing at cut-off date|57|||
28062109|NCT00098722|54718210|FG003|Double Blind Phase|Ongoing at cut-off date|0|||
28062110|NCT00098722|54718211|FG004|Double Blind Phase|Ongoing at cut-off date|0|||
28062111|NCT00098722|54718212|FG005|Double Blind Phase|Ongoing at cut-off date|0|||
28062112|NCT00098722|54718213|FG006|Double Blind Phase|Ongoing at cut-off date|0|||
28062113|NCT00098722|54718207|FG000|Double Blind Phase|Other|7|||
28062114|NCT00098722|54718208|FG001|Double Blind Phase|Other|8|||
28062115|NCT00098722|54718209|FG002|Double Blind Phase|Other|7|||
28062116|NCT00098722|54718210|FG003|Double Blind Phase|Other|0|||
28062117|NCT00098722|54718211|FG004|Double Blind Phase|Other|0|||
28062118|NCT00098722|54718212|FG005|Double Blind Phase|Other|0|||
28062119|NCT00098722|54718213|FG006|Double Blind Phase|Other|0|||
28062120|NCT00098722|54718207|FG000|Open Label Phase|Adverse Event|0|||
28062121|NCT00098722|54718208|FG001|Open Label Phase|Adverse Event|0|||
28062122|NCT00098722|54718209|FG002|Open Label Phase|Adverse Event|0|||
28062123|NCT00098722|54718210|FG003|Open Label Phase|Adverse Event|5|||
28062124|NCT00098722|54718211|FG004|Open Label Phase|Adverse Event|0|||
28062125|NCT00098722|54718212|FG005|Open Label Phase|Adverse Event|0|||
28062126|NCT00098722|54718213|FG006|Open Label Phase|Adverse Event|0|||
28062127|NCT00098722|54718207|FG000|Open Label Phase|Death|0|||
28062128|NCT00098722|54718208|FG001|Open Label Phase|Death|0|||
28062129|NCT00098722|54718209|FG002|Open Label Phase|Death|0|||
28062130|NCT00098722|54718210|FG003|Open Label Phase|Death|2|||
28062131|NCT00098722|54718211|FG004|Open Label Phase|Death|0|||
28062132|NCT00098722|54718212|FG005|Open Label Phase|Death|0|||
28062133|NCT00098722|54718213|FG006|Open Label Phase|Death|0|||
28062134|NCT00098722|54718207|FG000|Open Label Phase|Lack of Efficacy|0|||
28062135|NCT00098722|54718208|FG001|Open Label Phase|Lack of Efficacy|0|||
28062136|NCT00098722|54718209|FG002|Open Label Phase|Lack of Efficacy|0|||
28062137|NCT00098722|54718210|FG003|Open Label Phase|Lack of Efficacy|8|||
28062138|NCT00098722|54718211|FG004|Open Label Phase|Lack of Efficacy|0|||
28062139|NCT00098722|54718212|FG005|Open Label Phase|Lack of Efficacy|0|||
28062140|NCT00098722|54718213|FG006|Open Label Phase|Lack of Efficacy|0|||
28062141|NCT00098722|54718207|FG000|Open Label Phase|Pregnancy|0|||
28062142|NCT00098722|54718208|FG001|Open Label Phase|Pregnancy|0|||
28062143|NCT00098722|54718209|FG002|Open Label Phase|Pregnancy|0|||
28062144|NCT00098722|54718210|FG003|Open Label Phase|Pregnancy|1|||
28062145|NCT00098722|54718211|FG004|Open Label Phase|Pregnancy|0|||
28062146|NCT00098722|54718212|FG005|Open Label Phase|Pregnancy|0|||
28062147|NCT00098722|54718213|FG006|Open Label Phase|Pregnancy|0|||
28062148|NCT00098722|54718207|FG000|Open Label Phase|Participant defaulted|0|||
28062149|NCT00098722|54718208|FG001|Open Label Phase|Participant defaulted|0|||
28062150|NCT00098722|54718209|FG002|Open Label Phase|Participant defaulted|0|||
28062151|NCT00098722|54718210|FG003|Open Label Phase|Participant defaulted|18|||
28062152|NCT00098722|54718211|FG004|Open Label Phase|Participant defaulted|0|||
28062153|NCT00098722|54718212|FG005|Open Label Phase|Participant defaulted|0|||
28062154|NCT00098722|54718213|FG006|Open Label Phase|Participant defaulted|0|||
28062155|NCT00098722|54718207|FG000|Open Label Phase|Ongoing at cut-off date|0|||
28062156|NCT00098722|54718208|FG001|Open Label Phase|Ongoing at cut-off date|0|||
28062157|NCT00098722|54718209|FG002|Open Label Phase|Ongoing at cut-off date|0|||
28062158|NCT00098722|54718210|FG003|Open Label Phase|Ongoing at cut-off date|220|||
28062159|NCT00098722|54718211|FG004|Open Label Phase|Ongoing at cut-off date|50|||
28062160|NCT00098722|54718212|FG005|Open Label Phase|Ongoing at cut-off date|0|||
28062161|NCT00098722|54718213|FG006|Open Label Phase|Ongoing at cut-off date|0|||
28062162|NCT00098722|54718207|FG000|Open Label Phase|Other|0|||
28062163|NCT00098722|54718208|FG001|Open Label Phase|Other|0|||
28062164|NCT00098722|54718209|FG002|Open Label Phase|Other|0|||
28062165|NCT00098722|54718210|FG003|Open Label Phase|Other|18|||
28062166|NCT00098722|54718211|FG004|Open Label Phase|Other|0|||
28062167|NCT00098722|54718212|FG005|Open Label Phase|Other|0|||
28062168|NCT00098722|54718213|FG006|Open Label Phase|Other|0|||
28062169|NCT00098722|54718207|FG000|Observation Phase|Death|0|||
28062170|NCT00098722|54718208|FG001|Observation Phase|Death|0|||
28062171|NCT00098722|54718209|FG002|Observation Phase|Death|0|||
28062172|NCT00098722|54718210|FG003|Observation Phase|Death|0|||
28062173|NCT00098722|54718211|FG004|Observation Phase|Death|0|||
28062174|NCT00098722|54718212|FG005|Observation Phase|Death|5|||
28062175|NCT00098722|54718213|FG006|Observation Phase|Death|3|||
28062176|NCT00098722|54718207|FG000|Observation Phase|Lack of Efficacy|0|||
28062177|NCT00098722|54718208|FG001|Observation Phase|Lack of Efficacy|0|||
28062178|NCT00098722|54718209|FG002|Observation Phase|Lack of Efficacy|0|||
28062179|NCT00098722|54718210|FG003|Observation Phase|Lack of Efficacy|0|||
28062180|NCT00098722|54718211|FG004|Observation Phase|Lack of Efficacy|0|||
28062181|NCT00098722|54718212|FG005|Observation Phase|Lack of Efficacy|2|||
28062182|NCT00098722|54718213|FG006|Observation Phase|Lack of Efficacy|0|||
28062183|NCT00098722|54718207|FG000|Observation Phase|Participant defaulted|0|||
28062184|NCT00098722|54718208|FG001|Observation Phase|Participant defaulted|0|||
28062185|NCT00098722|54718209|FG002|Observation Phase|Participant defaulted|0|||
28062186|NCT00098722|54718210|FG003|Observation Phase|Participant defaulted|0|||
28062187|NCT00098722|54718211|FG004|Observation Phase|Participant defaulted|0|||
28062188|NCT00098722|54718212|FG005|Observation Phase|Participant defaulted|17|||
28062189|NCT00098722|54718213|FG006|Observation Phase|Participant defaulted|4|||
28062190|NCT00098722|54718207|FG000|Observation Phase|Other|0|||
28062191|NCT00098722|54718208|FG001|Observation Phase|Other|0|||
28062192|NCT00098722|54718209|FG002|Observation Phase|Other|0|||
28062193|NCT00098722|54718210|FG003|Observation Phase|Other|0|||
27815006|NCT03439293|54271775|FG000|Overall Study|Ongoing on Treatment|15|||
27815007|NCT03439293|54271775|FG000|Overall Study|Ongoing off Treatment|19|||
27815008|NCT03439293|54271775|FG000|Overall Study|Death|18|||
27815009|NCT03439293|54271775|FG000|Overall Study|Withdrawal by Subject|7|||
27815010|NCT03439293|54271775|FG000|Overall Study|Lost to Follow-up|2|||
27815011|NCT03423979|54271780|FG000|Overall Study|Death|1|||
27815012|NCT03239210|54271795|FG000|Overall Study|Lost to Follow-up|2|||
27815013|NCT03239210|54271796|FG001|Overall Study|Lost to Follow-up|2|||
27815014|NCT03239210|54271795|FG000|Overall Study|Withdrawal by subject (personal reasons)|2|||
27815015|NCT03239210|54271796|FG001|Overall Study|Withdrawal by subject (personal reasons)|2|||
27815016|NCT03239210|54271795|FG000|Overall Study|Withdrawal by subject (reported medical side effects)|2|||
27815017|NCT03239210|54271796|FG001|Overall Study|Withdrawal by subject (reported medical side effects)|1|||
27815018|NCT03227224|54271806|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
27815019|NCT03227224|54271807|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
27815020|NCT03227224|54271808|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
27815021|NCT03227224|54271809|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
27815022|NCT03227224|54271806|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
28062194|NCT00098722|54718211|FG004|Observation Phase|Other|0|||
27815023|NCT03227224|54271807|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
28062195|NCT00098722|54718212|FG005|Observation Phase|Other|21|||
28062196|NCT00098722|54718213|FG006|Observation Phase|Other|10|||
28062197|NCT00098254|54718225|FG000|Overall Study|Adverse Event|2|||
28062198|NCT00098254|54718225|FG000|Overall Study|Death|1|||
28062199|NCT00095056|54718231|FG000|Phase A (Weeks 0-12)|Adverse Event|1|||
28062200|NCT00095056|54718232|FG001|Phase A (Weeks 0-12)|Adverse Event|1|||
28062201|NCT00095056|54718231|FG000|Phase A (Weeks 0-12)|Withdrawal by Subject|3|||
28062202|NCT00095056|54718232|FG001|Phase A (Weeks 0-12)|Withdrawal by Subject|0|||
28062203|NCT00095056|54718231|FG000|Phase A (Weeks 0-12)|Death|1|||
28062204|NCT00095056|54718232|FG001|Phase A (Weeks 0-12)|Death|0|||
27815024|NCT03227224|54271808|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
28062205|NCT00095056|54718231|FG000|Phase A (Weeks 0-12)|Protocol specific criteria|2|||
28062206|NCT00095056|54718232|FG001|Phase A (Weeks 0-12)|Protocol specific criteria|0|||
28062207|NCT00095056|54718231|FG000|Phase B (Weeks 12-54)|Adverse Event|2|||
28062208|NCT00095056|54718232|FG001|Phase B (Weeks 12-54)|Adverse Event|2|||
28062209|NCT00095056|54718231|FG000|Phase B (Weeks 12-54)|Lost to Follow-up|1|||
28062210|NCT00095056|54718232|FG001|Phase B (Weeks 12-54)|Lost to Follow-up|0|||
28062211|NCT00095056|54718231|FG000|Phase B (Weeks 12-54)|Withdrawal by Subject|2|||
28062212|NCT00095056|54718232|FG001|Phase B (Weeks 12-54)|Withdrawal by Subject|1|||
28062213|NCT00095056|54718231|FG000|Phase B (Weeks 12-54)|Patient Moved|1|||
28062214|NCT00095056|54718232|FG001|Phase B (Weeks 12-54)|Patient Moved|0|||
28062215|NCT00095056|54718231|FG000|Phase B (Weeks 12-54)|Death|3|||
28062216|NCT00095056|54718232|FG001|Phase B (Weeks 12-54)|Death|1|||
27815025|NCT03227224|54271809|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
28062217|NCT00095056|54718231|FG000|Phase B (Weeks 12-54)|Protocol specific criteria|1|||
28062218|NCT00095056|54718232|FG001|Phase B (Weeks 12-54)|Protocol specific criteria|0|||
28062219|NCT00095056|54718231|FG000|Phase B (Weeks 12-54)|Protocol Violation|0|||
28062220|NCT00095056|54718232|FG001|Phase B (Weeks 12-54)|Protocol Violation|1|||
28062221|NCT00098020|54718238|FG000|Overall Study|Adverse Event|2|||
28062222|NCT00098020|54718238|FG000|Overall Study|Lost to Follow-up|1|||
28062223|NCT00098020|54718238|FG000|Overall Study|elevated liver enzymes|1|||
28062224|NCT00098020|54718238|FG000|Overall Study|Low urine PCR|1|||
28062225|NCT00098020|54718238|FG000|Overall Study|Low epidermal growth factor receptor|1|||
28062226|NCT00381680|54718244|FG000|Overall Study|Adverse Event|9|||
28062227|NCT00381680|54718245|FG001|Overall Study|Adverse Event|3|||
28062228|NCT00381680|54718244|FG000|Overall Study|Death|10|||
28062229|NCT00381680|54718245|FG001|Overall Study|Death|7|||
28062230|NCT00381680|54718244|FG000|Overall Study|Lost to Follow-up|3|||
28062231|NCT00381680|54718245|FG001|Overall Study|Lost to Follow-up|2|||
28062232|NCT00381680|54718244|FG000|Overall Study|Physician Decision|25|||
28062233|NCT00381680|54718245|FG001|Overall Study|Physician Decision|6|||
28062234|NCT00381680|54718244|FG000|Overall Study|Withdrawal by Subject|3|||
27815026|NCT03227224|54271806|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
27815027|NCT03227224|54271807|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
27815028|NCT03227224|54271808|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
27815029|NCT03227224|54271809|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
27815030|NCT03227224|54271806|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
27815031|NCT03227224|54271807|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
27815032|NCT03227224|54271808|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
27848351|NCT00980005|54341317|FG000|Overall Study|Withdrawal by Subject|6|||
28062235|NCT00381680|54718245|FG001|Overall Study|Withdrawal by Subject|1|||
28062236|NCT00381680|54718244|FG000|Overall Study|Entry onto another COG Trial|1|||
28062237|NCT00381680|54718245|FG001|Overall Study|Entry onto another COG Trial|2|||
28062238|NCT00381680|54718244|FG000|Overall Study|Alternative Therapy|11|||
28062239|NCT00381680|54718245|FG001|Overall Study|Alternative Therapy|5|||
28062240|NCT00381680|54718244|FG000|Overall Study|Secondary Malignancy|3|||
28062241|NCT00381680|54718245|FG001|Overall Study|Secondary Malignancy|0|||
28062242|NCT00381680|54718244|FG000|Overall Study|Delay initiation|1|||
28062243|NCT00381680|54718245|FG001|Overall Study|Delay initiation|0|||
28062244|NCT00381680|54718244|FG000|Overall Study|Stem Cell Transplant|26|||
28062245|NCT00381680|54718245|FG001|Overall Study|Stem Cell Transplant|10|||
28062246|NCT00381680|54718244|FG000|Overall Study|Relapse|18|||
28062247|NCT00381680|54718245|FG001|Overall Study|Relapse|9|||
28062248|NCT00381680|54718244|FG000|Overall Study|Induction Failure|4|||
28062249|NCT00381680|54718245|FG001|Overall Study|Induction Failure|1|||
28062250|NCT00381680|54718244|FG000|Overall Study|Progression|1|||
28062251|NCT00381680|54718245|FG001|Overall Study|Progression|1|||
28062252|NCT00381680|54718244|FG000|Overall Study|Other not otherwise specified|7|||
28062253|NCT00381680|54718245|FG001|Overall Study|Other not otherwise specified|2|||
28062254|NCT00381680|54718244|FG000|Overall Study|Ineligible|3|||
28062255|NCT00381680|54718245|FG001|Overall Study|Ineligible|1|||
28062256|NCT00360698|54718257|FG000|Run-In|Physician Decision|0|||
28062257|NCT00360698|54718258|FG001|Run-In|Physician Decision|1|||
28062258|NCT00360698|54718257|FG000|Run-In|Withdrawal by Subject|0|||
28062259|NCT00360698|54718258|FG001|Run-In|Withdrawal by Subject|2|||
28062260|NCT00360698|54718257|FG000|Run-In|Non compliance with treatment procedure|0|||
28062261|NCT00360698|54718258|FG001|Run-In|Non compliance with treatment procedure|1|||
28062262|NCT00360698|54718257|FG000|Run-In|Sponsor request|0|||
28062263|NCT00360698|54718258|FG001|Run-In|Sponsor request|2|||
28062264|NCT00360698|54718257|FG000|Run-In|Patient did not meet inclusion criteria|0|||
28062265|NCT00360698|54718258|FG001|Run-In|Patient did not meet inclusion criteria|1|||
28062266|NCT00360698|54718257|FG000|Run-In|Patient personal reasons|0|||
28062267|NCT00360698|54718258|FG001|Run-In|Patient personal reasons|2|||
28062268|NCT00360698|54718257|FG000|Run-In|Need of insulin with meals|0|||
28062269|NCT00360698|54718258|FG001|Run-In|Need of insulin with meals|1|||
28062270|NCT00360698|54718257|FG000|Treatment Period|Non compliance with treatment procedure|1|||
28062271|NCT00360698|54718258|FG001|Treatment Period|Non compliance with treatment procedure|0|||
28062272|NCT00360698|54718257|FG000|Treatment Period|Early termination by error|0|||
28062273|NCT00360698|54718258|FG001|Treatment Period|Early termination by error|1|||
28062274|NCT00380978|54718266|FG000|Overall Study|Refused allocated intervention|0|||
28062275|NCT00380978|54718267|FG001|Overall Study|Refused allocated intervention|6|||
28062276|NCT00380978|54718266|FG000|Overall Study|Wrong study envelope|0|||
28062277|NCT00380978|54718267|FG001|Overall Study|Wrong study envelope|2|||
28062278|NCT00380978|54718266|FG000|Overall Study|Allocation prior to analgesia request|1|||
27815033|NCT03227224|54271809|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
27815034|NCT03227224|54271806|FG000|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
27815035|NCT03227224|54271807|FG001|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
27815036|NCT03227224|54271808|FG002|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|1|||
27815037|NCT03227224|54271809|FG003|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
27815038|NCT03227224|54271806|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|2|||
27815039|NCT03227224|54271807|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
27815040|NCT03227224|54271808|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
27815041|NCT03227224|54271809|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|4|||
27815042|NCT03227224|54271806|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|2|||
27815043|NCT03227224|54271807|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
27815044|NCT03227224|54271808|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
27815045|NCT03227224|54271809|FG003|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
27815046|NCT03227224|54271806|FG000|Double-blind Treatment Period (6 Weeks)|Other|4|||
27815047|NCT03227224|54271807|FG001|Double-blind Treatment Period (6 Weeks)|Other|0|||
27815048|NCT03227224|54271808|FG002|Double-blind Treatment Period (6 Weeks)|Other|1|||
27815049|NCT03227224|54271809|FG003|Double-blind Treatment Period (6 Weeks)|Other|0|||
27815050|NCT03227224|54271806|FG000|Follow-up Phase (2 Weeks)|Other|4|||
27815051|NCT03227224|54271807|FG001|Follow-up Phase (2 Weeks)|Other|4|||
27815052|NCT03227224|54271808|FG002|Follow-up Phase (2 Weeks)|Other|6|||
27815053|NCT03227224|54271809|FG003|Follow-up Phase (2 Weeks)|Other|3|||
27815054|NCT03086343|54271828|FG000|Overall Study|Adverse Event|7|||
27815055|NCT03086343|54271829|FG001|Overall Study|Adverse Event|7|||
27815056|NCT03086343|54271828|FG000|Overall Study|Withdrawal by Subject|10|||
27815057|NCT03086343|54271829|FG001|Overall Study|Withdrawal by Subject|6|||
27815058|NCT03086343|54271828|FG000|Overall Study|Lost to Follow-up|3|||
27815059|NCT03086343|54271829|FG001|Overall Study|Lost to Follow-up|1|||
27815060|NCT03086343|54271828|FG000|Overall Study|Lack of Efficacy|4|||
27815061|NCT03086343|54271829|FG001|Overall Study|Lack of Efficacy|6|||
27815062|NCT03086343|54271828|FG000|Overall Study|Other, not specified|8|||
27815063|NCT03086343|54271829|FG001|Overall Study|Other, not specified|4|||
27815064|NCT03086343|54271828|FG000|Overall Study|Missing|0|||
27815065|NCT03086343|54271829|FG001|Overall Study|Missing|1|||
27815066|NCT02788045|54271873|FG000|Main Study (Up to Week 72)|Adverse Event|0|||
27815067|NCT02788045|54271874|FG001|Main Study (Up to Week 72)|Adverse Event|1|||
27815068|NCT02788045|54271875|FG002|Main Study (Up to Week 72)|Adverse Event|1|||
27815069|NCT02788045|54271873|FG000|Main Study (Up to Week 72)|Lost to Follow-up|5|||
27848352|NCT00980005|54341318|FG001|Overall Study|Withdrawal by Subject|17|||
28062279|NCT00380978|54718267|FG001|Overall Study|Allocation prior to analgesia request|2|||
28062280|NCT00380978|54718266|FG000|Overall Study|Parous patient|1|||
28062281|NCT00380978|54718267|FG001|Overall Study|Parous patient|0|||
28062282|NCT00162123|54718281|FG000|Overall Study|Disease progression|27|||
28062283|NCT00162123|54718282|FG001|Overall Study|Disease progression|19|||
27815070|NCT02788045|54271874|FG001|Main Study (Up to Week 72)|Lost to Follow-up|4|||
27815071|NCT02788045|54271875|FG002|Main Study (Up to Week 72)|Lost to Follow-up|3|||
27815072|NCT02788045|54271873|FG000|Main Study (Up to Week 72)|Pregnancy|1|||
27815073|NCT02788045|54271874|FG001|Main Study (Up to Week 72)|Pregnancy|1|||
27940089|NCT01195662|54596421|FG002|Double Blind Treatment Period|Administrative reason|1|||
27940090|NCT01195662|54596419|FG000|Double Blind Treatment Period|Requested discontinue treatment|1|||
28062284|NCT00162123|54718283|FG002|Overall Study|Disease progression|10|||
28062285|NCT00162123|54718284|FG003|Overall Study|Disease progression|4|||
28062286|NCT00162123|54718285|FG004|Overall Study|Disease progression|8|||
28062287|NCT00162123|54718286|FG005|Overall Study|Disease progression|3|||
28062288|NCT00162123|54718287|FG006|Overall Study|Disease progression|1|||
28062289|NCT00162123|54718288|FG007|Overall Study|Disease progression|0|||
28062290|NCT00162123|54718281|FG000|Overall Study|Study drug toxicity|6|||
28062291|NCT00162123|54718282|FG001|Overall Study|Study drug toxicity|1|||
28062292|NCT00162123|54718283|FG002|Overall Study|Study drug toxicity|5|||
28062293|NCT00162123|54718284|FG003|Overall Study|Study drug toxicity|0|||
28062294|NCT00162123|54718285|FG004|Overall Study|Study drug toxicity|4|||
28062295|NCT00162123|54718286|FG005|Overall Study|Study drug toxicity|1|||
28062296|NCT00162123|54718287|FG006|Overall Study|Study drug toxicity|1|||
28062297|NCT00162123|54718288|FG007|Overall Study|Study drug toxicity|0|||
28062298|NCT00162123|54718281|FG000|Overall Study|Death|3|||
28062299|NCT00162123|54718282|FG001|Overall Study|Death|3|||
28062300|NCT00162123|54718283|FG002|Overall Study|Death|1|||
28062301|NCT00162123|54718284|FG003|Overall Study|Death|1|||
28062302|NCT00162123|54718285|FG004|Overall Study|Death|1|||
28062303|NCT00162123|54718286|FG005|Overall Study|Death|1|||
28062304|NCT00162123|54718287|FG006|Overall Study|Death|0|||
28062305|NCT00162123|54718288|FG007|Overall Study|Death|0|||
28062306|NCT00162123|54718281|FG000|Overall Study|Withdrawal by Subject|2|||
28062307|NCT00162123|54718282|FG001|Overall Study|Withdrawal by Subject|0|||
28062308|NCT00162123|54718283|FG002|Overall Study|Withdrawal by Subject|2|||
28062309|NCT00162123|54718284|FG003|Overall Study|Withdrawal by Subject|1|||
28062310|NCT00162123|54718285|FG004|Overall Study|Withdrawal by Subject|1|||
28062311|NCT00162123|54718286|FG005|Overall Study|Withdrawal by Subject|2|||
28062312|NCT00162123|54718287|FG006|Overall Study|Withdrawal by Subject|1|||
28062313|NCT00162123|54718288|FG007|Overall Study|Withdrawal by Subject|0|||
28062314|NCT00162123|54718281|FG000|Overall Study|Deterioration without progression|2|||
28062315|NCT00162123|54718282|FG001|Overall Study|Deterioration without progression|2|||
28062316|NCT00162123|54718283|FG002|Overall Study|Deterioration without progression|3|||
28062317|NCT00162123|54718284|FG003|Overall Study|Deterioration without progression|0|||
28062318|NCT00162123|54718285|FG004|Overall Study|Deterioration without progression|1|||
28062319|NCT00162123|54718286|FG005|Overall Study|Deterioration without progression|0|||
28062320|NCT00162123|54718287|FG006|Overall Study|Deterioration without progression|0|||
28062321|NCT00162123|54718288|FG007|Overall Study|Deterioration without progression|0|||
28062322|NCT00162123|54718281|FG000|Overall Study|Adverse Event|1|||
28062323|NCT00162123|54718282|FG001|Overall Study|Adverse Event|2|||
28062324|NCT00162123|54718283|FG002|Overall Study|Adverse Event|0|||
28062325|NCT00162123|54718284|FG003|Overall Study|Adverse Event|2|||
28062326|NCT00162123|54718285|FG004|Overall Study|Adverse Event|1|||
28062327|NCT00162123|54718286|FG005|Overall Study|Adverse Event|0|||
28062328|NCT00162123|54718287|FG006|Overall Study|Adverse Event|0|||
28062329|NCT00162123|54718288|FG007|Overall Study|Adverse Event|0|||
28062330|NCT00162123|54718281|FG000|Overall Study|Not specified (before treatment)|2|||
28062331|NCT00162123|54718282|FG001|Overall Study|Not specified (before treatment)|0|||
28062332|NCT00162123|54718283|FG002|Overall Study|Not specified (before treatment)|0|||
28062333|NCT00162123|54718284|FG003|Overall Study|Not specified (before treatment)|0|||
28062334|NCT00162123|54718285|FG004|Overall Study|Not specified (before treatment)|12|||
28062335|NCT00162123|54718286|FG005|Overall Study|Not specified (before treatment)|1|||
28062336|NCT00162123|54718287|FG006|Overall Study|Not specified (before treatment)|0|||
28062337|NCT00162123|54718288|FG007|Overall Study|Not specified (before treatment)|0|||
28062338|NCT00162123|54718281|FG000|Overall Study|Not specified (after start of treatment)|0|||
28062339|NCT00162123|54718282|FG001|Overall Study|Not specified (after start of treatment)|0|||
28062340|NCT00162123|54718283|FG002|Overall Study|Not specified (after start of treatment)|0|||
28062341|NCT00162123|54718284|FG003|Overall Study|Not specified (after start of treatment)|0|||
28062342|NCT00162123|54718285|FG004|Overall Study|Not specified (after start of treatment)|3|||
28062343|NCT00162123|54718286|FG005|Overall Study|Not specified (after start of treatment)|0|||
28062344|NCT00162123|54718287|FG006|Overall Study|Not specified (after start of treatment)|0|||
28062345|NCT00162123|54718288|FG007|Overall Study|Not specified (after start of treatment)|0|||
28062346|NCT00162123|54718281|FG000|Overall Study|Physician Decision|1|||
28062347|NCT00162123|54718282|FG001|Overall Study|Physician Decision|2|||
28062348|NCT00162123|54718283|FG002|Overall Study|Physician Decision|0|||
28062349|NCT00162123|54718284|FG003|Overall Study|Physician Decision|0|||
28062350|NCT00162123|54718285|FG004|Overall Study|Physician Decision|0|||
28062351|NCT00162123|54718286|FG005|Overall Study|Physician Decision|1|||
28062352|NCT00162123|54718287|FG006|Overall Study|Physician Decision|1|||
28062353|NCT00162123|54718288|FG007|Overall Study|Physician Decision|0|||
28062354|NCT00162123|54718281|FG000|Overall Study|Tumor assessment only (not treated)|0|||
28062355|NCT00162123|54718282|FG001|Overall Study|Tumor assessment only (not treated)|0|||
28062356|NCT00162123|54718283|FG002|Overall Study|Tumor assessment only (not treated)|0|||
28062357|NCT00162123|54718284|FG003|Overall Study|Tumor assessment only (not treated)|0|||
28062358|NCT00162123|54718285|FG004|Overall Study|Tumor assessment only (not treated)|0|||
28062359|NCT00162123|54718286|FG005|Overall Study|Tumor assessment only (not treated)|0|||
28062360|NCT00162123|54718287|FG006|Overall Study|Tumor assessment only (not treated)|0|||
28062361|NCT00162123|54718288|FG007|Overall Study|Tumor assessment only (not treated)|1|||
28062362|NCT00162123|54718281|FG000|Overall Study|Follow-up only (not treated or assessed)|0|||
28062363|NCT00162123|54718282|FG001|Overall Study|Follow-up only (not treated or assessed)|0|||
28062364|NCT00162123|54718283|FG002|Overall Study|Follow-up only (not treated or assessed)|0|||
28062365|NCT00162123|54718284|FG003|Overall Study|Follow-up only (not treated or assessed)|0|||
28062366|NCT00162123|54718285|FG004|Overall Study|Follow-up only (not treated or assessed)|0|||
28062367|NCT00162123|54718286|FG005|Overall Study|Follow-up only (not treated or assessed)|0|||
28062368|NCT00162123|54718287|FG006|Overall Study|Follow-up only (not treated or assessed)|0|||
28062369|NCT00162123|54718288|FG007|Overall Study|Follow-up only (not treated or assessed)|57|||
28062370|NCT00227721|54718307|FG000|Overall Study|On study, but never treated.|1|||
28062371|NCT00226941|54718315|FG000|Overall Study|Withdrawal by subject - toxicity|0|||
28062372|NCT00226941|54718316|FG001|Overall Study|Withdrawal by subject - toxicity|0|||
28062373|NCT00226941|54718317|FG002|Overall Study|Withdrawal by subject - toxicity|0|||
28062374|NCT00226941|54718318|FG003|Overall Study|Withdrawal by subject - toxicity|1|||
28062375|NCT00226941|54718315|FG000|Overall Study|Withdrawn by investigator - unrelated AE|0|||
28062376|NCT00226941|54718316|FG001|Overall Study|Withdrawn by investigator - unrelated AE|0|||
28062377|NCT00226941|54718317|FG002|Overall Study|Withdrawn by investigator - unrelated AE|0|||
28062378|NCT00226941|54718318|FG003|Overall Study|Withdrawn by investigator - unrelated AE|1|||
28062379|NCT00356408|54718338|FG000|Overall Study|Adverse Event|9|||
28062380|NCT00356408|54718338|FG000|Overall Study|Lack of Efficacy|36|||
28062381|NCT00356408|54718338|FG000|Overall Study|Lost to Follow-up|2|||
28062382|NCT00356408|54718338|FG000|Overall Study|Withdrawal by Subject|6|||
28062383|NCT00356408|54718338|FG000|Overall Study|Other: Principal investigator discretion|3|||
28062384|NCT00356408|54718338|FG000|Overall Study|Other: Sponsor request|1|||
28062385|NCT00356408|54718338|FG000|Overall Study|Other: Azathioprine stopped|1|||
28062386|NCT00356408|54718338|FG000|Overall Study|Other: Failed to meet Inc/Exc criteria|1|||
28062387|NCT00356408|54718338|FG000|Overall Study|Other: Subject chose commerical dosing|1|||
28062388|NCT00509795|54718353|FG000|Overall Study|Adverse Event|4|||
28062389|NCT00509795|54718354|FG001|Overall Study|Adverse Event|3|||
28062390|NCT00509795|54718355|FG002|Overall Study|Adverse Event|5|||
28062391|NCT00509795|54718356|FG003|Overall Study|Adverse Event|4|||
28062392|NCT00509795|54718353|FG000|Overall Study|Death|3|||
28062393|NCT00509795|54718354|FG001|Overall Study|Death|1|||
28062394|NCT00509795|54718355|FG002|Overall Study|Death|2|||
28062395|NCT00509795|54718356|FG003|Overall Study|Death|7|||
28062396|NCT00509795|54718353|FG000|Overall Study|Lack of Efficacy|0|||
28062397|NCT00509795|54718354|FG001|Overall Study|Lack of Efficacy|0|||
28062398|NCT00509795|54718355|FG002|Overall Study|Lack of Efficacy|2|||
28062399|NCT00509795|54718356|FG003|Overall Study|Lack of Efficacy|2|||
28062400|NCT00509795|54718353|FG000|Overall Study|Lost to Follow-up|1|||
27815074|NCT02788045|54271875|FG002|Main Study (Up to Week 72)|Pregnancy|0|||
27815075|NCT02788045|54271873|FG000|Main Study (Up to Week 72)|Protocol Violation|1|||
27815076|NCT02788045|54271874|FG001|Main Study (Up to Week 72)|Protocol Violation|0|||
27815077|NCT02788045|54271875|FG002|Main Study (Up to Week 72)|Protocol Violation|0|||
28062401|NCT00509795|54718354|FG001|Overall Study|Lost to Follow-up|2|||
28062402|NCT00509795|54718355|FG002|Overall Study|Lost to Follow-up|4|||
28062403|NCT00509795|54718356|FG003|Overall Study|Lost to Follow-up|4|||
28062404|NCT00509795|54718353|FG000|Overall Study|OTHER|1|||
28062405|NCT00509795|54718354|FG001|Overall Study|OTHER|0|||
28062406|NCT00509795|54718355|FG002|Overall Study|OTHER|4|||
28062407|NCT00509795|54718356|FG003|Overall Study|OTHER|1|||
28062408|NCT00509795|54718353|FG000|Overall Study|Protocol Violation|3|||
28062409|NCT00509795|54718354|FG001|Overall Study|Protocol Violation|0|||
28062410|NCT00509795|54718355|FG002|Overall Study|Protocol Violation|3|||
28062411|NCT00509795|54718356|FG003|Overall Study|Protocol Violation|1|||
28062412|NCT00509795|54718353|FG000|Overall Study|Withdrawal by Subject|10|||
28062413|NCT00509795|54718354|FG001|Overall Study|Withdrawal by Subject|5|||
28062414|NCT00509795|54718355|FG002|Overall Study|Withdrawal by Subject|7|||
28062415|NCT00509795|54718356|FG003|Overall Study|Withdrawal by Subject|8|||
28062416|NCT00165789|54718371|FG000|Overall Study|Adverse Event|0|||
28062417|NCT00165789|54718372|FG001|Overall Study|Adverse Event|3|||
28062418|NCT00165789|54718373|FG002|Overall Study|Adverse Event|0|||
28062419|NCT00165789|54718374|FG003|Overall Study|Adverse Event|12|||
28062420|NCT00165789|54718371|FG000|Overall Study|Withdrawal by Subject|0|||
28062421|NCT00165789|54718372|FG001|Overall Study|Withdrawal by Subject|1|||
28062422|NCT00165789|54718373|FG002|Overall Study|Withdrawal by Subject|1|||
28062423|NCT00165789|54718374|FG003|Overall Study|Withdrawal by Subject|2|||
28062424|NCT00504257|54718384|FG000|Overall Study|Withdrawal by Subject|2|||
28062425|NCT00504257|54718384|FG000|Overall Study|ineligible histology|2|||
28062426|NCT00509093|54718388|FG000|Overall Study|Adverse Event|10|||
28062427|NCT00509093|54718388|FG000|Overall Study|Disease Progression|9|||
28062428|NCT00509093|54718388|FG000|Overall Study|Transformed into MDS|1|||
28062429|NCT00509093|54718388|FG000|Overall Study|Withdrawal by Subject|3|||
28062430|NCT00509093|54718388|FG000|Overall Study|Physician Decision|1|||
28062431|NCT00160641|54718392|FG000|Overall Study|Adverse Event|102|||
28062432|NCT00160641|54718392|FG000|Overall Study|Withdrawal by Subject|87|||
28062433|NCT00160641|54718392|FG000|Overall Study|Lost to Follow-up|8|||
28062434|NCT00160641|54718392|FG000|Overall Study|Lack of Efficacy|12|||
28062435|NCT00160641|54718392|FG000|Overall Study|Protocol Violation|3|||
28062436|NCT00160641|54718392|FG000|Overall Study|Other|9|||
28062437|NCT00493025|54718396|FG000|Overall Study|Physician Decision|19|||
28062438|NCT00160563|54718404|FG000|Overall Study|Adverse Event|1|||
28062439|NCT00160563|54718405|FG001|Overall Study|Adverse Event|1|||
28062440|NCT00160563|54718406|FG002|Overall Study|Adverse Event|1|||
28062441|NCT00160563|54718404|FG000|Overall Study|Lost to Follow-up|1|||
28062442|NCT00160563|54718405|FG001|Overall Study|Lost to Follow-up|1|||
28062443|NCT00160563|54718406|FG002|Overall Study|Lost to Follow-up|2|||
28062444|NCT00160563|54718404|FG000|Overall Study|Protocol Violation|0|||
28062445|NCT00160563|54718405|FG001|Overall Study|Protocol Violation|0|||
28062446|NCT00160563|54718406|FG002|Overall Study|Protocol Violation|3|||
28062447|NCT00160563|54718404|FG000|Overall Study|Withdrawal by Subject|1|||
28062448|NCT00160563|54718405|FG001|Overall Study|Withdrawal by Subject|2|||
28062449|NCT00160563|54718406|FG002|Overall Study|Withdrawal by Subject|3|||
28062450|NCT00160563|54718404|FG000|Overall Study|Other (listed in the study report)|48|||
28062451|NCT00160563|54718405|FG001|Overall Study|Other (listed in the study report)|40|||
28062452|NCT00160563|54718406|FG002|Overall Study|Other (listed in the study report)|81|||
28062453|NCT00160563|54718404|FG000|Overall Study|Missing reason|0|||
28062454|NCT00160563|54718405|FG001|Overall Study|Missing reason|1|||
28062455|NCT00160563|54718406|FG002|Overall Study|Missing reason|0|||
28062456|NCT00380744|54718422|FG000|Overall Study|Death|0|||
28062457|NCT00380744|54718423|FG001|Overall Study|Death|0|||
28062458|NCT00380744|54718424|FG002|Overall Study|Death|0|||
28062459|NCT00380744|54718425|FG003|Overall Study|Death|0|||
28062460|NCT00380744|54718426|FG004|Overall Study|Death|0|||
28062461|NCT00380744|54718427|FG005|Overall Study|Death|0|||
28062462|NCT00380744|54718428|FG006|Overall Study|Death|1|||
28062463|NCT00380744|54718422|FG000|Overall Study|Withdrawal by Subject|1|||
28062464|NCT00380744|54718423|FG001|Overall Study|Withdrawal by Subject|0|||
28062465|NCT00380744|54718424|FG002|Overall Study|Withdrawal by Subject|0|||
28062466|NCT00380744|54718425|FG003|Overall Study|Withdrawal by Subject|0|||
28062467|NCT00380744|54718426|FG004|Overall Study|Withdrawal by Subject|0|||
28062468|NCT00380744|54718427|FG005|Overall Study|Withdrawal by Subject|0|||
28062469|NCT00380744|54718428|FG006|Overall Study|Withdrawal by Subject|0|||
28062470|NCT00380588|54718447|FG000|Overall Study|Unequivocal Disease Progression|25|||
28062471|NCT00380588|54718448|FG001|Overall Study|Unequivocal Disease Progression|34|||
28062472|NCT00380588|54718447|FG000|Overall Study|Next Cycle Not Started|4|||
28062473|NCT00380588|54718448|FG001|Overall Study|Next Cycle Not Started|0|||
28062474|NCT00380588|54718447|FG000|Overall Study|Adverse Event|7|||
28062475|NCT00380588|54718448|FG001|Overall Study|Adverse Event|3|||
28062476|NCT00380588|54718447|FG000|Overall Study|Withdrawal by Subject|1|||
28062477|NCT00380588|54718448|FG001|Overall Study|Withdrawal by Subject|3|||
28062478|NCT00380588|54718447|FG000|Overall Study|Physician Decision|2|||
28062479|NCT00380588|54718448|FG001|Overall Study|Physician Decision|0|||
28062480|NCT00379808|54718454|FG000|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0|||
28062481|NCT00379808|54718455|FG001|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1|||
28062482|NCT00355784|54718464|FG000|Overall Study|Withdrawal by Subject|0|||
28062483|NCT00355784|54718465|FG001|Overall Study|Withdrawal by Subject|0|||
28062484|NCT00355784|54718466|FG002|Overall Study|Withdrawal by Subject|2|||
28062485|NCT00355472|54718475|FG000|Overall Study|Physician Decision|1|||
28062486|NCT00492557|54718489|FG000|Overall Study|Subject request|12|||
28062487|NCT00492557|54718490|FG001|Overall Study|Subject request|11|||
28062488|NCT00492557|54718489|FG000|Overall Study|Protocol Violation|7|||
28062489|NCT00492557|54718490|FG001|Overall Study|Protocol Violation|8|||
28062490|NCT00492557|54718489|FG000|Overall Study|Other|2|||
28062491|NCT00492557|54718490|FG001|Overall Study|Other|2|||
28062492|NCT00492557|54718489|FG000|Overall Study|Death|1|||
28062493|NCT00492557|54718490|FG001|Overall Study|Death|1|||
28062494|NCT00492557|54718489|FG000|Overall Study|Adverse Event|1|||
28062495|NCT00492557|54718490|FG001|Overall Study|Adverse Event|0|||
28062496|NCT00492557|54718489|FG000|Overall Study|Failed to return|1|||
28062497|NCT00492557|54718490|FG001|Overall Study|Failed to return|0|||
28062498|NCT00492557|54718489|FG000|Overall Study|Lost to Follow-up|0|||
28062499|NCT00492557|54718490|FG001|Overall Study|Lost to Follow-up|1|||
28062500|NCT00508391|54718501|FG000|First Treatment|Withdrawal by Subject|6|||
28062501|NCT00508391|54718502|FG001|First Treatment|Withdrawal by Subject|3|||
28062502|NCT00508391|54718501|FG000|Second Treatment|Withdrawal by Subject|2|||
28062503|NCT00508391|54718502|FG001|Second Treatment|Withdrawal by Subject|0|||
28062504|NCT00508157|54718512|FG000|Overall Study|Adverse Event|0|||
28062505|NCT00508157|54718513|FG001|Overall Study|Adverse Event|1|||
28062506|NCT00508157|54718512|FG000|Overall Study|Subject Withdrew Consent|1|||
28062507|NCT00508157|54718513|FG001|Overall Study|Subject Withdrew Consent|0|||
28062508|NCT00508157|54718512|FG000|Overall Study|Lost to Follow-up|1|||
28062509|NCT00508157|54718513|FG001|Overall Study|Lost to Follow-up|0|||
28062510|NCT00508157|54718512|FG000|Overall Study|Subject no longer met study criteria|0|||
28062511|NCT00508157|54718513|FG001|Overall Study|Subject no longer met study criteria|1|||
28062512|NCT00508157|54718512|FG000|Overall Study|Other known cause|0|||
28062513|NCT00508157|54718513|FG001|Overall Study|Other known cause|1|||
28062514|NCT00378560|54718521|FG000|Overall Study|Adverse Event|1|||
28062515|NCT00378560|54718522|FG001|Overall Study|Adverse Event|0|||
28062516|NCT00378560|54718521|FG000|Overall Study|Lost to Follow-up|24|||
28062517|NCT00378560|54718522|FG001|Overall Study|Lost to Follow-up|29|||
28062518|NCT00378560|54718521|FG000|Overall Study|Protocol Violation|2|||
28062519|NCT00378560|54718522|FG001|Overall Study|Protocol Violation|0|||
28062520|NCT00378560|54718521|FG000|Overall Study|Withdrawal by Subject|17|||
28062521|NCT00378560|54718522|FG001|Overall Study|Withdrawal by Subject|21|||
28062522|NCT00378560|54718521|FG000|Overall Study|Moved|4|||
28062523|NCT00378560|54718522|FG001|Overall Study|Moved|3|||
28062524|NCT00378560|54718521|FG000|Overall Study|Pregnancy|7|||
28062525|NCT00378560|54718522|FG001|Overall Study|Pregnancy|5|||
28062526|NCT00378560|54718521|FG000|Overall Study|Laboratory test values abnormal|1|||
28062527|NCT00378560|54718522|FG001|Overall Study|Laboratory test values abnormal|0|||
28062528|NCT00508001|54718531|FG000|Overall Study|Adverse Event|2|||
28062529|NCT00508001|54718532|FG001|Overall Study|Adverse Event|0|||
28062530|NCT00508001|54718533|FG002|Overall Study|Adverse Event|4|||
28062531|NCT00508001|54718531|FG000|Overall Study|condition under investigation worsened|13|||
28062532|NCT00508001|54718532|FG001|Overall Study|condition under investigation worsened|7|||
28062533|NCT00508001|54718533|FG002|Overall Study|condition under investigation worsened|1|||
28062534|NCT00508001|54718531|FG000|Overall Study|Death|0|||
28062535|NCT00508001|54718532|FG001|Overall Study|Death|1|||
28062536|NCT00508001|54718533|FG002|Overall Study|Death|1|||
28062537|NCT00508001|54718531|FG000|Overall Study|Withdrawal by Subject|4|||
28062538|NCT00508001|54718532|FG001|Overall Study|Withdrawal by Subject|4|||
28062539|NCT00508001|54718533|FG002|Overall Study|Withdrawal by Subject|1|||
28062540|NCT00507689|54718544|FG000|Pre-Randomization Period|Adverse Event|1|||
28062541|NCT00507689|54718545|FG001|Pre-Randomization Period|Adverse Event|0|||
28062542|NCT00507689|54718544|FG000|Pre-Randomization Period|Physician Decision|1|||
28062543|NCT00507689|54718545|FG001|Pre-Randomization Period|Physician Decision|0|||
28062544|NCT00507689|54718544|FG000|Pre-Randomization Period|Withdrawal by Subject|1|||
28062545|NCT00507689|54718545|FG001|Pre-Randomization Period|Withdrawal by Subject|0|||
28062546|NCT00507689|54718544|FG000|Randomized Period|Adverse Event|1|||
27848353|NCT00980005|54341317|FG000|Overall Study|Lost to Follow-up|37|||
28062547|NCT00507689|54718545|FG001|Randomized Period|Adverse Event|1|||
28062548|NCT00507689|54718544|FG000|Randomized Period|Withdrawal by Subject|0|||
28062549|NCT00507689|54718545|FG001|Randomized Period|Withdrawal by Subject|1|||
28062550|NCT00491387|54718552|FG000|Overall Study|study terminated|20|||
28062551|NCT00491075|54718556|FG000|Overall Study|Withdrawal by Subject|1|||
28062552|NCT00491075|54718556|FG000|Overall Study|Physician Decision|1|||
28062553|NCT00507455|54718563|FG000|Overall Study|Adverse Event|3|||
28062554|NCT00507455|54718564|FG001|Overall Study|Adverse Event|3|||
28062555|NCT00507455|54718565|FG002|Overall Study|Adverse Event|6|||
28062556|NCT00507455|54718563|FG000|Overall Study|Withdrawal by Subject|2|||
28062557|NCT00507455|54718564|FG001|Overall Study|Withdrawal by Subject|1|||
28062558|NCT00507455|54718565|FG002|Overall Study|Withdrawal by Subject|2|||
28062559|NCT00507455|54718563|FG000|Overall Study|Protocol Violation|4|||
28062560|NCT00507455|54718564|FG001|Overall Study|Protocol Violation|1|||
28062561|NCT00507455|54718565|FG002|Overall Study|Protocol Violation|1|||
28062562|NCT00507455|54718563|FG000|Overall Study|Lost to Follow-up|2|||
28062563|NCT00507455|54718564|FG001|Overall Study|Lost to Follow-up|0|||
28062564|NCT00507455|54718565|FG002|Overall Study|Lost to Follow-up|2|||
28062565|NCT00507455|54718563|FG000|Overall Study|Lack of Efficacy|0|||
28062566|NCT00507455|54718564|FG001|Overall Study|Lack of Efficacy|1|||
28062567|NCT00507455|54718565|FG002|Overall Study|Lack of Efficacy|0|||
28062568|NCT00507455|54718563|FG000|Overall Study|Other - miscellaneous reason|1|||
28062569|NCT00507455|54718564|FG001|Overall Study|Other - miscellaneous reason|0|||
28062570|NCT00507455|54718565|FG002|Overall Study|Other - miscellaneous reason|1|||
28062571|NCT00506831|54718573|FG000|Overall Study|Death|1|||
28062572|NCT00506831|54718573|FG000|Overall Study|Withdrawal by Subject|1|||
28062573|NCT00506753|54718579|FG000|Overall Study|Lost to Follow-up|21|||
28062574|NCT00506753|54718580|FG001|Overall Study|Lost to Follow-up|15|||
28062575|NCT00490919|54718588|FG000|Open-label Run-in Period|Adverse Event|239|||
28062576|NCT00490919|54718589|FG001|Open-label Run-in Period|Adverse Event|0|||
28062577|NCT00490919|54718590|FG002|Open-label Run-in Period|Adverse Event|0|||
28062578|NCT00490919|54718588|FG000|Open-label Run-in Period|Withdrawal by Subject|37|||
28062579|NCT00490919|54718589|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
28062580|NCT00490919|54718590|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
28062581|NCT00490919|54718588|FG000|Open-label Run-in Period|Lost to Follow-up|21|||
28062582|NCT00490919|54718589|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
28062583|NCT00490919|54718590|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
28062584|NCT00490919|54718588|FG000|Open-label Run-in Period|Lack of Efficacy|143|||
28062585|NCT00490919|54718589|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
28062586|NCT00490919|54718590|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
28062587|NCT00490919|54718588|FG000|Open-label Run-in Period|Administrative|40|||
28062588|NCT00490919|54718589|FG001|Open-label Run-in Period|Administrative|0|||
27815078|NCT02788045|54271873|FG000|Main Study (Up to Week 72)|Withdrawal by Subject|6|||
27815079|NCT02788045|54271874|FG001|Main Study (Up to Week 72)|Withdrawal by Subject|4|||
27815080|NCT02788045|54271875|FG002|Main Study (Up to Week 72)|Withdrawal by Subject|1|||
27815081|NCT02788045|54271873|FG000|Main Study (Up to Week 72)|Other|3|||
27815082|NCT02788045|54271874|FG001|Main Study (Up to Week 72)|Other|0|||
28062589|NCT00490919|54718590|FG002|Open-label Run-in Period|Administrative|0|||
28062590|NCT00490919|54718588|FG000|Open-label Run-in Period|Confirmed or suspected diversion|3|||
28062591|NCT00490919|54718589|FG001|Open-label Run-in Period|Confirmed or suspected diversion|0|||
28062592|NCT00490919|54718590|FG002|Open-label Run-in Period|Confirmed or suspected diversion|0|||
28062593|NCT00490919|54718588|FG000|Double-blind Phase|Adverse Event|0|||
28062594|NCT00490919|54718589|FG001|Double-blind Phase|Adverse Event|40|||
28062595|NCT00490919|54718590|FG002|Double-blind Phase|Adverse Event|20|||
28062596|NCT00490919|54718588|FG000|Double-blind Phase|Withdrawal by Subject|0|||
28062597|NCT00490919|54718589|FG001|Double-blind Phase|Withdrawal by Subject|10|||
28062598|NCT00490919|54718590|FG002|Double-blind Phase|Withdrawal by Subject|11|||
28062599|NCT00490919|54718588|FG000|Double-blind Phase|Lost to Follow-up|0|||
28062600|NCT00490919|54718589|FG001|Double-blind Phase|Lost to Follow-up|8|||
28062601|NCT00490919|54718590|FG002|Double-blind Phase|Lost to Follow-up|11|||
28062602|NCT00490919|54718588|FG000|Double-blind Phase|Lack of Efficacy|0|||
28062603|NCT00490919|54718589|FG001|Double-blind Phase|Lack of Efficacy|22|||
28062604|NCT00490919|54718590|FG002|Double-blind Phase|Lack of Efficacy|36|||
28062605|NCT00490919|54718588|FG000|Double-blind Phase|Administrative|0|||
28062606|NCT00490919|54718589|FG001|Double-blind Phase|Administrative|6|||
28062607|NCT00490919|54718590|FG002|Double-blind Phase|Administrative|6|||
28062608|NCT00503867|54718597|FG000|Overall Study|Lost to Follow-up|1|||
28062609|NCT00503867|54718597|FG000|Overall Study|Adverse Event|1|||
28062610|NCT00503399|54718603|FG000|Overall Study|Death|2|||
28062611|NCT00503399|54718604|FG001|Overall Study|Death|1|||
28062612|NCT00503399|54718603|FG000|Overall Study|Protocol Violation|1|||
28062613|NCT00503399|54718604|FG001|Overall Study|Protocol Violation|0|||
28062614|NCT00503399|54718603|FG000|Overall Study|Withdrawal by Subject|4|||
28062615|NCT00503399|54718604|FG001|Overall Study|Withdrawal by Subject|2|||
28062616|NCT00503399|54718603|FG000|Overall Study|Adverse Event|0|||
28062617|NCT00503399|54718604|FG001|Overall Study|Adverse Event|3|||
28062618|NCT00503399|54718603|FG000|Overall Study|Lost to Follow-up|0|||
28062619|NCT00503399|54718604|FG001|Overall Study|Lost to Follow-up|2|||
28062620|NCT00506519|54718613|FG000|Overall Study|Death|4|||
28062621|NCT00506519|54718614|FG001|Overall Study|Death|6|||
28062622|NCT00506519|54718615|FG002|Overall Study|Death|0|||
28062623|NCT00506519|54718613|FG000|Overall Study|Adverse Event|1|||
28062624|NCT00506519|54718614|FG001|Overall Study|Adverse Event|0|||
28062625|NCT00506519|54718615|FG002|Overall Study|Adverse Event|0|||
28062626|NCT00503009|54718629|FG000|Overall Study|Protocol Violation|1|||
28062627|NCT00503009|54718630|FG001|Overall Study|Protocol Violation|0|||
28062628|NCT00503009|54718631|FG002|Overall Study|Protocol Violation|1|||
28062629|NCT00503009|54718629|FG000|Overall Study|Withdrawal by Subject|0|||
28062630|NCT00503009|54718630|FG001|Overall Study|Withdrawal by Subject|1|||
28062631|NCT00503009|54718631|FG002|Overall Study|Withdrawal by Subject|1|||
28062632|NCT00503009|54718629|FG000|Overall Study|Physician Decision|0|||
28062633|NCT00503009|54718630|FG001|Overall Study|Physician Decision|1|||
28062634|NCT00503009|54718631|FG002|Overall Study|Physician Decision|1|||
28062635|NCT00160251|54718645|FG000|Prior to Amendment 2|Adverse Event|2|||
28062636|NCT00160251|54718646|FG001|Prior to Amendment 2|Adverse Event|1|||
28062637|NCT00160251|54718647|FG002|Prior to Amendment 2|Adverse Event|3|||
28062638|NCT00160251|54718648|FG003|Prior to Amendment 2|Adverse Event|1|||
28062639|NCT00160251|54718649|FG004|Prior to Amendment 2|Adverse Event|1|||
28062640|NCT00160251|54718650|FG005|Prior to Amendment 2|Adverse Event|1|||
28062641|NCT00160251|54718651|FG006|Prior to Amendment 2|Adverse Event|1|||
28062642|NCT00160251|54718652|FG007|Prior to Amendment 2|Adverse Event|0|||
28062643|NCT00160251|54718645|FG000|Prior to Amendment 2|Lack of Efficacy|0|||
28062644|NCT00160251|54718646|FG001|Prior to Amendment 2|Lack of Efficacy|4|||
28062645|NCT00160251|54718647|FG002|Prior to Amendment 2|Lack of Efficacy|37|||
28062646|NCT00160251|54718648|FG003|Prior to Amendment 2|Lack of Efficacy|35|||
28062647|NCT00160251|54718649|FG004|Prior to Amendment 2|Lack of Efficacy|24|||
28062648|NCT00160251|54718650|FG005|Prior to Amendment 2|Lack of Efficacy|55|||
28062649|NCT00160251|54718651|FG006|Prior to Amendment 2|Lack of Efficacy|0|||
28062650|NCT00160251|54718652|FG007|Prior to Amendment 2|Lack of Efficacy|0|||
28062651|NCT00160251|54718645|FG000|Prior to Amendment 2|Lost to Follow-up|0|||
28062652|NCT00160251|54718646|FG001|Prior to Amendment 2|Lost to Follow-up|0|||
28062653|NCT00160251|54718647|FG002|Prior to Amendment 2|Lost to Follow-up|1|||
28062654|NCT00160251|54718648|FG003|Prior to Amendment 2|Lost to Follow-up|0|||
28062655|NCT00160251|54718649|FG004|Prior to Amendment 2|Lost to Follow-up|1|||
28062656|NCT00160251|54718650|FG005|Prior to Amendment 2|Lost to Follow-up|1|||
28062657|NCT00160251|54718651|FG006|Prior to Amendment 2|Lost to Follow-up|0|||
28062658|NCT00160251|54718652|FG007|Prior to Amendment 2|Lost to Follow-up|0|||
28062659|NCT00160251|54718645|FG000|Prior to Amendment 2|Withdrawal by Subject|3|||
28062660|NCT00160251|54718646|FG001|Prior to Amendment 2|Withdrawal by Subject|1|||
28062661|NCT00160251|54718647|FG002|Prior to Amendment 2|Withdrawal by Subject|3|||
28062662|NCT00160251|54718648|FG003|Prior to Amendment 2|Withdrawal by Subject|4|||
28062663|NCT00160251|54718649|FG004|Prior to Amendment 2|Withdrawal by Subject|2|||
28062664|NCT00160251|54718650|FG005|Prior to Amendment 2|Withdrawal by Subject|3|||
28062665|NCT00160251|54718651|FG006|Prior to Amendment 2|Withdrawal by Subject|3|||
28062666|NCT00160251|54718652|FG007|Prior to Amendment 2|Withdrawal by Subject|0|||
28062667|NCT00160251|54718645|FG000|Prior to Amendment 2|Noncompliance with protocol|1|||
28062668|NCT00160251|54718646|FG001|Prior to Amendment 2|Noncompliance with protocol|0|||
28062669|NCT00160251|54718647|FG002|Prior to Amendment 2|Noncompliance with protocol|0|||
28062670|NCT00160251|54718648|FG003|Prior to Amendment 2|Noncompliance with protocol|0|||
28062671|NCT00160251|54718649|FG004|Prior to Amendment 2|Noncompliance with protocol|0|||
28062672|NCT00160251|54718650|FG005|Prior to Amendment 2|Noncompliance with protocol|0|||
28062673|NCT00160251|54718651|FG006|Prior to Amendment 2|Noncompliance with protocol|0|||
28062674|NCT00160251|54718652|FG007|Prior to Amendment 2|Noncompliance with protocol|0|||
28062675|NCT00160251|54718645|FG000|Prior to Amendment 2|Completed Treatment Phase|3|||
28062676|NCT00160251|54718646|FG001|Prior to Amendment 2|Completed Treatment Phase|0|||
28062677|NCT00160251|54718647|FG002|Prior to Amendment 2|Completed Treatment Phase|0|||
28062678|NCT00160251|54718648|FG003|Prior to Amendment 2|Completed Treatment Phase|0|||
28062679|NCT00160251|54718649|FG004|Prior to Amendment 2|Completed Treatment Phase|0|||
28062680|NCT00160251|54718650|FG005|Prior to Amendment 2|Completed Treatment Phase|23|||
28062681|NCT00160251|54718651|FG006|Prior to Amendment 2|Completed Treatment Phase|0|||
28062682|NCT00160251|54718652|FG007|Prior to Amendment 2|Completed Treatment Phase|0|||
28062683|NCT00160251|54718645|FG000|Post-amendment 2|Adverse Event|0|||
28062684|NCT00160251|54718646|FG001|Post-amendment 2|Adverse Event|0|||
28062685|NCT00160251|54718647|FG002|Post-amendment 2|Adverse Event|0|||
28062686|NCT00160251|54718648|FG003|Post-amendment 2|Adverse Event|0|||
28062687|NCT00160251|54718649|FG004|Post-amendment 2|Adverse Event|0|||
28062688|NCT00160251|54718650|FG005|Post-amendment 2|Adverse Event|0|||
28062689|NCT00160251|54718651|FG006|Post-amendment 2|Adverse Event|0|||
28062690|NCT00160251|54718652|FG007|Post-amendment 2|Adverse Event|20|||
28062691|NCT00160251|54718645|FG000|Post-amendment 2|Lack of Efficacy|0|||
28062692|NCT00160251|54718646|FG001|Post-amendment 2|Lack of Efficacy|0|||
28062693|NCT00160251|54718647|FG002|Post-amendment 2|Lack of Efficacy|0|||
27848354|NCT00980005|54341318|FG001|Overall Study|Lost to Follow-up|43|||
28062694|NCT00160251|54718648|FG003|Post-amendment 2|Lack of Efficacy|0|||
28062695|NCT00160251|54718649|FG004|Post-amendment 2|Lack of Efficacy|0|||
28062696|NCT00160251|54718650|FG005|Post-amendment 2|Lack of Efficacy|0|||
28062697|NCT00160251|54718651|FG006|Post-amendment 2|Lack of Efficacy|0|||
28062698|NCT00160251|54718652|FG007|Post-amendment 2|Lack of Efficacy|24|||
28062699|NCT00160251|54718645|FG000|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
28062700|NCT00160251|54718646|FG001|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
28062701|NCT00160251|54718647|FG002|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
28062702|NCT00160251|54718648|FG003|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
28062703|NCT00160251|54718649|FG004|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
28062704|NCT00160251|54718650|FG005|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
28062705|NCT00160251|54718651|FG006|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
28062706|NCT00160251|54718652|FG007|Post-amendment 2|Lost to follow-up/withdrawal by subject|11|||
27815083|NCT02788045|54271875|FG002|Main Study (Up to Week 72)|Other|0|||
27815084|NCT02788045|54271873|FG000|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|8|||
28062707|NCT00506441|54718709|FG000|Period 1; Open-label Period|Adverse Event|21|||
28062708|NCT00506441|54718710|FG001|Period 1; Open-label Period|Adverse Event|0|||
28062709|NCT00506441|54718709|FG000|Period 1; Open-label Period|Lack of Efficacy|13|||
28062710|NCT00506441|54718710|FG001|Period 1; Open-label Period|Lack of Efficacy|0|||
28062711|NCT00506441|54718709|FG000|Period 1; Open-label Period|Lost to Follow-up|2|||
28062712|NCT00506441|54718710|FG001|Period 1; Open-label Period|Lost to Follow-up|0|||
28062713|NCT00506441|54718709|FG000|Period 1; Open-label Period|Physician Decision|5|||
28062714|NCT00506441|54718710|FG001|Period 1; Open-label Period|Physician Decision|0|||
28062715|NCT00506441|54718709|FG000|Period 1; Open-label Period|Protocol Violation|9|||
28062716|NCT00506441|54718710|FG001|Period 1; Open-label Period|Protocol Violation|0|||
28062717|NCT00506441|54718709|FG000|Period 1; Open-label Period|Withdrawal by Subject|13|||
28062718|NCT00506441|54718710|FG001|Period 1; Open-label Period|Withdrawal by Subject|0|||
28062719|NCT00506441|54718709|FG000|Period 1; Open-label Period|Other Reasons|13|||
28062720|NCT00506441|54718710|FG001|Period 1; Open-label Period|Other Reasons|0|||
28062721|NCT00506441|54718709|FG000|Period 2; Double-blind Period|Adverse Event|0|||
28062722|NCT00506441|54718710|FG001|Period 2; Double-blind Period|Adverse Event|1|||
28062723|NCT00506441|54718709|FG000|Period 2; Double-blind Period|Lack of Efficacy|0|||
28062724|NCT00506441|54718710|FG001|Period 2; Double-blind Period|Lack of Efficacy|2|||
28062725|NCT00506441|54718709|FG000|Period 2; Double-blind Period|Physician Decision|1|||
28062726|NCT00506441|54718710|FG001|Period 2; Double-blind Period|Physician Decision|1|||
28062727|NCT00506441|54718709|FG000|Period 2; Double-blind Period|Withdrawal by Subject|1|||
28062728|NCT00506441|54718710|FG001|Period 2; Double-blind Period|Withdrawal by Subject|0|||
28062729|NCT00506441|54718709|FG000|Period 2; Double-blind Period|Other Reason|1|||
28062730|NCT00506441|54718710|FG001|Period 2; Double-blind Period|Other Reason|1|||
28062731|NCT00378014|54718737|FG000|Core (Randomization to Month 11)|Adverse Event|1|||
28062732|NCT00378014|54718738|FG001|Core (Randomization to Month 11)|Adverse Event|0|||
28062733|NCT00378014|54718737|FG000|Core (Randomization to Month 11)|Graft loss|1|||
28062734|NCT00378014|54718738|FG001|Core (Randomization to Month 11)|Graft loss|2|||
28062735|NCT00378014|54718737|FG000|Core (Randomization to Month 11)|Death|5|||
28062736|NCT00378014|54718738|FG001|Core (Randomization to Month 11)|Death|3|||
28062737|NCT00378014|54718737|FG000|Core (Randomization to Month 11)|Administrative Problems|2|||
28062738|NCT00378014|54718738|FG001|Core (Randomization to Month 11)|Administrative Problems|2|||
28062739|NCT00378014|54718737|FG000|Core (Randomization to Month 11)|Lost to Follow-up|0|||
28062740|NCT00378014|54718738|FG001|Core (Randomization to Month 11)|Lost to Follow-up|1|||
28062741|NCT00378014|54718737|FG000|Core (Randomization to Month 11)|Withdrawal by Subject|5|||
28062742|NCT00378014|54718738|FG001|Core (Randomization to Month 11)|Withdrawal by Subject|2|||
28062743|NCT00378014|54718737|FG000|Core (Randomization to Month 11)|Protocol deviation|0|||
28062744|NCT00378014|54718738|FG001|Core (Randomization to Month 11)|Protocol deviation|1|||
28062745|NCT00378014|54718737|FG000|Core (Randomization to Month 11)|Lack of Efficacy|0|||
28062746|NCT00378014|54718738|FG001|Core (Randomization to Month 11)|Lack of Efficacy|1|||
28062747|NCT00378014|54718737|FG000|Extension (Month 12 to Month 59)|Adverse Event|8|||
28062748|NCT00378014|54718738|FG001|Extension (Month 12 to Month 59)|Adverse Event|7|||
28062749|NCT00378014|54718737|FG000|Extension (Month 12 to Month 59)|Death|1|||
28062750|NCT00378014|54718738|FG001|Extension (Month 12 to Month 59)|Death|2|||
28062751|NCT00378014|54718737|FG000|Extension (Month 12 to Month 59)|Administrative problems|1|||
28062752|NCT00378014|54718738|FG001|Extension (Month 12 to Month 59)|Administrative problems|0|||
28062753|NCT00378014|54718737|FG000|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
28062754|NCT00378014|54718738|FG001|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
28062755|NCT00378014|54718737|FG000|Extension (Month 12 to Month 59)|Withdrawal by Subject|0|||
28062756|NCT00378014|54718738|FG001|Extension (Month 12 to Month 59)|Withdrawal by Subject|3|||
28062757|NCT00378014|54718737|FG000|Extension (Month 12 to Month 59)|Lack of Efficacy|3|||
28062758|NCT00378014|54718738|FG001|Extension (Month 12 to Month 59)|Lack of Efficacy|1|||
28062759|NCT00485303|54718746|FG000|Overall Study|Adverse Event|5|||
28062760|NCT00485303|54718746|FG000|Overall Study|Progressive Disease|44|||
28062761|NCT00485303|54718746|FG000|Overall Study|Other|3|||
28062762|NCT00485303|54718746|FG000|Overall Study|Initiation of new anti-cancer treatment|2|||
28062763|NCT00485303|54718746|FG000|Overall Study|Treatment ongoing at cutoff date|2|||
28062764|NCT00490841|54718750|FG000|Overall Study|Death|5|||
27815085|NCT02788045|54271874|FG001|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
28062765|NCT00490841|54718750|FG000|Overall Study|Withdrawal by Subject|4|||
28062766|NCT00490841|54718750|FG000|Overall Study|Lost to Follow-up|1|||
28062767|NCT00490841|54718750|FG000|Overall Study|30 day f/u, only non-study stent used|3|||
28062768|NCT00377858|54718757|FG000|Overall Study|Withdrawal by Subject|12|||
28062769|NCT00377858|54718758|FG001|Overall Study|Withdrawal by Subject|11|||
28062770|NCT00377858|54718757|FG000|Overall Study|Lost to Follow-up|6|||
28062771|NCT00377858|54718758|FG001|Overall Study|Lost to Follow-up|1|||
28062772|NCT00377858|54718757|FG000|Overall Study|Physician Decision|5|||
28062773|NCT00377858|54718758|FG001|Overall Study|Physician Decision|5|||
28062774|NCT00377858|54718757|FG000|Overall Study|Protocol Violation|3|||
28062775|NCT00377858|54718758|FG001|Overall Study|Protocol Violation|4|||
28062776|NCT00377858|54718757|FG000|Overall Study|Adverse Event|2|||
28062777|NCT00377858|54718758|FG001|Overall Study|Adverse Event|1|||
27815086|NCT02788045|54271875|FG002|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
28062778|NCT00377858|54718757|FG000|Overall Study|Entry Criteria Not Met|2|||
28062779|NCT00377858|54718758|FG001|Overall Study|Entry Criteria Not Met|0|||
28062780|NCT00377858|54718757|FG000|Overall Study|Sponsor Decision|1|||
28062781|NCT00377858|54718758|FG001|Overall Study|Sponsor Decision|2|||
28062782|NCT00377858|54718757|FG000|Overall Study|Death|0|||
28062783|NCT00377858|54718758|FG001|Overall Study|Death|3|||
28062784|NCT00502775|54718767|FG000|Overall Study|Adverse Event|1|||
28062785|NCT00502775|54718768|FG001|Overall Study|Adverse Event|2|||
28062786|NCT00502775|54718769|FG002|Overall Study|Adverse Event|1|||
28062787|NCT00502775|54718767|FG000|Overall Study|Protocol Violation|1|||
28062788|NCT00502775|54718768|FG001|Overall Study|Protocol Violation|5|||
28062789|NCT00502775|54718769|FG002|Overall Study|Protocol Violation|2|||
28062790|NCT00502775|54718767|FG000|Overall Study|Withdrawal by Subject|1|||
28062791|NCT00502775|54718768|FG001|Overall Study|Withdrawal by Subject|1|||
28062792|NCT00502775|54718769|FG002|Overall Study|Withdrawal by Subject|2|||
28062793|NCT00502775|54718767|FG000|Overall Study|Sponsor Terminated Study|1|||
28062794|NCT00502775|54718768|FG001|Overall Study|Sponsor Terminated Study|0|||
28062795|NCT00502775|54718769|FG002|Overall Study|Sponsor Terminated Study|1|||
28062796|NCT00502775|54718767|FG000|Overall Study|Non-compliance with eDiary|4|||
28062797|NCT00502775|54718768|FG001|Overall Study|Non-compliance with eDiary|1|||
28062798|NCT00502775|54718769|FG002|Overall Study|Non-compliance with eDiary|1|||
28062799|NCT00502775|54718767|FG000|Overall Study|Subject unable to swallow capsule|1|||
28062800|NCT00502775|54718768|FG001|Overall Study|Subject unable to swallow capsule|0|||
28062801|NCT00502775|54718769|FG002|Overall Study|Subject unable to swallow capsule|1|||
28062802|NCT00502775|54718767|FG000|Overall Study|Logpad compliance <80%|1|||
28062803|NCT00502775|54718768|FG001|Overall Study|Logpad compliance <80%|0|||
28062804|NCT00502775|54718769|FG002|Overall Study|Logpad compliance <80%|0|||
28062805|NCT00502775|54718767|FG000|Overall Study|Randomized in error|0|||
28062806|NCT00502775|54718768|FG001|Overall Study|Randomized in error|1|||
28062807|NCT00502775|54718769|FG002|Overall Study|Randomized in error|1|||
28062808|NCT00502775|54718767|FG000|Overall Study|Non-compliance|0|||
28062809|NCT00502775|54718768|FG001|Overall Study|Non-compliance|2|||
28062810|NCT00502775|54718769|FG002|Overall Study|Non-compliance|2|||
28062811|NCT00502775|54718767|FG000|Overall Study|Outside pollen area more than 48 hours|0|||
28062812|NCT00502775|54718768|FG001|Overall Study|Outside pollen area more than 48 hours|1|||
28062813|NCT00502775|54718769|FG002|Overall Study|Outside pollen area more than 48 hours|0|||
28062814|NCT00502775|54718767|FG000|Overall Study|Declining pollen counts|0|||
28062815|NCT00502775|54718768|FG001|Overall Study|Declining pollen counts|1|||
28062816|NCT00502775|54718769|FG002|Overall Study|Declining pollen counts|1|||
28062817|NCT00502775|54718767|FG000|Overall Study|Subject in jail|0|||
27815087|NCT02788045|54271873|FG000|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|8|||
27815088|NCT02788045|54271874|FG001|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
27815089|NCT02788045|54271875|FG002|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
27815090|NCT02788045|54271873|FG000|Long Term Extension (From Wk 72 to 264)|Other|1|||
27815091|NCT02788045|54271874|FG001|Long Term Extension (From Wk 72 to 264)|Other|0|||
27815092|NCT02788045|54271875|FG002|Long Term Extension (From Wk 72 to 264)|Other|0|||
27940091|NCT01195662|54596420|FG001|Double Blind Treatment Period|Requested discontinue treatment|0|||
28062818|NCT00502775|54718768|FG001|Overall Study|Subject in jail|1|||
28062819|NCT00502775|54718769|FG002|Overall Study|Subject in jail|0|||
28062820|NCT00502775|54718767|FG000|Overall Study|Subject took disallowed drug|0|||
28062821|NCT00502775|54718768|FG001|Overall Study|Subject took disallowed drug|0|||
28062822|NCT00502775|54718769|FG002|Overall Study|Subject took disallowed drug|1|||
28062823|NCT00502697|54718779|FG000|Overall Study|Withdrawal by Subject|3|||
27815093|NCT02466685|54271903|FG000|Overall Study|Adverse Event|6|||
28062824|NCT00502697|54718780|FG001|Overall Study|Withdrawal by Subject|1|||
28062825|NCT00502697|54718779|FG000|Overall Study|disenrolled due to pregnancy loss|3|||
28062826|NCT00502697|54718780|FG001|Overall Study|disenrolled due to pregnancy loss|5|||
28062827|NCT00502697|54718779|FG000|Overall Study|found not to meet eligibility criteria|3|||
28062828|NCT00502697|54718780|FG001|Overall Study|found not to meet eligibility criteria|4|||
28062829|NCT00502697|54718779|FG000|Overall Study|did not meet assignment criteria|4|||
28062830|NCT00502697|54718780|FG001|Overall Study|did not meet assignment criteria|2|||
28062831|NCT00485069|54718788|FG000|Overall Study|Adverse Event|10|||
28062832|NCT00485069|54718789|FG001|Overall Study|Adverse Event|4|||
28062833|NCT00485069|54718788|FG000|Overall Study|Lack of Efficacy|2|||
28062834|NCT00485069|54718789|FG001|Overall Study|Lack of Efficacy|1|||
28062835|NCT00485069|54718788|FG000|Overall Study|Protocol Violation|0|||
28062836|NCT00485069|54718789|FG001|Overall Study|Protocol Violation|1|||
28062837|NCT00485069|54718788|FG000|Overall Study|Withdrawal by Subject|6|||
28062838|NCT00485069|54718789|FG001|Overall Study|Withdrawal by Subject|6|||
28062839|NCT00355082|54718804|FG000|Double-Blind (DB) Treatment Phase|Adverse Event|4|||
28062840|NCT00355082|54718805|FG001|Double-Blind (DB) Treatment Phase|Adverse Event|10|||
28062841|NCT00355082|54718806|FG002|Double-Blind (DB) Treatment Phase|Adverse Event|0|||
28062842|NCT00355082|54718804|FG000|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9|||
28062843|NCT00355082|54718805|FG001|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8|||
28062844|NCT00355082|54718806|FG002|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0|||
28062845|NCT00355082|54718804|FG000|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6|||
28062846|NCT00355082|54718805|FG001|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7|||
28062847|NCT00355082|54718806|FG002|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0|||
28062848|NCT00355082|54718804|FG000|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
28062849|NCT00355082|54718805|FG001|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4|||
28062850|NCT00355082|54718806|FG002|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
28062851|NCT00355082|54718804|FG000|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
28062852|NCT00355082|54718805|FG001|Double-Blind (DB) Treatment Phase|Protocol Violation|4|||
28062853|NCT00355082|54718806|FG002|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
28062854|NCT00355082|54718804|FG000|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
28062855|NCT00355082|54718805|FG001|Double-Blind (DB) Treatment Phase|Pregnancy|1|||
28062856|NCT00355082|54718806|FG002|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
28062857|NCT00355082|54718804|FG000|Continuation Phase|Adverse Event|2|||
28062858|NCT00355082|54718805|FG001|Continuation Phase|Adverse Event|0|||
28062859|NCT00355082|54718806|FG002|Continuation Phase|Adverse Event|1|||
28062860|NCT00355082|54718804|FG000|Continuation Phase|Lost to Follow-up|2|||
28062861|NCT00355082|54718805|FG001|Continuation Phase|Lost to Follow-up|0|||
28062862|NCT00355082|54718806|FG002|Continuation Phase|Lost to Follow-up|1|||
28062863|NCT00355082|54718804|FG000|Continuation Phase|Protocol Violation|1|||
28062864|NCT00355082|54718805|FG001|Continuation Phase|Protocol Violation|0|||
28062865|NCT00355082|54718806|FG002|Continuation Phase|Protocol Violation|1|||
28062866|NCT00355082|54718804|FG000|Continuation Phase|Withdrawal by Subject|4|||
28062867|NCT00355082|54718805|FG001|Continuation Phase|Withdrawal by Subject|0|||
28062868|NCT00355082|54718806|FG002|Continuation Phase|Withdrawal by Subject|0|||
27815094|NCT02466685|54271904|FG001|Overall Study|Adverse Event|2|||
28062869|NCT00355082|54718804|FG000|Continuation Phase|Lack of Efficacy|5|||
28062870|NCT00355082|54718805|FG001|Continuation Phase|Lack of Efficacy|0|||
28062871|NCT00355082|54718806|FG002|Continuation Phase|Lack of Efficacy|0|||
28062872|NCT00355082|54718804|FG000|Continuation Phase|Site Closed by Sponsor|8|||
28062873|NCT00355082|54718805|FG001|Continuation Phase|Site Closed by Sponsor|0|||
28062874|NCT00355082|54718806|FG002|Continuation Phase|Site Closed by Sponsor|0|||
28062875|NCT00355082|54718804|FG000|Continuation Phase|Scheduling Error|1|||
28062876|NCT00355082|54718805|FG001|Continuation Phase|Scheduling Error|0|||
28062877|NCT00355082|54718806|FG002|Continuation Phase|Scheduling Error|0|||
28062878|NCT00355082|54718804|FG000|Continuation Phase|Ran Out of Drug Due to Travel|1|||
28062879|NCT00355082|54718805|FG001|Continuation Phase|Ran Out of Drug Due to Travel|0|||
28062880|NCT00355082|54718806|FG002|Continuation Phase|Ran Out of Drug Due to Travel|0|||
28062881|NCT00502307|54718817|FG000|Open Label Period (16 Weeks)|Progressive disease|50|||
28062882|NCT00502307|54718818|FG001|Open Label Period (16 Weeks)|Progressive disease|0|||
28062883|NCT00502307|54718819|FG002|Open Label Period (16 Weeks)|Progressive disease|0|||
28062884|NCT00502307|54718817|FG000|Open Label Period (16 Weeks)|Discontinued due to other reasons|26|||
28062885|NCT00502307|54718818|FG001|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
28062886|NCT00502307|54718819|FG002|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
28062887|NCT00502307|54718817|FG000|Double-Blind Period (12 Weeks)|Progressive disease|0|||
28062888|NCT00502307|54718818|FG001|Double-Blind Period (12 Weeks)|Progressive disease|23|||
28062889|NCT00502307|54718819|FG002|Double-Blind Period (12 Weeks)|Progressive disease|2|||
28062890|NCT00502307|54718817|FG000|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0|||
28062891|NCT00502307|54718818|FG001|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3|||
28062892|NCT00502307|54718819|FG002|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7|||
28062893|NCT00502307|54718817|FG000|Maintenance Period|Progressive disease|80|||
28062894|NCT00502307|54718818|FG001|Maintenance Period|Progressive disease|0|||
28062895|NCT00502307|54718819|FG002|Maintenance Period|Progressive disease|0|||
28062896|NCT00502307|54718817|FG000|Maintenance Period|Discontinued due to other reasons|68|||
28062897|NCT00502307|54718818|FG001|Maintenance Period|Discontinued due to other reasons|0|||
28062898|NCT00502307|54718819|FG002|Maintenance Period|Discontinued due to other reasons|0|||
28062899|NCT00484679|54718836|FG000|Overall Study|Withdrawal by Subject|3|||
28062900|NCT00377312|54718842|FG000|Overall Study|Adverse Event|1|||
28062901|NCT00377312|54718843|FG001|Overall Study|Adverse Event|1|||
28062902|NCT00377234|54718851|FG000|Overall Study|Adverse Event|14|||
28062903|NCT00377234|54718852|FG001|Overall Study|Adverse Event|17|||
28062904|NCT00377234|54718851|FG000|Overall Study|Withdrawal by Subject|11|||
28062905|NCT00377234|54718852|FG001|Overall Study|Withdrawal by Subject|9|||
28062906|NCT00377234|54718851|FG000|Overall Study|Lost to Follow-up|4|||
28062907|NCT00377234|54718852|FG001|Overall Study|Lost to Follow-up|2|||
28062908|NCT00377234|54718851|FG000|Overall Study|Administrative|2|||
28062909|NCT00377234|54718852|FG001|Overall Study|Administrative|1|||
28062910|NCT00377234|54718851|FG000|Overall Study|Not assigned|3|||
28062911|NCT00377234|54718852|FG001|Overall Study|Not assigned|2|||
28062912|NCT00377156|54718866|FG000|Overall Study|Death|23|||
28062913|NCT00377156|54718867|FG001|Overall Study|Death|19|||
28062914|NCT00377156|54718866|FG000|Overall Study|Withdrawal by Subject|16|||
28062915|NCT00377156|54718867|FG001|Overall Study|Withdrawal by Subject|24|||
28062916|NCT00377156|54718866|FG000|Overall Study|Had follow-up <90 d|3|||
28062917|NCT00377156|54718867|FG001|Overall Study|Had follow-up <90 d|6|||
28062918|NCT00377156|54718866|FG000|Overall Study|Cancellation|1|||
28062919|NCT00377156|54718867|FG001|Overall Study|Cancellation|0|||
28062920|NCT00377156|54718866|FG000|Overall Study|Refused testing|0|||
28062921|NCT00377156|54718867|FG001|Overall Study|Refused testing|1|||
28062922|NCT00377156|54718866|FG000|Overall Study|Ineligible|0|||
28062923|NCT00377156|54718867|FG001|Overall Study|Ineligible|1|||
27815095|NCT02466685|54271903|FG000|Overall Study|Lost to Follow-up|0|||
27815096|NCT02466685|54271904|FG001|Overall Study|Lost to Follow-up|2|||
27815097|NCT02466685|54271903|FG000|Overall Study|Withdrawal by Subject|1|||
27815098|NCT02466685|54271904|FG001|Overall Study|Withdrawal by Subject|1|||
28062924|NCT00377156|54718866|FG000|Overall Study|Disability or language problem|0|||
28062925|NCT00377156|54718867|FG001|Overall Study|Disability or language problem|1|||
28062926|NCT00377156|54718866|FG000|Overall Study|Other|5|||
28062927|NCT00377156|54718867|FG001|Overall Study|Other|2|||
28062928|NCT00376688|54718875|FG000|Overall Study|Adverse Event|3|||
28062929|NCT00376688|54718875|FG000|Overall Study|Death|1|||
28062930|NCT00376532|54718881|FG000|Overall Study|Lack sufficient blood sample|6|||
28062931|NCT00376532|54718882|FG001|Overall Study|Lack sufficient blood sample|6|||
28062932|NCT00376220|54718890|FG000|Overall Study|Lost to Follow-up|7|||
28062933|NCT00376220|54718891|FG001|Overall Study|Lost to Follow-up|10|||
28062934|NCT00376220|54718890|FG000|Overall Study|Withdrawal by Subject|3|||
27815099|NCT02453282|54271916|FG000|Overall Study|Death|275|||
27815100|NCT02453282|54271917|FG001|Overall Study|Death|277|||
27815101|NCT02453282|54271918|FG002|Overall Study|Death|296|||
28062935|NCT00376220|54718891|FG001|Overall Study|Withdrawal by Subject|2|||
28062936|NCT00375752|54718899|FG000|Overall Study|Lack of Efficacy|4|||
28062937|NCT00375752|54718900|FG001|Overall Study|Lack of Efficacy|4|||
28062938|NCT00375752|54718899|FG000|Overall Study|Adverse Event|1|||
28062939|NCT00375752|54718900|FG001|Overall Study|Adverse Event|6|||
28062940|NCT00375752|54718899|FG000|Overall Study|Withdrawal by Subject|6|||
28062941|NCT00375752|54718900|FG001|Overall Study|Withdrawal by Subject|1|||
28062942|NCT00375752|54718899|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
28062943|NCT00375752|54718900|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
28062944|NCT00375752|54718899|FG000|Overall Study|Protocol Violation|0|||
28062945|NCT00375752|54718900|FG001|Overall Study|Protocol Violation|2|||
28062946|NCT00375752|54718899|FG000|Overall Study|Administrative Problems|0|||
28062947|NCT00375752|54718900|FG001|Overall Study|Administrative Problems|1|||
28062948|NCT00484289|54718909|FG000|Long Term Phase|Adverse Event|1|||
28062949|NCT00484289|54718910|FG001|Long Term Phase|Adverse Event|17|||
28062950|NCT00484289|54718911|FG002|Long Term Phase|Adverse Event|5|||
28062951|NCT00484289|54718909|FG000|Long Term Phase|Withdrawal by Subject|0|||
28062952|NCT00484289|54718910|FG001|Long Term Phase|Withdrawal by Subject|7|||
28062953|NCT00484289|54718911|FG002|Long Term Phase|Withdrawal by Subject|6|||
28062954|NCT00484289|54718909|FG000|Long Term Phase|Inadequate response|2|||
28062955|NCT00484289|54718910|FG001|Long Term Phase|Inadequate response|7|||
28062956|NCT00484289|54718911|FG002|Long Term Phase|Inadequate response|4|||
28062957|NCT00484289|54718909|FG000|Long Term Phase|Other Reason|0|||
28062958|NCT00484289|54718910|FG001|Long Term Phase|Other Reason|5|||
28062959|NCT00484289|54718911|FG002|Long Term Phase|Other Reason|1|||
28062960|NCT00484289|54718909|FG000|Post Marketing Phase|Adverse Event|0|||
28062961|NCT00484289|54718910|FG001|Post Marketing Phase|Adverse Event|1|||
28062962|NCT00484289|54718911|FG002|Post Marketing Phase|Adverse Event|0|||
28062963|NCT00490529|54718920|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Death|4|||
28062964|NCT00490529|54718920|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4|||
28062965|NCT00490529|54718920|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1|||
28062966|NCT00490529|54718920|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1|||
28062967|NCT00490529|54718920|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1|||
28062968|NCT00490529|54718920|FG000|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1|||
28062969|NCT00333840|54718926|FG000|First-line Treatment Period|Adverse Event|38|||
28062970|NCT00333840|54718927|FG001|First-line Treatment Period|Adverse Event|37|||
28062971|NCT00333840|54718928|FG002|First-line Treatment Period|Adverse Event|0|||
28062972|NCT00333840|54718929|FG003|First-line Treatment Period|Adverse Event|0|||
28062973|NCT00333840|54718926|FG000|First-line Treatment Period|Abnormal laboratory values|3|||
27815102|NCT02453282|54271916|FG000|Overall Study|Lost to Follow-up|1|||
27815103|NCT02453282|54271917|FG001|Overall Study|Lost to Follow-up|0|||
27815104|NCT02453282|54271918|FG002|Overall Study|Lost to Follow-up|2|||
28062974|NCT00333840|54718927|FG001|First-line Treatment Period|Abnormal laboratory values|1|||
28062975|NCT00333840|54718928|FG002|First-line Treatment Period|Abnormal laboratory values|0|||
28062976|NCT00333840|54718929|FG003|First-line Treatment Period|Abnormal laboratory values|0|||
28062977|NCT00333840|54718926|FG000|First-line Treatment Period|Abnormal procedure|2|||
28062978|NCT00333840|54718927|FG001|First-line Treatment Period|Abnormal procedure|0|||
28062979|NCT00333840|54718928|FG002|First-line Treatment Period|Abnormal procedure|0|||
28062980|NCT00333840|54718929|FG003|First-line Treatment Period|Abnormal procedure|0|||
28062981|NCT00333840|54718926|FG000|First-line Treatment Period|Unsatisfactory therapeutic effect|88|||
28062982|NCT00333840|54718927|FG001|First-line Treatment Period|Unsatisfactory therapeutic effect|29|||
28062983|NCT00333840|54718928|FG002|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
28062984|NCT00333840|54718929|FG003|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
28062985|NCT00333840|54718926|FG000|First-line Treatment Period|No longer required study drug|21|||
28062986|NCT00333840|54718927|FG001|First-line Treatment Period|No longer required study drug|8|||
28062987|NCT00333840|54718928|FG002|First-line Treatment Period|No longer required study drug|0|||
28062988|NCT00333840|54718929|FG003|First-line Treatment Period|No longer required study drug|0|||
28062989|NCT00333840|54718926|FG000|First-line Treatment Period|Protocol Violation|17|||
28062990|NCT00333840|54718927|FG001|First-line Treatment Period|Protocol Violation|17|||
28062991|NCT00333840|54718928|FG002|First-line Treatment Period|Protocol Violation|0|||
28062992|NCT00333840|54718929|FG003|First-line Treatment Period|Protocol Violation|0|||
28062993|NCT00333840|54718926|FG000|First-line Treatment Period|Subject withdrew consent|57|||
28062994|NCT00333840|54718927|FG001|First-line Treatment Period|Subject withdrew consent|77|||
28062995|NCT00333840|54718928|FG002|First-line Treatment Period|Subject withdrew consent|0|||
28062996|NCT00333840|54718929|FG003|First-line Treatment Period|Subject withdrew consent|0|||
28062997|NCT00333840|54718926|FG000|First-line Treatment Period|Lost to Follow-up|15|||
28062998|NCT00333840|54718927|FG001|First-line Treatment Period|Lost to Follow-up|6|||
28062999|NCT00333840|54718928|FG002|First-line Treatment Period|Lost to Follow-up|0|||
28063000|NCT00333840|54718929|FG003|First-line Treatment Period|Lost to Follow-up|0|||
28063001|NCT00333840|54718926|FG000|First-line Treatment Period|Administrative problems|12|||
28063002|NCT00333840|54718927|FG001|First-line Treatment Period|Administrative problems|6|||
28063003|NCT00333840|54718928|FG002|First-line Treatment Period|Administrative problems|0|||
28063004|NCT00333840|54718929|FG003|First-line Treatment Period|Administrative problems|0|||
28063005|NCT00333840|54718926|FG000|First-line Treatment Period|Death|19|||
28063006|NCT00333840|54718927|FG001|First-line Treatment Period|Death|2|||
28063007|NCT00333840|54718928|FG002|First-line Treatment Period|Death|0|||
28063008|NCT00333840|54718929|FG003|First-line Treatment Period|Death|0|||
28063009|NCT00333840|54718926|FG000|First-line Treatment Period|Crossed over to other treatment arm|14|||
28063010|NCT00333840|54718927|FG001|First-line Treatment Period|Crossed over to other treatment arm|363|||
28063011|NCT00333840|54718928|FG002|First-line Treatment Period|Crossed over to other treatment arm|0|||
28063012|NCT00333840|54718929|FG003|First-line Treatment Period|Crossed over to other treatment arm|0|||
28063013|NCT00333840|54718926|FG000|Second-line Treatment Period|Adverse Event|0|||
28063014|NCT00333840|54718927|FG001|Second-line Treatment Period|Adverse Event|0|||
28063015|NCT00333840|54718928|FG002|Second-line Treatment Period|Adverse Event|3|||
28063016|NCT00333840|54718929|FG003|Second-line Treatment Period|Adverse Event|34|||
28063017|NCT00333840|54718926|FG000|Second-line Treatment Period|Abnormal Laboratory Values|0|||
28063018|NCT00333840|54718927|FG001|Second-line Treatment Period|Abnormal Laboratory Values|0|||
28063019|NCT00333840|54718928|FG002|Second-line Treatment Period|Abnormal Laboratory Values|0|||
28063020|NCT00333840|54718929|FG003|Second-line Treatment Period|Abnormal Laboratory Values|3|||
28063021|NCT00333840|54718926|FG000|Second-line Treatment Period|Abnormal procedure|0|||
28063022|NCT00333840|54718927|FG001|Second-line Treatment Period|Abnormal procedure|0|||
28063023|NCT00333840|54718928|FG002|Second-line Treatment Period|Abnormal procedure|0|||
28063024|NCT00333840|54718929|FG003|Second-line Treatment Period|Abnormal procedure|1|||
28063025|NCT00333840|54718926|FG000|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
28063026|NCT00333840|54718927|FG001|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
28063027|NCT00333840|54718928|FG002|Second-line Treatment Period|Unsatisfactory therapeutic effect|9|||
28063028|NCT00333840|54718929|FG003|Second-line Treatment Period|Unsatisfactory therapeutic effect|70|||
28063029|NCT00333840|54718926|FG000|Second-line Treatment Period|No longer required study drug|0|||
28063030|NCT00333840|54718927|FG001|Second-line Treatment Period|No longer required study drug|0|||
28063031|NCT00333840|54718928|FG002|Second-line Treatment Period|No longer required study drug|1|||
28063032|NCT00333840|54718929|FG003|Second-line Treatment Period|No longer required study drug|14|||
28063033|NCT00333840|54718926|FG000|Second-line Treatment Period|Protocol Violation|0|||
28063034|NCT00333840|54718927|FG001|Second-line Treatment Period|Protocol Violation|0|||
28063035|NCT00333840|54718928|FG002|Second-line Treatment Period|Protocol Violation|1|||
28063036|NCT00333840|54718929|FG003|Second-line Treatment Period|Protocol Violation|10|||
28063037|NCT00333840|54718926|FG000|Second-line Treatment Period|Subject withdrew consent|0|||
28063038|NCT00333840|54718927|FG001|Second-line Treatment Period|Subject withdrew consent|0|||
28063039|NCT00333840|54718928|FG002|Second-line Treatment Period|Subject withdrew consent|0|||
28063040|NCT00333840|54718929|FG003|Second-line Treatment Period|Subject withdrew consent|34|||
28063041|NCT00333840|54718926|FG000|Second-line Treatment Period|Lost to Follow-up|0|||
28063042|NCT00333840|54718927|FG001|Second-line Treatment Period|Lost to Follow-up|0|||
28063043|NCT00333840|54718928|FG002|Second-line Treatment Period|Lost to Follow-up|0|||
28063044|NCT00333840|54718929|FG003|Second-line Treatment Period|Lost to Follow-up|6|||
28063045|NCT00333840|54718926|FG000|Second-line Treatment Period|Administrative problems|0|||
28063046|NCT00333840|54718927|FG001|Second-line Treatment Period|Administrative problems|0|||
28063047|NCT00333840|54718928|FG002|Second-line Treatment Period|Administrative problems|0|||
28063048|NCT00333840|54718929|FG003|Second-line Treatment Period|Administrative problems|7|||
28063049|NCT00333840|54718926|FG000|Second-line Treatment Period|Death|0|||
28063050|NCT00333840|54718927|FG001|Second-line Treatment Period|Death|0|||
28063051|NCT00333840|54718928|FG002|Second-line Treatment Period|Death|0|||
28063052|NCT00333840|54718929|FG003|Second-line Treatment Period|Death|9|||
28063053|NCT00490451|54718945|FG000|Overall Study|Adverse Event|3|||
28063054|NCT00490451|54718946|FG001|Overall Study|Adverse Event|3|||
28063055|NCT00490451|54718945|FG000|Overall Study|Death|3|||
28063056|NCT00490451|54718946|FG001|Overall Study|Death|1|||
28063057|NCT00490451|54718945|FG000|Overall Study|Withdrawal by Subject|2|||
28063058|NCT00490451|54718946|FG001|Overall Study|Withdrawal by Subject|0|||
28063059|NCT00490451|54718945|FG000|Overall Study|Investigator Decision|1|||
28063060|NCT00490451|54718946|FG001|Overall Study|Investigator Decision|0|||
28063061|NCT00490451|54718945|FG000|Overall Study|Protocol Violation|1|||
28063062|NCT00490451|54718946|FG001|Overall Study|Protocol Violation|0|||
28063063|NCT00490451|54718945|FG000|Overall Study|Progressive Disease|53|||
28063064|NCT00490451|54718946|FG001|Overall Study|Progressive Disease|34|||
28063065|NCT00321906|54718954|FG000|Overall Study|Adverse Event|36|||
28063066|NCT00321906|54718955|FG001|Overall Study|Adverse Event|44|||
28063067|NCT00321906|54718954|FG000|Overall Study|Death|9|||
28063068|NCT00321906|54718955|FG001|Overall Study|Death|6|||
28063069|NCT00321906|54718954|FG000|Overall Study|Lost to Follow-up|1|||
28063070|NCT00321906|54718955|FG001|Overall Study|Lost to Follow-up|2|||
28063071|NCT00321906|54718954|FG000|Overall Study|Withdrawal by Subject|0|||
28063072|NCT00321906|54718955|FG001|Overall Study|Withdrawal by Subject|4|||
28063073|NCT00339144|54718964|FG000|Overall Study|Disease progression|5|||
28063074|NCT00339144|54718965|FG001|Overall Study|Disease progression|2|||
28063075|NCT00339144|54718966|FG002|Overall Study|Disease progression|2|||
28063076|NCT00339144|54718964|FG000|Overall Study|Study drug toxicity|3|||
28063077|NCT00339144|54718965|FG001|Overall Study|Study drug toxicity|1|||
28063078|NCT00339144|54718966|FG002|Overall Study|Study drug toxicity|1|||
28063079|NCT00339144|54718964|FG000|Overall Study|Participant's request to discontinuation|1|||
28105728|NCT01369498|54763336|FG000|Overall Study|Withdrawal of Consent|0|||
28105729|NCT01369498|54763337|FG001|Overall Study|Withdrawal of Consent|1|||
28105730|NCT01369498|54763338|FG002|Overall Study|Withdrawal of Consent|1|||
28105731|NCT01369498|54763339|FG003|Overall Study|Withdrawal of Consent|1|||
28105732|NCT01369498|54763336|FG000|Overall Study|Death|0|||
28105733|NCT01369498|54763337|FG001|Overall Study|Death|0|||
28105734|NCT01369498|54763338|FG002|Overall Study|Death|1|||
28105735|NCT01369498|54763339|FG003|Overall Study|Death|0|||
28105736|NCT01369498|54763336|FG000|Overall Study|Investigator's Discretion|1|||
28105737|NCT01369498|54763337|FG001|Overall Study|Investigator's Discretion|0|||
27815105|NCT02453282|54271916|FG000|Overall Study|Withdrawal by Subject|12|||
28063080|NCT00339144|54718965|FG001|Overall Study|Participant's request to discontinuation|0|||
28063081|NCT00339144|54718966|FG002|Overall Study|Participant's request to discontinuation|1|||
28063082|NCT00321828|54718975|FG000|Overall Study|Ineligible|3|||
28063083|NCT00321828|54718975|FG000|Overall Study|No follow up data|1|||
28105738|NCT01369498|54763338|FG002|Overall Study|Investigator's Discretion|1|||
28105739|NCT01369498|54763339|FG003|Overall Study|Investigator's Discretion|3|||
28063084|NCT00333138|54718982|FG000|Core Study (6 Months)|Adverse Event|4|||
28063085|NCT00333138|54718983|FG001|Core Study (6 Months)|Adverse Event|5|||
28063086|NCT00333138|54718984|FG002|Core Study (6 Months)|Adverse Event|8|||
28063087|NCT00333138|54718982|FG000|Core Study (6 Months)|Withdrawal by Subject|1|||
28063088|NCT00333138|54718983|FG001|Core Study (6 Months)|Withdrawal by Subject|1|||
28105740|NCT01369498|54763336|FG000|Overall Study|Unknown Reason|1|||
28105741|NCT01369498|54763337|FG001|Overall Study|Unknown Reason|0|||
28105742|NCT01369498|54763338|FG002|Overall Study|Unknown Reason|11|||
28105743|NCT01369498|54763339|FG003|Overall Study|Unknown Reason|6|||
28105744|NCT01369498|54763336|FG000|Overall Study|Disease Progression|0|||
28105745|NCT01369498|54763337|FG001|Overall Study|Disease Progression|0|||
28105746|NCT01369498|54763338|FG002|Overall Study|Disease Progression|0|||
28105747|NCT01369498|54763339|FG003|Overall Study|Disease Progression|1|||
28105748|NCT04709835|54763353|FG000|Overall Study|Withdrawal by Subject|0|||
28105749|NCT04709835|54763354|FG001|Overall Study|Withdrawal by Subject|1|||
28105750|NCT04709835|54763355|FG002|Overall Study|Withdrawal by Subject|0|||
28105751|NCT04407507|54763369|FG000|Overall Study|Withdrawal by Subject|0|||
28105752|NCT04407507|54763370|FG001|Overall Study|Withdrawal by Subject|1|||
28105753|NCT04698993|54763378|FG000|Overall Study|PCR results not accessible|2|||
28105754|NCT04698993|54763379|FG001|Overall Study|PCR results not accessible|7|||
28105755|NCT04698993|54763378|FG000|Overall Study|incomplete documentation of kit assessment prior to testing|1|||
28105756|NCT04698993|54763379|FG001|Overall Study|incomplete documentation of kit assessment prior to testing|0|||
28105757|NCT04359771|54763387|FG000|Overall Study|Lack of Efficacy|2|||
28105758|NCT04359771|54763388|FG001|Overall Study|Lack of Efficacy|2|||
28105759|NCT04356573|54763396|FG000|Overall Study|Didn't Qualify|1|||
28105760|NCT04356573|54763397|FG001|Overall Study|Didn't Qualify|0|||
28105761|NCT04352127|54763413|FG000|Overall Study|Unable to obtain readings|4|||
28105762|NCT04352127|54763414|FG001|Overall Study|Unable to obtain readings|1|||
28105763|NCT04351269|54763423|FG000|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|70|||
28105764|NCT04351269|54763424|FG001|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|32|||
28105765|NCT04351269|54763425|FG002|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|29|||
28105766|NCT04351269|54763423|FG000|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
28105767|NCT04351269|54763424|FG001|Overall Study|CanGaroo Envelope used during a previous procedure|1|||
28105768|NCT04351269|54763425|FG002|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
28105769|NCT04351269|54763423|FG000|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
28105770|NCT04351269|54763424|FG001|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
28105771|NCT04351269|54763425|FG002|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|0|||
28105772|NCT04351269|54763423|FG000|Overall Study|Subjects followed long-term at different health care system|0|||
28105773|NCT04351269|54763424|FG001|Overall Study|Subjects followed long-term at different health care system|4|||
28105774|NCT04351269|54763425|FG002|Overall Study|Subjects followed long-term at different health care system|0|||
28105775|NCT04351269|54763423|FG000|Overall Study|Lost to Follow-up|1|||
28105776|NCT04351269|54763424|FG001|Overall Study|Lost to Follow-up|3|||
28105777|NCT04351269|54763425|FG002|Overall Study|Lost to Follow-up|0|||
28105778|NCT04348851|54763440|FG000|Post-Test 1|Withdrawal by Subject|0|||
28105779|NCT04348851|54763441|FG001|Post-Test 1|Withdrawal by Subject|1|||
28105780|NCT04348851|54763442|FG002|Post-Test 1|Withdrawal by Subject|0|||
28105781|NCT04348851|54763443|FG003|Post-Test 1|Withdrawal by Subject|0|||
28105782|NCT04348851|54763440|FG000|Post-Test 1|Lost to Follow-up|0|||
28105783|NCT04348851|54763441|FG001|Post-Test 1|Lost to Follow-up|1|||
28105784|NCT04348851|54763442|FG002|Post-Test 1|Lost to Follow-up|0|||
28105785|NCT04348851|54763443|FG003|Post-Test 1|Lost to Follow-up|0|||
28105786|NCT04348851|54763440|FG000|Post-Test 2|Stroke survivor death|0|||
27815106|NCT02453282|54271917|FG001|Overall Study|Withdrawal by Subject|10|||
27815107|NCT02453282|54271918|FG002|Overall Study|Withdrawal by Subject|11|||
28063089|NCT00333138|54718984|FG002|Core Study (6 Months)|Withdrawal by Subject|2|||
28063090|NCT00333138|54718982|FG000|Core Study (6 Months)|Lack of Efficacy|1|||
28063091|NCT00333138|54718983|FG001|Core Study (6 Months)|Lack of Efficacy|0|||
28063092|NCT00333138|54718984|FG002|Core Study (6 Months)|Lack of Efficacy|0|||
28063093|NCT00333138|54718982|FG000|Core Study (6 Months)|Protocol Violation|1|||
28063094|NCT00333138|54718983|FG001|Core Study (6 Months)|Protocol Violation|0|||
28063095|NCT00333138|54718984|FG002|Core Study (6 Months)|Protocol Violation|1|||
28063096|NCT00333138|54718982|FG000|Core Study (6 Months)|Laboratory abnormality|0|||
28063097|NCT00333138|54718983|FG001|Core Study (6 Months)|Laboratory abnormality|0|||
28063098|NCT00333138|54718984|FG002|Core Study (6 Months)|Laboratory abnormality|1|||
28063099|NCT00333138|54718982|FG000|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3|||
28063100|NCT00333138|54718983|FG001|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
28063101|NCT00333138|54718984|FG002|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
28063102|NCT00333138|54718982|FG000|Extension Study (Month6 to End of Study)|Administrative problems|1|||
28063103|NCT00333138|54718983|FG001|Extension Study (Month6 to End of Study)|Administrative problems|1|||
28063104|NCT00333138|54718984|FG002|Extension Study (Month6 to End of Study)|Administrative problems|2|||
28063105|NCT00333138|54718982|FG000|Extension Study (Month6 to End of Study)|Adverse Event|15|||
28063106|NCT00333138|54718983|FG001|Extension Study (Month6 to End of Study)|Adverse Event|19|||
28105787|NCT04348851|54763441|FG001|Post-Test 2|Stroke survivor death|1|||
28105788|NCT04348851|54763442|FG002|Post-Test 2|Stroke survivor death|0|||
28105789|NCT04348851|54763443|FG003|Post-Test 2|Stroke survivor death|1|||
28105790|NCT04346199|54763455|FG000|Overall Study|Death|8|||
28105791|NCT04346199|54763456|FG001|Overall Study|Death|9|||
28105792|NCT04346199|54763455|FG000|Overall Study|Lost to Follow-up|0|||
28105793|NCT04346199|54763456|FG001|Overall Study|Lost to Follow-up|1|||
28105794|NCT04346199|54763455|FG000|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|2|||
28105795|NCT04346199|54763456|FG001|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|0|||
28105796|NCT04346199|54763455|FG000|Overall Study|Withdrawal by Subject|5|||
28105797|NCT04346199|54763456|FG001|Overall Study|Withdrawal by Subject|1|||
28105798|NCT04345653|54763462|FG000|Overall Study|Withdrawal by Subject|2|||
28105799|NCT04342689|54763469|FG000|Overall Study|Withdrawal by Subject|32|||
28105800|NCT04342689|54763470|FG001|Overall Study|Withdrawal by Subject|33|||
28105801|NCT04342689|54763469|FG000|Overall Study|Lost to Follow-up|10|||
28105802|NCT04342689|54763470|FG001|Overall Study|Lost to Follow-up|12|||
28105803|NCT04169061|54763478|FG000|Overall Study|Adverse Event|2|||
28105804|NCT04169061|54763478|FG000|Overall Study|Death|1|||
28105805|NCT04169061|54763478|FG000|Overall Study|Withdrawal by Subject|1|||
28105806|NCT04169061|54763478|FG000|Overall Study|Protocol Violation|1|||
28105807|NCT02792218|54763484|FG000|Overall Study|Patient/guardian decision|15|||
28105808|NCT02792218|54763485|FG001|Overall Study|Patient/guardian decision|42|||
28105809|NCT02792218|54763484|FG000|Overall Study|Adverse Event|15|||
28105810|NCT02792218|54763485|FG001|Overall Study|Adverse Event|14|||
28105811|NCT02792218|54763484|FG000|Overall Study|Lost to Follow-up|10|||
28105812|NCT02792218|54763485|FG001|Overall Study|Lost to Follow-up|5|||
28105813|NCT02792218|54763484|FG000|Overall Study|Lack of Efficacy|1|||
28105814|NCT02792218|54763485|FG001|Overall Study|Lack of Efficacy|12|||
28105815|NCT02792218|54763484|FG000|Overall Study|Physician Decision|4|||
28105816|NCT02792218|54763485|FG001|Overall Study|Physician Decision|4|||
28105817|NCT02792218|54763484|FG000|Overall Study|Protocol deviation|3|||
28105818|NCT02792218|54763485|FG001|Overall Study|Protocol deviation|2|||
28105819|NCT02792218|54763484|FG000|Overall Study|New therapy for study indication|0|||
28105820|NCT02792218|54763485|FG001|Overall Study|New therapy for study indication|1|||
28105821|NCT02792218|54763484|FG000|Overall Study|Non-compliance with study treatment|0|||
28105822|NCT02792218|54763485|FG001|Overall Study|Non-compliance with study treatment|1|||
28105823|NCT02792218|54763484|FG000|Overall Study|Pregnancy|1|||
28105824|NCT02792218|54763485|FG001|Overall Study|Pregnancy|0|||
28105825|NCT00153101|54763496|FG000|Overall Study|Lost to Follow-up|14|||
28105826|NCT00153101|54763497|FG001|Overall Study|Lost to Follow-up|14|||
28105827|NCT00153101|54763498|FG002|Overall Study|Lost to Follow-up|12|||
28105828|NCT00153101|54763499|FG003|Overall Study|Lost to Follow-up|5|||
27815108|NCT02453282|54271916|FG000|Overall Study|Participants ongoing at data cut-off|85|||
27815109|NCT02453282|54271917|FG001|Overall Study|Participants ongoing at data cut-off|84|||
27815110|NCT02453282|54271918|FG002|Overall Study|Participants ongoing at data cut-off|62|||
27815111|NCT02453282|54271916|FG000|Overall Study|Other|1|||
27815112|NCT02453282|54271917|FG001|Overall Study|Other|1|||
27815113|NCT02453282|54271918|FG002|Overall Study|Other|1|||
27815114|NCT02437318|54271930|FG000|Overall Study|Progressive disease|173|||
27815115|NCT02437318|54271931|FG001|Overall Study|Progressive disease|208|||
27815116|NCT02437318|54271930|FG000|Overall Study|Subject/guardian decision|22|||
27815117|NCT02437318|54271931|FG001|Overall Study|Subject/guardian decision|10|||
27815118|NCT02437318|54271930|FG000|Overall Study|Physician Decision|11|||
27815119|NCT02437318|54271931|FG001|Overall Study|Physician Decision|10|||
27815120|NCT02437318|54271930|FG000|Overall Study|Adverse Event|14|||
27815121|NCT02437318|54271931|FG001|Overall Study|Adverse Event|3|||
27815122|NCT02437318|54271930|FG000|Overall Study|Death|4|||
27815123|NCT02437318|54271931|FG001|Overall Study|Death|4|||
27815124|NCT02437318|54271930|FG000|Overall Study|Protocol Violation|5|||
27815125|NCT02437318|54271931|FG001|Overall Study|Protocol Violation|6|||
27815126|NCT02437318|54271930|FG000|Overall Study|Untreated|0|||
27815127|NCT02437318|54271931|FG001|Overall Study|Untreated|1|||
27815128|NCT02315703|54271945|FG000|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
27815129|NCT02315703|54271946|FG001|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
27815130|NCT02315703|54271947|FG002|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
27815131|NCT02315703|54271948|FG003|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
27815132|NCT02315703|54271949|FG004|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
27815133|NCT02315703|54271950|FG005|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
28105829|NCT00153101|54763500|FG004|Overall Study|Lost to Follow-up|5|||
28105830|NCT00153101|54763496|FG000|Overall Study|Withdrawal by Subject|3|||
27815134|NCT02315703|54271951|FG006|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
27815135|NCT02315703|54271952|FG007|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
27815136|NCT02315703|54271945|FG000|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
27815137|NCT02315703|54271946|FG001|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|5|||
28105831|NCT00153101|54763497|FG001|Overall Study|Withdrawal by Subject|4|||
28105832|NCT00153101|54763498|FG002|Overall Study|Withdrawal by Subject|3|||
28105833|NCT00153101|54763499|FG003|Overall Study|Withdrawal by Subject|3|||
28105834|NCT00153101|54763500|FG004|Overall Study|Withdrawal by Subject|5|||
28105835|NCT04401579|54763516|FG000|Overall Study|Death|23|||
27815138|NCT02315703|54271947|FG002|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
27815139|NCT02315703|54271948|FG003|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
27815140|NCT02315703|54271949|FG004|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
27815141|NCT02315703|54271950|FG005|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
27815142|NCT02315703|54271951|FG006|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
28105836|NCT04401579|54763517|FG001|Overall Study|Death|36|||
28105837|NCT04401579|54763516|FG000|Overall Study|Lost to Follow-up|40|||
28105838|NCT04401579|54763517|FG001|Overall Study|Lost to Follow-up|41|||
28105839|NCT04401579|54763516|FG000|Overall Study|Withdrawal by Subject|8|||
28105840|NCT04401579|54763517|FG001|Overall Study|Withdrawal by Subject|16|||
28105841|NCT04401579|54763516|FG000|Overall Study|Physician Decision|1|||
28105842|NCT04401579|54763517|FG001|Overall Study|Physician Decision|2|||
28105843|NCT04401579|54763516|FG000|Overall Study|Became ineligible after enrollment|1|||
28105844|NCT04401579|54763517|FG001|Overall Study|Became ineligible after enrollment|1|||
28105845|NCT04401579|54763516|FG000|Overall Study|Enrolled but treatment not administered|7|||
28105846|NCT04401579|54763517|FG001|Overall Study|Enrolled but treatment not administered|9|||
28105847|NCT04401579|54763516|FG000|Overall Study|Adverse Event|2|||
28105848|NCT04401579|54763517|FG001|Overall Study|Adverse Event|1|||
28105849|NCT04401579|54763516|FG000|Overall Study|Scheduling error|1|||
28105850|NCT04401579|54763517|FG001|Overall Study|Scheduling error|2|||
28105851|NCT04401579|54763516|FG000|Overall Study|Transferred to another hospital|1|||
28105852|NCT04401579|54763517|FG001|Overall Study|Transferred to another hospital|2|||
28105853|NCT04161807|54763523|FG000|Overall Study|Withdrawal by Subject|2|||
28105854|NCT04161807|54763523|FG000|Overall Study|Performed only 1 treatment|2|||
28105855|NCT04401423|54763529|FG000|Overall Study|Withdrawal by Subject|3|||
28105856|NCT04401423|54763530|FG001|Overall Study|Withdrawal by Subject|1|||
28105857|NCT04401423|54763529|FG000|Overall Study|Physician Decision|2|||
28105858|NCT04401423|54763530|FG001|Overall Study|Physician Decision|1|||
28105859|NCT04399161|54763541|FG000|Overall Study|Withdrawal by Subject|1|||
28105860|NCT04399161|54763542|FG001|Overall Study|Withdrawal by Subject|0|||
28105861|NCT04399161|54763543|FG002|Overall Study|Withdrawal by Subject|2|||
28105862|NCT04399161|54763541|FG000|Overall Study|Protocol Violation|1|||
28105863|NCT04399161|54763542|FG001|Overall Study|Protocol Violation|2|||
28105864|NCT04399161|54763543|FG002|Overall Study|Protocol Violation|0|||
28105865|NCT02076178|54763553|FG000|Oral Phase|Adverse Event|0|||
28105866|NCT02076178|54763554|FG001|Oral Phase|Adverse Event|7|||
28105867|NCT02076178|54763553|FG000|Oral Phase|Withdrawal by Subject|0|||
28105868|NCT02076178|54763554|FG001|Oral Phase|Withdrawal by Subject|4|||
28105869|NCT02076178|54763553|FG000|Oral Phase|Physician Decision|0|||
28105870|NCT02076178|54763554|FG001|Oral Phase|Physician Decision|1|||
28105871|NCT02076178|54763553|FG000|Injection Phase|Protocol defined stopping criteria|1|||
28105872|NCT02076178|54763554|FG001|Injection Phase|Protocol defined stopping criteria|0|||
28105873|NCT02076178|54763553|FG000|Injection Phase|Withdrawal by Subject|0|||
28105874|NCT02076178|54763554|FG001|Injection Phase|Withdrawal by Subject|3|||
28105875|NCT02076178|54763553|FG000|Injection Phase|Physician Decision|0|||
28105876|NCT02076178|54763554|FG001|Injection Phase|Physician Decision|3|||
28105877|NCT02076178|54763553|FG000|Injection Phase|Lost to Follow-up|0|||
28105878|NCT02076178|54763554|FG001|Injection Phase|Lost to Follow-up|1|||
28105879|NCT04160091|54763566|FG000|Overall Study|Terminated by Sponsor|7|||
28105880|NCT04160091|54763567|FG001|Overall Study|Terminated by Sponsor|3|||
28105881|NCT04160091|54763568|FG002|Overall Study|Terminated by Sponsor|5|||
28105882|NCT04160091|54763569|FG003|Overall Study|Terminated by Sponsor|2|||
28105883|NCT04160091|54763566|FG000|Overall Study|Noncompliance|0|||
28105884|NCT04160091|54763567|FG001|Overall Study|Noncompliance|0|||
28105885|NCT04160091|54763568|FG002|Overall Study|Noncompliance|0|||
28105886|NCT04160091|54763569|FG003|Overall Study|Noncompliance|1|||
28105887|NCT04160091|54763566|FG000|Overall Study|Withdrawal by Subject|0|||
28105888|NCT04160091|54763567|FG001|Overall Study|Withdrawal by Subject|0|||
28105889|NCT04160091|54763568|FG002|Overall Study|Withdrawal by Subject|0|||
28105890|NCT04160091|54763569|FG003|Overall Study|Withdrawal by Subject|1|||
28105891|NCT00149825|54763581|FG000|Overall Study|Intolerance to medication side effects|1|||
28105892|NCT00149825|54763582|FG001|Overall Study|Intolerance to medication side effects|2|||
28105893|NCT00149825|54763581|FG000|Overall Study|Time commitments|2|||
28105894|NCT00149825|54763582|FG001|Overall Study|Time commitments|1|||
28105895|NCT00149825|54763581|FG000|Overall Study|Not liking insomnia therapy|1|||
28105896|NCT00149825|54763582|FG001|Overall Study|Not liking insomnia therapy|0|||
28105897|NCT00149825|54763581|FG000|Overall Study|Other|1|||
28105898|NCT00149825|54763582|FG001|Overall Study|Other|0|||
28105899|NCT04397757|54763590|FG000|Overall Study|Death|3|||
28105900|NCT04397757|54763591|FG001|Overall Study|Death|11|||
28105901|NCT04397757|54763590|FG000|Overall Study|Withdrawal by Subject|2|||
28105902|NCT04397757|54763591|FG001|Overall Study|Withdrawal by Subject|0|||
28105903|NCT04397757|54763590|FG000|Overall Study|Lost to Follow-up|4|||
28105904|NCT04397757|54763591|FG001|Overall Study|Lost to Follow-up|3|||
28105905|NCT02792062|54763608|FG000|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1|||
28105906|NCT02792062|54763609|FG001|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
28105907|NCT02792062|54763610|FG002|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
28105908|NCT02792062|54763611|FG003|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
28105909|NCT02792062|54763612|FG004|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
28105910|NCT02792062|54763613|FG005|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
28105911|NCT00196937|54763624|FG000|Overall Study|Serious Adverse Event|1|||
28105912|NCT00196937|54763625|FG001|Overall Study|Serious Adverse Event|0|||
28105913|NCT00196937|54763626|FG002|Overall Study|Serious Adverse Event|0|||
28105914|NCT00196937|54763624|FG000|Overall Study|Non-serious adverse event|1|||
28105915|NCT00196937|54763625|FG001|Overall Study|Non-serious adverse event|1|||
28105916|NCT00196937|54763626|FG002|Overall Study|Non-serious adverse event|1|||
28105917|NCT00196937|54763624|FG000|Overall Study|Withdrawal by Subject|0|||
28105918|NCT00196937|54763625|FG001|Overall Study|Withdrawal by Subject|0|||
28105919|NCT00196937|54763626|FG002|Overall Study|Withdrawal by Subject|2|||
28105920|NCT00196937|54763624|FG000|Overall Study|Lost to Follow-up|4|||
28105921|NCT00196937|54763625|FG001|Overall Study|Lost to Follow-up|3|||
28105922|NCT00196937|54763626|FG002|Overall Study|Lost to Follow-up|3|||
28105923|NCT00196937|54763624|FG000|Overall Study|Other|3|||
28105924|NCT00196937|54763625|FG001|Overall Study|Other|1|||
28105925|NCT00196937|54763626|FG002|Overall Study|Other|1|||
28105926|NCT04397445|54763635|FG000|Overall Study|Withdrawal by Subject|1|||
28105927|NCT04397445|54763636|FG001|Overall Study|Withdrawal by Subject|0|||
28105928|NCT04397445|54763637|FG002|Overall Study|Withdrawal by Subject|0|||
28105929|NCT04397445|54763638|FG003|Overall Study|Withdrawal by Subject|0|||
28105930|NCT00191945|54763655|FG000|Double-Blind Acute Treatment|Parent's Decision|3|||
28105931|NCT00191945|54763656|FG001|Double-Blind Acute Treatment|Parent's Decision|0|||
28105932|NCT00191945|54763655|FG000|Double-Blind Acute Treatment|Lost to Follow-up|0|||
28105933|NCT00191945|54763656|FG001|Double-Blind Acute Treatment|Lost to Follow-up|1|||
28105934|NCT00191945|54763655|FG000|Double-Blind Acute Treatment|Non Protocol Compliance|3|||
28105935|NCT00191945|54763656|FG001|Double-Blind Acute Treatment|Non Protocol Compliance|0|||
28105936|NCT00191945|54763655|FG000|Double-Blind Acute Treatment|Physician Decision|0|||
28105937|NCT00191945|54763656|FG001|Double-Blind Acute Treatment|Physician Decision|2|||
28105938|NCT01369342|54763666|FG000|Overall Study|Withdrawal by Subject|7|||
28105939|NCT01369342|54763667|FG001|Overall Study|Withdrawal by Subject|7|||
28105940|NCT01369342|54763668|FG002|Overall Study|Withdrawal by Subject|2|||
28105941|NCT01369342|54763666|FG000|Overall Study|Lost to Follow-up|5|||
28105942|NCT01369342|54763667|FG001|Overall Study|Lost to Follow-up|2|||
28105943|NCT01369342|54763668|FG002|Overall Study|Lost to Follow-up|1|||
28105944|NCT01369342|54763666|FG000|Overall Study|Not Treated|1|||
28105945|NCT01369342|54763667|FG001|Overall Study|Not Treated|0|||
28105946|NCT01369342|54763668|FG002|Overall Study|Not Treated|0|||
28105947|NCT00191477|54763678|FG000|Overall Study|Tumor Recurrence|49|||
28105948|NCT00191477|54763679|FG001|Overall Study|Tumor Recurrence|48|||
28105949|NCT00191477|54763678|FG000|Overall Study|Death, Study Disease|1|||
28105950|NCT00191477|54763679|FG001|Overall Study|Death, Study Disease|1|||
27815143|NCT02315703|54271952|FG007|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
27815144|NCT02315703|54271945|FG000|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
27815145|NCT02315703|54271946|FG001|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
27815146|NCT02315703|54271947|FG002|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
27815147|NCT02315703|54271948|FG003|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
27815148|NCT02315703|54271949|FG004|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
27815149|NCT02315703|54271950|FG005|Main Study (From Week 0 up to Week 96)|Physician Decision|2|||
27815150|NCT02315703|54271951|FG006|Main Study (From Week 0 up to Week 96)|Physician Decision|1|||
27848355|NCT00980005|54341317|FG000|Overall Study|Other|4|||
28063107|NCT00333138|54718984|FG002|Extension Study (Month6 to End of Study)|Adverse Event|15|||
28063108|NCT00333138|54718982|FG000|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
28063109|NCT00333138|54718983|FG001|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
28063110|NCT00333138|54718984|FG002|Extension Study (Month6 to End of Study)|Protocol Violation|3|||
28063111|NCT00333138|54718982|FG000|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
28063112|NCT00333138|54718983|FG001|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13|||
28063113|NCT00333138|54718984|FG002|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
28063114|NCT00333138|54718982|FG000|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
28063115|NCT00333138|54718983|FG001|Extension Study (Month6 to End of Study)|Lack of Efficacy|4|||
28063116|NCT00333138|54718984|FG002|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
28063117|NCT00333138|54718982|FG000|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2|||
28105951|NCT00191477|54763678|FG000|Overall Study|Death, Other Cause|3|||
28105952|NCT00191477|54763679|FG001|Overall Study|Death, Other Cause|6|||
28105953|NCT00191477|54763678|FG000|Overall Study|Lost to Follow-up|23|||
28105954|NCT00191477|54763679|FG001|Overall Study|Lost to Follow-up|21|||
28105955|NCT00191477|54763678|FG000|Overall Study|Protocol Violation|1|||
28105956|NCT00191477|54763679|FG001|Overall Study|Protocol Violation|1|||
28105957|NCT00191477|54763678|FG000|Overall Study|Treatment Change|2|||
28105958|NCT00191477|54763679|FG001|Overall Study|Treatment Change|0|||
28105959|NCT00191477|54763678|FG000|Overall Study|Withdrawal by Subject|2|||
28105960|NCT00191477|54763679|FG001|Overall Study|Withdrawal by Subject|0|||
28105961|NCT00191477|54763678|FG000|Overall Study|Other|2|||
28105962|NCT00191477|54763679|FG001|Overall Study|Other|0|||
28105963|NCT00191477|54763678|FG000|Overall Study|Not Eligible|41|||
28105964|NCT00191477|54763679|FG001|Overall Study|Not Eligible|38|||
28105965|NCT00191477|54763678|FG000|Overall Study|Pathological Specimen Lost|1|||
28105966|NCT00191477|54763679|FG001|Overall Study|Pathological Specimen Lost|0|||
28105967|NCT00191477|54763678|FG000|Overall Study|Discontinued Prior to Instillation|13|||
28105968|NCT00191477|54763679|FG001|Overall Study|Discontinued Prior to Instillation|14|||
28105969|NCT04320615|54763687|FG000|Overall Study|Withdrawal by Subject|4|||
28105970|NCT04320615|54763688|FG001|Overall Study|Withdrawal by Subject|10|||
28105971|NCT04320615|54763687|FG000|Overall Study|Physician Decision|2|||
28105972|NCT04320615|54763688|FG001|Overall Study|Physician Decision|0|||
28105973|NCT04320615|54763687|FG000|Overall Study|Other|2|||
28063118|NCT00333138|54718983|FG001|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1|||
28063119|NCT00333138|54718984|FG002|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0|||
28063120|NCT00333138|54718982|FG000|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
28063121|NCT00333138|54718983|FG001|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
28063122|NCT00333138|54718984|FG002|Extension Study (Month6 to End of Study)|Lost to Follow-up|0|||
28063123|NCT00333138|54718982|FG000|Extension Study (Month6 to End of Study)|Death|0|||
28063124|NCT00333138|54718983|FG001|Extension Study (Month6 to End of Study)|Death|1|||
28105974|NCT04320615|54763688|FG001|Overall Study|Other|0|||
28105975|NCT04320615|54763687|FG000|Overall Study|Lost to Follow-up|5|||
28105976|NCT04320615|54763688|FG001|Overall Study|Lost to Follow-up|23|||
28105977|NCT04320615|54763687|FG000|Overall Study|Death|35|||
28105978|NCT04320615|54763688|FG001|Overall Study|Death|71|||
28105979|NCT00149747|54763700|FG000|Overall Study|Death|1|||
28105980|NCT00149747|54763701|FG001|Overall Study|Death|0|||
28105981|NCT00149747|54763700|FG000|Overall Study|Withdrawal by Subject|3|||
28105982|NCT00149747|54763701|FG001|Overall Study|Withdrawal by Subject|3|||
28105983|NCT00187889|54763709|FG000|Overall Study|Withdrawal by Subject|6|||
28105984|NCT00187889|54763710|FG001|Overall Study|Withdrawal by Subject|4|||
28105985|NCT00148343|54763719|FG000|Overall Study|Withdrawal by Subject|12|||
28105986|NCT00148343|54763720|FG001|Overall Study|Withdrawal by Subject|7|||
28105987|NCT00148343|54763719|FG000|Overall Study|Physician Decision|3|||
28105988|NCT00148343|54763720|FG001|Overall Study|Physician Decision|4|||
28105989|NCT04150341|54763726|FG000|Overall Study|Physician Decision|0|||
28105990|NCT04150341|54763727|FG001|Overall Study|Physician Decision|0|||
28105991|NCT04150341|54763728|FG002|Overall Study|Physician Decision|1|||
28105992|NCT04150341|54763729|FG003|Overall Study|Physician Decision|0|||
28105993|NCT04150341|54763730|FG004|Overall Study|Physician Decision|0|||
28105994|NCT04150341|54763731|FG005|Overall Study|Physician Decision|0|||
28105995|NCT04150341|54763726|FG000|Overall Study|Adverse Event|0|||
28105996|NCT04150341|54763727|FG001|Overall Study|Adverse Event|0|||
28105997|NCT04150341|54763728|FG002|Overall Study|Adverse Event|0|||
28105998|NCT04150341|54763729|FG003|Overall Study|Adverse Event|0|||
28105999|NCT04150341|54763730|FG004|Overall Study|Adverse Event|1|||
28106000|NCT04150341|54763731|FG005|Overall Study|Adverse Event|0|||
28106001|NCT00148109|54763743|FG000|Overall Study|Lack of Efficacy|10|||
28106002|NCT00148109|54763744|FG001|Overall Study|Lack of Efficacy|18|||
28106003|NCT00148109|54763743|FG000|Overall Study|Adverse Event|0|||
28106004|NCT00148109|54763744|FG001|Overall Study|Adverse Event|2|||
28106005|NCT00148109|54763743|FG000|Overall Study|Withdrawal by Subject|2|||
28106006|NCT00148109|54763744|FG001|Overall Study|Withdrawal by Subject|0|||
28106007|NCT00186485|54763750|FG000|Overall Study|Lost to Follow-up|3|||
28106008|NCT00147251|54763756|FG000|Recruitment and Enrollment|change in treatment guidelines|24|||
28106009|NCT00147251|54763757|FG001|Recruitment and Enrollment|change in treatment guidelines|25|||
28106010|NCT04390191|54763767|FG000|Overall Study|Withdrawal by Subject|1|||
28106011|NCT04390191|54763768|FG001|Overall Study|Withdrawal by Subject|0|||
28106012|NCT04405076|54763780|FG000|Part A (Blinded Phase)|Lost to Follow-up|6|||
28106013|NCT04405076|54763781|FG001|Part A (Blinded Phase)|Lost to Follow-up|6|||
27815151|NCT02315703|54271952|FG007|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
27815152|NCT02315703|54271945|FG000|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
27815153|NCT02315703|54271946|FG001|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
28106014|NCT04405076|54763782|FG002|Part A (Blinded Phase)|Lost to Follow-up|7|||
28106015|NCT04405076|54763783|FG003|Part A (Blinded Phase)|Lost to Follow-up|0|||
28106016|NCT04405076|54763784|FG004|Part A (Blinded Phase)|Lost to Follow-up|0|||
28106017|NCT04405076|54763785|FG005|Part A (Blinded Phase)|Lost to Follow-up|0|||
28106018|NCT04405076|54763786|FG006|Part A (Blinded Phase)|Lost to Follow-up|0|||
28106019|NCT04405076|54763787|FG007|Part A (Blinded Phase)|Lost to Follow-up|0|||
28106020|NCT04405076|54763788|FG008|Part A (Blinded Phase)|Lost to Follow-up|0|||
28106021|NCT04405076|54763780|FG000|Part A (Blinded Phase)|Physician Decision|1|||
28106022|NCT04405076|54763781|FG001|Part A (Blinded Phase)|Physician Decision|2|||
28106023|NCT04405076|54763782|FG002|Part A (Blinded Phase)|Physician Decision|0|||
28106024|NCT04405076|54763783|FG003|Part A (Blinded Phase)|Physician Decision|0|||
28106025|NCT04405076|54763784|FG004|Part A (Blinded Phase)|Physician Decision|0|||
28106026|NCT04405076|54763785|FG005|Part A (Blinded Phase)|Physician Decision|0|||
28106027|NCT04405076|54763786|FG006|Part A (Blinded Phase)|Physician Decision|0|||
28106028|NCT04405076|54763787|FG007|Part A (Blinded Phase)|Physician Decision|0|||
28106029|NCT04405076|54763788|FG008|Part A (Blinded Phase)|Physician Decision|0|||
28106030|NCT04405076|54763780|FG000|Part A (Blinded Phase)|Protocol Violation|3|||
28106031|NCT04405076|54763781|FG001|Part A (Blinded Phase)|Protocol Violation|3|||
28106032|NCT04405076|54763782|FG002|Part A (Blinded Phase)|Protocol Violation|8|||
28106033|NCT04405076|54763783|FG003|Part A (Blinded Phase)|Protocol Violation|0|||
28106034|NCT04405076|54763784|FG004|Part A (Blinded Phase)|Protocol Violation|0|||
28106035|NCT04405076|54763785|FG005|Part A (Blinded Phase)|Protocol Violation|0|||
28106036|NCT04405076|54763786|FG006|Part A (Blinded Phase)|Protocol Violation|0|||
28063125|NCT00333138|54718984|FG002|Extension Study (Month6 to End of Study)|Death|0|||
28063126|NCT00332202|54718996|FG000|Overall Study|Adverse Event|72|||
28063127|NCT00332202|54718997|FG001|Overall Study|Adverse Event|28|||
28063128|NCT00332202|54718996|FG000|Overall Study|Lost to Follow-up|2|||
28063129|NCT00332202|54718997|FG001|Overall Study|Lost to Follow-up|1|||
28063130|NCT00332202|54718996|FG000|Overall Study|Physician Decision|6|||
28063131|NCT00332202|54718997|FG001|Overall Study|Physician Decision|8|||
28063132|NCT00332202|54718996|FG000|Overall Study|Protocol Entry Criteria Not Met|6|||
28063133|NCT00332202|54718997|FG001|Overall Study|Protocol Entry Criteria Not Met|5|||
28063134|NCT00332202|54718996|FG000|Overall Study|Protocol Violation|7|||
28063135|NCT00332202|54718997|FG001|Overall Study|Protocol Violation|2|||
28063136|NCT00332202|54718996|FG000|Overall Study|Sponsor Decision|1|||
28106037|NCT04405076|54763787|FG007|Part A (Blinded Phase)|Protocol Violation|0|||
28106038|NCT04405076|54763788|FG008|Part A (Blinded Phase)|Protocol Violation|0|||
28063137|NCT00332202|54718997|FG001|Overall Study|Sponsor Decision|2|||
28063138|NCT00332202|54718996|FG000|Overall Study|Withdrawal by Subject|36|||
28063139|NCT00332202|54718997|FG001|Overall Study|Withdrawal by Subject|17|||
28063140|NCT00332202|54718996|FG000|Overall Study|Progressive Disease|106|||
28063141|NCT00332202|54718997|FG001|Overall Study|Progressive Disease|60|||
27848356|NCT00980005|54341318|FG001|Overall Study|Other|3|||
28063142|NCT00332202|54718996|FG000|Overall Study|Death|5|||
28063143|NCT00332202|54718997|FG001|Overall Study|Death|2|||
28106039|NCT04405076|54763780|FG000|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|1|||
28106040|NCT04405076|54763781|FG001|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
28106041|NCT04405076|54763782|FG002|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
28106042|NCT04405076|54763783|FG003|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
28106043|NCT04405076|54763784|FG004|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
28106044|NCT04405076|54763785|FG005|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
28063144|NCT00331422|54719012|FG000|Overall Study|Did not receive entire study regimen|5|||
28106045|NCT04405076|54763786|FG006|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
28106046|NCT04405076|54763787|FG007|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
28106047|NCT04405076|54763788|FG008|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
28106048|NCT04405076|54763780|FG000|Part A (Blinded Phase)|Withdrawal of consent (other)|1|||
28106049|NCT04405076|54763781|FG001|Part A (Blinded Phase)|Withdrawal of consent (other)|4|||
28106050|NCT04405076|54763782|FG002|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
28106051|NCT04405076|54763783|FG003|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
28106052|NCT04405076|54763784|FG004|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
28106053|NCT04405076|54763785|FG005|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
28106054|NCT04405076|54763786|FG006|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
28106055|NCT04405076|54763787|FG007|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
28106056|NCT04405076|54763788|FG008|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
28106057|NCT04405076|54763780|FG000|Part A (Blinded Phase)|Other than Specified|0|||
28106058|NCT04405076|54763781|FG001|Part A (Blinded Phase)|Other than Specified|0|||
28106059|NCT04405076|54763782|FG002|Part A (Blinded Phase)|Other than Specified|3|||
28106060|NCT04405076|54763783|FG003|Part A (Blinded Phase)|Other than Specified|0|||
28106061|NCT04405076|54763784|FG004|Part A (Blinded Phase)|Other than Specified|0|||
28106062|NCT04405076|54763785|FG005|Part A (Blinded Phase)|Other than Specified|0|||
28106063|NCT04405076|54763786|FG006|Part A (Blinded Phase)|Other than Specified|0|||
27815154|NCT02315703|54271947|FG002|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
28106064|NCT04405076|54763787|FG007|Part A (Blinded Phase)|Other than Specified|0|||
28106065|NCT04405076|54763788|FG008|Part A (Blinded Phase)|Other than Specified|0|||
28106066|NCT04405076|54763780|FG000|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
28106067|NCT04405076|54763781|FG001|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
28106068|NCT04405076|54763782|FG002|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
28106069|NCT04405076|54763783|FG003|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|6|||
28106070|NCT04405076|54763784|FG004|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|1|||
28106071|NCT04405076|54763785|FG005|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|4|||
28106072|NCT04405076|54763786|FG006|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
28106073|NCT04405076|54763787|FG007|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
28106074|NCT04405076|54763788|FG008|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
28106075|NCT04405076|54763780|FG000|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
27815155|NCT02315703|54271948|FG003|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
27815156|NCT02315703|54271949|FG004|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
27815157|NCT02315703|54271950|FG005|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
27815158|NCT02315703|54271951|FG006|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
27815159|NCT02315703|54271952|FG007|Main Study (From Week 0 up to Week 96)|Pregnancy|1|||
28106076|NCT04405076|54763781|FG001|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
28106077|NCT04405076|54763782|FG002|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
28106078|NCT04405076|54763783|FG003|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
28106079|NCT04405076|54763784|FG004|Part B (Open-Label Interventional Phase)|Physician Decision|1|||
28106080|NCT04405076|54763785|FG005|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
28106081|NCT04405076|54763786|FG006|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
28106082|NCT04405076|54763787|FG007|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
28106083|NCT04405076|54763788|FG008|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
27815160|NCT02315703|54271945|FG000|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
27815161|NCT02315703|54271946|FG001|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
28063145|NCT00331344|54719017|FG000|Phase I|Adverse Event|0|||
28063146|NCT00331344|54719018|FG001|Phase I|Adverse Event|0|||
28063147|NCT00331344|54719019|FG002|Phase I|Adverse Event|0|||
28063148|NCT00331344|54719020|FG003|Phase I|Adverse Event|1|||
28063149|NCT00331344|54719021|FG004|Phase I|Adverse Event|2|||
28063150|NCT00331344|54719022|FG005|Phase I|Adverse Event|2|||
28063151|NCT00331344|54719023|FG006|Phase I|Adverse Event|0|||
28063152|NCT00331344|54719024|FG007|Phase I|Adverse Event|1|||
28063153|NCT00331344|54719025|FG008|Phase I|Adverse Event|0|||
28063154|NCT00331344|54719017|FG000|Phase II|Death|0|||
28063155|NCT00331344|54719018|FG001|Phase II|Death|0|||
28063156|NCT00331344|54719019|FG002|Phase II|Death|0|||
28063157|NCT00331344|54719020|FG003|Phase II|Death|0|||
28063158|NCT00331344|54719021|FG004|Phase II|Death|0|||
28063159|NCT00331344|54719022|FG005|Phase II|Death|0|||
28063160|NCT00331344|54719023|FG006|Phase II|Death|0|||
28063161|NCT00331344|54719024|FG007|Phase II|Death|0|||
28063162|NCT00331344|54719025|FG008|Phase II|Death|4|||
28063163|NCT00321672|54719042|FG000|Overall Study|Withdrawal by Subject|5|||
28063164|NCT00321672|54719043|FG001|Overall Study|Withdrawal by Subject|1|||
28063165|NCT00321672|54719044|FG002|Overall Study|Withdrawal by Subject|2|||
28063166|NCT00321672|54719045|FG003|Overall Study|Withdrawal by Subject|0|||
28063167|NCT00321672|54719042|FG000|Overall Study|Noncompliance|1|||
28063168|NCT00321672|54719043|FG001|Overall Study|Noncompliance|2|||
28063169|NCT00321672|54719044|FG002|Overall Study|Noncompliance|1|||
28063170|NCT00321672|54719045|FG003|Overall Study|Noncompliance|0|||
28063171|NCT00321672|54719042|FG000|Overall Study|Adverse Event|1|||
28063172|NCT00321672|54719043|FG001|Overall Study|Adverse Event|1|||
28063173|NCT00321672|54719044|FG002|Overall Study|Adverse Event|0|||
28063174|NCT00321672|54719045|FG003|Overall Study|Adverse Event|0|||
28063175|NCT00321672|54719042|FG000|Overall Study|Lack of Efficacy|1|||
28063176|NCT00321672|54719043|FG001|Overall Study|Lack of Efficacy|1|||
28106084|NCT04405076|54763780|FG000|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
28106085|NCT04405076|54763781|FG001|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
28106086|NCT04405076|54763782|FG002|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
28106087|NCT04405076|54763783|FG003|Part B (Open-Label Interventional Phase)|Lost to Follow-up|6|||
28106088|NCT04405076|54763784|FG004|Part B (Open-Label Interventional Phase)|Lost to Follow-up|3|||
28106089|NCT04405076|54763785|FG005|Part B (Open-Label Interventional Phase)|Lost to Follow-up|2|||
28106090|NCT04405076|54763786|FG006|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
28106091|NCT04405076|54763787|FG007|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
28106092|NCT04405076|54763788|FG008|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
28106093|NCT04405076|54763780|FG000|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
28063177|NCT00321672|54719044|FG002|Overall Study|Lack of Efficacy|0|||
28063178|NCT00321672|54719045|FG003|Overall Study|Lack of Efficacy|0|||
28106094|NCT04405076|54763781|FG001|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
28106095|NCT04405076|54763782|FG002|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
28106096|NCT04405076|54763783|FG003|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
28106097|NCT04405076|54763784|FG004|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
28063179|NCT00321672|54719042|FG000|Overall Study|Lost to Follow-up|2|||
28063180|NCT00321672|54719043|FG001|Overall Study|Lost to Follow-up|0|||
28063181|NCT00321672|54719044|FG002|Overall Study|Lost to Follow-up|4|||
28063182|NCT00321672|54719045|FG003|Overall Study|Lost to Follow-up|2|||
28063183|NCT00321672|54719042|FG000|Overall Study|Death|1|||
28063184|NCT00321672|54719043|FG001|Overall Study|Death|0|||
28063185|NCT00321672|54719044|FG002|Overall Study|Death|0|||
28063186|NCT00321672|54719045|FG003|Overall Study|Death|0|||
28063187|NCT00321672|54719042|FG000|Overall Study|Too far to travel for visits|1|||
28063188|NCT00321672|54719043|FG001|Overall Study|Too far to travel for visits|0|||
28063189|NCT00321672|54719044|FG002|Overall Study|Too far to travel for visits|0|||
28063190|NCT00321672|54719045|FG003|Overall Study|Too far to travel for visits|0|||
28063191|NCT00321672|54719042|FG000|Overall Study|Incarcerated|0|||
28063192|NCT00321672|54719043|FG001|Overall Study|Incarcerated|0|||
28063193|NCT00321672|54719044|FG002|Overall Study|Incarcerated|2|||
28063194|NCT00321672|54719045|FG003|Overall Study|Incarcerated|0|||
28106098|NCT04405076|54763785|FG005|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
28106099|NCT04405076|54763786|FG006|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
28106100|NCT04405076|54763787|FG007|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|2|||
28106101|NCT04405076|54763788|FG008|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|1|||
28106102|NCT04405076|54763780|FG000|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
28106103|NCT04405076|54763781|FG001|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
28063195|NCT00321672|54719042|FG000|Overall Study|Moved out of state|0|||
28106104|NCT04405076|54763782|FG002|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
28106105|NCT04405076|54763783|FG003|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
28106106|NCT04405076|54763784|FG004|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
28106107|NCT04405076|54763785|FG005|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
28106108|NCT04405076|54763786|FG006|Part C (Rollover Proof of Concept)|Lost to Follow-up|2|||
28106109|NCT04405076|54763787|FG007|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
28106110|NCT04405076|54763788|FG008|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
28106111|NCT04311177|54763816|FG000|Overall Study|Adverse Event|3|||
28106112|NCT04311177|54763817|FG001|Overall Study|Adverse Event|1|||
28106113|NCT04311177|54763816|FG000|Overall Study|Physician Decision|4|||
27815162|NCT02315703|54271947|FG002|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|0|||
27815163|NCT02315703|54271948|FG003|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
27815164|NCT02315703|54271949|FG004|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|4|||
27815165|NCT02315703|54271950|FG005|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
28106114|NCT04311177|54763817|FG001|Overall Study|Physician Decision|3|||
28106115|NCT04311177|54763816|FG000|Overall Study|Withdrawal by Subject|1|||
28106116|NCT04311177|54763817|FG001|Overall Study|Withdrawal by Subject|0|||
28106117|NCT03267212|54763823|FG000|First Intervention|Lost to Follow-up|0|||
28106118|NCT03267212|54763824|FG001|First Intervention|Lost to Follow-up|2|||
28106119|NCT03267212|54763823|FG000|First Intervention|Withdrawal by Subject|1|||
28106120|NCT03267212|54763824|FG001|First Intervention|Withdrawal by Subject|1|||
28106121|NCT03267212|54763823|FG000|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1|||
28106122|NCT03267212|54763824|FG001|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0|||
28106123|NCT04292535|54763844|FG000|Overall Study|Withdrawal by Subject|0|||
28106124|NCT04292535|54763845|FG001|Overall Study|Withdrawal by Subject|0|||
28106125|NCT04292535|54763846|FG002|Overall Study|Withdrawal by Subject|0|||
28106126|NCT04292535|54763847|FG003|Overall Study|Withdrawal by Subject|0|||
28106127|NCT04292535|54763848|FG004|Overall Study|Withdrawal by Subject|0|||
28106128|NCT04292535|54763849|FG005|Overall Study|Withdrawal by Subject|0|||
28106129|NCT04292535|54763850|FG006|Overall Study|Withdrawal by Subject|0|||
28106130|NCT04292535|54763851|FG007|Overall Study|Withdrawal by Subject|1|||
28106131|NCT04292535|54763852|FG008|Overall Study|Withdrawal by Subject|0|||
28063196|NCT00321672|54719043|FG001|Overall Study|Moved out of state|1|||
28063197|NCT00321672|54719044|FG002|Overall Study|Moved out of state|1|||
28063198|NCT00321672|54719045|FG003|Overall Study|Moved out of state|0|||
28063199|NCT00321672|54719042|FG000|Overall Study|Protocol Violation|0|||
28063200|NCT00321672|54719043|FG001|Overall Study|Protocol Violation|0|||
28063201|NCT00321672|54719044|FG002|Overall Study|Protocol Violation|1|||
28063202|NCT00321672|54719045|FG003|Overall Study|Protocol Violation|0|||
28063203|NCT00321672|54719042|FG000|Overall Study|Diagnosis of testicular cancer|0|||
28063204|NCT00321672|54719043|FG001|Overall Study|Diagnosis of testicular cancer|1|||
28063205|NCT00321672|54719044|FG002|Overall Study|Diagnosis of testicular cancer|0|||
28063206|NCT00321672|54719045|FG003|Overall Study|Diagnosis of testicular cancer|0|||
28063207|NCT00321672|54719042|FG000|Overall Study|Extensive travel required for new job|0|||
28063208|NCT00321672|54719043|FG001|Overall Study|Extensive travel required for new job|1|||
28063209|NCT00321672|54719044|FG002|Overall Study|Extensive travel required for new job|0|||
28063210|NCT00321672|54719045|FG003|Overall Study|Extensive travel required for new job|0|||
28063211|NCT00321048|54719061|FG000|Overall Study|Withdrawal by Subject|6|||
28063212|NCT00321048|54719062|FG001|Overall Study|Withdrawal by Subject|8|||
28063213|NCT00330174|54719070|FG000|Overall Study|Withdrawal by Subject|7|||
28063214|NCT00330174|54719071|FG001|Overall Study|Withdrawal by Subject|7|||
28063215|NCT00330174|54719070|FG000|Overall Study|Lost to Follow-up|4|||
28063216|NCT00330174|54719071|FG001|Overall Study|Lost to Follow-up|1|||
28063217|NCT00330174|54719070|FG000|Overall Study|Clinical deterioration|1|||
28063218|NCT00330174|54719071|FG001|Overall Study|Clinical deterioration|2|||
28106132|NCT04292535|54763853|FG009|Overall Study|Withdrawal by Subject|0|||
28106133|NCT04292535|54763854|FG010|Overall Study|Withdrawal by Subject|0|||
28106134|NCT04292535|54763855|FG011|Overall Study|Withdrawal by Subject|0|||
28106135|NCT04292535|54763856|FG012|Overall Study|Withdrawal by Subject|0|||
28106136|NCT04292535|54763857|FG013|Overall Study|Withdrawal by Subject|0|||
28106137|NCT04292535|54763844|FG000|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
28106138|NCT04292535|54763845|FG001|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
28106139|NCT04292535|54763846|FG002|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
28106140|NCT04292535|54763847|FG003|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
28106141|NCT04292535|54763848|FG004|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
28106142|NCT04292535|54763849|FG005|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
28106143|NCT04292535|54763850|FG006|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
28106144|NCT04292535|54763851|FG007|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
28106145|NCT04292535|54763852|FG008|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
28106146|NCT04292535|54763853|FG009|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
28106147|NCT04292535|54763854|FG010|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
28106148|NCT04292535|54763855|FG011|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
28106149|NCT04292535|54763856|FG012|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
28106150|NCT04292535|54763857|FG013|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
28106151|NCT04292535|54763844|FG000|Overall Study|Report of Dizziness|0|||
28106152|NCT04292535|54763845|FG001|Overall Study|Report of Dizziness|0|||
28106153|NCT04292535|54763846|FG002|Overall Study|Report of Dizziness|0|||
28106154|NCT04292535|54763847|FG003|Overall Study|Report of Dizziness|0|||
28106155|NCT04292535|54763848|FG004|Overall Study|Report of Dizziness|0|||
28106156|NCT04292535|54763849|FG005|Overall Study|Report of Dizziness|0|||
28106157|NCT04292535|54763850|FG006|Overall Study|Report of Dizziness|0|||
28106158|NCT04292535|54763851|FG007|Overall Study|Report of Dizziness|0|||
28106159|NCT04292535|54763852|FG008|Overall Study|Report of Dizziness|0|||
28106160|NCT04292535|54763853|FG009|Overall Study|Report of Dizziness|0|||
28106161|NCT04292535|54763854|FG010|Overall Study|Report of Dizziness|0|||
28106162|NCT04292535|54763855|FG011|Overall Study|Report of Dizziness|0|||
28106163|NCT04292535|54763856|FG012|Overall Study|Report of Dizziness|0|||
28106164|NCT04292535|54763857|FG013|Overall Study|Report of Dizziness|1|||
28106165|NCT04292535|54763844|FG000|Overall Study|Equipment Failure|0|||
28106166|NCT04292535|54763845|FG001|Overall Study|Equipment Failure|0|||
28106167|NCT04292535|54763846|FG002|Overall Study|Equipment Failure|0|||
28106168|NCT04292535|54763847|FG003|Overall Study|Equipment Failure|0|||
28106169|NCT04292535|54763848|FG004|Overall Study|Equipment Failure|0|||
28106170|NCT04292535|54763849|FG005|Overall Study|Equipment Failure|0|||
28106171|NCT04292535|54763850|FG006|Overall Study|Equipment Failure|0|||
28106172|NCT04292535|54763851|FG007|Overall Study|Equipment Failure|0|||
28106173|NCT04292535|54763852|FG008|Overall Study|Equipment Failure|0|||
28106174|NCT04292535|54763853|FG009|Overall Study|Equipment Failure|0|||
28106175|NCT04292535|54763854|FG010|Overall Study|Equipment Failure|0|||
28106176|NCT04292535|54763855|FG011|Overall Study|Equipment Failure|1|||
28106177|NCT04292535|54763856|FG012|Overall Study|Equipment Failure|0|||
28106178|NCT04292535|54763857|FG013|Overall Study|Equipment Failure|0|||
28106179|NCT04385199|54763889|FG000|Overall Study|Withdrawal by Subject|1|||
28106180|NCT04385199|54763890|FG001|Overall Study|Withdrawal by Subject|0|||
28106181|NCT04284813|54763896|FG000|Overall Study|Withdrawal by Subject|1|||
28106182|NCT03263780|54763900|FG000|Overall Study|Withdrawal by Subject|3|||
28106183|NCT03263780|54763900|FG000|Overall Study|Ineligible (incomplete post-HIFU)|7|||
28106184|NCT02791438|54763906|FG000|Treatment Period|Adverse Event|1|||
28106185|NCT02791438|54763907|FG001|Treatment Period|Adverse Event|0|||
28106186|NCT02791438|54763906|FG000|Treatment Period|Withdrawal by Subject|0|||
28106187|NCT02791438|54763907|FG001|Treatment Period|Withdrawal by Subject|1|||
28106188|NCT02791438|54763906|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
28106189|NCT02791438|54763907|FG001|Treatment Period|Withdrawal by Parent/Guardian|0|||
28106190|NCT03712124|54763915|FG000|Overall Study|Protocol Violation|1|||
28106191|NCT03712124|54763916|FG001|Overall Study|Protocol Violation|0|||
28106192|NCT02791516|54763930|FG000|Overall Study|Withdrawal by Subject|1|||
27815166|NCT02315703|54271951|FG006|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
28063219|NCT00330174|54719070|FG000|Overall Study|Excessive missed visits|3|||
28063220|NCT00330174|54719071|FG001|Overall Study|Excessive missed visits|8|||
28063221|NCT00330174|54719070|FG000|Overall Study|Miscellaneous reasons|7|||
28063222|NCT00330174|54719071|FG001|Overall Study|Miscellaneous reasons|1|||
28063223|NCT00320424|54719077|FG000|Overall Study|Adverse Event|3|||
28063224|NCT00320424|54719077|FG000|Overall Study|Other|3|||
28063225|NCT00338286|54719083|FG000|Overall Study|Withdrawal by Subject|50|||
28063226|NCT00338286|54719084|FG001|Overall Study|Withdrawal by Subject|54|||
28063227|NCT00338286|54719083|FG000|Overall Study|Lost to Follow-up|80|||
28063228|NCT00338286|54719084|FG001|Overall Study|Lost to Follow-up|66|||
28063229|NCT00338286|54719083|FG000|Overall Study|Other|103|||
28063230|NCT00338286|54719084|FG001|Overall Study|Other|93|||
28106193|NCT02791516|54763931|FG001|Overall Study|Withdrawal by Subject|1|||
28106194|NCT03263702|54763939|FG000|Overall Study|Lost to Follow-up|2|||
27815167|NCT02315703|54271952|FG007|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|2|||
27815168|NCT02315703|54271945|FG000|Main Study (From Week 0 up to Week 96)|Other|4|||
27815169|NCT02315703|54271946|FG001|Main Study (From Week 0 up to Week 96)|Other|2|||
27815170|NCT02315703|54271947|FG002|Main Study (From Week 0 up to Week 96)|Other|2|||
28106195|NCT03263702|54763940|FG001|Overall Study|Lost to Follow-up|2|||
28106196|NCT03263702|54763939|FG000|Overall Study|Withdrawal by Subject|1|||
28106197|NCT03263702|54763940|FG001|Overall Study|Withdrawal by Subject|2|||
28106198|NCT03692871|54763948|FG000|Overall Study|Death|1|||
28063231|NCT00329784|54719094|FG000|Overall Study|Lost to Follow-up|0|||
28063232|NCT00329784|54719095|FG001|Overall Study|Lost to Follow-up|1|||
28063233|NCT00329784|54719096|FG002|Overall Study|Lost to Follow-up|0|||
27848357|NCT01044303|54341328|FG000|Overall Study|Lost to Follow-up|2|||
28063234|NCT00329784|54719097|FG003|Overall Study|Lost to Follow-up|0|||
28063235|NCT00329784|54719094|FG000|Overall Study|Withdrawal by Subject|4|||
28063236|NCT00329784|54719095|FG001|Overall Study|Withdrawal by Subject|2|||
28063237|NCT00329784|54719096|FG002|Overall Study|Withdrawal by Subject|0|||
28063238|NCT00329784|54719097|FG003|Overall Study|Withdrawal by Subject|0|||
28063239|NCT00329784|54719094|FG000|Overall Study|Other|1|||
28063240|NCT00329784|54719095|FG001|Overall Study|Other|2|||
28063241|NCT00329784|54719096|FG002|Overall Study|Other|0|||
28063242|NCT00329784|54719097|FG003|Overall Study|Other|0|||
28063243|NCT00337818|54719112|FG000|Overall Study|Lost to Follow-up|289|||
28063244|NCT00337818|54719113|FG001|Overall Study|Lost to Follow-up|91|||
28063245|NCT00337818|54719114|FG002|Overall Study|Lost to Follow-up|107|||
28063246|NCT00329550|54719125|FG000|Overall Study|Adverse Event|3|||
28063247|NCT00329550|54719126|FG001|Overall Study|Adverse Event|4|||
28063248|NCT00329550|54719127|FG002|Overall Study|Adverse Event|2|||
28063249|NCT00329550|54719125|FG000|Overall Study|Withdrawal of Consent|1|||
28063250|NCT00329550|54719126|FG001|Overall Study|Withdrawal of Consent|0|||
28063251|NCT00329550|54719127|FG002|Overall Study|Withdrawal of Consent|1|||
28063252|NCT00329550|54719125|FG000|Overall Study|Due to Relocation|0|||
28063253|NCT00329550|54719126|FG001|Overall Study|Due to Relocation|0|||
28063254|NCT00329550|54719127|FG002|Overall Study|Due to Relocation|1|||
28063255|NCT00375674|54719139|FG000|Overall Study|Other|26|||
28063256|NCT00375674|54719140|FG001|Overall Study|Other|18|||
28063257|NCT00375674|54719139|FG000|Overall Study|Death|67|||
28063258|NCT00375674|54719140|FG001|Overall Study|Death|76|||
28063259|NCT00375674|54719139|FG000|Overall Study|Participants refused further follow-up|31|||
28063260|NCT00375674|54719140|FG001|Overall Study|Participants refused further follow-up|30|||
28063261|NCT00375674|54719139|FG000|Overall Study|Lost to Follow-up|17|||
28063262|NCT00375674|54719140|FG001|Overall Study|Lost to Follow-up|15|||
28063263|NCT00375674|54719139|FG000|Overall Study|Enrolled but not treated|3|||
28063264|NCT00375674|54719140|FG001|Overall Study|Enrolled but not treated|2|||
28063265|NCT00350402|54719148|FG000|Overall Study|Lost to Follow-up|1|||
28063266|NCT00350402|54719149|FG001|Overall Study|Lost to Follow-up|1|||
28063267|NCT00320190|54719163|FG000|First 12 Months|Completed but did not enter extension|5|||
28063268|NCT00320190|54719164|FG001|First 12 Months|Completed but did not enter extension|3|||
28063269|NCT00320190|54719163|FG000|First 12 Months|Sponsor terminated study|2|||
28063270|NCT00320190|54719164|FG001|First 12 Months|Sponsor terminated study|2|||
28063271|NCT00320190|54719163|FG000|First 12 Months|Lost to Follow-up|0|||
28063272|NCT00320190|54719164|FG001|First 12 Months|Lost to Follow-up|1|||
28063273|NCT00320190|54719163|FG000|First 12 Months|Enrollment failure|0|||
28063274|NCT00320190|54719164|FG001|First 12 Months|Enrollment failure|1|||
28063275|NCT00320190|54719163|FG000|First 12 Months|Adverse event unrelated to study drug|1|||
28063276|NCT00320190|54719164|FG001|First 12 Months|Adverse event unrelated to study drug|0|||
28063277|NCT00320190|54719163|FG000|First 12 Months|Investigator request|0|||
28063278|NCT00320190|54719164|FG001|First 12 Months|Investigator request|1|||
28063279|NCT00320190|54719163|FG000|First 12 Months|Study drug toxicity|0|||
28063280|NCT00320190|54719164|FG001|First 12 Months|Study drug toxicity|1|||
28063281|NCT00320190|54719163|FG000|First 12 Months|Withdrawal by Subject|0|||
28063282|NCT00320190|54719164|FG001|First 12 Months|Withdrawal by Subject|1|||
28063283|NCT00320190|54719163|FG000|Long-term (12-month) Extension|Sponsor terminated study|7|||
28063284|NCT00320190|54719164|FG001|Long-term (12-month) Extension|Sponsor terminated study|0|||
28063285|NCT00320190|54719163|FG000|Long-term (12-month) Extension|Lack of major molecular response|1|||
28063286|NCT00320190|54719164|FG001|Long-term (12-month) Extension|Lack of major molecular response|2|||
28063287|NCT00320190|54719163|FG000|Long-term (12-month) Extension|Withdrawal by Subject|1|||
28063288|NCT00320190|54719164|FG001|Long-term (12-month) Extension|Withdrawal by Subject|0|||
28063289|NCT00320112|54719172|FG000|Overall Study|Lost to Follow-up|3|||
28063290|NCT00320112|54719173|FG001|Overall Study|Lost to Follow-up|4|||
28063291|NCT00320112|54719172|FG000|Overall Study|Withdrawal by Subject|3|||
28063292|NCT00320112|54719173|FG001|Overall Study|Withdrawal by Subject|0|||
28063293|NCT00320112|54719172|FG000|Overall Study|Death|2|||
28063294|NCT00320112|54719173|FG001|Overall Study|Death|1|||
28063295|NCT00319956|54719187|FG000|Overall Study|Death|20|||
28063296|NCT00319956|54719188|FG001|Overall Study|Death|24|||
28063297|NCT00349622|54719196|FG000|Overall Study|Death|168|||
28063298|NCT00349622|54719197|FG001|Overall Study|Death|86|||
28063299|NCT00349622|54719196|FG000|Overall Study|Lost to Follow-up|5|||
28063300|NCT00349622|54719197|FG001|Overall Study|Lost to Follow-up|1|||
28063301|NCT00349622|54719196|FG000|Overall Study|Withdrawal by Subject|5|||
28063302|NCT00349622|54719197|FG001|Overall Study|Withdrawal by Subject|9|||
28063303|NCT00354614|54719203|FG000|Overall Study|Lack of Efficacy|28|||
28063304|NCT00360308|54719210|FG000|Overall Study|Adverse Event|15|||
28063305|NCT00360308|54719211|FG001|Overall Study|Adverse Event|14|||
28106199|NCT03692871|54763949|FG001|Overall Study|Death|1|||
28106200|NCT03692871|54763948|FG000|Overall Study|Lost to Follow-up|24|||
28106201|NCT03692871|54763949|FG001|Overall Study|Lost to Follow-up|9|||
28106202|NCT03692871|54763948|FG000|Overall Study|Physician Decision|22|||
28106203|NCT03692871|54763949|FG001|Overall Study|Physician Decision|7|||
28106204|NCT03692871|54763948|FG000|Overall Study|Protocol Deviation|1|||
28106205|NCT03692871|54763949|FG001|Overall Study|Protocol Deviation|0|||
28106206|NCT03692871|54763948|FG000|Overall Study|Withdrawal by Parent/Guardian|77|||
28106207|NCT03692871|54763949|FG001|Overall Study|Withdrawal by Parent/Guardian|20|||
28106208|NCT04384107|54763957|FG000|Overall Study|Withdrawal By Parent/Guardian|8|||
28106209|NCT04384107|54763958|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
28106210|NCT04384107|54763957|FG000|Overall Study|Lost to Follow-up|1|||
28106211|NCT04384107|54763958|FG001|Overall Study|Lost to Follow-up|0|||
28106212|NCT04130919|54763967|FG000|Blinded Treatment Phase|Study terminated by sponsor|1|||
28106213|NCT04130919|54763968|FG001|Blinded Treatment Phase|Study terminated by sponsor|1|||
28106214|NCT04130919|54763969|FG002|Blinded Treatment Phase|Study terminated by sponsor|1|||
28106215|NCT04130919|54763970|FG003|Blinded Treatment Phase|Study terminated by sponsor|0|||
28106216|NCT04130919|54763971|FG004|Blinded Treatment Phase|Study terminated by sponsor|0|||
28106217|NCT04130919|54763972|FG005|Blinded Treatment Phase|Study terminated by sponsor|0|||
27940092|NCT01195662|54596421|FG002|Double Blind Treatment Period|Requested discontinue treatment|1|||
28063306|NCT00360308|54719212|FG002|Overall Study|Adverse Event|25|||
28063307|NCT00360308|54719210|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
28063308|NCT00360308|54719211|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
28063309|NCT00360308|54719212|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
28063310|NCT00360308|54719210|FG000|Overall Study|Protocol Violation|2|||
28063311|NCT00360308|54719211|FG001|Overall Study|Protocol Violation|1|||
28063312|NCT00360308|54719212|FG002|Overall Study|Protocol Violation|2|||
28063313|NCT00360308|54719210|FG000|Overall Study|Withdrawal by Subject|11|||
28063314|NCT00360308|54719211|FG001|Overall Study|Withdrawal by Subject|7|||
28063315|NCT00360308|54719212|FG002|Overall Study|Withdrawal by Subject|14|||
28063316|NCT00360308|54719210|FG000|Overall Study|Lack of Efficacy|3|||
28063317|NCT00360308|54719211|FG001|Overall Study|Lack of Efficacy|0|||
28063318|NCT00360308|54719212|FG002|Overall Study|Lack of Efficacy|2|||
28063319|NCT00360308|54719210|FG000|Overall Study|Other|2|||
28063320|NCT00360308|54719211|FG001|Overall Study|Other|1|||
28063321|NCT00360308|54719212|FG002|Overall Study|Other|1|||
28063322|NCT00360308|54719210|FG000|Overall Study|Study termination by sponsor|43|||
28063323|NCT00360308|54719211|FG001|Overall Study|Study termination by sponsor|55|||
28063324|NCT00360308|54719212|FG002|Overall Study|Study termination by sponsor|44|||
28063325|NCT00348686|54719224|FG000|Overall Study|Withdrawal by Subject|45|||
28063326|NCT00348686|54719224|FG000|Overall Study|Adverse Event|5|||
28063327|NCT00348686|54719224|FG000|Overall Study|Protocol Violation|6|||
28063328|NCT00348686|54719224|FG000|Overall Study|Lost to Follow-up|2|||
28063329|NCT00348686|54719224|FG000|Overall Study|Multiple Reasons|8|||
28063330|NCT00360230|54719235|FG000|Overall Study|Withdrawal by Subject|1|||
28063331|NCT00360230|54719236|FG001|Overall Study|Withdrawal by Subject|1|||
28063332|NCT00360230|54719237|FG002|Overall Study|Withdrawal by Subject|0|||
28063333|NCT00360230|54719238|FG003|Overall Study|Withdrawal by Subject|1|||
28063334|NCT00360230|54719239|FG004|Overall Study|Withdrawal by Subject|1|||
28063335|NCT00360230|54719240|FG005|Overall Study|Withdrawal by Subject|1|||
28063336|NCT00360230|54719241|FG006|Overall Study|Withdrawal by Subject|0|||
28063337|NCT00360230|54719235|FG000|Overall Study|Migrated|4|||
28063338|NCT00360230|54719236|FG001|Overall Study|Migrated|1|||
28063339|NCT00360230|54719237|FG002|Overall Study|Migrated|3|||
28063340|NCT00360230|54719238|FG003|Overall Study|Migrated|1|||
28063341|NCT00360230|54719239|FG004|Overall Study|Migrated|4|||
28063342|NCT00360230|54719240|FG005|Overall Study|Migrated|1|||
28063343|NCT00360230|54719241|FG006|Overall Study|Migrated|1|||
28063344|NCT00360230|54719235|FG000|Overall Study|Other|1|||
27815171|NCT02315703|54271948|FG003|Main Study (From Week 0 up to Week 96)|Other|2|||
28063345|NCT00360230|54719236|FG001|Overall Study|Other|0|||
28063346|NCT00360230|54719237|FG002|Overall Study|Other|0|||
28106218|NCT04130919|54763967|FG000|Blinded Treatment Phase|Adverse Event|0|||
28106219|NCT04130919|54763968|FG001|Blinded Treatment Phase|Adverse Event|0|||
28106220|NCT04130919|54763969|FG002|Blinded Treatment Phase|Adverse Event|1|||
28106221|NCT04130919|54763970|FG003|Blinded Treatment Phase|Adverse Event|0|||
28106222|NCT04130919|54763971|FG004|Blinded Treatment Phase|Adverse Event|0|||
28106223|NCT04130919|54763972|FG005|Blinded Treatment Phase|Adverse Event|0|||
28106224|NCT04130919|54763967|FG000|Blinded Treatment Phase|Disease worsening|0|||
28106225|NCT04130919|54763968|FG001|Blinded Treatment Phase|Disease worsening|0|||
28106226|NCT04130919|54763969|FG002|Blinded Treatment Phase|Disease worsening|1|||
28106227|NCT04130919|54763970|FG003|Blinded Treatment Phase|Disease worsening|0|||
28106228|NCT04130919|54763971|FG004|Blinded Treatment Phase|Disease worsening|0|||
28106229|NCT04130919|54763972|FG005|Blinded Treatment Phase|Disease worsening|0|||
28106230|NCT04130919|54763967|FG000|Blinded Treatment Phase|Investigator's decision|0|||
28106231|NCT04130919|54763968|FG001|Blinded Treatment Phase|Investigator's decision|1|||
28106232|NCT04130919|54763969|FG002|Blinded Treatment Phase|Investigator's decision|0|||
28106233|NCT04130919|54763970|FG003|Blinded Treatment Phase|Investigator's decision|0|||
28106234|NCT04130919|54763971|FG004|Blinded Treatment Phase|Investigator's decision|0|||
28106235|NCT04130919|54763972|FG005|Blinded Treatment Phase|Investigator's decision|0|||
28106236|NCT04130919|54763967|FG000|Blinded Treatment Phase|Withdrew consent|1|||
28106237|NCT04130919|54763968|FG001|Blinded Treatment Phase|Withdrew consent|0|||
28106238|NCT04130919|54763969|FG002|Blinded Treatment Phase|Withdrew consent|0|||
28106239|NCT04130919|54763970|FG003|Blinded Treatment Phase|Withdrew consent|0|||
28106240|NCT04130919|54763971|FG004|Blinded Treatment Phase|Withdrew consent|0|||
28106241|NCT04130919|54763972|FG005|Blinded Treatment Phase|Withdrew consent|0|||
28106242|NCT04130919|54763967|FG000|Open-label Treatment Phase|Withdrew consent|0|||
28063347|NCT00360230|54719238|FG003|Overall Study|Other|0|||
28063348|NCT00360230|54719239|FG004|Overall Study|Other|0|||
28063349|NCT00360230|54719240|FG005|Overall Study|Other|0|||
28063350|NCT00360230|54719241|FG006|Overall Study|Other|0|||
28063351|NCT00360230|54719235|FG000|Overall Study|Protocol Violation|0|||
28063352|NCT00360230|54719236|FG001|Overall Study|Protocol Violation|0|||
28063353|NCT00360230|54719237|FG002|Overall Study|Protocol Violation|0|||
28063354|NCT00360230|54719238|FG003|Overall Study|Protocol Violation|0|||
28063355|NCT00360230|54719239|FG004|Overall Study|Protocol Violation|0|||
28063356|NCT00360230|54719240|FG005|Overall Study|Protocol Violation|1|||
28063357|NCT00360230|54719241|FG006|Overall Study|Protocol Violation|0|||
28063358|NCT00360230|54719235|FG000|Overall Study|Death|0|||
28063359|NCT00360230|54719236|FG001|Overall Study|Death|1|||
28063360|NCT00360230|54719237|FG002|Overall Study|Death|0|||
28063361|NCT00360230|54719238|FG003|Overall Study|Death|0|||
28063362|NCT00360230|54719239|FG004|Overall Study|Death|0|||
28063363|NCT00360230|54719240|FG005|Overall Study|Death|1|||
28063364|NCT00360230|54719241|FG006|Overall Study|Death|1|||
28063365|NCT00348374|54719261|FG000|Overall Study|Adverse Event|1|||
28063366|NCT00348374|54719262|FG001|Overall Study|Adverse Event|4|||
28063367|NCT00348374|54719261|FG000|Overall Study|Lost to Follow-up|1|||
28063368|NCT00348374|54719262|FG001|Overall Study|Lost to Follow-up|3|||
28063369|NCT00348374|54719261|FG000|Overall Study|Withdrawal by Subject|5|||
28063370|NCT00348374|54719262|FG001|Overall Study|Withdrawal by Subject|5|||
28063371|NCT00348374|54719261|FG000|Overall Study|Other|11|||
28063372|NCT00348374|54719262|FG001|Overall Study|Other|12|||
28063373|NCT00348374|54719261|FG000|Overall Study|ongoing at date of cutoff|1|||
28063374|NCT00348374|54719262|FG001|Overall Study|ongoing at date of cutoff|1|||
28063375|NCT00348374|54719261|FG000|Overall Study|randomized but did not receive treatment|0|||
28063376|NCT00348374|54719262|FG001|Overall Study|randomized but did not receive treatment|7|||
28063377|NCT00353366|54719269|FG000|Overall Study|Adverse Event|8|||
28106243|NCT04130919|54763968|FG001|Open-label Treatment Phase|Withdrew consent|0|||
28106244|NCT04130919|54763969|FG002|Open-label Treatment Phase|Withdrew consent|0|||
28106245|NCT04130919|54763970|FG003|Open-label Treatment Phase|Withdrew consent|1|||
28106246|NCT04130919|54763971|FG004|Open-label Treatment Phase|Withdrew consent|1|||
28063378|NCT00353366|54719269|FG000|Overall Study|Protocol Violation|12|||
28063379|NCT00353366|54719269|FG000|Overall Study|Withdrawal by Subject|12|||
28063380|NCT00353366|54719269|FG000|Overall Study|Lost to Follow-up|92|||
28063381|NCT00353366|54719269|FG000|Overall Study|Other|19|||
28063382|NCT00352664|54719275|FG000|Overall Study|Withdrawal by Subject|7|||
28063383|NCT00352664|54719276|FG001|Overall Study|Withdrawal by Subject|0|||
28063384|NCT00490139|54719286|FG000|Overall Study|Death|106|||
28063385|NCT00490139|54719287|FG001|Overall Study|Death|119|||
28063386|NCT00490139|54719288|FG002|Overall Study|Death|168|||
28063387|NCT00490139|54719289|FG003|Overall Study|Death|135|||
28063388|NCT00490139|54719286|FG000|Overall Study|Lost to Follow-up|56|||
28063389|NCT00490139|54719287|FG001|Overall Study|Lost to Follow-up|46|||
28063390|NCT00490139|54719288|FG002|Overall Study|Lost to Follow-up|58|||
28063391|NCT00490139|54719289|FG003|Overall Study|Lost to Follow-up|56|||
28106247|NCT04130919|54763972|FG005|Open-label Treatment Phase|Withdrew consent|1|||
28106248|NCT04130919|54763967|FG000|Open-label Treatment Phase|Disease worsening|0|||
28106249|NCT04130919|54763968|FG001|Open-label Treatment Phase|Disease worsening|0|||
28106250|NCT04130919|54763969|FG002|Open-label Treatment Phase|Disease worsening|0|||
28106251|NCT04130919|54763970|FG003|Open-label Treatment Phase|Disease worsening|1|||
28106252|NCT04130919|54763971|FG004|Open-label Treatment Phase|Disease worsening|0|||
28106253|NCT04130919|54763972|FG005|Open-label Treatment Phase|Disease worsening|1|||
28106254|NCT04130919|54763967|FG000|Open-label Treatment Phase|Investigator's decision|0|||
28106255|NCT04130919|54763968|FG001|Open-label Treatment Phase|Investigator's decision|0|||
28106256|NCT04130919|54763969|FG002|Open-label Treatment Phase|Investigator's decision|0|||
28106257|NCT04130919|54763970|FG003|Open-label Treatment Phase|Investigator's decision|1|||
28106258|NCT04130919|54763971|FG004|Open-label Treatment Phase|Investigator's decision|0|||
28106259|NCT04130919|54763972|FG005|Open-label Treatment Phase|Investigator's decision|0|||
28106260|NCT04130919|54763967|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
28106261|NCT04130919|54763968|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
28106262|NCT04130919|54763969|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
28106263|NCT04130919|54763970|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
28106264|NCT04130919|54763971|FG004|Open-label Treatment Phase|Lost to Follow-up|0|||
28106265|NCT04130919|54763972|FG005|Open-label Treatment Phase|Lost to Follow-up|1|||
28106266|NCT04130919|54763967|FG000|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
28106267|NCT04130919|54763968|FG001|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
28106268|NCT04130919|54763969|FG002|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
28106269|NCT04130919|54763970|FG003|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
28106270|NCT04130919|54763971|FG004|Open-label Treatment Phase|MCS response not achieved at open-label week 10|1|||
28106271|NCT04130919|54763972|FG005|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
28106272|NCT04128267|54763986|FG000|Overall Study|Withdrawal by Subject|6|||
28106273|NCT04128267|54763986|FG000|Overall Study|Death|2|||
28106274|NCT04128267|54763986|FG000|Overall Study|Disease progression|1|||
28106275|NCT04128267|54763986|FG000|Overall Study|Participant had other medical issues|4|||
28106276|NCT04128267|54763986|FG000|Overall Study|Participant failed to respond to multiple attempts to contact|2|||
28106277|NCT03691779|54763990|FG000|Part B (24 Weeks)|Adverse Event|0|||
28106278|NCT03691779|54763991|FG001|Part B (24 Weeks)|Adverse Event|1|||
28106279|NCT03691779|54763990|FG000|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|0|||
28106280|NCT03691779|54763991|FG001|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|1|||
28106281|NCT04258995|54764000|FG000|Overall Study|Lost to Follow-up|1|||
28106282|NCT04258995|54764001|FG001|Overall Study|Lost to Follow-up|1|||
28106283|NCT04247061|54764007|FG000|Overall Study|Could not attend dental clinic visit due to state mandated closure due to Covid-19 pandemic|6|||
27848358|NCT00983437|54341335|FG000|Overall Study|Adverse Event|9|||
27848359|NCT00983437|54341335|FG000|Overall Study|Lack of Efficacy|1|||
27848360|NCT00983437|54341335|FG000|Overall Study|Withdrawal by Subject|8|||
27848361|NCT00983437|54341335|FG000|Overall Study|Noncompliance to Study Procedures|1|||
28063392|NCT00490139|54719286|FG000|Overall Study|Participant Withdrew Consent|146|||
28063393|NCT00490139|54719287|FG001|Overall Study|Participant Withdrew Consent|110|||
28063394|NCT00490139|54719288|FG002|Overall Study|Participant Withdrew Consent|208|||
28063395|NCT00490139|54719289|FG003|Overall Study|Participant Withdrew Consent|116|||
28063396|NCT00348140|54719304|FG000|Overall Study|Adverse Event|46|||
28063397|NCT00348140|54719305|FG001|Overall Study|Adverse Event|49|||
28063398|NCT00348140|54719306|FG002|Overall Study|Adverse Event|78|||
28063399|NCT00348140|54719304|FG000|Overall Study|Lost to Follow-up|4|||
28063400|NCT00348140|54719305|FG001|Overall Study|Lost to Follow-up|4|||
28063401|NCT00348140|54719306|FG002|Overall Study|Lost to Follow-up|4|||
28106284|NCT04247061|54764007|FG000|Overall Study|Subjects canceled their dental hygiene appt. (& thus the research visit) due to Covid-19 concerns|2|||
28106285|NCT04247061|54764007|FG000|Overall Study|Participant indicated inability to wear VR headset at dental appt.|1|||
28106286|NCT04241133|54764013|FG000|Overall Study|COVID19 Precautions|14|||
28106287|NCT04241133|54764014|FG001|Overall Study|COVID19 Precautions|34|||
28106288|NCT04123665|54764022|FG000|Overall Study|Withdrawal by Subject|7|||
28106289|NCT04123665|54764023|FG001|Overall Study|Withdrawal by Subject|0|||
28106290|NCT04123665|54764022|FG000|Overall Study|Lost to Follow-up|1|||
28106291|NCT04123665|54764023|FG001|Overall Study|Lost to Follow-up|0|||
28063402|NCT00348140|54719304|FG000|Overall Study|Protocol Violation|12|||
28063403|NCT00348140|54719305|FG001|Overall Study|Protocol Violation|13|||
28063404|NCT00348140|54719306|FG002|Overall Study|Protocol Violation|14|||
28063405|NCT00348140|54719304|FG000|Overall Study|Withdrawal by Subject|32|||
28063406|NCT00348140|54719305|FG001|Overall Study|Withdrawal by Subject|40|||
28063407|NCT00348140|54719306|FG002|Overall Study|Withdrawal by Subject|40|||
28063408|NCT00348140|54719304|FG000|Overall Study|Non-compliance|8|||
28063409|NCT00348140|54719305|FG001|Overall Study|Non-compliance|13|||
28063410|NCT00348140|54719306|FG002|Overall Study|Non-compliance|5|||
28063411|NCT00348140|54719304|FG000|Overall Study|Participant at risk due to study drug|2|||
28063412|NCT00348140|54719305|FG001|Overall Study|Participant at risk due to study drug|0|||
28063413|NCT00348140|54719306|FG002|Overall Study|Participant at risk due to study drug|0|||
28063414|NCT00348140|54719304|FG000|Overall Study|Conditional medication increased dose|1|||
28063415|NCT00348140|54719305|FG001|Overall Study|Conditional medication increased dose|0|||
28063416|NCT00348140|54719306|FG002|Overall Study|Conditional medication increased dose|0|||
28106292|NCT04232943|54764032|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
28106293|NCT04232943|54764033|FG001|Overall Study|Enrolled but Treatment not Administered|3|||
28063417|NCT00348140|54719304|FG000|Overall Study|Caregiver related|4|||
28106294|NCT04232943|54764034|FG002|Overall Study|Enrolled but Treatment not Administered|2|||
28106295|NCT04232943|54764032|FG000|Overall Study|Withdrawal by Subject|1|||
28106296|NCT04232943|54764033|FG001|Overall Study|Withdrawal by Subject|1|||
28106297|NCT04232943|54764034|FG002|Overall Study|Withdrawal by Subject|0|||
28106298|NCT03694275|54764045|FG000|Overall Study|Adverse Event|0|||
28106299|NCT03694275|54764046|FG001|Overall Study|Adverse Event|1|||
28106300|NCT03694275|54764045|FG000|Overall Study|Reason not Specified|0|||
28106301|NCT03694275|54764046|FG001|Overall Study|Reason not Specified|1|||
28106302|NCT04230213|54764053|FG000|TP1: Week 0 (Day 1) to Week 10|Other|8|||
28106303|NCT04230213|54764054|FG001|TP1: Week 0 (Day 1) to Week 10|Other|0|||
28106304|NCT04230213|54764055|FG002|TP1: Week 0 (Day 1) to Week 10|Other|0|||
28106305|NCT04230213|54764053|FG000|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|7|||
28106306|NCT04230213|54764054|FG001|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
28106307|NCT04230213|54764055|FG002|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
28106308|NCT04230213|54764053|FG000|TP1: Week 0 (Day 1) to Week 10|Physician Decision|3|||
28106309|NCT04230213|54764054|FG001|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
28106310|NCT04230213|54764055|FG002|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
28106311|NCT04230213|54764053|FG000|TP2: Week 10 to Week 16|Other|0|||
28106312|NCT04230213|54764054|FG001|TP2: Week 10 to Week 16|Other|2|||
28106313|NCT04230213|54764055|FG002|TP2: Week 10 to Week 16|Other|1|||
28106314|NCT04230213|54764053|FG000|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
28106315|NCT04230213|54764054|FG001|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
28106316|NCT04230213|54764055|FG002|TP2: Week 10 to Week 16|Withdrawal by Subject|2|||
28106317|NCT04230213|54764053|FG000|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
28106318|NCT04230213|54764054|FG001|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
28106319|NCT04230213|54764055|FG002|TP3: Week 16 to Week 22|Lost to Follow-up|1|||
28106320|NCT04230213|54764053|FG000|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
28106321|NCT04230213|54764054|FG001|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
28106322|NCT04230213|54764055|FG002|TP3: Week 16 to Week 22|Withdrawal by Subject|2|||
28106323|NCT04230213|54764053|FG000|TP3: Week 16 to Week 22|Physician Decision|0|||
28106324|NCT04230213|54764054|FG001|TP3: Week 16 to Week 22|Physician Decision|0|||
28106325|NCT04230213|54764055|FG002|TP3: Week 16 to Week 22|Physician Decision|1|||
28106326|NCT04230213|54764053|FG000|TP3: Week 16 to Week 22|Other|0|||
28106327|NCT04230213|54764054|FG001|TP3: Week 16 to Week 22|Other|1|||
28106328|NCT04230213|54764055|FG002|TP3: Week 16 to Week 22|Other|3|||
28106329|NCT04230213|54764053|FG000|TP4: Week 22 to Week 32|Other|0|||
27815172|NCT02315703|54271949|FG004|Main Study (From Week 0 up to Week 96)|Other|1|||
27848362|NCT00983437|54341335|FG000|Overall Study|Lost to Follow-up|2|||
28063418|NCT00348140|54719305|FG001|Overall Study|Caregiver related|7|||
28063419|NCT00348140|54719306|FG002|Overall Study|Caregiver related|3|||
28063420|NCT00348140|54719304|FG000|Overall Study|Participant hospitalised|3|||
28063421|NCT00348140|54719305|FG001|Overall Study|Participant hospitalised|0|||
28063422|NCT00348140|54719306|FG002|Overall Study|Participant hospitalised|0|||
28106330|NCT04230213|54764054|FG001|TP4: Week 22 to Week 32|Other|5|||
28106331|NCT04230213|54764055|FG002|TP4: Week 22 to Week 32|Other|5|||
28106332|NCT04230213|54764053|FG000|TP4: Week 22 to Week 32|Withdrawal by Subject|0|||
28106333|NCT04230213|54764054|FG001|TP4: Week 22 to Week 32|Withdrawal by Subject|1|||
28106334|NCT04230213|54764055|FG002|TP4: Week 22 to Week 32|Withdrawal by Subject|2|||
28106335|NCT04230213|54764053|FG000|TP4: Week 22 to Week 32|Physician Decision|0|||
28106336|NCT04230213|54764054|FG001|TP4: Week 22 to Week 32|Physician Decision|2|||
28106337|NCT04230213|54764055|FG002|TP4: Week 22 to Week 32|Physician Decision|1|||
28106338|NCT04230213|54764053|FG000|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
28106339|NCT04230213|54764054|FG001|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
28106340|NCT04230213|54764055|FG002|Follow up: Week 32 to Week 36|Withdrawal by Subject|1|||
28106341|NCT04230213|54764053|FG000|Follow up: Week 32 to Week 36|Other|0|||
28106342|NCT04230213|54764054|FG001|Follow up: Week 32 to Week 36|Other|1|||
28106343|NCT04230213|54764055|FG002|Follow up: Week 32 to Week 36|Other|1|||
28106344|NCT04222725|54764067|FG000|Overall Study|Adverse Event|0|||
28106345|NCT04222725|54764068|FG001|Overall Study|Adverse Event|1|||
28106346|NCT04222725|54764069|FG002|Overall Study|Adverse Event|0|||
28106347|NCT04222725|54764070|FG003|Overall Study|Adverse Event|0|||
28106348|NCT04213989|54764082|FG000|Overall Study|Withdrawal by Subject|3|||
28106349|NCT04213989|54764083|FG001|Overall Study|Withdrawal by Subject|2|||
28106350|NCT04213989|54764082|FG000|Overall Study|Physician Decision|1|||
28106351|NCT04213989|54764083|FG001|Overall Study|Physician Decision|0|||
28106352|NCT04213989|54764082|FG000|Overall Study|Lost to Follow-up|0|||
28106353|NCT04213989|54764083|FG001|Overall Study|Lost to Follow-up|4|||
28106354|NCT03242252|54764092|FG000|Overall Study|At the Participant's own Request|18|||
28106355|NCT03242252|54764093|FG001|Overall Study|At the Participant's own Request|10|||
28106356|NCT03242252|54764094|FG002|Overall Study|At the Participant's own Request|15|||
28106357|NCT03242252|54764092|FG000|Overall Study|Adverse Event|8|||
28106358|NCT03242252|54764093|FG001|Overall Study|Adverse Event|6|||
28106359|NCT03242252|54764094|FG002|Overall Study|Adverse Event|9|||
28106360|NCT03242252|54764092|FG000|Overall Study|Poor Compliance to Protocol|0|||
28106361|NCT03242252|54764093|FG001|Overall Study|Poor Compliance to Protocol|2|||
28106362|NCT03242252|54764094|FG002|Overall Study|Poor Compliance to Protocol|3|||
28106363|NCT03242252|54764092|FG000|Overall Study|Study Terminated by Sponsor|1|||
28106364|NCT03242252|54764093|FG001|Overall Study|Study Terminated by Sponsor|0|||
28106365|NCT03242252|54764094|FG002|Overall Study|Study Terminated by Sponsor|0|||
28106366|NCT03242252|54764092|FG000|Overall Study|Reason not Specified|4|||
28106367|NCT03242252|54764093|FG001|Overall Study|Reason not Specified|4|||
28106368|NCT03242252|54764094|FG002|Overall Study|Reason not Specified|1|||
28106369|NCT03242252|54764092|FG000|Overall Study|Lost to Follow-up|5|||
28106370|NCT03242252|54764093|FG001|Overall Study|Lost to Follow-up|1|||
28106371|NCT03242252|54764094|FG002|Overall Study|Lost to Follow-up|4|||
28106372|NCT04109391|54764111|FG000|Overall Study|Adverse Event|2|||
28106373|NCT04109391|54764112|FG001|Overall Study|Adverse Event|2|||
28106374|NCT04109391|54764113|FG002|Overall Study|Adverse Event|0|||
28106375|NCT04109391|54764111|FG000|Overall Study|Withdrawal by Subject|2|||
28106376|NCT04109391|54764112|FG001|Overall Study|Withdrawal by Subject|0|||
28106377|NCT04109391|54764113|FG002|Overall Study|Withdrawal by Subject|0|||
27815173|NCT02315703|54271950|FG005|Main Study (From Week 0 up to Week 96)|Other|2|||
27815174|NCT02315703|54271951|FG006|Main Study (From Week 0 up to Week 96)|Other|8|||
27815175|NCT02315703|54271952|FG007|Main Study (From Week 0 up to Week 96)|Other|2|||
28063423|NCT00348140|54719304|FG000|Overall Study|Efficacy related|1|||
28063424|NCT00348140|54719305|FG001|Overall Study|Efficacy related|1|||
28063425|NCT00348140|54719306|FG002|Overall Study|Efficacy related|0|||
28063426|NCT00348140|54719304|FG000|Overall Study|Administration related|3|||
28063427|NCT00348140|54719305|FG001|Overall Study|Administration related|1|||
28063428|NCT00348140|54719306|FG002|Overall Study|Administration related|1|||
28063429|NCT00348140|54719304|FG000|Overall Study|Unmet inclusion-exclusion criteria|1|||
28063430|NCT00348140|54719305|FG001|Overall Study|Unmet inclusion-exclusion criteria|0|||
28063431|NCT00348140|54719306|FG002|Overall Study|Unmet inclusion-exclusion criteria|1|||
28063432|NCT00348140|54719304|FG000|Overall Study|Participant unwell|1|||
28063433|NCT00348140|54719305|FG001|Overall Study|Participant unwell|0|||
28063434|NCT00348140|54719306|FG002|Overall Study|Participant unwell|0|||
28063435|NCT00348140|54719304|FG000|Overall Study|Screen failure|1|||
28063436|NCT00348140|54719305|FG001|Overall Study|Screen failure|0|||
28063437|NCT00348140|54719306|FG002|Overall Study|Screen failure|0|||
28063438|NCT00348140|54719304|FG000|Overall Study|Investigator decided to discontinue|4|||
27815176|NCT02315703|54271945|FG000|LTE (After Week 96 up to Week 336)|Lost to Follow-up|1|||
27815177|NCT02315703|54271946|FG001|LTE (After Week 96 up to Week 336)|Lost to Follow-up|2|||
28106378|NCT04109391|54764111|FG000|Overall Study|Pregnancy|1|||
28106379|NCT04109391|54764112|FG001|Overall Study|Pregnancy|0|||
28106380|NCT04109391|54764113|FG002|Overall Study|Pregnancy|0|||
28106381|NCT04109391|54764111|FG000|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|3|||
28106382|NCT04109391|54764112|FG001|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|1|||
28106383|NCT04109391|54764113|FG002|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|0|||
28106384|NCT04109391|54764111|FG000|Overall Study|Lost to Follow-up|0|||
28106385|NCT04109391|54764112|FG001|Overall Study|Lost to Follow-up|0|||
28106386|NCT04109391|54764113|FG002|Overall Study|Lost to Follow-up|1|||
28106387|NCT04109391|54764111|FG000|Overall Study|Lack of Efficacy|2|||
28106388|NCT04109391|54764112|FG001|Overall Study|Lack of Efficacy|2|||
28106389|NCT04109391|54764113|FG002|Overall Study|Lack of Efficacy|3|||
28106390|NCT04106817|54764124|FG000|Overall Study|Lost to Follow-up|1|||
28106391|NCT04106817|54764125|FG001|Overall Study|Lost to Follow-up|0|||
28106392|NCT04106817|54764126|FG002|Overall Study|Lost to Follow-up|0|||
28106393|NCT04097925|54764134|FG000|Overall Study|Withdrawal by Subject|1|||
28106394|NCT04195893|54764138|FG000|Second Intervention|Withdrawal by Subject|1|||
28106395|NCT04195893|54764139|FG001|Second Intervention|Withdrawal by Subject|0|||
28106396|NCT04195581|54764145|FG000|Comfilcon A With All in One Light|Withdrawal by Subject|4|||
28106397|NCT04195581|54764145|FG000|Comfilcon A With Hy-Care|Withdrawal by Subject|5|||
28106398|NCT04195581|54764145|FG000|Comfilcon A With Refine One Step|Withdrawal by Subject|1|||
28106399|NCT04195581|54764145|FG000|Fanfilcon A With All in One Light|Withdrawal by Subject|1|||
28106400|NCT04195581|54764145|FG000|Fanfilcon A With Hy-Care|Withdrawal by Subject|3|||
28106401|NCT04195581|54764145|FG000|Fanfilcon A With Refine One Step|Withdrawal by Subject|2|||
28106402|NCT04096365|54764163|FG000|Overall Study|Adverse Event|1|||
28106403|NCT04194489|54764167|FG000|Overall Study|Withdrawal by Subject|5|||
28106404|NCT04194489|54764167|FG000|Overall Study|Lost to Follow-up|48|||
28106405|NCT04094883|54764171|FG000|Overall Study|Withdrawal by Subject|1|||
28106406|NCT01368562|54764175|FG000|Overall Study|Adverse Event|1|||
28106407|NCT01368562|54764175|FG000|Overall Study|Disease progression|1|||
28106408|NCT01368562|54764175|FG000|Overall Study|Lost to Follow-up|1|||
28106409|NCT01368562|54764175|FG000|Overall Study|Death|6|||
28106410|NCT01368562|54764175|FG000|Overall Study|Unresponsive to treatment|5|||
28106411|NCT01368562|54764175|FG000|Overall Study|Other|3|||
28106412|NCT01368562|54764175|FG000|Overall Study|Other than specified|2|||
28106413|NCT03242018|54764182|FG000|Overall Study|Adverse Event|7|||
28106414|NCT03242018|54764183|FG001|Overall Study|Adverse Event|7|||
28106415|NCT03242018|54764184|FG002|Overall Study|Adverse Event|6|||
28106416|NCT03242018|54764182|FG000|Overall Study|Lost to Follow-up|2|||
28106417|NCT03242018|54764183|FG001|Overall Study|Lost to Follow-up|2|||
28106418|NCT03242018|54764184|FG002|Overall Study|Lost to Follow-up|2|||
28106419|NCT03242018|54764182|FG000|Overall Study|At the Participant's Own Request|5|||
28106420|NCT03242018|54764183|FG001|Overall Study|At the Participant's Own Request|1|||
28106421|NCT03242018|54764184|FG002|Overall Study|At the Participant's Own Request|4|||
28106422|NCT03242018|54764182|FG000|Overall Study|Reason Not Specified|3|||
28106423|NCT03242018|54764183|FG001|Overall Study|Reason Not Specified|4|||
28106424|NCT03242018|54764184|FG002|Overall Study|Reason Not Specified|1|||
28106425|NCT03242018|54764182|FG000|Overall Study|Study Terminated by Sponsor|1|||
28106426|NCT03242018|54764183|FG001|Overall Study|Study Terminated by Sponsor|0|||
28106427|NCT03242018|54764184|FG002|Overall Study|Study Terminated by Sponsor|1|||
28106428|NCT02789176|54764197|FG000|Overall Study|Death|0|||
28106429|NCT02789176|54764198|FG001|Overall Study|Death|0|||
28106430|NCT02789176|54764199|FG002|Overall Study|Death|3|||
28106431|NCT02789176|54764200|FG003|Overall Study|Death|0|||
28106432|NCT02789176|54764197|FG000|Overall Study|Withdrawal by Subject|0|||
28106433|NCT02789176|54764198|FG001|Overall Study|Withdrawal by Subject|0|||
27848363|NCT00983437|54341335|FG000|Overall Study|Other Reason|26|||
27848364|NCT01042977|54341341|FG000|Overall Study|Adverse Event|4|||
27848365|NCT01042977|54341342|FG001|Overall Study|Adverse Event|12|||
27848366|NCT01042977|54341341|FG000|Overall Study|Death|2|||
27848367|NCT01042977|54341342|FG001|Overall Study|Death|1|||
27848368|NCT01042977|54341341|FG000|Overall Study|Withdrawal by Subject|8|||
27848369|NCT01042977|54341342|FG001|Overall Study|Withdrawal by Subject|16|||
27848370|NCT01042977|54341341|FG000|Overall Study|Lost to Follow-up|0|||
27848371|NCT01042977|54341342|FG001|Overall Study|Lost to Follow-up|2|||
28106434|NCT02789176|54764199|FG002|Overall Study|Withdrawal by Subject|1|||
28106435|NCT02789176|54764200|FG003|Overall Study|Withdrawal by Subject|0|||
28106436|NCT02789176|54764197|FG000|Overall Study|Lost to Follow-up|8|||
28106437|NCT02789176|54764198|FG001|Overall Study|Lost to Follow-up|2|||
27848372|NCT01042977|54341341|FG000|Overall Study|Poor/non-compliance|3|||
28106438|NCT02789176|54764199|FG002|Overall Study|Lost to Follow-up|6|||
28106439|NCT02789176|54764200|FG003|Overall Study|Lost to Follow-up|1|||
28106440|NCT03259490|54764212|FG000|Period 1|Withdrawal by Subject|0|||
28106441|NCT03259490|54764213|FG001|Period 1|Withdrawal by Subject|1|||
27848373|NCT01042977|54341342|FG001|Overall Study|Poor/non-compliance|4|||
28106442|NCT03259490|54764212|FG000|Period 2|Protocol Violation|1|||
28106443|NCT03259490|54764213|FG001|Period 2|Protocol Violation|0|||
28106444|NCT03259334|54764222|FG000|Overall Study|Adverse Event|3|||
28106445|NCT03259334|54764223|FG001|Overall Study|Adverse Event|8|||
28106446|NCT03259334|54764224|FG002|Overall Study|Adverse Event|5|||
28106447|NCT03259334|54764222|FG000|Overall Study|Withdrawal by Subject|4|||
28106448|NCT03259334|54764223|FG001|Overall Study|Withdrawal by Subject|2|||
28106449|NCT03259334|54764224|FG002|Overall Study|Withdrawal by Subject|4|||
28106450|NCT03259334|54764222|FG000|Overall Study|Physician Decision|1|||
28106451|NCT03259334|54764223|FG001|Overall Study|Physician Decision|0|||
28106452|NCT03259334|54764224|FG002|Overall Study|Physician Decision|0|||
28106453|NCT03259334|54764222|FG000|Overall Study|Lost to Follow-up|0|||
28106454|NCT03259334|54764223|FG001|Overall Study|Lost to Follow-up|2|||
27815178|NCT02315703|54271947|FG002|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
27815179|NCT02315703|54271948|FG003|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
27815180|NCT02315703|54271949|FG004|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
27815181|NCT02315703|54271950|FG005|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
27815182|NCT02315703|54271951|FG006|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
27815183|NCT02315703|54271952|FG007|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
27815184|NCT02315703|54271945|FG000|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
27815185|NCT02315703|54271946|FG001|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|3|||
27815186|NCT02315703|54271947|FG002|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
27815187|NCT02315703|54271948|FG003|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
27815188|NCT02315703|54271949|FG004|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
27815189|NCT02315703|54271950|FG005|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
27815190|NCT02315703|54271951|FG006|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
27815191|NCT02315703|54271952|FG007|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
27815192|NCT02315703|54271945|FG000|LTE (After Week 96 up to Week 336)|Other|1|||
27815193|NCT02315703|54271946|FG001|LTE (After Week 96 up to Week 336)|Other|0|||
27815194|NCT02315703|54271947|FG002|LTE (After Week 96 up to Week 336)|Other|0|||
27815195|NCT02315703|54271948|FG003|LTE (After Week 96 up to Week 336)|Other|0|||
27815196|NCT02315703|54271949|FG004|LTE (After Week 96 up to Week 336)|Other|0|||
27815197|NCT02315703|54271950|FG005|LTE (After Week 96 up to Week 336)|Other|0|||
27815198|NCT02315703|54271951|FG006|LTE (After Week 96 up to Week 336)|Other|0|||
27815199|NCT02315703|54271952|FG007|LTE (After Week 96 up to Week 336)|Other|0|||
27815200|NCT02125461|54271972|FG000|Overall Study|Withdrawal by Subject|30|||
27815201|NCT02125461|54271973|FG001|Overall Study|Withdrawal by Subject|16|||
27815202|NCT02125461|54271972|FG000|Overall Study|Lost to Follow-up|8|||
27815203|NCT02125461|54271973|FG001|Overall Study|Lost to Follow-up|3|||
27815204|NCT02125461|54271972|FG000|Overall Study|Death|260|||
27815205|NCT02125461|54271973|FG001|Overall Study|Death|149|||
27815206|NCT02125461|54271972|FG000|Overall Study|Missing Termination Reason|0|||
27815207|NCT02125461|54271973|FG001|Overall Study|Missing Termination Reason|1|||
27815208|NCT02049359|54271981|FG000|Overall Study|Lost to Follow-up|26|||
27815209|NCT02049359|54271982|FG001|Overall Study|Lost to Follow-up|19|||
27815210|NCT01933932|54272010|FG000|Overall Study|Death|173|||
27815211|NCT01933932|54272011|FG001|Overall Study|Death|163|||
27815212|NCT01933932|54272010|FG000|Overall Study|Withdrawal by Subject|11|||
27815213|NCT01933932|54272011|FG001|Overall Study|Withdrawal by Subject|14|||
27815214|NCT01933932|54272010|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
27815215|NCT01933932|54272011|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
27815216|NCT01828112|54272023|FG000|Overall Study|Adverse Event|6|||
27815217|NCT01828112|54272024|FG001|Overall Study|Adverse Event|8|||
27815218|NCT01828112|54272023|FG000|Overall Study|Death|9|||
27815219|NCT01828112|54272024|FG001|Overall Study|Death|5|||
27815220|NCT01828112|54272023|FG000|Overall Study|Physician Decision|5|||
27815221|NCT01828112|54272024|FG001|Overall Study|Physician Decision|5|||
27815222|NCT01828112|54272023|FG000|Overall Study|Progressive disease|56|||
27815223|NCT01828112|54272024|FG001|Overall Study|Progressive disease|82|||
27815224|NCT01828112|54272023|FG000|Overall Study|Subject/guardian decision|6|||
27815225|NCT01828112|54272024|FG001|Overall Study|Subject/guardian decision|8|||
27815226|NCT01698905|54272030|FG000|Overall Study|Adverse Event|4|||
27815227|NCT01698905|54272030|FG000|Overall Study|Physician Decision|2|||
27815228|NCT01698905|54272030|FG000|Overall Study|Pregnancy|1|||
27815229|NCT01698905|54272030|FG000|Overall Study|Protocol Violation|1|||
27815230|NCT01698905|54272030|FG000|Overall Study|Subject/guardian decision|2|||
27815231|NCT01698905|54272030|FG000|Overall Study|Death|1|||
27815232|NCT01466686|54272041|FG000|Overall Study|Withdrawal by Subject|1|||
27815233|NCT01550289|54272047|FG000|Overall Study|Protocol Violation|1|||
27815234|NCT01550289|54272048|FG001|Overall Study|Protocol Violation|0|||
27815235|NCT01550289|54272047|FG000|Overall Study|Lost to Follow-up|1|||
27815236|NCT01550289|54272048|FG001|Overall Study|Lost to Follow-up|1|||
27815237|NCT01550289|54272047|FG000|Overall Study|Withdrawal by Subject|11|||
27815238|NCT01550289|54272048|FG001|Overall Study|Withdrawal by Subject|3|||
27815239|NCT01968031|54272059|FG000|Overall Study|Adverse Event|13|||
28106455|NCT03259334|54764224|FG002|Overall Study|Lost to Follow-up|1|||
28106456|NCT03259334|54764222|FG000|Overall Study|Protocol Deviation|0|||
28106457|NCT03259334|54764223|FG001|Overall Study|Protocol Deviation|3|||
28106458|NCT03259334|54764224|FG002|Overall Study|Protocol Deviation|2|||
28106459|NCT03259334|54764222|FG000|Overall Study|Lack of Efficacy|2|||
28106460|NCT03259334|54764223|FG001|Overall Study|Lack of Efficacy|0|||
28106461|NCT03259334|54764224|FG002|Overall Study|Lack of Efficacy|1|||
28106462|NCT03259334|54764222|FG000|Overall Study|Randomized but never treated|0|||
28106463|NCT03259334|54764223|FG001|Overall Study|Randomized but never treated|2|||
28106464|NCT03259334|54764224|FG002|Overall Study|Randomized but never treated|0|||
28106465|NCT01331824|54764232|FG000|Overall Study|Adverse Event|2|||
28106466|NCT01331824|54764232|FG000|Overall Study|Death|1|||
28106467|NCT01331824|54764232|FG000|Overall Study|Disease Progression|9|||
28106468|NCT01331824|54764232|FG000|Overall Study|Withdrawal by Subject|1|||
28106469|NCT03258710|54764236|FG000|Overall Study|Adverse Event|1|||
28106470|NCT03258710|54764236|FG000|Overall Study|Protocol-defined stopping criteria|1|||
28106471|NCT03258710|54764236|FG000|Overall Study|Physician Decision|1|||
28106472|NCT03240692|54764240|FG000|Overall Study|Physician Decision|1|||
28106473|NCT03240692|54764240|FG000|Overall Study|Withdrawal by Subject|1|||
28106474|NCT03233048|54764244|FG000|Overall Study|Withdrawal by Subject|1|||
28106475|NCT02937740|54764250|FG000|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3|||
28106476|NCT02937740|54764251|FG001|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14|||
28106477|NCT02937740|54764250|FG000|BID for 90 Days, 22 mg/Day|Adverse Event|0|||
28106478|NCT02937740|54764251|FG001|BID for 90 Days, 22 mg/Day|Adverse Event|10|||
28106479|NCT02937740|54764250|FG000|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2|||
28106480|NCT02937740|54764251|FG001|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7|||
28106481|NCT02937740|54764250|FG000|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1|||
28106482|NCT02937740|54764251|FG001|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0|||
28106483|NCT02937740|54764250|FG000|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0|||
28106484|NCT02937740|54764251|FG001|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1|||
28106485|NCT02937740|54764250|FG000|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0|||
28106486|NCT02937740|54764251|FG001|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1|||
28106487|NCT04173741|54764274|FG000|Overall Study|IVC measurement cannot be done|1|||
28106488|NCT04173741|54764275|FG001|Overall Study|IVC measurement cannot be done|1|||
28106489|NCT03231800|54764283|FG000|Overall Study|Lost to Follow-up|0|||
28106490|NCT03231800|54764284|FG001|Overall Study|Lost to Follow-up|2|||
28106491|NCT03231800|54764283|FG000|Overall Study|Protocol Violation|1|||
28106492|NCT03231800|54764284|FG001|Overall Study|Protocol Violation|1|||
28106493|NCT03231800|54764283|FG000|Overall Study|reason not provided|2|||
28106494|NCT03231800|54764284|FG001|Overall Study|reason not provided|0|||
28106495|NCT04085601|54764292|FG000|Overall Study|Lost to Follow-up|1|||
28106496|NCT04085601|54764293|FG001|Overall Study|Lost to Follow-up|0|||
28106497|NCT04085601|54764292|FG000|Overall Study|Death|1|||
28106498|NCT04085601|54764293|FG001|Overall Study|Death|1|||
28106499|NCT03230864|54764302|FG000|Prospective Confirmation (PC) Period|Adverse Event|3|||
28106500|NCT03230864|54764303|FG001|Prospective Confirmation (PC) Period|Adverse Event|0|||
28106501|NCT03230864|54764304|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
28106502|NCT03230864|54764305|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
28106503|NCT03230864|54764302|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
28106504|NCT03230864|54764303|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
28106505|NCT03230864|54764304|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
28106506|NCT03230864|54764305|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
28106507|NCT03230864|54764302|FG000|Prospective Confirmation (PC) Period|Protocol Violation|1|||
28106508|NCT03230864|54764303|FG001|Prospective Confirmation (PC) Period|Protocol Violation|2|||
28106509|NCT03230864|54764304|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
28106510|NCT03230864|54764305|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
28106511|NCT03230864|54764302|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|4|||
28106512|NCT03230864|54764303|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|1|||
28106513|NCT03230864|54764304|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
28106514|NCT03230864|54764305|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
28106515|NCT03230864|54764302|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14|||
28106516|NCT03230864|54764303|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5|||
28106517|NCT03230864|54764304|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
28106518|NCT03230864|54764305|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
28106519|NCT03230864|54764302|FG000|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
28106520|NCT03230864|54764303|FG001|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
28106521|NCT03230864|54764304|FG002|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
28106522|NCT03230864|54764305|FG003|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
28106523|NCT03230864|54764302|FG000|Prospective Confirmation (PC) Period|Study Personnel Decision|1|||
27815240|NCT01968031|54272060|FG001|Overall Study|Adverse Event|10|||
28106524|NCT03230864|54764303|FG001|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
28106525|NCT03230864|54764304|FG002|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
28106526|NCT03230864|54764305|FG003|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
28106527|NCT03230864|54764302|FG000|Double Blind Treatment (DBT) Period|Adverse Event|0|||
28106528|NCT03230864|54764303|FG001|Double Blind Treatment (DBT) Period|Adverse Event|0|||
28106529|NCT03230864|54764304|FG002|Double Blind Treatment (DBT) Period|Adverse Event|5|||
28106530|NCT03230864|54764305|FG003|Double Blind Treatment (DBT) Period|Adverse Event|1|||
28106531|NCT03230864|54764302|FG000|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
28106532|NCT03230864|54764303|FG001|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
28106533|NCT03230864|54764304|FG002|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
28106534|NCT03230864|54764305|FG003|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
28106535|NCT03230864|54764302|FG000|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
28106536|NCT03230864|54764303|FG001|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
28106537|NCT03230864|54764304|FG002|Double Blind Treatment (DBT) Period|Sponsor Decision|2|||
28106538|NCT03230864|54764305|FG003|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
28106539|NCT04085367|54764317|FG000|Overall Study|Adverse Event|1|||
28106540|NCT04085367|54764318|FG001|Overall Study|Adverse Event|1|||
28106541|NCT04085367|54764317|FG000|Overall Study|Withdrawal by Subject|13|||
28106542|NCT04085367|54764318|FG001|Overall Study|Withdrawal by Subject|4|||
28106543|NCT04085367|54764317|FG000|Overall Study|Lost to Follow-up|3|||
28106544|NCT04085367|54764318|FG001|Overall Study|Lost to Follow-up|1|||
28106545|NCT04085367|54764317|FG000|Overall Study|Other unspecified|2|||
28106546|NCT04085367|54764318|FG001|Overall Study|Other unspecified|1|||
28106547|NCT04085367|54764317|FG000|Overall Study|Status Unknown|1|||
28106548|NCT04085367|54764318|FG001|Overall Study|Status Unknown|1|||
28106549|NCT03228836|54764324|FG000|Overall Study|Adverse Event|3|||
28106550|NCT03228836|54764324|FG000|Overall Study|Withdrawal by Subject|1|||
28106551|NCT03228836|54764324|FG000|Overall Study|Death|1|||
28106552|NCT03228836|54764324|FG000|Overall Study|Physician Decision|1|||
28106553|NCT03228836|54764324|FG000|Overall Study|Disease Progression|7|||
28106554|NCT03228836|54764324|FG000|Overall Study|Other|4|||
28106555|NCT02937350|54764331|FG000|Overall Study|Withdrawal by Subject|0|||
28106556|NCT02937350|54764332|FG001|Overall Study|Withdrawal by Subject|1|||
28106557|NCT02937350|54764333|FG002|Overall Study|Withdrawal by Subject|0|||
28106558|NCT04085289|54764342|FG000|Overall Study|Withdrawal by Subject|0|||
28106559|NCT04085289|54764343|FG001|Overall Study|Withdrawal by Subject|0|||
28106560|NCT04085289|54764344|FG002|Overall Study|Withdrawal by Subject|1|||
28106561|NCT04080297|54764353|FG000|Overall Study|Adverse Event|1|||
28106562|NCT04080297|54764354|FG001|Overall Study|Adverse Event|3|||
27848374|NCT01042977|54341341|FG000|Overall Study|Subject no longer meets study criteria|15|||
27848375|NCT01042977|54341342|FG001|Overall Study|Subject no longer meets study criteria|13|||
27848376|NCT01042977|54341341|FG000|Overall Study|Incorrect enrollment|6|||
27848377|NCT01042977|54341342|FG001|Overall Study|Incorrect enrollment|4|||
28106563|NCT04080297|54764353|FG000|Overall Study|concurrent illness|1|||
28106564|NCT04080297|54764354|FG001|Overall Study|concurrent illness|0|||
28106565|NCT04013529|54764362|FG000|Overall Study|Withdrawal by Subject|1|||
28106566|NCT04013529|54764363|FG001|Overall Study|Withdrawal by Subject|1|||
28106567|NCT04011735|54764372|FG000|Overall Study|Withdrawal by Subject|1|||
28106568|NCT04011735|54764373|FG001|Overall Study|Withdrawal by Subject|0|||
28106569|NCT04011735|54764374|FG002|Overall Study|Withdrawal by Subject|1|||
28106570|NCT04011735|54764372|FG000|Overall Study|Met exclusion criteria after study entry|0|||
28106571|NCT04011735|54764373|FG001|Overall Study|Met exclusion criteria after study entry|1|||
28106572|NCT04011735|54764374|FG002|Overall Study|Met exclusion criteria after study entry|0|||
28106573|NCT04009629|54764386|FG000|Overall Study|Withdrawal by Subject|2|||
28106574|NCT04009629|54764387|FG001|Overall Study|Withdrawal by Subject|0|||
28106575|NCT04007367|54764396|FG000|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|43|||
27848378|NCT01042977|54341341|FG000|Overall Study|Safety|0|||
27848379|NCT01042977|54341342|FG001|Overall Study|Safety|2|||
27848380|NCT01042977|54341341|FG000|Overall Study|Administrative reason by sponsor|0|||
27848381|NCT01042977|54341342|FG001|Overall Study|Administrative reason by sponsor|1|||
27848382|NCT01042977|54341341|FG000|Overall Study|Various|3|||
28106576|NCT04007367|54764397|FG001|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
27848383|NCT01042977|54341342|FG001|Overall Study|Various|0|||
27848384|NCT01041573|54341352|FG000|Overall Study|Withdrawal by Subject|2|||
27848385|NCT01041573|54341353|FG001|Overall Study|Withdrawal by Subject|5|||
28106577|NCT04007367|54764398|FG002|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
28106578|NCT04007367|54764396|FG000|Open-Label Phase (8-Weeks)|Adverse Event|2|||
28106579|NCT04007367|54764397|FG001|Open-Label Phase (8-Weeks)|Adverse Event|0|||
28106580|NCT04007367|54764398|FG002|Open-Label Phase (8-Weeks)|Adverse Event|0|||
28106581|NCT04007367|54764396|FG000|Open-Label Phase (8-Weeks)|Withdrawal by Participant|2|||
28106582|NCT04007367|54764397|FG001|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
28106583|NCT04007367|54764398|FG002|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
28106584|NCT04007367|54764396|FG000|Open-Label Phase (8-Weeks)|Non-compliance|1|||
28106585|NCT04007367|54764397|FG001|Open-Label Phase (8-Weeks)|Non-compliance|0|||
28106586|NCT04007367|54764398|FG002|Open-Label Phase (8-Weeks)|Non-compliance|0|||
28106587|NCT04007367|54764396|FG000|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
28106588|NCT04007367|54764397|FG001|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
28106589|NCT04007367|54764398|FG002|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|2|||
28106590|NCT03694197|54764408|FG000|Overall Study|Adverse Event|9|||
28106591|NCT03694197|54764408|FG000|Overall Study|Protocol became inconvenient to participate|1|||
28106592|NCT03694197|54764408|FG000|Overall Study|Physician Decision|4|||
28106593|NCT03694197|54764408|FG000|Overall Study|Study terminated by sponsor|1350|||
28106594|NCT03694197|54764408|FG000|Overall Study|Participant moved|5|||
28106595|NCT03694197|54764408|FG000|Overall Study|Participant withdrew consent|10|||
28106596|NCT03694197|54764408|FG000|Overall Study|Related to IMP administration|1|||
28106597|NCT03694197|54764408|FG000|Overall Study|Not disclosed|5|||
28106598|NCT04365699|54764415|FG000|Overall Study|Death|2|||
28106599|NCT04365699|54764416|FG001|Overall Study|Death|5|||
27848386|NCT01041573|54341354|FG002|Overall Study|Withdrawal by Subject|2|||
27848387|NCT01041573|54341355|FG003|Overall Study|Withdrawal by Subject|0|||
27848388|NCT01041573|54341352|FG000|Overall Study|Death|1|||
27848389|NCT01041573|54341353|FG001|Overall Study|Death|0|||
27848390|NCT01041573|54341354|FG002|Overall Study|Death|0|||
27848391|NCT01041573|54341355|FG003|Overall Study|Death|0|||
27848392|NCT01041573|54341352|FG000|Overall Study|Lost to Follow-up|0|||
27848393|NCT01041573|54341353|FG001|Overall Study|Lost to Follow-up|1|||
27848394|NCT01041573|54341354|FG002|Overall Study|Lost to Follow-up|2|||
27848395|NCT01041573|54341355|FG003|Overall Study|Lost to Follow-up|1|||
27848396|NCT01041573|54341352|FG000|Overall Study|Adverse Event|0|||
27848397|NCT01041573|54341353|FG001|Overall Study|Adverse Event|2|||
27848398|NCT01041573|54341354|FG002|Overall Study|Adverse Event|0|||
27848399|NCT01041573|54341355|FG003|Overall Study|Adverse Event|0|||
27848400|NCT01041573|54341352|FG000|Overall Study|relocation|1|||
27848401|NCT01041573|54341353|FG001|Overall Study|relocation|4|||
28106600|NCT04365699|54764417|FG002|Overall Study|Death|15|||
28106601|NCT04005885|54764425|FG000|First Intervention|Withdrawal by Subject|1|||
28106602|NCT04005885|54764426|FG001|First Intervention|Withdrawal by Subject|1|||
27848402|NCT01041573|54341354|FG002|Overall Study|relocation|3|||
27848403|NCT01041573|54341355|FG003|Overall Study|relocation|1|||
27848404|NCT01041573|54341352|FG000|Overall Study|further blood extraction|0|||
27848405|NCT01041573|54341353|FG001|Overall Study|further blood extraction|1|||
27848406|NCT01041573|54341354|FG002|Overall Study|further blood extraction|0|||
28106603|NCT04005885|54764425|FG000|Second Intervention|Withdrawal by Subject|0|||
28106604|NCT04005885|54764426|FG001|Second Intervention|Withdrawal by Subject|2|||
28106605|NCT04003623|54764439|FG000|Overall Study|Withdrawal by Subject|1|||
28106606|NCT04003623|54764440|FG001|Overall Study|Withdrawal by Subject|0|||
28106607|NCT04480424|54764448|FG000|Overall Study|Withdrawal by Subject|0|||
28106608|NCT04480424|54764449|FG001|Overall Study|Withdrawal by Subject|2|||
28106609|NCT04480424|54764448|FG000|Overall Study|Lost to Follow-up|3|||
28106610|NCT04480424|54764449|FG001|Overall Study|Lost to Follow-up|3|||
28106611|NCT04480424|54764448|FG000|Overall Study|Death|14|||
28106612|NCT04480424|54764449|FG001|Overall Study|Death|16|||
28106613|NCT04480424|54764448|FG000|Overall Study|Reason not Specified|5|||
27848407|NCT01041573|54341355|FG003|Overall Study|further blood extraction|0|||
27848408|NCT01041573|54341352|FG000|Overall Study|positive to anti-HCV|1|||
27848409|NCT01041573|54341353|FG001|Overall Study|positive to anti-HCV|0|||
27848410|NCT01041573|54341354|FG002|Overall Study|positive to anti-HCV|0|||
27848411|NCT01041573|54341355|FG003|Overall Study|positive to anti-HCV|0|||
27848412|NCT01041495|54341382|FG000|Overall Study|Withdrawal by Subject|2|||
27848413|NCT01041495|54341383|FG001|Overall Study|Withdrawal by Subject|5|||
27848414|NCT01041495|54341382|FG000|Overall Study|Adverse Event|2|||
28106614|NCT04480424|54764449|FG001|Overall Study|Reason not Specified|5|||
28106615|NCT03256526|54764458|FG000|Overall Study|Adverse Event|1|||
28106616|NCT03256526|54764459|FG001|Overall Study|Adverse Event|0|||
28106617|NCT03256526|54764460|FG002|Overall Study|Adverse Event|1|||
28106618|NCT03256526|54764458|FG000|Overall Study|Lost to Follow-up|1|||
28106619|NCT03256526|54764459|FG001|Overall Study|Lost to Follow-up|0|||
28106620|NCT03256526|54764460|FG002|Overall Study|Lost to Follow-up|2|||
28106621|NCT03255980|54764472|FG000|Overall Study|Grade =>3 Skin Toxicity|1|||
28106622|NCT03255980|54764473|FG001|Overall Study|Grade =>3 Skin Toxicity|4|||
28106623|NCT03255980|54764474|FG002|Overall Study|Grade =>3 Skin Toxicity|6|||
28106624|NCT03255980|54764475|FG003|Overall Study|Grade =>3 Skin Toxicity|5|||
28106625|NCT03255980|54764472|FG000|Overall Study|Adverse Event|1|||
28106626|NCT03255980|54764473|FG001|Overall Study|Adverse Event|1|||
28106627|NCT03255980|54764474|FG002|Overall Study|Adverse Event|0|||
28106628|NCT03255980|54764475|FG003|Overall Study|Adverse Event|1|||
28106629|NCT03255980|54764472|FG000|Overall Study|Lack of compliance to study or assessmen|0|||
28106630|NCT03255980|54764473|FG001|Overall Study|Lack of compliance to study or assessmen|1|||
28106631|NCT03255980|54764474|FG002|Overall Study|Lack of compliance to study or assessmen|0|||
28106632|NCT03255980|54764475|FG003|Overall Study|Lack of compliance to study or assessmen|0|||
28106633|NCT03255980|54764472|FG000|Overall Study|Lost to Follow-up|1|||
28106634|NCT03255980|54764473|FG001|Overall Study|Lost to Follow-up|1|||
28106635|NCT03255980|54764474|FG002|Overall Study|Lost to Follow-up|0|||
28106636|NCT03255980|54764475|FG003|Overall Study|Lost to Follow-up|3|||
28106637|NCT03255980|54764472|FG000|Overall Study|Withdrawal by Subject|0|||
28106638|NCT03255980|54764473|FG001|Overall Study|Withdrawal by Subject|1|||
28106639|NCT03255980|54764474|FG002|Overall Study|Withdrawal by Subject|0|||
28106640|NCT03255980|54764475|FG003|Overall Study|Withdrawal by Subject|3|||
28106641|NCT03228212|54764485|FG000|Period 1|Adverse Event|1|||
28106642|NCT03228212|54764486|FG001|Period 1|Adverse Event|0|||
28106643|NCT03228212|54764485|FG000|Period 1|no longer meets eligibility criteria|0|||
28106644|NCT03228212|54764486|FG001|Period 1|no longer meets eligibility criteria|1|||
28106645|NCT03228212|54764485|FG000|Period 2|Lost to Follow-up|1|||
28106646|NCT03228212|54764486|FG001|Period 2|Lost to Follow-up|0|||
28106647|NCT04003155|54764495|FG000|Double-Blind (DB) Period (12 Weeks)|Adverse Event|9|||
28106648|NCT04003155|54764496|FG001|Double-Blind (DB) Period (12 Weeks)|Adverse Event|8|||
28106649|NCT04003155|54764497|FG002|Double-Blind (DB) Period (12 Weeks)|Adverse Event|5|||
27848415|NCT01041495|54341383|FG001|Overall Study|Adverse Event|1|||
27940093|NCT01195662|54596419|FG000|Double Blind Treatment Period|No Longer Meets Criteria|1|||
28106650|NCT04003155|54764498|FG003|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
28106651|NCT04003155|54764499|FG004|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
28106652|NCT04003155|54764495|FG000|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|3|||
28106653|NCT04003155|54764496|FG001|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
28106654|NCT04003155|54764497|FG002|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
28106655|NCT04003155|54764498|FG003|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
28106656|NCT04003155|54764499|FG004|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
27848416|NCT01041495|54341382|FG000|Overall Study|Lost to Follow-up|0|||
27848417|NCT01041495|54341383|FG001|Overall Study|Lost to Follow-up|1|||
27848418|NCT01041417|54341391|FG000|Overall Study|Adverse Event|5|||
27848419|NCT01041417|54341392|FG001|Overall Study|Adverse Event|2|||
27848420|NCT01041417|54341391|FG000|Overall Study|Lost to Follow-up|1|||
27848421|NCT01041417|54341392|FG001|Overall Study|Lost to Follow-up|1|||
28106657|NCT04003155|54764495|FG000|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|1|||
28106658|NCT04003155|54764496|FG001|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
28106659|NCT04003155|54764497|FG002|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
28106660|NCT04003155|54764498|FG003|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
27848422|NCT01041417|54341391|FG000|Overall Study|Death|1|||
27848423|NCT01041417|54341392|FG001|Overall Study|Death|0|||
27848424|NCT01040871|54341402|FG000|Overall Study|Adverse Event|6|||
27848425|NCT01040871|54341403|FG001|Overall Study|Adverse Event|2|||
27848426|NCT01040871|54341402|FG000|Overall Study|Withdrawal by Subject|2|||
27848427|NCT01040871|54341403|FG001|Overall Study|Withdrawal by Subject|0|||
28106661|NCT04003155|54764499|FG004|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
28106662|NCT04003155|54764495|FG000|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|9|||
28106663|NCT04003155|54764496|FG001|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|12|||
28106664|NCT04003155|54764497|FG002|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
28106665|NCT04003155|54764498|FG003|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
28106666|NCT04003155|54764499|FG004|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
28106667|NCT04003155|54764495|FG000|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|1|||
28106668|NCT04003155|54764496|FG001|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|7|||
28106669|NCT04003155|54764497|FG002|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|3|||
28106670|NCT04003155|54764498|FG003|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
28106671|NCT04003155|54764499|FG004|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
28106672|NCT04003155|54764495|FG000|Extension Period (EP) (40 Weeks)|Adverse Event|0|||
28106673|NCT04003155|54764496|FG001|Extension Period (EP) (40 Weeks)|Adverse Event|5|||
28106674|NCT04003155|54764497|FG002|Extension Period (EP) (40 Weeks)|Adverse Event|4|||
28106675|NCT04003155|54764498|FG003|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
28106676|NCT04003155|54764499|FG004|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
28106677|NCT04003155|54764495|FG000|Extension Period (EP) (40 Weeks)|Lost to Follow-up|0|||
27848428|NCT01040871|54341402|FG000|Overall Study|Death|1|||
27848429|NCT01040871|54341403|FG001|Overall Study|Death|3|||
27848430|NCT01040871|54341402|FG000|Overall Study|Lack of Efficacy|1|||
27848431|NCT01040871|54341403|FG001|Overall Study|Lack of Efficacy|1|||
27848432|NCT01040871|54341402|FG000|Overall Study|drug supply issue|1|||
27848433|NCT01040871|54341403|FG001|Overall Study|drug supply issue|0|||
27848434|NCT01040871|54341402|FG000|Overall Study|Randomized and Not Treated|2|||
27848435|NCT01040871|54341403|FG001|Overall Study|Randomized and Not Treated|1|||
27848436|NCT01040169|54341411|FG000|Overall Study|Lost to Follow-up|3|||
27848437|NCT01040169|54341412|FG001|Overall Study|Lost to Follow-up|8|||
27848438|NCT01673178|54341432|FG000|Overall Study|Lost to Follow-up|0|||
27848439|NCT01673178|54341433|FG001|Overall Study|Lost to Follow-up|1|||
27848440|NCT01673178|54341434|FG002|Overall Study|Lost to Follow-up|0|||
27848441|NCT01673178|54341435|FG003|Overall Study|Lost to Follow-up|0|||
27848442|NCT01673178|54341436|FG004|Overall Study|Lost to Follow-up|0|||
27848443|NCT01673178|54341432|FG000|Overall Study|Withdrawal by Subject|0|||
27848444|NCT01673178|54341433|FG001|Overall Study|Withdrawal by Subject|0|||
27848445|NCT01673178|54341434|FG002|Overall Study|Withdrawal by Subject|1|||
27848446|NCT01673178|54341435|FG003|Overall Study|Withdrawal by Subject|4|||
27848447|NCT01673178|54341436|FG004|Overall Study|Withdrawal by Subject|2|||
27815241|NCT01968031|54272061|FG002|Overall Study|Adverse Event|22|||
27815242|NCT01968031|54272059|FG000|Overall Study|Withdrawal by Subject|3|||
27815243|NCT01968031|54272060|FG001|Overall Study|Withdrawal by Subject|7|||
27815244|NCT01968031|54272061|FG002|Overall Study|Withdrawal by Subject|3|||
27815245|NCT01968031|54272059|FG000|Overall Study|Did not meet entry criteria|1|||
27815246|NCT01968031|54272060|FG001|Overall Study|Did not meet entry criteria|1|||
27815247|NCT01968031|54272061|FG002|Overall Study|Did not meet entry criteria|1|||
27815248|NCT01968031|54272059|FG000|Overall Study|Noncompliance|0|||
27815249|NCT01968031|54272060|FG001|Overall Study|Noncompliance|0|||
27815250|NCT01968031|54272061|FG002|Overall Study|Noncompliance|2|||
27848448|NCT01673178|54341432|FG000|Overall Study|Protocol Violation|1|||
27848449|NCT01673178|54341433|FG001|Overall Study|Protocol Violation|1|||
28106678|NCT04003155|54764496|FG001|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
28106679|NCT04003155|54764497|FG002|Extension Period (EP) (40 Weeks)|Lost to Follow-up|3|||
28106680|NCT04003155|54764498|FG003|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
28106681|NCT04003155|54764499|FG004|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
28106682|NCT04003155|54764495|FG000|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|0|||
28106683|NCT04003155|54764496|FG001|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|12|||
28106684|NCT04003155|54764497|FG002|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|7|||
28106685|NCT04003155|54764498|FG003|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|9|||
28106686|NCT04003155|54764499|FG004|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|5|||
28106687|NCT04003155|54764495|FG000|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
28106688|NCT04003155|54764496|FG001|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
28106689|NCT04003155|54764497|FG002|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
28106690|NCT04003155|54764498|FG003|Extension Period (EP) (40 Weeks)|Miscellaneous|2|||
28106691|NCT04003155|54764499|FG004|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
28106692|NCT04000815|54764520|FG000|Overall Study|Lost to Follow-up|9|||
28106693|NCT04000815|54764521|FG001|Overall Study|Lost to Follow-up|2|||
28106694|NCT04000815|54764522|FG002|Overall Study|Lost to Follow-up|3|||
28106695|NCT04000815|54764520|FG000|Overall Study|Withdrawal by Subject|4|||
28106696|NCT04000815|54764521|FG001|Overall Study|Withdrawal by Subject|3|||
28106697|NCT04000815|54764522|FG002|Overall Study|Withdrawal by Subject|2|||
28106698|NCT04000815|54764520|FG000|Overall Study|Right ovarian cyst occured|1|||
28106699|NCT04000815|54764521|FG001|Overall Study|Right ovarian cyst occured|0|||
28106700|NCT04000815|54764522|FG002|Overall Study|Right ovarian cyst occured|0|||
28106701|NCT04000815|54764520|FG000|Overall Study|Hypertension occured on follow up|0|||
28106702|NCT04000815|54764521|FG001|Overall Study|Hypertension occured on follow up|0|||
28106703|NCT04000815|54764522|FG002|Overall Study|Hypertension occured on follow up|2|||
28106704|NCT04000581|54764532|FG000|Overall Study|Withdrawal by Subject|0|||
28106705|NCT04000581|54764533|FG001|Overall Study|Withdrawal by Subject|1|||
28106706|NCT03848403|54764539|FG000|Period 2 (Day 8)|Adverse Event|1|||
28106707|NCT03848403|54764540|FG001|Period 2 (Day 8)|Adverse Event|2|||
28106708|NCT03848403|54764541|FG002|Period 2 (Day 8)|Adverse Event|2|||
28106709|NCT03848403|54764539|FG000|Period 2 (Day 8)|Physician Decision|0|||
28106710|NCT03848403|54764540|FG001|Period 2 (Day 8)|Physician Decision|1|||
28106711|NCT03848403|54764541|FG002|Period 2 (Day 8)|Physician Decision|0|||
28106712|NCT03848403|54764539|FG000|Period 2 (Day 8)|Sponsor Decision|8|||
28106713|NCT03848403|54764540|FG001|Period 2 (Day 8)|Sponsor Decision|6|||
28106714|NCT03848403|54764541|FG002|Period 2 (Day 8)|Sponsor Decision|5|||
28106715|NCT04054011|54764549|FG000|Overall Study|COVID|3|||
28106716|NCT04053465|54764557|FG000|Overall Study|Withdrawal by Subject|4|||
28106717|NCT04053465|54764558|FG001|Overall Study|Withdrawal by Subject|4|||
28106718|NCT00143507|54764566|FG000|Overall Study|Death|572|||
28106719|NCT00143507|54764567|FG001|Overall Study|Death|547|||
28106720|NCT00143507|54764566|FG000|Overall Study|Withdrawal by Subject|114|||
28106721|NCT00143507|54764567|FG001|Overall Study|Withdrawal by Subject|102|||
28106722|NCT00143507|54764566|FG000|Overall Study|Lost to Follow-up|1|||
28106723|NCT00143507|54764567|FG001|Overall Study|Lost to Follow-up|0|||
28106724|NCT00143507|54764566|FG000|Overall Study|Withdrawn by sponsor's decision|0|||
28106725|NCT00143507|54764567|FG001|Overall Study|Withdrawn by sponsor's decision|3|||
28106726|NCT03988803|54764573|FG000|Period 2|Prematurely discontinued from medication|2|||
28106727|NCT03988803|54764573|FG000|Period 2|Adverse Event|1|||
28106728|NCT00181883|54764581|FG000|Overall Study|Lack of Efficacy|2|||
28106729|NCT00181883|54764581|FG000|Overall Study|Treatment Limiting AEs|3|||
28106730|NCT00181883|54764581|FG000|Overall Study|Withdrawal by Subject|4|||
28106731|NCT00181883|54764581|FG000|Overall Study|Lost to Follow-up|1|||
28106732|NCT00180713|54764587|FG000|Overall Study|Withdrawal by Subject|2|||
28106733|NCT00180713|54764588|FG001|Overall Study|Withdrawal by Subject|0|||
28106734|NCT00180713|54764587|FG000|Overall Study|Adverse Event|3|||
28106735|NCT00180713|54764588|FG001|Overall Study|Adverse Event|3|||
28106736|NCT03988023|54764596|FG000|Overall Study|Non-compliance|3|||
27815251|NCT01968031|54272059|FG000|Overall Study|Failed inclusion criteria|0|||
27815252|NCT01968031|54272060|FG001|Overall Study|Failed inclusion criteria|2|||
27815253|NCT01968031|54272061|FG002|Overall Study|Failed inclusion criteria|0|||
27815254|NCT01968031|54272059|FG000|Overall Study|Death|0|||
27815255|NCT01968031|54272060|FG001|Overall Study|Death|0|||
27815256|NCT01968031|54272061|FG002|Overall Study|Death|1|||
27815257|NCT01968031|54272059|FG000|Overall Study|Prohibited concomitant medication|1|||
27815258|NCT01968031|54272060|FG001|Overall Study|Prohibited concomitant medication|0|||
27815259|NCT01968031|54272061|FG002|Overall Study|Prohibited concomitant medication|0|||
27815260|NCT01684215|54272073|FG000|Phase 1, Part 1|Adverse Event|1|||
27815261|NCT01684215|54272074|FG001|Phase 1, Part 1|Adverse Event|0|||
27815262|NCT01684215|54272075|FG002|Phase 1, Part 1|Adverse Event|0|||
27815263|NCT01684215|54272076|FG003|Phase 1, Part 1|Adverse Event|0|||
27815264|NCT01684215|54272073|FG000|Phase 1, Part 1|Objective progression or relapse|5|||
27815265|NCT01684215|54272074|FG001|Phase 1, Part 1|Objective progression or relapse|6|||
27848450|NCT01673178|54341434|FG002|Overall Study|Protocol Violation|0|||
28106737|NCT03988023|54764597|FG001|Overall Study|Non-compliance|0|||
28106738|NCT03988023|54764596|FG000|Overall Study|Withdrawal by Subject|39|||
28106739|NCT03988023|54764597|FG001|Overall Study|Withdrawal by Subject|37|||
28106740|NCT03988023|54764596|FG000|Overall Study|Adverse Event|0|||
28106741|NCT03988023|54764597|FG001|Overall Study|Adverse Event|2|||
28106742|NCT03988023|54764596|FG000|Overall Study|Physician Decision|0|||
28106743|NCT03988023|54764597|FG001|Overall Study|Physician Decision|1|||
28106744|NCT03988023|54764596|FG000|Overall Study|Lost to Follow-up|5|||
28106745|NCT03988023|54764597|FG001|Overall Study|Lost to Follow-up|8|||
28106746|NCT03988023|54764596|FG000|Overall Study|Sponsor decision to terminate follow up|10|||
28106747|NCT03988023|54764597|FG001|Overall Study|Sponsor decision to terminate follow up|12|||
28106748|NCT03988023|54764596|FG000|Overall Study|Lack of Efficacy|3|||
28106749|NCT03988023|54764597|FG001|Overall Study|Lack of Efficacy|1|||
28106750|NCT03988023|54764596|FG000|Overall Study|COVID-19 pandemic|225|||
27815266|NCT01684215|54272075|FG002|Phase 1, Part 1|Objective progression or relapse|0|||
27815267|NCT01684215|54272076|FG003|Phase 1, Part 1|Objective progression or relapse|0|||
27815268|NCT01684215|54272073|FG000|Phase 1, Part 2|Adverse Event|0|||
27815269|NCT01684215|54272074|FG001|Phase 1, Part 2|Adverse Event|0|||
27815270|NCT01684215|54272075|FG002|Phase 1, Part 2|Adverse Event|1|||
27815271|NCT01684215|54272076|FG003|Phase 1, Part 2|Adverse Event|0|||
27815272|NCT01684215|54272073|FG000|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
27848451|NCT01673178|54341435|FG003|Overall Study|Protocol Violation|1|||
27848452|NCT01673178|54341436|FG004|Overall Study|Protocol Violation|0|||
27848453|NCT01673178|54341432|FG000|Overall Study|Adverse Event|1|||
28106751|NCT03988023|54764597|FG001|Overall Study|COVID-19 pandemic|227|||
27848454|NCT01673178|54341433|FG001|Overall Study|Adverse Event|0|||
27848455|NCT01673178|54341434|FG002|Overall Study|Adverse Event|0|||
27848456|NCT01673178|54341435|FG003|Overall Study|Adverse Event|2|||
27848457|NCT01673178|54341436|FG004|Overall Study|Adverse Event|0|||
27848458|NCT01673178|54341432|FG000|Overall Study|Other|1|||
27848459|NCT01673178|54341433|FG001|Overall Study|Other|0|||
27848460|NCT01673178|54341434|FG002|Overall Study|Other|2|||
27848461|NCT01673178|54341435|FG003|Overall Study|Other|1|||
27848462|NCT01673178|54341436|FG004|Overall Study|Other|0|||
27815273|NCT01684215|54272074|FG001|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
27815274|NCT01684215|54272075|FG002|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4|||
28106752|NCT04052139|54764606|FG000|Overall Study|Lost to Follow-up|2|||
27848463|NCT03593213|54341465|FG000|Open-label Treatment Period (18 Weeks)|Adverse Event|39|||
27848464|NCT03593213|54341466|FG001|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
28106753|NCT04052139|54764607|FG001|Overall Study|Lost to Follow-up|0|||
28106754|NCT04052139|54764608|FG002|Overall Study|Lost to Follow-up|0|||
28106755|NCT04052139|54764606|FG000|Overall Study|Withdrawal by Subject|1|||
28106756|NCT04052139|54764607|FG001|Overall Study|Withdrawal by Subject|0|||
28106757|NCT04052139|54764608|FG002|Overall Study|Withdrawal by Subject|0|||
28106758|NCT03984825|54764616|FG000|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2|||
28106759|NCT03984825|54764616|FG000|Treatment Period 2 (Day 11 to 21)|Physician Decision|1|||
27940094|NCT01195662|54596420|FG001|Double Blind Treatment Period|No Longer Meets Criteria|5|||
28106760|NCT03984825|54764616|FG000|Treatment Period 2 (Day 11 to 21)|Adverse Event|3|||
28106761|NCT03981861|54764625|FG000|Overall Study|Withdrawal by Subject|3|||
28106762|NCT01332266|54764634|FG000|Phase 1b|Death|3|||
28106763|NCT01332266|54764635|FG001|Phase 1b|Death|3|||
28106764|NCT01332266|54764636|FG002|Phase 1b|Death|2|||
28106765|NCT01332266|54764637|FG003|Phase 1b|Death|0|||
28106766|NCT01332266|54764638|FG004|Phase 1b|Death|0|||
28106767|NCT01332266|54764634|FG000|Phase 1b|Lost to Follow-up|0|||
28106768|NCT01332266|54764635|FG001|Phase 1b|Lost to Follow-up|1|||
28106769|NCT01332266|54764636|FG002|Phase 1b|Lost to Follow-up|0|||
28106770|NCT01332266|54764637|FG003|Phase 1b|Lost to Follow-up|0|||
28106771|NCT01332266|54764638|FG004|Phase 1b|Lost to Follow-up|0|||
28106772|NCT01332266|54764634|FG000|Phase 1b|Withdrawal by Subject|1|||
28106773|NCT01332266|54764635|FG001|Phase 1b|Withdrawal by Subject|1|||
28106774|NCT01332266|54764636|FG002|Phase 1b|Withdrawal by Subject|1|||
28106775|NCT01332266|54764637|FG003|Phase 1b|Withdrawal by Subject|0|||
28106776|NCT01332266|54764638|FG004|Phase 1b|Withdrawal by Subject|0|||
28106777|NCT01332266|54764634|FG000|Phase 2|Death|0|||
28106778|NCT01332266|54764635|FG001|Phase 2|Death|0|||
28106779|NCT01332266|54764636|FG002|Phase 2|Death|0|||
28106780|NCT01332266|54764637|FG003|Phase 2|Death|33|||
28106781|NCT01332266|54764638|FG004|Phase 2|Death|36|||
28106782|NCT01332266|54764634|FG000|Phase 2|Lost to Follow-up|0|||
28106783|NCT01332266|54764635|FG001|Phase 2|Lost to Follow-up|0|||
28106784|NCT01332266|54764636|FG002|Phase 2|Lost to Follow-up|0|||
28106785|NCT01332266|54764637|FG003|Phase 2|Lost to Follow-up|2|||
28106786|NCT01332266|54764638|FG004|Phase 2|Lost to Follow-up|0|||
28106787|NCT01332266|54764634|FG000|Phase 2|Physician Decision|0|||
28106788|NCT01332266|54764635|FG001|Phase 2|Physician Decision|0|||
28106789|NCT01332266|54764636|FG002|Phase 2|Physician Decision|0|||
28106790|NCT01332266|54764637|FG003|Phase 2|Physician Decision|3|||
28106791|NCT01332266|54764638|FG004|Phase 2|Physician Decision|1|||
28106792|NCT01332266|54764634|FG000|Phase 2|Symptomatic deterioration|0|||
28106793|NCT01332266|54764635|FG001|Phase 2|Symptomatic deterioration|0|||
28106794|NCT01332266|54764636|FG002|Phase 2|Symptomatic deterioration|0|||
28106795|NCT01332266|54764637|FG003|Phase 2|Symptomatic deterioration|0|||
28106796|NCT01332266|54764638|FG004|Phase 2|Symptomatic deterioration|1|||
28106797|NCT01332266|54764634|FG000|Phase 2|Progression Disease|0|||
28106798|NCT01332266|54764635|FG001|Phase 2|Progression Disease|0|||
28106799|NCT01332266|54764636|FG002|Phase 2|Progression Disease|0|||
28106800|NCT01332266|54764637|FG003|Phase 2|Progression Disease|2|||
28106801|NCT01332266|54764638|FG004|Phase 2|Progression Disease|1|||
28106802|NCT01332266|54764634|FG000|Phase 2|Withdrawal by Subject|0|||
28106803|NCT01332266|54764635|FG001|Phase 2|Withdrawal by Subject|0|||
28106804|NCT01332266|54764636|FG002|Phase 2|Withdrawal by Subject|0|||
28106805|NCT01332266|54764637|FG003|Phase 2|Withdrawal by Subject|2|||
28106806|NCT01332266|54764638|FG004|Phase 2|Withdrawal by Subject|2|||
28106807|NCT03255824|54764653|FG000|Overall Study|Under-sedation|2|||
27815275|NCT01684215|54272076|FG003|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
27815276|NCT01684215|54272073|FG000|Phase 1, Part 2|Withdrawal by Subject|0|||
27815277|NCT01684215|54272074|FG001|Phase 1, Part 2|Withdrawal by Subject|0|||
27815278|NCT01684215|54272075|FG002|Phase 1, Part 2|Withdrawal by Subject|1|||
27815279|NCT01684215|54272076|FG003|Phase 1, Part 2|Withdrawal by Subject|0|||
27815280|NCT01684215|54272073|FG000|Phase 2|Death|0|||
27815281|NCT01684215|54272074|FG001|Phase 2|Death|0|||
27815282|NCT01684215|54272075|FG002|Phase 2|Death|0|||
27815283|NCT01684215|54272076|FG003|Phase 2|Death|8|||
27815284|NCT01684215|54272073|FG000|Phase 2|Study terminated by sponsor|0|||
27815285|NCT01684215|54272074|FG001|Phase 2|Study terminated by sponsor|0|||
27815286|NCT01684215|54272075|FG002|Phase 2|Study terminated by sponsor|0|||
28106808|NCT03255824|54764654|FG001|Overall Study|Under-sedation|1|||
28106809|NCT03238352|54764663|FG000|Overall Study|Lost to Follow-up|0|||
28106810|NCT03238352|54764664|FG001|Overall Study|Lost to Follow-up|2|||
28106811|NCT03238352|54764665|FG002|Overall Study|Lost to Follow-up|1|||
28106812|NCT03238352|54764663|FG000|Overall Study|Withdrawal by Subject|0|||
28106813|NCT03238352|54764664|FG001|Overall Study|Withdrawal by Subject|1|||
28106814|NCT03238352|54764665|FG002|Overall Study|Withdrawal by Subject|0|||
28106815|NCT00180479|54764675|FG000|Overall Study|Death|4|||
28106816|NCT00180479|54764676|FG001|Overall Study|Death|2|||
28106817|NCT00180479|54764675|FG000|Overall Study|Lost to Follow-up|9|||
28106818|NCT00180479|54764676|FG001|Overall Study|Lost to Follow-up|7|||
28106819|NCT00180479|54764675|FG000|Overall Study|Withdrawal by Subject|3|||
28106820|NCT00180479|54764676|FG001|Overall Study|Withdrawal by Subject|3|||
28106821|NCT00180479|54764675|FG000|Overall Study|Informed consent not signed|0|||
28106822|NCT00180479|54764676|FG001|Overall Study|Informed consent not signed|1|||
28106823|NCT03224234|54764686|FG000|Main Study|Lost to Follow-up|5|||
28063439|NCT00348140|54719305|FG001|Overall Study|Investigator decided to discontinue|1|||
28063440|NCT00348140|54719306|FG002|Overall Study|Investigator decided to discontinue|4|||
28063441|NCT00348140|54719304|FG000|Overall Study|Decided to discontinue on their own|1|||
28063442|NCT00348140|54719305|FG001|Overall Study|Decided to discontinue on their own|4|||
28063443|NCT00348140|54719306|FG002|Overall Study|Decided to discontinue on their own|1|||
28063444|NCT00348140|54719304|FG000|Overall Study|Use of prohibited drug|1|||
28063445|NCT00348140|54719305|FG001|Overall Study|Use of prohibited drug|0|||
28063446|NCT00348140|54719306|FG002|Overall Study|Use of prohibited drug|2|||
28106824|NCT03224234|54764687|FG001|Main Study|Lost to Follow-up|5|||
28106825|NCT02955069|54764701|FG000|Overall Study|Adverse Event|7|||
28106826|NCT02955069|54764702|FG001|Overall Study|Adverse Event|2|||
28106827|NCT02955069|54764701|FG000|Overall Study|Death|7|||
28106828|NCT02955069|54764702|FG001|Overall Study|Death|3|||
28106829|NCT02955069|54764701|FG000|Overall Study|Physician Decision|10|||
28106830|NCT02955069|54764702|FG001|Overall Study|Physician Decision|2|||
28106831|NCT02955069|54764701|FG000|Overall Study|Progressive disease|64|||
28106832|NCT02955069|54764702|FG001|Overall Study|Progressive disease|13|||
28106833|NCT02955069|54764701|FG000|Overall Study|Study terminated by sponsor|4|||
28106834|NCT02955069|54764702|FG001|Overall Study|Study terminated by sponsor|0|||
28106835|NCT02955069|54764701|FG000|Overall Study|Subject/Guardian decision|3|||
28106836|NCT02955069|54764702|FG001|Overall Study|Subject/Guardian decision|1|||
28106837|NCT03254108|54764715|FG000|Overall Study|Adverse Event|0|||
28106838|NCT03254108|54764716|FG001|Overall Study|Adverse Event|2|||
28106839|NCT03254108|54764717|FG002|Overall Study|Adverse Event|0|||
28106840|NCT03254108|54764718|FG003|Overall Study|Adverse Event|1|||
28106841|NCT03254108|54764719|FG004|Overall Study|Adverse Event|1|||
28106842|NCT03254108|54764715|FG000|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
28106843|NCT03254108|54764716|FG001|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
28106844|NCT03254108|54764717|FG002|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
28106845|NCT03254108|54764718|FG003|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
28106846|NCT03254108|54764719|FG004|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|2|||
28106847|NCT03773978|54764743|FG000|PK/Safety and OLLI Period|Adverse Event|1|||
28106848|NCT03773978|54764744|FG001|PK/Safety and OLLI Period|Adverse Event|0|||
28106849|NCT03773978|54764743|FG000|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|39|||
28106850|NCT03773978|54764744|FG001|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|0|||
28106851|NCT03773978|54764743|FG000|PK/Safety and OLLI Period|Lost to Follow-up|1|||
28106852|NCT03773978|54764744|FG001|PK/Safety and OLLI Period|Lost to Follow-up|0|||
28106853|NCT03773978|54764743|FG000|PK/Safety and OLLI Period|Withdrawal by Subject|3|||
28106854|NCT03773978|54764744|FG001|PK/Safety and OLLI Period|Withdrawal by Subject|0|||
28106855|NCT03773978|54764743|FG000|PK/Safety and OLLI Period|Due to epidemic or pandemic|6|||
27815287|NCT01684215|54272076|FG003|Phase 2|Study terminated by sponsor|30|||
27815288|NCT01684215|54272073|FG000|Phase 2|Enrolled but not treated|0|||
27815289|NCT01684215|54272074|FG001|Phase 2|Enrolled but not treated|0|||
27815290|NCT01684215|54272075|FG002|Phase 2|Enrolled but not treated|0|||
27815291|NCT01684215|54272076|FG003|Phase 2|Enrolled but not treated|1|||
27815292|NCT01684215|54272073|FG000|Phase 2|Lost to Follow-up|0|||
27815293|NCT01684215|54272074|FG001|Phase 2|Lost to Follow-up|0|||
27815294|NCT01684215|54272075|FG002|Phase 2|Lost to Follow-up|0|||
27815295|NCT01684215|54272076|FG003|Phase 2|Lost to Follow-up|4|||
27815296|NCT01549275|54272091|FG000|Overall Study|Lost to Follow-up|1|||
27815297|NCT01549275|54272092|FG001|Overall Study|Lost to Follow-up|0|||
27815298|NCT01908205|54272104|FG000|Overall Study|Lost to Follow-up|2|||
27815299|NCT01908205|54272105|FG001|Overall Study|Lost to Follow-up|0|||
28106856|NCT03773978|54764744|FG001|PK/Safety and OLLI Period|Due to epidemic or pandemic|0|||
28106857|NCT03773978|54764743|FG000|PK/Safety and OLLI Period|unexplainable flare disease|1|||
28106858|NCT03773978|54764744|FG001|PK/Safety and OLLI Period|unexplainable flare disease|0|||
28106859|NCT03773978|54764743|FG000|PK/Safety and OLLI Period|Protocol Violation|4|||
28106860|NCT03773978|54764744|FG001|PK/Safety and OLLI Period|Protocol Violation|0|||
28106861|NCT03773978|54764743|FG000|PK/Safety and OLLI Period|Participant transitioned to JAHX|1|||
28106862|NCT03773978|54764744|FG001|PK/Safety and OLLI Period|Participant transitioned to JAHX|0|||
28106863|NCT03773978|54764743|FG000|PK/Safety and OLLI Period|Investigational product was not delivered to the site|1|||
28106864|NCT03773978|54764744|FG001|PK/Safety and OLLI Period|Investigational product was not delivered to the site|0|||
28106865|NCT03773978|54764743|FG000|DBW Period|Adverse Event|2|||
28106866|NCT03773978|54764744|FG001|DBW Period|Adverse Event|2|||
28106867|NCT03773978|54764743|FG000|DBW Period|Failure to Meet Continuation Criteria|16|||
28106868|NCT03773978|54764744|FG001|DBW Period|Failure to Meet Continuation Criteria|40|||
28106869|NCT03773978|54764743|FG000|DBW Period|Withdrawal by Subject|2|||
28106870|NCT03773978|54764744|FG001|DBW Period|Withdrawal by Subject|1|||
28106871|NCT03773978|54764743|FG000|DBW Period|Due to epidemic or pandemic|5|||
28106872|NCT03773978|54764744|FG001|DBW Period|Due to epidemic or pandemic|6|||
28106873|NCT03773978|54764743|FG000|DBW Period|Study team decision|1|||
28106874|NCT03773978|54764744|FG001|DBW Period|Study team decision|0|||
28106875|NCT03253796|54764760|FG000|Period 1: Run-In|Adverse Event|4|||
28106876|NCT03253796|54764761|FG001|Period 1: Run-In|Adverse Event|0|||
28106877|NCT03253796|54764762|FG002|Period 1: Run-In|Adverse Event|0|||
28106878|NCT03253796|54764763|FG003|Period 1: Run-In|Adverse Event|0|||
28106879|NCT03253796|54764764|FG004|Period 1: Run-In|Adverse Event|0|||
28106880|NCT03253796|54764760|FG000|Period 1: Run-In|Lack of Efficacy|1|||
28106881|NCT03253796|54764761|FG001|Period 1: Run-In|Lack of Efficacy|0|||
28106882|NCT03253796|54764762|FG002|Period 1: Run-In|Lack of Efficacy|0|||
28106883|NCT03253796|54764763|FG003|Period 1: Run-In|Lack of Efficacy|0|||
28106884|NCT03253796|54764764|FG004|Period 1: Run-In|Lack of Efficacy|0|||
28106885|NCT03253796|54764760|FG000|Period 1: Run-In|Lack of Qualifying Event|98|||
28106886|NCT03253796|54764761|FG001|Period 1: Run-In|Lack of Qualifying Event|0|||
28106887|NCT03253796|54764762|FG002|Period 1: Run-In|Lack of Qualifying Event|0|||
28106888|NCT03253796|54764763|FG003|Period 1: Run-In|Lack of Qualifying Event|0|||
28106889|NCT03253796|54764764|FG004|Period 1: Run-In|Lack of Qualifying Event|0|||
28106890|NCT03253796|54764760|FG000|Period 1: Run-In|Protocol Violation|5|||
28106891|NCT03253796|54764761|FG001|Period 1: Run-In|Protocol Violation|0|||
28106892|NCT03253796|54764762|FG002|Period 1: Run-In|Protocol Violation|0|||
28106893|NCT03253796|54764763|FG003|Period 1: Run-In|Protocol Violation|0|||
28106894|NCT03253796|54764764|FG004|Period 1: Run-In|Protocol Violation|0|||
28106895|NCT03253796|54764760|FG000|Period 1: Run-In|Withdrawal by Subject|8|||
28106896|NCT03253796|54764761|FG001|Period 1: Run-In|Withdrawal by Subject|0|||
28106897|NCT03253796|54764762|FG002|Period 1: Run-In|Withdrawal by Subject|0|||
28106898|NCT03253796|54764763|FG003|Period 1: Run-In|Withdrawal by Subject|0|||
28106899|NCT03253796|54764764|FG004|Period 1: Run-In|Withdrawal by Subject|0|||
28106900|NCT03253796|54764760|FG000|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
28106901|NCT03253796|54764761|FG001|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
28106902|NCT03253796|54764762|FG002|Period 2: Withdrawal vs Continued Tx|Adverse Event|2|||
28106903|NCT03253796|54764763|FG003|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
28106904|NCT03253796|54764764|FG004|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
28106905|NCT03253796|54764760|FG000|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
27815300|NCT01908205|54272104|FG000|Overall Study|Withdrawal by Subject|3|||
27815301|NCT01908205|54272105|FG001|Overall Study|Withdrawal by Subject|1|||
27815302|NCT01549041|54272126|FG000|Overall Study|Lack of Efficacy|2|||
27815303|NCT01549041|54272127|FG001|Overall Study|Lack of Efficacy|4|||
27815304|NCT01549041|54272126|FG000|Overall Study|Adverse Event|0|||
27815305|NCT01549041|54272127|FG001|Overall Study|Adverse Event|4|||
27815306|NCT01907815|54272135|FG000|Overall Study|Withdrawal by Subject|1|||
27815307|NCT01907815|54272136|FG001|Overall Study|Withdrawal by Subject|0|||
27815308|NCT01548573|54272144|FG000|Overall Study|Death|3|||
27815309|NCT01548573|54272144|FG000|Overall Study|Withdrawal by Subject|2|||
27815310|NCT01907737|54272149|FG000|Overall Study|Withdrawal by Subject|1|||
27815311|NCT01570491|54272161|FG000|Overall Study|Lost to Follow-up|3|||
27815312|NCT01570491|54272162|FG001|Overall Study|Lost to Follow-up|1|||
27815313|NCT01570491|54272161|FG000|Overall Study|treatment: not given or discontinued|2|||
27815314|NCT01570491|54272162|FG001|Overall Study|treatment: not given or discontinued|0|||
27815315|NCT01929109|54272173|FG000|Period 1 (All Groups)|Deviation from protocol|0|||
28106906|NCT03253796|54764761|FG001|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
28106907|NCT03253796|54764762|FG002|Period 2: Withdrawal vs Continued Tx|Physician Decision|1|||
28106908|NCT03253796|54764763|FG003|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
27815316|NCT01929109|54272174|FG001|Period 1 (All Groups)|Deviation from protocol|0|||
27815317|NCT01929109|54272175|FG002|Period 1 (All Groups)|Deviation from protocol|1|||
27848465|NCT03593213|54341467|FG002|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
27848466|NCT03593213|54341468|FG003|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
27848467|NCT03593213|54341465|FG000|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|14|||
27848468|NCT03593213|54341466|FG001|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
27848469|NCT03593213|54341467|FG002|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
27848470|NCT03593213|54341468|FG003|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
28063447|NCT00348140|54719304|FG000|Overall Study|Disease progression|1|||
28063448|NCT00348140|54719305|FG001|Overall Study|Disease progression|2|||
28063449|NCT00348140|54719306|FG002|Overall Study|Disease progression|5|||
28063450|NCT00348140|54719304|FG000|Overall Study|Increased risk of cardiac infarction|0|||
28063451|NCT00348140|54719305|FG001|Overall Study|Increased risk of cardiac infarction|1|||
28063452|NCT00348140|54719306|FG002|Overall Study|Increased risk of cardiac infarction|0|||
28063453|NCT00348140|54719304|FG000|Overall Study|Serious adverse event|0|||
28063454|NCT00348140|54719305|FG001|Overall Study|Serious adverse event|1|||
28063455|NCT00348140|54719306|FG002|Overall Study|Serious adverse event|0|||
28063456|NCT00348140|54719304|FG000|Overall Study|Abnormal ECG|0|||
28063457|NCT00348140|54719305|FG001|Overall Study|Abnormal ECG|1|||
28106909|NCT03253796|54764764|FG004|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
28106910|NCT03253796|54764760|FG000|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
28106911|NCT03253796|54764761|FG001|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
28106912|NCT03253796|54764762|FG002|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|2|||
28106913|NCT03253796|54764763|FG003|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|3|||
28106914|NCT03253796|54764764|FG004|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
28106915|NCT03253796|54764760|FG000|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
28106916|NCT03253796|54764761|FG001|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
28106917|NCT03253796|54764762|FG002|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|1|||
28106918|NCT03253796|54764763|FG003|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
28106919|NCT03253796|54764764|FG004|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
28106920|NCT03253796|54764760|FG000|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
28106921|NCT03253796|54764761|FG001|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|10|||
28106922|NCT03253796|54764762|FG002|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|15|||
28106923|NCT03253796|54764763|FG003|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|38|||
28106924|NCT03253796|54764764|FG004|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
28106925|NCT03253796|54764760|FG000|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
28106926|NCT03253796|54764761|FG001|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
28106927|NCT03253796|54764762|FG002|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
28106928|NCT03253796|54764763|FG003|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
28106929|NCT03253796|54764764|FG004|Period 2: Open-Label Retreatment|Withdrawal by Subject|5|||
28106930|NCT03682107|54764784|FG000|Overall Study|Withdrawal by Subject|0|||
28106931|NCT03682107|54764785|FG001|Overall Study|Withdrawal by Subject|1|||
28106932|NCT03682107|54764786|FG002|Overall Study|Withdrawal by Subject|0|||
28106933|NCT03682107|54764787|FG003|Overall Study|Withdrawal by Subject|0|||
28106934|NCT03682107|54764788|FG004|Overall Study|Withdrawal by Subject|0|||
28106935|NCT03673046|54764802|FG000|Overall Study|Adverse Event|1|||
28106936|NCT03673046|54764803|FG001|Overall Study|Adverse Event|1|||
28106937|NCT03673046|54764802|FG000|Overall Study|Withdrawal by Subject|8|||
27815318|NCT01929109|54272176|FG003|Period 1 (All Groups)|Deviation from protocol|0|||
27815319|NCT01929109|54272177|FG004|Period 1 (All Groups)|Deviation from protocol|0|||
27815320|NCT01518153|54272192|FG000|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5|||
27815321|NCT01518153|54272193|FG001|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
27815322|NCT01518153|54272194|FG002|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
27815323|NCT01518153|54272192|FG000|Stem Cell Transplant|Death|2|||
27815324|NCT01518153|54272193|FG001|Stem Cell Transplant|Death|0|||
27815325|NCT01518153|54272194|FG002|Stem Cell Transplant|Death|0|||
27815326|NCT01518153|54272192|FG000|Stem Cell Transplant|Secondary graft failure|1|||
27815327|NCT01518153|54272193|FG001|Stem Cell Transplant|Secondary graft failure|0|||
27815328|NCT01518153|54272194|FG002|Stem Cell Transplant|Secondary graft failure|0|||
27815329|NCT01518153|54272192|FG000|Stem Cell Transplant|Adverse Event|1|||
27815330|NCT01518153|54272193|FG001|Stem Cell Transplant|Adverse Event|0|||
27815331|NCT01518153|54272194|FG002|Stem Cell Transplant|Adverse Event|0|||
27815332|NCT01518153|54272192|FG000|Donor Lymphocyte Infusion|Death|0|||
27815333|NCT01518153|54272193|FG001|Donor Lymphocyte Infusion|Death|2|||
27815334|NCT01518153|54272194|FG002|Donor Lymphocyte Infusion|Death|1|||
27848471|NCT03593213|54341465|FG000|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|85|||
28063458|NCT00348140|54719306|FG002|Overall Study|Abnormal ECG|3|||
28063459|NCT00348140|54719304|FG000|Overall Study|Participant died|0|||
28063460|NCT00348140|54719305|FG001|Overall Study|Participant died|1|||
28063461|NCT00348140|54719306|FG002|Overall Study|Participant died|0|||
28063462|NCT00348140|54719304|FG000|Overall Study|Exclusion criteria met|0|||
28063463|NCT00348140|54719305|FG001|Overall Study|Exclusion criteria met|0|||
28063464|NCT00348140|54719306|FG002|Overall Study|Exclusion criteria met|1|||
28063465|NCT00348140|54719304|FG000|Overall Study|Memory declined|0|||
28063466|NCT00348140|54719305|FG001|Overall Study|Memory declined|0|||
28063467|NCT00348140|54719306|FG002|Overall Study|Memory declined|1|||
28106938|NCT03673046|54764803|FG001|Overall Study|Withdrawal by Subject|2|||
28106939|NCT02956005|54764809|FG000|Overall Study|Not eligible|1|||
28106940|NCT02956005|54764809|FG000|Overall Study|Withdrawal by Subject|3|||
27815335|NCT01906489|54272204|FG000|Overall Study|Adverse Event|10|||
28063468|NCT00490061|54719315|FG000|Overall Study|Physician Decision|1|||
28063469|NCT00483119|54719321|FG000|Overall Study|Adverse Event|0|||
28063470|NCT00483119|54719322|FG001|Overall Study|Adverse Event|1|||
28063471|NCT00483119|54719321|FG000|Overall Study|Physician Decision|1|||
28063472|NCT00483119|54719322|FG001|Overall Study|Physician Decision|0|||
28063473|NCT00483041|54719330|FG000|Overall Study|ABNORMAL LAB DATA AT SCREENING|0|||
28063474|NCT00483041|54719331|FG001|Overall Study|ABNORMAL LAB DATA AT SCREENING|1|||
28063475|NCT00501293|54719339|FG000|Optimization Period|Enrolled in error|1|||
28063476|NCT00501293|54719340|FG001|Optimization Period|Enrolled in error|0|||
28063477|NCT00501293|54719339|FG000|Maintenance Period|Withdrawal by Subject|14|||
28063478|NCT00501293|54719340|FG001|Maintenance Period|Withdrawal by Subject|13|||
28063479|NCT00501293|54719339|FG000|Maintenance Period|Lost to Follow-up|12|||
28063480|NCT00501293|54719340|FG001|Maintenance Period|Lost to Follow-up|7|||
28063481|NCT00501293|54719339|FG000|Maintenance Period|Adverse Event|6|||
28063482|NCT00501293|54719340|FG001|Maintenance Period|Adverse Event|6|||
28063483|NCT00501293|54719339|FG000|Maintenance Period|Protocol Violation|2|||
28063484|NCT00501293|54719340|FG001|Maintenance Period|Protocol Violation|1|||
28063485|NCT00501293|54719339|FG000|Maintenance Period|Lack of Efficacy|4|||
28063486|NCT00501293|54719340|FG001|Maintenance Period|Lack of Efficacy|1|||
28063487|NCT00501293|54719339|FG000|Maintenance Period|Noncompliant with study medication|5|||
28063488|NCT00501293|54719340|FG001|Maintenance Period|Noncompliant with study medication|0|||
28063489|NCT00501293|54719339|FG000|Maintenance Period|Went into rehabilitation|1|||
28063490|NCT00501293|54719340|FG001|Maintenance Period|Went into rehabilitation|0|||
28063491|NCT00501293|54719339|FG000|Maintenance Period|Would not wear patch|1|||
28063492|NCT00501293|54719340|FG001|Maintenance Period|Would not wear patch|0|||
28063493|NCT00501293|54719339|FG000|Maintenance Period|Application site reaction|1|||
28106941|NCT02956005|54764809|FG000|Overall Study|Physician Decision|12|||
28106942|NCT03253094|54764819|FG000|Overall Study|Adverse Event|2|||
28106943|NCT03253094|54764820|FG001|Overall Study|Adverse Event|0|||
28106944|NCT03253094|54764821|FG002|Overall Study|Adverse Event|0|||
28106945|NCT03253094|54764822|FG003|Overall Study|Adverse Event|0|||
28106946|NCT03253094|54764823|FG004|Overall Study|Adverse Event|0|||
28106947|NCT03253094|54764824|FG005|Overall Study|Adverse Event|0|||
28106948|NCT03253094|54764819|FG000|Overall Study|Lack of Efficacy|0|||
28106949|NCT03253094|54764820|FG001|Overall Study|Lack of Efficacy|0|||
28106950|NCT03253094|54764821|FG002|Overall Study|Lack of Efficacy|2|||
28106951|NCT03253094|54764822|FG003|Overall Study|Lack of Efficacy|1|||
28106952|NCT03253094|54764823|FG004|Overall Study|Lack of Efficacy|2|||
28106953|NCT03253094|54764824|FG005|Overall Study|Lack of Efficacy|1|||
28106954|NCT03253094|54764819|FG000|Overall Study|Lost to Follow-up|0|||
28106955|NCT03253094|54764820|FG001|Overall Study|Lost to Follow-up|0|||
28106956|NCT03253094|54764821|FG002|Overall Study|Lost to Follow-up|1|||
28106957|NCT03253094|54764822|FG003|Overall Study|Lost to Follow-up|1|||
28106958|NCT03253094|54764823|FG004|Overall Study|Lost to Follow-up|0|||
28106959|NCT03253094|54764824|FG005|Overall Study|Lost to Follow-up|1|||
28106960|NCT03253094|54764819|FG000|Overall Study|Physician Decision|1|||
28106961|NCT03253094|54764820|FG001|Overall Study|Physician Decision|0|||
28106962|NCT03253094|54764821|FG002|Overall Study|Physician Decision|0|||
28106963|NCT03253094|54764822|FG003|Overall Study|Physician Decision|1|||
28106964|NCT03253094|54764823|FG004|Overall Study|Physician Decision|0|||
28106965|NCT03253094|54764824|FG005|Overall Study|Physician Decision|2|||
28106966|NCT03253094|54764819|FG000|Overall Study|Withdrawal by Subject|1|||
28106967|NCT03253094|54764820|FG001|Overall Study|Withdrawal by Subject|2|||
28106968|NCT03253094|54764821|FG002|Overall Study|Withdrawal by Subject|1|||
28106969|NCT03253094|54764822|FG003|Overall Study|Withdrawal by Subject|0|||
28106970|NCT03253094|54764823|FG004|Overall Study|Withdrawal by Subject|3|||
28106971|NCT03253094|54764824|FG005|Overall Study|Withdrawal by Subject|0|||
28106972|NCT03253094|54764819|FG000|Overall Study|Other|0|||
28106973|NCT03253094|54764820|FG001|Overall Study|Other|1|||
28106974|NCT03253094|54764821|FG002|Overall Study|Other|2|||
28106975|NCT03253094|54764822|FG003|Overall Study|Other|1|||
28106976|NCT03253094|54764823|FG004|Overall Study|Other|0|||
28106977|NCT03253094|54764824|FG005|Overall Study|Other|0|||
28106978|NCT03654885|54764840|FG000|Overall Study|Randomized, Not Treated: Consent Withdrawn|5|||
28106979|NCT03654885|54764841|FG001|Overall Study|Randomized, Not Treated: Consent Withdrawn|3|||
28106980|NCT03654885|54764840|FG000|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|0|||
28106981|NCT03654885|54764841|FG001|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|3|||
28106982|NCT03654885|54764840|FG000|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|7|||
28106983|NCT03654885|54764841|FG001|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|1|||
28106984|NCT03654885|54764840|FG000|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|7|||
28106985|NCT03654885|54764841|FG001|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|1|||
28106986|NCT03654885|54764840|FG000|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|1|||
28106987|NCT03654885|54764841|FG001|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|0|||
28106988|NCT03654885|54764840|FG000|Overall Study|Adverse Event in Study Eye|3|||
28106989|NCT03654885|54764841|FG001|Overall Study|Adverse Event in Study Eye|0|||
28106990|NCT03654885|54764840|FG000|Overall Study|Consent Withdrawn|1|||
28106991|NCT03654885|54764841|FG001|Overall Study|Consent Withdrawn|0|||
28106992|NCT03654885|54764840|FG000|Overall Study|Death|3|||
28106993|NCT03654885|54764841|FG001|Overall Study|Death|1|||
28106994|NCT03654885|54764840|FG000|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|0|||
28106995|NCT03654885|54764841|FG001|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|1|||
28106996|NCT03654885|54764840|FG000|Overall Study|Lost to Follow-up|3|||
28106997|NCT03654885|54764841|FG001|Overall Study|Lost to Follow-up|3|||
28106998|NCT03236246|54764849|FG000|24-Week Dose Titration Period|Withdrawal by Subject|8|||
28106999|NCT03236246|54764850|FG001|24-Week Dose Titration Period|Withdrawal by Subject|7|||
28107000|NCT03236246|54764849|FG000|24-Week Dose Titration Period|Lost to Follow-up|0|||
28107001|NCT03236246|54764850|FG001|24-Week Dose Titration Period|Lost to Follow-up|2|||
28107002|NCT03236246|54764849|FG000|24-Week Dose Titration Period|Study Drug Non-Compliance|3|||
28107003|NCT03236246|54764850|FG001|24-Week Dose Titration Period|Study Drug Non-Compliance|2|||
28107004|NCT03236246|54764849|FG000|24-Week Dose Titration Period|Investigator Judgement|1|||
28107005|NCT03236246|54764850|FG001|24-Week Dose Titration Period|Investigator Judgement|1|||
28107006|NCT03236246|54764849|FG000|24-Week Dose Titration Period|Prohibited Therapy|1|||
28107007|NCT03236246|54764850|FG001|24-Week Dose Titration Period|Prohibited Therapy|1|||
28107008|NCT03236246|54764849|FG000|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|0|||
28107009|NCT03236246|54764850|FG001|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|1|||
28107010|NCT03236246|54764849|FG000|24-Week Dose Titration Period|Death|3|||
28107011|NCT03236246|54764850|FG001|24-Week Dose Titration Period|Death|1|||
28107012|NCT03236246|54764849|FG000|24-Week Dose Titration Period|Protocol Violation|0|||
28107013|NCT03236246|54764850|FG001|24-Week Dose Titration Period|Protocol Violation|2|||
28107014|NCT03236246|54764849|FG000|24-Week Dose Titration Period|Adverse Event|7|||
28107015|NCT03236246|54764850|FG001|24-Week Dose Titration Period|Adverse Event|8|||
28107016|NCT03236246|54764849|FG000|24-Week Dose Titration Period|Captured as Other|1|||
28107017|NCT03236246|54764850|FG001|24-Week Dose Titration Period|Captured as Other|2|||
28107018|NCT03236246|54764849|FG000|24-Week Dose Maintenance Period|Withdrawal by Subject|1|||
28107019|NCT03236246|54764850|FG001|24-Week Dose Maintenance Period|Withdrawal by Subject|3|||
28107020|NCT03236246|54764849|FG000|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
28107021|NCT03236246|54764850|FG001|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
28107022|NCT03236246|54764849|FG000|24-Week Dose Maintenance Period|Prohibited Therapy|1|||
28107023|NCT03236246|54764850|FG001|24-Week Dose Maintenance Period|Prohibited Therapy|0|||
28063494|NCT00501293|54719340|FG001|Maintenance Period|Application site reaction|0|||
28063495|NCT00482729|54719349|FG000|Overall Study|Adverse Event|29|||
28063496|NCT00482729|54719350|FG001|Overall Study|Adverse Event|33|||
28063497|NCT00482729|54719349|FG000|Overall Study|Creatinine/Creatinine Clearance Criteria|0|||
28063498|NCT00482729|54719350|FG001|Overall Study|Creatinine/Creatinine Clearance Criteria|2|||
28063499|NCT00482729|54719349|FG000|Overall Study|Hyperglycemia Criteria|7|||
28063500|NCT00482729|54719350|FG001|Overall Study|Hyperglycemia Criteria|5|||
28063501|NCT00482729|54719349|FG000|Overall Study|Lack of Efficacy|4|||
28063502|NCT00482729|54719350|FG001|Overall Study|Lack of Efficacy|16|||
28063503|NCT00482729|54719349|FG000|Overall Study|Lost to Follow-up|86|||
28063504|NCT00482729|54719350|FG001|Overall Study|Lost to Follow-up|66|||
28063505|NCT00482729|54719349|FG000|Overall Study|Physician Decision|10|||
28107024|NCT03236246|54764849|FG000|24-Week Dose Maintenance Period|Death|0|||
28107025|NCT03236246|54764850|FG001|24-Week Dose Maintenance Period|Death|1|||
28107026|NCT03236246|54764849|FG000|24-Week Dose Maintenance Period|Adverse Event|0|||
28107027|NCT03236246|54764850|FG001|24-Week Dose Maintenance Period|Adverse Event|1|||
27815336|NCT01906489|54272205|FG001|Overall Study|Adverse Event|3|||
28063506|NCT00482729|54719350|FG001|Overall Study|Physician Decision|7|||
28063507|NCT00482729|54719349|FG000|Overall Study|Pregnancy|4|||
28063508|NCT00482729|54719350|FG001|Overall Study|Pregnancy|2|||
28063509|NCT00482729|54719349|FG000|Overall Study|Protocol Violation|10|||
28063510|NCT00482729|54719350|FG001|Overall Study|Protocol Violation|18|||
28063511|NCT00482729|54719349|FG000|Overall Study|Withdrawal by Subject|67|||
28063512|NCT00482729|54719350|FG001|Overall Study|Withdrawal by Subject|69|||
28063513|NCT00359762|54719358|FG000|Period II|Adverse Event|17|||
28063514|NCT00359762|54719359|FG001|Period II|Adverse Event|0|||
28063515|NCT00359762|54719360|FG002|Period II|Adverse Event|0|||
28063516|NCT00359762|54719361|FG003|Period II|Adverse Event|0|||
28063517|NCT00359762|54719362|FG004|Period II|Adverse Event|49|||
28063518|NCT00359762|54719358|FG000|Period II|Protocol Violation|18|||
28063519|NCT00359762|54719359|FG001|Period II|Protocol Violation|0|||
28063520|NCT00359762|54719360|FG002|Period II|Protocol Violation|0|||
28063521|NCT00359762|54719361|FG003|Period II|Protocol Violation|0|||
28063522|NCT00359762|54719362|FG004|Period II|Protocol Violation|11|||
28063523|NCT00359762|54719358|FG000|Period II|Physician Decision|17|||
28063524|NCT00359762|54719359|FG001|Period II|Physician Decision|0|||
28063525|NCT00359762|54719360|FG002|Period II|Physician Decision|0|||
27815337|NCT01906489|54272204|FG000|Overall Study|Worsening of CKD|6|||
27815338|NCT01906489|54272205|FG001|Overall Study|Worsening of CKD|4|||
27815339|NCT01906489|54272204|FG000|Overall Study|Withdrawal by Subject|5|||
27815340|NCT01906489|54272205|FG001|Overall Study|Withdrawal by Subject|0|||
27815341|NCT01906489|54272204|FG000|Overall Study|Worsening of Anemia|1|||
28063526|NCT00359762|54719361|FG003|Period II|Physician Decision|0|||
28063527|NCT00359762|54719362|FG004|Period II|Physician Decision|23|||
28063528|NCT00359762|54719358|FG000|Period II|Death|2|||
28063529|NCT00359762|54719359|FG001|Period II|Death|0|||
28063530|NCT00359762|54719360|FG002|Period II|Death|0|||
28063531|NCT00359762|54719361|FG003|Period II|Death|0|||
28063532|NCT00359762|54719362|FG004|Period II|Death|4|||
28063533|NCT00359762|54719358|FG000|Period II|Lack of Efficacy|11|||
28063534|NCT00359762|54719359|FG001|Period II|Lack of Efficacy|0|||
28063535|NCT00359762|54719360|FG002|Period II|Lack of Efficacy|0|||
28063536|NCT00359762|54719361|FG003|Period II|Lack of Efficacy|0|||
28107028|NCT02937584|54764856|FG000|Period 1|Adverse Event|1|||
28107029|NCT02937584|54764857|FG001|Period 1|Adverse Event|2|||
28107030|NCT02937584|54764856|FG000|Washout|Adverse Event|0|||
28063537|NCT00359762|54719362|FG004|Period II|Lack of Efficacy|8|||
28063538|NCT00359762|54719358|FG000|Period II|Lost to follow up|5|||
28063539|NCT00359762|54719359|FG001|Period II|Lost to follow up|0|||
28063540|NCT00359762|54719360|FG002|Period II|Lost to follow up|0|||
28063541|NCT00359762|54719361|FG003|Period II|Lost to follow up|0|||
28063542|NCT00359762|54719362|FG004|Period II|Lost to follow up|5|||
28063543|NCT00359762|54719358|FG000|Period II|Entry Criteria Not Met|8|||
28063544|NCT00359762|54719359|FG001|Period II|Entry Criteria Not Met|0|||
28063545|NCT00359762|54719360|FG002|Period II|Entry Criteria Not Met|0|||
28063546|NCT00359762|54719361|FG003|Period II|Entry Criteria Not Met|0|||
28063547|NCT00359762|54719362|FG004|Period II|Entry Criteria Not Met|4|||
27815342|NCT01906489|54272205|FG001|Overall Study|Worsening of Anemia|0|||
28063548|NCT00359762|54719358|FG000|Period II|Subject Decision|50|||
28063549|NCT00359762|54719359|FG001|Period II|Subject Decision|0|||
28063550|NCT00359762|54719360|FG002|Period II|Subject Decision|0|||
28063551|NCT00359762|54719361|FG003|Period II|Subject Decision|0|||
28063552|NCT00359762|54719362|FG004|Period II|Subject Decision|70|||
28063553|NCT00359762|54719358|FG000|Period III|Protocol Violation|0|||
28063554|NCT00359762|54719359|FG001|Period III|Protocol Violation|5|||
28063555|NCT00359762|54719360|FG002|Period III|Protocol Violation|3|||
28063556|NCT00359762|54719361|FG003|Period III|Protocol Violation|8|||
28063557|NCT00359762|54719362|FG004|Period III|Protocol Violation|0|||
28063558|NCT00359762|54719358|FG000|Period III|Adverse Event|0|||
28063559|NCT00359762|54719359|FG001|Period III|Adverse Event|3|||
28063560|NCT00359762|54719360|FG002|Period III|Adverse Event|4|||
28107031|NCT02937584|54764857|FG001|Washout|Adverse Event|1|||
28107032|NCT00179621|54764866|FG000|Double-Blind Period|Lack of Therapeutic Effect|59|||
28107033|NCT00179621|54764867|FG001|Double-Blind Period|Lack of Therapeutic Effect|35|||
28107034|NCT00179621|54764868|FG002|Double-Blind Period|Lack of Therapeutic Effect|19|||
28107035|NCT00179621|54764869|FG003|Double-Blind Period|Lack of Therapeutic Effect|0|||
28107036|NCT00179621|54764866|FG000|Double-Blind Period|Adverse Event|2|||
28107037|NCT00179621|54764867|FG001|Double-Blind Period|Adverse Event|7|||
28107038|NCT00179621|54764868|FG002|Double-Blind Period|Adverse Event|4|||
28107039|NCT00179621|54764869|FG003|Double-Blind Period|Adverse Event|0|||
28107040|NCT00179621|54764866|FG000|Double-Blind Period|Withdrawal by Subject|2|||
28107041|NCT00179621|54764867|FG001|Double-Blind Period|Withdrawal by Subject|1|||
28107042|NCT00179621|54764868|FG002|Double-Blind Period|Withdrawal by Subject|3|||
28107043|NCT00179621|54764869|FG003|Double-Blind Period|Withdrawal by Subject|0|||
28107044|NCT00179621|54764866|FG000|Double-Blind Period|Death|0|||
28107045|NCT00179621|54764867|FG001|Double-Blind Period|Death|1|||
28107046|NCT00179621|54764868|FG002|Double-Blind Period|Death|2|||
28107047|NCT00179621|54764869|FG003|Double-Blind Period|Death|0|||
28107048|NCT00179621|54764866|FG000|Double-Blind Period|Protocol Violation|1|||
28107049|NCT00179621|54764867|FG001|Double-Blind Period|Protocol Violation|0|||
28107050|NCT00179621|54764868|FG002|Double-Blind Period|Protocol Violation|0|||
28063561|NCT00359762|54719361|FG003|Period III|Adverse Event|10|||
28063562|NCT00359762|54719362|FG004|Period III|Adverse Event|0|||
28063563|NCT00359762|54719358|FG000|Period III|Physician Decision|0|||
28063564|NCT00359762|54719359|FG001|Period III|Physician Decision|5|||
28107051|NCT00179621|54764869|FG003|Double-Blind Period|Protocol Violation|0|||
28107052|NCT00179621|54764866|FG000|Double-Blind Period|Other|0|||
28107053|NCT00179621|54764867|FG001|Double-Blind Period|Other|2|||
28107054|NCT00179621|54764868|FG002|Double-Blind Period|Other|2|||
28107055|NCT00179621|54764869|FG003|Double-Blind Period|Other|0|||
28107056|NCT00179621|54764866|FG000|Open-Label Period|Lack of Therapeutic Effect|0|||
28107057|NCT00179621|54764867|FG001|Open-Label Period|Lack of Therapeutic Effect|19|||
28107058|NCT00179621|54764868|FG002|Open-Label Period|Lack of Therapeutic Effect|19|||
28107059|NCT00179621|54764869|FG003|Open-Label Period|Lack of Therapeutic Effect|31|||
28107060|NCT00179621|54764866|FG000|Open-Label Period|Adverse Event|0|||
28107061|NCT00179621|54764867|FG001|Open-Label Period|Adverse Event|6|||
28107062|NCT00179621|54764868|FG002|Open-Label Period|Adverse Event|5|||
28107063|NCT00179621|54764869|FG003|Open-Label Period|Adverse Event|6|||
28107064|NCT00179621|54764866|FG000|Open-Label Period|Withdrawal by Subject|0|||
28107065|NCT00179621|54764867|FG001|Open-Label Period|Withdrawal by Subject|2|||
28107066|NCT00179621|54764868|FG002|Open-Label Period|Withdrawal by Subject|2|||
28107067|NCT00179621|54764869|FG003|Open-Label Period|Withdrawal by Subject|2|||
28107068|NCT00179621|54764866|FG000|Open-Label Period|Death|0|||
28107069|NCT00179621|54764867|FG001|Open-Label Period|Death|0|||
28107070|NCT00179621|54764868|FG002|Open-Label Period|Death|1|||
28107071|NCT00179621|54764869|FG003|Open-Label Period|Death|2|||
28107072|NCT00179621|54764866|FG000|Open-Label Period|Other|0|||
28107073|NCT00179621|54764867|FG001|Open-Label Period|Other|1|||
28107074|NCT00179621|54764868|FG002|Open-Label Period|Other|1|||
28107075|NCT00179621|54764869|FG003|Open-Label Period|Other|2|||
28107076|NCT00179309|54764880|FG000|Treatment|Toxicity|2|||
28063565|NCT00359762|54719360|FG002|Period III|Physician Decision|9|||
28107077|NCT00179309|54764881|FG001|Treatment|Toxicity|3|||
28107078|NCT00179309|54764880|FG000|Treatment|Withdrawal by Subject|1|||
28107079|NCT00179309|54764881|FG001|Treatment|Withdrawal by Subject|2|||
28063566|NCT00359762|54719361|FG003|Period III|Physician Decision|15|||
28063567|NCT00359762|54719362|FG004|Period III|Physician Decision|0|||
28063568|NCT00359762|54719358|FG000|Period III|Lack of Efficacy|0|||
28107080|NCT00179309|54764880|FG000|Treatment|Allergy|1|||
28107081|NCT00179309|54764881|FG001|Treatment|Allergy|0|||
28107082|NCT00178685|54764902|FG000|Overall Study|Death|3|||
28063569|NCT00359762|54719359|FG001|Period III|Lack of Efficacy|7|||
27940095|NCT01195662|54596421|FG002|Double Blind Treatment Period|No Longer Meets Criteria|2|||
27940096|NCT01195662|54596419|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
27940097|NCT01195662|54596420|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
27940098|NCT01195662|54596421|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
27940099|NCT01195662|54596419|FG000|Double Blind Treatment Period|Non-specified|3|||
27940100|NCT01195662|54596420|FG001|Double Blind Treatment Period|Non-specified|0|||
27940101|NCT01195662|54596421|FG002|Double Blind Treatment Period|Non-specified|0|||
27940102|NCT01195662|54596419|FG000|Double Blind Treatment Period|Missing disposition information|0|||
27940103|NCT01195662|54596420|FG001|Double Blind Treatment Period|Missing disposition information|1|||
27940104|NCT01195662|54596421|FG002|Double Blind Treatment Period|Missing disposition information|1|||
27940105|NCT01195662|54596419|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2|||
28063570|NCT00359762|54719360|FG002|Period III|Lack of Efficacy|5|||
28063571|NCT00359762|54719361|FG003|Period III|Lack of Efficacy|9|||
28063572|NCT00359762|54719362|FG004|Period III|Lack of Efficacy|0|||
28063573|NCT00359762|54719358|FG000|Period III|Lost to follow up|0|||
28063574|NCT00359762|54719359|FG001|Period III|Lost to follow up|1|||
28063575|NCT00359762|54719360|FG002|Period III|Lost to follow up|1|||
28107083|NCT00178685|54764903|FG001|Overall Study|Death|3|||
28107084|NCT00178685|54764904|FG002|Overall Study|Death|6|||
28107085|NCT00178685|54764902|FG000|Overall Study|Lost to Follow-up|100|||
28107086|NCT00178685|54764903|FG001|Overall Study|Lost to Follow-up|187|||
28107087|NCT00178685|54764904|FG002|Overall Study|Lost to Follow-up|183|||
28107088|NCT00178685|54764902|FG000|Overall Study|Withdrawal by Subject|8|||
28107089|NCT00178685|54764903|FG001|Overall Study|Withdrawal by Subject|14|||
28107090|NCT00178685|54764904|FG002|Overall Study|Withdrawal by Subject|7|||
28063576|NCT00359762|54719361|FG003|Period III|Lost to follow up|2|||
28063577|NCT00359762|54719362|FG004|Period III|Lost to follow up|0|||
28063578|NCT00359762|54719358|FG000|Period III|Entry Criteria Not Met|0|||
28063579|NCT00359762|54719359|FG001|Period III|Entry Criteria Not Met|1|||
28107091|NCT02933528|54764912|FG000|Overall Study|Lost to Follow-up|2|||
28107092|NCT00177671|54764918|FG000|Overall Study|Withdrawal by Subject|5|||
28107093|NCT00177671|54764919|FG001|Overall Study|Withdrawal by Subject|6|||
28107094|NCT00177671|54764918|FG000|Overall Study|medical complications|2|||
28107095|NCT00177671|54764919|FG001|Overall Study|medical complications|0|||
28107096|NCT00177671|54764918|FG000|Overall Study|Adverse Event|6|||
28107097|NCT00177671|54764919|FG001|Overall Study|Adverse Event|0|||
28107098|NCT00177671|54764918|FG000|Overall Study|Physician Decision|12|||
27940106|NCT01195662|54596420|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0|||
27940107|NCT01195662|54596421|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1|||
28107099|NCT00177671|54764919|FG001|Overall Study|Physician Decision|8|||
27940108|NCT01195662|54596419|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1|||
27940109|NCT01195662|54596420|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
27940110|NCT01195662|54596421|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
28063580|NCT00359762|54719360|FG002|Period III|Entry Criteria Not Met|0|||
28063581|NCT00359762|54719361|FG003|Period III|Entry Criteria Not Met|1|||
28107100|NCT02933060|54764927|FG000|Overall Study|Withdrawal by Subject|0|||
28063582|NCT00359762|54719362|FG004|Period III|Entry Criteria Not Met|0|||
28063583|NCT00359762|54719358|FG000|Period III|Subject Decision|0|||
28107101|NCT02933060|54764928|FG001|Overall Study|Withdrawal by Subject|1|||
28107102|NCT03235154|54764934|FG000|Overall Study|Withdrawal by Subject|1|||
28107103|NCT03235154|54764934|FG000|Overall Study|Adverse Event|1|||
28107104|NCT03235154|54764934|FG000|Overall Study|Lost to Follow-up|2|||
28107105|NCT03234608|54764942|FG000|Overall Study|Lost to Follow-up|23|||
28107106|NCT03234608|54764943|FG001|Overall Study|Lost to Follow-up|21|||
28107107|NCT03248882|54764954|FG000|Overall Study|Adverse Event|3|||
28107108|NCT03248882|54764955|FG001|Overall Study|Adverse Event|3|||
28107109|NCT03248882|54764956|FG002|Overall Study|Adverse Event|2|||
28107110|NCT03248882|54764957|FG003|Overall Study|Adverse Event|6|||
28107111|NCT03248882|54764958|FG004|Overall Study|Adverse Event|9|||
28107112|NCT03248882|54764954|FG000|Overall Study|Lost to Follow-up|0|||
28107113|NCT03248882|54764955|FG001|Overall Study|Lost to Follow-up|0|||
28107114|NCT03248882|54764956|FG002|Overall Study|Lost to Follow-up|0|||
28107115|NCT03248882|54764957|FG003|Overall Study|Lost to Follow-up|0|||
28107116|NCT03248882|54764958|FG004|Overall Study|Lost to Follow-up|1|||
28063584|NCT00359762|54719359|FG001|Period III|Subject Decision|7|||
28063585|NCT00359762|54719360|FG002|Period III|Subject Decision|8|||
28063586|NCT00359762|54719361|FG003|Period III|Subject Decision|20|||
28063587|NCT00359762|54719362|FG004|Period III|Subject Decision|0|||
28063588|NCT00347438|54719376|FG000|Overall Study|Withdrawal by Subject|1|||
28063589|NCT00347438|54719376|FG000|Overall Study|Physician Decision|1|||
28063590|NCT00329238|54719382|FG000|Overall Study|Adverse Event|147|||
28063591|NCT00329238|54719383|FG001|Overall Study|Adverse Event|129|||
28063592|NCT00329238|54719382|FG000|Overall Study|Protocol Violation|23|||
28063593|NCT00329238|54719383|FG001|Overall Study|Protocol Violation|34|||
28063594|NCT00329238|54719382|FG000|Overall Study|Lost to Follow-up|2|||
28063595|NCT00329238|54719383|FG001|Overall Study|Lost to Follow-up|6|||
28063596|NCT00329238|54719382|FG000|Overall Study|Withdrawal by Subject|64|||
28063597|NCT00329238|54719383|FG001|Overall Study|Withdrawal by Subject|58|||
28107117|NCT03248882|54764954|FG000|Overall Study|Protocol Violation|2|||
28063598|NCT00329238|54719382|FG000|Overall Study|Other reason (not specified)|40|||
28063599|NCT00329238|54719383|FG001|Overall Study|Other reason (not specified)|54|||
28107118|NCT03248882|54764955|FG001|Overall Study|Protocol Violation|0|||
28107119|NCT03248882|54764956|FG002|Overall Study|Protocol Violation|2|||
28107120|NCT03248882|54764957|FG003|Overall Study|Protocol Violation|0|||
28107121|NCT03248882|54764958|FG004|Overall Study|Protocol Violation|1|||
28107122|NCT03248882|54764954|FG000|Overall Study|Withdrawal by Subject|2|||
28107123|NCT03248882|54764955|FG001|Overall Study|Withdrawal by Subject|2|||
28107124|NCT03248882|54764956|FG002|Overall Study|Withdrawal by Subject|3|||
28107125|NCT03248882|54764957|FG003|Overall Study|Withdrawal by Subject|4|||
28107126|NCT03248882|54764958|FG004|Overall Study|Withdrawal by Subject|2|||
28107127|NCT03233438|54764972|FG000|Overall Study|Lost to Follow-up|4|||
28107128|NCT03233438|54764973|FG001|Overall Study|Lost to Follow-up|9|||
28107129|NCT03233438|54764972|FG000|Overall Study|Withdrawal by Subject|2|||
28107130|NCT03233438|54764973|FG001|Overall Study|Withdrawal by Subject|1|||
28107131|NCT03233438|54764972|FG000|Overall Study|No recording of dalbavancin|0|||
28107132|NCT03233438|54764973|FG001|Overall Study|No recording of dalbavancin|1|||
28107133|NCT01368406|54764981|FG000|Overall Study|Lost to Follow-up|8|||
27815343|NCT01906489|54272204|FG000|Overall Study|Protocol Violation|0|||
28107134|NCT01368406|54764982|FG001|Overall Study|Lost to Follow-up|4|||
28107135|NCT01368406|54764981|FG000|Overall Study|Withdrawal by Subject|8|||
28107136|NCT01368406|54764982|FG001|Overall Study|Withdrawal by Subject|4|||
28107137|NCT01368406|54764981|FG000|Overall Study|relapse of the disease|3|||
28107138|NCT01368406|54764982|FG001|Overall Study|relapse of the disease|2|||
28107139|NCT01368406|54764981|FG000|Overall Study|started working|2|||
28107140|NCT01368406|54764982|FG001|Overall Study|started working|3|||
28107141|NCT00175877|54764988|FG000|Overall Study|Adverse Event|136|||
28107142|NCT00175877|54764988|FG000|Overall Study|Withdrawal by Subject|141|||
28107143|NCT00175877|54764988|FG000|Overall Study|Lost to Follow-up|9|||
28107144|NCT00175877|54764988|FG000|Overall Study|Lack of Efficacy|26|||
28107145|NCT00175877|54764988|FG000|Overall Study|Protocol Violation|15|||
27815344|NCT01906489|54272205|FG001|Overall Study|Protocol Violation|1|||
27815345|NCT01906489|54272204|FG000|Overall Study|Non- Compliance|1|||
27815346|NCT01906489|54272205|FG001|Overall Study|Non- Compliance|0|||
27940111|NCT01195272|54596430|FG000|Overall Study|Adverse Event|1|||
28107146|NCT00175877|54764988|FG000|Overall Study|Other Reason|20|||
28107147|NCT00175877|54764988|FG000|Overall Study|AE & Other|1|||
28107148|NCT00175877|54764988|FG000|Overall Study|Withdrawal by subject & Other|1|||
28107149|NCT02788474|54764994|FG000|Double Blind Treatment Period|Not treated|1|||
28107150|NCT02788474|54764995|FG001|Double Blind Treatment Period|Not treated|0|||
28107151|NCT02788474|54764994|FG000|Double Blind Treatment Period|Patient's refusal|3|||
28107152|NCT02788474|54764995|FG001|Double Blind Treatment Period|Patient's refusal|0|||
28107153|NCT02788474|54764994|FG000|Double Blind Treatment Period|Adverse Event|6|||
28107154|NCT02788474|54764995|FG001|Double Blind Treatment Period|Adverse Event|4|||
28107155|NCT02788474|54764994|FG000|Open Label Treatment Period|Adverse Event|29|||
28107156|NCT02788474|54764995|FG001|Open Label Treatment Period|Adverse Event|9|||
28107157|NCT02788474|54764994|FG000|Open Label Treatment Period|Other than reason specified|1|||
28107158|NCT02788474|54764995|FG001|Open Label Treatment Period|Other than reason specified|0|||
28107159|NCT02788474|54764994|FG000|Open Label Treatment Period|Patient's refusal|1|||
28107160|NCT02788474|54764995|FG001|Open Label Treatment Period|Patient's refusal|3|||
28107161|NCT02788474|54764994|FG000|Open Label Treatment Period|Non-compliance|1|||
28107162|NCT02788474|54764995|FG001|Open Label Treatment Period|Non-compliance|0|||
28107163|NCT03248492|54765007|FG000|Overall Study|Ongoing|23|||
28107164|NCT03248492|54765008|FG001|Overall Study|Ongoing|26|||
28107165|NCT03248492|54765009|FG002|Overall Study|Ongoing|3|||
28107166|NCT03248492|54765010|FG003|Overall Study|Ongoing|85|||
28107167|NCT03248492|54765011|FG004|Overall Study|Ongoing|2|||
28107168|NCT03248492|54765007|FG000|Overall Study|Progressive disease per RECIST v1.1|16|||
28107169|NCT03248492|54765008|FG001|Overall Study|Progressive disease per RECIST v1.1|12|||
28107170|NCT03248492|54765009|FG002|Overall Study|Progressive disease per RECIST v1.1|9|||
28107171|NCT03248492|54765010|FG003|Overall Study|Progressive disease per RECIST v1.1|22|||
28107172|NCT03248492|54765011|FG004|Overall Study|Progressive disease per RECIST v1.1|0|||
28107173|NCT03248492|54765007|FG000|Overall Study|Adverse Event|6|||
28107174|NCT03248492|54765008|FG001|Overall Study|Adverse Event|6|||
28107175|NCT03248492|54765009|FG002|Overall Study|Adverse Event|8|||
28107176|NCT03248492|54765010|FG003|Overall Study|Adverse Event|8|||
28107177|NCT03248492|54765011|FG004|Overall Study|Adverse Event|1|||
28107178|NCT03248492|54765007|FG000|Overall Study|Withdrawal by Subject|3|||
28107179|NCT03248492|54765008|FG001|Overall Study|Withdrawal by Subject|3|||
28107180|NCT03248492|54765009|FG002|Overall Study|Withdrawal by Subject|0|||
28107181|NCT03248492|54765010|FG003|Overall Study|Withdrawal by Subject|3|||
28107182|NCT03248492|54765011|FG004|Overall Study|Withdrawal by Subject|1|||
28107183|NCT03248492|54765007|FG000|Overall Study|Physician Decision|1|||
28107184|NCT03248492|54765008|FG001|Overall Study|Physician Decision|0|||
28107185|NCT03248492|54765009|FG002|Overall Study|Physician Decision|1|||
28107186|NCT03248492|54765010|FG003|Overall Study|Physician Decision|2|||
28107187|NCT03248492|54765011|FG004|Overall Study|Physician Decision|0|||
28107188|NCT03248492|54765007|FG000|Overall Study|Death|1|||
28107189|NCT03248492|54765008|FG001|Overall Study|Death|0|||
28107190|NCT03248492|54765009|FG002|Overall Study|Death|0|||
28107191|NCT03248492|54765010|FG003|Overall Study|Death|6|||
28107192|NCT03248492|54765011|FG004|Overall Study|Death|0|||
28107193|NCT03248492|54765007|FG000|Overall Study|Other|0|||
28107194|NCT03248492|54765008|FG001|Overall Study|Other|1|||
28063600|NCT00329160|54719391|FG000|Overall Study|Adverse Event|27|||
28063601|NCT00329160|54719391|FG000|Overall Study|Withdrawal by Subject|13|||
28063602|NCT00329160|54719391|FG000|Overall Study|Protocol Violation|2|||
28063603|NCT00329160|54719391|FG000|Overall Study|Did not Receive Study Drug|1|||
28063604|NCT00329160|54719391|FG000|Overall Study|Incomplete IVUS|45|||
28063605|NCT00328926|54719398|FG000|Overall Study|Pregnancy|2|||
28063606|NCT00328926|54719399|FG001|Overall Study|Pregnancy|1|||
28063607|NCT00328926|54719400|FG002|Overall Study|Pregnancy|0|||
28063608|NCT00328926|54719398|FG000|Overall Study|Lost to Follow-up|0|||
28063609|NCT00328926|54719399|FG001|Overall Study|Lost to Follow-up|1|||
28063610|NCT00328926|54719400|FG002|Overall Study|Lost to Follow-up|0|||
28063611|NCT00328926|54719398|FG000|Overall Study|Death|0|||
28063612|NCT00328926|54719399|FG001|Overall Study|Death|0|||
28063613|NCT00328926|54719400|FG002|Overall Study|Death|1|||
28063614|NCT00328926|54719398|FG000|Overall Study|In vitro fertilization treatment|0|||
28063615|NCT00328926|54719399|FG001|Overall Study|In vitro fertilization treatment|0|||
28063616|NCT00328926|54719400|FG002|Overall Study|In vitro fertilization treatment|1|||
28063617|NCT00328926|54719398|FG000|Overall Study|Lack of ovarian response|0|||
28063618|NCT00328926|54719399|FG001|Overall Study|Lack of ovarian response|1|||
28063619|NCT00328926|54719400|FG002|Overall Study|Lack of ovarian response|0|||
28063620|NCT00319254|54719408|FG000|Overall Study|Withdrawal by Subject|4|||
28063621|NCT00319254|54719408|FG000|Overall Study|Death|46|||
28063622|NCT00319254|54719408|FG000|Overall Study|Lost to Follow-up|2|||
28107195|NCT03248492|54765009|FG002|Overall Study|Other|0|||
28107196|NCT03248492|54765010|FG003|Overall Study|Other|4|||
28063623|NCT00319254|54719408|FG000|Overall Study|Enrolled, Not Treated|2|||
28063624|NCT00319098|54719416|FG000|Overall Study|Serious adverse event|3|||
28063625|NCT00319098|54719417|FG001|Overall Study|Serious adverse event|0|||
28063626|NCT00319098|54719416|FG000|Overall Study|Adverse Event|20|||
28107197|NCT03248492|54765011|FG004|Overall Study|Other|0|||
28107198|NCT03247556|54765034|FG000|Overall Study|Adverse Event|1|||
28107199|NCT03247556|54765035|FG001|Overall Study|Adverse Event|4|||
28063627|NCT00319098|54719417|FG001|Overall Study|Adverse Event|1|||
28107200|NCT03247556|54765036|FG002|Overall Study|Adverse Event|5|||
28107201|NCT03247556|54765034|FG000|Overall Study|Lost to Follow-up|5|||
28107202|NCT03247556|54765035|FG001|Overall Study|Lost to Follow-up|5|||
28107203|NCT03247556|54765036|FG002|Overall Study|Lost to Follow-up|4|||
28107204|NCT03247556|54765034|FG000|Overall Study|Consent Withdrawn by Caregiver|4|||
28107205|NCT03247556|54765035|FG001|Overall Study|Consent Withdrawn by Caregiver|1|||
28107206|NCT03247556|54765036|FG002|Overall Study|Consent Withdrawn by Caregiver|5|||
28107207|NCT03247556|54765034|FG000|Overall Study|Assent/consent Withdrawn by Subject|0|||
28107208|NCT03247556|54765035|FG001|Overall Study|Assent/consent Withdrawn by Subject|2|||
28107209|NCT03247556|54765036|FG002|Overall Study|Assent/consent Withdrawn by Subject|2|||
28063628|NCT00319098|54719416|FG000|Overall Study|Withdrawal by Subject|37|||
28063629|NCT00319098|54719417|FG001|Overall Study|Withdrawal by Subject|8|||
28063630|NCT00319098|54719416|FG000|Overall Study|Migrated/moved from study area|2|||
28063631|NCT00319098|54719417|FG001|Overall Study|Migrated/moved from study area|1|||
28063632|NCT00319098|54719416|FG000|Overall Study|Lost to Follow-up|37|||
28063633|NCT00319098|54719417|FG001|Overall Study|Lost to Follow-up|13|||
28063634|NCT00319098|54719416|FG000|Overall Study|Others|33|||
28063635|NCT00319098|54719417|FG001|Overall Study|Others|8|||
28063636|NCT00319098|54719416|FG000|Overall Study|Protocol Violation|3|||
28063637|NCT00319098|54719417|FG001|Overall Study|Protocol Violation|1|||
28063638|NCT00347360|54719442|FG000|Overall Study|Adverse Event|1|||
28063639|NCT00347360|54719443|FG001|Overall Study|Adverse Event|2|||
28063640|NCT00347360|54719444|FG002|Overall Study|Adverse Event|0|||
28063641|NCT00347360|54719445|FG003|Overall Study|Adverse Event|4|||
28063642|NCT00347360|54719446|FG004|Overall Study|Adverse Event|1|||
28063643|NCT00347360|54719447|FG005|Overall Study|Adverse Event|2|||
28107210|NCT03247556|54765034|FG000|Overall Study|Protocol Violation|2|||
28107211|NCT03247556|54765035|FG001|Overall Study|Protocol Violation|0|||
28107212|NCT03247556|54765036|FG002|Overall Study|Protocol Violation|1|||
28107213|NCT03247556|54765034|FG000|Overall Study|Subject did not meet inclusion criteria|0|||
28107214|NCT03247556|54765035|FG001|Overall Study|Subject did not meet inclusion criteria|0|||
28107215|NCT03247556|54765036|FG002|Overall Study|Subject did not meet inclusion criteria|1|||
28107216|NCT03216746|54765048|FG000|Overall Study|Lost to Follow-up|6|||
28107217|NCT03216746|54765049|FG001|Overall Study|Lost to Follow-up|8|||
28107218|NCT03216746|54765050|FG002|Overall Study|Lost to Follow-up|5|||
28107219|NCT03216746|54765051|FG003|Overall Study|Lost to Follow-up|6|||
28107220|NCT02787304|54765065|FG000|Overall Study|Adverse Event|9|||
28107221|NCT02787304|54765066|FG001|Overall Study|Adverse Event|3|||
28107222|NCT02787304|54765067|FG002|Overall Study|Adverse Event|8|||
28107223|NCT02787304|54765068|FG003|Overall Study|Adverse Event|1|||
28107224|NCT02787304|54765065|FG000|Overall Study|Withdrawal by Subject|1|||
28107225|NCT02787304|54765066|FG001|Overall Study|Withdrawal by Subject|4|||
28107226|NCT02787304|54765067|FG002|Overall Study|Withdrawal by Subject|0|||
28107227|NCT02787304|54765068|FG003|Overall Study|Withdrawal by Subject|0|||
28107228|NCT02787304|54765065|FG000|Overall Study|Lost to Follow-up|1|||
28063644|NCT00347360|54719448|FG006|Overall Study|Adverse Event|2|||
28063645|NCT00347360|54719449|FG007|Overall Study|Adverse Event|0|||
28063646|NCT00347360|54719450|FG008|Overall Study|Adverse Event|2|||
28063647|NCT00347360|54719451|FG009|Overall Study|Adverse Event|3|||
28063648|NCT00347360|54719452|FG010|Overall Study|Adverse Event|3|||
28063649|NCT00347360|54719453|FG011|Overall Study|Adverse Event|1|||
28063650|NCT00347360|54719454|FG012|Overall Study|Adverse Event|3|||
28063651|NCT00347360|54719455|FG013|Overall Study|Adverse Event|2|||
28063652|NCT00347360|54719456|FG014|Overall Study|Adverse Event|2|||
28063653|NCT00347360|54719442|FG000|Overall Study|Lost to Follow-up|0|||
28063654|NCT00347360|54719443|FG001|Overall Study|Lost to Follow-up|0|||
28107229|NCT02787304|54765066|FG001|Overall Study|Lost to Follow-up|0|||
28107230|NCT02787304|54765067|FG002|Overall Study|Lost to Follow-up|0|||
28107231|NCT02787304|54765068|FG003|Overall Study|Lost to Follow-up|1|||
28107232|NCT02787304|54765065|FG000|Overall Study|Noncompliance with study drug|0|||
28107233|NCT02787304|54765066|FG001|Overall Study|Noncompliance with study drug|0|||
28107234|NCT02787304|54765067|FG002|Overall Study|Noncompliance with study drug|1|||
28107235|NCT02787304|54765068|FG003|Overall Study|Noncompliance with study drug|0|||
28107236|NCT02787304|54765065|FG000|Overall Study|Physician Decision|0|||
28107237|NCT02787304|54765066|FG001|Overall Study|Physician Decision|0|||
28107238|NCT02787304|54765067|FG002|Overall Study|Physician Decision|1|||
28107239|NCT02787304|54765068|FG003|Overall Study|Physician Decision|0|||
28107240|NCT02787304|54765065|FG000|Overall Study|Study terminated by sponsor|25|||
28107241|NCT02787304|54765066|FG001|Overall Study|Study terminated by sponsor|31|||
28107242|NCT02787304|54765067|FG002|Overall Study|Study terminated by sponsor|31|||
28107243|NCT02787304|54765068|FG003|Overall Study|Study terminated by sponsor|32|||
27848472|NCT03593213|54341466|FG001|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
28063655|NCT00347360|54719444|FG002|Overall Study|Lost to Follow-up|0|||
28063656|NCT00347360|54719445|FG003|Overall Study|Lost to Follow-up|2|||
28107244|NCT02932904|54765082|FG000|Overall Study|Reason not Specified|1|||
28107245|NCT02932904|54765083|FG001|Overall Study|Reason not Specified|0|||
28107246|NCT02932904|54765084|FG002|Overall Study|Reason not Specified|2|||
28107247|NCT02932904|54765085|FG003|Overall Study|Reason not Specified|2|||
28107248|NCT02932904|54765082|FG000|Overall Study|Noncompliance with Study Drug|2|||
28107249|NCT02932904|54765083|FG001|Overall Study|Noncompliance with Study Drug|3|||
28107250|NCT02932904|54765084|FG002|Overall Study|Noncompliance with Study Drug|3|||
28107251|NCT02932904|54765085|FG003|Overall Study|Noncompliance with Study Drug|4|||
28107252|NCT02932904|54765082|FG000|Overall Study|Pregnancy|0|||
28107253|NCT02932904|54765083|FG001|Overall Study|Pregnancy|1|||
28107254|NCT02932904|54765084|FG002|Overall Study|Pregnancy|1|||
28107255|NCT02932904|54765085|FG003|Overall Study|Pregnancy|0|||
28107256|NCT02932904|54765082|FG000|Overall Study|Study Termination|0|||
28107257|NCT02932904|54765083|FG001|Overall Study|Study Termination|1|||
28107258|NCT02932904|54765084|FG002|Overall Study|Study Termination|0|||
28107259|NCT02932904|54765085|FG003|Overall Study|Study Termination|0|||
28107260|NCT02932904|54765082|FG000|Overall Study|Voluntary Withdrawal|2|||
28063657|NCT00347360|54719446|FG004|Overall Study|Lost to Follow-up|1|||
28063658|NCT00347360|54719447|FG005|Overall Study|Lost to Follow-up|1|||
28063659|NCT00347360|54719448|FG006|Overall Study|Lost to Follow-up|0|||
28063660|NCT00347360|54719449|FG007|Overall Study|Lost to Follow-up|1|||
28063661|NCT00347360|54719450|FG008|Overall Study|Lost to Follow-up|1|||
28063662|NCT00347360|54719451|FG009|Overall Study|Lost to Follow-up|2|||
28107261|NCT02932904|54765083|FG001|Overall Study|Voluntary Withdrawal|1|||
28107262|NCT02932904|54765084|FG002|Overall Study|Voluntary Withdrawal|4|||
28107263|NCT02932904|54765085|FG003|Overall Study|Voluntary Withdrawal|2|||
28107264|NCT02932904|54765082|FG000|Overall Study|Lost to Follow-up|5|||
28063663|NCT00347360|54719452|FG010|Overall Study|Lost to Follow-up|0|||
28063664|NCT00347360|54719453|FG011|Overall Study|Lost to Follow-up|0|||
28063665|NCT00347360|54719454|FG012|Overall Study|Lost to Follow-up|1|||
28063666|NCT00347360|54719455|FG013|Overall Study|Lost to Follow-up|0|||
28107265|NCT02932904|54765083|FG001|Overall Study|Lost to Follow-up|3|||
28107266|NCT02932904|54765084|FG002|Overall Study|Lost to Follow-up|6|||
28107267|NCT02932904|54765085|FG003|Overall Study|Lost to Follow-up|0|||
28107268|NCT02932904|54765082|FG000|Overall Study|Significant Protocol Deviation|2|||
28107269|NCT02932904|54765083|FG001|Overall Study|Significant Protocol Deviation|3|||
28107270|NCT02932904|54765084|FG002|Overall Study|Significant Protocol Deviation|6|||
28107271|NCT02932904|54765085|FG003|Overall Study|Significant Protocol Deviation|1|||
28063667|NCT00347360|54719456|FG014|Overall Study|Lost to Follow-up|0|||
28063668|NCT00347360|54719442|FG000|Overall Study|Protocol Violation|2|||
28107272|NCT02932904|54765082|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
28107273|NCT02932904|54765083|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
28107274|NCT02932904|54765084|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
28107275|NCT02932904|54765085|FG003|Overall Study|Pretreatment Event/Adverse Event|3|||
28107276|NCT02932904|54765082|FG000|Overall Study|Randomized But Not Treated|1|||
28107277|NCT02932904|54765083|FG001|Overall Study|Randomized But Not Treated|1|||
28107278|NCT02932904|54765084|FG002|Overall Study|Randomized But Not Treated|0|||
28107279|NCT02932904|54765085|FG003|Overall Study|Randomized But Not Treated|2|||
28107280|NCT00688376|54765100|FG000|Double-Blind Phase|Adverse Event|4|||
28107281|NCT00688376|54765101|FG001|Double-Blind Phase|Adverse Event|4|||
28107282|NCT00688376|54765100|FG000|Double-Blind Phase|Protocol Violation|1|||
28107283|NCT00688376|54765101|FG001|Double-Blind Phase|Protocol Violation|2|||
28107284|NCT00688376|54765100|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
28107285|NCT00688376|54765101|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
28107286|NCT00688376|54765100|FG000|Double-Blind Phase|Not treated|0|||
28107287|NCT00688376|54765101|FG001|Double-Blind Phase|Not treated|1|||
28063669|NCT00347360|54719443|FG001|Overall Study|Protocol Violation|3|||
27815347|NCT01906489|54272204|FG000|Overall Study|Sponsor Decision|1|||
27815348|NCT01906489|54272205|FG001|Overall Study|Sponsor Decision|0|||
27815349|NCT01906489|54272204|FG000|Overall Study|Lost to Follow-up|1|||
27815350|NCT01906489|54272205|FG001|Overall Study|Lost to Follow-up|1|||
27815351|NCT01906489|54272204|FG000|Overall Study|Other|1|||
27815352|NCT01906489|54272205|FG001|Overall Study|Other|0|||
27815353|NCT01517373|54272216|FG000|Run-in Period|Death|1|||
27848473|NCT03593213|54341467|FG002|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
27848474|NCT03593213|54341468|FG003|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
27815354|NCT01517373|54272217|FG001|Run-in Period|Death|0|||
27815355|NCT01517373|54272218|FG002|Run-in Period|Death|0|||
27848475|NCT03593213|54341465|FG000|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|51|||
27848476|NCT03593213|54341466|FG001|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
27848477|NCT03593213|54341467|FG002|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
27848478|NCT03593213|54341468|FG003|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
27848479|NCT03593213|54341465|FG000|Open-label Treatment Period (18 Weeks)|Death|1|||
27848480|NCT03593213|54341466|FG001|Open-label Treatment Period (18 Weeks)|Death|0|||
27848481|NCT03593213|54341467|FG002|Open-label Treatment Period (18 Weeks)|Death|0|||
27848482|NCT03593213|54341468|FG003|Open-label Treatment Period (18 Weeks)|Death|0|||
27848483|NCT03593213|54341465|FG000|Open-label Treatment Period (18 Weeks)|Protocol Deviation|5|||
28063670|NCT00347360|54719444|FG002|Overall Study|Protocol Violation|1|||
28063671|NCT00347360|54719445|FG003|Overall Study|Protocol Violation|2|||
28063672|NCT00347360|54719446|FG004|Overall Study|Protocol Violation|1|||
28063673|NCT00347360|54719447|FG005|Overall Study|Protocol Violation|2|||
27815356|NCT01517373|54272219|FG003|Run-in Period|Death|0|||
27815357|NCT01517373|54272220|FG004|Run-in Period|Death|0|||
27815358|NCT01517373|54272221|FG005|Run-in Period|Death|0|||
27940112|NCT01195272|54596430|FG000|Overall Study|Lack of Efficacy|3|||
27815359|NCT01517373|54272216|FG000|Run-in Period|Adverse Event|5|||
27815360|NCT01517373|54272217|FG001|Run-in Period|Adverse Event|0|||
27815361|NCT01517373|54272218|FG002|Run-in Period|Adverse Event|0|||
27815362|NCT01517373|54272219|FG003|Run-in Period|Adverse Event|0|||
27815363|NCT01517373|54272220|FG004|Run-in Period|Adverse Event|0|||
27815364|NCT01517373|54272221|FG005|Run-in Period|Adverse Event|0|||
27815365|NCT01517373|54272216|FG000|Run-in Period|Did not meet eligibility criteria|34|||
27815366|NCT01517373|54272217|FG001|Run-in Period|Did not meet eligibility criteria|0|||
27815367|NCT01517373|54272218|FG002|Run-in Period|Did not meet eligibility criteria|0|||
27815368|NCT01517373|54272219|FG003|Run-in Period|Did not meet eligibility criteria|0|||
27815369|NCT01517373|54272220|FG004|Run-in Period|Did not meet eligibility criteria|0|||
27815370|NCT01517373|54272221|FG005|Run-in Period|Did not meet eligibility criteria|0|||
27815371|NCT01517373|54272216|FG000|Run-in Period|Lost to Follow-up|1|||
27940113|NCT01194804|54596434|FG000|Overall Study|Withdrawal by Subject|1|||
27940114|NCT01194414|54596458|FG000|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11|||
27940115|NCT01194414|54596459|FG001|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8|||
27940116|NCT01194414|54596460|FG002|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
27940117|NCT01194414|54596461|FG003|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
27940118|NCT01194414|54596458|FG000|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9|||
27940119|NCT01194414|54596459|FG001|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5|||
27940120|NCT01194414|54596460|FG002|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
27940121|NCT01194414|54596461|FG003|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
27940122|NCT01194414|54596458|FG000|24 Weeks Double Blind Period|Protocol Violation|5|||
27940123|NCT01194414|54596459|FG001|24 Weeks Double Blind Period|Protocol Violation|3|||
27940124|NCT01194414|54596460|FG002|24 Weeks Double Blind Period|Protocol Violation|0|||
27940125|NCT01194414|54596461|FG003|24 Weeks Double Blind Period|Protocol Violation|0|||
27940126|NCT01194414|54596458|FG000|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
27940127|NCT01194414|54596459|FG001|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5|||
27940128|NCT01194414|54596460|FG002|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
27940129|NCT01194414|54596461|FG003|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
27940130|NCT01194414|54596458|FG000|24 Weeks Double Blind Period|Pregnancy|2|||
27940131|NCT01194414|54596459|FG001|24 Weeks Double Blind Period|Pregnancy|2|||
27940132|NCT01194414|54596460|FG002|24 Weeks Double Blind Period|Pregnancy|0|||
27940133|NCT01194414|54596461|FG003|24 Weeks Double Blind Period|Pregnancy|0|||
27940134|NCT01194414|54596458|FG000|24 Weeks Double Blind Period|Lost to Follow-up|2|||
27940135|NCT01194414|54596459|FG001|24 Weeks Double Blind Period|Lost to Follow-up|1|||
27940136|NCT01194414|54596460|FG002|24 Weeks Double Blind Period|Lost to Follow-up|0|||
27940137|NCT01194414|54596461|FG003|24 Weeks Double Blind Period|Lost to Follow-up|0|||
27940138|NCT01194414|54596458|FG000|24 Weeks Double Blind Period|Other|0|||
27940139|NCT01194414|54596459|FG001|24 Weeks Double Blind Period|Other|1|||
27940140|NCT01194414|54596460|FG002|24 Weeks Double Blind Period|Other|0|||
27940141|NCT01194414|54596461|FG003|24 Weeks Double Blind Period|Other|0|||
27940142|NCT01194414|54596458|FG000|24 Weeks Double Blind Period|Adverse Event|28|||
27848484|NCT03593213|54341466|FG001|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
27848485|NCT03593213|54341467|FG002|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
27848486|NCT03593213|54341468|FG003|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
27848487|NCT03593213|54341465|FG000|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|23|||
28107288|NCT00688376|54765100|FG000|Blinded Extension Phase|Adverse Event|3|||
28107289|NCT00688376|54765101|FG001|Blinded Extension Phase|Adverse Event|4|||
28063674|NCT00347360|54719448|FG006|Overall Study|Protocol Violation|0|||
28063675|NCT00347360|54719449|FG007|Overall Study|Protocol Violation|0|||
28063676|NCT00347360|54719450|FG008|Overall Study|Protocol Violation|1|||
28063677|NCT00347360|54719451|FG009|Overall Study|Protocol Violation|2|||
28063678|NCT00347360|54719452|FG010|Overall Study|Protocol Violation|0|||
28063679|NCT00347360|54719453|FG011|Overall Study|Protocol Violation|0|||
28107290|NCT00688376|54765100|FG000|Blinded Extension Phase|Withdrawal by Subject|0|||
28107291|NCT00688376|54765101|FG001|Blinded Extension Phase|Withdrawal by Subject|1|||
28107292|NCT00688376|54765100|FG000|Blinded Extension Phase|Physician Decision|1|||
28107293|NCT00688376|54765101|FG001|Blinded Extension Phase|Physician Decision|0|||
28107294|NCT00688376|54765100|FG000|Blinded Extension Phase|Other|1|||
28107295|NCT00688376|54765101|FG001|Blinded Extension Phase|Other|0|||
28107296|NCT03214952|54765109|FG000|Overall Study|Protocol Deviation|45|||
28107297|NCT03214952|54765109|FG000|Overall Study|Case Report Forms Uncollected|13|||
28107298|NCT01367704|54765115|FG000|Overall Study|Lost to Follow-up|47|||
28107299|NCT01367704|54765116|FG001|Overall Study|Lost to Follow-up|161|||
28107300|NCT03214094|54765122|FG000|Overall Study|Case Report Forms Uncollected|14|||
28107301|NCT03214094|54765122|FG000|Overall Study|Protocol Deviation|46|||
28107302|NCT01367236|54765128|FG000|Overall Study|Withdrawal by Subject|3|||
28107303|NCT01367236|54765129|FG001|Overall Study|Withdrawal by Subject|1|||
28107304|NCT03681951|54765143|FG000|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1|||
28107305|NCT03681951|54765144|FG001|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
28107306|NCT03681951|54765145|FG002|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
28107307|NCT03681951|54765146|FG003|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
28107308|NCT03681951|54765147|FG004|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
28107309|NCT03681951|54765148|FG005|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
28107310|NCT03681951|54765149|FG006|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
28107311|NCT03681951|54765150|FG007|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
28107312|NCT03681951|54765143|FG000|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4|||
28107313|NCT03681951|54765144|FG001|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
28107314|NCT03681951|54765145|FG002|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
28107315|NCT03681951|54765146|FG003|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
28107316|NCT03681951|54765147|FG004|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
28107317|NCT03681951|54765148|FG005|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
28107318|NCT03681951|54765149|FG006|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
27815372|NCT01517373|54272217|FG001|Run-in Period|Lost to Follow-up|0|||
27815373|NCT01517373|54272218|FG002|Run-in Period|Lost to Follow-up|0|||
27815374|NCT01517373|54272219|FG003|Run-in Period|Lost to Follow-up|0|||
27815375|NCT01517373|54272220|FG004|Run-in Period|Lost to Follow-up|0|||
27815376|NCT01517373|54272221|FG005|Run-in Period|Lost to Follow-up|0|||
27815377|NCT01517373|54272216|FG000|Run-in Period|Withdrawal by Subject|12|||
27815378|NCT01517373|54272217|FG001|Run-in Period|Withdrawal by Subject|0|||
27815379|NCT01517373|54272218|FG002|Run-in Period|Withdrawal by Subject|0|||
27815380|NCT01517373|54272219|FG003|Run-in Period|Withdrawal by Subject|0|||
27815381|NCT01517373|54272220|FG004|Run-in Period|Withdrawal by Subject|0|||
27815382|NCT01517373|54272221|FG005|Run-in Period|Withdrawal by Subject|0|||
27815383|NCT01517373|54272216|FG000|Run-in Period|Sponsor Decision|3|||
27815384|NCT01517373|54272217|FG001|Run-in Period|Sponsor Decision|0|||
28063680|NCT00347360|54719454|FG012|Overall Study|Protocol Violation|0|||
28063681|NCT00347360|54719455|FG013|Overall Study|Protocol Violation|1|||
28063682|NCT00347360|54719456|FG014|Overall Study|Protocol Violation|0|||
28063683|NCT00347360|54719442|FG000|Overall Study|Withdrawal by Subject|0|||
28063684|NCT00347360|54719443|FG001|Overall Study|Withdrawal by Subject|1|||
28063685|NCT00347360|54719444|FG002|Overall Study|Withdrawal by Subject|2|||
28063686|NCT00347360|54719445|FG003|Overall Study|Withdrawal by Subject|4|||
28063687|NCT00347360|54719446|FG004|Overall Study|Withdrawal by Subject|1|||
28063688|NCT00347360|54719447|FG005|Overall Study|Withdrawal by Subject|2|||
27815385|NCT01517373|54272218|FG002|Run-in Period|Sponsor Decision|0|||
27815386|NCT01517373|54272219|FG003|Run-in Period|Sponsor Decision|0|||
27815387|NCT01517373|54272220|FG004|Run-in Period|Sponsor Decision|0|||
27815388|NCT01517373|54272221|FG005|Run-in Period|Sponsor Decision|0|||
28063689|NCT00347360|54719448|FG006|Overall Study|Withdrawal by Subject|1|||
28063690|NCT00347360|54719449|FG007|Overall Study|Withdrawal by Subject|1|||
28063691|NCT00347360|54719450|FG008|Overall Study|Withdrawal by Subject|1|||
28063692|NCT00347360|54719451|FG009|Overall Study|Withdrawal by Subject|1|||
28063693|NCT00347360|54719452|FG010|Overall Study|Withdrawal by Subject|0|||
28063694|NCT00347360|54719453|FG011|Overall Study|Withdrawal by Subject|3|||
27815389|NCT01517373|54272216|FG000|Run-in Period|Other|1|||
28063695|NCT00347360|54719454|FG012|Overall Study|Withdrawal by Subject|4|||
28063696|NCT00347360|54719455|FG013|Overall Study|Withdrawal by Subject|2|||
28063697|NCT00347360|54719456|FG014|Overall Study|Withdrawal by Subject|1|||
28063698|NCT00347360|54719442|FG000|Overall Study|Lack of Efficacy|1|||
28063699|NCT00347360|54719443|FG001|Overall Study|Lack of Efficacy|1|||
28063700|NCT00347360|54719444|FG002|Overall Study|Lack of Efficacy|3|||
28063701|NCT00347360|54719445|FG003|Overall Study|Lack of Efficacy|1|||
28063702|NCT00347360|54719446|FG004|Overall Study|Lack of Efficacy|0|||
28063703|NCT00347360|54719447|FG005|Overall Study|Lack of Efficacy|1|||
28063704|NCT00347360|54719448|FG006|Overall Study|Lack of Efficacy|0|||
28063705|NCT00347360|54719449|FG007|Overall Study|Lack of Efficacy|1|||
28063706|NCT00347360|54719450|FG008|Overall Study|Lack of Efficacy|1|||
28063707|NCT00347360|54719451|FG009|Overall Study|Lack of Efficacy|0|||
28063708|NCT00347360|54719452|FG010|Overall Study|Lack of Efficacy|0|||
28063709|NCT00347360|54719453|FG011|Overall Study|Lack of Efficacy|0|||
28063710|NCT00347360|54719454|FG012|Overall Study|Lack of Efficacy|0|||
28063711|NCT00347360|54719455|FG013|Overall Study|Lack of Efficacy|0|||
28063712|NCT00347360|54719456|FG014|Overall Study|Lack of Efficacy|0|||
28063713|NCT00347360|54719442|FG000|Overall Study|Reason not listed/blank|1|||
28063714|NCT00347360|54719443|FG001|Overall Study|Reason not listed/blank|0|||
28063715|NCT00347360|54719444|FG002|Overall Study|Reason not listed/blank|0|||
28063716|NCT00347360|54719445|FG003|Overall Study|Reason not listed/blank|0|||
28063717|NCT00347360|54719446|FG004|Overall Study|Reason not listed/blank|0|||
28063718|NCT00347360|54719447|FG005|Overall Study|Reason not listed/blank|0|||
28063719|NCT00347360|54719448|FG006|Overall Study|Reason not listed/blank|1|||
28063720|NCT00347360|54719449|FG007|Overall Study|Reason not listed/blank|0|||
28063721|NCT00347360|54719450|FG008|Overall Study|Reason not listed/blank|0|||
28063722|NCT00347360|54719451|FG009|Overall Study|Reason not listed/blank|0|||
28063723|NCT00347360|54719452|FG010|Overall Study|Reason not listed/blank|0|||
28063724|NCT00347360|54719453|FG011|Overall Study|Reason not listed/blank|0|||
28063725|NCT00347360|54719454|FG012|Overall Study|Reason not listed/blank|0|||
28063726|NCT00347360|54719455|FG013|Overall Study|Reason not listed/blank|1|||
28063727|NCT00347360|54719456|FG014|Overall Study|Reason not listed/blank|0|||
28063728|NCT00347360|54719442|FG000|Overall Study|Per sponsors instruction|0|||
28063729|NCT00347360|54719443|FG001|Overall Study|Per sponsors instruction|1|||
28063730|NCT00347360|54719444|FG002|Overall Study|Per sponsors instruction|0|||
28063731|NCT00347360|54719445|FG003|Overall Study|Per sponsors instruction|0|||
28063732|NCT00347360|54719446|FG004|Overall Study|Per sponsors instruction|0|||
28063733|NCT00347360|54719447|FG005|Overall Study|Per sponsors instruction|0|||
28063734|NCT00347360|54719448|FG006|Overall Study|Per sponsors instruction|0|||
28063735|NCT00347360|54719449|FG007|Overall Study|Per sponsors instruction|0|||
28063736|NCT00347360|54719450|FG008|Overall Study|Per sponsors instruction|0|||
28063737|NCT00347360|54719451|FG009|Overall Study|Per sponsors instruction|0|||
28063738|NCT00347360|54719452|FG010|Overall Study|Per sponsors instruction|0|||
28063739|NCT00347360|54719453|FG011|Overall Study|Per sponsors instruction|0|||
28063740|NCT00347360|54719454|FG012|Overall Study|Per sponsors instruction|0|||
28063741|NCT00347360|54719455|FG013|Overall Study|Per sponsors instruction|0|||
28063742|NCT00347360|54719456|FG014|Overall Study|Per sponsors instruction|0|||
28063743|NCT00347360|54719442|FG000|Overall Study|P.I. recommended due to blood pressure|0|||
28063744|NCT00347360|54719443|FG001|Overall Study|P.I. recommended due to blood pressure|0|||
28063745|NCT00347360|54719444|FG002|Overall Study|P.I. recommended due to blood pressure|0|||
28063746|NCT00347360|54719445|FG003|Overall Study|P.I. recommended due to blood pressure|0|||
28063747|NCT00347360|54719446|FG004|Overall Study|P.I. recommended due to blood pressure|1|||
28063748|NCT00347360|54719447|FG005|Overall Study|P.I. recommended due to blood pressure|0|||
28063749|NCT00347360|54719448|FG006|Overall Study|P.I. recommended due to blood pressure|0|||
28063750|NCT00347360|54719449|FG007|Overall Study|P.I. recommended due to blood pressure|0|||
28063751|NCT00347360|54719450|FG008|Overall Study|P.I. recommended due to blood pressure|0|||
28063752|NCT00347360|54719451|FG009|Overall Study|P.I. recommended due to blood pressure|0|||
28063753|NCT00347360|54719452|FG010|Overall Study|P.I. recommended due to blood pressure|0|||
28063754|NCT00347360|54719453|FG011|Overall Study|P.I. recommended due to blood pressure|0|||
28063755|NCT00347360|54719454|FG012|Overall Study|P.I. recommended due to blood pressure|0|||
27815390|NCT01517373|54272217|FG001|Run-in Period|Other|0|||
27815391|NCT01517373|54272218|FG002|Run-in Period|Other|0|||
28107319|NCT03681951|54765150|FG007|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
28107320|NCT03681951|54765143|FG000|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3|||
28107321|NCT03681951|54765144|FG001|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
28107322|NCT03681951|54765145|FG002|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
28107323|NCT03681951|54765146|FG003|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
28107324|NCT03681951|54765147|FG004|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
28107325|NCT03681951|54765148|FG005|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
28107326|NCT03681951|54765149|FG006|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
28107327|NCT03681951|54765150|FG007|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
28107328|NCT03681405|54765175|FG000|Overall Study|Found to be ineligible after randomized|1|||
28107329|NCT03681405|54765176|FG001|Overall Study|Found to be ineligible after randomized|0|||
28107330|NCT00174785|54765186|FG000|Overall Study|Adverse Event|293|||
28107331|NCT00174785|54765187|FG001|Overall Study|Adverse Event|191|||
28107332|NCT00174785|54765186|FG000|Overall Study|Protocol Violation|14|||
28107333|NCT00174785|54765187|FG001|Overall Study|Protocol Violation|14|||
28107334|NCT00174785|54765186|FG000|Overall Study|Withdrawal by Subject|173|||
28107335|NCT00174785|54765187|FG001|Overall Study|Withdrawal by Subject|175|||
28107336|NCT00174785|54765186|FG000|Overall Study|Atrial Fibrillation/Flutter recurrence|110|||
28107337|NCT00174785|54765187|FG001|Overall Study|Atrial Fibrillation/Flutter recurrence|167|||
28107338|NCT00174785|54765186|FG000|Overall Study|Prohibited antiarrhythmic medication|39|||
28107339|NCT00174785|54765187|FG001|Overall Study|Prohibited antiarrhythmic medication|88|||
28107340|NCT00174785|54765186|FG000|Overall Study|Other prohibited medication|5|||
28107341|NCT00174785|54765187|FG001|Overall Study|Other prohibited medication|3|||
28107342|NCT00174785|54765186|FG000|Overall Study|Family request|6|||
28107343|NCT00174785|54765187|FG001|Overall Study|Family request|8|||
28107344|NCT00174785|54765186|FG000|Overall Study|Not pre-specified/Not coded|56|||
28107345|NCT00174785|54765187|FG001|Overall Study|Not pre-specified/Not coded|70|||
28107346|NCT03681093|54765196|FG000|Overall Study|Subject decision|0|||
28107347|NCT03681093|54765197|FG001|Overall Study|Subject decision|2|||
28107348|NCT03681093|54765198|FG002|Overall Study|Subject decision|1|||
28107349|NCT00166517|54765208|FG000|Overall Study|Lost to Follow-up|1|||
28107350|NCT00166517|54765209|FG001|Overall Study|Lost to Follow-up|0|||
28107351|NCT00166517|54765208|FG000|Overall Study|Protocol Violation|4|||
28107352|NCT00166517|54765209|FG001|Overall Study|Protocol Violation|1|||
28107353|NCT00166517|54765208|FG000|Overall Study|Withdrawal by Subject|0|||
28107354|NCT00166517|54765209|FG001|Overall Study|Withdrawal by Subject|1|||
28107355|NCT00166439|54765215|FG000|Overall Study|Ineligible|5|||
28107356|NCT00138671|54765221|FG000|Overall Study|Death|0|||
28107357|NCT00138671|54765222|FG001|Overall Study|Death|3|||
28107358|NCT00138671|54765221|FG000|Overall Study|Adverse Event|6|||
28107359|NCT00138671|54765222|FG001|Overall Study|Adverse Event|3|||
28107360|NCT00138671|54765221|FG000|Overall Study|Lost to Follow-up|1|||
28107361|NCT00138671|54765222|FG001|Overall Study|Lost to Follow-up|2|||
28107362|NCT00138671|54765221|FG000|Overall Study|Withdrawal by Subject|3|||
27940143|NCT01194414|54596459|FG001|24 Weeks Double Blind Period|Adverse Event|40|||
27940144|NCT01194414|54596460|FG002|24 Weeks Double Blind Period|Adverse Event|0|||
28063756|NCT00347360|54719455|FG013|Overall Study|P.I. recommended due to blood pressure|0|||
28063757|NCT00347360|54719456|FG014|Overall Study|P.I. recommended due to blood pressure|0|||
28063758|NCT00347360|54719442|FG000|Overall Study|Subject did not meet end of study ABPM|0|||
28063759|NCT00347360|54719443|FG001|Overall Study|Subject did not meet end of study ABPM|0|||
28063760|NCT00347360|54719444|FG002|Overall Study|Subject did not meet end of study ABPM|0|||
28063761|NCT00347360|54719445|FG003|Overall Study|Subject did not meet end of study ABPM|0|||
28063762|NCT00347360|54719446|FG004|Overall Study|Subject did not meet end of study ABPM|0|||
28063763|NCT00347360|54719447|FG005|Overall Study|Subject did not meet end of study ABPM|0|||
28063764|NCT00347360|54719448|FG006|Overall Study|Subject did not meet end of study ABPM|1|||
28063765|NCT00347360|54719449|FG007|Overall Study|Subject did not meet end of study ABPM|0|||
28063766|NCT00347360|54719450|FG008|Overall Study|Subject did not meet end of study ABPM|0|||
28107363|NCT00138671|54765222|FG001|Overall Study|Withdrawal by Subject|5|||
28107364|NCT00138671|54765221|FG000|Overall Study|Other|3|||
28107365|NCT00138671|54765222|FG001|Overall Study|Other|3|||
28107366|NCT01367158|54765241|FG000|Overall Study|Withdrew consent|0|||
28107367|NCT01367158|54765242|FG001|Overall Study|Withdrew consent|2|||
28107368|NCT01367158|54765243|FG002|Overall Study|Withdrew consent|1|||
28107369|NCT01367158|54765244|FG003|Overall Study|Withdrew consent|0|||
28107370|NCT01367158|54765245|FG004|Overall Study|Withdrew consent|2|||
28107371|NCT01367158|54765246|FG005|Overall Study|Withdrew consent|0|||
28107372|NCT01367158|54765247|FG006|Overall Study|Withdrew consent|0|||
28107373|NCT01367158|54765248|FG007|Overall Study|Withdrew consent|1|||
28107374|NCT01367158|54765249|FG008|Overall Study|Withdrew consent|0|||
28107375|NCT01367158|54765250|FG009|Overall Study|Withdrew consent|0|||
28107376|NCT01367158|54765251|FG010|Overall Study|Withdrew consent|0|||
28107377|NCT01367158|54765241|FG000|Overall Study|Lost to Follow-up|0|||
28107378|NCT01367158|54765242|FG001|Overall Study|Lost to Follow-up|0|||
28107379|NCT01367158|54765243|FG002|Overall Study|Lost to Follow-up|0|||
28107380|NCT01367158|54765244|FG003|Overall Study|Lost to Follow-up|1|||
28107381|NCT01367158|54765245|FG004|Overall Study|Lost to Follow-up|0|||
28107382|NCT01367158|54765246|FG005|Overall Study|Lost to Follow-up|2|||
28107383|NCT01367158|54765247|FG006|Overall Study|Lost to Follow-up|0|||
28107384|NCT01367158|54765248|FG007|Overall Study|Lost to Follow-up|1|||
28107385|NCT01367158|54765249|FG008|Overall Study|Lost to Follow-up|0|||
28107386|NCT01367158|54765250|FG009|Overall Study|Lost to Follow-up|0|||
28107387|NCT01367158|54765251|FG010|Overall Study|Lost to Follow-up|1|||
28107388|NCT01367158|54765241|FG000|Overall Study|Protocol Violation|0|||
28107389|NCT01367158|54765242|FG001|Overall Study|Protocol Violation|1|||
28107390|NCT01367158|54765243|FG002|Overall Study|Protocol Violation|0|||
28107391|NCT01367158|54765244|FG003|Overall Study|Protocol Violation|0|||
28107392|NCT01367158|54765245|FG004|Overall Study|Protocol Violation|0|||
28107393|NCT01367158|54765246|FG005|Overall Study|Protocol Violation|0|||
28107394|NCT01367158|54765247|FG006|Overall Study|Protocol Violation|0|||
28107395|NCT01367158|54765248|FG007|Overall Study|Protocol Violation|0|||
28107396|NCT01367158|54765249|FG008|Overall Study|Protocol Violation|0|||
28107397|NCT01367158|54765250|FG009|Overall Study|Protocol Violation|0|||
28107398|NCT01367158|54765251|FG010|Overall Study|Protocol Violation|0|||
28107399|NCT00130637|54765286|FG000|Overall Study|Adverse Event|2|||
28107400|NCT00130637|54765286|FG000|Overall Study|Withdrawal by Subject|1|||
28107401|NCT03679767|54765294|FG000|Overall Study|Death|16|||
28107402|NCT03679767|54765295|FG001|Overall Study|Death|11|||
28107403|NCT03679767|54765296|FG002|Overall Study|Death|17|||
28107404|NCT03679767|54765297|FG003|Overall Study|Death|10|||
28107405|NCT03679767|54765294|FG000|Overall Study|Lost to Follow-up|1|||
28107406|NCT03679767|54765295|FG001|Overall Study|Lost to Follow-up|1|||
28107407|NCT03679767|54765296|FG002|Overall Study|Lost to Follow-up|1|||
28107408|NCT03679767|54765297|FG003|Overall Study|Lost to Follow-up|1|||
28107409|NCT03679767|54765294|FG000|Overall Study|Withdrawal by Subject|0|||
28107410|NCT03679767|54765295|FG001|Overall Study|Withdrawal by Subject|0|||
28107411|NCT03679767|54765296|FG002|Overall Study|Withdrawal by Subject|0|||
28107412|NCT03679767|54765297|FG003|Overall Study|Withdrawal by Subject|1|||
28107413|NCT03679767|54765294|FG000|Overall Study|Follow-up Completed|18|||
28107414|NCT03679767|54765295|FG001|Overall Study|Follow-up Completed|11|||
28107415|NCT03679767|54765296|FG002|Overall Study|Follow-up Completed|11|||
28107416|NCT03679767|54765297|FG003|Overall Study|Follow-up Completed|20|||
28107417|NCT03679767|54765294|FG000|Overall Study|Entered Hospice Care|0|||
28107418|NCT03679767|54765295|FG001|Overall Study|Entered Hospice Care|0|||
28107419|NCT03679767|54765296|FG002|Overall Study|Entered Hospice Care|0|||
28107420|NCT03679767|54765297|FG003|Overall Study|Entered Hospice Care|1|||
28107421|NCT03679767|54765294|FG000|Overall Study|Progressive Disease|0|||
28107422|NCT03679767|54765295|FG001|Overall Study|Progressive Disease|0|||
28107423|NCT03679767|54765296|FG002|Overall Study|Progressive Disease|0|||
28107424|NCT03679767|54765297|FG003|Overall Study|Progressive Disease|1|||
28107425|NCT00130247|54765311|FG000|Overall Study|Pregnancy|1|||
28107426|NCT00130247|54765312|FG001|Overall Study|Pregnancy|0|||
28107427|NCT00130247|54765311|FG000|Overall Study|Post-randomization exclusion|1|||
28107428|NCT00130247|54765312|FG001|Overall Study|Post-randomization exclusion|2|||
28107429|NCT00130247|54765311|FG000|Overall Study|Not compliant with DOT|0|||
28107430|NCT00130247|54765312|FG001|Overall Study|Not compliant with DOT|2|||
28107431|NCT03678285|54765318|FG000|Overall Study|Adverse Event|2|||
28107432|NCT03678285|54765318|FG000|Overall Study|Withdrawal by subject prior to start of workout|1|||
28107433|NCT03678285|54765318|FG000|Overall Study|Dehydrated prior to start of workout|1|||
28107434|NCT04032171|54765324|FG000|Overall Study|Study Termination|1|||
28107435|NCT04032171|54765325|FG001|Overall Study|Study Termination|0|||
28107436|NCT00137423|54765333|FG000|Overall Study|Adverse Event|7|||
28107437|NCT00137423|54765334|FG001|Overall Study|Adverse Event|9|||
28107438|NCT00137423|54765333|FG000|Overall Study|consent withdrawn|1|||
28107439|NCT00137423|54765334|FG001|Overall Study|consent withdrawn|1|||
28107440|NCT00137423|54765333|FG000|Overall Study|Lack of Efficacy|31|||
28107441|NCT00137423|54765334|FG001|Overall Study|Lack of Efficacy|33|||
28107442|NCT00137423|54765333|FG000|Overall Study|Death|0|||
28107443|NCT00137423|54765334|FG001|Overall Study|Death|1|||
28107444|NCT02786836|54765344|FG000|Overall Study|Death|1|||
28107445|NCT02786836|54765344|FG000|Overall Study|Lack of Efficacy|2|||
28107446|NCT02786836|54765344|FG000|Overall Study|Protocol Violation|3|||
28107447|NCT02786836|54765344|FG000|Overall Study|Withdrawal by Subject|3|||
28107448|NCT02786836|54765344|FG000|Overall Study|Liver Transplantation|2|||
28107449|NCT02786836|54765344|FG000|Overall Study|Device or Pharmacy Issues|3|||
28107450|NCT00137267|54765351|FG000|Overall Study|Lost to Follow-up|15|||
28107451|NCT00137267|54765352|FG001|Overall Study|Lost to Follow-up|21|||
28107452|NCT00137111|54765362|FG000|Total Therapy|Death|35|||
28107453|NCT00137111|54765363|FG001|Total Therapy|Death|0|||
28107454|NCT00137111|54765364|FG002|Total Therapy|Death|0|||
28107455|NCT00137111|54765365|FG003|Total Therapy|Death|0|||
28107456|NCT00137111|54765362|FG000|Total Therapy|Non Compliance|5|||
28107457|NCT00137111|54765363|FG001|Total Therapy|Non Compliance|0|||
28107458|NCT00137111|54765364|FG002|Total Therapy|Non Compliance|0|||
28107459|NCT00137111|54765365|FG003|Total Therapy|Non Compliance|0|||
28107460|NCT00136955|54765372|FG000|Overall Study|Adverse Event|8|||
28107461|NCT00136955|54765372|FG000|Overall Study|Lost to Follow-up|1|||
28107462|NCT00136955|54765372|FG000|Overall Study|Withdrawal by Subject|2|||
28107463|NCT00136955|54765372|FG000|Overall Study|Incl. prog. disease, protocol violation|12|||
28107464|NCT00135707|54765378|FG000|Overall Study|Lost to Follow-up|94|||
28107465|NCT00135707|54765379|FG001|Overall Study|Lost to Follow-up|89|||
28107466|NCT00135707|54765378|FG000|Overall Study|Withdrawal by Subject|0|||
28107467|NCT00135707|54765379|FG001|Overall Study|Withdrawal by Subject|1|||
28107468|NCT00135707|54765378|FG000|Overall Study|Institutional review board request|1|||
28107469|NCT00135707|54765379|FG001|Overall Study|Institutional review board request|0|||
28107470|NCT00129701|54765389|FG000|Overall Study|Withdrawal by Subject|33|||
28107471|NCT00129623|54765398|FG000|Overall Study|Adverse Event|3|||
28107472|NCT00129623|54765399|FG001|Overall Study|Adverse Event|7|||
28107473|NCT00129623|54765398|FG000|Overall Study|Refused Treatment|5|||
28107474|NCT00129623|54765399|FG001|Overall Study|Refused Treatment|3|||
28107475|NCT00129623|54765398|FG000|Overall Study|Failure to Return|1|||
28107476|NCT00129623|54765399|FG001|Overall Study|Failure to Return|1|||
28063767|NCT00347360|54719451|FG009|Overall Study|Subject did not meet end of study ABPM|0|||
28107477|NCT00129623|54765398|FG000|Overall Study|Relocated job out of state|1|||
28063768|NCT00347360|54719452|FG010|Overall Study|Subject did not meet end of study ABPM|1|||
28063769|NCT00347360|54719453|FG011|Overall Study|Subject did not meet end of study ABPM|0|||
28063770|NCT00347360|54719454|FG012|Overall Study|Subject did not meet end of study ABPM|1|||
28063771|NCT00347360|54719455|FG013|Overall Study|Subject did not meet end of study ABPM|1|||
28063772|NCT00347360|54719456|FG014|Overall Study|Subject did not meet end of study ABPM|0|||
28063773|NCT00347360|54719442|FG000|Overall Study|Abnormal lab values|0|||
28063774|NCT00347360|54719443|FG001|Overall Study|Abnormal lab values|0|||
28063775|NCT00347360|54719444|FG002|Overall Study|Abnormal lab values|0|||
28063776|NCT00347360|54719445|FG003|Overall Study|Abnormal lab values|0|||
28107478|NCT00129623|54765399|FG001|Overall Study|Relocated job out of state|0|||
28107479|NCT00129623|54765398|FG000|Overall Study|Uncertainty to return|0|||
28107480|NCT00129623|54765399|FG001|Overall Study|Uncertainty to return|1|||
28107481|NCT00129545|54765410|FG000|Overall Study|Death|5|||
28107482|NCT00129545|54765411|FG001|Overall Study|Death|60|||
28107483|NCT00129545|54765412|FG002|Overall Study|Death|44|||
28107484|NCT00129545|54765410|FG000|Overall Study|Withdrawal by Subject|3|||
28107485|NCT00129545|54765411|FG001|Overall Study|Withdrawal by Subject|18|||
28107486|NCT00129545|54765412|FG002|Overall Study|Withdrawal by Subject|44|||
28107487|NCT00129545|54765410|FG000|Overall Study|Lost to Follow-up|2|||
28107488|NCT00129545|54765411|FG001|Overall Study|Lost to Follow-up|22|||
28107489|NCT00129545|54765412|FG002|Overall Study|Lost to Follow-up|13|||
28107490|NCT00129545|54765410|FG000|Overall Study|Physician Decision|0|||
28107491|NCT00129545|54765411|FG001|Overall Study|Physician Decision|3|||
28107492|NCT00129545|54765412|FG002|Overall Study|Physician Decision|10|||
28107493|NCT00129545|54765410|FG000|Overall Study|Device not implanted|16|||
28107494|NCT00129545|54765411|FG001|Overall Study|Device not implanted|61|||
28107495|NCT00129545|54765412|FG002|Overall Study|Device not implanted|0|||
28107496|NCT00129467|54765422|FG000|Received Intervention|Death|1|||
28107497|NCT00129467|54765423|FG001|Received Intervention|Death|1|||
28107498|NCT00129467|54765422|FG000|Received Intervention|Cardiac SAE (hypertension)|1|||
28107499|NCT00129467|54765423|FG001|Received Intervention|Cardiac SAE (hypertension)|1|||
28107500|NCT00129467|54765422|FG000|Received Intervention|Delirium|2|||
28107501|NCT00129467|54765423|FG001|Received Intervention|Delirium|0|||
28107502|NCT00129467|54765422|FG000|Received Intervention|Withdrawal by Subject|1|||
28107503|NCT00129467|54765423|FG001|Received Intervention|Withdrawal by Subject|0|||
28107504|NCT00129467|54765422|FG000|Received Intervention|Nausea|1|||
28107505|NCT00129467|54765423|FG001|Received Intervention|Nausea|0|||
28107506|NCT00129467|54765422|FG000|Received Intervention|Intolerance to citalopram|0|||
28107507|NCT00129467|54765423|FG001|Received Intervention|Intolerance to citalopram|1|||
28107508|NCT00129467|54765422|FG000|Received Intervention|Dizzyness, fatigue|0|||
28107509|NCT00129467|54765423|FG001|Received Intervention|Dizzyness, fatigue|1|||
28107510|NCT00129467|54765422|FG000|Open Label for SSRI+Methylphenidate Arm|Death|1|||
28107511|NCT00129467|54765423|FG001|Open Label for SSRI+Methylphenidate Arm|Death|0|||
28107512|NCT00129467|54765422|FG000|Open Label for SSRI+Methylphenidate Arm|Delirium|1|||
28107513|NCT00129467|54765423|FG001|Open Label for SSRI+Methylphenidate Arm|Delirium|0|||
28107514|NCT00129311|54765431|FG000|Overall Study|Withdrawal by Subject|12|||
28107515|NCT00129311|54765432|FG001|Overall Study|Withdrawal by Subject|19|||
28107516|NCT00133991|54765438|FG000|Overall Study|Death|4|||
28107517|NCT02784106|54765444|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3|||
28107518|NCT02784106|54765445|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5|||
28107519|NCT02784106|54765446|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
28107520|NCT02784106|54765447|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
28107521|NCT02784106|54765444|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
28107522|NCT02784106|54765445|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
28107523|NCT02784106|54765446|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
28107524|NCT02784106|54765447|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
28107525|NCT02784106|54765444|FG000|Double-Blind Treatment Period (12 Weeks)|Other|2|||
28107526|NCT02784106|54765445|FG001|Double-Blind Treatment Period (12 Weeks)|Other|0|||
28107527|NCT02784106|54765446|FG002|Double-Blind Treatment Period (12 Weeks)|Other|0|||
28107528|NCT02784106|54765447|FG003|Double-Blind Treatment Period (12 Weeks)|Other|0|||
28107529|NCT02784106|54765444|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
28107530|NCT02784106|54765445|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
28107531|NCT02784106|54765446|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
28107532|NCT02784106|54765447|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
28107533|NCT02784106|54765444|FG000|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
28107534|NCT02784106|54765445|FG001|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
28107535|NCT02784106|54765446|FG002|Open-Label Extension Period (26 Weeks)|Adverse Event|2|||
28107536|NCT02784106|54765447|FG003|Open-Label Extension Period (26 Weeks)|Adverse Event|1|||
28107537|NCT02784106|54765444|FG000|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
27851618|NCT00985673|54351075|FG001|Overall Study|Withdrawal by Subject|4|||
28063777|NCT00347360|54719446|FG004|Overall Study|Abnormal lab values|0|||
28063778|NCT00347360|54719447|FG005|Overall Study|Abnormal lab values|0|||
28063779|NCT00347360|54719448|FG006|Overall Study|Abnormal lab values|1|||
28063780|NCT00347360|54719449|FG007|Overall Study|Abnormal lab values|0|||
28063781|NCT00347360|54719450|FG008|Overall Study|Abnormal lab values|0|||
28063782|NCT00347360|54719451|FG009|Overall Study|Abnormal lab values|0|||
28063783|NCT00347360|54719452|FG010|Overall Study|Abnormal lab values|0|||
28063784|NCT00347360|54719453|FG011|Overall Study|Abnormal lab values|0|||
28063785|NCT00347360|54719454|FG012|Overall Study|Abnormal lab values|0|||
28063786|NCT00347360|54719455|FG013|Overall Study|Abnormal lab values|0|||
28063787|NCT00347360|54719456|FG014|Overall Study|Abnormal lab values|0|||
28063788|NCT00347360|54719442|FG000|Overall Study|PI recommended early withdrawal|0|||
28063789|NCT00347360|54719443|FG001|Overall Study|PI recommended early withdrawal|0|||
28063790|NCT00347360|54719444|FG002|Overall Study|PI recommended early withdrawal|0|||
28063791|NCT00347360|54719445|FG003|Overall Study|PI recommended early withdrawal|0|||
28063792|NCT00347360|54719446|FG004|Overall Study|PI recommended early withdrawal|0|||
28107538|NCT02784106|54765445|FG001|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
28107539|NCT02784106|54765446|FG002|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
28107540|NCT02784106|54765447|FG003|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
28107541|NCT02785900|54765458|FG000|Overall Study|Study Termination by Sponsor|64|||
28107542|NCT02785900|54765459|FG001|Overall Study|Study Termination by Sponsor|81|||
28107543|NCT02785900|54765458|FG000|Overall Study|Death|46|||
28107544|NCT02785900|54765459|FG001|Overall Study|Death|32|||
28107545|NCT02785900|54765458|FG000|Overall Study|Withdrawal by Subject|4|||
28107546|NCT02785900|54765459|FG001|Overall Study|Withdrawal by Subject|8|||
28107547|NCT02785900|54765458|FG000|Overall Study|Physician Decision|3|||
28107548|NCT02785900|54765459|FG001|Overall Study|Physician Decision|2|||
28107549|NCT00127205|54765468|FG000|Overall Study|Adverse Event|228|||
28107550|NCT00127205|54765469|FG001|Overall Study|Adverse Event|387|||
28107551|NCT00127205|54765470|FG002|Overall Study|Adverse Event|273|||
28107552|NCT00127205|54765468|FG000|Overall Study|Death|8|||
28107553|NCT00127205|54765469|FG001|Overall Study|Death|6|||
28107554|NCT00127205|54765470|FG002|Overall Study|Death|5|||
28107555|NCT00127205|54765468|FG000|Overall Study|Withdrawal by Subject|318|||
28107556|NCT00127205|54765469|FG001|Overall Study|Withdrawal by Subject|310|||
28107557|NCT00127205|54765470|FG002|Overall Study|Withdrawal by Subject|172|||
28107558|NCT00127205|54765468|FG000|Overall Study|Other-non protocol specified|142|||
28107559|NCT00127205|54765469|FG001|Overall Study|Other-non protocol specified|129|||
28107560|NCT00127205|54765470|FG002|Overall Study|Other-non protocol specified|77|||
28107561|NCT00127205|54765468|FG000|Overall Study|Data not reported|6|||
28107562|NCT00127205|54765469|FG001|Overall Study|Data not reported|10|||
28107563|NCT00127205|54765470|FG002|Overall Study|Data not reported|1|||
28107564|NCT00127205|54765468|FG000|Overall Study|Progression|127|||
28107565|NCT00127205|54765469|FG001|Overall Study|Progression|131|||
28107566|NCT00127205|54765470|FG002|Overall Study|Progression|84|||
28107567|NCT02785588|54765480|FG000|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1|||
28107568|NCT02785588|54765480|FG000|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1|||
28107569|NCT03670641|54765484|FG000|Overall Study|Lost to Follow-up|3|||
28107570|NCT04029519|54765491|FG000|Overall Study|Protocol Violation|1|||
28107571|NCT04029519|54765491|FG000|Overall Study|Withdrawal by Subject|3|||
28107572|NCT04029519|54765491|FG000|Overall Study|Lost to Follow-up|1|||
28107573|NCT03669861|54765495|FG000|Overall Study|Disease Flare|5|||
28107574|NCT03669861|54765495|FG000|Overall Study|Lack of Efficacy|2|||
28107575|NCT00127127|54765503|FG000|Overall Study|Adverse Event|0|||
27815392|NCT01517373|54272219|FG003|Run-in Period|Other|0|||
28107576|NCT00127127|54765504|FG001|Overall Study|Adverse Event|2|||
28107577|NCT00127127|54765505|FG002|Overall Study|Adverse Event|0|||
28107578|NCT00127127|54765506|FG003|Overall Study|Adverse Event|1|||
28107579|NCT00127127|54765503|FG000|Overall Study|Lack of Efficacy|1|||
28107580|NCT00127127|54765504|FG001|Overall Study|Lack of Efficacy|3|||
28107581|NCT00127127|54765505|FG002|Overall Study|Lack of Efficacy|0|||
28107582|NCT00127127|54765506|FG003|Overall Study|Lack of Efficacy|2|||
28107583|NCT03669549|54765543|FG000|Overall Study|Adverse Event|4|||
28107584|NCT03669549|54765543|FG000|Overall Study|Withdrawal by Subject|1|||
28107585|NCT03669549|54765543|FG000|Overall Study|Study terminated by the Sponsor|1|||
28107586|NCT00126659|54765554|FG000|Overall Study|Adverse Event|0|||
28107587|NCT00126659|54765555|FG001|Overall Study|Adverse Event|0|||
28107588|NCT00126659|54765556|FG002|Overall Study|Adverse Event|2|||
28107589|NCT04022733|54765564|FG000|Overall Study|conversion to open surgery|3|||
28107590|NCT04022733|54765565|FG001|Overall Study|conversion to open surgery|2|||
28107591|NCT04022733|54765564|FG000|Overall Study|bradycardia|0|||
28107592|NCT04022733|54765565|FG001|Overall Study|bradycardia|1|||
28107593|NCT03669081|54765573|FG000|Overall Study|Data could not be validated|1|||
28107594|NCT03669081|54765574|FG001|Overall Study|Data could not be validated|1|||
28107595|NCT03667053|54765583|FG000|Overall Study|Withdrawal by Subject|1|||
28107596|NCT03667053|54765584|FG001|Overall Study|Withdrawal by Subject|0|||
28107597|NCT03667053|54765585|FG002|Overall Study|Withdrawal by Subject|0|||
28107598|NCT03631407|54765602|FG000|Overall Study|Withdrawal by Subject|3|||
28107599|NCT03631407|54765603|FG001|Overall Study|Withdrawal by Subject|2|||
28107600|NCT03631407|54765602|FG000|Overall Study|Sponsor Decision|0|||
28107601|NCT03631407|54765603|FG001|Overall Study|Sponsor Decision|2|||
28107602|NCT03631407|54765602|FG000|Overall Study|Death|16|||
28107603|NCT03631407|54765603|FG001|Overall Study|Death|16|||
28107604|NCT03631407|54765602|FG000|Overall Study|Randomized by mistake without study treatment|1|||
28107605|NCT03631407|54765603|FG001|Overall Study|Randomized by mistake without study treatment|0|||
28107606|NCT03630393|54765620|FG000|Overall Study|Death|1|||
28107607|NCT03630393|54765621|FG001|Overall Study|Death|0|||
28107608|NCT03628599|54765638|FG000|Overall Study|Adverse Event|0|||
28107609|NCT03628599|54765639|FG001|Overall Study|Adverse Event|1|||
28107610|NCT03627195|54765665|FG000|Overall Study|OTHER (LACK OF EFFICACY)|1|||
28107611|NCT03627195|54765666|FG001|Overall Study|OTHER (LACK OF EFFICACY)|0|||
28107612|NCT03627195|54765667|FG002|Overall Study|OTHER (LACK OF EFFICACY)|0|||
28107613|NCT03627195|54765668|FG003|Overall Study|OTHER (LACK OF EFFICACY)|0|||
28107614|NCT03627195|54765669|FG004|Overall Study|OTHER (LACK OF EFFICACY)|0|||
28107615|NCT03627195|54765670|FG005|Overall Study|OTHER (LACK OF EFFICACY)|0|||
28107616|NCT00126581|54765686|FG000|Overall Study|Adverse Event|3|||
28107617|NCT00126581|54765687|FG001|Overall Study|Adverse Event|7|||
28107618|NCT00126581|54765686|FG000|Overall Study|Death|3|||
28107619|NCT00126581|54765687|FG001|Overall Study|Death|2|||
28107620|NCT00126581|54765686|FG000|Overall Study|Withdrawal by Subject|1|||
28107621|NCT00126581|54765687|FG001|Overall Study|Withdrawal by Subject|4|||
28107622|NCT00126581|54765686|FG000|Overall Study|Alternative therapy|3|||
28107623|NCT00126581|54765687|FG001|Overall Study|Alternative therapy|3|||
28107624|NCT00126581|54765686|FG000|Overall Study|Other illness/MD discretion|3|||
28107625|NCT00126581|54765687|FG001|Overall Study|Other illness/MD discretion|4|||
28107626|NCT03704584|54765697|FG000|Overall Study|Withdrawal by Subject|1|||
28107627|NCT03704584|54765698|FG001|Overall Study|Withdrawal by Subject|0|||
28107628|NCT03662997|54765708|FG000|Overall Study|Adverse Event|0|||
28107629|NCT03662997|54765709|FG001|Overall Study|Adverse Event|2|||
28107630|NCT03662997|54765710|FG002|Overall Study|Adverse Event|0|||
28107631|NCT03662997|54765711|FG003|Overall Study|Adverse Event|0|||
28107632|NCT03648879|54765723|FG000|Overall Study|Subject determined to have Cadherin-1 (CDH1) variant of uncertain significance.|1|||
28107633|NCT03647709|54765727|FG000|Overall Study|Lost to Follow-up|5|||
28107634|NCT03647709|54765727|FG000|Overall Study|Physician Decision|6|||
28107635|NCT03647709|54765727|FG000|Overall Study|Withdrawal by Subject|3|||
28107636|NCT03661983|54765733|FG000|Open Label Stabilization Phase|Adverse Event|5|||
28107637|NCT03661983|54765734|FG001|Open Label Stabilization Phase|Adverse Event|0|||
28107638|NCT03661983|54765735|FG002|Open Label Stabilization Phase|Adverse Event|0|||
28107639|NCT03661983|54765736|FG003|Open Label Stabilization Phase|Adverse Event|0|||
28107640|NCT03661983|54765733|FG000|Open Label Stabilization Phase|Lack of Efficacy|1|||
28107641|NCT03661983|54765734|FG001|Open Label Stabilization Phase|Lack of Efficacy|0|||
28107642|NCT03661983|54765735|FG002|Open Label Stabilization Phase|Lack of Efficacy|0|||
28107643|NCT03661983|54765736|FG003|Open Label Stabilization Phase|Lack of Efficacy|0|||
28107644|NCT03661983|54765733|FG000|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2|||
28107645|NCT03661983|54765734|FG001|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
28107646|NCT03661983|54765735|FG002|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
28107647|NCT03661983|54765736|FG003|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
28107648|NCT03661983|54765733|FG000|Open Label Stabilization Phase|Study Terminated by Sponsor|3|||
28107649|NCT03661983|54765734|FG001|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
28107650|NCT03661983|54765735|FG002|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
28107651|NCT03661983|54765736|FG003|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
28107652|NCT03661983|54765733|FG000|Double-blind Randomized Phase|Adverse Event|0|||
28107653|NCT03661983|54765734|FG001|Double-blind Randomized Phase|Adverse Event|1|||
28107654|NCT03661983|54765735|FG002|Double-blind Randomized Phase|Adverse Event|0|||
28107655|NCT03661983|54765736|FG003|Double-blind Randomized Phase|Adverse Event|0|||
28107656|NCT03661983|54765733|FG000|Double-blind Randomized Phase|Disease Relapse|0|||
28107657|NCT03661983|54765734|FG001|Double-blind Randomized Phase|Disease Relapse|0|||
28107658|NCT03661983|54765735|FG002|Double-blind Randomized Phase|Disease Relapse|0|||
28107659|NCT03661983|54765736|FG003|Double-blind Randomized Phase|Disease Relapse|6|||
28107660|NCT03661983|54765733|FG000|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
28107661|NCT03661983|54765734|FG001|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
28107662|NCT03661983|54765735|FG002|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
28107663|NCT03661983|54765736|FG003|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1|||
28107664|NCT03661983|54765733|FG000|Double-blind Randomized Phase|Study Terminated by Sponsor|0|||
28107665|NCT03661983|54765734|FG001|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
28107666|NCT03661983|54765735|FG002|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
28107667|NCT03661983|54765736|FG003|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
28107668|NCT02783170|54765747|FG000|Overall Study|Randomized but not Vaccinated|1|||
28107669|NCT02783170|54765748|FG001|Overall Study|Randomized but not Vaccinated|0|||
28107670|NCT03646305|54765759|FG000|Overall Study|Lost to Follow-up|4|||
28107671|NCT03646305|54765760|FG001|Overall Study|Lost to Follow-up|2|||
28107672|NCT03646305|54765761|FG002|Overall Study|Lost to Follow-up|2|||
28107673|NCT03646305|54765762|FG003|Overall Study|Lost to Follow-up|1|||
28107674|NCT03646305|54765759|FG000|Overall Study|Withdrawal by Subject|1|||
28107675|NCT03646305|54765760|FG001|Overall Study|Withdrawal by Subject|0|||
28107676|NCT03646305|54765761|FG002|Overall Study|Withdrawal by Subject|0|||
28107677|NCT03646305|54765762|FG003|Overall Study|Withdrawal by Subject|1|||
28107678|NCT02782780|54765778|FG000|Overall Study|dropped out after randomization.|7|||
28107679|NCT02782780|54765779|FG001|Overall Study|dropped out after randomization.|5|||
28107680|NCT02782780|54765778|FG000|Overall Study|Protocol Violation|0|||
28107681|NCT02782780|54765779|FG001|Overall Study|Protocol Violation|2|||
28107682|NCT00126503|54765791|FG000|Overall Study|disease progression|23|||
28107683|NCT00126503|54765792|FG001|Overall Study|disease progression|14|||
28107684|NCT00126503|54765791|FG000|Overall Study|Withdrawal by Subject|0|||
28107685|NCT00126503|54765792|FG001|Overall Study|Withdrawal by Subject|1|||
28107686|NCT00126503|54765791|FG000|Overall Study|alternative therapy|1|||
28107687|NCT00126503|54765792|FG001|Overall Study|alternative therapy|1|||
28107688|NCT00126503|54765791|FG000|Overall Study|other complicating disease|4|||
28107689|NCT00126503|54765792|FG001|Overall Study|other complicating disease|1|||
28107690|NCT00126503|54765791|FG000|Overall Study|Death|3|||
28107691|NCT00126503|54765792|FG001|Overall Study|Death|0|||
28107692|NCT00126503|54765791|FG000|Overall Study|Adverse Event|13|||
28107693|NCT00126503|54765792|FG001|Overall Study|Adverse Event|3|||
28107694|NCT00126503|54765791|FG000|Overall Study|non-compliant|1|||
28107695|NCT00126503|54765792|FG001|Overall Study|non-compliant|0|||
28107696|NCT00126503|54765791|FG000|Overall Study|Physician Decision|2|||
28107697|NCT00126503|54765792|FG001|Overall Study|Physician Decision|1|||
28107698|NCT00126425|54765804|FG000|Overall Study|Withdrawal by Subject|17|||
28107699|NCT00126425|54765805|FG001|Overall Study|Withdrawal by Subject|1|||
28107700|NCT00126425|54765804|FG000|Overall Study|Lost to Follow-up|8|||
28107701|NCT00126425|54765805|FG001|Overall Study|Lost to Follow-up|4|||
28107702|NCT00126425|54765804|FG000|Overall Study|Protocol Violation|9|||
28107703|NCT00126425|54765805|FG001|Overall Study|Protocol Violation|6|||
28107704|NCT00126425|54765804|FG000|Overall Study|Adverse Event|1|||
28107705|NCT00126425|54765805|FG001|Overall Study|Adverse Event|0|||
28107706|NCT00126425|54765804|FG000|Overall Study|Failed Inclusion Exclusion Criteria|1|||
28107707|NCT00126425|54765805|FG001|Overall Study|Failed Inclusion Exclusion Criteria|0|||
28107708|NCT00126425|54765804|FG000|Overall Study|Other|5|||
28107709|NCT00126425|54765805|FG001|Overall Study|Other|0|||
28107710|NCT00126191|54765813|FG000|Overall Study|Physician Decision|0|||
28107711|NCT00126191|54765814|FG001|Overall Study|Physician Decision|1|||
28107712|NCT00126191|54765813|FG000|Overall Study|Death|0|||
28107713|NCT00126191|54765814|FG001|Overall Study|Death|1|||
27940145|NCT01194414|54596461|FG003|24 Weeks Double Blind Period|Adverse Event|0|||
27940146|NCT01194414|54596458|FG000|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2|||
27940147|NCT01194414|54596459|FG001|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1|||
27940148|NCT01194414|54596460|FG002|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
28063793|NCT00347360|54719447|FG005|Overall Study|PI recommended early withdrawal|0|||
28063794|NCT00347360|54719448|FG006|Overall Study|PI recommended early withdrawal|0|||
28063795|NCT00347360|54719449|FG007|Overall Study|PI recommended early withdrawal|0|||
28063796|NCT00347360|54719450|FG008|Overall Study|PI recommended early withdrawal|0|||
28063797|NCT00347360|54719451|FG009|Overall Study|PI recommended early withdrawal|1|||
28063798|NCT00347360|54719452|FG010|Overall Study|PI recommended early withdrawal|0|||
28063799|NCT00347360|54719453|FG011|Overall Study|PI recommended early withdrawal|0|||
28063800|NCT00347360|54719454|FG012|Overall Study|PI recommended early withdrawal|0|||
28063801|NCT00347360|54719455|FG013|Overall Study|PI recommended early withdrawal|0|||
28063802|NCT00347360|54719456|FG014|Overall Study|PI recommended early withdrawal|0|||
28063803|NCT00347360|54719442|FG000|Overall Study|Did not meet criteria before ABPM|0|||
28063804|NCT00347360|54719443|FG001|Overall Study|Did not meet criteria before ABPM|0|||
28063805|NCT00347360|54719444|FG002|Overall Study|Did not meet criteria before ABPM|0|||
28063806|NCT00347360|54719445|FG003|Overall Study|Did not meet criteria before ABPM|0|||
28063807|NCT00347360|54719446|FG004|Overall Study|Did not meet criteria before ABPM|0|||
28063808|NCT00347360|54719447|FG005|Overall Study|Did not meet criteria before ABPM|0|||
28063809|NCT00347360|54719448|FG006|Overall Study|Did not meet criteria before ABPM|0|||
28063810|NCT00347360|54719449|FG007|Overall Study|Did not meet criteria before ABPM|0|||
27940149|NCT01194414|54596461|FG003|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
27940150|NCT01194414|54596458|FG000|24 Weeks Double Blind Period|Death|0|||
27940151|NCT01194414|54596459|FG001|24 Weeks Double Blind Period|Death|1|||
27940152|NCT01194414|54596460|FG002|24 Weeks Double Blind Period|Death|0|||
27940153|NCT01194414|54596461|FG003|24 Weeks Double Blind Period|Death|0|||
27940154|NCT01194414|54596458|FG000|72 Weeks Open Label Extension|Randomized but not Treated|3|||
27940155|NCT01194414|54596459|FG001|72 Weeks Open Label Extension|Randomized but not Treated|5|||
28063811|NCT00347360|54719450|FG008|Overall Study|Did not meet criteria before ABPM|0|||
28063812|NCT00347360|54719451|FG009|Overall Study|Did not meet criteria before ABPM|0|||
28063813|NCT00347360|54719452|FG010|Overall Study|Did not meet criteria before ABPM|1|||
28107714|NCT00124943|54765824|FG000|Phase II|Adverse Event|0|||
28107715|NCT00124943|54765825|FG001|Phase II|Adverse Event|2|||
28107716|NCT00124943|54765826|FG002|Phase II|Adverse Event|0|||
28107717|NCT00124943|54765827|FG003|Phase II|Adverse Event|1|||
28107718|NCT00124943|54765824|FG000|Phase II|Protocol Violation|0|||
28107719|NCT00124943|54765825|FG001|Phase II|Protocol Violation|0|||
28107720|NCT00124943|54765826|FG002|Phase II|Protocol Violation|0|||
27940156|NCT01194414|54596460|FG002|72 Weeks Open Label Extension|Randomized but not Treated|0|||
27940157|NCT01194414|54596461|FG003|72 Weeks Open Label Extension|Randomized but not Treated|0|||
27940158|NCT01194414|54596458|FG000|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20|||
27940159|NCT01194414|54596459|FG001|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14|||
27940160|NCT01194414|54596460|FG002|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1|||
27940161|NCT01194414|54596461|FG003|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6|||
27940162|NCT01194414|54596458|FG000|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9|||
27940163|NCT01194414|54596459|FG001|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11|||
27940164|NCT01194414|54596460|FG002|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2|||
27940165|NCT01194414|54596461|FG003|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3|||
27940166|NCT01194414|54596458|FG000|72 Weeks Open Label Extension|Lost to Follow-up|4|||
27940167|NCT01194414|54596459|FG001|72 Weeks Open Label Extension|Lost to Follow-up|3|||
27940168|NCT01194414|54596460|FG002|72 Weeks Open Label Extension|Lost to Follow-up|2|||
27940169|NCT01194414|54596461|FG003|72 Weeks Open Label Extension|Lost to Follow-up|1|||
28107721|NCT00124943|54765827|FG003|Phase II|Protocol Violation|1|||
28107722|NCT00124943|54765824|FG000|Phase II|Lost to Follow-up|0|||
28107723|NCT00124943|54765825|FG001|Phase II|Lost to Follow-up|0|||
28107724|NCT00124943|54765826|FG002|Phase II|Lost to Follow-up|0|||
28107725|NCT00124943|54765827|FG003|Phase II|Lost to Follow-up|1|||
28107726|NCT00124943|54765824|FG000|Phase II|Withdrawal by Subject|0|||
28107727|NCT00124943|54765825|FG001|Phase II|Withdrawal by Subject|0|||
28107728|NCT00124943|54765826|FG002|Phase II|Withdrawal by Subject|0|||
28107729|NCT00124943|54765827|FG003|Phase II|Withdrawal by Subject|2|||
28107730|NCT00124709|54765839|FG000|Overall Study|Randomized but did not take medication|3|||
28107731|NCT00124709|54765840|FG001|Overall Study|Randomized but did not take medication|1|||
28107732|NCT00124709|54765839|FG000|Overall Study|Adverse Event|3|||
28107733|NCT00124709|54765840|FG001|Overall Study|Adverse Event|0|||
28107734|NCT00124709|54765839|FG000|Overall Study|Lack of Efficacy|5|||
28107735|NCT00124709|54765840|FG001|Overall Study|Lack of Efficacy|10|||
28107736|NCT00124709|54765839|FG000|Overall Study|Protocol Violation|3|||
28107737|NCT00124709|54765840|FG001|Overall Study|Protocol Violation|5|||
28107738|NCT00124709|54765839|FG000|Overall Study|Withdrawal by Subject|127|||
28107739|NCT00124709|54765840|FG001|Overall Study|Withdrawal by Subject|136|||
28107740|NCT00124709|54765839|FG000|Overall Study|Lost to Follow-up|114|||
28107741|NCT00124709|54765840|FG001|Overall Study|Lost to Follow-up|120|||
28107742|NCT00108862|54765848|FG000|Overall Study|Death|31|||
28107743|NCT00108862|54765849|FG001|Overall Study|Death|37|||
28107744|NCT00108862|54765848|FG000|Overall Study|Withdrawal by Subject|10|||
28107745|NCT00108862|54765849|FG001|Overall Study|Withdrawal by Subject|6|||
28107746|NCT00108862|54765848|FG000|Overall Study|Lost to Follow-up|27|||
28107747|NCT00108862|54765849|FG001|Overall Study|Lost to Follow-up|19|||
28107748|NCT00564850|54765855|FG000|Overall Study|Protocol Violation|2|||
28107749|NCT00561340|54765861|FG000|Overall Study|refused to drink pediasure|6|||
28107750|NCT00561340|54765862|FG001|Overall Study|refused to drink pediasure|0|||
28107751|NCT00108628|54765870|FG000|Overall Study|Withdrawal by Subject|17|||
28107752|NCT00108628|54765871|FG001|Overall Study|Withdrawal by Subject|9|||
28107753|NCT00108628|54765870|FG000|Overall Study|Lack of Efficacy|2|||
28107754|NCT00108628|54765871|FG001|Overall Study|Lack of Efficacy|1|||
28107755|NCT00108628|54765870|FG000|Overall Study|Death|1|||
28107756|NCT00108628|54765871|FG001|Overall Study|Death|0|||
28107757|NCT02715856|54765879|FG000|Overall Study|Software Issues|12|||
27815393|NCT01517373|54272220|FG004|Run-in Period|Other|0|||
28107758|NCT02715856|54765880|FG001|Overall Study|Software Issues|7|||
28107759|NCT02715856|54765879|FG000|Overall Study|Death|6|||
28107760|NCT02715856|54765880|FG001|Overall Study|Death|5|||
28107761|NCT02715856|54765879|FG000|Overall Study|Non- Compliant|0|||
28107762|NCT02715856|54765880|FG001|Overall Study|Non- Compliant|40|||
28107763|NCT00108160|54765888|FG000|Overall Study|Lost to Follow-up|25|||
28107764|NCT00108160|54765889|FG001|Overall Study|Lost to Follow-up|12|||
28107765|NCT00108160|54765888|FG000|Overall Study|Death|1|||
28107766|NCT00108160|54765889|FG001|Overall Study|Death|2|||
28107767|NCT00108160|54765888|FG000|Overall Study|Withdrawal by Subject|4|||
28107768|NCT00108160|54765889|FG001|Overall Study|Withdrawal by Subject|2|||
28107769|NCT00108160|54765888|FG000|Overall Study|Protocol Violation|9|||
28107770|NCT00108160|54765889|FG001|Overall Study|Protocol Violation|5|||
28107771|NCT01366846|54765901|FG000|Overall Study|Withdrawal by Subject|2|||
28107772|NCT01366846|54765902|FG001|Overall Study|Withdrawal by Subject|0|||
28107773|NCT01366846|54765903|FG002|Overall Study|Withdrawal by Subject|0|||
28107774|NCT01366846|54765904|FG003|Overall Study|Withdrawal by Subject|0|||
28107775|NCT01366846|54765901|FG000|Overall Study|Communication Difficulties|1|||
28107776|NCT01366846|54765902|FG001|Overall Study|Communication Difficulties|4|||
27815394|NCT01517373|54272221|FG005|Run-in Period|Other|0|||
27815395|NCT01517373|54272216|FG000|Treatment Period|Adverse Event|0|||
27815396|NCT01517373|54272217|FG001|Treatment Period|Adverse Event|0|||
27815397|NCT01517373|54272218|FG002|Treatment Period|Adverse Event|0|||
28107777|NCT01366846|54765903|FG002|Overall Study|Communication Difficulties|0|||
28107778|NCT01366846|54765904|FG003|Overall Study|Communication Difficulties|1|||
28107779|NCT01366846|54765901|FG000|Overall Study|Scheduling Conflicts|0|||
28107780|NCT01366846|54765902|FG001|Overall Study|Scheduling Conflicts|0|||
28107781|NCT01366846|54765903|FG002|Overall Study|Scheduling Conflicts|1|||
28107782|NCT01366846|54765904|FG003|Overall Study|Scheduling Conflicts|0|||
28107783|NCT00108082|54765920|FG000|Overall Study|Adverse Event|14|||
28107784|NCT00108082|54765921|FG001|Overall Study|Adverse Event|12|||
28107785|NCT00108082|54765922|FG002|Overall Study|Adverse Event|17|||
28107786|NCT00108082|54765920|FG000|Overall Study|Lost to Follow-up|6|||
28107787|NCT00108082|54765921|FG001|Overall Study|Lost to Follow-up|3|||
28107788|NCT00108082|54765922|FG002|Overall Study|Lost to Follow-up|7|||
28107789|NCT00108082|54765920|FG000|Overall Study|Consent Withdrawn|3|||
28107790|NCT00108082|54765921|FG001|Overall Study|Consent Withdrawn|3|||
28107791|NCT00108082|54765922|FG002|Overall Study|Consent Withdrawn|5|||
28107792|NCT00108082|54765920|FG000|Overall Study|Protocol Violation|1|||
28107793|NCT00108082|54765921|FG001|Overall Study|Protocol Violation|2|||
28107794|NCT00108082|54765922|FG002|Overall Study|Protocol Violation|0|||
28107795|NCT00108082|54765920|FG000|Overall Study|Lack of Efficacy|3|||
28107796|NCT00108082|54765921|FG001|Overall Study|Lack of Efficacy|1|||
28107797|NCT00108082|54765922|FG002|Overall Study|Lack of Efficacy|2|||
28107798|NCT00108082|54765920|FG000|Overall Study|Amendment 4: > Month 12|5|||
28107799|NCT00108082|54765921|FG001|Overall Study|Amendment 4: > Month 12|7|||
28107800|NCT00108082|54765922|FG002|Overall Study|Amendment 4: > Month 12|5|||
28107801|NCT00108082|54765920|FG000|Overall Study|Woman of Child-bearing Potential|2|||
28107802|NCT00108082|54765921|FG001|Overall Study|Woman of Child-bearing Potential|0|||
28107803|NCT00108082|54765922|FG002|Overall Study|Woman of Child-bearing Potential|2|||
28107804|NCT00108082|54765920|FG000|Overall Study|Incorrectly Randomized|0|||
28107805|NCT00108082|54765921|FG001|Overall Study|Incorrectly Randomized|0|||
28107806|NCT00108082|54765922|FG002|Overall Study|Incorrectly Randomized|2|||
28107807|NCT00108082|54765920|FG000|Overall Study|Non-compliance|1|||
28107808|NCT00108082|54765921|FG001|Overall Study|Non-compliance|0|||
28107809|NCT00108082|54765922|FG002|Overall Study|Non-compliance|2|||
28107810|NCT00108082|54765920|FG000|Overall Study|Stopped Study Medication|0|||
28107811|NCT00108082|54765921|FG001|Overall Study|Stopped Study Medication|0|||
28107812|NCT00108082|54765922|FG002|Overall Study|Stopped Study Medication|1|||
28107813|NCT00108082|54765920|FG000|Overall Study|Site Closed Study|0|||
28107814|NCT00108082|54765921|FG001|Overall Study|Site Closed Study|2|||
28107815|NCT00108082|54765922|FG002|Overall Study|Site Closed Study|0|||
28107816|NCT00108082|54765920|FG000|Overall Study|Protocol Amendment|0|||
28107817|NCT00108082|54765921|FG001|Overall Study|Protocol Amendment|1|||
28107818|NCT00108082|54765922|FG002|Overall Study|Protocol Amendment|0|||
28107819|NCT00108082|54765920|FG000|Overall Study|Study Medication Not Tapered|0|||
28107820|NCT00108082|54765921|FG001|Overall Study|Study Medication Not Tapered|1|||
28107821|NCT00108082|54765922|FG002|Overall Study|Study Medication Not Tapered|0|||
28107822|NCT00108082|54765920|FG000|Overall Study|Subject Left Site Location|1|||
28107823|NCT00108082|54765921|FG001|Overall Study|Subject Left Site Location|0|||
28107824|NCT00108082|54765922|FG002|Overall Study|Subject Left Site Location|0|||
28107825|NCT00108082|54765920|FG000|Overall Study|Investigator Not at Site|1|||
28107826|NCT00108082|54765921|FG001|Overall Study|Investigator Not at Site|0|||
28107827|NCT00108082|54765922|FG002|Overall Study|Investigator Not at Site|0|||
28107828|NCT00108082|54765920|FG000|Overall Study|Blood Pressure Not Controlled|1|||
28107829|NCT00108082|54765921|FG001|Overall Study|Blood Pressure Not Controlled|0|||
28107830|NCT00108082|54765922|FG002|Overall Study|Blood Pressure Not Controlled|0|||
28107831|NCT00104728|54765934|FG000|Overall Study|screen failures|19|||
28107832|NCT02781844|54765942|FG000|Treatment Period 1|Adverse Event|0|||
28107833|NCT02781844|54765943|FG001|Treatment Period 1|Adverse Event|0|||
28107834|NCT02781844|54765944|FG002|Treatment Period 1|Adverse Event|0|||
28107835|NCT02781844|54765945|FG003|Treatment Period 1|Adverse Event|0|||
28107836|NCT02781844|54765946|FG004|Treatment Period 1|Adverse Event|0|||
28107837|NCT02781844|54765947|FG005|Treatment Period 1|Adverse Event|1|||
28107838|NCT02781844|54765948|FG006|Treatment Period 1|Adverse Event|0|||
28107839|NCT02781844|54765949|FG007|Treatment Period 1|Adverse Event|0|||
28107840|NCT02775916|54765967|FG000|Overall Study|Adverse Event|1|||
28107841|NCT02775916|54765968|FG001|Overall Study|Adverse Event|0|||
28107842|NCT02775916|54765967|FG000|Overall Study|Subject/Guardian Decision|2|||
28107843|NCT02775916|54765968|FG001|Overall Study|Subject/Guardian Decision|0|||
27815398|NCT01517373|54272219|FG003|Treatment Period|Adverse Event|0|||
27815399|NCT01517373|54272220|FG004|Treatment Period|Adverse Event|0|||
27815400|NCT01517373|54272221|FG005|Treatment Period|Adverse Event|2|||
27815401|NCT01517373|54272216|FG000|Treatment Period|Lost to Follow-up|0|||
28107844|NCT00122681|54765976|FG000|Overall Study|Adverse Event|20|||
28107845|NCT00122681|54765977|FG001|Overall Study|Adverse Event|16|||
28107846|NCT00122681|54765976|FG000|Overall Study|Lost to Follow-up|1080|||
27815402|NCT01517373|54272217|FG001|Treatment Period|Lost to Follow-up|0|||
27815403|NCT01517373|54272218|FG002|Treatment Period|Lost to Follow-up|1|||
27815404|NCT01517373|54272219|FG003|Treatment Period|Lost to Follow-up|1|||
27815405|NCT01517373|54272220|FG004|Treatment Period|Lost to Follow-up|0|||
27815406|NCT01517373|54272221|FG005|Treatment Period|Lost to Follow-up|0|||
27815407|NCT01517373|54272216|FG000|Treatment Period|Withdrawal by Subject|0|||
27815408|NCT01517373|54272217|FG001|Treatment Period|Withdrawal by Subject|3|||
27815409|NCT01517373|54272218|FG002|Treatment Period|Withdrawal by Subject|2|||
27815410|NCT01517373|54272219|FG003|Treatment Period|Withdrawal by Subject|2|||
27815411|NCT01517373|54272220|FG004|Treatment Period|Withdrawal by Subject|2|||
27815412|NCT01517373|54272221|FG005|Treatment Period|Withdrawal by Subject|3|||
28063814|NCT00347360|54719453|FG011|Overall Study|Did not meet criteria before ABPM|0|||
28063815|NCT00347360|54719454|FG012|Overall Study|Did not meet criteria before ABPM|0|||
27815413|NCT01517373|54272216|FG000|Treatment Period|Other|0|||
27815414|NCT01517373|54272217|FG001|Treatment Period|Other|0|||
27815415|NCT01517373|54272218|FG002|Treatment Period|Other|0|||
27815416|NCT01517373|54272219|FG003|Treatment Period|Other|0|||
27815417|NCT01517373|54272220|FG004|Treatment Period|Other|1|||
27815418|NCT01517373|54272221|FG005|Treatment Period|Other|0|||
27815419|NCT01517373|54272216|FG000|Treatment Period|Protocol Violation|0|||
27815420|NCT01517373|54272217|FG001|Treatment Period|Protocol Violation|0|||
27815421|NCT01517373|54272218|FG002|Treatment Period|Protocol Violation|0|||
27815422|NCT01517373|54272219|FG003|Treatment Period|Protocol Violation|0|||
27815423|NCT01517373|54272220|FG004|Treatment Period|Protocol Violation|1|||
27815424|NCT01517373|54272221|FG005|Treatment Period|Protocol Violation|0|||
27815425|NCT01517373|54272216|FG000|Treatment Period|Lack of Efficacy|0|||
27815426|NCT01517373|54272217|FG001|Treatment Period|Lack of Efficacy|1|||
27815427|NCT01517373|54272218|FG002|Treatment Period|Lack of Efficacy|1|||
27815428|NCT01517373|54272219|FG003|Treatment Period|Lack of Efficacy|3|||
27815429|NCT01517373|54272220|FG004|Treatment Period|Lack of Efficacy|2|||
27815430|NCT01517373|54272221|FG005|Treatment Period|Lack of Efficacy|0|||
28063816|NCT00347360|54719455|FG013|Overall Study|Did not meet criteria before ABPM|0|||
28063817|NCT00347360|54719456|FG014|Overall Study|Did not meet criteria before ABPM|0|||
27815431|NCT01517373|54272216|FG000|Treatment Period|Medication error without AEs|0|||
27815432|NCT01517373|54272217|FG001|Treatment Period|Medication error without AEs|0|||
27815433|NCT01517373|54272218|FG002|Treatment Period|Medication error without AEs|2|||
27815434|NCT01517373|54272219|FG003|Treatment Period|Medication error without AEs|1|||
27815435|NCT01517373|54272220|FG004|Treatment Period|Medication error without AEs|0|||
27815436|NCT01517373|54272221|FG005|Treatment Period|Medication error without AEs|2|||
27815437|NCT01517295|54272236|FG000|Overall Study|Physician Decision|1|||
27815438|NCT01517295|54272237|FG001|Overall Study|Physician Decision|0|||
27815439|NCT01541865|54272243|FG000|Overall Study|Lost to Follow-up|11|||
27815440|NCT01541865|54272243|FG000|Overall Study|Withdrawal by Subject|9|||
27815441|NCT01541865|54272243|FG000|Overall Study|Adverse Event|1|||
27815442|NCT01541865|54272243|FG000|Overall Study|Protocol Violation|1|||
27815443|NCT01541397|54272249|FG000|Overall Study|Study ended prior to data collection|4|||
27815444|NCT01541397|54272250|FG001|Overall Study|Study ended prior to data collection|2|||
27815445|NCT01548417|54272258|FG000|Overall Study|Withdrawal by Subject|0|||
27815446|NCT01548417|54272259|FG001|Overall Study|Withdrawal by Subject|2|||
27815447|NCT01546857|54272267|FG000|Overall Study|Withdrawal by Subject|2|||
27815448|NCT01546857|54272268|FG001|Overall Study|Withdrawal by Subject|3|||
27815449|NCT01540851|54272277|FG000|Overall Study|Lost to Follow-up|14|||
27815450|NCT01540851|54272278|FG001|Overall Study|Lost to Follow-up|15|||
27815451|NCT01540851|54272277|FG000|Overall Study|Withdrawal by Subject|7|||
28063818|NCT00347360|54719442|FG000|Overall Study|Randomized in error|0|||
28063819|NCT00347360|54719443|FG001|Overall Study|Randomized in error|0|||
28063820|NCT00347360|54719444|FG002|Overall Study|Randomized in error|0|||
28063821|NCT00347360|54719445|FG003|Overall Study|Randomized in error|0|||
28063822|NCT00347360|54719446|FG004|Overall Study|Randomized in error|0|||
28063823|NCT00347360|54719447|FG005|Overall Study|Randomized in error|0|||
28107847|NCT00122681|54765977|FG001|Overall Study|Lost to Follow-up|1097|||
28063824|NCT00347360|54719448|FG006|Overall Study|Randomized in error|0|||
28063825|NCT00347360|54719449|FG007|Overall Study|Randomized in error|0|||
28063826|NCT00347360|54719450|FG008|Overall Study|Randomized in error|0|||
28063827|NCT00347360|54719451|FG009|Overall Study|Randomized in error|0|||
28063828|NCT00347360|54719452|FG010|Overall Study|Randomized in error|0|||
28063829|NCT00347360|54719453|FG011|Overall Study|Randomized in error|1|||
28063830|NCT00347360|54719454|FG012|Overall Study|Randomized in error|0|||
28063831|NCT00347360|54719455|FG013|Overall Study|Randomized in error|0|||
28063832|NCT00347360|54719456|FG014|Overall Study|Randomized in error|0|||
28063833|NCT00347360|54719442|FG000|Overall Study|Failed inclusion criteria #4|0|||
28107848|NCT00122681|54765976|FG000|Overall Study|Protocol Violation|7|||
28107849|NCT00122681|54765977|FG001|Overall Study|Protocol Violation|10|||
28107850|NCT00122681|54765976|FG000|Overall Study|Withdrawal by Subject|257|||
28107851|NCT00122681|54765977|FG001|Overall Study|Withdrawal by Subject|251|||
28107852|NCT00122681|54765976|FG000|Overall Study|Personal reasons|150|||
28107853|NCT00122681|54765977|FG001|Overall Study|Personal reasons|147|||
28107854|NCT02774278|54765991|FG000|Overall Study|Lack of Efficacy|199|||
28107855|NCT02774278|54765991|FG000|Overall Study|Death|29|||
28107856|NCT02774278|54765991|FG000|Overall Study|Adverse event/intercurrent illness|16|||
28107857|NCT02774278|54765991|FG000|Overall Study|Refused treatment/did not cooperate|9|||
28107858|NCT02774278|54765991|FG000|Overall Study|Administrative reasons|6|||
28107859|NCT02774278|54765991|FG000|Overall Study|Withdrawal by Subject|3|||
28107860|NCT02774278|54765991|FG000|Overall Study|Protocol Violation|2|||
28107861|NCT03621189|54765997|FG000|Overall Study|Withdrawal by Subject|0|||
28107862|NCT03621189|54765998|FG001|Overall Study|Withdrawal by Subject|3|||
28107863|NCT03621189|54765997|FG000|Overall Study|Physician Decision|0|||
28107864|NCT03621189|54765998|FG001|Overall Study|Physician Decision|2|||
28107865|NCT00122135|54766007|FG000|Overall Study|Withdrawal by Subject|3|||
28107866|NCT00122135|54766008|FG001|Overall Study|Withdrawal by Subject|0|||
28107867|NCT03645057|54766018|FG000|Randomization to Baseline|Lost to Follow-up|1|||
28107868|NCT03645057|54766019|FG001|Randomization to Baseline|Lost to Follow-up|0|||
28107869|NCT03645057|54766020|FG002|Randomization to Baseline|Lost to Follow-up|1|||
28107870|NCT03645057|54766021|FG003|Randomization to Baseline|Lost to Follow-up|0|||
28107871|NCT03645057|54766018|FG000|Baseline to Six Weeks|Withdrawal by Subject|1|||
28107872|NCT03645057|54766019|FG001|Baseline to Six Weeks|Withdrawal by Subject|0|||
28107873|NCT03645057|54766020|FG002|Baseline to Six Weeks|Withdrawal by Subject|1|||
28107874|NCT03645057|54766021|FG003|Baseline to Six Weeks|Withdrawal by Subject|0|||
28107875|NCT03645057|54766018|FG000|Baseline to Six Weeks|Lost to Follow-up|5|||
28107876|NCT03645057|54766019|FG001|Baseline to Six Weeks|Lost to Follow-up|2|||
28107877|NCT03645057|54766020|FG002|Baseline to Six Weeks|Lost to Follow-up|5|||
28107878|NCT03645057|54766021|FG003|Baseline to Six Weeks|Lost to Follow-up|2|||
28107879|NCT03645057|54766018|FG000|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
28107880|NCT03645057|54766019|FG001|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
28107881|NCT03645057|54766020|FG002|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
28107882|NCT03645057|54766021|FG003|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
28107883|NCT00132041|54766027|FG000|Baseline|Ineligible|6|||
28107884|NCT00132041|54766027|FG000|3 Months Post Ablation|Transplant|1|||
28107885|NCT00132041|54766027|FG000|3 Months Post Ablation|Non-Protocol Treatment|2|||
28107886|NCT00132041|54766027|FG000|6 Months Post Ablation|Withdrawal by Subject|2|||
27940170|NCT01194414|54596458|FG000|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3|||
28063834|NCT00347360|54719443|FG001|Overall Study|Failed inclusion criteria #4|0|||
28063835|NCT00347360|54719444|FG002|Overall Study|Failed inclusion criteria #4|0|||
28107887|NCT00132041|54766027|FG000|6 Months Post Ablation|Death|2|||
28107888|NCT00132041|54766027|FG000|6 Months Post Ablation|Transplant|6|||
28107889|NCT00132041|54766027|FG000|9 Months Post Ablation|Death|1|||
28107890|NCT00132041|54766027|FG000|9 Months Post Ablation|Transplant|1|||
28107891|NCT00132041|54766027|FG000|12 Months Post Ablation|Withdrawal by Subject|1|||
28107892|NCT00132041|54766027|FG000|12 Months Post Ablation|Death|1|||
28107893|NCT00132041|54766027|FG000|12 Months Post Ablation|Transplant|1|||
28107894|NCT00132041|54766027|FG000|12 Months Post Ablation|non-protocol Treatment|1|||
28107895|NCT00132041|54766027|FG000|15 Months Post Ablation|Withdrawal by Subject|1|||
28107896|NCT00132041|54766027|FG000|15 Months Post Ablation|Death|1|||
28107897|NCT00132041|54766027|FG000|15 Months Post Ablation|Transplant|5|||
28107898|NCT00132041|54766027|FG000|15 Months Post Ablation|Non-Protocol Treatment|1|||
28107899|NCT00132041|54766027|FG000|18 Months Post Ablation|Withdrawal by Subject|1|||
28107900|NCT00132041|54766027|FG000|18 Months Post Ablation|Transplant|1|||
28107901|NCT00132041|54766027|FG000|18 Months Post Ablation|Non-Protocol Treatment|3|||
28107902|NCT00132041|54766027|FG000|18 Months Post Ablation|ExtraHepatic tumor|1|||
28107903|NCT03643575|54766037|FG000|Washout: 7 Days|Withdrew consent due to illness|0|||
28107904|NCT03643575|54766038|FG001|Washout: 7 Days|Withdrew consent due to illness|0|||
28107905|NCT03643575|54766039|FG002|Washout: 7 Days|Withdrew consent due to illness|0|||
28107906|NCT03643575|54766040|FG003|Washout: 7 Days|Withdrew consent due to illness|1|||
28107907|NCT03643575|54766041|FG004|Washout: 7 Days|Withdrew consent due to illness|0|||
27848488|NCT03593213|54341466|FG001|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
28063836|NCT00347360|54719445|FG003|Overall Study|Failed inclusion criteria #4|0|||
28063837|NCT00347360|54719446|FG004|Overall Study|Failed inclusion criteria #4|0|||
28107908|NCT03643575|54766042|FG005|Washout: 7 Days|Withdrew consent due to illness|0|||
28107909|NCT03643575|54766037|FG000|Washout: 7 Days|Adverse Event|1|||
28107910|NCT03643575|54766038|FG001|Washout: 7 Days|Adverse Event|0|||
28107911|NCT03643575|54766039|FG002|Washout: 7 Days|Adverse Event|0|||
28107912|NCT03643575|54766040|FG003|Washout: 7 Days|Adverse Event|0|||
28107913|NCT03643575|54766041|FG004|Washout: 7 Days|Adverse Event|0|||
28107914|NCT03643575|54766042|FG005|Washout: 7 Days|Adverse Event|0|||
28107915|NCT03643575|54766037|FG000|Washout: 7 Days|Non compliance check in|0|||
28107916|NCT03643575|54766038|FG001|Washout: 7 Days|Non compliance check in|1|||
28107917|NCT03643575|54766039|FG002|Washout: 7 Days|Non compliance check in|0|||
28107918|NCT03643575|54766040|FG003|Washout: 7 Days|Non compliance check in|0|||
28063838|NCT00347360|54719447|FG005|Overall Study|Failed inclusion criteria #4|0|||
28063839|NCT00347360|54719448|FG006|Overall Study|Failed inclusion criteria #4|0|||
28063840|NCT00347360|54719449|FG007|Overall Study|Failed inclusion criteria #4|0|||
28107919|NCT03643575|54766041|FG004|Washout: 7 Days|Non compliance check in|0|||
28107920|NCT03643575|54766042|FG005|Washout: 7 Days|Non compliance check in|0|||
28107921|NCT02768194|54766050|FG000|Period 1|Adverse Event|0|||
28107922|NCT02768194|54766051|FG001|Period 1|Adverse Event|0|||
28107923|NCT02768194|54766052|FG002|Period 1|Adverse Event|0|||
28107924|NCT02768194|54766053|FG003|Period 1|Adverse Event|1|||
28107925|NCT02768194|54766054|FG004|Period 1|Adverse Event|0|||
28107926|NCT02768194|54766055|FG005|Period 1|Adverse Event|0|||
28107927|NCT02768194|54766050|FG000|Period 2|Other (Reason not specified)|1|||
28107928|NCT02768194|54766051|FG001|Period 2|Other (Reason not specified)|0|||
28107929|NCT02768194|54766052|FG002|Period 2|Other (Reason not specified)|0|||
28107930|NCT02768194|54766053|FG003|Period 2|Other (Reason not specified)|0|||
28107931|NCT02768194|54766054|FG004|Period 2|Other (Reason not specified)|0|||
28107932|NCT02768194|54766055|FG005|Period 2|Other (Reason not specified)|0|||
28107933|NCT02768194|54766050|FG000|Period 3|Other (Reason not specified)|0|||
28107934|NCT02768194|54766051|FG001|Period 3|Other (Reason not specified)|1|||
28107935|NCT02768194|54766052|FG002|Period 3|Other (Reason not specified)|0|||
28107936|NCT02768194|54766053|FG003|Period 3|Other (Reason not specified)|0|||
28107937|NCT02768194|54766054|FG004|Period 3|Other (Reason not specified)|0|||
28107938|NCT02768194|54766055|FG005|Period 3|Other (Reason not specified)|0|||
28107939|NCT00130793|54766065|FG000|Overall Study|Lost to Follow-up|1|||
28107940|NCT00130793|54766066|FG001|Overall Study|Lost to Follow-up|4|||
28107941|NCT00130793|54766065|FG000|Overall Study|Withdrew consent|2|||
27848489|NCT03593213|54341467|FG002|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
28063841|NCT00347360|54719450|FG008|Overall Study|Failed inclusion criteria #4|0|||
28063842|NCT00347360|54719451|FG009|Overall Study|Failed inclusion criteria #4|0|||
28063843|NCT00347360|54719452|FG010|Overall Study|Failed inclusion criteria #4|0|||
28107942|NCT00130793|54766066|FG001|Overall Study|Withdrew consent|0|||
28107943|NCT03818399|54766073|FG000|Overall Study|Lost to Follow-up|11|||
28107944|NCT03818399|54766073|FG000|Overall Study|Withdrawal by Subject|1|||
28107945|NCT03818399|54766073|FG000|Overall Study|Protocol Violation|2|||
28107946|NCT03642873|54766077|FG000|Third Intervention (1 Day)|Screen failure|0|||
28107947|NCT03642873|54766078|FG001|Third Intervention (1 Day)|Screen failure|0|||
28107948|NCT03642873|54766079|FG002|Third Intervention (1 Day)|Screen failure|0|||
28107949|NCT03642873|54766080|FG003|Third Intervention (1 Day)|Screen failure|0|||
28107950|NCT03642873|54766081|FG004|Third Intervention (1 Day)|Screen failure|1|||
28107951|NCT03642873|54766082|FG005|Third Intervention (1 Day)|Screen failure|0|||
28107952|NCT03818321|54766096|FG000|Overall Study|Withdrawal by Subject|1|||
28107953|NCT03818321|54766097|FG001|Overall Study|Withdrawal by Subject|2|||
28107954|NCT03616977|54766103|FG000|Period 1|Physician Decision|0|||
28107955|NCT03616977|54766104|FG001|Period 1|Physician Decision|1|||
28107956|NCT03616977|54766103|FG000|Period 3|Adverse Event|1|||
28107957|NCT03616977|54766104|FG001|Period 3|Adverse Event|1|||
28107958|NCT02767570|54766113|FG000|Overall Study|Lost to Follow-up|3|||
28107959|NCT02767570|54766114|FG001|Overall Study|Lost to Follow-up|0|||
28107960|NCT02767570|54766113|FG000|Overall Study|COVID shutdown|2|||
28107961|NCT02767570|54766114|FG001|Overall Study|COVID shutdown|5|||
28107962|NCT02767570|54766113|FG000|Overall Study|Increased pain|2|||
28107963|NCT02767570|54766114|FG001|Overall Study|Increased pain|0|||
28107964|NCT02767570|54766113|FG000|Overall Study|Withdrawal by Subject|1|||
28107965|NCT02767570|54766114|FG001|Overall Study|Withdrawal by Subject|3|||
28107966|NCT02767570|54766113|FG000|Overall Study|Unrelated medical issue|1|||
28107967|NCT02767570|54766114|FG001|Overall Study|Unrelated medical issue|1|||
28107968|NCT02767570|54766113|FG000|Overall Study|Received intra-articular injection|0|||
28107969|NCT02767570|54766114|FG001|Overall Study|Received intra-articular injection|1|||
28107970|NCT03816761|54766123|FG000|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
28107971|NCT03816761|54766124|FG001|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
28107972|NCT03816761|54766125|FG002|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
28107973|NCT03816761|54766126|FG003|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
28107974|NCT03816761|54766127|FG004|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
28107975|NCT03816761|54766128|FG005|First Treatment Period (7 Days)|Withdrawal by Subject|1|||
28107976|NCT03816761|54766123|FG000|Second Treatment Period (7 Days)|Unclassified|0|||
28107977|NCT03816761|54766124|FG001|Second Treatment Period (7 Days)|Unclassified|0|||
28107978|NCT03816761|54766125|FG002|Second Treatment Period (7 Days)|Unclassified|0|||
28107979|NCT03816761|54766126|FG003|Second Treatment Period (7 Days)|Unclassified|1|||
28107980|NCT03816761|54766127|FG004|Second Treatment Period (7 Days)|Unclassified|0|||
28063844|NCT00347360|54719453|FG011|Overall Study|Failed inclusion criteria #4|1|||
28063845|NCT00347360|54719454|FG012|Overall Study|Failed inclusion criteria #4|0|||
28063846|NCT00347360|54719455|FG013|Overall Study|Failed inclusion criteria #4|0|||
28063847|NCT00347360|54719456|FG014|Overall Study|Failed inclusion criteria #4|0|||
28063848|NCT00347360|54719442|FG000|Overall Study|Prolonged duration between visits|0|||
28063849|NCT00347360|54719443|FG001|Overall Study|Prolonged duration between visits|0|||
28063850|NCT00347360|54719444|FG002|Overall Study|Prolonged duration between visits|0|||
28063851|NCT00347360|54719445|FG003|Overall Study|Prolonged duration between visits|0|||
28107981|NCT03816761|54766128|FG005|Second Treatment Period (7 Days)|Unclassified|0|||
28063852|NCT00347360|54719446|FG004|Overall Study|Prolonged duration between visits|0|||
28107982|NCT02770612|54766150|FG000|Overall Study|Met exclusion criteria (postop LOS>7d)|1|||
28063853|NCT00347360|54719447|FG005|Overall Study|Prolonged duration between visits|0|||
28063854|NCT00347360|54719448|FG006|Overall Study|Prolonged duration between visits|0|||
28063855|NCT00347360|54719449|FG007|Overall Study|Prolonged duration between visits|0|||
28063856|NCT00347360|54719450|FG008|Overall Study|Prolonged duration between visits|0|||
28063857|NCT00347360|54719451|FG009|Overall Study|Prolonged duration between visits|0|||
28063858|NCT00347360|54719452|FG010|Overall Study|Prolonged duration between visits|0|||
28063859|NCT00347360|54719453|FG011|Overall Study|Prolonged duration between visits|0|||
28063860|NCT00347360|54719454|FG012|Overall Study|Prolonged duration between visits|1|||
28063861|NCT00347360|54719455|FG013|Overall Study|Prolonged duration between visits|0|||
28063862|NCT00347360|54719456|FG014|Overall Study|Prolonged duration between visits|0|||
28107983|NCT03575871|54766157|FG000|Overall Study|Adverse Event|5|||
28107984|NCT03575871|54766158|FG001|Overall Study|Adverse Event|5|||
28107985|NCT03575871|54766159|FG002|Overall Study|Adverse Event|8|||
28107986|NCT03575871|54766157|FG000|Overall Study|Death|1|||
28107987|NCT03575871|54766158|FG001|Overall Study|Death|0|||
28063863|NCT00347360|54719442|FG000|Overall Study|Subject left town, ran out of study drug|0|||
28063864|NCT00347360|54719443|FG001|Overall Study|Subject left town, ran out of study drug|0|||
28063865|NCT00347360|54719444|FG002|Overall Study|Subject left town, ran out of study drug|0|||
28063866|NCT00347360|54719445|FG003|Overall Study|Subject left town, ran out of study drug|0|||
28063867|NCT00347360|54719446|FG004|Overall Study|Subject left town, ran out of study drug|0|||
28107988|NCT03575871|54766159|FG002|Overall Study|Death|0|||
28107989|NCT03575871|54766157|FG000|Overall Study|Lack of Efficacy|5|||
28107990|NCT03575871|54766158|FG001|Overall Study|Lack of Efficacy|4|||
28107991|NCT03575871|54766159|FG002|Overall Study|Lack of Efficacy|7|||
28107992|NCT03575871|54766157|FG000|Overall Study|Lost to Follow-up|1|||
28107993|NCT03575871|54766158|FG001|Overall Study|Lost to Follow-up|1|||
28107994|NCT03575871|54766159|FG002|Overall Study|Lost to Follow-up|1|||
28107995|NCT03575871|54766157|FG000|Overall Study|Protocol Deviation|1|||
28107996|NCT03575871|54766158|FG001|Overall Study|Protocol Deviation|1|||
28063868|NCT00347360|54719447|FG005|Overall Study|Subject left town, ran out of study drug|0|||
28063869|NCT00347360|54719448|FG006|Overall Study|Subject left town, ran out of study drug|0|||
28063870|NCT00347360|54719449|FG007|Overall Study|Subject left town, ran out of study drug|0|||
28063871|NCT00347360|54719450|FG008|Overall Study|Subject left town, ran out of study drug|0|||
28063872|NCT00347360|54719451|FG009|Overall Study|Subject left town, ran out of study drug|0|||
28063873|NCT00347360|54719452|FG010|Overall Study|Subject left town, ran out of study drug|0|||
28063874|NCT00347360|54719453|FG011|Overall Study|Subject left town, ran out of study drug|0|||
28063875|NCT00347360|54719454|FG012|Overall Study|Subject left town, ran out of study drug|0|||
28063876|NCT00347360|54719455|FG013|Overall Study|Subject left town, ran out of study drug|1|||
28063877|NCT00347360|54719456|FG014|Overall Study|Subject left town, ran out of study drug|0|||
28063878|NCT00347360|54719442|FG000|Overall Study|Subject refuse to sign updated consent|0|||
28063879|NCT00347360|54719443|FG001|Overall Study|Subject refuse to sign updated consent|0|||
28063880|NCT00347360|54719444|FG002|Overall Study|Subject refuse to sign updated consent|0|||
28063881|NCT00347360|54719445|FG003|Overall Study|Subject refuse to sign updated consent|0|||
28063882|NCT00347360|54719446|FG004|Overall Study|Subject refuse to sign updated consent|0|||
28063883|NCT00347360|54719447|FG005|Overall Study|Subject refuse to sign updated consent|0|||
28063884|NCT00347360|54719448|FG006|Overall Study|Subject refuse to sign updated consent|0|||
28063885|NCT00347360|54719449|FG007|Overall Study|Subject refuse to sign updated consent|0|||
28063886|NCT00347360|54719450|FG008|Overall Study|Subject refuse to sign updated consent|0|||
28063887|NCT00347360|54719451|FG009|Overall Study|Subject refuse to sign updated consent|0|||
28063888|NCT00347360|54719452|FG010|Overall Study|Subject refuse to sign updated consent|0|||
28063889|NCT00347360|54719453|FG011|Overall Study|Subject refuse to sign updated consent|0|||
28063890|NCT00347360|54719454|FG012|Overall Study|Subject refuse to sign updated consent|0|||
28063891|NCT00347360|54719455|FG013|Overall Study|Subject refuse to sign updated consent|0|||
28063892|NCT00347360|54719456|FG014|Overall Study|Subject refuse to sign updated consent|1|||
28063893|NCT00347360|54719442|FG000|Overall Study|Visits conflicted with new job|0|||
28063894|NCT00347360|54719443|FG001|Overall Study|Visits conflicted with new job|0|||
28063895|NCT00347360|54719444|FG002|Overall Study|Visits conflicted with new job|0|||
28063896|NCT00347360|54719445|FG003|Overall Study|Visits conflicted with new job|0|||
28063897|NCT00347360|54719446|FG004|Overall Study|Visits conflicted with new job|0|||
28063898|NCT00347360|54719447|FG005|Overall Study|Visits conflicted with new job|0|||
28063899|NCT00347360|54719448|FG006|Overall Study|Visits conflicted with new job|1|||
28063900|NCT00347360|54719449|FG007|Overall Study|Visits conflicted with new job|0|||
28063901|NCT00347360|54719450|FG008|Overall Study|Visits conflicted with new job|0|||
28063902|NCT00347360|54719451|FG009|Overall Study|Visits conflicted with new job|0|||
28063903|NCT00347360|54719452|FG010|Overall Study|Visits conflicted with new job|0|||
28063904|NCT00347360|54719453|FG011|Overall Study|Visits conflicted with new job|0|||
28063905|NCT00347360|54719454|FG012|Overall Study|Visits conflicted with new job|0|||
28063906|NCT00347360|54719455|FG013|Overall Study|Visits conflicted with new job|0|||
28063907|NCT00347360|54719456|FG014|Overall Study|Visits conflicted with new job|0|||
28063908|NCT00319020|54719490|FG000|Overall Study|Death|2|||
28063909|NCT00319020|54719491|FG001|Overall Study|Death|2|||
28063910|NCT00319020|54719490|FG000|Overall Study|Withdrawal by Subject|4|||
28063911|NCT00319020|54719491|FG001|Overall Study|Withdrawal by Subject|1|||
28063912|NCT00319020|54719490|FG000|Overall Study|F-1 completed but not enrolled in F-2|1|||
28063913|NCT00319020|54719491|FG001|Overall Study|F-1 completed but not enrolled in F-2|0|||
28063914|NCT00319020|54719490|FG000|Overall Study|Administrative reason|0|||
28063915|NCT00319020|54719491|FG001|Overall Study|Administrative reason|5|||
28063916|NCT00319020|54719490|FG000|Overall Study|Disease progression|0|||
28063917|NCT00319020|54719491|FG001|Overall Study|Disease progression|2|||
28063918|NCT00319020|54719490|FG000|Overall Study|Transplant|0|||
28063919|NCT00319020|54719491|FG001|Overall Study|Transplant|1|||
28063920|NCT00319020|54719490|FG000|Overall Study|Treatment failure|0|||
28063921|NCT00319020|54719491|FG001|Overall Study|Treatment failure|1|||
28063922|NCT00319020|54719490|FG000|Overall Study|Adverse Event|0|||
28063923|NCT00319020|54719491|FG001|Overall Study|Adverse Event|1|||
28063924|NCT00352118|54719499|FG000|Overall Study|Physician Decision|4|||
28063925|NCT00318474|54719505|FG000|Overall Study|Adverse Event|1|||
28063926|NCT00318474|54719506|FG001|Overall Study|Adverse Event|1|||
28063927|NCT00318474|54719505|FG000|Overall Study|Lost to Follow-up|0|||
28063928|NCT00318474|54719506|FG001|Overall Study|Lost to Follow-up|1|||
28063929|NCT00318474|54719505|FG000|Overall Study|Pregnancy|0|||
28063930|NCT00318474|54719506|FG001|Overall Study|Pregnancy|2|||
28063931|NCT00318474|54719505|FG000|Overall Study|Protocol Violation|1|||
28063932|NCT00318474|54719506|FG001|Overall Study|Protocol Violation|0|||
28063933|NCT00318474|54719505|FG000|Overall Study|Withdrawal by Subject|3|||
28063934|NCT00318474|54719506|FG001|Overall Study|Withdrawal by Subject|2|||
28063935|NCT00318474|54719505|FG000|Overall Study|Fall in GFR|3|||
28063936|NCT00318474|54719506|FG001|Overall Study|Fall in GFR|3|||
28063937|NCT00318474|54719505|FG000|Overall Study|Post-therapy hyperflycemia|0|||
28063938|NCT00318474|54719506|FG001|Overall Study|Post-therapy hyperflycemia|1|||
28063939|NCT00318474|54719505|FG000|Overall Study|Trial terminated|10|||
28063940|NCT00318474|54719506|FG001|Overall Study|Trial terminated|7|||
28063941|NCT00350870|54719516|FG000|Overall Study|Withdrawal by Subject|21|||
28063942|NCT00350870|54719517|FG001|Overall Study|Withdrawal by Subject|17|||
28063943|NCT00350870|54719518|FG002|Overall Study|Withdrawal by Subject|15|||
28063944|NCT00350870|54719519|FG003|Overall Study|Withdrawal by Subject|14|||
28063945|NCT00350870|54719516|FG000|Overall Study|Physician Decision|1|||
28063946|NCT00350870|54719517|FG001|Overall Study|Physician Decision|0|||
28063947|NCT00350870|54719518|FG002|Overall Study|Physician Decision|1|||
28063948|NCT00350870|54719519|FG003|Overall Study|Physician Decision|1|||
28077013|NCT00094458|54731722|FG000|OLE: Open-Label Extension|Patient decision|0|||
28077014|NCT00094458|54731723|FG001|OLE: Open-Label Extension|Patient decision|0|||
28077015|NCT00094458|54731724|FG002|OLE: Open-Label Extension|Patient decision|0|||
28077016|NCT00094458|54731725|FG003|OLE: Open-Label Extension|Patient decision|0|||
28077017|NCT00094458|54731726|FG004|OLE: Open-Label Extension|Patient decision|1|||
28077018|NCT00094458|54731727|FG005|OLE: Open-Label Extension|Patient decision|0|||
28077019|NCT00406367|54731743|FG000|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4|||
28077020|NCT00406367|54731744|FG001|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0|||
28077021|NCT00406367|54731743|FG000|Main Period - 6 to 20 Weeks|Consent Withdrawn|1|||
28077022|NCT00406367|54731744|FG001|Main Period - 6 to 20 Weeks|Consent Withdrawn|0|||
28077023|NCT00406367|54731743|FG000|Main Period - 6 to 20 Weeks|Lost to Follow-up|0|||
28077024|NCT00406367|54731744|FG001|Main Period - 6 to 20 Weeks|Lost to Follow-up|1|||
28077025|NCT00406367|54731743|FG000|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0|||
28077026|NCT00406367|54731744|FG001|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1|||
28077027|NCT00406367|54731743|FG000|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2|||
28077028|NCT00406367|54731744|FG001|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0|||
28077029|NCT00406367|54731743|FG000|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6|||
28077030|NCT00406367|54731744|FG001|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0|||
28077031|NCT00406367|54731743|FG000|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
28077032|NCT00406367|54731744|FG001|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
28077033|NCT00406367|54731743|FG000|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4|||
28077034|NCT00406367|54731744|FG001|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0|||
28077035|NCT00406367|54731743|FG000|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1|||
28077036|NCT00406367|54731744|FG001|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0|||
28077037|NCT00406367|54731743|FG000|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1|||
28077038|NCT00406367|54731744|FG001|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0|||
28077039|NCT00406367|54731743|FG000|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1|||
28077040|NCT00406367|54731744|FG001|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0|||
28077041|NCT00406367|54731743|FG000|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1|||
28077042|NCT00406367|54731744|FG001|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0|||
28077043|NCT00394589|54731753|FG000|Overall Study|Adverse Event|2|||
28077044|NCT00394589|54731754|FG001|Overall Study|Adverse Event|1|||
28077045|NCT00394589|54731755|FG002|Overall Study|Adverse Event|2|||
28077046|NCT00394589|54731753|FG000|Overall Study|Lack of Efficacy|2|||
28077047|NCT00394589|54731754|FG001|Overall Study|Lack of Efficacy|2|||
28077048|NCT00394589|54731755|FG002|Overall Study|Lack of Efficacy|3|||
28077049|NCT00394589|54731753|FG000|Overall Study|Protocol Violation|4|||
28077050|NCT00394589|54731754|FG001|Overall Study|Protocol Violation|0|||
28077051|NCT00394589|54731755|FG002|Overall Study|Protocol Violation|2|||
28107997|NCT03575871|54766159|FG002|Overall Study|Protocol Deviation|1|||
28107998|NCT03575871|54766157|FG000|Overall Study|Withdrawal by Subject|6|||
28107999|NCT03575871|54766158|FG001|Overall Study|Withdrawal by Subject|1|||
28108000|NCT03575871|54766159|FG002|Overall Study|Withdrawal by Subject|9|||
28108001|NCT03575871|54766157|FG000|Overall Study|Other than specified|2|||
28108002|NCT03575871|54766158|FG001|Overall Study|Other than specified|2|||
28108003|NCT03575871|54766159|FG002|Overall Study|Other than specified|0|||
28108004|NCT03642717|54766167|FG000|Overall Study|Lost to Follow-up|2|||
28108005|NCT03642717|54766167|FG000|Overall Study|Inclusion/exclusion criteria violation|33|||
28108006|NCT03642717|54766167|FG000|Overall Study|Taken study drug prior to contract date|3|||
28108007|NCT02766478|54766174|FG000|Overall Study|Withdrawal by Subject|1|||
27940171|NCT01194414|54596459|FG001|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5|||
28077052|NCT00068406|54731763|FG000|Overall Study|Ineligible-improper pre-protocol treatm|1|||
28077053|NCT00068406|54731763|FG000|Overall Study|Ineligible-Inadequate Pathology|2|||
28077054|NCT00403559|54731769|FG000|Overall Study|Adverse Event|0|||
28077055|NCT00403559|54731770|FG001|Overall Study|Adverse Event|1|||
28108008|NCT02766478|54766175|FG001|Overall Study|Withdrawal by Subject|1|||
28108009|NCT02766400|54766183|FG000|Overall Study|Death|1|||
28108010|NCT02766400|54766184|FG001|Overall Study|Death|2|||
28108011|NCT02766400|54766183|FG000|Overall Study|Withdrawal by Subject|1|||
28108012|NCT02766400|54766184|FG001|Overall Study|Withdrawal by Subject|0|||
28108013|NCT00104650|54766193|FG000|Treatment Period (25 Weeks)|Physician Decision|0|||
28108014|NCT00104650|54766194|FG001|Treatment Period (25 Weeks)|Physician Decision|0|||
28108015|NCT00104650|54766195|FG002|Treatment Period (25 Weeks)|Physician Decision|1|||
28108016|NCT00104650|54766193|FG000|Treatment Period (25 Weeks)|Withdrawal by Subject|2|||
28108017|NCT00104650|54766194|FG001|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
28108018|NCT00104650|54766195|FG002|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
28108019|NCT00104650|54766193|FG000|Treatment Period (25 Weeks)|Death|7|||
28108020|NCT00104650|54766194|FG001|Treatment Period (25 Weeks)|Death|5|||
28063949|NCT00350792|54719529|FG000|Overall Study|Adverse Event|11|||
28063950|NCT00350792|54719529|FG000|Overall Study|Death from Study Disease|1|||
28063951|NCT00350792|54719529|FG000|Overall Study|Death from Study Drug Toxicity|1|||
28063952|NCT00350792|54719529|FG000|Overall Study|Death Not Study Drug Related|2|||
28063953|NCT00350792|54719529|FG000|Overall Study|Protocol Violation|1|||
28063954|NCT00350792|54719529|FG000|Overall Study|Withdrawal by Subject|4|||
28063955|NCT00350792|54719529|FG000|Overall Study|Physician Decision|2|||
28063956|NCT00350792|54719529|FG000|Overall Study|Lack of Efficacy|11|||
28063957|NCT00317772|54719537|FG000|Overall Study|Adverse Event|0|||
28063958|NCT00317772|54719538|FG001|Overall Study|Adverse Event|0|||
28108021|NCT00104650|54766195|FG002|Treatment Period (25 Weeks)|Death|6|||
28108022|NCT00104650|54766193|FG000|Treatment Period (25 Weeks)|Disease progression|2|||
28108023|NCT00104650|54766194|FG001|Treatment Period (25 Weeks)|Disease progression|3|||
28108024|NCT00104650|54766195|FG002|Treatment Period (25 Weeks)|Disease progression|2|||
28108025|NCT00104650|54766193|FG000|Treatment Period (25 Weeks)|Ineligibility determined|0|||
28108026|NCT00104650|54766194|FG001|Treatment Period (25 Weeks)|Ineligibility determined|1|||
28108027|NCT00104650|54766195|FG002|Treatment Period (25 Weeks)|Ineligibility determined|0|||
28108028|NCT00104650|54766193|FG000|Treatment Period (25 Weeks)|Other|1|||
28108029|NCT00104650|54766194|FG001|Treatment Period (25 Weeks)|Other|0|||
28108030|NCT00104650|54766195|FG002|Treatment Period (25 Weeks)|Other|0|||
28108031|NCT00104650|54766193|FG000|Treatment Period (25 Weeks)|Protocol deviation|0|||
28108032|NCT00104650|54766194|FG001|Treatment Period (25 Weeks)|Protocol deviation|1|||
28108033|NCT00104650|54766195|FG002|Treatment Period (25 Weeks)|Protocol deviation|0|||
28108034|NCT00104650|54766193|FG000|Follow-up Period|Physician Decision|1|||
28108035|NCT00104650|54766194|FG001|Follow-up Period|Physician Decision|1|||
28108036|NCT00104650|54766195|FG002|Follow-up Period|Physician Decision|0|||
28108037|NCT00104650|54766193|FG000|Follow-up Period|Adverse Event|1|||
28108038|NCT00104650|54766194|FG001|Follow-up Period|Adverse Event|0|||
28108039|NCT00104650|54766195|FG002|Follow-up Period|Adverse Event|1|||
28108040|NCT00104650|54766193|FG000|Follow-up Period|Withdrawal by Subject|0|||
28108041|NCT00104650|54766194|FG001|Follow-up Period|Withdrawal by Subject|3|||
28108042|NCT00104650|54766195|FG002|Follow-up Period|Withdrawal by Subject|3|||
28108043|NCT00104650|54766193|FG000|Follow-up Period|Death|6|||
28108044|NCT00104650|54766194|FG001|Follow-up Period|Death|6|||
28108045|NCT00104650|54766195|FG002|Follow-up Period|Death|4|||
28108046|NCT00104650|54766193|FG000|Follow-up Period|Disease progression|3|||
28108047|NCT00104650|54766194|FG001|Follow-up Period|Disease progression|1|||
28108048|NCT00104650|54766195|FG002|Follow-up Period|Disease progression|0|||
28108049|NCT00104650|54766193|FG000|Follow-up Period|Lost to Follow-up|0|||
28108050|NCT00104650|54766194|FG001|Follow-up Period|Lost to Follow-up|1|||
28108051|NCT00104650|54766195|FG002|Follow-up Period|Lost to Follow-up|2|||
28108052|NCT00104650|54766193|FG000|Follow-up Period|Other|0|||
28108053|NCT00104650|54766194|FG001|Follow-up Period|Other|1|||
28108054|NCT00104650|54766195|FG002|Follow-up Period|Other|0|||
28108055|NCT03732807|54766210|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
28108056|NCT03732807|54766211|FG001|Treatment Period (up to Week 24)|Adverse Event|0|||
28108057|NCT03732807|54766212|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
28108058|NCT03732807|54766213|FG003|Treatment Period (up to Week 24)|Adverse Event|4|||
28108059|NCT03732807|54766214|FG004|Treatment Period (up to Week 24)|Adverse Event|2|||
28108060|NCT03732807|54766215|FG005|Treatment Period (up to Week 24)|Adverse Event|0|||
28108061|NCT03732807|54766216|FG006|Treatment Period (up to Week 24)|Adverse Event|1|||
27943481|NCT01147068|54600392|FG002|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
28108062|NCT03732807|54766210|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
28108063|NCT03732807|54766211|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
28108064|NCT03732807|54766212|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
28108065|NCT03732807|54766213|FG003|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
28108066|NCT03732807|54766214|FG004|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
28108067|NCT03732807|54766215|FG005|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
28108068|NCT03732807|54766216|FG006|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
28108069|NCT03732807|54766210|FG000|Treatment Period (up to Week 24)|Physician Decision|0|||
28108070|NCT03732807|54766211|FG001|Treatment Period (up to Week 24)|Physician Decision|1|||
28108071|NCT03732807|54766212|FG002|Treatment Period (up to Week 24)|Physician Decision|2|||
28063959|NCT00317772|54719539|FG002|Overall Study|Adverse Event|0|||
28108072|NCT03732807|54766213|FG003|Treatment Period (up to Week 24)|Physician Decision|5|||
28108073|NCT03732807|54766214|FG004|Treatment Period (up to Week 24)|Physician Decision|0|||
28108074|NCT03732807|54766215|FG005|Treatment Period (up to Week 24)|Physician Decision|0|||
28108075|NCT03732807|54766216|FG006|Treatment Period (up to Week 24)|Physician Decision|1|||
28108076|NCT03732807|54766210|FG000|Treatment Period (up to Week 24)|Pregnancy|1|||
28108077|NCT03732807|54766211|FG001|Treatment Period (up to Week 24)|Pregnancy|0|||
28108078|NCT03732807|54766212|FG002|Treatment Period (up to Week 24)|Pregnancy|0|||
28108079|NCT03732807|54766213|FG003|Treatment Period (up to Week 24)|Pregnancy|0|||
28108080|NCT03732807|54766214|FG004|Treatment Period (up to Week 24)|Pregnancy|1|||
28108081|NCT03732807|54766215|FG005|Treatment Period (up to Week 24)|Pregnancy|0|||
28108082|NCT03732807|54766216|FG006|Treatment Period (up to Week 24)|Pregnancy|1|||
28108083|NCT03732807|54766210|FG000|Treatment Period (up to Week 24)|Protocol Violation|1|||
28108084|NCT03732807|54766211|FG001|Treatment Period (up to Week 24)|Protocol Violation|1|||
28108085|NCT03732807|54766212|FG002|Treatment Period (up to Week 24)|Protocol Violation|0|||
28108086|NCT03732807|54766213|FG003|Treatment Period (up to Week 24)|Protocol Violation|0|||
28108087|NCT03732807|54766214|FG004|Treatment Period (up to Week 24)|Protocol Violation|0|||
28108088|NCT03732807|54766215|FG005|Treatment Period (up to Week 24)|Protocol Violation|0|||
28108089|NCT03732807|54766216|FG006|Treatment Period (up to Week 24)|Protocol Violation|0|||
28108090|NCT03732807|54766210|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
28108091|NCT03732807|54766211|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
28108092|NCT03732807|54766212|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
28108093|NCT03732807|54766213|FG003|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
28108094|NCT03732807|54766214|FG004|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
28108095|NCT03732807|54766215|FG005|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
28108096|NCT03732807|54766216|FG006|Treatment Period (up to Week 24)|Withdrawal by Subject|2|||
28108097|NCT03732807|54766210|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
28108098|NCT03732807|54766211|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
28108099|NCT03732807|54766212|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
28108100|NCT03732807|54766213|FG003|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
28108101|NCT03732807|54766214|FG004|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
28108102|NCT03732807|54766215|FG005|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
28108103|NCT03732807|54766216|FG006|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
28108104|NCT03732807|54766210|FG000|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
28108105|NCT03732807|54766211|FG001|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
28108106|NCT03732807|54766212|FG002|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
28108107|NCT03732807|54766213|FG003|Treatment Extension (Week 25 up to 48)|Adverse Event|1|||
28108108|NCT03732807|54766214|FG004|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
28108109|NCT03732807|54766215|FG005|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
28108110|NCT03732807|54766216|FG006|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
28108111|NCT03732807|54766210|FG000|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|2|||
28108112|NCT03732807|54766211|FG001|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
28108113|NCT03732807|54766212|FG002|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
28108114|NCT03732807|54766213|FG003|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
28108115|NCT03732807|54766214|FG004|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
28108116|NCT03732807|54766215|FG005|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
28108117|NCT03732807|54766216|FG006|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
28108118|NCT03732807|54766210|FG000|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
28108119|NCT03732807|54766211|FG001|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
28108120|NCT03732807|54766212|FG002|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
28108121|NCT03732807|54766213|FG003|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
28108122|NCT03732807|54766214|FG004|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
28108123|NCT03732807|54766215|FG005|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
28108124|NCT03732807|54766216|FG006|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
28108125|NCT03732807|54766210|FG000|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
28108126|NCT03732807|54766211|FG001|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|1|||
28108127|NCT03732807|54766212|FG002|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
28108128|NCT03732807|54766213|FG003|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
28108129|NCT03732807|54766214|FG004|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
28108130|NCT03732807|54766215|FG005|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
28108131|NCT03732807|54766216|FG006|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
28108132|NCT03732807|54766210|FG000|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
28108133|NCT03732807|54766211|FG001|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
28108134|NCT03732807|54766212|FG002|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
28108135|NCT03732807|54766213|FG003|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
28108136|NCT03732807|54766214|FG004|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
28108137|NCT03732807|54766215|FG005|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
28108138|NCT03732807|54766216|FG006|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
28108139|NCT03732807|54766210|FG000|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|3|||
28108140|NCT03732807|54766211|FG001|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|2|||
28108141|NCT03732807|54766212|FG002|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
28108142|NCT03732807|54766213|FG003|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
28108143|NCT03732807|54766214|FG004|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|0|||
28108144|NCT03732807|54766215|FG005|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
28108145|NCT03732807|54766216|FG006|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
28108146|NCT03732807|54766210|FG000|Treatment Extension (Week 25 up to 48)|Other|1|||
28108147|NCT03732807|54766211|FG001|Treatment Extension (Week 25 up to 48)|Other|4|||
28108148|NCT03732807|54766212|FG002|Treatment Extension (Week 25 up to 48)|Other|0|||
28108149|NCT03732807|54766213|FG003|Treatment Extension (Week 25 up to 48)|Other|2|||
28108150|NCT03732807|54766214|FG004|Treatment Extension (Week 25 up to 48)|Other|0|||
28108151|NCT03732807|54766215|FG005|Treatment Extension (Week 25 up to 48)|Other|0|||
28108152|NCT03732807|54766216|FG006|Treatment Extension (Week 25 up to 48)|Other|0|||
28159977|NCT02737475|54830025|FG003|Overall Study|Participant withdrew consent|0|||
28159978|NCT02737475|54830026|FG004|Overall Study|Participant withdrew consent|0|||
28159979|NCT02737475|54830027|FG005|Overall Study|Participant withdrew consent|2|||
28159980|NCT02737475|54830028|FG006|Overall Study|Participant withdrew consent|0|||
28159981|NCT02737475|54830029|FG007|Overall Study|Participant withdrew consent|0|||
28159982|NCT02737475|54830030|FG008|Overall Study|Participant withdrew consent|0|||
28159983|NCT02737475|54830031|FG009|Overall Study|Participant withdrew consent|0|||
28159984|NCT02737475|54830032|FG010|Overall Study|Participant withdrew consent|0|||
28159985|NCT02737475|54830033|FG011|Overall Study|Participant withdrew consent|0|||
28159986|NCT02737475|54830034|FG012|Overall Study|Participant withdrew consent|0|||
28159987|NCT02737475|54830035|FG013|Overall Study|Participant withdrew consent|0|||
28159988|NCT02737475|54830036|FG014|Overall Study|Participant withdrew consent|1|||
28159989|NCT02737475|54830037|FG015|Overall Study|Participant withdrew consent|0|||
28159990|NCT02737475|54830038|FG016|Overall Study|Participant withdrew consent|0|||
28159991|NCT02737475|54830039|FG017|Overall Study|Participant withdrew consent|2|||
28159992|NCT02737475|54830040|FG018|Overall Study|Participant withdrew consent|1|||
28159993|NCT02737475|54830041|FG019|Overall Study|Participant withdrew consent|0|||
28159994|NCT02737475|54830042|FG020|Overall Study|Participant withdrew consent|2|||
28159995|NCT02737475|54830043|FG021|Overall Study|Participant withdrew consent|0|||
28159996|NCT02737475|54830044|FG022|Overall Study|Participant withdrew consent|0|||
28159997|NCT02737475|54830045|FG023|Overall Study|Participant withdrew consent|0|||
28159998|NCT02737475|54830046|FG024|Overall Study|Participant withdrew consent|0|||
28159999|NCT02737475|54830047|FG025|Overall Study|Participant withdrew consent|0|||
28160000|NCT02737475|54830048|FG026|Overall Study|Participant withdrew consent|0|||
28160001|NCT02737475|54830022|FG000|Overall Study|Lost to Follow-up|0|||
27940172|NCT01194414|54596460|FG002|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
28160002|NCT02737475|54830023|FG001|Overall Study|Lost to Follow-up|0|||
28160003|NCT02737475|54830024|FG002|Overall Study|Lost to Follow-up|0|||
28160004|NCT02737475|54830025|FG003|Overall Study|Lost to Follow-up|0|||
28160005|NCT02737475|54830026|FG004|Overall Study|Lost to Follow-up|0|||
28108153|NCT00104416|54766235|FG000|Double-Blind Phase|Adverse Event|2|||
28108154|NCT00104416|54766236|FG001|Double-Blind Phase|Adverse Event|1|||
28108155|NCT00104416|54766237|FG002|Double-Blind Phase|Adverse Event|0|||
28108156|NCT00104416|54766238|FG003|Double-Blind Phase|Adverse Event|0|||
28108157|NCT00104416|54766239|FG004|Double-Blind Phase|Adverse Event|0|||
28108158|NCT00104416|54766235|FG000|Double-Blind Phase|Lost to Follow-up|0|||
28108159|NCT00104416|54766236|FG001|Double-Blind Phase|Lost to Follow-up|1|||
28108160|NCT00104416|54766237|FG002|Double-Blind Phase|Lost to Follow-up|0|||
28108161|NCT00104416|54766238|FG003|Double-Blind Phase|Lost to Follow-up|0|||
28108162|NCT00104416|54766239|FG004|Double-Blind Phase|Lost to Follow-up|0|||
28108163|NCT00104416|54766235|FG000|Double-Blind Phase|Protocol Violation|0|||
28108164|NCT00104416|54766236|FG001|Double-Blind Phase|Protocol Violation|1|||
28108165|NCT00104416|54766237|FG002|Double-Blind Phase|Protocol Violation|0|||
28108166|NCT00104416|54766238|FG003|Double-Blind Phase|Protocol Violation|0|||
28108167|NCT00104416|54766239|FG004|Double-Blind Phase|Protocol Violation|0|||
28108168|NCT00104416|54766235|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
28108169|NCT00104416|54766236|FG001|Double-Blind Phase|Withdrawal by Subject|3|||
28108170|NCT00104416|54766237|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
28108171|NCT00104416|54766238|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
28108172|NCT00104416|54766239|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
28108173|NCT00104416|54766235|FG000|Double-Blind Phase|Pregnancy|1|||
28108174|NCT00104416|54766236|FG001|Double-Blind Phase|Pregnancy|0|||
28108175|NCT00104416|54766237|FG002|Double-Blind Phase|Pregnancy|0|||
28108176|NCT00104416|54766238|FG003|Double-Blind Phase|Pregnancy|0|||
28108177|NCT00104416|54766239|FG004|Double-Blind Phase|Pregnancy|0|||
28108178|NCT00104416|54766235|FG000|Double-Blind Phase|Participant Did Not Take Drug|3|||
28108179|NCT00104416|54766236|FG001|Double-Blind Phase|Participant Did Not Take Drug|4|||
28108180|NCT00104416|54766237|FG002|Double-Blind Phase|Participant Did Not Take Drug|0|||
28108181|NCT00104416|54766238|FG003|Double-Blind Phase|Participant Did Not Take Drug|0|||
28108182|NCT00104416|54766239|FG004|Double-Blind Phase|Participant Did Not Take Drug|0|||
28108183|NCT00104416|54766235|FG000|Continuation Phase|Adverse Event|0|||
28108184|NCT00104416|54766236|FG001|Continuation Phase|Adverse Event|0|||
28108185|NCT00104416|54766237|FG002|Continuation Phase|Adverse Event|2|||
28108186|NCT00104416|54766238|FG003|Continuation Phase|Adverse Event|0|||
28108187|NCT00104416|54766239|FG004|Continuation Phase|Adverse Event|2|||
28108188|NCT00104416|54766235|FG000|Continuation Phase|Lost to Follow-up|0|||
28108189|NCT00104416|54766236|FG001|Continuation Phase|Lost to Follow-up|0|||
28108190|NCT00104416|54766237|FG002|Continuation Phase|Lost to Follow-up|1|||
28108191|NCT00104416|54766238|FG003|Continuation Phase|Lost to Follow-up|0|||
28108192|NCT00104416|54766239|FG004|Continuation Phase|Lost to Follow-up|1|||
28108193|NCT00104416|54766235|FG000|Continuation Phase|Withdrawal by Subject|0|||
28108194|NCT00104416|54766236|FG001|Continuation Phase|Withdrawal by Subject|0|||
28108195|NCT00104416|54766237|FG002|Continuation Phase|Withdrawal by Subject|2|||
28108196|NCT00104416|54766238|FG003|Continuation Phase|Withdrawal by Subject|1|||
28108197|NCT00104416|54766239|FG004|Continuation Phase|Withdrawal by Subject|1|||
28108198|NCT00104416|54766235|FG000|Continuation Phase|Pregnancy|0|||
27848490|NCT03593213|54341468|FG003|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
27848491|NCT03593213|54341465|FG000|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|90|||
27940173|NCT01194414|54596461|FG003|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
28108199|NCT00104416|54766236|FG001|Continuation Phase|Pregnancy|0|||
28108200|NCT00104416|54766237|FG002|Continuation Phase|Pregnancy|1|||
28108201|NCT00104416|54766238|FG003|Continuation Phase|Pregnancy|1|||
28108202|NCT00104416|54766239|FG004|Continuation Phase|Pregnancy|0|||
28108203|NCT00104416|54766235|FG000|Continuation Phase|Non-compliance|0|||
28108204|NCT00104416|54766236|FG001|Continuation Phase|Non-compliance|0|||
28108205|NCT00104416|54766237|FG002|Continuation Phase|Non-compliance|0|||
28108206|NCT00104416|54766238|FG003|Continuation Phase|Non-compliance|0|||
28108207|NCT00104416|54766239|FG004|Continuation Phase|Non-compliance|1|||
28108208|NCT03639987|54766253|FG000|Overall Study|Study terminated by sponsor|26|||
28108209|NCT03639987|54766254|FG001|Overall Study|Study terminated by sponsor|25|||
28108210|NCT03639987|54766253|FG000|Overall Study|Lost to Follow-up|0|||
28108211|NCT03639987|54766254|FG001|Overall Study|Lost to Follow-up|1|||
28108212|NCT02766088|54766260|FG000|Overall Study|Sponsor study termination|498|||
28108213|NCT02766088|54766260|FG000|Overall Study|Migrated/moved from the study area|1|||
28108214|NCT02766088|54766260|FG000|Overall Study|Lost to Follow-up|5|||
28108215|NCT02766088|54766260|FG000|Overall Study|Other|1|||
28108216|NCT02766088|54766260|FG000|Overall Study|Death|1|||
28108217|NCT03639675|54766264|FG000|Overall Study|Withdrawal by Subject|1|||
28108218|NCT03635775|54766272|FG000|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
28108219|NCT03635775|54766273|FG001|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
28108220|NCT03635775|54766274|FG002|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
28108221|NCT03635775|54766275|FG003|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1|||
28108222|NCT03610581|54766287|FG000|Overall Study|Study terminated by sponsor|2|||
27815452|NCT01540851|54272278|FG001|Overall Study|Withdrawal by Subject|3|||
27815453|NCT01516749|54272286|FG000|Active Therapy|Lost to Follow-up|1|||
28063960|NCT00317772|54719540|FG003|Overall Study|Adverse Event|2|||
28063961|NCT00317772|54719537|FG000|Overall Study|Disease Progression|2|||
28063962|NCT00317772|54719538|FG001|Overall Study|Disease Progression|2|||
28063963|NCT00317772|54719539|FG002|Overall Study|Disease Progression|1|||
28063964|NCT00317772|54719540|FG003|Overall Study|Disease Progression|7|||
28108223|NCT03610581|54766288|FG001|Overall Study|Study terminated by sponsor|0|||
28108224|NCT03610581|54766287|FG000|Overall Study|Other|0|||
28108225|NCT03610581|54766288|FG001|Overall Study|Other|1|||
28108226|NCT03610581|54766287|FG000|Overall Study|Withdrawal by Subject|1|||
28108227|NCT03610581|54766288|FG001|Overall Study|Withdrawal by Subject|0|||
28108228|NCT03610269|54766294|FG000|Overall Study|Physician Decision|10|||
28063965|NCT00350636|54719553|FG000|Overall Study|Adverse Event|19|||
28063966|NCT00350636|54719554|FG001|Overall Study|Adverse Event|13|||
28063967|NCT00350636|54719553|FG000|Overall Study|Protocol Violation|1|||
28063968|NCT00350636|54719554|FG001|Overall Study|Protocol Violation|3|||
28063969|NCT00350636|54719553|FG000|Overall Study|Withdrawal by Subject|13|||
28063970|NCT00350636|54719554|FG001|Overall Study|Withdrawal by Subject|17|||
28108229|NCT03610269|54766294|FG000|Overall Study|Protocol Violation|1|||
28108230|NCT03610269|54766294|FG000|Overall Study|Unable to draw blood|1|||
28063971|NCT00350636|54719553|FG000|Overall Study|Lost to Follow-up|9|||
28063972|NCT00350636|54719554|FG001|Overall Study|Lost to Follow-up|8|||
28063973|NCT00350636|54719553|FG000|Overall Study|Physician Decision|0|||
28063974|NCT00350636|54719554|FG001|Overall Study|Physician Decision|2|||
28063975|NCT00350636|54719553|FG000|Overall Study|Other|1|||
28063976|NCT00350636|54719554|FG001|Overall Study|Other|2|||
28063977|NCT00346268|54719562|FG000|Overall Study|Adverse Event|1|||
28063978|NCT00346268|54719563|FG001|Overall Study|Adverse Event|0|||
28063979|NCT00346268|54719562|FG000|Overall Study|Protocol Violation|1|||
28063980|NCT00346268|54719563|FG001|Overall Study|Protocol Violation|0|||
28063981|NCT00346268|54719562|FG000|Overall Study|Participant refused|0|||
28063982|NCT00346268|54719563|FG001|Overall Study|Participant refused|3|||
28108231|NCT03610269|54766294|FG000|Overall Study|Screen fail|4|||
28108232|NCT00121667|54766302|FG000|Short Term (ST) Period|Lack of Efficacy|25|||
27815454|NCT01516749|54272286|FG000|Follow-up Off Therapy|Lost to Follow-up|1|||
27815455|NCT01516437|54272294|FG000|Overall Study|Reason not specified|0|||
27815456|NCT01516437|54272295|FG001|Overall Study|Reason not specified|0|||
28063983|NCT00327444|54719571|FG000|Double Blind Treatment (DB) Period|Disease progression|10|||
28063984|NCT00327444|54719572|FG001|Double Blind Treatment (DB) Period|Disease progression|13|||
28063985|NCT00327444|54719571|FG000|Double Blind Treatment (DB) Period|Adverse Event|5|||
28063986|NCT00327444|54719572|FG001|Double Blind Treatment (DB) Period|Adverse Event|5|||
28108233|NCT00121667|54766303|FG001|Short Term (ST) Period|Lack of Efficacy|22|||
28108234|NCT00121667|54766304|FG002|Short Term (ST) Period|Lack of Efficacy|27|||
28108235|NCT00121667|54766305|FG003|Short Term (ST) Period|Lack of Efficacy|44|||
28063987|NCT00327444|54719571|FG000|Double Blind Treatment (DB) Period|Subject request|0|||
28063988|NCT00327444|54719572|FG001|Double Blind Treatment (DB) Period|Subject request|1|||
28063989|NCT00327444|54719571|FG000|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11|||
28063990|NCT00327444|54719572|FG001|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10|||
28063991|NCT00327444|54719571|FG000|Open Label Treatment (OL) Period|Disease progression|8|||
28063992|NCT00327444|54719572|FG001|Open Label Treatment (OL) Period|Disease progression|7|||
28063993|NCT00327444|54719571|FG000|Open Label Treatment (OL) Period|Adverse Event|2|||
28063994|NCT00327444|54719572|FG001|Open Label Treatment (OL) Period|Adverse Event|2|||
28063995|NCT00327444|54719571|FG000|Open Label Treatment (OL) Period|Worsening dyspnea|0|||
28063996|NCT00327444|54719572|FG001|Open Label Treatment (OL) Period|Worsening dyspnea|1|||
28063997|NCT00327444|54719571|FG000|Open Label Treatment (OL) Period|Ongoing Treatment|1|||
28063998|NCT00327444|54719572|FG001|Open Label Treatment (OL) Period|Ongoing Treatment|0|||
28063999|NCT00337610|54719582|FG000|Overall Study|Adverse Event|2|||
28108236|NCT00121667|54766302|FG000|Short Term (ST) Period|Subject Withdrew Consent|8|||
28108237|NCT00121667|54766303|FG001|Short Term (ST) Period|Subject Withdrew Consent|13|||
28108238|NCT00121667|54766304|FG002|Short Term (ST) Period|Subject Withdrew Consent|4|||
28108239|NCT00121667|54766305|FG003|Short Term (ST) Period|Subject Withdrew Consent|11|||
28108240|NCT00121667|54766302|FG000|Short Term (ST) Period|Adverse Event|5|||
28108241|NCT00121667|54766303|FG001|Short Term (ST) Period|Adverse Event|6|||
28108242|NCT00121667|54766304|FG002|Short Term (ST) Period|Adverse Event|5|||
28108243|NCT00121667|54766305|FG003|Short Term (ST) Period|Adverse Event|3|||
28108244|NCT00121667|54766302|FG000|Short Term (ST) Period|Lost to Follow-up|3|||
28108245|NCT00121667|54766303|FG001|Short Term (ST) Period|Lost to Follow-up|4|||
28108246|NCT00121667|54766304|FG002|Short Term (ST) Period|Lost to Follow-up|4|||
28108247|NCT00121667|54766305|FG003|Short Term (ST) Period|Lost to Follow-up|3|||
28108248|NCT00121667|54766302|FG000|Short Term (ST) Period|Poor / Non-compliance|0|||
28108249|NCT00121667|54766303|FG001|Short Term (ST) Period|Poor / Non-compliance|1|||
28108250|NCT00121667|54766304|FG002|Short Term (ST) Period|Poor / Non-compliance|1|||
28108251|NCT00121667|54766305|FG003|Short Term (ST) Period|Poor / Non-compliance|2|||
28108252|NCT00121667|54766302|FG000|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
28108253|NCT00121667|54766303|FG001|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
28108254|NCT00121667|54766304|FG002|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
28108255|NCT00121667|54766305|FG003|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
28108256|NCT00121667|54766302|FG000|Short Term (ST) Period|Other Reason|3|||
28108257|NCT00121667|54766303|FG001|Short Term (ST) Period|Other Reason|0|||
28108258|NCT00121667|54766304|FG002|Short Term (ST) Period|Other Reason|0|||
28108259|NCT00121667|54766305|FG003|Short Term (ST) Period|Other Reason|0|||
28108260|NCT00121667|54766302|FG000|Short Term (ST) Period|Death|0|||
28108261|NCT00121667|54766303|FG001|Short Term (ST) Period|Death|0|||
28108262|NCT00121667|54766304|FG002|Short Term (ST) Period|Death|0|||
28108263|NCT00121667|54766305|FG003|Short Term (ST) Period|Death|1|||
27815457|NCT01516437|54272296|FG002|Overall Study|Reason not specified|1|||
27815458|NCT01516437|54272297|FG003|Overall Study|Reason not specified|1|||
27815459|NCT01515423|54272311|FG000|Open Label Phase|Adverse Event|57|||
27815460|NCT01515423|54272312|FG001|Open Label Phase|Adverse Event|0|||
27815461|NCT01515423|54272313|FG002|Open Label Phase|Adverse Event|0|||
27815462|NCT01515423|54272311|FG000|Open Label Phase|Death|2|||
27815463|NCT01515423|54272312|FG001|Open Label Phase|Death|0|||
27815464|NCT01515423|54272313|FG002|Open Label Phase|Death|0|||
28108264|NCT00121667|54766302|FG000|Short Term (ST) Period|Pregnancy|0|||
28108265|NCT00121667|54766303|FG001|Short Term (ST) Period|Pregnancy|0|||
28108266|NCT00121667|54766304|FG002|Short Term (ST) Period|Pregnancy|0|||
28108267|NCT00121667|54766305|FG003|Short Term (ST) Period|Pregnancy|1|||
28108268|NCT00121667|54766302|FG000|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54|||
28108269|NCT00121667|54766303|FG001|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51|||
28108270|NCT00121667|54766304|FG002|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42|||
28108271|NCT00121667|54766305|FG003|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65|||
28108272|NCT00121667|54766302|FG000|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38|||
28108273|NCT00121667|54766303|FG001|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34|||
28108274|NCT00121667|54766304|FG002|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26|||
28108275|NCT00121667|54766305|FG003|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30|||
28064000|NCT00337610|54719583|FG001|Overall Study|Adverse Event|2|||
28064001|NCT00337610|54719582|FG000|Overall Study|Death|0|||
28064002|NCT00337610|54719583|FG001|Overall Study|Death|1|||
28064003|NCT00337610|54719582|FG000|Overall Study|Lack of Efficacy|6|||
28108276|NCT00121667|54766302|FG000|Short Term (ST) + Long Term (LT) Period|Adverse Event|12|||
28108277|NCT00121667|54766303|FG001|Short Term (ST) + Long Term (LT) Period|Adverse Event|18|||
27815465|NCT01515423|54272311|FG000|Open Label Phase|Lack of Efficacy|117|||
27815466|NCT01515423|54272312|FG001|Open Label Phase|Lack of Efficacy|0|||
28108278|NCT00121667|54766304|FG002|Short Term (ST) + Long Term (LT) Period|Adverse Event|13|||
28108279|NCT00121667|54766305|FG003|Short Term (ST) + Long Term (LT) Period|Adverse Event|10|||
28108280|NCT00121667|54766302|FG000|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
28108281|NCT00121667|54766303|FG001|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
28108282|NCT00121667|54766304|FG002|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13|||
28108283|NCT00121667|54766305|FG003|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16|||
28108284|NCT00121667|54766302|FG000|Short Term (ST) + Long Term (LT) Period|Other Reason|5|||
28108285|NCT00121667|54766303|FG001|Short Term (ST) + Long Term (LT) Period|Other Reason|7|||
28108286|NCT00121667|54766304|FG002|Short Term (ST) + Long Term (LT) Period|Other Reason|6|||
28108287|NCT00121667|54766305|FG003|Short Term (ST) + Long Term (LT) Period|Other Reason|3|||
28108288|NCT00121667|54766302|FG000|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3|||
28064004|NCT00337610|54719583|FG001|Overall Study|Lack of Efficacy|3|||
28064005|NCT00337610|54719582|FG000|Overall Study|Lost to Follow-up|3|||
28064006|NCT00337610|54719583|FG001|Overall Study|Lost to Follow-up|3|||
28064007|NCT00337610|54719582|FG000|Overall Study|Withdrawal by Subject|6|||
28064008|NCT00337610|54719583|FG001|Overall Study|Withdrawal by Subject|5|||
28064009|NCT00316914|54719591|FG000|Overall Study|Withdrawal by Subject|5|||
28108289|NCT00121667|54766303|FG001|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6|||
28108290|NCT00121667|54766304|FG002|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5|||
28108291|NCT00121667|54766305|FG003|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9|||
28108292|NCT00121667|54766302|FG000|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3|||
28108293|NCT00121667|54766303|FG001|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5|||
28108294|NCT00121667|54766304|FG002|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8|||
28108295|NCT00121667|54766305|FG003|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4|||
28108296|NCT00121667|54766302|FG000|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
28108297|NCT00121667|54766303|FG001|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
28108298|NCT00121667|54766304|FG002|Short Term (ST) + Long Term (LT) Period|Pregnancy|0|||
28108299|NCT00121667|54766305|FG003|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
28108300|NCT00121667|54766302|FG000|Short Term (ST) + Long Term (LT) Period|Death|1|||
28108301|NCT00121667|54766303|FG001|Short Term (ST) + Long Term (LT) Period|Death|0|||
28108302|NCT00121667|54766304|FG002|Short Term (ST) + Long Term (LT) Period|Death|0|||
28108303|NCT00121667|54766305|FG003|Short Term (ST) + Long Term (LT) Period|Death|2|||
28108304|NCT02954601|54766319|FG000|First Intervention (Five Days)|Withdrawal by Subject|0|||
28108305|NCT02954601|54766320|FG001|First Intervention (Five Days)|Withdrawal by Subject|0|||
28108306|NCT02954601|54766321|FG002|First Intervention (Five Days)|Withdrawal by Subject|1|||
28108307|NCT02954601|54766322|FG003|First Intervention (Five Days)|Withdrawal by Subject|0|||
28108308|NCT03633903|54766334|FG000|Overall Study|Withdrawal by Subject|1|||
28108309|NCT03633903|54766335|FG001|Overall Study|Withdrawal by Subject|2|||
28108310|NCT03633903|54766334|FG000|Overall Study|Lost to Follow-up|5|||
28108311|NCT03633903|54766335|FG001|Overall Study|Lost to Follow-up|5|||
28064010|NCT00316914|54719592|FG001|Overall Study|Withdrawal by Subject|3|||
28064011|NCT00316914|54719591|FG000|Overall Study|Adverse Event|8|||
28064012|NCT00316914|54719592|FG001|Overall Study|Adverse Event|7|||
28064013|NCT00316914|54719591|FG000|Overall Study|Other Problems|6|||
28064014|NCT00316914|54719592|FG001|Overall Study|Other Problems|11|||
28064015|NCT00316914|54719591|FG000|Overall Study|Missing end of treatment documentation|14|||
28064016|NCT00316914|54719592|FG001|Overall Study|Missing end of treatment documentation|15|||
28064017|NCT00336284|54719600|FG000|Overall Study|Death|52|||
28064018|NCT00336284|54719601|FG001|Overall Study|Death|26|||
28064019|NCT00336284|54719600|FG000|Overall Study|Lost to Follow-up|82|||
27815467|NCT01515423|54272313|FG002|Open Label Phase|Lack of Efficacy|0|||
28064020|NCT00336284|54719601|FG001|Overall Study|Lost to Follow-up|61|||
27815468|NCT01515423|54272311|FG000|Open Label Phase|Lost to Follow-up|21|||
27815469|NCT01515423|54272312|FG001|Open Label Phase|Lost to Follow-up|0|||
27815470|NCT01515423|54272313|FG002|Open Label Phase|Lost to Follow-up|0|||
27815471|NCT01515423|54272311|FG000|Open Label Phase|Withdrawal by Subject|118|||
27815472|NCT01515423|54272312|FG001|Open Label Phase|Withdrawal by Subject|0|||
27815473|NCT01515423|54272313|FG002|Open Label Phase|Withdrawal by Subject|0|||
27815474|NCT01515423|54272311|FG000|Open Label Phase|excluded from DB Phase|70|||
27815475|NCT01515423|54272312|FG001|Open Label Phase|excluded from DB Phase|0|||
27815476|NCT01515423|54272313|FG002|Open Label Phase|excluded from DB Phase|0|||
27815477|NCT01515423|54272311|FG000|Open Label Phase|Other|28|||
27815478|NCT01515423|54272312|FG001|Open Label Phase|Other|0|||
27815479|NCT01515423|54272313|FG002|Open Label Phase|Other|0|||
28160006|NCT02737475|54830027|FG005|Overall Study|Lost to Follow-up|0|||
27815480|NCT01515423|54272311|FG000|DOUBLE BLIND|Adverse Event|0|||
28160007|NCT02737475|54830028|FG006|Overall Study|Lost to Follow-up|0|||
28160008|NCT02737475|54830029|FG007|Overall Study|Lost to Follow-up|0|||
28160009|NCT02737475|54830030|FG008|Overall Study|Lost to Follow-up|0|||
28160010|NCT02737475|54830031|FG009|Overall Study|Lost to Follow-up|0|||
28160011|NCT02737475|54830032|FG010|Overall Study|Lost to Follow-up|0|||
28160012|NCT02737475|54830033|FG011|Overall Study|Lost to Follow-up|0|||
28160013|NCT02737475|54830034|FG012|Overall Study|Lost to Follow-up|0|||
28160014|NCT02737475|54830035|FG013|Overall Study|Lost to Follow-up|0|||
28160015|NCT02737475|54830036|FG014|Overall Study|Lost to Follow-up|0|||
28160016|NCT02737475|54830037|FG015|Overall Study|Lost to Follow-up|1|||
28160017|NCT02737475|54830038|FG016|Overall Study|Lost to Follow-up|0|||
28160018|NCT02737475|54830039|FG017|Overall Study|Lost to Follow-up|0|||
28160019|NCT02737475|54830040|FG018|Overall Study|Lost to Follow-up|0|||
28160020|NCT02737475|54830041|FG019|Overall Study|Lost to Follow-up|0|||
28160021|NCT02737475|54830042|FG020|Overall Study|Lost to Follow-up|0|||
28160022|NCT02737475|54830043|FG021|Overall Study|Lost to Follow-up|0|||
28160023|NCT02737475|54830044|FG022|Overall Study|Lost to Follow-up|0|||
28160024|NCT02737475|54830045|FG023|Overall Study|Lost to Follow-up|0|||
28160025|NCT02737475|54830046|FG024|Overall Study|Lost to Follow-up|0|||
28160026|NCT02737475|54830047|FG025|Overall Study|Lost to Follow-up|0|||
28160027|NCT02737475|54830048|FG026|Overall Study|Lost to Follow-up|0|||
28160028|NCT02737475|54830022|FG000|Overall Study|Disease Progression|0|||
28160029|NCT02737475|54830023|FG001|Overall Study|Disease Progression|0|||
28160030|NCT02737475|54830024|FG002|Overall Study|Disease Progression|0|||
28160031|NCT02737475|54830025|FG003|Overall Study|Disease Progression|0|||
28160032|NCT02737475|54830026|FG004|Overall Study|Disease Progression|0|||
28160033|NCT02737475|54830027|FG005|Overall Study|Disease Progression|0|||
28160034|NCT02737475|54830028|FG006|Overall Study|Disease Progression|0|||
28160035|NCT02737475|54830029|FG007|Overall Study|Disease Progression|0|||
28160036|NCT02737475|54830030|FG008|Overall Study|Disease Progression|0|||
28160037|NCT02737475|54830031|FG009|Overall Study|Disease Progression|0|||
28160038|NCT02737475|54830032|FG010|Overall Study|Disease Progression|0|||
28160039|NCT02737475|54830033|FG011|Overall Study|Disease Progression|0|||
28160040|NCT02737475|54830034|FG012|Overall Study|Disease Progression|0|||
28160041|NCT02737475|54830035|FG013|Overall Study|Disease Progression|0|||
28160042|NCT02737475|54830036|FG014|Overall Study|Disease Progression|0|||
28160043|NCT02737475|54830037|FG015|Overall Study|Disease Progression|0|||
28160044|NCT02737475|54830038|FG016|Overall Study|Disease Progression|0|||
28160045|NCT02737475|54830039|FG017|Overall Study|Disease Progression|0|||
28160046|NCT02737475|54830040|FG018|Overall Study|Disease Progression|0|||
28160047|NCT02737475|54830041|FG019|Overall Study|Disease Progression|0|||
28160048|NCT02737475|54830042|FG020|Overall Study|Disease Progression|0|||
28160049|NCT02737475|54830043|FG021|Overall Study|Disease Progression|0|||
28160050|NCT02737475|54830044|FG022|Overall Study|Disease Progression|0|||
28160051|NCT02737475|54830045|FG023|Overall Study|Disease Progression|0|||
28160052|NCT02737475|54830046|FG024|Overall Study|Disease Progression|0|||
28160053|NCT02737475|54830047|FG025|Overall Study|Disease Progression|0|||
28160054|NCT02737475|54830048|FG026|Overall Study|Disease Progression|1|||
28160055|NCT02557672|54830138|FG000|Overall Study|Withdrawal by Subject|4|||
28160056|NCT02557672|54830139|FG001|Overall Study|Withdrawal by Subject|2|||
28160057|NCT02714426|54830151|FG000|Overall Study|Withdrawal by Subject|2|||
28108312|NCT03607695|54766341|FG000|10 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|1|||
28108313|NCT03607695|54766341|FG000|16 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|2|||
28108314|NCT03557775|54766348|FG000|Overall Study|Withdrawal by Subject|1|||
28108315|NCT03557775|54766349|FG001|Overall Study|Withdrawal by Subject|2|||
28108316|NCT03557775|54766350|FG002|Overall Study|Withdrawal by Subject|4|||
28108317|NCT03557775|54766348|FG000|Overall Study|Physician Decision|0|||
28108318|NCT03557775|54766349|FG001|Overall Study|Physician Decision|1|||
28108319|NCT03557775|54766350|FG002|Overall Study|Physician Decision|0|||
27940174|NCT01194414|54596458|FG000|72 Weeks Open Label Extension|Pregnancy|1|||
27815481|NCT01515423|54272312|FG001|DOUBLE BLIND|Adverse Event|15|||
27940175|NCT01194414|54596459|FG001|72 Weeks Open Label Extension|Pregnancy|3|||
27940176|NCT01194414|54596460|FG002|72 Weeks Open Label Extension|Pregnancy|1|||
27815482|NCT01515423|54272313|FG002|DOUBLE BLIND|Adverse Event|13|||
27815483|NCT01515423|54272311|FG000|DOUBLE BLIND|Death|0|||
27815484|NCT01515423|54272312|FG001|DOUBLE BLIND|Death|1|||
27815485|NCT01515423|54272313|FG002|DOUBLE BLIND|Death|2|||
28108320|NCT00121199|54766358|FG000|Overall Study|Adverse Event|11|||
28108321|NCT00121199|54766358|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
28108322|NCT00121199|54766358|FG000|Overall Study|Progression/Relapse|1|||
28108323|NCT00121199|54766358|FG000|Overall Study|Death|3|||
28108324|NCT00121199|54766358|FG000|Overall Study|Other - Not Protocol Specified|3|||
28108325|NCT00121199|54766358|FG000|Overall Study|Ineligible|9|||
28108326|NCT00119405|54766362|FG000|Overall Study|Withdrawal by Subject|1|||
28108327|NCT00119015|54766368|FG000|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48|||
28108328|NCT00119015|54766369|FG001|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
27815486|NCT01515423|54272311|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
27815487|NCT01515423|54272312|FG001|DOUBLE BLIND|Lost to Follow-up|7|||
27815488|NCT01515423|54272313|FG002|DOUBLE BLIND|Lost to Follow-up|12|||
28064021|NCT00336284|54719600|FG000|Overall Study|Withdrawal by Physician or Subject|102|||
28064022|NCT00336284|54719601|FG001|Overall Study|Withdrawal by Physician or Subject|64|||
28064023|NCT00316602|54719609|FG000|Overall Study|Withdrawal by Subject|3|||
28064024|NCT00316602|54719610|FG001|Overall Study|Withdrawal by Subject|2|||
28064025|NCT00316602|54719609|FG000|Overall Study|Subject unwilling/unable to comply with|3|||
28064026|NCT00316602|54719610|FG001|Overall Study|Subject unwilling/unable to comply with|17|||
28064027|NCT00316602|54719609|FG000|Overall Study|Adverse Event|1|||
28064028|NCT00316602|54719610|FG001|Overall Study|Adverse Event|0|||
28064029|NCT00316602|54719609|FG000|Overall Study|Other|3|||
28064030|NCT00316602|54719610|FG001|Overall Study|Other|6|||
28108329|NCT00119015|54766370|FG002|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
28108330|NCT01981850|54766383|FG000|Main Phase Stage 1|Death|2|||
28108331|NCT01981850|54766384|FG001|Main Phase Stage 1|Death|0|||
28064031|NCT00335972|54719618|FG000|Overall Study|not given treatments|0|||
28064032|NCT00335972|54719619|FG001|Overall Study|not given treatments|3|||
28064033|NCT00346034|54719625|FG000|Overall Study|Adverse Event|34|||
28064034|NCT00346034|54719625|FG000|Overall Study|Lack of Efficacy|8|||
28108332|NCT01981850|54766385|FG002|Main Phase Stage 1|Death|0|||
28108333|NCT01981850|54766386|FG003|Main Phase Stage 1|Death|0|||
28108334|NCT01981850|54766387|FG004|Main Phase Stage 1|Death|0|||
28108335|NCT01981850|54766388|FG005|Main Phase Stage 1|Death|0|||
28064035|NCT00346034|54719625|FG000|Overall Study|Withdrawal by Subject|13|||
28064036|NCT00346034|54719625|FG000|Overall Study|Patient Stopped Taking Study Drug|1|||
28064037|NCT00346034|54719625|FG000|Overall Study|Not Willing to Follow Dosing Regimen|1|||
28064038|NCT00345878|54719631|FG000|Overall Study|Adverse Event|1|||
28064039|NCT00345878|54719632|FG001|Overall Study|Adverse Event|0|||
28108336|NCT01981850|54766389|FG006|Main Phase Stage 1|Death|0|||
28108337|NCT01981850|54766390|FG007|Main Phase Stage 1|Death|0|||
28064040|NCT00345878|54719631|FG000|Overall Study|Lost to Follow-up|2|||
28108338|NCT01981850|54766391|FG008|Main Phase Stage 1|Death|0|||
28064041|NCT00345878|54719632|FG001|Overall Study|Lost to Follow-up|1|||
28064042|NCT00345878|54719631|FG000|Overall Study|Other|1|||
28064043|NCT00345878|54719632|FG001|Overall Study|Other|0|||
28064044|NCT00335738|54719640|FG000|Overall Study|Physician Decision|6|||
28064045|NCT00335738|54719641|FG001|Overall Study|Physician Decision|0|||
28064046|NCT00335738|54719640|FG000|Overall Study|Withdrawal by Subject|2|||
28064047|NCT00335738|54719641|FG001|Overall Study|Withdrawal by Subject|0|||
28064048|NCT00335738|54719640|FG000|Overall Study|Ineligible|3|||
28064049|NCT00335738|54719641|FG001|Overall Study|Ineligible|4|||
28064050|NCT00334958|54719659|FG000|Overall Study|Medication Noncompliance|0|||
28064051|NCT00334958|54719660|FG001|Overall Study|Medication Noncompliance|3|||
28064052|NCT00334958|54719659|FG000|Overall Study|Protocol Violation|2|||
28064053|NCT00334958|54719660|FG001|Overall Study|Protocol Violation|2|||
28064054|NCT00334958|54719659|FG000|Overall Study|Request of the investigator or sponsor|0|||
28064055|NCT00334958|54719660|FG001|Overall Study|Request of the investigator or sponsor|1|||
28064056|NCT00334958|54719659|FG000|Overall Study|Withdrawal by Subject|7|||
28064057|NCT00334958|54719660|FG001|Overall Study|Withdrawal by Subject|4|||
28064058|NCT00334958|54719659|FG000|Overall Study|Adverse Event|27|||
28064059|NCT00334958|54719660|FG001|Overall Study|Adverse Event|12|||
28064060|NCT00334958|54719659|FG000|Overall Study|Other|1|||
28064061|NCT00334958|54719660|FG001|Overall Study|Other|2|||
28108339|NCT01981850|54766392|FG009|Main Phase Stage 1|Death|0|||
28108340|NCT01981850|54766383|FG000|Main Phase Stage 1|Informed Consent Withdrawn|1|||
28108341|NCT01981850|54766384|FG001|Main Phase Stage 1|Informed Consent Withdrawn|0|||
28108342|NCT01981850|54766385|FG002|Main Phase Stage 1|Informed Consent Withdrawn|0|||
27940177|NCT01194414|54596461|FG003|72 Weeks Open Label Extension|Pregnancy|1|||
27940178|NCT01194414|54596458|FG000|72 Weeks Open Label Extension|Other|2|||
28064062|NCT00326898|54719669|FG000|Overall Study|Disease progression|52|||
28064063|NCT00326898|54719670|FG001|Overall Study|Disease progression|54|||
28064064|NCT00326898|54719671|FG002|Overall Study|Disease progression|102|||
27940179|NCT01194414|54596459|FG001|72 Weeks Open Label Extension|Other|1|||
27940180|NCT01194414|54596460|FG002|72 Weeks Open Label Extension|Other|0|||
28064065|NCT00326898|54719669|FG000|Overall Study|Adverse Event|124|||
28108343|NCT01981850|54766386|FG003|Main Phase Stage 1|Informed Consent Withdrawn|0|||
28108344|NCT01981850|54766387|FG004|Main Phase Stage 1|Informed Consent Withdrawn|0|||
28108345|NCT01981850|54766388|FG005|Main Phase Stage 1|Informed Consent Withdrawn|0|||
28108346|NCT01981850|54766389|FG006|Main Phase Stage 1|Informed Consent Withdrawn|0|||
28108347|NCT01981850|54766390|FG007|Main Phase Stage 1|Informed Consent Withdrawn|0|||
28108348|NCT01981850|54766391|FG008|Main Phase Stage 1|Informed Consent Withdrawn|0|||
28108349|NCT01981850|54766392|FG009|Main Phase Stage 1|Informed Consent Withdrawn|0|||
28108350|NCT01981850|54766383|FG000|Main Phase Stage 1|Lack of Efficacy|0|||
28108351|NCT01981850|54766384|FG001|Main Phase Stage 1|Lack of Efficacy|2|||
28108352|NCT01981850|54766385|FG002|Main Phase Stage 1|Lack of Efficacy|0|||
28108353|NCT01981850|54766386|FG003|Main Phase Stage 1|Lack of Efficacy|0|||
28108354|NCT01981850|54766387|FG004|Main Phase Stage 1|Lack of Efficacy|0|||
28108355|NCT01981850|54766388|FG005|Main Phase Stage 1|Lack of Efficacy|0|||
28108356|NCT01981850|54766389|FG006|Main Phase Stage 1|Lack of Efficacy|0|||
28108357|NCT01981850|54766390|FG007|Main Phase Stage 1|Lack of Efficacy|0|||
28108358|NCT01981850|54766391|FG008|Main Phase Stage 1|Lack of Efficacy|0|||
28108359|NCT01981850|54766392|FG009|Main Phase Stage 1|Lack of Efficacy|0|||
28108360|NCT01981850|54766383|FG000|Main Phase Stage 1|Various reasons|0|||
28108361|NCT01981850|54766384|FG001|Main Phase Stage 1|Various reasons|0|||
28108362|NCT01981850|54766385|FG002|Main Phase Stage 1|Various reasons|2|||
28108363|NCT01981850|54766386|FG003|Main Phase Stage 1|Various reasons|0|||
28108364|NCT01981850|54766387|FG004|Main Phase Stage 1|Various reasons|0|||
28108365|NCT01981850|54766388|FG005|Main Phase Stage 1|Various reasons|0|||
28108366|NCT01981850|54766389|FG006|Main Phase Stage 1|Various reasons|0|||
28108367|NCT01981850|54766390|FG007|Main Phase Stage 1|Various reasons|0|||
28108368|NCT01981850|54766391|FG008|Main Phase Stage 1|Various reasons|0|||
28108369|NCT01981850|54766392|FG009|Main Phase Stage 1|Various reasons|0|||
28108370|NCT01981850|54766383|FG000|Main Phase Stage 2|Adverse Event|0|||
28108371|NCT01981850|54766384|FG001|Main Phase Stage 2|Adverse Event|0|||
28108372|NCT01981850|54766385|FG002|Main Phase Stage 2|Adverse Event|0|||
28064066|NCT00326898|54719670|FG001|Overall Study|Adverse Event|128|||
28064067|NCT00326898|54719671|FG002|Overall Study|Adverse Event|33|||
28064068|NCT00326898|54719669|FG000|Overall Study|Death|2|||
28064069|NCT00326898|54719670|FG001|Overall Study|Death|0|||
28108373|NCT01981850|54766386|FG003|Main Phase Stage 2|Adverse Event|0|||
28108374|NCT01981850|54766387|FG004|Main Phase Stage 2|Adverse Event|6|||
28108375|NCT01981850|54766388|FG005|Main Phase Stage 2|Adverse Event|5|||
28108376|NCT01981850|54766389|FG006|Main Phase Stage 2|Adverse Event|7|||
28108377|NCT01981850|54766390|FG007|Main Phase Stage 2|Adverse Event|0|||
28064070|NCT00326898|54719671|FG002|Overall Study|Death|0|||
28064071|NCT00326898|54719669|FG000|Overall Study|Withdrawal by Subject|134|||
28108378|NCT01981850|54766391|FG008|Main Phase Stage 2|Adverse Event|0|||
28108379|NCT01981850|54766392|FG009|Main Phase Stage 2|Adverse Event|0|||
28108380|NCT01981850|54766383|FG000|Main Phase Stage 2|Informed Consent Withdrawn|0|||
28108381|NCT01981850|54766384|FG001|Main Phase Stage 2|Informed Consent Withdrawn|0|||
28108382|NCT01981850|54766385|FG002|Main Phase Stage 2|Informed Consent Withdrawn|0|||
28108383|NCT01981850|54766386|FG003|Main Phase Stage 2|Informed Consent Withdrawn|0|||
28108384|NCT01981850|54766387|FG004|Main Phase Stage 2|Informed Consent Withdrawn|4|||
28108385|NCT01981850|54766388|FG005|Main Phase Stage 2|Informed Consent Withdrawn|3|||
28108386|NCT01981850|54766389|FG006|Main Phase Stage 2|Informed Consent Withdrawn|3|||
28108387|NCT01981850|54766390|FG007|Main Phase Stage 2|Informed Consent Withdrawn|0|||
28108388|NCT01981850|54766391|FG008|Main Phase Stage 2|Informed Consent Withdrawn|0|||
28108389|NCT01981850|54766392|FG009|Main Phase Stage 2|Informed Consent Withdrawn|0|||
28108390|NCT01981850|54766383|FG000|Main Phase Stage 2|Lack of Efficacy|0|||
28108391|NCT01981850|54766384|FG001|Main Phase Stage 2|Lack of Efficacy|0|||
28108392|NCT01981850|54766385|FG002|Main Phase Stage 2|Lack of Efficacy|0|||
28108393|NCT01981850|54766386|FG003|Main Phase Stage 2|Lack of Efficacy|0|||
28108394|NCT01981850|54766387|FG004|Main Phase Stage 2|Lack of Efficacy|1|||
28108395|NCT01981850|54766388|FG005|Main Phase Stage 2|Lack of Efficacy|2|||
28108396|NCT01981850|54766389|FG006|Main Phase Stage 2|Lack of Efficacy|0|||
28108397|NCT01981850|54766390|FG007|Main Phase Stage 2|Lack of Efficacy|0|||
28108398|NCT01981850|54766391|FG008|Main Phase Stage 2|Lack of Efficacy|0|||
28108399|NCT01981850|54766392|FG009|Main Phase Stage 2|Lack of Efficacy|0|||
28108400|NCT01981850|54766383|FG000|Main Phase Stage 2|Various reasons|0|||
28108401|NCT01981850|54766384|FG001|Main Phase Stage 2|Various reasons|0|||
28108402|NCT01981850|54766385|FG002|Main Phase Stage 2|Various reasons|0|||
28108403|NCT01981850|54766386|FG003|Main Phase Stage 2|Various reasons|0|||
28108404|NCT01981850|54766387|FG004|Main Phase Stage 2|Various reasons|2|||
28108405|NCT01981850|54766388|FG005|Main Phase Stage 2|Various reasons|0|||
28108406|NCT01981850|54766389|FG006|Main Phase Stage 2|Various reasons|1|||
28108407|NCT01981850|54766390|FG007|Main Phase Stage 2|Various reasons|0|||
28108408|NCT01981850|54766391|FG008|Main Phase Stage 2|Various reasons|0|||
28108409|NCT01981850|54766392|FG009|Main Phase Stage 2|Various reasons|0|||
28108410|NCT01981850|54766383|FG000|Main Phase Stage 2|Progressive Disease|0|||
28108411|NCT01981850|54766384|FG001|Main Phase Stage 2|Progressive Disease|0|||
28108412|NCT01981850|54766385|FG002|Main Phase Stage 2|Progressive Disease|0|||
28108413|NCT01981850|54766386|FG003|Main Phase Stage 2|Progressive Disease|0|||
28108414|NCT01981850|54766387|FG004|Main Phase Stage 2|Progressive Disease|0|||
28108415|NCT01981850|54766388|FG005|Main Phase Stage 2|Progressive Disease|6|||
28108416|NCT01981850|54766389|FG006|Main Phase Stage 2|Progressive Disease|6|||
28064072|NCT00326898|54719670|FG001|Overall Study|Withdrawal by Subject|128|||
28064073|NCT00326898|54719671|FG002|Overall Study|Withdrawal by Subject|32|||
28064074|NCT00326898|54719669|FG000|Overall Study|Alternative therapy|1|||
28064075|NCT00326898|54719670|FG001|Overall Study|Alternative therapy|0|||
28064076|NCT00326898|54719671|FG002|Overall Study|Alternative therapy|0|||
28064077|NCT00326898|54719669|FG000|Overall Study|Other complicating disease|5|||
28064078|NCT00326898|54719670|FG001|Overall Study|Other complicating disease|5|||
28064079|NCT00326898|54719671|FG002|Overall Study|Other complicating disease|4|||
28064080|NCT00326898|54719669|FG000|Overall Study|Other/Missing/Unknown|33|||
28064081|NCT00326898|54719670|FG001|Overall Study|Other/Missing/Unknown|28|||
28064082|NCT00326898|54719671|FG002|Overall Study|Other/Missing/Unknown|32|||
28064083|NCT00326118|54719681|FG000|Active Phase|Withdrawal by Subject|4|||
28064084|NCT00326118|54719682|FG001|Active Phase|Withdrawal by Subject|1|||
28064085|NCT00334802|54719691|FG000|Overall Study|Progressive Disease|2|||
28064086|NCT00334802|54719692|FG001|Overall Study|Progressive Disease|24|||
28064087|NCT00334802|54719691|FG000|Overall Study|Toxicity|1|||
28064088|NCT00334802|54719692|FG001|Overall Study|Toxicity|5|||
28064089|NCT00334802|54719691|FG000|Overall Study|Lack of Efficacy|1|||
28064090|NCT00334802|54719692|FG001|Overall Study|Lack of Efficacy|3|||
28064091|NCT00334802|54719691|FG000|Overall Study|Patient Condition Aggrevated|1|||
28064092|NCT00334802|54719692|FG001|Overall Study|Patient Condition Aggrevated|0|||
28064093|NCT00334802|54719691|FG000|Overall Study|Physician Decision|1|||
28064094|NCT00334802|54719692|FG001|Overall Study|Physician Decision|0|||
28064095|NCT00334802|54719691|FG000|Overall Study|Withdrawal by Subject|0|||
28064096|NCT00334802|54719692|FG001|Overall Study|Withdrawal by Subject|4|||
28064097|NCT00334802|54719691|FG000|Overall Study|Adverse Event|0|||
28064098|NCT00334802|54719692|FG001|Overall Study|Adverse Event|3|||
28064099|NCT00334802|54719691|FG000|Overall Study|Criteria for Starting Next Cycle Not Met|0|||
28064100|NCT00334802|54719692|FG001|Overall Study|Criteria for Starting Next Cycle Not Met|1|||
28064101|NCT00307164|54719703|FG000|Overall Study|Death|1|||
28064102|NCT00307164|54719704|FG001|Overall Study|Death|0|||
28108417|NCT01981850|54766390|FG007|Main Phase Stage 2|Progressive Disease|0|||
28108418|NCT01981850|54766391|FG008|Main Phase Stage 2|Progressive Disease|0|||
28108419|NCT01981850|54766392|FG009|Main Phase Stage 2|Progressive Disease|0|||
28108420|NCT01981850|54766383|FG000|Open Label Extension (OLE)|Adverse Event|0|||
28108421|NCT01981850|54766384|FG001|Open Label Extension (OLE)|Adverse Event|0|||
28108422|NCT01981850|54766385|FG002|Open Label Extension (OLE)|Adverse Event|0|||
28108423|NCT01981850|54766386|FG003|Open Label Extension (OLE)|Adverse Event|0|||
28108424|NCT01981850|54766387|FG004|Open Label Extension (OLE)|Adverse Event|0|||
28108425|NCT01981850|54766388|FG005|Open Label Extension (OLE)|Adverse Event|0|||
28108426|NCT01981850|54766389|FG006|Open Label Extension (OLE)|Adverse Event|0|||
28108427|NCT01981850|54766390|FG007|Open Label Extension (OLE)|Adverse Event|2|||
28108428|NCT01981850|54766391|FG008|Open Label Extension (OLE)|Adverse Event|1|||
28108429|NCT01981850|54766392|FG009|Open Label Extension (OLE)|Adverse Event|8|||
28108430|NCT01981850|54766383|FG000|Open Label Extension (OLE)|Lack of Efficacy|0|||
27815489|NCT01515423|54272311|FG000|DOUBLE BLIND|Pregnancy|0|||
27815490|NCT01515423|54272312|FG001|DOUBLE BLIND|Pregnancy|2|||
27815491|NCT01515423|54272313|FG002|DOUBLE BLIND|Pregnancy|0|||
27815492|NCT01515423|54272311|FG000|DOUBLE BLIND|Withdrawal by Subject|0|||
27815493|NCT01515423|54272312|FG001|DOUBLE BLIND|Withdrawal by Subject|50|||
27815494|NCT01515423|54272313|FG002|DOUBLE BLIND|Withdrawal by Subject|53|||
27815495|NCT01515423|54272311|FG000|DOUBLE BLIND|Other|0|||
27815496|NCT01515423|54272312|FG001|DOUBLE BLIND|Other|6|||
27815497|NCT01515423|54272313|FG002|DOUBLE BLIND|Other|12|||
27815498|NCT01515423|54272311|FG000|DOUBLE BLIND|Blind broken by investigator|0|||
27815499|NCT01515423|54272312|FG001|DOUBLE BLIND|Blind broken by investigator|1|||
27815500|NCT01515423|54272313|FG002|DOUBLE BLIND|Blind broken by investigator|0|||
27815501|NCT00637156|54272322|FG000|Overall Study|Withdrawal by Subject|0|||
27815502|NCT00637156|54272323|FG001|Overall Study|Withdrawal by Subject|7|||
27815503|NCT00637156|54272322|FG000|Overall Study|Death|0|||
27815504|NCT00637156|54272323|FG001|Overall Study|Death|1|||
27815505|NCT00637156|54272322|FG000|Overall Study|Lost to Follow-up|10|||
27815506|NCT00637156|54272323|FG001|Overall Study|Lost to Follow-up|16|||
27815507|NCT00637000|54272331|FG000|Overall Study|Withdrawal by Subject|4|||
27815508|NCT00637000|54272332|FG001|Overall Study|Withdrawal by Subject|3|||
27815509|NCT01515189|54272340|FG000|Induction|Disease Progression|109|||
27815510|NCT01515189|54272341|FG001|Induction|Disease Progression|155|||
28108431|NCT01981850|54766384|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
28108432|NCT01981850|54766385|FG002|Open Label Extension (OLE)|Lack of Efficacy|0|||
28108433|NCT01981850|54766386|FG003|Open Label Extension (OLE)|Lack of Efficacy|0|||
28108434|NCT01981850|54766387|FG004|Open Label Extension (OLE)|Lack of Efficacy|0|||
28108435|NCT01981850|54766388|FG005|Open Label Extension (OLE)|Lack of Efficacy|0|||
28108436|NCT01981850|54766389|FG006|Open Label Extension (OLE)|Lack of Efficacy|0|||
28108437|NCT01981850|54766390|FG007|Open Label Extension (OLE)|Lack of Efficacy|4|||
28108438|NCT01981850|54766391|FG008|Open Label Extension (OLE)|Lack of Efficacy|1|||
27815511|NCT01515189|54272340|FG000|Induction|Study drug toxicity|86|||
27815512|NCT01515189|54272341|FG001|Induction|Study drug toxicity|36|||
27815513|NCT01515189|54272340|FG000|Induction|Death|24|||
27815514|NCT01515189|54272341|FG001|Induction|Death|17|||
27815515|NCT01515189|54272340|FG000|Induction|Adverse Event|14|||
27815516|NCT01515189|54272341|FG001|Induction|Adverse Event|9|||
27815517|NCT01515189|54272340|FG000|Induction|Withdrawal by Subject|3|||
27815518|NCT01515189|54272341|FG001|Induction|Withdrawal by Subject|9|||
27815519|NCT01515189|54272340|FG000|Induction|No longer meets study criteria|0|||
28108439|NCT01981850|54766392|FG009|Open Label Extension (OLE)|Lack of Efficacy|19|||
28108440|NCT01981850|54766383|FG000|Open Label Extension (OLE)|Various reasons|0|||
28108441|NCT01981850|54766384|FG001|Open Label Extension (OLE)|Various reasons|0|||
28108442|NCT01981850|54766385|FG002|Open Label Extension (OLE)|Various reasons|0|||
28108443|NCT01981850|54766386|FG003|Open Label Extension (OLE)|Various reasons|0|||
28108444|NCT01981850|54766387|FG004|Open Label Extension (OLE)|Various reasons|0|||
28108445|NCT01981850|54766388|FG005|Open Label Extension (OLE)|Various reasons|0|||
28108446|NCT01981850|54766389|FG006|Open Label Extension (OLE)|Various reasons|0|||
28108447|NCT01981850|54766390|FG007|Open Label Extension (OLE)|Various reasons|3|||
28108448|NCT01981850|54766391|FG008|Open Label Extension (OLE)|Various reasons|1|||
28108449|NCT01981850|54766392|FG009|Open Label Extension (OLE)|Various reasons|3|||
28108450|NCT01981850|54766383|FG000|Open Label Extension (OLE)|Progressive Disease|0|||
28108451|NCT01981850|54766384|FG001|Open Label Extension (OLE)|Progressive Disease|0|||
28108452|NCT01981850|54766385|FG002|Open Label Extension (OLE)|Progressive Disease|0|||
28108453|NCT01981850|54766386|FG003|Open Label Extension (OLE)|Progressive Disease|0|||
28108454|NCT01981850|54766387|FG004|Open Label Extension (OLE)|Progressive Disease|0|||
28108455|NCT01981850|54766388|FG005|Open Label Extension (OLE)|Progressive Disease|0|||
28108456|NCT01981850|54766389|FG006|Open Label Extension (OLE)|Progressive Disease|0|||
28108457|NCT01981850|54766390|FG007|Open Label Extension (OLE)|Progressive Disease|3|||
28108458|NCT01981850|54766391|FG008|Open Label Extension (OLE)|Progressive Disease|2|||
28108459|NCT01981850|54766392|FG009|Open Label Extension (OLE)|Progressive Disease|9|||
28108460|NCT01981850|54766383|FG000|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
28108461|NCT01981850|54766384|FG001|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
28108462|NCT01981850|54766385|FG002|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
28108463|NCT01981850|54766386|FG003|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
28108464|NCT01981850|54766387|FG004|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
28108465|NCT01981850|54766388|FG005|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
28108466|NCT01981850|54766389|FG006|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
28108467|NCT01981850|54766390|FG007|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
28108468|NCT01981850|54766391|FG008|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
28108469|NCT01981850|54766392|FG009|Open Label Extension (OLE)|Informed Consent Withdrawn|8|||
28108470|NCT01981850|54766383|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
28108471|NCT01981850|54766384|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
28108472|NCT01981850|54766385|FG002|Open Label Extension (OLE)|Lost to Follow-up|0|||
28108473|NCT01981850|54766386|FG003|Open Label Extension (OLE)|Lost to Follow-up|0|||
28108474|NCT01981850|54766387|FG004|Open Label Extension (OLE)|Lost to Follow-up|0|||
28108475|NCT01981850|54766388|FG005|Open Label Extension (OLE)|Lost to Follow-up|0|||
28108476|NCT01981850|54766389|FG006|Open Label Extension (OLE)|Lost to Follow-up|0|||
28108477|NCT01981850|54766390|FG007|Open Label Extension (OLE)|Lost to Follow-up|0|||
28108478|NCT01981850|54766391|FG008|Open Label Extension (OLE)|Lost to Follow-up|0|||
28108479|NCT01981850|54766392|FG009|Open Label Extension (OLE)|Lost to Follow-up|1|||
28108480|NCT03557307|54766424|FG000|Period 1: To End of OCS Reduction Phase|Withdrawal by Subject|10|||
28108481|NCT03557307|54766424|FG000|Period 1: To End of OCS Reduction Phase|Adverse Event|7|||
28108482|NCT03557307|54766424|FG000|Period 1: To End of OCS Reduction Phase|Protocol Violation|6|||
28108483|NCT03557307|54766424|FG000|Period 1: To End of OCS Reduction Phase|Lost to Follow-up|5|||
28108484|NCT03557307|54766424|FG000|Period 1: To End of OCS Reduction Phase|other|3|||
28108485|NCT03557307|54766424|FG000|Period 1: To End of OCS Reduction Phase|Death|2|||
28108486|NCT03557307|54766424|FG000|Period 1: To End of OCS Reduction Phase|Failure to meet inclusion/exclusion criteria|2|||
28108487|NCT03557307|54766424|FG000|Period 2: Maintenance Phase|Adverse Event|4|||
28108488|NCT03557307|54766424|FG000|Period 2: Maintenance Phase|Death|3|||
28108489|NCT03557307|54766424|FG000|Period 2: Maintenance Phase|Lost to Follow-up|2|||
28108490|NCT03557307|54766424|FG000|Period 2: Maintenance Phase|Pregnancy|2|||
28108491|NCT03557307|54766424|FG000|Period 2: Maintenance Phase|Protocol Violation|11|||
28108492|NCT03557307|54766424|FG000|Period 2: Maintenance Phase|Withdrawal by Subject|2|||
28108493|NCT03557307|54766424|FG000|Period 2: Maintenance Phase|other|3|||
28108494|NCT00118703|54766436|FG000|Overall Study|Protocol Violation|1|||
28108495|NCT00118703|54766437|FG001|Overall Study|Protocol Violation|0|||
28108496|NCT00118703|54766436|FG000|Overall Study|Adverse Event|1|||
28108497|NCT00118703|54766437|FG001|Overall Study|Adverse Event|1|||
28108498|NCT00118703|54766436|FG000|Overall Study|Participant took two different treatment|0|||
28108499|NCT00118703|54766437|FG001|Overall Study|Participant took two different treatment|1|||
28108500|NCT00118703|54766436|FG000|Overall Study|Withdrawal by Subject|2|||
28108501|NCT00118703|54766437|FG001|Overall Study|Withdrawal by Subject|5|||
28108502|NCT00118703|54766436|FG000|Overall Study|Lost to Follow-up|1|||
28108503|NCT00118703|54766437|FG001|Overall Study|Lost to Follow-up|2|||
28108504|NCT00104104|54766445|FG000|Overall Study|Adverse Event|8|||
28108505|NCT00104104|54766446|FG001|Overall Study|Adverse Event|8|||
28108506|NCT00104104|54766445|FG000|Overall Study|Abnormal laboratory value(s)|20|||
28108507|NCT00104104|54766446|FG001|Overall Study|Abnormal laboratory value(s)|14|||
28108508|NCT00104104|54766445|FG000|Overall Study|Lack of Efficacy|0|||
28108509|NCT00104104|54766446|FG001|Overall Study|Lack of Efficacy|3|||
28108510|NCT00104104|54766445|FG000|Overall Study|Condition no longer requires study drug|7|||
28108511|NCT00104104|54766446|FG001|Overall Study|Condition no longer requires study drug|4|||
28108512|NCT00104104|54766445|FG000|Overall Study|Protocol Violation|5|||
28108513|NCT00104104|54766446|FG001|Overall Study|Protocol Violation|2|||
28108514|NCT00104104|54766445|FG000|Overall Study|Withdrawal by Subject|11|||
28108515|NCT00104104|54766446|FG001|Overall Study|Withdrawal by Subject|15|||
28108516|NCT00104104|54766445|FG000|Overall Study|Lost to Follow-up|3|||
28108517|NCT00104104|54766446|FG001|Overall Study|Lost to Follow-up|7|||
28108518|NCT00104104|54766445|FG000|Overall Study|Administrative problems|12|||
28108519|NCT00104104|54766446|FG001|Overall Study|Administrative problems|13|||
28108520|NCT00104104|54766445|FG000|Overall Study|Death|9|||
28108521|NCT00104104|54766446|FG001|Overall Study|Death|6|||
28108522|NCT03557151|54766454|FG000|Randomization to 3 Months|Lost to Follow-up|2|||
28108523|NCT03557151|54766455|FG001|Randomization to 3 Months|Lost to Follow-up|2|||
28108524|NCT03557151|54766454|FG000|6 to 9 Months|moved out of state/discontinued care at Nemours|2|||
28108525|NCT03557151|54766455|FG001|6 to 9 Months|moved out of state/discontinued care at Nemours|0|||
28108526|NCT03557151|54766454|FG000|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|0|||
28108527|NCT03557151|54766455|FG001|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|2|||
28108528|NCT00115739|54766463|FG000|Overall Study|Lost to Follow-up|3|||
28108529|NCT01347086|54766479|FG000|Overall Study|failed screening visit|0|||
28108530|NCT01347086|54766480|FG001|Overall Study|failed screening visit|0|||
28108531|NCT01347086|54766481|FG002|Overall Study|failed screening visit|1|||
28108532|NCT01347086|54766482|FG003|Overall Study|failed screening visit|0|||
28108533|NCT01347086|54766483|FG004|Overall Study|failed screening visit|0|||
28108534|NCT01347086|54766484|FG005|Overall Study|failed screening visit|0|||
28108535|NCT01347086|54766485|FG006|Overall Study|failed screening visit|1|||
28108536|NCT01347086|54766486|FG007|Overall Study|failed screening visit|1|||
28108537|NCT01347086|54766487|FG008|Overall Study|failed screening visit|0|||
28108538|NCT01347086|54766488|FG009|Overall Study|failed screening visit|1|||
28108539|NCT03605745|54766520|FG000|Overall Study|Study was terminated for business reasons|47|||
28108540|NCT03246152|54766524|FG000|Overall Study|Lost to Follow-up|2|||
28108541|NCT03246152|54766524|FG000|Overall Study|Protocol Violation|1|||
28108542|NCT03571581|54766528|FG000|Overall Study|Death|2|||
28108543|NCT03571581|54766528|FG000|Overall Study|Withdrawal by Subject|2|||
28108544|NCT00115349|54766537|FG000|Overall Study|Study closed due to low enrollment.|11|||
28108545|NCT00115349|54766538|FG001|Overall Study|Study closed due to low enrollment.|9|||
28108546|NCT00115037|54766546|FG000|Phase1|Lost to Follow-up|16|||
28108547|NCT00115037|54766547|FG001|Phase1|Lost to Follow-up|23|||
28108548|NCT00115037|54766548|FG002|Phase1|Lost to Follow-up|0|||
28108549|NCT00115037|54766549|FG003|Phase1|Lost to Follow-up|0|||
28108550|NCT00115037|54766550|FG004|Phase1|Lost to Follow-up|0|||
28108551|NCT00115037|54766551|FG005|Phase1|Lost to Follow-up|0|||
27815520|NCT01515189|54272341|FG001|Induction|No longer meets study criteria|2|||
28108552|NCT00115037|54766546|FG000|Phase1|Withdrawal by Subject|9|||
28108553|NCT00115037|54766547|FG001|Phase1|Withdrawal by Subject|4|||
28108554|NCT00115037|54766548|FG002|Phase1|Withdrawal by Subject|0|||
28108555|NCT00115037|54766549|FG003|Phase1|Withdrawal by Subject|0|||
28108556|NCT00115037|54766550|FG004|Phase1|Withdrawal by Subject|0|||
28108557|NCT00115037|54766551|FG005|Phase1|Withdrawal by Subject|0|||
28108558|NCT00115037|54766546|FG000|Phase2|Death|0|||
28108559|NCT00115037|54766547|FG001|Phase2|Death|0|||
28108560|NCT00115037|54766548|FG002|Phase2|Death|1|||
28108561|NCT00115037|54766549|FG003|Phase2|Death|0|||
28108562|NCT00115037|54766550|FG004|Phase2|Death|0|||
28108563|NCT00115037|54766551|FG005|Phase2|Death|1|||
28108564|NCT00115037|54766546|FG000|Phase2|Withdrawal by Subject|0|||
28108565|NCT00115037|54766547|FG001|Phase2|Withdrawal by Subject|0|||
28108566|NCT00115037|54766548|FG002|Phase2|Withdrawal by Subject|2|||
28108567|NCT00115037|54766549|FG003|Phase2|Withdrawal by Subject|1|||
28108568|NCT00115037|54766550|FG004|Phase2|Withdrawal by Subject|2|||
28108569|NCT00115037|54766551|FG005|Phase2|Withdrawal by Subject|1|||
28108570|NCT00115037|54766546|FG000|Phase2|Lost to Follow-up|0|||
28108571|NCT00115037|54766547|FG001|Phase2|Lost to Follow-up|0|||
28108572|NCT00115037|54766548|FG002|Phase2|Lost to Follow-up|12|||
28108573|NCT00115037|54766549|FG003|Phase2|Lost to Follow-up|14|||
28108574|NCT00115037|54766550|FG004|Phase2|Lost to Follow-up|4|||
28108575|NCT00115037|54766551|FG005|Phase2|Lost to Follow-up|10|||
28108576|NCT03214640|54766569|FG000|Overall Study|Protocol Violation|1|||
28108577|NCT03214640|54766570|FG001|Overall Study|Protocol Violation|2|||
28108578|NCT03214640|54766571|FG002|Overall Study|Protocol Violation|1|||
28108579|NCT03214640|54766572|FG003|Overall Study|Protocol Violation|4|||
28108580|NCT03214406|54766584|FG000|Overall Study|did not meet enrollment criteria|9|||
28108581|NCT03214406|54766585|FG001|Overall Study|did not meet enrollment criteria|13|||
28108582|NCT03214406|54766584|FG000|Overall Study|Withdrawal by Subject|1|||
28108583|NCT03214406|54766585|FG001|Overall Study|Withdrawal by Subject|0|||
28108584|NCT03214406|54766584|FG000|Overall Study|Lost to Follow-up|0|||
28108585|NCT03214406|54766585|FG001|Overall Study|Lost to Follow-up|2|||
28108586|NCT03213938|54766593|FG000|Overall Study|Lost to Follow-up|4|||
28108587|NCT03213938|54766594|FG001|Overall Study|Lost to Follow-up|3|||
28108588|NCT03213938|54766593|FG000|Overall Study|Lack of Efficacy|1|||
28108589|NCT03213938|54766594|FG001|Overall Study|Lack of Efficacy|0|||
28108590|NCT03213938|54766593|FG000|Overall Study|Decline to participate|5|||
28108591|NCT03213938|54766594|FG001|Overall Study|Decline to participate|4|||
28108592|NCT03213938|54766593|FG000|Overall Study|Without reason|4|||
28108593|NCT03213938|54766594|FG001|Overall Study|Without reason|5|||
28108594|NCT03604497|54766600|FG000|Overall Study|Protocol Violation|52|||
28108595|NCT03213626|54766608|FG000|Overall Study|Adverse Event|1|||
28108596|NCT03213626|54766608|FG000|Overall Study|Progressive Disease|6|||
28108597|NCT03604341|54766614|FG000|Overall Study|Withdrawal by Subject|1|||
28108598|NCT03604341|54766615|FG001|Overall Study|Withdrawal by Subject|1|||
28108599|NCT03604341|54766614|FG000|Overall Study|Adverse Event|1|||
28108600|NCT03604341|54766615|FG001|Overall Study|Adverse Event|0|||
28108601|NCT03604341|54766614|FG000|Overall Study|Protocol Violation|0|||
28108602|NCT03604341|54766615|FG001|Overall Study|Protocol Violation|1|||
28108603|NCT03603639|54766621|FG000|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
28108604|NCT03603639|54766622|FG001|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
28108605|NCT03603639|54766623|FG002|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
28108606|NCT03603639|54766624|FG003|Washout Period (at Least 3 Weeks)|Adverse Event|1|||
28108607|NCT03603639|54766625|FG004|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
28108608|NCT03603639|54766626|FG005|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
28108609|NCT03603639|54766621|FG000|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
28108610|NCT03603639|54766622|FG001|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
28108611|NCT03603639|54766623|FG002|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
28108612|NCT03603639|54766624|FG003|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
28108613|NCT03603639|54766625|FG004|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
28108614|NCT03603639|54766626|FG005|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
28108615|NCT00114959|54766640|FG000|Overall Study|Lack of Efficacy|6|||
28108616|NCT00114959|54766640|FG000|Overall Study|Physician Decision|1|||
27940181|NCT01194414|54596461|FG003|72 Weeks Open Label Extension|Other|0|||
28108617|NCT00114959|54766640|FG000|Overall Study|Death|1|||
28108618|NCT02778100|54766646|FG000|Period 1 (Common Cold)|Withdrawal by Subject|1|||
28108619|NCT02778100|54766647|FG001|Period 1 (Common Cold)|Withdrawal by Subject|0|||
28108620|NCT00118157|54766655|FG000|Overall Study|Adverse Event|2|||
28108621|NCT00118157|54766655|FG000|Overall Study|Death|8|||
28108622|NCT00118157|54766655|FG000|Overall Study|Withdrawal by Subject|2|||
28108623|NCT02762500|54766662|FG000|Overall Study|Lack of Efficacy|1|||
28108624|NCT02762500|54766663|FG001|Overall Study|Lack of Efficacy|0|||
28108625|NCT02762500|54766662|FG000|Overall Study|Withdrawal by Subject|1|||
28108626|NCT02762500|54766663|FG001|Overall Study|Withdrawal by Subject|1|||
28108627|NCT02762500|54766662|FG000|Overall Study|Adverse Event|0|||
28108628|NCT02762500|54766663|FG001|Overall Study|Adverse Event|2|||
28108629|NCT03552549|54766671|FG000|Overall Study|Disease progression|25|||
28108630|NCT03552549|54766672|FG001|Overall Study|Disease progression|17|||
28108631|NCT03552549|54766671|FG000|Overall Study|Adverse event in first 12 months|12|||
28108632|NCT03552549|54766672|FG001|Overall Study|Adverse event in first 12 months|8|||
28108633|NCT03552549|54766671|FG000|Overall Study|Withdrawal by Subject|7|||
28108634|NCT03552549|54766672|FG001|Overall Study|Withdrawal by Subject|7|||
28108635|NCT03552549|54766671|FG000|Overall Study|Unknown (no reason provided)|4|||
28108636|NCT03552549|54766672|FG001|Overall Study|Unknown (no reason provided)|2|||
28108637|NCT03552549|54766671|FG000|Overall Study|Not in participant's best interest|2|||
28108638|NCT03552549|54766672|FG001|Overall Study|Not in participant's best interest|1|||
28108639|NCT03552549|54766671|FG000|Overall Study|Did not complete study treatment|2|||
28108640|NCT03552549|54766672|FG001|Overall Study|Did not complete study treatment|3|||
28108641|NCT03552549|54766671|FG000|Overall Study|Did not meet eligibility criteria|1|||
28108642|NCT03552549|54766672|FG001|Overall Study|Did not meet eligibility criteria|0|||
28108643|NCT03552549|54766671|FG000|Overall Study|Administrative|0|||
28108644|NCT03552549|54766672|FG001|Overall Study|Administrative|14|||
28108645|NCT00117845|54766678|FG000|Overall Study|stopped treatment/drug supplyinterrupted|1|||
28108646|NCT02761642|54766682|FG000|Overall Study|Did not Receive Study Treatment|3|||
28108647|NCT02761642|54766682|FG000|Overall Study|Adverse Event|13|||
28108648|NCT02761642|54766682|FG000|Overall Study|Withdrawal by Subject|2|||
28108649|NCT02761642|54766682|FG000|Overall Study|Non-compliant|7|||
28108650|NCT02761642|54766682|FG000|Overall Study|Death|3|||
28108651|NCT02761642|54766682|FG000|Overall Study|Lack of Efficacy|20|||
28108652|NCT02761642|54766682|FG000|Overall Study|Physician Decision|1|||
28108653|NCT02761642|54766682|FG000|Overall Study|Reason Unspecified|21|||
28108654|NCT00113555|54766686|FG000|Overall Study|Baseline Failure|59|||
28108655|NCT00113555|54766686|FG000|Overall Study|Permanently Explanted|7|||
28108656|NCT00113555|54766686|FG000|Overall Study|Death|1|||
28108657|NCT00113555|54766686|FG000|Overall Study|Missed Followup|4|||
28108658|NCT00113555|54766686|FG000|Overall Study|Lost to Follow-up|8|||
28108659|NCT03189524|54766694|FG000|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|7|||
28108660|NCT03189524|54766695|FG001|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|5|||
28108661|NCT03189524|54766696|FG002|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|11|||
28108662|NCT03189524|54766694|FG000|Overall Study|Death|2|||
28108663|NCT03189524|54766695|FG001|Overall Study|Death|2|||
28108664|NCT03189524|54766696|FG002|Overall Study|Death|1|||
28108665|NCT03189524|54766694|FG000|Overall Study|Lost to Follow-up|1|||
28108666|NCT03189524|54766695|FG001|Overall Study|Lost to Follow-up|0|||
28108667|NCT03189524|54766696|FG002|Overall Study|Lost to Follow-up|8|||
28108668|NCT03189524|54766694|FG000|Overall Study|Withdrawal by Subject|1|||
28108669|NCT03189524|54766695|FG001|Overall Study|Withdrawal by Subject|1|||
28108670|NCT03189524|54766696|FG002|Overall Study|Withdrawal by Subject|3|||
28108671|NCT03189524|54766694|FG000|Overall Study|Progressive Disease|0|||
28108672|NCT03189524|54766695|FG001|Overall Study|Progressive Disease|2|||
28108673|NCT03189524|54766696|FG002|Overall Study|Progressive Disease|0|||
28108674|NCT03600909|54766711|FG000|Overall Study|Not treated|0|||
28108675|NCT03600909|54766712|FG001|Overall Study|Not treated|3|||
28108676|NCT03600909|54766713|FG002|Overall Study|Not treated|0|||
28108677|NCT03189446|54766721|FG000|Overall Study|Adverse Event|2|||
28108678|NCT03189446|54766721|FG000|Overall Study|Withdrawal by Subject|2|||
28108679|NCT03189446|54766721|FG000|Overall Study|Physician Decision|1|||
28108680|NCT03212690|54766725|FG000|Overall Study|Protocol Violation|1|||
28108681|NCT03568461|54766729|FG000|Overall Study|Death|7|||
28108682|NCT03568461|54766729|FG000|Overall Study|Physician Decision|5|||
28108683|NCT03568461|54766729|FG000|Overall Study|Subject decision|5|||
28108684|NCT03568461|54766729|FG000|Overall Study|Lost to Follow-up|1|||
28108685|NCT03188120|54766733|FG000|Overall Study|Adverse Event|4|||
28108686|NCT03188120|54766733|FG000|Overall Study|Insufficient Effectiveness|8|||
28108687|NCT03188120|54766733|FG000|Overall Study|Improved|12|||
28108688|NCT03188120|54766733|FG000|Overall Study|Lost to Follow-up|7|||
28108689|NCT03188120|54766733|FG000|Overall Study|Other than specified|3|||
28108690|NCT03188120|54766733|FG000|Overall Study|No visit after the first visit|13|||
28108691|NCT02895945|54766739|FG000|Overall Study|Physician Decision|2|||
28108692|NCT02895945|54766740|FG001|Overall Study|Physician Decision|1|||
28108693|NCT02777554|54766748|FG000|Overall Study|Adverse Event|4|||
28108694|NCT02777554|54766749|FG001|Overall Study|Adverse Event|4|||
28108695|NCT02777554|54766750|FG002|Overall Study|Adverse Event|0|||
28108696|NCT02777554|54766751|FG003|Overall Study|Adverse Event|1|||
28108697|NCT02777554|54766752|FG004|Overall Study|Adverse Event|0|||
28108698|NCT02777554|54766753|FG005|Overall Study|Adverse Event|0|||
28108699|NCT02777554|54766748|FG000|Overall Study|Withdrawal by Subject|3|||
28108700|NCT02777554|54766749|FG001|Overall Study|Withdrawal by Subject|1|||
28108701|NCT02777554|54766750|FG002|Overall Study|Withdrawal by Subject|1|||
28108702|NCT02777554|54766751|FG003|Overall Study|Withdrawal by Subject|0|||
28108703|NCT02777554|54766752|FG004|Overall Study|Withdrawal by Subject|0|||
28108704|NCT02777554|54766753|FG005|Overall Study|Withdrawal by Subject|0|||
28108705|NCT02777554|54766748|FG000|Overall Study|Discharged early due to hurricane|22|||
28108706|NCT02777554|54766749|FG001|Overall Study|Discharged early due to hurricane|20|||
28108707|NCT02777554|54766750|FG002|Overall Study|Discharged early due to hurricane|0|||
28108708|NCT02777554|54766751|FG003|Overall Study|Discharged early due to hurricane|0|||
28108709|NCT02777554|54766752|FG004|Overall Study|Discharged early due to hurricane|0|||
28108710|NCT02777554|54766753|FG005|Overall Study|Discharged early due to hurricane|0|||
28108711|NCT02777554|54766748|FG000|Overall Study|Other - Miscellaneous|1|||
28108712|NCT02777554|54766749|FG001|Overall Study|Other - Miscellaneous|0|||
28108713|NCT02777554|54766750|FG002|Overall Study|Other - Miscellaneous|0|||
28108714|NCT02777554|54766751|FG003|Overall Study|Other - Miscellaneous|0|||
28108715|NCT02777554|54766752|FG004|Overall Study|Other - Miscellaneous|0|||
28108716|NCT02777554|54766753|FG005|Overall Study|Other - Miscellaneous|0|||
28108717|NCT03550209|54766777|FG000|Overall Study|Lost to Follow-up|1|||
28108718|NCT03550209|54766778|FG001|Overall Study|Lost to Follow-up|0|||
28108719|NCT03550209|54766779|FG002|Overall Study|Lost to Follow-up|1|||
28108720|NCT03550209|54766780|FG003|Overall Study|Lost to Follow-up|0|||
28108721|NCT03550209|54766777|FG000|Overall Study|Withdrawal by Subject|0|||
28108722|NCT03550209|54766778|FG001|Overall Study|Withdrawal by Subject|3|||
28108723|NCT03550209|54766779|FG002|Overall Study|Withdrawal by Subject|1|||
28108724|NCT03550209|54766780|FG003|Overall Study|Withdrawal by Subject|2|||
28108725|NCT03550209|54766777|FG000|Overall Study|Excluded due to ineligibility after randomization|0|||
28108726|NCT03550209|54766778|FG001|Overall Study|Excluded due to ineligibility after randomization|0|||
28108727|NCT03550209|54766779|FG002|Overall Study|Excluded due to ineligibility after randomization|0|||
28108728|NCT03550209|54766780|FG003|Overall Study|Excluded due to ineligibility after randomization|2|||
28108729|NCT03032510|54766792|FG000|Overall Study|Adverse Event|5|||
28108730|NCT03032510|54766793|FG001|Overall Study|Adverse Event|2|||
28108731|NCT03032510|54766792|FG000|Overall Study|Lost to Follow-up|8|||
28108732|NCT03032510|54766793|FG001|Overall Study|Lost to Follow-up|7|||
28108733|NCT03032510|54766792|FG000|Overall Study|Withdrawal by Subject|8|||
28108734|NCT03032510|54766793|FG001|Overall Study|Withdrawal by Subject|7|||
28108735|NCT03032510|54766792|FG000|Overall Study|Subject noncompliance|4|||
28108736|NCT03032510|54766793|FG001|Overall Study|Subject noncompliance|2|||
28108737|NCT03032510|54766792|FG000|Overall Study|Physician Decision|2|||
28108738|NCT03032510|54766793|FG001|Overall Study|Physician Decision|0|||
28108739|NCT03599349|54766803|FG000|Overall Study|Lost to Follow-up|1|||
28108740|NCT03599193|54766813|FG000|Overall Study|Adverse Event|0|||
28108741|NCT03599193|54766814|FG001|Overall Study|Adverse Event|2|||
28108742|NCT03599193|54766813|FG000|Overall Study|Withdrawal by Subject|1|||
28108743|NCT03599193|54766814|FG001|Overall Study|Withdrawal by Subject|0|||
28108744|NCT03599193|54766813|FG000|Overall Study|Protocol Violation|1|||
28108745|NCT03599193|54766814|FG001|Overall Study|Protocol Violation|0|||
28108746|NCT03599193|54766813|FG000|Overall Study|Lost to Follow-up|0|||
28108747|NCT03599193|54766814|FG001|Overall Study|Lost to Follow-up|1|||
28108748|NCT03166124|54766823|FG000|Treatment Period 1|Adverse Event|0|||
28108749|NCT03166124|54766824|FG001|Treatment Period 1|Adverse Event|0|||
28108750|NCT03166124|54766825|FG002|Treatment Period 1|Adverse Event|1|||
28108751|NCT03166124|54766826|FG003|Treatment Period 1|Adverse Event|0|||
28108752|NCT03166124|54766823|FG000|Wash-out Period|Withdrawal by Subject|0|||
28108753|NCT03166124|54766824|FG001|Wash-out Period|Withdrawal by Subject|1|||
28108754|NCT03166124|54766825|FG002|Wash-out Period|Withdrawal by Subject|0|||
28108755|NCT03166124|54766826|FG003|Wash-out Period|Withdrawal by Subject|1|||
28108756|NCT03166124|54766823|FG000|Wash-out Period|Adverse Event|0|||
28108757|NCT03166124|54766824|FG001|Wash-out Period|Adverse Event|1|||
28108758|NCT03166124|54766825|FG002|Wash-out Period|Adverse Event|1|||
28108759|NCT03166124|54766826|FG003|Wash-out Period|Adverse Event|0|||
28108760|NCT03567291|54766837|FG000|Period I|Adverse Event|14|||
28108761|NCT03567291|54766838|FG001|Period I|Adverse Event|0|||
28108762|NCT03567291|54766839|FG002|Period I|Adverse Event|0|||
28108763|NCT03567291|54766840|FG003|Period I|Adverse Event|0|||
28108764|NCT03567291|54766837|FG000|Period I|Protocol Violation|1|||
28108765|NCT03567291|54766838|FG001|Period I|Protocol Violation|0|||
28108766|NCT03567291|54766839|FG002|Period I|Protocol Violation|0|||
28108767|NCT03567291|54766840|FG003|Period I|Protocol Violation|0|||
28108768|NCT03567291|54766837|FG000|Period I|Withdrawal by Subject|23|||
28108769|NCT03567291|54766838|FG001|Period I|Withdrawal by Subject|0|||
28108770|NCT03567291|54766839|FG002|Period I|Withdrawal by Subject|0|||
28108771|NCT03567291|54766840|FG003|Period I|Withdrawal by Subject|0|||
28108772|NCT03567291|54766837|FG000|Period I|Lost to Follow-up|2|||
28108773|NCT03567291|54766838|FG001|Period I|Lost to Follow-up|0|||
28108774|NCT03567291|54766839|FG002|Period I|Lost to Follow-up|0|||
28108775|NCT03567291|54766840|FG003|Period I|Lost to Follow-up|0|||
28108776|NCT03567291|54766837|FG000|Period I|Terminated by sponsor|44|||
28108777|NCT03567291|54766838|FG001|Period I|Terminated by sponsor|0|||
28108778|NCT03567291|54766839|FG002|Period I|Terminated by sponsor|0|||
28108779|NCT03567291|54766840|FG003|Period I|Terminated by sponsor|0|||
28108780|NCT03567291|54766837|FG000|Period I|Missing or unknown|7|||
28108781|NCT03567291|54766838|FG001|Period I|Missing or unknown|0|||
28108782|NCT03567291|54766839|FG002|Period I|Missing or unknown|0|||
28108783|NCT03567291|54766840|FG003|Period I|Missing or unknown|0|||
28108784|NCT03567291|54766837|FG000|Period II|Adverse Event|0|||
28108785|NCT03567291|54766838|FG001|Period II|Adverse Event|1|||
28108786|NCT03567291|54766839|FG002|Period II|Adverse Event|0|||
28108787|NCT03567291|54766840|FG003|Period II|Adverse Event|0|||
28108788|NCT03567291|54766837|FG000|Period II|Missing or unknown|0|||
28108789|NCT03567291|54766838|FG001|Period II|Missing or unknown|2|||
28108790|NCT03567291|54766839|FG002|Period II|Missing or unknown|1|||
28108791|NCT03567291|54766840|FG003|Period II|Missing or unknown|0|||
28108792|NCT03567291|54766837|FG000|Period III|Adverse Event|0|||
28108793|NCT03567291|54766838|FG001|Period III|Adverse Event|0|||
28108794|NCT03567291|54766839|FG002|Period III|Adverse Event|0|||
28108795|NCT03567291|54766840|FG003|Period III|Adverse Event|4|||
28108796|NCT03567291|54766837|FG000|Period III|Withdrawal by Subject|0|||
28108797|NCT03567291|54766838|FG001|Period III|Withdrawal by Subject|0|||
28108798|NCT03567291|54766839|FG002|Period III|Withdrawal by Subject|0|||
27815521|NCT01515189|54272340|FG000|Induction|Lost to Follow-up|1|||
27815522|NCT01515189|54272341|FG001|Induction|Lost to Follow-up|0|||
27815523|NCT01515189|54272340|FG000|Induction|Other|0|||
27815524|NCT01515189|54272341|FG001|Induction|Other|4|||
27815525|NCT01515189|54272340|FG000|First Re-Induction Phase|Disease progression|6|||
27815526|NCT01515189|54272341|FG001|First Re-Induction Phase|Disease progression|14|||
27815527|NCT01515189|54272340|FG000|First Re-Induction Phase|Study drug toxicity|5|||
27815528|NCT01515189|54272341|FG001|First Re-Induction Phase|Study drug toxicity|0|||
27815529|NCT01515189|54272340|FG000|First Re-Induction Phase|Withdrawal by Subject|1|||
27815530|NCT01515189|54272341|FG001|First Re-Induction Phase|Withdrawal by Subject|1|||
27815531|NCT01515189|54272340|FG000|First Re-Induction Phase|No longer meets study criteria|1|||
27815532|NCT01515189|54272341|FG001|First Re-Induction Phase|No longer meets study criteria|0|||
27815533|NCT01515189|54272340|FG000|First Re-Induction Phase|Other|1|||
27815534|NCT01515189|54272341|FG001|First Re-Induction Phase|Other|0|||
27815535|NCT01546623|54272349|FG000|Overall Study|Adverse Event|2|||
27815536|NCT01546623|54272350|FG001|Overall Study|Adverse Event|3|||
27815537|NCT01546623|54272349|FG000|Overall Study|Major Protocol Deviation|1|||
27815538|NCT01546623|54272350|FG001|Overall Study|Major Protocol Deviation|1|||
27815539|NCT01546623|54272349|FG000|Overall Study|High Prostate specific antigen|2|||
27815540|NCT01546623|54272350|FG001|Overall Study|High Prostate specific antigen|1|||
27815541|NCT01546623|54272349|FG000|Overall Study|Did Not Receive Study Drug|1|||
27815542|NCT01546623|54272350|FG001|Overall Study|Did Not Receive Study Drug|1|||
27815543|NCT01546155|54272356|FG000|Overall Study|could not tolerate long scan duration|3|||
27815544|NCT00636610|54272362|FG000|Overall Study|Adverse Event|4|||
27815545|NCT00636610|54272363|FG001|Overall Study|Adverse Event|4|||
27815546|NCT00636610|54272362|FG000|Overall Study|Death|6|||
27815547|NCT00636610|54272363|FG001|Overall Study|Death|3|||
27815548|NCT00636610|54272362|FG000|Overall Study|Physician decision to withdraw patient|15|||
27815549|NCT00636610|54272363|FG001|Overall Study|Physician decision to withdraw patient|9|||
27815550|NCT00636610|54272362|FG000|Overall Study|Subject decision to withdraw|15|||
27815551|NCT00636610|54272363|FG001|Overall Study|Subject decision to withdraw|11|||
27815552|NCT00636610|54272362|FG000|Overall Study|Disease progression - radiographic|41|||
27815553|NCT00636610|54272363|FG001|Overall Study|Disease progression - radiographic|51|||
27815554|NCT00636610|54272362|FG000|Overall Study|Disease progression - clinical|8|||
28064103|NCT00307164|54719703|FG000|Overall Study|Severe debilitation, unable to continue|1|||
28064104|NCT00307164|54719704|FG001|Overall Study|Severe debilitation, unable to continue|0|||
28064105|NCT00307164|54719703|FG000|Overall Study|Subject/parent not able to get to clinic|2|||
28064106|NCT00307164|54719704|FG001|Overall Study|Subject/parent not able to get to clinic|1|||
28064107|NCT00307164|54719703|FG000|Overall Study|Withdrawal by Subject|1|||
28064108|NCT00307164|54719704|FG001|Overall Study|Withdrawal by Subject|8|||
28064109|NCT00307164|54719703|FG000|Overall Study|Not compliant with requirements|4|||
28064110|NCT00307164|54719704|FG001|Overall Study|Not compliant with requirements|4|||
28064111|NCT00307164|54719703|FG000|Overall Study|Lost to Follow-up|6|||
28064112|NCT00307164|54719704|FG001|Overall Study|Lost to Follow-up|1|||
28064113|NCT03827564|54719712|FG000|Overall Study|Discontinued due to Study Termination|1|||
28064114|NCT03827564|54719713|FG001|Overall Study|Discontinued due to Study Termination|0|||
28064115|NCT00307086|54719719|FG000|Overall Study|ineligible|5|||
28064116|NCT00325416|54719725|FG000|Phase I: Dose Escalation|Pre-transplant screen failure|8|||
28064117|NCT00325416|54719726|FG001|Phase I: Dose Escalation|Pre-transplant screen failure|9|||
28108799|NCT03567291|54766840|FG003|Period III|Withdrawal by Subject|4|||
28108800|NCT03567291|54766837|FG000|Period III|Lost to Follow-up|0|||
28108801|NCT03567291|54766838|FG001|Period III|Lost to Follow-up|0|||
28108802|NCT03567291|54766839|FG002|Period III|Lost to Follow-up|0|||
28108803|NCT03567291|54766840|FG003|Period III|Lost to Follow-up|1|||
27815555|NCT00636610|54272363|FG001|Overall Study|Disease progression - clinical|3|||
27815556|NCT00636610|54272362|FG000|Overall Study|Reason for discontinuation not available|3|||
27815557|NCT00636610|54272363|FG001|Overall Study|Reason for discontinuation not available|2|||
27815558|NCT00635050|54272371|FG000|Overall Study|Withdrawal by Subject|1|||
27815559|NCT00634504|54272380|FG000|Overall Study|Protocol Violation|1|||
27815560|NCT00634504|54272381|FG001|Overall Study|Protocol Violation|0|||
28108804|NCT03567291|54766837|FG000|Period III|Terminated by sponsor|0|||
28108805|NCT03567291|54766838|FG001|Period III|Terminated by sponsor|0|||
28108806|NCT03567291|54766839|FG002|Period III|Terminated by sponsor|0|||
28108807|NCT03567291|54766840|FG003|Period III|Terminated by sponsor|68|||
28108808|NCT03567291|54766837|FG000|Period III|Missing or unknown|0|||
28108809|NCT03567291|54766838|FG001|Period III|Missing or unknown|0|||
28108810|NCT03567291|54766839|FG002|Period III|Missing or unknown|0|||
28108811|NCT03567291|54766840|FG003|Period III|Missing or unknown|8|||
28108812|NCT02777242|54766846|FG000|Overall Study|Other|2|||
28108813|NCT02777242|54766846|FG000|Overall Study|Lost to Follow-up|1|||
28108814|NCT02777242|54766846|FG000|Overall Study|Multiple|1|||
28108815|NCT02777242|54766846|FG000|Overall Study|Sponsor's request|1|||
28108816|NCT02777242|54766846|FG000|Overall Study|Withdrawal by Subject|1|||
28108817|NCT03212144|54766852|FG000|First Sequence (4 Weeks)|Lost to Follow-up|1|||
28108818|NCT03212144|54766853|FG001|First Sequence (4 Weeks)|Lost to Follow-up|0|||
28108819|NCT03212144|54766852|FG000|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
28108820|NCT03212144|54766853|FG001|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
28108821|NCT03566979|54766863|FG000|Overall Study|Withdrawal by Subject|2|||
28108822|NCT03566979|54766864|FG001|Overall Study|Withdrawal by Subject|0|||
28108823|NCT03566979|54766865|FG002|Overall Study|Withdrawal by Subject|1|||
28108824|NCT03566979|54766866|FG003|Overall Study|Withdrawal by Subject|1|||
28108825|NCT03566979|54766863|FG000|Overall Study|Lost to Follow-up|2|||
28108826|NCT03566979|54766864|FG001|Overall Study|Lost to Follow-up|7|||
28108827|NCT03566979|54766865|FG002|Overall Study|Lost to Follow-up|9|||
28108828|NCT03566979|54766866|FG003|Overall Study|Lost to Follow-up|5|||
28108829|NCT03566979|54766863|FG000|Overall Study|Adverse Event|1|||
28108830|NCT03566979|54766864|FG001|Overall Study|Adverse Event|0|||
28108831|NCT03566979|54766865|FG002|Overall Study|Adverse Event|0|||
27815561|NCT00634114|54272390|FG000|Overall Study|Adverse Event|6|||
28108832|NCT03566979|54766866|FG003|Overall Study|Adverse Event|0|||
28108833|NCT00116831|54766878|FG000|Overall Study|Adverse Event|14|||
28108834|NCT00116831|54766879|FG001|Overall Study|Adverse Event|16|||
28108835|NCT00116831|54766878|FG000|Overall Study|Baseline IVUS determined unevaluable|12|||
28108836|NCT00116831|54766879|FG001|Overall Study|Baseline IVUS determined unevaluable|11|||
28108837|NCT00116831|54766878|FG000|Overall Study|Lost to Follow-up|8|||
28108838|NCT00116831|54766879|FG001|Overall Study|Lost to Follow-up|6|||
28108839|NCT00116831|54766878|FG000|Overall Study|Protocol Violation|3|||
28108840|NCT00116831|54766879|FG001|Overall Study|Protocol Violation|6|||
28108841|NCT00116831|54766878|FG000|Overall Study|Hypoglycaemic events|1|||
28108842|NCT00116831|54766879|FG001|Overall Study|Hypoglycaemic events|0|||
28108843|NCT00116831|54766878|FG000|Overall Study|Low haemoglobin on screening|1|||
28108844|NCT00116831|54766879|FG001|Overall Study|Low haemoglobin on screening|0|||
28108845|NCT00116831|54766878|FG000|Overall Study|Withdrawn investigational product|1|||
28108846|NCT00116831|54766879|FG001|Overall Study|Withdrawn investigational product|0|||
27940182|NCT01194414|54596458|FG000|72 Weeks Open Label Extension|Protocol Violation|0|||
28064118|NCT00325416|54719725|FG000|Phase I: Dose Escalation|Denial of insurance coverage|7|||
28064119|NCT00325416|54719726|FG001|Phase I: Dose Escalation|Denial of insurance coverage|4|||
28064120|NCT00325416|54719725|FG000|Phase I: Dose Escalation|Withdrawal by Subject|7|||
28064121|NCT00325416|54719726|FG001|Phase I: Dose Escalation|Withdrawal by Subject|2|||
28064122|NCT00325416|54719725|FG000|Phase I: Dose Escalation|Inability to collect adequate stem cells|0|||
28064123|NCT00325416|54719726|FG001|Phase I: Dose Escalation|Inability to collect adequate stem cells|1|||
28064124|NCT00325416|54719725|FG000|Phase II: Treatment at MTD|denial of insurance coverage|0|||
28064125|NCT00325416|54719726|FG001|Phase II: Treatment at MTD|denial of insurance coverage|1|||
28064126|NCT00325416|54719725|FG000|Phase II: Treatment at MTD|Withdrawal by Subject|0|||
28064127|NCT00325416|54719726|FG001|Phase II: Treatment at MTD|Withdrawal by Subject|1|||
28064128|NCT00314808|54719732|FG000|Overall Study|Disease Progression without AE|4|||
28064129|NCT00314808|54719732|FG000|Overall Study|Withdrawal by Subject/PI without AE|4|||
28064130|NCT00314574|54719738|FG000|Overall Study|Death|3|||
28064131|NCT00314574|54719739|FG001|Overall Study|Death|0|||
28064132|NCT00314574|54719738|FG000|Overall Study|Adverse Event|11|||
28064133|NCT00314574|54719739|FG001|Overall Study|Adverse Event|16|||
28108847|NCT00116831|54766878|FG000|Overall Study|Withdrawal by Subject|32|||
28108848|NCT00116831|54766879|FG001|Overall Study|Withdrawal by Subject|32|||
28108849|NCT00116831|54766878|FG000|Overall Study|Insufficient therapeutic effect|0|||
28108850|NCT00116831|54766879|FG001|Overall Study|Insufficient therapeutic effect|1|||
28108851|NCT00116831|54766878|FG000|Overall Study|Missing data for participant|1|||
28108852|NCT00116831|54766879|FG001|Overall Study|Missing data for participant|0|||
28108853|NCT02777086|54766887|FG000|Overall Study|Lost to Follow-up|96|||
28108854|NCT02777086|54766888|FG001|Overall Study|Lost to Follow-up|99|||
28108855|NCT03549429|54766896|FG000|Overall Study|Protocol Violation|5|||
28108856|NCT03549429|54766897|FG001|Overall Study|Protocol Violation|3|||
28108857|NCT02784704|54766907|FG000|Overall Study|Adverse Event|4|||
28108858|NCT02784704|54766908|FG001|Overall Study|Adverse Event|2|||
28108859|NCT02784704|54766907|FG000|Overall Study|Lost to Follow-up|6|||
28108860|NCT02784704|54766908|FG001|Overall Study|Lost to Follow-up|4|||
28108861|NCT02784704|54766907|FG000|Overall Study|Withdrawal by Subject|1|||
28108862|NCT02784704|54766908|FG001|Overall Study|Withdrawal by Subject|3|||
28108863|NCT02784704|54766907|FG000|Overall Study|Subject Non Compliance|2|||
28108864|NCT02784704|54766908|FG001|Overall Study|Subject Non Compliance|0|||
28108865|NCT03566823|54766919|FG000|Overall Study|Lack of Efficacy|0|||
28108866|NCT03566823|54766920|FG001|Overall Study|Lack of Efficacy|1|||
28108867|NCT03566823|54766921|FG002|Overall Study|Lack of Efficacy|0|||
28108868|NCT03566823|54766919|FG000|Overall Study|Withdrawal by Subject|1|||
27815562|NCT00634114|54272391|FG001|Overall Study|Adverse Event|8|||
27815563|NCT00634114|54272392|FG002|Overall Study|Adverse Event|3|||
27815564|NCT00634114|54272390|FG000|Overall Study|Withdrawal by Subject|9|||
27815565|NCT00634114|54272391|FG001|Overall Study|Withdrawal by Subject|6|||
28108869|NCT03566823|54766920|FG001|Overall Study|Withdrawal by Subject|2|||
28108870|NCT03566823|54766921|FG002|Overall Study|Withdrawal by Subject|0|||
27815566|NCT00634114|54272392|FG002|Overall Study|Withdrawal by Subject|11|||
28108871|NCT03566823|54766919|FG000|Overall Study|Adverse Event|1|||
28108872|NCT03566823|54766920|FG001|Overall Study|Adverse Event|0|||
28108873|NCT03566823|54766921|FG002|Overall Study|Adverse Event|2|||
28108874|NCT03549117|54766931|FG000|Overall Study|Withdrawal by Subject|1|||
28108875|NCT03549117|54766932|FG001|Overall Study|Withdrawal by Subject|0|||
28108876|NCT03183908|54766940|FG000|Overall Study|Missing Symptom Diary Data|0|||
28108877|NCT03183908|54766941|FG001|Overall Study|Missing Symptom Diary Data|2|||
28108878|NCT03565887|54766953|FG000|Overall Study|Adverse Event|1|||
28108879|NCT03565887|54766954|FG001|Overall Study|Adverse Event|0|||
28108880|NCT03565887|54766953|FG000|Overall Study|Withdrawal by Subject|0|||
28108881|NCT03565887|54766954|FG001|Overall Study|Withdrawal by Subject|2|||
28108882|NCT03183518|54766960|FG000|Overall Study|Other (Not specified)|2|||
28108883|NCT03183518|54766960|FG000|Overall Study|Other (Withdrawal of consent)|1|||
28108884|NCT00116753|54766968|FG000|Overall Study|Adverse Event|16|||
28108885|NCT00116753|54766969|FG001|Overall Study|Adverse Event|10|||
28108886|NCT00116753|54766970|FG002|Overall Study|Adverse Event|7|||
28108887|NCT00116753|54766968|FG000|Overall Study|Withdrawal by Subject|11|||
28108888|NCT00116753|54766969|FG001|Overall Study|Withdrawal by Subject|12|||
28108889|NCT00116753|54766970|FG002|Overall Study|Withdrawal by Subject|8|||
28108890|NCT00116753|54766968|FG000|Overall Study|Lost to Follow-up|0|||
28108891|NCT00116753|54766969|FG001|Overall Study|Lost to Follow-up|2|||
28108892|NCT00116753|54766970|FG002|Overall Study|Lost to Follow-up|1|||
28108893|NCT00116753|54766968|FG000|Overall Study|Protocol Violation|0|||
28108894|NCT00116753|54766969|FG001|Overall Study|Protocol Violation|0|||
28108895|NCT00116753|54766970|FG002|Overall Study|Protocol Violation|1|||
28108896|NCT00116753|54766968|FG000|Overall Study|Did not Fulfil Eligibility Criteria|1|||
28108897|NCT00116753|54766969|FG001|Overall Study|Did not Fulfil Eligibility Criteria|1|||
28108898|NCT00116753|54766970|FG002|Overall Study|Did not Fulfil Eligibility Criteria|3|||
28108899|NCT00116753|54766968|FG000|Overall Study|Disease Progression|3|||
28108900|NCT00116753|54766969|FG001|Overall Study|Disease Progression|4|||
28108901|NCT00116753|54766970|FG002|Overall Study|Disease Progression|3|||
28108902|NCT00116753|54766968|FG000|Overall Study|Abnormal Echocardiogram|0|||
28108903|NCT00116753|54766969|FG001|Overall Study|Abnormal Echocardiogram|0|||
28108904|NCT00116753|54766970|FG002|Overall Study|Abnormal Echocardiogram|1|||
28108905|NCT00116753|54766968|FG000|Overall Study|Progressive Parkinson's Disease|1|||
28108906|NCT00116753|54766969|FG001|Overall Study|Progressive Parkinson's Disease|0|||
28108907|NCT00116753|54766970|FG002|Overall Study|Progressive Parkinson's Disease|0|||
28108908|NCT00116753|54766968|FG000|Overall Study|Dosing Error|0|||
28108909|NCT00116753|54766969|FG001|Overall Study|Dosing Error|1|||
28108910|NCT00116753|54766970|FG002|Overall Study|Dosing Error|0|||
28108911|NCT00113399|54766989|FG000|Overall Study|Death|1|||
28108912|NCT00113399|54766990|FG001|Overall Study|Death|1|||
28108913|NCT00113399|54766989|FG000|Overall Study|Withdrawal by Subject|1|||
28108914|NCT00113399|54766990|FG001|Overall Study|Withdrawal by Subject|2|||
27815567|NCT00634114|54272390|FG000|Overall Study|Lost to Follow-up|0|||
27815568|NCT00634114|54272391|FG001|Overall Study|Lost to Follow-up|0|||
27815569|NCT00634114|54272392|FG002|Overall Study|Lost to Follow-up|1|||
28108915|NCT00113399|54766989|FG000|Overall Study|Complete Response|0|||
27848492|NCT03593213|54341466|FG001|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
27848493|NCT03593213|54341467|FG002|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
27848494|NCT03593213|54341468|FG003|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
27848495|NCT03593213|54341465|FG000|Open-label Treatment Period (18 Weeks)|Reason not Specified|13|||
27848496|NCT03593213|54341466|FG001|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
27848497|NCT03593213|54341467|FG002|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
27848498|NCT03593213|54341468|FG003|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
27848499|NCT03593213|54341465|FG000|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|104|||
27848500|NCT03593213|54341466|FG001|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
27848501|NCT03593213|54341467|FG002|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
27848502|NCT03593213|54341468|FG003|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
27848503|NCT03593213|54341465|FG000|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|0|||
27848504|NCT03593213|54341466|FG001|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|15|||
27848505|NCT03593213|54341467|FG002|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|9|||
27815570|NCT00634114|54272390|FG000|Overall Study|Protocol Violation|3|||
27940183|NCT01194414|54596459|FG001|72 Weeks Open Label Extension|Protocol Violation|0|||
27940184|NCT01194414|54596460|FG002|72 Weeks Open Label Extension|Protocol Violation|0|||
27940185|NCT01194414|54596461|FG003|72 Weeks Open Label Extension|Protocol Violation|1|||
27848506|NCT03593213|54341468|FG003|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|8|||
28108916|NCT00113399|54766990|FG001|Overall Study|Complete Response|1|||
28108917|NCT00113399|54766989|FG000|Overall Study|Other|0|||
28108918|NCT00113399|54766990|FG001|Overall Study|Other|1|||
28108919|NCT00113087|54766998|FG000|Overall Study|Death or Transplant|14|||
28108920|NCT00113087|54766999|FG001|Overall Study|Death or Transplant|16|||
28108921|NCT00113087|54766998|FG000|Overall Study|Family or MD withdrew subject|10|||
27848507|NCT03593213|54341465|FG000|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
27848508|NCT03593213|54341466|FG001|Double-blind Treatment Period (26 Weeks)|Adverse Event|2|||
27940186|NCT01194414|54596458|FG000|72 Weeks Open Label Extension|Adverse Event|35|||
27940187|NCT01194414|54596459|FG001|72 Weeks Open Label Extension|Adverse Event|21|||
28108922|NCT00113087|54766999|FG001|Overall Study|Family or MD withdrew subject|5|||
27815571|NCT00634114|54272391|FG001|Overall Study|Protocol Violation|3|||
27815572|NCT00634114|54272392|FG002|Overall Study|Protocol Violation|1|||
27815573|NCT00634114|54272390|FG000|Overall Study|Pregnancy|1|||
27815574|NCT00634114|54272391|FG001|Overall Study|Pregnancy|0|||
27815575|NCT00634114|54272392|FG002|Overall Study|Pregnancy|0|||
27815576|NCT00634114|54272390|FG000|Overall Study|Incorrect enrolment|0|||
27815577|NCT00634114|54272391|FG001|Overall Study|Incorrect enrolment|1|||
27815578|NCT00634114|54272392|FG002|Overall Study|Incorrect enrolment|0|||
27815579|NCT00634114|54272390|FG000|Overall Study|Recurrence of reflux esophagitis|5|||
27815580|NCT00634114|54272391|FG001|Overall Study|Recurrence of reflux esophagitis|15|||
27815581|NCT00634114|54272392|FG002|Overall Study|Recurrence of reflux esophagitis|21|||
27815582|NCT00634114|54272390|FG000|Overall Study|Difficult to continue|3|||
27815583|NCT00634114|54272391|FG001|Overall Study|Difficult to continue|1|||
27815584|NCT00634114|54272392|FG002|Overall Study|Difficult to continue|1|||
27815585|NCT00634114|54272390|FG000|Overall Study|Other reason|1|||
28108923|NCT00112463|54767005|FG000|Overall Study|Physician Decision|1|||
28108924|NCT00112463|54767005|FG000|Overall Study|Progression|30|||
28108925|NCT00112463|54767005|FG000|Overall Study|Second Primary|1|||
27815586|NCT00634114|54272391|FG001|Overall Study|Other reason|1|||
28108926|NCT00112463|54767005|FG000|Overall Study|Toxicity|3|||
28108927|NCT00112463|54767005|FG000|Overall Study|Withdrawal by Subject|2|||
28108928|NCT00112463|54767005|FG000|Overall Study|Never started treatment|2|||
28108929|NCT03548415|54767015|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
28108930|NCT03548415|54767016|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
28108931|NCT03548415|54767017|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
28108932|NCT03548415|54767018|FG003|Overall Study|Adverse Event or Serious Adverse Event|0|||
28108933|NCT03548415|54767019|FG004|Overall Study|Adverse Event or Serious Adverse Event|1|||
28108934|NCT00112385|54767035|FG000|Overall Study|Lost to Follow-up|1|||
28108935|NCT00112385|54767036|FG001|Overall Study|Lost to Follow-up|0|||
27815587|NCT00634114|54272392|FG002|Overall Study|Other reason|1|||
28108936|NCT00112385|54767035|FG000|Overall Study|Withdrawal by Subject|0|||
28108937|NCT00112385|54767036|FG001|Overall Study|Withdrawal by Subject|1|||
28108938|NCT03548337|54767044|FG000|Infant Series|Withdrawal by Parent/Guardian|8|||
28108939|NCT03548337|54767045|FG001|Infant Series|Withdrawal by Parent/Guardian|8|||
28108940|NCT03548337|54767044|FG000|Infant Series|No Longer Met Eligibility Criteria|1|||
28108941|NCT03548337|54767045|FG001|Infant Series|No Longer Met Eligibility Criteria|0|||
28108942|NCT03548337|54767044|FG000|Infant Series|Lost to Follow-up|2|||
28108943|NCT03548337|54767045|FG001|Infant Series|Lost to Follow-up|1|||
28108944|NCT03548337|54767044|FG000|Infant Series|Adverse Event|0|||
28108945|NCT03548337|54767045|FG001|Infant Series|Adverse Event|2|||
28108946|NCT03548337|54767044|FG000|Infant Series|Randomized but Not Vaccinated|1|||
27815588|NCT00634036|54272402|FG000|Overall Study|Lost to Follow-up|1|||
27815589|NCT00634036|54272403|FG001|Overall Study|Lost to Follow-up|1|||
27815590|NCT00634036|54272402|FG000|Overall Study|Withdrawal by Subject|1|||
27815591|NCT00634036|54272403|FG001|Overall Study|Withdrawal by Subject|1|||
27815592|NCT01545375|54272411|FG000|Overall Study|Adverse Event|2|||
27815593|NCT01545375|54272412|FG001|Overall Study|Adverse Event|1|||
27815594|NCT01545375|54272411|FG000|Overall Study|Lost to Follow-up|34|||
27815595|NCT01545375|54272412|FG001|Overall Study|Lost to Follow-up|31|||
27815596|NCT01545375|54272411|FG000|Overall Study|Protocol Violation|3|||
27815597|NCT01545375|54272412|FG001|Overall Study|Protocol Violation|3|||
27815598|NCT01545375|54272411|FG000|Overall Study|Withdrawal by Subject|58|||
27815599|NCT01545375|54272412|FG001|Overall Study|Withdrawal by Subject|55|||
27815600|NCT01539837|54272421|FG000|Overall Study|reduce neutrophil level|0|||
27815601|NCT01539837|54272422|FG001|Overall Study|reduce neutrophil level|1|||
27815602|NCT01539837|54272423|FG002|Overall Study|reduce neutrophil level|1|||
27815603|NCT01539837|54272421|FG000|Overall Study|bad compliance|0|||
27815604|NCT01539837|54272422|FG001|Overall Study|bad compliance|0|||
27815605|NCT01539837|54272423|FG002|Overall Study|bad compliance|1|||
27815606|NCT01539759|54272433|FG000|Overall Study|Lost to Follow-up|6|||
27815607|NCT01539759|54272434|FG001|Overall Study|Lost to Follow-up|8|||
27815608|NCT00633022|54272443|FG000|Overall Study|Adverse Event|1|||
27815609|NCT00633022|54272444|FG001|Overall Study|Adverse Event|0|||
27815610|NCT00633022|54272445|FG002|Overall Study|Adverse Event|5|||
27815611|NCT00633022|54272443|FG000|Overall Study|Physician Decision|0|||
27815612|NCT00633022|54272444|FG001|Overall Study|Physician Decision|1|||
27815613|NCT00633022|54272445|FG002|Overall Study|Physician Decision|0|||
27815614|NCT00630994|54272453|FG000|Overall Study|Adverse Event|1|||
27815615|NCT00630994|54272453|FG000|Overall Study|Disease Progression|1|||
27815616|NCT00630994|54272453|FG000|Overall Study|Lack of Efficacy|1|||
27815617|NCT00630994|54272453|FG000|Overall Study|Other|1|||
27815618|NCT00630838|54272459|FG000|Overall Study|Death|0|||
27815619|NCT00630838|54272460|FG001|Overall Study|Death|1|||
27815620|NCT00630838|54272459|FG000|Overall Study|Lost to Follow-up|0|||
27815621|NCT00630838|54272460|FG001|Overall Study|Lost to Follow-up|1|||
27815622|NCT00630058|54272470|FG000|Overall Study|Adverse Event|1|||
27815623|NCT00630058|54272471|FG001|Overall Study|Adverse Event|1|||
27815624|NCT00630058|54272470|FG000|Overall Study|Withdrawal by Subject|0|||
27815625|NCT00630058|54272471|FG001|Overall Study|Withdrawal by Subject|1|||
27815626|NCT00630058|54272470|FG000|Overall Study|stopping criteria|3|||
27815627|NCT00630058|54272471|FG001|Overall Study|stopping criteria|2|||
27815628|NCT01925794|54272477|FG000|180 Days|Death|2|||
27815629|NCT01925794|54272477|FG000|180 Days|Withdrawal by Subject|2|||
28108947|NCT03548337|54767045|FG001|Infant Series|Randomized but Not Vaccinated|0|||
28108948|NCT03548337|54767044|FG000|Toddler Dose|Withdrawal by parent/guardian|1|||
28108949|NCT03548337|54767045|FG001|Toddler Dose|Withdrawal by parent/guardian|1|||
28108950|NCT03596151|54767057|FG000|Overall Study|Withdrawal by Subject|1|||
28108951|NCT03547635|54767064|FG000|Overall Study|Adverse Event|5|||
28108952|NCT03547635|54767065|FG001|Overall Study|Adverse Event|2|||
28108953|NCT03547635|54767066|FG002|Overall Study|Adverse Event|3|||
28108954|NCT03547635|54767064|FG000|Overall Study|Lost to Follow-up|1|||
28108955|NCT03547635|54767065|FG001|Overall Study|Lost to Follow-up|3|||
28108956|NCT03547635|54767066|FG002|Overall Study|Lost to Follow-up|4|||
28108957|NCT03547635|54767064|FG000|Overall Study|Withdrawal by Subject|1|||
28108958|NCT03547635|54767065|FG001|Overall Study|Withdrawal by Subject|0|||
28108959|NCT03547635|54767066|FG002|Overall Study|Withdrawal by Subject|0|||
28108960|NCT03547635|54767064|FG000|Overall Study|Withdrawal By PI|0|||
28108961|NCT03547635|54767065|FG001|Overall Study|Withdrawal By PI|1|||
28108962|NCT03547635|54767066|FG002|Overall Study|Withdrawal By PI|0|||
28108963|NCT03547635|54767064|FG000|Overall Study|Withdrawal by Sponsor|0|||
28108964|NCT03547635|54767065|FG001|Overall Study|Withdrawal by Sponsor|0|||
28108965|NCT03547635|54767066|FG002|Overall Study|Withdrawal by Sponsor|1|||
28108966|NCT03547635|54767064|FG000|Overall Study|Errant Randomization before Treatment|0|||
28108967|NCT03547635|54767065|FG001|Overall Study|Errant Randomization before Treatment|1|||
28108968|NCT03547635|54767066|FG002|Overall Study|Errant Randomization before Treatment|0|||
28108969|NCT03547635|54767064|FG000|Overall Study|Withdrawal by Subject|1|||
28108970|NCT03547635|54767065|FG001|Overall Study|Withdrawal by Subject|0|||
28108971|NCT03547635|54767066|FG002|Overall Study|Withdrawal by Subject|0|||
28108972|NCT03182738|54767120|FG000|Overall Study|Lost to Follow-up|9|||
28108973|NCT03182738|54767121|FG001|Overall Study|Lost to Follow-up|3|||
28108974|NCT03182738|54767120|FG000|Overall Study|Pregnancy|0|||
28108975|NCT03182738|54767121|FG001|Overall Study|Pregnancy|1|||
28108976|NCT03182738|54767120|FG000|Overall Study|Withdrawal by Subject|0|||
28108977|NCT03182738|54767121|FG001|Overall Study|Withdrawal by Subject|1|||
28108978|NCT03547167|54767129|FG000|Overall Study|Withdrawal by Subject|34|||
28108979|NCT03547167|54767130|FG001|Overall Study|Withdrawal by Subject|12|||
28108980|NCT03547167|54767129|FG000|Overall Study|Screen Failure|0|||
28108981|NCT03547167|54767130|FG001|Overall Study|Screen Failure|1|||
28108982|NCT03547167|54767129|FG000|Overall Study|Lost to Follow-up|59|||
28108983|NCT03547167|54767130|FG001|Overall Study|Lost to Follow-up|15|||
28108984|NCT03547167|54767129|FG000|Overall Study|Death|4|||
28108985|NCT03547167|54767130|FG001|Overall Study|Death|2|||
28108986|NCT03560739|54767144|FG000|Overall Study|Adverse Event|0|||
28108987|NCT03560739|54767145|FG001|Overall Study|Adverse Event|1|||
28108988|NCT03560739|54767146|FG002|Overall Study|Adverse Event|0|||
28108989|NCT03560739|54767147|FG003|Overall Study|Adverse Event|0|||
28108990|NCT00101686|54767167|FG000|Overall Study|Progressive Disease|37|||
28064134|NCT00314574|54719738|FG000|Overall Study|Lost to Follow-up|19|||
28064135|NCT00314574|54719739|FG001|Overall Study|Lost to Follow-up|25|||
28064136|NCT00314574|54719738|FG000|Overall Study|Withdrawal by Subject|33|||
28064137|NCT00314574|54719739|FG001|Overall Study|Withdrawal by Subject|22|||
28064138|NCT00314574|54719738|FG000|Overall Study|Physician Decision|22|||
28064139|NCT00314574|54719739|FG001|Overall Study|Physician Decision|15|||
28064140|NCT00314574|54719738|FG000|Overall Study|Pregnancy|6|||
28064141|NCT00314574|54719739|FG001|Overall Study|Pregnancy|4|||
28064142|NCT00314574|54719738|FG000|Overall Study|Data unknown at database lock|0|||
28064143|NCT00314574|54719739|FG001|Overall Study|Data unknown at database lock|1|||
28064144|NCT00314340|54719745|FG000|Overall Study|lost interest|1|||
28064145|NCT00306852|54719753|FG000|Overall Study|Death|14|||
28064146|NCT00306852|54719754|FG001|Overall Study|Death|14|||
28064147|NCT00306852|54719753|FG000|Overall Study|Lost to Follow-up|15|||
28064148|NCT00306852|54719754|FG001|Overall Study|Lost to Follow-up|24|||
28064149|NCT00314262|54719760|FG000|Overall Study|Adverse Event|2|||
28064150|NCT00314262|54719760|FG000|Overall Study|Withdrawal by Subject|2|||
28064151|NCT00314262|54719760|FG000|Overall Study|Physician Decision|1|||
28064152|NCT00333866|54719768|FG000|Overall Study|Adverse Event|23|||
28064153|NCT00333866|54719769|FG001|Overall Study|Adverse Event|37|||
28064154|NCT00333866|54719770|FG002|Overall Study|Adverse Event|38|||
28064155|NCT00333866|54719771|FG003|Overall Study|Adverse Event|47|||
28064156|NCT00333866|54719768|FG000|Overall Study|Other|3|||
28064157|NCT00333866|54719769|FG001|Overall Study|Other|2|||
28064158|NCT00333866|54719770|FG002|Overall Study|Other|2|||
28108991|NCT00101686|54767168|FG001|Overall Study|Progressive Disease|28|||
28108992|NCT00101686|54767169|FG002|Overall Study|Progressive Disease|37|||
28108993|NCT00101686|54767170|FG003|Overall Study|Progressive Disease|38|||
28108994|NCT00101686|54767171|FG004|Overall Study|Progressive Disease|28|||
28108995|NCT00101686|54767172|FG005|Overall Study|Progressive Disease|25|||
28108996|NCT00101686|54767173|FG006|Overall Study|Progressive Disease|5|||
28064159|NCT00333866|54719771|FG003|Overall Study|Other|2|||
28064160|NCT00333866|54719768|FG000|Overall Study|Lack of Efficacy|8|||
28064161|NCT00333866|54719769|FG001|Overall Study|Lack of Efficacy|6|||
28064162|NCT00333866|54719770|FG002|Overall Study|Lack of Efficacy|3|||
28108997|NCT00101686|54767174|FG007|Overall Study|Progressive Disease|7|||
28108998|NCT00101686|54767175|FG008|Overall Study|Progressive Disease|10|||
28108999|NCT00101686|54767176|FG009|Overall Study|Progressive Disease|8|||
28109000|NCT00101686|54767167|FG000|Overall Study|initiation other anti-cancer treatment|4|||
28109001|NCT00101686|54767168|FG001|Overall Study|initiation other anti-cancer treatment|3|||
28109002|NCT00101686|54767169|FG002|Overall Study|initiation other anti-cancer treatment|4|||
28109003|NCT00101686|54767170|FG003|Overall Study|initiation other anti-cancer treatment|3|||
28109004|NCT00101686|54767171|FG004|Overall Study|initiation other anti-cancer treatment|1|||
27815630|NCT01925794|54272477|FG000|270 Days|Death|2|||
27815631|NCT01925794|54272477|FG000|270 Days|Protocol Violation|3|||
27815632|NCT00989950|54272489|FG000|Randomized Phase|Protocol Violation|1|||
27815633|NCT00989950|54272490|FG001|Randomized Phase|Protocol Violation|0|||
27815634|NCT00989950|54272491|FG002|Randomized Phase|Protocol Violation|0|||
28064163|NCT00333866|54719771|FG003|Overall Study|Lack of Efficacy|5|||
28109005|NCT00101686|54767172|FG005|Overall Study|initiation other anti-cancer treatment|1|||
28109006|NCT00101686|54767173|FG006|Overall Study|initiation other anti-cancer treatment|2|||
28109007|NCT00101686|54767174|FG007|Overall Study|initiation other anti-cancer treatment|2|||
28109008|NCT00101686|54767175|FG008|Overall Study|initiation other anti-cancer treatment|3|||
28109009|NCT00101686|54767176|FG009|Overall Study|initiation other anti-cancer treatment|3|||
28109010|NCT00101686|54767167|FG000|Overall Study|>3 week delay treatment due toxicity|6|||
28109011|NCT00101686|54767168|FG001|Overall Study|>3 week delay treatment due toxicity|2|||
28109012|NCT00101686|54767169|FG002|Overall Study|>3 week delay treatment due toxicity|1|||
28109013|NCT00101686|54767170|FG003|Overall Study|>3 week delay treatment due toxicity|2|||
28109014|NCT00101686|54767171|FG004|Overall Study|>3 week delay treatment due toxicity|7|||
28109015|NCT00101686|54767172|FG005|Overall Study|>3 week delay treatment due toxicity|3|||
28109016|NCT00101686|54767173|FG006|Overall Study|>3 week delay treatment due toxicity|2|||
28109017|NCT00101686|54767174|FG007|Overall Study|>3 week delay treatment due toxicity|1|||
28109018|NCT00101686|54767175|FG008|Overall Study|>3 week delay treatment due toxicity|3|||
28109019|NCT00101686|54767176|FG009|Overall Study|>3 week delay treatment due toxicity|0|||
28109020|NCT00101686|54767167|FG000|Overall Study|unacceptable toxicity|3|||
28109021|NCT00101686|54767168|FG001|Overall Study|unacceptable toxicity|9|||
28109022|NCT00101686|54767169|FG002|Overall Study|unacceptable toxicity|10|||
28109023|NCT00101686|54767170|FG003|Overall Study|unacceptable toxicity|6|||
28109024|NCT00101686|54767171|FG004|Overall Study|unacceptable toxicity|16|||
28109025|NCT00101686|54767172|FG005|Overall Study|unacceptable toxicity|10|||
28109026|NCT00101686|54767173|FG006|Overall Study|unacceptable toxicity|4|||
28109027|NCT00101686|54767174|FG007|Overall Study|unacceptable toxicity|2|||
28109028|NCT00101686|54767175|FG008|Overall Study|unacceptable toxicity|1|||
28109029|NCT00101686|54767176|FG009|Overall Study|unacceptable toxicity|4|||
28109030|NCT00101686|54767167|FG000|Overall Study|Randomized but did not receive treament|1|||
28109031|NCT00101686|54767168|FG001|Overall Study|Randomized but did not receive treament|6|||
28109032|NCT00101686|54767169|FG002|Overall Study|Randomized but did not receive treament|2|||
28109033|NCT00101686|54767170|FG003|Overall Study|Randomized but did not receive treament|2|||
28064164|NCT00333866|54719768|FG000|Overall Study|Lost to Follow-up|1|||
28109034|NCT00101686|54767171|FG004|Overall Study|Randomized but did not receive treament|2|||
28109035|NCT00101686|54767172|FG005|Overall Study|Randomized but did not receive treament|2|||
28109036|NCT00101686|54767173|FG006|Overall Study|Randomized but did not receive treament|0|||
28109037|NCT00101686|54767174|FG007|Overall Study|Randomized but did not receive treament|1|||
27815635|NCT00989950|54272492|FG003|Randomized Phase|Protocol Violation|0|||
27940188|NCT01194414|54596460|FG002|72 Weeks Open Label Extension|Adverse Event|2|||
27940189|NCT01194414|54596461|FG003|72 Weeks Open Label Extension|Adverse Event|12|||
28064165|NCT00333866|54719769|FG001|Overall Study|Lost to Follow-up|2|||
28064166|NCT00333866|54719770|FG002|Overall Study|Lost to Follow-up|2|||
28064167|NCT00333866|54719771|FG003|Overall Study|Lost to Follow-up|2|||
28064168|NCT00333866|54719768|FG000|Overall Study|Withdrawal by Subject|8|||
28064169|NCT00333866|54719769|FG001|Overall Study|Withdrawal by Subject|14|||
28109038|NCT00101686|54767175|FG008|Overall Study|Randomized but did not receive treament|0|||
28064170|NCT00333866|54719770|FG002|Overall Study|Withdrawal by Subject|4|||
27815636|NCT00989950|54272489|FG000|Randomized Phase|Adverse Event|0|||
28064171|NCT00333866|54719771|FG003|Overall Study|Withdrawal by Subject|9|||
28109039|NCT00101686|54767176|FG009|Overall Study|Randomized but did not receive treament|1|||
28109040|NCT00101686|54767167|FG000|Overall Study|intercurrent non-cancer related illness|0|||
28109041|NCT00101686|54767168|FG001|Overall Study|intercurrent non-cancer related illness|0|||
27940190|NCT01194414|54596458|FG000|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
28064172|NCT00333866|54719768|FG000|Overall Study|Randomized but not Treated|5|||
28064173|NCT00333866|54719769|FG001|Overall Study|Randomized but not Treated|3|||
28064174|NCT00333866|54719770|FG002|Overall Study|Randomized but not Treated|2|||
28064175|NCT00333866|54719771|FG003|Overall Study|Randomized but not Treated|1|||
28064176|NCT00324740|54719781|FG000|Overall Study|Withdrawal by Subject|1|||
28064177|NCT00324740|54719782|FG001|Overall Study|Withdrawal by Subject|0|||
28064178|NCT00324740|54719783|FG002|Overall Study|Withdrawal by Subject|1|||
28064179|NCT00333788|54719790|FG000|Overall Study|Adverse Event|44|||
28064180|NCT00333788|54719790|FG000|Overall Study|Lack of Efficacy|80|||
28064181|NCT00333788|54719790|FG000|Overall Study|Lost to Follow-up|2|||
27815637|NCT00989950|54272490|FG001|Randomized Phase|Adverse Event|1|||
28064182|NCT00333788|54719790|FG000|Overall Study|Withdrawal by Subject|24|||
28064183|NCT00333788|54719790|FG000|Overall Study|Other: Non-compliance|2|||
28064184|NCT00333788|54719790|FG000|Overall Study|Other: Moved|2|||
28109042|NCT00101686|54767169|FG002|Overall Study|intercurrent non-cancer related illness|2|||
28109043|NCT00101686|54767170|FG003|Overall Study|intercurrent non-cancer related illness|0|||
28109044|NCT00101686|54767171|FG004|Overall Study|intercurrent non-cancer related illness|1|||
28109045|NCT00101686|54767172|FG005|Overall Study|intercurrent non-cancer related illness|3|||
28109046|NCT00101686|54767173|FG006|Overall Study|intercurrent non-cancer related illness|1|||
28109047|NCT00101686|54767174|FG007|Overall Study|intercurrent non-cancer related illness|0|||
28109048|NCT00101686|54767175|FG008|Overall Study|intercurrent non-cancer related illness|1|||
28109049|NCT00101686|54767176|FG009|Overall Study|intercurrent non-cancer related illness|1|||
28109050|NCT00101686|54767167|FG000|Overall Study|Physician Decision|10|||
28109051|NCT00101686|54767168|FG001|Overall Study|Physician Decision|13|||
28109052|NCT00101686|54767169|FG002|Overall Study|Physician Decision|6|||
28109053|NCT00101686|54767170|FG003|Overall Study|Physician Decision|7|||
28109054|NCT00101686|54767171|FG004|Overall Study|Physician Decision|8|||
28109055|NCT00101686|54767172|FG005|Overall Study|Physician Decision|9|||
28109056|NCT00101686|54767173|FG006|Overall Study|Physician Decision|5|||
28109057|NCT00101686|54767174|FG007|Overall Study|Physician Decision|5|||
28109058|NCT00101686|54767175|FG008|Overall Study|Physician Decision|1|||
28109059|NCT00101686|54767176|FG009|Overall Study|Physician Decision|1|||
28109060|NCT00101686|54767167|FG000|Overall Study|Other|1|||
28109061|NCT00101686|54767168|FG001|Overall Study|Other|4|||
28109062|NCT00101686|54767169|FG002|Overall Study|Other|1|||
28109063|NCT00101686|54767170|FG003|Overall Study|Other|6|||
28109064|NCT00101686|54767171|FG004|Overall Study|Other|2|||
28109065|NCT00101686|54767172|FG005|Overall Study|Other|12|||
28109066|NCT00101686|54767173|FG006|Overall Study|Other|1|||
28109067|NCT00101686|54767174|FG007|Overall Study|Other|5|||
28109068|NCT00101686|54767175|FG008|Overall Study|Other|3|||
28109069|NCT00101686|54767176|FG009|Overall Study|Other|3|||
28109070|NCT00101686|54767167|FG000|Overall Study|Withdrawal by Subject|9|||
28109071|NCT00101686|54767168|FG001|Overall Study|Withdrawal by Subject|8|||
28109072|NCT00101686|54767169|FG002|Overall Study|Withdrawal by Subject|6|||
28109073|NCT00101686|54767170|FG003|Overall Study|Withdrawal by Subject|8|||
28109074|NCT00101686|54767171|FG004|Overall Study|Withdrawal by Subject|8|||
28109075|NCT00101686|54767172|FG005|Overall Study|Withdrawal by Subject|7|||
27815638|NCT00989950|54272491|FG002|Randomized Phase|Adverse Event|0|||
27815639|NCT00989950|54272492|FG003|Randomized Phase|Adverse Event|0|||
27815640|NCT01905943|54272502|FG000|Overall Study|Withdrawal of consent|90|||
27815641|NCT01905943|54272502|FG000|Overall Study|Lost to Follow-up|16|||
27815642|NCT01905943|54272502|FG000|Overall Study|Investigator discretion|7|||
27815643|NCT01905943|54272502|FG000|Overall Study|Death|186|||
27815644|NCT01905943|54272502|FG000|Overall Study|Adverse Event|3|||
27815645|NCT01905943|54272502|FG000|Overall Study|Other|12|||
27815646|NCT01905553|54272523|FG000|Period 2|Adverse Event|1|||
27815647|NCT01905553|54272524|FG001|Period 2|Adverse Event|0|||
27815648|NCT01929031|54272534|FG000|Overall Study|Adverse Event|3|||
27815649|NCT01929031|54272535|FG001|Overall Study|Adverse Event|1|||
27815650|NCT01929031|54272536|FG002|Overall Study|Adverse Event|1|||
27815651|NCT01929031|54272537|FG003|Overall Study|Adverse Event|0|||
27815652|NCT01929031|54272538|FG004|Overall Study|Adverse Event|0|||
27815653|NCT01929031|54272539|FG005|Overall Study|Adverse Event|0|||
27815654|NCT01929031|54272534|FG000|Overall Study|Protocol Violation|1|||
28064185|NCT00333788|54719790|FG000|Overall Study|Other: Recurrent squamaous cell cancer|1|||
28064186|NCT00333788|54719790|FG000|Overall Study|Other: Investigator decision|1|||
28109076|NCT00101686|54767173|FG006|Overall Study|Withdrawal by Subject|7|||
28109077|NCT00101686|54767174|FG007|Overall Study|Withdrawal by Subject|7|||
28109078|NCT00101686|54767175|FG008|Overall Study|Withdrawal by Subject|8|||
28109079|NCT00101686|54767176|FG009|Overall Study|Withdrawal by Subject|9|||
28109080|NCT00101452|54767196|FG000|Overall Study|Adverse Event|2|||
28109081|NCT00101452|54767197|FG001|Overall Study|Adverse Event|0|||
28109082|NCT00101452|54767198|FG002|Overall Study|Adverse Event|1|||
28109083|NCT00101452|54767196|FG000|Overall Study|Lost to Follow-up|13|||
28109084|NCT00101452|54767197|FG001|Overall Study|Lost to Follow-up|8|||
28109085|NCT00101452|54767198|FG002|Overall Study|Lost to Follow-up|14|||
28109086|NCT00101452|54767196|FG000|Overall Study|Withdrawal by Subject|10|||
28109087|NCT00101452|54767197|FG001|Overall Study|Withdrawal by Subject|14|||
28109088|NCT00101452|54767198|FG002|Overall Study|Withdrawal by Subject|9|||
28109089|NCT00101452|54767196|FG000|Overall Study|Baseline Fail|2|||
28109090|NCT00101452|54767197|FG001|Overall Study|Baseline Fail|1|||
28109091|NCT00101452|54767198|FG002|Overall Study|Baseline Fail|2|||
28109092|NCT00101452|54767196|FG000|Overall Study|Physician Decision|0|||
28109093|NCT00101452|54767197|FG001|Overall Study|Physician Decision|3|||
28109094|NCT00101452|54767198|FG002|Overall Study|Physician Decision|2|||
28109095|NCT00101452|54767196|FG000|Overall Study|Protocol Violation|2|||
28109096|NCT00101452|54767197|FG001|Overall Study|Protocol Violation|1|||
28109097|NCT00101452|54767198|FG002|Overall Study|Protocol Violation|3|||
28109098|NCT00101452|54767196|FG000|Overall Study|Other|15|||
28109099|NCT00101452|54767197|FG001|Overall Study|Other|16|||
28109100|NCT00101452|54767198|FG002|Overall Study|Other|12|||
28109101|NCT03546621|54767214|FG000|Overall Study|Withdrawal by Subject|0|||
28109102|NCT03546621|54767215|FG001|Overall Study|Withdrawal by Subject|1|||
28109103|NCT03546621|54767216|FG002|Overall Study|Withdrawal by Subject|2|||
28109104|NCT03546621|54767217|FG003|Overall Study|Withdrawal by Subject|1|||
28109105|NCT03546621|54767214|FG000|Overall Study|Lost to Follow-up|0|||
28109106|NCT03546621|54767215|FG001|Overall Study|Lost to Follow-up|1|||
28109107|NCT03546621|54767216|FG002|Overall Study|Lost to Follow-up|0|||
28109108|NCT03546621|54767217|FG003|Overall Study|Lost to Follow-up|0|||
28109109|NCT03546621|54767214|FG000|Overall Study|Adverse Event|0|||
28109110|NCT03546621|54767215|FG001|Overall Study|Adverse Event|1|||
28109111|NCT03546621|54767216|FG002|Overall Study|Adverse Event|0|||
28109112|NCT03546621|54767217|FG003|Overall Study|Adverse Event|1|||
28109113|NCT03546621|54767214|FG000|Overall Study|Progressive disease|0|||
28109114|NCT03546621|54767215|FG001|Overall Study|Progressive disease|0|||
28109115|NCT03546621|54767216|FG002|Overall Study|Progressive disease|0|||
28109116|NCT03546621|54767217|FG003|Overall Study|Progressive disease|1|||
28109117|NCT02761330|54767227|FG000|Treatment Week 1|Withdrawal by Subject|0|||
28109118|NCT02761330|54767228|FG001|Treatment Week 1|Withdrawal by Subject|0|||
28109119|NCT02761330|54767229|FG002|Treatment Week 1|Withdrawal by Subject|0|||
27815655|NCT01929031|54272535|FG001|Overall Study|Protocol Violation|0|||
27815656|NCT01929031|54272536|FG002|Overall Study|Protocol Violation|0|||
27815657|NCT01929031|54272537|FG003|Overall Study|Protocol Violation|0|||
27815658|NCT01929031|54272538|FG004|Overall Study|Protocol Violation|0|||
27815659|NCT01929031|54272539|FG005|Overall Study|Protocol Violation|1|||
27815660|NCT01929031|54272534|FG000|Overall Study|Reason other than specified above|0|||
27815661|NCT01929031|54272535|FG001|Overall Study|Reason other than specified above|1|||
27815662|NCT01929031|54272536|FG002|Overall Study|Reason other than specified above|0|||
27815663|NCT01929031|54272537|FG003|Overall Study|Reason other than specified above|0|||
27815664|NCT01929031|54272538|FG004|Overall Study|Reason other than specified above|1|||
27815665|NCT01929031|54272539|FG005|Overall Study|Reason other than specified above|0|||
27815666|NCT00989092|54272551|FG000|Overall Study|Physician Decision|9|||
27815667|NCT00989092|54272552|FG001|Overall Study|Physician Decision|6|||
27815668|NCT00989092|54272551|FG000|Overall Study|Adverse Event|20|||
27815669|NCT00989092|54272552|FG001|Overall Study|Adverse Event|1|||
27815670|NCT00989092|54272551|FG000|Overall Study|Chemotherapy initiated|12|||
27815671|NCT00989092|54272552|FG001|Overall Study|Chemotherapy initiated|4|||
27815672|NCT00989092|54272551|FG000|Overall Study|Withdrawal by Subject|17|||
27940191|NCT01194414|54596459|FG001|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
27940192|NCT01194414|54596460|FG002|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
28109120|NCT02761330|54767230|FG003|Treatment Week 1|Withdrawal by Subject|1|||
28109121|NCT02761330|54767231|FG004|Treatment Week 1|Withdrawal by Subject|0|||
27815673|NCT00989092|54272552|FG001|Overall Study|Withdrawal by Subject|9|||
28109122|NCT02761330|54767232|FG005|Treatment Week 1|Withdrawal by Subject|1|||
28109123|NCT03559257|54767248|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
28109124|NCT03559257|54767249|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
28109125|NCT03559257|54767248|FG000|Double Blind Treatment Period|Protocol Violation|1|||
28109126|NCT03559257|54767249|FG001|Double Blind Treatment Period|Protocol Violation|4|||
28109127|NCT03559257|54767248|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
28109128|NCT03559257|54767249|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
28109129|NCT03559257|54767248|FG000|Double Blind Treatment Period|Adverse Event|0|||
28109130|NCT03559257|54767249|FG001|Double Blind Treatment Period|Adverse Event|1|||
28109131|NCT03559257|54767248|FG000|Double Blind Treatment Period|Screen Failure|0|||
28109132|NCT03559257|54767249|FG001|Double Blind Treatment Period|Screen Failure|1|||
28109133|NCT03559257|54767248|FG000|Open-label Treatment Period|Adverse Event|1|||
28109134|NCT03559257|54767249|FG001|Open-label Treatment Period|Adverse Event|4|||
27815674|NCT00989092|54272551|FG000|Overall Study|Death|14|||
27815675|NCT00989092|54272552|FG001|Overall Study|Death|2|||
27815676|NCT00989092|54272551|FG000|Overall Study|Ineligibility determined|3|||
28109135|NCT03559257|54767248|FG000|Open-label Treatment Period|Lack of Efficacy|3|||
28109136|NCT03559257|54767249|FG001|Open-label Treatment Period|Lack of Efficacy|2|||
28109137|NCT03559257|54767248|FG000|Open-label Treatment Period|Withdrawal by Subject|3|||
28109138|NCT03559257|54767249|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
28109139|NCT03559257|54767248|FG000|Open-label Treatment Period|Protocol Violation|2|||
28109140|NCT03559257|54767249|FG001|Open-label Treatment Period|Protocol Violation|0|||
28109141|NCT03559257|54767248|FG000|Open-label Treatment Period|Lost to Follow-up|1|||
28109142|NCT03559257|54767249|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
28109143|NCT03559257|54767248|FG000|Open-label Treatment Period|Physician Decision|0|||
28109144|NCT03559257|54767249|FG001|Open-label Treatment Period|Physician Decision|1|||
28109145|NCT02892513|54767260|FG000|Overall Study|Withdrawal by Subject|0|||
28109146|NCT02892513|54767261|FG001|Overall Study|Withdrawal by Subject|1|||
28109147|NCT03558555|54767269|FG000|Overall Study|Lost to Follow-up|2|||
28109148|NCT03558555|54767270|FG001|Overall Study|Lost to Follow-up|1|||
28109149|NCT03541317|54767278|FG000|Stage 2 of the Implementation|Withdrawal by Subject|1|||
28109150|NCT03541317|54767279|FG001|Stage 2 of the Implementation|Withdrawal by Subject|0|||
28109151|NCT03541317|54767280|FG002|Stage 2 of the Implementation|Withdrawal by Subject|0|||
28109152|NCT03541317|54767281|FG003|Stage 2 of the Implementation|Withdrawal by Subject|0|||
28109153|NCT03541317|54767282|FG004|Stage 2 of the Implementation|Withdrawal by Subject|0|||
28109154|NCT03541317|54767283|FG005|Stage 2 of the Implementation|Withdrawal by Subject|0|||
28109155|NCT03590613|54767295|FG000|Period 2, 4 Days|Physician Decision|0|||
28109156|NCT03590613|54767296|FG001|Period 2, 4 Days|Physician Decision|0|||
28109157|NCT03590613|54767297|FG002|Period 2, 4 Days|Physician Decision|0|||
28109158|NCT03590613|54767298|FG003|Period 2, 4 Days|Physician Decision|1|||
28109159|NCT03557931|54767314|FG000|Overall Study|Adverse Event|4|||
28109160|NCT03557931|54767315|FG001|Overall Study|Adverse Event|6|||
28109161|NCT03557931|54767316|FG002|Overall Study|Adverse Event|1|||
28109162|NCT03557931|54767314|FG000|Overall Study|Lost to Follow-up|4|||
28109163|NCT03557931|54767315|FG001|Overall Study|Lost to Follow-up|4|||
28109164|NCT03557931|54767316|FG002|Overall Study|Lost to Follow-up|1|||
28109165|NCT03557931|54767314|FG000|Overall Study|Protocol Violation|1|||
28109166|NCT03557931|54767315|FG001|Overall Study|Protocol Violation|4|||
28109167|NCT03557931|54767316|FG002|Overall Study|Protocol Violation|1|||
28109168|NCT03557931|54767314|FG000|Overall Study|Withdrawal by Subject|14|||
28109169|NCT03557931|54767315|FG001|Overall Study|Withdrawal by Subject|0|||
28109170|NCT03557931|54767316|FG002|Overall Study|Withdrawal by Subject|7|||
28109171|NCT03557931|54767314|FG000|Overall Study|Miscellaneous|8|||
28109172|NCT03557931|54767315|FG001|Overall Study|Miscellaneous|5|||
28109173|NCT03557931|54767316|FG002|Overall Study|Miscellaneous|3|||
28109174|NCT03522675|54767326|FG000|Overall Study|Screen fail|1|||
28109175|NCT03522675|54767326|FG000|Overall Study|Non-reactive to histamine|1|||
28109176|NCT00294047|54767336|FG000|Month 48|Adverse Event|28|||
28109177|NCT00294047|54767337|FG001|Month 48|Adverse Event|13|||
28109178|NCT00294047|54767336|FG000|Month 48|Protocol Violation|4|||
28109179|NCT00294047|54767337|FG001|Month 48|Protocol Violation|4|||
28109180|NCT00294047|54767336|FG000|Month 48|Withdrawal by Subject|111|||
28109181|NCT00294047|54767337|FG001|Month 48|Withdrawal by Subject|115|||
28109182|NCT00294047|54767336|FG000|Month 48|Lost to Follow-up|272|||
28109183|NCT00294047|54767337|FG001|Month 48|Lost to Follow-up|287|||
28109184|NCT00294047|54767336|FG000|Month 48|Other|10|||
28109185|NCT00294047|54767337|FG001|Month 48|Other|14|||
28109186|NCT00294047|54767336|FG000|Month 84|Adverse Event|4|||
28109187|NCT00294047|54767337|FG001|Month 84|Adverse Event|2|||
27815677|NCT00989092|54272552|FG001|Overall Study|Ineligibility determined|3|||
28109188|NCT00294047|54767336|FG000|Month 84|Protocol Violation|1|||
28109189|NCT00294047|54767337|FG001|Month 84|Protocol Violation|1|||
28109190|NCT00294047|54767336|FG000|Month 84|Withdrawal by Subject|33|||
28109191|NCT00294047|54767337|FG001|Month 84|Withdrawal by Subject|31|||
28109192|NCT00294047|54767336|FG000|Month 84|Lost to Follow-up|187|||
28109193|NCT00294047|54767337|FG001|Month 84|Lost to Follow-up|190|||
28109194|NCT00294047|54767336|FG000|Month 84|Absent Cervix|2|||
28109195|NCT00294047|54767337|FG001|Month 84|Absent Cervix|0|||
28109196|NCT00294047|54767336|FG000|Month 84|Work related reasons|4|||
28109197|NCT00294047|54767337|FG001|Month 84|Work related reasons|2|||
28109198|NCT00294047|54767336|FG000|Month 84|Center closed, subject did not transfer|1|||
28109199|NCT00294047|54767337|FG001|Month 84|Center closed, subject did not transfer|0|||
28109200|NCT00294047|54767336|FG000|Month 84|Family problems|2|||
28109201|NCT00294047|54767337|FG001|Month 84|Family problems|2|||
28109202|NCT00294047|54767336|FG000|Month 84|Lack of time|3|||
28109203|NCT00294047|54767337|FG001|Month 84|Lack of time|1|||
28109204|NCT00294047|54767336|FG000|Month 84|Personal reason|2|||
28109205|NCT00294047|54767337|FG001|Month 84|Personal reason|4|||
27848509|NCT03593213|54341467|FG002|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
27848510|NCT03593213|54341468|FG003|Double-blind Treatment Period (26 Weeks)|Adverse Event|4|||
27848511|NCT03593213|54341465|FG000|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|0|||
27848512|NCT03593213|54341466|FG001|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|4|||
27848513|NCT03593213|54341467|FG002|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|2|||
27848514|NCT03593213|54341468|FG003|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|3|||
27848515|NCT03593213|54341465|FG000|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|0|||
27848516|NCT03593213|54341466|FG001|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|5|||
27848517|NCT03593213|54341467|FG002|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|4|||
27848518|NCT03593213|54341468|FG003|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|1|||
27848519|NCT03593213|54341465|FG000|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
27848520|NCT03593213|54341466|FG001|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
27848521|NCT03593213|54341467|FG002|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
27848522|NCT03593213|54341468|FG003|Double-blind Treatment Period (26 Weeks)|Pregnancy|1|||
27848523|NCT03593213|54341465|FG000|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|0|||
27848524|NCT03593213|54341466|FG001|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|3|||
27848525|NCT03593213|54341467|FG002|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|2|||
27848526|NCT03593213|54341468|FG003|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|5|||
27848527|NCT03593213|54341465|FG000|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
27848528|NCT03593213|54341466|FG001|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|1|||
27848529|NCT03593213|54341467|FG002|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|2|||
27848530|NCT03593213|54341468|FG003|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
27848531|NCT03593213|54341465|FG000|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|0|||
27848532|NCT03593213|54341466|FG001|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|9|||
27848533|NCT03593213|54341467|FG002|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|11|||
27848534|NCT03593213|54341468|FG003|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|13|||
27848535|NCT03593213|54341465|FG000|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
28109206|NCT00294047|54767336|FG000|Month 84|Subject does not want male physician|1|||
28109207|NCT00294047|54767337|FG001|Month 84|Subject does not want male physician|0|||
28109208|NCT00294047|54767336|FG000|Month 84|Transport reimbursement delayed|0|||
28109209|NCT00294047|54767337|FG001|Month 84|Transport reimbursement delayed|1|||
28109210|NCT00294047|54767336|FG000|Month 84|Unable to reach study site|1|||
28109211|NCT00294047|54767337|FG001|Month 84|Unable to reach study site|0|||
28109212|NCT00294047|54767336|FG000|Month 84|Under investigation locally|1|||
28109213|NCT00294047|54767337|FG001|Month 84|Under investigation locally|0|||
28109214|NCT00294047|54767336|FG000|Month 84|Visit missed|0|||
28109215|NCT00294047|54767337|FG001|Month 84|Visit missed|1|||
28109216|NCT00294047|54767336|FG000|Month 84|No consent for Month 84 Follow-up|731|||
28109217|NCT00294047|54767337|FG001|Month 84|No consent for Month 84 Follow-up|754|||
28109218|NCT00293813|54767347|FG000|Overall Study|Physician Decision|0|||
28109219|NCT00293813|54767348|FG001|Overall Study|Physician Decision|1|||
28109220|NCT00293813|54767349|FG002|Overall Study|Physician Decision|0|||
28109221|NCT00293813|54767347|FG000|Overall Study|Adverse Event|3|||
28109222|NCT00293813|54767348|FG001|Overall Study|Adverse Event|1|||
28109223|NCT00293813|54767349|FG002|Overall Study|Adverse Event|1|||
28109224|NCT00293813|54767347|FG000|Overall Study|Withdrawal by Subject|7|||
28109225|NCT00293813|54767348|FG001|Overall Study|Withdrawal by Subject|4|||
28109226|NCT00293813|54767349|FG002|Overall Study|Withdrawal by Subject|4|||
28109227|NCT00293813|54767347|FG000|Overall Study|Lost to Follow-up|3|||
28109228|NCT00293813|54767348|FG001|Overall Study|Lost to Follow-up|2|||
28109229|NCT00293813|54767349|FG002|Overall Study|Lost to Follow-up|3|||
28109230|NCT00293813|54767347|FG000|Overall Study|Noncompliance|0|||
28109231|NCT00293813|54767348|FG001|Overall Study|Noncompliance|1|||
28109232|NCT00293813|54767349|FG002|Overall Study|Noncompliance|0|||
28109233|NCT00293579|54767357|FG000|Overall Study|Withdrawal by Subject|1|||
28109234|NCT00293423|54767364|FG000|Surgical Resection|Less than a 90% extent of resection|0|||
28109235|NCT00293423|54767365|FG001|Surgical Resection|Less than a 90% extent of resection|1|||
28109236|NCT00293423|54767364|FG000|Surgical Resection|Postoperative Karnofsky Performance Score <70%|0|||
28109237|NCT00293423|54767365|FG001|Surgical Resection|Postoperative Karnofsky Performance Score <70%|4|||
28109238|NCT00293423|54767364|FG000|Surgical Resection|Insufficient tumor obtained to generate vaccine|9|||
28109239|NCT00293423|54767365|FG001|Surgical Resection|Insufficient tumor obtained to generate vaccine|13|||
28109240|NCT00293423|54767364|FG000|Surgical Resection|disease progression prior to initial vaccination|2|||
28109241|NCT00293423|54767365|FG001|Surgical Resection|disease progression prior to initial vaccination|9|||
28109242|NCT00293423|54767364|FG000|Surgical Resection|processing error during surgical resection|1|||
28109243|NCT00293423|54767365|FG001|Surgical Resection|processing error during surgical resection|0|||
28109244|NCT00293423|54767364|FG000|Surgical Resection|Withdrawal by Subject|4|||
28109245|NCT00293423|54767365|FG001|Surgical Resection|Withdrawal by Subject|0|||
28109246|NCT00293423|54767364|FG000|Vaccination Treatment Period|Received < 4 required vaccinations|0|||
28109247|NCT00293423|54767365|FG001|Vaccination Treatment Period|Received < 4 required vaccinations|3|||
28109248|NCT03538743|54767380|FG000|Overall Study|Adverse Event|0|||
28109249|NCT03538743|54767381|FG001|Overall Study|Adverse Event|0|||
28109250|NCT03538743|54767382|FG002|Overall Study|Adverse Event|1|||
28109251|NCT03538743|54767383|FG003|Overall Study|Adverse Event|1|||
28109252|NCT03538743|54767384|FG004|Overall Study|Adverse Event|0|||
28109253|NCT03538743|54767385|FG005|Overall Study|Adverse Event|0|||
28109254|NCT03538743|54767386|FG006|Overall Study|Adverse Event|0|||
28109255|NCT03538743|54767387|FG007|Overall Study|Adverse Event|0|||
28109256|NCT03538743|54767388|FG008|Overall Study|Adverse Event|0|||
28109257|NCT03538743|54767380|FG000|Overall Study|Non-Treatment-Related Reasons|0|||
28109258|NCT03538743|54767381|FG001|Overall Study|Non-Treatment-Related Reasons|0|||
28109259|NCT03538743|54767382|FG002|Overall Study|Non-Treatment-Related Reasons|0|||
28109260|NCT03538743|54767383|FG003|Overall Study|Non-Treatment-Related Reasons|0|||
28109261|NCT03538743|54767384|FG004|Overall Study|Non-Treatment-Related Reasons|0|||
28109262|NCT03538743|54767385|FG005|Overall Study|Non-Treatment-Related Reasons|0|||
28109263|NCT03538743|54767386|FG006|Overall Study|Non-Treatment-Related Reasons|0|||
28109264|NCT03538743|54767387|FG007|Overall Study|Non-Treatment-Related Reasons|0|||
28109265|NCT03538743|54767388|FG008|Overall Study|Non-Treatment-Related Reasons|3|||
28109266|NCT03538743|54767380|FG000|Overall Study|Withdrawal by Subject|0|||
27848536|NCT03593213|54341466|FG001|Double-blind Treatment Period (26 Weeks)|Reason not Specified|1|||
27848537|NCT03593213|54341467|FG002|Double-blind Treatment Period (26 Weeks)|Reason not Specified|3|||
27848538|NCT03593213|54341468|FG003|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
27848539|NCT00013611|54341512|FG000|Overall Study|Lost to Follow-up|91|||
27848540|NCT00013611|54341513|FG001|Overall Study|Lost to Follow-up|100|||
27848541|NCT00010257|54341521|FG000|Overall Study|Withdrawal by Subject|1|||
27848542|NCT00010257|54341522|FG001|Overall Study|Withdrawal by Subject|0|||
27848543|NCT00211757|54341560|FG000|Overall Study|Withdrawal by Subject|1|||
27848544|NCT00211757|54341561|FG001|Overall Study|Withdrawal by Subject|1|||
27848545|NCT00211757|54341560|FG000|Overall Study|Lack of Efficacy|0|||
27848546|NCT00211757|54341561|FG001|Overall Study|Lack of Efficacy|1|||
27848547|NCT02639052|54341578|FG000|Overall Study|Lost to Follow-up|1|||
27848548|NCT02635776|54341685|FG000|Overall Study|Physician Decision|1|||
27848549|NCT02635776|54341686|FG001|Overall Study|Physician Decision|0|||
27848550|NCT02635776|54341685|FG000|Overall Study|Adverse Event|51|||
27848551|NCT02635776|54341686|FG001|Overall Study|Adverse Event|3|||
27848552|NCT02635776|54341685|FG000|Overall Study|Withdrawal by Subject|41|||
27848553|NCT02635776|54341686|FG001|Overall Study|Withdrawal by Subject|7|||
27848554|NCT02635776|54341685|FG000|Overall Study|Lost to Follow-up|4|||
27848555|NCT02635776|54341686|FG001|Overall Study|Lost to Follow-up|0|||
27848556|NCT02635776|54341685|FG000|Overall Study|Other reasons|5|||
27848557|NCT02635776|54341686|FG001|Overall Study|Other reasons|1|||
28109267|NCT03538743|54767381|FG001|Overall Study|Withdrawal by Subject|0|||
28109268|NCT03538743|54767382|FG002|Overall Study|Withdrawal by Subject|0|||
27848558|NCT02704403|54341700|FG000|Overall Study|Randomized and not treated (due to non-compliance with protocol)|4|||
27848559|NCT02704403|54341701|FG001|Overall Study|Randomized and not treated (due to non-compliance with protocol)|3|||
27848560|NCT02704403|54341700|FG000|Overall Study|Administrative reasons by sponsor|1251|||
27848561|NCT02704403|54341701|FG001|Overall Study|Administrative reasons by sponsor|616|||
27848562|NCT02704403|54341700|FG000|Overall Study|Death|4|||
27848563|NCT02704403|54341701|FG001|Overall Study|Death|3|||
27848564|NCT02704403|54341700|FG000|Overall Study|Endpoint event|52|||
27848565|NCT02704403|54341701|FG001|Overall Study|Endpoint event|24|||
27848566|NCT02704403|54341700|FG000|Overall Study|Lost to Follow-up|22|||
27848567|NCT02704403|54341701|FG001|Overall Study|Lost to Follow-up|11|||
27848568|NCT02704403|54341700|FG000|Overall Study|Protocol Violation|15|||
27848569|NCT02704403|54341701|FG001|Overall Study|Protocol Violation|15|||
27848570|NCT02704403|54341700|FG000|Overall Study|Adverse Event|2|||
27848571|NCT02704403|54341701|FG001|Overall Study|Adverse Event|0|||
27848572|NCT02704403|54341700|FG000|Overall Study|Withdrawal by Subject|85|||
27848573|NCT02704403|54341701|FG001|Overall Study|Withdrawal by Subject|45|||
27848574|NCT02704403|54341700|FG000|Overall Study|Investigator decision|1|||
27848575|NCT02704403|54341701|FG001|Overall Study|Investigator decision|1|||
27848576|NCT02704403|54341700|FG000|Overall Study|Follow-up not possible|1|||
27848577|NCT02704403|54341701|FG001|Overall Study|Follow-up not possible|2|||
27848578|NCT02636868|54341736|FG000|Overall Study|Death|0|||
27848579|NCT02636868|54341737|FG001|Overall Study|Death|1|||
27848580|NCT02636868|54341738|FG002|Overall Study|Death|2|||
27848581|NCT02635386|54341819|FG000|Overall Study|Pregnancy|2|||
27848582|NCT02635386|54341820|FG001|Overall Study|Pregnancy|0|||
27848583|NCT02635386|54341821|FG002|Overall Study|Pregnancy|0|||
27848584|NCT02635386|54341822|FG003|Overall Study|Pregnancy|0|||
27848585|NCT02635386|54341823|FG004|Overall Study|Pregnancy|2|||
27848586|NCT02635386|54341819|FG000|Overall Study|Withdrawal by Subject|1|||
27848587|NCT02635386|54341820|FG001|Overall Study|Withdrawal by Subject|1|||
27848588|NCT02635386|54341821|FG002|Overall Study|Withdrawal by Subject|0|||
28064187|NCT00333788|54719790|FG000|Overall Study|Other: Quality of life concern|1|||
28064188|NCT00333788|54719790|FG000|Overall Study|Other: Sponsor decision|1|||
28109269|NCT03538743|54767383|FG003|Overall Study|Withdrawal by Subject|1|||
28109270|NCT03538743|54767384|FG004|Overall Study|Withdrawal by Subject|0|||
28109271|NCT03538743|54767385|FG005|Overall Study|Withdrawal by Subject|0|||
28109272|NCT03538743|54767386|FG006|Overall Study|Withdrawal by Subject|0|||
28109273|NCT03538743|54767387|FG007|Overall Study|Withdrawal by Subject|0|||
28109274|NCT03538743|54767388|FG008|Overall Study|Withdrawal by Subject|0|||
28109275|NCT03521817|54767418|FG000|Overall Study|Protocol Violation|0|||
28064189|NCT00333788|54719790|FG000|Overall Study|Other: Subject in need of an Entocort|1|||
28064190|NCT00333788|54719790|FG000|Overall Study|Other: Medical monitor decision|1|||
28064191|NCT00333788|54719790|FG000|Overall Study|Other: Physician decision|1|||
28064192|NCT00333788|54719790|FG000|Overall Study|Other: Signed consent for another study|1|||
28064193|NCT00324116|54719794|FG000|Overall Study|Adverse Event|5|||
28064194|NCT00324116|54719794|FG000|Overall Study|Lack of Efficacy|17|||
28064195|NCT00324116|54719794|FG000|Overall Study|Withdrawal by Subject|5|||
28064196|NCT00324116|54719794|FG000|Overall Study|Other|5|||
28064197|NCT00332696|54719800|FG000|Overall Study|Death|24|||
28064198|NCT00332696|54719801|FG001|Overall Study|Death|14|||
28064199|NCT00332696|54719800|FG000|Overall Study|Insufficient therapeutic effect|4|||
28064200|NCT00332696|54719801|FG001|Overall Study|Insufficient therapeutic effect|11|||
28064201|NCT00332696|54719800|FG000|Overall Study|Adverse Event|1|||
28064202|NCT00332696|54719801|FG001|Overall Study|Adverse Event|2|||
28064203|NCT00332696|54719800|FG000|Overall Study|Condition does not justify treatment|0|||
28064204|NCT00332696|54719801|FG001|Overall Study|Condition does not justify treatment|2|||
28064205|NCT00332696|54719800|FG000|Overall Study|Lost to Follow-up|0|||
28064206|NCT00332696|54719801|FG001|Overall Study|Lost to Follow-up|1|||
28064207|NCT00332696|54719800|FG000|Overall Study|Withdrawal by Subject|1|||
28064208|NCT00332696|54719801|FG001|Overall Study|Withdrawal by Subject|0|||
28064209|NCT00313716|54719813|FG000|Overall Study|Death|3|||
28064210|NCT00313716|54719814|FG001|Overall Study|Death|2|||
28064211|NCT00313716|54719815|FG002|Overall Study|Death|9|||
28064212|NCT00313716|54719816|FG003|Overall Study|Death|3|||
28064213|NCT00313716|54719817|FG004|Overall Study|Death|5|||
28064214|NCT00313716|54719818|FG005|Overall Study|Death|9|||
28064215|NCT00313716|54719813|FG000|Overall Study|Lost to Follow-up|2|||
28064216|NCT00313716|54719814|FG001|Overall Study|Lost to Follow-up|5|||
28064217|NCT00313716|54719815|FG002|Overall Study|Lost to Follow-up|2|||
28064218|NCT00313716|54719816|FG003|Overall Study|Lost to Follow-up|1|||
28064219|NCT00313716|54719817|FG004|Overall Study|Lost to Follow-up|0|||
28064220|NCT00313716|54719818|FG005|Overall Study|Lost to Follow-up|4|||
28064221|NCT00313716|54719813|FG000|Overall Study|Withdrawal by Subject|0|||
28064222|NCT00313716|54719814|FG001|Overall Study|Withdrawal by Subject|1|||
28109276|NCT03521817|54767419|FG001|Overall Study|Protocol Violation|1|||
28064223|NCT00313716|54719815|FG002|Overall Study|Withdrawal by Subject|1|||
28064224|NCT00313716|54719816|FG003|Overall Study|Withdrawal by Subject|0|||
28064225|NCT00313716|54719817|FG004|Overall Study|Withdrawal by Subject|1|||
28064226|NCT00313716|54719818|FG005|Overall Study|Withdrawal by Subject|0|||
28109277|NCT03538431|54767425|FG000|Overall Study|Physician Decision|0|||
28109278|NCT03538431|54767426|FG001|Overall Study|Physician Decision|1|||
28109279|NCT03538431|54767425|FG000|Overall Study|Withdrawal by Subject|1|||
28109280|NCT03538431|54767426|FG001|Overall Study|Withdrawal by Subject|0|||
27848589|NCT02635386|54341822|FG003|Overall Study|Withdrawal by Subject|1|||
28109281|NCT03521193|54767436|FG000|Overall Study|Withdrawal by Subject|8|||
28109282|NCT03521193|54767437|FG001|Overall Study|Withdrawal by Subject|0|||
27848590|NCT02635386|54341823|FG004|Overall Study|Withdrawal by Subject|0|||
27848591|NCT02635386|54341819|FG000|Overall Study|Physician Decision|0|||
27848592|NCT02635386|54341820|FG001|Overall Study|Physician Decision|1|||
27848593|NCT02635386|54341821|FG002|Overall Study|Physician Decision|0|||
27848594|NCT02635386|54341822|FG003|Overall Study|Physician Decision|0|||
27848595|NCT02635386|54341823|FG004|Overall Study|Physician Decision|0|||
27848596|NCT02635386|54341819|FG000|Overall Study|Moved Out of State|0|||
27848597|NCT02635386|54341820|FG001|Overall Study|Moved Out of State|1|||
28109283|NCT03521193|54767436|FG000|Overall Study|non compliant to ASA treatment|8|||
27848598|NCT02635386|54341821|FG002|Overall Study|Moved Out of State|0|||
27848599|NCT02635386|54341822|FG003|Overall Study|Moved Out of State|0|||
27848600|NCT02635386|54341823|FG004|Overall Study|Moved Out of State|0|||
27848601|NCT02635386|54341819|FG000|Overall Study|Noncompliant|0|||
27848602|NCT02635386|54341820|FG001|Overall Study|Noncompliant|2|||
27848603|NCT02635386|54341821|FG002|Overall Study|Noncompliant|1|||
27848604|NCT02635386|54341822|FG003|Overall Study|Noncompliant|1|||
27848605|NCT02635386|54341823|FG004|Overall Study|Noncompliant|1|||
27848606|NCT02635386|54341819|FG000|Overall Study|side effects|0|||
27848607|NCT02635386|54341820|FG001|Overall Study|side effects|0|||
27848608|NCT02635386|54341821|FG002|Overall Study|side effects|1|||
27848609|NCT02635386|54341822|FG003|Overall Study|side effects|4|||
27848610|NCT02635386|54341823|FG004|Overall Study|side effects|6|||
27848611|NCT02635386|54341819|FG000|Overall Study|needed other major surgery|0|||
27848612|NCT02635386|54341820|FG001|Overall Study|needed other major surgery|1|||
27848613|NCT02635386|54341821|FG002|Overall Study|needed other major surgery|0|||
27848614|NCT02635386|54341822|FG003|Overall Study|needed other major surgery|0|||
27848615|NCT02635386|54341823|FG004|Overall Study|needed other major surgery|0|||
27848616|NCT02635386|54341819|FG000|Overall Study|Other medical problems not drug related|0|||
27848617|NCT02635386|54341820|FG001|Overall Study|Other medical problems not drug related|0|||
27848618|NCT02635386|54341821|FG002|Overall Study|Other medical problems not drug related|0|||
27848619|NCT02635386|54341822|FG003|Overall Study|Other medical problems not drug related|1|||
27940193|NCT01194414|54596461|FG003|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
27940194|NCT01194414|54596458|FG000|72 Weeks Open Label Extension|Death|1|||
28109284|NCT03521193|54767437|FG001|Overall Study|non compliant to ASA treatment|0|||
28109285|NCT00293267|54767446|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
28109286|NCT00293267|54767447|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
28109287|NCT00293267|54767446|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
28109288|NCT00293267|54767447|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
28109289|NCT00293267|54767446|FG000|Primary Study - Double-Blind Week 0-48|Death|3|||
28109290|NCT00293267|54767447|FG001|Primary Study - Double-Blind Week 0-48|Death|3|||
28109291|NCT00293267|54767446|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0|||
28109292|NCT00293267|54767447|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
28109293|NCT00293267|54767446|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
28109294|NCT00293267|54767447|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
28109295|NCT00293267|54767446|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
28109296|NCT00293267|54767447|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
28109297|NCT00293267|54767446|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33|||
28109298|NCT00293267|54767447|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60|||
28109299|NCT00293267|54767446|FG000|Extension - Double-Blind Week 49-156|Adverse Event|1|||
28109300|NCT00293267|54767447|FG001|Extension - Double-Blind Week 49-156|Adverse Event|4|||
28109301|NCT00293267|54767446|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|7|||
28109302|NCT00293267|54767447|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|1|||
28109303|NCT00293267|54767446|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|4|||
28109304|NCT00293267|54767447|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|0|||
27815678|NCT00989092|54272551|FG000|Overall Study|Lost to Follow-up|6|||
27815679|NCT00989092|54272552|FG001|Overall Study|Lost to Follow-up|2|||
27815680|NCT00989092|54272551|FG000|Overall Study|Other|3|||
27815681|NCT00989092|54272552|FG001|Overall Study|Other|1|||
27815682|NCT00989092|54272551|FG000|Overall Study|Protocol deviation|2|||
27815683|NCT00989092|54272552|FG001|Overall Study|Protocol deviation|0|||
27815684|NCT00989092|54272551|FG000|Overall Study|Erythropoietin therapy initiated|2|||
27815685|NCT00989092|54272552|FG001|Overall Study|Erythropoietin therapy initiated|0|||
27815686|NCT00989092|54272551|FG000|Overall Study|Did not receive study drug|2|||
27815687|NCT00989092|54272552|FG001|Overall Study|Did not receive study drug|0|||
27815688|NCT00988858|54272559|FG000|Overall Study|Adverse Event|7|||
28109305|NCT00293267|54767446|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13|||
28109306|NCT00293267|54767447|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4|||
28109307|NCT00293267|54767446|FG000|Extension - Double-Blind Week 49-156|Death|3|||
28109308|NCT00293267|54767447|FG001|Extension - Double-Blind Week 49-156|Death|0|||
28109309|NCT00293267|54767446|FG000|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2|||
28109310|NCT00293267|54767447|FG001|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0|||
28109311|NCT00293267|54767446|FG000|Extension - Double-Blind Week 49-156|Other Reason|7|||
28109312|NCT00293267|54767447|FG001|Extension - Double-Blind Week 49-156|Other Reason|0|||
28109313|NCT00293267|54767446|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
28109314|NCT00293267|54767447|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6|||
27815689|NCT00988858|54272559|FG000|Overall Study|Death|1|||
27940195|NCT01194414|54596459|FG001|72 Weeks Open Label Extension|Death|2|||
27940196|NCT01194414|54596460|FG002|72 Weeks Open Label Extension|Death|0|||
27940197|NCT01194414|54596461|FG003|72 Weeks Open Label Extension|Death|2|||
28109315|NCT00293267|54767446|FG000|Extension - Open-Label Week 157-240|Adverse Event|5|||
28109316|NCT00293267|54767447|FG001|Extension - Open-Label Week 157-240|Adverse Event|0|||
28109317|NCT00293267|54767446|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|7|||
27815690|NCT00988858|54272559|FG000|Overall Study|Physician Decision|1|||
28109318|NCT00293267|54767447|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
28109319|NCT00293267|54767446|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|1|||
28109320|NCT00293267|54767447|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
28109321|NCT00293267|54767446|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|2|||
28109322|NCT00293267|54767447|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
28109323|NCT00293267|54767446|FG000|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2|||
28109324|NCT00293267|54767447|FG001|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0|||
28109325|NCT00293267|54767446|FG000|Extension - Open-Label Week 157-240|Other Reason|3|||
28109326|NCT00293267|54767447|FG001|Extension - Open-Label Week 157-240|Other Reason|1|||
28109327|NCT00293267|54767446|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|2|||
28109328|NCT00293267|54767447|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|3|||
28109329|NCT00293267|54767446|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23|||
28109330|NCT00293267|54767447|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19|||
28109331|NCT00293267|54767446|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2|||
28109332|NCT00293267|54767447|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4|||
28109333|NCT00293267|54767446|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
28109334|NCT00293267|54767447|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
28109335|NCT00293267|54767446|FG000|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0|||
28109336|NCT00293267|54767447|FG001|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2|||
28109337|NCT00293267|54767446|FG000|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0|||
28109338|NCT00293267|54767447|FG001|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2|||
28109339|NCT00293267|54767446|FG000|Open-Label Post Virologic Failure Phase|Other Reason|4|||
28109340|NCT00293267|54767447|FG001|Open-Label Post Virologic Failure Phase|Other Reason|5|||
27815691|NCT00988858|54272559|FG000|Overall Study|Sponsor Decision|1|||
27815692|NCT00986986|54272565|FG000|Overall Study|Lost to Follow-up|0|||
28064227|NCT00313170|54719839|FG000|Overall Study|Death|2|||
28064228|NCT00313170|54719840|FG001|Overall Study|Death|4|||
28064229|NCT00313170|54719841|FG002|Overall Study|Death|2|||
28109341|NCT03520959|54767457|FG000|Overall Study|Study terminated by Sponsor|0|||
28109342|NCT03520959|54767458|FG001|Overall Study|Study terminated by Sponsor|1|||
28109343|NCT03537261|54767466|FG000|Overall Study|Lost to Follow-up|4|||
28109344|NCT03537261|54767467|FG001|Overall Study|Lost to Follow-up|5|||
28109345|NCT03537261|54767466|FG000|Overall Study|Withdrawal by Subject|4|||
28109346|NCT03537261|54767467|FG001|Overall Study|Withdrawal by Subject|6|||
28109347|NCT03537261|54767466|FG000|Overall Study|Did not return study questionnaires|0|||
28109348|NCT03537261|54767467|FG001|Overall Study|Did not return study questionnaires|1|||
28109349|NCT03536949|54767475|FG000|Overall Study|Adverse Event|4|||
28109350|NCT03536949|54767476|FG001|Overall Study|Adverse Event|0|||
28109351|NCT03536949|54767475|FG000|Overall Study|Lost to Follow-up|2|||
28109352|NCT03536949|54767476|FG001|Overall Study|Lost to Follow-up|1|||
28064230|NCT00313170|54719839|FG000|Overall Study|Adverse Event|1|||
28064231|NCT00313170|54719840|FG001|Overall Study|Adverse Event|2|||
28064232|NCT00313170|54719841|FG002|Overall Study|Adverse Event|0|||
28064233|NCT00313170|54719839|FG000|Overall Study|Disease progression|31|||
28064234|NCT00313170|54719840|FG001|Overall Study|Disease progression|26|||
28109353|NCT03536949|54767475|FG000|Overall Study|Withdrawal by Subject|6|||
27815693|NCT00986986|54272566|FG001|Overall Study|Lost to Follow-up|1|||
27815694|NCT01904773|54272573|FG000|Screen|Screen failure|3|||
27815695|NCT01904773|54272574|FG001|Screen|Screen failure|0|||
27815696|NCT01904773|54272575|FG002|Screen|Screen failure|0|||
28064235|NCT00313170|54719841|FG002|Overall Study|Disease progression|27|||
28064236|NCT00313170|54719839|FG000|Overall Study|Withdrawal by Subject|1|||
28109354|NCT03536949|54767476|FG001|Overall Study|Withdrawal by Subject|0|||
28109355|NCT03536949|54767475|FG000|Overall Study|Non-compliance|2|||
28109356|NCT03536949|54767476|FG001|Overall Study|Non-compliance|1|||
28109357|NCT03588741|54767482|FG000|Overall Study|Withdrawal by Subject|1|||
28109358|NCT00111917|54767488|FG000|Overall Study|Withdrawal by Subject|1|||
28109359|NCT00111917|54767489|FG001|Overall Study|Withdrawal by Subject|1|||
28109360|NCT03520569|54767499|FG000|Overall Study|Withdrawal by Subject|1|||
28109361|NCT00111839|54767512|FG000|Overall Study|Disease Progression|30|||
28109362|NCT00111839|54767513|FG001|Overall Study|Disease Progression|33|||
28109363|NCT00111839|54767514|FG002|Overall Study|Disease Progression|33|||
28109364|NCT00111839|54767512|FG000|Overall Study|Adverse Event|5|||
28109365|NCT00111839|54767513|FG001|Overall Study|Adverse Event|3|||
28109366|NCT00111839|54767514|FG002|Overall Study|Adverse Event|1|||
28109367|NCT00111839|54767512|FG000|Overall Study|Protocol Violation|2|||
28109368|NCT00111839|54767513|FG001|Overall Study|Protocol Violation|4|||
28109369|NCT00111839|54767514|FG002|Overall Study|Protocol Violation|2|||
28109370|NCT00111839|54767512|FG000|Overall Study|Death|1|||
28109371|NCT00111839|54767513|FG001|Overall Study|Death|1|||
28109372|NCT00111839|54767514|FG002|Overall Study|Death|6|||
28109373|NCT00111839|54767512|FG000|Overall Study|Withdrawal by Subject|2|||
28109374|NCT00111839|54767513|FG001|Overall Study|Withdrawal by Subject|2|||
28109375|NCT00111839|54767514|FG002|Overall Study|Withdrawal by Subject|2|||
28109376|NCT00111839|54767512|FG000|Overall Study|Lost to Follow-up|1|||
28109377|NCT00111839|54767513|FG001|Overall Study|Lost to Follow-up|0|||
28109378|NCT00111839|54767514|FG002|Overall Study|Lost to Follow-up|0|||
28109379|NCT00111839|54767512|FG000|Overall Study|Logistical Constraint|1|||
28109380|NCT00111839|54767513|FG001|Overall Study|Logistical Constraint|0|||
28109381|NCT00111839|54767514|FG002|Overall Study|Logistical Constraint|0|||
28109382|NCT00111839|54767512|FG000|Overall Study|Other|6|||
28109383|NCT00111839|54767513|FG001|Overall Study|Other|3|||
28109384|NCT00111839|54767514|FG002|Overall Study|Other|3|||
28109385|NCT00111839|54767512|FG000|Overall Study|Randomized but Not Treated|0|||
28109386|NCT00111839|54767513|FG001|Overall Study|Randomized but Not Treated|0|||
28109387|NCT00111839|54767514|FG002|Overall Study|Randomized but Not Treated|2|||
28109388|NCT00111761|54767524|FG000|Part 1|Physician Decision|0|||
28109389|NCT00111761|54767525|FG001|Part 1|Physician Decision|1|||
28109390|NCT00111761|54767524|FG000|Part 1|Death|0|||
28109391|NCT00111761|54767525|FG001|Part 1|Death|2|||
28109392|NCT00111761|54767524|FG000|Part 1|Other|0|||
28109393|NCT00111761|54767525|FG001|Part 1|Other|1|||
28109394|NCT00111761|54767524|FG000|Part 1|Withdrawal by Subject|0|||
28109395|NCT00111761|54767525|FG001|Part 1|Withdrawal by Subject|1|||
28109396|NCT00111761|54767524|FG000|Part 2|Adverse Event|1|||
28109397|NCT00111761|54767525|FG001|Part 2|Adverse Event|0|||
28109398|NCT00111761|54767524|FG000|Part 2|Physician Decision|1|||
28109399|NCT00111761|54767525|FG001|Part 2|Physician Decision|0|||
28109400|NCT00111761|54767524|FG000|Part 2|Death|1|||
28109401|NCT00111761|54767525|FG001|Part 2|Death|0|||
28109402|NCT00111761|54767524|FG000|Part 2|Disease progression|3|||
28109403|NCT00111761|54767525|FG001|Part 2|Disease progression|0|||
28109404|NCT00111761|54767524|FG000|Part 2|Protocol-specified criteria|1|||
28109405|NCT00111761|54767525|FG001|Part 2|Protocol-specified criteria|0|||
28109406|NCT00111761|54767524|FG000|Part 2|Other|1|||
28109407|NCT00111761|54767525|FG001|Part 2|Other|0|||
28109408|NCT03519867|54767541|FG000|Overall Study|Adverse Event|1|||
28109409|NCT03519867|54767542|FG001|Overall Study|Adverse Event|1|||
28109410|NCT03519867|54767543|FG002|Overall Study|Adverse Event|0|||
27815697|NCT01904773|54272576|FG003|Screen|Screen failure|0|||
28064237|NCT00313170|54719840|FG001|Overall Study|Withdrawal by Subject|0|||
28064238|NCT00313170|54719841|FG002|Overall Study|Withdrawal by Subject|1|||
28064239|NCT00313170|54719839|FG000|Overall Study|Incorrect enrollment|0|||
28064240|NCT00313170|54719840|FG001|Overall Study|Incorrect enrollment|2|||
28064241|NCT00313170|54719841|FG002|Overall Study|Incorrect enrollment|1|||
28064242|NCT00313170|54719839|FG000|Overall Study|Lost to Follow-up|0|||
28064243|NCT00313170|54719840|FG001|Overall Study|Lost to Follow-up|0|||
28064244|NCT00313170|54719841|FG002|Overall Study|Lost to Follow-up|1|||
28064245|NCT00313170|54719839|FG000|Overall Study|Progression (investigators opinion)|1|||
28064246|NCT00313170|54719840|FG001|Overall Study|Progression (investigators opinion)|0|||
28109411|NCT03519867|54767544|FG003|Overall Study|Adverse Event|0|||
28109412|NCT03519867|54767545|FG004|Overall Study|Adverse Event|0|||
28064247|NCT00313170|54719841|FG002|Overall Study|Progression (investigators opinion)|0|||
28109413|NCT03519867|54767546|FG005|Overall Study|Adverse Event|0|||
28109414|NCT03519867|54767547|FG006|Overall Study|Adverse Event|0|||
28109415|NCT03519867|54767548|FG007|Overall Study|Adverse Event|0|||
28109416|NCT03519867|54767549|FG008|Overall Study|Adverse Event|0|||
28064248|NCT00332462|54719850|FG000|Overall Study|Adverse Event|5|||
28109417|NCT03519867|54767550|FG009|Overall Study|Adverse Event|0|||
28109418|NCT03519867|54767541|FG000|Overall Study|Protocol Violation|0|||
28109419|NCT03519867|54767542|FG001|Overall Study|Protocol Violation|0|||
28109420|NCT03519867|54767543|FG002|Overall Study|Protocol Violation|0|||
28109421|NCT03519867|54767544|FG003|Overall Study|Protocol Violation|0|||
28109422|NCT03519867|54767545|FG004|Overall Study|Protocol Violation|0|||
28109423|NCT03519867|54767546|FG005|Overall Study|Protocol Violation|1|||
28109424|NCT03519867|54767547|FG006|Overall Study|Protocol Violation|0|||
28109425|NCT03519867|54767548|FG007|Overall Study|Protocol Violation|0|||
28109426|NCT03519867|54767549|FG008|Overall Study|Protocol Violation|0|||
28109427|NCT03519867|54767550|FG009|Overall Study|Protocol Violation|0|||
28109428|NCT03519867|54767541|FG000|Overall Study|Admin. of relaxant other than Zemuron®|0|||
28109429|NCT03519867|54767542|FG001|Overall Study|Admin. of relaxant other than Zemuron®|0|||
28109430|NCT03519867|54767543|FG002|Overall Study|Admin. of relaxant other than Zemuron®|0|||
28109431|NCT03519867|54767544|FG003|Overall Study|Admin. of relaxant other than Zemuron®|0|||
28109432|NCT03519867|54767545|FG004|Overall Study|Admin. of relaxant other than Zemuron®|0|||
28109433|NCT03519867|54767546|FG005|Overall Study|Admin. of relaxant other than Zemuron®|0|||
28109434|NCT03519867|54767547|FG006|Overall Study|Admin. of relaxant other than Zemuron®|1|||
28109435|NCT03519867|54767548|FG007|Overall Study|Admin. of relaxant other than Zemuron®|0|||
28109436|NCT03519867|54767549|FG008|Overall Study|Admin. of relaxant other than Zemuron®|0|||
28109437|NCT03519867|54767550|FG009|Overall Study|Admin. of relaxant other than Zemuron®|0|||
28109438|NCT03519867|54767541|FG000|Overall Study|Admin. of other reversal agent|1|||
28109439|NCT03519867|54767542|FG001|Overall Study|Admin. of other reversal agent|1|||
28109440|NCT03519867|54767543|FG002|Overall Study|Admin. of other reversal agent|0|||
28109441|NCT03519867|54767544|FG003|Overall Study|Admin. of other reversal agent|0|||
28109442|NCT03519867|54767545|FG004|Overall Study|Admin. of other reversal agent|0|||
28109443|NCT03519867|54767546|FG005|Overall Study|Admin. of other reversal agent|1|||
28109444|NCT03519867|54767547|FG006|Overall Study|Admin. of other reversal agent|0|||
28109445|NCT03519867|54767548|FG007|Overall Study|Admin. of other reversal agent|0|||
28109446|NCT03519867|54767549|FG008|Overall Study|Admin. of other reversal agent|0|||
28109447|NCT03519867|54767550|FG009|Overall Study|Admin. of other reversal agent|0|||
28109448|NCT03519867|54767541|FG000|Overall Study|Reason not provided|1|||
28109449|NCT03519867|54767542|FG001|Overall Study|Reason not provided|1|||
28109450|NCT03519867|54767543|FG002|Overall Study|Reason not provided|1|||
28109451|NCT03519867|54767544|FG003|Overall Study|Reason not provided|1|||
28109452|NCT03519867|54767545|FG004|Overall Study|Reason not provided|0|||
28109453|NCT03519867|54767546|FG005|Overall Study|Reason not provided|1|||
28109454|NCT03519867|54767547|FG006|Overall Study|Reason not provided|0|||
28109455|NCT03519867|54767548|FG007|Overall Study|Reason not provided|1|||
28109456|NCT03519867|54767549|FG008|Overall Study|Reason not provided|1|||
28109457|NCT03519867|54767550|FG009|Overall Study|Reason not provided|0|||
28109458|NCT03519087|54767574|FG000|Clinic Evaluation|Physician Decision|15|||
28109459|NCT03519087|54767575|FG001|Clinic Evaluation|Physician Decision|18|||
28109460|NCT03519087|54767576|FG002|Clinic Evaluation|Physician Decision|0|||
28109461|NCT03519087|54767577|FG003|Clinic Evaluation|Physician Decision|0|||
28109462|NCT03519087|54767578|FG004|Clinic Evaluation|Physician Decision|0|||
28109463|NCT03519087|54767574|FG000|Clinic Evaluation|Protocol Violation|1|||
28109464|NCT03519087|54767575|FG001|Clinic Evaluation|Protocol Violation|0|||
28109465|NCT03519087|54767576|FG002|Clinic Evaluation|Protocol Violation|0|||
28109466|NCT03519087|54767577|FG003|Clinic Evaluation|Protocol Violation|0|||
28109467|NCT03519087|54767578|FG004|Clinic Evaluation|Protocol Violation|0|||
28109468|NCT03519087|54767574|FG000|Re-randomization for Treatment|Withdrawal by Subject|25|||
28109469|NCT03519087|54767575|FG001|Re-randomization for Treatment|Withdrawal by Subject|29|||
28109470|NCT03519087|54767576|FG002|Re-randomization for Treatment|Withdrawal by Subject|0|||
28064249|NCT00332462|54719850|FG000|Overall Study|Abnormal Lab Value|1|||
28064250|NCT00332462|54719850|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
28064251|NCT00332462|54719850|FG000|Overall Study|no longer requires study drug|1|||
28064252|NCT00332462|54719850|FG000|Overall Study|Death|3|||
28064253|NCT00332462|54719850|FG000|Overall Study|Graft Loss|2|||
28064254|NCT00324038|54719859|FG000|Overall Study|Adverse Event|38|||
28064255|NCT00324038|54719860|FG001|Overall Study|Adverse Event|23|||
28064256|NCT00324038|54719859|FG000|Overall Study|Lack of Efficacy|5|||
28064257|NCT00324038|54719860|FG001|Overall Study|Lack of Efficacy|13|||
28064258|NCT00324038|54719859|FG000|Overall Study|Lost to Follow-up|0|||
28064259|NCT00324038|54719860|FG001|Overall Study|Lost to Follow-up|2|||
28064260|NCT00324038|54719859|FG000|Overall Study|Other|6|||
28109471|NCT03519087|54767577|FG003|Re-randomization for Treatment|Withdrawal by Subject|0|||
28109472|NCT03519087|54767578|FG004|Re-randomization for Treatment|Withdrawal by Subject|0|||
28109473|NCT03519087|54767574|FG000|Re-randomization for Treatment|Not appropriate|2|||
28109474|NCT03519087|54767575|FG001|Re-randomization for Treatment|Not appropriate|3|||
28109475|NCT03519087|54767576|FG002|Re-randomization for Treatment|Not appropriate|0|||
28109476|NCT03519087|54767577|FG003|Re-randomization for Treatment|Not appropriate|0|||
28109477|NCT03519087|54767578|FG004|Re-randomization for Treatment|Not appropriate|0|||
28109478|NCT03519087|54767574|FG000|Laboratory Testing|Lost to Follow-up|0|||
28109479|NCT03519087|54767575|FG001|Laboratory Testing|Lost to Follow-up|0|||
28109480|NCT03519087|54767576|FG002|Laboratory Testing|Lost to Follow-up|2|||
28109481|NCT03519087|54767577|FG003|Laboratory Testing|Lost to Follow-up|3|||
28109482|NCT03519087|54767578|FG004|Laboratory Testing|Lost to Follow-up|6|||
28109483|NCT03519087|54767574|FG000|Laboratory Testing|Protocol Violation|0|||
28109484|NCT03519087|54767575|FG001|Laboratory Testing|Protocol Violation|0|||
28109485|NCT03519087|54767576|FG002|Laboratory Testing|Protocol Violation|0|||
28109486|NCT03519087|54767577|FG003|Laboratory Testing|Protocol Violation|1|||
28109487|NCT03519087|54767578|FG004|Laboratory Testing|Protocol Violation|0|||
28109488|NCT02763046|54767597|FG000|Overall Study|Adverse Event|5|||
28109489|NCT02763046|54767598|FG001|Overall Study|Adverse Event|4|||
28109490|NCT02763046|54767599|FG002|Overall Study|Adverse Event|0|||
28109491|NCT02763046|54767597|FG000|Overall Study|Lack of Efficacy|1|||
28109492|NCT02763046|54767598|FG001|Overall Study|Lack of Efficacy|1|||
28109493|NCT02763046|54767599|FG002|Overall Study|Lack of Efficacy|3|||
28109494|NCT02763046|54767597|FG000|Overall Study|Physician Decision|1|||
28109495|NCT02763046|54767598|FG001|Overall Study|Physician Decision|0|||
28109496|NCT02763046|54767599|FG002|Overall Study|Physician Decision|1|||
28109497|NCT02763046|54767597|FG000|Overall Study|Subject/guardian decision|2|||
28109498|NCT02763046|54767598|FG001|Overall Study|Subject/guardian decision|0|||
28109499|NCT02763046|54767599|FG002|Overall Study|Subject/guardian decision|4|||
28109500|NCT03518073|54767616|FG000|Overall Study|Adverse Event|2|||
28109501|NCT03518073|54767617|FG001|Overall Study|Adverse Event|4|||
28109502|NCT03518073|54767618|FG002|Overall Study|Adverse Event|2|||
28109503|NCT03518073|54767616|FG000|Overall Study|Death|2|||
28109504|NCT03518073|54767617|FG001|Overall Study|Death|1|||
28109505|NCT03518073|54767618|FG002|Overall Study|Death|3|||
28109506|NCT03518073|54767616|FG000|Overall Study|Lost to Follow-up|1|||
28109507|NCT03518073|54767617|FG001|Overall Study|Lost to Follow-up|0|||
28109508|NCT03518073|54767618|FG002|Overall Study|Lost to Follow-up|1|||
28109509|NCT03518073|54767616|FG000|Overall Study|Physician Decision|5|||
28109510|NCT03518073|54767617|FG001|Overall Study|Physician Decision|0|||
28109511|NCT03518073|54767618|FG002|Overall Study|Physician Decision|2|||
28109512|NCT03518073|54767616|FG000|Overall Study|Progressive disease|1|||
28109513|NCT03518073|54767617|FG001|Overall Study|Progressive disease|1|||
28109514|NCT03518073|54767618|FG002|Overall Study|Progressive disease|1|||
28109515|NCT03518073|54767616|FG000|Overall Study|Protocol Violation|1|||
28109516|NCT03518073|54767617|FG001|Overall Study|Protocol Violation|0|||
28109517|NCT03518073|54767618|FG002|Overall Study|Protocol Violation|0|||
28109518|NCT03518073|54767616|FG000|Overall Study|Withdrawal by Subject|30|||
28109519|NCT03518073|54767617|FG001|Overall Study|Withdrawal by Subject|34|||
28109520|NCT03518073|54767618|FG002|Overall Study|Withdrawal by Subject|29|||
28109521|NCT03518073|54767616|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
28109522|NCT03518073|54767617|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|6|||
28109523|NCT03518073|54767618|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|7|||
28109524|NCT03518073|54767616|FG000|Overall Study|Covid-19|1|||
28109525|NCT03518073|54767617|FG001|Overall Study|Covid-19|2|||
28109526|NCT03518073|54767618|FG002|Overall Study|Covid-19|1|||
28109527|NCT02759692|54767628|FG000|Period 1|Test article no longer available|1|||
28109528|NCT02759692|54767629|FG001|Period 1|Test article no longer available|1|||
28109529|NCT02759692|54767628|FG000|Period 1|No longer meets eligibility criteria.|1|||
28064261|NCT00324038|54719860|FG001|Overall Study|Other|13|||
28064262|NCT00159861|54719868|FG000|Core Study - 16 Weeks|Death|3|||
28064263|NCT00159861|54719869|FG001|Core Study - 16 Weeks|Death|0|||
28064264|NCT00159861|54719868|FG000|Core Study - 16 Weeks|Adverse Event|12|||
28064265|NCT00159861|54719869|FG001|Core Study - 16 Weeks|Adverse Event|6|||
28064266|NCT00159861|54719868|FG000|Core Study - 16 Weeks|Lack of Efficacy|2|||
28064267|NCT00159861|54719869|FG001|Core Study - 16 Weeks|Lack of Efficacy|3|||
28064268|NCT00159861|54719868|FG000|Core Study - 16 Weeks|Reason Unspecified|5|||
28064269|NCT00159861|54719869|FG001|Core Study - 16 Weeks|Reason Unspecified|3|||
28064270|NCT00159861|54719868|FG000|Core Study - 16 Weeks|Subject Defaulted|1|||
28064271|NCT00159861|54719869|FG001|Core Study - 16 Weeks|Subject Defaulted|0|||
28064272|NCT00159861|54719868|FG000|Core Study - 16 Weeks|Randomized but not Treated|2|||
28064273|NCT00159861|54719869|FG001|Core Study - 16 Weeks|Randomized but not Treated|0|||
28064274|NCT00159861|54719868|FG000|Extension Study - up to 3 Years|Death|24|||
28064275|NCT00159861|54719869|FG001|Extension Study - up to 3 Years|Death|28|||
28064276|NCT00159861|54719868|FG000|Extension Study - up to 3 Years|Adverse Event|14|||
28109530|NCT02759692|54767629|FG001|Period 1|No longer meets eligibility criteria.|0|||
28109531|NCT02759692|54767628|FG000|Period 1|Miss-Randomized|1|||
28109532|NCT02759692|54767629|FG001|Period 1|Miss-Randomized|1|||
27815698|NCT01904773|54272577|FG004|Screen|Screen failure|0|||
27815699|NCT01904773|54272578|FG005|Screen|Screen failure|0|||
27815700|NCT01904773|54272579|FG006|Screen|Screen failure|0|||
27815701|NCT01904773|54272580|FG007|Screen|Screen failure|0|||
28109533|NCT02759692|54767628|FG000|Period 2|Lost to Follow-up|1|||
28109534|NCT02759692|54767629|FG001|Period 2|Lost to Follow-up|0|||
28109535|NCT02759692|54767628|FG000|Period 2|Test article no longer available|0|||
28109536|NCT02759692|54767629|FG001|Period 2|Test article no longer available|1|||
28109537|NCT03586167|54767637|FG000|Overall Study|Other|1|||
28109538|NCT03586167|54767638|FG001|Overall Study|Other|0|||
28109539|NCT02762578|54767646|FG000|Overall Study|Adverse Event|1|||
28109540|NCT02762578|54767647|FG001|Overall Study|Adverse Event|6|||
27815702|NCT01904773|54272581|FG008|Screen|Screen failure|0|||
27815703|NCT01904773|54272573|FG000|Screen|Withdrawal by Subject|1|||
27815704|NCT01904773|54272574|FG001|Screen|Withdrawal by Subject|0|||
27815705|NCT01904773|54272575|FG002|Screen|Withdrawal by Subject|0|||
27815706|NCT01904773|54272576|FG003|Screen|Withdrawal by Subject|0|||
27815707|NCT01904773|54272577|FG004|Screen|Withdrawal by Subject|0|||
27815708|NCT01904773|54272578|FG005|Screen|Withdrawal by Subject|0|||
27815709|NCT01904773|54272579|FG006|Screen|Withdrawal by Subject|0|||
27815710|NCT01904773|54272580|FG007|Screen|Withdrawal by Subject|0|||
27815711|NCT01904773|54272581|FG008|Screen|Withdrawal by Subject|0|||
27815712|NCT01904773|54272573|FG000|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1|||
27815713|NCT01904773|54272574|FG001|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
27815714|NCT01904773|54272575|FG002|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
27815715|NCT01904773|54272576|FG003|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
27815716|NCT01904773|54272577|FG004|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
27815717|NCT01904773|54272578|FG005|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
27815718|NCT01904773|54272579|FG006|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
27815719|NCT01904773|54272580|FG007|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
27815720|NCT01904773|54272581|FG008|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
27815721|NCT01904773|54272573|FG000|First Intervention|Adverse Event|0|||
27815722|NCT01904773|54272574|FG001|First Intervention|Adverse Event|0|||
28109541|NCT02762578|54767646|FG000|Overall Study|Protocol Violation|4|||
28109542|NCT02762578|54767647|FG001|Overall Study|Protocol Violation|2|||
28109543|NCT02762578|54767646|FG000|Overall Study|Withdrawal by Subject|4|||
28109544|NCT02762578|54767647|FG001|Overall Study|Withdrawal by Subject|2|||
28109545|NCT02762578|54767646|FG000|Overall Study|Unclassified|6|||
28109546|NCT02762578|54767647|FG001|Overall Study|Unclassified|0|||
28109547|NCT03514641|54767657|FG000|603A: 0-12 Week Study Period|Protocol Violation|3|||
28109548|NCT03514641|54767658|FG001|603A: 0-12 Week Study Period|Protocol Violation|3|||
28109549|NCT03514641|54767659|FG002|603A: 0-12 Week Study Period|Protocol Violation|0|||
28109550|NCT03514641|54767660|FG003|603A: 0-12 Week Study Period|Protocol Violation|0|||
28109551|NCT03514641|54767657|FG000|603A: 0-12 Week Study Period|Adverse Event|5|||
28109552|NCT03514641|54767658|FG001|603A: 0-12 Week Study Period|Adverse Event|2|||
28109553|NCT03514641|54767659|FG002|603A: 0-12 Week Study Period|Adverse Event|0|||
27815723|NCT01904773|54272575|FG002|First Intervention|Adverse Event|0|||
27815724|NCT01904773|54272576|FG003|First Intervention|Adverse Event|0|||
27815725|NCT01904773|54272577|FG004|First Intervention|Adverse Event|0|||
27815726|NCT01904773|54272578|FG005|First Intervention|Adverse Event|0|||
27815727|NCT01904773|54272579|FG006|First Intervention|Adverse Event|1|||
27815728|NCT01904773|54272580|FG007|First Intervention|Adverse Event|0|||
27815729|NCT01904773|54272581|FG008|First Intervention|Adverse Event|0|||
27815730|NCT01904773|54272573|FG000|Placebo Washout First Intervention|Condition worsened|0|||
27815731|NCT01904773|54272574|FG001|Placebo Washout First Intervention|Condition worsened|1|||
27815732|NCT01904773|54272575|FG002|Placebo Washout First Intervention|Condition worsened|0|||
27815733|NCT01904773|54272576|FG003|Placebo Washout First Intervention|Condition worsened|0|||
27815734|NCT01904773|54272577|FG004|Placebo Washout First Intervention|Condition worsened|0|||
27815735|NCT01904773|54272578|FG005|Placebo Washout First Intervention|Condition worsened|0|||
27815736|NCT01904773|54272579|FG006|Placebo Washout First Intervention|Condition worsened|0|||
27848620|NCT02635386|54341823|FG004|Overall Study|Other medical problems not drug related|0|||
28109554|NCT03514641|54767660|FG003|603A: 0-12 Week Study Period|Adverse Event|0|||
28109555|NCT03514641|54767657|FG000|603A: 0-12 Week Study Period|Withdrawal by Subject|7|||
28109556|NCT03514641|54767658|FG001|603A: 0-12 Week Study Period|Withdrawal by Subject|5|||
27815737|NCT01904773|54272580|FG007|Placebo Washout First Intervention|Condition worsened|0|||
27815738|NCT01904773|54272581|FG008|Placebo Washout First Intervention|Condition worsened|0|||
27815739|NCT01904773|54272573|FG000|Fifth Intervention|Adverse Event|0|||
27815740|NCT01904773|54272574|FG001|Fifth Intervention|Adverse Event|0|||
27815741|NCT01904773|54272575|FG002|Fifth Intervention|Adverse Event|0|||
28109557|NCT03514641|54767659|FG002|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
28109558|NCT03514641|54767660|FG003|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
28109559|NCT03514641|54767657|FG000|603A: 0-12 Week Study Period|Lost to Follow-up|10|||
28109560|NCT03514641|54767658|FG001|603A: 0-12 Week Study Period|Lost to Follow-up|9|||
28109561|NCT03514641|54767659|FG002|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
28109562|NCT03514641|54767660|FG003|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
28109563|NCT03514641|54767657|FG000|603A: 0-12 Week Study Period|Physician Decision|1|||
28109564|NCT03514641|54767658|FG001|603A: 0-12 Week Study Period|Physician Decision|0|||
28109565|NCT03514641|54767659|FG002|603A: 0-12 Week Study Period|Physician Decision|0|||
28109566|NCT03514641|54767660|FG003|603A: 0-12 Week Study Period|Physician Decision|0|||
28109567|NCT03514641|54767657|FG000|603A: 0-12 Week Study Period|Lack of Efficacy|1|||
28109568|NCT03514641|54767658|FG001|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
28109569|NCT03514641|54767659|FG002|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
28109570|NCT03514641|54767660|FG003|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
28109571|NCT03514641|54767657|FG000|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
28109572|NCT03514641|54767658|FG001|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|1|||
28109573|NCT03514641|54767659|FG002|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
28109574|NCT03514641|54767660|FG003|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
28109575|NCT03514641|54767657|FG000|603B: 24-36 Week Study Period|Protocol Violation|0|||
27815742|NCT01904773|54272576|FG003|Fifth Intervention|Adverse Event|0|||
27815743|NCT01904773|54272577|FG004|Fifth Intervention|Adverse Event|0|||
27815744|NCT01904773|54272578|FG005|Fifth Intervention|Adverse Event|0|||
28109576|NCT03514641|54767658|FG001|603B: 24-36 Week Study Period|Protocol Violation|0|||
28109577|NCT03514641|54767659|FG002|603B: 24-36 Week Study Period|Protocol Violation|0|||
28109578|NCT03514641|54767660|FG003|603B: 24-36 Week Study Period|Protocol Violation|2|||
28109579|NCT03514641|54767657|FG000|603B: 24-36 Week Study Period|Adverse Event|0|||
28109580|NCT03514641|54767658|FG001|603B: 24-36 Week Study Period|Adverse Event|0|||
28109581|NCT03514641|54767659|FG002|603B: 24-36 Week Study Period|Adverse Event|3|||
28109582|NCT03514641|54767660|FG003|603B: 24-36 Week Study Period|Adverse Event|1|||
28109583|NCT03514641|54767657|FG000|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
28109584|NCT03514641|54767658|FG001|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
28109585|NCT03514641|54767659|FG002|603B: 24-36 Week Study Period|Withdrawal by Subject|2|||
28109586|NCT03514641|54767660|FG003|603B: 24-36 Week Study Period|Withdrawal by Subject|3|||
28109587|NCT03514641|54767657|FG000|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
28109588|NCT03514641|54767658|FG001|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
28109589|NCT03514641|54767659|FG002|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
28109590|NCT03514641|54767660|FG003|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
28109591|NCT03514641|54767657|FG000|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
28109592|NCT03514641|54767658|FG001|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
28109593|NCT03514641|54767659|FG002|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
28109594|NCT03514641|54767660|FG003|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
28109595|NCT00100828|54767672|FG000|Overall Study|Physician Decision|6|||
28109596|NCT00100048|54767681|FG000|Cohort I & II-Combination Therapy Phase|Never Treated|2|||
28109597|NCT00100048|54767682|FG001|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
28109598|NCT00100048|54767683|FG002|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
28109599|NCT00100048|54767684|FG003|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
28109600|NCT00100048|54767685|FG004|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
28109601|NCT00100048|54767686|FG005|Cohort I & II-Combination Therapy Phase|Never Treated|1|||
28109602|NCT00100048|54767681|FG000|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
28109603|NCT00100048|54767682|FG001|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
28109604|NCT00100048|54767683|FG002|Cohort I & II-Combination Therapy Phase|Adverse Event|2|||
28109605|NCT00100048|54767684|FG003|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
28064277|NCT00159861|54719869|FG001|Extension Study - up to 3 Years|Adverse Event|14|||
28064278|NCT00159861|54719868|FG000|Extension Study - up to 3 Years|Lack of Efficacy|5|||
28064279|NCT00159861|54719869|FG001|Extension Study - up to 3 Years|Lack of Efficacy|1|||
28064280|NCT00159861|54719868|FG000|Extension Study - up to 3 Years|Reason Unspecified|12|||
28064281|NCT00159861|54719869|FG001|Extension Study - up to 3 Years|Reason Unspecified|19|||
28064282|NCT00159861|54719868|FG000|Extension Study - up to 3 Years|Withdrawal by Subject|7|||
28064283|NCT00159861|54719869|FG001|Extension Study - up to 3 Years|Withdrawal by Subject|9|||
28064284|NCT00331760|54719882|FG000|Overall Study|Ineligible / no protocol treatment|15|||
28077056|NCT00403559|54731769|FG000|Overall Study|Lost to Follow-up|3|||
28109606|NCT00100048|54767685|FG004|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
28109607|NCT00100048|54767686|FG005|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
28109608|NCT00100048|54767681|FG000|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1|||
28109609|NCT00100048|54767682|FG001|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3|||
28109610|NCT00100048|54767683|FG002|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
28109611|NCT00100048|54767684|FG003|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
28109612|NCT00100048|54767685|FG004|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
28109613|NCT00100048|54767686|FG005|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2|||
28109614|NCT00100048|54767681|FG000|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
28109615|NCT00100048|54767682|FG001|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1|||
28109616|NCT00100048|54767683|FG002|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
28109617|NCT00100048|54767684|FG003|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
28109618|NCT00100048|54767685|FG004|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0|||
28109619|NCT00100048|54767686|FG005|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
28109620|NCT00100048|54767681|FG000|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1|||
28109621|NCT00100048|54767682|FG001|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
28109622|NCT00100048|54767683|FG002|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
28109623|NCT00100048|54767684|FG003|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5|||
28109624|NCT00100048|54767685|FG004|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0|||
28109625|NCT00100048|54767686|FG005|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4|||
28109626|NCT00100048|54767681|FG000|Cohort I & II-Combination Therapy Phase|Other Reason|7|||
28109627|NCT00100048|54767682|FG001|Cohort I & II-Combination Therapy Phase|Other Reason|1|||
28109628|NCT00100048|54767683|FG002|Cohort I & II-Combination Therapy Phase|Other Reason|4|||
28109629|NCT00100048|54767684|FG003|Cohort I & II-Combination Therapy Phase|Other Reason|2|||
28109630|NCT00100048|54767685|FG004|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
28109631|NCT00100048|54767686|FG005|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
28109632|NCT00100048|54767681|FG000|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
28109633|NCT00100048|54767682|FG001|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
28109634|NCT00100048|54767683|FG002|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
28109635|NCT00100048|54767684|FG003|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
28109636|NCT00100048|54767685|FG004|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
28109637|NCT00100048|54767686|FG005|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
28109638|NCT00100048|54767681|FG000|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
28109639|NCT00100048|54767682|FG001|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
28109640|NCT00100048|54767683|FG002|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
28109641|NCT00100048|54767684|FG003|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1|||
28109642|NCT00100048|54767685|FG004|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
28109643|NCT00100048|54767686|FG005|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
28109644|NCT02757430|54767711|FG000|Overall Study|Physician Decision|6|||
28109645|NCT02757430|54767711|FG000|Overall Study|Inclusion/Exclusion criteria not met|3|||
28109646|NCT02757430|54767711|FG000|Overall Study|No informed consent|1|||
28109647|NCT02757430|54767711|FG000|Overall Study|No procedure performed|2|||
28109648|NCT02757352|54767727|FG000|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2|||
28109649|NCT02757352|54767728|FG001|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
28109650|NCT02757352|54767729|FG002|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1|||
28109651|NCT02757352|54767730|FG003|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
28109652|NCT02757352|54767731|FG004|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
28109653|NCT02757352|54767732|FG005|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
28109654|NCT02757352|54767733|FG006|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
28109655|NCT02757352|54767734|FG007|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
28109656|NCT02757352|54767735|FG008|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
28109657|NCT02757352|54767736|FG009|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
28109658|NCT02757352|54767727|FG000|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
28109659|NCT02757352|54767728|FG001|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
28109660|NCT02757352|54767729|FG002|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1|||
28109661|NCT02757352|54767730|FG003|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
28109662|NCT02757352|54767731|FG004|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
28109663|NCT02757352|54767732|FG005|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
28109664|NCT02757352|54767733|FG006|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
28109665|NCT02757352|54767734|FG007|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
28109666|NCT02757352|54767735|FG008|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
28109667|NCT02757352|54767736|FG009|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
27815745|NCT01904773|54272579|FG006|Fifth Intervention|Adverse Event|0|||
28109668|NCT02757352|54767727|FG000|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6|||
28109669|NCT02757352|54767728|FG001|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1|||
28109670|NCT02757352|54767729|FG002|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2|||
28109671|NCT02757352|54767730|FG003|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
28109672|NCT02757352|54767731|FG004|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
28109673|NCT02757352|54767732|FG005|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
28109674|NCT02757352|54767733|FG006|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
28109675|NCT02757352|54767734|FG007|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
28109676|NCT02757352|54767735|FG008|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
28109677|NCT02757352|54767736|FG009|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
28109678|NCT02757352|54767727|FG000|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
28109679|NCT02757352|54767728|FG001|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1|||
28109680|NCT02757352|54767729|FG002|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
28109681|NCT02757352|54767730|FG003|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
28109682|NCT02757352|54767731|FG004|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
28109683|NCT02757352|54767732|FG005|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
28109684|NCT02757352|54767733|FG006|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
28109685|NCT02757352|54767734|FG007|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
28109686|NCT02757352|54767735|FG008|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
28109687|NCT02757352|54767736|FG009|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
28109688|NCT02757352|54767727|FG000|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
28109689|NCT02757352|54767728|FG001|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1|||
28109690|NCT02757352|54767729|FG002|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
28109691|NCT02757352|54767730|FG003|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
28109692|NCT02757352|54767731|FG004|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
28109693|NCT02757352|54767732|FG005|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
28109694|NCT02757352|54767733|FG006|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
28109695|NCT02757352|54767734|FG007|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
28109696|NCT02757352|54767735|FG008|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
28109697|NCT02757352|54767736|FG009|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
28109698|NCT02757352|54767727|FG000|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
28109699|NCT02757352|54767728|FG001|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
28109700|NCT02757352|54767729|FG002|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4|||
28109701|NCT02757352|54767730|FG003|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
28109702|NCT02757352|54767731|FG004|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
28109703|NCT02757352|54767732|FG005|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
28109704|NCT02757352|54767733|FG006|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
28109705|NCT02757352|54767734|FG007|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
28109706|NCT02757352|54767735|FG008|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
28109707|NCT02757352|54767736|FG009|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
28109708|NCT02757352|54767727|FG000|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62|||
28109709|NCT02757352|54767728|FG001|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40|||
28109710|NCT02757352|54767729|FG002|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42|||
28109711|NCT02757352|54767730|FG003|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
28109712|NCT02757352|54767731|FG004|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
28109713|NCT02757352|54767732|FG005|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
28109714|NCT02757352|54767733|FG006|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
28109715|NCT02757352|54767734|FG007|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
28109716|NCT02757352|54767735|FG008|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
28109717|NCT02757352|54767736|FG009|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
28109718|NCT02757352|54767727|FG000|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
28109719|NCT02757352|54767728|FG001|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
28109720|NCT02757352|54767729|FG002|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
28109721|NCT02757352|54767730|FG003|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3|||
28109722|NCT02757352|54767731|FG004|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
28109723|NCT02757352|54767732|FG005|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1|||
28109724|NCT02757352|54767733|FG006|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
28109725|NCT02757352|54767734|FG007|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
28109726|NCT02757352|54767735|FG008|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
28109727|NCT02757352|54767736|FG009|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
28109728|NCT02757352|54767727|FG000|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
28109729|NCT02757352|54767728|FG001|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
28109730|NCT02757352|54767729|FG002|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
28109731|NCT02757352|54767730|FG003|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2|||
28109732|NCT02757352|54767731|FG004|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
28109733|NCT02757352|54767732|FG005|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4|||
28109734|NCT02757352|54767733|FG006|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
28109735|NCT02757352|54767734|FG007|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
28109736|NCT02757352|54767735|FG008|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
28109737|NCT02757352|54767736|FG009|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
28109738|NCT02757352|54767727|FG000|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
28109739|NCT02757352|54767728|FG001|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
28109740|NCT02757352|54767729|FG002|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
28109741|NCT02757352|54767730|FG003|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
28109742|NCT02757352|54767731|FG004|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1|||
28109743|NCT02757352|54767732|FG005|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
28109744|NCT02757352|54767733|FG006|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
27815746|NCT01904773|54272580|FG007|Fifth Intervention|Adverse Event|1|||
27815747|NCT01904773|54272581|FG008|Fifth Intervention|Adverse Event|0|||
27815748|NCT01904773|54272573|FG000|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
27940198|NCT01194258|54596473|FG000|Titration Period|Withdrawal by Subject|6|||
27940199|NCT01194258|54596474|FG001|Titration Period|Withdrawal by Subject|0|||
27815749|NCT01904773|54272574|FG001|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1|||
27815750|NCT01904773|54272575|FG002|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
28064285|NCT00331760|54719883|FG001|Overall Study|Ineligible / no protocol treatment|8|||
28064286|NCT00225147|54719894|FG000|Open-label Phase|Lost to Follow-up|0|||
28064287|NCT00225147|54719895|FG001|Open-label Phase|Lost to Follow-up|0|||
28064288|NCT00225147|54719896|FG002|Open-label Phase|Lost to Follow-up|0|||
28064289|NCT00225147|54719897|FG003|Open-label Phase|Lost to Follow-up|4|||
28064290|NCT00225147|54719894|FG000|Open-label Phase|Withdrawal by Subject|0|||
28064291|NCT00225147|54719895|FG001|Open-label Phase|Withdrawal by Subject|0|||
28064292|NCT00225147|54719896|FG002|Open-label Phase|Withdrawal by Subject|0|||
28064293|NCT00225147|54719897|FG003|Open-label Phase|Withdrawal by Subject|6|||
28109745|NCT02757352|54767734|FG007|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
28109746|NCT02757352|54767735|FG008|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
28109747|NCT02757352|54767736|FG009|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
27815751|NCT01904773|54272576|FG003|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
27815752|NCT01904773|54272577|FG004|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
28077057|NCT00403559|54731770|FG001|Overall Study|Lost to Follow-up|3|||
28077058|NCT00403559|54731769|FG000|Overall Study|Withdrawal by Subject|1|||
28077059|NCT00403559|54731770|FG001|Overall Study|Withdrawal by Subject|0|||
28077060|NCT00403481|54731778|FG000|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1|||
28077061|NCT00403481|54731778|FG000|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1|||
28077062|NCT00403481|54731778|FG000|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3|||
28077063|NCT00403481|54731778|FG000|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1|||
28077064|NCT00403481|54731778|FG000|Olm 40 mg|Adverse Event|2|||
28077065|NCT00403481|54731778|FG000|Olm 40 mg|Protocol Violation|1|||
28077066|NCT00403481|54731778|FG000|Olm 40 mg|Withdrawal by Subject|1|||
28077067|NCT00403481|54731778|FG000|Olm 40 mg|Other|1|||
28077068|NCT00403481|54731778|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2|||
28109748|NCT02757352|54767727|FG000|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
28109749|NCT02757352|54767728|FG001|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
28109750|NCT02757352|54767729|FG002|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
28109751|NCT02757352|54767730|FG003|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
28109752|NCT02757352|54767731|FG004|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
28109753|NCT02757352|54767732|FG005|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1|||
28109754|NCT02757352|54767733|FG006|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
28109755|NCT02757352|54767734|FG007|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
28109756|NCT02757352|54767735|FG008|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
28109757|NCT02757352|54767736|FG009|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
28109758|NCT02757352|54767727|FG000|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
28109759|NCT02757352|54767728|FG001|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
28109760|NCT02757352|54767729|FG002|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
28109761|NCT02757352|54767730|FG003|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2|||
28109762|NCT02757352|54767731|FG004|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
28109763|NCT02757352|54767732|FG005|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
28109764|NCT02757352|54767733|FG006|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
28109765|NCT02757352|54767734|FG007|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
28109766|NCT02757352|54767735|FG008|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
28109767|NCT02757352|54767736|FG009|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
28109768|NCT02757352|54767727|FG000|Follow-Up Period|Adverse Event|0|||
28109769|NCT02757352|54767728|FG001|Follow-Up Period|Adverse Event|0|||
28109770|NCT02757352|54767729|FG002|Follow-Up Period|Adverse Event|0|||
28109771|NCT02757352|54767730|FG003|Follow-Up Period|Adverse Event|0|||
28109772|NCT02757352|54767731|FG004|Follow-Up Period|Adverse Event|0|||
28109773|NCT02757352|54767732|FG005|Follow-Up Period|Adverse Event|0|||
28109774|NCT02757352|54767733|FG006|Follow-Up Period|Adverse Event|1|||
28109775|NCT02757352|54767734|FG007|Follow-Up Period|Adverse Event|0|||
28109776|NCT02757352|54767735|FG008|Follow-Up Period|Adverse Event|2|||
28109777|NCT02757352|54767736|FG009|Follow-Up Period|Adverse Event|0|||
28109778|NCT02757352|54767727|FG000|Follow-Up Period|Lost to Follow-up|0|||
28109779|NCT02757352|54767728|FG001|Follow-Up Period|Lost to Follow-up|0|||
28109780|NCT02757352|54767729|FG002|Follow-Up Period|Lost to Follow-up|0|||
28109781|NCT02757352|54767730|FG003|Follow-Up Period|Lost to Follow-up|0|||
28109782|NCT02757352|54767731|FG004|Follow-Up Period|Lost to Follow-up|0|||
28109783|NCT02757352|54767732|FG005|Follow-Up Period|Lost to Follow-up|0|||
28109784|NCT02757352|54767733|FG006|Follow-Up Period|Lost to Follow-up|0|||
28109785|NCT02757352|54767734|FG007|Follow-Up Period|Lost to Follow-up|0|||
28109786|NCT02757352|54767735|FG008|Follow-Up Period|Lost to Follow-up|1|||
28109787|NCT02757352|54767736|FG009|Follow-Up Period|Lost to Follow-up|0|||
28109788|NCT02757352|54767727|FG000|Follow-Up Period|Lack of Efficacy|0|||
28109789|NCT02757352|54767728|FG001|Follow-Up Period|Lack of Efficacy|0|||
28109790|NCT02757352|54767729|FG002|Follow-Up Period|Lack of Efficacy|0|||
28109791|NCT02757352|54767730|FG003|Follow-Up Period|Lack of Efficacy|0|||
28109792|NCT02757352|54767731|FG004|Follow-Up Period|Lack of Efficacy|0|||
28109793|NCT02757352|54767732|FG005|Follow-Up Period|Lack of Efficacy|0|||
28109794|NCT02757352|54767733|FG006|Follow-Up Period|Lack of Efficacy|0|||
27848621|NCT02634606|54341930|FG000|Overall Study|unable to obtain the drug at start|13|||
27848622|NCT01672866|54341976|FG000|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40|||
27848623|NCT01672866|54341977|FG001|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42|||
28109795|NCT02757352|54767734|FG007|Follow-Up Period|Lack of Efficacy|0|||
28109796|NCT02757352|54767735|FG008|Follow-Up Period|Lack of Efficacy|1|||
28109797|NCT02757352|54767736|FG009|Follow-Up Period|Lack of Efficacy|1|||
28109798|NCT02757352|54767727|FG000|Follow-Up Period|Withdrawal by Subject|0|||
28109799|NCT02757352|54767728|FG001|Follow-Up Period|Withdrawal by Subject|0|||
28109800|NCT02757352|54767729|FG002|Follow-Up Period|Withdrawal by Subject|0|||
28109801|NCT02757352|54767730|FG003|Follow-Up Period|Withdrawal by Subject|0|||
28109802|NCT02757352|54767731|FG004|Follow-Up Period|Withdrawal by Subject|0|||
28109803|NCT02757352|54767732|FG005|Follow-Up Period|Withdrawal by Subject|0|||
28109804|NCT02757352|54767733|FG006|Follow-Up Period|Withdrawal by Subject|0|||
28109805|NCT02757352|54767734|FG007|Follow-Up Period|Withdrawal by Subject|1|||
28109806|NCT02757352|54767735|FG008|Follow-Up Period|Withdrawal by Subject|6|||
28109807|NCT02757352|54767736|FG009|Follow-Up Period|Withdrawal by Subject|2|||
28109808|NCT04588480|54767769|FG000|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
28109809|NCT04588480|54767770|FG001|Unblinded Phase: From 6 to 12 Months|Protocol Violation|1|||
28109810|NCT04588480|54767771|FG002|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
28109811|NCT04588480|54767769|FG000|Unblinded Phase: From 6 to 12 Months|Other|2|||
28109812|NCT04588480|54767770|FG001|Unblinded Phase: From 6 to 12 Months|Other|2|||
28109813|NCT04588480|54767771|FG002|Unblinded Phase: From 6 to 12 Months|Other|0|||
28109814|NCT02756650|54767778|FG000|Overall Study|Physician Decision|1|||
28109815|NCT02756650|54767778|FG000|Overall Study|Adverse Event|1|||
28109816|NCT00110357|54767784|FG000|Overall Study|Deterioration without progression|2|||
28109817|NCT00110357|54767785|FG001|Overall Study|Deterioration without progression|0|||
28109818|NCT00110357|54767784|FG000|Overall Study|Disease progression/relapse|20|||
28109819|NCT00110357|54767785|FG001|Overall Study|Disease progression/relapse|15|||
28109820|NCT00110357|54767784|FG000|Overall Study|Study Closure|1|||
28109821|NCT00110357|54767785|FG001|Overall Study|Study Closure|0|||
28109822|NCT00110357|54767784|FG000|Overall Study|Study Drug Toxicity|1|||
28109823|NCT00110357|54767785|FG001|Overall Study|Study Drug Toxicity|3|||
28109824|NCT00110357|54767784|FG000|Overall Study|Withdrawal by Subject|3|||
28109825|NCT00110357|54767785|FG001|Overall Study|Withdrawal by Subject|1|||
28109826|NCT02752906|54767820|FG000|Overall Study|Protocol Violation|2|||
28109827|NCT02752906|54767821|FG001|Overall Study|Protocol Violation|1|||
28109828|NCT02752906|54767820|FG000|Overall Study|Withdrawal by Subject|2|||
28109829|NCT02752906|54767821|FG001|Overall Study|Withdrawal by Subject|2|||
28109830|NCT02752906|54767820|FG000|Overall Study|Lost to Follow-up|3|||
28109831|NCT02752906|54767821|FG001|Overall Study|Lost to Follow-up|2|||
28109832|NCT02756338|54767827|FG000|Overall Study|Withdrawn by Investigator|1|||
28109833|NCT02756338|54767827|FG000|Overall Study|Device Replaced with Pacemaker|4|||
28109834|NCT00293033|54767831|FG000|Open-label Titration Period|Adverse Event|10|||
28109835|NCT00293033|54767831|FG000|Open-label Titration Period|Death|3|||
28109836|NCT00293033|54767831|FG000|Open-label Titration Period|Lack of Efficacy|5|||
28109837|NCT00293033|54767831|FG000|Open-label Titration Period|Protocol Violation|2|||
27848624|NCT01672866|54341978|FG002|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35|||
27848625|NCT01672866|54341976|FG000|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9|||
27848626|NCT01672866|54341977|FG001|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8|||
28109838|NCT00293033|54767831|FG000|Open-label Titration Period|Withdrawal by Subject|22|||
28109839|NCT00293033|54767831|FG000|Open-label Titration Period|Noncompliance and other|27|||
28109840|NCT00293033|54767831|FG000|Double-blind Treatment Period|Adverse Event|3|||
28109841|NCT00293033|54767831|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
28109842|NCT00293033|54767831|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
28109843|NCT00293033|54767831|FG000|Double-blind Treatment Period|Noncompliance|4|||
28109844|NCT02756182|54767839|FG000|Overall Study|StudyTechnical Difficulties|4|||
28109845|NCT03823703|54767848|FG000|Overall Study|Sponsor request|0|||
28109846|NCT03823703|54767849|FG001|Overall Study|Sponsor request|3|||
28109847|NCT03823703|54767850|FG002|Overall Study|Sponsor request|4|||
28109848|NCT03823703|54767848|FG000|Overall Study|Adverse Event|3|||
28109849|NCT03823703|54767849|FG001|Overall Study|Adverse Event|1|||
28109850|NCT03823703|54767850|FG002|Overall Study|Adverse Event|0|||
28109851|NCT03823703|54767848|FG000|Overall Study|Withdrawal by Subject|0|||
28109852|NCT03823703|54767849|FG001|Overall Study|Withdrawal by Subject|1|||
28109853|NCT03823703|54767850|FG002|Overall Study|Withdrawal by Subject|0|||
28109854|NCT00109577|54767860|FG000|Overall Study|Withdrawal by Subject|3|||
28109855|NCT00109577|54767861|FG001|Overall Study|Withdrawal by Subject|3|||
28109856|NCT02755090|54767869|FG000|Overall Study|equipment malfunction|1|||
28109857|NCT02755090|54767870|FG001|Overall Study|equipment malfunction|0|||
28109858|NCT00109343|54767879|FG000|Overall Study|Adverse Event|1|||
27848627|NCT01672866|54341978|FG002|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12|||
28064294|NCT00313014|54719912|FG000|Overall Study|Withdrawal by Subject|11|||
28064295|NCT00313014|54719913|FG001|Overall Study|Withdrawal by Subject|7|||
28064296|NCT00313014|54719914|FG002|Overall Study|Withdrawal by Subject|5|||
28064297|NCT00313014|54719912|FG000|Overall Study|Adverse Event|14|||
28064298|NCT00313014|54719913|FG001|Overall Study|Adverse Event|29|||
28064299|NCT00313014|54719914|FG002|Overall Study|Adverse Event|16|||
28064300|NCT00313014|54719912|FG000|Overall Study|Lost to Follow-up|7|||
28064301|NCT00313014|54719913|FG001|Overall Study|Lost to Follow-up|6|||
28109859|NCT00109343|54767880|FG001|Overall Study|Adverse Event|0|||
28109860|NCT00109343|54767881|FG002|Overall Study|Adverse Event|2|||
28109861|NCT00109343|54767879|FG000|Overall Study|Lack of Efficacy|1|||
28109862|NCT00109343|54767880|FG001|Overall Study|Lack of Efficacy|0|||
28109863|NCT00109343|54767881|FG002|Overall Study|Lack of Efficacy|0|||
28109864|NCT00109343|54767879|FG000|Overall Study|Lost to Follow-up|35|||
28109865|NCT00109343|54767880|FG001|Overall Study|Lost to Follow-up|20|||
28109866|NCT00109343|54767881|FG002|Overall Study|Lost to Follow-up|14|||
28109867|NCT00109343|54767879|FG000|Overall Study|Protocol Violation|1|||
28109868|NCT00109343|54767880|FG001|Overall Study|Protocol Violation|2|||
28109869|NCT00109343|54767881|FG002|Overall Study|Protocol Violation|2|||
28109870|NCT00109343|54767879|FG000|Overall Study|Withdrawal by Subject|15|||
28109871|NCT00109343|54767880|FG001|Overall Study|Withdrawal by Subject|11|||
28109872|NCT00109343|54767881|FG002|Overall Study|Withdrawal by Subject|10|||
28109873|NCT00109343|54767879|FG000|Overall Study|Subject Moved|6|||
28109874|NCT00109343|54767880|FG001|Overall Study|Subject Moved|2|||
28109875|NCT00109343|54767881|FG002|Overall Study|Subject Moved|1|||
28109876|NCT00109343|54767879|FG000|Overall Study|Other|5|||
28109877|NCT00109343|54767880|FG001|Overall Study|Other|2|||
28109878|NCT00109343|54767881|FG002|Overall Study|Other|1|||
28109879|NCT00108485|54767891|FG000|Overall Study|Withdrawal by Subject|3|||
28109880|NCT00108485|54767892|FG001|Overall Study|Withdrawal by Subject|0|||
28109881|NCT00108485|54767891|FG000|Overall Study|Lost to Follow-up|0|||
28109882|NCT00108485|54767892|FG001|Overall Study|Lost to Follow-up|2|||
28109883|NCT00107783|54767900|FG000|Overall Study|Adverse Event|0|||
28109884|NCT00107783|54767901|FG001|Overall Study|Adverse Event|2|||
28109885|NCT00107783|54767900|FG000|Overall Study|Death|0|||
28109886|NCT00107783|54767901|FG001|Overall Study|Death|1|||
28109887|NCT00107783|54767900|FG000|Overall Study|Withdrawal by Subject|2|||
28109888|NCT00107783|54767901|FG001|Overall Study|Withdrawal by Subject|0|||
28109889|NCT00107783|54767900|FG000|Overall Study|Second hip replacement|1|||
28109890|NCT00107783|54767901|FG001|Overall Study|Second hip replacement|1|||
28109891|NCT00095303|54767909|FG000|Main Study|Lost to Follow-up|91|||
28109892|NCT00095303|54767910|FG001|Main Study|Lost to Follow-up|87|||
28109893|NCT00095303|54767909|FG000|Follow Up Study|Lost to Follow-up|59|||
28109894|NCT00095303|54767910|FG001|Follow Up Study|Lost to Follow-up|58|||
28109895|NCT00105521|54767920|FG000|Overall Study|Other|1|||
28109896|NCT00105521|54767921|FG001|Overall Study|Other|1|||
28109897|NCT00105521|54767922|FG002|Overall Study|Other|2|||
28109898|NCT00105521|54767923|FG003|Overall Study|Other|0|||
28109899|NCT00105521|54767920|FG000|Overall Study|Adverse Event|10|||
28109900|NCT00105521|54767921|FG001|Overall Study|Adverse Event|4|||
28109901|NCT00105521|54767922|FG002|Overall Study|Adverse Event|10|||
28109902|NCT00105521|54767923|FG003|Overall Study|Adverse Event|8|||
28109903|NCT00105521|54767920|FG000|Overall Study|Withdrawal by Subject|1|||
28109904|NCT00105521|54767921|FG001|Overall Study|Withdrawal by Subject|0|||
28109905|NCT00105521|54767922|FG002|Overall Study|Withdrawal by Subject|1|||
28109906|NCT00105521|54767923|FG003|Overall Study|Withdrawal by Subject|4|||
28109907|NCT00105521|54767920|FG000|Overall Study|Lack of Efficacy|0|||
28109908|NCT00105521|54767921|FG001|Overall Study|Lack of Efficacy|0|||
28109909|NCT00105521|54767922|FG002|Overall Study|Lack of Efficacy|0|||
28109910|NCT00105521|54767923|FG003|Overall Study|Lack of Efficacy|1|||
28109911|NCT00105521|54767920|FG000|Overall Study|Protocol Violation|3|||
28109912|NCT00105521|54767921|FG001|Overall Study|Protocol Violation|5|||
28109913|NCT00105521|54767922|FG002|Overall Study|Protocol Violation|4|||
28109914|NCT00105521|54767923|FG003|Overall Study|Protocol Violation|4|||
27848628|NCT01672866|54341976|FG000|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
28109915|NCT00105521|54767920|FG000|Overall Study|Lost to Follow-up|0|||
28109916|NCT00105521|54767921|FG001|Overall Study|Lost to Follow-up|1|||
28109917|NCT00105521|54767922|FG002|Overall Study|Lost to Follow-up|0|||
28109918|NCT00105521|54767923|FG003|Overall Study|Lost to Follow-up|0|||
28109919|NCT00291551|54767933|FG000|Overall Study|Death|7|||
28109920|NCT00291551|54767933|FG000|Overall Study|Withdrawal by Subject|6|||
28109921|NCT02752048|54767962|FG000|Overall Study|Withdrawal by Subject|0|||
28109922|NCT02752048|54767963|FG001|Overall Study|Withdrawal by Subject|0|||
28109923|NCT02752048|54767964|FG002|Overall Study|Withdrawal by Subject|3|||
28109924|NCT00095147|54767979|FG000|Double-blind Period 1 (Days 1-197)|Death|1|||
28109925|NCT00095147|54767980|FG001|Double-blind Period 1 (Days 1-197)|Death|0|||
28109926|NCT00095147|54767981|FG002|Double-blind Period 1 (Days 1-197)|Death|0|||
28109927|NCT00095147|54767982|FG003|Double-blind Period 1 (Days 1-197)|Death|0|||
28109928|NCT00095147|54767983|FG004|Double-blind Period 1 (Days 1-197)|Death|0|||
28109929|NCT00095147|54767979|FG000|Double-blind Period 1 (Days 1-197)|Adverse Event|2|||
28109930|NCT00095147|54767980|FG001|Double-blind Period 1 (Days 1-197)|Adverse Event|8|||
28109931|NCT00095147|54767981|FG002|Double-blind Period 1 (Days 1-197)|Adverse Event|1|||
27848629|NCT01672866|54341977|FG001|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
28109932|NCT00095147|54767982|FG003|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
28109933|NCT00095147|54767983|FG004|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
28109934|NCT00095147|54767979|FG000|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
28109935|NCT00095147|54767980|FG001|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
28109936|NCT00095147|54767981|FG002|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1|||
28109937|NCT00095147|54767982|FG003|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
28109938|NCT00095147|54767983|FG004|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
28109939|NCT00095147|54767979|FG000|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
28109940|NCT00095147|54767980|FG001|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
28109941|NCT00095147|54767981|FG002|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
28109942|NCT00095147|54767982|FG003|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
28109943|NCT00095147|54767983|FG004|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
28109944|NCT00095147|54767979|FG000|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
28109945|NCT00095147|54767980|FG001|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
28109946|NCT00095147|54767981|FG002|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
28109947|NCT00095147|54767982|FG003|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
28109948|NCT00095147|54767983|FG004|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
28109949|NCT00095147|54767979|FG000|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
28109950|NCT00095147|54767980|FG001|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
28109951|NCT00095147|54767981|FG002|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
28109952|NCT00095147|54767982|FG003|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
28109953|NCT00095147|54767983|FG004|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
28109954|NCT00095147|54767979|FG000|Double-blind Period 2 (Days 198-365)|Death|0|||
28109955|NCT00095147|54767980|FG001|Double-blind Period 2 (Days 198-365)|Death|1|||
28109956|NCT00095147|54767981|FG002|Double-blind Period 2 (Days 198-365)|Death|0|||
28109957|NCT00095147|54767982|FG003|Double-blind Period 2 (Days 198-365)|Death|1|||
28109958|NCT00095147|54767983|FG004|Double-blind Period 2 (Days 198-365)|Death|0|||
28109959|NCT00095147|54767979|FG000|Double-blind Period 2 (Days 198-365)|Adverse Event|2|||
28109960|NCT00095147|54767980|FG001|Double-blind Period 2 (Days 198-365)|Adverse Event|4|||
28109961|NCT00095147|54767981|FG002|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
28109962|NCT00095147|54767982|FG003|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
28109963|NCT00095147|54767983|FG004|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
28109964|NCT00095147|54767979|FG000|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2|||
28109965|NCT00095147|54767980|FG001|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4|||
28109966|NCT00095147|54767981|FG002|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
28109967|NCT00095147|54767982|FG003|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1|||
28109968|NCT00095147|54767983|FG004|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
28109969|NCT00095147|54767979|FG000|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3|||
28109970|NCT00095147|54767980|FG001|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2|||
28109971|NCT00095147|54767981|FG002|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
28109972|NCT00095147|54767982|FG003|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
28109973|NCT00095147|54767983|FG004|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
28109974|NCT00095147|54767979|FG000|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
28109975|NCT00095147|54767980|FG001|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
28109976|NCT00095147|54767981|FG002|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
28109977|NCT00095147|54767982|FG003|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
28109978|NCT00095147|54767983|FG004|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
28109979|NCT00095147|54767979|FG000|Long-term Extension Period|Death|0|||
28109980|NCT00095147|54767980|FG001|Long-term Extension Period|Death|0|||
28109981|NCT00095147|54767981|FG002|Long-term Extension Period|Death|0|||
28109982|NCT00095147|54767982|FG003|Long-term Extension Period|Death|0|||
28109983|NCT00095147|54767983|FG004|Long-term Extension Period|Death|3|||
28109984|NCT00095147|54767979|FG000|Long-term Extension Period|Adverse Event|0|||
28109985|NCT00095147|54767980|FG001|Long-term Extension Period|Adverse Event|0|||
28109986|NCT00095147|54767981|FG002|Long-term Extension Period|Adverse Event|0|||
28109987|NCT00095147|54767982|FG003|Long-term Extension Period|Adverse Event|0|||
28109988|NCT00095147|54767983|FG004|Long-term Extension Period|Adverse Event|11|||
28109989|NCT00095147|54767979|FG000|Long-term Extension Period|Lack of Efficacy|0|||
28109990|NCT00095147|54767980|FG001|Long-term Extension Period|Lack of Efficacy|0|||
28109991|NCT00095147|54767981|FG002|Long-term Extension Period|Lack of Efficacy|0|||
28109992|NCT00095147|54767982|FG003|Long-term Extension Period|Lack of Efficacy|0|||
28109993|NCT00095147|54767983|FG004|Long-term Extension Period|Lack of Efficacy|9|||
28109994|NCT00095147|54767979|FG000|Long-term Extension Period|Lost to Follow-up|0|||
28109995|NCT00095147|54767980|FG001|Long-term Extension Period|Lost to Follow-up|0|||
28109996|NCT00095147|54767981|FG002|Long-term Extension Period|Lost to Follow-up|0|||
28109997|NCT00095147|54767982|FG003|Long-term Extension Period|Lost to Follow-up|0|||
28109998|NCT00095147|54767983|FG004|Long-term Extension Period|Lost to Follow-up|6|||
28109999|NCT00095147|54767979|FG000|Long-term Extension Period|Withdrawal of consent|0|||
28110000|NCT00095147|54767980|FG001|Long-term Extension Period|Withdrawal of consent|0|||
28110001|NCT00095147|54767981|FG002|Long-term Extension Period|Withdrawal of consent|0|||
28110002|NCT00095147|54767982|FG003|Long-term Extension Period|Withdrawal of consent|0|||
28110003|NCT00095147|54767983|FG004|Long-term Extension Period|Withdrawal of consent|12|||
27848630|NCT01672866|54341978|FG002|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5|||
27848631|NCT01672866|54341976|FG000|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
27848632|NCT01672866|54341977|FG001|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
27848633|NCT01672866|54341978|FG002|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
27848634|NCT01672866|54341976|FG000|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
27848635|NCT01672866|54341977|FG001|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
27848636|NCT01672866|54341978|FG002|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2|||
27848637|NCT01672866|54341976|FG000|Blinded Phase (up to 240 Weeks)|Protocol Violation|2|||
27848638|NCT01672866|54341977|FG001|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
27848639|NCT01672866|54341978|FG002|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
27848640|NCT01672866|54341976|FG000|Blinded Phase (up to 240 Weeks)|Death|0|||
27848641|NCT01672866|54341977|FG001|Blinded Phase (up to 240 Weeks)|Death|0|||
27848642|NCT01672866|54341978|FG002|Blinded Phase (up to 240 Weeks)|Death|1|||
27848643|NCT01672866|54341976|FG000|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3|||
27848644|NCT01672866|54341977|FG001|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
27848645|NCT01672866|54341978|FG002|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
27848646|NCT01672866|54341976|FG000|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11|||
27848647|NCT01672866|54341977|FG001|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15|||
27848648|NCT01672866|54341978|FG002|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16|||
28064302|NCT00313014|54719914|FG002|Overall Study|Lost to Follow-up|10|||
28064303|NCT00313014|54719912|FG000|Overall Study|Administrative|9|||
28064304|NCT00313014|54719913|FG001|Overall Study|Administrative|6|||
28064305|NCT00313014|54719914|FG002|Overall Study|Administrative|14|||
28064306|NCT00313014|54719912|FG000|Overall Study|Lack of Efficacy|52|||
28064307|NCT00313014|54719913|FG001|Overall Study|Lack of Efficacy|25|||
28064308|NCT00313014|54719914|FG002|Overall Study|Lack of Efficacy|16|||
28064309|NCT00157209|54719925|FG000|Overall Study|Ongoing at data cut-off|10|||
28064310|NCT00157209|54719926|FG001|Overall Study|Ongoing at data cut-off|0|||
28064311|NCT00312858|54719934|FG000|Overall Study|Adverse Event|0|||
28064312|NCT00312858|54719935|FG001|Overall Study|Adverse Event|1|||
28064313|NCT00312858|54719934|FG000|Overall Study|Lost to Follow-up|25|||
28064314|NCT00312858|54719935|FG001|Overall Study|Lost to Follow-up|42|||
28064315|NCT00312858|54719934|FG000|Overall Study|Protocol Violation|3|||
28064316|NCT00312858|54719935|FG001|Overall Study|Protocol Violation|8|||
28064317|NCT00312858|54719934|FG000|Overall Study|Withdraw by Participant|20|||
28064318|NCT00312858|54719935|FG001|Overall Study|Withdraw by Participant|20|||
28064319|NCT00312858|54719934|FG000|Overall Study|Participant Moved|11|||
28064320|NCT00312858|54719935|FG001|Overall Study|Participant Moved|10|||
28064321|NCT00312858|54719934|FG000|Overall Study|Other|9|||
28064322|NCT00312858|54719935|FG001|Overall Study|Other|12|||
28064323|NCT00312702|54719944|FG000|Immunization Phase|Lost to Follow-up|0|||
28064324|NCT00312702|54719945|FG001|Immunization Phase|Lost to Follow-up|1|||
28064325|NCT00312702|54719946|FG002|Immunization Phase|Lost to Follow-up|0|||
28064326|NCT00156819|54719957|FG000|Overall Study|Lost to Follow-up|1|||
28064327|NCT00156819|54719958|FG001|Overall Study|Lost to Follow-up|1|||
28064328|NCT00156819|54719959|FG002|Overall Study|Lost to Follow-up|3|||
28064329|NCT03825042|54719969|FG000|Overall Study|Adverse Event|1|||
28064330|NCT03825042|54719970|FG001|Overall Study|Adverse Event|0|||
28064331|NCT03825042|54719969|FG000|Overall Study|Withdrawal by Subject|1|||
28064332|NCT03825042|54719970|FG001|Overall Study|Withdrawal by Subject|0|||
28064333|NCT00129987|54719978|FG000|1st Educational Session|Withdrawal by Subject|141|||
28064334|NCT00129987|54719979|FG001|1st Educational Session|Withdrawal by Subject|109|||
28064335|NCT00129987|54719978|FG000|1 Year|Withdrawal by Subject|32|||
28064336|NCT00129987|54719979|FG001|1 Year|Withdrawal by Subject|21|||
28064337|NCT00224133|54719985|FG000|Overall Study|Adverse Event|93|||
28064338|NCT00224133|54719985|FG000|Overall Study|Protocol Violation|6|||
28064339|NCT00224133|54719985|FG000|Overall Study|Withdrawal by Subject|33|||
28064340|NCT00224133|54719985|FG000|Overall Study|Lack of Efficacy|58|||
28064341|NCT00224133|54719985|FG000|Overall Study|Lost to Follow-up|21|||
28064342|NCT00224133|54719985|FG000|Overall Study|Physician Decision|1|||
28064343|NCT00224133|54719985|FG000|Overall Study|Other|14|||
28064344|NCT00224055|54719991|FG000|Overall Study|Adverse Event|9|||
28064345|NCT00224055|54719992|FG001|Overall Study|Adverse Event|3|||
28064346|NCT00224055|54719991|FG000|Overall Study|Lost to Follow-up|1|||
28064347|NCT00224055|54719992|FG001|Overall Study|Lost to Follow-up|2|||
28064348|NCT00224055|54719991|FG000|Overall Study|Protocol Violation|1|||
28064349|NCT00224055|54719992|FG001|Overall Study|Protocol Violation|1|||
28064350|NCT00224055|54719991|FG000|Overall Study|Inclusion Violation|3|||
28064351|NCT00224055|54719992|FG001|Overall Study|Inclusion Violation|6|||
28064352|NCT00224055|54719991|FG000|Overall Study|Withdrawal by Subject|0|||
28064353|NCT00224055|54719992|FG001|Overall Study|Withdrawal by Subject|2|||
28064354|NCT00224055|54719991|FG000|Overall Study|Other|1|||
28064355|NCT00224055|54719992|FG001|Overall Study|Other|0|||
28064356|NCT00150969|54720000|FG000|24 Month Main Study|Adverse Event|3|||
28064357|NCT00150969|54720001|FG001|24 Month Main Study|Adverse Event|4|||
28064358|NCT00150969|54720000|FG000|24 Month Main Study|Death|1|||
27848649|NCT01672866|54341976|FG000|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8|||
27848650|NCT01672866|54341977|FG001|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
27848651|NCT01672866|54341978|FG002|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
27848652|NCT01672866|54341976|FG000|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
27848653|NCT01672866|54341977|FG001|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0|||
27848654|NCT01672866|54341978|FG002|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
27848655|NCT01672866|54341976|FG000|Open-Label Phase (up to 240 Weeks)|Death|1|||
27848656|NCT01672866|54341977|FG001|Open-Label Phase (up to 240 Weeks)|Death|0|||
27848657|NCT01672866|54341978|FG002|Open-Label Phase (up to 240 Weeks)|Death|0|||
27848658|NCT01672866|54341976|FG000|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1|||
27848659|NCT01672866|54341977|FG001|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
27848660|NCT01672866|54341978|FG002|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
27848661|NCT04465877|54342204|FG000|Overall Study|Noncompliant with study requirements|0|||
27848662|NCT04465877|54342205|FG001|Overall Study|Noncompliant with study requirements|0|||
27848663|NCT04465877|54342206|FG002|Overall Study|Noncompliant with study requirements|1|||
27848664|NCT04465877|54342207|FG003|Overall Study|Noncompliant with study requirements|0|||
27848665|NCT04267133|54342264|FG000|Overall Study|Withdrawal by Subject|1|||
27848666|NCT04267133|54342264|FG000|Overall Study|Adverse Event|4|||
27848667|NCT02631876|54342395|FG000|Overall Study|Death|96|||
27848668|NCT02631876|54342396|FG001|Overall Study|Death|50|||
27848669|NCT02631876|54342395|FG000|Overall Study|Investigator's discretion|1|||
27848670|NCT02631876|54342396|FG001|Overall Study|Investigator's discretion|0|||
28064359|NCT00150969|54720001|FG001|24 Month Main Study|Death|1|||
28064360|NCT00150969|54720000|FG000|24 Month Main Study|Lack of Efficacy|1|||
28064361|NCT00150969|54720001|FG001|24 Month Main Study|Lack of Efficacy|8|||
28064362|NCT00150969|54720000|FG000|24 Month Main Study|Lost to Follow-up|3|||
28064363|NCT00150969|54720001|FG001|24 Month Main Study|Lost to Follow-up|2|||
28064364|NCT00150969|54720000|FG000|24 Month Main Study|Protocol Violation|4|||
28064365|NCT00150969|54720001|FG001|24 Month Main Study|Protocol Violation|2|||
28064366|NCT00150969|54720000|FG000|24 Month Main Study|Withdrawal by Subject|7|||
28064367|NCT00150969|54720001|FG001|24 Month Main Study|Withdrawal by Subject|4|||
28064368|NCT00150969|54720000|FG000|24-48 Month Extension|Withdrawal by Subject|6|||
28064369|NCT00150969|54720001|FG001|24-48 Month Extension|Withdrawal by Subject|5|||
28064370|NCT00150969|54720000|FG000|24-48 Month Extension|Lack of Efficacy|0|||
28064371|NCT00150969|54720001|FG001|24-48 Month Extension|Lack of Efficacy|1|||
28064372|NCT00150969|54720000|FG000|24-48 Month Extension|Adverse Event|1|||
28064373|NCT00150969|54720001|FG001|24-48 Month Extension|Adverse Event|3|||
28064374|NCT00150969|54720000|FG000|24-48 Month Extension|Other Reason|81|||
28064375|NCT00150969|54720001|FG001|24-48 Month Extension|Other Reason|91|||
28064376|NCT00150345|54720010|FG000|Overall Study|Death|5|||
28064377|NCT00150345|54720011|FG001|Overall Study|Death|2|||
28064378|NCT00150345|54720010|FG000|Overall Study|Adverse Event|8|||
28064379|NCT00150345|54720011|FG001|Overall Study|Adverse Event|6|||
28064380|NCT00150345|54720010|FG000|Overall Study|Lack of Efficacy|5|||
28064381|NCT00150345|54720011|FG001|Overall Study|Lack of Efficacy|4|||
28064382|NCT00150345|54720010|FG000|Overall Study|Withdrawal by Subject|3|||
28064383|NCT00150345|54720011|FG001|Overall Study|Withdrawal by Subject|4|||
28064384|NCT00150345|54720010|FG000|Overall Study|Laboratory abnormality|1|||
28064385|NCT00150345|54720011|FG001|Overall Study|Laboratory abnormality|2|||
28064386|NCT00150345|54720010|FG000|Overall Study|Other|12|||
28064387|NCT00150345|54720011|FG001|Overall Study|Other|14|||
28064388|NCT00223977|54720021|FG000|Overall Study|Adverse Event|7|||
28064389|NCT00223977|54720022|FG001|Overall Study|Adverse Event|10|||
28064390|NCT00223977|54720023|FG002|Overall Study|Adverse Event|0|||
28064391|NCT00223977|54720021|FG000|Overall Study|Protocol Violation|0|||
28064392|NCT00223977|54720022|FG001|Overall Study|Protocol Violation|0|||
28064393|NCT00223977|54720023|FG002|Overall Study|Protocol Violation|1|||
28064394|NCT00223977|54720021|FG000|Overall Study|Withdrawal by Subject|1|||
28064395|NCT00223977|54720022|FG001|Overall Study|Withdrawal by Subject|1|||
28064396|NCT00223977|54720023|FG002|Overall Study|Withdrawal by Subject|2|||
28064397|NCT00223977|54720021|FG000|Overall Study|Other|1|||
28064398|NCT00223977|54720022|FG001|Overall Study|Other|0|||
28064399|NCT00223977|54720023|FG002|Overall Study|Other|0|||
28064400|NCT00148941|54720035|FG000|Overall Study|Lost to Follow-up|17|||
28064401|NCT00148941|54720036|FG001|Overall Study|Lost to Follow-up|24|||
28064402|NCT00148941|54720037|FG002|Overall Study|Lost to Follow-up|18|||
27848671|NCT02631876|54342395|FG000|Overall Study|Lost to Follow-up|2|||
27848672|NCT02631876|54342396|FG001|Overall Study|Lost to Follow-up|0|||
28064403|NCT00148941|54720038|FG003|Overall Study|Lost to Follow-up|22|||
28064404|NCT00148941|54720035|FG000|Overall Study|Withdrawal by Subject|1|||
28064405|NCT00148941|54720036|FG001|Overall Study|Withdrawal by Subject|0|||
28064406|NCT00148941|54720037|FG002|Overall Study|Withdrawal by Subject|1|||
28110004|NCT00095147|54767979|FG000|Long-term Extension Period|Pregnancy|0|||
28110005|NCT00095147|54767980|FG001|Long-term Extension Period|Pregnancy|0|||
28110006|NCT00095147|54767981|FG002|Long-term Extension Period|Pregnancy|0|||
28110007|NCT00095147|54767982|FG003|Long-term Extension Period|Pregnancy|0|||
28110008|NCT00095147|54767983|FG004|Long-term Extension Period|Pregnancy|1|||
28110009|NCT00095147|54767979|FG000|Long-term Extension Period|No longer meets study criteria|0|||
28110010|NCT00095147|54767980|FG001|Long-term Extension Period|No longer meets study criteria|0|||
28110011|NCT00095147|54767981|FG002|Long-term Extension Period|No longer meets study criteria|0|||
28110012|NCT00095147|54767982|FG003|Long-term Extension Period|No longer meets study criteria|0|||
28110013|NCT00095147|54767983|FG004|Long-term Extension Period|No longer meets study criteria|1|||
28110014|NCT00095147|54767979|FG000|Long-term Extension Period|Participant chose to use Revellex|0|||
28110015|NCT00095147|54767980|FG001|Long-term Extension Period|Participant chose to use Revellex|0|||
28110016|NCT00095147|54767981|FG002|Long-term Extension Period|Participant chose to use Revellex|0|||
28110017|NCT00095147|54767982|FG003|Long-term Extension Period|Participant chose to use Revellex|0|||
28110018|NCT00095147|54767983|FG004|Long-term Extension Period|Participant chose to use Revellex|1|||
28110019|NCT00095147|54767979|FG000|Long-term Extension Period|Leaving country|0|||
28110020|NCT00095147|54767980|FG001|Long-term Extension Period|Leaving country|0|||
28110021|NCT00095147|54767981|FG002|Long-term Extension Period|Leaving country|0|||
28110022|NCT00095147|54767982|FG003|Long-term Extension Period|Leaving country|0|||
28110023|NCT00095147|54767983|FG004|Long-term Extension Period|Leaving country|1|||
28110024|NCT02751580|54768001|FG000|Overall Study|Lost to Follow-up|4|||
28110025|NCT02751580|54768001|FG000|Overall Study|Death|2|||
28110026|NCT02751502|54768005|FG000|Overall Study|Lack of funding|4|||
28110027|NCT02257918|54768012|FG000|Overall Study|Lost to Follow-up|4|||
28110028|NCT02257918|54768013|FG001|Overall Study|Lost to Follow-up|1|||
28110029|NCT02257918|54768014|FG002|Overall Study|Lost to Follow-up|0|||
28110030|NCT02257918|54768012|FG000|Overall Study|Withdrawal by Subject|0|||
28110031|NCT02257918|54768013|FG001|Overall Study|Withdrawal by Subject|0|||
28110032|NCT02257918|54768014|FG002|Overall Study|Withdrawal by Subject|1|||
28110033|NCT02257918|54768012|FG000|Overall Study|Pregnancy|0|||
28110034|NCT02257918|54768013|FG001|Overall Study|Pregnancy|0|||
27815753|NCT01904773|54272578|FG005|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
27815754|NCT01904773|54272579|FG006|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
27848673|NCT02631876|54342395|FG000|Overall Study|Withdrawal by Subject|16|||
27848674|NCT02631876|54342396|FG001|Overall Study|Withdrawal by Subject|9|||
27815755|NCT01904773|54272580|FG007|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
27815756|NCT01904773|54272581|FG008|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
27815757|NCT01928719|54272595|FG000|Overall Study|Lost to Follow-up|26|||
27815758|NCT01928719|54272596|FG001|Overall Study|Lost to Follow-up|11|||
27815759|NCT01928719|54272595|FG000|Overall Study|Withdrawal by Subject|22|||
27815760|NCT01928719|54272596|FG001|Overall Study|Withdrawal by Subject|7|||
27815761|NCT01928719|54272595|FG000|Overall Study|Protocol Violation|3|||
27815762|NCT01928719|54272596|FG001|Overall Study|Protocol Violation|1|||
27815763|NCT01928719|54272595|FG000|Overall Study|Adverse Event|1|||
27815764|NCT01928719|54272596|FG001|Overall Study|Adverse Event|0|||
27815765|NCT00986674|54272607|FG000|Overall Study|Lack of Efficacy|28|||
27815766|NCT00986674|54272608|FG001|Overall Study|Lack of Efficacy|25|||
27848675|NCT02631876|54342395|FG000|Overall Study|Other than specified|4|||
27848676|NCT02631876|54342396|FG001|Overall Study|Other than specified|4|||
27848677|NCT02633046|54342425|FG000|Overall Study|Adverse Event|8|||
28110035|NCT02257918|54768014|FG002|Overall Study|Pregnancy|1|||
28110036|NCT02751424|54768031|FG000|Part 2|Adverse Event|0|||
28110037|NCT02751424|54768032|FG001|Part 2|Adverse Event|0|||
28110038|NCT02751424|54768033|FG002|Part 2|Adverse Event|0|||
28110039|NCT02751424|54768034|FG003|Part 2|Adverse Event|0|||
28110040|NCT02751424|54768035|FG004|Part 2|Adverse Event|0|||
28110041|NCT02751424|54768036|FG005|Part 2|Adverse Event|0|||
28110042|NCT02751424|54768037|FG006|Part 2|Adverse Event|0|||
28110043|NCT02751424|54768038|FG007|Part 2|Adverse Event|5|||
28110044|NCT02751424|54768039|FG008|Part 2|Adverse Event|0|||
28110045|NCT00094835|54768069|FG000|Overall Study|Physician Decision|1|||
28110046|NCT00094835|54768070|FG001|Overall Study|Physician Decision|0|||
28110047|NCT00094835|54768071|FG002|Overall Study|Physician Decision|0|||
28110048|NCT00094835|54768072|FG003|Overall Study|Physician Decision|0|||
28110049|NCT00094835|54768073|FG004|Overall Study|Physician Decision|0|||
28110050|NCT00094835|54768074|FG005|Overall Study|Physician Decision|1|||
28110051|NCT00094835|54768075|FG006|Overall Study|Physician Decision|0|||
28110052|NCT00094835|54768069|FG000|Overall Study|Withdrawal by Subject|0|||
28110053|NCT00094835|54768070|FG001|Overall Study|Withdrawal by Subject|0|||
28110054|NCT00094835|54768071|FG002|Overall Study|Withdrawal by Subject|0|||
28110055|NCT00094835|54768072|FG003|Overall Study|Withdrawal by Subject|0|||
28110056|NCT00094835|54768073|FG004|Overall Study|Withdrawal by Subject|0|||
28110057|NCT00094835|54768074|FG005|Overall Study|Withdrawal by Subject|0|||
28110058|NCT00094835|54768075|FG006|Overall Study|Withdrawal by Subject|1|||
28110059|NCT00094835|54768069|FG000|Overall Study|Lost to Follow-up|0|||
28110060|NCT00094835|54768070|FG001|Overall Study|Lost to Follow-up|0|||
28110061|NCT00094835|54768071|FG002|Overall Study|Lost to Follow-up|0|||
28110062|NCT00094835|54768072|FG003|Overall Study|Lost to Follow-up|0|||
28110063|NCT00094835|54768073|FG004|Overall Study|Lost to Follow-up|1|||
28110064|NCT00094835|54768074|FG005|Overall Study|Lost to Follow-up|0|||
28110065|NCT00094835|54768075|FG006|Overall Study|Lost to Follow-up|0|||
28110066|NCT00094835|54768069|FG000|Overall Study|Death|1|||
28110067|NCT00094835|54768070|FG001|Overall Study|Death|0|||
28110068|NCT00094835|54768071|FG002|Overall Study|Death|0|||
28110069|NCT00094835|54768072|FG003|Overall Study|Death|0|||
28110070|NCT00094835|54768073|FG004|Overall Study|Death|1|||
28110071|NCT00094835|54768074|FG005|Overall Study|Death|0|||
28110072|NCT00094835|54768075|FG006|Overall Study|Death|0|||
28110073|NCT00094835|54768069|FG000|Overall Study|Non-compliance|1|||
28110074|NCT00094835|54768070|FG001|Overall Study|Non-compliance|2|||
28110075|NCT00094835|54768071|FG002|Overall Study|Non-compliance|2|||
28110076|NCT00094835|54768072|FG003|Overall Study|Non-compliance|0|||
28110077|NCT00094835|54768073|FG004|Overall Study|Non-compliance|2|||
28110078|NCT00094835|54768074|FG005|Overall Study|Non-compliance|2|||
28110079|NCT00094835|54768075|FG006|Overall Study|Non-compliance|1|||
28110080|NCT00094835|54768069|FG000|Overall Study|Other|1|||
28110081|NCT00094835|54768070|FG001|Overall Study|Other|1|||
28110082|NCT00094835|54768071|FG002|Overall Study|Other|1|||
28110083|NCT00094835|54768072|FG003|Overall Study|Other|1|||
28110084|NCT00094835|54768073|FG004|Overall Study|Other|0|||
28110085|NCT00094835|54768074|FG005|Overall Study|Other|0|||
28110086|NCT00094835|54768075|FG006|Overall Study|Other|0|||
28110087|NCT00094757|54768099|FG000|Overall Study|Adverse Event|11|||
28110088|NCT00094757|54768100|FG001|Overall Study|Adverse Event|9|||
28110089|NCT00094757|54768101|FG002|Overall Study|Adverse Event|6|||
28110090|NCT00094757|54768099|FG000|Overall Study|Lack of Efficacy|11|||
28110091|NCT00094757|54768100|FG001|Overall Study|Lack of Efficacy|15|||
28110092|NCT00094757|54768101|FG002|Overall Study|Lack of Efficacy|8|||
28110093|NCT00094757|54768099|FG000|Overall Study|Lost to Follow-up|3|||
28110094|NCT00094757|54768100|FG001|Overall Study|Lost to Follow-up|5|||
28110095|NCT00094757|54768101|FG002|Overall Study|Lost to Follow-up|6|||
28110096|NCT00094757|54768099|FG000|Overall Study|Patient Moved|2|||
28110097|NCT00094757|54768100|FG001|Overall Study|Patient Moved|1|||
28110098|NCT00094757|54768101|FG002|Overall Study|Patient Moved|1|||
28110099|NCT00094757|54768099|FG000|Overall Study|Protocol Violation|8|||
28110100|NCT00094757|54768100|FG001|Overall Study|Protocol Violation|5|||
28110101|NCT00094757|54768101|FG002|Overall Study|Protocol Violation|3|||
28110102|NCT00094757|54768099|FG000|Overall Study|Withdrawal by Subject|14|||
28110103|NCT00094757|54768100|FG001|Overall Study|Withdrawal by Subject|21|||
28110104|NCT00094757|54768101|FG002|Overall Study|Withdrawal by Subject|5|||
28110105|NCT00094757|54768099|FG000|Overall Study|Other|3|||
28110106|NCT00094757|54768100|FG001|Overall Study|Other|3|||
28110107|NCT00094757|54768101|FG002|Overall Study|Other|1|||
28110108|NCT00094757|54768099|FG000|Overall Study|Protocol specified discontinuation|1|||
28110109|NCT00094757|54768100|FG001|Overall Study|Protocol specified discontinuation|3|||
28110110|NCT00094757|54768101|FG002|Overall Study|Protocol specified discontinuation|0|||
28110111|NCT00082433|54768111|FG000|Overall Study|Adverse Event|12|||
28110112|NCT00082433|54768112|FG001|Overall Study|Adverse Event|17|||
28110113|NCT00082433|54768111|FG000|Overall Study|Death|8|||
28110114|NCT00082433|54768112|FG001|Overall Study|Death|18|||
28110115|NCT00082433|54768111|FG000|Overall Study|Disease Progression/Relapse|270|||
28110116|NCT00082433|54768112|FG001|Overall Study|Disease Progression/Relapse|388|||
28110117|NCT00082433|54768111|FG000|Overall Study|Physician Decision|50|||
28110118|NCT00082433|54768112|FG001|Overall Study|Physician Decision|61|||
28110119|NCT00082433|54768111|FG000|Overall Study|Lost to Follow-up|1|||
28110120|NCT00082433|54768112|FG001|Overall Study|Lost to Follow-up|2|||
28110121|NCT00082433|54768111|FG000|Overall Study|Study Drug Toxicity|179|||
28110122|NCT00082433|54768112|FG001|Overall Study|Study Drug Toxicity|66|||
28110123|NCT00082433|54768111|FG000|Overall Study|Withdrawal by Subject|55|||
28110124|NCT00082433|54768112|FG001|Overall Study|Withdrawal by Subject|30|||
28110125|NCT00082433|54768111|FG000|Overall Study|Still On Treatment|2|||
28110126|NCT00082433|54768112|FG001|Overall Study|Still On Treatment|1|||
28110127|NCT00082433|54768111|FG000|Overall Study|Not Treated|12|||
28110128|NCT00082433|54768112|FG001|Overall Study|Not Treated|11|||
28110129|NCT00082433|54768111|FG000|Overall Study|Ineligible|2|||
28110130|NCT00082433|54768112|FG001|Overall Study|Ineligible|1|||
28110131|NCT00082433|54768111|FG000|Overall Study|Noncompliance|2|||
28110132|NCT00082433|54768112|FG001|Overall Study|Noncompliance|1|||
28110133|NCT00082433|54768111|FG000|Overall Study|New primary cancer|1|||
28110134|NCT00082433|54768112|FG001|Overall Study|New primary cancer|0|||
28110135|NCT00082433|54768111|FG000|Overall Study|Impending surgery|0|||
28110136|NCT00082433|54768112|FG001|Overall Study|Impending surgery|1|||
28110137|NCT00094445|54768118|FG000|Overall Study|Withdrawal by Subject|3|||
28110138|NCT00094445|54768118|FG000|Overall Study|Lost to Follow-up|1|||
28110139|NCT00094445|54768118|FG000|Overall Study|Progressive Disease|2|||
28110140|NCT00082355|54768122|FG000|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1|||
28110141|NCT00082355|54768122|FG000|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1|||
28110142|NCT00082355|54768122|FG000|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28|||
28110143|NCT00094055|54768126|FG000|Overall Study|Adverse Event|11|||
28110144|NCT00094055|54768126|FG000|Overall Study|Death|4|||
28110145|NCT00094055|54768126|FG000|Overall Study|Lack of Efficacy|17|||
28110146|NCT00094055|54768126|FG000|Overall Study|Lost to Follow-up|2|||
28110147|NCT00094055|54768126|FG000|Overall Study|progressive disease|2|||
28110148|NCT00094055|54768126|FG000|Overall Study|clinical progression|1|||
28110149|NCT00094055|54768126|FG000|Overall Study|roll-over to another study|14|||
28110150|NCT00094055|54768126|FG000|Overall Study|Withdrawal by Subject|9|||
28110151|NCT00099983|54768132|FG000|Overall Study|Lost to Follow-up|2|||
28110152|NCT00099983|54768133|FG001|Overall Study|Lost to Follow-up|3|||
28110153|NCT00099983|54768132|FG000|Overall Study|Missing Source Documents|14|||
28110154|NCT00099983|54768133|FG001|Overall Study|Missing Source Documents|15|||
27815767|NCT00986674|54272609|FG002|Overall Study|Lack of Efficacy|23|||
28110155|NCT00099983|54768132|FG000|Overall Study|Withdrawal by Subject|3|||
28110156|NCT00099983|54768133|FG001|Overall Study|Withdrawal by Subject|2|||
28110157|NCT00099983|54768132|FG000|Overall Study|Adverse Event|1|||
28110158|NCT00099983|54768133|FG001|Overall Study|Adverse Event|1|||
28110159|NCT00099983|54768132|FG000|Overall Study|Lack of Efficacy|0|||
28110160|NCT00099983|54768133|FG001|Overall Study|Lack of Efficacy|1|||
28110161|NCT00099983|54768132|FG000|Overall Study|Unable to return for appointments|1|||
28110162|NCT00099983|54768133|FG001|Overall Study|Unable to return for appointments|1|||
28110163|NCT00099983|54768132|FG000|Overall Study|Moved|1|||
28110164|NCT00099983|54768133|FG001|Overall Study|Moved|0|||
28110165|NCT00099983|54768132|FG000|Overall Study|Other psychiatric problem|1|||
28110166|NCT00099983|54768133|FG001|Overall Study|Other psychiatric problem|0|||
28110167|NCT00099983|54768132|FG000|Overall Study|Incarcerated|0|||
28110168|NCT00099983|54768133|FG001|Overall Study|Incarcerated|1|||
28110169|NCT00099983|54768132|FG000|Overall Study|Intolerant of burden of visits|0|||
28110170|NCT00099983|54768133|FG001|Overall Study|Intolerant of burden of visits|1|||
28110171|NCT00099983|54768132|FG000|Overall Study|Other issue|1|||
28110172|NCT00099983|54768133|FG001|Overall Study|Other issue|0|||
28110173|NCT00099359|54768142|FG000|Overall Study|Death|11|||
28110174|NCT00099359|54768143|FG001|Overall Study|Death|15|||
28110175|NCT00099359|54768144|FG002|Overall Study|Death|17|||
28110176|NCT00099359|54768142|FG000|Overall Study|Withdrawal by Subject|19|||
28110177|NCT00099359|54768143|FG001|Overall Study|Withdrawal by Subject|19|||
27815768|NCT00986674|54272607|FG000|Overall Study|Adverse Event|4|||
27815769|NCT00986674|54272608|FG001|Overall Study|Adverse Event|8|||
27815770|NCT00986674|54272609|FG002|Overall Study|Adverse Event|9|||
27815771|NCT00986674|54272607|FG000|Overall Study|Death|5|||
27815772|NCT00986674|54272608|FG001|Overall Study|Death|0|||
27815773|NCT00986674|54272609|FG002|Overall Study|Death|4|||
27815774|NCT00986674|54272607|FG000|Overall Study|Withdrawal by Subject|6|||
27815775|NCT00986674|54272608|FG001|Overall Study|Withdrawal by Subject|2|||
27815776|NCT00986674|54272609|FG002|Overall Study|Withdrawal by Subject|1|||
27815777|NCT00986674|54272607|FG000|Overall Study|alternative therapy|0|||
27815778|NCT00986674|54272608|FG001|Overall Study|alternative therapy|0|||
27815779|NCT00986674|54272609|FG002|Overall Study|alternative therapy|1|||
27815780|NCT00986674|54272607|FG000|Overall Study|not start protocol therapy|4|||
27815781|NCT00986674|54272608|FG001|Overall Study|not start protocol therapy|3|||
27815782|NCT00986674|54272609|FG002|Overall Study|not start protocol therapy|1|||
27815783|NCT00986674|54272607|FG000|Overall Study|unknown/not specify|0|||
28110178|NCT00099359|54768144|FG002|Overall Study|Withdrawal by Subject|23|||
28110179|NCT00099359|54768142|FG000|Overall Study|Lost to Follow-up|15|||
28110180|NCT00099359|54768143|FG001|Overall Study|Lost to Follow-up|24|||
28110181|NCT00099359|54768144|FG002|Overall Study|Lost to Follow-up|24|||
28110182|NCT00099359|54768142|FG000|Overall Study|moved out of area|9|||
28110183|NCT00099359|54768143|FG001|Overall Study|moved out of area|7|||
28110184|NCT00099359|54768144|FG002|Overall Study|moved out of area|4|||
28110185|NCT00092495|54768166|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
28110186|NCT00092495|54768167|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
28110187|NCT00092495|54768168|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
28110188|NCT00092495|54768169|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|4|||
28110189|NCT00092495|54768170|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
28110190|NCT00092495|54768166|FG000|Base Study Vaccination Period|Extended|0|||
28110191|NCT00092495|54768167|FG001|Base Study Vaccination Period|Extended|0|||
28110192|NCT00092495|54768168|FG002|Base Study Vaccination Period|Extended|0|||
28110193|NCT00092495|54768169|FG003|Base Study Vaccination Period|Extended|1|||
28110194|NCT00092495|54768170|FG004|Base Study Vaccination Period|Extended|0|||
28110195|NCT00092495|54768166|FG000|Base Study Vaccination Period|*Clinical AE|1|||
28110196|NCT00092495|54768167|FG001|Base Study Vaccination Period|*Clinical AE|0|||
28110197|NCT00092495|54768168|FG002|Base Study Vaccination Period|*Clinical AE|1|||
28110198|NCT00092495|54768169|FG003|Base Study Vaccination Period|*Clinical AE|2|||
28110199|NCT00092495|54768170|FG004|Base Study Vaccination Period|*Clinical AE|0|||
28110200|NCT00092495|54768166|FG000|Base Study Vaccination Period|*Other reasons|1|||
28110201|NCT00092495|54768167|FG001|Base Study Vaccination Period|*Other reasons|0|||
28110202|NCT00092495|54768168|FG002|Base Study Vaccination Period|*Other reasons|0|||
28110203|NCT00092495|54768169|FG003|Base Study Vaccination Period|*Other reasons|1|||
28110204|NCT00092495|54768170|FG004|Base Study Vaccination Period|*Other reasons|0|||
28110205|NCT00092495|54768166|FG000|Base Study Vaccination Period|*Pregnancy|0|||
28110206|NCT00092495|54768167|FG001|Base Study Vaccination Period|*Pregnancy|2|||
28110207|NCT00092495|54768168|FG002|Base Study Vaccination Period|*Pregnancy|5|||
28110208|NCT00092495|54768169|FG003|Base Study Vaccination Period|*Pregnancy|7|||
28110209|NCT00092495|54768170|FG004|Base Study Vaccination Period|*Pregnancy|0|||
28110210|NCT00092495|54768166|FG000|Base Study Vaccination Period|Adverse Event|1|||
28110211|NCT00092495|54768167|FG001|Base Study Vaccination Period|Adverse Event|0|||
28110212|NCT00092495|54768168|FG002|Base Study Vaccination Period|Adverse Event|0|||
28110213|NCT00092495|54768169|FG003|Base Study Vaccination Period|Adverse Event|3|||
28110214|NCT00092495|54768170|FG004|Base Study Vaccination Period|Adverse Event|0|||
28110215|NCT00092495|54768166|FG000|Base Study Vaccination Period|Lost to Follow-up|16|||
28110216|NCT00092495|54768167|FG001|Base Study Vaccination Period|Lost to Follow-up|6|||
28110217|NCT00092495|54768168|FG002|Base Study Vaccination Period|Lost to Follow-up|11|||
28110218|NCT00092495|54768169|FG003|Base Study Vaccination Period|Lost to Follow-up|36|||
28110219|NCT00092495|54768170|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
28110220|NCT00092495|54768166|FG000|Base Study Vaccination Period|Moved|3|||
28110221|NCT00092495|54768167|FG001|Base Study Vaccination Period|Moved|1|||
28110222|NCT00092495|54768168|FG002|Base Study Vaccination Period|Moved|2|||
28110223|NCT00092495|54768169|FG003|Base Study Vaccination Period|Moved|2|||
28110224|NCT00092495|54768170|FG004|Base Study Vaccination Period|Moved|0|||
28110225|NCT00092495|54768166|FG000|Base Study Vaccination Period|Other|1|||
28110226|NCT00092495|54768167|FG001|Base Study Vaccination Period|Other|1|||
27815784|NCT00986674|54272608|FG001|Overall Study|unknown/not specify|7|||
27815785|NCT00986674|54272609|FG002|Overall Study|unknown/not specify|9|||
28110227|NCT00092495|54768168|FG002|Base Study Vaccination Period|Other|0|||
28110228|NCT00092495|54768169|FG003|Base Study Vaccination Period|Other|2|||
28110229|NCT00092495|54768170|FG004|Base Study Vaccination Period|Other|0|||
28110230|NCT00092495|54768166|FG000|Base Study Vaccination Period|Pregnancy|2|||
28110231|NCT00092495|54768167|FG001|Base Study Vaccination Period|Pregnancy|0|||
28110232|NCT00092495|54768168|FG002|Base Study Vaccination Period|Pregnancy|0|||
28110233|NCT00092495|54768169|FG003|Base Study Vaccination Period|Pregnancy|0|||
28110234|NCT00092495|54768170|FG004|Base Study Vaccination Period|Pregnancy|0|||
28110235|NCT00092495|54768166|FG000|Base Study Vaccination Period|Parent Withdrew Consent|1|||
28110236|NCT00092495|54768167|FG001|Base Study Vaccination Period|Parent Withdrew Consent|1|||
28110237|NCT00092495|54768168|FG002|Base Study Vaccination Period|Parent Withdrew Consent|1|||
27815786|NCT00986440|54272619|FG000|Overall Study|Progressive disease|27|||
27815787|NCT00986440|54272620|FG001|Overall Study|Progressive disease|37|||
28110238|NCT00092495|54768169|FG003|Base Study Vaccination Period|Parent Withdrew Consent|5|||
28110239|NCT00092495|54768170|FG004|Base Study Vaccination Period|Parent Withdrew Consent|0|||
28110240|NCT00092495|54768166|FG000|Base Study Vaccination Period|Protocol Violation|1|||
28110241|NCT00092495|54768167|FG001|Base Study Vaccination Period|Protocol Violation|0|||
28110242|NCT00092495|54768168|FG002|Base Study Vaccination Period|Protocol Violation|0|||
28110243|NCT00092495|54768169|FG003|Base Study Vaccination Period|Protocol Violation|0|||
28110244|NCT00092495|54768170|FG004|Base Study Vaccination Period|Protocol Violation|0|||
28110245|NCT00092495|54768166|FG000|Base Study Vaccination Period|Withdrawal by Subject|9|||
28110246|NCT00092495|54768167|FG001|Base Study Vaccination Period|Withdrawal by Subject|10|||
28110247|NCT00092495|54768168|FG002|Base Study Vaccination Period|Withdrawal by Subject|14|||
28110248|NCT00092495|54768169|FG003|Base Study Vaccination Period|Withdrawal by Subject|25|||
28110249|NCT00092495|54768170|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
28110250|NCT00092495|54768166|FG000|Base Study Follow-up Period|Extended|0|||
28110251|NCT00092495|54768167|FG001|Base Study Follow-up Period|Extended|0|||
28110252|NCT00092495|54768168|FG002|Base Study Follow-up Period|Extended|1|||
28110253|NCT00092495|54768169|FG003|Base Study Follow-up Period|Extended|2|||
28110254|NCT00092495|54768170|FG004|Base Study Follow-up Period|Extended|0|||
28110255|NCT00092495|54768166|FG000|Base Study Follow-up Period|Lost to Follow-up|1|||
28110256|NCT00092495|54768167|FG001|Base Study Follow-up Period|Lost to Follow-up|3|||
28110257|NCT00092495|54768168|FG002|Base Study Follow-up Period|Lost to Follow-up|3|||
28110258|NCT00092495|54768169|FG003|Base Study Follow-up Period|Lost to Follow-up|12|||
28110259|NCT00092495|54768170|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
28110260|NCT00092495|54768166|FG000|Base Study Follow-up Period|Withdrawal by Subject|2|||
28110261|NCT00092495|54768167|FG001|Base Study Follow-up Period|Withdrawal by Subject|0|||
28110262|NCT00092495|54768168|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
28110263|NCT00092495|54768169|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
28110264|NCT00092495|54768170|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
28110265|NCT00092417|54768185|FG000|Overall Study|Lost to Follow-up|2|||
28110266|NCT00092417|54768186|FG001|Overall Study|Lost to Follow-up|0|||
28110267|NCT00092417|54768185|FG000|Overall Study|Withdrawal by Subject|2|||
28110268|NCT00092417|54768186|FG001|Overall Study|Withdrawal by Subject|1|||
28110269|NCT00092417|54768185|FG000|Overall Study|Other|1|||
28110270|NCT00092417|54768186|FG001|Overall Study|Other|0|||
28110271|NCT00091949|54768194|FG000|Overall Study|Withdrawal by Subject|117|||
28110272|NCT00091949|54768195|FG001|Overall Study|Withdrawal by Subject|110|||
28110273|NCT00091949|54768194|FG000|Overall Study|Lost to Follow-up|58|||
28110274|NCT00091949|54768195|FG001|Overall Study|Lost to Follow-up|41|||
28110275|NCT02258542|54768205|FG000|Overall Study|eg. not made to the visit|7|||
28110276|NCT02258542|54768206|FG001|Overall Study|eg. not made to the visit|4|||
28110277|NCT02258542|54768207|FG002|Overall Study|eg. not made to the visit|0|||
28110278|NCT02258542|54768208|FG003|Overall Study|eg. not made to the visit|1|||
28110279|NCT02258542|54768205|FG000|Overall Study|study specific discount. criteria|1|||
28110280|NCT02258542|54768206|FG001|Overall Study|study specific discount. criteria|1|||
28110281|NCT02258542|54768207|FG002|Overall Study|study specific discount. criteria|0|||
28110282|NCT02258542|54768208|FG003|Overall Study|study specific discount. criteria|0|||
28110283|NCT02258542|54768205|FG000|Overall Study|Withdrawal by Subject|20|||
28110284|NCT02258542|54768206|FG001|Overall Study|Withdrawal by Subject|20|||
28110285|NCT02258542|54768207|FG002|Overall Study|Withdrawal by Subject|7|||
28110286|NCT02258542|54768208|FG003|Overall Study|Withdrawal by Subject|1|||
28110287|NCT02258542|54768205|FG000|Overall Study|Lost to Follow-up|5|||
28110288|NCT02258542|54768206|FG001|Overall Study|Lost to Follow-up|12|||
28110289|NCT02258542|54768207|FG002|Overall Study|Lost to Follow-up|1|||
28110290|NCT02258542|54768208|FG003|Overall Study|Lost to Follow-up|2|||
28110291|NCT02258542|54768205|FG000|Overall Study|Death|5|||
28110292|NCT02258542|54768206|FG001|Overall Study|Death|4|||
28110293|NCT02258542|54768207|FG002|Overall Study|Death|0|||
28110294|NCT02258542|54768208|FG003|Overall Study|Death|1|||
28110295|NCT02258542|54768205|FG000|Overall Study|Adverse Event|3|||
28110296|NCT02258542|54768206|FG001|Overall Study|Adverse Event|4|||
28110297|NCT02258542|54768207|FG002|Overall Study|Adverse Event|0|||
28110298|NCT02258542|54768208|FG003|Overall Study|Adverse Event|0|||
28110299|NCT02258542|54768205|FG000|Overall Study|Protocol Violation|1|||
28110300|NCT02258542|54768206|FG001|Overall Study|Protocol Violation|2|||
28110301|NCT02258542|54768207|FG002|Overall Study|Protocol Violation|0|||
28110302|NCT02258542|54768208|FG003|Overall Study|Protocol Violation|0|||
28110303|NCT02258542|54768205|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
28110304|NCT02258542|54768206|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
28110305|NCT02258542|54768207|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
28110306|NCT02258542|54768208|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
28110307|NCT00091793|54768238|FG000|Overall Study|Adverse Event|1|||
28110308|NCT00091793|54768239|FG001|Overall Study|Adverse Event|2|||
28110309|NCT00091793|54768238|FG000|Overall Study|Withdrawal by Subject|10|||
28110310|NCT00091793|54768239|FG001|Overall Study|Withdrawal by Subject|15|||
28110311|NCT00091793|54768238|FG000|Overall Study|Ineligibility determined|2|||
28110312|NCT00091793|54768239|FG001|Overall Study|Ineligibility determined|0|||
27848678|NCT02633046|54342425|FG000|Overall Study|Physician Decision|7|||
28110313|NCT00091793|54768238|FG000|Overall Study|Lost to Follow-up|7|||
28110314|NCT00091793|54768239|FG001|Overall Study|Lost to Follow-up|5|||
28110315|NCT00091793|54768238|FG000|Overall Study|Noncompliance|2|||
28110316|NCT00091793|54768239|FG001|Overall Study|Noncompliance|0|||
28110317|NCT00091793|54768238|FG000|Overall Study|Other|2|||
28110318|NCT00091793|54768239|FG001|Overall Study|Other|0|||
28110319|NCT00098813|54768245|FG000|Overall Study|Death|8|||
28110320|NCT00098813|54768245|FG000|Overall Study|Protocol Violation|1|||
28110321|NCT00098813|54768245|FG000|Overall Study|Withdrawal by Subject|7|||
28110322|NCT00098813|54768245|FG000|Overall Study|Progression of Disease|1|||
28110323|NCT00098813|54768245|FG000|Overall Study|Other complicating disease|1|||
28110324|NCT00098813|54768245|FG000|Overall Study|Reversal of RAI resistance|1|||
28110325|NCT00090857|54768251|FG000|Overall Study|Lost to Follow-up|0|||
28110326|NCT00090857|54768252|FG001|Overall Study|Lost to Follow-up|1|||
28110327|NCT00090857|54768251|FG000|Overall Study|Withdrawal by Subject|2|||
28110328|NCT00090857|54768252|FG001|Overall Study|Withdrawal by Subject|0|||
28110329|NCT00090857|54768251|FG000|Overall Study|Adverse Event|2|||
28110330|NCT00090857|54768252|FG001|Overall Study|Adverse Event|2|||
28110331|NCT00090779|54768264|FG000|Step 1|Withdrawal by Subject|4|||
28110332|NCT00090779|54768265|FG001|Step 1|Withdrawal by Subject|2|||
28110333|NCT00090779|54768264|FG000|Step 1|Lost to Follow-up|3|||
28110334|NCT00090779|54768265|FG001|Step 1|Lost to Follow-up|2|||
28110335|NCT00090779|54768264|FG000|Step 1|Death|0|||
28110336|NCT00090779|54768265|FG001|Step 1|Death|2|||
28110337|NCT00090779|54768264|FG000|Step 1|Physician Decision|1|||
28110338|NCT00090779|54768265|FG001|Step 1|Physician Decision|0|||
28110339|NCT00090779|54768264|FG000|Step 1|Pregnancy|1|||
28110340|NCT00090779|54768265|FG001|Step 1|Pregnancy|0|||
28110341|NCT00090779|54768264|FG000|Step 1|Non-compliance to study requirements|0|||
28110342|NCT00090779|54768265|FG001|Step 1|Non-compliance to study requirements|1|||
28110343|NCT00090779|54768264|FG000|Step 1|Subject relocated|2|||
28110344|NCT00090779|54768265|FG001|Step 1|Subject relocated|8|||
28110345|NCT00090779|54768264|FG000|Step 2|Off study per study closure|6|||
28110346|NCT00090779|54768265|FG001|Step 2|Off study per study closure|16|||
28110347|NCT00090779|54768264|FG000|Step 2|Subject relocated|0|||
28110348|NCT00090779|54768265|FG001|Step 2|Subject relocated|1|||
28110349|NCT00090779|54768264|FG000|Step 2|Non-compliance to study requirements|0|||
28110350|NCT00090779|54768265|FG001|Step 2|Non-compliance to study requirements|1|||
28110351|NCT00090779|54768264|FG000|Step 3|Initiation of ART and off extended study|3|||
28110352|NCT00090779|54768265|FG001|Step 3|Initiation of ART and off extended study|2|||
28110353|NCT00090779|54768264|FG000|Step 3|Off extended study due to study closure|4|||
28110354|NCT00090779|54768265|FG001|Step 3|Off extended study due to study closure|3|||
28110355|NCT00098345|54768271|FG000|Overall Study|Adverse Event|7|||
28110356|NCT00098345|54768271|FG000|Overall Study|Withdrawal by Subject|2|||
28110357|NCT00098345|54768271|FG000|Overall Study|progression|4|||
28110358|NCT02224456|54768275|FG000|Overall Study|Lack of Efficacy|1|||
28110359|NCT02224456|54768275|FG000|Overall Study|Lost to Follow-up|15|||
28110360|NCT02224456|54768275|FG000|Overall Study|Withdrawal by Subject|9|||
28110361|NCT02224456|54768275|FG000|Overall Study|Physician Decision|3|||
28110362|NCT02224456|54768275|FG000|Overall Study|Death|2|||
28110363|NCT02224456|54768275|FG000|Overall Study|Pregnancy|4|||
28110364|NCT02224456|54768275|FG000|Overall Study|Protocol Violation|1|||
28110365|NCT02224456|54768275|FG000|Overall Study|Treatment Interruptions of ≥28 days|1|||
28110366|NCT00097721|54768281|FG000|Overall Study|Adverse Event|8|||
28110367|NCT00097721|54768282|FG001|Overall Study|Adverse Event|1|||
28110368|NCT00097721|54768281|FG000|Overall Study|Withdrawal by Subject|6|||
28110369|NCT00097721|54768282|FG001|Overall Study|Withdrawal by Subject|1|||
28110370|NCT00097721|54768281|FG000|Overall Study|Progressive Disease|55|||
28110371|NCT00097721|54768282|FG001|Overall Study|Progressive Disease|27|||
28110372|NCT00097721|54768281|FG000|Overall Study|Physician Decision|1|||
28110373|NCT00097721|54768282|FG001|Overall Study|Physician Decision|3|||
28110374|NCT00097721|54768281|FG000|Overall Study|Reason not given|1|||
28110375|NCT00097721|54768282|FG001|Overall Study|Reason not given|1|||
28110376|NCT03553498|54768290|FG000|Overall Study|Missing primary outcome|1|||
28110377|NCT03553498|54768291|FG001|Overall Study|Missing primary outcome|2|||
28110378|NCT00096941|54768297|FG000|Overall Study|disease progression|3|||
28110379|NCT00096785|54768303|FG000|Overall Study|Lost to Follow-up|1|||
28110380|NCT00096785|54768304|FG001|Overall Study|Lost to Follow-up|0|||
28110381|NCT00096785|54768303|FG000|Overall Study|Withdrawal by Subject|0|||
28110382|NCT00096785|54768304|FG001|Overall Study|Withdrawal by Subject|1|||
28110383|NCT00096785|54768303|FG000|Overall Study|Relocated|1|||
28110384|NCT00096785|54768304|FG001|Overall Study|Relocated|0|||
28110385|NCT03285178|54768339|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|3|||
28110386|NCT03285178|54768340|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
28110387|NCT03285178|54768341|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
28110388|NCT03285178|54768342|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
28110389|NCT03285178|54768343|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
28110390|NCT03285178|54768344|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
28160058|NCT02714426|54830152|FG001|Overall Study|Withdrawal by Subject|2|||
28110391|NCT03285178|54768345|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
28110392|NCT03285178|54768339|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|1|||
28110393|NCT03285178|54768340|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
28110394|NCT03285178|54768341|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
28110395|NCT03285178|54768342|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
28110396|NCT03285178|54768343|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
28110397|NCT03285178|54768344|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
28110398|NCT03285178|54768345|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
28110399|NCT03285178|54768339|FG000|Single-Blind Run-In Period|Protocol Violation|11|||
28110400|NCT03285178|54768340|FG001|Single-Blind Run-In Period|Protocol Violation|0|||
28110401|NCT03285178|54768341|FG002|Single-Blind Run-In Period|Protocol Violation|0|||
28110402|NCT03285178|54768342|FG003|Single-Blind Run-In Period|Protocol Violation|0|||
28110403|NCT03285178|54768343|FG004|Single-Blind Run-In Period|Protocol Violation|0|||
28110404|NCT03285178|54768344|FG005|Single-Blind Run-In Period|Protocol Violation|0|||
28110405|NCT03285178|54768345|FG006|Single-Blind Run-In Period|Protocol Violation|0|||
28110406|NCT03285178|54768339|FG000|Single-Blind Run-In Period|Withdrawal by Subject|1|||
28110407|NCT03285178|54768340|FG001|Single-Blind Run-In Period|Withdrawal by Subject|0|||
28110408|NCT03285178|54768341|FG002|Single-Blind Run-In Period|Withdrawal by Subject|0|||
28110409|NCT03285178|54768342|FG003|Single-Blind Run-In Period|Withdrawal by Subject|0|||
28110410|NCT03285178|54768343|FG004|Single-Blind Run-In Period|Withdrawal by Subject|0|||
28110411|NCT03285178|54768344|FG005|Single-Blind Run-In Period|Withdrawal by Subject|0|||
28110412|NCT03285178|54768345|FG006|Single-Blind Run-In Period|Withdrawal by Subject|0|||
28110413|NCT03285178|54768339|FG000|Single-Blind Run-In Period|Physician Decision|2|||
28110414|NCT03285178|54768340|FG001|Single-Blind Run-In Period|Physician Decision|0|||
28110415|NCT03285178|54768341|FG002|Single-Blind Run-In Period|Physician Decision|0|||
28110416|NCT03285178|54768342|FG003|Single-Blind Run-In Period|Physician Decision|0|||
28110417|NCT03285178|54768343|FG004|Single-Blind Run-In Period|Physician Decision|0|||
28110418|NCT03285178|54768344|FG005|Single-Blind Run-In Period|Physician Decision|0|||
28110419|NCT03285178|54768345|FG006|Single-Blind Run-In Period|Physician Decision|0|||
28110420|NCT03285178|54768339|FG000|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
28110421|NCT03285178|54768340|FG001|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
28110422|NCT03285178|54768341|FG002|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
28110423|NCT03285178|54768342|FG003|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
28110424|NCT03285178|54768343|FG004|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
28110425|NCT03285178|54768344|FG005|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
28110426|NCT03285178|54768345|FG006|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
28110427|NCT03285178|54768339|FG000|Double-Blind Treatment Period|Adverse Event|0|||
28110428|NCT03285178|54768340|FG001|Double-Blind Treatment Period|Adverse Event|0|||
28110429|NCT03285178|54768341|FG002|Double-Blind Treatment Period|Adverse Event|0|||
28110430|NCT03285178|54768342|FG003|Double-Blind Treatment Period|Adverse Event|0|||
28110431|NCT03285178|54768343|FG004|Double-Blind Treatment Period|Adverse Event|0|||
28110432|NCT03285178|54768344|FG005|Double-Blind Treatment Period|Adverse Event|0|||
28110433|NCT03285178|54768345|FG006|Double-Blind Treatment Period|Adverse Event|2|||
28110434|NCT03285178|54768339|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
28110435|NCT03285178|54768340|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
28110436|NCT03285178|54768341|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
28110437|NCT03285178|54768342|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
28110438|NCT03285178|54768343|FG004|Double-Blind Treatment Period|Lost to Follow-up|2|||
28110439|NCT03285178|54768344|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
28110440|NCT03285178|54768345|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
28110441|NCT03285178|54768339|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
28110442|NCT03285178|54768340|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
28110443|NCT03285178|54768341|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
28110444|NCT03285178|54768342|FG003|Double-Blind Treatment Period|Withdrawal by Subject|1|||
28110445|NCT03285178|54768343|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
28110446|NCT03285178|54768344|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
28110447|NCT03285178|54768345|FG006|Double-Blind Treatment Period|Withdrawal by Subject|1|||
28110448|NCT03285178|54768339|FG000|Double-Blind Treatment Period|COVID-19|0|||
28110449|NCT03285178|54768340|FG001|Double-Blind Treatment Period|COVID-19|0|||
28110450|NCT03285178|54768341|FG002|Double-Blind Treatment Period|COVID-19|1|||
28110451|NCT03285178|54768342|FG003|Double-Blind Treatment Period|COVID-19|0|||
28110452|NCT03285178|54768343|FG004|Double-Blind Treatment Period|COVID-19|0|||
28110453|NCT03285178|54768344|FG005|Double-Blind Treatment Period|COVID-19|0|||
28110454|NCT03285178|54768345|FG006|Double-Blind Treatment Period|COVID-19|0|||
28110455|NCT00090545|54768369|FG000|Overall Study|Disease progression on study|21|||
28110456|NCT00090545|54768370|FG001|Overall Study|Disease progression on study|17|||
28110457|NCT00090545|54768369|FG000|Overall Study|Refused further treatment|1|||
28110458|NCT00090545|54768370|FG001|Overall Study|Refused further treatment|4|||
28110459|NCT00090545|54768369|FG000|Overall Study|Death|0|||
28110460|NCT00090545|54768370|FG001|Overall Study|Death|1|||
28110461|NCT00090545|54768369|FG000|Overall Study|Adverse Event|0|||
28110462|NCT00090545|54768370|FG001|Overall Study|Adverse Event|2|||
28110463|NCT03249376|54768380|FG000|Overall Study|Adverse Event|11|||
28110464|NCT03249376|54768381|FG001|Overall Study|Adverse Event|5|||
28110465|NCT03249376|54768380|FG000|Overall Study|Lack of Efficacy|2|||
28110466|NCT03249376|54768381|FG001|Overall Study|Lack of Efficacy|4|||
28110467|NCT03249376|54768380|FG000|Overall Study|Protocol Violation|3|||
28110468|NCT03249376|54768381|FG001|Overall Study|Protocol Violation|2|||
28110469|NCT03249376|54768380|FG000|Overall Study|Physician Decision|0|||
28110470|NCT03249376|54768381|FG001|Overall Study|Physician Decision|2|||
28110471|NCT03249376|54768380|FG000|Overall Study|Withdrawal by Subject|3|||
28110472|NCT03249376|54768381|FG001|Overall Study|Withdrawal by Subject|9|||
28110473|NCT03249376|54768380|FG000|Overall Study|LTFU|2|||
28110474|NCT03249376|54768381|FG001|Overall Study|LTFU|1|||
28110475|NCT00070109|54768392|FG000|Overall Study|Death|1|||
28110476|NCT00070109|54768393|FG001|Overall Study|Death|1|||
28110477|NCT00070109|54768394|FG002|Overall Study|Death|0|||
28110478|NCT00070109|54768395|FG003|Overall Study|Death|0|||
28110479|NCT00070109|54768396|FG004|Overall Study|Death|1|||
28110480|NCT00070109|54768392|FG000|Overall Study|Lack of Efficacy|6|||
28110481|NCT00070109|54768393|FG001|Overall Study|Lack of Efficacy|4|||
28110482|NCT00070109|54768394|FG002|Overall Study|Lack of Efficacy|5|||
28110483|NCT00070109|54768395|FG003|Overall Study|Lack of Efficacy|15|||
28110484|NCT00070109|54768396|FG004|Overall Study|Lack of Efficacy|5|||
28110485|NCT00070109|54768392|FG000|Overall Study|Physician Decision|1|||
28110486|NCT00070109|54768393|FG001|Overall Study|Physician Decision|0|||
28110487|NCT00070109|54768394|FG002|Overall Study|Physician Decision|0|||
28110488|NCT00070109|54768395|FG003|Overall Study|Physician Decision|0|||
28110489|NCT00070109|54768396|FG004|Overall Study|Physician Decision|0|||
28110490|NCT00070109|54768392|FG000|Overall Study|Withdrawal by Subject|0|||
28110491|NCT00070109|54768393|FG001|Overall Study|Withdrawal by Subject|1|||
28110492|NCT00070109|54768394|FG002|Overall Study|Withdrawal by Subject|1|||
28110493|NCT00070109|54768395|FG003|Overall Study|Withdrawal by Subject|0|||
28110494|NCT00070109|54768396|FG004|Overall Study|Withdrawal by Subject|0|||
28110495|NCT00070109|54768392|FG000|Overall Study|Adverse Event|0|||
28110496|NCT00070109|54768393|FG001|Overall Study|Adverse Event|0|||
28110497|NCT00070109|54768394|FG002|Overall Study|Adverse Event|2|||
28110498|NCT00070109|54768395|FG003|Overall Study|Adverse Event|4|||
28110499|NCT00070109|54768396|FG004|Overall Study|Adverse Event|2|||
28110500|NCT00070109|54768392|FG000|Overall Study|removed from prot thpy prior to chemo|0|||
28110501|NCT00070109|54768393|FG001|Overall Study|removed from prot thpy prior to chemo|0|||
28110502|NCT00070109|54768394|FG002|Overall Study|removed from prot thpy prior to chemo|0|||
28110503|NCT00070109|54768395|FG003|Overall Study|removed from prot thpy prior to chemo|1|||
28110504|NCT00070109|54768396|FG004|Overall Study|removed from prot thpy prior to chemo|0|||
28110505|NCT00090233|54768417|FG000|Overall Study|Randomized Not Vaccinated (Visit 1)|609|||
28110506|NCT00090233|54768418|FG001|Overall Study|Randomized Not Vaccinated (Visit 1)|627|||
28110507|NCT00090233|54768417|FG000|Overall Study|Adverse Event|214|||
28110508|NCT00090233|54768418|FG001|Overall Study|Adverse Event|198|||
28110509|NCT00090233|54768417|FG000|Overall Study|Lost to Follow-up|68|||
28110510|NCT00090233|54768418|FG001|Overall Study|Lost to Follow-up|95|||
28110511|NCT00090233|54768417|FG000|Overall Study|Protocol Violation|960|||
28110512|NCT00090233|54768418|FG001|Overall Study|Protocol Violation|1022|||
28110513|NCT00090233|54768417|FG000|Overall Study|Withdrawal by Subject|182|||
28110514|NCT00090233|54768418|FG001|Overall Study|Withdrawal by Subject|211|||
28110515|NCT00090233|54768417|FG000|Overall Study|Moved|203|||
28110516|NCT00090233|54768418|FG001|Overall Study|Moved|189|||
28110517|NCT00090233|54768417|FG000|Overall Study|Other|1211|||
28110518|NCT00090233|54768418|FG001|Overall Study|Other|1160|||
28110519|NCT00090233|54768417|FG000|Overall Study|Data not available at data cut-off point|1552|||
28110520|NCT00090233|54768418|FG001|Overall Study|Data not available at data cut-off point|1563|||
28110521|NCT00069953|54768428|FG000|Overall Study|Protocol Violation|2|||
28110522|NCT02750800|54768438|FG000|Overall Study|Adverse Event|18|||
28110523|NCT02750800|54768438|FG000|Overall Study|Lost to Follow-up|12|||
28110524|NCT02750800|54768438|FG000|Overall Study|Investigator decision|53|||
28110525|NCT02750800|54768438|FG000|Overall Study|Patient request|12|||
28110526|NCT02750800|54768438|FG000|Overall Study|Other, not specified|3|||
28110527|NCT01329562|54768458|FG000|Overall Study|Protocol Violation|5|||
28110528|NCT01329562|54768459|FG001|Overall Study|Protocol Violation|3|||
28110529|NCT01329562|54768458|FG000|Overall Study|Lost to Follow-up|1|||
28110530|NCT01329562|54768459|FG001|Overall Study|Lost to Follow-up|1|||
28110531|NCT01329562|54768458|FG000|Overall Study|Subject withdrew due to personal issues.|3|||
28110532|NCT01329562|54768459|FG001|Overall Study|Subject withdrew due to personal issues.|2|||
28110533|NCT01329562|54768458|FG000|Overall Study|Physician Decision|0|||
28110534|NCT01329562|54768459|FG001|Overall Study|Physician Decision|1|||
28110535|NCT00069641|54768470|FG000|Overall Study|Death|1|||
28110536|NCT00069641|54768471|FG001|Overall Study|Death|0|||
28110537|NCT00069641|54768472|FG002|Overall Study|Death|1|||
28110538|NCT03653026|54768483|FG000|Part 1: Placebo-controlled Period|Adverse Event|5|||
28110539|NCT03653026|54768484|FG001|Part 1: Placebo-controlled Period|Adverse Event|6|||
28110540|NCT03653026|54768485|FG002|Part 1: Placebo-controlled Period|Adverse Event|0|||
28110541|NCT03653026|54768486|FG003|Part 1: Placebo-controlled Period|Adverse Event|0|||
28110542|NCT03653026|54768483|FG000|Part 1: Placebo-controlled Period|Withdrawal by Subject|6|||
28110543|NCT03653026|54768484|FG001|Part 1: Placebo-controlled Period|Withdrawal by Subject|4|||
28110544|NCT03653026|54768485|FG002|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
28110545|NCT03653026|54768486|FG003|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
28110546|NCT03653026|54768483|FG000|Part 1: Placebo-controlled Period|Other|0|||
28110547|NCT03653026|54768484|FG001|Part 1: Placebo-controlled Period|Other|3|||
28110548|NCT03653026|54768485|FG002|Part 1: Placebo-controlled Period|Other|0|||
28110549|NCT03653026|54768486|FG003|Part 1: Placebo-controlled Period|Other|0|||
28110550|NCT03653026|54768483|FG000|Part 2: Open-label Extension|Adverse Event|0|||
28110551|NCT03653026|54768484|FG001|Part 2: Open-label Extension|Adverse Event|0|||
28110552|NCT03653026|54768485|FG002|Part 2: Open-label Extension|Adverse Event|1|||
28110553|NCT03653026|54768486|FG003|Part 2: Open-label Extension|Adverse Event|1|||
28110554|NCT03653026|54768483|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
28110555|NCT03653026|54768484|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
28110556|NCT03653026|54768485|FG002|Part 2: Open-label Extension|Withdrawal by Subject|1|||
28110557|NCT03653026|54768486|FG003|Part 2: Open-label Extension|Withdrawal by Subject|2|||
28110558|NCT03653026|54768483|FG000|Part 2: Open-label Extension|Other|0|||
28110559|NCT03653026|54768484|FG001|Part 2: Open-label Extension|Other|0|||
28110560|NCT03653026|54768485|FG002|Part 2: Open-label Extension|Other|1|||
28110561|NCT03653026|54768486|FG003|Part 2: Open-label Extension|Other|2|||
28110562|NCT01329328|54768497|FG000|Overall Study|Withdrawal by Subject|2|||
28110563|NCT01329328|54768498|FG001|Overall Study|Withdrawal by Subject|4|||
28110564|NCT01329328|54768499|FG002|Overall Study|Withdrawal by Subject|3|||
28110565|NCT01337986|54768509|FG000|Overall Study|Adverse Event|2|||
28110566|NCT01337986|54768510|FG001|Overall Study|Adverse Event|2|||
28110567|NCT01337986|54768509|FG000|Overall Study|Lost to Follow-up|1|||
28110568|NCT01337986|54768510|FG001|Overall Study|Lost to Follow-up|0|||
28110569|NCT01337986|54768509|FG000|Overall Study|Protocol Violation|0|||
28110570|NCT01337986|54768510|FG001|Overall Study|Protocol Violation|3|||
28110571|NCT01337674|54768534|FG000|Treatment Period 1|Adverse Event|0|||
28110572|NCT01337674|54768535|FG001|Treatment Period 1|Adverse Event|1|||
28110573|NCT01337674|54768536|FG002|Treatment Period 1|Adverse Event|0|||
28110574|NCT01337674|54768537|FG003|Treatment Period 1|Adverse Event|0|||
28110575|NCT01337674|54768534|FG000|Treatment Period 1|Discontinued due to blood draws|0|||
28110576|NCT01337674|54768535|FG001|Treatment Period 1|Discontinued due to blood draws|0|||
28110577|NCT01337674|54768536|FG002|Treatment Period 1|Discontinued due to blood draws|0|||
28110578|NCT01337674|54768537|FG003|Treatment Period 1|Discontinued due to blood draws|1|||
28110579|NCT01337674|54768534|FG000|Treatment Period 2|Withdrawal by Subject|0|||
28110580|NCT01337674|54768535|FG001|Treatment Period 2|Withdrawal by Subject|0|||
28110581|NCT01337674|54768536|FG002|Treatment Period 2|Withdrawal by Subject|1|||
28110582|NCT01337674|54768537|FG003|Treatment Period 2|Withdrawal by Subject|0|||
28110583|NCT02750410|54768552|FG000|Double-Blind Treatment Period|Adverse Event|2|||
28110584|NCT02750410|54768553|FG001|Double-Blind Treatment Period|Adverse Event|2|||
28110585|NCT02750410|54768552|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
28110586|NCT02750410|54768553|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
28110587|NCT02750410|54768552|FG000|Open-Label Extension Period|Adverse Event|5|||
28110588|NCT02750410|54768553|FG001|Open-Label Extension Period|Adverse Event|3|||
28110589|NCT02750410|54768552|FG000|Open-Label Extension Period|Protocol Violation|0|||
28110590|NCT02750410|54768553|FG001|Open-Label Extension Period|Protocol Violation|1|||
28110591|NCT02750410|54768552|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
28110592|NCT02750410|54768553|FG001|Open-Label Extension Period|Withdrawal by Subject|2|||
28110593|NCT02750332|54768563|FG000|Treatment Period 1|Withdrawal by Subject|0|||
28110594|NCT02750332|54768564|FG001|Treatment Period 1|Withdrawal by Subject|1|||
28110595|NCT01337596|54768579|FG000|Overall Study|Withdrawal by Subject|0|||
28110596|NCT01337596|54768580|FG001|Overall Study|Withdrawal by Subject|0|||
28110597|NCT01337596|54768581|FG002|Overall Study|Withdrawal by Subject|0|||
28110598|NCT01337596|54768582|FG003|Overall Study|Withdrawal by Subject|0|||
28110599|NCT01337596|54768583|FG004|Overall Study|Withdrawal by Subject|2|||
28110600|NCT01337596|54768584|FG005|Overall Study|Withdrawal by Subject|0|||
28110601|NCT01337596|54768585|FG006|Overall Study|Withdrawal by Subject|0|||
27815788|NCT00986440|54272619|FG000|Overall Study|Serious adverse event or adverse event|9|||
27815789|NCT00986440|54272620|FG001|Overall Study|Serious adverse event or adverse event|2|||
28110602|NCT01337596|54768586|FG007|Overall Study|Withdrawal by Subject|0|||
28110603|NCT01337596|54768587|FG008|Overall Study|Withdrawal by Subject|0|||
28110604|NCT00069095|54768616|FG000|Primary Treatment Phase|Ongoing|0|||
28110605|NCT00069095|54768617|FG001|Primary Treatment Phase|Ongoing|0|||
28110606|NCT00069095|54768618|FG002|Primary Treatment Phase|Ongoing|5|||
28110607|NCT00069095|54768619|FG003|Primary Treatment Phase|Ongoing|7|||
28110608|NCT00069095|54768620|FG004|Primary Treatment Phase|Ongoing|7|||
27848679|NCT02633046|54342425|FG000|Overall Study|Withdrawal by Subject|8|||
28110609|NCT00069095|54768621|FG005|Primary Treatment Phase|Ongoing|4|||
28110610|NCT00069095|54768616|FG000|Primary Treatment Phase|Admin/Other|29|||
28110611|NCT00069095|54768617|FG001|Primary Treatment Phase|Admin/Other|38|||
28110612|NCT00069095|54768618|FG002|Primary Treatment Phase|Admin/Other|31|||
28110613|NCT00069095|54768619|FG003|Primary Treatment Phase|Admin/Other|45|||
28110614|NCT00069095|54768620|FG004|Primary Treatment Phase|Admin/Other|48|||
28110615|NCT00069095|54768621|FG005|Primary Treatment Phase|Admin/Other|42|||
28110616|NCT00069095|54768616|FG000|Primary Treatment Phase|Adverse Event|99|||
28110617|NCT00069095|54768617|FG001|Primary Treatment Phase|Adverse Event|92|||
28110618|NCT00069095|54768618|FG002|Primary Treatment Phase|Adverse Event|71|||
28110619|NCT00069095|54768619|FG003|Primary Treatment Phase|Adverse Event|72|||
28110620|NCT00069095|54768620|FG004|Primary Treatment Phase|Adverse Event|109|||
28110621|NCT00069095|54768621|FG005|Primary Treatment Phase|Adverse Event|101|||
28110622|NCT00069095|54768616|FG000|Primary Treatment Phase|Death|14|||
27848680|NCT02633046|54342425|FG000|Overall Study|Increased proteinuria|2|||
27940200|NCT01194258|54596475|FG002|Titration Period|Withdrawal by Subject|0|||
28110623|NCT00069095|54768617|FG001|Primary Treatment Phase|Death|8|||
28110624|NCT00069095|54768618|FG002|Primary Treatment Phase|Death|2|||
28110625|NCT00069095|54768619|FG003|Primary Treatment Phase|Death|5|||
28110626|NCT00069095|54768620|FG004|Primary Treatment Phase|Death|8|||
28110627|NCT00069095|54768621|FG005|Primary Treatment Phase|Death|8|||
28110628|NCT00069095|54768616|FG000|Primary Treatment Phase|Failure to return|5|||
28110629|NCT00069095|54768617|FG001|Primary Treatment Phase|Failure to return|5|||
28110630|NCT00069095|54768618|FG002|Primary Treatment Phase|Failure to return|0|||
28110631|NCT00069095|54768619|FG003|Primary Treatment Phase|Failure to return|0|||
28110632|NCT00069095|54768620|FG004|Primary Treatment Phase|Failure to return|0|||
28110633|NCT00069095|54768621|FG005|Primary Treatment Phase|Failure to return|2|||
28110634|NCT00069095|54768616|FG000|Primary Treatment Phase|Insufficient Therapeutic Response|131|||
28110635|NCT00069095|54768617|FG001|Primary Treatment Phase|Insufficient Therapeutic Response|127|||
28110636|NCT00069095|54768618|FG002|Primary Treatment Phase|Insufficient Therapeutic Response|175|||
28110637|NCT00069095|54768619|FG003|Primary Treatment Phase|Insufficient Therapeutic Response|154|||
28110638|NCT00069095|54768620|FG004|Primary Treatment Phase|Insufficient Therapeutic Response|101|||
28110639|NCT00069095|54768621|FG005|Primary Treatment Phase|Insufficient Therapeutic Response|102|||
28110640|NCT00069095|54768616|FG000|Primary Treatment Phase|Refused treatment|15|||
28110641|NCT00069095|54768617|FG001|Primary Treatment Phase|Refused treatment|26|||
28110642|NCT00069095|54768618|FG002|Primary Treatment Phase|Refused treatment|17|||
28110643|NCT00069095|54768619|FG003|Primary Treatment Phase|Refused treatment|31|||
28110644|NCT00069095|54768620|FG004|Primary Treatment Phase|Refused treatment|24|||
28110645|NCT00069095|54768621|FG005|Primary Treatment Phase|Refused treatment|27|||
28110646|NCT00069095|54768616|FG000|Primary Treatment Phase|Withdrew|2|||
28110647|NCT00069095|54768617|FG001|Primary Treatment Phase|Withdrew|3|||
28110648|NCT00069095|54768618|FG002|Primary Treatment Phase|Withdrew|8|||
28110649|NCT00069095|54768619|FG003|Primary Treatment Phase|Withdrew|2|||
28110650|NCT00069095|54768620|FG004|Primary Treatment Phase|Withdrew|4|||
28110651|NCT00069095|54768621|FG005|Primary Treatment Phase|Withdrew|9|||
28110652|NCT00069095|54768616|FG000|Primary Treatment Phase|Other Violation|0|||
28110653|NCT00069095|54768617|FG001|Primary Treatment Phase|Other Violation|1|||
28110654|NCT00069095|54768618|FG002|Primary Treatment Phase|Other Violation|1|||
28110655|NCT00069095|54768619|FG003|Primary Treatment Phase|Other Violation|1|||
27940201|NCT01194258|54596476|FG003|Titration Period|Withdrawal by Subject|0|||
28064407|NCT00148941|54720038|FG003|Overall Study|Withdrawal by Subject|0|||
28064408|NCT00148941|54720035|FG000|Overall Study|Other|0|||
28064409|NCT00148941|54720036|FG001|Overall Study|Other|0|||
28064410|NCT00148941|54720037|FG002|Overall Study|Other|1|||
28064411|NCT00148941|54720038|FG003|Overall Study|Other|2|||
28064412|NCT00148317|54720048|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8|||
28064413|NCT00148317|54720048|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2|||
28064414|NCT00148317|54720048|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1|||
28064415|NCT00323882|54720060|FG000|Overall Study|Adverse Event|2|||
28064416|NCT00323882|54720061|FG001|Overall Study|Adverse Event|1|||
28064417|NCT00323882|54720062|FG002|Overall Study|Adverse Event|1|||
28064418|NCT00323882|54720063|FG003|Overall Study|Adverse Event|1|||
28064419|NCT00323882|54720064|FG004|Overall Study|Adverse Event|3|||
28064420|NCT00323882|54720060|FG000|Overall Study|Disease Progression|6|||
28064421|NCT00323882|54720061|FG001|Overall Study|Disease Progression|4|||
28064422|NCT00323882|54720062|FG002|Overall Study|Disease Progression|10|||
28064423|NCT00323882|54720063|FG003|Overall Study|Disease Progression|5|||
28064424|NCT00323882|54720064|FG004|Overall Study|Disease Progression|22|||
28064425|NCT00323882|54720060|FG000|Overall Study|Death|0|||
28064426|NCT00323882|54720061|FG001|Overall Study|Death|1|||
28064427|NCT00323882|54720062|FG002|Overall Study|Death|1|||
28064428|NCT00323882|54720063|FG003|Overall Study|Death|0|||
28064429|NCT00323882|54720064|FG004|Overall Study|Death|5|||
28064430|NCT00323882|54720060|FG000|Overall Study|Lost to Follow-up|0|||
28064431|NCT00323882|54720061|FG001|Overall Study|Lost to Follow-up|0|||
28064432|NCT00323882|54720062|FG002|Overall Study|Lost to Follow-up|1|||
27815790|NCT00986440|54272619|FG000|Overall Study|Withdrawal by Subject|1|||
27815791|NCT00986440|54272620|FG001|Overall Study|Withdrawal by Subject|2|||
27815792|NCT00986440|54272619|FG000|Overall Study|Screen failure (not dosed)|4|||
27815793|NCT00986440|54272620|FG001|Overall Study|Screen failure (not dosed)|2|||
27815794|NCT01904383|54272626|FG000|Overall Study|CRF not collected|117|||
27815795|NCT01904383|54272626|FG000|Overall Study|Reason not listed|147|||
27815796|NCT01904383|54272626|FG000|Overall Study|Lost to Follow-up|674|||
27815797|NCT01904383|54272626|FG000|Overall Study|Lack of Efficacy|370|||
27815798|NCT01904383|54272626|FG000|Overall Study|Improvement|141|||
27815799|NCT01904383|54272626|FG000|Overall Study|Adverse Event|271|||
27815800|NCT01904383|54272626|FG000|Overall Study|No patient visit after entry|54|||
27815801|NCT01904149|54272636|FG000|Overall Study|Adverse Event|3|||
27815802|NCT01904149|54272637|FG001|Overall Study|Adverse Event|4|||
27815803|NCT01904149|54272638|FG002|Overall Study|Adverse Event|0|||
27815804|NCT01904149|54272639|FG003|Overall Study|Adverse Event|1|||
27815805|NCT01904149|54272640|FG004|Overall Study|Adverse Event|1|||
27815806|NCT01904149|54272641|FG005|Overall Study|Adverse Event|2|||
27815807|NCT01904149|54272636|FG000|Overall Study|Lack of Efficacy|0|||
27815808|NCT01904149|54272637|FG001|Overall Study|Lack of Efficacy|3|||
27815809|NCT01904149|54272638|FG002|Overall Study|Lack of Efficacy|1|||
27815810|NCT01904149|54272639|FG003|Overall Study|Lack of Efficacy|3|||
27815811|NCT01904149|54272640|FG004|Overall Study|Lack of Efficacy|3|||
27815812|NCT01904149|54272641|FG005|Overall Study|Lack of Efficacy|1|||
27815813|NCT01904149|54272636|FG000|Overall Study|Withdrawal by Subject|1|||
27815814|NCT01904149|54272637|FG001|Overall Study|Withdrawal by Subject|3|||
27815815|NCT01904149|54272638|FG002|Overall Study|Withdrawal by Subject|1|||
27815816|NCT01904149|54272639|FG003|Overall Study|Withdrawal by Subject|0|||
27815817|NCT01904149|54272640|FG004|Overall Study|Withdrawal by Subject|1|||
27815818|NCT01904149|54272641|FG005|Overall Study|Withdrawal by Subject|0|||
27815819|NCT01904149|54272636|FG000|Overall Study|Protocol Violation|0|||
27815820|NCT01904149|54272637|FG001|Overall Study|Protocol Violation|1|||
27815821|NCT01904149|54272638|FG002|Overall Study|Protocol Violation|0|||
27815822|NCT01904149|54272639|FG003|Overall Study|Protocol Violation|0|||
27815823|NCT01904149|54272640|FG004|Overall Study|Protocol Violation|0|||
27815824|NCT01904149|54272641|FG005|Overall Study|Protocol Violation|0|||
27815825|NCT01904149|54272636|FG000|Overall Study|non compliance with study drug|1|||
27815826|NCT01904149|54272637|FG001|Overall Study|non compliance with study drug|0|||
27815827|NCT01904149|54272638|FG002|Overall Study|non compliance with study drug|0|||
27815828|NCT01904149|54272639|FG003|Overall Study|non compliance with study drug|0|||
27815829|NCT01904149|54272640|FG004|Overall Study|non compliance with study drug|0|||
27815830|NCT01904149|54272641|FG005|Overall Study|non compliance with study drug|0|||
27815831|NCT00986362|54272659|FG000|Overall Study|Death|2|||
27940202|NCT01194258|54596477|FG004|Titration Period|Withdrawal by Subject|0|||
27940203|NCT01194258|54596473|FG000|Titration Period|Lost to Follow-up|2|||
28110656|NCT00069095|54768620|FG004|Primary Treatment Phase|Other Violation|0|||
28110657|NCT00069095|54768621|FG005|Primary Treatment Phase|Other Violation|1|||
28110658|NCT00069095|54768616|FG000|Primary Treatment Phase|Violation criteria|0|||
28110659|NCT00069095|54768617|FG001|Primary Treatment Phase|Violation criteria|2|||
28110660|NCT00069095|54768618|FG002|Primary Treatment Phase|Violation criteria|4|||
28110661|NCT00069095|54768619|FG003|Primary Treatment Phase|Violation criteria|3|||
28110662|NCT00069095|54768620|FG004|Primary Treatment Phase|Violation criteria|1|||
28110663|NCT00069095|54768621|FG005|Primary Treatment Phase|Violation criteria|5|||
28110664|NCT00069095|54768616|FG000|Post-study Treatment Phase|Missing reason|1|||
28110665|NCT00069095|54768617|FG001|Post-study Treatment Phase|Missing reason|3|||
28110666|NCT00069095|54768618|FG002|Post-study Treatment Phase|Missing reason|12|||
28110667|NCT00069095|54768619|FG003|Post-study Treatment Phase|Missing reason|8|||
28110668|NCT00069095|54768620|FG004|Post-study Treatment Phase|Missing reason|18|||
28110669|NCT00069095|54768621|FG005|Post-study Treatment Phase|Missing reason|17|||
28110670|NCT00069095|54768616|FG000|Post-study Treatment Phase|Adverse Event|2|||
28110671|NCT00069095|54768617|FG001|Post-study Treatment Phase|Adverse Event|3|||
28110672|NCT00069095|54768618|FG002|Post-study Treatment Phase|Adverse Event|1|||
28110673|NCT00069095|54768619|FG003|Post-study Treatment Phase|Adverse Event|0|||
28110674|NCT00069095|54768620|FG004|Post-study Treatment Phase|Adverse Event|5|||
28110675|NCT00069095|54768621|FG005|Post-study Treatment Phase|Adverse Event|1|||
28110676|NCT00069095|54768616|FG000|Post-study Treatment Phase|Eligible for surgery|2|||
28110677|NCT00069095|54768617|FG001|Post-study Treatment Phase|Eligible for surgery|0|||
28110678|NCT00069095|54768618|FG002|Post-study Treatment Phase|Eligible for surgery|0|||
28110679|NCT00069095|54768619|FG003|Post-study Treatment Phase|Eligible for surgery|0|||
28110680|NCT00069095|54768620|FG004|Post-study Treatment Phase|Eligible for surgery|0|||
28110681|NCT00069095|54768621|FG005|Post-study Treatment Phase|Eligible for surgery|0|||
28110682|NCT00069095|54768616|FG000|Post-study Treatment Phase|Insufficient therapeutic response|1|||
28110683|NCT00069095|54768617|FG001|Post-study Treatment Phase|Insufficient therapeutic response|4|||
28110684|NCT00069095|54768618|FG002|Post-study Treatment Phase|Insufficient therapeutic response|5|||
28110685|NCT00069095|54768619|FG003|Post-study Treatment Phase|Insufficient therapeutic response|6|||
28110686|NCT00069095|54768620|FG004|Post-study Treatment Phase|Insufficient therapeutic response|7|||
28110687|NCT00069095|54768621|FG005|Post-study Treatment Phase|Insufficient therapeutic response|9|||
28110688|NCT00069095|54768616|FG000|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
28110689|NCT00069095|54768617|FG001|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
28110690|NCT00069095|54768618|FG002|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
28110691|NCT00069095|54768619|FG003|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
28110692|NCT00069095|54768620|FG004|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
28110693|NCT00069095|54768621|FG005|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
28110694|NCT00069095|54768616|FG000|Post-study Treatment Phase|Participant had complete response|1|||
28110695|NCT00069095|54768617|FG001|Post-study Treatment Phase|Participant had complete response|1|||
28110696|NCT00069095|54768618|FG002|Post-study Treatment Phase|Participant had complete response|0|||
28110697|NCT00069095|54768619|FG003|Post-study Treatment Phase|Participant had complete response|0|||
28110698|NCT00069095|54768620|FG004|Post-study Treatment Phase|Participant had complete response|0|||
28110699|NCT00069095|54768621|FG005|Post-study Treatment Phase|Participant had complete response|0|||
28110700|NCT00069095|54768616|FG000|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
28110701|NCT00069095|54768617|FG001|Post-study Treatment Phase|More than 21 days delay between cycles|1|||
28110702|NCT00069095|54768618|FG002|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
28110703|NCT00069095|54768619|FG003|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
28110704|NCT00069095|54768620|FG004|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
28110705|NCT00069095|54768621|FG005|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
28110706|NCT00069095|54768616|FG000|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
28110707|NCT00069095|54768617|FG001|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
28110708|NCT00069095|54768618|FG002|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
28110709|NCT00069095|54768619|FG003|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
27815832|NCT00986362|54272660|FG001|Overall Study|Death|0|||
27815833|NCT00986362|54272659|FG000|Overall Study|Lost to Follow-up|0|||
28110710|NCT00069095|54768620|FG004|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
28110711|NCT00069095|54768621|FG005|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
28110712|NCT00069095|54768616|FG000|Post-study Treatment Phase|Participant withdrew consent|0|||
28110713|NCT00069095|54768617|FG001|Post-study Treatment Phase|Participant withdrew consent|0|||
28110714|NCT00069095|54768618|FG002|Post-study Treatment Phase|Participant withdrew consent|1|||
28110715|NCT00069095|54768619|FG003|Post-study Treatment Phase|Participant withdrew consent|0|||
28110716|NCT00069095|54768620|FG004|Post-study Treatment Phase|Participant withdrew consent|0|||
27815834|NCT00986362|54272660|FG001|Overall Study|Lost to Follow-up|1|||
28110717|NCT00069095|54768621|FG005|Post-study Treatment Phase|Participant withdrew consent|0|||
28110718|NCT00069095|54768616|FG000|Post-study Treatment Phase|Participant will start new treatment|0|||
28110719|NCT00069095|54768617|FG001|Post-study Treatment Phase|Participant will start new treatment|0|||
28110720|NCT00069095|54768618|FG002|Post-study Treatment Phase|Participant will start new treatment|1|||
28110721|NCT00069095|54768619|FG003|Post-study Treatment Phase|Participant will start new treatment|0|||
28110722|NCT00069095|54768620|FG004|Post-study Treatment Phase|Participant will start new treatment|0|||
28110723|NCT00069095|54768621|FG005|Post-study Treatment Phase|Participant will start new treatment|0|||
28110724|NCT00069095|54768616|FG000|Post-study Treatment Phase|Participant wanted break from treatment|0|||
28110725|NCT00069095|54768617|FG001|Post-study Treatment Phase|Participant wanted break from treatment|0|||
28110726|NCT00069095|54768618|FG002|Post-study Treatment Phase|Participant wanted break from treatment|0|||
28110727|NCT00069095|54768619|FG003|Post-study Treatment Phase|Participant wanted break from treatment|1|||
28110728|NCT00069095|54768620|FG004|Post-study Treatment Phase|Participant wanted break from treatment|0|||
28110729|NCT00069095|54768621|FG005|Post-study Treatment Phase|Participant wanted break from treatment|0|||
28110730|NCT00069095|54768616|FG000|Post-study Treatment Phase|Participant completed treatment|0|||
28110731|NCT00069095|54768617|FG001|Post-study Treatment Phase|Participant completed treatment|0|||
28110732|NCT00069095|54768618|FG002|Post-study Treatment Phase|Participant completed treatment|0|||
28110733|NCT00069095|54768619|FG003|Post-study Treatment Phase|Participant completed treatment|1|||
28110734|NCT00069095|54768620|FG004|Post-study Treatment Phase|Participant completed treatment|0|||
28110735|NCT00069095|54768621|FG005|Post-study Treatment Phase|Participant completed treatment|0|||
28110736|NCT00069095|54768616|FG000|Post-study Treatment Phase|Surgery|0|||
28110737|NCT00069095|54768617|FG001|Post-study Treatment Phase|Surgery|0|||
28110738|NCT00069095|54768618|FG002|Post-study Treatment Phase|Surgery|0|||
28110739|NCT00069095|54768619|FG003|Post-study Treatment Phase|Surgery|1|||
27815835|NCT01890421|54272666|FG000|Overall Study|Adverse Event|1|||
27815836|NCT01890421|54272666|FG000|Overall Study|Other reason|10|||
27815837|NCT00985738|54272672|FG000|Overall Study|Study closed prematurely|8|||
27815838|NCT00985738|54272673|FG001|Overall Study|Study closed prematurely|8|||
28064433|NCT00323882|54720063|FG003|Overall Study|Lost to Follow-up|0|||
27815839|NCT01928485|54272681|FG000|Overall Study|Physician Decision|0|||
28064434|NCT00323882|54720064|FG004|Overall Study|Lost to Follow-up|1|||
28064435|NCT00323882|54720060|FG000|Overall Study|Other|0|||
28064436|NCT00323882|54720061|FG001|Overall Study|Other|0|||
28064437|NCT00323882|54720062|FG002|Overall Study|Other|0|||
28064438|NCT00323882|54720063|FG003|Overall Study|Other|1|||
28064439|NCT00323882|54720064|FG004|Overall Study|Other|1|||
28064440|NCT00331682|54720085|FG000|Overall Study|Adverse Event|1|||
28064441|NCT00323492|54720091|FG000|Study Phase 1|Adverse Event|2|||
28110740|NCT00069095|54768620|FG004|Post-study Treatment Phase|Surgery|1|||
28110741|NCT00069095|54768621|FG005|Post-study Treatment Phase|Surgery|0|||
28110742|NCT00069095|54768616|FG000|Post-study Treatment Phase|Death|0|||
28110743|NCT00069095|54768617|FG001|Post-study Treatment Phase|Death|0|||
28110744|NCT00069095|54768618|FG002|Post-study Treatment Phase|Death|0|||
28110745|NCT00069095|54768619|FG003|Post-study Treatment Phase|Death|0|||
28110746|NCT00069095|54768620|FG004|Post-study Treatment Phase|Death|1|||
28110747|NCT00069095|54768621|FG005|Post-study Treatment Phase|Death|0|||
28110748|NCT00069095|54768616|FG000|Post-study Treatment Phase|Participant had progressive disease|0|||
28110749|NCT00069095|54768617|FG001|Post-study Treatment Phase|Participant had progressive disease|0|||
28110750|NCT00069095|54768618|FG002|Post-study Treatment Phase|Participant had progressive disease|0|||
28110751|NCT00069095|54768619|FG003|Post-study Treatment Phase|Participant had progressive disease|0|||
28110752|NCT00069095|54768620|FG004|Post-study Treatment Phase|Participant had progressive disease|1|||
28110753|NCT00069095|54768621|FG005|Post-study Treatment Phase|Participant had progressive disease|0|||
28110754|NCT00069095|54768616|FG000|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
28110755|NCT00069095|54768617|FG001|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
28110756|NCT00069095|54768618|FG002|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
28110757|NCT00069095|54768619|FG003|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
28110758|NCT00069095|54768620|FG004|Post-study Treatment Phase|Participant/Physician decision to stop|1|||
28110759|NCT00069095|54768621|FG005|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
28110760|NCT00069095|54768616|FG000|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
28110761|NCT00069095|54768617|FG001|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
28110762|NCT00069095|54768618|FG002|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
28110763|NCT00069095|54768619|FG003|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
28110764|NCT00069095|54768620|FG004|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1|||
28110765|NCT00069095|54768621|FG005|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
28110766|NCT00069095|54768616|FG000|Post-study Treatment Phase|Investigator decision|0|||
28110767|NCT00069095|54768617|FG001|Post-study Treatment Phase|Investigator decision|0|||
28110768|NCT00069095|54768618|FG002|Post-study Treatment Phase|Investigator decision|0|||
28110769|NCT00069095|54768619|FG003|Post-study Treatment Phase|Investigator decision|0|||
28110770|NCT00069095|54768620|FG004|Post-study Treatment Phase|Investigator decision|0|||
28110771|NCT00069095|54768621|FG005|Post-study Treatment Phase|Investigator decision|1|||
28110772|NCT00069095|54768616|FG000|Follow-up Phase|Death|174|||
28110773|NCT00069095|54768617|FG001|Follow-up Phase|Death|206|||
28110774|NCT00069095|54768618|FG002|Follow-up Phase|Death|120|||
28110775|NCT00069095|54768619|FG003|Follow-up Phase|Death|112|||
28110776|NCT00069095|54768620|FG004|Follow-up Phase|Death|92|||
28110777|NCT00069095|54768621|FG005|Follow-up Phase|Death|101|||
28110778|NCT00086411|54768637|FG000|Overall Study|Lost to Follow-up|11|||
28110779|NCT00086411|54768638|FG001|Overall Study|Lost to Follow-up|11|||
28110780|NCT00086411|54768639|FG002|Overall Study|Lost to Follow-up|13|||
28110781|NCT00086411|54768640|FG003|Overall Study|Lost to Follow-up|12|||
28110782|NCT00068237|54768651|FG000|Overall Study|Ineligible|3|||
28110783|NCT00068237|54768651|FG000|Overall Study|No protocol treatment received|2|||
28110784|NCT00055601|54768657|FG000|Overall Study|Protocol Violation|1|||
28110785|NCT00055601|54768658|FG001|Overall Study|Protocol Violation|1|||
28110786|NCT00055601|54768657|FG000|Overall Study|No protocol treatment received|1|||
28110787|NCT00055601|54768658|FG001|Overall Study|No protocol treatment received|1|||
28110788|NCT03806231|54768666|FG000|Overall Study|Physician Decision|1|||
28110789|NCT03806231|54768667|FG001|Overall Study|Physician Decision|0|||
28110790|NCT03806231|54768666|FG000|Overall Study|Withdrawal by Subject|1|||
28110791|NCT03806231|54768667|FG001|Overall Study|Withdrawal by Subject|0|||
28110792|NCT00054275|54768673|FG000|Overall Study|Withdrawal by Subject|4|||
28110793|NCT00054275|54768673|FG000|Overall Study|Adverse Event|5|||
28110794|NCT00054275|54768673|FG000|Overall Study|Progressive disease in cycle 1|1|||
28110795|NCT00054275|54768673|FG000|Overall Study|Physician Decision|1|||
28110796|NCT00053417|54768681|FG000|Overall Study|Adverse Event|1|||
28110797|NCT00053417|54768682|FG001|Overall Study|Adverse Event|0|||
28110798|NCT00053417|54768683|FG002|Overall Study|Adverse Event|1|||
28110799|NCT00053417|54768684|FG003|Overall Study|Adverse Event|5|||
28110800|NCT00053417|54768681|FG000|Overall Study|Non-Compliance|0|||
28110801|NCT00053417|54768682|FG001|Overall Study|Non-Compliance|0|||
28110802|NCT00053417|54768683|FG002|Overall Study|Non-Compliance|0|||
28110803|NCT00053417|54768684|FG003|Overall Study|Non-Compliance|1|||
28110804|NCT00053417|54768681|FG000|Overall Study|Withdrawal by Subject|0|||
28110805|NCT00053417|54768682|FG001|Overall Study|Withdrawal by Subject|1|||
28110806|NCT00053417|54768683|FG002|Overall Study|Withdrawal by Subject|0|||
28110807|NCT00053417|54768684|FG003|Overall Study|Withdrawal by Subject|0|||
28064442|NCT00323492|54720092|FG001|Study Phase 1|Adverse Event|0|||
28064443|NCT00323492|54720093|FG002|Study Phase 1|Adverse Event|0|||
28064444|NCT00323492|54720091|FG000|Study Phase 2|Adverse Event|1|||
28064445|NCT00323492|54720092|FG001|Study Phase 2|Adverse Event|0|||
28064446|NCT00323492|54720093|FG002|Study Phase 2|Adverse Event|0|||
28064447|NCT00323492|54720091|FG000|Study Phase 2|Physician Decision|1|||
28064448|NCT00323492|54720092|FG001|Study Phase 2|Physician Decision|0|||
28064449|NCT00323492|54720093|FG002|Study Phase 2|Physician Decision|0|||
28064450|NCT00323492|54720091|FG000|Study Phase 2|Lost to Follow-up|1|||
28064451|NCT00323492|54720092|FG001|Study Phase 2|Lost to Follow-up|0|||
28064452|NCT00323492|54720093|FG002|Study Phase 2|Lost to Follow-up|0|||
28064453|NCT00323492|54720091|FG000|Study Phase 2|Withdrawal by Subject|0|||
28064454|NCT00323492|54720092|FG001|Study Phase 2|Withdrawal by Subject|1|||
28064455|NCT00323492|54720093|FG002|Study Phase 2|Withdrawal by Subject|0|||
28064456|NCT00323492|54720091|FG000|Study Phase 2|Noncompliance with study schedule|0|||
28064457|NCT00323492|54720092|FG001|Study Phase 2|Noncompliance with study schedule|0|||
28064458|NCT00323492|54720093|FG002|Study Phase 2|Noncompliance with study schedule|1|||
28064459|NCT00323492|54720091|FG000|Study Phase 2|Protocol Violation|1|||
28064460|NCT00323492|54720092|FG001|Study Phase 2|Protocol Violation|0|||
28064461|NCT00323492|54720093|FG002|Study Phase 2|Protocol Violation|0|||
28064462|NCT00331136|54720104|FG000|Overall Study|Adverse Event|3|||
28064463|NCT00331136|54720105|FG001|Overall Study|Adverse Event|5|||
28064464|NCT00331136|54720106|FG002|Overall Study|Adverse Event|0|||
28064465|NCT00331136|54720107|FG003|Overall Study|Adverse Event|1|||
28064466|NCT00331136|54720104|FG000|Overall Study|Withdrawal by Subject|0|||
28064467|NCT00331136|54720105|FG001|Overall Study|Withdrawal by Subject|1|||
28064468|NCT00331136|54720106|FG002|Overall Study|Withdrawal by Subject|0|||
28064469|NCT00331136|54720107|FG003|Overall Study|Withdrawal by Subject|0|||
28064470|NCT00331136|54720104|FG000|Overall Study|Lost to Follow-up|0|||
28064471|NCT00331136|54720105|FG001|Overall Study|Lost to Follow-up|1|||
28064472|NCT00331136|54720106|FG002|Overall Study|Lost to Follow-up|0|||
28064473|NCT00331136|54720107|FG003|Overall Study|Lost to Follow-up|0|||
28064474|NCT00331136|54720104|FG000|Overall Study|Protocol Violation|1|||
28064475|NCT00331136|54720105|FG001|Overall Study|Protocol Violation|0|||
28064476|NCT00331136|54720106|FG002|Overall Study|Protocol Violation|0|||
28064477|NCT00331136|54720107|FG003|Overall Study|Protocol Violation|0|||
28110808|NCT00053417|54768681|FG000|Overall Study|Lost to Follow-up|1|||
28110809|NCT00053417|54768682|FG001|Overall Study|Lost to Follow-up|1|||
28110810|NCT00053417|54768683|FG002|Overall Study|Lost to Follow-up|0|||
28110811|NCT00053417|54768684|FG003|Overall Study|Lost to Follow-up|0|||
28110812|NCT00052715|54768694|FG000|Overall Study|wrong histology|1|||
28110813|NCT00051311|54768700|FG000|Overall Study|Starting new study|0|||
28110814|NCT00051311|54768701|FG001|Overall Study|Starting new study|1|||
28110815|NCT00051311|54768700|FG000|Overall Study|Pt. to pursue treatment for progressive disease|0|||
28110816|NCT00051311|54768701|FG001|Overall Study|Pt. to pursue treatment for progressive disease|1|||
28110817|NCT00051311|54768700|FG000|Overall Study|Death of recipient|8|||
28110818|NCT00051311|54768701|FG001|Overall Study|Death of recipient|8|||
28110819|NCT00051311|54768700|FG000|Overall Study|Recipient taken off study|4|||
28110820|NCT00051311|54768701|FG001|Overall Study|Recipient taken off study|4|||
28110821|NCT00049673|54768707|FG000|Overall Study|No receive treatment/lost to follow-up|1|||
28110822|NCT00049673|54768708|FG001|Overall Study|No receive treatment/lost to follow-up|3|||
28110823|NCT00049127|54768719|FG000|Overall Study|Withdrawal by Subject|0|||
28110824|NCT00049127|54768720|FG001|Overall Study|Withdrawal by Subject|0|||
28110825|NCT00049127|54768721|FG002|Overall Study|Withdrawal by Subject|1|||
28110826|NCT00049127|54768722|FG003|Overall Study|Withdrawal by Subject|0|||
28110827|NCT00049127|54768723|FG004|Overall Study|Withdrawal by Subject|0|||
28110828|NCT00066365|54768737|FG000|Overall Study|Adverse Event|1|||
28110829|NCT00066365|54768738|FG001|Overall Study|Adverse Event|0|||
28110830|NCT00066365|54768737|FG000|Overall Study|Lack of Efficacy|15|||
28110831|NCT00066365|54768738|FG001|Overall Study|Lack of Efficacy|12|||
28110832|NCT00066365|54768737|FG000|Overall Study|Physician Decision|1|||
28110833|NCT00066365|54768738|FG001|Overall Study|Physician Decision|0|||
28110834|NCT00066365|54768737|FG000|Overall Study|No viable tumor after 1 cycle of therapy|2|||
28110835|NCT00066365|54768738|FG001|Overall Study|No viable tumor after 1 cycle of therapy|0|||
28110836|NCT00066365|54768737|FG000|Overall Study|Ineligible|4|||
28110837|NCT00066365|54768738|FG001|Overall Study|Ineligible|2|||
28110838|NCT00048581|54768748|FG000|Double-Blind Period|Adverse Event|9|||
28110839|NCT00048581|54768749|FG001|Double-Blind Period|Adverse Event|5|||
28110840|NCT00048581|54768750|FG002|Double-Blind Period|Adverse Event|0|||
28110841|NCT00048581|54768748|FG000|Double-Blind Period|Lack of Efficacy|14|||
28110842|NCT00048581|54768749|FG001|Double-Blind Period|Lack of Efficacy|27|||
28110843|NCT00048581|54768750|FG002|Double-Blind Period|Lack of Efficacy|0|||
28110844|NCT00048581|54768748|FG000|Double-Blind Period|Lost to Follow-up|5|||
28110845|NCT00048581|54768749|FG001|Double-Blind Period|Lost to Follow-up|0|||
28110846|NCT00048581|54768750|FG002|Double-Blind Period|Lost to Follow-up|0|||
28110847|NCT00048581|54768748|FG000|Double-Blind Period|Withdrawal by Subject|5|||
28110848|NCT00048581|54768749|FG001|Double-Blind Period|Withdrawal by Subject|2|||
28110849|NCT00048581|54768750|FG002|Double-Blind Period|Withdrawal by Subject|0|||
28110850|NCT00048581|54768748|FG000|Double-Blind Period|Participant Has History of Lymphopenia|1|||
28110851|NCT00048581|54768749|FG001|Double-Blind Period|Participant Has History of Lymphopenia|0|||
28110852|NCT00048581|54768750|FG002|Double-Blind Period|Participant Has History of Lymphopenia|0|||
28110853|NCT00048581|54768748|FG000|Double-Blind Period|Investigator Decision|1|||
28110854|NCT00048581|54768749|FG001|Double-Blind Period|Investigator Decision|0|||
28110855|NCT00048581|54768750|FG002|Double-Blind Period|Investigator Decision|0|||
28110856|NCT00048581|54768748|FG000|Open-Label Period|Death|0|||
28110857|NCT00048581|54768749|FG001|Open-Label Period|Death|0|||
28110858|NCT00048581|54768750|FG002|Open-Label Period|Death|4|||
28110859|NCT00048581|54768748|FG000|Open-Label Period|Adverse Event|0|||
28110860|NCT00048581|54768749|FG001|Open-Label Period|Adverse Event|0|||
28110861|NCT00048581|54768750|FG002|Open-Label Period|Adverse Event|37|||
28110862|NCT00048581|54768748|FG000|Open-Label Period|Lack of Efficacy|0|||
28110863|NCT00048581|54768749|FG001|Open-Label Period|Lack of Efficacy|0|||
28110864|NCT00048581|54768750|FG002|Open-Label Period|Lack of Efficacy|69|||
28110865|NCT00048581|54768748|FG000|Open-Label Period|Lost to Follow-up|0|||
28110866|NCT00048581|54768749|FG001|Open-Label Period|Lost to Follow-up|0|||
28110867|NCT00048581|54768750|FG002|Open-Label Period|Lost to Follow-up|14|||
28110868|NCT00048581|54768748|FG000|Open-Label Period|Withdrawal by Subject|0|||
28110869|NCT00048581|54768749|FG001|Open-Label Period|Withdrawal by Subject|0|||
28110870|NCT00048581|54768750|FG002|Open-Label Period|Withdrawal by Subject|20|||
28110871|NCT00048581|54768748|FG000|Open-Label Period|No Longer Meets Study Criteria|0|||
28110872|NCT00048581|54768749|FG001|Open-Label Period|No Longer Meets Study Criteria|0|||
28110873|NCT00048581|54768750|FG002|Open-Label Period|No Longer Meets Study Criteria|2|||
28110874|NCT00048581|54768748|FG000|Open-Label Period|Poor/Non-compliance|0|||
28110875|NCT00048581|54768749|FG001|Open-Label Period|Poor/Non-compliance|0|||
28110876|NCT00048581|54768750|FG002|Open-Label Period|Poor/Non-compliance|5|||
28110877|NCT00048581|54768748|FG000|Open-Label Period|Pregnancy|0|||
28110878|NCT00048581|54768749|FG001|Open-Label Period|Pregnancy|0|||
28110879|NCT00048581|54768750|FG002|Open-Label Period|Pregnancy|7|||
28110880|NCT00048581|54768748|FG000|Open-Label Period|Study Site Closure|0|||
28110881|NCT00048581|54768749|FG001|Open-Label Period|Study Site Closure|0|||
28110882|NCT00048581|54768750|FG002|Open-Label Period|Study Site Closure|2|||
28110883|NCT00048581|54768748|FG000|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
28110884|NCT00048581|54768749|FG001|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
28110885|NCT00048581|54768750|FG002|Open-Label Period|Continue ABA With Primary Rheumatologist|3|||
28110886|NCT00048581|54768748|FG000|Open-Label Period|Problem With Transportation To Site|0|||
28110887|NCT00048581|54768749|FG001|Open-Label Period|Problem With Transportation To Site|0|||
28110888|NCT00048581|54768750|FG002|Open-Label Period|Problem With Transportation To Site|1|||
28110889|NCT00048581|54768748|FG000|Open-Label Period|Primary Investigator Retired|0|||
28110890|NCT00048581|54768749|FG001|Open-Label Period|Primary Investigator Retired|0|||
28110891|NCT00048581|54768750|FG002|Open-Label Period|Primary Investigator Retired|2|||
28110892|NCT00048581|54768748|FG000|Open-Label Period|Study Ended By Sponsor|0|||
28110893|NCT00048581|54768749|FG001|Open-Label Period|Study Ended By Sponsor|0|||
28110894|NCT00048581|54768750|FG002|Open-Label Period|Study Ended By Sponsor|1|||
28110895|NCT00048347|54768763|FG000|Overall Study|Screen failure|2|||
28110896|NCT00065507|54768769|FG000|Overall Study|Death|16|||
28110897|NCT00065507|54768770|FG001|Overall Study|Death|17|||
28110898|NCT00065507|54768769|FG000|Overall Study|Adverse Event|4|||
28110899|NCT00065507|54768770|FG001|Overall Study|Adverse Event|3|||
28110900|NCT00065507|54768769|FG000|Overall Study|Lack of Efficacy|0|||
28110901|NCT00065507|54768770|FG001|Overall Study|Lack of Efficacy|6|||
28110902|NCT00065507|54768769|FG000|Overall Study|Poor/Non-compliance|3|||
28110903|NCT00065507|54768770|FG001|Overall Study|Poor/Non-compliance|2|||
28110904|NCT00065507|54768769|FG000|Overall Study|Lost to Follow-up|3|||
28110905|NCT00065507|54768770|FG001|Overall Study|Lost to Follow-up|0|||
28110906|NCT00065507|54768769|FG000|Overall Study|Subject Withdrew Consent|2|||
28110907|NCT00065507|54768770|FG001|Overall Study|Subject Withdrew Consent|1|||
28110908|NCT00065507|54768769|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
28110909|NCT00065507|54768770|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
28110910|NCT00065429|54768787|FG000|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
28110911|NCT00065429|54768788|FG001|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
28110912|NCT00065429|54768789|FG002|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
28110913|NCT00065429|54768790|FG003|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
28110914|NCT00065429|54768791|FG004|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
28110915|NCT00065429|54768792|FG005|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1|||
28110916|NCT00065429|54768793|FG006|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
28110917|NCT00065429|54768787|FG000|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
28110918|NCT00065429|54768788|FG001|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
28110919|NCT00065429|54768789|FG002|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1|||
28110920|NCT00065429|54768790|FG003|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
28110921|NCT00065429|54768791|FG004|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
28110922|NCT00065429|54768792|FG005|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
28110923|NCT00065429|54768793|FG006|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
28110924|NCT00065429|54768787|FG000|Phase I - May 2001 - Oct 2002|Physician Decision|1|||
28110925|NCT00065429|54768788|FG001|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
28110926|NCT00065429|54768789|FG002|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
28110927|NCT00065429|54768790|FG003|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
28110928|NCT00065429|54768791|FG004|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
28110929|NCT00065429|54768792|FG005|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
28110930|NCT00065429|54768793|FG006|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
28110931|NCT00065429|54768787|FG000|Phase I - May 2001 - Oct 2002|Death|0|||
28110932|NCT00065429|54768788|FG001|Phase I - May 2001 - Oct 2002|Death|0|||
28110933|NCT00065429|54768789|FG002|Phase I - May 2001 - Oct 2002|Death|0|||
28110934|NCT00065429|54768790|FG003|Phase I - May 2001 - Oct 2002|Death|0|||
28110935|NCT00065429|54768791|FG004|Phase I - May 2001 - Oct 2002|Death|1|||
28110936|NCT00065429|54768792|FG005|Phase I - May 2001 - Oct 2002|Death|0|||
28110937|NCT00065429|54768793|FG006|Phase I - May 2001 - Oct 2002|Death|0|||
28110938|NCT00065429|54768787|FG000|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
28110939|NCT00065429|54768788|FG001|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
28110940|NCT00065429|54768789|FG002|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
28110941|NCT00065429|54768790|FG003|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
28110942|NCT00065429|54768791|FG004|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
28110943|NCT00065429|54768792|FG005|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
28110944|NCT00065429|54768793|FG006|Phase I - May 2001 - Oct 2002|Adverse Event|2|||
28110945|NCT00065429|54768787|FG000|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
28110946|NCT00065429|54768788|FG001|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
28110947|NCT00065429|54768789|FG002|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
28110948|NCT00065429|54768790|FG003|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
28110949|NCT00065429|54768791|FG004|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4|||
28110950|NCT00065429|54768792|FG005|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
28110951|NCT00065429|54768793|FG006|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
28110952|NCT00065429|54768787|FG000|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
28110953|NCT00065429|54768788|FG001|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
28110954|NCT00065429|54768789|FG002|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
28110955|NCT00065429|54768790|FG003|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
28110956|NCT00065429|54768791|FG004|Phase II - Apr 2003 - Aug 2008|Adverse Event|2|||
28110957|NCT00065429|54768792|FG005|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
28110958|NCT00065429|54768793|FG006|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
28110959|NCT00048035|54768810|FG000|Core Period|Early Withdrawals|4|||
28110960|NCT00048035|54768811|FG001|Core Period|Early Withdrawals|2|||
28110961|NCT00048035|54768812|FG002|Core Period|Early Withdrawals|1|||
28110962|NCT00048035|54768813|FG003|Core Period|Early Withdrawals|1|||
28110963|NCT00048035|54768814|FG004|Core Period|Early Withdrawals|1|||
28110964|NCT00048035|54768815|FG005|Core Period|Early Withdrawals|1|||
28110965|NCT00048035|54768816|FG006|Core Period|Early Withdrawals|0|||
28110966|NCT00048035|54768817|FG007|Core Period|Early Withdrawals|0|||
28110967|NCT00048035|54768810|FG000|Extension Year 1|Early Withdrawals|0|||
28110968|NCT00048035|54768811|FG001|Extension Year 1|Early Withdrawals|0|||
28110969|NCT00048035|54768812|FG002|Extension Year 1|Early Withdrawals|0|||
28110970|NCT00048035|54768813|FG003|Extension Year 1|Early Withdrawals|0|||
28110971|NCT00048035|54768814|FG004|Extension Year 1|Early Withdrawals|0|||
27815840|NCT01928485|54272682|FG001|Overall Study|Physician Decision|1|||
27815841|NCT00985504|54272690|FG000|Acute Treatment Period|Adverse Event|3|||
27815842|NCT00985504|54272691|FG001|Acute Treatment Period|Adverse Event|4|||
27815843|NCT00985504|54272690|FG000|Acute Treatment Period|Entry Criteria Not Met|1|||
27815844|NCT00985504|54272691|FG001|Acute Treatment Period|Entry Criteria Not Met|2|||
27815845|NCT00985504|54272690|FG000|Acute Treatment Period|Protocol Violation|2|||
27815846|NCT00985504|54272691|FG001|Acute Treatment Period|Protocol Violation|0|||
27815847|NCT00985504|54272690|FG000|Acute Treatment Period|Sponsor Decision|0|||
27815848|NCT00985504|54272691|FG001|Acute Treatment Period|Sponsor Decision|1|||
27815849|NCT00985504|54272690|FG000|Acute Treatment Period|Withdrawal by Subject|9|||
27815850|NCT00985504|54272691|FG001|Acute Treatment Period|Withdrawal by Subject|5|||
27815851|NCT00985504|54272690|FG000|Optimization Period|Adverse Event|7|||
27815852|NCT00985504|54272691|FG001|Optimization Period|Adverse Event|9|||
27815853|NCT00985504|54272690|FG000|Optimization Period|Death|0|||
27815854|NCT00985504|54272691|FG001|Optimization Period|Death|1|||
27815855|NCT00985504|54272690|FG000|Optimization Period|Lack of Efficacy|5|||
27815856|NCT00985504|54272691|FG001|Optimization Period|Lack of Efficacy|3|||
27815857|NCT00985504|54272690|FG000|Optimization Period|Lost to Follow-up|0|||
27815858|NCT00985504|54272691|FG001|Optimization Period|Lost to Follow-up|1|||
27815859|NCT00985504|54272690|FG000|Optimization Period|Physician Decision|1|||
27815860|NCT00985504|54272691|FG001|Optimization Period|Physician Decision|0|||
27815861|NCT00985504|54272690|FG000|Optimization Period|Protocol Violation|3|||
27815862|NCT00985504|54272691|FG001|Optimization Period|Protocol Violation|1|||
27815863|NCT00985504|54272690|FG000|Optimization Period|Withdrawal by Subject|10|||
27815864|NCT00985504|54272691|FG001|Optimization Period|Withdrawal by Subject|8|||
27815865|NCT00985426|54272699|FG000|Overall Study|Adverse Event|0|||
27815866|NCT00985426|54272700|FG001|Overall Study|Adverse Event|1|||
27815867|NCT00985426|54272699|FG000|Overall Study|Subject Non-Compliance|3|||
27815868|NCT00985426|54272700|FG001|Overall Study|Subject Non-Compliance|3|||
27815869|NCT00985426|54272699|FG000|Overall Study|Withdrawal by Subject|12|||
27815870|NCT00985426|54272700|FG001|Overall Study|Withdrawal by Subject|16|||
27815871|NCT00985426|54272699|FG000|Overall Study|Lost to Follow-up|8|||
27815872|NCT00985426|54272700|FG001|Overall Study|Lost to Follow-up|10|||
27815873|NCT00985426|54272699|FG000|Overall Study|Death|7|||
27815874|NCT00985426|54272700|FG001|Overall Study|Death|3|||
27815875|NCT00985426|54272699|FG000|Overall Study|Protocol Violation|2|||
27815876|NCT00985426|54272700|FG001|Overall Study|Protocol Violation|0|||
27815877|NCT00985426|54272699|FG000|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
27815878|NCT00985426|54272700|FG001|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
27815879|NCT00985192|54272706|FG000|Overall Study|Withdrawal by Subject|1|||
27815880|NCT00985192|54272706|FG000|Overall Study|Disease Progression|1|||
27815881|NCT00985192|54272706|FG000|Overall Study|Determined to be Ineligible During Trial|2|||
27815882|NCT00985114|54272712|FG000|Overall Study|Adverse Event|1|||
27815883|NCT00985114|54272713|FG001|Overall Study|Adverse Event|0|||
27815884|NCT00985114|54272712|FG000|Overall Study|Withdrawal by Subject|0|||
27815885|NCT00985114|54272713|FG001|Overall Study|Withdrawal by Subject|2|||
27815886|NCT00984568|54272721|FG000|Overall Study|Withdrawal by Subject|1|||
27815887|NCT00984568|54272722|FG001|Overall Study|Withdrawal by Subject|2|||
27815888|NCT00984568|54272721|FG000|Overall Study|Lack of Efficacy|2|||
27815889|NCT00984568|54272722|FG001|Overall Study|Lack of Efficacy|0|||
27815890|NCT00984568|54272721|FG000|Overall Study|Adverse Event|2|||
27815891|NCT00984568|54272722|FG001|Overall Study|Adverse Event|0|||
27815892|NCT00984568|54272721|FG000|Overall Study|Did Not Meet Randomization Criteria|1|||
27815893|NCT00984568|54272722|FG001|Overall Study|Did Not Meet Randomization Criteria|0|||
27815894|NCT00984568|54272721|FG000|Overall Study|Lost to Follow-up|0|||
27815895|NCT00984568|54272722|FG001|Overall Study|Lost to Follow-up|1|||
27815896|NCT00984568|54272721|FG000|Overall Study|Opportunistic Infection|1|||
28110972|NCT00048035|54768815|FG005|Extension Year 1|Early Withdrawals|0|||
27815897|NCT00984568|54272722|FG001|Overall Study|Opportunistic Infection|0|||
27815898|NCT00984568|54272721|FG000|Overall Study|Unknown Reason|1|||
27815899|NCT00984568|54272722|FG001|Overall Study|Unknown Reason|3|||
27815900|NCT00984256|54272730|FG000|Overall Study|Withdrawal by Subject|0|||
27815901|NCT00984256|54272731|FG001|Overall Study|Withdrawal by Subject|1|||
27815902|NCT00984022|54272748|FG000|Overall Study|Lost to Follow-up|10|||
27815903|NCT00984022|54272749|FG001|Overall Study|Lost to Follow-up|14|||
28110973|NCT00048035|54768816|FG006|Extension Year 1|Early Withdrawals|11|||
28110974|NCT00048035|54768817|FG007|Extension Year 1|Early Withdrawals|11|||
28110975|NCT00048035|54768810|FG000|Extension Year 2|Early Withdrawals|0|||
28110976|NCT00048035|54768811|FG001|Extension Year 2|Early Withdrawals|0|||
28110977|NCT00048035|54768812|FG002|Extension Year 2|Early Withdrawals|0|||
28110978|NCT00048035|54768813|FG003|Extension Year 2|Early Withdrawals|0|||
28110979|NCT00048035|54768814|FG004|Extension Year 2|Early Withdrawals|0|||
28110980|NCT00048035|54768815|FG005|Extension Year 2|Early Withdrawals|0|||
28110981|NCT00048035|54768816|FG006|Extension Year 2|Early Withdrawals|3|||
28110982|NCT00048035|54768817|FG007|Extension Year 2|Early Withdrawals|3|||
28110983|NCT00047879|54768834|FG000|Overall Study|Progressive disease|4|||
28064478|NCT00331136|54720104|FG000|Overall Study|Not treated|1|||
28064479|NCT00331136|54720105|FG001|Overall Study|Not treated|0|||
28064480|NCT00331136|54720106|FG002|Overall Study|Not treated|0|||
28064481|NCT00331136|54720107|FG003|Overall Study|Not treated|0|||
28064482|NCT00323414|54720119|FG000|Overall Study|Withdrawal by Subject|0|||
28064483|NCT00323414|54720120|FG001|Overall Study|Withdrawal by Subject|1|||
28064484|NCT00330668|54720126|FG000|BID Dosing Period|Adverse Event|1|||
28064485|NCT00330668|54720126|FG000|BID Dosing Period|Lost to Follow-up|7|||
28064486|NCT00330668|54720126|FG000|BID Dosing Period|Non-Compliance|5|||
28064487|NCT00330668|54720126|FG000|BID Dosing Period|Withdrawal by Subject|19|||
28064488|NCT00330668|54720126|FG000|BID Dosing Period|Sponsor's decision|1|||
28064489|NCT00330668|54720126|FG000|BID Dosing Period|Other|3|||
28064490|NCT00330668|54720126|FG000|QD Dosing Period|Sponsor decision to terminate study|74|||
28064491|NCT00330668|54720126|FG000|QD Dosing Period|Other|1|||
28064492|NCT00330668|54720126|FG000|QD Dosing Period|Withdrawal by Subject|1|||
28064493|NCT00330668|54720126|FG000|QD Dosing Period|Lost to Follow-up|2|||
28064494|NCT00306384|54720133|FG000|Overall Study|Adverse Event|103|||
28064495|NCT00306384|54720134|FG001|Overall Study|Adverse Event|87|||
28064496|NCT00306384|54720135|FG002|Overall Study|Adverse Event|40|||
28064497|NCT00306384|54720133|FG000|Overall Study|Major protocol deviation|43|||
28064498|NCT00306384|54720134|FG001|Overall Study|Major protocol deviation|51|||
28064499|NCT00306384|54720135|FG002|Overall Study|Major protocol deviation|18|||
28064500|NCT00306384|54720133|FG000|Overall Study|Lost to Follow-up|57|||
28064501|NCT00306384|54720134|FG001|Overall Study|Lost to Follow-up|41|||
28064502|NCT00306384|54720135|FG002|Overall Study|Lost to Follow-up|35|||
28064503|NCT00306384|54720133|FG000|Overall Study|Voluntary withdrawal|199|||
28064504|NCT00306384|54720134|FG001|Overall Study|Voluntary withdrawal|187|||
28064505|NCT00306384|54720135|FG002|Overall Study|Voluntary withdrawal|91|||
28064506|NCT00306384|54720133|FG000|Overall Study|Study termination|1|||
28064507|NCT00306384|54720134|FG001|Overall Study|Study termination|0|||
28064508|NCT00306384|54720135|FG002|Overall Study|Study termination|1|||
28064509|NCT00306384|54720133|FG000|Overall Study|Pregnancy|3|||
28064510|NCT00306384|54720134|FG001|Overall Study|Pregnancy|1|||
28064511|NCT00306384|54720135|FG002|Overall Study|Pregnancy|1|||
28064512|NCT00306384|54720133|FG000|Overall Study|Lack of Efficacy|26|||
28064513|NCT00306384|54720134|FG001|Overall Study|Lack of Efficacy|40|||
28064514|NCT00306384|54720135|FG002|Overall Study|Lack of Efficacy|38|||
28064515|NCT00306384|54720133|FG000|Overall Study|Investigator discretion|28|||
28064516|NCT00306384|54720134|FG001|Overall Study|Investigator discretion|31|||
28064517|NCT00306384|54720135|FG002|Overall Study|Investigator discretion|21|||
28064518|NCT00306384|54720133|FG000|Overall Study|Other|80|||
28064519|NCT00306384|54720134|FG001|Overall Study|Other|70|||
28064520|NCT00306384|54720135|FG002|Overall Study|Other|32|||
28064521|NCT00306384|54720133|FG000|Overall Study|Site closure|2|||
28064522|NCT00306384|54720134|FG001|Overall Study|Site closure|0|||
28110984|NCT00047879|54768835|FG001|Overall Study|Progressive disease|3|||
28110985|NCT00064337|54768841|FG000|PBSCC or Induction/PBSCC|Not protocol-specified|7|||
28110986|NCT00064337|54768841|FG000|PBSCC or Induction/PBSCC|Adverse Event|6|||
28110987|NCT00064337|54768841|FG000|PBSCC or Induction/PBSCC|Progression|3|||
28110988|NCT00064337|54768841|FG000|PBSCC or Induction/PBSCC|Patient Refusal|2|||
28110989|NCT00064337|54768841|FG000|PBSCC or Induction/PBSCC|Death|2|||
28110990|NCT00064337|54768841|FG000|Transplant|Adverse Event|9|||
28110991|NCT00064337|54768841|FG000|Transplant|Not protocol-specified|5|||
28110992|NCT00064337|54768841|FG000|Transplant|Death|3|||
28110993|NCT00064337|54768841|FG000|Transplant|Patient Refusal|2|||
27940204|NCT01194258|54596474|FG001|Titration Period|Lost to Follow-up|0|||
27940205|NCT01194258|54596475|FG002|Titration Period|Lost to Follow-up|0|||
27940206|NCT01194258|54596476|FG003|Titration Period|Lost to Follow-up|0|||
27940207|NCT01194258|54596477|FG004|Titration Period|Lost to Follow-up|0|||
27940208|NCT01194258|54596473|FG000|Titration Period|Titration failure|3|||
27940209|NCT01194258|54596474|FG001|Titration Period|Titration failure|0|||
27940210|NCT01194258|54596475|FG002|Titration Period|Titration failure|0|||
27940211|NCT01194258|54596476|FG003|Titration Period|Titration failure|0|||
27940212|NCT01194258|54596477|FG004|Titration Period|Titration failure|0|||
27940213|NCT01194258|54596473|FG000|Period 1 (12 Weeks)|Death|0|||
27940214|NCT01194258|54596474|FG001|Period 1 (12 Weeks)|Death|0|||
27940215|NCT01194258|54596475|FG002|Period 1 (12 Weeks)|Death|0|||
27940216|NCT01194258|54596476|FG003|Period 1 (12 Weeks)|Death|0|||
27940217|NCT01194258|54596477|FG004|Period 1 (12 Weeks)|Death|1|||
28110994|NCT00064337|54768841|FG000|Transplant|Progression|2|||
28110995|NCT00064337|54768841|FG000|Maintenance|Adverse Event|3|||
28110996|NCT00064337|54768841|FG000|Maintenance|Progression|2|||
28110997|NCT00064337|54768841|FG000|Maintenance|On treatment at time of analysis|2|||
28110998|NCT00064337|54768841|FG000|Maintenance|Not protocol-specified|2|||
28110999|NCT00064337|54768841|FG000|Maintenance|Death|1|||
28111000|NCT00064259|54768848|FG000|Overall Study|Adverse Event|1|||
28111001|NCT00064259|54768849|FG001|Overall Study|Adverse Event|0|||
28111002|NCT00064259|54768850|FG002|Overall Study|Adverse Event|0|||
28111003|NCT00064259|54768851|FG003|Overall Study|Adverse Event|1|||
28111004|NCT00044213|54768860|FG000|Overall Study|Withdrawal by Subject|50|||
28111005|NCT00044213|54768861|FG001|Overall Study|Withdrawal by Subject|65|||
28111006|NCT00044213|54768862|FG002|Overall Study|Withdrawal by Subject|91|||
28111007|NCT00044213|54768863|FG003|Overall Study|Withdrawal by Subject|83|||
28111008|NCT00044213|54768860|FG000|Overall Study|Death|42|||
28111009|NCT00044213|54768861|FG001|Overall Study|Death|42|||
27815904|NCT01890265|54272761|FG000|Overall Study|Other (Unspecified reason)|0|||
27815905|NCT01890265|54272762|FG001|Overall Study|Other (Unspecified reason)|1|||
27815906|NCT01890265|54272763|FG002|Overall Study|Other (Unspecified reason)|0|||
28111010|NCT00044213|54768862|FG002|Overall Study|Death|42|||
28111011|NCT00044213|54768863|FG003|Overall Study|Death|49|||
28111012|NCT00044213|54768860|FG000|Overall Study|Lost to Follow-up|8|||
28111013|NCT00044213|54768861|FG001|Overall Study|Lost to Follow-up|5|||
28111014|NCT00044213|54768862|FG002|Overall Study|Lost to Follow-up|5|||
28111015|NCT00044213|54768863|FG003|Overall Study|Lost to Follow-up|4|||
28111016|NCT00064025|54768873|FG000|Overall Study|Ineligible|4|||
28111017|NCT00064025|54768873|FG000|Overall Study|Inevaluable|3|||
28111018|NCT00043979|54768881|FG000|Period 1|recipient with progressive disease|7|||
28111019|NCT00043979|54768882|FG001|Period 1|recipient with progressive disease|4|||
28111020|NCT00043979|54768883|FG002|Period 1|recipient with progressive disease|3|||
28111021|NCT00039377|54768900|FG000|Initial Registration|Adverse Event|2|||
28111022|NCT00039377|54768901|FG001|Initial Registration|Adverse Event|0|||
28111023|NCT00039377|54768902|FG002|Initial Registration|Adverse Event|0|||
28111024|NCT00039377|54768903|FG003|Initial Registration|Adverse Event|0|||
28111025|NCT00039377|54768900|FG000|Initial Registration|Relapsed|6|||
28111026|NCT00039377|54768901|FG001|Initial Registration|Relapsed|0|||
28111027|NCT00039377|54768902|FG002|Initial Registration|Relapsed|0|||
28111028|NCT00039377|54768903|FG003|Initial Registration|Relapsed|0|||
28111029|NCT00039377|54768900|FG000|Initial Registration|Received non-protocol therapy|11|||
28111030|NCT00039377|54768901|FG001|Initial Registration|Received non-protocol therapy|0|||
28111031|NCT00039377|54768902|FG002|Initial Registration|Received non-protocol therapy|0|||
28111032|NCT00039377|54768903|FG003|Initial Registration|Received non-protocol therapy|0|||
28111033|NCT00039377|54768900|FG000|Initial Registration|Withdrawal by Subject|3|||
28111034|NCT00039377|54768901|FG001|Initial Registration|Withdrawal by Subject|0|||
28111035|NCT00039377|54768902|FG002|Initial Registration|Withdrawal by Subject|0|||
28111036|NCT00039377|54768903|FG003|Initial Registration|Withdrawal by Subject|0|||
28111037|NCT00154102|54768913|FG000|Overall Study|investigational study phase ongoing|7|||
28111038|NCT00154102|54768914|FG001|Overall Study|investigational study phase ongoing|2|||
28111039|NCT03687502|54768937|FG000|Overall Study|IV was removed prior to radiology visit for ultrasound|1|||
28111040|NCT03687502|54768937|FG000|Overall Study|Lumason not available|1|||
28111041|NCT00035555|54768946|FG000|Overall Study|Adverse Event|5|||
27815907|NCT01890265|54272764|FG003|Overall Study|Other (Unspecified reason)|0|||
27940218|NCT01194258|54596473|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
28111042|NCT00035555|54768947|FG001|Overall Study|Adverse Event|8|||
28111043|NCT00035555|54768948|FG002|Overall Study|Adverse Event|9|||
28111044|NCT00035555|54768946|FG000|Overall Study|Allograft loss|1|||
28111045|NCT00035555|54768947|FG001|Overall Study|Allograft loss|1|||
28111046|NCT00035555|54768948|FG002|Overall Study|Allograft loss|2|||
28111047|NCT00035555|54768946|FG000|Overall Study|Death|0|||
28111048|NCT00035555|54768947|FG001|Overall Study|Death|0|||
28111049|NCT00035555|54768948|FG002|Overall Study|Death|2|||
28111050|NCT00035555|54768946|FG000|Overall Study|Lost to Follow-up|0|||
28111051|NCT00035555|54768947|FG001|Overall Study|Lost to Follow-up|0|||
28111052|NCT00035555|54768948|FG002|Overall Study|Lost to Follow-up|1|||
28111053|NCT00035555|54768946|FG000|Overall Study|Noncompliance|0|||
28111054|NCT00035555|54768947|FG001|Overall Study|Noncompliance|1|||
28111055|NCT00035555|54768948|FG002|Overall Study|Noncompliance|1|||
28111056|NCT00035555|54768946|FG000|Overall Study|Prohibited medication|1|||
28111057|NCT00035555|54768947|FG001|Overall Study|Prohibited medication|1|||
28111058|NCT00035555|54768948|FG002|Overall Study|Prohibited medication|0|||
28111059|NCT00035555|54768946|FG000|Overall Study|Treatment failure/lack of efficacy|7|||
28111060|NCT00035555|54768947|FG001|Overall Study|Treatment failure/lack of efficacy|5|||
28111061|NCT00035555|54768948|FG002|Overall Study|Treatment failure/lack of efficacy|3|||
28111062|NCT00035555|54768946|FG000|Overall Study|Withdrawal by Subject|2|||
28111063|NCT00035555|54768947|FG001|Overall Study|Withdrawal by Subject|0|||
28111064|NCT00035555|54768948|FG002|Overall Study|Withdrawal by Subject|2|||
28111065|NCT00035555|54768946|FG000|Overall Study|Investigator deemed not a good candidate|0|||
28111066|NCT00035555|54768947|FG001|Overall Study|Investigator deemed not a good candidate|0|||
28111067|NCT00035555|54768948|FG002|Overall Study|Investigator deemed not a good candidate|1|||
28111068|NCT00035555|54768946|FG000|Overall Study|Received cyclosporin in error|0|||
28111069|NCT00035555|54768947|FG001|Overall Study|Received cyclosporin in error|0|||
28111070|NCT00035555|54768948|FG002|Overall Study|Received cyclosporin in error|1|||
28111071|NCT03894046|54768960|FG000|Overall Study|Protocol Violation|1|||
28111072|NCT03894046|54768961|FG001|Overall Study|Protocol Violation|0|||
28111073|NCT03894046|54768962|FG002|Overall Study|Protocol Violation|0|||
28111074|NCT03894046|54768960|FG000|Overall Study|Adverse Event|0|||
28111075|NCT03894046|54768961|FG001|Overall Study|Adverse Event|1|||
28111076|NCT03894046|54768962|FG002|Overall Study|Adverse Event|0|||
28111077|NCT03894046|54768960|FG000|Overall Study|Withdrawal by Subject|2|||
28111078|NCT03894046|54768961|FG001|Overall Study|Withdrawal by Subject|3|||
28111079|NCT03894046|54768962|FG002|Overall Study|Withdrawal by Subject|1|||
28111080|NCT03894046|54768960|FG000|Overall Study|Death|15|||
28111081|NCT03894046|54768961|FG001|Overall Study|Death|21|||
28111082|NCT03894046|54768962|FG002|Overall Study|Death|4|||
28111083|NCT03894046|54768960|FG000|Overall Study|No growth of ABC|2|||
28111084|NCT03894046|54768961|FG001|Overall Study|No growth of ABC|1|||
28111085|NCT03894046|54768962|FG002|Overall Study|No growth of ABC|0|||
28111086|NCT03894046|54768960|FG000|Overall Study|Physician Decision|1|||
28111087|NCT03894046|54768961|FG001|Overall Study|Physician Decision|1|||
28111088|NCT03894046|54768962|FG002|Overall Study|Physician Decision|1|||
28111089|NCT03894046|54768960|FG000|Overall Study|Prohibited concomitant medication|1|||
28111090|NCT03894046|54768961|FG001|Overall Study|Prohibited concomitant medication|0|||
28111091|NCT03894046|54768962|FG002|Overall Study|Prohibited concomitant medication|0|||
28111092|NCT03894046|54768960|FG000|Overall Study|Transferred to other arm/group|1|||
28111093|NCT03894046|54768961|FG001|Overall Study|Transferred to other arm/group|1|||
28111094|NCT03894046|54768962|FG002|Overall Study|Transferred to other arm/group|0|||
28111095|NCT00033371|54768971|FG000|Overall Study|Adverse Event|1|||
28111096|NCT00033371|54768972|FG001|Overall Study|Adverse Event|5|||
28111097|NCT00033371|54768971|FG000|Overall Study|Lost to Follow-up|2|||
28111098|NCT00033371|54768972|FG001|Overall Study|Lost to Follow-up|1|||
28111099|NCT00033371|54768971|FG000|Overall Study|Withdrawal by Subject|3|||
28111100|NCT00033371|54768972|FG001|Overall Study|Withdrawal by Subject|3|||
28111101|NCT00033371|54768971|FG000|Overall Study|Disease Progression|0|||
28111102|NCT00033371|54768972|FG001|Overall Study|Disease Progression|1|||
28111103|NCT00081731|54768984|FG000|Overall Study|scientific integrity issue|8|||
28111104|NCT00081731|54768985|FG001|Overall Study|scientific integrity issue|8|||
28111105|NCT00079937|54768993|FG000|Overall Study|Adverse Event|2|||
28111106|NCT00079937|54768994|FG001|Overall Study|Adverse Event|1|||
28111107|NCT00079937|54768993|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
28111108|NCT00079937|54768994|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
28111109|NCT00079937|54768993|FG000|Overall Study|Subject no longer requires study drug|3|||
28111110|NCT00079937|54768994|FG001|Overall Study|Subject no longer requires study drug|0|||
28111111|NCT00079937|54768993|FG000|Overall Study|Protocol Violation|8|||
28111112|NCT00079937|54768994|FG001|Overall Study|Protocol Violation|6|||
28111113|NCT00079937|54768993|FG000|Overall Study|Withdrawal by Subject|21|||
28111114|NCT00079937|54768994|FG001|Overall Study|Withdrawal by Subject|7|||
28064523|NCT00306384|54720135|FG002|Overall Study|Site closure|0|||
28064524|NCT00305604|54720145|FG000|Overall Study|Adverse Event|6|||
28064525|NCT00305604|54720146|FG001|Overall Study|Adverse Event|3|||
28111115|NCT00079937|54768993|FG000|Overall Study|Lost to Follow-up|12|||
28111116|NCT00079937|54768994|FG001|Overall Study|Lost to Follow-up|5|||
28111117|NCT00079937|54768993|FG000|Overall Study|Administrative problems|22|||
28111118|NCT00079937|54768994|FG001|Overall Study|Administrative problems|11|||
28111119|NCT00909610|54769002|FG000|Period: First Intervention|Adverse Event|0|||
28111120|NCT00909610|54769003|FG001|Period: First Intervention|Adverse Event|1|||
28111121|NCT00909610|54769002|FG000|Period: Washout of 28 Days|Withdrawal by Subject|3|||
28111122|NCT00909610|54769003|FG001|Period: Washout of 28 Days|Withdrawal by Subject|6|||
28111123|NCT00909610|54769002|FG000|Period: Second Intervention|Adverse Event|1|||
28111124|NCT00909610|54769003|FG001|Period: Second Intervention|Adverse Event|0|||
28111125|NCT03126110|54769025|FG000|Phase 1|Death|2|||
28111126|NCT03126110|54769026|FG001|Phase 1|Death|2|||
28111127|NCT03126110|54769027|FG002|Phase 1|Death|4|||
28111128|NCT03126110|54769028|FG003|Phase 1|Death|3|||
28111129|NCT03126110|54769029|FG004|Phase 1|Death|4|||
28111130|NCT03126110|54769030|FG005|Phase 1|Death|4|||
28111131|NCT03126110|54769031|FG006|Phase 1|Death|3|||
28111132|NCT03126110|54769032|FG007|Phase 1|Death|4|||
28111133|NCT03126110|54769033|FG008|Phase 1|Death|5|||
28111134|NCT03126110|54769034|FG009|Phase 1|Death|2|||
28111135|NCT03126110|54769035|FG010|Phase 1|Death|6|||
28111136|NCT03126110|54769036|FG011|Phase 1|Death|0|||
28111137|NCT03126110|54769037|FG012|Phase 1|Death|0|||
28111138|NCT03126110|54769038|FG013|Phase 1|Death|0|||
28111139|NCT03126110|54769039|FG014|Phase 1|Death|0|||
28064526|NCT00305604|54720145|FG000|Overall Study|Lack of Efficacy|11|||
28064527|NCT00305604|54720146|FG001|Overall Study|Lack of Efficacy|18|||
28064528|NCT00305604|54720145|FG000|Overall Study|Lost to Follow-up|0|||
28064529|NCT00305604|54720146|FG001|Overall Study|Lost to Follow-up|4|||
28064530|NCT00305604|54720145|FG000|Overall Study|Protocol Violation|2|||
28064531|NCT00305604|54720146|FG001|Overall Study|Protocol Violation|1|||
28064532|NCT00305604|54720145|FG000|Overall Study|Withdrawal by Subject|12|||
28064533|NCT00305604|54720146|FG001|Overall Study|Withdrawal by Subject|21|||
28064534|NCT00305604|54720145|FG000|Overall Study|Patient moved|1|||
28064535|NCT00305604|54720146|FG001|Overall Study|Patient moved|0|||
28064536|NCT00501059|54720154|FG000|Overall Study|Protocol Violation|80|||
28064537|NCT00501059|54720155|FG001|Overall Study|Protocol Violation|69|||
28064538|NCT00501059|54720154|FG000|Overall Study|Death|140|||
28064539|NCT00501059|54720155|FG001|Overall Study|Death|137|||
28064540|NCT00501059|54720154|FG000|Overall Study|Other|236|||
28064541|NCT00501059|54720155|FG001|Overall Study|Other|239|||
28064542|NCT00501059|54720154|FG000|Overall Study|Missing end-of-study page|91|||
28064543|NCT00501059|54720155|FG001|Overall Study|Missing end-of-study page|92|||
28064544|NCT00501059|54720154|FG000|Overall Study|Clinical endpoint reached|110|||
28064545|NCT00501059|54720155|FG001|Overall Study|Clinical endpoint reached|123|||
28064546|NCT00501059|54720154|FG000|Overall Study|Insufficient therapeutic effect|4|||
28064547|NCT00501059|54720155|FG001|Overall Study|Insufficient therapeutic effect|5|||
28064548|NCT00501059|54720154|FG000|Overall Study|Consent withdrawn by subject|817|||
28064549|NCT00501059|54720155|FG001|Overall Study|Consent withdrawn by subject|873|||
27940219|NCT01194258|54596474|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
27940220|NCT01194258|54596475|FG002|Period 2 (12 Weeks)|Lost to Follow-up|0|||
28111140|NCT03126110|54769040|FG015|Phase 1|Death|0|||
28111141|NCT03126110|54769041|FG016|Phase 1|Death|0|||
28111142|NCT03126110|54769025|FG000|Phase 1|Lost to Follow-up|0|||
28111143|NCT03126110|54769026|FG001|Phase 1|Lost to Follow-up|1|||
28111144|NCT03126110|54769027|FG002|Phase 1|Lost to Follow-up|0|||
28111145|NCT03126110|54769028|FG003|Phase 1|Lost to Follow-up|0|||
28111146|NCT03126110|54769029|FG004|Phase 1|Lost to Follow-up|0|||
28111147|NCT03126110|54769030|FG005|Phase 1|Lost to Follow-up|0|||
28111148|NCT03126110|54769031|FG006|Phase 1|Lost to Follow-up|0|||
28111149|NCT03126110|54769032|FG007|Phase 1|Lost to Follow-up|0|||
28111150|NCT03126110|54769033|FG008|Phase 1|Lost to Follow-up|1|||
28111151|NCT03126110|54769034|FG009|Phase 1|Lost to Follow-up|0|||
28111152|NCT03126110|54769035|FG010|Phase 1|Lost to Follow-up|0|||
28111153|NCT03126110|54769036|FG011|Phase 1|Lost to Follow-up|0|||
28111154|NCT03126110|54769037|FG012|Phase 1|Lost to Follow-up|0|||
28111155|NCT03126110|54769038|FG013|Phase 1|Lost to Follow-up|0|||
28111156|NCT03126110|54769039|FG014|Phase 1|Lost to Follow-up|0|||
28111157|NCT03126110|54769040|FG015|Phase 1|Lost to Follow-up|0|||
28111158|NCT03126110|54769041|FG016|Phase 1|Lost to Follow-up|0|||
28111159|NCT03126110|54769025|FG000|Phase 1|Withdrawal by Subject|1|||
28111160|NCT03126110|54769026|FG001|Phase 1|Withdrawal by Subject|0|||
28111161|NCT03126110|54769027|FG002|Phase 1|Withdrawal by Subject|0|||
28111162|NCT03126110|54769028|FG003|Phase 1|Withdrawal by Subject|1|||
28111163|NCT03126110|54769029|FG004|Phase 1|Withdrawal by Subject|1|||
28111164|NCT03126110|54769030|FG005|Phase 1|Withdrawal by Subject|0|||
28111165|NCT03126110|54769031|FG006|Phase 1|Withdrawal by Subject|0|||
28111166|NCT03126110|54769032|FG007|Phase 1|Withdrawal by Subject|0|||
28111167|NCT03126110|54769033|FG008|Phase 1|Withdrawal by Subject|2|||
28111168|NCT03126110|54769034|FG009|Phase 1|Withdrawal by Subject|1|||
28111169|NCT03126110|54769035|FG010|Phase 1|Withdrawal by Subject|0|||
28111170|NCT03126110|54769036|FG011|Phase 1|Withdrawal by Subject|0|||
28111171|NCT03126110|54769037|FG012|Phase 1|Withdrawal by Subject|0|||
28111172|NCT03126110|54769038|FG013|Phase 1|Withdrawal by Subject|0|||
28111173|NCT03126110|54769039|FG014|Phase 1|Withdrawal by Subject|0|||
28111174|NCT03126110|54769040|FG015|Phase 1|Withdrawal by Subject|0|||
28111175|NCT03126110|54769041|FG016|Phase 1|Withdrawal by Subject|0|||
28111176|NCT03126110|54769025|FG000|Phase 1|Safety follow-up no longer necessary|1|||
28111177|NCT03126110|54769026|FG001|Phase 1|Safety follow-up no longer necessary|0|||
28111178|NCT03126110|54769027|FG002|Phase 1|Safety follow-up no longer necessary|0|||
28111179|NCT03126110|54769028|FG003|Phase 1|Safety follow-up no longer necessary|0|||
28111180|NCT03126110|54769029|FG004|Phase 1|Safety follow-up no longer necessary|0|||
28111181|NCT03126110|54769030|FG005|Phase 1|Safety follow-up no longer necessary|0|||
28111182|NCT03126110|54769031|FG006|Phase 1|Safety follow-up no longer necessary|0|||
28111183|NCT03126110|54769032|FG007|Phase 1|Safety follow-up no longer necessary|0|||
28111184|NCT03126110|54769033|FG008|Phase 1|Safety follow-up no longer necessary|0|||
28111185|NCT03126110|54769034|FG009|Phase 1|Safety follow-up no longer necessary|0|||
28111186|NCT03126110|54769035|FG010|Phase 1|Safety follow-up no longer necessary|0|||
28111187|NCT03126110|54769036|FG011|Phase 1|Safety follow-up no longer necessary|0|||
28111188|NCT03126110|54769037|FG012|Phase 1|Safety follow-up no longer necessary|0|||
28111189|NCT03126110|54769038|FG013|Phase 1|Safety follow-up no longer necessary|0|||
28111190|NCT03126110|54769039|FG014|Phase 1|Safety follow-up no longer necessary|0|||
28111191|NCT03126110|54769040|FG015|Phase 1|Safety follow-up no longer necessary|0|||
28111192|NCT03126110|54769041|FG016|Phase 1|Safety follow-up no longer necessary|0|||
28111193|NCT03126110|54769025|FG000|Phase 1|Survival follow-up no longer necessary|0|||
28111194|NCT03126110|54769026|FG001|Phase 1|Survival follow-up no longer necessary|0|||
28111195|NCT03126110|54769027|FG002|Phase 1|Survival follow-up no longer necessary|1|||
28111196|NCT03126110|54769028|FG003|Phase 1|Survival follow-up no longer necessary|0|||
28111197|NCT03126110|54769029|FG004|Phase 1|Survival follow-up no longer necessary|0|||
28111198|NCT03126110|54769030|FG005|Phase 1|Survival follow-up no longer necessary|0|||
28111199|NCT03126110|54769031|FG006|Phase 1|Survival follow-up no longer necessary|0|||
28111200|NCT03126110|54769032|FG007|Phase 1|Survival follow-up no longer necessary|0|||
28111201|NCT03126110|54769033|FG008|Phase 1|Survival follow-up no longer necessary|0|||
28111202|NCT03126110|54769034|FG009|Phase 1|Survival follow-up no longer necessary|0|||
28111203|NCT03126110|54769035|FG010|Phase 1|Survival follow-up no longer necessary|0|||
28111204|NCT03126110|54769036|FG011|Phase 1|Survival follow-up no longer necessary|0|||
28111205|NCT03126110|54769037|FG012|Phase 1|Survival follow-up no longer necessary|0|||
28111206|NCT03126110|54769038|FG013|Phase 1|Survival follow-up no longer necessary|0|||
28111207|NCT03126110|54769039|FG014|Phase 1|Survival follow-up no longer necessary|0|||
27940221|NCT01194258|54596476|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
27940222|NCT01194258|54596477|FG004|Period 2 (12 Weeks)|Lost to Follow-up|2|||
27940223|NCT01194258|54596473|FG000|Period 2 (12 Weeks)|Adverse Event|0|||
27940224|NCT01194258|54596474|FG001|Period 2 (12 Weeks)|Adverse Event|1|||
27940225|NCT01194258|54596475|FG002|Period 2 (12 Weeks)|Adverse Event|0|||
27940226|NCT01194258|54596476|FG003|Period 2 (12 Weeks)|Adverse Event|0|||
27940227|NCT01194258|54596477|FG004|Period 2 (12 Weeks)|Adverse Event|0|||
28064550|NCT00501059|54720154|FG000|Overall Study|Non-compliant with study treatment|23|||
28064551|NCT00501059|54720155|FG001|Overall Study|Non-compliant with study treatment|16|||
28111208|NCT03126110|54769040|FG015|Phase 1|Survival follow-up no longer necessary|0|||
28111209|NCT03126110|54769041|FG016|Phase 1|Survival follow-up no longer necessary|0|||
28111210|NCT03126110|54769025|FG000|Phase 2|Study terminated by the sponsor|0|||
28111211|NCT03126110|54769026|FG001|Phase 2|Study terminated by the sponsor|0|||
28111212|NCT03126110|54769027|FG002|Phase 2|Study terminated by the sponsor|0|||
28111213|NCT03126110|54769028|FG003|Phase 2|Study terminated by the sponsor|0|||
28111214|NCT03126110|54769029|FG004|Phase 2|Study terminated by the sponsor|0|||
27815908|NCT01890265|54272765|FG004|Overall Study|Other (Unspecified reason)|0|||
27815909|NCT01890265|54272766|FG005|Overall Study|Other (Unspecified reason)|0|||
27815910|NCT01890265|54272761|FG000|Overall Study|Progressive disease|6|||
28064552|NCT00501059|54720154|FG000|Overall Study|Reason not given|3|||
28064553|NCT00501059|54720155|FG001|Overall Study|Reason not given|1|||
28064554|NCT00501059|54720154|FG000|Overall Study|Adverse Event|129|||
28064555|NCT00501059|54720155|FG001|Overall Study|Adverse Event|122|||
28064556|NCT00501059|54720154|FG000|Overall Study|Lost to Follow-up|210|||
28064557|NCT00501059|54720155|FG001|Overall Study|Lost to Follow-up|198|||
28064558|NCT00501059|54720154|FG000|Overall Study|Not treated|25|||
28064559|NCT00501059|54720155|FG001|Overall Study|Not treated|17|||
28064560|NCT00344318|54720167|FG000|Overall Study|Adverse Event|0|||
28064561|NCT00344318|54720168|FG001|Overall Study|Adverse Event|3|||
28064562|NCT00344318|54720169|FG002|Overall Study|Adverse Event|0|||
28064563|NCT00344318|54720170|FG003|Overall Study|Adverse Event|1|||
28064564|NCT00344318|54720167|FG000|Overall Study|Withdrawal by Subject|2|||
28064565|NCT00344318|54720168|FG001|Overall Study|Withdrawal by Subject|2|||
28064566|NCT00344318|54720169|FG002|Overall Study|Withdrawal by Subject|0|||
28064567|NCT00344318|54720170|FG003|Overall Study|Withdrawal by Subject|2|||
28064568|NCT00344318|54720167|FG000|Overall Study|Lost to Follow-up|2|||
28064569|NCT00344318|54720168|FG001|Overall Study|Lost to Follow-up|0|||
28064570|NCT00344318|54720169|FG002|Overall Study|Lost to Follow-up|1|||
28111215|NCT03126110|54769030|FG005|Phase 2|Study terminated by the sponsor|0|||
27851619|NCT00985673|54351076|FG002|Overall Study|Withdrawal by Subject|5|||
28064571|NCT00344318|54720170|FG003|Overall Study|Lost to Follow-up|0|||
28064572|NCT00323258|54720184|FG000|Primary Outcome (Phone Call at 6 Months)|Death|1|||
28111216|NCT03126110|54769031|FG006|Phase 2|Study terminated by the sponsor|0|||
28111217|NCT03126110|54769032|FG007|Phase 2|Study terminated by the sponsor|0|||
28111218|NCT03126110|54769033|FG008|Phase 2|Study terminated by the sponsor|0|||
28111219|NCT03126110|54769034|FG009|Phase 2|Study terminated by the sponsor|0|||
28111220|NCT03126110|54769035|FG010|Phase 2|Study terminated by the sponsor|0|||
28111221|NCT03126110|54769036|FG011|Phase 2|Study terminated by the sponsor|0|||
28111222|NCT03126110|54769037|FG012|Phase 2|Study terminated by the sponsor|0|||
28111223|NCT03126110|54769038|FG013|Phase 2|Study terminated by the sponsor|4|||
28111224|NCT03126110|54769039|FG014|Phase 2|Study terminated by the sponsor|0|||
28111225|NCT03126110|54769040|FG015|Phase 2|Study terminated by the sponsor|0|||
28064573|NCT00323258|54720185|FG001|Primary Outcome (Phone Call at 6 Months)|Death|2|||
28064574|NCT00323258|54720184|FG000|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12|||
28064575|NCT00323258|54720185|FG001|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11|||
28064576|NCT00323258|54720184|FG000|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1|||
28111226|NCT03126110|54769041|FG016|Phase 2|Study terminated by the sponsor|0|||
28111227|NCT03126110|54769025|FG000|Phase 2|Withdrawal by Subject|0|||
28111228|NCT03126110|54769026|FG001|Phase 2|Withdrawal by Subject|0|||
27815911|NCT01890265|54272762|FG001|Overall Study|Progressive disease|6|||
27815912|NCT01890265|54272763|FG002|Overall Study|Progressive disease|0|||
27815913|NCT01890265|54272764|FG003|Overall Study|Progressive disease|0|||
27815914|NCT01890265|54272765|FG004|Overall Study|Progressive disease|0|||
27815915|NCT01890265|54272766|FG005|Overall Study|Progressive disease|0|||
27815916|NCT01890265|54272761|FG000|Overall Study|Adverse Event|2|||
27815917|NCT01890265|54272762|FG001|Overall Study|Adverse Event|1|||
27815918|NCT01890265|54272763|FG002|Overall Study|Adverse Event|0|||
28064577|NCT00323258|54720185|FG001|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5|||
28064578|NCT00323258|54720184|FG000|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2|||
28064579|NCT00323258|54720185|FG001|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1|||
28111229|NCT03126110|54769027|FG002|Phase 2|Withdrawal by Subject|0|||
28111230|NCT03126110|54769028|FG003|Phase 2|Withdrawal by Subject|0|||
28111231|NCT03126110|54769029|FG004|Phase 2|Withdrawal by Subject|0|||
28111232|NCT03126110|54769030|FG005|Phase 2|Withdrawal by Subject|0|||
28111233|NCT03126110|54769031|FG006|Phase 2|Withdrawal by Subject|0|||
28111234|NCT03126110|54769032|FG007|Phase 2|Withdrawal by Subject|0|||
28111235|NCT03126110|54769033|FG008|Phase 2|Withdrawal by Subject|0|||
28111236|NCT03126110|54769034|FG009|Phase 2|Withdrawal by Subject|0|||
28111237|NCT03126110|54769035|FG010|Phase 2|Withdrawal by Subject|0|||
28111238|NCT03126110|54769036|FG011|Phase 2|Withdrawal by Subject|1|||
28111239|NCT03126110|54769037|FG012|Phase 2|Withdrawal by Subject|3|||
28111240|NCT03126110|54769038|FG013|Phase 2|Withdrawal by Subject|3|||
28111241|NCT03126110|54769039|FG014|Phase 2|Withdrawal by Subject|2|||
28111242|NCT03126110|54769040|FG015|Phase 2|Withdrawal by Subject|1|||
28111243|NCT03126110|54769041|FG016|Phase 2|Withdrawal by Subject|0|||
28111244|NCT03126110|54769025|FG000|Phase 2|Lost to Follow-up|0|||
28111245|NCT03126110|54769026|FG001|Phase 2|Lost to Follow-up|0|||
28111246|NCT03126110|54769027|FG002|Phase 2|Lost to Follow-up|0|||
28111247|NCT03126110|54769028|FG003|Phase 2|Lost to Follow-up|0|||
28111248|NCT03126110|54769029|FG004|Phase 2|Lost to Follow-up|0|||
28111249|NCT03126110|54769030|FG005|Phase 2|Lost to Follow-up|0|||
28111250|NCT03126110|54769031|FG006|Phase 2|Lost to Follow-up|0|||
28111251|NCT03126110|54769032|FG007|Phase 2|Lost to Follow-up|0|||
28111252|NCT03126110|54769033|FG008|Phase 2|Lost to Follow-up|0|||
28111253|NCT03126110|54769034|FG009|Phase 2|Lost to Follow-up|0|||
28111254|NCT03126110|54769035|FG010|Phase 2|Lost to Follow-up|0|||
28111255|NCT03126110|54769036|FG011|Phase 2|Lost to Follow-up|1|||
28111256|NCT03126110|54769037|FG012|Phase 2|Lost to Follow-up|1|||
28111257|NCT03126110|54769038|FG013|Phase 2|Lost to Follow-up|1|||
28111258|NCT03126110|54769039|FG014|Phase 2|Lost to Follow-up|2|||
28111259|NCT03126110|54769040|FG015|Phase 2|Lost to Follow-up|0|||
28111260|NCT03126110|54769041|FG016|Phase 2|Lost to Follow-up|0|||
27940228|NCT01194258|54596473|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
28064580|NCT00323258|54720184|FG000|Secondary Outcome (6 Mon Refill Records)|Death|1|||
28064581|NCT00323258|54720185|FG001|Secondary Outcome (6 Mon Refill Records)|Death|2|||
28064582|NCT00323258|54720184|FG000|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12|||
28064583|NCT00323258|54720185|FG001|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10|||
28064584|NCT00323258|54720184|FG000|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1|||
28111261|NCT03126110|54769025|FG000|Phase 2|Death|0|||
28064585|NCT00323258|54720185|FG001|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2|||
28111262|NCT03126110|54769026|FG001|Phase 2|Death|0|||
28111263|NCT03126110|54769027|FG002|Phase 2|Death|0|||
28111264|NCT03126110|54769028|FG003|Phase 2|Death|0|||
28111265|NCT03126110|54769029|FG004|Phase 2|Death|0|||
28111266|NCT03126110|54769030|FG005|Phase 2|Death|0|||
28111267|NCT03126110|54769031|FG006|Phase 2|Death|0|||
28111268|NCT03126110|54769032|FG007|Phase 2|Death|0|||
28111269|NCT03126110|54769033|FG008|Phase 2|Death|0|||
28111270|NCT03126110|54769034|FG009|Phase 2|Death|0|||
28111271|NCT03126110|54769035|FG010|Phase 2|Death|0|||
27815919|NCT01890265|54272764|FG003|Overall Study|Adverse Event|0|||
27815920|NCT01890265|54272765|FG004|Overall Study|Adverse Event|0|||
28111272|NCT03126110|54769036|FG011|Phase 2|Death|6|||
28111273|NCT03126110|54769037|FG012|Phase 2|Death|12|||
28111274|NCT03126110|54769038|FG013|Phase 2|Death|25|||
28111275|NCT03126110|54769039|FG014|Phase 2|Death|11|||
28111276|NCT03126110|54769040|FG015|Phase 2|Death|3|||
28111277|NCT03126110|54769041|FG016|Phase 2|Death|2|||
28111278|NCT03126110|54769025|FG000|Phase 2|Progressive Disease|0|||
28111279|NCT03126110|54769026|FG001|Phase 2|Progressive Disease|0|||
28111280|NCT03126110|54769027|FG002|Phase 2|Progressive Disease|0|||
28111281|NCT03126110|54769028|FG003|Phase 2|Progressive Disease|0|||
28111282|NCT03126110|54769029|FG004|Phase 2|Progressive Disease|0|||
28111283|NCT03126110|54769030|FG005|Phase 2|Progressive Disease|0|||
28111284|NCT03126110|54769031|FG006|Phase 2|Progressive Disease|0|||
28111285|NCT03126110|54769032|FG007|Phase 2|Progressive Disease|0|||
28111286|NCT03126110|54769033|FG008|Phase 2|Progressive Disease|0|||
28111287|NCT03126110|54769034|FG009|Phase 2|Progressive Disease|0|||
28111288|NCT03126110|54769035|FG010|Phase 2|Progressive Disease|0|||
28111289|NCT03126110|54769036|FG011|Phase 2|Progressive Disease|0|||
28111290|NCT03126110|54769037|FG012|Phase 2|Progressive Disease|0|||
28111291|NCT03126110|54769038|FG013|Phase 2|Progressive Disease|1|||
28111292|NCT03126110|54769039|FG014|Phase 2|Progressive Disease|0|||
28111293|NCT03126110|54769040|FG015|Phase 2|Progressive Disease|0|||
28111294|NCT03126110|54769041|FG016|Phase 2|Progressive Disease|0|||
28111295|NCT03126110|54769025|FG000|Phase 2|Started new treatment|0|||
28111296|NCT03126110|54769026|FG001|Phase 2|Started new treatment|0|||
28111297|NCT03126110|54769027|FG002|Phase 2|Started new treatment|0|||
28111298|NCT03126110|54769028|FG003|Phase 2|Started new treatment|0|||
28111299|NCT03126110|54769029|FG004|Phase 2|Started new treatment|0|||
28111300|NCT03126110|54769030|FG005|Phase 2|Started new treatment|0|||
28111301|NCT03126110|54769031|FG006|Phase 2|Started new treatment|0|||
28111302|NCT03126110|54769032|FG007|Phase 2|Started new treatment|0|||
28111303|NCT03126110|54769033|FG008|Phase 2|Started new treatment|0|||
28111304|NCT03126110|54769034|FG009|Phase 2|Started new treatment|0|||
28111305|NCT03126110|54769035|FG010|Phase 2|Started new treatment|0|||
28111306|NCT03126110|54769036|FG011|Phase 2|Started new treatment|0|||
28111307|NCT03126110|54769037|FG012|Phase 2|Started new treatment|0|||
28111308|NCT03126110|54769038|FG013|Phase 2|Started new treatment|0|||
28111309|NCT03126110|54769039|FG014|Phase 2|Started new treatment|1|||
28111310|NCT03126110|54769040|FG015|Phase 2|Started new treatment|0|||
28111311|NCT03126110|54769041|FG016|Phase 2|Started new treatment|0|||
28111312|NCT00905164|54769091|FG000|Period 1|Protocol Violation|0|||
28111313|NCT00905164|54769092|FG001|Period 1|Protocol Violation|1|||
28111314|NCT03181958|54769099|FG000|Overall Study|Lost to Follow-up|17|||
28111315|NCT03181958|54769100|FG001|Overall Study|Lost to Follow-up|21|||
28111316|NCT03181958|54769101|FG002|Overall Study|Lost to Follow-up|15|||
28111317|NCT03165110|54769109|FG000|Overall Study|Anroid phone software incompatibility|1|||
28064586|NCT00322868|54720191|FG000|Overall Study|disease progression|1|||
28064587|NCT00322712|54720196|FG000|Overall Study|treated with bevacizumab not cetuximab|1|||
28064588|NCT00343382|54720203|FG000|Overall Study|Adverse Event|2|||
28064589|NCT00343382|54720204|FG001|Overall Study|Adverse Event|10|||
28064590|NCT00343382|54720205|FG002|Overall Study|Adverse Event|7|||
28064591|NCT00343382|54720203|FG000|Overall Study|Withdrawal by Subject|1|||
28064592|NCT00343382|54720204|FG001|Overall Study|Withdrawal by Subject|2|||
28064593|NCT00343382|54720205|FG002|Overall Study|Withdrawal by Subject|6|||
28064594|NCT00343382|54720203|FG000|Overall Study|Other Reason Not Specified|1|||
28064595|NCT00343382|54720204|FG001|Overall Study|Other Reason Not Specified|2|||
28064596|NCT00343382|54720205|FG002|Overall Study|Other Reason Not Specified|4|||
28064597|NCT00481871|54720218|FG000|Overall Study|Progressive Disease - pt withdrew|0|||
28064598|NCT00481871|54720219|FG001|Overall Study|Progressive Disease - pt withdrew|0|||
28064599|NCT00481871|54720220|FG002|Overall Study|Progressive Disease - pt withdrew|1|||
28064600|NCT00481871|54720221|FG003|Overall Study|Progressive Disease - pt withdrew|0|||
28064601|NCT00481871|54720222|FG004|Overall Study|Progressive Disease - pt withdrew|0|||
28064602|NCT00329420|54720233|FG000|Re-induction Phase|Lack of Efficacy|0|||
28064603|NCT00329420|54720234|FG001|Re-induction Phase|Lack of Efficacy|1|||
28064604|NCT00329420|54720235|FG002|Re-induction Phase|Lack of Efficacy|0|||
28064605|NCT00329420|54720233|FG000|Re-induction Phase|Withdrawal of Consent|0|||
28064606|NCT00329420|54720234|FG001|Re-induction Phase|Withdrawal of Consent|0|||
28064607|NCT00329420|54720235|FG002|Re-induction Phase|Withdrawal of Consent|1|||
28064608|NCT00329420|54720233|FG000|Re-induction Phase|Did not respond to re-induction|6|||
28064609|NCT00329420|54720234|FG001|Re-induction Phase|Did not respond to re-induction|5|||
28064610|NCT00329420|54720235|FG002|Re-induction Phase|Did not respond to re-induction|7|||
28064611|NCT00329420|54720233|FG000|4-weekly Dosing Phase (Responders Only)|Adverse Event|2|||
28111318|NCT00079781|54769116|FG000|Pre-implant Period|Withdrawal by Subject|2|||
28111319|NCT00079781|54769117|FG001|Pre-implant Period|Withdrawal by Subject|0|||
28111320|NCT00079781|54769118|FG002|Pre-implant Period|Withdrawal by Subject|0|||
28111321|NCT00079781|54769116|FG000|Pre-implant Period|Did not meet I/E criteria|1|||
28111322|NCT00079781|54769117|FG001|Pre-implant Period|Did not meet I/E criteria|1|||
28111323|NCT00079781|54769118|FG002|Pre-implant Period|Did not meet I/E criteria|1|||
28111324|NCT00079781|54769116|FG000|Follow-up Period|Withdrawal by Subject|3|||
28111325|NCT00079781|54769117|FG001|Follow-up Period|Withdrawal by Subject|0|||
28111326|NCT00079781|54769118|FG002|Follow-up Period|Withdrawal by Subject|1|||
28111327|NCT00079781|54769116|FG000|Follow-up Period|Lost to Follow-up|1|||
28111328|NCT00079781|54769117|FG001|Follow-up Period|Lost to Follow-up|0|||
28111329|NCT00079781|54769118|FG002|Follow-up Period|Lost to Follow-up|0|||
28111330|NCT00079781|54769116|FG000|Follow-up Period|Death|0|||
28111331|NCT00079781|54769117|FG001|Follow-up Period|Death|0|||
28111332|NCT00079781|54769118|FG002|Follow-up Period|Death|1|||
28111333|NCT03176966|54769126|FG000|Baseline to 3 Months (1st Intervention)|Death|2|||
28111334|NCT03176966|54769127|FG001|Baseline to 3 Months (1st Intervention)|Death|1|||
28111335|NCT03176966|54769126|FG000|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|1|||
28111336|NCT03176966|54769127|FG001|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|4|||
28111337|NCT03176966|54769126|FG000|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|1|||
28111338|NCT03176966|54769127|FG001|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|2|||
28111339|NCT03176966|54769126|FG000|3 Month to 6 Months (2nd Intervention)|Death|0|||
28111340|NCT03176966|54769127|FG001|3 Month to 6 Months (2nd Intervention)|Death|1|||
28111341|NCT03176966|54769126|FG000|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|3|||
28111342|NCT03176966|54769127|FG001|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|4|||
28111343|NCT03176966|54769126|FG000|3 Month to 6 Months (2nd Intervention)|Physician Decision|1|||
28111344|NCT03176966|54769127|FG001|3 Month to 6 Months (2nd Intervention)|Physician Decision|0|||
28111345|NCT03176966|54769126|FG000|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|2|||
28111346|NCT03176966|54769127|FG001|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|0|||
28111347|NCT03175562|54769133|FG000|Overall Study|Adverse Event|1|||
27815921|NCT01890265|54272766|FG005|Overall Study|Adverse Event|0|||
27815922|NCT01890265|54272761|FG000|Overall Study|Death|2|||
27815923|NCT01890265|54272762|FG001|Overall Study|Death|3|||
27815924|NCT01890265|54272763|FG002|Overall Study|Death|1|||
27815925|NCT01890265|54272764|FG003|Overall Study|Death|0|||
27815926|NCT01890265|54272765|FG004|Overall Study|Death|0|||
27815927|NCT01890265|54272766|FG005|Overall Study|Death|0|||
27815928|NCT01890265|54272761|FG000|Overall Study|Withdrawal by Subject|0|||
27815929|NCT01890265|54272762|FG001|Overall Study|Withdrawal by Subject|2|||
27815930|NCT01890265|54272763|FG002|Overall Study|Withdrawal by Subject|3|||
27815931|NCT01890265|54272764|FG003|Overall Study|Withdrawal by Subject|0|||
27815932|NCT01890265|54272765|FG004|Overall Study|Withdrawal by Subject|2|||
27815933|NCT01890265|54272766|FG005|Overall Study|Withdrawal by Subject|0|||
27815934|NCT01928329|54272787|FG000|Overall Study|Withdrew Consent Prior to Receiving Drug|1|||
27815935|NCT01928329|54272788|FG001|Overall Study|Withdrew Consent Prior to Receiving Drug|3|||
27815936|NCT01928329|54272787|FG000|Overall Study|Removed from Study Prior to Receiving Dr|0|||
27815937|NCT01928329|54272788|FG001|Overall Study|Removed from Study Prior to Receiving Dr|1|||
27815938|NCT01928329|54272787|FG000|Overall Study|Adverse Event|5|||
27815939|NCT01928329|54272788|FG001|Overall Study|Adverse Event|3|||
27815940|NCT01928329|54272787|FG000|Overall Study|Stopping Rule: Lost Greater than 5kg|4|||
27815941|NCT01928329|54272788|FG001|Overall Study|Stopping Rule: Lost Greater than 5kg|1|||
27815942|NCT01928329|54272787|FG000|Overall Study|Withdrawal by Subject|1|||
27815943|NCT01928329|54272788|FG001|Overall Study|Withdrawal by Subject|5|||
27815944|NCT01928329|54272787|FG000|Overall Study|Physician Decision|1|||
27815945|NCT01928329|54272788|FG001|Overall Study|Physician Decision|1|||
27815946|NCT01890109|54272796|FG000|Overall Study|Withdrawal by Subject|0|||
27815947|NCT01890109|54272797|FG001|Overall Study|Withdrawal by Subject|3|||
27815948|NCT01890109|54272796|FG000|Overall Study|Lost to Follow-up|1|||
27815949|NCT01890109|54272797|FG001|Overall Study|Lost to Follow-up|2|||
27815950|NCT00982930|54272804|FG000|Overall Study|Adverse Event|1|||
27940229|NCT01194258|54596474|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
27815951|NCT00982930|54272804|FG000|Overall Study|Withdrawal by Subject|1|||
27940230|NCT01194258|54596475|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
27815952|NCT00982930|54272804|FG000|Overall Study|Administrative Problems|2|||
27815953|NCT00981682|54272808|FG000|Overall Study|Adverse Event|48|||
27815954|NCT00981682|54272808|FG000|Overall Study|Withdrawal by Subject|52|||
27815955|NCT00981682|54272808|FG000|Overall Study|Lost to Follow-up|14|||
28111348|NCT03175562|54769133|FG000|Overall Study|Lost to Follow-up|3|||
28111349|NCT03175562|54769133|FG000|Overall Study|Withdrawal by Subject|7|||
28111350|NCT03175562|54769133|FG000|Overall Study|Other (Not Specified)|5|||
28111351|NCT00079391|54769140|FG000|Overall Study|Withdrawal by Subject|1|||
28111352|NCT03209570|54769148|FG000|Overall Study|Death|1|||
28111353|NCT03209570|54769149|FG001|Overall Study|Death|0|||
28111354|NCT03209570|54769148|FG000|Overall Study|Incomplete Data|8|||
28111355|NCT03209570|54769149|FG001|Overall Study|Incomplete Data|10|||
28111356|NCT03209570|54769148|FG000|Overall Study|Protocol Violation|1|||
28111357|NCT03209570|54769149|FG001|Overall Study|Protocol Violation|0|||
28111358|NCT03209570|54769148|FG000|Overall Study|Withdrawal by Subject|0|||
28111359|NCT03209570|54769149|FG001|Overall Study|Withdrawal by Subject|3|||
28111360|NCT03209492|54769155|FG000|Overall Study|Case Report Forms Uncollected|5|||
28111361|NCT03208244|54769159|FG000|Overall Study|Death|1|||
28111362|NCT03175172|54769163|FG000|Overall Study|Death|3|||
28111363|NCT03175172|54769163|FG000|Overall Study|Withdrawal by Subject|3|||
28111364|NCT03175172|54769163|FG000|Overall Study|Lost to Follow-up|1|||
28111365|NCT03175172|54769163|FG000|Overall Study|Study Terminated by Sponsor|3|||
28111366|NCT03172364|54769169|FG000|Overall Study|Adverse Event|1|||
28111367|NCT03172364|54769170|FG001|Overall Study|Adverse Event|1|||
28111368|NCT03172364|54769169|FG000|Overall Study|Protocol Violation|1|||
28111369|NCT03172364|54769170|FG001|Overall Study|Protocol Violation|0|||
28111370|NCT00078767|54769178|FG000|Overall Study|Withdrawal by Subject|1|||
28111371|NCT00078767|54769179|FG001|Overall Study|Withdrawal by Subject|1|||
28111372|NCT03208088|54769185|FG000|Period 2|Withdrawal by Subject|0|||
28111373|NCT03208088|54769186|FG001|Period 2|Withdrawal by Subject|0|||
28111374|NCT03208088|54769187|FG002|Period 2|Withdrawal by Subject|0|||
28111375|NCT03208088|54769188|FG003|Period 2|Withdrawal by Subject|0|||
28111376|NCT03208088|54769189|FG004|Period 2|Withdrawal by Subject|0|||
28111377|NCT03208088|54769190|FG005|Period 2|Withdrawal by Subject|0|||
28111378|NCT03208088|54769191|FG006|Period 2|Withdrawal by Subject|0|||
28111379|NCT03208088|54769192|FG007|Period 2|Withdrawal by Subject|0|||
28111380|NCT03208088|54769193|FG008|Period 2|Withdrawal by Subject|1|||
28111381|NCT03208088|54769194|FG009|Period 2|Withdrawal by Subject|0|||
28111382|NCT03208088|54769185|FG000|Period 3|Unsatisfactory Test Article|0|||
28111383|NCT03208088|54769186|FG001|Period 3|Unsatisfactory Test Article|0|||
28111384|NCT03208088|54769187|FG002|Period 3|Unsatisfactory Test Article|0|||
28111385|NCT03208088|54769188|FG003|Period 3|Unsatisfactory Test Article|1|||
28111386|NCT03208088|54769189|FG004|Period 3|Unsatisfactory Test Article|0|||
28111387|NCT03208088|54769190|FG005|Period 3|Unsatisfactory Test Article|0|||
28111388|NCT03208088|54769191|FG006|Period 3|Unsatisfactory Test Article|0|||
28111389|NCT03208088|54769192|FG007|Period 3|Unsatisfactory Test Article|0|||
28111390|NCT03208088|54769193|FG008|Period 3|Unsatisfactory Test Article|0|||
28111391|NCT03208088|54769194|FG009|Period 3|Unsatisfactory Test Article|0|||
28111392|NCT03208088|54769185|FG000|Period 4|Unsatisfactory Test Article|0|||
28111393|NCT03208088|54769186|FG001|Period 4|Unsatisfactory Test Article|0|||
28111394|NCT03208088|54769187|FG002|Period 4|Unsatisfactory Test Article|0|||
28111395|NCT03208088|54769188|FG003|Period 4|Unsatisfactory Test Article|1|||
28111396|NCT03208088|54769189|FG004|Period 4|Unsatisfactory Test Article|0|||
28111397|NCT03208088|54769190|FG005|Period 4|Unsatisfactory Test Article|0|||
28111398|NCT03208088|54769191|FG006|Period 4|Unsatisfactory Test Article|0|||
28111399|NCT03208088|54769192|FG007|Period 4|Unsatisfactory Test Article|0|||
28111400|NCT03208088|54769193|FG008|Period 4|Unsatisfactory Test Article|0|||
28111401|NCT03208088|54769194|FG009|Period 4|Unsatisfactory Test Article|0|||
28111402|NCT00078377|54769209|FG000|Overall Study|Adverse Event|2|||
28111403|NCT00078377|54769210|FG001|Overall Study|Adverse Event|5|||
28111404|NCT00078377|54769211|FG002|Overall Study|Adverse Event|1|||
28111405|NCT00078377|54769209|FG000|Overall Study|Lack of Efficacy|2|||
28111406|NCT00078377|54769210|FG001|Overall Study|Lack of Efficacy|0|||
28111407|NCT00078377|54769211|FG002|Overall Study|Lack of Efficacy|2|||
28111408|NCT00078377|54769209|FG000|Overall Study|Lost to Follow-up|0|||
28111409|NCT00078377|54769210|FG001|Overall Study|Lost to Follow-up|1|||
28111410|NCT00078377|54769211|FG002|Overall Study|Lost to Follow-up|1|||
28111411|NCT00078377|54769209|FG000|Overall Study|Physician Decision|2|||
28111412|NCT00078377|54769210|FG001|Overall Study|Physician Decision|0|||
28111413|NCT00078377|54769211|FG002|Overall Study|Physician Decision|0|||
28111414|NCT00078377|54769209|FG000|Overall Study|Withdrawal by Subject|3|||
28111415|NCT00078377|54769210|FG001|Overall Study|Withdrawal by Subject|4|||
28111416|NCT00078377|54769211|FG002|Overall Study|Withdrawal by Subject|4|||
28111417|NCT00078377|54769209|FG000|Overall Study|Miscellaneous|2|||
28111418|NCT00078377|54769210|FG001|Overall Study|Miscellaneous|6|||
28111419|NCT00078377|54769211|FG002|Overall Study|Miscellaneous|1|||
28111420|NCT00886600|54769224|FG000|Double-blind Monotherapy|Adverse Event|1|||
28111421|NCT00886600|54769225|FG001|Double-blind Monotherapy|Adverse Event|1|||
28111422|NCT00886600|54769226|FG002|Double-blind Monotherapy|Adverse Event|1|||
28111423|NCT00886600|54769227|FG003|Double-blind Monotherapy|Adverse Event|1|||
28111424|NCT00886600|54769224|FG000|Double-blind Monotherapy|Protocol Violation|0|||
28111425|NCT00886600|54769225|FG001|Double-blind Monotherapy|Protocol Violation|0|||
28111426|NCT00886600|54769226|FG002|Double-blind Monotherapy|Protocol Violation|0|||
28111427|NCT00886600|54769227|FG003|Double-blind Monotherapy|Protocol Violation|1|||
28111428|NCT00886600|54769224|FG000|Double-blind Monotherapy|Withdrawal by Subject|1|||
28111429|NCT00886600|54769225|FG001|Double-blind Monotherapy|Withdrawal by Subject|0|||
28111430|NCT00886600|54769226|FG002|Double-blind Monotherapy|Withdrawal by Subject|0|||
28111431|NCT00886600|54769227|FG003|Double-blind Monotherapy|Withdrawal by Subject|0|||
28111432|NCT00886600|54769224|FG000|Combination Therapy Period|Adverse Event|0|||
28111433|NCT00886600|54769225|FG001|Combination Therapy Period|Adverse Event|0|||
28111434|NCT00886600|54769226|FG002|Combination Therapy Period|Adverse Event|1|||
28111435|NCT00886600|54769227|FG003|Combination Therapy Period|Adverse Event|0|||
28111436|NCT00886600|54769224|FG000|Combination Therapy Period|Protocol Violation|0|||
28111437|NCT00886600|54769225|FG001|Combination Therapy Period|Protocol Violation|0|||
28111438|NCT00886600|54769226|FG002|Combination Therapy Period|Protocol Violation|1|||
28111439|NCT00886600|54769227|FG003|Combination Therapy Period|Protocol Violation|0|||
28111440|NCT03172130|54769235|FG000|Overall Study|Failure to tolerate CPAP/Sham CPAP|3|||
28111441|NCT03172130|54769236|FG001|Overall Study|Failure to tolerate CPAP/Sham CPAP|1|||
28111442|NCT00870688|54769252|FG000|Overall Study|Lost to Follow-up|2|||
28111443|NCT00870688|54769252|FG000|Overall Study|Death, Unrelated|1|||
28111444|NCT00870688|54769252|FG000|Overall Study|Granules in the Stools|1|||
28111445|NCT00869128|54769255|FG000|Overall Study|lack of Compliance|6|||
28111446|NCT00869128|54769256|FG001|Overall Study|lack of Compliance|6|||
28111447|NCT00077675|54769262|FG000|Overall Study|Adverse Event|1|||
28111448|NCT00077675|54769263|FG001|Overall Study|Adverse Event|2|||
28111449|NCT00077675|54769262|FG000|Overall Study|Lost to Follow-up|6|||
28111450|NCT00077675|54769263|FG001|Overall Study|Lost to Follow-up|3|||
28111451|NCT00077675|54769262|FG000|Overall Study|Withdrawal by Subject|1|||
28111452|NCT00077675|54769263|FG001|Overall Study|Withdrawal by Subject|0|||
28111453|NCT00077675|54769262|FG000|Overall Study|Other|0|||
28111454|NCT00077675|54769263|FG001|Overall Study|Other|1|||
28111455|NCT00077675|54769262|FG000|Overall Study|Never received study treatment|3|||
28111456|NCT00077675|54769263|FG001|Overall Study|Never received study treatment|3|||
28111457|NCT02576444|54769280|FG000|Overall Study|Death|1|||
28111458|NCT02576444|54769281|FG001|Overall Study|Death|1|||
28111459|NCT02576444|54769282|FG002|Overall Study|Death|0|||
28111460|NCT02576444|54769283|FG003|Overall Study|Death|0|||
28111461|NCT02576444|54769280|FG000|Overall Study|Withdrawal by Subject|0|||
28111462|NCT02576444|54769281|FG001|Overall Study|Withdrawal by Subject|0|||
28111463|NCT02576444|54769282|FG002|Overall Study|Withdrawal by Subject|2|||
28111464|NCT02576444|54769283|FG003|Overall Study|Withdrawal by Subject|0|||
28111465|NCT02576444|54769280|FG000|Overall Study|Adverse Event|0|||
28111466|NCT02576444|54769281|FG001|Overall Study|Adverse Event|0|||
28111467|NCT02576444|54769282|FG002|Overall Study|Adverse Event|1|||
28111468|NCT02576444|54769283|FG003|Overall Study|Adverse Event|0|||
28111469|NCT02576444|54769280|FG000|Overall Study|Physician Decision|0|||
28111470|NCT02576444|54769281|FG001|Overall Study|Physician Decision|0|||
28111471|NCT02576444|54769282|FG002|Overall Study|Physician Decision|1|||
28111472|NCT02576444|54769283|FG003|Overall Study|Physician Decision|0|||
28111473|NCT00850174|54769294|FG000|Washout: One Week|Withdrawal by Subject|0|||
28111474|NCT00850174|54769295|FG001|Washout: One Week|Withdrawal by Subject|2|||
28111475|NCT00850174|54769294|FG000|Second Intervention|Withdrawal by Subject|1|||
28111476|NCT00850174|54769295|FG001|Second Intervention|Withdrawal by Subject|0|||
28111477|NCT00077207|54769306|FG000|Overall Study|Adverse Event|5|||
28111478|NCT00077207|54769306|FG000|Overall Study|Lack of Efficacy|12|||
28111479|NCT00077207|54769306|FG000|Overall Study|Physician Decision|6|||
28111480|NCT00077207|54769306|FG000|Overall Study|Withdrawal by Subject|6|||
28111481|NCT00077207|54769306|FG000|Overall Study|Ineligible|1|||
28111482|NCT03206918|54769311|FG000|Overall Study|Death|11|||
28111483|NCT03206918|54769311|FG000|Overall Study|Withdrawal by Subject|5|||
28111484|NCT03206918|54769311|FG000|Overall Study|Study terminated by sponsor|12|||
28111485|NCT03206918|54769311|FG000|Overall Study|Lost to Follow-up|3|||
28111486|NCT03206918|54769311|FG000|Overall Study|Transferred to extension study BGB-3111-LTE1 (NCT04170283)|60|||
28111487|NCT03206216|54769318|FG000|Overall Study|Withdrawal by Subject|0|||
28111488|NCT03206216|54769319|FG001|Overall Study|Withdrawal by Subject|1|||
28111489|NCT03169244|54769327|FG000|Overall Study|Lost to Follow-up|1|||
28111490|NCT03169244|54769328|FG001|Overall Study|Lost to Follow-up|2|||
28111491|NCT03169244|54769327|FG000|Overall Study|Adverse Event|1|||
28111492|NCT03169244|54769328|FG001|Overall Study|Adverse Event|0|||
28111493|NCT03169244|54769327|FG000|Overall Study|Withdrawal by Subject|2|||
28111494|NCT03169244|54769328|FG001|Overall Study|Withdrawal by Subject|2|||
28111495|NCT03169244|54769327|FG000|Overall Study|Physician Decision|1|||
28111496|NCT03169244|54769328|FG001|Overall Study|Physician Decision|0|||
28111497|NCT02486042|54769336|FG000|Overall Study|Physician Decision|1|||
28111498|NCT02486042|54769337|FG001|Overall Study|Physician Decision|7|||
28111499|NCT02486042|54769336|FG000|Overall Study|Hospital transfer|2|||
28111500|NCT02486042|54769337|FG001|Overall Study|Hospital transfer|2|||
28111501|NCT02486042|54769336|FG000|Overall Study|Withdrawal by Subject|0|||
28111502|NCT02486042|54769337|FG001|Overall Study|Withdrawal by Subject|2|||
28111503|NCT00057941|54769345|FG000|Overall Study|Death|1|||
28111504|NCT00057941|54769346|FG001|Overall Study|Death|2|||
28111505|NCT00057941|54769345|FG000|Overall Study|Adverse Event|7|||
28111506|NCT00057941|54769346|FG001|Overall Study|Adverse Event|9|||
28111507|NCT00057941|54769345|FG000|Overall Study|Lack of Efficacy|54|||
28111508|NCT00057941|54769346|FG001|Overall Study|Lack of Efficacy|53|||
28111509|NCT00057941|54769345|FG000|Overall Study|Withdrawal by Subject|6|||
28111510|NCT00057941|54769346|FG001|Overall Study|Withdrawal by Subject|1|||
28111511|NCT00057941|54769345|FG000|Overall Study|still on treatment|3|||
28111512|NCT00057941|54769346|FG001|Overall Study|still on treatment|1|||
28111513|NCT00057941|54769345|FG000|Overall Study|insurance, symptomatic deterioration|1|||
28111514|NCT00057941|54769346|FG001|Overall Study|insurance, symptomatic deterioration|3|||
28111515|NCT00057941|54769345|FG000|Overall Study|Ineligible|2|||
28111516|NCT00057941|54769346|FG001|Overall Study|Ineligible|5|||
28111517|NCT00075881|54769361|FG000|Overall Study|Lack of Efficacy|18|||
28111518|NCT00075881|54769361|FG000|Overall Study|Adverse Event|7|||
28111519|NCT00075881|54769361|FG000|Overall Study|Death|1|||
28111520|NCT00075881|54769361|FG000|Overall Study|Withdrawal by Subject|2|||
28111521|NCT00075881|54769361|FG000|Overall Study|Protocol Violation|4|||
28111522|NCT00075881|54769361|FG000|Overall Study|other complicating disease|3|||
28111523|NCT00075881|54769361|FG000|Overall Study|other|4|||
28111524|NCT00075881|54769361|FG000|Overall Study|missing data|2|||
28111525|NCT00075881|54769361|FG000|Overall Study|Ineligible|1|||
28111526|NCT00075881|54769361|FG000|Overall Study|never start protocol therapy|1|||
28064612|NCT00329420|54720234|FG001|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
28064613|NCT00329420|54720235|FG002|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
28064614|NCT00329420|54720233|FG000|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
28064615|NCT00329420|54720234|FG001|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
28064616|NCT00329420|54720235|FG002|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0|||
28064617|NCT00329420|54720233|FG000|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1|||
28064618|NCT00329420|54720234|FG001|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
28111527|NCT00838630|54769369|FG000|First Intervention|Adverse Event|1|||
28111528|NCT00838630|54769370|FG001|First Intervention|Adverse Event|0|||
28111529|NCT00838630|54769369|FG000|Washout: 7 Days|Protocol Violation|1|||
28111530|NCT00838630|54769370|FG001|Washout: 7 Days|Protocol Violation|0|||
28111531|NCT02996474|54769374|FG000|Overall Study|Physician Decision|5|||
28111532|NCT03667924|54769381|FG000|Baseline Completed|Lost to Follow-up|0|||
28111533|NCT03667924|54769382|FG001|Baseline Completed|Lost to Follow-up|2|||
28111534|NCT03667924|54769383|FG002|Baseline Completed|Lost to Follow-up|0|||
28111535|NCT03667924|54769381|FG000|1-month Completed/Training (Volunteers)|One client was hospitalized;|1|||
28111536|NCT03667924|54769382|FG001|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
28111537|NCT03667924|54769383|FG002|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
28111538|NCT03667924|54769381|FG000|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
28111539|NCT03667924|54769382|FG001|1-month Completed/Training (Volunteers)|Did not complete full training|16|||
28111540|NCT03667924|54769383|FG002|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
28111541|NCT03667924|54769381|FG000|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
28111542|NCT03667924|54769382|FG001|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
28111543|NCT03667924|54769383|FG002|1-month Completed/Training (Volunteers)|Lost to Follow-up|1|||
28111544|NCT03667924|54769381|FG000|3-month/Volunteers Who Enrolled Clients|Death|1|||
28111545|NCT03667924|54769382|FG001|3-month/Volunteers Who Enrolled Clients|Death|0|||
28111546|NCT03667924|54769383|FG002|3-month/Volunteers Who Enrolled Clients|Death|0|||
28111547|NCT03667924|54769381|FG000|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
28111548|NCT03667924|54769382|FG001|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|10|||
28111549|NCT03667924|54769383|FG002|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
28111550|NCT03667924|54769381|FG000|Post-study Interview Completed|Lost to Follow-up|0|||
28111551|NCT03667924|54769382|FG001|Post-study Interview Completed|Lost to Follow-up|1|||
28111552|NCT03667924|54769383|FG002|Post-study Interview Completed|Lost to Follow-up|0|||
28111553|NCT03205046|54769395|FG000|Overall Study|Death|10|||
28111554|NCT03205046|54769396|FG001|Overall Study|Death|6|||
28111555|NCT03205046|54769395|FG000|Overall Study|Withdrawal by Subject|1|||
28111556|NCT03205046|54769396|FG001|Overall Study|Withdrawal by Subject|2|||
28111557|NCT03205046|54769395|FG000|Overall Study|Lost to Follow-up|0|||
28111558|NCT03205046|54769396|FG001|Overall Study|Lost to Follow-up|1|||
28111559|NCT03205046|54769395|FG000|Overall Study|Study terminated by sponsor|2|||
28111560|NCT03205046|54769396|FG001|Overall Study|Study terminated by sponsor|1|||
28111561|NCT03204812|54769402|FG000|Overall Study|Adverse Event|3|||
28111562|NCT02339090|54769408|FG000|Overall Study|Adverse Event|1|||
28111563|NCT02339090|54769409|FG001|Overall Study|Adverse Event|0|||
28111564|NCT02339090|54769408|FG000|Overall Study|Lost to Follow-up|0|||
28111565|NCT02339090|54769409|FG001|Overall Study|Lost to Follow-up|1|||
28111566|NCT02339090|54769408|FG000|Overall Study|Non-compliance With Study Drug|0|||
28111567|NCT02339090|54769409|FG001|Overall Study|Non-compliance With Study Drug|1|||
28111568|NCT02339090|54769408|FG000|Overall Study|Withdrawal by Subject|2|||
28111569|NCT02339090|54769409|FG001|Overall Study|Withdrawal by Subject|1|||
28111570|NCT02339090|54769408|FG000|Overall Study|Poor Growth|3|||
28111571|NCT02339090|54769409|FG001|Overall Study|Poor Growth|0|||
28111572|NCT02339090|54769408|FG000|Overall Study|Randomized but not treated|0|||
28111573|NCT02339090|54769409|FG001|Overall Study|Randomized but not treated|2|||
28111574|NCT03524092|54769430|FG000|Blinded Maintenance Period (Wk 0-40)|Adverse Event|16|||
28111575|NCT03524092|54769431|FG001|Blinded Maintenance Period (Wk 0-40)|Adverse Event|6|||
28111576|NCT03524092|54769432|FG002|Blinded Maintenance Period (Wk 0-40)|Adverse Event|1|||
28111577|NCT03524092|54769433|FG003|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
28111578|NCT03524092|54769434|FG004|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
28111579|NCT03524092|54769435|FG005|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
28111580|NCT03524092|54769430|FG000|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|8|||
28111581|NCT03524092|54769431|FG001|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|6|||
28111582|NCT03524092|54769432|FG002|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|7|||
28111583|NCT03524092|54769433|FG003|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
28111584|NCT03524092|54769434|FG004|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
28111585|NCT03524092|54769435|FG005|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
28111586|NCT03524092|54769430|FG000|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
28111587|NCT03524092|54769431|FG001|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|1|||
28111588|NCT03524092|54769432|FG002|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
28111589|NCT03524092|54769433|FG003|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
28111590|NCT03524092|54769434|FG004|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
28111591|NCT03524092|54769435|FG005|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
28111592|NCT03524092|54769430|FG000|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
28111593|NCT03524092|54769431|FG001|Blinded Maintenance Period (Wk 0-40)|Physician Decision|1|||
28111594|NCT03524092|54769432|FG002|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
28111595|NCT03524092|54769433|FG003|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
28111596|NCT03524092|54769434|FG004|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
28111597|NCT03524092|54769435|FG005|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
28111598|NCT03524092|54769430|FG000|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
28111599|NCT03524092|54769431|FG001|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
28111600|NCT03524092|54769432|FG002|Blinded Maintenance Period (Wk 0-40)|Pregnancy|1|||
28111601|NCT03524092|54769433|FG003|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
28111602|NCT03524092|54769434|FG004|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
28111603|NCT03524092|54769435|FG005|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
28111604|NCT03524092|54769430|FG000|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
28111605|NCT03524092|54769431|FG001|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
28111606|NCT03524092|54769432|FG002|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
28111607|NCT03524092|54769433|FG003|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
28111608|NCT03524092|54769434|FG004|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
28111609|NCT03524092|54769435|FG005|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
28111610|NCT03524092|54769430|FG000|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|7|||
28111611|NCT03524092|54769431|FG001|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|8|||
28111612|NCT03524092|54769432|FG002|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|6|||
28111613|NCT03524092|54769433|FG003|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
28111614|NCT03524092|54769434|FG004|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
28111615|NCT03524092|54769435|FG005|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
28111616|NCT03524092|54769430|FG000|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|42|||
28111617|NCT03524092|54769431|FG001|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|19|||
28111618|NCT03524092|54769432|FG002|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|29|||
28111619|NCT03524092|54769433|FG003|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
28111620|NCT03524092|54769434|FG004|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
28111621|NCT03524092|54769435|FG005|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
28111622|NCT03524092|54769430|FG000|Loss of Response Rescue Period|Adverse Event|0|||
28111623|NCT03524092|54769431|FG001|Loss of Response Rescue Period|Adverse Event|0|||
28111624|NCT03524092|54769432|FG002|Loss of Response Rescue Period|Adverse Event|0|||
28111625|NCT03524092|54769433|FG003|Loss of Response Rescue Period|Adverse Event|2|||
28111626|NCT03524092|54769434|FG004|Loss of Response Rescue Period|Adverse Event|0|||
28111627|NCT03524092|54769435|FG005|Loss of Response Rescue Period|Adverse Event|0|||
28111628|NCT03524092|54769430|FG000|Loss of Response Rescue Period|Lack of Efficacy|0|||
28111629|NCT03524092|54769431|FG001|Loss of Response Rescue Period|Lack of Efficacy|0|||
28111630|NCT03524092|54769432|FG002|Loss of Response Rescue Period|Lack of Efficacy|0|||
28111631|NCT03524092|54769433|FG003|Loss of Response Rescue Period|Lack of Efficacy|5|||
27815956|NCT00981682|54272808|FG000|Overall Study|Lack of Efficacy|13|||
27815957|NCT00981682|54272808|FG000|Overall Study|Protocol Violation|6|||
27815958|NCT00981682|54272808|FG000|Overall Study|administrative|9|||
27815959|NCT01903993|54272814|FG000|Overall Study|Death|118|||
27815960|NCT01903993|54272815|FG001|Overall Study|Death|121|||
27815961|NCT01903993|54272814|FG000|Overall Study|Withdrawal by Subject|15|||
27815962|NCT01903993|54272815|FG001|Overall Study|Withdrawal by Subject|4|||
28064619|NCT00329420|54720235|FG002|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
28064620|NCT00329108|54720247|FG000|Overall Study|Adverse Event|2|||
28064621|NCT00329108|54720248|FG001|Overall Study|Adverse Event|2|||
28064622|NCT00329108|54720247|FG000|Overall Study|Lack of Efficacy|3|||
28064623|NCT00329108|54720248|FG001|Overall Study|Lack of Efficacy|3|||
28064624|NCT00329108|54720247|FG000|Overall Study|Withdrawal by Subject|0|||
28064625|NCT00329108|54720248|FG001|Overall Study|Withdrawal by Subject|2|||
28064626|NCT00329108|54720247|FG000|Overall Study|symptomatic deterioration|1|||
28064627|NCT00329108|54720248|FG001|Overall Study|symptomatic deterioration|1|||
28064628|NCT00329108|54720247|FG000|Overall Study|Subject no longer willing to participate|2|||
28064629|NCT00329108|54720248|FG001|Overall Study|Subject no longer willing to participate|2|||
28064630|NCT00329108|54720247|FG000|Overall Study|study terminated by sponsor|1|||
28064631|NCT00329108|54720248|FG001|Overall Study|study terminated by sponsor|0|||
28064632|NCT00329108|54720247|FG000|Overall Study|withdrew patient after SAE resolved|1|||
27815963|NCT01903993|54272814|FG000|Overall Study|Lost to Follow-up|2|||
28064633|NCT00329108|54720248|FG001|Overall Study|withdrew patient after SAE resolved|0|||
28064634|NCT00329108|54720247|FG000|Overall Study|Protocol Violation|0|||
27815964|NCT01903993|54272815|FG001|Overall Study|Lost to Follow-up|3|||
28111632|NCT03524092|54769434|FG004|Loss of Response Rescue Period|Lack of Efficacy|0|||
28111633|NCT03524092|54769435|FG005|Loss of Response Rescue Period|Lack of Efficacy|0|||
28111634|NCT03524092|54769430|FG000|Loss of Response Rescue Period|Pregnancy|0|||
28111635|NCT03524092|54769431|FG001|Loss of Response Rescue Period|Pregnancy|0|||
28111636|NCT03524092|54769432|FG002|Loss of Response Rescue Period|Pregnancy|0|||
28111637|NCT03524092|54769433|FG003|Loss of Response Rescue Period|Pregnancy|1|||
28111638|NCT03524092|54769434|FG004|Loss of Response Rescue Period|Pregnancy|0|||
28111639|NCT03524092|54769435|FG005|Loss of Response Rescue Period|Pregnancy|0|||
28111640|NCT03524092|54769430|FG000|Loss of Response Rescue Period|Withdrawal by Subject|0|||
28111641|NCT03524092|54769431|FG001|Loss of Response Rescue Period|Withdrawal by Subject|0|||
28111642|NCT03524092|54769432|FG002|Loss of Response Rescue Period|Withdrawal by Subject|0|||
28111643|NCT03524092|54769433|FG003|Loss of Response Rescue Period|Withdrawal by Subject|1|||
28111644|NCT03524092|54769434|FG004|Loss of Response Rescue Period|Withdrawal by Subject|0|||
28111645|NCT03524092|54769435|FG005|Loss of Response Rescue Period|Withdrawal by Subject|0|||
28111646|NCT03524092|54769430|FG000|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
28111647|NCT03524092|54769431|FG001|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
28111648|NCT03524092|54769432|FG002|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
28111649|NCT03524092|54769433|FG003|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
28111650|NCT03524092|54769434|FG004|Open Label Extended Induction (Wk 0-12)|Adverse Event|11|||
28111651|NCT03524092|54769435|FG005|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
28111652|NCT03524092|54769430|FG000|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
28111653|NCT03524092|54769431|FG001|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
28111654|NCT03524092|54769432|FG002|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
28111655|NCT03524092|54769433|FG003|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
28111656|NCT03524092|54769434|FG004|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|4|||
28111657|NCT03524092|54769435|FG005|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
28111658|NCT03524092|54769430|FG000|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
28111659|NCT03524092|54769431|FG001|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
28111660|NCT03524092|54769432|FG002|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
28111661|NCT03524092|54769433|FG003|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
28111662|NCT03524092|54769434|FG004|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|162|||
28111663|NCT03524092|54769435|FG005|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
28111664|NCT03524092|54769430|FG000|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
28111665|NCT03524092|54769431|FG001|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
28111666|NCT03524092|54769432|FG002|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
28111667|NCT03524092|54769433|FG003|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
28111668|NCT03524092|54769434|FG004|Open Label Extended Induction (Wk 0-12)|Physician Decision|1|||
28111669|NCT03524092|54769435|FG005|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
28111670|NCT03524092|54769430|FG000|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
28111671|NCT03524092|54769431|FG001|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
28111672|NCT03524092|54769432|FG002|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
28111673|NCT03524092|54769433|FG003|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
28111674|NCT03524092|54769434|FG004|Open Label Extended Induction (Wk 0-12)|Protocol Violation|5|||
28111675|NCT03524092|54769435|FG005|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
28111676|NCT03524092|54769430|FG000|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
28111677|NCT03524092|54769431|FG001|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
28111678|NCT03524092|54769432|FG002|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
28111679|NCT03524092|54769433|FG003|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
28111680|NCT03524092|54769434|FG004|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|6|||
28111681|NCT03524092|54769435|FG005|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
28111682|NCT03524092|54769430|FG000|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
28111683|NCT03524092|54769431|FG001|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
28111684|NCT03524092|54769432|FG002|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
28111685|NCT03524092|54769433|FG003|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
28111686|NCT03524092|54769434|FG004|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|1|||
28111687|NCT03524092|54769435|FG005|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
28111688|NCT03524092|54769430|FG000|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
28111689|NCT03524092|54769431|FG001|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
28111690|NCT03524092|54769432|FG002|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
28111691|NCT03524092|54769433|FG003|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
28111692|NCT03524092|54769434|FG004|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
28111693|NCT03524092|54769435|FG005|Open Label Maintenance Period (Wk 12-40)|Adverse Event|4|||
28111694|NCT03524092|54769430|FG000|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
28111695|NCT03524092|54769431|FG001|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
28111696|NCT03524092|54769432|FG002|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
28111697|NCT03524092|54769433|FG003|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
28111698|NCT03524092|54769434|FG004|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
28111699|NCT03524092|54769435|FG005|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|1|||
28111700|NCT03524092|54769430|FG000|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
28111701|NCT03524092|54769431|FG001|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
28111702|NCT03524092|54769432|FG002|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
28111703|NCT03524092|54769433|FG003|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
28111704|NCT03524092|54769434|FG004|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
28111705|NCT03524092|54769435|FG005|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|9|||
28111706|NCT03524092|54769430|FG000|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
28111707|NCT03524092|54769431|FG001|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
28111708|NCT03524092|54769432|FG002|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
28111709|NCT03524092|54769433|FG003|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
28111710|NCT03524092|54769434|FG004|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
28111711|NCT03524092|54769435|FG005|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|1|||
28111712|NCT03331562|54769448|FG000|Overall Study|Adverse Event|2|||
28111713|NCT03331562|54769449|FG001|Overall Study|Adverse Event|0|||
28111714|NCT03331562|54769448|FG000|Overall Study|Death|1|||
28111715|NCT03331562|54769449|FG001|Overall Study|Death|0|||
28111716|NCT02038634|54769461|FG000|Overall Study|Lost to Follow-up|0|||
28111717|NCT02038634|54769462|FG001|Overall Study|Lost to Follow-up|1|||
28111718|NCT00836056|54769470|FG000|First Intervention|Adverse Event|1|||
28111719|NCT00836056|54769471|FG001|First Intervention|Adverse Event|0|||
28111720|NCT03200912|54769478|FG000|Overall Study|Adverse Event|3|||
28111721|NCT03200912|54769479|FG001|Overall Study|Adverse Event|0|||
28111722|NCT03200912|54769480|FG002|Overall Study|Adverse Event|0|||
28111723|NCT03200912|54769478|FG000|Overall Study|Withdrawal by Subject|1|||
28111724|NCT03200912|54769479|FG001|Overall Study|Withdrawal by Subject|2|||
28111725|NCT03200912|54769480|FG002|Overall Study|Withdrawal by Subject|4|||
28111726|NCT03200912|54769478|FG000|Overall Study|Non-compliance with study drug|0|||
28111727|NCT03200912|54769479|FG001|Overall Study|Non-compliance with study drug|1|||
28111728|NCT03200912|54769480|FG002|Overall Study|Non-compliance with study drug|0|||
28111729|NCT00835666|54769490|FG000|Washout|Protocol Violation|1|||
28111730|NCT00835666|54769491|FG001|Washout|Protocol Violation|0|||
28111731|NCT00835666|54769490|FG000|Washout|Withdrawal by Subject|1|||
28111732|NCT00835666|54769491|FG001|Washout|Withdrawal by Subject|0|||
28111733|NCT03200366|54769505|FG000|Patient Navigation Intervention Given|Death|0|||
28111734|NCT03200366|54769506|FG001|Patient Navigation Intervention Given|Death|2|||
28111735|NCT03200366|54769507|FG002|Patient Navigation Intervention Given|Death|0|||
28111736|NCT03200366|54769505|FG000|Patient Navigation Intervention Given|Lost to Follow-up|0|||
28111737|NCT03200366|54769506|FG001|Patient Navigation Intervention Given|Lost to Follow-up|25|||
28111738|NCT03200366|54769507|FG002|Patient Navigation Intervention Given|Lost to Follow-up|0|||
28111739|NCT03200366|54769505|FG000|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
28064635|NCT00329108|54720248|FG001|Overall Study|Protocol Violation|2|||
28064636|NCT00329030|54720256|FG000|Overall Study|Withdrawal by Subject|1|||
28064637|NCT00329030|54720257|FG001|Overall Study|Withdrawal by Subject|3|||
28064638|NCT00329030|54720256|FG000|Overall Study|Progressive Disease|6|||
28064639|NCT00329030|54720257|FG001|Overall Study|Progressive Disease|2|||
28064640|NCT00329030|54720256|FG000|Overall Study|Ineligible Pathology|1|||
28064641|NCT00329030|54720257|FG001|Overall Study|Ineligible Pathology|1|||
28064642|NCT00328562|54720263|FG000|Overall Study|Disease progression|1|||
28064643|NCT00328172|54720272|FG000|Overall Study|Adverse Event|3|||
28064644|NCT00328172|54720273|FG001|Overall Study|Adverse Event|2|||
28064645|NCT00328172|54720274|FG002|Overall Study|Adverse Event|1|||
28064646|NCT00328172|54720275|FG003|Overall Study|Adverse Event|2|||
28064647|NCT00328172|54720276|FG004|Overall Study|Adverse Event|1|||
28064648|NCT00328172|54720272|FG000|Overall Study|Protocol Violation|0|||
28064649|NCT00328172|54720273|FG001|Overall Study|Protocol Violation|1|||
28064650|NCT00328172|54720274|FG002|Overall Study|Protocol Violation|1|||
28064651|NCT00328172|54720275|FG003|Overall Study|Protocol Violation|0|||
28064652|NCT00328172|54720276|FG004|Overall Study|Protocol Violation|0|||
28064653|NCT00328172|54720272|FG000|Overall Study|Lost to Follow-up|1|||
28064654|NCT00328172|54720273|FG001|Overall Study|Lost to Follow-up|1|||
28064655|NCT00328172|54720274|FG002|Overall Study|Lost to Follow-up|2|||
28064656|NCT00328172|54720275|FG003|Overall Study|Lost to Follow-up|1|||
28064657|NCT00328172|54720276|FG004|Overall Study|Lost to Follow-up|1|||
28111740|NCT03200366|54769506|FG001|Patient Navigation Intervention Given|Not attempted/missed by nurse|1|||
28111741|NCT03200366|54769507|FG002|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
27815965|NCT01903993|54272814|FG000|Overall Study|Study Terminated by Sponsor|8|||
27815966|NCT01903993|54272815|FG001|Overall Study|Study Terminated by Sponsor|14|||
28111742|NCT03200366|54769505|FG000|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
28111743|NCT03200366|54769506|FG001|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|2|||
28111744|NCT03200366|54769507|FG002|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
28111745|NCT03200366|54769505|FG000|Patient Navigation Intervention Given|Declined navigation intervention|0|||
28111746|NCT03200366|54769506|FG001|Patient Navigation Intervention Given|Declined navigation intervention|1|||
28111747|NCT03200366|54769507|FG002|Patient Navigation Intervention Given|Declined navigation intervention|0|||
28111748|NCT03200366|54769505|FG000|6 Month Post-Baseline Interview|Death|1|||
28111749|NCT03200366|54769506|FG001|6 Month Post-Baseline Interview|Death|1|||
28111750|NCT03200366|54769507|FG002|6 Month Post-Baseline Interview|Death|1|||
28111751|NCT03200366|54769505|FG000|6 Month Post-Baseline Interview|Lost to Follow-up|27|||
28111752|NCT03200366|54769506|FG001|6 Month Post-Baseline Interview|Lost to Follow-up|21|||
28111753|NCT03200366|54769507|FG002|6 Month Post-Baseline Interview|Lost to Follow-up|17|||
28111754|NCT03200366|54769505|FG000|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
28111755|NCT03200366|54769506|FG001|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
28111756|NCT03200366|54769507|FG002|6 Month Post-Baseline Interview|Withdrawal by Subject|0|||
28111757|NCT03200366|54769505|FG000|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|1|||
28111758|NCT03200366|54769506|FG001|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
28111759|NCT03200366|54769507|FG002|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
28111760|NCT03200366|54769505|FG000|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
28111761|NCT03200366|54769506|FG001|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
28111762|NCT03200366|54769507|FG002|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|1|||
28111763|NCT03200366|54769505|FG000|9 Month Post-Baseline Interview|Death|1|||
28111764|NCT03200366|54769506|FG001|9 Month Post-Baseline Interview|Death|1|||
28111765|NCT03200366|54769507|FG002|9 Month Post-Baseline Interview|Death|1|||
28111766|NCT03200366|54769505|FG000|9 Month Post-Baseline Interview|Lost to Follow-up|23|||
28111767|NCT03200366|54769506|FG001|9 Month Post-Baseline Interview|Lost to Follow-up|18|||
28111768|NCT03200366|54769507|FG002|9 Month Post-Baseline Interview|Lost to Follow-up|9|||
28111769|NCT03200366|54769505|FG000|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
27815967|NCT01903993|54272814|FG000|Overall Study|Terminated by Sponsor After 31 Aug 2018|0|||
28111770|NCT03200366|54769506|FG001|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
28111771|NCT03200366|54769507|FG002|9 Month Post-Baseline Interview|Withdrawal by PI|1|||
28111772|NCT03200366|54769505|FG000|9 Month Post-Baseline Interview|Refused interview|0|||
28111773|NCT03200366|54769506|FG001|9 Month Post-Baseline Interview|Refused interview|2|||
28111774|NCT03200366|54769507|FG002|9 Month Post-Baseline Interview|Refused interview|0|||
28111775|NCT00835354|54769519|FG000|First Intervention|Adverse Event|0|||
28111776|NCT00835354|54769520|FG001|First Intervention|Adverse Event|1|||
28111777|NCT00835042|54769551|FG000|First Intervention|Withdrawal by Subject|3|||
28111778|NCT00835042|54769552|FG001|First Intervention|Withdrawal by Subject|0|||
28111779|NCT00835042|54769551|FG000|First Intervention|Adverse Event|1|||
28111780|NCT00835042|54769552|FG001|First Intervention|Adverse Event|2|||
28111781|NCT00835042|54769551|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
28111782|NCT00835042|54769552|FG001|Washout of 21 Days|Withdrawal by Subject|2|||
28111783|NCT00834418|54769589|FG000|Overall Study|Adverse Event|0|||
28111784|NCT00834418|54769590|FG001|Overall Study|Adverse Event|2|||
28111785|NCT00834340|54769596|FG000|Washout|Adverse Event|1|||
28111786|NCT00834340|54769597|FG001|Washout|Adverse Event|0|||
28111787|NCT00834340|54769596|FG000|Washout|Withdrawal by Subject|1|||
28111788|NCT00834340|54769597|FG001|Washout|Withdrawal by Subject|0|||
28111789|NCT00151996|54769603|FG000|Overall Study|Adverse Event|3|||
28111790|NCT00151996|54769604|FG001|Overall Study|Adverse Event|2|||
28111791|NCT00151996|54769603|FG000|Overall Study|Withdrawal by Subject|1|||
28111792|NCT00151996|54769604|FG001|Overall Study|Withdrawal by Subject|1|||
28111793|NCT00151996|54769603|FG000|Overall Study|Protocol Violation|1|||
28111794|NCT00151996|54769604|FG001|Overall Study|Protocol Violation|2|||
28111795|NCT00151996|54769603|FG000|Overall Study|Sponsor's decision|0|||
28111796|NCT00151996|54769604|FG001|Overall Study|Sponsor's decision|2|||
27815968|NCT01903993|54272815|FG001|Overall Study|Terminated by Sponsor After 31 Aug 2018|2|||
27815969|NCT00981292|54272828|FG000|Day 1|Protocol Violation|1|||
27815970|NCT00981292|54272829|FG001|Day 1|Protocol Violation|0|||
27815971|NCT00981292|54272830|FG002|Day 1|Protocol Violation|0|||
27815972|NCT00981292|54272831|FG003|Day 1|Protocol Violation|0|||
27815973|NCT00981292|54272832|FG004|Day 1|Protocol Violation|0|||
27815974|NCT00981292|54272833|FG005|Day 1|Protocol Violation|2|||
27815975|NCT00981292|54272828|FG000|Day 2|Protocol Violation|2|||
27815976|NCT00981292|54272829|FG001|Day 2|Protocol Violation|0|||
27815977|NCT00981292|54272830|FG002|Day 2|Protocol Violation|0|||
27815978|NCT00981292|54272831|FG003|Day 2|Protocol Violation|0|||
27815979|NCT00981292|54272832|FG004|Day 2|Protocol Violation|0|||
27815980|NCT00981292|54272833|FG005|Day 2|Protocol Violation|0|||
27815981|NCT00981292|54272828|FG000|Day 3|Protocol Violation|0|||
27815982|NCT00981292|54272829|FG001|Day 3|Protocol Violation|0|||
27815983|NCT00981292|54272830|FG002|Day 3|Protocol Violation|0|||
28111797|NCT00830206|54769612|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
28111798|NCT00830206|54769613|FG001|Washout: 21 Days|Withdrawal by Subject|1|||
28111799|NCT00829504|54769619|FG000|First Intervention|Adverse Event|1|||
28111800|NCT00829504|54769620|FG001|First Intervention|Adverse Event|0|||
28111801|NCT00829504|54769619|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
28111802|NCT00829504|54769620|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
28111803|NCT00829504|54769619|FG000|Second Intervention|Physician Decision|1|||
28111804|NCT00829504|54769620|FG001|Second Intervention|Physician Decision|0|||
28111805|NCT00829426|54769626|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
28111806|NCT00829426|54769627|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
28111807|NCT00152464|54769633|FG000|Overall Study|Adverse Event|3|||
28111808|NCT00152464|54769634|FG001|Overall Study|Adverse Event|6|||
28111809|NCT00152464|54769633|FG000|Overall Study|Lost to Follow-up|8|||
28111810|NCT00152464|54769634|FG001|Overall Study|Lost to Follow-up|4|||
28111811|NCT00152464|54769633|FG000|Overall Study|Protocol Violation|3|||
28111812|NCT00152464|54769634|FG001|Overall Study|Protocol Violation|1|||
28111813|NCT00152464|54769633|FG000|Overall Study|Withdrawal by Subject|21|||
28111814|NCT00152464|54769634|FG001|Overall Study|Withdrawal by Subject|22|||
28111815|NCT00152464|54769633|FG000|Overall Study|Atopic dermatitis poorly controlled|0|||
27815984|NCT00981292|54272831|FG003|Day 3|Protocol Violation|0|||
27815985|NCT00981292|54272832|FG004|Day 3|Protocol Violation|0|||
27815986|NCT00981292|54272833|FG005|Day 3|Protocol Violation|1|||
28111816|NCT00152464|54769634|FG001|Overall Study|Atopic dermatitis poorly controlled|1|||
28111817|NCT00152464|54769633|FG000|Overall Study|Eczema deterioration|0|||
28111818|NCT00152464|54769634|FG001|Overall Study|Eczema deterioration|1|||
27815987|NCT00980044|54272848|FG000|Overall Study|Withdrawal by Subject|5|||
27815988|NCT00980044|54272849|FG001|Overall Study|Withdrawal by Subject|7|||
28111819|NCT00152464|54769633|FG000|Overall Study|Parent decision|1|||
28111820|NCT00152464|54769634|FG001|Overall Study|Parent decision|1|||
28111821|NCT00152464|54769633|FG000|Overall Study|Investigator decision|1|||
28111822|NCT00152464|54769634|FG001|Overall Study|Investigator decision|0|||
28111823|NCT00152464|54769633|FG000|Overall Study|Lack of Efficacy|1|||
28111824|NCT00152464|54769634|FG001|Overall Study|Lack of Efficacy|0|||
28111825|NCT00152464|54769633|FG000|Overall Study|Eczema poorly controlled|1|||
28111826|NCT00152464|54769634|FG001|Overall Study|Eczema poorly controlled|0|||
28111827|NCT00152464|54769633|FG000|Overall Study|Patient relocated|1|||
28111828|NCT00152464|54769634|FG001|Overall Study|Patient relocated|0|||
28111829|NCT00674440|54769640|FG000|Overall Study|consented but not scanned (Withdrawn due to genetics)|1|||
28111830|NCT00674440|54769640|FG000|Overall Study|did not have surgery, so unevaluable|7|||
28111831|NCT00674440|54769640|FG000|Overall Study|had atypical histology or had second PET scan after initial surgery - not counted twice|3|||
28111832|NCT02742766|54769664|FG000|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
28111833|NCT02742766|54769665|FG001|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
28111834|NCT02742766|54769666|FG002|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
28111835|NCT02742766|54769667|FG003|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
28111836|NCT02742766|54769668|FG004|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
28111837|NCT02742766|54769669|FG005|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
28111838|NCT02742766|54769670|FG006|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
28111839|NCT02742766|54769671|FG007|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
28111840|NCT02742766|54769672|FG008|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
28111841|NCT02742766|54769673|FG009|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
28111842|NCT02742766|54769674|FG010|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
28111843|NCT02742766|54769675|FG011|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
28111844|NCT02742766|54769676|FG012|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
28111845|NCT02742766|54769677|FG013|Part 2 (Up to 22 Days)|Withdrawal by Subject|1|||
28111846|NCT02742766|54769678|FG014|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
28111847|NCT02742766|54769679|FG015|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
28111848|NCT02742766|54769680|FG016|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
28111849|NCT02742766|54769681|FG017|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
28111850|NCT02742766|54769682|FG018|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
28111851|NCT02742766|54769664|FG000|Part 2 (Up to 22 Days)|Physician Decision|0|||
28111852|NCT02742766|54769665|FG001|Part 2 (Up to 22 Days)|Physician Decision|0|||
28111853|NCT02742766|54769666|FG002|Part 2 (Up to 22 Days)|Physician Decision|0|||
28111854|NCT02742766|54769667|FG003|Part 2 (Up to 22 Days)|Physician Decision|0|||
28111855|NCT02742766|54769668|FG004|Part 2 (Up to 22 Days)|Physician Decision|0|||
28111856|NCT02742766|54769669|FG005|Part 2 (Up to 22 Days)|Physician Decision|0|||
28111857|NCT02742766|54769670|FG006|Part 2 (Up to 22 Days)|Physician Decision|0|||
28111858|NCT02742766|54769671|FG007|Part 2 (Up to 22 Days)|Physician Decision|0|||
28111859|NCT02742766|54769672|FG008|Part 2 (Up to 22 Days)|Physician Decision|0|||
28111860|NCT02742766|54769673|FG009|Part 2 (Up to 22 Days)|Physician Decision|0|||
28111861|NCT02742766|54769674|FG010|Part 2 (Up to 22 Days)|Physician Decision|0|||
28111862|NCT02742766|54769675|FG011|Part 2 (Up to 22 Days)|Physician Decision|0|||
28111863|NCT02742766|54769676|FG012|Part 2 (Up to 22 Days)|Physician Decision|2|||
27815989|NCT00980044|54272850|FG002|Overall Study|Withdrawal by Subject|3|||
27815990|NCT00980044|54272848|FG000|Overall Study|Protocol Violation|0|||
28111864|NCT02742766|54769677|FG013|Part 2 (Up to 22 Days)|Physician Decision|5|||
28111865|NCT02742766|54769678|FG014|Part 2 (Up to 22 Days)|Physician Decision|0|||
28111866|NCT02742766|54769679|FG015|Part 2 (Up to 22 Days)|Physician Decision|1|||
28111867|NCT02742766|54769680|FG016|Part 2 (Up to 22 Days)|Physician Decision|0|||
28111868|NCT02742766|54769681|FG017|Part 2 (Up to 22 Days)|Physician Decision|0|||
28111869|NCT02742766|54769682|FG018|Part 2 (Up to 22 Days)|Physician Decision|0|||
28111870|NCT01468922|54769760|FG000|Overall Study|Screening failure|0|||
28111871|NCT01468922|54769761|FG001|Overall Study|Screening failure|0|||
28111872|NCT01468922|54769762|FG002|Overall Study|Screening failure|0|||
28111873|NCT01468922|54769763|FG003|Overall Study|Screening failure|0|||
28111874|NCT01468922|54769764|FG004|Overall Study|Screening failure|0|||
28111875|NCT01468922|54769765|FG005|Overall Study|Screening failure|0|||
28111876|NCT01468922|54769766|FG006|Overall Study|Screening failure|0|||
28111877|NCT01468922|54769767|FG007|Overall Study|Screening failure|0|||
28111878|NCT01468922|54769768|FG008|Overall Study|Screening failure|1|||
28111879|NCT01468922|54769760|FG000|Overall Study|Per patient choice|1|||
28111880|NCT01468922|54769761|FG001|Overall Study|Per patient choice|0|||
28111881|NCT01468922|54769762|FG002|Overall Study|Per patient choice|0|||
28111882|NCT01468922|54769763|FG003|Overall Study|Per patient choice|0|||
28111883|NCT01468922|54769764|FG004|Overall Study|Per patient choice|0|||
28111884|NCT01468922|54769765|FG005|Overall Study|Per patient choice|0|||
28111885|NCT01468922|54769766|FG006|Overall Study|Per patient choice|0|||
28111886|NCT01468922|54769767|FG007|Overall Study|Per patient choice|0|||
28111887|NCT01468922|54769768|FG008|Overall Study|Per patient choice|0|||
28111888|NCT01468922|54769760|FG000|Overall Study|Switched to alternative treatment|1|||
28111889|NCT01468922|54769761|FG001|Overall Study|Switched to alternative treatment|0|||
28111890|NCT01468922|54769762|FG002|Overall Study|Switched to alternative treatment|0|||
28111891|NCT01468922|54769763|FG003|Overall Study|Switched to alternative treatment|0|||
28111892|NCT01468922|54769764|FG004|Overall Study|Switched to alternative treatment|1|||
28111893|NCT01468922|54769765|FG005|Overall Study|Switched to alternative treatment|0|||
28111894|NCT01468922|54769766|FG006|Overall Study|Switched to alternative treatment|0|||
28111895|NCT01468922|54769767|FG007|Overall Study|Switched to alternative treatment|0|||
28111896|NCT01468922|54769768|FG008|Overall Study|Switched to alternative treatment|0|||
28111897|NCT01468922|54769760|FG000|Overall Study|Enrolled on new protocol|0|||
28111898|NCT01468922|54769761|FG001|Overall Study|Enrolled on new protocol|0|||
28111899|NCT01468922|54769762|FG002|Overall Study|Enrolled on new protocol|0|||
28111900|NCT01468922|54769763|FG003|Overall Study|Enrolled on new protocol|0|||
28111901|NCT01468922|54769764|FG004|Overall Study|Enrolled on new protocol|1|||
28111902|NCT01468922|54769765|FG005|Overall Study|Enrolled on new protocol|0|||
28111903|NCT01468922|54769766|FG006|Overall Study|Enrolled on new protocol|0|||
28111904|NCT01468922|54769767|FG007|Overall Study|Enrolled on new protocol|0|||
28111905|NCT01468922|54769768|FG008|Overall Study|Enrolled on new protocol|0|||
28111906|NCT01468922|54769760|FG000|Overall Study|Adverse Event|0|||
28111907|NCT01468922|54769761|FG001|Overall Study|Adverse Event|0|||
28111908|NCT01468922|54769762|FG002|Overall Study|Adverse Event|0|||
28111909|NCT01468922|54769763|FG003|Overall Study|Adverse Event|0|||
28111910|NCT01468922|54769764|FG004|Overall Study|Adverse Event|0|||
28111911|NCT01468922|54769765|FG005|Overall Study|Adverse Event|0|||
28111912|NCT01468922|54769766|FG006|Overall Study|Adverse Event|0|||
28111913|NCT01468922|54769767|FG007|Overall Study|Adverse Event|1|||
28111914|NCT01468922|54769768|FG008|Overall Study|Adverse Event|0|||
28111915|NCT01468922|54769760|FG000|Overall Study|Infection of blood|0|||
28111916|NCT01468922|54769761|FG001|Overall Study|Infection of blood|0|||
28111917|NCT01468922|54769762|FG002|Overall Study|Infection of blood|0|||
28111918|NCT01468922|54769763|FG003|Overall Study|Infection of blood|0|||
28111919|NCT01468922|54769764|FG004|Overall Study|Infection of blood|0|||
28111920|NCT01468922|54769765|FG005|Overall Study|Infection of blood|0|||
28111921|NCT01468922|54769766|FG006|Overall Study|Infection of blood|0|||
28111922|NCT01468922|54769767|FG007|Overall Study|Infection of blood|1|||
28111923|NCT01468922|54769768|FG008|Overall Study|Infection of blood|0|||
28111924|NCT01468922|54769760|FG000|Overall Study|Patient choice - surgery|0|||
28111925|NCT01468922|54769761|FG001|Overall Study|Patient choice - surgery|0|||
28111926|NCT01468922|54769762|FG002|Overall Study|Patient choice - surgery|0|||
28111927|NCT01468922|54769763|FG003|Overall Study|Patient choice - surgery|0|||
28111928|NCT01468922|54769764|FG004|Overall Study|Patient choice - surgery|0|||
28111929|NCT01468922|54769765|FG005|Overall Study|Patient choice - surgery|0|||
28111930|NCT01468922|54769766|FG006|Overall Study|Patient choice - surgery|0|||
28111931|NCT01468922|54769767|FG007|Overall Study|Patient choice - surgery|1|||
28111932|NCT01468922|54769768|FG008|Overall Study|Patient choice - surgery|0|||
28111933|NCT01468922|54769760|FG000|Overall Study|Refused further treatment|0|||
28111934|NCT01468922|54769761|FG001|Overall Study|Refused further treatment|0|||
28111935|NCT01468922|54769762|FG002|Overall Study|Refused further treatment|0|||
28111936|NCT01468922|54769763|FG003|Overall Study|Refused further treatment|0|||
28111937|NCT01468922|54769764|FG004|Overall Study|Refused further treatment|0|||
28111938|NCT01468922|54769765|FG005|Overall Study|Refused further treatment|0|||
28111939|NCT01468922|54769766|FG006|Overall Study|Refused further treatment|0|||
28111940|NCT01468922|54769767|FG007|Overall Study|Refused further treatment|1|||
28111941|NCT01468922|54769768|FG008|Overall Study|Refused further treatment|0|||
28111942|NCT01381094|54769791|FG000|Overall Study|Adverse Event|1|||
28111943|NCT01381094|54769792|FG001|Overall Study|Adverse Event|2|||
28111944|NCT01381094|54769793|FG002|Overall Study|Adverse Event|0|||
28111945|NCT01381094|54769794|FG003|Overall Study|Adverse Event|1|||
28111946|NCT01381094|54769795|FG004|Overall Study|Adverse Event|0|||
28111947|NCT01381094|54769791|FG000|Overall Study|Lost to Follow-up|0|||
28111948|NCT01381094|54769792|FG001|Overall Study|Lost to Follow-up|0|||
28111949|NCT01381094|54769793|FG002|Overall Study|Lost to Follow-up|0|||
28111950|NCT01381094|54769794|FG003|Overall Study|Lost to Follow-up|0|||
28111951|NCT01381094|54769795|FG004|Overall Study|Lost to Follow-up|1|||
27815991|NCT00980044|54272849|FG001|Overall Study|Protocol Violation|0|||
27815992|NCT00980044|54272850|FG002|Overall Study|Protocol Violation|2|||
27815993|NCT01903837|54272865|FG000|Part A|Withdrawal by Subject|4|||
27815994|NCT01903837|54272866|FG001|Part A|Withdrawal by Subject|9|||
27815995|NCT01903837|54272867|FG002|Part A|Withdrawal by Subject|8|||
27815996|NCT01903837|54272868|FG003|Part A|Withdrawal by Subject|5|||
28111952|NCT01381094|54769791|FG000|Overall Study|Withdrawal of informed consent|0|||
28111953|NCT01381094|54769792|FG001|Overall Study|Withdrawal of informed consent|1|||
28111954|NCT01381094|54769793|FG002|Overall Study|Withdrawal of informed consent|0|||
28111955|NCT01381094|54769794|FG003|Overall Study|Withdrawal of informed consent|0|||
28111956|NCT01381094|54769795|FG004|Overall Study|Withdrawal of informed consent|0|||
28111957|NCT01381094|54769791|FG000|Overall Study|Participant given Aranesp injection|1|||
28111958|NCT01381094|54769792|FG001|Overall Study|Participant given Aranesp injection|0|||
28111959|NCT01381094|54769793|FG002|Overall Study|Participant given Aranesp injection|0|||
28111960|NCT01381094|54769794|FG003|Overall Study|Participant given Aranesp injection|0|||
28111961|NCT01381094|54769795|FG004|Overall Study|Participant given Aranesp injection|0|||
28111962|NCT03197558|54769807|FG000|Overall Study|Tubes not placed|1|||
28111963|NCT03197324|54769813|FG000|Overall Study|Adverse Event|0|||
28111964|NCT03197324|54769814|FG001|Overall Study|Adverse Event|1|||
28111965|NCT03162614|54769826|FG000|Overall Study|Lost to Follow-up|2|||
28111966|NCT03162614|54769827|FG001|Overall Study|Lost to Follow-up|1|||
28111967|NCT03162614|54769828|FG002|Overall Study|Lost to Follow-up|1|||
28111968|NCT03162614|54769829|FG003|Overall Study|Lost to Follow-up|1|||
28111969|NCT03162614|54769830|FG004|Overall Study|Lost to Follow-up|2|||
28111970|NCT03162614|54769831|FG005|Overall Study|Lost to Follow-up|0|||
28111971|NCT03162614|54769826|FG000|Overall Study|Protocol Violation|0|||
28111972|NCT03162614|54769827|FG001|Overall Study|Protocol Violation|1|||
28111973|NCT03162614|54769828|FG002|Overall Study|Protocol Violation|0|||
28111974|NCT03162614|54769829|FG003|Overall Study|Protocol Violation|1|||
28111975|NCT03162614|54769830|FG004|Overall Study|Protocol Violation|0|||
28111976|NCT03162614|54769831|FG005|Overall Study|Protocol Violation|0|||
28111977|NCT03162614|54769826|FG000|Overall Study|Withdrawal by Subject|2|||
28111978|NCT03162614|54769827|FG001|Overall Study|Withdrawal by Subject|1|||
28111979|NCT03162614|54769828|FG002|Overall Study|Withdrawal by Subject|1|||
28111980|NCT03162614|54769829|FG003|Overall Study|Withdrawal by Subject|1|||
28111981|NCT03162614|54769830|FG004|Overall Study|Withdrawal by Subject|0|||
28111982|NCT03162614|54769831|FG005|Overall Study|Withdrawal by Subject|0|||
28111983|NCT03162614|54769826|FG000|Overall Study|Missed vaccination, exclusion criteria|2|||
28111984|NCT03162614|54769827|FG001|Overall Study|Missed vaccination, exclusion criteria|2|||
28111985|NCT03162614|54769828|FG002|Overall Study|Missed vaccination, exclusion criteria|2|||
28111986|NCT03162614|54769829|FG003|Overall Study|Missed vaccination, exclusion criteria|4|||
28111987|NCT03162614|54769830|FG004|Overall Study|Missed vaccination, exclusion criteria|3|||
28111988|NCT03162614|54769831|FG005|Overall Study|Missed vaccination, exclusion criteria|0|||
28111989|NCT03160898|54769849|FG000|Overall Study|Adverse Event|4|||
28111990|NCT03160898|54769850|FG001|Overall Study|Adverse Event|8|||
28111991|NCT03160898|54769851|FG002|Overall Study|Adverse Event|7|||
28111992|NCT03160898|54769852|FG003|Overall Study|Adverse Event|10|||
28111993|NCT03160898|54769849|FG000|Overall Study|Death|1|||
28111994|NCT03160898|54769850|FG001|Overall Study|Death|0|||
28111995|NCT03160898|54769851|FG002|Overall Study|Death|0|||
28111996|NCT03160898|54769852|FG003|Overall Study|Death|1|||
28111997|NCT03160898|54769849|FG000|Overall Study|Difficulty Traveling to Clinic Visits|3|||
28111998|NCT03160898|54769850|FG001|Overall Study|Difficulty Traveling to Clinic Visits|0|||
28111999|NCT03160898|54769851|FG002|Overall Study|Difficulty Traveling to Clinic Visits|0|||
27815997|NCT01903837|54272865|FG000|Part A|Adverse Event|3|||
27815998|NCT01903837|54272866|FG001|Part A|Adverse Event|6|||
28112000|NCT03160898|54769852|FG003|Overall Study|Difficulty Traveling to Clinic Visits|1|||
28112001|NCT03160898|54769849|FG000|Overall Study|Lost to Follow-up|1|||
28112002|NCT03160898|54769850|FG001|Overall Study|Lost to Follow-up|1|||
28112003|NCT03160898|54769851|FG002|Overall Study|Lost to Follow-up|1|||
28112004|NCT03160898|54769852|FG003|Overall Study|Lost to Follow-up|2|||
28112005|NCT03160898|54769849|FG000|Overall Study|Physician Decision|1|||
28112006|NCT03160898|54769850|FG001|Overall Study|Physician Decision|0|||
28112007|NCT03160898|54769851|FG002|Overall Study|Physician Decision|0|||
28112008|NCT03160898|54769852|FG003|Overall Study|Physician Decision|1|||
28112009|NCT03160898|54769849|FG000|Overall Study|Progressive Disease|4|||
28112010|NCT03160898|54769850|FG001|Overall Study|Progressive Disease|1|||
28112011|NCT03160898|54769851|FG002|Overall Study|Progressive Disease|2|||
28112012|NCT03160898|54769852|FG003|Overall Study|Progressive Disease|1|||
28112013|NCT03160898|54769849|FG000|Overall Study|Protocol Violation|1|||
28112014|NCT03160898|54769850|FG001|Overall Study|Protocol Violation|0|||
28112015|NCT03160898|54769851|FG002|Overall Study|Protocol Violation|2|||
28112016|NCT03160898|54769852|FG003|Overall Study|Protocol Violation|0|||
28112017|NCT03160898|54769849|FG000|Overall Study|Sponsor Discretion|2|||
28112018|NCT03160898|54769850|FG001|Overall Study|Sponsor Discretion|0|||
28112019|NCT03160898|54769851|FG002|Overall Study|Sponsor Discretion|0|||
28112020|NCT03160898|54769852|FG003|Overall Study|Sponsor Discretion|0|||
28112021|NCT03160898|54769849|FG000|Overall Study|Withdrawal by Subject|1|||
28112022|NCT03160898|54769850|FG001|Overall Study|Withdrawal by Subject|3|||
28112023|NCT03160898|54769851|FG002|Overall Study|Withdrawal by Subject|2|||
28112024|NCT03160898|54769852|FG003|Overall Study|Withdrawal by Subject|1|||
28112025|NCT03160898|54769849|FG000|Overall Study|Other|2|||
28112026|NCT03160898|54769850|FG001|Overall Study|Other|0|||
28112027|NCT03160898|54769851|FG002|Overall Study|Other|2|||
28112028|NCT03160898|54769852|FG003|Overall Study|Other|2|||
28112029|NCT03193736|54769863|FG000|Overall Study|Death|2|||
28112030|NCT03193736|54769863|FG000|Overall Study|Withdrawal by Subject|1|||
28112031|NCT03193736|54769863|FG000|Overall Study|Lost to Follow-up|1|||
28112032|NCT03193736|54769863|FG000|Overall Study|implant not received|1|||
28112033|NCT03192488|54769880|FG000|First Washout (>6d)|Withdrawal by Subject|0|||
28112034|NCT03192488|54769881|FG001|First Washout (>6d)|Withdrawal by Subject|0|||
28112035|NCT03192488|54769882|FG002|First Washout (>6d)|Withdrawal by Subject|1|||
28112036|NCT03192488|54769883|FG003|First Washout (>6d)|Withdrawal by Subject|0|||
28112037|NCT03192488|54769884|FG004|First Washout (>6d)|Withdrawal by Subject|0|||
28112038|NCT03192488|54769885|FG005|First Washout (>6d)|Withdrawal by Subject|1|||
28112039|NCT03192488|54769880|FG000|Third Intervention (d1)|Adverse Event|0|||
28112040|NCT03192488|54769881|FG001|Third Intervention (d1)|Adverse Event|0|||
28112041|NCT03192488|54769882|FG002|Third Intervention (d1)|Adverse Event|0|||
28112042|NCT03192488|54769883|FG003|Third Intervention (d1)|Adverse Event|0|||
28112043|NCT03192488|54769884|FG004|Third Intervention (d1)|Adverse Event|1|||
28112044|NCT03192488|54769885|FG005|Third Intervention (d1)|Adverse Event|0|||
28112045|NCT03192176|54769907|FG000|Overall Study|Adverse Event|1|||
28112046|NCT03192176|54769908|FG001|Overall Study|Adverse Event|0|||
28112047|NCT03192176|54769909|FG002|Overall Study|Adverse Event|4|||
28112048|NCT03192176|54769910|FG003|Overall Study|Adverse Event|5|||
28112049|NCT03192176|54769911|FG004|Overall Study|Adverse Event|3|||
28112050|NCT03192176|54769912|FG005|Overall Study|Adverse Event|2|||
28112051|NCT03192176|54769913|FG006|Overall Study|Adverse Event|3|||
28112052|NCT03192176|54769914|FG007|Overall Study|Adverse Event|3|||
28112053|NCT03192176|54769907|FG000|Overall Study|Lost to Follow-up|0|||
28112054|NCT03192176|54769908|FG001|Overall Study|Lost to Follow-up|0|||
27848681|NCT02633046|54342425|FG000|Overall Study|Participant decided not to continue with open label extension|1|||
27848682|NCT02633046|54342425|FG000|Overall Study|Mutual decision patient and physician|1|||
27848683|NCT01672788|54342484|FG000|Washout Period 2 (7 Days)|Adverse Event|0|||
27848684|NCT01672788|54342485|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
27848685|NCT01672788|54342486|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
27848686|NCT01672788|54342487|FG003|Washout Period 2 (7 Days)|Adverse Event|1|||
27848687|NCT02632110|54342502|FG000|Overall Study|Withdrawal by Subject|1|||
27848688|NCT02632110|54342503|FG001|Overall Study|Withdrawal by Subject|1|||
27848689|NCT02632110|54342504|FG002|Overall Study|Withdrawal by Subject|0|||
27848690|NCT02632110|54342505|FG003|Overall Study|Withdrawal by Subject|0|||
27848691|NCT02632110|54342506|FG004|Overall Study|Withdrawal by Subject|1|||
27848692|NCT02632110|54342507|FG005|Overall Study|Withdrawal by Subject|1|||
27848693|NCT02632110|54342508|FG006|Overall Study|Withdrawal by Subject|3|||
27848694|NCT02632110|54342509|FG007|Overall Study|Withdrawal by Subject|3|||
27848695|NCT02632110|54342510|FG008|Overall Study|Withdrawal by Subject|1|||
27848696|NCT02632110|54342511|FG009|Overall Study|Withdrawal by Subject|1|||
27848697|NCT01672710|54342753|FG000|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0|||
27848698|NCT01672710|54342754|FG001|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1|||
28112055|NCT03192176|54769909|FG002|Overall Study|Lost to Follow-up|1|||
28112056|NCT03192176|54769910|FG003|Overall Study|Lost to Follow-up|2|||
28112057|NCT03192176|54769911|FG004|Overall Study|Lost to Follow-up|3|||
28112058|NCT03192176|54769912|FG005|Overall Study|Lost to Follow-up|1|||
28112059|NCT03192176|54769913|FG006|Overall Study|Lost to Follow-up|1|||
28112060|NCT03192176|54769914|FG007|Overall Study|Lost to Follow-up|1|||
28112061|NCT03192176|54769907|FG000|Overall Study|Physician Decision|1|||
28112062|NCT03192176|54769908|FG001|Overall Study|Physician Decision|0|||
28112063|NCT03192176|54769909|FG002|Overall Study|Physician Decision|0|||
28112064|NCT03192176|54769910|FG003|Overall Study|Physician Decision|0|||
28112065|NCT03192176|54769911|FG004|Overall Study|Physician Decision|0|||
28112066|NCT03192176|54769912|FG005|Overall Study|Physician Decision|2|||
28112067|NCT03192176|54769913|FG006|Overall Study|Physician Decision|1|||
28112068|NCT03192176|54769914|FG007|Overall Study|Physician Decision|0|||
28112069|NCT03192176|54769907|FG000|Overall Study|Protocol Deviation|1|||
28112070|NCT03192176|54769908|FG001|Overall Study|Protocol Deviation|1|||
28112071|NCT03192176|54769909|FG002|Overall Study|Protocol Deviation|0|||
28112072|NCT03192176|54769910|FG003|Overall Study|Protocol Deviation|0|||
28112073|NCT03192176|54769911|FG004|Overall Study|Protocol Deviation|2|||
28112074|NCT03192176|54769912|FG005|Overall Study|Protocol Deviation|0|||
28112075|NCT03192176|54769913|FG006|Overall Study|Protocol Deviation|0|||
28112076|NCT03192176|54769914|FG007|Overall Study|Protocol Deviation|0|||
28112077|NCT03192176|54769907|FG000|Overall Study|Withdrawal by Subject|3|||
28112078|NCT03192176|54769908|FG001|Overall Study|Withdrawal by Subject|4|||
28112079|NCT03192176|54769909|FG002|Overall Study|Withdrawal by Subject|0|||
28112080|NCT03192176|54769910|FG003|Overall Study|Withdrawal by Subject|4|||
28112081|NCT03192176|54769911|FG004|Overall Study|Withdrawal by Subject|3|||
28112082|NCT03192176|54769912|FG005|Overall Study|Withdrawal by Subject|4|||
28112083|NCT03192176|54769913|FG006|Overall Study|Withdrawal by Subject|4|||
28112084|NCT03192176|54769914|FG007|Overall Study|Withdrawal by Subject|2|||
28112085|NCT03192176|54769907|FG000|Overall Study|Miscellaneous|1|||
28112086|NCT03192176|54769908|FG001|Overall Study|Miscellaneous|0|||
28112087|NCT03192176|54769909|FG002|Overall Study|Miscellaneous|1|||
28112088|NCT03192176|54769910|FG003|Overall Study|Miscellaneous|1|||
28112089|NCT03192176|54769911|FG004|Overall Study|Miscellaneous|1|||
27848699|NCT01672710|54342753|FG000|3 Month Follow up|Lost to Follow-up|2|||
27848700|NCT01672710|54342754|FG001|3 Month Follow up|Lost to Follow-up|3|||
27848701|NCT01672710|54342753|FG000|3 Month Follow up|follow up due after termination date|4|||
28112090|NCT03192176|54769912|FG005|Overall Study|Miscellaneous|2|||
28112091|NCT03192176|54769913|FG006|Overall Study|Miscellaneous|0|||
28112092|NCT03192176|54769914|FG007|Overall Study|Miscellaneous|1|||
28112093|NCT01642004|54769935|FG000|Randomization|Adverse Event unrelated to study drug|1|||
28112094|NCT01642004|54769936|FG001|Randomization|Adverse Event unrelated to study drug|0|||
28112095|NCT01642004|54769935|FG000|Randomization|Participant withdrew consent|1|||
28112096|NCT01642004|54769936|FG001|Randomization|Participant withdrew consent|6|||
28112097|NCT01642004|54769935|FG000|Randomization|No longer meets study criteria|2|||
28112098|NCT01642004|54769936|FG001|Randomization|No longer meets study criteria|2|||
28112099|NCT01642004|54769935|FG000|Treatment|Disease progression|95|||
28112100|NCT01642004|54769936|FG001|Treatment|Disease progression|79|||
28112101|NCT01642004|54769935|FG000|Treatment|Study drug toxicity|10|||
28112102|NCT01642004|54769936|FG001|Treatment|Study drug toxicity|13|||
28112103|NCT01642004|54769935|FG000|Treatment|Death|1|||
28112104|NCT01642004|54769936|FG001|Treatment|Death|1|||
28112105|NCT01642004|54769935|FG000|Treatment|Adverse event unrelated to study drug|9|||
28112106|NCT01642004|54769936|FG001|Treatment|Adverse event unrelated to study drug|13|||
28112107|NCT01642004|54769935|FG000|Treatment|Maximum clinical benefit|1|||
28112108|NCT01642004|54769936|FG001|Treatment|Maximum clinical benefit|9|||
28112109|NCT01642004|54769935|FG000|Treatment|Poor/non-compliance|1|||
28112110|NCT01642004|54769936|FG001|Treatment|Poor/non-compliance|0|||
28112111|NCT01642004|54769935|FG000|Treatment|No longer meets study criteria|1|||
28112112|NCT01642004|54769936|FG001|Treatment|No longer meets study criteria|2|||
28112113|NCT01642004|54769935|FG000|Treatment|Other reasons|2|||
28112114|NCT01642004|54769936|FG001|Treatment|Other reasons|0|||
28112115|NCT01642004|54769935|FG000|Treatment|Not reported|0|||
28112116|NCT01642004|54769936|FG001|Treatment|Not reported|3|||
28112117|NCT01642004|54769935|FG000|Treatment|Participant request to discontinue study treatment|6|||
28112118|NCT01642004|54769936|FG001|Treatment|Participant request to discontinue study treatment|4|||
28112119|NCT01642004|54769935|FG000|Treatment|Participant withdrew consent|5|||
28112120|NCT01642004|54769936|FG001|Treatment|Participant withdrew consent|5|||
28112121|NCT00042289|54769992|FG000|Overall Study|Lost to Follow-up|3|||
28112122|NCT00042289|54769993|FG001|Overall Study|Lost to Follow-up|0|||
28112123|NCT00042289|54769994|FG002|Overall Study|Lost to Follow-up|0|||
28112124|NCT00042289|54769995|FG003|Overall Study|Lost to Follow-up|1|||
28112125|NCT00042289|54769996|FG004|Overall Study|Lost to Follow-up|3|||
28112126|NCT00042289|54769997|FG005|Overall Study|Lost to Follow-up|3|||
28112127|NCT00042289|54769998|FG006|Overall Study|Lost to Follow-up|6|||
28112128|NCT00042289|54769999|FG007|Overall Study|Lost to Follow-up|1|||
28112129|NCT00042289|54770000|FG008|Overall Study|Lost to Follow-up|1|||
28112130|NCT00042289|54770001|FG009|Overall Study|Lost to Follow-up|0|||
28112131|NCT00042289|54770002|FG010|Overall Study|Lost to Follow-up|0|||
28112132|NCT00042289|54770003|FG011|Overall Study|Lost to Follow-up|0|||
28112133|NCT00042289|54770004|FG012|Overall Study|Lost to Follow-up|0|||
28112134|NCT00042289|54770005|FG013|Overall Study|Lost to Follow-up|0|||
28112135|NCT00042289|54770006|FG014|Overall Study|Lost to Follow-up|0|||
28112136|NCT00042289|54770007|FG015|Overall Study|Lost to Follow-up|1|||
27848702|NCT01672710|54342754|FG001|3 Month Follow up|follow up due after termination date|1|||
27848703|NCT02630472|54342789|FG000|Overall Study|Physician Decision|10|||
28112137|NCT00042289|54770008|FG016|Overall Study|Lost to Follow-up|1|||
28112138|NCT00042289|54770009|FG017|Overall Study|Lost to Follow-up|0|||
28112139|NCT00042289|54770010|FG018|Overall Study|Lost to Follow-up|3|||
28112140|NCT00042289|54770011|FG019|Overall Study|Lost to Follow-up|2|||
28112141|NCT00042289|54770012|FG020|Overall Study|Lost to Follow-up|0|||
28112142|NCT00042289|54770013|FG021|Overall Study|Lost to Follow-up|0|||
28112143|NCT00042289|54770014|FG022|Overall Study|Lost to Follow-up|0|||
28112144|NCT00042289|54770015|FG023|Overall Study|Lost to Follow-up|0|||
28112145|NCT00042289|54770016|FG024|Overall Study|Lost to Follow-up|0|||
28112146|NCT00042289|54770017|FG025|Overall Study|Lost to Follow-up|0|||
28112147|NCT00042289|54770018|FG026|Overall Study|Lost to Follow-up|2|||
28112148|NCT00042289|54770019|FG027|Overall Study|Lost to Follow-up|2|||
28112149|NCT00042289|54770020|FG028|Overall Study|Lost to Follow-up|2|||
28112150|NCT00042289|54770021|FG029|Overall Study|Lost to Follow-up|0|||
28112151|NCT00042289|54770022|FG030|Overall Study|Lost to Follow-up|0|||
28112152|NCT00042289|54770023|FG031|Overall Study|Lost to Follow-up|2|||
28112153|NCT00042289|54770024|FG032|Overall Study|Lost to Follow-up|1|||
28112154|NCT00042289|54770025|FG033|Overall Study|Lost to Follow-up|1|||
28112155|NCT00042289|54770026|FG034|Overall Study|Lost to Follow-up|1|||
28112156|NCT00042289|54770027|FG035|Overall Study|Lost to Follow-up|2|||
28112157|NCT00042289|54770028|FG036|Overall Study|Lost to Follow-up|1|||
28112158|NCT00042289|54770029|FG037|Overall Study|Lost to Follow-up|1|||
28112159|NCT00042289|54770030|FG038|Overall Study|Lost to Follow-up|0|||
28112160|NCT00042289|54770031|FG039|Overall Study|Lost to Follow-up|5|||
28112161|NCT00042289|54770032|FG040|Overall Study|Lost to Follow-up|0|||
28112162|NCT00042289|54770033|FG041|Overall Study|Lost to Follow-up|2|||
28112163|NCT00042289|54770034|FG042|Overall Study|Lost to Follow-up|2|||
28112164|NCT00042289|54770035|FG043|Overall Study|Lost to Follow-up|0|||
28112165|NCT00042289|54770036|FG044|Overall Study|Lost to Follow-up|0|||
28112166|NCT00042289|54770037|FG045|Overall Study|Lost to Follow-up|1|||
28112167|NCT00042289|54770038|FG046|Overall Study|Lost to Follow-up|0|||
28112168|NCT00042289|54769992|FG000|Overall Study|Other reason|0|||
28112169|NCT00042289|54769993|FG001|Overall Study|Other reason|0|||
28112170|NCT00042289|54769994|FG002|Overall Study|Other reason|0|||
28112171|NCT00042289|54769995|FG003|Overall Study|Other reason|2|||
28112172|NCT00042289|54769996|FG004|Overall Study|Other reason|0|||
28112173|NCT00042289|54769997|FG005|Overall Study|Other reason|0|||
28112174|NCT00042289|54769998|FG006|Overall Study|Other reason|0|||
28112175|NCT00042289|54769999|FG007|Overall Study|Other reason|0|||
28112176|NCT00042289|54770000|FG008|Overall Study|Other reason|0|||
28112177|NCT00042289|54770001|FG009|Overall Study|Other reason|0|||
28112178|NCT00042289|54770002|FG010|Overall Study|Other reason|0|||
28112179|NCT00042289|54770003|FG011|Overall Study|Other reason|0|||
28112180|NCT00042289|54770004|FG012|Overall Study|Other reason|0|||
28112181|NCT00042289|54770005|FG013|Overall Study|Other reason|0|||
28112182|NCT00042289|54770006|FG014|Overall Study|Other reason|0|||
28112183|NCT00042289|54770007|FG015|Overall Study|Other reason|0|||
28112184|NCT00042289|54770008|FG016|Overall Study|Other reason|0|||
28112185|NCT00042289|54770009|FG017|Overall Study|Other reason|0|||
28112186|NCT00042289|54770010|FG018|Overall Study|Other reason|1|||
28112187|NCT00042289|54770011|FG019|Overall Study|Other reason|0|||
28112188|NCT00042289|54770012|FG020|Overall Study|Other reason|0|||
28112189|NCT00042289|54770013|FG021|Overall Study|Other reason|0|||
28112190|NCT00042289|54770014|FG022|Overall Study|Other reason|0|||
28112191|NCT00042289|54770015|FG023|Overall Study|Other reason|1|||
28112192|NCT00042289|54770016|FG024|Overall Study|Other reason|0|||
28112193|NCT00042289|54770017|FG025|Overall Study|Other reason|0|||
28112194|NCT00042289|54770018|FG026|Overall Study|Other reason|1|||
28112195|NCT00042289|54770019|FG027|Overall Study|Other reason|0|||
28112196|NCT00042289|54770020|FG028|Overall Study|Other reason|3|||
28112197|NCT00042289|54770021|FG029|Overall Study|Other reason|0|||
27848704|NCT02630472|54342790|FG001|Overall Study|Physician Decision|0|||
28112198|NCT00042289|54770022|FG030|Overall Study|Other reason|0|||
28112199|NCT00042289|54770023|FG031|Overall Study|Other reason|1|||
28112200|NCT00042289|54770024|FG032|Overall Study|Other reason|0|||
28112201|NCT00042289|54770025|FG033|Overall Study|Other reason|1|||
28112202|NCT00042289|54770026|FG034|Overall Study|Other reason|0|||
28112203|NCT00042289|54770027|FG035|Overall Study|Other reason|2|||
28112204|NCT00042289|54770028|FG036|Overall Study|Other reason|0|||
28112205|NCT00042289|54770029|FG037|Overall Study|Other reason|0|||
28112206|NCT00042289|54770030|FG038|Overall Study|Other reason|0|||
28112207|NCT00042289|54770031|FG039|Overall Study|Other reason|0|||
27848705|NCT01670526|54342826|FG000|Overall Study|Withdrawal by Subject|3|||
28112208|NCT00042289|54770032|FG040|Overall Study|Other reason|0|||
28112209|NCT00042289|54770033|FG041|Overall Study|Other reason|0|||
28112210|NCT00042289|54770034|FG042|Overall Study|Other reason|0|||
28112211|NCT00042289|54770035|FG043|Overall Study|Other reason|1|||
28112212|NCT00042289|54770036|FG044|Overall Study|Other reason|0|||
28112213|NCT00042289|54770037|FG045|Overall Study|Other reason|0|||
27940231|NCT01194258|54596476|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
28064658|NCT00328172|54720272|FG000|Overall Study|Withdrawal by Subject|1|||
28112214|NCT00042289|54770038|FG046|Overall Study|Other reason|0|||
27940232|NCT01194258|54596477|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
27940233|NCT01193556|54596490|FG000|Overall Study|Study termination|26|||
27940234|NCT01193556|54596491|FG001|Overall Study|Study termination|25|||
28112215|NCT00042289|54769992|FG000|Overall Study|Severe debilitation, unable to continue|0|||
28112216|NCT00042289|54769993|FG001|Overall Study|Severe debilitation, unable to continue|0|||
28112217|NCT00042289|54769994|FG002|Overall Study|Severe debilitation, unable to continue|0|||
28112218|NCT00042289|54769995|FG003|Overall Study|Severe debilitation, unable to continue|0|||
28112219|NCT00042289|54769996|FG004|Overall Study|Severe debilitation, unable to continue|0|||
28112220|NCT00042289|54769997|FG005|Overall Study|Severe debilitation, unable to continue|0|||
28112221|NCT00042289|54769998|FG006|Overall Study|Severe debilitation, unable to continue|0|||
28112222|NCT00042289|54769999|FG007|Overall Study|Severe debilitation, unable to continue|0|||
28112223|NCT00042289|54770000|FG008|Overall Study|Severe debilitation, unable to continue|0|||
28112224|NCT00042289|54770001|FG009|Overall Study|Severe debilitation, unable to continue|0|||
28112225|NCT00042289|54770002|FG010|Overall Study|Severe debilitation, unable to continue|0|||
28112226|NCT00042289|54770003|FG011|Overall Study|Severe debilitation, unable to continue|0|||
28112227|NCT00042289|54770004|FG012|Overall Study|Severe debilitation, unable to continue|0|||
28112228|NCT00042289|54770005|FG013|Overall Study|Severe debilitation, unable to continue|0|||
28112229|NCT00042289|54770006|FG014|Overall Study|Severe debilitation, unable to continue|0|||
28112230|NCT00042289|54770007|FG015|Overall Study|Severe debilitation, unable to continue|0|||
28112231|NCT00042289|54770008|FG016|Overall Study|Severe debilitation, unable to continue|0|||
28112232|NCT00042289|54770009|FG017|Overall Study|Severe debilitation, unable to continue|0|||
28112233|NCT00042289|54770010|FG018|Overall Study|Severe debilitation, unable to continue|0|||
28112234|NCT00042289|54770011|FG019|Overall Study|Severe debilitation, unable to continue|0|||
28112235|NCT00042289|54770012|FG020|Overall Study|Severe debilitation, unable to continue|0|||
28112236|NCT00042289|54770013|FG021|Overall Study|Severe debilitation, unable to continue|1|||
28112237|NCT00042289|54770014|FG022|Overall Study|Severe debilitation, unable to continue|0|||
28112238|NCT00042289|54770015|FG023|Overall Study|Severe debilitation, unable to continue|1|||
28112239|NCT00042289|54770016|FG024|Overall Study|Severe debilitation, unable to continue|0|||
28112240|NCT00042289|54770017|FG025|Overall Study|Severe debilitation, unable to continue|0|||
28112241|NCT00042289|54770018|FG026|Overall Study|Severe debilitation, unable to continue|0|||
28112242|NCT00042289|54770019|FG027|Overall Study|Severe debilitation, unable to continue|1|||
28112243|NCT00042289|54770020|FG028|Overall Study|Severe debilitation, unable to continue|0|||
28112244|NCT00042289|54770021|FG029|Overall Study|Severe debilitation, unable to continue|0|||
28112245|NCT00042289|54770022|FG030|Overall Study|Severe debilitation, unable to continue|0|||
28112246|NCT00042289|54770023|FG031|Overall Study|Severe debilitation, unable to continue|1|||
28112247|NCT00042289|54770024|FG032|Overall Study|Severe debilitation, unable to continue|1|||
28112248|NCT00042289|54770025|FG033|Overall Study|Severe debilitation, unable to continue|0|||
28112249|NCT00042289|54770026|FG034|Overall Study|Severe debilitation, unable to continue|0|||
28112250|NCT00042289|54770027|FG035|Overall Study|Severe debilitation, unable to continue|0|||
28112251|NCT00042289|54770028|FG036|Overall Study|Severe debilitation, unable to continue|0|||
28112252|NCT00042289|54770029|FG037|Overall Study|Severe debilitation, unable to continue|0|||
28112253|NCT00042289|54770030|FG038|Overall Study|Severe debilitation, unable to continue|0|||
28112254|NCT00042289|54770031|FG039|Overall Study|Severe debilitation, unable to continue|0|||
28112255|NCT00042289|54770032|FG040|Overall Study|Severe debilitation, unable to continue|0|||
27815999|NCT01903837|54272867|FG002|Part A|Adverse Event|9|||
27816000|NCT01903837|54272868|FG003|Part A|Adverse Event|6|||
28112256|NCT00042289|54770033|FG041|Overall Study|Severe debilitation, unable to continue|0|||
28112257|NCT00042289|54770034|FG042|Overall Study|Severe debilitation, unable to continue|0|||
28112258|NCT00042289|54770035|FG043|Overall Study|Severe debilitation, unable to continue|0|||
28112259|NCT00042289|54770036|FG044|Overall Study|Severe debilitation, unable to continue|0|||
28112260|NCT00042289|54770037|FG045|Overall Study|Severe debilitation, unable to continue|0|||
28112261|NCT00042289|54770038|FG046|Overall Study|Severe debilitation, unable to continue|0|||
28112262|NCT00042289|54769992|FG000|Overall Study|Site closed|0|||
28112263|NCT00042289|54769993|FG001|Overall Study|Site closed|0|||
28112264|NCT00042289|54769994|FG002|Overall Study|Site closed|0|||
28112265|NCT00042289|54769995|FG003|Overall Study|Site closed|0|||
28112266|NCT00042289|54769996|FG004|Overall Study|Site closed|0|||
28112267|NCT00042289|54769997|FG005|Overall Study|Site closed|0|||
28112268|NCT00042289|54769998|FG006|Overall Study|Site closed|0|||
28112269|NCT00042289|54769999|FG007|Overall Study|Site closed|0|||
28112270|NCT00042289|54770000|FG008|Overall Study|Site closed|0|||
28112271|NCT00042289|54770001|FG009|Overall Study|Site closed|0|||
28112272|NCT00042289|54770002|FG010|Overall Study|Site closed|0|||
28112273|NCT00042289|54770003|FG011|Overall Study|Site closed|0|||
28112274|NCT00042289|54770004|FG012|Overall Study|Site closed|0|||
28112275|NCT00042289|54770005|FG013|Overall Study|Site closed|0|||
28112276|NCT00042289|54770006|FG014|Overall Study|Site closed|0|||
28112277|NCT00042289|54770007|FG015|Overall Study|Site closed|0|||
28112278|NCT00042289|54770008|FG016|Overall Study|Site closed|0|||
28112279|NCT00042289|54770009|FG017|Overall Study|Site closed|0|||
28112280|NCT00042289|54770010|FG018|Overall Study|Site closed|0|||
28112281|NCT00042289|54770011|FG019|Overall Study|Site closed|0|||
28112282|NCT00042289|54770012|FG020|Overall Study|Site closed|0|||
28112283|NCT00042289|54770013|FG021|Overall Study|Site closed|0|||
28112284|NCT00042289|54770014|FG022|Overall Study|Site closed|0|||
28112285|NCT00042289|54770015|FG023|Overall Study|Site closed|0|||
28112286|NCT00042289|54770016|FG024|Overall Study|Site closed|0|||
28112287|NCT00042289|54770017|FG025|Overall Study|Site closed|0|||
28112288|NCT00042289|54770018|FG026|Overall Study|Site closed|0|||
28112289|NCT00042289|54770019|FG027|Overall Study|Site closed|0|||
28112290|NCT00042289|54770020|FG028|Overall Study|Site closed|0|||
28112291|NCT00042289|54770021|FG029|Overall Study|Site closed|0|||
28112292|NCT00042289|54770022|FG030|Overall Study|Site closed|0|||
28112293|NCT00042289|54770023|FG031|Overall Study|Site closed|3|||
28112294|NCT00042289|54770024|FG032|Overall Study|Site closed|0|||
28112295|NCT00042289|54770025|FG033|Overall Study|Site closed|0|||
28112296|NCT00042289|54770026|FG034|Overall Study|Site closed|0|||
28112297|NCT00042289|54770027|FG035|Overall Study|Site closed|0|||
28112298|NCT00042289|54770028|FG036|Overall Study|Site closed|1|||
28112299|NCT00042289|54770029|FG037|Overall Study|Site closed|0|||
28112300|NCT00042289|54770030|FG038|Overall Study|Site closed|0|||
28112301|NCT00042289|54770031|FG039|Overall Study|Site closed|0|||
28112302|NCT00042289|54770032|FG040|Overall Study|Site closed|0|||
28112303|NCT00042289|54770033|FG041|Overall Study|Site closed|0|||
28112304|NCT00042289|54770034|FG042|Overall Study|Site closed|1|||
28112305|NCT00042289|54770035|FG043|Overall Study|Site closed|0|||
28112306|NCT00042289|54770036|FG044|Overall Study|Site closed|0|||
28112307|NCT00042289|54770037|FG045|Overall Study|Site closed|0|||
27816001|NCT01903837|54272865|FG000|Part A|Lost to Follow-up|9|||
27816002|NCT01903837|54272866|FG001|Part A|Lost to Follow-up|7|||
27816003|NCT01903837|54272867|FG002|Part A|Lost to Follow-up|7|||
27816004|NCT01903837|54272868|FG003|Part A|Lost to Follow-up|2|||
27816005|NCT01903837|54272865|FG000|Part A|Non-compliance with study drug|1|||
27816006|NCT01903837|54272866|FG001|Part A|Non-compliance with study drug|4|||
27816007|NCT01903837|54272867|FG002|Part A|Non-compliance with study drug|4|||
27816008|NCT01903837|54272868|FG003|Part A|Non-compliance with study drug|0|||
27816009|NCT01903837|54272865|FG000|Part A|Physician Decision|1|||
27816010|NCT01903837|54272866|FG001|Part A|Physician Decision|1|||
27816011|NCT01903837|54272867|FG002|Part A|Physician Decision|0|||
27816012|NCT01903837|54272868|FG003|Part A|Physician Decision|0|||
27816013|NCT01903837|54272865|FG000|Part A|Protocol Violation|1|||
27816014|NCT01903837|54272866|FG001|Part A|Protocol Violation|1|||
27816015|NCT01903837|54272867|FG002|Part A|Protocol Violation|0|||
28064659|NCT00328172|54720273|FG001|Overall Study|Withdrawal by Subject|1|||
28064660|NCT00328172|54720274|FG002|Overall Study|Withdrawal by Subject|1|||
28064661|NCT00328172|54720275|FG003|Overall Study|Withdrawal by Subject|6|||
28064662|NCT00328172|54720276|FG004|Overall Study|Withdrawal by Subject|0|||
28064663|NCT00328172|54720272|FG000|Overall Study|Lack of Efficacy|14|||
28064664|NCT00328172|54720273|FG001|Overall Study|Lack of Efficacy|9|||
28064665|NCT00328172|54720274|FG002|Overall Study|Lack of Efficacy|4|||
28064666|NCT00328172|54720275|FG003|Overall Study|Lack of Efficacy|4|||
28064667|NCT00328172|54720276|FG004|Overall Study|Lack of Efficacy|3|||
27816016|NCT01903837|54272868|FG003|Part A|Protocol Violation|0|||
28064668|NCT00328172|54720272|FG000|Overall Study|Other reason (not specified)|3|||
28064669|NCT00328172|54720273|FG001|Overall Study|Other reason (not specified)|0|||
28064670|NCT00328172|54720274|FG002|Overall Study|Other reason (not specified)|1|||
28112308|NCT00042289|54770038|FG046|Overall Study|Site closed|0|||
28112309|NCT00042289|54769992|FG000|Overall Study|Participant not willing to adhere to requirements|0|||
28112310|NCT00042289|54769993|FG001|Overall Study|Participant not willing to adhere to requirements|0|||
27816017|NCT01903837|54272865|FG000|Part B|Lost to Follow-up|0|||
28112311|NCT00042289|54769994|FG002|Overall Study|Participant not willing to adhere to requirements|0|||
28112312|NCT00042289|54769995|FG003|Overall Study|Participant not willing to adhere to requirements|3|||
28112313|NCT00042289|54769996|FG004|Overall Study|Participant not willing to adhere to requirements|0|||
28112314|NCT00042289|54769997|FG005|Overall Study|Participant not willing to adhere to requirements|0|||
28112315|NCT00042289|54769998|FG006|Overall Study|Participant not willing to adhere to requirements|0|||
28112316|NCT00042289|54769999|FG007|Overall Study|Participant not willing to adhere to requirements|0|||
28112317|NCT00042289|54770000|FG008|Overall Study|Participant not willing to adhere to requirements|0|||
28112318|NCT00042289|54770001|FG009|Overall Study|Participant not willing to adhere to requirements|0|||
28112319|NCT00042289|54770002|FG010|Overall Study|Participant not willing to adhere to requirements|0|||
28112320|NCT00042289|54770003|FG011|Overall Study|Participant not willing to adhere to requirements|0|||
28112321|NCT00042289|54770004|FG012|Overall Study|Participant not willing to adhere to requirements|0|||
28112322|NCT00042289|54770005|FG013|Overall Study|Participant not willing to adhere to requirements|0|||
28112323|NCT00042289|54770006|FG014|Overall Study|Participant not willing to adhere to requirements|0|||
28112324|NCT00042289|54770007|FG015|Overall Study|Participant not willing to adhere to requirements|0|||
28112325|NCT00042289|54770008|FG016|Overall Study|Participant not willing to adhere to requirements|0|||
28112326|NCT00042289|54770009|FG017|Overall Study|Participant not willing to adhere to requirements|0|||
28112327|NCT00042289|54770010|FG018|Overall Study|Participant not willing to adhere to requirements|4|||
28112328|NCT00042289|54770011|FG019|Overall Study|Participant not willing to adhere to requirements|2|||
28112329|NCT00042289|54770012|FG020|Overall Study|Participant not willing to adhere to requirements|0|||
28112330|NCT00042289|54770013|FG021|Overall Study|Participant not willing to adhere to requirements|2|||
28112331|NCT00042289|54770014|FG022|Overall Study|Participant not willing to adhere to requirements|1|||
28112332|NCT00042289|54770015|FG023|Overall Study|Participant not willing to adhere to requirements|1|||
28112333|NCT00042289|54770016|FG024|Overall Study|Participant not willing to adhere to requirements|0|||
28112334|NCT00042289|54770017|FG025|Overall Study|Participant not willing to adhere to requirements|1|||
28112335|NCT00042289|54770018|FG026|Overall Study|Participant not willing to adhere to requirements|2|||
28112336|NCT00042289|54770019|FG027|Overall Study|Participant not willing to adhere to requirements|0|||
27816018|NCT01903837|54272866|FG001|Part B|Lost to Follow-up|3|||
27816019|NCT01903837|54272867|FG002|Part B|Lost to Follow-up|3|||
27816020|NCT01903837|54272868|FG003|Part B|Lost to Follow-up|4|||
27816021|NCT01903837|54272865|FG000|Part B|Withdrawal by Subject|1|||
27816022|NCT01903837|54272866|FG001|Part B|Withdrawal by Subject|2|||
27816023|NCT01903837|54272867|FG002|Part B|Withdrawal by Subject|0|||
27816024|NCT01903837|54272868|FG003|Part B|Withdrawal by Subject|3|||
27816025|NCT01903837|54272865|FG000|Part B|Adverse Event|3|||
27816026|NCT01903837|54272866|FG001|Part B|Adverse Event|0|||
27816027|NCT01903837|54272867|FG002|Part B|Adverse Event|2|||
27816028|NCT01903837|54272868|FG003|Part B|Adverse Event|0|||
27816029|NCT01903837|54272865|FG000|Part B|Non-compliance with study drug|2|||
27816030|NCT01903837|54272866|FG001|Part B|Non-compliance with study drug|0|||
27816031|NCT01903837|54272867|FG002|Part B|Non-compliance with study drug|0|||
27816032|NCT01903837|54272868|FG003|Part B|Non-compliance with study drug|1|||
27816033|NCT01903837|54272865|FG000|Part B|Incarceration|2|||
27816034|NCT01903837|54272866|FG001|Part B|Incarceration|0|||
27816035|NCT01903837|54272867|FG002|Part B|Incarceration|0|||
27940235|NCT00951496|54596504|FG000|Overall Study|Did not initiate study treatment|10|||
27816036|NCT01903837|54272868|FG003|Part B|Incarceration|1|||
27816037|NCT01903837|54272865|FG000|Part B|Physician Decision|1|||
27816038|NCT01903837|54272866|FG001|Part B|Physician Decision|0|||
28112337|NCT00042289|54770020|FG028|Overall Study|Participant not willing to adhere to requirements|1|||
28112338|NCT00042289|54770021|FG029|Overall Study|Participant not willing to adhere to requirements|0|||
28112339|NCT00042289|54770022|FG030|Overall Study|Participant not willing to adhere to requirements|0|||
28112340|NCT00042289|54770023|FG031|Overall Study|Participant not willing to adhere to requirements|1|||
28112341|NCT00042289|54770024|FG032|Overall Study|Participant not willing to adhere to requirements|1|||
28112342|NCT00042289|54770025|FG033|Overall Study|Participant not willing to adhere to requirements|3|||
28112343|NCT00042289|54770026|FG034|Overall Study|Participant not willing to adhere to requirements|1|||
28112344|NCT00042289|54770027|FG035|Overall Study|Participant not willing to adhere to requirements|1|||
28112345|NCT00042289|54770028|FG036|Overall Study|Participant not willing to adhere to requirements|2|||
28112346|NCT00042289|54770029|FG037|Overall Study|Participant not willing to adhere to requirements|0|||
28112347|NCT00042289|54770030|FG038|Overall Study|Participant not willing to adhere to requirements|2|||
28112348|NCT00042289|54770031|FG039|Overall Study|Participant not willing to adhere to requirements|0|||
28112349|NCT00042289|54770032|FG040|Overall Study|Participant not willing to adhere to requirements|0|||
28112350|NCT00042289|54770033|FG041|Overall Study|Participant not willing to adhere to requirements|0|||
28112351|NCT00042289|54770034|FG042|Overall Study|Participant not willing to adhere to requirements|2|||
28112352|NCT00042289|54770035|FG043|Overall Study|Participant not willing to adhere to requirements|1|||
28112353|NCT00042289|54770036|FG044|Overall Study|Participant not willing to adhere to requirements|0|||
28112354|NCT00042289|54770037|FG045|Overall Study|Participant not willing to adhere to requirements|0|||
28112355|NCT00042289|54770038|FG046|Overall Study|Participant not willing to adhere to requirements|1|||
28112356|NCT00042289|54769992|FG000|Overall Study|Protocol Violation|0|||
28112357|NCT00042289|54769993|FG001|Overall Study|Protocol Violation|0|||
28112358|NCT00042289|54769994|FG002|Overall Study|Protocol Violation|0|||
28112359|NCT00042289|54769995|FG003|Overall Study|Protocol Violation|0|||
28112360|NCT00042289|54769996|FG004|Overall Study|Protocol Violation|0|||
28112361|NCT00042289|54769997|FG005|Overall Study|Protocol Violation|1|||
28112362|NCT00042289|54769998|FG006|Overall Study|Protocol Violation|0|||
28112363|NCT00042289|54769999|FG007|Overall Study|Protocol Violation|1|||
28112364|NCT00042289|54770000|FG008|Overall Study|Protocol Violation|0|||
28112365|NCT00042289|54770001|FG009|Overall Study|Protocol Violation|0|||
28112366|NCT00042289|54770002|FG010|Overall Study|Protocol Violation|0|||
28112367|NCT00042289|54770003|FG011|Overall Study|Protocol Violation|0|||
28112368|NCT00042289|54770004|FG012|Overall Study|Protocol Violation|0|||
28112369|NCT00042289|54770005|FG013|Overall Study|Protocol Violation|0|||
28112370|NCT00042289|54770006|FG014|Overall Study|Protocol Violation|0|||
28112371|NCT00042289|54770007|FG015|Overall Study|Protocol Violation|0|||
28112372|NCT00042289|54770008|FG016|Overall Study|Protocol Violation|0|||
28112373|NCT00042289|54770009|FG017|Overall Study|Protocol Violation|0|||
28112374|NCT00042289|54770010|FG018|Overall Study|Protocol Violation|0|||
28112375|NCT00042289|54770011|FG019|Overall Study|Protocol Violation|0|||
28112376|NCT00042289|54770012|FG020|Overall Study|Protocol Violation|0|||
28112377|NCT00042289|54770013|FG021|Overall Study|Protocol Violation|0|||
28112378|NCT00042289|54770014|FG022|Overall Study|Protocol Violation|0|||
28112379|NCT00042289|54770015|FG023|Overall Study|Protocol Violation|1|||
28112380|NCT00042289|54770016|FG024|Overall Study|Protocol Violation|1|||
28112381|NCT00042289|54770017|FG025|Overall Study|Protocol Violation|0|||
28112382|NCT00042289|54770018|FG026|Overall Study|Protocol Violation|2|||
28112383|NCT00042289|54770019|FG027|Overall Study|Protocol Violation|0|||
28112384|NCT00042289|54770020|FG028|Overall Study|Protocol Violation|0|||
28112385|NCT00042289|54770021|FG029|Overall Study|Protocol Violation|0|||
28112386|NCT00042289|54770022|FG030|Overall Study|Protocol Violation|1|||
28112387|NCT00042289|54770023|FG031|Overall Study|Protocol Violation|0|||
28112388|NCT00042289|54770024|FG032|Overall Study|Protocol Violation|0|||
28112389|NCT00042289|54770025|FG033|Overall Study|Protocol Violation|0|||
28112390|NCT00042289|54770026|FG034|Overall Study|Protocol Violation|0|||
28112391|NCT00042289|54770027|FG035|Overall Study|Protocol Violation|0|||
28112392|NCT00042289|54770028|FG036|Overall Study|Protocol Violation|0|||
28112393|NCT00042289|54770029|FG037|Overall Study|Protocol Violation|0|||
28112394|NCT00042289|54770030|FG038|Overall Study|Protocol Violation|0|||
28112395|NCT00042289|54770031|FG039|Overall Study|Protocol Violation|0|||
28112396|NCT00042289|54770032|FG040|Overall Study|Protocol Violation|0|||
28112397|NCT00042289|54770033|FG041|Overall Study|Protocol Violation|1|||
28112398|NCT00042289|54770034|FG042|Overall Study|Protocol Violation|1|||
28112399|NCT00042289|54770035|FG043|Overall Study|Protocol Violation|1|||
28112400|NCT00042289|54770036|FG044|Overall Study|Protocol Violation|0|||
28112401|NCT00042289|54770037|FG045|Overall Study|Protocol Violation|0|||
28112402|NCT00042289|54770038|FG046|Overall Study|Protocol Violation|0|||
28112403|NCT00042289|54769992|FG000|Overall Study|Withdrawal by Subject|4|||
28112404|NCT00042289|54769993|FG001|Overall Study|Withdrawal by Subject|1|||
28112405|NCT00042289|54769994|FG002|Overall Study|Withdrawal by Subject|0|||
28112406|NCT00042289|54769995|FG003|Overall Study|Withdrawal by Subject|2|||
28112407|NCT00042289|54769996|FG004|Overall Study|Withdrawal by Subject|0|||
28112408|NCT00042289|54769997|FG005|Overall Study|Withdrawal by Subject|2|||
27816039|NCT01903837|54272867|FG002|Part B|Physician Decision|0|||
28112409|NCT00042289|54769998|FG006|Overall Study|Withdrawal by Subject|0|||
28112410|NCT00042289|54769999|FG007|Overall Study|Withdrawal by Subject|0|||
28112411|NCT00042289|54770000|FG008|Overall Study|Withdrawal by Subject|0|||
28112412|NCT00042289|54770001|FG009|Overall Study|Withdrawal by Subject|1|||
28112413|NCT00042289|54770002|FG010|Overall Study|Withdrawal by Subject|0|||
28112414|NCT00042289|54770003|FG011|Overall Study|Withdrawal by Subject|0|||
28112415|NCT00042289|54770004|FG012|Overall Study|Withdrawal by Subject|2|||
28112416|NCT00042289|54770005|FG013|Overall Study|Withdrawal by Subject|0|||
28112417|NCT00042289|54770006|FG014|Overall Study|Withdrawal by Subject|0|||
28112418|NCT00042289|54770007|FG015|Overall Study|Withdrawal by Subject|0|||
28112419|NCT00042289|54770008|FG016|Overall Study|Withdrawal by Subject|0|||
28112420|NCT00042289|54770009|FG017|Overall Study|Withdrawal by Subject|0|||
28112421|NCT00042289|54770010|FG018|Overall Study|Withdrawal by Subject|0|||
28112422|NCT00042289|54770011|FG019|Overall Study|Withdrawal by Subject|0|||
28112423|NCT00042289|54770012|FG020|Overall Study|Withdrawal by Subject|0|||
28112424|NCT00042289|54770013|FG021|Overall Study|Withdrawal by Subject|1|||
28112425|NCT00042289|54770014|FG022|Overall Study|Withdrawal by Subject|1|||
28112426|NCT00042289|54770015|FG023|Overall Study|Withdrawal by Subject|1|||
28112427|NCT00042289|54770016|FG024|Overall Study|Withdrawal by Subject|0|||
28112428|NCT00042289|54770017|FG025|Overall Study|Withdrawal by Subject|0|||
28112429|NCT00042289|54770018|FG026|Overall Study|Withdrawal by Subject|1|||
28112430|NCT00042289|54770019|FG027|Overall Study|Withdrawal by Subject|0|||
28112431|NCT00042289|54770020|FG028|Overall Study|Withdrawal by Subject|2|||
28112432|NCT00042289|54770021|FG029|Overall Study|Withdrawal by Subject|0|||
28112433|NCT00042289|54770022|FG030|Overall Study|Withdrawal by Subject|0|||
28112434|NCT00042289|54770023|FG031|Overall Study|Withdrawal by Subject|1|||
28112435|NCT00042289|54770024|FG032|Overall Study|Withdrawal by Subject|2|||
28112436|NCT00042289|54770025|FG033|Overall Study|Withdrawal by Subject|1|||
28112437|NCT00042289|54770026|FG034|Overall Study|Withdrawal by Subject|0|||
28112438|NCT00042289|54770027|FG035|Overall Study|Withdrawal by Subject|0|||
28112439|NCT00042289|54770028|FG036|Overall Study|Withdrawal by Subject|0|||
28112440|NCT00042289|54770029|FG037|Overall Study|Withdrawal by Subject|1|||
28112441|NCT00042289|54770030|FG038|Overall Study|Withdrawal by Subject|0|||
28112442|NCT00042289|54770031|FG039|Overall Study|Withdrawal by Subject|0|||
28112443|NCT00042289|54770032|FG040|Overall Study|Withdrawal by Subject|0|||
28112444|NCT00042289|54770033|FG041|Overall Study|Withdrawal by Subject|0|||
28112445|NCT00042289|54770034|FG042|Overall Study|Withdrawal by Subject|1|||
28112446|NCT00042289|54770035|FG043|Overall Study|Withdrawal by Subject|0|||
28112447|NCT00042289|54770036|FG044|Overall Study|Withdrawal by Subject|0|||
28112448|NCT00042289|54770037|FG045|Overall Study|Withdrawal by Subject|0|||
28112449|NCT00042289|54770038|FG046|Overall Study|Withdrawal by Subject|0|||
28112450|NCT02886728|54770210|FG000|Overall Study|Withdrew Consent|31|||
28112451|NCT02886728|54770211|FG001|Overall Study|Withdrew Consent|13|||
28112452|NCT02886728|54770212|FG002|Overall Study|Withdrew Consent|11|||
28112453|NCT02886728|54770213|FG003|Overall Study|Withdrew Consent|47|||
28112454|NCT02886728|54770210|FG000|Overall Study|Lost to Follow-up|12|||
28112455|NCT02886728|54770211|FG001|Overall Study|Lost to Follow-up|6|||
28112456|NCT02886728|54770212|FG002|Overall Study|Lost to Follow-up|13|||
28112457|NCT02886728|54770213|FG003|Overall Study|Lost to Follow-up|12|||
27816040|NCT01903837|54272868|FG003|Part B|Physician Decision|2|||
27816041|NCT01903837|54272865|FG000|Part B|Lack of Efficacy|0|||
27816042|NCT01903837|54272866|FG001|Part B|Lack of Efficacy|1|||
27816043|NCT01903837|54272867|FG002|Part B|Lack of Efficacy|0|||
27816044|NCT01903837|54272868|FG003|Part B|Lack of Efficacy|0|||
27816045|NCT01903525|54272901|FG000|Overall Study|Lost to Follow-up|5|||
27816046|NCT01903525|54272902|FG001|Overall Study|Lost to Follow-up|9|||
27816047|NCT01903525|54272901|FG000|Overall Study|Adverse Event|0|||
27816048|NCT01903525|54272902|FG001|Overall Study|Adverse Event|1|||
27816049|NCT00981526|54272910|FG000|Overall Study|Withdrawal by Subject|0|||
27816050|NCT00981526|54272911|FG001|Overall Study|Withdrawal by Subject|2|||
28112458|NCT02886728|54770210|FG000|Overall Study|Adverse Event|13|||
28112459|NCT02886728|54770211|FG001|Overall Study|Adverse Event|5|||
27816051|NCT00981526|54272910|FG000|Overall Study|Physician Decision|4|||
27816052|NCT00981526|54272911|FG001|Overall Study|Physician Decision|4|||
27816053|NCT01927861|54272921|FG000|Extension Phase (104 Weeks)|Adverse Event|0|||
28112460|NCT02886728|54770212|FG002|Overall Study|Adverse Event|5|||
28112461|NCT02886728|54770213|FG003|Overall Study|Adverse Event|11|||
28112462|NCT02886728|54770210|FG000|Overall Study|Investigator's Discretion|11|||
28112463|NCT02886728|54770211|FG001|Overall Study|Investigator's Discretion|7|||
28112464|NCT02886728|54770212|FG002|Overall Study|Investigator's Discretion|5|||
28112465|NCT02886728|54770213|FG003|Overall Study|Investigator's Discretion|11|||
28112466|NCT02886728|54770210|FG000|Overall Study|Death|3|||
27816054|NCT01927861|54272922|FG001|Extension Phase (104 Weeks)|Adverse Event|2|||
27816055|NCT01927861|54272921|FG000|Extension Phase (104 Weeks)|Unclassified|0|||
28112467|NCT02886728|54770211|FG001|Overall Study|Death|1|||
28112468|NCT02886728|54770212|FG002|Overall Study|Death|0|||
27816056|NCT01927861|54272922|FG001|Extension Phase (104 Weeks)|Unclassified|1|||
28112469|NCT02886728|54770213|FG003|Overall Study|Death|0|||
28112470|NCT02886728|54770210|FG000|Overall Study|Protocol Violation|0|||
28112471|NCT02886728|54770211|FG001|Overall Study|Protocol Violation|0|||
28112472|NCT02886728|54770212|FG002|Overall Study|Protocol Violation|0|||
28112473|NCT02886728|54770213|FG003|Overall Study|Protocol Violation|4|||
28112474|NCT02886728|54770210|FG000|Overall Study|Non-Compliance with Study Drug|1|||
28112475|NCT02886728|54770211|FG001|Overall Study|Non-Compliance with Study Drug|0|||
28112476|NCT02886728|54770212|FG002|Overall Study|Non-Compliance with Study Drug|1|||
28112477|NCT02886728|54770213|FG003|Overall Study|Non-Compliance with Study Drug|0|||
28112478|NCT02886728|54770210|FG000|Overall Study|Pregnancy|0|||
28112479|NCT02886728|54770211|FG001|Overall Study|Pregnancy|0|||
28112480|NCT02886728|54770212|FG002|Overall Study|Pregnancy|1|||
28112481|NCT02886728|54770213|FG003|Overall Study|Pregnancy|0|||
28112482|NCT02886728|54770210|FG000|Overall Study|Randomized but Not Dosed|1|||
28112483|NCT02886728|54770211|FG001|Overall Study|Randomized but Not Dosed|0|||
28112484|NCT02886728|54770212|FG002|Overall Study|Randomized but Not Dosed|0|||
28112485|NCT02886728|54770213|FG003|Overall Study|Randomized but Not Dosed|2|||
28112486|NCT00039871|54770223|FG000|Overall Study|Adverse Event|165|||
28112487|NCT00039871|54770223|FG000|Overall Study|Lost to Follow-up|18|||
28112488|NCT00039871|54770223|FG000|Overall Study|Protocol Violation|24|||
28112489|NCT00039871|54770223|FG000|Overall Study|Withdrawal by Subject|97|||
28112490|NCT00039871|54770223|FG000|Overall Study|Did not meet eligibility criteria|11|||
28112491|NCT00039871|54770223|FG000|Overall Study|Administrative|1|||
28112492|NCT00039871|54770223|FG000|Overall Study|Discontinued at Week 12 per protocol|1061|||
28112493|NCT00039871|54770223|FG000|Overall Study|Never entered follow-up|7|||
28112494|NCT00015457|54770227|FG000|First Intervention|Adverse Event|0|||
28112495|NCT00015457|54770228|FG001|First Intervention|Adverse Event|2|||
27816057|NCT01927627|54272928|FG000|Overall Study|Adverse Event|3|||
27816058|NCT01927627|54272928|FG000|Overall Study|Lack of Efficacy|1|||
27816059|NCT01927627|54272928|FG000|Overall Study|Financial Concerns|1|||
27816060|NCT01889251|54272934|FG000|Overall Study|Adverse Event|1|||
27816061|NCT01889251|54272935|FG001|Overall Study|Adverse Event|0|||
28112496|NCT00015457|54770227|FG000|First Intervention|Lack of Efficacy|0|||
28112497|NCT00015457|54770228|FG001|First Intervention|Lack of Efficacy|1|||
28112498|NCT00015457|54770227|FG000|Second Intervention|Withdrawal by Subject|1|||
28112499|NCT00015457|54770228|FG001|Second Intervention|Withdrawal by Subject|0|||
28112500|NCT03191630|54770241|FG000|Overall Study|Lost to Follow-up|7|||
28112501|NCT03191630|54770242|FG001|Overall Study|Lost to Follow-up|7|||
28112502|NCT03191552|54770253|FG000|Overall Study|Lost to Follow-up|1|||
28112503|NCT03191552|54770254|FG001|Overall Study|Lost to Follow-up|0|||
28112504|NCT03191552|54770255|FG002|Overall Study|Lost to Follow-up|0|||
28112505|NCT03191552|54770253|FG000|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
28112506|NCT03191552|54770254|FG001|Overall Study|Undergone surgery (Progressive hip dyspl|1|||
28112507|NCT03191552|54770255|FG002|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
28112508|NCT03191396|54770269|FG000|Overall Study|Lost to Follow-up|0|||
28112509|NCT03191396|54770270|FG001|Overall Study|Lost to Follow-up|3|||
28112510|NCT03191396|54770269|FG000|Overall Study|Withdrawal by Subject|3|||
28112511|NCT03191396|54770270|FG001|Overall Study|Withdrawal by Subject|2|||
28112512|NCT00007345|54770278|FG000|Overall Study|Refused further treatment|0|||
28112513|NCT00007345|54770279|FG001|Overall Study|Refused further treatment|7|||
28112514|NCT00007345|54770278|FG000|Overall Study|Switched to alternative treatment|0|||
28112515|NCT00007345|54770279|FG001|Overall Study|Switched to alternative treatment|3|||
28112516|NCT00007345|54770278|FG000|Overall Study|Intercurrent illness|1|||
28112517|NCT00007345|54770279|FG001|Overall Study|Intercurrent illness|0|||
27816062|NCT01616563|54272941|FG000|Overall Study|Lost to Follow-up|40|||
28112518|NCT00007345|54770278|FG000|Overall Study|Death on study|1|||
28112519|NCT00007345|54770279|FG001|Overall Study|Death on study|1|||
28112520|NCT03405662|54770287|FG000|Overall Study|COVID-19 restriction|1|||
28112521|NCT03405662|54770288|FG001|Overall Study|COVID-19 restriction|0|||
28112522|NCT03405662|54770287|FG000|Overall Study|unblinding|0|||
28112523|NCT03405662|54770288|FG001|Overall Study|unblinding|1|||
28112524|NCT03405662|54770287|FG000|Overall Study|placement in memory care facility|0|||
28112525|NCT03405662|54770288|FG001|Overall Study|placement in memory care facility|2|||
28112526|NCT00031447|54770296|FG000|Overall Study|Lost to Follow-up|0|||
28112527|NCT00031447|54770297|FG001|Overall Study|Lost to Follow-up|1|||
28112528|NCT00031447|54770296|FG000|Overall Study|Non-compliant|1|||
28112529|NCT00031447|54770297|FG001|Overall Study|Non-compliant|1|||
28112530|NCT00031447|54770296|FG000|Overall Study|Re-activation of Disease|2|||
28112531|NCT00031447|54770297|FG001|Overall Study|Re-activation of Disease|1|||
28112532|NCT00031447|54770296|FG000|Overall Study|Disruption of blinded study drug supply|7|||
28112533|NCT00031447|54770297|FG001|Overall Study|Disruption of blinded study drug supply|4|||
28112534|NCT00006721|54770306|FG000|Overall Study|Adverse Event|0|||
28112535|NCT00006721|54770307|FG001|Overall Study|Adverse Event|4|||
27816063|NCT01616173|54272949|FG000|Overall Study|Lost to Follow-up|0|||
27816064|NCT01616173|54272950|FG001|Overall Study|Lost to Follow-up|2|||
27816065|NCT01616173|54272951|FG002|Overall Study|Lost to Follow-up|0|||
27816066|NCT01544595|54272965|FG000|Status at Week 68|Adverse Event|3|||
27816067|NCT01544595|54272966|FG001|Status at Week 68|Adverse Event|2|||
27816068|NCT01544595|54272967|FG002|Status at Week 68|Adverse Event|1|||
27816069|NCT01544595|54272968|FG003|Status at Week 68|Adverse Event|0|||
27816070|NCT01544595|54272969|FG004|Status at Week 68|Adverse Event|0|||
27816071|NCT01544595|54272970|FG005|Status at Week 68|Adverse Event|0|||
27816072|NCT01544595|54272965|FG000|Status at Week 68|Lack of Efficacy|1|||
27816073|NCT01544595|54272966|FG001|Status at Week 68|Lack of Efficacy|0|||
27816074|NCT01544595|54272967|FG002|Status at Week 68|Lack of Efficacy|0|||
27816075|NCT01544595|54272968|FG003|Status at Week 68|Lack of Efficacy|0|||
27816076|NCT01544595|54272969|FG004|Status at Week 68|Lack of Efficacy|0|||
27816077|NCT01544595|54272970|FG005|Status at Week 68|Lack of Efficacy|0|||
27816078|NCT01544595|54272965|FG000|Status at Week 68|Lost to Follow-up|1|||
27816079|NCT01544595|54272966|FG001|Status at Week 68|Lost to Follow-up|1|||
27816080|NCT01544595|54272967|FG002|Status at Week 68|Lost to Follow-up|0|||
27816081|NCT01544595|54272968|FG003|Status at Week 68|Lost to Follow-up|0|||
27816082|NCT01544595|54272969|FG004|Status at Week 68|Lost to Follow-up|0|||
28112536|NCT00006721|54770308|FG002|Overall Study|Adverse Event|4|||
28112537|NCT00006721|54770306|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
28112538|NCT00006721|54770307|FG001|Overall Study|Refusal Unrelated to Adverse Event|0|||
28112539|NCT00006721|54770308|FG002|Overall Study|Refusal Unrelated to Adverse Event|8|||
28112540|NCT00006721|54770306|FG000|Overall Study|Progression/Relapse|0|||
28112541|NCT00006721|54770307|FG001|Overall Study|Progression/Relapse|1|||
28112542|NCT00006721|54770308|FG002|Overall Study|Progression/Relapse|2|||
28112543|NCT00006721|54770306|FG000|Overall Study|Death|0|||
27816083|NCT01544595|54272970|FG005|Status at Week 68|Lost to Follow-up|0|||
27816084|NCT01544595|54272965|FG000|Status at Week 68|Non-compliance with study treatment|1|||
27816085|NCT01544595|54272966|FG001|Status at Week 68|Non-compliance with study treatment|0|||
27816086|NCT01544595|54272967|FG002|Status at Week 68|Non-compliance with study treatment|0|||
28112544|NCT00006721|54770307|FG001|Overall Study|Death|1|||
28112545|NCT00006721|54770308|FG002|Overall Study|Death|2|||
28112546|NCT00006721|54770306|FG000|Overall Study|Other - Not Protocol Specified|0|||
28112547|NCT00006721|54770307|FG001|Overall Study|Other - Not Protocol Specified|7|||
28112548|NCT00006721|54770308|FG002|Overall Study|Other - Not Protocol Specified|7|||
28112549|NCT00006721|54770306|FG000|Overall Study|Ineligible|2|||
28112550|NCT00006721|54770307|FG001|Overall Study|Ineligible|12|||
28112551|NCT00006721|54770308|FG002|Overall Study|Ineligible|10|||
28112552|NCT00006721|54770306|FG000|Overall Study|Eligible but no Treatment Received|1|||
28112553|NCT00006721|54770307|FG001|Overall Study|Eligible but no Treatment Received|0|||
28112554|NCT00006721|54770308|FG002|Overall Study|Eligible but no Treatment Received|0|||
28112555|NCT00006409|54770324|FG000|Baseline|Protocol Violation|48|||
28112556|NCT00006409|54770325|FG001|Baseline|Protocol Violation|70|||
28112557|NCT00006409|54770326|FG002|Baseline|Protocol Violation|0|||
28112558|NCT00006409|54770327|FG003|Baseline|Protocol Violation|0|||
28112559|NCT00006409|54770328|FG004|Baseline|Protocol Violation|0|||
28112560|NCT00006409|54770329|FG005|Baseline|Protocol Violation|0|||
28112561|NCT00006409|54770324|FG000|Post-2 Year Intervention|Protocol Violation|0|||
28112562|NCT00006409|54770325|FG001|Post-2 Year Intervention|Protocol Violation|0|||
28112563|NCT00006409|54770326|FG002|Post-2 Year Intervention|Protocol Violation|251|||
28112564|NCT00006409|54770327|FG003|Post-2 Year Intervention|Protocol Violation|168|||
28112565|NCT00006409|54770328|FG004|Post-2 Year Intervention|Protocol Violation|0|||
28112566|NCT00006409|54770329|FG005|Post-2 Year Intervention|Protocol Violation|0|||
28112567|NCT00006409|54770324|FG000|Post-3 Year Intervention|Protocol Violation|0|||
28112568|NCT00006409|54770325|FG001|Post-3 Year Intervention|Protocol Violation|0|||
28112569|NCT00006409|54770326|FG002|Post-3 Year Intervention|Protocol Violation|0|||
28112570|NCT00006409|54770327|FG003|Post-3 Year Intervention|Protocol Violation|0|||
28112571|NCT00006409|54770328|FG004|Post-3 Year Intervention|Protocol Violation|62|||
28112572|NCT00006409|54770329|FG005|Post-3 Year Intervention|Protocol Violation|62|||
28112573|NCT00006289|54770345|FG000|First Intervention (5 Weeks)|Adverse Event|1|||
28112574|NCT00006289|54770346|FG001|First Intervention (5 Weeks)|Adverse Event|0|||
28112575|NCT00006289|54770345|FG000|Second Intervention (5 Weeks)|Protocol Violation|1|||
28112576|NCT00006289|54770346|FG001|Second Intervention (5 Weeks)|Protocol Violation|1|||
28112577|NCT00005947|54770364|FG000|Overall Study|Death|54|||
28112578|NCT00005947|54770365|FG001|Overall Study|Death|40|||
28112579|NCT00005947|54770364|FG000|Overall Study|Patient Refused to Continue|2|||
28112580|NCT00005947|54770365|FG001|Overall Study|Patient Refused to Continue|1|||
28112581|NCT00005947|54770364|FG000|Overall Study|Site Closure|1|||
28112582|NCT00005947|54770365|FG001|Overall Study|Site Closure|0|||
28112583|NCT00005047|54770377|FG000|Overall Study|Withdrawal by Subject|12|||
28112584|NCT00005047|54770378|FG001|Overall Study|Withdrawal by Subject|0|||
28112585|NCT00005047|54770379|FG002|Overall Study|Withdrawal by Subject|0|||
28112586|NCT00005047|54770380|FG003|Overall Study|Withdrawal by Subject|0|||
28112587|NCT00005047|54770377|FG000|Overall Study|Adverse Event|5|||
28112588|NCT00005047|54770378|FG001|Overall Study|Adverse Event|0|||
28112589|NCT00005047|54770379|FG002|Overall Study|Adverse Event|0|||
28112590|NCT00005047|54770380|FG003|Overall Study|Adverse Event|0|||
28112591|NCT00005047|54770377|FG000|Overall Study|Lost to Follow-up|1|||
28112592|NCT00005047|54770378|FG001|Overall Study|Lost to Follow-up|0|||
28112593|NCT00005047|54770379|FG002|Overall Study|Lost to Follow-up|0|||
28112594|NCT00005047|54770380|FG003|Overall Study|Lost to Follow-up|0|||
28112595|NCT00005047|54770377|FG000|Overall Study|Lack of Efficacy|1|||
28112596|NCT00005047|54770378|FG001|Overall Study|Lack of Efficacy|0|||
28112597|NCT00005047|54770379|FG002|Overall Study|Lack of Efficacy|0|||
28112598|NCT00005047|54770380|FG003|Overall Study|Lack of Efficacy|0|||
28112599|NCT00003901|54770390|FG000|Overall Study|Adverse Event|1|||
28112600|NCT00003901|54770390|FG000|Overall Study|Withdrawal by Subject|1|||
28112601|NCT00003901|54770390|FG000|Overall Study|Ineligible|6|||
28112602|NCT00003901|54770390|FG000|Overall Study|CT Scan not within protocol requirement|2|||
28112603|NCT00003901|54770390|FG000|Overall Study|Chest X-Ray not done prior registration|1|||
28112604|NCT00003901|54770390|FG000|Overall Study|Medical problems|6|||
28112605|NCT00003895|54770399|FG000|Overall Study|Adverse Event|4|||
28112606|NCT00003895|54770400|FG001|Overall Study|Adverse Event|0|||
28112607|NCT00003895|54770399|FG000|Overall Study|Lack of Efficacy|1|||
28112608|NCT00003895|54770400|FG001|Overall Study|Lack of Efficacy|1|||
28112609|NCT00003895|54770399|FG000|Overall Study|Patient Vacation|2|||
28112610|NCT00003895|54770400|FG001|Overall Study|Patient Vacation|0|||
28112611|NCT00003895|54770399|FG000|Overall Study|Withdrawal by Subject|0|||
28112612|NCT00003895|54770400|FG001|Overall Study|Withdrawal by Subject|3|||
28112613|NCT03800173|54770411|FG000|Overall Study|Lost to Follow-up|0|||
28112614|NCT03800173|54770412|FG001|Overall Study|Lost to Follow-up|0|||
28112615|NCT03800173|54770413|FG002|Overall Study|Lost to Follow-up|0|||
28112616|NCT03800173|54770414|FG003|Overall Study|Lost to Follow-up|0|||
28112617|NCT03800173|54770415|FG004|Overall Study|Lost to Follow-up|1|||
28112618|NCT00003631|54770434|FG000|Overall Study|Patient not treated|1|||
28112619|NCT00003631|54770435|FG001|Overall Study|Patient not treated|0|||
28112620|NCT00003631|54770436|FG002|Overall Study|Patient not treated|1|||
28112621|NCT00003631|54770434|FG000|Overall Study|Protocol Violation|1|||
28112622|NCT00003631|54770435|FG001|Overall Study|Protocol Violation|0|||
28112623|NCT00003631|54770436|FG002|Overall Study|Protocol Violation|0|||
28112624|NCT00003631|54770434|FG000|Overall Study|Adverse Event|1|||
28112625|NCT00003631|54770435|FG001|Overall Study|Adverse Event|1|||
28112626|NCT00003631|54770436|FG002|Overall Study|Adverse Event|5|||
28112627|NCT00003631|54770434|FG000|Overall Study|Death|0|||
28112628|NCT00003631|54770435|FG001|Overall Study|Death|0|||
28112629|NCT00003631|54770436|FG002|Overall Study|Death|1|||
28112630|NCT00003631|54770434|FG000|Overall Study|Evaluable for toxicity only|0|||
28112631|NCT00003631|54770435|FG001|Overall Study|Evaluable for toxicity only|0|||
28112632|NCT00003631|54770436|FG002|Overall Study|Evaluable for toxicity only|2|||
28112633|NCT00003535|54770444|FG000|Overall Study|Not evaluable|5|||
28112634|NCT00003511|54770448|FG000|Overall Study|Not evaluable|4|||
28112635|NCT00003499|54770452|FG000|Overall Study|Not evaluable|8|||
28112636|NCT00003487|54770456|FG000|Overall Study|Not evaluable|2|||
28112637|NCT00003475|54770460|FG000|Overall Study|Not evaluable|13|||
28112638|NCT00003457|54770465|FG000|Overall Study|Not evaluable|9|||
28112639|NCT00030901|54770471|FG000|Initial Registration|Ineligible|167|||
28112640|NCT00030901|54770472|FG001|Initial Registration|Ineligible|0|||
28112641|NCT00030901|54770473|FG002|Initial Registration|Ineligible|0|||
28112642|NCT00030901|54770471|FG000|Randomization|Adverse Event|0|||
28112643|NCT00030901|54770472|FG001|Randomization|Adverse Event|11|||
28112644|NCT00030901|54770473|FG002|Randomization|Adverse Event|7|||
28112645|NCT00030901|54770471|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
28112646|NCT00030901|54770472|FG001|Randomization|Refusal Unrelated to Adverse Event|16|||
28112647|NCT00030901|54770473|FG002|Randomization|Refusal Unrelated to Adverse Event|10|||
28112648|NCT00030901|54770471|FG000|Randomization|Progression/Relapse|0|||
28112649|NCT00030901|54770472|FG001|Randomization|Progression/Relapse|22|||
28112650|NCT00030901|54770473|FG002|Randomization|Progression/Relapse|21|||
28112651|NCT00030901|54770471|FG000|Randomization|Death|0|||
28112652|NCT00030901|54770472|FG001|Randomization|Death|1|||
28112653|NCT00030901|54770473|FG002|Randomization|Death|3|||
28112654|NCT00030901|54770471|FG000|Randomization|Other|0|||
28112655|NCT00030901|54770472|FG001|Randomization|Other|36|||
28112656|NCT00030901|54770473|FG002|Randomization|Other|33|||
28112657|NCT00030901|54770471|FG000|Randomization|Ineligible|0|||
28112658|NCT00030901|54770472|FG001|Randomization|Ineligible|15|||
28112659|NCT00030901|54770473|FG002|Randomization|Ineligible|14|||
28112660|NCT00003199|54770479|FG000|Overall Study|Refused Post-Transplant Immunotherapy|5|||
28112661|NCT00003199|54770479|FG000|Overall Study|Lack of insurance clearance|2|||
28112662|NCT00003199|54770479|FG000|Overall Study|Screen fail|15|||
28112663|NCT00030823|54770483|FG000|Overall Study|Withdrawal by Subject|1|||
28064671|NCT00328172|54720275|FG003|Overall Study|Other reason (not specified)|0|||
28064672|NCT00328172|54720276|FG004|Overall Study|Other reason (not specified)|0|||
28064673|NCT00328094|54720290|FG000|Overall Study|Physician Decision|3|||
28064674|NCT00328094|54720291|FG001|Overall Study|Physician Decision|3|||
28064675|NCT00500903|54720300|FG000|Overall Study|Occurrence of Adverse Event(s)|10|||
28064676|NCT00500903|54720301|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
28064677|NCT00500903|54720302|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
28064678|NCT00500903|54720300|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
28064679|NCT00500903|54720301|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
28064680|NCT00500903|54720302|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
28064681|NCT00500903|54720300|FG000|Overall Study|Progressive Disease|41|||
28064682|NCT00500903|54720301|FG001|Overall Study|Progressive Disease|2|||
28064683|NCT00500903|54720302|FG002|Overall Study|Progressive Disease|15|||
28064684|NCT00500903|54720300|FG000|Overall Study|Patient Declined Further Treatment|0|||
28064685|NCT00500903|54720301|FG001|Overall Study|Patient Declined Further Treatment|0|||
28064686|NCT00500903|54720302|FG002|Overall Study|Patient Declined Further Treatment|3|||
28064687|NCT00500903|54720300|FG000|Overall Study|Symptomatic Deterioration|2|||
28064688|NCT00500903|54720301|FG001|Overall Study|Symptomatic Deterioration|0|||
28064689|NCT00500903|54720302|FG002|Overall Study|Symptomatic Deterioration|0|||
28064690|NCT00500903|54720300|FG000|Overall Study|Reason Not Specified|10|||
28064691|NCT00500903|54720301|FG001|Overall Study|Reason Not Specified|0|||
28064692|NCT00500903|54720302|FG002|Overall Study|Reason Not Specified|2|||
28064693|NCT00295932|54720351|FG000|Overall Study|Not Treated|0|||
28064694|NCT00295932|54720352|FG001|Overall Study|Not Treated|0|||
28064695|NCT00295932|54720353|FG002|Overall Study|Not Treated|0|||
28112664|NCT00001849|54770487|FG000|Overall Study|Death|4|||
28064696|NCT00295932|54720354|FG003|Overall Study|Not Treated|0|||
28064697|NCT00295932|54720355|FG004|Overall Study|Not Treated|0|||
28112665|NCT00001849|54770487|FG000|Overall Study|Lost to Follow-up|2|||
28112666|NCT00001849|54770487|FG000|Overall Study|Withdrawal by Subject|2|||
28112667|NCT00001849|54770487|FG000|Overall Study|tumor remained occult|6|||
28112668|NCT01342952|54770504|FG000|Overall Study|Adverse Event|0|||
27816087|NCT01544595|54272968|FG003|Status at Week 68|Non-compliance with study treatment|1|||
28064698|NCT00295932|54720356|FG005|Overall Study|Not Treated|0|||
28112669|NCT01342952|54770505|FG001|Overall Study|Adverse Event|5|||
28112670|NCT01342952|54770506|FG002|Overall Study|Adverse Event|1|||
28112671|NCT01342952|54770507|FG003|Overall Study|Adverse Event|0|||
28112672|NCT01342952|54770504|FG000|Overall Study|Lost to Follow-up|0|||
28112673|NCT01342952|54770505|FG001|Overall Study|Lost to Follow-up|2|||
28112674|NCT01342952|54770506|FG002|Overall Study|Lost to Follow-up|0|||
28064699|NCT00295932|54720357|FG006|Overall Study|Not Treated|0|||
28064700|NCT00295932|54720358|FG007|Overall Study|Not Treated|0|||
28064701|NCT00295932|54720359|FG008|Overall Study|Not Treated|0|||
28064702|NCT00295932|54720360|FG009|Overall Study|Not Treated|0|||
28112675|NCT01342952|54770507|FG003|Overall Study|Lost to Follow-up|0|||
28112676|NCT01342952|54770504|FG000|Overall Study|Withdrawal by Subject|1|||
28112677|NCT01342952|54770505|FG001|Overall Study|Withdrawal by Subject|1|||
28112678|NCT01342952|54770506|FG002|Overall Study|Withdrawal by Subject|0|||
28112679|NCT01342952|54770507|FG003|Overall Study|Withdrawal by Subject|0|||
28112680|NCT01342952|54770504|FG000|Overall Study|Physician Decision|3|||
28112681|NCT01342952|54770505|FG001|Overall Study|Physician Decision|3|||
28112682|NCT01342952|54770506|FG002|Overall Study|Physician Decision|1|||
28112683|NCT01342952|54770507|FG003|Overall Study|Physician Decision|0|||
28112684|NCT02886884|54770534|FG000|Follow-up|Withdrawal by Subject|0|||
28112685|NCT02886884|54770535|FG001|Follow-up|Withdrawal by Subject|0|||
28112686|NCT02886884|54770536|FG002|Follow-up|Withdrawal by Subject|0|||
28112687|NCT02886884|54770537|FG003|Follow-up|Withdrawal by Subject|1|||
28112688|NCT01240694|54770556|FG000|Overall Study|Adverse Event|9|||
28112689|NCT01240694|54770556|FG000|Overall Study|Lack of Efficacy|6|||
28112690|NCT01240694|54770556|FG000|Overall Study|Withdrawal by Subject|6|||
28112691|NCT01240694|54770556|FG000|Overall Study|Protocol Violation|2|||
28112692|NCT01240694|54770556|FG000|Overall Study|Lost to Follow-up|2|||
28112693|NCT01240694|54770556|FG000|Overall Study|Other than specified|3|||
28112694|NCT01240694|54770556|FG000|Overall Study|Withdrawn due to early study termination|107|||
28112695|NCT01112306|54770560|FG000|Overall Study|Death|175|||
28112696|NCT01112306|54770560|FG000|Overall Study|Lost to Follow-up|9|||
28112697|NCT01112306|54770560|FG000|Overall Study|Withdrawal by Subject|31|||
28112698|NCT01112306|54770560|FG000|Overall Study|Other|70|||
28112699|NCT03162224|54770567|FG000|Overall Study|Death|4|||
28112700|NCT03162224|54770568|FG001|Overall Study|Death|5|||
28112701|NCT03162224|54770569|FG002|Overall Study|Death|8|||
28112702|NCT03162224|54770567|FG000|Overall Study|Withdrawal by Subject|1|||
28112703|NCT03162224|54770568|FG001|Overall Study|Withdrawal by Subject|0|||
28112704|NCT03162224|54770569|FG002|Overall Study|Withdrawal by Subject|1|||
28112705|NCT03162224|54770567|FG000|Overall Study|Lost to Follow-up|0|||
28112706|NCT03162224|54770568|FG001|Overall Study|Lost to Follow-up|1|||
28112707|NCT03162224|54770569|FG002|Overall Study|Lost to Follow-up|0|||
28112708|NCT03162224|54770567|FG000|Overall Study|Other|6|||
28112709|NCT03162224|54770568|FG001|Overall Study|Other|2|||
28112710|NCT03162224|54770569|FG002|Overall Study|Other|1|||
28112711|NCT02886338|54770608|FG000|Overall Study|Withdrawal by Subject|1|||
28112712|NCT00004124|54770614|FG000|Overall Study|Received no protocol therapy|12|||
28112713|NCT00004124|54770615|FG001|Overall Study|Received no protocol therapy|20|||
28064703|NCT00295932|54720361|FG010|Overall Study|Not Treated|1|||
28064704|NCT00305448|54720390|FG000|Overall Study|Protocol Violation|0|||
28064705|NCT00305448|54720391|FG001|Overall Study|Protocol Violation|1|||
28064706|NCT00305448|54720392|FG002|Overall Study|Protocol Violation|0|||
28064707|NCT00305448|54720390|FG000|Overall Study|Withdrawal by Subject|2|||
28064708|NCT00305448|54720391|FG001|Overall Study|Withdrawal by Subject|0|||
28064709|NCT00305448|54720392|FG002|Overall Study|Withdrawal by Subject|1|||
28064710|NCT00305448|54720390|FG000|Overall Study|Adverse Event|1|||
28112714|NCT00383552|54770625|FG000|Overall Study|Adverse Event|7|||
27940236|NCT00951496|54596505|FG001|Overall Study|Did not initiate study treatment|8|||
27940237|NCT00951496|54596506|FG002|Overall Study|Did not initiate study treatment|13|||
27940238|NCT01193244|54596519|FG000|Overall Study|Withdrawal by Subject|79|||
28064711|NCT00305448|54720391|FG001|Overall Study|Adverse Event|0|||
28112715|NCT00383552|54770626|FG001|Overall Study|Adverse Event|6|||
28112716|NCT00383552|54770627|FG002|Overall Study|Adverse Event|9|||
28112717|NCT00383552|54770628|FG003|Overall Study|Adverse Event|6|||
28112718|NCT00383552|54770625|FG000|Overall Study|Lack of Efficacy|4|||
28112719|NCT00383552|54770626|FG001|Overall Study|Lack of Efficacy|13|||
28112720|NCT00383552|54770627|FG002|Overall Study|Lack of Efficacy|29|||
28112721|NCT00383552|54770628|FG003|Overall Study|Lack of Efficacy|42|||
28112722|NCT00383552|54770625|FG000|Overall Study|Lost to Follow-up|0|||
28064712|NCT00305448|54720392|FG002|Overall Study|Adverse Event|1|||
28064713|NCT00305448|54720390|FG000|Overall Study|Disease Progression|27|||
28112723|NCT00383552|54770626|FG001|Overall Study|Lost to Follow-up|1|||
28112724|NCT00383552|54770627|FG002|Overall Study|Lost to Follow-up|5|||
28112725|NCT00383552|54770628|FG003|Overall Study|Lost to Follow-up|1|||
28112726|NCT00383552|54770625|FG000|Overall Study|Did not wish to continue (unrelated)|4|||
28112727|NCT00383552|54770626|FG001|Overall Study|Did not wish to continue (unrelated)|9|||
28112728|NCT00383552|54770627|FG002|Overall Study|Did not wish to continue (unrelated)|5|||
28112729|NCT00383552|54770628|FG003|Overall Study|Did not wish to continue (unrelated)|6|||
28112730|NCT00383552|54770625|FG000|Overall Study|Did not wish to continue (related)|1|||
28112731|NCT00383552|54770626|FG001|Overall Study|Did not wish to continue (related)|0|||
28112732|NCT00383552|54770627|FG002|Overall Study|Did not wish to continue (related)|2|||
28112733|NCT00383552|54770628|FG003|Overall Study|Did not wish to continue (related)|3|||
28112734|NCT00383552|54770625|FG000|Overall Study|Noncompliance with the protocol|11|||
28112735|NCT00383552|54770626|FG001|Overall Study|Noncompliance with the protocol|6|||
28112736|NCT00383552|54770627|FG002|Overall Study|Noncompliance with the protocol|8|||
28112737|NCT00383552|54770628|FG003|Overall Study|Noncompliance with the protocol|10|||
28112738|NCT00383552|54770625|FG000|Overall Study|Did not meet protocol eligibility|8|||
28112739|NCT00383552|54770626|FG001|Overall Study|Did not meet protocol eligibility|6|||
28112740|NCT00383552|54770627|FG002|Overall Study|Did not meet protocol eligibility|2|||
28112741|NCT00383552|54770628|FG003|Overall Study|Did not meet protocol eligibility|3|||
28112742|NCT00383552|54770625|FG000|Overall Study|Administrative|1|||
28112743|NCT00383552|54770626|FG001|Overall Study|Administrative|0|||
28112744|NCT00383552|54770627|FG002|Overall Study|Administrative|1|||
28112745|NCT00383552|54770628|FG003|Overall Study|Administrative|1|||
28112746|NCT03158012|54770645|FG000|Overall Study|Withdrawal by Subject|0|||
28112747|NCT03158012|54770646|FG001|Overall Study|Withdrawal by Subject|1|||
28112748|NCT01776424|54770655|FG000|Antithrombotic Part (Double Blind)|Lost to Follow-up|10|||
28112749|NCT01776424|54770656|FG001|Antithrombotic Part (Double Blind)|Lost to Follow-up|8|||
28112750|NCT01776424|54770657|FG002|Antithrombotic Part (Double Blind)|Lost to Follow-up|9|||
28112751|NCT01776424|54770655|FG000|Antithrombotic Part (Double Blind)|Withdrawal by Subject|10|||
28112752|NCT01776424|54770656|FG001|Antithrombotic Part (Double Blind)|Withdrawal by Subject|11|||
28112753|NCT01776424|54770657|FG002|Antithrombotic Part (Double Blind)|Withdrawal by Subject|15|||
28112754|NCT01776424|54770655|FG000|LTOLE Part (Open Label)|Lost to Follow-up|6|||
28112755|NCT01776424|54770656|FG001|LTOLE Part (Open Label)|Lost to Follow-up|2|||
28112756|NCT01776424|54770657|FG002|LTOLE Part (Open Label)|Lost to Follow-up|5|||
28112757|NCT01776424|54770655|FG000|LTOLE Part (Open Label)|Refused|5|||
28112758|NCT01776424|54770656|FG001|LTOLE Part (Open Label)|Refused|2|||
28112759|NCT01776424|54770657|FG002|LTOLE Part (Open Label)|Refused|11|||
28112760|NCT01776424|54770655|FG000|LTOLE Part (Open Label)|Missing final visit|68|||
28112761|NCT01776424|54770656|FG001|LTOLE Part (Open Label)|Missing final visit|58|||
28112762|NCT01776424|54770657|FG002|LTOLE Part (Open Label)|Missing final visit|62|||
28112763|NCT03799627|54770683|FG000|Overall Study|Adverse Event|1|||
28112764|NCT03799627|54770684|FG001|Overall Study|Adverse Event|2|||
28112765|NCT03799627|54770685|FG002|Overall Study|Adverse Event|0|||
27940239|NCT01193244|54596520|FG001|Overall Study|Withdrawal by Subject|97|||
27940240|NCT01193244|54596519|FG000|Overall Study|Other|303|||
28112766|NCT03799627|54770686|FG003|Overall Study|Adverse Event|0|||
28112767|NCT03799627|54770687|FG004|Overall Study|Adverse Event|2|||
28112768|NCT03799627|54770688|FG005|Overall Study|Adverse Event|5|||
27940241|NCT01193244|54596520|FG001|Overall Study|Other|278|||
27940242|NCT01193244|54596519|FG000|Overall Study|Lost to Follow-up|6|||
27940243|NCT01193244|54596520|FG001|Overall Study|Lost to Follow-up|15|||
27940244|NCT01192152|54596526|FG000|Period 1|left prematurely (while on treatment B)|0|||
27940245|NCT01192152|54596527|FG001|Period 1|left prematurely (while on treatment B)|1|||
27940246|NCT01192152|54596526|FG000|Period 3|family emergency|1|||
27940247|NCT01192152|54596527|FG001|Period 3|family emergency|0|||
27940248|NCT01191840|54596537|FG000|Overall Study|withdrew consent|2|||
27940249|NCT01191840|54596538|FG001|Overall Study|withdrew consent|1|||
27940250|NCT01191840|54596537|FG000|Overall Study|Subject discontinued treatment|1|||
27940251|NCT01191840|54596538|FG001|Overall Study|Subject discontinued treatment|2|||
28112769|NCT03799627|54770689|FG006|Overall Study|Adverse Event|0|||
28112770|NCT03799627|54770690|FG007|Overall Study|Adverse Event|2|||
28112771|NCT03799627|54770691|FG008|Overall Study|Adverse Event|0|||
28112772|NCT03799627|54770683|FG000|Overall Study|Physician Decision|2|||
28112773|NCT03799627|54770684|FG001|Overall Study|Physician Decision|2|||
28112774|NCT03799627|54770685|FG002|Overall Study|Physician Decision|0|||
28112775|NCT03799627|54770686|FG003|Overall Study|Physician Decision|0|||
28112776|NCT03799627|54770687|FG004|Overall Study|Physician Decision|2|||
28112777|NCT03799627|54770688|FG005|Overall Study|Physician Decision|2|||
28112778|NCT03799627|54770689|FG006|Overall Study|Physician Decision|0|||
28112779|NCT03799627|54770690|FG007|Overall Study|Physician Decision|0|||
28112780|NCT03799627|54770691|FG008|Overall Study|Physician Decision|0|||
28112781|NCT03799627|54770683|FG000|Overall Study|Withdrawal by Subject|1|||
27940252|NCT01191840|54596537|FG000|Overall Study|Lost to Follow-up|4|||
27940253|NCT01191840|54596538|FG001|Overall Study|Lost to Follow-up|6|||
28112782|NCT03799627|54770684|FG001|Overall Study|Withdrawal by Subject|1|||
28112783|NCT03799627|54770685|FG002|Overall Study|Withdrawal by Subject|0|||
28112784|NCT03799627|54770686|FG003|Overall Study|Withdrawal by Subject|2|||
28112785|NCT03799627|54770687|FG004|Overall Study|Withdrawal by Subject|0|||
28112786|NCT03799627|54770688|FG005|Overall Study|Withdrawal by Subject|3|||
27816088|NCT01544595|54272969|FG004|Status at Week 68|Non-compliance with study treatment|0|||
27816089|NCT01544595|54272970|FG005|Status at Week 68|Non-compliance with study treatment|0|||
27816090|NCT01544595|54272965|FG000|Status at Week 68|Protocol Violation|2|||
27816091|NCT01544595|54272966|FG001|Status at Week 68|Protocol Violation|0|||
27816092|NCT01544595|54272967|FG002|Status at Week 68|Protocol Violation|1|||
27816093|NCT01544595|54272968|FG003|Status at Week 68|Protocol Violation|1|||
27816094|NCT01544595|54272969|FG004|Status at Week 68|Protocol Violation|0|||
27816095|NCT01544595|54272970|FG005|Status at Week 68|Protocol Violation|0|||
27816096|NCT01544595|54272965|FG000|Status at Week 68|Technical problems|1|||
27816097|NCT01544595|54272966|FG001|Status at Week 68|Technical problems|0|||
27816098|NCT01544595|54272967|FG002|Status at Week 68|Technical problems|0|||
27816099|NCT01544595|54272968|FG003|Status at Week 68|Technical problems|1|||
27816100|NCT01544595|54272969|FG004|Status at Week 68|Technical problems|0|||
27816101|NCT01544595|54272970|FG005|Status at Week 68|Technical problems|0|||
27816102|NCT01544595|54272965|FG000|Status at Week 68|Withdrawal by Subject|0|||
27816103|NCT01544595|54272966|FG001|Status at Week 68|Withdrawal by Subject|1|||
27816104|NCT01544595|54272967|FG002|Status at Week 68|Withdrawal by Subject|1|||
27816105|NCT01544595|54272968|FG003|Status at Week 68|Withdrawal by Subject|2|||
27816106|NCT01544595|54272969|FG004|Status at Week 68|Withdrawal by Subject|0|||
27816107|NCT01544595|54272970|FG005|Status at Week 68|Withdrawal by Subject|0|||
28112787|NCT03799627|54770689|FG006|Overall Study|Withdrawal by Subject|0|||
28112788|NCT03799627|54770690|FG007|Overall Study|Withdrawal by Subject|0|||
27848706|NCT01670526|54342827|FG001|Overall Study|Withdrawal by Subject|1|||
28064714|NCT00305448|54720391|FG001|Overall Study|Disease Progression|31|||
28112789|NCT03799627|54770691|FG008|Overall Study|Withdrawal by Subject|0|||
28112790|NCT03799627|54770683|FG000|Overall Study|Lack of Efficacy|0|||
28112791|NCT03799627|54770684|FG001|Overall Study|Lack of Efficacy|0|||
28112792|NCT03799627|54770685|FG002|Overall Study|Lack of Efficacy|0|||
28112793|NCT03799627|54770686|FG003|Overall Study|Lack of Efficacy|1|||
28112794|NCT03799627|54770687|FG004|Overall Study|Lack of Efficacy|0|||
28112795|NCT03799627|54770688|FG005|Overall Study|Lack of Efficacy|0|||
28112796|NCT03799627|54770689|FG006|Overall Study|Lack of Efficacy|0|||
28112797|NCT03799627|54770690|FG007|Overall Study|Lack of Efficacy|0|||
28112798|NCT03799627|54770691|FG008|Overall Study|Lack of Efficacy|0|||
28112799|NCT03799627|54770683|FG000|Overall Study|Lost to Follow-up|0|||
27816108|NCT01544595|54272965|FG000|Status at Week 68|Moved to treatment period ≤ wk 68|30|||
27816109|NCT01544595|54272966|FG001|Status at Week 68|Moved to treatment period ≤ wk 68|13|||
27848707|NCT01670526|54342826|FG000|Overall Study|Lost to Follow-up|9|||
28064715|NCT00305448|54720392|FG002|Overall Study|Disease Progression|28|||
28064716|NCT00305448|54720390|FG000|Overall Study|Subjective Disease Progression|1|||
28064717|NCT00305448|54720391|FG001|Overall Study|Subjective Disease Progression|2|||
28064718|NCT00305448|54720392|FG002|Overall Study|Subjective Disease Progression|2|||
28064719|NCT00305448|54720390|FG000|Overall Study|Tumor Marker Elevation|0|||
28064720|NCT00305448|54720391|FG001|Overall Study|Tumor Marker Elevation|0|||
28064721|NCT00305448|54720392|FG002|Overall Study|Tumor Marker Elevation|1|||
28064722|NCT00305058|54720403|FG000|Overall Study|Participant too young|1|||
28064723|NCT00305058|54720404|FG001|Overall Study|Participant too young|0|||
28064724|NCT00305058|54720403|FG000|Overall Study|Missing data collection instrument|3|||
28064725|NCT00305058|54720404|FG001|Overall Study|Missing data collection instrument|2|||
28064726|NCT00305058|54720403|FG000|Overall Study|Missing outcome data|3|||
28064727|NCT00305058|54720404|FG001|Overall Study|Missing outcome data|2|||
28064728|NCT00295854|54720413|FG000|Overall Study|Adverse Event|7|||
28112800|NCT03799627|54770684|FG001|Overall Study|Lost to Follow-up|0|||
28112801|NCT03799627|54770685|FG002|Overall Study|Lost to Follow-up|0|||
28112802|NCT03799627|54770686|FG003|Overall Study|Lost to Follow-up|0|||
28112803|NCT03799627|54770687|FG004|Overall Study|Lost to Follow-up|0|||
28112804|NCT03799627|54770688|FG005|Overall Study|Lost to Follow-up|0|||
28112805|NCT03799627|54770689|FG006|Overall Study|Lost to Follow-up|1|||
28112806|NCT03799627|54770690|FG007|Overall Study|Lost to Follow-up|0|||
28112807|NCT03799627|54770691|FG008|Overall Study|Lost to Follow-up|1|||
28112808|NCT03799627|54770683|FG000|Overall Study|Death|0|||
28112809|NCT03799627|54770684|FG001|Overall Study|Death|0|||
28112810|NCT03799627|54770685|FG002|Overall Study|Death|0|||
28112811|NCT03799627|54770686|FG003|Overall Study|Death|1|||
28112812|NCT03799627|54770687|FG004|Overall Study|Death|0|||
28112813|NCT03799627|54770688|FG005|Overall Study|Death|0|||
28112814|NCT03799627|54770689|FG006|Overall Study|Death|0|||
28112815|NCT03799627|54770690|FG007|Overall Study|Death|0|||
28112816|NCT03799627|54770691|FG008|Overall Study|Death|0|||
28112817|NCT03799627|54770683|FG000|Overall Study|Study Drug Put on Hold|1|||
28112818|NCT03799627|54770684|FG001|Overall Study|Study Drug Put on Hold|0|||
28112819|NCT03799627|54770685|FG002|Overall Study|Study Drug Put on Hold|0|||
28112820|NCT03799627|54770686|FG003|Overall Study|Study Drug Put on Hold|0|||
28112821|NCT03799627|54770687|FG004|Overall Study|Study Drug Put on Hold|0|||
28112822|NCT03799627|54770688|FG005|Overall Study|Study Drug Put on Hold|0|||
28112823|NCT03799627|54770689|FG006|Overall Study|Study Drug Put on Hold|0|||
28112824|NCT03799627|54770690|FG007|Overall Study|Study Drug Put on Hold|0|||
28112825|NCT03799627|54770691|FG008|Overall Study|Study Drug Put on Hold|0|||
28112826|NCT03799627|54770683|FG000|Overall Study|Due to Urgent Safety Measures Letter|1|||
28112827|NCT03799627|54770684|FG001|Overall Study|Due to Urgent Safety Measures Letter|2|||
28112828|NCT03799627|54770685|FG002|Overall Study|Due to Urgent Safety Measures Letter|0|||
28112829|NCT03799627|54770686|FG003|Overall Study|Due to Urgent Safety Measures Letter|2|||
28112830|NCT03799627|54770687|FG004|Overall Study|Due to Urgent Safety Measures Letter|1|||
28112831|NCT03799627|54770688|FG005|Overall Study|Due to Urgent Safety Measures Letter|0|||
28112832|NCT03799627|54770689|FG006|Overall Study|Due to Urgent Safety Measures Letter|0|||
28112833|NCT03799627|54770690|FG007|Overall Study|Due to Urgent Safety Measures Letter|0|||
28112834|NCT03799627|54770691|FG008|Overall Study|Due to Urgent Safety Measures Letter|0|||
28112835|NCT03799627|54770683|FG000|Overall Study|Kidney Transplantation|1|||
28112836|NCT03799627|54770684|FG001|Overall Study|Kidney Transplantation|0|||
28112837|NCT03799627|54770685|FG002|Overall Study|Kidney Transplantation|0|||
28112838|NCT03799627|54770686|FG003|Overall Study|Kidney Transplantation|1|||
28112839|NCT03799627|54770687|FG004|Overall Study|Kidney Transplantation|1|||
28112840|NCT03799627|54770688|FG005|Overall Study|Kidney Transplantation|0|||
28112841|NCT03799627|54770689|FG006|Overall Study|Kidney Transplantation|0|||
28112842|NCT03799627|54770690|FG007|Overall Study|Kidney Transplantation|0|||
28112843|NCT03799627|54770691|FG008|Overall Study|Kidney Transplantation|0|||
28112844|NCT03799627|54770683|FG000|Overall Study|Participant Was on Rescue Epogen|0|||
28112845|NCT03799627|54770684|FG001|Overall Study|Participant Was on Rescue Epogen|1|||
28112846|NCT03799627|54770685|FG002|Overall Study|Participant Was on Rescue Epogen|0|||
28112847|NCT03799627|54770686|FG003|Overall Study|Participant Was on Rescue Epogen|0|||
28112848|NCT03799627|54770687|FG004|Overall Study|Participant Was on Rescue Epogen|0|||
28112849|NCT03799627|54770688|FG005|Overall Study|Participant Was on Rescue Epogen|0|||
28112850|NCT03799627|54770689|FG006|Overall Study|Participant Was on Rescue Epogen|1|||
28112851|NCT03799627|54770690|FG007|Overall Study|Participant Was on Rescue Epogen|0|||
28112852|NCT03799627|54770691|FG008|Overall Study|Participant Was on Rescue Epogen|1|||
28112853|NCT03799627|54770683|FG000|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
28112854|NCT03799627|54770684|FG001|Overall Study|Placed on Dose Hold Until End of Treatment|1|||
28112855|NCT03799627|54770685|FG002|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
28112856|NCT03799627|54770686|FG003|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
28112857|NCT03799627|54770687|FG004|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
28112858|NCT03799627|54770688|FG005|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
28112859|NCT03799627|54770689|FG006|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
28112860|NCT03799627|54770690|FG007|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
28112861|NCT03799627|54770691|FG008|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
28112862|NCT03799627|54770683|FG000|Overall Study|Met Exclusion Criteria|0|||
28112863|NCT03799627|54770684|FG001|Overall Study|Met Exclusion Criteria|0|||
28112864|NCT03799627|54770685|FG002|Overall Study|Met Exclusion Criteria|0|||
28112865|NCT03799627|54770686|FG003|Overall Study|Met Exclusion Criteria|1|||
28112866|NCT03799627|54770687|FG004|Overall Study|Met Exclusion Criteria|0|||
28112867|NCT03799627|54770688|FG005|Overall Study|Met Exclusion Criteria|0|||
28112868|NCT03799627|54770689|FG006|Overall Study|Met Exclusion Criteria|0|||
28112869|NCT03799627|54770690|FG007|Overall Study|Met Exclusion Criteria|0|||
28112870|NCT03799627|54770691|FG008|Overall Study|Met Exclusion Criteria|0|||
28112871|NCT03799627|54770683|FG000|Overall Study|Investigational Product Noncompliance|0|||
28112872|NCT03799627|54770684|FG001|Overall Study|Investigational Product Noncompliance|0|||
28112873|NCT03799627|54770685|FG002|Overall Study|Investigational Product Noncompliance|0|||
28112874|NCT03799627|54770686|FG003|Overall Study|Investigational Product Noncompliance|1|||
28112875|NCT03799627|54770687|FG004|Overall Study|Investigational Product Noncompliance|0|||
28112876|NCT03799627|54770688|FG005|Overall Study|Investigational Product Noncompliance|0|||
28112877|NCT03799627|54770689|FG006|Overall Study|Investigational Product Noncompliance|0|||
28112878|NCT03799627|54770690|FG007|Overall Study|Investigational Product Noncompliance|0|||
28112879|NCT03799627|54770691|FG008|Overall Study|Investigational Product Noncompliance|0|||
28112880|NCT03799627|54770683|FG000|Overall Study|Participant Relocation|0|||
28112881|NCT03799627|54770684|FG001|Overall Study|Participant Relocation|0|||
28112882|NCT03799627|54770685|FG002|Overall Study|Participant Relocation|0|||
28112883|NCT03799627|54770686|FG003|Overall Study|Participant Relocation|1|||
28112884|NCT03799627|54770687|FG004|Overall Study|Participant Relocation|0|||
28112885|NCT03799627|54770688|FG005|Overall Study|Participant Relocation|1|||
28112886|NCT03799627|54770689|FG006|Overall Study|Participant Relocation|0|||
28112887|NCT03799627|54770690|FG007|Overall Study|Participant Relocation|0|||
28112888|NCT03799627|54770691|FG008|Overall Study|Participant Relocation|0|||
28112889|NCT03799627|54770683|FG000|Overall Study|Eurofin Issue|0|||
28112890|NCT03799627|54770684|FG001|Overall Study|Eurofin Issue|0|||
28112891|NCT03799627|54770685|FG002|Overall Study|Eurofin Issue|0|||
28112892|NCT03799627|54770686|FG003|Overall Study|Eurofin Issue|0|||
28112893|NCT03799627|54770687|FG004|Overall Study|Eurofin Issue|1|||
28112894|NCT03799627|54770688|FG005|Overall Study|Eurofin Issue|0|||
28112895|NCT03799627|54770689|FG006|Overall Study|Eurofin Issue|0|||
28112896|NCT03799627|54770690|FG007|Overall Study|Eurofin Issue|0|||
28112897|NCT03799627|54770691|FG008|Overall Study|Eurofin Issue|0|||
28112898|NCT03799627|54770683|FG000|Overall Study|Noncompliance with Site Instructions|0|||
28112899|NCT03799627|54770684|FG001|Overall Study|Noncompliance with Site Instructions|0|||
28112900|NCT03799627|54770685|FG002|Overall Study|Noncompliance with Site Instructions|0|||
28112901|NCT03799627|54770686|FG003|Overall Study|Noncompliance with Site Instructions|0|||
28112902|NCT03799627|54770687|FG004|Overall Study|Noncompliance with Site Instructions|1|||
28112903|NCT03799627|54770688|FG005|Overall Study|Noncompliance with Site Instructions|0|||
28112904|NCT03799627|54770689|FG006|Overall Study|Noncompliance with Site Instructions|0|||
28112905|NCT03799627|54770690|FG007|Overall Study|Noncompliance with Site Instructions|0|||
28112906|NCT03799627|54770691|FG008|Overall Study|Noncompliance with Site Instructions|0|||
28112907|NCT03799627|54770683|FG000|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
28112908|NCT03799627|54770684|FG001|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
28112909|NCT03799627|54770685|FG002|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
28112910|NCT03799627|54770686|FG003|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
28112911|NCT03799627|54770687|FG004|Overall Study|Participant's Last Dose Prior to End of Treatment|1|||
28112912|NCT03799627|54770688|FG005|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
28112913|NCT03799627|54770689|FG006|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
27848708|NCT01670526|54342827|FG001|Overall Study|Lost to Follow-up|5|||
27848709|NCT02630706|54342871|FG000|Overall Study|Adverse Event|2|||
28112914|NCT03799627|54770690|FG007|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
28112915|NCT03799627|54770691|FG008|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
28112916|NCT03799627|54770683|FG000|Overall Study|Changes In Hemoglobin Values|1|||
28112917|NCT03799627|54770684|FG001|Overall Study|Changes In Hemoglobin Values|2|||
28112918|NCT03799627|54770685|FG002|Overall Study|Changes In Hemoglobin Values|1|||
28112919|NCT03799627|54770686|FG003|Overall Study|Changes In Hemoglobin Values|0|||
28112920|NCT03799627|54770687|FG004|Overall Study|Changes In Hemoglobin Values|0|||
28112921|NCT03799627|54770688|FG005|Overall Study|Changes In Hemoglobin Values|2|||
28112922|NCT03799627|54770689|FG006|Overall Study|Changes In Hemoglobin Values|1|||
28112923|NCT03799627|54770690|FG007|Overall Study|Changes In Hemoglobin Values|0|||
28112924|NCT03799627|54770691|FG008|Overall Study|Changes In Hemoglobin Values|1|||
28112925|NCT00756574|54770732|FG000|Overall Study|Withdrawal by Subject|9|||
28112926|NCT00756574|54770733|FG001|Overall Study|Withdrawal by Subject|7|||
28112927|NCT00756574|54770732|FG000|Overall Study|Lost to Follow-up|4|||
28112928|NCT00756574|54770733|FG001|Overall Study|Lost to Follow-up|4|||
28112929|NCT02743780|54770742|FG000|Part 3 (7 Days)|Adverse Event|0|||
28112930|NCT02743780|54770743|FG001|Part 3 (7 Days)|Adverse Event|0|||
28112931|NCT02743780|54770744|FG002|Part 3 (7 Days)|Adverse Event|1|||
28112932|NCT02743780|54770745|FG003|Part 3 (7 Days)|Adverse Event|0|||
28112933|NCT02743780|54770746|FG004|Part 3 (7 Days)|Adverse Event|0|||
28112934|NCT02880956|54770770|FG000|Overall Study|Adverse Event|3|||
27816110|NCT01544595|54272967|FG002|Status at Week 68|Moved to treatment period ≤ wk 68|60|||
27816111|NCT01544595|54272968|FG003|Status at Week 68|Moved to treatment period ≤ wk 68|46|||
27816112|NCT01544595|54272969|FG004|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
27816113|NCT01544595|54272970|FG005|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
28112935|NCT02880956|54770771|FG001|Overall Study|Adverse Event|6|||
28112936|NCT02880956|54770772|FG002|Overall Study|Adverse Event|5|||
28112937|NCT02880956|54770773|FG003|Overall Study|Adverse Event|4|||
28112938|NCT02880956|54770770|FG000|Overall Study|Withdrawal by Subject|9|||
28112939|NCT02880956|54770771|FG001|Overall Study|Withdrawal by Subject|4|||
28112940|NCT02880956|54770772|FG002|Overall Study|Withdrawal by Subject|6|||
28112941|NCT02880956|54770773|FG003|Overall Study|Withdrawal by Subject|11|||
28112942|NCT02880956|54770770|FG000|Overall Study|Lost to Follow-up|0|||
28112943|NCT02880956|54770771|FG001|Overall Study|Lost to Follow-up|1|||
28112944|NCT02880956|54770772|FG002|Overall Study|Lost to Follow-up|0|||
28112945|NCT02880956|54770773|FG003|Overall Study|Lost to Follow-up|0|||
28112946|NCT02880956|54770770|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
28112947|NCT02880956|54770771|FG001|Overall Study|COVID-19 Logistical Restrictions|2|||
28112948|NCT02880956|54770772|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
28112949|NCT02880956|54770773|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
28112950|NCT02880956|54770770|FG000|Overall Study|Other, Not Specified|4|||
28112951|NCT02880956|54770771|FG001|Overall Study|Other, Not Specified|2|||
28112952|NCT02880956|54770772|FG002|Overall Study|Other, Not Specified|0|||
27816114|NCT01544595|54272965|FG000|Status at Week 156|Withdrawal by Subject|9|||
27816115|NCT01544595|54272966|FG001|Status at Week 156|Withdrawal by Subject|10|||
27816116|NCT01544595|54272967|FG002|Status at Week 156|Withdrawal by Subject|4|||
28064729|NCT00295854|54720414|FG001|Overall Study|Adverse Event|7|||
28064730|NCT00295854|54720415|FG002|Overall Study|Adverse Event|6|||
28064731|NCT00295854|54720413|FG000|Overall Study|Protocol Violation|1|||
28064732|NCT00295854|54720414|FG001|Overall Study|Protocol Violation|1|||
28064733|NCT00295854|54720415|FG002|Overall Study|Protocol Violation|1|||
28064734|NCT00295854|54720413|FG000|Overall Study|Lost to Follow-up|2|||
28064735|NCT00295854|54720414|FG001|Overall Study|Lost to Follow-up|0|||
28064736|NCT00295854|54720415|FG002|Overall Study|Lost to Follow-up|1|||
28064737|NCT00295854|54720413|FG000|Overall Study|Withdrawal by Subject|3|||
28064738|NCT00295854|54720414|FG001|Overall Study|Withdrawal by Subject|7|||
28064739|NCT00295854|54720415|FG002|Overall Study|Withdrawal by Subject|4|||
28064740|NCT00295854|54720413|FG000|Overall Study|did not continue to meet criteria|1|||
28064741|NCT00295854|54720414|FG001|Overall Study|did not continue to meet criteria|1|||
28064742|NCT00295854|54720415|FG002|Overall Study|did not continue to meet criteria|2|||
28064743|NCT00295854|54720413|FG000|Overall Study|required a prohibited medication|1|||
28064744|NCT00295854|54720414|FG001|Overall Study|required a prohibited medication|0|||
28064745|NCT00295854|54720415|FG002|Overall Study|required a prohibited medication|0|||
28112953|NCT02880956|54770773|FG003|Overall Study|Other, Not Specified|3|||
28112954|NCT01352416|54770790|FG000|Overall Study|Physician Decision|1|||
28112955|NCT01352416|54770791|FG001|Overall Study|Physician Decision|2|||
28112956|NCT01352416|54770792|FG002|Overall Study|Physician Decision|2|||
28112957|NCT01352416|54770793|FG003|Overall Study|Physician Decision|1|||
28112958|NCT00439738|54770805|FG000|Overall Study|Withdrawal by Subject|16|||
28112959|NCT00439738|54770806|FG001|Overall Study|Withdrawal by Subject|13|||
28112960|NCT00439738|54770805|FG000|Overall Study|Adverse Event|6|||
28112961|NCT00439738|54770806|FG001|Overall Study|Adverse Event|4|||
28112962|NCT00439738|54770805|FG000|Overall Study|Lost to Follow-up|5|||
28112963|NCT00439738|54770806|FG001|Overall Study|Lost to Follow-up|6|||
28112964|NCT00439738|54770805|FG000|Overall Study|Protocol Violation|6|||
28112965|NCT00439738|54770806|FG001|Overall Study|Protocol Violation|3|||
28112966|NCT00439738|54770805|FG000|Overall Study|Lack of Efficacy|2|||
28112967|NCT00439738|54770806|FG001|Overall Study|Lack of Efficacy|2|||
28112968|NCT00439738|54770805|FG000|Overall Study|Abnormal Lab Values|1|||
28112969|NCT00439738|54770806|FG001|Overall Study|Abnormal Lab Values|0|||
28112970|NCT00338104|54770813|FG000|Overall Study|Protocol Violation|2|||
28112971|NCT00338104|54770814|FG001|Overall Study|Protocol Violation|1|||
28112972|NCT00338104|54770815|FG002|Overall Study|Protocol Violation|3|||
28112973|NCT02883452|54770826|FG000|Overall Study|Withdrawal by Subject|1|||
28112974|NCT02883452|54770827|FG001|Overall Study|Withdrawal by Subject|1|||
28112975|NCT02883452|54770828|FG002|Overall Study|Withdrawal by Subject|3|||
28112976|NCT02883452|54770829|FG003|Overall Study|Withdrawal by Subject|0|||
28112977|NCT02883452|54770830|FG004|Overall Study|Withdrawal by Subject|2|||
28112978|NCT02883452|54770831|FG005|Overall Study|Withdrawal by Subject|5|||
28112979|NCT02883452|54770826|FG000|Overall Study|Disease progression|1|||
28112980|NCT02883452|54770827|FG001|Overall Study|Disease progression|0|||
28112981|NCT02883452|54770828|FG002|Overall Study|Disease progression|0|||
28112982|NCT02883452|54770829|FG003|Overall Study|Disease progression|1|||
28112983|NCT02883452|54770830|FG004|Overall Study|Disease progression|4|||
28112984|NCT02883452|54770831|FG005|Overall Study|Disease progression|5|||
28112985|NCT02883452|54770826|FG000|Overall Study|Adverse Event|2|||
28112986|NCT02883452|54770827|FG001|Overall Study|Adverse Event|1|||
28112987|NCT02883452|54770828|FG002|Overall Study|Adverse Event|1|||
28112988|NCT02883452|54770829|FG003|Overall Study|Adverse Event|1|||
28112989|NCT02883452|54770830|FG004|Overall Study|Adverse Event|1|||
28112990|NCT02883452|54770831|FG005|Overall Study|Adverse Event|3|||
28112991|NCT02883452|54770826|FG000|Overall Study|Physician Decision|0|||
28112992|NCT02883452|54770827|FG001|Overall Study|Physician Decision|0|||
28112993|NCT02883452|54770828|FG002|Overall Study|Physician Decision|0|||
28112994|NCT02883452|54770829|FG003|Overall Study|Physician Decision|0|||
28112995|NCT02883452|54770830|FG004|Overall Study|Physician Decision|4|||
28112996|NCT02883452|54770831|FG005|Overall Study|Physician Decision|1|||
28112997|NCT02883452|54770826|FG000|Overall Study|Death|1|||
28112998|NCT02883452|54770827|FG001|Overall Study|Death|0|||
28112999|NCT02883452|54770828|FG002|Overall Study|Death|1|||
28113000|NCT02883452|54770829|FG003|Overall Study|Death|0|||
28113001|NCT02883452|54770830|FG004|Overall Study|Death|0|||
28113002|NCT02883452|54770831|FG005|Overall Study|Death|0|||
28113003|NCT02883452|54770826|FG000|Overall Study|Other|0|||
28113004|NCT02883452|54770827|FG001|Overall Study|Other|0|||
28113005|NCT02883452|54770828|FG002|Overall Study|Other|0|||
28113006|NCT02883452|54770829|FG003|Overall Study|Other|0|||
28113007|NCT02883452|54770830|FG004|Overall Study|Other|0|||
28113008|NCT02883452|54770831|FG005|Overall Study|Other|1|||
28113009|NCT00151372|54770848|FG000|Overall Study|Death|12|||
28113010|NCT00151372|54770849|FG001|Overall Study|Death|11|||
28113011|NCT00151372|54770848|FG000|Overall Study|Lost to Follow-up|5|||
28113012|NCT00151372|54770849|FG001|Overall Study|Lost to Follow-up|5|||
28113013|NCT00151372|54770848|FG000|Overall Study|Too sick medically to continue|5|||
28113014|NCT00151372|54770849|FG001|Overall Study|Too sick medically to continue|6|||
28113015|NCT00151372|54770848|FG000|Overall Study|Withdrawal by Subject|7|||
28113016|NCT00151372|54770849|FG001|Overall Study|Withdrawal by Subject|7|||
28113017|NCT02603809|54770861|FG000|Overall Study|Withdrawal by Subject|4|||
28113018|NCT02603809|54770862|FG001|Overall Study|Withdrawal by Subject|1|||
28113019|NCT02603809|54770863|FG002|Overall Study|Withdrawal by Subject|2|||
28113020|NCT02603809|54770864|FG003|Overall Study|Withdrawal by Subject|3|||
28113021|NCT02603809|54770865|FG004|Overall Study|Withdrawal by Subject|3|||
28113022|NCT02603809|54770866|FG005|Overall Study|Withdrawal by Subject|4|||
28113023|NCT02603809|54770861|FG000|Overall Study|Lost to Follow-up|2|||
28113024|NCT02603809|54770862|FG001|Overall Study|Lost to Follow-up|3|||
28113025|NCT02603809|54770863|FG002|Overall Study|Lost to Follow-up|1|||
28113026|NCT02603809|54770864|FG003|Overall Study|Lost to Follow-up|4|||
28113027|NCT02603809|54770865|FG004|Overall Study|Lost to Follow-up|2|||
28113028|NCT02603809|54770866|FG005|Overall Study|Lost to Follow-up|2|||
28113029|NCT02603809|54770861|FG000|Overall Study|Pre-specified discontinuation criteria|3|||
28113030|NCT02603809|54770862|FG001|Overall Study|Pre-specified discontinuation criteria|3|||
28113031|NCT02603809|54770863|FG002|Overall Study|Pre-specified discontinuation criteria|2|||
28113032|NCT02603809|54770864|FG003|Overall Study|Pre-specified discontinuation criteria|2|||
28113033|NCT02603809|54770865|FG004|Overall Study|Pre-specified discontinuation criteria|3|||
28113034|NCT02603809|54770866|FG005|Overall Study|Pre-specified discontinuation criteria|1|||
28113035|NCT02603809|54770861|FG000|Overall Study|Physician Decision|0|||
28113036|NCT02603809|54770862|FG001|Overall Study|Physician Decision|0|||
28113037|NCT02603809|54770863|FG002|Overall Study|Physician Decision|0|||
28113038|NCT02603809|54770864|FG003|Overall Study|Physician Decision|1|||
28113039|NCT02603809|54770865|FG004|Overall Study|Physician Decision|2|||
28113040|NCT02603809|54770866|FG005|Overall Study|Physician Decision|1|||
28113041|NCT02603809|54770861|FG000|Overall Study|Adverse Event|3|||
28113042|NCT02603809|54770862|FG001|Overall Study|Adverse Event|0|||
28113043|NCT02603809|54770863|FG002|Overall Study|Adverse Event|2|||
28113044|NCT02603809|54770864|FG003|Overall Study|Adverse Event|2|||
28113045|NCT02603809|54770865|FG004|Overall Study|Adverse Event|1|||
28113046|NCT02603809|54770866|FG005|Overall Study|Adverse Event|1|||
28113047|NCT02603809|54770861|FG000|Overall Study|Lack of Efficacy|0|||
28113048|NCT02603809|54770862|FG001|Overall Study|Lack of Efficacy|1|||
28113049|NCT02603809|54770863|FG002|Overall Study|Lack of Efficacy|0|||
28113050|NCT02603809|54770864|FG003|Overall Study|Lack of Efficacy|0|||
28113051|NCT02603809|54770865|FG004|Overall Study|Lack of Efficacy|0|||
28113052|NCT02603809|54770866|FG005|Overall Study|Lack of Efficacy|1|||
28113053|NCT02741596|54770897|FG000|Overall Study|Adverse Event|1|||
28113054|NCT02741596|54770898|FG001|Overall Study|Adverse Event|5|||
28113055|NCT02741596|54770897|FG000|Overall Study|Lost to Follow-up|1|||
28113056|NCT02741596|54770898|FG001|Overall Study|Lost to Follow-up|1|||
28113057|NCT02741596|54770897|FG000|Overall Study|Physician Decision|2|||
28113058|NCT02741596|54770898|FG001|Overall Study|Physician Decision|1|||
28113059|NCT02741596|54770897|FG000|Overall Study|Pregnancy|3|||
28113060|NCT02741596|54770898|FG001|Overall Study|Pregnancy|1|||
28113061|NCT02741596|54770897|FG000|Overall Study|Other (Unspecified)|0|||
27816117|NCT01544595|54272968|FG003|Status at Week 156|Withdrawal by Subject|9|||
27816118|NCT01544595|54272969|FG004|Status at Week 156|Withdrawal by Subject|20|||
28113062|NCT02741596|54770898|FG001|Overall Study|Other (Unspecified)|3|||
28113063|NCT02741596|54770897|FG000|Overall Study|Subject withdrawn-Other|17|||
28113064|NCT02741596|54770898|FG001|Overall Study|Subject withdrawn-Other|4|||
28113065|NCT02741596|54770897|FG000|Overall Study|Subject withdrawn-to commercial product|54|||
28113066|NCT02741596|54770898|FG001|Overall Study|Subject withdrawn-to commercial product|63|||
28113067|NCT03147248|54770910|FG000|Overall Study|Adverse Event|0|||
28113068|NCT03147248|54770911|FG001|Overall Study|Adverse Event|2|||
28113069|NCT03147248|54770912|FG002|Overall Study|Adverse Event|2|||
28113070|NCT03147248|54770913|FG003|Overall Study|Adverse Event|2|||
28113071|NCT03147248|54770914|FG004|Overall Study|Adverse Event|6|||
28113072|NCT03147248|54770915|FG005|Overall Study|Adverse Event|11|||
28113073|NCT03147248|54770910|FG000|Overall Study|Disease progression|1|||
28113074|NCT03147248|54770911|FG001|Overall Study|Disease progression|0|||
28113075|NCT03147248|54770912|FG002|Overall Study|Disease progression|0|||
28113076|NCT03147248|54770913|FG003|Overall Study|Disease progression|0|||
28113077|NCT03147248|54770914|FG004|Overall Study|Disease progression|0|||
28113078|NCT03147248|54770915|FG005|Overall Study|Disease progression|2|||
28113079|NCT03147248|54770910|FG000|Overall Study|Withdrawal by Subject|0|||
28113080|NCT03147248|54770911|FG001|Overall Study|Withdrawal by Subject|0|||
28113081|NCT03147248|54770912|FG002|Overall Study|Withdrawal by Subject|0|||
28113082|NCT03147248|54770913|FG003|Overall Study|Withdrawal by Subject|0|||
28113083|NCT03147248|54770914|FG004|Overall Study|Withdrawal by Subject|12|||
28113084|NCT03147248|54770915|FG005|Overall Study|Withdrawal by Subject|9|||
28113085|NCT03147248|54770910|FG000|Overall Study|Protocol Violation|0|||
28113086|NCT03147248|54770911|FG001|Overall Study|Protocol Violation|0|||
28113087|NCT03147248|54770912|FG002|Overall Study|Protocol Violation|0|||
28113088|NCT03147248|54770913|FG003|Overall Study|Protocol Violation|0|||
28113089|NCT03147248|54770914|FG004|Overall Study|Protocol Violation|2|||
28113090|NCT03147248|54770915|FG005|Overall Study|Protocol Violation|0|||
28113091|NCT03147248|54770910|FG000|Overall Study|Lost to Follow-up|0|||
28113092|NCT03147248|54770911|FG001|Overall Study|Lost to Follow-up|0|||
28113093|NCT03147248|54770912|FG002|Overall Study|Lost to Follow-up|0|||
28113094|NCT03147248|54770913|FG003|Overall Study|Lost to Follow-up|0|||
28113095|NCT03147248|54770914|FG004|Overall Study|Lost to Follow-up|2|||
28113096|NCT03147248|54770915|FG005|Overall Study|Lost to Follow-up|0|||
28113097|NCT03147248|54770910|FG000|Overall Study|Pregnancy|0|||
28113098|NCT03147248|54770911|FG001|Overall Study|Pregnancy|0|||
28113099|NCT03147248|54770912|FG002|Overall Study|Pregnancy|0|||
27816119|NCT01544595|54272970|FG005|Status at Week 156|Withdrawal by Subject|6|||
28113100|NCT03147248|54770913|FG003|Overall Study|Pregnancy|0|||
28113101|NCT03147248|54770914|FG004|Overall Study|Pregnancy|1|||
28113102|NCT03147248|54770915|FG005|Overall Study|Pregnancy|0|||
28113103|NCT03147248|54770910|FG000|Overall Study|Death|0|||
28113104|NCT03147248|54770911|FG001|Overall Study|Death|0|||
28113105|NCT03147248|54770912|FG002|Overall Study|Death|0|||
28113106|NCT03147248|54770913|FG003|Overall Study|Death|0|||
28113107|NCT03147248|54770914|FG004|Overall Study|Death|0|||
28113108|NCT03147248|54770915|FG005|Overall Study|Death|4|||
28113109|NCT03147248|54770910|FG000|Overall Study|Physician Decision|0|||
28113110|NCT03147248|54770911|FG001|Overall Study|Physician Decision|0|||
28113111|NCT03147248|54770912|FG002|Overall Study|Physician Decision|0|||
28113112|NCT03147248|54770913|FG003|Overall Study|Physician Decision|0|||
28113113|NCT03147248|54770914|FG004|Overall Study|Physician Decision|2|||
28113114|NCT03147248|54770915|FG005|Overall Study|Physician Decision|4|||
28113115|NCT03147248|54770910|FG000|Overall Study|Prolonged Dosing Interval|0|||
28113116|NCT03147248|54770911|FG001|Overall Study|Prolonged Dosing Interval|0|||
28113117|NCT03147248|54770912|FG002|Overall Study|Prolonged Dosing Interval|0|||
28113118|NCT03147248|54770913|FG003|Overall Study|Prolonged Dosing Interval|0|||
28113119|NCT03147248|54770914|FG004|Overall Study|Prolonged Dosing Interval|1|||
28113120|NCT03147248|54770915|FG005|Overall Study|Prolonged Dosing Interval|1|||
28113121|NCT03796039|54770931|FG000|Overall Study|Death|2|||
28113122|NCT03796039|54770932|FG001|Overall Study|Death|1|||
28113123|NCT03796039|54770931|FG000|Overall Study|Withdrawal by Subject|7|||
28113124|NCT03796039|54770932|FG001|Overall Study|Withdrawal by Subject|4|||
28113125|NCT03151304|54770938|FG000|Overall Study|Termination of study by Sponsor|23|||
28113126|NCT03151304|54770938|FG000|Overall Study|missing|3|||
28113127|NCT03151304|54770938|FG000|Overall Study|Withdrawal by Subject|8|||
28113128|NCT03151304|54770938|FG000|Overall Study|multiple reasons|30|||
28113129|NCT03152552|54770947|FG000|Treatment Period 1 (12 Weeks)|Death|0|||
27816120|NCT01544595|54272965|FG000|Status at Week 156|Adverse Event|9|||
28113130|NCT03152552|54770948|FG001|Treatment Period 1 (12 Weeks)|Death|1|||
28113131|NCT03152552|54770949|FG002|Treatment Period 1 (12 Weeks)|Death|0|||
28113132|NCT03152552|54770950|FG003|Treatment Period 1 (12 Weeks)|Death|0|||
28113133|NCT03152552|54770951|FG004|Treatment Period 1 (12 Weeks)|Death|1|||
28113134|NCT03152552|54770947|FG000|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
28113135|NCT03152552|54770948|FG001|Treatment Period 1 (12 Weeks)|Protocol deviation|1|||
28113136|NCT03152552|54770949|FG002|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
28113137|NCT03152552|54770950|FG003|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
28113138|NCT03152552|54770951|FG004|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
28113139|NCT03152552|54770947|FG000|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8|||
28113140|NCT03152552|54770948|FG001|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9|||
28113141|NCT03152552|54770949|FG002|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
28113142|NCT03152552|54770950|FG003|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
28113143|NCT03152552|54770951|FG004|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20|||
28113144|NCT03152552|54770947|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
28113145|NCT03152552|54770948|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
28113146|NCT03152552|54770949|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
28113147|NCT03152552|54770950|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
28113148|NCT03152552|54770951|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
27816121|NCT01544595|54272966|FG001|Status at Week 156|Adverse Event|11|||
28113149|NCT03152552|54770947|FG000|Treatment Period 1 (12 Weeks)|Technical problems|0|||
28113150|NCT03152552|54770948|FG001|Treatment Period 1 (12 Weeks)|Technical problems|0|||
28113151|NCT03152552|54770949|FG002|Treatment Period 1 (12 Weeks)|Technical problems|1|||
28113152|NCT03152552|54770950|FG003|Treatment Period 1 (12 Weeks)|Technical problems|0|||
28113153|NCT03152552|54770951|FG004|Treatment Period 1 (12 Weeks)|Technical problems|0|||
28113154|NCT03152552|54770947|FG000|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
28113155|NCT03152552|54770948|FG001|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
28113156|NCT03152552|54770949|FG002|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
28113157|NCT03152552|54770950|FG003|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1|||
28113158|NCT03152552|54770951|FG004|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
28113159|NCT03152552|54770947|FG000|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6|||
28113160|NCT03152552|54770948|FG001|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5|||
28113161|NCT03152552|54770949|FG002|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
28113162|NCT03152552|54770950|FG003|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
27940254|NCT01191840|54596537|FG000|Overall Study|Non Staph Infection|4|||
27940255|NCT01191840|54596538|FG001|Overall Study|Non Staph Infection|3|||
27940256|NCT01191840|54596537|FG000|Overall Study|ineligible at enrollment|1|||
27940257|NCT01191840|54596538|FG001|Overall Study|ineligible at enrollment|0|||
27940258|NCT01191840|54596537|FG000|Overall Study|IRB approval lapse|0|||
27940259|NCT01191840|54596538|FG001|Overall Study|IRB approval lapse|2|||
27940260|NCT01191840|54596537|FG000|Overall Study|lab error speciation - non Staph infecti|0|||
27940261|NCT01191840|54596538|FG001|Overall Study|lab error speciation - non Staph infecti|1|||
27940262|NCT01191840|54596537|FG000|Overall Study|Withdrawal by Subject|2|||
27940263|NCT01191840|54596538|FG001|Overall Study|Withdrawal by Subject|0|||
27816122|NCT01544595|54272967|FG002|Status at Week 156|Adverse Event|1|||
27816123|NCT01544595|54272968|FG003|Status at Week 156|Adverse Event|3|||
27940264|NCT00943072|54596550|FG000|Overall Study|Adverse Event|0|||
28113163|NCT03152552|54770951|FG004|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11|||
28113164|NCT03151226|54770964|FG000|Overall Study|Withdrawal by Subject|2|||
28113165|NCT03151226|54770964|FG000|Overall Study|not wear device correctly|1|||
27816124|NCT01544595|54272969|FG004|Status at Week 156|Adverse Event|4|||
27816125|NCT01544595|54272970|FG005|Status at Week 156|Adverse Event|2|||
27816126|NCT01544595|54272965|FG000|Status at Week 156|Lost to Follow-up|4|||
27816127|NCT01544595|54272966|FG001|Status at Week 156|Lost to Follow-up|4|||
27816128|NCT01544595|54272967|FG002|Status at Week 156|Lost to Follow-up|0|||
27816129|NCT01544595|54272968|FG003|Status at Week 156|Lost to Follow-up|1|||
27816130|NCT01544595|54272969|FG004|Status at Week 156|Lost to Follow-up|4|||
27816131|NCT01544595|54272970|FG005|Status at Week 156|Lost to Follow-up|1|||
28113166|NCT03151148|54770970|FG000|Overall Study|Lost to Follow-up|1|||
28113167|NCT03151148|54770971|FG001|Overall Study|Lost to Follow-up|0|||
28113168|NCT03151148|54770970|FG000|Overall Study|Withdrawal by Subject|1|||
28113169|NCT03151148|54770971|FG001|Overall Study|Withdrawal by Subject|0|||
28113170|NCT02741518|54770980|FG000|Overall Study|Withdrawal by Subject|1|||
28113171|NCT02741518|54770981|FG001|Overall Study|Withdrawal by Subject|1|||
28113172|NCT03145766|54770992|FG000|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
28113173|NCT03145766|54770993|FG001|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
28113174|NCT03145766|54770994|FG002|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0|||
28113175|NCT03145766|54770995|FG003|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
28113176|NCT03145766|54770996|FG004|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2|||
28113177|NCT03145766|54770992|FG000|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
28113178|NCT03145766|54770993|FG001|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
28113179|NCT03145766|54770994|FG002|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
28113180|NCT03145766|54770995|FG003|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2|||
28113181|NCT03145766|54770996|FG004|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
28113182|NCT03145766|54770992|FG000|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
27816132|NCT01544595|54272965|FG000|Status at Week 156|Non-compliance with study treatement|0|||
28113183|NCT03145766|54770993|FG001|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
28113184|NCT03145766|54770994|FG002|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
28113185|NCT03145766|54770995|FG003|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3|||
28113186|NCT03145766|54770996|FG004|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
28113187|NCT03145766|54770992|FG000|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4|||
28113188|NCT03145766|54770993|FG001|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
28113189|NCT03145766|54770994|FG002|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
28113190|NCT03145766|54770995|FG003|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
28113191|NCT03145766|54770996|FG004|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0|||
28113192|NCT03145766|54770992|FG000|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2|||
28113193|NCT03145766|54770993|FG001|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
28113194|NCT03145766|54770994|FG002|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
28113195|NCT03145766|54770995|FG003|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1|||
28113196|NCT03145766|54770996|FG004|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
28113197|NCT03145766|54770992|FG000|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
28113198|NCT03145766|54770993|FG001|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1|||
28113199|NCT03145766|54770994|FG002|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
28113200|NCT03145766|54770995|FG003|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2|||
27816133|NCT01544595|54272966|FG001|Status at Week 156|Non-compliance with study treatement|1|||
27816134|NCT01544595|54272967|FG002|Status at Week 156|Non-compliance with study treatement|0|||
27816135|NCT01544595|54272968|FG003|Status at Week 156|Non-compliance with study treatement|1|||
28113201|NCT03145766|54770996|FG004|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3|||
28113202|NCT03145766|54770992|FG000|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
28113203|NCT03145766|54770993|FG001|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
28113204|NCT03145766|54770994|FG002|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
28113205|NCT03145766|54770995|FG003|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
28113206|NCT03145766|54770996|FG004|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
28113207|NCT03145064|54771009|FG000|Overall Study|Death|24|||
28113208|NCT03145064|54771009|FG000|Overall Study|Lost to Follow-up|3|||
28113209|NCT03145064|54771009|FG000|Overall Study|Withdrawal by Subject|6|||
28113210|NCT03145064|54771009|FG000|Overall Study|Study ended by sponsor once primary/ secondary analysis was complete and participants discontinued|4|||
28113211|NCT03145064|54771009|FG000|Overall Study|Other: Transferred to Long term Extension (LTE) study BGB-3111-LTE1 (NCT04170283)|4|||
28113212|NCT03787615|54771034|FG000|Overall Study|Withdrawal by Subject|2|||
28113213|NCT03787615|54771034|FG000|Overall Study|Lost to Follow-up|2|||
28113214|NCT03784963|54771043|FG000|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|12|||
28113215|NCT03784963|54771044|FG001|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|10|||
27816136|NCT01544595|54272969|FG004|Status at Week 156|Non-compliance with study treatement|0|||
27816137|NCT01544595|54272970|FG005|Status at Week 156|Non-compliance with study treatement|1|||
27816138|NCT01544595|54272965|FG000|Status at Week 156|Physician Decision|0|||
27816139|NCT01544595|54272966|FG001|Status at Week 156|Physician Decision|3|||
27816140|NCT01544595|54272967|FG002|Status at Week 156|Physician Decision|1|||
27816141|NCT01544595|54272968|FG003|Status at Week 156|Physician Decision|0|||
27816142|NCT01544595|54272969|FG004|Status at Week 156|Physician Decision|0|||
27816143|NCT01544595|54272970|FG005|Status at Week 156|Physician Decision|0|||
27816144|NCT01544595|54272965|FG000|Status at Week 156|Pregnancy|2|||
27816145|NCT01544595|54272966|FG001|Status at Week 156|Pregnancy|3|||
27816146|NCT01544595|54272967|FG002|Status at Week 156|Pregnancy|0|||
27940265|NCT00943072|54596551|FG001|Overall Study|Adverse Event|3|||
28064746|NCT00295854|54720413|FG000|Overall Study|Other|3|||
28064747|NCT00295854|54720414|FG001|Overall Study|Other|5|||
28064748|NCT00295854|54720415|FG002|Overall Study|Other|1|||
28064749|NCT00327470|54720425|FG000|Overall Study|Randomized, but not treated|0|||
28064750|NCT00327470|54720426|FG001|Overall Study|Randomized, but not treated|2|||
28064751|NCT00327470|54720425|FG000|Overall Study|Adverse Event|9|||
28064752|NCT00327470|54720426|FG001|Overall Study|Adverse Event|14|||
28064753|NCT00327470|54720425|FG000|Overall Study|Lack of Efficacy|7|||
28064754|NCT00327470|54720426|FG001|Overall Study|Lack of Efficacy|19|||
28064755|NCT00327470|54720425|FG000|Overall Study|Other|5|||
28064756|NCT00327470|54720426|FG001|Overall Study|Other|9|||
28064757|NCT00327470|54720425|FG000|Overall Study|Lost to Follow-up|1|||
28064758|NCT00327470|54720426|FG001|Overall Study|Lost to Follow-up|3|||
28064759|NCT00327470|54720425|FG000|Overall Study|Withdrawal by Subject|6|||
28064760|NCT00327470|54720426|FG001|Overall Study|Withdrawal by Subject|12|||
28113216|NCT03784963|54771045|FG002|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|1|||
28113217|NCT03784963|54771046|FG003|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|0|||
28113218|NCT03787303|54771056|FG000|Overall Study|Death|1|||
28113219|NCT03787303|54771056|FG000|Overall Study|Premature Termination of Study|1|||
28113220|NCT04170296|54771062|FG000|Overall Study|Adverse Event|1|||
28113221|NCT04170296|54771063|FG001|Overall Study|Adverse Event|0|||
28113222|NCT04170296|54771062|FG000|Overall Study|Withdrawal by Subject|3|||
28113223|NCT04170296|54771063|FG001|Overall Study|Withdrawal by Subject|2|||
28113224|NCT04170296|54771062|FG000|Overall Study|Lost to Follow-up|4|||
28113225|NCT04170296|54771063|FG001|Overall Study|Lost to Follow-up|2|||
28113226|NCT03141788|54771090|FG000|Overall Study|Lost to Follow-up|1|||
28113227|NCT03141788|54771090|FG000|Overall Study|Protocol Violation|3|||
28113228|NCT03141788|54771090|FG000|Overall Study|Withdrawal by Subject|4|||
28113229|NCT03781375|54771099|FG000|Double-blind Phase|Adverse Event|0|||
28113230|NCT03781375|54771100|FG001|Double-blind Phase|Adverse Event|1|||
28113231|NCT03781375|54771099|FG000|Double-blind Phase|Lack of Response|6|||
28113232|NCT03781375|54771100|FG001|Double-blind Phase|Lack of Response|2|||
28113233|NCT03781375|54771099|FG000|Double-blind Phase|Other|1|||
28113234|NCT03781375|54771100|FG001|Double-blind Phase|Other|3|||
28113235|NCT03781375|54771099|FG000|Open-label Phase|Protocol Issues|0|||
28113236|NCT03781375|54771100|FG001|Open-label Phase|Protocol Issues|1|||
28113237|NCT03781375|54771099|FG000|Open-label Phase|Suboptimal Clinical Response|1|||
28113238|NCT03781375|54771100|FG001|Open-label Phase|Suboptimal Clinical Response|0|||
28113239|NCT03781375|54771099|FG000|Open-label Phase|Other|2|||
28113240|NCT03781375|54771100|FG001|Open-label Phase|Other|2|||
28113241|NCT03779503|54771107|FG000|First Intervention|Adverse Event|0|||
28113242|NCT03779503|54771108|FG001|First Intervention|Adverse Event|1|||
28113243|NCT03779503|54771107|FG000|First Intervention|Withdrawal by Subject|1|||
28113244|NCT03779503|54771108|FG001|First Intervention|Withdrawal by Subject|0|||
28113245|NCT03150056|54771120|FG000|Overall Study|Withdrawal by Subject|0|||
28064761|NCT00327470|54720425|FG000|Overall Study|Death|1|||
28064762|NCT00327470|54720426|FG001|Overall Study|Death|4|||
28064763|NCT00322556|54720432|FG000|Overall Study|Adverse Event|1|||
28064764|NCT00322556|54720432|FG000|Overall Study|Withdrawal by Subject|1|||
28064765|NCT00322556|54720432|FG000|Overall Study|Lost to Follow-up|3|||
28064766|NCT00322556|54720432|FG000|Overall Study|Other Reason|7|||
28064767|NCT00321932|54720441|FG000|Overall Study|Death|3|||
28064768|NCT00321932|54720442|FG001|Overall Study|Death|6|||
28064769|NCT00321932|54720441|FG000|Overall Study|Withdrawal by Subject|3|||
28064770|NCT00321932|54720442|FG001|Overall Study|Withdrawal by Subject|6|||
28064771|NCT00321932|54720441|FG000|Overall Study|Early relapse|2|||
28064772|NCT00321932|54720442|FG001|Overall Study|Early relapse|8|||
28064773|NCT00321932|54720441|FG000|Overall Study|Missing data|2|||
28113246|NCT03150056|54771121|FG001|Overall Study|Withdrawal by Subject|0|||
28113247|NCT03150056|54771122|FG002|Overall Study|Withdrawal by Subject|0|||
28113248|NCT03150056|54771123|FG003|Overall Study|Withdrawal by Subject|0|||
28113249|NCT03150056|54771124|FG004|Overall Study|Withdrawal by Subject|0|||
28113250|NCT03150056|54771125|FG005|Overall Study|Withdrawal by Subject|2|||
28113251|NCT03150056|54771120|FG000|Overall Study|Study terminated by Sponsor|1|||
27940266|NCT00943072|54596550|FG000|Overall Study|Death|0|||
27940267|NCT00943072|54596551|FG001|Overall Study|Death|2|||
27940268|NCT00943072|54596550|FG000|Overall Study|Withdrawal by Subject|3|||
27940269|NCT00943072|54596551|FG001|Overall Study|Withdrawal by Subject|1|||
27940270|NCT00943072|54596550|FG000|Overall Study|Protocol Violation|0|||
27940271|NCT00943072|54596551|FG001|Overall Study|Protocol Violation|1|||
27940272|NCT00943072|54596550|FG000|Overall Study|Lost to Follow-up|1|||
27940273|NCT00943072|54596551|FG001|Overall Study|Lost to Follow-up|2|||
27940274|NCT00943072|54596550|FG000|Overall Study|Lack of Efficacy|0|||
27940275|NCT00943072|54596551|FG001|Overall Study|Lack of Efficacy|4|||
27940276|NCT00943072|54596550|FG000|Overall Study|Other|1|||
27848710|NCT02630706|54342872|FG001|Overall Study|Adverse Event|1|||
27848711|NCT02630706|54342873|FG002|Overall Study|Adverse Event|1|||
27848712|NCT02630706|54342871|FG000|Overall Study|Lost to Follow-up|0|||
27940277|NCT00943072|54596551|FG001|Overall Study|Other|1|||
27848713|NCT02630706|54342872|FG001|Overall Study|Lost to Follow-up|1|||
27848714|NCT02630706|54342873|FG002|Overall Study|Lost to Follow-up|2|||
27848715|NCT02630706|54342871|FG000|Overall Study|Physician Decision|1|||
27848716|NCT02630706|54342872|FG001|Overall Study|Physician Decision|1|||
27848717|NCT02630706|54342873|FG002|Overall Study|Physician Decision|0|||
27848718|NCT02630706|54342871|FG000|Overall Study|Pregnancy|0|||
27848719|NCT02630706|54342872|FG001|Overall Study|Pregnancy|1|||
27848720|NCT02630706|54342873|FG002|Overall Study|Pregnancy|0|||
27848721|NCT02630706|54342871|FG000|Overall Study|Withdrawal by Subject|4|||
27940278|NCT00942994|54596561|FG000|Overall Study|Adverse Event|7|||
27940279|NCT00942994|54596562|FG001|Overall Study|Adverse Event|4|||
27940280|NCT00942994|54596561|FG000|Overall Study|Abnormal laboratory value(s)|1|||
27940281|NCT00942994|54596562|FG001|Overall Study|Abnormal laboratory value(s)|0|||
27940282|NCT00942994|54596561|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
27848722|NCT02630706|54342872|FG001|Overall Study|Withdrawal by Subject|5|||
27848723|NCT02630706|54342873|FG002|Overall Study|Withdrawal by Subject|7|||
27848724|NCT02089997|54343050|FG000|Overall Study|Case report forms uncollected|99|||
27940283|NCT00942994|54596562|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
27848725|NCT02089997|54343050|FG000|Overall Study|Protocol Violation|147|||
27940284|NCT00942994|54596561|FG000|Overall Study|Patient withdrew consent|5|||
27940285|NCT00942994|54596562|FG001|Overall Study|Patient withdrew consent|8|||
27940286|NCT00942994|54596561|FG000|Overall Study|Lost to Follow-up|1|||
28113252|NCT03150056|54771121|FG001|Overall Study|Study terminated by Sponsor|3|||
28113253|NCT03150056|54771122|FG002|Overall Study|Study terminated by Sponsor|1|||
28113254|NCT03150056|54771123|FG003|Overall Study|Study terminated by Sponsor|1|||
28113255|NCT03150056|54771124|FG004|Overall Study|Study terminated by Sponsor|5|||
28113256|NCT03150056|54771125|FG005|Overall Study|Study terminated by Sponsor|6|||
28113257|NCT03150056|54771120|FG000|Overall Study|Death|9|||
28113258|NCT03150056|54771121|FG001|Overall Study|Death|2|||
28113259|NCT03150056|54771122|FG002|Overall Study|Death|2|||
28113260|NCT03150056|54771123|FG003|Overall Study|Death|7|||
28113261|NCT03150056|54771124|FG004|Overall Study|Death|8|||
28113262|NCT03150056|54771125|FG005|Overall Study|Death|10|||
28113263|NCT02640664|54771145|FG000|Epoch 1|Withdrawal of informed consent|1|||
28113264|NCT02640664|54771146|FG001|Epoch 1|Withdrawal of informed consent|0|||
28113265|NCT02640664|54771147|FG002|Epoch 1|Withdrawal of informed consent|0|||
28113266|NCT02640664|54771145|FG000|Epoch 1|Death|0|||
28113267|NCT02640664|54771146|FG001|Epoch 1|Death|0|||
28113268|NCT02640664|54771147|FG002|Epoch 1|Death|1|||
28113269|NCT02640664|54771145|FG000|Epoch 2|Withdrawal of informed consent|3|||
28113270|NCT02640664|54771146|FG001|Epoch 2|Withdrawal of informed consent|4|||
28113271|NCT02640664|54771147|FG002|Epoch 2|Withdrawal of informed consent|2|||
28113272|NCT02640664|54771145|FG000|Epoch 2|Subject/guardian decision|0|||
28113273|NCT02640664|54771146|FG001|Epoch 2|Subject/guardian decision|2|||
28113274|NCT02640664|54771147|FG002|Epoch 2|Subject/guardian decision|2|||
27940287|NCT00942994|54596562|FG001|Overall Study|Lost to Follow-up|4|||
28113275|NCT02640664|54771145|FG000|Epoch 2|Lost to Follow-up|3|||
28113276|NCT02640664|54771146|FG001|Epoch 2|Lost to Follow-up|4|||
28113277|NCT02640664|54771147|FG002|Epoch 2|Lost to Follow-up|1|||
28113278|NCT02640664|54771145|FG000|Epoch 2|Death|0|||
28113279|NCT02640664|54771146|FG001|Epoch 2|Death|0|||
28113280|NCT02640664|54771147|FG002|Epoch 2|Death|1|||
28113281|NCT00812006|54771159|FG000|Overall Study|Lost to Follow-up|0|||
28113282|NCT00812006|54771160|FG001|Overall Study|Lost to Follow-up|0|||
28113283|NCT00812006|54771161|FG002|Overall Study|Lost to Follow-up|2|||
28113284|NCT00812006|54771159|FG000|Overall Study|Physician Decision|0|||
28113285|NCT00812006|54771160|FG001|Overall Study|Physician Decision|0|||
28113286|NCT00812006|54771161|FG002|Overall Study|Physician Decision|1|||
28113287|NCT00812006|54771159|FG000|Overall Study|Withdrawal by Subject|2|||
28113288|NCT00812006|54771160|FG001|Overall Study|Withdrawal by Subject|1|||
27816147|NCT01544595|54272968|FG003|Status at Week 156|Pregnancy|0|||
27816148|NCT01544595|54272969|FG004|Status at Week 156|Pregnancy|0|||
27816149|NCT01544595|54272970|FG005|Status at Week 156|Pregnancy|0|||
27816150|NCT01544595|54272965|FG000|Status at Week 156|Protocol Violation|3|||
27816151|NCT01544595|54272966|FG001|Status at Week 156|Protocol Violation|1|||
27816152|NCT01544595|54272967|FG002|Status at Week 156|Protocol Violation|2|||
27816153|NCT01544595|54272968|FG003|Status at Week 156|Protocol Violation|2|||
27816154|NCT01544595|54272969|FG004|Status at Week 156|Protocol Violation|0|||
27816155|NCT01544595|54272970|FG005|Status at Week 156|Protocol Violation|0|||
27816156|NCT01544595|54272965|FG000|Status at Week 156|Technical problems|3|||
27816157|NCT01544595|54272966|FG001|Status at Week 156|Technical problems|1|||
27816158|NCT01544595|54272967|FG002|Status at Week 156|Technical problems|0|||
28113289|NCT00812006|54771161|FG002|Overall Study|Withdrawal by Subject|1|||
28113290|NCT00812006|54771159|FG000|Overall Study|Lack of Qualifying Event|4|||
28113291|NCT00812006|54771160|FG001|Overall Study|Lack of Qualifying Event|2|||
27816159|NCT01544595|54272968|FG003|Status at Week 156|Technical problems|1|||
27816160|NCT01544595|54272969|FG004|Status at Week 156|Technical problems|0|||
27816161|NCT01544595|54272970|FG005|Status at Week 156|Technical problems|0|||
27816162|NCT01544595|54272965|FG000|Status at Week 156|Moved to treatment period ≤ wk 156|86|||
28113292|NCT00812006|54771161|FG002|Overall Study|Lack of Qualifying Event|2|||
28113293|NCT03772327|54771176|FG000|Overall Study|Lost to Follow-up|3|||
28113294|NCT03772327|54771177|FG001|Overall Study|Lost to Follow-up|4|||
28113295|NCT03772327|54771176|FG000|Overall Study|Withdrawal by Subject|2|||
28113296|NCT03772327|54771177|FG001|Overall Study|Withdrawal by Subject|3|||
28113297|NCT04364763|54771220|FG000|Overall Study|Death|1|||
28113298|NCT04364763|54771221|FG001|Overall Study|Death|2|||
28113299|NCT04364763|54771220|FG000|Overall Study|Lost to Follow-up|1|||
28113300|NCT04364763|54771221|FG001|Overall Study|Lost to Follow-up|0|||
28113301|NCT04247815|54771238|FG000|Overall Study|Adverse Event|1|||
28113302|NCT04247815|54771239|FG001|Overall Study|Adverse Event|0|||
28113303|NCT04247815|54771238|FG000|Overall Study|Withdrawal by Subject|1|||
28113304|NCT04247815|54771239|FG001|Overall Study|Withdrawal by Subject|0|||
28113305|NCT04247815|54771238|FG000|Overall Study|Protocol Violation|0|||
28113306|NCT04247815|54771239|FG001|Overall Study|Protocol Violation|1|||
28113307|NCT03432819|54771274|FG000|Overall Study|Lost to Follow-up|2|||
28113308|NCT03432819|54771275|FG001|Overall Study|Lost to Follow-up|2|||
28113309|NCT03432819|54771274|FG000|Overall Study|Withdrawal by Subject|5|||
28113310|NCT03432819|54771275|FG001|Overall Study|Withdrawal by Subject|3|||
28113311|NCT03272347|54771294|FG000|Overall Study|Death|0|||
28113312|NCT03272347|54771295|FG001|Overall Study|Death|0|||
28113313|NCT03272347|54771296|FG002|Overall Study|Death|0|||
28113314|NCT03272347|54771297|FG003|Overall Study|Death|1|||
28113315|NCT03272347|54771294|FG000|Overall Study|Lost to Follow-up|1|||
28113316|NCT03272347|54771295|FG001|Overall Study|Lost to Follow-up|3|||
28113317|NCT03272347|54771296|FG002|Overall Study|Lost to Follow-up|5|||
28113318|NCT03272347|54771297|FG003|Overall Study|Lost to Follow-up|1|||
28113319|NCT03272347|54771294|FG000|Overall Study|Physician Decision|4|||
27816163|NCT01544595|54272966|FG001|Status at Week 156|Moved to treatment period ≤ wk 156|44|||
27816164|NCT01544595|54272967|FG002|Status at Week 156|Moved to treatment period ≤ wk 156|131|||
28113320|NCT03272347|54771295|FG001|Overall Study|Physician Decision|2|||
28113321|NCT03272347|54771296|FG002|Overall Study|Physician Decision|5|||
28113322|NCT03272347|54771297|FG003|Overall Study|Physician Decision|4|||
28113323|NCT03272347|54771294|FG000|Overall Study|Screen Failure|1|||
28113324|NCT03272347|54771295|FG001|Overall Study|Screen Failure|0|||
28113325|NCT03272347|54771296|FG002|Overall Study|Screen Failure|0|||
28113326|NCT03272347|54771297|FG003|Overall Study|Screen Failure|0|||
28113327|NCT03272347|54771294|FG000|Overall Study|Withdrawal by Subject|5|||
28113328|NCT03272347|54771295|FG001|Overall Study|Withdrawal by Subject|1|||
28113329|NCT03272347|54771296|FG002|Overall Study|Withdrawal by Subject|2|||
28113330|NCT03272347|54771297|FG003|Overall Study|Withdrawal by Subject|1|||
28113331|NCT03259568|54771319|FG000|Overall Study|Participant performance was low|3|||
27816165|NCT01544595|54272968|FG003|Status at Week 156|Moved to treatment period ≤ wk 156|145|||
27816166|NCT01544595|54272969|FG004|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
28113332|NCT03239470|54771329|FG000|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|1|||
28113333|NCT03239470|54771330|FG001|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|0|||
28113334|NCT03167723|54771336|FG000|Overall Study|Protocol Violation|4|||
28113335|NCT03167723|54771337|FG001|Overall Study|Protocol Violation|6|||
28113336|NCT03103152|54771349|FG000|Overall Study|Physician Decision|5|||
28113337|NCT03103152|54771350|FG001|Overall Study|Physician Decision|2|||
28113338|NCT03103152|54771351|FG002|Overall Study|Physician Decision|6|||
28113339|NCT03103152|54771352|FG003|Overall Study|Physician Decision|3|||
28113340|NCT03103152|54771353|FG004|Overall Study|Physician Decision|3|||
28113341|NCT03103152|54771354|FG005|Overall Study|Physician Decision|1|||
28113342|NCT03103152|54771349|FG000|Overall Study|Protocol Violation|2|||
28113343|NCT03103152|54771350|FG001|Overall Study|Protocol Violation|2|||
28113344|NCT03103152|54771351|FG002|Overall Study|Protocol Violation|1|||
28113345|NCT03103152|54771352|FG003|Overall Study|Protocol Violation|2|||
28113346|NCT03103152|54771353|FG004|Overall Study|Protocol Violation|1|||
28113347|NCT03103152|54771354|FG005|Overall Study|Protocol Violation|1|||
28113348|NCT03103152|54771349|FG000|Overall Study|Inter-current illness|0|||
28113349|NCT03103152|54771350|FG001|Overall Study|Inter-current illness|0|||
28113350|NCT03103152|54771351|FG002|Overall Study|Inter-current illness|1|||
28113351|NCT03103152|54771352|FG003|Overall Study|Inter-current illness|0|||
28113352|NCT03103152|54771353|FG004|Overall Study|Inter-current illness|0|||
28113353|NCT03103152|54771354|FG005|Overall Study|Inter-current illness|0|||
28113354|NCT03103152|54771349|FG000|Overall Study|Death|0|||
27816167|NCT01544595|54272970|FG005|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
27816168|NCT01544595|54272965|FG000|Status at Week 156|Lack of Efficacy|1|||
27816169|NCT01544595|54272966|FG001|Status at Week 156|Lack of Efficacy|0|||
27816170|NCT01544595|54272967|FG002|Status at Week 156|Lack of Efficacy|1|||
27816171|NCT01544595|54272968|FG003|Status at Week 156|Lack of Efficacy|4|||
27816172|NCT01544595|54272969|FG004|Status at Week 156|Lack of Efficacy|10|||
27816173|NCT01544595|54272970|FG005|Status at Week 156|Lack of Efficacy|5|||
27816174|NCT01539525|54272991|FG000|Overall Study|Lost to Follow-up|19|||
27816175|NCT01539525|54272992|FG001|Overall Study|Lost to Follow-up|12|||
27816176|NCT01539525|54272993|FG002|Overall Study|Lost to Follow-up|11|||
27816177|NCT01539525|54272991|FG000|Overall Study|Withdrawal by Subject|0|||
28113355|NCT03103152|54771350|FG001|Overall Study|Death|1|||
28113356|NCT03103152|54771351|FG002|Overall Study|Death|0|||
28113357|NCT03103152|54771352|FG003|Overall Study|Death|0|||
28113358|NCT03103152|54771353|FG004|Overall Study|Death|0|||
28113359|NCT03103152|54771354|FG005|Overall Study|Death|0|||
28113360|NCT03103152|54771349|FG000|Overall Study|Adverse Event|0|||
28113361|NCT03103152|54771350|FG001|Overall Study|Adverse Event|0|||
27816178|NCT01539525|54272992|FG001|Overall Study|Withdrawal by Subject|3|||
27816179|NCT01539525|54272993|FG002|Overall Study|Withdrawal by Subject|2|||
27816180|NCT01539525|54272991|FG000|Overall Study|Protocol Violation|1|||
27816181|NCT01539525|54272992|FG001|Overall Study|Protocol Violation|1|||
27816182|NCT01539525|54272993|FG002|Overall Study|Protocol Violation|4|||
27816183|NCT01513551|54273007|FG000|Overall Study|Death|0|||
27816184|NCT01513551|54273008|FG001|Overall Study|Death|1|||
27816185|NCT01513551|54273009|FG002|Overall Study|Death|0|||
28113362|NCT03103152|54771351|FG002|Overall Study|Adverse Event|1|||
28113363|NCT03103152|54771352|FG003|Overall Study|Adverse Event|0|||
28113364|NCT03103152|54771353|FG004|Overall Study|Adverse Event|0|||
28113365|NCT03103152|54771354|FG005|Overall Study|Adverse Event|1|||
28113366|NCT03103152|54771349|FG000|Overall Study|Withdrawal by Subject|1|||
28113367|NCT03103152|54771350|FG001|Overall Study|Withdrawal by Subject|0|||
28113368|NCT03103152|54771351|FG002|Overall Study|Withdrawal by Subject|1|||
28113369|NCT03103152|54771352|FG003|Overall Study|Withdrawal by Subject|1|||
28113370|NCT03103152|54771353|FG004|Overall Study|Withdrawal by Subject|1|||
28113371|NCT03103152|54771354|FG005|Overall Study|Withdrawal by Subject|1|||
27816186|NCT01513551|54273007|FG000|Overall Study|Lost to Follow-up|3|||
27848726|NCT01363661|54343056|FG000|Overall Study|Adverse Event|9|||
28064774|NCT00321932|54720442|FG001|Overall Study|Missing data|1|||
28113372|NCT03103152|54771349|FG000|Overall Study|Patient wishes to come off active surveillance|2|||
28113373|NCT03103152|54771350|FG001|Overall Study|Patient wishes to come off active surveillance|0|||
28113374|NCT03103152|54771351|FG002|Overall Study|Patient wishes to come off active surveillance|1|||
28113375|NCT03103152|54771352|FG003|Overall Study|Patient wishes to come off active surveillance|1|||
28113376|NCT03103152|54771353|FG004|Overall Study|Patient wishes to come off active surveillance|1|||
28113377|NCT03103152|54771354|FG005|Overall Study|Patient wishes to come off active surveillance|3|||
28113378|NCT03103152|54771349|FG000|Overall Study|Unacceptable side effects|0|||
28113379|NCT03103152|54771350|FG001|Overall Study|Unacceptable side effects|0|||
28113380|NCT03103152|54771351|FG002|Overall Study|Unacceptable side effects|0|||
28113381|NCT03103152|54771352|FG003|Overall Study|Unacceptable side effects|0|||
28113382|NCT03103152|54771353|FG004|Overall Study|Unacceptable side effects|0|||
28113383|NCT03103152|54771354|FG005|Overall Study|Unacceptable side effects|1|||
28113384|NCT03103152|54771349|FG000|Overall Study|Lost to Follow-up|0|||
28064775|NCT00326612|54720451|FG000|Overall Study|They did not have a seizure requiring tx|129|||
28064776|NCT00326612|54720452|FG001|Overall Study|They did not have a seizure requiring tx|137|||
28064777|NCT00325130|54720464|FG000|Overall Study|Lost to Follow-up|6|||
28064778|NCT00325130|54720465|FG001|Overall Study|Lost to Follow-up|14|||
28064779|NCT00325130|54720464|FG000|Overall Study|Withdrawal by Subject|12|||
28064780|NCT00325130|54720465|FG001|Overall Study|Withdrawal by Subject|14|||
28064781|NCT00325130|54720464|FG000|Overall Study|Protocol Deviation|0|||
28113385|NCT03103152|54771350|FG001|Overall Study|Lost to Follow-up|1|||
28113386|NCT03103152|54771351|FG002|Overall Study|Lost to Follow-up|0|||
28113387|NCT03103152|54771352|FG003|Overall Study|Lost to Follow-up|1|||
28113388|NCT03103152|54771353|FG004|Overall Study|Lost to Follow-up|0|||
28113389|NCT03103152|54771354|FG005|Overall Study|Lost to Follow-up|1|||
28064782|NCT00325130|54720465|FG001|Overall Study|Protocol Deviation|1|||
28064783|NCT00325130|54720464|FG000|Overall Study|Moved|0|||
28064784|NCT00325130|54720465|FG001|Overall Study|Moved|1|||
28064785|NCT00325130|54720464|FG000|Overall Study|Patient Discontinued for Other|1|||
28113390|NCT03103152|54771349|FG000|Overall Study|Testicular pain|0|||
28113391|NCT03103152|54771350|FG001|Overall Study|Testicular pain|0|||
28113392|NCT03103152|54771351|FG002|Overall Study|Testicular pain|0|||
28113393|NCT03103152|54771352|FG003|Overall Study|Testicular pain|1|||
28113394|NCT03103152|54771353|FG004|Overall Study|Testicular pain|0|||
28113395|NCT03103152|54771354|FG005|Overall Study|Testicular pain|0|||
27816187|NCT01513551|54273008|FG001|Overall Study|Lost to Follow-up|5|||
27816188|NCT01513551|54273009|FG002|Overall Study|Lost to Follow-up|2|||
27816189|NCT01513551|54273007|FG000|Overall Study|Withdrawal by Subject|1|||
28113396|NCT03033901|54771368|FG000|Overall Study|Ineligible for Polysomnography (PSG)|59|||
27816190|NCT01513551|54273008|FG001|Overall Study|Withdrawal by Subject|0|||
28113397|NCT03033901|54771368|FG000|Overall Study|Refused PSG|23|||
28113398|NCT03033901|54771368|FG000|Overall Study|Total Sleep Time < 2 hours|12|||
28113399|NCT03033901|54771368|FG000|Overall Study|Missing Oximetry Data|3|||
28113400|NCT02603887|54771411|FG000|Stage 1|Adverse Event|4|||
28113401|NCT02603887|54771411|FG000|Stage 1|Disease progression|1|||
28113402|NCT02603887|54771411|FG000|Stage 2|FDA guidance|1|||
27816191|NCT01513551|54273009|FG002|Overall Study|Withdrawal by Subject|2|||
27816192|NCT01513551|54273007|FG000|Overall Study|Randomized but not vaccinated|0|||
28113403|NCT02475681|54771427|FG000|Overall Study|Death|16|||
28113404|NCT02475681|54771428|FG001|Overall Study|Death|6|||
28113405|NCT02475681|54771429|FG002|Overall Study|Death|9|||
28113406|NCT02475681|54771427|FG000|Overall Study|Physician Decision|0|||
28113407|NCT02475681|54771428|FG001|Overall Study|Physician Decision|3|||
28113408|NCT02475681|54771429|FG002|Overall Study|Physician Decision|1|||
28113409|NCT02475681|54771427|FG000|Overall Study|Withdrawal by Subject|12|||
28113410|NCT02475681|54771428|FG001|Overall Study|Withdrawal by Subject|6|||
28113411|NCT02475681|54771429|FG002|Overall Study|Withdrawal by Subject|9|||
28113412|NCT02475681|54771427|FG000|Overall Study|Lost to Follow-up|2|||
28113413|NCT02475681|54771428|FG001|Overall Study|Lost to Follow-up|1|||
28113414|NCT02475681|54771429|FG002|Overall Study|Lost to Follow-up|3|||
28113415|NCT02475681|54771427|FG000|Overall Study|Ongoing in Study|0|||
28113416|NCT02475681|54771428|FG001|Overall Study|Ongoing in Study|163|||
28113417|NCT02475681|54771429|FG002|Overall Study|Ongoing in Study|157|||
28113418|NCT02475681|54771427|FG000|Overall Study|Reasons other than above listed|2|||
28113419|NCT02475681|54771428|FG001|Overall Study|Reasons other than above listed|0|||
28113420|NCT02475681|54771429|FG002|Overall Study|Reasons other than above listed|0|||
28113421|NCT02315196|54771439|FG000|Overall Study|Withdrew consent|9|||
27816193|NCT01513551|54273008|FG001|Overall Study|Randomized but not vaccinated|0|||
27816194|NCT01513551|54273009|FG002|Overall Study|Randomized but not vaccinated|1|||
27816195|NCT01513473|54273019|FG000|Main Trial (26 Weeks)|Adverse Event|0|||
27816196|NCT01513473|54273020|FG001|Main Trial (26 Weeks)|Adverse Event|2|||
27816197|NCT01513473|54273019|FG000|Main Trial (26 Weeks)|Withdrawal by Subject|4|||
28113422|NCT02133573|54771445|FG000|Overall Study|Withdrawal by Maternal Subjects|2|||
28113423|NCT02133573|54771446|FG001|Overall Study|Withdrawal by Maternal Subjects|1|||
28113424|NCT02133573|54771445|FG000|Overall Study|Child Deaths|3|||
28113425|NCT02133573|54771446|FG001|Overall Study|Child Deaths|5|||
28113426|NCT02133573|54771445|FG000|Overall Study|Child Declined Follow Ups|2|||
28113427|NCT02133573|54771446|FG001|Overall Study|Child Declined Follow Ups|1|||
28113428|NCT02133573|54771445|FG000|Overall Study|Child missing primary endpoint score due to child's inability to test|2|||
27816198|NCT01513473|54273020|FG001|Main Trial (26 Weeks)|Withdrawal by Subject|7|||
27816199|NCT01513473|54273019|FG000|Main Trial (26 Weeks)|Unclassified|0|||
28113429|NCT02133573|54771446|FG001|Overall Study|Child missing primary endpoint score due to child's inability to test|1|||
28113430|NCT02059005|54771458|FG000|Overall Study|Death|1|||
28113431|NCT02059005|54771459|FG001|Overall Study|Death|3|||
28113432|NCT02059005|54771458|FG000|Overall Study|Lost to Follow-up|19|||
28113433|NCT02059005|54771459|FG001|Overall Study|Lost to Follow-up|19|||
28113434|NCT02059005|54771458|FG000|Overall Study|Incarceration|0|||
28113435|NCT02059005|54771459|FG001|Overall Study|Incarceration|1|||
28113436|NCT02059005|54771458|FG000|Overall Study|Inpatient|0|||
28113437|NCT02059005|54771459|FG001|Overall Study|Inpatient|1|||
28113438|NCT01393821|54771469|FG000|Overall Study|Cancel|1|||
28113439|NCT01393821|54771470|FG001|Overall Study|Cancel|1|||
27816200|NCT01513473|54273020|FG001|Main Trial (26 Weeks)|Unclassified|2|||
27816201|NCT01513473|54273019|FG000|Extension Trial (26 Weeks)|Adverse Event|0|||
27816202|NCT01513473|54273020|FG001|Extension Trial (26 Weeks)|Adverse Event|1|||
27816203|NCT01513473|54273019|FG000|Extension Trial (26 Weeks)|Withdrawal by Subject|1|||
27816204|NCT01513473|54273020|FG001|Extension Trial (26 Weeks)|Withdrawal by Subject|5|||
27816205|NCT01513317|54273028|FG000|Overall Study|Withdrawal by Subject|15|||
27816206|NCT01513317|54273029|FG001|Overall Study|Withdrawal by Subject|4|||
27816207|NCT01513317|54273028|FG000|Overall Study|Death|1|||
27848727|NCT01363661|54343057|FG001|Overall Study|Adverse Event|2|||
28113440|NCT01393821|54771469|FG000|Overall Study|not evaluable for primary endpoint|4|||
28113441|NCT01393821|54771470|FG001|Overall Study|not evaluable for primary endpoint|2|||
28113442|NCT01199575|54771476|FG000|Overall Study|Withdrawal by Subject|5|||
28113443|NCT00496873|54771487|FG000|Overall Study|Ineligible|2|||
28113444|NCT00496873|54771487|FG000|Overall Study|Death|2|||
27816208|NCT01513317|54273029|FG001|Overall Study|Death|1|||
28113445|NCT00496873|54771487|FG000|Overall Study|Withdrawal by Subject|3|||
28113446|NCT00492778|54771493|FG000|Overall Study|Ineligible by Pathology Review|8|||
28113447|NCT00492778|54771494|FG001|Overall Study|Ineligible by Pathology Review|1|||
28113448|NCT03775681|54771528|FG000|Overall Study|Physician Decision|3|||
28113449|NCT03774823|54771534|FG000|Overall Study|Withdrawal by Subject|1|||
28113450|NCT03774823|54771535|FG001|Overall Study|Withdrawal by Subject|1|||
28113451|NCT03149042|54771541|FG000|Overall Study|Invasive FFR not performed|21|||
28113452|NCT03149042|54771541|FG000|Overall Study|Poor CT Image Quality|1|||
28113453|NCT03149042|54771541|FG000|Overall Study|Invasive FFR Measurement cancelled|1|||
28113454|NCT03774433|54771546|FG000|Overall Study|Participants who completed less than 12 EMAs are not included in the final analysis|14|||
28113455|NCT03136484|54771552|FG000|Overall Study|Withdrawal by Subject|19|||
28113456|NCT03136484|54771553|FG001|Overall Study|Withdrawal by Subject|14|||
28113457|NCT03136484|54771552|FG000|Overall Study|Lost to Follow-up|7|||
28113458|NCT03136484|54771553|FG001|Overall Study|Lost to Follow-up|8|||
27816209|NCT01513317|54273028|FG000|Overall Study|Study terminated by sponsor|18|||
27816210|NCT01513317|54273029|FG001|Overall Study|Study terminated by sponsor|18|||
27816211|NCT01513317|54273028|FG000|Overall Study|Other|0|||
27816212|NCT01513317|54273029|FG001|Overall Study|Other|1|||
28113459|NCT03136484|54771552|FG000|Overall Study|Death|1|||
28113460|NCT03136484|54771553|FG001|Overall Study|Death|0|||
28113461|NCT03922711|54771562|FG000|Overall Study|Adverse Event|3|||
28113462|NCT03922711|54771563|FG001|Overall Study|Adverse Event|2|||
28113463|NCT03922711|54771564|FG002|Overall Study|Adverse Event|2|||
28113464|NCT03922711|54771562|FG000|Overall Study|Protocol Violation|1|||
28113465|NCT03922711|54771563|FG001|Overall Study|Protocol Violation|0|||
28113466|NCT03922711|54771564|FG002|Overall Study|Protocol Violation|0|||
28113467|NCT03922711|54771562|FG000|Overall Study|Withdrawal by Subject|0|||
27816213|NCT03824392|54273039|FG000|Overall Study|Adverse Event|1|||
27816214|NCT03824392|54273040|FG001|Overall Study|Adverse Event|0|||
27816215|NCT03824392|54273041|FG002|Overall Study|Adverse Event|0|||
27816216|NCT03824392|54273042|FG003|Overall Study|Adverse Event|0|||
27816217|NCT03824392|54273039|FG000|Overall Study|Investigator Decision|0|||
27816218|NCT03824392|54273040|FG001|Overall Study|Investigator Decision|1|||
27816219|NCT03824392|54273041|FG002|Overall Study|Investigator Decision|0|||
27816220|NCT03824392|54273042|FG003|Overall Study|Investigator Decision|0|||
27816221|NCT03824392|54273039|FG000|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|2|||
27816222|NCT03824392|54273040|FG001|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
27816223|NCT03824392|54273041|FG002|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|3|||
27816224|NCT03824392|54273042|FG003|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
27816225|NCT01901653|54273065|FG000|Overall Study|Death|2|||
27816226|NCT01901653|54273066|FG001|Overall Study|Death|1|||
28064786|NCT00325130|54720465|FG001|Overall Study|Patient Discontinued for Other|0|||
28064787|NCT00321854|54720473|FG000|Overall Study|Adverse Event|41|||
28064788|NCT00321854|54720474|FG001|Overall Study|Adverse Event|43|||
28064789|NCT00321854|54720473|FG000|Overall Study|Lack of Efficacy|9|||
28064790|NCT00321854|54720474|FG001|Overall Study|Lack of Efficacy|14|||
28064791|NCT00321854|54720473|FG000|Overall Study|Protocol Violation|6|||
28064792|NCT00321854|54720474|FG001|Overall Study|Protocol Violation|5|||
28064793|NCT00321854|54720473|FG000|Overall Study|Lost to Follow-up|0|||
28064794|NCT00321854|54720474|FG001|Overall Study|Lost to Follow-up|2|||
28064795|NCT00321854|54720473|FG000|Overall Study|Withdrawal by Subject|6|||
28064796|NCT00321854|54720474|FG001|Overall Study|Withdrawal by Subject|17|||
28064797|NCT00321854|54720473|FG000|Overall Study|Other|1|||
28064798|NCT00321854|54720474|FG001|Overall Study|Other|1|||
28064799|NCT00310388|54720482|FG000|Primary Reporting Phase|Adverse Event|101|||
28064800|NCT00310388|54720483|FG001|Primary Reporting Phase|Adverse Event|0|||
28064801|NCT00310388|54720482|FG000|Primary Reporting Phase|Lack of Efficacy|56|||
28064802|NCT00310388|54720483|FG001|Primary Reporting Phase|Lack of Efficacy|0|||
28064803|NCT00310388|54720482|FG000|Primary Reporting Phase|Withdrawal by Subject|97|||
28064804|NCT00310388|54720483|FG001|Primary Reporting Phase|Withdrawal by Subject|0|||
28064805|NCT00310388|54720482|FG000|Primary Reporting Phase|Protocol Violation|10|||
28064806|NCT00310388|54720483|FG001|Primary Reporting Phase|Protocol Violation|0|||
28064807|NCT00310388|54720482|FG000|Primary Reporting Phase|Pregnancy|3|||
28064808|NCT00310388|54720483|FG001|Primary Reporting Phase|Pregnancy|0|||
28064809|NCT00310388|54720482|FG000|Primary Reporting Phase|Change in participant medical condition|3|||
28064810|NCT00310388|54720483|FG001|Primary Reporting Phase|Change in participant medical condition|0|||
28064811|NCT00310388|54720482|FG000|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3|||
28064812|NCT00310388|54720483|FG001|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0|||
28064813|NCT00310388|54720482|FG000|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3|||
28064814|NCT00310388|54720483|FG001|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0|||
28064815|NCT00310388|54720482|FG000|Primary Reporting Phase|Physician Decision|2|||
28064816|NCT00310388|54720483|FG001|Primary Reporting Phase|Physician Decision|0|||
28113468|NCT03922711|54771563|FG001|Overall Study|Withdrawal by Subject|3|||
28113469|NCT03922711|54771564|FG002|Overall Study|Withdrawal by Subject|1|||
28064817|NCT00310388|54720482|FG000|Primary Reporting Phase|Request of the sponsor|19|||
27816227|NCT01901653|54273067|FG002|Overall Study|Death|8|||
27816228|NCT01901653|54273068|FG003|Overall Study|Death|3|||
28064818|NCT00310388|54720483|FG001|Primary Reporting Phase|Request of the sponsor|0|||
28113470|NCT03922711|54771562|FG000|Overall Study|Not further specified|0|||
28113471|NCT03922711|54771563|FG001|Overall Study|Not further specified|0|||
28113472|NCT03922711|54771564|FG002|Overall Study|Not further specified|1|||
28113473|NCT02877680|54771573|FG000|Overall Study|Lost to Follow-up|1|||
28113474|NCT02877680|54771574|FG001|Overall Study|Lost to Follow-up|1|||
27816229|NCT01901653|54273069|FG004|Overall Study|Death|2|||
27816230|NCT01901653|54273070|FG005|Overall Study|Death|2|||
27816231|NCT01901653|54273071|FG006|Overall Study|Death|6|||
27816232|NCT01901653|54273072|FG007|Overall Study|Death|9|||
27816233|NCT01901653|54273073|FG008|Overall Study|Death|1|||
27816234|NCT01901653|54273074|FG009|Overall Study|Death|16|||
27816235|NCT01901653|54273075|FG010|Overall Study|Death|2|||
27816236|NCT01901653|54273076|FG011|Overall Study|Death|15|||
27816237|NCT01901653|54273077|FG012|Overall Study|Death|4|||
28113475|NCT03141086|54771586|FG000|Overall Study|Study Terminated By Sponsor|1|||
28113476|NCT03141086|54771587|FG001|Overall Study|Study Terminated By Sponsor|1|||
28113477|NCT03141086|54771586|FG000|Overall Study|Withdrawal by Subject|0|||
28113478|NCT03141086|54771587|FG001|Overall Study|Withdrawal by Subject|1|||
28113479|NCT03141086|54771586|FG000|Overall Study|Protocol Violation|0|||
28113480|NCT03141086|54771587|FG001|Overall Study|Protocol Violation|1|||
28113481|NCT03141086|54771586|FG000|Overall Study|Adverse Event|0|||
28113482|NCT03141086|54771587|FG001|Overall Study|Adverse Event|2|||
28113483|NCT03135548|54771596|FG000|Overall Study|Lost to Follow-up|3|||
27816238|NCT01901653|54273065|FG000|Overall Study|Lost to Follow-up|1|||
27816239|NCT01901653|54273066|FG001|Overall Study|Lost to Follow-up|0|||
27816240|NCT01901653|54273067|FG002|Overall Study|Lost to Follow-up|2|||
27816241|NCT01901653|54273068|FG003|Overall Study|Lost to Follow-up|0|||
27816242|NCT01901653|54273069|FG004|Overall Study|Lost to Follow-up|0|||
27816243|NCT01901653|54273070|FG005|Overall Study|Lost to Follow-up|1|||
27816244|NCT01901653|54273071|FG006|Overall Study|Lost to Follow-up|0|||
27816245|NCT01901653|54273072|FG007|Overall Study|Lost to Follow-up|1|||
27816246|NCT01901653|54273073|FG008|Overall Study|Lost to Follow-up|0|||
27816247|NCT01901653|54273074|FG009|Overall Study|Lost to Follow-up|0|||
27816248|NCT01901653|54273075|FG010|Overall Study|Lost to Follow-up|0|||
27816249|NCT01901653|54273076|FG011|Overall Study|Lost to Follow-up|0|||
27816250|NCT01901653|54273077|FG012|Overall Study|Lost to Follow-up|0|||
27816251|NCT01901653|54273065|FG000|Overall Study|Withdrawal by Subject|0|||
27816252|NCT01901653|54273066|FG001|Overall Study|Withdrawal by Subject|0|||
28113484|NCT03135548|54771597|FG001|Overall Study|Lost to Follow-up|0|||
27816253|NCT01901653|54273067|FG002|Overall Study|Withdrawal by Subject|0|||
28064819|NCT00310388|54720482|FG000|Primary Reporting Phase|Failed to return|8|||
28064820|NCT00310388|54720483|FG001|Primary Reporting Phase|Failed to return|0|||
28064821|NCT00310388|54720482|FG000|Primary Reporting Phase|Participant request unrelated to study|2|||
28113485|NCT03135548|54771598|FG002|Overall Study|Lost to Follow-up|0|||
28113486|NCT03135548|54771596|FG000|Overall Study|Withdrawal by Subject|2|||
28113487|NCT03135548|54771597|FG001|Overall Study|Withdrawal by Subject|2|||
27816254|NCT01901653|54273068|FG003|Overall Study|Withdrawal by Subject|0|||
28064822|NCT00310388|54720483|FG001|Primary Reporting Phase|Participant request unrelated to study|0|||
28064823|NCT00310388|54720482|FG000|Primary Reporting Phase|Participant request|2|||
28064824|NCT00310388|54720483|FG001|Primary Reporting Phase|Participant request|0|||
28064825|NCT00310388|54720482|FG000|Primary Reporting Phase|Ministry of Health decision|25|||
28064826|NCT00310388|54720483|FG001|Primary Reporting Phase|Ministry of Health decision|0|||
28113488|NCT03135548|54771598|FG002|Overall Study|Withdrawal by Subject|1|||
27816255|NCT01901653|54273069|FG004|Overall Study|Withdrawal by Subject|0|||
27816256|NCT01901653|54273070|FG005|Overall Study|Withdrawal by Subject|0|||
27816257|NCT01901653|54273071|FG006|Overall Study|Withdrawal by Subject|1|||
27816258|NCT01901653|54273072|FG007|Overall Study|Withdrawal by Subject|0|||
28113489|NCT03135548|54771596|FG000|Overall Study|Other than listed|0|||
28113490|NCT03135548|54771597|FG001|Overall Study|Other than listed|2|||
27816259|NCT01901653|54273073|FG008|Overall Study|Withdrawal by Subject|0|||
28113491|NCT03135548|54771598|FG002|Overall Study|Other than listed|2|||
28113492|NCT03134222|54771609|FG000|Treatment Period (Up to Week 12)|Adverse Event|4|||
28113493|NCT03134222|54771610|FG001|Treatment Period (Up to Week 12)|Adverse Event|1|||
28113494|NCT03134222|54771611|FG002|Treatment Period (Up to Week 12)|Adverse Event|0|||
28113495|NCT03134222|54771612|FG003|Treatment Period (Up to Week 12)|Adverse Event|0|||
28113496|NCT03134222|54771613|FG004|Treatment Period (Up to Week 12)|Adverse Event|0|||
28113497|NCT03134222|54771609|FG000|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
28113498|NCT03134222|54771610|FG001|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
28113499|NCT03134222|54771611|FG002|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
28113500|NCT03134222|54771612|FG003|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
28113501|NCT03134222|54771613|FG004|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
28113502|NCT03134222|54771609|FG000|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
27816260|NCT01901653|54273074|FG009|Overall Study|Withdrawal by Subject|0|||
27816261|NCT01901653|54273075|FG010|Overall Study|Withdrawal by Subject|0|||
28113503|NCT03134222|54771610|FG001|Treatment Period (Up to Week 12)|Withdrew Consent|1|||
28113504|NCT03134222|54771611|FG002|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
28113505|NCT03134222|54771612|FG003|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
28113506|NCT03134222|54771613|FG004|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
28113507|NCT03134222|54771609|FG000|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
28113508|NCT03134222|54771610|FG001|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
28113509|NCT03134222|54771611|FG002|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
28113510|NCT03134222|54771612|FG003|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
27816262|NCT01901653|54273076|FG011|Overall Study|Withdrawal by Subject|0|||
27816263|NCT01901653|54273077|FG012|Overall Study|Withdrawal by Subject|0|||
27816264|NCT01901653|54273065|FG000|Overall Study|Alive at Study Termination by Sponsor|0|||
27816265|NCT01901653|54273066|FG001|Overall Study|Alive at Study Termination by Sponsor|0|||
27816266|NCT01901653|54273067|FG002|Overall Study|Alive at Study Termination by Sponsor|1|||
27816267|NCT01901653|54273068|FG003|Overall Study|Alive at Study Termination by Sponsor|0|||
27816268|NCT01901653|54273069|FG004|Overall Study|Alive at Study Termination by Sponsor|0|||
27816269|NCT01901653|54273070|FG005|Overall Study|Alive at Study Termination by Sponsor|0|||
27816270|NCT01901653|54273071|FG006|Overall Study|Alive at Study Termination by Sponsor|0|||
27816271|NCT01901653|54273072|FG007|Overall Study|Alive at Study Termination by Sponsor|0|||
27816272|NCT01901653|54273073|FG008|Overall Study|Alive at Study Termination by Sponsor|0|||
27816273|NCT01901653|54273074|FG009|Overall Study|Alive at Study Termination by Sponsor|2|||
27940288|NCT00942994|54596561|FG000|Overall Study|Protocol deviation|1|||
28064827|NCT00310388|54720482|FG000|Primary Reporting Phase|Discontinuation of study|1|||
28064828|NCT00310388|54720483|FG001|Primary Reporting Phase|Discontinuation of study|0|||
28064829|NCT00310388|54720482|FG000|Primary Reporting Phase|Participant Immigrated to New Zealand|1|||
28064830|NCT00310388|54720483|FG001|Primary Reporting Phase|Participant Immigrated to New Zealand|0|||
28064831|NCT00310388|54720482|FG000|Primary Reporting Phase|Termination of study at sponsor request|3|||
28064832|NCT00310388|54720483|FG001|Primary Reporting Phase|Termination of study at sponsor request|0|||
28064833|NCT00310388|54720482|FG000|Primary Reporting Phase|Ongoing SAE from parent study|1|||
28064834|NCT00310388|54720483|FG001|Primary Reporting Phase|Ongoing SAE from parent study|0|||
28064835|NCT00310388|54720482|FG000|Primary Reporting Phase|Due to pigmentation risk concerns|2|||
28064836|NCT00310388|54720483|FG001|Primary Reporting Phase|Due to pigmentation risk concerns|0|||
28064837|NCT00310388|54720482|FG000|Primary Reporting Phase|Participant passed away|1|||
28064838|NCT00310388|54720483|FG001|Primary Reporting Phase|Participant passed away|0|||
28064839|NCT00310388|54720482|FG000|Primary Reporting Phase|Participant retired the informed consent|1|||
28064840|NCT00310388|54720483|FG001|Primary Reporting Phase|Participant retired the informed consent|0|||
28064841|NCT00310388|54720482|FG000|Primary Reporting Phase|Missing|1|||
28064842|NCT00310388|54720483|FG001|Primary Reporting Phase|Missing|0|||
28064843|NCT00310388|54720482|FG000|Primary Reporting Phase|Other|1|||
28064844|NCT00310388|54720483|FG001|Primary Reporting Phase|Other|0|||
28064845|NCT00310388|54720482|FG000|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0|||
28064846|NCT00310388|54720483|FG001|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5|||
28064847|NCT00310388|54720482|FG000|Safety Follow-up Continuation Phase|Adverse Event|0|||
28064848|NCT00310388|54720483|FG001|Safety Follow-up Continuation Phase|Adverse Event|1|||
28064849|NCT00310388|54720482|FG000|Safety Follow-up Continuation Phase|Withdrawal by Subject|0|||
28064850|NCT00310388|54720483|FG001|Safety Follow-up Continuation Phase|Withdrawal by Subject|5|||
28064851|NCT00310388|54720482|FG000|Safety Follow-up Continuation Phase|Study Closed/Terminated|0|||
28064852|NCT00310388|54720483|FG001|Safety Follow-up Continuation Phase|Study Closed/Terminated|2|||
28064853|NCT00500357|54720488|FG000|Overall Study|Death|1|||
28064854|NCT00309842|54720503|FG000|Overall Study|Lost to Follow-up|1|||
28064855|NCT00325754|54720509|FG000|Overall Study|Adverse Event|4|||
28064856|NCT00325754|54720510|FG001|Overall Study|Adverse Event|1|||
28064857|NCT00499889|54720516|FG000|Overall Study|Infection prior to treatment|1|||
28064858|NCT00309608|54720525|FG000|Overall Study|Adverse Event|1|||
28064859|NCT00309608|54720526|FG001|Overall Study|Adverse Event|5|||
28064860|NCT00309608|54720527|FG002|Overall Study|Adverse Event|3|||
28064861|NCT00309608|54720528|FG003|Overall Study|Adverse Event|2|||
28064862|NCT00309608|54720529|FG004|Overall Study|Adverse Event|3|||
28064863|NCT00309608|54720525|FG000|Overall Study|Protocol Violation|2|||
28064864|NCT00309608|54720526|FG001|Overall Study|Protocol Violation|0|||
28064865|NCT00309608|54720527|FG002|Overall Study|Protocol Violation|0|||
28064866|NCT00309608|54720528|FG003|Overall Study|Protocol Violation|0|||
28113511|NCT03134222|54771613|FG004|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
28113512|NCT03134222|54771609|FG000|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
28113513|NCT03134222|54771610|FG001|Treatment Period (Week 12 to 48)|Withdrew Consent|2|||
28113514|NCT03134222|54771611|FG002|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
27816274|NCT01901653|54273075|FG010|Overall Study|Alive at Study Termination by Sponsor|0|||
27816275|NCT01901653|54273076|FG011|Overall Study|Alive at Study Termination by Sponsor|1|||
27816276|NCT01901653|54273077|FG012|Overall Study|Alive at Study Termination by Sponsor|1|||
27816277|NCT01925989|54273105|FG000|Period 1|Sponsor Decision|1|||
27816278|NCT01925989|54273106|FG001|Period 1|Sponsor Decision|1|||
27816279|NCT01925989|54273107|FG002|Period 1|Sponsor Decision|0|||
28113515|NCT03134222|54771612|FG003|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
28113516|NCT03134222|54771613|FG004|Treatment Period (Week 12 to 48)|Withdrew Consent|1|||
28113517|NCT03134222|54771609|FG000|Treatment Period (Week 12 to 48)|Lack of Efficacy|2|||
28113518|NCT03134222|54771610|FG001|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
28113519|NCT03134222|54771611|FG002|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
28113520|NCT03134222|54771612|FG003|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
27816280|NCT01925989|54273105|FG000|Period 1|Withdrawal by Subject|0|||
27816281|NCT01925989|54273106|FG001|Period 1|Withdrawal by Subject|1|||
27816282|NCT01925989|54273107|FG002|Period 1|Withdrawal by Subject|0|||
27816283|NCT01901419|54273121|FG000|Overall Study|Protocol Violation|2|||
27816284|NCT01901419|54273122|FG001|Overall Study|Protocol Violation|6|||
27816285|NCT01901419|54273121|FG000|Overall Study|unavailable researchers|6|||
27816286|NCT01901419|54273122|FG001|Overall Study|unavailable researchers|3|||
27816287|NCT01901341|54273149|FG000|Overall Study|Adverse Event|4|||
27816288|NCT01901341|54273150|FG001|Overall Study|Adverse Event|2|||
27816289|NCT01901341|54273149|FG000|Overall Study|Lack of Efficacy|0|||
27816290|NCT01901341|54273150|FG001|Overall Study|Lack of Efficacy|2|||
27816291|NCT01901341|54273149|FG000|Overall Study|Lost to Follow-up|0|||
27816292|NCT01901341|54273150|FG001|Overall Study|Lost to Follow-up|1|||
27816293|NCT01901341|54273149|FG000|Overall Study|Protocol Violation|2|||
27816294|NCT01901341|54273150|FG001|Overall Study|Protocol Violation|0|||
27816295|NCT01901341|54273149|FG000|Overall Study|Study Terminated by Sponsor|13|||
27816296|NCT01901341|54273150|FG001|Overall Study|Study Terminated by Sponsor|15|||
27816297|NCT01901341|54273149|FG000|Overall Study|Withdrawal by Subject|1|||
27816298|NCT01901341|54273150|FG001|Overall Study|Withdrawal by Subject|1|||
27816299|NCT01615939|54273159|FG000|Overall Study|Lost to Follow-up|5|||
27816300|NCT01615939|54273160|FG001|Overall Study|Lost to Follow-up|0|||
27816301|NCT01901185|54273166|FG000|Overall Study|Withdrawal by Subject|2|||
27816302|NCT01888003|54273173|FG000|Overall Study|Study Terminated|5|||
27816303|NCT01888003|54273174|FG001|Overall Study|Study Terminated|6|||
27816304|NCT01888003|54273175|FG002|Overall Study|Study Terminated|40|||
27816305|NCT01925209|54273241|FG000|Treatment Epoch|Physician Decision|1|||
27816306|NCT01925209|54273242|FG001|Treatment Epoch|Physician Decision|0|||
27816307|NCT01925209|54273243|FG002|Treatment Epoch|Physician Decision|0|||
27816308|NCT01925209|54273244|FG003|Treatment Epoch|Physician Decision|0|||
27816309|NCT01925209|54273241|FG000|Treatment Epoch|Non-compliance with study treatment|0|||
27816310|NCT01925209|54273242|FG001|Treatment Epoch|Non-compliance with study treatment|0|||
27816311|NCT01925209|54273243|FG002|Treatment Epoch|Non-compliance with study treatment|0|||
27816312|NCT01925209|54273244|FG003|Treatment Epoch|Non-compliance with study treatment|1|||
27816313|NCT01925209|54273241|FG000|Treatment Epoch|Death|1|||
27816314|NCT01925209|54273242|FG001|Treatment Epoch|Death|0|||
27816315|NCT01925209|54273243|FG002|Treatment Epoch|Death|0|||
27816316|NCT01925209|54273244|FG003|Treatment Epoch|Death|0|||
27816317|NCT01925209|54273241|FG000|Treatment Epoch|Protocol deviation|0|||
27816318|NCT01925209|54273242|FG001|Treatment Epoch|Protocol deviation|0|||
27816319|NCT01925209|54273243|FG002|Treatment Epoch|Protocol deviation|1|||
27816320|NCT01925209|54273244|FG003|Treatment Epoch|Protocol deviation|1|||
27816321|NCT01925209|54273241|FG000|Treatment Epoch|Withdrawal by Subject|4|||
27816322|NCT01925209|54273242|FG001|Treatment Epoch|Withdrawal by Subject|3|||
27816323|NCT01925209|54273243|FG002|Treatment Epoch|Withdrawal by Subject|3|||
27816324|NCT01925209|54273244|FG003|Treatment Epoch|Withdrawal by Subject|2|||
27816325|NCT01925209|54273241|FG000|Treatment Epoch|Adverse Event|3|||
27816326|NCT01925209|54273242|FG001|Treatment Epoch|Adverse Event|5|||
27816327|NCT01925209|54273243|FG002|Treatment Epoch|Adverse Event|3|||
27816328|NCT01925209|54273244|FG003|Treatment Epoch|Adverse Event|1|||
27816329|NCT01925209|54273241|FG000|Maintenance Treatment Epoch|Withdrawal by Subject|0|||
27816330|NCT01925209|54273242|FG001|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
27816331|NCT01925209|54273243|FG002|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
27816332|NCT01925209|54273244|FG003|Maintenance Treatment Epoch|Withdrawal by Subject|2|||
27816333|NCT01925209|54273241|FG000|Maintenance Treatment Epoch|Adverse Event|0|||
27816334|NCT01925209|54273242|FG001|Maintenance Treatment Epoch|Adverse Event|0|||
27816335|NCT01925209|54273243|FG002|Maintenance Treatment Epoch|Adverse Event|1|||
27816336|NCT01925209|54273244|FG003|Maintenance Treatment Epoch|Adverse Event|0|||
27816337|NCT01925209|54273241|FG000|Follow-up|Adverse Event|1|||
28113521|NCT03134222|54771613|FG004|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
27816338|NCT01925209|54273242|FG001|Follow-up|Adverse Event|4|||
27816339|NCT01925209|54273243|FG002|Follow-up|Adverse Event|0|||
27816340|NCT01925209|54273244|FG003|Follow-up|Adverse Event|1|||
27816341|NCT01925209|54273241|FG000|Follow-up|Physician Decision|0|||
27816342|NCT01925209|54273242|FG001|Follow-up|Physician Decision|0|||
27816343|NCT01925209|54273243|FG002|Follow-up|Physician Decision|1|||
27816344|NCT01925209|54273244|FG003|Follow-up|Physician Decision|0|||
27816345|NCT01925209|54273241|FG000|Follow-up|Non-compliance with study treatment|0|||
27816346|NCT01925209|54273242|FG001|Follow-up|Non-compliance with study treatment|0|||
27816347|NCT01925209|54273243|FG002|Follow-up|Non-compliance with study treatment|0|||
27816348|NCT01925209|54273244|FG003|Follow-up|Non-compliance with study treatment|1|||
27816349|NCT01925209|54273241|FG000|Follow-up|Withdrawal by Subject|0|||
27816350|NCT01925209|54273242|FG001|Follow-up|Withdrawal by Subject|2|||
27816351|NCT01925209|54273243|FG002|Follow-up|Withdrawal by Subject|0|||
27816352|NCT01925209|54273244|FG003|Follow-up|Withdrawal by Subject|2|||
27816353|NCT01614925|54273256|FG000|Overall Study|Withdrawal by Subject|1|||
27816354|NCT01614925|54273257|FG001|Overall Study|Withdrawal by Subject|0|||
27816355|NCT01614925|54273256|FG000|Overall Study|Protocol Violation|3|||
27816356|NCT01614925|54273257|FG001|Overall Study|Protocol Violation|2|||
27816357|NCT01886833|54273263|FG000|Overall Study|IgA not available from both periods|204|||
27816358|NCT01898923|54273272|FG000|Overall Study|Lack of Efficacy|5|||
27816359|NCT01898923|54273273|FG001|Overall Study|Lack of Efficacy|6|||
27816360|NCT01898923|54273272|FG000|Overall Study|Adverse Event|3|||
28064867|NCT00309608|54720529|FG004|Overall Study|Protocol Violation|0|||
28064868|NCT00309608|54720525|FG000|Overall Study|Lost to Follow-up|0|||
28064869|NCT00309608|54720526|FG001|Overall Study|Lost to Follow-up|0|||
28064870|NCT00309608|54720527|FG002|Overall Study|Lost to Follow-up|2|||
28064871|NCT00309608|54720528|FG003|Overall Study|Lost to Follow-up|0|||
28064872|NCT00309608|54720529|FG004|Overall Study|Lost to Follow-up|1|||
28064873|NCT00309608|54720525|FG000|Overall Study|Withdrawal by Subject|1|||
28064874|NCT00309608|54720526|FG001|Overall Study|Withdrawal by Subject|4|||
28064875|NCT00309608|54720527|FG002|Overall Study|Withdrawal by Subject|2|||
28064876|NCT00309608|54720528|FG003|Overall Study|Withdrawal by Subject|0|||
28064877|NCT00309608|54720529|FG004|Overall Study|Withdrawal by Subject|0|||
28064878|NCT00309608|54720525|FG000|Overall Study|Other incl. Lack of efficacy|10|||
28064879|NCT00309608|54720526|FG001|Overall Study|Other incl. Lack of efficacy|4|||
28064880|NCT00309608|54720527|FG002|Overall Study|Other incl. Lack of efficacy|3|||
28064881|NCT00309608|54720528|FG003|Overall Study|Other incl. Lack of efficacy|4|||
28064882|NCT00309608|54720529|FG004|Overall Study|Other incl. Lack of efficacy|0|||
28064883|NCT00309452|54720543|FG000|Overall Study|Withdrawal by Subject|3|||
27816361|NCT01898923|54273273|FG001|Overall Study|Adverse Event|1|||
27816362|NCT01898923|54273272|FG000|Overall Study|Lost to Follow-up|0|||
27816363|NCT01898923|54273273|FG001|Overall Study|Lost to Follow-up|1|||
27816364|NCT01898923|54273272|FG000|Overall Study|Withdrawal by Subject|4|||
27816365|NCT01898923|54273273|FG001|Overall Study|Withdrawal by Subject|7|||
28064884|NCT00309452|54720544|FG001|Overall Study|Withdrawal by Subject|0|||
28064885|NCT00308750|54720553|FG000|Overall Study|Adverse Event|9|||
28064886|NCT00308750|54720554|FG001|Overall Study|Adverse Event|9|||
28064887|NCT00308750|54720555|FG002|Overall Study|Adverse Event|13|||
28064888|NCT00308750|54720553|FG000|Overall Study|Withdrawal by Subject|6|||
28113522|NCT03134222|54771609|FG000|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
28113523|NCT03134222|54771610|FG001|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
28113524|NCT03134222|54771611|FG002|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
28113525|NCT03134222|54771612|FG003|Treatment Period (Week 12 to 48)|Investigator's Discretion|1|||
28113526|NCT03134222|54771613|FG004|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
28113527|NCT03134222|54771609|FG000|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
28113528|NCT03134222|54771610|FG001|Treatment Period (Week 12 to 48)|Lost to Follow-up|1|||
28113529|NCT03134222|54771611|FG002|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
28113530|NCT03134222|54771612|FG003|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
28113531|NCT03134222|54771613|FG004|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
28113532|NCT03769753|54771623|FG000|Overall Study|Not Treated|6|||
28113533|NCT03769753|54771623|FG000|Overall Study|Inevaluable - No Evidence of Disease|1|||
28113534|NCT03263923|54771638|FG000|Overall Study|Withdrawal by Subject|10|||
28113535|NCT03263923|54771639|FG001|Overall Study|Withdrawal by Subject|8|||
28113536|NCT03263923|54771638|FG000|Overall Study|Lost to Follow-up|15|||
28113537|NCT03263923|54771639|FG001|Overall Study|Lost to Follow-up|13|||
28113538|NCT03139604|54771649|FG000|Overall Study|Other|7|||
28113539|NCT03139604|54771650|FG001|Overall Study|Other|3|||
28113540|NCT03139604|54771649|FG000|Overall Study|Withdrawal by Subject|16|||
28113541|NCT03139604|54771650|FG001|Overall Study|Withdrawal by Subject|17|||
28113542|NCT03139604|54771649|FG000|Overall Study|Physician Decision|1|||
28113543|NCT03139604|54771650|FG001|Overall Study|Physician Decision|2|||
28113544|NCT03139604|54771649|FG000|Overall Study|Lost to Follow-up|3|||
28113545|NCT03139604|54771650|FG001|Overall Study|Lost to Follow-up|1|||
28113546|NCT03139604|54771649|FG000|Overall Study|Death|65|||
28113547|NCT03139604|54771650|FG001|Overall Study|Death|67|||
28113548|NCT03139604|54771649|FG000|Overall Study|Study Terminated by Sponsor|122|||
28113549|NCT03139604|54771650|FG001|Overall Study|Study Terminated by Sponsor|127|||
28113550|NCT03139604|54771649|FG000|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|5|||
28113551|NCT03139604|54771650|FG001|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|3|||
28113552|NCT03139448|54771659|FG000|Overall Study|Lack of Efficacy|6|||
28113553|NCT03139448|54771660|FG001|Overall Study|Lack of Efficacy|7|||
28113554|NCT03139448|54771659|FG000|Overall Study|Location of procedure changed|2|||
28113555|NCT03139448|54771660|FG001|Overall Study|Location of procedure changed|8|||
28113556|NCT03139448|54771659|FG000|Overall Study|Withdrawal by Subject|3|||
28113557|NCT03139448|54771660|FG001|Overall Study|Withdrawal by Subject|6|||
28113558|NCT03139448|54771659|FG000|Overall Study|Screen fail|1|||
28113559|NCT03139448|54771660|FG001|Overall Study|Screen fail|3|||
28113560|NCT03139448|54771659|FG000|Overall Study|Physician Decision|0|||
28113561|NCT03139448|54771660|FG001|Overall Study|Physician Decision|2|||
28113562|NCT02875340|54771666|FG000|Overall Study|Death|2|||
28113563|NCT02875340|54771666|FG000|Overall Study|Withdrawal by Subject|2|||
28113564|NCT02875340|54771666|FG000|Overall Study|Physician Decision|3|||
28113565|NCT02875340|54771666|FG000|Overall Study|Adverse Event|1|||
28113566|NCT03237325|54771678|FG000|Overall Study|Lost to Follow-up|3|||
28113567|NCT03237325|54771679|FG001|Overall Study|Lost to Follow-up|5|||
28113568|NCT03237325|54771678|FG000|Overall Study|Physician Decision|2|||
28113569|NCT03237325|54771679|FG001|Overall Study|Physician Decision|4|||
28113570|NCT03237325|54771678|FG000|Overall Study|Withdrawal by Subject|9|||
28113571|NCT03237325|54771679|FG001|Overall Study|Withdrawal by Subject|12|||
28113572|NCT03237325|54771678|FG000|Overall Study|Noncompliance with Study Procedures|1|||
28113573|NCT03237325|54771679|FG001|Overall Study|Noncompliance with Study Procedures|1|||
28113574|NCT03237325|54771678|FG000|Overall Study|Termination by Sponsor|0|||
28113575|NCT03237325|54771679|FG001|Overall Study|Termination by Sponsor|1|||
28113576|NCT03237325|54771678|FG000|Overall Study|Reason other than described|0|||
28113577|NCT03237325|54771679|FG001|Overall Study|Reason other than described|2|||
28113578|NCT03113383|54771685|FG000|Overall Study|Death|4|||
28113579|NCT03113383|54771686|FG001|Overall Study|Death|0|||
28113580|NCT03762265|54771707|FG000|BT Period: Weeks 1 to 37|Adverse Event|7|||
28113581|NCT03762265|54771708|FG001|BT Period: Weeks 1 to 37|Adverse Event|2|||
28113582|NCT03762265|54771707|FG000|BT Period: Weeks 1 to 37|Lack of Efficacy|1|||
28113583|NCT03762265|54771708|FG001|BT Period: Weeks 1 to 37|Lack of Efficacy|0|||
28113584|NCT03762265|54771707|FG000|BT Period: Weeks 1 to 37|Physician Decision|1|||
28113585|NCT03762265|54771708|FG001|BT Period: Weeks 1 to 37|Physician Decision|0|||
28113586|NCT03762265|54771707|FG000|BT Period: Weeks 1 to 37|Required prohibited medication|2|||
28113587|NCT03762265|54771708|FG001|BT Period: Weeks 1 to 37|Required prohibited medication|0|||
28113588|NCT03762265|54771707|FG000|BT Period: Weeks 1 to 37|Withdrawal by Subject|4|||
28113589|NCT03762265|54771708|FG001|BT Period: Weeks 1 to 37|Withdrawal by Subject|0|||
28113590|NCT03762265|54771707|FG000|BT Period: Weeks 1 to 37|Other|0|||
28113591|NCT03762265|54771708|FG001|BT Period: Weeks 1 to 37|Other|1|||
28113592|NCT03762265|54771707|FG000|OLE Period: Weeks 37 to 61|Adverse Event|1|||
28113593|NCT03762265|54771708|FG001|OLE Period: Weeks 37 to 61|Adverse Event|2|||
28113594|NCT03762265|54771707|FG000|OLE Period: Weeks 37 to 61|Lack of Efficacy|3|||
28113595|NCT03762265|54771708|FG001|OLE Period: Weeks 37 to 61|Lack of Efficacy|2|||
28113596|NCT03762265|54771707|FG000|OLE Period: Weeks 37 to 61|Non-compliance with study drug|1|||
28113597|NCT03762265|54771708|FG001|OLE Period: Weeks 37 to 61|Non-compliance with study drug|0|||
28113598|NCT03762265|54771707|FG000|OLE Period: Weeks 37 to 61|Study terminated by sponsor|8|||
28113599|NCT03762265|54771708|FG001|OLE Period: Weeks 37 to 61|Study terminated by sponsor|10|||
28113600|NCT03762265|54771707|FG000|OLE Period: Weeks 37 to 61|Withdrawal by Subject|3|||
28113601|NCT03762265|54771708|FG001|OLE Period: Weeks 37 to 61|Withdrawal by Subject|2|||
28113602|NCT03762265|54771707|FG000|LTE Period: Weeks 61 to 109|Lack of Efficacy|0|||
28113603|NCT03762265|54771708|FG001|LTE Period: Weeks 61 to 109|Lack of Efficacy|1|||
28113604|NCT03762265|54771707|FG000|LTE Period: Weeks 61 to 109|Study terminated by sponsor|28|||
28113605|NCT03762265|54771708|FG001|LTE Period: Weeks 61 to 109|Study terminated by sponsor|25|||
28113606|NCT03762265|54771707|FG000|LTE Period: Weeks 61 to 109|Withdrawal by Subject|0|||
28113607|NCT03762265|54771708|FG001|LTE Period: Weeks 61 to 109|Withdrawal by Subject|2|||
28113608|NCT03762265|54771707|FG000|LTE Period: Weeks 61 to 109|Other|1|||
28113609|NCT03762265|54771708|FG001|LTE Period: Weeks 61 to 109|Other|0|||
28113610|NCT03131960|54771732|FG000|Overall Study|Adverse Event|0|||
28113611|NCT03131960|54771733|FG001|Overall Study|Adverse Event|1|||
28113612|NCT03225170|54771742|FG000|Overall Study|Lost to Follow-up|4|||
28113613|NCT03225170|54771743|FG001|Overall Study|Lost to Follow-up|4|||
28113614|NCT03225170|54771744|FG002|Overall Study|Lost to Follow-up|0|||
28113615|NCT03225170|54771742|FG000|Overall Study|Did not complete intervention/control writing exercise|0|||
28113616|NCT03225170|54771743|FG001|Overall Study|Did not complete intervention/control writing exercise|1|||
28113617|NCT03225170|54771744|FG002|Overall Study|Did not complete intervention/control writing exercise|0|||
28064889|NCT00308750|54720554|FG001|Overall Study|Withdrawal by Subject|2|||
28064890|NCT00308750|54720555|FG002|Overall Study|Withdrawal by Subject|3|||
28064891|NCT00308750|54720553|FG000|Overall Study|Physician Decision|3|||
28064892|NCT00308750|54720554|FG001|Overall Study|Physician Decision|4|||
28064893|NCT00308750|54720555|FG002|Overall Study|Physician Decision|3|||
28064894|NCT00308750|54720553|FG000|Overall Study|Sponsor Decision|1|||
28064895|NCT00308750|54720554|FG001|Overall Study|Sponsor Decision|0|||
28064896|NCT00308750|54720555|FG002|Overall Study|Sponsor Decision|0|||
28064897|NCT00308750|54720553|FG000|Overall Study|Disease Progression|47|||
28064898|NCT00308750|54720554|FG001|Overall Study|Disease Progression|24|||
28064899|NCT00308750|54720555|FG002|Overall Study|Disease Progression|28|||
28064900|NCT00308750|54720553|FG000|Overall Study|Unrelated Complication|3|||
28064901|NCT00308750|54720554|FG001|Overall Study|Unrelated Complication|0|||
28064902|NCT00308750|54720555|FG002|Overall Study|Unrelated Complication|1|||
28064903|NCT00308750|54720553|FG000|Overall Study|Death|1|||
28064904|NCT00308750|54720554|FG001|Overall Study|Death|0|||
28064905|NCT00308750|54720555|FG002|Overall Study|Death|1|||
28064906|NCT00308750|54720553|FG000|Overall Study|Protocol Violation|1|||
28064907|NCT00308750|54720554|FG001|Overall Study|Protocol Violation|0|||
28064908|NCT00308750|54720555|FG002|Overall Study|Protocol Violation|0|||
28064909|NCT00308750|54720553|FG000|Overall Study|New Primary Disease Identified|1|||
28064910|NCT00308750|54720554|FG001|Overall Study|New Primary Disease Identified|1|||
28064911|NCT00308750|54720555|FG002|Overall Study|New Primary Disease Identified|0|||
28064912|NCT00489359|54720566|FG000|Overall Study|Death|0|||
28064913|NCT00489359|54720567|FG001|Overall Study|Death|2|||
28064914|NCT00489359|54720566|FG000|Overall Study|Progressive Disease|5|||
28064915|NCT00489359|54720567|FG001|Overall Study|Progressive Disease|6|||
28064916|NCT00489359|54720566|FG000|Overall Study|Lost to Follow-up|1|||
28064917|NCT00489359|54720567|FG001|Overall Study|Lost to Follow-up|0|||
28064918|NCT00489359|54720566|FG000|Overall Study|Withdrawal by Subject|1|||
28064919|NCT00489359|54720567|FG001|Overall Study|Withdrawal by Subject|5|||
28064920|NCT00489359|54720566|FG000|Overall Study|Adverse Event|0|||
28113618|NCT02115139|54771750|FG000|Overall Study|Protocol Violation|1|||
28113619|NCT02115139|54771750|FG000|Overall Study|treatment discontinuation|6|||
28113620|NCT01763827|54771798|FG000|Overall Study|Withdrawal by Subject|1|||
28064921|NCT00489359|54720567|FG001|Overall Study|Adverse Event|16|||
28064922|NCT00481247|54720580|FG000|Overall Study|Death|0|||
28064923|NCT00481247|54720581|FG001|Overall Study|Death|1|||
28064924|NCT00481247|54720580|FG000|Overall Study|Disease progression|18|||
28113621|NCT01763827|54771799|FG001|Overall Study|Withdrawal by Subject|0|||
28113622|NCT01763827|54771800|FG002|Overall Study|Withdrawal by Subject|0|||
28113623|NCT01763827|54771801|FG003|Overall Study|Withdrawal by Subject|0|||
28113624|NCT01763827|54771802|FG004|Overall Study|Withdrawal by Subject|2|||
28113625|NCT01763827|54771803|FG005|Overall Study|Withdrawal by Subject|0|||
28113626|NCT01763827|54771798|FG000|Overall Study|Decision by sponsor|2|||
28113627|NCT01763827|54771799|FG001|Overall Study|Decision by sponsor|0|||
28113628|NCT01763827|54771800|FG002|Overall Study|Decision by sponsor|3|||
28113629|NCT01763827|54771801|FG003|Overall Study|Decision by sponsor|0|||
28113630|NCT01763827|54771802|FG004|Overall Study|Decision by sponsor|2|||
28113631|NCT01763827|54771803|FG005|Overall Study|Decision by sponsor|1|||
28113632|NCT01763827|54771798|FG000|Overall Study|Lost to Follow-up|0|||
28113633|NCT01763827|54771799|FG001|Overall Study|Lost to Follow-up|1|||
28113634|NCT01763827|54771800|FG002|Overall Study|Lost to Follow-up|1|||
28113635|NCT01763827|54771801|FG003|Overall Study|Lost to Follow-up|1|||
28113636|NCT01763827|54771802|FG004|Overall Study|Lost to Follow-up|2|||
28113637|NCT01763827|54771803|FG005|Overall Study|Lost to Follow-up|1|||
28113638|NCT01732783|54771856|FG000|Overall Study|Discontinued Panitumumab Treatment|106|||
28113639|NCT01732783|54771857|FG001|Overall Study|Discontinued Panitumumab Treatment|25|||
28113640|NCT01732783|54771858|FG002|Overall Study|Discontinued Panitumumab Treatment|7|||
28113641|NCT01732783|54771856|FG000|Overall Study|Death|13|||
28113642|NCT01732783|54771857|FG001|Overall Study|Death|4|||
28113643|NCT01732783|54771858|FG002|Overall Study|Death|1|||
28113644|NCT01732783|54771856|FG000|Overall Study|Lost to Follow-up|7|||
28113645|NCT01732783|54771857|FG001|Overall Study|Lost to Follow-up|1|||
28113646|NCT01732783|54771858|FG002|Overall Study|Lost to Follow-up|1|||
28113647|NCT01732783|54771856|FG000|Overall Study|Administrative Decision|8|||
28113648|NCT01732783|54771857|FG001|Overall Study|Administrative Decision|2|||
28113649|NCT01732783|54771858|FG002|Overall Study|Administrative Decision|1|||
28113650|NCT01732783|54771856|FG000|Overall Study|Withdrawal by Subject|1|||
28113651|NCT01732783|54771857|FG001|Overall Study|Withdrawal by Subject|0|||
28113652|NCT01732783|54771858|FG002|Overall Study|Withdrawal by Subject|0|||
28113653|NCT02787850|54771885|FG000|Overall Study|Withdrawal by Subject|0|||
28113654|NCT02787850|54771886|FG001|Overall Study|Withdrawal by Subject|1|||
28113655|NCT01375777|54771910|FG000|Overall Study|Withdrawal by Subject|0|||
28113656|NCT01375777|54771911|FG001|Overall Study|Withdrawal by Subject|2|||
28113657|NCT01375777|54771912|FG002|Overall Study|Withdrawal by Subject|1|||
28113658|NCT01375777|54771913|FG003|Overall Study|Withdrawal by Subject|0|||
28113659|NCT01375777|54771914|FG004|Overall Study|Withdrawal by Subject|1|||
28113660|NCT01375777|54771915|FG005|Overall Study|Withdrawal by Subject|1|||
28113661|NCT01375777|54771916|FG006|Overall Study|Withdrawal by Subject|1|||
28113662|NCT01375777|54771917|FG007|Overall Study|Withdrawal by Subject|2|||
28113663|NCT01375777|54771918|FG008|Overall Study|Withdrawal by Subject|1|||
28113664|NCT01375777|54771910|FG000|Overall Study|Lost to Follow-up|1|||
28113665|NCT01375777|54771911|FG001|Overall Study|Lost to Follow-up|0|||
28113666|NCT01375777|54771912|FG002|Overall Study|Lost to Follow-up|0|||
28113667|NCT01375777|54771913|FG003|Overall Study|Lost to Follow-up|0|||
28113668|NCT01375777|54771914|FG004|Overall Study|Lost to Follow-up|0|||
28113669|NCT01375777|54771915|FG005|Overall Study|Lost to Follow-up|0|||
28113670|NCT01375777|54771916|FG006|Overall Study|Lost to Follow-up|1|||
28113671|NCT01375777|54771917|FG007|Overall Study|Lost to Follow-up|0|||
28113672|NCT01375777|54771918|FG008|Overall Study|Lost to Follow-up|0|||
28113673|NCT01375777|54771910|FG000|Overall Study|Other|1|||
28113674|NCT01375777|54771911|FG001|Overall Study|Other|1|||
28113675|NCT01375777|54771912|FG002|Overall Study|Other|0|||
28113676|NCT01375777|54771913|FG003|Overall Study|Other|0|||
28113677|NCT01375777|54771914|FG004|Overall Study|Other|0|||
28113678|NCT01375777|54771915|FG005|Overall Study|Other|0|||
28113679|NCT01375777|54771916|FG006|Overall Study|Other|0|||
28113680|NCT01375777|54771917|FG007|Overall Study|Other|0|||
28113681|NCT01375777|54771918|FG008|Overall Study|Other|1|||
28113682|NCT02431702|54771938|FG000|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7|||
28113683|NCT02431702|54771939|FG001|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
28113684|NCT02431702|54771940|FG002|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
28113685|NCT02431702|54771941|FG003|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
28113686|NCT02431702|54771942|FG004|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
28113687|NCT02431702|54771943|FG005|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
28113688|NCT02431702|54771944|FG006|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
28113689|NCT02431702|54771938|FG000|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11|||
28113690|NCT02431702|54771939|FG001|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
28113691|NCT02431702|54771940|FG002|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
28113692|NCT02431702|54771941|FG003|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
28113693|NCT02431702|54771942|FG004|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
28113694|NCT02431702|54771943|FG005|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
28113695|NCT02431702|54771944|FG006|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23|||
28113696|NCT02431702|54771938|FG000|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9|||
28113697|NCT02431702|54771939|FG001|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
28113698|NCT02431702|54771940|FG002|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
28113699|NCT02431702|54771941|FG003|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
28113700|NCT02431702|54771942|FG004|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
28113701|NCT02431702|54771943|FG005|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
28113702|NCT02431702|54771944|FG006|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6|||
28113703|NCT02431702|54771938|FG000|Part 1: 2-Month Oral Run-in Phase|Other|5|||
28113704|NCT02431702|54771939|FG001|Part 1: 2-Month Oral Run-in Phase|Other|0|||
28113705|NCT02431702|54771940|FG002|Part 1: 2-Month Oral Run-in Phase|Other|0|||
28113706|NCT02431702|54771941|FG003|Part 1: 2-Month Oral Run-in Phase|Other|0|||
28113707|NCT02431702|54771942|FG004|Part 1: 2-Month Oral Run-in Phase|Other|0|||
28113708|NCT02431702|54771943|FG005|Part 1: 2-Month Oral Run-in Phase|Other|0|||
28113709|NCT02431702|54771944|FG006|Part 1: 2-Month Oral Run-in Phase|Other|3|||
28113710|NCT02431702|54771938|FG000|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2|||
28113711|NCT02431702|54771939|FG001|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
28113712|NCT02431702|54771940|FG002|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
28113713|NCT02431702|54771941|FG003|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
28113714|NCT02431702|54771942|FG004|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
28113715|NCT02431702|54771943|FG005|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
28113716|NCT02431702|54771944|FG006|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
28113717|NCT02431702|54771938|FG000|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
28113718|NCT02431702|54771939|FG001|Part 2: 9Month Disease Progression Phase|Adverse Event|5|||
28113719|NCT02431702|54771940|FG002|Part 2: 9Month Disease Progression Phase|Adverse Event|1|||
28113720|NCT02431702|54771941|FG003|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
28113721|NCT02431702|54771942|FG004|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
28113722|NCT02431702|54771943|FG005|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
28113723|NCT02431702|54771944|FG006|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
28113724|NCT02431702|54771938|FG000|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
28113725|NCT02431702|54771939|FG001|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6|||
28113726|NCT02431702|54771940|FG002|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13|||
28113727|NCT02431702|54771941|FG003|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
28113728|NCT02431702|54771942|FG004|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
28113729|NCT02431702|54771943|FG005|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
28113730|NCT02431702|54771944|FG006|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
28064925|NCT00481247|54720581|FG001|Overall Study|Disease progression|22|||
28064926|NCT00481247|54720580|FG000|Overall Study|Intolerance|42|||
28064927|NCT00481247|54720581|FG001|Overall Study|Intolerance|17|||
28064928|NCT00481247|54720580|FG000|Overall Study|Treatment failure|10|||
28064929|NCT00481247|54720581|FG001|Overall Study|Treatment failure|14|||
28064930|NCT00481247|54720580|FG000|Overall Study|AE unrelated to study drug|13|||
28064931|NCT00481247|54720581|FG001|Overall Study|AE unrelated to study drug|4|||
28064932|NCT00481247|54720580|FG000|Overall Study|Withdrawal by Subject|8|||
28064933|NCT00481247|54720581|FG001|Overall Study|Withdrawal by Subject|13|||
28064934|NCT00481247|54720580|FG000|Overall Study|Pregnancy|2|||
28064935|NCT00481247|54720581|FG001|Overall Study|Pregnancy|1|||
28064936|NCT00481247|54720580|FG000|Overall Study|Lost to Follow-up|1|||
28064937|NCT00481247|54720581|FG001|Overall Study|Lost to Follow-up|2|||
28064938|NCT00481247|54720580|FG000|Overall Study|Poor compliance/noncompliance|1|||
28064939|NCT00481247|54720581|FG001|Overall Study|Poor compliance/noncompliance|7|||
28064940|NCT00481247|54720580|FG000|Overall Study|Administrative reason by sponsor|157|||
28064941|NCT00481247|54720581|FG001|Overall Study|Administrative reason by sponsor|162|||
28064942|NCT00481247|54720580|FG000|Overall Study|Varied|6|||
28064943|NCT00481247|54720581|FG001|Overall Study|Varied|15|||
28064944|NCT00481247|54720580|FG000|Overall Study|Did not receive treatment|1|||
28113731|NCT02431702|54771938|FG000|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
28113732|NCT02431702|54771939|FG001|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11|||
28113733|NCT02431702|54771940|FG002|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8|||
28113734|NCT02431702|54771941|FG003|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
28113735|NCT02431702|54771942|FG004|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
28113736|NCT02431702|54771943|FG005|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
28113737|NCT02431702|54771944|FG006|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
28113738|NCT02431702|54771938|FG000|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
28113739|NCT02431702|54771939|FG001|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2|||
28113740|NCT02431702|54771940|FG002|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
28113741|NCT02431702|54771941|FG003|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
28113742|NCT02431702|54771942|FG004|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
28113743|NCT02431702|54771943|FG005|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
28113744|NCT02431702|54771944|FG006|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
28113745|NCT02431702|54771938|FG000|Part 2: 9Month Disease Progression Phase|Other|0|||
28113746|NCT02431702|54771939|FG001|Part 2: 9Month Disease Progression Phase|Other|2|||
28113747|NCT02431702|54771940|FG002|Part 2: 9Month Disease Progression Phase|Other|2|||
28113748|NCT02431702|54771941|FG003|Part 2: 9Month Disease Progression Phase|Other|0|||
28113749|NCT02431702|54771942|FG004|Part 2: 9Month Disease Progression Phase|Other|0|||
28113750|NCT02431702|54771943|FG005|Part 2: 9Month Disease Progression Phase|Other|0|||
28113751|NCT02431702|54771944|FG006|Part 2: 9Month Disease Progression Phase|Other|0|||
28113752|NCT02431702|54771938|FG000|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
28113753|NCT02431702|54771939|FG001|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
28113754|NCT02431702|54771940|FG002|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5|||
28113755|NCT02431702|54771941|FG003|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
28113756|NCT02431702|54771942|FG004|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
28113757|NCT02431702|54771943|FG005|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
28113758|NCT02431702|54771944|FG006|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
28113759|NCT02431702|54771938|FG000|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
28113760|NCT02431702|54771939|FG001|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
28113761|NCT02431702|54771940|FG002|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
28113762|NCT02431702|54771941|FG003|Part 3: 9 Month of Additional Treatment|Adverse Event|2|||
28113763|NCT02431702|54771942|FG004|Part 3: 9 Month of Additional Treatment|Adverse Event|3|||
28113764|NCT02431702|54771943|FG005|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
28113765|NCT02431702|54771944|FG006|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
28113766|NCT02431702|54771938|FG000|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
28113767|NCT02431702|54771939|FG001|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
28113768|NCT02431702|54771940|FG002|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
28113769|NCT02431702|54771941|FG003|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1|||
28113770|NCT02431702|54771942|FG004|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
28113771|NCT02431702|54771943|FG005|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5|||
28113772|NCT02431702|54771944|FG006|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
28113773|NCT02431702|54771938|FG000|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
28113774|NCT02431702|54771939|FG001|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
28113775|NCT02431702|54771940|FG002|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
27940289|NCT00942994|54596562|FG001|Overall Study|Protocol deviation|2|||
27940290|NCT00942604|54596570|FG000|Overall Study|Protocol Violation|1|||
27940291|NCT00942604|54596571|FG001|Overall Study|Protocol Violation|1|||
27940292|NCT00942604|54596570|FG000|Overall Study|Adverse Event|0|||
27940293|NCT00942604|54596571|FG001|Overall Study|Adverse Event|1|||
27940294|NCT00942604|54596570|FG000|Overall Study|Withdrawal by Subject|0|||
27940295|NCT00942604|54596571|FG001|Overall Study|Withdrawal by Subject|1|||
28064945|NCT00481247|54720581|FG001|Overall Study|Did not receive treatment|2|||
28064946|NCT00480857|54720587|FG000|Overall Study|Lack of Efficacy|2|||
28064947|NCT00480779|54720593|FG000|Overall Study|Other|2|||
28064948|NCT00480779|54720594|FG001|Overall Study|Other|0|||
28064949|NCT00480779|54720593|FG000|Overall Study|Job and Health-related|0|||
28064950|NCT00480779|54720594|FG001|Overall Study|Job and Health-related|3|||
28064951|NCT00499031|54720600|FG000|Overall Study|Improper pre-protocol treatment|1|||
28064952|NCT00499031|54720600|FG000|Overall Study|Required test not done|1|||
28064953|NCT00499031|54720600|FG000|Overall Study|Never treated|1|||
28064954|NCT00498797|54720606|FG000|Overall Study|Withdrawal by Subject|4|||
28064955|NCT00498797|54720607|FG001|Overall Study|Withdrawal by Subject|2|||
28064956|NCT00498797|54720606|FG000|Overall Study|Adverse Event|12|||
28064957|NCT00498797|54720607|FG001|Overall Study|Adverse Event|5|||
28064958|NCT00498797|54720606|FG000|Overall Study|Condition under investigation worsened|19|||
28064959|NCT00498797|54720607|FG001|Overall Study|Condition under investigation worsened|21|||
28113776|NCT02431702|54771941|FG003|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5|||
28113777|NCT02431702|54771942|FG004|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
28113778|NCT02431702|54771943|FG005|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
28113779|NCT02431702|54771944|FG006|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
28113780|NCT02431702|54771938|FG000|Part 3: 9 Month of Additional Treatment|Other|0|||
28113781|NCT02431702|54771939|FG001|Part 3: 9 Month of Additional Treatment|Other|0|||
28113782|NCT02431702|54771940|FG002|Part 3: 9 Month of Additional Treatment|Other|0|||
28113783|NCT02431702|54771941|FG003|Part 3: 9 Month of Additional Treatment|Other|1|||
28113784|NCT02431702|54771942|FG004|Part 3: 9 Month of Additional Treatment|Other|1|||
28113785|NCT02431702|54771943|FG005|Part 3: 9 Month of Additional Treatment|Other|6|||
28113786|NCT02431702|54771944|FG006|Part 3: 9 Month of Additional Treatment|Other|0|||
28113787|NCT02086552|54771977|FG000|Overall Study|Withdrawal by Subject|1|||
28113788|NCT03131570|54772022|FG000|Overall Study|Adverse Event|1|||
28113789|NCT03131570|54772023|FG001|Overall Study|Adverse Event|0|||
28113790|NCT02930018|54772033|FG000|Overall Study|Lost to Follow-up|1|||
28113791|NCT02930018|54772034|FG001|Overall Study|Lost to Follow-up|1|||
28113792|NCT02930018|54772033|FG000|Overall Study|Withdrawal by Subject|5|||
28113793|NCT02930018|54772034|FG001|Overall Study|Withdrawal by Subject|2|||
28113794|NCT02875028|54772042|FG000|Washout Period|Withdrawal by Subject|0|||
28113795|NCT02875028|54772043|FG001|Washout Period|Withdrawal by Subject|1|||
28113796|NCT00943618|54772054|FG000|Overall Study|Lost to Follow-up|38|||
28113797|NCT00943618|54772055|FG001|Overall Study|Lost to Follow-up|48|||
28113798|NCT00943618|54772056|FG002|Overall Study|Lost to Follow-up|20|||
28113799|NCT00943618|54772054|FG000|Overall Study|Discontinued Medication|17|||
28113800|NCT00943618|54772055|FG001|Overall Study|Discontinued Medication|29|||
28113801|NCT00943618|54772056|FG002|Overall Study|Discontinued Medication|11|||
28113802|NCT02710084|54772079|FG000|First Phase - 12 Weeks|Withdrawal by Subject|3|||
28113803|NCT02710084|54772080|FG001|First Phase - 12 Weeks|Withdrawal by Subject|1|||
28113804|NCT02849990|54772087|FG000|Overall Study|Adverse Event|1|||
28113805|NCT02849990|54772087|FG000|Overall Study|Withdrawal by Subject|1|||
28113806|NCT02017964|54772091|FG000|Overall Study|Patient deemed ineligible|1|||
28113807|NCT01956110|54772097|FG000|Overall Study|Protocol Violation|25|||
28113808|NCT01956110|54772098|FG001|Overall Study|Protocol Violation|11|||
28113809|NCT01956110|54772097|FG000|Overall Study|Adverse Event|9|||
28064960|NCT00498797|54720606|FG000|Overall Study|Other|3|||
28064961|NCT00498797|54720607|FG001|Overall Study|Other|1|||
28064962|NCT00498485|54720615|FG000|Overall Study|Adverse Event|1|||
28113810|NCT01956110|54772098|FG001|Overall Study|Adverse Event|10|||
28064963|NCT00498485|54720616|FG001|Overall Study|Adverse Event|5|||
28064964|NCT00480077|54720626|FG000|Overall Study|Death|19|||
28064965|NCT00480077|54720627|FG001|Overall Study|Death|15|||
28064966|NCT00480077|54720626|FG000|Overall Study|early exit|12|||
28064967|NCT00480077|54720627|FG001|Overall Study|early exit|11|||
28064968|NCT00498173|54720635|FG000|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|2|||
28113811|NCT01956110|54772097|FG000|Overall Study|Personal reasons|1|||
28113812|NCT01956110|54772098|FG001|Overall Study|Personal reasons|1|||
28113813|NCT03116828|54772129|FG000|Overall Study|Adverse Event|1|||
28113814|NCT03116828|54772130|FG001|Overall Study|Adverse Event|10|||
28113815|NCT03116828|54772129|FG000|Overall Study|Withdrawal by Subject|4|||
28113816|NCT03116828|54772130|FG001|Overall Study|Withdrawal by Subject|8|||
28113817|NCT03116828|54772129|FG000|Overall Study|OTHER|3|||
28113818|NCT03116828|54772130|FG001|Overall Study|OTHER|3|||
28113819|NCT03938272|54772138|FG000|Overall Study|Withdrawal by Subject|1|||
28113820|NCT03938272|54772139|FG001|Overall Study|Withdrawal by Subject|0|||
28113821|NCT03938272|54772138|FG000|Overall Study|Physician Decision|0|||
28113822|NCT03938272|54772139|FG001|Overall Study|Physician Decision|2|||
28113823|NCT03938272|54772138|FG000|Overall Study|Study termination by sponsor|10|||
28113824|NCT03938272|54772139|FG001|Overall Study|Study termination by sponsor|8|||
28113825|NCT02565914|54772145|FG000|Overall Study|Adverse Event|17|||
28113826|NCT02565914|54772145|FG000|Overall Study|Withdrawal of consent (not due to AE)|25|||
28113827|NCT02565914|54772145|FG000|Overall Study|Lost to Follow-up|12|||
28113828|NCT02565914|54772145|FG000|Overall Study|Death (not treatment emergent)|1|||
28113829|NCT02565914|54772145|FG000|Overall Study|Other noncompliance|6|||
28113830|NCT02565914|54772145|FG000|Overall Study|Physician Decision|6|||
28113831|NCT02565914|54772145|FG000|Overall Study|Parent study termination by sponsor|1|||
28113832|NCT02565914|54772145|FG000|Overall Study|Commercial drug available|5|||
28113833|NCT02565914|54772145|FG000|Overall Study|Other|18|||
28113834|NCT02565914|54772145|FG000|Overall Study|Enrolled, but did not receive study drug|2|||
28113835|NCT03126344|54772169|FG000|Overall Study|Lost to Follow-up|0|||
28113836|NCT03126344|54772170|FG001|Overall Study|Lost to Follow-up|0|||
28113837|NCT03126344|54772171|FG002|Overall Study|Lost to Follow-up|5|||
28113838|NCT03115112|54772192|FG000|Overall Study|Adverse Event|5|||
28113839|NCT03115112|54772193|FG001|Overall Study|Adverse Event|1|||
28113840|NCT03115112|54772192|FG000|Overall Study|Withdrawal by Subject|4|||
28113841|NCT03115112|54772193|FG001|Overall Study|Withdrawal by Subject|2|||
28113842|NCT03115112|54772192|FG000|Overall Study|Lost to Follow-up|0|||
28113843|NCT03115112|54772193|FG001|Overall Study|Lost to Follow-up|1|||
28113844|NCT03115112|54772192|FG000|Overall Study|Death|1|||
28113845|NCT03115112|54772193|FG001|Overall Study|Death|0|||
28113846|NCT03115112|54772192|FG000|Overall Study|Pregnancy|1|||
28113847|NCT03115112|54772193|FG001|Overall Study|Pregnancy|0|||
28113848|NCT03115112|54772192|FG000|Overall Study|Site closure|1|||
28113849|NCT03115112|54772193|FG001|Overall Study|Site closure|1|||
28113850|NCT03556358|54772212|FG000|Overall Study|Subjects Randomized that did not Treat|3|||
28113851|NCT03556358|54772213|FG001|Overall Study|Subjects Randomized that did not Treat|0|||
28113852|NCT03556358|54772212|FG000|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|7|||
28113853|NCT03556358|54772213|FG001|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|5|||
28113854|NCT03556358|54772212|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|0|||
28113855|NCT03556358|54772213|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|1|||
28113856|NCT03556358|54772212|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Death|0|||
28113857|NCT03556358|54772213|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Death|1|||
28113858|NCT03556358|54772212|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|0|||
28113859|NCT03556358|54772213|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|2|||
28113860|NCT03556358|54772212|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|0|||
28113861|NCT03556358|54772213|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|1|||
28113862|NCT03556358|54772212|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|1|||
28113863|NCT03556358|54772213|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|2|||
28113864|NCT03228680|54772221|FG000|Overall Study|Adverse Event|13|||
28113865|NCT03228680|54772222|FG001|Overall Study|Adverse Event|18|||
28113866|NCT03228680|54772221|FG000|Overall Study|Randomization failure|0|||
28113867|NCT03228680|54772222|FG001|Overall Study|Randomization failure|1|||
28113868|NCT03228680|54772221|FG000|Overall Study|Withdrawal by Subject|1|||
28113869|NCT03228680|54772222|FG001|Overall Study|Withdrawal by Subject|0|||
28113870|NCT03228680|54772221|FG000|Overall Study|Other|9|||
28113871|NCT03228680|54772222|FG001|Overall Study|Other|16|||
28113872|NCT04490018|54772237|FG000|Overall Study|Protocol Violation|0|||
28113873|NCT04490018|54772238|FG001|Overall Study|Protocol Violation|2|||
28113874|NCT04490018|54772239|FG002|Overall Study|Protocol Violation|1|||
28113875|NCT04490018|54772237|FG000|Overall Study|Lost to Follow-up|2|||
28113876|NCT04490018|54772238|FG001|Overall Study|Lost to Follow-up|2|||
28113877|NCT04490018|54772239|FG002|Overall Study|Lost to Follow-up|0|||
28113878|NCT04490018|54772237|FG000|Overall Study|Withdrawal by Subject|2|||
28113879|NCT04490018|54772238|FG001|Overall Study|Withdrawal by Subject|1|||
28113880|NCT04490018|54772239|FG002|Overall Study|Withdrawal by Subject|0|||
28113881|NCT04490018|54772237|FG000|Overall Study|Withdrawal by parent/guardian|2|||
28113882|NCT04490018|54772238|FG001|Overall Study|Withdrawal by parent/guardian|3|||
28113883|NCT04490018|54772239|FG002|Overall Study|Withdrawal by parent/guardian|0|||
28113884|NCT03118934|54772265|FG000|Overall Study|Adverse Event|0|||
28113885|NCT03118934|54772266|FG001|Overall Study|Adverse Event|0|||
28113886|NCT03118934|54772267|FG002|Overall Study|Adverse Event|0|||
28113887|NCT03118934|54772268|FG003|Overall Study|Adverse Event|0|||
28113888|NCT03118934|54772269|FG004|Overall Study|Adverse Event|0|||
28113889|NCT03118934|54772270|FG005|Overall Study|Adverse Event|1|||
28113890|NCT03118934|54772265|FG000|Overall Study|Physician Decision|0|||
28113891|NCT03118934|54772266|FG001|Overall Study|Physician Decision|0|||
28113892|NCT03118934|54772267|FG002|Overall Study|Physician Decision|0|||
28113893|NCT03118934|54772268|FG003|Overall Study|Physician Decision|0|||
28113894|NCT03118934|54772269|FG004|Overall Study|Physician Decision|0|||
28113895|NCT03118934|54772270|FG005|Overall Study|Physician Decision|1|||
28113896|NCT03118934|54772265|FG000|Overall Study|Discontinued prior to exposure|0|||
28113897|NCT03118934|54772266|FG001|Overall Study|Discontinued prior to exposure|1|||
28113898|NCT03118934|54772267|FG002|Overall Study|Discontinued prior to exposure|1|||
28113899|NCT03118934|54772268|FG003|Overall Study|Discontinued prior to exposure|1|||
28113900|NCT03118934|54772269|FG004|Overall Study|Discontinued prior to exposure|2|||
28113901|NCT03118934|54772270|FG005|Overall Study|Discontinued prior to exposure|0|||
28113902|NCT03114488|54772280|FG000|Time Period 2|Withdrawal by Subject|1|||
28113903|NCT03114488|54772281|FG001|Time Period 2|Withdrawal by Subject|3|||
28113904|NCT03135262|54772300|FG000|Overall Study|discontinued due to worsening of pre-existing medical condition|1|||
28113905|NCT03135262|54772301|FG001|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
28113906|NCT03135262|54772302|FG002|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
28113907|NCT03135262|54772303|FG003|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
28113908|NCT03135262|54772304|FG004|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
28113909|NCT03135262|54772300|FG000|Overall Study|Progression of disease|0|||
28113910|NCT03135262|54772301|FG001|Overall Study|Progression of disease|0|||
28113911|NCT03135262|54772302|FG002|Overall Study|Progression of disease|0|||
28113912|NCT03135262|54772303|FG003|Overall Study|Progression of disease|1|||
28113913|NCT03135262|54772304|FG004|Overall Study|Progression of disease|0|||
28113914|NCT03135262|54772300|FG000|Overall Study|Death|6|||
28113915|NCT03135262|54772301|FG001|Overall Study|Death|2|||
28113916|NCT03135262|54772302|FG002|Overall Study|Death|2|||
28113917|NCT03135262|54772303|FG003|Overall Study|Death|2|||
28113918|NCT03135262|54772304|FG004|Overall Study|Death|0|||
28113919|NCT03135262|54772300|FG000|Overall Study|Withdrawal by Subject|0|||
28113920|NCT03135262|54772301|FG001|Overall Study|Withdrawal by Subject|0|||
28113921|NCT03135262|54772302|FG002|Overall Study|Withdrawal by Subject|1|||
28113922|NCT03135262|54772303|FG003|Overall Study|Withdrawal by Subject|0|||
28113923|NCT03135262|54772304|FG004|Overall Study|Withdrawal by Subject|1|||
28113924|NCT03135262|54772300|FG000|Overall Study|Study terminated by sponsor|2|||
28113925|NCT03135262|54772301|FG001|Overall Study|Study terminated by sponsor|4|||
28113926|NCT03135262|54772302|FG002|Overall Study|Study terminated by sponsor|4|||
28113927|NCT03135262|54772303|FG003|Overall Study|Study terminated by sponsor|3|||
28113928|NCT03135262|54772304|FG004|Overall Study|Study terminated by sponsor|0|||
28113929|NCT03535194|54772339|FG000|Induction Period|Adverse Event|2|||
28113930|NCT03535194|54772340|FG001|Induction Period|Adverse Event|2|||
28113931|NCT03535194|54772341|FG002|Induction Period|Adverse Event|1|||
28113932|NCT03535194|54772342|FG003|Induction Period|Adverse Event|3|||
28113933|NCT03535194|54772343|FG004|Induction Period|Adverse Event|0|||
28113934|NCT03535194|54772339|FG000|Induction Period|Death|0|||
28113935|NCT03535194|54772340|FG001|Induction Period|Death|1|||
28113936|NCT03535194|54772341|FG002|Induction Period|Death|0|||
28113937|NCT03535194|54772342|FG003|Induction Period|Death|0|||
28113938|NCT03535194|54772343|FG004|Induction Period|Death|0|||
27816366|NCT01898923|54273272|FG000|Overall Study|Physician Decision|3|||
28113939|NCT03535194|54772339|FG000|Induction Period|Lack of Efficacy|1|||
27816367|NCT01898923|54273273|FG001|Overall Study|Physician Decision|4|||
27816368|NCT01898923|54273272|FG000|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|1|||
28113940|NCT03535194|54772340|FG001|Induction Period|Lack of Efficacy|3|||
28113941|NCT03535194|54772341|FG002|Induction Period|Lack of Efficacy|2|||
28113942|NCT03535194|54772342|FG003|Induction Period|Lack of Efficacy|2|||
28113943|NCT03535194|54772343|FG004|Induction Period|Lack of Efficacy|0|||
28113944|NCT03535194|54772339|FG000|Induction Period|Lost to Follow-up|3|||
28113945|NCT03535194|54772340|FG001|Induction Period|Lost to Follow-up|5|||
28113946|NCT03535194|54772341|FG002|Induction Period|Lost to Follow-up|2|||
28113947|NCT03535194|54772342|FG003|Induction Period|Lost to Follow-up|3|||
28113948|NCT03535194|54772343|FG004|Induction Period|Lost to Follow-up|0|||
28113949|NCT03535194|54772339|FG000|Induction Period|Physician Decision|1|||
28113950|NCT03535194|54772340|FG001|Induction Period|Physician Decision|1|||
28113951|NCT03535194|54772341|FG002|Induction Period|Physician Decision|0|||
28113952|NCT03535194|54772342|FG003|Induction Period|Physician Decision|0|||
28113953|NCT03535194|54772343|FG004|Induction Period|Physician Decision|0|||
28113954|NCT03535194|54772339|FG000|Induction Period|Protocol Violation|1|||
28113955|NCT03535194|54772340|FG001|Induction Period|Protocol Violation|0|||
28113956|NCT03535194|54772341|FG002|Induction Period|Protocol Violation|0|||
28113957|NCT03535194|54772342|FG003|Induction Period|Protocol Violation|1|||
28113958|NCT03535194|54772343|FG004|Induction Period|Protocol Violation|0|||
28113959|NCT03535194|54772339|FG000|Induction Period|Screen Failure|0|||
28113960|NCT03535194|54772340|FG001|Induction Period|Screen Failure|1|||
28113961|NCT03535194|54772341|FG002|Induction Period|Screen Failure|0|||
28113962|NCT03535194|54772342|FG003|Induction Period|Screen Failure|0|||
28113963|NCT03535194|54772343|FG004|Induction Period|Screen Failure|0|||
28113964|NCT03535194|54772339|FG000|Induction Period|Withdrawal by Subject|3|||
28113965|NCT03535194|54772340|FG001|Induction Period|Withdrawal by Subject|4|||
28113966|NCT03535194|54772341|FG002|Induction Period|Withdrawal by Subject|3|||
28113967|NCT03535194|54772342|FG003|Induction Period|Withdrawal by Subject|2|||
28113968|NCT03535194|54772343|FG004|Induction Period|Withdrawal by Subject|0|||
28113969|NCT03535194|54772339|FG000|Maintenance Period|Adverse Event|6|||
28113970|NCT03535194|54772340|FG001|Maintenance Period|Adverse Event|5|||
28113971|NCT03535194|54772341|FG002|Maintenance Period|Adverse Event|1|||
28113972|NCT03535194|54772342|FG003|Maintenance Period|Adverse Event|11|||
28113973|NCT03535194|54772343|FG004|Maintenance Period|Adverse Event|4|||
28113974|NCT03535194|54772339|FG000|Maintenance Period|Lack of Efficacy|3|||
28113975|NCT03535194|54772340|FG001|Maintenance Period|Lack of Efficacy|2|||
28113976|NCT03535194|54772341|FG002|Maintenance Period|Lack of Efficacy|5|||
28113977|NCT03535194|54772342|FG003|Maintenance Period|Lack of Efficacy|9|||
28113978|NCT03535194|54772343|FG004|Maintenance Period|Lack of Efficacy|0|||
28113979|NCT03535194|54772339|FG000|Maintenance Period|Lost to Follow-up|4|||
28113980|NCT03535194|54772340|FG001|Maintenance Period|Lost to Follow-up|2|||
28113981|NCT03535194|54772341|FG002|Maintenance Period|Lost to Follow-up|1|||
28113982|NCT03535194|54772342|FG003|Maintenance Period|Lost to Follow-up|5|||
28113983|NCT03535194|54772343|FG004|Maintenance Period|Lost to Follow-up|2|||
28113984|NCT03535194|54772339|FG000|Maintenance Period|Other|1|||
28113985|NCT03535194|54772340|FG001|Maintenance Period|Other|2|||
28113986|NCT03535194|54772341|FG002|Maintenance Period|Other|0|||
28113987|NCT03535194|54772342|FG003|Maintenance Period|Other|0|||
28113988|NCT03535194|54772343|FG004|Maintenance Period|Other|0|||
28113989|NCT03535194|54772339|FG000|Maintenance Period|Physician Decision|1|||
28113990|NCT03535194|54772340|FG001|Maintenance Period|Physician Decision|2|||
28113991|NCT03535194|54772341|FG002|Maintenance Period|Physician Decision|0|||
28113992|NCT03535194|54772342|FG003|Maintenance Period|Physician Decision|2|||
28113993|NCT03535194|54772343|FG004|Maintenance Period|Physician Decision|0|||
28113994|NCT03535194|54772339|FG000|Maintenance Period|Pregnancy|0|||
28113995|NCT03535194|54772340|FG001|Maintenance Period|Pregnancy|0|||
28113996|NCT03535194|54772341|FG002|Maintenance Period|Pregnancy|0|||
28113997|NCT03535194|54772342|FG003|Maintenance Period|Pregnancy|2|||
28113998|NCT03535194|54772343|FG004|Maintenance Period|Pregnancy|0|||
28113999|NCT03535194|54772339|FG000|Maintenance Period|Protocol Violation|0|||
28114000|NCT03535194|54772340|FG001|Maintenance Period|Protocol Violation|1|||
28114001|NCT03535194|54772341|FG002|Maintenance Period|Protocol Violation|0|||
28114002|NCT03535194|54772342|FG003|Maintenance Period|Protocol Violation|0|||
28114003|NCT03535194|54772343|FG004|Maintenance Period|Protocol Violation|0|||
28114004|NCT03535194|54772339|FG000|Maintenance Period|Withdrawal by Subject|7|||
28114005|NCT03535194|54772340|FG001|Maintenance Period|Withdrawal by Subject|2|||
28114006|NCT03535194|54772341|FG002|Maintenance Period|Withdrawal by Subject|1|||
28114007|NCT03535194|54772342|FG003|Maintenance Period|Withdrawal by Subject|8|||
28114008|NCT03535194|54772343|FG004|Maintenance Period|Withdrawal by Subject|0|||
28114009|NCT03535194|54772339|FG000|Post-Treatment Followup Period|Adverse Event|4|||
28114010|NCT03535194|54772340|FG001|Post-Treatment Followup Period|Adverse Event|5|||
28114011|NCT03535194|54772341|FG002|Post-Treatment Followup Period|Adverse Event|1|||
28114012|NCT03535194|54772342|FG003|Post-Treatment Followup Period|Adverse Event|8|||
28114013|NCT03535194|54772343|FG004|Post-Treatment Followup Period|Adverse Event|0|||
28114014|NCT03535194|54772339|FG000|Post-Treatment Followup Period|Lack of Efficacy|3|||
28114015|NCT03535194|54772340|FG001|Post-Treatment Followup Period|Lack of Efficacy|4|||
28114016|NCT03535194|54772341|FG002|Post-Treatment Followup Period|Lack of Efficacy|5|||
28114017|NCT03535194|54772342|FG003|Post-Treatment Followup Period|Lack of Efficacy|4|||
28114018|NCT03535194|54772343|FG004|Post-Treatment Followup Period|Lack of Efficacy|0|||
28114019|NCT03535194|54772339|FG000|Post-Treatment Followup Period|Lost to Follow-up|1|||
28114020|NCT03535194|54772340|FG001|Post-Treatment Followup Period|Lost to Follow-up|1|||
28114021|NCT03535194|54772341|FG002|Post-Treatment Followup Period|Lost to Follow-up|1|||
28114022|NCT03535194|54772342|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
28114023|NCT03535194|54772343|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
28114024|NCT03535194|54772339|FG000|Post-Treatment Followup Period|Other|1|||
28114025|NCT03535194|54772340|FG001|Post-Treatment Followup Period|Other|0|||
28114026|NCT03535194|54772341|FG002|Post-Treatment Followup Period|Other|0|||
28114027|NCT03535194|54772342|FG003|Post-Treatment Followup Period|Other|5|||
28114028|NCT03535194|54772343|FG004|Post-Treatment Followup Period|Other|0|||
28114029|NCT03535194|54772339|FG000|Post-Treatment Followup Period|Physician Decision|0|||
28114030|NCT03535194|54772340|FG001|Post-Treatment Followup Period|Physician Decision|2|||
28114031|NCT03535194|54772341|FG002|Post-Treatment Followup Period|Physician Decision|1|||
28114032|NCT03535194|54772342|FG003|Post-Treatment Followup Period|Physician Decision|1|||
28114033|NCT03535194|54772343|FG004|Post-Treatment Followup Period|Physician Decision|0|||
28114034|NCT03535194|54772339|FG000|Post-Treatment Followup Period|Withdrawal by Subject|2|||
28114035|NCT03535194|54772340|FG001|Post-Treatment Followup Period|Withdrawal by Subject|2|||
28114036|NCT03535194|54772341|FG002|Post-Treatment Followup Period|Withdrawal by Subject|3|||
28114037|NCT03535194|54772342|FG003|Post-Treatment Followup Period|Withdrawal by Subject|6|||
28114038|NCT03535194|54772343|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
28114039|NCT03559530|54772367|FG000|Overall Study|non-location of medical records|44|||
28114040|NCT03559530|54772368|FG001|Overall Study|non-location of medical records|0|||
28114041|NCT03559530|54772367|FG000|Overall Study|culture results not considered for treat|29|||
28114042|NCT03559530|54772368|FG001|Overall Study|culture results not considered for treat|0|||
28114043|NCT03559530|54772367|FG000|Overall Study|duplicate cases|8|||
27816369|NCT01898923|54273273|FG001|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|2|||
27816370|NCT01924429|54273281|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|3|||
27816371|NCT01924429|54273282|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
27816372|NCT01898299|54273292|FG000|Post Treatment (One Month)|Lost to Follow-up|3|||
27816373|NCT01898299|54273293|FG001|Post Treatment (One Month)|Lost to Follow-up|4|||
27816374|NCT01886287|54273299|FG000|Overall Study|Radiographic disease progression|1|||
27816375|NCT01886287|54273299|FG000|Overall Study|Clinical progression due to disease|1|||
27816376|NCT01885195|54273303|FG000|Overall Study|Adverse Event|29|||
27816377|NCT01885195|54273303|FG000|Overall Study|Death|1|||
27816378|NCT01885195|54273303|FG000|Overall Study|Disease Progression|67|||
27816379|NCT01885195|54273303|FG000|Overall Study|Protocol Deviation|2|||
27816380|NCT01885195|54273303|FG000|Overall Study|Physician Decision|3|||
27816381|NCT01885195|54273303|FG000|Overall Study|Patient/guardian decision|8|||
27816382|NCT01896895|54273310|FG000|Double-blind MP|Physician Decision|0|||
27816383|NCT01896895|54273311|FG001|Double-blind MP|Physician Decision|0|||
27816384|NCT01896895|54273312|FG002|Double-blind MP|Physician Decision|1|||
27816385|NCT01896895|54273313|FG003|Double-blind MP|Physician Decision|0|||
27816386|NCT01896895|54273310|FG000|Double-blind MP|Withdrawal by Subject|0|||
27816387|NCT01896895|54273311|FG001|Double-blind MP|Withdrawal by Subject|2|||
27816388|NCT01896895|54273312|FG002|Double-blind MP|Withdrawal by Subject|1|||
27816389|NCT01896895|54273313|FG003|Double-blind MP|Withdrawal by Subject|0|||
27816390|NCT01896895|54273310|FG000|Double-blind MP|Lost to Follow-up|1|||
27816391|NCT01896895|54273311|FG001|Double-blind MP|Lost to Follow-up|0|||
27816392|NCT01896895|54273312|FG002|Double-blind MP|Lost to Follow-up|1|||
27816393|NCT01896895|54273313|FG003|Double-blind MP|Lost to Follow-up|0|||
27940296|NCT00942604|54596570|FG000|Overall Study|Patient relocation|1|||
27816394|NCT01923181|54273356|FG000|Overall Study|Protocol Violation|2|||
27816395|NCT01923181|54273357|FG001|Overall Study|Protocol Violation|2|||
27816396|NCT01923181|54273358|FG002|Overall Study|Protocol Violation|0|||
27816397|NCT01923181|54273359|FG003|Overall Study|Protocol Violation|2|||
27816398|NCT01923181|54273360|FG004|Overall Study|Protocol Violation|2|||
28114044|NCT03559530|54772368|FG001|Overall Study|duplicate cases|0|||
28114045|NCT03559530|54772367|FG000|Overall Study|other species of Acinetobacte|7|||
27816399|NCT01923181|54273361|FG005|Overall Study|Protocol Violation|1|||
27816400|NCT01923181|54273362|FG006|Overall Study|Protocol Violation|1|||
27816401|NCT01923181|54273363|FG007|Overall Study|Protocol Violation|2|||
27816402|NCT01923181|54273364|FG008|Overall Study|Protocol Violation|1|||
27816403|NCT01923181|54273356|FG000|Overall Study|Withdrawal by Subject|0|||
28114046|NCT03559530|54772368|FG001|Overall Study|other species of Acinetobacte|0|||
28114047|NCT03559530|54772367|FG000|Overall Study|contamination / colonization|3|||
28114048|NCT03559530|54772368|FG001|Overall Study|contamination / colonization|0|||
28114049|NCT03124784|54772396|FG000|Overall Study|Adverse Event|1|||
28114050|NCT03124784|54772396|FG000|Overall Study|Computer/Equip Malfunction|1|||
28114051|NCT03531840|54772404|FG000|Overall Study|Death on study|3|||
28114052|NCT03531840|54772405|FG001|Overall Study|Death on study|2|||
28114053|NCT03531840|54772406|FG002|Overall Study|Death on study|1|||
28114054|NCT03531840|54772407|FG003|Overall Study|Death on study|2|||
28114055|NCT03531840|54772404|FG000|Overall Study|Death during follow up|2|||
28114056|NCT03531840|54772405|FG001|Overall Study|Death during follow up|3|||
28114057|NCT03531840|54772406|FG002|Overall Study|Death during follow up|4|||
28114058|NCT03531840|54772407|FG003|Overall Study|Death during follow up|1|||
28114059|NCT03110900|54772424|FG000|Overall Study|Sponsor withdrew|1|||
28114060|NCT03110900|54772425|FG001|Overall Study|Sponsor withdrew|1|||
28114061|NCT03867734|54772431|FG000|Overall Study|Lost to Follow-up|2|||
28114062|NCT03446456|54772441|FG000|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
28114063|NCT03446456|54772442|FG001|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
28114064|NCT03446456|54772441|FG000|Overall Study|Lost to Follow-up|1|||
28114065|NCT03446456|54772442|FG001|Overall Study|Lost to Follow-up|3|||
28114066|NCT03446456|54772441|FG000|Overall Study|Participant failed the toxicology test|1|||
28114067|NCT03446456|54772442|FG001|Overall Study|Participant failed the toxicology test|0|||
28114068|NCT03446456|54772441|FG000|Overall Study|Break down of the experimental equipment|1|||
28114069|NCT03446456|54772442|FG001|Overall Study|Break down of the experimental equipment|0|||
28114070|NCT03495102|54772451|FG000|Overall Study|Adverse Event|5|||
27940297|NCT00942604|54596571|FG001|Overall Study|Patient relocation|1|||
27940298|NCT01188564|54596579|FG000|Double-blind Phase|randomized not treated|1|||
27940299|NCT01188564|54596580|FG001|Double-blind Phase|randomized not treated|0|||
27940300|NCT01187550|54596588|FG000|Overall Study|Protocol Violation|3|||
27940301|NCT01187550|54596589|FG001|Overall Study|Protocol Violation|1|||
27816404|NCT01923181|54273357|FG001|Overall Study|Withdrawal by Subject|1|||
27816405|NCT01923181|54273358|FG002|Overall Study|Withdrawal by Subject|0|||
27940302|NCT01187550|54596588|FG000|Overall Study|Other|3|||
27940303|NCT01187550|54596589|FG001|Overall Study|Other|0|||
27940304|NCT01187550|54596588|FG000|Overall Study|Randomized but not treated|8|||
27940305|NCT01187550|54596589|FG001|Overall Study|Randomized but not treated|0|||
27940306|NCT01186770|54596599|FG000|Overall Study|Ineligibility|0|||
27940307|NCT01186770|54596600|FG001|Overall Study|Ineligibility|0|||
27940308|NCT01186770|54596601|FG002|Overall Study|Ineligibility|2|||
27940309|NCT01186770|54596602|FG003|Overall Study|Ineligibility|0|||
27940310|NCT01186770|54596599|FG000|Overall Study|Protocol Violation|7|||
28114071|NCT03495102|54772452|FG001|Overall Study|Adverse Event|7|||
28114072|NCT03495102|54772453|FG002|Overall Study|Adverse Event|10|||
28114073|NCT03495102|54772451|FG000|Overall Study|Death|3|||
28114074|NCT03495102|54772452|FG001|Overall Study|Death|4|||
28114075|NCT03495102|54772453|FG002|Overall Study|Death|4|||
28114076|NCT03495102|54772451|FG000|Overall Study|Lost to Follow-up|15|||
28114077|NCT03495102|54772452|FG001|Overall Study|Lost to Follow-up|16|||
28114078|NCT03495102|54772453|FG002|Overall Study|Lost to Follow-up|17|||
28114079|NCT03495102|54772451|FG000|Overall Study|Physician Decision|2|||
28114080|NCT03495102|54772452|FG001|Overall Study|Physician Decision|0|||
28114081|NCT03495102|54772453|FG002|Overall Study|Physician Decision|2|||
28114082|NCT03495102|54772451|FG000|Overall Study|Withdrawal by Subject|25|||
28114083|NCT03495102|54772452|FG001|Overall Study|Withdrawal by Subject|36|||
28114084|NCT03495102|54772453|FG002|Overall Study|Withdrawal by Subject|18|||
28114085|NCT03495102|54772451|FG000|Overall Study|Protocol Violation|1|||
28114086|NCT03495102|54772452|FG001|Overall Study|Protocol Violation|1|||
28114087|NCT03495102|54772453|FG002|Overall Study|Protocol Violation|0|||
28114088|NCT03495102|54772451|FG000|Overall Study|Site Closure|3|||
27816406|NCT01923181|54273359|FG003|Overall Study|Withdrawal by Subject|1|||
27816407|NCT01923181|54273360|FG004|Overall Study|Withdrawal by Subject|4|||
27816408|NCT01923181|54273361|FG005|Overall Study|Withdrawal by Subject|2|||
27940311|NCT01186770|54596600|FG001|Overall Study|Protocol Violation|9|||
28114089|NCT03495102|54772452|FG001|Overall Study|Site Closure|1|||
28114090|NCT03495102|54772453|FG002|Overall Study|Site Closure|2|||
28114091|NCT03495102|54772451|FG000|Overall Study|Non-compliance|1|||
28114092|NCT03495102|54772452|FG001|Overall Study|Non-compliance|0|||
28114093|NCT03495102|54772453|FG002|Overall Study|Non-compliance|0|||
28114094|NCT03495102|54772451|FG000|Overall Study|Participant Duplicated at Another Site|0|||
28114095|NCT03495102|54772452|FG001|Overall Study|Participant Duplicated at Another Site|0|||
28114096|NCT03495102|54772453|FG002|Overall Study|Participant Duplicated at Another Site|1|||
28114097|NCT03495102|54772451|FG000|Overall Study|Primary Care Physician Recommendation|0|||
28114098|NCT03495102|54772452|FG001|Overall Study|Primary Care Physician Recommendation|1|||
28114099|NCT03495102|54772453|FG002|Overall Study|Primary Care Physician Recommendation|0|||
28114100|NCT03495102|54772451|FG000|Overall Study|Relocated to Another Country|0|||
27816409|NCT01923181|54273362|FG006|Overall Study|Withdrawal by Subject|4|||
27816410|NCT01923181|54273363|FG007|Overall Study|Withdrawal by Subject|3|||
27816411|NCT01923181|54273364|FG008|Overall Study|Withdrawal by Subject|1|||
27816412|NCT01923181|54273356|FG000|Overall Study|Other|1|||
27816413|NCT01923181|54273357|FG001|Overall Study|Other|0|||
27816414|NCT01923181|54273358|FG002|Overall Study|Other|0|||
27816415|NCT01923181|54273359|FG003|Overall Study|Other|1|||
27816416|NCT01923181|54273360|FG004|Overall Study|Other|0|||
27816417|NCT01923181|54273361|FG005|Overall Study|Other|0|||
27816418|NCT01923181|54273362|FG006|Overall Study|Other|0|||
27816419|NCT01923181|54273363|FG007|Overall Study|Other|0|||
27816420|NCT01923181|54273364|FG008|Overall Study|Other|0|||
28114101|NCT03495102|54772452|FG001|Overall Study|Relocated to Another Country|1|||
28114102|NCT03495102|54772453|FG002|Overall Study|Relocated to Another Country|0|||
28114103|NCT03495102|54772451|FG000|Overall Study|Participant was in Rehabilitation|1|||
28114104|NCT03495102|54772452|FG001|Overall Study|Participant was in Rehabilitation|0|||
28114105|NCT03495102|54772453|FG002|Overall Study|Participant was in Rehabilitation|0|||
28114106|NCT03105362|54772461|FG000|Overall Study|Withdrawal by Subject|1|||
28114107|NCT03105362|54772461|FG000|Overall Study|Lost to Follow-up|1|||
28114108|NCT03559218|54772470|FG000|Overall Study|Withdrawal by Subject|1|||
28114109|NCT03559218|54772471|FG001|Overall Study|Withdrawal by Subject|0|||
28114110|NCT03104816|54772480|FG000|Overall Study|Lack of Efficacy|0|||
28114111|NCT03104816|54772481|FG001|Overall Study|Lack of Efficacy|2|||
28114112|NCT03104816|54772482|FG002|Overall Study|Lack of Efficacy|0|||
28114113|NCT03104816|54772480|FG000|Overall Study|Protocol Violation|2|||
27816421|NCT01923181|54273356|FG000|Overall Study|Lost to Follow-up|0|||
27816422|NCT01923181|54273357|FG001|Overall Study|Lost to Follow-up|3|||
27816423|NCT01923181|54273358|FG002|Overall Study|Lost to Follow-up|2|||
28114114|NCT03104816|54772481|FG001|Overall Study|Protocol Violation|0|||
28114115|NCT03104816|54772482|FG002|Overall Study|Protocol Violation|2|||
28114116|NCT03559062|54772493|FG000|Overall Study|Other|0|||
28114117|NCT03559062|54772494|FG001|Overall Study|Other|1|||
28114118|NCT03559062|54772495|FG002|Overall Study|Other|0|||
28114119|NCT00089791|54772506|FG000|Overall Study|Physician Decision|6|||
28114120|NCT00089791|54772507|FG001|Overall Study|Physician Decision|3|||
28114121|NCT00089791|54772506|FG000|Overall Study|Adverse Event|81|||
28114122|NCT00089791|54772507|FG001|Overall Study|Adverse Event|93|||
28114123|NCT00089791|54772506|FG000|Overall Study|Withdrawal by Subject|403|||
28114124|NCT00089791|54772507|FG001|Overall Study|Withdrawal by Subject|344|||
28114125|NCT00089791|54772506|FG000|Overall Study|Death|78|||
28114126|NCT00089791|54772507|FG001|Overall Study|Death|62|||
28114127|NCT00089791|54772506|FG000|Overall Study|Disease progression|7|||
28114128|NCT00089791|54772507|FG001|Overall Study|Disease progression|3|||
28114129|NCT00089791|54772506|FG000|Overall Study|Ineligibility determined|12|||
28114130|NCT00089791|54772507|FG001|Overall Study|Ineligibility determined|9|||
28114131|NCT00089791|54772506|FG000|Overall Study|Lost to Follow-up|57|||
28114132|NCT00089791|54772507|FG001|Overall Study|Lost to Follow-up|57|||
28114133|NCT00089791|54772506|FG000|Overall Study|Noncompliance|17|||
27816424|NCT01923181|54273359|FG003|Overall Study|Lost to Follow-up|1|||
27816425|NCT01923181|54273360|FG004|Overall Study|Lost to Follow-up|2|||
27940312|NCT01186770|54596601|FG002|Overall Study|Protocol Violation|12|||
27816426|NCT01923181|54273361|FG005|Overall Study|Lost to Follow-up|1|||
27816427|NCT01923181|54273362|FG006|Overall Study|Lost to Follow-up|3|||
27816428|NCT01923181|54273363|FG007|Overall Study|Lost to Follow-up|3|||
27816429|NCT01923181|54273364|FG008|Overall Study|Lost to Follow-up|1|||
27816430|NCT01896271|54273387|FG000|Overall Study|Physician Decision|10|||
27816431|NCT01884571|54273400|FG000|Overall Study|Adverse Event|1|||
27816432|NCT01884571|54273400|FG000|Overall Study|Death|2|||
27816433|NCT01884571|54273400|FG000|Overall Study|Withdrawal by Subject|2|||
27816434|NCT01884571|54273400|FG000|Overall Study|Disease progression|3|||
28114134|NCT00089791|54772507|FG001|Overall Study|Noncompliance|13|||
28114135|NCT00089791|54772506|FG000|Overall Study|Other|20|||
28114136|NCT00089791|54772507|FG001|Overall Study|Other|32|||
28114137|NCT00089791|54772506|FG000|Overall Study|Protocol deviation|12|||
27816435|NCT01884337|54273406|FG000|Treatment|Adverse Event|2|||
27816436|NCT01884337|54273407|FG001|Treatment|Adverse Event|2|||
27816437|NCT01884337|54273406|FG000|Treatment|Subj. request to discont. treatment|2|||
27816438|NCT01884337|54273407|FG001|Treatment|Subj. request to discont. treatment|0|||
27816439|NCT01884337|54273406|FG000|Follow-up Period|Lost to Follow-up|1|||
28114138|NCT00089791|54772507|FG001|Overall Study|Protocol deviation|10|||
28114139|NCT00089791|54772506|FG000|Overall Study|Requirement for alternative therapy|7|||
28114140|NCT00089791|54772507|FG001|Overall Study|Requirement for alternative therapy|4|||
28114141|NCT03558672|54772513|FG000|Overall Study|Study Early Termination|10|||
28114142|NCT03558516|54772519|FG000|Overall Study|Protocol Violation|2|||
28114143|NCT03558516|54772520|FG001|Overall Study|Protocol Violation|2|||
28114144|NCT03557970|54772528|FG000|Overall Study|Study closure|1|||
28114145|NCT03557970|54772529|FG001|Overall Study|Study closure|0|||
28114146|NCT03557970|54772528|FG000|Overall Study|Physician Decision|0|||
27816440|NCT01884337|54273407|FG001|Follow-up Period|Lost to Follow-up|1|||
27816441|NCT01922089|54273415|FG000|Overall Study|Adverse Event|18|||
27816442|NCT01922089|54273416|FG001|Overall Study|Adverse Event|13|||
27816443|NCT01922089|54273415|FG000|Overall Study|Protocol Deviation|10|||
28114147|NCT03557970|54772529|FG001|Overall Study|Physician Decision|1|||
28114148|NCT03557970|54772528|FG000|Overall Study|Death|0|||
28114149|NCT03557970|54772529|FG001|Overall Study|Death|1|||
28114150|NCT02815280|54772537|FG000|Double-Blind Phase|Adverse Event|1|||
28114151|NCT02815280|54772538|FG001|Double-Blind Phase|Adverse Event|1|||
28114152|NCT02815280|54772537|FG000|Double-Blind Phase|Lost to Follow-up|10|||
28114153|NCT02815280|54772538|FG001|Double-Blind Phase|Lost to Follow-up|9|||
28114154|NCT02815280|54772537|FG000|Double-Blind Phase|Withdrawal by Subject|20|||
28114155|NCT02815280|54772538|FG001|Double-Blind Phase|Withdrawal by Subject|11|||
28114156|NCT02815280|54772537|FG000|Double-Blind Phase|Protocol Violation|2|||
28114157|NCT02815280|54772538|FG001|Double-Blind Phase|Protocol Violation|2|||
28114158|NCT02815280|54772537|FG000|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3|||
28114159|NCT02815280|54772538|FG001|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2|||
28114160|NCT02815280|54772537|FG000|Open-Label Phase|Adverse Event|2|||
28114161|NCT02815280|54772538|FG001|Open-Label Phase|Adverse Event|3|||
28114162|NCT02815280|54772537|FG000|Open-Label Phase|Lost to Follow-up|18|||
28114163|NCT02815280|54772538|FG001|Open-Label Phase|Lost to Follow-up|9|||
28114164|NCT02815280|54772537|FG000|Open-Label Phase|Withdrawal by Subject|33|||
28114165|NCT02815280|54772538|FG001|Open-Label Phase|Withdrawal by Subject|18|||
28114166|NCT02815280|54772537|FG000|Open-Label Phase|Protocol Violation|3|||
28114167|NCT02815280|54772538|FG001|Open-Label Phase|Protocol Violation|0|||
28114168|NCT02815280|54772537|FG000|Open-Label Phase|Administrative|26|||
28114169|NCT02815280|54772538|FG001|Open-Label Phase|Administrative|12|||
28114170|NCT02815280|54772537|FG000|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5|||
28114171|NCT02815280|54772538|FG001|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2|||
28114172|NCT02737930|54772550|FG000|Overall Study|Withdrawal by Subject|0|||
28114173|NCT02737930|54772551|FG001|Overall Study|Withdrawal by Subject|1|||
28114174|NCT03493698|54772557|FG000|Treatment Period C|Adverse Event|1|||
28114175|NCT03493698|54772557|FG000|Treatment Period C|Withdrawal by Subject|1|||
28114176|NCT02737852|54772571|FG000|Overall Study|Withdrawal by Subject|2|||
28114177|NCT03528174|54772575|FG000|Overall Study|Adverse Event|1|||
28114178|NCT03528174|54772575|FG000|Overall Study|sensors dislodged|1|||
28114179|NCT03109184|54772585|FG000|Overall Study|Lost to Follow-up|6|||
28114180|NCT03109184|54772586|FG001|Overall Study|Lost to Follow-up|6|||
28114181|NCT03109184|54772585|FG000|Overall Study|Withdrawal by Subject|1|||
28114182|NCT03109184|54772586|FG001|Overall Study|Withdrawal by Subject|1|||
28114183|NCT03493542|54772604|FG000|Overall Study|Ongoing|2|||
28114184|NCT03493542|54772605|FG001|Overall Study|Ongoing|3|||
28114185|NCT03493542|54772604|FG000|Overall Study|Withdrawal by parent or guardian|3|||
28114186|NCT03493542|54772605|FG001|Overall Study|Withdrawal by parent or guardian|0|||
28114187|NCT03493542|54772604|FG000|Overall Study|Withdrawal by Subject|2|||
28114188|NCT03493542|54772605|FG001|Overall Study|Withdrawal by Subject|6|||
28114189|NCT03493386|54772613|FG000|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
28114190|NCT03493386|54772614|FG001|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
28114191|NCT03493386|54772615|FG002|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
28114192|NCT03493386|54772616|FG003|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
28114193|NCT03478644|54772635|FG000|Phase 2|Withdrawal by Subject|2|||
28114194|NCT03478644|54772636|FG001|Phase 2|Withdrawal by Subject|1|||
28114195|NCT03478644|54772635|FG000|Phase 2|Lost to Follow-up|1|||
28114196|NCT03478644|54772636|FG001|Phase 2|Lost to Follow-up|0|||
28114197|NCT03527550|54772644|FG000|Overall Study|Lost to Follow-up|4|||
28114198|NCT03527550|54772645|FG001|Overall Study|Lost to Follow-up|2|||
28114199|NCT03527550|54772644|FG000|Overall Study|Withdrawal by Subject|4|||
28114200|NCT03527550|54772645|FG001|Overall Study|Withdrawal by Subject|1|||
28114201|NCT03527550|54772644|FG000|Overall Study|Participant reported exclusion criterion after study enrollment.|1|||
28114202|NCT03527550|54772645|FG001|Overall Study|Participant reported exclusion criterion after study enrollment.|0|||
27816444|NCT01922089|54273416|FG001|Overall Study|Protocol Deviation|7|||
28114203|NCT03475056|54772655|FG000|Overall Study|Lost to Follow-up|0|||
28114204|NCT03475056|54772656|FG001|Overall Study|Lost to Follow-up|1|||
28114205|NCT03475056|54772655|FG000|Overall Study|Moved from Area|0|||
28114206|NCT03475056|54772656|FG001|Overall Study|Moved from Area|2|||
28114207|NCT00938912|54772663|FG000|Overall Study|Withdrawal by Subject|28|||
28114208|NCT00938912|54772663|FG000|Overall Study|Lost to Follow-up|4|||
28114209|NCT00938912|54772663|FG000|Overall Study|Lack of Efficacy|43|||
27940313|NCT01186770|54596602|FG003|Overall Study|Protocol Violation|14|||
27816445|NCT01922089|54273415|FG000|Overall Study|Withdrawal by Subject|3|||
27816446|NCT01922089|54273416|FG001|Overall Study|Withdrawal by Subject|4|||
27816447|NCT01922089|54273415|FG000|Overall Study|administrative problems|4|||
27940314|NCT01186770|54596599|FG000|Overall Study|Adverse Event|2|||
28114210|NCT00938912|54772663|FG000|Overall Study|Adverse event, non-fatal|24|||
28114211|NCT00938912|54772663|FG000|Overall Study|Adverse event, fatal|1|||
28114212|NCT00938912|54772663|FG000|Overall Study|Participant self adjusted antiepileptic medication|1|||
28114213|NCT00938912|54772663|FG000|Overall Study|Participant had a creatinine clearance less than 30 mL/min|1|||
28114214|NCT00938912|54772663|FG000|Overall Study|Participant needed prohibit medication|1|||
28114215|NCT00938912|54772663|FG000|Overall Study|Participant was scheduled for lobal resection|1|||
28114216|NCT00938912|54772663|FG000|Overall Study|Did not meet Eligibility criteria|1|||
28114217|NCT00938912|54772663|FG000|Overall Study|Participant relocated not related to AE|1|||
28114218|NCT00938912|54772663|FG000|Overall Study|Participant moved to another city|1|||
28114219|NCT00938912|54772663|FG000|Overall Study|Participant experienced break through seizures|1|||
28114220|NCT00938912|54772663|FG000|Overall Study|No longer wished to participate in the study|1|||
28114221|NCT00938912|54772663|FG000|Overall Study|Protocol Deviation|2|||
27816448|NCT01922089|54273416|FG001|Overall Study|administrative problems|1|||
27940315|NCT01186770|54596600|FG001|Overall Study|Adverse Event|9|||
27816449|NCT01922089|54273415|FG000|Overall Study|Physician Decision|2|||
27940316|NCT01186770|54596601|FG002|Overall Study|Adverse Event|7|||
28114222|NCT03473808|54772670|FG000|Overall Study|Withdrawal by Subject|1|||
28114223|NCT03473340|54772676|FG000|Overall Study|Follow up not possible due to COVID restrictions|3|||
28114224|NCT03473340|54772677|FG001|Overall Study|Follow up not possible due to COVID restrictions|0|||
28114225|NCT03473340|54772676|FG000|Overall Study|Withdrawal by Subject|1|||
28114226|NCT03473340|54772677|FG001|Overall Study|Withdrawal by Subject|0|||
28114227|NCT03473340|54772676|FG000|Overall Study|Lost to Follow-up|1|||
28114228|NCT03473340|54772677|FG001|Overall Study|Lost to Follow-up|2|||
28114229|NCT03490032|54772686|FG000|Overall Study|family issue (child custody)|1|||
28114230|NCT03490032|54772687|FG001|Overall Study|family issue (child custody)|0|||
28114231|NCT03490032|54772688|FG002|Overall Study|family issue (child custody)|0|||
28114232|NCT03489720|54772708|FG000|Overall Study|Withdrawal by Subject|2|||
28114233|NCT03489720|54772709|FG001|Overall Study|Withdrawal by Subject|0|||
28114234|NCT03527160|54772721|FG000|Overall Study|No urine collected|13|||
28114235|NCT03527160|54772721|FG000|Overall Study|No clinical serum creatinine collected|6|||
28114236|NCT03527160|54772721|FG000|Overall Study|Did not meet inclusion|2|||
28114237|NCT03739138|54772731|FG000|Overall Study|Death|0|||
28114238|NCT03739138|54772732|FG001|Overall Study|Death|7|||
28114239|NCT03739138|54772733|FG002|Overall Study|Death|4|||
28114240|NCT03739138|54772734|FG003|Overall Study|Death|13|||
28114241|NCT03739138|54772735|FG004|Overall Study|Death|0|||
28114242|NCT03739138|54772731|FG000|Overall Study|Lost to Follow-up|0|||
28114243|NCT03739138|54772732|FG001|Overall Study|Lost to Follow-up|0|||
28114244|NCT03739138|54772733|FG002|Overall Study|Lost to Follow-up|1|||
28114245|NCT03739138|54772734|FG003|Overall Study|Lost to Follow-up|0|||
28114246|NCT03739138|54772735|FG004|Overall Study|Lost to Follow-up|0|||
28114247|NCT03739138|54772731|FG000|Overall Study|Study Terminated By Sponsor|0|||
28114248|NCT03739138|54772732|FG001|Overall Study|Study Terminated By Sponsor|0|||
28114249|NCT03739138|54772733|FG002|Overall Study|Study Terminated By Sponsor|0|||
28114250|NCT03739138|54772734|FG003|Overall Study|Study Terminated By Sponsor|4|||
28114251|NCT03739138|54772735|FG004|Overall Study|Study Terminated By Sponsor|0|||
28114252|NCT03739138|54772731|FG000|Overall Study|Withdrawal by Subject|0|||
28114253|NCT03739138|54772732|FG001|Overall Study|Withdrawal by Subject|0|||
28114254|NCT03739138|54772733|FG002|Overall Study|Withdrawal by Subject|0|||
28114255|NCT03739138|54772734|FG003|Overall Study|Withdrawal by Subject|1|||
28114256|NCT03739138|54772735|FG004|Overall Study|Withdrawal by Subject|0|||
28114257|NCT03472326|54772745|FG000|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
28114258|NCT03472326|54772746|FG001|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
28114259|NCT03472326|54772747|FG002|Part 2: Combination Therapy|Study Terminated by Sponsor|1|||
28114260|NCT03472326|54772748|FG003|Part 2: Combination Therapy|Study Terminated by Sponsor|2|||
28114261|NCT03472326|54772745|FG000|Part 2: Combination Therapy|Pregnancy|0|||
28114262|NCT03472326|54772746|FG001|Part 2: Combination Therapy|Pregnancy|0|||
28114263|NCT03472326|54772747|FG002|Part 2: Combination Therapy|Pregnancy|0|||
28114264|NCT03472326|54772748|FG003|Part 2: Combination Therapy|Pregnancy|1|||
28114265|NCT02737618|54772757|FG000|Overall Study|Withdrawal by Subject|9|||
28114266|NCT03472014|54772761|FG000|Overall Study|Lost to Follow-up|4|||
28114267|NCT03526458|54772767|FG000|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
28114268|NCT03526458|54772768|FG001|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
28114269|NCT03526458|54772767|FG000|Overall Study|Stone passed, surgery cancelled|2|||
28114270|NCT03526458|54772768|FG001|Overall Study|Stone passed, surgery cancelled|1|||
28114271|NCT03526458|54772767|FG000|Overall Study|Withdrawal by Subject|1|||
28114272|NCT03526458|54772768|FG001|Overall Study|Withdrawal by Subject|0|||
28114273|NCT03526458|54772767|FG000|Overall Study|Physician Decision|2|||
28114274|NCT03526458|54772768|FG001|Overall Study|Physician Decision|1|||
28114275|NCT03526458|54772767|FG000|Overall Study|Lack of equipment|1|||
28064969|NCT00498173|54720636|FG001|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|1|||
28064970|NCT00498173|54720637|FG002|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|0|||
28064971|NCT00295620|54720647|FG000|Overall Study|Lost to Follow-up|9|||
28064972|NCT00295620|54720648|FG001|Overall Study|Lost to Follow-up|5|||
28064973|NCT00295620|54720647|FG000|Overall Study|Withdrawal by Subject|37|||
28064974|NCT00295620|54720648|FG001|Overall Study|Withdrawal by Subject|50|||
28064975|NCT00295620|54720647|FG000|Overall Study|Death|206|||
28064976|NCT00295620|54720648|FG001|Overall Study|Death|207|||
28064977|NCT00295620|54720647|FG000|Overall Study|Other reasons|10|||
28064978|NCT00295620|54720648|FG001|Overall Study|Other reasons|9|||
28064979|NCT00295620|54720647|FG000|Overall Study|Discontinuation by sponsor|580|||
28064980|NCT00295620|54720648|FG001|Overall Study|Discontinuation by sponsor|593|||
28064981|NCT00295620|54720647|FG000|Overall Study|Protocol Violation|30|||
28064982|NCT00295620|54720648|FG001|Overall Study|Protocol Violation|32|||
28064983|NCT00310440|54720656|FG000|Overall Study|Lost to Follow-up|17|||
28064984|NCT00310440|54720657|FG001|Overall Study|Lost to Follow-up|8|||
28064985|NCT00310440|54720656|FG000|Overall Study|Withdrawal by Subject|2|||
28064986|NCT00310440|54720657|FG001|Overall Study|Withdrawal by Subject|1|||
28064987|NCT00310440|54720656|FG000|Overall Study|Missed 12 Month Visit|7|||
28114276|NCT03526458|54772768|FG001|Overall Study|Lack of equipment|1|||
28114277|NCT03488238|54772774|FG000|Overall Study|Equipment malfunction|1|||
28114278|NCT03488238|54772774|FG000|Overall Study|Adverse Event|1|||
28114279|NCT03525834|54772778|FG000|Overall Study|Progressive disease|1|||
28114280|NCT03525444|54772820|FG000|Overall Study|Adverse Event|0|||
28114281|NCT03525444|54772821|FG001|Overall Study|Adverse Event|1|||
28114282|NCT03525444|54772820|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
28114283|NCT03525444|54772821|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
28114284|NCT03525444|54772820|FG000|Overall Study|Other|0|||
28114285|NCT03525444|54772821|FG001|Overall Study|Other|1|||
28114286|NCT03487848|54772828|FG000|Overall Study|Lost to Follow-up|1|||
28114287|NCT03524664|54772834|FG000|Overall Study|Withdrawal by Subject|1|||
28114288|NCT03524664|54772835|FG001|Overall Study|Withdrawal by Subject|2|||
28114289|NCT03524664|54772834|FG000|Overall Study|Lost to Follow-up|4|||
28114290|NCT03524664|54772835|FG001|Overall Study|Lost to Follow-up|13|||
28114291|NCT04377620|54772844|FG000|Overall Study|Death|42|||
28114292|NCT04377620|54772845|FG001|Overall Study|Death|48|||
28114293|NCT04377620|54772846|FG002|Overall Study|Death|36|||
28114294|NCT04377620|54772844|FG000|Overall Study|Withdrawal by Subject|0|||
28114295|NCT04377620|54772845|FG001|Overall Study|Withdrawal by Subject|2|||
28114296|NCT04377620|54772846|FG002|Overall Study|Withdrawal by Subject|0|||
28114297|NCT03486834|54772858|FG000|Overall Study|Withdrawal by Subject|46|||
28114298|NCT03486834|54772859|FG001|Overall Study|Withdrawal by Subject|46|||
28114299|NCT03486834|54772860|FG002|Overall Study|Withdrawal by Subject|52|||
28114300|NCT03486834|54772858|FG000|Overall Study|Adverse Event|8|||
28114301|NCT03486834|54772859|FG001|Overall Study|Adverse Event|7|||
28114302|NCT03486834|54772860|FG002|Overall Study|Adverse Event|0|||
28114303|NCT03486834|54772858|FG000|Overall Study|Lost to Follow-up|41|||
28114304|NCT03486834|54772859|FG001|Overall Study|Lost to Follow-up|24|||
28114305|NCT03486834|54772860|FG002|Overall Study|Lost to Follow-up|39|||
28114306|NCT03486834|54772858|FG000|Overall Study|Non-compliance with Study Drug|2|||
28114307|NCT03486834|54772859|FG001|Overall Study|Non-compliance with Study Drug|2|||
28114308|NCT03486834|54772860|FG002|Overall Study|Non-compliance with Study Drug|0|||
28114309|NCT03486834|54772858|FG000|Overall Study|Physician Decision|5|||
28114310|NCT03486834|54772859|FG001|Overall Study|Physician Decision|2|||
28114311|NCT03486834|54772860|FG002|Overall Study|Physician Decision|3|||
28114312|NCT03486834|54772858|FG000|Overall Study|Pregnancy|10|||
28114313|NCT03486834|54772859|FG001|Overall Study|Pregnancy|12|||
28114314|NCT03486834|54772860|FG002|Overall Study|Pregnancy|12|||
27816450|NCT01922089|54273416|FG001|Overall Study|Physician Decision|3|||
27816451|NCT01922089|54273415|FG000|Overall Study|Death|2|||
27816452|NCT01922089|54273416|FG001|Overall Study|Death|1|||
27816453|NCT01922089|54273415|FG000|Overall Study|Lost to Follow-up|0|||
27816454|NCT01922089|54273416|FG001|Overall Study|Lost to Follow-up|1|||
27816455|NCT01884025|54273424|FG000|Overall Study|Lost to Follow-up|3|||
28114315|NCT03486834|54772858|FG000|Overall Study|Protocol Deviation|2|||
28114316|NCT03486834|54772859|FG001|Overall Study|Protocol Deviation|3|||
28114317|NCT03486834|54772860|FG002|Overall Study|Protocol Deviation|3|||
28114318|NCT03486834|54772858|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
28114319|NCT03486834|54772859|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
28114320|NCT03486834|54772860|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
28114321|NCT03486834|54772858|FG000|Overall Study|Randomized but not treated|4|||
28114322|NCT03486834|54772859|FG001|Overall Study|Randomized but not treated|4|||
27816456|NCT01884025|54273425|FG001|Overall Study|Lost to Follow-up|4|||
28114323|NCT03486834|54772860|FG002|Overall Study|Randomized but not treated|1|||
28114324|NCT03522948|54772870|FG000|Overall Study|Lost to Follow-up|1|||
27816457|NCT01896193|54273435|FG000|Overall Study|Lack of Efficacy|20|||
27816458|NCT01896193|54273436|FG001|Overall Study|Lack of Efficacy|11|||
27816459|NCT01896193|54273435|FG000|Overall Study|Protocol Violation|0|||
28114325|NCT03406078|54772876|FG000|Overall Study|Death|1|||
28114326|NCT03406078|54772877|FG001|Overall Study|Death|0|||
28114327|NCT03406078|54772876|FG000|Overall Study|Lost to Follow-up|0|||
28114328|NCT03406078|54772877|FG001|Overall Study|Lost to Follow-up|1|||
28114329|NCT03406078|54772876|FG000|Overall Study|Withdrawal by Subject|5|||
28114330|NCT03406078|54772877|FG001|Overall Study|Withdrawal by Subject|2|||
28114331|NCT03634033|54772890|FG000|Overall Study|Did not have a post-assessment|384|||
28114332|NCT03634033|54772891|FG001|Overall Study|Did not have a post-assessment|291|||
28114333|NCT03634033|54772892|FG002|Overall Study|Did not have a post-assessment|114|||
28114334|NCT03634033|54772893|FG003|Overall Study|Did not have a post-assessment|161|||
28114335|NCT03634033|54772894|FG004|Overall Study|Did not have a post-assessment|5|||
28114336|NCT03634033|54772895|FG005|Overall Study|Did not have a post-assessment|0|||
28114337|NCT03634033|54772896|FG006|Overall Study|Did not have a post-assessment|0|||
28114338|NCT03634033|54772890|FG000|Overall Study|Death|0|||
28114339|NCT03634033|54772891|FG001|Overall Study|Death|0|||
28114340|NCT03634033|54772892|FG002|Overall Study|Death|0|||
28114341|NCT03634033|54772893|FG003|Overall Study|Death|0|||
28114342|NCT03634033|54772894|FG004|Overall Study|Death|0|||
28114343|NCT03634033|54772895|FG005|Overall Study|Death|7|||
28114344|NCT03634033|54772896|FG006|Overall Study|Death|7|||
28114345|NCT03634033|54772890|FG000|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
28114346|NCT03634033|54772891|FG001|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
28114347|NCT03634033|54772892|FG002|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
28114348|NCT03634033|54772893|FG003|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
28114349|NCT03634033|54772894|FG004|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
28114350|NCT03634033|54772895|FG005|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
28114351|NCT03634033|54772896|FG006|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
28114352|NCT03634033|54772890|FG000|Overall Study|Lost to Follow-up|0|||
28114353|NCT03634033|54772891|FG001|Overall Study|Lost to Follow-up|0|||
28114354|NCT03634033|54772892|FG002|Overall Study|Lost to Follow-up|0|||
28114355|NCT03634033|54772893|FG003|Overall Study|Lost to Follow-up|0|||
28114356|NCT03634033|54772894|FG004|Overall Study|Lost to Follow-up|0|||
28114357|NCT03634033|54772895|FG005|Overall Study|Lost to Follow-up|1|||
28114358|NCT03634033|54772896|FG006|Overall Study|Lost to Follow-up|2|||
28114359|NCT03634033|54772890|FG000|Overall Study|Withdrawal by Subject|0|||
28114360|NCT03634033|54772891|FG001|Overall Study|Withdrawal by Subject|0|||
28114361|NCT03634033|54772892|FG002|Overall Study|Withdrawal by Subject|0|||
28114362|NCT03634033|54772893|FG003|Overall Study|Withdrawal by Subject|0|||
28114363|NCT03634033|54772894|FG004|Overall Study|Withdrawal by Subject|0|||
28114364|NCT03634033|54772895|FG005|Overall Study|Withdrawal by Subject|0|||
28114365|NCT03634033|54772896|FG006|Overall Study|Withdrawal by Subject|1|||
28114366|NCT03103100|54772930|FG000|Overall Study|Adverse Event|1|||
27816460|NCT01896193|54273436|FG001|Overall Study|Protocol Violation|1|||
27816461|NCT01896193|54273435|FG000|Overall Study|Withdrew Consent|1|||
27816462|NCT01896193|54273436|FG001|Overall Study|Withdrew Consent|0|||
27816463|NCT01922011|54273446|FG000|Overall Study|Protocol Violation|0|||
27816464|NCT01922011|54273447|FG001|Overall Study|Protocol Violation|1|||
27816465|NCT01922011|54273446|FG000|Overall Study|Physician Decision|0|||
27816466|NCT01922011|54273447|FG001|Overall Study|Physician Decision|1|||
27816467|NCT01922011|54273446|FG000|Overall Study|Parent/Guardian Decision|3|||
27816468|NCT01922011|54273447|FG001|Overall Study|Parent/Guardian Decision|0|||
27816469|NCT01922011|54273446|FG000|Overall Study|Lost to Follow-up|0|||
27816470|NCT01922011|54273447|FG001|Overall Study|Lost to Follow-up|1|||
27816471|NCT01922011|54273446|FG000|Overall Study|Missed Test-of-Cure Visit|0|||
27816472|NCT01922011|54273447|FG001|Overall Study|Missed Test-of-Cure Visit|2|||
27816473|NCT01922011|54273446|FG000|Overall Study|Not Treated|1|||
27816474|NCT01922011|54273447|FG001|Overall Study|Not Treated|0|||
27816475|NCT01922011|54273446|FG000|Overall Study|Lack of willing home health agency|1|||
28114367|NCT03103100|54772931|FG001|Overall Study|Adverse Event|0|||
27816476|NCT01922011|54273447|FG001|Overall Study|Lack of willing home health agency|0|||
28114368|NCT03103100|54772932|FG002|Overall Study|Adverse Event|0|||
27816477|NCT01922011|54273446|FG000|Overall Study|Randomized in error|1|||
27816478|NCT01922011|54273447|FG001|Overall Study|Randomized in error|0|||
27816479|NCT01883635|54273461|FG000|Overall Study|Withdrawal by Subject|4|||
27816480|NCT01883635|54273462|FG001|Overall Study|Withdrawal by Subject|0|||
28114369|NCT03103100|54772930|FG000|Overall Study|Physician Decision|1|||
28114370|NCT03103100|54772931|FG001|Overall Study|Physician Decision|0|||
28114371|NCT03103100|54772932|FG002|Overall Study|Physician Decision|2|||
27848728|NCT01363661|54343056|FG000|Overall Study|Withdrawal by Subject|1|||
27848729|NCT01363661|54343057|FG001|Overall Study|Withdrawal by Subject|1|||
27848730|NCT01363661|54343056|FG000|Overall Study|Protocol Violation|1|||
27848731|NCT01363661|54343057|FG001|Overall Study|Protocol Violation|0|||
27848732|NCT01363661|54343056|FG000|Overall Study|Lost to Follow-up|3|||
27848733|NCT01363661|54343057|FG001|Overall Study|Lost to Follow-up|1|||
27848734|NCT02628600|54343065|FG000|Overall Study|Death|2|||
27848735|NCT02628600|54343066|FG001|Overall Study|Death|1|||
27848736|NCT02628600|54343065|FG000|Overall Study|Adverse Event|3|||
27848737|NCT02628600|54343066|FG001|Overall Study|Adverse Event|20|||
27848738|NCT02628600|54343065|FG000|Overall Study|Protocol Violation|0|||
27848739|NCT02628600|54343066|FG001|Overall Study|Protocol Violation|1|||
27848740|NCT02628600|54343065|FG000|Overall Study|Lack of Efficacy|2|||
27848741|NCT02628600|54343066|FG001|Overall Study|Lack of Efficacy|0|||
27848742|NCT02628600|54343065|FG000|Overall Study|Withdrawal by Subject|13|||
27848743|NCT02628600|54343066|FG001|Overall Study|Withdrawal by Subject|8|||
27848744|NCT02628600|54343065|FG000|Overall Study|Lost to Follow-up|1|||
27848745|NCT02628600|54343066|FG001|Overall Study|Lost to Follow-up|0|||
27848746|NCT02628600|54343065|FG000|Overall Study|Physician Decision|2|||
27848747|NCT02628600|54343066|FG001|Overall Study|Physician Decision|2|||
27848748|NCT02628600|54343065|FG000|Overall Study|Other not specified|1|||
27848749|NCT02628600|54343066|FG001|Overall Study|Other not specified|0|||
27848750|NCT00591318|54343083|FG000|Overall Study|Lack of Efficacy|2|||
27848751|NCT00591318|54343084|FG001|Overall Study|Lack of Efficacy|0|||
27848752|NCT00591318|54343083|FG000|Overall Study|Adverse Event|2|||
27940317|NCT01186770|54596602|FG003|Overall Study|Adverse Event|9|||
28114372|NCT03438006|54772940|FG000|Overall Study|Adverse Event|1|||
28114373|NCT03438006|54772940|FG000|Overall Study|Lost to Follow-up|67|||
28114374|NCT03438006|54772940|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|47|||
28114375|NCT03438006|54772940|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|3|||
28114376|NCT04206020|54772946|FG000|Overall Study|Adverse Event|1|||
28114377|NCT04206020|54772947|FG001|Overall Study|Adverse Event|4|||
28114378|NCT04206020|54772946|FG000|Overall Study|Protocol Violation|2|||
27816481|NCT01921387|54273470|FG000|Overall Study|Adverse Event|1|||
27816482|NCT01895335|54273474|FG000|Overall Study|Adverse Event|106|||
27816483|NCT01895335|54273474|FG000|Overall Study|Lack of Efficacy|53|||
27816484|NCT01895335|54273474|FG000|Overall Study|Poor Compliance to Protocol|11|||
27816485|NCT01895335|54273474|FG000|Overall Study|Included But Not treated|1|||
27816486|NCT01895335|54273474|FG000|Overall Study|Other than Specified Above|44|||
27816487|NCT01617655|54273480|FG000|Overall Study|Adverse Event|2|||
27816488|NCT01617655|54273481|FG001|Overall Study|Adverse Event|3|||
27816489|NCT01617655|54273480|FG000|Overall Study|Poor compliance to protocol|1|||
27816490|NCT01617655|54273481|FG001|Overall Study|Poor compliance to protocol|4|||
27816491|NCT01617655|54273480|FG000|Overall Study|Participants moved|0|||
27816492|NCT01617655|54273481|FG001|Overall Study|Participants moved|4|||
27816493|NCT01617655|54273480|FG000|Overall Study|Consent withdrawn by participant|1|||
27816494|NCT01617655|54273481|FG001|Overall Study|Consent withdrawn by participant|1|||
27816495|NCT01617655|54273480|FG000|Overall Study|Last visit outside protocol visit window|1|||
27816496|NCT01617655|54273481|FG001|Overall Study|Last visit outside protocol visit window|10|||
27816497|NCT01617655|54273480|FG000|Overall Study|Site closure|3|||
27816498|NCT01617655|54273481|FG001|Overall Study|Site closure|5|||
27816499|NCT01617655|54273480|FG000|Overall Study|Other than specified above|1|||
27816500|NCT01617655|54273481|FG001|Overall Study|Other than specified above|2|||
27848753|NCT00591318|54343084|FG001|Overall Study|Adverse Event|0|||
27848754|NCT01360632|54343097|FG000|Phase A (8 Weeks)|Lost to Follow-up|27|||
27848755|NCT01360632|54343098|FG001|Phase A (8 Weeks)|Lost to Follow-up|0|||
27848756|NCT01360632|54343099|FG002|Phase A (8 Weeks)|Lost to Follow-up|0|||
27848757|NCT01360632|54343100|FG003|Phase A (8 Weeks)|Lost to Follow-up|0|||
27848758|NCT01360632|54343101|FG004|Phase A (8 Weeks)|Lost to Follow-up|0|||
27940318|NCT01186770|54596599|FG000|Overall Study|Withdrawal by Subject|15|||
28064988|NCT00310440|54720657|FG001|Overall Study|Missed 12 Month Visit|4|||
28064989|NCT00304356|54720663|FG000|Nitazoxanide|Physician Decision|5|||
28064990|NCT00304356|54720663|FG000|Nitazoxanide|Physician Decision|1|||
28064991|NCT00304356|54720663|FG000|Nitazoxanide|number is 0|1|||
28064992|NCT00304356|54720663|FG000|Nitazoxanide|Physician Decision|1|||
28064993|NCT00304356|54720663|FG000|Nitazoxanide|Physician Decision|1|||
28064994|NCT00304356|54720663|FG000|Nitazoxanide|Physician Decision|1|||
28064995|NCT00321620|54720669|FG000|Overall Study|Death|269|||
28064996|NCT00321620|54720670|FG001|Overall Study|Death|294|||
28064997|NCT00321620|54720669|FG000|Overall Study|Withdrawal by Subject|164|||
28064998|NCT00321620|54720670|FG001|Overall Study|Withdrawal by Subject|147|||
28064999|NCT00321620|54720669|FG000|Overall Study|Disease progression|113|||
28065000|NCT00321620|54720670|FG001|Overall Study|Disease progression|117|||
28065001|NCT00321620|54720669|FG000|Overall Study|Adverse Event|43|||
28065002|NCT00321620|54720670|FG001|Overall Study|Adverse Event|56|||
28065003|NCT00321620|54720669|FG000|Overall Study|Lost to Follow-up|13|||
28065004|NCT00321620|54720670|FG001|Overall Study|Lost to Follow-up|9|||
28114379|NCT04206020|54772947|FG001|Overall Study|Protocol Violation|0|||
28114380|NCT04206020|54772946|FG000|Overall Study|Withdrawal by Subject|2|||
28114381|NCT04206020|54772947|FG001|Overall Study|Withdrawal by Subject|0|||
28114382|NCT04206020|54772946|FG000|Overall Study|Lost to Follow-up|2|||
28114383|NCT04206020|54772947|FG001|Overall Study|Lost to Follow-up|0|||
28114384|NCT04206020|54772946|FG000|Overall Study|Pregnancy|0|||
28114385|NCT04206020|54772947|FG001|Overall Study|Pregnancy|1|||
28114386|NCT04206020|54772946|FG000|Overall Study|Unable to attend visits|1|||
28114387|NCT04206020|54772947|FG001|Overall Study|Unable to attend visits|2|||
28114388|NCT03466086|54772953|FG000|Period 1|Sponsor decision due to study timeline|1|||
28114389|NCT03466086|54772954|FG001|Period 1|Sponsor decision due to study timeline|0|||
28114390|NCT03466086|54772953|FG000|Period 1|Withdrawal by Subject|1|||
28114391|NCT03466086|54772954|FG001|Period 1|Withdrawal by Subject|0|||
28114392|NCT03101462|54772962|FG000|Overall Study|Missed Visit 02 and/or Visit 03|1|||
28114393|NCT03101462|54772963|FG001|Overall Study|Missed Visit 02 and/or Visit 03|1|||
28114394|NCT02873936|54772972|FG000|Overall Study|Withdrew Consent|4|||
28114395|NCT02873936|54772973|FG001|Overall Study|Withdrew Consent|11|||
28114396|NCT02873936|54772974|FG002|Overall Study|Withdrew Consent|20|||
28114397|NCT02873936|54772972|FG000|Overall Study|Investigator's Discretion|3|||
28114398|NCT02873936|54772973|FG001|Overall Study|Investigator's Discretion|5|||
28114399|NCT02873936|54772974|FG002|Overall Study|Investigator's Discretion|4|||
28114400|NCT02873936|54772972|FG000|Overall Study|Adverse Event|3|||
28114401|NCT02873936|54772973|FG001|Overall Study|Adverse Event|5|||
28114402|NCT02873936|54772974|FG002|Overall Study|Adverse Event|3|||
28114403|NCT02873936|54772972|FG000|Overall Study|Protocol Violation|0|||
28114404|NCT02873936|54772973|FG001|Overall Study|Protocol Violation|1|||
28114405|NCT02873936|54772974|FG002|Overall Study|Protocol Violation|3|||
28114406|NCT02873936|54772972|FG000|Overall Study|Lost to Follow-up|1|||
28114407|NCT02873936|54772973|FG001|Overall Study|Lost to Follow-up|1|||
28114408|NCT02873936|54772974|FG002|Overall Study|Lost to Follow-up|1|||
28114409|NCT02873936|54772972|FG000|Overall Study|Non-compliance With Study Drug|1|||
27816501|NCT01895101|54273492|FG000|Overall Study|OPCAB procedure|1|||
27816502|NCT01895101|54273493|FG001|Overall Study|OPCAB procedure|1|||
27816503|NCT01895101|54273494|FG002|Overall Study|OPCAB procedure|3|||
27816504|NCT01895101|54273492|FG000|Overall Study|Withdrawal by Subject|0|||
27816505|NCT01895101|54273493|FG001|Overall Study|Withdrawal by Subject|1|||
27816506|NCT01895101|54273494|FG002|Overall Study|Withdrawal by Subject|2|||
27816507|NCT01895101|54273492|FG000|Overall Study|another study, enrolled in other study|0|||
27816508|NCT01895101|54273493|FG001|Overall Study|another study, enrolled in other study|1|||
27848759|NCT01360632|54343097|FG000|Phase A (8 Weeks)|Adverse Event|60|||
28114410|NCT02873936|54772973|FG001|Overall Study|Non-compliance With Study Drug|0|||
28114411|NCT02873936|54772974|FG002|Overall Study|Non-compliance With Study Drug|1|||
28114412|NCT02873936|54772972|FG000|Overall Study|Randomized but not Dosed|1|||
28114413|NCT02873936|54772973|FG001|Overall Study|Randomized but not Dosed|0|||
28114414|NCT02873936|54772974|FG002|Overall Study|Randomized but not Dosed|0|||
28114415|NCT02874794|54772984|FG000|Overall Study|Physician Decision|3|||
28114416|NCT02874794|54772985|FG001|Overall Study|Physician Decision|2|||
28114417|NCT02874794|54772984|FG000|Overall Study|Withdrawal by Subject|2|||
28114418|NCT02874794|54772985|FG001|Overall Study|Withdrawal by Subject|8|||
28114419|NCT02874794|54772984|FG000|Overall Study|Death|2|||
28114420|NCT02874794|54772985|FG001|Overall Study|Death|1|||
28114421|NCT03102710|54772997|FG000|Overall Study|Dental metal affected MRI scan quality|1|||
27816509|NCT01895101|54273494|FG002|Overall Study|another study, enrolled in other study|0|||
27816510|NCT01895101|54273492|FG000|Overall Study|Death|0|||
28114422|NCT03102710|54772998|FG001|Overall Study|Dental metal affected MRI scan quality|0|||
28114423|NCT03102710|54772999|FG002|Overall Study|Dental metal affected MRI scan quality|0|||
28114424|NCT03102710|54772997|FG000|Overall Study|Technical issues during final MRI scan|0|||
28114425|NCT03102710|54772998|FG001|Overall Study|Technical issues during final MRI scan|1|||
28114426|NCT03102710|54772999|FG002|Overall Study|Technical issues during final MRI scan|0|||
28114427|NCT03102710|54772997|FG000|Overall Study|Nausea during MRI scan|0|||
28114428|NCT03102710|54772998|FG001|Overall Study|Nausea during MRI scan|1|||
27816511|NCT01895101|54273493|FG001|Overall Study|Death|1|||
28114429|NCT03102710|54772999|FG002|Overall Study|Nausea during MRI scan|0|||
28114430|NCT03102710|54772997|FG000|Overall Study|Subject unable to attend final session|0|||
28114431|NCT03102710|54772998|FG001|Overall Study|Subject unable to attend final session|1|||
28114432|NCT03102710|54772999|FG002|Overall Study|Subject unable to attend final session|0|||
28114433|NCT03101150|54773009|FG000|Overall Study|Lost to Follow-up|2|||
28114434|NCT03101150|54773010|FG001|Overall Study|Lost to Follow-up|4|||
28114435|NCT03101150|54773009|FG000|Overall Study|Miscarriage|3|||
28114436|NCT03101150|54773010|FG001|Overall Study|Miscarriage|6|||
27816512|NCT01895101|54273494|FG002|Overall Study|Death|0|||
27816513|NCT01895101|54273492|FG000|Overall Study|coagulation disorder|0|||
27816514|NCT01895101|54273493|FG001|Overall Study|coagulation disorder|1|||
27816515|NCT01895101|54273494|FG002|Overall Study|coagulation disorder|0|||
27816516|NCT01894477|54273504|FG000|Overall Study|Protocol Violation|0|||
27816517|NCT01894477|54273505|FG001|Overall Study|Protocol Violation|1|||
27816518|NCT01894477|54273504|FG000|Overall Study|protocol changed due SC changed to cord|0|||
27816519|NCT01894477|54273505|FG001|Overall Study|protocol changed due SC changed to cord|1|||
27816520|NCT01894243|54273514|FG000|Overall Study|Adverse Event|0|||
27940319|NCT01186770|54596600|FG001|Overall Study|Withdrawal by Subject|13|||
28114437|NCT03101930|54773019|FG000|Overall Study|Withdrawal by Subject|2|||
28114438|NCT03101930|54773020|FG001|Overall Study|Withdrawal by Subject|1|||
28114439|NCT03101930|54773021|FG002|Overall Study|Withdrawal by Subject|2|||
28114440|NCT02928848|54773031|FG000|Arm 2|Withdrawal by Subject|1|||
28114441|NCT02928848|54773032|FG001|Arm 2|Withdrawal by Subject|0|||
28114442|NCT02928770|54773040|FG000|Overall Study|Withdrawal by Subject|2|||
28114443|NCT03100838|54773044|FG000|Overall Study|Adverse Event|1|||
28114444|NCT03100838|54773045|FG001|Overall Study|Adverse Event|0|||
28114445|NCT03100838|54773046|FG002|Overall Study|Adverse Event|0|||
28114446|NCT03100838|54773047|FG003|Overall Study|Adverse Event|0|||
28114447|NCT03100838|54773044|FG000|Overall Study|Physician Decision|1|||
28114448|NCT03100838|54773045|FG001|Overall Study|Physician Decision|1|||
28114449|NCT03100838|54773046|FG002|Overall Study|Physician Decision|1|||
28114450|NCT03100838|54773047|FG003|Overall Study|Physician Decision|1|||
28114451|NCT03100838|54773044|FG000|Overall Study|Pregnancy|0|||
28114452|NCT03100838|54773045|FG001|Overall Study|Pregnancy|1|||
28114453|NCT03100838|54773046|FG002|Overall Study|Pregnancy|0|||
28114454|NCT03100838|54773047|FG003|Overall Study|Pregnancy|0|||
28114455|NCT03100838|54773044|FG000|Overall Study|Lost to Follow-up|0|||
28114456|NCT03100838|54773045|FG001|Overall Study|Lost to Follow-up|0|||
28114457|NCT03100838|54773046|FG002|Overall Study|Lost to Follow-up|1|||
28114458|NCT03100838|54773047|FG003|Overall Study|Lost to Follow-up|0|||
28114459|NCT03480750|54773063|FG000|Overall Study|Withdrawal by Subject|0|||
28114460|NCT03480750|54773064|FG001|Overall Study|Withdrawal by Subject|1|||
28114461|NCT03480750|54773065|FG002|Overall Study|Withdrawal by Subject|0|||
28114462|NCT03480750|54773066|FG003|Overall Study|Withdrawal by Subject|0|||
28114463|NCT03480750|54773067|FG004|Overall Study|Withdrawal by Subject|0|||
28114464|NCT03480750|54773068|FG005|Overall Study|Withdrawal by Subject|0|||
28114465|NCT03480750|54773063|FG000|Overall Study|The interruption in Trientine shippment|0|||
28114466|NCT03480750|54773064|FG001|Overall Study|The interruption in Trientine shippment|0|||
28114467|NCT03480750|54773065|FG002|Overall Study|The interruption in Trientine shippment|0|||
28114468|NCT03480750|54773066|FG003|Overall Study|The interruption in Trientine shippment|0|||
28114469|NCT03480750|54773067|FG004|Overall Study|The interruption in Trientine shippment|0|||
28114470|NCT03480750|54773068|FG005|Overall Study|The interruption in Trientine shippment|1|||
28114471|NCT03462030|54773093|FG000|Overall Study|Withdrawal by Subject|1|||
28114472|NCT03462030|54773094|FG001|Overall Study|Withdrawal by Subject|1|||
28114473|NCT03412734|54773102|FG000|Overall Study|Incorrect labeling of samples|2|||
28114474|NCT03412734|54773103|FG001|Overall Study|Incorrect labeling of samples|0|||
28114475|NCT03412734|54773102|FG000|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1|||
28114476|NCT03412734|54773103|FG001|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0|||
28114477|NCT02374814|54773115|FG000|Overall Study|Lost to Follow-up|1|||
27816521|NCT01894243|54273515|FG001|Overall Study|Adverse Event|1|||
27816522|NCT01894243|54273516|FG002|Overall Study|Adverse Event|2|||
28114478|NCT02374814|54773116|FG001|Overall Study|Lost to Follow-up|1|||
28114479|NCT02374814|54773117|FG002|Overall Study|Lost to Follow-up|0|||
28114480|NCT02374814|54773118|FG003|Overall Study|Lost to Follow-up|1|||
28114481|NCT02374814|54773119|FG004|Overall Study|Lost to Follow-up|0|||
28114482|NCT02374814|54773120|FG005|Overall Study|Lost to Follow-up|0|||
28114483|NCT02374814|54773115|FG000|Overall Study|Withdrawal by Subject|0|||
28114484|NCT02374814|54773116|FG001|Overall Study|Withdrawal by Subject|0|||
28114485|NCT02374814|54773117|FG002|Overall Study|Withdrawal by Subject|1|||
28114486|NCT02374814|54773118|FG003|Overall Study|Withdrawal by Subject|1|||
28114487|NCT02374814|54773119|FG004|Overall Study|Withdrawal by Subject|0|||
28114488|NCT02374814|54773120|FG005|Overall Study|Withdrawal by Subject|0|||
28114489|NCT04608344|54773144|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|0|||
28114490|NCT04608344|54773145|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|1|||
28114491|NCT04608344|54773144|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|1|||
28114492|NCT04608344|54773145|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|0|||
28114493|NCT03433482|54773163|FG000|Overall Study|Lost to Follow-up|1|||
28114494|NCT03433482|54773164|FG001|Overall Study|Lost to Follow-up|0|||
28114495|NCT03433482|54773165|FG002|Overall Study|Lost to Follow-up|1|||
28114496|NCT03433482|54773166|FG003|Overall Study|Lost to Follow-up|1|||
28114497|NCT03433482|54773163|FG000|Overall Study|Withdrawal by Subject|0|||
28114498|NCT03433482|54773164|FG001|Overall Study|Withdrawal by Subject|0|||
28114499|NCT03433482|54773165|FG002|Overall Study|Withdrawal by Subject|1|||
28114500|NCT03433482|54773166|FG003|Overall Study|Withdrawal by Subject|0|||
28114501|NCT03433482|54773163|FG000|Overall Study|Unknown reason|0|||
28114502|NCT03433482|54773164|FG001|Overall Study|Unknown reason|0|||
28114503|NCT03433482|54773165|FG002|Overall Study|Unknown reason|2|||
28065005|NCT00321620|54720669|FG000|Overall Study|Physician Decision|4|||
28065006|NCT00321620|54720670|FG001|Overall Study|Physician Decision|1|||
28065007|NCT00321620|54720669|FG000|Overall Study|Noncompliance|14|||
28065008|NCT00321620|54720670|FG001|Overall Study|Noncompliance|7|||
28065009|NCT00321620|54720669|FG000|Overall Study|Protocol deviation|4|||
28065010|NCT00321620|54720670|FG001|Overall Study|Protocol deviation|3|||
28065011|NCT00321620|54720669|FG000|Overall Study|Ineligibility determined|2|||
28065012|NCT00321620|54720670|FG001|Overall Study|Ineligibility determined|3|||
28065013|NCT00321620|54720669|FG000|Overall Study|Participant request|75|||
28065014|NCT00321620|54720670|FG001|Overall Study|Participant request|52|||
28065015|NCT00321620|54720669|FG000|Overall Study|Other|42|||
28065016|NCT00321620|54720670|FG001|Overall Study|Other|33|||
28065017|NCT00304278|54720676|FG000|Overall Study|lack of insurance coverage for chemoRT|1|||
28114504|NCT03433482|54773166|FG003|Overall Study|Unknown reason|0|||
28065018|NCT00304278|54720676|FG000|Overall Study|PT had medical condition preventing TX|1|||
28114505|NCT03432858|54773179|FG000|Overall Study|Protocol Violation|2|||
28114506|NCT03432858|54773180|FG001|Overall Study|Protocol Violation|1|||
28114507|NCT03432858|54773181|FG002|Overall Study|Protocol Violation|9|||
28065019|NCT00291018|54720683|FG000|Overall Study|Not Consented or Declined PAS|12|||
28114508|NCT03432858|54773179|FG000|Overall Study|Withdrawal by Subject|0|||
28114509|NCT03432858|54773180|FG001|Overall Study|Withdrawal by Subject|1|||
28114510|NCT03432858|54773181|FG002|Overall Study|Withdrawal by Subject|1|||
28114511|NCT03432858|54773179|FG000|Overall Study|Procedure canceled/rescheduled|0|||
28114512|NCT03432858|54773180|FG001|Overall Study|Procedure canceled/rescheduled|9|||
28114513|NCT03432858|54773181|FG002|Overall Study|Procedure canceled/rescheduled|6|||
28114514|NCT03432858|54773179|FG000|Overall Study|Required postop mobilization with splinting|0|||
28114515|NCT03432858|54773180|FG001|Overall Study|Required postop mobilization with splinting|0|||
28114516|NCT03432858|54773181|FG002|Overall Study|Required postop mobilization with splinting|1|||
28114517|NCT03432390|54773191|FG000|Apnea Period|Protocol Violation|2|||
28114518|NCT03432390|54773192|FG001|Apnea Period|Protocol Violation|2|||
28114519|NCT03456960|54773204|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
28114520|NCT03456960|54773205|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
28114521|NCT03456960|54773206|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
28114522|NCT03456960|54773207|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|2|||
28114523|NCT03456960|54773208|FG004|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
28114524|NCT03456960|54773209|FG005|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
28114525|NCT03456960|54773204|FG000|Period 2 (1 Day)|Adverse Event|1|||
28114526|NCT03456960|54773205|FG001|Period 2 (1 Day)|Adverse Event|0|||
28114527|NCT03456960|54773206|FG002|Period 2 (1 Day)|Adverse Event|0|||
28114528|NCT03456960|54773207|FG003|Period 2 (1 Day)|Adverse Event|1|||
28114529|NCT03456960|54773208|FG004|Period 2 (1 Day)|Adverse Event|0|||
28114530|NCT03456960|54773209|FG005|Period 2 (1 Day)|Adverse Event|0|||
28114531|NCT03430986|54773227|FG000|24-week Control Period|Adverse Event|1|||
28114532|NCT03430986|54773228|FG001|24-week Control Period|Adverse Event|0|||
28114533|NCT03430986|54773227|FG000|24-week Control Period|Lost to Follow-up|2|||
28114534|NCT03430986|54773228|FG001|24-week Control Period|Lost to Follow-up|2|||
28114535|NCT03430986|54773227|FG000|24-week Control Period|Withdrawal by Participant|5|||
28114536|NCT03430986|54773228|FG001|24-week Control Period|Withdrawal by Participant|0|||
28114537|NCT03430986|54773227|FG000|24-week Control Period|Protocol Deviation|0|||
28114538|NCT03430986|54773228|FG001|24-week Control Period|Protocol Deviation|2|||
28114539|NCT03430986|54773227|FG000|24-week Post-Control Period|Lost to Follow-up|1|||
28114540|NCT03430986|54773228|FG001|24-week Post-Control Period|Lost to Follow-up|1|||
28114541|NCT03430986|54773227|FG000|24-week Post-Control Period|Withdrawal by Participant|0|||
28114542|NCT03430986|54773228|FG001|24-week Post-Control Period|Withdrawal by Participant|1|||
28114543|NCT03448536|54773239|FG000|Overall Study|Protocol Violation|2|||
28114544|NCT03448536|54773240|FG001|Overall Study|Protocol Violation|0|||
28114545|NCT03448536|54773239|FG000|Overall Study|Pregnancy|1|||
28114546|NCT03448536|54773240|FG001|Overall Study|Pregnancy|0|||
28114547|NCT03448536|54773239|FG000|Overall Study|Withdrawal by Subject|1|||
28114548|NCT03448536|54773240|FG001|Overall Study|Withdrawal by Subject|2|||
28114549|NCT03448536|54773239|FG000|Overall Study|Lost to Follow-up|3|||
28114550|NCT03448536|54773240|FG001|Overall Study|Lost to Follow-up|2|||
28114551|NCT03448536|54773239|FG000|Overall Study|Inadequate pain reporter|1|||
28114552|NCT03448536|54773240|FG001|Overall Study|Inadequate pain reporter|0|||
28114553|NCT03448536|54773239|FG000|Overall Study|Other|3|||
28114554|NCT03448536|54773240|FG001|Overall Study|Other|0|||
27816523|NCT01894243|54273514|FG000|Overall Study|Death|0|||
27816524|NCT01894243|54273515|FG001|Overall Study|Death|0|||
27816525|NCT01894243|54273516|FG002|Overall Study|Death|3|||
27816526|NCT01894243|54273514|FG000|Overall Study|Lack of Efficacy|3|||
27816527|NCT01894243|54273515|FG001|Overall Study|Lack of Efficacy|3|||
27816528|NCT01894243|54273516|FG002|Overall Study|Lack of Efficacy|1|||
27816529|NCT01894243|54273514|FG000|Overall Study|Condition under investigation worsened|8|||
27816530|NCT01894243|54273515|FG001|Overall Study|Condition under investigation worsened|6|||
27816531|NCT01894243|54273516|FG002|Overall Study|Condition under investigation worsened|2|||
27816532|NCT01894243|54273514|FG000|Overall Study|Subject decision|1|||
27816533|NCT01894243|54273515|FG001|Overall Study|Subject decision|0|||
27816534|NCT01894243|54273516|FG002|Overall Study|Subject decision|0|||
27816535|NCT01894243|54273514|FG000|Overall Study|Other|1|||
27816536|NCT01894243|54273515|FG001|Overall Study|Other|0|||
27816537|NCT01894243|54273516|FG002|Overall Study|Other|0|||
27816538|NCT03822832|54273533|FG000|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
28114555|NCT03448536|54773239|FG000|Overall Study|Physician Decision|1|||
28114556|NCT03448536|54773240|FG001|Overall Study|Physician Decision|0|||
27816539|NCT03822832|54273534|FG001|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
27816540|NCT03822832|54273533|FG000|Period 1 - Double Blind Period|Lost to Follow-up|1|||
28114557|NCT03448224|54773248|FG000|Overall Study|Provided same answer to every question|1|||
27816541|NCT03822832|54273534|FG001|Period 1 - Double Blind Period|Lost to Follow-up|1|||
27816542|NCT03822832|54273533|FG000|Period 1 - Double Blind Period|Protocol Violation|1|||
27816543|NCT03822832|54273534|FG001|Period 1 - Double Blind Period|Protocol Violation|1|||
27816544|NCT03822832|54273533|FG000|Period 1 - Double Blind Period|Lack of Efficacy|2|||
27816545|NCT03822832|54273534|FG001|Period 1 - Double Blind Period|Lack of Efficacy|1|||
27816546|NCT03822832|54273533|FG000|Period 1 - Double Blind Period|Adverse Event|3|||
27816547|NCT03822832|54273534|FG001|Period 1 - Double Blind Period|Adverse Event|5|||
27816548|NCT03822832|54273533|FG000|Re-allocation|Not re-allocated to open label period|2|||
27816549|NCT03822832|54273534|FG001|Re-allocation|Not re-allocated to open label period|6|||
27816550|NCT03822832|54273533|FG000|Period 2 - Open Label Period|Lost to Follow-up|1|||
27816551|NCT03822832|54273534|FG001|Period 2 - Open Label Period|Lost to Follow-up|0|||
27816552|NCT03822832|54273533|FG000|Period 2 - Open Label Period|Adverse Event|0|||
27816553|NCT03822832|54273534|FG001|Period 2 - Open Label Period|Adverse Event|3|||
27816554|NCT01513239|54273544|FG000|Period 1: Main Phase|Adverse Event|1|||
27816555|NCT01513239|54273545|FG001|Period 1: Main Phase|Adverse Event|1|||
27816556|NCT01513239|54273546|FG002|Period 1: Main Phase|Adverse Event|2|||
27816557|NCT01513239|54273547|FG003|Period 1: Main Phase|Adverse Event|0|||
27816558|NCT01513239|54273548|FG004|Period 1: Main Phase|Adverse Event|0|||
27816559|NCT01513239|54273549|FG005|Period 1: Main Phase|Adverse Event|0|||
27816560|NCT01513239|54273544|FG000|Period 1: Main Phase|Death|29|||
27816561|NCT01513239|54273545|FG001|Period 1: Main Phase|Death|22|||
27816562|NCT01513239|54273546|FG002|Period 1: Main Phase|Death|32|||
28114558|NCT03448224|54773249|FG001|Overall Study|Provided same answer to every question|0|||
28114559|NCT03424044|54773255|FG000|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
28114560|NCT03424044|54773256|FG001|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
28114561|NCT03424044|54773257|FG002|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1|||
28114562|NCT03424044|54773258|FG003|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
28114563|NCT03424044|54773259|FG004|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
28114564|NCT03424044|54773260|FG005|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
28114565|NCT03424044|54773261|FG006|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
28114566|NCT03424044|54773262|FG007|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
28114567|NCT03424044|54773263|FG008|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
28114568|NCT03424044|54773255|FG000|First Intervention (76 Hours)|Adverse Event|0|||
28114569|NCT03424044|54773256|FG001|First Intervention (76 Hours)|Adverse Event|0|||
28114570|NCT03424044|54773257|FG002|First Intervention (76 Hours)|Adverse Event|0|||
28114571|NCT03424044|54773258|FG003|First Intervention (76 Hours)|Adverse Event|0|||
28114572|NCT03424044|54773259|FG004|First Intervention (76 Hours)|Adverse Event|1|||
28114573|NCT03424044|54773260|FG005|First Intervention (76 Hours)|Adverse Event|0|||
28114574|NCT03424044|54773261|FG006|First Intervention (76 Hours)|Adverse Event|0|||
28114575|NCT03424044|54773262|FG007|First Intervention (76 Hours)|Adverse Event|0|||
28114576|NCT03424044|54773263|FG008|First Intervention (76 Hours)|Adverse Event|0|||
28114577|NCT03424044|54773255|FG000|First Intervention (76 Hours)|device issues|0|||
28114578|NCT03424044|54773256|FG001|First Intervention (76 Hours)|device issues|0|||
28114579|NCT03424044|54773257|FG002|First Intervention (76 Hours)|device issues|0|||
28114580|NCT03424044|54773258|FG003|First Intervention (76 Hours)|device issues|0|||
28114581|NCT03424044|54773259|FG004|First Intervention (76 Hours)|device issues|0|||
28114582|NCT03424044|54773260|FG005|First Intervention (76 Hours)|device issues|0|||
28114583|NCT03424044|54773261|FG006|First Intervention (76 Hours)|device issues|1|||
28114584|NCT03424044|54773262|FG007|First Intervention (76 Hours)|device issues|1|||
28114585|NCT03424044|54773263|FG008|First Intervention (76 Hours)|device issues|1|||
28114586|NCT03424044|54773255|FG000|Third Intervention (76 Hours)|Adverse Event|1|||
28114587|NCT03424044|54773256|FG001|Third Intervention (76 Hours)|Adverse Event|0|||
28114588|NCT03424044|54773257|FG002|Third Intervention (76 Hours)|Adverse Event|0|||
28114589|NCT03424044|54773258|FG003|Third Intervention (76 Hours)|Adverse Event|0|||
28114590|NCT03424044|54773259|FG004|Third Intervention (76 Hours)|Adverse Event|0|||
28114591|NCT03424044|54773260|FG005|Third Intervention (76 Hours)|Adverse Event|0|||
28114592|NCT03424044|54773261|FG006|Third Intervention (76 Hours)|Adverse Event|1|||
28114593|NCT03424044|54773262|FG007|Third Intervention (76 Hours)|Adverse Event|0|||
28114594|NCT03424044|54773263|FG008|Third Intervention (76 Hours)|Adverse Event|0|||
28114595|NCT03424044|54773255|FG000|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
28114596|NCT03424044|54773256|FG001|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
27816563|NCT01513239|54273547|FG003|Period 1: Main Phase|Death|0|||
27816564|NCT01513239|54273548|FG004|Period 1: Main Phase|Death|0|||
27816565|NCT01513239|54273549|FG005|Period 1: Main Phase|Death|0|||
27816566|NCT01513239|54273544|FG000|Period 1: Main Phase|Lost to Follow-up|11|||
27816567|NCT01513239|54273545|FG001|Period 1: Main Phase|Lost to Follow-up|10|||
28114597|NCT03424044|54773257|FG002|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
28114598|NCT03424044|54773258|FG003|Third Intervention (76 Hours)|Withdrawal by Subject|1|||
28114599|NCT03424044|54773259|FG004|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
28114600|NCT03424044|54773260|FG005|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
28114601|NCT03424044|54773261|FG006|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
28114602|NCT03424044|54773262|FG007|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
28114603|NCT03424044|54773263|FG008|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
28114604|NCT03422250|54773277|FG000|Intervention|Adverse Event|0|||
28114605|NCT03422250|54773278|FG001|Intervention|Adverse Event|1|||
28114606|NCT03422250|54773279|FG002|Intervention|Adverse Event|0|||
28114607|NCT03422250|54773280|FG003|Intervention|Adverse Event|1|||
28114608|NCT03422250|54773277|FG000|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|1|||
28114609|NCT03422250|54773278|FG001|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
28114610|NCT03422250|54773279|FG002|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|2|||
28114611|NCT03422250|54773280|FG003|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
28114612|NCT03422250|54773277|FG000|Follow-up|Withdrawal by Subject|0|||
28114613|NCT03422250|54773278|FG001|Follow-up|Withdrawal by Subject|0|||
28114614|NCT03422250|54773279|FG002|Follow-up|Withdrawal by Subject|0|||
28114615|NCT03422250|54773280|FG003|Follow-up|Withdrawal by Subject|1|||
28114616|NCT03422250|54773277|FG000|Follow-up|Adverse Event|0|||
28114617|NCT03422250|54773278|FG001|Follow-up|Adverse Event|0|||
28114618|NCT03422250|54773279|FG002|Follow-up|Adverse Event|0|||
28114619|NCT03422250|54773280|FG003|Follow-up|Adverse Event|1|||
28114620|NCT01266031|54773295|FG000|Overall Study|Not treated|0|||
28114621|NCT01266031|54773296|FG001|Overall Study|Not treated|3|||
28114622|NCT01266031|54773297|FG002|Overall Study|Not treated|2|||
28114623|NCT00075725|54773328|FG000|Overall Study|Adverse Event|6|||
28114624|NCT00075725|54773329|FG001|Overall Study|Adverse Event|6|||
28114625|NCT00075725|54773330|FG002|Overall Study|Adverse Event|20|||
28114626|NCT00075725|54773331|FG003|Overall Study|Adverse Event|8|||
28114627|NCT00075725|54773332|FG004|Overall Study|Adverse Event|4|||
28114628|NCT00075725|54773333|FG005|Overall Study|Adverse Event|38|||
27816568|NCT01513239|54273546|FG002|Period 1: Main Phase|Lost to Follow-up|6|||
28114629|NCT00075725|54773334|FG006|Overall Study|Adverse Event|3|||
28114630|NCT00075725|54773335|FG007|Overall Study|Adverse Event|51|||
28114631|NCT00075725|54773336|FG008|Overall Study|Adverse Event|15|||
28114632|NCT00075725|54773337|FG009|Overall Study|Adverse Event|4|||
28114633|NCT00075725|54773338|FG010|Overall Study|Adverse Event|2|||
27816569|NCT01513239|54273547|FG003|Period 1: Main Phase|Lost to Follow-up|0|||
28114634|NCT00075725|54773339|FG011|Overall Study|Adverse Event|2|||
28114635|NCT00075725|54773328|FG000|Overall Study|Death|3|||
28114636|NCT00075725|54773329|FG001|Overall Study|Death|5|||
28114637|NCT00075725|54773330|FG002|Overall Study|Death|10|||
28114638|NCT00075725|54773331|FG003|Overall Study|Death|2|||
28114639|NCT00075725|54773332|FG004|Overall Study|Death|3|||
28114640|NCT00075725|54773333|FG005|Overall Study|Death|25|||
28114641|NCT00075725|54773334|FG006|Overall Study|Death|4|||
28114642|NCT00075725|54773335|FG007|Overall Study|Death|22|||
28114643|NCT00075725|54773336|FG008|Overall Study|Death|14|||
28114644|NCT00075725|54773337|FG009|Overall Study|Death|4|||
28114645|NCT00075725|54773338|FG010|Overall Study|Death|3|||
28114646|NCT00075725|54773339|FG011|Overall Study|Death|0|||
28114647|NCT00075725|54773328|FG000|Overall Study|Lost to Follow-up|1|||
28114648|NCT00075725|54773329|FG001|Overall Study|Lost to Follow-up|1|||
28114649|NCT00075725|54773330|FG002|Overall Study|Lost to Follow-up|4|||
28114650|NCT00075725|54773331|FG003|Overall Study|Lost to Follow-up|1|||
28065020|NCT00291018|54720684|FG001|Overall Study|Not Consented or Declined PAS|15|||
28065021|NCT00291018|54720685|FG002|Overall Study|Not Consented or Declined PAS|15|||
28065022|NCT00291018|54720683|FG000|Overall Study|Death|3|||
28065023|NCT00291018|54720684|FG001|Overall Study|Death|3|||
28065024|NCT00291018|54720685|FG002|Overall Study|Death|4|||
28065025|NCT00291018|54720683|FG000|Overall Study|Withdrawal by Subject|2|||
28065026|NCT00291018|54720684|FG001|Overall Study|Withdrawal by Subject|8|||
28065027|NCT00291018|54720685|FG002|Overall Study|Withdrawal by Subject|1|||
28065028|NCT00291018|54720683|FG000|Overall Study|Failures|5|||
28065029|NCT00291018|54720684|FG001|Overall Study|Failures|12|||
28065030|NCT00291018|54720685|FG002|Overall Study|Failures|5|||
28065031|NCT00291018|54720683|FG000|Overall Study|Lost to Follow-up|3|||
28065032|NCT00291018|54720684|FG001|Overall Study|Lost to Follow-up|4|||
28065033|NCT00291018|54720685|FG002|Overall Study|Lost to Follow-up|18|||
28065034|NCT00320606|54720696|FG000|Overall Study|Adverse Event|1|||
28065035|NCT00320606|54720696|FG000|Overall Study|Protocol Violation|1|||
28065036|NCT00320606|54720696|FG000|Overall Study|Withdrawal by Subject|1|||
28065037|NCT00307736|54720701|FG000|Overall Study|Adverse Event|0|||
28065038|NCT00307736|54720702|FG001|Overall Study|Adverse Event|0|||
28065039|NCT00307736|54720703|FG002|Overall Study|Adverse Event|1|||
28065040|NCT00307736|54720704|FG003|Overall Study|Adverse Event|3|||
28065041|NCT00307736|54720701|FG000|Overall Study|Withdrawal by Subject|0|||
28065042|NCT00307736|54720702|FG001|Overall Study|Withdrawal by Subject|0|||
28065043|NCT00307736|54720703|FG002|Overall Study|Withdrawal by Subject|2|||
28065044|NCT00307736|54720704|FG003|Overall Study|Withdrawal by Subject|0|||
28065045|NCT00320528|54720718|FG000|Study Period II|Adverse Event|3|||
28065046|NCT00320528|54720719|FG001|Study Period II|Adverse Event|4|||
28065047|NCT00320528|54720720|FG002|Study Period II|Adverse Event|8|||
28065048|NCT00320528|54720718|FG000|Study Period II|Parent/Caregiver Decision|8|||
28065049|NCT00320528|54720719|FG001|Study Period II|Parent/Caregiver Decision|3|||
28065050|NCT00320528|54720720|FG002|Study Period II|Parent/Caregiver Decision|11|||
28065051|NCT00320528|54720718|FG000|Study Period II|Withdrawal by Subject|0|||
28065052|NCT00320528|54720719|FG001|Study Period II|Withdrawal by Subject|1|||
28065053|NCT00320528|54720720|FG002|Study Period II|Withdrawal by Subject|1|||
28065054|NCT00320528|54720718|FG000|Study Period II|Entry Criteria Exclusion|0|||
28065055|NCT00320528|54720719|FG001|Study Period II|Entry Criteria Exclusion|2|||
28065056|NCT00320528|54720720|FG002|Study Period II|Entry Criteria Exclusion|2|||
28065057|NCT00320528|54720718|FG000|Study Period III|Adverse Event|1|||
28065058|NCT00320528|54720719|FG001|Study Period III|Adverse Event|0|||
28065059|NCT00320528|54720720|FG002|Study Period III|Adverse Event|0|||
28065060|NCT00320528|54720718|FG000|Study Period III|Lost to Follow-up|1|||
28065061|NCT00320528|54720719|FG001|Study Period III|Lost to Follow-up|0|||
28065062|NCT00320528|54720720|FG002|Study Period III|Lost to Follow-up|0|||
28065063|NCT00320528|54720718|FG000|Study Period III|Withdrawal by Subject|1|||
28065064|NCT00320528|54720719|FG001|Study Period III|Withdrawal by Subject|1|||
28065065|NCT00320528|54720720|FG002|Study Period III|Withdrawal by Subject|2|||
28065066|NCT00320528|54720718|FG000|Study Period III|Lack of Efficacy|2|||
28065067|NCT00320528|54720719|FG001|Study Period III|Lack of Efficacy|0|||
28065068|NCT00320528|54720720|FG002|Study Period III|Lack of Efficacy|0|||
28114651|NCT00075725|54773332|FG004|Overall Study|Lost to Follow-up|0|||
28114652|NCT00075725|54773333|FG005|Overall Study|Lost to Follow-up|13|||
28114653|NCT00075725|54773334|FG006|Overall Study|Lost to Follow-up|2|||
28114654|NCT00075725|54773335|FG007|Overall Study|Lost to Follow-up|4|||
27816570|NCT01513239|54273548|FG004|Period 1: Main Phase|Lost to Follow-up|0|||
27816571|NCT01513239|54273549|FG005|Period 1: Main Phase|Lost to Follow-up|0|||
27816572|NCT01513239|54273544|FG000|Period 1: Main Phase|Physician Decision|4|||
28114655|NCT00075725|54773336|FG008|Overall Study|Lost to Follow-up|1|||
28114656|NCT00075725|54773337|FG009|Overall Study|Lost to Follow-up|0|||
28114657|NCT00075725|54773338|FG010|Overall Study|Lost to Follow-up|0|||
28114658|NCT00075725|54773339|FG011|Overall Study|Lost to Follow-up|0|||
28114659|NCT00075725|54773328|FG000|Overall Study|Physician Decision|2|||
28114660|NCT00075725|54773329|FG001|Overall Study|Physician Decision|6|||
28114661|NCT00075725|54773330|FG002|Overall Study|Physician Decision|5|||
28114662|NCT00075725|54773331|FG003|Overall Study|Physician Decision|8|||
28114663|NCT00075725|54773332|FG004|Overall Study|Physician Decision|4|||
28114664|NCT00075725|54773333|FG005|Overall Study|Physician Decision|19|||
28114665|NCT00075725|54773334|FG006|Overall Study|Physician Decision|3|||
28114666|NCT00075725|54773335|FG007|Overall Study|Physician Decision|17|||
28114667|NCT00075725|54773336|FG008|Overall Study|Physician Decision|5|||
28114668|NCT00075725|54773337|FG009|Overall Study|Physician Decision|0|||
28114669|NCT00075725|54773338|FG010|Overall Study|Physician Decision|1|||
28114670|NCT00075725|54773339|FG011|Overall Study|Physician Decision|0|||
28114671|NCT00075725|54773328|FG000|Overall Study|Pregnancy|0|||
28114672|NCT00075725|54773329|FG001|Overall Study|Pregnancy|0|||
28114673|NCT00075725|54773330|FG002|Overall Study|Pregnancy|0|||
28114674|NCT00075725|54773331|FG003|Overall Study|Pregnancy|0|||
28114675|NCT00075725|54773332|FG004|Overall Study|Pregnancy|0|||
28114676|NCT00075725|54773333|FG005|Overall Study|Pregnancy|1|||
28114677|NCT00075725|54773334|FG006|Overall Study|Pregnancy|0|||
28114678|NCT00075725|54773335|FG007|Overall Study|Pregnancy|1|||
28114679|NCT00075725|54773336|FG008|Overall Study|Pregnancy|0|||
28114680|NCT00075725|54773337|FG009|Overall Study|Pregnancy|0|||
28114681|NCT00075725|54773338|FG010|Overall Study|Pregnancy|0|||
28114682|NCT00075725|54773339|FG011|Overall Study|Pregnancy|0|||
28114683|NCT00075725|54773328|FG000|Overall Study|Protocol Violation|1|||
28114684|NCT00075725|54773329|FG001|Overall Study|Protocol Violation|1|||
28114685|NCT00075725|54773330|FG002|Overall Study|Protocol Violation|0|||
28114686|NCT00075725|54773331|FG003|Overall Study|Protocol Violation|3|||
28114687|NCT00075725|54773332|FG004|Overall Study|Protocol Violation|3|||
28114688|NCT00075725|54773333|FG005|Overall Study|Protocol Violation|2|||
28114689|NCT00075725|54773334|FG006|Overall Study|Protocol Violation|1|||
28114690|NCT00075725|54773335|FG007|Overall Study|Protocol Violation|2|||
28114691|NCT00075725|54773336|FG008|Overall Study|Protocol Violation|3|||
28114692|NCT00075725|54773337|FG009|Overall Study|Protocol Violation|0|||
28114693|NCT00075725|54773338|FG010|Overall Study|Protocol Violation|0|||
28114694|NCT00075725|54773339|FG011|Overall Study|Protocol Violation|1|||
28114695|NCT00075725|54773328|FG000|Overall Study|Withdrawal by Subject|12|||
28114696|NCT00075725|54773329|FG001|Overall Study|Withdrawal by Subject|3|||
28114697|NCT00075725|54773330|FG002|Overall Study|Withdrawal by Subject|6|||
28114698|NCT00075725|54773331|FG003|Overall Study|Withdrawal by Subject|10|||
28114699|NCT00075725|54773332|FG004|Overall Study|Withdrawal by Subject|6|||
28114700|NCT00075725|54773333|FG005|Overall Study|Withdrawal by Subject|27|||
28114701|NCT00075725|54773334|FG006|Overall Study|Withdrawal by Subject|7|||
28114702|NCT00075725|54773335|FG007|Overall Study|Withdrawal by Subject|31|||
28114703|NCT00075725|54773336|FG008|Overall Study|Withdrawal by Subject|10|||
28114704|NCT00075725|54773337|FG009|Overall Study|Withdrawal by Subject|2|||
28114705|NCT00075725|54773338|FG010|Overall Study|Withdrawal by Subject|0|||
28114706|NCT00075725|54773339|FG011|Overall Study|Withdrawal by Subject|0|||
28114707|NCT00075725|54773328|FG000|Overall Study|Disease Progression, all other reasons|17|||
28114708|NCT00075725|54773329|FG001|Overall Study|Disease Progression, all other reasons|5|||
28065069|NCT00320528|54720718|FG000|Study Period III|Parent/Caregiver Decision|14|||
28065070|NCT00320528|54720719|FG001|Study Period III|Parent/Caregiver Decision|3|||
28065071|NCT00320528|54720720|FG002|Study Period III|Parent/Caregiver Decision|11|||
28065072|NCT00320528|54720718|FG000|Study Period III|Protocol Violation|0|||
28065073|NCT00320528|54720719|FG001|Study Period III|Protocol Violation|1|||
28065074|NCT00320528|54720720|FG002|Study Period III|Protocol Violation|0|||
28065075|NCT00320528|54720718|FG000|Study Period III|Physician Decision|0|||
28065076|NCT00320528|54720719|FG001|Study Period III|Physician Decision|1|||
28114709|NCT00075725|54773330|FG002|Overall Study|Disease Progression, all other reasons|33|||
28114710|NCT00075725|54773331|FG003|Overall Study|Disease Progression, all other reasons|6|||
28114711|NCT00075725|54773332|FG004|Overall Study|Disease Progression, all other reasons|21|||
27816573|NCT01513239|54273545|FG001|Period 1: Main Phase|Physician Decision|4|||
27848760|NCT01360632|54343098|FG001|Phase A (8 Weeks)|Adverse Event|0|||
28114712|NCT00075725|54773333|FG005|Overall Study|Disease Progression, all other reasons|59|||
28114713|NCT00075725|54773334|FG006|Overall Study|Disease Progression, all other reasons|20|||
28114714|NCT00075725|54773335|FG007|Overall Study|Disease Progression, all other reasons|46|||
28114715|NCT00075725|54773336|FG008|Overall Study|Disease Progression, all other reasons|21|||
28114716|NCT00075725|54773337|FG009|Overall Study|Disease Progression, all other reasons|4|||
28114717|NCT00075725|54773338|FG010|Overall Study|Disease Progression, all other reasons|0|||
28114718|NCT00075725|54773339|FG011|Overall Study|Disease Progression, all other reasons|5|||
28114719|NCT00075725|54773328|FG000|Overall Study|Patient off treatment|0|||
28114720|NCT00075725|54773329|FG001|Overall Study|Patient off treatment|0|||
28114721|NCT00075725|54773330|FG002|Overall Study|Patient off treatment|1|||
28114722|NCT00075725|54773331|FG003|Overall Study|Patient off treatment|2|||
27816574|NCT01513239|54273546|FG002|Period 1: Main Phase|Physician Decision|4|||
28114723|NCT00075725|54773332|FG004|Overall Study|Patient off treatment|1|||
28114724|NCT00075725|54773333|FG005|Overall Study|Patient off treatment|0|||
28114725|NCT00075725|54773334|FG006|Overall Study|Patient off treatment|0|||
28114726|NCT00075725|54773335|FG007|Overall Study|Patient off treatment|2|||
28114727|NCT00075725|54773336|FG008|Overall Study|Patient off treatment|1|||
28114728|NCT00075725|54773337|FG009|Overall Study|Patient off treatment|0|||
28114729|NCT00075725|54773338|FG010|Overall Study|Patient off treatment|0|||
28114730|NCT00075725|54773339|FG011|Overall Study|Patient off treatment|0|||
28114731|NCT00075725|54773328|FG000|Overall Study|Ineligible or wrong diagnosis|8|||
28114732|NCT00075725|54773329|FG001|Overall Study|Ineligible or wrong diagnosis|3|||
28114733|NCT00075725|54773330|FG002|Overall Study|Ineligible or wrong diagnosis|3|||
28114734|NCT00075725|54773331|FG003|Overall Study|Ineligible or wrong diagnosis|10|||
28114735|NCT00075725|54773332|FG004|Overall Study|Ineligible or wrong diagnosis|3|||
28114736|NCT00075725|54773333|FG005|Overall Study|Ineligible or wrong diagnosis|17|||
28114737|NCT00075725|54773334|FG006|Overall Study|Ineligible or wrong diagnosis|6|||
28114738|NCT00075725|54773335|FG007|Overall Study|Ineligible or wrong diagnosis|9|||
28114739|NCT00075725|54773336|FG008|Overall Study|Ineligible or wrong diagnosis|10|||
28114740|NCT00075725|54773337|FG009|Overall Study|Ineligible or wrong diagnosis|1|||
28114741|NCT00075725|54773338|FG010|Overall Study|Ineligible or wrong diagnosis|2|||
28114742|NCT00075725|54773339|FG011|Overall Study|Ineligible or wrong diagnosis|4|||
28114743|NCT00075725|54773328|FG000|Overall Study|Pt/Guardian refused RT therapy|1|||
28114744|NCT00075725|54773329|FG001|Overall Study|Pt/Guardian refused RT therapy|0|||
28114745|NCT00075725|54773330|FG002|Overall Study|Pt/Guardian refused RT therapy|1|||
28114746|NCT00075725|54773331|FG003|Overall Study|Pt/Guardian refused RT therapy|2|||
28114747|NCT00075725|54773332|FG004|Overall Study|Pt/Guardian refused RT therapy|1|||
28114748|NCT00075725|54773333|FG005|Overall Study|Pt/Guardian refused RT therapy|0|||
28114749|NCT00075725|54773334|FG006|Overall Study|Pt/Guardian refused RT therapy|0|||
28114750|NCT00075725|54773335|FG007|Overall Study|Pt/Guardian refused RT therapy|0|||
28114751|NCT00075725|54773336|FG008|Overall Study|Pt/Guardian refused RT therapy|0|||
28114752|NCT00075725|54773337|FG009|Overall Study|Pt/Guardian refused RT therapy|0|||
28114753|NCT00075725|54773338|FG010|Overall Study|Pt/Guardian refused RT therapy|0|||
28114754|NCT00075725|54773339|FG011|Overall Study|Pt/Guardian refused RT therapy|0|||
28114755|NCT00075725|54773328|FG000|Overall Study|Pt non compliant with therapy|2|||
28114756|NCT00075725|54773329|FG001|Overall Study|Pt non compliant with therapy|1|||
28114757|NCT00075725|54773330|FG002|Overall Study|Pt non compliant with therapy|1|||
28114758|NCT00075725|54773331|FG003|Overall Study|Pt non compliant with therapy|0|||
28114759|NCT00075725|54773332|FG004|Overall Study|Pt non compliant with therapy|2|||
28114760|NCT00075725|54773333|FG005|Overall Study|Pt non compliant with therapy|14|||
28114761|NCT00075725|54773334|FG006|Overall Study|Pt non compliant with therapy|2|||
28114762|NCT00075725|54773335|FG007|Overall Study|Pt non compliant with therapy|5|||
28114763|NCT00075725|54773336|FG008|Overall Study|Pt non compliant with therapy|3|||
28114764|NCT00075725|54773337|FG009|Overall Study|Pt non compliant with therapy|0|||
27816575|NCT01513239|54273547|FG003|Period 1: Main Phase|Physician Decision|0|||
28114765|NCT00075725|54773338|FG010|Overall Study|Pt non compliant with therapy|0|||
28114766|NCT00075725|54773339|FG011|Overall Study|Pt non compliant with therapy|0|||
28114767|NCT00075725|54773328|FG000|Overall Study|Pt age out of range for treatment|0|||
28114768|NCT00075725|54773329|FG001|Overall Study|Pt age out of range for treatment|1|||
28114769|NCT00075725|54773330|FG002|Overall Study|Pt age out of range for treatment|0|||
28114770|NCT00075725|54773331|FG003|Overall Study|Pt age out of range for treatment|0|||
28114771|NCT00075725|54773332|FG004|Overall Study|Pt age out of range for treatment|0|||
28114772|NCT00075725|54773333|FG005|Overall Study|Pt age out of range for treatment|1|||
28114773|NCT00075725|54773334|FG006|Overall Study|Pt age out of range for treatment|0|||
28114774|NCT00075725|54773335|FG007|Overall Study|Pt age out of range for treatment|1|||
28114775|NCT00075725|54773336|FG008|Overall Study|Pt age out of range for treatment|0|||
28114776|NCT00075725|54773337|FG009|Overall Study|Pt age out of range for treatment|0|||
28114777|NCT00075725|54773338|FG010|Overall Study|Pt age out of range for treatment|0|||
28114778|NCT00075725|54773339|FG011|Overall Study|Pt age out of range for treatment|0|||
28114779|NCT00075725|54773328|FG000|Overall Study|Insurance issues|0|||
28114780|NCT00075725|54773329|FG001|Overall Study|Insurance issues|1|||
28114781|NCT00075725|54773330|FG002|Overall Study|Insurance issues|0|||
28114782|NCT00075725|54773331|FG003|Overall Study|Insurance issues|1|||
28114783|NCT00075725|54773332|FG004|Overall Study|Insurance issues|1|||
28114784|NCT00075725|54773333|FG005|Overall Study|Insurance issues|1|||
28114785|NCT00075725|54773334|FG006|Overall Study|Insurance issues|0|||
28114786|NCT00075725|54773335|FG007|Overall Study|Insurance issues|1|||
28114787|NCT00075725|54773336|FG008|Overall Study|Insurance issues|0|||
28114788|NCT00075725|54773337|FG009|Overall Study|Insurance issues|0|||
28114789|NCT00075725|54773338|FG010|Overall Study|Insurance issues|0|||
28114790|NCT00075725|54773339|FG011|Overall Study|Insurance issues|0|||
28114791|NCT00075725|54773328|FG000|Overall Study|MRD positive after extended ind|0|||
28114792|NCT00075725|54773329|FG001|Overall Study|MRD positive after extended ind|1|||
28114793|NCT00075725|54773330|FG002|Overall Study|MRD positive after extended ind|1|||
28114794|NCT00075725|54773331|FG003|Overall Study|MRD positive after extended ind|0|||
28114795|NCT00075725|54773332|FG004|Overall Study|MRD positive after extended ind|1|||
28114796|NCT00075725|54773333|FG005|Overall Study|MRD positive after extended ind|2|||
28114797|NCT00075725|54773334|FG006|Overall Study|MRD positive after extended ind|0|||
28114798|NCT00075725|54773335|FG007|Overall Study|MRD positive after extended ind|1|||
28114799|NCT00075725|54773336|FG008|Overall Study|MRD positive after extended ind|0|||
28114800|NCT00075725|54773337|FG009|Overall Study|MRD positive after extended ind|0|||
28114801|NCT00075725|54773338|FG010|Overall Study|MRD positive after extended ind|0|||
28114802|NCT00075725|54773339|FG011|Overall Study|MRD positive after extended ind|0|||
28114803|NCT00075725|54773328|FG000|Overall Study|Pt has very high risk ALL characteristic|15|||
28114804|NCT00075725|54773329|FG001|Overall Study|Pt has very high risk ALL characteristic|11|||
28114805|NCT00075725|54773330|FG002|Overall Study|Pt has very high risk ALL characteristic|26|||
28114806|NCT00075725|54773331|FG003|Overall Study|Pt has very high risk ALL characteristic|18|||
28114807|NCT00075725|54773332|FG004|Overall Study|Pt has very high risk ALL characteristic|11|||
28114808|NCT00075725|54773333|FG005|Overall Study|Pt has very high risk ALL characteristic|75|||
28114809|NCT00075725|54773334|FG006|Overall Study|Pt has very high risk ALL characteristic|23|||
28114810|NCT00075725|54773335|FG007|Overall Study|Pt has very high risk ALL characteristic|74|||
28114811|NCT00075725|54773336|FG008|Overall Study|Pt has very high risk ALL characteristic|29|||
28114812|NCT00075725|54773337|FG009|Overall Study|Pt has very high risk ALL characteristic|1|||
28114813|NCT00075725|54773338|FG010|Overall Study|Pt has very high risk ALL characteristic|0|||
28114814|NCT00075725|54773339|FG011|Overall Study|Pt has very high risk ALL characteristic|3|||
28114815|NCT00075725|54773328|FG000|Overall Study|Inevaluable|1|||
28114816|NCT00075725|54773329|FG001|Overall Study|Inevaluable|1|||
28114817|NCT00075725|54773330|FG002|Overall Study|Inevaluable|4|||
28114818|NCT00075725|54773331|FG003|Overall Study|Inevaluable|2|||
28114819|NCT00075725|54773332|FG004|Overall Study|Inevaluable|2|||
28114820|NCT00075725|54773333|FG005|Overall Study|Inevaluable|9|||
28114821|NCT00075725|54773334|FG006|Overall Study|Inevaluable|1|||
28114822|NCT00075725|54773335|FG007|Overall Study|Inevaluable|11|||
28114823|NCT00075725|54773336|FG008|Overall Study|Inevaluable|2|||
28114824|NCT00075725|54773337|FG009|Overall Study|Inevaluable|0|||
28114825|NCT00075725|54773338|FG010|Overall Study|Inevaluable|1|||
28114826|NCT00075725|54773339|FG011|Overall Study|Inevaluable|0|||
28114827|NCT00075725|54773328|FG000|Overall Study|Other|4|||
28114828|NCT00075725|54773329|FG001|Overall Study|Other|2|||
28114829|NCT00075725|54773330|FG002|Overall Study|Other|1|||
28114830|NCT00075725|54773331|FG003|Overall Study|Other|1|||
28114831|NCT00075725|54773332|FG004|Overall Study|Other|1|||
28114832|NCT00075725|54773333|FG005|Overall Study|Other|4|||
28114833|NCT00075725|54773334|FG006|Overall Study|Other|2|||
28114834|NCT00075725|54773335|FG007|Overall Study|Other|9|||
28114835|NCT00075725|54773336|FG008|Overall Study|Other|2|||
28114836|NCT00075725|54773337|FG009|Overall Study|Other|1|||
28114837|NCT00075725|54773338|FG010|Overall Study|Other|0|||
28114838|NCT00075725|54773339|FG011|Overall Study|Other|3|||
28114839|NCT00075725|54773328|FG000|Overall Study|Pt trying to find a BM donor|0|||
28114840|NCT00075725|54773329|FG001|Overall Study|Pt trying to find a BM donor|1|||
28114841|NCT00075725|54773330|FG002|Overall Study|Pt trying to find a BM donor|0|||
28114842|NCT00075725|54773331|FG003|Overall Study|Pt trying to find a BM donor|0|||
28114843|NCT00075725|54773332|FG004|Overall Study|Pt trying to find a BM donor|0|||
28114844|NCT00075725|54773333|FG005|Overall Study|Pt trying to find a BM donor|0|||
28114845|NCT00075725|54773334|FG006|Overall Study|Pt trying to find a BM donor|0|||
28114846|NCT00075725|54773335|FG007|Overall Study|Pt trying to find a BM donor|0|||
28114847|NCT00075725|54773336|FG008|Overall Study|Pt trying to find a BM donor|0|||
28114848|NCT00075725|54773337|FG009|Overall Study|Pt trying to find a BM donor|0|||
28114849|NCT00075725|54773338|FG010|Overall Study|Pt trying to find a BM donor|0|||
28114850|NCT00075725|54773339|FG011|Overall Study|Pt trying to find a BM donor|0|||
28114851|NCT00075725|54773328|FG000|Overall Study|Clinic chart lost unable to recreate|0|||
28114852|NCT00075725|54773329|FG001|Overall Study|Clinic chart lost unable to recreate|0|||
28114853|NCT00075725|54773330|FG002|Overall Study|Clinic chart lost unable to recreate|1|||
28114854|NCT00075725|54773331|FG003|Overall Study|Clinic chart lost unable to recreate|0|||
28114855|NCT00075725|54773332|FG004|Overall Study|Clinic chart lost unable to recreate|0|||
28114856|NCT00075725|54773333|FG005|Overall Study|Clinic chart lost unable to recreate|0|||
28114857|NCT00075725|54773334|FG006|Overall Study|Clinic chart lost unable to recreate|0|||
28114858|NCT00075725|54773335|FG007|Overall Study|Clinic chart lost unable to recreate|0|||
28114859|NCT00075725|54773336|FG008|Overall Study|Clinic chart lost unable to recreate|0|||
28114860|NCT00075725|54773337|FG009|Overall Study|Clinic chart lost unable to recreate|0|||
28114861|NCT00075725|54773338|FG010|Overall Study|Clinic chart lost unable to recreate|0|||
28114862|NCT00075725|54773339|FG011|Overall Study|Clinic chart lost unable to recreate|0|||
28114863|NCT00075725|54773328|FG000|Overall Study|Unsuccessful institutional transfer|0|||
28114864|NCT00075725|54773329|FG001|Overall Study|Unsuccessful institutional transfer|0|||
28114865|NCT00075725|54773330|FG002|Overall Study|Unsuccessful institutional transfer|2|||
28114866|NCT00075725|54773331|FG003|Overall Study|Unsuccessful institutional transfer|0|||
28114867|NCT00075725|54773332|FG004|Overall Study|Unsuccessful institutional transfer|0|||
28114868|NCT00075725|54773333|FG005|Overall Study|Unsuccessful institutional transfer|0|||
28114869|NCT00075725|54773334|FG006|Overall Study|Unsuccessful institutional transfer|0|||
28114870|NCT00075725|54773335|FG007|Overall Study|Unsuccessful institutional transfer|0|||
28114871|NCT00075725|54773336|FG008|Overall Study|Unsuccessful institutional transfer|0|||
28114872|NCT00075725|54773337|FG009|Overall Study|Unsuccessful institutional transfer|1|||
28114873|NCT00075725|54773338|FG010|Overall Study|Unsuccessful institutional transfer|0|||
28114874|NCT00075725|54773339|FG011|Overall Study|Unsuccessful institutional transfer|0|||
28114875|NCT00075725|54773328|FG000|Overall Study|specimen(s) not submitted|0|||
28114876|NCT00075725|54773329|FG001|Overall Study|specimen(s) not submitted|0|||
28114877|NCT00075725|54773330|FG002|Overall Study|specimen(s) not submitted|2|||
28114878|NCT00075725|54773331|FG003|Overall Study|specimen(s) not submitted|0|||
28114879|NCT00075725|54773332|FG004|Overall Study|specimen(s) not submitted|0|||
28114880|NCT00075725|54773333|FG005|Overall Study|specimen(s) not submitted|0|||
28114881|NCT00075725|54773334|FG006|Overall Study|specimen(s) not submitted|0|||
28114882|NCT00075725|54773335|FG007|Overall Study|specimen(s) not submitted|0|||
28114883|NCT00075725|54773336|FG008|Overall Study|specimen(s) not submitted|0|||
28114884|NCT00075725|54773337|FG009|Overall Study|specimen(s) not submitted|0|||
28114885|NCT00075725|54773338|FG010|Overall Study|specimen(s) not submitted|0|||
28114886|NCT00075725|54773339|FG011|Overall Study|specimen(s) not submitted|0|||
28114887|NCT00075725|54773328|FG000|Overall Study|Pt went to transplant|0|||
28114888|NCT00075725|54773329|FG001|Overall Study|Pt went to transplant|0|||
28114889|NCT00075725|54773330|FG002|Overall Study|Pt went to transplant|0|||
28114890|NCT00075725|54773331|FG003|Overall Study|Pt went to transplant|1|||
28114891|NCT00075725|54773332|FG004|Overall Study|Pt went to transplant|0|||
28114892|NCT00075725|54773333|FG005|Overall Study|Pt went to transplant|1|||
28114893|NCT00075725|54773334|FG006|Overall Study|Pt went to transplant|0|||
28114894|NCT00075725|54773335|FG007|Overall Study|Pt went to transplant|0|||
28114895|NCT00075725|54773336|FG008|Overall Study|Pt went to transplant|0|||
28114896|NCT00075725|54773337|FG009|Overall Study|Pt went to transplant|0|||
28114897|NCT00075725|54773338|FG010|Overall Study|Pt went to transplant|0|||
28114898|NCT00075725|54773339|FG011|Overall Study|Pt went to transplant|0|||
28114899|NCT00075725|54773328|FG000|Overall Study|Pt received additional steroids|0|||
28114900|NCT00075725|54773329|FG001|Overall Study|Pt received additional steroids|0|||
28114901|NCT00075725|54773330|FG002|Overall Study|Pt received additional steroids|0|||
28114902|NCT00075725|54773331|FG003|Overall Study|Pt received additional steroids|1|||
28114903|NCT00075725|54773332|FG004|Overall Study|Pt received additional steroids|0|||
28114904|NCT00075725|54773333|FG005|Overall Study|Pt received additional steroids|0|||
28114905|NCT00075725|54773334|FG006|Overall Study|Pt received additional steroids|0|||
28114906|NCT00075725|54773335|FG007|Overall Study|Pt received additional steroids|0|||
28114907|NCT00075725|54773336|FG008|Overall Study|Pt received additional steroids|0|||
28114908|NCT00075725|54773337|FG009|Overall Study|Pt received additional steroids|0|||
28114909|NCT00075725|54773338|FG010|Overall Study|Pt received additional steroids|0|||
28114910|NCT00075725|54773339|FG011|Overall Study|Pt received additional steroids|0|||
28114911|NCT00075725|54773328|FG000|Overall Study|Pt relocated|0|||
28114912|NCT00075725|54773329|FG001|Overall Study|Pt relocated|0|||
28114913|NCT00075725|54773330|FG002|Overall Study|Pt relocated|0|||
28114914|NCT00075725|54773331|FG003|Overall Study|Pt relocated|2|||
28114915|NCT00075725|54773332|FG004|Overall Study|Pt relocated|0|||
28114916|NCT00075725|54773333|FG005|Overall Study|Pt relocated|1|||
28114917|NCT00075725|54773334|FG006|Overall Study|Pt relocated|1|||
28114918|NCT00075725|54773335|FG007|Overall Study|Pt relocated|2|||
28114919|NCT00075725|54773336|FG008|Overall Study|Pt relocated|1|||
28114920|NCT00075725|54773337|FG009|Overall Study|Pt relocated|0|||
28114921|NCT00075725|54773338|FG010|Overall Study|Pt relocated|0|||
28114922|NCT00075725|54773339|FG011|Overall Study|Pt relocated|0|||
28114923|NCT00075725|54773328|FG000|Overall Study|Institution Terminated|0|||
28114924|NCT00075725|54773329|FG001|Overall Study|Institution Terminated|0|||
28114925|NCT00075725|54773330|FG002|Overall Study|Institution Terminated|0|||
27816576|NCT01513239|54273548|FG004|Period 1: Main Phase|Physician Decision|0|||
27816577|NCT01513239|54273549|FG005|Period 1: Main Phase|Physician Decision|0|||
27816578|NCT01513239|54273544|FG000|Period 1: Main Phase|Protocol Violation|2|||
27816579|NCT01513239|54273545|FG001|Period 1: Main Phase|Protocol Violation|2|||
27816580|NCT01513239|54273546|FG002|Period 1: Main Phase|Protocol Violation|2|||
27816581|NCT01513239|54273547|FG003|Period 1: Main Phase|Protocol Violation|0|||
27816582|NCT01513239|54273548|FG004|Period 1: Main Phase|Protocol Violation|0|||
27816583|NCT01513239|54273549|FG005|Period 1: Main Phase|Protocol Violation|0|||
27816584|NCT01513239|54273544|FG000|Period 1: Main Phase|Technical Problems|1|||
27816585|NCT01513239|54273545|FG001|Period 1: Main Phase|Technical Problems|2|||
27816586|NCT01513239|54273546|FG002|Period 1: Main Phase|Technical Problems|0|||
27816587|NCT01513239|54273547|FG003|Period 1: Main Phase|Technical Problems|0|||
27816588|NCT01513239|54273548|FG004|Period 1: Main Phase|Technical Problems|0|||
27816589|NCT01513239|54273549|FG005|Period 1: Main Phase|Technical Problems|0|||
27816590|NCT01513239|54273544|FG000|Period 1: Main Phase|Withdrawal by Subject|27|||
27816591|NCT01513239|54273545|FG001|Period 1: Main Phase|Withdrawal by Subject|29|||
27816592|NCT01513239|54273546|FG002|Period 1: Main Phase|Withdrawal by Subject|42|||
28065077|NCT00320528|54720720|FG002|Study Period III|Physician Decision|2|||
28065078|NCT00320528|54720718|FG000|Study Period III|Sponsor Decision|0|||
28065079|NCT00320528|54720719|FG001|Study Period III|Sponsor Decision|0|||
28065080|NCT00320528|54720720|FG002|Study Period III|Sponsor Decision|1|||
28065081|NCT00320528|54720718|FG000|Study Period III|Atomoxetine Commercially Available|68|||
28065082|NCT00320528|54720719|FG001|Study Period III|Atomoxetine Commercially Available|25|||
28065083|NCT00320528|54720720|FG002|Study Period III|Atomoxetine Commercially Available|90|||
28065084|NCT00320372|54720731|FG000|Overall Study|Physician Decision|4|||
28065085|NCT00320372|54720732|FG001|Overall Study|Physician Decision|7|||
28065086|NCT00320372|54720731|FG000|Overall Study|Death|7|||
28065087|NCT00320372|54720732|FG001|Overall Study|Death|8|||
28065088|NCT00320372|54720731|FG000|Overall Study|Withdrawal by Subject|55|||
28065089|NCT00320372|54720732|FG001|Overall Study|Withdrawal by Subject|37|||
28065090|NCT00320372|54720731|FG000|Overall Study|Non-Compliance|40|||
28065091|NCT00320372|54720732|FG001|Overall Study|Non-Compliance|39|||
28065092|NCT00320372|54720731|FG000|Overall Study|Did not Meet (I/E)|3|||
28065093|NCT00320372|54720732|FG001|Overall Study|Did not Meet (I/E)|1|||
28065094|NCT00320372|54720731|FG000|Overall Study|Other (i.e. lost to f/u, site closure)|86|||
28065095|NCT00320372|54720732|FG001|Overall Study|Other (i.e. lost to f/u, site closure)|71|||
28065096|NCT00294762|54720748|FG000|Overall Study|Did not receive study treatment|3|||
28065097|NCT00294762|54720749|FG001|Overall Study|Did not receive study treatment|3|||
28065098|NCT00294684|54720757|FG000|Overall Study|Lost to Follow-up|5|||
28065099|NCT00294684|54720758|FG001|Overall Study|Lost to Follow-up|8|||
28065100|NCT00307034|54720766|FG000|Overall Study|Adverse Event|1|||
28065101|NCT00307034|54720767|FG001|Overall Study|Adverse Event|2|||
28065102|NCT00307034|54720766|FG000|Overall Study|Withdrawal by Subject|1|||
28065103|NCT00307034|54720767|FG001|Overall Study|Withdrawal by Subject|2|||
28065104|NCT00307034|54720766|FG000|Overall Study|Lost to Follow-up|0|||
28065105|NCT00307034|54720767|FG001|Overall Study|Lost to Follow-up|3|||
28065106|NCT00320216|54720778|FG000|Overall Study|Adverse Event|0|||
28065107|NCT00320216|54720779|FG001|Overall Study|Adverse Event|6|||
28065108|NCT00320216|54720780|FG002|Overall Study|Adverse Event|0|||
28114926|NCT00075725|54773331|FG003|Overall Study|Institution Terminated|0|||
28114927|NCT00075725|54773332|FG004|Overall Study|Institution Terminated|1|||
28114928|NCT00075725|54773333|FG005|Overall Study|Institution Terminated|0|||
27816593|NCT01513239|54273547|FG003|Period 1: Main Phase|Withdrawal by Subject|0|||
27816594|NCT01513239|54273548|FG004|Period 1: Main Phase|Withdrawal by Subject|0|||
27816595|NCT01513239|54273549|FG005|Period 1: Main Phase|Withdrawal by Subject|0|||
27816596|NCT01513239|54273544|FG000|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
27816597|NCT01513239|54273545|FG001|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
27816598|NCT01513239|54273546|FG002|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
28065109|NCT00320216|54720781|FG003|Overall Study|Adverse Event|2|||
28065110|NCT00320216|54720782|FG004|Overall Study|Adverse Event|2|||
28065111|NCT00320216|54720778|FG000|Overall Study|Lack of Efficacy|6|||
28114929|NCT00075725|54773334|FG006|Overall Study|Institution Terminated|0|||
28114930|NCT00075725|54773335|FG007|Overall Study|Institution Terminated|3|||
28114931|NCT00075725|54773336|FG008|Overall Study|Institution Terminated|0|||
28114932|NCT00075725|54773337|FG009|Overall Study|Institution Terminated|0|||
28114933|NCT00075725|54773338|FG010|Overall Study|Institution Terminated|0|||
28114934|NCT00075725|54773339|FG011|Overall Study|Institution Terminated|0|||
28114935|NCT00075725|54773328|FG000|Overall Study|Study Closure|1|||
28114936|NCT00075725|54773329|FG001|Overall Study|Study Closure|0|||
28114937|NCT00075725|54773330|FG002|Overall Study|Study Closure|0|||
28114938|NCT00075725|54773331|FG003|Overall Study|Study Closure|0|||
28114939|NCT00075725|54773332|FG004|Overall Study|Study Closure|1|||
28114940|NCT00075725|54773333|FG005|Overall Study|Study Closure|3|||
28114941|NCT00075725|54773334|FG006|Overall Study|Study Closure|0|||
28114942|NCT00075725|54773335|FG007|Overall Study|Study Closure|1|||
28114943|NCT00075725|54773336|FG008|Overall Study|Study Closure|0|||
28114944|NCT00075725|54773337|FG009|Overall Study|Study Closure|0|||
28114945|NCT00075725|54773338|FG010|Overall Study|Study Closure|0|||
28114946|NCT00075725|54773339|FG011|Overall Study|Study Closure|0|||
27816599|NCT01513239|54273547|FG003|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5|||
27816600|NCT01513239|54273548|FG004|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3|||
28114947|NCT00075725|54773328|FG000|Overall Study|Other complications|0|||
28114948|NCT00075725|54773329|FG001|Overall Study|Other complications|0|||
28114949|NCT00075725|54773330|FG002|Overall Study|Other complications|0|||
28114950|NCT00075725|54773331|FG003|Overall Study|Other complications|0|||
28114951|NCT00075725|54773332|FG004|Overall Study|Other complications|0|||
28114952|NCT00075725|54773333|FG005|Overall Study|Other complications|1|||
28114953|NCT00075725|54773334|FG006|Overall Study|Other complications|0|||
28114954|NCT00075725|54773335|FG007|Overall Study|Other complications|0|||
28114955|NCT00075725|54773336|FG008|Overall Study|Other complications|0|||
28114956|NCT00075725|54773337|FG009|Overall Study|Other complications|0|||
28114957|NCT00075725|54773338|FG010|Overall Study|Other complications|0|||
28114958|NCT00075725|54773339|FG011|Overall Study|Other complications|0|||
28114959|NCT00075725|54773328|FG000|Overall Study|Pt care terminated due to pt behavior|0|||
28114960|NCT00075725|54773329|FG001|Overall Study|Pt care terminated due to pt behavior|0|||
28114961|NCT00075725|54773330|FG002|Overall Study|Pt care terminated due to pt behavior|0|||
27816601|NCT01513239|54273549|FG005|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2|||
27816602|NCT01513239|54273544|FG000|Period 2: 9 Month Extension Phase|Death|0|||
28065112|NCT00320216|54720779|FG001|Overall Study|Lack of Efficacy|2|||
28065113|NCT00320216|54720780|FG002|Overall Study|Lack of Efficacy|1|||
28065114|NCT00320216|54720781|FG003|Overall Study|Lack of Efficacy|0|||
28065115|NCT00320216|54720782|FG004|Overall Study|Lack of Efficacy|1|||
28065116|NCT00320216|54720778|FG000|Overall Study|Lost to Follow-up|3|||
28114962|NCT00075725|54773331|FG003|Overall Study|Pt care terminated due to pt behavior|0|||
28114963|NCT00075725|54773332|FG004|Overall Study|Pt care terminated due to pt behavior|0|||
28114964|NCT00075725|54773333|FG005|Overall Study|Pt care terminated due to pt behavior|0|||
28114965|NCT00075725|54773334|FG006|Overall Study|Pt care terminated due to pt behavior|0|||
28114966|NCT00075725|54773335|FG007|Overall Study|Pt care terminated due to pt behavior|1|||
28114967|NCT00075725|54773336|FG008|Overall Study|Pt care terminated due to pt behavior|0|||
28114968|NCT00075725|54773337|FG009|Overall Study|Pt care terminated due to pt behavior|0|||
28114969|NCT00075725|54773338|FG010|Overall Study|Pt care terminated due to pt behavior|0|||
28114970|NCT00075725|54773339|FG011|Overall Study|Pt care terminated due to pt behavior|0|||
28114971|NCT00075725|54773328|FG000|Overall Study|Pt incarcerated|0|||
28114972|NCT00075725|54773329|FG001|Overall Study|Pt incarcerated|0|||
28065117|NCT00320216|54720779|FG001|Overall Study|Lost to Follow-up|0|||
28065118|NCT00320216|54720780|FG002|Overall Study|Lost to Follow-up|0|||
28065119|NCT00320216|54720781|FG003|Overall Study|Lost to Follow-up|0|||
28065120|NCT00320216|54720782|FG004|Overall Study|Lost to Follow-up|0|||
28065121|NCT00320216|54720778|FG000|Overall Study|Other|7|||
28065122|NCT00320216|54720779|FG001|Overall Study|Other|2|||
28065123|NCT00320216|54720780|FG002|Overall Study|Other|5|||
28065124|NCT00320216|54720781|FG003|Overall Study|Other|1|||
28065125|NCT00320216|54720782|FG004|Overall Study|Other|3|||
28065126|NCT00290706|54720803|FG000|Overall Study|Withdrawal by Subject|2|||
28065127|NCT00290706|54720804|FG001|Overall Study|Withdrawal by Subject|0|||
28065128|NCT00290706|54720805|FG002|Overall Study|Withdrawal by Subject|0|||
28065129|NCT00290706|54720806|FG003|Overall Study|Withdrawal by Subject|0|||
28065130|NCT00290706|54720803|FG000|Overall Study|Progressive Disease|3|||
28065131|NCT00290706|54720804|FG001|Overall Study|Progressive Disease|5|||
27816603|NCT01513239|54273545|FG001|Period 2: 9 Month Extension Phase|Death|0|||
27816604|NCT01513239|54273546|FG002|Period 2: 9 Month Extension Phase|Death|0|||
27816605|NCT01513239|54273547|FG003|Period 2: 9 Month Extension Phase|Death|2|||
27848761|NCT01360632|54343099|FG002|Phase A (8 Weeks)|Adverse Event|0|||
28065132|NCT00290706|54720805|FG002|Overall Study|Progressive Disease|4|||
28065133|NCT00290706|54720806|FG003|Overall Study|Progressive Disease|10|||
28065134|NCT00290706|54720803|FG000|Overall Study|Adverse Event|0|||
28114973|NCT00075725|54773330|FG002|Overall Study|Pt incarcerated|0|||
28114974|NCT00075725|54773331|FG003|Overall Study|Pt incarcerated|0|||
28114975|NCT00075725|54773332|FG004|Overall Study|Pt incarcerated|0|||
28065135|NCT00290706|54720804|FG001|Overall Study|Adverse Event|1|||
28065136|NCT00290706|54720805|FG002|Overall Study|Adverse Event|2|||
28065137|NCT00290706|54720806|FG003|Overall Study|Adverse Event|0|||
28065138|NCT00290706|54720803|FG000|Overall Study|Receive auto transplant or radiation|0|||
28065139|NCT00290706|54720804|FG001|Overall Study|Receive auto transplant or radiation|0|||
28065140|NCT00290706|54720805|FG002|Overall Study|Receive auto transplant or radiation|0|||
28065141|NCT00290706|54720806|FG003|Overall Study|Receive auto transplant or radiation|1|||
28065142|NCT00290706|54720803|FG000|Overall Study|Physician Decision|0|||
28065143|NCT00290706|54720804|FG001|Overall Study|Physician Decision|0|||
28065144|NCT00290706|54720805|FG002|Overall Study|Physician Decision|0|||
28065145|NCT00290706|54720806|FG003|Overall Study|Physician Decision|1|||
28065146|NCT00303186|54720817|FG000|Overall Study|Other|52|||
28065147|NCT00294060|54720821|FG000|Overall Study|Death|225|||
28065148|NCT00294060|54720821|FG000|Overall Study|Other|59|||
28065149|NCT00294060|54720821|FG000|Overall Study|Lost to Follow-up|55|||
28065150|NCT00294060|54720821|FG000|Overall Study|Withdrawal by Subject|11|||
28065151|NCT00294060|54720821|FG000|Overall Study|Physician Decision|797|||
28065152|NCT00294060|54720821|FG000|Overall Study|Medical condition|3|||
28065153|NCT00294060|54720821|FG000|Overall Study|Device explanted/not replaced|23|||
28065154|NCT00303108|54720828|FG000|Overall Study|Adverse Event|5|||
28065155|NCT00303108|54720829|FG001|Overall Study|Adverse Event|6|||
28114976|NCT00075725|54773333|FG005|Overall Study|Pt incarcerated|0|||
28114977|NCT00075725|54773334|FG006|Overall Study|Pt incarcerated|0|||
28114978|NCT00075725|54773335|FG007|Overall Study|Pt incarcerated|1|||
28114979|NCT00075725|54773336|FG008|Overall Study|Pt incarcerated|0|||
28114980|NCT00075725|54773337|FG009|Overall Study|Pt incarcerated|0|||
27940320|NCT01186770|54596601|FG002|Overall Study|Withdrawal by Subject|11|||
27940321|NCT01186770|54596602|FG003|Overall Study|Withdrawal by Subject|17|||
28114981|NCT00075725|54773338|FG010|Overall Study|Pt incarcerated|0|||
28114982|NCT00075725|54773339|FG011|Overall Study|Pt incarcerated|0|||
28114983|NCT02953782|54773378|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Death|5|||
28114984|NCT02953782|54773379|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Death|2|||
28114985|NCT02953782|54773380|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
28114986|NCT02953782|54773381|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
28114987|NCT02953782|54773382|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Death|4|||
28114988|NCT02953782|54773383|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
28114989|NCT02953782|54773384|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
28114990|NCT02953782|54773385|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
28114991|NCT02953782|54773378|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
28114992|NCT02953782|54773379|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
28114993|NCT02953782|54773380|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2|||
28114994|NCT02953782|54773381|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
28114995|NCT02953782|54773382|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
28114996|NCT02953782|54773383|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
28114997|NCT02953782|54773384|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
28114998|NCT02953782|54773385|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
28114999|NCT02953782|54773378|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
28115000|NCT02953782|54773379|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
28115001|NCT02953782|54773380|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
28115002|NCT02953782|54773381|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
28115003|NCT02953782|54773382|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
28115004|NCT02953782|54773383|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
28115005|NCT02953782|54773384|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
27940322|NCT01186770|54596599|FG000|Overall Study|Lost to Follow-up|10|||
28115006|NCT02953782|54773385|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
28115007|NCT02953782|54773378|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
28115008|NCT02953782|54773379|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
28115009|NCT02953782|54773380|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
28115010|NCT02953782|54773381|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
28115011|NCT02953782|54773382|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
28115012|NCT02953782|54773383|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
28115013|NCT02953782|54773384|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
28160059|NCT02925923|54830165|FG000|Overall Study|blood samples hemolyzed|0|||
27816606|NCT01513239|54273548|FG004|Period 2: 9 Month Extension Phase|Death|5|||
27816607|NCT01513239|54273549|FG005|Period 2: 9 Month Extension Phase|Death|2|||
27940323|NCT01186770|54596600|FG001|Overall Study|Lost to Follow-up|6|||
27940324|NCT01186770|54596601|FG002|Overall Study|Lost to Follow-up|14|||
28065156|NCT00303108|54720830|FG002|Overall Study|Adverse Event|7|||
28065157|NCT00303108|54720828|FG000|Overall Study|Patient Request|4|||
28065158|NCT00303108|54720829|FG001|Overall Study|Patient Request|2|||
28065159|NCT00303108|54720830|FG002|Overall Study|Patient Request|8|||
28115014|NCT02953782|54773385|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
28115015|NCT02953782|54773378|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
28115016|NCT02953782|54773379|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
28115017|NCT02953782|54773380|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
28115018|NCT02953782|54773381|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
28115019|NCT02953782|54773382|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
28115020|NCT02953782|54773383|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Death|14|||
28115021|NCT02953782|54773384|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Death|11|||
28115022|NCT02953782|54773385|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Death|8|||
28115023|NCT02953782|54773378|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
28115024|NCT02953782|54773379|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
28115025|NCT02953782|54773380|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
28115026|NCT02953782|54773381|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
28115027|NCT02953782|54773382|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
28115028|NCT02953782|54773383|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1|||
28115029|NCT02953782|54773384|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2|||
28115030|NCT02953782|54773385|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3|||
28115031|NCT02953782|54773378|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
28115032|NCT02953782|54773379|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
28115033|NCT02953782|54773380|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
28115034|NCT02953782|54773381|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
28115035|NCT02953782|54773382|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
28115036|NCT02953782|54773383|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
28115037|NCT02953782|54773384|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
28115038|NCT02953782|54773385|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4|||
28115039|NCT02953782|54773378|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
28115040|NCT02953782|54773379|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
28115041|NCT02953782|54773380|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
28115042|NCT02953782|54773381|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
28115043|NCT02953782|54773382|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
28115044|NCT02953782|54773383|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
28115045|NCT02953782|54773384|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1|||
28115046|NCT02953782|54773385|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
28115047|NCT03760081|54773408|FG000|Overall Study|Miscellaneous|0|||
28115048|NCT03760081|54773409|FG001|Overall Study|Miscellaneous|1|||
28115049|NCT03760081|54773408|FG000|Overall Study|Progressive Disease|5|||
28065160|NCT00303108|54720828|FG000|Overall Study|Failed Entry|1|||
28065161|NCT00303108|54720829|FG001|Overall Study|Failed Entry|0|||
28065162|NCT00303108|54720830|FG002|Overall Study|Failed Entry|1|||
28065163|NCT00303108|54720828|FG000|Overall Study|ineligible|2|||
28065164|NCT00303108|54720829|FG001|Overall Study|ineligible|1|||
28065165|NCT00303108|54720830|FG002|Overall Study|ineligible|0|||
28065166|NCT00302952|54720839|FG000|Overall Study|Physician Decision|1|||
28065167|NCT00302952|54720840|FG001|Overall Study|Physician Decision|1|||
28065168|NCT00302952|54720839|FG000|Overall Study|Withdrawal by Subject|2|||
28065169|NCT00302952|54720840|FG001|Overall Study|Withdrawal by Subject|3|||
28065170|NCT00302952|54720839|FG000|Overall Study|Elevated SGOT (AST) lab value|0|||
28065171|NCT00302952|54720840|FG001|Overall Study|Elevated SGOT (AST) lab value|1|||
28065172|NCT00302718|54720850|FG000|Overall Study|Participant left the hospital|1|||
28065173|NCT00302718|54720851|FG001|Overall Study|Participant left the hospital|0|||
28065174|NCT00302718|54720852|FG002|Overall Study|Participant left the hospital|0|||
28065175|NCT00302718|54720853|FG003|Overall Study|Participant left the hospital|1|||
28065176|NCT00302718|54720850|FG000|Overall Study|Withdrawal by Subject|0|||
28065177|NCT00302718|54720851|FG001|Overall Study|Withdrawal by Subject|1|||
28065178|NCT00302718|54720852|FG002|Overall Study|Withdrawal by Subject|0|||
28065179|NCT00302718|54720853|FG003|Overall Study|Withdrawal by Subject|0|||
28065180|NCT00302718|54720850|FG000|Overall Study|Participant left primary care setting|0|||
27848762|NCT01360632|54343100|FG003|Phase A (8 Weeks)|Adverse Event|0|||
28115050|NCT03760081|54773409|FG001|Overall Study|Progressive Disease|10|||
28115051|NCT03760081|54773408|FG000|Overall Study|Death|1|||
28115052|NCT03760081|54773409|FG001|Overall Study|Death|1|||
28115053|NCT03422172|54773417|FG000|Oral lead-in Phase (4 Weeks)|Adverse Event|1|||
28115054|NCT03422172|54773417|FG000|Injection Phase (Week 5 to Week 41)|Lost to Follow-up|1|||
28115055|NCT03422172|54773417|FG000|Injection Phase (Week 5 to Week 41)|Withdrawal by Subject|3|||
28115056|NCT00057863|54773426|FG000|Overall Study|Death|1|||
28115057|NCT00057863|54773426|FG000|Overall Study|Withdrawal by Subject|2|||
28115058|NCT00075023|54773432|FG000|Pilot Study|Physician Decision|1|||
28115059|NCT00075023|54773433|FG001|Pilot Study|Physician Decision|2|||
28065181|NCT00302718|54720851|FG001|Overall Study|Participant left primary care setting|0|||
28065182|NCT00302718|54720852|FG002|Overall Study|Participant left primary care setting|2|||
28065183|NCT00302718|54720853|FG003|Overall Study|Participant left primary care setting|1|||
28065184|NCT00302328|54720871|FG000|Overall Study|Physician Decision|0|||
28065185|NCT00302328|54720872|FG001|Overall Study|Physician Decision|1|||
28065186|NCT00302328|54720873|FG002|Overall Study|Physician Decision|0|||
28065187|NCT00301080|54720884|FG000|Original Version (2 Arms & 4 Weeks)|Never received drug|1|||
28065188|NCT00301080|54720885|FG001|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
28065189|NCT00301080|54720886|FG002|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
28065190|NCT00301080|54720887|FG003|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
28065191|NCT00301080|54720888|FG004|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
28065192|NCT00290238|54720899|FG000|Overall Study|Study terminated|27|||
28065193|NCT00290238|54720900|FG001|Overall Study|Study terminated|27|||
28065194|NCT00290238|54720899|FG000|Overall Study|Lost to Follow-up|0|||
28115060|NCT00075023|54773432|FG000|Pilot Study|Withdrawal by Subject|1|||
28115061|NCT00075023|54773433|FG001|Pilot Study|Withdrawal by Subject|0|||
28115062|NCT00074711|54773442|FG000|Overall Study|Withdrawal by Subject|1|||
28115063|NCT00074711|54773443|FG001|Overall Study|Withdrawal by Subject|1|||
28115064|NCT00074711|54773442|FG000|Overall Study|Lost to Follow-up|10|||
28115065|NCT00074711|54773443|FG001|Overall Study|Lost to Follow-up|8|||
28115066|NCT00074711|54773442|FG000|Overall Study|Participant stopped study drug|4|||
28115067|NCT00074711|54773443|FG001|Overall Study|Participant stopped study drug|6|||
28115068|NCT03420300|54773449|FG000|Overall Study|Death|2|||
28115069|NCT03419598|54773453|FG000|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2|||
28115070|NCT03407430|54773461|FG000|Washout|Protocol Violation|1|||
28115071|NCT03407430|54773462|FG001|Washout|Protocol Violation|0|||
28115072|NCT03407118|54773475|FG000|Period 2|Withdrawal by Subject|1|||
28115073|NCT03407118|54773476|FG001|Period 2|Withdrawal by Subject|0|||
28115074|NCT03406962|54773482|FG000|Overall Study|Death|2|||
28115075|NCT03406962|54773482|FG000|Overall Study|Adverse Event|1|||
28115076|NCT03406260|54773493|FG000|Period 1|Adverse Event|0|||
28115077|NCT03406260|54773494|FG001|Period 1|Adverse Event|0|||
28115078|NCT03406260|54773495|FG002|Period 1|Adverse Event|0|||
28115079|NCT03406260|54773496|FG003|Period 1|Adverse Event|0|||
28115080|NCT03406260|54773497|FG004|Period 1|Adverse Event|1|||
28115081|NCT03406260|54773498|FG005|Period 1|Adverse Event|0|||
28115082|NCT03419364|54773511|FG000|Overall Study|Delivery due to maternal condition|2|||
28115083|NCT03419364|54773512|FG001|Overall Study|Delivery due to maternal condition|0|||
28115084|NCT03419364|54773513|FG002|Overall Study|Delivery due to maternal condition|0|||
28115085|NCT02954172|54773523|FG000|Overall Study|Protocol Violation|3|||
28115086|NCT02954172|54773524|FG001|Overall Study|Protocol Violation|0|||
28115087|NCT02954172|54773523|FG000|Overall Study|allergic reaction|2|||
28115088|NCT02954172|54773524|FG001|Overall Study|allergic reaction|1|||
28115089|NCT02954172|54773523|FG000|Overall Study|non-measurable lesions at baseline|1|||
28115090|NCT02954172|54773524|FG001|Overall Study|non-measurable lesions at baseline|2|||
28115091|NCT02953938|54773533|FG000|Overall Study|Adverse Event|0|||
27848763|NCT01360632|54343101|FG004|Phase A (8 Weeks)|Adverse Event|0|||
28065195|NCT00290238|54720900|FG001|Overall Study|Lost to Follow-up|1|||
28115092|NCT02953938|54773534|FG001|Overall Study|Adverse Event|1|||
28115093|NCT02953938|54773533|FG000|Overall Study|Withdrawal by Subject|1|||
28115094|NCT02953938|54773534|FG001|Overall Study|Withdrawal by Subject|1|||
28115095|NCT03758443|54773545|FG000|Induction Period|Adverse Event|2|||
28115096|NCT03758443|54773546|FG001|Induction Period|Adverse Event|4|||
28115097|NCT03758443|54773547|FG002|Induction Period|Adverse Event|2|||
28115098|NCT03758443|54773548|FG003|Induction Period|Adverse Event|3|||
28115099|NCT03758443|54773545|FG000|Induction Period|Physician Decision|1|||
28115100|NCT03758443|54773546|FG001|Induction Period|Physician Decision|1|||
28115101|NCT03758443|54773547|FG002|Induction Period|Physician Decision|3|||
27940325|NCT01186770|54596602|FG003|Overall Study|Lost to Follow-up|9|||
28065196|NCT00290238|54720899|FG000|Overall Study|Withdrawal by Subject|15|||
28065197|NCT00290238|54720900|FG001|Overall Study|Withdrawal by Subject|13|||
28065198|NCT00289848|54720908|FG000|Overall Study|Adverse Event|6|||
28065199|NCT00289848|54720909|FG001|Overall Study|Adverse Event|4|||
28065200|NCT00289848|54720908|FG000|Overall Study|Death|1|||
28065201|NCT00289848|54720909|FG001|Overall Study|Death|0|||
28065202|NCT00289848|54720908|FG000|Overall Study|Lack of Efficacy|20|||
28065203|NCT00289848|54720909|FG001|Overall Study|Lack of Efficacy|24|||
28065204|NCT00289848|54720908|FG000|Overall Study|Lost to Follow-up|3|||
28065205|NCT00289848|54720909|FG001|Overall Study|Lost to Follow-up|1|||
28065206|NCT00289848|54720908|FG000|Overall Study|Protocol Violation|5|||
28065207|NCT00289848|54720909|FG001|Overall Study|Protocol Violation|2|||
28065208|NCT00289848|54720908|FG000|Overall Study|Withdrawal by Subject|5|||
28065209|NCT00289848|54720909|FG001|Overall Study|Withdrawal by Subject|11|||
28065210|NCT00289848|54720908|FG000|Overall Study|Patient Moved|6|||
28065211|NCT00289848|54720909|FG001|Overall Study|Patient Moved|2|||
28065212|NCT00289848|54720908|FG000|Overall Study|Open-Label AHA Treatment Requested|0|||
28065213|NCT00289848|54720909|FG001|Overall Study|Open-Label AHA Treatment Requested|1|||
28065214|NCT00289770|54720915|FG000|Year 15|Withdrawal by Subject|1|||
28065215|NCT00289536|54720919|FG000|Period 3|Lost to Follow-up|0|||
28065216|NCT00289536|54720920|FG001|Period 3|Lost to Follow-up|0|||
28065217|NCT00289536|54720921|FG002|Period 3|Lost to Follow-up|1|||
28065218|NCT00289458|54720930|FG000|Overall Study|Death|1|||
28065219|NCT00289458|54720931|FG001|Overall Study|Death|0|||
28065220|NCT00289458|54720932|FG002|Overall Study|Death|0|||
28065221|NCT00289458|54720930|FG000|Overall Study|Physician Decision|3|||
28065222|NCT00289458|54720931|FG001|Overall Study|Physician Decision|4|||
28065223|NCT00289458|54720932|FG002|Overall Study|Physician Decision|2|||
28065224|NCT00289458|54720930|FG000|Overall Study|Withdrawal by Subject|2|||
28065225|NCT00289458|54720931|FG001|Overall Study|Withdrawal by Subject|2|||
28065226|NCT00289458|54720932|FG002|Overall Study|Withdrawal by Subject|4|||
28065227|NCT00288912|54720943|FG000|Overall Study|Developed exclusion criterion|4|||
28065228|NCT00288912|54720944|FG001|Overall Study|Developed exclusion criterion|6|||
28065229|NCT00288912|54720945|FG002|Overall Study|Developed exclusion criterion|7|||
28065230|NCT00288912|54720943|FG000|Overall Study|Lost to Follow-up|9|||
28065231|NCT00288912|54720944|FG001|Overall Study|Lost to Follow-up|6|||
28065232|NCT00288912|54720945|FG002|Overall Study|Lost to Follow-up|9|||
28065233|NCT00288912|54720943|FG000|Overall Study|Withdrawal by Subject|4|||
28065234|NCT00288912|54720944|FG001|Overall Study|Withdrawal by Subject|5|||
28065235|NCT00288912|54720945|FG002|Overall Study|Withdrawal by Subject|12|||
28065236|NCT00305864|54720957|FG000|Overall Study|Ineligible / No protocol treatment|0|||
28065237|NCT00305864|54720958|FG001|Overall Study|Ineligible / No protocol treatment|1|||
28065238|NCT00305864|54720959|FG002|Overall Study|Ineligible / No protocol treatment|1|||
28065239|NCT00305864|54720960|FG003|Overall Study|Ineligible / No protocol treatment|13|||
28065240|NCT00295880|54720970|FG000|Overall Study|IBMI unit could not be volume reduced|1|||
28065241|NCT00295880|54720970|FG000|Overall Study|Unit randomization did not occur|1|||
28065242|NCT00319982|54720976|FG000|Overall Study|Withdrawal by Subject|1|||
28065243|NCT00319982|54720977|FG001|Overall Study|Withdrawal by Subject|0|||
28065244|NCT00319592|54720985|FG000|Overall Study|Protocol Violation|1|||
28065245|NCT00319592|54720986|FG001|Overall Study|Protocol Violation|0|||
28065246|NCT00319592|54720985|FG000|Overall Study|Physician Decision|0|||
28065247|NCT00319592|54720986|FG001|Overall Study|Physician Decision|1|||
28065248|NCT00295490|54720996|FG000|Overall Study|Protocol Violation|0|||
28065249|NCT00295490|54720997|FG001|Overall Study|Protocol Violation|0|||
27940326|NCT01186770|54596599|FG000|Overall Study|Insufficient response to treatment|7|||
27940327|NCT01186770|54596600|FG001|Overall Study|Insufficient response to treatment|8|||
27940328|NCT01186770|54596601|FG002|Overall Study|Insufficient response to treatment|5|||
27940329|NCT01186770|54596602|FG003|Overall Study|Insufficient response to treatment|7|||
27940330|NCT01186770|54596599|FG000|Overall Study|Other than specified|0|||
27940331|NCT01186770|54596600|FG001|Overall Study|Other than specified|1|||
27940332|NCT01186770|54596601|FG002|Overall Study|Other than specified|1|||
27940333|NCT01186770|54596602|FG003|Overall Study|Other than specified|2|||
27940334|NCT01186692|54596612|FG000|Overall Study|Not Catheterized|11|||
27940335|NCT01186692|54596612|FG000|Overall Study|Futher testing contraindicated implant|19|||
27940336|NCT01186692|54596612|FG000|Overall Study|Adverse Event|2|||
27940337|NCT01186458|54596620|FG000|Overall Study|Adverse Event|1|||
27940338|NCT01185834|54596624|FG000|Overall Study|Lost to Follow-up|2|||
27940339|NCT01185834|54596624|FG000|Overall Study|Discomfort|4|||
28065250|NCT00295490|54720998|FG002|Overall Study|Protocol Violation|3|||
28065251|NCT00295490|54720999|FG003|Overall Study|Protocol Violation|3|||
28065252|NCT00295490|54720996|FG000|Overall Study|Withdrawal by Subject|0|||
28065253|NCT00295490|54720997|FG001|Overall Study|Withdrawal by Subject|2|||
28065254|NCT00295490|54720998|FG002|Overall Study|Withdrawal by Subject|0|||
28115102|NCT03758443|54773548|FG003|Induction Period|Physician Decision|0|||
28115103|NCT03758443|54773545|FG000|Induction Period|Protocol Violation|0|||
28115104|NCT03758443|54773546|FG001|Induction Period|Protocol Violation|0|||
28115105|NCT03758443|54773547|FG002|Induction Period|Protocol Violation|0|||
28115106|NCT03758443|54773548|FG003|Induction Period|Protocol Violation|1|||
28115107|NCT03758443|54773545|FG000|Induction Period|Withdrawal by Subject|3|||
28115108|NCT03758443|54773546|FG001|Induction Period|Withdrawal by Subject|2|||
28115109|NCT03758443|54773547|FG002|Induction Period|Withdrawal by Subject|2|||
28115110|NCT03758443|54773548|FG003|Induction Period|Withdrawal by Subject|4|||
28115111|NCT03758443|54773545|FG000|Extended Induction Period|Adverse Event|1|||
28115112|NCT03758443|54773546|FG001|Extended Induction Period|Adverse Event|1|||
28115113|NCT03758443|54773547|FG002|Extended Induction Period|Adverse Event|0|||
28115114|NCT03758443|54773548|FG003|Extended Induction Period|Adverse Event|1|||
28115115|NCT03758443|54773545|FG000|Extended Induction Period|Lost to Follow-up|1|||
28115116|NCT03758443|54773546|FG001|Extended Induction Period|Lost to Follow-up|0|||
28115117|NCT03758443|54773547|FG002|Extended Induction Period|Lost to Follow-up|0|||
28115118|NCT03758443|54773548|FG003|Extended Induction Period|Lost to Follow-up|0|||
28115119|NCT03758443|54773545|FG000|Extended Induction Period|Physician Decision|2|||
28115120|NCT03758443|54773546|FG001|Extended Induction Period|Physician Decision|1|||
28115121|NCT03758443|54773547|FG002|Extended Induction Period|Physician Decision|2|||
28115122|NCT03758443|54773548|FG003|Extended Induction Period|Physician Decision|2|||
28115123|NCT03758443|54773545|FG000|Extended Induction Period|Protocol Violation|0|||
28115124|NCT03758443|54773546|FG001|Extended Induction Period|Protocol Violation|0|||
28115125|NCT03758443|54773547|FG002|Extended Induction Period|Protocol Violation|0|||
28115126|NCT03758443|54773548|FG003|Extended Induction Period|Protocol Violation|1|||
27940340|NCT01185834|54596624|FG000|Overall Study|Biomicroscopy|4|||
27940341|NCT01185834|54596624|FG000|Overall Study|Time/Job Conflict|2|||
27940342|NCT01185834|54596624|FG000|Overall Study|Early exit - Site error|2|||
27940343|NCT01185600|54596630|FG000|Overall Study|Adverse Event|1|||
27940344|NCT01185600|54596631|FG001|Overall Study|Adverse Event|1|||
27940345|NCT01185600|54596630|FG000|Overall Study|Death|0|||
27940346|NCT01185600|54596631|FG001|Overall Study|Death|1|||
27940347|NCT01185600|54596630|FG000|Overall Study|Lost to Follow-up|0|||
28065255|NCT00295490|54720999|FG003|Overall Study|Withdrawal by Subject|1|||
28065256|NCT00295490|54720996|FG000|Overall Study|Lost to Follow-up|0|||
28065257|NCT00295490|54720997|FG001|Overall Study|Lost to Follow-up|0|||
28065258|NCT00295490|54720998|FG002|Overall Study|Lost to Follow-up|1|||
28065259|NCT00295490|54720999|FG003|Overall Study|Lost to Follow-up|0|||
28065260|NCT00295490|54720996|FG000|Overall Study|Adverse Event|1|||
28065261|NCT00295490|54720997|FG001|Overall Study|Adverse Event|0|||
28065262|NCT00295490|54720998|FG002|Overall Study|Adverse Event|0|||
28065263|NCT00295490|54720999|FG003|Overall Study|Adverse Event|0|||
28065264|NCT00295490|54720996|FG000|Overall Study|Other|0|||
28065265|NCT00295490|54720997|FG001|Overall Study|Other|2|||
28065266|NCT00295490|54720998|FG002|Overall Study|Other|0|||
28065267|NCT00295490|54720999|FG003|Overall Study|Other|1|||
28065268|NCT00305006|54721011|FG000|Overall Study|Withdrawal by Subject|1|||
28115127|NCT03758443|54773545|FG000|Extended Induction Period|Withdrawal by Subject|8|||
28115128|NCT03758443|54773546|FG001|Extended Induction Period|Withdrawal by Subject|1|||
27940348|NCT01185600|54596631|FG001|Overall Study|Lost to Follow-up|5|||
27940349|NCT01185600|54596630|FG000|Overall Study|Physician Decision|29|||
27940350|NCT01185600|54596631|FG001|Overall Study|Physician Decision|35|||
28065269|NCT00305006|54721012|FG001|Overall Study|Withdrawal by Subject|0|||
28065270|NCT00305006|54721011|FG000|Overall Study|Failure to complete pretest|0|||
28115129|NCT03758443|54773547|FG002|Extended Induction Period|Withdrawal by Subject|7|||
28065271|NCT00305006|54721012|FG001|Overall Study|Failure to complete pretest|1|||
28065272|NCT00319436|54721020|FG000|Overall Study|Withdrawal by Subject|6|||
28065273|NCT00319436|54721021|FG001|Overall Study|Withdrawal by Subject|7|||
28065274|NCT00319046|54721027|FG000|Overall Study|withdrawal of subject's consent|7|||
28065275|NCT00319046|54721027|FG000|Overall Study|administrative reason|1|||
28065276|NCT00303602|54721033|FG000|Overall Study|Adverse Event|2|||
28115130|NCT03758443|54773548|FG003|Extended Induction Period|Withdrawal by Subject|3|||
28115131|NCT03758443|54773545|FG000|Extended Induction Period|Miscellaneous|1|||
28115132|NCT03758443|54773546|FG001|Extended Induction Period|Miscellaneous|0|||
28115133|NCT03758443|54773547|FG002|Extended Induction Period|Miscellaneous|0|||
28065277|NCT00303602|54721034|FG001|Overall Study|Adverse Event|2|||
28065278|NCT00303602|54721033|FG000|Overall Study|Withdrawal by Subject|5|||
28065279|NCT00303602|54721034|FG001|Overall Study|Withdrawal by Subject|6|||
28065280|NCT00303602|54721033|FG000|Overall Study|Lost to Follow-up|5|||
28065281|NCT00303602|54721034|FG001|Overall Study|Lost to Follow-up|2|||
28065282|NCT00303602|54721033|FG000|Overall Study|Protocol entry criteria not met|2|||
28065283|NCT00303602|54721034|FG001|Overall Study|Protocol entry criteria not met|2|||
28065284|NCT00303602|54721033|FG000|Overall Study|Physician Decision|2|||
28065285|NCT00303602|54721034|FG001|Overall Study|Physician Decision|1|||
28065286|NCT00303602|54721033|FG000|Overall Study|Noncompliance|2|||
28065287|NCT00303602|54721034|FG001|Overall Study|Noncompliance|2|||
28065288|NCT00303602|54721033|FG000|Overall Study|Protocol Violation|1|||
28065289|NCT00303602|54721034|FG001|Overall Study|Protocol Violation|0|||
28065290|NCT00299130|54721043|FG000|Treatment Period (up to 5 Years)|Adverse Event|13|||
28065291|NCT00299130|54721044|FG001|Treatment Period (up to 5 Years)|Adverse Event|8|||
28115134|NCT03758443|54773548|FG003|Extended Induction Period|Miscellaneous|0|||
28115135|NCT03758443|54773545|FG000|Maintenance Period|Adverse Event|1|||
28115136|NCT03758443|54773546|FG001|Maintenance Period|Adverse Event|2|||
28115137|NCT03758443|54773547|FG002|Maintenance Period|Adverse Event|0|||
28115138|NCT03758443|54773548|FG003|Maintenance Period|Adverse Event|0|||
28115139|NCT03758443|54773545|FG000|Maintenance Period|Lost to Follow-up|0|||
28115140|NCT03758443|54773546|FG001|Maintenance Period|Lost to Follow-up|0|||
28115141|NCT03758443|54773547|FG002|Maintenance Period|Lost to Follow-up|0|||
28115142|NCT03758443|54773548|FG003|Maintenance Period|Lost to Follow-up|1|||
28115143|NCT03758443|54773545|FG000|Maintenance Period|Persistent Loss of Response During Maintenance|3|||
28115144|NCT03758443|54773546|FG001|Maintenance Period|Persistent Loss of Response During Maintenance|1|||
28115145|NCT03758443|54773547|FG002|Maintenance Period|Persistent Loss of Response During Maintenance|2|||
28115146|NCT03758443|54773548|FG003|Maintenance Period|Persistent Loss of Response During Maintenance|0|||
28115147|NCT03758443|54773545|FG000|Maintenance Period|Protocol Violation|0|||
28115148|NCT03758443|54773546|FG001|Maintenance Period|Protocol Violation|1|||
28115149|NCT03758443|54773547|FG002|Maintenance Period|Protocol Violation|0|||
27816608|NCT01513239|54273544|FG000|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
27816609|NCT01513239|54273545|FG001|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
27816610|NCT01513239|54273546|FG002|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
27816611|NCT01513239|54273547|FG003|Period 2: 9 Month Extension Phase|Lost to Follow-up|2|||
27816612|NCT01513239|54273548|FG004|Period 2: 9 Month Extension Phase|Lost to Follow-up|1|||
27816613|NCT01513239|54273549|FG005|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
27816614|NCT01513239|54273544|FG000|Period 2: 9 Month Extension Phase|Physician Decision|0|||
27816615|NCT01513239|54273545|FG001|Period 2: 9 Month Extension Phase|Physician Decision|0|||
27816616|NCT01513239|54273546|FG002|Period 2: 9 Month Extension Phase|Physician Decision|0|||
27816617|NCT01513239|54273547|FG003|Period 2: 9 Month Extension Phase|Physician Decision|1|||
27816618|NCT01513239|54273548|FG004|Period 2: 9 Month Extension Phase|Physician Decision|0|||
27816619|NCT01513239|54273549|FG005|Period 2: 9 Month Extension Phase|Physician Decision|0|||
27816620|NCT01513239|54273544|FG000|Period 2: 9 Month Extension Phase|Technical Problems|0|||
27816621|NCT01513239|54273545|FG001|Period 2: 9 Month Extension Phase|Technical Problems|0|||
27816622|NCT01513239|54273546|FG002|Period 2: 9 Month Extension Phase|Technical Problems|0|||
27816623|NCT01513239|54273547|FG003|Period 2: 9 Month Extension Phase|Technical Problems|0|||
27816624|NCT01513239|54273548|FG004|Period 2: 9 Month Extension Phase|Technical Problems|1|||
27816625|NCT01513239|54273549|FG005|Period 2: 9 Month Extension Phase|Technical Problems|1|||
27848764|NCT01360632|54343097|FG000|Phase A (8 Weeks)|Met Withdrawal Criteria|45|||
27848765|NCT01360632|54343098|FG001|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
27848766|NCT01360632|54343099|FG002|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
27848767|NCT01360632|54343100|FG003|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
27848768|NCT01360632|54343101|FG004|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
27848769|NCT01360632|54343097|FG000|Phase A (8 Weeks)|Physician Decision|10|||
27848770|NCT01360632|54343098|FG001|Phase A (8 Weeks)|Physician Decision|0|||
27848771|NCT01360632|54343099|FG002|Phase A (8 Weeks)|Physician Decision|0|||
27848772|NCT01360632|54343100|FG003|Phase A (8 Weeks)|Physician Decision|0|||
27848773|NCT01360632|54343101|FG004|Phase A (8 Weeks)|Physician Decision|0|||
28065292|NCT00299130|54721045|FG002|Treatment Period (up to 5 Years)|Adverse Event|13|||
28065293|NCT00299130|54721043|FG000|Treatment Period (up to 5 Years)|Death|1|||
28115150|NCT03758443|54773548|FG003|Maintenance Period|Protocol Violation|0|||
27816626|NCT01544127|54273564|FG000|Overall Study|Lost to Follow-up|4|||
27816627|NCT01544127|54273565|FG001|Overall Study|Lost to Follow-up|2|||
27816628|NCT01544127|54273566|FG002|Overall Study|Lost to Follow-up|9|||
27816629|NCT01544127|54273564|FG000|Overall Study|Withdrawal by Subject|2|||
27816630|NCT01544127|54273565|FG001|Overall Study|Withdrawal by Subject|2|||
27816631|NCT01544127|54273566|FG002|Overall Study|Withdrawal by Subject|1|||
27816632|NCT01544127|54273564|FG000|Overall Study|Discharged out of catchment area|1|||
27816633|NCT01544127|54273565|FG001|Overall Study|Discharged out of catchment area|1|||
27816634|NCT01544127|54273566|FG002|Overall Study|Discharged out of catchment area|1|||
27816635|NCT01544127|54273564|FG000|Overall Study|Death|1|||
27816636|NCT01544127|54273565|FG001|Overall Study|Death|0|||
27816637|NCT01544127|54273566|FG002|Overall Study|Death|0|||
27816638|NCT01544127|54273564|FG000|Overall Study|Jail or Prison|1|||
27816639|NCT01544127|54273565|FG001|Overall Study|Jail or Prison|1|||
27816640|NCT01544127|54273566|FG002|Overall Study|Jail or Prison|2|||
27816641|NCT01544127|54273564|FG000|Overall Study|Became Psychotic|1|||
27816642|NCT01544127|54273565|FG001|Overall Study|Became Psychotic|0|||
28115151|NCT03758443|54773545|FG000|Maintenance Period|Study Terminated by Sponsor|11|||
28065294|NCT00299130|54721044|FG001|Treatment Period (up to 5 Years)|Death|3|||
28065295|NCT00299130|54721045|FG002|Treatment Period (up to 5 Years)|Death|1|||
28065296|NCT00299130|54721043|FG000|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19|||
28065297|NCT00299130|54721044|FG001|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
28065298|NCT00299130|54721045|FG002|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
28115152|NCT03758443|54773546|FG001|Maintenance Period|Study Terminated by Sponsor|16|||
28115153|NCT03758443|54773547|FG002|Maintenance Period|Study Terminated by Sponsor|9|||
28115154|NCT03758443|54773548|FG003|Maintenance Period|Study Terminated by Sponsor|11|||
28115155|NCT03758443|54773545|FG000|Maintenance Period|Withdrawal by Subject|1|||
28115156|NCT03758443|54773546|FG001|Maintenance Period|Withdrawal by Subject|0|||
28115157|NCT03758443|54773547|FG002|Maintenance Period|Withdrawal by Subject|1|||
28115158|NCT03758443|54773548|FG003|Maintenance Period|Withdrawal by Subject|1|||
28115159|NCT03758443|54773545|FG000|Maintenance Period|Miscellaneous|0|||
28115160|NCT03758443|54773546|FG001|Maintenance Period|Miscellaneous|0|||
28115161|NCT03758443|54773547|FG002|Maintenance Period|Miscellaneous|1|||
28115162|NCT03758443|54773548|FG003|Maintenance Period|Miscellaneous|0|||
28115163|NCT03442764|54773570|FG000|Overall Study|Adverse Event|1|||
28115164|NCT03442764|54773571|FG001|Overall Study|Adverse Event|0|||
28115165|NCT03442764|54773572|FG002|Overall Study|Adverse Event|0|||
28115166|NCT03442296|54773583|FG000|3 Month Follow-up|Death|3|||
28115167|NCT03442296|54773584|FG001|3 Month Follow-up|Death|1|||
28115168|NCT03442296|54773583|FG000|3 Month Follow-up|Lost to Follow-up|1|||
28115169|NCT03442296|54773584|FG001|3 Month Follow-up|Lost to Follow-up|1|||
28115170|NCT03442296|54773583|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
28115171|NCT03442296|54773584|FG001|3 Month Follow-up|Withdrawal by Subject|0|||
28115172|NCT03442296|54773583|FG000|3 Month Follow-up|Obtained Hearing Aids|0|||
28115173|NCT03442296|54773584|FG001|3 Month Follow-up|Obtained Hearing Aids|1|||
28115174|NCT03442296|54773583|FG000|12 Month Follow-up|Incomplete measurement|1|||
28115175|NCT03442296|54773584|FG001|12 Month Follow-up|Incomplete measurement|1|||
28115176|NCT03441984|54773592|FG000|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
28115177|NCT03441984|54773593|FG001|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
28115178|NCT03441984|54773594|FG002|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1|||
28115179|NCT03441984|54773595|FG003|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
28115180|NCT03441984|54773596|FG004|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
28115181|NCT03441984|54773597|FG005|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
28115182|NCT03441984|54773598|FG006|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
28115183|NCT03441984|54773599|FG007|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
28115184|NCT03441984|54773600|FG008|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
28115185|NCT03441984|54773601|FG009|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
28115186|NCT03441984|54773602|FG010|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
28065299|NCT00299130|54721043|FG000|Treatment Period (up to 5 Years)|Protocol Violation|0|||
27816643|NCT01544127|54273566|FG002|Overall Study|Became Psychotic|0|||
27816644|NCT01544127|54273564|FG000|Overall Study|Researcher withdrew|1|||
27816645|NCT01544127|54273565|FG001|Overall Study|Researcher withdrew|0|||
28065300|NCT00299130|54721044|FG001|Treatment Period (up to 5 Years)|Protocol Violation|1|||
28065301|NCT00299130|54721045|FG002|Treatment Period (up to 5 Years)|Protocol Violation|0|||
28065302|NCT00299130|54721043|FG000|Treatment Period (up to 5 Years)|Refused Treatment|12|||
28065303|NCT00299130|54721044|FG001|Treatment Period (up to 5 Years)|Refused Treatment|12|||
28115187|NCT03441984|54773603|FG011|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
27816646|NCT01544127|54273566|FG002|Overall Study|Researcher withdrew|0|||
28115188|NCT03441360|54773621|FG000|Overall Study|Radiological disease progression|5|||
28115189|NCT03441360|54773622|FG001|Overall Study|Radiological disease progression|6|||
27816647|NCT01544127|54273564|FG000|Overall Study|Went active duty|0|||
28115190|NCT03441360|54773623|FG002|Overall Study|Radiological disease progression|4|||
28115191|NCT03441360|54773621|FG000|Overall Study|Clinical disease progression|2|||
28115192|NCT03441360|54773622|FG001|Overall Study|Clinical disease progression|2|||
28115193|NCT03441360|54773623|FG002|Overall Study|Clinical disease progression|0|||
28115194|NCT03441360|54773621|FG000|Overall Study|Adverse Event|1|||
28115195|NCT03441360|54773622|FG001|Overall Study|Adverse Event|0|||
28115196|NCT03441360|54773623|FG002|Overall Study|Adverse Event|1|||
28115197|NCT01347840|54773631|FG000|Overall Study|Withdrawal by Subject|1|||
28115198|NCT01347762|54773639|FG000|Overall Study|Lost to Follow-up|0|||
28115199|NCT01347762|54773640|FG001|Overall Study|Lost to Follow-up|1|||
28115200|NCT01347762|54773641|FG002|Overall Study|Lost to Follow-up|6|||
28115201|NCT01347762|54773642|FG003|Overall Study|Lost to Follow-up|5|||
28115202|NCT01347762|54773639|FG000|Overall Study|Withdrawal by Subject|4|||
28115203|NCT01347762|54773640|FG001|Overall Study|Withdrawal by Subject|1|||
28115204|NCT01347762|54773641|FG002|Overall Study|Withdrawal by Subject|3|||
28115205|NCT01347762|54773642|FG003|Overall Study|Withdrawal by Subject|3|||
28115206|NCT03438396|54773652|FG000|Overall Study|Reason Not Specified|9|||
28115207|NCT03438396|54773652|FG000|Overall Study|Withdrawal by Subject|5|||
28115208|NCT03438396|54773652|FG000|Overall Study|Lost to Follow-up|2|||
28115209|NCT03438396|54773652|FG000|Overall Study|Death|85|||
28115210|NCT03438396|54773652|FG000|Overall Study|Not treated|1|||
28115211|NCT00073307|54773658|FG000|Double-Blind (DB, as of ~31May2005)|Adverse Event|22|||
28115212|NCT00073307|54773659|FG001|Double-Blind (DB, as of ~31May2005)|Adverse Event|17|||
28115213|NCT00073307|54773660|FG002|Double-Blind (DB, as of ~31May2005)|Adverse Event|0|||
28115214|NCT00073307|54773658|FG000|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1|||
28115215|NCT00073307|54773659|FG001|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6|||
28115216|NCT00073307|54773660|FG002|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0|||
28115217|NCT00073307|54773658|FG000|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6|||
28115218|NCT00073307|54773659|FG001|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11|||
28115219|NCT00073307|54773660|FG002|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0|||
28115220|NCT00073307|54773658|FG000|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
28115221|NCT00073307|54773659|FG001|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
28115222|NCT00073307|54773660|FG002|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0|||
28115223|NCT00073307|54773658|FG000|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1|||
28115224|NCT00073307|54773659|FG001|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2|||
28115225|NCT00073307|54773660|FG002|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0|||
28115226|NCT00073307|54773658|FG000|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1|||
28115227|NCT00073307|54773659|FG001|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
28115228|NCT00073307|54773660|FG002|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
28115229|NCT00073307|54773658|FG000|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
28115230|NCT00073307|54773659|FG001|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1|||
28115231|NCT00073307|54773660|FG002|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
28065304|NCT00299130|54721045|FG002|Treatment Period (up to 5 Years)|Refused Treatment|19|||
28065305|NCT00299130|54721043|FG000|Treatment Period (up to 5 Years)|Failure to Return|4|||
28065306|NCT00299130|54721044|FG001|Treatment Period (up to 5 Years)|Failure to Return|6|||
28065307|NCT00299130|54721045|FG002|Treatment Period (up to 5 Years)|Failure to Return|6|||
28065308|NCT00299130|54721043|FG000|Treatment Period (up to 5 Years)|Reason not Specified|4|||
28065309|NCT00299130|54721044|FG001|Treatment Period (up to 5 Years)|Reason not Specified|6|||
28065310|NCT00299130|54721045|FG002|Treatment Period (up to 5 Years)|Reason not Specified|4|||
28065311|NCT00299130|54721043|FG000|Treatment Period (up to 5 Years)|Withdrawal by Subject|0|||
28065312|NCT00299130|54721044|FG001|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
28065313|NCT00299130|54721045|FG002|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
28065314|NCT00299130|54721043|FG000|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
28065315|NCT00299130|54721044|FG001|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9|||
28065316|NCT00299130|54721045|FG002|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
28065317|NCT00299130|54721043|FG000|Safety Follow-up (SFU) (48 Weeks)|Death|4|||
28065318|NCT00299130|54721044|FG001|Safety Follow-up (SFU) (48 Weeks)|Death|5|||
28065319|NCT00299130|54721045|FG002|Safety Follow-up (SFU) (48 Weeks)|Death|3|||
28065320|NCT00299130|54721043|FG000|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
28065321|NCT00299130|54721044|FG001|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
28065322|NCT00299130|54721045|FG002|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2|||
28065323|NCT00299130|54721043|FG000|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14|||
28065324|NCT00299130|54721044|FG001|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7|||
28065325|NCT00299130|54721045|FG002|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15|||
28065326|NCT00299130|54721043|FG000|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
28115232|NCT00073307|54773658|FG000|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165|||
28115233|NCT00073307|54773659|FG001|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114|||
28115234|NCT00073307|54773660|FG002|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0|||
28115235|NCT00073307|54773658|FG000|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
28115236|NCT00073307|54773659|FG001|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1|||
28115237|NCT00073307|54773660|FG002|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
28115238|NCT00073307|54773658|FG000|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17|||
28115239|NCT00073307|54773659|FG001|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0|||
28115240|NCT00073307|54773660|FG002|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19|||
28115241|NCT00073307|54773658|FG000|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
28115242|NCT00073307|54773659|FG001|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0|||
28115243|NCT00073307|54773660|FG002|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
28115244|NCT00073307|54773658|FG000|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19|||
28115245|NCT00073307|54773659|FG001|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0|||
28115246|NCT00073307|54773660|FG002|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9|||
28115247|NCT00073307|54773658|FG000|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37|||
28115248|NCT00073307|54773659|FG001|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0|||
28115249|NCT00073307|54773660|FG002|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28|||
28115250|NCT00073307|54773658|FG000|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
28115251|NCT00073307|54773659|FG001|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0|||
28115252|NCT00073307|54773660|FG002|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
28115253|NCT00073307|54773658|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
28115254|NCT00073307|54773659|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0|||
28115255|NCT00073307|54773660|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
28115256|NCT00073307|54773658|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
28115257|NCT00073307|54773659|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
28115258|NCT00073307|54773660|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3|||
28115259|NCT00073307|54773658|FG000|Open Label-Sorafenib Only [30Jun2008]|Missing|3|||
28115260|NCT00073307|54773659|FG001|Open Label-Sorafenib Only [30Jun2008]|Missing|0|||
28115261|NCT00073307|54773660|FG002|Open Label-Sorafenib Only [30Jun2008]|Missing|1|||
28115262|NCT00073307|54773658|FG000|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19|||
28115263|NCT00073307|54773659|FG001|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0|||
28115264|NCT00073307|54773660|FG002|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9|||
28115265|NCT00073307|54773658|FG000|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35|||
28115266|NCT00073307|54773659|FG001|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0|||
28115267|NCT00073307|54773660|FG002|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83|||
28115268|NCT03388164|54773671|FG000|Overall Study|Withdrawal by Subject|3|||
28115269|NCT03388164|54773672|FG001|Overall Study|Withdrawal by Subject|1|||
28115270|NCT03403374|54773678|FG000|Overall Study|Lost to Follow-up|1|||
28115271|NCT03387462|54773682|FG000|Overall Study|Lost to Follow-up|1|||
28115272|NCT03756883|54773689|FG000|Overall Study|Adverse Event|2|||
28115273|NCT03756883|54773690|FG001|Overall Study|Adverse Event|2|||
28065327|NCT00299130|54721044|FG001|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1|||
28065328|NCT00299130|54721045|FG002|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
28065329|NCT00299130|54721043|FG000|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
28065330|NCT00299130|54721044|FG001|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
28065331|NCT00299130|54721045|FG002|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21|||
28065332|NCT00299130|54721043|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
28115274|NCT03756883|54773691|FG002|Overall Study|Adverse Event|2|||
28115275|NCT03756883|54773689|FG000|Overall Study|Lack of Efficacy|0|||
28115276|NCT03756883|54773690|FG001|Overall Study|Lack of Efficacy|1|||
28115277|NCT03756883|54773691|FG002|Overall Study|Lack of Efficacy|2|||
28115278|NCT03756883|54773689|FG000|Overall Study|Lost to Follow-up|3|||
28115279|NCT03756883|54773690|FG001|Overall Study|Lost to Follow-up|3|||
28115280|NCT03756883|54773691|FG002|Overall Study|Lost to Follow-up|0|||
28115281|NCT03756883|54773689|FG000|Overall Study|Protocol Violation|2|||
28115282|NCT03756883|54773690|FG001|Overall Study|Protocol Violation|0|||
27816648|NCT01544127|54273565|FG001|Overall Study|Went active duty|0|||
27816649|NCT01544127|54273566|FG002|Overall Study|Went active duty|1|||
27816650|NCT01512693|54273577|FG000|Overall Study|Withdrawal by Subject|0|||
27816651|NCT01512693|54273578|FG001|Overall Study|Withdrawal by Subject|1|||
27816652|NCT01458340|54273587|FG000|Overall Study|Adverse Event|5|||
27816653|NCT01458340|54273588|FG001|Overall Study|Adverse Event|4|||
28065333|NCT00299130|54721044|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Death|3|||
28065334|NCT00299130|54721045|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
28065335|NCT00299130|54721043|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0|||
28065336|NCT00299130|54721044|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
27816654|NCT01458340|54273589|FG002|Overall Study|Adverse Event|2|||
28065337|NCT00299130|54721045|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
28115283|NCT03756883|54773691|FG002|Overall Study|Protocol Violation|1|||
28115284|NCT03756883|54773689|FG000|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
28115285|NCT03756883|54773690|FG001|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
28115286|NCT03756883|54773691|FG002|Overall Study|Significant Worsening of Condition requiring Therapy|2|||
28115287|NCT03756883|54773689|FG000|Overall Study|Withdrawal by Subject|4|||
28115288|NCT03756883|54773690|FG001|Overall Study|Withdrawal by Subject|1|||
28115289|NCT03756883|54773691|FG002|Overall Study|Withdrawal by Subject|0|||
28115290|NCT03756883|54773689|FG000|Overall Study|Other Reasons|2|||
28065338|NCT00299130|54721043|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0|||
28065339|NCT00299130|54721044|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3|||
28065340|NCT00299130|54721045|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4|||
28065341|NCT00288054|54721060|FG000|Overall Study|Protocol Violation|2|||
28065342|NCT00288054|54721060|FG000|Overall Study|Lack of Efficacy|16|||
28065343|NCT00288054|54721060|FG000|Overall Study|Adverse Event|3|||
28065344|NCT00288054|54721060|FG000|Overall Study|Withdrawal by Subject|1|||
28065345|NCT00288054|54721060|FG000|Overall Study|Not protocol specified|2|||
28065346|NCT00287586|54721068|FG000|Overall Study|Withdrew Consent|19|||
28065347|NCT00287586|54721069|FG001|Overall Study|Withdrew Consent|30|||
28065348|NCT00287586|54721068|FG000|Overall Study|Lost to Follow-up|5|||
28065349|NCT00287586|54721069|FG001|Overall Study|Lost to Follow-up|4|||
28065350|NCT00287586|54721068|FG000|Overall Study|Death|2|||
28115291|NCT03756883|54773690|FG001|Overall Study|Other Reasons|4|||
28115292|NCT03756883|54773691|FG002|Overall Study|Other Reasons|0|||
28115293|NCT03386994|54773702|FG000|Overall Study|Lung transplant|1|||
28115294|NCT03386994|54773702|FG000|Overall Study|Adverse Event|14|||
28115295|NCT03386994|54773702|FG000|Overall Study|Lost to Follow-up|4|||
28115296|NCT03386994|54773702|FG000|Overall Study|Withdrawal by Subject|3|||
28115297|NCT03386994|54773702|FG000|Overall Study|Death|16|||
28115298|NCT03756571|54773719|FG000|Overall Study|Lost to Follow-up|1|||
28115299|NCT03756571|54773720|FG001|Overall Study|Lost to Follow-up|1|||
28115300|NCT03386448|54773728|FG000|Overall Study|Adverse Event|0|||
28115301|NCT03386448|54773729|FG001|Overall Study|Adverse Event|2|||
28115302|NCT02951988|54773738|FG000|Open-Label Treatment Period|Miscellaneous Reasons|8|||
28115303|NCT02951988|54773739|FG001|Open-Label Treatment Period|Miscellaneous Reasons|0|||
28115304|NCT02951988|54773740|FG002|Open-Label Treatment Period|Miscellaneous Reasons|0|||
28115305|NCT02951988|54773741|FG003|Open-Label Treatment Period|Miscellaneous Reasons|0|||
28115306|NCT02951988|54773738|FG000|Open-Label Treatment Period|Study terminated by sponsor|9|||
28115307|NCT02951988|54773739|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
28115308|NCT02951988|54773740|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
28115309|NCT02951988|54773741|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
28115310|NCT02951988|54773738|FG000|Open-Label Treatment Period|Non-compliance with background ADT|2|||
28115311|NCT02951988|54773739|FG001|Open-Label Treatment Period|Non-compliance with background ADT|0|||
28115312|NCT02951988|54773740|FG002|Open-Label Treatment Period|Non-compliance with background ADT|0|||
28115313|NCT02951988|54773741|FG003|Open-Label Treatment Period|Non-compliance with background ADT|0|||
28115314|NCT02951988|54773738|FG000|Open-Label Treatment Period|Non-compliance with study drug|5|||
28115315|NCT02951988|54773739|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
28115316|NCT02951988|54773740|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
28115317|NCT02951988|54773741|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
28115318|NCT02951988|54773738|FG000|Open-Label Treatment Period|Protocol Violation|22|||
28115319|NCT02951988|54773739|FG001|Open-Label Treatment Period|Protocol Violation|0|||
28115320|NCT02951988|54773740|FG002|Open-Label Treatment Period|Protocol Violation|0|||
28115321|NCT02951988|54773741|FG003|Open-Label Treatment Period|Protocol Violation|0|||
28115322|NCT02951988|54773738|FG000|Open-Label Treatment Period|Pregnancy|2|||
28115323|NCT02951988|54773739|FG001|Open-Label Treatment Period|Pregnancy|0|||
28115324|NCT02951988|54773740|FG002|Open-Label Treatment Period|Pregnancy|0|||
28115325|NCT02951988|54773741|FG003|Open-Label Treatment Period|Pregnancy|0|||
28115326|NCT02951988|54773738|FG000|Open-Label Treatment Period|Lost to Follow-up|28|||
28065351|NCT00287586|54721069|FG001|Overall Study|Death|3|||
28065352|NCT00287586|54721068|FG000|Overall Study|Elevated Hematocrit|3|||
28115327|NCT02951988|54773739|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
28115328|NCT02951988|54773740|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
28115329|NCT02951988|54773741|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
28115330|NCT02951988|54773738|FG000|Open-Label Treatment Period|Withdrawal by Subject|78|||
28115331|NCT02951988|54773739|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
28115332|NCT02951988|54773740|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
28115333|NCT02951988|54773741|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
28115334|NCT02951988|54773738|FG000|Open-Label Treatment Period|Lack of Efficacy|49|||
28115335|NCT02951988|54773739|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
28115336|NCT02951988|54773740|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
28115337|NCT02951988|54773741|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
28115338|NCT02951988|54773738|FG000|Open-Label Treatment Period|Adverse Event|45|||
28115339|NCT02951988|54773739|FG001|Open-Label Treatment Period|Adverse Event|0|||
28115340|NCT02951988|54773740|FG002|Open-Label Treatment Period|Adverse Event|0|||
28115341|NCT02951988|54773741|FG003|Open-Label Treatment Period|Adverse Event|0|||
28115342|NCT02951988|54773738|FG000|Double-Blind Treatment Period|Site terminated by sponsor|0|||
28115343|NCT02951988|54773739|FG001|Double-Blind Treatment Period|Site terminated by sponsor|0|||
28115344|NCT02951988|54773740|FG002|Double-Blind Treatment Period|Site terminated by sponsor|1|||
28115345|NCT02951988|54773741|FG003|Double-Blind Treatment Period|Site terminated by sponsor|1|||
28115346|NCT02951988|54773738|FG000|Double-Blind Treatment Period|Study terminated by sponsor|0|||
28115347|NCT02951988|54773739|FG001|Double-Blind Treatment Period|Study terminated by sponsor|58|||
28115348|NCT02951988|54773740|FG002|Double-Blind Treatment Period|Study terminated by sponsor|54|||
27816655|NCT01458340|54273587|FG000|Overall Study|Lost to Follow-up|3|||
27816656|NCT01458340|54273588|FG001|Overall Study|Lost to Follow-up|3|||
27816657|NCT01458340|54273589|FG002|Overall Study|Lost to Follow-up|10|||
27816658|NCT01458340|54273587|FG000|Overall Study|Miscellaneous|0|||
27816659|NCT01458340|54273588|FG001|Overall Study|Miscellaneous|1|||
27816660|NCT01458340|54273589|FG002|Overall Study|Miscellaneous|0|||
27816661|NCT01458340|54273587|FG000|Overall Study|Physician Decision|1|||
27816662|NCT01458340|54273588|FG001|Overall Study|Physician Decision|1|||
27816663|NCT01458340|54273589|FG002|Overall Study|Physician Decision|2|||
27816664|NCT01458340|54273587|FG000|Overall Study|Protocol Violation|6|||
27816665|NCT01458340|54273588|FG001|Overall Study|Protocol Violation|6|||
27816666|NCT01458340|54273589|FG002|Overall Study|Protocol Violation|5|||
27816667|NCT01458340|54273587|FG000|Overall Study|Withdrawal by Subject|12|||
27816668|NCT01458340|54273588|FG001|Overall Study|Withdrawal by Subject|6|||
27816669|NCT01458340|54273589|FG002|Overall Study|Withdrawal by Subject|4|||
27816670|NCT01539291|54273644|FG000|Study GS-US-312-0116|Adverse Event|9|||
27816671|NCT01539291|54273645|FG001|Study GS-US-312-0116|Adverse Event|0|||
28065353|NCT00287586|54721069|FG001|Overall Study|Elevated Hematocrit|0|||
28065354|NCT00287586|54721068|FG000|Overall Study|Rash|3|||
28065355|NCT00287586|54721069|FG001|Overall Study|Rash|0|||
28065356|NCT00287586|54721068|FG000|Overall Study|Elevated Prostate Specific Antigen|2|||
28065357|NCT00287586|54721069|FG001|Overall Study|Elevated Prostate Specific Antigen|0|||
28065358|NCT00287586|54721068|FG000|Overall Study|Stroke|2|||
28065359|NCT00287586|54721069|FG001|Overall Study|Stroke|0|||
28065360|NCT00287586|54721068|FG000|Overall Study|Myocardial Infarction|1|||
28065361|NCT00287586|54721069|FG001|Overall Study|Myocardial Infarction|0|||
27816672|NCT01539291|54273646|FG002|Study GS-US-312-0116|Adverse Event|0|||
27816673|NCT01539291|54273647|FG003|Study GS-US-312-0116|Adverse Event|0|||
28065362|NCT00287586|54721068|FG000|Overall Study|Lower Urinary Tract Symptoms|1|||
28065363|NCT00287586|54721069|FG001|Overall Study|Lower Urinary Tract Symptoms|0|||
28065364|NCT00287586|54721068|FG000|Overall Study|Cognitive Impairment|1|||
28065365|NCT00287586|54721069|FG001|Overall Study|Cognitive Impairment|0|||
28115349|NCT02951988|54773741|FG003|Double-Blind Treatment Period|Study terminated by sponsor|69|||
28115350|NCT02951988|54773738|FG000|Double-Blind Treatment Period|Non-compliance with study drug|0|||
28115351|NCT02951988|54773739|FG001|Double-Blind Treatment Period|Non-compliance with study drug|1|||
28115352|NCT02951988|54773740|FG002|Double-Blind Treatment Period|Non-compliance with study drug|3|||
28115353|NCT02951988|54773741|FG003|Double-Blind Treatment Period|Non-compliance with study drug|0|||
28115354|NCT02951988|54773738|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
28115355|NCT02951988|54773739|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
28115356|NCT02951988|54773740|FG002|Double-Blind Treatment Period|Protocol Violation|4|||
28115357|NCT02951988|54773741|FG003|Double-Blind Treatment Period|Protocol Violation|8|||
28115358|NCT02951988|54773738|FG000|Double-Blind Treatment Period|Pregnancy|0|||
27816674|NCT01539291|54273644|FG000|Study GS-US-312-0116|Physician Decision|1|||
27816675|NCT01539291|54273645|FG001|Study GS-US-312-0116|Physician Decision|0|||
28115359|NCT02951988|54773739|FG001|Double-Blind Treatment Period|Pregnancy|1|||
27816676|NCT01539291|54273646|FG002|Study GS-US-312-0116|Physician Decision|0|||
27816677|NCT01539291|54273647|FG003|Study GS-US-312-0116|Physician Decision|0|||
28065366|NCT00287586|54721068|FG000|Overall Study|Pancreatic Cancer|1|||
28065367|NCT00287586|54721069|FG001|Overall Study|Pancreatic Cancer|3|||
28115360|NCT02951988|54773740|FG002|Double-Blind Treatment Period|Pregnancy|1|||
28115361|NCT02951988|54773741|FG003|Double-Blind Treatment Period|Pregnancy|0|||
28115362|NCT02951988|54773738|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
28115363|NCT02951988|54773739|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
28115364|NCT02951988|54773740|FG002|Double-Blind Treatment Period|Lost to Follow-up|12|||
28115365|NCT02951988|54773741|FG003|Double-Blind Treatment Period|Lost to Follow-up|3|||
28115366|NCT02951988|54773738|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
28115367|NCT02951988|54773739|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
28115368|NCT02951988|54773740|FG002|Double-Blind Treatment Period|Withdrawal by Subject|22|||
28115369|NCT02951988|54773741|FG003|Double-Blind Treatment Period|Withdrawal by Subject|28|||
28065368|NCT00287586|54721068|FG000|Overall Study|Sleep Apnea|1|||
28115370|NCT02951988|54773738|FG000|Double-Blind Treatment Period|Adverse Event|0|||
28115371|NCT02951988|54773739|FG001|Double-Blind Treatment Period|Adverse Event|8|||
28115372|NCT02951988|54773740|FG002|Double-Blind Treatment Period|Adverse Event|3|||
28115373|NCT02951988|54773741|FG003|Double-Blind Treatment Period|Adverse Event|6|||
28115374|NCT02951988|54773738|FG000|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
28115375|NCT02951988|54773739|FG001|Double-Blind Treatment Period|Miscellaneous Reasons|2|||
28115376|NCT02951988|54773740|FG002|Double-Blind Treatment Period|Miscellaneous Reasons|1|||
28115377|NCT02951988|54773741|FG003|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
28115378|NCT00009737|54773753|FG000|Overall Study|Adverse Event|112|||
28115379|NCT00009737|54773754|FG001|Overall Study|Adverse Event|75|||
28115380|NCT00009737|54773753|FG000|Overall Study|Death|4|||
28115381|NCT00009737|54773754|FG001|Overall Study|Death|6|||
28115382|NCT00009737|54773753|FG000|Overall Study|Lack of Efficacy|17|||
28065369|NCT00287586|54721069|FG001|Overall Study|Sleep Apnea|0|||
28065370|NCT00287586|54721068|FG000|Overall Study|Shoulder Pain|1|||
28065371|NCT00287586|54721069|FG001|Overall Study|Shoulder Pain|0|||
28065372|NCT00287586|54721068|FG000|Overall Study|Inappropriate Behaviour with Staff|1|||
28065373|NCT00287586|54721069|FG001|Overall Study|Inappropriate Behaviour with Staff|0|||
28065374|NCT00287586|54721068|FG000|Overall Study|Nonadherence|1|||
28065375|NCT00287586|54721069|FG001|Overall Study|Nonadherence|1|||
28065376|NCT00287586|54721068|FG000|Overall Study|Enrolled in Another Study|1|||
28065377|NCT00287586|54721069|FG001|Overall Study|Enrolled in Another Study|0|||
28065378|NCT00287586|54721068|FG000|Overall Study|Major Depression|0|||
28065379|NCT00287586|54721069|FG001|Overall Study|Major Depression|2|||
28065380|NCT00287586|54721068|FG000|Overall Study|Lung Cancer|0|||
28065381|NCT00287586|54721069|FG001|Overall Study|Lung Cancer|2|||
28065382|NCT00287586|54721068|FG000|Overall Study|Elevated IPSS Score|0|||
28065383|NCT00287586|54721069|FG001|Overall Study|Elevated IPSS Score|1|||
28065384|NCT00287586|54721068|FG000|Overall Study|Retroperitoneal Cancer|0|||
28065385|NCT00287586|54721069|FG001|Overall Study|Retroperitoneal Cancer|1|||
28065386|NCT00287586|54721068|FG000|Overall Study|Mastodynia and Gynecomastia|0|||
28065387|NCT00287586|54721069|FG001|Overall Study|Mastodynia and Gynecomastia|1|||
28065388|NCT00287586|54721068|FG000|Overall Study|Mood Swings and Irritability|0|||
28065389|NCT00287586|54721069|FG001|Overall Study|Mood Swings and Irritability|1|||
28065390|NCT00287586|54721068|FG000|Overall Study|Bradycardia|0|||
28065391|NCT00287586|54721069|FG001|Overall Study|Bradycardia|1|||
28115383|NCT00009737|54773754|FG001|Overall Study|Lack of Efficacy|15|||
28115384|NCT00009737|54773753|FG000|Overall Study|Violation of Selection Criteria at Entry|13|||
28115385|NCT00009737|54773754|FG001|Overall Study|Violation of Selection Criteria at Entry|9|||
28115386|NCT00009737|54773753|FG000|Overall Study|Other Protocol Violation|1|||
28115387|NCT00009737|54773754|FG001|Overall Study|Other Protocol Violation|0|||
28115388|NCT00009737|54773753|FG000|Overall Study|Refused Treatment|15|||
28115389|NCT00009737|54773754|FG001|Overall Study|Refused Treatment|16|||
28115390|NCT00009737|54773753|FG000|Overall Study|Lost to Follow-up|1|||
28115391|NCT00009737|54773754|FG001|Overall Study|Lost to Follow-up|1|||
27816678|NCT01539291|54273644|FG000|Study GS-US-312-0116|Withdrawal by Subject|12|||
27816679|NCT01539291|54273645|FG001|Study GS-US-312-0116|Withdrawal by Subject|0|||
27816680|NCT01539291|54273646|FG002|Study GS-US-312-0116|Withdrawal by Subject|0|||
27816681|NCT01539291|54273647|FG003|Study GS-US-312-0116|Withdrawal by Subject|0|||
27816682|NCT01539291|54273644|FG000|Study GS-US-312-0116|Study Terminated by Sponsor|2|||
27816683|NCT01539291|54273645|FG001|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
27816684|NCT01539291|54273646|FG002|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
27816685|NCT01539291|54273647|FG003|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
28115392|NCT00009737|54773753|FG000|Overall Study|Administrative/Other Reasons|7|||
28115393|NCT00009737|54773754|FG001|Overall Study|Administrative/Other Reasons|1|||
28115394|NCT03417102|54773762|FG000|Overall Study|Adverse Event|0|||
28115395|NCT03417102|54773763|FG001|Overall Study|Adverse Event|1|||
28115396|NCT03417102|54773762|FG000|Overall Study|Related to Coronavirus Pandemic (Covid-19)|0|||
28115397|NCT03417102|54773763|FG001|Overall Study|Related to Coronavirus Pandemic (Covid-19)|3|||
28115398|NCT03417102|54773762|FG000|Overall Study|Other|0|||
28115399|NCT03417102|54773763|FG001|Overall Study|Other|1|||
27816686|NCT01539291|54273644|FG000|Study GS-US-312-0116|Other|1|||
28065392|NCT00287586|54721068|FG000|Overall Study|Itchy Swollen Eyes|0|||
28115400|NCT03417024|54773769|FG000|Overall Study|Study Termination prior to follow-up|11|||
28115401|NCT03417024|54773769|FG000|Overall Study|Physician Decision|2|||
28115402|NCT00028769|54773773|FG000|Overall Study|Adverse Event|2|||
28115403|NCT00028769|54773773|FG000|Overall Study|Refusal Unrelated to Adverse Events|1|||
28115404|NCT00028769|54773773|FG000|Overall Study|Progression or Death|31|||
28115405|NCT00028769|54773773|FG000|Overall Study|Other - Not Protocol Specified|1|||
28115406|NCT00028769|54773773|FG000|Overall Study|Ineligible|5|||
28115407|NCT00028769|54773773|FG000|Overall Study|Not Analyzable|1|||
28115408|NCT02953314|54773779|FG000|Overall Study|Adverse Event|0|||
28115409|NCT02953314|54773780|FG001|Overall Study|Adverse Event|1|||
28115410|NCT02953314|54773779|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
28115411|NCT02953314|54773780|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
28115412|NCT03402750|54773788|FG000|Overall Study|Lost to Follow-up|2|||
28115413|NCT03402750|54773789|FG001|Overall Study|Lost to Follow-up|1|||
28115414|NCT00007475|54773798|FG000|Overall Study|Withdrawal by Subject|1|||
28115415|NCT00007475|54773799|FG001|Overall Study|Withdrawal by Subject|0|||
27816687|NCT01539291|54273645|FG001|Study GS-US-312-0116|Other|0|||
28065393|NCT00287586|54721069|FG001|Overall Study|Itchy Swollen Eyes|1|||
28065394|NCT00287586|54721068|FG000|Overall Study|Recurrent Melanoma|0|||
28065395|NCT00287586|54721069|FG001|Overall Study|Recurrent Melanoma|1|||
28065396|NCT00287118|54721075|FG000|Overall Study|Adverse Event|30|||
28065397|NCT00287118|54721075|FG000|Overall Study|Death|1|||
28065398|NCT00287118|54721075|FG000|Overall Study|Lack of Efficacy|11|||
28065399|NCT00287118|54721075|FG000|Overall Study|Lost to Follow-up|1|||
28065400|NCT00287118|54721075|FG000|Overall Study|Protocol Violation|2|||
28065401|NCT00287118|54721075|FG000|Overall Study|Other|7|||
28065402|NCT00293202|54721081|FG000|Overall Study|Withdrawal by Subject|1|||
28065403|NCT00293202|54721082|FG001|Overall Study|Withdrawal by Subject|2|||
28065404|NCT00293202|54721081|FG000|Overall Study|positive ANA (antinuclear antibody)|1|||
28065405|NCT00293202|54721082|FG001|Overall Study|positive ANA (antinuclear antibody)|0|||
28065406|NCT00293202|54721081|FG000|Overall Study|on-hold due to fistula maturation time|1|||
28065407|NCT00293202|54721082|FG001|Overall Study|on-hold due to fistula maturation time|0|||
28065408|NCT00298896|54721092|FG000|Overall Study|Death|3|||
28065409|NCT00298896|54721092|FG000|Overall Study|Physician Decision|2|||
28065410|NCT00298896|54721092|FG000|Overall Study|Intercurrent Illness|1|||
28065411|NCT00298896|54721092|FG000|Overall Study|Disease Progression|41|||
28065412|NCT00298896|54721092|FG000|Overall Study|Withdrawal by Subject|2|||
28065413|NCT00298896|54721092|FG000|Overall Study|Assigned to treatment in error|1|||
28115416|NCT00007475|54773800|FG002|Overall Study|Withdrawal by Subject|0|||
28115417|NCT00007475|54773801|FG003|Overall Study|Withdrawal by Subject|0|||
28115418|NCT00007475|54773798|FG000|Overall Study|Adverse Event|3|||
28115419|NCT00007475|54773799|FG001|Overall Study|Adverse Event|0|||
28115420|NCT00007475|54773800|FG002|Overall Study|Adverse Event|0|||
28115421|NCT00007475|54773801|FG003|Overall Study|Adverse Event|0|||
28115422|NCT00025883|54773813|FG000|Overall Study|had atypical progeriod lipodystrophy|4|||
28115423|NCT00025883|54773813|FG000|Overall Study|no baseline data|1|||
28115424|NCT00025883|54773813|FG000|Overall Study|Death|1|||
28115425|NCT00025883|54773813|FG000|Overall Study|Adverse Event|1|||
28115426|NCT00025883|54773813|FG000|Overall Study|didn't reach 6 months of Metreleptin|10|||
28115427|NCT00072293|54773820|FG000|Overall Study|Lost to Follow-up|1|||
28115428|NCT00072293|54773821|FG001|Overall Study|Lost to Follow-up|1|||
28115429|NCT00072293|54773820|FG000|Overall Study|Withdrawal by Subject|0|||
28115430|NCT00072293|54773821|FG001|Overall Study|Withdrawal by Subject|1|||
28115431|NCT03753763|54773829|FG000|Overall Study|Adverse Event|2|||
28115432|NCT03753763|54773830|FG001|Overall Study|Adverse Event|0|||
28115433|NCT03753763|54773829|FG000|Overall Study|Withdrawal by Subject|3|||
28115434|NCT03753763|54773830|FG001|Overall Study|Withdrawal by Subject|1|||
28115435|NCT03753763|54773829|FG000|Overall Study|clinical deterioration|1|||
28115436|NCT03753763|54773830|FG001|Overall Study|clinical deterioration|0|||
28115437|NCT03384966|54773839|FG000|Randomized at End of Screening Period|Physician decision due to adverse event|1|||
28115438|NCT03384966|54773840|FG001|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
28115439|NCT03384966|54773841|FG002|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
28115440|NCT03384966|54773839|FG000|Follow-up Period|Adverse Event|1|||
28115441|NCT03384966|54773840|FG001|Follow-up Period|Adverse Event|0|||
28115442|NCT03384966|54773841|FG002|Follow-up Period|Adverse Event|0|||
28115443|NCT03402126|54773858|FG000|Overall Study|Lost to Follow-up|6|||
28115444|NCT03402126|54773858|FG000|Overall Study|Protocol Violation|10|||
28115445|NCT03402126|54773858|FG000|Overall Study|Sponsor request/Study termination|29|||
28115446|NCT03402126|54773858|FG000|Overall Study|Study product no longer in use|1|||
28115447|NCT03402126|54773858|FG000|Overall Study|Technical problems|1|||
28115448|NCT03402126|54773858|FG000|Overall Study|Withdrawal by Subject|6|||
28115449|NCT03402126|54773858|FG000|Overall Study|Physician Decision|2|||
28115450|NCT03402126|54773858|FG000|Overall Study|upgrade to Cardiac Resynchronization Therapy-Defibrillator/stage IV cancer|3|||
28115451|NCT03402126|54773858|FG000|Overall Study|Death|4|||
28115452|NCT03355326|54773864|FG000|Overall Study|Protocol Violation|3|||
28115453|NCT03355326|54773865|FG001|Overall Study|Protocol Violation|3|||
28115454|NCT03353220|54773871|FG000|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|4|||
28115455|NCT03353220|54773872|FG001|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|7|||
28115456|NCT03751657|54773880|FG000|Overall Study|Physician Decision|0|||
28115457|NCT03751657|54773881|FG001|Overall Study|Physician Decision|1|||
28115458|NCT03751657|54773880|FG000|Overall Study|Withdrawal by Subject|1|||
28115459|NCT03751657|54773881|FG001|Overall Study|Withdrawal by Subject|1|||
28115460|NCT03751657|54773880|FG000|Overall Study|Lost to Follow-up|2|||
28115461|NCT03751657|54773881|FG001|Overall Study|Lost to Follow-up|1|||
28115462|NCT00025259|54773894|FG000|Overall Study|Death|1|||
28115463|NCT00025259|54773895|FG001|Overall Study|Death|3|||
28115464|NCT00025259|54773896|FG002|Overall Study|Death|0|||
28115465|NCT00025259|54773897|FG003|Overall Study|Death|3|||
28115466|NCT00025259|54773898|FG004|Overall Study|Death|0|||
28115467|NCT00025259|54773899|FG005|Overall Study|Death|1|||
28115468|NCT00025259|54773900|FG006|Overall Study|Death|2|||
28115469|NCT00025259|54773894|FG000|Overall Study|Lack of Efficacy|2|||
28115470|NCT00025259|54773895|FG001|Overall Study|Lack of Efficacy|46|||
28115471|NCT00025259|54773896|FG002|Overall Study|Lack of Efficacy|60|||
28115472|NCT00025259|54773897|FG003|Overall Study|Lack of Efficacy|78|||
28115473|NCT00025259|54773898|FG004|Overall Study|Lack of Efficacy|11|||
28115474|NCT00025259|54773899|FG005|Overall Study|Lack of Efficacy|30|||
28115475|NCT00025259|54773900|FG006|Overall Study|Lack of Efficacy|38|||
28115476|NCT00025259|54773894|FG000|Overall Study|Lost to Follow-up|2|||
28115477|NCT00025259|54773895|FG001|Overall Study|Lost to Follow-up|9|||
28115478|NCT00025259|54773896|FG002|Overall Study|Lost to Follow-up|13|||
28115479|NCT00025259|54773897|FG003|Overall Study|Lost to Follow-up|13|||
28115480|NCT00025259|54773898|FG004|Overall Study|Lost to Follow-up|1|||
28115481|NCT00025259|54773899|FG005|Overall Study|Lost to Follow-up|3|||
28115482|NCT00025259|54773900|FG006|Overall Study|Lost to Follow-up|1|||
28115483|NCT00025259|54773894|FG000|Overall Study|Physician Decision|12|||
28115484|NCT00025259|54773895|FG001|Overall Study|Physician Decision|1|||
28115485|NCT00025259|54773896|FG002|Overall Study|Physician Decision|0|||
28115486|NCT00025259|54773897|FG003|Overall Study|Physician Decision|5|||
28115487|NCT00025259|54773898|FG004|Overall Study|Physician Decision|4|||
28115488|NCT00025259|54773899|FG005|Overall Study|Physician Decision|2|||
28115489|NCT00025259|54773900|FG006|Overall Study|Physician Decision|1|||
28115490|NCT00025259|54773894|FG000|Overall Study|Protocol Violation|3|||
28115491|NCT00025259|54773895|FG001|Overall Study|Protocol Violation|2|||
28115492|NCT00025259|54773896|FG002|Overall Study|Protocol Violation|2|||
28115493|NCT00025259|54773897|FG003|Overall Study|Protocol Violation|1|||
28115494|NCT00025259|54773898|FG004|Overall Study|Protocol Violation|2|||
28115495|NCT00025259|54773899|FG005|Overall Study|Protocol Violation|1|||
28115496|NCT00025259|54773900|FG006|Overall Study|Protocol Violation|3|||
28115497|NCT00025259|54773894|FG000|Overall Study|Withdrawal by Subject|9|||
28115498|NCT00025259|54773895|FG001|Overall Study|Withdrawal by Subject|27|||
28115499|NCT00025259|54773896|FG002|Overall Study|Withdrawal by Subject|6|||
28115500|NCT00025259|54773897|FG003|Overall Study|Withdrawal by Subject|14|||
28115501|NCT00025259|54773898|FG004|Overall Study|Withdrawal by Subject|11|||
28115502|NCT00025259|54773899|FG005|Overall Study|Withdrawal by Subject|8|||
28115503|NCT00025259|54773900|FG006|Overall Study|Withdrawal by Subject|3|||
28115504|NCT00025259|54773894|FG000|Overall Study|Ineligible|14|||
28115505|NCT00025259|54773895|FG001|Overall Study|Ineligible|1|||
28115506|NCT00025259|54773896|FG002|Overall Study|Ineligible|0|||
28115507|NCT00025259|54773897|FG003|Overall Study|Ineligible|0|||
28115508|NCT00025259|54773898|FG004|Overall Study|Ineligible|6|||
28115509|NCT00025259|54773899|FG005|Overall Study|Ineligible|0|||
28115510|NCT00025259|54773900|FG006|Overall Study|Ineligible|1|||
28115511|NCT00025259|54773894|FG000|Overall Study|Randomization error|1|||
28115512|NCT00025259|54773895|FG001|Overall Study|Randomization error|0|||
28115513|NCT00025259|54773896|FG002|Overall Study|Randomization error|0|||
28115514|NCT00025259|54773897|FG003|Overall Study|Randomization error|0|||
28115515|NCT00025259|54773898|FG004|Overall Study|Randomization error|1|||
28115516|NCT00025259|54773899|FG005|Overall Study|Randomization error|7|||
28115517|NCT00025259|54773900|FG006|Overall Study|Randomization error|2|||
28115518|NCT00025259|54773894|FG000|Overall Study|Adverse Event|1|||
28115519|NCT00025259|54773895|FG001|Overall Study|Adverse Event|0|||
28115520|NCT00025259|54773896|FG002|Overall Study|Adverse Event|0|||
28115521|NCT00025259|54773897|FG003|Overall Study|Adverse Event|0|||
28115522|NCT00025259|54773898|FG004|Overall Study|Adverse Event|0|||
28115523|NCT00025259|54773899|FG005|Overall Study|Adverse Event|0|||
28115524|NCT00025259|54773900|FG006|Overall Study|Adverse Event|0|||
28115525|NCT03351738|54773925|FG000|Overall Study|Withdrawal by Subject|0|||
28115526|NCT03351738|54773926|FG001|Overall Study|Withdrawal by Subject|1|||
28115527|NCT03351738|54773927|FG002|Overall Study|Withdrawal by Subject|0|||
28115528|NCT03351738|54773928|FG003|Overall Study|Withdrawal by Subject|1|||
28115529|NCT03351738|54773929|FG004|Overall Study|Withdrawal by Subject|0|||
28115530|NCT03351738|54773930|FG005|Overall Study|Withdrawal by Subject|0|||
28115531|NCT03351114|54773949|FG000|Overall Study|Withdrawal by Subject|1|||
28115532|NCT03350256|54773953|FG000|Overall Study|Inclusion/exclusion violation|4|||
28115533|NCT03350256|54773953|FG000|Overall Study|Recommended for other therapies|2|||
28115534|NCT03350256|54773953|FG000|Overall Study|Protocol Violation|3|||
28115535|NCT03350256|54773953|FG000|Overall Study|Non compliance|2|||
28115536|NCT03350256|54773953|FG000|Overall Study|Denial by insurance|1|||
28115537|NCT03350256|54773953|FG000|Overall Study|Adverse Event|2|||
28115538|NCT03350256|54773953|FG000|Overall Study|Trial failure|12|||
28115539|NCT03350256|54773953|FG000|Overall Study|Did not proceed to permanent implant|3|||
28115540|NCT03350256|54773953|FG000|Overall Study|Withdrawal by Subject|3|||
28115541|NCT03350256|54773953|FG000|Overall Study|Subject moving out of state|1|||
28115542|NCT03350256|54773953|FG000|Overall Study|Lost to Follow-up|1|||
28115543|NCT03350256|54773953|FG000|Overall Study|Lack of Efficacy|2|||
28115544|NCT00024167|54773960|FG000|Overall Study|Death|53|||
28115545|NCT00024167|54773961|FG001|Overall Study|Death|47|||
28115546|NCT00022763|54773970|FG000|Overall Study|Adverse Event|1|||
28115547|NCT00022763|54773971|FG001|Overall Study|Adverse Event|2|||
28115548|NCT00022763|54773970|FG000|Overall Study|Injection Site Reactions|0|||
28115549|NCT00022763|54773971|FG001|Overall Study|Injection Site Reactions|2|||
28115550|NCT00022763|54773970|FG000|Overall Study|Death|0|||
28115551|NCT00022763|54773971|FG001|Overall Study|Death|1|||
28115552|NCT00022763|54773970|FG000|Overall Study|Lost to Follow-up|0|||
27848774|NCT01360632|54343097|FG000|Phase A (8 Weeks)|Withdrawal by Subject|74|||
28115553|NCT00022763|54773971|FG001|Overall Study|Lost to Follow-up|3|||
28115554|NCT00022763|54773970|FG000|Overall Study|Withdrawal by Subject|4|||
28115555|NCT00022763|54773971|FG001|Overall Study|Withdrawal by Subject|7|||
28115556|NCT00022763|54773970|FG000|Overall Study|Insufficient Therapy|1|||
28115557|NCT00022763|54773971|FG001|Overall Study|Insufficient Therapy|0|||
28115558|NCT00022763|54773970|FG000|Overall Study|Admin|3|||
28115559|NCT00022763|54773971|FG001|Overall Study|Admin|2|||
28115560|NCT00071513|54773978|FG000|Intervention Component|Withdrawal by Subject|2|||
28115561|NCT00071513|54773979|FG001|Intervention Component|Withdrawal by Subject|3|||
28115562|NCT00071513|54773978|FG000|Follow-up Assessment|Withdrawal by Subject|6|||
28115563|NCT00071513|54773979|FG001|Follow-up Assessment|Withdrawal by Subject|6|||
28115564|NCT00006389|54773987|FG000|Overall Study|Adverse Event|1|||
28115565|NCT00006305|54773996|FG000|Overall Study|Withdrawal by Subject|17|||
28115566|NCT00006305|54773997|FG001|Overall Study|Withdrawal by Subject|10|||
28115567|NCT00006305|54773998|FG002|Overall Study|Withdrawal by Subject|15|||
28115568|NCT00006305|54773999|FG003|Overall Study|Withdrawal by Subject|14|||
28115569|NCT03529773|54774049|FG000|Overall Study|Adverse Event|0|||
28115570|NCT03529773|54774050|FG001|Overall Study|Adverse Event|0|||
28115571|NCT03529773|54774051|FG002|Overall Study|Adverse Event|0|||
28115572|NCT03529773|54774052|FG003|Overall Study|Adverse Event|0|||
28115573|NCT03529773|54774053|FG004|Overall Study|Adverse Event|0|||
28115574|NCT03529773|54774054|FG005|Overall Study|Adverse Event|0|||
28115575|NCT03529773|54774055|FG006|Overall Study|Adverse Event|0|||
28115576|NCT03529773|54774056|FG007|Overall Study|Adverse Event|0|||
28115577|NCT03529773|54774057|FG008|Overall Study|Adverse Event|0|||
28115578|NCT03529773|54774058|FG009|Overall Study|Adverse Event|0|||
28115579|NCT03529773|54774059|FG010|Overall Study|Adverse Event|0|||
28115580|NCT03529773|54774060|FG011|Overall Study|Adverse Event|0|||
28115581|NCT03529773|54774061|FG012|Overall Study|Adverse Event|0|||
28115582|NCT03529773|54774062|FG013|Overall Study|Adverse Event|0|||
28115583|NCT03529773|54774063|FG014|Overall Study|Adverse Event|0|||
28115584|NCT03529773|54774064|FG015|Overall Study|Adverse Event|0|||
28115585|NCT03529773|54774065|FG016|Overall Study|Adverse Event|0|||
28115586|NCT03529773|54774066|FG017|Overall Study|Adverse Event|0|||
28115587|NCT03529773|54774067|FG018|Overall Study|Adverse Event|0|||
28115588|NCT03529773|54774068|FG019|Overall Study|Adverse Event|0|||
28115589|NCT03529773|54774069|FG020|Overall Study|Adverse Event|0|||
28115590|NCT03529773|54774070|FG021|Overall Study|Adverse Event|0|||
28115591|NCT03529773|54774071|FG022|Overall Study|Adverse Event|0|||
28115592|NCT03529773|54774072|FG023|Overall Study|Adverse Event|0|||
28115593|NCT03529773|54774073|FG024|Overall Study|Adverse Event|0|||
28115594|NCT03529773|54774074|FG025|Overall Study|Adverse Event|0|||
28115595|NCT03529773|54774075|FG026|Overall Study|Adverse Event|0|||
28115596|NCT03529773|54774076|FG027|Overall Study|Adverse Event|0|||
28115597|NCT03529773|54774077|FG028|Overall Study|Adverse Event|0|||
28115598|NCT03529773|54774078|FG029|Overall Study|Adverse Event|0|||
28115599|NCT03529773|54774079|FG030|Overall Study|Adverse Event|1|||
28115600|NCT03529773|54774080|FG031|Overall Study|Adverse Event|0|||
28115601|NCT03529773|54774081|FG032|Overall Study|Adverse Event|0|||
28115602|NCT03529773|54774082|FG033|Overall Study|Adverse Event|0|||
28115603|NCT03529773|54774083|FG034|Overall Study|Adverse Event|0|||
28115604|NCT03529773|54774084|FG035|Overall Study|Adverse Event|1|||
28115605|NCT03529773|54774085|FG036|Overall Study|Adverse Event|0|||
28115606|NCT03529773|54774086|FG037|Overall Study|Adverse Event|0|||
28115607|NCT03529773|54774087|FG038|Overall Study|Adverse Event|1|||
28115608|NCT03529773|54774088|FG039|Overall Study|Adverse Event|1|||
28115609|NCT03529773|54774049|FG000|Overall Study|Death|0|||
28115610|NCT03529773|54774050|FG001|Overall Study|Death|0|||
28115611|NCT03529773|54774051|FG002|Overall Study|Death|0|||
28115612|NCT03529773|54774052|FG003|Overall Study|Death|0|||
28115613|NCT03529773|54774053|FG004|Overall Study|Death|0|||
28115614|NCT03529773|54774054|FG005|Overall Study|Death|0|||
28115615|NCT03529773|54774055|FG006|Overall Study|Death|0|||
27940351|NCT01185600|54596630|FG000|Overall Study|Withdrawal by Subject|1|||
28115616|NCT03529773|54774056|FG007|Overall Study|Death|0|||
28115617|NCT03529773|54774057|FG008|Overall Study|Death|0|||
28115618|NCT03529773|54774058|FG009|Overall Study|Death|0|||
28115619|NCT03529773|54774059|FG010|Overall Study|Death|0|||
28115620|NCT03529773|54774060|FG011|Overall Study|Death|0|||
28115621|NCT03529773|54774061|FG012|Overall Study|Death|1|||
28115622|NCT03529773|54774062|FG013|Overall Study|Death|0|||
28115623|NCT03529773|54774063|FG014|Overall Study|Death|0|||
28115624|NCT03529773|54774064|FG015|Overall Study|Death|0|||
28115625|NCT03529773|54774065|FG016|Overall Study|Death|0|||
28115626|NCT03529773|54774066|FG017|Overall Study|Death|0|||
28115627|NCT03529773|54774067|FG018|Overall Study|Death|0|||
28115628|NCT03529773|54774068|FG019|Overall Study|Death|1|||
27816688|NCT01539291|54273646|FG002|Study GS-US-312-0116|Other|0|||
27816689|NCT01539291|54273647|FG003|Study GS-US-312-0116|Other|0|||
27816690|NCT01539291|54273644|FG000|Study GS-US-312-0117|Adverse Event|22|||
27816691|NCT01539291|54273645|FG001|Study GS-US-312-0117|Adverse Event|1|||
27816692|NCT01539291|54273646|FG002|Study GS-US-312-0117|Adverse Event|9|||
27816693|NCT01539291|54273647|FG003|Study GS-US-312-0117|Adverse Event|12|||
28065414|NCT00286494|54721099|FG000|Overall Study|Hyperglycemic rescue|12|||
28065415|NCT00286494|54721100|FG001|Overall Study|Hyperglycemic rescue|19|||
28065416|NCT00286494|54721101|FG002|Overall Study|Hyperglycemic rescue|18|||
28065417|NCT00286494|54721099|FG000|Overall Study|Withdrawal by Subject|2|||
28065418|NCT00286494|54721100|FG001|Overall Study|Withdrawal by Subject|10|||
28065419|NCT00286494|54721101|FG002|Overall Study|Withdrawal by Subject|9|||
28065420|NCT00286494|54721099|FG000|Overall Study|Adverse Event|3|||
28065421|NCT00286494|54721100|FG001|Overall Study|Adverse Event|8|||
28065422|NCT00286494|54721101|FG002|Overall Study|Adverse Event|6|||
28065423|NCT00286494|54721099|FG000|Overall Study|Physician Decision|5|||
28065424|NCT00286494|54721100|FG001|Overall Study|Physician Decision|5|||
28065425|NCT00286494|54721101|FG002|Overall Study|Physician Decision|1|||
28065426|NCT00286494|54721099|FG000|Overall Study|Lost to Follow-up|3|||
28065427|NCT00286494|54721100|FG001|Overall Study|Lost to Follow-up|1|||
28065428|NCT00286494|54721101|FG002|Overall Study|Lost to Follow-up|3|||
28065429|NCT00286494|54721099|FG000|Overall Study|Protocol Violation|1|||
27816694|NCT01539291|54273644|FG000|Study GS-US-312-0117|Physician Decision|9|||
27816695|NCT01539291|54273645|FG001|Study GS-US-312-0117|Physician Decision|0|||
28065430|NCT00286494|54721100|FG001|Overall Study|Protocol Violation|1|||
28065431|NCT00286494|54721101|FG002|Overall Study|Protocol Violation|2|||
28115629|NCT03529773|54774069|FG020|Overall Study|Death|0|||
28115630|NCT03529773|54774070|FG021|Overall Study|Death|0|||
28115631|NCT03529773|54774071|FG022|Overall Study|Death|1|||
28115632|NCT03529773|54774072|FG023|Overall Study|Death|0|||
28115633|NCT03529773|54774073|FG024|Overall Study|Death|0|||
28115634|NCT03529773|54774074|FG025|Overall Study|Death|0|||
28115635|NCT03529773|54774075|FG026|Overall Study|Death|0|||
28115636|NCT03529773|54774076|FG027|Overall Study|Death|0|||
28115637|NCT03529773|54774077|FG028|Overall Study|Death|0|||
28115638|NCT03529773|54774078|FG029|Overall Study|Death|0|||
28115639|NCT03529773|54774079|FG030|Overall Study|Death|0|||
28115640|NCT03529773|54774080|FG031|Overall Study|Death|0|||
28115641|NCT03529773|54774081|FG032|Overall Study|Death|0|||
28115642|NCT03529773|54774082|FG033|Overall Study|Death|1|||
28115643|NCT03529773|54774083|FG034|Overall Study|Death|1|||
28115644|NCT03529773|54774084|FG035|Overall Study|Death|0|||
28115645|NCT03529773|54774085|FG036|Overall Study|Death|1|||
28115646|NCT03529773|54774086|FG037|Overall Study|Death|0|||
27848775|NCT01360632|54343098|FG001|Phase A (8 Weeks)|Withdrawal by Subject|0|||
27848776|NCT01360632|54343099|FG002|Phase A (8 Weeks)|Withdrawal by Subject|0|||
27848777|NCT01360632|54343100|FG003|Phase A (8 Weeks)|Withdrawal by Subject|0|||
27848778|NCT01360632|54343101|FG004|Phase A (8 Weeks)|Withdrawal by Subject|0|||
27848779|NCT01360632|54343097|FG000|Phase A (8 Weeks)|Protocol Deviation|39|||
27848780|NCT01360632|54343098|FG001|Phase A (8 Weeks)|Protocol Deviation|0|||
27848781|NCT01360632|54343099|FG002|Phase A (8 Weeks)|Protocol Deviation|0|||
28115647|NCT03529773|54774087|FG038|Overall Study|Death|0|||
28115648|NCT03529773|54774088|FG039|Overall Study|Death|0|||
28115649|NCT03529773|54774049|FG000|Overall Study|Lost to Follow-up|0|||
28115650|NCT03529773|54774050|FG001|Overall Study|Lost to Follow-up|0|||
28115651|NCT03529773|54774051|FG002|Overall Study|Lost to Follow-up|1|||
28115652|NCT03529773|54774052|FG003|Overall Study|Lost to Follow-up|0|||
28115653|NCT03529773|54774053|FG004|Overall Study|Lost to Follow-up|1|||
28115654|NCT03529773|54774054|FG005|Overall Study|Lost to Follow-up|1|||
28115655|NCT03529773|54774055|FG006|Overall Study|Lost to Follow-up|0|||
28115656|NCT03529773|54774056|FG007|Overall Study|Lost to Follow-up|0|||
28115657|NCT03529773|54774057|FG008|Overall Study|Lost to Follow-up|0|||
28115658|NCT03529773|54774058|FG009|Overall Study|Lost to Follow-up|0|||
28115659|NCT03529773|54774059|FG010|Overall Study|Lost to Follow-up|0|||
28115660|NCT03529773|54774060|FG011|Overall Study|Lost to Follow-up|0|||
28115661|NCT03529773|54774061|FG012|Overall Study|Lost to Follow-up|0|||
28115662|NCT03529773|54774062|FG013|Overall Study|Lost to Follow-up|1|||
28115663|NCT03529773|54774063|FG014|Overall Study|Lost to Follow-up|4|||
28115664|NCT03529773|54774064|FG015|Overall Study|Lost to Follow-up|1|||
28115665|NCT03529773|54774065|FG016|Overall Study|Lost to Follow-up|1|||
28115666|NCT03529773|54774066|FG017|Overall Study|Lost to Follow-up|0|||
28115667|NCT03529773|54774067|FG018|Overall Study|Lost to Follow-up|1|||
28115668|NCT03529773|54774068|FG019|Overall Study|Lost to Follow-up|1|||
27816696|NCT01539291|54273646|FG002|Study GS-US-312-0117|Physician Decision|6|||
27816697|NCT01539291|54273647|FG003|Study GS-US-312-0117|Physician Decision|4|||
27816698|NCT01539291|54273644|FG000|Study GS-US-312-0117|Withdrawal by Subject|5|||
27816699|NCT01539291|54273645|FG001|Study GS-US-312-0117|Withdrawal by Subject|0|||
27816700|NCT01539291|54273646|FG002|Study GS-US-312-0117|Withdrawal by Subject|6|||
27816701|NCT01539291|54273647|FG003|Study GS-US-312-0117|Withdrawal by Subject|4|||
27816702|NCT01539291|54273644|FG000|Study GS-US-312-0117|Study Terminated by Sponsor|3|||
27816703|NCT01539291|54273645|FG001|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
28115669|NCT03529773|54774069|FG020|Overall Study|Lost to Follow-up|2|||
27816704|NCT01539291|54273646|FG002|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
27848782|NCT01360632|54343100|FG003|Phase A (8 Weeks)|Protocol Deviation|0|||
28115670|NCT03529773|54774070|FG021|Overall Study|Lost to Follow-up|4|||
28115671|NCT03529773|54774071|FG022|Overall Study|Lost to Follow-up|3|||
28115672|NCT03529773|54774072|FG023|Overall Study|Lost to Follow-up|4|||
28115673|NCT03529773|54774073|FG024|Overall Study|Lost to Follow-up|3|||
28115674|NCT03529773|54774074|FG025|Overall Study|Lost to Follow-up|5|||
28115675|NCT03529773|54774075|FG026|Overall Study|Lost to Follow-up|5|||
28115676|NCT03529773|54774076|FG027|Overall Study|Lost to Follow-up|0|||
28115677|NCT03529773|54774077|FG028|Overall Study|Lost to Follow-up|0|||
28115678|NCT03529773|54774078|FG029|Overall Study|Lost to Follow-up|0|||
28115679|NCT03529773|54774079|FG030|Overall Study|Lost to Follow-up|1|||
28115680|NCT03529773|54774080|FG031|Overall Study|Lost to Follow-up|0|||
28115681|NCT03529773|54774081|FG032|Overall Study|Lost to Follow-up|0|||
28115682|NCT03529773|54774082|FG033|Overall Study|Lost to Follow-up|1|||
28115683|NCT03529773|54774083|FG034|Overall Study|Lost to Follow-up|1|||
28115684|NCT03529773|54774084|FG035|Overall Study|Lost to Follow-up|0|||
28115685|NCT03529773|54774085|FG036|Overall Study|Lost to Follow-up|0|||
28115686|NCT03529773|54774086|FG037|Overall Study|Lost to Follow-up|3|||
28115687|NCT03529773|54774087|FG038|Overall Study|Lost to Follow-up|1|||
28115688|NCT03529773|54774088|FG039|Overall Study|Lost to Follow-up|1|||
28115689|NCT03529773|54774049|FG000|Overall Study|No longer meets eligibility criteria|0|||
28115690|NCT03529773|54774050|FG001|Overall Study|No longer meets eligibility criteria|0|||
28115691|NCT03529773|54774051|FG002|Overall Study|No longer meets eligibility criteria|0|||
28115692|NCT03529773|54774052|FG003|Overall Study|No longer meets eligibility criteria|0|||
28115693|NCT03529773|54774053|FG004|Overall Study|No longer meets eligibility criteria|0|||
28115694|NCT03529773|54774054|FG005|Overall Study|No longer meets eligibility criteria|0|||
28115695|NCT03529773|54774055|FG006|Overall Study|No longer meets eligibility criteria|0|||
28115696|NCT03529773|54774056|FG007|Overall Study|No longer meets eligibility criteria|0|||
28115697|NCT03529773|54774057|FG008|Overall Study|No longer meets eligibility criteria|0|||
28115698|NCT03529773|54774058|FG009|Overall Study|No longer meets eligibility criteria|0|||
28115699|NCT03529773|54774059|FG010|Overall Study|No longer meets eligibility criteria|0|||
28115700|NCT03529773|54774060|FG011|Overall Study|No longer meets eligibility criteria|0|||
28115701|NCT03529773|54774061|FG012|Overall Study|No longer meets eligibility criteria|0|||
28115702|NCT03529773|54774062|FG013|Overall Study|No longer meets eligibility criteria|0|||
28115703|NCT03529773|54774063|FG014|Overall Study|No longer meets eligibility criteria|0|||
28115704|NCT03529773|54774064|FG015|Overall Study|No longer meets eligibility criteria|0|||
28115705|NCT03529773|54774065|FG016|Overall Study|No longer meets eligibility criteria|0|||
28115706|NCT03529773|54774066|FG017|Overall Study|No longer meets eligibility criteria|0|||
28115707|NCT03529773|54774067|FG018|Overall Study|No longer meets eligibility criteria|0|||
28115708|NCT03529773|54774068|FG019|Overall Study|No longer meets eligibility criteria|0|||
28115709|NCT03529773|54774069|FG020|Overall Study|No longer meets eligibility criteria|0|||
28115710|NCT03529773|54774070|FG021|Overall Study|No longer meets eligibility criteria|0|||
28115711|NCT03529773|54774071|FG022|Overall Study|No longer meets eligibility criteria|1|||
28115712|NCT03529773|54774072|FG023|Overall Study|No longer meets eligibility criteria|0|||
28115713|NCT03529773|54774073|FG024|Overall Study|No longer meets eligibility criteria|0|||
28115714|NCT03529773|54774074|FG025|Overall Study|No longer meets eligibility criteria|0|||
28115715|NCT03529773|54774075|FG026|Overall Study|No longer meets eligibility criteria|0|||
28115716|NCT03529773|54774076|FG027|Overall Study|No longer meets eligibility criteria|0|||
28115717|NCT03529773|54774077|FG028|Overall Study|No longer meets eligibility criteria|0|||
28115718|NCT03529773|54774078|FG029|Overall Study|No longer meets eligibility criteria|0|||
28115719|NCT03529773|54774079|FG030|Overall Study|No longer meets eligibility criteria|0|||
28115720|NCT03529773|54774080|FG031|Overall Study|No longer meets eligibility criteria|0|||
28115721|NCT03529773|54774081|FG032|Overall Study|No longer meets eligibility criteria|0|||
28115722|NCT03529773|54774082|FG033|Overall Study|No longer meets eligibility criteria|0|||
28115723|NCT03529773|54774083|FG034|Overall Study|No longer meets eligibility criteria|0|||
28115724|NCT03529773|54774084|FG035|Overall Study|No longer meets eligibility criteria|0|||
28115725|NCT03529773|54774085|FG036|Overall Study|No longer meets eligibility criteria|0|||
28115726|NCT03529773|54774086|FG037|Overall Study|No longer meets eligibility criteria|0|||
28115727|NCT03529773|54774087|FG038|Overall Study|No longer meets eligibility criteria|1|||
28115728|NCT03529773|54774088|FG039|Overall Study|No longer meets eligibility criteria|0|||
28115729|NCT03529773|54774049|FG000|Overall Study|Other|0|||
27816705|NCT01539291|54273647|FG003|Study GS-US-312-0117|Study Terminated by Sponsor|5|||
27816706|NCT01539291|54273644|FG000|Study GS-US-312-0117|Other|2|||
28115730|NCT03529773|54774050|FG001|Overall Study|Other|0|||
28115731|NCT03529773|54774051|FG002|Overall Study|Other|0|||
28115732|NCT03529773|54774052|FG003|Overall Study|Other|0|||
28115733|NCT03529773|54774053|FG004|Overall Study|Other|0|||
28115734|NCT03529773|54774054|FG005|Overall Study|Other|0|||
28115735|NCT03529773|54774055|FG006|Overall Study|Other|0|||
28115736|NCT03529773|54774056|FG007|Overall Study|Other|0|||
28115737|NCT03529773|54774057|FG008|Overall Study|Other|0|||
28115738|NCT03529773|54774058|FG009|Overall Study|Other|0|||
28115739|NCT03529773|54774059|FG010|Overall Study|Other|0|||
28115740|NCT03529773|54774060|FG011|Overall Study|Other|0|||
28115741|NCT03529773|54774061|FG012|Overall Study|Other|1|||
28115742|NCT03529773|54774062|FG013|Overall Study|Other|0|||
28115743|NCT03529773|54774063|FG014|Overall Study|Other|2|||
28115744|NCT03529773|54774064|FG015|Overall Study|Other|0|||
28115745|NCT03529773|54774065|FG016|Overall Study|Other|0|||
28115746|NCT03529773|54774066|FG017|Overall Study|Other|3|||
28115747|NCT03529773|54774067|FG018|Overall Study|Other|0|||
28115748|NCT03529773|54774068|FG019|Overall Study|Other|0|||
28115749|NCT03529773|54774069|FG020|Overall Study|Other|1|||
28115750|NCT03529773|54774070|FG021|Overall Study|Other|0|||
28115751|NCT03529773|54774071|FG022|Overall Study|Other|1|||
28115752|NCT03529773|54774072|FG023|Overall Study|Other|0|||
28115753|NCT03529773|54774073|FG024|Overall Study|Other|3|||
28115754|NCT03529773|54774074|FG025|Overall Study|Other|2|||
28115755|NCT03529773|54774075|FG026|Overall Study|Other|2|||
28115756|NCT03529773|54774076|FG027|Overall Study|Other|0|||
28115757|NCT03529773|54774077|FG028|Overall Study|Other|0|||
28115758|NCT03529773|54774078|FG029|Overall Study|Other|0|||
28115759|NCT03529773|54774079|FG030|Overall Study|Other|0|||
28115760|NCT03529773|54774080|FG031|Overall Study|Other|0|||
28115761|NCT03529773|54774081|FG032|Overall Study|Other|0|||
28115762|NCT03529773|54774082|FG033|Overall Study|Other|0|||
28115763|NCT03529773|54774083|FG034|Overall Study|Other|1|||
28115764|NCT03529773|54774084|FG035|Overall Study|Other|1|||
28115765|NCT03529773|54774085|FG036|Overall Study|Other|0|||
28115766|NCT03529773|54774086|FG037|Overall Study|Other|0|||
28115767|NCT03529773|54774087|FG038|Overall Study|Other|0|||
28115768|NCT03529773|54774088|FG039|Overall Study|Other|0|||
28115769|NCT03529773|54774049|FG000|Overall Study|Physician Decision|0|||
28115770|NCT03529773|54774050|FG001|Overall Study|Physician Decision|0|||
28115771|NCT03529773|54774051|FG002|Overall Study|Physician Decision|0|||
28115772|NCT03529773|54774052|FG003|Overall Study|Physician Decision|0|||
28115773|NCT03529773|54774053|FG004|Overall Study|Physician Decision|0|||
28115774|NCT03529773|54774054|FG005|Overall Study|Physician Decision|0|||
28115775|NCT03529773|54774055|FG006|Overall Study|Physician Decision|0|||
28115776|NCT03529773|54774056|FG007|Overall Study|Physician Decision|0|||
28115777|NCT03529773|54774057|FG008|Overall Study|Physician Decision|0|||
28115778|NCT03529773|54774058|FG009|Overall Study|Physician Decision|0|||
28115779|NCT03529773|54774059|FG010|Overall Study|Physician Decision|0|||
28115780|NCT03529773|54774060|FG011|Overall Study|Physician Decision|0|||
28115781|NCT03529773|54774061|FG012|Overall Study|Physician Decision|0|||
28115782|NCT03529773|54774062|FG013|Overall Study|Physician Decision|0|||
28115783|NCT03529773|54774063|FG014|Overall Study|Physician Decision|0|||
28115784|NCT03529773|54774064|FG015|Overall Study|Physician Decision|0|||
28115785|NCT03529773|54774065|FG016|Overall Study|Physician Decision|0|||
28115786|NCT03529773|54774066|FG017|Overall Study|Physician Decision|0|||
28115787|NCT03529773|54774067|FG018|Overall Study|Physician Decision|0|||
28115788|NCT03529773|54774068|FG019|Overall Study|Physician Decision|1|||
28115789|NCT03529773|54774069|FG020|Overall Study|Physician Decision|1|||
28115790|NCT03529773|54774070|FG021|Overall Study|Physician Decision|0|||
28115791|NCT03529773|54774071|FG022|Overall Study|Physician Decision|0|||
28115792|NCT03529773|54774072|FG023|Overall Study|Physician Decision|0|||
28115793|NCT03529773|54774073|FG024|Overall Study|Physician Decision|0|||
28115794|NCT03529773|54774074|FG025|Overall Study|Physician Decision|0|||
28115795|NCT03529773|54774075|FG026|Overall Study|Physician Decision|0|||
28115796|NCT03529773|54774076|FG027|Overall Study|Physician Decision|0|||
28115797|NCT03529773|54774077|FG028|Overall Study|Physician Decision|0|||
28115798|NCT03529773|54774078|FG029|Overall Study|Physician Decision|0|||
28115799|NCT03529773|54774079|FG030|Overall Study|Physician Decision|0|||
28115800|NCT03529773|54774080|FG031|Overall Study|Physician Decision|0|||
28115801|NCT03529773|54774081|FG032|Overall Study|Physician Decision|0|||
28115802|NCT03529773|54774082|FG033|Overall Study|Physician Decision|0|||
28115803|NCT03529773|54774083|FG034|Overall Study|Physician Decision|0|||
28115804|NCT03529773|54774084|FG035|Overall Study|Physician Decision|0|||
28115805|NCT03529773|54774085|FG036|Overall Study|Physician Decision|0|||
27816707|NCT01539291|54273645|FG001|Study GS-US-312-0117|Other|1|||
28115806|NCT03529773|54774086|FG037|Overall Study|Physician Decision|0|||
28115807|NCT03529773|54774087|FG038|Overall Study|Physician Decision|0|||
28115808|NCT03529773|54774088|FG039|Overall Study|Physician Decision|0|||
28115809|NCT03529773|54774049|FG000|Overall Study|Protocol Violation|0|||
28115810|NCT03529773|54774050|FG001|Overall Study|Protocol Violation|0|||
28115811|NCT03529773|54774051|FG002|Overall Study|Protocol Violation|0|||
28115812|NCT03529773|54774052|FG003|Overall Study|Protocol Violation|0|||
28115813|NCT03529773|54774053|FG004|Overall Study|Protocol Violation|0|||
28115814|NCT03529773|54774054|FG005|Overall Study|Protocol Violation|0|||
28115815|NCT03529773|54774055|FG006|Overall Study|Protocol Violation|0|||
28115816|NCT03529773|54774056|FG007|Overall Study|Protocol Violation|0|||
28115817|NCT03529773|54774057|FG008|Overall Study|Protocol Violation|0|||
28115818|NCT03529773|54774058|FG009|Overall Study|Protocol Violation|0|||
28115819|NCT03529773|54774059|FG010|Overall Study|Protocol Violation|0|||
28115820|NCT03529773|54774060|FG011|Overall Study|Protocol Violation|0|||
28115821|NCT03529773|54774061|FG012|Overall Study|Protocol Violation|0|||
28115822|NCT03529773|54774062|FG013|Overall Study|Protocol Violation|0|||
28115823|NCT03529773|54774063|FG014|Overall Study|Protocol Violation|0|||
28115824|NCT03529773|54774064|FG015|Overall Study|Protocol Violation|0|||
28115825|NCT03529773|54774065|FG016|Overall Study|Protocol Violation|0|||
28115826|NCT03529773|54774066|FG017|Overall Study|Protocol Violation|0|||
28115827|NCT03529773|54774067|FG018|Overall Study|Protocol Violation|0|||
28115828|NCT03529773|54774068|FG019|Overall Study|Protocol Violation|0|||
28115829|NCT03529773|54774069|FG020|Overall Study|Protocol Violation|0|||
28115830|NCT03529773|54774070|FG021|Overall Study|Protocol Violation|0|||
28115831|NCT03529773|54774071|FG022|Overall Study|Protocol Violation|0|||
28115832|NCT03529773|54774072|FG023|Overall Study|Protocol Violation|0|||
28115833|NCT03529773|54774073|FG024|Overall Study|Protocol Violation|0|||
28115834|NCT03529773|54774074|FG025|Overall Study|Protocol Violation|0|||
28115835|NCT03529773|54774075|FG026|Overall Study|Protocol Violation|0|||
28115836|NCT03529773|54774076|FG027|Overall Study|Protocol Violation|0|||
28115837|NCT03529773|54774077|FG028|Overall Study|Protocol Violation|0|||
28115838|NCT03529773|54774078|FG029|Overall Study|Protocol Violation|0|||
28115839|NCT03529773|54774079|FG030|Overall Study|Protocol Violation|1|||
28115840|NCT03529773|54774080|FG031|Overall Study|Protocol Violation|0|||
28115841|NCT03529773|54774081|FG032|Overall Study|Protocol Violation|0|||
28115842|NCT03529773|54774082|FG033|Overall Study|Protocol Violation|0|||
28115843|NCT03529773|54774083|FG034|Overall Study|Protocol Violation|0|||
28115844|NCT03529773|54774084|FG035|Overall Study|Protocol Violation|0|||
28115845|NCT03529773|54774085|FG036|Overall Study|Protocol Violation|0|||
28115846|NCT03529773|54774086|FG037|Overall Study|Protocol Violation|0|||
28115847|NCT03529773|54774087|FG038|Overall Study|Protocol Violation|0|||
28115848|NCT03529773|54774088|FG039|Overall Study|Protocol Violation|0|||
28115849|NCT03529773|54774049|FG000|Overall Study|Withdrawal by Subject|0|||
28115850|NCT03529773|54774050|FG001|Overall Study|Withdrawal by Subject|0|||
28115851|NCT03529773|54774051|FG002|Overall Study|Withdrawal by Subject|0|||
28115852|NCT03529773|54774052|FG003|Overall Study|Withdrawal by Subject|0|||
28115853|NCT03529773|54774053|FG004|Overall Study|Withdrawal by Subject|0|||
28115854|NCT03529773|54774054|FG005|Overall Study|Withdrawal by Subject|0|||
28115855|NCT03529773|54774055|FG006|Overall Study|Withdrawal by Subject|0|||
28115856|NCT03529773|54774056|FG007|Overall Study|Withdrawal by Subject|1|||
28115857|NCT03529773|54774057|FG008|Overall Study|Withdrawal by Subject|0|||
28065432|NCT00298740|54721109|FG000|Overall Study|Lack of Efficacy|6|||
28065433|NCT00298740|54721109|FG000|Overall Study|Withdrawal by Subject|3|||
28065434|NCT00285012|54721115|FG000|Assigned to Study Treatment (Tx)|Other|2|||
28065435|NCT00285012|54721116|FG001|Assigned to Study Treatment (Tx)|Other|3|||
28065436|NCT00285012|54721115|FG000|Received Study Tx|Death|2|||
28065437|NCT00285012|54721116|FG001|Received Study Tx|Death|1|||
28065438|NCT00285012|54721115|FG000|Received Study Tx|Adverse Event|5|||
28065439|NCT00285012|54721116|FG001|Received Study Tx|Adverse Event|11|||
28115858|NCT03529773|54774058|FG009|Overall Study|Withdrawal by Subject|1|||
28115859|NCT03529773|54774059|FG010|Overall Study|Withdrawal by Subject|1|||
28115860|NCT03529773|54774060|FG011|Overall Study|Withdrawal by Subject|0|||
27940352|NCT01185600|54596631|FG001|Overall Study|Withdrawal by Subject|1|||
28065440|NCT00285012|54721115|FG000|Received Study Tx|Lack of Efficacy|0|||
28115861|NCT03529773|54774061|FG012|Overall Study|Withdrawal by Subject|0|||
28115862|NCT03529773|54774062|FG013|Overall Study|Withdrawal by Subject|0|||
28065441|NCT00285012|54721116|FG001|Received Study Tx|Lack of Efficacy|3|||
28115863|NCT03529773|54774063|FG014|Overall Study|Withdrawal by Subject|0|||
28115864|NCT03529773|54774064|FG015|Overall Study|Withdrawal by Subject|3|||
28115865|NCT03529773|54774065|FG016|Overall Study|Withdrawal by Subject|0|||
28115866|NCT03529773|54774066|FG017|Overall Study|Withdrawal by Subject|2|||
28115867|NCT03529773|54774067|FG018|Overall Study|Withdrawal by Subject|3|||
28115868|NCT03529773|54774068|FG019|Overall Study|Withdrawal by Subject|1|||
28115869|NCT03529773|54774069|FG020|Overall Study|Withdrawal by Subject|3|||
28115870|NCT03529773|54774070|FG021|Overall Study|Withdrawal by Subject|1|||
28115871|NCT03529773|54774071|FG022|Overall Study|Withdrawal by Subject|1|||
28115872|NCT03529773|54774072|FG023|Overall Study|Withdrawal by Subject|2|||
28115873|NCT03529773|54774073|FG024|Overall Study|Withdrawal by Subject|2|||
28115874|NCT03529773|54774074|FG025|Overall Study|Withdrawal by Subject|4|||
28115875|NCT03529773|54774075|FG026|Overall Study|Withdrawal by Subject|2|||
28115876|NCT03529773|54774076|FG027|Overall Study|Withdrawal by Subject|1|||
28115877|NCT03529773|54774077|FG028|Overall Study|Withdrawal by Subject|1|||
27816708|NCT01539291|54273646|FG002|Study GS-US-312-0117|Other|1|||
27816709|NCT01539291|54273647|FG003|Study GS-US-312-0117|Other|1|||
27816710|NCT01538199|54273670|FG000|Overall Study|Lost to Follow-up|1|||
27816711|NCT01538199|54273671|FG001|Overall Study|Lost to Follow-up|2|||
27816712|NCT01538199|54273672|FG002|Overall Study|Lost to Follow-up|1|||
27816713|NCT01538199|54273673|FG003|Overall Study|Lost to Follow-up|0|||
27816714|NCT01538199|54273670|FG000|Overall Study|participant did not have time|1|||
27816715|NCT01538199|54273671|FG001|Overall Study|participant did not have time|0|||
27816716|NCT01538199|54273672|FG002|Overall Study|participant did not have time|0|||
27816717|NCT01538199|54273673|FG003|Overall Study|participant did not have time|2|||
27816718|NCT01538199|54273670|FG000|Overall Study|Lack of Efficacy|0|||
27816719|NCT01538199|54273671|FG001|Overall Study|Lack of Efficacy|1|||
27816720|NCT01538199|54273672|FG002|Overall Study|Lack of Efficacy|0|||
27816721|NCT01538199|54273673|FG003|Overall Study|Lack of Efficacy|0|||
28065442|NCT00285012|54721115|FG000|Received Study Tx|Lost to Follow-up|29|||
28065443|NCT00285012|54721116|FG001|Received Study Tx|Lost to Follow-up|31|||
28065444|NCT00285012|54721115|FG000|Received Study Tx|Withdrawal by Subject|31|||
28065445|NCT00285012|54721116|FG001|Received Study Tx|Withdrawal by Subject|43|||
28065446|NCT00285012|54721115|FG000|Received Study Tx|Other|5|||
28065447|NCT00285012|54721116|FG001|Received Study Tx|Other|5|||
28065448|NCT00284934|54721124|FG000|Overall Study|Adverse Event|1|||
28065449|NCT00284934|54721125|FG001|Overall Study|Adverse Event|2|||
28065450|NCT00284934|54721124|FG000|Overall Study|Other reasons|3|||
28065451|NCT00284934|54721125|FG001|Overall Study|Other reasons|1|||
28115878|NCT03529773|54774078|FG029|Overall Study|Withdrawal by Subject|0|||
28115879|NCT03529773|54774079|FG030|Overall Study|Withdrawal by Subject|0|||
28115880|NCT03529773|54774080|FG031|Overall Study|Withdrawal by Subject|0|||
28115881|NCT03529773|54774081|FG032|Overall Study|Withdrawal by Subject|0|||
28115882|NCT03529773|54774082|FG033|Overall Study|Withdrawal by Subject|0|||
28065452|NCT00284856|54721134|FG000|Overall Study|Adverse Event|3|||
28115883|NCT03529773|54774083|FG034|Overall Study|Withdrawal by Subject|1|||
28115884|NCT03529773|54774084|FG035|Overall Study|Withdrawal by Subject|2|||
27816722|NCT01511445|54273692|FG000|Overall Study|Lost to Follow-up|3|||
27816723|NCT01511445|54273693|FG001|Overall Study|Lost to Follow-up|1|||
27816724|NCT01511445|54273692|FG000|Overall Study|Protocol Violation|1|||
28065453|NCT00284856|54721135|FG001|Overall Study|Adverse Event|3|||
28115885|NCT03529773|54774085|FG036|Overall Study|Withdrawal by Subject|0|||
28115886|NCT03529773|54774086|FG037|Overall Study|Withdrawal by Subject|2|||
28115887|NCT03529773|54774087|FG038|Overall Study|Withdrawal by Subject|1|||
28115888|NCT03529773|54774088|FG039|Overall Study|Withdrawal by Subject|1|||
28115889|NCT03529773|54774049|FG000|Overall Study|Screen Failure|0|||
28115890|NCT03529773|54774050|FG001|Overall Study|Screen Failure|0|||
28115891|NCT03529773|54774051|FG002|Overall Study|Screen Failure|0|||
28115892|NCT03529773|54774052|FG003|Overall Study|Screen Failure|0|||
28115893|NCT03529773|54774053|FG004|Overall Study|Screen Failure|0|||
28115894|NCT03529773|54774054|FG005|Overall Study|Screen Failure|0|||
28115895|NCT03529773|54774055|FG006|Overall Study|Screen Failure|0|||
28115896|NCT03529773|54774056|FG007|Overall Study|Screen Failure|0|||
28115897|NCT03529773|54774057|FG008|Overall Study|Screen Failure|0|||
28115898|NCT03529773|54774058|FG009|Overall Study|Screen Failure|0|||
28115899|NCT03529773|54774059|FG010|Overall Study|Screen Failure|0|||
28115900|NCT03529773|54774060|FG011|Overall Study|Screen Failure|0|||
28115901|NCT03529773|54774061|FG012|Overall Study|Screen Failure|0|||
28115902|NCT03529773|54774062|FG013|Overall Study|Screen Failure|0|||
28115903|NCT03529773|54774063|FG014|Overall Study|Screen Failure|0|||
28115904|NCT03529773|54774064|FG015|Overall Study|Screen Failure|0|||
28115905|NCT03529773|54774065|FG016|Overall Study|Screen Failure|0|||
28115906|NCT03529773|54774066|FG017|Overall Study|Screen Failure|0|||
28115907|NCT03529773|54774067|FG018|Overall Study|Screen Failure|0|||
28115908|NCT03529773|54774068|FG019|Overall Study|Screen Failure|0|||
28115909|NCT03529773|54774069|FG020|Overall Study|Screen Failure|0|||
28115910|NCT03529773|54774070|FG021|Overall Study|Screen Failure|0|||
28115911|NCT03529773|54774071|FG022|Overall Study|Screen Failure|0|||
28115912|NCT03529773|54774072|FG023|Overall Study|Screen Failure|0|||
28115913|NCT03529773|54774073|FG024|Overall Study|Screen Failure|0|||
27816725|NCT01511445|54273693|FG001|Overall Study|Protocol Violation|3|||
27816726|NCT01511445|54273692|FG000|Overall Study|Protocol Violation|1|||
27816727|NCT01511445|54273693|FG001|Overall Study|Protocol Violation|0|||
28115914|NCT03529773|54774074|FG025|Overall Study|Screen Failure|0|||
28115915|NCT03529773|54774075|FG026|Overall Study|Screen Failure|0|||
28115916|NCT03529773|54774076|FG027|Overall Study|Screen Failure|0|||
28115917|NCT03529773|54774077|FG028|Overall Study|Screen Failure|0|||
28115918|NCT03529773|54774078|FG029|Overall Study|Screen Failure|0|||
28115919|NCT03529773|54774079|FG030|Overall Study|Screen Failure|0|||
28115920|NCT03529773|54774080|FG031|Overall Study|Screen Failure|0|||
28115921|NCT03529773|54774081|FG032|Overall Study|Screen Failure|0|||
28115922|NCT03529773|54774082|FG033|Overall Study|Screen Failure|0|||
28115923|NCT03529773|54774083|FG034|Overall Study|Screen Failure|0|||
27816728|NCT01543503|54273701|FG000|Overall Study|Lost to Follow-up|32|||
27816729|NCT01543503|54273702|FG001|Overall Study|Lost to Follow-up|36|||
27816730|NCT01543503|54273701|FG000|Overall Study|Adverse Event|9|||
27816731|NCT01543503|54273702|FG001|Overall Study|Adverse Event|13|||
27816732|NCT01543503|54273701|FG000|Overall Study|Lack of Efficacy|4|||
27816733|NCT01543503|54273702|FG001|Overall Study|Lack of Efficacy|16|||
27816734|NCT01543503|54273701|FG000|Overall Study|Participant withdrew informed consent|8|||
27816735|NCT01543503|54273702|FG001|Overall Study|Participant withdrew informed consent|10|||
27816736|NCT01543503|54273701|FG000|Overall Study|Change of jobs|0|||
27816737|NCT01543503|54273702|FG001|Overall Study|Change of jobs|1|||
27816738|NCT01543503|54273701|FG000|Overall Study|Intolerance to the biologic treatment|0|||
27816739|NCT01543503|54273702|FG001|Overall Study|Intolerance to the biologic treatment|1|||
27816740|NCT01543503|54273701|FG000|Overall Study|Probable overlap of RA with fibromyalgia|1|||
27816741|NCT01543503|54273702|FG001|Overall Study|Probable overlap of RA with fibromyalgia|0|||
27816742|NCT01543503|54273701|FG000|Overall Study|Participant did not complete last visit|0|||
27816743|NCT01543503|54273702|FG001|Overall Study|Participant did not complete last visit|2|||
27816744|NCT01543503|54273701|FG000|Overall Study|Refused to continue treatment|7|||
27816745|NCT01543503|54273702|FG001|Overall Study|Refused to continue treatment|0|||
27816746|NCT01543503|54273701|FG000|Overall Study|Incorrect medication received|1|||
27816747|NCT01543503|54273702|FG001|Overall Study|Incorrect medication received|0|||
27816748|NCT01543503|54273701|FG000|Overall Study|Participant moved to another city|2|||
27816749|NCT01543503|54273702|FG001|Overall Study|Participant moved to another city|0|||
27816750|NCT01543503|54273701|FG000|Overall Study|Participant will not return for visits|0|||
27816751|NCT01543503|54273702|FG001|Overall Study|Participant will not return for visits|2|||
27816752|NCT01543503|54273701|FG000|Overall Study|Participant transferred to another city|1|||
27816753|NCT01543503|54273702|FG001|Overall Study|Participant transferred to another city|0|||
28115924|NCT03529773|54774084|FG035|Overall Study|Screen Failure|0|||
27816754|NCT01543503|54273701|FG000|Overall Study|Participant moved to Scotland|1|||
27816755|NCT01543503|54273702|FG001|Overall Study|Participant moved to Scotland|0|||
27816756|NCT01543503|54273701|FG000|Overall Study|Participant decision to stop treatment|1|||
27816757|NCT01543503|54273702|FG001|Overall Study|Participant decision to stop treatment|0|||
27816758|NCT01543503|54273701|FG000|Overall Study|Investigator did not wish to participate|1|||
27816759|NCT01543503|54273702|FG001|Overall Study|Investigator did not wish to participate|1|||
27848783|NCT01360632|54343101|FG004|Phase A (8 Weeks)|Protocol Deviation|0|||
27848784|NCT01360632|54343097|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
27848785|NCT01360632|54343098|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
27848786|NCT01360632|54343099|FG002|Phase B (6 Weeks)|Lost to Follow-up|1|||
27848787|NCT01360632|54343100|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
27940353|NCT01185600|54596630|FG000|Overall Study|Hold by DSMB|1|||
28065454|NCT00284856|54721136|FG002|Overall Study|Adverse Event|3|||
28065455|NCT00284856|54721134|FG000|Overall Study|Lack of Efficacy|2|||
28065456|NCT00284856|54721135|FG001|Overall Study|Lack of Efficacy|1|||
28065457|NCT00284856|54721136|FG002|Overall Study|Lack of Efficacy|8|||
28065458|NCT00284856|54721134|FG000|Overall Study|Lost to Follow-up|25|||
28065459|NCT00284856|54721135|FG001|Overall Study|Lost to Follow-up|21|||
28065460|NCT00284856|54721136|FG002|Overall Study|Lost to Follow-up|22|||
28065461|NCT00284856|54721134|FG000|Overall Study|Protocol Violation|5|||
28065462|NCT00284856|54721135|FG001|Overall Study|Protocol Violation|4|||
28065463|NCT00284856|54721136|FG002|Overall Study|Protocol Violation|5|||
28065464|NCT00284856|54721134|FG000|Overall Study|Withdrawal by Subject|12|||
28065465|NCT00284856|54721135|FG001|Overall Study|Withdrawal by Subject|16|||
28065466|NCT00284856|54721136|FG002|Overall Study|Withdrawal by Subject|18|||
28065467|NCT00284856|54721134|FG000|Overall Study|Other|4|||
28065468|NCT00284856|54721135|FG001|Overall Study|Other|5|||
28065469|NCT00284856|54721136|FG002|Overall Study|Other|4|||
28065470|NCT00298272|54721146|FG000|Double-blind Phase|Adverse Event|2|||
28065471|NCT00298272|54721147|FG001|Double-blind Phase|Adverse Event|0|||
28065472|NCT00298272|54721146|FG000|Double-blind Phase|Failure to Return|2|||
27940354|NCT01185600|54596631|FG001|Overall Study|Hold by DSMB|2|||
28115925|NCT03529773|54774085|FG036|Overall Study|Screen Failure|1|||
28115926|NCT03529773|54774086|FG037|Overall Study|Screen Failure|1|||
28115927|NCT03529773|54774087|FG038|Overall Study|Screen Failure|0|||
28115928|NCT03529773|54774088|FG039|Overall Study|Screen Failure|1|||
28115929|NCT03529773|54774049|FG000|Overall Study|Randomized but not vaccinated|0|||
28115930|NCT03529773|54774050|FG001|Overall Study|Randomized but not vaccinated|0|||
28115931|NCT03529773|54774051|FG002|Overall Study|Randomized but not vaccinated|0|||
28115932|NCT03529773|54774052|FG003|Overall Study|Randomized but not vaccinated|0|||
28115933|NCT03529773|54774053|FG004|Overall Study|Randomized but not vaccinated|0|||
28115934|NCT03529773|54774054|FG005|Overall Study|Randomized but not vaccinated|0|||
28115935|NCT03529773|54774055|FG006|Overall Study|Randomized but not vaccinated|0|||
28115936|NCT03529773|54774056|FG007|Overall Study|Randomized but not vaccinated|0|||
28115937|NCT03529773|54774057|FG008|Overall Study|Randomized but not vaccinated|0|||
28115938|NCT03529773|54774058|FG009|Overall Study|Randomized but not vaccinated|0|||
28115939|NCT03529773|54774059|FG010|Overall Study|Randomized but not vaccinated|0|||
28115940|NCT03529773|54774060|FG011|Overall Study|Randomized but not vaccinated|0|||
28115941|NCT03529773|54774061|FG012|Overall Study|Randomized but not vaccinated|0|||
28115942|NCT03529773|54774062|FG013|Overall Study|Randomized but not vaccinated|0|||
28115943|NCT03529773|54774063|FG014|Overall Study|Randomized but not vaccinated|0|||
28115944|NCT03529773|54774064|FG015|Overall Study|Randomized but not vaccinated|0|||
28115945|NCT03529773|54774065|FG016|Overall Study|Randomized but not vaccinated|0|||
28115946|NCT03529773|54774066|FG017|Overall Study|Randomized but not vaccinated|1|||
28115947|NCT03529773|54774067|FG018|Overall Study|Randomized but not vaccinated|0|||
28115948|NCT03529773|54774068|FG019|Overall Study|Randomized but not vaccinated|0|||
28115949|NCT03529773|54774069|FG020|Overall Study|Randomized but not vaccinated|0|||
28115950|NCT03529773|54774070|FG021|Overall Study|Randomized but not vaccinated|0|||
28115951|NCT03529773|54774071|FG022|Overall Study|Randomized but not vaccinated|0|||
28115952|NCT03529773|54774072|FG023|Overall Study|Randomized but not vaccinated|0|||
28115953|NCT03529773|54774073|FG024|Overall Study|Randomized but not vaccinated|0|||
28115954|NCT03529773|54774074|FG025|Overall Study|Randomized but not vaccinated|0|||
28115955|NCT03529773|54774075|FG026|Overall Study|Randomized but not vaccinated|0|||
28115956|NCT03529773|54774076|FG027|Overall Study|Randomized but not vaccinated|1|||
28115957|NCT03529773|54774077|FG028|Overall Study|Randomized but not vaccinated|0|||
28115958|NCT03529773|54774078|FG029|Overall Study|Randomized but not vaccinated|0|||
28115959|NCT03529773|54774079|FG030|Overall Study|Randomized but not vaccinated|0|||
28115960|NCT03529773|54774080|FG031|Overall Study|Randomized but not vaccinated|0|||
28115961|NCT03529773|54774081|FG032|Overall Study|Randomized but not vaccinated|0|||
28115962|NCT03529773|54774082|FG033|Overall Study|Randomized but not vaccinated|0|||
28115963|NCT03529773|54774083|FG034|Overall Study|Randomized but not vaccinated|0|||
28115964|NCT03529773|54774084|FG035|Overall Study|Randomized but not vaccinated|0|||
28115965|NCT03529773|54774085|FG036|Overall Study|Randomized but not vaccinated|0|||
28115966|NCT03529773|54774086|FG037|Overall Study|Randomized but not vaccinated|0|||
28115967|NCT03529773|54774087|FG038|Overall Study|Randomized but not vaccinated|0|||
28115968|NCT03529773|54774088|FG039|Overall Study|Randomized but not vaccinated|0|||
28115969|NCT03799211|54774193|FG000|Overall Study|Lost to Follow-up|2|||
28115970|NCT03799211|54774194|FG001|Overall Study|Lost to Follow-up|13|||
28115971|NCT03799211|54774193|FG000|Overall Study|Withdrawal by Subject|2|||
28115972|NCT03799211|54774194|FG001|Overall Study|Withdrawal by Subject|0|||
28115973|NCT03349710|54774206|FG000|Treatment Period|Death|0|||
28115974|NCT03349710|54774207|FG001|Treatment Period|Death|0|||
28115975|NCT03349710|54774208|FG002|Treatment Period|Death|1|||
28115976|NCT03349710|54774209|FG003|Treatment Period|Death|0|||
28115977|NCT03349710|54774206|FG000|Treatment Period|Disease Progression|0|||
28115978|NCT03349710|54774207|FG001|Treatment Period|Disease Progression|2|||
28115979|NCT03349710|54774208|FG002|Treatment Period|Disease Progression|0|||
28115980|NCT03349710|54774209|FG003|Treatment Period|Disease Progression|1|||
28115981|NCT03349710|54774206|FG000|Treatment Period|Study Drug Toxicity|1|||
28115982|NCT03349710|54774207|FG001|Treatment Period|Study Drug Toxicity|0|||
28115983|NCT03349710|54774208|FG002|Treatment Period|Study Drug Toxicity|1|||
28115984|NCT03349710|54774209|FG003|Treatment Period|Study Drug Toxicity|1|||
28115985|NCT03349710|54774206|FG000|Treatment Period|Adverse event unrelated to Study Drug|2|||
28115986|NCT03349710|54774207|FG001|Treatment Period|Adverse event unrelated to Study Drug|1|||
28115987|NCT03349710|54774208|FG002|Treatment Period|Adverse event unrelated to Study Drug|1|||
28115988|NCT03349710|54774209|FG003|Treatment Period|Adverse event unrelated to Study Drug|1|||
28115989|NCT03349710|54774206|FG000|Treatment Period|admin reason by sponsor|0|||
28115990|NCT03349710|54774207|FG001|Treatment Period|admin reason by sponsor|7|||
28115991|NCT03349710|54774208|FG002|Treatment Period|admin reason by sponsor|0|||
28115992|NCT03349710|54774209|FG003|Treatment Period|admin reason by sponsor|19|||
28115993|NCT03349710|54774206|FG000|Treatment Period|Other Reason|2|||
28115994|NCT03349710|54774207|FG001|Treatment Period|Other Reason|0|||
28115995|NCT03349710|54774208|FG002|Treatment Period|Other Reason|2|||
28115996|NCT03349710|54774209|FG003|Treatment Period|Other Reason|1|||
28115997|NCT03349710|54774206|FG000|Treatment Period|completed|6|||
28115998|NCT03349710|54774207|FG001|Treatment Period|completed|0|||
28115999|NCT03349710|54774208|FG002|Treatment Period|completed|18|||
28116000|NCT03349710|54774209|FG003|Treatment Period|completed|1|||
28116001|NCT03349710|54774206|FG000|Treatment Period|participant request to discontinue|0|||
28116002|NCT03349710|54774207|FG001|Treatment Period|participant request to discontinue|0|||
28116003|NCT03349710|54774208|FG002|Treatment Period|participant request to discontinue|4|||
28116004|NCT03349710|54774209|FG003|Treatment Period|participant request to discontinue|0|||
28116005|NCT03349710|54774206|FG000|Treatment Period|participant withdrew consent|1|||
28116006|NCT03349710|54774207|FG001|Treatment Period|participant withdrew consent|0|||
28116007|NCT03349710|54774208|FG002|Treatment Period|participant withdrew consent|0|||
28116008|NCT03349710|54774209|FG003|Treatment Period|participant withdrew consent|0|||
28116009|NCT03511053|54774219|FG000|Overall Study|Withdrawal by Subject|1|||
28116010|NCT03377634|54774225|FG000|Study Period|Adverse Event|1|||
28116011|NCT03377634|54774226|FG001|Study Period|Adverse Event|0|||
28116012|NCT03377634|54774225|FG000|Study Period|Withdrawal by Subject|1|||
28116013|NCT03377634|54774226|FG001|Study Period|Withdrawal by Subject|0|||
28116014|NCT03528369|54774235|FG000|Overall Study|Withdrawal by Subject|2|||
28116015|NCT03528369|54774236|FG001|Overall Study|Withdrawal by Subject|0|||
28116016|NCT03528369|54774237|FG002|Overall Study|Withdrawal by Subject|0|||
28116017|NCT03528369|54774235|FG000|Overall Study|Lost to Follow-up|1|||
28116018|NCT03528369|54774236|FG001|Overall Study|Lost to Follow-up|0|||
28116019|NCT03528369|54774237|FG002|Overall Study|Lost to Follow-up|0|||
28116020|NCT03528369|54774235|FG000|Overall Study|Adverse Event|0|||
28116021|NCT03528369|54774236|FG001|Overall Study|Adverse Event|1|||
28116022|NCT03528369|54774237|FG002|Overall Study|Adverse Event|0|||
28116023|NCT00006011|54774248|FG000|Overall Study|Disease progression|13|||
28116024|NCT00006011|54774249|FG001|Overall Study|Disease progression|6|||
28116025|NCT00006011|54774250|FG002|Overall Study|Disease progression|26|||
28116026|NCT00006011|54774248|FG000|Overall Study|Refused further treatment|15|||
28116027|NCT00006011|54774249|FG001|Overall Study|Refused further treatment|13|||
28116028|NCT00006011|54774250|FG002|Overall Study|Refused further treatment|26|||
28116029|NCT00006011|54774248|FG000|Overall Study|Adverse Event|15|||
28116030|NCT00006011|54774249|FG001|Overall Study|Adverse Event|39|||
28116031|NCT00006011|54774250|FG002|Overall Study|Adverse Event|5|||
28116032|NCT00006011|54774248|FG000|Overall Study|Death|0|||
28116033|NCT00006011|54774249|FG001|Overall Study|Death|1|||
28116034|NCT00006011|54774250|FG002|Overall Study|Death|2|||
28116035|NCT00006011|54774248|FG000|Overall Study|Other|4|||
28116036|NCT00006011|54774249|FG001|Overall Study|Other|2|||
28116037|NCT00006011|54774250|FG002|Overall Study|Other|5|||
28116038|NCT00006011|54774248|FG000|Overall Study|Ineligible|18|||
28116039|NCT00006011|54774249|FG001|Overall Study|Ineligible|16|||
28116040|NCT00006011|54774250|FG002|Overall Study|Ineligible|9|||
28116041|NCT03377556|54774256|FG000|Overall Study|Adverse Event|5|||
28116042|NCT03377556|54774256|FG000|Overall Study|Refusal unrelated to adverse events|1|||
28116043|NCT03377556|54774256|FG000|Overall Study|Progression/relapse|38|||
28116044|NCT03377556|54774256|FG000|Overall Study|Death|3|||
28116045|NCT03750955|54774262|FG000|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
28116046|NCT03750955|54774263|FG001|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
28116047|NCT03750955|54774262|FG000|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
28116048|NCT03750955|54774263|FG001|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
28116049|NCT00005957|54774273|FG000|Overall Study|No treated|3|||
28116050|NCT00005957|54774274|FG001|Overall Study|No treated|9|||
27848788|NCT01360632|54343101|FG004|Phase B (6 Weeks)|Lost to Follow-up|0|||
27848789|NCT01360632|54343097|FG000|Phase B (6 Weeks)|Adverse Event|0|||
28116051|NCT00005957|54774273|FG000|Overall Study|Crossover to the other arm|5|||
28116052|NCT00005957|54774274|FG001|Overall Study|Crossover to the other arm|19|||
28116053|NCT00005879|54774282|FG000|Overall Study|Withdrawal by Subject|8|||
28116054|NCT00005879|54774283|FG001|Overall Study|Withdrawal by Subject|10|||
28116055|NCT03583359|54774291|FG000|Overall Study|Withdrawal by Subject|15|||
28116056|NCT03583359|54774292|FG001|Overall Study|Withdrawal by Subject|6|||
28116057|NCT03583359|54774291|FG000|Overall Study|Lost to Follow-up|12|||
28116058|NCT03583359|54774292|FG001|Overall Study|Lost to Follow-up|3|||
28116059|NCT03583359|54774291|FG000|Overall Study|Adverse Event|0|||
28116060|NCT03583359|54774292|FG001|Overall Study|Adverse Event|1|||
28116061|NCT03583359|54774291|FG000|Overall Study|Protocol Violation|0|||
28116062|NCT03583359|54774292|FG001|Overall Study|Protocol Violation|1|||
28116063|NCT03583359|54774291|FG000|Overall Study|Other|2|||
28116064|NCT03583359|54774292|FG001|Overall Study|Other|1|||
28116065|NCT03510663|54774306|FG000|Overall Study|Withdrawal by Subject|0|||
28116066|NCT03510663|54774307|FG001|Overall Study|Withdrawal by Subject|1|||
28116067|NCT03510663|54774308|FG002|Overall Study|Withdrawal by Subject|0|||
28116068|NCT03510663|54774309|FG003|Overall Study|Withdrawal by Subject|0|||
28116069|NCT03510663|54774310|FG004|Overall Study|Withdrawal by Subject|0|||
28116070|NCT03510663|54774311|FG005|Overall Study|Withdrawal by Subject|0|||
28116071|NCT03510663|54774312|FG006|Overall Study|Withdrawal by Subject|0|||
28116072|NCT03510663|54774313|FG007|Overall Study|Withdrawal by Subject|0|||
28116073|NCT03510273|54774323|FG000|Overall Study|Withdrawal by Subject|2|||
28116074|NCT03510273|54774323|FG000|Overall Study|Care outside study, ineligible to cont.|3|||
27848790|NCT01360632|54343098|FG001|Phase B (6 Weeks)|Adverse Event|3|||
28116075|NCT03510273|54774323|FG000|Overall Study|Moved away from study area|4|||
28116076|NCT03582813|54774333|FG000|Overall Study|Lost to Follow-up|18|||
28116077|NCT03582813|54774334|FG001|Overall Study|Lost to Follow-up|21|||
27940355|NCT01185522|54596640|FG000|Overall Study|Lack of Efficacy|28|||
28116078|NCT03582813|54774333|FG000|Overall Study|Withdrawal by Subject|1|||
28116079|NCT03582813|54774334|FG001|Overall Study|Withdrawal by Subject|0|||
28116080|NCT03480009|54774344|FG000|Overall Study|Lost to Follow-up|4|||
28116081|NCT03480009|54774345|FG001|Overall Study|Lost to Follow-up|5|||
28116082|NCT03480009|54774346|FG002|Overall Study|Lost to Follow-up|4|||
28116083|NCT03480009|54774347|FG003|Overall Study|Lost to Follow-up|0|||
28116084|NCT03399786|54774362|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
28116085|NCT03399786|54774363|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
28116086|NCT03399786|54774364|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
28116087|NCT03399786|54774365|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
28116088|NCT03399786|54774362|FG000|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
28116089|NCT03399786|54774363|FG001|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
28116090|NCT03399786|54774364|FG002|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|1|||
28116091|NCT03399786|54774365|FG003|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
28116092|NCT03399786|54774362|FG000|Open-label Treatment Period (OLTP)|Pregnancy|0|||
28116093|NCT03399786|54774363|FG001|Open-label Treatment Period (OLTP)|Pregnancy|0|||
28116094|NCT03399786|54774364|FG002|Open-label Treatment Period (OLTP)|Pregnancy|0|||
28116095|NCT03399786|54774365|FG003|Open-label Treatment Period (OLTP)|Pregnancy|1|||
28116096|NCT03505593|54774373|FG000|Overall Study|Withdrawal by Subject|1|||
28116097|NCT03505593|54774373|FG000|Overall Study|Died before procedure|1|||
28116098|NCT03505593|54774373|FG000|Overall Study|Anatomical abnormality|1|||
28116099|NCT03505593|54774373|FG000|Overall Study|Unable to pass through esophagus|1|||
28116100|NCT03505593|54774373|FG000|Overall Study|Obstruction by Endotracheal tube|1|||
28116101|NCT03504189|54774377|FG000|Overall Study|Withdrawal by Subject|1|||
28116102|NCT03504189|54774377|FG000|Overall Study|Screening Failure|1|||
28116103|NCT03504189|54774377|FG000|Overall Study|Device Failure|2|||
28116104|NCT03374358|54774388|FG000|Overall Study|Withdrawal by Subject|0|||
28116105|NCT03374358|54774389|FG001|Overall Study|Withdrawal by Subject|2|||
28116106|NCT03372096|54774395|FG000|Overall Study|Study Closed|8|||
28116107|NCT00004859|54774404|FG000|Overall Study|Lack of Efficacy|43|||
28116108|NCT00004859|54774405|FG001|Overall Study|Lack of Efficacy|113|||
28116109|NCT00004859|54774404|FG000|Overall Study|Adverse Event|31|||
28116110|NCT00004859|54774405|FG001|Overall Study|Adverse Event|93|||
28116111|NCT00004859|54774404|FG000|Overall Study|Death|5|||
28116112|NCT00004859|54774405|FG001|Overall Study|Death|5|||
28116113|NCT00004859|54774404|FG000|Overall Study|Withdrawal by Subject|7|||
28116114|NCT00004859|54774405|FG001|Overall Study|Withdrawal by Subject|33|||
28116115|NCT00004859|54774404|FG000|Overall Study|Protocol Violation|2|||
28116116|NCT00004859|54774405|FG001|Overall Study|Protocol Violation|2|||
28116117|NCT00004859|54774404|FG000|Overall Study|other disease|0|||
28116118|NCT00004859|54774405|FG001|Overall Study|other disease|3|||
28116119|NCT00004859|54774404|FG000|Overall Study|error|3|||
28116120|NCT00004859|54774405|FG001|Overall Study|error|1|||
28116121|NCT00004859|54774404|FG000|Overall Study|missing data|14|||
28116122|NCT00004859|54774405|FG001|Overall Study|missing data|11|||
28116123|NCT00004859|54774404|FG000|Overall Study|Other|13|||
27816760|NCT01543503|54273701|FG000|Overall Study|Participant recruited after closing date|0|||
28065473|NCT00298272|54721147|FG001|Double-blind Phase|Failure to Return|0|||
28065474|NCT00298272|54721146|FG000|Double-blind Phase|Protocol Violation|2|||
28065475|NCT00298272|54721147|FG001|Double-blind Phase|Protocol Violation|0|||
28065476|NCT00298272|54721146|FG000|Double-blind Phase|Withdrawal by Subject|2|||
28065477|NCT00298272|54721147|FG001|Double-blind Phase|Withdrawal by Subject|0|||
28065478|NCT00298272|54721146|FG000|Open Label Retreatment Phase|Adverse Event|1|||
28065479|NCT00298272|54721147|FG001|Open Label Retreatment Phase|Adverse Event|2|||
28065480|NCT00298272|54721146|FG000|Open Label Retreatment Phase|Insufficient Therapeutic Response|2|||
28065481|NCT00298272|54721147|FG001|Open Label Retreatment Phase|Insufficient Therapeutic Response|1|||
28065482|NCT00298272|54721146|FG000|Open Label Retreatment Phase|Failure to Return|1|||
28116124|NCT00004859|54774405|FG001|Overall Study|Other|21|||
28116125|NCT03500679|54774415|FG000|Overall Study|Lost to Follow-up|6|||
28116126|NCT03500679|54774416|FG001|Overall Study|Lost to Follow-up|3|||
27816761|NCT01543503|54273702|FG001|Overall Study|Participant recruited after closing date|1|||
27816762|NCT01543503|54273701|FG000|Overall Study|Site stopped participation|5|||
27816763|NCT01543503|54273702|FG001|Overall Study|Site stopped participation|1|||
28116127|NCT03500679|54774415|FG000|Overall Study|Withdrawal by Subject|3|||
28116128|NCT03500679|54774416|FG001|Overall Study|Withdrawal by Subject|0|||
28116129|NCT03348930|54774422|FG000|Washout (1 Week)|Lost to Follow-up|1|||
28116130|NCT03348930|54774423|FG001|Washout (1 Week)|Lost to Follow-up|1|||
28116131|NCT03500211|54774431|FG000|Overall Study|Withdrawal by Subject|1|||
28116132|NCT03500211|54774432|FG001|Overall Study|Withdrawal by Subject|1|||
28116133|NCT03478683|54774440|FG000|Overall Study|Adverse Event|5|||
28116134|NCT03478683|54774441|FG001|Overall Study|Adverse Event|3|||
28116135|NCT03478683|54774440|FG000|Overall Study|Lost to Follow-up|0|||
28116136|NCT03478683|54774441|FG001|Overall Study|Lost to Follow-up|5|||
28116137|NCT03478683|54774440|FG000|Overall Study|Physician Decision|1|||
28116138|NCT03478683|54774441|FG001|Overall Study|Physician Decision|3|||
28116139|NCT03478683|54774440|FG000|Overall Study|Withdrawal by Subject|7|||
28116140|NCT03478683|54774441|FG001|Overall Study|Withdrawal by Subject|7|||
28116141|NCT03478371|54774447|FG000|Overall Study|non-compliance|1|||
28116142|NCT03478371|54774447|FG000|Overall Study|Lost to Follow-up|4|||
28116143|NCT03477903|54774457|FG000|Overall Study|Study Terminated by Sponsor|1|||
28116144|NCT03475875|54774461|FG000|Period 1|Lost to Follow-up|1|||
28116145|NCT03475875|54774462|FG001|Period 1|Lost to Follow-up|0|||
28116146|NCT03475875|54774461|FG000|Period 1|Adverse Event|2|||
28065483|NCT00298272|54721147|FG001|Open Label Retreatment Phase|Failure to Return|0|||
28065484|NCT00298272|54721146|FG000|Open Label Retreatment Phase|Protocol Violation|2|||
28065485|NCT00298272|54721147|FG001|Open Label Retreatment Phase|Protocol Violation|1|||
28065486|NCT00298272|54721146|FG000|Open Label Retreatment Phase|Withdrawal by Subject|1|||
28116147|NCT03475875|54774462|FG001|Period 1|Adverse Event|1|||
28116148|NCT03475875|54774461|FG000|Period 2|Adverse Event|3|||
28116149|NCT03475875|54774462|FG001|Period 2|Adverse Event|0|||
28116150|NCT03475875|54774461|FG000|Period 2|Protocol Violation|0|||
28116151|NCT03475875|54774462|FG001|Period 2|Protocol Violation|1|||
28116152|NCT03474081|54774470|FG000|Overall Study|Adverse Event|6|||
28065487|NCT00298272|54721147|FG001|Open Label Retreatment Phase|Withdrawal by Subject|0|||
28065488|NCT00298272|54721146|FG000|Open Label Retreatment Phase|Administrative/Other Reason|2|||
28065489|NCT00298272|54721147|FG001|Open Label Retreatment Phase|Administrative/Other Reason|0|||
28065490|NCT00298272|54721146|FG000|Safety Follow-up Phase|Failure to Return|1|||
28065491|NCT00298272|54721147|FG001|Safety Follow-up Phase|Failure to Return|1|||
28065492|NCT00298272|54721146|FG000|Safety Follow-up Phase|Withdrawal by Subject|2|||
28065493|NCT00298272|54721147|FG001|Safety Follow-up Phase|Withdrawal by Subject|2|||
28065494|NCT00298272|54721146|FG000|Safety Follow-up Phase|Administrative/Other Reason|1|||
28065495|NCT00298272|54721147|FG001|Safety Follow-up Phase|Administrative/Other Reason|1|||
28065496|NCT00283842|54721161|FG000|Overall Study|Adverse Event|8|||
28065497|NCT00283842|54721162|FG001|Overall Study|Adverse Event|7|||
28065498|NCT00283842|54721163|FG002|Overall Study|Adverse Event|21|||
28065499|NCT00283842|54721164|FG003|Overall Study|Adverse Event|21|||
28065500|NCT00283842|54721165|FG004|Overall Study|Adverse Event|5|||
28065501|NCT00283842|54721161|FG000|Overall Study|Protocol Violation|1|||
28065502|NCT00283842|54721162|FG001|Overall Study|Protocol Violation|5|||
28065503|NCT00283842|54721163|FG002|Overall Study|Protocol Violation|4|||
28065504|NCT00283842|54721164|FG003|Overall Study|Protocol Violation|0|||
28065505|NCT00283842|54721165|FG004|Overall Study|Protocol Violation|0|||
28065506|NCT00283842|54721161|FG000|Overall Study|Protocol deviation|0|||
28065507|NCT00283842|54721162|FG001|Overall Study|Protocol deviation|0|||
28065508|NCT00283842|54721163|FG002|Overall Study|Protocol deviation|0|||
28116153|NCT03474081|54774471|FG001|Overall Study|Adverse Event|3|||
28116154|NCT03474081|54774470|FG000|Overall Study|Lost to Follow-up|2|||
28116155|NCT03474081|54774471|FG001|Overall Study|Lost to Follow-up|1|||
28116156|NCT03474081|54774470|FG000|Overall Study|Physician Decision|3|||
28116157|NCT03474081|54774471|FG001|Overall Study|Physician Decision|2|||
28116158|NCT03474081|54774470|FG000|Overall Study|Withdrawal by Subject|5|||
28116159|NCT03474081|54774471|FG001|Overall Study|Withdrawal by Subject|7|||
28116160|NCT03474081|54774470|FG000|Overall Study|Investigator site closed|1|||
28116161|NCT03474081|54774471|FG001|Overall Study|Investigator site closed|0|||
28065509|NCT00283842|54721164|FG003|Overall Study|Protocol deviation|0|||
27816764|NCT01543503|54273701|FG000|Overall Study|Participant did not attend a visit|1|||
28065510|NCT00283842|54721165|FG004|Overall Study|Protocol deviation|2|||
28116162|NCT03346434|54774483|FG000|Overall Study|Randomized in Error|0|||
28116163|NCT03346434|54774484|FG001|Overall Study|Randomized in Error|0|||
27816765|NCT01543503|54273702|FG001|Overall Study|Participant did not attend a visit|0|||
28116164|NCT03346434|54774485|FG002|Overall Study|Randomized in Error|0|||
28116165|NCT03346434|54774486|FG003|Overall Study|Randomized in Error|0|||
28116166|NCT03346434|54774487|FG004|Overall Study|Randomized in Error|1|||
27816766|NCT01543503|54273701|FG000|Overall Study|Moved to other rheumatologic site|0|||
28065511|NCT00283842|54721161|FG000|Overall Study|Withdrawal by Subject|2|||
28065512|NCT00283842|54721162|FG001|Overall Study|Withdrawal by Subject|1|||
28065513|NCT00283842|54721163|FG002|Overall Study|Withdrawal by Subject|1|||
28065514|NCT00283842|54721164|FG003|Overall Study|Withdrawal by Subject|5|||
28065515|NCT00283842|54721165|FG004|Overall Study|Withdrawal by Subject|4|||
28065516|NCT00283842|54721161|FG000|Overall Study|Lack of Efficacy|1|||
28065517|NCT00283842|54721162|FG001|Overall Study|Lack of Efficacy|3|||
28065518|NCT00283842|54721163|FG002|Overall Study|Lack of Efficacy|1|||
28065519|NCT00283842|54721164|FG003|Overall Study|Lack of Efficacy|0|||
28065520|NCT00283842|54721165|FG004|Overall Study|Lack of Efficacy|3|||
28065521|NCT00283842|54721161|FG000|Overall Study|Lost to Follow-up|0|||
28065522|NCT00283842|54721162|FG001|Overall Study|Lost to Follow-up|2|||
28065523|NCT00283842|54721163|FG002|Overall Study|Lost to Follow-up|4|||
28065524|NCT00283842|54721164|FG003|Overall Study|Lost to Follow-up|1|||
28065525|NCT00283842|54721165|FG004|Overall Study|Lost to Follow-up|1|||
28065526|NCT00298038|54721179|FG000|Overall Study|Lost to Follow-up|0|||
28065527|NCT00298038|54721180|FG001|Overall Study|Lost to Follow-up|1|||
28065528|NCT00298038|54721179|FG000|Overall Study|Liver Transplant|0|||
28065529|NCT00298038|54721180|FG001|Overall Study|Liver Transplant|1|||
28065530|NCT00298038|54721179|FG000|Overall Study|Protocol Violation|1|||
28065531|NCT00298038|54721180|FG001|Overall Study|Protocol Violation|3|||
28116167|NCT03346434|54774488|FG005|Overall Study|Randomized in Error|0|||
28116168|NCT03346434|54774483|FG000|Overall Study|Withdrawal by Subject|0|||
28116169|NCT03346434|54774484|FG001|Overall Study|Withdrawal by Subject|0|||
28065532|NCT00298038|54721179|FG000|Overall Study|Death|6|||
28065533|NCT00298038|54721180|FG001|Overall Study|Death|3|||
28065534|NCT00298038|54721179|FG000|Overall Study|Withdrawal by Subject|6|||
28065535|NCT00298038|54721180|FG001|Overall Study|Withdrawal by Subject|9|||
28065536|NCT00298038|54721179|FG000|Overall Study|Adverse Event|8|||
28065537|NCT00298038|54721180|FG001|Overall Study|Adverse Event|7|||
28116170|NCT03346434|54774485|FG002|Overall Study|Withdrawal by Subject|1|||
28116171|NCT03346434|54774486|FG003|Overall Study|Withdrawal by Subject|0|||
28116172|NCT03346434|54774487|FG004|Overall Study|Withdrawal by Subject|1|||
28116173|NCT03346434|54774488|FG005|Overall Study|Withdrawal by Subject|0|||
28116174|NCT03346434|54774483|FG000|Overall Study|Lost to Follow-up|0|||
28116175|NCT03346434|54774484|FG001|Overall Study|Lost to Follow-up|0|||
28116176|NCT03346434|54774485|FG002|Overall Study|Lost to Follow-up|0|||
28116177|NCT03346434|54774486|FG003|Overall Study|Lost to Follow-up|0|||
28116178|NCT03346434|54774487|FG004|Overall Study|Lost to Follow-up|1|||
28116179|NCT03346434|54774488|FG005|Overall Study|Lost to Follow-up|1|||
28116180|NCT03346434|54774483|FG000|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
28116181|NCT03346434|54774484|FG001|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
28116182|NCT03346434|54774485|FG002|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
28116183|NCT03346434|54774486|FG003|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
28116184|NCT03346434|54774487|FG004|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|75|||
28116185|NCT03346434|54774488|FG005|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|81|||
28116186|NCT03393000|54774506|FG000|Overall Study|Death|11|||
28116187|NCT03393000|54774506|FG000|Overall Study|Withdrawal by Subject|2|||
28116188|NCT03393000|54774506|FG000|Overall Study|Physician Decision|1|||
28116189|NCT03370770|54774510|FG000|Overall Study|Patient was followed in another hospital center|1|||
28116190|NCT03370770|54774510|FG000|Overall Study|Progressive Disease|98|||
28116191|NCT03370770|54774510|FG000|Overall Study|Adverse Event|2|||
28116192|NCT03370770|54774510|FG000|Overall Study|Death|5|||
28116193|NCT03473301|54774517|FG000|Overall Study|Protocol Violation|4|||
28116194|NCT03473301|54774518|FG001|Overall Study|Protocol Violation|0|||
28116195|NCT03473301|54774519|FG002|Overall Study|Protocol Violation|0|||
28116196|NCT03473301|54774517|FG000|Overall Study|Withdrawal by Subject|0|||
28116197|NCT03473301|54774518|FG001|Overall Study|Withdrawal by Subject|1|||
28116198|NCT03473301|54774519|FG002|Overall Study|Withdrawal by Subject|0|||
28116199|NCT03473301|54774517|FG000|Overall Study|Missed study visit due to pandemic restrictions|7|||
28116200|NCT03473301|54774518|FG001|Overall Study|Missed study visit due to pandemic restrictions|5|||
28116201|NCT03473301|54774519|FG002|Overall Study|Missed study visit due to pandemic restrictions|6|||
27940356|NCT01185522|54596640|FG000|Overall Study|Lost to Follow-up|19|||
28116202|NCT03390426|54774531|FG000|Overall Study|Protocol Violation|0|||
28065538|NCT00298038|54721179|FG000|Overall Study|Breakthrough overt HE episode|28|||
28065539|NCT00298038|54721180|FG001|Overall Study|Breakthrough overt HE episode|69|||
28065540|NCT00298038|54721179|FG000|Overall Study|Noncompliance|1|||
28065541|NCT00298038|54721180|FG001|Overall Study|Noncompliance|0|||
28065542|NCT00298038|54721179|FG000|Overall Study|Cocaine Abuse|1|||
28065543|NCT00298038|54721180|FG001|Overall Study|Cocaine Abuse|0|||
28065544|NCT00298038|54721179|FG000|Overall Study|Severe Gastrointestinal Bleed|1|||
28065545|NCT00298038|54721180|FG001|Overall Study|Severe Gastrointestinal Bleed|0|||
28116203|NCT03390426|54774532|FG001|Overall Study|Protocol Violation|1|||
28116204|NCT03472521|54774540|FG000|Overall Study|Lost to Follow-up|3|||
28116205|NCT03472521|54774541|FG001|Overall Study|Lost to Follow-up|2|||
28116206|NCT03472521|54774540|FG000|Overall Study|Discontinued intervention|3|||
28116207|NCT03472521|54774541|FG001|Overall Study|Discontinued intervention|1|||
28116208|NCT02906020|54774557|FG000|Part 1: Dose Escalation Period|Adverse Event|0|||
28116209|NCT02906020|54774558|FG001|Part 1: Dose Escalation Period|Adverse Event|1|||
28116210|NCT02906020|54774559|FG002|Part 1: Dose Escalation Period|Adverse Event|0|||
28116211|NCT02906020|54774560|FG003|Part 1: Dose Escalation Period|Adverse Event|1|||
28116212|NCT02906020|54774561|FG004|Part 1: Dose Escalation Period|Adverse Event|0|||
28116213|NCT02906020|54774562|FG005|Part 1: Dose Escalation Period|Adverse Event|0|||
28116214|NCT02906020|54774563|FG006|Part 1: Dose Escalation Period|Adverse Event|0|||
28116215|NCT02906020|54774564|FG007|Part 1: Dose Escalation Period|Adverse Event|0|||
28116216|NCT02906020|54774565|FG008|Part 1: Dose Escalation Period|Adverse Event|0|||
28116217|NCT02906020|54774566|FG009|Part 1: Dose Escalation Period|Adverse Event|0|||
28116218|NCT02906020|54774567|FG010|Part 1: Dose Escalation Period|Adverse Event|0|||
28116219|NCT02906020|54774568|FG011|Part 1: Dose Escalation Period|Adverse Event|0|||
28116220|NCT02906020|54774569|FG012|Part 1: Dose Escalation Period|Adverse Event|0|||
28116221|NCT02906020|54774570|FG013|Part 1: Dose Escalation Period|Adverse Event|0|||
28116222|NCT02906020|54774571|FG014|Part 1: Dose Escalation Period|Adverse Event|0|||
28116223|NCT02906020|54774572|FG015|Part 1: Dose Escalation Period|Adverse Event|0|||
28116224|NCT02906020|54774557|FG000|Part 2: Double-blind Treatment Period|Adverse Event|0|||
28116225|NCT02906020|54774558|FG001|Part 2: Double-blind Treatment Period|Adverse Event|0|||
28116226|NCT02906020|54774559|FG002|Part 2: Double-blind Treatment Period|Adverse Event|0|||
28116227|NCT02906020|54774560|FG003|Part 2: Double-blind Treatment Period|Adverse Event|0|||
28116228|NCT02906020|54774561|FG004|Part 2: Double-blind Treatment Period|Adverse Event|0|||
28116229|NCT02906020|54774562|FG005|Part 2: Double-blind Treatment Period|Adverse Event|0|||
28116230|NCT02906020|54774563|FG006|Part 2: Double-blind Treatment Period|Adverse Event|0|||
28116231|NCT02906020|54774564|FG007|Part 2: Double-blind Treatment Period|Adverse Event|0|||
28116232|NCT02906020|54774565|FG008|Part 2: Double-blind Treatment Period|Adverse Event|6|||
28116233|NCT02906020|54774566|FG009|Part 2: Double-blind Treatment Period|Adverse Event|15|||
28116234|NCT02906020|54774567|FG010|Part 2: Double-blind Treatment Period|Adverse Event|0|||
28116235|NCT02906020|54774568|FG011|Part 2: Double-blind Treatment Period|Adverse Event|0|||
28116236|NCT02906020|54774569|FG012|Part 2: Double-blind Treatment Period|Adverse Event|0|||
28116237|NCT02906020|54774570|FG013|Part 2: Double-blind Treatment Period|Adverse Event|0|||
28116238|NCT02906020|54774571|FG014|Part 2: Double-blind Treatment Period|Adverse Event|0|||
28116239|NCT02906020|54774572|FG015|Part 2: Double-blind Treatment Period|Adverse Event|0|||
28116240|NCT02906020|54774557|FG000|Part 2: Double-blind Treatment Period|Other|0|||
28116241|NCT02906020|54774558|FG001|Part 2: Double-blind Treatment Period|Other|0|||
28116242|NCT02906020|54774559|FG002|Part 2: Double-blind Treatment Period|Other|0|||
28116243|NCT02906020|54774560|FG003|Part 2: Double-blind Treatment Period|Other|0|||
28116244|NCT02906020|54774561|FG004|Part 2: Double-blind Treatment Period|Other|0|||
28116245|NCT02906020|54774562|FG005|Part 2: Double-blind Treatment Period|Other|0|||
28116246|NCT02906020|54774563|FG006|Part 2: Double-blind Treatment Period|Other|0|||
28116247|NCT02906020|54774564|FG007|Part 2: Double-blind Treatment Period|Other|0|||
28116248|NCT02906020|54774565|FG008|Part 2: Double-blind Treatment Period|Other|6|||
28116249|NCT02906020|54774566|FG009|Part 2: Double-blind Treatment Period|Other|10|||
28116250|NCT02906020|54774567|FG010|Part 2: Double-blind Treatment Period|Other|0|||
28116251|NCT02906020|54774568|FG011|Part 2: Double-blind Treatment Period|Other|0|||
28116252|NCT02906020|54774569|FG012|Part 2: Double-blind Treatment Period|Other|0|||
28116253|NCT02906020|54774570|FG013|Part 2: Double-blind Treatment Period|Other|0|||
28116254|NCT02906020|54774571|FG014|Part 2: Double-blind Treatment Period|Other|0|||
28116255|NCT02906020|54774572|FG015|Part 2: Double-blind Treatment Period|Other|0|||
28116256|NCT02906020|54774557|FG000|Part 2: Long-term Follow-up Period|Adverse Event|0|||
28116257|NCT02906020|54774558|FG001|Part 2: Long-term Follow-up Period|Adverse Event|0|||
28116258|NCT02906020|54774559|FG002|Part 2: Long-term Follow-up Period|Adverse Event|0|||
28116259|NCT02906020|54774560|FG003|Part 2: Long-term Follow-up Period|Adverse Event|0|||
28116260|NCT02906020|54774561|FG004|Part 2: Long-term Follow-up Period|Adverse Event|0|||
28116261|NCT02906020|54774562|FG005|Part 2: Long-term Follow-up Period|Adverse Event|0|||
28116262|NCT02906020|54774563|FG006|Part 2: Long-term Follow-up Period|Adverse Event|0|||
28116263|NCT02906020|54774564|FG007|Part 2: Long-term Follow-up Period|Adverse Event|0|||
28116264|NCT02906020|54774565|FG008|Part 2: Long-term Follow-up Period|Adverse Event|0|||
28116265|NCT02906020|54774566|FG009|Part 2: Long-term Follow-up Period|Adverse Event|0|||
28116266|NCT02906020|54774567|FG010|Part 2: Long-term Follow-up Period|Adverse Event|0|||
28116267|NCT02906020|54774568|FG011|Part 2: Long-term Follow-up Period|Adverse Event|0|||
28116268|NCT02906020|54774569|FG012|Part 2: Long-term Follow-up Period|Adverse Event|10|||
28116269|NCT02906020|54774570|FG013|Part 2: Long-term Follow-up Period|Adverse Event|4|||
28116270|NCT02906020|54774571|FG014|Part 2: Long-term Follow-up Period|Adverse Event|0|||
28116271|NCT02906020|54774572|FG015|Part 2: Long-term Follow-up Period|Adverse Event|0|||
28116272|NCT02906020|54774557|FG000|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
28116273|NCT02906020|54774558|FG001|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
28116274|NCT02906020|54774559|FG002|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
28116275|NCT02906020|54774560|FG003|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
28116276|NCT02906020|54774561|FG004|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
28116277|NCT02906020|54774562|FG005|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
28116278|NCT02906020|54774563|FG006|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
28116279|NCT02906020|54774564|FG007|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
28116280|NCT02906020|54774565|FG008|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
28116281|NCT02906020|54774566|FG009|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
28116282|NCT02906020|54774567|FG010|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
28116283|NCT02906020|54774568|FG011|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
28116284|NCT02906020|54774569|FG012|Part 2: Long-term Follow-up Period|Progressive Disease|7|||
28116285|NCT02906020|54774570|FG013|Part 2: Long-term Follow-up Period|Progressive Disease|4|||
28116286|NCT02906020|54774571|FG014|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
28116287|NCT02906020|54774572|FG015|Part 2: Long-term Follow-up Period|Progressive Disease|1|||
28116288|NCT02906020|54774557|FG000|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
28116289|NCT02906020|54774558|FG001|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
28116290|NCT02906020|54774559|FG002|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
28116291|NCT02906020|54774560|FG003|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
28116292|NCT02906020|54774561|FG004|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
28116293|NCT02906020|54774562|FG005|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
28116294|NCT02906020|54774563|FG006|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
28116295|NCT02906020|54774564|FG007|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
28116296|NCT02906020|54774565|FG008|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
28116297|NCT02906020|54774566|FG009|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
28116298|NCT02906020|54774567|FG010|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
28116299|NCT02906020|54774568|FG011|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
28116300|NCT02906020|54774569|FG012|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
28116301|NCT02906020|54774570|FG013|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
28116302|NCT02906020|54774571|FG014|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
28116303|NCT02906020|54774572|FG015|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
28116304|NCT02906020|54774557|FG000|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
28116305|NCT02906020|54774558|FG001|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
28116306|NCT02906020|54774559|FG002|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
28116307|NCT02906020|54774560|FG003|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
28116308|NCT02906020|54774561|FG004|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
28116309|NCT02906020|54774562|FG005|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
27940357|NCT01185522|54596640|FG000|Overall Study|Withdrawal by Subject|10|||
27940358|NCT01185522|54596640|FG000|Overall Study|Poor tolerance|39|||
27940359|NCT01185522|54596640|FG000|Overall Study|Other reasons|12|||
28116310|NCT02906020|54774563|FG006|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
28116311|NCT02906020|54774564|FG007|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
28116312|NCT02906020|54774565|FG008|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
28116313|NCT02906020|54774566|FG009|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
28116314|NCT02906020|54774567|FG010|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
28116315|NCT02906020|54774568|FG011|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
28116316|NCT02906020|54774569|FG012|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|1|||
28116317|NCT02906020|54774570|FG013|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|4|||
28116318|NCT02906020|54774571|FG014|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
28116319|NCT02906020|54774572|FG015|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
28116320|NCT02906020|54774557|FG000|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
28116321|NCT02906020|54774558|FG001|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
28116322|NCT02906020|54774559|FG002|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
28116323|NCT02906020|54774560|FG003|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
28116324|NCT02906020|54774561|FG004|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
28116325|NCT02906020|54774562|FG005|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
28116326|NCT02906020|54774563|FG006|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
28116327|NCT02906020|54774564|FG007|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
28116328|NCT02906020|54774565|FG008|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
28116329|NCT02906020|54774566|FG009|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
28116330|NCT02906020|54774567|FG010|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
28116331|NCT02906020|54774568|FG011|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
28116332|NCT02906020|54774569|FG012|Part 2: Long-term Follow-up Period|Study terminated by sponsor|67|||
28116333|NCT02906020|54774570|FG013|Part 2: Long-term Follow-up Period|Study terminated by sponsor|64|||
28116334|NCT02906020|54774571|FG014|Part 2: Long-term Follow-up Period|Study terminated by sponsor|7|||
28116335|NCT02906020|54774572|FG015|Part 2: Long-term Follow-up Period|Study terminated by sponsor|8|||
28116336|NCT02906020|54774557|FG000|Part 2: Long-term Follow-up Period|Other|0|||
28116337|NCT02906020|54774558|FG001|Part 2: Long-term Follow-up Period|Other|0|||
28116338|NCT02906020|54774559|FG002|Part 2: Long-term Follow-up Period|Other|0|||
28116339|NCT02906020|54774560|FG003|Part 2: Long-term Follow-up Period|Other|0|||
28116340|NCT02906020|54774561|FG004|Part 2: Long-term Follow-up Period|Other|0|||
28116341|NCT02906020|54774562|FG005|Part 2: Long-term Follow-up Period|Other|0|||
28116342|NCT02906020|54774563|FG006|Part 2: Long-term Follow-up Period|Other|0|||
28116343|NCT02906020|54774564|FG007|Part 2: Long-term Follow-up Period|Other|0|||
28116344|NCT02906020|54774565|FG008|Part 2: Long-term Follow-up Period|Other|0|||
28116345|NCT02906020|54774566|FG009|Part 2: Long-term Follow-up Period|Other|0|||
28116346|NCT02906020|54774567|FG010|Part 2: Long-term Follow-up Period|Other|0|||
28116347|NCT02906020|54774568|FG011|Part 2: Long-term Follow-up Period|Other|0|||
28116348|NCT02906020|54774569|FG012|Part 2: Long-term Follow-up Period|Other|13|||
28116349|NCT02906020|54774570|FG013|Part 2: Long-term Follow-up Period|Other|8|||
28116350|NCT02906020|54774571|FG014|Part 2: Long-term Follow-up Period|Other|3|||
28116351|NCT02906020|54774572|FG015|Part 2: Long-term Follow-up Period|Other|2|||
28116352|NCT03499353|54774600|FG000|Treatment|Adverse Event|3|||
28116353|NCT03499353|54774600|FG000|Treatment|Progressive Disease|10|||
28116354|NCT03499353|54774600|FG000|Treatment|Other|1|||
28116355|NCT03499353|54774600|FG000|Treatment|Withdrawal by Subject|2|||
28116356|NCT03499353|54774600|FG000|Long-Term Follow-up|Death|2|||
28116357|NCT03499353|54774600|FG000|Long-Term Follow-up|Study Terminated By Sponsor|55|||
28116358|NCT03499353|54774600|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
28116359|NCT03368664|54774604|FG000|Phase1: Prior DMT:Month -4 to Month 0|Physician Decision|1|||
28116360|NCT03368664|54774604|FG000|Phase1: Prior DMT:Month -4 to Month 0|Participant was withdrawn from study|1|||
28116361|NCT03368664|54774604|FG000|Phase1: Prior DMT:Month -4 to Month 0|Principal Investigator and Parents Decision|1|||
28116362|NCT03368664|54774604|FG000|Phase1: Prior DMT:Month -4 to Month 0|Still on Prior DMT Phase or missing Completion|1|||
28116363|NCT00004259|54774616|FG000|Overall Study|Protocol Violation|1|||
28116364|NCT00004259|54774617|FG001|Overall Study|Protocol Violation|2|||
28116365|NCT00004259|54774618|FG002|Overall Study|Protocol Violation|0|||
28116366|NCT00004259|54774619|FG003|Overall Study|Protocol Violation|0|||
28116367|NCT00004259|54774616|FG000|Overall Study|Withdrawal by Subject|0|||
28116368|NCT00004259|54774617|FG001|Overall Study|Withdrawal by Subject|2|||
28116369|NCT00004259|54774618|FG002|Overall Study|Withdrawal by Subject|0|||
28116370|NCT00004259|54774619|FG003|Overall Study|Withdrawal by Subject|0|||
28116371|NCT03365934|54774643|FG000|Overall Study|Adverse Event|1|||
28116372|NCT03365934|54774643|FG000|Overall Study|Withdrawal by Subject|1|||
28116373|NCT03468855|54774652|FG000|Overall Study|Adverse Event|2|||
28116374|NCT03468855|54774652|FG000|Overall Study|Lost to Follow-up|5|||
28116375|NCT03468855|54774652|FG000|Overall Study|Withdrawal by Subject|3|||
28116376|NCT03468855|54774652|FG000|Overall Study|Inclusion/Exclusion Enrollment Violator|1|||
28116377|NCT03738865|54774658|FG000|Overall Study|Withdrawal by Subject|3|||
28116378|NCT03738865|54774659|FG001|Overall Study|Withdrawal by Subject|3|||
28065546|NCT00283686|54721190|FG000|Overall Study|Death|1|||
28065547|NCT00283686|54721191|FG001|Overall Study|Death|1|||
28065548|NCT00283686|54721192|FG002|Overall Study|Death|1|||
28065549|NCT00283686|54721193|FG003|Overall Study|Death|0|||
28065550|NCT00283686|54721190|FG000|Overall Study|Lost to Follow-up|21|||
28065551|NCT00283686|54721191|FG001|Overall Study|Lost to Follow-up|31|||
28065552|NCT00283686|54721192|FG002|Overall Study|Lost to Follow-up|26|||
28065553|NCT00283686|54721193|FG003|Overall Study|Lost to Follow-up|20|||
28116379|NCT03738865|54774658|FG000|Overall Study|Adverse Event|2|||
28116380|NCT03738865|54774659|FG001|Overall Study|Adverse Event|0|||
28116381|NCT03738865|54774658|FG000|Overall Study|Physician Decision|0|||
28116382|NCT03738865|54774659|FG001|Overall Study|Physician Decision|1|||
28116383|NCT03524157|54774668|FG000|Overall Study|cytology not readable|0|||
28116384|NCT03524157|54774669|FG001|Overall Study|cytology not readable|0|||
28116385|NCT03524157|54774670|FG002|Overall Study|cytology not readable|1|||
28116386|NCT03437733|54774684|FG000|Overall Study|Eligibility criteria not met|0|||
28116387|NCT03437733|54774685|FG001|Overall Study|Eligibility criteria not met|3|||
28116388|NCT03468543|54774693|FG000|Overall Study|Protocol stopping rules met|3|||
28116389|NCT03467763|54774697|FG000|Overall Study|Lost to Follow-up|1|||
28116390|NCT03467763|54774697|FG000|Overall Study|Protocol Violation|2|||
28116391|NCT00004031|54774705|FG000|Overall Study|Adverse Event|5|||
28116392|NCT00004031|54774706|FG001|Overall Study|Adverse Event|0|||
28116393|NCT00004031|54774705|FG000|Overall Study|Refusal unrelated to adverse events|2|||
28116394|NCT00004031|54774706|FG001|Overall Study|Refusal unrelated to adverse events|11|||
28116395|NCT00004031|54774705|FG000|Overall Study|Progression/relapse|9|||
28116396|NCT00004031|54774706|FG001|Overall Study|Progression/relapse|4|||
28116397|NCT00004031|54774705|FG000|Overall Study|Death|3|||
28116398|NCT00004031|54774706|FG001|Overall Study|Death|1|||
28116399|NCT00004031|54774705|FG000|Overall Study|Other- not protocol specified|3|||
28116400|NCT00004031|54774706|FG001|Overall Study|Other- not protocol specified|3|||
28116401|NCT00004031|54774705|FG000|Overall Study|Reason under review|3|||
28116402|NCT00004031|54774706|FG001|Overall Study|Reason under review|2|||
28116403|NCT03467217|54774716|FG000|Overall Study|Trial stopped early|5|||
28116404|NCT03467217|54774717|FG001|Overall Study|Trial stopped early|2|||
28116405|NCT03467217|54774716|FG000|Overall Study|Clinic closed due to COVID-19 pandemic|5|||
28116406|NCT03467217|54774717|FG001|Overall Study|Clinic closed due to COVID-19 pandemic|2|||
28116407|NCT03467217|54774716|FG000|Overall Study|Lost to Follow-up|0|||
28116408|NCT03467217|54774717|FG001|Overall Study|Lost to Follow-up|2|||
28116409|NCT00003875|54774723|FG000|Overall Study|Screen Failed|1|||
28116410|NCT03495453|54774729|FG000|Overall Study|Withdrawal by Subject|0|||
28116411|NCT03495453|54774730|FG001|Overall Study|Withdrawal by Subject|1|||
28116412|NCT03364686|54774736|FG000|Overall Study|Physician Decision|2|||
28116413|NCT03437577|54774743|FG000|Pre-Randomization|Withdrawal by Subject|0|||
28116414|NCT03437577|54774744|FG001|Pre-Randomization|Withdrawal by Subject|0|||
28116415|NCT03437577|54774745|FG002|Pre-Randomization|Withdrawal by Subject|10|||
28116416|NCT03437577|54774743|FG000|Post-Randomization|Physician Decision|0|||
28116417|NCT03437577|54774744|FG001|Post-Randomization|Physician Decision|2|||
28116418|NCT03437577|54774745|FG002|Post-Randomization|Physician Decision|0|||
27816767|NCT01543503|54273702|FG001|Overall Study|Moved to other rheumatologic site|1|||
28116419|NCT03336528|54774753|FG000|Overall Study|Protocol Violation|1|||
28116420|NCT03336528|54774754|FG001|Overall Study|Protocol Violation|1|||
28116421|NCT03336528|54774753|FG000|Overall Study|Discharged within 48 hours of study medication|8|||
28116422|NCT03336528|54774754|FG001|Overall Study|Discharged within 48 hours of study medication|6|||
28116423|NCT03336528|54774753|FG000|Overall Study|Did not receive study medication|1|||
28116424|NCT03336528|54774754|FG001|Overall Study|Did not receive study medication|2|||
28116425|NCT03364608|54774762|FG000|Overall Study|Withdrawal by Subject|4|||
28116426|NCT03364608|54774762|FG000|Overall Study|Protocol Violation|2|||
28116427|NCT03364608|54774762|FG000|Overall Study|Lost to Follow-up|2|||
28116428|NCT00003869|54774776|FG000|Overall Study|Adverse Event|14|||
28116429|NCT00003869|54774777|FG001|Overall Study|Adverse Event|3|||
28116430|NCT00003869|54774776|FG000|Overall Study|Withdrawal by Subject|21|||
28116431|NCT00003869|54774777|FG001|Overall Study|Withdrawal by Subject|3|||
28116432|NCT00003869|54774776|FG000|Overall Study|Death|1|||
28116433|NCT00003869|54774777|FG001|Overall Study|Death|2|||
28116434|NCT00003869|54774776|FG000|Overall Study|Alternative treatmnt, medical problems|5|||
28116435|NCT00003869|54774777|FG001|Overall Study|Alternative treatmnt, medical problems|4|||
28116436|NCT03344640|54774785|FG000|Overall Study|Adverse Event|1|||
28116437|NCT03344640|54774786|FG001|Overall Study|Adverse Event|0|||
28116438|NCT03344640|54774785|FG000|Overall Study|Physician Decision|1|||
28116439|NCT03344640|54774786|FG001|Overall Study|Physician Decision|1|||
28116440|NCT03344640|54774785|FG000|Overall Study|Withdrawal by Subject|1|||
28116441|NCT03344640|54774786|FG001|Overall Study|Withdrawal by Subject|2|||
28116442|NCT03344640|54774785|FG000|Follow-up Epoch|Withdrawal by Subject|0|||
28116443|NCT03344640|54774786|FG001|Follow-up Epoch|Withdrawal by Subject|2|||
28116444|NCT03344562|54774794|FG000|Overall Study|Withdrawal by Subject|2|||
28116445|NCT03344562|54774795|FG001|Overall Study|Withdrawal by Subject|0|||
28116446|NCT00003659|54774801|FG000|Overall Study|Withdrawal by Subject|3|||
28116447|NCT03494985|54774809|FG000|Overall Study|Adverse Event|3|||
28116448|NCT03494985|54774810|FG001|Overall Study|Adverse Event|2|||
28116449|NCT03494985|54774811|FG002|Overall Study|Adverse Event|3|||
28116450|NCT03494985|54774812|FG003|Overall Study|Adverse Event|0|||
28116451|NCT03494985|54774809|FG000|Overall Study|Other (Withdrawal of consent)|2|||
28116452|NCT03494985|54774810|FG001|Overall Study|Other (Withdrawal of consent)|3|||
28116453|NCT03494985|54774811|FG002|Overall Study|Other (Withdrawal of consent)|2|||
28116454|NCT03494985|54774812|FG003|Overall Study|Other (Withdrawal of consent)|5|||
28116455|NCT03494985|54774809|FG000|Overall Study|Other (Not specified)|0|||
28116456|NCT03494985|54774810|FG001|Overall Study|Other (Not specified)|1|||
28116457|NCT03494985|54774811|FG002|Overall Study|Other (Not specified)|1|||
28116458|NCT03494985|54774812|FG003|Overall Study|Other (Not specified)|0|||
28116459|NCT03437265|54774822|FG000|Overall Study|Protocol Violation|6|||
28116460|NCT00003509|54774826|FG000|Overall Study|Not evaluable|5|||
28116461|NCT03344172|54774832|FG000|Overall Study|Received <1 dose of treatment|1|||
28116462|NCT03344172|54774833|FG001|Overall Study|Received <1 dose of treatment|0|||
28116463|NCT03465891|54774841|FG000|Overall Study|Withdrawal by Subject|0|||
28116464|NCT03465891|54774842|FG001|Overall Study|Withdrawal by Subject|1|||
28116465|NCT03465891|54774841|FG000|Overall Study|Disease progression|1|||
28116466|NCT03465891|54774842|FG001|Overall Study|Disease progression|0|||
28116467|NCT03363906|54774848|FG000|Period 1 (Reference or Test)|Adverse Event|1|||
27816768|NCT01543503|54273701|FG000|Overall Study|Participant consented to another study|0|||
27816769|NCT01543503|54273702|FG001|Overall Study|Participant consented to another study|2|||
27816770|NCT01543503|54273701|FG000|Overall Study|Participant went to United States|1|||
28065554|NCT00283686|54721190|FG000|Overall Study|Less than full participation|7|||
28065555|NCT00283686|54721191|FG001|Overall Study|Less than full participation|9|||
28065556|NCT00283686|54721192|FG002|Overall Study|Less than full participation|6|||
28065557|NCT00283686|54721193|FG003|Overall Study|Less than full participation|12|||
28065558|NCT00297882|54721205|FG000|Day 14|Lack of Efficacy|12|||
28065559|NCT00297882|54721206|FG001|Day 14|Lack of Efficacy|49|||
28065560|NCT00297882|54721205|FG000|Day 28|Lost to Follow-up|13|||
28065561|NCT00297882|54721206|FG001|Day 28|Lost to Follow-up|23|||
28065562|NCT00297882|54721205|FG000|Day 28|Lack of Efficacy|3|||
28065563|NCT00297882|54721206|FG001|Day 28|Lack of Efficacy|0|||
28065564|NCT00297648|54721214|FG000|Overall Study|Adverse Event|13|||
28065565|NCT00297648|54721214|FG000|Overall Study|Lack of Efficacy|18|||
28065566|NCT00297648|54721214|FG000|Overall Study|Lost to Follow-up|1|||
28065567|NCT00297648|54721214|FG000|Overall Study|Withdrawal by Subject|3|||
28065568|NCT00297648|54721214|FG000|Overall Study|Other: Incompliance|1|||
28116468|NCT03363906|54774849|FG001|Period 1 (Reference or Test)|Adverse Event|2|||
28116469|NCT03363906|54774848|FG000|Period 2 (Test or Reference)|Adverse Event|2|||
28116470|NCT03363906|54774849|FG001|Period 2 (Test or Reference)|Adverse Event|0|||
28116471|NCT03363906|54774848|FG000|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
28116472|NCT03363906|54774849|FG001|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
28116473|NCT03363906|54774848|FG000|Period 2 (Test or Reference)|Lost to Follow-up|1|||
28116474|NCT03363906|54774849|FG001|Period 2 (Test or Reference)|Lost to Follow-up|0|||
28116475|NCT00003473|54774855|FG000|Overall Study|Three patients were not evaluable.|3|||
28116476|NCT03343626|54774867|FG000|Overall Study|Lost to Follow-up|4|||
28116477|NCT03343626|54774868|FG001|Overall Study|Lost to Follow-up|3|||
28116478|NCT03343626|54774869|FG002|Overall Study|Lost to Follow-up|2|||
28116479|NCT03343626|54774870|FG003|Overall Study|Lost to Follow-up|5|||
28116480|NCT03343626|54774871|FG004|Overall Study|Lost to Follow-up|4|||
28116481|NCT03343626|54774872|FG005|Overall Study|Lost to Follow-up|4|||
28116482|NCT03343626|54774873|FG006|Overall Study|Lost to Follow-up|4|||
28116483|NCT03343626|54774874|FG007|Overall Study|Lost to Follow-up|7|||
28116484|NCT03343626|54774867|FG000|Overall Study|Withdrawal of Consent|2|||
28116485|NCT03343626|54774868|FG001|Overall Study|Withdrawal of Consent|1|||
28116486|NCT03343626|54774869|FG002|Overall Study|Withdrawal of Consent|0|||
28116487|NCT03343626|54774870|FG003|Overall Study|Withdrawal of Consent|3|||
28116488|NCT03343626|54774871|FG004|Overall Study|Withdrawal of Consent|3|||
28116489|NCT03343626|54774872|FG005|Overall Study|Withdrawal of Consent|1|||
28116490|NCT03343626|54774873|FG006|Overall Study|Withdrawal of Consent|1|||
28116491|NCT03343626|54774874|FG007|Overall Study|Withdrawal of Consent|2|||
28116492|NCT03343626|54774867|FG000|Overall Study|Reason not Specified|0|||
28116493|NCT03343626|54774868|FG001|Overall Study|Reason not Specified|1|||
28116494|NCT03343626|54774869|FG002|Overall Study|Reason not Specified|0|||
28116495|NCT03343626|54774870|FG003|Overall Study|Reason not Specified|0|||
28116496|NCT03343626|54774871|FG004|Overall Study|Reason not Specified|0|||
28116497|NCT03343626|54774872|FG005|Overall Study|Reason not Specified|0|||
28116498|NCT03343626|54774873|FG006|Overall Study|Reason not Specified|0|||
28116499|NCT03343626|54774874|FG007|Overall Study|Reason not Specified|1|||
28116500|NCT03343626|54774867|FG000|Overall Study|Data Entry Error|0|||
28116501|NCT03343626|54774868|FG001|Overall Study|Data Entry Error|0|||
28116502|NCT03343626|54774869|FG002|Overall Study|Data Entry Error|0|||
28116503|NCT03343626|54774870|FG003|Overall Study|Data Entry Error|0|||
28116504|NCT03343626|54774871|FG004|Overall Study|Data Entry Error|0|||
28116505|NCT03343626|54774872|FG005|Overall Study|Data Entry Error|0|||
28116506|NCT03343626|54774873|FG006|Overall Study|Data Entry Error|0|||
28116507|NCT03343626|54774874|FG007|Overall Study|Data Entry Error|1|||
28116508|NCT03334422|54774899|FG000|Overall Study|Adverse Event|1|||
28116509|NCT03334422|54774900|FG001|Overall Study|Adverse Event|3|||
28116510|NCT03334422|54774901|FG002|Overall Study|Adverse Event|2|||
28116511|NCT03334422|54774902|FG003|Overall Study|Adverse Event|2|||
28116512|NCT03334422|54774899|FG000|Overall Study|Lack of Efficacy|10|||
28116513|NCT03334422|54774900|FG001|Overall Study|Lack of Efficacy|2|||
28116514|NCT03334422|54774901|FG002|Overall Study|Lack of Efficacy|7|||
28116515|NCT03334422|54774902|FG003|Overall Study|Lack of Efficacy|3|||
28116516|NCT03334422|54774899|FG000|Overall Study|Withdrawal by Subject|8|||
28065569|NCT00283296|54721218|FG000|Overall Study|in-home trial not completed|5|||
28065570|NCT00297492|54721226|FG000|Set Quit Date|Lost to Follow-up|7|||
28065571|NCT00297492|54721227|FG001|Set Quit Date|Lost to Follow-up|13|||
28065572|NCT00297492|54721228|FG002|Set Quit Date|Lost to Follow-up|5|||
28116517|NCT03334422|54774900|FG001|Overall Study|Withdrawal by Subject|3|||
28116518|NCT03334422|54774901|FG002|Overall Study|Withdrawal by Subject|1|||
28116519|NCT03334422|54774902|FG003|Overall Study|Withdrawal by Subject|0|||
27816771|NCT01543503|54273702|FG001|Overall Study|Participant went to United States|0|||
28065573|NCT00297492|54721226|FG000|6 Month Follow-up|Lost to Follow-up|63|||
28065574|NCT00297492|54721227|FG001|6 Month Follow-up|Lost to Follow-up|49|||
28065575|NCT00297492|54721228|FG002|6 Month Follow-up|Lost to Follow-up|27|||
28065576|NCT00297258|54721236|FG000|Overall Study|Disease Progression, Relapse, Death|120|||
28065577|NCT00297258|54721236|FG000|Overall Study|Toxicity (or Toxic Death)|10|||
28065578|NCT00297258|54721236|FG000|Overall Study|Patient Refusal: Not Related to Toxicity|2|||
28065579|NCT00297258|54721236|FG000|Overall Study|Intercurrent Illness|3|||
28065580|NCT00297258|54721236|FG000|Overall Study|Intercurrent Death|2|||
27816772|NCT01543503|54273701|FG000|Overall Study|Screen failure|1|||
27816773|NCT01543503|54273702|FG001|Overall Study|Screen failure|0|||
27816774|NCT01511055|54273708|FG000|Overall Study|Withdrawal by Subject|6|||
27816775|NCT01537887|54273721|FG000|Period 1|Physician Decision|0|||
28065581|NCT00297258|54721236|FG000|Overall Study|Deteriorization of General Condition|1|||
28065582|NCT00297258|54721236|FG000|Overall Study|Radiotherapy to Destroy Last Lesion|1|||
28065583|NCT00297258|54721236|FG000|Overall Study|Surgery Performed on Target Lesion|1|||
28065584|NCT00297258|54721236|FG000|Overall Study|Switch to Commercial Treatment|1|||
28065585|NCT00297258|54721236|FG000|Overall Study|Interruption: Cold/Flu-like Symptoms|1|||
28116520|NCT03334422|54774899|FG000|Overall Study|Lost to Follow-up|0|||
28116521|NCT03334422|54774900|FG001|Overall Study|Lost to Follow-up|0|||
28116522|NCT03334422|54774901|FG002|Overall Study|Lost to Follow-up|0|||
28116523|NCT03334422|54774902|FG003|Overall Study|Lost to Follow-up|1|||
28116524|NCT03334422|54774899|FG000|Overall Study|Inability to obtain laboratory samples|0|||
28116525|NCT03334422|54774900|FG001|Overall Study|Inability to obtain laboratory samples|1|||
28116526|NCT03334422|54774901|FG002|Overall Study|Inability to obtain laboratory samples|0|||
28116527|NCT03334422|54774902|FG003|Overall Study|Inability to obtain laboratory samples|0|||
28116528|NCT03334422|54774899|FG000|Overall Study|Pregnancy|0|||
28116529|NCT03334422|54774900|FG001|Overall Study|Pregnancy|1|||
28116530|NCT03334422|54774901|FG002|Overall Study|Pregnancy|0|||
28116531|NCT03334422|54774902|FG003|Overall Study|Pregnancy|0|||
28116532|NCT03362190|54774921|FG000|Overall Study|Adverse Event|0|||
28116533|NCT03362190|54774922|FG001|Overall Study|Adverse Event|0|||
28116534|NCT03362190|54774923|FG002|Overall Study|Adverse Event|0|||
28116535|NCT03362190|54774924|FG003|Overall Study|Adverse Event|1|||
28116536|NCT03362190|54774921|FG000|Overall Study|Withdrawal by Subject|0|||
28116537|NCT03362190|54774922|FG001|Overall Study|Withdrawal by Subject|0|||
28116538|NCT03362190|54774923|FG002|Overall Study|Withdrawal by Subject|0|||
28116539|NCT03362190|54774924|FG003|Overall Study|Withdrawal by Subject|1|||
28116540|NCT02323126|54774940|FG000|Overall Study|Patient / guardian decision|0|||
28116541|NCT02323126|54774941|FG001|Overall Study|Patient / guardian decision|1|||
28116542|NCT02323126|54774942|FG002|Overall Study|Patient / guardian decision|2|||
28116543|NCT02323126|54774940|FG000|Overall Study|Progressive disease|14|||
28116544|NCT02323126|54774941|FG001|Overall Study|Progressive disease|8|||
28116545|NCT02323126|54774942|FG002|Overall Study|Progressive disease|14|||
28116546|NCT02323126|54774940|FG000|Overall Study|Physician Decision|0|||
28116547|NCT02323126|54774941|FG001|Overall Study|Physician Decision|1|||
28116548|NCT02323126|54774942|FG002|Overall Study|Physician Decision|3|||
28116549|NCT02323126|54774940|FG000|Overall Study|Death|1|||
28116550|NCT02323126|54774941|FG001|Overall Study|Death|1|||
28116551|NCT02323126|54774942|FG002|Overall Study|Death|4|||
28116552|NCT02323126|54774940|FG000|Overall Study|Adverse Event|3|||
28116553|NCT02323126|54774941|FG001|Overall Study|Adverse Event|5|||
28116554|NCT02323126|54774942|FG002|Overall Study|Adverse Event|7|||
28116555|NCT03491553|54774959|FG000|Main Study (Up to Week 48)|Adverse Event|0|||
28116556|NCT03491553|54774960|FG001|Main Study (Up to Week 48)|Adverse Event|0|||
28116557|NCT03491553|54774961|FG002|Main Study (Up to Week 48)|Adverse Event|0|||
28116558|NCT03491553|54774962|FG003|Main Study (Up to Week 48)|Adverse Event|1|||
28116559|NCT03491553|54774963|FG004|Main Study (Up to Week 48)|Adverse Event|0|||
28116560|NCT03491553|54774964|FG005|Main Study (Up to Week 48)|Adverse Event|0|||
28116561|NCT03491553|54774959|FG000|Main Study (Up to Week 48)|Withdrew Consent|1|||
28116562|NCT03491553|54774960|FG001|Main Study (Up to Week 48)|Withdrew Consent|1|||
28116563|NCT03491553|54774961|FG002|Main Study (Up to Week 48)|Withdrew Consent|0|||
28116564|NCT03491553|54774962|FG003|Main Study (Up to Week 48)|Withdrew Consent|0|||
28116565|NCT03491553|54774963|FG004|Main Study (Up to Week 48)|Withdrew Consent|0|||
28116566|NCT03491553|54774964|FG005|Main Study (Up to Week 48)|Withdrew Consent|0|||
28116567|NCT00003377|54774985|FG000|Period I|Dose Limiting Toxicity(DLT)|0|||
28116568|NCT00003377|54774986|FG001|Period I|Dose Limiting Toxicity(DLT)|0|||
28116569|NCT00003377|54774987|FG002|Period I|Dose Limiting Toxicity(DLT)|1|||
28116570|NCT00003377|54774988|FG003|Period I|Dose Limiting Toxicity(DLT)|1|||
28116571|NCT00003377|54774989|FG004|Period I|Dose Limiting Toxicity(DLT)|0|||
28116572|NCT00003377|54774985|FG000|Period II|Ureteral stent complications|0|||
28116573|NCT00003377|54774986|FG001|Period II|Ureteral stent complications|0|||
27816776|NCT01537887|54273722|FG001|Period 1|Physician Decision|0|||
28116574|NCT00003377|54774987|FG002|Period II|Ureteral stent complications|0|||
28116575|NCT00003377|54774988|FG003|Period II|Ureteral stent complications|0|||
28116576|NCT00003377|54774989|FG004|Period II|Ureteral stent complications|1|||
28116577|NCT00651742|54775002|FG000|Overall Study|Objective Disease Progression|22|||
28116578|NCT00651742|54775002|FG000|Overall Study|Toxicity|3|||
28116579|NCT00651742|54775002|FG000|Overall Study|Investigator Judgment|1|||
28116580|NCT00651742|54775002|FG000|Overall Study|Withdrawal of Consent|1|||
28116581|NCT00651742|54775002|FG000|Overall Study|Enrolled but not treated|1|||
28116582|NCT00002651|54775008|FG000|Induction|Adverse Event|44|||
28116583|NCT00002651|54775009|FG001|Induction|Adverse Event|0|||
28116584|NCT00002651|54775010|FG002|Induction|Adverse Event|0|||
28116585|NCT00002651|54775008|FG000|Induction|Refusal unrelated to adverse event|50|||
28116586|NCT00002651|54775009|FG001|Induction|Refusal unrelated to adverse event|0|||
28116587|NCT00002651|54775010|FG002|Induction|Refusal unrelated to adverse event|0|||
28116588|NCT00002651|54775008|FG000|Induction|Progression/relapse|274|||
28116589|NCT00002651|54775009|FG001|Induction|Progression/relapse|0|||
28116590|NCT00002651|54775010|FG002|Induction|Progression/relapse|0|||
28116591|NCT00002651|54775008|FG000|Induction|Death|62|||
28116592|NCT00002651|54775009|FG001|Induction|Death|0|||
28116593|NCT00002651|54775010|FG002|Induction|Death|0|||
28116594|NCT00002651|54775008|FG000|Induction|Other|823|||
28116595|NCT00002651|54775009|FG001|Induction|Other|0|||
28116596|NCT00002651|54775010|FG002|Induction|Other|0|||
28116597|NCT00002651|54775008|FG000|Induction|not eligible|90|||
28116598|NCT00002651|54775009|FG001|Induction|not eligible|0|||
28116599|NCT00002651|54775010|FG002|Induction|not eligible|0|||
28116600|NCT00002651|54775008|FG000|Consolidation and Randomization|Adverse Event|0|||
28116601|NCT00002651|54775009|FG001|Consolidation and Randomization|Adverse Event|36|||
28116602|NCT00002651|54775010|FG002|Consolidation and Randomization|Adverse Event|14|||
28116603|NCT00002651|54775008|FG000|Consolidation and Randomization|Refusal unrelated to adverse event|0|||
28116604|NCT00002651|54775009|FG001|Consolidation and Randomization|Refusal unrelated to adverse event|53|||
28116605|NCT00002651|54775010|FG002|Consolidation and Randomization|Refusal unrelated to adverse event|75|||
28116606|NCT00002651|54775008|FG000|Consolidation and Randomization|Progression/relapse|0|||
28116607|NCT00002651|54775009|FG001|Consolidation and Randomization|Progression/relapse|295|||
28116608|NCT00002651|54775010|FG002|Consolidation and Randomization|Progression/relapse|298|||
28116609|NCT00002651|54775008|FG000|Consolidation and Randomization|Death|0|||
28116610|NCT00002651|54775009|FG001|Consolidation and Randomization|Death|38|||
28116611|NCT00002651|54775010|FG002|Consolidation and Randomization|Death|48|||
28116612|NCT00002651|54775008|FG000|Consolidation and Randomization|Other|0|||
28116613|NCT00002651|54775009|FG001|Consolidation and Randomization|Other|314|||
28116614|NCT00002651|54775010|FG002|Consolidation and Randomization|Other|313|||
28116615|NCT00002651|54775008|FG000|Consolidation and Randomization|not eligible|0|||
28116616|NCT00002651|54775009|FG001|Consolidation and Randomization|not eligible|102|||
28116617|NCT00002651|54775010|FG002|Consolidation and Randomization|not eligible|112|||
28065586|NCT00496769|54721245|FG000|Double Blind|>=1 reason assigned per patient|558|||
28116618|NCT00002597|54775020|FG000|Overall Study|Protocol Violation|19|||
28116619|NCT00002597|54775021|FG001|Overall Study|Protocol Violation|17|||
28116620|NCT00002597|54775020|FG000|Overall Study|Withdrawal by Subject|7|||
28116621|NCT00002597|54775021|FG001|Overall Study|Withdrawal by Subject|6|||
28116622|NCT03435081|54775030|FG000|Week 0 to Week 16|Lack of Efficacy|6|||
28116623|NCT03435081|54775031|FG001|Week 0 to Week 16|Lack of Efficacy|5|||
28116624|NCT03435081|54775032|FG002|Week 0 to Week 16|Lack of Efficacy|0|||
28116625|NCT03435081|54775030|FG000|Week 0 to Week 16|Adverse Event|2|||
28116626|NCT03435081|54775031|FG001|Week 0 to Week 16|Adverse Event|2|||
28116627|NCT03435081|54775032|FG002|Week 0 to Week 16|Adverse Event|2|||
28116628|NCT03435081|54775030|FG000|Week 0 to Week 16|Withdrawal by Subject|8|||
28116629|NCT03435081|54775031|FG001|Week 0 to Week 16|Withdrawal by Subject|7|||
28116630|NCT03435081|54775032|FG002|Week 0 to Week 16|Withdrawal by Subject|10|||
28116631|NCT03435081|54775030|FG000|Week 0 to Week 16|Lost to Follow-up|3|||
28116632|NCT03435081|54775031|FG001|Week 0 to Week 16|Lost to Follow-up|1|||
28116633|NCT03435081|54775032|FG002|Week 0 to Week 16|Lost to Follow-up|4|||
28116634|NCT03435081|54775030|FG000|Week 0 to Week 16|Pregnancy|1|||
28116635|NCT03435081|54775031|FG001|Week 0 to Week 16|Pregnancy|0|||
28116636|NCT03435081|54775032|FG002|Week 0 to Week 16|Pregnancy|0|||
28116637|NCT03435081|54775030|FG000|Week 0 to Week 16|Non-compliance|1|||
28116638|NCT03435081|54775031|FG001|Week 0 to Week 16|Non-compliance|0|||
27848791|NCT01360632|54343099|FG002|Phase B (6 Weeks)|Adverse Event|9|||
28065587|NCT00496769|54721246|FG001|Double Blind|>=1 reason assigned per patient|649|||
28065588|NCT00496769|54721247|FG002|Double Blind|>=1 reason assigned per patient|0|||
28065589|NCT00496769|54721245|FG000|Open Label|>=1 reason assigned per patient|0|||
28065590|NCT00496769|54721246|FG001|Open Label|>=1 reason assigned per patient|0|||
28065591|NCT00496769|54721247|FG002|Open Label|>=1 reason assigned per patient|1011|||
28065592|NCT00478673|54721256|FG000|30-Days Post-Procedure|Death|2|||
28065593|NCT00478673|54721256|FG000|30-Days Post-Procedure|Withdrawal by Subject|1|||
28065594|NCT00478673|54721256|FG000|30-Days Post-Procedure|Missed Visit|7|||
28065595|NCT00478673|54721256|FG000|12-Months Post-Procedure|Death|23|||
28065596|NCT00478673|54721256|FG000|12-Months Post-Procedure|Lost to Follow-up|4|||
28065597|NCT00478673|54721256|FG000|12-Months Post-Procedure|Withdrawal by Subject|6|||
28116639|NCT03435081|54775032|FG002|Week 0 to Week 16|Non-compliance|2|||
28116640|NCT03435081|54775030|FG000|Week 0 to Week 16|Inadequate Response|0|||
28116641|NCT03435081|54775031|FG001|Week 0 to Week 16|Inadequate Response|1|||
28116642|NCT03435081|54775032|FG002|Week 0 to Week 16|Inadequate Response|0|||
28116643|NCT03435081|54775030|FG000|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
28116644|NCT03435081|54775031|FG001|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
28116645|NCT03435081|54775032|FG002|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|1|||
28116646|NCT03435081|54775030|FG000|Week 16 to Week 104|Lack of Efficacy|2|||
28116647|NCT03435081|54775031|FG001|Week 16 to Week 104|Lack of Efficacy|11|||
28116648|NCT03435081|54775032|FG002|Week 16 to Week 104|Lack of Efficacy|10|||
28116649|NCT03435081|54775030|FG000|Week 16 to Week 104|Adverse Event|1|||
28116650|NCT03435081|54775031|FG001|Week 16 to Week 104|Adverse Event|0|||
28116651|NCT03435081|54775032|FG002|Week 16 to Week 104|Adverse Event|2|||
28116652|NCT03435081|54775030|FG000|Week 16 to Week 104|Withdrawal by Subject|0|||
28116653|NCT03435081|54775031|FG001|Week 16 to Week 104|Withdrawal by Subject|1|||
28116654|NCT03435081|54775032|FG002|Week 16 to Week 104|Withdrawal by Subject|2|||
28116655|NCT03435081|54775030|FG000|Week 16 to Week 104|Lost to Follow-up|0|||
28116656|NCT03435081|54775031|FG001|Week 16 to Week 104|Lost to Follow-up|1|||
28116657|NCT03435081|54775032|FG002|Week 16 to Week 104|Lost to Follow-up|4|||
28116658|NCT03435081|54775030|FG000|Week 16 to Week 104|Non--Compliance|0|||
28116659|NCT03435081|54775031|FG001|Week 16 to Week 104|Non--Compliance|0|||
28116660|NCT03435081|54775032|FG002|Week 16 to Week 104|Non--Compliance|1|||
28116661|NCT02738008|54775047|FG000|Overall Study|Study Terminated by Sponsor|1|||
28116662|NCT02738008|54775048|FG001|Overall Study|Study Terminated by Sponsor|5|||
28116663|NCT02738008|54775049|FG002|Overall Study|Study Terminated by Sponsor|3|||
28116664|NCT02738008|54775047|FG000|Overall Study|Adverse Event|0|||
28116665|NCT02738008|54775048|FG001|Overall Study|Adverse Event|1|||
28116666|NCT02738008|54775049|FG002|Overall Study|Adverse Event|2|||
28116667|NCT03489369|54775061|FG000|Overall Study|Documented Progressive Disease|3|||
28116668|NCT03489369|54775062|FG001|Overall Study|Documented Progressive Disease|2|||
28116669|NCT03489369|54775063|FG002|Overall Study|Documented Progressive Disease|3|||
28116670|NCT03489369|54775064|FG003|Overall Study|Documented Progressive Disease|6|||
28116671|NCT03489369|54775061|FG000|Overall Study|Clinical Progression (Worsening of Clini|0|||
28116672|NCT03489369|54775062|FG001|Overall Study|Clinical Progression (Worsening of Clini|1|||
28116673|NCT03489369|54775063|FG002|Overall Study|Clinical Progression (Worsening of Clini|0|||
28116674|NCT03489369|54775064|FG003|Overall Study|Clinical Progression (Worsening of Clini|0|||
28116675|NCT03257254|54775074|FG000|Overall Study|Withdrawal by Subject|7|||
28116676|NCT03257254|54775074|FG000|Overall Study|Lost to Follow-up|9|||
28116677|NCT03257254|54775074|FG000|Overall Study|Study discontinued by sponsor|5|||
28116678|NCT03738475|54775080|FG000|Overall Study|Participant Non-Compliance|1|||
28116679|NCT03738475|54775081|FG001|Overall Study|Participant Non-Compliance|0|||
28116680|NCT03084718|54775092|FG000|Overall Study|Withdrawal by Subject|4|||
28116681|NCT03084718|54775093|FG001|Overall Study|Withdrawal by Subject|3|||
28116682|NCT03084718|54775094|FG002|Overall Study|Withdrawal by Subject|4|||
28116683|NCT03084718|54775095|FG003|Overall Study|Withdrawal by Subject|0|||
28116684|NCT03084718|54775096|FG004|Overall Study|Withdrawal by Subject|0|||
28116685|NCT03084718|54775092|FG000|Overall Study|Physician Decision|1|||
28116686|NCT03084718|54775093|FG001|Overall Study|Physician Decision|0|||
28116687|NCT03084718|54775094|FG002|Overall Study|Physician Decision|0|||
28116688|NCT03084718|54775095|FG003|Overall Study|Physician Decision|0|||
28116689|NCT03084718|54775096|FG004|Overall Study|Physician Decision|0|||
28116690|NCT03084718|54775092|FG000|Overall Study|Adverse Event|3|||
28116691|NCT03084718|54775093|FG001|Overall Study|Adverse Event|5|||
28116692|NCT03084718|54775094|FG002|Overall Study|Adverse Event|5|||
28116693|NCT03084718|54775095|FG003|Overall Study|Adverse Event|8|||
28116694|NCT03084718|54775096|FG004|Overall Study|Adverse Event|2|||
28116695|NCT03084718|54775092|FG000|Overall Study|Lack of Efficacy|2|||
28065598|NCT00478673|54721256|FG000|12-Months Post-Procedure|Missed Visit|25|||
28065599|NCT00478673|54721256|FG000|12-Months Post-Procedure|Visit Not Required by Protocol|6|||
28065600|NCT00488345|54721263|FG000|Overall Study|Adverse Event|0|||
28065601|NCT00488345|54721264|FG001|Overall Study|Adverse Event|1|||
28065602|NCT00488345|54721265|FG002|Overall Study|Adverse Event|1|||
28065603|NCT00488345|54721263|FG000|Overall Study|Unable to administer antibiotics at home|0|||
28065604|NCT00488345|54721264|FG001|Overall Study|Unable to administer antibiotics at home|1|||
28065605|NCT00488345|54721265|FG002|Overall Study|Unable to administer antibiotics at home|0|||
28065606|NCT00488345|54721263|FG000|Overall Study|Institutional Review Board review|0|||
28116696|NCT03084718|54775093|FG001|Overall Study|Lack of Efficacy|0|||
28116697|NCT03084718|54775094|FG002|Overall Study|Lack of Efficacy|1|||
28116698|NCT03084718|54775095|FG003|Overall Study|Lack of Efficacy|4|||
28116699|NCT03084718|54775096|FG004|Overall Study|Lack of Efficacy|0|||
28116700|NCT03084718|54775092|FG000|Overall Study|Lost to Follow-up|0|||
28116701|NCT03084718|54775093|FG001|Overall Study|Lost to Follow-up|1|||
28116702|NCT03084718|54775094|FG002|Overall Study|Lost to Follow-up|0|||
28116703|NCT03084718|54775095|FG003|Overall Study|Lost to Follow-up|0|||
28116704|NCT03084718|54775096|FG004|Overall Study|Lost to Follow-up|2|||
28116705|NCT03084718|54775092|FG000|Overall Study|Protocol Violation|0|||
28116706|NCT03084718|54775093|FG001|Overall Study|Protocol Violation|0|||
28116707|NCT03084718|54775094|FG002|Overall Study|Protocol Violation|1|||
28116708|NCT03084718|54775095|FG003|Overall Study|Protocol Violation|0|||
28116709|NCT03084718|54775096|FG004|Overall Study|Protocol Violation|0|||
28116710|NCT03084718|54775092|FG000|Overall Study|Death|0|||
28116711|NCT03084718|54775093|FG001|Overall Study|Death|1|||
28116712|NCT03084718|54775094|FG002|Overall Study|Death|0|||
28116713|NCT03084718|54775095|FG003|Overall Study|Death|0|||
28116714|NCT03084718|54775096|FG004|Overall Study|Death|0|||
28116715|NCT03084718|54775092|FG000|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
28116716|NCT03084718|54775093|FG001|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
28116717|NCT03084718|54775094|FG002|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
28116718|NCT03084718|54775095|FG003|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|2|||
28116719|NCT03084718|54775096|FG004|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
28116720|NCT04321252|54775120|FG000|Overall Study|Withdrawal by Subject|0|||
28116721|NCT04321252|54775121|FG001|Overall Study|Withdrawal by Subject|0|||
28116722|NCT04321252|54775122|FG002|Overall Study|Withdrawal by Subject|0|||
28116723|NCT04321252|54775123|FG003|Overall Study|Withdrawal by Subject|0|||
28116724|NCT04321252|54775124|FG004|Overall Study|Withdrawal by Subject|0|||
28116725|NCT04321252|54775125|FG005|Overall Study|Withdrawal by Subject|1|||
28116726|NCT04321252|54775126|FG006|Overall Study|Withdrawal by Subject|0|||
28116727|NCT04321252|54775127|FG007|Overall Study|Withdrawal by Subject|0|||
28116728|NCT04321252|54775128|FG008|Overall Study|Withdrawal by Subject|0|||
28116729|NCT03433677|54775160|FG000|Period 1|Protocol Violation|1|||
28116730|NCT03433677|54775161|FG001|Period 1|Protocol Violation|0|||
28116731|NCT03433677|54775160|FG000|Period 2|Withdrawal by Subject|1|||
28116732|NCT03433677|54775161|FG001|Period 2|Withdrawal by Subject|1|||
28116733|NCT02492711|54775171|FG000|Overall Study|Adverse Event|9|||
28116734|NCT02492711|54775172|FG001|Overall Study|Adverse Event|9|||
28116735|NCT02492711|54775173|FG002|Overall Study|Adverse Event|2|||
28116736|NCT02492711|54775171|FG000|Overall Study|Death|3|||
28116737|NCT02492711|54775172|FG001|Overall Study|Death|3|||
28116738|NCT02492711|54775173|FG002|Overall Study|Death|0|||
28116739|NCT02492711|54775171|FG000|Overall Study|Withdrawal by Subject|10|||
28116740|NCT02492711|54775172|FG001|Overall Study|Withdrawal by Subject|16|||
28116741|NCT02492711|54775173|FG002|Overall Study|Withdrawal by Subject|5|||
28116742|NCT02492711|54775171|FG000|Overall Study|Physician Decision|10|||
28116743|NCT02492711|54775172|FG001|Overall Study|Physician Decision|6|||
28116744|NCT02492711|54775173|FG002|Overall Study|Physician Decision|4|||
28116745|NCT02492711|54775171|FG000|Overall Study|Lost to Follow-up|0|||
28116746|NCT02492711|54775172|FG001|Overall Study|Lost to Follow-up|0|||
28116747|NCT02492711|54775173|FG002|Overall Study|Lost to Follow-up|1|||
28065607|NCT00488345|54721264|FG001|Overall Study|Institutional Review Board review|0|||
28065608|NCT00488345|54721265|FG002|Overall Study|Institutional Review Board review|1|||
28116748|NCT02492711|54775171|FG000|Overall Study|study treatment delay|2|||
28116749|NCT02492711|54775172|FG001|Overall Study|study treatment delay|1|||
28116750|NCT02492711|54775173|FG002|Overall Study|study treatment delay|0|||
28116751|NCT02492711|54775171|FG000|Overall Study|change in chemotherapy|0|||
28116752|NCT02492711|54775172|FG001|Overall Study|change in chemotherapy|1|||
28116753|NCT02492711|54775173|FG002|Overall Study|change in chemotherapy|0|||
28116754|NCT02492711|54775171|FG000|Overall Study|never treated|2|||
28116755|NCT02492711|54775172|FG001|Overall Study|never treated|4|||
28065609|NCT00488345|54721263|FG000|Overall Study|Surgical team recommendation|0|||
28065610|NCT00488345|54721264|FG001|Overall Study|Surgical team recommendation|1|||
28065611|NCT00488345|54721265|FG002|Overall Study|Surgical team recommendation|0|||
28065612|NCT00488345|54721263|FG000|Overall Study|Parent/legal guardian request|0|||
28065613|NCT00488345|54721264|FG001|Overall Study|Parent/legal guardian request|1|||
28065614|NCT00488345|54721265|FG002|Overall Study|Parent/legal guardian request|1|||
28065615|NCT00283062|54721278|FG000|Overall Study|Did not receive any study medication|5|||
28065616|NCT00283062|54721279|FG001|Overall Study|Did not receive any study medication|4|||
28065617|NCT00283062|54721280|FG002|Overall Study|Did not receive any study medication|36|||
28065618|NCT00283062|54721281|FG003|Overall Study|Did not receive any study medication|45|||
28116756|NCT02492711|54775173|FG002|Overall Study|never treated|0|||
28065619|NCT00283062|54721278|FG000|Overall Study|Adverse Event|2|||
28065620|NCT00283062|54721279|FG001|Overall Study|Adverse Event|0|||
28116757|NCT02492711|54775171|FG000|Overall Study|Other|0|||
28116758|NCT02492711|54775172|FG001|Overall Study|Other|0|||
28116759|NCT02492711|54775173|FG002|Overall Study|Other|1|||
28116760|NCT01147822|54775188|FG000|Overall Study|Death|66|||
28116761|NCT01147822|54775189|FG001|Overall Study|Death|59|||
28116762|NCT01147822|54775188|FG000|Overall Study|Protocol Violation|0|||
28116763|NCT01147822|54775189|FG001|Overall Study|Protocol Violation|1|||
28116764|NCT01147822|54775188|FG000|Overall Study|Lost to Follow-up|3|||
28116765|NCT01147822|54775189|FG001|Overall Study|Lost to Follow-up|2|||
28116766|NCT01147822|54775188|FG000|Overall Study|Physician Decision|0|||
28116767|NCT01147822|54775189|FG001|Overall Study|Physician Decision|2|||
28116768|NCT01147822|54775188|FG000|Overall Study|Withdrawal by Subject|8|||
28116769|NCT01147822|54775189|FG001|Overall Study|Withdrawal by Subject|13|||
28116770|NCT01147822|54775188|FG000|Overall Study|Not Completed/Ongoing|111|||
28116771|NCT01147822|54775189|FG001|Overall Study|Not Completed/Ongoing|102|||
28116772|NCT03431337|54775197|FG000|Overall Study|Lost to Follow-up|21|||
28116773|NCT03431337|54775198|FG001|Overall Study|Lost to Follow-up|19|||
28116774|NCT03431337|54775197|FG000|Overall Study|Withdrawal by Subject|8|||
28116775|NCT03431337|54775198|FG001|Overall Study|Withdrawal by Subject|3|||
28116776|NCT03738241|54775218|FG000|Overall Study|Withdrawal by Subject|0|||
28116777|NCT03738241|54775219|FG001|Overall Study|Withdrawal by Subject|0|||
28116778|NCT03738241|54775220|FG002|Overall Study|Withdrawal by Subject|0|||
28116779|NCT03738241|54775221|FG003|Overall Study|Withdrawal by Subject|0|||
28116780|NCT03738241|54775222|FG004|Overall Study|Withdrawal by Subject|0|||
28116781|NCT03738241|54775223|FG005|Overall Study|Withdrawal by Subject|0|||
28116782|NCT03738241|54775224|FG006|Overall Study|Withdrawal by Subject|0|||
28116783|NCT03738241|54775225|FG007|Overall Study|Withdrawal by Subject|0|||
28116784|NCT03738241|54775226|FG008|Overall Study|Withdrawal by Subject|0|||
28116785|NCT03738241|54775227|FG009|Overall Study|Withdrawal by Subject|1|||
28116786|NCT03738241|54775218|FG000|Overall Study|Physician Decision|0|||
28116787|NCT03738241|54775219|FG001|Overall Study|Physician Decision|0|||
28116788|NCT03738241|54775220|FG002|Overall Study|Physician Decision|0|||
28116789|NCT03738241|54775221|FG003|Overall Study|Physician Decision|0|||
28116790|NCT03738241|54775222|FG004|Overall Study|Physician Decision|0|||
28116791|NCT03738241|54775223|FG005|Overall Study|Physician Decision|0|||
28116792|NCT03738241|54775224|FG006|Overall Study|Physician Decision|0|||
28116793|NCT03738241|54775225|FG007|Overall Study|Physician Decision|0|||
28116794|NCT03738241|54775226|FG008|Overall Study|Physician Decision|1|||
28116795|NCT03738241|54775227|FG009|Overall Study|Physician Decision|0|||
28116796|NCT03738241|54775218|FG000|Overall Study|Adverse Event|1|||
28116797|NCT03738241|54775219|FG001|Overall Study|Adverse Event|0|||
28116798|NCT03738241|54775220|FG002|Overall Study|Adverse Event|0|||
28116799|NCT03738241|54775221|FG003|Overall Study|Adverse Event|0|||
28116800|NCT03738241|54775222|FG004|Overall Study|Adverse Event|0|||
28116801|NCT03738241|54775223|FG005|Overall Study|Adverse Event|0|||
28116802|NCT03738241|54775224|FG006|Overall Study|Adverse Event|0|||
28116803|NCT03738241|54775225|FG007|Overall Study|Adverse Event|0|||
28116804|NCT03738241|54775226|FG008|Overall Study|Adverse Event|0|||
28116805|NCT03738241|54775227|FG009|Overall Study|Adverse Event|0|||
28116806|NCT03430245|54775249|FG000|Overall Study|Withdrawal by Subject|6|||
28116807|NCT03430245|54775249|FG000|Overall Study|Lost to Follow-up|1|||
28116808|NCT03461289|54775253|FG000|Overall Study|Death|1|||
28116809|NCT03452943|54775259|FG000|Titration Period (7 Weeks)|Adverse Event|1|||
28116810|NCT03452943|54775260|FG001|Titration Period (7 Weeks)|Adverse Event|1|||
28116811|NCT03452943|54775259|FG000|Titration Period (7 Weeks)|Protocol Violation|0|||
28116812|NCT03452943|54775260|FG001|Titration Period (7 Weeks)|Protocol Violation|1|||
28116813|NCT03452943|54775259|FG000|Titration Period (7 Weeks)|Withdrawal by Subject|3|||
28065621|NCT00283062|54721280|FG002|Overall Study|Adverse Event|1|||
28065622|NCT00283062|54721281|FG003|Overall Study|Adverse Event|0|||
28065623|NCT00283062|54721278|FG000|Overall Study|Lost to Follow-up|1|||
28065624|NCT00283062|54721279|FG001|Overall Study|Lost to Follow-up|0|||
28065625|NCT00283062|54721280|FG002|Overall Study|Lost to Follow-up|1|||
28065626|NCT00283062|54721281|FG003|Overall Study|Lost to Follow-up|0|||
28065627|NCT00283062|54721278|FG000|Overall Study|Progressive disease|0|||
28065628|NCT00283062|54721279|FG001|Overall Study|Progressive disease|0|||
28065629|NCT00283062|54721280|FG002|Overall Study|Progressive disease|1|||
28116814|NCT03452943|54775260|FG001|Titration Period (7 Weeks)|Withdrawal by Subject|2|||
28116815|NCT03452943|54775259|FG000|Titration Period (7 Weeks)|Lost to Follow-up|1|||
28116816|NCT03452943|54775260|FG001|Titration Period (7 Weeks)|Lost to Follow-up|0|||
28116817|NCT03452943|54775259|FG000|Maintenance Period (5 Weeks)|Adverse Event|1|||
28116818|NCT03452943|54775260|FG001|Maintenance Period (5 Weeks)|Adverse Event|0|||
28065630|NCT00283062|54721281|FG003|Overall Study|Progressive disease|0|||
28116819|NCT03452943|54775259|FG000|Maintenance Period (5 Weeks)|Withdrawal by Subject|2|||
28116820|NCT03452943|54775260|FG001|Maintenance Period (5 Weeks)|Withdrawal by Subject|0|||
28116821|NCT03481725|54775268|FG000|Overall Study|Withdrawal by Subject|1|||
28116822|NCT03481725|54775269|FG001|Overall Study|Withdrawal by Subject|0|||
28116823|NCT03480243|54775277|FG000|Padsevonil (Period 2)|Consent withdrawal by subject|1|||
28116824|NCT03480243|54775277|FG000|Padsevonil and Erythromycin (Period 3b)|Un-cooperative behaviour|1|||
28116825|NCT03426345|54775292|FG000|Overall Study|Adverse Event|4|||
28116826|NCT03426345|54775293|FG001|Overall Study|Adverse Event|4|||
28065631|NCT00283062|54721278|FG000|Overall Study|Participant did not wish to continue|3|||
28116827|NCT03426345|54775292|FG000|Overall Study|Lack of Efficacy|1|||
28116828|NCT03426345|54775293|FG001|Overall Study|Lack of Efficacy|0|||
28116829|NCT03426345|54775292|FG000|Overall Study|Withdrawal by Subject|5|||
28116830|NCT03426345|54775293|FG001|Overall Study|Withdrawal by Subject|6|||
28116831|NCT03426345|54775292|FG000|Overall Study|Lost to Follow-up|3|||
28116832|NCT03426345|54775293|FG001|Overall Study|Lost to Follow-up|1|||
28116833|NCT03426345|54775292|FG000|Overall Study|Protocol Deviation|3|||
28116834|NCT03426345|54775293|FG001|Overall Study|Protocol Deviation|4|||
28116835|NCT03426345|54775292|FG000|Overall Study|Reason Not Specified|1|||
28116836|NCT03426345|54775293|FG001|Overall Study|Reason Not Specified|2|||
28116837|NCT03426345|54775292|FG000|Overall Study|Missing Completion Status|1|||
28116838|NCT03426345|54775293|FG001|Overall Study|Missing Completion Status|0|||
28116839|NCT03426267|54775302|FG000|Overall Study|Physician Decision|1|||
28065632|NCT00283062|54721279|FG001|Overall Study|Participant did not wish to continue|2|||
28065633|NCT00283062|54721280|FG002|Overall Study|Participant did not wish to continue|1|||
28065634|NCT00283062|54721281|FG003|Overall Study|Participant did not wish to continue|0|||
28065635|NCT00283062|54721278|FG000|Overall Study|Undefined|0|||
28065636|NCT00283062|54721279|FG001|Overall Study|Undefined|1|||
28065637|NCT00283062|54721280|FG002|Overall Study|Undefined|1|||
28065638|NCT00283062|54721281|FG003|Overall Study|Undefined|4|||
28065639|NCT00283062|54721278|FG000|Overall Study|chemotherapy not completed (cycle 6)|1|||
28065640|NCT00283062|54721279|FG001|Overall Study|chemotherapy not completed (cycle 6)|0|||
28065641|NCT00283062|54721280|FG002|Overall Study|chemotherapy not completed (cycle 6)|0|||
28065642|NCT00283062|54721281|FG003|Overall Study|chemotherapy not completed (cycle 6)|0|||
28065643|NCT00282984|54721293|FG000|Overall Study|Death|2|||
28065644|NCT00282984|54721294|FG001|Overall Study|Death|5|||
28065645|NCT00282984|54721293|FG000|Overall Study|Adverse Event|8|||
28065646|NCT00282984|54721294|FG001|Overall Study|Adverse Event|5|||
28065647|NCT00282984|54721293|FG000|Overall Study|Lack of Efficacy|0|||
28065648|NCT00282984|54721294|FG001|Overall Study|Lack of Efficacy|2|||
28065649|NCT00282984|54721293|FG000|Overall Study|Lost to Follow-up|14|||
28116840|NCT03426267|54775303|FG001|Overall Study|Physician Decision|4|||
28116841|NCT03426267|54775302|FG000|Overall Study|Lost to Follow-up|1|||
28116842|NCT03426267|54775303|FG001|Overall Study|Lost to Follow-up|0|||
28116843|NCT03426267|54775302|FG000|Overall Study|Withdrawal by Subject|4|||
28116844|NCT03426267|54775303|FG001|Overall Study|Withdrawal by Subject|10|||
28116845|NCT03426267|54775302|FG000|Overall Study|Protocol Violation|1|||
28116846|NCT03426267|54775303|FG001|Overall Study|Protocol Violation|3|||
28116847|NCT03426267|54775302|FG000|Overall Study|Adverse Event|9|||
28116848|NCT03426267|54775303|FG001|Overall Study|Adverse Event|27|||
28116849|NCT03426267|54775302|FG000|Overall Study|Prohibited Treatment Intake|2|||
28116850|NCT03426267|54775303|FG001|Overall Study|Prohibited Treatment Intake|3|||
28116851|NCT03426267|54775302|FG000|Overall Study|Lack of Efficacy|0|||
28116852|NCT03426267|54775303|FG001|Overall Study|Lack of Efficacy|25|||
28116853|NCT03426267|54775302|FG000|Overall Study|other|3|||
28116854|NCT03426267|54775303|FG001|Overall Study|other|0|||
28116855|NCT03412929|54775309|FG000|Overall Study|Protocol Violation|3|||
28116856|NCT03451773|54775315|FG000|Overall Study|Death on study|1|||
28116857|NCT03451773|54775316|FG001|Overall Study|Death on study|5|||
28116858|NCT03451773|54775315|FG000|Overall Study|Death during follow-up period|0|||
28116859|NCT03451773|54775316|FG001|Overall Study|Death during follow-up period|1|||
28116860|NCT03425253|54775323|FG000|Overall Study|Adverse Event|2|||
28116861|NCT03425253|54775323|FG000|Overall Study|Lost to Follow-up|3|||
28116862|NCT03425253|54775323|FG000|Overall Study|Withdrew Consent|6|||
28116863|NCT03425253|54775323|FG000|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5|||
28116864|NCT03424239|54775328|FG000|Overall Study|Withdrawal by Subject|2|||
28116865|NCT03451071|54775332|FG000|First Vaccine|Withdrawal by Subject|1|||
28065650|NCT00282984|54721294|FG001|Overall Study|Lost to Follow-up|10|||
28065651|NCT00282984|54721293|FG000|Overall Study|Withdrawal by Participant|22|||
28116866|NCT03451071|54775332|FG000|Second Vaccine|Lost to Follow-up|19|||
28116867|NCT03451071|54775332|FG000|Third Vaccine|Lost to Follow-up|22|||
28116868|NCT03451071|54775332|FG000|Final Questionnaire and Blood Draw|Lost to Follow-up|4|||
28116869|NCT03449979|54775340|FG000|Overall Study|Technical difficulty|0|||
28116870|NCT03449979|54775341|FG001|Overall Study|Technical difficulty|0|||
28116871|NCT03449979|54775342|FG002|Overall Study|Technical difficulty|0|||
28065652|NCT00282984|54721294|FG001|Overall Study|Withdrawal by Participant|34|||
28065653|NCT00282984|54721293|FG000|Overall Study|Participant stopped study medication|2|||
28065654|NCT00282984|54721294|FG001|Overall Study|Participant stopped study medication|2|||
28065655|NCT00282984|54721293|FG000|Overall Study|Participant only allowed phone follow-up|0|||
28065656|NCT00282984|54721294|FG001|Overall Study|Participant only allowed phone follow-up|1|||
28065657|NCT00282984|54721293|FG000|Overall Study|Participant used antipsychosis meds|0|||
28065658|NCT00282984|54721294|FG001|Overall Study|Participant used antipsychosis meds|1|||
28116872|NCT03449979|54775343|FG003|Overall Study|Technical difficulty|1|||
28116873|NCT03449199|54775356|FG000|Overall Study|Lost to Follow-up|1|||
28116874|NCT03449199|54775357|FG001|Overall Study|Lost to Follow-up|1|||
28065659|NCT00282984|54721293|FG000|Overall Study|lack of motivation|1|||
28116875|NCT03449199|54775358|FG002|Overall Study|Lost to Follow-up|0|||
28116876|NCT03449199|54775356|FG000|Overall Study|Protocol Deviation|0|||
28116877|NCT03449199|54775357|FG001|Overall Study|Protocol Deviation|0|||
28116878|NCT03449199|54775358|FG002|Overall Study|Protocol Deviation|1|||
28116879|NCT03449199|54775356|FG000|Overall Study|Withdrawal by Subject|0|||
28116880|NCT03449199|54775357|FG001|Overall Study|Withdrawal by Subject|0|||
28116881|NCT03449199|54775358|FG002|Overall Study|Withdrawal by Subject|1|||
28116882|NCT03421431|54775372|FG000|Overall Study|Adverse Event|2|||
28116883|NCT03421431|54775373|FG001|Overall Study|Adverse Event|1|||
28116884|NCT03421431|54775374|FG002|Overall Study|Adverse Event|12|||
28116885|NCT03421431|54775372|FG000|Overall Study|Lost to Follow-up|1|||
28116886|NCT03421431|54775373|FG001|Overall Study|Lost to Follow-up|1|||
28116887|NCT03421431|54775374|FG002|Overall Study|Lost to Follow-up|1|||
28116888|NCT03421431|54775372|FG000|Overall Study|Withdrawal by Subject|3|||
28116889|NCT03421431|54775373|FG001|Overall Study|Withdrawal by Subject|2|||
28116890|NCT03421431|54775374|FG002|Overall Study|Withdrawal by Subject|1|||
28116891|NCT03421431|54775372|FG000|Overall Study|Protocol Violation|0|||
28116892|NCT03421431|54775373|FG001|Overall Study|Protocol Violation|1|||
28116893|NCT03421431|54775374|FG002|Overall Study|Protocol Violation|0|||
28116894|NCT03421431|54775372|FG000|Overall Study|Participant met Stopping Rules|0|||
28116895|NCT03421431|54775373|FG001|Overall Study|Participant met Stopping Rules|1|||
28116896|NCT03421431|54775374|FG002|Overall Study|Participant met Stopping Rules|0|||
28116897|NCT03448419|54775386|FG000|Overall Study|Adverse Event|10|||
28116898|NCT03448419|54775387|FG001|Overall Study|Adverse Event|9|||
28116899|NCT03448419|54775386|FG000|Overall Study|Lost to Follow-up|0|||
28116900|NCT03448419|54775387|FG001|Overall Study|Lost to Follow-up|2|||
28116901|NCT03448419|54775386|FG000|Overall Study|Withdrawal by Subject|3|||
28116902|NCT03448419|54775387|FG001|Overall Study|Withdrawal by Subject|1|||
28116903|NCT03448419|54775386|FG000|Overall Study|Not treated|0|||
28116904|NCT03448419|54775387|FG001|Overall Study|Not treated|1|||
28116905|NCT03448419|54775386|FG000|Overall Study|Patient did not attend all visits|0|||
28116906|NCT03448419|54775387|FG001|Overall Study|Patient did not attend all visits|2|||
28116907|NCT03448419|54775386|FG000|Overall Study|Withdrawn by Sponsor|0|||
28116908|NCT03448419|54775387|FG001|Overall Study|Withdrawn by Sponsor|1|||
28116909|NCT03419403|54775398|FG000|Overall Study|Withdrawal by Subject|5|||
28116910|NCT03419403|54775399|FG001|Overall Study|Withdrawal by Subject|2|||
28116911|NCT03419403|54775400|FG002|Overall Study|Withdrawal by Subject|5|||
28116912|NCT03419403|54775401|FG003|Overall Study|Withdrawal by Subject|1|||
28116913|NCT03419403|54775398|FG000|Overall Study|Progressive disease (per protocol)|0|||
28116914|NCT03419403|54775399|FG001|Overall Study|Progressive disease (per protocol)|2|||
28116915|NCT03419403|54775400|FG002|Overall Study|Progressive disease (per protocol)|2|||
28116916|NCT03419403|54775401|FG003|Overall Study|Progressive disease (per protocol)|0|||
28116917|NCT03419403|54775398|FG000|Overall Study|Other, not specified|6|||
28116918|NCT03419403|54775399|FG001|Overall Study|Other, not specified|4|||
28116919|NCT03419403|54775400|FG002|Overall Study|Other, not specified|5|||
28116920|NCT03419403|54775401|FG003|Overall Study|Other, not specified|1|||
28116921|NCT03419403|54775398|FG000|Overall Study|Left study due to COVID-19 restrictions|1|||
28116922|NCT03419403|54775399|FG001|Overall Study|Left study due to COVID-19 restrictions|1|||
28116923|NCT03419403|54775400|FG002|Overall Study|Left study due to COVID-19 restrictions|0|||
28116924|NCT03419403|54775401|FG003|Overall Study|Left study due to COVID-19 restrictions|0|||
28116925|NCT03447249|54775411|FG000|Overall Study|Adverse Event|1|||
28116926|NCT03447249|54775412|FG001|Overall Study|Adverse Event|0|||
28116927|NCT03447249|54775411|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
28116928|NCT03447249|54775412|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
28065660|NCT00282984|54721294|FG001|Overall Study|lack of motivation|0|||
28065661|NCT00282984|54721293|FG000|Overall Study|in prison|0|||
28065662|NCT00282984|54721294|FG001|Overall Study|in prison|1|||
28065663|NCT00282984|54721293|FG000|Overall Study|Protocol Violation|2|||
28065664|NCT00282984|54721294|FG001|Overall Study|Protocol Violation|0|||
28065665|NCT00282438|54721302|FG000|Overall Study|Lack of Efficacy|1|||
28065666|NCT00282438|54721303|FG001|Overall Study|Lack of Efficacy|0|||
28065667|NCT00282438|54721302|FG000|Overall Study|Death|0|||
28065668|NCT00282438|54721303|FG001|Overall Study|Death|1|||
28065669|NCT00296400|54721312|FG000|Overall Study|Adverse Event|7|||
28065670|NCT00296400|54721313|FG001|Overall Study|Adverse Event|7|||
28065671|NCT00296400|54721314|FG002|Overall Study|Adverse Event|7|||
28065672|NCT00296400|54721312|FG000|Overall Study|Withdrawal by Subject|5|||
28116929|NCT03447249|54775411|FG000|Overall Study|Other|3|||
28116930|NCT03447249|54775412|FG001|Overall Study|Other|0|||
28116931|NCT03418545|54775422|FG000|Overall Study|Withdrawal by Participant|2|||
28116932|NCT03418545|54775423|FG001|Overall Study|Withdrawal by Participant|4|||
28116933|NCT03418545|54775422|FG000|Overall Study|Lost to Follow-up|3|||
28116934|NCT03418545|54775423|FG001|Overall Study|Lost to Follow-up|5|||
28116935|NCT03418545|54775422|FG000|Overall Study|Reason Not Specified|0|||
28116936|NCT03418545|54775423|FG001|Overall Study|Reason Not Specified|1|||
28116937|NCT03418545|54775422|FG000|Overall Study|Missing Completion Status|0|||
28116938|NCT03418545|54775423|FG001|Overall Study|Missing Completion Status|1|||
28116939|NCT03409731|54775432|FG000|Overall Study|Withdrawal by Subject|1|||
28116940|NCT03409731|54775432|FG000|Overall Study|Death|2|||
28116941|NCT03446781|54775438|FG000|Overall Study|Lost to Follow-up|11|||
28116942|NCT03446781|54775439|FG001|Overall Study|Lost to Follow-up|5|||
28116943|NCT03446781|54775438|FG000|Overall Study|Withdrawal by Subject|9|||
28116944|NCT03446781|54775439|FG001|Overall Study|Withdrawal by Subject|7|||
28116945|NCT03446781|54775438|FG000|Overall Study|Adverse Event|8|||
28116946|NCT03446781|54775439|FG001|Overall Study|Adverse Event|2|||
28116947|NCT03446781|54775438|FG000|Overall Study|Protocol Violation|0|||
28116948|NCT03446781|54775439|FG001|Overall Study|Protocol Violation|3|||
28116949|NCT03445065|54775471|FG000|Overall Study|Withdrawal by Subject|3|||
28116950|NCT03445065|54775472|FG001|Overall Study|Withdrawal by Subject|6|||
28116951|NCT03445065|54775473|FG002|Overall Study|Withdrawal by Subject|2|||
28116952|NCT03445065|54775474|FG003|Overall Study|Withdrawal by Subject|2|||
28065673|NCT00296400|54721313|FG001|Overall Study|Withdrawal by Subject|6|||
28065674|NCT00296400|54721314|FG002|Overall Study|Withdrawal by Subject|2|||
28065675|NCT00296400|54721312|FG000|Overall Study|Incorrect enrollment|2|||
28065676|NCT00296400|54721313|FG001|Overall Study|Incorrect enrollment|0|||
28065677|NCT00296400|54721314|FG002|Overall Study|Incorrect enrollment|0|||
28065678|NCT00296400|54721312|FG000|Overall Study|Protocol Violation|1|||
28065679|NCT00296400|54721313|FG001|Overall Study|Protocol Violation|1|||
28065680|NCT00296400|54721314|FG002|Overall Study|Protocol Violation|1|||
28065681|NCT00296400|54721312|FG000|Overall Study|Lost to Follow-up|1|||
28065682|NCT00296400|54721313|FG001|Overall Study|Lost to Follow-up|1|||
28065683|NCT00296400|54721314|FG002|Overall Study|Lost to Follow-up|2|||
28065684|NCT00296400|54721312|FG000|Overall Study|Study specific discontinuation criteria|0|||
28116953|NCT03445065|54775471|FG000|Overall Study|Other|4|||
28116954|NCT03445065|54775472|FG001|Overall Study|Other|3|||
28065685|NCT00296400|54721313|FG001|Overall Study|Study specific discontinuation criteria|0|||
28116955|NCT03445065|54775473|FG002|Overall Study|Other|3|||
28116956|NCT03445065|54775474|FG003|Overall Study|Other|1|||
28116957|NCT01224106|54775499|FG000|Double-Blind Treatment Phase|Death|3|||
28116958|NCT01224106|54775500|FG001|Double-Blind Treatment Phase|Death|0|||
28116959|NCT01224106|54775501|FG002|Double-Blind Treatment Phase|Death|0|||
28116960|NCT01224106|54775502|FG003|Double-Blind Treatment Phase|Death|0|||
28116961|NCT01224106|54775503|FG004|Double-Blind Treatment Phase|Death|0|||
28116962|NCT01224106|54775499|FG000|Double-Blind Treatment Phase|Physician Decision|6|||
28116963|NCT01224106|54775500|FG001|Double-Blind Treatment Phase|Physician Decision|5|||
28116964|NCT01224106|54775501|FG002|Double-Blind Treatment Phase|Physician Decision|4|||
28116965|NCT01224106|54775502|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
28116966|NCT01224106|54775503|FG004|Double-Blind Treatment Phase|Physician Decision|0|||
28116967|NCT01224106|54775499|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
28116968|NCT01224106|54775500|FG001|Double-Blind Treatment Phase|Adverse Event|5|||
28116969|NCT01224106|54775501|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
28116970|NCT01224106|54775502|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
28116971|NCT01224106|54775503|FG004|Double-Blind Treatment Phase|Adverse Event|0|||
28116972|NCT01224106|54775499|FG000|Double-Blind Treatment Phase|Other|0|||
28116973|NCT01224106|54775500|FG001|Double-Blind Treatment Phase|Other|0|||
28116974|NCT01224106|54775501|FG002|Double-Blind Treatment Phase|Other|1|||
28116975|NCT01224106|54775502|FG003|Double-Blind Treatment Phase|Other|0|||
28116976|NCT01224106|54775503|FG004|Double-Blind Treatment Phase|Other|0|||
28116977|NCT01224106|54775499|FG000|Double-Blind Treatment Phase|Participant/legal guardian decision|7|||
28116978|NCT01224106|54775500|FG001|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
28116979|NCT01224106|54775501|FG002|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
28116980|NCT01224106|54775502|FG003|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
28116981|NCT01224106|54775503|FG004|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
28116982|NCT01224106|54775499|FG000|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|62|||
28116983|NCT01224106|54775500|FG001|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|68|||
28116984|NCT01224106|54775501|FG002|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|63|||
28116985|NCT01224106|54775502|FG003|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
28116986|NCT01224106|54775503|FG004|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
28116987|NCT01224106|54775499|FG000|Double-Blind Treatment Phase|Lost to Follow-up|1|||
28116988|NCT01224106|54775500|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
28116989|NCT01224106|54775501|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
28116990|NCT01224106|54775502|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
28116991|NCT01224106|54775503|FG004|Double-Blind Treatment Phase|Lost to Follow-up|0|||
28116992|NCT01224106|54775499|FG000|Open-Label Extension (OLE) Phase|Death|0|||
28116993|NCT01224106|54775500|FG001|Open-Label Extension (OLE) Phase|Death|0|||
28116994|NCT01224106|54775501|FG002|Open-Label Extension (OLE) Phase|Death|0|||
28116995|NCT01224106|54775502|FG003|Open-Label Extension (OLE) Phase|Death|1|||
27940360|NCT01185366|54596647|FG000|First Line Therapy|Insurance Coverage Denied|1|||
27940361|NCT01185366|54596648|FG001|First Line Therapy|Insurance Coverage Denied|1|||
27940362|NCT01185366|54596647|FG000|First Line Therapy|Withdrawal by Subject|1|||
27940363|NCT01185366|54596648|FG001|First Line Therapy|Withdrawal by Subject|0|||
28116996|NCT01224106|54775503|FG004|Open-Label Extension (OLE) Phase|Death|3|||
28116997|NCT01224106|54775499|FG000|Open-Label Extension (OLE) Phase|Adverse Event|0|||
28116998|NCT01224106|54775500|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
28116999|NCT01224106|54775501|FG002|Open-Label Extension (OLE) Phase|Adverse Event|0|||
28117000|NCT01224106|54775502|FG003|Open-Label Extension (OLE) Phase|Adverse Event|2|||
28117001|NCT01224106|54775503|FG004|Open-Label Extension (OLE) Phase|Adverse Event|6|||
28117002|NCT01224106|54775499|FG000|Open-Label Extension (OLE) Phase|Physician Decision|0|||
28117003|NCT01224106|54775500|FG001|Open-Label Extension (OLE) Phase|Physician Decision|0|||
28117004|NCT01224106|54775501|FG002|Open-Label Extension (OLE) Phase|Physician Decision|0|||
28117005|NCT01224106|54775502|FG003|Open-Label Extension (OLE) Phase|Physician Decision|2|||
28117006|NCT01224106|54775503|FG004|Open-Label Extension (OLE) Phase|Physician Decision|7|||
28117007|NCT01224106|54775499|FG000|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
28117008|NCT01224106|54775500|FG001|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
28117009|NCT01224106|54775501|FG002|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
28117010|NCT01224106|54775502|FG003|Open-Label Extension (OLE) Phase|Withdrawal by Subject|6|||
28117011|NCT01224106|54775503|FG004|Open-Label Extension (OLE) Phase|Withdrawal by Subject|15|||
28117012|NCT01224106|54775499|FG000|Open-Label Extension (OLE) Phase|Other|0|||
28117013|NCT01224106|54775500|FG001|Open-Label Extension (OLE) Phase|Other|0|||
27940364|NCT01185366|54596647|FG000|First Line Therapy|Lack of Metastatic Site|1|||
28117014|NCT01224106|54775501|FG002|Open-Label Extension (OLE) Phase|Other|0|||
28117015|NCT01224106|54775502|FG003|Open-Label Extension (OLE) Phase|Other|5|||
28117016|NCT01224106|54775503|FG004|Open-Label Extension (OLE) Phase|Other|3|||
28117017|NCT03409107|54775523|FG000|Overall Study|Withdrawal by Subject|4|||
28117018|NCT03409107|54775524|FG001|Overall Study|Withdrawal by Subject|2|||
28117019|NCT03409107|54775523|FG000|Overall Study|Physician Decision|1|||
28117020|NCT03409107|54775524|FG001|Overall Study|Physician Decision|0|||
28117021|NCT03409107|54775523|FG000|Overall Study|Lost to Follow-up|7|||
28117022|NCT03409107|54775524|FG001|Overall Study|Lost to Follow-up|2|||
28117023|NCT03409107|54775523|FG000|Overall Study|Adverse Event|5|||
28117024|NCT03409107|54775524|FG001|Overall Study|Adverse Event|3|||
28117025|NCT03408873|54775538|FG000|Visit 1 Assessment (Baseline)|Lost to Follow-up|3|||
28117026|NCT03408873|54775538|FG000|Visit 2 Assessment|Lost to Follow-up|1|||
28117027|NCT03408873|54775538|FG000|Visit 3 Assessment|Withdrawal by Subject|1|||
28117028|NCT03408873|54775538|FG000|Visit 4 Assessment|Lost to Follow-up|2|||
28117029|NCT03408873|54775538|FG000|Visit 5 Assessment|Lost to Follow-up|1|||
28117030|NCT03408873|54775538|FG000|Visit 6 Assessment|Withdrawal by Subject|1|||
28117031|NCT03780959|54775545|FG000|Part 1|Adverse Event|1|||
28117032|NCT03780959|54775546|FG001|Part 1|Adverse Event|0|||
28117033|NCT03780959|54775547|FG002|Part 1|Adverse Event|0|||
28117034|NCT03780959|54775545|FG000|Part 1|Withdrawal by Subject|1|||
28117035|NCT03780959|54775546|FG001|Part 1|Withdrawal by Subject|0|||
28117036|NCT03780959|54775547|FG002|Part 1|Withdrawal by Subject|0|||
28117037|NCT03780959|54775545|FG000|Part 1|Withdrawal by Parent/Guardian|1|||
28117038|NCT03780959|54775546|FG001|Part 1|Withdrawal by Parent/Guardian|0|||
28117039|NCT03780959|54775547|FG002|Part 1|Withdrawal by Parent/Guardian|0|||
28117040|NCT03780959|54775545|FG000|Part 1|Response Status|2|||
28117041|NCT03780959|54775546|FG001|Part 1|Response Status|0|||
28117042|NCT03780959|54775547|FG002|Part 1|Response Status|0|||
28117043|NCT03780959|54775545|FG000|Part 2|Withdrawal by Parent/Guardian|0|||
28117044|NCT03780959|54775546|FG001|Part 2|Withdrawal by Parent/Guardian|1|||
28117045|NCT03780959|54775547|FG002|Part 2|Withdrawal by Parent/Guardian|0|||
28117046|NCT03780959|54775545|FG000|Part 2|Response Status|0|||
28117047|NCT03780959|54775546|FG001|Part 2|Response Status|18|||
28117048|NCT03780959|54775547|FG002|Part 2|Response Status|6|||
28117049|NCT03408639|54775559|FG000|Overall Study|Death|5|||
28117050|NCT03408639|54775560|FG001|Overall Study|Death|5|||
28117051|NCT03408639|54775559|FG000|Overall Study|Lost to Follow-up|1|||
28117052|NCT03408639|54775560|FG001|Overall Study|Lost to Follow-up|4|||
28117053|NCT03408639|54775559|FG000|Overall Study|Withdrawal by Subject|2|||
28117054|NCT03408639|54775560|FG001|Overall Study|Withdrawal by Subject|7|||
28117055|NCT03408639|54775559|FG000|Overall Study|Physician Decision|3|||
28117056|NCT03408639|54775560|FG001|Overall Study|Physician Decision|6|||
28065686|NCT00296400|54721314|FG002|Overall Study|Study specific discontinuation criteria|1|||
28065687|NCT00296400|54721312|FG000|Overall Study|Visit 10 was performed earlier|0|||
28065688|NCT00296400|54721313|FG001|Overall Study|Visit 10 was performed earlier|1|||
28065689|NCT00296400|54721314|FG002|Overall Study|Visit 10 was performed earlier|0|||
28065690|NCT00296400|54721312|FG000|Overall Study|Pregnancy|1|||
28065691|NCT00296400|54721313|FG001|Overall Study|Pregnancy|2|||
28065692|NCT00296400|54721314|FG002|Overall Study|Pregnancy|0|||
28065693|NCT00296244|54721327|FG000|Overall Study|Underwent retransplant|0|||
28065694|NCT00296244|54721328|FG001|Overall Study|Underwent retransplant|1|||
28065695|NCT00274716|54721345|FG000|Phase A|Other non-reported reason|4|||
28065696|NCT00274716|54721346|FG001|Phase A|Other non-reported reason|2|||
28065697|NCT00274716|54721347|FG002|Phase A|Other non-reported reason|1|||
28065698|NCT00274716|54721348|FG003|Phase A|Other non-reported reason|2|||
28065699|NCT00274716|54721349|FG004|Phase A|Other non-reported reason|0|||
28065700|NCT00274716|54721350|FG005|Phase A|Other non-reported reason|1|||
28117057|NCT03810235|54775568|FG000|Overall Study|Withdrawal by Subject|2|||
28117058|NCT03810235|54775569|FG001|Overall Study|Withdrawal by Subject|0|||
28117059|NCT03408483|54775578|FG000|Overall Study|Physician Decision|3|||
28117060|NCT03408483|54775579|FG001|Overall Study|Physician Decision|3|||
28117061|NCT03408483|54775578|FG000|Overall Study|Lost to Follow-up|3|||
28117062|NCT03408483|54775579|FG001|Overall Study|Lost to Follow-up|0|||
28065701|NCT00274716|54721345|FG000|Phase A|Participant moved|0|||
28065702|NCT00274716|54721346|FG001|Phase A|Participant moved|0|||
28065703|NCT00274716|54721347|FG002|Phase A|Participant moved|1|||
28065704|NCT00274716|54721348|FG003|Phase A|Participant moved|0|||
28065705|NCT00274716|54721349|FG004|Phase A|Participant moved|0|||
28117063|NCT03777917|54775587|FG000|Overall Study|Withdrawal by Subject|1|||
28117064|NCT03777917|54775588|FG001|Overall Study|Withdrawal by Subject|0|||
28117065|NCT03777917|54775587|FG000|Overall Study|Physician Decision|1|||
28117066|NCT03777917|54775588|FG001|Overall Study|Physician Decision|0|||
28117067|NCT03777917|54775587|FG000|Overall Study|Lost to Follow-up|6|||
28117068|NCT03777917|54775588|FG001|Overall Study|Lost to Follow-up|2|||
28117069|NCT03777917|54775587|FG000|Overall Study|Other|1|||
28117070|NCT03777917|54775588|FG001|Overall Study|Other|0|||
28117071|NCT03777059|54775599|FG000|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
28117072|NCT03777059|54775600|FG001|DB Treatment Period (Up to Week 12)|Adverse Event|9|||
28117073|NCT03777059|54775601|FG002|DB Treatment Period (Up to Week 12)|Adverse Event|4|||
28117074|NCT03777059|54775602|FG003|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
28117075|NCT03777059|54775599|FG000|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
28117076|NCT03777059|54775600|FG001|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
28117077|NCT03777059|54775601|FG002|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
28117078|NCT03777059|54775602|FG003|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
28117079|NCT03777059|54775599|FG000|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
28117080|NCT03777059|54775600|FG001|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|9|||
28117081|NCT03777059|54775601|FG002|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
28117082|NCT03777059|54775602|FG003|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|10|||
28117083|NCT03777059|54775599|FG000|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
28117084|NCT03777059|54775600|FG001|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
28117085|NCT03777059|54775601|FG002|DB Treatment Period (Up to Week 12)|Lost to Follow-up|4|||
28117086|NCT03777059|54775602|FG003|DB Treatment Period (Up to Week 12)|Lost to Follow-up|5|||
28117087|NCT03777059|54775599|FG000|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
28117088|NCT03777059|54775600|FG001|DB Treatment Period (Up to Week 12)|Pregnancy|1|||
28117089|NCT03777059|54775601|FG002|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
28117090|NCT03777059|54775602|FG003|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
28117091|NCT03777059|54775599|FG000|DB Treatment Period (Up to Week 12)|Protocol Deviation|4|||
28117092|NCT03777059|54775600|FG001|DB Treatment Period (Up to Week 12)|Protocol Deviation|5|||
28117093|NCT03777059|54775601|FG002|DB Treatment Period (Up to Week 12)|Protocol Deviation|7|||
28117094|NCT03777059|54775602|FG003|DB Treatment Period (Up to Week 12)|Protocol Deviation|8|||
28117095|NCT03777059|54775599|FG000|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
28117096|NCT03777059|54775600|FG001|DB Treatment Period (Up to Week 12)|Reason Not Specified|2|||
28117097|NCT03777059|54775601|FG002|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
28117098|NCT03777059|54775602|FG003|DB Treatment Period (Up to Week 12)|Reason Not Specified|1|||
28117099|NCT03777059|54775599|FG000|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
28117100|NCT03777059|54775600|FG001|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|3|||
28117101|NCT03777059|54775601|FG002|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|4|||
28117102|NCT03777059|54775602|FG003|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
28117103|NCT03777059|54775599|FG000|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
28117104|NCT03777059|54775600|FG001|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|1|||
28117105|NCT03777059|54775601|FG002|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
27816777|NCT01537887|54273723|FG002|Period 1|Physician Decision|0|||
28065706|NCT00274716|54721350|FG005|Phase A|Participant moved|1|||
28065707|NCT00274716|54721345|FG000|Phase A|Site Terminated|0|||
28065708|NCT00274716|54721346|FG001|Phase A|Site Terminated|0|||
28065709|NCT00274716|54721347|FG002|Phase A|Site Terminated|0|||
28065710|NCT00274716|54721348|FG003|Phase A|Site Terminated|1|||
28065711|NCT00274716|54721349|FG004|Phase A|Site Terminated|0|||
28117106|NCT03777059|54775602|FG003|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|3|||
28117107|NCT03777059|54775599|FG000|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
28117108|NCT03777059|54775600|FG001|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
28117109|NCT03777059|54775601|FG002|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
28065712|NCT00274716|54721350|FG005|Phase A|Site Terminated|0|||
27816778|NCT01537887|54273724|FG003|Period 1|Physician Decision|0|||
28065713|NCT00274716|54721345|FG000|Phase A|Protocol Violation|1|||
28065714|NCT00274716|54721346|FG001|Phase A|Protocol Violation|0|||
28065715|NCT00274716|54721347|FG002|Phase A|Protocol Violation|0|||
28117110|NCT03777059|54775602|FG003|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
28117111|NCT03777059|54775599|FG000|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
28117112|NCT03777059|54775600|FG001|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
28117113|NCT03777059|54775601|FG002|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
28117114|NCT03777059|54775602|FG003|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
28117115|NCT03100058|54775621|FG000|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
28117116|NCT03100058|54775622|FG001|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
28117117|NCT03100058|54775623|FG002|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4|||
28117118|NCT03100058|54775624|FG003|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8|||
28117119|NCT03100058|54775625|FG004|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1|||
28117120|NCT03100058|54775626|FG005|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
28117121|NCT03100058|54775627|FG006|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3|||
28117122|NCT03100058|54775628|FG007|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11|||
28117123|NCT03100058|54775629|FG008|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2|||
28117124|NCT03100058|54775630|FG009|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
28117125|NCT03100058|54775631|FG010|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
28117126|NCT03100058|54775632|FG011|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
28117127|NCT03100058|54775633|FG012|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
28117128|NCT03100058|54775621|FG000|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
28117129|NCT03100058|54775622|FG001|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
28117130|NCT03100058|54775623|FG002|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3|||
28117131|NCT03100058|54775624|FG003|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
28117132|NCT03100058|54775625|FG004|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
28117133|NCT03100058|54775626|FG005|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
28117134|NCT03100058|54775627|FG006|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
28117135|NCT03100058|54775628|FG007|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
28117136|NCT03100058|54775629|FG008|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
28117137|NCT03100058|54775630|FG009|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
28117138|NCT03100058|54775631|FG010|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
28117139|NCT03100058|54775632|FG011|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
28117140|NCT03100058|54775633|FG012|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
28117141|NCT03100058|54775621|FG000|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
28117142|NCT03100058|54775622|FG001|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
28117143|NCT03100058|54775623|FG002|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
28117144|NCT03100058|54775624|FG003|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
28117145|NCT03100058|54775625|FG004|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
28117146|NCT03100058|54775626|FG005|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
28117147|NCT03100058|54775627|FG006|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
28117148|NCT03100058|54775628|FG007|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
28117149|NCT03100058|54775629|FG008|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
28117150|NCT03100058|54775630|FG009|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
28117151|NCT03100058|54775631|FG010|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
28117152|NCT03100058|54775632|FG011|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
28117153|NCT03100058|54775633|FG012|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
28117154|NCT03100058|54775621|FG000|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
28117155|NCT03100058|54775622|FG001|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
28117156|NCT03100058|54775623|FG002|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
28117157|NCT03100058|54775624|FG003|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
28117158|NCT03100058|54775625|FG004|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
28117159|NCT03100058|54775626|FG005|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
28117160|NCT03100058|54775627|FG006|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
28117161|NCT03100058|54775628|FG007|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
27940365|NCT01185366|54596648|FG001|First Line Therapy|Lack of Metastatic Site|0|||
28065716|NCT00274716|54721348|FG003|Phase A|Protocol Violation|1|||
28065717|NCT00274716|54721349|FG004|Phase A|Protocol Violation|0|||
28065718|NCT00274716|54721350|FG005|Phase A|Protocol Violation|0|||
28065719|NCT00274716|54721345|FG000|Phase A|Met criteria for discontinuation|1|||
28065720|NCT00274716|54721346|FG001|Phase A|Met criteria for discontinuation|1|||
28065721|NCT00274716|54721347|FG002|Phase A|Met criteria for discontinuation|0|||
28065722|NCT00274716|54721348|FG003|Phase A|Met criteria for discontinuation|0|||
28065723|NCT00274716|54721349|FG004|Phase A|Met criteria for discontinuation|0|||
28065724|NCT00274716|54721350|FG005|Phase A|Met criteria for discontinuation|0|||
28065725|NCT00274716|54721345|FG000|Phase A|Withdrawal by Subject|2|||
28065726|NCT00274716|54721346|FG001|Phase A|Withdrawal by Subject|2|||
28065727|NCT00274716|54721347|FG002|Phase A|Withdrawal by Subject|1|||
28065728|NCT00274716|54721348|FG003|Phase A|Withdrawal by Subject|3|||
28117162|NCT03100058|54775629|FG008|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
28117163|NCT03100058|54775630|FG009|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
28117164|NCT03100058|54775631|FG010|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
28117165|NCT03100058|54775632|FG011|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
28117166|NCT03100058|54775633|FG012|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
28117167|NCT03100058|54775621|FG000|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
28117168|NCT03100058|54775622|FG001|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
28117169|NCT03100058|54775623|FG002|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
28117170|NCT03100058|54775624|FG003|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
28117171|NCT03100058|54775625|FG004|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
28117172|NCT03100058|54775626|FG005|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
28117173|NCT03100058|54775627|FG006|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
28117174|NCT03100058|54775628|FG007|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
28117175|NCT03100058|54775629|FG008|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
28117176|NCT03100058|54775630|FG009|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
28117177|NCT03100058|54775631|FG010|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
28117178|NCT03100058|54775632|FG011|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
28117179|NCT03100058|54775633|FG012|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
28117180|NCT03100058|54775621|FG000|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
27816779|NCT01537887|54273725|FG004|Period 1|Physician Decision|1|||
27816780|NCT01537887|54273726|FG005|Period 1|Physician Decision|1|||
27816781|NCT01537887|54273721|FG000|Period 1|Did not receive treatment|0|||
27816782|NCT01537887|54273722|FG001|Period 1|Did not receive treatment|0|||
27816783|NCT01537887|54273723|FG002|Period 1|Did not receive treatment|1|||
27816784|NCT01537887|54273724|FG003|Period 1|Did not receive treatment|0|||
27816785|NCT01537887|54273725|FG004|Period 1|Did not receive treatment|0|||
27816786|NCT01537887|54273726|FG005|Period 1|Did not receive treatment|0|||
27816787|NCT01537887|54273721|FG000|Period 2|Withdrawal by Subject|0|||
27816788|NCT01537887|54273722|FG001|Period 2|Withdrawal by Subject|1|||
27816789|NCT01537887|54273723|FG002|Period 2|Withdrawal by Subject|0|||
27816790|NCT01537887|54273724|FG003|Period 2|Withdrawal by Subject|0|||
27816791|NCT01537887|54273725|FG004|Period 2|Withdrawal by Subject|0|||
27816792|NCT01537887|54273726|FG005|Period 2|Withdrawal by Subject|0|||
27816793|NCT01537887|54273721|FG000|Period 3|Adverse Event|0|||
27816794|NCT01537887|54273722|FG001|Period 3|Adverse Event|0|||
27816795|NCT01537887|54273723|FG002|Period 3|Adverse Event|1|||
27816796|NCT01537887|54273724|FG003|Period 3|Adverse Event|0|||
27816797|NCT01537887|54273725|FG004|Period 3|Adverse Event|0|||
27816798|NCT01537887|54273726|FG005|Period 3|Adverse Event|0|||
27816799|NCT01537887|54273721|FG000|Period 3|Withdrawal by Subject|0|||
27816800|NCT01537887|54273722|FG001|Period 3|Withdrawal by Subject|1|||
27816801|NCT01537887|54273723|FG002|Period 3|Withdrawal by Subject|0|||
27816802|NCT01537887|54273724|FG003|Period 3|Withdrawal by Subject|0|||
27816803|NCT01537887|54273725|FG004|Period 3|Withdrawal by Subject|0|||
27816804|NCT01537887|54273726|FG005|Period 3|Withdrawal by Subject|0|||
27816805|NCT01489527|54273736|FG000|Overall Study|Pregnancy|9|||
27816806|NCT01489527|54273737|FG001|Overall Study|Pregnancy|14|||
27816807|NCT01489527|54273736|FG000|Overall Study|Participant moved|6|||
28117181|NCT03100058|54775622|FG001|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
28117182|NCT03100058|54775623|FG002|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
28117183|NCT03100058|54775624|FG003|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
28117184|NCT03100058|54775625|FG004|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
28117185|NCT03100058|54775626|FG005|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
28117186|NCT03100058|54775627|FG006|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
28117187|NCT03100058|54775628|FG007|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
28117188|NCT03100058|54775629|FG008|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
28117189|NCT03100058|54775630|FG009|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
28117190|NCT03100058|54775631|FG010|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
28117191|NCT03100058|54775632|FG011|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
27816808|NCT01489527|54273737|FG001|Overall Study|Participant moved|7|||
27816809|NCT01489527|54273736|FG000|Overall Study|Withdrawal by Subject|0|||
27816810|NCT01489527|54273737|FG001|Overall Study|Withdrawal by Subject|4|||
28117192|NCT03100058|54775633|FG012|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
28117193|NCT03100058|54775621|FG000|Epoch 3 (24 Weeks of Treatment)|Death|0|||
27816811|NCT01489527|54273736|FG000|Overall Study|Lost to Follow-up|5|||
27816812|NCT01489527|54273737|FG001|Overall Study|Lost to Follow-up|1|||
27816813|NCT01489527|54273736|FG000|Overall Study|Procedures|1|||
27816814|NCT01489527|54273737|FG001|Overall Study|Procedures|0|||
27816815|NCT01489527|54273736|FG000|Overall Study|Not compliant|1|||
27816816|NCT01489527|54273737|FG001|Overall Study|Not compliant|0|||
27816817|NCT01487577|54273750|FG000|Overall Study|Became ineligible after signing consent|1|||
27816818|NCT01536951|54273756|FG000|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
28117194|NCT03100058|54775622|FG001|Epoch 3 (24 Weeks of Treatment)|Death|1|||
28117195|NCT03100058|54775623|FG002|Epoch 3 (24 Weeks of Treatment)|Death|0|||
27816819|NCT01536951|54273757|FG001|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
27816820|NCT01536951|54273758|FG002|First Intervention and Washout Period 1|Withdrawal by Subject|1|||
27816821|NCT01536951|54273759|FG003|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
28117196|NCT03100058|54775624|FG003|Epoch 3 (24 Weeks of Treatment)|Death|0|||
28117197|NCT03100058|54775625|FG004|Epoch 3 (24 Weeks of Treatment)|Death|0|||
28117198|NCT03100058|54775626|FG005|Epoch 3 (24 Weeks of Treatment)|Death|0|||
28117199|NCT03100058|54775627|FG006|Epoch 3 (24 Weeks of Treatment)|Death|0|||
28117200|NCT03100058|54775628|FG007|Epoch 3 (24 Weeks of Treatment)|Death|0|||
28117201|NCT03100058|54775629|FG008|Epoch 3 (24 Weeks of Treatment)|Death|0|||
28117202|NCT03100058|54775630|FG009|Epoch 3 (24 Weeks of Treatment)|Death|0|||
28117203|NCT03100058|54775631|FG010|Epoch 3 (24 Weeks of Treatment)|Death|0|||
28117204|NCT03100058|54775632|FG011|Epoch 3 (24 Weeks of Treatment)|Death|0|||
28117205|NCT03100058|54775633|FG012|Epoch 3 (24 Weeks of Treatment)|Death|0|||
28117206|NCT03100058|54775621|FG000|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1|||
28117207|NCT03100058|54775622|FG001|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
28117208|NCT03100058|54775623|FG002|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
28117209|NCT03100058|54775624|FG003|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
28117210|NCT03100058|54775625|FG004|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
28117211|NCT03100058|54775626|FG005|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
28117212|NCT03100058|54775627|FG006|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
28117213|NCT03100058|54775628|FG007|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
28117214|NCT03100058|54775629|FG008|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
28117215|NCT03100058|54775630|FG009|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
28117216|NCT03100058|54775631|FG010|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
28117217|NCT03100058|54775632|FG011|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
28117218|NCT03100058|54775633|FG012|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
28117219|NCT03100058|54775621|FG000|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
28117220|NCT03100058|54775622|FG001|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
28117221|NCT03100058|54775623|FG002|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
28117222|NCT03100058|54775624|FG003|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
28117223|NCT03100058|54775625|FG004|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
28117224|NCT03100058|54775626|FG005|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
28117225|NCT03100058|54775627|FG006|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1|||
28117226|NCT03100058|54775628|FG007|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
28117227|NCT03100058|54775629|FG008|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
28117228|NCT03100058|54775630|FG009|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
28117229|NCT03100058|54775631|FG010|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
28117230|NCT03100058|54775632|FG011|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
28117231|NCT03100058|54775633|FG012|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
28117232|NCT03100058|54775621|FG000|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
28117233|NCT03100058|54775622|FG001|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
28117234|NCT03100058|54775623|FG002|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
28117235|NCT03100058|54775624|FG003|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
28117236|NCT03100058|54775625|FG004|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
28117237|NCT03100058|54775626|FG005|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
28117238|NCT03100058|54775627|FG006|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
28117239|NCT03100058|54775628|FG007|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
28117240|NCT03100058|54775629|FG008|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
28117241|NCT03100058|54775630|FG009|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
28117242|NCT03100058|54775631|FG010|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4|||
28117243|NCT03100058|54775632|FG011|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2|||
28117244|NCT03100058|54775633|FG012|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1|||
28117245|NCT03100058|54775621|FG000|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
28117246|NCT03100058|54775622|FG001|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
28117247|NCT03100058|54775623|FG002|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
28117248|NCT03100058|54775624|FG003|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
28117249|NCT03100058|54775625|FG004|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
28117250|NCT03100058|54775626|FG005|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
27816822|NCT01536951|54273760|FG004|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
28117251|NCT03100058|54775627|FG006|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
28117252|NCT03100058|54775628|FG007|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
28117253|NCT03100058|54775629|FG008|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
28117254|NCT03100058|54775630|FG009|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
28117255|NCT03100058|54775631|FG010|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3|||
28117256|NCT03100058|54775632|FG011|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1|||
28117257|NCT03100058|54775633|FG012|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
28117258|NCT03100058|54775621|FG000|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
28117259|NCT03100058|54775622|FG001|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
28117260|NCT03100058|54775623|FG002|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
28117261|NCT03100058|54775624|FG003|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
28117262|NCT03100058|54775625|FG004|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
28117263|NCT03100058|54775626|FG005|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
28117264|NCT03100058|54775627|FG006|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
28117265|NCT03100058|54775628|FG007|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
28117266|NCT03100058|54775629|FG008|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
28117267|NCT03100058|54775630|FG009|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4|||
28117268|NCT03100058|54775631|FG010|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7|||
28117269|NCT03100058|54775632|FG011|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
28117270|NCT03100058|54775633|FG012|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2|||
28117271|NCT03100058|54775621|FG000|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
28117272|NCT03100058|54775622|FG001|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
28117273|NCT03100058|54775623|FG002|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
28117274|NCT03100058|54775624|FG003|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
28117275|NCT03100058|54775625|FG004|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
28117276|NCT03100058|54775626|FG005|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
28117277|NCT03100058|54775627|FG006|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
28117278|NCT03100058|54775628|FG007|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
28117279|NCT03100058|54775629|FG008|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
28117280|NCT03100058|54775630|FG009|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
28117281|NCT03100058|54775631|FG010|Epoch 4 (Last 24 Weeks of the Study)|Death|1|||
28117282|NCT03100058|54775632|FG011|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
28117283|NCT03100058|54775633|FG012|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
28117284|NCT03100058|54775621|FG000|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
28117285|NCT03100058|54775622|FG001|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
28117286|NCT03100058|54775623|FG002|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
28117287|NCT03100058|54775624|FG003|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
28117288|NCT03100058|54775625|FG004|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
27816823|NCT01536951|54273761|FG005|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
27816824|NCT01536951|54273762|FG006|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
27816825|NCT01536951|54273763|FG007|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
27816826|NCT01536951|54273764|FG008|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
27816827|NCT01536951|54273756|FG000|Second Intervention and Washout Period 2|Adverse Event|0|||
27816828|NCT01536951|54273757|FG001|Second Intervention and Washout Period 2|Adverse Event|0|||
27816829|NCT01536951|54273758|FG002|Second Intervention and Washout Period 2|Adverse Event|0|||
27816830|NCT01536951|54273759|FG003|Second Intervention and Washout Period 2|Adverse Event|0|||
27816831|NCT01536951|54273760|FG004|Second Intervention and Washout Period 2|Adverse Event|0|||
27816832|NCT01536951|54273761|FG005|Second Intervention and Washout Period 2|Adverse Event|0|||
27816833|NCT01536951|54273762|FG006|Second Intervention and Washout Period 2|Adverse Event|0|||
27816834|NCT01536951|54273763|FG007|Second Intervention and Washout Period 2|Adverse Event|1|||
27816835|NCT01536951|54273764|FG008|Second Intervention and Washout Period 2|Adverse Event|0|||
27816836|NCT01536795|54273789|FG000|Overall Study|Lost to Follow-up|0|||
27816837|NCT01536795|54273790|FG001|Overall Study|Lost to Follow-up|2|||
27816838|NCT01536795|54273789|FG000|Overall Study|Lack of Efficacy|1|||
27816839|NCT01536795|54273790|FG001|Overall Study|Lack of Efficacy|0|||
27816840|NCT01536561|54273800|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|40|||
27816841|NCT01536561|54273800|FG000|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2|||
27816842|NCT01536561|54273800|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
27816843|NCT01536561|54273800|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1|||
28065729|NCT00274716|54721349|FG004|Phase A|Withdrawal by Subject|0|||
28117289|NCT03100058|54775626|FG005|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
28117290|NCT03100058|54775627|FG006|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
27816844|NCT01536561|54273800|FG000|Dosimetric and Therapeutic Treatment|Death|2|||
28117291|NCT03100058|54775628|FG007|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
28117292|NCT03100058|54775629|FG008|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
28117293|NCT03100058|54775630|FG009|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
28117294|NCT03100058|54775631|FG010|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
28117295|NCT03100058|54775632|FG011|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
28117296|NCT03100058|54775633|FG012|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1|||
28117297|NCT03100058|54775621|FG000|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
28117298|NCT03100058|54775622|FG001|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
28117299|NCT03100058|54775623|FG002|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
28117300|NCT03100058|54775624|FG003|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
28117301|NCT03100058|54775625|FG004|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
28117302|NCT03100058|54775626|FG005|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
28117303|NCT03100058|54775627|FG006|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
28117304|NCT03100058|54775628|FG007|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
28117305|NCT03100058|54775629|FG008|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
28117306|NCT03100058|54775630|FG009|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1|||
28117307|NCT03100058|54775631|FG010|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
28117308|NCT03100058|54775632|FG011|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
28117309|NCT03100058|54775633|FG012|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
28117310|NCT02871778|54775679|FG000|Part A: Treatment Period 1|Adverse Event|1|||
28117311|NCT02871778|54775680|FG001|Part A: Treatment Period 1|Adverse Event|1|||
28117312|NCT02871778|54775681|FG002|Part A: Treatment Period 1|Adverse Event|1|||
28117313|NCT02871778|54775682|FG003|Part A: Treatment Period 1|Adverse Event|0|||
28117314|NCT02871778|54775683|FG004|Part A: Treatment Period 1|Adverse Event|0|||
28117315|NCT02871778|54775684|FG005|Part A: Treatment Period 1|Adverse Event|0|||
28117316|NCT02871778|54775685|FG006|Part A: Treatment Period 1|Adverse Event|0|||
28117317|NCT02871778|54775686|FG007|Part A: Treatment Period 1|Adverse Event|0|||
28117318|NCT02871778|54775679|FG000|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
28117319|NCT02871778|54775680|FG001|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
28117320|NCT02871778|54775681|FG002|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
28117321|NCT02871778|54775682|FG003|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
28117322|NCT02871778|54775683|FG004|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
28117323|NCT02871778|54775684|FG005|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
28117324|NCT02871778|54775685|FG006|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
28117325|NCT02871778|54775686|FG007|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
28117326|NCT02871778|54775679|FG000|Part A: Treatment Period 1|Noncompliant with study drug|0|||
28117327|NCT02871778|54775680|FG001|Part A: Treatment Period 1|Noncompliant with study drug|0|||
28117328|NCT02871778|54775681|FG002|Part A: Treatment Period 1|Noncompliant with study drug|1|||
28117329|NCT02871778|54775682|FG003|Part A: Treatment Period 1|Noncompliant with study drug|0|||
28117330|NCT02871778|54775683|FG004|Part A: Treatment Period 1|Noncompliant with study drug|0|||
28117331|NCT02871778|54775684|FG005|Part A: Treatment Period 1|Noncompliant with study drug|0|||
28117332|NCT02871778|54775685|FG006|Part A: Treatment Period 1|Noncompliant with study drug|0|||
28117333|NCT02871778|54775686|FG007|Part A: Treatment Period 1|Noncompliant with study drug|0|||
28117334|NCT02871778|54775679|FG000|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
28117335|NCT02871778|54775680|FG001|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
28117336|NCT02871778|54775681|FG002|Part A: Treatment Period 1|Other withdrawal criteria met|1|||
28117337|NCT02871778|54775682|FG003|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
27816845|NCT01536561|54273800|FG000|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13|||
27848792|NCT01360632|54343100|FG003|Phase B (6 Weeks)|Adverse Event|3|||
28117338|NCT02871778|54775683|FG004|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
28117339|NCT02871778|54775684|FG005|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
28117340|NCT02871778|54775685|FG006|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
28117341|NCT02871778|54775686|FG007|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
28117342|NCT02871778|54775679|FG000|Part A: Treatment Period 1|Wrong drug shipment|0|||
28117343|NCT02871778|54775680|FG001|Part A: Treatment Period 1|Wrong drug shipment|1|||
28117344|NCT02871778|54775681|FG002|Part A: Treatment Period 1|Wrong drug shipment|0|||
28117345|NCT02871778|54775682|FG003|Part A: Treatment Period 1|Wrong drug shipment|0|||
28117346|NCT02871778|54775683|FG004|Part A: Treatment Period 1|Wrong drug shipment|0|||
28117347|NCT02871778|54775684|FG005|Part A: Treatment Period 1|Wrong drug shipment|0|||
28117348|NCT02871778|54775685|FG006|Part A: Treatment Period 1|Wrong drug shipment|0|||
28117349|NCT02871778|54775686|FG007|Part A: Treatment Period 1|Wrong drug shipment|0|||
28117350|NCT02871778|54775679|FG000|Part A: Treatment Period 2|Adverse Event|2|||
28117351|NCT02871778|54775680|FG001|Part A: Treatment Period 2|Adverse Event|2|||
28117352|NCT02871778|54775681|FG002|Part A: Treatment Period 2|Adverse Event|0|||
28117353|NCT02871778|54775682|FG003|Part A: Treatment Period 2|Adverse Event|0|||
28117354|NCT02871778|54775683|FG004|Part A: Treatment Period 2|Adverse Event|0|||
28117355|NCT02871778|54775684|FG005|Part A: Treatment Period 2|Adverse Event|0|||
28117356|NCT02871778|54775685|FG006|Part A: Treatment Period 2|Adverse Event|0|||
28117357|NCT02871778|54775686|FG007|Part A: Treatment Period 2|Adverse Event|0|||
28117358|NCT02871778|54775679|FG000|Part A: Treatment Period 2|Lost to Follow-up|0|||
28117359|NCT02871778|54775680|FG001|Part A: Treatment Period 2|Lost to Follow-up|0|||
28117360|NCT02871778|54775681|FG002|Part A: Treatment Period 2|Lost to Follow-up|0|||
28117361|NCT02871778|54775682|FG003|Part A: Treatment Period 2|Lost to Follow-up|1|||
28117362|NCT02871778|54775683|FG004|Part A: Treatment Period 2|Lost to Follow-up|0|||
28117363|NCT02871778|54775684|FG005|Part A: Treatment Period 2|Lost to Follow-up|0|||
28117364|NCT02871778|54775685|FG006|Part A: Treatment Period 2|Lost to Follow-up|0|||
28117365|NCT02871778|54775686|FG007|Part A: Treatment Period 2|Lost to Follow-up|0|||
28117366|NCT02871778|54775679|FG000|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
28117367|NCT02871778|54775680|FG001|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
28117368|NCT02871778|54775681|FG002|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
28117369|NCT02871778|54775682|FG003|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
28117370|NCT02871778|54775683|FG004|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
28117371|NCT02871778|54775684|FG005|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
28117372|NCT02871778|54775685|FG006|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
28117373|NCT02871778|54775686|FG007|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
28117374|NCT02871778|54775679|FG000|Part B: Treatment Period 3|Adverse Event|0|||
28117375|NCT02871778|54775680|FG001|Part B: Treatment Period 3|Adverse Event|0|||
28117376|NCT02871778|54775681|FG002|Part B: Treatment Period 3|Adverse Event|0|||
28117377|NCT02871778|54775682|FG003|Part B: Treatment Period 3|Adverse Event|0|||
28117378|NCT02871778|54775683|FG004|Part B: Treatment Period 3|Adverse Event|1|||
28117379|NCT02871778|54775684|FG005|Part B: Treatment Period 3|Adverse Event|1|||
28117380|NCT02871778|54775685|FG006|Part B: Treatment Period 3|Adverse Event|1|||
28117381|NCT02871778|54775686|FG007|Part B: Treatment Period 3|Adverse Event|0|||
28117382|NCT01471444|54775719|FG000|Overall Study|Physician Decision|3|||
28117383|NCT01471444|54775720|FG001|Overall Study|Physician Decision|2|||
28117384|NCT01471444|54775719|FG000|Overall Study|Withdrawal by Subject|0|||
28117385|NCT01471444|54775720|FG001|Overall Study|Withdrawal by Subject|1|||
28117386|NCT03443427|54775738|FG000|Overall Study|Adverse Event|2|||
28117387|NCT03443427|54775739|FG001|Overall Study|Adverse Event|3|||
28117388|NCT03443427|54775738|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
28117389|NCT03443427|54775739|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
28117390|NCT03443427|54775738|FG000|Overall Study|Other|4|||
28117391|NCT03443427|54775739|FG001|Overall Study|Other|6|||
28117392|NCT03417219|54775747|FG000|Overall Study|Lost to Follow-up|0|||
28117393|NCT03417219|54775748|FG001|Overall Study|Lost to Follow-up|3|||
28117394|NCT02953821|54775756|FG000|Overall Study|Adverse Event|0|||
28117395|NCT02953821|54775757|FG001|Overall Study|Adverse Event|4|||
28117396|NCT02953821|54775756|FG000|Overall Study|Death|1|||
28117397|NCT02953821|54775757|FG001|Overall Study|Death|0|||
28117398|NCT02953821|54775756|FG000|Overall Study|Progressive Disease|5|||
28117399|NCT02953821|54775757|FG001|Overall Study|Progressive Disease|1|||
28117400|NCT02953821|54775756|FG000|Overall Study|Lost to Follow-up|2|||
28117401|NCT02953821|54775757|FG001|Overall Study|Lost to Follow-up|0|||
28117402|NCT02953821|54775756|FG000|Overall Study|Physician Decision|1|||
28117403|NCT02953821|54775757|FG001|Overall Study|Physician Decision|1|||
28117404|NCT02953821|54775756|FG000|Overall Study|Withdrawal by Subject|3|||
28117405|NCT02953821|54775757|FG001|Overall Study|Withdrawal by Subject|3|||
28117406|NCT02953821|54775756|FG000|Overall Study|Change of address|0|||
28117407|NCT02953821|54775757|FG001|Overall Study|Change of address|1|||
28117408|NCT02953821|54775756|FG000|Overall Study|Lack of Efficacy|1|||
28117409|NCT02953821|54775757|FG001|Overall Study|Lack of Efficacy|0|||
28117410|NCT02953821|54775756|FG000|Overall Study|Out of state for indeterminate time|0|||
28117411|NCT02953821|54775757|FG001|Overall Study|Out of state for indeterminate time|1|||
28117412|NCT02953821|54775756|FG000|Overall Study|No improvement|0|||
28117413|NCT02953821|54775757|FG001|Overall Study|No improvement|1|||
28117414|NCT02953821|54775756|FG000|Overall Study|Refused follow-up visit|2|||
28117415|NCT02953821|54775757|FG001|Overall Study|Refused follow-up visit|1|||
28117416|NCT03783923|54775767|FG000|Placebo-Controlled Period (26 Weeks)|Study Terminated|3|||
28117417|NCT03783923|54775768|FG001|Placebo-Controlled Period (26 Weeks)|Study Terminated|2|||
28117418|NCT03783923|54775767|FG000|Placebo-Controlled Period (26 Weeks)|Adverse Event|1|||
28117419|NCT03783923|54775768|FG001|Placebo-Controlled Period (26 Weeks)|Adverse Event|0|||
28117420|NCT03783923|54775767|FG000|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
28117421|NCT03783923|54775768|FG001|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
28117422|NCT03783923|54775767|FG000|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
28117423|NCT03783923|54775768|FG001|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
28117424|NCT03783923|54775767|FG000|Open-Label Extension (26 Weeks)|Study Terminated|0|||
28117425|NCT03783923|54775768|FG001|Open-Label Extension (26 Weeks)|Study Terminated|1|||
28117426|NCT03417141|54775772|FG000|Overall Study|Withdrawal by Subject|1|||
28117427|NCT03417141|54775772|FG000|Overall Study|Protocol Violation|3|||
28117428|NCT03724981|54775780|FG000|First Device|Protocol Violation|1|||
28117429|NCT03724981|54775781|FG001|First Device|Protocol Violation|1|||
28117430|NCT03442569|54775789|FG000|Overall Study|Subject was ineligible after enrollment|1|||
28117431|NCT01347879|54775795|FG000|Overall Study|Adverse Event|0|||
28117432|NCT01347879|54775796|FG001|Overall Study|Adverse Event|12|||
28117433|NCT01347879|54775795|FG000|Overall Study|Lost to Follow-up|2|||
28117434|NCT01347879|54775796|FG001|Overall Study|Lost to Follow-up|0|||
28117435|NCT01347879|54775795|FG000|Overall Study|Withdrawal by Subject|3|||
28117436|NCT01347879|54775796|FG001|Overall Study|Withdrawal by Subject|2|||
28117437|NCT01347879|54775795|FG000|Overall Study|Other|2|||
28117438|NCT01347879|54775796|FG001|Overall Study|Other|3|||
28117439|NCT03441789|54775813|FG000|Overall Study|Withdrawal by Subject|1|||
28117440|NCT03441789|54775814|FG001|Overall Study|Withdrawal by Subject|1|||
28117441|NCT03441789|54775813|FG000|Overall Study|Adverse Event|0|||
28117442|NCT03441789|54775814|FG001|Overall Study|Adverse Event|1|||
28117443|NCT03441789|54775813|FG000|Overall Study|Protocol Violation|0|||
28117444|NCT03441789|54775814|FG001|Overall Study|Protocol Violation|1|||
28117445|NCT03441789|54775813|FG000|Overall Study|Lost to Follow-up|0|||
28117446|NCT03441789|54775814|FG001|Overall Study|Lost to Follow-up|1|||
28117447|NCT03387735|54775826|FG000|Overall Study|Lost to Follow-up|4|||
28117448|NCT03387735|54775827|FG001|Overall Study|Lost to Follow-up|8|||
28117449|NCT03387735|54775826|FG000|Overall Study|Death|4|||
28117450|NCT03387735|54775827|FG001|Overall Study|Death|8|||
28117451|NCT03439137|54775835|FG000|Overall Study|Adverse Event|16|||
28117452|NCT03439137|54775836|FG001|Overall Study|Adverse Event|12|||
28117453|NCT03439137|54775835|FG000|Overall Study|Physician Decision|0|||
28117454|NCT03439137|54775836|FG001|Overall Study|Physician Decision|5|||
28117455|NCT03439137|54775835|FG000|Overall Study|Withdrawal by Subject|14|||
28117456|NCT03439137|54775836|FG001|Overall Study|Withdrawal by Subject|4|||
28117457|NCT03439137|54775835|FG000|Overall Study|Conducting rescue therapy|2|||
28117458|NCT03439137|54775836|FG001|Overall Study|Conducting rescue therapy|1|||
28117459|NCT03439137|54775835|FG000|Overall Study|Difficult to control Hb|10|||
28117460|NCT03439137|54775836|FG001|Overall Study|Difficult to control Hb|2|||
28117461|NCT03439137|54775835|FG000|Overall Study|Initiation of a renal transplant|0|||
28117462|NCT03439137|54775836|FG001|Overall Study|Initiation of a renal transplant|2|||
28117463|NCT04055090|54775844|FG000|Overall Study|screen failure|1|||
28117464|NCT04055090|54775845|FG001|Overall Study|screen failure|0|||
28117465|NCT04055090|54775844|FG000|Overall Study|Withdrawal by Subject|1|||
28117466|NCT04055090|54775845|FG001|Overall Study|Withdrawal by Subject|0|||
28117467|NCT03403413|54775868|FG000|Overall Study|Lack of Efficacy|2|||
28117468|NCT03354663|54775883|FG000|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4|||
28117469|NCT03354663|54775883|FG000|Enrollment to Catheter Insertion|Adverse Event|1|||
28117470|NCT03354663|54775883|FG000|Completed 30-day Visit|Withdrawal by Subject|1|||
27816846|NCT01536405|54273818|FG000|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8|||
27816847|NCT01536405|54273819|FG001|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4|||
27816848|NCT01536405|54273818|FG000|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12|||
27940366|NCT01185366|54596647|FG000|Crossover to Second Line Therapy|Adverse Event|3|||
28117471|NCT03354663|54775883|FG000|Completed 30-day Visit|Missed Visit|1|||
28117472|NCT03721705|54775893|FG000|Overall Study|Adverse Event|2|||
28117473|NCT03721705|54775894|FG001|Overall Study|Adverse Event|0|||
28117474|NCT03721705|54775893|FG000|Overall Study|Withdrawal by Subject|4|||
28117475|NCT03721705|54775894|FG001|Overall Study|Withdrawal by Subject|10|||
28117476|NCT03721705|54775893|FG000|Overall Study|No Suitable Study Partner|1|||
28117477|NCT03721705|54775894|FG001|Overall Study|No Suitable Study Partner|0|||
28117478|NCT03721705|54775893|FG000|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|3|||
28117479|NCT03721705|54775894|FG001|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|7|||
28117480|NCT03721705|54775893|FG000|Overall Study|Death|0|||
28117481|NCT03721705|54775894|FG001|Overall Study|Death|1|||
28117482|NCT03720847|54775900|FG000|Washout|Physician Decision|1|||
28117483|NCT03720847|54775901|FG001|Washout|Physician Decision|2|||
28117484|NCT02631070|54775910|FG000|Overall Study|Withdrawal by Subject|35|||
28117485|NCT02631070|54775911|FG001|Overall Study|Withdrawal by Subject|13|||
28117486|NCT02631070|54775910|FG000|Overall Study|Death|45|||
28117487|NCT02631070|54775911|FG001|Overall Study|Death|24|||
28117488|NCT02631070|54775910|FG000|Overall Study|Lost to Follow-up|5|||
28117489|NCT02631070|54775911|FG001|Overall Study|Lost to Follow-up|1|||
28117490|NCT02631070|54775910|FG000|Overall Study|Transition to rollover protocol|52|||
28117491|NCT02631070|54775911|FG001|Overall Study|Transition to rollover protocol|21|||
28117492|NCT02631070|54775910|FG000|Overall Study|Other reasons|12|||
28117493|NCT02631070|54775911|FG001|Overall Study|Other reasons|5|||
28117494|NCT00741988|54775919|FG000|Overall Study|Adverse Event|2|||
28117495|NCT00741988|54775920|FG001|Overall Study|Adverse Event|4|||
28117496|NCT00741988|54775919|FG000|Overall Study|Lack of Efficacy|2|||
28117497|NCT00741988|54775920|FG001|Overall Study|Lack of Efficacy|0|||
28117498|NCT03354429|54775928|FG000|Overall Study|Withdrawal by Subject|8|||
28117499|NCT03354429|54775929|FG001|Overall Study|Withdrawal by Subject|7|||
28117500|NCT03354429|54775928|FG000|Overall Study|Lost to Follow-up|1|||
28117501|NCT03354429|54775929|FG001|Overall Study|Lost to Follow-up|0|||
28117502|NCT03352713|54775935|FG000|Overall Study|Lost to Follow-up|8|||
28117503|NCT03352713|54775935|FG000|Overall Study|Withdrawn by investigator|5|||
28117504|NCT03352713|54775935|FG000|Overall Study|Completed 0 EMAs|8|||
28117505|NCT03352713|54775935|FG000|Overall Study|Device incompatible/stolen|5|||
28117506|NCT03901144|54775939|FG000|Overall Study|Lost to Follow-up|1|||
28117507|NCT03901144|54775940|FG001|Overall Study|Lost to Follow-up|1|||
28117508|NCT03901144|54775941|FG002|Overall Study|Lost to Follow-up|1|||
28117509|NCT03901144|54775942|FG003|Overall Study|Lost to Follow-up|1|||
28117510|NCT02952261|54775954|FG000|Overall Study|Withdrawal by Subject|4|||
28117511|NCT02952261|54775955|FG001|Overall Study|Withdrawal by Subject|5|||
28117512|NCT02952261|54775954|FG000|Overall Study|Protocol Violation|1|||
28117513|NCT02952261|54775955|FG001|Overall Study|Protocol Violation|0|||
28117514|NCT03384693|54775961|FG000|Overall Study|Adverse Event|3|||
28117515|NCT03718429|54775973|FG000|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
28117516|NCT03718429|54775974|FG001|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
28117517|NCT03718429|54775975|FG002|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
28117518|NCT03718429|54775976|FG003|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
28117519|NCT01285102|54775996|FG000|Overall Study|Closed to accrual by sponsor due to poor accrual and challenge with dosing|4|||
28117520|NCT03382899|54776030|FG000|Overall Study|Ineligibility Determined|0|||
28117521|NCT03382899|54776031|FG001|Overall Study|Ineligibility Determined|1|||
28117522|NCT03382899|54776030|FG000|Overall Study|Lost to Follow-up|0|||
28117523|NCT03382899|54776031|FG001|Overall Study|Lost to Follow-up|1|||
28117524|NCT03382899|54776030|FG000|Overall Study|Sponsor's decision|31|||
28117525|NCT03382899|54776031|FG001|Overall Study|Sponsor's decision|28|||
28117526|NCT03382899|54776030|FG000|Overall Study|Withdrawal by Subject|0|||
28117527|NCT03382899|54776031|FG001|Overall Study|Withdrawal by Subject|5|||
28117528|NCT00709852|54776037|FG000|Period 1|Adverse Event|2|||
28117529|NCT00709852|54776038|FG001|Period 1|Adverse Event|0|||
28117530|NCT00709852|54776037|FG000|Period 1|Withdrawal by Subject|4|||
28117531|NCT00709852|54776038|FG001|Period 1|Withdrawal by Subject|2|||
28117532|NCT00709852|54776037|FG000|Period 1|Protocol Violation|1|||
28117533|NCT00709852|54776038|FG001|Period 1|Protocol Violation|0|||
28117534|NCT00709852|54776037|FG000|Period 1|Defective scanner|0|||
28117535|NCT00709852|54776038|FG001|Period 1|Defective scanner|1|||
28117536|NCT00709852|54776037|FG000|Period 1|Lost to Follow-up|1|||
28117537|NCT00709852|54776038|FG001|Period 1|Lost to Follow-up|0|||
28117538|NCT00709852|54776037|FG000|Period 2|Protocol Violation|4|||
28117539|NCT00709852|54776038|FG001|Period 2|Protocol Violation|1|||
28117540|NCT00709852|54776037|FG000|Period 2|Adverse Event|1|||
28117541|NCT00709852|54776038|FG001|Period 2|Adverse Event|1|||
28117542|NCT00709852|54776037|FG000|Period 2|Lost to Follow-up|1|||
28117543|NCT00709852|54776038|FG001|Period 2|Lost to Follow-up|0|||
28117544|NCT00709852|54776037|FG000|Period 2|No 72-hour follow-up|3|||
28117545|NCT00709852|54776038|FG001|Period 2|No 72-hour follow-up|0|||
28117546|NCT03382041|54776055|FG000|Overall Study|Consent Form Lost|2|||
28117547|NCT03382041|54776056|FG001|Overall Study|Consent Form Lost|1|||
28117548|NCT03382041|54776055|FG000|Overall Study|Withdrawal by Subject|1|||
28117549|NCT03382041|54776056|FG001|Overall Study|Withdrawal by Subject|4|||
28117550|NCT03382041|54776055|FG000|Overall Study|Lost to Follow-up|1|||
28117551|NCT03382041|54776056|FG001|Overall Study|Lost to Follow-up|4|||
28117552|NCT03351231|54776062|FG000|Combination Therapy Period|Administrative reason by the Sponsor|1|||
28117553|NCT03351231|54776062|FG000|Combination Therapy Period|Disease progression|2|||
28117554|NCT03351231|54776062|FG000|Combination Therapy Period|Study drug toxicity|1|||
28117555|NCT03351231|54776062|FG000|Combination Therapy Period|Adverse Event unrelated to study drug|1|||
28117556|NCT03351231|54776062|FG000|Safety Follow-Up Period|Participant withdrew consent|1|||
28117557|NCT03351231|54776062|FG000|Safety Follow-Up Period|Other reason|2|||
28117558|NCT03381339|54776068|FG000|Overall Study|Protocol Violation|4|||
28117559|NCT03381339|54776069|FG001|Overall Study|Protocol Violation|3|||
28117560|NCT03381339|54776068|FG000|Overall Study|Lost to Follow-up|0|||
28117561|NCT03381339|54776069|FG001|Overall Study|Lost to Follow-up|1|||
28117562|NCT03401229|54776077|FG000|Overall Study|Lost to Follow-up|2|||
28117563|NCT03401229|54776078|FG001|Overall Study|Lost to Follow-up|1|||
28117564|NCT03401229|54776077|FG000|Overall Study|Other|1|||
28117565|NCT03401229|54776078|FG001|Overall Study|Other|3|||
28117566|NCT03401229|54776077|FG000|Overall Study|Adverse Event|8|||
28117567|NCT03401229|54776078|FG001|Overall Study|Adverse Event|6|||
28117568|NCT03401229|54776077|FG000|Overall Study|Withdrawal by Subject|29|||
28117569|NCT03401229|54776078|FG001|Overall Study|Withdrawal by Subject|26|||
28117570|NCT03401229|54776077|FG000|Overall Study|COVID-19|0|||
28117571|NCT03401229|54776078|FG001|Overall Study|COVID-19|1|||
28117572|NCT03349515|54776086|FG000|Overall Study|Lack of Efficacy|2|||
28117573|NCT03349515|54776087|FG001|Overall Study|Lack of Efficacy|0|||
28117574|NCT03349515|54776086|FG000|Overall Study|Physician Decision|3|||
28117575|NCT03349515|54776087|FG001|Overall Study|Physician Decision|1|||
28117576|NCT03349437|54776093|FG000|Screening|Screen Fail|4|||
28117577|NCT03349437|54776094|FG001|Screening|Screen Fail|0|||
28117578|NCT03349437|54776095|FG002|Screening|Screen Fail|0|||
28117579|NCT03349437|54776093|FG000|Screening|Withdrawn|1|||
28117580|NCT03349437|54776094|FG001|Screening|Withdrawn|0|||
28117581|NCT03349437|54776095|FG002|Screening|Withdrawn|0|||
28117582|NCT03380091|54776104|FG000|Overall Study|Withdrawal by Subject|2|||
28117583|NCT03380091|54776105|FG001|Overall Study|Withdrawal by Subject|1|||
28117584|NCT03379233|54776115|FG000|Overall Study|Technical issues with Concept 2 inhalers|1|||
28117585|NCT03379233|54776116|FG001|Overall Study|Technical issues with Concept 2 inhalers|6|||
28117586|NCT01377922|54776124|FG000|Overall Study|rescue tx after part 2, entered part 4|1|||
28117587|NCT01377922|54776125|FG001|Overall Study|rescue tx after part 2, entered part 4|0|||
28117588|NCT03372603|54776131|FG000|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1|||
28117589|NCT03372603|54776132|FG001|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0|||
28117590|NCT03372603|54776131|FG000|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1|||
28117591|NCT03372603|54776132|FG001|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0|||
28065730|NCT00274716|54721350|FG005|Phase A|Withdrawal by Subject|1|||
27848793|NCT01360632|54343101|FG004|Phase B (6 Weeks)|Adverse Event|0|||
28065731|NCT00274716|54721345|FG000|Phase A|Adverse Event|2|||
28065732|NCT00274716|54721346|FG001|Phase A|Adverse Event|3|||
28065733|NCT00274716|54721347|FG002|Phase A|Adverse Event|3|||
28065734|NCT00274716|54721348|FG003|Phase A|Adverse Event|0|||
28065735|NCT00274716|54721349|FG004|Phase A|Adverse Event|2|||
28065736|NCT00274716|54721350|FG005|Phase A|Adverse Event|0|||
28065737|NCT00274716|54721345|FG000|Phase A|Completed but did not enter Phase B|1|||
28065738|NCT00274716|54721346|FG001|Phase A|Completed but did not enter Phase B|2|||
28065739|NCT00274716|54721347|FG002|Phase A|Completed but did not enter Phase B|2|||
28065740|NCT00274716|54721348|FG003|Phase A|Completed but did not enter Phase B|2|||
28065741|NCT00274716|54721349|FG004|Phase A|Completed but did not enter Phase B|1|||
28065742|NCT00274716|54721350|FG005|Phase A|Completed but did not enter Phase B|1|||
28065743|NCT00274716|54721345|FG000|Phase B|Adverse Event|0|||
28065744|NCT00274716|54721346|FG001|Phase B|Adverse Event|0|||
28065745|NCT00274716|54721347|FG002|Phase B|Adverse Event|2|||
28065746|NCT00274716|54721348|FG003|Phase B|Adverse Event|0|||
28065747|NCT00274716|54721349|FG004|Phase B|Adverse Event|0|||
28065748|NCT00274716|54721350|FG005|Phase B|Adverse Event|1|||
28065749|NCT00274716|54721345|FG000|Phase B|Protocol Violation|0|||
28065750|NCT00274716|54721346|FG001|Phase B|Protocol Violation|2|||
28117592|NCT01377844|54776140|FG000|Overall Study|Withdrawal by Subject|25|||
28117593|NCT01377844|54776141|FG001|Overall Study|Withdrawal by Subject|28|||
28117594|NCT01377844|54776140|FG000|Overall Study|Protocol Violation|2|||
28117595|NCT01377844|54776141|FG001|Overall Study|Protocol Violation|3|||
28117596|NCT01377844|54776140|FG000|Overall Study|Adverse Event|3|||
28117597|NCT01377844|54776141|FG001|Overall Study|Adverse Event|0|||
28117598|NCT01377844|54776140|FG000|Overall Study|Physician Decision|6|||
28117599|NCT01377844|54776141|FG001|Overall Study|Physician Decision|3|||
28117600|NCT01377844|54776140|FG000|Overall Study|Study terminated by Sponsor|0|||
28117601|NCT01377844|54776141|FG001|Overall Study|Study terminated by Sponsor|1|||
28117602|NCT03372369|54776150|FG000|Qualification Period|Withdrawal by Subject|16|||
28117603|NCT03372369|54776151|FG001|Qualification Period|Withdrawal by Subject|13|||
28117604|NCT03372369|54776150|FG000|Qualification Period|Inconsistent Eligibility Results|10|||
28117605|NCT03372369|54776151|FG001|Qualification Period|Inconsistent Eligibility Results|9|||
28117606|NCT03372369|54776150|FG000|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
28117607|NCT03372369|54776151|FG001|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
28117608|NCT03371355|54776161|FG000|Overall Study|Investigator judgment|0|||
28117609|NCT03371355|54776162|FG001|Overall Study|Investigator judgment|0|||
28117610|NCT03371355|54776163|FG002|Overall Study|Investigator judgment|1|||
28117611|NCT03371355|54776164|FG003|Overall Study|Investigator judgment|1|||
28117612|NCT03371355|54776161|FG000|Overall Study|Voluntary withdrawal|1|||
28117613|NCT03371355|54776162|FG001|Overall Study|Voluntary withdrawal|0|||
28117614|NCT03371355|54776163|FG002|Overall Study|Voluntary withdrawal|1|||
28117615|NCT03371355|54776164|FG003|Overall Study|Voluntary withdrawal|2|||
28117616|NCT03371355|54776161|FG000|Overall Study|Adverse Event|0|||
28117617|NCT03371355|54776162|FG001|Overall Study|Adverse Event|1|||
28117618|NCT03371355|54776163|FG002|Overall Study|Adverse Event|2|||
28117619|NCT03371355|54776164|FG003|Overall Study|Adverse Event|3|||
28117620|NCT03371355|54776161|FG000|Overall Study|Reason not Specified|0|||
28117621|NCT03371355|54776162|FG001|Overall Study|Reason not Specified|1|||
28117622|NCT03371355|54776163|FG002|Overall Study|Reason not Specified|0|||
28117623|NCT03371355|54776164|FG003|Overall Study|Reason not Specified|1|||
28117624|NCT03370419|54776178|FG000|Overall Study|Lost to Follow-up|16|||
28117625|NCT03369951|54776186|FG000|Overall Study|Withdrawal by Subject|3|||
28117626|NCT03369951|54776186|FG000|Overall Study|Death|1|||
28117627|NCT03369951|54776186|FG000|Overall Study|Lost to Follow-up|1|||
28117628|NCT03369951|54776186|FG000|Overall Study|Protocol Violation|1|||
28117629|NCT04040192|54776190|FG000|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|18|||
28117630|NCT04040192|54776191|FG001|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
28117631|NCT04040192|54776192|FG002|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
28117632|NCT04040192|54776190|FG000|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|14|||
28117633|NCT04040192|54776191|FG001|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
28117634|NCT04040192|54776192|FG002|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
28117635|NCT04040192|54776190|FG000|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|3|||
28117636|NCT04040192|54776191|FG001|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
28117637|NCT04040192|54776192|FG002|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
28117638|NCT04040192|54776190|FG000|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|3|||
28117639|NCT04040192|54776191|FG001|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
28117640|NCT04040192|54776192|FG002|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
28117641|NCT04040192|54776190|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|8|||
28117642|NCT04040192|54776191|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
28117643|NCT04040192|54776192|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
28117644|NCT04040192|54776190|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|18|||
28117645|NCT04040192|54776191|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
28117646|NCT04040192|54776192|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
28117647|NCT04040192|54776190|FG000|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|152|||
28117648|NCT04040192|54776191|FG001|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
28117649|NCT04040192|54776192|FG002|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
28117650|NCT04040192|54776190|FG000|Open Label Run-in Period (up to 8 Weeks)|Other|11|||
28117651|NCT04040192|54776191|FG001|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
28065751|NCT00274716|54721347|FG002|Phase B|Protocol Violation|0|||
28065752|NCT00274716|54721348|FG003|Phase B|Protocol Violation|0|||
28065753|NCT00274716|54721349|FG004|Phase B|Protocol Violation|0|||
28065754|NCT00274716|54721350|FG005|Phase B|Protocol Violation|0|||
28065755|NCT00274716|54721345|FG000|Phase B|Withdrawal by Subject|0|||
28065756|NCT00274716|54721346|FG001|Phase B|Withdrawal by Subject|1|||
28065757|NCT00274716|54721347|FG002|Phase B|Withdrawal by Subject|0|||
28065758|NCT00274716|54721348|FG003|Phase B|Withdrawal by Subject|0|||
28065759|NCT00274716|54721349|FG004|Phase B|Withdrawal by Subject|0|||
28117652|NCT04040192|54776192|FG002|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
28065760|NCT00274716|54721350|FG005|Phase B|Withdrawal by Subject|0|||
28117653|NCT04040192|54776190|FG000|Double Blind Period (up to 52 Weeks)|Adverse Event|0|||
28117654|NCT04040192|54776191|FG001|Double Blind Period (up to 52 Weeks)|Adverse Event|3|||
28117655|NCT04040192|54776192|FG002|Double Blind Period (up to 52 Weeks)|Adverse Event|1|||
28117656|NCT04040192|54776190|FG000|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|0|||
28117657|NCT04040192|54776191|FG001|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|6|||
28117658|NCT04040192|54776192|FG002|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|10|||
28117659|NCT04040192|54776190|FG000|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
28117660|NCT04040192|54776191|FG001|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
28117661|NCT04040192|54776192|FG002|Double Blind Period (up to 52 Weeks)|Physician Decision|2|||
28117662|NCT04040192|54776190|FG000|Double Blind Period (up to 52 Weeks)|Protocol Violation|0|||
28117663|NCT04040192|54776191|FG001|Double Blind Period (up to 52 Weeks)|Protocol Violation|1|||
28117664|NCT04040192|54776192|FG002|Double Blind Period (up to 52 Weeks)|Protocol Violation|3|||
28117665|NCT04040192|54776190|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|0|||
28117666|NCT04040192|54776191|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|6|||
28117667|NCT04040192|54776192|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|11|||
28117668|NCT04040192|54776190|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|0|||
28117669|NCT04040192|54776191|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|8|||
28117670|NCT04040192|54776192|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|7|||
28117671|NCT04040192|54776190|FG000|Double Blind Period (up to 52 Weeks)|Other|0|||
28117672|NCT04040192|54776191|FG001|Double Blind Period (up to 52 Weeks)|Other|29|||
28117673|NCT04040192|54776192|FG002|Double Blind Period (up to 52 Weeks)|Other|18|||
28117674|NCT04040192|54776190|FG000|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
28117675|NCT04040192|54776191|FG001|Double Blind Period (up to 52 Weeks)|Pregnancy|2|||
28117676|NCT04040192|54776192|FG002|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
28117677|NCT04040192|54776190|FG000|Double Blind Period (up to 52 Weeks)|Missing|0|||
28117678|NCT04040192|54776191|FG001|Double Blind Period (up to 52 Weeks)|Missing|2|||
28117679|NCT04040192|54776192|FG002|Double Blind Period (up to 52 Weeks)|Missing|5|||
28117680|NCT03368859|54776216|FG000|Overall Study|Withdrew Consent|5|||
28117681|NCT03368859|54776217|FG001|Overall Study|Withdrew Consent|4|||
28117682|NCT03368859|54776216|FG000|Overall Study|Death|12|||
28117683|NCT03368859|54776217|FG001|Overall Study|Death|6|||
28117684|NCT03368859|54776216|FG000|Overall Study|Study terminated by Sponsor|18|||
28117685|NCT03368859|54776217|FG001|Overall Study|Study terminated by Sponsor|23|||
28117686|NCT03368859|54776216|FG000|Overall Study|Other|1|||
28117687|NCT03368859|54776217|FG001|Overall Study|Other|1|||
28117688|NCT03096314|54776231|FG000|Screened Vitamin D Deficient|Lost to Follow-up|9|||
28117689|NCT03096314|54776232|FG001|Screened Vitamin D Deficient|Lost to Follow-up|12|||
28117690|NCT03335163|54776238|FG000|Overall Study|Not eligible due to laboratory criteria|3|||
28117691|NCT03335163|54776238|FG000|Overall Study|Withdrawal by Subject|18|||
28117692|NCT03364335|54776264|FG000|Overall Study|Adverse Event|3|||
28117693|NCT03364335|54776265|FG001|Overall Study|Adverse Event|4|||
28117694|NCT03364335|54776266|FG002|Overall Study|Adverse Event|1|||
28117695|NCT03364335|54776267|FG003|Overall Study|Adverse Event|2|||
28117696|NCT03364335|54776268|FG004|Overall Study|Adverse Event|0|||
28117697|NCT03364335|54776264|FG000|Overall Study|Lost to Follow-up|7|||
28117698|NCT03364335|54776265|FG001|Overall Study|Lost to Follow-up|7|||
28117699|NCT03364335|54776266|FG002|Overall Study|Lost to Follow-up|10|||
28117700|NCT03364335|54776267|FG003|Overall Study|Lost to Follow-up|11|||
28117701|NCT03364335|54776268|FG004|Overall Study|Lost to Follow-up|11|||
28117702|NCT03334695|54776291|FG000|Overall Study|Lost to Follow-up|3|||
28117703|NCT03334695|54776292|FG001|Overall Study|Lost to Follow-up|3|||
28117704|NCT03334695|54776291|FG000|Overall Study|Physician Decision|1|||
28117705|NCT03334695|54776292|FG001|Overall Study|Physician Decision|2|||
28117706|NCT03334695|54776291|FG000|Overall Study|Protocol Violation|0|||
28117707|NCT03334695|54776292|FG001|Overall Study|Protocol Violation|1|||
28117708|NCT03364023|54776300|FG000|Overall Study|Lost to Follow-up|3|||
28117709|NCT03364023|54776300|FG000|Overall Study|Death|14|||
28117710|NCT03764813|54776324|FG000|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
28117711|NCT03764813|54776325|FG001|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
28117712|NCT03764813|54776326|FG002|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
28117713|NCT03764813|54776327|FG003|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
28117714|NCT03363321|54776348|FG000|Overall Study|Withdrawal by Subject|0|||
28117715|NCT03363321|54776349|FG001|Overall Study|Withdrawal by Subject|1|||
28117716|NCT03363321|54776350|FG002|Overall Study|Withdrawal by Subject|0|||
28117717|NCT03363321|54776351|FG003|Overall Study|Withdrawal by Subject|1|||
28117718|NCT03363321|54776352|FG004|Overall Study|Withdrawal by Subject|0|||
28117719|NCT03361605|54776365|FG000|Overall Study|Analyzable data not available|3|||
28117720|NCT03829046|54776371|FG000|Overall Study|Withdrawal by Subject|1|||
28117721|NCT03829046|54776372|FG001|Overall Study|Withdrawal by Subject|0|||
28117722|NCT03361293|54776380|FG000|Overall Study|Lost to Follow-up|0|||
28117723|NCT03361293|54776381|FG001|Overall Study|Lost to Follow-up|2|||
28117724|NCT03361293|54776380|FG000|Overall Study|Withdrawal by Subject|1|||
28117725|NCT03361293|54776381|FG001|Overall Study|Withdrawal by Subject|3|||
28117726|NCT03361137|54776392|FG000|Overall Study|Reason not specified|1|||
28117727|NCT03361137|54776393|FG001|Overall Study|Reason not specified|0|||
28117728|NCT03361137|54776394|FG002|Overall Study|Reason not specified|0|||
28117729|NCT03361137|54776395|FG003|Overall Study|Reason not specified|0|||
28117730|NCT03361137|54776396|FG004|Overall Study|Reason not specified|0|||
28117731|NCT03360747|54776410|FG000|Overall Study|Voluntary Withdrawal|1|||
28117732|NCT03359811|54776416|FG000|Overall Study|Protocol Violation|2|||
28117733|NCT03359811|54776417|FG001|Overall Study|Protocol Violation|0|||
28065761|NCT00274716|54721345|FG000|Phase B|Participant moved|1|||
28065762|NCT00274716|54721346|FG001|Phase B|Participant moved|0|||
28065763|NCT00274716|54721347|FG002|Phase B|Participant moved|0|||
28065764|NCT00274716|54721348|FG003|Phase B|Participant moved|0|||
28065765|NCT00274716|54721349|FG004|Phase B|Participant moved|0|||
28065766|NCT00274716|54721350|FG005|Phase B|Participant moved|0|||
28065767|NCT00274716|54721345|FG000|Phase B|Other non-reported reason|0|||
28065768|NCT00274716|54721346|FG001|Phase B|Other non-reported reason|0|||
28065769|NCT00274716|54721347|FG002|Phase B|Other non-reported reason|1|||
28117734|NCT03728426|54776424|FG000|Overall Study|Death|3|||
28117735|NCT02095678|54776430|FG000|Overall Study|Withdrawal by Subject|0|||
28117736|NCT02095678|54776431|FG001|Overall Study|Withdrawal by Subject|1|||
28117737|NCT02095678|54776430|FG000|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11|||
28117738|NCT02095678|54776431|FG001|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12|||
28117739|NCT02095678|54776430|FG000|Overall Study|lesion impacted by previous treatment|1|||
28117740|NCT02095678|54776431|FG001|Overall Study|lesion impacted by previous treatment|1|||
28117741|NCT02095678|54776430|FG000|Overall Study|No Confirmed Diagnosis|0|||
28065770|NCT00274716|54721348|FG003|Phase B|Other non-reported reason|1|||
28065771|NCT00274716|54721349|FG004|Phase B|Other non-reported reason|0|||
28117742|NCT02095678|54776431|FG001|Overall Study|No Confirmed Diagnosis|3|||
28117743|NCT02095678|54776430|FG000|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
28117744|NCT02095678|54776431|FG001|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
28117745|NCT02095678|54776430|FG000|Overall Study|No Visible Lesion or Pathological Finding|4|||
28117746|NCT02095678|54776431|FG001|Overall Study|No Visible Lesion or Pathological Finding|0|||
28117747|NCT03763877|54776444|FG000|Overall Study|Withdrawal by Subject|3|||
28117748|NCT03763877|54776445|FG001|Overall Study|Withdrawal by Subject|1|||
28117749|NCT03763877|54776446|FG002|Overall Study|Withdrawal by Subject|3|||
28117750|NCT03763877|54776447|FG003|Overall Study|Withdrawal by Subject|4|||
28117751|NCT03763877|54776444|FG000|Overall Study|Adverse Event|1|||
28117752|NCT03763877|54776445|FG001|Overall Study|Adverse Event|1|||
28117753|NCT03763877|54776446|FG002|Overall Study|Adverse Event|3|||
28117754|NCT03763877|54776447|FG003|Overall Study|Adverse Event|1|||
28117755|NCT03763877|54776444|FG000|Overall Study|Protocol Violation|1|||
28117756|NCT03763877|54776445|FG001|Overall Study|Protocol Violation|1|||
28117757|NCT03763877|54776446|FG002|Overall Study|Protocol Violation|0|||
28117758|NCT03763877|54776447|FG003|Overall Study|Protocol Violation|0|||
28117759|NCT03763877|54776444|FG000|Overall Study|Lost to Follow-up|0|||
28065772|NCT00274716|54721350|FG005|Phase B|Other non-reported reason|0|||
28117760|NCT03763877|54776445|FG001|Overall Study|Lost to Follow-up|1|||
28117761|NCT03763877|54776446|FG002|Overall Study|Lost to Follow-up|1|||
28117762|NCT03763877|54776447|FG003|Overall Study|Lost to Follow-up|0|||
28117763|NCT03358407|54776480|FG000|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
28117764|NCT03358407|54776481|FG001|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
28117765|NCT03358407|54776482|FG002|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1|||
27816849|NCT01536405|54273819|FG001|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18|||
27816850|NCT01536405|54273818|FG000|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20|||
27816851|NCT01536405|54273819|FG001|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22|||
27816852|NCT01536405|54273818|FG000|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17|||
27816853|NCT01536405|54273819|FG001|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13|||
27816854|NCT01536405|54273818|FG000|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
27816855|NCT01536405|54273819|FG001|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
27816856|NCT01536405|54273818|FG000|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9|||
27816857|NCT01536405|54273819|FG001|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10|||
27816858|NCT01536405|54273818|FG000|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
27816859|NCT01536405|54273819|FG001|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
27816860|NCT01536405|54273818|FG000|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3|||
27816861|NCT01536405|54273819|FG001|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2|||
27816862|NCT01536405|54273818|FG000|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1|||
27816863|NCT01536405|54273819|FG001|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0|||
27816864|NCT01536405|54273818|FG000|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16|||
27816865|NCT01536405|54273819|FG001|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14|||
27816866|NCT01536405|54273818|FG000|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0|||
27816867|NCT01536405|54273819|FG001|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2|||
27816868|NCT01536405|54273818|FG000|Visit 4 to Extended Study Follow-up|Adverse Event|0|||
27816869|NCT01536405|54273819|FG001|Visit 4 to Extended Study Follow-up|Adverse Event|1|||
27816870|NCT01536405|54273818|FG000|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
27816871|NCT01536405|54273819|FG001|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
27816872|NCT01487265|54273825|FG000|Overall Study|Adverse Event|8|||
27816873|NCT01487265|54273825|FG000|Overall Study|Withdrawal by Subject|5|||
27816874|NCT01487265|54273825|FG000|Overall Study|Disease Progression|21|||
27816875|NCT01487265|54273825|FG000|Overall Study|Death|2|||
27816876|NCT01487265|54273825|FG000|Overall Study|Still on Treatment|1|||
27816877|NCT01485627|54273831|FG000|Overall Study|Patient withdrew|6|||
27848794|NCT01360632|54343097|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
28117766|NCT03358407|54776483|FG003|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
28117767|NCT03358407|54776484|FG004|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
28117768|NCT03358407|54776485|FG005|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
28117769|NCT03358407|54776486|FG006|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
28117770|NCT03358407|54776487|FG007|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
28117771|NCT03358407|54776488|FG008|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
28117772|NCT03358407|54776489|FG009|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
27940367|NCT01185366|54596648|FG001|Crossover to Second Line Therapy|Adverse Event|6|||
28117773|NCT03358407|54776480|FG000|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
28117774|NCT03358407|54776481|FG001|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
27816878|NCT01485627|54273832|FG001|Overall Study|Patient withdrew|5|||
27816879|NCT01485627|54273831|FG000|Overall Study|Patient died|3|||
27816880|NCT01485627|54273832|FG001|Overall Study|Patient died|1|||
27816881|NCT01485627|54273831|FG000|Overall Study|Patient lost to followup|0|||
27816882|NCT01485627|54273832|FG001|Overall Study|Patient lost to followup|1|||
27816883|NCT01485627|54273831|FG000|Overall Study|Caregiver withdrew|3|||
27816884|NCT01485627|54273832|FG001|Overall Study|Caregiver withdrew|3|||
27816885|NCT01485627|54273831|FG000|Overall Study|Caregiver lost to follow up|11|||
27816886|NCT01485627|54273832|FG001|Overall Study|Caregiver lost to follow up|12|||
27816887|NCT01485627|54273831|FG000|Overall Study|Caregiver died|1|||
27816888|NCT01485627|54273832|FG001|Overall Study|Caregiver died|0|||
27816889|NCT01485627|54273831|FG000|Overall Study|caregiver was not bereaved|42|||
27816890|NCT01485627|54273832|FG001|Overall Study|caregiver was not bereaved|35|||
27816891|NCT01508325|54273855|FG000|Overall Study|Withdrawal by Subject|8|||
27816892|NCT01508325|54273856|FG001|Overall Study|Withdrawal by Subject|9|||
27816893|NCT01508325|54273855|FG000|Overall Study|Protocol Violation|0|||
28065773|NCT00274716|54721345|FG000|Phase B|Lost to Follow-up|0|||
28065774|NCT00274716|54721346|FG001|Phase B|Lost to Follow-up|1|||
28065775|NCT00274716|54721347|FG002|Phase B|Lost to Follow-up|0|||
27816894|NCT01508325|54273856|FG001|Overall Study|Protocol Violation|3|||
27816895|NCT01508325|54273855|FG000|Overall Study|Physician Decision|2|||
27816896|NCT01508325|54273856|FG001|Overall Study|Physician Decision|1|||
27816897|NCT01508325|54273855|FG000|Overall Study|Adverse Event|1|||
27816898|NCT01508325|54273856|FG001|Overall Study|Adverse Event|0|||
27816899|NCT01508325|54273855|FG000|Overall Study|Lost to Follow-up|5|||
27816900|NCT01508325|54273856|FG001|Overall Study|Lost to Follow-up|6|||
27816901|NCT01508325|54273855|FG000|Overall Study|Other|2|||
27816902|NCT01508325|54273856|FG001|Overall Study|Other|2|||
27816903|NCT01508169|54273864|FG000|Overall Study|Adverse Event|1|||
27816904|NCT01508169|54273865|FG001|Overall Study|Adverse Event|0|||
27816905|NCT01508169|54273864|FG000|Overall Study|Withdrawal by Subject|1|||
27816906|NCT01508169|54273865|FG001|Overall Study|Withdrawal by Subject|0|||
27816907|NCT01508169|54273864|FG000|Overall Study|Lost to Follow-up|1|||
27816908|NCT01508169|54273865|FG001|Overall Study|Lost to Follow-up|2|||
27816909|NCT01536171|54273877|FG000|Overall Study|Withdrawal by Subject|1|||
27816910|NCT01536093|54273884|FG000|Overall Study|Death|1|||
27816911|NCT01536093|54273885|FG001|Overall Study|Death|2|||
27816912|NCT01536093|54273884|FG000|Overall Study|absence of maternal colostrum|2|||
27816913|NCT01536093|54273885|FG001|Overall Study|absence of maternal colostrum|0|||
27816914|NCT01536093|54273884|FG000|Overall Study|Withdrawal by Subject|0|||
27816915|NCT01536093|54273885|FG001|Overall Study|Withdrawal by Subject|1|||
27816916|NCT01536015|54273893|FG000|Overall Study|Adverse Event|1|||
27816917|NCT01536015|54273894|FG001|Overall Study|Adverse Event|4|||
28065776|NCT00274716|54721348|FG003|Phase B|Lost to Follow-up|0|||
28065777|NCT00274716|54721349|FG004|Phase B|Lost to Follow-up|0|||
27816918|NCT01536015|54273893|FG000|Overall Study|Lost to Follow-up|0|||
27816919|NCT01536015|54273894|FG001|Overall Study|Lost to Follow-up|1|||
27816920|NCT01536015|54273893|FG000|Overall Study|Inclusion Criterion not met|2|||
28065778|NCT00274716|54721350|FG005|Phase B|Lost to Follow-up|0|||
27816921|NCT01536015|54273894|FG001|Overall Study|Inclusion Criterion not met|0|||
28117775|NCT03358407|54776482|FG002|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
27816922|NCT01536015|54273893|FG000|Overall Study|Study closure|5|||
27816923|NCT01536015|54273894|FG001|Overall Study|Study closure|5|||
27816924|NCT01484691|54273903|FG000|Overall Study|Withdrawal by Subject|1|||
27816925|NCT01484691|54273904|FG001|Overall Study|Withdrawal by Subject|1|||
27816926|NCT01484691|54273905|FG002|Overall Study|Withdrawal by Subject|1|||
27816927|NCT01484691|54273903|FG000|Overall Study|Physician Decision|0|||
27816928|NCT01484691|54273904|FG001|Overall Study|Physician Decision|2|||
27816929|NCT01484691|54273905|FG002|Overall Study|Physician Decision|1|||
27816930|NCT01535235|54273916|FG000|Overall Study|Adverse Event|1|||
27816931|NCT01535235|54273917|FG001|Overall Study|Adverse Event|0|||
28117776|NCT03358407|54776483|FG003|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
28117777|NCT03358407|54776484|FG004|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1|||
28117778|NCT03358407|54776485|FG005|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
28117779|NCT03358407|54776486|FG006|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
28117780|NCT03358407|54776487|FG007|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
28117781|NCT03358407|54776488|FG008|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
27816932|NCT01483599|54273961|FG000|Controlled Period (CP) (up to Week 16)|Adverse Event|2|||
27816933|NCT01483599|54273962|FG001|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
27816934|NCT01483599|54273963|FG002|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
27816935|NCT01483599|54273964|FG003|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
27816936|NCT01483599|54273965|FG004|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
27816937|NCT01483599|54273966|FG005|Controlled Period (CP) (up to Week 16)|Adverse Event|4|||
27816938|NCT01483599|54273967|FG006|Controlled Period (CP) (up to Week 16)|Adverse Event|3|||
27816939|NCT01483599|54273968|FG007|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
27816940|NCT01483599|54273969|FG008|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
27816941|NCT01483599|54273970|FG009|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
27816942|NCT01483599|54273971|FG010|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
27816943|NCT01483599|54273972|FG011|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
27816944|NCT01483599|54273973|FG012|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
28117782|NCT03358407|54776489|FG009|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
28117783|NCT03358407|54776480|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
28117784|NCT03358407|54776481|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
28117785|NCT03358407|54776482|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
28117786|NCT03358407|54776483|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
28117787|NCT03358407|54776484|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
28117788|NCT03358407|54776485|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1|||
28117789|NCT03358407|54776486|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
28117790|NCT03358407|54776487|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2|||
28117791|NCT03358407|54776488|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
28117792|NCT03358407|54776489|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
28117793|NCT03358407|54776480|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
28117794|NCT03358407|54776481|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
28117795|NCT03358407|54776482|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
28117796|NCT03358407|54776483|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
28117797|NCT03358407|54776484|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
28117798|NCT03358407|54776485|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
28117799|NCT03358407|54776486|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
28117800|NCT03358407|54776487|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
28117801|NCT03358407|54776488|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
28117802|NCT03358407|54776489|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
28117803|NCT03358407|54776480|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
28117804|NCT03358407|54776481|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
28117805|NCT03358407|54776482|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
28117806|NCT03358407|54776483|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
28117807|NCT03358407|54776484|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
28117808|NCT03358407|54776485|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
28117809|NCT03358407|54776486|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
28117810|NCT03358407|54776487|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
28117811|NCT03358407|54776488|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
28117812|NCT03358407|54776489|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
28117813|NCT03358407|54776480|FG000|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
28117814|NCT03358407|54776481|FG001|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
28117815|NCT03358407|54776482|FG002|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
28117816|NCT03358407|54776483|FG003|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
28117817|NCT03358407|54776484|FG004|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
28117818|NCT03358407|54776485|FG005|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
28117819|NCT03358407|54776486|FG006|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
28117820|NCT03358407|54776487|FG007|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6|||
28117821|NCT03358407|54776488|FG008|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
28117822|NCT03358407|54776489|FG009|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
28117823|NCT02950545|54776531|FG000|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
28117824|NCT02950545|54776532|FG001|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
28117825|NCT02950545|54776533|FG002|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
28117826|NCT02950545|54776534|FG003|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
28117827|NCT02950545|54776535|FG004|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
28117828|NCT02950545|54776536|FG005|Session 1 (70 Minutes)|Withdrawal by Subject|1|||
28117829|NCT02950545|54776531|FG000|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
28117830|NCT02950545|54776532|FG001|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
28117831|NCT02950545|54776533|FG002|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
28117832|NCT02950545|54776534|FG003|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
28117833|NCT02950545|54776535|FG004|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
28117834|NCT02950545|54776536|FG005|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
28117835|NCT02950545|54776531|FG000|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
28117836|NCT02950545|54776532|FG001|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
28117837|NCT02950545|54776533|FG002|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
28117838|NCT02950545|54776534|FG003|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
28117839|NCT02950545|54776535|FG004|Session 2 (70 Minutes)|Withdrawal by Subject|1|||
28117840|NCT02950545|54776536|FG005|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
28117841|NCT02950545|54776531|FG000|Washout 2 (5 Minutes)|Withdrawal by Subject|1|||
28117842|NCT02950545|54776532|FG001|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
28117843|NCT02950545|54776533|FG002|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
28117844|NCT02950545|54776534|FG003|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
28117845|NCT02950545|54776535|FG004|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
28117846|NCT02950545|54776536|FG005|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
28117847|NCT02950545|54776531|FG000|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
28117848|NCT02950545|54776532|FG001|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
28117849|NCT02950545|54776533|FG002|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
28117850|NCT02950545|54776534|FG003|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
28117851|NCT02950545|54776535|FG004|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
28117852|NCT02950545|54776536|FG005|Session 3 (70 Minutes)|Withdrawal by Subject|1|||
28117853|NCT03358329|54776542|FG000|Overall Study|Lost to Follow-up|2|||
28117854|NCT03358329|54776542|FG000|Overall Study|Withdrawal by Subject|2|||
28117855|NCT03357471|54776558|FG000|Overall Study|Adverse Event|1|||
28117856|NCT03357471|54776559|FG001|Overall Study|Adverse Event|0|||
28117857|NCT03357471|54776558|FG000|Overall Study|Lost to Follow-up|1|||
28117858|NCT03357471|54776559|FG001|Overall Study|Lost to Follow-up|0|||
28117859|NCT03356145|54776567|FG000|Overall Study|Withdrawal by Subject|2|||
28117860|NCT03356145|54776568|FG001|Overall Study|Withdrawal by Subject|1|||
28117861|NCT03356145|54776567|FG000|Overall Study|Did not meet inclusion criteria|1|||
28117862|NCT03356145|54776568|FG001|Overall Study|Did not meet inclusion criteria|0|||
28117863|NCT03342963|54776578|FG000|Overall Study|Adverse Event|1|||
28117864|NCT03342963|54776579|FG001|Overall Study|Adverse Event|2|||
28117865|NCT03342963|54776580|FG002|Overall Study|Adverse Event|0|||
28117866|NCT03342963|54776581|FG003|Overall Study|Adverse Event|0|||
28117867|NCT03342963|54776578|FG000|Overall Study|Withdrawal by Subject|1|||
28117868|NCT03342963|54776579|FG001|Overall Study|Withdrawal by Subject|0|||
28117869|NCT03342963|54776580|FG002|Overall Study|Withdrawal by Subject|0|||
28117870|NCT03342963|54776581|FG003|Overall Study|Withdrawal by Subject|0|||
28117871|NCT03361956|54776596|FG000|Overall Study|Adverse Event|1|||
28117872|NCT03361956|54776597|FG001|Overall Study|Adverse Event|0|||
28117873|NCT03361956|54776598|FG002|Overall Study|Adverse Event|1|||
28117874|NCT03361956|54776599|FG003|Overall Study|Adverse Event|1|||
28117875|NCT03361956|54776600|FG004|Overall Study|Adverse Event|0|||
28117876|NCT03361956|54776596|FG000|Overall Study|Other|0|||
28117877|NCT03361956|54776597|FG001|Overall Study|Other|0|||
28117878|NCT03361956|54776598|FG002|Overall Study|Other|0|||
28117879|NCT03361956|54776599|FG003|Overall Study|Other|1|||
28117880|NCT03361956|54776600|FG004|Overall Study|Other|0|||
28117881|NCT03361956|54776596|FG000|Overall Study|Withdrawal by Subject|2|||
28117882|NCT03361956|54776597|FG001|Overall Study|Withdrawal by Subject|2|||
27816945|NCT01483599|54273974|FG013|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
27816946|NCT01483599|54273961|FG000|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
28117883|NCT03361956|54776598|FG002|Overall Study|Withdrawal by Subject|2|||
28117884|NCT03361956|54776599|FG003|Overall Study|Withdrawal by Subject|0|||
28117885|NCT03361956|54776600|FG004|Overall Study|Withdrawal by Subject|3|||
28117886|NCT03361956|54776596|FG000|Overall Study|Disease Relapse|0|||
28117887|NCT03361956|54776597|FG001|Overall Study|Disease Relapse|0|||
28117888|NCT03361956|54776598|FG002|Overall Study|Disease Relapse|1|||
28117889|NCT03361956|54776599|FG003|Overall Study|Disease Relapse|0|||
28117890|NCT03361956|54776600|FG004|Overall Study|Disease Relapse|0|||
28117891|NCT03361956|54776596|FG000|Overall Study|Physician Decision|0|||
28117892|NCT03361956|54776597|FG001|Overall Study|Physician Decision|2|||
28117893|NCT03361956|54776598|FG002|Overall Study|Physician Decision|0|||
28117894|NCT03361956|54776599|FG003|Overall Study|Physician Decision|1|||
28117895|NCT03361956|54776600|FG004|Overall Study|Physician Decision|0|||
28117896|NCT03361956|54776596|FG000|Overall Study|Lost to Follow-up|0|||
28117897|NCT03361956|54776597|FG001|Overall Study|Lost to Follow-up|0|||
28117898|NCT03361956|54776598|FG002|Overall Study|Lost to Follow-up|1|||
28117899|NCT03361956|54776599|FG003|Overall Study|Lost to Follow-up|1|||
28117900|NCT03361956|54776600|FG004|Overall Study|Lost to Follow-up|2|||
28117901|NCT03361176|54776671|FG000|Overall Study|Lost to Follow-up|1|||
28117902|NCT03361176|54776672|FG001|Overall Study|Lost to Follow-up|2|||
28117903|NCT03361176|54776671|FG000|Overall Study|Adverse Event|0|||
28117904|NCT03361176|54776672|FG001|Overall Study|Adverse Event|2|||
28117905|NCT03361176|54776671|FG000|Overall Study|Withdrawal by Subject|0|||
28117906|NCT03361176|54776672|FG001|Overall Study|Withdrawal by Subject|1|||
28117907|NCT05283499|54776680|FG000|Overall Study|Did not receive intervention|1|||
28117908|NCT05283499|54776681|FG001|Overall Study|Did not receive intervention|2|||
28117909|NCT05271175|54776690|FG000|One Week Follow up|Lost to Follow-up|10|||
28117910|NCT05271175|54776691|FG001|One Week Follow up|Lost to Follow-up|7|||
28117911|NCT05271175|54776692|FG002|One Week Follow up|Lost to Follow-up|5|||
27816947|NCT01483599|54273962|FG001|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
27816948|NCT01483599|54273963|FG002|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
27816949|NCT01483599|54273964|FG003|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
27816950|NCT01483599|54273965|FG004|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
27816951|NCT01483599|54273966|FG005|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
27816952|NCT01483599|54273967|FG006|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
27816953|NCT01483599|54273968|FG007|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
27816954|NCT01483599|54273969|FG008|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
27816955|NCT01483599|54273970|FG009|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
27816956|NCT01483599|54273971|FG010|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
27816957|NCT01483599|54273972|FG011|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
27816958|NCT01483599|54273973|FG012|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
27816959|NCT01483599|54273974|FG013|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
27816960|NCT01483599|54273961|FG000|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1|||
27816961|NCT01483599|54273962|FG001|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
27816962|NCT01483599|54273963|FG002|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
27816963|NCT01483599|54273964|FG003|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
27816964|NCT01483599|54273965|FG004|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
27816965|NCT01483599|54273966|FG005|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
27816966|NCT01483599|54273967|FG006|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
28117912|NCT05271175|54776690|FG000|One Month Follow up|Lost to Follow-up|12|||
27816967|NCT01483599|54273968|FG007|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
27816968|NCT01483599|54273969|FG008|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
27816969|NCT01483599|54273970|FG009|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
28065779|NCT00282048|54721368|FG000|Overall Study|Lack of Efficacy|30|||
28065780|NCT00282048|54721368|FG000|Overall Study|Adverse Event|22|||
28065781|NCT00282048|54721368|FG000|Overall Study|Withdrawal by Subject|1|||
28065782|NCT00282048|54721368|FG000|Overall Study|Other|8|||
28065783|NCT00282048|54721368|FG000|Overall Study|Ongoing|1|||
28065784|NCT00474539|54721374|FG000|Infant Series|Withdrawal by Subject|3|||
28065785|NCT00474539|54721375|FG001|Infant Series|Withdrawal by Subject|4|||
28065786|NCT00474539|54721374|FG000|Infant Series|Randomization error|5|||
28065787|NCT00474539|54721375|FG001|Infant Series|Randomization error|0|||
28065788|NCT00474539|54721374|FG000|Infant Series|Lost to Follow-up|2|||
28065789|NCT00474539|54721375|FG001|Infant Series|Lost to Follow-up|1|||
28065790|NCT00474539|54721374|FG000|Infant Series|Protocol Violation|0|||
28065791|NCT00474539|54721375|FG001|Infant Series|Protocol Violation|1|||
28065792|NCT00474539|54721374|FG000|After Infant Series|Lost to Follow-up|3|||
28065793|NCT00474539|54721375|FG001|After Infant Series|Lost to Follow-up|0|||
28065794|NCT00474539|54721374|FG000|After Infant Series|Withdrawal by Subject|1|||
28065795|NCT00474539|54721375|FG001|After Infant Series|Withdrawal by Subject|0|||
28065796|NCT00474539|54721374|FG000|Toddler Dose|Protocol Violation|1|||
28065797|NCT00474539|54721375|FG001|Toddler Dose|Protocol Violation|0|||
28117913|NCT05271175|54776691|FG001|One Month Follow up|Lost to Follow-up|7|||
28117914|NCT05271175|54776692|FG002|One Month Follow up|Lost to Follow-up|9|||
28117915|NCT05271175|54776690|FG000|Six Months Follow up|Lost to Follow-up|8|||
28117916|NCT05271175|54776691|FG001|Six Months Follow up|Lost to Follow-up|2|||
28117917|NCT05271175|54776692|FG002|Six Months Follow up|Lost to Follow-up|2|||
28117918|NCT03098030|54776704|FG000|Overall Study|Death|10|||
27816970|NCT01483599|54273971|FG010|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
27816971|NCT01483599|54273972|FG011|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
28117919|NCT03098030|54776705|FG001|Overall Study|Death|156|||
28117920|NCT03098030|54776706|FG002|Overall Study|Death|156|||
28117921|NCT03098030|54776707|FG003|Overall Study|Death|82|||
28117922|NCT03098030|54776704|FG000|Overall Study|Withdrawal by Subject|0|||
28117923|NCT03098030|54776705|FG001|Overall Study|Withdrawal by Subject|7|||
28117924|NCT03098030|54776706|FG002|Overall Study|Withdrawal by Subject|8|||
28117925|NCT03098030|54776707|FG003|Overall Study|Withdrawal by Subject|2|||
28117926|NCT03098030|54776704|FG000|Overall Study|Lost to Follow-up|0|||
28117927|NCT03098030|54776705|FG001|Overall Study|Lost to Follow-up|0|||
28117928|NCT03098030|54776706|FG002|Overall Study|Lost to Follow-up|2|||
28117929|NCT03098030|54776707|FG003|Overall Study|Lost to Follow-up|1|||
28117930|NCT03341637|54776718|FG000|Overall Study|Lost to Follow-up|1|||
28117931|NCT03341637|54776719|FG001|Overall Study|Lost to Follow-up|0|||
28117932|NCT03341637|54776718|FG000|Overall Study|Withdrawal by Subject|3|||
28117933|NCT03341637|54776719|FG001|Overall Study|Withdrawal by Subject|3|||
27816972|NCT01483599|54273973|FG012|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
27816973|NCT01483599|54273974|FG013|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
28117934|NCT03341637|54776718|FG000|Overall Study|Reason not Specified|1|||
28117935|NCT03341637|54776719|FG001|Overall Study|Reason not Specified|1|||
27816974|NCT01483599|54273961|FG000|Controlled Period (CP) (up to Week 16)|Other|0|||
27816975|NCT01483599|54273962|FG001|Controlled Period (CP) (up to Week 16)|Other|2|||
27816976|NCT01483599|54273963|FG002|Controlled Period (CP) (up to Week 16)|Other|0|||
27816977|NCT01483599|54273964|FG003|Controlled Period (CP) (up to Week 16)|Other|1|||
27816978|NCT01483599|54273965|FG004|Controlled Period (CP) (up to Week 16)|Other|1|||
27816979|NCT01483599|54273966|FG005|Controlled Period (CP) (up to Week 16)|Other|0|||
28117936|NCT01378858|54776727|FG000|Overall Study|Withdrawal by Subject|4|||
28117937|NCT01378858|54776728|FG001|Overall Study|Withdrawal by Subject|4|||
28117938|NCT02891850|54776736|FG000|Overall Study|Adverse Event|3|||
28117939|NCT02891850|54776737|FG001|Overall Study|Adverse Event|0|||
28117940|NCT02891850|54776736|FG000|Overall Study|Death|0|||
28117941|NCT02891850|54776737|FG001|Overall Study|Death|4|||
28117942|NCT02891850|54776736|FG000|Overall Study|Physician Decision|1|||
28117943|NCT02891850|54776737|FG001|Overall Study|Physician Decision|0|||
28117944|NCT02891850|54776736|FG000|Overall Study|Pregnancy|1|||
28117945|NCT02891850|54776737|FG001|Overall Study|Pregnancy|0|||
28117946|NCT02891850|54776736|FG000|Overall Study|Withdrawal by Subject|2|||
28117947|NCT02891850|54776737|FG001|Overall Study|Withdrawal by Subject|3|||
28117948|NCT05594173|54776743|FG000|Overall Study|Adverse Event|1|||
28117949|NCT05594173|54776743|FG000|Overall Study|COVID-19 Pandemic|2|||
28117950|NCT03339999|54776756|FG000|Overall Study|Adverse Event|1|||
28117951|NCT03339999|54776757|FG001|Overall Study|Adverse Event|2|||
28117952|NCT03339999|54776758|FG002|Overall Study|Adverse Event|2|||
28117953|NCT03339999|54776759|FG003|Overall Study|Adverse Event|1|||
28117954|NCT03339999|54776756|FG000|Overall Study|Lack of Efficacy|0|||
28117955|NCT03339999|54776757|FG001|Overall Study|Lack of Efficacy|1|||
28117956|NCT03339999|54776758|FG002|Overall Study|Lack of Efficacy|0|||
28117957|NCT03339999|54776759|FG003|Overall Study|Lack of Efficacy|0|||
28117958|NCT03339999|54776756|FG000|Overall Study|Lost to Follow-up|0|||
28117959|NCT03339999|54776757|FG001|Overall Study|Lost to Follow-up|0|||
28117960|NCT03339999|54776758|FG002|Overall Study|Lost to Follow-up|0|||
28117961|NCT03339999|54776759|FG003|Overall Study|Lost to Follow-up|1|||
27816980|NCT01483599|54273967|FG006|Controlled Period (CP) (up to Week 16)|Other|0|||
27816981|NCT01483599|54273968|FG007|Controlled Period (CP) (up to Week 16)|Other|0|||
28117962|NCT03339999|54776756|FG000|Overall Study|Study Terminated by Sponsor|6|||
28117963|NCT03339999|54776757|FG001|Overall Study|Study Terminated by Sponsor|3|||
28117964|NCT03339999|54776758|FG002|Overall Study|Study Terminated by Sponsor|4|||
28117965|NCT03339999|54776759|FG003|Overall Study|Study Terminated by Sponsor|3|||
27816982|NCT01483599|54273969|FG008|Controlled Period (CP) (up to Week 16)|Other|0|||
27816983|NCT01483599|54273970|FG009|Controlled Period (CP) (up to Week 16)|Other|0|||
28117966|NCT03339453|54776772|FG000|First Visit of Glucagon Treatment|Adverse Event|0|||
28117967|NCT03339453|54776773|FG001|First Visit of Glucagon Treatment|Adverse Event|1|||
28117968|NCT03359850|54776817|FG000|PK Phase (Up to Day 8)|Physician Decision|0|||
28117969|NCT03359850|54776818|FG001|PK Phase (Up to Day 8)|Physician Decision|1|||
27940368|NCT01185366|54596647|FG000|Crossover to Second Line Therapy|Physician Decision|5|||
27816984|NCT01483599|54273971|FG010|Controlled Period (CP) (up to Week 16)|Other|0|||
28065798|NCT00281580|54721422|FG000|Overall Study|Adverse Event|2|||
28065799|NCT00281580|54721423|FG001|Overall Study|Adverse Event|0|||
28065800|NCT00281580|54721424|FG002|Overall Study|Adverse Event|2|||
28065801|NCT00281580|54721425|FG003|Overall Study|Adverse Event|4|||
28065802|NCT00281580|54721426|FG004|Overall Study|Adverse Event|1|||
28065803|NCT00281580|54721427|FG005|Overall Study|Adverse Event|0|||
28065804|NCT00281580|54721428|FG006|Overall Study|Adverse Event|1|||
28065805|NCT00281580|54721429|FG007|Overall Study|Adverse Event|0|||
28065806|NCT00281580|54721430|FG008|Overall Study|Adverse Event|1|||
28065807|NCT00281580|54721431|FG009|Overall Study|Adverse Event|6|||
28117970|NCT03359850|54776817|FG000|PK Phase (Up to Day 8)|Adverse Event|1|||
28117971|NCT03359850|54776818|FG001|PK Phase (Up to Day 8)|Adverse Event|0|||
28117972|NCT03359850|54776817|FG000|Extension Phase (Up to 28 Months)|Death|2|||
28117973|NCT03359850|54776818|FG001|Extension Phase (Up to 28 Months)|Death|4|||
28117974|NCT03359850|54776817|FG000|Extension Phase (Up to 28 Months)|Withdrawal by Subject|1|||
28117975|NCT03359850|54776818|FG001|Extension Phase (Up to 28 Months)|Withdrawal by Subject|2|||
28117976|NCT03359850|54776817|FG000|Extension Phase (Up to 28 Months)|Disease Progression|5|||
28117977|NCT03359850|54776818|FG001|Extension Phase (Up to 28 Months)|Disease Progression|0|||
28117978|NCT00114140|54776837|FG000|Overall Study|Protocol Violation|7|||
28117979|NCT03712345|54776851|FG000|Overall Study|Failure to meet randomization criteria|0|||
28117980|NCT03712345|54776852|FG001|Overall Study|Failure to meet randomization criteria|0|||
28117981|NCT03712345|54776853|FG002|Overall Study|Failure to meet randomization criteria|1|||
28117982|NCT03358290|54776866|FG000|Overall Study|Study discontinued by Sponsor|0|||
28117983|NCT03358290|54776867|FG001|Overall Study|Study discontinued by Sponsor|1|||
28117984|NCT03358290|54776868|FG002|Overall Study|Study discontinued by Sponsor|1|||
28117985|NCT03358290|54776869|FG003|Overall Study|Study discontinued by Sponsor|0|||
28117986|NCT03358290|54776870|FG004|Overall Study|Study discontinued by Sponsor|0|||
28117987|NCT03358290|54776866|FG000|Overall Study|Adverse Event|0|||
28117988|NCT03358290|54776867|FG001|Overall Study|Adverse Event|0|||
28117989|NCT03358290|54776868|FG002|Overall Study|Adverse Event|1|||
28117990|NCT03358290|54776869|FG003|Overall Study|Adverse Event|2|||
28117991|NCT03358290|54776870|FG004|Overall Study|Adverse Event|0|||
28117992|NCT03358290|54776866|FG000|Overall Study|Withdrawal by Subject|0|||
28117993|NCT03358290|54776867|FG001|Overall Study|Withdrawal by Subject|0|||
28117994|NCT03358290|54776868|FG002|Overall Study|Withdrawal by Subject|0|||
28117995|NCT03358290|54776869|FG003|Overall Study|Withdrawal by Subject|0|||
28117996|NCT03358290|54776870|FG004|Overall Study|Withdrawal by Subject|1|||
28117997|NCT03089216|54776886|FG000|Overall Study|Adverse Event|0|||
28117998|NCT03089216|54776887|FG001|Overall Study|Adverse Event|0|||
28117999|NCT03089216|54776888|FG002|Overall Study|Adverse Event|0|||
28118000|NCT03089216|54776889|FG003|Overall Study|Adverse Event|1|||
28118001|NCT03339726|54776906|FG000|Overall Study|Withdrawal by Subject|1|||
28118002|NCT03339726|54776907|FG001|Overall Study|Withdrawal by Subject|0|||
28118003|NCT03339726|54776908|FG002|Overall Study|Withdrawal by Subject|0|||
28118004|NCT03339726|54776906|FG000|Overall Study|Lost to Follow-up|0|||
28118005|NCT03339726|54776907|FG001|Overall Study|Lost to Follow-up|1|||
28118006|NCT03339726|54776908|FG002|Overall Study|Lost to Follow-up|0|||
28118007|NCT03339297|54776918|FG000|Overall Study|Relapse of Hematologic Disease|1|||
28118008|NCT03339297|54776919|FG001|Overall Study|Relapse of Hematologic Disease|0|||
28118009|NCT03339297|54776918|FG000|Overall Study|Death|10|||
28118010|NCT03339297|54776919|FG001|Overall Study|Death|7|||
28118011|NCT03339297|54776918|FG000|Overall Study|Hepatic Candidosis|1|||
28118012|NCT03339297|54776919|FG001|Overall Study|Hepatic Candidosis|0|||
28118013|NCT03339297|54776918|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
28118014|NCT03339297|54776919|FG001|Overall Study|Adverse Event, Serious Fatal|2|||
28118015|NCT03339297|54776918|FG000|Overall Study|Consent Withdrawn by Participant|3|||
28118016|NCT03339297|54776919|FG001|Overall Study|Consent Withdrawn by Participant|3|||
28118017|NCT03339297|54776918|FG000|Overall Study|Disease Relapse|2|||
28118018|NCT03339297|54776919|FG001|Overall Study|Disease Relapse|0|||
28118019|NCT03339297|54776918|FG000|Overall Study|Physician Decision|1|||
28118020|NCT03339297|54776919|FG001|Overall Study|Physician Decision|1|||
28118021|NCT03339297|54776918|FG000|Overall Study|Relapse of Disease New Transplant Performed|1|||
28118022|NCT03339297|54776919|FG001|Overall Study|Relapse of Disease New Transplant Performed|0|||
28118023|NCT03339297|54776918|FG000|Overall Study|Problems with Donor and Diagnosis of Early Relapse|1|||
28118024|NCT03339297|54776919|FG001|Overall Study|Problems with Donor and Diagnosis of Early Relapse|0|||
28118025|NCT03339297|54776918|FG000|Overall Study|Early Termination, Did Not Proceed to Transplant|1|||
28118026|NCT03339297|54776919|FG001|Overall Study|Early Termination, Did Not Proceed to Transplant|0|||
28118027|NCT03339297|54776918|FG000|Overall Study|Adverse Event, Non-fatal|1|||
28118028|NCT03339297|54776919|FG001|Overall Study|Adverse Event, Non-fatal|0|||
28118029|NCT03339297|54776918|FG000|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|0|||
28118030|NCT03339297|54776919|FG001|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|1|||
28118031|NCT03339297|54776918|FG000|Overall Study|Patient Was Not Eligible|1|||
28118032|NCT03339297|54776919|FG001|Overall Study|Patient Was Not Eligible|0|||
28118033|NCT03713281|54776945|FG000|Overall Study|Lens handling difficuluties|2|||
28118034|NCT03713281|54776945|FG000|Overall Study|Subject was not dispensed enough lenses|1|||
28118035|NCT03339219|54776949|FG000|Overall Study|Death|12|||
28118036|NCT03339219|54776949|FG000|Overall Study|Site Terminated by Sponsor|22|||
28118037|NCT03339219|54776949|FG000|Overall Study|Withdrawal by Subject|1|||
28118038|NCT03338673|54776955|FG000|Overall Study|Lost to Follow-up|1|||
28118039|NCT03338673|54776956|FG001|Overall Study|Lost to Follow-up|1|||
28118040|NCT02949024|54776964|FG000|Overall Study|Withdrawal by Subject|0|||
28118041|NCT02949024|54776965|FG001|Overall Study|Withdrawal by Subject|1|||
28118042|NCT03093428|54776975|FG000|Overall Study|Not eligible for treatment|2|||
28118043|NCT03093428|54776976|FG001|Overall Study|Not eligible for treatment|1|||
28118044|NCT03093428|54776975|FG000|Overall Study|Progression|14|||
28118045|NCT03093428|54776976|FG001|Overall Study|Progression|4|||
28118046|NCT03093428|54776975|FG000|Overall Study|Death|1|||
28118047|NCT03093428|54776976|FG001|Overall Study|Death|0|||
28118048|NCT03093428|54776975|FG000|Overall Study|Adverse Event|1|||
28118049|NCT03093428|54776976|FG001|Overall Study|Adverse Event|0|||
27816985|NCT01483599|54273972|FG011|Controlled Period (CP) (up to Week 16)|Other|0|||
27816986|NCT01483599|54273973|FG012|Controlled Period (CP) (up to Week 16)|Other|0|||
28118050|NCT03093428|54776975|FG000|Overall Study|Withdrawal by Subject|1|||
28118051|NCT03093428|54776976|FG001|Overall Study|Withdrawal by Subject|1|||
28118052|NCT02735980|54776985|FG000|Overall Study|Adverse Event|0|||
28118053|NCT02735980|54776986|FG001|Overall Study|Adverse Event|4|||
28118054|NCT02735980|54776987|FG002|Overall Study|Adverse Event|1|||
28118055|NCT02735980|54776985|FG000|Overall Study|Death|5|||
28118056|NCT02735980|54776986|FG001|Overall Study|Death|4|||
28118057|NCT02735980|54776987|FG002|Overall Study|Death|0|||
28118058|NCT02735980|54776985|FG000|Overall Study|Physician Decision|3|||
28118059|NCT02735980|54776986|FG001|Overall Study|Physician Decision|1|||
28118060|NCT02735980|54776987|FG002|Overall Study|Physician Decision|0|||
28118061|NCT02735980|54776985|FG000|Overall Study|Screen failure|1|||
28118062|NCT02735980|54776986|FG001|Overall Study|Screen failure|0|||
28118063|NCT02735980|54776987|FG002|Overall Study|Screen failure|0|||
28118064|NCT02735980|54776985|FG000|Overall Study|Withdrawal by Subject|1|||
28118065|NCT02735980|54776986|FG001|Overall Study|Withdrawal by Subject|2|||
28118066|NCT02735980|54776987|FG002|Overall Study|Withdrawal by Subject|0|||
28118067|NCT03338400|54777002|FG000|Overall Study|Lost to Follow-up|1|||
28118068|NCT03338400|54777003|FG001|Overall Study|Lost to Follow-up|2|||
28118069|NCT03337113|54777021|FG000|Overall Study|Adverse Event|1|||
28118070|NCT03337113|54777022|FG001|Overall Study|Adverse Event|1|||
28118071|NCT03337113|54777023|FG002|Overall Study|Adverse Event|0|||
28118072|NCT03337113|54777024|FG003|Overall Study|Adverse Event|1|||
28118073|NCT03337113|54777021|FG000|Overall Study|Physician Decision|0|||
28118074|NCT03337113|54777022|FG001|Overall Study|Physician Decision|2|||
28118075|NCT03337113|54777023|FG002|Overall Study|Physician Decision|0|||
28118076|NCT03337113|54777024|FG003|Overall Study|Physician Decision|1|||
28118077|NCT03337113|54777021|FG000|Overall Study|Withdrawal by Subject|0|||
28118078|NCT03337113|54777022|FG001|Overall Study|Withdrawal by Subject|0|||
28118079|NCT03337113|54777023|FG002|Overall Study|Withdrawal by Subject|1|||
28118080|NCT03337113|54777024|FG003|Overall Study|Withdrawal by Subject|0|||
28118081|NCT03092726|54777036|FG000|Overall Study|Adverse Event|3|||
28118082|NCT03092726|54777037|FG001|Overall Study|Adverse Event|10|||
28118083|NCT03092726|54777036|FG000|Overall Study|Lack of Efficacy|0|||
28118084|NCT03092726|54777037|FG001|Overall Study|Lack of Efficacy|1|||
28118085|NCT03092726|54777036|FG000|Overall Study|Lost to Follow-up|1|||
28118086|NCT03092726|54777037|FG001|Overall Study|Lost to Follow-up|0|||
28118087|NCT03092726|54777036|FG000|Overall Study|Withdrawal by Subject|5|||
28118088|NCT03092726|54777037|FG001|Overall Study|Withdrawal by Subject|3|||
28118089|NCT03338010|54777045|FG000|Overall Study|Withdrawal by Subject|14|||
28118090|NCT03338010|54777046|FG001|Overall Study|Withdrawal by Subject|8|||
28118091|NCT03338010|54777045|FG000|Overall Study|Lost to Follow-up|4|||
28118092|NCT03338010|54777046|FG001|Overall Study|Lost to Follow-up|2|||
28118093|NCT03338010|54777045|FG000|Overall Study|Adverse Event|3|||
28118094|NCT03338010|54777046|FG001|Overall Study|Adverse Event|2|||
28118095|NCT03338010|54777045|FG000|Overall Study|Physician Decision|2|||
28118096|NCT03338010|54777046|FG001|Overall Study|Physician Decision|2|||
28118097|NCT03338010|54777045|FG000|Overall Study|Non-Compliance with Study Drug|0|||
28118098|NCT03338010|54777046|FG001|Overall Study|Non-Compliance with Study Drug|3|||
28118099|NCT03338010|54777045|FG000|Overall Study|Protocol Violation|0|||
28118100|NCT03338010|54777046|FG001|Overall Study|Protocol Violation|1|||
28118101|NCT03337542|54777052|FG000|Overall Study|Withdrew Consent|17|||
28118102|NCT03337542|54777052|FG000|Overall Study|Allergic Adverse Event|1|||
28118103|NCT03337542|54777052|FG000|Overall Study|Chronic /Recurrent GI Adverse Event/Symptoms|1|||
28118104|NCT03337542|54777052|FG000|Overall Study|Lost to Follow-up|1|||
28118105|NCT03337542|54777052|FG000|Overall Study|Unable to Participate in Study Due to Relocation|1|||
28118106|NCT01328548|54777059|FG000|Overall Study|Death|3|||
28118107|NCT01328548|54777060|FG001|Overall Study|Death|0|||
28118108|NCT01328548|54777059|FG000|Overall Study|Protocol Violation|1|||
28118109|NCT01328548|54777060|FG001|Overall Study|Protocol Violation|0|||
28118110|NCT03337308|54777098|FG000|Overall Study|Adverse Event|2|||
28118111|NCT03337308|54777099|FG001|Overall Study|Adverse Event|3|||
28118112|NCT03337308|54777100|FG002|Overall Study|Adverse Event|3|||
28118113|NCT03337308|54777101|FG003|Overall Study|Adverse Event|1|||
28118114|NCT03337308|54777098|FG000|Overall Study|Lost to Follow-up|1|||
28118115|NCT03337308|54777099|FG001|Overall Study|Lost to Follow-up|2|||
28118116|NCT03337308|54777100|FG002|Overall Study|Lost to Follow-up|0|||
28118117|NCT03337308|54777101|FG003|Overall Study|Lost to Follow-up|0|||
28118118|NCT03337308|54777098|FG000|Overall Study|Withdrawal by Subject|2|||
28118119|NCT03337308|54777099|FG001|Overall Study|Withdrawal by Subject|1|||
28118120|NCT03337308|54777100|FG002|Overall Study|Withdrawal by Subject|2|||
28118121|NCT03337308|54777101|FG003|Overall Study|Withdrawal by Subject|1|||
28118122|NCT03337308|54777098|FG000|Overall Study|Protocol Violation|0|||
28118123|NCT03337308|54777099|FG001|Overall Study|Protocol Violation|1|||
28118124|NCT03337308|54777100|FG002|Overall Study|Protocol Violation|0|||
28118125|NCT03337308|54777101|FG003|Overall Study|Protocol Violation|0|||
28118126|NCT03337152|54777113|FG000|Overall Study|Physician Decision|1|||
28118127|NCT03337152|54777114|FG001|Overall Study|Physician Decision|0|||
28118128|NCT03337152|54777113|FG000|Overall Study|Lost to Follow-up|1|||
28118129|NCT03337152|54777114|FG001|Overall Study|Lost to Follow-up|3|||
28118130|NCT03337152|54777113|FG000|Overall Study|Adverse Event|3|||
28118131|NCT03337152|54777114|FG001|Overall Study|Adverse Event|1|||
28118132|NCT03337152|54777113|FG000|Overall Study|Stopped drug dosing due to study halt|6|||
28118133|NCT03337152|54777114|FG001|Overall Study|Stopped drug dosing due to study halt|7|||
28118134|NCT03710161|54777128|FG000|Overall Study|Study halted due to COVID pandemic|3|||
28118135|NCT03710161|54777129|FG001|Overall Study|Study halted due to COVID pandemic|2|||
28118136|NCT03091400|54777137|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
28118137|NCT03091400|54777138|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
28118138|NCT01318993|54777144|FG000|Overall Study|Adverse Event|53|||
28118139|NCT01318993|54777144|FG000|Overall Study|Lack of Efficacy|121|||
28118140|NCT01318993|54777144|FG000|Overall Study|Protocol Violation|3|||
28118141|NCT01318993|54777144|FG000|Overall Study|Protocol based stopping criteria|6|||
28118142|NCT01318993|54777144|FG000|Overall Study|Study closed or terminated|174|||
28118143|NCT01318993|54777144|FG000|Overall Study|Lost to Follow-up|4|||
28118144|NCT01318993|54777144|FG000|Overall Study|Physician Decision|13|||
28118145|NCT01318993|54777144|FG000|Overall Study|Withdrawal by Subject|24|||
28118146|NCT03090152|54777151|FG000|Overall Study|Withdrawal by Subject|0|||
28118147|NCT03090152|54777152|FG001|Overall Study|Withdrawal by Subject|2|||
28118148|NCT03090152|54777153|FG002|Overall Study|Withdrawal by Subject|1|||
28118149|NCT03090152|54777151|FG000|Overall Study|Surgery Canceled|1|||
28118150|NCT03090152|54777152|FG001|Overall Study|Surgery Canceled|0|||
28118151|NCT03090152|54777153|FG002|Overall Study|Surgery Canceled|0|||
28118152|NCT03090152|54777151|FG000|Overall Study|Epidural catheter could not be placed|0|||
28118153|NCT03090152|54777152|FG001|Overall Study|Epidural catheter could not be placed|2|||
28118154|NCT03090152|54777153|FG002|Overall Study|Epidural catheter could not be placed|0|||
28118155|NCT04252287|54777163|FG000|Overall Study|Death|5|||
28118156|NCT04252287|54777164|FG001|Overall Study|Death|3|||
28118157|NCT04252287|54777163|FG000|Overall Study|Lost to Follow-up|4|||
28118158|NCT04252287|54777164|FG001|Overall Study|Lost to Follow-up|6|||
28118159|NCT04252287|54777163|FG000|Overall Study|Withdrawal by Subject|19|||
28118160|NCT04252287|54777164|FG001|Overall Study|Withdrawal by Subject|16|||
28118161|NCT04252287|54777163|FG000|Overall Study|Protocol Violation|3|||
28118162|NCT04252287|54777164|FG001|Overall Study|Protocol Violation|4|||
28118163|NCT02735200|54777176|FG000|Overall Study|Lost to Follow-up|0|||
28118164|NCT02735200|54777177|FG001|Overall Study|Lost to Follow-up|5|||
28118165|NCT02735200|54777176|FG000|Overall Study|Withdrawal by Subject|8|||
28118166|NCT02735200|54777177|FG001|Overall Study|Withdrawal by Subject|0|||
28118167|NCT02946918|54777185|FG000|Overall Study|Patient unblinded himself|1|||
28118168|NCT02946918|54777186|FG001|Overall Study|Patient unblinded himself|0|||
28118169|NCT02946918|54777185|FG000|Overall Study|Physician Decision|0|||
28118170|NCT02946918|54777186|FG001|Overall Study|Physician Decision|2|||
28118171|NCT02946918|54777185|FG000|Overall Study|Ran out of study medication|0|||
28118172|NCT02946918|54777186|FG001|Overall Study|Ran out of study medication|1|||
28118173|NCT02734810|54777207|FG000|Overall Study|Adverse Event|1|||
28118174|NCT02734810|54777208|FG001|Overall Study|Adverse Event|0|||
28118175|NCT02734810|54777207|FG000|Overall Study|Lack of Efficacy|1|||
28118176|NCT02734810|54777208|FG001|Overall Study|Lack of Efficacy|0|||
28118177|NCT03656068|54777233|FG000|Overall Study|Withdrawal by Subject|4|||
28118178|NCT03656068|54777233|FG000|Overall Study|Adverse Event|1|||
28118179|NCT02944383|54777240|FG000|Overall Study|Lost to Follow-up|0|||
28118180|NCT02944383|54777241|FG001|Overall Study|Lost to Follow-up|0|||
28118181|NCT02944383|54777242|FG002|Overall Study|Lost to Follow-up|1|||
28118182|NCT02944383|54777240|FG000|Overall Study|Withdrawal by Subject|1|||
28118183|NCT02944383|54777241|FG001|Overall Study|Withdrawal by Subject|0|||
28118184|NCT02944383|54777242|FG002|Overall Study|Withdrawal by Subject|0|||
28118185|NCT03768089|54777270|FG000|Part A|Lost to Follow-up|0|||
28118186|NCT03768089|54777271|FG001|Part A|Lost to Follow-up|0|||
28118187|NCT03768089|54777272|FG002|Part A|Lost to Follow-up|0|||
28118188|NCT03768089|54777273|FG003|Part A|Lost to Follow-up|0|||
28118189|NCT03768089|54777274|FG004|Part A|Lost to Follow-up|1|||
28118190|NCT03768089|54777275|FG005|Part A|Lost to Follow-up|0|||
28118191|NCT03768089|54777276|FG006|Part A|Lost to Follow-up|0|||
28118192|NCT03768089|54777277|FG007|Part A|Lost to Follow-up|0|||
28118193|NCT03768089|54777278|FG008|Part A|Lost to Follow-up|0|||
28118194|NCT03768089|54777279|FG009|Part A|Lost to Follow-up|0|||
28118195|NCT03768089|54777280|FG010|Part A|Lost to Follow-up|0|||
28118196|NCT03768089|54777281|FG011|Part A|Lost to Follow-up|0|||
28118197|NCT03768089|54777282|FG012|Part A|Lost to Follow-up|0|||
28118198|NCT03768089|54777283|FG013|Part A|Lost to Follow-up|0|||
28118199|NCT03768089|54777284|FG014|Part A|Lost to Follow-up|0|||
28118200|NCT03768089|54777285|FG015|Part A|Lost to Follow-up|0|||
28118201|NCT03768089|54777286|FG016|Part A|Lost to Follow-up|0|||
28118202|NCT03768089|54777287|FG017|Part A|Lost to Follow-up|0|||
28118203|NCT03768089|54777270|FG000|Part C|Randomized, Never Dosed|0|||
28118204|NCT03768089|54777271|FG001|Part C|Randomized, Never Dosed|0|||
28118205|NCT03768089|54777272|FG002|Part C|Randomized, Never Dosed|0|||
28118206|NCT03768089|54777273|FG003|Part C|Randomized, Never Dosed|0|||
28118207|NCT03768089|54777274|FG004|Part C|Randomized, Never Dosed|0|||
28118208|NCT03768089|54777275|FG005|Part C|Randomized, Never Dosed|0|||
28118209|NCT03768089|54777276|FG006|Part C|Randomized, Never Dosed|0|||
28118210|NCT03768089|54777277|FG007|Part C|Randomized, Never Dosed|0|||
28118211|NCT03768089|54777278|FG008|Part C|Randomized, Never Dosed|0|||
28118212|NCT03768089|54777279|FG009|Part C|Randomized, Never Dosed|0|||
28118213|NCT03768089|54777280|FG010|Part C|Randomized, Never Dosed|0|||
28118214|NCT03768089|54777281|FG011|Part C|Randomized, Never Dosed|0|||
28118215|NCT03768089|54777282|FG012|Part C|Randomized, Never Dosed|0|||
28118216|NCT03768089|54777283|FG013|Part C|Randomized, Never Dosed|0|||
28118217|NCT03768089|54777284|FG014|Part C|Randomized, Never Dosed|1|||
28118218|NCT03768089|54777285|FG015|Part C|Randomized, Never Dosed|0|||
28118219|NCT03768089|54777286|FG016|Part C|Randomized, Never Dosed|0|||
28118220|NCT03768089|54777287|FG017|Part C|Randomized, Never Dosed|0|||
27816987|NCT01483599|54273974|FG013|Controlled Period (CP) (up to Week 16)|Other|0|||
27816988|NCT01483599|54273961|FG000|After Controlled Period(Week 16-Week 40)|Death|0|||
27816989|NCT01483599|54273962|FG001|After Controlled Period(Week 16-Week 40)|Death|0|||
27816990|NCT01483599|54273963|FG002|After Controlled Period(Week 16-Week 40)|Death|0|||
27816991|NCT01483599|54273964|FG003|After Controlled Period(Week 16-Week 40)|Death|0|||
27816992|NCT01483599|54273965|FG004|After Controlled Period(Week 16-Week 40)|Death|0|||
28065808|NCT00281580|54721432|FG010|Overall Study|Adverse Event|0|||
28065809|NCT00281580|54721433|FG011|Overall Study|Adverse Event|5|||
28065810|NCT00281580|54721434|FG012|Overall Study|Adverse Event|8|||
28065811|NCT00281580|54721435|FG013|Overall Study|Adverse Event|2|||
28065812|NCT00281580|54721436|FG014|Overall Study|Adverse Event|3|||
28065813|NCT00281580|54721437|FG015|Overall Study|Adverse Event|3|||
28065814|NCT00281580|54721422|FG000|Overall Study|Protocol Violation|0|||
28065815|NCT00281580|54721423|FG001|Overall Study|Protocol Violation|0|||
28065816|NCT00281580|54721424|FG002|Overall Study|Protocol Violation|1|||
28065817|NCT00281580|54721425|FG003|Overall Study|Protocol Violation|1|||
28065818|NCT00281580|54721426|FG004|Overall Study|Protocol Violation|0|||
28065819|NCT00281580|54721427|FG005|Overall Study|Protocol Violation|0|||
28065820|NCT00281580|54721428|FG006|Overall Study|Protocol Violation|1|||
28065821|NCT00281580|54721429|FG007|Overall Study|Protocol Violation|0|||
28065822|NCT00281580|54721430|FG008|Overall Study|Protocol Violation|2|||
28065823|NCT00281580|54721431|FG009|Overall Study|Protocol Violation|0|||
28065824|NCT00281580|54721432|FG010|Overall Study|Protocol Violation|1|||
28065825|NCT00281580|54721433|FG011|Overall Study|Protocol Violation|2|||
28065826|NCT00281580|54721434|FG012|Overall Study|Protocol Violation|0|||
28065827|NCT00281580|54721435|FG013|Overall Study|Protocol Violation|1|||
28065828|NCT00281580|54721436|FG014|Overall Study|Protocol Violation|1|||
28065829|NCT00281580|54721437|FG015|Overall Study|Protocol Violation|3|||
28065830|NCT00281580|54721422|FG000|Overall Study|Withdrawal by Subject|3|||
28065831|NCT00281580|54721423|FG001|Overall Study|Withdrawal by Subject|0|||
28065832|NCT00281580|54721424|FG002|Overall Study|Withdrawal by Subject|1|||
28065833|NCT00281580|54721425|FG003|Overall Study|Withdrawal by Subject|1|||
28065834|NCT00281580|54721426|FG004|Overall Study|Withdrawal by Subject|1|||
28065835|NCT00281580|54721427|FG005|Overall Study|Withdrawal by Subject|2|||
28065836|NCT00281580|54721428|FG006|Overall Study|Withdrawal by Subject|2|||
28065837|NCT00281580|54721429|FG007|Overall Study|Withdrawal by Subject|0|||
28065838|NCT00281580|54721430|FG008|Overall Study|Withdrawal by Subject|1|||
28065839|NCT00281580|54721431|FG009|Overall Study|Withdrawal by Subject|4|||
28065840|NCT00281580|54721432|FG010|Overall Study|Withdrawal by Subject|1|||
28065841|NCT00281580|54721433|FG011|Overall Study|Withdrawal by Subject|1|||
28118221|NCT03086330|54777348|FG000|Overall Study|Withdrawal by Subject|3|||
28118222|NCT03086330|54777349|FG001|Overall Study|Withdrawal by Subject|2|||
28118223|NCT03086330|54777348|FG000|Overall Study|Lost to Follow-up|1|||
28118224|NCT03086330|54777349|FG001|Overall Study|Lost to Follow-up|2|||
28118225|NCT02943993|54777381|FG000|Overall Study|Withdrawal by Subject|52|||
28118226|NCT02943993|54777381|FG000|Overall Study|Transfer to another institution|6|||
28118227|NCT02943993|54777381|FG000|Overall Study|Lost to Follow-up|135|||
28118228|NCT02943993|54777381|FG000|Overall Study|Death|98|||
28118229|NCT02943993|54777381|FG000|Overall Study|Other reason for premature termination|32|||
28118230|NCT02943993|54777381|FG000|Overall Study|Missing reason for termination|7|||
28118231|NCT02943447|54777405|FG000|Blinded Study Phase|Withdrew Consent|1|||
28118232|NCT02943447|54777406|FG001|Blinded Study Phase|Withdrew Consent|2|||
28118233|NCT02943447|54777407|FG002|Blinded Study Phase|Withdrew Consent|1|||
28118234|NCT02943447|54777405|FG000|Blinded Study Phase|Adverse Event|3|||
28118235|NCT02943447|54777406|FG001|Blinded Study Phase|Adverse Event|0|||
28118236|NCT02943447|54777407|FG002|Blinded Study Phase|Adverse Event|0|||
28118237|NCT02943447|54777405|FG000|Blinded Study Phase|Investigator's discretion|1|||
28118238|NCT02943447|54777406|FG001|Blinded Study Phase|Investigator's discretion|0|||
28118239|NCT02943447|54777407|FG002|Blinded Study Phase|Investigator's discretion|0|||
28118240|NCT02943447|54777405|FG000|Open-Label Extension Phase|Study terminated by sponsor|10|||
28118241|NCT02943447|54777406|FG001|Open-Label Extension Phase|Study terminated by sponsor|12|||
28118242|NCT02943447|54777407|FG002|Open-Label Extension Phase|Study terminated by sponsor|6|||
28118243|NCT02943447|54777405|FG000|Open-Label Extension Phase|Adverse Event|4|||
28118244|NCT02943447|54777406|FG001|Open-Label Extension Phase|Adverse Event|7|||
28118245|NCT02943447|54777407|FG002|Open-Label Extension Phase|Adverse Event|3|||
28118246|NCT02943447|54777405|FG000|Open-Label Extension Phase|Lack of Efficacy|3|||
28118247|NCT02943447|54777406|FG001|Open-Label Extension Phase|Lack of Efficacy|4|||
28118248|NCT02943447|54777407|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
28118249|NCT02943447|54777405|FG000|Open-Label Extension Phase|Withdrew consent|1|||
28118250|NCT02943447|54777406|FG001|Open-Label Extension Phase|Withdrew consent|1|||
28118251|NCT02943447|54777407|FG002|Open-Label Extension Phase|Withdrew consent|1|||
28118252|NCT02943447|54777405|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
28118253|NCT02943447|54777406|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
28118254|NCT02943447|54777407|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
28118255|NCT02844777|54777436|FG000|Overall Study|Withdrawal by Subject|2|||
28118256|NCT02844777|54777437|FG001|Overall Study|Withdrawal by Subject|0|||
28118257|NCT02844777|54777438|FG002|Overall Study|Withdrawal by Subject|0|||
28118258|NCT04003142|54777449|FG000|Double-blind Period (12 Weeks)|Adverse Event|1|||
28118259|NCT04003142|54777450|FG001|Double-blind Period (12 Weeks)|Adverse Event|1|||
28118260|NCT04003142|54777451|FG002|Double-blind Period (12 Weeks)|Adverse Event|2|||
28118261|NCT04003142|54777452|FG003|Double-blind Period (12 Weeks)|Adverse Event|0|||
28118262|NCT04003142|54777453|FG004|Double-blind Period (12 Weeks)|Adverse Event|0|||
28118263|NCT04003142|54777449|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
28118264|NCT04003142|54777450|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
28118265|NCT04003142|54777451|FG002|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
28118266|NCT04003142|54777452|FG003|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
28118267|NCT04003142|54777453|FG004|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
28118268|NCT04003142|54777449|FG000|Double-blind Period (12 Weeks)|Protocol Deviation|1|||
28118269|NCT04003142|54777450|FG001|Double-blind Period (12 Weeks)|Protocol Deviation|5|||
28118270|NCT04003142|54777451|FG002|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
28118271|NCT04003142|54777452|FG003|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
28118272|NCT04003142|54777453|FG004|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
28118273|NCT04003142|54777449|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|11|||
28118274|NCT04003142|54777450|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
28118275|NCT04003142|54777451|FG002|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
28118276|NCT04003142|54777452|FG003|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
28118277|NCT04003142|54777453|FG004|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
28118278|NCT04003142|54777449|FG000|Double-blind Period (12 Weeks)|Miscellaneous|2|||
28118279|NCT04003142|54777450|FG001|Double-blind Period (12 Weeks)|Miscellaneous|1|||
28118280|NCT04003142|54777451|FG002|Double-blind Period (12 Weeks)|Miscellaneous|2|||
28118281|NCT04003142|54777452|FG003|Double-blind Period (12 Weeks)|Miscellaneous|0|||
28118282|NCT04003142|54777453|FG004|Double-blind Period (12 Weeks)|Miscellaneous|0|||
28118283|NCT04003142|54777449|FG000|Extension Period (40 Weeks)|Adverse Event|0|||
28118284|NCT04003142|54777450|FG001|Extension Period (40 Weeks)|Adverse Event|4|||
28118285|NCT04003142|54777451|FG002|Extension Period (40 Weeks)|Adverse Event|4|||
28118286|NCT04003142|54777452|FG003|Extension Period (40 Weeks)|Adverse Event|2|||
28118287|NCT04003142|54777453|FG004|Extension Period (40 Weeks)|Adverse Event|3|||
28118288|NCT04003142|54777449|FG000|Extension Period (40 Weeks)|Death|0|||
28118289|NCT04003142|54777450|FG001|Extension Period (40 Weeks)|Death|0|||
28118290|NCT04003142|54777451|FG002|Extension Period (40 Weeks)|Death|0|||
28118291|NCT04003142|54777452|FG003|Extension Period (40 Weeks)|Death|0|||
28118292|NCT04003142|54777453|FG004|Extension Period (40 Weeks)|Death|1|||
28118293|NCT04003142|54777449|FG000|Extension Period (40 Weeks)|Lost to Follow-up|0|||
28118294|NCT04003142|54777450|FG001|Extension Period (40 Weeks)|Lost to Follow-up|2|||
28118295|NCT04003142|54777451|FG002|Extension Period (40 Weeks)|Lost to Follow-up|1|||
28118296|NCT04003142|54777452|FG003|Extension Period (40 Weeks)|Lost to Follow-up|2|||
28118297|NCT04003142|54777453|FG004|Extension Period (40 Weeks)|Lost to Follow-up|1|||
28118298|NCT04003142|54777449|FG000|Extension Period (40 Weeks)|Protocol Deviation|0|||
28118299|NCT04003142|54777450|FG001|Extension Period (40 Weeks)|Protocol Deviation|0|||
28118300|NCT04003142|54777451|FG002|Extension Period (40 Weeks)|Protocol Deviation|2|||
28118301|NCT04003142|54777452|FG003|Extension Period (40 Weeks)|Protocol Deviation|0|||
28118302|NCT04003142|54777453|FG004|Extension Period (40 Weeks)|Protocol Deviation|0|||
28118303|NCT04003142|54777449|FG000|Extension Period (40 Weeks)|Withdrawal by Subject|0|||
28118304|NCT04003142|54777450|FG001|Extension Period (40 Weeks)|Withdrawal by Subject|17|||
28118305|NCT04003142|54777451|FG002|Extension Period (40 Weeks)|Withdrawal by Subject|14|||
28118306|NCT04003142|54777452|FG003|Extension Period (40 Weeks)|Withdrawal by Subject|9|||
28118307|NCT04003142|54777453|FG004|Extension Period (40 Weeks)|Withdrawal by Subject|5|||
28118308|NCT04003142|54777449|FG000|Extension Period (40 Weeks)|Miscellaneous|0|||
28118309|NCT04003142|54777450|FG001|Extension Period (40 Weeks)|Miscellaneous|4|||
28118310|NCT04003142|54777451|FG002|Extension Period (40 Weeks)|Miscellaneous|1|||
28118311|NCT04003142|54777452|FG003|Extension Period (40 Weeks)|Miscellaneous|0|||
28118312|NCT04003142|54777453|FG004|Extension Period (40 Weeks)|Miscellaneous|2|||
28118313|NCT02612337|54777473|FG000|Overall Study|Lack of Efficacy|1|||
28118314|NCT02612337|54777474|FG001|Overall Study|Lack of Efficacy|0|||
27816993|NCT01483599|54273966|FG005|After Controlled Period(Week 16-Week 40)|Death|0|||
27816994|NCT01483599|54273967|FG006|After Controlled Period(Week 16-Week 40)|Death|0|||
28118315|NCT02612337|54777473|FG000|Overall Study|Withdrawal by Subject|2|||
28118316|NCT02612337|54777474|FG001|Overall Study|Withdrawal by Subject|2|||
28118317|NCT02612337|54777473|FG000|Overall Study|Did not receive study drug|0|||
28118318|NCT02612337|54777474|FG001|Overall Study|Did not receive study drug|1|||
28118319|NCT03532451|54777488|FG000|Overall Study|Withdrawal by Subject|0|||
28118320|NCT03532451|54777489|FG001|Overall Study|Withdrawal by Subject|1|||
28118321|NCT03532451|54777488|FG000|Overall Study|Progression prior to the surgery|1|||
28118322|NCT03532451|54777489|FG001|Overall Study|Progression prior to the surgery|0|||
28118323|NCT03085238|54777495|FG000|Overall Study|Adverse Event|2|||
28118324|NCT03085238|54777495|FG000|Overall Study|Death|2|||
28118325|NCT03383666|54777508|FG000|Overall Study|Withdrawal by Subject|2|||
28118326|NCT03383666|54777508|FG000|Overall Study|Lost to Follow-up|2|||
28118327|NCT03086018|54777512|FG000|Final Testing for End of Trial|Adverse Event|1|||
28118328|NCT03086018|54777512|FG000|Final Testing for End of Trial|Withdrawal by Subject|1|||
28118329|NCT03319953|54777522|FG000|Period 2 (Day 49 to 154)|Withdrawal by Subject|1|||
28118330|NCT03319953|54777523|FG001|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
28118331|NCT03319953|54777524|FG002|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
28118332|NCT03319953|54777525|FG003|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
28118333|NCT03319953|54777522|FG000|Period 2 (Day 49 to 154)|Reason not Specified|0|||
28118334|NCT03319953|54777523|FG001|Period 2 (Day 49 to 154)|Reason not Specified|0|||
28118335|NCT03319953|54777524|FG002|Period 2 (Day 49 to 154)|Reason not Specified|1|||
28118336|NCT03319953|54777525|FG003|Period 2 (Day 49 to 154)|Reason not Specified|1|||
28118337|NCT02927834|54777536|FG000|Overall Study|Lost to Follow-up|1|||
28118338|NCT02927834|54777537|FG001|Overall Study|Lost to Follow-up|2|||
28118339|NCT02927834|54777538|FG002|Overall Study|Lost to Follow-up|2|||
28118340|NCT01964547|54777552|FG000|Overall Study|Adverse Event|8|||
28118341|NCT01964547|54777553|FG001|Overall Study|Adverse Event|2|||
28118342|NCT01964547|54777552|FG000|Overall Study|Withdrawal by Subject|4|||
28118343|NCT01964547|54777553|FG001|Overall Study|Withdrawal by Subject|7|||
27816995|NCT01483599|54273968|FG007|After Controlled Period(Week 16-Week 40)|Death|0|||
28118344|NCT01964547|54777552|FG000|Overall Study|Lost to Follow-up|0|||
27816996|NCT01483599|54273969|FG008|After Controlled Period(Week 16-Week 40)|Death|1|||
28118345|NCT01964547|54777553|FG001|Overall Study|Lost to Follow-up|1|||
28118346|NCT01964547|54777552|FG000|Overall Study|Withdrawal by Investigator|0|||
28118347|NCT01964547|54777553|FG001|Overall Study|Withdrawal by Investigator|1|||
28118348|NCT03319719|54777559|FG000|Overall Study|Lost to Follow-up|1|||
28118349|NCT03318783|54777567|FG000|Overall Study|Withdrawal by Subject|0|||
28118350|NCT03318783|54777568|FG001|Overall Study|Withdrawal by Subject|1|||
28118351|NCT03318783|54777567|FG000|Overall Study|Death|0|||
28118352|NCT03318783|54777568|FG001|Overall Study|Death|1|||
28118353|NCT01313689|54777579|FG000|24-Week Randomization 1|Adverse Event|10|||
28118354|NCT01313689|54777580|FG001|24-Week Randomization 1|Adverse Event|5|||
28118355|NCT01313689|54777581|FG002|24-Week Randomization 1|Adverse Event|0|||
28118356|NCT01313689|54777582|FG003|24-Week Randomization 1|Adverse Event|0|||
28118357|NCT01313689|54777583|FG004|24-Week Randomization 1|Adverse Event|0|||
28118358|NCT01313689|54777579|FG000|24-Week Randomization 1|Physician Decision|4|||
28118359|NCT01313689|54777580|FG001|24-Week Randomization 1|Physician Decision|5|||
28118360|NCT01313689|54777581|FG002|24-Week Randomization 1|Physician Decision|0|||
28118361|NCT01313689|54777582|FG003|24-Week Randomization 1|Physician Decision|0|||
28118362|NCT01313689|54777583|FG004|24-Week Randomization 1|Physician Decision|0|||
28118363|NCT01313689|54777579|FG000|24-Week Randomization 1|Withdrawal by Subject|5|||
28118364|NCT01313689|54777580|FG001|24-Week Randomization 1|Withdrawal by Subject|0|||
28118365|NCT01313689|54777581|FG002|24-Week Randomization 1|Withdrawal by Subject|0|||
28118366|NCT01313689|54777582|FG003|24-Week Randomization 1|Withdrawal by Subject|0|||
28118367|NCT01313689|54777583|FG004|24-Week Randomization 1|Withdrawal by Subject|0|||
28118368|NCT01313689|54777579|FG000|24-Week Randomization 2|Adverse Event|0|||
28118369|NCT01313689|54777580|FG001|24-Week Randomization 2|Adverse Event|0|||
28118370|NCT01313689|54777581|FG002|24-Week Randomization 2|Adverse Event|2|||
28118371|NCT01313689|54777582|FG003|24-Week Randomization 2|Adverse Event|0|||
28118372|NCT01313689|54777583|FG004|24-Week Randomization 2|Adverse Event|8|||
28118373|NCT01313689|54777579|FG000|24-Week Randomization 2|Withdrawal by Subject|0|||
28118374|NCT01313689|54777580|FG001|24-Week Randomization 2|Withdrawal by Subject|0|||
28118375|NCT01313689|54777581|FG002|24-Week Randomization 2|Withdrawal by Subject|1|||
28118376|NCT01313689|54777582|FG003|24-Week Randomization 2|Withdrawal by Subject|1|||
28118377|NCT01313689|54777583|FG004|24-Week Randomization 2|Withdrawal by Subject|3|||
28118378|NCT01313689|54777579|FG000|24-Week Randomization 2|Physician Decision|0|||
28118379|NCT01313689|54777580|FG001|24-Week Randomization 2|Physician Decision|0|||
28118380|NCT01313689|54777581|FG002|24-Week Randomization 2|Physician Decision|0|||
28118381|NCT01313689|54777582|FG003|24-Week Randomization 2|Physician Decision|0|||
28118382|NCT01313689|54777583|FG004|24-Week Randomization 2|Physician Decision|4|||
28118383|NCT03318315|54777605|FG000|Overall Study|Lost to Follow-up|3|||
28118384|NCT03318315|54777606|FG001|Overall Study|Lost to Follow-up|2|||
28118385|NCT03318315|54777607|FG002|Overall Study|Lost to Follow-up|1|||
28118386|NCT03318315|54777605|FG000|Overall Study|Protocol Violation|1|||
28118387|NCT03318315|54777606|FG001|Overall Study|Protocol Violation|1|||
28118388|NCT03318315|54777607|FG002|Overall Study|Protocol Violation|1|||
28118389|NCT03318315|54777605|FG000|Overall Study|Withdrawal by Subject|0|||
28118390|NCT03318315|54777606|FG001|Overall Study|Withdrawal by Subject|0|||
28118391|NCT03318315|54777607|FG002|Overall Study|Withdrawal by Subject|2|||
28118392|NCT04460183|54777618|FG000|Overall Study|Lost to Follow-up|3|||
28118393|NCT04460183|54777619|FG001|Overall Study|Lost to Follow-up|1|||
28118394|NCT04460183|54777618|FG000|Overall Study|Withdrawal by Subject|1|||
28118395|NCT04460183|54777619|FG001|Overall Study|Withdrawal by Subject|0|||
28118396|NCT03710083|54777625|FG000|Overall Study|Withdrawal by Subject|2|||
28118397|NCT03710083|54777625|FG000|Overall Study|Unsuccessful Procedure|1|||
28118398|NCT03318003|54777631|FG000|Overall Study|Withdrawal by Subject|1|||
28118399|NCT03318003|54777632|FG001|Overall Study|Withdrawal by Subject|1|||
28118400|NCT03318003|54777631|FG000|Overall Study|fetal loss|0|||
28118401|NCT03318003|54777632|FG001|Overall Study|fetal loss|1|||
28118402|NCT03317379|54777641|FG000|Overall Study|Lost to Follow-up|0|||
28118403|NCT03317379|54777642|FG001|Overall Study|Lost to Follow-up|3|||
28118404|NCT03317379|54777643|FG002|Overall Study|Lost to Follow-up|2|||
28118405|NCT03316911|54777653|FG000|Overall Study|Lost to Follow-up|33|||
28118406|NCT03316911|54777654|FG001|Overall Study|Lost to Follow-up|29|||
28118407|NCT01106391|54777660|FG000|Overall Study|Death|12|||
28118408|NCT01106391|54777660|FG000|Overall Study|Withdrawal by Subject|7|||
28118409|NCT03316131|54777664|FG000|Treatment Period 2|Protocol deviation|1|||
28118410|NCT03316131|54777665|FG001|Treatment Period 2|Protocol deviation|0|||
28118411|NCT03301415|54777671|FG000|Overall Study|Lost to Follow-up|2|||
28118412|NCT03301415|54777671|FG000|Overall Study|Unable to comply with visit schedule|2|||
28118413|NCT02732938|54777677|FG000|Overall Study|Death|0|||
28118414|NCT02732938|54777678|FG001|Overall Study|Death|11|||
28118415|NCT02732938|54777679|FG002|Overall Study|Death|0|||
28118416|NCT02732938|54777677|FG000|Overall Study|Randomized but did not receive treatment|0|||
27816997|NCT01483599|54273970|FG009|After Controlled Period(Week 16-Week 40)|Death|0|||
27816998|NCT01483599|54273971|FG010|After Controlled Period(Week 16-Week 40)|Death|0|||
27816999|NCT01483599|54273972|FG011|After Controlled Period(Week 16-Week 40)|Death|0|||
27817000|NCT01483599|54273973|FG012|After Controlled Period(Week 16-Week 40)|Death|0|||
27817001|NCT01483599|54273974|FG013|After Controlled Period(Week 16-Week 40)|Death|0|||
27817002|NCT01483599|54273961|FG000|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
27817003|NCT01483599|54273962|FG001|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
27817004|NCT01483599|54273963|FG002|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
27817005|NCT01483599|54273964|FG003|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
27817006|NCT01483599|54273965|FG004|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
27817007|NCT01483599|54273966|FG005|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
27817008|NCT01483599|54273967|FG006|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
27817009|NCT01483599|54273968|FG007|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
27817010|NCT01483599|54273969|FG008|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
27817011|NCT01483599|54273970|FG009|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
27817012|NCT01483599|54273971|FG010|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
27817013|NCT01483599|54273972|FG011|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
27817014|NCT01483599|54273973|FG012|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
27817015|NCT01483599|54273974|FG013|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
27817016|NCT01483599|54273961|FG000|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
27817017|NCT01483599|54273962|FG001|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
27817018|NCT01483599|54273963|FG002|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
27817019|NCT01483599|54273964|FG003|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
27817020|NCT01483599|54273965|FG004|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
27817021|NCT01483599|54273966|FG005|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
27817022|NCT01483599|54273967|FG006|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
27817023|NCT01483599|54273968|FG007|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
27817024|NCT01483599|54273969|FG008|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
27817025|NCT01483599|54273970|FG009|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
27817026|NCT01483599|54273971|FG010|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
27817027|NCT01483599|54273972|FG011|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
27817028|NCT01483599|54273973|FG012|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
27817029|NCT01483599|54273974|FG013|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
27817030|NCT01483599|54273961|FG000|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
27817031|NCT01483599|54273962|FG001|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
27817032|NCT01483599|54273963|FG002|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
27817033|NCT01483599|54273964|FG003|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
27848795|NCT01360632|54343098|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
27817034|NCT01483599|54273965|FG004|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
27817035|NCT01483599|54273966|FG005|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
27817036|NCT01483599|54273967|FG006|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
27848796|NCT01360632|54343099|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
27848797|NCT01360632|54343100|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|1|||
27848798|NCT01360632|54343101|FG004|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
27848799|NCT01360632|54343097|FG000|Phase B (6 Weeks)|Physician Decision|0|||
27848800|NCT01360632|54343098|FG001|Phase B (6 Weeks)|Physician Decision|0|||
27848801|NCT01360632|54343099|FG002|Phase B (6 Weeks)|Physician Decision|0|||
27848802|NCT01360632|54343100|FG003|Phase B (6 Weeks)|Physician Decision|1|||
27848803|NCT01360632|54343101|FG004|Phase B (6 Weeks)|Physician Decision|0|||
27848804|NCT01360632|54343097|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
27848805|NCT01360632|54343098|FG001|Phase B (6 Weeks)|Withdrawal by Subject|4|||
27848806|NCT01360632|54343099|FG002|Phase B (6 Weeks)|Withdrawal by Subject|4|||
27848807|NCT01360632|54343100|FG003|Phase B (6 Weeks)|Withdrawal by Subject|7|||
27848808|NCT01360632|54343101|FG004|Phase B (6 Weeks)|Withdrawal by Subject|0|||
27848809|NCT01360632|54343097|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
27848810|NCT01360632|54343098|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
27848811|NCT01360632|54343099|FG002|Phase B (6 Weeks)|Protocol Deviation|4|||
28118417|NCT02732938|54777678|FG001|Overall Study|Randomized but did not receive treatment|1|||
28118418|NCT02732938|54777679|FG002|Overall Study|Randomized but did not receive treatment|0|||
28118419|NCT02732938|54777677|FG000|Overall Study|Refused further follow-up|1|||
28118420|NCT02732938|54777678|FG001|Overall Study|Refused further follow-up|0|||
28118421|NCT02732938|54777679|FG002|Overall Study|Refused further follow-up|0|||
28118422|NCT02732938|54777677|FG000|Overall Study|Study terminated by sponsor|3|||
28118423|NCT02732938|54777678|FG001|Overall Study|Study terminated by sponsor|6|||
28118424|NCT02732938|54777679|FG002|Overall Study|Study terminated by sponsor|0|||
28118425|NCT04647721|54777687|FG000|Overall Study|Withdrawal by Subject|0|||
28118426|NCT04647721|54777688|FG001|Overall Study|Withdrawal by Subject|2|||
28118427|NCT04647721|54777687|FG000|Overall Study|Lost to Follow-up|2|||
28118428|NCT04647721|54777688|FG001|Overall Study|Lost to Follow-up|0|||
28118429|NCT03718000|54777709|FG000|Overall Study|Relocation|2|||
28118430|NCT03718000|54777710|FG001|Overall Study|Relocation|4|||
28118431|NCT03718000|54777709|FG000|Overall Study|Pregnancy|0|||
28118432|NCT03718000|54777710|FG001|Overall Study|Pregnancy|1|||
28118433|NCT03063203|54777717|FG000|Overall Study|Chose alternative therapy|3|||
28118434|NCT03063203|54777717|FG000|Overall Study|Death|2|||
28118435|NCT03063203|54777717|FG000|Overall Study|Disease progression|4|||
28118436|NCT03063203|54777717|FG000|Overall Study|Physician Decision|5|||
28118437|NCT02891226|54777736|FG000|Period 1 (Weeks 0 to 12)|Adverse Event|4|||
28118438|NCT02891226|54777737|FG001|Period 1 (Weeks 0 to 12)|Adverse Event|1|||
28118439|NCT02891226|54777738|FG002|Period 1 (Weeks 0 to 12)|Adverse Event|3|||
28118440|NCT02891226|54777739|FG003|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
28118441|NCT02891226|54777740|FG004|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
28118442|NCT02891226|54777741|FG005|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
28118443|NCT02891226|54777742|FG006|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
28118444|NCT02891226|54777743|FG007|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
28118445|NCT02891226|54777744|FG008|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
28118446|NCT02891226|54777745|FG009|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
28118447|NCT02891226|54777746|FG010|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
28118448|NCT02891226|54777747|FG011|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
28118449|NCT02891226|54777748|FG012|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
28118450|NCT02891226|54777749|FG013|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
28118451|NCT02891226|54777750|FG014|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
28118452|NCT02891226|54777751|FG015|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
28118453|NCT02891226|54777736|FG000|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
28118454|NCT02891226|54777737|FG001|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
28118455|NCT02891226|54777738|FG002|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
28118456|NCT02891226|54777739|FG003|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
28118457|NCT02891226|54777740|FG004|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
28118458|NCT02891226|54777741|FG005|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
27848812|NCT01360632|54343100|FG003|Phase B (6 Weeks)|Protocol Deviation|1|||
28065842|NCT00281580|54721434|FG012|Overall Study|Withdrawal by Subject|2|||
28065843|NCT00281580|54721435|FG013|Overall Study|Withdrawal by Subject|2|||
28065844|NCT00281580|54721436|FG014|Overall Study|Withdrawal by Subject|1|||
28065845|NCT00281580|54721437|FG015|Overall Study|Withdrawal by Subject|5|||
28065846|NCT00281580|54721422|FG000|Overall Study|Lack of Efficacy|2|||
28065847|NCT00281580|54721423|FG001|Overall Study|Lack of Efficacy|1|||
28065848|NCT00281580|54721424|FG002|Overall Study|Lack of Efficacy|1|||
28065849|NCT00281580|54721425|FG003|Overall Study|Lack of Efficacy|6|||
28065850|NCT00281580|54721426|FG004|Overall Study|Lack of Efficacy|2|||
28065851|NCT00281580|54721427|FG005|Overall Study|Lack of Efficacy|0|||
28065852|NCT00281580|54721428|FG006|Overall Study|Lack of Efficacy|0|||
28065853|NCT00281580|54721429|FG007|Overall Study|Lack of Efficacy|0|||
28065854|NCT00281580|54721430|FG008|Overall Study|Lack of Efficacy|0|||
28065855|NCT00281580|54721431|FG009|Overall Study|Lack of Efficacy|0|||
28065856|NCT00281580|54721432|FG010|Overall Study|Lack of Efficacy|0|||
28065857|NCT00281580|54721433|FG011|Overall Study|Lack of Efficacy|1|||
28065858|NCT00281580|54721434|FG012|Overall Study|Lack of Efficacy|0|||
28065859|NCT00281580|54721435|FG013|Overall Study|Lack of Efficacy|2|||
28065860|NCT00281580|54721436|FG014|Overall Study|Lack of Efficacy|1|||
28065861|NCT00281580|54721437|FG015|Overall Study|Lack of Efficacy|0|||
28065862|NCT00281580|54721422|FG000|Overall Study|Lost to Follow-up|0|||
28065863|NCT00281580|54721423|FG001|Overall Study|Lost to Follow-up|0|||
28065864|NCT00281580|54721424|FG002|Overall Study|Lost to Follow-up|0|||
28065865|NCT00281580|54721425|FG003|Overall Study|Lost to Follow-up|3|||
28065866|NCT00281580|54721426|FG004|Overall Study|Lost to Follow-up|0|||
28065867|NCT00281580|54721427|FG005|Overall Study|Lost to Follow-up|1|||
28065868|NCT00281580|54721428|FG006|Overall Study|Lost to Follow-up|0|||
28065869|NCT00281580|54721429|FG007|Overall Study|Lost to Follow-up|1|||
27848813|NCT01360632|54343101|FG004|Phase B (6 Weeks)|Protocol Deviation|0|||
27848814|NCT01360632|54343097|FG000|Phase B (6 Weeks)|Lack of Efficacy|0|||
28065870|NCT00281580|54721430|FG008|Overall Study|Lost to Follow-up|2|||
28065871|NCT00281580|54721431|FG009|Overall Study|Lost to Follow-up|1|||
28065872|NCT00281580|54721432|FG010|Overall Study|Lost to Follow-up|1|||
28065873|NCT00281580|54721433|FG011|Overall Study|Lost to Follow-up|0|||
28065874|NCT00281580|54721434|FG012|Overall Study|Lost to Follow-up|1|||
28065875|NCT00281580|54721435|FG013|Overall Study|Lost to Follow-up|0|||
28065876|NCT00281580|54721436|FG014|Overall Study|Lost to Follow-up|0|||
28118459|NCT02891226|54777742|FG006|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
28118460|NCT02891226|54777743|FG007|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
28118461|NCT02891226|54777744|FG008|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
28118462|NCT02891226|54777745|FG009|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
28118463|NCT02891226|54777746|FG010|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
28118464|NCT02891226|54777747|FG011|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
28118465|NCT02891226|54777748|FG012|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
28118466|NCT02891226|54777749|FG013|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
28118467|NCT02891226|54777750|FG014|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
28118468|NCT02891226|54777751|FG015|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
28118469|NCT02891226|54777736|FG000|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
28118470|NCT02891226|54777737|FG001|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
28118471|NCT02891226|54777738|FG002|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
28118472|NCT02891226|54777739|FG003|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|2|||
28118473|NCT02891226|54777740|FG004|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
28118474|NCT02891226|54777741|FG005|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
28118475|NCT02891226|54777742|FG006|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
28118476|NCT02891226|54777743|FG007|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
28118477|NCT02891226|54777744|FG008|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
28118478|NCT02891226|54777745|FG009|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
28118479|NCT02891226|54777746|FG010|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
28118480|NCT02891226|54777747|FG011|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
28118481|NCT02891226|54777748|FG012|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
28118482|NCT02891226|54777749|FG013|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
28118483|NCT02891226|54777750|FG014|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
28118484|NCT02891226|54777751|FG015|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
28118485|NCT02891226|54777736|FG000|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
28118486|NCT02891226|54777737|FG001|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
28118487|NCT02891226|54777738|FG002|Period 1 (Weeks 0 to 12)|Enrollment Failure|1|||
28118488|NCT02891226|54777739|FG003|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
28118489|NCT02891226|54777740|FG004|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
28118490|NCT02891226|54777741|FG005|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
28118491|NCT02891226|54777742|FG006|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
28118492|NCT02891226|54777743|FG007|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
28118493|NCT02891226|54777744|FG008|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
28118494|NCT02891226|54777745|FG009|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
28118495|NCT02891226|54777746|FG010|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
28118496|NCT02891226|54777747|FG011|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
28118497|NCT02891226|54777748|FG012|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
28118498|NCT02891226|54777749|FG013|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
28118499|NCT02891226|54777750|FG014|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
28118500|NCT02891226|54777751|FG015|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
28118501|NCT02891226|54777736|FG000|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
28118502|NCT02891226|54777737|FG001|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
28118503|NCT02891226|54777738|FG002|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
28118504|NCT02891226|54777739|FG003|Period 1 (Weeks 0 to 12)|Sponsor Decision|1|||
28118505|NCT02891226|54777740|FG004|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
28118506|NCT02891226|54777741|FG005|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
28118507|NCT02891226|54777742|FG006|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
28118508|NCT02891226|54777743|FG007|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
28118509|NCT02891226|54777744|FG008|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
28118510|NCT02891226|54777745|FG009|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
28118511|NCT02891226|54777746|FG010|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
28118512|NCT02891226|54777747|FG011|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
28118513|NCT02891226|54777748|FG012|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
28118514|NCT02891226|54777749|FG013|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
28118515|NCT02891226|54777750|FG014|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
28118516|NCT02891226|54777751|FG015|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
28118517|NCT02891226|54777736|FG000|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
28118518|NCT02891226|54777737|FG001|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
28118519|NCT02891226|54777738|FG002|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
28118520|NCT02891226|54777739|FG003|Period 1 (Weeks 0 to 12)|Lack of Efficacy|1|||
28118521|NCT02891226|54777740|FG004|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
28118522|NCT02891226|54777741|FG005|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
28118523|NCT02891226|54777742|FG006|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
28118524|NCT02891226|54777743|FG007|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
28118525|NCT02891226|54777744|FG008|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
28118526|NCT02891226|54777745|FG009|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
28118527|NCT02891226|54777746|FG010|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
28118528|NCT02891226|54777747|FG011|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
28118529|NCT02891226|54777748|FG012|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
28118530|NCT02891226|54777749|FG013|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
28118531|NCT02891226|54777750|FG014|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
28118532|NCT02891226|54777751|FG015|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
28118533|NCT02891226|54777736|FG000|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
28118534|NCT02891226|54777737|FG001|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
28118535|NCT02891226|54777738|FG002|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
28118536|NCT02891226|54777739|FG003|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
28118537|NCT02891226|54777740|FG004|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
28118538|NCT02891226|54777741|FG005|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
27817037|NCT01483599|54273968|FG007|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
27817038|NCT01483599|54273969|FG008|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
27817039|NCT01483599|54273970|FG009|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
27817040|NCT01483599|54273971|FG010|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2|||
27817041|NCT01483599|54273972|FG011|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
27817042|NCT01483599|54273973|FG012|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
27817043|NCT01483599|54273974|FG013|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
27817044|NCT01483599|54273961|FG000|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
27817045|NCT01483599|54273962|FG001|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
27817046|NCT01483599|54273963|FG002|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
27817047|NCT01483599|54273964|FG003|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
27817048|NCT01483599|54273965|FG004|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
27817049|NCT01483599|54273966|FG005|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
27817050|NCT01483599|54273967|FG006|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
27817051|NCT01483599|54273968|FG007|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
27817052|NCT01483599|54273969|FG008|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5|||
27817053|NCT01483599|54273970|FG009|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
27817054|NCT01483599|54273971|FG010|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
27817055|NCT01483599|54273972|FG011|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
27817056|NCT01483599|54273973|FG012|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1|||
28065877|NCT00281580|54721437|FG015|Overall Study|Lost to Follow-up|0|||
27817057|NCT01483599|54273974|FG013|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4|||
28065878|NCT00281580|54721422|FG000|Overall Study|Randomised in error; pregnancy; moving|0|||
28065879|NCT00281580|54721423|FG001|Overall Study|Randomised in error; pregnancy; moving|0|||
28065880|NCT00281580|54721424|FG002|Overall Study|Randomised in error; pregnancy; moving|0|||
28065881|NCT00281580|54721425|FG003|Overall Study|Randomised in error; pregnancy; moving|2|||
28065882|NCT00281580|54721426|FG004|Overall Study|Randomised in error; pregnancy; moving|0|||
28065883|NCT00281580|54721427|FG005|Overall Study|Randomised in error; pregnancy; moving|0|||
28065884|NCT00281580|54721428|FG006|Overall Study|Randomised in error; pregnancy; moving|1|||
28065885|NCT00281580|54721429|FG007|Overall Study|Randomised in error; pregnancy; moving|0|||
28065886|NCT00281580|54721430|FG008|Overall Study|Randomised in error; pregnancy; moving|2|||
28065887|NCT00281580|54721431|FG009|Overall Study|Randomised in error; pregnancy; moving|1|||
28065888|NCT00281580|54721432|FG010|Overall Study|Randomised in error; pregnancy; moving|1|||
28065889|NCT00281580|54721433|FG011|Overall Study|Randomised in error; pregnancy; moving|1|||
28065890|NCT00281580|54721434|FG012|Overall Study|Randomised in error; pregnancy; moving|2|||
28065891|NCT00281580|54721435|FG013|Overall Study|Randomised in error; pregnancy; moving|0|||
28065892|NCT00281580|54721436|FG014|Overall Study|Randomised in error; pregnancy; moving|1|||
28065893|NCT00281580|54721437|FG015|Overall Study|Randomised in error; pregnancy; moving|2|||
28065894|NCT00495755|54721506|FG000|Overall Study|Adverse Event|3|||
28065895|NCT00495677|54721518|FG000|Stage 1 (25 Days)|Adverse Event|0|||
28065896|NCT00495677|54721519|FG001|Stage 1 (25 Days)|Adverse Event|0|||
28065897|NCT00495677|54721520|FG002|Stage 1 (25 Days)|Adverse Event|1|||
28065898|NCT00495677|54721521|FG003|Stage 1 (25 Days)|Adverse Event|0|||
28065899|NCT00495677|54721522|FG004|Stage 1 (25 Days)|Adverse Event|0|||
28065900|NCT00495677|54721523|FG005|Stage 1 (25 Days)|Adverse Event|0|||
28065901|NCT00495677|54721524|FG006|Stage 1 (25 Days)|Adverse Event|0|||
28065902|NCT00495521|54721542|FG000|Overall Study|Physician Decision|0|||
28065903|NCT00495521|54721543|FG001|Overall Study|Physician Decision|1|||
28065904|NCT00273858|54721549|FG000|Overall Study|Not completed 24 month observation time|334|||
28065905|NCT00273858|54721549|FG000|Overall Study|Lost to Follow-up|101|||
28065906|NCT00273858|54721549|FG000|Overall Study|Withdrawal by Subject|21|||
28065907|NCT00273858|54721549|FG000|Overall Study|Adverse Event|81|||
28065908|NCT00494507|54721557|FG000|Double-Blind Phase|Adverse Event|2|||
28065909|NCT00494507|54721558|FG001|Double-Blind Phase|Adverse Event|0|||
28065910|NCT00494507|54721559|FG002|Double-Blind Phase|Adverse Event|1|||
28065911|NCT00494507|54721560|FG003|Double-Blind Phase|Adverse Event|0|||
28065912|NCT00494507|54721557|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
28065913|NCT00494507|54721558|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
28065914|NCT00494507|54721559|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
28065915|NCT00494507|54721560|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
28065916|NCT00494507|54721557|FG000|Double-Blind Phase|Subject Non-compliance|0|||
28118539|NCT02891226|54777742|FG006|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
27848815|NCT01360632|54343098|FG001|Phase B (6 Weeks)|Lack of Efficacy|1|||
27848816|NCT01360632|54343099|FG002|Phase B (6 Weeks)|Lack of Efficacy|0|||
27848817|NCT01360632|54343100|FG003|Phase B (6 Weeks)|Lack of Efficacy|0|||
27848818|NCT01360632|54343101|FG004|Phase B (6 Weeks)|Lack of Efficacy|0|||
27848819|NCT01360632|54343097|FG000|Phase A+|Lost to Follow-up|0|||
27848820|NCT01360632|54343098|FG001|Phase A+|Lost to Follow-up|0|||
27848821|NCT01360632|54343099|FG002|Phase A+|Lost to Follow-up|0|||
27848822|NCT01360632|54343100|FG003|Phase A+|Lost to Follow-up|0|||
27848823|NCT01360632|54343101|FG004|Phase A+|Lost to Follow-up|2|||
27817058|NCT01483599|54273961|FG000|After Controlled Period(Week 16-Week 40)|Other|0|||
27817059|NCT01483599|54273962|FG001|After Controlled Period(Week 16-Week 40)|Other|0|||
27817060|NCT01483599|54273963|FG002|After Controlled Period(Week 16-Week 40)|Other|0|||
27817061|NCT01483599|54273964|FG003|After Controlled Period(Week 16-Week 40)|Other|0|||
27817062|NCT01483599|54273965|FG004|After Controlled Period(Week 16-Week 40)|Other|0|||
27817063|NCT01483599|54273966|FG005|After Controlled Period(Week 16-Week 40)|Other|0|||
27817064|NCT01483599|54273967|FG006|After Controlled Period(Week 16-Week 40)|Other|0|||
27817065|NCT01483599|54273968|FG007|After Controlled Period(Week 16-Week 40)|Other|1|||
27817066|NCT01483599|54273969|FG008|After Controlled Period(Week 16-Week 40)|Other|0|||
27817067|NCT01483599|54273970|FG009|After Controlled Period(Week 16-Week 40)|Other|4|||
27817068|NCT01483599|54273971|FG010|After Controlled Period(Week 16-Week 40)|Other|0|||
27817069|NCT01483599|54273972|FG011|After Controlled Period(Week 16-Week 40)|Other|0|||
27817070|NCT01483599|54273973|FG012|After Controlled Period(Week 16-Week 40)|Other|1|||
27817071|NCT01483599|54273974|FG013|After Controlled Period(Week 16-Week 40)|Other|0|||
27817072|NCT01507545|54274067|FG000|Overall Study|Withdrawal by Subject|6|||
27817073|NCT01507545|54274068|FG001|Overall Study|Withdrawal by Subject|2|||
27817074|NCT01507545|54274067|FG000|Overall Study|Lost to Follow-up|1|||
27817075|NCT01507545|54274068|FG001|Overall Study|Lost to Follow-up|0|||
27817076|NCT01507545|54274067|FG000|Overall Study|Discontinuation of the study by sponsor|11|||
27817077|NCT01507545|54274068|FG001|Overall Study|Discontinuation of the study by sponsor|9|||
27817078|NCT01507545|54274067|FG000|Overall Study|Progressive disease|60|||
27817079|NCT01507545|54274068|FG001|Overall Study|Progressive disease|27|||
27817080|NCT01507545|54274067|FG000|Overall Study|Other|6|||
27817081|NCT01507545|54274068|FG001|Overall Study|Other|4|||
27817082|NCT01482819|54274074|FG000|Overall Study|Lost to Follow-up|2|||
27817083|NCT01534533|54274086|FG000|Overall Study|Lost to Follow-up|3|||
27817084|NCT01534533|54274087|FG001|Overall Study|Lost to Follow-up|0|||
27817085|NCT01534533|54274088|FG002|Overall Study|Lost to Follow-up|4|||
27817086|NCT01534533|54274089|FG003|Overall Study|Lost to Follow-up|3|||
27817087|NCT01534533|54274086|FG000|Overall Study|Withdrawal by Subject|5|||
27817088|NCT01534533|54274087|FG001|Overall Study|Withdrawal by Subject|3|||
27848824|NCT01360632|54343097|FG000|Phase A+|Adverse Event|0|||
27848825|NCT01360632|54343098|FG001|Phase A+|Adverse Event|0|||
28118540|NCT02891226|54777743|FG007|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
28118541|NCT02891226|54777744|FG008|Period 2 (Weeks 12 to 52)|Adverse Event|3|||
28118542|NCT02891226|54777745|FG009|Period 2 (Weeks 12 to 52)|Adverse Event|7|||
28118543|NCT02891226|54777746|FG010|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
28118544|NCT02891226|54777747|FG011|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
28118545|NCT02891226|54777748|FG012|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
28118546|NCT02891226|54777749|FG013|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
28118547|NCT02891226|54777750|FG014|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
28118548|NCT02891226|54777751|FG015|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
28118549|NCT02891226|54777736|FG000|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
28118550|NCT02891226|54777737|FG001|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
28118551|NCT02891226|54777738|FG002|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
28118552|NCT02891226|54777739|FG003|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
28118553|NCT02891226|54777740|FG004|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
28118554|NCT02891226|54777741|FG005|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
28118555|NCT02891226|54777742|FG006|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
28118556|NCT02891226|54777743|FG007|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
28118557|NCT02891226|54777744|FG008|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
28118558|NCT02891226|54777745|FG009|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
28118559|NCT02891226|54777746|FG010|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
28118560|NCT02891226|54777747|FG011|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
28118561|NCT02891226|54777748|FG012|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
27817089|NCT01534533|54274088|FG002|Overall Study|Withdrawal by Subject|4|||
27817090|NCT01534533|54274089|FG003|Overall Study|Withdrawal by Subject|1|||
27817091|NCT01506609|54274223|FG000|Overall Study|Adverse Event Related to Progression|0|||
27817092|NCT01506609|54274224|FG001|Overall Study|Adverse Event Related to Progression|0|||
27817093|NCT01506609|54274225|FG002|Overall Study|Adverse Event Related to Progression|0|||
27848826|NCT01360632|54343099|FG002|Phase A+|Adverse Event|0|||
27848827|NCT01360632|54343100|FG003|Phase A+|Adverse Event|0|||
27848828|NCT01360632|54343101|FG004|Phase A+|Adverse Event|2|||
27848829|NCT01360632|54343097|FG000|Phase A+|Met Withdrawal Criteria|0|||
28118562|NCT02891226|54777749|FG013|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
28118563|NCT02891226|54777750|FG014|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
28118564|NCT02891226|54777751|FG015|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
28118565|NCT02891226|54777736|FG000|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
28118566|NCT02891226|54777737|FG001|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
28118567|NCT02891226|54777738|FG002|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
28118568|NCT02891226|54777739|FG003|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
28118569|NCT02891226|54777740|FG004|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
28118570|NCT02891226|54777741|FG005|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
28118571|NCT02891226|54777742|FG006|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
28118572|NCT02891226|54777743|FG007|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|2|||
28118573|NCT02891226|54777744|FG008|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
28118574|NCT02891226|54777745|FG009|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|6|||
28118575|NCT02891226|54777746|FG010|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
28118576|NCT02891226|54777747|FG011|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
28118577|NCT02891226|54777748|FG012|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
28118578|NCT02891226|54777749|FG013|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
28118579|NCT02891226|54777750|FG014|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
28118580|NCT02891226|54777751|FG015|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
28118581|NCT02891226|54777736|FG000|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
28118582|NCT02891226|54777737|FG001|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
28118583|NCT02891226|54777738|FG002|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
28118584|NCT02891226|54777739|FG003|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
28118585|NCT02891226|54777740|FG004|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|1|||
28118586|NCT02891226|54777741|FG005|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
28118587|NCT02891226|54777742|FG006|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
28118588|NCT02891226|54777743|FG007|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
28118589|NCT02891226|54777744|FG008|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
28118590|NCT02891226|54777745|FG009|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
28118591|NCT02891226|54777746|FG010|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
28118592|NCT02891226|54777747|FG011|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
28118593|NCT02891226|54777748|FG012|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
28118594|NCT02891226|54777749|FG013|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
28118595|NCT02891226|54777750|FG014|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
28118596|NCT02891226|54777751|FG015|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
28118597|NCT02891226|54777736|FG000|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
28118598|NCT02891226|54777737|FG001|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
28118599|NCT02891226|54777738|FG002|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
28118600|NCT02891226|54777739|FG003|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
28118601|NCT02891226|54777740|FG004|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
28118602|NCT02891226|54777741|FG005|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
28118603|NCT02891226|54777742|FG006|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|1|||
28118604|NCT02891226|54777743|FG007|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
28118605|NCT02891226|54777744|FG008|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
28118606|NCT02891226|54777745|FG009|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
28118607|NCT02891226|54777746|FG010|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
28118608|NCT02891226|54777747|FG011|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
28118609|NCT02891226|54777748|FG012|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
28118610|NCT02891226|54777749|FG013|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
28118611|NCT02891226|54777750|FG014|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
28118612|NCT02891226|54777751|FG015|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
28118613|NCT02891226|54777736|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
28118614|NCT02891226|54777737|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
28118615|NCT02891226|54777738|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
28118616|NCT02891226|54777739|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
28118617|NCT02891226|54777740|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
28118618|NCT02891226|54777741|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
28118619|NCT02891226|54777742|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
28118620|NCT02891226|54777743|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
28118621|NCT02891226|54777744|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
28118622|NCT02891226|54777745|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
28118623|NCT02891226|54777746|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
28118624|NCT02891226|54777747|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
28118625|NCT02891226|54777748|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
28118626|NCT02891226|54777749|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
28118627|NCT02891226|54777750|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
28118628|NCT02891226|54777751|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
28118629|NCT02891226|54777736|FG000|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
28118630|NCT02891226|54777737|FG001|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
28118631|NCT02891226|54777738|FG002|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
28118632|NCT02891226|54777739|FG003|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
28118633|NCT02891226|54777740|FG004|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
28118634|NCT02891226|54777741|FG005|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
28118635|NCT02891226|54777742|FG006|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
28118636|NCT02891226|54777743|FG007|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|1|||
28118637|NCT02891226|54777744|FG008|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
28118638|NCT02891226|54777745|FG009|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
28118639|NCT02891226|54777746|FG010|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
28118640|NCT02891226|54777747|FG011|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
28118641|NCT02891226|54777748|FG012|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
27817094|NCT01506609|54274226|FG003|Overall Study|Adverse Event Related to Progression|3|||
28065917|NCT00494507|54721558|FG001|Double-Blind Phase|Subject Non-compliance|0|||
28065918|NCT00494507|54721559|FG002|Double-Blind Phase|Subject Non-compliance|1|||
28065919|NCT00494507|54721560|FG003|Double-Blind Phase|Subject Non-compliance|0|||
28065920|NCT00494507|54721557|FG000|Double-Blind Phase|Negative DNA test|0|||
28065921|NCT00494507|54721558|FG001|Double-Blind Phase|Negative DNA test|0|||
28118642|NCT02891226|54777749|FG013|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
28118643|NCT02891226|54777750|FG014|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
28118644|NCT02891226|54777751|FG015|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
28118645|NCT02891226|54777736|FG000|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
28118646|NCT02891226|54777737|FG001|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
28118647|NCT02891226|54777738|FG002|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
28065922|NCT00494507|54721559|FG002|Double-Blind Phase|Negative DNA test|0|||
28065923|NCT00494507|54721560|FG003|Double-Blind Phase|Negative DNA test|1|||
28065924|NCT00494507|54721557|FG000|Open-Label Phase|Adverse Event|0|||
28065925|NCT00494507|54721558|FG001|Open-Label Phase|Adverse Event|1|||
28065926|NCT00494507|54721559|FG002|Open-Label Phase|Adverse Event|5|||
28065927|NCT00494507|54721560|FG003|Open-Label Phase|Adverse Event|3|||
28065928|NCT00494507|54721557|FG000|Open-Label Phase|Worsening Disease|0|||
28065929|NCT00494507|54721558|FG001|Open-Label Phase|Worsening Disease|0|||
28118648|NCT02891226|54777739|FG003|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
28118649|NCT02891226|54777740|FG004|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
28118650|NCT02891226|54777741|FG005|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
28118651|NCT02891226|54777742|FG006|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
28118652|NCT02891226|54777743|FG007|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
28118653|NCT02891226|54777744|FG008|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|1|||
28118654|NCT02891226|54777745|FG009|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
28118655|NCT02891226|54777746|FG010|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
28118656|NCT02891226|54777747|FG011|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
28118657|NCT02891226|54777748|FG012|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
28118658|NCT02891226|54777749|FG013|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
28118659|NCT02891226|54777750|FG014|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
28118660|NCT02891226|54777751|FG015|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
28118661|NCT02891226|54777736|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
28118662|NCT02891226|54777737|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
28118663|NCT02891226|54777738|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
28118664|NCT02891226|54777739|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
28118665|NCT02891226|54777740|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
28118666|NCT02891226|54777741|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
28118667|NCT02891226|54777742|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
28118668|NCT02891226|54777743|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
28118669|NCT02891226|54777744|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
28065930|NCT00494507|54721559|FG002|Open-Label Phase|Worsening Disease|0|||
28065931|NCT00494507|54721560|FG003|Open-Label Phase|Worsening Disease|2|||
28065932|NCT00292188|54721582|FG000|Single-Blind|Adverse Event|14|||
28065933|NCT00292188|54721583|FG001|Single-Blind|Adverse Event|0|||
28065934|NCT00292188|54721584|FG002|Single-Blind|Adverse Event|0|||
28065935|NCT00292188|54721582|FG000|Single-Blind|Lack of Efficacy|2|||
28065936|NCT00292188|54721583|FG001|Single-Blind|Lack of Efficacy|0|||
28065937|NCT00292188|54721584|FG002|Single-Blind|Lack of Efficacy|0|||
28065938|NCT00292188|54721582|FG000|Single-Blind|Laboratory Abnormality|5|||
28065939|NCT00292188|54721583|FG001|Single-Blind|Laboratory Abnormality|0|||
28065940|NCT00292188|54721584|FG002|Single-Blind|Laboratory Abnormality|0|||
28065941|NCT00292188|54721582|FG000|Single-Blind|Lost to Follow-up|3|||
28065942|NCT00292188|54721583|FG001|Single-Blind|Lost to Follow-up|0|||
28065943|NCT00292188|54721584|FG002|Single-Blind|Lost to Follow-up|0|||
28065944|NCT00292188|54721582|FG000|Single-Blind|Other|77|||
28065945|NCT00292188|54721583|FG001|Single-Blind|Other|0|||
28065946|NCT00292188|54721584|FG002|Single-Blind|Other|0|||
28065947|NCT00292188|54721582|FG000|Single-Blind|Withdrawal by Subject|12|||
28065948|NCT00292188|54721583|FG001|Single-Blind|Withdrawal by Subject|0|||
28065949|NCT00292188|54721584|FG002|Single-Blind|Withdrawal by Subject|0|||
28065950|NCT00292188|54721582|FG000|Single-Blind|Did not receive treatment|1|||
28065951|NCT00292188|54721583|FG001|Single-Blind|Did not receive treatment|0|||
28065952|NCT00292188|54721584|FG002|Single-Blind|Did not receive treatment|0|||
28065953|NCT00292188|54721582|FG000|Double-Blind|Adverse Event|0|||
28065954|NCT00292188|54721583|FG001|Double-Blind|Adverse Event|25|||
28065955|NCT00292188|54721584|FG002|Double-Blind|Adverse Event|9|||
28065956|NCT00292188|54721582|FG000|Double-Blind|Lack of Efficacy|0|||
28065957|NCT00292188|54721583|FG001|Double-Blind|Lack of Efficacy|2|||
28065958|NCT00292188|54721584|FG002|Double-Blind|Lack of Efficacy|12|||
28065959|NCT00292188|54721582|FG000|Double-Blind|Lost to Follow-up|0|||
28065960|NCT00292188|54721583|FG001|Double-Blind|Lost to Follow-up|1|||
28065961|NCT00292188|54721584|FG002|Double-Blind|Lost to Follow-up|0|||
28065962|NCT00292188|54721582|FG000|Double-Blind|Other|0|||
28065963|NCT00292188|54721583|FG001|Double-Blind|Other|3|||
28065964|NCT00292188|54721584|FG002|Double-Blind|Other|4|||
28065965|NCT00292188|54721582|FG000|Double-Blind|Withdrawal by Subject|0|||
28065966|NCT00292188|54721583|FG001|Double-Blind|Withdrawal by Subject|0|||
28065967|NCT00292188|54721584|FG002|Double-Blind|Withdrawal by Subject|3|||
28065968|NCT00292188|54721582|FG000|Double-Blind|Laboratory Abnormality|0|||
28065969|NCT00292188|54721583|FG001|Double-Blind|Laboratory Abnormality|0|||
28065970|NCT00292188|54721584|FG002|Double-Blind|Laboratory Abnormality|1|||
28065971|NCT00272844|54721591|FG000|Overall Study|Withdrawal by Subject|5|||
28065972|NCT00271596|54721597|FG000|Overall Study|Protocol Violation|1|||
28065973|NCT00271596|54721598|FG001|Overall Study|Protocol Violation|0|||
28065974|NCT00271596|54721597|FG000|Overall Study|Withdrawal by Subject|0|||
28065975|NCT00271596|54721598|FG001|Overall Study|Withdrawal by Subject|1|||
28065976|NCT00291642|54721609|FG000|Overall Study|Adverse Event|1|||
28065977|NCT00291642|54721610|FG001|Overall Study|Adverse Event|0|||
28065978|NCT00291642|54721611|FG002|Overall Study|Adverse Event|1|||
28065979|NCT00291642|54721612|FG003|Overall Study|Adverse Event|0|||
28118670|NCT02891226|54777745|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|1|||
28118671|NCT02891226|54777746|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
28118672|NCT02891226|54777747|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
28118673|NCT02891226|54777748|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
28118674|NCT02891226|54777749|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
28118675|NCT02891226|54777750|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
28118676|NCT02891226|54777751|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
28118677|NCT02891226|54777736|FG000|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
28118678|NCT02891226|54777737|FG001|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
28118679|NCT02891226|54777738|FG002|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
28118680|NCT02891226|54777739|FG003|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
28118681|NCT02891226|54777740|FG004|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
28118682|NCT02891226|54777741|FG005|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
28118683|NCT02891226|54777742|FG006|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
28118684|NCT02891226|54777743|FG007|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
28118685|NCT02891226|54777744|FG008|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
28118686|NCT02891226|54777745|FG009|Period 2 (Weeks 12 to 52)|Sponsor Decision|1|||
28118687|NCT02891226|54777746|FG010|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
28118688|NCT02891226|54777747|FG011|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
28118689|NCT02891226|54777748|FG012|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
28118690|NCT02891226|54777749|FG013|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
28118691|NCT02891226|54777750|FG014|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
28118692|NCT02891226|54777751|FG015|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
28118693|NCT02891226|54777736|FG000|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
28118694|NCT02891226|54777737|FG001|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
28118695|NCT02891226|54777738|FG002|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
28065980|NCT00291642|54721613|FG004|Overall Study|Adverse Event|1|||
28065981|NCT00291642|54721609|FG000|Overall Study|Patient missed visit|0|||
28065982|NCT00291642|54721610|FG001|Overall Study|Patient missed visit|0|||
28065983|NCT00291642|54721611|FG002|Overall Study|Patient missed visit|1|||
28065984|NCT00291642|54721612|FG003|Overall Study|Patient missed visit|0|||
28065985|NCT00291642|54721613|FG004|Overall Study|Patient missed visit|0|||
28065986|NCT00291642|54721609|FG000|Overall Study|Intake of prohibited medication|1|||
28065987|NCT00291642|54721610|FG001|Overall Study|Intake of prohibited medication|0|||
28065988|NCT00291642|54721611|FG002|Overall Study|Intake of prohibited medication|0|||
28065989|NCT00291642|54721612|FG003|Overall Study|Intake of prohibited medication|0|||
28065990|NCT00291642|54721613|FG004|Overall Study|Intake of prohibited medication|0|||
28065991|NCT00280566|54721627|FG000|Period 1 Open Label Ziprasidone|Lack of Efficacy|31|||
28065992|NCT00280566|54721628|FG001|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
28065993|NCT00280566|54721629|FG002|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
28065994|NCT00280566|54721627|FG000|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3|||
28065995|NCT00280566|54721628|FG001|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
28065996|NCT00280566|54721629|FG002|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
28065997|NCT00280566|54721627|FG000|Period 1 Open Label Ziprasidone|Adverse Event|148|||
28065998|NCT00280566|54721628|FG001|Period 1 Open Label Ziprasidone|Adverse Event|0|||
28065999|NCT00280566|54721629|FG002|Period 1 Open Label Ziprasidone|Adverse Event|0|||
28066000|NCT00280566|54721627|FG000|Period 1 Open Label Ziprasidone|Lost to Follow-up|35|||
28066001|NCT00280566|54721628|FG001|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
28066002|NCT00280566|54721629|FG002|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
28066003|NCT00280566|54721627|FG000|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76|||
28066004|NCT00280566|54721628|FG001|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
28066005|NCT00280566|54721629|FG002|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
28066006|NCT00280566|54721627|FG000|Period 1 Open Label Ziprasidone|Miscellaneous|50|||
28066007|NCT00280566|54721628|FG001|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
28066008|NCT00280566|54721629|FG002|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
28066009|NCT00280566|54721627|FG000|Period 2 Double Blind|Lack of Efficacy|0|||
28066010|NCT00280566|54721628|FG001|Period 2 Double Blind|Lack of Efficacy|9|||
28066011|NCT00280566|54721629|FG002|Period 2 Double Blind|Lack of Efficacy|22|||
28066012|NCT00280566|54721627|FG000|Period 2 Double Blind|Laboratory Abnormality|0|||
28066013|NCT00280566|54721628|FG001|Period 2 Double Blind|Laboratory Abnormality|1|||
28066014|NCT00280566|54721629|FG002|Period 2 Double Blind|Laboratory Abnormality|0|||
28066015|NCT00280566|54721627|FG000|Period 2 Double Blind|Adverse Event|0|||
28066016|NCT00280566|54721628|FG001|Period 2 Double Blind|Adverse Event|11|||
28066017|NCT00280566|54721629|FG002|Period 2 Double Blind|Adverse Event|15|||
28066018|NCT00280566|54721627|FG000|Period 2 Double Blind|Lost to Follow-up|0|||
28066019|NCT00280566|54721628|FG001|Period 2 Double Blind|Lost to Follow-up|3|||
28066020|NCT00280566|54721629|FG002|Period 2 Double Blind|Lost to Follow-up|6|||
28066021|NCT00280566|54721627|FG000|Period 2 Double Blind|Withdrawal by Subject|0|||
28118696|NCT02891226|54777739|FG003|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
28118697|NCT02891226|54777740|FG004|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
28118698|NCT02891226|54777741|FG005|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
28118699|NCT02891226|54777742|FG006|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
28118700|NCT02891226|54777743|FG007|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
28118701|NCT02891226|54777744|FG008|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
28118702|NCT02891226|54777745|FG009|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
28118703|NCT02891226|54777746|FG010|Period 3 (Weeks 52 to 208)|Adverse Event|5|||
28118704|NCT02891226|54777747|FG011|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
28118705|NCT02891226|54777748|FG012|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
28118706|NCT02891226|54777749|FG013|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
28118707|NCT02891226|54777750|FG014|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
28118708|NCT02891226|54777751|FG015|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
28118709|NCT02891226|54777736|FG000|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
28118710|NCT02891226|54777737|FG001|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
28118711|NCT02891226|54777738|FG002|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
28118712|NCT02891226|54777739|FG003|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
28118713|NCT02891226|54777740|FG004|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
28118714|NCT02891226|54777741|FG005|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
28118715|NCT02891226|54777742|FG006|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
28118716|NCT02891226|54777743|FG007|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
28118717|NCT02891226|54777744|FG008|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
28118718|NCT02891226|54777745|FG009|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
28118719|NCT02891226|54777746|FG010|Period 3 (Weeks 52 to 208)|Lost to Follow-up|1|||
28118720|NCT02891226|54777747|FG011|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
28118721|NCT02891226|54777748|FG012|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
28118722|NCT02891226|54777749|FG013|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
28118723|NCT02891226|54777750|FG014|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
28118724|NCT02891226|54777751|FG015|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
28118725|NCT02891226|54777736|FG000|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
28118726|NCT02891226|54777737|FG001|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
28118727|NCT02891226|54777738|FG002|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
28118728|NCT02891226|54777739|FG003|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
28118729|NCT02891226|54777740|FG004|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
28118730|NCT02891226|54777741|FG005|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
28118731|NCT02891226|54777742|FG006|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
28118732|NCT02891226|54777743|FG007|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
28118733|NCT02891226|54777744|FG008|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
28118734|NCT02891226|54777745|FG009|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
28118735|NCT02891226|54777746|FG010|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|14|||
28118736|NCT02891226|54777747|FG011|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
28118737|NCT02891226|54777748|FG012|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
28118738|NCT02891226|54777749|FG013|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
28118739|NCT02891226|54777750|FG014|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
28118740|NCT02891226|54777751|FG015|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
28118741|NCT02891226|54777736|FG000|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
28118742|NCT02891226|54777737|FG001|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
28118743|NCT02891226|54777738|FG002|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
28066022|NCT00280566|54721628|FG001|Period 2 Double Blind|Withdrawal by Subject|9|||
28066023|NCT00280566|54721629|FG002|Period 2 Double Blind|Withdrawal by Subject|9|||
28066024|NCT00280566|54721627|FG000|Period 2 Double Blind|miscellaneous|0|||
28066025|NCT00280566|54721628|FG001|Period 2 Double Blind|miscellaneous|10|||
28066026|NCT00280566|54721629|FG002|Period 2 Double Blind|miscellaneous|5|||
28066027|NCT00270894|54721636|FG000|Overall Study|Adverse Event|1|||
28066028|NCT00270894|54721636|FG000|Overall Study|Withdrawal by Subject|1|||
28066029|NCT00317642|54721642|FG000|Overall Study|Not Received Either Study Drug|1|||
28066030|NCT00317642|54721643|FG001|Overall Study|Not Received Either Study Drug|3|||
28066031|NCT00317642|54721642|FG000|Overall Study|Physician Decision|15|||
28066032|NCT00317642|54721643|FG001|Overall Study|Physician Decision|7|||
28066033|NCT00317642|54721642|FG000|Overall Study|Participant declined treatment|14|||
28066034|NCT00317642|54721643|FG001|Overall Study|Participant declined treatment|3|||
28066035|NCT00317642|54721642|FG000|Overall Study|Adverse Event|17|||
28066036|NCT00317642|54721643|FG001|Overall Study|Adverse Event|5|||
28066037|NCT00317642|54721642|FG000|Overall Study|Treatment Failure|56|||
28066038|NCT00317642|54721643|FG001|Overall Study|Treatment Failure|102|||
28066039|NCT00317642|54721642|FG000|Overall Study|Disease Recurrence|1|||
28066040|NCT00317642|54721643|FG001|Overall Study|Disease Recurrence|2|||
28118744|NCT02891226|54777739|FG003|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
27848830|NCT01360632|54343098|FG001|Phase A+|Met Withdrawal Criteria|0|||
28066041|NCT00317642|54721642|FG000|Overall Study|Death|14|||
28118745|NCT02891226|54777740|FG004|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
28118746|NCT02891226|54777741|FG005|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
28118747|NCT02891226|54777742|FG006|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
28118748|NCT02891226|54777743|FG007|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
28066042|NCT00317642|54721643|FG001|Overall Study|Death|7|||
27817095|NCT01506609|54274227|FG004|Overall Study|Adverse Event Related to Progression|7|||
27817096|NCT01506609|54274228|FG005|Overall Study|Adverse Event Related to Progression|3|||
28118749|NCT02891226|54777744|FG008|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
28118750|NCT02891226|54777745|FG009|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
28118751|NCT02891226|54777746|FG010|Period 3 (Weeks 52 to 208)|Roll over to AMAX|108|||
28118752|NCT02891226|54777747|FG011|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
28118753|NCT02891226|54777748|FG012|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
28118754|NCT02891226|54777749|FG013|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
28118755|NCT02891226|54777750|FG014|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
28118756|NCT02891226|54777751|FG015|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
28118757|NCT02891226|54777736|FG000|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
27848831|NCT01360632|54343099|FG002|Phase A+|Met Withdrawal Criteria|0|||
27848832|NCT01360632|54343100|FG003|Phase A+|Met Withdrawal Criteria|0|||
27848833|NCT01360632|54343101|FG004|Phase A+|Met Withdrawal Criteria|7|||
27848834|NCT01360632|54343097|FG000|Phase A+|Physician Decision|0|||
27848835|NCT01360632|54343098|FG001|Phase A+|Physician Decision|0|||
27848836|NCT01360632|54343099|FG002|Phase A+|Physician Decision|0|||
27817097|NCT01506609|54274223|FG000|Overall Study|Adverse Event Not Related to Progression|0|||
27817098|NCT01506609|54274224|FG001|Overall Study|Adverse Event Not Related to Progression|1|||
27848837|NCT01360632|54343100|FG003|Phase A+|Physician Decision|0|||
27848838|NCT01360632|54343101|FG004|Phase A+|Physician Decision|3|||
27848839|NCT01360632|54343097|FG000|Phase A+|Withdrawal by Subject|0|||
27848840|NCT01360632|54343098|FG001|Phase A+|Withdrawal by Subject|0|||
27848841|NCT01360632|54343099|FG002|Phase A+|Withdrawal by Subject|0|||
27848842|NCT01360632|54343100|FG003|Phase A+|Withdrawal by Subject|0|||
27848843|NCT01360632|54343101|FG004|Phase A+|Withdrawal by Subject|8|||
28066043|NCT00317642|54721642|FG000|Overall Study|Not Continue to Consolidation|2|||
28066044|NCT00317642|54721643|FG001|Overall Study|Not Continue to Consolidation|0|||
28066045|NCT00317642|54721642|FG000|Overall Study|Withdrawal by Subject|0|||
28066046|NCT00317642|54721643|FG001|Overall Study|Withdrawal by Subject|1|||
28066047|NCT00317642|54721642|FG000|Overall Study|Referred For Transplantation|1|||
28066048|NCT00317642|54721643|FG001|Overall Study|Referred For Transplantation|0|||
28066049|NCT00317642|54721642|FG000|Overall Study|AML Not Centrally Confirmed|1|||
28066050|NCT00317642|54721643|FG001|Overall Study|AML Not Centrally Confirmed|5|||
28066051|NCT00295022|54721659|FG000|Overall Study|Adverse Event|1|||
28066052|NCT00295022|54721660|FG001|Overall Study|Adverse Event|1|||
27817099|NCT01506609|54274225|FG002|Overall Study|Adverse Event Not Related to Progression|0|||
28066053|NCT00295022|54721661|FG002|Overall Study|Adverse Event|2|||
28118758|NCT02891226|54777737|FG001|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
27817100|NCT01506609|54274226|FG003|Overall Study|Adverse Event Not Related to Progression|6|||
27817101|NCT01506609|54274227|FG004|Overall Study|Adverse Event Not Related to Progression|10|||
27817102|NCT01506609|54274228|FG005|Overall Study|Adverse Event Not Related to Progression|5|||
27817103|NCT01506609|54274223|FG000|Overall Study|Withdrawal by Subject|0|||
27817104|NCT01506609|54274224|FG001|Overall Study|Withdrawal by Subject|0|||
27817105|NCT01506609|54274225|FG002|Overall Study|Withdrawal by Subject|0|||
27848844|NCT01360632|54343097|FG000|Phase A+|Protocol Deviation|0|||
27848845|NCT01360632|54343098|FG001|Phase A+|Protocol Deviation|0|||
27940369|NCT01185366|54596648|FG001|Crossover to Second Line Therapy|Physician Decision|1|||
28118759|NCT02891226|54777738|FG002|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
27848846|NCT01360632|54343099|FG002|Phase A+|Protocol Deviation|0|||
27848847|NCT01360632|54343100|FG003|Phase A+|Protocol Deviation|0|||
28066054|NCT00295022|54721659|FG000|Overall Study|Lost to Follow-up|0|||
27848848|NCT01360632|54343101|FG004|Phase A+|Protocol Deviation|3|||
28066055|NCT00295022|54721660|FG001|Overall Study|Lost to Follow-up|0|||
27848849|NCT04157400|54343147|FG000|Overall Study|Withdrawal by Subject|1|||
27848850|NCT04157400|54343147|FG000|Overall Study|Lost to Follow-up|3|||
27848851|NCT02626182|54343221|FG000|Overall Study|Adverse Event|2|||
28118760|NCT02891226|54777739|FG003|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
28118761|NCT02891226|54777740|FG004|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
28118762|NCT02891226|54777741|FG005|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
28118763|NCT02891226|54777742|FG006|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
28118764|NCT02891226|54777743|FG007|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
28118765|NCT02891226|54777744|FG008|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
28118766|NCT02891226|54777745|FG009|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
28118767|NCT02891226|54777746|FG010|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|2|||
28118768|NCT02891226|54777747|FG011|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
28118769|NCT02891226|54777748|FG012|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
28118770|NCT02891226|54777749|FG013|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
28118771|NCT02891226|54777750|FG014|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
28118772|NCT02891226|54777751|FG015|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
28118773|NCT02891226|54777736|FG000|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
28118774|NCT02891226|54777737|FG001|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
28118775|NCT02891226|54777738|FG002|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
28118776|NCT02891226|54777739|FG003|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
28118777|NCT02891226|54777740|FG004|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
28118778|NCT02891226|54777741|FG005|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
28118779|NCT02891226|54777742|FG006|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
28118780|NCT02891226|54777743|FG007|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
28118781|NCT02891226|54777744|FG008|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
28118782|NCT02891226|54777745|FG009|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
28118783|NCT02891226|54777746|FG010|Period 3 (Weeks 52 to 208)|Lack of Efficacy|3|||
28118784|NCT02891226|54777747|FG011|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
28118785|NCT02891226|54777748|FG012|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
28118786|NCT02891226|54777749|FG013|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
28118787|NCT02891226|54777750|FG014|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
28118788|NCT02891226|54777751|FG015|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
28118789|NCT02891226|54777736|FG000|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
28118790|NCT02891226|54777737|FG001|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
28118791|NCT02891226|54777738|FG002|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
28118792|NCT02891226|54777739|FG003|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
28118793|NCT02891226|54777740|FG004|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
28118794|NCT02891226|54777741|FG005|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
28118795|NCT02891226|54777742|FG006|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
28118796|NCT02891226|54777743|FG007|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
28118797|NCT02891226|54777744|FG008|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
28118798|NCT02891226|54777745|FG009|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
28118799|NCT02891226|54777746|FG010|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|2|||
28118800|NCT02891226|54777747|FG011|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
28118801|NCT02891226|54777748|FG012|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
28118802|NCT02891226|54777749|FG013|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
28118803|NCT02891226|54777750|FG014|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
28118804|NCT02891226|54777751|FG015|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
28118805|NCT02891226|54777736|FG000|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
28118806|NCT02891226|54777737|FG001|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
28118807|NCT02891226|54777738|FG002|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
27817106|NCT01506609|54274226|FG003|Overall Study|Withdrawal by Subject|9|||
27817107|NCT01506609|54274227|FG004|Overall Study|Withdrawal by Subject|7|||
27817108|NCT01506609|54274228|FG005|Overall Study|Withdrawal by Subject|7|||
27817109|NCT01506609|54274223|FG000|Overall Study|Lost to Follow-up|0|||
27817110|NCT01506609|54274224|FG001|Overall Study|Lost to Follow-up|0|||
27817111|NCT01506609|54274225|FG002|Overall Study|Lost to Follow-up|0|||
27817112|NCT01506609|54274226|FG003|Overall Study|Lost to Follow-up|1|||
27817113|NCT01506609|54274227|FG004|Overall Study|Lost to Follow-up|2|||
27817114|NCT01506609|54274228|FG005|Overall Study|Lost to Follow-up|0|||
27817115|NCT01506609|54274223|FG000|Overall Study|Sponsor Discontinued Study|0|||
27817116|NCT01506609|54274224|FG001|Overall Study|Sponsor Discontinued Study|0|||
27848852|NCT02626182|54343222|FG001|Overall Study|Adverse Event|0|||
28118808|NCT02891226|54777739|FG003|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
28118809|NCT02891226|54777740|FG004|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
28118810|NCT02891226|54777741|FG005|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
28118811|NCT02891226|54777742|FG006|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
28118812|NCT02891226|54777743|FG007|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
28118813|NCT02891226|54777744|FG008|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
28118814|NCT02891226|54777745|FG009|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
27817117|NCT01506609|54274225|FG002|Overall Study|Sponsor Discontinued Study|0|||
27817118|NCT01506609|54274226|FG003|Overall Study|Sponsor Discontinued Study|2|||
27817119|NCT01506609|54274227|FG004|Overall Study|Sponsor Discontinued Study|2|||
27817120|NCT01506609|54274228|FG005|Overall Study|Sponsor Discontinued Study|0|||
27817121|NCT01506609|54274223|FG000|Overall Study|Progressive Disease per Protocol|1|||
27817122|NCT01506609|54274224|FG001|Overall Study|Progressive Disease per Protocol|0|||
27817123|NCT01506609|54274225|FG002|Overall Study|Progressive Disease per Protocol|0|||
27817124|NCT01506609|54274226|FG003|Overall Study|Progressive Disease per Protocol|64|||
27817125|NCT01506609|54274227|FG004|Overall Study|Progressive Disease per Protocol|57|||
27817126|NCT01506609|54274228|FG005|Overall Study|Progressive Disease per Protocol|74|||
27817127|NCT01506609|54274223|FG000|Overall Study|Other, Not Specified|0|||
27817128|NCT01506609|54274224|FG001|Overall Study|Other, Not Specified|0|||
27817129|NCT01506609|54274225|FG002|Overall Study|Other, Not Specified|0|||
27817130|NCT01506609|54274226|FG003|Overall Study|Other, Not Specified|10|||
27817131|NCT01506609|54274227|FG004|Overall Study|Other, Not Specified|7|||
27817132|NCT01506609|54274228|FG005|Overall Study|Other, Not Specified|3|||
27817133|NCT01506609|54274223|FG000|Overall Study|Missing / Unknown Reason|1|||
27817134|NCT01506609|54274224|FG001|Overall Study|Missing / Unknown Reason|0|||
27817135|NCT01506609|54274225|FG002|Overall Study|Missing / Unknown Reason|1|||
27817136|NCT01506609|54274226|FG003|Overall Study|Missing / Unknown Reason|4|||
27817137|NCT01506609|54274227|FG004|Overall Study|Missing / Unknown Reason|4|||
28118815|NCT02891226|54777746|FG010|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|2|||
28118816|NCT02891226|54777747|FG011|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
28118817|NCT02891226|54777748|FG012|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
28118818|NCT02891226|54777749|FG013|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
28118819|NCT02891226|54777750|FG014|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
28118820|NCT02891226|54777751|FG015|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
28066056|NCT00295022|54721661|FG002|Overall Study|Lost to Follow-up|1|||
28066057|NCT00295022|54721659|FG000|Overall Study|Withdrawal by Subject|0|||
28066058|NCT00295022|54721660|FG001|Overall Study|Withdrawal by Subject|0|||
28066059|NCT00295022|54721661|FG002|Overall Study|Withdrawal by Subject|2|||
28066060|NCT00303446|54721673|FG000|Overall Study|Withdrawal by Subject|2|||
28118821|NCT02891226|54777736|FG000|Follow-up Period|Withdrawal by Subject|0|||
28118822|NCT02891226|54777737|FG001|Follow-up Period|Withdrawal by Subject|0|||
28118823|NCT02891226|54777738|FG002|Follow-up Period|Withdrawal by Subject|0|||
28118824|NCT02891226|54777739|FG003|Follow-up Period|Withdrawal by Subject|0|||
28118825|NCT02891226|54777740|FG004|Follow-up Period|Withdrawal by Subject|0|||
28118826|NCT02891226|54777741|FG005|Follow-up Period|Withdrawal by Subject|0|||
28118827|NCT02891226|54777742|FG006|Follow-up Period|Withdrawal by Subject|0|||
28118828|NCT02891226|54777743|FG007|Follow-up Period|Withdrawal by Subject|0|||
28118829|NCT02891226|54777744|FG008|Follow-up Period|Withdrawal by Subject|0|||
28118830|NCT02891226|54777745|FG009|Follow-up Period|Withdrawal by Subject|0|||
28118831|NCT02891226|54777746|FG010|Follow-up Period|Withdrawal by Subject|0|||
28118832|NCT02891226|54777747|FG011|Follow-up Period|Withdrawal by Subject|1|||
28118833|NCT02891226|54777748|FG012|Follow-up Period|Withdrawal by Subject|0|||
28118834|NCT02891226|54777749|FG013|Follow-up Period|Withdrawal by Subject|0|||
28118835|NCT02891226|54777750|FG014|Follow-up Period|Withdrawal by Subject|1|||
28118836|NCT02891226|54777751|FG015|Follow-up Period|Withdrawal by Subject|1|||
28118837|NCT03612856|54777778|FG000|Pre-dose Period|Physician Decision|0|||
28118838|NCT03612856|54777779|FG001|Pre-dose Period|Physician Decision|1|||
28066061|NCT00303446|54721674|FG001|Overall Study|Withdrawal by Subject|2|||
28066062|NCT00303446|54721673|FG000|Overall Study|Death|0|||
28066063|NCT00303446|54721674|FG001|Overall Study|Death|1|||
28118839|NCT03612856|54777780|FG002|Pre-dose Period|Physician Decision|1|||
28118840|NCT03612856|54777778|FG000|Pre-dose Period|Withdrawal by Subject|0|||
28118841|NCT03612856|54777779|FG001|Pre-dose Period|Withdrawal by Subject|1|||
28118842|NCT03612856|54777780|FG002|Pre-dose Period|Withdrawal by Subject|0|||
28118843|NCT03333837|54777793|FG000|Overall Study|Adverse Event|2|||
27817138|NCT01506609|54274228|FG005|Overall Study|Missing / Unknown Reason|2|||
27817139|NCT01506453|54274252|FG000|Overall Study|Withdrawal prior to treatment|0|||
27817140|NCT01506453|54274253|FG001|Overall Study|Withdrawal prior to treatment|2|||
27817141|NCT01482429|54274261|FG000|Care Usual|Protocol Violation|0|||
28066064|NCT00303446|54721673|FG000|Overall Study|Physician Decision|0|||
27848853|NCT01669902|54343329|FG000|Overall Study|Adverse Event|11|||
28118844|NCT03333837|54777794|FG001|Overall Study|Adverse Event|1|||
28118845|NCT03333837|54777795|FG002|Overall Study|Adverse Event|1|||
28118846|NCT03333837|54777796|FG003|Overall Study|Adverse Event|1|||
28118847|NCT03333837|54777797|FG004|Overall Study|Adverse Event|0|||
28118848|NCT03333837|54777793|FG000|Overall Study|Caregiver withdrew|0|||
28118849|NCT03333837|54777794|FG001|Overall Study|Caregiver withdrew|2|||
28118850|NCT03333837|54777795|FG002|Overall Study|Caregiver withdrew|1|||
28118851|NCT03333837|54777796|FG003|Overall Study|Caregiver withdrew|0|||
28118852|NCT03333837|54777797|FG004|Overall Study|Caregiver withdrew|0|||
28118853|NCT03333837|54777793|FG000|Overall Study|Withdrawal by Subject|0|||
28118854|NCT03333837|54777794|FG001|Overall Study|Withdrawal by Subject|0|||
28118855|NCT03333837|54777795|FG002|Overall Study|Withdrawal by Subject|1|||
28118856|NCT03333837|54777796|FG003|Overall Study|Withdrawal by Subject|1|||
28118857|NCT03333837|54777797|FG004|Overall Study|Withdrawal by Subject|3|||
28118858|NCT03333837|54777793|FG000|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
28118859|NCT03333837|54777794|FG001|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
28118860|NCT03333837|54777795|FG002|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|2|||
28118861|NCT03333837|54777796|FG003|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
28118862|NCT03333837|54777797|FG004|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
28118863|NCT03708211|54777815|FG000|Overall Study|Progressive Disease|10|||
28118864|NCT03708211|54777816|FG001|Overall Study|Progressive Disease|7|||
28118865|NCT03708211|54777815|FG000|Overall Study|Withdrawal by Subject|0|||
28118866|NCT03708211|54777816|FG001|Overall Study|Withdrawal by Subject|1|||
28118867|NCT03708211|54777815|FG000|Overall Study|Other|2|||
28118868|NCT03708211|54777816|FG001|Overall Study|Other|0|||
28118869|NCT02948634|54777826|FG000|Overall Study|Lack of efficacy and study suspended|10|||
28118870|NCT02948634|54777827|FG001|Overall Study|Lack of efficacy and study suspended|2|||
28118871|NCT02945046|54777836|FG000|Overall Study|Adverse Event|1|||
28118872|NCT02945046|54777837|FG001|Overall Study|Adverse Event|0|||
28118873|NCT02945046|54777838|FG002|Overall Study|Adverse Event|2|||
28118874|NCT02945046|54777836|FG000|Overall Study|Withdrawal by Subject|3|||
28118875|NCT02945046|54777837|FG001|Overall Study|Withdrawal by Subject|3|||
28118876|NCT02945046|54777838|FG002|Overall Study|Withdrawal by Subject|3|||
28118877|NCT02945046|54777836|FG000|Overall Study|Protocol Violation|2|||
28118878|NCT02945046|54777837|FG001|Overall Study|Protocol Violation|3|||
28118879|NCT02945046|54777838|FG002|Overall Study|Protocol Violation|2|||
28118880|NCT02945046|54777836|FG000|Overall Study|Lost to Follow-up|1|||
28118881|NCT02945046|54777837|FG001|Overall Study|Lost to Follow-up|1|||
28118882|NCT02945046|54777838|FG002|Overall Study|Lost to Follow-up|0|||
28118883|NCT02945046|54777836|FG000|Overall Study|Lack of Efficacy|1|||
28118884|NCT02945046|54777837|FG001|Overall Study|Lack of Efficacy|2|||
28118885|NCT02945046|54777838|FG002|Overall Study|Lack of Efficacy|1|||
28118886|NCT02945046|54777836|FG000|Overall Study|Other than specified|5|||
28118887|NCT02945046|54777837|FG001|Overall Study|Other than specified|4|||
28118888|NCT02945046|54777838|FG002|Overall Study|Other than specified|7|||
28118889|NCT03705793|54777848|FG000|Overall Study|Lost to Follow-up|3|||
28118890|NCT03705793|54777849|FG001|Overall Study|Lost to Follow-up|4|||
28118891|NCT03705793|54777848|FG000|Overall Study|Withdrawal by Subject|2|||
28118892|NCT03705793|54777849|FG001|Overall Study|Withdrawal by Subject|1|||
28118893|NCT02944968|54777868|FG000|Overall Study|Subject excluded before study procedure|1|||
28118894|NCT02944968|54777868|FG000|Overall Study|Subject didn't meet eligibility criteria|2|||
28118895|NCT03761797|54777872|FG000|Overall Study|Changing hospital|11|||
28118896|NCT03761797|54777872|FG000|Overall Study|Improvement/remission|6|||
28118897|NCT03761797|54777872|FG000|Overall Study|Withdrawal by Subject|19|||
28118898|NCT03761797|54777872|FG000|Overall Study|Lost to Follow-up|33|||
28118899|NCT03761797|54777872|FG000|Overall Study|Adverse Event|37|||
28118900|NCT03761797|54777872|FG000|Overall Study|Case report form (CRF) not collected|5|||
28118901|NCT03761797|54777872|FG000|Overall Study|No patient visit after entry|13|||
28118902|NCT03761797|54777872|FG000|Overall Study|Switch to other diabetes medication|10|||
28118903|NCT03761797|54777872|FG000|Overall Study|Prevention for recurrence of cystitis|1|||
28118904|NCT03761797|54777872|FG000|Overall Study|Postoperative therapy of esophageal cancer|1|||
28118905|NCT03761797|54777872|FG000|Overall Study|Insufficient effectives|2|||
28118906|NCT03761797|54777872|FG000|Overall Study|Excessive alcohol intake|1|||
28118907|NCT02944656|54777878|FG000|Overall Study|No longer eligible|3|||
28118908|NCT02944656|54777879|FG001|Overall Study|No longer eligible|0|||
28118909|NCT02944656|54777878|FG000|Overall Study|Lost to Follow-up|7|||
28118910|NCT02944656|54777879|FG001|Overall Study|Lost to Follow-up|10|||
28118911|NCT02713529|54777892|FG000|Overall Study|Withdrawal by Subject|3|||
28118912|NCT02713529|54777893|FG001|Overall Study|Withdrawal by Subject|1|||
28118913|NCT02713529|54777894|FG002|Overall Study|Withdrawal by Subject|4|||
28118914|NCT02713529|54777895|FG003|Overall Study|Withdrawal by Subject|2|||
28118915|NCT02713529|54777896|FG004|Overall Study|Withdrawal by Subject|0|||
28118916|NCT02713529|54777897|FG005|Overall Study|Withdrawal by Subject|1|||
28118917|NCT02713529|54777898|FG006|Overall Study|Withdrawal by Subject|1|||
28118918|NCT02713529|54777892|FG000|Overall Study|Lost to Follow-up|1|||
28118919|NCT02713529|54777893|FG001|Overall Study|Lost to Follow-up|0|||
28118920|NCT02713529|54777894|FG002|Overall Study|Lost to Follow-up|1|||
28118921|NCT02713529|54777895|FG003|Overall Study|Lost to Follow-up|0|||
28118922|NCT02713529|54777896|FG004|Overall Study|Lost to Follow-up|0|||
28118923|NCT02713529|54777897|FG005|Overall Study|Lost to Follow-up|0|||
28118924|NCT02713529|54777898|FG006|Overall Study|Lost to Follow-up|0|||
28118925|NCT02713529|54777892|FG000|Overall Study|Death|3|||
28118926|NCT02713529|54777893|FG001|Overall Study|Death|3|||
28118927|NCT02713529|54777894|FG002|Overall Study|Death|26|||
28118928|NCT02713529|54777895|FG003|Overall Study|Death|27|||
28118929|NCT02713529|54777896|FG004|Overall Study|Death|3|||
28118930|NCT02713529|54777897|FG005|Overall Study|Death|13|||
28118931|NCT02713529|54777898|FG006|Overall Study|Death|3|||
28118932|NCT03707821|54777924|FG000|Overall Study|Protocol Violation|0|||
28118933|NCT03707821|54777925|FG001|Overall Study|Protocol Violation|1|||
28118934|NCT03707821|54777924|FG000|Overall Study|Unsatisfactory Visual Response|1|||
28118935|NCT03707821|54777925|FG001|Overall Study|Unsatisfactory Visual Response|0|||
28118936|NCT03707821|54777924|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
28118937|NCT03707821|54777925|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
28118938|NCT04546581|54777933|FG000|Overall Study|Adverse Event|9|||
28118939|NCT04546581|54777934|FG001|Overall Study|Adverse Event|3|||
28118940|NCT04546581|54777933|FG000|Overall Study|Physician Decision|0|||
28118941|NCT04546581|54777934|FG001|Overall Study|Physician Decision|1|||
28118942|NCT04546581|54777933|FG000|Overall Study|Protocol Violation|1|||
28118943|NCT04546581|54777934|FG001|Overall Study|Protocol Violation|2|||
28118944|NCT04546581|54777933|FG000|Overall Study|Withdrawal by Subject|3|||
28118945|NCT04546581|54777934|FG001|Overall Study|Withdrawal by Subject|7|||
28118946|NCT03707587|54777942|FG000|Overall Study|Death|0|||
28118947|NCT03707587|54777943|FG001|Overall Study|Death|1|||
28118948|NCT03312933|54777953|FG000|Overall Study|Protocol Violation|15|||
28118949|NCT03312933|54777953|FG000|Overall Study|Lost to Follow-up|36|||
28118950|NCT03312933|54777953|FG000|Overall Study|Withdrawal by Subject|3|||
28118951|NCT02561273|54777959|FG000|Overall Study|Protocol Violation|1|||
28118952|NCT02561273|54777960|FG001|Overall Study|Protocol Violation|0|||
28118953|NCT03312543|54777970|FG000|Before Treatment (Screening to Baseline)|Lost to Follow-up|0|||
28118954|NCT03312543|54777971|FG001|Before Treatment (Screening to Baseline)|Lost to Follow-up|2|||
28118955|NCT03312543|54777970|FG000|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1|||
28118956|NCT03312543|54777971|FG001|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2|||
28118957|NCT03312543|54777970|FG000|Treatment (Baseline to Week 12)|Withdrawal by Subject|3|||
28118958|NCT03312543|54777971|FG001|Treatment (Baseline to Week 12)|Withdrawal by Subject|4|||
28118959|NCT03312543|54777970|FG000|Treatment (Baseline to Week 12)|Protocol Violation|1|||
28118960|NCT03312543|54777971|FG001|Treatment (Baseline to Week 12)|Protocol Violation|1|||
28118961|NCT03312543|54777970|FG000|Regression (Week 12 to Week 24)|Protocol Violation|1|||
28118962|NCT03312543|54777971|FG001|Regression (Week 12 to Week 24)|Protocol Violation|1|||
28118963|NCT03312543|54777970|FG000|Regression (Week 12 to Week 24)|Death|0|||
28118964|NCT03312543|54777971|FG001|Regression (Week 12 to Week 24)|Death|1|||
28118965|NCT02392559|54778000|FG000|Overall Study|Withdrawal by Subject|0|||
28118966|NCT02392559|54778001|FG001|Overall Study|Withdrawal by Subject|1|||
28118967|NCT03332589|54778015|FG000|Overall Study|Lack of Efficacy|2|||
28118968|NCT03332589|54778016|FG001|Overall Study|Lack of Efficacy|0|||
28118969|NCT03332589|54778017|FG002|Overall Study|Lack of Efficacy|0|||
28118970|NCT03332589|54778015|FG000|Overall Study|Adverse Event|1|||
28118971|NCT03332589|54778016|FG001|Overall Study|Adverse Event|0|||
28118972|NCT03332589|54778017|FG002|Overall Study|Adverse Event|0|||
28118973|NCT03332589|54778015|FG000|Overall Study|Death|1|||
28118974|NCT03332589|54778016|FG001|Overall Study|Death|0|||
28118975|NCT03332589|54778017|FG002|Overall Study|Death|0|||
28118976|NCT00458003|54778027|FG000|Overall Study|Non protocol spinal anesthesia|1|||
28118977|NCT00458003|54778028|FG001|Overall Study|Non protocol spinal anesthesia|1|||
28118978|NCT02061293|54778038|FG000|Overall Study|Elevated Blood Pressure|1|||
28118979|NCT02061293|54778039|FG001|Overall Study|Elevated Blood Pressure|1|||
28118980|NCT02913612|54778049|FG000|Overall Study|Lost to Follow-up|6|||
28118981|NCT02913612|54778050|FG001|Overall Study|Lost to Follow-up|5|||
27940370|NCT01185366|54596647|FG000|Crossover to Second Line Therapy|Withdrawal by Subject|1|||
28118982|NCT02913612|54778051|FG002|Overall Study|Lost to Follow-up|2|||
28118983|NCT02913612|54778052|FG003|Overall Study|Lost to Follow-up|0|||
28118984|NCT02913612|54778049|FG000|Overall Study|Physician Decision|1|||
28118985|NCT02913612|54778050|FG001|Overall Study|Physician Decision|4|||
28118986|NCT02913612|54778051|FG002|Overall Study|Physician Decision|1|||
28118987|NCT02913612|54778052|FG003|Overall Study|Physician Decision|0|||
28118988|NCT02913612|54778049|FG000|Overall Study|Withdrawal by Subject|2|||
28118989|NCT02913612|54778050|FG001|Overall Study|Withdrawal by Subject|4|||
28118990|NCT02913612|54778051|FG002|Overall Study|Withdrawal by Subject|0|||
28118991|NCT02913612|54778052|FG003|Overall Study|Withdrawal by Subject|0|||
28118992|NCT02913612|54778049|FG000|Overall Study|Hemangioma resolved|1|||
28118993|NCT02913612|54778050|FG001|Overall Study|Hemangioma resolved|0|||
28118994|NCT02913612|54778051|FG002|Overall Study|Hemangioma resolved|0|||
28118995|NCT02913612|54778052|FG003|Overall Study|Hemangioma resolved|0|||
28118996|NCT02913612|54778049|FG000|Overall Study|Local IRB decision|1|||
28118997|NCT02913612|54778050|FG001|Overall Study|Local IRB decision|0|||
28118998|NCT02913612|54778051|FG002|Overall Study|Local IRB decision|0|||
28118999|NCT02913612|54778052|FG003|Overall Study|Local IRB decision|0|||
28119000|NCT02913612|54778049|FG000|Overall Study|Study drug non-compliance|1|||
28119001|NCT02913612|54778050|FG001|Overall Study|Study drug non-compliance|1|||
28119002|NCT02913612|54778051|FG002|Overall Study|Study drug non-compliance|0|||
28119003|NCT02913612|54778052|FG003|Overall Study|Study drug non-compliance|0|||
28119004|NCT02913612|54778049|FG000|Overall Study|Insurance issues|0|||
28119005|NCT02913612|54778050|FG001|Overall Study|Insurance issues|1|||
28119006|NCT02913612|54778051|FG002|Overall Study|Insurance issues|0|||
28119007|NCT02913612|54778052|FG003|Overall Study|Insurance issues|0|||
28119008|NCT02913612|54778049|FG000|Overall Study|Needed to treat second hemangioma|0|||
28119009|NCT02913612|54778050|FG001|Overall Study|Needed to treat second hemangioma|1|||
28119010|NCT02913612|54778051|FG002|Overall Study|Needed to treat second hemangioma|0|||
28119011|NCT02913612|54778052|FG003|Overall Study|Needed to treat second hemangioma|0|||
28119012|NCT02913612|54778049|FG000|Overall Study|Study completion criteria not met|0|||
28119013|NCT02913612|54778050|FG001|Overall Study|Study completion criteria not met|1|||
28119014|NCT02913612|54778051|FG002|Overall Study|Study completion criteria not met|0|||
28119015|NCT02913612|54778052|FG003|Overall Study|Study completion criteria not met|0|||
28119016|NCT02913612|54778049|FG000|Overall Study|Ineligible|0|||
28119017|NCT02913612|54778050|FG001|Overall Study|Ineligible|1|||
28119018|NCT02913612|54778051|FG002|Overall Study|Ineligible|0|||
28119019|NCT02913612|54778052|FG003|Overall Study|Ineligible|0|||
28119020|NCT03312231|54778066|FG000|Overall Study|Lost to Follow-up|2|||
28119021|NCT03312231|54778067|FG001|Overall Study|Lost to Follow-up|6|||
28119022|NCT03312231|54778068|FG002|Overall Study|Lost to Follow-up|1|||
28119023|NCT03312231|54778069|FG003|Overall Study|Lost to Follow-up|3|||
28119024|NCT03312231|54778070|FG004|Overall Study|Lost to Follow-up|1|||
28119025|NCT03312231|54778066|FG000|Overall Study|Withdrawal by Subject|0|||
28119026|NCT03312231|54778067|FG001|Overall Study|Withdrawal by Subject|3|||
28119027|NCT03312231|54778068|FG002|Overall Study|Withdrawal by Subject|1|||
28119028|NCT03312231|54778069|FG003|Overall Study|Withdrawal by Subject|0|||
28119029|NCT03312231|54778070|FG004|Overall Study|Withdrawal by Subject|0|||
28119030|NCT03312231|54778066|FG000|Overall Study|Death|0|||
28119031|NCT03312231|54778067|FG001|Overall Study|Death|1|||
28119032|NCT03312231|54778068|FG002|Overall Study|Death|1|||
28119033|NCT03312231|54778069|FG003|Overall Study|Death|0|||
28119034|NCT03312231|54778070|FG004|Overall Study|Death|0|||
28119035|NCT03312231|54778066|FG000|Overall Study|Study Vaccination not Received|1|||
28119036|NCT03312231|54778067|FG001|Overall Study|Study Vaccination not Received|1|||
28119037|NCT03312231|54778068|FG002|Overall Study|Study Vaccination not Received|1|||
28119038|NCT03312231|54778069|FG003|Overall Study|Study Vaccination not Received|0|||
28119039|NCT03312231|54778070|FG004|Overall Study|Study Vaccination not Received|0|||
28119040|NCT03323736|54778085|FG000|Overall Study|Screen Failure|14|||
28119041|NCT03323736|54778086|FG001|Overall Study|Screen Failure|9|||
28119042|NCT03323736|54778087|FG002|Overall Study|Screen Failure|1|||
28119043|NCT03323736|54778085|FG000|Overall Study|Withdrawal Before Treatment|3|||
28119044|NCT03323736|54778086|FG001|Overall Study|Withdrawal Before Treatment|1|||
28119045|NCT03323736|54778087|FG002|Overall Study|Withdrawal Before Treatment|1|||
28119046|NCT03323736|54778085|FG000|Overall Study|Iontophoresis fill/no iontophoresis|2|||
28119047|NCT03323736|54778086|FG001|Overall Study|Iontophoresis fill/no iontophoresis|2|||
28119048|NCT03323736|54778087|FG002|Overall Study|Iontophoresis fill/no iontophoresis|0|||
28119049|NCT03311841|54778102|FG000|14-day Wash-out|Adverse Event|0|||
28119050|NCT03311841|54778103|FG001|14-day Wash-out|Adverse Event|1|||
28119051|NCT03311841|54778104|FG002|14-day Wash-out|Adverse Event|0|||
28119052|NCT03311841|54778105|FG003|14-day Wash-out|Adverse Event|0|||
28119053|NCT03311841|54778106|FG004|14-day Wash-out|Adverse Event|0|||
28119054|NCT03311841|54778102|FG000|14-day Wash-out|Non-Compliance With Study Drug|0|||
28119055|NCT03311841|54778103|FG001|14-day Wash-out|Non-Compliance With Study Drug|0|||
27817142|NCT01482429|54274262|FG001|Care Usual|Protocol Violation|172|||
28119056|NCT03311841|54778104|FG002|14-day Wash-out|Non-Compliance With Study Drug|0|||
28119057|NCT03311841|54778105|FG003|14-day Wash-out|Non-Compliance With Study Drug|1|||
28119058|NCT03311841|54778106|FG004|14-day Wash-out|Non-Compliance With Study Drug|0|||
28119059|NCT03311373|54778139|FG000|Overall Study|Adverse Event|1|||
28119060|NCT03311373|54778139|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
28119061|NCT03311373|54778139|FG000|Overall Study|Lost to Follow-up|1|||
28119062|NCT03311373|54778139|FG000|Overall Study|Physician Decision|1|||
28119063|NCT03311373|54778139|FG000|Overall Study|Withdrawal by Subject|3|||
28119064|NCT01155375|54778151|FG000|Overall Study|Adverse Event|1|||
28119065|NCT01155375|54778152|FG001|Overall Study|Adverse Event|0|||
28119066|NCT00628095|54778170|FG000|Overall Study|Adverse Event|5|||
28119067|NCT00628095|54778171|FG001|Overall Study|Adverse Event|3|||
28119068|NCT00628095|54778170|FG000|Overall Study|Lack of Efficacy|0|||
28119069|NCT00628095|54778171|FG001|Overall Study|Lack of Efficacy|3|||
28119070|NCT00628095|54778170|FG000|Overall Study|Withdrawal by Subject|2|||
28119071|NCT00628095|54778171|FG001|Overall Study|Withdrawal by Subject|0|||
28119072|NCT00628095|54778170|FG000|Overall Study|Other|0|||
28119073|NCT00628095|54778171|FG001|Overall Study|Other|1|||
28119074|NCT02889861|54778179|FG000|Overall Study|Ongoing in Survival Follow-up|2|||
28119075|NCT03325881|54778190|FG000|Overall Study|Protocol Violation|0|||
28119076|NCT03325881|54778191|FG001|Overall Study|Protocol Violation|1|||
28119077|NCT03325881|54778190|FG000|Overall Study|Withdrawal by Subject|0|||
28119078|NCT03325881|54778191|FG001|Overall Study|Withdrawal by Subject|2|||
28119079|NCT03325881|54778190|FG000|Overall Study|Lack of Efficacy|2|||
28119080|NCT03325881|54778191|FG001|Overall Study|Lack of Efficacy|0|||
28119081|NCT03325881|54778190|FG000|Overall Study|Not treated|1|||
28119082|NCT03325881|54778191|FG001|Overall Study|Not treated|0|||
28119083|NCT02887989|54778201|FG000|Overall Study|Withdrawal by Subject|8|||
28119084|NCT02887989|54778202|FG001|Overall Study|Withdrawal by Subject|11|||
28119085|NCT02887989|54778201|FG000|Overall Study|Death|1|||
28119086|NCT02887989|54778202|FG001|Overall Study|Death|0|||
28119087|NCT02887521|54778210|FG000|Overall Study|Withdrawal by Subject|0|||
28119088|NCT02887521|54778211|FG001|Overall Study|Withdrawal by Subject|3|||
28119089|NCT03305055|54778219|FG000|Overall Study|Withdrawal by Subject|0|||
27817143|NCT01482429|54274261|FG000|Care Usual|Lost to Follow-up|0|||
28119090|NCT03305055|54778220|FG001|Overall Study|Withdrawal by Subject|1|||
28119091|NCT03305055|54778219|FG000|Overall Study|Adverse Event|1|||
28119092|NCT03305055|54778220|FG001|Overall Study|Adverse Event|1|||
28119093|NCT02763189|54778228|FG000|Overall Study|Device failure|0|||
28119094|NCT02763189|54778229|FG001|Overall Study|Device failure|2|||
28119095|NCT03273387|54778237|FG000|Overall Study|Death|2|||
28119096|NCT03273387|54778238|FG001|Overall Study|Death|2|||
28119097|NCT03273387|54778237|FG000|Overall Study|Withdrawal by Subject|1|||
28119098|NCT03273387|54778238|FG001|Overall Study|Withdrawal by Subject|1|||
28119099|NCT01328080|54778244|FG000|Overall Study|Lost to Follow-up|5|||
28119100|NCT02649946|54778263|FG000|Overall Study|Withdrawal by Subject|1|||
28119101|NCT02649946|54778264|FG001|Overall Study|Withdrawal by Subject|1|||
28119102|NCT02649946|54778263|FG000|Overall Study|Death|7|||
28119103|NCT02649946|54778264|FG001|Overall Study|Death|9|||
28119104|NCT02649946|54778263|FG000|Overall Study|Physician Decision|1|||
28119105|NCT02649946|54778264|FG001|Overall Study|Physician Decision|0|||
28119106|NCT02649946|54778263|FG000|Overall Study|Lost to Follow-up|2|||
28119107|NCT02649946|54778264|FG001|Overall Study|Lost to Follow-up|1|||
28119108|NCT02649946|54778263|FG000|Overall Study|Erroneously enrolled|1|||
28119109|NCT02649946|54778264|FG001|Overall Study|Erroneously enrolled|0|||
28119110|NCT02649946|54778263|FG000|Overall Study|Missed 6-month follow-up visit|0|||
28119111|NCT02649946|54778264|FG001|Overall Study|Missed 6-month follow-up visit|4|||
27817144|NCT01482429|54274262|FG001|Care Usual|Lost to Follow-up|1|||
27817145|NCT01482429|54274261|FG000|Protocol|Protocol Violation|275|||
27817146|NCT01482429|54274262|FG001|Protocol|Protocol Violation|0|||
27817147|NCT01504971|54274268|FG000|Overall Study|Physician Decision|13|||
27817148|NCT01479777|54274276|FG000|Overall Study|Physician Decision|2|||
27817149|NCT01479621|54274286|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93|||
27817150|NCT01479621|54274287|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
27817151|NCT01479621|54274288|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
27817152|NCT01479621|54274289|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
27817153|NCT01479621|54274290|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
27817154|NCT01479621|54274291|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
27817155|NCT01479621|54274292|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
28119112|NCT03273153|54778272|FG000|Overall Study|Adverse Event|1|||
28119113|NCT03273153|54778273|FG001|Overall Study|Adverse Event|2|||
28119114|NCT03273153|54778272|FG000|Overall Study|Missing|0|||
28119115|NCT03273153|54778273|FG001|Overall Study|Missing|2|||
28119116|NCT03273153|54778272|FG000|Overall Study|Other|3|||
28119117|NCT03273153|54778273|FG001|Overall Study|Other|2|||
28119118|NCT03273153|54778272|FG000|Overall Study|Symptomatic Deterioration|0|||
28119119|NCT03273153|54778273|FG001|Overall Study|Symptomatic Deterioration|1|||
28119120|NCT03273153|54778272|FG000|Overall Study|Progressive Disease|6|||
28119121|NCT03273153|54778273|FG001|Overall Study|Progressive Disease|5|||
28119122|NCT03273153|54778272|FG000|Overall Study|Physician Decision|1|||
28119123|NCT03273153|54778273|FG001|Overall Study|Physician Decision|3|||
28119124|NCT03273153|54778272|FG000|Overall Study|Study Terminated by Sponsor|112|||
28119125|NCT03273153|54778273|FG001|Overall Study|Study Terminated by Sponsor|102|||
27817156|NCT01479621|54274286|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19|||
27817157|NCT01479621|54274287|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
27817158|NCT01479621|54274288|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
27817159|NCT01479621|54274289|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
27817160|NCT01479621|54274290|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
27817161|NCT01479621|54274291|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
27817162|NCT01479621|54274292|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
27817163|NCT01479621|54274286|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153|||
27817164|NCT01479621|54274287|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
27817165|NCT01479621|54274288|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
27817166|NCT01479621|54274289|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
27817167|NCT01479621|54274290|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
27817168|NCT01479621|54274291|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
27817169|NCT01479621|54274292|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
27817170|NCT01479621|54274286|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7|||
27817171|NCT01479621|54274287|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
27817172|NCT01479621|54274288|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
27817173|NCT01479621|54274289|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
27817174|NCT01479621|54274290|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
27817175|NCT01479621|54274291|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
27817176|NCT01479621|54274292|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
27817177|NCT01479621|54274286|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
27817178|NCT01479621|54274287|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
27817179|NCT01479621|54274288|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
27817180|NCT01479621|54274289|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
27848854|NCT01669902|54343329|FG000|Overall Study|Lack of Efficacy|10|||
28066065|NCT00303446|54721674|FG001|Overall Study|Physician Decision|1|||
28066066|NCT00316706|54721682|FG000|Overall Study|Lost to Follow-up|38|||
28066067|NCT00316706|54721683|FG001|Overall Study|Lost to Follow-up|48|||
28066068|NCT00291486|54721694|FG000|Overall Study|Adverse Event|0|||
27848855|NCT01669902|54343329|FG000|Overall Study|Other|8|||
27848856|NCT01670292|54343362|FG000|Overall Study|Lost to Follow-up|14|||
28066069|NCT00291486|54721695|FG001|Overall Study|Adverse Event|3|||
28066070|NCT00291486|54721696|FG002|Overall Study|Adverse Event|0|||
28066071|NCT00291486|54721697|FG003|Overall Study|Adverse Event|1|||
28066072|NCT00291486|54721698|FG004|Overall Study|Adverse Event|0|||
28066073|NCT00291486|54721694|FG000|Overall Study|Withdrawal by Subject|0|||
28066074|NCT00291486|54721695|FG001|Overall Study|Withdrawal by Subject|0|||
28066075|NCT00291486|54721696|FG002|Overall Study|Withdrawal by Subject|0|||
28066076|NCT00291486|54721697|FG003|Overall Study|Withdrawal by Subject|0|||
28066077|NCT00291486|54721698|FG004|Overall Study|Withdrawal by Subject|1|||
28066078|NCT00291486|54721694|FG000|Overall Study|Disease progression|1|||
28066079|NCT00291486|54721695|FG001|Overall Study|Disease progression|0|||
28066080|NCT00291486|54721696|FG002|Overall Study|Disease progression|1|||
28066081|NCT00291486|54721697|FG003|Overall Study|Disease progression|0|||
28119126|NCT03273153|54778272|FG000|Overall Study|Withdrawal by Subject|26|||
28119127|NCT03273153|54778273|FG001|Overall Study|Withdrawal by Subject|25|||
28119128|NCT03273153|54778272|FG000|Overall Study|Protocol Deviation|3|||
28119129|NCT03273153|54778273|FG001|Overall Study|Protocol Deviation|0|||
28119130|NCT03273153|54778272|FG000|Overall Study|Lost to Follow-up|6|||
28119131|NCT03273153|54778273|FG001|Overall Study|Lost to Follow-up|11|||
28119132|NCT03273153|54778272|FG000|Overall Study|Death|66|||
28119133|NCT03273153|54778273|FG001|Overall Study|Death|69|||
28119134|NCT03323034|54778285|FG000|Overall Study|Lack of Efficacy|5|||
28119135|NCT03323034|54778286|FG001|Overall Study|Lack of Efficacy|5|||
28119136|NCT03323034|54778287|FG002|Overall Study|Lack of Efficacy|6|||
28119137|NCT03323034|54778288|FG003|Overall Study|Lack of Efficacy|5|||
28119138|NCT03323034|54778289|FG004|Overall Study|Lack of Efficacy|5|||
28119139|NCT03323034|54778285|FG000|Overall Study|Physician Decision|0|||
28119140|NCT03323034|54778286|FG001|Overall Study|Physician Decision|0|||
28119141|NCT03323034|54778287|FG002|Overall Study|Physician Decision|0|||
28119142|NCT03323034|54778288|FG003|Overall Study|Physician Decision|0|||
28119143|NCT03323034|54778289|FG004|Overall Study|Physician Decision|1|||
28119144|NCT03323034|54778285|FG000|Overall Study|Withdrawal by Subject|1|||
27848857|NCT01360554|54343599|FG000|Overall Study|Death|359|||
28066082|NCT00291486|54721698|FG004|Overall Study|Disease progression|0|||
28119145|NCT03323034|54778286|FG001|Overall Study|Withdrawal by Subject|1|||
28066083|NCT00301964|54721719|FG000|Overall Study|Second primary|2|||
28066084|NCT00301964|54721719|FG000|Overall Study|Wrong primary|1|||
28119146|NCT03323034|54778287|FG002|Overall Study|Withdrawal by Subject|0|||
28119147|NCT03323034|54778288|FG003|Overall Study|Withdrawal by Subject|1|||
28119148|NCT03323034|54778289|FG004|Overall Study|Withdrawal by Subject|0|||
28119149|NCT03270657|54778320|FG000|Overall Study|Withdrawal by Subject|1|||
28119150|NCT03303417|54778324|FG000|Overall Study|Withdrawal by Subject|1|||
28119151|NCT03303417|54778325|FG001|Overall Study|Withdrawal by Subject|1|||
28119152|NCT02943564|54778334|FG000|Overall Study|Miscellaneous Reasons|0|||
28119153|NCT02943564|54778335|FG001|Overall Study|Miscellaneous Reasons|0|||
28119154|NCT02943564|54778336|FG002|Overall Study|Miscellaneous Reasons|3|||
28119155|NCT02943564|54778334|FG000|Overall Study|Site terminated by sponsor|0|||
28119156|NCT02943564|54778335|FG001|Overall Study|Site terminated by sponsor|1|||
28119157|NCT02943564|54778336|FG002|Overall Study|Site terminated by sponsor|0|||
28119158|NCT02943564|54778334|FG000|Overall Study|Non-compliance with study drug|0|||
28119159|NCT02943564|54778335|FG001|Overall Study|Non-compliance with study drug|1|||
28119160|NCT02943564|54778336|FG002|Overall Study|Non-compliance with study drug|0|||
28119161|NCT02943564|54778334|FG000|Overall Study|Pregnancy|0|||
28119162|NCT02943564|54778335|FG001|Overall Study|Pregnancy|1|||
28119163|NCT02943564|54778336|FG002|Overall Study|Pregnancy|1|||
28119164|NCT02943564|54778334|FG000|Overall Study|Protocol Violation|2|||
28119165|NCT02943564|54778335|FG001|Overall Study|Protocol Violation|2|||
28119166|NCT02943564|54778336|FG002|Overall Study|Protocol Violation|2|||
28119167|NCT02943564|54778334|FG000|Overall Study|Lost to Follow-up|1|||
28119168|NCT02943564|54778335|FG001|Overall Study|Lost to Follow-up|0|||
28119169|NCT02943564|54778336|FG002|Overall Study|Lost to Follow-up|0|||
28119170|NCT02943564|54778334|FG000|Overall Study|Withdrawal by Subject|6|||
28119171|NCT02943564|54778335|FG001|Overall Study|Withdrawal by Subject|5|||
28119172|NCT02943564|54778336|FG002|Overall Study|Withdrawal by Subject|2|||
28119173|NCT02943564|54778334|FG000|Overall Study|Adverse Event|1|||
28119174|NCT02943564|54778335|FG001|Overall Study|Adverse Event|2|||
28119175|NCT02943564|54778336|FG002|Overall Study|Adverse Event|1|||
28119176|NCT02943564|54778334|FG000|Overall Study|Lack of Efficacy|0|||
27817181|NCT01479621|54274290|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
27817182|NCT01479621|54274291|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
28119177|NCT02943564|54778335|FG001|Overall Study|Lack of Efficacy|1|||
28119178|NCT02943564|54778336|FG002|Overall Study|Lack of Efficacy|0|||
28119179|NCT03268941|54778348|FG000|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
28119180|NCT03268941|54778349|FG001|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
28119181|NCT03268941|54778350|FG002|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
28119182|NCT03268941|54778351|FG003|Part 1 (Days 1 to 9)|Withdrawal by Subject|1|||
28119183|NCT03268941|54778352|FG004|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
28119184|NCT03268941|54778353|FG005|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
28119185|NCT03268941|54778354|FG006|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
28119186|NCT03268941|54778348|FG000|Part 1 (Days 1 to 9)|Adverse Event|0|||
28119187|NCT03268941|54778349|FG001|Part 1 (Days 1 to 9)|Adverse Event|0|||
28119188|NCT03268941|54778350|FG002|Part 1 (Days 1 to 9)|Adverse Event|0|||
28119189|NCT03268941|54778351|FG003|Part 1 (Days 1 to 9)|Adverse Event|1|||
28119190|NCT03268941|54778352|FG004|Part 1 (Days 1 to 9)|Adverse Event|0|||
28119191|NCT03268941|54778353|FG005|Part 1 (Days 1 to 9)|Adverse Event|0|||
28119192|NCT03268941|54778354|FG006|Part 1 (Days 1 to 9)|Adverse Event|0|||
28119193|NCT03268941|54778348|FG000|Part 1 (Days 1 to 9)|Protocol Deviation|1|||
28119194|NCT03268941|54778349|FG001|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
28119195|NCT03268941|54778350|FG002|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
28119196|NCT03268941|54778351|FG003|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
28119197|NCT03268941|54778352|FG004|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
28119198|NCT03268941|54778353|FG005|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
28119199|NCT03268941|54778354|FG006|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
28119200|NCT03268941|54778348|FG000|Part 2: Days 17 to 25|Reason not specified|0|||
28119201|NCT03268941|54778349|FG001|Part 2: Days 17 to 25|Reason not specified|0|||
28119202|NCT03268941|54778350|FG002|Part 2: Days 17 to 25|Reason not specified|0|||
28119203|NCT03268941|54778351|FG003|Part 2: Days 17 to 25|Reason not specified|0|||
28119204|NCT03268941|54778352|FG004|Part 2: Days 17 to 25|Reason not specified|0|||
28119205|NCT03268941|54778353|FG005|Part 2: Days 17 to 25|Reason not specified|0|||
28119206|NCT03268941|54778354|FG006|Part 2: Days 17 to 25|Reason not specified|1|||
28119207|NCT03268941|54778348|FG000|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
28119208|NCT03268941|54778349|FG001|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
28119209|NCT03268941|54778350|FG002|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
28119210|NCT03268941|54778351|FG003|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
28119211|NCT03268941|54778352|FG004|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
28119212|NCT03268941|54778353|FG005|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
28119213|NCT03268941|54778354|FG006|Part 2: Days 17 to 25|Withdrawal by Subject|1|||
28119214|NCT03245619|54778431|FG000|Part A (Up to Day 22)|Physician Decision|4|||
28119215|NCT03245619|54778432|FG001|Part A (Up to Day 22)|Physician Decision|6|||
28119216|NCT03245619|54778433|FG002|Part A (Up to Day 22)|Physician Decision|6|||
28119217|NCT03245619|54778434|FG003|Part A (Up to Day 22)|Physician Decision|0|||
27817183|NCT01479621|54274292|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
28119218|NCT03245619|54778435|FG004|Part A (Up to Day 22)|Physician Decision|0|||
28119219|NCT03245619|54778436|FG005|Part A (Up to Day 22)|Physician Decision|0|||
28119220|NCT03245619|54778437|FG006|Part A (Up to Day 22)|Physician Decision|0|||
28119221|NCT03245619|54778438|FG007|Part A (Up to Day 22)|Physician Decision|0|||
28119222|NCT03245619|54778439|FG008|Part A (Up to Day 22)|Physician Decision|0|||
28119223|NCT03245619|54778440|FG009|Part A (Up to Day 22)|Physician Decision|0|||
28119224|NCT03245619|54778441|FG010|Part A (Up to Day 22)|Physician Decision|0|||
28119225|NCT03245619|54778442|FG011|Part A (Up to Day 22)|Physician Decision|0|||
28119226|NCT03245619|54778443|FG012|Part A (Up to Day 22)|Physician Decision|0|||
28119227|NCT03245619|54778444|FG013|Part A (Up to Day 22)|Physician Decision|0|||
28119228|NCT03245619|54778445|FG014|Part A (Up to Day 22)|Physician Decision|0|||
28119229|NCT03245619|54778446|FG015|Part A (Up to Day 22)|Physician Decision|0|||
28119230|NCT03245619|54778447|FG016|Part A (Up to Day 22)|Physician Decision|0|||
28119231|NCT04472650|54778508|FG000|Washout Period (Minimum 14 Days)|Adverse Event|1|||
28119232|NCT04472650|54778509|FG001|Washout Period (Minimum 14 Days)|Adverse Event|0|||
28119233|NCT02606461|54778521|FG000|Period 1: Double-blinded Period|Randomized but no treatment|0|||
28119234|NCT02606461|54778522|FG001|Period 1: Double-blinded Period|Randomized but no treatment|0|||
28119235|NCT02606461|54778523|FG002|Period 1: Double-blinded Period|Randomized but no treatment|1|||
28119236|NCT02606461|54778524|FG003|Period 1: Double-blinded Period|Randomized but no treatment|0|||
28119237|NCT02606461|54778525|FG004|Period 1: Double-blinded Period|Randomized but no treatment|0|||
28119238|NCT02606461|54778526|FG005|Period 1: Double-blinded Period|Randomized but no treatment|0|||
28119239|NCT03321396|54778541|FG000|Overall Study|Physician Decision|1|||
28119240|NCT03244917|54778547|FG000|Overall Study|Lost to Follow-up|2|||
28119241|NCT03244917|54778548|FG001|Overall Study|Lost to Follow-up|2|||
28119242|NCT03321006|54778556|FG000|Overall Study|Death|1|||
28119243|NCT03321006|54778557|FG001|Overall Study|Death|0|||
28119244|NCT03321006|54778556|FG000|Overall Study|Lack of Efficacy|1|||
28119245|NCT03321006|54778557|FG001|Overall Study|Lack of Efficacy|0|||
28119246|NCT02593123|54778574|FG000|Overall Study|Physician Decision|2|||
28119247|NCT02593123|54778575|FG001|Overall Study|Physician Decision|1|||
28119248|NCT02593123|54778574|FG000|Overall Study|Relapse|1|||
28119249|NCT02593123|54778575|FG001|Overall Study|Relapse|1|||
28119250|NCT03302559|54778583|FG000|Overall Study|Adverse Event|2|||
28119251|NCT03302559|54778583|FG000|Overall Study|Lost to Follow-up|1|||
28119252|NCT03302559|54778583|FG000|Overall Study|Withdrew Consent|3|||
28119253|NCT03302247|54778587|FG000|Overall Study|the study has closed prematurely|2|||
28119254|NCT03302247|54778587|FG000|Overall Study|Death|1|||
28119255|NCT04993339|54778593|FG000|Overall Study|Lost to Follow-up|0|||
28119256|NCT04993339|54778594|FG001|Overall Study|Lost to Follow-up|1|||
28119257|NCT04993339|54778593|FG000|Overall Study|no MRI scan|3|||
28119258|NCT04993339|54778594|FG001|Overall Study|no MRI scan|1|||
28119259|NCT04974697|54778602|FG000|Overall Study|Unsatisfactory lens fitting due to test article|1|||
28119260|NCT04974697|54778602|FG000|Overall Study|Lens discomfort|1|||
28119261|NCT03265119|54778610|FG000|Overall Study|Adverse Event|2|||
28119262|NCT03265119|54778611|FG001|Overall Study|Adverse Event|1|||
28119263|NCT03265119|54778610|FG000|Overall Study|Lack of Efficacy|3|||
28119264|NCT03265119|54778611|FG001|Overall Study|Lack of Efficacy|0|||
28119265|NCT03265119|54778610|FG000|Overall Study|Protocol Violation|1|||
28119266|NCT03265119|54778611|FG001|Overall Study|Protocol Violation|2|||
28119267|NCT03265119|54778610|FG000|Overall Study|Withdrawal by Subject|2|||
28119268|NCT03265119|54778611|FG001|Overall Study|Withdrawal by Subject|4|||
28119269|NCT03265119|54778610|FG000|Overall Study|Lost to Follow-up|1|||
28119270|NCT03265119|54778611|FG001|Overall Study|Lost to Follow-up|0|||
28119271|NCT03265119|54778610|FG000|Overall Study|Lack of Compliance|1|||
28119272|NCT03265119|54778611|FG001|Overall Study|Lack of Compliance|0|||
28119273|NCT04952701|54778617|FG000|Control Lens|Physician Decision|4|||
28119274|NCT04952701|54778617|FG000|Test Lens|Physician Decision|1|||
28119275|NCT04723173|54778623|FG000|Subjective Listening Effort Scaling|One participant was not able to perform the test as required by the study protocol.|1|||
28119276|NCT04919317|54778637|FG000|Hospitalization and Wound Follow-up|Protocol Violation|0|||
28119277|NCT04919317|54778638|FG001|Hospitalization and Wound Follow-up|Protocol Violation|5|||
28119278|NCT04919317|54778637|FG000|SF-36 Quality of Life Survey Completion|Lost to Follow-up|12|||
28119279|NCT04919317|54778638|FG001|SF-36 Quality of Life Survey Completion|Lost to Follow-up|6|||
28119280|NCT04919161|54778646|FG000|Overall Study|Early participant discharge from rehabilitation program after session 4|1|||
28066085|NCT00301964|54721719|FG000|Overall Study|Inadequate pathology|1|||
28066086|NCT00268242|54721729|FG000|Overall Study|Death|1|||
28066087|NCT00294554|54721735|FG000|Overall Study|Lack of Efficacy|0|||
28066088|NCT00294554|54721736|FG001|Overall Study|Lack of Efficacy|1|||
28066089|NCT00294554|54721735|FG000|Overall Study|Physician Decision|0|||
28066090|NCT00294554|54721736|FG001|Overall Study|Physician Decision|1|||
28066091|NCT00294398|54721744|FG000|Overall Study|Lost to Follow-up|21|||
28066092|NCT00294398|54721745|FG001|Overall Study|Lost to Follow-up|26|||
28066093|NCT00279708|54721753|FG000|Overall Study|Withdrawal by Subject|2|||
28066094|NCT00279708|54721754|FG001|Overall Study|Withdrawal by Subject|3|||
28066095|NCT00279708|54721753|FG000|Overall Study|Adverse Event|1|||
28066096|NCT00279708|54721754|FG001|Overall Study|Adverse Event|1|||
28066097|NCT00299702|54721762|FG000|Overall Study|Death|1|||
28066098|NCT00299702|54721763|FG001|Overall Study|Death|0|||
28066099|NCT00299702|54721762|FG000|Overall Study|Adverse Event|0|||
28066100|NCT00299702|54721763|FG001|Overall Study|Adverse Event|4|||
28119281|NCT04919161|54778647|FG001|Overall Study|Early participant discharge from rehabilitation program after session 4|0|||
28119282|NCT04919161|54778646|FG000|Overall Study|Flare-up of existing orthopedic condition after session 4|0|||
28119283|NCT04919161|54778647|FG001|Overall Study|Flare-up of existing orthopedic condition after session 4|1|||
28119284|NCT04919161|54778646|FG000|Overall Study|Acute ankle sprain after session 1|0|||
28119285|NCT04919161|54778647|FG001|Overall Study|Acute ankle sprain after session 1|1|||
28119286|NCT03262389|54778675|FG000|Overall Study|Machine malfunction Day 1, no return Day 2|1|||
28119287|NCT03262389|54778675|FG000|Overall Study|opted out of the study once his clinical FDG PET CT was done.|1|||
28119288|NCT03262389|54778675|FG000|Overall Study|opted out of PET/MR|1|||
28119289|NCT03262233|54778683|FG000|Overall Study|Withdrawal by Subject|12|||
28119290|NCT03262233|54778684|FG001|Overall Study|Withdrawal by Subject|8|||
28119291|NCT03262233|54778685|FG002|Overall Study|Withdrawal by Subject|21|||
28119292|NCT03262233|54778686|FG003|Overall Study|Withdrawal by Subject|13|||
28119293|NCT03262233|54778683|FG000|Overall Study|Declined due to shock|1|||
28119294|NCT03262233|54778684|FG001|Overall Study|Declined due to shock|2|||
28119295|NCT03262233|54778685|FG002|Overall Study|Declined due to shock|2|||
28119296|NCT03262233|54778686|FG003|Overall Study|Declined due to shock|3|||
28119297|NCT03262233|54778683|FG000|Overall Study|Protocol Violation|5|||
28119298|NCT03262233|54778684|FG001|Overall Study|Protocol Violation|10|||
28119299|NCT03262233|54778685|FG002|Overall Study|Protocol Violation|2|||
28119300|NCT03262233|54778686|FG003|Overall Study|Protocol Violation|13|||
28119301|NCT03262233|54778683|FG000|Overall Study|data collection artifact|0|||
28119302|NCT03262233|54778684|FG001|Overall Study|data collection artifact|1|||
28119303|NCT03262233|54778685|FG002|Overall Study|data collection artifact|0|||
28119304|NCT03262233|54778686|FG003|Overall Study|data collection artifact|0|||
28119305|NCT03261531|54778697|FG000|Overall Study|Withdrawal by Subject|4|||
28119306|NCT04151290|54778701|FG000|Overall Study|The COVID-19 Pandemic made it hard for subjects to complete the study.|286|||
28119307|NCT03260205|54778720|FG000|Overall Study|Adverse Event|2|||
28119308|NCT03260205|54778721|FG001|Overall Study|Adverse Event|0|||
28119309|NCT03260205|54778722|FG002|Overall Study|Adverse Event|2|||
28119310|NCT03260205|54778723|FG003|Overall Study|Adverse Event|2|||
28119311|NCT03260205|54778724|FG004|Overall Study|Adverse Event|4|||
28119312|NCT03260205|54778720|FG000|Overall Study|Lost to Follow-up|2|||
28119313|NCT03260205|54778721|FG001|Overall Study|Lost to Follow-up|2|||
28119314|NCT03260205|54778722|FG002|Overall Study|Lost to Follow-up|1|||
28119315|NCT03260205|54778723|FG003|Overall Study|Lost to Follow-up|1|||
28119316|NCT03260205|54778724|FG004|Overall Study|Lost to Follow-up|5|||
28119317|NCT03260205|54778720|FG000|Overall Study|Protocol Violation|0|||
28119318|NCT03260205|54778721|FG001|Overall Study|Protocol Violation|0|||
28119319|NCT03260205|54778722|FG002|Overall Study|Protocol Violation|2|||
28119320|NCT03260205|54778723|FG003|Overall Study|Protocol Violation|0|||
28119321|NCT03260205|54778724|FG004|Overall Study|Protocol Violation|1|||
28119322|NCT03260205|54778720|FG000|Overall Study|Withdrawal by Participant or Parent/LAR|4|||
28119323|NCT03260205|54778721|FG001|Overall Study|Withdrawal by Participant or Parent/LAR|5|||
28119324|NCT03260205|54778722|FG002|Overall Study|Withdrawal by Participant or Parent/LAR|1|||
28119325|NCT03260205|54778723|FG003|Overall Study|Withdrawal by Participant or Parent/LAR|0|||
28119326|NCT03260205|54778724|FG004|Overall Study|Withdrawal by Participant or Parent/LAR|2|||
28119327|NCT03260205|54778720|FG000|Overall Study|Other: Unspecified|0|||
28119328|NCT03260205|54778721|FG001|Overall Study|Other: Unspecified|0|||
28119329|NCT03260205|54778722|FG002|Overall Study|Other: Unspecified|3|||
28119330|NCT03260205|54778723|FG003|Overall Study|Other: Unspecified|1|||
28119331|NCT03260205|54778724|FG004|Overall Study|Other: Unspecified|1|||
28119332|NCT03260205|54778720|FG000|Overall Study|Participant Who Did Not Received AnyDose|1|||
28119333|NCT03260205|54778721|FG001|Overall Study|Participant Who Did Not Received AnyDose|1|||
28119334|NCT03260205|54778722|FG002|Overall Study|Participant Who Did Not Received AnyDose|2|||
28119335|NCT03260205|54778723|FG003|Overall Study|Participant Who Did Not Received AnyDose|3|||
28119336|NCT03260205|54778724|FG004|Overall Study|Participant Who Did Not Received AnyDose|1|||
28119337|NCT04666441|54778749|FG000|Overall Study|Lost to Follow-up|1|||
28119338|NCT04666441|54778750|FG001|Overall Study|Lost to Follow-up|4|||
28119339|NCT04666441|54778751|FG002|Overall Study|Lost to Follow-up|1|||
28119340|NCT04666441|54778752|FG003|Overall Study|Lost to Follow-up|3|||
27848858|NCT01360554|54343600|FG001|Overall Study|Death|371|||
28119341|NCT04666441|54778753|FG004|Overall Study|Lost to Follow-up|0|||
27848859|NCT01360554|54343599|FG000|Overall Study|Lost to Follow-up|4|||
28119342|NCT04666441|54778754|FG005|Overall Study|Lost to Follow-up|2|||
28119343|NCT04666441|54778755|FG006|Overall Study|Lost to Follow-up|2|||
28119344|NCT04666441|54778756|FG007|Overall Study|Lost to Follow-up|2|||
28119345|NCT04666441|54778749|FG000|Overall Study|Subject Decision|1|||
28119346|NCT04666441|54778750|FG001|Overall Study|Subject Decision|1|||
28119347|NCT04666441|54778751|FG002|Overall Study|Subject Decision|3|||
28119348|NCT04666441|54778752|FG003|Overall Study|Subject Decision|1|||
28119349|NCT04666441|54778753|FG004|Overall Study|Subject Decision|0|||
27848860|NCT01360554|54343600|FG001|Overall Study|Lost to Follow-up|4|||
28066101|NCT00299702|54721762|FG000|Overall Study|Lost to Follow-up|18|||
28066102|NCT00299702|54721763|FG001|Overall Study|Lost to Follow-up|10|||
28066103|NCT00299702|54721762|FG000|Overall Study|Withdrawal by Subject|25|||
27848861|NCT01360554|54343599|FG000|Overall Study|Withdrawal by Subject|23|||
27848862|NCT01360554|54343600|FG001|Overall Study|Withdrawal by Subject|24|||
27817184|NCT01479621|54274286|FG000|Treatment Period|Adverse Event|0|||
27817185|NCT01479621|54274287|FG001|Treatment Period|Adverse Event|0|||
27817186|NCT01479621|54274288|FG002|Treatment Period|Adverse Event|0|||
27817187|NCT01479621|54274289|FG003|Treatment Period|Adverse Event|0|||
27817188|NCT01479621|54274290|FG004|Treatment Period|Adverse Event|1|||
27817189|NCT01479621|54274291|FG005|Treatment Period|Adverse Event|2|||
27817190|NCT01479621|54274292|FG006|Treatment Period|Adverse Event|2|||
27817191|NCT01479621|54274286|FG000|Treatment Period|Withdrawal by Subject|0|||
27817192|NCT01479621|54274287|FG001|Treatment Period|Withdrawal by Subject|4|||
27817193|NCT01479621|54274288|FG002|Treatment Period|Withdrawal by Subject|2|||
27817194|NCT01479621|54274289|FG003|Treatment Period|Withdrawal by Subject|2|||
27817195|NCT01479621|54274290|FG004|Treatment Period|Withdrawal by Subject|5|||
27817196|NCT01479621|54274291|FG005|Treatment Period|Withdrawal by Subject|5|||
28119350|NCT04666441|54778754|FG005|Overall Study|Subject Decision|1|||
28066104|NCT00299702|54721763|FG001|Overall Study|Withdrawal by Subject|23|||
27848863|NCT01360554|54343599|FG000|Overall Study|Study terminated by sponsor|49|||
27848864|NCT01360554|54343600|FG001|Overall Study|Study terminated by sponsor|37|||
27848865|NCT01360554|54343599|FG000|Overall Study|Other, not specified|1|||
28066105|NCT00299702|54721762|FG000|Overall Study|Pregnancy|0|||
28066106|NCT00299702|54721763|FG001|Overall Study|Pregnancy|1|||
28066107|NCT00299702|54721762|FG000|Overall Study|Insufficient Response|4|||
28066108|NCT00299702|54721763|FG001|Overall Study|Insufficient Response|3|||
28066109|NCT00299702|54721762|FG000|Overall Study|Admin issues, sponsor decision, etc.|5|||
28066110|NCT00299702|54721763|FG001|Overall Study|Admin issues, sponsor decision, etc.|9|||
28066111|NCT00291330|54721771|FG000|Overall Study|Adverse Event|47|||
28066112|NCT00291330|54721772|FG001|Overall Study|Adverse Event|40|||
28066113|NCT00291330|54721771|FG000|Overall Study|Protocol Violation|13|||
28066114|NCT00291330|54721772|FG001|Overall Study|Protocol Violation|20|||
28066115|NCT00291330|54721771|FG000|Overall Study|Lost to Follow-up|16|||
27848866|NCT01360554|54343600|FG001|Overall Study|Other, not specified|0|||
27848867|NCT01360554|54343599|FG000|Overall Study|Randomized but not treated.|3|||
27848868|NCT01360554|54343600|FG001|Overall Study|Randomized but not treated.|3|||
27848869|NCT01360398|54343622|FG000|Overall Study|Withdrawal by Subject|14|||
27848870|NCT01360398|54343622|FG000|Overall Study|Other|7|||
27848871|NCT01360398|54343622|FG000|Overall Study|Migrated/moved from study area|1|||
27848872|NCT02626026|54343632|FG000|Overall Study|Randomized but Never Treated|0|||
27848873|NCT02626026|54343633|FG001|Overall Study|Randomized but Never Treated|0|||
27848874|NCT02626026|54343634|FG002|Overall Study|Randomized but Never Treated|0|||
28066116|NCT00291330|54721772|FG001|Overall Study|Lost to Follow-up|11|||
28119351|NCT04666441|54778755|FG006|Overall Study|Subject Decision|3|||
28119352|NCT04666441|54778756|FG007|Overall Study|Subject Decision|2|||
28119353|NCT03320850|54778793|FG000|Overall Study|Lost to Follow-up|0|||
28119354|NCT03320850|54778794|FG001|Overall Study|Lost to Follow-up|0|||
28119355|NCT03320850|54778795|FG002|Overall Study|Lost to Follow-up|0|||
28119356|NCT03320850|54778796|FG003|Overall Study|Lost to Follow-up|0|||
28119357|NCT03320850|54778797|FG004|Overall Study|Lost to Follow-up|1|||
28119358|NCT03320850|54778798|FG005|Overall Study|Lost to Follow-up|2|||
28119359|NCT03320850|54778799|FG006|Overall Study|Lost to Follow-up|2|||
28119360|NCT03320850|54778800|FG007|Overall Study|Lost to Follow-up|0|||
28119361|NCT03320850|54778801|FG008|Overall Study|Lost to Follow-up|6|||
28119362|NCT03320850|54778802|FG009|Overall Study|Lost to Follow-up|4|||
28119363|NCT03320850|54778793|FG000|Overall Study|Withdrawal by Subject|0|||
28119364|NCT03320850|54778794|FG001|Overall Study|Withdrawal by Subject|0|||
28119365|NCT03320850|54778795|FG002|Overall Study|Withdrawal by Subject|0|||
28119366|NCT03320850|54778796|FG003|Overall Study|Withdrawal by Subject|0|||
28119367|NCT03320850|54778797|FG004|Overall Study|Withdrawal by Subject|1|||
28119368|NCT03320850|54778798|FG005|Overall Study|Withdrawal by Subject|2|||
28119369|NCT03320850|54778799|FG006|Overall Study|Withdrawal by Subject|4|||
28119370|NCT03320850|54778800|FG007|Overall Study|Withdrawal by Subject|5|||
28119371|NCT03320850|54778801|FG008|Overall Study|Withdrawal by Subject|2|||
28119372|NCT03320850|54778802|FG009|Overall Study|Withdrawal by Subject|1|||
28119373|NCT03320850|54778793|FG000|Overall Study|Lack of Efficacy|0|||
28119374|NCT03320850|54778794|FG001|Overall Study|Lack of Efficacy|0|||
28119375|NCT03320850|54778795|FG002|Overall Study|Lack of Efficacy|0|||
28119376|NCT03320850|54778796|FG003|Overall Study|Lack of Efficacy|1|||
28119377|NCT03320850|54778797|FG004|Overall Study|Lack of Efficacy|0|||
28119378|NCT03320850|54778798|FG005|Overall Study|Lack of Efficacy|1|||
28066117|NCT00291330|54721771|FG000|Overall Study|Withdrawal by Subject|22|||
28066118|NCT00291330|54721772|FG001|Overall Study|Withdrawal by Subject|25|||
28066119|NCT00291330|54721771|FG000|Overall Study|Other|3|||
28066120|NCT00291330|54721772|FG001|Overall Study|Other|1|||
28066121|NCT00267150|54721778|FG000|Overall Study|Adverse Event|1|||
28066122|NCT00278148|54721782|FG000|Phase II - Expansion Phase|Disease progression|0|||
28066123|NCT00278148|54721783|FG001|Phase II - Expansion Phase|Disease progression|0|||
28066124|NCT00278148|54721784|FG002|Phase II - Expansion Phase|Disease progression|4|||
28119379|NCT03320850|54778799|FG006|Overall Study|Lack of Efficacy|0|||
28119380|NCT03320850|54778800|FG007|Overall Study|Lack of Efficacy|2|||
28119381|NCT03320850|54778801|FG008|Overall Study|Lack of Efficacy|0|||
28119382|NCT03320850|54778802|FG009|Overall Study|Lack of Efficacy|3|||
27848875|NCT02626026|54343635|FG003|Overall Study|Randomized but Never Treated|0|||
27848876|NCT02626026|54343636|FG004|Overall Study|Randomized but Never Treated|1|||
28119383|NCT03320850|54778793|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
28119384|NCT03320850|54778794|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
28119385|NCT03320850|54778795|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
28119386|NCT03320850|54778796|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
28119387|NCT03320850|54778797|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
28119388|NCT03320850|54778798|FG005|Overall Study|Failure to Meet Randomization Criteria|1|||
28119389|NCT03320850|54778799|FG006|Overall Study|Failure to Meet Randomization Criteria|0|||
28119390|NCT03320850|54778800|FG007|Overall Study|Failure to Meet Randomization Criteria|0|||
28119391|NCT03320850|54778801|FG008|Overall Study|Failure to Meet Randomization Criteria|0|||
28119392|NCT03320850|54778802|FG009|Overall Study|Failure to Meet Randomization Criteria|0|||
28119393|NCT03320850|54778793|FG000|Overall Study|Adverse Event|0|||
28119394|NCT03320850|54778794|FG001|Overall Study|Adverse Event|0|||
28119395|NCT03320850|54778795|FG002|Overall Study|Adverse Event|0|||
28119396|NCT03320850|54778796|FG003|Overall Study|Adverse Event|0|||
28119397|NCT03320850|54778797|FG004|Overall Study|Adverse Event|0|||
28119398|NCT03320850|54778798|FG005|Overall Study|Adverse Event|2|||
28119399|NCT03320850|54778799|FG006|Overall Study|Adverse Event|1|||
28119400|NCT03320850|54778800|FG007|Overall Study|Adverse Event|0|||
28119401|NCT03320850|54778801|FG008|Overall Study|Adverse Event|2|||
28119402|NCT03320850|54778802|FG009|Overall Study|Adverse Event|0|||
28119403|NCT03320850|54778793|FG000|Overall Study|Reason Not Specified|0|||
28119404|NCT03320850|54778794|FG001|Overall Study|Reason Not Specified|0|||
28119405|NCT03320850|54778795|FG002|Overall Study|Reason Not Specified|0|||
28119406|NCT03320850|54778796|FG003|Overall Study|Reason Not Specified|0|||
28119407|NCT03320850|54778797|FG004|Overall Study|Reason Not Specified|0|||
28119408|NCT03320850|54778798|FG005|Overall Study|Reason Not Specified|1|||
28119409|NCT03320850|54778799|FG006|Overall Study|Reason Not Specified|0|||
28119410|NCT03320850|54778800|FG007|Overall Study|Reason Not Specified|0|||
28119411|NCT03320850|54778801|FG008|Overall Study|Reason Not Specified|0|||
28119412|NCT03320850|54778802|FG009|Overall Study|Reason Not Specified|1|||
28119413|NCT03301623|54778831|FG000|Overall Study|Death|3|||
28119414|NCT03301623|54778832|FG001|Overall Study|Death|1|||
28119415|NCT03301623|54778831|FG000|Overall Study|Withdrawal by Subject|11|||
28119416|NCT03301623|54778832|FG001|Overall Study|Withdrawal by Subject|13|||
28119417|NCT03301623|54778831|FG000|Overall Study|Lost to Follow-up|3|||
28119418|NCT03301623|54778832|FG001|Overall Study|Lost to Follow-up|1|||
28119419|NCT03319212|54778840|FG000|Overall Study|Discontinued as moving out of local area|0|||
28119420|NCT03319212|54778841|FG001|Overall Study|Discontinued as moving out of local area|1|||
28119421|NCT03319212|54778840|FG000|Overall Study|Adverse Event|2|||
28119422|NCT03319212|54778841|FG001|Overall Study|Adverse Event|2|||
28119423|NCT03319212|54778840|FG000|Overall Study|Withdrawal by Subject|0|||
28119424|NCT03319212|54778841|FG001|Overall Study|Withdrawal by Subject|1|||
28119425|NCT03319212|54778840|FG000|Overall Study|Lost to Follow-up|0|||
28119426|NCT03319212|54778841|FG001|Overall Study|Lost to Follow-up|1|||
28119427|NCT03319212|54778840|FG000|Overall Study|Physician Decision|1|||
28119428|NCT03319212|54778841|FG001|Overall Study|Physician Decision|0|||
28119429|NCT04656691|54778846|FG000|Overall Study|Adverse Event|1|||
28119430|NCT03301155|54778852|FG000|Overall Study|Сompliance with exclusion criteria|8|||
28119431|NCT03301155|54778853|FG001|Overall Study|Сompliance with exclusion criteria|7|||
28119432|NCT01952730|54778859|FG000|Overall Study|FDA shut down core lab used by study|1|||
28119433|NCT03316170|54778865|FG000|Overall Study|Death|1|||
28119434|NCT03316170|54778866|FG001|Overall Study|Death|0|||
28119435|NCT03316170|54778865|FG000|Overall Study|Lost to Follow-up|6|||
28119436|NCT03316170|54778866|FG001|Overall Study|Lost to Follow-up|7|||
27817197|NCT01479621|54274292|FG006|Treatment Period|Withdrawal by Subject|1|||
27817198|NCT01479621|54274286|FG000|Treatment Period|Physician Decision|0|||
27817199|NCT01479621|54274287|FG001|Treatment Period|Physician Decision|0|||
27817200|NCT01479621|54274288|FG002|Treatment Period|Physician Decision|0|||
27817201|NCT01479621|54274289|FG003|Treatment Period|Physician Decision|0|||
27817202|NCT01479621|54274290|FG004|Treatment Period|Physician Decision|1|||
27817203|NCT01479621|54274291|FG005|Treatment Period|Physician Decision|1|||
27817204|NCT01479621|54274292|FG006|Treatment Period|Physician Decision|0|||
27817205|NCT01479621|54274286|FG000|Treatment Period|Non-compliance to study drug|0|||
27817206|NCT01479621|54274287|FG001|Treatment Period|Non-compliance to study drug|1|||
27817207|NCT01479621|54274288|FG002|Treatment Period|Non-compliance to study drug|0|||
27817208|NCT01479621|54274289|FG003|Treatment Period|Non-compliance to study drug|0|||
27817209|NCT01479621|54274290|FG004|Treatment Period|Non-compliance to study drug|0|||
28119437|NCT03257865|54778875|FG000|Overall Study|Adverse Event|4|||
28119438|NCT03257865|54778876|FG001|Overall Study|Adverse Event|8|||
28119439|NCT03257865|54778875|FG000|Overall Study|Lack of Efficacy|1|||
28119440|NCT03257865|54778876|FG001|Overall Study|Lack of Efficacy|2|||
27817210|NCT01479621|54274291|FG005|Treatment Period|Non-compliance to study drug|0|||
27817211|NCT01479621|54274292|FG006|Treatment Period|Non-compliance to study drug|1|||
28119441|NCT03257865|54778875|FG000|Overall Study|Non-compliance with Study Drug|0|||
28119442|NCT03257865|54778876|FG001|Overall Study|Non-compliance with Study Drug|2|||
28119443|NCT03257865|54778875|FG000|Overall Study|Withdrawal by Subject|23|||
28119444|NCT03257865|54778876|FG001|Overall Study|Withdrawal by Subject|17|||
28119445|NCT03257865|54778875|FG000|Overall Study|Physician Decision|3|||
28119446|NCT03257865|54778876|FG001|Overall Study|Physician Decision|1|||
27817212|NCT01479621|54274286|FG000|Treatment Period|Protocol Violation|0|||
28119447|NCT03257865|54778875|FG000|Overall Study|Other|0|||
28119448|NCT03257865|54778876|FG001|Overall Study|Other|1|||
28119449|NCT03257865|54778875|FG000|Overall Study|Lost to Follow-up|4|||
28119450|NCT03257865|54778876|FG001|Overall Study|Lost to Follow-up|4|||
28119451|NCT04617847|54778884|FG000|Overall Study|Withdrawal by Subject|1|||
28119452|NCT04617847|54778885|FG001|Overall Study|Withdrawal by Subject|0|||
28119453|NCT04617847|54778884|FG000|Overall Study|Adverse Event|0|||
28119454|NCT04617847|54778885|FG001|Overall Study|Adverse Event|2|||
28119455|NCT04617847|54778884|FG000|Overall Study|Death|0|||
28119456|NCT04617847|54778885|FG001|Overall Study|Death|1|||
28119457|NCT04617847|54778884|FG000|Overall Study|Termination of Study by Sponsor|2|||
28119458|NCT04617847|54778885|FG001|Overall Study|Termination of Study by Sponsor|21|||
28119459|NCT04615507|54778895|FG000|Period 1|Covid-19 exposure|2|||
28119460|NCT04615507|54778896|FG001|Period 1|Covid-19 exposure|1|||
28119461|NCT04615507|54778895|FG000|Period 2|Covid-19 exposure|0|||
28119462|NCT04615507|54778896|FG001|Period 2|Covid-19 exposure|1|||
28119463|NCT04615507|54778895|FG000|Period 2|Protocol Violation|1|||
28119464|NCT04615507|54778896|FG001|Period 2|Protocol Violation|0|||
28119465|NCT04615507|54778895|FG000|Period 2|Withdrawal by Subject|1|||
28119466|NCT04615507|54778896|FG001|Period 2|Withdrawal by Subject|0|||
28119467|NCT04615507|54778895|FG000|Period 2|Adverse Event|0|||
28119468|NCT04615507|54778896|FG001|Period 2|Adverse Event|1|||
28119469|NCT04615507|54778895|FG000|Period 3|Covid-19 exposure|0|||
28119470|NCT04615507|54778896|FG001|Period 3|Covid-19 exposure|1|||
28119471|NCT04120233|54778908|FG000|Overall Study|Adverse Event|0|||
28119472|NCT04120233|54778909|FG001|Overall Study|Adverse Event|0|||
28119473|NCT04120233|54778910|FG002|Overall Study|Adverse Event|0|||
28119474|NCT04120233|54778911|FG003|Overall Study|Adverse Event|0|||
28119475|NCT04120233|54778912|FG004|Overall Study|Adverse Event|1|||
28119476|NCT04120233|54778913|FG005|Overall Study|Adverse Event|0|||
28119477|NCT01610700|54778929|FG000|Overall Study|Adverse Event|3|||
28119478|NCT01610700|54778930|FG001|Overall Study|Adverse Event|1|||
28119479|NCT01610700|54778929|FG000|Overall Study|Withdrawal by Subject|0|||
28119480|NCT01610700|54778930|FG001|Overall Study|Withdrawal by Subject|1|||
28119481|NCT01610700|54778929|FG000|Overall Study|subject took one dose of street cannabis|0|||
28119482|NCT01610700|54778930|FG001|Overall Study|subject took one dose of street cannabis|1|||
28119483|NCT03256851|54778939|FG000|Overall Study|Withdrawal by Subject|1|||
28119484|NCT03256851|54778940|FG001|Overall Study|Withdrawal by Subject|0|||
28119485|NCT04837807|54778946|FG000|First Sequence (Week 1)|Withdrawal by Subject|0|||
28119486|NCT04837807|54778947|FG001|First Sequence (Week 1)|Withdrawal by Subject|1|||
28119487|NCT03256695|54778953|FG000|Overall Study|Adverse Event|8|||
28119488|NCT03256695|54778953|FG000|Overall Study|Death|2|||
28119489|NCT03256695|54778953|FG000|Overall Study|Withdrawal by Subject|14|||
28119490|NCT03256695|54778953|FG000|Overall Study|Non-compliance with study drug|1|||
28119491|NCT03256695|54778953|FG000|Overall Study|Lost to Follow-up|3|||
28119492|NCT03256695|54778953|FG000|Overall Study|Lack of Efficacy|3|||
28119493|NCT03256695|54778953|FG000|Overall Study|Protocol Violation|5|||
28119494|NCT03256695|54778953|FG000|Overall Study|Other than specified|3|||
28119495|NCT03305016|54778957|FG000|Overall Study|Withdrawal by Subject|2|||
28119496|NCT03297021|54778964|FG000|Overall Study|Incomplete/illegible data sheet|4|||
28119497|NCT03297021|54778965|FG001|Overall Study|Incomplete/illegible data sheet|2|||
28119498|NCT03297021|54778966|FG002|Overall Study|Incomplete/illegible data sheet|3|||
28119499|NCT03297021|54778964|FG000|Overall Study|Missing Post-Op Data|1|||
28119500|NCT03297021|54778965|FG001|Overall Study|Missing Post-Op Data|2|||
28119501|NCT03297021|54778966|FG002|Overall Study|Missing Post-Op Data|1|||
28119502|NCT04820491|54778976|FG000|Overall Study|Withdrawal by Subject|1|||
28066125|NCT00278148|54721782|FG000|Phase II - Expansion Phase|Adverse Event|0|||
28066126|NCT00278148|54721783|FG001|Phase II - Expansion Phase|Adverse Event|0|||
28066127|NCT00278148|54721784|FG002|Phase II - Expansion Phase|Adverse Event|2|||
28066128|NCT00299546|54721794|FG000|Overall Study|Death|3|||
28066129|NCT00299546|54721795|FG001|Overall Study|Death|2|||
28066130|NCT00299546|54721796|FG002|Overall Study|Death|0|||
28066131|NCT00299546|54721794|FG000|Overall Study|Lost to Follow-up|2|||
28066132|NCT00299546|54721795|FG001|Overall Study|Lost to Follow-up|2|||
28066133|NCT00299546|54721796|FG002|Overall Study|Lost to Follow-up|5|||
28066134|NCT00299546|54721794|FG000|Overall Study|Adverse Event|37|||
28066135|NCT00299546|54721795|FG001|Overall Study|Adverse Event|22|||
28066136|NCT00299546|54721796|FG002|Overall Study|Adverse Event|27|||
28066137|NCT00299546|54721794|FG000|Overall Study|Unsatisfactory therapeutic effect|34|||
28066138|NCT00299546|54721795|FG001|Overall Study|Unsatisfactory therapeutic effect|39|||
28066139|NCT00299546|54721796|FG002|Overall Study|Unsatisfactory therapeutic effect|34|||
28066140|NCT00299546|54721794|FG000|Overall Study|Other|24|||
28066141|NCT00299546|54721795|FG001|Overall Study|Other|26|||
28066142|NCT00299546|54721796|FG002|Overall Study|Other|19|||
28066143|NCT00299546|54721794|FG000|Overall Study|Not treated|0|||
28066144|NCT00299546|54721795|FG001|Overall Study|Not treated|1|||
28066145|NCT00299546|54721796|FG002|Overall Study|Not treated|1|||
28066146|NCT00299156|54721808|FG000|Period 2 (Randomized)|Screen Failure|0|||
28066147|NCT00299156|54721809|FG001|Period 2 (Randomized)|Screen Failure|1|||
28119503|NCT04820491|54778977|FG001|Overall Study|Withdrawal by Subject|0|||
28119504|NCT01988571|54778985|FG000|Overall Study|Death|3|||
28119505|NCT01988571|54778986|FG001|Overall Study|Death|1|||
28119506|NCT01988571|54778985|FG000|Overall Study|Physician Decision|2|||
28119507|NCT01988571|54778986|FG001|Overall Study|Physician Decision|1|||
28119508|NCT01988571|54778985|FG000|Overall Study|Lost to Follow-up|3|||
28119509|NCT01988571|54778986|FG001|Overall Study|Lost to Follow-up|0|||
28119510|NCT01988571|54778985|FG000|Overall Study|Withdrawal by Subject|31|||
28119511|NCT01988571|54778986|FG001|Overall Study|Withdrawal by Subject|33|||
28119512|NCT04794751|54778992|FG000|Period 1|incorrect fitting guide was used to fit subject|2|||
28119513|NCT04794751|54778993|FG001|Period 1|incorrect fitting guide was used to fit subject|1|||
28119514|NCT04794751|54778992|FG000|Period 1|Subject no longer meets eligibility criteria|0|||
28119515|NCT04794751|54778993|FG001|Period 1|Subject no longer meets eligibility criteria|1|||
28119516|NCT04794751|54778992|FG000|Period 1|Protocol Violation|0|||
28119517|NCT04794751|54778993|FG001|Period 1|Protocol Violation|2|||
28119518|NCT04794751|54778992|FG000|Period 1|Withdrawal by Subject|0|||
28119519|NCT04794751|54778993|FG001|Period 1|Withdrawal by Subject|1|||
28119520|NCT04794751|54778992|FG000|Period 2|Withdrawal by Subject|0|||
28119521|NCT04794751|54778993|FG001|Period 2|Withdrawal by Subject|1|||
28119522|NCT04794751|54778992|FG000|Period 2|incorrect fitting guide was used to fit subject|0|||
28119523|NCT04794751|54778993|FG001|Period 2|incorrect fitting guide was used to fit subject|2|||
28119524|NCT04794751|54778992|FG000|Period 2|Protocol Violation|1|||
28119525|NCT04794751|54778993|FG001|Period 2|Protocol Violation|0|||
28119526|NCT04578457|54779008|FG000|Hearing Aid Without NR Enabled (0)|Withdrawal by Subject|2|||
28119527|NCT04578457|54779008|FG000|Hearing Aid With NR (1)|Withdrawal by Subject|2|||
28119528|NCT04578457|54779008|FG000|Hearing Aid With NR (2)|Withdrawal by Subject|2|||
28066148|NCT00299156|54721810|FG002|Period 2 (Randomized)|Screen Failure|0|||
28066149|NCT00277212|54721818|FG000|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61|||
28119529|NCT04578457|54779008|FG000|Hearing Aid With NR (4)|Withdrawal by Subject|2|||
28119530|NCT03334188|54779018|FG000|Overall Study|Withdrawal by Subject|0|||
28119531|NCT03334188|54779019|FG001|Overall Study|Withdrawal by Subject|1|||
28119532|NCT03334188|54779018|FG000|Overall Study|Death|1|||
28119533|NCT03334188|54779019|FG001|Overall Study|Death|0|||
28119534|NCT03334188|54779018|FG000|Overall Study|Never had qualifying clinic visit|7|||
28119535|NCT03334188|54779019|FG001|Overall Study|Never had qualifying clinic visit|7|||
28119536|NCT03333876|54779028|FG000|Screening Period|Screen Failure|4|||
28119537|NCT03333876|54779028|FG000|Nasal Dilator|Bed Partner Lost to follow up|6|||
28119538|NCT03333876|54779028|FG000|Mandibular Advancement|Adverse Event|2|||
28119539|NCT03333876|54779028|FG000|Mandibular Advancement|Product Damage|2|||
28119540|NCT03294681|54779041|FG000|Overall Study|Withdrawal by Subject|1|||
28119541|NCT01140867|54779045|FG000|Overall Study|Adverse Event|22|||
28119542|NCT01140867|54779045|FG000|Overall Study|Lack of Efficacy|3|||
28119543|NCT01140867|54779045|FG000|Overall Study|Lost to Follow-up|2|||
28119544|NCT01140867|54779045|FG000|Overall Study|Withdrawal by Subject|1|||
28119545|NCT01140867|54779045|FG000|Overall Study|Protocol Violation|1|||
28119546|NCT01140867|54779045|FG000|Overall Study|Uncooperative patient|2|||
28119547|NCT01140867|54779045|FG000|Overall Study|Medication Noncompliance|2|||
28119548|NCT04572997|54779049|FG000|Overall Study|Adverse Event|1|||
27817213|NCT01479621|54274287|FG001|Treatment Period|Protocol Violation|9|||
28066150|NCT00277212|54721819|FG001|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
28066151|NCT00277212|54721820|FG002|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
28066152|NCT00277212|54721818|FG000|Phase 1 - Single-Blind Treatment|Adverse Event|93|||
28066153|NCT00277212|54721819|FG001|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
28066154|NCT00277212|54721820|FG002|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
28066155|NCT00277212|54721818|FG000|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96|||
28066156|NCT00277212|54721819|FG001|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
28066157|NCT00277212|54721820|FG002|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
28066158|NCT00277212|54721818|FG000|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87|||
28066159|NCT00277212|54721819|FG001|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
28066160|NCT00277212|54721820|FG002|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
28066161|NCT00277212|54721818|FG000|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35|||
28066162|NCT00277212|54721819|FG001|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
28066163|NCT00277212|54721820|FG002|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
28119549|NCT02943096|54779059|FG000|Overall Study|Lack of Efficacy|0|||
28119550|NCT02943096|54779060|FG001|Overall Study|Lack of Efficacy|1|||
28119551|NCT04571515|54779071|FG000|Overall Study|Physician Decision|0|||
28119552|NCT04571515|54779072|FG001|Overall Study|Physician Decision|0|||
28119553|NCT04571515|54779073|FG002|Overall Study|Physician Decision|0|||
28119554|NCT04571515|54779074|FG003|Overall Study|Physician Decision|0|||
28119555|NCT04571515|54779075|FG004|Overall Study|Physician Decision|1|||
28119556|NCT04571515|54779071|FG000|Overall Study|Withdrawal by Subject|0|||
28119557|NCT04571515|54779072|FG001|Overall Study|Withdrawal by Subject|0|||
28119558|NCT04571515|54779073|FG002|Overall Study|Withdrawal by Subject|0|||
28119559|NCT04571515|54779074|FG003|Overall Study|Withdrawal by Subject|0|||
28119560|NCT04571515|54779075|FG004|Overall Study|Withdrawal by Subject|1|||
28119561|NCT04571515|54779071|FG000|Overall Study|insufficient pain|1|||
28119562|NCT04571515|54779072|FG001|Overall Study|insufficient pain|0|||
28119563|NCT04571515|54779073|FG002|Overall Study|insufficient pain|0|||
28119564|NCT04571515|54779074|FG003|Overall Study|insufficient pain|0|||
28119565|NCT04571515|54779075|FG004|Overall Study|insufficient pain|1|||
28119566|NCT03292653|54779090|FG000|Overall Study|Adverse Event|0|||
28119567|NCT03292653|54779091|FG001|Overall Study|Adverse Event|0|||
28119568|NCT03292653|54779092|FG002|Overall Study|Adverse Event|1|||
28119569|NCT03292653|54779090|FG000|Overall Study|Did not Receive Treatment|1|||
28119570|NCT03292653|54779091|FG001|Overall Study|Did not Receive Treatment|0|||
28119571|NCT03292653|54779092|FG002|Overall Study|Did not Receive Treatment|0|||
28119572|NCT03858634|54779103|FG000|Overall Study|Withdrawal by Subject|1|||
28119573|NCT03858634|54779104|FG001|Overall Study|Withdrawal by Subject|0|||
28119574|NCT03858634|54779103|FG000|Overall Study|Adverse Event|1|||
28119575|NCT03858634|54779104|FG001|Overall Study|Adverse Event|0|||
28119576|NCT03858634|54779103|FG000|Overall Study|Lost to Follow-up|0|||
28119577|NCT03858634|54779104|FG001|Overall Study|Lost to Follow-up|1|||
28119578|NCT03858634|54779103|FG000|Overall Study|Other, Not Specified|1|||
28119579|NCT03858634|54779104|FG001|Overall Study|Other, Not Specified|1|||
28119580|NCT02891070|54779120|FG000|Overall Study|Adverse Event|1|||
28119581|NCT02891070|54779121|FG001|Overall Study|Adverse Event|0|||
28119582|NCT02891070|54779120|FG000|Overall Study|Physician Decision|0|||
28119583|NCT02891070|54779121|FG001|Overall Study|Physician Decision|1|||
28119584|NCT02891070|54779120|FG000|Overall Study|Lost to Follow-up|4|||
28119585|NCT02891070|54779121|FG001|Overall Study|Lost to Follow-up|4|||
28119586|NCT02891070|54779120|FG000|Overall Study|Other|1|||
28119587|NCT02891070|54779121|FG001|Overall Study|Other|0|||
28119588|NCT02891070|54779120|FG000|Overall Study|Protocol Violation|0|||
27817214|NCT01479621|54274288|FG002|Treatment Period|Protocol Violation|6|||
27817215|NCT01479621|54274289|FG003|Treatment Period|Protocol Violation|5|||
27817216|NCT01479621|54274290|FG004|Treatment Period|Protocol Violation|2|||
27817217|NCT01479621|54274291|FG005|Treatment Period|Protocol Violation|10|||
27817218|NCT01479621|54274292|FG006|Treatment Period|Protocol Violation|6|||
27817219|NCT01479621|54274286|FG000|Treatment Period|Pregnancy|0|||
27817220|NCT01479621|54274287|FG001|Treatment Period|Pregnancy|0|||
27817221|NCT01479621|54274288|FG002|Treatment Period|Pregnancy|2|||
27817222|NCT01479621|54274289|FG003|Treatment Period|Pregnancy|0|||
27817223|NCT01479621|54274290|FG004|Treatment Period|Pregnancy|0|||
27817224|NCT01479621|54274291|FG005|Treatment Period|Pregnancy|0|||
27817225|NCT01479621|54274292|FG006|Treatment Period|Pregnancy|0|||
27817226|NCT01479621|54274286|FG000|Treatment Period|Sponsor request subject to be withdrawn|0|||
27817227|NCT01479621|54274287|FG001|Treatment Period|Sponsor request subject to be withdrawn|2|||
27817228|NCT01479621|54274288|FG002|Treatment Period|Sponsor request subject to be withdrawn|3|||
27817229|NCT01479621|54274289|FG003|Treatment Period|Sponsor request subject to be withdrawn|1|||
27817230|NCT01479621|54274290|FG004|Treatment Period|Sponsor request subject to be withdrawn|1|||
27817231|NCT01479621|54274291|FG005|Treatment Period|Sponsor request subject to be withdrawn|1|||
27817232|NCT01479621|54274292|FG006|Treatment Period|Sponsor request subject to be withdrawn|3|||
27817233|NCT01479621|54274286|FG000|Treatment Period|Lost to Follow-up|0|||
27817234|NCT01479621|54274287|FG001|Treatment Period|Lost to Follow-up|0|||
27817235|NCT01479621|54274288|FG002|Treatment Period|Lost to Follow-up|1|||
27817236|NCT01479621|54274289|FG003|Treatment Period|Lost to Follow-up|0|||
27817237|NCT01479621|54274290|FG004|Treatment Period|Lost to Follow-up|2|||
27817238|NCT01479621|54274291|FG005|Treatment Period|Lost to Follow-up|2|||
27817239|NCT01479621|54274292|FG006|Treatment Period|Lost to Follow-up|1|||
27817240|NCT01479621|54274286|FG000|Treatment Period|Met stopping criteria|0|||
27817241|NCT01479621|54274287|FG001|Treatment Period|Met stopping criteria|8|||
27817242|NCT01479621|54274288|FG002|Treatment Period|Met stopping criteria|7|||
27817243|NCT01479621|54274289|FG003|Treatment Period|Met stopping criteria|4|||
27817244|NCT01479621|54274290|FG004|Treatment Period|Met stopping criteria|9|||
27817245|NCT01479621|54274291|FG005|Treatment Period|Met stopping criteria|20|||
27817246|NCT01479621|54274292|FG006|Treatment Period|Met stopping criteria|6|||
27817247|NCT01479465|54274340|FG000|Overall Study|Disease Progression|9|||
27817248|NCT01479465|54274341|FG001|Overall Study|Disease Progression|61|||
27817249|NCT01479465|54274342|FG002|Overall Study|Disease Progression|65|||
28119589|NCT02891070|54779121|FG001|Overall Study|Protocol Violation|1|||
27817250|NCT01479465|54274343|FG003|Overall Study|Disease Progression|70|||
27817251|NCT01479465|54274340|FG000|Overall Study|Study Discontinued by Sponsor|0|||
27817252|NCT01479465|54274341|FG001|Overall Study|Study Discontinued by Sponsor|7|||
28119590|NCT02891070|54779120|FG000|Overall Study|Withdrawal by Subject|1|||
28119591|NCT02891070|54779121|FG001|Overall Study|Withdrawal by Subject|2|||
28119592|NCT02891070|54779120|FG000|Overall Study|Death|3|||
28119593|NCT02891070|54779121|FG001|Overall Study|Death|0|||
28119594|NCT03255291|54779133|FG000|Overall Study|Determined to be ineligible|10|||
28119595|NCT03255291|54779134|FG001|Overall Study|Determined to be ineligible|12|||
27817253|NCT01479465|54274342|FG002|Overall Study|Study Discontinued by Sponsor|5|||
27817254|NCT01479465|54274343|FG003|Overall Study|Study Discontinued by Sponsor|3|||
27817255|NCT01479465|54274340|FG000|Overall Study|Adverse Event|0|||
27817256|NCT01479465|54274341|FG001|Overall Study|Adverse Event|3|||
27817257|NCT01479465|54274342|FG002|Overall Study|Adverse Event|6|||
27817258|NCT01479465|54274343|FG003|Overall Study|Adverse Event|4|||
27817259|NCT01479465|54274340|FG000|Overall Study|Investigator Discretion|1|||
28119596|NCT03255291|54779135|FG002|Overall Study|Determined to be ineligible|6|||
28119597|NCT03255291|54779136|FG003|Overall Study|Determined to be ineligible|6|||
28119598|NCT03255291|54779137|FG004|Overall Study|Determined to be ineligible|5|||
28119599|NCT03255291|54779138|FG005|Overall Study|Determined to be ineligible|10|||
27817260|NCT01479465|54274341|FG001|Overall Study|Investigator Discretion|4|||
27817261|NCT01479465|54274342|FG002|Overall Study|Investigator Discretion|2|||
27817262|NCT01479465|54274343|FG003|Overall Study|Investigator Discretion|4|||
27848877|NCT02626026|54343637|FG005|Overall Study|Randomized but Never Treated|0|||
27848878|NCT01765296|54343897|FG000|Overall Study|Protocol Violation|0|||
27817263|NCT01479465|54274340|FG000|Overall Study|Subject Request|1|||
27817264|NCT01479465|54274341|FG001|Overall Study|Subject Request|3|||
28119600|NCT03255291|54779133|FG000|Overall Study|Baseline data collection issues|3|||
27817265|NCT01479465|54274342|FG002|Overall Study|Subject Request|4|||
28119601|NCT03255291|54779134|FG001|Overall Study|Baseline data collection issues|0|||
28119602|NCT03255291|54779135|FG002|Overall Study|Baseline data collection issues|0|||
28119603|NCT03255291|54779136|FG003|Overall Study|Baseline data collection issues|0|||
28119604|NCT03255291|54779137|FG004|Overall Study|Baseline data collection issues|2|||
28119605|NCT03255291|54779138|FG005|Overall Study|Baseline data collection issues|0|||
28119606|NCT00381381|54779156|FG000|Overall Study|Adverse Event|3|||
28119607|NCT00381381|54779156|FG000|Overall Study|Lost to Follow-up|52|||
28119608|NCT00381381|54779156|FG000|Overall Study|Withdrawal by Subject|9|||
28119609|NCT02939937|54779162|FG000|Overall Study|Adverse Event|5|||
28119610|NCT02939937|54779163|FG001|Overall Study|Adverse Event|0|||
28119611|NCT02939937|54779162|FG000|Overall Study|Lost to Follow-up|1|||
28119612|NCT02939937|54779163|FG001|Overall Study|Lost to Follow-up|3|||
28119613|NCT02939079|54779171|FG000|Overall Study|Adverse Event|2|||
28119614|NCT02939079|54779172|FG001|Overall Study|Adverse Event|1|||
28119615|NCT02939079|54779171|FG000|Overall Study|Lost to Follow-up|0|||
28119616|NCT02939079|54779172|FG001|Overall Study|Lost to Follow-up|2|||
28119617|NCT02939079|54779171|FG000|Overall Study|Protocol Violation|1|||
28119618|NCT02939079|54779172|FG001|Overall Study|Protocol Violation|0|||
28119619|NCT02939079|54779171|FG000|Overall Study|Withdrawal by Subject|0|||
28119620|NCT02939079|54779172|FG001|Overall Study|Withdrawal by Subject|1|||
28119621|NCT02939079|54779171|FG000|Overall Study|relapse during the study|1|||
28119622|NCT02939079|54779172|FG001|Overall Study|relapse during the study|1|||
28119623|NCT04562155|54779182|FG000|Overall Study|COVID-19 pandemic|0|||
28119624|NCT04562155|54779183|FG001|Overall Study|COVID-19 pandemic|0|||
28119625|NCT04562155|54779184|FG002|Overall Study|COVID-19 pandemic|0|||
28119626|NCT04562155|54779185|FG003|Overall Study|COVID-19 pandemic|1|||
28119627|NCT04562155|54779182|FG000|Overall Study|Adverse Event|7|||
28119628|NCT04562155|54779183|FG001|Overall Study|Adverse Event|3|||
28119629|NCT04562155|54779184|FG002|Overall Study|Adverse Event|8|||
28119630|NCT04562155|54779185|FG003|Overall Study|Adverse Event|1|||
28119631|NCT04562155|54779182|FG000|Overall Study|Withdrawal by Subject|3|||
28119632|NCT04562155|54779183|FG001|Overall Study|Withdrawal by Subject|6|||
28119633|NCT04562155|54779184|FG002|Overall Study|Withdrawal by Subject|3|||
28119634|NCT04562155|54779185|FG003|Overall Study|Withdrawal by Subject|3|||
28119635|NCT04562155|54779182|FG000|Overall Study|Participant personal reason|1|||
28119636|NCT04562155|54779183|FG001|Overall Study|Participant personal reason|0|||
28119637|NCT04562155|54779184|FG002|Overall Study|Participant personal reason|2|||
28119638|NCT04562155|54779185|FG003|Overall Study|Participant personal reason|1|||
28119639|NCT03313050|54779199|FG000|Stage 2: 12 Months|Adverse Event|0|||
27848879|NCT01765296|54343898|FG001|Overall Study|Protocol Violation|5|||
27848880|NCT01765296|54343899|FG002|Overall Study|Protocol Violation|4|||
27848881|NCT01765296|54343897|FG000|Overall Study|Withdrawal by Subject|4|||
27848882|NCT01765296|54343898|FG001|Overall Study|Withdrawal by Subject|2|||
27817266|NCT01479465|54274343|FG003|Overall Study|Subject Request|2|||
27817267|NCT01479465|54274340|FG000|Overall Study|Subject Withdrew Consent|0|||
28119640|NCT03313050|54779200|FG001|Stage 2: 12 Months|Adverse Event|0|||
28119641|NCT03313050|54779201|FG002|Stage 2: 12 Months|Adverse Event|0|||
28119642|NCT03313050|54779202|FG003|Stage 2: 12 Months|Adverse Event|1|||
28119643|NCT03313050|54779199|FG000|Stage 2: 12 Months|Death|0|||
28119644|NCT03313050|54779200|FG001|Stage 2: 12 Months|Death|0|||
28119645|NCT03313050|54779201|FG002|Stage 2: 12 Months|Death|3|||
28119646|NCT03313050|54779202|FG003|Stage 2: 12 Months|Death|0|||
28119647|NCT03313050|54779199|FG000|Stage 2: 12 Months|Lost to Follow-up|0|||
28119648|NCT03313050|54779200|FG001|Stage 2: 12 Months|Lost to Follow-up|0|||
27817268|NCT01479465|54274341|FG001|Overall Study|Subject Withdrew Consent|5|||
28119649|NCT03313050|54779201|FG002|Stage 2: 12 Months|Lost to Follow-up|1|||
27848883|NCT01765296|54343899|FG002|Overall Study|Withdrawal by Subject|2|||
28119650|NCT03313050|54779202|FG003|Stage 2: 12 Months|Lost to Follow-up|5|||
28119651|NCT03313050|54779199|FG000|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
28119652|NCT03313050|54779200|FG001|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
28119653|NCT03313050|54779201|FG002|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
28119654|NCT03313050|54779202|FG003|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3|||
28119655|NCT03313050|54779199|FG000|Stage 2: 12 Months|Protocol deviation|0|||
28119656|NCT03313050|54779200|FG001|Stage 2: 12 Months|Protocol deviation|0|||
28119657|NCT03313050|54779201|FG002|Stage 2: 12 Months|Protocol deviation|7|||
28119658|NCT03313050|54779202|FG003|Stage 2: 12 Months|Protocol deviation|7|||
28119659|NCT03313050|54779199|FG000|Stage 2: 12 Months|Withdrawal by Subject|0|||
28119660|NCT03313050|54779200|FG001|Stage 2: 12 Months|Withdrawal by Subject|0|||
28119661|NCT03313050|54779201|FG002|Stage 2: 12 Months|Withdrawal by Subject|0|||
28119662|NCT03313050|54779202|FG003|Stage 2: 12 Months|Withdrawal by Subject|3|||
28119663|NCT03313050|54779199|FG000|Stage 2: 12 Months|Other|0|||
28119664|NCT03313050|54779200|FG001|Stage 2: 12 Months|Other|0|||
28119665|NCT03313050|54779201|FG002|Stage 2: 12 Months|Other|0|||
28119666|NCT03313050|54779202|FG003|Stage 2: 12 Months|Other|1|||
28119667|NCT04755595|54779221|FG000|Overall Study|Lost to Follow-up|1|||
28119668|NCT04749745|54779226|FG000|Overall Study|Withdrawal by Subject|1|||
27848884|NCT01765296|54343897|FG000|Overall Study|Adverse Event|1|||
27848885|NCT01765296|54343898|FG001|Overall Study|Adverse Event|13|||
27848886|NCT01765296|54343899|FG002|Overall Study|Adverse Event|5|||
27848887|NCT01765296|54343897|FG000|Overall Study|Lack of Efficacy|0|||
27848888|NCT01765296|54343898|FG001|Overall Study|Lack of Efficacy|0|||
27848889|NCT01765296|54343899|FG002|Overall Study|Lack of Efficacy|2|||
27848890|NCT02089685|54343973|FG000|Overall Study|Adverse Event|1|||
27848891|NCT02089685|54343974|FG001|Overall Study|Adverse Event|0|||
27848892|NCT02089685|54343975|FG002|Overall Study|Adverse Event|0|||
27848893|NCT02089685|54343976|FG003|Overall Study|Adverse Event|0|||
27848894|NCT02089685|54343977|FG004|Overall Study|Adverse Event|1|||
27848895|NCT02089685|54343978|FG005|Overall Study|Adverse Event|0|||
28119669|NCT04749745|54779227|FG001|Overall Study|Withdrawal by Subject|0|||
28119670|NCT03257436|54779233|FG000|Overall Study|Withdrawal by Subject|76|||
28119671|NCT03257436|54779233|FG000|Overall Study|Death|19|||
28119672|NCT04748341|54779239|FG000|Overall Study|Lost to Follow-up|1|||
28119673|NCT04748341|54779240|FG001|Overall Study|Lost to Follow-up|1|||
28119674|NCT01328002|54779246|FG000|Open-Label Period|Inclusion/exclusion criteria not met|66|||
28119675|NCT01328002|54779247|FG001|Open-Label Period|Inclusion/exclusion criteria not met|0|||
28119676|NCT01328002|54779246|FG000|Open-Label Period|Adverse Event|8|||
28119677|NCT01328002|54779247|FG001|Open-Label Period|Adverse Event|0|||
28119678|NCT01328002|54779246|FG000|Open-Label Period|Lack of Efficacy|3|||
28119679|NCT01328002|54779247|FG001|Open-Label Period|Lack of Efficacy|0|||
28119680|NCT01328002|54779246|FG000|Open-Label Period|Protocol Violation|2|||
28119681|NCT01328002|54779247|FG001|Open-Label Period|Protocol Violation|0|||
28119682|NCT01328002|54779246|FG000|Open-Label Period|Withdrawal by Subject|9|||
28119683|NCT01328002|54779247|FG001|Open-Label Period|Withdrawal by Subject|0|||
28119684|NCT01328002|54779246|FG000|Open-Label Period|Lost to Follow-up|6|||
28119685|NCT01328002|54779247|FG001|Open-Label Period|Lost to Follow-up|0|||
28119686|NCT01328002|54779246|FG000|Open-Label Period|Other Reason|2|||
28119687|NCT01328002|54779247|FG001|Open-Label Period|Other Reason|0|||
28119688|NCT01328002|54779246|FG000|Double-Blind Period|Adverse Event|1|||
28119689|NCT01328002|54779247|FG001|Double-Blind Period|Adverse Event|0|||
28119690|NCT01328002|54779246|FG000|Double-Blind Period|Lack of Efficacy|1|||
28119691|NCT01328002|54779247|FG001|Double-Blind Period|Lack of Efficacy|0|||
28119692|NCT02579265|54779256|FG000|Overall Study|Weaned off earlier than 28 days|44|||
28119693|NCT02579265|54779257|FG001|Overall Study|Weaned off earlier than 28 days|43|||
28119694|NCT02579265|54779256|FG000|Overall Study|Adverse Event|2|||
28119695|NCT02579265|54779257|FG001|Overall Study|Adverse Event|0|||
28119696|NCT02579265|54779256|FG000|Overall Study|Any other reason not specified|0|||
28119697|NCT02579265|54779257|FG001|Overall Study|Any other reason not specified|2|||
28119698|NCT02579265|54779256|FG000|Overall Study|Withdrawal by Subject|2|||
28119699|NCT02579265|54779257|FG001|Overall Study|Withdrawal by Subject|0|||
27848896|NCT02089685|54343973|FG000|Overall Study|Clinical Progression|4|||
27848897|NCT02089685|54343974|FG001|Overall Study|Clinical Progression|0|||
28119700|NCT02579265|54779256|FG000|Overall Study|Physician Decision|1|||
27848898|NCT02089685|54343975|FG002|Overall Study|Clinical Progression|0|||
27848899|NCT02089685|54343976|FG003|Overall Study|Clinical Progression|5|||
27848900|NCT02089685|54343977|FG004|Overall Study|Clinical Progression|1|||
28119701|NCT02579265|54779257|FG001|Overall Study|Physician Decision|0|||
28119702|NCT02579265|54779256|FG000|Overall Study|Withdrawal due to increased conjugated bilirubin|1|||
28119703|NCT02579265|54779257|FG001|Overall Study|Withdrawal due to increased conjugated bilirubin|0|||
28119704|NCT03289533|54779263|FG000|Overall Study|Death|12|||
28119705|NCT03289533|54779263|FG000|Overall Study|Terminated from study by sponsor|10|||
28119706|NCT04727749|54779269|FG000|Overall Study|Lost to Follow-up|10|||
28119707|NCT04727749|54779270|FG001|Overall Study|Lost to Follow-up|3|||
27848901|NCT02089685|54343978|FG005|Overall Study|Clinical Progression|2|||
28119708|NCT04547023|54779280|FG000|Overall Study|Did Not Receive Intervention|3|||
28119709|NCT04547023|54779281|FG001|Overall Study|Did Not Receive Intervention|2|||
28119710|NCT04547023|54779280|FG000|Overall Study|Lost to Follow-up|1|||
28119711|NCT04547023|54779281|FG001|Overall Study|Lost to Follow-up|1|||
28119712|NCT03697993|54779291|FG000|Overall Study|Became Ineligible after Enrollment|1|||
28119713|NCT03697993|54779292|FG001|Overall Study|Became Ineligible after Enrollment|3|||
28119714|NCT03697993|54779291|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
28119715|NCT03697993|54779292|FG001|Overall Study|Enrolled but Treatment not Administered|1|||
28119716|NCT03697993|54779291|FG000|Overall Study|Lost to Follow-up|3|||
28119717|NCT03697993|54779292|FG001|Overall Study|Lost to Follow-up|0|||
28119718|NCT03697993|54779291|FG000|Overall Study|Physician Decision|4|||
28119719|NCT03697993|54779292|FG001|Overall Study|Physician Decision|0|||
28119720|NCT03697993|54779291|FG000|Overall Study|Initial Urine Culture Negative|0|||
28119721|NCT03697993|54779292|FG001|Overall Study|Initial Urine Culture Negative|1|||
28119722|NCT03289455|54779302|FG000|Overall Study|Death|1|||
28119723|NCT03289455|54779303|FG001|Overall Study|Death|0|||
28119724|NCT03289455|54779304|FG002|Overall Study|Death|0|||
28119725|NCT03289455|54779302|FG000|Overall Study|Sponsor decision due to covid19 restrictions|0|||
28119726|NCT03289455|54779303|FG001|Overall Study|Sponsor decision due to covid19 restrictions|1|||
28119727|NCT03289455|54779304|FG002|Overall Study|Sponsor decision due to covid19 restrictions|0|||
28119728|NCT03289455|54779302|FG000|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
28119729|NCT03289455|54779303|FG001|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
28119730|NCT03289455|54779304|FG002|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1|||
28119731|NCT03289455|54779302|FG000|Overall Study|Progressive disease|3|||
28119732|NCT03289455|54779303|FG001|Overall Study|Progressive disease|4|||
28119733|NCT03289455|54779304|FG002|Overall Study|Progressive disease|5|||
28119734|NCT04484857|54779313|FG000|Overall Study|Adverse Event|2|||
28119735|NCT04484857|54779313|FG000|Overall Study|Death|10|||
28119736|NCT04484857|54779313|FG000|Overall Study|Withdrawal by Subject|3|||
28119737|NCT04484857|54779313|FG000|Overall Study|Transferred/Relocation|5|||
28119738|NCT04484857|54779313|FG000|Overall Study|Kidney Transplant|7|||
28119739|NCT04484857|54779313|FG000|Overall Study|Other than specified|4|||
28119740|NCT04484857|54779313|FG000|Overall Study|Participants continued an Optional Extension of Roxadustat Treatment|216|||
28119741|NCT04095793|54779317|FG000|Overall Study|Adverse Event|3|||
28119742|NCT04095793|54779317|FG000|Overall Study|Study Terminated by Sponsor|103|||
28119743|NCT04095793|54779317|FG000|Overall Study|Withdrawal by Subject|4|||
28119744|NCT04482439|54779321|FG000|Overall Study|Lost to Follow-up|1|||
28119745|NCT04482439|54779321|FG000|Overall Study|Unrelated illness|1|||
28119746|NCT04535947|54779328|FG000|Overall Study|Adverse Event|1|||
28119747|NCT04535947|54779329|FG001|Overall Study|Adverse Event|4|||
28119748|NCT04535947|54779328|FG000|Overall Study|Other reasons not specified|2|||
28119749|NCT04535947|54779329|FG001|Overall Study|Other reasons not specified|0|||
28119750|NCT04535947|54779328|FG000|Overall Study|Withdrawal by Subject|1|||
28119751|NCT04535947|54779329|FG001|Overall Study|Withdrawal by Subject|1|||
28119752|NCT04474405|54779341|FG000|Overall Study|Withdrawal by Subject|0|||
28119753|NCT04474405|54779342|FG001|Overall Study|Withdrawal by Subject|0|||
28119754|NCT04474405|54779343|FG002|Overall Study|Withdrawal by Subject|1|||
28119755|NCT04474405|54779344|FG003|Overall Study|Withdrawal by Subject|0|||
28119756|NCT04474405|54779345|FG004|Overall Study|Withdrawal by Subject|1|||
27817269|NCT01479465|54274342|FG002|Overall Study|Subject Withdrew Consent|2|||
27817270|NCT01479465|54274343|FG003|Overall Study|Subject Withdrew Consent|1|||
27817271|NCT01479465|54274340|FG000|Overall Study|Protocol Violation|0|||
27817272|NCT01479465|54274341|FG001|Overall Study|Protocol Violation|1|||
27817273|NCT01479465|54274342|FG002|Overall Study|Protocol Violation|1|||
27817274|NCT01479465|54274343|FG003|Overall Study|Protocol Violation|0|||
27817275|NCT01479465|54274340|FG000|Overall Study|Death|0|||
27817276|NCT01479465|54274341|FG001|Overall Study|Death|0|||
27817277|NCT01479465|54274342|FG002|Overall Study|Death|0|||
28119757|NCT04474405|54779346|FG005|Overall Study|Withdrawal by Subject|0|||
28119758|NCT04474405|54779341|FG000|Overall Study|Other|0|||
28119759|NCT04474405|54779342|FG001|Overall Study|Other|0|||
28119760|NCT04474405|54779343|FG002|Overall Study|Other|0|||
28119761|NCT04474405|54779344|FG003|Overall Study|Other|0|||
28119762|NCT04474405|54779345|FG004|Overall Study|Other|3|||
28119763|NCT04474405|54779346|FG005|Overall Study|Other|0|||
28119764|NCT04531813|54779360|FG000|Overall Study|Protocol Violation|1|||
28119765|NCT04531813|54779360|FG000|Overall Study|Withdrawal by Subject|1|||
28119766|NCT03538444|54779366|FG000|Overall Study|opioid withdrawal|1|||
27817278|NCT01479465|54274343|FG003|Overall Study|Death|1|||
28119767|NCT03538444|54779367|FG001|Overall Study|opioid withdrawal|0|||
28119768|NCT01199302|54779377|FG000|Overall Study|Adverse Event|1|||
28119769|NCT01199302|54779378|FG001|Overall Study|Adverse Event|1|||
28119770|NCT01199302|54779379|FG002|Overall Study|Adverse Event|2|||
28119771|NCT01199302|54779380|FG003|Overall Study|Adverse Event|0|||
28119772|NCT01199302|54779377|FG000|Overall Study|Withdrawal by Subject|2|||
27817279|NCT01479465|54274340|FG000|Overall Study|Lost to Follow-up|0|||
28119773|NCT01199302|54779378|FG001|Overall Study|Withdrawal by Subject|2|||
28119774|NCT01199302|54779379|FG002|Overall Study|Withdrawal by Subject|3|||
28119775|NCT01199302|54779380|FG003|Overall Study|Withdrawal by Subject|0|||
28119776|NCT01199302|54779377|FG000|Overall Study|Disease Progression|3|||
28119777|NCT01199302|54779378|FG001|Overall Study|Disease Progression|4|||
28119778|NCT01199302|54779379|FG002|Overall Study|Disease Progression|4|||
28119779|NCT01199302|54779380|FG003|Overall Study|Disease Progression|2|||
28119780|NCT01199302|54779377|FG000|Overall Study|Study Termination|13|||
28119781|NCT01199302|54779378|FG001|Overall Study|Study Termination|8|||
28119782|NCT01199302|54779379|FG002|Overall Study|Study Termination|11|||
28119783|NCT01199302|54779380|FG003|Overall Study|Study Termination|9|||
28119784|NCT01199302|54779377|FG000|Overall Study|Lost to Follow-up|0|||
28119785|NCT01199302|54779378|FG001|Overall Study|Lost to Follow-up|1|||
28119786|NCT01199302|54779379|FG002|Overall Study|Lost to Follow-up|0|||
28119787|NCT01199302|54779380|FG003|Overall Study|Lost to Follow-up|0|||
28119788|NCT01199302|54779377|FG000|Overall Study|Other|1|||
28119789|NCT01199302|54779378|FG001|Overall Study|Other|0|||
28119790|NCT01199302|54779379|FG002|Overall Study|Other|0|||
28119791|NCT01199302|54779380|FG003|Overall Study|Other|0|||
28119792|NCT03332784|54779407|FG000|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
28119793|NCT03332784|54779408|FG001|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
28119794|NCT03332784|54779409|FG002|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
28119795|NCT03332784|54779410|FG003|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
28119796|NCT03332784|54779411|FG004|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
28119797|NCT03332784|54779412|FG005|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
28119798|NCT03332784|54779413|FG006|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
28119799|NCT03332784|54779414|FG007|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
28119800|NCT03332784|54779415|FG008|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
28119801|NCT03332784|54779416|FG009|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
28119802|NCT03332784|54779417|FG010|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
28119803|NCT03332784|54779418|FG011|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
28119804|NCT03332784|54779419|FG012|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
28119805|NCT03332784|54779420|FG013|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
28119806|NCT03332784|54779421|FG014|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
28119807|NCT03332784|54779422|FG015|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
28119808|NCT03332784|54779423|FG016|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
28119809|NCT03332784|54779424|FG017|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
28119810|NCT03332784|54779425|FG018|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
28119811|NCT03332784|54779426|FG019|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
28119812|NCT04465357|54779490|FG000|Overall Study|Adverse Event|2|||
28119813|NCT04465357|54779490|FG000|Overall Study|Lack of Efficacy|1|||
28119814|NCT04465357|54779490|FG000|Overall Study|Lost to Follow-up|2|||
28119815|NCT04465357|54779490|FG000|Overall Study|Withdrawal by Subject|6|||
28119816|NCT04465357|54779490|FG000|Overall Study|Protocol specified withdrawal criterion met|2|||
28119817|NCT03332628|54779494|FG000|Overall Study|Physician Decision|2|||
28119818|NCT04516759|54779501|FG000|Overall Study|Withdrawal by Subject|1|||
28119819|NCT04516759|54779502|FG001|Overall Study|Withdrawal by Subject|1|||
28119820|NCT04516759|54779501|FG000|Overall Study|Other|0|||
28119821|NCT04516759|54779502|FG001|Overall Study|Other|1|||
28119822|NCT03332160|54779510|FG000|Overall Study|Withdrawal by Subject|1|||
28119823|NCT03332160|54779511|FG001|Overall Study|Withdrawal by Subject|1|||
28119824|NCT03332160|54779510|FG000|Overall Study|Adverse Event|0|||
28119825|NCT03332160|54779511|FG001|Overall Study|Adverse Event|1|||
28119826|NCT03332160|54779510|FG000|Overall Study|Developed Exclusion Criteria|0|||
28119827|NCT03332160|54779511|FG001|Overall Study|Developed Exclusion Criteria|1|||
28119828|NCT03332160|54779510|FG000|Overall Study|Non-adherence to treatment|0|||
28119829|NCT03332160|54779511|FG001|Overall Study|Non-adherence to treatment|2|||
28119830|NCT03312114|54779518|FG000|Overall Study|All the five enrolled dropped out of the|5|||
28119831|NCT03694327|54779525|FG000|Overall Study|Lost to Follow-up|13|||
28119832|NCT03694327|54779526|FG001|Overall Study|Lost to Follow-up|23|||
28119833|NCT03330288|54779534|FG000|Overall Study|Other reason|1|||
28119834|NCT03330288|54779535|FG001|Overall Study|Other reason|1|||
28119835|NCT03330288|54779534|FG000|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|1|||
28119836|NCT03330288|54779535|FG001|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|0|||
28119837|NCT03330288|54779534|FG000|Overall Study|Adverse Event|1|||
28119838|NCT03330288|54779535|FG001|Overall Study|Adverse Event|0|||
28119839|NCT03330288|54779534|FG000|Overall Study|Withdrawal by Subject|1|||
28119840|NCT03330288|54779535|FG001|Overall Study|Withdrawal by Subject|0|||
28119841|NCT03330288|54779534|FG000|Overall Study|Lost to Follow-up|26|||
28119842|NCT03330288|54779535|FG001|Overall Study|Lost to Follow-up|7|||
28119843|NCT03084536|54779544|FG000|Overall Study|Determined to be ineligible|0|||
28119844|NCT03084536|54779545|FG001|Overall Study|Determined to be ineligible|0|||
28119845|NCT03084536|54779546|FG002|Overall Study|Determined to be ineligible|16|||
28119846|NCT03084536|54779544|FG000|Overall Study|Withdrawal by Subject|0|||
28119847|NCT03084536|54779545|FG001|Overall Study|Withdrawal by Subject|0|||
28119848|NCT03084536|54779546|FG002|Overall Study|Withdrawal by Subject|4|||
28119849|NCT03084536|54779544|FG000|Overall Study|Physician Decision|0|||
28119850|NCT03084536|54779545|FG001|Overall Study|Physician Decision|0|||
28119851|NCT03084536|54779546|FG002|Overall Study|Physician Decision|3|||
28119852|NCT03084536|54779544|FG000|Overall Study|Death|0|||
28119853|NCT03084536|54779545|FG001|Overall Study|Death|0|||
28119854|NCT03084536|54779546|FG002|Overall Study|Death|1|||
28119855|NCT03084536|54779544|FG000|Overall Study|Lost to Follow-up|0|||
28119856|NCT03084536|54779545|FG001|Overall Study|Lost to Follow-up|0|||
28119857|NCT03084536|54779546|FG002|Overall Study|Lost to Follow-up|1|||
28119858|NCT03084536|54779544|FG000|Overall Study|Protocol Violation|0|||
28119859|NCT03084536|54779545|FG001|Overall Study|Protocol Violation|0|||
28119860|NCT03084536|54779546|FG002|Overall Study|Protocol Violation|1|||
28119861|NCT03084536|54779544|FG000|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
28119862|NCT03084536|54779545|FG001|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
28119863|NCT03084536|54779546|FG002|Overall Study|Withdrawn due to time of surgery being moved up.|1|||
28119864|NCT05291936|54779553|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
28119865|NCT05291936|54779554|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
28119866|NCT05291936|54779553|FG000|Period 1|Withdrew Consent during study|1|||
28119867|NCT05291936|54779554|FG001|Period 1|Withdrew Consent during study|0|||
28119868|NCT05291936|54779553|FG000|Period 2|Adverse Event|0|||
28119869|NCT05291936|54779554|FG001|Period 2|Adverse Event|1|||
28066164|NCT00277212|54721818|FG000|Phase 1 - Single-Blind Treatment|Pregnancy|6|||
28066165|NCT00277212|54721819|FG001|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
28066166|NCT00277212|54721820|FG002|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
28066167|NCT00277212|54721818|FG000|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44|||
28066168|NCT00277212|54721819|FG001|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
28066169|NCT00277212|54721820|FG002|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
28066170|NCT00277212|54721818|FG000|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1|||
28066171|NCT00277212|54721819|FG001|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
28066172|NCT00277212|54721820|FG002|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
28066173|NCT00277212|54721818|FG000|Phase 1 - Single-Blind Treatment|Other Reasons|12|||
28066174|NCT00277212|54721819|FG001|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
28066175|NCT00277212|54721820|FG002|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
28066176|NCT00277212|54721818|FG000|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0|||
28066177|NCT00277212|54721819|FG001|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54|||
28066178|NCT00277212|54721820|FG002|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39|||
28066179|NCT00277212|54721818|FG000|Phase 2 - Double-Blind Treatment|Adverse Event|0|||
28066180|NCT00277212|54721819|FG001|Phase 2 - Double-Blind Treatment|Adverse Event|10|||
28066181|NCT00277212|54721820|FG002|Phase 2 - Double-Blind Treatment|Adverse Event|16|||
28066182|NCT00277212|54721818|FG000|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0|||
28066183|NCT00277212|54721819|FG001|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17|||
28066184|NCT00277212|54721820|FG002|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16|||
28066185|NCT00277212|54721818|FG000|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0|||
28066186|NCT00277212|54721819|FG001|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
28066187|NCT00277212|54721820|FG002|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
28066188|NCT00277212|54721818|FG000|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0|||
28066189|NCT00277212|54721819|FG001|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7|||
28066190|NCT00277212|54721820|FG002|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8|||
28066191|NCT00277212|54721818|FG000|Phase 2 - Double-Blind Treatment|Pregnancy|0|||
28066192|NCT00277212|54721819|FG001|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
28066193|NCT00277212|54721820|FG002|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
28066194|NCT00277212|54721818|FG000|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0|||
28066195|NCT00277212|54721819|FG001|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4|||
28066196|NCT00277212|54721820|FG002|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6|||
28066197|NCT00277212|54721818|FG000|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0|||
28066198|NCT00277212|54721819|FG001|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1|||
28066199|NCT00277212|54721820|FG002|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3|||
28066200|NCT00277212|54721818|FG000|Phase 2 - Double-Blind Treatment|Other reasons|0|||
28066201|NCT00277212|54721819|FG001|Phase 2 - Double-Blind Treatment|Other reasons|7|||
28066202|NCT00277212|54721820|FG002|Phase 2 - Double-Blind Treatment|Other reasons|5|||
28119870|NCT05291936|54779553|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
28119871|NCT05291936|54779554|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
28119872|NCT03289143|54779564|FG000|Overall Study|Caregiver Unavailability|1|||
28119873|NCT03289143|54779565|FG001|Overall Study|Caregiver Unavailability|1|||
28119874|NCT03289143|54779566|FG002|Overall Study|Caregiver Unavailability|0|||
27848902|NCT02089685|54343973|FG000|Overall Study|Excluded Medication|1|||
27848903|NCT02089685|54343974|FG001|Overall Study|Excluded Medication|0|||
27848904|NCT02089685|54343975|FG002|Overall Study|Excluded Medication|0|||
27848905|NCT02089685|54343976|FG003|Overall Study|Excluded Medication|11|||
27848906|NCT02089685|54343977|FG004|Overall Study|Excluded Medication|2|||
27848907|NCT02089685|54343978|FG005|Overall Study|Excluded Medication|1|||
27848908|NCT02089685|54343973|FG000|Overall Study|Progressive disease|13|||
27848909|NCT02089685|54343974|FG001|Overall Study|Progressive disease|10|||
27848910|NCT02089685|54343975|FG002|Overall Study|Progressive disease|3|||
27848911|NCT02089685|54343976|FG003|Overall Study|Progressive disease|51|||
27848912|NCT02089685|54343977|FG004|Overall Study|Progressive disease|17|||
28066203|NCT00276744|54721828|FG000|PART A|Reason unknown|98|||
28066204|NCT00251316|54721834|FG000|Overall Study|Physician Decision|2|||
28066205|NCT00251316|54721835|FG001|Overall Study|Physician Decision|3|||
28066206|NCT00293462|54721844|FG000|Overall Study|Withdrawal by Subject|4|||
28066207|NCT00293462|54721845|FG001|Overall Study|Withdrawal by Subject|3|||
28066208|NCT00293462|54721846|FG002|Overall Study|Withdrawal by Subject|8|||
28066209|NCT00293462|54721844|FG000|Overall Study|Death|1|||
28066210|NCT00293462|54721845|FG001|Overall Study|Death|0|||
28066211|NCT00293462|54721846|FG002|Overall Study|Death|0|||
28066212|NCT00293462|54721844|FG000|Overall Study|Lost to Follow-up|0|||
28066213|NCT00293462|54721845|FG001|Overall Study|Lost to Follow-up|1|||
28066214|NCT00293462|54721846|FG002|Overall Study|Lost to Follow-up|0|||
28066215|NCT00293462|54721844|FG000|Overall Study|Change Treatment Regimen (ineligible)|1|||
28066216|NCT00293462|54721845|FG001|Overall Study|Change Treatment Regimen (ineligible)|0|||
28066217|NCT00293462|54721846|FG002|Overall Study|Change Treatment Regimen (ineligible)|0|||
28066218|NCT00293462|54721844|FG000|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
28066219|NCT00293462|54721845|FG001|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1|||
28066220|NCT00293462|54721846|FG002|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
28066221|NCT00293462|54721844|FG000|Overall Study|Refuse Radiation Treatment|1|||
28066222|NCT00293462|54721845|FG001|Overall Study|Refuse Radiation Treatment|0|||
28066223|NCT00293462|54721846|FG002|Overall Study|Refuse Radiation Treatment|0|||
28066224|NCT00293462|54721844|FG000|Overall Study|No Show|0|||
28066225|NCT00293462|54721845|FG001|Overall Study|No Show|0|||
28066226|NCT00293462|54721846|FG002|Overall Study|No Show|1|||
28066227|NCT00293462|54721844|FG000|Overall Study|Went back to his home country|0|||
28066228|NCT00293462|54721845|FG001|Overall Study|Went back to his home country|0|||
28066229|NCT00293462|54721846|FG002|Overall Study|Went back to his home country|1|||
28066230|NCT00293462|54721844|FG000|Overall Study|Blood clot after chemotherapy|0|||
28066231|NCT00293462|54721845|FG001|Overall Study|Blood clot after chemotherapy|0|||
28066232|NCT00293462|54721846|FG002|Overall Study|Blood clot after chemotherapy|1|||
28066233|NCT00293462|54721844|FG000|Overall Study|Ischemic stroke after chemotherapy|0|||
28066234|NCT00293462|54721845|FG001|Overall Study|Ischemic stroke after chemotherapy|0|||
28066235|NCT00293462|54721846|FG002|Overall Study|Ischemic stroke after chemotherapy|1|||
28066236|NCT00293462|54721844|FG000|Overall Study|Possible Tracheostomy leakage|0|||
28066237|NCT00293462|54721845|FG001|Overall Study|Possible Tracheostomy leakage|1|||
28066238|NCT00293462|54721846|FG002|Overall Study|Possible Tracheostomy leakage|0|||
28066239|NCT00293462|54721844|FG000|Overall Study|Low radiation dose in oral cavity|0|||
28066240|NCT00293462|54721845|FG001|Overall Study|Low radiation dose in oral cavity|1|||
28066241|NCT00293462|54721846|FG002|Overall Study|Low radiation dose in oral cavity|0|||
28066242|NCT00293462|54721844|FG000|Overall Study|Physician Decision|0|||
28066243|NCT00293462|54721845|FG001|Overall Study|Physician Decision|1|||
28066244|NCT00293462|54721846|FG002|Overall Study|Physician Decision|0|||
28066245|NCT00316082|54721859|FG000|Overall Study|Lack of Efficacy|2|||
28066246|NCT00316082|54721860|FG001|Overall Study|Lack of Efficacy|3|||
28066247|NCT00316082|54721861|FG002|Overall Study|Lack of Efficacy|3|||
28066248|NCT00316082|54721862|FG003|Overall Study|Lack of Efficacy|4|||
28066249|NCT00316082|54721863|FG004|Overall Study|Lack of Efficacy|6|||
28066250|NCT00316082|54721859|FG000|Overall Study|Withdrawal of Consent by Subject|10|||
28066251|NCT00316082|54721860|FG001|Overall Study|Withdrawal of Consent by Subject|8|||
28066252|NCT00316082|54721861|FG002|Overall Study|Withdrawal of Consent by Subject|2|||
28066253|NCT00316082|54721862|FG003|Overall Study|Withdrawal of Consent by Subject|9|||
28066254|NCT00316082|54721863|FG004|Overall Study|Withdrawal of Consent by Subject|5|||
27817280|NCT01479465|54274341|FG001|Overall Study|Lost to Follow-up|0|||
27848913|NCT02089685|54343978|FG005|Overall Study|Progressive disease|12|||
28066255|NCT00316082|54721859|FG000|Overall Study|Lost to Follow-up|7|||
27848914|NCT02089685|54343973|FG000|Overall Study|Follow up ended by sponsor|2|||
27848915|NCT02089685|54343974|FG001|Overall Study|Follow up ended by sponsor|2|||
27848916|NCT02089685|54343975|FG002|Overall Study|Follow up ended by sponsor|0|||
27848917|NCT02089685|54343976|FG003|Overall Study|Follow up ended by sponsor|70|||
27848918|NCT02089685|54343977|FG004|Overall Study|Follow up ended by sponsor|26|||
27848919|NCT02089685|54343978|FG005|Overall Study|Follow up ended by sponsor|26|||
27848920|NCT02089685|54343973|FG000|Overall Study|Withdrawal by Subject|0|||
27848921|NCT02089685|54343974|FG001|Overall Study|Withdrawal by Subject|2|||
27848922|NCT02089685|54343975|FG002|Overall Study|Withdrawal by Subject|0|||
27848923|NCT02089685|54343976|FG003|Overall Study|Withdrawal by Subject|8|||
27848924|NCT02089685|54343977|FG004|Overall Study|Withdrawal by Subject|1|||
27848925|NCT02089685|54343978|FG005|Overall Study|Withdrawal by Subject|1|||
28119875|NCT03289143|54779567|FG003|Overall Study|Caregiver Unavailability|0|||
28119876|NCT03289143|54779564|FG000|Overall Study|Research Department Closure|0|||
28119877|NCT03289143|54779565|FG001|Overall Study|Research Department Closure|0|||
28119878|NCT03289143|54779566|FG002|Overall Study|Research Department Closure|1|||
28119879|NCT03289143|54779567|FG003|Overall Study|Research Department Closure|0|||
28119880|NCT03289143|54779564|FG000|Overall Study|Caregiver and Participant Withdrew Consent|0|||
28119881|NCT03289143|54779565|FG001|Overall Study|Caregiver and Participant Withdrew Consent|0|||
28119882|NCT03289143|54779566|FG002|Overall Study|Caregiver and Participant Withdrew Consent|1|||
28119883|NCT03289143|54779567|FG003|Overall Study|Caregiver and Participant Withdrew Consent|0|||
28119884|NCT03289143|54779564|FG000|Overall Study|Medical Monitor Decision|1|||
28119885|NCT03289143|54779565|FG001|Overall Study|Medical Monitor Decision|0|||
28119886|NCT03289143|54779566|FG002|Overall Study|Medical Monitor Decision|0|||
28119887|NCT03289143|54779567|FG003|Overall Study|Medical Monitor Decision|0|||
28119888|NCT03289143|54779564|FG000|Overall Study|Participant Non-Compliance|0|||
28119889|NCT03289143|54779565|FG001|Overall Study|Participant Non-Compliance|0|||
28119890|NCT03289143|54779566|FG002|Overall Study|Participant Non-Compliance|1|||
28119891|NCT03289143|54779567|FG003|Overall Study|Participant Non-Compliance|0|||
28119892|NCT03289143|54779564|FG000|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
28119893|NCT03289143|54779565|FG001|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
28119894|NCT03289143|54779566|FG002|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|1|||
28119895|NCT03289143|54779567|FG003|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
28119896|NCT03289143|54779564|FG000|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
28119897|NCT03289143|54779565|FG001|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
28119898|NCT03289143|54779566|FG002|Overall Study|Participant Non Compliance With Concomitant Medications|1|||
28119899|NCT03289143|54779567|FG003|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
28119900|NCT03289143|54779564|FG000|Overall Study|Caregiver Passed Away|1|||
28119901|NCT03289143|54779565|FG001|Overall Study|Caregiver Passed Away|0|||
28119902|NCT03289143|54779566|FG002|Overall Study|Caregiver Passed Away|0|||
28119903|NCT03289143|54779567|FG003|Overall Study|Caregiver Passed Away|0|||
28119904|NCT03289143|54779564|FG000|Overall Study|Physician Decision|0|||
28119905|NCT03289143|54779565|FG001|Overall Study|Physician Decision|2|||
28119906|NCT03289143|54779566|FG002|Overall Study|Physician Decision|2|||
28119907|NCT03289143|54779567|FG003|Overall Study|Physician Decision|2|||
28119908|NCT03289143|54779564|FG000|Overall Study|Protocol Deviation|2|||
28119909|NCT03289143|54779565|FG001|Overall Study|Protocol Deviation|1|||
28119910|NCT03289143|54779566|FG002|Overall Study|Protocol Deviation|3|||
28119911|NCT03289143|54779567|FG003|Overall Study|Protocol Deviation|1|||
28119912|NCT03289143|54779564|FG000|Overall Study|Study Terminated By Sponsor|101|||
28119913|NCT03289143|54779565|FG001|Overall Study|Study Terminated By Sponsor|75|||
28119914|NCT03289143|54779566|FG002|Overall Study|Study Terminated By Sponsor|100|||
28119915|NCT03289143|54779567|FG003|Overall Study|Study Terminated By Sponsor|69|||
28119916|NCT03289143|54779564|FG000|Overall Study|Withdrawal by Subject|14|||
28119917|NCT03289143|54779565|FG001|Overall Study|Withdrawal by Subject|6|||
27848926|NCT02089685|54343973|FG000|Overall Study|Status not recorded|1|||
27848927|NCT02089685|54343974|FG001|Overall Study|Status not recorded|0|||
27848928|NCT02089685|54343975|FG002|Overall Study|Status not recorded|0|||
27848929|NCT02089685|54343976|FG003|Overall Study|Status not recorded|0|||
27848930|NCT02089685|54343977|FG004|Overall Study|Status not recorded|1|||
27848931|NCT02089685|54343978|FG005|Overall Study|Status not recorded|0|||
28119918|NCT03289143|54779566|FG002|Overall Study|Withdrawal by Subject|14|||
28119919|NCT03289143|54779567|FG003|Overall Study|Withdrawal by Subject|12|||
28119920|NCT03289143|54779564|FG000|Overall Study|Adverse Event|10|||
28119921|NCT03289143|54779565|FG001|Overall Study|Adverse Event|7|||
28119922|NCT03289143|54779566|FG002|Overall Study|Adverse Event|6|||
28119923|NCT03289143|54779567|FG003|Overall Study|Adverse Event|5|||
28119924|NCT03289143|54779564|FG000|Overall Study|Death|2|||
28119925|NCT03289143|54779565|FG001|Overall Study|Death|0|||
28119926|NCT03289143|54779566|FG002|Overall Study|Death|2|||
28119927|NCT03289143|54779567|FG003|Overall Study|Death|1|||
28119928|NCT03289143|54779564|FG000|Overall Study|Lost to Follow-up|2|||
28119929|NCT03289143|54779565|FG001|Overall Study|Lost to Follow-up|1|||
28119930|NCT03289143|54779566|FG002|Overall Study|Lost to Follow-up|1|||
28119931|NCT03289143|54779567|FG003|Overall Study|Lost to Follow-up|0|||
28119932|NCT03289143|54779564|FG000|Overall Study|Participant No Longer Has Study Partner|0|||
28119933|NCT03289143|54779565|FG001|Overall Study|Participant No Longer Has Study Partner|0|||
28119934|NCT03289143|54779566|FG002|Overall Study|Participant No Longer Has Study Partner|0|||
28119935|NCT03289143|54779567|FG003|Overall Study|Participant No Longer Has Study Partner|1|||
28119936|NCT03289143|54779564|FG000|Overall Study|Withdrawal by Caregiver|0|||
28119937|NCT03289143|54779565|FG001|Overall Study|Withdrawal by Caregiver|1|||
28119938|NCT03289143|54779566|FG002|Overall Study|Withdrawal by Caregiver|0|||
28119939|NCT03289143|54779567|FG003|Overall Study|Withdrawal by Caregiver|0|||
28119940|NCT03289143|54779564|FG000|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
28119941|NCT03289143|54779565|FG001|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
28119942|NCT03289143|54779566|FG002|Overall Study|Caregiver Passed Away & Family Moved Out of State|1|||
28119943|NCT03289143|54779567|FG003|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
27817281|NCT01479465|54274342|FG002|Overall Study|Lost to Follow-up|1|||
27817282|NCT01479465|54274343|FG003|Overall Study|Lost to Follow-up|0|||
27817283|NCT01503021|54274407|FG000|Overall Study|Adverse Event|7|||
28119944|NCT03289143|54779564|FG000|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
28119945|NCT03289143|54779565|FG001|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
27817284|NCT01503021|54274408|FG001|Overall Study|Adverse Event|6|||
28119946|NCT03289143|54779566|FG002|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
28119947|NCT03289143|54779567|FG003|Overall Study|Absence of Consistent and Reliable Caregiver|1|||
28119948|NCT03311724|54779586|FG000|Overall Study|Physician Decision|0|||
28119949|NCT03311724|54779587|FG001|Overall Study|Physician Decision|0|||
28119950|NCT03311724|54779588|FG002|Overall Study|Physician Decision|0|||
28119951|NCT03311724|54779589|FG003|Overall Study|Physician Decision|1|||
28119952|NCT03311724|54779586|FG000|Overall Study|Protocol Violation|1|||
28119953|NCT03311724|54779587|FG001|Overall Study|Protocol Violation|0|||
28119954|NCT03311724|54779588|FG002|Overall Study|Protocol Violation|1|||
28119955|NCT03311724|54779589|FG003|Overall Study|Protocol Violation|0|||
28119956|NCT03311724|54779586|FG000|Overall Study|Withdrawal by Subject|1|||
28119957|NCT03311724|54779587|FG001|Overall Study|Withdrawal by Subject|1|||
28119958|NCT03311724|54779588|FG002|Overall Study|Withdrawal by Subject|0|||
28119959|NCT03311724|54779589|FG003|Overall Study|Withdrawal by Subject|0|||
28119960|NCT03311724|54779586|FG000|Overall Study|Lost to Follow-up|1|||
28119961|NCT03311724|54779587|FG001|Overall Study|Lost to Follow-up|0|||
28119962|NCT03311724|54779588|FG002|Overall Study|Lost to Follow-up|0|||
28119963|NCT03311724|54779589|FG003|Overall Study|Lost to Follow-up|0|||
28119964|NCT03311724|54779586|FG000|Overall Study|Sponsor Decision|0|||
28119965|NCT03311724|54779587|FG001|Overall Study|Sponsor Decision|0|||
28119966|NCT03311724|54779588|FG002|Overall Study|Sponsor Decision|1|||
28119967|NCT03311724|54779589|FG003|Overall Study|Sponsor Decision|0|||
28119968|NCT03311646|54779611|FG000|Overall Study|Physician Decision|1|||
28119969|NCT03311646|54779611|FG000|Overall Study|Withdrawal by Subject|5|||
28119970|NCT03311646|54779611|FG000|Overall Study|Lost to Follow-up|5|||
27817285|NCT01503021|54274407|FG000|Overall Study|Death|0|||
27817286|NCT01503021|54274408|FG001|Overall Study|Death|2|||
27817287|NCT01503021|54274407|FG000|Overall Study|Lost to Follow-up|2|||
27817288|NCT01503021|54274408|FG001|Overall Study|Lost to Follow-up|0|||
28119971|NCT03311646|54779611|FG000|Overall Study|PI Withdrawal for Positive Drug Screen|4|||
28119972|NCT01672892|54779618|FG000|Overall Study|Protocol Violation|7|||
28119973|NCT01672892|54779619|FG001|Overall Study|Protocol Violation|3|||
28119974|NCT03288987|54779630|FG000|Overall Study|Protocol Violation|10|||
28119975|NCT03288987|54779631|FG001|Overall Study|Protocol Violation|4|||
28119976|NCT02939781|54779637|FG000|Overall Study|Protocol Violation|8|||
28119977|NCT02939781|54779637|FG000|Overall Study|Withdrawal by Subject|1|||
27817289|NCT01503021|54274407|FG000|Overall Study|Physician Decision|3|||
28119978|NCT03083990|54779653|FG000|Overall Study|Adverse Event|1|||
28119979|NCT03083990|54779654|FG001|Overall Study|Adverse Event|0|||
28119980|NCT03252015|54779672|FG000|Overall Study|Withdrawal by Subject|0|||
28119981|NCT03252015|54779673|FG001|Overall Study|Withdrawal by Subject|1|||
28119982|NCT03252015|54779674|FG002|Overall Study|Withdrawal by Subject|1|||
28119983|NCT03252015|54779675|FG003|Overall Study|Withdrawal by Subject|0|||
28119984|NCT03252015|54779672|FG000|Overall Study|Adverse Event|1|||
28119985|NCT03252015|54779673|FG001|Overall Study|Adverse Event|0|||
28119986|NCT03252015|54779674|FG002|Overall Study|Adverse Event|0|||
28119987|NCT03252015|54779675|FG003|Overall Study|Adverse Event|1|||
28119988|NCT03083132|54779701|FG000|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|0|||
28119989|NCT03083132|54779702|FG001|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|2|||
28119990|NCT03083132|54779701|FG000|Last 12 Weeks (Drug for All Subjects)|Physician Decision|1|||
27817290|NCT01503021|54274408|FG001|Overall Study|Physician Decision|0|||
27817291|NCT01503021|54274407|FG000|Overall Study|Protocol Violation|1|||
27817292|NCT01503021|54274408|FG001|Overall Study|Protocol Violation|3|||
28119991|NCT03083132|54779702|FG001|Last 12 Weeks (Drug for All Subjects)|Physician Decision|0|||
28119992|NCT03083132|54779701|FG000|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|0|||
28119993|NCT03083132|54779702|FG001|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|1|||
28119994|NCT03683823|54779710|FG000|Post-treatment Assessment|Withdrawal by Subject|1|||
28119995|NCT03683823|54779711|FG001|Post-treatment Assessment|Withdrawal by Subject|1|||
28119996|NCT03683823|54779710|FG000|Post-treatment Assessment|Lost to Follow-up|0|||
28119997|NCT03683823|54779711|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
28119998|NCT03683823|54779710|FG000|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
28119999|NCT03683823|54779711|FG001|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
28120000|NCT03285711|54779719|FG000|Blinded Phase (Up to Week 16)|Adverse Event|2|||
28120001|NCT03285711|54779720|FG001|Blinded Phase (Up to Week 16)|Adverse Event|1|||
28120002|NCT03285711|54779721|FG002|Blinded Phase (Up to Week 16)|Adverse Event|0|||
28120003|NCT03285711|54779722|FG003|Blinded Phase (Up to Week 16)|Adverse Event|0|||
28120004|NCT03285711|54779719|FG000|Blinded Phase (Up to Week 16)|Protocol Violation|1|||
28120005|NCT03285711|54779720|FG001|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
28120006|NCT03285711|54779721|FG002|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
28120007|NCT03285711|54779722|FG003|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
28120008|NCT03285711|54779719|FG000|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
28120009|NCT03285711|54779720|FG001|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
28120010|NCT03285711|54779721|FG002|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1|||
28120011|NCT03285711|54779722|FG003|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
28120012|NCT03285711|54779719|FG000|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
28120013|NCT03285711|54779720|FG001|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1|||
28120014|NCT03285711|54779721|FG002|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
28120015|NCT03285711|54779722|FG003|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
28120016|NCT02927366|54779734|FG000|Overall Study|Adverse Event|1|||
28120017|NCT02927366|54779735|FG001|Overall Study|Adverse Event|0|||
28120018|NCT02927366|54779734|FG000|Overall Study|Patient schedule|1|||
28120019|NCT02927366|54779735|FG001|Overall Study|Patient schedule|0|||
28120020|NCT03249909|54779744|FG000|Overall Study|Withdrawal by Subject|3|||
28120021|NCT03249909|54779745|FG001|Overall Study|Withdrawal by Subject|0|||
28120022|NCT03249909|54779746|FG002|Overall Study|Withdrawal by Subject|0|||
28120023|NCT03249909|54779744|FG000|Overall Study|Adverse Event|3|||
28120024|NCT03249909|54779745|FG001|Overall Study|Adverse Event|0|||
28120025|NCT03249909|54779746|FG002|Overall Study|Adverse Event|0|||
28120026|NCT03249909|54779744|FG000|Overall Study|Lost to Follow-up|0|||
28120027|NCT03249909|54779745|FG001|Overall Study|Lost to Follow-up|1|||
28120028|NCT03249909|54779746|FG002|Overall Study|Lost to Follow-up|0|||
28120029|NCT03081884|54779757|FG000|Overall Study|deferred prostate cancer treatment|1|||
28120030|NCT03081884|54779757|FG000|Overall Study|metastasis managed with systemic therapy|3|||
28120031|NCT03077438|54779764|FG000|Overall Study|Protocol Violation|3|||
28120032|NCT03077438|54779765|FG001|Overall Study|Protocol Violation|5|||
28120033|NCT03077438|54779764|FG000|Overall Study|Withdrawal by Subject|3|||
28120034|NCT03077438|54779765|FG001|Overall Study|Withdrawal by Subject|6|||
28120035|NCT03077438|54779764|FG000|Overall Study|Lost to Follow-up|6|||
28120036|NCT03077438|54779765|FG001|Overall Study|Lost to Follow-up|3|||
28120037|NCT03076970|54779775|FG000|Washout Period 2|Adverse Event|0|||
28120038|NCT03076970|54779776|FG001|Washout Period 2|Adverse Event|0|||
28120039|NCT03076970|54779777|FG002|Washout Period 2|Adverse Event|0|||
28120040|NCT03076970|54779778|FG003|Washout Period 2|Adverse Event|0|||
28120041|NCT03076970|54779779|FG004|Washout Period 2|Adverse Event|1|||
28120042|NCT03076970|54779780|FG005|Washout Period 2|Adverse Event|0|||
28120043|NCT03076970|54779775|FG000|Period 3|Withdrawal by Subject|0|||
28120044|NCT03076970|54779776|FG001|Period 3|Withdrawal by Subject|0|||
28120045|NCT03076970|54779777|FG002|Period 3|Withdrawal by Subject|0|||
28120046|NCT03076970|54779778|FG003|Period 3|Withdrawal by Subject|0|||
28120047|NCT03076970|54779779|FG004|Period 3|Withdrawal by Subject|0|||
28120048|NCT03076970|54779780|FG005|Period 3|Withdrawal by Subject|1|||
28120049|NCT03076970|54779775|FG000|Period 3|Failure to meet I/E criteria|0|||
28120050|NCT03076970|54779776|FG001|Period 3|Failure to meet I/E criteria|0|||
28120051|NCT03076970|54779777|FG002|Period 3|Failure to meet I/E criteria|0|||
28120052|NCT03076970|54779778|FG003|Period 3|Failure to meet I/E criteria|0|||
28120053|NCT03076970|54779779|FG004|Period 3|Failure to meet I/E criteria|1|||
28120054|NCT03076970|54779780|FG005|Period 3|Failure to meet I/E criteria|0|||
28120055|NCT00726596|54779793|FG000|Overall Study|Adverse Event|2|||
28120056|NCT00726596|54779794|FG001|Overall Study|Adverse Event|1|||
28120057|NCT00726596|54779793|FG000|Overall Study|Withdrawal by Subject|3|||
28120058|NCT00726596|54779794|FG001|Overall Study|Withdrawal by Subject|3|||
28120059|NCT02890992|54779817|FG000|130 Weeks Open-Label Extension Period|Adverse Event|0|||
28120060|NCT02890992|54779818|FG001|130 Weeks Open-Label Extension Period|Adverse Event|1|||
28120061|NCT02890992|54779819|FG002|130 Weeks Open-Label Extension Period|Adverse Event|0|||
28120062|NCT02890992|54779820|FG003|130 Weeks Open-Label Extension Period|Adverse Event|0|||
28120063|NCT02890992|54779821|FG004|130 Weeks Open-Label Extension Period|Adverse Event|0|||
28120064|NCT02890992|54779822|FG005|130 Weeks Open-Label Extension Period|Adverse Event|0|||
28120065|NCT02890992|54779823|FG006|130 Weeks Open-Label Extension Period|Adverse Event|0|||
28120066|NCT02890992|54779824|FG007|130 Weeks Open-Label Extension Period|Adverse Event|0|||
28120067|NCT02890992|54779817|FG000|130 Weeks Open-Label Extension Period|Included but not treated|0|||
28120068|NCT02890992|54779818|FG001|130 Weeks Open-Label Extension Period|Included but not treated|0|||
28120069|NCT02890992|54779819|FG002|130 Weeks Open-Label Extension Period|Included but not treated|0|||
28120070|NCT02890992|54779820|FG003|130 Weeks Open-Label Extension Period|Included but not treated|0|||
28120071|NCT02890992|54779821|FG004|130 Weeks Open-Label Extension Period|Included but not treated|0|||
28120072|NCT02890992|54779822|FG005|130 Weeks Open-Label Extension Period|Included but not treated|0|||
28120073|NCT02890992|54779823|FG006|130 Weeks Open-Label Extension Period|Included but not treated|1|||
28120074|NCT02890992|54779824|FG007|130 Weeks Open-Label Extension Period|Included but not treated|1|||
28120075|NCT02890992|54779817|FG000|130 Weeks Open-Label Extension Period|Other than specified|0|||
28120076|NCT02890992|54779818|FG001|130 Weeks Open-Label Extension Period|Other than specified|2|||
28120077|NCT02890992|54779819|FG002|130 Weeks Open-Label Extension Period|Other than specified|0|||
28120078|NCT02890992|54779820|FG003|130 Weeks Open-Label Extension Period|Other than specified|0|||
28120079|NCT02890992|54779821|FG004|130 Weeks Open-Label Extension Period|Other than specified|0|||
28120080|NCT02890992|54779822|FG005|130 Weeks Open-Label Extension Period|Other than specified|0|||
28120081|NCT02890992|54779823|FG006|130 Weeks Open-Label Extension Period|Other than specified|0|||
28120082|NCT02890992|54779824|FG007|130 Weeks Open-Label Extension Period|Other than specified|0|||
28120083|NCT03076190|54779869|FG000|Overall Study|Lost to Follow-up|9|||
28120084|NCT03076190|54779870|FG001|Overall Study|Lost to Follow-up|34|||
28120085|NCT03076190|54779869|FG000|Overall Study|Excluded from Analysis (zero duration ev|9|||
28120086|NCT03076190|54779870|FG001|Overall Study|Excluded from Analysis (zero duration ev|7|||
28120087|NCT03329196|54779881|FG000|Overall Study|Adverse Event|10|||
28120088|NCT03329196|54779882|FG001|Overall Study|Adverse Event|5|||
28120089|NCT03329196|54779881|FG000|Overall Study|Physician Decision|2|||
28120090|NCT03329196|54779882|FG001|Overall Study|Physician Decision|2|||
28120091|NCT03329196|54779881|FG000|Overall Study|Withdrawal by Subject|11|||
28120092|NCT03329196|54779882|FG001|Overall Study|Withdrawal by Subject|3|||
28120093|NCT03329196|54779881|FG000|Overall Study|Hepatic function abnormalities|0|||
28120094|NCT03329196|54779882|FG001|Overall Study|Hepatic function abnormalities|1|||
28120095|NCT03329196|54779881|FG000|Overall Study|Conducting rescue therapy before Week 24|2|||
28120096|NCT03329196|54779882|FG001|Overall Study|Conducting rescue therapy before Week 24|1|||
28120097|NCT03329196|54779881|FG000|Overall Study|Difficult to control Hb|2|||
28120098|NCT03329196|54779882|FG001|Overall Study|Difficult to control Hb|3|||
28120099|NCT03329196|54779881|FG000|Overall Study|Dialysis or renal transplant|13|||
28120100|NCT03329196|54779882|FG001|Overall Study|Dialysis or renal transplant|15|||
28120101|NCT03328182|54779888|FG000|Overall Study|Withdrawal by Subject|1|||
28120102|NCT03328182|54779888|FG000|Overall Study|Protocol Violation|2|||
28120103|NCT03328182|54779888|FG000|Overall Study|No Product Evaluated|1|||
28120104|NCT03327402|54779892|FG000|Overall Study|Withdrawal by Subject|1|||
28120105|NCT03327402|54779892|FG000|Overall Study|Other (Visit Out-Of-Window)|1|||
28120106|NCT03075878|54779896|FG000|Overall Study|Physician Decision|1|||
28120107|NCT03326856|54779905|FG000|Overall Study|Lost to Follow-up|1|||
28120108|NCT03326856|54779906|FG001|Overall Study|Lost to Follow-up|1|||
28120109|NCT03326856|54779907|FG002|Overall Study|Lost to Follow-up|0|||
27817293|NCT01503021|54274407|FG000|Overall Study|Withdrawal by Subject|9|||
27817294|NCT01503021|54274408|FG001|Overall Study|Withdrawal by Subject|8|||
27817295|NCT01503021|54274407|FG000|Overall Study|Moved, received transplant, etc.|5|||
27817296|NCT01503021|54274408|FG001|Overall Study|Moved, received transplant, etc.|7|||
27817297|NCT01531725|54274419|FG000|Overall Study|Protocol Violation|5|||
27817298|NCT01478373|54274423|FG000|Treatment Phase|Protocol Violation|1|||
27817299|NCT01478373|54274423|FG000|Survival Phase|Adverse Event|8|||
27817300|NCT01478373|54274423|FG000|Survival Phase|Protocol Violation|1|||
27817301|NCT01478373|54274423|FG000|Survival Phase|crossover to another study|2|||
27817302|NCT01478373|54274423|FG000|Survival Phase|Progressive Disease|27|||
27817303|NCT01502709|54274429|FG000|Overall Study|Lost to Follow-up|4|||
27817304|NCT01502709|54274430|FG001|Overall Study|Lost to Follow-up|0|||
27848932|NCT02089685|54343973|FG000|Overall Study|Death|0|||
27848933|NCT02089685|54343974|FG001|Overall Study|Death|0|||
27848934|NCT02089685|54343975|FG002|Overall Study|Death|0|||
27848935|NCT02089685|54343976|FG003|Overall Study|Death|7|||
27848936|NCT02089685|54343977|FG004|Overall Study|Death|2|||
27848937|NCT02089685|54343978|FG005|Overall Study|Death|5|||
27848938|NCT02089685|54343973|FG000|Overall Study|Lost to Follow-up|0|||
27848939|NCT02089685|54343974|FG001|Overall Study|Lost to Follow-up|0|||
27848940|NCT02089685|54343975|FG002|Overall Study|Lost to Follow-up|0|||
27848941|NCT02089685|54343976|FG003|Overall Study|Lost to Follow-up|1|||
27848942|NCT02089685|54343977|FG004|Overall Study|Lost to Follow-up|0|||
28066256|NCT00316082|54721860|FG001|Overall Study|Lost to Follow-up|6|||
28066257|NCT00316082|54721861|FG002|Overall Study|Lost to Follow-up|7|||
28066258|NCT00316082|54721862|FG003|Overall Study|Lost to Follow-up|8|||
28066259|NCT00316082|54721863|FG004|Overall Study|Lost to Follow-up|6|||
28066260|NCT00316082|54721859|FG000|Overall Study|Poor/noncompliance|6|||
28066261|NCT00316082|54721860|FG001|Overall Study|Poor/noncompliance|1|||
28066262|NCT00316082|54721861|FG002|Overall Study|Poor/noncompliance|4|||
28066263|NCT00316082|54721862|FG003|Overall Study|Poor/noncompliance|1|||
28066264|NCT00316082|54721863|FG004|Overall Study|Poor/noncompliance|4|||
28066265|NCT00316082|54721859|FG000|Overall Study|Adverse Event|4|||
28066266|NCT00316082|54721860|FG001|Overall Study|Adverse Event|2|||
28066267|NCT00316082|54721861|FG002|Overall Study|Adverse Event|5|||
28066268|NCT00316082|54721862|FG003|Overall Study|Adverse Event|1|||
28066269|NCT00316082|54721863|FG004|Overall Study|Adverse Event|3|||
28066270|NCT00316082|54721859|FG000|Overall Study|Subject no longer meets study criteria|3|||
28066271|NCT00316082|54721860|FG001|Overall Study|Subject no longer meets study criteria|1|||
28066272|NCT00316082|54721861|FG002|Overall Study|Subject no longer meets study criteria|2|||
28066273|NCT00316082|54721862|FG003|Overall Study|Subject no longer meets study criteria|2|||
28066274|NCT00316082|54721863|FG004|Overall Study|Subject no longer meets study criteria|1|||
28120110|NCT03326856|54779908|FG003|Overall Study|Lost to Follow-up|0|||
28120111|NCT03326856|54779909|FG004|Overall Study|Lost to Follow-up|0|||
28120112|NCT03309696|54779923|FG000|Overall Study|Analysis of TEP data could not be completed|0|||
28120113|NCT03309696|54779924|FG001|Overall Study|Analysis of TEP data could not be completed|5|||
28120114|NCT03309696|54779925|FG002|Overall Study|Analysis of TEP data could not be completed|0|||
27848943|NCT02089685|54343978|FG005|Overall Study|Lost to Follow-up|0|||
27848944|NCT02089685|54343973|FG000|Overall Study|Physician Decision|0|||
27848945|NCT02089685|54343974|FG001|Overall Study|Physician Decision|0|||
27848946|NCT02089685|54343975|FG002|Overall Study|Physician Decision|0|||
27848947|NCT02089685|54343976|FG003|Overall Study|Physician Decision|0|||
27848948|NCT02089685|54343977|FG004|Overall Study|Physician Decision|0|||
27848949|NCT02089685|54343978|FG005|Overall Study|Physician Decision|4|||
27817305|NCT01477749|54274437|FG000|Overall Study|Physician Decision|4|||
27817306|NCT01502631|54274467|FG000|Overall Study|Adverse Event|5|||
27817307|NCT01502631|54274468|FG001|Overall Study|Adverse Event|8|||
27817308|NCT01502631|54274467|FG000|Overall Study|Lost to Follow-up|2|||
27817309|NCT01502631|54274468|FG001|Overall Study|Lost to Follow-up|2|||
27817310|NCT01502631|54274467|FG000|Overall Study|Participant withdrew consent|2|||
27817311|NCT01502631|54274468|FG001|Overall Study|Participant withdrew consent|4|||
27817312|NCT01502631|54274467|FG000|Overall Study|Participant non-compliant|1|||
27817313|NCT01502631|54274468|FG001|Overall Study|Participant non-compliant|0|||
27817314|NCT01502631|54274467|FG000|Overall Study|Investigator's decision|0|||
27817315|NCT01502631|54274468|FG001|Overall Study|Investigator's decision|1|||
27817316|NCT01502631|54274467|FG000|Overall Study|Other|10|||
27817317|NCT01502631|54274468|FG001|Overall Study|Other|5|||
27817318|NCT01475721|54274524|FG000|Overall Study|Death|3|||
27817319|NCT01475721|54274525|FG001|Overall Study|Death|6|||
27817320|NCT01475721|54274524|FG000|Overall Study|Withdrawal by Subject|8|||
27817321|NCT01475721|54274525|FG001|Overall Study|Withdrawal by Subject|8|||
27817322|NCT01530087|54274549|FG000|Overall Study|Physician Decision|2|||
27817323|NCT01475487|54274567|FG000|Overall Study|had to leave early for personal reasons|2|||
27817324|NCT01475487|54274568|FG001|Overall Study|had to leave early for personal reasons|1|||
27817325|NCT01475331|54274576|FG000|Overall Study|Osteophyte obstruction of the proximal|1|||
27848950|NCT02089685|54343973|FG000|Overall Study|Screen failure|1|||
27848951|NCT02089685|54343974|FG001|Overall Study|Screen failure|0|||
27817326|NCT01475331|54274577|FG001|Overall Study|Osteophyte obstruction of the proximal|0|||
27817327|NCT01475331|54274576|FG000|Overall Study|excessive main duct communication|1|||
28120115|NCT03309696|54779926|FG003|Overall Study|Analysis of TEP data could not be completed|0|||
28120116|NCT03075644|54779940|FG000|Overall Study|Withdrawal by Subject|1|||
28120117|NCT03075644|54779941|FG001|Overall Study|Withdrawal by Subject|1|||
28120118|NCT03075410|54779957|FG000|Part A-Period 2 (14 Days)|Personal reasons|1|||
28120119|NCT03075410|54779958|FG001|Part A-Period 2 (14 Days)|Personal reasons|0|||
28120120|NCT03075410|54779959|FG002|Part A-Period 2 (14 Days)|Personal reasons|1|||
28120121|NCT03075410|54779960|FG003|Part A-Period 2 (14 Days)|Personal reasons|0|||
28120122|NCT03075410|54779961|FG004|Part A-Period 2 (14 Days)|Personal reasons|0|||
28120123|NCT03075410|54779962|FG005|Part A-Period 2 (14 Days)|Personal reasons|0|||
27817328|NCT01475331|54274577|FG001|Overall Study|excessive main duct communication|1|||
27817329|NCT01475331|54274576|FG000|Overall Study|Loss of needle positioning due pt. cough|1|||
27817330|NCT01475331|54274577|FG001|Overall Study|Loss of needle positioning due pt. cough|0|||
27817331|NCT01475331|54274576|FG000|Overall Study|Sign of malignancy during the procedure|2|||
27817332|NCT01475331|54274577|FG001|Overall Study|Sign of malignancy during the procedure|0|||
27817333|NCT01475331|54274576|FG000|Overall Study|cyst found to be prohibitively small|0|||
27817334|NCT01475331|54274577|FG001|Overall Study|cyst found to be prohibitively small|1|||
27817335|NCT01500213|54274585|FG000|Overall Study|Adverse Event|35|||
27817336|NCT01500213|54274586|FG001|Overall Study|Adverse Event|35|||
27817337|NCT01500213|54274585|FG000|Overall Study|Chemo Completed or Change in Therapy|84|||
27848952|NCT02089685|54343975|FG002|Overall Study|Screen failure|0|||
27848953|NCT02089685|54343976|FG003|Overall Study|Screen failure|0|||
27848954|NCT02089685|54343977|FG004|Overall Study|Screen failure|0|||
27848955|NCT02089685|54343978|FG005|Overall Study|Screen failure|0|||
27848956|NCT05282004|54344036|FG000|Overall Study|Adverse Event|2|||
27848957|NCT05004649|54344040|FG000|Overall Study|Eligibility Criteria - Threshold|4|||
27848958|NCT05004649|54344040|FG000|Overall Study|Lost to Follow-up|1|||
27848959|NCT05004649|54344040|FG000|Overall Study|Withdrawal by Subject|2|||
27848960|NCT05004649|54344040|FG000|Overall Study|COVID-19|1|||
27848961|NCT04666298|54344050|FG000|Overall Study|Subject decision|1|||
27848962|NCT04666298|54344051|FG001|Overall Study|Subject decision|0|||
27848963|NCT04666298|54344052|FG002|Overall Study|Subject decision|0|||
27848964|NCT04666298|54344053|FG003|Overall Study|Subject decision|2|||
27848965|NCT04666298|54344050|FG000|Overall Study|Death|1|||
27848966|NCT04666298|54344051|FG001|Overall Study|Death|0|||
27848967|NCT04666298|54344052|FG002|Overall Study|Death|0|||
27848968|NCT04666298|54344053|FG003|Overall Study|Death|0|||
27848969|NCT04666298|54344050|FG000|Overall Study|Lost to Follow-up|0|||
27848970|NCT04666298|54344051|FG001|Overall Study|Lost to Follow-up|0|||
28120124|NCT03075410|54779963|FG006|Part A-Period 2 (14 Days)|Personal reasons|0|||
27817338|NCT01500213|54274586|FG001|Overall Study|Chemo Completed or Change in Therapy|81|||
27817339|NCT01500213|54274585|FG000|Overall Study|Withdrawal by Subject|28|||
27848971|NCT04666298|54344052|FG002|Overall Study|Lost to Follow-up|0|||
27848972|NCT04666298|54344053|FG003|Overall Study|Lost to Follow-up|1|||
27848973|NCT04666298|54344050|FG000|Overall Study|Physician Decision|0|||
27848974|NCT04666298|54344051|FG001|Overall Study|Physician Decision|0|||
27848975|NCT04666298|54344052|FG002|Overall Study|Physician Decision|0|||
27848976|NCT04666298|54344053|FG003|Overall Study|Physician Decision|1|||
27848977|NCT04666298|54344050|FG000|Overall Study|Protocol deviation|0|||
27848978|NCT04666298|54344051|FG001|Overall Study|Protocol deviation|0|||
27848979|NCT04666298|54344052|FG002|Overall Study|Protocol deviation|1|||
27848980|NCT04666298|54344053|FG003|Overall Study|Protocol deviation|0|||
27848981|NCT04581200|54344065|FG000|Overall Study|Lost to Follow-up|6|||
27848982|NCT04581200|54344066|FG001|Overall Study|Lost to Follow-up|5|||
27848983|NCT04303780|54344101|FG000|Overall Study|Death|104|||
27848984|NCT04303780|54344102|FG001|Overall Study|Death|85|||
27848985|NCT04303780|54344101|FG000|Overall Study|Lost to Follow-up|5|||
27848986|NCT04303780|54344102|FG001|Overall Study|Lost to Follow-up|2|||
27817340|NCT01500213|54274586|FG001|Overall Study|Withdrawal by Subject|37|||
27817341|NCT01500213|54274585|FG000|Overall Study|Death|7|||
27848987|NCT04303780|54344101|FG000|Overall Study|Withdrawal by Subject|12|||
27848988|NCT04303780|54344102|FG001|Overall Study|Withdrawal by Subject|39|||
27848989|NCT04303780|54344101|FG000|Overall Study|Ongoing in study|50|||
27848990|NCT04303780|54344102|FG001|Overall Study|Ongoing in study|45|||
27848991|NCT04188301|54344112|FG000|Month 3|Lost to Follow-up|0|||
27848992|NCT04188301|54344113|FG001|Month 3|Lost to Follow-up|0|||
27848993|NCT04188301|54344114|FG002|Month 3|Lost to Follow-up|1|||
27848994|NCT04188301|54344112|FG000|Month 12|Lost to Follow-up|0|||
27848995|NCT04188301|54344113|FG001|Month 12|Lost to Follow-up|0|||
27848996|NCT04188301|54344114|FG002|Month 12|Lost to Follow-up|2|||
27848997|NCT04188301|54344112|FG000|Month 12|Death|1|||
27848998|NCT04188301|54344113|FG001|Month 12|Death|1|||
27848999|NCT04188301|54344114|FG002|Month 12|Death|0|||
27849000|NCT04188301|54344112|FG000|Month 18|Lost to Follow-up|6|||
27849001|NCT04188301|54344113|FG001|Month 18|Lost to Follow-up|0|||
27849002|NCT04188301|54344114|FG002|Month 18|Lost to Follow-up|0|||
27849003|NCT04006925|54344124|FG000|Overall Study|Side effects|2|||
27849004|NCT04006925|54344125|FG001|Overall Study|Side effects|0|||
27849005|NCT03599713|54344137|FG000|Overall Study|Death|26|||
27849006|NCT03599713|54344138|FG001|Overall Study|Death|3|||
27849007|NCT03599713|54344137|FG000|Overall Study|Withdrawal by Subject|6|||
27849008|NCT03599713|54344138|FG001|Overall Study|Withdrawal by Subject|0|||
27849009|NCT03599713|54344137|FG000|Overall Study|Ongoing|69|||
27849010|NCT03599713|54344138|FG001|Overall Study|Ongoing|3|||
27849011|NCT03597061|54344148|FG000|Overall Study|Lost to Follow-up|1|||
27849012|NCT03597061|54344149|FG001|Overall Study|Lost to Follow-up|0|||
27849013|NCT03597061|54344148|FG000|Overall Study|Protocol Violation|0|||
27849014|NCT03597061|54344149|FG001|Overall Study|Protocol Violation|1|||
27849015|NCT03148795|54344177|FG000|Overall Study|Death|6|||
27849016|NCT03148795|54344177|FG000|Overall Study|Adverse Event|5|||
27849017|NCT03148795|54344177|FG000|Overall Study|Other|15|||
27817342|NCT01500213|54274586|FG001|Overall Study|Death|3|||
27817343|NCT01500213|54274585|FG000|Overall Study|Disease Progression|13|||
27817344|NCT01500213|54274586|FG001|Overall Study|Disease Progression|21|||
27817345|NCT01500213|54274585|FG000|Overall Study|Protocol Violation|19|||
27817346|NCT01500213|54274586|FG001|Overall Study|Protocol Violation|19|||
27817347|NCT01500213|54274585|FG000|Overall Study|Physician Decision|12|||
27817348|NCT01500213|54274586|FG001|Overall Study|Physician Decision|10|||
27817349|NCT01500213|54274585|FG000|Overall Study|Lack of Efficacy|9|||
27817350|NCT01500213|54274586|FG001|Overall Study|Lack of Efficacy|7|||
27817351|NCT01500213|54274585|FG000|Overall Study|Lost to Follow-up|3|||
27817352|NCT01500213|54274586|FG001|Overall Study|Lost to Follow-up|6|||
27817353|NCT01500213|54274585|FG000|Overall Study|Other Reasons|7|||
27817354|NCT01500213|54274586|FG001|Overall Study|Other Reasons|5|||
27817355|NCT01475253|54274616|FG000|Randomized, Blinded Study|Withdrawal by Subject|1|||
27817356|NCT01475253|54274617|FG001|Randomized, Blinded Study|Withdrawal by Subject|1|||
27817357|NCT01475253|54274618|FG002|Randomized, Blinded Study|Withdrawal by Subject|0|||
27817358|NCT01475253|54274619|FG003|Randomized, Blinded Study|Withdrawal by Subject|0|||
27817359|NCT01475253|54274616|FG000|Randomized, Blinded Study|Lost to Follow-up|1|||
27817360|NCT01475253|54274617|FG001|Randomized, Blinded Study|Lost to Follow-up|0|||
27817361|NCT01475253|54274618|FG002|Randomized, Blinded Study|Lost to Follow-up|0|||
27817362|NCT01475253|54274619|FG003|Randomized, Blinded Study|Lost to Follow-up|0|||
27817363|NCT01500135|54274677|FG000|Overall Study|Withdrawal of Consent|4|||
27817364|NCT01500135|54274678|FG001|Overall Study|Withdrawal of Consent|0|||
27817365|NCT01500135|54274677|FG000|Overall Study|Lost to Follow-up|6|||
27817366|NCT01500135|54274678|FG001|Overall Study|Lost to Follow-up|4|||
27817367|NCT01500135|54274677|FG000|Overall Study|Fatal Adverse Event (AE)|5|||
27817368|NCT01500135|54274678|FG001|Overall Study|Fatal Adverse Event (AE)|5|||
27849018|NCT03148795|54344177|FG000|Overall Study|No Longer Clinically Benefitting|2|||
27849019|NCT03148795|54344177|FG000|Overall Study|Global Deterioration Of Health Status|6|||
27849020|NCT03148795|54344177|FG000|Overall Study|Withdrawal by Subject|2|||
27849021|NCT03148795|54344177|FG000|Overall Study|Progressive Disease|62|||
27849022|NCT03148795|54344177|FG000|Overall Study|Ongoing|30|||
27849023|NCT03146845|54344183|FG000|Overall Study|Reference ulcer healed|1|||
27849024|NCT03146845|54344184|FG001|Overall Study|Reference ulcer healed|0|||
27849025|NCT03146845|54344183|FG000|Overall Study|Physician Decision|1|||
27849026|NCT03146845|54344184|FG001|Overall Study|Physician Decision|0|||
27849027|NCT03146845|54344183|FG000|Overall Study|Adverse Event|1|||
27849028|NCT03146845|54344184|FG001|Overall Study|Adverse Event|0|||
27849029|NCT03146845|54344183|FG000|Overall Study|Withdrawal by Subject|2|||
27849030|NCT03146845|54344184|FG001|Overall Study|Withdrawal by Subject|0|||
27849031|NCT03146845|54344183|FG000|Overall Study|Noncompliance|0|||
27849032|NCT03146845|54344184|FG001|Overall Study|Noncompliance|1|||
27849033|NCT03146845|54344183|FG000|Overall Study|Protocol Violation|0|||
27849034|NCT03146845|54344184|FG001|Overall Study|Protocol Violation|2|||
27849035|NCT03146845|54344183|FG000|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|0|||
27849036|NCT03146845|54344184|FG001|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|1|||
27849037|NCT02975700|54344190|FG000|Overall Study|Adverse Event|1|||
27849038|NCT02975700|54344190|FG000|Overall Study|Progressive disease|3|||
27849039|NCT02975700|54344190|FG000|Overall Study|Failed screening criteria|2|||
27849040|NCT02895360|54344200|FG000|Phase 1 - 30 mg/m² Cohort|Progressive disease|4|||
27849041|NCT02895360|54344201|FG001|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
27849042|NCT02895360|54344202|FG002|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
27849043|NCT02895360|54344203|FG003|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
27849044|NCT02895360|54344204|FG004|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
27849045|NCT02895360|54344205|FG005|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
27849046|NCT02895360|54344200|FG000|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
27849047|NCT02895360|54344201|FG001|Phase 1 - 45 mg/m² Cohort|Progressive disease|3|||
27849048|NCT02895360|54344202|FG002|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
27849049|NCT02895360|54344203|FG003|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
27849050|NCT02895360|54344204|FG004|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
27849051|NCT02895360|54344205|FG005|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
27849052|NCT02895360|54344200|FG000|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
27849053|NCT02895360|54344201|FG001|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
27849054|NCT02895360|54344202|FG002|Phase 1 - 70 mg/m² Cohort|Adverse Event|2|||
27849055|NCT02895360|54344203|FG003|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
27849056|NCT02895360|54344204|FG004|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
27849057|NCT02895360|54344205|FG005|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
27849058|NCT02895360|54344200|FG000|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
27849059|NCT02895360|54344201|FG001|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
27849060|NCT02895360|54344202|FG002|Phase 1 - 70 mg/m² Cohort|Progressive disease|7|||
27849061|NCT02895360|54344203|FG003|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
27849062|NCT02895360|54344204|FG004|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
27849063|NCT02895360|54344205|FG005|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
27849064|NCT02895360|54344200|FG000|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
27849065|NCT02895360|54344201|FG001|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
27849066|NCT02895360|54344202|FG002|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
27849067|NCT02895360|54344203|FG003|Phase 1 - 90 mg/m² Cohort|Progressive disease|4|||
27849068|NCT02895360|54344204|FG004|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
27849069|NCT02895360|54344205|FG005|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
27817369|NCT01500135|54274677|FG000|Overall Study|Principal Investigator (PI) Discretion|1|||
27817370|NCT01500135|54274678|FG001|Overall Study|Principal Investigator (PI) Discretion|0|||
27817371|NCT01500135|54274677|FG000|Overall Study|Patient Missed Scheduled Appointments|0|||
27817372|NCT01500135|54274678|FG001|Overall Study|Patient Missed Scheduled Appointments|1|||
27817373|NCT01500135|54274677|FG000|Overall Study|Participant was a Safety Concern|1|||
27817374|NCT01500135|54274678|FG001|Overall Study|Participant was a Safety Concern|0|||
27817375|NCT01500135|54274677|FG000|Overall Study|Patient Unable to Make Follow-up Visit|0|||
27817376|NCT01500135|54274678|FG001|Overall Study|Patient Unable to Make Follow-up Visit|1|||
27817377|NCT01475097|54274690|FG000|Overall Study|Protocol Violation|1|||
27817378|NCT01475097|54274691|FG001|Overall Study|Protocol Violation|1|||
27817379|NCT01529385|54274699|FG000|Overall Study|Lost to Follow-up|2|||
27817380|NCT01529385|54274700|FG001|Overall Study|Lost to Follow-up|1|||
27817381|NCT01474551|54274706|FG000|Overall Study|Death|1|||
27817382|NCT01500057|54274741|FG000|Overall Study|Lost to Follow-up|6|||
27817383|NCT01500057|54274742|FG001|Overall Study|Lost to Follow-up|4|||
27817384|NCT01499667|54274760|FG000|Overall Study|administrative problems|4|||
27817385|NCT01499667|54274761|FG001|Overall Study|administrative problems|5|||
27817386|NCT01499667|54274762|FG002|Overall Study|administrative problems|5|||
27849070|NCT02895360|54344200|FG000|Phase 2a|Adverse Event|0|||
27849071|NCT02895360|54344201|FG001|Phase 2a|Adverse Event|0|||
27849072|NCT02895360|54344202|FG002|Phase 2a|Adverse Event|0|||
27849073|NCT02895360|54344203|FG003|Phase 2a|Adverse Event|0|||
27849074|NCT02895360|54344204|FG004|Phase 2a|Adverse Event|0|||
27849075|NCT02895360|54344205|FG005|Phase 2a|Adverse Event|1|||
27849076|NCT02895360|54344200|FG000|Phase 2a|Progressive disease|0|||
27849077|NCT02895360|54344201|FG001|Phase 2a|Progressive disease|0|||
27817387|NCT01499667|54274760|FG000|Overall Study|Protocol Violation|1|||
27817388|NCT01499667|54274761|FG001|Overall Study|Protocol Violation|3|||
27817389|NCT01499667|54274762|FG002|Overall Study|Protocol Violation|2|||
27849078|NCT02895360|54344202|FG002|Phase 2a|Progressive disease|0|||
27849079|NCT02895360|54344203|FG003|Phase 2a|Progressive disease|0|||
27849080|NCT02895360|54344204|FG004|Phase 2a|Progressive disease|11|||
27849081|NCT02895360|54344205|FG005|Phase 2a|Progressive disease|11|||
27849082|NCT02863809|54344239|FG000|Overall Study|Adverse Event|8|||
27849083|NCT02863809|54344240|FG001|Overall Study|Adverse Event|8|||
27849084|NCT02863809|54344239|FG000|Overall Study|Withdrawal by Subject|0|||
27849085|NCT02863809|54344240|FG001|Overall Study|Withdrawal by Subject|1|||
27849086|NCT02863809|54344239|FG000|Overall Study|Lost to Follow-up|1|||
27849087|NCT02863809|54344240|FG001|Overall Study|Lost to Follow-up|1|||
27849088|NCT02863809|54344239|FG000|Overall Study|Death|1|||
27849089|NCT02863809|54344240|FG001|Overall Study|Death|0|||
27849090|NCT02829957|54344248|FG000|Overall Study|Lost to Follow-up|2|||
27849091|NCT02829957|54344249|FG001|Overall Study|Lost to Follow-up|1|||
27849092|NCT02753530|54344273|FG000|Overall Study|Adverse Event|7|||
27849093|NCT02753530|54344274|FG001|Overall Study|Adverse Event|1|||
27849094|NCT02753530|54344273|FG000|Overall Study|Death|0|||
27849095|NCT02753530|54344274|FG001|Overall Study|Death|1|||
27849096|NCT02753530|54344273|FG000|Overall Study|Physician Decision|0|||
27849097|NCT02753530|54344274|FG001|Overall Study|Physician Decision|1|||
27849098|NCT02753530|54344273|FG000|Overall Study|Protocol Violation|1|||
27849099|NCT02753530|54344274|FG001|Overall Study|Protocol Violation|0|||
27849100|NCT02753530|54344273|FG000|Overall Study|Withdrawal by Subject|4|||
27849101|NCT02753530|54344274|FG001|Overall Study|Withdrawal by Subject|3|||
27849102|NCT02717611|54344280|FG000|Overall Study|Death|13|||
27849103|NCT02717611|54344280|FG000|Overall Study|Withdrawal by Subject|6|||
27849104|NCT02717611|54344280|FG000|Overall Study|Active, not recruiting|40|||
27849105|NCT02717611|54344280|FG000|Overall Study|Complicating disease|1|||
27849106|NCT02362035|54344288|FG000|Overall Study|Death|67|||
27849107|NCT02362035|54344288|FG000|Overall Study|Lost to Follow-up|3|||
27849108|NCT02362035|54344288|FG000|Overall Study|Adverse Event|1|||
27849109|NCT02362035|54344288|FG000|Overall Study|Physician Decision|1|||
27849110|NCT02362035|54344288|FG000|Overall Study|Subject started another cancer therapy|10|||
27849111|NCT02362035|54344288|FG000|Overall Study|Study terminated by sponsor|45|||
27849112|NCT02362035|54344288|FG000|Overall Study|Decision by subject not related to AE/SAE|2|||
27849113|NCT02362035|54344288|FG000|Overall Study|Decision by PI not related to AE/SAE|1|||
27849114|NCT02362035|54344288|FG000|Overall Study|Disease progression|11|||
27849115|NCT02362035|54344288|FG000|Overall Study|Withdrawal by Subject|20|||
27849116|NCT02328014|54344296|FG000|Overall Study|Adverse Event|1|||
27849117|NCT02328014|54344297|FG001|Overall Study|Adverse Event|0|||
27817390|NCT01499667|54274760|FG000|Overall Study|Adverse Event|0|||
27817391|NCT01499667|54274761|FG001|Overall Study|Adverse Event|2|||
27817392|NCT01499667|54274762|FG002|Overall Study|Adverse Event|2|||
27817393|NCT01499667|54274760|FG000|Overall Study|Withdrawal by Subject|2|||
27817394|NCT01499667|54274761|FG001|Overall Study|Withdrawal by Subject|1|||
27817395|NCT01499667|54274762|FG002|Overall Study|Withdrawal by Subject|1|||
27817396|NCT01499667|54274760|FG000|Overall Study|Lack of Efficacy|2|||
27817397|NCT01499667|54274761|FG001|Overall Study|Lack of Efficacy|0|||
27817398|NCT01499667|54274762|FG002|Overall Study|Lack of Efficacy|0|||
27817399|NCT01499511|54274772|FG000|Overall Study|Death|1|||
27817400|NCT01499511|54274773|FG001|Overall Study|Death|0|||
27817401|NCT01474317|54274793|FG000|Overall Study|Adverse Event|1|||
27817402|NCT01474317|54274793|FG000|Overall Study|Subject ineligible for study|1|||
27817403|NCT01499355|54274889|FG000|Run-In Period|Study Termination|15|||
27817404|NCT01499355|54274890|FG001|Run-In Period|Study Termination|0|||
27817405|NCT01499355|54274891|FG002|Run-In Period|Study Termination|0|||
27849118|NCT02328014|54344298|FG002|Overall Study|Adverse Event|0|||
28120125|NCT03075410|54779964|FG007|Part A-Period 2 (14 Days)|Personal reasons|0|||
27849119|NCT02328014|54344299|FG003|Overall Study|Adverse Event|1|||
27849120|NCT02328014|54344296|FG000|Overall Study|Death|0|||
27849121|NCT02328014|54344297|FG001|Overall Study|Death|0|||
27849122|NCT02328014|54344298|FG002|Overall Study|Death|0|||
27849123|NCT02328014|54344299|FG003|Overall Study|Death|4|||
28120126|NCT03075410|54779965|FG008|Part A-Period 2 (14 Days)|Personal reasons|0|||
28120127|NCT03075410|54779957|FG000|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1|||
27817406|NCT01499355|54274892|FG003|Run-In Period|Study Termination|0|||
27817407|NCT01499355|54274889|FG000|Run-In Period|Other|3|||
27849124|NCT02328014|54344296|FG000|Overall Study|Physician Decision|0|||
27849125|NCT02328014|54344297|FG001|Overall Study|Physician Decision|0|||
27849126|NCT02328014|54344298|FG002|Overall Study|Physician Decision|0|||
27849127|NCT02328014|54344299|FG003|Overall Study|Physician Decision|1|||
27817408|NCT01499355|54274890|FG001|Run-In Period|Other|0|||
27817409|NCT01499355|54274891|FG002|Run-In Period|Other|0|||
27849128|NCT02328014|54344296|FG000|Overall Study|Disease Progression|1|||
27849129|NCT02328014|54344297|FG001|Overall Study|Disease Progression|0|||
27849130|NCT02328014|54344298|FG002|Overall Study|Disease Progression|1|||
27849131|NCT02328014|54344299|FG003|Overall Study|Disease Progression|3|||
27849132|NCT02328014|54344296|FG000|Overall Study|Study Terminated by Sponsor|4|||
27849133|NCT02328014|54344297|FG001|Overall Study|Study Terminated by Sponsor|1|||
27849134|NCT02328014|54344298|FG002|Overall Study|Study Terminated by Sponsor|1|||
27849135|NCT02328014|54344299|FG003|Overall Study|Study Terminated by Sponsor|0|||
27849136|NCT02328014|54344296|FG000|Overall Study|Subject Started Another Cancer Therapy|0|||
27849137|NCT02328014|54344297|FG001|Overall Study|Subject Started Another Cancer Therapy|5|||
27849138|NCT02328014|54344298|FG002|Overall Study|Subject Started Another Cancer Therapy|4|||
27849139|NCT02328014|54344299|FG003|Overall Study|Subject Started Another Cancer Therapy|12|||
27849140|NCT02328014|54344296|FG000|Overall Study|Withdrawal by Subject|0|||
27849141|NCT02328014|54344297|FG001|Overall Study|Withdrawal by Subject|0|||
27849142|NCT02328014|54344298|FG002|Overall Study|Withdrawal by Subject|0|||
27849143|NCT02328014|54344299|FG003|Overall Study|Withdrawal by Subject|1|||
27849144|NCT02289079|54344311|FG000|Overall Study|Physician Decision|2|||
27849145|NCT02289079|54344312|FG001|Overall Study|Physician Decision|0|||
27849146|NCT02289079|54344311|FG000|Overall Study|Lost to Follow-up|0|||
27849147|NCT02289079|54344312|FG001|Overall Study|Lost to Follow-up|1|||
27849148|NCT02213926|54344342|FG000|Overall Study|Death|59|||
27849149|NCT02213926|54344342|FG000|Overall Study|Withdrawal by Subject|10|||
27849150|NCT02213926|54344342|FG000|Overall Study|study terminated by sponsor|51|||
27849151|NCT02213926|54344342|FG000|Overall Study|Lost to Follow-up|3|||
27849152|NCT02213926|54344342|FG000|Overall Study|SITE CLOSURE - PI RETIREMENT|1|||
27849153|NCT02095132|54344371|FG000|Overall Study|Adverse Event|0|||
27849154|NCT02095132|54344372|FG001|Overall Study|Adverse Event|0|||
27849155|NCT02095132|54344373|FG002|Overall Study|Adverse Event|0|||
27849156|NCT02095132|54344374|FG003|Overall Study|Adverse Event|0|||
27849157|NCT02095132|54344375|FG004|Overall Study|Adverse Event|1|||
27849158|NCT02095132|54344376|FG005|Overall Study|Adverse Event|0|||
27849159|NCT02095132|54344377|FG006|Overall Study|Adverse Event|1|||
27849160|NCT02095132|54344378|FG007|Overall Study|Adverse Event|0|||
27849161|NCT02095132|54344379|FG008|Overall Study|Adverse Event|0|||
27849162|NCT02095132|54344371|FG000|Overall Study|Death|0|||
27849163|NCT02095132|54344372|FG001|Overall Study|Death|0|||
27849164|NCT02095132|54344373|FG002|Overall Study|Death|0|||
27849165|NCT02095132|54344374|FG003|Overall Study|Death|0|||
27849166|NCT02095132|54344375|FG004|Overall Study|Death|0|||
27849167|NCT02095132|54344376|FG005|Overall Study|Death|0|||
27849168|NCT02095132|54344377|FG006|Overall Study|Death|1|||
27849169|NCT02095132|54344378|FG007|Overall Study|Death|0|||
27849170|NCT02095132|54344379|FG008|Overall Study|Death|0|||
27849171|NCT02095132|54344371|FG000|Overall Study|Lack of Efficacy|3|||
27849172|NCT02095132|54344372|FG001|Overall Study|Lack of Efficacy|5|||
27849173|NCT02095132|54344373|FG002|Overall Study|Lack of Efficacy|2|||
27849174|NCT02095132|54344374|FG003|Overall Study|Lack of Efficacy|8|||
27849175|NCT02095132|54344375|FG004|Overall Study|Lack of Efficacy|3|||
27849176|NCT02095132|54344376|FG005|Overall Study|Lack of Efficacy|6|||
27849177|NCT02095132|54344377|FG006|Overall Study|Lack of Efficacy|10|||
27849178|NCT02095132|54344378|FG007|Overall Study|Lack of Efficacy|9|||
27849179|NCT02095132|54344379|FG008|Overall Study|Lack of Efficacy|8|||
27849180|NCT02095132|54344371|FG000|Overall Study|Physician Decision|1|||
27849181|NCT02095132|54344372|FG001|Overall Study|Physician Decision|0|||
27849182|NCT02095132|54344373|FG002|Overall Study|Physician Decision|0|||
27849183|NCT02095132|54344374|FG003|Overall Study|Physician Decision|0|||
27849184|NCT02095132|54344375|FG004|Overall Study|Physician Decision|0|||
27849185|NCT02095132|54344376|FG005|Overall Study|Physician Decision|0|||
27849186|NCT02095132|54344377|FG006|Overall Study|Physician Decision|1|||
27849187|NCT02095132|54344378|FG007|Overall Study|Physician Decision|0|||
27849188|NCT02095132|54344379|FG008|Overall Study|Physician Decision|2|||
27849189|NCT02095132|54344371|FG000|Overall Study|Withdrawal by Subject|0|||
27849190|NCT02095132|54344372|FG001|Overall Study|Withdrawal by Subject|0|||
27849191|NCT02095132|54344373|FG002|Overall Study|Withdrawal by Subject|2|||
27817410|NCT01499355|54274892|FG003|Run-In Period|Other|0|||
27849192|NCT02095132|54344374|FG003|Overall Study|Withdrawal by Subject|2|||
27817411|NCT01499355|54274889|FG000|Run-In Period|Death|2|||
27817412|NCT01499355|54274890|FG001|Run-In Period|Death|0|||
27817413|NCT01499355|54274891|FG002|Run-In Period|Death|0|||
27817414|NCT01499355|54274892|FG003|Run-In Period|Death|0|||
27817415|NCT01499355|54274889|FG000|Run-In Period|Investigator Decision|2|||
27817416|NCT01499355|54274890|FG001|Run-In Period|Investigator Decision|0|||
27817417|NCT01499355|54274891|FG002|Run-In Period|Investigator Decision|0|||
27817418|NCT01499355|54274892|FG003|Run-In Period|Investigator Decision|0|||
27849193|NCT02095132|54344375|FG004|Overall Study|Withdrawal by Subject|3|||
27849194|NCT02095132|54344376|FG005|Overall Study|Withdrawal by Subject|0|||
27817419|NCT01499355|54274889|FG000|Run-In Period|Consent Withdrawn|1|||
27817420|NCT01499355|54274890|FG001|Run-In Period|Consent Withdrawn|0|||
27849195|NCT02095132|54344377|FG006|Overall Study|Withdrawal by Subject|5|||
27849196|NCT02095132|54344378|FG007|Overall Study|Withdrawal by Subject|0|||
27849197|NCT02095132|54344379|FG008|Overall Study|Withdrawal by Subject|0|||
27849198|NCT00602667|54344439|FG000|Overall Study|Still on Therapy|0|||
28066275|NCT00316082|54721859|FG000|Overall Study|Physician Decision|1|||
28066276|NCT00316082|54721860|FG001|Overall Study|Physician Decision|1|||
27817421|NCT01499355|54274891|FG002|Run-In Period|Consent Withdrawn|0|||
27817422|NCT01499355|54274892|FG003|Run-In Period|Consent Withdrawn|0|||
27849199|NCT00602667|54344440|FG001|Overall Study|Still on Therapy|2|||
27849200|NCT00602667|54344441|FG002|Overall Study|Still on Therapy|2|||
27849201|NCT00602667|54344439|FG000|Overall Study|Death|0|||
27849202|NCT00602667|54344440|FG001|Overall Study|Death|1|||
27849203|NCT00602667|54344441|FG002|Overall Study|Death|1|||
27849204|NCT00602667|54344439|FG000|Overall Study|Family request|3|||
27817423|NCT01499355|54274889|FG000|Run-In Period|Adverse Event|8|||
27817424|NCT01499355|54274890|FG001|Run-In Period|Adverse Event|0|||
27817425|NCT01499355|54274891|FG002|Run-In Period|Adverse Event|0|||
27817426|NCT01499355|54274892|FG003|Run-In Period|Adverse Event|0|||
27817427|NCT01499355|54274889|FG000|Double-Blind Period|Adverse Event|0|||
27817428|NCT01499355|54274890|FG001|Double-Blind Period|Adverse Event|2|||
27817429|NCT01499355|54274891|FG002|Double-Blind Period|Adverse Event|3|||
27817430|NCT01499355|54274892|FG003|Double-Blind Period|Adverse Event|2|||
27817431|NCT01499355|54274889|FG000|Double-Blind Period|Study Termination|0|||
27817432|NCT01499355|54274890|FG001|Double-Blind Period|Study Termination|18|||
27817433|NCT01499355|54274891|FG002|Double-Blind Period|Study Termination|16|||
27817434|NCT01499355|54274892|FG003|Double-Blind Period|Study Termination|14|||
27817435|NCT01499355|54274889|FG000|Double-Blind Period|Other|0|||
27817436|NCT01499355|54274890|FG001|Double-Blind Period|Other|1|||
27817437|NCT01499355|54274891|FG002|Double-Blind Period|Other|2|||
27817438|NCT01499355|54274892|FG003|Double-Blind Period|Other|2|||
27849205|NCT00602667|54344440|FG001|Overall Study|Family request|25|||
27849206|NCT00602667|54344441|FG002|Overall Study|Family request|6|||
27849207|NCT00602667|54344439|FG000|Overall Study|Excessive toxicity|1|||
27849208|NCT00602667|54344440|FG001|Overall Study|Excessive toxicity|1|||
27849209|NCT00602667|54344441|FG002|Overall Study|Excessive toxicity|0|||
27849210|NCT00602667|54344439|FG000|Overall Study|Second malignancy|0|||
27849211|NCT00602667|54344440|FG001|Overall Study|Second malignancy|1|||
27849212|NCT00602667|54344441|FG002|Overall Study|Second malignancy|0|||
27849213|NCT00602667|54344439|FG000|Overall Study|Physician Decision|2|||
27849214|NCT00602667|54344440|FG001|Overall Study|Physician Decision|3|||
27849215|NCT00602667|54344441|FG002|Overall Study|Physician Decision|8|||
27849216|NCT00602667|54344439|FG000|Overall Study|Progressive disease|13|||
27849217|NCT00602667|54344440|FG001|Overall Study|Progressive disease|48|||
27849218|NCT00602667|54344441|FG002|Overall Study|Progressive disease|45|||
27849219|NCT00602667|54344439|FG000|Overall Study|Progressive disease prior to therapy|0|||
27849220|NCT00602667|54344440|FG001|Overall Study|Progressive disease prior to therapy|0|||
27849221|NCT00602667|54344441|FG002|Overall Study|Progressive disease prior to therapy|1|||
27849222|NCT00569127|54344480|FG000|Overall Study|Adverse Event|57|||
27849223|NCT00569127|54344481|FG001|Overall Study|Adverse Event|47|||
27817439|NCT01499355|54274889|FG000|Double-Blind Period|Death|0|||
27817440|NCT01499355|54274890|FG001|Double-Blind Period|Death|1|||
27817441|NCT01499355|54274891|FG002|Double-Blind Period|Death|0|||
27817442|NCT01499355|54274892|FG003|Double-Blind Period|Death|0|||
27817443|NCT01499355|54274889|FG000|Double-Blind Period|Investigator Decision|0|||
27817444|NCT01499355|54274890|FG001|Double-Blind Period|Investigator Decision|0|||
27817445|NCT01499355|54274891|FG002|Double-Blind Period|Investigator Decision|3|||
27817446|NCT01499355|54274892|FG003|Double-Blind Period|Investigator Decision|3|||
27817447|NCT01499355|54274889|FG000|Double-Blind Period|Consent Withdrawn|0|||
27817448|NCT01499355|54274890|FG001|Double-Blind Period|Consent Withdrawn|0|||
27817449|NCT01499355|54274891|FG002|Double-Blind Period|Consent Withdrawn|1|||
27817450|NCT01499355|54274892|FG003|Double-Blind Period|Consent Withdrawn|2|||
27817451|NCT01499355|54274889|FG000|Double-Blind Period|Lost to Follow-up|0|||
27817452|NCT01499355|54274890|FG001|Double-Blind Period|Lost to Follow-up|1|||
27817453|NCT01499355|54274891|FG002|Double-Blind Period|Lost to Follow-up|0|||
27817454|NCT01499355|54274892|FG003|Double-Blind Period|Lost to Follow-up|0|||
27817455|NCT01474239|54274913|FG000|Overall Study|Disease Progression|37|||
27817456|NCT01474239|54274914|FG001|Overall Study|Disease Progression|25|||
27817457|NCT01474239|54274913|FG000|Overall Study|Adverse Event|12|||
27817458|NCT01474239|54274914|FG001|Overall Study|Adverse Event|3|||
27817459|NCT01474239|54274913|FG000|Overall Study|Withdrawal by Subject|1|||
27817460|NCT01474239|54274914|FG001|Overall Study|Withdrawal by Subject|2|||
27817461|NCT01474239|54274913|FG000|Overall Study|Death|1|||
27817462|NCT01474239|54274914|FG001|Overall Study|Death|1|||
27940371|NCT01185366|54596648|FG001|Crossover to Second Line Therapy|Withdrawal by Subject|0|||
27817463|NCT01474239|54274913|FG000|Overall Study|Clinical Disease Progression|7|||
27817464|NCT01474239|54274914|FG001|Overall Study|Clinical Disease Progression|1|||
27817465|NCT01474239|54274913|FG000|Overall Study|Withdrawal for Economic Reason|1|||
27817466|NCT01474239|54274914|FG001|Overall Study|Withdrawal for Economic Reason|0|||
27817467|NCT01473381|54274924|FG000|Overall Study|Adverse Event|8|||
27849224|NCT00569127|54344480|FG000|Overall Study|Withdrawal by Subject|13|||
27849225|NCT00569127|54344481|FG001|Overall Study|Withdrawal by Subject|27|||
27849226|NCT00569127|54344480|FG000|Overall Study|Progression|99|||
27849227|NCT00569127|54344481|FG001|Overall Study|Progression|100|||
27849228|NCT00569127|54344480|FG000|Overall Study|Death|4|||
27849229|NCT00569127|54344481|FG001|Overall Study|Death|3|||
27849230|NCT00569127|54344480|FG000|Overall Study|Other|20|||
27849231|NCT00569127|54344481|FG001|Overall Study|Other|19|||
27849232|NCT00569127|54344480|FG000|Overall Study|Lost to Follow-up|0|||
27849233|NCT00569127|54344481|FG001|Overall Study|Lost to Follow-up|3|||
27849234|NCT00569127|54344480|FG000|Overall Study|Not Eligible|14|||
27849235|NCT00569127|54344481|FG001|Overall Study|Not Eligible|11|||
27849236|NCT00569127|54344480|FG000|Overall Study|Still on Treatment|7|||
27849237|NCT00569127|54344481|FG001|Overall Study|Still on Treatment|3|||
27849238|NCT02088905|54344518|FG000|Overall Study|Withdrawal by Subject|5|||
27849239|NCT02088905|54344519|FG001|Overall Study|Withdrawal by Subject|1|||
27849240|NCT02088047|54344527|FG000|Overall Study|Withdrawal by Subject|1|||
27849241|NCT02088047|54344528|FG001|Overall Study|Withdrawal by Subject|0|||
27849242|NCT02086565|54344554|FG000|Overall Study|Lost to Follow-up|9|||
27849243|NCT02086565|54344555|FG001|Overall Study|Lost to Follow-up|7|||
27849244|NCT02086565|54344554|FG000|Overall Study|Withdrawal by Subject|2|||
27849245|NCT02086565|54344555|FG001|Overall Study|Withdrawal by Subject|1|||
27849246|NCT02086565|54344554|FG000|Overall Study|Death|3|||
27849247|NCT02086565|54344555|FG001|Overall Study|Death|2|||
27849248|NCT02086565|54344554|FG000|Overall Study|withdrawn by research team|2|||
27849249|NCT02086565|54344555|FG001|Overall Study|withdrawn by research team|2|||
27849250|NCT02085941|54344563|FG000|Overall Study|Lack of Efficacy|1|||
27849251|NCT02085941|54344564|FG001|Overall Study|Lack of Efficacy|0|||
27849252|NCT02085941|54344563|FG000|Overall Study|Death|6|||
27849253|NCT02085941|54344564|FG001|Overall Study|Death|1|||
27849254|NCT02085941|54344563|FG000|Overall Study|Lost to Follow-up|1|||
27849255|NCT02085941|54344564|FG001|Overall Study|Lost to Follow-up|0|||
27849256|NCT02085941|54344563|FG000|Overall Study|Physician Decision|0|||
27849257|NCT02085941|54344564|FG001|Overall Study|Physician Decision|2|||
27849258|NCT02085785|54344572|FG000|Overall Study|Withdrawal by Subject|2|||
28066277|NCT00316082|54721861|FG002|Overall Study|Physician Decision|2|||
28066278|NCT00316082|54721862|FG003|Overall Study|Physician Decision|1|||
28066279|NCT00316082|54721863|FG004|Overall Study|Physician Decision|1|||
28066280|NCT00316082|54721859|FG000|Overall Study|Death|0|||
28066281|NCT00316082|54721860|FG001|Overall Study|Death|0|||
28066282|NCT00316082|54721861|FG002|Overall Study|Death|1|||
28120128|NCT03075410|54779958|FG001|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
28120129|NCT03075410|54779959|FG002|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
28120130|NCT03075410|54779960|FG003|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
28120131|NCT03075410|54779961|FG004|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
28120132|NCT03075410|54779962|FG005|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
28066283|NCT00316082|54721862|FG003|Overall Study|Death|0|||
28066284|NCT00316082|54721863|FG004|Overall Study|Death|0|||
28066285|NCT00316082|54721859|FG000|Overall Study|Administrative reason by sponsor|0|||
28066286|NCT00316082|54721860|FG001|Overall Study|Administrative reason by sponsor|0|||
28066287|NCT00316082|54721861|FG002|Overall Study|Administrative reason by sponsor|1|||
28066288|NCT00316082|54721862|FG003|Overall Study|Administrative reason by sponsor|0|||
28066289|NCT00316082|54721863|FG004|Overall Study|Administrative reason by sponsor|0|||
28066290|NCT00316004|54721882|FG000|Overall Study|Subject was not given study fluid.|14|||
28066291|NCT00316004|54721883|FG001|Overall Study|Subject was not given study fluid.|14|||
28066292|NCT00316004|54721884|FG002|Overall Study|Subject was not given study fluid.|21|||
28066293|NCT00298766|54721892|FG000|Overall Study|Adverse Event|18|||
28066294|NCT00298766|54721892|FG000|Overall Study|Death|2|||
28066295|NCT00298766|54721892|FG000|Overall Study|Withdrawal by Subject|9|||
28066296|NCT00298766|54721892|FG000|Overall Study|Treatment ongoing|4|||
28066297|NCT00298766|54721892|FG000|Overall Study|Progression of amyloid markers|4|||
28066298|NCT00298766|54721892|FG000|Overall Study|Deterioration in KPS and organ function|1|||
28066299|NCT00298766|54721892|FG000|Overall Study|Subjects overall condition deterioration|4|||
28066300|NCT00298766|54721892|FG000|Overall Study|Other|4|||
28066301|NCT00315458|54721898|FG000|Overall Study|Administrative|0|||
28066302|NCT00315458|54721899|FG001|Overall Study|Administrative|3|||
28066303|NCT00315458|54721900|FG002|Overall Study|Administrative|8|||
28066304|NCT00315458|54721901|FG003|Overall Study|Administrative|21|||
28066305|NCT00315458|54721898|FG000|Overall Study|Adverse Event|2|||
28066306|NCT00315458|54721899|FG001|Overall Study|Adverse Event|4|||
28066307|NCT00315458|54721900|FG002|Overall Study|Adverse Event|23|||
28066308|NCT00315458|54721901|FG003|Overall Study|Adverse Event|3|||
28066309|NCT00315458|54721898|FG000|Overall Study|Lost to Follow-up|1|||
28066310|NCT00315458|54721899|FG001|Overall Study|Lost to Follow-up|2|||
27849259|NCT02085785|54344573|FG001|Overall Study|Withdrawal by Subject|1|||
27849260|NCT02085785|54344572|FG000|Overall Study|Lost to Follow-up|0|||
27849261|NCT02085785|54344573|FG001|Overall Study|Lost to Follow-up|1|||
27849262|NCT02085161|54344601|FG000|Overall Study|Not Treated|1|||
27849263|NCT02085161|54344602|FG001|Overall Study|Not Treated|0|||
27849264|NCT02085161|54344603|FG002|Overall Study|Not Treated|0|||
27849265|NCT02085161|54344604|FG003|Overall Study|Not Treated|0|||
27849266|NCT02085161|54344601|FG000|Overall Study|Adverse Event|8|||
28066311|NCT00315458|54721900|FG002|Overall Study|Lost to Follow-up|0|||
28066312|NCT00315458|54721901|FG003|Overall Study|Lost to Follow-up|2|||
28066313|NCT00315458|54721898|FG000|Overall Study|Withdrawal by Subject|0|||
28120133|NCT03075410|54779963|FG006|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
28120134|NCT03075410|54779964|FG007|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
28120135|NCT03075410|54779965|FG008|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
28120136|NCT03071276|54780007|FG000|Overall Study|Adverse Event|1|||
28120137|NCT03071276|54780007|FG000|Overall Study|Lack of Efficacy|14|||
28120138|NCT03074162|54780017|FG000|Period 1 Including Washout 1|Withdrawal by Subject|0|||
28120139|NCT03074162|54780018|FG001|Period 1 Including Washout 1|Withdrawal by Subject|0|||
28120140|NCT03074162|54780019|FG002|Period 1 Including Washout 1|Withdrawal by Subject|1|||
28120141|NCT03074162|54780020|FG003|Period 1 Including Washout 1|Withdrawal by Subject|0|||
28120142|NCT03074162|54780021|FG004|Period 1 Including Washout 1|Withdrawal by Subject|0|||
28120143|NCT03074162|54780022|FG005|Period 1 Including Washout 1|Withdrawal by Subject|0|||
28120144|NCT03074162|54780017|FG000|Period 2 Including Washout 2|Withdrawal by Subject|0|||
28120145|NCT03074162|54780018|FG001|Period 2 Including Washout 2|Withdrawal by Subject|0|||
28120146|NCT03074162|54780019|FG002|Period 2 Including Washout 2|Withdrawal by Subject|1|||
28120147|NCT03074162|54780020|FG003|Period 2 Including Washout 2|Withdrawal by Subject|0|||
28120148|NCT03074162|54780021|FG004|Period 2 Including Washout 2|Withdrawal by Subject|0|||
28120149|NCT03074162|54780022|FG005|Period 2 Including Washout 2|Withdrawal by Subject|1|||
28120150|NCT03074162|54780017|FG000|Period 3|Withdrawal by Subject|1|||
28120151|NCT03074162|54780018|FG001|Period 3|Withdrawal by Subject|0|||
28120152|NCT03074162|54780019|FG002|Period 3|Withdrawal by Subject|0|||
28120153|NCT03074162|54780020|FG003|Period 3|Withdrawal by Subject|0|||
28120154|NCT03074162|54780021|FG004|Period 3|Withdrawal by Subject|1|||
28120155|NCT03074162|54780022|FG005|Period 3|Withdrawal by Subject|0|||
28120156|NCT03070964|54780030|FG000|Overall Study|Progressive disease|8|||
28120157|NCT03070964|54780030|FG000|Overall Study|Treatment-unrelated adverse event|2|||
28120158|NCT03070964|54780030|FG000|Overall Study|Never treated|1|||
28120159|NCT03070964|54780030|FG000|Overall Study|Physician Decision|1|||
28120160|NCT03070964|54780030|FG000|Overall Study|Withdrawal by Subject|1|||
28120161|NCT03070964|54780030|FG000|Overall Study|Adverse Event|1|||
28120162|NCT04065074|54780034|FG000|Overall Study|Adverse Event|1|||
28120163|NCT04065074|54780034|FG000|Overall Study|Protocol Non-Compliance after injection|1|||
28120164|NCT02888106|54780044|FG000|Overall Study|Withdrawal by Subject|1|||
28120165|NCT02888106|54780045|FG001|Overall Study|Withdrawal by Subject|2|||
28120166|NCT02888106|54780046|FG002|Overall Study|Withdrawal by Subject|0|||
28120167|NCT02888106|54780047|FG003|Overall Study|Withdrawal by Subject|1|||
28120168|NCT02888106|54780048|FG004|Overall Study|Withdrawal by Subject|0|||
28120169|NCT02888106|54780049|FG005|Overall Study|Withdrawal by Subject|0|||
28120170|NCT02888106|54780044|FG000|Overall Study|Lost to Follow-up|1|||
28120171|NCT02888106|54780045|FG001|Overall Study|Lost to Follow-up|0|||
28120172|NCT02888106|54780046|FG002|Overall Study|Lost to Follow-up|0|||
28120173|NCT02888106|54780047|FG003|Overall Study|Lost to Follow-up|1|||
28120174|NCT02888106|54780048|FG004|Overall Study|Lost to Follow-up|0|||
28120175|NCT02888106|54780049|FG005|Overall Study|Lost to Follow-up|1|||
28120176|NCT02888106|54780044|FG000|Overall Study|Adverse Event|2|||
28120177|NCT02888106|54780045|FG001|Overall Study|Adverse Event|0|||
28120178|NCT02888106|54780046|FG002|Overall Study|Adverse Event|0|||
28120179|NCT02888106|54780047|FG003|Overall Study|Adverse Event|0|||
28120180|NCT02888106|54780048|FG004|Overall Study|Adverse Event|0|||
28120181|NCT02888106|54780049|FG005|Overall Study|Adverse Event|0|||
28120182|NCT02888106|54780044|FG000|Overall Study|Withdrawal of consent|0|||
28120183|NCT02888106|54780045|FG001|Overall Study|Withdrawal of consent|0|||
28120184|NCT02888106|54780046|FG002|Overall Study|Withdrawal of consent|0|||
28120185|NCT02888106|54780047|FG003|Overall Study|Withdrawal of consent|0|||
28120186|NCT02888106|54780048|FG004|Overall Study|Withdrawal of consent|1|||
28120187|NCT02888106|54780049|FG005|Overall Study|Withdrawal of consent|0|||
28120188|NCT02888106|54780044|FG000|Overall Study|Pregnancy|1|||
28120189|NCT02888106|54780045|FG001|Overall Study|Pregnancy|0|||
28120190|NCT02888106|54780046|FG002|Overall Study|Pregnancy|0|||
28120191|NCT02888106|54780047|FG003|Overall Study|Pregnancy|0|||
28120192|NCT02888106|54780048|FG004|Overall Study|Pregnancy|0|||
28120193|NCT02888106|54780049|FG005|Overall Study|Pregnancy|0|||
28120194|NCT03793010|54780071|FG000|Overall Study|Withdrawal by Subject|5|||
28120195|NCT03793010|54780072|FG001|Overall Study|Withdrawal by Subject|7|||
28120196|NCT03793010|54780071|FG000|Overall Study|Withdrawn by Investigator or Sponsor|19|||
28120197|NCT03793010|54780072|FG001|Overall Study|Withdrawn by Investigator or Sponsor|18|||
28120198|NCT03793010|54780071|FG000|Overall Study|Lost to Follow-up|1|||
28120199|NCT03793010|54780072|FG001|Overall Study|Lost to Follow-up|2|||
28120200|NCT03793010|54780071|FG000|Overall Study|Patient couldn't sit still for injection|1|||
28120201|NCT03793010|54780072|FG001|Overall Study|Patient couldn't sit still for injection|0|||
28120202|NCT03793010|54780071|FG000|Overall Study|Withdrew to pursue other treatment|1|||
28120203|NCT03793010|54780072|FG001|Overall Study|Withdrew to pursue other treatment|0|||
28120204|NCT03793010|54780071|FG000|Overall Study|Did not meet eligibility criteria|1|||
28120205|NCT03793010|54780072|FG001|Overall Study|Did not meet eligibility criteria|0|||
28120206|NCT03304626|54780080|FG000|Overall Study|Adverse Event|1|||
28120207|NCT03304626|54780081|FG001|Overall Study|Adverse Event|0|||
28120208|NCT03304626|54780080|FG000|Overall Study|Lack of Efficacy|1|||
28120209|NCT03304626|54780081|FG001|Overall Study|Lack of Efficacy|1|||
28120210|NCT03274986|54780090|FG000|Overall Study|Withdrawal by Subject|0|||
28120211|NCT03274986|54780091|FG001|Overall Study|Withdrawal by Subject|1|||
28120212|NCT03274986|54780090|FG000|Overall Study|Lost to Follow-up|0|||
28120213|NCT03274986|54780091|FG001|Overall Study|Lost to Follow-up|1|||
28120214|NCT02919306|54780106|FG000|Overall Study|Withdrawal by Subject|1|||
28120215|NCT02919306|54780107|FG001|Overall Study|Withdrawal by Subject|0|||
28120216|NCT02919306|54780106|FG000|Overall Study|Protocol Violation|1|||
28120217|NCT02919306|54780107|FG001|Overall Study|Protocol Violation|0|||
28120218|NCT03274440|54780113|FG000|Overall Study|Time commitment too great|1|||
28120219|NCT03274440|54780114|FG001|Overall Study|Time commitment too great|0|||
28120220|NCT03274440|54780115|FG002|Overall Study|Time commitment too great|0|||
28120221|NCT03274440|54780116|FG003|Overall Study|Time commitment too great|1|||
28120222|NCT03274440|54780117|FG004|Overall Study|Time commitment too great|0|||
28120223|NCT03274440|54780118|FG005|Overall Study|Time commitment too great|0|||
28120224|NCT03268746|54780126|FG000|Overall Study|Withdrawal by Subject|1|||
28120225|NCT03268590|54780137|FG000|Overall Study|Previously unknown exclusion criteria|1|||
28120226|NCT03267576|54780146|FG000|Period 2: Day 44 to 71|Lost to Follow-up|0|||
28120227|NCT03267576|54780147|FG001|Period 2: Day 44 to 71|Lost to Follow-up|1|||
28120228|NCT03267576|54780146|FG000|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
28120229|NCT03267576|54780147|FG001|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
28120230|NCT03267264|54780157|FG000|Overall Study|Withdrawal by Subject|1|||
28120231|NCT03267264|54780158|FG001|Overall Study|Withdrawal by Subject|0|||
28120232|NCT03267264|54780159|FG002|Overall Study|Withdrawal by Subject|2|||
27817468|NCT01473381|54274925|FG001|Overall Study|Adverse Event|20|||
28120233|NCT03267264|54780160|FG003|Overall Study|Withdrawal by Subject|4|||
28120234|NCT03244800|54780177|FG000|Overall Study|Adverse Event|0|||
28120235|NCT03244800|54780178|FG001|Overall Study|Adverse Event|1|||
28120236|NCT03244800|54780179|FG002|Overall Study|Adverse Event|0|||
28120237|NCT03244800|54780180|FG003|Overall Study|Adverse Event|1|||
28120238|NCT03244800|54780177|FG000|Overall Study|Withdrew treatment|0|||
28120239|NCT03244800|54780178|FG001|Overall Study|Withdrew treatment|0|||
28120240|NCT03244800|54780179|FG002|Overall Study|Withdrew treatment|0|||
28120241|NCT03244800|54780180|FG003|Overall Study|Withdrew treatment|1|||
28120242|NCT04516291|54780201|FG000|Treatment Period (24 Weeks)|Other|1|||
28120243|NCT04516291|54780202|FG001|Treatment Period (24 Weeks)|Other|0|||
28120244|NCT04516291|54780203|FG002|Treatment Period (24 Weeks)|Other|0|||
28120245|NCT04516291|54780204|FG003|Treatment Period (24 Weeks)|Other|2|||
28120246|NCT04516291|54780205|FG004|Treatment Period (24 Weeks)|Other|2|||
28120247|NCT04516291|54780206|FG005|Treatment Period (24 Weeks)|Other|4|||
28120248|NCT04516291|54780207|FG006|Treatment Period (24 Weeks)|Other|2|||
28120249|NCT04516291|54780208|FG007|Treatment Period (24 Weeks)|Other|0|||
28120250|NCT04516291|54780201|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
28120251|NCT04516291|54780202|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
28120252|NCT04516291|54780203|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
28120253|NCT04516291|54780204|FG003|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
28120254|NCT04516291|54780205|FG004|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
28120255|NCT04516291|54780206|FG005|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
28120256|NCT04516291|54780207|FG006|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
28120257|NCT04516291|54780208|FG007|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
28120258|NCT04516291|54780201|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
28120259|NCT04516291|54780202|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
28120260|NCT04516291|54780203|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
28120261|NCT04516291|54780204|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
28120262|NCT04516291|54780205|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
27817469|NCT01473381|54274926|FG002|Overall Study|Adverse Event|25|||
28120263|NCT04516291|54780206|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
28120264|NCT04516291|54780207|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
28120265|NCT04516291|54780208|FG007|Treatment Period (24 Weeks)|Protocol Violation|0|||
28120266|NCT04516291|54780201|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
28120267|NCT04516291|54780202|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|1|||
28120268|NCT04516291|54780203|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
28120269|NCT04516291|54780204|FG003|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
28120270|NCT04516291|54780205|FG004|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
28120271|NCT04516291|54780206|FG005|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
28120272|NCT04516291|54780207|FG006|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
28120273|NCT04516291|54780208|FG007|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
28120274|NCT04516291|54780201|FG000|Treatment Period (24 Weeks)|Adverse Event|1|||
28120275|NCT04516291|54780202|FG001|Treatment Period (24 Weeks)|Adverse Event|2|||
28120276|NCT04516291|54780203|FG002|Treatment Period (24 Weeks)|Adverse Event|3|||
28120277|NCT04516291|54780204|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
28120278|NCT04516291|54780205|FG004|Treatment Period (24 Weeks)|Adverse Event|9|||
28120279|NCT04516291|54780206|FG005|Treatment Period (24 Weeks)|Adverse Event|4|||
28120280|NCT04516291|54780207|FG006|Treatment Period (24 Weeks)|Adverse Event|7|||
28120281|NCT04516291|54780208|FG007|Treatment Period (24 Weeks)|Adverse Event|14|||
28120282|NCT04516291|54780201|FG000|Follow-up Period (12 Weeks)|Other|0|||
28120283|NCT04516291|54780202|FG001|Follow-up Period (12 Weeks)|Other|1|||
28120284|NCT04516291|54780203|FG002|Follow-up Period (12 Weeks)|Other|0|||
28120285|NCT04516291|54780204|FG003|Follow-up Period (12 Weeks)|Other|2|||
28120286|NCT04516291|54780205|FG004|Follow-up Period (12 Weeks)|Other|0|||
28120287|NCT04516291|54780206|FG005|Follow-up Period (12 Weeks)|Other|0|||
28120288|NCT04516291|54780207|FG006|Follow-up Period (12 Weeks)|Other|0|||
28120289|NCT04516291|54780208|FG007|Follow-up Period (12 Weeks)|Other|0|||
28120290|NCT04516291|54780201|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
28120291|NCT04516291|54780202|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
28120292|NCT04516291|54780203|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
28120293|NCT04516291|54780204|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
28120294|NCT04516291|54780205|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
28120295|NCT04516291|54780206|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
28120296|NCT04516291|54780207|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
28120297|NCT04516291|54780208|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
28120298|NCT04516291|54780201|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
28120299|NCT04516291|54780202|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
28120300|NCT04516291|54780203|FG002|Follow-up Period (12 Weeks)|Adverse Event|1|||
28120301|NCT04516291|54780204|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
28120302|NCT04516291|54780205|FG004|Follow-up Period (12 Weeks)|Adverse Event|1|||
28120303|NCT04516291|54780206|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
28120304|NCT04516291|54780207|FG006|Follow-up Period (12 Weeks)|Adverse Event|0|||
28120305|NCT04516291|54780208|FG007|Follow-up Period (12 Weeks)|Adverse Event|0|||
28120306|NCT03243630|54780226|FG000|Overall Study|Protocol Violation|1|||
28120307|NCT03243630|54780226|FG000|Overall Study|Physician Decision|1|||
28120308|NCT04450381|54780234|FG000|Overall Study|Protocol Violation|4|||
28120309|NCT04450381|54780234|FG000|Overall Study|Wrong device setting|2|||
28120310|NCT03068468|54780240|FG000|Placebo-Controlled Period|Randomized but not Treated|1|||
28120311|NCT03068468|54780241|FG001|Placebo-Controlled Period|Randomized but not Treated|3|||
28120312|NCT03068468|54780242|FG002|Placebo-Controlled Period|Randomized but not Treated|0|||
28120313|NCT03068468|54780243|FG003|Placebo-Controlled Period|Randomized but not Treated|0|||
28120314|NCT03068468|54780240|FG000|Placebo-Controlled Period|Lack of Efficacy|0|||
28120315|NCT03068468|54780241|FG001|Placebo-Controlled Period|Lack of Efficacy|1|||
28120316|NCT03068468|54780242|FG002|Placebo-Controlled Period|Lack of Efficacy|0|||
28120317|NCT03068468|54780243|FG003|Placebo-Controlled Period|Lack of Efficacy|0|||
28120318|NCT03068468|54780240|FG000|Placebo-Controlled Period|Adverse Event|16|||
28120319|NCT03068468|54780241|FG001|Placebo-Controlled Period|Adverse Event|21|||
28120320|NCT03068468|54780242|FG002|Placebo-Controlled Period|Adverse Event|0|||
28120321|NCT03068468|54780243|FG003|Placebo-Controlled Period|Adverse Event|0|||
28120322|NCT03068468|54780240|FG000|Placebo-Controlled Period|Withdrawal by Subject|3|||
28120323|NCT03068468|54780241|FG001|Placebo-Controlled Period|Withdrawal by Subject|11|||
28120324|NCT03068468|54780242|FG002|Placebo-Controlled Period|Withdrawal by Subject|0|||
28120325|NCT03068468|54780243|FG003|Placebo-Controlled Period|Withdrawal by Subject|0|||
28120326|NCT03068468|54780240|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
28120327|NCT03068468|54780241|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2|||
28120328|NCT03068468|54780242|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
28120329|NCT03068468|54780243|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
28120330|NCT03068468|54780240|FG000|Placebo-Controlled Period|Reason Not Specified|1|||
28120331|NCT03068468|54780241|FG001|Placebo-Controlled Period|Reason Not Specified|6|||
28120332|NCT03068468|54780242|FG002|Placebo-Controlled Period|Reason Not Specified|0|||
28120333|NCT03068468|54780243|FG003|Placebo-Controlled Period|Reason Not Specified|0|||
27940372|NCT01185366|54596647|FG000|Crossover to Second Line Therapy|Continued with 1st drug|5|||
27940373|NCT01185366|54596648|FG001|Crossover to Second Line Therapy|Continued with 1st drug|3|||
27940374|NCT01185288|54596658|FG000|Overall Study|Adverse Event|7|||
27940375|NCT01185288|54596659|FG001|Overall Study|Adverse Event|6|||
27940376|NCT01185288|54596658|FG000|Overall Study|Withdrawal by Subject|6|||
27940377|NCT01185288|54596659|FG001|Overall Study|Withdrawal by Subject|4|||
27940378|NCT01185288|54596658|FG000|Overall Study|Lost to Follow-up|2|||
28120334|NCT03068468|54780240|FG000|Placebo-Controlled Period|Death|0|||
28120335|NCT03068468|54780241|FG001|Placebo-Controlled Period|Death|1|||
28120336|NCT03068468|54780242|FG002|Placebo-Controlled Period|Death|0|||
28120337|NCT03068468|54780243|FG003|Placebo-Controlled Period|Death|0|||
28120338|NCT03068468|54780240|FG000|Open-Label Extension Period|Lack of Efficacy|0|||
28120339|NCT03068468|54780241|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
28120340|NCT03068468|54780242|FG002|Open-Label Extension Period|Lack of Efficacy|1|||
28120341|NCT03068468|54780243|FG003|Open-Label Extension Period|Lack of Efficacy|2|||
28120342|NCT03068468|54780240|FG000|Open-Label Extension Period|Adverse Event|0|||
28120343|NCT03068468|54780241|FG001|Open-Label Extension Period|Adverse Event|0|||
28120344|NCT03068468|54780242|FG002|Open-Label Extension Period|Adverse Event|13|||
28120345|NCT03068468|54780243|FG003|Open-Label Extension Period|Adverse Event|17|||
28120346|NCT03068468|54780240|FG000|Open-Label Extension Period|Withdrawal by Subject|0|||
28120347|NCT03068468|54780241|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
28120348|NCT03068468|54780242|FG002|Open-Label Extension Period|Withdrawal by Subject|7|||
28120349|NCT03068468|54780243|FG003|Open-Label Extension Period|Withdrawal by Subject|20|||
28120350|NCT03068468|54780240|FG000|Open-Label Extension Period|Death|0|||
28120351|NCT03068468|54780241|FG001|Open-Label Extension Period|Death|0|||
28120352|NCT03068468|54780242|FG002|Open-Label Extension Period|Death|0|||
28120353|NCT03068468|54780243|FG003|Open-Label Extension Period|Death|1|||
28120354|NCT03068468|54780240|FG000|Open-Label Extension Period|Lost to Follow-up|0|||
28120355|NCT03068468|54780241|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
28120356|NCT03068468|54780242|FG002|Open-Label Extension Period|Lost to Follow-up|1|||
28120357|NCT03068468|54780243|FG003|Open-Label Extension Period|Lost to Follow-up|0|||
28120358|NCT03068468|54780240|FG000|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
28120359|NCT03068468|54780241|FG001|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
28120360|NCT03068468|54780242|FG002|Open-Label Extension Period|Failure to Meet Randomization Criteria|2|||
28120361|NCT03068468|54780243|FG003|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
28120362|NCT03068468|54780240|FG000|Open-Label Extension Period|Withdrawal by Sponsor|0|||
28120363|NCT03068468|54780241|FG001|Open-Label Extension Period|Withdrawal by Sponsor|0|||
28120364|NCT03068468|54780242|FG002|Open-Label Extension Period|Withdrawal by Sponsor|115|||
28120365|NCT03068468|54780243|FG003|Open-Label Extension Period|Withdrawal by Sponsor|228|||
28120366|NCT03068468|54780240|FG000|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
28120367|NCT03068468|54780241|FG001|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
28120368|NCT03068468|54780242|FG002|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
28120369|NCT03068468|54780243|FG003|Open-Label Extension Period|Withdrawal by Parent/Guardian|4|||
28120370|NCT03068468|54780240|FG000|Open-Label Extension Period|Reason not Specified|0|||
28120371|NCT03068468|54780241|FG001|Open-Label Extension Period|Reason not Specified|0|||
28120372|NCT03068468|54780242|FG002|Open-Label Extension Period|Reason not Specified|1|||
28120373|NCT03068468|54780243|FG003|Open-Label Extension Period|Reason not Specified|4|||
28120374|NCT04512001|54780253|FG000|Week 0 to Week 24|Adverse Event|14|||
28066314|NCT00315458|54721899|FG001|Overall Study|Withdrawal by Subject|3|||
28066315|NCT00315458|54721900|FG002|Overall Study|Withdrawal by Subject|0|||
28066316|NCT00315458|54721901|FG003|Overall Study|Withdrawal by Subject|2|||
28066317|NCT00315458|54721898|FG000|Overall Study|Lack of Efficacy|0|||
28066318|NCT00315458|54721899|FG001|Overall Study|Lack of Efficacy|0|||
28066319|NCT00315458|54721900|FG002|Overall Study|Lack of Efficacy|20|||
28066320|NCT00315458|54721901|FG003|Overall Study|Lack of Efficacy|1|||
28120375|NCT04512001|54780254|FG001|Week 0 to Week 24|Adverse Event|10|||
28120376|NCT04512001|54780255|FG002|Week 0 to Week 24|Adverse Event|0|||
27849267|NCT02085161|54344602|FG001|Overall Study|Adverse Event|5|||
28066321|NCT00315458|54721898|FG000|Overall Study|Did not qualify|0|||
28066322|NCT00315458|54721899|FG001|Overall Study|Did not qualify|0|||
28066323|NCT00315458|54721900|FG002|Overall Study|Did not qualify|1|||
28066324|NCT00315458|54721901|FG003|Overall Study|Did not qualify|0|||
28120377|NCT04512001|54780256|FG003|Week 0 to Week 24|Adverse Event|0|||
28120378|NCT04512001|54780257|FG004|Week 0 to Week 24|Adverse Event|0|||
28120379|NCT04512001|54780253|FG000|Week 0 to Week 24|Death|0|||
27849268|NCT02085161|54344603|FG002|Overall Study|Adverse Event|4|||
28066325|NCT00293384|54721911|FG000|Overall Study|Non-compliance|2|||
28120380|NCT04512001|54780254|FG001|Week 0 to Week 24|Death|2|||
28120381|NCT04512001|54780255|FG002|Week 0 to Week 24|Death|0|||
28120382|NCT04512001|54780256|FG003|Week 0 to Week 24|Death|0|||
28120383|NCT04512001|54780257|FG004|Week 0 to Week 24|Death|0|||
28120384|NCT04512001|54780253|FG000|Week 0 to Week 24|Withdrawal by Subject|16|||
28120385|NCT04512001|54780254|FG001|Week 0 to Week 24|Withdrawal by Subject|9|||
28120386|NCT04512001|54780255|FG002|Week 0 to Week 24|Withdrawal by Subject|0|||
28120387|NCT04512001|54780256|FG003|Week 0 to Week 24|Withdrawal by Subject|0|||
28120388|NCT04512001|54780257|FG004|Week 0 to Week 24|Withdrawal by Subject|0|||
28120389|NCT04512001|54780253|FG000|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
28120390|NCT04512001|54780254|FG001|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
28120391|NCT04512001|54780255|FG002|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
28120392|NCT04512001|54780256|FG003|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
28120393|NCT04512001|54780257|FG004|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
28120394|NCT04512001|54780253|FG000|Week 0 to Week 24|Withdrawal By Sponsor's Decision|1|||
28120395|NCT04512001|54780254|FG001|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
28120396|NCT04512001|54780255|FG002|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
28120397|NCT04512001|54780256|FG003|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
28120398|NCT04512001|54780257|FG004|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
28120399|NCT04512001|54780253|FG000|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
28120400|NCT04512001|54780254|FG001|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|1|||
28120401|NCT04512001|54780255|FG002|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
28120402|NCT04512001|54780256|FG003|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
28120403|NCT04512001|54780257|FG004|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
28120404|NCT04512001|54780253|FG000|Week 24 to Week 63|Adverse Event|0|||
28120405|NCT04512001|54780254|FG001|Week 24 to Week 63|Adverse Event|0|||
28120406|NCT04512001|54780255|FG002|Week 24 to Week 63|Adverse Event|13|||
28120407|NCT04512001|54780256|FG003|Week 24 to Week 63|Adverse Event|8|||
28120408|NCT04512001|54780257|FG004|Week 24 to Week 63|Adverse Event|6|||
28120409|NCT04512001|54780253|FG000|Week 24 to Week 63|Lost to Follow-up|0|||
28120410|NCT04512001|54780254|FG001|Week 24 to Week 63|Lost to Follow-up|0|||
28120411|NCT04512001|54780255|FG002|Week 24 to Week 63|Lost to Follow-up|1|||
28120412|NCT04512001|54780256|FG003|Week 24 to Week 63|Lost to Follow-up|1|||
28120413|NCT04512001|54780257|FG004|Week 24 to Week 63|Lost to Follow-up|1|||
28120414|NCT04512001|54780253|FG000|Week 24 to Week 63|Death|0|||
28120415|NCT04512001|54780254|FG001|Week 24 to Week 63|Death|0|||
28120416|NCT04512001|54780255|FG002|Week 24 to Week 63|Death|0|||
28120417|NCT04512001|54780256|FG003|Week 24 to Week 63|Death|1|||
28120418|NCT04512001|54780257|FG004|Week 24 to Week 63|Death|1|||
28120419|NCT04512001|54780253|FG000|Week 24 to Week 63|Withdrawal by Subject|0|||
28120420|NCT04512001|54780254|FG001|Week 24 to Week 63|Withdrawal by Subject|0|||
28120421|NCT04512001|54780255|FG002|Week 24 to Week 63|Withdrawal by Subject|6|||
28120422|NCT04512001|54780256|FG003|Week 24 to Week 63|Withdrawal by Subject|4|||
28120423|NCT04512001|54780257|FG004|Week 24 to Week 63|Withdrawal by Subject|6|||
28120424|NCT04512001|54780253|FG000|Week 24 to Week 63|Miscellaneous|0|||
28120425|NCT04512001|54780254|FG001|Week 24 to Week 63|Miscellaneous|0|||
28120426|NCT04512001|54780255|FG002|Week 24 to Week 63|Miscellaneous|3|||
28120427|NCT04512001|54780256|FG003|Week 24 to Week 63|Miscellaneous|2|||
28120428|NCT04512001|54780257|FG004|Week 24 to Week 63|Miscellaneous|1|||
28120429|NCT04447417|54780272|FG000|Overall Study|Withdrawal by Subject|1|||
28120430|NCT04447417|54780273|FG001|Overall Study|Withdrawal by Subject|0|||
28120431|NCT04447417|54780272|FG000|Overall Study|Failure to meet inclusion criteria|1|||
28120432|NCT04447417|54780273|FG001|Overall Study|Failure to meet inclusion criteria|0|||
28120433|NCT04447417|54780272|FG000|Overall Study|Lost to Follow-up|1|||
28120434|NCT04447417|54780273|FG001|Overall Study|Lost to Follow-up|0|||
28120435|NCT02787044|54780281|FG000|Overall Study|Lost to Follow-up|15|||
28120436|NCT02787044|54780282|FG001|Overall Study|Lost to Follow-up|19|||
28120437|NCT01345019|54780294|FG000|Blinded Treatment Phase|Death|147|||
28120438|NCT01345019|54780295|FG001|Blinded Treatment Phase|Death|137|||
28066326|NCT00293384|54721911|FG000|Overall Study|Missed dosage/study drug|1|||
28066327|NCT00293384|54721911|FG000|Overall Study|Ineligible|2|||
28066328|NCT00297830|54721918|FG000|6 Month Visit|Death|1|||
28066329|NCT00297830|54721919|FG001|6 Month Visit|Death|0|||
28066330|NCT00297830|54721920|FG002|6 Month Visit|Death|2|||
28066331|NCT00297830|54721918|FG000|6 Month Visit|Withdrawal by Subject|2|||
28066332|NCT00297830|54721919|FG001|6 Month Visit|Withdrawal by Subject|1|||
28066333|NCT00297830|54721920|FG002|6 Month Visit|Withdrawal by Subject|1|||
28120439|NCT01345019|54780294|FG000|Blinded Treatment Phase|Withdrawal by Subject|103|||
28120440|NCT01345019|54780295|FG001|Blinded Treatment Phase|Withdrawal by Subject|112|||
28120441|NCT01345019|54780294|FG000|Blinded Treatment Phase|Completed Survival Follow-up|21|||
28120442|NCT01345019|54780295|FG001|Blinded Treatment Phase|Completed Survival Follow-up|9|||
28120443|NCT01345019|54780294|FG000|Blinded Treatment Phase|Disease Progression|12|||
28120444|NCT01345019|54780295|FG001|Blinded Treatment Phase|Disease Progression|10|||
28120445|NCT01345019|54780294|FG000|Blinded Treatment Phase|Adverse Event|6|||
28120446|NCT01345019|54780295|FG001|Blinded Treatment Phase|Adverse Event|13|||
28120447|NCT01345019|54780294|FG000|Blinded Treatment Phase|Administrative Decision|10|||
28120448|NCT01345019|54780295|FG001|Blinded Treatment Phase|Administrative Decision|8|||
28120449|NCT01345019|54780294|FG000|Blinded Treatment Phase|Noncompliance|5|||
28120450|NCT01345019|54780295|FG001|Blinded Treatment Phase|Noncompliance|3|||
27940379|NCT01185288|54596659|FG001|Overall Study|Lost to Follow-up|5|||
28066334|NCT00297830|54721918|FG000|6 Month Visit|Adverse Event|0|||
28066335|NCT00297830|54721919|FG001|6 Month Visit|Adverse Event|1|||
28066336|NCT00297830|54721920|FG002|6 Month Visit|Adverse Event|0|||
28120451|NCT01345019|54780294|FG000|Blinded Treatment Phase|Ineligibility Determined|1|||
28120452|NCT01345019|54780295|FG001|Blinded Treatment Phase|Ineligibility Determined|6|||
28120453|NCT01345019|54780294|FG000|Blinded Treatment Phase|Protocol Deviation|5|||
28120454|NCT01345019|54780295|FG001|Blinded Treatment Phase|Protocol Deviation|0|||
28120455|NCT01345019|54780294|FG000|Blinded Treatment Phase|Other, Not Specified|2|||
28120456|NCT01345019|54780295|FG001|Blinded Treatment Phase|Other, Not Specified|3|||
28120457|NCT01345019|54780294|FG000|Blinded Treatment Phase|Lost to Follow-up|6|||
28120458|NCT01345019|54780295|FG001|Blinded Treatment Phase|Lost to Follow-up|3|||
28120459|NCT01345019|54780294|FG000|Open Label Treatment Phase|Death|49|||
28120460|NCT01345019|54780295|FG001|Open Label Treatment Phase|Death|48|||
28120461|NCT01345019|54780294|FG000|Open Label Treatment Phase|Withdrawal by Subject|49|||
28120462|NCT01345019|54780295|FG001|Open Label Treatment Phase|Withdrawal by Subject|47|||
28120463|NCT01345019|54780294|FG000|Open Label Treatment Phase|Adverse Event|30|||
28120464|NCT01345019|54780295|FG001|Open Label Treatment Phase|Adverse Event|51|||
28120465|NCT01345019|54780294|FG000|Open Label Treatment Phase|Administrative Decision|30|||
28120466|NCT01345019|54780295|FG001|Open Label Treatment Phase|Administrative Decision|15|||
28120467|NCT01345019|54780294|FG000|Open Label Treatment Phase|Disease Progression|17|||
28120468|NCT01345019|54780295|FG001|Open Label Treatment Phase|Disease Progression|18|||
28120469|NCT01345019|54780294|FG000|Open Label Treatment Phase|Noncompliance|5|||
28120470|NCT01345019|54780295|FG001|Open Label Treatment Phase|Noncompliance|4|||
28120471|NCT01345019|54780294|FG000|Open Label Treatment Phase|Lost to Follow-up|1|||
28120472|NCT01345019|54780295|FG001|Open Label Treatment Phase|Lost to Follow-up|2|||
28120473|NCT01345019|54780294|FG000|Open Label Treatment Phase|Pregnancy|1|||
28120474|NCT01345019|54780295|FG001|Open Label Treatment Phase|Pregnancy|0|||
28120475|NCT01345019|54780294|FG000|Open Label Treatment Phase|Other, Not Specified|9|||
28120476|NCT01345019|54780295|FG001|Open Label Treatment Phase|Other, Not Specified|7|||
28120477|NCT01345019|54780294|FG000|Open Label Treatment Phase|Protocol Violation|0|||
28120478|NCT01345019|54780295|FG001|Open Label Treatment Phase|Protocol Violation|1|||
28120479|NCT04507867|54780305|FG000|Overall Study|Death|7|||
28120480|NCT04507867|54780306|FG001|Overall Study|Death|1|||
27817470|NCT01473381|54274927|FG003|Overall Study|Adverse Event|17|||
27817471|NCT01473381|54274924|FG000|Overall Study|Insufficient Therapeutic Response|10|||
27817472|NCT01473381|54274925|FG001|Overall Study|Insufficient Therapeutic Response|1|||
27817473|NCT01473381|54274926|FG002|Overall Study|Insufficient Therapeutic Response|2|||
27817474|NCT01473381|54274927|FG003|Overall Study|Insufficient Therapeutic Response|3|||
27817475|NCT01473381|54274924|FG000|Overall Study|Protocol Violation|17|||
27817476|NCT01473381|54274925|FG001|Overall Study|Protocol Violation|23|||
27817477|NCT01473381|54274926|FG002|Overall Study|Protocol Violation|19|||
27817478|NCT01473381|54274927|FG003|Overall Study|Protocol Violation|17|||
27817479|NCT01473381|54274924|FG000|Overall Study|Withdrawal of Consent|20|||
27817480|NCT01473381|54274925|FG001|Overall Study|Withdrawal of Consent|21|||
27817481|NCT01473381|54274926|FG002|Overall Study|Withdrawal of Consent|20|||
27817482|NCT01473381|54274927|FG003|Overall Study|Withdrawal of Consent|26|||
27817483|NCT01473381|54274924|FG000|Overall Study|Lost to Follow-up|25|||
28120481|NCT03069716|54780330|FG000|Run-in Period (2 Weeks)|Adverse Event|1|||
28120482|NCT03069716|54780331|FG001|Run-in Period (2 Weeks)|Adverse Event|0|||
28120483|NCT03069716|54780332|FG002|Run-in Period (2 Weeks)|Adverse Event|0|||
28120484|NCT03069716|54780330|FG000|Run-in Period (2 Weeks)|Protocol Violation|1|||
28120485|NCT03069716|54780331|FG001|Run-in Period (2 Weeks)|Protocol Violation|0|||
28120486|NCT03069716|54780332|FG002|Run-in Period (2 Weeks)|Protocol Violation|0|||
27817484|NCT01473381|54274925|FG001|Overall Study|Lost to Follow-up|28|||
27817485|NCT01473381|54274926|FG002|Overall Study|Lost to Follow-up|35|||
28066337|NCT00297830|54721918|FG000|12 Month Visit|Lost to Follow-up|1|||
28066338|NCT00297830|54721919|FG001|12 Month Visit|Lost to Follow-up|0|||
28066339|NCT00297830|54721920|FG002|12 Month Visit|Lost to Follow-up|0|||
28066340|NCT00297830|54721918|FG000|12 Month Visit|Adverse Event|0|||
28066341|NCT00297830|54721919|FG001|12 Month Visit|Adverse Event|3|||
28066342|NCT00297830|54721920|FG002|12 Month Visit|Adverse Event|0|||
28066343|NCT00297830|54721918|FG000|12 Month Visit|Withdrawal by Subject|0|||
28066344|NCT00297830|54721919|FG001|12 Month Visit|Withdrawal by Subject|3|||
28120487|NCT03069716|54780330|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|5|||
28120488|NCT03069716|54780331|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
28120489|NCT03069716|54780332|FG002|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
28120490|NCT03069716|54780330|FG000|Randomized Treatment|Withdrawal by Subject|0|||
28120491|NCT03069716|54780331|FG001|Randomized Treatment|Withdrawal by Subject|2|||
28120492|NCT03069716|54780332|FG002|Randomized Treatment|Withdrawal by Subject|0|||
27817486|NCT01473381|54274927|FG003|Overall Study|Lost to Follow-up|23|||
27817487|NCT01473381|54274924|FG000|Overall Study|Other Reasons|0|||
28120493|NCT03693625|54780345|FG000|Overall Study|Adverse Event|2|||
28120494|NCT03693625|54780346|FG001|Overall Study|Adverse Event|0|||
28120495|NCT03693625|54780345|FG000|Overall Study|Study Terminated By Sponsor|20|||
28120496|NCT03693625|54780346|FG001|Overall Study|Study Terminated By Sponsor|7|||
28120497|NCT03693625|54780345|FG000|Overall Study|Withdrawal by Subject|1|||
28120498|NCT03693625|54780346|FG001|Overall Study|Withdrawal by Subject|1|||
28120499|NCT01265537|54780354|FG000|Overall Study|Adverse Event|2|||
28120500|NCT01265537|54780355|FG001|Overall Study|Adverse Event|1|||
28120501|NCT01265537|54780354|FG000|Overall Study|Physician Decision|0|||
28120502|NCT01265537|54780355|FG001|Overall Study|Physician Decision|1|||
28120503|NCT04396639|54780361|FG000|Overall Study|Withdrawal by Subject|1|||
28120504|NCT04396639|54780361|FG000|Overall Study|Other|1|||
28120505|NCT04432298|54780367|FG000|Overall Study|Other than specified|1|||
28120506|NCT04432298|54780368|FG001|Overall Study|Other than specified|0|||
28120507|NCT04432298|54780367|FG000|Overall Study|Lost to Follow-up|0|||
28120508|NCT04432298|54780368|FG001|Overall Study|Lost to Follow-up|1|||
27849269|NCT02085161|54344604|FG003|Overall Study|Adverse Event|5|||
28066345|NCT00297830|54721920|FG002|12 Month Visit|Withdrawal by Subject|0|||
28066346|NCT00296816|54721930|FG000|Overall Study|Disease Progression|37|||
28066347|NCT00296816|54721930|FG000|Overall Study|Adverse Event|18|||
28066348|NCT00296816|54721930|FG000|Overall Study|Investigator/Participant request|5|||
28066349|NCT00296816|54721930|FG000|Overall Study|Non-compliance|1|||
28066350|NCT00296816|54721930|FG000|Overall Study|Missing for end of treatment|4|||
28066351|NCT00296816|54721930|FG000|Overall Study|Progression based on CA-125 (biomarker)|2|||
28066352|NCT00296816|54721930|FG000|Overall Study|Poor performance status|1|||
28066353|NCT00296816|54721930|FG000|Overall Study|Relocation to Florida|1|||
28066354|NCT00296816|54721930|FG000|Overall Study|Noncompliance/decision to discontinue|1|||
28066355|NCT00296816|54721930|FG000|Overall Study|Urine protein/creatinine ratio delay|1|||
28066356|NCT00296816|54721930|FG000|Overall Study|Neuropathy/patient preference|1|||
28066357|NCT00296816|54721930|FG000|Overall Study|Proteinuria|1|||
28066358|NCT00296816|54721930|FG000|Overall Study|ineligibility due to radiation treatment|1|||
28066359|NCT00314132|54721936|FG000|Overall Study|Lost to Follow-up|3|||
28066360|NCT00314132|54721937|FG001|Overall Study|Lost to Follow-up|13|||
28066361|NCT00314132|54721936|FG000|Overall Study|Withdrawal by Subject|3|||
28066362|NCT00314132|54721937|FG001|Overall Study|Withdrawal by Subject|5|||
28066363|NCT00314132|54721936|FG000|Overall Study|Adverse Event|1|||
28066364|NCT00314132|54721937|FG001|Overall Study|Adverse Event|0|||
28066365|NCT00314132|54721936|FG000|Overall Study|Physician Decision|1|||
28066366|NCT00314132|54721937|FG001|Overall Study|Physician Decision|0|||
28066367|NCT00097786|54721949|FG000|Overall Study|lost to follow-up for all-cause death|296|||
28066368|NCT00097786|54721950|FG001|Overall Study|lost to follow-up for all-cause death|292|||
28066369|NCT00097786|54721951|FG002|Overall Study|lost to follow-up for all-cause death|313|||
28066370|NCT00097786|54721952|FG003|Overall Study|lost to follow-up for all-cause death|310|||
28066371|NCT00117988|54721962|FG000|Overall Study|Death|3|||
28066372|NCT00117988|54721962|FG000|Overall Study|Adverse Event|1|||
28066373|NCT00117676|54721968|FG000|Double-blind Period Through Week 48|Randomized but Not Treated|4|||
28066374|NCT00117676|54721969|FG001|Double-blind Period Through Week 48|Randomized but Not Treated|3|||
28066375|NCT00117676|54721968|FG000|Double-blind Period Through Week 48|Lost to Follow-up|1|||
28066376|NCT00117676|54721969|FG001|Double-blind Period Through Week 48|Lost to Follow-up|0|||
28066377|NCT00117676|54721968|FG000|Double-blind Period Through Week 48|Protocol Violation|0|||
28066378|NCT00117676|54721969|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
28066379|NCT00117676|54721968|FG000|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5|||
28066380|NCT00117676|54721969|FG001|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2|||
28066381|NCT00117676|54721968|FG000|Double-blind Period Through Week 48|Withdrew Consent|0|||
28066382|NCT00117676|54721969|FG001|Double-blind Period Through Week 48|Withdrew Consent|1|||
28066383|NCT00117676|54721968|FG000|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2|||
28066384|NCT00117676|54721969|FG001|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0|||
28066385|NCT00117676|54721968|FG000|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3|||
28066386|NCT00117676|54721969|FG001|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
28066387|NCT00117676|54721968|FG000|Open-label Period: Weeks 49 - 96|Withdrew Consent|5|||
28066388|NCT00117676|54721969|FG001|Open-label Period: Weeks 49 - 96|Withdrew Consent|1|||
28066389|NCT00117676|54721968|FG000|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4|||
28066390|NCT00117676|54721969|FG001|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1|||
28066391|NCT00117676|54721968|FG000|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1|||
28066392|NCT00117676|54721969|FG001|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0|||
28066393|NCT00117676|54721968|FG000|Open-label Period: Weeks 97 - 144|Withdrew Consent|1|||
28066394|NCT00117676|54721969|FG001|Open-label Period: Weeks 97 - 144|Withdrew Consent|0|||
28120509|NCT04432298|54780367|FG000|Overall Study|Death|3|||
28120510|NCT04432298|54780368|FG001|Overall Study|Death|2|||
28120511|NCT04432298|54780367|FG000|Overall Study|Withdrawal by Subject|2|||
28120512|NCT04432298|54780368|FG001|Overall Study|Withdrawal by Subject|0|||
28120513|NCT04167085|54780376|FG000|Baseline|Withdrawal by Subject|2|||
28120514|NCT04167085|54780377|FG001|Baseline|Withdrawal by Subject|1|||
28120515|NCT04167085|54780376|FG000|Washout (1 Month)|Withdrawal by Subject|1|||
28120516|NCT04167085|54780377|FG001|Washout (1 Month)|Withdrawal by Subject|0|||
28120517|NCT04162795|54780383|FG000|Overall Study|Other|16|||
28120518|NCT04162795|54780383|FG000|Overall Study|Screen failures|10|||
28120519|NCT03069482|54780389|FG000|Overall Study|Lost to Follow-up|0|||
28120520|NCT03069482|54780390|FG001|Overall Study|Lost to Follow-up|1|||
28120521|NCT03069482|54780389|FG000|Overall Study|Physician Decision|1|||
28120522|NCT03069482|54780390|FG001|Overall Study|Physician Decision|0|||
28120523|NCT03266172|54780402|FG000|Part A: Period 1(2 Days)|Withdrawal by Subject|1|||
28120524|NCT03266172|54780403|FG001|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
28120525|NCT03266172|54780404|FG002|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
28120526|NCT03266172|54780402|FG000|Part A: Washout Period (7 Days)|Adverse Event|1|||
28120527|NCT03266172|54780403|FG001|Part A: Washout Period (7 Days)|Adverse Event|0|||
28120528|NCT03266172|54780404|FG002|Part A: Washout Period (7 Days)|Adverse Event|0|||
28120529|NCT03266172|54780402|FG000|Part A: Washout Period (7 Days)|Withdrawal by Subject|1|||
28120530|NCT03266172|54780403|FG001|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
28120531|NCT03266172|54780404|FG002|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
28120532|NCT03266172|54780402|FG000|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
28120533|NCT03266172|54780403|FG001|Part B: Washout (7 Days)|Withdrawal by Subject|2|||
28120534|NCT03266172|54780404|FG002|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
28120535|NCT03266172|54780402|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
28120536|NCT03266172|54780403|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
28120537|NCT03266172|54780404|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
28120538|NCT03266172|54780402|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
28120539|NCT03266172|54780403|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
28120540|NCT03266172|54780404|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
28120541|NCT04356937|54780456|FG000|Treatment (mITT Population)|Intubated before receiving study treatment|0|||
28120542|NCT04356937|54780457|FG001|Treatment (mITT Population)|Intubated before receiving study treatment|1|||
28120543|NCT03301740|54780469|FG000|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1|||
28120544|NCT03301740|54780470|FG001|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0|||
28120545|NCT03301740|54780469|FG000|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1|||
28120546|NCT03301740|54780470|FG001|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0|||
28120547|NCT04355767|54780478|FG000|Overall Study|Withdrawal by Subject|2|||
28120548|NCT04355767|54780479|FG001|Overall Study|Withdrawal by Subject|2|||
28120549|NCT04355767|54780478|FG000|Overall Study|Death|5|||
28120550|NCT04355767|54780479|FG001|Overall Study|Death|1|||
28120551|NCT00882050|54780488|FG000|Overall Study|Physician Decision|1|||
28120552|NCT00882050|54780489|FG001|Overall Study|Physician Decision|0|||
28120553|NCT00882050|54780490|FG002|Overall Study|Physician Decision|0|||
28120554|NCT03266094|54780498|FG000|Overall Study|Lost to Follow-up|1|||
28120555|NCT03266094|54780498|FG000|Overall Study|Withdrawal by Subject|1|||
28120556|NCT04161079|54780504|FG000|Clinical Investigation 2010-040|Adverse Event|1|||
28120557|NCT03243084|54780514|FG000|Washout (1-3 Weeks)|Lost to Follow-up|1|||
28120558|NCT03243084|54780515|FG001|Washout (1-3 Weeks)|Lost to Follow-up|0|||
28120559|NCT04353817|54780524|FG000|Overall Study|Adverse Event|0|||
28120560|NCT04353817|54780525|FG001|Overall Study|Adverse Event|1|||
28120561|NCT00159588|54780534|FG000|5 Month Follow-up|Withdrawal by Subject|2|||
28120562|NCT00159588|54780535|FG001|5 Month Follow-up|Withdrawal by Subject|4|||
28120563|NCT00159588|54780536|FG002|5 Month Follow-up|Withdrawal by Subject|2|||
28120564|NCT03265938|54780547|FG000|Overall Study|Withdrawal by Subject|1|||
28120565|NCT03265938|54780547|FG000|Overall Study|Physician Decision|1|||
28120566|NCT03265938|54780547|FG000|Overall Study|friable mass|6|||
28120567|NCT04353037|54780556|FG000|Overall Study|Lost to Follow-up|0|||
28120568|NCT04353037|54780557|FG001|Overall Study|Lost to Follow-up|1|||
28120569|NCT04353037|54780558|FG002|Overall Study|Lost to Follow-up|2|||
28120570|NCT04353037|54780559|FG003|Overall Study|Lost to Follow-up|3|||
28120571|NCT04353037|54780556|FG000|Overall Study|Withdrawal by Subject|0|||
28120572|NCT04353037|54780557|FG001|Overall Study|Withdrawal by Subject|2|||
28120573|NCT04353037|54780558|FG002|Overall Study|Withdrawal by Subject|3|||
28120574|NCT04353037|54780559|FG003|Overall Study|Withdrawal by Subject|5|||
28120575|NCT04353037|54780556|FG000|Overall Study|Adverse Event|0|||
28120576|NCT04353037|54780557|FG001|Overall Study|Adverse Event|0|||
28120577|NCT04353037|54780558|FG002|Overall Study|Adverse Event|2|||
28120578|NCT04353037|54780559|FG003|Overall Study|Adverse Event|0|||
28120579|NCT04353037|54780556|FG000|Overall Study|Exposure Change|0|||
28120580|NCT04353037|54780557|FG001|Overall Study|Exposure Change|0|||
28120581|NCT04353037|54780558|FG002|Overall Study|Exposure Change|0|||
28120582|NCT04353037|54780559|FG003|Overall Study|Exposure Change|2|||
28120583|NCT04349917|54780573|FG000|First Intervention (2-4 Hours)|Withdrawal by Subject|0|||
28120584|NCT04349917|54780574|FG001|First Intervention (2-4 Hours)|Withdrawal by Subject|1|||
28120585|NCT04349917|54780573|FG000|First Intervention (2-4 Hours)|Unable to Swallow Pill|0|||
28120586|NCT04349917|54780574|FG001|First Intervention (2-4 Hours)|Unable to Swallow Pill|1|||
28120587|NCT04156399|54780581|FG000|Overall Study|hospitalization unrelated to acupuncture|1|||
28120588|NCT04156399|54780581|FG000|Overall Study|study suspension due to COVID pandemic|3|||
28120589|NCT03300570|54780587|FG000|Overall Study|Adverse Event|0|||
28120590|NCT03300570|54780588|FG001|Overall Study|Adverse Event|1|||
28120591|NCT03300570|54780587|FG000|Overall Study|Withdrawal by Subject|1|||
28120592|NCT03300570|54780588|FG001|Overall Study|Withdrawal by Subject|0|||
28120593|NCT03300570|54780587|FG000|Overall Study|Inadequate bowel prep|1|||
28120594|NCT03300570|54780588|FG001|Overall Study|Inadequate bowel prep|0|||
28120595|NCT04154605|54780597|FG000|Overall Study|Procedure Canceled|1|||
28120596|NCT04154605|54780598|FG001|Overall Study|Procedure Canceled|1|||
28120597|NCT04154605|54780597|FG000|Overall Study|Missed follow up|1|||
28120598|NCT04154605|54780598|FG001|Overall Study|Missed follow up|1|||
28120599|NCT04154605|54780597|FG000|Overall Study|Withdrawal by Subject|1|||
28120600|NCT04154605|54780598|FG001|Overall Study|Withdrawal by Subject|0|||
28120601|NCT03264456|54780604|FG000|Overall Study|Withdrawal by Subject|3|||
28120602|NCT03264456|54780604|FG000|Overall Study|Lost to Follow-up|1|||
28120603|NCT03853694|54780611|FG000|Overall Study|Protocol Violation|3|||
28120604|NCT03853694|54780612|FG001|Overall Study|Protocol Violation|5|||
28120605|NCT03853694|54780613|FG002|Overall Study|Protocol Violation|3|||
28120606|NCT03853694|54780611|FG000|Overall Study|Delivered early|0|||
28120607|NCT03853694|54780612|FG001|Overall Study|Delivered early|1|||
28120608|NCT03853694|54780613|FG002|Overall Study|Delivered early|0|||
28120609|NCT03853694|54780611|FG000|Overall Study|not suitable to proceed|0|||
28120610|NCT03853694|54780612|FG001|Overall Study|not suitable to proceed|1|||
28120611|NCT03853694|54780613|FG002|Overall Study|not suitable to proceed|0|||
28120612|NCT03853694|54780611|FG000|Overall Study|difficult surgery|0|||
28120613|NCT03853694|54780612|FG001|Overall Study|difficult surgery|0|||
28120614|NCT03853694|54780613|FG002|Overall Study|difficult surgery|1|||
28120615|NCT03853694|54780611|FG000|Overall Study|Lost to Follow-up|0|||
28120616|NCT03853694|54780612|FG001|Overall Study|Lost to Follow-up|1|||
28120617|NCT03853694|54780613|FG002|Overall Study|Lost to Follow-up|0|||
28120618|NCT03853694|54780611|FG000|Overall Study|Withdrawal by Subject|0|||
28120619|NCT03853694|54780612|FG001|Overall Study|Withdrawal by Subject|1|||
28120620|NCT03853694|54780613|FG002|Overall Study|Withdrawal by Subject|0|||
28120621|NCT04154293|54780624|FG000|Overall Study|Withdrawal by Subject|2|||
28120622|NCT04154293|54780625|FG001|Overall Study|Withdrawal by Subject|3|||
28120623|NCT04154293|54780626|FG002|Overall Study|Withdrawal by Subject|1|||
28120624|NCT04154293|54780624|FG000|Overall Study|Physician Decision|0|||
28120625|NCT04154293|54780625|FG001|Overall Study|Physician Decision|0|||
28120626|NCT04154293|54780626|FG002|Overall Study|Physician Decision|1|||
28120627|NCT04342897|54780636|FG000|Overall Study|Death|7|||
28120628|NCT04342897|54780637|FG001|Overall Study|Death|4|||
28120629|NCT04342897|54780636|FG000|Overall Study|Lost to Follow-up|6|||
28120630|NCT04342897|54780637|FG001|Overall Study|Lost to Follow-up|6|||
28120631|NCT04342897|54780636|FG000|Overall Study|Withdrawal by Subject|1|||
28120632|NCT04342897|54780637|FG001|Overall Study|Withdrawal by Subject|2|||
28120633|NCT04340557|54780645|FG000|Overall Study|Transferred to ICU and/or death|1|||
28120634|NCT04340557|54780646|FG001|Overall Study|Transferred to ICU and/or death|2|||
28120635|NCT04382053|54780654|FG000|Overall Study|Death|6|||
28120636|NCT04382053|54780655|FG001|Overall Study|Death|8|||
28120637|NCT04382053|54780654|FG000|Overall Study|Lost to Follow-up|0|||
28120638|NCT04382053|54780655|FG001|Overall Study|Lost to Follow-up|2|||
28120639|NCT04382053|54780654|FG000|Overall Study|Protocol Deviation|1|||
28120640|NCT04382053|54780655|FG001|Overall Study|Protocol Deviation|2|||
28120641|NCT04382053|54780654|FG000|Overall Study|Withdrawal by Subject|2|||
28120642|NCT04382053|54780655|FG001|Overall Study|Withdrawal by Subject|1|||
28120643|NCT03066830|54780664|FG000|Overall Study|At the Participant's own Request|16|||
28120644|NCT03066830|54780665|FG001|Overall Study|At the Participant's own Request|17|||
28120645|NCT03066830|54780664|FG000|Overall Study|Other|3|||
28120646|NCT03066830|54780665|FG001|Overall Study|Other|0|||
28120647|NCT03066830|54780664|FG000|Overall Study|Poor Compliance to Protocol|1|||
28120648|NCT03066830|54780665|FG001|Overall Study|Poor Compliance to Protocol|0|||
28120649|NCT03066830|54780664|FG000|Overall Study|Adverse Event|2|||
28120650|NCT03066830|54780665|FG001|Overall Study|Adverse Event|2|||
28120651|NCT03066830|54780664|FG000|Overall Study|Lost to Follow-up|11|||
28120652|NCT03066830|54780665|FG001|Overall Study|Lost to Follow-up|3|||
28120653|NCT04380961|54780674|FG000|Overall Study|Lost to Follow-up|17|||
28120654|NCT04380961|54780675|FG001|Overall Study|Lost to Follow-up|11|||
28120655|NCT04380961|54780674|FG000|Overall Study|Withdrawal by Subject|3|||
28120656|NCT04380961|54780675|FG001|Overall Study|Withdrawal by Subject|0|||
27817488|NCT01473381|54274925|FG001|Overall Study|Other Reasons|0|||
27817489|NCT01473381|54274926|FG002|Overall Study|Other Reasons|1|||
28120657|NCT04380961|54780674|FG000|Overall Study|Death|22|||
28120658|NCT04380961|54780675|FG001|Overall Study|Death|16|||
28120659|NCT04380961|54780674|FG000|Overall Study|Other|1|||
28120660|NCT04380961|54780675|FG001|Overall Study|Other|0|||
28120661|NCT04380961|54780674|FG000|Overall Study|Randomized but Not Treated|1|||
28120662|NCT04380961|54780675|FG001|Overall Study|Randomized but Not Treated|2|||
28120663|NCT04331899|54780685|FG000|Trial Period (28 Days)|Withdrawal by Subject|2|||
28120664|NCT04331899|54780686|FG001|Trial Period (28 Days)|Withdrawal by Subject|2|||
28120665|NCT03063632|54780694|FG000|Overall Study|Death|4|||
28120666|NCT03063632|54780695|FG001|Overall Study|Death|6|||
28120667|NCT03063632|54780694|FG000|Overall Study|Lost to Follow-up|0|||
28120668|NCT03063632|54780695|FG001|Overall Study|Lost to Follow-up|1|||
28120669|NCT03063632|54780694|FG000|Overall Study|Withdrawal by Subject|0|||
28120670|NCT03063632|54780695|FG001|Overall Study|Withdrawal by Subject|2|||
28120671|NCT03063632|54780694|FG000|Overall Study|Physician Decision|2|||
28120672|NCT03063632|54780695|FG001|Overall Study|Physician Decision|0|||
28120673|NCT03063632|54780694|FG000|Overall Study|Other: Disease progression; starting another treatment|1|||
28120674|NCT03063632|54780695|FG001|Overall Study|Other: Disease progression; starting another treatment|1|||
28120675|NCT04328467|54780706|FG000|Overall Study|Did not meet inclusion criteria after randomization|4|||
28120676|NCT04328467|54780707|FG001|Overall Study|Did not meet inclusion criteria after randomization|2|||
28120677|NCT04328467|54780708|FG002|Overall Study|Did not meet inclusion criteria after randomization|1|||
28120678|NCT04328077|54780720|FG000|Overall Study|Lost to Follow-up|0|||
28120679|NCT04328077|54780721|FG001|Overall Study|Lost to Follow-up|1|||
28120680|NCT04328077|54780722|FG002|Overall Study|Lost to Follow-up|0|||
28120681|NCT04328077|54780723|FG003|Overall Study|Lost to Follow-up|0|||
27817490|NCT01473381|54274927|FG003|Overall Study|Other Reasons|3|||
27817491|NCT01499277|54274969|FG000|Overall Study|Adverse Event|3|||
27817492|NCT01499277|54274970|FG001|Overall Study|Adverse Event|6|||
27817493|NCT01499277|54274969|FG000|Overall Study|Death|3|||
27817494|NCT01499277|54274970|FG001|Overall Study|Death|2|||
27817495|NCT01499277|54274969|FG000|Overall Study|Lost to Follow-up|15|||
28120682|NCT04328077|54780720|FG000|Overall Study|Withdrawal by Subject|0|||
28120683|NCT04328077|54780721|FG001|Overall Study|Withdrawal by Subject|1|||
28120684|NCT04328077|54780722|FG002|Overall Study|Withdrawal by Subject|1|||
28120685|NCT04328077|54780723|FG003|Overall Study|Withdrawal by Subject|3|||
28120686|NCT03691831|54780741|FG000|Overall Study|Lost to Follow-up|16|||
27817496|NCT01499277|54274970|FG001|Overall Study|Lost to Follow-up|8|||
28120687|NCT03691831|54780742|FG001|Overall Study|Lost to Follow-up|12|||
28120688|NCT03691831|54780741|FG000|Overall Study|Withdrawal by Subject|9|||
28120689|NCT03691831|54780742|FG001|Overall Study|Withdrawal by Subject|17|||
28120690|NCT03691831|54780741|FG000|Overall Study|Investigator Decision|2|||
28120691|NCT03691831|54780742|FG001|Overall Study|Investigator Decision|2|||
28120692|NCT04320745|54780759|FG000|Overall Study|Adverse Event|26|||
28120693|NCT04320745|54780759|FG000|Overall Study|Withdrawal by Subject|4|||
28120694|NCT04320745|54780759|FG000|Overall Study|Lost to Follow-up|12|||
28120695|NCT04320745|54780759|FG000|Overall Study|Protocol Deviation|2|||
28120696|NCT04320745|54780759|FG000|Overall Study|Non-compliance With Study Drug|2|||
28120697|NCT04320745|54780759|FG000|Overall Study|Reason Not Specified|1|||
28120698|NCT03063086|54780763|FG000|Overall Study|technical problems|1|||
28120699|NCT03063086|54780764|FG001|Overall Study|technical problems|0|||
28120700|NCT03063086|54780765|FG002|Overall Study|technical problems|0|||
28120701|NCT03063086|54780766|FG003|Overall Study|technical problems|0|||
27817497|NCT01499277|54274969|FG000|Overall Study|Protocol Violation|2|||
27817498|NCT01499277|54274970|FG001|Overall Study|Protocol Violation|3|||
27817499|NCT01499277|54274969|FG000|Overall Study|Withdrawal by Subject|16|||
27817500|NCT01499277|54274970|FG001|Overall Study|Withdrawal by Subject|6|||
27817501|NCT01499277|54274969|FG000|Overall Study|Lack of therapeutic response and other|8|||
28120702|NCT03063086|54780767|FG004|Overall Study|technical problems|0|||
28120703|NCT03063086|54780768|FG005|Overall Study|technical problems|0|||
28120704|NCT03063086|54780763|FG000|Overall Study|Adverse Event|1|||
28120705|NCT03063086|54780764|FG001|Overall Study|Adverse Event|1|||
28120706|NCT03063086|54780765|FG002|Overall Study|Adverse Event|1|||
27817502|NCT01499277|54274970|FG001|Overall Study|Lack of therapeutic response and other|7|||
28120707|NCT03063086|54780766|FG003|Overall Study|Adverse Event|1|||
28120708|NCT03063086|54780767|FG004|Overall Study|Adverse Event|0|||
28120709|NCT03063086|54780768|FG005|Overall Study|Adverse Event|0|||
28120710|NCT03063086|54780763|FG000|Overall Study|subject/guardian decision|1|||
28120711|NCT03063086|54780764|FG001|Overall Study|subject/guardian decision|0|||
28120712|NCT03063086|54780765|FG002|Overall Study|subject/guardian decision|0|||
28120713|NCT03063086|54780766|FG003|Overall Study|subject/guardian decision|0|||
28120714|NCT03063086|54780767|FG004|Overall Study|subject/guardian decision|0|||
28120715|NCT03063086|54780768|FG005|Overall Study|subject/guardian decision|0|||
28120716|NCT03063086|54780763|FG000|Overall Study|Non-compliance with study treatment|0|||
28120717|NCT03063086|54780764|FG001|Overall Study|Non-compliance with study treatment|0|||
28120718|NCT03063086|54780765|FG002|Overall Study|Non-compliance with study treatment|0|||
28120719|NCT03063086|54780766|FG003|Overall Study|Non-compliance with study treatment|1|||
28120720|NCT03063086|54780767|FG004|Overall Study|Non-compliance with study treatment|0|||
28120721|NCT03063086|54780768|FG005|Overall Study|Non-compliance with study treatment|1|||
28120722|NCT03063086|54780763|FG000|Overall Study|Physician Decision|0|||
28120723|NCT03063086|54780764|FG001|Overall Study|Physician Decision|0|||
28120724|NCT03063086|54780765|FG002|Overall Study|Physician Decision|0|||
28120725|NCT03063086|54780766|FG003|Overall Study|Physician Decision|1|||
28120726|NCT03063086|54780767|FG004|Overall Study|Physician Decision|0|||
28120727|NCT03063086|54780768|FG005|Overall Study|Physician Decision|0|||
28120728|NCT04128007|54780779|FG000|Overall Study|Withdrawal by Subject|9|||
28120729|NCT04128007|54780780|FG001|Overall Study|Withdrawal by Subject|6|||
28120730|NCT04128007|54780779|FG000|Overall Study|Protocol Violation|1|||
28120731|NCT04128007|54780780|FG001|Overall Study|Protocol Violation|0|||
28120732|NCT04128007|54780779|FG000|Overall Study|Lost to Follow-up|8|||
27817503|NCT01499199|54274995|FG000|Overall Study|Adverse Event|1|||
28120733|NCT04128007|54780780|FG001|Overall Study|Lost to Follow-up|7|||
28120734|NCT04128007|54780779|FG000|Overall Study|Adverse Event|5|||
28120735|NCT04128007|54780780|FG001|Overall Study|Adverse Event|2|||
28120736|NCT04128007|54780779|FG000|Overall Study|Not reported|0|||
28120737|NCT04128007|54780780|FG001|Overall Study|Not reported|2|||
28120738|NCT04318093|54780788|FG000|Overall Study|Adverse Event|2|||
28120739|NCT04318093|54780789|FG001|Overall Study|Adverse Event|2|||
28120740|NCT04318093|54780788|FG000|Overall Study|Participant withdrew consent|1|||
28120741|NCT04318093|54780789|FG001|Overall Study|Participant withdrew consent|0|||
28120742|NCT04318093|54780788|FG000|Overall Study|Other reasons|0|||
28120743|NCT04318093|54780789|FG001|Overall Study|Other reasons|1|||
28120744|NCT04123405|54780800|FG000|Overall Study|Adverse Event|1|||
28120745|NCT04123405|54780801|FG001|Overall Study|Adverse Event|2|||
28120746|NCT04123405|54780802|FG002|Overall Study|Adverse Event|3|||
28120747|NCT04123405|54780803|FG003|Overall Study|Adverse Event|3|||
28120748|NCT04123405|54780800|FG000|Overall Study|Exclusion criteria met|1|||
28120749|NCT04123405|54780801|FG001|Overall Study|Exclusion criteria met|2|||
28120750|NCT04123405|54780802|FG002|Overall Study|Exclusion criteria met|0|||
27940380|NCT01185288|54596658|FG000|Overall Study|Lack of Efficacy|2|||
27940381|NCT01185288|54596659|FG001|Overall Study|Lack of Efficacy|0|||
27940382|NCT01185288|54596658|FG000|Overall Study|Investigator discretion|1|||
27940383|NCT01185288|54596659|FG001|Overall Study|Investigator discretion|0|||
27940384|NCT01185288|54596658|FG000|Overall Study|Did not meet inclusion criteria|1|||
27940385|NCT01185288|54596659|FG001|Overall Study|Did not meet inclusion criteria|0|||
27940386|NCT01185288|54596658|FG000|Overall Study|Noncompliance|0|||
27940387|NCT01185288|54596659|FG001|Overall Study|Noncompliance|1|||
27940388|NCT01184508|54596667|FG000|Overall Study|Adverse Event|4|||
27940389|NCT01184508|54596668|FG001|Overall Study|Adverse Event|6|||
27940390|NCT01184508|54596667|FG000|Overall Study|Lack of Efficacy|1|||
27940391|NCT01184508|54596668|FG001|Overall Study|Lack of Efficacy|1|||
27940392|NCT01184508|54596667|FG000|Overall Study|Lost to Follow-up|1|||
27940393|NCT01184508|54596668|FG001|Overall Study|Lost to Follow-up|1|||
27940394|NCT01184508|54596667|FG000|Overall Study|Physician Decision|1|||
27940395|NCT01184508|54596668|FG001|Overall Study|Physician Decision|0|||
27940396|NCT01184508|54596667|FG000|Overall Study|Protocol Violation|3|||
27940397|NCT01184508|54596668|FG001|Overall Study|Protocol Violation|1|||
27940398|NCT01184508|54596667|FG000|Overall Study|Sponsor Decision|5|||
27940399|NCT01184508|54596668|FG001|Overall Study|Sponsor Decision|2|||
27940400|NCT01184508|54596667|FG000|Overall Study|Withdrawal by Subject|1|||
27940401|NCT01184508|54596668|FG001|Overall Study|Withdrawal by Subject|3|||
27940402|NCT01184508|54596667|FG000|Overall Study|Randomized, Not Treated|0|||
27940403|NCT01184508|54596668|FG001|Overall Study|Randomized, Not Treated|1|||
27940404|NCT01184118|54596675|FG000|Overall Study|Only asthma step 1 - screen fail|1|||
27940405|NCT01184118|54596675|FG000|Overall Study|No physiologic confirmation of asthma|8|||
27940406|NCT01184118|54596675|FG000|Overall Study|FEV1 <60% predicted|2|||
27940407|NCT01184118|54596675|FG000|Overall Study|Exclusionary medical condition|2|||
27940408|NCT01184118|54596675|FG000|Overall Study|Withdrawal by Subject|5|||
27940409|NCT01183884|54596679|FG000|Overall Study|Progressive Disease|26|||
27940410|NCT01183884|54596679|FG000|Overall Study|Adverse Event|3|||
27940411|NCT01183884|54596679|FG000|Overall Study|Withdrawal by Subject|1|||
27940412|NCT01183884|54596679|FG000|Overall Study|Other Complicating Disease|3|||
27940413|NCT01183884|54596679|FG000|Overall Study|Not Treated|1|||
27940414|NCT01183884|54596679|FG000|Overall Study|Other|4|||
27940415|NCT01183260|54596685|FG000|Overall Study|Intraop screen failure|2|||
27940416|NCT01183260|54596686|FG001|Overall Study|Intraop screen failure|0|||
27940417|NCT01183260|54596685|FG000|Overall Study|Withdrawal by Subject|1|||
28120751|NCT04123405|54780803|FG003|Overall Study|Exclusion criteria met|2|||
28120752|NCT04123405|54780800|FG000|Overall Study|Withdrawal by Subject|1|||
28120753|NCT04123405|54780801|FG001|Overall Study|Withdrawal by Subject|3|||
28120754|NCT04123405|54780802|FG002|Overall Study|Withdrawal by Subject|0|||
28120755|NCT04123405|54780803|FG003|Overall Study|Withdrawal by Subject|2|||
28120756|NCT04123405|54780800|FG000|Overall Study|Contact to subject lost|0|||
28120757|NCT04123405|54780801|FG001|Overall Study|Contact to subject lost|0|||
28120758|NCT04123405|54780802|FG002|Overall Study|Contact to subject lost|0|||
28120759|NCT04123405|54780803|FG003|Overall Study|Contact to subject lost|1|||
28120760|NCT04123405|54780800|FG000|Overall Study|screening failure|1|||
28120761|NCT04123405|54780801|FG001|Overall Study|screening failure|0|||
28120762|NCT04123405|54780802|FG002|Overall Study|screening failure|0|||
28120763|NCT04123405|54780803|FG003|Overall Study|screening failure|0|||
28120764|NCT04314037|54780832|FG000|Treatment Period 2|Adverse Event|1|||
28120765|NCT04314037|54780833|FG001|Treatment Period 2|Adverse Event|0|||
28120766|NCT04314037|54780832|FG000|Treatment Period 3|Protocol Violation|1|||
28120767|NCT04314037|54780833|FG001|Treatment Period 3|Protocol Violation|0|||
28120768|NCT04314037|54780832|FG000|Treatment Period 3|Adverse Event|0|||
28120769|NCT04314037|54780833|FG001|Treatment Period 3|Adverse Event|1|||
28120770|NCT03056300|54780849|FG000|Overall Study|Surgical reason per study protocol|3|||
28120771|NCT03061214|54780856|FG000|Overall Study|Withdrawal by Subject|21|||
28120772|NCT03061214|54780857|FG001|Overall Study|Withdrawal by Subject|26|||
28120773|NCT03061214|54780858|FG002|Overall Study|Withdrawal by Subject|9|||
28120774|NCT03061214|54780856|FG000|Overall Study|Lost to Follow-up|3|||
28120775|NCT03061214|54780857|FG001|Overall Study|Lost to Follow-up|1|||
28120776|NCT03061214|54780858|FG002|Overall Study|Lost to Follow-up|1|||
28120777|NCT03061214|54780856|FG000|Overall Study|Death|1|||
28120778|NCT03061214|54780857|FG001|Overall Study|Death|1|||
28120779|NCT03061214|54780858|FG002|Overall Study|Death|0|||
27940418|NCT01183260|54596686|FG001|Overall Study|Withdrawal by Subject|1|||
27940419|NCT01183260|54596685|FG000|Overall Study|Revised within 30 days|0|||
27940420|NCT01183260|54596686|FG001|Overall Study|Revised within 30 days|1|||
27940421|NCT01183260|54596685|FG000|Overall Study|Death|1|||
27940422|NCT01183260|54596686|FG001|Overall Study|Death|0|||
27940423|NCT01191762|54596694|FG000|Overall Study|Adverse Event|1|||
28066395|NCT00117676|54721968|FG000|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2|||
28066396|NCT00117676|54721969|FG001|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0|||
28066397|NCT00117676|54721968|FG000|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3|||
28066398|NCT00117676|54721969|FG001|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1|||
28066399|NCT00117676|54721968|FG000|Open-label Period: Weeks 145 - 192|Withdrew Consent|5|||
28066400|NCT00117676|54721969|FG001|Open-label Period: Weeks 145 - 192|Withdrew Consent|2|||
28066401|NCT00117676|54721968|FG000|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
28066402|NCT00117676|54721969|FG001|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
28066403|NCT00117676|54721968|FG000|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0|||
28066404|NCT00117676|54721969|FG001|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1|||
28066405|NCT00117676|54721968|FG000|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
28066406|NCT00117676|54721969|FG001|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0|||
28066407|NCT00117676|54721968|FG000|Open-label Period: Weeks 193 - 240|Withdrew Consent|4|||
28066408|NCT00117676|54721969|FG001|Open-label Period: Weeks 193 - 240|Withdrew Consent|1|||
28066409|NCT00117676|54721968|FG000|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0|||
28066410|NCT00117676|54721969|FG001|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1|||
28066411|NCT00117676|54721968|FG000|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2|||
28066412|NCT00117676|54721969|FG001|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1|||
28066413|NCT00117676|54721968|FG000|Open-label Period: Weeks 241 - 288|Protocol Violation|2|||
28066414|NCT00117676|54721969|FG001|Open-label Period: Weeks 241 - 288|Protocol Violation|0|||
28066415|NCT00117676|54721968|FG000|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1|||
28066416|NCT00117676|54721969|FG001|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
28066417|NCT00117676|54721968|FG000|Open-label Period: Weeks 241 - 288|Withdrew Consent|5|||
28066418|NCT00117676|54721969|FG001|Open-label Period: Weeks 241 - 288|Withdrew Consent|1|||
28066419|NCT00117676|54721968|FG000|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7|||
28066420|NCT00117676|54721969|FG001|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4|||
28066421|NCT00117676|54721968|FG000|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
28066422|NCT00117676|54721969|FG001|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
28066423|NCT00117676|54721968|FG000|Open-label Period: Weeks 289 - 336|Withdrew Consent|0|||
28066424|NCT00117676|54721969|FG001|Open-label Period: Weeks 289 - 336|Withdrew Consent|1|||
28066425|NCT00117676|54721968|FG000|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
28066426|NCT00117676|54721969|FG001|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
28066427|NCT00117676|54721968|FG000|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3|||
28066428|NCT00117676|54721969|FG001|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1|||
28066429|NCT00117676|54721968|FG000|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1|||
28066430|NCT00117676|54721969|FG001|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0|||
28066431|NCT00117676|54721968|FG000|Open-label Period: Weeks 337 - 384|Withdrew Consent|2|||
28120780|NCT04115839|54780869|FG000|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
28120781|NCT04115839|54780870|FG001|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|13|||
28120782|NCT04115839|54780871|FG002|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
28120783|NCT04115839|54780872|FG003|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
28120784|NCT04115839|54780873|FG004|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
28120785|NCT04115839|54780874|FG005|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
28120786|NCT04115839|54780875|FG006|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
28120787|NCT04115839|54780869|FG000|Main Study (Up to 16 Weeks)|Withdrew Consent|2|||
28120788|NCT04115839|54780870|FG001|Main Study (Up to 16 Weeks)|Withdrew Consent|1|||
28120789|NCT04115839|54780871|FG002|Main Study (Up to 16 Weeks)|Withdrew Consent|3|||
27940424|NCT01191762|54596695|FG001|Overall Study|Adverse Event|0|||
27940425|NCT01723774|54596704|FG000|Neoadjuvant|Ki67 > 10%|4|||
27940426|NCT01723774|54596705|FG001|Neoadjuvant|Ki67 > 10%|0|||
27940427|NCT01723774|54596706|FG002|Neoadjuvant|Ki67 > 10%|10|||
27940428|NCT01723774|54596707|FG003|Neoadjuvant|Ki67 > 10%|0|||
27940429|NCT01723774|54596704|FG000|Neoadjuvant|Withdrawal by Subject|3|||
27940430|NCT01723774|54596705|FG001|Neoadjuvant|Withdrawal by Subject|1|||
27940431|NCT01723774|54596706|FG002|Neoadjuvant|Withdrawal by Subject|0|||
27940432|NCT01723774|54596707|FG003|Neoadjuvant|Withdrawal by Subject|0|||
27940433|NCT01723774|54596704|FG000|Neoadjuvant|Disease progression|0|||
27940434|NCT01723774|54596705|FG001|Neoadjuvant|Disease progression|1|||
27940435|NCT01723774|54596706|FG002|Neoadjuvant|Disease progression|1|||
27940436|NCT01723774|54596707|FG003|Neoadjuvant|Disease progression|0|||
27940437|NCT01723774|54596704|FG000|Neoadjuvant|Adverse Event|0|||
27940438|NCT01723774|54596705|FG001|Neoadjuvant|Adverse Event|1|||
27940439|NCT01723774|54596706|FG002|Neoadjuvant|Adverse Event|2|||
27940440|NCT01723774|54596707|FG003|Neoadjuvant|Adverse Event|0|||
28120790|NCT04115839|54780872|FG003|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
28120791|NCT04115839|54780873|FG004|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
28120792|NCT04115839|54780874|FG005|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
28120793|NCT04115839|54780875|FG006|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
28120794|NCT04115839|54780869|FG000|Main Study (Up to 16 Weeks)|Adverse Event|2|||
28120795|NCT04115839|54780870|FG001|Main Study (Up to 16 Weeks)|Adverse Event|0|||
28120796|NCT04115839|54780871|FG002|Main Study (Up to 16 Weeks)|Adverse Event|0|||
28120797|NCT04115839|54780872|FG003|Main Study (Up to 16 Weeks)|Adverse Event|0|||
28120798|NCT04115839|54780873|FG004|Main Study (Up to 16 Weeks)|Adverse Event|0|||
28120799|NCT04115839|54780874|FG005|Main Study (Up to 16 Weeks)|Adverse Event|0|||
28120800|NCT04115839|54780875|FG006|Main Study (Up to 16 Weeks)|Adverse Event|0|||
28120801|NCT04115839|54780869|FG000|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
28120802|NCT04115839|54780870|FG001|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
28120803|NCT04115839|54780871|FG002|Main Study (Up to 16 Weeks)|Investigator's Discretion|1|||
28120804|NCT04115839|54780872|FG003|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
28120805|NCT04115839|54780873|FG004|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
28120806|NCT04115839|54780874|FG005|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
28120807|NCT04115839|54780875|FG006|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
28120808|NCT04115839|54780869|FG000|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
28120809|NCT04115839|54780870|FG001|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
28120810|NCT04115839|54780871|FG002|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
28120811|NCT04115839|54780872|FG003|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|17|||
28120812|NCT04115839|54780873|FG004|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|19|||
28120813|NCT04115839|54780874|FG005|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|10|||
28120814|NCT04115839|54780875|FG006|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|8|||
28120815|NCT04115839|54780869|FG000|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
28120816|NCT04115839|54780870|FG001|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
28120817|NCT04115839|54780871|FG002|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
27817504|NCT01499199|54274995|FG000|Overall Study|Lack of Efficacy|1|||
27940441|NCT01723774|54596704|FG000|Neoadjuvant|High estradiol|0|||
27940442|NCT01723774|54596705|FG001|Neoadjuvant|High estradiol|1|||
27940443|NCT01723774|54596706|FG002|Neoadjuvant|High estradiol|0|||
27940444|NCT01723774|54596707|FG003|Neoadjuvant|High estradiol|0|||
28120818|NCT04115839|54780872|FG003|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
28120819|NCT04115839|54780873|FG004|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
28120820|NCT04115839|54780874|FG005|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
28120821|NCT04115839|54780875|FG006|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
28120822|NCT01561430|54780904|FG000|Overall Study|Adverse Event|0|||
28120823|NCT01561430|54780905|FG001|Overall Study|Adverse Event|0|||
28120824|NCT01561430|54780906|FG002|Overall Study|Adverse Event|3|||
28120825|NCT01561430|54780907|FG003|Overall Study|Adverse Event|1|||
28120826|NCT01561430|54780904|FG000|Overall Study|Withdrawal by Subject|0|||
28120827|NCT01561430|54780905|FG001|Overall Study|Withdrawal by Subject|0|||
28120828|NCT01561430|54780906|FG002|Overall Study|Withdrawal by Subject|1|||
28120829|NCT01561430|54780907|FG003|Overall Study|Withdrawal by Subject|0|||
28120830|NCT01561430|54780904|FG000|Overall Study|Physician Decision|0|||
28120831|NCT01561430|54780905|FG001|Overall Study|Physician Decision|1|||
28120832|NCT01561430|54780906|FG002|Overall Study|Physician Decision|0|||
28120833|NCT01561430|54780907|FG003|Overall Study|Physician Decision|0|||
28120834|NCT01561430|54780904|FG000|Overall Study|Sponsor Decision|1|||
28120835|NCT01561430|54780905|FG001|Overall Study|Sponsor Decision|14|||
28120836|NCT01561430|54780906|FG002|Overall Study|Sponsor Decision|13|||
28120837|NCT01561430|54780907|FG003|Overall Study|Sponsor Decision|12|||
28120838|NCT03000530|54780943|FG000|Overall Study|Adverse Event|0|||
28120839|NCT03000530|54780944|FG001|Overall Study|Adverse Event|0|||
28120840|NCT03000530|54780945|FG002|Overall Study|Adverse Event|2|||
28120841|NCT03000530|54780943|FG000|Overall Study|Lost to Follow-up|0|||
28120842|NCT03000530|54780944|FG001|Overall Study|Lost to Follow-up|3|||
28120843|NCT03000530|54780945|FG002|Overall Study|Lost to Follow-up|1|||
28120844|NCT03000530|54780943|FG000|Overall Study|Withdrawal by Subject|0|||
28120845|NCT03000530|54780944|FG001|Overall Study|Withdrawal by Subject|2|||
28120846|NCT03000530|54780945|FG002|Overall Study|Withdrawal by Subject|1|||
28120847|NCT03060512|54780958|FG000|Overall Study|Adverse Event|4|||
27849270|NCT02085161|54344601|FG000|Overall Study|Protocol Violation|0|||
28120848|NCT03060512|54780959|FG001|Overall Study|Adverse Event|6|||
28120849|NCT03060512|54780958|FG000|Overall Study|Lost to Follow-up|1|||
28120850|NCT03060512|54780959|FG001|Overall Study|Lost to Follow-up|1|||
28120851|NCT03060512|54780958|FG000|Overall Study|Withdrawal by Subject|1|||
28120852|NCT03060512|54780959|FG001|Overall Study|Withdrawal by Subject|0|||
28120853|NCT03060512|54780958|FG000|Overall Study|Non-compliance with study medication|1|||
28120854|NCT03060512|54780959|FG001|Overall Study|Non-compliance with study medication|2|||
28120855|NCT02539160|54781047|FG000|Phase 1 Pre-crossover|Adverse Event|3|||
28120856|NCT02539160|54781048|FG001|Phase 1 Pre-crossover|Adverse Event|3|||
28120857|NCT02539160|54781049|FG002|Phase 1 Pre-crossover|Adverse Event|2|||
28120858|NCT02539160|54781050|FG003|Phase 1 Pre-crossover|Adverse Event|1|||
28120859|NCT02539160|54781047|FG000|Phase 1 Pre-crossover|Withdrawal by Subject|2|||
28120860|NCT02539160|54781048|FG001|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
28120861|NCT02539160|54781049|FG002|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
28120862|NCT02539160|54781050|FG003|Phase 1 Pre-crossover|Withdrawal by Subject|0|||
28120863|NCT02539160|54781047|FG000|Phase 1 Pre-crossover|Protocol Violation|0|||
28120864|NCT02539160|54781048|FG001|Phase 1 Pre-crossover|Protocol Violation|0|||
28120865|NCT02539160|54781049|FG002|Phase 1 Pre-crossover|Protocol Violation|0|||
28120866|NCT02539160|54781050|FG003|Phase 1 Pre-crossover|Protocol Violation|2|||
28120867|NCT04292899|54781064|FG000|Overall Study|Death|21|||
28120868|NCT04292899|54781065|FG001|Overall Study|Death|28|||
28120869|NCT04292899|54781066|FG002|Overall Study|Death|188|||
28120870|NCT04292899|54781067|FG003|Overall Study|Death|371|||
28120871|NCT04292899|54781064|FG000|Overall Study|Lost to Follow-up|8|||
28120872|NCT04292899|54781065|FG001|Overall Study|Lost to Follow-up|4|||
28120873|NCT04292899|54781066|FG002|Overall Study|Lost to Follow-up|22|||
28120874|NCT04292899|54781067|FG003|Overall Study|Lost to Follow-up|235|||
28120875|NCT04292899|54781064|FG000|Overall Study|Withdrew consent|1|||
28120876|NCT04292899|54781065|FG001|Overall Study|Withdrew consent|0|||
28120877|NCT04292899|54781066|FG002|Overall Study|Withdrew consent|11|||
28120878|NCT04292899|54781067|FG003|Overall Study|Withdrew consent|32|||
28120879|NCT04292899|54781064|FG000|Overall Study|Adverse Event|2|||
28120880|NCT04292899|54781065|FG001|Overall Study|Adverse Event|1|||
28120881|NCT04292899|54781066|FG002|Overall Study|Adverse Event|2|||
28120882|NCT04292899|54781067|FG003|Overall Study|Adverse Event|2|||
28120883|NCT04292899|54781064|FG000|Overall Study|Investigator's Discretion|0|||
28120884|NCT04292899|54781065|FG001|Overall Study|Investigator's Discretion|0|||
28120885|NCT04292899|54781066|FG002|Overall Study|Investigator's Discretion|0|||
28120886|NCT04292899|54781067|FG003|Overall Study|Investigator's Discretion|3|||
28120887|NCT04292899|54781064|FG000|Overall Study|Non-compliance With Study Drug|0|||
28120888|NCT04292899|54781065|FG001|Overall Study|Non-compliance With Study Drug|0|||
28120889|NCT04292899|54781066|FG002|Overall Study|Non-compliance With Study Drug|0|||
28120890|NCT04292899|54781067|FG003|Overall Study|Non-compliance With Study Drug|1|||
28120891|NCT04292899|54781064|FG000|Overall Study|Protocol Violation|0|||
28120892|NCT04292899|54781065|FG001|Overall Study|Protocol Violation|0|||
28120893|NCT04292899|54781066|FG002|Overall Study|Protocol Violation|0|||
28120894|NCT04292899|54781067|FG003|Overall Study|Protocol Violation|1|||
28120895|NCT03241173|54781086|FG000|Overall Study|Death|3|||
28120896|NCT03241173|54781087|FG001|Overall Study|Death|2|||
28120897|NCT03241173|54781088|FG002|Overall Study|Death|4|||
28120898|NCT03241173|54781089|FG003|Overall Study|Death|4|||
28120899|NCT03241173|54781090|FG004|Overall Study|Death|2|||
28120900|NCT03241173|54781091|FG005|Overall Study|Death|2|||
28120901|NCT03241173|54781092|FG006|Overall Study|Death|3|||
28120902|NCT03241173|54781093|FG007|Overall Study|Death|1|||
28120903|NCT03241173|54781094|FG008|Overall Study|Death|0|||
28120904|NCT03241173|54781095|FG009|Overall Study|Death|5|||
28120905|NCT03241173|54781096|FG010|Overall Study|Death|4|||
28120906|NCT03241173|54781097|FG011|Overall Study|Death|3|||
28120907|NCT03241173|54781098|FG012|Overall Study|Death|0|||
28120908|NCT03241173|54781099|FG013|Overall Study|Death|0|||
28120909|NCT03241173|54781100|FG014|Overall Study|Death|0|||
28120910|NCT03241173|54781086|FG000|Overall Study|Withdrawal by Subject|0|||
28120911|NCT03241173|54781087|FG001|Overall Study|Withdrawal by Subject|0|||
28120912|NCT03241173|54781088|FG002|Overall Study|Withdrawal by Subject|1|||
28120913|NCT03241173|54781089|FG003|Overall Study|Withdrawal by Subject|0|||
28120914|NCT03241173|54781090|FG004|Overall Study|Withdrawal by Subject|0|||
28120915|NCT03241173|54781091|FG005|Overall Study|Withdrawal by Subject|1|||
28120916|NCT03241173|54781092|FG006|Overall Study|Withdrawal by Subject|0|||
28120917|NCT03241173|54781093|FG007|Overall Study|Withdrawal by Subject|0|||
28120918|NCT03241173|54781094|FG008|Overall Study|Withdrawal by Subject|0|||
28120919|NCT03241173|54781095|FG009|Overall Study|Withdrawal by Subject|0|||
28120920|NCT03241173|54781096|FG010|Overall Study|Withdrawal by Subject|0|||
28120921|NCT03241173|54781097|FG011|Overall Study|Withdrawal by Subject|0|||
28120922|NCT03241173|54781098|FG012|Overall Study|Withdrawal by Subject|0|||
28120923|NCT03241173|54781099|FG013|Overall Study|Withdrawal by Subject|0|||
28120924|NCT03241173|54781100|FG014|Overall Study|Withdrawal by Subject|0|||
28120925|NCT03241173|54781086|FG000|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
28120926|NCT03241173|54781087|FG001|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
28120927|NCT03241173|54781088|FG002|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
28120928|NCT03241173|54781089|FG003|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
28120929|NCT03241173|54781090|FG004|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
28120930|NCT03241173|54781091|FG005|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
28120931|NCT03241173|54781092|FG006|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
28120932|NCT03241173|54781093|FG007|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
28120933|NCT03241173|54781094|FG008|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
28120934|NCT03241173|54781095|FG009|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
28120935|NCT03241173|54781096|FG010|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
28120936|NCT03241173|54781097|FG011|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|3|||
27817505|NCT01499043|54274999|FG000|Overall Study|Progressive disease (radiographic)|2|||
27817506|NCT01499043|54274999|FG000|Overall Study|Progressive disease (clinical)|1|||
28120937|NCT03241173|54781098|FG012|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
28120938|NCT03241173|54781099|FG013|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
28120939|NCT03241173|54781100|FG014|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
28120940|NCT03241173|54781086|FG000|Overall Study|Lost to Follow-up|0|||
28120941|NCT03241173|54781087|FG001|Overall Study|Lost to Follow-up|0|||
28120942|NCT03241173|54781088|FG002|Overall Study|Lost to Follow-up|0|||
28120943|NCT03241173|54781089|FG003|Overall Study|Lost to Follow-up|0|||
28066432|NCT00117676|54721969|FG001|Open-label Period: Weeks 337 - 384|Withdrew Consent|1|||
28066433|NCT00117676|54721968|FG000|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0|||
28066434|NCT00117676|54721969|FG001|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1|||
28066435|NCT00117676|54721968|FG000|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0|||
28066436|NCT00117676|54721969|FG001|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1|||
28066437|NCT00117676|54721968|FG000|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1|||
28066438|NCT00117676|54721969|FG001|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0|||
28066439|NCT00117676|54721968|FG000|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
28120944|NCT03241173|54781090|FG004|Overall Study|Lost to Follow-up|1|||
28120945|NCT03241173|54781091|FG005|Overall Study|Lost to Follow-up|0|||
27817507|NCT01499043|54274999|FG000|Overall Study|Withdrawal by Subject|2|||
28120946|NCT03241173|54781092|FG006|Overall Study|Lost to Follow-up|0|||
28120947|NCT03241173|54781093|FG007|Overall Study|Lost to Follow-up|0|||
28120948|NCT03241173|54781094|FG008|Overall Study|Lost to Follow-up|0|||
28120949|NCT03241173|54781095|FG009|Overall Study|Lost to Follow-up|1|||
28120950|NCT03241173|54781096|FG010|Overall Study|Lost to Follow-up|0|||
28120951|NCT03241173|54781097|FG011|Overall Study|Lost to Follow-up|0|||
27817508|NCT01499043|54274999|FG000|Overall Study|Adverse Event|1|||
27817509|NCT01498887|54275073|FG000|Overall Study|Administrative problems|1|||
27817510|NCT01498887|54275074|FG001|Overall Study|Administrative problems|0|||
27817511|NCT01498887|54275073|FG000|Overall Study|Lost to Follow-up|1|||
27817512|NCT01498887|54275074|FG001|Overall Study|Lost to Follow-up|1|||
27817513|NCT01498887|54275073|FG000|Overall Study|Withdrawal by Subject|1|||
27817514|NCT01498887|54275074|FG001|Overall Study|Withdrawal by Subject|0|||
27817515|NCT01498887|54275073|FG000|Overall Study|Protocol Violation|1|||
27817516|NCT01498887|54275074|FG001|Overall Study|Protocol Violation|3|||
27817517|NCT01498887|54275073|FG000|Overall Study|Lack of Efficacy|5|||
27817518|NCT01498887|54275074|FG001|Overall Study|Lack of Efficacy|3|||
27817519|NCT01498887|54275073|FG000|Overall Study|Abnormal result from test procedure|1|||
27817520|NCT01498887|54275074|FG001|Overall Study|Abnormal result from test procedure|1|||
27817521|NCT01498887|54275073|FG000|Overall Study|Abnormal laboratory value|2|||
27817522|NCT01498887|54275074|FG001|Overall Study|Abnormal laboratory value|2|||
27817523|NCT01498887|54275073|FG000|Overall Study|Adverse Event|4|||
27817524|NCT01498887|54275074|FG001|Overall Study|Adverse Event|1|||
27817525|NCT01498653|54275083|FG000|Overall Study|Adverse Event|2|||
27817526|NCT01498653|54275084|FG001|Overall Study|Adverse Event|2|||
27817527|NCT01498653|54275083|FG000|Overall Study|Lack of Efficacy|12|||
28066440|NCT00117676|54721969|FG001|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
28066441|NCT00117676|54721968|FG000|Open-label Period: Weeks 433 - 480|Withdrew Consent|0|||
28066442|NCT00117676|54721969|FG001|Open-label Period: Weeks 433 - 480|Withdrew Consent|1|||
28066443|NCT00251004|54721983|FG000|Overall Study|Withdrawal by Subject|23|||
28066444|NCT00251004|54721984|FG001|Overall Study|Withdrawal by Subject|16|||
28066445|NCT00251004|54721985|FG002|Overall Study|Withdrawal by Subject|14|||
28066446|NCT00251004|54721983|FG000|Overall Study|Death|9|||
28066447|NCT00251004|54721984|FG001|Overall Study|Death|10|||
28066448|NCT00251004|54721985|FG002|Overall Study|Death|8|||
28066449|NCT00251004|54721983|FG000|Overall Study|Lost to Follow-up|1|||
28066450|NCT00251004|54721984|FG001|Overall Study|Lost to Follow-up|2|||
28066451|NCT00251004|54721985|FG002|Overall Study|Lost to Follow-up|1|||
28066452|NCT00251004|54721983|FG000|Overall Study|Graft Loss|12|||
28066453|NCT00251004|54721984|FG001|Overall Study|Graft Loss|13|||
28066454|NCT00251004|54721985|FG002|Overall Study|Graft Loss|8|||
28066455|NCT00275340|54721995|FG000|Overall Study|Lost to Follow-up|2|||
28066456|NCT00275340|54721996|FG001|Overall Study|Lost to Follow-up|4|||
28066457|NCT00275262|54722002|FG000|Overall Study|Adverse Event|2|||
28066458|NCT00275262|54722003|FG001|Overall Study|Adverse Event|0|||
28066459|NCT00275262|54722002|FG000|Overall Study|Disease progression|2|||
28066460|NCT00275262|54722003|FG001|Overall Study|Disease progression|5|||
28066461|NCT00275262|54722002|FG000|Overall Study|Lost to Follow-up|0|||
28066462|NCT00275262|54722003|FG001|Overall Study|Lost to Follow-up|2|||
28066463|NCT00275262|54722002|FG000|Overall Study|Protocol Violation|0|||
28066464|NCT00275262|54722003|FG001|Overall Study|Protocol Violation|2|||
28120952|NCT03241173|54781098|FG012|Overall Study|Lost to Follow-up|0|||
27817528|NCT01498653|54275084|FG001|Overall Study|Lack of Efficacy|26|||
27817529|NCT01498653|54275083|FG000|Overall Study|Protocol Violation|0|||
28120953|NCT03241173|54781099|FG013|Overall Study|Lost to Follow-up|0|||
27849271|NCT02085161|54344602|FG001|Overall Study|Protocol Violation|1|||
28066465|NCT00275262|54722002|FG000|Overall Study|Death|1|||
28066466|NCT00275262|54722003|FG001|Overall Study|Death|0|||
28066467|NCT00275262|54722002|FG000|Overall Study|Started Chemotherapy|1|||
28066468|NCT00275262|54722003|FG001|Overall Study|Started Chemotherapy|0|||
27817530|NCT01498653|54275084|FG001|Overall Study|Protocol Violation|4|||
28066469|NCT00275028|54722009|FG000|Overall Study|Withdrew consent before treatment began|1|||
27817531|NCT01498653|54275083|FG000|Overall Study|Lost to Follow-up|1|||
27817532|NCT01498653|54275084|FG001|Overall Study|Lost to Follow-up|0|||
28066470|NCT00275028|54722009|FG000|Overall Study|Withdrawal by Subject|5|||
28120954|NCT03241173|54781100|FG014|Overall Study|Lost to Follow-up|0|||
28120955|NCT03264066|54781134|FG000|Overall Study|Adverse Event|1|||
28120956|NCT03264066|54781135|FG001|Overall Study|Adverse Event|1|||
28120957|NCT03264066|54781136|FG002|Overall Study|Adverse Event|0|||
28120958|NCT03264066|54781137|FG003|Overall Study|Adverse Event|0|||
28120959|NCT03264066|54781138|FG004|Overall Study|Adverse Event|0|||
28120960|NCT03264066|54781139|FG005|Overall Study|Adverse Event|0|||
28120961|NCT03264066|54781134|FG000|Overall Study|Death|12|||
28120962|NCT03264066|54781135|FG001|Overall Study|Death|12|||
28120963|NCT03264066|54781136|FG002|Overall Study|Death|8|||
28120964|NCT03264066|54781137|FG003|Overall Study|Death|10|||
28120965|NCT03264066|54781138|FG004|Overall Study|Death|6|||
28120966|NCT03264066|54781139|FG005|Overall Study|Death|1|||
28120967|NCT03264066|54781134|FG000|Overall Study|Lost to Follow-up|1|||
28120968|NCT03264066|54781135|FG001|Overall Study|Lost to Follow-up|0|||
28120969|NCT03264066|54781136|FG002|Overall Study|Lost to Follow-up|0|||
28120970|NCT03264066|54781137|FG003|Overall Study|Lost to Follow-up|0|||
28120971|NCT03264066|54781138|FG004|Overall Study|Lost to Follow-up|0|||
28120972|NCT03264066|54781139|FG005|Overall Study|Lost to Follow-up|0|||
28120973|NCT03264066|54781134|FG000|Overall Study|Progressive Disease|0|||
28120974|NCT03264066|54781135|FG001|Overall Study|Progressive Disease|2|||
28120975|NCT03264066|54781136|FG002|Overall Study|Progressive Disease|1|||
28120976|NCT03264066|54781137|FG003|Overall Study|Progressive Disease|0|||
28120977|NCT03264066|54781138|FG004|Overall Study|Progressive Disease|0|||
28120978|NCT03264066|54781139|FG005|Overall Study|Progressive Disease|0|||
28120979|NCT03264066|54781134|FG000|Overall Study|Study Terminated by Sponsor|5|||
28120980|NCT03264066|54781135|FG001|Overall Study|Study Terminated by Sponsor|5|||
28120981|NCT03264066|54781136|FG002|Overall Study|Study Terminated by Sponsor|8|||
28120982|NCT03264066|54781137|FG003|Overall Study|Study Terminated by Sponsor|5|||
28120983|NCT03264066|54781138|FG004|Overall Study|Study Terminated by Sponsor|1|||
28120984|NCT03264066|54781139|FG005|Overall Study|Study Terminated by Sponsor|2|||
28120985|NCT03264066|54781134|FG000|Overall Study|Withdrawal by Subject|1|||
28120986|NCT03264066|54781135|FG001|Overall Study|Withdrawal by Subject|0|||
28120987|NCT03264066|54781136|FG002|Overall Study|Withdrawal by Subject|0|||
28120988|NCT03264066|54781137|FG003|Overall Study|Withdrawal by Subject|5|||
28120989|NCT03264066|54781138|FG004|Overall Study|Withdrawal by Subject|0|||
28120990|NCT03264066|54781139|FG005|Overall Study|Withdrawal by Subject|0|||
28120991|NCT03759041|54781157|FG000|Overall Study|Withdrawal by Subject|4|||
28120992|NCT03759041|54781158|FG001|Overall Study|Withdrawal by Subject|10|||
28120993|NCT03759041|54781159|FG002|Overall Study|Withdrawal by Subject|10|||
27817533|NCT01498653|54275083|FG000|Overall Study|Physician Decision|2|||
28066471|NCT00275028|54722009|FG000|Overall Study|Adverse Event|9|||
28120994|NCT03759041|54781157|FG000|Overall Study|Adverse Event|1|||
28120995|NCT03759041|54781158|FG001|Overall Study|Adverse Event|3|||
28120996|NCT03759041|54781159|FG002|Overall Study|Adverse Event|4|||
28120997|NCT03759041|54781157|FG000|Overall Study|Lack of Efficacy|0|||
28120998|NCT03759041|54781158|FG001|Overall Study|Lack of Efficacy|0|||
28066472|NCT00275028|54722009|FG000|Overall Study|Progressive Disease|30|||
28066473|NCT00275028|54722009|FG000|Overall Study|Physician Decision|2|||
28066474|NCT00471497|54722016|FG000|Core Treatment Phase|Abnormal Laboratory Values|3|||
28066475|NCT00471497|54722017|FG001|Core Treatment Phase|Abnormal Laboratory Values|9|||
28066476|NCT00471497|54722018|FG002|Core Treatment Phase|Abnormal Laboratory Values|9|||
28066477|NCT00471497|54722016|FG000|Core Treatment Phase|Abnormal Test Procedures|1|||
28066478|NCT00471497|54722017|FG001|Core Treatment Phase|Abnormal Test Procedures|0|||
28066479|NCT00471497|54722018|FG002|Core Treatment Phase|Abnormal Test Procedures|1|||
28066480|NCT00471497|54722016|FG000|Core Treatment Phase|Condition no longer requires study drug|0|||
28066481|NCT00471497|54722017|FG001|Core Treatment Phase|Condition no longer requires study drug|1|||
28066482|NCT00471497|54722018|FG002|Core Treatment Phase|Condition no longer requires study drug|0|||
28066483|NCT00471497|54722016|FG000|Core Treatment Phase|Withdrawal by Subject|31|||
28066484|NCT00471497|54722017|FG001|Core Treatment Phase|Withdrawal by Subject|29|||
28066485|NCT00471497|54722018|FG002|Core Treatment Phase|Withdrawal by Subject|34|||
28066486|NCT00471497|54722016|FG000|Core Treatment Phase|Lost to Follow-up|6|||
28066487|NCT00471497|54722017|FG001|Core Treatment Phase|Lost to Follow-up|6|||
28120999|NCT03759041|54781159|FG002|Overall Study|Lack of Efficacy|1|||
28121000|NCT03759041|54781157|FG000|Overall Study|Study Terminated by Sponsor|15|||
28121001|NCT03759041|54781158|FG001|Overall Study|Study Terminated by Sponsor|16|||
28121002|NCT03759041|54781159|FG002|Overall Study|Study Terminated by Sponsor|10|||
28121003|NCT03759041|54781157|FG000|Overall Study|Other reason for discontinuation|0|||
28066488|NCT00471497|54722018|FG002|Core Treatment Phase|Lost to Follow-up|3|||
28066489|NCT00471497|54722016|FG000|Core Treatment Phase|Death|3|||
28121004|NCT03759041|54781158|FG001|Overall Study|Other reason for discontinuation|2|||
28121005|NCT03759041|54781159|FG002|Overall Study|Other reason for discontinuation|1|||
28121006|NCT03759041|54781157|FG000|Overall Study|Lost to Follow-up|7|||
28121007|NCT03759041|54781158|FG001|Overall Study|Lost to Follow-up|2|||
28121008|NCT03759041|54781159|FG002|Overall Study|Lost to Follow-up|2|||
28121009|NCT03759041|54781157|FG000|Overall Study|Subjects did not have a discontinuation page completed|0|||
28121010|NCT03759041|54781158|FG001|Overall Study|Subjects did not have a discontinuation page completed|1|||
27817534|NCT01498653|54275084|FG001|Overall Study|Physician Decision|0|||
27817535|NCT01498653|54275083|FG000|Overall Study|Withdrawal by Subject|2|||
28121011|NCT03759041|54781159|FG002|Overall Study|Subjects did not have a discontinuation page completed|0|||
28121012|NCT04110145|54781172|FG000|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
28121013|NCT04110145|54781173|FG001|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
28121014|NCT04110145|54781174|FG002|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
28121015|NCT04110145|54781175|FG003|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|1|||
28121016|NCT04110145|54781176|FG004|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
28121017|NCT02477618|54781190|FG000|Overall Study|Completed Visits but Discontinued Drug|2|||
28121018|NCT02477618|54781191|FG001|Overall Study|Completed Visits but Discontinued Drug|1|||
28121019|NCT02477618|54781190|FG000|Overall Study|Died in Double-Blind Treatment Period|11|||
28121020|NCT02477618|54781191|FG001|Overall Study|Died in Double-Blind Treatment Period|11|||
28121021|NCT02477618|54781190|FG000|Overall Study|Adverse Event|1|||
28121022|NCT02477618|54781191|FG001|Overall Study|Adverse Event|1|||
28121023|NCT02477618|54781190|FG000|Overall Study|Transferred Away from Study Site|1|||
28121024|NCT02477618|54781191|FG001|Overall Study|Transferred Away from Study Site|0|||
28121025|NCT02477618|54781190|FG000|Overall Study|Left Study Site for Rehabilitation|0|||
28121026|NCT02477618|54781191|FG001|Overall Study|Left Study Site for Rehabilitation|1|||
28121027|NCT04102501|54781199|FG000|Overall Study|Withdrawal by Subject|7|||
28121028|NCT04102501|54781200|FG001|Overall Study|Withdrawal by Subject|9|||
28121029|NCT04102501|54781199|FG000|Overall Study|Adverse Event|1|||
28121030|NCT04102501|54781200|FG001|Overall Study|Adverse Event|3|||
28121031|NCT03285477|54781210|FG000|Treatment and Response Assessment Period|Death|1|||
28121032|NCT03285477|54781211|FG001|Treatment and Response Assessment Period|Death|0|||
28121033|NCT03285477|54781210|FG000|Treatment and Response Assessment Period|Withdrawn of Consent|1|||
28121034|NCT03285477|54781211|FG001|Treatment and Response Assessment Period|Withdrawn of Consent|0|||
28121035|NCT03285477|54781210|FG000|Recurrence Follow-up Period|Lost to Follow-up|0|||
28121036|NCT03285477|54781211|FG001|Recurrence Follow-up Period|Lost to Follow-up|1|||
28121037|NCT03285477|54781210|FG000|Recurrence Follow-up Period|Withdrawal of consent|1|||
28121038|NCT03285477|54781211|FG001|Recurrence Follow-up Period|Withdrawal of consent|3|||
28121039|NCT03285477|54781210|FG000|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|5|||
28121040|NCT03285477|54781211|FG001|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|51|||
28121041|NCT04289623|54781228|FG000|Wave 1 Emails|Email was not delivered|268|||
28121042|NCT04289623|54781229|FG001|Wave 1 Emails|Email was not delivered|257|||
28121043|NCT04289623|54781230|FG002|Wave 1 Emails|Email was not delivered|0|||
28121044|NCT04289623|54781231|FG003|Wave 1 Emails|Email was not delivered|0|||
28121045|NCT04289623|54781232|FG004|Wave 1 Emails|Email was not delivered|0|||
28121046|NCT04289623|54781233|FG005|Wave 1 Emails|Email was not delivered|0|||
28121047|NCT03248037|54781249|FG000|Overall Study|Withdrawal by Subject|6|||
28121048|NCT03248037|54781250|FG001|Overall Study|Withdrawal by Subject|9|||
28121049|NCT03248037|54781249|FG000|Overall Study|Adverse Event|15|||
28121050|NCT03248037|54781250|FG001|Overall Study|Adverse Event|0|||
28121051|NCT04287517|54781265|FG000|Overall Study|Withdrawal by Subject|1|||
28121052|NCT04287517|54781266|FG001|Overall Study|Withdrawal by Subject|1|||
28121053|NCT03284229|54781272|FG000|Overall Study|Lost to Follow-up|3|||
28121054|NCT03242928|54781279|FG000|Overall Study|Adverse Event|2|||
28121055|NCT03242928|54781280|FG001|Overall Study|Adverse Event|1|||
28121056|NCT03242928|54781279|FG000|Overall Study|Lost to Follow-up|2|||
28121057|NCT03242928|54781280|FG001|Overall Study|Lost to Follow-up|0|||
28121058|NCT03242928|54781279|FG000|Overall Study|Physician Decision|0|||
28121059|NCT03242928|54781280|FG001|Overall Study|Physician Decision|1|||
28121060|NCT03242928|54781279|FG000|Overall Study|Withdrawal by Subject|5|||
28121061|NCT03242928|54781280|FG001|Overall Study|Withdrawal by Subject|3|||
28121062|NCT03300024|54781288|FG000|Overall Study|Physician Decision|4|||
28121063|NCT03300024|54781289|FG001|Overall Study|Physician Decision|6|||
28121064|NCT04276207|54781297|FG000|Period 1|Withdrawal by Subject|0|||
27817536|NCT01498653|54275084|FG001|Overall Study|Withdrawal by Subject|3|||
27817537|NCT01498575|54275092|FG000|Overall Sample|Withdrawal by Subject|60|||
27817538|NCT01498575|54275093|FG001|Overall Sample|Withdrawal by Subject|14|||
27817539|NCT01498575|54275092|FG000|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19|||
27817540|NCT01498575|54275093|FG001|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6|||
28066490|NCT00471497|54722017|FG001|Core Treatment Phase|Death|9|||
28066491|NCT00471497|54722018|FG002|Core Treatment Phase|Death|3|||
28066492|NCT00471497|54722016|FG000|Core Treatment Phase|Disease Progression|10|||
28066493|NCT00471497|54722017|FG001|Core Treatment Phase|Disease Progression|2|||
28066494|NCT00471497|54722018|FG002|Core Treatment Phase|Disease Progression|4|||
28066495|NCT00471497|54722016|FG000|Core Treatment Phase|Protocol Violation|6|||
28066496|NCT00471497|54722017|FG001|Core Treatment Phase|Protocol Violation|15|||
28066497|NCT00471497|54722018|FG002|Core Treatment Phase|Protocol Violation|11|||
28066498|NCT00471497|54722016|FG000|Core Treatment Phase|Sub optimal response or treat. failure|19|||
27817541|NCT01498575|54275092|FG000|On the Road Driving Assessment (ODA)|Protocol Violation|23|||
27817542|NCT01498575|54275093|FG001|On the Road Driving Assessment (ODA)|Protocol Violation|18|||
27817543|NCT01498185|54275104|FG000|Overall Study|Adverse Event|0|||
27817544|NCT01498185|54275105|FG001|Overall Study|Adverse Event|0|||
27817545|NCT01498185|54275106|FG002|Overall Study|Adverse Event|0|||
27817546|NCT01498185|54275107|FG003|Overall Study|Adverse Event|1|||
27817547|NCT01498185|54275108|FG004|Overall Study|Adverse Event|0|||
27817548|NCT01498185|54275104|FG000|Overall Study|Withdrawal by Subject|1|||
27817549|NCT01498185|54275105|FG001|Overall Study|Withdrawal by Subject|1|||
27817550|NCT01498185|54275106|FG002|Overall Study|Withdrawal by Subject|0|||
28121065|NCT04276207|54781298|FG001|Period 1|Withdrawal by Subject|1|||
28121066|NCT03282357|54781304|FG000|Overall Study|Lost to Follow-up|3|||
28121067|NCT03282357|54781304|FG000|Overall Study|Withdrawal by Subject|4|||
28121068|NCT03282357|54781304|FG000|Overall Study|Adverse Event|1|||
28121069|NCT03282357|54781304|FG000|Overall Study|Other|9|||
28121070|NCT04272775|54781311|FG000|Overall Study|Study Terminated by Sponsor|1|||
28121071|NCT04272775|54781312|FG001|Overall Study|Study Terminated by Sponsor|0|||
28121072|NCT04272775|54781311|FG000|Overall Study|Protocol Violation|0|||
28121073|NCT04272775|54781312|FG001|Overall Study|Protocol Violation|1|||
28121074|NCT04272775|54781311|FG000|Overall Study|Symptomatic Deterioration|1|||
28121075|NCT04272775|54781312|FG001|Overall Study|Symptomatic Deterioration|1|||
28121076|NCT04272775|54781311|FG000|Overall Study|Withdrawal by Subject|1|||
28121077|NCT04272775|54781312|FG001|Overall Study|Withdrawal by Subject|2|||
28121078|NCT04272775|54781311|FG000|Overall Study|Adverse Event|1|||
28121079|NCT04272775|54781312|FG001|Overall Study|Adverse Event|2|||
28121080|NCT04272775|54781311|FG000|Overall Study|Progressive Disease|3|||
28121081|NCT04272775|54781312|FG001|Overall Study|Progressive Disease|1|||
28121082|NCT03232983|54781318|FG000|Period 1|Physician Decision|0|||
28121083|NCT03232983|54781319|FG001|Period 1|Physician Decision|0|||
28121084|NCT03232983|54781320|FG002|Period 1|Physician Decision|1|||
28121085|NCT03232983|54781321|FG003|Period 1|Physician Decision|0|||
28121086|NCT03232983|54781318|FG000|Washout Period 2|Physician Decision|0|||
28121087|NCT03232983|54781319|FG001|Washout Period 2|Physician Decision|0|||
28121088|NCT03232983|54781320|FG002|Washout Period 2|Physician Decision|1|||
28121089|NCT03232983|54781321|FG003|Washout Period 2|Physician Decision|0|||
28121090|NCT03232983|54781318|FG000|Washout Period 2|Withdrawal by Subject|0|||
28121091|NCT03232983|54781319|FG001|Washout Period 2|Withdrawal by Subject|0|||
28121092|NCT03232983|54781320|FG002|Washout Period 2|Withdrawal by Subject|0|||
28121093|NCT03232983|54781321|FG003|Washout Period 2|Withdrawal by Subject|1|||
28121094|NCT03232983|54781318|FG000|Period 4|Withdrawal by Subject|1|||
28121095|NCT03232983|54781319|FG001|Period 4|Withdrawal by Subject|0|||
28121096|NCT03232983|54781320|FG002|Period 4|Withdrawal by Subject|0|||
28121097|NCT03232983|54781321|FG003|Period 4|Withdrawal by Subject|0|||
28121098|NCT04102345|54781335|FG000|Overall Study|Withdrawal by Subject|1|||
28121099|NCT04102345|54781336|FG001|Overall Study|Withdrawal by Subject|0|||
28121100|NCT04271605|54781342|FG000|Overall Study|The study was terminated because of the duration of funding was only one year.|5|||
28121101|NCT03299244|54781348|FG000|Overall Study|Withdrawal by Subject|34|||
28121102|NCT03299244|54781349|FG001|Overall Study|Withdrawal by Subject|29|||
28121103|NCT03299244|54781348|FG000|Overall Study|Decision by Sponsor|4|||
28121104|NCT03299244|54781349|FG001|Overall Study|Decision by Sponsor|5|||
28121105|NCT03299244|54781348|FG000|Overall Study|Death|9|||
28121106|NCT03299244|54781349|FG001|Overall Study|Death|4|||
28121107|NCT03757715|54781358|FG000|Overall Study|Lost to Follow-up|4|||
28121108|NCT03757715|54781359|FG001|Overall Study|Lost to Follow-up|9|||
28121109|NCT03757715|54781358|FG000|Overall Study|Withdrawal by Subject|1|||
28121110|NCT03757715|54781359|FG001|Overall Study|Withdrawal by Subject|1|||
28121111|NCT03281577|54781369|FG000|Overall Study|Adverse Event|0|||
27817551|NCT01498185|54275107|FG003|Overall Study|Withdrawal by Subject|2|||
27817552|NCT01498185|54275108|FG004|Overall Study|Withdrawal by Subject|1|||
28121112|NCT03281577|54781370|FG001|Overall Study|Adverse Event|0|||
27849272|NCT02085161|54344603|FG002|Overall Study|Protocol Violation|0|||
28121113|NCT03281577|54781371|FG002|Overall Study|Adverse Event|0|||
28121114|NCT03281577|54781372|FG003|Overall Study|Adverse Event|1|||
28121115|NCT03281577|54781369|FG000|Overall Study|Withdrawal by Subject|1|||
28121116|NCT03281577|54781370|FG001|Overall Study|Withdrawal by Subject|0|||
28121117|NCT03281577|54781371|FG002|Overall Study|Withdrawal by Subject|0|||
28121118|NCT03281577|54781372|FG003|Overall Study|Withdrawal by Subject|0|||
28121119|NCT04098367|54781388|FG000|Overall Study|Adverse Event|0|||
28121120|NCT04098367|54781389|FG001|Overall Study|Adverse Event|0|||
28121121|NCT04098367|54781390|FG002|Overall Study|Adverse Event|1|||
28121122|NCT04098367|54781388|FG000|Overall Study|Lost to Follow-up|1|||
27817553|NCT01498185|54275104|FG000|Overall Study|No longer met criteria, etc|0|||
27817554|NCT01498185|54275105|FG001|Overall Study|No longer met criteria, etc|0|||
28121123|NCT04098367|54781389|FG001|Overall Study|Lost to Follow-up|5|||
28121124|NCT04098367|54781390|FG002|Overall Study|Lost to Follow-up|2|||
28121125|NCT04098367|54781388|FG000|Overall Study|Withdrawal by Subject|0|||
28121126|NCT04098367|54781389|FG001|Overall Study|Withdrawal by Subject|0|||
28121127|NCT04098367|54781390|FG002|Overall Study|Withdrawal by Subject|1|||
28121128|NCT04098367|54781388|FG000|Overall Study|Sick . Could not attend visit|1|||
28121129|NCT04098367|54781389|FG001|Overall Study|Sick . Could not attend visit|0|||
28121130|NCT04098367|54781390|FG002|Overall Study|Sick . Could not attend visit|0|||
28121131|NCT03759587|54781405|FG000|Overall Study|Ongoing|19|||
28121132|NCT04091659|54781411|FG000|Overall Study|Protocol Violation|3|||
28121133|NCT04091659|54781412|FG001|Overall Study|Protocol Violation|0|||
28121134|NCT04091659|54781411|FG000|Overall Study|Lost to Follow-up|0|||
28121135|NCT04091659|54781412|FG001|Overall Study|Lost to Follow-up|1|||
28121136|NCT04256785|54781449|FG000|Overall Study|Adverse Event|8|||
28121137|NCT04256785|54781450|FG001|Overall Study|Adverse Event|6|||
28121138|NCT04256785|54781449|FG000|Overall Study|Lack of Efficacy|3|||
28121139|NCT04256785|54781450|FG001|Overall Study|Lack of Efficacy|4|||
28121140|NCT04256785|54781449|FG000|Overall Study|Lost to Follow-up|7|||
28121141|NCT04256785|54781450|FG001|Overall Study|Lost to Follow-up|7|||
28121142|NCT04256785|54781449|FG000|Overall Study|Protocol Violation|1|||
28121143|NCT04256785|54781450|FG001|Overall Study|Protocol Violation|0|||
28121144|NCT04256785|54781449|FG000|Overall Study|Withdrawal by Subject|4|||
28121145|NCT04256785|54781450|FG001|Overall Study|Withdrawal by Subject|1|||
28121146|NCT04256785|54781449|FG000|Overall Study|Surgery or quarantined due to Covid-19|5|||
28121147|NCT04256785|54781450|FG001|Overall Study|Surgery or quarantined due to Covid-19|7|||
28121148|NCT02959918|54781472|FG000|Overall Study|Adverse Event|1|||
28121149|NCT02959918|54781473|FG001|Overall Study|Adverse Event|1|||
28121150|NCT02959918|54781474|FG002|Overall Study|Adverse Event|2|||
28121151|NCT02959918|54781475|FG003|Overall Study|Adverse Event|0|||
28121152|NCT02959918|54781476|FG004|Overall Study|Adverse Event|0|||
28121153|NCT02959918|54781477|FG005|Overall Study|Adverse Event|2|||
28121154|NCT02959918|54781478|FG006|Overall Study|Adverse Event|2|||
28121155|NCT02959918|54781479|FG007|Overall Study|Adverse Event|1|||
28121156|NCT02959918|54781480|FG008|Overall Study|Adverse Event|2|||
28121157|NCT02959918|54781481|FG009|Overall Study|Adverse Event|1|||
28121158|NCT02959918|54781482|FG010|Overall Study|Adverse Event|1|||
28121159|NCT02959918|54781483|FG011|Overall Study|Adverse Event|3|||
28121160|NCT02959918|54781484|FG012|Overall Study|Adverse Event|2|||
28121161|NCT02959918|54781485|FG013|Overall Study|Adverse Event|4|||
28121162|NCT02959918|54781472|FG000|Overall Study|Lost to Follow-up|0|||
28121163|NCT02959918|54781473|FG001|Overall Study|Lost to Follow-up|0|||
28121164|NCT02959918|54781474|FG002|Overall Study|Lost to Follow-up|0|||
28121165|NCT02959918|54781475|FG003|Overall Study|Lost to Follow-up|0|||
28121166|NCT02959918|54781476|FG004|Overall Study|Lost to Follow-up|0|||
28121167|NCT02959918|54781477|FG005|Overall Study|Lost to Follow-up|0|||
28121168|NCT02959918|54781478|FG006|Overall Study|Lost to Follow-up|0|||
28121169|NCT02959918|54781479|FG007|Overall Study|Lost to Follow-up|0|||
28121170|NCT02959918|54781480|FG008|Overall Study|Lost to Follow-up|0|||
28121171|NCT02959918|54781481|FG009|Overall Study|Lost to Follow-up|1|||
28121172|NCT02959918|54781482|FG010|Overall Study|Lost to Follow-up|0|||
28121173|NCT02959918|54781483|FG011|Overall Study|Lost to Follow-up|0|||
28121174|NCT02959918|54781484|FG012|Overall Study|Lost to Follow-up|1|||
27849273|NCT02085161|54344604|FG003|Overall Study|Protocol Violation|1|||
28121175|NCT02959918|54781485|FG013|Overall Study|Lost to Follow-up|0|||
28121176|NCT02959918|54781472|FG000|Overall Study|Withdrawal by Subject|0|||
28121177|NCT02959918|54781473|FG001|Overall Study|Withdrawal by Subject|0|||
28121178|NCT02959918|54781474|FG002|Overall Study|Withdrawal by Subject|1|||
28121179|NCT02959918|54781475|FG003|Overall Study|Withdrawal by Subject|2|||
28121180|NCT02959918|54781476|FG004|Overall Study|Withdrawal by Subject|0|||
28121181|NCT02959918|54781477|FG005|Overall Study|Withdrawal by Subject|0|||
28121182|NCT02959918|54781478|FG006|Overall Study|Withdrawal by Subject|1|||
28121183|NCT02959918|54781479|FG007|Overall Study|Withdrawal by Subject|0|||
28121184|NCT02959918|54781480|FG008|Overall Study|Withdrawal by Subject|1|||
28121185|NCT02959918|54781481|FG009|Overall Study|Withdrawal by Subject|1|||
28121186|NCT02959918|54781482|FG010|Overall Study|Withdrawal by Subject|2|||
28121187|NCT02959918|54781483|FG011|Overall Study|Withdrawal by Subject|3|||
28121188|NCT02959918|54781484|FG012|Overall Study|Withdrawal by Subject|1|||
28121189|NCT02959918|54781485|FG013|Overall Study|Withdrawal by Subject|1|||
28121190|NCT02959918|54781472|FG000|Overall Study|Protocol Violation|0|||
28121191|NCT02959918|54781473|FG001|Overall Study|Protocol Violation|0|||
28121192|NCT02959918|54781474|FG002|Overall Study|Protocol Violation|1|||
28121193|NCT02959918|54781475|FG003|Overall Study|Protocol Violation|0|||
28121194|NCT02959918|54781476|FG004|Overall Study|Protocol Violation|0|||
28121195|NCT02959918|54781477|FG005|Overall Study|Protocol Violation|1|||
28121196|NCT02959918|54781478|FG006|Overall Study|Protocol Violation|0|||
28121197|NCT02959918|54781479|FG007|Overall Study|Protocol Violation|0|||
28121198|NCT02959918|54781480|FG008|Overall Study|Protocol Violation|2|||
28121199|NCT02959918|54781481|FG009|Overall Study|Protocol Violation|1|||
28121200|NCT02959918|54781482|FG010|Overall Study|Protocol Violation|0|||
28121201|NCT02959918|54781483|FG011|Overall Study|Protocol Violation|1|||
28121202|NCT02959918|54781484|FG012|Overall Study|Protocol Violation|1|||
28121203|NCT02959918|54781485|FG013|Overall Study|Protocol Violation|0|||
28121204|NCT02959918|54781472|FG000|Overall Study|Stopping Rule Met|1|||
28121205|NCT02959918|54781473|FG001|Overall Study|Stopping Rule Met|0|||
28121206|NCT02959918|54781474|FG002|Overall Study|Stopping Rule Met|3|||
28121207|NCT02959918|54781475|FG003|Overall Study|Stopping Rule Met|4|||
28121208|NCT02959918|54781476|FG004|Overall Study|Stopping Rule Met|5|||
28121209|NCT02959918|54781477|FG005|Overall Study|Stopping Rule Met|3|||
28121210|NCT02959918|54781478|FG006|Overall Study|Stopping Rule Met|2|||
28121211|NCT02959918|54781479|FG007|Overall Study|Stopping Rule Met|4|||
28121212|NCT02959918|54781480|FG008|Overall Study|Stopping Rule Met|1|||
28121213|NCT02959918|54781481|FG009|Overall Study|Stopping Rule Met|1|||
28121214|NCT02959918|54781482|FG010|Overall Study|Stopping Rule Met|3|||
28121215|NCT02959918|54781483|FG011|Overall Study|Stopping Rule Met|5|||
28121216|NCT02959918|54781484|FG012|Overall Study|Stopping Rule Met|2|||
28121217|NCT02959918|54781485|FG013|Overall Study|Stopping Rule Met|1|||
28121218|NCT02959918|54781472|FG000|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
28121219|NCT02959918|54781473|FG001|Overall Study|Sponsor Decision, Pause in Clinical Trial|2|||
28121220|NCT02959918|54781474|FG002|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
28121221|NCT02959918|54781475|FG003|Overall Study|Sponsor Decision, Pause in Clinical Trial|3|||
28121222|NCT02959918|54781476|FG004|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
28121223|NCT02959918|54781477|FG005|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
28121224|NCT02959918|54781478|FG006|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
28121225|NCT02959918|54781479|FG007|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
28121226|NCT02959918|54781480|FG008|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
28121227|NCT02959918|54781481|FG009|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
28121228|NCT02959918|54781482|FG010|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
28121229|NCT02959918|54781483|FG011|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
28121230|NCT02959918|54781484|FG012|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
28121231|NCT02959918|54781485|FG013|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
28121232|NCT02959918|54781472|FG000|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
28121233|NCT02959918|54781473|FG001|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
28121234|NCT02959918|54781474|FG002|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
28121235|NCT02959918|54781475|FG003|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
28121236|NCT02959918|54781476|FG004|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
28121237|NCT02959918|54781477|FG005|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
28121238|NCT02959918|54781478|FG006|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
28121239|NCT02959918|54781479|FG007|Overall Study|Subject Hospitalized, out of window for next dosing period|1|||
28121240|NCT02959918|54781480|FG008|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
28121241|NCT02959918|54781481|FG009|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
28121242|NCT02959918|54781482|FG010|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
28121243|NCT02959918|54781483|FG011|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
28121244|NCT02959918|54781484|FG012|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
28121245|NCT02959918|54781485|FG013|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
28121246|NCT02959918|54781472|FG000|Overall Study|PI Discretion due to abnormal Hgb results|0|||
28121247|NCT02959918|54781473|FG001|Overall Study|PI Discretion due to abnormal Hgb results|0|||
28121248|NCT02959918|54781474|FG002|Overall Study|PI Discretion due to abnormal Hgb results|0|||
28121249|NCT02959918|54781475|FG003|Overall Study|PI Discretion due to abnormal Hgb results|0|||
28121250|NCT02959918|54781476|FG004|Overall Study|PI Discretion due to abnormal Hgb results|0|||
28121251|NCT02959918|54781477|FG005|Overall Study|PI Discretion due to abnormal Hgb results|0|||
28121252|NCT02959918|54781478|FG006|Overall Study|PI Discretion due to abnormal Hgb results|0|||
28121253|NCT02959918|54781479|FG007|Overall Study|PI Discretion due to abnormal Hgb results|0|||
28121254|NCT02959918|54781480|FG008|Overall Study|PI Discretion due to abnormal Hgb results|1|||
28121255|NCT02959918|54781481|FG009|Overall Study|PI Discretion due to abnormal Hgb results|0|||
28121256|NCT02959918|54781482|FG010|Overall Study|PI Discretion due to abnormal Hgb results|0|||
28121257|NCT02959918|54781483|FG011|Overall Study|PI Discretion due to abnormal Hgb results|0|||
28121258|NCT02959918|54781484|FG012|Overall Study|PI Discretion due to abnormal Hgb results|0|||
28121259|NCT02959918|54781485|FG013|Overall Study|PI Discretion due to abnormal Hgb results|0|||
28121260|NCT02959918|54781472|FG000|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
28121261|NCT02959918|54781473|FG001|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
28121262|NCT02959918|54781474|FG002|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
28121263|NCT02959918|54781475|FG003|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
28121264|NCT02959918|54781476|FG004|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
28121265|NCT02959918|54781477|FG005|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
28121266|NCT02959918|54781478|FG006|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
28121267|NCT02959918|54781479|FG007|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
28121268|NCT02959918|54781480|FG008|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
28121269|NCT02959918|54781481|FG009|Overall Study|Subject under-dosed with study drug and removed by Sponsor|1|||
28121270|NCT02959918|54781482|FG010|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
28121271|NCT02959918|54781483|FG011|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
28121272|NCT02959918|54781484|FG012|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
28121273|NCT02959918|54781485|FG013|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
28121274|NCT03263442|54781520|FG000|Inpatient Phase|Death|1|||
28121275|NCT03263442|54781521|FG001|Inpatient Phase|Death|0|||
28121276|NCT03263442|54781520|FG000|Inpatient Phase|Withdrawal by Subject|1|||
28121277|NCT03263442|54781521|FG001|Inpatient Phase|Withdrawal by Subject|0|||
28121278|NCT03263442|54781520|FG000|Inpatient Phase|Inadequate Drug Exposure|0|||
28121279|NCT03263442|54781521|FG001|Inpatient Phase|Inadequate Drug Exposure|1|||
28121280|NCT03263442|54781520|FG000|1-month Follow-Up|Lost to Follow-up|1|||
28121281|NCT03263442|54781521|FG001|1-month Follow-Up|Lost to Follow-up|0|||
28121282|NCT03263442|54781520|FG000|3-month Follow-Up|Lost to Follow-up|1|||
28121283|NCT03263442|54781521|FG001|3-month Follow-Up|Lost to Follow-up|3|||
28121284|NCT03263442|54781520|FG000|6-month Follow-Up|Lost to Follow-up|2|||
28121285|NCT03263442|54781521|FG001|6-month Follow-Up|Lost to Follow-up|2|||
28121286|NCT04245709|54781529|FG000|Overall Study|Adverse Event|13|||
28121287|NCT04245709|54781529|FG000|Overall Study|Risk of travel during COVID19 pandemic|1|||
28121288|NCT04091581|54781535|FG000|Overall Study|Lost to Follow-up|0|||
28121289|NCT04091581|54781536|FG001|Overall Study|Lost to Follow-up|1|||
28121290|NCT02940522|54781544|FG000|Overall Study|Lost to Follow-up|1|||
28121291|NCT02940522|54781545|FG001|Overall Study|Lost to Follow-up|2|||
28121292|NCT02940522|54781544|FG000|Overall Study|Withdrawal by Subject|1|||
28121293|NCT02940522|54781545|FG001|Overall Study|Withdrawal by Subject|0|||
28121294|NCT03262038|54781553|FG000|Overall Study|Withdrawal by Subject|0|||
28121295|NCT03262038|54781554|FG001|Overall Study|Withdrawal by Subject|1|||
28121296|NCT02472964|54781562|FG000|Part 1 (up to Week 24)|Adverse Event|2|||
28121297|NCT02472964|54781563|FG001|Part 1 (up to Week 24)|Adverse Event|4|||
28121298|NCT02472964|54781562|FG000|Part 1 (up to Week 24)|disease progression|58|||
28121299|NCT02472964|54781563|FG001|Part 1 (up to Week 24)|disease progression|47|||
28121300|NCT02472964|54781562|FG000|Part 1 (up to Week 24)|Death|3|||
28121301|NCT02472964|54781563|FG001|Part 1 (up to Week 24)|Death|6|||
28121302|NCT02472964|54781562|FG000|Part 1 (up to Week 24)|Physician Decision|3|||
28121303|NCT02472964|54781563|FG001|Part 1 (up to Week 24)|Physician Decision|1|||
28121304|NCT02472964|54781562|FG000|Part 1 (up to Week 24)|Lost to Follow-up|0|||
28121305|NCT02472964|54781563|FG001|Part 1 (up to Week 24)|Lost to Follow-up|1|||
28121306|NCT02472964|54781562|FG000|Part 1 (up to Week 24)|Withdrawal by Subject|7|||
28121307|NCT02472964|54781563|FG001|Part 1 (up to Week 24)|Withdrawal by Subject|2|||
28121308|NCT02472964|54781562|FG000|Part 1 (up to Week 24)|Other|2|||
28121309|NCT02472964|54781563|FG001|Part 1 (up to Week 24)|Other|1|||
28121310|NCT02472964|54781562|FG000|Part 2 (Week 24-week 48)|Adverse Event|4|||
28121311|NCT02472964|54781563|FG001|Part 2 (Week 24-week 48)|Adverse Event|2|||
28121312|NCT02472964|54781562|FG000|Part 2 (Week 24-week 48)|Disease Progression|52|||
28121313|NCT02472964|54781563|FG001|Part 2 (Week 24-week 48)|Disease Progression|56|||
28121314|NCT02472964|54781562|FG000|Part 2 (Week 24-week 48)|Death|0|||
28121315|NCT02472964|54781563|FG001|Part 2 (Week 24-week 48)|Death|1|||
28121316|NCT02472964|54781562|FG000|Part 2 (Week 24-week 48)|Physician Decision|1|||
28121317|NCT02472964|54781563|FG001|Part 2 (Week 24-week 48)|Physician Decision|1|||
28121318|NCT02472964|54781562|FG000|Part 2 (Week 24-week 48)|Lost to Follow-up|2|||
28121319|NCT02472964|54781563|FG001|Part 2 (Week 24-week 48)|Lost to Follow-up|1|||
28121320|NCT02472964|54781562|FG000|Part 2 (Week 24-week 48)|Withdrawal by Subject|3|||
28121321|NCT02472964|54781563|FG001|Part 2 (Week 24-week 48)|Withdrawal by Subject|1|||
28121322|NCT02472964|54781562|FG000|Part 2 (Week 24-week 48)|Protocol Violation|3|||
28121323|NCT02472964|54781563|FG001|Part 2 (Week 24-week 48)|Protocol Violation|1|||
28121324|NCT04079803|54781576|FG000|Overall Study|Withdrawal by Subject|0|||
28121325|NCT04079803|54781577|FG001|Overall Study|Withdrawal by Subject|0|||
28121326|NCT04079803|54781578|FG002|Overall Study|Withdrawal by Subject|1|||
28121327|NCT03278613|54781606|FG000|Overall Study|Lost to Follow-up|3|||
28121328|NCT03278613|54781607|FG001|Overall Study|Lost to Follow-up|1|||
28121329|NCT03761147|54781615|FG000|Overall Study|Withdrawal by Subject|6|||
28121330|NCT03761147|54781616|FG001|Overall Study|Withdrawal by Subject|1|||
28121331|NCT03761147|54781615|FG000|Overall Study|Adverse Event|1|||
28121332|NCT03761147|54781616|FG001|Overall Study|Adverse Event|3|||
28121333|NCT04076917|54781622|FG000|Overall Study|No AF episodes detected during Pre-Holter Observation period|49|||
28121334|NCT04076917|54781622|FG000|Overall Study|Study closure|13|||
28121335|NCT04076917|54781622|FG000|Overall Study|Physician Decision|3|||
28121336|NCT04076917|54781622|FG000|Overall Study|Death|1|||
28121337|NCT04076917|54781622|FG000|Overall Study|Lost to Follow-up|1|||
28121338|NCT04076917|54781622|FG000|Overall Study|Withdrawal by Subject|1|||
28121339|NCT04076917|54781622|FG000|Overall Study|Mean R-wave sensing is < 0.25 mV during Pre-Holter observation period|1|||
28121340|NCT04222699|54781626|FG000|Overall Study|Lost to Follow-up|2|||
28121341|NCT02731690|54781639|FG000|Overall Study|Adverse Event|1|||
28121342|NCT02731690|54781639|FG000|Overall Study|Withdrawal by Subject|3|||
28121343|NCT02731690|54781639|FG000|Overall Study|Discontinuation of Study by Sponsor|26|||
28121344|NCT04075513|54781645|FG000|Overall Study|Withdrawal by Subject|2|||
28121345|NCT04075513|54781646|FG001|Overall Study|Withdrawal by Subject|2|||
28121346|NCT04075513|54781645|FG000|Overall Study|Lack of Efficacy|1|||
28121347|NCT04075513|54781646|FG001|Overall Study|Lack of Efficacy|0|||
28121348|NCT04075513|54781645|FG000|Overall Study|Lost to Follow-up|4|||
28121349|NCT04075513|54781646|FG001|Overall Study|Lost to Follow-up|2|||
28121350|NCT04075513|54781645|FG000|Overall Study|Switch to insulin pump|1|||
28121351|NCT04075513|54781646|FG001|Overall Study|Switch to insulin pump|0|||
28121352|NCT04073407|54781654|FG000|Part 1|Withdrawal by Subject|1|||
28121353|NCT04073407|54781655|FG001|Part 1|Withdrawal by Subject|0|||
28121354|NCT04073407|54781654|FG000|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|4|||
28121355|NCT04073407|54781655|FG001|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|1|||
28121356|NCT04073407|54781654|FG000|Part 2|Withdrawal by Subject|0|||
28121357|NCT04073407|54781655|FG001|Part 2|Withdrawal by Subject|1|||
28121358|NCT02778204|54781665|FG000|Overall Study|Adverse Event|1|||
28121359|NCT02778204|54781666|FG001|Overall Study|Adverse Event|0|||
28121360|NCT02778204|54781667|FG002|Overall Study|Adverse Event|0|||
28121361|NCT02778204|54781668|FG003|Overall Study|Adverse Event|0|||
28121362|NCT02778204|54781665|FG000|Overall Study|Withdrawal by Subject|0|||
28121363|NCT02778204|54781666|FG001|Overall Study|Withdrawal by Subject|0|||
28121364|NCT02778204|54781667|FG002|Overall Study|Withdrawal by Subject|1|||
28121365|NCT02778204|54781668|FG003|Overall Study|Withdrawal by Subject|2|||
28121366|NCT02778204|54781665|FG000|Overall Study|Lost to Follow-up|1|||
28121367|NCT02778204|54781666|FG001|Overall Study|Lost to Follow-up|0|||
28121368|NCT02778204|54781667|FG002|Overall Study|Lost to Follow-up|2|||
28121369|NCT02778204|54781668|FG003|Overall Study|Lost to Follow-up|1|||
28121370|NCT02778204|54781665|FG000|Overall Study|Protocol Violation|0|||
28121371|NCT02778204|54781666|FG001|Overall Study|Protocol Violation|0|||
28121372|NCT02778204|54781667|FG002|Overall Study|Protocol Violation|1|||
28121373|NCT02778204|54781668|FG003|Overall Study|Protocol Violation|0|||
28121374|NCT02778204|54781665|FG000|Overall Study|Eligibility Violation|0|||
28121375|NCT02778204|54781666|FG001|Overall Study|Eligibility Violation|0|||
28121376|NCT02778204|54781667|FG002|Overall Study|Eligibility Violation|0|||
28121377|NCT02778204|54781668|FG003|Overall Study|Eligibility Violation|1|||
28121378|NCT04072159|54781682|FG000|Overall Study|Lost to Follow-up|6|||
28121379|NCT04072159|54781683|FG001|Overall Study|Lost to Follow-up|6|||
28121380|NCT04072159|54781682|FG000|Overall Study|Withdrawal by Subject|2|||
28121381|NCT04072159|54781683|FG001|Overall Study|Withdrawal by Subject|0|||
28121382|NCT03232281|54781693|FG000|Overall Study|Adverse Event|1|||
28121383|NCT03232281|54781694|FG001|Overall Study|Adverse Event|1|||
28121384|NCT03232281|54781693|FG000|Overall Study|Withdrawal by Subject|5|||
28121385|NCT03232281|54781694|FG001|Overall Study|Withdrawal by Subject|4|||
28121386|NCT03232281|54781693|FG000|Overall Study|Protocol Deviation|1|||
28121387|NCT03232281|54781694|FG001|Overall Study|Protocol Deviation|1|||
28121388|NCT04071301|54781700|FG000|Overall Study|Withdrawal by Subject|6|||
28121389|NCT04071301|54781700|FG000|Overall Study|Death|1|||
28121390|NCT03261336|54781704|FG000|Overall Study|Adverse Event|1|||
28121391|NCT00462748|54781711|FG000|Overall Study|Adverse Event|7|||
28121392|NCT00462748|54781712|FG001|Overall Study|Adverse Event|5|||
27817555|NCT01498185|54275106|FG002|Overall Study|No longer met criteria, etc|0|||
27817556|NCT01498185|54275107|FG003|Overall Study|No longer met criteria, etc|0|||
27817557|NCT01498185|54275108|FG004|Overall Study|No longer met criteria, etc|2|||
27817558|NCT01528605|54275130|FG000|Overall Study|Lost to Follow-up|1|||
28066499|NCT00471497|54722017|FG001|Core Treatment Phase|Sub optimal response or treat. failure|11|||
28066500|NCT00471497|54722018|FG002|Core Treatment Phase|Sub optimal response or treat. failure|13|||
28066501|NCT00471497|54722016|FG000|Core Treatment Phase|Administrative problems|14|||
28066502|NCT00471497|54722017|FG001|Core Treatment Phase|Administrative problems|14|||
27817559|NCT01528605|54275131|FG001|Overall Study|Lost to Follow-up|0|||
27817560|NCT01528605|54275132|FG002|Overall Study|Lost to Follow-up|1|||
27817561|NCT01528605|54275133|FG003|Overall Study|Lost to Follow-up|1|||
28066503|NCT00471497|54722018|FG002|Core Treatment Phase|Administrative problems|12|||
28066504|NCT00471497|54722016|FG000|Core Treatment Phase|Adverse Event|43|||
28066505|NCT00471497|54722017|FG001|Core Treatment Phase|Adverse Event|53|||
28066506|NCT00471497|54722018|FG002|Core Treatment Phase|Adverse Event|89|||
28066507|NCT00471497|54722016|FG000|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2|||
28066508|NCT00471497|54722017|FG001|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
28066509|NCT00471497|54722018|FG002|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
28066510|NCT00471497|54722016|FG000|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46|||
28066511|NCT00471497|54722017|FG001|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26|||
28066512|NCT00471497|54722018|FG002|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3|||
28066513|NCT00471497|54722016|FG000|Extension Phase|Adverse Event|9|||
28066514|NCT00471497|54722017|FG001|Extension Phase|Adverse Event|5|||
28121393|NCT00462748|54781713|FG002|Overall Study|Adverse Event|9|||
28121394|NCT00462748|54781711|FG000|Overall Study|Protocol Violation|0|||
28121395|NCT00462748|54781712|FG001|Overall Study|Protocol Violation|2|||
27817562|NCT01528605|54275134|FG004|Overall Study|Lost to Follow-up|0|||
28121396|NCT00462748|54781713|FG002|Overall Study|Protocol Violation|1|||
27817563|NCT01528605|54275135|FG005|Overall Study|Lost to Follow-up|0|||
27817564|NCT01528605|54275130|FG000|Overall Study|Death|1|||
28121397|NCT00462748|54781711|FG000|Overall Study|Withdrew consent|3|||
28121398|NCT00462748|54781712|FG001|Overall Study|Withdrew consent|3|||
28121399|NCT00462748|54781713|FG002|Overall Study|Withdrew consent|0|||
28121400|NCT00462748|54781711|FG000|Overall Study|Lost to Follow-up|1|||
28121401|NCT00462748|54781712|FG001|Overall Study|Lost to Follow-up|1|||
28121402|NCT00462748|54781713|FG002|Overall Study|Lost to Follow-up|1|||
28121403|NCT00462748|54781711|FG000|Overall Study|Discontinued after 41 days Rx|1|||
28121404|NCT00462748|54781712|FG001|Overall Study|Discontinued after 41 days Rx|0|||
28121405|NCT00462748|54781713|FG002|Overall Study|Discontinued after 41 days Rx|0|||
28121406|NCT04206085|54781724|FG000|Overall Study|Lost to Follow-up|0|||
28121407|NCT04206085|54781725|FG001|Overall Study|Lost to Follow-up|1|||
28121408|NCT04206085|54781726|FG002|Overall Study|Lost to Follow-up|0|||
28121409|NCT04206085|54781724|FG000|Overall Study|Lost to Follow-up|0|||
28121410|NCT04206085|54781725|FG001|Overall Study|Lost to Follow-up|0|||
28121411|NCT04206085|54781726|FG002|Overall Study|Lost to Follow-up|1|||
28121412|NCT04202497|54781734|FG000|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|1|||
28121413|NCT04202497|54781735|FG001|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
28121414|NCT04202497|54781736|FG002|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
28121415|NCT04202497|54781737|FG003|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
28121416|NCT03297294|54781753|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30|||
28121417|NCT03297294|54781754|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31|||
28121418|NCT03297294|54781755|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
28121419|NCT03297294|54781756|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
28121420|NCT03297294|54781757|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
28121421|NCT03297294|54781753|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
28121422|NCT03297294|54781754|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
28121423|NCT03297294|54781755|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
28121424|NCT03297294|54781756|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
28121425|NCT03297294|54781757|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
28121426|NCT03297294|54781753|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
28121427|NCT03297294|54781754|FG001|Double-Blind Treatment Period (DB)|Adverse Event|1|||
28121428|NCT03297294|54781755|FG002|Double-Blind Treatment Period (DB)|Adverse Event|0|||
28121429|NCT03297294|54781756|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
28121430|NCT03297294|54781757|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
28121431|NCT03297294|54781753|FG000|Double-Blind Treatment Period (DB)|Physician Decision|1|||
28121432|NCT03297294|54781754|FG001|Double-Blind Treatment Period (DB)|Physician Decision|1|||
28121433|NCT03297294|54781755|FG002|Double-Blind Treatment Period (DB)|Physician Decision|0|||
28121434|NCT03297294|54781756|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
28121435|NCT03297294|54781757|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
28121436|NCT03297294|54781753|FG000|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
28121437|NCT03297294|54781754|FG001|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
28121438|NCT03297294|54781755|FG002|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
28121439|NCT03297294|54781756|FG003|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1|||
28121440|NCT03297294|54781757|FG004|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
28121441|NCT03238911|54781771|FG000|Overall Study|Withdrawal by Subject|1|||
28121442|NCT03238911|54781772|FG001|Overall Study|Withdrawal by Subject|2|||
28121443|NCT03238911|54781771|FG000|Overall Study|Lost to Follow-up|2|||
28121444|NCT03238911|54781772|FG001|Overall Study|Lost to Follow-up|1|||
28121445|NCT00418834|54781781|FG000|Overall Study|Adverse Event|16|||
28121446|NCT00418834|54781782|FG001|Overall Study|Adverse Event|9|||
28121447|NCT00418834|54781781|FG000|Overall Study|Lost to Follow-up|0|||
28121448|NCT00418834|54781782|FG001|Overall Study|Lost to Follow-up|1|||
28121449|NCT00418834|54781781|FG000|Overall Study|Protocol Violation|4|||
28121450|NCT00418834|54781782|FG001|Overall Study|Protocol Violation|3|||
28121451|NCT00418834|54781781|FG000|Overall Study|Withdrawal by Subject|3|||
28121452|NCT00418834|54781782|FG001|Overall Study|Withdrawal by Subject|7|||
28121453|NCT03276975|54781790|FG000|Overall Study|Withdrawal by Subject|1|||
28121454|NCT03276975|54781791|FG001|Overall Study|Withdrawal by Subject|0|||
28121455|NCT03297216|54781799|FG000|Overall Study|Death|0|||
28121456|NCT03297216|54781800|FG001|Overall Study|Death|1|||
28121457|NCT03297216|54781799|FG000|Overall Study|Miscarriage|0|||
28121458|NCT03297216|54781800|FG001|Overall Study|Miscarriage|2|||
28121459|NCT03297216|54781799|FG000|Overall Study|Lost to Follow-up|3|||
28121460|NCT03297216|54781800|FG001|Overall Study|Lost to Follow-up|2|||
28121461|NCT03260868|54781815|FG000|Overall Study|Poor Compliance to Protocol|0|||
28121462|NCT03260868|54781816|FG001|Overall Study|Poor Compliance to Protocol|2|||
28121463|NCT03260868|54781815|FG000|Overall Study|Study Terminated By Sponsor|2|||
28121464|NCT03260868|54781816|FG001|Overall Study|Study Terminated By Sponsor|1|||
28121465|NCT03260868|54781815|FG000|Overall Study|Other than specified above|1|||
28121466|NCT03260868|54781816|FG001|Overall Study|Other than specified above|0|||
28121467|NCT03293394|54781824|FG000|Follow-up (6 Months)|Adverse Event|4|||
27817565|NCT01528605|54275131|FG001|Overall Study|Death|0|||
27817566|NCT01528605|54275132|FG002|Overall Study|Death|0|||
27817567|NCT01528605|54275133|FG003|Overall Study|Death|0|||
27817568|NCT01528605|54275134|FG004|Overall Study|Death|0|||
27817569|NCT01528605|54275135|FG005|Overall Study|Death|0|||
27817570|NCT01528215|54275151|FG000|Enrollment to 1 Year Follow-up|Adverse Event|4|||
27817571|NCT01528215|54275152|FG001|Enrollment to 1 Year Follow-up|Adverse Event|1|||
27817572|NCT01528215|54275151|FG000|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
27817573|NCT01528215|54275152|FG001|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
27817574|NCT01528215|54275151|FG000|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10|||
27817575|NCT01528215|54275152|FG001|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13|||
27817576|NCT01528215|54275151|FG000|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3|||
27817577|NCT01528215|54275152|FG001|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0|||
27817578|NCT01527357|54275160|FG000|Overall Study|Death|8|||
27817579|NCT01527357|54275161|FG001|Overall Study|Death|2|||
27817580|NCT01527357|54275160|FG000|Overall Study|Lost to Follow-up|6|||
27817581|NCT01527357|54275161|FG001|Overall Study|Lost to Follow-up|4|||
27817582|NCT01527357|54275160|FG000|Overall Study|Withdrew Consent|1|||
27817583|NCT01527357|54275161|FG001|Overall Study|Withdrew Consent|1|||
27817584|NCT01527357|54275160|FG000|Overall Study|Non-compliance|0|||
27817585|NCT01527357|54275161|FG001|Overall Study|Non-compliance|1|||
27817586|NCT01527357|54275160|FG000|Overall Study|No Day 29 Visit|0|||
27817587|NCT01527357|54275161|FG001|Overall Study|No Day 29 Visit|1|||
27817588|NCT01527357|54275160|FG000|Overall Study|Did Not Receive Treatment|2|||
27817589|NCT01527357|54275161|FG001|Overall Study|Did Not Receive Treatment|0|||
27817590|NCT01526889|54275180|FG000|Treatment Period|Adverse Event|2|||
27817591|NCT01526889|54275181|FG001|Treatment Period|Adverse Event|0|||
27817592|NCT01526889|54275180|FG000|Treatment Extension Period|Administrative problems|1|||
27817593|NCT01526889|54275181|FG001|Treatment Extension Period|Administrative problems|0|||
28066515|NCT00471497|54722018|FG002|Extension Phase|Adverse Event|1|||
28066516|NCT00471497|54722016|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
28066517|NCT00471497|54722017|FG001|Extension Phase|Unsatisfactory therapeutic effect|6|||
28066518|NCT00471497|54722018|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
28066519|NCT00471497|54722016|FG000|Extension Phase|Withdrawal by Subject|3|||
28066520|NCT00471497|54722017|FG001|Extension Phase|Withdrawal by Subject|1|||
28066521|NCT00471497|54722018|FG002|Extension Phase|Withdrawal by Subject|0|||
28066522|NCT00471497|54722016|FG000|Extension Phase|Lost to Follow-up|2|||
28066523|NCT00471497|54722017|FG001|Extension Phase|Lost to Follow-up|0|||
28066524|NCT00471497|54722018|FG002|Extension Phase|Lost to Follow-up|0|||
28066525|NCT00471497|54722016|FG000|Extension Phase|Death|1|||
28066526|NCT00471497|54722017|FG001|Extension Phase|Death|0|||
28066527|NCT00471497|54722018|FG002|Extension Phase|Death|0|||
28066528|NCT00471497|54722016|FG000|Extension Phase|Disease progression|2|||
28066529|NCT00471497|54722017|FG001|Extension Phase|Disease progression|0|||
28066530|NCT00471497|54722018|FG002|Extension Phase|Disease progression|0|||
28066531|NCT00471497|54722016|FG000|Extension Phase|Protocol Violation|2|||
28066532|NCT00471497|54722017|FG001|Extension Phase|Protocol Violation|2|||
28066533|NCT00471497|54722018|FG002|Extension Phase|Protocol Violation|0|||
28066534|NCT00493649|54722029|FG000|Overall Study|Adverse Event|44|||
28066535|NCT00493649|54722029|FG000|Overall Study|Patient Request|21|||
28066536|NCT00493649|54722029|FG000|Overall Study|Investigator Request|2|||
28066537|NCT00493649|54722029|FG000|Overall Study|Disease Progression|1|||
28066538|NCT00493649|54722029|FG000|Overall Study|Lost to Follow-up|1|||
28066539|NCT00493649|54722029|FG000|Overall Study|Other|13|||
28066540|NCT00471107|54722039|FG000|Overall Study|Technical problems/data loss|3|||
28066541|NCT00471107|54722040|FG001|Overall Study|Technical problems/data loss|1|||
28066542|NCT00471107|54722041|FG002|Overall Study|Technical problems/data loss|3|||
28066543|NCT00488033|54722051|FG000|Overall Study|Withdrawal by Subject|1|||
28066544|NCT00488033|54722052|FG001|Overall Study|Withdrawal by Subject|0|||
28066545|NCT00117598|54722061|FG000|Prior to Treatment Cross Over|Death|40|||
27817594|NCT01472835|54275193|FG000|Overall Study|Lost to Follow-up|2|||
28066546|NCT00117598|54722062|FG001|Prior to Treatment Cross Over|Death|41|||
28066547|NCT00117598|54722063|FG002|Prior to Treatment Cross Over|Death|37|||
28066548|NCT00117598|54722064|FG003|Prior to Treatment Cross Over|Death|0|||
28066549|NCT00117598|54722065|FG004|Prior to Treatment Cross Over|Death|0|||
28066550|NCT00117598|54722061|FG000|Prior to Treatment Cross Over|Lost to Follow-up|0|||
28066551|NCT00117598|54722062|FG001|Prior to Treatment Cross Over|Lost to Follow-up|2|||
28066552|NCT00117598|54722063|FG002|Prior to Treatment Cross Over|Lost to Follow-up|2|||
28121468|NCT03293394|54781825|FG001|Follow-up (6 Months)|Adverse Event|2|||
28066553|NCT00117598|54722064|FG003|Prior to Treatment Cross Over|Lost to Follow-up|0|||
28066554|NCT00117598|54722065|FG004|Prior to Treatment Cross Over|Lost to Follow-up|0|||
28066555|NCT00117598|54722061|FG000|Prior to Treatment Cross Over|Withdrawal by Subject|2|||
27817595|NCT01472835|54275194|FG001|Overall Study|Lost to Follow-up|0|||
27817596|NCT01526733|54275207|FG000|Phase 1|Protocol Violation|1|||
27817597|NCT01526733|54275208|FG001|Phase 1|Protocol Violation|0|||
27817598|NCT01526733|54275207|FG000|Phase 1|Withdrawal by Subject|1|||
27817599|NCT01526733|54275208|FG001|Phase 1|Withdrawal by Subject|1|||
27817600|NCT01472757|54275253|FG000|Overall Study|Withdrawal by Subject|1|||
27817601|NCT01472757|54275254|FG001|Overall Study|Withdrawal by Subject|2|||
27817602|NCT01472757|54275255|FG002|Overall Study|Withdrawal by Subject|2|||
27817603|NCT01472757|54275256|FG003|Overall Study|Withdrawal by Subject|0|||
27817604|NCT01472757|54275253|FG000|Overall Study|Asthma exacerbation|4|||
27817605|NCT01472757|54275254|FG001|Overall Study|Asthma exacerbation|1|||
27817606|NCT01472757|54275255|FG002|Overall Study|Asthma exacerbation|2|||
27817607|NCT01472757|54275256|FG003|Overall Study|Asthma exacerbation|1|||
27817608|NCT01472757|54275253|FG000|Overall Study|Treatment period withdrawal criteria met|21|||
27817609|NCT01472757|54275254|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
27817610|NCT01472757|54275255|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
27817611|NCT01472757|54275256|FG003|Overall Study|Treatment period withdrawal criteria met|12|||
27817612|NCT01472757|54275253|FG000|Overall Study|Protocol Violation|3|||
28121469|NCT03259308|54781834|FG000|Overall Study|Adverse Event|5|||
28121470|NCT03259308|54781835|FG001|Overall Study|Adverse Event|4|||
28121471|NCT03259308|54781836|FG002|Overall Study|Adverse Event|1|||
28121472|NCT03259308|54781834|FG000|Overall Study|Withdrawal by Subject|2|||
28121473|NCT03259308|54781835|FG001|Overall Study|Withdrawal by Subject|1|||
28121474|NCT03259308|54781836|FG002|Overall Study|Withdrawal by Subject|3|||
28121475|NCT03259308|54781834|FG000|Overall Study|Lost to Follow-up|0|||
28121476|NCT03259308|54781835|FG001|Overall Study|Lost to Follow-up|0|||
28121477|NCT03259308|54781836|FG002|Overall Study|Lost to Follow-up|1|||
28121478|NCT03259308|54781834|FG000|Overall Study|Pregnancy|0|||
28121479|NCT03259308|54781835|FG001|Overall Study|Pregnancy|0|||
28121480|NCT03259308|54781836|FG002|Overall Study|Pregnancy|1|||
28121481|NCT03259308|54781834|FG000|Overall Study|Protocol Deviation|0|||
28121482|NCT03259308|54781835|FG001|Overall Study|Protocol Deviation|3|||
28121483|NCT03259308|54781836|FG002|Overall Study|Protocol Deviation|0|||
28121484|NCT03259308|54781834|FG000|Overall Study|Lack of Efficacy|0|||
28121485|NCT03259308|54781835|FG001|Overall Study|Lack of Efficacy|0|||
28121486|NCT03259308|54781836|FG002|Overall Study|Lack of Efficacy|1|||
28121487|NCT03258762|54781846|FG000|Overall Study|Lost to Follow-up|0|||
28121488|NCT03258762|54781847|FG001|Overall Study|Lost to Follow-up|1|||
28121489|NCT04502589|54781856|FG000|Overall Study|Physician Decision|1|||
28121490|NCT04502589|54781857|FG001|Overall Study|Physician Decision|0|||
28121491|NCT03291288|54781863|FG000|Drug-drug Interaction Phase|Adverse Event|2|||
28121492|NCT03291288|54781864|FG001|Drug-drug Interaction Phase|Adverse Event|0|||
28121493|NCT03291288|54781863|FG000|Drug-drug Interaction Phase|Disease progression|1|||
28121494|NCT03291288|54781864|FG001|Drug-drug Interaction Phase|Disease progression|0|||
28121495|NCT03291288|54781863|FG000|Drug-drug Interaction Phase|Other|3|||
28121496|NCT03291288|54781864|FG001|Drug-drug Interaction Phase|Other|0|||
28121497|NCT03291288|54781863|FG000|Pexidartinib Only|Ongoing|0|||
28121498|NCT03291288|54781864|FG001|Pexidartinib Only|Ongoing|2|||
28121499|NCT03257358|54781889|FG000|Overall Study|Adverse Event|25|||
28121500|NCT03257358|54781890|FG001|Overall Study|Adverse Event|12|||
28121501|NCT03257358|54781889|FG000|Overall Study|Lack of Efficacy|1|||
28121502|NCT03257358|54781890|FG001|Overall Study|Lack of Efficacy|1|||
28121503|NCT03257358|54781889|FG000|Overall Study|Lost to Follow-up|12|||
28121504|NCT03257358|54781890|FG001|Overall Study|Lost to Follow-up|4|||
28121505|NCT03257358|54781889|FG000|Overall Study|Non-compliance with fingolimod treatment|4|||
28121506|NCT03257358|54781890|FG001|Overall Study|Non-compliance with fingolimod treatment|2|||
27817613|NCT01472757|54275254|FG001|Overall Study|Protocol Violation|2|||
27817614|NCT01472757|54275255|FG002|Overall Study|Protocol Violation|4|||
27817615|NCT01472757|54275256|FG003|Overall Study|Protocol Violation|4|||
27817616|NCT01472757|54275253|FG000|Overall Study|Other reasons|1|||
27817617|NCT01472757|54275254|FG001|Overall Study|Other reasons|0|||
28066556|NCT00117598|54722062|FG001|Prior to Treatment Cross Over|Withdrawal by Subject|1|||
28066557|NCT00117598|54722063|FG002|Prior to Treatment Cross Over|Withdrawal by Subject|4|||
28066558|NCT00117598|54722064|FG003|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
28121507|NCT03257358|54781889|FG000|Overall Study|Physician Decision|2|||
28121508|NCT03257358|54781890|FG001|Overall Study|Physician Decision|2|||
28121509|NCT03257358|54781889|FG000|Overall Study|Protocol Violation|5|||
28121510|NCT03257358|54781890|FG001|Overall Study|Protocol Violation|3|||
28066559|NCT00117598|54722065|FG004|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
28066560|NCT00117598|54722061|FG000|Prior to Treatment Cross Over|Other|15|||
28066561|NCT00117598|54722062|FG001|Prior to Treatment Cross Over|Other|9|||
28066562|NCT00117598|54722063|FG002|Prior to Treatment Cross Over|Other|9|||
28121511|NCT03257358|54781889|FG000|Overall Study|Technical problems|4|||
28121512|NCT03257358|54781890|FG001|Overall Study|Technical problems|1|||
27817618|NCT01472757|54275255|FG002|Overall Study|Other reasons|2|||
27817619|NCT01472757|54275256|FG003|Overall Study|Other reasons|2|||
28121513|NCT03257358|54781889|FG000|Overall Study|Withdrawal by Subject|8|||
28121514|NCT03257358|54781890|FG001|Overall Study|Withdrawal by Subject|3|||
28121515|NCT03257358|54781889|FG000|Overall Study|Withdrawal of informed consent|9|||
28121516|NCT03257358|54781890|FG001|Overall Study|Withdrawal of informed consent|5|||
28121517|NCT03257358|54781889|FG000|Overall Study|New therapy for study indication|1|||
28121518|NCT03257358|54781890|FG001|Overall Study|New therapy for study indication|0|||
28121519|NCT03257358|54781889|FG000|Overall Study|No longer requires treatment|0|||
28121520|NCT03257358|54781890|FG001|Overall Study|No longer requires treatment|1|||
28121521|NCT02936037|54781898|FG000|Double-Blind Treatment Period|Protocol Violation|1|||
28121522|NCT02936037|54781899|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
28121523|NCT02936037|54781898|FG000|Double-Blind Treatment Period|Suicidal risk, etc.|2|||
28121524|NCT02936037|54781899|FG001|Double-Blind Treatment Period|Suicidal risk, etc.|8|||
28121525|NCT02936037|54781898|FG000|Double-Blind Treatment Period|Lack of Efficacy|4|||
28121526|NCT02936037|54781899|FG001|Double-Blind Treatment Period|Lack of Efficacy|12|||
28121527|NCT02936037|54781898|FG000|Double-Blind Treatment Period|Death|0|||
28121528|NCT02936037|54781899|FG001|Double-Blind Treatment Period|Death|1|||
28121529|NCT02936037|54781898|FG000|Double-Blind Treatment Period|Adverse Event|11|||
28121530|NCT02936037|54781899|FG001|Double-Blind Treatment Period|Adverse Event|11|||
28121531|NCT02936037|54781898|FG000|Double-Blind Treatment Period|Withdrawal by Subject|31|||
28121532|NCT02936037|54781899|FG001|Double-Blind Treatment Period|Withdrawal by Subject|28|||
28121533|NCT02936037|54781898|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
28121534|NCT02936037|54781899|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
28121535|NCT02936037|54781898|FG000|Open Label Extension|Adverse Event|0|||
28121536|NCT02936037|54781899|FG001|Open Label Extension|Adverse Event|3|||
28121537|NCT02936037|54781898|FG000|Open Label Extension|Other|0|||
28121538|NCT02936037|54781899|FG001|Open Label Extension|Other|3|||
28121539|NCT02936037|54781898|FG000|Open Label Extension|Withdrawal by Subject|0|||
28121540|NCT02936037|54781899|FG001|Open Label Extension|Withdrawal by Subject|4|||
28121541|NCT03288714|54781907|FG000|Overall Study|Lost to Follow-up|2|||
28121542|NCT03288714|54781908|FG001|Overall Study|Lost to Follow-up|1|||
28121543|NCT03288714|54781907|FG000|Overall Study|Non-compliance with study schedule|2|||
28121544|NCT03288714|54781908|FG001|Overall Study|Non-compliance with study schedule|0|||
28121545|NCT03288714|54781907|FG000|Overall Study|Withdrawal by Subject|3|||
28121546|NCT03288714|54781908|FG001|Overall Study|Withdrawal by Subject|1|||
28121547|NCT03288714|54781907|FG000|Overall Study|Clinical Worsening|2|||
28121548|NCT03288714|54781908|FG001|Overall Study|Clinical Worsening|1|||
28121549|NCT03288714|54781907|FG000|Overall Study|Adverse Event|1|||
27817620|NCT01472289|54275275|FG000|Overall Study|Death|2|||
27817621|NCT01525875|54275294|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
27817622|NCT01525875|54275295|FG001|Placebo-controlled Period|Withdrawal by Subject|2|||
27817623|NCT01525875|54275294|FG000|Open-label Period|Lost to Follow-up|0|||
28066563|NCT00117598|54722064|FG003|Prior to Treatment Cross Over|Other|0|||
28066564|NCT00117598|54722065|FG004|Prior to Treatment Cross Over|Other|0|||
28066565|NCT00117598|54722061|FG000|After Treament Cross Over|Death|0|||
28066566|NCT00117598|54722062|FG001|After Treament Cross Over|Death|0|||
28066567|NCT00117598|54722063|FG002|After Treament Cross Over|Death|0|||
28066568|NCT00117598|54722064|FG003|After Treament Cross Over|Death|1|||
28066569|NCT00117598|54722065|FG004|After Treament Cross Over|Death|2|||
28066570|NCT00117598|54722061|FG000|After Treament Cross Over|Withdrawal by Subject|0|||
28066571|NCT00117598|54722062|FG001|After Treament Cross Over|Withdrawal by Subject|0|||
28066572|NCT00117598|54722063|FG002|After Treament Cross Over|Withdrawal by Subject|0|||
28066573|NCT00117598|54722064|FG003|After Treament Cross Over|Withdrawal by Subject|1|||
28066574|NCT00117598|54722065|FG004|After Treament Cross Over|Withdrawal by Subject|0|||
28066575|NCT00117598|54722061|FG000|After Treament Cross Over|Other|0|||
28066576|NCT00117598|54722062|FG001|After Treament Cross Over|Other|0|||
28066577|NCT00117598|54722063|FG002|After Treament Cross Over|Other|0|||
28066578|NCT00117598|54722064|FG003|After Treament Cross Over|Other|1|||
28066579|NCT00117598|54722065|FG004|After Treament Cross Over|Other|2|||
28066580|NCT00469859|54722077|FG000|Overall Study|Inevaluable|0|||
28066581|NCT00469859|54722078|FG001|Overall Study|Inevaluable|2|||
28066582|NCT00093808|54722084|FG000|Overall Study|Cancel participation before receiving tx|1|||
28066583|NCT00093808|54722084|FG000|Overall Study|Protocol Violation|1|||
28066584|NCT00469079|54722091|FG000|Overall Study|Lack of Efficacy|3|||
28066585|NCT00469079|54722092|FG001|Overall Study|Lack of Efficacy|8|||
28066586|NCT00469079|54722093|FG002|Overall Study|Lack of Efficacy|5|||
28066587|NCT00469079|54722091|FG000|Overall Study|Adverse Event|1|||
28066588|NCT00469079|54722092|FG001|Overall Study|Adverse Event|3|||
28066589|NCT00469079|54722093|FG002|Overall Study|Adverse Event|2|||
28066590|NCT00469079|54722091|FG000|Overall Study|Lost to Follow-up|4|||
28066591|NCT00469079|54722092|FG001|Overall Study|Lost to Follow-up|8|||
28066592|NCT00469079|54722093|FG002|Overall Study|Lost to Follow-up|10|||
28066593|NCT00469079|54722091|FG000|Overall Study|Withdrawal by Subject|1|||
28066594|NCT00469079|54722092|FG001|Overall Study|Withdrawal by Subject|2|||
28066595|NCT00469079|54722093|FG002|Overall Study|Withdrawal by Subject|2|||
28066596|NCT00469079|54722091|FG000|Overall Study|Ineligible|0|||
28066597|NCT00469079|54722092|FG001|Overall Study|Ineligible|1|||
28066598|NCT00469079|54722093|FG002|Overall Study|Ineligible|0|||
28066599|NCT00093496|54722109|FG000|Overall Study|Protocol Violation|1|||
28066600|NCT00093496|54722110|FG001|Overall Study|Protocol Violation|3|||
28121550|NCT03288714|54781908|FG001|Overall Study|Adverse Event|0|||
28121551|NCT04068181|54781920|FG000|Overall Study|Withdrawal by Subject|2|||
28121552|NCT04068181|54781921|FG001|Overall Study|Withdrawal by Subject|0|||
28121553|NCT04068181|54781922|FG002|Overall Study|Withdrawal by Subject|0|||
28121554|NCT04068181|54781923|FG003|Overall Study|Withdrawal by Subject|0|||
28121555|NCT04068181|54781920|FG000|Overall Study|Lost to Follow-up|1|||
28121556|NCT04068181|54781921|FG001|Overall Study|Lost to Follow-up|0|||
28121557|NCT04068181|54781922|FG002|Overall Study|Lost to Follow-up|0|||
28121558|NCT04068181|54781923|FG003|Overall Study|Lost to Follow-up|0|||
28121559|NCT04068181|54781920|FG000|Overall Study|Death|8|||
28121560|NCT04068181|54781921|FG001|Overall Study|Death|8|||
28121561|NCT04068181|54781922|FG002|Overall Study|Death|4|||
28121562|NCT04068181|54781923|FG003|Overall Study|Death|2|||
28121563|NCT04068181|54781920|FG000|Overall Study|Continuing Study|16|||
28121564|NCT04068181|54781921|FG001|Overall Study|Continuing Study|7|||
28121565|NCT04068181|54781922|FG002|Overall Study|Continuing Study|11|||
28121566|NCT04068181|54781923|FG003|Overall Study|Continuing Study|13|||
28121567|NCT03256578|54781935|FG000|Overall Study|Excluded Post Randomization|66|||
28121568|NCT03256578|54781936|FG001|Overall Study|Excluded Post Randomization|56|||
28121569|NCT03227445|54781942|FG000|Period 1 (28 Days)|Adverse Event|1|||
28121570|NCT03227445|54781943|FG001|Period 1 (28 Days)|Adverse Event|2|||
28121571|NCT03227445|54781944|FG002|Period 1 (28 Days)|Adverse Event|0|||
28121572|NCT03227445|54781945|FG003|Period 1 (28 Days)|Adverse Event|1|||
28121573|NCT03227445|54781942|FG000|Period 1 (28 Days)|Protocol Violation|1|||
28121574|NCT03227445|54781943|FG001|Period 1 (28 Days)|Protocol Violation|0|||
28121575|NCT03227445|54781944|FG002|Period 1 (28 Days)|Protocol Violation|0|||
28121576|NCT03227445|54781945|FG003|Period 1 (28 Days)|Protocol Violation|0|||
28121577|NCT03227445|54781942|FG000|Period 1 (28 Days)|Withdrawal by Subject|0|||
28121578|NCT03227445|54781943|FG001|Period 1 (28 Days)|Withdrawal by Subject|0|||
28121579|NCT03227445|54781944|FG002|Period 1 (28 Days)|Withdrawal by Subject|1|||
28121580|NCT03227445|54781945|FG003|Period 1 (28 Days)|Withdrawal by Subject|1|||
28121581|NCT03227445|54781942|FG000|Period 2 (28 Days)|Adverse Event|1|||
28121582|NCT03227445|54781943|FG001|Period 2 (28 Days)|Adverse Event|0|||
28121583|NCT03227445|54781944|FG002|Period 2 (28 Days)|Adverse Event|2|||
28121584|NCT03227445|54781945|FG003|Period 2 (28 Days)|Adverse Event|1|||
28121585|NCT03227445|54781942|FG000|Period 2 (28 Days)|Protocol Violation|0|||
28121586|NCT03227445|54781943|FG001|Period 2 (28 Days)|Protocol Violation|0|||
28121587|NCT03227445|54781944|FG002|Period 2 (28 Days)|Protocol Violation|0|||
28121588|NCT03227445|54781945|FG003|Period 2 (28 Days)|Protocol Violation|1|||
28121589|NCT03227445|54781942|FG000|Period 2 (28 Days)|Withdrawal by Subject|0|||
28121590|NCT03227445|54781943|FG001|Period 2 (28 Days)|Withdrawal by Subject|1|||
28121591|NCT03227445|54781944|FG002|Period 2 (28 Days)|Withdrawal by Subject|0|||
28121592|NCT03227445|54781945|FG003|Period 2 (28 Days)|Withdrawal by Subject|1|||
28121593|NCT04067401|54781956|FG000|Overall Study|Withdrawal by Subject|7|||
28121594|NCT04067401|54781957|FG001|Overall Study|Withdrawal by Subject|0|||
28121595|NCT04067401|54781956|FG000|Overall Study|no data provided|1|||
28121596|NCT04067401|54781957|FG001|Overall Study|no data provided|0|||
28121597|NCT04194151|54781969|FG000|Overall Study|Physician Decision|1|||
28121598|NCT04194151|54781970|FG001|Overall Study|Physician Decision|1|||
28121599|NCT04194151|54781971|FG002|Overall Study|Physician Decision|1|||
28121600|NCT04194151|54781972|FG003|Overall Study|Physician Decision|1|||
28121601|NCT04194151|54781973|FG004|Overall Study|Physician Decision|0|||
28121602|NCT04194151|54781974|FG005|Overall Study|Physician Decision|1|||
28121603|NCT04194151|54781969|FG000|Overall Study|Monitorization problem|0|||
28121604|NCT04194151|54781970|FG001|Overall Study|Monitorization problem|1|||
28121605|NCT04194151|54781971|FG002|Overall Study|Monitorization problem|0|||
28121606|NCT04194151|54781972|FG003|Overall Study|Monitorization problem|0|||
28121607|NCT04194151|54781973|FG004|Overall Study|Monitorization problem|0|||
28121608|NCT04194151|54781974|FG005|Overall Study|Monitorization problem|0|||
28121609|NCT03820323|54781990|FG000|Overall Study|Lost to Follow-up|2|||
28121610|NCT03820323|54781991|FG001|Overall Study|Lost to Follow-up|1|||
28121611|NCT03820323|54781990|FG000|Overall Study|Missed 12-month visit|22|||
28121612|NCT03820323|54781991|FG001|Overall Study|Missed 12-month visit|14|||
28121613|NCT03820323|54781990|FG000|Overall Study|Death|2|||
28121614|NCT03820323|54781991|FG001|Overall Study|Death|1|||
28121615|NCT03820323|54781990|FG000|Overall Study|Transferred out|13|||
28121616|NCT03820323|54781991|FG001|Overall Study|Transferred out|11|||
28121617|NCT03820323|54781990|FG000|Overall Study|Terminated|0|||
28121618|NCT03820323|54781991|FG001|Overall Study|Terminated|3|||
28121619|NCT03820323|54781990|FG000|Overall Study|Withdrawal by Subject|1|||
28121620|NCT03820323|54781991|FG001|Overall Study|Withdrawal by Subject|6|||
28121621|NCT03287622|54782006|FG000|Overall Study|Withdrawal by Subject|1|||
28121622|NCT03287622|54782007|FG001|Overall Study|Withdrawal by Subject|0|||
28121623|NCT03287622|54782006|FG000|Overall Study|Lost to Follow-up|27|||
28121624|NCT03287622|54782007|FG001|Overall Study|Lost to Follow-up|15|||
28121625|NCT03287622|54782006|FG000|Overall Study|No prescripion after surgery|28|||
28121626|NCT03287622|54782007|FG001|Overall Study|No prescripion after surgery|31|||
28121627|NCT03287622|54782006|FG000|Overall Study|prolonged Length of stay|2|||
28121628|NCT03287622|54782007|FG001|Overall Study|prolonged Length of stay|0|||
28121629|NCT03287622|54782006|FG000|Overall Study|surgery related|0|||
28121630|NCT03287622|54782007|FG001|Overall Study|surgery related|2|||
28121631|NCT04063657|54782022|FG000|Overall Study|Lost to Follow-up|1|||
28121632|NCT04063657|54782023|FG001|Overall Study|Lost to Follow-up|0|||
28121633|NCT04058353|54782040|FG000|Overall Study|Adverse Event|2|||
28121634|NCT04058353|54782041|FG001|Overall Study|Adverse Event|1|||
28121635|NCT04058353|54782040|FG000|Overall Study|Physician Decision|1|||
28121636|NCT04058353|54782041|FG001|Overall Study|Physician Decision|0|||
28121637|NCT04058353|54782040|FG000|Overall Study|Other|1|||
28121638|NCT04058353|54782041|FG001|Overall Study|Other|0|||
28121639|NCT03226353|54782048|FG000|Overall Study|Withdrawal by Subject|1|||
28121640|NCT03226353|54782048|FG000|Overall Study|Screen Failure|5|||
28121641|NCT02730598|54782057|FG000|Overall Study|Withdrawal by Subject|3|||
28121642|NCT02730598|54782058|FG001|Overall Study|Withdrawal by Subject|3|||
28121643|NCT02730598|54782057|FG000|Overall Study|Protocol Violation|0|||
28121644|NCT02730598|54782058|FG001|Overall Study|Protocol Violation|1|||
28121645|NCT02730598|54782057|FG000|Overall Study|Unrelated Injury affecting outcomes.|1|||
28121646|NCT02730598|54782058|FG001|Overall Study|Unrelated Injury affecting outcomes.|0|||
27817624|NCT01525875|54275295|FG001|Open-label Period|Lost to Follow-up|2|||
28121647|NCT03226275|54782068|FG000|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
28121648|NCT03226275|54782069|FG001|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
28121649|NCT03226275|54782070|FG002|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1|||
28121650|NCT03226275|54782071|FG003|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
28121651|NCT03226275|54782068|FG000|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
28121652|NCT03226275|54782069|FG001|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
28121653|NCT03226275|54782070|FG002|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
28121654|NCT03226275|54782071|FG003|Treatment Period 1 (8 Days)|Protocol non-compliance|1|||
28121655|NCT04189081|54782084|FG000|Overall Study|Lost to Follow-up|1|||
28121656|NCT04189081|54782085|FG001|Overall Study|Lost to Follow-up|0|||
28121657|NCT04189081|54782086|FG002|Overall Study|Lost to Follow-up|0|||
28121658|NCT04189081|54782084|FG000|Overall Study|Withdrawal by Subject|0|||
28121659|NCT04189081|54782085|FG001|Overall Study|Withdrawal by Subject|0|||
28121660|NCT04189081|54782086|FG002|Overall Study|Withdrawal by Subject|1|||
28121661|NCT04187989|54782096|FG000|Overall Study - 3-Month Follow-Up|Lost to Follow-up|6|||
28121662|NCT04187989|54782097|FG001|Overall Study - 3-Month Follow-Up|Lost to Follow-up|8|||
28121663|NCT04187989|54782096|FG000|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
28121664|NCT04187989|54782097|FG001|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
28121665|NCT01150890|54782107|FG000|Overall Study|Other|0|||
28121666|NCT01150890|54782108|FG001|Overall Study|Other|1|||
28121667|NCT01150890|54782109|FG002|Overall Study|Other|0|||
28121668|NCT01150890|54782110|FG003|Overall Study|Other|2|||
28121669|NCT01150890|54782107|FG000|Overall Study|Pregnancy|0|||
28121670|NCT01150890|54782108|FG001|Overall Study|Pregnancy|0|||
28121671|NCT01150890|54782109|FG002|Overall Study|Pregnancy|0|||
27817625|NCT01525641|54275301|FG000|Overall Study|Case report form not collected|25|||
27817626|NCT01525641|54275301|FG000|Overall Study|No visit since the first visit|16|||
27817627|NCT01525641|54275301|FG000|Overall Study|Adverse Event|73|||
27817628|NCT01525641|54275301|FG000|Overall Study|Lack of Efficacy|24|||
27817629|NCT01525641|54275301|FG000|Overall Study|Improvement|5|||
27817630|NCT01525641|54275301|FG000|Overall Study|Lost to follow-up (relocation)|1|||
27817631|NCT01525641|54275301|FG000|Overall Study|Lost to follow-up (Unknown reason)|10|||
27817632|NCT01525641|54275301|FG000|Overall Study|Lost to follow-up (Changing hospital)|19|||
27817633|NCT01525641|54275301|FG000|Overall Study|Other than stated above|7|||
28121672|NCT01150890|54782110|FG003|Overall Study|Pregnancy|1|||
28121673|NCT01150890|54782107|FG000|Overall Study|Administrative Decision|4|||
28121674|NCT01150890|54782108|FG001|Overall Study|Administrative Decision|4|||
28121675|NCT01150890|54782109|FG002|Overall Study|Administrative Decision|5|||
28121676|NCT01150890|54782110|FG003|Overall Study|Administrative Decision|6|||
28121677|NCT01150890|54782107|FG000|Overall Study|Ineligibility determined|0|||
28121678|NCT01150890|54782108|FG001|Overall Study|Ineligibility determined|1|||
28121679|NCT01150890|54782109|FG002|Overall Study|Ineligibility determined|0|||
28121680|NCT01150890|54782110|FG003|Overall Study|Ineligibility determined|0|||
28121681|NCT01150890|54782107|FG000|Overall Study|Adverse Event|0|||
28121682|NCT01150890|54782108|FG001|Overall Study|Adverse Event|0|||
28121683|NCT01150890|54782109|FG002|Overall Study|Adverse Event|2|||
27817634|NCT01496469|54275316|FG000|Overall Study|Adverse Event|1|||
27817635|NCT01496469|54275317|FG001|Overall Study|Adverse Event|0|||
28121684|NCT01150890|54782110|FG003|Overall Study|Adverse Event|0|||
28121685|NCT01150890|54782107|FG000|Overall Study|Withdrawal by Subject|0|||
28121686|NCT01150890|54782108|FG001|Overall Study|Withdrawal by Subject|0|||
28121687|NCT01150890|54782109|FG002|Overall Study|Withdrawal by Subject|2|||
28121688|NCT01150890|54782110|FG003|Overall Study|Withdrawal by Subject|1|||
27817636|NCT01496469|54275316|FG000|Overall Study|Protocol Violation|2|||
27817637|NCT01496469|54275317|FG001|Overall Study|Protocol Violation|0|||
28121689|NCT01150890|54782107|FG000|Overall Study|Disease progression|0|||
27817638|NCT01496469|54275316|FG000|Overall Study|Lost to Follow-up|1|||
27817639|NCT01496469|54275317|FG001|Overall Study|Lost to Follow-up|1|||
27817640|NCT01496469|54275316|FG000|Overall Study|Withdrawal by Subject|4|||
27817641|NCT01496469|54275317|FG001|Overall Study|Withdrawal by Subject|4|||
27817642|NCT01496469|54275316|FG000|Overall Study|BP exceeds protocol limits|1|||
27817643|NCT01496469|54275317|FG001|Overall Study|BP exceeds protocol limits|2|||
27817644|NCT01496469|54275316|FG000|Overall Study|Other|1|||
27817645|NCT01496469|54275317|FG001|Overall Study|Other|1|||
27817646|NCT01471353|54275332|FG000|Overall Study|remain on study|3|||
27817647|NCT01525407|54275338|FG000|Overall Study|Change in recipient treatment plan|2|||
27817648|NCT01525407|54275339|FG001|Overall Study|Change in recipient treatment plan|2|||
27817649|NCT01525407|54275338|FG000|Overall Study|Withdrawal by Subject|0|||
27817650|NCT01525407|54275339|FG001|Overall Study|Withdrawal by Subject|1|||
27817651|NCT01525407|54275338|FG000|Overall Study|Transplant was delayed|0|||
27817652|NCT01525407|54275339|FG001|Overall Study|Transplant was delayed|1|||
27817653|NCT01525407|54275338|FG000|Overall Study|Delay in Transplant|1|||
27817654|NCT01525407|54275339|FG001|Overall Study|Delay in Transplant|0|||
28066601|NCT00117286|54722117|FG000|Overall Study|Adverse Event|12|||
28066602|NCT00117286|54722118|FG001|Overall Study|Adverse Event|6|||
28066603|NCT00117286|54722117|FG000|Overall Study|Lost to Follow-up|2|||
27817655|NCT01471197|54275347|FG000|Overall Study|Disease Progression|4|||
28066604|NCT00117286|54722118|FG001|Overall Study|Lost to Follow-up|0|||
28066605|NCT00117286|54722117|FG000|Overall Study|Protocol Violation|3|||
28066606|NCT00117286|54722118|FG001|Overall Study|Protocol Violation|3|||
28066607|NCT00117286|54722117|FG000|Overall Study|Withdrawal by Subject|6|||
28066608|NCT00117286|54722118|FG001|Overall Study|Withdrawal by Subject|2|||
28066609|NCT00117286|54722117|FG000|Overall Study|Physician Decision|3|||
28066610|NCT00117286|54722118|FG001|Overall Study|Physician Decision|7|||
28066611|NCT00117286|54722117|FG000|Overall Study|Lack of Efficacy|2|||
28121690|NCT01150890|54782108|FG001|Overall Study|Disease progression|7|||
28121691|NCT01150890|54782109|FG002|Overall Study|Disease progression|3|||
28121692|NCT01150890|54782110|FG003|Overall Study|Disease progression|7|||
28121693|NCT04057573|54782125|FG000|24-Week Double-Blind Period|Adverse Event|2|||
28121694|NCT04057573|54782126|FG001|24-Week Double-Blind Period|Adverse Event|0|||
28121695|NCT04057573|54782127|FG002|24-Week Double-Blind Period|Adverse Event|0|||
28121696|NCT04057573|54782128|FG003|24-Week Double-Blind Period|Adverse Event|0|||
28121697|NCT04057573|54782125|FG000|24-Week Double-Blind Period|Lack of Efficacy|0|||
27817656|NCT01471197|54275348|FG001|Overall Study|Disease Progression|2|||
28066612|NCT00117286|54722118|FG001|Overall Study|Lack of Efficacy|1|||
28066613|NCT00117286|54722117|FG000|Overall Study|Research site closing|0|||
28121698|NCT04057573|54782126|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
28121699|NCT04057573|54782127|FG002|24-Week Double-Blind Period|Lack of Efficacy|0|||
28121700|NCT04057573|54782128|FG003|24-Week Double-Blind Period|Lack of Efficacy|0|||
28121701|NCT04057573|54782125|FG000|24-Week Double-Blind Period|Lost to Follow-up|11|||
28121702|NCT04057573|54782126|FG001|24-Week Double-Blind Period|Lost to Follow-up|6|||
28121703|NCT04057573|54782127|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
28121704|NCT04057573|54782128|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
28121705|NCT04057573|54782125|FG000|24-Week Double-Blind Period|Physician Decision|1|||
28121706|NCT04057573|54782126|FG001|24-Week Double-Blind Period|Physician Decision|0|||
28121707|NCT04057573|54782127|FG002|24-Week Double-Blind Period|Physician Decision|0|||
28121708|NCT04057573|54782128|FG003|24-Week Double-Blind Period|Physician Decision|0|||
28121709|NCT04057573|54782125|FG000|24-Week Double-Blind Period|Pregnancy|1|||
28121710|NCT04057573|54782126|FG001|24-Week Double-Blind Period|Pregnancy|0|||
28121711|NCT04057573|54782127|FG002|24-Week Double-Blind Period|Pregnancy|0|||
28121712|NCT04057573|54782128|FG003|24-Week Double-Blind Period|Pregnancy|0|||
28121713|NCT04057573|54782125|FG000|24-Week Double-Blind Period|Withdrawal by Subject|10|||
28121714|NCT04057573|54782126|FG001|24-Week Double-Blind Period|Withdrawal by Subject|8|||
28121715|NCT04057573|54782127|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
28121716|NCT04057573|54782128|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
28121717|NCT04057573|54782125|FG000|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|3|||
28121718|NCT04057573|54782126|FG001|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|1|||
28121719|NCT04057573|54782127|FG002|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
28121720|NCT04057573|54782128|FG003|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
28121721|NCT04057573|54782125|FG000|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|1|||
28121722|NCT04057573|54782126|FG001|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
28121723|NCT04057573|54782127|FG002|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
28121724|NCT04057573|54782128|FG003|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
28121725|NCT04057573|54782125|FG000|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
28121726|NCT04057573|54782126|FG001|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|1|||
28121727|NCT04057573|54782127|FG002|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
28121728|NCT04057573|54782128|FG003|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
28121729|NCT04057573|54782125|FG000|24-Week Double-Blind Period|Not Treated|1|||
28121730|NCT04057573|54782126|FG001|24-Week Double-Blind Period|Not Treated|0|||
28121731|NCT04057573|54782127|FG002|24-Week Double-Blind Period|Not Treated|0|||
28121732|NCT04057573|54782128|FG003|24-Week Double-Blind Period|Not Treated|0|||
28121733|NCT04057573|54782125|FG000|28-Week Treatment Extension Period|Adverse Event|0|||
28121734|NCT04057573|54782126|FG001|28-Week Treatment Extension Period|Adverse Event|0|||
28121735|NCT04057573|54782127|FG002|28-Week Treatment Extension Period|Adverse Event|1|||
28121736|NCT04057573|54782128|FG003|28-Week Treatment Extension Period|Adverse Event|0|||
28121737|NCT04057573|54782125|FG000|28-Week Treatment Extension Period|Lack of Efficacy|0|||
28121738|NCT04057573|54782126|FG001|28-Week Treatment Extension Period|Lack of Efficacy|0|||
28121739|NCT04057573|54782127|FG002|28-Week Treatment Extension Period|Lack of Efficacy|1|||
28121740|NCT04057573|54782128|FG003|28-Week Treatment Extension Period|Lack of Efficacy|0|||
28121741|NCT04057573|54782125|FG000|28-Week Treatment Extension Period|Lost to Follow-up|0|||
28121742|NCT04057573|54782126|FG001|28-Week Treatment Extension Period|Lost to Follow-up|0|||
28121743|NCT04057573|54782127|FG002|28-Week Treatment Extension Period|Lost to Follow-up|9|||
28121744|NCT04057573|54782128|FG003|28-Week Treatment Extension Period|Lost to Follow-up|10|||
28121745|NCT04057573|54782125|FG000|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
28121746|NCT04057573|54782126|FG001|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
28121747|NCT04057573|54782127|FG002|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
28121748|NCT04057573|54782128|FG003|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
28121749|NCT04057573|54782125|FG000|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
28121750|NCT04057573|54782126|FG001|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
28121751|NCT04057573|54782127|FG002|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|1|||
28121752|NCT04057573|54782128|FG003|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
28121753|NCT04054765|54782141|FG000|Baseline|Withdrawal by Subject|5|||
28121754|NCT04054765|54782142|FG001|Baseline|Withdrawal by Subject|3|||
28121755|NCT04054765|54782141|FG000|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|8|||
28121756|NCT04054765|54782142|FG001|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|3|||
28121757|NCT04054765|54782141|FG000|3-month Follow up|Withdrawal by Subject|0|||
28121758|NCT04054765|54782142|FG001|3-month Follow up|Withdrawal by Subject|3|||
28121759|NCT04054765|54782141|FG000|6-month Follow up|Lost to Follow-up|32|||
28121760|NCT04054765|54782142|FG001|6-month Follow up|Lost to Follow-up|32|||
28121761|NCT04179721|54782150|FG000|Overall Study|COVID-19 Related Lost of Followup|11|||
28121762|NCT04179721|54782151|FG001|Overall Study|COVID-19 Related Lost of Followup|13|||
28121763|NCT04179721|54782150|FG000|Overall Study|Lost to Follow-up|0|||
28121764|NCT04179721|54782151|FG001|Overall Study|Lost to Follow-up|1|||
28121765|NCT03286218|54782157|FG000|Qualification Phase Period 1|Adverse Event|1|||
28121766|NCT03286218|54782158|FG001|Qualification Phase Period 1|Adverse Event|0|||
28121767|NCT03286218|54782159|FG002|Qualification Phase Period 1|Adverse Event|0|||
28121768|NCT03286218|54782160|FG003|Qualification Phase Period 1|Adverse Event|0|||
28121769|NCT03286218|54782161|FG004|Qualification Phase Period 1|Adverse Event|0|||
28121770|NCT03286218|54782162|FG005|Qualification Phase Period 1|Adverse Event|0|||
28121771|NCT03286218|54782163|FG006|Qualification Phase Period 1|Adverse Event|0|||
28121772|NCT03286218|54782164|FG007|Qualification Phase Period 1|Adverse Event|0|||
28121773|NCT03286218|54782165|FG008|Qualification Phase Period 1|Adverse Event|0|||
28121774|NCT03286218|54782166|FG009|Qualification Phase Period 1|Adverse Event|0|||
28121775|NCT03286218|54782167|FG010|Qualification Phase Period 1|Adverse Event|0|||
28121776|NCT03286218|54782168|FG011|Qualification Phase Period 1|Adverse Event|0|||
28121777|NCT03286218|54782157|FG000|Qualification Phase Period 1|Withdrawal by Subject|0|||
28121778|NCT03286218|54782158|FG001|Qualification Phase Period 1|Withdrawal by Subject|1|||
28121779|NCT03286218|54782159|FG002|Qualification Phase Period 1|Withdrawal by Subject|0|||
28121780|NCT03286218|54782160|FG003|Qualification Phase Period 1|Withdrawal by Subject|0|||
28121781|NCT03286218|54782161|FG004|Qualification Phase Period 1|Withdrawal by Subject|0|||
28121782|NCT03286218|54782162|FG005|Qualification Phase Period 1|Withdrawal by Subject|0|||
28121783|NCT03286218|54782163|FG006|Qualification Phase Period 1|Withdrawal by Subject|0|||
28121784|NCT03286218|54782164|FG007|Qualification Phase Period 1|Withdrawal by Subject|0|||
28121785|NCT03286218|54782165|FG008|Qualification Phase Period 1|Withdrawal by Subject|0|||
28121786|NCT03286218|54782166|FG009|Qualification Phase Period 1|Withdrawal by Subject|0|||
28121787|NCT03286218|54782167|FG010|Qualification Phase Period 1|Withdrawal by Subject|0|||
28121788|NCT03286218|54782168|FG011|Qualification Phase Period 1|Withdrawal by Subject|0|||
28121789|NCT03286218|54782157|FG000|Qualification Phase Period 2|Adverse Event|0|||
28121790|NCT03286218|54782158|FG001|Qualification Phase Period 2|Adverse Event|1|||
28121791|NCT03286218|54782159|FG002|Qualification Phase Period 2|Adverse Event|0|||
28121792|NCT03286218|54782160|FG003|Qualification Phase Period 2|Adverse Event|0|||
28121793|NCT03286218|54782161|FG004|Qualification Phase Period 2|Adverse Event|0|||
28121794|NCT03286218|54782162|FG005|Qualification Phase Period 2|Adverse Event|0|||
28121795|NCT03286218|54782163|FG006|Qualification Phase Period 2|Adverse Event|0|||
28121796|NCT03286218|54782164|FG007|Qualification Phase Period 2|Adverse Event|0|||
28121797|NCT03286218|54782165|FG008|Qualification Phase Period 2|Adverse Event|0|||
28121798|NCT03286218|54782166|FG009|Qualification Phase Period 2|Adverse Event|0|||
28121799|NCT03286218|54782167|FG010|Qualification Phase Period 2|Adverse Event|0|||
28121800|NCT03286218|54782168|FG011|Qualification Phase Period 2|Adverse Event|0|||
28121801|NCT03286218|54782157|FG000|Qualification Phase Period 2|Failure to meet randomization criteria|14|||
28121802|NCT03286218|54782158|FG001|Qualification Phase Period 2|Failure to meet randomization criteria|15|||
28121803|NCT03286218|54782159|FG002|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
28121804|NCT03286218|54782160|FG003|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
28121805|NCT03286218|54782161|FG004|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
28121806|NCT03286218|54782162|FG005|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
28121807|NCT03286218|54782163|FG006|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
28121808|NCT03286218|54782164|FG007|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
28121809|NCT03286218|54782165|FG008|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
28121810|NCT03286218|54782166|FG009|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
28121811|NCT03286218|54782167|FG010|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
28121812|NCT03286218|54782168|FG011|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
28121813|NCT03286218|54782157|FG000|Qualification Phase Period 2|Lost to Follow-up|0|||
28121814|NCT03286218|54782158|FG001|Qualification Phase Period 2|Lost to Follow-up|1|||
28121815|NCT03286218|54782159|FG002|Qualification Phase Period 2|Lost to Follow-up|0|||
28121816|NCT03286218|54782160|FG003|Qualification Phase Period 2|Lost to Follow-up|0|||
28121817|NCT03286218|54782161|FG004|Qualification Phase Period 2|Lost to Follow-up|0|||
28121818|NCT03286218|54782162|FG005|Qualification Phase Period 2|Lost to Follow-up|0|||
28121819|NCT03286218|54782163|FG006|Qualification Phase Period 2|Lost to Follow-up|0|||
28121820|NCT03286218|54782164|FG007|Qualification Phase Period 2|Lost to Follow-up|0|||
28121821|NCT03286218|54782165|FG008|Qualification Phase Period 2|Lost to Follow-up|0|||
28121822|NCT03286218|54782166|FG009|Qualification Phase Period 2|Lost to Follow-up|0|||
28121823|NCT03286218|54782167|FG010|Qualification Phase Period 2|Lost to Follow-up|0|||
28121824|NCT03286218|54782168|FG011|Qualification Phase Period 2|Lost to Follow-up|0|||
28121825|NCT03286218|54782157|FG000|Qualification Phase Period 2|Protocol Violation|2|||
28121826|NCT03286218|54782158|FG001|Qualification Phase Period 2|Protocol Violation|0|||
28121827|NCT03286218|54782159|FG002|Qualification Phase Period 2|Protocol Violation|0|||
28121828|NCT03286218|54782160|FG003|Qualification Phase Period 2|Protocol Violation|0|||
28121829|NCT03286218|54782161|FG004|Qualification Phase Period 2|Protocol Violation|0|||
28121830|NCT03286218|54782162|FG005|Qualification Phase Period 2|Protocol Violation|0|||
28121831|NCT03286218|54782163|FG006|Qualification Phase Period 2|Protocol Violation|0|||
28121832|NCT03286218|54782164|FG007|Qualification Phase Period 2|Protocol Violation|0|||
28121833|NCT03286218|54782165|FG008|Qualification Phase Period 2|Protocol Violation|0|||
28121834|NCT03286218|54782166|FG009|Qualification Phase Period 2|Protocol Violation|0|||
28121835|NCT03286218|54782167|FG010|Qualification Phase Period 2|Protocol Violation|0|||
28121836|NCT03286218|54782168|FG011|Qualification Phase Period 2|Protocol Violation|0|||
28121837|NCT03286218|54782157|FG000|Qualification Phase Period 2|Withdrawal by Subject|1|||
28121838|NCT03286218|54782158|FG001|Qualification Phase Period 2|Withdrawal by Subject|2|||
28121839|NCT03286218|54782159|FG002|Qualification Phase Period 2|Withdrawal by Subject|0|||
28121840|NCT03286218|54782160|FG003|Qualification Phase Period 2|Withdrawal by Subject|0|||
28121841|NCT03286218|54782161|FG004|Qualification Phase Period 2|Withdrawal by Subject|0|||
28121842|NCT03286218|54782162|FG005|Qualification Phase Period 2|Withdrawal by Subject|0|||
28121843|NCT03286218|54782163|FG006|Qualification Phase Period 2|Withdrawal by Subject|0|||
28121844|NCT03286218|54782164|FG007|Qualification Phase Period 2|Withdrawal by Subject|0|||
28121845|NCT03286218|54782165|FG008|Qualification Phase Period 2|Withdrawal by Subject|0|||
28121846|NCT03286218|54782166|FG009|Qualification Phase Period 2|Withdrawal by Subject|0|||
28121847|NCT03286218|54782167|FG010|Qualification Phase Period 2|Withdrawal by Subject|0|||
28121848|NCT03286218|54782168|FG011|Qualification Phase Period 2|Withdrawal by Subject|0|||
28121849|NCT03286218|54782157|FG000|Treatment Phase Period 1|Withdrawal by Subject|0|||
28121850|NCT03286218|54782158|FG001|Treatment Phase Period 1|Withdrawal by Subject|0|||
28121851|NCT03286218|54782159|FG002|Treatment Phase Period 1|Withdrawal by Subject|1|||
28121852|NCT03286218|54782160|FG003|Treatment Phase Period 1|Withdrawal by Subject|1|||
28121853|NCT03286218|54782161|FG004|Treatment Phase Period 1|Withdrawal by Subject|0|||
28121854|NCT03286218|54782162|FG005|Treatment Phase Period 1|Withdrawal by Subject|1|||
28121855|NCT03286218|54782163|FG006|Treatment Phase Period 1|Withdrawal by Subject|0|||
28121856|NCT03286218|54782164|FG007|Treatment Phase Period 1|Withdrawal by Subject|0|||
28121857|NCT03286218|54782165|FG008|Treatment Phase Period 1|Withdrawal by Subject|0|||
28121858|NCT03286218|54782166|FG009|Treatment Phase Period 1|Withdrawal by Subject|0|||
28121859|NCT03286218|54782167|FG010|Treatment Phase Period 1|Withdrawal by Subject|0|||
28121860|NCT03286218|54782168|FG011|Treatment Phase Period 1|Withdrawal by Subject|1|||
28121861|NCT03286218|54782157|FG000|Treatment Phase Period 4|Withdrawal by Subject|0|||
28121862|NCT03286218|54782158|FG001|Treatment Phase Period 4|Withdrawal by Subject|0|||
27849274|NCT02085161|54344601|FG000|Overall Study|Withdrawal by Subject|2|||
28121863|NCT03286218|54782159|FG002|Treatment Phase Period 4|Withdrawal by Subject|0|||
28121864|NCT03286218|54782160|FG003|Treatment Phase Period 4|Withdrawal by Subject|0|||
28121865|NCT03286218|54782161|FG004|Treatment Phase Period 4|Withdrawal by Subject|0|||
28121866|NCT03286218|54782162|FG005|Treatment Phase Period 4|Withdrawal by Subject|0|||
28121867|NCT03286218|54782163|FG006|Treatment Phase Period 4|Withdrawal by Subject|0|||
28121868|NCT03286218|54782164|FG007|Treatment Phase Period 4|Withdrawal by Subject|0|||
28121869|NCT03286218|54782165|FG008|Treatment Phase Period 4|Withdrawal by Subject|0|||
28121870|NCT03286218|54782166|FG009|Treatment Phase Period 4|Withdrawal by Subject|0|||
28121871|NCT03286218|54782167|FG010|Treatment Phase Period 4|Withdrawal by Subject|0|||
28121872|NCT03286218|54782168|FG011|Treatment Phase Period 4|Withdrawal by Subject|1|||
28121873|NCT03224325|54782202|FG000|Overall Study|Adverse Event|1|||
28121874|NCT03224325|54782203|FG001|Overall Study|Adverse Event|0|||
28121875|NCT03224325|54782204|FG002|Overall Study|Adverse Event|0|||
28121876|NCT03224325|54782205|FG003|Overall Study|Adverse Event|0|||
28121877|NCT03224325|54782206|FG004|Overall Study|Adverse Event|0|||
28121878|NCT03224325|54782207|FG005|Overall Study|Adverse Event|0|||
28121879|NCT03224325|54782208|FG006|Overall Study|Adverse Event|1|||
28121880|NCT03224325|54782202|FG000|Overall Study|Withdrawal by Subject|0|||
28121881|NCT03224325|54782203|FG001|Overall Study|Withdrawal by Subject|0|||
28121882|NCT03224325|54782204|FG002|Overall Study|Withdrawal by Subject|0|||
28121883|NCT03224325|54782205|FG003|Overall Study|Withdrawal by Subject|1|||
28121884|NCT03224325|54782206|FG004|Overall Study|Withdrawal by Subject|0|||
28121885|NCT03224325|54782207|FG005|Overall Study|Withdrawal by Subject|0|||
28121886|NCT03224325|54782208|FG006|Overall Study|Withdrawal by Subject|0|||
28121887|NCT04016779|54782232|FG000|Overall Study|Adverse Event|9|||
28121888|NCT04016779|54782233|FG001|Overall Study|Adverse Event|17|||
28121889|NCT04016779|54782232|FG000|Overall Study|Lack of Efficacy|4|||
28121890|NCT04016779|54782233|FG001|Overall Study|Lack of Efficacy|1|||
28121891|NCT04016779|54782232|FG000|Overall Study|Lost to Follow-up|5|||
28121892|NCT04016779|54782233|FG001|Overall Study|Lost to Follow-up|14|||
28121893|NCT04016779|54782232|FG000|Overall Study|Physician Decision|1|||
28121894|NCT04016779|54782233|FG001|Overall Study|Physician Decision|3|||
28121895|NCT04016779|54782232|FG000|Overall Study|Withdrawal by Subject|6|||
28121896|NCT04016779|54782233|FG001|Overall Study|Withdrawal by Subject|8|||
28121897|NCT04016779|54782232|FG000|Overall Study|Non-compliance with Study Drug|2|||
28121898|NCT04016779|54782233|FG001|Overall Study|Non-compliance with Study Drug|3|||
28121899|NCT04016779|54782232|FG000|Overall Study|Other, Multiple categories|17|||
28121900|NCT04016779|54782233|FG001|Overall Study|Other, Multiple categories|17|||
28121901|NCT02857426|54782243|FG000|Overall Study|Disease progression|34|||
28121902|NCT02857426|54782244|FG001|Overall Study|Disease progression|13|||
28121903|NCT02857426|54782243|FG000|Overall Study|Study drug toxicity|4|||
28121904|NCT02857426|54782244|FG001|Overall Study|Study drug toxicity|1|||
28121905|NCT02857426|54782243|FG000|Overall Study|Death|1|||
28121906|NCT02857426|54782244|FG001|Overall Study|Death|0|||
28121907|NCT02857426|54782243|FG000|Overall Study|Adverse event unrelated to study drug|6|||
28121908|NCT02857426|54782244|FG001|Overall Study|Adverse event unrelated to study drug|2|||
28121909|NCT02857426|54782243|FG000|Overall Study|Participant withdrew consent|1|||
28121910|NCT02857426|54782244|FG001|Overall Study|Participant withdrew consent|1|||
28121911|NCT02857426|54782243|FG000|Overall Study|Maximum clinical benefit|1|||
28121912|NCT02857426|54782244|FG001|Overall Study|Maximum clinical benefit|0|||
28121913|NCT02857426|54782243|FG000|Overall Study|Completed treatment|0|||
27817657|NCT01471197|54275347|FG000|Overall Study|Death|1|||
28121914|NCT02857426|54782244|FG001|Overall Study|Completed treatment|2|||
28121915|NCT01127256|54782252|FG000|Overall Study|Adverse Event|13|||
28121916|NCT01127256|54782253|FG001|Overall Study|Adverse Event|13|||
28121917|NCT01127256|54782252|FG000|Overall Study|Lack of Efficacy|4|||
28121918|NCT01127256|54782253|FG001|Overall Study|Lack of Efficacy|0|||
28121919|NCT01127256|54782252|FG000|Overall Study|Lost to Follow-up|16|||
28121920|NCT01127256|54782253|FG001|Overall Study|Lost to Follow-up|17|||
28121921|NCT01127256|54782252|FG000|Overall Study|Withdrawal by Subject|5|||
28121922|NCT01127256|54782253|FG001|Overall Study|Withdrawal by Subject|9|||
28121923|NCT01127256|54782252|FG000|Overall Study|Protocol Violation|1|||
28121924|NCT01127256|54782253|FG001|Overall Study|Protocol Violation|0|||
28121925|NCT03668613|54782261|FG000|Overall Study|Adverse Event|0|||
28121926|NCT03668613|54782262|FG001|Overall Study|Adverse Event|2|||
28121927|NCT03668613|54782261|FG000|Overall Study|Lack of Efficacy|0|||
28121928|NCT03668613|54782262|FG001|Overall Study|Lack of Efficacy|1|||
28121929|NCT04016311|54782271|FG000|Overall Study|Withdrawal by Subject|1|||
28121930|NCT04016311|54782272|FG001|Overall Study|Withdrawal by Subject|0|||
28121931|NCT04052425|54782282|FG000|24-Week Double-blind Period|Adverse Event|0|||
28121932|NCT04052425|54782283|FG001|24-Week Double-blind Period|Adverse Event|1|||
28121933|NCT04052425|54782284|FG002|24-Week Double-blind Period|Adverse Event|0|||
28121934|NCT04052425|54782285|FG003|24-Week Double-blind Period|Adverse Event|0|||
27817658|NCT01471197|54275348|FG001|Overall Study|Death|0|||
27817659|NCT01471197|54275347|FG000|Overall Study|Study Drug Toxicity|1|||
27817660|NCT01471197|54275348|FG001|Overall Study|Study Drug Toxicity|0|||
28121935|NCT04052425|54782282|FG000|24-Week Double-blind Period|Lack of Efficacy|0|||
28066614|NCT00117286|54722118|FG001|Overall Study|Research site closing|2|||
28121936|NCT04052425|54782283|FG001|24-Week Double-blind Period|Lack of Efficacy|1|||
28121937|NCT04052425|54782284|FG002|24-Week Double-blind Period|Lack of Efficacy|0|||
28121938|NCT04052425|54782285|FG003|24-Week Double-blind Period|Lack of Efficacy|0|||
28121939|NCT04052425|54782282|FG000|24-Week Double-blind Period|Lost to Follow-up|14|||
28121940|NCT04052425|54782283|FG001|24-Week Double-blind Period|Lost to Follow-up|7|||
28121941|NCT04052425|54782284|FG002|24-Week Double-blind Period|Lost to Follow-up|0|||
28121942|NCT04052425|54782285|FG003|24-Week Double-blind Period|Lost to Follow-up|0|||
28121943|NCT04052425|54782282|FG000|24-Week Double-blind Period|Physician Decision|1|||
28121944|NCT04052425|54782283|FG001|24-Week Double-blind Period|Physician Decision|0|||
28121945|NCT04052425|54782284|FG002|24-Week Double-blind Period|Physician Decision|0|||
28121946|NCT04052425|54782285|FG003|24-Week Double-blind Period|Physician Decision|0|||
28121947|NCT04052425|54782282|FG000|24-Week Double-blind Period|Protocol Violation|1|||
28121948|NCT04052425|54782283|FG001|24-Week Double-blind Period|Protocol Violation|0|||
28121949|NCT04052425|54782284|FG002|24-Week Double-blind Period|Protocol Violation|0|||
28121950|NCT04052425|54782285|FG003|24-Week Double-blind Period|Protocol Violation|0|||
28121951|NCT04052425|54782282|FG000|24-Week Double-blind Period|Withdrawal by Subject|9|||
28121952|NCT04052425|54782283|FG001|24-Week Double-blind Period|Withdrawal by Subject|10|||
28121953|NCT04052425|54782284|FG002|24-Week Double-blind Period|Withdrawal by Subject|0|||
28121954|NCT04052425|54782285|FG003|24-Week Double-blind Period|Withdrawal by Subject|0|||
28121955|NCT04052425|54782282|FG000|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|3|||
28121956|NCT04052425|54782283|FG001|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
28121957|NCT04052425|54782284|FG002|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
28121958|NCT04052425|54782285|FG003|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
28121959|NCT04052425|54782282|FG000|28-Week Treatment-Extension Period|Adverse Event|0|||
28121960|NCT04052425|54782283|FG001|28-Week Treatment-Extension Period|Adverse Event|0|||
28121961|NCT04052425|54782284|FG002|28-Week Treatment-Extension Period|Adverse Event|1|||
28121962|NCT04052425|54782285|FG003|28-Week Treatment-Extension Period|Adverse Event|0|||
28121963|NCT04052425|54782282|FG000|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
28121964|NCT04052425|54782283|FG001|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
28121965|NCT04052425|54782284|FG002|28-Week Treatment-Extension Period|Lack of Efficacy|1|||
28121966|NCT04052425|54782285|FG003|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
28121967|NCT04052425|54782282|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
28121968|NCT04052425|54782283|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
28121969|NCT04052425|54782284|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
28121970|NCT04052425|54782285|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|1|||
28121971|NCT04052425|54782282|FG000|28-Week Treatment-Extension Period|Physician Decision|0|||
28121972|NCT04052425|54782283|FG001|28-Week Treatment-Extension Period|Physician Decision|0|||
28121973|NCT04052425|54782284|FG002|28-Week Treatment-Extension Period|Physician Decision|0|||
28121974|NCT04052425|54782285|FG003|28-Week Treatment-Extension Period|Physician Decision|1|||
28121975|NCT04052425|54782282|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
28121976|NCT04052425|54782283|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
28121977|NCT04052425|54782284|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|10|||
28121978|NCT04052425|54782285|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|7|||
28121979|NCT04052425|54782282|FG000|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
28121980|NCT04052425|54782283|FG001|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
28121981|NCT04052425|54782284|FG002|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|1|||
28121982|NCT04052425|54782285|FG003|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
28121983|NCT04052425|54782282|FG000|28-Week Treatment-Extension Period|Participant Moved|0|||
28121984|NCT04052425|54782283|FG001|28-Week Treatment-Extension Period|Participant Moved|0|||
28121985|NCT04052425|54782284|FG002|28-Week Treatment-Extension Period|Participant Moved|1|||
28121986|NCT04052425|54782285|FG003|28-Week Treatment-Extension Period|Participant Moved|1|||
28121987|NCT03235089|54782295|FG000|Overall Study|Lost to Follow-up|1|||
28121988|NCT03235089|54782296|FG001|Overall Study|Lost to Follow-up|1|||
28121989|NCT03235089|54782295|FG000|Overall Study|Physician Decision|2|||
28121990|NCT03235089|54782296|FG001|Overall Study|Physician Decision|2|||
28121991|NCT04013191|54782305|FG000|Overall Study|Adverse Event|1|||
28121992|NCT04013191|54782306|FG001|Overall Study|Adverse Event|0|||
28121993|NCT03285594|54782319|FG000|Overall Study|At the Participant's Own Request|10|||
28121994|NCT03285594|54782320|FG001|Overall Study|At the Participant's Own Request|5|||
28121995|NCT03285594|54782321|FG002|Overall Study|At the Participant's Own Request|21|||
28121996|NCT03285594|54782319|FG000|Overall Study|Adverse Event|2|||
28121997|NCT03285594|54782320|FG001|Overall Study|Adverse Event|2|||
28121998|NCT03285594|54782321|FG002|Overall Study|Adverse Event|6|||
28121999|NCT03285594|54782319|FG000|Overall Study|Poor Compliance to Protocol|0|||
28122000|NCT03285594|54782320|FG001|Overall Study|Poor Compliance to Protocol|0|||
28122001|NCT03285594|54782321|FG002|Overall Study|Poor Compliance to Protocol|1|||
28122002|NCT03285594|54782319|FG000|Overall Study|Lost to Follow-up|0|||
28122003|NCT03285594|54782320|FG001|Overall Study|Lost to Follow-up|0|||
28122004|NCT03285594|54782321|FG002|Overall Study|Lost to Follow-up|1|||
28122005|NCT03285594|54782319|FG000|Overall Study|Reason Not Specified|3|||
28122006|NCT03285594|54782320|FG001|Overall Study|Reason Not Specified|4|||
28122007|NCT03285594|54782321|FG002|Overall Study|Reason Not Specified|8|||
28122008|NCT03234465|54782332|FG000|Overall Study|Adverse Event|4|||
28122009|NCT03234465|54782333|FG001|Overall Study|Adverse Event|2|||
28122010|NCT03234465|54782332|FG000|Overall Study|Death|0|||
28122011|NCT03234465|54782333|FG001|Overall Study|Death|1|||
28122012|NCT03234465|54782332|FG000|Overall Study|Lost to Follow-up|1|||
28122013|NCT03234465|54782333|FG001|Overall Study|Lost to Follow-up|1|||
28122014|NCT03234465|54782332|FG000|Overall Study|Withdrawal by Subject|12|||
28122015|NCT03234465|54782333|FG001|Overall Study|Withdrawal by Subject|27|||
28122016|NCT03234465|54782332|FG000|Overall Study|Symptomatic deterioration|0|||
28122017|NCT03234465|54782333|FG001|Overall Study|Symptomatic deterioration|1|||
28122018|NCT03234465|54782332|FG000|Overall Study|Non-compliance|2|||
28122019|NCT03234465|54782333|FG001|Overall Study|Non-compliance|0|||
28122020|NCT03234465|54782332|FG000|Overall Study|Other|14|||
28122021|NCT03234465|54782333|FG001|Overall Study|Other|8|||
28122022|NCT03290131|54782342|FG000|Overall Study|Adverse Event|22|||
28122023|NCT03290131|54782343|FG001|Overall Study|Adverse Event|57|||
28122024|NCT03290131|54782344|FG002|Overall Study|Adverse Event|11|||
28122025|NCT03290131|54782342|FG000|Overall Study|Withdrawal by Subject|18|||
28122026|NCT03290131|54782343|FG001|Overall Study|Withdrawal by Subject|13|||
28122027|NCT03290131|54782344|FG002|Overall Study|Withdrawal by Subject|8|||
28122028|NCT03290131|54782342|FG000|Overall Study|MS Relapse|2|||
28122029|NCT03290131|54782343|FG001|Overall Study|MS Relapse|1|||
28122030|NCT03290131|54782344|FG002|Overall Study|MS Relapse|0|||
28122031|NCT03290131|54782342|FG000|Overall Study|Unknown reason|0|||
28122032|NCT03290131|54782343|FG001|Overall Study|Unknown reason|1|||
28122033|NCT03290131|54782344|FG002|Overall Study|Unknown reason|0|||
28122034|NCT04050865|54782355|FG000|Overall Study|Adverse Event|1|||
28122035|NCT04050865|54782356|FG001|Overall Study|Adverse Event|0|||
28122036|NCT04050865|54782355|FG000|Overall Study|no insert|1|||
28122037|NCT04050865|54782356|FG001|Overall Study|no insert|0|||
28122038|NCT04050865|54782355|FG000|Overall Study|Only 1 insert|2|||
27817661|NCT01524783|54275382|FG000|Blinded Period|Adverse Event|64|||
27817662|NCT01524783|54275383|FG001|Blinded Period|Adverse Event|7|||
27817663|NCT01524783|54275384|FG002|Blinded Period|Adverse Event|0|||
28122039|NCT04050865|54782356|FG001|Overall Study|Only 1 insert|3|||
27817664|NCT01524783|54275382|FG000|Blinded Period|Disease Progression|89|||
28122040|NCT04050865|54782355|FG000|Overall Study|Physician Decision|0|||
28122041|NCT04050865|54782356|FG001|Overall Study|Physician Decision|1|||
28122042|NCT04050865|54782355|FG000|Overall Study|Withdrawal by Subject|0|||
28122043|NCT04050865|54782356|FG001|Overall Study|Withdrawal by Subject|1|||
28122044|NCT03283566|54782364|FG000|Overall Study|Lost to Follow-up|1|||
27817665|NCT01524783|54275383|FG001|Blinded Period|Disease Progression|75|||
28122045|NCT03283566|54782365|FG001|Overall Study|Lost to Follow-up|2|||
28122046|NCT03210519|54782373|FG000|Overall Study|Adverse Event|2|||
28122047|NCT03210519|54782374|FG001|Overall Study|Adverse Event|0|||
28122048|NCT04048681|54782380|FG000|Overall Study|family emergency|0|||
28122049|NCT04048681|54782381|FG001|Overall Study|family emergency|0|||
28122050|NCT04048681|54782382|FG002|Overall Study|family emergency|0|||
28122051|NCT04048681|54782383|FG003|Overall Study|family emergency|1|||
28122052|NCT04048681|54782384|FG004|Overall Study|family emergency|0|||
28122053|NCT04007107|54782392|FG000|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
28122054|NCT04007107|54782393|FG001|Treatment Period 2 (Day 1)|Withdrawal by Subject|1|||
28122055|NCT04007107|54782394|FG002|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
28122056|NCT04007107|54782395|FG003|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
28122057|NCT04046341|54782400|FG000|Overall Study|Lost to Follow-up|2|||
28122058|NCT04046341|54782400|FG000|Overall Study|Withdrawal by Subject|1|||
28122059|NCT03233529|54782404|FG000|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1|||
28122060|NCT03233529|54782404|FG000|Open-Label Period (Day 15 to Day 71)|Adverse Event|1|||
28122061|NCT04006171|54782414|FG000|Overall Study|Withdrawal by Subject|8|||
28122062|NCT04006171|54782415|FG001|Overall Study|Withdrawal by Subject|7|||
28122063|NCT04006171|54782414|FG000|Overall Study|missing serum samples|2|||
28122064|NCT04006171|54782415|FG001|Overall Study|missing serum samples|2|||
28122065|NCT04006171|54782414|FG000|Overall Study|insufficient sample volume|2|||
28122066|NCT04006171|54782415|FG001|Overall Study|insufficient sample volume|3|||
28122067|NCT04043143|54782428|FG000|Overall Study|Lost to Follow-up|5|||
28122068|NCT04043143|54782429|FG001|Overall Study|Lost to Follow-up|5|||
28122069|NCT04043143|54782428|FG000|Overall Study|screen failure|1|||
28122070|NCT04043143|54782429|FG001|Overall Study|screen failure|0|||
28122071|NCT03283098|54782437|FG000|Overall Study|Withdrawal by Subject|0|||
28122072|NCT03283098|54782438|FG001|Overall Study|Withdrawal by Subject|1|||
28122073|NCT03655951|54782446|FG000|Overall Study|Lost to Follow-up|39|||
28122074|NCT03655951|54782447|FG001|Overall Study|Lost to Follow-up|20|||
28122075|NCT03655951|54782446|FG000|Overall Study|Withdrawal by Subject|0|||
28122076|NCT03655951|54782447|FG001|Overall Study|Withdrawal by Subject|1|||
28122077|NCT02527798|54782459|FG000|Overall Study|Physician Decision|1|||
28122078|NCT02527798|54782460|FG001|Overall Study|Physician Decision|0|||
28122079|NCT02527798|54782461|FG002|Overall Study|Physician Decision|1|||
28122080|NCT02527798|54782462|FG003|Overall Study|Physician Decision|1|||
28122081|NCT02527798|54782463|FG004|Overall Study|Physician Decision|0|||
28122082|NCT02527798|54782464|FG005|Overall Study|Physician Decision|0|||
28122083|NCT02527798|54782459|FG000|Overall Study|Death|0|||
28122084|NCT02527798|54782460|FG001|Overall Study|Death|0|||
28122085|NCT02527798|54782461|FG002|Overall Study|Death|1|||
28122086|NCT02527798|54782462|FG003|Overall Study|Death|0|||
28122087|NCT02527798|54782463|FG004|Overall Study|Death|0|||
28122088|NCT02527798|54782464|FG005|Overall Study|Death|0|||
28122089|NCT02527798|54782459|FG000|Overall Study|Withdrawal by Subject|0|||
28122090|NCT02527798|54782460|FG001|Overall Study|Withdrawal by Subject|1|||
28122091|NCT02527798|54782461|FG002|Overall Study|Withdrawal by Subject|2|||
28122092|NCT02527798|54782462|FG003|Overall Study|Withdrawal by Subject|0|||
28122093|NCT02527798|54782463|FG004|Overall Study|Withdrawal by Subject|0|||
28122094|NCT02527798|54782464|FG005|Overall Study|Withdrawal by Subject|0|||
28122095|NCT02527798|54782459|FG000|Overall Study|Reason undisclosed|1|||
28122096|NCT02527798|54782460|FG001|Overall Study|Reason undisclosed|0|||
28122097|NCT02527798|54782461|FG002|Overall Study|Reason undisclosed|1|||
28122098|NCT02527798|54782462|FG003|Overall Study|Reason undisclosed|0|||
28122099|NCT02527798|54782463|FG004|Overall Study|Reason undisclosed|0|||
28122100|NCT02527798|54782464|FG005|Overall Study|Reason undisclosed|0|||
28122101|NCT02527798|54782459|FG000|Overall Study|Did not receive intervention|1|||
28122102|NCT02527798|54782460|FG001|Overall Study|Did not receive intervention|1|||
28122103|NCT02527798|54782461|FG002|Overall Study|Did not receive intervention|0|||
28066615|NCT00265122|54722130|FG000|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
28066616|NCT00265122|54722131|FG001|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
28066617|NCT00265122|54722132|FG002|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3|||
28066618|NCT00265122|54722133|FG003|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
28066619|NCT00265122|54722134|FG004|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
28066620|NCT00265122|54722135|FG005|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
28066621|NCT00265122|54722130|FG000|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
28066622|NCT00265122|54722131|FG001|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
28122104|NCT02527798|54782462|FG003|Overall Study|Did not receive intervention|0|||
28122105|NCT02527798|54782463|FG004|Overall Study|Did not receive intervention|0|||
28122106|NCT02527798|54782464|FG005|Overall Study|Did not receive intervention|0|||
28122107|NCT03188991|54782495|FG000|Overall Study|Withdrawal by Subject|0|||
28122108|NCT03188991|54782496|FG001|Overall Study|Withdrawal by Subject|0|||
28122109|NCT03188991|54782497|FG002|Overall Study|Withdrawal by Subject|0|||
28122110|NCT03188991|54782498|FG003|Overall Study|Withdrawal by Subject|1|||
28122111|NCT03857542|54782510|FG000|Overall Study|Adverse Event|1|||
28122112|NCT03857542|54782511|FG001|Overall Study|Adverse Event|3|||
28122113|NCT03857542|54782510|FG000|Overall Study|Withdrawal by Subject|2|||
28122114|NCT03857542|54782511|FG001|Overall Study|Withdrawal by Subject|1|||
28122115|NCT03857542|54782510|FG000|Overall Study|Lost to Follow-up|2|||
28122116|NCT03857542|54782511|FG001|Overall Study|Lost to Follow-up|1|||
28122117|NCT03857542|54782510|FG000|Overall Study|Reason not Specified|1|||
28122118|NCT03857542|54782511|FG001|Overall Study|Reason not Specified|0|||
27817666|NCT01524783|54275384|FG002|Blinded Period|Disease Progression|0|||
27817667|NCT01524783|54275382|FG000|Blinded Period|Withdrawal by Subject|19|||
27817668|NCT01524783|54275383|FG001|Blinded Period|Withdrawal by Subject|6|||
27817669|NCT01524783|54275384|FG002|Blinded Period|Withdrawal by Subject|0|||
27817670|NCT01524783|54275382|FG000|Blinded Period|Protocol deviation|2|||
27817671|NCT01524783|54275383|FG001|Blinded Period|Protocol deviation|1|||
27817672|NCT01524783|54275384|FG002|Blinded Period|Protocol deviation|0|||
27817673|NCT01524783|54275382|FG000|Blinded Period|Death|5|||
27817674|NCT01524783|54275383|FG001|Blinded Period|Death|2|||
27817675|NCT01524783|54275384|FG002|Blinded Period|Death|0|||
27817676|NCT01524783|54275382|FG000|Open-label Period|Disease progression|13|||
27817677|NCT01524783|54275383|FG001|Open-label Period|Disease progression|0|||
27817678|NCT01524783|54275384|FG002|Open-label Period|Disease progression|2|||
27817679|NCT01524783|54275382|FG000|Open-label Period|Administrative problems|5|||
27817680|NCT01524783|54275383|FG001|Open-label Period|Administrative problems|0|||
27817681|NCT01524783|54275384|FG002|Open-label Period|Administrative problems|2|||
27817682|NCT01524783|54275382|FG000|Open-label Period|Adverse Event|5|||
27817683|NCT01524783|54275383|FG001|Open-label Period|Adverse Event|0|||
27817684|NCT01524783|54275384|FG002|Open-label Period|Adverse Event|1|||
27817685|NCT01524783|54275382|FG000|Open-label Period|Withdrawal by Subject|2|||
27817686|NCT01524783|54275383|FG001|Open-label Period|Withdrawal by Subject|0|||
27817687|NCT01524783|54275384|FG002|Open-label Period|Withdrawal by Subject|1|||
27817688|NCT01524783|54275382|FG000|Open-label Period|Protocol deviation|1|||
27817689|NCT01524783|54275383|FG001|Open-label Period|Protocol deviation|0|||
27817690|NCT01524783|54275384|FG002|Open-label Period|Protocol deviation|0|||
27817691|NCT01494987|54275398|FG000|Overall Study|Adverse Event|6|||
27817692|NCT01494987|54275399|FG001|Overall Study|Adverse Event|5|||
27817693|NCT01494987|54275398|FG000|Overall Study|Hyperglycemia|6|||
27817694|NCT01494987|54275399|FG001|Overall Study|Hyperglycemia|4|||
27817695|NCT01494987|54275398|FG000|Overall Study|Investigator's Discretion|1|||
27817696|NCT01494987|54275399|FG001|Overall Study|Investigator's Discretion|2|||
27817697|NCT01494987|54275398|FG000|Overall Study|Lost to Follow-up|1|||
27817698|NCT01494987|54275399|FG001|Overall Study|Lost to Follow-up|1|||
27817699|NCT01494987|54275398|FG000|Overall Study|Protocol Violation|3|||
27817700|NCT01494987|54275399|FG001|Overall Study|Protocol Violation|3|||
27817701|NCT01494987|54275398|FG000|Overall Study|Subject Non-Compliance|9|||
27817702|NCT01494987|54275399|FG001|Overall Study|Subject Non-Compliance|10|||
28066623|NCT00265122|54722132|FG002|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
28066624|NCT00265122|54722133|FG003|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
28066625|NCT00265122|54722134|FG004|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
28066626|NCT00265122|54722135|FG005|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
28066627|NCT00265122|54722130|FG000|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
28066628|NCT00265122|54722131|FG001|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
28066629|NCT00265122|54722132|FG002|Intervention Period 1 (Weeks 0 to 8):|Other|2|||
28066630|NCT00265122|54722133|FG003|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
28066631|NCT00265122|54722134|FG004|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
28066632|NCT00265122|54722135|FG005|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
28066633|NCT00265122|54722130|FG000|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2|||
28122119|NCT03209973|54782518|FG000|Overall Study|Withdrawal by Subject|7|||
28122120|NCT03209973|54782518|FG000|Overall Study|Lost to Follow-up|2|||
27817703|NCT01494987|54275398|FG000|Overall Study|Subject Withdrew Consent|2|||
27817704|NCT01494987|54275399|FG001|Overall Study|Subject Withdrew Consent|3|||
27817705|NCT01470417|54275407|FG000|Overall Study|Disease progression|0|||
27817706|NCT01470417|54275408|FG001|Overall Study|Disease progression|2|||
27817707|NCT01524627|54275416|FG000|Overall Study|Physician Decision|0|||
27817708|NCT01524627|54275417|FG001|Overall Study|Physician Decision|1|||
27817709|NCT01524627|54275416|FG000|Overall Study|Lost to Follow-up|1|||
27817710|NCT01524627|54275417|FG001|Overall Study|Lost to Follow-up|1|||
27831259|NCT01787591|54307663|FG000|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
27831260|NCT01787591|54307664|FG001|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
27817711|NCT01469637|54275425|FG000|First Intervention|Unacceptable behavior|0|||
27817712|NCT01469637|54275426|FG001|First Intervention|Unacceptable behavior|1|||
27817713|NCT01469637|54275425|FG000|Second Intervention|Incarcerated|1|||
28122121|NCT03209973|54782518|FG000|Overall Study|Death|8|||
28122122|NCT03209973|54782518|FG000|Overall Study|Transferred to Long Term Extension (LTE) study|32|||
28122123|NCT03209973|54782518|FG000|Overall Study|Sponsor Decision|18|||
28122124|NCT03209973|54782518|FG000|Overall Study|Participant Withdrew Due to Higher Risk than Benefit of Treatment|1|||
28122125|NCT03209973|54782518|FG000|Overall Study|Participant Refused to Return to Treatment|2|||
28122126|NCT03751631|54782524|FG000|Overall Study|Withdrawal by Subject|0|||
28122127|NCT03751631|54782525|FG001|Overall Study|Withdrawal by Subject|0|||
28122128|NCT03751631|54782526|FG002|Overall Study|Withdrawal by Subject|1|||
28122129|NCT03751631|54782527|FG003|Overall Study|Withdrawal by Subject|1|||
28122130|NCT03751631|54782528|FG004|Overall Study|Withdrawal by Subject|0|||
28122131|NCT03751631|54782529|FG005|Overall Study|Withdrawal by Subject|0|||
28122132|NCT03688711|54782542|FG000|Overall Study|Withdrawal by Subject|0|||
28122133|NCT03688711|54782543|FG001|Overall Study|Withdrawal by Subject|1|||
28122134|NCT03188055|54782551|FG000|Overall Study|Unavailable for training|0|||
28122135|NCT03188055|54782552|FG001|Overall Study|Unavailable for training|0|||
28122136|NCT03188055|54782553|FG002|Overall Study|Unavailable for training|19|||
28122137|NCT03188055|54782554|FG003|Overall Study|Unavailable for training|0|||
28122138|NCT03188055|54782555|FG004|Overall Study|Unavailable for training|0|||
28122139|NCT03188055|54782556|FG005|Overall Study|Unavailable for training||||
28122140|NCT03188055|54782551|FG000|Overall Study|Lost to Follow-up|0|||
28122141|NCT03188055|54782552|FG001|Overall Study|Lost to Follow-up|18|||
28122142|NCT03188055|54782553|FG002|Overall Study|Lost to Follow-up|0|||
28122143|NCT03188055|54782554|FG003|Overall Study|Lost to Follow-up|11|||
28122144|NCT03188055|54782555|FG004|Overall Study|Lost to Follow-up|0|||
28122145|NCT03188055|54782556|FG005|Overall Study|Lost to Follow-up||||
28122146|NCT03188055|54782551|FG000|Overall Study|Withdrawal by Subject|0|||
28122147|NCT03188055|54782552|FG001|Overall Study|Withdrawal by Subject|1|||
28122148|NCT03188055|54782553|FG002|Overall Study|Withdrawal by Subject|0|||
28122149|NCT03188055|54782554|FG003|Overall Study|Withdrawal by Subject|1|||
28122150|NCT03188055|54782555|FG004|Overall Study|Withdrawal by Subject|0|||
28122151|NCT03188055|54782556|FG005|Overall Study|Withdrawal by Subject||||
28122152|NCT04035577|54782567|FG000|Overall Study|Lost to Follow-up|1|||
28122153|NCT04035577|54782567|FG000|Overall Study|Withdrawal by Subject|1|||
28122154|NCT03655717|54782595|FG000|Overall Study|Withdrawal by Subject|4|||
28122155|NCT03655717|54782596|FG001|Overall Study|Withdrawal by Subject|8|||
28122156|NCT03655717|54782597|FG002|Overall Study|Withdrawal by Subject|1|||
27817714|NCT01469637|54275426|FG001|Second Intervention|Incarcerated|0|||
27817715|NCT04842747|54275846|FG000|Overall Study|Withdrawal by Subject|6|||
28122157|NCT03655717|54782598|FG003|Overall Study|Withdrawal by Subject|0|||
28122158|NCT03655717|54782599|FG004|Overall Study|Withdrawal by Subject|0|||
28122159|NCT03655717|54782600|FG005|Overall Study|Withdrawal by Subject|1|||
28122160|NCT03655717|54782601|FG006|Overall Study|Withdrawal by Subject|3|||
28122161|NCT03655717|54782602|FG007|Overall Study|Withdrawal by Subject|1|||
28122162|NCT03655717|54782603|FG008|Overall Study|Withdrawal by Subject|2|||
28122163|NCT03655717|54782604|FG009|Overall Study|Withdrawal by Subject|0|||
28122164|NCT03655717|54782605|FG010|Overall Study|Withdrawal by Subject|0|||
28122165|NCT03655717|54782606|FG011|Overall Study|Withdrawal by Subject|1|||
28122166|NCT03655717|54782607|FG012|Overall Study|Withdrawal by Subject|0|||
28122167|NCT03655717|54782608|FG013|Overall Study|Withdrawal by Subject|3|||
28122168|NCT03655717|54782609|FG014|Overall Study|Withdrawal by Subject|0|||
28122169|NCT03655717|54782610|FG015|Overall Study|Withdrawal by Subject|1|||
28122170|NCT03655717|54782611|FG016|Overall Study|Withdrawal by Subject|0|||
28122171|NCT03655717|54782612|FG017|Overall Study|Withdrawal by Subject|0|||
28122172|NCT03655717|54782613|FG018|Overall Study|Withdrawal by Subject|1|||
28122173|NCT03655717|54782614|FG019|Overall Study|Withdrawal by Subject|0|||
28122174|NCT03655717|54782615|FG020|Overall Study|Withdrawal by Subject|0|||
28122175|NCT03655717|54782616|FG021|Overall Study|Withdrawal by Subject|1|||
28122176|NCT03655717|54782617|FG022|Overall Study|Withdrawal by Subject|2|||
28122177|NCT03655717|54782618|FG023|Overall Study|Withdrawal by Subject|1|||
28122178|NCT03655717|54782619|FG024|Overall Study|Withdrawal by Subject|1|||
28122179|NCT03655717|54782620|FG025|Overall Study|Withdrawal by Subject|0|||
28122180|NCT03655717|54782595|FG000|Overall Study|Physician Decision|3|||
28122181|NCT03655717|54782596|FG001|Overall Study|Physician Decision|3|||
28122182|NCT03655717|54782597|FG002|Overall Study|Physician Decision|0|||
28122183|NCT03655717|54782598|FG003|Overall Study|Physician Decision|0|||
28122184|NCT03655717|54782599|FG004|Overall Study|Physician Decision|0|||
28122185|NCT03655717|54782600|FG005|Overall Study|Physician Decision|0|||
28122186|NCT03655717|54782601|FG006|Overall Study|Physician Decision|0|||
28122187|NCT03655717|54782602|FG007|Overall Study|Physician Decision|0|||
28122188|NCT03655717|54782603|FG008|Overall Study|Physician Decision|0|||
28122189|NCT03655717|54782604|FG009|Overall Study|Physician Decision|1|||
28122190|NCT03655717|54782605|FG010|Overall Study|Physician Decision|0|||
28122191|NCT03655717|54782606|FG011|Overall Study|Physician Decision|0|||
28122192|NCT03655717|54782607|FG012|Overall Study|Physician Decision|0|||
28122193|NCT03655717|54782608|FG013|Overall Study|Physician Decision|0|||
28122194|NCT03655717|54782609|FG014|Overall Study|Physician Decision|0|||
28122195|NCT03655717|54782610|FG015|Overall Study|Physician Decision|0|||
28122196|NCT03655717|54782611|FG016|Overall Study|Physician Decision|0|||
28122197|NCT03655717|54782612|FG017|Overall Study|Physician Decision|0|||
28122198|NCT03655717|54782613|FG018|Overall Study|Physician Decision|0|||
28122199|NCT03655717|54782614|FG019|Overall Study|Physician Decision|1|||
28122200|NCT03655717|54782615|FG020|Overall Study|Physician Decision|0|||
28122201|NCT03655717|54782616|FG021|Overall Study|Physician Decision|0|||
28122202|NCT03655717|54782617|FG022|Overall Study|Physician Decision|0|||
28122203|NCT03655717|54782618|FG023|Overall Study|Physician Decision|1|||
28122204|NCT03655717|54782619|FG024|Overall Study|Physician Decision|0|||
28122205|NCT03655717|54782620|FG025|Overall Study|Physician Decision|0|||
28122206|NCT03655717|54782595|FG000|Overall Study|Lost to Follow-up|3|||
28122207|NCT03655717|54782596|FG001|Overall Study|Lost to Follow-up|1|||
28122208|NCT03655717|54782597|FG002|Overall Study|Lost to Follow-up|0|||
28122209|NCT03655717|54782598|FG003|Overall Study|Lost to Follow-up|1|||
28122210|NCT03655717|54782599|FG004|Overall Study|Lost to Follow-up|0|||
28122211|NCT03655717|54782600|FG005|Overall Study|Lost to Follow-up|1|||
28122212|NCT03655717|54782601|FG006|Overall Study|Lost to Follow-up|0|||
28122213|NCT03655717|54782602|FG007|Overall Study|Lost to Follow-up|0|||
28122214|NCT03655717|54782603|FG008|Overall Study|Lost to Follow-up|0|||
28122215|NCT03655717|54782604|FG009|Overall Study|Lost to Follow-up|0|||
28122216|NCT03655717|54782605|FG010|Overall Study|Lost to Follow-up|0|||
28122217|NCT03655717|54782606|FG011|Overall Study|Lost to Follow-up|1|||
28122218|NCT03655717|54782607|FG012|Overall Study|Lost to Follow-up|0|||
28122219|NCT03655717|54782608|FG013|Overall Study|Lost to Follow-up|0|||
28122220|NCT03655717|54782609|FG014|Overall Study|Lost to Follow-up|0|||
28122221|NCT03655717|54782610|FG015|Overall Study|Lost to Follow-up|0|||
28122222|NCT03655717|54782611|FG016|Overall Study|Lost to Follow-up|0|||
28122223|NCT03655717|54782612|FG017|Overall Study|Lost to Follow-up|0|||
28122224|NCT03655717|54782613|FG018|Overall Study|Lost to Follow-up|0|||
28122225|NCT03655717|54782614|FG019|Overall Study|Lost to Follow-up|0|||
28122226|NCT03655717|54782615|FG020|Overall Study|Lost to Follow-up|0|||
28122227|NCT03655717|54782616|FG021|Overall Study|Lost to Follow-up|0|||
28122228|NCT03655717|54782617|FG022|Overall Study|Lost to Follow-up|0|||
28122229|NCT03655717|54782618|FG023|Overall Study|Lost to Follow-up|0|||
28122230|NCT03655717|54782619|FG024|Overall Study|Lost to Follow-up|0|||
28122231|NCT03655717|54782620|FG025|Overall Study|Lost to Follow-up|0|||
28122232|NCT04032613|54782636|FG000|Overall Study|Did not complete post-program assessment|5|||
28122233|NCT04032613|54782637|FG001|Overall Study|Did not complete post-program assessment|2|||
28122234|NCT04000165|54782643|FG000|Overall Study|Physician Decision|1|||
28122235|NCT04000165|54782643|FG000|Overall Study|Withdrawal by Subject|1|||
28122236|NCT03187197|54782650|FG000|Overall Study|Stopped Pradaxa®/VKA|11|||
28122237|NCT03187197|54782651|FG001|Overall Study|Stopped Pradaxa®/VKA|65|||
28122238|NCT03187197|54782652|FG002|Overall Study|Stopped Pradaxa®/VKA|4|||
28122239|NCT03187197|54782650|FG000|Overall Study|Withdrawal by Subject|8|||
28122240|NCT03187197|54782651|FG001|Overall Study|Withdrawal by Subject|63|||
28122241|NCT03187197|54782652|FG002|Overall Study|Withdrawal by Subject|4|||
28122242|NCT03187197|54782650|FG000|Overall Study|Lost to Follow-up|1|||
28122243|NCT03187197|54782651|FG001|Overall Study|Lost to Follow-up|60|||
28122244|NCT03187197|54782652|FG002|Overall Study|Lost to Follow-up|7|||
28122245|NCT03187197|54782650|FG000|Overall Study|Adverse Event|6|||
28122246|NCT03187197|54782651|FG001|Overall Study|Adverse Event|29|||
28122247|NCT03187197|54782652|FG002|Overall Study|Adverse Event|0|||
28122248|NCT03187197|54782650|FG000|Overall Study|Death|0|||
28122249|NCT03187197|54782651|FG001|Overall Study|Death|11|||
28122250|NCT03187197|54782652|FG002|Overall Study|Death|0|||
28122251|NCT03187197|54782650|FG000|Overall Study|Administrative problem|1|||
28122252|NCT03187197|54782651|FG001|Overall Study|Administrative problem|1|||
28122253|NCT03187197|54782652|FG002|Overall Study|Administrative problem|0|||
28122254|NCT03187197|54782650|FG000|Overall Study|Reason not listed|2|||
28122255|NCT03187197|54782651|FG001|Overall Study|Reason not listed|54|||
28122256|NCT03187197|54782652|FG002|Overall Study|Reason not listed|1|||
28122257|NCT03187197|54782650|FG000|Overall Study|Missing|1|||
28122258|NCT03187197|54782651|FG001|Overall Study|Missing|32|||
28122259|NCT03187197|54782652|FG002|Overall Study|Missing|3|||
28122260|NCT03187197|54782650|FG000|Overall Study|Status missing|2|||
28122261|NCT03187197|54782651|FG001|Overall Study|Status missing|33|||
28122262|NCT03187197|54782652|FG002|Overall Study|Status missing|3|||
28122263|NCT03187197|54782650|FG000|Overall Study|NA in incl/excl criteria, not analyzed.|14|||
28122264|NCT03187197|54782651|FG001|Overall Study|NA in incl/excl criteria, not analyzed.|45|||
28122265|NCT03187197|54782652|FG002|Overall Study|NA in incl/excl criteria, not analyzed.|1|||
28122266|NCT04000009|54782660|FG000|Overall Study|Adverse Event|13|||
28122267|NCT04000009|54782660|FG000|Overall Study|Lack of Efficacy|7|||
28122268|NCT04000009|54782660|FG000|Overall Study|Lost to Follow-up|8|||
28122269|NCT04000009|54782660|FG000|Overall Study|Noncompliance with study drug|4|||
28122270|NCT04000009|54782660|FG000|Overall Study|Physician Decision|1|||
28122271|NCT04000009|54782660|FG000|Overall Study|Use of prohibited medication|3|||
28122272|NCT04000009|54782660|FG000|Overall Study|Pregnancy|1|||
28122273|NCT04000009|54782660|FG000|Overall Study|Withdrawal by Subject|22|||
28122274|NCT04000009|54782660|FG000|Overall Study|Study terminated by sponsor|98|||
28122275|NCT04000009|54782660|FG000|Overall Study|Not further specified|8|||
28122276|NCT03282240|54782667|FG000|Overall Study|Adverse Event|2|||
28122277|NCT03282240|54782668|FG001|Overall Study|Adverse Event|2|||
28122278|NCT03282240|54782669|FG002|Overall Study|Adverse Event|0|||
28122279|NCT03282240|54782667|FG000|Overall Study|Lost to Follow-up|3|||
28122280|NCT03282240|54782668|FG001|Overall Study|Lost to Follow-up|0|||
28122281|NCT03282240|54782669|FG002|Overall Study|Lost to Follow-up|0|||
28122282|NCT03282240|54782667|FG000|Overall Study|Protocol Deviation|4|||
28122283|NCT03282240|54782668|FG001|Overall Study|Protocol Deviation|1|||
28122284|NCT03282240|54782669|FG002|Overall Study|Protocol Deviation|2|||
28122285|NCT03282240|54782667|FG000|Overall Study|Withdrawal by Subject|1|||
28122286|NCT03282240|54782668|FG001|Overall Study|Withdrawal by Subject|0|||
28122287|NCT03282240|54782669|FG002|Overall Study|Withdrawal by Subject|1|||
28122288|NCT03185949|54782682|FG000|ITT Analysis|Withdrawal by Subject|4|||
28122289|NCT03185949|54782683|FG001|ITT Analysis|Withdrawal by Subject|3|||
28122290|NCT03185949|54782682|FG000|PP Analysis|Protocol Violation|2|||
28122291|NCT03185949|54782683|FG001|PP Analysis|Protocol Violation|2|||
28122292|NCT03185949|54782682|FG000|PP Analysis|Failed/Incomplete LGA embolization|0|||
28122293|NCT03185949|54782683|FG001|PP Analysis|Failed/Incomplete LGA embolization|2|||
28122294|NCT03655405|54782693|FG000|Overall Study|Death after initial data collection|4|||
28122295|NCT03655405|54782694|FG001|Overall Study|Death after initial data collection|2|||
28122296|NCT03655405|54782693|FG000|Overall Study|Died before initial data collection|1|||
28122297|NCT03655405|54782694|FG001|Overall Study|Died before initial data collection|2|||
28122298|NCT03655405|54782693|FG000|Overall Study|Protocol Violation|0|||
28122299|NCT03655405|54782694|FG001|Overall Study|Protocol Violation|1|||
28122300|NCT03510598|54782700|FG000|Overall Study|Withdrawal by Subject|1|||
28122301|NCT03222141|54782704|FG000|Overall Study|Death|15|||
28122302|NCT03222141|54782704|FG000|Overall Study|Lost to Follow-up|3|||
28122303|NCT04029961|54782711|FG000|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|1|||
28122304|NCT04029961|54782712|FG001|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|0|||
28122305|NCT04029961|54782711|FG000|Overall Study|Change in Treatment Course|0|||
28122306|NCT04029961|54782712|FG001|Overall Study|Change in Treatment Course|1|||
28122307|NCT03997825|54782718|FG000|Overall Study|Death|3|||
28122308|NCT03997825|54782718|FG000|Overall Study|Lost to Follow-up|10|||
28122309|NCT03997825|54782718|FG000|Overall Study|Withdrawal by Subject|3|||
28122310|NCT03997825|54782718|FG000|Overall Study|Refused participation|1|||
28122311|NCT04024891|54782724|FG000|Overall Study|Pregnancy|0|||
28122312|NCT04024891|54782725|FG001|Overall Study|Pregnancy|1|||
28122313|NCT03250182|54782731|FG000|Overall Study|Withdrawal by Subject|1|||
28122314|NCT03993379|54782739|FG000|Overall Study|The study was terminated early due to business decision.|0|||
28122315|NCT03993379|54782740|FG001|Overall Study|The study was terminated early due to business decision.|2|||
28122316|NCT03993379|54782741|FG002|Overall Study|The study was terminated early due to business decision.|0|||
28122317|NCT03993379|54782742|FG003|Overall Study|The study was terminated early due to business decision.|0|||
28122318|NCT03993379|54782739|FG000|Overall Study|Withdrawal by Subject|0|||
28122319|NCT03993379|54782740|FG001|Overall Study|Withdrawal by Subject|1|||
28122320|NCT03993379|54782741|FG002|Overall Study|Withdrawal by Subject|0|||
28122321|NCT03993379|54782742|FG003|Overall Study|Withdrawal by Subject|0|||
28122322|NCT03370120|54782752|FG000|Overall Study|Adverse event, non-fatal|24|||
28122323|NCT03370120|54782752|FG000|Overall Study|Withdrawal by Subject|6|||
28122324|NCT03370120|54782752|FG000|Overall Study|Lost to Follow-up|1|||
28122325|NCT03370120|54782752|FG000|Overall Study|Lack of Efficacy|37|||
28122326|NCT03370120|54782752|FG000|Overall Study|Per sponsor's instructions|1|||
28122327|NCT03370120|54782752|FG000|Overall Study|Study was terminated by parent company UCB|2|||
28122328|NCT03370120|54782752|FG000|Overall Study|The study was ended by the promoter|3|||
28122329|NCT03370120|54782752|FG000|Overall Study|Discontinuation of drug development|3|||
28122330|NCT03370120|54782752|FG000|Overall Study|End of project|2|||
28122331|NCT03370120|54782752|FG000|Overall Study|Premature study closure|2|||
28122332|NCT03370120|54782752|FG000|Overall Study|Premature program termination|1|||
28122333|NCT03370120|54782752|FG000|Overall Study|Premature study termination|7|||
28122334|NCT03370120|54782752|FG000|Overall Study|Trial terminated by sponsor|2|||
28122335|NCT03370120|54782752|FG000|Overall Study|Trial discontinued by sponsor|2|||
28122336|NCT03370120|54782752|FG000|Overall Study|Study ended|15|||
28122337|NCT03370120|54782752|FG000|Overall Study|Clinical trial has been cancelled|1|||
28122338|NCT03370120|54782752|FG000|Overall Study|End of study per sponsor decision|2|||
28122339|NCT03370120|54782752|FG000|Overall Study|Promoter's decision|2|||
28122340|NCT03370120|54782752|FG000|Overall Study|The trial has been suspended|3|||
28122341|NCT03370120|54782752|FG000|Overall Study|Sponsor stopped PSL development based on data|3|||
28122342|NCT03370120|54782752|FG000|Overall Study|Early termination by order of sponsor|2|||
27817716|NCT04842747|54275847|FG001|Overall Study|Withdrawal by Subject|2|||
28122343|NCT03370120|54782752|FG000|Overall Study|Discontinuation of the study|5|||
28122344|NCT03370120|54782752|FG000|Overall Study|End of clinical trial discontinuation|1|||
28122345|NCT03370120|54782752|FG000|Overall Study|Because the clinical trial ended halfway|4|||
28122346|NCT03370120|54782752|FG000|Overall Study|Development discontinued|5|||
28122347|NCT03370120|54782752|FG000|Overall Study|Padsenovil program closed|3|||
28122348|NCT03370120|54782752|FG000|Overall Study|End of project|2|||
28122349|NCT03370120|54782752|FG000|Overall Study|Termination of project|1|||
28122350|NCT03370120|54782752|FG000|Overall Study|The study was interrupted by sponsor|4|||
28122351|NCT03370120|54782752|FG000|Overall Study|The protocol was interrupted by sponsor|1|||
28122352|NCT03370120|54782752|FG000|Overall Study|End of sponsor decision|1|||
28122353|NCT03370120|54782752|FG000|Overall Study|The study was terminated prematurely by study lead|1|||
28122354|NCT03370120|54782752|FG000|Overall Study|Early termination of studies|5|||
28122355|NCT03370120|54782752|FG000|Overall Study|This study is ended early|1|||
28122356|NCT03370120|54782752|FG000|Overall Study|End of padsevonil program|2|||
28122357|NCT03370120|54782752|FG000|Overall Study|Decision of sponsor|6|||
28122358|NCT03370120|54782752|FG000|Overall Study|Asked by the sponsor|3|||
28122359|NCT03370120|54782752|FG000|Overall Study|Sponsor decision to stop the protocol|1|||
28122360|NCT03370120|54782752|FG000|Overall Study|PI decision poor compliance from participant|1|||
28122361|NCT03370120|54782752|FG000|Overall Study|Promoter ended the study|3|||
28122362|NCT03370120|54782752|FG000|Overall Study|Premature study close by sponsor's decision|4|||
28122363|NCT03370120|54782752|FG000|Overall Study|Study terminated by sponsor|33|||
28122364|NCT03370120|54782752|FG000|Overall Study|Sponsor prematurely terminated this study|2|||
28122365|NCT03370120|54782752|FG000|Overall Study|Sponsor decision to terminate study|63|||
28122366|NCT03370120|54782752|FG000|Overall Study|Program closure|3|||
28122367|NCT03370120|54782752|FG000|Overall Study|Study ended prematurely|1|||
28122368|NCT03370120|54782752|FG000|Overall Study|Study stopped by sponsor|2|||
28122369|NCT03370120|54782752|FG000|Overall Study|Program termination|55|||
28122370|NCT03370120|54782752|FG000|Overall Study|Sponsor decision|62|||
28122371|NCT03370120|54782752|FG000|Overall Study|Sponsor study closure|10|||
28122372|NCT03247686|54782760|FG000|Overall Study|Withdrawal by Subject|1|||
28122373|NCT03247686|54782761|FG001|Overall Study|Withdrawal by Subject|2|||
28122374|NCT03990649|54782772|FG000|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
28122375|NCT03990649|54782773|FG001|Part A: DB Treatment Period (15 Weeks)|Adverse Event|1|||
28122376|NCT03990649|54782774|FG002|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
28122377|NCT03990649|54782772|FG000|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
28122378|NCT03990649|54782773|FG001|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|1|||
28122379|NCT03990649|54782774|FG002|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
28122380|NCT03990649|54782772|FG000|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|2|||
28122381|NCT03990649|54782773|FG001|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
28122382|NCT03990649|54782774|FG002|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
28122383|NCT03990649|54782772|FG000|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
28122384|NCT03990649|54782773|FG001|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
28122385|NCT03990649|54782774|FG002|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|0|||
28122386|NCT03990649|54782772|FG000|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
28122387|NCT03990649|54782773|FG001|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
28122388|NCT03990649|54782774|FG002|Part B: OL Extension Period (14 Weeks)|Adverse Event|1|||
28122389|NCT03990649|54782772|FG000|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
28122390|NCT03990649|54782773|FG001|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
28122391|NCT03990649|54782774|FG002|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|2|||
28122392|NCT03990649|54782772|FG000|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
28122393|NCT03990649|54782773|FG001|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
28122394|NCT03990649|54782774|FG002|Part B: OL Extension Period (14 Weeks)|Reason not Specified|1|||
28122395|NCT03185481|54782781|FG000|Overall Study|Adverse Event|1|||
28122396|NCT03185481|54782781|FG000|Overall Study|Study Terminated by Sponsor|4|||
28122397|NCT03652675|54782787|FG000|Overall Study|Lost to Follow-up|4|||
28122398|NCT03652675|54782788|FG001|Overall Study|Lost to Follow-up|4|||
28122399|NCT03241368|54782794|FG000|Overall Study|MRE Stricture or Patency Capsule Failure|25|||
28122400|NCT03241368|54782794|FG000|Overall Study|Lost to Follow-up|1|||
28122401|NCT03241368|54782794|FG000|Overall Study|Physician Decision|6|||
28122402|NCT03241368|54782794|FG000|Overall Study|Withdrawal by Subject|6|||
28122403|NCT03241368|54782794|FG000|Overall Study|Protocol Violation|1|||
28122404|NCT03220581|54782801|FG000|Overall Study|Withdrawal by Subject|0|||
28122405|NCT03220581|54782802|FG001|Overall Study|Withdrawal by Subject|1|||
28122406|NCT03220581|54782801|FG000|Overall Study|Lost to Follow-up|3|||
28122407|NCT03220581|54782802|FG001|Overall Study|Lost to Follow-up|6|||
28122408|NCT02954575|54782810|FG000|Overall Study|Withdrawal by Subject|2|||
28122409|NCT02954575|54782810|FG000|Overall Study|Adverse Event|1|||
28122410|NCT03184701|54782818|FG000|Overall Study|Death|3|||
28122411|NCT03184701|54782818|FG000|Overall Study|Physician Decision|3|||
28122412|NCT03184701|54782818|FG000|Overall Study|Withdrawal by Subject|6|||
28122413|NCT03184701|54782818|FG000|Overall Study|Lost to Follow-up|5|||
28122414|NCT03247530|54782825|FG000|Overall Study|Withdrawal by caregiver|19|||
28122415|NCT03247530|54782826|FG001|Overall Study|Withdrawal by caregiver|8|||
28122416|NCT03247530|54782827|FG002|Overall Study|Withdrawal by caregiver|10|||
28122417|NCT03247530|54782825|FG000|Overall Study|Lost to Follow-up|3|||
28122418|NCT03247530|54782826|FG001|Overall Study|Lost to Follow-up|9|||
28122419|NCT03247530|54782827|FG002|Overall Study|Lost to Follow-up|6|||
28122420|NCT03247530|54782825|FG000|Overall Study|Adverse Event|2|||
28122421|NCT03247530|54782826|FG001|Overall Study|Adverse Event|5|||
28122422|NCT03247530|54782827|FG002|Overall Study|Adverse Event|2|||
28122423|NCT03247530|54782825|FG000|Overall Study|Failure to follow procedure|1|||
28122424|NCT03247530|54782826|FG001|Overall Study|Failure to follow procedure|1|||
28122425|NCT03247530|54782827|FG002|Overall Study|Failure to follow procedure|1|||
28122426|NCT03247530|54782825|FG000|Overall Study|Withdrawal by Subject|1|||
28122427|NCT03247530|54782826|FG001|Overall Study|Withdrawal by Subject|1|||
28122428|NCT03247530|54782827|FG002|Overall Study|Withdrawal by Subject|0|||
28122429|NCT03247530|54782825|FG000|Overall Study|Study medication misuse|0|||
28122430|NCT03247530|54782826|FG001|Overall Study|Study medication misuse|1|||
28122431|NCT03247530|54782827|FG002|Overall Study|Study medication misuse|0|||
28122432|NCT03247530|54782825|FG000|Overall Study|Other, multiple categories|1|||
28122433|NCT03247530|54782826|FG001|Overall Study|Other, multiple categories|3|||
28122434|NCT03247530|54782827|FG002|Overall Study|Other, multiple categories|1|||
28122435|NCT03246672|54782838|FG000|Overall Study|Lost to Follow-up|2|||
28122436|NCT03983317|54782842|FG000|Overall Study|Physician Decision|5|||
28122437|NCT03207243|54782848|FG000|Overall Study|Adverse Event|2|||
28122438|NCT03207243|54782849|FG001|Overall Study|Adverse Event|2|||
28122439|NCT03207243|54782848|FG000|Overall Study|Loss of Asthma Control|47|||
28122440|NCT03207243|54782849|FG001|Overall Study|Loss of Asthma Control|31|||
28122441|NCT03207243|54782848|FG000|Overall Study|Withdrawal by Subject|2|||
28122442|NCT03207243|54782849|FG001|Overall Study|Withdrawal by Subject|4|||
28122443|NCT03207243|54782848|FG000|Overall Study|Physician Decision|1|||
28122444|NCT03207243|54782849|FG001|Overall Study|Physician Decision|1|||
28122445|NCT03207243|54782848|FG000|Overall Study|Lost to Follow-up|0|||
28122446|NCT03207243|54782849|FG001|Overall Study|Lost to Follow-up|1|||
28122447|NCT03207243|54782848|FG000|Overall Study|Protocol Specified Withdrawal Criteria|7|||
28122448|NCT03207243|54782849|FG001|Overall Study|Protocol Specified Withdrawal Criteria|2|||
28122449|NCT03207243|54782848|FG000|Overall Study|Protocol Violation|0|||
28122450|NCT03207243|54782849|FG001|Overall Study|Protocol Violation|3|||
28066634|NCT00265122|54722131|FG001|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
28066635|NCT00265122|54722132|FG002|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
28066636|NCT00265122|54722133|FG003|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
28066637|NCT00265122|54722134|FG004|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
28066638|NCT00265122|54722135|FG005|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0|||
28066639|NCT00265122|54722130|FG000|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
28066640|NCT00265122|54722131|FG001|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
28066641|NCT00265122|54722132|FG002|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
28066642|NCT00265122|54722133|FG003|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
28122451|NCT03982069|54782860|FG000|Overall Study|Lost to Follow-up|5|||
28122452|NCT03982069|54782861|FG001|Overall Study|Lost to Follow-up|5|||
28122453|NCT03982069|54782862|FG002|Overall Study|Lost to Follow-up|3|||
28122454|NCT03982069|54782863|FG003|Overall Study|Lost to Follow-up|5|||
28122455|NCT03982069|54782860|FG000|Overall Study|Physician Decision|0|||
28122456|NCT03982069|54782861|FG001|Overall Study|Physician Decision|1|||
28122457|NCT03982069|54782862|FG002|Overall Study|Physician Decision|0|||
28122458|NCT03982069|54782863|FG003|Overall Study|Physician Decision|0|||
28122459|NCT03982069|54782860|FG000|Overall Study|Withdrawal by Subject|2|||
28122460|NCT03982069|54782861|FG001|Overall Study|Withdrawal by Subject|1|||
28122461|NCT03982069|54782862|FG002|Overall Study|Withdrawal by Subject|5|||
28122462|NCT03982069|54782863|FG003|Overall Study|Withdrawal by Subject|2|||
28122463|NCT03982069|54782860|FG000|Overall Study|Specimen loss|3|||
28122464|NCT03982069|54782861|FG001|Overall Study|Specimen loss|3|||
28122465|NCT03982069|54782862|FG002|Overall Study|Specimen loss|1|||
28122466|NCT03982069|54782863|FG003|Overall Study|Specimen loss|1|||
28122467|NCT02937870|54782871|FG000|Overall Study|Adverse Event|1|||
28122468|NCT02937870|54782871|FG000|Overall Study|Protocol Deviation|2|||
28122469|NCT03629041|54782885|FG000|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
28122470|NCT03629041|54782886|FG001|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1|||
28122471|NCT03629041|54782887|FG002|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
28122472|NCT03629041|54782888|FG003|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
27849275|NCT02085161|54344602|FG001|Overall Study|Withdrawal by Subject|4|||
27849276|NCT02085161|54344603|FG002|Overall Study|Withdrawal by Subject|0|||
27849277|NCT02085161|54344604|FG003|Overall Study|Withdrawal by Subject|3|||
28066643|NCT00265122|54722134|FG004|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
28122473|NCT03219723|54782906|FG000|Overall Study|Case Report Forms Uncollected|6|||
28122474|NCT03219723|54782906|FG000|Overall Study|Protocol Deviation|4|||
28122475|NCT03628417|54782910|FG000|Overall Study|Death|1|||
28122476|NCT03628417|54782911|FG001|Overall Study|Death|1|||
28122477|NCT03184077|54782923|FG000|Overall Study|Lost to Follow-up|21|||
28122478|NCT03184077|54782924|FG001|Overall Study|Lost to Follow-up|21|||
28122479|NCT03245736|54782930|FG000|Overall Study|Adverse Event|1|||
28122480|NCT03245736|54782930|FG000|Overall Study|Progressive Disease|4|||
28122481|NCT02954887|54782934|FG000|Overall Study|Withdrawal by Subject|3|||
28122482|NCT02954887|54782934|FG000|Overall Study|Lack of Efficacy|3|||
28122483|NCT02954887|54782934|FG000|Overall Study|Other|1|||
28122484|NCT03183063|54782941|FG000|Overall Study|Withdrawal by Subject|2|||
28066644|NCT00265122|54722135|FG005|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
28122485|NCT03183063|54782942|FG001|Overall Study|Withdrawal by Subject|0|||
28122486|NCT03183063|54782943|FG002|Overall Study|Withdrawal by Subject|0|||
28122487|NCT03183063|54782941|FG000|Overall Study|Physician Decision|3|||
28122488|NCT03183063|54782942|FG001|Overall Study|Physician Decision|4|||
28122489|NCT03183063|54782943|FG002|Overall Study|Physician Decision|4|||
28122490|NCT03182829|54782959|FG000|Overall Study|Protocol Violation|12|||
28122491|NCT03182829|54782960|FG001|Overall Study|Protocol Violation|12|||
28122492|NCT03182829|54782959|FG000|Overall Study|Other|4|||
28122493|NCT03182829|54782960|FG001|Overall Study|Other|3|||
28122494|NCT03278028|54782968|FG000|Overall Study|Lost to Follow-up|1|||
28122495|NCT03278028|54782969|FG001|Overall Study|Lost to Follow-up|0|||
28122496|NCT03278028|54782968|FG000|Overall Study|Withdrawal by Subject|3|||
28122497|NCT03278028|54782969|FG001|Overall Study|Withdrawal by Subject|1|||
28122498|NCT03278028|54782968|FG000|Overall Study|Pregnancy|0|||
28122499|NCT03278028|54782969|FG001|Overall Study|Pregnancy|1|||
28122500|NCT03181503|54782977|FG000|Overall Study|Adverse Event|2|||
28122501|NCT03181503|54782978|FG001|Overall Study|Adverse Event|2|||
28122502|NCT03181503|54782977|FG000|Overall Study|Protocol Violation|1|||
28122503|NCT03181503|54782978|FG001|Overall Study|Protocol Violation|0|||
28122504|NCT03181503|54782977|FG000|Overall Study|Withdrawal by Subject|3|||
28122505|NCT03181503|54782978|FG001|Overall Study|Withdrawal by Subject|0|||
28122506|NCT03181503|54782977|FG000|Overall Study|Lost to Follow-up|1|||
28122507|NCT03181503|54782978|FG001|Overall Study|Lost to Follow-up|1|||
28122508|NCT03277794|54782989|FG000|Overall Study|Lost to Follow-up|2|||
28122509|NCT03277794|54782990|FG001|Overall Study|Lost to Follow-up|4|||
28122510|NCT03277794|54782989|FG000|Overall Study|Withdrew due to high acuity|1|||
28066645|NCT00265122|54722130|FG000|Intervention Period 2 (Weeks 8 to 28):|Other|4|||
28066646|NCT00265122|54722131|FG001|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
28066647|NCT00265122|54722132|FG002|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
28066648|NCT00265122|54722133|FG003|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
28066649|NCT00265122|54722134|FG004|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
28066650|NCT00265122|54722135|FG005|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
28066651|NCT00116584|54722156|FG000|Overall Study|Withdrawal by Subject|1|||
28066652|NCT00116584|54722157|FG001|Overall Study|Withdrawal by Subject|0|||
28066653|NCT00116584|54722156|FG000|Overall Study|Protocol Violation|1|||
28066654|NCT00116584|54722157|FG001|Overall Study|Protocol Violation|1|||
28122511|NCT03277794|54782990|FG001|Overall Study|Withdrew due to high acuity|0|||
28122512|NCT03276078|54782997|FG000|Overall Study|Adverse Event|1|||
28122513|NCT03180801|54783004|FG000|Overall Study|Physician Decision|3|||
28122514|NCT03180801|54783005|FG001|Overall Study|Physician Decision|3|||
28122515|NCT03180801|54783006|FG002|Overall Study|Physician Decision|1|||
28066655|NCT00096538|54722163|FG000|Overall Study|Withdrawal by Subject|1|||
28122516|NCT03180801|54783004|FG000|Overall Study|Non-compliance|1|||
28122517|NCT03180801|54783005|FG001|Overall Study|Non-compliance|4|||
28122518|NCT03180801|54783006|FG002|Overall Study|Non-compliance|0|||
28122519|NCT03180801|54783004|FG000|Overall Study|Inoculation Target Reached|1|||
28122520|NCT03180801|54783005|FG001|Overall Study|Inoculation Target Reached|1|||
28122521|NCT03180801|54783006|FG002|Overall Study|Inoculation Target Reached|3|||
28122522|NCT03180801|54783004|FG000|Overall Study|Adverse Event|1|||
28122523|NCT03180801|54783005|FG001|Overall Study|Adverse Event|0|||
28122524|NCT03180801|54783006|FG002|Overall Study|Adverse Event|2|||
28122525|NCT03180801|54783004|FG000|Overall Study|Withdrawal by Subject|2|||
28122526|NCT03180801|54783005|FG001|Overall Study|Withdrawal by Subject|2|||
28122527|NCT03180801|54783006|FG002|Overall Study|Withdrawal by Subject|1|||
28122528|NCT03180801|54783004|FG000|Overall Study|Lost to Follow-up|0|||
28122529|NCT03180801|54783005|FG001|Overall Study|Lost to Follow-up|2|||
28122530|NCT03180801|54783006|FG002|Overall Study|Lost to Follow-up|3|||
28122531|NCT03742271|54783017|FG000|Overall Study|Unsatisfactory Visual Response|1|||
28122532|NCT03742271|54783017|FG000|Overall Study|Withdrawal by Subject|3|||
28122533|NCT03742271|54783017|FG000|Overall Study|Lost to Follow-up|4|||
28122534|NCT03742271|54783017|FG000|Overall Study|Failed Insertion & removal|3|||
28122535|NCT03742271|54783017|FG000|Overall Study|Protocol Violation|1|||
28122536|NCT03214224|54783021|FG000|Overall Study|Protocol Violation|1|||
28122537|NCT03214224|54783021|FG000|Overall Study|Withdrawal by Subject|2|||
28122538|NCT03214224|54783021|FG000|Overall Study|Practice controls or therapists|6|||
28122539|NCT03180645|54783028|FG000|Overall Study|Adverse Event|0|||
28122540|NCT03180645|54783029|FG001|Overall Study|Adverse Event|1|||
28122541|NCT03180645|54783030|FG002|Overall Study|Adverse Event|2|||
28122542|NCT03750695|54783042|FG000|Overall Study|Lost to Follow-up|0|||
28122543|NCT03750695|54783043|FG001|Overall Study|Lost to Follow-up|1|||
28122544|NCT03748823|54783056|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
28122545|NCT03748823|54783057|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
28122546|NCT03748823|54783056|FG000|Extension Period|Withdrawal by Subject|1|||
28066656|NCT00239928|54722167|FG000|Overall Study|Lack of Efficacy|1|||
28066657|NCT00239928|54722167|FG000|Overall Study|Adverse Event|4|||
28122547|NCT03748823|54783057|FG001|Extension Period|Withdrawal by Subject|2|||
28122548|NCT03748823|54783056|FG000|Extension Period|Death|0|||
28122549|NCT03748823|54783057|FG001|Extension Period|Death|1|||
28122550|NCT03748823|54783056|FG000|Extension Period|Protocol Violation|1|||
28122551|NCT03748823|54783057|FG001|Extension Period|Protocol Violation|0|||
28122552|NCT03748823|54783056|FG000|Extension Period|Ongoing in the Extension Period|41|||
28122553|NCT03748823|54783057|FG001|Extension Period|Ongoing in the Extension Period|84|||
28122554|NCT03231228|54783066|FG000|Overall Study|Lost to Follow-up|2|||
28122555|NCT03231228|54783067|FG001|Overall Study|Lost to Follow-up|0|||
28122556|NCT03231228|54783066|FG000|Overall Study|Physician Decision|1|||
28122557|NCT03231228|54783067|FG001|Overall Study|Physician Decision|0|||
28122558|NCT03213366|54783075|FG000|Overall Study|Lost to Follow-up|9|||
28122559|NCT03213366|54783076|FG001|Overall Study|Lost to Follow-up|4|||
28122560|NCT03213210|54783082|FG000|Overall Study|Lost to Follow-up|2|||
28122561|NCT03213210|54783082|FG000|Overall Study|Study termination|3|||
28122562|NCT02932878|54783088|FG000|Overall Study|Due to Lab Results|2|||
28122563|NCT02932878|54783089|FG001|Overall Study|Due to Lab Results|1|||
28122564|NCT03230292|54783095|FG000|Overall Study|Adverse Event|1|||
28122565|NCT03230292|54783095|FG000|Overall Study|Protocol Violation|1|||
28122566|NCT03230292|54783095|FG000|Overall Study|Lost to Follow-up|1|||
28066658|NCT00239928|54722167|FG000|Overall Study|Not need to continue study|3|||
28066659|NCT00239928|54722167|FG000|Overall Study|Withdrawal by Subject|2|||
28066660|NCT00116428|54722173|FG000|Overall Study|Withdrawal by Subject|2|||
28066661|NCT00116428|54722174|FG001|Overall Study|Withdrawal by Subject|5|||
28066662|NCT00116428|54722173|FG000|Overall Study|Did not meet inclusion criteria|1|||
28066663|NCT00116428|54722174|FG001|Overall Study|Did not meet inclusion criteria|0|||
28066664|NCT00468845|54722186|FG000|Overall Study|Adverse Event|9|||
28066665|NCT00468845|54722187|FG001|Overall Study|Adverse Event|14|||
28066666|NCT00468845|54722188|FG002|Overall Study|Adverse Event|11|||
28066667|NCT00468845|54722186|FG000|Overall Study|Lost to Follow-up|2|||
28066668|NCT00468845|54722187|FG001|Overall Study|Lost to Follow-up|1|||
28066669|NCT00468845|54722188|FG002|Overall Study|Lost to Follow-up|2|||
28122567|NCT03230292|54783095|FG000|Overall Study|Withdrawal by Subject|3|||
28122568|NCT03228420|54783107|FG000|Overall Study|Lost to Follow-up|5|||
28122569|NCT03228420|54783108|FG001|Overall Study|Lost to Follow-up|3|||
28122570|NCT03228420|54783107|FG000|Overall Study|Withdrawal by Subject|10|||
27817717|NCT04842747|54275846|FG000|Overall Study|Lost to Follow-up|1|||
28066670|NCT00468845|54722186|FG000|Overall Study|Other|4|||
28066671|NCT00468845|54722187|FG001|Overall Study|Other|9|||
28066672|NCT00468845|54722188|FG002|Overall Study|Other|5|||
28122571|NCT03228420|54783108|FG001|Overall Study|Withdrawal by Subject|0|||
28122572|NCT03228420|54783107|FG000|Overall Study|Adverse Event|5|||
28122573|NCT03228420|54783108|FG001|Overall Study|Adverse Event|2|||
28122574|NCT03117049|54783116|FG000|Overall Study|Continued the follow-up period|109|||
28122575|NCT03117049|54783117|FG001|Overall Study|Continued the follow-up period|129|||
28066673|NCT00468845|54722186|FG000|Overall Study|No longer willing to participate|5|||
28066674|NCT00468845|54722187|FG001|Overall Study|No longer willing to participate|6|||
28122576|NCT03117049|54783116|FG000|Overall Study|Died|82|||
28122577|NCT03117049|54783117|FG001|Overall Study|Died|93|||
28122578|NCT03117049|54783116|FG000|Overall Study|Consent withdrawal|7|||
28122579|NCT03117049|54783117|FG001|Overall Study|Consent withdrawal|6|||
28122580|NCT03117049|54783116|FG000|Overall Study|Missing contact|3|||
28122581|NCT03117049|54783117|FG001|Overall Study|Missing contact|3|||
28122582|NCT03746483|54783125|FG000|Overall Study|Adverse Event|0|||
28122583|NCT03746483|54783126|FG001|Overall Study|Adverse Event|1|||
28122584|NCT03746483|54783125|FG000|Overall Study|Lack of Efficacy|3|||
28122585|NCT03746483|54783126|FG001|Overall Study|Lack of Efficacy|2|||
28122586|NCT03746483|54783125|FG000|Overall Study|Lost to Follow-up|1|||
28122587|NCT03746483|54783126|FG001|Overall Study|Lost to Follow-up|0|||
28122588|NCT03746483|54783125|FG000|Overall Study|Protocol Violation|2|||
28122589|NCT03746483|54783126|FG001|Overall Study|Protocol Violation|0|||
28122590|NCT03746405|54783136|FG000|Overall Study|Withdrawal by Subject|3|||
28122591|NCT03746405|54783137|FG001|Overall Study|Withdrawal by Subject|0|||
28122592|NCT03746405|54783136|FG000|Overall Study|technical difficulties|0|||
28122593|NCT03746405|54783137|FG001|Overall Study|technical difficulties|2|||
28122594|NCT03226392|54783145|FG000|Overall Study|Protocol Deviation|1|||
28122595|NCT03226392|54783146|FG001|Overall Study|Protocol Deviation|0|||
28122596|NCT03226392|54783145|FG000|Overall Study|Physician Decision|1|||
28122597|NCT03226392|54783146|FG001|Overall Study|Physician Decision|0|||
28122598|NCT03226392|54783145|FG000|Overall Study|Lost to Follow-up|1|||
28122599|NCT03226392|54783146|FG001|Overall Study|Lost to Follow-up|0|||
28122600|NCT03226392|54783145|FG000|Overall Study|Adverse Event|1|||
28122601|NCT03226392|54783146|FG001|Overall Study|Adverse Event|0|||
28122602|NCT03226392|54783145|FG000|Overall Study|Technical Problems|0|||
28122603|NCT03226392|54783146|FG001|Overall Study|Technical Problems|2|||
28122604|NCT03226392|54783145|FG000|Overall Study|Subject/Guardian Decision|7|||
28122605|NCT03226392|54783146|FG001|Overall Study|Subject/Guardian Decision|6|||
28122606|NCT03205371|54783164|FG000|Overall Study|Withdrawal by Subject|4|||
28122607|NCT03205371|54783165|FG001|Overall Study|Withdrawal by Subject|1|||
28122608|NCT03205371|54783166|FG002|Overall Study|Withdrawal by Subject|0|||
28122609|NCT03205371|54783167|FG003|Overall Study|Withdrawal by Subject|0|||
28122610|NCT03205371|54783168|FG004|Overall Study|Withdrawal by Subject|0|||
28122611|NCT03205371|54783169|FG005|Overall Study|Withdrawal by Subject|0|||
28122612|NCT03205371|54783170|FG006|Overall Study|Withdrawal by Subject|4|||
28122613|NCT03205371|54783171|FG007|Overall Study|Withdrawal by Subject|0|||
28122614|NCT03205371|54783172|FG008|Overall Study|Withdrawal by Subject|2|||
28122615|NCT03205371|54783173|FG009|Overall Study|Withdrawal by Subject|0|||
28122616|NCT03205371|54783174|FG010|Overall Study|Withdrawal by Subject|0|||
28122617|NCT03205371|54783175|FG011|Overall Study|Withdrawal by Subject|1|||
28122618|NCT03205371|54783164|FG000|Overall Study|Lost to Follow-up|0|||
28122619|NCT03205371|54783165|FG001|Overall Study|Lost to Follow-up|0|||
28066675|NCT00468845|54722188|FG002|Overall Study|No longer willing to participate|10|||
28066676|NCT00468845|54722186|FG000|Overall Study|Randomized, not treated|1|||
28066677|NCT00468845|54722187|FG001|Overall Study|Randomized, not treated|4|||
28066678|NCT00468845|54722188|FG002|Overall Study|Randomized, not treated|2|||
28066679|NCT00468299|54722198|FG000|Overall Study|Withdrawal by Subject|0|||
28066680|NCT00468299|54722199|FG001|Overall Study|Withdrawal by Subject|1|||
28066681|NCT00468143|54722207|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|3|||
28066682|NCT00468143|54722208|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|4|||
28122620|NCT03205371|54783166|FG002|Overall Study|Lost to Follow-up|0|||
28122621|NCT03205371|54783167|FG003|Overall Study|Lost to Follow-up|0|||
28122622|NCT03205371|54783168|FG004|Overall Study|Lost to Follow-up|0|||
28122623|NCT03205371|54783169|FG005|Overall Study|Lost to Follow-up|0|||
28122624|NCT03205371|54783170|FG006|Overall Study|Lost to Follow-up|5|||
28066683|NCT00468143|54722207|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
28122625|NCT03205371|54783171|FG007|Overall Study|Lost to Follow-up|2|||
28122626|NCT03205371|54783172|FG008|Overall Study|Lost to Follow-up|3|||
28122627|NCT03205371|54783173|FG009|Overall Study|Lost to Follow-up|0|||
28122628|NCT03205371|54783174|FG010|Overall Study|Lost to Follow-up|0|||
28122629|NCT03205371|54783175|FG011|Overall Study|Lost to Follow-up|0|||
28122630|NCT03205371|54783164|FG000|Overall Study|Protocol Violation|0|||
28122631|NCT03205371|54783165|FG001|Overall Study|Protocol Violation|0|||
28122632|NCT03205371|54783166|FG002|Overall Study|Protocol Violation|0|||
28122633|NCT03205371|54783167|FG003|Overall Study|Protocol Violation|0|||
28122634|NCT03205371|54783168|FG004|Overall Study|Protocol Violation|0|||
28122635|NCT03205371|54783169|FG005|Overall Study|Protocol Violation|0|||
28122636|NCT03205371|54783170|FG006|Overall Study|Protocol Violation|1|||
28122637|NCT03205371|54783171|FG007|Overall Study|Protocol Violation|0|||
28122638|NCT03205371|54783172|FG008|Overall Study|Protocol Violation|0|||
28122639|NCT03205371|54783173|FG009|Overall Study|Protocol Violation|0|||
28122640|NCT03205371|54783174|FG010|Overall Study|Protocol Violation|0|||
28122641|NCT03205371|54783175|FG011|Overall Study|Protocol Violation|0|||
28122642|NCT03205371|54783164|FG000|Overall Study|Adverse Event|0|||
28122643|NCT03205371|54783165|FG001|Overall Study|Adverse Event|0|||
28122644|NCT03205371|54783166|FG002|Overall Study|Adverse Event|0|||
28122645|NCT03205371|54783167|FG003|Overall Study|Adverse Event|0|||
28122646|NCT03205371|54783168|FG004|Overall Study|Adverse Event|0|||
28122647|NCT03205371|54783169|FG005|Overall Study|Adverse Event|0|||
28122648|NCT03205371|54783170|FG006|Overall Study|Adverse Event|0|||
28122649|NCT03205371|54783171|FG007|Overall Study|Adverse Event|1|||
28122650|NCT03205371|54783172|FG008|Overall Study|Adverse Event|0|||
28122651|NCT03205371|54783173|FG009|Overall Study|Adverse Event|0|||
28122652|NCT03205371|54783174|FG010|Overall Study|Adverse Event|0|||
28066684|NCT00468143|54722208|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
28066685|NCT00467831|54722214|FG000|Overall Study|Death|2|||
28122653|NCT03205371|54783175|FG011|Overall Study|Adverse Event|0|||
28122654|NCT03682705|54783227|FG000|Overall Study|Adverse Event|1|||
28066686|NCT00467831|54722214|FG000|Overall Study|Withdrawal by Subject|1|||
28066687|NCT00467753|54722220|FG000|Overall Study|Lost to Follow-up|1|||
28066688|NCT00467753|54722221|FG001|Overall Study|Lost to Follow-up|2|||
28066689|NCT00467753|54722220|FG000|Overall Study|Adverse Event|2|||
28066690|NCT00467753|54722221|FG001|Overall Study|Adverse Event|0|||
28066691|NCT00116272|54722233|FG000|Overall Study|Lost to Follow-up|11|||
28066692|NCT00116272|54722234|FG001|Overall Study|Lost to Follow-up|6|||
28066693|NCT00467597|54722246|FG000|Overall Study|Withdrawal by Subject|2|||
28066694|NCT00467597|54722247|FG001|Overall Study|Withdrawal by Subject|0|||
28066695|NCT00115804|54722257|FG000|Overall Study|Adverse Event|2|||
28066696|NCT00467519|54722265|FG000|Overall Study|Protocol Violation|8|||
28066697|NCT00467519|54722266|FG001|Overall Study|Protocol Violation|4|||
28066698|NCT00467519|54722265|FG000|Overall Study|Lost to Follow-up|2|||
28066699|NCT00467519|54722266|FG001|Overall Study|Lost to Follow-up|9|||
28066700|NCT00467519|54722265|FG000|Overall Study|Withdrawal by Subject|4|||
28066701|NCT00467519|54722266|FG001|Overall Study|Withdrawal by Subject|10|||
28066702|NCT00264810|54722274|FG000|Baseline|Withdrawal by Subject|10|||
28066703|NCT00264810|54722275|FG001|Baseline|Withdrawal by Subject|10|||
28066704|NCT00264810|54722274|FG000|Baseline|Physician Decision|7|||
28066705|NCT00264810|54722275|FG001|Baseline|Physician Decision|8|||
28066706|NCT00264810|54722274|FG000|Baseline|Subject Compliance Failure|3|||
28122655|NCT03682705|54783228|FG001|Overall Study|Adverse Event|1|||
28122656|NCT03682705|54783229|FG002|Overall Study|Adverse Event|1|||
28122657|NCT03682705|54783230|FG003|Overall Study|Adverse Event|0|||
28066707|NCT00264810|54722275|FG001|Baseline|Subject Compliance Failure|3|||
28122658|NCT03682705|54783231|FG004|Overall Study|Adverse Event|1|||
28122659|NCT03682705|54783232|FG005|Overall Study|Adverse Event|1|||
28122660|NCT03682705|54783227|FG000|Overall Study|Withdrawal by Subject|1|||
28122661|NCT03682705|54783228|FG001|Overall Study|Withdrawal by Subject|3|||
28122662|NCT03682705|54783229|FG002|Overall Study|Withdrawal by Subject|2|||
28122663|NCT03682705|54783230|FG003|Overall Study|Withdrawal by Subject|4|||
28122664|NCT03682705|54783231|FG004|Overall Study|Withdrawal by Subject|0|||
28122665|NCT03682705|54783232|FG005|Overall Study|Withdrawal by Subject|1|||
28122666|NCT03682705|54783227|FG000|Overall Study|Other, not specified|0|||
28122667|NCT03682705|54783228|FG001|Overall Study|Other, not specified|0|||
28122668|NCT03682705|54783229|FG002|Overall Study|Other, not specified|0|||
28122669|NCT03682705|54783230|FG003|Overall Study|Other, not specified|1|||
28122670|NCT03682705|54783231|FG004|Overall Study|Other, not specified|2|||
28122671|NCT03682705|54783232|FG005|Overall Study|Other, not specified|0|||
28122672|NCT03682705|54783227|FG000|Overall Study|Lost to Follow-up|0|||
28122673|NCT03682705|54783228|FG001|Overall Study|Lost to Follow-up|0|||
28122674|NCT03682705|54783229|FG002|Overall Study|Lost to Follow-up|0|||
28122675|NCT03682705|54783230|FG003|Overall Study|Lost to Follow-up|0|||
28122676|NCT03682705|54783231|FG004|Overall Study|Lost to Follow-up|3|||
28122677|NCT03682705|54783232|FG005|Overall Study|Lost to Follow-up|0|||
28122678|NCT03179787|54783246|FG000|Overall Study|Lost to Follow-up|15|||
28122679|NCT03179787|54783246|FG000|Overall Study|Case report failures|2|||
28122680|NCT03179787|54783246|FG000|Overall Study|Treatment not administered|1|||
28122681|NCT03745937|54783254|FG000|Overall Study|Withdrawal by Subject|0|||
28122682|NCT03745937|54783255|FG001|Overall Study|Withdrawal by Subject|0|||
28122683|NCT03745937|54783256|FG002|Overall Study|Withdrawal by Subject|0|||
28122684|NCT03745937|54783257|FG003|Overall Study|Withdrawal by Subject|1|||
28122685|NCT03745937|54783254|FG000|Overall Study|Not-specifed|0|||
28122686|NCT03745937|54783255|FG001|Overall Study|Not-specifed|1|||
28122687|NCT03745937|54783256|FG002|Overall Study|Not-specifed|0|||
27817718|NCT04842747|54275847|FG001|Overall Study|Lost to Follow-up|2|||
27817719|NCT04842747|54275846|FG000|Overall Study|Physician Decision|1|||
27817720|NCT04842747|54275847|FG001|Overall Study|Physician Decision|0|||
27817721|NCT04842747|54275846|FG000|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|1|||
27817722|NCT04842747|54275847|FG001|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|0|||
27817723|NCT04810481|54275855|FG000|Overall Study|Disqualified data sets|10|||
27817724|NCT04810481|54275856|FG001|Overall Study|Disqualified data sets|28|||
27817725|NCT04664400|54275875|FG000|Overall Study|Withdrawal by Subject|2|||
27817726|NCT04657770|54275880|FG000|Overall Study|Withdrawal by Subject|3|||
27817727|NCT04657770|54275880|FG000|Overall Study|Completed training but withdrew before follow-up testing due to change in medical status|1|||
27817728|NCT04496453|54275884|FG000|Overall Study|Lost to Follow-up|6|||
27817729|NCT04482647|54275888|FG000|Overall Study|Time constraints|2|||
27817730|NCT04482647|54275888|FG000|Overall Study|Health issues|1|||
27817731|NCT04482647|54275888|FG000|Overall Study|Death in the family|1|||
27817732|NCT04482647|54275888|FG000|Overall Study|Disliked the intervention|1|||
28066708|NCT00264810|54722274|FG000|Baseline|Insufficient Seizure Frequency|2|||
28122688|NCT03745937|54783257|FG003|Overall Study|Not-specifed|1|||
28122689|NCT02956057|54783274|FG000|Overall Study|Discontinued intervention|14|||
28122690|NCT02956057|54783275|FG001|Overall Study|Discontinued intervention|10|||
28122691|NCT02956057|54783276|FG002|Overall Study|Discontinued intervention|7|||
28122692|NCT02956057|54783277|FG003|Overall Study|Discontinued intervention|14|||
28122693|NCT02956057|54783278|FG004|Overall Study|Discontinued intervention|4|||
28122694|NCT02956057|54783279|FG005|Overall Study|Discontinued intervention|17|||
28122695|NCT02956057|54783274|FG000|Overall Study|Lost to Follow-up|0|||
28122696|NCT02956057|54783275|FG001|Overall Study|Lost to Follow-up|2|||
28122697|NCT02956057|54783276|FG002|Overall Study|Lost to Follow-up|1|||
28122698|NCT02956057|54783277|FG003|Overall Study|Lost to Follow-up|1|||
28122699|NCT02956057|54783278|FG004|Overall Study|Lost to Follow-up|1|||
28122700|NCT02956057|54783279|FG005|Overall Study|Lost to Follow-up|0|||
28122701|NCT03179319|54783295|FG000|Overall Study|Lost to Follow-up|6|||
28122702|NCT03179319|54783296|FG001|Overall Study|Lost to Follow-up|0|||
28122703|NCT03627091|54783305|FG000|Overall Study|Adverse Event|0|||
27817733|NCT04482647|54275888|FG000|Overall Study|No reasons specified|7|||
27817734|NCT04440163|54275900|FG000|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|26|||
28066709|NCT00264810|54722275|FG001|Baseline|Insufficient Seizure Frequency|2|||
28066710|NCT00264810|54722274|FG000|Baseline|Did not Meet/Maintain Study I/E Criteria|1|||
28066711|NCT00264810|54722275|FG001|Baseline|Did not Meet/Maintain Study I/E Criteria|2|||
28066712|NCT00264810|54722274|FG000|Baseline|Other|0|||
28066713|NCT00264810|54722275|FG001|Baseline|Other|1|||
28066714|NCT00264810|54722274|FG000|Stimulation Optimization Period|Withdrawal by Subject|1|||
28066715|NCT00264810|54722275|FG001|Stimulation Optimization Period|Withdrawal by Subject|0|||
28066716|NCT00264810|54722274|FG000|Stimulation Optimization Period|Death|0|||
28122704|NCT03627091|54783306|FG001|Overall Study|Adverse Event|0|||
28122705|NCT03627091|54783307|FG002|Overall Study|Adverse Event|2|||
28122706|NCT03627091|54783305|FG000|Overall Study|Withdrawal by Subject|2|||
28122707|NCT03627091|54783306|FG001|Overall Study|Withdrawal by Subject|0|||
28122708|NCT03627091|54783307|FG002|Overall Study|Withdrawal by Subject|2|||
28122709|NCT03627091|54783305|FG000|Overall Study|Physician Decision|2|||
28122710|NCT03627091|54783306|FG001|Overall Study|Physician Decision|0|||
28122711|NCT03627091|54783307|FG002|Overall Study|Physician Decision|0|||
28122712|NCT03627091|54783305|FG000|Overall Study|Site terminated by sponsor|0|||
28122713|NCT03627091|54783306|FG001|Overall Study|Site terminated by sponsor|1|||
28122714|NCT03627091|54783307|FG002|Overall Study|Site terminated by sponsor|0|||
28122715|NCT03627091|54783305|FG000|Overall Study|Disease relapse|7|||
28122716|NCT03627091|54783306|FG001|Overall Study|Disease relapse|5|||
28122717|NCT03627091|54783307|FG002|Overall Study|Disease relapse|1|||
28122718|NCT03627091|54783305|FG000|Overall Study|Other|1|||
28122719|NCT03627091|54783306|FG001|Overall Study|Other|0|||
28122720|NCT03627091|54783307|FG002|Overall Study|Other|0|||
28122721|NCT04237584|54783320|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
28122722|NCT04237584|54783321|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
28122723|NCT04237584|54783322|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
28122724|NCT04237584|54783323|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
28122725|NCT04237584|54783320|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
28122726|NCT04237584|54783321|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
28122727|NCT04237584|54783322|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|0|||
28122728|NCT04237584|54783323|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
28122729|NCT04237584|54783320|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
28122730|NCT04237584|54783321|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
28122731|NCT04237584|54783322|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|2|||
28122732|NCT04237584|54783323|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
28122733|NCT04237584|54783320|FG000|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
28122734|NCT04237584|54783321|FG001|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
28122735|NCT04237584|54783322|FG002|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|2|||
28122736|NCT04237584|54783323|FG003|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|3|||
28122737|NCT04237584|54783320|FG000|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
28122738|NCT04237584|54783321|FG001|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
28122739|NCT04237584|54783322|FG002|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|1|||
28122740|NCT04237584|54783323|FG003|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
28122741|NCT03224598|54783340|FG000|Overall Study|Lost to Follow-up|0|||
28122742|NCT03224598|54783341|FG001|Overall Study|Lost to Follow-up|2|||
28122743|NCT03224598|54783342|FG002|Overall Study|Lost to Follow-up|0|||
28122744|NCT03224598|54783340|FG000|Overall Study|Other|0|||
28122745|NCT03224598|54783341|FG001|Overall Study|Other|1|||
28122746|NCT03224598|54783342|FG002|Overall Study|Other|0|||
28122747|NCT03681691|54783352|FG000|Overall Study|COVID|1|||
28122748|NCT03681691|54783353|FG001|Overall Study|COVID|0|||
28122749|NCT03681691|54783352|FG000|Overall Study|prolonged bleeding|1|||
28122750|NCT03681691|54783353|FG001|Overall Study|prolonged bleeding|0|||
28122751|NCT03681691|54783352|FG000|Overall Study|veins would not stay open during the PET scan.|0|||
28122752|NCT03681691|54783353|FG001|Overall Study|veins would not stay open during the PET scan.|1|||
28122753|NCT02935842|54783365|FG000|Testing and Therapy Period 2|Withdrawal by Subject|2|||
28066717|NCT00264810|54722275|FG001|Stimulation Optimization Period|Death|1|||
28066718|NCT00264810|54722274|FG000|Blinded Evaluation Period|Explant due to infection|1|||
28066719|NCT00264810|54722275|FG001|Blinded Evaluation Period|Explant due to infection|1|||
28066720|NCT00264810|54722274|FG000|Open Label Evaluation Period|Explant due to infection|1|||
28066721|NCT00264810|54722275|FG001|Open Label Evaluation Period|Explant due to infection|1|||
28066722|NCT00264810|54722274|FG000|Open Label Evaluation Period|Death|3|||
28066723|NCT00264810|54722275|FG001|Open Label Evaluation Period|Death|2|||
28066724|NCT00264810|54722274|FG000|Open Label Evaluation Period|Pursue Other Treatment Options|2|||
28066725|NCT00264810|54722275|FG001|Open Label Evaluation Period|Pursue Other Treatment Options|3|||
28066726|NCT00467363|54722285|FG000|Overall Study|Lost to Follow-up|80|||
28066727|NCT00467363|54722286|FG001|Overall Study|Lost to Follow-up|70|||
28066728|NCT00091390|54722292|FG000|Overall Study|Protocol Violation|1|||
28066729|NCT00091390|54722292|FG000|Overall Study|No protocol treatment|3|||
28066730|NCT00239226|54722300|FG000|Overall Study|permAF during stabilization period|0|||
28066731|NCT00239226|54722301|FG001|Overall Study|permAF during stabilization period|0|||
28066732|NCT00239226|54722302|FG002|Overall Study|permAF during stabilization period|0|||
28066733|NCT00239226|54722303|FG003|Overall Study|permAF during stabilization period|3|||
28066734|NCT00239226|54722300|FG000|Overall Study|Lost to Follow-up|1|||
28066735|NCT00239226|54722301|FG001|Overall Study|Lost to Follow-up|0|||
28066736|NCT00239226|54722302|FG002|Overall Study|Lost to Follow-up|1|||
28066737|NCT00239226|54722303|FG003|Overall Study|Lost to Follow-up|0|||
28066738|NCT00467285|54722315|FG000|Overall Study|Lost to Follow-up|4|||
28066739|NCT00467285|54722316|FG001|Overall Study|Lost to Follow-up|4|||
28066740|NCT00264576|54722326|FG000|Overall Study|Lost to Follow-up|1|||
28066741|NCT00264576|54722327|FG001|Overall Study|Lost to Follow-up|1|||
28066742|NCT00466505|54722334|FG000|Overall Study|disease progression|13|||
28066743|NCT00466505|54722334|FG000|Overall Study|Adverse Event|4|||
28122754|NCT02935842|54783366|FG001|Testing and Therapy Period 2|Withdrawal by Subject|0|||
28122755|NCT02935842|54783367|FG002|Testing and Therapy Period 2|Withdrawal by Subject|0|||
28122756|NCT02935842|54783368|FG003|Testing and Therapy Period 2|Withdrawal by Subject|0|||
28122757|NCT02935842|54783365|FG000|Testing and Therapy Period 3|Required other therapy (dysphagia)|1|||
28122758|NCT02935842|54783366|FG001|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
28122759|NCT02935842|54783367|FG002|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
28122760|NCT02935842|54783368|FG003|Testing and Therapy Period 3|Required other therapy (dysphagia)|0|||
28122761|NCT02935842|54783365|FG000|Testing and Therapy Period 3|Accident prior to treatment|2|||
28122762|NCT02935842|54783366|FG001|Testing and Therapy Period 3|Accident prior to treatment|2|||
28122763|NCT02935842|54783367|FG002|Testing and Therapy Period 3|Accident prior to treatment|0|||
28122764|NCT02935842|54783368|FG003|Testing and Therapy Period 3|Accident prior to treatment|0|||
28122765|NCT02935842|54783365|FG000|Testing and Therapy Period 3|Lost to Follow-up|0|||
28122766|NCT02935842|54783366|FG001|Testing and Therapy Period 3|Lost to Follow-up|0|||
28122767|NCT02935842|54783367|FG002|Testing and Therapy Period 3|Lost to Follow-up|0|||
28122768|NCT02935842|54783368|FG003|Testing and Therapy Period 3|Lost to Follow-up|1|||
28122769|NCT02935842|54783365|FG000|Testing and Therapy Period 3|Withdrawal by Subject|0|||
28122770|NCT02935842|54783366|FG001|Testing and Therapy Period 3|Withdrawal by Subject|0|||
28122771|NCT02935842|54783367|FG002|Testing and Therapy Period 3|Withdrawal by Subject|3|||
28122772|NCT02935842|54783368|FG003|Testing and Therapy Period 3|Withdrawal by Subject|0|||
28122773|NCT01064479|54783387|FG000|Overall Study|Death|10|||
28122774|NCT01064479|54783388|FG001|Overall Study|Death|11|||
28122775|NCT01064479|54783387|FG000|Overall Study|Withdrawal by Subject|2|||
28122776|NCT01064479|54783388|FG001|Overall Study|Withdrawal by Subject|2|||
28122777|NCT01064479|54783387|FG000|Overall Study|Disease progression|1|||
28122778|NCT01064479|54783388|FG001|Overall Study|Disease progression|1|||
28122779|NCT01064479|54783387|FG000|Overall Study|Toxicity|1|||
28122780|NCT01064479|54783388|FG001|Overall Study|Toxicity|1|||
28122781|NCT01064479|54783387|FG000|Overall Study|Other|1|||
28122782|NCT01064479|54783388|FG001|Overall Study|Other|2|||
28122783|NCT03680911|54783396|FG000|At Home Treatment|Study Termination|3|||
28122784|NCT03680911|54783397|FG001|At Home Treatment|Study Termination|0|||
28122785|NCT03680911|54783396|FG000|At Home Treatment|Lost to Follow-up|0|||
28122786|NCT03680911|54783397|FG001|At Home Treatment|Lost to Follow-up|1|||
28122787|NCT03680911|54783396|FG000|At Home Treatment|Withdrawal by Subject|0|||
28122788|NCT03680911|54783397|FG001|At Home Treatment|Withdrawal by Subject|2|||
28122789|NCT03680911|54783396|FG000|Visit 3 (4 Month Follow up)|Study Termination|0|||
28122790|NCT03680911|54783397|FG001|Visit 3 (4 Month Follow up)|Study Termination|1|||
28122791|NCT03224130|54783405|FG000|Overall Study|consent issue|0|||
28122792|NCT03224130|54783406|FG001|Overall Study|consent issue|1|||
28122793|NCT03680521|54783414|FG000|Overall Study|Ongoing in long-term follow up|7|||
28122794|NCT03680521|54783415|FG001|Overall Study|Ongoing in long-term follow up|11|||
28122795|NCT03679741|54783424|FG000|Period 1|No longer meet eligibility criteria|1|||
28122796|NCT03679741|54783425|FG001|Period 1|No longer meet eligibility criteria|0|||
28122797|NCT03679741|54783424|FG000|Period 1|Lost to Follow-up|0|||
28066744|NCT00467051|54722338|FG000|Overall Study|Adverse Event|2|||
28066745|NCT00264498|54722345|FG000|Randomized Treatment|Death|0|||
28066746|NCT00264498|54722346|FG001|Randomized Treatment|Death|3|||
28066747|NCT00264498|54722345|FG000|Randomized Treatment|Withdrawal by Subject|0|||
28066748|NCT00264498|54722346|FG001|Randomized Treatment|Withdrawal by Subject|1|||
28066749|NCT00264498|54722345|FG000|Randomized Treatment|Objective disease Progression|13|||
28066750|NCT00264498|54722346|FG001|Randomized Treatment|Objective disease Progression|14|||
28066751|NCT00264498|54722345|FG000|Randomized Treatment|Physician Decision|1|||
28066752|NCT00264498|54722346|FG001|Randomized Treatment|Physician Decision|0|||
28066753|NCT00264498|54722345|FG000|Randomized Treatment|Incorrectly randomized|1|||
28066754|NCT00264498|54722346|FG001|Randomized Treatment|Incorrectly randomized|0|||
28122798|NCT03679741|54783425|FG001|Period 1|Lost to Follow-up|1|||
28122799|NCT03679741|54783424|FG000|Period 1|Adverse Event|1|||
28122800|NCT03679741|54783425|FG001|Period 1|Adverse Event|1|||
28122801|NCT03679741|54783424|FG000|Period 1|Withdrawal by Subject|0|||
28122802|NCT03679741|54783425|FG001|Period 1|Withdrawal by Subject|1|||
28122803|NCT03679741|54783424|FG000|Period 2|Adverse Event|2|||
28122804|NCT03679741|54783425|FG001|Period 2|Adverse Event|1|||
28122805|NCT03679741|54783424|FG000|Period 2|Withdrawal by Subject|1|||
28122806|NCT03679741|54783425|FG001|Period 2|Withdrawal by Subject|1|||
28122807|NCT03678103|54783431|FG000|Overall Study|Withdrawn prior to completion|4|||
28122808|NCT03649477|54783438|FG000|Overall Study|Adverse Event|2|||
28122809|NCT03649477|54783439|FG001|Overall Study|Adverse Event|0|||
28122810|NCT03649477|54783440|FG002|Overall Study|Adverse Event|0|||
28122811|NCT03677869|54783448|FG000|Overall Study|Withdrawal by Subject|1|||
28122812|NCT03677401|54783454|FG000|Overall Study|Adverse Event|4|||
28122813|NCT03677401|54783455|FG001|Overall Study|Adverse Event|14|||
28122814|NCT03677401|54783454|FG000|Overall Study|Lack of Efficacy|3|||
28122815|NCT03677401|54783455|FG001|Overall Study|Lack of Efficacy|1|||
28122816|NCT03677401|54783454|FG000|Overall Study|Withdrawal by Subject|2|||
28122817|NCT03677401|54783455|FG001|Overall Study|Withdrawal by Subject|2|||
28122818|NCT03677401|54783454|FG000|Overall Study|Sponsor decision|0|||
28122819|NCT03677401|54783455|FG001|Overall Study|Sponsor decision|1|||
28122820|NCT03677401|54783454|FG000|Overall Study|Reason Unspecified|1|||
28122821|NCT03677401|54783455|FG001|Overall Study|Reason Unspecified|0|||
28122822|NCT03218787|54783461|FG000|Overall Study|Lost to Follow-up|12|||
28122823|NCT03218787|54783461|FG000|Overall Study|Withdrawal by Subject|72|||
28122824|NCT03218787|54783461|FG000|Overall Study|Physician Decision|11|||
28122825|NCT03218787|54783461|FG000|Overall Study|Death|111|||
28122826|NCT01348087|54783465|FG000|Overall Study|Unsatisfactory therapeutic effect|35|||
28122827|NCT01348087|54783465|FG000|Overall Study|Administrative problems|79|||
28122828|NCT01348087|54783465|FG000|Overall Study|protocol deviation|1|||
28122829|NCT01348087|54783465|FG000|Overall Study|Lost to Follow-up|1|||
28122830|NCT01348087|54783465|FG000|Overall Study|Subject withdrew consent|7|||
28122831|NCT01348087|54783465|FG000|Overall Study|Adverse Event|25|||
28122832|NCT01347931|54783479|FG000|Standard Oxygen Therapy|Withdrawal by Subject|1|||
28122833|NCT03645421|54783489|FG000|Overall Study|Adverse Event|0|||
28122834|NCT03645421|54783490|FG001|Overall Study|Adverse Event|0|||
28122835|NCT03645421|54783491|FG002|Overall Study|Adverse Event|4|||
28122836|NCT03645421|54783492|FG003|Overall Study|Adverse Event|1|||
28122837|NCT03645421|54783489|FG000|Overall Study|Withdrawal by patient|0|||
28122838|NCT03645421|54783490|FG001|Overall Study|Withdrawal by patient|0|||
28122839|NCT03645421|54783491|FG002|Overall Study|Withdrawal by patient|0|||
28122840|NCT03645421|54783492|FG003|Overall Study|Withdrawal by patient|3|||
28122841|NCT03645421|54783489|FG000|Overall Study|Study specific withdrawal criteria|0|||
28122842|NCT03645421|54783490|FG001|Overall Study|Study specific withdrawal criteria|0|||
28122843|NCT03645421|54783491|FG002|Overall Study|Study specific withdrawal criteria|1|||
28122844|NCT03645421|54783492|FG003|Overall Study|Study specific withdrawal criteria|0|||
28122845|NCT03207750|54783507|FG000|Overall Study|Adverse Event|3|||
28122846|NCT03207750|54783508|FG001|Overall Study|Adverse Event|2|||
28122847|NCT03207750|54783507|FG000|Overall Study|Lost to Follow-up|21|||
28122848|NCT03207750|54783508|FG001|Overall Study|Lost to Follow-up|29|||
28122849|NCT03207750|54783507|FG000|Overall Study|Protocol Violation|0|||
28122850|NCT03207750|54783508|FG001|Overall Study|Protocol Violation|1|||
28122851|NCT03207750|54783507|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11|||
28122852|NCT03207750|54783508|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13|||
28122853|NCT03207750|54783507|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
28122854|NCT03207750|54783508|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10|||
28122855|NCT03207750|54783507|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10|||
28122856|NCT03207750|54783508|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5|||
28122857|NCT03207750|54783507|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1|||
28122858|NCT03207750|54783508|FG001|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2|||
28122859|NCT03207750|54783507|FG000|Overall Study|OTHER, NOT SPECIFIED|5|||
28122860|NCT03207750|54783508|FG001|Overall Study|OTHER, NOT SPECIFIED|4|||
28122861|NCT03674281|54783517|FG000|Overall Study|screen failure|2|||
28122862|NCT03674281|54783518|FG001|Overall Study|screen failure|0|||
28122863|NCT03674281|54783519|FG002|Overall Study|screen failure|0|||
28122864|NCT03674281|54783517|FG000|Overall Study|Withdrawal by Subject|1|||
28122865|NCT03674281|54783518|FG001|Overall Study|Withdrawal by Subject|3|||
28122866|NCT03674281|54783519|FG002|Overall Study|Withdrawal by Subject|3|||
28122867|NCT03673345|54783543|FG000|Overall Study|Lost to Follow-up|1|||
28122868|NCT03673345|54783544|FG001|Overall Study|Lost to Follow-up|0|||
28122869|NCT03673345|54783545|FG002|Overall Study|Lost to Follow-up|3|||
28122870|NCT03673345|54783546|FG003|Overall Study|Lost to Follow-up|3|||
28122871|NCT03673345|54783547|FG004|Overall Study|Lost to Follow-up|2|||
28122872|NCT03673345|54783548|FG005|Overall Study|Lost to Follow-up|1|||
28122873|NCT03673345|54783549|FG006|Overall Study|Lost to Follow-up|0|||
28122874|NCT03673345|54783550|FG007|Overall Study|Lost to Follow-up|0|||
28122875|NCT03673345|54783543|FG000|Overall Study|Withdrawal by Subject|1|||
28122876|NCT03673345|54783544|FG001|Overall Study|Withdrawal by Subject|0|||
28122877|NCT03673345|54783545|FG002|Overall Study|Withdrawal by Subject|4|||
28122878|NCT03673345|54783546|FG003|Overall Study|Withdrawal by Subject|2|||
28122879|NCT03673345|54783547|FG004|Overall Study|Withdrawal by Subject|0|||
28122880|NCT03673345|54783548|FG005|Overall Study|Withdrawal by Subject|0|||
28122881|NCT03673345|54783549|FG006|Overall Study|Withdrawal by Subject|0|||
28122882|NCT03673345|54783550|FG007|Overall Study|Withdrawal by Subject|0|||
28122883|NCT03673345|54783543|FG000|Overall Study|Physician Decision|0|||
28122884|NCT03673345|54783544|FG001|Overall Study|Physician Decision|0|||
28122885|NCT03673345|54783545|FG002|Overall Study|Physician Decision|2|||
28122886|NCT03673345|54783546|FG003|Overall Study|Physician Decision|0|||
28122887|NCT03673345|54783547|FG004|Overall Study|Physician Decision|0|||
28122888|NCT03673345|54783548|FG005|Overall Study|Physician Decision|0|||
28122889|NCT03673345|54783549|FG006|Overall Study|Physician Decision|0|||
28122890|NCT03673345|54783550|FG007|Overall Study|Physician Decision|0|||
28122891|NCT03223662|54783568|FG000|Overall Study|Physician Decision|1|||
28122892|NCT03223662|54783568|FG000|Overall Study|Study closure|1|||
28122893|NCT03672097|54783572|FG000|Period 1|Withdrawal by Subject|2|||
28122894|NCT03672097|54783572|FG000|Period 1|Adverse Event|1|||
28122895|NCT03672097|54783572|FG000|Period 1|Did not receive treatment|1|||
28122896|NCT03672097|54783572|FG000|Period 2|Withdrawal by Subject|3|||
28122897|NCT03672097|54783572|FG000|Period 2|Other|1|||
28122898|NCT03847896|54783581|FG000|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
28122899|NCT03847896|54783582|FG001|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
27817735|NCT04440163|54275901|FG001|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|15|||
28122900|NCT03847896|54783583|FG002|Overall Study|Randomized in error and did not receive randomized study treatment|1|||
28122901|NCT03847896|54783584|FG003|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
28122902|NCT03847896|54783585|FG004|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
28122903|NCT03847896|54783581|FG000|Overall Study|Withdrawal by Subject|2|||
28122904|NCT03847896|54783582|FG001|Overall Study|Withdrawal by Subject|10|||
28122905|NCT03847896|54783583|FG002|Overall Study|Withdrawal by Subject|5|||
28122906|NCT03847896|54783584|FG003|Overall Study|Withdrawal by Subject|9|||
28122907|NCT03847896|54783585|FG004|Overall Study|Withdrawal by Subject|8|||
28122908|NCT03847896|54783581|FG000|Overall Study|Withdrawal by parent/guardian|0|||
28122909|NCT03847896|54783582|FG001|Overall Study|Withdrawal by parent/guardian|0|||
28122910|NCT03847896|54783583|FG002|Overall Study|Withdrawal by parent/guardian|1|||
28122911|NCT03847896|54783584|FG003|Overall Study|Withdrawal by parent/guardian|0|||
28122912|NCT03847896|54783585|FG004|Overall Study|Withdrawal by parent/guardian|0|||
28122913|NCT03847896|54783581|FG000|Overall Study|Adverse Event|2|||
28122914|NCT03847896|54783582|FG001|Overall Study|Adverse Event|1|||
28122915|NCT03847896|54783583|FG002|Overall Study|Adverse Event|3|||
28122916|NCT03847896|54783584|FG003|Overall Study|Adverse Event|2|||
28122917|NCT03847896|54783585|FG004|Overall Study|Adverse Event|4|||
28122918|NCT03847896|54783581|FG000|Overall Study|A severe exacerbation event|0|||
28122919|NCT03847896|54783582|FG001|Overall Study|A severe exacerbation event|0|||
28122920|NCT03847896|54783583|FG002|Overall Study|A severe exacerbation event|0|||
28122921|NCT03847896|54783584|FG003|Overall Study|A severe exacerbation event|0|||
28122922|NCT03847896|54783585|FG004|Overall Study|A severe exacerbation event|3|||
28122923|NCT03847896|54783581|FG000|Overall Study|Protocol Violation|0|||
28122924|NCT03847896|54783582|FG001|Overall Study|Protocol Violation|2|||
28122925|NCT03847896|54783583|FG002|Overall Study|Protocol Violation|1|||
28122926|NCT03847896|54783584|FG003|Overall Study|Protocol Violation|0|||
28122927|NCT03847896|54783585|FG004|Overall Study|Protocol Violation|2|||
28122928|NCT03847896|54783581|FG000|Overall Study|Lost to Follow-up|0|||
28122929|NCT03847896|54783582|FG001|Overall Study|Lost to Follow-up|0|||
28122930|NCT03847896|54783583|FG002|Overall Study|Lost to Follow-up|0|||
28122931|NCT03847896|54783584|FG003|Overall Study|Lost to Follow-up|1|||
28122932|NCT03847896|54783585|FG004|Overall Study|Lost to Follow-up|0|||
28122933|NCT03847896|54783581|FG000|Overall Study|Condition under investigation worsened|0|||
27817736|NCT04440163|54275902|FG002|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|42|||
27817737|NCT04440163|54275903|FG003|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|22|||
27817738|NCT04440163|54275904|FG004|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|30|||
27817739|NCT04440163|54275905|FG005|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|3|||
27817740|NCT04440163|54275906|FG006|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|18|||
27817741|NCT04440163|54275907|FG007|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|5|||
27817742|NCT04440163|54275900|FG000|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
27849278|NCT02085161|54344601|FG000|Overall Study|Other Reason|1|||
28122934|NCT03847896|54783582|FG001|Overall Study|Condition under investigation worsened|0|||
28122935|NCT03847896|54783583|FG002|Overall Study|Condition under investigation worsened|0|||
28122936|NCT03847896|54783584|FG003|Overall Study|Condition under investigation worsened|1|||
28122937|NCT03847896|54783585|FG004|Overall Study|Condition under investigation worsened|1|||
28122938|NCT03847896|54783581|FG000|Overall Study|Lack of Efficacy|0|||
28122939|NCT03847896|54783582|FG001|Overall Study|Lack of Efficacy|0|||
28122940|NCT03847896|54783583|FG002|Overall Study|Lack of Efficacy|0|||
28122941|NCT03847896|54783584|FG003|Overall Study|Lack of Efficacy|2|||
28122942|NCT03847896|54783585|FG004|Overall Study|Lack of Efficacy|2|||
28122943|NCT03847896|54783581|FG000|Overall Study|Other reasons|3|||
28122944|NCT03847896|54783582|FG001|Overall Study|Other reasons|3|||
28122945|NCT03847896|54783583|FG002|Overall Study|Other reasons|1|||
28122946|NCT03847896|54783584|FG003|Overall Study|Other reasons|2|||
28122947|NCT03847896|54783585|FG004|Overall Study|Other reasons|1|||
28122948|NCT03670537|54783597|FG000|Overall Study|Protocol Violation|1|||
28122949|NCT03619837|54783601|FG000|Screening|received organs from HCV-negative donors|47|||
28122950|NCT03619837|54783601|FG000|Screening|died on the wait-list|2|||
27849279|NCT02085161|54344602|FG001|Overall Study|Other Reason|0|||
28122951|NCT03619837|54783601|FG000|Screening|remained on the wait list|40|||
28122952|NCT03619837|54783601|FG000|Screening|didn't meet eligibility criteria|3|||
28122953|NCT03619837|54783601|FG000|Screening|withdrew consent|2|||
28122954|NCT03619837|54783601|FG000|Screening|never listed for HCV-viremic donor|1|||
28122955|NCT03619837|54783601|FG000|Screening|developed exclusion criteria|2|||
28122956|NCT03619837|54783601|FG000|Screening|excluded by the investigator due to non-compliance|1|||
28122957|NCT03206970|54783605|FG000|Overall Study|Death|21|||
28122958|NCT03206970|54783605|FG000|Overall Study|Withdrawal by Subject|13|||
28122959|NCT03206970|54783605|FG000|Overall Study|Lost to Follow-up|3|||
28122960|NCT03206970|54783605|FG000|Overall Study|Primary and secondary objectives were met and remaining participants transferred to LTE by sponsor|49|||
28122961|NCT03644173|54783609|FG000|Participants at Last Visit (Pre-surveys)|Lost to Follow-up|21|||
28122962|NCT03644173|54783609|FG000|Participants at the 1-month Follow up|Lost to Follow-up|2|||
28122963|NCT03644173|54783609|FG000|Participants at the 1-month Follow up|Death|2|||
28122964|NCT03644173|54783609|FG000|Participants at the 3-month Follow up|Lost to Follow-up|2|||
28122965|NCT03178851|54783617|FG000|Overall Study|Death|48|||
28122966|NCT03178851|54783618|FG001|Overall Study|Death|2|||
28122967|NCT03178851|54783619|FG002|Overall Study|Death|25|||
28122968|NCT03178851|54783617|FG000|Overall Study|Withdrawal by Subject|8|||
28122969|NCT03178851|54783618|FG001|Overall Study|Withdrawal by Subject|0|||
28122970|NCT03178851|54783619|FG002|Overall Study|Withdrawal by Subject|0|||
28122971|NCT03178851|54783617|FG000|Overall Study|Lost to Follow-up|5|||
28122972|NCT03178851|54783618|FG001|Overall Study|Lost to Follow-up|2|||
28122973|NCT03178851|54783619|FG002|Overall Study|Lost to Follow-up|0|||
28122974|NCT03178851|54783617|FG000|Overall Study|Adverse Event|0|||
28122975|NCT03178851|54783618|FG001|Overall Study|Adverse Event|0|||
28122976|NCT03178851|54783619|FG002|Overall Study|Adverse Event|1|||
28122977|NCT03178851|54783617|FG000|Overall Study|Study Termination by Sponsor|31|||
28122978|NCT03178851|54783618|FG001|Overall Study|Study Termination by Sponsor|7|||
28122979|NCT03178851|54783619|FG002|Overall Study|Study Termination by Sponsor|26|||
28122980|NCT03643159|54783630|FG000|Overall Study|Adverse Event|1|||
28122981|NCT03643159|54783630|FG000|Overall Study|Withdrawal by Subject|1|||
28122982|NCT03205566|54783637|FG000|Phase 1|Protocol Violation|1|||
28122983|NCT03205566|54783638|FG001|Phase 1|Protocol Violation|1|||
28122984|NCT02935452|54783650|FG000|Overall Study|work and life commintment|3|||
28122985|NCT02935452|54783651|FG001|Overall Study|work and life commintment|1|||
28122986|NCT03178773|54783659|FG000|Overall Study|Death|0|||
28122987|NCT03178773|54783660|FG001|Overall Study|Death|1|||
28122988|NCT03178773|54783659|FG000|Overall Study|Lost to Follow-up|29|||
28122989|NCT03178773|54783660|FG001|Overall Study|Lost to Follow-up|25|||
28122990|NCT03178773|54783659|FG000|Overall Study|Withdrawal by Subject|10|||
28122991|NCT03178773|54783660|FG001|Overall Study|Withdrawal by Subject|14|||
28122992|NCT03713034|54783669|FG000|Overall Study|Withdrawn by staff for incomplete consent forms|5|||
28122993|NCT03713034|54783670|FG001|Overall Study|Withdrawn by staff for incomplete consent forms|4|||
28122994|NCT03218397|54783680|FG000|Overall Study|Prior positive blood culture|8|||
28122995|NCT03218397|54783681|FG001|Overall Study|Prior positive blood culture|13|||
28122996|NCT03218397|54783680|FG000|Overall Study|Comfort care|8|||
28122997|NCT03218397|54783681|FG001|Overall Study|Comfort care|5|||
28122998|NCT03218397|54783680|FG000|Overall Study|Comfort care and positive blood culture|1|||
28122999|NCT03218397|54783681|FG001|Overall Study|Comfort care and positive blood culture|0|||
28123000|NCT03218397|54783680|FG000|Overall Study|Comfort care and mixed culture|0|||
28123001|NCT03218397|54783681|FG001|Overall Study|Comfort care and mixed culture|1|||
28123002|NCT03218397|54783680|FG000|Overall Study|Mixed culture|2|||
28123003|NCT03218397|54783681|FG001|Overall Study|Mixed culture|2|||
28123004|NCT03218397|54783680|FG000|Overall Study|Inaccessible hospital records|2|||
28123005|NCT03218397|54783681|FG001|Overall Study|Inaccessible hospital records|5|||
28123006|NCT03218397|54783680|FG000|Overall Study|No gram-negative bacilli (GNB)|0|||
28123007|NCT03218397|54783681|FG001|Overall Study|No gram-negative bacilli (GNB)|2|||
27817743|NCT04440163|54275901|FG001|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
27817744|NCT04440163|54275902|FG002|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
27817745|NCT04440163|54275903|FG003|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
27817746|NCT04440163|54275904|FG004|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
27817747|NCT04440163|54275905|FG005|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
27817748|NCT04440163|54275906|FG006|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
27817749|NCT04440163|54275907|FG007|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
27817750|NCT04440163|54275900|FG000|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
28123008|NCT03218397|54783680|FG000|Overall Study|Randomized during laboratory off hours|2|||
28123009|NCT03218397|54783681|FG001|Overall Study|Randomized during laboratory off hours|1|||
28123010|NCT03618823|54783689|FG000|Overall Study|Lost to Follow-up|63|||
28123011|NCT03618823|54783690|FG001|Overall Study|Lost to Follow-up|61|||
28123012|NCT03640507|54783702|FG000|Overall Study|Withdrawal by Subject|0|||
27817751|NCT04440163|54275901|FG001|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|1|||
27817752|NCT04440163|54275902|FG002|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
27817753|NCT04440163|54275903|FG003|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
27817754|NCT04440163|54275904|FG004|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
27817755|NCT04440163|54275905|FG005|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|0|||
27817756|NCT04440163|54275906|FG006|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
27817757|NCT04440163|54275907|FG007|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
27817758|NCT04440163|54275900|FG000|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
27817759|NCT04440163|54275901|FG001|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
27817760|NCT04440163|54275902|FG002|Vaccination Phase (Approx. 7 Months)|Pregnancy|2|||
27817761|NCT04440163|54275903|FG003|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
27817762|NCT04440163|54275904|FG004|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
27817763|NCT04440163|54275905|FG005|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
27817764|NCT04440163|54275906|FG006|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
27817765|NCT04440163|54275907|FG007|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
27817766|NCT04440163|54275900|FG000|Vaccination Phase (Approx. 7 Months)|Protocol Violation|1|||
27817767|NCT04440163|54275901|FG001|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
27817768|NCT04440163|54275902|FG002|Vaccination Phase (Approx. 7 Months)|Protocol Violation|5|||
27817769|NCT04440163|54275903|FG003|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
27817770|NCT04440163|54275904|FG004|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
27817771|NCT04440163|54275905|FG005|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
27817772|NCT04440163|54275906|FG006|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
27817773|NCT04440163|54275907|FG007|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
28123013|NCT03640507|54783703|FG001|Overall Study|Withdrawal by Subject|0|||
28123014|NCT03640507|54783704|FG002|Overall Study|Withdrawal by Subject|1|||
28123015|NCT02937636|54783714|FG000|Overall Study|Other (Not specified)|3|||
28123016|NCT02937636|54783715|FG001|Overall Study|Other (Not specified)|2|||
28123017|NCT03638635|54783724|FG000|Initial Hospitalization|Study terminated prematurely|0|||
28123018|NCT03638635|54783725|FG001|Initial Hospitalization|Study terminated prematurely|1|||
28123019|NCT03638635|54783724|FG000|Initial Hospitalization|Withdrawal by study personnel|0|||
28123020|NCT03638635|54783725|FG001|Initial Hospitalization|Withdrawal by study personnel|1|||
28123021|NCT03638635|54783724|FG000|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39|||
28123022|NCT03638635|54783725|FG001|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22|||
28123023|NCT03204981|54783731|FG000|Overall Study|Physician Decision|2|||
28123024|NCT03204981|54783731|FG000|Overall Study|Screen failures (no inducible VT or PVCs)|4|||
28123025|NCT03205488|54783740|FG000|Overall Study|Adverse Event|1|||
28123026|NCT03205488|54783741|FG001|Overall Study|Adverse Event|2|||
28123027|NCT03205488|54783742|FG002|Overall Study|Adverse Event|4|||
28123028|NCT03205488|54783740|FG000|Overall Study|Protocol Violation|0|||
28123029|NCT03205488|54783741|FG001|Overall Study|Protocol Violation|0|||
28123030|NCT03205488|54783742|FG002|Overall Study|Protocol Violation|1|||
28123031|NCT03204279|54783756|FG000|Overall Study|Withdrawal by Subject|0|||
28123032|NCT03204279|54783757|FG001|Overall Study|Withdrawal by Subject|1|||
28123033|NCT03173547|54783766|FG000|Overall Study|Adverse Event|2|||
28123034|NCT03173547|54783767|FG001|Overall Study|Adverse Event|0|||
28123035|NCT03173547|54783766|FG000|Overall Study|Withdrawal by Subject|2|||
28123036|NCT03173547|54783767|FG001|Overall Study|Withdrawal by Subject|2|||
28123037|NCT02954653|54783775|FG000|Overall Study|Death|3|||
28123038|NCT02954653|54783776|FG001|Overall Study|Death|1|||
28123039|NCT02954653|54783777|FG002|Overall Study|Death|0|||
28123040|NCT02954653|54783778|FG003|Overall Study|Death|0|||
28123041|NCT02954653|54783779|FG004|Overall Study|Death|0|||
28123042|NCT02954653|54783780|FG005|Overall Study|Death|0|||
28123043|NCT02954653|54783781|FG006|Overall Study|Death|0|||
28123044|NCT02954653|54783782|FG007|Overall Study|Death|0|||
27817774|NCT04440163|54275900|FG000|Vaccination Phase (Approx. 7 Months)|Other|0|||
28123045|NCT02954653|54783783|FG008|Overall Study|Death|0|||
28123046|NCT02954653|54783775|FG000|Overall Study|Randomized but did not receive treatment|1|||
28123047|NCT02954653|54783776|FG001|Overall Study|Randomized but did not receive treatment|0|||
28123048|NCT02954653|54783777|FG002|Overall Study|Randomized but did not receive treatment|0|||
28123049|NCT02954653|54783778|FG003|Overall Study|Randomized but did not receive treatment|0|||
28123050|NCT02954653|54783779|FG004|Overall Study|Randomized but did not receive treatment|0|||
28123051|NCT02954653|54783780|FG005|Overall Study|Randomized but did not receive treatment|0|||
28123052|NCT02954653|54783781|FG006|Overall Study|Randomized but did not receive treatment|0|||
28123053|NCT02954653|54783782|FG007|Overall Study|Randomized but did not receive treatment|0|||
28123054|NCT02954653|54783783|FG008|Overall Study|Randomized but did not receive treatment|0|||
28123055|NCT02954653|54783775|FG000|Overall Study|Started another anti-cancer therapy|0|||
28123056|NCT02954653|54783776|FG001|Overall Study|Started another anti-cancer therapy|1|||
28123057|NCT02954653|54783777|FG002|Overall Study|Started another anti-cancer therapy|0|||
28123058|NCT02954653|54783778|FG003|Overall Study|Started another anti-cancer therapy|0|||
28123059|NCT02954653|54783779|FG004|Overall Study|Started another anti-cancer therapy|0|||
28123060|NCT02954653|54783780|FG005|Overall Study|Started another anti-cancer therapy|0|||
28123061|NCT02954653|54783781|FG006|Overall Study|Started another anti-cancer therapy|0|||
28123062|NCT02954653|54783782|FG007|Overall Study|Started another anti-cancer therapy|0|||
28123063|NCT02954653|54783783|FG008|Overall Study|Started another anti-cancer therapy|0|||
28123064|NCT02954653|54783775|FG000|Overall Study|Treatment failure and consent withdrawal|0|||
28123065|NCT02954653|54783776|FG001|Overall Study|Treatment failure and consent withdrawal|1|||
28123066|NCT02954653|54783777|FG002|Overall Study|Treatment failure and consent withdrawal|0|||
28123067|NCT02954653|54783778|FG003|Overall Study|Treatment failure and consent withdrawal|0|||
28123068|NCT02954653|54783779|FG004|Overall Study|Treatment failure and consent withdrawal|0|||
28123069|NCT02954653|54783780|FG005|Overall Study|Treatment failure and consent withdrawal|0|||
28123070|NCT02954653|54783781|FG006|Overall Study|Treatment failure and consent withdrawal|0|||
28123071|NCT02954653|54783782|FG007|Overall Study|Treatment failure and consent withdrawal|0|||
28123072|NCT02954653|54783783|FG008|Overall Study|Treatment failure and consent withdrawal|0|||
28123073|NCT03173313|54783797|FG000|Overall Study|Lost to Follow-up|2|||
28123074|NCT03173313|54783798|FG001|Overall Study|Lost to Follow-up|3|||
28123075|NCT03173313|54783797|FG000|Overall Study|Withdrawal by Subject|0|||
27940445|NCT01723774|54596704|FG000|Adjuvant|Still on active treatment|0|||
27940446|NCT01723774|54596705|FG001|Adjuvant|Still on active treatment|0|||
28123076|NCT03173313|54783798|FG001|Overall Study|Withdrawal by Subject|1|||
28123077|NCT03173313|54783797|FG000|Overall Study|Death|5|||
28123078|NCT03173313|54783798|FG001|Overall Study|Death|0|||
28123079|NCT03173313|54783797|FG000|Overall Study|Physician Decision|1|||
28123080|NCT03173313|54783798|FG001|Overall Study|Physician Decision|0|||
28123081|NCT03173313|54783797|FG000|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0|||
28123082|NCT03173313|54783798|FG001|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1|||
28123083|NCT03173313|54783797|FG000|Overall Study|Bone Fracture|1|||
28123084|NCT03173313|54783798|FG001|Overall Study|Bone Fracture|0|||
28123085|NCT03215667|54783804|FG000|Overall Study|Physician Decision|4|||
28123086|NCT03634579|54783808|FG000|Overall Study|study termination|9|||
28123087|NCT02730208|54783814|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
28123088|NCT02730208|54783815|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
28123089|NCT01291511|54783823|FG000|Cross-Titration and Stabilization Phase|Withdrawal by Subject|107|||
28123090|NCT01291511|54783824|FG001|Cross-Titration and Stabilization Phase|Withdrawal by Subject|0|||
28123091|NCT01291511|54783823|FG000|Cross-Titration and Stabilization Phase|Adverse Event|92|||
28123092|NCT01291511|54783824|FG001|Cross-Titration and Stabilization Phase|Adverse Event|0|||
28123093|NCT01291511|54783823|FG000|Cross-Titration and Stabilization Phase|Administrative problems|30|||
27940447|NCT01723774|54596706|FG002|Adjuvant|Still on active treatment|0|||
27940448|NCT01723774|54596707|FG003|Adjuvant|Still on active treatment|1|||
27940449|NCT01190514|54596716|FG000|First Intervention (Period 1)|Adverse Event|1|||
27940450|NCT01190514|54596717|FG001|First Intervention (Period 1)|Adverse Event|0|||
27940451|NCT01190514|54596718|FG002|First Intervention (Period 1)|Adverse Event|0|||
27940452|NCT01190514|54596719|FG003|First Intervention (Period 1)|Adverse Event|0|||
27940453|NCT01190514|54596716|FG000|Third Intervention (Period 3)|Adverse Event|1|||
27940454|NCT01190514|54596717|FG001|Third Intervention (Period 3)|Adverse Event|0|||
28123094|NCT01291511|54783824|FG001|Cross-Titration and Stabilization Phase|Administrative problems|0|||
27940455|NCT01190514|54596718|FG002|Third Intervention (Period 3)|Adverse Event|0|||
28066755|NCT00264498|54722345|FG000|Randomized Treatment|Study Closure|1|||
28066756|NCT00264498|54722346|FG001|Randomized Treatment|Study Closure|0|||
28066757|NCT00264498|54722345|FG000|Randomized Treatment|Protocol Violation|1|||
28066758|NCT00264498|54722346|FG001|Randomized Treatment|Protocol Violation|0|||
28066759|NCT00264498|54722345|FG000|Crossover Treatment|Death|1|||
28066760|NCT00264498|54722346|FG001|Crossover Treatment|Death|3|||
28066761|NCT00264498|54722345|FG000|Crossover Treatment|Objective disease progression|4|||
28066762|NCT00264498|54722346|FG001|Crossover Treatment|Objective disease progression|5|||
28066763|NCT00264498|54722345|FG000|Crossover Treatment|Study closure|0|||
28066764|NCT00264498|54722346|FG001|Crossover Treatment|Study closure|1|||
28123095|NCT01291511|54783823|FG000|Cross-Titration and Stabilization Phase|Lack of Efficacy|28|||
28123096|NCT01291511|54783824|FG001|Cross-Titration and Stabilization Phase|Lack of Efficacy|0|||
28123097|NCT01291511|54783823|FG000|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|25|||
28123098|NCT01291511|54783824|FG001|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|0|||
28123099|NCT01291511|54783823|FG000|Cross-Titration and Stabilization Phase|Lost to Follow-up|24|||
28123100|NCT01291511|54783824|FG001|Cross-Titration and Stabilization Phase|Lost to Follow-up|0|||
28123101|NCT01291511|54783823|FG000|Cross-Titration and Stabilization Phase|Protocol Violation|13|||
28123102|NCT01291511|54783824|FG001|Cross-Titration and Stabilization Phase|Protocol Violation|0|||
28123103|NCT01291511|54783823|FG000|Cross-Titration and Stabilization Phase|Abnormal test|6|||
28123104|NCT01291511|54783824|FG001|Cross-Titration and Stabilization Phase|Abnormal test|0|||
28123105|NCT01291511|54783823|FG000|Cross-Titration and Stabilization Phase|Death|1|||
28123106|NCT01291511|54783824|FG001|Cross-Titration and Stabilization Phase|Death|0|||
28123107|NCT01291511|54783823|FG000|Double-blind Relapse Prevention Phase|Administrative problems|45|||
28123108|NCT01291511|54783824|FG001|Double-blind Relapse Prevention Phase|Administrative problems|29|||
28123109|NCT01291511|54783823|FG000|Double-blind Relapse Prevention Phase|Withdrawal by Subject|14|||
28123110|NCT01291511|54783824|FG001|Double-blind Relapse Prevention Phase|Withdrawal by Subject|10|||
28123111|NCT01291511|54783823|FG000|Double-blind Relapse Prevention Phase|Lost to Follow-up|6|||
28123112|NCT01291511|54783824|FG001|Double-blind Relapse Prevention Phase|Lost to Follow-up|4|||
28123113|NCT01291511|54783823|FG000|Double-blind Relapse Prevention Phase|Adverse Event|5|||
28123114|NCT01291511|54783824|FG001|Double-blind Relapse Prevention Phase|Adverse Event|0|||
28123115|NCT01291511|54783823|FG000|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|4|||
28123116|NCT01291511|54783824|FG001|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|2|||
28123117|NCT01291511|54783823|FG000|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
28123118|NCT01291511|54783824|FG001|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
28123119|NCT01291511|54783823|FG000|Double-blind Relapse Prevention Phase|Lack of Efficacy|0|||
28123120|NCT01291511|54783824|FG001|Double-blind Relapse Prevention Phase|Lack of Efficacy|2|||
28123121|NCT01291511|54783823|FG000|Double-blind Relapse Prevention Phase|Abnormal test|1|||
28123122|NCT01291511|54783824|FG001|Double-blind Relapse Prevention Phase|Abnormal test|0|||
28123123|NCT01291511|54783823|FG000|Double-blind Relapse Prevention Phase|Death|1|||
28123124|NCT01291511|54783824|FG001|Double-blind Relapse Prevention Phase|Death|0|||
28123125|NCT03170349|54783831|FG000|At 30 Days Follow-up|Death|1|||
28123126|NCT03170349|54783831|FG000|At 6 Months Follow-up|Death|3|||
28123127|NCT03170349|54783831|FG000|At 6 Months Follow-up|Withdrawal by Subject|1|||
28123128|NCT03170349|54783831|FG000|At 6 Months Follow-up|Exited for Other Reasons|5|||
28123129|NCT03170349|54783831|FG000|At 1 Year Follow-up|Death|6|||
28123130|NCT03170349|54783831|FG000|At 1 Year Follow-up|Exited for Other Reasons|2|||
28123131|NCT03201900|54783835|FG000|Treatment Phase (Up to 62 Weeks)|Adverse Event|9|||
28123132|NCT03201900|54783835|FG000|Treatment Phase (Up to 62 Weeks)|Subject Choice|1|||
28123133|NCT03201900|54783835|FG000|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6|||
28123134|NCT03201900|54783835|FG000|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2|||
28123135|NCT03201900|54783835|FG000|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6|||
28123136|NCT03201900|54783835|FG000|Treatment Phase (Up to 62 Weeks)|Other than specified|11|||
28123137|NCT03201900|54783835|FG000|Treatment Phase (Up to 62 Weeks)|Not treated|2|||
28123138|NCT03201900|54783835|FG000|Extension Phase (From Week 63 to 156)|Subject choice|1|||
28123139|NCT03201900|54783835|FG000|Extension Phase (From Week 63 to 156)|Pregnancy|1|||
28123140|NCT03201900|54783835|FG000|Extension Phase (From Week 63 to 156)|Inadequate therapeutic effect|1|||
28123141|NCT03201900|54783835|FG000|Extension Phase (From Week 63 to 156)|Lost to Follow-up|1|||
28123142|NCT03201900|54783835|FG000|Extension Phase (From Week 63 to 156)|Withdrawal of consent|3|||
28123143|NCT03201900|54783835|FG000|Extension Phase (From Week 63 to 156)|Other|1|||
28123144|NCT03170271|54783850|FG000|Overall Study|Adverse Event|7|||
28123145|NCT03170271|54783851|FG001|Overall Study|Adverse Event|2|||
28123146|NCT03170271|54783850|FG000|Overall Study|Lost to Follow-up|0|||
28123147|NCT03170271|54783851|FG001|Overall Study|Lost to Follow-up|1|||
28123148|NCT03170271|54783850|FG000|Overall Study|Physician Decision|1|||
28123149|NCT03170271|54783851|FG001|Overall Study|Physician Decision|0|||
28123150|NCT03170271|54783850|FG000|Overall Study|Protocol-specified withdrawal criterion|2|||
28123151|NCT03170271|54783851|FG001|Overall Study|Protocol-specified withdrawal criterion|1|||
28123152|NCT03170271|54783850|FG000|Overall Study|Withdrawal by Subject|17|||
28123153|NCT03170271|54783851|FG001|Overall Study|Withdrawal by Subject|5|||
28123154|NCT03170271|54783850|FG000|Overall Study|Other|2|||
28123155|NCT03170271|54783851|FG001|Overall Study|Other|2|||
28123156|NCT03170271|54783850|FG000|Overall Study|Randomized in error|4|||
28123157|NCT03170271|54783851|FG001|Overall Study|Randomized in error|0|||
28123158|NCT03613129|54783861|FG000|Pre-treatment Assessment|Protocol Violation|2|||
28123159|NCT03613129|54783862|FG001|Pre-treatment Assessment|Protocol Violation|0|||
28123160|NCT03613129|54783863|FG002|Pre-treatment Assessment|Protocol Violation|0|||
28123161|NCT03613129|54783864|FG003|Pre-treatment Assessment|Protocol Violation|0|||
28123162|NCT03613129|54783865|FG004|Pre-treatment Assessment|Protocol Violation|0|||
28123163|NCT03613129|54783861|FG000|Pre-treatment Assessment|Withdrawal by Subject|1|||
28123164|NCT03613129|54783862|FG001|Pre-treatment Assessment|Withdrawal by Subject|0|||
28123165|NCT03613129|54783863|FG002|Pre-treatment Assessment|Withdrawal by Subject|0|||
28123166|NCT03613129|54783864|FG003|Pre-treatment Assessment|Withdrawal by Subject|0|||
28123167|NCT03613129|54783865|FG004|Pre-treatment Assessment|Withdrawal by Subject|0|||
28123168|NCT03235284|54783880|FG000|Overall Study|Adverse Event|1|||
28123169|NCT03235284|54783881|FG001|Overall Study|Adverse Event|2|||
28123170|NCT03235284|54783882|FG002|Overall Study|Adverse Event|1|||
28123171|NCT03170193|54783897|FG000|Overall Study|Withdrawal by Subject|0|||
28123172|NCT03170193|54783898|FG001|Overall Study|Withdrawal by Subject|0|||
28123173|NCT03170193|54783899|FG002|Overall Study|Withdrawal by Subject|0|||
28123174|NCT03170193|54783900|FG003|Overall Study|Withdrawal by Subject|1|||
28123175|NCT03170193|54783901|FG004|Overall Study|Withdrawal by Subject|0|||
28123176|NCT03170193|54783902|FG005|Overall Study|Withdrawal by Subject|0|||
28123177|NCT03170193|54783903|FG006|Overall Study|Withdrawal by Subject|0|||
28123178|NCT03170193|54783897|FG000|Overall Study|Lost to Follow-up|1|||
28123179|NCT03170193|54783898|FG001|Overall Study|Lost to Follow-up|1|||
28123180|NCT03170193|54783899|FG002|Overall Study|Lost to Follow-up|0|||
28123181|NCT03170193|54783900|FG003|Overall Study|Lost to Follow-up|0|||
28123182|NCT03170193|54783901|FG004|Overall Study|Lost to Follow-up|0|||
28123183|NCT03170193|54783902|FG005|Overall Study|Lost to Follow-up|0|||
28123184|NCT03170193|54783903|FG006|Overall Study|Lost to Follow-up|0|||
28123185|NCT03633331|54783925|FG000|Overall Study|Withdrawal by Subject|1|||
28123186|NCT03201003|54783931|FG000|Overall Study|Adverse Event|14|||
28123187|NCT03201003|54783932|FG001|Overall Study|Adverse Event|1|||
28123188|NCT03201003|54783931|FG000|Overall Study|Other reasons|5|||
28123189|NCT03201003|54783932|FG001|Overall Study|Other reasons|1|||
28123190|NCT03201003|54783931|FG000|Overall Study|Withdrawal by Subject|4|||
28123191|NCT03201003|54783932|FG001|Overall Study|Withdrawal by Subject|1|||
28123192|NCT03201003|54783931|FG000|Overall Study|Lost to Follow-up|2|||
28123193|NCT03201003|54783932|FG001|Overall Study|Lost to Follow-up|0|||
28123194|NCT03201003|54783931|FG000|Overall Study|Protocol Violation|1|||
28123195|NCT03201003|54783932|FG001|Overall Study|Protocol Violation|0|||
28123196|NCT03166215|54783940|FG000|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
28123197|NCT03166215|54783941|FG001|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2|||
28123198|NCT03166215|54783942|FG002|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
28123199|NCT03166215|54783940|FG000|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
28123200|NCT03166215|54783941|FG001|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
28123201|NCT03166215|54783942|FG002|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2|||
28123202|NCT03168711|54783964|FG000|Overall Study|Adverse Event|2|||
28123203|NCT03168711|54783965|FG001|Overall Study|Adverse Event|0|||
28123204|NCT03168711|54783964|FG000|Overall Study|Withdrawal by Subject|0|||
28123205|NCT03168711|54783965|FG001|Overall Study|Withdrawal by Subject|1|||
28123206|NCT03168711|54783964|FG000|Overall Study|Death|0|||
28123207|NCT03168711|54783965|FG001|Overall Study|Death|1|||
28123208|NCT03738215|54783974|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
28123209|NCT03738215|54783975|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|1|||
28123210|NCT03738215|54783976|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
28123211|NCT03738215|54783974|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
28123212|NCT03738215|54783975|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
28123213|NCT03738215|54783976|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
28123214|NCT03738215|54783974|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
28123215|NCT03738215|54783975|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
28123216|NCT03738215|54783976|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|18|||
28123217|NCT03738215|54783974|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|13|||
28123218|NCT03738215|54783975|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|11|||
28123219|NCT03738215|54783976|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|9|||
28123220|NCT03738215|54783974|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
28123221|NCT03738215|54783975|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
28123222|NCT03738215|54783976|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
28123223|NCT03738215|54783974|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
28123224|NCT03738215|54783975|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
28123225|NCT03738215|54783976|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|5|||
28123226|NCT03738215|54783974|FG000|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
28123227|NCT03738215|54783975|FG001|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
28123228|NCT03738215|54783976|FG002|Safety Follow Up Period (4 Weeks)|Adverse Event|1|||
28123229|NCT03738215|54783974|FG000|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
28123230|NCT03738215|54783975|FG001|Safety Follow Up Period (4 Weeks)|Reason Not Specified|2|||
28123231|NCT03738215|54783976|FG002|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
28123232|NCT03738215|54783974|FG000|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
28123233|NCT03738215|54783975|FG001|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
28123234|NCT03738215|54783976|FG002|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|3|||
28123235|NCT03738215|54783974|FG000|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
28123236|NCT03738215|54783975|FG001|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
28123237|NCT03738215|54783976|FG002|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|4|||
28123238|NCT03199911|54783986|FG000|Overall Study|Lost to Follow-up|5|||
28123239|NCT03199911|54783987|FG001|Overall Study|Lost to Follow-up|5|||
28123240|NCT03199911|54783986|FG000|Overall Study|Did not proceed with surgery|2|||
28123241|NCT03199911|54783987|FG001|Overall Study|Did not proceed with surgery|1|||
28123242|NCT03736967|54783997|FG000|Overall Study|Withdrawal by Subject|26|||
28123243|NCT03736967|54783998|FG001|Overall Study|Withdrawal by Subject|25|||
28123244|NCT03736967|54783999|FG002|Overall Study|Withdrawal by Subject|23|||
28123245|NCT03736967|54784000|FG003|Overall Study|Withdrawal by Subject|26|||
28123246|NCT03736967|54783997|FG000|Overall Study|Lost to Follow-up|3|||
28123247|NCT03736967|54783998|FG001|Overall Study|Lost to Follow-up|2|||
28123248|NCT03736967|54783999|FG002|Overall Study|Lost to Follow-up|1|||
28123249|NCT03736967|54784000|FG003|Overall Study|Lost to Follow-up|1|||
28123250|NCT03736967|54783997|FG000|Overall Study|Physician Decision|1|||
28123251|NCT03736967|54783998|FG001|Overall Study|Physician Decision|0|||
28123252|NCT03736967|54783999|FG002|Overall Study|Physician Decision|0|||
28123253|NCT03736967|54784000|FG003|Overall Study|Physician Decision|1|||
28123254|NCT03736967|54783997|FG000|Overall Study|Adverse Event|0|||
28123255|NCT03736967|54783998|FG001|Overall Study|Adverse Event|1|||
28123256|NCT03736967|54783999|FG002|Overall Study|Adverse Event|0|||
28123257|NCT03736967|54784000|FG003|Overall Study|Adverse Event|1|||
28123258|NCT03736967|54783997|FG000|Overall Study|Death|0|||
28123259|NCT03736967|54783998|FG001|Overall Study|Death|0|||
28123260|NCT03736967|54783999|FG002|Overall Study|Death|0|||
28123261|NCT03736967|54784000|FG003|Overall Study|Death|1|||
28123262|NCT03736967|54783997|FG000|Overall Study|Randomized but never treated|1|||
28123263|NCT03736967|54783998|FG001|Overall Study|Randomized but never treated|0|||
28123264|NCT03736967|54783999|FG002|Overall Study|Randomized but never treated|0|||
28123265|NCT03736967|54784000|FG003|Overall Study|Randomized but never treated|0|||
28123266|NCT03168555|54784013|FG000|Visit 1 (Pro-operative)|intercurrent disease, drop-out before visit 1|1|||
28123267|NCT03168555|54784013|FG000|Visit 2 (Post-operative)|Lost to Follow-up|1|||
28123268|NCT03168555|54784013|FG000|Visit 2 (Post-operative)|Adverse Event|1|||
28123269|NCT03168555|54784013|FG000|Visit 2 (Post-operative)|Withdrawal by Subject|2|||
28123270|NCT03235050|54784025|FG000|Overall Study|Adverse Event|0|||
28123271|NCT03235050|54784026|FG001|Overall Study|Adverse Event|0|||
28123272|NCT03235050|54784027|FG002|Overall Study|Adverse Event|1|||
28123273|NCT03235050|54784028|FG003|Overall Study|Adverse Event|4|||
28123274|NCT03235050|54784029|FG004|Overall Study|Adverse Event|1|||
28123275|NCT03235050|54784025|FG000|Overall Study|Death|0|||
28123276|NCT03235050|54784026|FG001|Overall Study|Death|0|||
28123277|NCT03235050|54784027|FG002|Overall Study|Death|0|||
28123278|NCT03235050|54784028|FG003|Overall Study|Death|2|||
28123279|NCT03235050|54784029|FG004|Overall Study|Death|1|||
28123280|NCT03235050|54784025|FG000|Overall Study|Lost to Follow-up|1|||
28123281|NCT03235050|54784026|FG001|Overall Study|Lost to Follow-up|2|||
28123282|NCT03235050|54784027|FG002|Overall Study|Lost to Follow-up|1|||
28123283|NCT03235050|54784028|FG003|Overall Study|Lost to Follow-up|2|||
28123284|NCT03235050|54784029|FG004|Overall Study|Lost to Follow-up|0|||
28123285|NCT03235050|54784025|FG000|Overall Study|Withdrawal by Subject|3|||
28123286|NCT03235050|54784026|FG001|Overall Study|Withdrawal by Subject|2|||
28123287|NCT03235050|54784027|FG002|Overall Study|Withdrawal by Subject|2|||
28123288|NCT03235050|54784028|FG003|Overall Study|Withdrawal by Subject|5|||
28123289|NCT03235050|54784029|FG004|Overall Study|Withdrawal by Subject|7|||
28123290|NCT03235050|54784025|FG000|Overall Study|Other reasons|0|||
28123291|NCT03235050|54784026|FG001|Overall Study|Other reasons|1|||
28123292|NCT03235050|54784027|FG002|Overall Study|Other reasons|0|||
28123293|NCT03235050|54784028|FG003|Overall Study|Other reasons|1|||
28123294|NCT03235050|54784029|FG004|Overall Study|Other reasons|2|||
28123295|NCT04502212|54784058|FG000|Overall Study|Unevaluable data; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
27849280|NCT02085161|54344603|FG002|Overall Study|Other Reason|1|||
28123296|NCT04502212|54784058|FG000|Overall Study|Clamp protocol deviation; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
28123297|NCT03167619|54784065|FG000|Overall Study|Death|11|||
28123298|NCT03167619|54784066|FG001|Overall Study|Death|8|||
28123299|NCT03167619|54784065|FG000|Overall Study|Withdrawal by Subject|1|||
27817775|NCT04440163|54275901|FG001|Vaccination Phase (Approx. 7 Months)|Other|0|||
27817776|NCT04440163|54275902|FG002|Vaccination Phase (Approx. 7 Months)|Other|3|||
28123300|NCT03167619|54784066|FG001|Overall Study|Withdrawal by Subject|2|||
28123301|NCT03167619|54784065|FG000|Overall Study|Physician Decision|0|||
28123302|NCT03167619|54784066|FG001|Overall Study|Physician Decision|1|||
28123303|NCT03578809|54784076|FG000|Overall Study|Death|0|||
28123304|NCT03578809|54784077|FG001|Overall Study|Death|2|||
28123305|NCT03578809|54784078|FG002|Overall Study|Death|0|||
28123306|NCT03578809|54784079|FG003|Overall Study|Death|1|||
28123307|NCT03578809|54784076|FG000|Overall Study|Lost to Follow-up|0|||
28123308|NCT03578809|54784077|FG001|Overall Study|Lost to Follow-up|1|||
28123309|NCT03578809|54784078|FG002|Overall Study|Lost to Follow-up|0|||
28123310|NCT03578809|54784079|FG003|Overall Study|Lost to Follow-up|0|||
28123311|NCT03578809|54784076|FG000|Overall Study|Withdrawal by Subject|3|||
28123312|NCT03578809|54784077|FG001|Overall Study|Withdrawal by Subject|5|||
28123313|NCT03578809|54784078|FG002|Overall Study|Withdrawal by Subject|2|||
28123314|NCT03578809|54784079|FG003|Overall Study|Withdrawal by Subject|0|||
28123315|NCT03578809|54784076|FG000|Overall Study|Other|3|||
28123316|NCT03578809|54784077|FG001|Overall Study|Other|6|||
28123317|NCT03578809|54784078|FG002|Overall Study|Other|2|||
28123318|NCT03578809|54784079|FG003|Overall Study|Other|8|||
28123319|NCT03198507|54784094|FG000|Overall Study|Withdrawal by Subject|1|||
28123320|NCT03198507|54784095|FG001|Overall Study|Withdrawal by Subject|0|||
28123321|NCT03610165|54784103|FG000|Overall Study|Device didn't work|0|||
28123322|NCT03610165|54784104|FG001|Overall Study|Device didn't work|1|||
28123323|NCT03609619|54784112|FG000|Overall Study|Adverse Event|1|||
28123324|NCT03609619|54784113|FG001|Overall Study|Adverse Event|0|||
28123325|NCT03609619|54784112|FG000|Overall Study|Lack of Efficacy|1|||
28123326|NCT03609619|54784113|FG001|Overall Study|Lack of Efficacy|2|||
28123327|NCT03609619|54784112|FG000|Overall Study|Protocol Violation|5|||
28123328|NCT03609619|54784113|FG001|Overall Study|Protocol Violation|0|||
28123329|NCT03609619|54784112|FG000|Overall Study|Withdrawal by Subject|2|||
28123330|NCT03609619|54784113|FG001|Overall Study|Withdrawal by Subject|3|||
28123331|NCT03609619|54784112|FG000|Overall Study|Lost to Follow-up|1|||
28123332|NCT03609619|54784113|FG001|Overall Study|Lost to Follow-up|1|||
28123333|NCT03167151|54784122|FG000|Overall Study|Withdrawal by Subject|1|||
28123334|NCT03167151|54784123|FG001|Overall Study|Withdrawal by Subject|0|||
28123335|NCT03167151|54784124|FG002|Overall Study|Withdrawal by Subject|0|||
28123336|NCT03167151|54784122|FG000|Overall Study|No evidence of tumour at surgery|0|||
28123337|NCT03167151|54784123|FG001|Overall Study|No evidence of tumour at surgery|1|||
27817777|NCT04440163|54275903|FG003|Vaccination Phase (Approx. 7 Months)|Other|2|||
27817778|NCT04440163|54275904|FG004|Vaccination Phase (Approx. 7 Months)|Other|0|||
28066765|NCT00264498|54722345|FG000|Crossover Treatment|Withdrawal by Subject|1|||
28066766|NCT00264498|54722346|FG001|Crossover Treatment|Withdrawal by Subject|0|||
28066767|NCT00466193|54722354|FG000|Overall Study|Adverse Event|0|||
28066768|NCT00466193|54722355|FG001|Overall Study|Adverse Event|1|||
28066769|NCT00466193|54722354|FG000|Overall Study|Lost to Follow-up|2|||
28066770|NCT00466193|54722355|FG001|Overall Study|Lost to Follow-up|4|||
28066771|NCT00466193|54722354|FG000|Overall Study|Physician Decision|1|||
28066772|NCT00466193|54722355|FG001|Overall Study|Physician Decision|0|||
28066773|NCT00466193|54722354|FG000|Overall Study|Protocol Violation|1|||
28066774|NCT00466193|54722355|FG001|Overall Study|Protocol Violation|1|||
28066775|NCT00466193|54722354|FG000|Overall Study|Withdrawal by Subject|7|||
28066776|NCT00466193|54722355|FG001|Overall Study|Withdrawal by Subject|2|||
28066777|NCT00466193|54722354|FG000|Overall Study|Patient refused Visit 4 procedures|1|||
28066778|NCT00466193|54722355|FG001|Overall Study|Patient refused Visit 4 procedures|0|||
28066779|NCT00263562|54722363|FG000|Overall Study|Protocol Violation|3|||
28066780|NCT00263562|54722364|FG001|Overall Study|Protocol Violation|0|||
28066781|NCT00454181|54722374|FG000|Overall Study|Adverse Event|1|||
28066782|NCT00454181|54722375|FG001|Overall Study|Adverse Event|1|||
28066783|NCT00454181|54722374|FG000|Overall Study|Lost to Follow-up|11|||
28066784|NCT00454181|54722375|FG001|Overall Study|Lost to Follow-up|1|||
28066785|NCT00454181|54722374|FG000|Overall Study|Protocol Violation|1|||
28066786|NCT00454181|54722375|FG001|Overall Study|Protocol Violation|1|||
28066787|NCT00454181|54722374|FG000|Overall Study|Withdrawal by Subject|2|||
28066788|NCT00454181|54722375|FG001|Overall Study|Withdrawal by Subject|0|||
28066789|NCT00237744|54722384|FG000|Overall Study|Withdrawal by Subject|3|||
28066790|NCT00237744|54722385|FG001|Overall Study|Withdrawal by Subject|1|||
28066791|NCT00237744|54722386|FG002|Overall Study|Withdrawal by Subject|0|||
28066792|NCT00237042|54722400|FG000|Treatment|Became ineligible post-randomization|0|||
28066793|NCT00237042|54722401|FG001|Treatment|Became ineligible post-randomization|1|||
28066794|NCT00237042|54722402|FG002|Treatment|Became ineligible post-randomization|16|||
28066795|NCT00237042|54722400|FG000|Treatment|Moved out of state|1|||
28066796|NCT00237042|54722401|FG001|Treatment|Moved out of state|1|||
28066797|NCT00237042|54722402|FG002|Treatment|Moved out of state|1|||
28066798|NCT00237042|54722400|FG000|Treatment|Completed no treatment|5|||
28066799|NCT00237042|54722401|FG001|Treatment|Completed no treatment|5|||
28066800|NCT00237042|54722402|FG002|Treatment|Completed no treatment|21|||
28066801|NCT00237042|54722400|FG000|Short Term (6 Month) Follow up|Lost to Follow-up|9|||
28066802|NCT00237042|54722401|FG001|Short Term (6 Month) Follow up|Lost to Follow-up|8|||
28066803|NCT00237042|54722402|FG002|Short Term (6 Month) Follow up|Lost to Follow-up|11|||
28123338|NCT03167151|54784124|FG002|Overall Study|No evidence of tumour at surgery|1|||
28123339|NCT03660943|54784134|FG000|Overall Study|Adverse Event|5|||
28123340|NCT03660943|54784135|FG001|Overall Study|Adverse Event|3|||
28123341|NCT03660943|54784134|FG000|Overall Study|Death|0|||
28123342|NCT03660943|54784135|FG001|Overall Study|Death|2|||
28123343|NCT03660943|54784134|FG000|Overall Study|Lost to Follow-up|7|||
28123344|NCT03660943|54784135|FG001|Overall Study|Lost to Follow-up|3|||
28123345|NCT03660943|54784134|FG000|Overall Study|Protocol Violation|3|||
28123346|NCT03660943|54784135|FG001|Overall Study|Protocol Violation|5|||
28123347|NCT03660943|54784134|FG000|Overall Study|Withdrawal by Subject|8|||
28123348|NCT03660943|54784135|FG001|Overall Study|Withdrawal by Subject|15|||
28123349|NCT03660943|54784134|FG000|Overall Study|Lack of Efficacy|9|||
28123350|NCT03660943|54784135|FG001|Overall Study|Lack of Efficacy|12|||
28123351|NCT03660943|54784134|FG000|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|4|||
28123352|NCT03660943|54784135|FG001|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|13|||
28123353|NCT03167073|54784143|FG000|Overall Study|Stillbirth|1|||
28123354|NCT03167073|54784144|FG001|Overall Study|Stillbirth|0|||
28123355|NCT03657277|54784150|FG000|Overall Study|Physician Decision|2|||
28123356|NCT03657277|54784150|FG000|Overall Study|Lost to Follow-up|1|||
28123357|NCT03657277|54784150|FG000|Overall Study|Covid-19 Research Halt at University of Iowa-Withdrawal of subjects|8|||
28123358|NCT03197883|54784156|FG000|Overall Study|Adverse Event|1|||
28123359|NCT03197883|54784157|FG001|Overall Study|Adverse Event|1|||
28123360|NCT03197883|54784156|FG000|Overall Study|Lost to Follow-up|1|||
28123361|NCT03197883|54784157|FG001|Overall Study|Lost to Follow-up|0|||
28123362|NCT03197883|54784156|FG000|Overall Study|Protocol Violation|1|||
28123363|NCT03197883|54784157|FG001|Overall Study|Protocol Violation|0|||
28123364|NCT03197883|54784156|FG000|Overall Study|Other (Not Specified)|0|||
28123365|NCT03197883|54784157|FG001|Overall Study|Other (Not Specified)|5|||
28123366|NCT03234036|54784166|FG000|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
28123367|NCT03234036|54784167|FG001|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
28123368|NCT03234036|54784168|FG002|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
28123369|NCT03234036|54784169|FG003|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
28123370|NCT03606109|54784187|FG000|Overall Study|Lost to Follow-up|2|||
28123371|NCT03606109|54784188|FG001|Overall Study|Lost to Follow-up|1|||
28123372|NCT03768336|54784194|FG000|Overall Study|Lost to Follow-up|3|||
28123373|NCT03768336|54784195|FG001|Overall Study|Lost to Follow-up|2|||
28123374|NCT03768336|54784194|FG000|Overall Study|Became Ineligible|2|||
28123375|NCT03768336|54784195|FG001|Overall Study|Became Ineligible|0|||
28123376|NCT03768336|54784194|FG000|Overall Study|Missed final survey (3-month follow-up)|1|||
28123377|NCT03768336|54784195|FG001|Overall Study|Missed final survey (3-month follow-up)|0|||
28123378|NCT03768336|54784194|FG000|Overall Study|Missed final survey (post-treatment|0|||
28123379|NCT03768336|54784195|FG001|Overall Study|Missed final survey (post-treatment|1|||
28123380|NCT02729896|54784205|FG000|Overall Study|Death|0|||
28123381|NCT02729896|54784206|FG001|Overall Study|Death|2|||
28123382|NCT02729896|54784207|FG002|Overall Study|Death|13|||
28123383|NCT02729896|54784205|FG000|Overall Study|Lost to Follow-up|0|||
28123384|NCT02729896|54784206|FG001|Overall Study|Lost to Follow-up|2|||
28123385|NCT02729896|54784207|FG002|Overall Study|Lost to Follow-up|3|||
28123386|NCT02729896|54784205|FG000|Overall Study|Other|0|||
28123387|NCT02729896|54784206|FG001|Overall Study|Other|2|||
28123388|NCT02729896|54784207|FG002|Overall Study|Other|0|||
28123389|NCT02729896|54784205|FG000|Overall Study|Physician Decision|1|||
28123390|NCT02729896|54784206|FG001|Overall Study|Physician Decision|2|||
28123391|NCT02729896|54784207|FG002|Overall Study|Physician Decision|3|||
28123392|NCT02729896|54784205|FG000|Overall Study|Progressive Disease|0|||
28123393|NCT02729896|54784206|FG001|Overall Study|Progressive Disease|1|||
28123394|NCT02729896|54784207|FG002|Overall Study|Progressive Disease|0|||
28123395|NCT02729896|54784205|FG000|Overall Study|Withdrawal by Subject|1|||
28123396|NCT02729896|54784206|FG001|Overall Study|Withdrawal by Subject|0|||
28123397|NCT02729896|54784207|FG002|Overall Study|Withdrawal by Subject|3|||
28123398|NCT03575065|54784218|FG000|Overall Study|Death|31|||
28123399|NCT03575065|54784219|FG001|Overall Study|Death|12|||
28123400|NCT03575065|54784218|FG000|Overall Study|Sponsor's Decision|28|||
28123401|NCT03575065|54784219|FG001|Overall Study|Sponsor's Decision|13|||
28123402|NCT03575065|54784218|FG000|Overall Study|Withdrawal by Subject|2|||
28123403|NCT03575065|54784219|FG001|Overall Study|Withdrawal by Subject|1|||
28123404|NCT03575065|54784218|FG000|Overall Study|Lost to Follow-up|1|||
28123405|NCT03575065|54784219|FG001|Overall Study|Lost to Follow-up|0|||
28123406|NCT03514134|54784228|FG000|Overall Study|Lost to Follow-up|0|||
27849281|NCT02085161|54344604|FG003|Overall Study|Other Reason|1|||
28123407|NCT03514134|54784229|FG001|Overall Study|Lost to Follow-up|1|||
28123408|NCT03188718|54784235|FG000|Overall Study|Participant noncompliance|4|||
28123409|NCT03188718|54784235|FG000|Overall Study|Withdrawal by Subject|1|||
28123410|NCT03188718|54784235|FG000|Overall Study|Device failure|3|||
28123411|NCT03574753|54784239|FG000|Overall Study|Adverse Event|3|||
28123412|NCT03574753|54784239|FG000|Overall Study|Progression/relapse|19|||
28123413|NCT03574753|54784239|FG000|Overall Study|Death|1|||
28123414|NCT03573505|54784246|FG000|Overall Study|Adverse Event|1|||
28123415|NCT03573505|54784247|FG001|Overall Study|Adverse Event|1|||
28123416|NCT03573505|54784246|FG000|Overall Study|Consent withdrawn|0|||
28123417|NCT03573505|54784247|FG001|Overall Study|Consent withdrawn|1|||
28123418|NCT03573505|54784246|FG000|Overall Study|Disease progression|0|||
27849282|NCT02082977|54345487|FG000|Part 1 (Up to 3.2 Years)|Death|1|||
28123419|NCT03573505|54784247|FG001|Overall Study|Disease progression|1|||
28123420|NCT03573505|54784246|FG000|Overall Study|Site Terminated by Sponsor|1|||
28123421|NCT03573505|54784247|FG001|Overall Study|Site Terminated by Sponsor|1|||
28123422|NCT03573505|54784246|FG000|Overall Study|Study terminated by sponsor|50|||
28123423|NCT03573505|54784247|FG001|Overall Study|Study terminated by sponsor|45|||
28123424|NCT03573505|54784246|FG000|Overall Study|Reason not specified|0|||
28123425|NCT03573505|54784247|FG001|Overall Study|Reason not specified|1|||
28123426|NCT03573505|54784246|FG000|Overall Study|Death|0|||
28123427|NCT03573505|54784247|FG001|Overall Study|Death|4|||
28123428|NCT01376908|54784256|FG000|Overall Study|Protocol Violation|1|||
28123429|NCT01376908|54784257|FG001|Overall Study|Protocol Violation|1|||
28123430|NCT01376908|54784256|FG000|Overall Study|Withdrawal by Subject|1|||
27817779|NCT04440163|54275905|FG005|Vaccination Phase (Approx. 7 Months)|Other|1|||
27817780|NCT04440163|54275906|FG006|Vaccination Phase (Approx. 7 Months)|Other|0|||
27817781|NCT04440163|54275907|FG007|Vaccination Phase (Approx. 7 Months)|Other|1|||
27817782|NCT04440163|54275900|FG000|Vaccination Phase (Approx. 7 Months)|Adverse Event|3|||
27817783|NCT04440163|54275901|FG001|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
27817784|NCT04440163|54275902|FG002|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
27817785|NCT04440163|54275903|FG003|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
27817786|NCT04440163|54275904|FG004|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
27817787|NCT04440163|54275905|FG005|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
27817788|NCT04440163|54275906|FG006|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
27817789|NCT04440163|54275907|FG007|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
27817790|NCT04440163|54275900|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|11|||
27817791|NCT04440163|54275901|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
27817792|NCT04440163|54275902|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|18|||
27817793|NCT04440163|54275903|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|14|||
27817794|NCT04440163|54275904|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|10|||
27817795|NCT04440163|54275905|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|3|||
27817796|NCT04440163|54275906|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
27817797|NCT04440163|54275907|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|4|||
27817798|NCT04440163|54275900|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|10|||
27817799|NCT04440163|54275901|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
27817800|NCT04440163|54275902|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|11|||
27817801|NCT04440163|54275903|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|7|||
28123431|NCT01376908|54784257|FG001|Overall Study|Withdrawal by Subject|2|||
28123432|NCT02668653|54784272|FG000|Overall Study|Refractory disease|41|||
28123433|NCT02668653|54784273|FG001|Overall Study|Refractory disease|70|||
28123434|NCT02668653|54784272|FG000|Overall Study|Relapse|44|||
28123435|NCT02668653|54784273|FG001|Overall Study|Relapse|65|||
28123436|NCT02668653|54784272|FG000|Overall Study|Adverse Event|58|||
28123437|NCT02668653|54784273|FG001|Overall Study|Adverse Event|23|||
28123438|NCT02668653|54784272|FG000|Overall Study|Subject decision to stop study drug|25|||
28123439|NCT02668653|54784273|FG001|Overall Study|Subject decision to stop study drug|23|||
28123440|NCT02668653|54784272|FG000|Overall Study|Other reasons not specified|16|||
28123441|NCT02668653|54784273|FG001|Overall Study|Other reasons not specified|11|||
28123442|NCT02668653|54784272|FG000|Overall Study|Non-protocol-specified AML therapy|12|||
27817802|NCT04440163|54275904|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|16|||
27817803|NCT04440163|54275905|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
28123443|NCT02668653|54784273|FG001|Overall Study|Non-protocol-specified AML therapy|6|||
28123444|NCT02668653|54784272|FG000|Overall Study|Investigator decision|10|||
28123445|NCT02668653|54784273|FG001|Overall Study|Investigator decision|7|||
28123446|NCT02668653|54784272|FG000|Overall Study|Failure to meet continuation criteria|5|||
27817804|NCT04440163|54275906|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|3|||
27849283|NCT02082977|54345488|FG001|Part 1 (Up to 3.2 Years)|Death|0|||
27849284|NCT02082977|54345489|FG002|Part 1 (Up to 3.2 Years)|Death|0|||
27849285|NCT02082977|54345490|FG003|Part 1 (Up to 3.2 Years)|Death|0|||
27849286|NCT02082977|54345491|FG004|Part 1 (Up to 3.2 Years)|Death|0|||
27849287|NCT02082977|54345492|FG005|Part 1 (Up to 3.2 Years)|Death|1|||
27849288|NCT02082977|54345493|FG006|Part 1 (Up to 3.2 Years)|Death|2|||
27849289|NCT02082977|54345494|FG007|Part 1 (Up to 3.2 Years)|Death|0|||
27849290|NCT02082977|54345495|FG008|Part 1 (Up to 3.2 Years)|Death|1|||
27849291|NCT02082977|54345496|FG009|Part 1 (Up to 3.2 Years)|Death|0|||
27849292|NCT02082977|54345487|FG000|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
27849293|NCT02082977|54345488|FG001|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
27849294|NCT02082977|54345489|FG002|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
27849295|NCT02082977|54345490|FG003|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
27849296|NCT02082977|54345491|FG004|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
27849297|NCT02082977|54345492|FG005|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
27849298|NCT02082977|54345493|FG006|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
27849299|NCT02082977|54345494|FG007|Part 1 (Up to 3.2 Years)|Study closed/terminated|2|||
27849300|NCT02082977|54345495|FG008|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
27849301|NCT02082977|54345496|FG009|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
27849302|NCT02082977|54345487|FG000|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
27849303|NCT02082977|54345488|FG001|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
27849304|NCT02082977|54345489|FG002|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
27849305|NCT02082977|54345490|FG003|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
27849306|NCT02082977|54345491|FG004|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
27849307|NCT02082977|54345492|FG005|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1|||
27849308|NCT02082977|54345493|FG006|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
27849309|NCT02082977|54345494|FG007|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
27849310|NCT02082977|54345495|FG008|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
27817805|NCT04440163|54275907|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|2|||
27817806|NCT04440163|54275900|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|5|||
27817807|NCT04440163|54275901|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
27817808|NCT04440163|54275902|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
27817809|NCT04440163|54275903|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
27849311|NCT02082977|54345496|FG009|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
27849312|NCT02082977|54345487|FG000|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
27849313|NCT02082977|54345488|FG001|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
27940456|NCT01190514|54596719|FG003|Third Intervention (Period 3)|Adverse Event|0|||
28066804|NCT00237042|54722400|FG000|Long Term (12 Month) Follow up|Lost to Follow-up|11|||
28066805|NCT00237042|54722401|FG001|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
27817810|NCT04440163|54275904|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|7|||
27817811|NCT04440163|54275905|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
27817812|NCT04440163|54275906|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
27817813|NCT04440163|54275907|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
27817814|NCT04440163|54275900|FG000|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|3|||
27817815|NCT04440163|54275901|FG001|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|5|||
27817816|NCT04440163|54275902|FG002|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
27817817|NCT04440163|54275903|FG003|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
27817818|NCT04440163|54275904|FG004|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
27940457|NCT01190436|54596729|FG000|Overall Study|Lost to Follow-up|35|||
28066806|NCT00237042|54722402|FG002|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
28066807|NCT00465647|54722414|FG000|Overall Study|Administrative|2|||
28066808|NCT00465647|54722415|FG001|Overall Study|Administrative|2|||
28066809|NCT00465647|54722416|FG002|Overall Study|Administrative|3|||
28066810|NCT00465647|54722417|FG003|Overall Study|Administrative|2|||
28066811|NCT00465647|54722414|FG000|Overall Study|Adverse Event|2|||
28066812|NCT00465647|54722415|FG001|Overall Study|Adverse Event|0|||
27849314|NCT02082977|54345489|FG002|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
27849315|NCT02082977|54345490|FG003|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
27849316|NCT02082977|54345491|FG004|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
27849317|NCT02082977|54345492|FG005|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
28066813|NCT00465647|54722416|FG002|Overall Study|Adverse Event|3|||
28066814|NCT00465647|54722417|FG003|Overall Study|Adverse Event|2|||
28066815|NCT00465647|54722414|FG000|Overall Study|Withdrawal by Subject|1|||
28123447|NCT02668653|54784273|FG001|Overall Study|Failure to meet continuation criteria|12|||
28123448|NCT02668653|54784272|FG000|Overall Study|Lost to Follow-up|1|||
28123449|NCT02668653|54784273|FG001|Overall Study|Lost to Follow-up|0|||
28123450|NCT02668653|54784272|FG000|Overall Study|Pregnancy|0|||
28123451|NCT02668653|54784273|FG001|Overall Study|Pregnancy|1|||
28123452|NCT02668653|54784272|FG000|Overall Study|Death|0|||
28123453|NCT02668653|54784273|FG001|Overall Study|Death|1|||
28123454|NCT03736031|54784281|FG000|Overall Study|Death|2|||
28123455|NCT03736031|54784282|FG001|Overall Study|Death|4|||
28123456|NCT03736031|54784281|FG000|Overall Study|Lost to Follow-up|21|||
28123457|NCT03736031|54784282|FG001|Overall Study|Lost to Follow-up|2|||
28123458|NCT03736031|54784281|FG000|Overall Study|Withdrawal by Subject|9|||
28123459|NCT03736031|54784282|FG001|Overall Study|Withdrawal by Subject|0|||
28123460|NCT03555565|54784288|FG000|Overall Study|Case Report Forms Uncollected|2|||
28123461|NCT03555565|54784288|FG000|Overall Study|Protocol Deviation|13|||
28123462|NCT03602053|54784295|FG000|Overall Study|Withdrawal by Subject|7|||
28123463|NCT03602053|54784296|FG001|Overall Study|Withdrawal by Subject|9|||
28123464|NCT03602053|54784297|FG002|Overall Study|Withdrawal by Subject|7|||
28123465|NCT03602053|54784295|FG000|Overall Study|Lost to Follow-up|5|||
28123466|NCT03602053|54784296|FG001|Overall Study|Lost to Follow-up|6|||
28123467|NCT03602053|54784297|FG002|Overall Study|Lost to Follow-up|0|||
28123468|NCT03602053|54784295|FG000|Overall Study|Protocol Violation|3|||
28123469|NCT03602053|54784296|FG001|Overall Study|Protocol Violation|0|||
28123470|NCT03602053|54784297|FG002|Overall Study|Protocol Violation|4|||
28123471|NCT03602053|54784295|FG000|Overall Study|Physician Decision|1|||
28123472|NCT03602053|54784296|FG001|Overall Study|Physician Decision|0|||
28123473|NCT03602053|54784297|FG002|Overall Study|Physician Decision|0|||
28123474|NCT03602053|54784295|FG000|Overall Study|migration|2|||
28123475|NCT03602053|54784296|FG001|Overall Study|migration|3|||
28123476|NCT03602053|54784297|FG002|Overall Study|migration|0|||
28123477|NCT03602053|54784295|FG000|Overall Study|Other|1|||
28123478|NCT03602053|54784296|FG001|Overall Study|Other|0|||
28123479|NCT03602053|54784297|FG002|Overall Study|Other|0|||
28123480|NCT04831515|54784309|FG000|First Intervention|Adverse Event|0|||
28123481|NCT04831515|54784310|FG001|First Intervention|Adverse Event|1|||
28123482|NCT03554629|54784316|FG000|Overall Study|Inadequate data|6|||
28123483|NCT03196791|54784346|FG000|Overall Study|Protocol Violation|7|||
28123484|NCT03196791|54784347|FG001|Overall Study|Protocol Violation|3|||
28123485|NCT03196791|54784346|FG000|Overall Study|Withdrawal by Subject|3|||
28123486|NCT03196791|54784347|FG001|Overall Study|Withdrawal by Subject|2|||
28123487|NCT03196635|54784353|FG000|Overall Study|Withdrawal by Subject|1|||
28123488|NCT03194217|54784375|FG000|Overall Study|Adverse Event|0|||
28123489|NCT03194217|54784376|FG001|Overall Study|Adverse Event|2|||
28123490|NCT03194217|54784377|FG002|Overall Study|Adverse Event|3|||
28123491|NCT03194217|54784378|FG003|Overall Study|Adverse Event|3|||
28123492|NCT03194217|54784375|FG000|Overall Study|Failure to meet randomisation criteria|0|||
28123493|NCT03194217|54784376|FG001|Overall Study|Failure to meet randomisation criteria|0|||
28123494|NCT03194217|54784377|FG002|Overall Study|Failure to meet randomisation criteria|0|||
28123495|NCT03194217|54784378|FG003|Overall Study|Failure to meet randomisation criteria|1|||
28123496|NCT03194217|54784375|FG000|Overall Study|Other|0|||
28123497|NCT03194217|54784376|FG001|Overall Study|Other|1|||
28123498|NCT03194217|54784377|FG002|Overall Study|Other|1|||
27817819|NCT04440163|54275905|FG005|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
27817820|NCT04440163|54275906|FG006|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|2|||
27817821|NCT04440163|54275907|FG007|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
27817822|NCT04440163|54275900|FG000|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
27817823|NCT04440163|54275901|FG001|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
27817824|NCT04440163|54275902|FG002|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
28066816|NCT00465647|54722415|FG001|Overall Study|Withdrawal by Subject|2|||
28066817|NCT00465647|54722416|FG002|Overall Study|Withdrawal by Subject|2|||
28066818|NCT00465647|54722417|FG003|Overall Study|Withdrawal by Subject|7|||
28066819|NCT00465647|54722414|FG000|Overall Study|"The other reasons included loss of IV"|8|||
28066820|NCT00465647|54722415|FG001|Overall Study|"The other reasons included loss of IV"|4|||
28066821|NCT00465647|54722416|FG002|Overall Study|"The other reasons included loss of IV"|3|||
28066822|NCT00465647|54722417|FG003|Overall Study|"The other reasons included loss of IV"|2|||
28066823|NCT00465569|54722439|FG000|Overall Study|persistent eczema during dose escalation|1|||
28066824|NCT00465569|54722440|FG001|Overall Study|persistent eczema during dose escalation|0|||
28066825|NCT00090766|54722449|FG000|Overall Study|Nephrectomy Planned|0|||
28066826|NCT00090766|54722450|FG001|Overall Study|Nephrectomy Planned|0|||
28066827|NCT00090766|54722451|FG002|Overall Study|Nephrectomy Planned|1|||
28066828|NCT00090766|54722449|FG000|Overall Study|Death|1|||
28066829|NCT00090766|54722450|FG001|Overall Study|Death|0|||
28066830|NCT00090766|54722451|FG002|Overall Study|Death|0|||
28066831|NCT00090766|54722449|FG000|Overall Study|Admin|0|||
28066832|NCT00090766|54722450|FG001|Overall Study|Admin|2|||
28066833|NCT00090766|54722451|FG002|Overall Study|Admin|0|||
28066834|NCT00090766|54722449|FG000|Overall Study|Lost to Follow-up|2|||
28066835|NCT00090766|54722450|FG001|Overall Study|Lost to Follow-up|0|||
28123499|NCT03194217|54784378|FG003|Overall Study|Other|0|||
28123500|NCT00709618|54784388|FG000|Overall Study|Withdrawal by Subject|4|||
28123501|NCT00709618|54784388|FG000|Overall Study|Lost to Follow-up|1|||
28123502|NCT00709618|54784388|FG000|Overall Study|Study Closed/Terminated|25|||
28123503|NCT03193047|54784394|FG000|Overall Study|Physician Decision|1|||
28123504|NCT03193047|54784395|FG001|Overall Study|Physician Decision|0|||
28123505|NCT03193047|54784394|FG000|Overall Study|Participant Left State|1|||
28123506|NCT03193047|54784395|FG001|Overall Study|Participant Left State|0|||
28123507|NCT02918019|54784407|FG000|Overall Study|Death|0|||
28123508|NCT02918019|54784408|FG001|Overall Study|Death|0|||
28123509|NCT02918019|54784409|FG002|Overall Study|Death|1|||
28123510|NCT02918019|54784410|FG003|Overall Study|Death|0|||
28123511|NCT02918019|54784407|FG000|Overall Study|Lost to Follow-up|1|||
28123512|NCT02918019|54784408|FG001|Overall Study|Lost to Follow-up|1|||
28123513|NCT02918019|54784409|FG002|Overall Study|Lost to Follow-up|0|||
28123514|NCT02918019|54784410|FG003|Overall Study|Lost to Follow-up|1|||
27817825|NCT04440163|54275903|FG003|Follow-up Phase (Approx. 5 Months)|Protocol Violation|1|||
27817826|NCT04440163|54275904|FG004|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
27817827|NCT04440163|54275905|FG005|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
27817828|NCT04440163|54275906|FG006|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
27817829|NCT04440163|54275907|FG007|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
27817830|NCT04304508|54275938|FG000|Overall Study|Subject Decision|29|||
27817831|NCT04304508|54275939|FG001|Overall Study|Subject Decision|39|||
27817832|NCT04304508|54275940|FG002|Overall Study|Subject Decision|37|||
27817833|NCT04304508|54275941|FG003|Overall Study|Subject Decision|48|||
27817834|NCT04304508|54275938|FG000|Overall Study|Death|6|||
27817835|NCT04304508|54275939|FG001|Overall Study|Death|1|||
27817836|NCT04304508|54275940|FG002|Overall Study|Death|8|||
27817837|NCT04304508|54275941|FG003|Overall Study|Death|5|||
27817838|NCT04304508|54275938|FG000|Overall Study|Non-compliance With Study Drug|3|||
27817839|NCT04304508|54275939|FG001|Overall Study|Non-compliance With Study Drug|1|||
27940458|NCT01190436|54596729|FG000|Overall Study|Other|4|||
27940459|NCT01035255|54596736|FG000|Overall Study|Death|724|||
28066836|NCT00090766|54722451|FG002|Overall Study|Lost to Follow-up|2|||
28066837|NCT00465179|54722461|FG000|Overall Study|Adverse Event|4|||
28066838|NCT00465179|54722461|FG000|Overall Study|Withdrawal by Subject|2|||
28066839|NCT00465179|54722461|FG000|Overall Study|Progression of Disease|47|||
28066840|NCT00465101|54722465|FG000|Overall Study|Aborted Proc./Treatment Not Attempted|3|||
28066841|NCT00465101|54722465|FG000|Overall Study|Change in health precluded follow up|4|||
28066842|NCT00465101|54722465|FG000|Overall Study|Did not meet study criteria|4|||
28066843|NCT00465101|54722465|FG000|Overall Study|Lost to Follow-up|5|||
28066844|NCT00465101|54722465|FG000|Overall Study|Other|6|||
28066845|NCT00465101|54722465|FG000|Overall Study|Pt. Insurance not accepted at center|2|||
28066846|NCT00465101|54722465|FG000|Overall Study|Patient postponed procedure|1|||
28066847|NCT00465101|54722465|FG000|Overall Study|Site closed due to IRB expiration|1|||
28123515|NCT02918019|54784407|FG000|Overall Study|Principal investigator request|0|||
28123516|NCT02918019|54784408|FG001|Overall Study|Principal investigator request|0|||
28123517|NCT02918019|54784409|FG002|Overall Study|Principal investigator request|0|||
28123518|NCT02918019|54784410|FG003|Overall Study|Principal investigator request|1|||
28123519|NCT02918019|54784407|FG000|Overall Study|Physician Decision|1|||
28123520|NCT02918019|54784408|FG001|Overall Study|Physician Decision|3|||
28123521|NCT02918019|54784409|FG002|Overall Study|Physician Decision|2|||
27817840|NCT04304508|54275940|FG002|Overall Study|Non-compliance With Study Drug|2|||
28066848|NCT00465101|54722465|FG000|Overall Study|Unable to obtain IRB approval|1|||
28066849|NCT00465101|54722465|FG000|Overall Study|Death|3|||
27817841|NCT04304508|54275941|FG003|Overall Study|Non-compliance With Study Drug|0|||
28066850|NCT00465101|54722465|FG000|Overall Study|Withdrawal by Subject|25|||
28066851|NCT00465101|54722465|FG000|Overall Study|Physician Decision|1|||
28123522|NCT02918019|54784410|FG003|Overall Study|Physician Decision|0|||
28123523|NCT02918019|54784407|FG000|Overall Study|Protocol deviation|1|||
28123524|NCT02918019|54784408|FG001|Overall Study|Protocol deviation|1|||
28123525|NCT02918019|54784409|FG002|Overall Study|Protocol deviation|0|||
28123526|NCT02918019|54784410|FG003|Overall Study|Protocol deviation|2|||
28123527|NCT02918019|54784407|FG000|Overall Study|Withdrawal by Subject|3|||
28123528|NCT02918019|54784408|FG001|Overall Study|Withdrawal by Subject|4|||
28123529|NCT02918019|54784409|FG002|Overall Study|Withdrawal by Subject|6|||
28123530|NCT02918019|54784410|FG003|Overall Study|Withdrawal by Subject|4|||
28123531|NCT02918019|54784407|FG000|Overall Study|Adverse Event|0|||
28123532|NCT02918019|54784408|FG001|Overall Study|Adverse Event|1|||
28123533|NCT02918019|54784409|FG002|Overall Study|Adverse Event|0|||
28123534|NCT02918019|54784410|FG003|Overall Study|Adverse Event|1|||
27817842|NCT04304508|54275938|FG000|Overall Study|Switching To Other Therapy|1|||
27817843|NCT04304508|54275939|FG001|Overall Study|Switching To Other Therapy|1|||
27817844|NCT04304508|54275940|FG002|Overall Study|Switching To Other Therapy|1|||
27817845|NCT04304508|54275941|FG003|Overall Study|Switching To Other Therapy|2|||
28066852|NCT00465101|54722465|FG000|Overall Study|Withdrew consent prior to procedure|3|||
28066853|NCT00084136|54722494|FG000|PI Comparison|Death|10|||
28066854|NCT00084136|54722495|FG001|PI Comparison|Death|9|||
28066855|NCT00084136|54722496|FG002|PI Comparison|Death|0|||
28066856|NCT00084136|54722494|FG000|PI Comparison|Lost to Follow-up|11|||
28123535|NCT03055988|54784428|FG000|Period 1|Adverse Event|0|||
28123536|NCT03055988|54784429|FG001|Period 1|Adverse Event|1|||
28123537|NCT03055988|54784428|FG000|Period 1|Lost to Follow-up|1|||
28123538|NCT03055988|54784429|FG001|Period 1|Lost to Follow-up|0|||
28123539|NCT03055988|54784428|FG000|Period 1|Withdrawal by Subject|0|||
28123540|NCT03055988|54784429|FG001|Period 1|Withdrawal by Subject|4|||
28066857|NCT00084136|54722495|FG001|PI Comparison|Lost to Follow-up|8|||
28066858|NCT00084136|54722496|FG002|PI Comparison|Lost to Follow-up|0|||
28066859|NCT00084136|54722494|FG000|PI Comparison|Withdrawal by Subject|33|||
28066860|NCT00084136|54722495|FG001|PI Comparison|Withdrawal by Subject|30|||
28066861|NCT00084136|54722496|FG002|PI Comparison|Withdrawal by Subject|0|||
28066862|NCT00084136|54722494|FG000|PI Comparison|Clinic site closed|1|||
28066863|NCT00084136|54722495|FG001|PI Comparison|Clinic site closed|0|||
28066864|NCT00084136|54722496|FG002|PI Comparison|Clinic site closed|0|||
28066865|NCT00084136|54722494|FG000|NRTI Comparison|Death|20|||
28066866|NCT00084136|54722495|FG001|NRTI Comparison|Death|0|||
28066867|NCT00084136|54722496|FG002|NRTI Comparison|Death|18|||
28066868|NCT00084136|54722494|FG000|NRTI Comparison|Lost to Follow-up|14|||
28066869|NCT00084136|54722495|FG001|NRTI Comparison|Lost to Follow-up|0|||
28066870|NCT00084136|54722496|FG002|NRTI Comparison|Lost to Follow-up|12|||
28066871|NCT00084136|54722494|FG000|NRTI Comparison|Withdrawal by Subject|54|||
28123541|NCT03055988|54784428|FG000|Period 2|Adverse Event|0|||
28123542|NCT03055988|54784429|FG001|Period 2|Adverse Event|1|||
28123543|NCT03055988|54784428|FG000|Period 2|Other than listed|1|||
28123544|NCT03055988|54784429|FG001|Period 2|Other than listed|1|||
28123545|NCT01250912|54784435|FG000|Overall Study|Lost to Follow-up|1|||
28123546|NCT03733301|54784445|FG000|Overall Study|Screen Fail|1|||
28123547|NCT03733301|54784446|FG001|Overall Study|Screen Fail|0|||
28123548|NCT03733301|54784447|FG002|Overall Study|Screen Fail|0|||
28123549|NCT03733301|54784445|FG000|Overall Study|Non-compliance|1|||
28123550|NCT03733301|54784446|FG001|Overall Study|Non-compliance|0|||
28123551|NCT03733301|54784447|FG002|Overall Study|Non-compliance|0|||
28123552|NCT03733301|54784445|FG000|Overall Study|Lack of Efficacy|2|||
28123553|NCT03733301|54784446|FG001|Overall Study|Lack of Efficacy|3|||
27817846|NCT04304508|54275938|FG000|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
28066872|NCT00084136|54722495|FG001|NRTI Comparison|Withdrawal by Subject|0|||
28066873|NCT00084136|54722496|FG002|NRTI Comparison|Withdrawal by Subject|38|||
28066874|NCT00084136|54722494|FG000|NRTI Comparison|Clinic site closed|12|||
28066875|NCT00084136|54722495|FG001|NRTI Comparison|Clinic site closed|0|||
28123554|NCT03733301|54784447|FG002|Overall Study|Lack of Efficacy|0|||
28123555|NCT03733301|54784445|FG000|Overall Study|Adverse Event|0|||
28123556|NCT03733301|54784446|FG001|Overall Study|Adverse Event|1|||
28123557|NCT03733301|54784447|FG002|Overall Study|Adverse Event|3|||
28123558|NCT03733301|54784445|FG000|Overall Study|Withdrawal by Subject|3|||
28123559|NCT03733301|54784446|FG001|Overall Study|Withdrawal by Subject|5|||
28123560|NCT03733301|54784447|FG002|Overall Study|Withdrawal by Subject|1|||
28123561|NCT02871297|54784456|FG000|Overall Study|Adverse Event|34|||
28123562|NCT02871297|54784456|FG000|Overall Study|Lack of Efficacy|10|||
28123563|NCT02871297|54784456|FG000|Overall Study|Non-compliance with study drug|15|||
28123564|NCT02871297|54784456|FG000|Overall Study|Protocol Violation|3|||
28123565|NCT02871297|54784456|FG000|Overall Study|Withdrawal by Subject|20|||
28123566|NCT02871297|54784456|FG000|Overall Study|Lost to Follow-up|13|||
28123567|NCT02871297|54784456|FG000|Overall Study|Rolled over to 13546A|2|||
28123568|NCT02871297|54784456|FG000|Overall Study|Other than specified|39|||
28123569|NCT03554005|54784466|FG000|Overall Study|Not in participant's best interest|0|||
28123570|NCT03554005|54784467|FG001|Overall Study|Not in participant's best interest|0|||
28123571|NCT03554005|54784468|FG002|Overall Study|Not in participant's best interest|0|||
28123572|NCT03554005|54784469|FG003|Overall Study|Not in participant's best interest|0|||
28123573|NCT03554005|54784470|FG004|Overall Study|Not in participant's best interest|0|||
28123574|NCT03554005|54784471|FG005|Overall Study|Not in participant's best interest|1|||
28123575|NCT03554005|54784466|FG000|Overall Study|Disease Progression|1|||
28123576|NCT03554005|54784467|FG001|Overall Study|Disease Progression|1|||
28123577|NCT03554005|54784468|FG002|Overall Study|Disease Progression|1|||
28123578|NCT03554005|54784469|FG003|Overall Study|Disease Progression|1|||
28123579|NCT03554005|54784470|FG004|Overall Study|Disease Progression|5|||
28123580|NCT03554005|54784471|FG005|Overall Study|Disease Progression|6|||
28123581|NCT03554005|54784466|FG000|Overall Study|Adverse Event|0|||
28123582|NCT03554005|54784467|FG001|Overall Study|Adverse Event|0|||
28123583|NCT03554005|54784468|FG002|Overall Study|Adverse Event|0|||
28123584|NCT03554005|54784469|FG003|Overall Study|Adverse Event|0|||
28123585|NCT03554005|54784470|FG004|Overall Study|Adverse Event|0|||
28123586|NCT03554005|54784471|FG005|Overall Study|Adverse Event|3|||
28123587|NCT03554005|54784466|FG000|Overall Study|Physician Decision|0|||
28123588|NCT03554005|54784467|FG001|Overall Study|Physician Decision|0|||
28123589|NCT03554005|54784468|FG002|Overall Study|Physician Decision|0|||
28123590|NCT03554005|54784469|FG003|Overall Study|Physician Decision|0|||
28123591|NCT03554005|54784470|FG004|Overall Study|Physician Decision|1|||
28123592|NCT03554005|54784471|FG005|Overall Study|Physician Decision|0|||
28123593|NCT03554005|54784466|FG000|Overall Study|Other|0|||
28123594|NCT03554005|54784467|FG001|Overall Study|Other|0|||
28123595|NCT03554005|54784468|FG002|Overall Study|Other|0|||
28123596|NCT03554005|54784469|FG003|Overall Study|Other|0|||
28123597|NCT03554005|54784470|FG004|Overall Study|Other|0|||
28123598|NCT03554005|54784471|FG005|Overall Study|Other|1|||
28123599|NCT00709228|54784485|FG000|Overall Study|Not treated|14|||
28123600|NCT00709228|54784485|FG000|Overall Study|Eligibility criteria not met|281|||
28123601|NCT00709228|54784485|FG000|Overall Study|Adverse events|2|||
28123602|NCT00709228|54784485|FG000|Overall Study|Discontinued treatment|14|||
28123603|NCT00709228|54784485|FG000|Overall Study|Did not enter follow-up|4|||
28123604|NCT00709228|54784485|FG000|Overall Study|Discontinued follow-up|5|||
28123605|NCT00709228|54784485|FG000|Overall Study|Disease progression|1|||
28123606|NCT00709228|54784485|FG000|Overall Study|Lost to Follow-up|6|||
28123607|NCT00709228|54784485|FG000|Overall Study|Non-compliance|5|||
28123608|NCT03219372|54784508|FG000|Overall Study|Withdrawal by Subject|1|||
28123609|NCT03219372|54784509|FG001|Overall Study|Withdrawal by Subject|0|||
28123610|NCT03056690|54784524|FG000|Overall Study|Adverse Event|3|||
28123611|NCT03056690|54784525|FG001|Overall Study|Adverse Event|2|||
28123612|NCT03056690|54784524|FG000|Overall Study|Lack of Efficacy|1|||
28123613|NCT03056690|54784525|FG001|Overall Study|Lack of Efficacy|2|||
28123614|NCT03056690|54784524|FG000|Overall Study|Lost to Follow-up|3|||
28123615|NCT03056690|54784525|FG001|Overall Study|Lost to Follow-up|2|||
28123616|NCT03056690|54784524|FG000|Overall Study|Protocol Violation|2|||
28123617|NCT03056690|54784525|FG001|Overall Study|Protocol Violation|2|||
28123618|NCT03056690|54784524|FG000|Overall Study|Withdrawal by Subject|3|||
28123619|NCT03056690|54784525|FG001|Overall Study|Withdrawal by Subject|6|||
28123620|NCT03056690|54784524|FG000|Overall Study|Non-compliance with Study Drug|1|||
28123621|NCT03056690|54784525|FG001|Overall Study|Non-compliance with Study Drug|0|||
28123622|NCT03056690|54784524|FG000|Overall Study|Miscellaneous|1|||
28123623|NCT03056690|54784525|FG001|Overall Study|Miscellaneous|2|||
27940460|NCT01035255|54596737|FG001|Overall Study|Death|844|||
28123624|NCT03191799|54784531|FG000|Overall Study|Withdrawal by Subject|4|||
28123625|NCT03191799|54784531|FG000|Overall Study|Physician Decision|2|||
28123626|NCT03191799|54784531|FG000|Overall Study|Lost to Follow-up|1|||
28123627|NCT03191799|54784531|FG000|Overall Study|Death|2|||
28123628|NCT00708916|54784535|FG000|Overall Study|Subject Noncompliance|2|||
28123629|NCT00708916|54784535|FG000|Overall Study|Adverse Event|2|||
28123630|NCT02352753|54784540|FG000|6-Month Dosing Period|Decision by sponsor|2|||
28123631|NCT02352753|54784540|FG000|6-Month Dosing Period|Withdrawal by Subject|34|||
28123632|NCT02352753|54784540|FG000|6-Month Dosing Period|Lost to Follow-up|2|||
28123633|NCT02352753|54784540|FG000|6-Month Dosing Period|Transitioning to Q3M|60|||
28123634|NCT02352753|54784540|FG000|3-Month Dosing Period|Decision by sponsor|14|||
28066876|NCT00084136|54722496|FG002|NRTI Comparison|Clinic site closed|14|||
28066877|NCT00084136|54722494|FG000|NRTI Comparison|Not reason above|1|||
28066878|NCT00084136|54722495|FG001|NRTI Comparison|Not reason above|0|||
28123635|NCT02352753|54784540|FG000|3-Month Dosing Period|Withdrawal by Subject|6|||
28123636|NCT04532294|54784551|FG000|Overall Study|Withdrawal by Subject|0|||
28123637|NCT04532294|54784552|FG001|Overall Study|Withdrawal by Subject|0|||
28123638|NCT04532294|54784553|FG002|Overall Study|Withdrawal by Subject|1|||
28123639|NCT04532294|54784551|FG000|Overall Study|Participants Not Dosed|0|||
28123640|NCT04532294|54784552|FG001|Overall Study|Participants Not Dosed|0|||
28123641|NCT04532294|54784553|FG002|Overall Study|Participants Not Dosed|2|||
28123642|NCT03197766|54784565|FG000|Overall Study|Withdrawal by Subject|2|||
28123643|NCT03197766|54784566|FG001|Overall Study|Withdrawal by Subject|0|||
28123644|NCT03738332|54784572|FG000|Overall Study|Withdrawal by Subject|1|||
28123645|NCT03173456|54784582|FG000|Baseline|Medication dispensing system malfunction'|0|||
28123646|NCT03173456|54784583|FG001|Baseline|Medication dispensing system malfunction'|1|||
28123647|NCT03173456|54784584|FG002|Baseline|Medication dispensing system malfunction'|0|||
28123648|NCT03173456|54784585|FG003|Baseline|Medication dispensing system malfunction'|0|||
28123649|NCT03173456|54784586|FG004|Baseline|Medication dispensing system malfunction'|2|||
28123650|NCT03173456|54784582|FG000|2 Hour Follow-up|Withdrawal by Subject|0|||
28123651|NCT03173456|54784583|FG001|2 Hour Follow-up|Withdrawal by Subject|1|||
28066879|NCT00084136|54722496|FG002|NRTI Comparison|Not reason above|0|||
28066880|NCT03812380|54722507|FG000|Overall Study|Protocol Violation|3|||
28066881|NCT03812380|54722508|FG001|Overall Study|Protocol Violation|3|||
28066882|NCT03812380|54722507|FG000|Overall Study|Withdrawal by Subject|5|||
28066883|NCT03812380|54722508|FG001|Overall Study|Withdrawal by Subject|4|||
28066884|NCT03812380|54722507|FG000|Overall Study|Early termination of study|14|||
28066885|NCT03812380|54722508|FG001|Overall Study|Early termination of study|14|||
28123652|NCT03173456|54784584|FG002|2 Hour Follow-up|Withdrawal by Subject|1|||
28123653|NCT03173456|54784585|FG003|2 Hour Follow-up|Withdrawal by Subject|1|||
28123654|NCT03173456|54784586|FG004|2 Hour Follow-up|Withdrawal by Subject|2|||
28123655|NCT03197376|54784609|FG000|Primary and Booster Phase|Adverse Event|0|||
28123656|NCT03197376|54784610|FG001|Primary and Booster Phase|Adverse Event|0|||
28066886|NCT00464945|54722516|FG000|Infant Series|Withdrawal by parent/guardian request|2|||
28123657|NCT03197376|54784611|FG002|Primary and Booster Phase|Adverse Event|0|||
28123658|NCT03197376|54784612|FG003|Primary and Booster Phase|Adverse Event|1|||
28123659|NCT03197376|54784609|FG000|Primary and Booster Phase|Death|1|||
28123660|NCT03197376|54784610|FG001|Primary and Booster Phase|Death|0|||
28123661|NCT03197376|54784611|FG002|Primary and Booster Phase|Death|0|||
28123662|NCT03197376|54784612|FG003|Primary and Booster Phase|Death|2|||
28123663|NCT03197376|54784609|FG000|Primary and Booster Phase|Lost to Follow-up|0|||
28123664|NCT03197376|54784610|FG001|Primary and Booster Phase|Lost to Follow-up|0|||
28123665|NCT03197376|54784611|FG002|Primary and Booster Phase|Lost to Follow-up|1|||
28123666|NCT03197376|54784612|FG003|Primary and Booster Phase|Lost to Follow-up|0|||
28123667|NCT03197376|54784609|FG000|Primary and Booster Phase|Physician Decision|1|||
28123668|NCT03197376|54784610|FG001|Primary and Booster Phase|Physician Decision|0|||
28123669|NCT03197376|54784611|FG002|Primary and Booster Phase|Physician Decision|1|||
28123670|NCT03197376|54784612|FG003|Primary and Booster Phase|Physician Decision|3|||
28123671|NCT03197376|54784609|FG000|Primary and Booster Phase|Withdrawal by subject's parents|11|||
28123672|NCT03197376|54784610|FG001|Primary and Booster Phase|Withdrawal by subject's parents|10|||
28123673|NCT03197376|54784611|FG002|Primary and Booster Phase|Withdrawal by subject's parents|14|||
28123674|NCT03197376|54784612|FG003|Primary and Booster Phase|Withdrawal by subject's parents|11|||
28123675|NCT03197376|54784609|FG000|Primary and Booster Phase|Ineligibility criteria|1|||
28123676|NCT03197376|54784610|FG001|Primary and Booster Phase|Ineligibility criteria|1|||
28123677|NCT03197376|54784611|FG002|Primary and Booster Phase|Ineligibility criteria|4|||
28123678|NCT03197376|54784612|FG003|Primary and Booster Phase|Ineligibility criteria|2|||
28123679|NCT03197376|54784609|FG000|Primary and Booster Phase|Not vaccine related|1|||
28123680|NCT03197376|54784610|FG001|Primary and Booster Phase|Not vaccine related|2|||
28123681|NCT03197376|54784611|FG002|Primary and Booster Phase|Not vaccine related|0|||
28123682|NCT03197376|54784612|FG003|Primary and Booster Phase|Not vaccine related|6|||
28123683|NCT03197376|54784609|FG000|Immune Persistence Phase|Lost to Follow-up|0|||
28123684|NCT03197376|54784610|FG001|Immune Persistence Phase|Lost to Follow-up|0|||
28123685|NCT03197376|54784611|FG002|Immune Persistence Phase|Lost to Follow-up|2|||
28123686|NCT03197376|54784612|FG003|Immune Persistence Phase|Lost to Follow-up|1|||
28123687|NCT03197376|54784609|FG000|Immune Persistence Phase|Withdrawal by subject's parents|4|||
28123688|NCT03197376|54784610|FG001|Immune Persistence Phase|Withdrawal by subject's parents|4|||
28123689|NCT03197376|54784611|FG002|Immune Persistence Phase|Withdrawal by subject's parents|2|||
28123690|NCT03197376|54784612|FG003|Immune Persistence Phase|Withdrawal by subject's parents|3|||
28123691|NCT03197376|54784609|FG000|Immune Persistence Phase|Not vaccine related|1|||
28123692|NCT03197376|54784610|FG001|Immune Persistence Phase|Not vaccine related|0|||
28123693|NCT03197376|54784611|FG002|Immune Persistence Phase|Not vaccine related|1|||
28123694|NCT03197376|54784612|FG003|Immune Persistence Phase|Not vaccine related|1|||
28123695|NCT03600805|54784649|FG000|Overall Study|Adverse Event|2|||
28123696|NCT03600805|54784650|FG001|Overall Study|Adverse Event|1|||
28123697|NCT03600805|54784651|FG002|Overall Study|Adverse Event|1|||
28123698|NCT03600805|54784652|FG003|Overall Study|Adverse Event|7|||
28123699|NCT03600805|54784649|FG000|Overall Study|Lack of Efficacy|2|||
28123700|NCT03600805|54784650|FG001|Overall Study|Lack of Efficacy|1|||
28123701|NCT03600805|54784651|FG002|Overall Study|Lack of Efficacy|0|||
28123702|NCT03600805|54784652|FG003|Overall Study|Lack of Efficacy|0|||
28123703|NCT03600805|54784649|FG000|Overall Study|Withdrawal by Subject|1|||
28123704|NCT03600805|54784650|FG001|Overall Study|Withdrawal by Subject|0|||
28123705|NCT03600805|54784651|FG002|Overall Study|Withdrawal by Subject|0|||
28123706|NCT03600805|54784652|FG003|Overall Study|Withdrawal by Subject|1|||
28123707|NCT03600805|54784649|FG000|Overall Study|Other unspecified|14|||
28123708|NCT03600805|54784650|FG001|Overall Study|Other unspecified|6|||
28123709|NCT03600805|54784651|FG002|Overall Study|Other unspecified|7|||
28123710|NCT03600805|54784652|FG003|Overall Study|Other unspecified|11|||
28123711|NCT02729740|54784664|FG000|Overall Study|Early Termination|130|||
28123712|NCT02729740|54784664|FG000|Overall Study|Other|1|||
28123713|NCT03196284|54784674|FG000|Main Part|Withdrawal by Subject|0|||
28123714|NCT03196284|54784675|FG001|Main Part|Withdrawal by Subject|1|||
28123715|NCT03196284|54784676|FG002|Main Part|Withdrawal by Subject|0|||
28123716|NCT03196284|54784674|FG000|Extension Part|Lack of Efficacy|0|||
28123717|NCT03196284|54784675|FG001|Extension Part|Lack of Efficacy|0|||
28123718|NCT03196284|54784676|FG002|Extension Part|Lack of Efficacy|1|||
28123719|NCT03196284|54784674|FG000|Extension Part|Withdrawal by Subject|0|||
28123720|NCT03196284|54784675|FG001|Extension Part|Withdrawal by Subject|0|||
27940461|NCT01035255|54596736|FG000|Overall Study|Lost to Follow-up|2|||
28123721|NCT03196284|54784676|FG002|Extension Part|Withdrawal by Subject|1|||
28123722|NCT03196284|54784674|FG000|Extension Part|Physician Decision|0|||
28123723|NCT03196284|54784675|FG001|Extension Part|Physician Decision|0|||
28123724|NCT03196284|54784676|FG002|Extension Part|Physician Decision|1|||
28123725|NCT03730961|54784698|FG000|Overall Study|Adverse Event|0|||
28123726|NCT03730961|54784699|FG001|Overall Study|Adverse Event|1|||
28123727|NCT01078454|54784707|FG000|Overall Study|Adverse Event|1|||
28123728|NCT01078454|54784708|FG001|Overall Study|Adverse Event|1|||
28123729|NCT01078454|54784707|FG000|Overall Study|Death|0|||
28123730|NCT01078454|54784708|FG001|Overall Study|Death|1|||
28123731|NCT03345004|54784725|FG000|Overall Study|Physician Decision|1|||
28123732|NCT03345004|54784726|FG001|Overall Study|Physician Decision|0|||
28123733|NCT03345004|54784725|FG000|Overall Study|Withdrawal by Subject|0|||
28123734|NCT03345004|54784726|FG001|Overall Study|Withdrawal by Subject|1|||
28123735|NCT03552757|54784737|FG000|Overall Study|Withdrawal by Subject|10|||
28123736|NCT03552757|54784738|FG001|Overall Study|Withdrawal by Subject|5|||
28123737|NCT03552757|54784739|FG002|Overall Study|Withdrawal by Subject|12|||
28123738|NCT03552757|54784737|FG000|Overall Study|Lost to Follow-up|2|||
28123739|NCT03552757|54784738|FG001|Overall Study|Lost to Follow-up|7|||
28123740|NCT03552757|54784739|FG002|Overall Study|Lost to Follow-up|7|||
28123741|NCT03552757|54784737|FG000|Overall Study|Death|1|||
28123742|NCT03552757|54784738|FG001|Overall Study|Death|1|||
28123743|NCT03552757|54784739|FG002|Overall Study|Death|1|||
28123744|NCT03730103|54784752|FG000|Overall Study|Did not meet inclusion criteria|0|||
28123745|NCT03730103|54784753|FG001|Overall Study|Did not meet inclusion criteria|5|||
28123746|NCT03727841|54784761|FG000|Overall Study|Physician Decision|3|||
28123747|NCT03727841|54784762|FG001|Overall Study|Physician Decision|1|||
28123748|NCT03552523|54784768|FG000|Overall Study|Withdrawal by Subject|1|||
28123749|NCT03552523|54784769|FG001|Overall Study|Withdrawal by Subject|1|||
28123750|NCT03345550|54784777|FG000|Overall Study|Withdrawal by Subject|1|||
28123751|NCT03345550|54784778|FG001|Overall Study|Withdrawal by Subject|0|||
28123752|NCT03345550|54784777|FG000|Overall Study|Lost to Follow-up|4|||
28123753|NCT03345550|54784778|FG001|Overall Study|Lost to Follow-up|5|||
28123754|NCT03186378|54784786|FG000|Overall Study|Lost to Follow-up|1|||
28123755|NCT03186378|54784787|FG001|Overall Study|Lost to Follow-up|0|||
28123756|NCT00687596|54784795|FG000|Overall Study|Adverse Event (AE)|10|||
28123757|NCT00687596|54784796|FG001|Overall Study|Adverse Event (AE)|3|||
28123758|NCT00687596|54784795|FG000|Overall Study|Radiological Disease Progression|6|||
28123759|NCT00687596|54784796|FG001|Overall Study|Radiological Disease Progression|2|||
28123760|NCT00687596|54784795|FG000|Overall Study|Clinical Disease Progression|1|||
28123761|NCT00687596|54784796|FG001|Overall Study|Clinical Disease Progression|3|||
28123762|NCT00687596|54784795|FG000|Overall Study|Investigator Discretion|3|||
28123763|NCT00687596|54784796|FG001|Overall Study|Investigator Discretion|1|||
28123764|NCT00687596|54784795|FG000|Overall Study|Sponsor Terminated Study|6|||
28123765|NCT00687596|54784796|FG001|Overall Study|Sponsor Terminated Study|17|||
28123766|NCT02892409|54784804|FG000|Overall Study|Adverse Event|1|||
28123767|NCT02892409|54784805|FG001|Overall Study|Adverse Event|0|||
28123768|NCT02892409|54784804|FG000|Overall Study|Withdrawal by Subject|2|||
28123769|NCT02892409|54784805|FG001|Overall Study|Withdrawal by Subject|1|||
28123770|NCT03219216|54784813|FG000|Overall Study|Lost to Follow-up|0|||
28123771|NCT03219216|54784814|FG001|Overall Study|Lost to Follow-up|1|||
28123772|NCT03195660|54784828|FG000|Overall Study|The study was terminated|2|||
28123773|NCT03194490|54784834|FG000|Overall Study|Lost to Follow-up|1|||
28123774|NCT03194490|54784835|FG001|Overall Study|Lost to Follow-up|3|||
28123775|NCT03194490|54784834|FG000|Overall Study|participant developed specific neck pain|1|||
28123776|NCT03194490|54784835|FG001|Overall Study|participant developed specific neck pain|0|||
28123777|NCT03217968|54784842|FG000|Overall Study|Withdrawal by Subject|4|||
28123778|NCT03217968|54784842|FG000|Overall Study|Lost to Follow-up|1|||
28123779|NCT03217968|54784842|FG000|Overall Study|Protocol Violation|6|||
28123780|NCT03192306|54784848|FG000|Overall Study|Did not treat cold sore during study|149|||
28123781|NCT03192306|54784849|FG001|Overall Study|Did not treat cold sore during study|143|||
28123782|NCT03192306|54784848|FG000|Overall Study|Withdrawal by Subject|1|||
28123783|NCT03192306|54784849|FG001|Overall Study|Withdrawal by Subject|1|||
28123784|NCT03192306|54784848|FG000|Overall Study|Lost to Follow-up|1|||
28123785|NCT03192306|54784849|FG001|Overall Study|Lost to Follow-up|0|||
28123786|NCT03192306|54784848|FG000|Overall Study|Protocol Violation|1|||
27817847|NCT04304508|54275939|FG001|Overall Study|Subject Decision: COVID-19 Pandemic Related|1|||
28123787|NCT03192306|54784849|FG001|Overall Study|Protocol Violation|1|||
28123788|NCT03216954|54784872|FG000|Overall Study|Adverse Event|0|||
28123789|NCT03216954|54784873|FG001|Overall Study|Adverse Event|0|||
28123790|NCT03216954|54784874|FG002|Overall Study|Adverse Event|1|||
28123791|NCT03216954|54784875|FG003|Overall Study|Adverse Event|0|||
28123792|NCT03216954|54784876|FG004|Overall Study|Adverse Event|1|||
28123793|NCT03216954|54784872|FG000|Overall Study|Withdrawal by Subject|2|||
28123794|NCT03216954|54784873|FG001|Overall Study|Withdrawal by Subject|0|||
28123795|NCT03216954|54784874|FG002|Overall Study|Withdrawal by Subject|0|||
28123796|NCT03216954|54784875|FG003|Overall Study|Withdrawal by Subject|0|||
28123797|NCT03216954|54784876|FG004|Overall Study|Withdrawal by Subject|0|||
28123798|NCT03216954|54784872|FG000|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
28123799|NCT03216954|54784873|FG001|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1|||
28123800|NCT03216954|54784874|FG002|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
28123801|NCT03216954|54784875|FG003|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
28123802|NCT03216954|54784876|FG004|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
28123803|NCT03599089|54784888|FG000|Overall Study|Lost to Follow-up|1|||
27817848|NCT04304508|54275940|FG002|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
28123804|NCT03599089|54784889|FG001|Overall Study|Lost to Follow-up|0|||
28123805|NCT03599089|54784890|FG002|Overall Study|Lost to Follow-up|0|||
28123806|NCT03599089|54784891|FG003|Overall Study|Lost to Follow-up|0|||
28123807|NCT03599089|54784888|FG000|Overall Study|Withdrawal by Subject|2|||
28123808|NCT03599089|54784889|FG001|Overall Study|Withdrawal by Subject|1|||
28123809|NCT03599089|54784890|FG002|Overall Study|Withdrawal by Subject|0|||
28123810|NCT03599089|54784891|FG003|Overall Study|Withdrawal by Subject|0|||
28123811|NCT03599089|54784888|FG000|Overall Study|Lack of Efficacy|0|||
28123812|NCT03599089|54784889|FG001|Overall Study|Lack of Efficacy|0|||
28123813|NCT03599089|54784890|FG002|Overall Study|Lack of Efficacy|1|||
28123814|NCT03599089|54784891|FG003|Overall Study|Lack of Efficacy|2|||
28123815|NCT03192150|54784903|FG000|Overall Study|Adverse Event|14|||
28123816|NCT03192150|54784904|FG001|Overall Study|Adverse Event|12|||
28123817|NCT03192150|54784903|FG000|Overall Study|Lack of Efficacy|23|||
28123818|NCT03192150|54784904|FG001|Overall Study|Lack of Efficacy|30|||
28123819|NCT03192150|54784903|FG000|Overall Study|Lost to Follow-up|1|||
28123820|NCT03192150|54784904|FG001|Overall Study|Lost to Follow-up|1|||
28123821|NCT03192150|54784903|FG000|Overall Study|Withdrawal by Subject|4|||
28123822|NCT03192150|54784904|FG001|Overall Study|Withdrawal by Subject|2|||
28123823|NCT03192150|54784903|FG000|Overall Study|Protocol Violation|5|||
28123824|NCT03192150|54784904|FG001|Overall Study|Protocol Violation|2|||
28123825|NCT03192150|54784903|FG000|Overall Study|Surgery Canceled|6|||
28123826|NCT03192150|54784904|FG001|Overall Study|Surgery Canceled|2|||
28123827|NCT03192150|54784903|FG000|Overall Study|Other-Various Administrative Reasons|2|||
28123828|NCT03192150|54784904|FG001|Overall Study|Other-Various Administrative Reasons|5|||
28123829|NCT03597529|54784912|FG000|Overall Study|Lost to Follow-up|10|||
28123830|NCT03597529|54784913|FG001|Overall Study|Lost to Follow-up|12|||
28123831|NCT03597529|54784912|FG000|Overall Study|Physician Decision|3|||
28123832|NCT03597529|54784913|FG001|Overall Study|Physician Decision|1|||
28123833|NCT03597529|54784912|FG000|Overall Study|Withdrawal by Subject|6|||
28123834|NCT03597529|54784913|FG001|Overall Study|Withdrawal by Subject|3|||
28123835|NCT03597529|54784912|FG000|Overall Study|Non-compliant with study activities|1|||
28123836|NCT03597529|54784913|FG001|Overall Study|Non-compliant with study activities|2|||
28123837|NCT03180528|54784919|FG000|Overall Study|Adverse Event|1|||
28123838|NCT03180528|54784919|FG000|Overall Study|Withdrawal by Subject|1|||
28123839|NCT03180528|54784919|FG000|Overall Study|Eligible and enrolled, but withdrawn due to abnormal baseline laboratory values.|1|||
27817849|NCT04304508|54275941|FG003|Overall Study|Subject Decision: COVID-19 Pandemic Related|2|||
27817850|NCT04304508|54275938|FG000|Overall Study|Withdrawal by Subject|7|||
27817851|NCT04304508|54275939|FG001|Overall Study|Withdrawal by Subject|5|||
27817852|NCT04304508|54275940|FG002|Overall Study|Withdrawal by Subject|11|||
27817853|NCT04304508|54275941|FG003|Overall Study|Withdrawal by Subject|6|||
27817854|NCT04304508|54275938|FG000|Overall Study|Logistical Difficulties|2|||
27817855|NCT04304508|54275939|FG001|Overall Study|Logistical Difficulties|2|||
27817856|NCT04304508|54275940|FG002|Overall Study|Logistical Difficulties|3|||
27817857|NCT04304508|54275941|FG003|Overall Study|Logistical Difficulties|2|||
27817858|NCT04304508|54275938|FG000|Overall Study|Missing Information|1|||
27817859|NCT04304508|54275939|FG001|Overall Study|Missing Information|2|||
28123840|NCT03597295|54784923|FG000|Overall Study|Death|70|||
28123841|NCT03597295|54784923|FG000|Overall Study|Lost to Follow-up|7|||
28123842|NCT03180138|54784930|FG000|Overall Study|Mobile-phone could not be verified|2|||
28123843|NCT03180138|54784931|FG001|Overall Study|Mobile-phone could not be verified|13|||
28123844|NCT03180138|54784932|FG002|Overall Study|Mobile-phone could not be verified|15|||
28123845|NCT03180138|54784930|FG000|Overall Study|No prior immunization records|17|||
27817860|NCT04304508|54275940|FG002|Overall Study|Missing Information|1|||
28123846|NCT03180138|54784931|FG001|Overall Study|No prior immunization records|0|||
27940462|NCT01035255|54596737|FG001|Overall Study|Lost to Follow-up|5|||
28123847|NCT03180138|54784932|FG002|Overall Study|No prior immunization records|6|||
28123848|NCT03180138|54784930|FG000|Overall Study|Found to be >24 mon after randomization|3|||
27817861|NCT04304508|54275941|FG003|Overall Study|Missing Information|3|||
27817862|NCT04304508|54275938|FG000|Overall Study|Other|7|||
28123849|NCT03180138|54784931|FG001|Overall Study|Found to be >24 mon after randomization|0|||
28123850|NCT03180138|54784932|FG002|Overall Study|Found to be >24 mon after randomization|3|||
28123851|NCT03597139|54784942|FG000|Overall Study|Adverse Event|3|||
28123852|NCT03597139|54784943|FG001|Overall Study|Adverse Event|0|||
28123853|NCT03597139|54784942|FG000|Overall Study|Protocol Non-compliance|1|||
28123854|NCT03597139|54784943|FG001|Overall Study|Protocol Non-compliance|0|||
28123855|NCT03179202|54784949|FG000|Overall Study|Screen Failure|67|||
28123856|NCT03179202|54784949|FG000|Overall Study|Subject Lost to Follow Up|12|||
28123857|NCT03179202|54784949|FG000|Overall Study|Withdrawal by Subject|7|||
27817863|NCT04304508|54275939|FG001|Overall Study|Other|6|||
27849318|NCT02082977|54345493|FG006|Part 1 (Up to 3.2 Years)|Physician Decision|4|||
28123858|NCT03179202|54784949|FG000|Overall Study|Adverse Event|3|||
28123859|NCT03179202|54784949|FG000|Overall Study|Unrelated Death Reported in All-Cause Mortality|1|||
28123860|NCT03179202|54784949|FG000|Overall Study|Other Reason: Incarceration after Enrollment|1|||
28123861|NCT00708214|54784958|FG000|Overall Study|Other Adverse Event|3|||
28123862|NCT00708214|54784959|FG001|Overall Study|Other Adverse Event|6|||
28123863|NCT00708214|54784960|FG002|Overall Study|Other Adverse Event|2|||
28123864|NCT00708214|54784958|FG000|Overall Study|Other|0|||
28123865|NCT00708214|54784959|FG001|Overall Study|Other|1|||
28123866|NCT00708214|54784960|FG002|Overall Study|Other|1|||
28123867|NCT00708214|54784958|FG000|Overall Study|Progressive Disease|4|||
28123868|NCT00708214|54784959|FG001|Overall Study|Progressive Disease|6|||
28123869|NCT00708214|54784960|FG002|Overall Study|Progressive Disease|5|||
28123870|NCT03570697|54784975|FG000|Overall Study|Lost to Follow-up|0|||
28123871|NCT03570697|54784976|FG001|Overall Study|Lost to Follow-up|1|||
28123872|NCT03570697|54784975|FG000|Overall Study|Death|2|||
28123873|NCT03570697|54784976|FG001|Overall Study|Death|0|||
28123874|NCT03570697|54784975|FG000|Overall Study|Withdrawal by Subject|4|||
28123875|NCT03570697|54784976|FG001|Overall Study|Withdrawal by Subject|2|||
28123876|NCT03569371|54784993|FG000|Overall Study|Lack of Efficacy|1|||
28123877|NCT03569371|54784993|FG000|Overall Study|Lost to Follow-up|1|||
28123878|NCT03569371|54784993|FG000|Overall Study|Adverse Event|1|||
28123879|NCT01318070|54785000|FG000|Overall Study|Adverse Event|1|||
28123880|NCT01318070|54785001|FG001|Overall Study|Adverse Event|1|||
28123881|NCT01318070|54785002|FG002|Overall Study|Adverse Event|5|||
28123882|NCT01318070|54785000|FG000|Overall Study|Withdrawal by Subject|0|||
28123883|NCT01318070|54785001|FG001|Overall Study|Withdrawal by Subject|1|||
28123884|NCT01318070|54785002|FG002|Overall Study|Withdrawal by Subject|1|||
28123885|NCT01318070|54785000|FG000|Overall Study|Lack of Efficacy|0|||
28123886|NCT01318070|54785001|FG001|Overall Study|Lack of Efficacy|0|||
28123887|NCT01318070|54785002|FG002|Overall Study|Lack of Efficacy|1|||
28123888|NCT01318070|54785000|FG000|Overall Study|Principal Investigator Discretion|1|||
28123889|NCT01318070|54785001|FG001|Overall Study|Principal Investigator Discretion|0|||
28123890|NCT01318070|54785002|FG002|Overall Study|Principal Investigator Discretion|0|||
28123891|NCT02895295|54785013|FG000|Overall Study|Survey Non-response|71|||
28123892|NCT02895295|54785014|FG001|Overall Study|Survey Non-response|94|||
28123893|NCT02895295|54785015|FG002|Overall Study|Survey Non-response|92|||
28123894|NCT00245960|54785025|FG000|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|6|||
28123895|NCT00245960|54785026|FG001|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|7|||
28123896|NCT00245960|54785025|FG000|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|0|||
28123897|NCT00245960|54785026|FG001|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|1|||
28123898|NCT00245960|54785025|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|2|||
28123899|NCT00245960|54785026|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|0|||
28123900|NCT00245960|54785025|FG000|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|2|||
28123901|NCT00245960|54785026|FG001|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|1|||
28123902|NCT00245960|54785025|FG000|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|3|||
28123903|NCT00245960|54785026|FG001|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|0|||
28123904|NCT00245960|54785025|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
28123905|NCT00245960|54785026|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
28123906|NCT00245960|54785025|FG000|Period 2 (Open Label): 13-24 Weeks|Adverse Event|8|||
28123907|NCT00245960|54785026|FG001|Period 2 (Open Label): 13-24 Weeks|Adverse Event|4|||
28123908|NCT00245960|54785025|FG000|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
28123909|NCT00245960|54785026|FG001|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
28123910|NCT00245960|54785025|FG000|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|2|||
28123911|NCT00245960|54785026|FG001|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|5|||
28123912|NCT00245960|54785025|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|1|||
28123913|NCT00245960|54785026|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|3|||
28123914|NCT00245960|54785025|FG000|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|1|||
28123915|NCT00245960|54785026|FG001|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|3|||
28123916|NCT00245960|54785025|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|0|||
28123917|NCT00245960|54785026|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|1|||
28123918|NCT02729194|54785032|FG000|Overall Study|Withdrawal by Subject|3|||
28123919|NCT03178266|54785038|FG000|Overall Study|Death|0|||
28123920|NCT03178266|54785039|FG001|Overall Study|Death|1|||
28123921|NCT03178266|54785038|FG000|Overall Study|Disont. Early|0|||
28123922|NCT03178266|54785039|FG001|Overall Study|Disont. Early|1|||
28123923|NCT03178266|54785038|FG000|Overall Study|Withdrawal by Subject|0|||
28123924|NCT03178266|54785039|FG001|Overall Study|Withdrawal by Subject|2|||
28123925|NCT03548935|54785047|FG000|Overall Study|Withdrawal by Subject|26|||
28123926|NCT03548935|54785048|FG001|Overall Study|Withdrawal by Subject|17|||
27817864|NCT04304508|54275940|FG002|Overall Study|Other|5|||
27817865|NCT04304508|54275941|FG003|Overall Study|Other|4|||
27817866|NCT04304508|54275938|FG000|Overall Study|Physician Decision: COVID-19 Pandemic Related|1|||
27817867|NCT04304508|54275939|FG001|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
27817868|NCT04304508|54275940|FG002|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
27817869|NCT04304508|54275941|FG003|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
27817870|NCT04304508|54275938|FG000|Overall Study|Physician Decision|3|||
27817871|NCT04304508|54275939|FG001|Overall Study|Physician Decision|4|||
27817872|NCT04304508|54275940|FG002|Overall Study|Physician Decision|9|||
27817873|NCT04304508|54275941|FG003|Overall Study|Physician Decision|7|||
27817874|NCT04304508|54275938|FG000|Overall Study|Study drug never administered|10|||
27817875|NCT04304508|54275939|FG001|Overall Study|Study drug never administered|4|||
27817876|NCT04304508|54275940|FG002|Overall Study|Study drug never administered|4|||
27817877|NCT04304508|54275941|FG003|Overall Study|Study drug never administered|4|||
27817878|NCT04304508|54275938|FG000|Overall Study|Adverse Event|49|||
27817879|NCT04304508|54275939|FG001|Overall Study|Adverse Event|50|||
27817880|NCT04304508|54275940|FG002|Overall Study|Adverse Event|51|||
27940463|NCT01035255|54596736|FG000|Overall Study|patient's request|15|||
28066887|NCT00464945|54722517|FG001|Infant Series|Withdrawal by parent/guardian request|1|||
28066888|NCT00464945|54722516|FG000|Infant Series|Protocol Violation|1|||
28066889|NCT00464945|54722517|FG001|Infant Series|Protocol Violation|0|||
28066890|NCT00464945|54722516|FG000|Infant Series|Lost to Follow-up|1|||
28066891|NCT00464945|54722517|FG001|Infant Series|Lost to Follow-up|0|||
28066892|NCT00464945|54722516|FG000|After Infant Series|Withdrawal by Subject|0|||
28066893|NCT00464945|54722517|FG001|After Infant Series|Withdrawal by Subject|2|||
28066894|NCT00464945|54722516|FG000|Toddler Dose|Lost to Follow-up|0|||
28066895|NCT00464945|54722517|FG001|Toddler Dose|Lost to Follow-up|1|||
28066896|NCT00464087|54722542|FG000|Overall Study|No PCI per inclusion criteria|0|||
28066897|NCT00464087|54722543|FG001|Overall Study|No PCI per inclusion criteria|0|||
28066898|NCT00464087|54722544|FG002|Overall Study|No PCI per inclusion criteria|29|||
28066899|NCT00452699|54722554|FG000|Overall Study|Adverse Event|10|||
28066900|NCT00452699|54722555|FG001|Overall Study|Adverse Event|3|||
28066901|NCT00452699|54722554|FG000|Overall Study|Lack of Efficacy|6|||
28066902|NCT00452699|54722555|FG001|Overall Study|Lack of Efficacy|4|||
28066903|NCT00452699|54722554|FG000|Overall Study|Lost to Follow-up|6|||
28066904|NCT00452699|54722555|FG001|Overall Study|Lost to Follow-up|9|||
28066905|NCT00452699|54722554|FG000|Overall Study|Protocol Violation|21|||
28066906|NCT00452699|54722555|FG001|Overall Study|Protocol Violation|25|||
28066907|NCT00452699|54722554|FG000|Overall Study|Withdrawal by Subject|26|||
28066908|NCT00452699|54722555|FG001|Overall Study|Withdrawal by Subject|25|||
28066909|NCT00452699|54722554|FG000|Overall Study|Other|12|||
27817881|NCT04304508|54275941|FG003|Overall Study|Adverse Event|56|||
28066910|NCT00452699|54722555|FG001|Overall Study|Other|7|||
28066911|NCT00069784|54722563|FG000|Overall Study|Adverse Event|105|||
28066912|NCT00069784|54722564|FG001|Overall Study|Adverse Event|0|||
28123927|NCT03548935|54785047|FG000|Overall Study|Lost to Follow-up|39|||
28123928|NCT03548935|54785048|FG001|Overall Study|Lost to Follow-up|28|||
28066913|NCT00069784|54722563|FG000|Overall Study|Withdrawal by Subject|1090|||
28066914|NCT00069784|54722564|FG001|Overall Study|Withdrawal by Subject|0|||
28066915|NCT00069784|54722563|FG000|Overall Study|Other|17|||
28123929|NCT03548935|54785047|FG000|Overall Study|Death|1|||
28123930|NCT03548935|54785048|FG001|Overall Study|Death|1|||
28123931|NCT03547687|54785054|FG000|Overall Study|Withdrawal by Subject|1|||
28123932|NCT03547687|54785054|FG000|Overall Study|Death|1|||
28123933|NCT03547531|54785060|FG000|Overall Study|not coming in data collection : sick|2|||
28123934|NCT03547531|54785061|FG001|Overall Study|not coming in data collection : sick|2|||
28123935|NCT03547531|54785060|FG000|Overall Study|having family occasion|0|||
28123936|NCT03547531|54785061|FG001|Overall Study|having family occasion|2|||
28123937|NCT03566485|54785069|FG000|Overall Study|Disease progression|5|||
28123938|NCT03566485|54785070|FG001|Overall Study|Disease progression|4|||
28123939|NCT03566485|54785069|FG000|Overall Study|Clinical progression|0|||
28123940|NCT03566485|54785070|FG001|Overall Study|Clinical progression|1|||
28123941|NCT03566485|54785069|FG000|Overall Study|Toxicity|0|||
28123942|NCT03566485|54785070|FG001|Overall Study|Toxicity|2|||
28123943|NCT03176238|54785078|FG000|Overall Study|Unacceptable AEs|15|||
28123944|NCT03176238|54785079|FG001|Overall Study|Unacceptable AEs|8|||
28123945|NCT03176238|54785078|FG000|Overall Study|Abnormal lab value(s)|2|||
28123946|NCT03176238|54785079|FG001|Overall Study|Abnormal lab value(s)|0|||
28123947|NCT03176238|54785078|FG000|Overall Study|Inter-current illness|0|||
28123948|NCT03176238|54785079|FG001|Overall Study|Inter-current illness|1|||
28123949|NCT03176238|54785078|FG000|Overall Study|Consent withdrawal|14|||
28123950|NCT03176238|54785079|FG001|Overall Study|Consent withdrawal|2|||
28123951|NCT03176238|54785078|FG000|Overall Study|Lost to Follow-up|3|||
28123952|NCT03176238|54785079|FG001|Overall Study|Lost to Follow-up|0|||
28123953|NCT03176238|54785078|FG000|Overall Study|Administrative problems|1|||
28123954|NCT03176238|54785079|FG001|Overall Study|Administrative problems|0|||
28123955|NCT03176238|54785078|FG000|Overall Study|Death|3|||
28123956|NCT03176238|54785079|FG001|Overall Study|Death|0|||
28123957|NCT03176238|54785078|FG000|Overall Study|Disease Progression|133|||
28123958|NCT03176238|54785079|FG001|Overall Study|Disease Progression|22|||
28123959|NCT03176238|54785078|FG000|Overall Study|Tx duration completed per EAP|0|||
28123960|NCT03176238|54785079|FG001|Overall Study|Tx duration completed per EAP|1|||
28123961|NCT03176238|54785078|FG000|Overall Study|Patient is switched to commercial drug|16|||
28123962|NCT03176238|54785079|FG001|Overall Study|Patient is switched to commercial drug|1|||
28123963|NCT03176238|54785078|FG000|Overall Study|Protocol Violation|1|||
28123964|NCT03176238|54785079|FG001|Overall Study|Protocol Violation|0|||
28123965|NCT03176238|54785078|FG000|Overall Study|Changes in the patient's condition|2|||
28123966|NCT03176238|54785079|FG001|Overall Study|Changes in the patient's condition|1|||
28123967|NCT03176238|54785078|FG000|Overall Study|Everolimus dose interrupt > 4 wks|9|||
28123968|NCT03176238|54785079|FG001|Overall Study|Everolimus dose interrupt > 4 wks|0|||
27849319|NCT02082977|54345494|FG007|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
28066916|NCT00069784|54722564|FG001|Overall Study|Other|0|||
28066917|NCT03811834|54722570|FG000|Period 1 ( 7 Days)|Adverse Event|1|||
28066918|NCT00090610|54722585|FG000|Overall Study|Withdrawal by Subject|1|||
28066919|NCT00090610|54722586|FG001|Overall Study|Withdrawal by Subject|1|||
28066920|NCT00463385|54722596|FG000|Overall Study|Other|4|||
28066921|NCT00463385|54722597|FG001|Overall Study|Other|3|||
28066922|NCT00463385|54722598|FG002|Overall Study|Other|6|||
28066923|NCT00463385|54722599|FG003|Overall Study|Other|4|||
28066924|NCT00463385|54722596|FG000|Overall Study|Adverse Event|5|||
28066925|NCT00463385|54722597|FG001|Overall Study|Adverse Event|8|||
28066926|NCT00463385|54722598|FG002|Overall Study|Adverse Event|4|||
28066927|NCT00463385|54722599|FG003|Overall Study|Adverse Event|2|||
28066928|NCT00463385|54722596|FG000|Overall Study|Lack of Efficacy|6|||
28066929|NCT00463385|54722597|FG001|Overall Study|Lack of Efficacy|6|||
28066930|NCT00463385|54722598|FG002|Overall Study|Lack of Efficacy|7|||
28066931|NCT00463385|54722599|FG003|Overall Study|Lack of Efficacy|9|||
28066932|NCT00463385|54722596|FG000|Overall Study|Withdrawal by Subject|3|||
28066933|NCT00463385|54722597|FG001|Overall Study|Withdrawal by Subject|3|||
28066934|NCT00463385|54722598|FG002|Overall Study|Withdrawal by Subject|3|||
28066935|NCT00463385|54722599|FG003|Overall Study|Withdrawal by Subject|4|||
28066936|NCT00463385|54722596|FG000|Overall Study|Lost to Follow-up|0|||
28066937|NCT00463385|54722597|FG001|Overall Study|Lost to Follow-up|0|||
27849320|NCT02082977|54345495|FG008|Part 1 (Up to 3.2 Years)|Physician Decision|2|||
27849321|NCT02082977|54345496|FG009|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
28066938|NCT00463385|54722598|FG002|Overall Study|Lost to Follow-up|0|||
28066939|NCT00463385|54722599|FG003|Overall Study|Lost to Follow-up|1|||
28066940|NCT00463385|54722596|FG000|Overall Study|Death|2|||
28066941|NCT00463385|54722597|FG001|Overall Study|Death|1|||
28066942|NCT00463385|54722598|FG002|Overall Study|Death|2|||
28123969|NCT03565315|54785093|FG000|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
28123970|NCT03565315|54785094|FG001|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
28123971|NCT03565315|54785095|FG002|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
28123972|NCT03565315|54785096|FG003|Overall Study|IND Sponsor/PI Voluntary Study Pause|1|||
28123973|NCT03565237|54785119|FG000|Overall Study|Non-compliance of Investigational Product|1|||
27817882|NCT04304508|54275938|FG000|Overall Study|Lost to Follow-up|1|||
28066943|NCT00463385|54722599|FG003|Overall Study|Death|0|||
28066944|NCT00463385|54722596|FG000|Overall Study|Missing|2|||
28123974|NCT03565237|54785119|FG000|Overall Study|Physician Decision|1|||
28123975|NCT01345682|54785125|FG000|Overall Study|Progressive disease per RECIST|226|||
28123976|NCT01345682|54785126|FG001|Overall Study|Progressive disease per RECIST|93|||
28123977|NCT01345682|54785125|FG000|Overall Study|Worsening of underlying cancer disease|23|||
28123978|NCT01345682|54785126|FG001|Overall Study|Worsening of underlying cancer disease|12|||
28123979|NCT01345682|54785125|FG000|Overall Study|Adverse Event|51|||
28123980|NCT01345682|54785126|FG001|Overall Study|Adverse Event|41|||
28123981|NCT01345682|54785125|FG000|Overall Study|Non-compliance with protocol|0|||
28123982|NCT01345682|54785126|FG001|Overall Study|Non-compliance with protocol|1|||
28123983|NCT01345682|54785125|FG000|Overall Study|Lost to Follow-up|0|||
28123984|NCT01345682|54785126|FG001|Overall Study|Lost to Follow-up|1|||
28123985|NCT01345682|54785125|FG000|Overall Study|Refused to continue trial medication|16|||
28123986|NCT01345682|54785126|FG001|Overall Study|Refused to continue trial medication|9|||
28123987|NCT01345682|54785125|FG000|Overall Study|Not treated|2|||
28123988|NCT01345682|54785126|FG001|Overall Study|Not treated|1|||
28123989|NCT01345682|54785125|FG000|Overall Study|Reason other than those specified above|4|||
27817883|NCT04304508|54275939|FG001|Overall Study|Lost to Follow-up|5|||
27817884|NCT04304508|54275940|FG002|Overall Study|Lost to Follow-up|2|||
27817885|NCT04304508|54275941|FG003|Overall Study|Lost to Follow-up|3|||
27817886|NCT04206332|54275970|FG000|Part A|Lost to Follow-up|0|||
27817887|NCT04206332|54275971|FG001|Part A|Lost to Follow-up|1|||
27817888|NCT04206332|54275972|FG002|Part A|Lost to Follow-up|0|||
27817889|NCT04206332|54275973|FG003|Part A|Lost to Follow-up|0|||
27817890|NCT04206332|54275974|FG004|Part A|Lost to Follow-up|0|||
27817891|NCT04206332|54275975|FG005|Part A|Lost to Follow-up|0|||
27940464|NCT01035255|54596737|FG001|Overall Study|patient's request|13|||
28066945|NCT00463385|54722597|FG001|Overall Study|Missing|0|||
28066946|NCT00463385|54722598|FG002|Overall Study|Missing|0|||
28066947|NCT00463385|54722599|FG003|Overall Study|Missing|2|||
28066948|NCT00463385|54722596|FG000|Overall Study|1 participant received commercial drug|0|||
28066949|NCT00463385|54722597|FG001|Overall Study|1 participant received commercial drug|1|||
28066950|NCT00463385|54722598|FG002|Overall Study|1 participant received commercial drug|0|||
28066951|NCT00463385|54722599|FG003|Overall Study|1 participant received commercial drug|0|||
28066952|NCT00463229|54722619|FG000|Overall Study|Lost to Follow-up|5|||
28066953|NCT00463229|54722620|FG001|Overall Study|Lost to Follow-up|7|||
28066954|NCT00463229|54722619|FG000|Overall Study|Death|4|||
28066955|NCT00463229|54722620|FG001|Overall Study|Death|3|||
28066956|NCT03839693|54722630|FG000|Overall Study|Lost to Follow-up|0|||
28066957|NCT03839693|54722631|FG001|Overall Study|Lost to Follow-up|2|||
28066958|NCT03839693|54722632|FG002|Overall Study|Lost to Follow-up|2|||
28066959|NCT03839693|54722630|FG000|Overall Study|Withdrawal by Subject|1|||
28123990|NCT01345682|54785126|FG001|Overall Study|Reason other than those specified above|3|||
28123991|NCT03562117|54785135|FG000|Part 1, Up to 3 Days|Adverse Event|1|||
28123992|NCT03562117|54785136|FG001|Part 1, Up to 3 Days|Adverse Event|0|||
28123993|NCT03562117|54785137|FG002|Part 1, Up to 3 Days|Adverse Event|0|||
28123994|NCT03561883|54785147|FG000|Overall Study|Adverse Event|10|||
28123995|NCT03561883|54785148|FG001|Overall Study|Adverse Event|13|||
28123996|NCT03561883|54785147|FG000|Overall Study|Non-Compliance With Study Drug|1|||
28123997|NCT03561883|54785148|FG001|Overall Study|Non-Compliance With Study Drug|2|||
28123998|NCT03561883|54785147|FG000|Overall Study|Protocol Violation|2|||
28123999|NCT03561883|54785148|FG001|Overall Study|Protocol Violation|3|||
27817892|NCT04206332|54275976|FG006|Part A|Lost to Follow-up|0|||
27940465|NCT01190124|54596746|FG000|Overall Study|Death|3|||
27940466|NCT01190124|54596747|FG001|Overall Study|Death|0|||
27940467|NCT01190124|54596748|FG002|Overall Study|Death|0|||
27940468|NCT01190124|54596746|FG000|Overall Study|Therapeutic Failure|12|||
27940469|NCT01190124|54596747|FG001|Overall Study|Therapeutic Failure|0|||
27940470|NCT01190124|54596748|FG002|Overall Study|Therapeutic Failure|1|||
27940471|NCT01190124|54596746|FG000|Overall Study|Lost to Follow-up|2|||
27940472|NCT01190124|54596747|FG001|Overall Study|Lost to Follow-up|0|||
27940473|NCT01190124|54596748|FG002|Overall Study|Lost to Follow-up|0|||
27940474|NCT01189890|54596761|FG000|Overall Study|Adverse Event|3|||
27940475|NCT01189890|54596762|FG001|Overall Study|Adverse Event|4|||
27940476|NCT01189890|54596761|FG000|Overall Study|Lack of Efficacy|7|||
28066960|NCT03839693|54722631|FG001|Overall Study|Withdrawal by Subject|0|||
28066961|NCT03839693|54722632|FG002|Overall Study|Withdrawal by Subject|2|||
28124000|NCT03561883|54785147|FG000|Overall Study|Withdrawal by Subject|14|||
28124001|NCT03561883|54785148|FG001|Overall Study|Withdrawal by Subject|6|||
28124002|NCT03561883|54785147|FG000|Overall Study|Lost to Follow-up|2|||
28124003|NCT03561883|54785148|FG001|Overall Study|Lost to Follow-up|6|||
28124004|NCT03561883|54785147|FG000|Overall Study|Study Terminated by Sponsor|12|||
28124005|NCT03561883|54785148|FG001|Overall Study|Study Terminated by Sponsor|11|||
28124006|NCT03561883|54785147|FG000|Overall Study|Physician Decision|1|||
28124007|NCT03561883|54785148|FG001|Overall Study|Physician Decision|0|||
28124008|NCT03561883|54785147|FG000|Overall Study|Randomized by Mistake|1|||
28124009|NCT03561883|54785148|FG001|Overall Study|Randomized by Mistake|0|||
28124010|NCT03561883|54785147|FG000|Overall Study|Other, Not Specified|3|||
28124011|NCT03561883|54785148|FG001|Overall Study|Other, Not Specified|2|||
28124012|NCT03546907|54785156|FG000|Overall Study|Lack of Efficacy|1|||
28124013|NCT03546907|54785157|FG001|Overall Study|Lack of Efficacy|1|||
28124014|NCT03546907|54785156|FG000|Overall Study|Withdrawal by Subject|8|||
28124015|NCT03546907|54785157|FG001|Overall Study|Withdrawal by Subject|9|||
28124016|NCT03546907|54785156|FG000|Overall Study|Adverse events (AEs)|7|||
28124017|NCT03546907|54785157|FG001|Overall Study|Adverse events (AEs)|10|||
28124018|NCT03546907|54785156|FG000|Overall Study|Other-unspecified|1|||
28124019|NCT03546907|54785157|FG001|Overall Study|Other-unspecified|1|||
28124020|NCT01318382|54785163|FG000|Overall Study|Physician Decision|2|||
28124021|NCT01318382|54785163|FG000|Overall Study|Device Malfunction|10|||
28124022|NCT01318382|54785163|FG000|Overall Study|Protocol Violation|1|||
28124023|NCT03053180|54785181|FG000|Overall Study|Failure to Return|1|||
28124024|NCT03560869|54785185|FG000|Overall Study|Withdrawal by Subject|3|||
28124025|NCT03560869|54785186|FG001|Overall Study|Withdrawal by Subject|4|||
28124026|NCT03560869|54785185|FG000|Overall Study|Screening failure|4|||
28124027|NCT03560869|54785186|FG001|Overall Study|Screening failure|4|||
28124028|NCT03560869|54785185|FG000|Overall Study|Withdrawal by PI|0|||
28124029|NCT03560869|54785186|FG001|Overall Study|Withdrawal by PI|1|||
27817893|NCT04206332|54275977|FG007|Part A|Lost to Follow-up|0|||
28066962|NCT03839693|54722630|FG000|Overall Study|subject moved out of the area|1|||
28066963|NCT03839693|54722631|FG001|Overall Study|subject moved out of the area|0|||
28066964|NCT03839693|54722632|FG002|Overall Study|subject moved out of the area|0|||
28066965|NCT00068692|54722645|FG000|Step 1: Registration|Disese progression/relapse|5|||
28066966|NCT00068692|54722646|FG001|Step 1: Registration|Disese progression/relapse|0|||
28066967|NCT00068692|54722647|FG002|Step 1: Registration|Disese progression/relapse|0|||
28124030|NCT03590743|54785194|FG000|Overall Study|Withdrawal by Subject|0|||
28124031|NCT03590743|54785195|FG001|Overall Study|Withdrawal by Subject|1|||
28124032|NCT03053102|54785201|FG000|Study Part 2: 84-Day Treatment|Adverse Event|1|||
28124033|NCT03053102|54785201|FG000|Study Part 2: 84-Day Treatment|Withdrawal by Subject|1|||
27817894|NCT04206332|54275978|FG008|Part A|Lost to Follow-up|0|||
27940477|NCT01189890|54596762|FG001|Overall Study|Lack of Efficacy|2|||
27940478|NCT01189890|54596761|FG000|Overall Study|Lost to Follow-up|1|||
27940479|NCT01189890|54596762|FG001|Overall Study|Lost to Follow-up|7|||
27940480|NCT01189890|54596761|FG000|Overall Study|Protocol Violation|1|||
28066968|NCT00068692|54722648|FG003|Step 1: Registration|Disese progression/relapse|0|||
28066969|NCT00068692|54722649|FG004|Step 1: Registration|Disese progression/relapse|0|||
28124034|NCT03589885|54785209|FG000|Treatment Period 1-Randomized Set|Adverse Event|0|||
28124035|NCT03589885|54785210|FG001|Treatment Period 1-Randomized Set|Adverse Event|1|||
28124036|NCT03589885|54785211|FG002|Treatment Period 1-Randomized Set|Adverse Event|0|||
28124037|NCT03589885|54785212|FG003|Treatment Period 1-Randomized Set|Adverse Event|0|||
28124038|NCT03589885|54785213|FG004|Treatment Period 1-Randomized Set|Adverse Event|0|||
28124039|NCT03589885|54785209|FG000|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
28124040|NCT03589885|54785210|FG001|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
28124041|NCT03589885|54785211|FG002|Treatment Period 1-Randomized Set|Lack of Efficacy|2|||
28124042|NCT03589885|54785212|FG003|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
28124043|NCT03589885|54785213|FG004|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
28124044|NCT03589885|54785209|FG000|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
28124045|NCT03589885|54785210|FG001|Treatment Period 1-Randomized Set|Lost to Follow-up|1|||
28124046|NCT03589885|54785211|FG002|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
28124047|NCT03589885|54785212|FG003|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
28124048|NCT03589885|54785213|FG004|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
28124049|NCT03589885|54785209|FG000|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
28124050|NCT03589885|54785210|FG001|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
28124051|NCT03589885|54785211|FG002|Treatment Period 1-Randomized Set|Withdrawal by Subject|1|||
28124052|NCT03589885|54785212|FG003|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
28124053|NCT03589885|54785213|FG004|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
28124054|NCT03589885|54785209|FG000|Treatment Period 2-Randomized Set|Adverse Event|0|||
28124055|NCT03589885|54785210|FG001|Treatment Period 2-Randomized Set|Adverse Event|1|||
28124056|NCT03589885|54785211|FG002|Treatment Period 2-Randomized Set|Adverse Event|0|||
28124057|NCT03589885|54785212|FG003|Treatment Period 2-Randomized Set|Adverse Event|0|||
28124058|NCT03589885|54785213|FG004|Treatment Period 2-Randomized Set|Adverse Event|0|||
28124059|NCT03589885|54785209|FG000|Treatment Period 2-Randomized Set|Pregnancy|1|||
28124060|NCT03589885|54785210|FG001|Treatment Period 2-Randomized Set|Pregnancy|0|||
28124061|NCT03589885|54785211|FG002|Treatment Period 2-Randomized Set|Pregnancy|0|||
28124062|NCT03589885|54785212|FG003|Treatment Period 2-Randomized Set|Pregnancy|0|||
28124063|NCT03589885|54785213|FG004|Treatment Period 2-Randomized Set|Pregnancy|0|||
28124064|NCT03589885|54785209|FG000|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
27940481|NCT01189890|54596762|FG001|Overall Study|Protocol Violation|5|||
27940482|NCT01189890|54596761|FG000|Overall Study|Withdrawal by Subject|15|||
27940483|NCT01189890|54596762|FG001|Overall Study|Withdrawal by Subject|11|||
27940484|NCT01189890|54596761|FG000|Overall Study|Non Compliance|0|||
27940485|NCT01189890|54596762|FG001|Overall Study|Non Compliance|1|||
28066970|NCT00068692|54722650|FG005|Step 1: Registration|Disese progression/relapse|0|||
28066971|NCT00068692|54722651|FG006|Step 1: Registration|Disese progression/relapse|0|||
28066972|NCT00068692|54722652|FG007|Step 1: Registration|Disese progression/relapse|0|||
28066973|NCT00068692|54722645|FG000|Step 1: Registration|Adverse Event|7|||
28066974|NCT00068692|54722646|FG001|Step 1: Registration|Adverse Event|0|||
28066975|NCT00068692|54722647|FG002|Step 1: Registration|Adverse Event|0|||
28066976|NCT00068692|54722648|FG003|Step 1: Registration|Adverse Event|0|||
28066977|NCT00068692|54722649|FG004|Step 1: Registration|Adverse Event|0|||
28124065|NCT03589885|54785210|FG001|Treatment Period 2-Randomized Set|Lost to Follow-up|3|||
28124066|NCT03589885|54785211|FG002|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
28124067|NCT03589885|54785212|FG003|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
28124068|NCT03589885|54785213|FG004|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
28124069|NCT03589885|54785209|FG000|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
28124070|NCT03589885|54785210|FG001|Treatment Period 2-Randomized Set|Withdrawal by Subject|1|||
28124071|NCT03589885|54785211|FG002|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
28124072|NCT03589885|54785212|FG003|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
28124073|NCT03589885|54785213|FG004|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
28124074|NCT03545503|54785233|FG000|Overall Study|Protocol Violation|14|||
28124075|NCT03545503|54785234|FG001|Overall Study|Protocol Violation|16|||
28124076|NCT03545113|54785242|FG000|Overall Study|Surgery Cancelled|1|||
28124077|NCT03545113|54785243|FG001|Overall Study|Surgery Cancelled|0|||
28124078|NCT03545113|54785242|FG000|Overall Study|Death|1|||
28124079|NCT03545113|54785243|FG001|Overall Study|Death|0|||
28124080|NCT03545113|54785242|FG000|Overall Study|Adverse Event|2|||
28124081|NCT03545113|54785243|FG001|Overall Study|Adverse Event|0|||
28124082|NCT03545113|54785242|FG000|Overall Study|Received different surgery|1|||
28124083|NCT03545113|54785243|FG001|Overall Study|Received different surgery|0|||
28124084|NCT03214380|54785255|FG000|Lead-in|Adverse Event|3|||
28124085|NCT03214380|54785256|FG001|Lead-in|Adverse Event|0|||
28066978|NCT00068692|54722650|FG005|Step 1: Registration|Adverse Event|0|||
28066979|NCT00068692|54722651|FG006|Step 1: Registration|Adverse Event|0|||
28066980|NCT00068692|54722652|FG007|Step 1: Registration|Adverse Event|0|||
28066981|NCT00068692|54722645|FG000|Step 1: Registration|Death|1|||
28066982|NCT00068692|54722646|FG001|Step 1: Registration|Death|0|||
28066983|NCT00068692|54722647|FG002|Step 1: Registration|Death|0|||
28066984|NCT00068692|54722648|FG003|Step 1: Registration|Death|0|||
28066985|NCT00068692|54722649|FG004|Step 1: Registration|Death|0|||
28066986|NCT00068692|54722650|FG005|Step 1: Registration|Death|0|||
28066987|NCT00068692|54722651|FG006|Step 1: Registration|Death|0|||
28066988|NCT00068692|54722652|FG007|Step 1: Registration|Death|0|||
28066989|NCT00068692|54722645|FG000|Step 1: Registration|Withdrawal by Subject|11|||
28066990|NCT00068692|54722646|FG001|Step 1: Registration|Withdrawal by Subject|0|||
28066991|NCT00068692|54722647|FG002|Step 1: Registration|Withdrawal by Subject|0|||
28124086|NCT03214380|54785257|FG002|Lead-in|Adverse Event|0|||
28124087|NCT03214380|54785258|FG003|Lead-in|Adverse Event|1|||
28124088|NCT03214380|54785259|FG004|Lead-in|Adverse Event|0|||
28124089|NCT03214380|54785260|FG005|Lead-in|Adverse Event|0|||
28124090|NCT03214380|54785255|FG000|Lead-in|Lost to Follow-up|4|||
28124091|NCT03214380|54785256|FG001|Lead-in|Lost to Follow-up|0|||
28066992|NCT00068692|54722648|FG003|Step 1: Registration|Withdrawal by Subject|0|||
28124092|NCT03214380|54785257|FG002|Lead-in|Lost to Follow-up|0|||
28124093|NCT03214380|54785258|FG003|Lead-in|Lost to Follow-up|1|||
28124094|NCT03214380|54785259|FG004|Lead-in|Lost to Follow-up|0|||
28124095|NCT03214380|54785260|FG005|Lead-in|Lost to Follow-up|0|||
28124096|NCT03214380|54785255|FG000|Lead-in|Eligibility Criteria|3|||
28124097|NCT03214380|54785256|FG001|Lead-in|Eligibility Criteria|0|||
28124098|NCT03214380|54785257|FG002|Lead-in|Eligibility Criteria|0|||
28124099|NCT03214380|54785258|FG003|Lead-in|Eligibility Criteria|0|||
27817895|NCT04206332|54275979|FG009|Part A|Lost to Follow-up|0|||
27817896|NCT04206332|54275980|FG010|Part A|Lost to Follow-up|0|||
27817897|NCT04206332|54275981|FG011|Part A|Lost to Follow-up|0|||
27817898|NCT04206332|54275982|FG012|Part A|Lost to Follow-up|0|||
28066993|NCT00068692|54722649|FG004|Step 1: Registration|Withdrawal by Subject|0|||
28124100|NCT03214380|54785259|FG004|Lead-in|Eligibility Criteria|0|||
28124101|NCT03214380|54785260|FG005|Lead-in|Eligibility Criteria|0|||
28124102|NCT03214380|54785255|FG000|Lead-in|Physician Decision|6|||
28124103|NCT03214380|54785256|FG001|Lead-in|Physician Decision|0|||
28124104|NCT03214380|54785257|FG002|Lead-in|Physician Decision|0|||
28124105|NCT03214380|54785258|FG003|Lead-in|Physician Decision|0|||
28124106|NCT03214380|54785259|FG004|Lead-in|Physician Decision|0|||
28124107|NCT03214380|54785260|FG005|Lead-in|Physician Decision|0|||
28124108|NCT03214380|54785255|FG000|Lead-in|Protocol Deviation|7|||
28124109|NCT03214380|54785256|FG001|Lead-in|Protocol Deviation|0|||
28124110|NCT03214380|54785257|FG002|Lead-in|Protocol Deviation|0|||
27817899|NCT04206332|54275983|FG013|Part A|Lost to Follow-up|0|||
27817900|NCT04206332|54275984|FG014|Part A|Lost to Follow-up|0|||
27817901|NCT04206332|54275985|FG015|Part A|Lost to Follow-up|0|||
27817902|NCT04206332|54275986|FG016|Part A|Lost to Follow-up|0|||
28124111|NCT03214380|54785258|FG003|Lead-in|Protocol Deviation|3|||
28124112|NCT03214380|54785259|FG004|Lead-in|Protocol Deviation|0|||
28124113|NCT03214380|54785260|FG005|Lead-in|Protocol Deviation|0|||
28124114|NCT03214380|54785255|FG000|Lead-in|Withdrawal by Subject|41|||
28124115|NCT03214380|54785256|FG001|Lead-in|Withdrawal by Subject|0|||
28124116|NCT03214380|54785257|FG002|Lead-in|Withdrawal by Subject|0|||
28124117|NCT03214380|54785258|FG003|Lead-in|Withdrawal by Subject|14|||
28124118|NCT03214380|54785259|FG004|Lead-in|Withdrawal by Subject|0|||
28124119|NCT03214380|54785260|FG005|Lead-in|Withdrawal by Subject|0|||
28124120|NCT03214380|54785255|FG000|Lead-in|Family Emergency|1|||
28124121|NCT03214380|54785256|FG001|Lead-in|Family Emergency|0|||
28124122|NCT03214380|54785257|FG002|Lead-in|Family Emergency|0|||
28124123|NCT03214380|54785258|FG003|Lead-in|Family Emergency|0|||
28124124|NCT03214380|54785259|FG004|Lead-in|Family Emergency|0|||
28124125|NCT03214380|54785260|FG005|Lead-in|Family Emergency|0|||
28124126|NCT03214380|54785255|FG000|Lead-in|Natural Disaster|9|||
28124127|NCT03214380|54785256|FG001|Lead-in|Natural Disaster|0|||
28124128|NCT03214380|54785257|FG002|Lead-in|Natural Disaster|0|||
28124129|NCT03214380|54785258|FG003|Lead-in|Natural Disaster|0|||
28124130|NCT03214380|54785259|FG004|Lead-in|Natural Disaster|0|||
28124131|NCT03214380|54785260|FG005|Lead-in|Natural Disaster|0|||
28124132|NCT03214380|54785255|FG000|Lead-in|Non Compliance|1|||
28124133|NCT03214380|54785256|FG001|Lead-in|Non Compliance|0|||
28124134|NCT03214380|54785257|FG002|Lead-in|Non Compliance|0|||
28124135|NCT03214380|54785258|FG003|Lead-in|Non Compliance|0|||
28124136|NCT03214380|54785259|FG004|Lead-in|Non Compliance|0|||
28124137|NCT03214380|54785260|FG005|Lead-in|Non Compliance|0|||
28124138|NCT03214380|54785255|FG000|Lead-in|Participant Schedule|2|||
27817903|NCT04206332|54275970|FG000|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
27817904|NCT04206332|54275971|FG001|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
27817905|NCT04206332|54275972|FG002|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
27817906|NCT04206332|54275973|FG003|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
27817907|NCT04206332|54275974|FG004|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
28124139|NCT03214380|54785256|FG001|Lead-in|Participant Schedule|0|||
28124140|NCT03214380|54785257|FG002|Lead-in|Participant Schedule|0|||
27817908|NCT04206332|54275975|FG005|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|8|||
27817909|NCT04206332|54275976|FG006|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
27817910|NCT04206332|54275977|FG007|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
27817911|NCT04206332|54275978|FG008|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
27817912|NCT04206332|54275979|FG009|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
27817913|NCT04206332|54275980|FG010|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
27817914|NCT04206332|54275981|FG011|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
27817915|NCT04206332|54275982|FG012|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
27849322|NCT02082977|54345487|FG000|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
28124141|NCT03214380|54785258|FG003|Lead-in|Participant Schedule|0|||
28124142|NCT03214380|54785259|FG004|Lead-in|Participant Schedule|0|||
28124143|NCT03214380|54785260|FG005|Lead-in|Participant Schedule|0|||
28124144|NCT03214380|54785255|FG000|Treatment Period|Adverse Event|0|||
28124145|NCT03214380|54785256|FG001|Treatment Period|Adverse Event|1|||
28124146|NCT03214380|54785257|FG002|Treatment Period|Adverse Event|1|||
28124147|NCT03214380|54785258|FG003|Treatment Period|Adverse Event|0|||
28124148|NCT03214380|54785259|FG004|Treatment Period|Adverse Event|1|||
28124149|NCT03214380|54785260|FG005|Treatment Period|Adverse Event|0|||
28124150|NCT03214380|54785255|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
28124151|NCT03214380|54785256|FG001|Treatment Period|Non-Compliance with Study Drug|0|||
27849323|NCT02082977|54345488|FG001|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
28124152|NCT03214380|54785257|FG002|Treatment Period|Non-Compliance with Study Drug|0|||
28124153|NCT03214380|54785258|FG003|Treatment Period|Non-Compliance with Study Drug|0|||
28124154|NCT03214380|54785259|FG004|Treatment Period|Non-Compliance with Study Drug|1|||
28124155|NCT03214380|54785260|FG005|Treatment Period|Non-Compliance with Study Drug|0|||
28124156|NCT03214380|54785255|FG000|Treatment Period|Withdrawal by Subject|0|||
28124157|NCT03214380|54785256|FG001|Treatment Period|Withdrawal by Subject|10|||
28124158|NCT03214380|54785257|FG002|Treatment Period|Withdrawal by Subject|8|||
28124159|NCT03214380|54785258|FG003|Treatment Period|Withdrawal by Subject|0|||
28124160|NCT03214380|54785259|FG004|Treatment Period|Withdrawal by Subject|7|||
28124161|NCT03214380|54785260|FG005|Treatment Period|Withdrawal by Subject|11|||
28124162|NCT03214380|54785255|FG000|Treatment Period|Death|0|||
28124163|NCT03214380|54785256|FG001|Treatment Period|Death|1|||
28124164|NCT03214380|54785257|FG002|Treatment Period|Death|2|||
28124165|NCT03214380|54785258|FG003|Treatment Period|Death|0|||
28124166|NCT03214380|54785259|FG004|Treatment Period|Death|0|||
28124167|NCT03214380|54785260|FG005|Treatment Period|Death|0|||
28124168|NCT03214380|54785255|FG000|Treatment Period|Lost to Follow-up|0|||
28066994|NCT00068692|54722650|FG005|Step 1: Registration|Withdrawal by Subject|0|||
28066995|NCT00068692|54722651|FG006|Step 1: Registration|Withdrawal by Subject|0|||
28066996|NCT00068692|54722652|FG007|Step 1: Registration|Withdrawal by Subject|0|||
28066997|NCT00068692|54722645|FG000|Step 1: Registration|Alternative therapy|2|||
28066998|NCT00068692|54722646|FG001|Step 1: Registration|Alternative therapy|0|||
28066999|NCT00068692|54722647|FG002|Step 1: Registration|Alternative therapy|0|||
28067000|NCT00068692|54722648|FG003|Step 1: Registration|Alternative therapy|0|||
28067001|NCT00068692|54722649|FG004|Step 1: Registration|Alternative therapy|0|||
28067002|NCT00068692|54722650|FG005|Step 1: Registration|Alternative therapy|0|||
28067003|NCT00068692|54722651|FG006|Step 1: Registration|Alternative therapy|0|||
28067004|NCT00068692|54722652|FG007|Step 1: Registration|Alternative therapy|0|||
28067005|NCT00068692|54722645|FG000|Step 1: Registration|Complicating disease|2|||
28067006|NCT00068692|54722646|FG001|Step 1: Registration|Complicating disease|0|||
28067007|NCT00068692|54722647|FG002|Step 1: Registration|Complicating disease|0|||
28067008|NCT00068692|54722648|FG003|Step 1: Registration|Complicating disease|0|||
28067009|NCT00068692|54722649|FG004|Step 1: Registration|Complicating disease|0|||
28067010|NCT00068692|54722650|FG005|Step 1: Registration|Complicating disease|0|||
28124169|NCT03214380|54785256|FG001|Treatment Period|Lost to Follow-up|6|||
28124170|NCT03214380|54785257|FG002|Treatment Period|Lost to Follow-up|3|||
28124171|NCT03214380|54785258|FG003|Treatment Period|Lost to Follow-up|0|||
28124172|NCT03214380|54785259|FG004|Treatment Period|Lost to Follow-up|0|||
28124173|NCT03214380|54785260|FG005|Treatment Period|Lost to Follow-up|0|||
28124174|NCT03214380|54785255|FG000|Treatment Period|Participant schedule|0|||
28124175|NCT03214380|54785256|FG001|Treatment Period|Participant schedule|0|||
28124176|NCT03214380|54785257|FG002|Treatment Period|Participant schedule|1|||
28124177|NCT03214380|54785258|FG003|Treatment Period|Participant schedule|0|||
28124178|NCT03214380|54785259|FG004|Treatment Period|Participant schedule|0|||
28124179|NCT03214380|54785260|FG005|Treatment Period|Participant schedule|0|||
28124180|NCT03214380|54785255|FG000|Treatment Period|Treatment Interruption|0|||
28124181|NCT03214380|54785256|FG001|Treatment Period|Treatment Interruption|0|||
28124182|NCT03214380|54785257|FG002|Treatment Period|Treatment Interruption|1|||
28124183|NCT03214380|54785258|FG003|Treatment Period|Treatment Interruption|0|||
28124184|NCT03214380|54785259|FG004|Treatment Period|Treatment Interruption|0|||
28124185|NCT03214380|54785260|FG005|Treatment Period|Treatment Interruption|0|||
28124186|NCT02674464|54785274|FG000|Overall Study|Death|10|||
28124187|NCT02674464|54785275|FG001|Overall Study|Death|21|||
28124188|NCT02674464|54785274|FG000|Overall Study|Withdrawal by Subject|24|||
28124189|NCT02674464|54785275|FG001|Overall Study|Withdrawal by Subject|44|||
28124190|NCT02674464|54785274|FG000|Overall Study|Lost to Follow-up|97|||
28124191|NCT02674464|54785275|FG001|Overall Study|Lost to Follow-up|92|||
28124192|NCT02674464|54785274|FG000|Overall Study|Outside survey window|6|||
28124193|NCT02674464|54785275|FG001|Overall Study|Outside survey window|3|||
28124194|NCT03172026|54785283|FG000|Overall Study|Withdrawal by Subject|1|||
28124195|NCT03172026|54785284|FG001|Overall Study|Withdrawal by Subject|0|||
28124196|NCT03172026|54785283|FG000|Overall Study|COVID restrictions|1|||
28124197|NCT03172026|54785284|FG001|Overall Study|COVID restrictions|0|||
28124198|NCT01343888|54785294|FG000|Overall Study|Adverse Event|12|||
28124199|NCT01343888|54785295|FG001|Overall Study|Adverse Event|22|||
28124200|NCT01343888|54785296|FG002|Overall Study|Adverse Event|5|||
28124201|NCT01343888|54785294|FG000|Overall Study|Lack of Efficacy|9|||
28124202|NCT01343888|54785295|FG001|Overall Study|Lack of Efficacy|9|||
28124203|NCT01343888|54785296|FG002|Overall Study|Lack of Efficacy|13|||
28124204|NCT01343888|54785294|FG000|Overall Study|Lost to Follow-up|0|||
28124205|NCT01343888|54785295|FG001|Overall Study|Lost to Follow-up|2|||
28124206|NCT01343888|54785296|FG002|Overall Study|Lost to Follow-up|1|||
28124207|NCT01343888|54785294|FG000|Overall Study|Protocol Violation|0|||
28124208|NCT01343888|54785295|FG001|Overall Study|Protocol Violation|2|||
28124209|NCT01343888|54785296|FG002|Overall Study|Protocol Violation|0|||
28124210|NCT01343888|54785294|FG000|Overall Study|Withdrawal by Subject|4|||
28124211|NCT01343888|54785295|FG001|Overall Study|Withdrawal by Subject|4|||
28124212|NCT01343888|54785296|FG002|Overall Study|Withdrawal by Subject|2|||
28124213|NCT01343888|54785294|FG000|Overall Study|other than stated above|0|||
28124214|NCT01343888|54785295|FG001|Overall Study|other than stated above|0|||
28124215|NCT01343888|54785296|FG002|Overall Study|other than stated above|1|||
28124216|NCT03589807|54785310|FG000|Overall Study|Lost to Follow-up|0|||
28067011|NCT00068692|54722651|FG006|Step 1: Registration|Complicating disease|0|||
28067012|NCT00068692|54722652|FG007|Step 1: Registration|Complicating disease|0|||
28067013|NCT00068692|54722645|FG000|Step 1: Registration|Protocol Violation|1|||
28124217|NCT03589807|54785311|FG001|Overall Study|Lost to Follow-up|2|||
28124218|NCT03589807|54785312|FG002|Overall Study|Lost to Follow-up|2|||
28124219|NCT03589807|54785313|FG003|Overall Study|Lost to Follow-up|3|||
28124220|NCT03589807|54785314|FG004|Overall Study|Lost to Follow-up|1|||
28124221|NCT03589807|54785315|FG005|Overall Study|Lost to Follow-up|1|||
28124222|NCT03589807|54785310|FG000|Overall Study|Withdrawal by Subject|0|||
28124223|NCT03589807|54785311|FG001|Overall Study|Withdrawal by Subject|5|||
28124224|NCT03589807|54785312|FG002|Overall Study|Withdrawal by Subject|0|||
28124225|NCT03589807|54785313|FG003|Overall Study|Withdrawal by Subject|0|||
28124226|NCT03589807|54785314|FG004|Overall Study|Withdrawal by Subject|0|||
28124227|NCT03589807|54785315|FG005|Overall Study|Withdrawal by Subject|0|||
28124228|NCT03589807|54785310|FG000|Overall Study|Protocol Violation|0|||
28124229|NCT03589807|54785311|FG001|Overall Study|Protocol Violation|0|||
28124230|NCT03589807|54785312|FG002|Overall Study|Protocol Violation|0|||
28124231|NCT03589807|54785313|FG003|Overall Study|Protocol Violation|1|||
28124232|NCT03589807|54785314|FG004|Overall Study|Protocol Violation|0|||
28124233|NCT03589807|54785315|FG005|Overall Study|Protocol Violation|0|||
28124234|NCT03589807|54785310|FG000|Overall Study|Enrolled but treatment not administered|0|||
28124235|NCT03589807|54785311|FG001|Overall Study|Enrolled but treatment not administered|0|||
28124236|NCT03589807|54785312|FG002|Overall Study|Enrolled but treatment not administered|0|||
28124237|NCT03589807|54785313|FG003|Overall Study|Enrolled but treatment not administered|0|||
28124238|NCT03589807|54785314|FG004|Overall Study|Enrolled but treatment not administered|1|||
28124239|NCT03589807|54785315|FG005|Overall Study|Enrolled but treatment not administered|0|||
28124240|NCT03544333|54785334|FG000|Overall Study|Withdrawal by Subject|1|||
28124241|NCT03544333|54785335|FG001|Overall Study|Withdrawal by Subject|0|||
28124242|NCT03560245|54785343|FG000|Overall Study|Withdrawal by Subject|3|||
28124243|NCT03560245|54785344|FG001|Overall Study|Withdrawal by Subject|2|||
28124244|NCT03560245|54785343|FG000|Overall Study|Adverse Event|1|||
28124245|NCT03560245|54785344|FG001|Overall Study|Adverse Event|1|||
28124246|NCT03560245|54785343|FG000|Overall Study|Protocol Violation|1|||
28124247|NCT03560245|54785344|FG001|Overall Study|Protocol Violation|0|||
28124248|NCT03560245|54785343|FG000|Overall Study|Death|0|||
28124249|NCT03560245|54785344|FG001|Overall Study|Death|1|||
28124250|NCT03560245|54785343|FG000|Overall Study|Lost to Follow-up|0|||
28124251|NCT03560245|54785344|FG001|Overall Study|Lost to Follow-up|1|||
28124252|NCT03560245|54785343|FG000|Overall Study|Physician Decision|0|||
28124253|NCT03560245|54785344|FG001|Overall Study|Physician Decision|1|||
28124254|NCT03560245|54785343|FG000|Overall Study|Other|0|||
28124255|NCT03560245|54785344|FG001|Overall Study|Other|1|||
28124256|NCT00707434|54785352|FG000|Overall Study|Adverse Event|1|||
28124257|NCT03054428|54785359|FG000|Overall Study|Physician Decision|0|||
28124258|NCT03054428|54785360|FG001|Overall Study|Physician Decision|1|||
28124259|NCT03054428|54785361|FG002|Overall Study|Physician Decision|1|||
28124260|NCT03054428|54785359|FG000|Overall Study|Lack of Efficacy|3|||
28124261|NCT03054428|54785360|FG001|Overall Study|Lack of Efficacy|1|||
28124262|NCT03054428|54785361|FG002|Overall Study|Lack of Efficacy|0|||
28124263|NCT03054428|54785359|FG000|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
28124264|NCT03054428|54785360|FG001|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
28124265|NCT03054428|54785361|FG002|Overall Study|Discontinued to enroll in OLE: enrolled|1|||
28124266|NCT03054428|54785359|FG000|Overall Study|Discont'd to enroll in OLE: not enrolled|1|||
28124267|NCT03054428|54785360|FG001|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
28124268|NCT03054428|54785361|FG002|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
28124269|NCT03054428|54785359|FG000|Overall Study|Transitioned to OLE study|76|||
28124270|NCT03054428|54785360|FG001|Overall Study|Transitioned to OLE study|76|||
28124271|NCT03054428|54785361|FG002|Overall Study|Transitioned to OLE study|73|||
27849324|NCT02082977|54345489|FG002|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
27849325|NCT02082977|54345490|FG003|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
27849326|NCT02082977|54345491|FG004|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
27849327|NCT02082977|54345492|FG005|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
28124272|NCT03054428|54785359|FG000|Overall Study|Withdrawal by Subject|3|||
28124273|NCT03054428|54785360|FG001|Overall Study|Withdrawal by Subject|2|||
28124274|NCT03054428|54785361|FG002|Overall Study|Withdrawal by Subject|3|||
27849328|NCT02082977|54345493|FG006|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
28124275|NCT03054428|54785359|FG000|Overall Study|Lost to Follow-up|0|||
28124276|NCT03054428|54785360|FG001|Overall Study|Lost to Follow-up|0|||
28124277|NCT03054428|54785361|FG002|Overall Study|Lost to Follow-up|1|||
28124278|NCT03558997|54785373|FG000|Overall Study|Adverse Event|0|||
28124279|NCT03558997|54785374|FG001|Overall Study|Adverse Event|2|||
28124280|NCT03558997|54785375|FG002|Overall Study|Adverse Event|5|||
28124281|NCT03558997|54785376|FG003|Overall Study|Adverse Event|1|||
28124282|NCT03558997|54785373|FG000|Overall Study|Physician Decision|0|||
28124283|NCT03558997|54785374|FG001|Overall Study|Physician Decision|0|||
28124284|NCT03558997|54785375|FG002|Overall Study|Physician Decision|1|||
28124285|NCT03558997|54785376|FG003|Overall Study|Physician Decision|0|||
28124286|NCT03558997|54785373|FG000|Overall Study|Withdrawal by Subject|1|||
28124287|NCT03558997|54785374|FG001|Overall Study|Withdrawal by Subject|0|||
28124288|NCT03558997|54785375|FG002|Overall Study|Withdrawal by Subject|1|||
28124289|NCT03558997|54785376|FG003|Overall Study|Withdrawal by Subject|1|||
28124290|NCT03558997|54785373|FG000|Overall Study|Lost to Follow-up|0|||
28124291|NCT03558997|54785374|FG001|Overall Study|Lost to Follow-up|0|||
28124292|NCT03558997|54785375|FG002|Overall Study|Lost to Follow-up|1|||
28124293|NCT03558997|54785376|FG003|Overall Study|Lost to Follow-up|0|||
28124294|NCT03052400|54785391|FG000|Overall Study|Lost to Follow-up|1|||
28124295|NCT03052400|54785392|FG001|Overall Study|Lost to Follow-up|0|||
28124296|NCT03052400|54785391|FG000|Overall Study|Withdrawal by Subject|0|||
28124297|NCT03052400|54785392|FG001|Overall Study|Withdrawal by Subject|1|||
28124298|NCT03538951|54785400|FG000|Overall Study|Withdrawal by Subject|1|||
28124299|NCT03538951|54785401|FG001|Overall Study|Withdrawal by Subject|2|||
28124300|NCT03052322|54785409|FG000|Overall Study|Other un-specified|1|||
28124301|NCT03052322|54785410|FG001|Overall Study|Other un-specified|2|||
28124302|NCT03052322|54785409|FG000|Overall Study|Withdrawal by Subject|10|||
28124303|NCT03052322|54785410|FG001|Overall Study|Withdrawal by Subject|9|||
28124304|NCT03052322|54785409|FG000|Overall Study|Death|0|||
28124305|NCT03052322|54785410|FG001|Overall Study|Death|2|||
28124306|NCT03052322|54785409|FG000|Overall Study|Lack of Efficacy|1|||
28124307|NCT03052322|54785410|FG001|Overall Study|Lack of Efficacy|2|||
28124308|NCT03052322|54785409|FG000|Overall Study|Protocol Violation|1|||
28124309|NCT03052322|54785410|FG001|Overall Study|Protocol Violation|0|||
28124310|NCT03052322|54785409|FG000|Overall Study|Lost to Follow-up|2|||
28124311|NCT03052322|54785410|FG001|Overall Study|Lost to Follow-up|4|||
28124312|NCT03052322|54785409|FG000|Overall Study|Adverse Event|6|||
28124313|NCT03052322|54785410|FG001|Overall Study|Adverse Event|13|||
28124314|NCT03521791|54785418|FG000|Overall Study|Protocol Violation|7|||
28124315|NCT03521791|54785419|FG001|Overall Study|Protocol Violation|17|||
28124316|NCT03521635|54785427|FG000|Overall Study|Adverse Event|1|||
28124317|NCT03521635|54785428|FG001|Overall Study|Adverse Event|1|||
28124318|NCT03521635|54785427|FG000|Overall Study|Refused to complete study visit|1|||
28124319|NCT03521635|54785428|FG001|Overall Study|Refused to complete study visit|0|||
28124320|NCT03521635|54785427|FG000|Overall Study|Refused to continue trial medication|2|||
28124321|NCT03521635|54785428|FG001|Overall Study|Refused to continue trial medication|2|||
28124322|NCT03521635|54785427|FG000|Overall Study|Lost to Follow-up|0|||
28124323|NCT03521635|54785428|FG001|Overall Study|Lost to Follow-up|1|||
28124324|NCT03521635|54785427|FG000|Overall Study|Meet exclusion criteria|0|||
28124325|NCT03521635|54785428|FG001|Overall Study|Meet exclusion criteria|1|||
28124326|NCT03521635|54785427|FG000|Overall Study|Patient not taken study medicine|0|||
28124327|NCT03521635|54785428|FG001|Overall Study|Patient not taken study medicine|1|||
28124328|NCT03170544|54785446|FG000|Part 1|Lost to Follow-up|1|||
28124329|NCT03170544|54785447|FG001|Part 1|Lost to Follow-up|0|||
28124330|NCT03170544|54785448|FG002|Part 1|Lost to Follow-up|0|||
28124331|NCT03170544|54785449|FG003|Part 1|Lost to Follow-up|0|||
28124332|NCT03170544|54785450|FG004|Part 1|Lost to Follow-up|0|||
28124333|NCT03170544|54785451|FG005|Part 1|Lost to Follow-up|0|||
28124334|NCT03170544|54785452|FG006|Part 1|Lost to Follow-up|0|||
28124335|NCT03170544|54785453|FG007|Part 1|Lost to Follow-up|0|||
28124336|NCT03170544|54785454|FG008|Part 1|Lost to Follow-up|0|||
28124337|NCT03170544|54785455|FG009|Part 1|Lost to Follow-up|0|||
28124338|NCT03170544|54785456|FG010|Part 1|Lost to Follow-up|0|||
28124339|NCT03170544|54785457|FG011|Part 1|Lost to Follow-up|0|||
28124340|NCT03170544|54785446|FG000|Part 1|Not treated|0|||
28124341|NCT03170544|54785447|FG001|Part 1|Not treated|0|||
28124342|NCT03170544|54785448|FG002|Part 1|Not treated|0|||
28124343|NCT03170544|54785449|FG003|Part 1|Not treated|1|||
28124344|NCT03170544|54785450|FG004|Part 1|Not treated|0|||
28124345|NCT03170544|54785451|FG005|Part 1|Not treated|0|||
28124346|NCT03170544|54785452|FG006|Part 1|Not treated|0|||
27817916|NCT04206332|54275983|FG013|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
28124347|NCT03170544|54785453|FG007|Part 1|Not treated|0|||
28124348|NCT03170544|54785454|FG008|Part 1|Not treated|0|||
28124349|NCT03170544|54785455|FG009|Part 1|Not treated|0|||
28124350|NCT03170544|54785456|FG010|Part 1|Not treated|0|||
28124351|NCT03170544|54785457|FG011|Part 1|Not treated|0|||
28124352|NCT03582943|54785542|FG000|Allocated to Groups|Withdrawal by Subject|1|||
28124353|NCT03582943|54785543|FG001|Allocated to Groups|Withdrawal by Subject|1|||
28124354|NCT03582943|54785542|FG000|Intervention and Follow up|Withdrawal by Subject|4|||
28124355|NCT03582943|54785543|FG001|Intervention and Follow up|Withdrawal by Subject|2|||
28124356|NCT03582943|54785542|FG000|Analyzed|Protocol Violation|4|||
28124357|NCT03582943|54785543|FG001|Analyzed|Protocol Violation|1|||
27817917|NCT04206332|54275984|FG014|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
27817918|NCT04206332|54275985|FG015|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
27817919|NCT04206332|54275986|FG016|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
27817920|NCT04206332|54275970|FG000|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
27817921|NCT04206332|54275971|FG001|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
28124358|NCT03532009|54785551|FG000|Overall Study|Other|1|||
28124359|NCT03532009|54785552|FG001|Overall Study|Other|1|||
28124360|NCT03532009|54785551|FG000|Overall Study|Death|1|||
28124361|NCT03532009|54785552|FG001|Overall Study|Death|1|||
28124362|NCT03532009|54785551|FG000|Overall Study|Withdrawal by Patient|0|||
27817922|NCT04206332|54275972|FG002|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
27817923|NCT04206332|54275973|FG003|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
27817924|NCT04206332|54275974|FG004|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
27817925|NCT04206332|54275975|FG005|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
27817926|NCT04206332|54275976|FG006|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
27849329|NCT02082977|54345494|FG007|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2|||
27849330|NCT02082977|54345495|FG008|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
28067014|NCT00068692|54722646|FG001|Step 1: Registration|Protocol Violation|0|||
28067015|NCT00068692|54722647|FG002|Step 1: Registration|Protocol Violation|0|||
28067016|NCT00068692|54722648|FG003|Step 1: Registration|Protocol Violation|0|||
28067017|NCT00068692|54722649|FG004|Step 1: Registration|Protocol Violation|0|||
28067018|NCT00068692|54722650|FG005|Step 1: Registration|Protocol Violation|0|||
28067019|NCT00068692|54722651|FG006|Step 1: Registration|Protocol Violation|0|||
28124363|NCT03532009|54785552|FG001|Overall Study|Withdrawal by Patient|2|||
28124364|NCT03520387|54785563|FG000|Pre-Randomization|Withdrawal by Subject|1|||
28124365|NCT03520387|54785564|FG001|Pre-Randomization|Withdrawal by Subject|0|||
28124366|NCT03520387|54785565|FG002|Pre-Randomization|Withdrawal by Subject|0|||
28124367|NCT03520387|54785566|FG003|Pre-Randomization|Withdrawal by Subject|0|||
28124368|NCT03520387|54785567|FG004|Pre-Randomization|Withdrawal by Subject|0|||
28124369|NCT03520387|54785563|FG000|Pre-Randomization|Failed eligibility criteria or run-in period criteria|2|||
28124370|NCT03520387|54785564|FG001|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
28124371|NCT03520387|54785565|FG002|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
28124372|NCT03520387|54785566|FG003|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
28124373|NCT03520387|54785567|FG004|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
28124374|NCT03170232|54785580|FG000|Overall Study|Adverse Event|0|||
28067020|NCT00068692|54722652|FG007|Step 1: Registration|Protocol Violation|0|||
28067021|NCT00068692|54722645|FG000|Step 1: Registration|Not eligible|6|||
28067022|NCT00068692|54722646|FG001|Step 1: Registration|Not eligible|0|||
28124375|NCT03170232|54785581|FG001|Overall Study|Adverse Event|1|||
28124376|NCT03170232|54785580|FG000|Overall Study|Protocol Violation|0|||
28124377|NCT03170232|54785581|FG001|Overall Study|Protocol Violation|1|||
28124378|NCT03170232|54785580|FG000|Overall Study|Lack of Efficacy|0|||
28124379|NCT03170232|54785581|FG001|Overall Study|Lack of Efficacy|1|||
28124380|NCT03170232|54785580|FG000|Overall Study|Study closed/terminated|26|||
28124381|NCT03170232|54785581|FG001|Overall Study|Study closed/terminated|23|||
28124382|NCT03170232|54785580|FG000|Overall Study|Lost to Follow-up|1|||
28124383|NCT03170232|54785581|FG001|Overall Study|Lost to Follow-up|0|||
28124384|NCT03170232|54785580|FG000|Overall Study|Withdrawal by Subject|0|||
28124385|NCT03170232|54785581|FG001|Overall Study|Withdrawal by Subject|1|||
28124386|NCT03519919|54785587|FG000|Overall Study|Withdrawal by Subject|1|||
28124387|NCT03519919|54785587|FG000|Overall Study|Lack of Efficacy|1|||
28124388|NCT03519919|54785587|FG000|Overall Study|Screen Failure|1|||
28124389|NCT03478969|54785620|FG000|Overall Study|Withdrawal by Subject|4|||
28124390|NCT03478969|54785621|FG001|Overall Study|Withdrawal by Subject|7|||
28124391|NCT03478969|54785622|FG002|Overall Study|Withdrawal by Subject|6|||
28124392|NCT03478969|54785620|FG000|Overall Study|Adverse Event|2|||
28124393|NCT03478969|54785621|FG001|Overall Study|Adverse Event|0|||
27940486|NCT01189890|54596761|FG000|Overall Study|Physician Decision|5|||
27940487|NCT01189890|54596762|FG001|Overall Study|Physician Decision|4|||
28067023|NCT00068692|54722647|FG002|Step 1: Registration|Not eligible|0|||
28067024|NCT00068692|54722648|FG003|Step 1: Registration|Not eligible|0|||
28067025|NCT00068692|54722649|FG004|Step 1: Registration|Not eligible|0|||
28067026|NCT00068692|54722650|FG005|Step 1: Registration|Not eligible|0|||
28067027|NCT00068692|54722651|FG006|Step 1: Registration|Not eligible|0|||
28067028|NCT00068692|54722652|FG007|Step 1: Registration|Not eligible|0|||
28067029|NCT00068692|54722645|FG000|Step 1: Registration|Other|2|||
28067030|NCT00068692|54722646|FG001|Step 1: Registration|Other|0|||
28067031|NCT00068692|54722647|FG002|Step 1: Registration|Other|0|||
28067032|NCT00068692|54722648|FG003|Step 1: Registration|Other|0|||
28067033|NCT00068692|54722649|FG004|Step 1: Registration|Other|0|||
28067034|NCT00068692|54722650|FG005|Step 1: Registration|Other|0|||
28067035|NCT00068692|54722651|FG006|Step 1: Registration|Other|0|||
28067036|NCT00068692|54722652|FG007|Step 1: Registration|Other|0|||
28067037|NCT00068692|54722645|FG000|Step 1: Registration|Not start protocol therapy|3|||
28067038|NCT00068692|54722646|FG001|Step 1: Registration|Not start protocol therapy|0|||
28067039|NCT00068692|54722647|FG002|Step 1: Registration|Not start protocol therapy|0|||
28067040|NCT00068692|54722648|FG003|Step 1: Registration|Not start protocol therapy|0|||
28067041|NCT00068692|54722649|FG004|Step 1: Registration|Not start protocol therapy|0|||
28067042|NCT00068692|54722650|FG005|Step 1: Registration|Not start protocol therapy|0|||
28067043|NCT00068692|54722651|FG006|Step 1: Registration|Not start protocol therapy|0|||
28067044|NCT00068692|54722652|FG007|Step 1: Registration|Not start protocol therapy|0|||
28067045|NCT00068692|54722645|FG000|Step 1: Registration|Registered but not randomized|0|||
28067046|NCT00068692|54722646|FG001|Step 1: Registration|Registered but not randomized|1|||
28067047|NCT00068692|54722647|FG002|Step 1: Registration|Registered but not randomized|0|||
28067048|NCT00068692|54722648|FG003|Step 1: Registration|Registered but not randomized|0|||
28067049|NCT00068692|54722649|FG004|Step 1: Registration|Registered but not randomized|0|||
28067050|NCT00068692|54722650|FG005|Step 1: Registration|Registered but not randomized|0|||
28067051|NCT00068692|54722651|FG006|Step 1: Registration|Registered but not randomized|0|||
28067052|NCT00068692|54722652|FG007|Step 1: Registration|Registered but not randomized|0|||
28067053|NCT00068692|54722645|FG000|Step 2: Randomization|Disesae progression/replase|0|||
28067054|NCT00068692|54722646|FG001|Step 2: Randomization|Disesae progression/replase|0|||
28067055|NCT00068692|54722647|FG002|Step 2: Randomization|Disesae progression/replase|1|||
28067056|NCT00068692|54722648|FG003|Step 2: Randomization|Disesae progression/replase|1|||
28067057|NCT00068692|54722649|FG004|Step 2: Randomization|Disesae progression/replase|0|||
28067058|NCT00068692|54722650|FG005|Step 2: Randomization|Disesae progression/replase|0|||
28067059|NCT00068692|54722651|FG006|Step 2: Randomization|Disesae progression/replase|0|||
28067060|NCT00068692|54722652|FG007|Step 2: Randomization|Disesae progression/replase|0|||
28067061|NCT00068692|54722645|FG000|Step 2: Randomization|Adverse Event|0|||
28067062|NCT00068692|54722646|FG001|Step 2: Randomization|Adverse Event|0|||
28067063|NCT00068692|54722647|FG002|Step 2: Randomization|Adverse Event|4|||
28067064|NCT00068692|54722648|FG003|Step 2: Randomization|Adverse Event|2|||
28067065|NCT00068692|54722649|FG004|Step 2: Randomization|Adverse Event|2|||
28124394|NCT03478969|54785622|FG002|Overall Study|Adverse Event|1|||
28067066|NCT00068692|54722650|FG005|Step 2: Randomization|Adverse Event|3|||
28067067|NCT00068692|54722651|FG006|Step 2: Randomization|Adverse Event|4|||
28067068|NCT00068692|54722652|FG007|Step 2: Randomization|Adverse Event|4|||
28067069|NCT00068692|54722645|FG000|Step 2: Randomization|Death|0|||
28067070|NCT00068692|54722646|FG001|Step 2: Randomization|Death|0|||
28067071|NCT00068692|54722647|FG002|Step 2: Randomization|Death|0|||
28124395|NCT03478969|54785620|FG000|Overall Study|Pregnancy|1|||
28124396|NCT03478969|54785621|FG001|Overall Study|Pregnancy|0|||
28124397|NCT03478969|54785622|FG002|Overall Study|Pregnancy|0|||
28067072|NCT00068692|54722648|FG003|Step 2: Randomization|Death|0|||
28067073|NCT00068692|54722649|FG004|Step 2: Randomization|Death|1|||
28067074|NCT00068692|54722650|FG005|Step 2: Randomization|Death|0|||
28067075|NCT00068692|54722651|FG006|Step 2: Randomization|Death|0|||
28067076|NCT00068692|54722652|FG007|Step 2: Randomization|Death|1|||
28067077|NCT00068692|54722645|FG000|Step 2: Randomization|Withdrawal by Subject|0|||
28124398|NCT03478969|54785620|FG000|Overall Study|Personal Reasons|1|||
28124399|NCT03478969|54785621|FG001|Overall Study|Personal Reasons|0|||
28124400|NCT03478969|54785622|FG002|Overall Study|Personal Reasons|1|||
28124401|NCT03478969|54785620|FG000|Overall Study|Covid-19|1|||
28124402|NCT03478969|54785621|FG001|Overall Study|Covid-19|4|||
28124403|NCT03478969|54785622|FG002|Overall Study|Covid-19|3|||
28124404|NCT03478969|54785620|FG000|Overall Study|Multiple Reasons|0|||
28124405|NCT03478969|54785621|FG001|Overall Study|Multiple Reasons|1|||
28124406|NCT03478969|54785622|FG002|Overall Study|Multiple Reasons|1|||
28124407|NCT03478969|54785620|FG000|Overall Study|Eligibility Criteria|0|||
28124408|NCT03478969|54785621|FG001|Overall Study|Eligibility Criteria|0|||
28124409|NCT03478969|54785622|FG002|Overall Study|Eligibility Criteria|5|||
28124410|NCT03478969|54785620|FG000|Overall Study|Lost to Follow-up|0|||
28124411|NCT03478969|54785621|FG001|Overall Study|Lost to Follow-up|0|||
28124412|NCT03478969|54785622|FG002|Overall Study|Lost to Follow-up|1|||
28124413|NCT04823949|54785653|FG000|Overall Study|Withdrawal by Subject|0|||
28124414|NCT04823949|54785654|FG001|Overall Study|Withdrawal by Subject|4|||
28124415|NCT04823949|54785653|FG000|Overall Study|Physician Decision|0|||
28124416|NCT04823949|54785654|FG001|Overall Study|Physician Decision|1|||
28124417|NCT04499482|54785669|FG000|Foods Containing 10 g Soy Flour|One subject dropped from the study at Day 3 as the subject could not meet the demands of the study|1|||
28124418|NCT04408794|54785688|FG000|Overall Study|Adverse Event|43|||
28124419|NCT04408794|54785688|FG000|Overall Study|Infrequent study drug usage|43|||
28124420|NCT04408794|54785688|FG000|Overall Study|Lack of Efficacy|61|||
28124421|NCT04408794|54785688|FG000|Overall Study|Lost to Follow-up|33|||
28124422|NCT04408794|54785688|FG000|Overall Study|Non-compliance|6|||
28124423|NCT04408794|54785688|FG000|Overall Study|Physician Decision|1|||
28124424|NCT04408794|54785688|FG000|Overall Study|Pregnancy|6|||
28124425|NCT04408794|54785688|FG000|Overall Study|Protocol Deviation|9|||
28124426|NCT04408794|54785688|FG000|Overall Study|Sheehan-STS Result|1|||
28124427|NCT04408794|54785688|FG000|Overall Study|Withdrawal by Subject|57|||
28124428|NCT04408794|54785688|FG000|Overall Study|Terminated study prematurely due to COVID-19 - Adverse Event|2|||
28124429|NCT04408794|54785688|FG000|Overall Study|Never Treated Migraine|5|||
28124430|NCT04305405|54785723|FG000|Overall Study|Withdrawal by parent/guardian|0|||
28124431|NCT04305405|54785724|FG001|Overall Study|Withdrawal by parent/guardian|1|||
28124432|NCT04152200|54785741|FG000|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|6|||
28067078|NCT00068692|54722646|FG001|Step 2: Randomization|Withdrawal by Subject|0|||
28124433|NCT04152200|54785742|FG001|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|15|||
28124434|NCT03905694|54785750|FG000|Long-term Extension Period|Remained in this Period at Time of Data Cut|18|||
28067079|NCT00068692|54722647|FG002|Step 2: Randomization|Withdrawal by Subject|4|||
28067080|NCT00068692|54722648|FG003|Step 2: Randomization|Withdrawal by Subject|6|||
28067081|NCT00068692|54722649|FG004|Step 2: Randomization|Withdrawal by Subject|3|||
28067082|NCT00068692|54722650|FG005|Step 2: Randomization|Withdrawal by Subject|2|||
28067083|NCT00068692|54722651|FG006|Step 2: Randomization|Withdrawal by Subject|0|||
28067084|NCT00068692|54722652|FG007|Step 2: Randomization|Withdrawal by Subject|3|||
28067085|NCT00068692|54722645|FG000|Step 2: Randomization|alternative therapy|0|||
28067086|NCT00068692|54722646|FG001|Step 2: Randomization|alternative therapy|0|||
28067087|NCT00068692|54722647|FG002|Step 2: Randomization|alternative therapy|0|||
28067088|NCT00068692|54722648|FG003|Step 2: Randomization|alternative therapy|1|||
28067089|NCT00068692|54722649|FG004|Step 2: Randomization|alternative therapy|1|||
28067090|NCT00068692|54722650|FG005|Step 2: Randomization|alternative therapy|0|||
28067091|NCT00068692|54722651|FG006|Step 2: Randomization|alternative therapy|0|||
28124435|NCT03681184|54785756|FG000|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0|||
28124436|NCT03681184|54785757|FG001|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1|||
28124437|NCT03681184|54785756|FG000|3-Month Blinded Extension Period|Remained in this Period at Time of Data Cut|12|||
28124438|NCT03681184|54785757|FG001|3-Month Blinded Extension Period|Remained in this Period at Time of Data Cut|23|||
28124439|NCT03681184|54785756|FG000|Open-Label Extension Period|Remained in this Period at Time of Data Cut|1|||
28124440|NCT03681184|54785757|FG001|Open-Label Extension Period|Remained in this Period at Time of Data Cut|1|||
28124441|NCT03668119|54785765|FG000|Pre-treatment|Disease Progression|1|||
28124442|NCT03668119|54785766|FG001|Pre-treatment|Disease Progression|0|||
28124443|NCT03668119|54785765|FG000|Treatment|Disease Progression|75|||
28067092|NCT00068692|54722652|FG007|Step 2: Randomization|alternative therapy|0|||
28067093|NCT00068692|54722645|FG000|Step 2: Randomization|Physician Decision|0|||
28067094|NCT00068692|54722646|FG001|Step 2: Randomization|Physician Decision|0|||
28067095|NCT00068692|54722647|FG002|Step 2: Randomization|Physician Decision|0|||
28124444|NCT03668119|54785766|FG001|Treatment|Disease Progression|55|||
28124445|NCT03668119|54785765|FG000|Treatment|Study drug toxicity|19|||
28124446|NCT03668119|54785766|FG001|Treatment|Study drug toxicity|1|||
28124447|NCT03668119|54785765|FG000|Treatment|Death|3|||
28124448|NCT03668119|54785766|FG001|Treatment|Death|0|||
28124449|NCT03668119|54785765|FG000|Treatment|Adverse Event unrelated to Study drug|4|||
28124450|NCT03668119|54785766|FG001|Treatment|Adverse Event unrelated to Study drug|3|||
28124451|NCT03668119|54785765|FG000|Treatment|Withdrawal by Subject|2|||
28124452|NCT03668119|54785766|FG001|Treatment|Withdrawal by Subject|1|||
28124453|NCT03668119|54785765|FG000|Treatment|Participant request to discontinue study treatment|3|||
28124454|NCT03668119|54785766|FG001|Treatment|Participant request to discontinue study treatment|1|||
28124455|NCT03668119|54785765|FG000|Treatment|Maximum Clinical Benefit|0|||
28124456|NCT03668119|54785766|FG001|Treatment|Maximum Clinical Benefit|1|||
28124457|NCT03668119|54785765|FG000|Treatment|Participants completed treatment|20|||
28124458|NCT03668119|54785766|FG001|Treatment|Participants completed treatment|8|||
28124459|NCT03668119|54785765|FG000|Treatment|Other reasons|1|||
28124460|NCT03668119|54785766|FG001|Treatment|Other reasons|2|||
28124461|NCT03543410|54785781|FG000|Overall Study|Adverse Event|10|||
28124462|NCT03543410|54785782|FG001|Overall Study|Adverse Event|8|||
28124463|NCT03543410|54785783|FG002|Overall Study|Adverse Event|2|||
28124464|NCT03543410|54785781|FG000|Overall Study|Lack of Efficacy|0|||
28124465|NCT03543410|54785782|FG001|Overall Study|Lack of Efficacy|1|||
28124466|NCT03543410|54785783|FG002|Overall Study|Lack of Efficacy|0|||
28124467|NCT03543410|54785781|FG000|Overall Study|Lost to Follow-up|0|||
28124468|NCT03543410|54785782|FG001|Overall Study|Lost to Follow-up|1|||
28124469|NCT03543410|54785783|FG002|Overall Study|Lost to Follow-up|0|||
28124470|NCT03543410|54785781|FG000|Overall Study|Withdrawal by Subject|5|||
28067096|NCT00068692|54722648|FG003|Step 2: Randomization|Physician Decision|1|||
27817927|NCT04206332|54275977|FG007|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|3|||
27817928|NCT04206332|54275978|FG008|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
27817929|NCT04206332|54275979|FG009|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
27817930|NCT04206332|54275980|FG010|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
27817931|NCT04206332|54275981|FG011|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
27817932|NCT04206332|54275982|FG012|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
28067097|NCT00068692|54722649|FG004|Step 2: Randomization|Physician Decision|1|||
28124471|NCT03543410|54785782|FG001|Overall Study|Withdrawal by Subject|2|||
28124472|NCT03543410|54785783|FG002|Overall Study|Withdrawal by Subject|8|||
28124473|NCT03543410|54785781|FG000|Overall Study|Protocol Violation|0|||
28124474|NCT03543410|54785782|FG001|Overall Study|Protocol Violation|1|||
28124475|NCT03543410|54785783|FG002|Overall Study|Protocol Violation|0|||
28124476|NCT03543410|54785781|FG000|Overall Study|Due to COVID-19|4|||
28124477|NCT03543410|54785782|FG001|Overall Study|Due to COVID-19|0|||
28124478|NCT03543410|54785783|FG002|Overall Study|Due to COVID-19|2|||
28124479|NCT03543410|54785781|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
28124480|NCT03543410|54785782|FG001|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
28124481|NCT03543410|54785783|FG002|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|2|||
28124482|NCT03543410|54785781|FG000|Overall Study|Not Due to COVID-19|2|||
28124483|NCT03543410|54785782|FG001|Overall Study|Not Due to COVID-19|0|||
28124484|NCT03543410|54785783|FG002|Overall Study|Not Due to COVID-19|1|||
28067098|NCT00068692|54722650|FG005|Step 2: Randomization|Physician Decision|0|||
28067099|NCT00068692|54722651|FG006|Step 2: Randomization|Physician Decision|0|||
28067100|NCT00068692|54722652|FG007|Step 2: Randomization|Physician Decision|0|||
28067101|NCT00068692|54722645|FG000|Step 2: Randomization|Other|0|||
28067102|NCT00068692|54722646|FG001|Step 2: Randomization|Other|0|||
28067103|NCT00068692|54722647|FG002|Step 2: Randomization|Other|0|||
28067104|NCT00068692|54722648|FG003|Step 2: Randomization|Other|1|||
28067105|NCT00068692|54722649|FG004|Step 2: Randomization|Other|0|||
28067106|NCT00068692|54722650|FG005|Step 2: Randomization|Other|1|||
28067107|NCT00068692|54722651|FG006|Step 2: Randomization|Other|0|||
28067108|NCT00068692|54722652|FG007|Step 2: Randomization|Other|0|||
28067109|NCT00068692|54722645|FG000|Step 2: Randomization|never start protocol therapy|0|||
28067110|NCT00068692|54722646|FG001|Step 2: Randomization|never start protocol therapy|0|||
28067111|NCT00068692|54722647|FG002|Step 2: Randomization|never start protocol therapy|1|||
28124485|NCT03294590|54785793|FG000|Overall Study|Lost to Follow-up|105|||
28124486|NCT03294590|54785794|FG001|Overall Study|Lost to Follow-up|107|||
28124487|NCT02908074|54785808|FG000|Overall Study|sponsor/ICON decision|0|||
28124488|NCT02908074|54785809|FG001|Overall Study|sponsor/ICON decision|0|||
28124489|NCT02908074|54785810|FG002|Overall Study|sponsor/ICON decision|1|||
28124490|NCT02908074|54785811|FG003|Overall Study|sponsor/ICON decision|0|||
28124491|NCT02908074|54785812|FG004|Overall Study|sponsor/ICON decision|0|||
28124492|NCT02908074|54785813|FG005|Overall Study|sponsor/ICON decision|0|||
28124493|NCT02908074|54785808|FG000|Overall Study|Protocol Violation|0|||
28124494|NCT02908074|54785809|FG001|Overall Study|Protocol Violation|1|||
28124495|NCT02908074|54785810|FG002|Overall Study|Protocol Violation|0|||
28124496|NCT02908074|54785811|FG003|Overall Study|Protocol Violation|0|||
28124497|NCT02908074|54785812|FG004|Overall Study|Protocol Violation|0|||
28124498|NCT02908074|54785813|FG005|Overall Study|Protocol Violation|0|||
28124499|NCT02908074|54785808|FG000|Overall Study|Adverse Event|5|||
28124500|NCT02908074|54785809|FG001|Overall Study|Adverse Event|2|||
28124501|NCT02908074|54785810|FG002|Overall Study|Adverse Event|0|||
28124502|NCT02908074|54785811|FG003|Overall Study|Adverse Event|0|||
28124503|NCT02908074|54785812|FG004|Overall Study|Adverse Event|1|||
28124504|NCT02908074|54785813|FG005|Overall Study|Adverse Event|0|||
28124505|NCT02908074|54785808|FG000|Overall Study|AESI|1|||
28124506|NCT02908074|54785809|FG001|Overall Study|AESI|0|||
28124507|NCT02908074|54785810|FG002|Overall Study|AESI|1|||
28124508|NCT02908074|54785811|FG003|Overall Study|AESI|0|||
28124509|NCT02908074|54785812|FG004|Overall Study|AESI|1|||
28124510|NCT02908074|54785813|FG005|Overall Study|AESI|0|||
28124511|NCT02908074|54785808|FG000|Overall Study|Discontinuation criteria per protocol|0|||
28124512|NCT02908074|54785809|FG001|Overall Study|Discontinuation criteria per protocol|0|||
28124513|NCT02908074|54785810|FG002|Overall Study|Discontinuation criteria per protocol|1|||
28124514|NCT02908074|54785811|FG003|Overall Study|Discontinuation criteria per protocol|0|||
28124515|NCT02908074|54785812|FG004|Overall Study|Discontinuation criteria per protocol|0|||
28124516|NCT02908074|54785813|FG005|Overall Study|Discontinuation criteria per protocol|1|||
28124517|NCT02908074|54785808|FG000|Overall Study|Withdrawal by Subject|3|||
28124518|NCT02908074|54785809|FG001|Overall Study|Withdrawal by Subject|2|||
28124519|NCT02908074|54785810|FG002|Overall Study|Withdrawal by Subject|2|||
28124520|NCT02908074|54785811|FG003|Overall Study|Withdrawal by Subject|2|||
28067112|NCT00068692|54722648|FG003|Step 2: Randomization|never start protocol therapy|0|||
28067113|NCT00068692|54722649|FG004|Step 2: Randomization|never start protocol therapy|1|||
28067114|NCT00068692|54722650|FG005|Step 2: Randomization|never start protocol therapy|0|||
28067115|NCT00068692|54722651|FG006|Step 2: Randomization|never start protocol therapy|0|||
28067116|NCT00068692|54722652|FG007|Step 2: Randomization|never start protocol therapy|0|||
28067117|NCT00463151|54722669|FG000|Overall Study|Adverse Event|0|||
28067118|NCT00463151|54722670|FG001|Overall Study|Adverse Event|0|||
28067119|NCT00463151|54722671|FG002|Overall Study|Adverse Event|1|||
28067120|NCT00463151|54722672|FG003|Overall Study|Adverse Event|0|||
28067121|NCT00463151|54722669|FG000|Overall Study|Lack of Efficacy|2|||
28067122|NCT00463151|54722670|FG001|Overall Study|Lack of Efficacy|5|||
28067123|NCT00463151|54722671|FG002|Overall Study|Lack of Efficacy|2|||
28067124|NCT00463151|54722672|FG003|Overall Study|Lack of Efficacy|5|||
28067125|NCT00463151|54722669|FG000|Overall Study|Protocol Violation|0|||
28067126|NCT00463151|54722670|FG001|Overall Study|Protocol Violation|0|||
28067127|NCT00463151|54722671|FG002|Overall Study|Protocol Violation|0|||
28067128|NCT00463151|54722672|FG003|Overall Study|Protocol Violation|1|||
28067129|NCT00463151|54722669|FG000|Overall Study|Withdrawal by Subject|0|||
28067130|NCT00463151|54722670|FG001|Overall Study|Withdrawal by Subject|0|||
28067131|NCT00463151|54722671|FG002|Overall Study|Withdrawal by Subject|0|||
28067132|NCT00463151|54722672|FG003|Overall Study|Withdrawal by Subject|1|||
28067133|NCT00068380|54722682|FG000|Overall Study|Withdrawal by Subject|3|||
28124521|NCT02908074|54785812|FG004|Overall Study|Withdrawal by Subject|2|||
28067134|NCT00068380|54722682|FG000|Overall Study|Adverse Event|2|||
28067135|NCT00067990|54722688|FG000|Overall Study|Death|5|||
28124522|NCT02908074|54785813|FG005|Overall Study|Withdrawal by Subject|2|||
28124523|NCT02908074|54785808|FG000|Overall Study|Lost to Follow-up|0|||
28124524|NCT02908074|54785809|FG001|Overall Study|Lost to Follow-up|1|||
28124525|NCT02908074|54785810|FG002|Overall Study|Lost to Follow-up|1|||
28124526|NCT02908074|54785811|FG003|Overall Study|Lost to Follow-up|1|||
28124527|NCT02908074|54785812|FG004|Overall Study|Lost to Follow-up|0|||
28124528|NCT02908074|54785813|FG005|Overall Study|Lost to Follow-up|1|||
28124529|NCT02907359|54785832|FG000|Overall Study|Death|234|||
28124530|NCT02907359|54785833|FG001|Overall Study|Death|117|||
28124531|NCT02907359|54785832|FG000|Overall Study|Withdrawal by Subject|6|||
28124532|NCT02907359|54785833|FG001|Overall Study|Withdrawal by Subject|11|||
28124533|NCT02907359|54785832|FG000|Overall Study|Lost to Follow-up|1|||
28124534|NCT02907359|54785833|FG001|Overall Study|Lost to Follow-up|0|||
28124535|NCT02714205|54785841|FG000|Overall Study|Cannot tolerate medication|1|||
28124536|NCT02714205|54785842|FG001|Overall Study|Cannot tolerate medication|0|||
28124537|NCT02714205|54785841|FG000|Overall Study|Adverse Event|2|||
28067136|NCT00067990|54722689|FG001|Overall Study|Death|7|||
28067137|NCT00067990|54722688|FG000|Overall Study|ESRD, Non IF/TA|1|||
28124538|NCT02714205|54785842|FG001|Overall Study|Adverse Event|0|||
28124539|NCT02714205|54785841|FG000|Overall Study|Too busy|1|||
28124540|NCT02714205|54785842|FG001|Overall Study|Too busy|0|||
28124541|NCT02714205|54785841|FG000|Overall Study|Incomplete outcome data|0|||
28124542|NCT02714205|54785842|FG001|Overall Study|Incomplete outcome data|1|||
28124543|NCT02369458|54785866|FG000|Overall Study|Determined to be not eligible|1|||
28124544|NCT02369458|54785867|FG001|Overall Study|Determined to be not eligible|0|||
28124545|NCT02152995|54785875|FG000|Overall Study|Withdrawal by Subject|1|||
28124546|NCT02152995|54785876|FG001|Overall Study|Withdrawal by Subject|0|||
28124547|NCT00583752|54785885|FG000|Overall Study|Lost to Follow-up|5|||
28124548|NCT00583752|54785886|FG001|Overall Study|Lost to Follow-up|5|||
28124549|NCT02318784|54785893|FG000|Overall Study|Adverse Event|13|||
28124550|NCT02318784|54785893|FG000|Overall Study|Death|2|||
28124551|NCT02318784|54785893|FG000|Overall Study|Progressive Disease|37|||
28124552|NCT02318784|54785893|FG000|Overall Study|Withdrawal by Subject|10|||
28124553|NCT03170154|54785908|FG000|Overall Study|Lost to Follow-up|4|||
28124554|NCT03170154|54785908|FG000|Overall Study|Death|2|||
28124555|NCT03170154|54785908|FG000|Overall Study|Withdrawal by Subject|2|||
28124556|NCT03518125|54785923|FG000|Overall Study|Lost to Follow-up|0|||
28124557|NCT03518125|54785924|FG001|Overall Study|Lost to Follow-up|2|||
28124558|NCT03518125|54785925|FG002|Overall Study|Lost to Follow-up|0|||
28124559|NCT03518125|54785926|FG003|Overall Study|Lost to Follow-up|0|||
28124560|NCT03518125|54785927|FG004|Overall Study|Lost to Follow-up|3|||
28124561|NCT03518125|54785928|FG005|Overall Study|Lost to Follow-up|5|||
28124562|NCT03518125|54785923|FG000|Overall Study|Physician Decision|0|||
28124563|NCT03518125|54785924|FG001|Overall Study|Physician Decision|1|||
28124564|NCT03518125|54785925|FG002|Overall Study|Physician Decision|0|||
28124565|NCT03518125|54785926|FG003|Overall Study|Physician Decision|0|||
28124566|NCT03518125|54785927|FG004|Overall Study|Physician Decision|0|||
28124567|NCT03518125|54785928|FG005|Overall Study|Physician Decision|0|||
28124568|NCT03518125|54785923|FG000|Overall Study|Withdrawal by Subject|1|||
28124569|NCT03518125|54785924|FG001|Overall Study|Withdrawal by Subject|1|||
28067138|NCT00067990|54722689|FG001|Overall Study|ESRD, Non IF/TA|3|||
28067139|NCT00067990|54722688|FG000|Overall Study|Withdrawal by Subject|4|||
28067140|NCT00067990|54722689|FG001|Overall Study|Withdrawal by Subject|12|||
28067141|NCT00090220|54722697|FG000|Base Study Vaccination Period|Randomized not Vaccinated|1|||
28067142|NCT00090220|54722698|FG001|Base Study Vaccination Period|Randomized not Vaccinated|1|||
28067143|NCT00090220|54722699|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
28067144|NCT00090220|54722700|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
28067145|NCT00090220|54722701|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
28067146|NCT00090220|54722702|FG005|Base Study Vaccination Period|Randomized not Vaccinated|0|||
28067147|NCT00090220|54722697|FG000|Base Study Vaccination Period|Adverse Event|6|||
28067148|NCT00090220|54722698|FG001|Base Study Vaccination Period|Adverse Event|1|||
28067149|NCT00090220|54722699|FG002|Base Study Vaccination Period|Adverse Event|0|||
28067150|NCT00090220|54722700|FG003|Base Study Vaccination Period|Adverse Event|0|||
28124570|NCT03518125|54785925|FG002|Overall Study|Withdrawal by Subject|0|||
28124571|NCT03518125|54785926|FG003|Overall Study|Withdrawal by Subject|1|||
28124572|NCT03518125|54785927|FG004|Overall Study|Withdrawal by Subject|1|||
28124573|NCT03518125|54785928|FG005|Overall Study|Withdrawal by Subject|3|||
28124574|NCT03518125|54785923|FG000|Overall Study|Missed Day 394 Visit|1|||
28124575|NCT03518125|54785924|FG001|Overall Study|Missed Day 394 Visit|0|||
28124576|NCT03518125|54785925|FG002|Overall Study|Missed Day 394 Visit|0|||
28124577|NCT03518125|54785926|FG003|Overall Study|Missed Day 394 Visit|0|||
28124578|NCT03518125|54785927|FG004|Overall Study|Missed Day 394 Visit|0|||
28124579|NCT03518125|54785928|FG005|Overall Study|Missed Day 394 Visit|0|||
28124580|NCT03169530|54785945|FG000|Overall Study|Study ended by NIH|15|||
28124581|NCT03169530|54785946|FG001|Overall Study|Study ended by NIH|17|||
28124582|NCT03478891|54785964|FG000|Overall Study|Enrolled, but product never administered|0|||
28124583|NCT03478891|54785965|FG001|Overall Study|Enrolled, but product never administered|0|||
28124584|NCT03478891|54785966|FG002|Overall Study|Enrolled, but product never administered|1|||
28124585|NCT03478891|54785964|FG000|Overall Study|Moved from area|0|||
28124586|NCT03478891|54785965|FG001|Overall Study|Moved from area|0|||
28124587|NCT03478891|54785966|FG002|Overall Study|Moved from area|1|||
28124588|NCT03478891|54785964|FG000|Overall Study|Lost to Follow-up|1|||
28124589|NCT03478891|54785965|FG001|Overall Study|Lost to Follow-up|0|||
28124590|NCT03478891|54785966|FG002|Overall Study|Lost to Follow-up|1|||
28124591|NCT01585103|54785978|FG000|Overall Study|Unable to swallow Cytosponge|6|||
28124592|NCT03168906|54785984|FG000|Overall Study|Lack of Efficacy|6|||
28124593|NCT03168906|54785985|FG001|Overall Study|Lack of Efficacy|6|||
28124594|NCT00706966|54785992|FG000|Overall Study|Adverse Event|1|||
28124595|NCT03478657|54786026|FG000|Overall Study|Withdrawal by Subject|0|||
28124596|NCT03478657|54786027|FG001|Overall Study|Withdrawal by Subject|1|||
28124597|NCT03515941|54786035|FG000|Overall Study|Adverse Event|1|||
28124598|NCT03515941|54786036|FG001|Overall Study|Adverse Event|0|||
28124599|NCT03011034|54786044|FG000|Overall Study|Adverse Event|1|||
28124600|NCT03011034|54786045|FG001|Overall Study|Adverse Event|0|||
28124601|NCT03515629|54786053|FG000|Overall Study|Death|0|||
28124602|NCT03515629|54786054|FG001|Overall Study|Death|1|||
28124603|NCT03515629|54786055|FG002|Overall Study|Death|1|||
28124604|NCT03515629|54786053|FG000|Overall Study|Progressive disease|0|||
28124605|NCT03515629|54786054|FG001|Overall Study|Progressive disease|1|||
28124606|NCT03515629|54786055|FG002|Overall Study|Progressive disease|0|||
28124607|NCT03512353|54786064|FG000|Overall Study|Sponsor Decision|3|||
28124608|NCT03512353|54786064|FG000|Overall Study|Death|1|||
28124609|NCT03512275|54786072|FG000|Overall Study|Withdrawal by Subject|1|||
28124610|NCT03512275|54786073|FG001|Overall Study|Withdrawal by Subject|3|||
28124611|NCT03512275|54786072|FG000|Overall Study|Physician Decision|0|||
28124612|NCT03512275|54786073|FG001|Overall Study|Physician Decision|1|||
28124613|NCT03512275|54786072|FG000|Overall Study|Lost to Follow-up|0|||
28124614|NCT03512275|54786073|FG001|Overall Study|Lost to Follow-up|3|||
28124615|NCT03512275|54786072|FG000|Overall Study|Other|1|||
27849331|NCT02082977|54345496|FG009|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
27849332|NCT01624259|54345530|FG000|Overall Study|Adverse Event|18|||
27849333|NCT01624259|54345531|FG001|Overall Study|Adverse Event|18|||
28124616|NCT03512275|54786073|FG001|Overall Study|Other|0|||
28124617|NCT03473197|54786079|FG000|Overall Study|Adverse Event|4|||
28124618|NCT03473197|54786079|FG000|Overall Study|Lost to Follow-up|1|||
28124619|NCT03473197|54786079|FG000|Overall Study|Withdrawal by Subject|5|||
28124620|NCT03511105|54786085|FG000|Overall Study|Adverse Event|1|||
28124621|NCT03511105|54786086|FG001|Overall Study|Adverse Event|0|||
28124622|NCT03511105|54786085|FG000|Overall Study|Withdrew consent|1|||
28124623|NCT03511105|54786086|FG001|Overall Study|Withdrew consent|0|||
28124624|NCT03510715|54786106|FG000|Overall Study|Adverse Event|1|||
28124625|NCT03510715|54786107|FG001|Overall Study|Adverse Event|0|||
28124626|NCT03508843|54786114|FG000|Overall Study|Withdrawal by Subject|1|||
28124627|NCT03508843|54786114|FG000|Overall Study|technical difficulties|2|||
27849334|NCT01624259|54345530|FG000|Overall Study|Protocol Violation|1|||
28124628|NCT03508609|54786118|FG000|Overall Study|Withdrawal by Subject|1|||
28124629|NCT03054350|54786128|FG000|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
28124630|NCT03054350|54786129|FG001|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
28124631|NCT03054350|54786130|FG002|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|1|||
28124632|NCT03054350|54786131|FG003|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
28124633|NCT03054350|54786132|FG004|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
28124634|NCT03054350|54786133|FG005|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|3|||
28124635|NCT03054350|54786128|FG000|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
28124636|NCT03054350|54786129|FG001|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
28124637|NCT03054350|54786130|FG002|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|1|||
28124638|NCT03054350|54786131|FG003|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
27849335|NCT01624259|54345531|FG001|Overall Study|Protocol Violation|2|||
28124639|NCT03054350|54786132|FG004|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
28124640|NCT03054350|54786133|FG005|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
28124641|NCT03054350|54786128|FG000|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
28124642|NCT03054350|54786129|FG001|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
28124643|NCT03054350|54786130|FG002|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
28124644|NCT03054350|54786131|FG003|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
28124645|NCT03054350|54786132|FG004|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
28124646|NCT03054350|54786133|FG005|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
28124647|NCT03054350|54786128|FG000|Dose Adjustment and Maintenance Period|Captured as Other|0|||
28124648|NCT03054350|54786129|FG001|Dose Adjustment and Maintenance Period|Captured as Other|0|||
28124649|NCT03054350|54786130|FG002|Dose Adjustment and Maintenance Period|Captured as Other|1|||
28124650|NCT03054350|54786131|FG003|Dose Adjustment and Maintenance Period|Captured as Other|0|||
28124651|NCT03054350|54786132|FG004|Dose Adjustment and Maintenance Period|Captured as Other|0|||
28124652|NCT03054350|54786133|FG005|Dose Adjustment and Maintenance Period|Captured as Other|0|||
28124653|NCT03528577|54786164|FG000|Sequence 1|Failed Spirometry|1|||
28124654|NCT03528577|54786164|FG000|Sequence 1|Restricted medication|1|||
28124655|NCT03528577|54786164|FG000|Sequence 2|Adverse Event|1|||
28124656|NCT03528577|54786164|FG000|Sequence 2|Withdrawal by Subject|1|||
27817933|NCT04206332|54275983|FG013|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
27817934|NCT04206332|54275984|FG014|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
27817935|NCT04206332|54275985|FG015|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
28124657|NCT03528577|54786164|FG000|Sequence 2|Failed Spirometry|1|||
28124658|NCT03528577|54786164|FG000|Sequence 3|Failed Spirometry|1|||
28124659|NCT03528577|54786164|FG000|Sequence 4|Failed Spirometry|2|||
28124660|NCT03528577|54786164|FG000|Sequence 4|Adverse Event|1|||
28124661|NCT00706654|54786174|FG000|Conversion Phase|Lost to Follow-up|4|||
28124662|NCT00706654|54786175|FG001|Conversion Phase|Lost to Follow-up|0|||
28124663|NCT00706654|54786176|FG002|Conversion Phase|Lost to Follow-up|0|||
28124664|NCT00706654|54786177|FG003|Conversion Phase|Lost to Follow-up|0|||
28124665|NCT00706654|54786174|FG000|Conversion Phase|Sponsor Discontinued Trial|8|||
28124666|NCT00706654|54786175|FG001|Conversion Phase|Sponsor Discontinued Trial|0|||
28124667|NCT00706654|54786176|FG002|Conversion Phase|Sponsor Discontinued Trial|0|||
28124668|NCT00706654|54786177|FG003|Conversion Phase|Sponsor Discontinued Trial|0|||
28124669|NCT00706654|54786174|FG000|Conversion Phase|Met Withdrawal Criteria|2|||
28124670|NCT00706654|54786175|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
28124671|NCT00706654|54786176|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
28124672|NCT00706654|54786177|FG003|Conversion Phase|Met Withdrawal Criteria|0|||
28124673|NCT00706654|54786174|FG000|Conversion Phase|Withdrawn by Investigator|14|||
28124674|NCT00706654|54786175|FG001|Conversion Phase|Withdrawn by Investigator|0|||
28124675|NCT00706654|54786176|FG002|Conversion Phase|Withdrawn by Investigator|0|||
28124676|NCT00706654|54786177|FG003|Conversion Phase|Withdrawn by Investigator|0|||
28124677|NCT00706654|54786174|FG000|Conversion Phase|Withdrew Consent|38|||
28124678|NCT00706654|54786175|FG001|Conversion Phase|Withdrew Consent|0|||
28124679|NCT00706654|54786176|FG002|Conversion Phase|Withdrew Consent|0|||
28124680|NCT00706654|54786177|FG003|Conversion Phase|Withdrew Consent|0|||
28124681|NCT00706654|54786174|FG000|Conversion Phase|Adverse Event|18|||
28124682|NCT00706654|54786175|FG001|Conversion Phase|Adverse Event|0|||
28124683|NCT00706654|54786176|FG002|Conversion Phase|Adverse Event|0|||
28124684|NCT00706654|54786177|FG003|Conversion Phase|Adverse Event|0|||
28124685|NCT00706654|54786174|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|9|||
28124686|NCT00706654|54786175|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
28124687|NCT00706654|54786176|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
28124688|NCT00706654|54786177|FG003|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
28124689|NCT00706654|54786174|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|2|||
28124690|NCT00706654|54786175|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
28124691|NCT00706654|54786176|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
28124692|NCT00706654|54786177|FG003|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
28124693|NCT00706654|54786174|FG000|Oral Stabilization Phase|Lost to Follow-up|17|||
28124694|NCT00706654|54786175|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
28124695|NCT00706654|54786176|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
28124696|NCT00706654|54786177|FG003|Oral Stabilization Phase|Lost to Follow-up|0|||
28124697|NCT00706654|54786174|FG000|Oral Stabilization Phase|Sponsor Discontinue Trial|19|||
28124698|NCT00706654|54786175|FG001|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
28124699|NCT00706654|54786176|FG002|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
28124700|NCT00706654|54786177|FG003|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
28124701|NCT00706654|54786174|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|15|||
27817936|NCT04206332|54275986|FG016|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
27817937|NCT04206332|54275970|FG000|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
27817938|NCT04206332|54275971|FG001|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
27817939|NCT04206332|54275972|FG002|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
27817940|NCT04206332|54275973|FG003|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
27817941|NCT04206332|54275974|FG004|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
27817942|NCT04206332|54275975|FG005|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
27817943|NCT04206332|54275976|FG006|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
28124702|NCT00706654|54786175|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
28124703|NCT00706654|54786176|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
28124704|NCT00706654|54786177|FG003|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
28124705|NCT00706654|54786174|FG000|Oral Stabilization Phase|Withdrawn by Investigator|21|||
28124706|NCT00706654|54786175|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
28124707|NCT00706654|54786176|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
28124708|NCT00706654|54786177|FG003|Oral Stabilization Phase|Withdrawn by Investigator|0|||
28124709|NCT00706654|54786174|FG000|Oral Stabilization Phase|Withdrew consent|55|||
28124710|NCT00706654|54786175|FG001|Oral Stabilization Phase|Withdrew consent|0|||
28124711|NCT00706654|54786176|FG002|Oral Stabilization Phase|Withdrew consent|0|||
28124712|NCT00706654|54786177|FG003|Oral Stabilization Phase|Withdrew consent|0|||
28124713|NCT00706654|54786174|FG000|Oral Stabilization Phase|Protocol Deviation|2|||
28124714|NCT00706654|54786175|FG001|Oral Stabilization Phase|Protocol Deviation|0|||
28124715|NCT00706654|54786176|FG002|Oral Stabilization Phase|Protocol Deviation|0|||
28124716|NCT00706654|54786177|FG003|Oral Stabilization Phase|Protocol Deviation|0|||
28124717|NCT00706654|54786174|FG000|Oral Stabilization Phase|Adverse Event|21|||
28124718|NCT00706654|54786175|FG001|Oral Stabilization Phase|Adverse Event|0|||
28124719|NCT00706654|54786176|FG002|Oral Stabilization Phase|Adverse Event|0|||
28124720|NCT00706654|54786177|FG003|Oral Stabilization Phase|Adverse Event|0|||
28124721|NCT00706654|54786174|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20|||
28124722|NCT00706654|54786175|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
28124723|NCT00706654|54786176|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
28124724|NCT00706654|54786177|FG003|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
28124725|NCT00706654|54786174|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10|||
28124726|NCT00706654|54786175|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
28124727|NCT00706654|54786176|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
28124728|NCT00706654|54786177|FG003|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
28124729|NCT00706654|54786174|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
28124730|NCT00706654|54786175|FG001|Depot Maintenance Phase|Lost to Follow-up|4|||
28124731|NCT00706654|54786176|FG002|Depot Maintenance Phase|Lost to Follow-up|10|||
28124732|NCT00706654|54786177|FG003|Depot Maintenance Phase|Lost to Follow-up|6|||
28124733|NCT00706654|54786174|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
28124734|NCT00706654|54786175|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|4|||
28124735|NCT00706654|54786176|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|6|||
28124736|NCT00706654|54786177|FG003|Depot Maintenance Phase|Met Withdrawal Criteria|5|||
28124737|NCT00706654|54786174|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
28124738|NCT00706654|54786175|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
28124739|NCT00706654|54786176|FG002|Depot Maintenance Phase|Withdrawn by Investigator|12|||
28124740|NCT00706654|54786177|FG003|Depot Maintenance Phase|Withdrawn by Investigator|8|||
28124741|NCT00706654|54786174|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
28124742|NCT00706654|54786175|FG001|Depot Maintenance Phase|Withdrew Consent|21|||
28124743|NCT00706654|54786176|FG002|Depot Maintenance Phase|Withdrew Consent|29|||
28124744|NCT00706654|54786177|FG003|Depot Maintenance Phase|Withdrew Consent|14|||
28124745|NCT00706654|54786174|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
28124746|NCT00706654|54786175|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
28124747|NCT00706654|54786176|FG002|Depot Maintenance Phase|Protocol Deviation|3|||
28124748|NCT00706654|54786177|FG003|Depot Maintenance Phase|Protocol Deviation|1|||
28124749|NCT00706654|54786174|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
28124750|NCT00706654|54786175|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|8|||
28124751|NCT00706654|54786176|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
28124752|NCT00706654|54786177|FG003|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
28124753|NCT00706654|54786174|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
28124754|NCT00706654|54786175|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
28124755|NCT00706654|54786176|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|12|||
28124756|NCT00706654|54786177|FG003|Depot Maintenance Phase|Impending Relapse with Adverse Event|17|||
28124757|NCT00706654|54786174|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
28124758|NCT00706654|54786175|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
28124759|NCT00706654|54786176|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
28124760|NCT00706654|54786177|FG003|Depot Maintenance Phase|Impending Relapse without Adverse Event|12|||
28124761|NCT03471871|54786189|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
28124762|NCT03471871|54786190|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
28124763|NCT03471871|54786191|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1|||
28124764|NCT03471871|54786192|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
28124765|NCT03471871|54786193|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
28124766|NCT03471871|54786189|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
27940488|NCT01189890|54596761|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
28124767|NCT03471871|54786190|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
28124768|NCT03471871|54786191|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
28124769|NCT03471871|54786192|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
28124770|NCT03471871|54786193|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
28124771|NCT03471871|54786189|FG000|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
28124772|NCT03471871|54786190|FG001|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
28124773|NCT03471871|54786191|FG002|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
28124774|NCT03471871|54786192|FG003|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
28124775|NCT03471871|54786193|FG004|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1|||
28124776|NCT03471871|54786189|FG000|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
28124777|NCT03471871|54786190|FG001|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
28124778|NCT03471871|54786191|FG002|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
28124779|NCT03471871|54786192|FG003|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
28124780|NCT03471871|54786193|FG004|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1|||
28124781|NCT03471871|54786189|FG000|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
28124782|NCT03471871|54786190|FG001|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
28124783|NCT03471871|54786191|FG002|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
28124784|NCT03471871|54786192|FG003|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1|||
28124785|NCT03471871|54786193|FG004|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
28124786|NCT01957176|54786211|FG000|Overall Study|Adverse Event|2|||
28124787|NCT01957176|54786212|FG001|Overall Study|Adverse Event|0|||
28124788|NCT01957176|54786211|FG000|Overall Study|Physician Decision|2|||
28124789|NCT01957176|54786212|FG001|Overall Study|Physician Decision|1|||
28124790|NCT01957176|54786211|FG000|Overall Study|Withdrawal by Subject|1|||
28124791|NCT01957176|54786212|FG001|Overall Study|Withdrawal by Subject|0|||
28124792|NCT03527173|54786221|FG000|Overall Study|Lost to Follow-up|4|||
28124793|NCT03527173|54786222|FG001|Overall Study|Lost to Follow-up|2|||
28124794|NCT03527173|54786221|FG000|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1|||
28124795|NCT03527173|54786222|FG001|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0|||
28124796|NCT03527173|54786221|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
28124797|NCT03527173|54786222|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
28124798|NCT03527173|54786221|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
27817944|NCT04206332|54275977|FG007|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
27817945|NCT04206332|54275978|FG008|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
28067151|NCT00090220|54722701|FG004|Base Study Vaccination Period|Adverse Event|0|||
28067152|NCT00090220|54722702|FG005|Base Study Vaccination Period|Adverse Event|0|||
28067153|NCT00090220|54722697|FG000|Base Study Vaccination Period|Lost to Follow-up|24|||
28067154|NCT00090220|54722698|FG001|Base Study Vaccination Period|Lost to Follow-up|28|||
28067155|NCT00090220|54722699|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
28067156|NCT00090220|54722700|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
28067157|NCT00090220|54722701|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
28067158|NCT00090220|54722702|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
28067159|NCT00090220|54722697|FG000|Base Study Vaccination Period|Withdrawal by Subject|23|||
28067160|NCT00090220|54722698|FG001|Base Study Vaccination Period|Withdrawal by Subject|27|||
28067161|NCT00090220|54722699|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
28067162|NCT00090220|54722700|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
28067163|NCT00090220|54722701|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
28067164|NCT00090220|54722702|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
28067165|NCT00090220|54722697|FG000|Base Study Vaccination Period|Patient Moved|6|||
28067166|NCT00090220|54722698|FG001|Base Study Vaccination Period|Patient Moved|2|||
28067167|NCT00090220|54722699|FG002|Base Study Vaccination Period|Patient Moved|0|||
28067168|NCT00090220|54722700|FG003|Base Study Vaccination Period|Patient Moved|0|||
28067169|NCT00090220|54722701|FG004|Base Study Vaccination Period|Patient Moved|0|||
28067170|NCT00090220|54722702|FG005|Base Study Vaccination Period|Patient Moved|0|||
28067171|NCT00090220|54722697|FG000|Base Study Vaccination Period|Other|4|||
28067172|NCT00090220|54722698|FG001|Base Study Vaccination Period|Other|4|||
28067173|NCT00090220|54722699|FG002|Base Study Vaccination Period|Other|0|||
28067174|NCT00090220|54722700|FG003|Base Study Vaccination Period|Other|0|||
28067175|NCT00090220|54722701|FG004|Base Study Vaccination Period|Other|0|||
28067176|NCT00090220|54722702|FG005|Base Study Vaccination Period|Other|0|||
27817946|NCT04206332|54275979|FG009|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
27817947|NCT04206332|54275980|FG010|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
28067177|NCT00090220|54722697|FG000|Base Study Follow-up Period|Adverse Event|6|||
28067178|NCT00090220|54722698|FG001|Base Study Follow-up Period|Adverse Event|1|||
28124799|NCT03527173|54786222|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
28124800|NCT00707980|54786228|FG000|Overall Study|Adverse Event|49|||
28124801|NCT00707980|54786228|FG000|Overall Study|Lack of Efficacy|35|||
28124802|NCT00707980|54786228|FG000|Overall Study|Non-Compliance with Study Drug|28|||
28124803|NCT00707980|54786228|FG000|Overall Study|Protocol Deviations|19|||
28124804|NCT00707980|54786228|FG000|Overall Study|Withdrawal of Consent|81|||
28124805|NCT00707980|54786228|FG000|Overall Study|Lost to Follow-up|59|||
28124806|NCT00707980|54786228|FG000|Overall Study|Other|39|||
28124807|NCT03506425|54786235|FG000|Overall Study|Adverse Event|1|||
28124808|NCT03506425|54786236|FG001|Overall Study|Adverse Event|3|||
28124809|NCT03506425|54786237|FG002|Overall Study|Adverse Event|0|||
28124810|NCT03506425|54786235|FG000|Overall Study|Death|1|||
28124811|NCT03506425|54786236|FG001|Overall Study|Death|0|||
28124812|NCT03506425|54786237|FG002|Overall Study|Death|0|||
28124813|NCT03506425|54786235|FG000|Overall Study|Withdrawal by Subject|0|||
28124814|NCT03506425|54786236|FG001|Overall Study|Withdrawal by Subject|0|||
28124815|NCT03506425|54786237|FG002|Overall Study|Withdrawal by Subject|1|||
28124816|NCT03051620|54786246|FG000|Overall Study|Lost to Follow-up|6|||
28124817|NCT03051620|54786246|FG000|Overall Study|n=124 enrolled in extension (all completed)|12|||
28124818|NCT03053492|54786252|FG000|Overall Study|Adverse Event|1|||
28124819|NCT03053492|54786253|FG001|Overall Study|Adverse Event|1|||
28124820|NCT03053492|54786252|FG000|Overall Study|Withdrawal by Subject|7|||
28124821|NCT03053492|54786253|FG001|Overall Study|Withdrawal by Subject|5|||
28124822|NCT04239872|54786259|FG000|Overall Study|Lost to Follow-up|0|||
28124823|NCT04239872|54786260|FG001|Overall Study|Lost to Follow-up|1|||
28124824|NCT03164772|54786268|FG000|Overall Study|Death|4|||
28124825|NCT03164772|54786269|FG001|Overall Study|Death|2|||
28067179|NCT00090220|54722699|FG002|Base Study Follow-up Period|Adverse Event|0|||
28067180|NCT00090220|54722700|FG003|Base Study Follow-up Period|Adverse Event|0|||
28067181|NCT00090220|54722701|FG004|Base Study Follow-up Period|Adverse Event|0|||
28124826|NCT03164772|54786268|FG000|Overall Study|Adverse Event|1|||
28124827|NCT03164772|54786269|FG001|Overall Study|Adverse Event|4|||
28124828|NCT03164772|54786268|FG000|Overall Study|Progressive Disease|11|||
28124829|NCT03164772|54786269|FG001|Overall Study|Progressive Disease|21|||
28124830|NCT03164772|54786268|FG000|Overall Study|Physician Decision|2|||
28124831|NCT03164772|54786269|FG001|Overall Study|Physician Decision|0|||
28124832|NCT03164772|54786268|FG000|Overall Study|Withdrawal by Subject|0|||
28124833|NCT03164772|54786269|FG001|Overall Study|Withdrawal by Subject|4|||
28124834|NCT03050450|54786292|FG000|Overall Study|Physician Decision|1|||
28124835|NCT03050450|54786293|FG001|Overall Study|Physician Decision|0|||
28124836|NCT03050450|54786294|FG002|Overall Study|Physician Decision|0|||
28124837|NCT03050450|54786295|FG003|Overall Study|Physician Decision|0|||
28124838|NCT03050450|54786296|FG004|Overall Study|Physician Decision|0|||
28124839|NCT03505021|54786310|FG000|Overall Study|Protocol Violation|1|||
28124840|NCT03505021|54786311|FG001|Overall Study|Protocol Violation|0|||
28124841|NCT03505021|54786310|FG000|Overall Study|Death|9|||
28124842|NCT03505021|54786311|FG001|Overall Study|Death|8|||
28124843|NCT03505021|54786310|FG000|Overall Study|Consent withdrawn by subject|6|||
28124844|NCT03505021|54786311|FG001|Overall Study|Consent withdrawn by subject|1|||
28124845|NCT03505021|54786310|FG000|Overall Study|Lost to Follow-up|5|||
28124846|NCT03505021|54786311|FG001|Overall Study|Lost to Follow-up|3|||
28067182|NCT00090220|54722702|FG005|Base Study Follow-up Period|Adverse Event|0|||
28067183|NCT00090220|54722697|FG000|Base Study Follow-up Period|Lost to Follow-up|88|||
28067184|NCT00090220|54722698|FG001|Base Study Follow-up Period|Lost to Follow-up|78|||
28067185|NCT00090220|54722699|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
28067186|NCT00090220|54722700|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
28067187|NCT00090220|54722701|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
28067188|NCT00090220|54722702|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
28067189|NCT00090220|54722697|FG000|Base Study Follow-up Period|Withdrawal by Subject|27|||
28067190|NCT00090220|54722698|FG001|Base Study Follow-up Period|Withdrawal by Subject|36|||
28067191|NCT00090220|54722699|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
28067192|NCT00090220|54722700|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
28067193|NCT00090220|54722701|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
28067194|NCT00090220|54722702|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
28067195|NCT00090220|54722697|FG000|Base Study Follow-up Period|Patient Moved|20|||
28067196|NCT00090220|54722698|FG001|Base Study Follow-up Period|Patient Moved|28|||
28067197|NCT00090220|54722699|FG002|Base Study Follow-up Period|Patient Moved|0|||
28124847|NCT03505021|54786310|FG000|Overall Study|Adverse Event|26|||
28124848|NCT03505021|54786311|FG001|Overall Study|Adverse Event|9|||
28124849|NCT03505021|54786310|FG000|Overall Study|Disease progression|33|||
28124850|NCT03505021|54786311|FG001|Overall Study|Disease progression|17|||
28124851|NCT03505021|54786310|FG000|Overall Study|Other|11|||
28124852|NCT03505021|54786311|FG001|Overall Study|Other|5|||
28124853|NCT03505021|54786310|FG000|Overall Study|Personal reason|21|||
28124854|NCT03505021|54786311|FG001|Overall Study|Personal reason|12|||
28124855|NCT03050372|54786317|FG000|Adaptation Night (Night #1 PSG)|Adverse Event|1|||
28124856|NCT03050372|54786318|FG001|Adaptation Night (Night #1 PSG)|Adverse Event|0|||
28067198|NCT00090220|54722700|FG003|Base Study Follow-up Period|Patient Moved|0|||
28124857|NCT03050372|54786317|FG000|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0|||
28124858|NCT03050372|54786318|FG001|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1|||
28124859|NCT03470545|54786325|FG000|Overall Study|Death|0|||
28124860|NCT03470545|54786326|FG001|Overall Study|Death|1|||
28124861|NCT03470545|54786325|FG000|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|1|||
28124862|NCT03470545|54786326|FG001|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|0|||
28124863|NCT03470545|54786325|FG000|Overall Study|Adverse Event|2|||
28124864|NCT03470545|54786326|FG001|Overall Study|Adverse Event|0|||
28124865|NCT03470545|54786325|FG000|Overall Study|Withdrawal by Subject|1|||
28124866|NCT03470545|54786326|FG001|Overall Study|Withdrawal by Subject|1|||
28124867|NCT03470545|54786325|FG000|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|0|||
28124868|NCT03470545|54786326|FG001|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|1|||
28124869|NCT03163446|54786335|FG000|Overall Study|Unable to return for Day 180 visit|2|||
28124870|NCT03163446|54786336|FG001|Overall Study|Unable to return for Day 180 visit|0|||
28124871|NCT03163446|54786335|FG000|Overall Study|Withdrawal by Subject|2|||
28124872|NCT03163446|54786336|FG001|Overall Study|Withdrawal by Subject|6|||
28124873|NCT03163446|54786335|FG000|Overall Study|Death|16|||
28124874|NCT03163446|54786336|FG001|Overall Study|Death|5|||
28124875|NCT03163446|54786335|FG000|Overall Study|Lost to Follow-up|6|||
28124876|NCT03163446|54786336|FG001|Overall Study|Lost to Follow-up|5|||
28067199|NCT00090220|54722701|FG004|Base Study Follow-up Period|Patient Moved|0|||
28067200|NCT00090220|54722702|FG005|Base Study Follow-up Period|Patient Moved|0|||
28067201|NCT00090220|54722697|FG000|Base Study Follow-up Period|Other|19|||
28067202|NCT00090220|54722698|FG001|Base Study Follow-up Period|Other|21|||
28067203|NCT00090220|54722699|FG002|Base Study Follow-up Period|Other|0|||
28067204|NCT00090220|54722700|FG003|Base Study Follow-up Period|Other|0|||
28067205|NCT00090220|54722701|FG004|Base Study Follow-up Period|Other|0|||
28067206|NCT00090220|54722702|FG005|Base Study Follow-up Period|Other|0|||
28067207|NCT00090220|54722697|FG000|Extension 1 (EXT1)|Adverse Event|0|||
28067208|NCT00090220|54722698|FG001|Extension 1 (EXT1)|Adverse Event|0|||
28067209|NCT00090220|54722699|FG002|Extension 1 (EXT1)|Adverse Event|4|||
28067210|NCT00090220|54722700|FG003|Extension 1 (EXT1)|Adverse Event|0|||
28067211|NCT00090220|54722701|FG004|Extension 1 (EXT1)|Adverse Event|0|||
28067212|NCT00090220|54722702|FG005|Extension 1 (EXT1)|Adverse Event|0|||
28067213|NCT00090220|54722697|FG000|Extension 1 (EXT1)|Lost to Follow-up|0|||
28067214|NCT00090220|54722698|FG001|Extension 1 (EXT1)|Lost to Follow-up|0|||
28067215|NCT00090220|54722699|FG002|Extension 1 (EXT1)|Lost to Follow-up|22|||
28067216|NCT00090220|54722700|FG003|Extension 1 (EXT1)|Lost to Follow-up|0|||
28067217|NCT00090220|54722701|FG004|Extension 1 (EXT1)|Lost to Follow-up|0|||
28067218|NCT00090220|54722702|FG005|Extension 1 (EXT1)|Lost to Follow-up|0|||
28067219|NCT00090220|54722697|FG000|Extension 1 (EXT1)|Moved|0|||
28067220|NCT00090220|54722698|FG001|Extension 1 (EXT1)|Moved|0|||
28067221|NCT00090220|54722699|FG002|Extension 1 (EXT1)|Moved|2|||
28067222|NCT00090220|54722700|FG003|Extension 1 (EXT1)|Moved|1|||
28067223|NCT00090220|54722701|FG004|Extension 1 (EXT1)|Moved|0|||
28067224|NCT00090220|54722702|FG005|Extension 1 (EXT1)|Moved|0|||
28067225|NCT00090220|54722697|FG000|Extension 1 (EXT1)|Withdrawal by Subject|0|||
28067226|NCT00090220|54722698|FG001|Extension 1 (EXT1)|Withdrawal by Subject|0|||
28067227|NCT00090220|54722699|FG002|Extension 1 (EXT1)|Withdrawal by Subject|25|||
28067228|NCT00090220|54722700|FG003|Extension 1 (EXT1)|Withdrawal by Subject|0|||
28067229|NCT00090220|54722701|FG004|Extension 1 (EXT1)|Withdrawal by Subject|0|||
28067230|NCT00090220|54722702|FG005|Extension 1 (EXT1)|Withdrawal by Subject|0|||
28067231|NCT00090220|54722697|FG000|Extension 1 (EXT1)|Protocol Violation|0|||
28067232|NCT00090220|54722698|FG001|Extension 1 (EXT1)|Protocol Violation|0|||
28067233|NCT00090220|54722699|FG002|Extension 1 (EXT1)|Protocol Violation|0|||
28067234|NCT00090220|54722700|FG003|Extension 1 (EXT1)|Protocol Violation|1|||
28067235|NCT00090220|54722701|FG004|Extension 1 (EXT1)|Protocol Violation|0|||
28067236|NCT00090220|54722702|FG005|Extension 1 (EXT1)|Protocol Violation|0|||
28067237|NCT00090220|54722697|FG000|Extension 1 (EXT1)|Other reason|0|||
28067238|NCT00090220|54722698|FG001|Extension 1 (EXT1)|Other reason|0|||
28067239|NCT00090220|54722699|FG002|Extension 1 (EXT1)|Other reason|2|||
28067240|NCT00090220|54722700|FG003|Extension 1 (EXT1)|Other reason|0|||
28124877|NCT03163446|54786335|FG000|Overall Study|Physician Decision|1|||
28124878|NCT03163446|54786336|FG001|Overall Study|Physician Decision|1|||
27817948|NCT04206332|54275981|FG011|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
27817949|NCT04206332|54275982|FG012|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
28067241|NCT00090220|54722701|FG004|Extension 1 (EXT1)|Other reason|0|||
28067242|NCT00090220|54722702|FG005|Extension 1 (EXT1)|Other reason|0|||
28067243|NCT00090220|54722697|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
28067244|NCT00090220|54722698|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
28067245|NCT00090220|54722699|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
28067246|NCT00090220|54722700|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
28124879|NCT03163446|54786335|FG000|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|1|||
28124880|NCT03163446|54786336|FG001|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|0|||
28124881|NCT03722485|54786350|FG000|Overall Study|Withdrawal by Subject|1|||
28124882|NCT03722485|54786351|FG001|Overall Study|Withdrawal by Subject|0|||
28124883|NCT03722485|54786350|FG000|Overall Study|Adverse Event|0|||
28124884|NCT03722485|54786351|FG001|Overall Study|Adverse Event|2|||
28124885|NCT03722485|54786350|FG000|Overall Study|subject discharged prior to study completion|1|||
28124886|NCT03722485|54786351|FG001|Overall Study|subject discharged prior to study completion|5|||
28124887|NCT03722485|54786350|FG000|Overall Study|eligibility criteria not met|2|||
28124888|NCT03722485|54786351|FG001|Overall Study|eligibility criteria not met|0|||
28124889|NCT03047720|54786381|FG000|First Intervention (6weeks)|Participant data entry insufficient|7|||
28124890|NCT03047720|54786382|FG001|First Intervention (6weeks)|Participant data entry insufficient|0|||
28124891|NCT03626168|54786407|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
27817950|NCT04206332|54275983|FG013|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
28124892|NCT03626168|54786408|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
28124893|NCT03626168|54786407|FG000|First Intervention (4 Weeks)|Began a medication that precluded participation|0|||
28124894|NCT03626168|54786408|FG001|First Intervention (4 Weeks)|Began a medication that precluded participation|1|||
28124895|NCT03626168|54786407|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
28124896|NCT03626168|54786408|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
28124897|NCT02966873|54786416|FG000|Overall Study|Lost to Follow-up|16|||
28124898|NCT02966873|54786417|FG001|Overall Study|Lost to Follow-up|15|||
28124899|NCT01389024|54786425|FG000|Overall Study|Withdrawal by Subject|0|||
27940489|NCT01189890|54596762|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
28124900|NCT01389024|54786426|FG001|Overall Study|Withdrawal by Subject|1|||
28124901|NCT01389024|54786425|FG000|Overall Study|Lost to Follow-up|1|||
28124902|NCT01389024|54786426|FG001|Overall Study|Lost to Follow-up|0|||
28124903|NCT03050060|54786436|FG000|Overall Study|Adverse Event|7|||
28124904|NCT03050060|54786436|FG000|Overall Study|Withdrawal by Subject|1|||
28124905|NCT03050060|54786436|FG000|Overall Study|Progression|7|||
28124906|NCT00706342|54786449|FG000|Overall Study|Adverse Event|3|||
28124907|NCT00706342|54786449|FG000|Overall Study|Not responding to treatment|2|||
28124908|NCT00706342|54786449|FG000|Overall Study|Withdrawn due to failure to respond|1|||
28124909|NCT00706342|54786449|FG000|Overall Study|Death|1|||
28124910|NCT00706342|54786449|FG000|Overall Study|Withdrew from the study on his own.|1|||
28067247|NCT00090220|54722701|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|38|||
28067248|NCT00090220|54722702|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|23|||
28067249|NCT00090220|54722697|FG000|Long-term Follow-up (EXT2)|Death|0|||
28067250|NCT00090220|54722698|FG001|Long-term Follow-up (EXT2)|Death|0|||
28124911|NCT00706342|54786449|FG000|Overall Study|Investigator discretion|2|||
28124912|NCT00706342|54786449|FG000|Overall Study|Non-responder Week 12|1|||
28124913|NCT00706342|54786449|FG000|Overall Study|Ongoing|6|||
28124914|NCT00706342|54786449|FG000|Overall Study|WIthdrawal of consent|1|||
28124915|NCT03049748|54786455|FG000|Overall Study|Lost to Follow-up|1|||
28124916|NCT03049748|54786456|FG001|Overall Study|Lost to Follow-up|0|||
28124917|NCT03049748|54786455|FG000|Overall Study|Death|3|||
28124918|NCT03049748|54786456|FG001|Overall Study|Death|0|||
28124919|NCT03049748|54786455|FG000|Overall Study|Withdrawal by Subject|0|||
28124920|NCT03049748|54786456|FG001|Overall Study|Withdrawal by Subject|3|||
28124921|NCT03049748|54786455|FG000|Overall Study|Protocol Violation|0|||
28124922|NCT03049748|54786456|FG001|Overall Study|Protocol Violation|2|||
28124923|NCT03049748|54786455|FG000|Overall Study|Moved out of state (relocation)|0|||
28124924|NCT03049748|54786456|FG001|Overall Study|Moved out of state (relocation)|1|||
28124925|NCT03501277|54786470|FG000|Intervention Period 1 (4 Days)|Other|0|||
28124926|NCT03501277|54786471|FG001|Intervention Period 1 (4 Days)|Other|0|||
28124927|NCT03501277|54786472|FG002|Intervention Period 1 (4 Days)|Other|1|||
28124928|NCT03501277|54786473|FG003|Intervention Period 1 (4 Days)|Other|0|||
28124929|NCT03501277|54786470|FG000|Intervention Period 1 (4 Days)|Adverse Event|0|||
28124930|NCT03501277|54786471|FG001|Intervention Period 1 (4 Days)|Adverse Event|0|||
28124931|NCT03501277|54786472|FG002|Intervention Period 1 (4 Days)|Adverse Event|0|||
28124932|NCT03501277|54786473|FG003|Intervention Period 1 (4 Days)|Adverse Event|1|||
28124933|NCT03501277|54786470|FG000|Intervention Period 2 (4 Days)|Adverse Event|0|||
28124934|NCT03501277|54786471|FG001|Intervention Period 2 (4 Days)|Adverse Event|0|||
28124935|NCT03501277|54786472|FG002|Intervention Period 2 (4 Days)|Adverse Event|0|||
28124936|NCT03501277|54786473|FG003|Intervention Period 2 (4 Days)|Adverse Event|1|||
28124937|NCT03501277|54786470|FG000|Intervention Period 3 (4 Days)|Adverse Event|0|||
27831261|NCT01787591|54307665|FG002|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
28067251|NCT00090220|54722699|FG002|Long-term Follow-up (EXT2)|Death|0|||
28067252|NCT00090220|54722700|FG003|Long-term Follow-up (EXT2)|Death|0|||
28067253|NCT00090220|54722701|FG004|Long-term Follow-up (EXT2)|Death|1|||
28067254|NCT00090220|54722702|FG005|Long-term Follow-up (EXT2)|Death|1|||
28067255|NCT00090220|54722697|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
28124938|NCT03501277|54786471|FG001|Intervention Period 3 (4 Days)|Adverse Event|0|||
27817951|NCT04206332|54275984|FG014|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
28124939|NCT03501277|54786472|FG002|Intervention Period 3 (4 Days)|Adverse Event|0|||
28124940|NCT03501277|54786473|FG003|Intervention Period 3 (4 Days)|Adverse Event|1|||
28124941|NCT03500419|54786485|FG000|Overall Study|Withdrawal by Subject|2|||
28124942|NCT03500419|54786486|FG001|Overall Study|Withdrawal by Subject|25|||
28124943|NCT03500341|54786492|FG000|Overall Study|Withdrawn prior to Completion|2|||
28124944|NCT01316900|54786513|FG000|Overall Study|Adverse Event|10|||
28124945|NCT01316900|54786514|FG001|Overall Study|Adverse Event|10|||
28124946|NCT01316900|54786515|FG002|Overall Study|Adverse Event|15|||
28124947|NCT01316900|54786516|FG003|Overall Study|Adverse Event|9|||
28124948|NCT01316900|54786513|FG000|Overall Study|Lack of Efficacy|17|||
28124949|NCT01316900|54786514|FG001|Overall Study|Lack of Efficacy|9|||
28124950|NCT01316900|54786515|FG002|Overall Study|Lack of Efficacy|5|||
28124951|NCT01316900|54786516|FG003|Overall Study|Lack of Efficacy|7|||
28124952|NCT01316900|54786513|FG000|Overall Study|Protocol Violation|7|||
28124953|NCT01316900|54786514|FG001|Overall Study|Protocol Violation|1|||
28124954|NCT01316900|54786515|FG002|Overall Study|Protocol Violation|4|||
28124955|NCT01316900|54786516|FG003|Overall Study|Protocol Violation|0|||
28124956|NCT01316900|54786513|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
28124957|NCT01316900|54786514|FG001|Overall Study|Protocol-defined Stopping Criteria|3|||
28124958|NCT01316900|54786515|FG002|Overall Study|Protocol-defined Stopping Criteria|10|||
28124959|NCT01316900|54786516|FG003|Overall Study|Protocol-defined Stopping Criteria|5|||
28124960|NCT01316900|54786513|FG000|Overall Study|Lost to Follow-up|1|||
28124961|NCT01316900|54786514|FG001|Overall Study|Lost to Follow-up|0|||
28124962|NCT01316900|54786515|FG002|Overall Study|Lost to Follow-up|1|||
28124963|NCT01316900|54786516|FG003|Overall Study|Lost to Follow-up|1|||
28124964|NCT01316900|54786513|FG000|Overall Study|Withdrawal by Subject|7|||
28124965|NCT01316900|54786514|FG001|Overall Study|Withdrawal by Subject|8|||
28124966|NCT01316900|54786515|FG002|Overall Study|Withdrawal by Subject|6|||
28124967|NCT01316900|54786516|FG003|Overall Study|Withdrawal by Subject|9|||
28124968|NCT03714815|54786526|FG000|Overall Study|Physician Decision|2|||
28124969|NCT03714815|54786526|FG000|Overall Study|Withdrawal by Subject|2|||
28124970|NCT03714815|54786526|FG000|Overall Study|Death|11|||
28124971|NCT00936390|54786532|FG000|Overall Study|Protocol Violation|21|||
28124972|NCT00936390|54786533|FG001|Overall Study|Protocol Violation|25|||
28124973|NCT03499873|54786544|FG000|Overall Study|Withdrawal by Subject|4|||
28124974|NCT03499873|54786545|FG001|Overall Study|Withdrawal by Subject|6|||
28124975|NCT03499873|54786546|FG002|Overall Study|Withdrawal by Subject|1|||
28124976|NCT03499873|54786544|FG000|Overall Study|Subjects condition worsened|0|||
27817952|NCT04206332|54275985|FG015|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
27817953|NCT04206332|54275986|FG016|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
27817954|NCT04206332|54275970|FG000|Part C|Withdrawal by Subject|0|||
27817955|NCT04206332|54275971|FG001|Part C|Withdrawal by Subject|0|||
27817956|NCT04206332|54275972|FG002|Part C|Withdrawal by Subject|0|||
27817957|NCT04206332|54275973|FG003|Part C|Withdrawal by Subject|0|||
27817958|NCT04206332|54275974|FG004|Part C|Withdrawal by Subject|0|||
27817959|NCT04206332|54275975|FG005|Part C|Withdrawal by Subject|0|||
27817960|NCT04206332|54275976|FG006|Part C|Withdrawal by Subject|0|||
27817961|NCT04206332|54275977|FG007|Part C|Withdrawal by Subject|0|||
27817962|NCT04206332|54275978|FG008|Part C|Withdrawal by Subject|0|||
27817963|NCT04206332|54275979|FG009|Part C|Withdrawal by Subject|0|||
27817964|NCT04206332|54275980|FG010|Part C|Withdrawal by Subject|0|||
27817965|NCT04206332|54275981|FG011|Part C|Withdrawal by Subject|0|||
27817966|NCT04206332|54275982|FG012|Part C|Withdrawal by Subject|0|||
27817967|NCT04206332|54275983|FG013|Part C|Withdrawal by Subject|0|||
27817968|NCT04206332|54275984|FG014|Part C|Withdrawal by Subject|2|||
27817969|NCT04206332|54275985|FG015|Part C|Withdrawal by Subject|0|||
27817970|NCT04206332|54275986|FG016|Part C|Withdrawal by Subject|0|||
28124977|NCT03499873|54786545|FG001|Overall Study|Subjects condition worsened|3|||
28124978|NCT03499873|54786546|FG002|Overall Study|Subjects condition worsened|11|||
28124979|NCT03499873|54786544|FG000|Overall Study|Adverse Event|8|||
28124980|NCT03499873|54786545|FG001|Overall Study|Adverse Event|3|||
28124981|NCT03499873|54786546|FG002|Overall Study|Adverse Event|6|||
28124982|NCT03499873|54786544|FG000|Overall Study|Physician Decision|1|||
28124983|NCT03499873|54786545|FG001|Overall Study|Physician Decision|0|||
28124984|NCT03499873|54786546|FG002|Overall Study|Physician Decision|0|||
28124985|NCT03499873|54786544|FG000|Overall Study|Administrative reasons|0|||
28124986|NCT03499873|54786545|FG001|Overall Study|Administrative reasons|1|||
27817971|NCT03830866|54276071|FG000|Overall Study|Ongoing study at DCO|312|||
27817972|NCT03830866|54276072|FG001|Overall Study|Ongoing study at DCO|295|||
27817973|NCT03830866|54276071|FG000|Overall Study|Death|58|||
27817974|NCT03830866|54276072|FG001|Overall Study|Death|74|||
27817975|NCT03830866|54276071|FG000|Overall Study|Lost to Follow-up|0|||
27817976|NCT03830866|54276072|FG001|Overall Study|Lost to Follow-up|1|||
28124987|NCT03499873|54786546|FG002|Overall Study|Administrative reasons|0|||
28124988|NCT03499873|54786544|FG000|Overall Study|Concomitant therapy|5|||
28124989|NCT03499873|54786545|FG001|Overall Study|Concomitant therapy|4|||
28124990|NCT03499873|54786546|FG002|Overall Study|Concomitant therapy|7|||
28124991|NCT03499873|54786544|FG000|Overall Study|Miscellaneous|1|||
28124992|NCT03499873|54786545|FG001|Overall Study|Miscellaneous|2|||
27817977|NCT03830866|54276071|FG000|Overall Study|Withdrawal by Subject|15|||
28124993|NCT03499873|54786546|FG002|Overall Study|Miscellaneous|2|||
28124994|NCT03499873|54786544|FG000|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
28124995|NCT03499873|54786545|FG001|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
28124996|NCT03499873|54786546|FG002|Overall Study|Investigational Product (IP) Missed dose compliance|0|||
28124997|NCT03467971|54786556|FG000|Treatment Period 2|Withdrawal by Subject|0|||
28124998|NCT03467971|54786557|FG001|Treatment Period 2|Withdrawal by Subject|1|||
28124999|NCT03049280|54786573|FG000|Overall Study|Physician Decision|1|||
28125000|NCT03048500|54786579|FG000|2 Cycles of Treatment|Withdrawal by Subject|1|||
28125001|NCT03048500|54786579|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|4|||
28125002|NCT03048500|54786579|FG000|Reached 1st Response/Continued Treatment|Death|1|||
28125003|NCT03048500|54786579|FG000|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1|||
28125004|NCT03048500|54786579|FG000|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1|||
28125005|NCT03048500|54786579|FG000|Follow up for 3 Years|Currently in Follow-up|4|||
28125006|NCT03048500|54786579|FG000|Follow up for 3 Years|Death|12|||
28125007|NCT00908076|54786585|FG000|Overall Study|Lack of Efficacy|1|||
28125008|NCT00908076|54786586|FG001|Overall Study|Lack of Efficacy|1|||
28125009|NCT03467425|54786594|FG000|Overall Study|Adverse Event|9|||
28125010|NCT03467425|54786595|FG001|Overall Study|Adverse Event|9|||
28125011|NCT03467425|54786594|FG000|Overall Study|Lack of Efficacy|3|||
28125012|NCT03467425|54786595|FG001|Overall Study|Lack of Efficacy|1|||
28125013|NCT03467425|54786594|FG000|Overall Study|Protocol Violation|0|||
28125014|NCT03467425|54786595|FG001|Overall Study|Protocol Violation|1|||
28125015|NCT03467425|54786594|FG000|Overall Study|Lost to Follow-up|18|||
27817978|NCT03830866|54276072|FG001|Overall Study|Withdrawal by Subject|13|||
28125016|NCT03467425|54786595|FG001|Overall Study|Lost to Follow-up|25|||
28125017|NCT03467425|54786594|FG000|Overall Study|Physician Decision|2|||
28125018|NCT03467425|54786595|FG001|Overall Study|Physician Decision|1|||
28125019|NCT03467425|54786594|FG000|Overall Study|Withdrawal by Subject|15|||
28125020|NCT03467425|54786595|FG001|Overall Study|Withdrawal by Subject|17|||
28125021|NCT02886702|54786604|FG000|Overall Study|Other|4|||
28125022|NCT02886702|54786605|FG001|Overall Study|Other|3|||
28125023|NCT02886702|54786606|FG002|Overall Study|Other|9|||
28125024|NCT02886702|54786604|FG000|Overall Study|Withdrawal by Subject|24|||
28125025|NCT02886702|54786605|FG001|Overall Study|Withdrawal by Subject|18|||
28125026|NCT02886702|54786606|FG002|Overall Study|Withdrawal by Subject|22|||
28125027|NCT02886702|54786604|FG000|Overall Study|Significant Worsening of Condition|0|||
28125028|NCT02886702|54786605|FG001|Overall Study|Significant Worsening of Condition|1|||
28125029|NCT02886702|54786606|FG002|Overall Study|Significant Worsening of Condition|0|||
28125030|NCT02886702|54786604|FG000|Overall Study|Protocol Violation|2|||
28125031|NCT02886702|54786605|FG001|Overall Study|Protocol Violation|2|||
28125032|NCT02886702|54786606|FG002|Overall Study|Protocol Violation|1|||
28125033|NCT02886702|54786604|FG000|Overall Study|Non-Compliance With Study Drug|0|||
28125034|NCT02886702|54786605|FG001|Overall Study|Non-Compliance With Study Drug|1|||
28125035|NCT02886702|54786606|FG002|Overall Study|Non-Compliance With Study Drug|4|||
28125036|NCT02886702|54786604|FG000|Overall Study|Lost to Follow-up|11|||
28125037|NCT02886702|54786605|FG001|Overall Study|Lost to Follow-up|13|||
28125038|NCT02886702|54786606|FG002|Overall Study|Lost to Follow-up|8|||
28125039|NCT02886702|54786604|FG000|Overall Study|Lack of Efficacy|3|||
27817979|NCT03830866|54276071|FG000|Overall Study|No longer eligible due to additional cancer diagnosis|0|||
27831262|NCT01787591|54307666|FG003|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1|||
28125040|NCT02886702|54786605|FG001|Overall Study|Lack of Efficacy|4|||
28125041|NCT02886702|54786606|FG002|Overall Study|Lack of Efficacy|5|||
28125042|NCT02886702|54786604|FG000|Overall Study|Adverse Event|4|||
28067256|NCT00090220|54722698|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
28067257|NCT00090220|54722699|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
28067258|NCT00090220|54722700|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
28067259|NCT00090220|54722701|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
28067260|NCT00090220|54722702|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
28125043|NCT02886702|54786605|FG001|Overall Study|Adverse Event|9|||
28125044|NCT02886702|54786606|FG002|Overall Study|Adverse Event|3|||
28125045|NCT02886702|54786604|FG000|Overall Study|Administrative Reasons|0|||
28125046|NCT02886702|54786605|FG001|Overall Study|Administrative Reasons|0|||
28125047|NCT02886702|54786606|FG002|Overall Study|Administrative Reasons|1|||
28125048|NCT03498313|54786620|FG000|Experimental Period 1|Adverse Event|1|||
28125049|NCT03498313|54786621|FG001|Experimental Period 1|Adverse Event|0|||
28125050|NCT03498313|54786622|FG002|Experimental Period 1|Adverse Event|0|||
28125051|NCT03498313|54786623|FG003|Experimental Period 1|Adverse Event|1|||
28125052|NCT03498313|54786624|FG004|Experimental Period 1|Adverse Event|0|||
28067261|NCT00090220|54722697|FG000|Long-term Follow-up (EXT2)|Other|0|||
28067262|NCT00090220|54722698|FG001|Long-term Follow-up (EXT2)|Other|0|||
28067263|NCT00090220|54722699|FG002|Long-term Follow-up (EXT2)|Other|0|||
28125053|NCT03498313|54786625|FG005|Experimental Period 1|Adverse Event|0|||
28125054|NCT03498313|54786620|FG000|Experimental Period 1|Withdrawal by Subject|0|||
28125055|NCT03498313|54786621|FG001|Experimental Period 1|Withdrawal by Subject|1|||
28125056|NCT03498313|54786622|FG002|Experimental Period 1|Withdrawal by Subject|0|||
28125057|NCT03498313|54786623|FG003|Experimental Period 1|Withdrawal by Subject|0|||
28125058|NCT03498313|54786624|FG004|Experimental Period 1|Withdrawal by Subject|0|||
28125059|NCT03498313|54786625|FG005|Experimental Period 1|Withdrawal by Subject|0|||
28125060|NCT03498313|54786620|FG000|Washout Period 1|Anovulation|1|||
28125061|NCT03498313|54786621|FG001|Washout Period 1|Anovulation|0|||
28125062|NCT03498313|54786622|FG002|Washout Period 1|Anovulation|0|||
28125063|NCT03498313|54786623|FG003|Washout Period 1|Anovulation|0|||
28125064|NCT03498313|54786624|FG004|Washout Period 1|Anovulation|0|||
28125065|NCT03498313|54786625|FG005|Washout Period 1|Anovulation|0|||
28125066|NCT03498313|54786620|FG000|Washout Period 1|Withdrawal by Subject|0|||
28125067|NCT03498313|54786621|FG001|Washout Period 1|Withdrawal by Subject|3|||
28125068|NCT03498313|54786622|FG002|Washout Period 1|Withdrawal by Subject|0|||
28125069|NCT03498313|54786623|FG003|Washout Period 1|Withdrawal by Subject|1|||
28125070|NCT03498313|54786624|FG004|Washout Period 1|Withdrawal by Subject|0|||
28125071|NCT03498313|54786625|FG005|Washout Period 1|Withdrawal by Subject|1|||
28067264|NCT00090220|54722700|FG003|Long-term Follow-up (EXT2)|Other|0|||
28067265|NCT00090220|54722701|FG004|Long-term Follow-up (EXT2)|Other|1|||
28067266|NCT00090220|54722702|FG005|Long-term Follow-up (EXT2)|Other|0|||
28067267|NCT00263328|54722722|FG000|Overall Study|Death|0|||
28067268|NCT00263328|54722723|FG001|Overall Study|Death|0|||
28067269|NCT00263328|54722724|FG002|Overall Study|Death|1|||
28067270|NCT00263328|54722722|FG000|Overall Study|Lost to Follow-up|1|||
28067271|NCT00263328|54722723|FG001|Overall Study|Lost to Follow-up|1|||
28067272|NCT00263328|54722724|FG002|Overall Study|Lost to Follow-up|0|||
28067273|NCT00263328|54722722|FG000|Overall Study|Withdrawal by Subject|3|||
28067274|NCT00263328|54722723|FG001|Overall Study|Withdrawal by Subject|0|||
28125072|NCT03498313|54786620|FG000|Experimental Period 2|Adverse Event|0|||
28125073|NCT03498313|54786621|FG001|Experimental Period 2|Adverse Event|0|||
28125074|NCT03498313|54786622|FG002|Experimental Period 2|Adverse Event|0|||
28125075|NCT03498313|54786623|FG003|Experimental Period 2|Adverse Event|0|||
28067275|NCT00263328|54722724|FG002|Overall Study|Withdrawal by Subject|1|||
28067276|NCT00263328|54722722|FG000|Overall Study|Other|3|||
28067277|NCT00263328|54722723|FG001|Overall Study|Other|0|||
28067278|NCT00263328|54722724|FG002|Overall Study|Other|1|||
28067279|NCT00263328|54722722|FG000|Overall Study|Adverse Event|1|||
28067280|NCT00263328|54722723|FG001|Overall Study|Adverse Event|1|||
28125076|NCT03498313|54786624|FG004|Experimental Period 2|Adverse Event|1|||
28125077|NCT03498313|54786625|FG005|Experimental Period 2|Adverse Event|2|||
28125078|NCT03498313|54786620|FG000|Washout Period 2|Physician Decision|1|||
28125079|NCT03498313|54786621|FG001|Washout Period 2|Physician Decision|0|||
28125080|NCT03498313|54786622|FG002|Washout Period 2|Physician Decision|0|||
28125081|NCT03498313|54786623|FG003|Washout Period 2|Physician Decision|1|||
28125082|NCT03498313|54786624|FG004|Washout Period 2|Physician Decision|0|||
28125083|NCT03498313|54786625|FG005|Washout Period 2|Physician Decision|1|||
28125084|NCT03498313|54786620|FG000|Washout Period 2|Withdrawal by Subject|3|||
28125085|NCT03498313|54786621|FG001|Washout Period 2|Withdrawal by Subject|2|||
28125086|NCT03498313|54786622|FG002|Washout Period 2|Withdrawal by Subject|0|||
27817980|NCT03830866|54276072|FG001|Overall Study|No longer eligible due to additional cancer diagnosis|1|||
27817981|NCT03830866|54276071|FG000|Overall Study|Other|0|||
27817982|NCT03830866|54276072|FG001|Overall Study|Other|1|||
27817983|NCT03790111|54276078|FG000|Overall Study|Study did not meet its primary endpoint.|53|||
27817984|NCT03780543|54276085|FG000|Overall Study|Adverse Event|1|||
27817985|NCT03780543|54276086|FG001|Overall Study|Adverse Event|0|||
27817986|NCT03780543|54276087|FG002|Overall Study|Adverse Event|2|||
27817987|NCT03780543|54276085|FG000|Overall Study|Lost to Follow-up|2|||
27817988|NCT03780543|54276086|FG001|Overall Study|Lost to Follow-up|0|||
27817989|NCT03780543|54276087|FG002|Overall Study|Lost to Follow-up|1|||
27817990|NCT03780543|54276085|FG000|Overall Study|Study terminated by Sponsor|8|||
27817991|NCT03780543|54276086|FG001|Overall Study|Study terminated by Sponsor|7|||
27817992|NCT03780543|54276087|FG002|Overall Study|Study terminated by Sponsor|13|||
27817993|NCT03780543|54276085|FG000|Overall Study|Withdrawal by Subject|1|||
27817994|NCT03780543|54276086|FG001|Overall Study|Withdrawal by Subject|8|||
27817995|NCT03780543|54276087|FG002|Overall Study|Withdrawal by Subject|1|||
27817996|NCT03780543|54276085|FG000|Overall Study|Noncompliance with study drug|1|||
27817997|NCT03780543|54276086|FG001|Overall Study|Noncompliance with study drug|0|||
27817998|NCT03780543|54276087|FG002|Overall Study|Noncompliance with study drug|0|||
27817999|NCT03745820|54276100|FG000|Overall Study|Adverse Event|0|||
27818000|NCT03745820|54276101|FG001|Overall Study|Adverse Event|3|||
27818001|NCT03745820|54276102|FG002|Overall Study|Adverse Event|2|||
27818002|NCT03745820|54276100|FG000|Overall Study|Non-Compliance with Study Drug|4|||
27818003|NCT03745820|54276101|FG001|Overall Study|Non-Compliance with Study Drug|3|||
27818004|NCT03745820|54276102|FG002|Overall Study|Non-Compliance with Study Drug|0|||
27818005|NCT03745820|54276100|FG000|Overall Study|Withdrawal by Subject|4|||
27818006|NCT03745820|54276101|FG001|Overall Study|Withdrawal by Subject|4|||
28067281|NCT00263328|54722724|FG002|Overall Study|Adverse Event|4|||
28067282|NCT00262860|54722734|FG000|Overall Study|Adverse Event|2|||
28067283|NCT00236184|54722740|FG000|Overall Study|Adverse Event|5|||
28067284|NCT00236184|54722741|FG001|Overall Study|Adverse Event|2|||
28067285|NCT00236184|54722740|FG000|Overall Study|Lack of Efficacy|0|||
28067286|NCT00236184|54722741|FG001|Overall Study|Lack of Efficacy|1|||
28067287|NCT00236184|54722740|FG000|Overall Study|Lost to Follow-up|3|||
28067288|NCT00236184|54722741|FG001|Overall Study|Lost to Follow-up|4|||
28067289|NCT00236184|54722740|FG000|Overall Study|Physician Decision|1|||
28067290|NCT00236184|54722741|FG001|Overall Study|Physician Decision|1|||
28067291|NCT00236184|54722740|FG000|Overall Study|Withdrawal by Subject|3|||
28067292|NCT00236184|54722741|FG001|Overall Study|Withdrawal by Subject|0|||
28067293|NCT00236184|54722740|FG000|Overall Study|Protocol Violation|3|||
28067294|NCT00236184|54722741|FG001|Overall Study|Protocol Violation|0|||
28067295|NCT00236184|54722740|FG000|Overall Study|non-compliance with study drug|2|||
28067296|NCT00236184|54722741|FG001|Overall Study|non-compliance with study drug|1|||
28067297|NCT00236184|54722740|FG000|Overall Study|other|1|||
28067298|NCT00236184|54722741|FG001|Overall Study|other|2|||
28067299|NCT00296504|54722755|FG000|Interim Analysis|Withdrawal by Subject|8|||
28067300|NCT00296504|54722756|FG001|Interim Analysis|Withdrawal by Subject|0|||
28067301|NCT00296504|54722757|FG002|Interim Analysis|Withdrawal by Subject|12|||
28067302|NCT00296504|54722758|FG003|Interim Analysis|Withdrawal by Subject|0|||
28067303|NCT00296504|54722759|FG004|Interim Analysis|Withdrawal by Subject|5|||
28067304|NCT00296504|54722760|FG005|Interim Analysis|Withdrawal by Subject|5|||
28067305|NCT00296504|54722761|FG006|Interim Analysis|Withdrawal by Subject|9|||
28125087|NCT03498313|54786623|FG003|Washout Period 2|Withdrawal by Subject|0|||
28125088|NCT03498313|54786624|FG004|Washout Period 2|Withdrawal by Subject|2|||
28125089|NCT03498313|54786625|FG005|Washout Period 2|Withdrawal by Subject|0|||
28125090|NCT03498313|54786620|FG000|Washout Period 2|Anovulation|0|||
28125091|NCT03498313|54786621|FG001|Washout Period 2|Anovulation|0|||
27818007|NCT03745820|54276102|FG002|Overall Study|Withdrawal by Subject|4|||
27818008|NCT03745820|54276100|FG000|Overall Study|Physician decision unrelated to safety/efficacy|0|||
27818009|NCT03745820|54276101|FG001|Overall Study|Physician decision unrelated to safety/efficacy|0|||
27831263|NCT01812707|54307681|FG000|Overall Study|Adverse Event|0|||
28067306|NCT00296504|54722762|FG007|Interim Analysis|Withdrawal by Subject|3|||
28067307|NCT00296504|54722763|FG008|Interim Analysis|Withdrawal by Subject|0|||
28067308|NCT00296504|54722755|FG000|Interim Analysis|Lost to Follow-up|13|||
28067309|NCT00296504|54722756|FG001|Interim Analysis|Lost to Follow-up|3|||
27818010|NCT03745820|54276102|FG002|Overall Study|Physician decision unrelated to safety/efficacy|4|||
27818011|NCT03745820|54276100|FG000|Overall Study|Lost to Follow-up|2|||
27818012|NCT03745820|54276101|FG001|Overall Study|Lost to Follow-up|0|||
27818013|NCT03745820|54276102|FG002|Overall Study|Lost to Follow-up|3|||
27818014|NCT03745820|54276100|FG000|Overall Study|Reason not Specified|2|||
27818015|NCT03745820|54276101|FG001|Overall Study|Reason not Specified|4|||
27818016|NCT03745820|54276102|FG002|Overall Study|Reason not Specified|1|||
27818017|NCT03699631|54276110|FG000|Overall Study|Adverse Event|3|||
27818018|NCT03686150|54276124|FG000|Overall Study|Withdrawal by Subject|1|||
27818019|NCT03686150|54276125|FG001|Overall Study|Withdrawal by Subject|1|||
27818020|NCT03686150|54276126|FG002|Overall Study|Withdrawal by Subject|1|||
27818021|NCT03686150|54276127|FG003|Overall Study|Withdrawal by Subject|0|||
27818022|NCT03686150|54276128|FG004|Overall Study|Withdrawal by Subject|1|||
27818023|NCT03686150|54276129|FG005|Overall Study|Withdrawal by Subject|2|||
27818024|NCT03686150|54276124|FG000|Overall Study|Physician Decision|1|||
27818025|NCT03686150|54276125|FG001|Overall Study|Physician Decision|0|||
27818026|NCT03686150|54276126|FG002|Overall Study|Physician Decision|0|||
27818027|NCT03686150|54276127|FG003|Overall Study|Physician Decision|0|||
27818028|NCT03686150|54276128|FG004|Overall Study|Physician Decision|0|||
27818029|NCT03686150|54276129|FG005|Overall Study|Physician Decision|1|||
27818030|NCT03686150|54276124|FG000|Overall Study|Lost to Follow-up|0|||
27818031|NCT03686150|54276125|FG001|Overall Study|Lost to Follow-up|1|||
27818032|NCT03686150|54276126|FG002|Overall Study|Lost to Follow-up|0|||
27818033|NCT03686150|54276127|FG003|Overall Study|Lost to Follow-up|0|||
27818034|NCT03686150|54276128|FG004|Overall Study|Lost to Follow-up|0|||
27818035|NCT03686150|54276129|FG005|Overall Study|Lost to Follow-up|0|||
27818036|NCT03604172|54276146|FG000|Overall Study|Lost to Follow-up|1|||
27818037|NCT03604172|54276147|FG001|Overall Study|Lost to Follow-up|2|||
27818038|NCT03530124|54276155|FG000|Overall Study|Withdrawal by Subject|0|||
27818039|NCT03530124|54276156|FG001|Overall Study|Withdrawal by Subject|1|||
27818040|NCT03530124|54276155|FG000|Overall Study|Protocol Violation|1|||
27818041|NCT03530124|54276156|FG001|Overall Study|Protocol Violation|0|||
27818042|NCT03530124|54276155|FG000|Overall Study|Discharged prior to study completion|1|||
27818043|NCT03530124|54276156|FG001|Overall Study|Discharged prior to study completion|0|||
27818044|NCT03496207|54276165|FG000|Base Study|Adverse Event|0|||
27818045|NCT03496207|54276166|FG001|Base Study|Adverse Event|0|||
27818046|NCT03496207|54276167|FG002|Base Study|Adverse Event|1|||
27818047|NCT03496207|54276168|FG003|Base Study|Adverse Event|1|||
27818048|NCT03496207|54276169|FG004|Base Study|Adverse Event|4|||
27818049|NCT03496207|54276165|FG000|Base Study|Death|0|||
27818050|NCT03496207|54276166|FG001|Base Study|Death|0|||
27818051|NCT03496207|54276167|FG002|Base Study|Death|0|||
27818052|NCT03496207|54276168|FG003|Base Study|Death|0|||
27818053|NCT03496207|54276169|FG004|Base Study|Death|1|||
27818054|NCT03496207|54276165|FG000|Base Study|Withdrawal by Subject|0|||
27818055|NCT03496207|54276166|FG001|Base Study|Withdrawal by Subject|0|||
27818056|NCT03496207|54276167|FG002|Base Study|Withdrawal by Subject|1|||
28067310|NCT00296504|54722757|FG002|Interim Analysis|Lost to Follow-up|26|||
28067311|NCT00296504|54722758|FG003|Interim Analysis|Lost to Follow-up|8|||
28067312|NCT00296504|54722759|FG004|Interim Analysis|Lost to Follow-up|14|||
28067313|NCT00296504|54722760|FG005|Interim Analysis|Lost to Follow-up|4|||
28067314|NCT00296504|54722761|FG006|Interim Analysis|Lost to Follow-up|11|||
28067315|NCT00296504|54722762|FG007|Interim Analysis|Lost to Follow-up|4|||
28067316|NCT00296504|54722763|FG008|Interim Analysis|Lost to Follow-up|0|||
28067317|NCT00296504|54722755|FG000|Interim Analysis|Clinical Progression|1|||
28067318|NCT00296504|54722756|FG001|Interim Analysis|Clinical Progression|0|||
28067319|NCT00296504|54722757|FG002|Interim Analysis|Clinical Progression|1|||
28067320|NCT00296504|54722758|FG003|Interim Analysis|Clinical Progression|1|||
28067321|NCT00296504|54722759|FG004|Interim Analysis|Clinical Progression|0|||
28067322|NCT00296504|54722760|FG005|Interim Analysis|Clinical Progression|2|||
28067323|NCT00296504|54722761|FG006|Interim Analysis|Clinical Progression|1|||
28067324|NCT00296504|54722762|FG007|Interim Analysis|Clinical Progression|2|||
28067325|NCT00296504|54722763|FG008|Interim Analysis|Clinical Progression|0|||
27818057|NCT03496207|54276168|FG003|Base Study|Withdrawal by Subject|0|||
27818058|NCT03496207|54276169|FG004|Base Study|Withdrawal by Subject|1|||
27818059|NCT03496207|54276165|FG000|Extension Period|Adverse Event|0|||
27818060|NCT03496207|54276166|FG001|Extension Period|Adverse Event|0|||
27818061|NCT03496207|54276167|FG002|Extension Period|Adverse Event|0|||
28067326|NCT00296504|54722755|FG000|Interim Analysis|Insufficient Viral Load Response|5|||
27818062|NCT03496207|54276168|FG003|Extension Period|Adverse Event|1|||
27818063|NCT03496207|54276169|FG004|Extension Period|Adverse Event|1|||
27818064|NCT03496207|54276165|FG000|Extension Period|Death|1|||
27818065|NCT03496207|54276166|FG001|Extension Period|Death|0|||
28067327|NCT00296504|54722756|FG001|Interim Analysis|Insufficient Viral Load Response|1|||
27818066|NCT03496207|54276167|FG002|Extension Period|Death|0|||
27818067|NCT03496207|54276168|FG003|Extension Period|Death|1|||
27818068|NCT03496207|54276169|FG004|Extension Period|Death|2|||
27818069|NCT03496207|54276165|FG000|Extension Period|Withdrawal by Subject|1|||
27818070|NCT03496207|54276166|FG001|Extension Period|Withdrawal by Subject|0|||
27818071|NCT03496207|54276167|FG002|Extension Period|Withdrawal by Subject|0|||
27818072|NCT03496207|54276168|FG003|Extension Period|Withdrawal by Subject|1|||
28125092|NCT03498313|54786622|FG002|Washout Period 2|Anovulation|0|||
28125093|NCT03498313|54786623|FG003|Washout Period 2|Anovulation|0|||
28125094|NCT03498313|54786624|FG004|Washout Period 2|Anovulation|0|||
28125095|NCT03498313|54786625|FG005|Washout Period 2|Anovulation|1|||
28125096|NCT02601014|54786635|FG000|Overall Study|Adverse Event|3|||
28125097|NCT02601014|54786636|FG001|Overall Study|Adverse Event|3|||
28125098|NCT02601014|54786635|FG000|Overall Study|Death|3|||
28125099|NCT02601014|54786636|FG001|Overall Study|Death|1|||
28125100|NCT02601014|54786635|FG000|Overall Study|Disease progression|4|||
28125101|NCT02601014|54786636|FG001|Overall Study|Disease progression|8|||
28125102|NCT01307046|54786644|FG000|Overall Study|Adverse Event|3|||
28125103|NCT01307046|54786645|FG001|Overall Study|Adverse Event|3|||
28125104|NCT01307046|54786644|FG000|Overall Study|Lack of Efficacy|0|||
28125105|NCT01307046|54786645|FG001|Overall Study|Lack of Efficacy|2|||
28125106|NCT01307046|54786644|FG000|Overall Study|Physician Decision|2|||
28125107|NCT01307046|54786645|FG001|Overall Study|Physician Decision|0|||
28125108|NCT01307046|54786644|FG000|Overall Study|Withdrawal by Subject|1|||
28125109|NCT01307046|54786645|FG001|Overall Study|Withdrawal by Subject|1|||
28125110|NCT01307046|54786644|FG000|Overall Study|Serum Potassium Withdrawal Criteria Met|4|||
28125111|NCT01307046|54786645|FG001|Overall Study|Serum Potassium Withdrawal Criteria Met|2|||
28125112|NCT01307046|54786644|FG000|Overall Study|Blood Pressure Withdrawal Criteria Met|2|||
28125113|NCT01307046|54786645|FG001|Overall Study|Blood Pressure Withdrawal Criteria Met|3|||
28125114|NCT03495817|54786651|FG000|26 Week Open Label|Adverse Event|3|||
28125115|NCT03495817|54786651|FG000|26 Week Open Label|Withdrawal by Subject|4|||
28125116|NCT03495817|54786651|FG000|26 Week Open Label|Lost to Follow-up|1|||
28125117|NCT03495817|54786651|FG000|26 Week Extension|Lost to Follow-up|2|||
28125118|NCT02886624|54786655|FG000|12-week Post Treatment Follow-up|Death|1|||
28125119|NCT02886624|54786655|FG000|48-week Post Treatment Follow-up|Lost to Follow-up|1|||
28125120|NCT02963766|54786662|FG000|Double-Blind Period|Adverse Event|1|||
28125121|NCT02963766|54786663|FG001|Double-Blind Period|Adverse Event|0|||
28125122|NCT02963766|54786664|FG002|Double-Blind Period|Adverse Event|1|||
28125123|NCT02963766|54786662|FG000|Double-Blind Period|Physician Decision|1|||
28125124|NCT02963766|54786663|FG001|Double-Blind Period|Physician Decision|0|||
28125125|NCT02963766|54786664|FG002|Double-Blind Period|Physician Decision|0|||
28125126|NCT02963766|54786662|FG000|Double-Blind Period|Withdrawal by Subject|1|||
28125127|NCT02963766|54786663|FG001|Double-Blind Period|Withdrawal by Subject|1|||
28125128|NCT02963766|54786664|FG002|Double-Blind Period|Withdrawal by Subject|0|||
28125129|NCT02963766|54786662|FG000|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
28125130|NCT02963766|54786663|FG001|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
28125131|NCT02963766|54786664|FG002|Double-Blind Period|Withdrawal by Parent or Guardian|1|||
28125132|NCT02963766|54786662|FG000|Double-Blind Period|Protocol Violation|1|||
28125133|NCT02963766|54786663|FG001|Double-Blind Period|Protocol Violation|0|||
28125134|NCT02963766|54786664|FG002|Double-Blind Period|Protocol Violation|0|||
28125135|NCT02963766|54786662|FG000|Double-Blind Period|Lost to Follow-up|0|||
27818073|NCT03496207|54276169|FG004|Extension Period|Withdrawal by Subject|1|||
28125136|NCT02963766|54786663|FG001|Double-Blind Period|Lost to Follow-up|1|||
28125137|NCT02963766|54786664|FG002|Double-Blind Period|Lost to Follow-up|0|||
28125138|NCT02963766|54786662|FG000|Open Label Extension (OLE)|Physician Decision|1|||
28125139|NCT02963766|54786663|FG001|Open Label Extension (OLE)|Physician Decision|2|||
28125140|NCT02963766|54786664|FG002|Open Label Extension (OLE)|Physician Decision|2|||
27818074|NCT03496207|54276165|FG000|Extension Period|Elevated hemoglobin levels|0|||
28125141|NCT02963766|54786662|FG000|Open Label Extension (OLE)|Withdrawal by Subject|1|||
28125142|NCT02963766|54786663|FG001|Open Label Extension (OLE)|Withdrawal by Subject|1|||
28125143|NCT02963766|54786664|FG002|Open Label Extension (OLE)|Withdrawal by Subject|0|||
27818075|NCT03496207|54276166|FG001|Extension Period|Elevated hemoglobin levels|0|||
27818076|NCT03496207|54276167|FG002|Extension Period|Elevated hemoglobin levels|0|||
27818077|NCT03496207|54276168|FG003|Extension Period|Elevated hemoglobin levels|0|||
27818078|NCT03496207|54276169|FG004|Extension Period|Elevated hemoglobin levels|1|||
27818079|NCT03204188|54276199|FG000|Immunotherapy Phase (1 Year)|Adverse Event|4|||
27818080|NCT03204188|54276199|FG000|Immunotherapy Phase (1 Year)|Death|1|||
27940490|NCT01189812|54596770|FG000|Overall Study|Withdrawal by Subject|2|||
27940491|NCT01189812|54596771|FG001|Overall Study|Withdrawal by Subject|3|||
28125144|NCT04839965|54786684|FG000|Overall Study|Death|6|||
28125145|NCT04839965|54786685|FG001|Overall Study|Death|6|||
28125146|NCT04839965|54786684|FG000|Overall Study|Lost to Follow-up|1|||
28125147|NCT04839965|54786685|FG001|Overall Study|Lost to Follow-up|0|||
28125148|NCT03466099|54786694|FG000|Overall Study|Adverse Event|1|||
28125149|NCT03466099|54786695|FG001|Overall Study|Adverse Event|1|||
28125150|NCT03466099|54786696|FG002|Overall Study|Adverse Event|1|||
28125151|NCT03466099|54786694|FG000|Overall Study|Withdrawal by Subject|2|||
28125152|NCT03466099|54786695|FG001|Overall Study|Withdrawal by Subject|3|||
28125153|NCT03466099|54786696|FG002|Overall Study|Withdrawal by Subject|1|||
28125154|NCT03466099|54786694|FG000|Overall Study|Use of rescue medication|8|||
28125155|NCT03466099|54786695|FG001|Overall Study|Use of rescue medication|9|||
28125156|NCT03466099|54786696|FG002|Overall Study|Use of rescue medication|13|||
28125157|NCT03466099|54786694|FG000|Overall Study|Rescued without meeting criteria|4|||
28125158|NCT03466099|54786695|FG001|Overall Study|Rescued without meeting criteria|1|||
28125159|NCT03466099|54786696|FG002|Overall Study|Rescued without meeting criteria|1|||
28125160|NCT03466099|54786694|FG000|Overall Study|Subject compliance|2|||
28125161|NCT03466099|54786695|FG001|Overall Study|Subject compliance|0|||
28125162|NCT03466099|54786696|FG002|Overall Study|Subject compliance|0|||
28125163|NCT03466099|54786694|FG000|Overall Study|Worsening disease|0|||
28125164|NCT03466099|54786695|FG001|Overall Study|Worsening disease|0|||
28125165|NCT03466099|54786696|FG002|Overall Study|Worsening disease|1|||
28125166|NCT00739674|54786706|FG000|Overall Study|Screening failures|19|||
28125167|NCT00739674|54786707|FG001|Overall Study|Screening failures|17|||
28125168|NCT00739674|54786706|FG000|Overall Study|Site 212 removal|19|||
28125169|NCT00739674|54786707|FG001|Overall Study|Site 212 removal|13|||
28125170|NCT00739674|54786706|FG000|Overall Study|No follow-up data|33|||
28125171|NCT00739674|54786707|FG001|Overall Study|No follow-up data|18|||
28125172|NCT00739674|54786706|FG000|Overall Study|Dietician consultation >30 days|1|||
28125173|NCT00739674|54786707|FG001|Overall Study|Dietician consultation >30 days|9|||
28125174|NCT00739674|54786706|FG000|Overall Study|Adverse Event|22|||
28125175|NCT00739674|54786707|FG001|Overall Study|Adverse Event|13|||
28125176|NCT00739674|54786706|FG000|Overall Study|Death|1|||
28125177|NCT00739674|54786707|FG001|Overall Study|Death|0|||
28125178|NCT00739674|54786706|FG000|Overall Study|Lack of Efficacy|1|||
28125179|NCT00739674|54786707|FG001|Overall Study|Lack of Efficacy|0|||
28125180|NCT00739674|54786706|FG000|Overall Study|Lost to Follow-up|52|||
28125181|NCT00739674|54786707|FG001|Overall Study|Lost to Follow-up|30|||
28125182|NCT00739674|54786706|FG000|Overall Study|Protocol Violation|5|||
28125183|NCT00739674|54786707|FG001|Overall Study|Protocol Violation|5|||
28125184|NCT00739674|54786706|FG000|Overall Study|Withdrawal by Subject|9|||
28125185|NCT00739674|54786707|FG001|Overall Study|Withdrawal by Subject|9|||
28125186|NCT00739674|54786706|FG000|Overall Study|Reason missing|2|||
28125187|NCT00739674|54786707|FG001|Overall Study|Reason missing|0|||
28125188|NCT00739674|54786706|FG000|Overall Study|Clinic closed|6|||
28125189|NCT00739674|54786707|FG001|Overall Study|Clinic closed|4|||
28125190|NCT00739674|54786706|FG000|Overall Study|Patient moved|3|||
28125191|NCT00739674|54786707|FG001|Overall Study|Patient moved|2|||
28125192|NCT00739674|54786706|FG000|Overall Study|Non compliant|4|||
28125193|NCT00739674|54786707|FG001|Overall Study|Non compliant|0|||
28125194|NCT00739674|54786706|FG000|Overall Study|Unable to attend visit|3|||
28125195|NCT00739674|54786707|FG001|Overall Study|Unable to attend visit|1|||
28125196|NCT00739674|54786706|FG000|Overall Study|Home monitoring off meds|1|||
28125197|NCT00739674|54786707|FG001|Overall Study|Home monitoring off meds|0|||
28125198|NCT00739674|54786706|FG000|Overall Study|Erectile dysfunction|0|||
28125199|NCT00739674|54786707|FG001|Overall Study|Erectile dysfunction|1|||
28125200|NCT03494725|54786715|FG000|Overall Study|Withdrawal by Subject|0|||
28125201|NCT03494725|54786716|FG001|Overall Study|Withdrawal by Subject|2|||
28125202|NCT03494725|54786715|FG000|Overall Study|Antibiotic use|1|||
28125203|NCT03494725|54786716|FG001|Overall Study|Antibiotic use|0|||
28125204|NCT00705718|54786730|FG000|Overall Study|Death|6|||
28125205|NCT00705718|54786731|FG001|Overall Study|Death|6|||
28125206|NCT00705718|54786730|FG000|Overall Study|Not due for Visit|0|||
28125207|NCT00705718|54786731|FG001|Overall Study|Not due for Visit|12|||
28125208|NCT00705718|54786730|FG000|Overall Study|Follow up not done|1|||
28125209|NCT00705718|54786731|FG001|Overall Study|Follow up not done|4|||
28125210|NCT03435211|54786746|FG000|Overall Study|Unable to achieve minimum desaturation level|1|||
28125211|NCT03465709|54786759|FG000|Overall Study|Study/Site Terminated by Sponsor|14|||
28125212|NCT03465709|54786759|FG000|Overall Study|Withdrawal by Subject|3|||
28125213|NCT03435055|54786765|FG000|Screening|Physician Decision|2|||
28125214|NCT03435055|54786765|FG000|Received Intervention|Did not complete nitrous administration|3|||
28125215|NCT03434977|54786778|FG000|Washout Period (at Least 6 Days)|Adverse Event|0|||
28125216|NCT03434977|54786779|FG001|Washout Period (at Least 6 Days)|Adverse Event|1|||
28125217|NCT03434119|54786787|FG000|Overall Study|Randomized but not treated|1|||
28125218|NCT03434119|54786788|FG001|Overall Study|Randomized but not treated|0|||
28125219|NCT03434119|54786787|FG000|Overall Study|Adverse Event|1|||
28125220|NCT03434119|54786788|FG001|Overall Study|Adverse Event|0|||
28125221|NCT03434119|54786787|FG000|Overall Study|Poor Compliance to Protocol|0|||
28125222|NCT03434119|54786788|FG001|Overall Study|Poor Compliance to Protocol|1|||
28125223|NCT03434119|54786787|FG000|Overall Study|Study Terminated by Sponsor|91|||
28125224|NCT03434119|54786788|FG001|Overall Study|Study Terminated by Sponsor|102|||
28125225|NCT03434119|54786787|FG000|Overall Study|Withdrawal by Subject|7|||
28125226|NCT03434119|54786788|FG001|Overall Study|Withdrawal by Subject|5|||
27818081|NCT03204188|54276199|FG000|Follow-up Phase (Extension Study)|Progression of Disease|4|||
27818082|NCT03204188|54276199|FG000|Follow-up Phase (Extension Study)|Adverse Event|2|||
27940492|NCT01189812|54596770|FG000|Overall Study|Adverse Event|1|||
27940493|NCT01189812|54596771|FG001|Overall Study|Adverse Event|0|||
28125227|NCT03434119|54786787|FG000|Overall Study|Other than specified|7|||
28125228|NCT03434119|54786788|FG001|Overall Study|Other than specified|5|||
28125229|NCT00378378|54786797|FG000|Overall Study|Withdrawal by Subject|0|||
28125230|NCT00378378|54786798|FG001|Overall Study|Withdrawal by Subject|1|||
28125231|NCT00378378|54786799|FG002|Overall Study|Withdrawal by Subject|0|||
28125232|NCT00378378|54786797|FG000|Overall Study|Treatment Failure|0|||
28125233|NCT00378378|54786798|FG001|Overall Study|Treatment Failure|0|||
28125234|NCT00378378|54786799|FG002|Overall Study|Treatment Failure|1|||
28125235|NCT00378378|54786797|FG000|Overall Study|Non-compliance with protocol|0|||
28125236|NCT00378378|54786798|FG001|Overall Study|Non-compliance with protocol|0|||
28125237|NCT00378378|54786799|FG002|Overall Study|Non-compliance with protocol|1|||
28125238|NCT03490981|54786809|FG000|Overall Study|Lost to Follow-up|1|||
28125239|NCT03490981|54786810|FG001|Overall Study|Lost to Follow-up|2|||
28125240|NCT03160716|54786816|FG000|Overall Study|Lost to Follow-up|1|||
28125241|NCT03713021|54786820|FG000|Overall Study|Did not have CT sim scan available|6|||
28125242|NCT03713021|54786820|FG000|Overall Study|Not eligible|4|||
28125243|NCT03713021|54786820|FG000|Overall Study|Issues with TraceIT markers|5|||
28125244|NCT03160560|54786828|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
28125245|NCT03160560|54786829|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
28125246|NCT03160560|54786830|FG002|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
28125247|NCT03160560|54786831|FG003|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
28125248|NCT03160560|54786828|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
28125249|NCT03160560|54786829|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
28125250|NCT03160560|54786830|FG002|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
28125251|NCT03160560|54786831|FG003|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
28125252|NCT03489343|54786848|FG000|Overall Study|Documented progressive disease|1|||
28125253|NCT03489343|54786849|FG001|Overall Study|Documented progressive disease|0|||
28125254|NCT03489343|54786850|FG002|Overall Study|Documented progressive disease|3|||
28125255|NCT03489343|54786851|FG003|Overall Study|Documented progressive disease|1|||
28125256|NCT03489343|54786852|FG004|Overall Study|Documented progressive disease|3|||
28125257|NCT03489343|54786853|FG005|Overall Study|Documented progressive disease|5|||
28125258|NCT03489343|54786854|FG006|Overall Study|Documented progressive disease|4|||
28125259|NCT03489343|54786848|FG000|Overall Study|Adverse Event|0|||
28125260|NCT03489343|54786849|FG001|Overall Study|Adverse Event|1|||
28125261|NCT03489343|54786850|FG002|Overall Study|Adverse Event|0|||
28125262|NCT03489343|54786851|FG003|Overall Study|Adverse Event|0|||
28125263|NCT03489343|54786852|FG004|Overall Study|Adverse Event|0|||
28125264|NCT03489343|54786853|FG005|Overall Study|Adverse Event|1|||
28125265|NCT03489343|54786854|FG006|Overall Study|Adverse Event|0|||
28125266|NCT03489343|54786848|FG000|Overall Study|Withdrawal by Subject|0|||
28125267|NCT03489343|54786849|FG001|Overall Study|Withdrawal by Subject|0|||
28125268|NCT03489343|54786850|FG002|Overall Study|Withdrawal by Subject|0|||
28125269|NCT03489343|54786851|FG003|Overall Study|Withdrawal by Subject|1|||
28125270|NCT03489343|54786852|FG004|Overall Study|Withdrawal by Subject|0|||
28125271|NCT03489343|54786853|FG005|Overall Study|Withdrawal by Subject|1|||
28125272|NCT03489343|54786854|FG006|Overall Study|Withdrawal by Subject|1|||
28125273|NCT03489343|54786848|FG000|Overall Study|Clinical progression|0|||
28125274|NCT03489343|54786849|FG001|Overall Study|Clinical progression|0|||
28125275|NCT03489343|54786850|FG002|Overall Study|Clinical progression|0|||
28125276|NCT03489343|54786851|FG003|Overall Study|Clinical progression|1|||
28125277|NCT03489343|54786852|FG004|Overall Study|Clinical progression|0|||
28125278|NCT03489343|54786853|FG005|Overall Study|Clinical progression|0|||
28125279|NCT03489343|54786854|FG006|Overall Study|Clinical progression|1|||
28125280|NCT03489109|54786872|FG000|Overall Study|Lost to Follow-up|1|||
28125281|NCT03489109|54786873|FG001|Overall Study|Lost to Follow-up|2|||
28125282|NCT03709823|54786885|FG000|Overall Study|Adverse Event|0|||
28125283|NCT03709823|54786886|FG001|Overall Study|Adverse Event|0|||
28125284|NCT03709823|54786887|FG002|Overall Study|Adverse Event|1|||
28125285|NCT03709823|54786888|FG003|Overall Study|Adverse Event|0|||
28125286|NCT03709823|54786889|FG004|Overall Study|Adverse Event|0|||
28125287|NCT03709823|54786890|FG005|Overall Study|Adverse Event|0|||
28125288|NCT03709823|54786885|FG000|Overall Study|Lost to Follow-up|2|||
28125289|NCT03709823|54786886|FG001|Overall Study|Lost to Follow-up|2|||
28125290|NCT03709823|54786887|FG002|Overall Study|Lost to Follow-up|2|||
28125291|NCT03709823|54786888|FG003|Overall Study|Lost to Follow-up|1|||
28125292|NCT03709823|54786889|FG004|Overall Study|Lost to Follow-up|1|||
28125293|NCT03709823|54786890|FG005|Overall Study|Lost to Follow-up|0|||
28125294|NCT03709823|54786885|FG000|Overall Study|Withdrawal by Subject|1|||
28125295|NCT03709823|54786886|FG001|Overall Study|Withdrawal by Subject|3|||
28125296|NCT03709823|54786887|FG002|Overall Study|Withdrawal by Subject|0|||
28125297|NCT03709823|54786888|FG003|Overall Study|Withdrawal by Subject|0|||
28125298|NCT03709823|54786889|FG004|Overall Study|Withdrawal by Subject|0|||
28125299|NCT03709823|54786890|FG005|Overall Study|Withdrawal by Subject|0|||
28125300|NCT03709823|54786885|FG000|Overall Study|Other, Not Specified|0|||
28125301|NCT03709823|54786886|FG001|Overall Study|Other, Not Specified|0|||
28125302|NCT03709823|54786887|FG002|Overall Study|Other, Not Specified|0|||
28125303|NCT03709823|54786888|FG003|Overall Study|Other, Not Specified|1|||
28125304|NCT03709823|54786889|FG004|Overall Study|Other, Not Specified|0|||
28125305|NCT03709823|54786890|FG005|Overall Study|Other, Not Specified|0|||
28125306|NCT03488563|54786910|FG000|Overall Study|Lost to Follow-up|7|||
28125307|NCT03488563|54786911|FG001|Overall Study|Lost to Follow-up|6|||
28125308|NCT03488563|54786912|FG002|Overall Study|Lost to Follow-up|7|||
28125309|NCT03488563|54786910|FG000|Overall Study|Withdrawal by Subject|8|||
28125310|NCT03488563|54786911|FG001|Overall Study|Withdrawal by Subject|7|||
28125311|NCT03488563|54786912|FG002|Overall Study|Withdrawal by Subject|7|||
28125312|NCT03488563|54786910|FG000|Overall Study|Physician Decision|0|||
28125313|NCT03488563|54786911|FG001|Overall Study|Physician Decision|0|||
28125314|NCT03488563|54786912|FG002|Overall Study|Physician Decision|1|||
28125315|NCT03488563|54786910|FG000|Overall Study|Protocol Violation|3|||
28125316|NCT03488563|54786911|FG001|Overall Study|Protocol Violation|2|||
28125317|NCT03488563|54786912|FG002|Overall Study|Protocol Violation|6|||
28125318|NCT03488563|54786910|FG000|Overall Study|Subject did not meet minimum number of migraines per month|1|||
28125319|NCT03488563|54786911|FG001|Overall Study|Subject did not meet minimum number of migraines per month|0|||
28125320|NCT03488563|54786912|FG002|Overall Study|Subject did not meet minimum number of migraines per month|0|||
28125321|NCT03488563|54786910|FG000|Overall Study|Use of prohibited medication|2|||
28125322|NCT03488563|54786911|FG001|Overall Study|Use of prohibited medication|0|||
28125323|NCT03488563|54786912|FG002|Overall Study|Use of prohibited medication|0|||
28125324|NCT03488563|54786910|FG000|Overall Study|Adverse Event|1|||
28125325|NCT03488563|54786911|FG001|Overall Study|Adverse Event|0|||
28125326|NCT03488563|54786912|FG002|Overall Study|Adverse Event|1|||
28125327|NCT03488563|54786910|FG000|Overall Study|Subject returned for ET visit|0|||
28125328|NCT03488563|54786911|FG001|Overall Study|Subject returned for ET visit|1|||
28125329|NCT03488563|54786912|FG002|Overall Study|Subject returned for ET visit|0|||
28125330|NCT03488563|54786910|FG000|Overall Study|Sponsor's decision|0|||
28125331|NCT03488563|54786911|FG001|Overall Study|Sponsor's decision|0|||
28125332|NCT03488563|54786912|FG002|Overall Study|Sponsor's decision|1|||
28125333|NCT00706030|54786926|FG000|Overall Study|Disease Progression|4|||
28125334|NCT00706030|54786927|FG001|Overall Study|Disease Progression|6|||
28125335|NCT00706030|54786928|FG002|Overall Study|Disease Progression|46|||
28125336|NCT00706030|54786929|FG003|Overall Study|Disease Progression|12|||
28125337|NCT00706030|54786926|FG000|Overall Study|Adverse Event|1|||
28125338|NCT00706030|54786927|FG001|Overall Study|Adverse Event|0|||
28125339|NCT00706030|54786928|FG002|Overall Study|Adverse Event|4|||
28125340|NCT00706030|54786929|FG003|Overall Study|Adverse Event|2|||
28125341|NCT00706030|54786926|FG000|Overall Study|Withdrawal by Subject|1|||
28125342|NCT00706030|54786927|FG001|Overall Study|Withdrawal by Subject|0|||
28125343|NCT00706030|54786928|FG002|Overall Study|Withdrawal by Subject|2|||
28125344|NCT00706030|54786929|FG003|Overall Study|Withdrawal by Subject|0|||
28125345|NCT00706030|54786926|FG000|Overall Study|Physician Decision|0|||
28125346|NCT00706030|54786927|FG001|Overall Study|Physician Decision|0|||
28125347|NCT00706030|54786928|FG002|Overall Study|Physician Decision|2|||
28125348|NCT00706030|54786929|FG003|Overall Study|Physician Decision|0|||
28125349|NCT00706030|54786926|FG000|Overall Study|Not recorded|0|||
28125350|NCT00706030|54786927|FG001|Overall Study|Not recorded|0|||
28125351|NCT00706030|54786928|FG002|Overall Study|Not recorded|2|||
27940494|NCT01189812|54596770|FG000|Overall Study|Out of Window|4|||
27940495|NCT01189812|54596771|FG001|Overall Study|Out of Window|3|||
28125352|NCT00706030|54786929|FG003|Overall Study|Not recorded|0|||
28125353|NCT00706030|54786926|FG000|Overall Study|Protocol Violation|0|||
28125354|NCT00706030|54786927|FG001|Overall Study|Protocol Violation|0|||
28125355|NCT00706030|54786928|FG002|Overall Study|Protocol Violation|1|||
28125356|NCT00706030|54786929|FG003|Overall Study|Protocol Violation|1|||
28125357|NCT00706030|54786926|FG000|Overall Study|Failed to return|0|||
28125358|NCT00706030|54786927|FG001|Overall Study|Failed to return|0|||
28125359|NCT00706030|54786928|FG002|Overall Study|Failed to return|1|||
28125360|NCT00706030|54786929|FG003|Overall Study|Failed to return|0|||
28125361|NCT00706030|54786926|FG000|Overall Study|Symptomatic Deterioration|0|||
28125362|NCT00706030|54786927|FG001|Overall Study|Symptomatic Deterioration|0|||
28125363|NCT00706030|54786928|FG002|Overall Study|Symptomatic Deterioration|1|||
28125364|NCT00706030|54786929|FG003|Overall Study|Symptomatic Deterioration|0|||
28125365|NCT00706030|54786926|FG000|Overall Study|No treatment received|0|||
28125366|NCT00706030|54786927|FG001|Overall Study|No treatment received|0|||
28125367|NCT00706030|54786928|FG002|Overall Study|No treatment received|0|||
28125368|NCT00706030|54786929|FG003|Overall Study|No treatment received|1|||
27940496|NCT01189812|54596770|FG000|Overall Study|Moved out of State|1|||
28067328|NCT00296504|54722757|FG002|Interim Analysis|Insufficient Viral Load Response|12|||
28067329|NCT00296504|54722758|FG003|Interim Analysis|Insufficient Viral Load Response|2|||
28067330|NCT00296504|54722759|FG004|Interim Analysis|Insufficient Viral Load Response|7|||
28067331|NCT00296504|54722760|FG005|Interim Analysis|Insufficient Viral Load Response|9|||
28067332|NCT00296504|54722761|FG006|Interim Analysis|Insufficient Viral Load Response|2|||
28067333|NCT00296504|54722762|FG007|Interim Analysis|Insufficient Viral Load Response|24|||
28067334|NCT00296504|54722763|FG008|Interim Analysis|Insufficient Viral Load Response|0|||
28067335|NCT00296504|54722755|FG000|Interim Analysis|Adverse Event|0|||
28067336|NCT00296504|54722756|FG001|Interim Analysis|Adverse Event|0|||
28067337|NCT00296504|54722757|FG002|Interim Analysis|Adverse Event|13|||
28067338|NCT00296504|54722758|FG003|Interim Analysis|Adverse Event|4|||
28067339|NCT00296504|54722759|FG004|Interim Analysis|Adverse Event|6|||
28067340|NCT00296504|54722760|FG005|Interim Analysis|Adverse Event|3|||
28067341|NCT00296504|54722761|FG006|Interim Analysis|Adverse Event|4|||
28067342|NCT00296504|54722762|FG007|Interim Analysis|Adverse Event|5|||
28067343|NCT00296504|54722763|FG008|Interim Analysis|Adverse Event|0|||
28067344|NCT00296504|54722755|FG000|Interim Analysis|Protocol Violation|0|||
28067345|NCT00296504|54722756|FG001|Interim Analysis|Protocol Violation|0|||
28067346|NCT00296504|54722757|FG002|Interim Analysis|Protocol Violation|2|||
28067347|NCT00296504|54722758|FG003|Interim Analysis|Protocol Violation|0|||
28067348|NCT00296504|54722759|FG004|Interim Analysis|Protocol Violation|1|||
28067349|NCT00296504|54722760|FG005|Interim Analysis|Protocol Violation|0|||
28067350|NCT00296504|54722761|FG006|Interim Analysis|Protocol Violation|0|||
28067351|NCT00296504|54722762|FG007|Interim Analysis|Protocol Violation|1|||
28067352|NCT00296504|54722763|FG008|Interim Analysis|Protocol Violation|0|||
28067353|NCT00296504|54722755|FG000|Interim Analysis|Insufficient CD4 Response|0|||
28125369|NCT00706030|54786926|FG000|Overall Study|Death|0|||
28125370|NCT00706030|54786927|FG001|Overall Study|Death|0|||
28125371|NCT00706030|54786928|FG002|Overall Study|Death|1|||
28125372|NCT00706030|54786929|FG003|Overall Study|Death|0|||
28125373|NCT03488251|54786944|FG000|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|1|||
27940497|NCT01189812|54596771|FG001|Overall Study|Moved out of State|2|||
28125374|NCT03488251|54786945|FG001|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
28125375|NCT03488251|54786946|FG002|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
28125376|NCT03488251|54786947|FG003|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
27940498|NCT00950950|54596779|FG000|Overall Study|Adverse Event|1|||
27940499|NCT00950950|54596780|FG001|Overall Study|Adverse Event|0|||
27940500|NCT00950950|54596779|FG000|Overall Study|Withdrawal by Subject|0|||
27940501|NCT00950950|54596780|FG001|Overall Study|Withdrawal by Subject|1|||
27940502|NCT00950872|54596787|FG000|Overall Study|Withdrawal by Subject|1|||
27940503|NCT00950872|54596787|FG000|Overall Study|Did not have surgery|2|||
27940504|NCT01189500|54596791|FG000|Period 1: TAMOX Alone|Adverse Event|1|||
27940505|NCT01189500|54596791|FG000|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1|||
27940506|NCT00938860|54596800|FG000|Overall Study|Adverse Event|2|||
27940507|NCT00938860|54596801|FG001|Overall Study|Adverse Event|1|||
27940508|NCT00938860|54596800|FG000|Overall Study|Abnormal laboratory values|2|||
27940509|NCT00938860|54596801|FG001|Overall Study|Abnormal laboratory values|2|||
27940510|NCT00938860|54596800|FG000|Overall Study|Withdrawal by Subject|11|||
27940511|NCT00938860|54596801|FG001|Overall Study|Withdrawal by Subject|8|||
27940512|NCT00938860|54596800|FG000|Overall Study|Lost to Follow-up|4|||
27940513|NCT00938860|54596801|FG001|Overall Study|Lost to Follow-up|4|||
28067354|NCT00296504|54722756|FG001|Interim Analysis|Insufficient CD4 Response|0|||
28067355|NCT00296504|54722757|FG002|Interim Analysis|Insufficient CD4 Response|0|||
28067356|NCT00296504|54722758|FG003|Interim Analysis|Insufficient CD4 Response|0|||
28067357|NCT00296504|54722759|FG004|Interim Analysis|Insufficient CD4 Response|1|||
27818083|NCT03112590|54276206|FG000|Overall Study|Adverse Event|0|||
28067358|NCT00296504|54722760|FG005|Interim Analysis|Insufficient CD4 Response|1|||
28067359|NCT00296504|54722761|FG006|Interim Analysis|Insufficient CD4 Response|0|||
28125377|NCT03488251|54786944|FG000|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|1|||
28125378|NCT03488251|54786945|FG001|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
28125379|NCT03488251|54786946|FG002|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
28125380|NCT03488251|54786947|FG003|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
28125381|NCT03488251|54786944|FG000|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|4|||
28125382|NCT03488251|54786945|FG001|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
28125383|NCT03488251|54786946|FG002|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
28125384|NCT03488251|54786947|FG003|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
28067360|NCT00296504|54722762|FG007|Interim Analysis|Insufficient CD4 Response|0|||
28067361|NCT00296504|54722763|FG008|Interim Analysis|Insufficient CD4 Response|0|||
28067362|NCT00296504|54722755|FG000|Interim Analysis|Switched to Commercially Available Drug|2|||
28067363|NCT00296504|54722756|FG001|Interim Analysis|Switched to Commercially Available Drug|0|||
28067364|NCT00296504|54722757|FG002|Interim Analysis|Switched to Commercially Available Drug|4|||
28067365|NCT00296504|54722758|FG003|Interim Analysis|Switched to Commercially Available Drug|1|||
28067366|NCT00296504|54722759|FG004|Interim Analysis|Switched to Commercially Available Drug|0|||
28067367|NCT00296504|54722760|FG005|Interim Analysis|Switched to Commercially Available Drug|5|||
28067368|NCT00296504|54722761|FG006|Interim Analysis|Switched to Commercially Available Drug|3|||
28067369|NCT00296504|54722762|FG007|Interim Analysis|Switched to Commercially Available Drug|4|||
28067370|NCT00296504|54722763|FG008|Interim Analysis|Switched to Commercially Available Drug|0|||
28067371|NCT00296504|54722755|FG000|Interim Analysis|Pregnancy|4|||
28067372|NCT00296504|54722756|FG001|Interim Analysis|Pregnancy|1|||
28067373|NCT00296504|54722757|FG002|Interim Analysis|Pregnancy|4|||
28067374|NCT00296504|54722758|FG003|Interim Analysis|Pregnancy|2|||
28067375|NCT00296504|54722759|FG004|Interim Analysis|Pregnancy|0|||
28067376|NCT00296504|54722760|FG005|Interim Analysis|Pregnancy|1|||
28067377|NCT00296504|54722761|FG006|Interim Analysis|Pregnancy|1|||
28067378|NCT00296504|54722762|FG007|Interim Analysis|Pregnancy|1|||
28067379|NCT00296504|54722763|FG008|Interim Analysis|Pregnancy|0|||
28067380|NCT00296504|54722755|FG000|Interim Analysis|Death|1|||
28067381|NCT00296504|54722756|FG001|Interim Analysis|Death|0|||
28067382|NCT00296504|54722757|FG002|Interim Analysis|Death|3|||
28067383|NCT00296504|54722758|FG003|Interim Analysis|Death|0|||
28067384|NCT00296504|54722759|FG004|Interim Analysis|Death|0|||
28067385|NCT00296504|54722760|FG005|Interim Analysis|Death|0|||
28067386|NCT00296504|54722761|FG006|Interim Analysis|Death|0|||
28067387|NCT00296504|54722762|FG007|Interim Analysis|Death|0|||
28067388|NCT00296504|54722763|FG008|Interim Analysis|Death|0|||
28067389|NCT00296504|54722755|FG000|Interim Analysis|Participant Non-compliant|0|||
28067390|NCT00296504|54722756|FG001|Interim Analysis|Participant Non-compliant|1|||
28067391|NCT00296504|54722757|FG002|Interim Analysis|Participant Non-compliant|2|||
28125385|NCT03488251|54786944|FG000|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|1|||
27940514|NCT00938860|54596800|FG000|Overall Study|Administration problems|2|||
27940515|NCT00938860|54596801|FG001|Overall Study|Administration problems|0|||
27940516|NCT00938860|54596800|FG000|Overall Study|Death|1|||
28067392|NCT00296504|54722758|FG003|Interim Analysis|Participant Non-compliant|1|||
28067393|NCT00296504|54722759|FG004|Interim Analysis|Participant Non-compliant|1|||
28067394|NCT00296504|54722760|FG005|Interim Analysis|Participant Non-compliant|3|||
28067395|NCT00296504|54722761|FG006|Interim Analysis|Participant Non-compliant|6|||
27818084|NCT03112590|54276207|FG001|Overall Study|Adverse Event|1|||
28125386|NCT03488251|54786945|FG001|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
28125387|NCT03488251|54786946|FG002|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
28125388|NCT03488251|54786947|FG003|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
28125389|NCT03488251|54786944|FG000|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|1|||
28125390|NCT03488251|54786945|FG001|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
28125391|NCT03488251|54786946|FG002|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
28125392|NCT03488251|54786947|FG003|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
28125393|NCT02727322|54786960|FG000|Overall Study|Withdrawal by Subject|1|||
28125394|NCT02727322|54786961|FG001|Overall Study|Withdrawal by Subject|1|||
28125395|NCT02727322|54786960|FG000|Overall Study|Protocol Violation|1|||
28125396|NCT02727322|54786961|FG001|Overall Study|Protocol Violation|0|||
28125397|NCT03431857|54786971|FG000|Overall Study|Death|6|||
28125398|NCT03431857|54786971|FG000|Overall Study|Lost to Follow-up|41|||
28125399|NCT03431857|54786971|FG000|Overall Study|Adverse Event|6|||
28125400|NCT03431857|54786971|FG000|Overall Study|Withdrawal by Subject|1|||
28125401|NCT03487549|54786977|FG000|Overall Study|Protocol Violation|0|||
28125402|NCT03487549|54786978|FG001|Overall Study|Protocol Violation|1|||
28125403|NCT03487549|54786977|FG000|Overall Study|Lost to Follow-up|2|||
28125404|NCT03487549|54786978|FG001|Overall Study|Lost to Follow-up|1|||
28125405|NCT03487549|54786977|FG000|Overall Study|Withdrawal by Subject|2|||
28125406|NCT03487549|54786978|FG001|Overall Study|Withdrawal by Subject|0|||
28125407|NCT03464383|54786987|FG000|Overall Study|Lost to Follow-up|1|||
28125408|NCT03464383|54786988|FG001|Overall Study|Lost to Follow-up|0|||
28125409|NCT03464383|54786989|FG002|Overall Study|Lost to Follow-up|0|||
28125410|NCT03464383|54786987|FG000|Overall Study|Withdrawal by Subject|0|||
28125411|NCT03464383|54786988|FG001|Overall Study|Withdrawal by Subject|1|||
28125412|NCT03464383|54786989|FG002|Overall Study|Withdrawal by Subject|0|||
28125413|NCT01444092|54786998|FG000|Overall Study|Adverse Event|8|||
28125414|NCT01444092|54786998|FG000|Overall Study|Protocol Violation|1|||
28125415|NCT01444092|54786998|FG000|Overall Study|Withdrawal by Subject|1|||
28125416|NCT01444092|54786998|FG000|Overall Study|Other Eligibility criteria|7|||
28125417|NCT01265784|54787005|FG000|Overall Study|Lost to Follow-up|5|||
28125418|NCT01265784|54787006|FG001|Overall Study|Lost to Follow-up|3|||
28125419|NCT01265784|54787007|FG002|Overall Study|Lost to Follow-up|2|||
27818085|NCT03112590|54276208|FG002|Overall Study|Adverse Event|0|||
27818086|NCT03060629|54276218|FG000|Overall Study|Death|4|||
27818087|NCT03060629|54276219|FG001|Overall Study|Death|5|||
28125420|NCT01265784|54787005|FG000|Overall Study|Withdrawal by Subject|0|||
28067396|NCT00296504|54722762|FG007|Interim Analysis|Participant Non-compliant|2|||
27818088|NCT03060629|54276218|FG000|Overall Study|Withdrawal by Subject|50|||
27818089|NCT03060629|54276219|FG001|Overall Study|Withdrawal by Subject|35|||
27818090|NCT03060629|54276218|FG000|Overall Study|Unable to Adhere to Visit Schedule|21|||
27818091|NCT03060629|54276219|FG001|Overall Study|Unable to Adhere to Visit Schedule|23|||
27818092|NCT03060629|54276218|FG000|Overall Study|Participant Relocate|15|||
27818093|NCT03060629|54276219|FG001|Overall Study|Participant Relocate|15|||
27818094|NCT03060629|54276218|FG000|Overall Study|Unable to Contact Participant|34|||
27818095|NCT03060629|54276219|FG001|Overall Study|Unable to Contact Participant|23|||
27818096|NCT03060629|54276218|FG000|Overall Study|Investigator Decision|7|||
28067397|NCT00296504|54722763|FG008|Interim Analysis|Participant Non-compliant|0|||
28067398|NCT00296504|54722755|FG000|Interim Analysis|Participant Wanted to Become Pregnant|0|||
28067399|NCT00296504|54722756|FG001|Interim Analysis|Participant Wanted to Become Pregnant|0|||
28067400|NCT00296504|54722757|FG002|Interim Analysis|Participant Wanted to Become Pregnant|2|||
28067401|NCT00296504|54722758|FG003|Interim Analysis|Participant Wanted to Become Pregnant|0|||
28067402|NCT00296504|54722759|FG004|Interim Analysis|Participant Wanted to Become Pregnant|0|||
28067403|NCT00296504|54722760|FG005|Interim Analysis|Participant Wanted to Become Pregnant|1|||
28067404|NCT00296504|54722761|FG006|Interim Analysis|Participant Wanted to Become Pregnant|0|||
28067405|NCT00296504|54722762|FG007|Interim Analysis|Participant Wanted to Become Pregnant|0|||
28125421|NCT01265784|54787006|FG001|Overall Study|Withdrawal by Subject|5|||
28125422|NCT01265784|54787007|FG002|Overall Study|Withdrawal by Subject|0|||
28125423|NCT01265784|54787005|FG000|Overall Study|Physician Decision|1|||
28125424|NCT01265784|54787006|FG001|Overall Study|Physician Decision|0|||
28125425|NCT01265784|54787007|FG002|Overall Study|Physician Decision|1|||
28125426|NCT01265784|54787005|FG000|Overall Study|Adverse Event|1|||
27818097|NCT03060629|54276219|FG001|Overall Study|Investigator Decision|7|||
27818098|NCT03060629|54276218|FG000|Overall Study|Study Terminated by Sponsor|1100|||
28125427|NCT01265784|54787006|FG001|Overall Study|Adverse Event|0|||
28125428|NCT01265784|54787007|FG002|Overall Study|Adverse Event|0|||
28125429|NCT01265784|54787005|FG000|Overall Study|Death|3|||
28125430|NCT01265784|54787006|FG001|Overall Study|Death|0|||
28125431|NCT01265784|54787007|FG002|Overall Study|Death|0|||
28125432|NCT01265784|54787005|FG000|Overall Study|Protocol Violation|2|||
28125433|NCT01265784|54787006|FG001|Overall Study|Protocol Violation|0|||
28125434|NCT01265784|54787007|FG002|Overall Study|Protocol Violation|0|||
28125435|NCT01265784|54787005|FG000|Overall Study|Incorrectly Randomized|0|||
28125436|NCT01265784|54787006|FG001|Overall Study|Incorrectly Randomized|0|||
28125437|NCT01265784|54787007|FG002|Overall Study|Incorrectly Randomized|1|||
28125438|NCT03156504|54787015|FG000|Overall Study|Withdrawal by Subject|1|||
28125439|NCT03159468|54787025|FG000|Overall Study|Withdrawal by Subject|0|||
28125440|NCT03159468|54787026|FG001|Overall Study|Withdrawal by Subject|0|||
28125441|NCT03159468|54787027|FG002|Overall Study|Withdrawal by Subject|3|||
28125442|NCT03159468|54787028|FG003|Overall Study|Withdrawal by Subject|0|||
28125443|NCT03159468|54787029|FG004|Overall Study|Withdrawal by Subject|0|||
28125444|NCT03159468|54787030|FG005|Overall Study|Withdrawal by Subject|0|||
28125445|NCT03430063|54787047|FG000|Overall Study|Adverse Event|0|||
28125446|NCT03430063|54787048|FG001|Overall Study|Adverse Event|1|||
28125447|NCT03430063|54787049|FG002|Overall Study|Adverse Event|0|||
28125448|NCT03430063|54787047|FG000|Overall Study|Death|3|||
28125449|NCT03430063|54787048|FG001|Overall Study|Death|2|||
28125450|NCT03430063|54787049|FG002|Overall Study|Death|3|||
28125451|NCT03430063|54787047|FG000|Overall Study|Lost to Follow-up|0|||
28125452|NCT03430063|54787048|FG001|Overall Study|Lost to Follow-up|1|||
28125453|NCT03430063|54787049|FG002|Overall Study|Lost to Follow-up|0|||
28125454|NCT03430063|54787047|FG000|Overall Study|Withdrawal by Subject|0|||
28125455|NCT03430063|54787048|FG001|Overall Study|Withdrawal by Subject|0|||
28125456|NCT03430063|54787049|FG002|Overall Study|Withdrawal by Subject|1|||
28125457|NCT03430063|54787047|FG000|Overall Study|Withdrawal of consent|3|||
28125458|NCT03430063|54787048|FG001|Overall Study|Withdrawal of consent|1|||
28125459|NCT03430063|54787049|FG002|Overall Study|Withdrawal of consent|2|||
28125460|NCT03430063|54787047|FG000|Overall Study|Progressive disease|1|||
28125461|NCT03430063|54787048|FG001|Overall Study|Progressive disease|2|||
28125462|NCT03430063|54787049|FG002|Overall Study|Progressive disease|1|||
28125463|NCT03430063|54787047|FG000|Overall Study|Other un-specified|1|||
28125464|NCT03430063|54787048|FG001|Overall Study|Other un-specified|1|||
28125465|NCT03430063|54787049|FG002|Overall Study|Other un-specified|0|||
28125466|NCT03430063|54787047|FG000|Overall Study|Randomized, but never treated|0|||
28125467|NCT03430063|54787048|FG001|Overall Study|Randomized, but never treated|0|||
28125468|NCT03430063|54787049|FG002|Overall Study|Randomized, but never treated|1|||
28125469|NCT03158220|54787060|FG000|Overall Study|Screen Failure|0|||
28125470|NCT03158220|54787061|FG001|Overall Study|Screen Failure|1|||
28125471|NCT03158220|54787060|FG000|Overall Study|Withdrawal by Subject|8|||
28125472|NCT03158220|54787061|FG001|Overall Study|Withdrawal by Subject|9|||
28125473|NCT03158220|54787060|FG000|Overall Study|Status unknown|0|||
28125474|NCT03158220|54787061|FG001|Overall Study|Status unknown|1|||
28125475|NCT03158220|54787060|FG000|Overall Study|Lost to Follow-up|8|||
28125476|NCT03158220|54787061|FG001|Overall Study|Lost to Follow-up|5|||
28125477|NCT03158220|54787060|FG000|Overall Study|Physician Decision|1|||
28125478|NCT03158220|54787061|FG001|Overall Study|Physician Decision|0|||
28125479|NCT03156270|54787067|FG000|Overall Study|Failed pre-treatment screening|1|||
28125480|NCT03156270|54787067|FG000|Overall Study|Lost to Follow-up|1|||
28125481|NCT03429049|54787075|FG000|Overall Study|Adverse Event|2|||
28125482|NCT03429049|54787076|FG001|Overall Study|Adverse Event|3|||
28125483|NCT03429049|54787075|FG000|Overall Study|Death|0|||
28125484|NCT03429049|54787076|FG001|Overall Study|Death|1|||
28125485|NCT03429049|54787075|FG000|Overall Study|Lack of Efficacy|4|||
28125486|NCT03429049|54787076|FG001|Overall Study|Lack of Efficacy|2|||
28125487|NCT03429049|54787075|FG000|Overall Study|Lost to Follow-up|9|||
28125488|NCT03429049|54787076|FG001|Overall Study|Lost to Follow-up|8|||
28125489|NCT03429049|54787075|FG000|Overall Study|Physician Decision|1|||
28125490|NCT03429049|54787076|FG001|Overall Study|Physician Decision|0|||
28125491|NCT03429049|54787075|FG000|Overall Study|Protocol Violation|3|||
28125492|NCT03429049|54787076|FG001|Overall Study|Protocol Violation|0|||
28125493|NCT03429049|54787075|FG000|Overall Study|Sponsor Decision|2|||
28125494|NCT03429049|54787076|FG001|Overall Study|Sponsor Decision|0|||
28125495|NCT03429049|54787075|FG000|Overall Study|Withdrawal by Subject|4|||
28125496|NCT03429049|54787076|FG001|Overall Study|Withdrawal by Subject|20|||
28125497|NCT03429049|54787075|FG000|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|3|||
28125498|NCT03429049|54787076|FG001|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|8|||
28125499|NCT03428815|54787084|FG000|Overall Study|Lost to Follow-up|2|||
28125500|NCT03428815|54787085|FG001|Overall Study|Lost to Follow-up|2|||
28125501|NCT03428815|54787084|FG000|Overall Study|suspension of study activities due to Covid-19 pandemic|5|||
28125502|NCT03428815|54787085|FG001|Overall Study|suspension of study activities due to Covid-19 pandemic|2|||
28125503|NCT03428815|54787084|FG000|Overall Study|Intermittent fitting issues that affected reliability of data|3|||
28125504|NCT03428815|54787085|FG001|Overall Study|Intermittent fitting issues that affected reliability of data|1|||
28125505|NCT03155724|54787091|FG000|Overall Study|Death|3|||
28125506|NCT03155724|54787091|FG000|Overall Study|Physician Decision|1|||
28125507|NCT03155724|54787091|FG000|Overall Study|Study closure|7|||
28125508|NCT03426787|54787095|FG000|Overall Study|Withdrawal by Subject|6|||
28125509|NCT03426787|54787095|FG000|Overall Study|Lost to Follow-up|7|||
28125510|NCT03426787|54787095|FG000|Overall Study|Unrelated to intervention death|1|||
28125511|NCT03426631|54787105|FG000|Overall Study|Lost to Follow-up|0|||
28125512|NCT03426631|54787106|FG001|Overall Study|Lost to Follow-up|1|||
28125513|NCT03484429|54787114|FG000|Overall Study|Withdrawal by Subject|1|||
28125514|NCT03484429|54787115|FG001|Overall Study|Withdrawal by Subject|0|||
28125515|NCT03484429|54787114|FG000|Overall Study|Adverse Event|2|||
28125516|NCT03484429|54787115|FG001|Overall Study|Adverse Event|0|||
28125517|NCT03484273|54787121|FG000|Overall Study|Equipment Malfunction|1|||
28125518|NCT03484273|54787121|FG000|Overall Study|Data excluded from analysis|1|||
28125519|NCT02724592|54787135|FG000|Overall Study|Lost to Follow-up|4|||
28125520|NCT02724592|54787136|FG001|Overall Study|Lost to Follow-up|1|||
28125521|NCT03154476|54787144|FG000|Overall Study|Lost to Follow-up|4|||
28125522|NCT03154476|54787145|FG001|Overall Study|Lost to Follow-up|4|||
28125523|NCT02726074|54787151|FG000|Overall Study|Withdrawal by Subject|4|||
28125524|NCT02726074|54787151|FG000|Overall Study|Adverse Event|14|||
28125525|NCT02726074|54787151|FG000|Overall Study|Protocol Violation|3|||
28125526|NCT02726074|54787151|FG000|Overall Study|Lost to Follow-up|2|||
28125527|NCT02726074|54787151|FG000|Overall Study|Others|3|||
28125528|NCT03482635|54787159|FG000|Overall Study|Lack of Efficacy|0|||
28125529|NCT03482635|54787160|FG001|Overall Study|Lack of Efficacy|0|||
28125530|NCT03482635|54787161|FG002|Overall Study|Lack of Efficacy|1|||
28125531|NCT03482635|54787162|FG003|Overall Study|Lack of Efficacy|3|||
28125532|NCT03482635|54787159|FG000|Overall Study|Adverse Event|2|||
28125533|NCT03482635|54787160|FG001|Overall Study|Adverse Event|2|||
28125534|NCT03482635|54787161|FG002|Overall Study|Adverse Event|0|||
28125535|NCT03482635|54787162|FG003|Overall Study|Adverse Event|3|||
28125536|NCT03482635|54787159|FG000|Overall Study|Withdrawal by Subject|2|||
28125537|NCT03482635|54787160|FG001|Overall Study|Withdrawal by Subject|1|||
27818099|NCT03060629|54276219|FG001|Overall Study|Study Terminated by Sponsor|1123|||
28125538|NCT03482635|54787161|FG002|Overall Study|Withdrawal by Subject|0|||
28125539|NCT03482635|54787162|FG003|Overall Study|Withdrawal by Subject|1|||
28125540|NCT03482635|54787159|FG000|Overall Study|Withdrawn by Principle Investigator|1|||
27818100|NCT03060629|54276218|FG000|Overall Study|Other|4|||
28125541|NCT03482635|54787160|FG001|Overall Study|Withdrawn by Principle Investigator|0|||
28125542|NCT03482635|54787161|FG002|Overall Study|Withdrawn by Principle Investigator|0|||
28125543|NCT03482635|54787162|FG003|Overall Study|Withdrawn by Principle Investigator|0|||
28125544|NCT03482635|54787159|FG000|Overall Study|Not treated|0|||
28125545|NCT03482635|54787160|FG001|Overall Study|Not treated|0|||
28125546|NCT03482635|54787161|FG002|Overall Study|Not treated|0|||
28125547|NCT03482635|54787162|FG003|Overall Study|Not treated|1|||
28125548|NCT03712787|54787176|FG000|Overall Study|Adverse Event|2|||
28125549|NCT03712787|54787177|FG001|Overall Study|Adverse Event|3|||
28125550|NCT03712787|54787178|FG002|Overall Study|Adverse Event|0|||
28125551|NCT03712787|54787179|FG003|Overall Study|Adverse Event|4|||
28125552|NCT03712787|54787176|FG000|Overall Study|Withdrawal by Subject|4|||
28125553|NCT03712787|54787177|FG001|Overall Study|Withdrawal by Subject|14|||
28125554|NCT03712787|54787178|FG002|Overall Study|Withdrawal by Subject|12|||
28125555|NCT03712787|54787179|FG003|Overall Study|Withdrawal by Subject|8|||
28125556|NCT03712787|54787176|FG000|Overall Study|Lost to Follow-up|1|||
28125557|NCT03712787|54787177|FG001|Overall Study|Lost to Follow-up|1|||
28125558|NCT03712787|54787178|FG002|Overall Study|Lost to Follow-up|2|||
28125559|NCT03712787|54787179|FG003|Overall Study|Lost to Follow-up|1|||
28125560|NCT03712787|54787176|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
28125561|NCT03712787|54787177|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
28125562|NCT03712787|54787178|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
28125563|NCT03712787|54787179|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
28125564|NCT03712787|54787176|FG000|Overall Study|COVID-19 Infection|0|||
28125565|NCT03712787|54787177|FG001|Overall Study|COVID-19 Infection|1|||
28125566|NCT03712787|54787178|FG002|Overall Study|COVID-19 Infection|0|||
28125567|NCT03712787|54787179|FG003|Overall Study|COVID-19 Infection|0|||
28125568|NCT03712787|54787176|FG000|Overall Study|Other, Not Specified|79|||
28125569|NCT03712787|54787177|FG001|Overall Study|Other, Not Specified|77|||
28125570|NCT03712787|54787178|FG002|Overall Study|Other, Not Specified|74|||
28125571|NCT03712787|54787179|FG003|Overall Study|Other, Not Specified|78|||
27818101|NCT03060629|54276219|FG001|Overall Study|Other|4|||
28125572|NCT03048422|54787211|FG000|Overall Study|Death|1|||
28125573|NCT03048422|54787212|FG001|Overall Study|Death|0|||
28125574|NCT03048422|54787213|FG002|Overall Study|Death|0|||
28125575|NCT03048422|54787211|FG000|Overall Study|Lost to Follow-up|5|||
28125576|NCT03048422|54787212|FG001|Overall Study|Lost to Follow-up|0|||
28125577|NCT03048422|54787213|FG002|Overall Study|Lost to Follow-up|1|||
28125578|NCT03048422|54787211|FG000|Overall Study|Withdrawal by Subject|5|||
28125579|NCT03048422|54787212|FG001|Overall Study|Withdrawal by Subject|7|||
28125580|NCT03048422|54787213|FG002|Overall Study|Withdrawal by Subject|4|||
28125581|NCT03048422|54787211|FG000|Overall Study|Moved|3|||
28125582|NCT03048422|54787212|FG001|Overall Study|Moved|2|||
28125583|NCT03048422|54787213|FG002|Overall Study|Moved|2|||
28125584|NCT03048422|54787211|FG000|Overall Study|Noncompliant with Study Requirements|2|||
28125585|NCT03048422|54787212|FG001|Overall Study|Noncompliant with Study Requirements|1|||
28125586|NCT03048422|54787213|FG002|Overall Study|Noncompliant with Study Requirements|2|||
28125587|NCT03048422|54787211|FG000|Overall Study|Not Able to Get to Clinic|1|||
28125588|NCT03048422|54787212|FG001|Overall Study|Not Able to Get to Clinic|0|||
28125589|NCT03048422|54787213|FG002|Overall Study|Not Able to Get to Clinic|0|||
28125590|NCT04664855|54787233|FG000|Overall Study|Withdrawal by Subject|0|||
28125591|NCT04664855|54787234|FG001|Overall Study|Withdrawal by Subject|2|||
28125592|NCT04664153|54787244|FG000|Overall Study|Lack of Efficacy|0|||
28125593|NCT04664153|54787245|FG001|Overall Study|Lack of Efficacy|0|||
28125594|NCT04664153|54787246|FG002|Overall Study|Lack of Efficacy|1|||
28125595|NCT04664153|54787247|FG003|Overall Study|Lack of Efficacy|0|||
28125596|NCT04664153|54787244|FG000|Overall Study|Physician Decision|0|||
28125597|NCT04664153|54787245|FG001|Overall Study|Physician Decision|0|||
28125598|NCT04664153|54787246|FG002|Overall Study|Physician Decision|1|||
28125599|NCT04664153|54787247|FG003|Overall Study|Physician Decision|0|||
28125600|NCT04664153|54787244|FG000|Overall Study|Withdrawal by Subject|3|||
27818102|NCT03021486|54276228|FG000|Overall Study|Withdrawal by Subject|1|||
28125601|NCT04664153|54787245|FG001|Overall Study|Withdrawal by Subject|2|||
28125602|NCT04664153|54787246|FG002|Overall Study|Withdrawal by Subject|1|||
28125603|NCT04664153|54787247|FG003|Overall Study|Withdrawal by Subject|2|||
28125604|NCT04664153|54787244|FG000|Overall Study|Other|0|||
27818103|NCT03021486|54276229|FG001|Overall Study|Withdrawal by Subject|1|||
28125605|NCT04664153|54787245|FG001|Overall Study|Other|1|||
28125606|NCT04664153|54787246|FG002|Overall Study|Other|0|||
28125607|NCT04664153|54787247|FG003|Overall Study|Other|0|||
28125608|NCT04664153|54787244|FG000|Overall Study|Adverse Event|4|||
28125609|NCT04664153|54787245|FG001|Overall Study|Adverse Event|0|||
28125610|NCT04664153|54787246|FG002|Overall Study|Adverse Event|1|||
28125611|NCT04664153|54787247|FG003|Overall Study|Adverse Event|0|||
28125612|NCT04663295|54787259|FG000|Run-in Period|Withdrawal by Subject|3|||
28125613|NCT04663295|54787259|FG000|Overall Study Period|Pregnancy|1|||
28125614|NCT04663295|54787259|FG000|Overall Study Period|Withdrawn by Parent/Guardian|1|||
27818104|NCT03021486|54276230|FG002|Overall Study|Withdrawal by Subject|3|||
28125615|NCT04228445|54787270|FG000|Overall Study|Lost to Follow-up|1|||
28125616|NCT04228445|54787271|FG001|Overall Study|Lost to Follow-up|1|||
28125617|NCT04228445|54787270|FG000|Overall Study|Physician Decision|1|||
28125618|NCT04228445|54787271|FG001|Overall Study|Physician Decision|2|||
28125619|NCT04228445|54787270|FG000|Overall Study|Withdrawal by Subject|0|||
28125620|NCT04228445|54787271|FG001|Overall Study|Withdrawal by Subject|1|||
28125621|NCT04228445|54787270|FG000|Overall Study|Planned procedure not performed after randomization, study drug not administered|1|||
28125622|NCT04228445|54787271|FG001|Overall Study|Planned procedure not performed after randomization, study drug not administered|0|||
28125623|NCT04641299|54787283|FG000|Overall Study|Adverse Event|0|||
28125624|NCT04641299|54787284|FG001|Overall Study|Adverse Event|0|||
28125625|NCT04641299|54787285|FG002|Overall Study|Adverse Event|2|||
28125626|NCT04641299|54787286|FG003|Overall Study|Adverse Event|0|||
28125627|NCT04641299|54787283|FG000|Overall Study|Lost to Follow-up|0|||
28125628|NCT04641299|54787284|FG001|Overall Study|Lost to Follow-up|1|||
28125629|NCT04641299|54787285|FG002|Overall Study|Lost to Follow-up|0|||
28125630|NCT04641299|54787286|FG003|Overall Study|Lost to Follow-up|0|||
28125631|NCT04641299|54787283|FG000|Overall Study|Withdrawal by Subject|1|||
28125632|NCT04641299|54787284|FG001|Overall Study|Withdrawal by Subject|0|||
28125633|NCT04641299|54787285|FG002|Overall Study|Withdrawal by Subject|0|||
28125634|NCT04641299|54787286|FG003|Overall Study|Withdrawal by Subject|0|||
28125635|NCT04641299|54787283|FG000|Overall Study|Reason not given|1|||
28125636|NCT04641299|54787284|FG001|Overall Study|Reason not given|0|||
28125637|NCT04641299|54787285|FG002|Overall Study|Reason not given|0|||
28125638|NCT04641299|54787286|FG003|Overall Study|Reason not given|0|||
27818105|NCT03021486|54276228|FG000|Overall Study|Did not develop an RASS score of at least >= 1|7|||
28125639|NCT03703817|54787302|FG000|Overall Study|Not meeting eligibility criteria|7|||
28125640|NCT03703817|54787303|FG001|Overall Study|Not meeting eligibility criteria|4|||
28125641|NCT03698591|54787311|FG000|Overall Study|Withdrawal by Subject|2|||
28125642|NCT03698591|54787312|FG001|Overall Study|Withdrawal by Subject|2|||
28125643|NCT03698591|54787311|FG000|Overall Study|Failed drug screen|1|||
27818106|NCT03021486|54276229|FG001|Overall Study|Did not develop an RASS score of at least >= 1|5|||
28125644|NCT03698591|54787312|FG001|Overall Study|Failed drug screen|1|||
28125645|NCT03698591|54787311|FG000|Overall Study|Failed health screen|0|||
28125646|NCT03698591|54787312|FG001|Overall Study|Failed health screen|1|||
28125647|NCT03698591|54787311|FG000|Overall Study|Ineligible for financial compensation|1|||
28125648|NCT03698591|54787312|FG001|Overall Study|Ineligible for financial compensation|0|||
28125649|NCT03698591|54787311|FG000|Overall Study|Equipment Error|1|||
28125650|NCT03698591|54787312|FG001|Overall Study|Equipment Error|0|||
28125651|NCT03698591|54787311|FG000|Overall Study|Could not establish TMS dosage|0|||
28125652|NCT03698591|54787312|FG001|Overall Study|Could not establish TMS dosage|1|||
28125653|NCT04606199|54787318|FG000|Overall Study|Withdrawal by Subject|2|||
28125654|NCT05085665|54787324|FG000|Overall Study|Physician Decision|2|||
28125655|NCT05017493|54787330|FG000|Overall Study|Withdrawal by Subject|26|||
28125656|NCT05017493|54787331|FG001|Overall Study|Withdrawal by Subject|0|||
28125657|NCT05017493|54787330|FG000|Overall Study|Physician Decision|15|||
28125658|NCT05017493|54787331|FG001|Overall Study|Physician Decision|0|||
28125659|NCT05017493|54787330|FG000|Overall Study|Protocol Violation|81|||
28125660|NCT05017493|54787331|FG001|Overall Study|Protocol Violation|0|||
28125661|NCT04599803|54787337|FG000|Overall Study|Withdrawal by Subject|5|||
28125662|NCT04599803|54787337|FG000|Overall Study|Lost to Follow-up|26|||
28125663|NCT05002985|54787341|FG000|Overall Study|Withdrawal by Subject|1|||
28125664|NCT04580303|54787347|FG000|Overall Study|Adverse Event|0|||
28125665|NCT04580303|54787348|FG001|Overall Study|Adverse Event|1|||
28125666|NCT04580303|54787349|FG002|Overall Study|Adverse Event|0|||
28125667|NCT04580303|54787350|FG003|Overall Study|Adverse Event|0|||
28125668|NCT04580303|54787347|FG000|Overall Study|Withdrawal by Subject|0|||
28125669|NCT04580303|54787348|FG001|Overall Study|Withdrawal by Subject|0|||
28125670|NCT04580303|54787349|FG002|Overall Study|Withdrawal by Subject|1|||
28125671|NCT04580303|54787350|FG003|Overall Study|Withdrawal by Subject|0|||
28125672|NCT04577183|54787360|FG000|Overall Study|Death|1|||
28125673|NCT04577183|54787360|FG000|Overall Study|Withdrawal by Subject|3|||
28125674|NCT04577183|54787360|FG000|Overall Study|Early termination|2|||
28125675|NCT03704051|54787364|FG000|Overall Study|Withdrawal by Subject|4|||
28125676|NCT03704051|54787365|FG001|Overall Study|Withdrawal by Subject|0|||
28125677|NCT04574999|54787375|FG000|Overall Study|Adverse Event|1|||
28125678|NCT04574999|54787376|FG001|Overall Study|Adverse Event|0|||
28125679|NCT04574999|54787375|FG000|Overall Study|Lack of Efficacy|2|||
28125680|NCT04574999|54787376|FG001|Overall Study|Lack of Efficacy|3|||
28125681|NCT04574999|54787375|FG000|Overall Study|Protocol Violation|1|||
28125682|NCT04574999|54787376|FG001|Overall Study|Protocol Violation|0|||
28125683|NCT04574999|54787375|FG000|Overall Study|Withdrawal by Subject|2|||
28125684|NCT04574999|54787376|FG001|Overall Study|Withdrawal by Subject|2|||
28125685|NCT04574999|54787375|FG000|Overall Study|Lost to Follow-up|1|||
28125686|NCT04574999|54787376|FG001|Overall Study|Lost to Follow-up|0|||
28125687|NCT04574999|54787375|FG000|Overall Study|Personal problems|1|||
28125688|NCT04574999|54787376|FG001|Overall Study|Personal problems|0|||
28125689|NCT04574999|54787375|FG000|Overall Study|Previous planned surgery|1|||
28125690|NCT04574999|54787376|FG001|Overall Study|Previous planned surgery|0|||
28125691|NCT04565249|54787386|FG000|Overall Study|Death|0|||
28125692|NCT04565249|54787387|FG001|Overall Study|Death|0|||
28125693|NCT04565249|54787388|FG002|Overall Study|Death|0|||
28125694|NCT04565249|54787389|FG003|Overall Study|Death|1|||
28125695|NCT04942925|54787401|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
28125696|NCT04942925|54787402|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
28125697|NCT04942925|54787401|FG000|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
28125698|NCT04942925|54787402|FG001|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
28125699|NCT04854707|54787414|FG000|Overall Study|Lack of Efficacy|78|||
28125700|NCT04854707|54787415|FG001|Overall Study|Lack of Efficacy|59|||
28125701|NCT04854707|54787416|FG002|Overall Study|Lack of Efficacy|30|||
28125702|NCT04557371|54787431|FG000|Overall Study|Covid-19-related|0|||
28125703|NCT04557371|54787432|FG001|Overall Study|Covid-19-related|1|||
28125704|NCT04557371|54787433|FG002|Overall Study|Covid-19-related|0|||
28125705|NCT04557371|54787431|FG000|Overall Study|Withdrawal by Subject|0|||
28125706|NCT04557371|54787432|FG001|Overall Study|Withdrawal by Subject|1|||
28125707|NCT04557371|54787433|FG002|Overall Study|Withdrawal by Subject|0|||
28125708|NCT04557371|54787431|FG000|Overall Study|Adverse Event|1|||
28125709|NCT04557371|54787432|FG001|Overall Study|Adverse Event|0|||
28125710|NCT04557371|54787433|FG002|Overall Study|Adverse Event|0|||
28125711|NCT04821245|54787441|FG000|Overall Study|Withdrawal by Subject|3|||
28125712|NCT04821245|54787441|FG000|Overall Study|Physician Decision|1|||
28125713|NCT04821245|54787441|FG000|Overall Study|Protocol Violation|5|||
28125714|NCT04539275|54787449|FG000|Overall Study|Death|2|||
28125715|NCT04539275|54787450|FG001|Overall Study|Death|4|||
28125716|NCT04539275|54787449|FG000|Overall Study|Lost to Follow-up|1|||
28125717|NCT04539275|54787450|FG001|Overall Study|Lost to Follow-up|1|||
28125718|NCT04539275|54787449|FG000|Overall Study|Withdrawal by Subject|3|||
28125719|NCT04539275|54787450|FG001|Overall Study|Withdrawal by Subject|0|||
28125720|NCT04784897|54787459|FG000|Overall Study|Death|4|||
28125721|NCT04784897|54787460|FG001|Overall Study|Death|2|||
28125722|NCT04784897|54787461|FG002|Overall Study|Death|1|||
28125723|NCT04784897|54787459|FG000|Overall Study|Withdrawal by Subject|0|||
28125724|NCT04784897|54787460|FG001|Overall Study|Withdrawal by Subject|0|||
28125725|NCT04784897|54787461|FG002|Overall Study|Withdrawal by Subject|1|||
28125726|NCT02780804|54787475|FG000|Overall Study|Death|1|||
28125727|NCT02780804|54787476|FG001|Overall Study|Death|0|||
27818107|NCT03021486|54276230|FG002|Overall Study|Did not develop an RASS score of at least >= 1|6|||
27818108|NCT02999789|54276242|FG000|Overall Study|Withdrawal by Subject|0|||
27818109|NCT02999789|54276243|FG001|Overall Study|Withdrawal by Subject|1|||
27818110|NCT02999789|54276242|FG000|Overall Study|Became ineligible|1|||
27818111|NCT02999789|54276243|FG001|Overall Study|Became ineligible|2|||
27818112|NCT02949128|54276250|FG000|Initial Evaluation Period|Failed to Meet Eligibility Criteria|2|||
27818113|NCT02949128|54276250|FG000|Initial Evaluation Period|Adverse Event|3|||
27818114|NCT02949128|54276250|FG000|Initial Evaluation Period|Death|2|||
27818115|NCT02949128|54276250|FG000|Initial Evaluation Period|Physician Decision|1|||
27818116|NCT02949128|54276250|FG000|Initial Evaluation Period|Protocol Violation|1|||
27818117|NCT02949128|54276250|FG000|Extension Period|Withdrawal by Subject|5|||
27818118|NCT02949128|54276250|FG000|Extension Period|Protocol Violation|1|||
27818119|NCT02949128|54276250|FG000|Extension Period|Physician Decision|2|||
27818120|NCT02949128|54276250|FG000|Extension Period|Ongoing in Extension Period as of 07/02/2019|41|||
27818121|NCT02923115|54276269|FG000|Overall Study|Lost to Follow-up|0|||
27818122|NCT02923115|54276270|FG001|Overall Study|Lost to Follow-up|0|||
27818123|NCT02923115|54276271|FG002|Overall Study|Lost to Follow-up|0|||
27818124|NCT02923115|54276272|FG003|Overall Study|Lost to Follow-up|1|||
27818125|NCT02923115|54276273|FG004|Overall Study|Lost to Follow-up|0|||
27818126|NCT02923115|54276274|FG005|Overall Study|Lost to Follow-up|0|||
27818127|NCT02923115|54276269|FG000|Overall Study|Withdrawal by Subject|0|||
27818128|NCT02923115|54276270|FG001|Overall Study|Withdrawal by Subject|1|||
27818129|NCT02923115|54276271|FG002|Overall Study|Withdrawal by Subject|0|||
27818130|NCT02923115|54276272|FG003|Overall Study|Withdrawal by Subject|0|||
27818131|NCT02923115|54276273|FG004|Overall Study|Withdrawal by Subject|0|||
27818132|NCT02923115|54276274|FG005|Overall Study|Withdrawal by Subject|0|||
27818133|NCT02923115|54276269|FG000|Overall Study|Randomized, but not dosed|0|||
27818134|NCT02923115|54276270|FG001|Overall Study|Randomized, but not dosed|0|||
27818135|NCT02923115|54276271|FG002|Overall Study|Randomized, but not dosed|3|||
27818136|NCT02923115|54276272|FG003|Overall Study|Randomized, but not dosed|1|||
27849336|NCT01624259|54345530|FG000|Overall Study|Withdrawal by Subject|5|||
27849337|NCT01624259|54345531|FG001|Overall Study|Withdrawal by Subject|7|||
28067406|NCT00296504|54722763|FG008|Interim Analysis|Participant Wanted to Become Pregnant|0|||
28067407|NCT00296504|54722755|FG000|Interim Analysis|To Simplify Treatment|0|||
28067408|NCT00296504|54722756|FG001|Interim Analysis|To Simplify Treatment|0|||
28067409|NCT00296504|54722757|FG002|Interim Analysis|To Simplify Treatment|1|||
28067410|NCT00296504|54722758|FG003|Interim Analysis|To Simplify Treatment|0|||
28067411|NCT00296504|54722759|FG004|Interim Analysis|To Simplify Treatment|0|||
28067412|NCT00296504|54722760|FG005|Interim Analysis|To Simplify Treatment|0|||
28067413|NCT00296504|54722761|FG006|Interim Analysis|To Simplify Treatment|2|||
28067414|NCT00296504|54722762|FG007|Interim Analysis|To Simplify Treatment|0|||
28067415|NCT00296504|54722763|FG008|Interim Analysis|To Simplify Treatment|0|||
28067416|NCT00296504|54722755|FG000|Interim Analysis|Participant Had Problems with Alcohol|0|||
28067417|NCT00296504|54722756|FG001|Interim Analysis|Participant Had Problems with Alcohol|0|||
28067418|NCT00296504|54722757|FG002|Interim Analysis|Participant Had Problems with Alcohol|1|||
28125728|NCT02780804|54787477|FG002|Overall Study|Death|0|||
28125729|NCT02780804|54787475|FG000|Overall Study|Lack of Efficacy|5|||
27818137|NCT02923115|54276273|FG004|Overall Study|Randomized, but not dosed|5|||
27818138|NCT02923115|54276274|FG005|Overall Study|Randomized, but not dosed|0|||
27818139|NCT02910583|54276290|FG000|Overall Study|Withdrawal by Subject|6|||
27818140|NCT02910583|54276291|FG001|Overall Study|Withdrawal by Subject|7|||
28125730|NCT02780804|54787476|FG001|Overall Study|Lack of Efficacy|8|||
28125731|NCT02780804|54787477|FG002|Overall Study|Lack of Efficacy|4|||
28125732|NCT02780804|54787475|FG000|Overall Study|Physician Decision|0|||
28125733|NCT02780804|54787476|FG001|Overall Study|Physician Decision|0|||
28125734|NCT02780804|54787477|FG002|Overall Study|Physician Decision|2|||
28125735|NCT02780804|54787475|FG000|Overall Study|Withdrawal by Subject|0|||
28125736|NCT02780804|54787476|FG001|Overall Study|Withdrawal by Subject|1|||
28125737|NCT02780804|54787477|FG002|Overall Study|Withdrawal by Subject|0|||
28125738|NCT04537949|54787494|FG000|Overall Study|personal reasons not related to the IMP|1|||
28125739|NCT04537949|54787495|FG001|Overall Study|personal reasons not related to the IMP|0|||
28125740|NCT04537949|54787496|FG002|Overall Study|personal reasons not related to the IMP|0|||
28125741|NCT04537949|54787497|FG003|Overall Study|personal reasons not related to the IMP|0|||
28125742|NCT04537949|54787498|FG004|Overall Study|personal reasons not related to the IMP|0|||
28125743|NCT04537949|54787499|FG005|Overall Study|personal reasons not related to the IMP|0|||
28125744|NCT04537949|54787500|FG006|Overall Study|personal reasons not related to the IMP|0|||
28125745|NCT04537949|54787501|FG007|Overall Study|personal reasons not related to the IMP|0|||
28125746|NCT04532099|54787522|FG000|First Wear Period (30 Days)|Withdrawal by Subject|1|||
28125747|NCT04532099|54787523|FG001|First Wear Period (30 Days)|Withdrawal by Subject|0|||
28125748|NCT04532099|54787524|FG002|First Wear Period (30 Days)|Withdrawal by Subject|0|||
28125749|NCT03041792|54787538|FG000|Overall Study|Adverse Event|4|||
28125750|NCT03041792|54787539|FG001|Overall Study|Adverse Event|0|||
28125751|NCT03041792|54787538|FG000|Overall Study|Death in the family|0|||
28125752|NCT03041792|54787539|FG001|Overall Study|Death in the family|2|||
28125753|NCT03041792|54787538|FG000|Overall Study|Randomized but not treated|0|||
28125754|NCT03041792|54787539|FG001|Overall Study|Randomized but not treated|1|||
28125755|NCT04507763|54787545|FG000|Overall Study|Participants did not meet entrance criteria|201|||
28125756|NCT03045302|54787552|FG000|Overall Study|Pre-treatment adverse event|1|||
28125757|NCT00705484|54787558|FG000|Overall Study|Adverse Event|28|||
28125758|NCT00705484|54787559|FG001|Overall Study|Adverse Event|27|||
28125759|NCT00705484|54787558|FG000|Overall Study|Lost to Follow-up|169|||
28125760|NCT00705484|54787559|FG001|Overall Study|Lost to Follow-up|250|||
28125761|NCT00705484|54787558|FG000|Overall Study|Withdrawal by Subject|96|||
28125762|NCT00705484|54787559|FG001|Overall Study|Withdrawal by Subject|72|||
28125763|NCT00705484|54787558|FG000|Overall Study|Administrative|89|||
28125764|NCT00705484|54787559|FG001|Overall Study|Administrative|59|||
28125765|NCT04523831|54787569|FG000|Overall Study|Lost to Follow-up|15|||
28125766|NCT04523831|54787570|FG001|Overall Study|Lost to Follow-up|17|||
28125767|NCT04523831|54787569|FG000|Overall Study|Death|0|||
28125768|NCT04523831|54787570|FG001|Overall Study|Death|3|||
28125769|NCT04523831|54787569|FG000|Overall Study|Adverse Event|2|||
28125770|NCT04523831|54787570|FG001|Overall Study|Adverse Event|0|||
28125771|NCT04707664|54787581|FG000|Overall Study|Adverse Event|2|||
28125772|NCT04707664|54787582|FG001|Overall Study|Adverse Event|0|||
28125773|NCT04707664|54787581|FG000|Overall Study|Death|1|||
28125774|NCT04707664|54787582|FG001|Overall Study|Death|2|||
28125775|NCT04707664|54787581|FG000|Overall Study|Withdrawal by Subject|13|||
28125776|NCT04707664|54787582|FG001|Overall Study|Withdrawal by Subject|21|||
28125777|NCT04707664|54787581|FG000|Overall Study|Lost to Follow-up|11|||
28125778|NCT04707664|54787582|FG001|Overall Study|Lost to Follow-up|13|||
28125779|NCT04707664|54787581|FG000|Overall Study|Not treated|2|||
28125780|NCT04707664|54787582|FG001|Overall Study|Not treated|0|||
28125781|NCT01316276|54787588|FG000|Overall Study|Death|1|||
28125782|NCT01316276|54787588|FG000|Overall Study|Adverse Event|19|||
28125783|NCT01316276|54787588|FG000|Overall Study|Withdrawal of consent|24|||
28125784|NCT01316276|54787588|FG000|Overall Study|Lost to Follow-up|1|||
28125785|NCT01316276|54787588|FG000|Overall Study|Other|22|||
28125786|NCT04668989|54787593|FG000|First Intervention|Covid-19 related self-isolation|0|||
28125787|NCT04668989|54787594|FG001|First Intervention|Covid-19 related self-isolation|1|||
28125788|NCT04668989|54787593|FG000|Second Intervention|Adverse Event|0|||
28125789|NCT04668989|54787594|FG001|Second Intervention|Adverse Event|1|||
28125790|NCT03700385|54787600|FG000|Overall Study|Lost to Follow-up|1|||
28125791|NCT04498403|54787606|FG000|Overall Study|Adverse Event|1|||
28125792|NCT04498403|54787607|FG001|Overall Study|Adverse Event|0|||
28125793|NCT04498403|54787606|FG000|Overall Study|Study Terminated By Sponsor|29|||
28125794|NCT04498403|54787607|FG001|Overall Study|Study Terminated By Sponsor|10|||
28125795|NCT04362137|54787615|FG000|Overall Study|Death|9|||
28125796|NCT04362137|54787616|FG001|Overall Study|Death|3|||
28125797|NCT04362137|54787615|FG000|Overall Study|Patient decision|6|||
28125798|NCT04362137|54787616|FG001|Overall Study|Patient decision|3|||
28125799|NCT04362137|54787615|FG000|Overall Study|Adverse Event|1|||
28125800|NCT04362137|54787616|FG001|Overall Study|Adverse Event|0|||
28125801|NCT04362137|54787615|FG000|Overall Study|Lost to Follow-up|1|||
28125802|NCT04362137|54787616|FG001|Overall Study|Lost to Follow-up|0|||
28125803|NCT04362137|54787615|FG000|Overall Study|Protocol deviation|1|||
28125804|NCT04362137|54787616|FG001|Overall Study|Protocol deviation|0|||
28125805|NCT05099380|54787624|FG000|Overall Study|Subject enrolled in error|1|||
28125806|NCT05099380|54787625|FG001|Overall Study|Subject enrolled in error|0|||
28125807|NCT05099380|54787624|FG000|Overall Study|Study Procedure|1|||
28125808|NCT05099380|54787625|FG001|Overall Study|Study Procedure|0|||
28125809|NCT05099380|54787624|FG000|Overall Study|Protocol Violation|1|||
28125810|NCT05099380|54787625|FG001|Overall Study|Protocol Violation|0|||
28125811|NCT05099380|54787624|FG000|Overall Study|Adverse Event|1|||
28125812|NCT05099380|54787625|FG001|Overall Study|Adverse Event|1|||
28125813|NCT05099380|54787624|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
28125814|NCT05099380|54787625|FG001|Overall Study|Subject no longer meets eligibility criteria|0|||
28125815|NCT03614728|54787635|FG000|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|1|||
28125816|NCT03614728|54787636|FG001|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
28125817|NCT03614728|54787637|FG002|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
28125818|NCT03614728|54787638|FG003|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
28125819|NCT03614728|54787635|FG000|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
28125820|NCT03614728|54787636|FG001|Part 1 (Up to 30.8 Months)|Physician Decision|1|||
28125821|NCT03614728|54787637|FG002|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
28125822|NCT03614728|54787638|FG003|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
28125823|NCT03154086|54787661|FG000|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
28125824|NCT03154086|54787662|FG001|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
28125825|NCT03154086|54787663|FG002|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
28125826|NCT03154086|54787664|FG003|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1|||
28125827|NCT03154086|54787665|FG004|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
28125828|NCT03154086|54787666|FG005|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
28125829|NCT03154086|54787667|FG006|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
28125830|NCT03154086|54787668|FG007|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
28125831|NCT03154086|54787669|FG008|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
28125832|NCT03154086|54787670|FG009|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
28125833|NCT03154086|54787671|FG010|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
28125834|NCT03154086|54787672|FG011|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
28125835|NCT03154086|54787673|FG012|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
28125836|NCT03154086|54787674|FG013|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
28125837|NCT03154086|54787675|FG014|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
28125838|NCT03154086|54787661|FG000|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
28125839|NCT03154086|54787662|FG001|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1|||
28125840|NCT03154086|54787663|FG002|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
28125841|NCT03154086|54787664|FG003|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
28125842|NCT03154086|54787665|FG004|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
28125843|NCT03154086|54787666|FG005|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
28125844|NCT03154086|54787667|FG006|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
28067419|NCT00296504|54722758|FG003|Interim Analysis|Participant Had Problems with Alcohol|0|||
28067420|NCT00296504|54722759|FG004|Interim Analysis|Participant Had Problems with Alcohol|0|||
28067421|NCT00296504|54722760|FG005|Interim Analysis|Participant Had Problems with Alcohol|0|||
28067422|NCT00296504|54722761|FG006|Interim Analysis|Participant Had Problems with Alcohol|0|||
28067423|NCT00296504|54722762|FG007|Interim Analysis|Participant Had Problems with Alcohol|0|||
28067424|NCT00296504|54722763|FG008|Interim Analysis|Participant Had Problems with Alcohol|0|||
28067425|NCT00296504|54722755|FG000|Interim Analysis|Participant Moved|1|||
28125845|NCT03154086|54787668|FG007|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
28125846|NCT03154086|54787669|FG008|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
28125847|NCT03154086|54787670|FG009|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
28125848|NCT03154086|54787671|FG010|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
28125849|NCT03154086|54787672|FG011|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
28125850|NCT03154086|54787673|FG012|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
28125851|NCT03154086|54787674|FG013|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
28125852|NCT03154086|54787675|FG014|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
27818141|NCT02910583|54276290|FG000|Overall Study|Other, Not Specified|1|||
27818142|NCT02910583|54276291|FG001|Overall Study|Other, Not Specified|0|||
27818143|NCT02779855|54276328|FG000|Overall Study|Withdrawal by patient prior to treatment|1|||
27818144|NCT02779855|54276329|FG001|Overall Study|Withdrawal by patient prior to treatment|0|||
27818145|NCT02779855|54276330|FG002|Overall Study|Withdrawal by patient prior to treatment|0|||
27818146|NCT02487394|54276350|FG000|Phase 1|Withdrawal by Subject|0|||
27818147|NCT02487394|54276351|FG001|Phase 1|Withdrawal by Subject|1|||
27818148|NCT02063724|54276370|FG000|Overall Study|Disease progression|1|||
27818149|NCT02029846|54276376|FG000|Overall Study|n=1 each arm|1|||
27818150|NCT02029846|54276377|FG001|Overall Study|n=1 each arm|1|||
27818151|NCT02028884|54276386|FG000|Double-blind Period|Adverse Event|5|||
27818152|NCT02028884|54276387|FG001|Double-blind Period|Adverse Event|3|||
27818153|NCT02028884|54276388|FG002|Double-blind Period|Adverse Event|0|||
27818154|NCT02028884|54276386|FG000|Double-blind Period|Eligibility Violation|1|||
27818155|NCT02028884|54276387|FG001|Double-blind Period|Eligibility Violation|0|||
27818156|NCT02028884|54276388|FG002|Double-blind Period|Eligibility Violation|0|||
27818157|NCT02028884|54276386|FG000|Double-blind Period|Non-Compliance With Study Drug|2|||
27818158|NCT02028884|54276387|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
27818159|NCT02028884|54276388|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
27818160|NCT02028884|54276386|FG000|Double-blind Period|Withdrawal by Subject|2|||
27818161|NCT02028884|54276387|FG001|Double-blind Period|Withdrawal by Subject|0|||
27818162|NCT02028884|54276388|FG002|Double-blind Period|Withdrawal by Subject|0|||
27818163|NCT02028884|54276386|FG000|Open-label Extension Period|Adverse Event|3|||
27818164|NCT02028884|54276387|FG001|Open-label Extension Period|Adverse Event|1|||
27818165|NCT02028884|54276388|FG002|Open-label Extension Period|Adverse Event|0|||
27818166|NCT02028884|54276386|FG000|Open-label Extension Period|Lack of Efficacy|3|||
27818167|NCT02028884|54276387|FG001|Open-label Extension Period|Lack of Efficacy|0|||
27818168|NCT02028884|54276388|FG002|Open-label Extension Period|Lack of Efficacy|0|||
27818169|NCT02028884|54276386|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
27818170|NCT02028884|54276387|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
27818171|NCT02028884|54276388|FG002|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
27818172|NCT02028884|54276386|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
27818173|NCT02028884|54276387|FG001|Open-label Extension Period|Withdrawal by Subject|6|||
27818174|NCT02028884|54276388|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
27818175|NCT02028884|54276386|FG000|Open-label Extension Period|Switched to another treatment option|3|||
27818176|NCT02028884|54276387|FG001|Open-label Extension Period|Switched to another treatment option|0|||
27818177|NCT02028884|54276388|FG002|Open-label Extension Period|Switched to another treatment option|0|||
27818178|NCT01701674|54276423|FG000|Overall Study|Unable to safely complete treatment|1|||
27818179|NCT01467427|54276444|FG000|Overall Study|Withdrawal by Subject|1|||
27818180|NCT01467427|54276445|FG001|Overall Study|Withdrawal by Subject|0|||
28125853|NCT03154086|54787661|FG000|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
28125854|NCT03154086|54787662|FG001|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
28125855|NCT03154086|54787663|FG002|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1|||
28125856|NCT03154086|54787664|FG003|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
28125857|NCT03154086|54787665|FG004|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
28125858|NCT03154086|54787666|FG005|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
28125859|NCT03154086|54787667|FG006|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
27818181|NCT01467427|54276444|FG000|Overall Study|Entered extension phase|11|||
27818182|NCT01467427|54276445|FG001|Overall Study|Entered extension phase|11|||
27818183|NCT01467427|54276444|FG000|Overall Study|Not continuing in extension phase|0|||
27818184|NCT01467427|54276445|FG001|Overall Study|Not continuing in extension phase|2|||
27818185|NCT01422187|54276454|FG000|Overall Study|Personal reason|1|||
27849338|NCT01624259|54345530|FG000|Overall Study|Physician Decision|1|||
28125860|NCT03154086|54787668|FG007|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
28125861|NCT03154086|54787669|FG008|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
28125862|NCT03154086|54787670|FG009|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
28125863|NCT03154086|54787671|FG010|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
28125864|NCT03154086|54787672|FG011|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
28125865|NCT03154086|54787673|FG012|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
28125866|NCT03154086|54787674|FG013|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
28125867|NCT03154086|54787675|FG014|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
28125868|NCT03154086|54787661|FG000|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1|||
27818186|NCT01422187|54276455|FG001|Overall Study|Personal reason|0|||
27818187|NCT01422187|54276456|FG002|Overall Study|Personal reason|0|||
27818188|NCT01422187|54276454|FG000|Overall Study|Lost to Follow-up|0|||
27818189|NCT01422187|54276455|FG001|Overall Study|Lost to Follow-up|1|||
27818190|NCT01422187|54276456|FG002|Overall Study|Lost to Follow-up|0|||
27818191|NCT00472212|54276466|FG000|Overall Study|Lost to Follow-up|6|||
28125869|NCT03154086|54787662|FG001|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
28125870|NCT03154086|54787663|FG002|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
28125871|NCT03154086|54787664|FG003|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
28125872|NCT03154086|54787665|FG004|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
28125873|NCT03154086|54787666|FG005|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
28125874|NCT03154086|54787667|FG006|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
28125875|NCT03154086|54787668|FG007|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
28125876|NCT03154086|54787669|FG008|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
28125877|NCT03154086|54787670|FG009|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
28125878|NCT03154086|54787671|FG010|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
28125879|NCT03154086|54787672|FG011|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
28125880|NCT03154086|54787673|FG012|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
28125881|NCT03154086|54787674|FG013|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
28125882|NCT03154086|54787675|FG014|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
28125883|NCT03154086|54787661|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
28067426|NCT00296504|54722756|FG001|Interim Analysis|Participant Moved|0|||
28125884|NCT03154086|54787662|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
28125885|NCT03154086|54787663|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
28125886|NCT03154086|54787664|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
28125887|NCT03154086|54787665|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
28125888|NCT03154086|54787666|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
28125889|NCT03154086|54787667|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
28125890|NCT03154086|54787668|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
27818192|NCT00472212|54276467|FG001|Overall Study|Lost to Follow-up|4|||
28067427|NCT00296504|54722757|FG002|Interim Analysis|Participant Moved|1|||
28067428|NCT00296504|54722758|FG003|Interim Analysis|Participant Moved|0|||
28125891|NCT03154086|54787669|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1|||
28125892|NCT03154086|54787670|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
28125893|NCT03154086|54787671|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
28125894|NCT03154086|54787672|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
28125895|NCT03154086|54787673|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
28067429|NCT00296504|54722759|FG004|Interim Analysis|Participant Moved|0|||
28067430|NCT00296504|54722760|FG005|Interim Analysis|Participant Moved|1|||
28067431|NCT00296504|54722761|FG006|Interim Analysis|Participant Moved|1|||
28067432|NCT00296504|54722762|FG007|Interim Analysis|Participant Moved|0|||
28067433|NCT00296504|54722763|FG008|Interim Analysis|Participant Moved|0|||
28067434|NCT00296504|54722755|FG000|Interim Analysis|Participant Was Incarcerated|2|||
28067435|NCT00296504|54722756|FG001|Interim Analysis|Participant Was Incarcerated|0|||
28067436|NCT00296504|54722757|FG002|Interim Analysis|Participant Was Incarcerated|1|||
28067437|NCT00296504|54722758|FG003|Interim Analysis|Participant Was Incarcerated|0|||
28067438|NCT00296504|54722759|FG004|Interim Analysis|Participant Was Incarcerated|0|||
28067439|NCT00296504|54722760|FG005|Interim Analysis|Participant Was Incarcerated|0|||
28067440|NCT00296504|54722761|FG006|Interim Analysis|Participant Was Incarcerated|0|||
28067441|NCT00296504|54722762|FG007|Interim Analysis|Participant Was Incarcerated|0|||
28067442|NCT00296504|54722763|FG008|Interim Analysis|Participant Was Incarcerated|0|||
28067443|NCT00296504|54722755|FG000|Interim Analysis|Resistance to FPV|0|||
28067444|NCT00296504|54722756|FG001|Interim Analysis|Resistance to FPV|0|||
28067445|NCT00296504|54722757|FG002|Interim Analysis|Resistance to FPV|1|||
28125896|NCT03154086|54787674|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
28125897|NCT03154086|54787675|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
28125898|NCT03154086|54787661|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
28125899|NCT03154086|54787662|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
28125900|NCT03154086|54787663|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
28125901|NCT03154086|54787664|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
28125902|NCT03154086|54787665|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
28125903|NCT03154086|54787666|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
28125904|NCT03154086|54787667|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
28125905|NCT03154086|54787668|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1|||
28125906|NCT03154086|54787669|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
28125907|NCT03154086|54787670|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
28125908|NCT03154086|54787671|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
28125909|NCT03154086|54787672|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
28125910|NCT03154086|54787673|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
28125911|NCT03154086|54787674|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
28125912|NCT03154086|54787675|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
28125913|NCT03154086|54787661|FG000|Part B (Up to 25 Days)|Adverse Event|0|||
28125914|NCT03154086|54787662|FG001|Part B (Up to 25 Days)|Adverse Event|0|||
28125915|NCT03154086|54787663|FG002|Part B (Up to 25 Days)|Adverse Event|0|||
28125916|NCT03154086|54787664|FG003|Part B (Up to 25 Days)|Adverse Event|0|||
28125917|NCT03154086|54787665|FG004|Part B (Up to 25 Days)|Adverse Event|0|||
28125918|NCT03154086|54787666|FG005|Part B (Up to 25 Days)|Adverse Event|0|||
28125919|NCT03154086|54787667|FG006|Part B (Up to 25 Days)|Adverse Event|0|||
28125920|NCT03154086|54787668|FG007|Part B (Up to 25 Days)|Adverse Event|0|||
28125921|NCT03154086|54787669|FG008|Part B (Up to 25 Days)|Adverse Event|0|||
28125922|NCT03154086|54787670|FG009|Part B (Up to 25 Days)|Adverse Event|0|||
28125923|NCT03154086|54787671|FG010|Part B (Up to 25 Days)|Adverse Event|1|||
28125924|NCT03154086|54787672|FG011|Part B (Up to 25 Days)|Adverse Event|0|||
28125925|NCT03154086|54787673|FG012|Part B (Up to 25 Days)|Adverse Event|0|||
28125926|NCT03154086|54787674|FG013|Part B (Up to 25 Days)|Adverse Event|0|||
28125927|NCT03154086|54787675|FG014|Part B (Up to 25 Days)|Adverse Event|0|||
28125928|NCT02723344|54787738|FG000|Overall Study|Lost to Follow-up|0|||
28125929|NCT02723344|54787739|FG001|Overall Study|Lost to Follow-up|4|||
28125930|NCT02723188|54787748|FG000|Overall Study|Withdrawal by Subject|1|||
28125931|NCT02723188|54787749|FG001|Overall Study|Withdrawal by Subject|0|||
28125932|NCT02723188|54787750|FG002|Overall Study|Withdrawal by Subject|0|||
28125933|NCT00705406|54787760|FG000|Overall Study|Lost to Follow-up|3|||
28125934|NCT00705406|54787761|FG001|Overall Study|Lost to Follow-up|3|||
28125935|NCT00705406|54787760|FG000|Overall Study|Did not receive study drug|1|||
28125936|NCT00705406|54787761|FG001|Overall Study|Did not receive study drug|2|||
28125937|NCT03155178|54787772|FG000|Overall Study|Did not meet treatment day baseline|7|||
28125938|NCT03155178|54787773|FG001|Overall Study|Did not meet treatment day baseline|7|||
28125939|NCT03155178|54787774|FG002|Overall Study|Did not meet treatment day baseline|7|||
28125940|NCT03155178|54787775|FG003|Overall Study|Did not meet treatment day baseline|7|||
28125941|NCT00705250|54787799|FG000|Overall Study|Withdrawal by Subject|1|||
28125942|NCT00705250|54787799|FG000|Overall Study|Patient died in car accident|1|||
28125943|NCT03078192|54787805|FG000|Overall Study|Withdrawal by Subject|2|||
28125944|NCT03078192|54787806|FG001|Overall Study|Withdrawal by Subject|1|||
28125945|NCT03078192|54787805|FG000|Overall Study|screen failure|0|||
28125946|NCT03078192|54787806|FG001|Overall Study|screen failure|3|||
28125947|NCT00703846|54787812|FG000|Overall Study|Adverse Event|8|||
28125948|NCT00703846|54787812|FG000|Overall Study|Lost to Follow-up|55|||
28125949|NCT00703846|54787812|FG000|Overall Study|Lack of Efficacy|15|||
28125950|NCT00703846|54787812|FG000|Overall Study|Noncompliance with Study Treatment|2|||
28125951|NCT00703846|54787812|FG000|Overall Study|Withdrawal by Subject|40|||
28125952|NCT00703846|54787812|FG000|Overall Study|Death|1|||
28125953|NCT00703846|54787812|FG000|Overall Study|Other|14|||
28125954|NCT00703846|54787812|FG000|Overall Study|Did Not Receive Study Drug|2|||
28125955|NCT01314872|54787827|FG000|Treatment Period 1|Protocol Violation|2|||
28125956|NCT01314872|54787828|FG001|Treatment Period 1|Protocol Violation|1|||
28125957|NCT01314872|54787829|FG002|Treatment Period 1|Protocol Violation|1|||
28125958|NCT01314872|54787830|FG003|Treatment Period 1|Protocol Violation|0|||
28125959|NCT01314872|54787831|FG004|Treatment Period 1|Protocol Violation|1|||
28125960|NCT01314872|54787832|FG005|Treatment Period 1|Protocol Violation|0|||
28125961|NCT01314872|54787833|FG006|Treatment Period 1|Protocol Violation|0|||
28125962|NCT01314872|54787834|FG007|Treatment Period 1|Protocol Violation|0|||
28125963|NCT01314872|54787835|FG008|Treatment Period 1|Protocol Violation|0|||
28125964|NCT01314872|54787836|FG009|Treatment Period 1|Protocol Violation|1|||
28125965|NCT01314872|54787837|FG010|Treatment Period 1|Protocol Violation|1|||
28125966|NCT01314872|54787838|FG011|Treatment Period 1|Protocol Violation|0|||
28125967|NCT01314872|54787839|FG012|Treatment Period 1|Protocol Violation|0|||
28125968|NCT01314872|54787840|FG013|Treatment Period 1|Protocol Violation|0|||
28125969|NCT01314872|54787841|FG014|Treatment Period 1|Protocol Violation|0|||
28125970|NCT01314872|54787827|FG000|Treatment Period 1|Physician Decision|0|||
28125971|NCT01314872|54787828|FG001|Treatment Period 1|Physician Decision|1|||
28125972|NCT01314872|54787829|FG002|Treatment Period 1|Physician Decision|0|||
28125973|NCT01314872|54787830|FG003|Treatment Period 1|Physician Decision|1|||
28125974|NCT01314872|54787831|FG004|Treatment Period 1|Physician Decision|0|||
28125975|NCT01314872|54787832|FG005|Treatment Period 1|Physician Decision|0|||
28125976|NCT01314872|54787833|FG006|Treatment Period 1|Physician Decision|0|||
28125977|NCT01314872|54787834|FG007|Treatment Period 1|Physician Decision|0|||
28125978|NCT01314872|54787835|FG008|Treatment Period 1|Physician Decision|0|||
28125979|NCT01314872|54787836|FG009|Treatment Period 1|Physician Decision|1|||
28125980|NCT01314872|54787837|FG010|Treatment Period 1|Physician Decision|0|||
28125981|NCT01314872|54787838|FG011|Treatment Period 1|Physician Decision|0|||
28125982|NCT01314872|54787839|FG012|Treatment Period 1|Physician Decision|0|||
28125983|NCT01314872|54787840|FG013|Treatment Period 1|Physician Decision|0|||
28125984|NCT01314872|54787841|FG014|Treatment Period 1|Physician Decision|0|||
28125985|NCT01314872|54787827|FG000|Treatment Period 1|Lack of Efficacy|1|||
28125986|NCT01314872|54787828|FG001|Treatment Period 1|Lack of Efficacy|0|||
28125987|NCT01314872|54787829|FG002|Treatment Period 1|Lack of Efficacy|0|||
28125988|NCT01314872|54787830|FG003|Treatment Period 1|Lack of Efficacy|0|||
27940517|NCT00938860|54596801|FG001|Overall Study|Death|1|||
27940518|NCT00938860|54596800|FG000|Overall Study|Protocol Violation|3|||
27940519|NCT00938860|54596801|FG001|Overall Study|Protocol Violation|1|||
27940520|NCT00938470|54596809|FG000|Overall Study|Disease Progression|3|||
27940521|NCT00938470|54596810|FG001|Overall Study|Disease Progression|0|||
28125989|NCT01314872|54787831|FG004|Treatment Period 1|Lack of Efficacy|0|||
28125990|NCT01314872|54787832|FG005|Treatment Period 1|Lack of Efficacy|1|||
28125991|NCT01314872|54787833|FG006|Treatment Period 1|Lack of Efficacy|0|||
28125992|NCT01314872|54787834|FG007|Treatment Period 1|Lack of Efficacy|2|||
28125993|NCT01314872|54787835|FG008|Treatment Period 1|Lack of Efficacy|0|||
28125994|NCT01314872|54787836|FG009|Treatment Period 1|Lack of Efficacy|0|||
28125995|NCT01314872|54787837|FG010|Treatment Period 1|Lack of Efficacy|0|||
28125996|NCT01314872|54787838|FG011|Treatment Period 1|Lack of Efficacy|0|||
28125997|NCT01314872|54787839|FG012|Treatment Period 1|Lack of Efficacy|0|||
28125998|NCT01314872|54787840|FG013|Treatment Period 1|Lack of Efficacy|0|||
28125999|NCT01314872|54787841|FG014|Treatment Period 1|Lack of Efficacy|0|||
28126000|NCT01314872|54787827|FG000|Treatment Period 1|Adverse event, non-fatal|4|||
28126001|NCT01314872|54787828|FG001|Treatment Period 1|Adverse event, non-fatal|2|||
28126002|NCT01314872|54787829|FG002|Treatment Period 1|Adverse event, non-fatal|3|||
28126003|NCT01314872|54787830|FG003|Treatment Period 1|Adverse event, non-fatal|2|||
28126004|NCT01314872|54787831|FG004|Treatment Period 1|Adverse event, non-fatal|2|||
28126005|NCT01314872|54787832|FG005|Treatment Period 1|Adverse event, non-fatal|4|||
28126006|NCT01314872|54787833|FG006|Treatment Period 1|Adverse event, non-fatal|4|||
28126007|NCT01314872|54787834|FG007|Treatment Period 1|Adverse event, non-fatal|2|||
28126008|NCT01314872|54787835|FG008|Treatment Period 1|Adverse event, non-fatal|3|||
28126009|NCT01314872|54787836|FG009|Treatment Period 1|Adverse event, non-fatal|0|||
28126010|NCT01314872|54787837|FG010|Treatment Period 1|Adverse event, non-fatal|1|||
28126011|NCT01314872|54787838|FG011|Treatment Period 1|Adverse event, non-fatal|0|||
28126012|NCT01314872|54787839|FG012|Treatment Period 1|Adverse event, non-fatal|0|||
27940522|NCT00938470|54596809|FG000|Overall Study|Alternate Treatment|1|||
28126013|NCT01314872|54787840|FG013|Treatment Period 1|Adverse event, non-fatal|0|||
28126014|NCT01314872|54787841|FG014|Treatment Period 1|Adverse event, non-fatal|0|||
28126015|NCT01314872|54787827|FG000|Treatment Period 1|Withdrawal by Subject|3|||
27940523|NCT00938470|54596810|FG001|Overall Study|Alternate Treatment|0|||
27940524|NCT00938470|54596809|FG000|Overall Study|Death|3|||
28126016|NCT01314872|54787828|FG001|Treatment Period 1|Withdrawal by Subject|1|||
28126017|NCT01314872|54787829|FG002|Treatment Period 1|Withdrawal by Subject|0|||
28126018|NCT01314872|54787830|FG003|Treatment Period 1|Withdrawal by Subject|2|||
28126019|NCT01314872|54787831|FG004|Treatment Period 1|Withdrawal by Subject|3|||
28126020|NCT01314872|54787832|FG005|Treatment Period 1|Withdrawal by Subject|1|||
28126021|NCT01314872|54787833|FG006|Treatment Period 1|Withdrawal by Subject|3|||
28126022|NCT01314872|54787834|FG007|Treatment Period 1|Withdrawal by Subject|2|||
28126023|NCT01314872|54787835|FG008|Treatment Period 1|Withdrawal by Subject|2|||
28126024|NCT01314872|54787836|FG009|Treatment Period 1|Withdrawal by Subject|2|||
28126025|NCT01314872|54787837|FG010|Treatment Period 1|Withdrawal by Subject|1|||
28126026|NCT01314872|54787838|FG011|Treatment Period 1|Withdrawal by Subject|0|||
28126027|NCT01314872|54787839|FG012|Treatment Period 1|Withdrawal by Subject|0|||
28126028|NCT01314872|54787840|FG013|Treatment Period 1|Withdrawal by Subject|0|||
28126029|NCT01314872|54787841|FG014|Treatment Period 1|Withdrawal by Subject|0|||
28126030|NCT01314872|54787827|FG000|Treatment Period 1|Lost to Follow-up|0|||
28126031|NCT01314872|54787828|FG001|Treatment Period 1|Lost to Follow-up|1|||
28126032|NCT01314872|54787829|FG002|Treatment Period 1|Lost to Follow-up|2|||
28126033|NCT01314872|54787830|FG003|Treatment Period 1|Lost to Follow-up|2|||
28126034|NCT01314872|54787831|FG004|Treatment Period 1|Lost to Follow-up|1|||
28126035|NCT01314872|54787832|FG005|Treatment Period 1|Lost to Follow-up|1|||
28126036|NCT01314872|54787833|FG006|Treatment Period 1|Lost to Follow-up|1|||
28126037|NCT01314872|54787834|FG007|Treatment Period 1|Lost to Follow-up|1|||
28126038|NCT01314872|54787835|FG008|Treatment Period 1|Lost to Follow-up|1|||
28126039|NCT01314872|54787836|FG009|Treatment Period 1|Lost to Follow-up|0|||
28126040|NCT01314872|54787837|FG010|Treatment Period 1|Lost to Follow-up|0|||
28126041|NCT01314872|54787838|FG011|Treatment Period 1|Lost to Follow-up|0|||
28126042|NCT01314872|54787839|FG012|Treatment Period 1|Lost to Follow-up|0|||
28126043|NCT01314872|54787840|FG013|Treatment Period 1|Lost to Follow-up|0|||
28126044|NCT01314872|54787841|FG014|Treatment Period 1|Lost to Follow-up|0|||
28126045|NCT01314872|54787827|FG000|Period 2|Protocol Violation|0|||
28126046|NCT01314872|54787828|FG001|Period 2|Protocol Violation|0|||
28126047|NCT01314872|54787829|FG002|Period 2|Protocol Violation|0|||
28126048|NCT01314872|54787830|FG003|Period 2|Protocol Violation|0|||
28126049|NCT01314872|54787831|FG004|Period 2|Protocol Violation|0|||
28126050|NCT01314872|54787832|FG005|Period 2|Protocol Violation|0|||
28126051|NCT01314872|54787833|FG006|Period 2|Protocol Violation|0|||
28126052|NCT01314872|54787834|FG007|Period 2|Protocol Violation|0|||
28126053|NCT01314872|54787835|FG008|Period 2|Protocol Violation|0|||
28126054|NCT01314872|54787836|FG009|Period 2|Protocol Violation|0|||
27818193|NCT00378105|54276475|FG000|Overall Study|Adverse Event|3|||
27818194|NCT00378105|54276476|FG001|Overall Study|Adverse Event|1|||
28126055|NCT01314872|54787837|FG010|Period 2|Protocol Violation|0|||
27818195|NCT00378105|54276475|FG000|Overall Study|Withdrawal by Subject|3|||
27818196|NCT00378105|54276476|FG001|Overall Study|Withdrawal by Subject|3|||
28126056|NCT01314872|54787838|FG011|Period 2|Protocol Violation|3|||
28126057|NCT01314872|54787839|FG012|Period 2|Protocol Violation|3|||
28126058|NCT01314872|54787840|FG013|Period 2|Protocol Violation|2|||
28126059|NCT01314872|54787841|FG014|Period 2|Protocol Violation|0|||
28126060|NCT01314872|54787827|FG000|Period 2|Non-compliance with study drug|0|||
28126061|NCT01314872|54787828|FG001|Period 2|Non-compliance with study drug|0|||
28126062|NCT01314872|54787829|FG002|Period 2|Non-compliance with study drug|0|||
28126063|NCT01314872|54787830|FG003|Period 2|Non-compliance with study drug|0|||
28126064|NCT01314872|54787831|FG004|Period 2|Non-compliance with study drug|0|||
28126065|NCT01314872|54787832|FG005|Period 2|Non-compliance with study drug|0|||
28126066|NCT01314872|54787833|FG006|Period 2|Non-compliance with study drug|0|||
28126067|NCT01314872|54787834|FG007|Period 2|Non-compliance with study drug|0|||
28126068|NCT01314872|54787835|FG008|Period 2|Non-compliance with study drug|0|||
28126069|NCT01314872|54787836|FG009|Period 2|Non-compliance with study drug|0|||
28126070|NCT01314872|54787837|FG010|Period 2|Non-compliance with study drug|0|||
28126071|NCT01314872|54787838|FG011|Period 2|Non-compliance with study drug|3|||
28126072|NCT01314872|54787839|FG012|Period 2|Non-compliance with study drug|3|||
27818197|NCT00378105|54276475|FG000|Overall Study|Death|1|||
28126073|NCT01314872|54787840|FG013|Period 2|Non-compliance with study drug|1|||
28126074|NCT01314872|54787841|FG014|Period 2|Non-compliance with study drug|2|||
28126075|NCT01314872|54787827|FG000|Period 2|Lack of Efficacy|0|||
28126076|NCT01314872|54787828|FG001|Period 2|Lack of Efficacy|0|||
28126077|NCT01314872|54787829|FG002|Period 2|Lack of Efficacy|0|||
28126078|NCT01314872|54787830|FG003|Period 2|Lack of Efficacy|0|||
28126079|NCT01314872|54787831|FG004|Period 2|Lack of Efficacy|0|||
28126080|NCT01314872|54787832|FG005|Period 2|Lack of Efficacy|0|||
28126081|NCT01314872|54787833|FG006|Period 2|Lack of Efficacy|0|||
28126082|NCT01314872|54787834|FG007|Period 2|Lack of Efficacy|0|||
28126083|NCT01314872|54787835|FG008|Period 2|Lack of Efficacy|0|||
28126084|NCT01314872|54787836|FG009|Period 2|Lack of Efficacy|0|||
28126085|NCT01314872|54787837|FG010|Period 2|Lack of Efficacy|0|||
28126086|NCT01314872|54787838|FG011|Period 2|Lack of Efficacy|7|||
28126087|NCT01314872|54787839|FG012|Period 2|Lack of Efficacy|12|||
28126088|NCT01314872|54787840|FG013|Period 2|Lack of Efficacy|9|||
28126089|NCT01314872|54787841|FG014|Period 2|Lack of Efficacy|2|||
28126090|NCT01314872|54787827|FG000|Period 2|Pregnancy|0|||
28126091|NCT01314872|54787828|FG001|Period 2|Pregnancy|0|||
28126092|NCT01314872|54787829|FG002|Period 2|Pregnancy|0|||
28126093|NCT01314872|54787830|FG003|Period 2|Pregnancy|0|||
27818198|NCT00378105|54276476|FG001|Overall Study|Death|0|||
27818199|NCT00378105|54276475|FG000|Overall Study|Going to transplant|7|||
27818200|NCT00378105|54276476|FG001|Overall Study|Going to transplant|8|||
27818201|NCT00378105|54276475|FG000|Overall Study|Progressive disease|3|||
27818202|NCT00378105|54276476|FG001|Overall Study|Progressive disease|3|||
27818203|NCT00378105|54276475|FG000|Overall Study|remain on study|3|||
27818204|NCT00378105|54276476|FG001|Overall Study|remain on study|11|||
27818205|NCT00378105|54276475|FG000|Overall Study|Physician Decision|0|||
27818206|NCT00378105|54276476|FG001|Overall Study|Physician Decision|2|||
27818207|NCT00378105|54276475|FG000|Overall Study|Going non-protocol therapy|0|||
27818208|NCT00378105|54276476|FG001|Overall Study|Going non-protocol therapy|1|||
27940525|NCT00938470|54596810|FG001|Overall Study|Death|2|||
28126094|NCT01314872|54787831|FG004|Period 2|Pregnancy|0|||
28126095|NCT01314872|54787832|FG005|Period 2|Pregnancy|0|||
28126096|NCT01314872|54787833|FG006|Period 2|Pregnancy|0|||
28126097|NCT01314872|54787834|FG007|Period 2|Pregnancy|0|||
28126098|NCT01314872|54787835|FG008|Period 2|Pregnancy|0|||
28126099|NCT01314872|54787836|FG009|Period 2|Pregnancy|0|||
28126100|NCT01314872|54787837|FG010|Period 2|Pregnancy|0|||
28126101|NCT01314872|54787838|FG011|Period 2|Pregnancy|0|||
28126102|NCT01314872|54787839|FG012|Period 2|Pregnancy|0|||
27818209|NCT00378105|54276475|FG000|Overall Study|necessity to increase lenalidomide dose|0|||
28126103|NCT01314872|54787840|FG013|Period 2|Pregnancy|0|||
28126104|NCT01314872|54787841|FG014|Period 2|Pregnancy|1|||
28126105|NCT01314872|54787827|FG000|Period 2|Study terminated by Sponsor|0|||
27818210|NCT00378105|54276476|FG001|Overall Study|necessity to increase lenalidomide dose|1|||
27818211|NCT00139477|54276485|FG000|First Intervention -Baseline to 6Months|No Longer Interested|6|||
28126106|NCT01314872|54787828|FG001|Period 2|Study terminated by Sponsor|0|||
28126107|NCT01314872|54787829|FG002|Period 2|Study terminated by Sponsor|0|||
28126108|NCT01314872|54787830|FG003|Period 2|Study terminated by Sponsor|0|||
28126109|NCT01314872|54787831|FG004|Period 2|Study terminated by Sponsor|0|||
28126110|NCT01314872|54787832|FG005|Period 2|Study terminated by Sponsor|0|||
28126111|NCT01314872|54787833|FG006|Period 2|Study terminated by Sponsor|0|||
28126112|NCT01314872|54787834|FG007|Period 2|Study terminated by Sponsor|0|||
28126113|NCT01314872|54787835|FG008|Period 2|Study terminated by Sponsor|0|||
28126114|NCT01314872|54787836|FG009|Period 2|Study terminated by Sponsor|0|||
28126115|NCT01314872|54787837|FG010|Period 2|Study terminated by Sponsor|0|||
28126116|NCT01314872|54787838|FG011|Period 2|Study terminated by Sponsor|2|||
28126117|NCT01314872|54787839|FG012|Period 2|Study terminated by Sponsor|2|||
28126118|NCT01314872|54787840|FG013|Period 2|Study terminated by Sponsor|3|||
28126119|NCT01314872|54787841|FG014|Period 2|Study terminated by Sponsor|0|||
28126120|NCT01314872|54787827|FG000|Period 2|Adverse event, non-fatal|0|||
28126121|NCT01314872|54787828|FG001|Period 2|Adverse event, non-fatal|0|||
28126122|NCT01314872|54787829|FG002|Period 2|Adverse event, non-fatal|0|||
28126123|NCT01314872|54787830|FG003|Period 2|Adverse event, non-fatal|0|||
28126124|NCT01314872|54787831|FG004|Period 2|Adverse event, non-fatal|0|||
28126125|NCT01314872|54787832|FG005|Period 2|Adverse event, non-fatal|0|||
28126126|NCT01314872|54787833|FG006|Period 2|Adverse event, non-fatal|0|||
28126127|NCT01314872|54787834|FG007|Period 2|Adverse event, non-fatal|0|||
28126128|NCT01314872|54787835|FG008|Period 2|Adverse event, non-fatal|0|||
28126129|NCT01314872|54787836|FG009|Period 2|Adverse event, non-fatal|0|||
28126130|NCT01314872|54787837|FG010|Period 2|Adverse event, non-fatal|0|||
28126131|NCT01314872|54787838|FG011|Period 2|Adverse event, non-fatal|13|||
28126132|NCT01314872|54787839|FG012|Period 2|Adverse event, non-fatal|16|||
28126133|NCT01314872|54787840|FG013|Period 2|Adverse event, non-fatal|24|||
28126134|NCT01314872|54787841|FG014|Period 2|Adverse event, non-fatal|9|||
28126135|NCT01314872|54787827|FG000|Period 2|Withdrawal by Subject|0|||
28126136|NCT01314872|54787828|FG001|Period 2|Withdrawal by Subject|0|||
28126137|NCT01314872|54787829|FG002|Period 2|Withdrawal by Subject|0|||
28126138|NCT01314872|54787830|FG003|Period 2|Withdrawal by Subject|0|||
28126139|NCT01314872|54787831|FG004|Period 2|Withdrawal by Subject|0|||
28126140|NCT01314872|54787832|FG005|Period 2|Withdrawal by Subject|0|||
28126141|NCT01314872|54787833|FG006|Period 2|Withdrawal by Subject|0|||
28126142|NCT01314872|54787834|FG007|Period 2|Withdrawal by Subject|0|||
28126143|NCT01314872|54787835|FG008|Period 2|Withdrawal by Subject|0|||
28126144|NCT01314872|54787836|FG009|Period 2|Withdrawal by Subject|0|||
28126145|NCT01314872|54787837|FG010|Period 2|Withdrawal by Subject|0|||
28126146|NCT01314872|54787838|FG011|Period 2|Withdrawal by Subject|14|||
28126147|NCT01314872|54787839|FG012|Period 2|Withdrawal by Subject|17|||
28126148|NCT01314872|54787840|FG013|Period 2|Withdrawal by Subject|12|||
28126149|NCT01314872|54787841|FG014|Period 2|Withdrawal by Subject|4|||
28126150|NCT01314872|54787827|FG000|Period 2|Lost to Follow-up|0|||
28126151|NCT01314872|54787828|FG001|Period 2|Lost to Follow-up|0|||
28126152|NCT01314872|54787829|FG002|Period 2|Lost to Follow-up|0|||
28126153|NCT01314872|54787830|FG003|Period 2|Lost to Follow-up|0|||
28126154|NCT01314872|54787831|FG004|Period 2|Lost to Follow-up|0|||
28126155|NCT01314872|54787832|FG005|Period 2|Lost to Follow-up|0|||
28126156|NCT01314872|54787833|FG006|Period 2|Lost to Follow-up|0|||
28126157|NCT01314872|54787834|FG007|Period 2|Lost to Follow-up|0|||
27818212|NCT00139477|54276486|FG001|First Intervention -Baseline to 6Months|No Longer Interested|7|||
28126158|NCT01314872|54787835|FG008|Period 2|Lost to Follow-up|0|||
28126159|NCT01314872|54787836|FG009|Period 2|Lost to Follow-up|0|||
28126160|NCT01314872|54787837|FG010|Period 2|Lost to Follow-up|0|||
28126161|NCT01314872|54787838|FG011|Period 2|Lost to Follow-up|6|||
28126162|NCT01314872|54787839|FG012|Period 2|Lost to Follow-up|7|||
28126163|NCT01314872|54787840|FG013|Period 2|Lost to Follow-up|2|||
28126164|NCT01314872|54787841|FG014|Period 2|Lost to Follow-up|6|||
28126165|NCT00703924|54787875|FG000|Overall Study|Withdrawal by Subject|1|||
28126166|NCT00703924|54787876|FG001|Overall Study|Withdrawal by Subject|1|||
28126167|NCT03152526|54787888|FG000|Overall Study|Withdrawal by Subject|0|||
28126168|NCT03152526|54787889|FG001|Overall Study|Withdrawal by Subject|1|||
28126169|NCT03149328|54787897|FG000|Overall Study|Withdrawal by Subject|30|||
28126170|NCT03149328|54787898|FG001|Overall Study|Withdrawal by Subject|26|||
28126171|NCT03149328|54787897|FG000|Overall Study|Changed Dialysis Modality|18|||
28126172|NCT03149328|54787898|FG001|Overall Study|Changed Dialysis Modality|1|||
28126173|NCT03149328|54787897|FG000|Overall Study|Transplant|9|||
28126174|NCT03149328|54787898|FG001|Overall Study|Transplant|1|||
28126175|NCT03149328|54787897|FG000|Overall Study|Lost to Follow-up|25|||
28126176|NCT03149328|54787898|FG001|Overall Study|Lost to Follow-up|16|||
28126177|NCT03149328|54787897|FG000|Overall Study|Left Study Site|1|||
28126178|NCT03149328|54787898|FG001|Overall Study|Left Study Site|2|||
28126179|NCT03149328|54787897|FG000|Overall Study|Language Barrier|1|||
28126180|NCT03149328|54787898|FG001|Overall Study|Language Barrier|0|||
28126181|NCT04296942|54787947|FG000|Overall Study|Study closure by sponsor|1|||
28126182|NCT04296942|54787948|FG001|Overall Study|Study closure by sponsor|0|||
28126183|NCT04296942|54787949|FG002|Overall Study|Study closure by sponsor|0|||
28126184|NCT01315028|54788016|FG000|Overall Study|Lost to Follow-up|1|||
28126185|NCT01315028|54788017|FG001|Overall Study|Lost to Follow-up|0|||
28126186|NCT01315028|54788016|FG000|Overall Study|Death|0|||
28126187|NCT01315028|54788017|FG001|Overall Study|Death|1|||
28126188|NCT02720536|54788023|FG000|Overall Study|Primary reason (PR) - subject withdrawal|11|||
28126189|NCT02720536|54788023|FG000|Overall Study|PR - pregnancy|2|||
28126190|NCT02720536|54788023|FG000|Overall Study|PR - unsatisfactory therapeutic effect|2|||
28126191|NCT02720536|54788023|FG000|Overall Study|PR - death|1|||
28126192|NCT02720536|54788023|FG000|Overall Study|PR - adverse event|1|||
28126193|NCT02720536|54788023|FG000|Overall Study|PR - abnormal lab value(s)|1|||
28126194|NCT02720536|54788023|FG000|Overall Study|PR- unwilling to comply with procedures|1|||
28126195|NCT03168438|54788035|FG000|Overall Study|Long term follow-up declined, study terminated by sponsor|0|||
28126196|NCT03168438|54788036|FG001|Overall Study|Long term follow-up declined, study terminated by sponsor|1|||
28126197|NCT03137784|54788043|FG000|Overall Study|Adverse Event|1|||
28126198|NCT03137784|54788044|FG001|Overall Study|Adverse Event|1|||
28126199|NCT03137784|54788045|FG002|Overall Study|Adverse Event|0|||
27818213|NCT00139477|54276485|FG000|First Intervention -Baseline to 6Months|Relocation|1|||
27818214|NCT00139477|54276486|FG001|First Intervention -Baseline to 6Months|Relocation|2|||
28067446|NCT00296504|54722758|FG003|Interim Analysis|Resistance to FPV|0|||
28067447|NCT00296504|54722759|FG004|Interim Analysis|Resistance to FPV|0|||
28067448|NCT00296504|54722760|FG005|Interim Analysis|Resistance to FPV|0|||
28067449|NCT00296504|54722761|FG006|Interim Analysis|Resistance to FPV|0|||
28067450|NCT00296504|54722762|FG007|Interim Analysis|Resistance to FPV|0|||
28067451|NCT00296504|54722763|FG008|Interim Analysis|Resistance to FPV|0|||
28067452|NCT00296504|54722755|FG000|Interim Analysis|Physician Decision|0|||
28067453|NCT00296504|54722756|FG001|Interim Analysis|Physician Decision|0|||
28067454|NCT00296504|54722757|FG002|Interim Analysis|Physician Decision|1|||
28067455|NCT00296504|54722758|FG003|Interim Analysis|Physician Decision|0|||
28067456|NCT00296504|54722759|FG004|Interim Analysis|Physician Decision|0|||
28067457|NCT00296504|54722760|FG005|Interim Analysis|Physician Decision|0|||
28067458|NCT00296504|54722761|FG006|Interim Analysis|Physician Decision|0|||
28067459|NCT00296504|54722762|FG007|Interim Analysis|Physician Decision|0|||
28067460|NCT00296504|54722763|FG008|Interim Analysis|Physician Decision|0|||
28067461|NCT00296504|54722755|FG000|Interim Analysis|Principle Investigator Discretion|2|||
28126200|NCT03137784|54788046|FG003|Overall Study|Adverse Event|0|||
28126201|NCT03137784|54788047|FG004|Overall Study|Adverse Event|0|||
28126202|NCT03137784|54788048|FG005|Overall Study|Adverse Event|0|||
28126203|NCT03137784|54788043|FG000|Overall Study|Subject/guardian decision|1|||
28126204|NCT03137784|54788044|FG001|Overall Study|Subject/guardian decision|0|||
28126205|NCT03137784|54788045|FG002|Overall Study|Subject/guardian decision|0|||
28126206|NCT03137784|54788046|FG003|Overall Study|Subject/guardian decision|0|||
28126207|NCT03137784|54788047|FG004|Overall Study|Subject/guardian decision|0|||
28126208|NCT03137784|54788048|FG005|Overall Study|Subject/guardian decision|0|||
28126209|NCT03137784|54788043|FG000|Overall Study|Non-compliance with study treatment|0|||
28126210|NCT03137784|54788044|FG001|Overall Study|Non-compliance with study treatment|0|||
28126211|NCT03137784|54788045|FG002|Overall Study|Non-compliance with study treatment|0|||
28126212|NCT03137784|54788046|FG003|Overall Study|Non-compliance with study treatment|0|||
28126213|NCT03137784|54788047|FG004|Overall Study|Non-compliance with study treatment|1|||
28126214|NCT03137784|54788048|FG005|Overall Study|Non-compliance with study treatment|0|||
28126215|NCT01314716|54788058|FG000|Double-Blind Phase|Randomized but not treated|1|||
28126216|NCT01314716|54788059|FG001|Double-Blind Phase|Randomized but not treated|1|||
28126217|NCT01314716|54788058|FG000|Double-Blind Phase|Adverse Event|10|||
28126218|NCT01314716|54788059|FG001|Double-Blind Phase|Adverse Event|4|||
28126219|NCT01314716|54788058|FG000|Double-Blind Phase|Withdrawal by Subject|5|||
28126220|NCT01314716|54788059|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
28126221|NCT01314716|54788058|FG000|Double-Blind Phase|Lost to Follow-up|0|||
28126222|NCT01314716|54788059|FG001|Double-Blind Phase|Lost to Follow-up|1|||
28126223|NCT01314716|54788058|FG000|Double-Blind Phase|Sponsor request|1|||
28126224|NCT01314716|54788059|FG001|Double-Blind Phase|Sponsor request|2|||
28126225|NCT01314716|54788058|FG000|Double-Blind Phase|Physician Decision|0|||
28126226|NCT01314716|54788059|FG001|Double-Blind Phase|Physician Decision|1|||
27818215|NCT00139477|54276485|FG000|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
27818216|NCT00139477|54276486|FG001|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
28126227|NCT01314716|54788058|FG000|Open-Label Phase|Adverse Event|4|||
28126228|NCT01314716|54788059|FG001|Open-Label Phase|Adverse Event|6|||
28126229|NCT01314716|54788058|FG000|Open-Label Phase|Withdrawal by Subject|1|||
28126230|NCT01314716|54788059|FG001|Open-Label Phase|Withdrawal by Subject|2|||
28126231|NCT01314716|54788058|FG000|Open-Label Phase|Physician Decision|5|||
28126232|NCT01314716|54788059|FG001|Open-Label Phase|Physician Decision|4|||
28126233|NCT03144180|54788069|FG000|Overall Study|STAT Delivery|1|||
28126234|NCT03144180|54788070|FG001|Overall Study|STAT Delivery|1|||
28126235|NCT03144180|54788069|FG000|Overall Study|Provider forgot to fill out forms|1|||
28126236|NCT03144180|54788070|FG001|Overall Study|Provider forgot to fill out forms|3|||
28126237|NCT03144180|54788069|FG000|Overall Study|Provider forgot to use the Q-cup|0|||
28126238|NCT03144180|54788070|FG001|Overall Study|Provider forgot to use the Q-cup|1|||
28126239|NCT03144180|54788069|FG000|Overall Study|Scrub tech removed tube cap|0|||
28126240|NCT03144180|54788070|FG001|Overall Study|Scrub tech removed tube cap|1|||
28126241|NCT01465334|54788080|FG000|Overall Study|Disease Progression|1|||
27818217|NCT00139477|54276485|FG000|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2|||
27818218|NCT00139477|54276486|FG001|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0|||
27818219|NCT00139477|54276485|FG000|Second Intervention -6Months to 12Months|No Longer Interested|0|||
27818220|NCT00139477|54276486|FG001|Second Intervention -6Months to 12Months|No Longer Interested|2|||
27818221|NCT00139477|54276485|FG000|Second Intervention -6Months to 12Months|Relocation|1|||
27818222|NCT00139477|54276486|FG001|Second Intervention -6Months to 12Months|Relocation|0|||
27818223|NCT00139477|54276485|FG000|Second Intervention -6Months to 12Months|Lost to Follow-up|4|||
27818224|NCT00139477|54276486|FG001|Second Intervention -6Months to 12Months|Lost to Follow-up|3|||
28067462|NCT00296504|54722756|FG001|Interim Analysis|Principle Investigator Discretion|0|||
28067463|NCT00296504|54722757|FG002|Interim Analysis|Principle Investigator Discretion|1|||
28067464|NCT00296504|54722758|FG003|Interim Analysis|Principle Investigator Discretion|1|||
28067465|NCT00296504|54722759|FG004|Interim Analysis|Principle Investigator Discretion|0|||
28067466|NCT00296504|54722760|FG005|Interim Analysis|Principle Investigator Discretion|0|||
28067467|NCT00296504|54722761|FG006|Interim Analysis|Principle Investigator Discretion|0|||
28067468|NCT00296504|54722762|FG007|Interim Analysis|Principle Investigator Discretion|0|||
28067469|NCT00296504|54722763|FG008|Interim Analysis|Principle Investigator Discretion|0|||
28067470|NCT00296504|54722755|FG000|Interim Analysis|Principle Investigator Terminated Study|0|||
28067471|NCT00296504|54722756|FG001|Interim Analysis|Principle Investigator Terminated Study|0|||
28067472|NCT00296504|54722757|FG002|Interim Analysis|Principle Investigator Terminated Study|1|||
28067473|NCT00296504|54722758|FG003|Interim Analysis|Principle Investigator Terminated Study|0|||
28067474|NCT00296504|54722759|FG004|Interim Analysis|Principle Investigator Terminated Study|0|||
28067475|NCT00296504|54722760|FG005|Interim Analysis|Principle Investigator Terminated Study|0|||
28067476|NCT00296504|54722761|FG006|Interim Analysis|Principle Investigator Terminated Study|0|||
28126242|NCT01465334|54788081|FG001|Overall Study|Disease Progression|0|||
28126243|NCT01465334|54788080|FG000|Overall Study|Adverse Event|1|||
28126244|NCT01465334|54788081|FG001|Overall Study|Adverse Event|0|||
28126245|NCT01465334|54788080|FG000|Overall Study|Richter's transformation|0|||
28126246|NCT01465334|54788081|FG001|Overall Study|Richter's transformation|3|||
28126247|NCT01465334|54788080|FG000|Overall Study|Refractory Disease|0|||
28126248|NCT01465334|54788081|FG001|Overall Study|Refractory Disease|3|||
28126249|NCT00702208|54788087|FG000|Overall Study|Lost to Follow-up|28|||
28126250|NCT00702208|54788087|FG000|Overall Study|Did not self-lavage|1|||
27818225|NCT01469013|54276806|FG000|Part A (Treatment Period)|Adverse Event|1|||
27818226|NCT01469013|54276807|FG001|Part A (Treatment Period)|Adverse Event|0|||
27818227|NCT01469013|54276808|FG002|Part A (Treatment Period)|Adverse Event|0|||
27818228|NCT01469013|54276809|FG003|Part A (Treatment Period)|Adverse Event|0|||
27818229|NCT01469013|54276810|FG004|Part A (Treatment Period)|Adverse Event|1|||
27818230|NCT01469013|54276811|FG005|Part A (Treatment Period)|Adverse Event|0|||
27818231|NCT01469013|54276812|FG006|Part A (Treatment Period)|Adverse Event|0|||
27818232|NCT01469013|54276813|FG007|Part A (Treatment Period)|Adverse Event|0|||
27818233|NCT01469013|54276814|FG008|Part A (Treatment Period)|Adverse Event|0|||
27818234|NCT01469013|54276815|FG009|Part A (Treatment Period)|Adverse Event|0|||
28067477|NCT00296504|54722762|FG007|Interim Analysis|Principle Investigator Terminated Study|0|||
28067478|NCT00296504|54722763|FG008|Interim Analysis|Principle Investigator Terminated Study|0|||
28126251|NCT00702208|54788087|FG000|Overall Study|Unsatisfactory colposcopy|2|||
28126252|NCT02718898|54788104|FG000|Blinded Treatment Period|Adverse Event|5|||
28126253|NCT02718898|54788105|FG001|Blinded Treatment Period|Adverse Event|1|||
28126254|NCT02718898|54788106|FG002|Blinded Treatment Period|Adverse Event|0|||
28126255|NCT02718898|54788107|FG003|Blinded Treatment Period|Adverse Event|0|||
28126256|NCT02718898|54788108|FG004|Blinded Treatment Period|Adverse Event|0|||
28126257|NCT02718898|54788109|FG005|Blinded Treatment Period|Adverse Event|0|||
28126258|NCT02718898|54788110|FG006|Blinded Treatment Period|Adverse Event|0|||
28126259|NCT02718898|54788104|FG000|Blinded Treatment Period|Physician Decision|1|||
27818235|NCT01469013|54276816|FG010|Part A (Treatment Period)|Adverse Event|0|||
27818236|NCT01469013|54276817|FG011|Part A (Treatment Period)|Adverse Event|0|||
27818237|NCT01469013|54276818|FG012|Part A (Treatment Period)|Adverse Event|0|||
27818238|NCT01469013|54276806|FG000|Part A (Treatment Period)|Withdrawal by Subject|0|||
27818239|NCT01469013|54276807|FG001|Part A (Treatment Period)|Withdrawal by Subject|0|||
28126260|NCT02718898|54788105|FG001|Blinded Treatment Period|Physician Decision|0|||
28126261|NCT02718898|54788106|FG002|Blinded Treatment Period|Physician Decision|0|||
28126262|NCT02718898|54788107|FG003|Blinded Treatment Period|Physician Decision|0|||
28126263|NCT02718898|54788108|FG004|Blinded Treatment Period|Physician Decision|0|||
27818240|NCT01469013|54276808|FG002|Part A (Treatment Period)|Withdrawal by Subject|1|||
28126264|NCT02718898|54788109|FG005|Blinded Treatment Period|Physician Decision|0|||
28126265|NCT02718898|54788110|FG006|Blinded Treatment Period|Physician Decision|0|||
28126266|NCT02718898|54788104|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
28126267|NCT02718898|54788105|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
28126268|NCT02718898|54788106|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
28126269|NCT02718898|54788107|FG003|Blinded Treatment Period|Lack of Efficacy|0|||
28126270|NCT02718898|54788108|FG004|Blinded Treatment Period|Lack of Efficacy|0|||
28126271|NCT02718898|54788109|FG005|Blinded Treatment Period|Lack of Efficacy|0|||
28126272|NCT02718898|54788110|FG006|Blinded Treatment Period|Lack of Efficacy|0|||
28126273|NCT02718898|54788104|FG000|Blinded Treatment Period|Lost to Follow-up|2|||
28126274|NCT02718898|54788105|FG001|Blinded Treatment Period|Lost to Follow-up|0|||
28126275|NCT02718898|54788106|FG002|Blinded Treatment Period|Lost to Follow-up|0|||
28126276|NCT02718898|54788107|FG003|Blinded Treatment Period|Lost to Follow-up|0|||
28126277|NCT02718898|54788108|FG004|Blinded Treatment Period|Lost to Follow-up|0|||
28126278|NCT02718898|54788109|FG005|Blinded Treatment Period|Lost to Follow-up|0|||
28126279|NCT02718898|54788110|FG006|Blinded Treatment Period|Lost to Follow-up|0|||
28126280|NCT02718898|54788104|FG000|Open Label Treatment Period (OLTP)|Adverse Event|0|||
27831264|NCT01812707|54307682|FG001|Overall Study|Adverse Event|0|||
28126281|NCT02718898|54788105|FG001|Open Label Treatment Period (OLTP)|Adverse Event|0|||
28126282|NCT02718898|54788106|FG002|Open Label Treatment Period (OLTP)|Adverse Event|1|||
28126283|NCT02718898|54788107|FG003|Open Label Treatment Period (OLTP)|Adverse Event|1|||
28126284|NCT02718898|54788108|FG004|Open Label Treatment Period (OLTP)|Adverse Event|0|||
28126285|NCT02718898|54788109|FG005|Open Label Treatment Period (OLTP)|Adverse Event|0|||
28126286|NCT02718898|54788110|FG006|Open Label Treatment Period (OLTP)|Adverse Event|0|||
28126287|NCT02718898|54788104|FG000|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
28126288|NCT02718898|54788105|FG001|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
28126289|NCT02718898|54788106|FG002|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
28126290|NCT02718898|54788107|FG003|Open Label Treatment Period (OLTP)|Lost to Follow-up|2|||
28126291|NCT02718898|54788108|FG004|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
28126292|NCT02718898|54788109|FG005|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
28126293|NCT02718898|54788110|FG006|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
28126294|NCT02718898|54788104|FG000|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
28126295|NCT02718898|54788105|FG001|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
28126296|NCT02718898|54788106|FG002|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
28126297|NCT02718898|54788107|FG003|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3|||
28126298|NCT02718898|54788108|FG004|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
28126299|NCT02718898|54788109|FG005|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
28126300|NCT02718898|54788110|FG006|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
28126301|NCT02718898|54788104|FG000|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
28126302|NCT02718898|54788105|FG001|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
28126303|NCT02718898|54788106|FG002|Open Label Treatment Period (OLTP)|Lack of Efficacy|1|||
28126304|NCT02718898|54788107|FG003|Open Label Treatment Period (OLTP)|Lack of Efficacy|2|||
28126305|NCT02718898|54788108|FG004|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
28126306|NCT02718898|54788109|FG005|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
28126307|NCT02718898|54788110|FG006|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
28126308|NCT02718898|54788104|FG000|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
28126309|NCT02718898|54788105|FG001|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
28126310|NCT02718898|54788106|FG002|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
28126311|NCT02718898|54788107|FG003|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1|||
28126312|NCT02718898|54788108|FG004|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
28126313|NCT02718898|54788109|FG005|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
28126314|NCT02718898|54788110|FG006|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
28126315|NCT02718898|54788104|FG000|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
28126316|NCT02718898|54788105|FG001|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
28126317|NCT02718898|54788106|FG002|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
28126318|NCT02718898|54788107|FG003|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1|||
28126319|NCT02718898|54788108|FG004|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
28126320|NCT02718898|54788109|FG005|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
28126321|NCT02718898|54788110|FG006|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
28126322|NCT02718898|54788104|FG000|Post Treatment Follow-up Period|Adverse Event|0|||
28126323|NCT02718898|54788105|FG001|Post Treatment Follow-up Period|Adverse Event|0|||
28126324|NCT02718898|54788106|FG002|Post Treatment Follow-up Period|Adverse Event|0|||
28126325|NCT02718898|54788107|FG003|Post Treatment Follow-up Period|Adverse Event|0|||
28126326|NCT02718898|54788108|FG004|Post Treatment Follow-up Period|Adverse Event|0|||
28126327|NCT02718898|54788109|FG005|Post Treatment Follow-up Period|Adverse Event|1|||
28126328|NCT02718898|54788110|FG006|Post Treatment Follow-up Period|Adverse Event|1|||
28126329|NCT02718898|54788104|FG000|Post Treatment Follow-up Period|Lost to Follow-up|0|||
28126330|NCT02718898|54788105|FG001|Post Treatment Follow-up Period|Lost to Follow-up|0|||
28126331|NCT02718898|54788106|FG002|Post Treatment Follow-up Period|Lost to Follow-up|0|||
28126332|NCT02718898|54788107|FG003|Post Treatment Follow-up Period|Lost to Follow-up|0|||
28126333|NCT02718898|54788108|FG004|Post Treatment Follow-up Period|Lost to Follow-up|1|||
28126334|NCT02718898|54788109|FG005|Post Treatment Follow-up Period|Lost to Follow-up|5|||
28126335|NCT02718898|54788110|FG006|Post Treatment Follow-up Period|Lost to Follow-up|1|||
28126336|NCT02718898|54788104|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
28126337|NCT02718898|54788105|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
28126338|NCT02718898|54788106|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
28126339|NCT02718898|54788107|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
28126340|NCT02718898|54788108|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
28126341|NCT02718898|54788109|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|5|||
28126342|NCT02718898|54788110|FG006|Post Treatment Follow-up Period|Withdrawal by Subject|3|||
28126343|NCT03143166|54788127|FG000|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1|||
28126344|NCT02879994|54788133|FG000|Overall Study|off treatment early|7|||
28126345|NCT02879994|54788133|FG000|Overall Study|Adverse Event|2|||
28126346|NCT02879994|54788133|FG000|Overall Study|Death|2|||
28126347|NCT03142932|54788139|FG000|Overall Study|Lost to Follow-up|2|||
28126348|NCT03142932|54788140|FG001|Overall Study|Lost to Follow-up|11|||
28126349|NCT00702052|54788146|FG000|Overall Study|Adverse Event|23|||
28126350|NCT00702052|54788146|FG000|Overall Study|Disease Progression|30|||
27818241|NCT01469013|54276809|FG003|Part A (Treatment Period)|Withdrawal by Subject|0|||
27818242|NCT01469013|54276810|FG004|Part A (Treatment Period)|Withdrawal by Subject|0|||
27818243|NCT01469013|54276811|FG005|Part A (Treatment Period)|Withdrawal by Subject|0|||
28126351|NCT00702052|54788146|FG000|Overall Study|Withdrawal by Subject|5|||
28126352|NCT03140280|54788150|FG000|Overall Study|Physician Decision|5|||
28126353|NCT03136380|54788156|FG000|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
28126354|NCT03136380|54788157|FG001|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
28126355|NCT03136380|54788158|FG002|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
28126356|NCT03136380|54788159|FG003|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
28126357|NCT03136380|54788160|FG004|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
28126358|NCT03136068|54788180|FG000|Overall Study|Lost to Follow-up|1|||
28126359|NCT03136068|54788181|FG001|Overall Study|Lost to Follow-up|1|||
28126360|NCT03136068|54788180|FG000|Overall Study|Protocol Violation|1|||
28126361|NCT03136068|54788181|FG001|Overall Study|Protocol Violation|0|||
28126362|NCT02585232|54788189|FG000|Overall Study|Lost to Follow-up|8|||
28126363|NCT02585232|54788190|FG001|Overall Study|Lost to Follow-up|8|||
28126364|NCT02585232|54788189|FG000|Overall Study|Withdrawal by Subject|4|||
28126365|NCT02585232|54788190|FG001|Overall Study|Withdrawal by Subject|8|||
28126366|NCT03377790|54788219|FG000|Overall Study|Withdrawal by Subject|1|||
28126367|NCT03377790|54788220|FG001|Overall Study|Withdrawal by Subject|0|||
28126368|NCT03377790|54788219|FG000|Overall Study|Adverse Event|1|||
28126369|NCT03377790|54788220|FG001|Overall Study|Adverse Event|0|||
28126370|NCT03377790|54788219|FG000|Overall Study|Lost to Follow-up|0|||
28126371|NCT03377790|54788220|FG001|Overall Study|Lost to Follow-up|2|||
28126372|NCT03377790|54788219|FG000|Overall Study|Randomized but not treated|1|||
28126373|NCT03377790|54788220|FG001|Overall Study|Randomized but not treated|0|||
28126374|NCT03377790|54788219|FG000|Overall Study|Withdrawn by Parent/Guardian|7|||
28126375|NCT03377790|54788220|FG001|Overall Study|Withdrawn by Parent/Guardian|4|||
28126376|NCT02717494|54788229|FG000|First Intervention (Step 1)|Lost to Follow-up|4|||
28126377|NCT02717494|54788230|FG001|First Intervention (Step 1)|Lost to Follow-up|7|||
28126378|NCT02717494|54788231|FG002|First Intervention (Step 1)|Lost to Follow-up|3|||
28126379|NCT02717494|54788229|FG000|First Intervention (Step 1)|Withdrawal by Subject|2|||
28126380|NCT02717494|54788230|FG001|First Intervention (Step 1)|Withdrawal by Subject|0|||
28126381|NCT02717494|54788231|FG002|First Intervention (Step 1)|Withdrawal by Subject|1|||
28126382|NCT02717494|54788229|FG000|First Intervention (Step 1)|Death|0|||
28126383|NCT02717494|54788230|FG001|First Intervention (Step 1)|Death|0|||
28126384|NCT02717494|54788231|FG002|First Intervention (Step 1)|Death|1|||
28126385|NCT02717494|54788229|FG000|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
28126386|NCT02717494|54788230|FG001|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
28126387|NCT02717494|54788231|FG002|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4|||
28126388|NCT01844856|54788259|FG000|Overall Study|Lost to Follow-up|15|||
27818244|NCT01469013|54276812|FG006|Part A (Treatment Period)|Withdrawal by Subject|0|||
27818245|NCT01469013|54276813|FG007|Part A (Treatment Period)|Withdrawal by Subject|0|||
28067479|NCT00296504|54722755|FG000|Interim Analysis|Non-adherence|2|||
28067480|NCT00296504|54722756|FG001|Interim Analysis|Non-adherence|0|||
28067481|NCT00296504|54722757|FG002|Interim Analysis|Non-adherence|0|||
28067482|NCT00296504|54722758|FG003|Interim Analysis|Non-adherence|0|||
28067483|NCT00296504|54722759|FG004|Interim Analysis|Non-adherence|1|||
28067484|NCT00296504|54722760|FG005|Interim Analysis|Non-adherence|0|||
28067485|NCT00296504|54722761|FG006|Interim Analysis|Non-adherence|0|||
28067486|NCT00296504|54722762|FG007|Interim Analysis|Non-adherence|1|||
28067487|NCT00296504|54722763|FG008|Interim Analysis|Non-adherence|0|||
28067488|NCT00296504|54722755|FG000|Interim Analysis|Site Closing|1|||
28067489|NCT00296504|54722756|FG001|Interim Analysis|Site Closing|0|||
28126389|NCT01844856|54788260|FG001|Overall Study|Lost to Follow-up|3|||
28126390|NCT01844856|54788259|FG000|Overall Study|Adverse Event|3|||
28126391|NCT01844856|54788260|FG001|Overall Study|Adverse Event|6|||
28126392|NCT01844856|54788259|FG000|Overall Study|Withdrawal by Subject|3|||
28126393|NCT01844856|54788260|FG001|Overall Study|Withdrawal by Subject|2|||
28126394|NCT01844856|54788259|FG000|Overall Study|Noncompliance|2|||
28126395|NCT01844856|54788260|FG001|Overall Study|Noncompliance|3|||
28126396|NCT01844856|54788259|FG000|Overall Study|Enterococcus Resistant|0|||
28126397|NCT01844856|54788260|FG001|Overall Study|Enterococcus Resistant|1|||
28126398|NCT01844856|54788259|FG000|Overall Study|Inadvertently Not Scheduled|1|||
28126399|NCT01844856|54788260|FG001|Overall Study|Inadvertently Not Scheduled|0|||
27818246|NCT01469013|54276814|FG008|Part A (Treatment Period)|Withdrawal by Subject|0|||
27818247|NCT01469013|54276815|FG009|Part A (Treatment Period)|Withdrawal by Subject|0|||
27818248|NCT01469013|54276816|FG010|Part A (Treatment Period)|Withdrawal by Subject|0|||
28126400|NCT01844856|54788259|FG000|Overall Study|Randomized but was a Screen Failure|0|||
28126401|NCT01844856|54788260|FG001|Overall Study|Randomized but was a Screen Failure|1|||
27831265|NCT01812707|54307683|FG002|Overall Study|Adverse Event|0|||
28126402|NCT03135210|54788296|FG000|Overall Study|Death|0|||
28126403|NCT03135210|54788297|FG001|Overall Study|Death|1|||
28126404|NCT00701662|54788303|FG000|Overall Study|Lack of Efficacy|1|||
28126405|NCT02878590|54788307|FG000|Overall Study|Withdrawal by Subject|2|||
28126406|NCT04634409|54788338|FG000|Overall Study|Death|0|||
28126407|NCT04634409|54788339|FG001|Overall Study|Death|0|||
28126408|NCT04634409|54788340|FG002|Overall Study|Death|0|||
28126409|NCT04634409|54788341|FG003|Overall Study|Death|0|||
28126410|NCT04634409|54788342|FG004|Overall Study|Death|0|||
28126411|NCT04634409|54788343|FG005|Overall Study|Death|0|||
28126412|NCT04634409|54788344|FG006|Overall Study|Death|0|||
28126413|NCT04634409|54788345|FG007|Overall Study|Death|0|||
28126414|NCT04634409|54788346|FG008|Overall Study|Death|0|||
28126415|NCT04634409|54788347|FG009|Overall Study|Death|0|||
28126416|NCT04634409|54788348|FG010|Overall Study|Death|1|||
28126417|NCT04634409|54788349|FG011|Overall Study|Death|0|||
28126418|NCT04634409|54788350|FG012|Overall Study|Death|1|||
28126419|NCT04634409|54788351|FG013|Overall Study|Death|0|||
28126420|NCT04634409|54788352|FG014|Overall Study|Death|0|||
28126421|NCT04634409|54788353|FG015|Overall Study|Death|0|||
28126422|NCT04634409|54788354|FG016|Overall Study|Death|0|||
28126423|NCT04634409|54788355|FG017|Overall Study|Death|0|||
27818249|NCT01469013|54276817|FG011|Part A (Treatment Period)|Withdrawal by Subject|0|||
27818250|NCT01469013|54276818|FG012|Part A (Treatment Period)|Withdrawal by Subject|0|||
27818251|NCT01469013|54276806|FG000|Part B (Extension Period)|Adverse Event|0|||
27818252|NCT01469013|54276807|FG001|Part B (Extension Period)|Adverse Event|0|||
28126424|NCT04634409|54788356|FG018|Overall Study|Death|0|||
28126425|NCT04634409|54788357|FG019|Overall Study|Death|0|||
28126426|NCT04634409|54788358|FG020|Overall Study|Death|0|||
28126427|NCT04634409|54788359|FG021|Overall Study|Death|0|||
28126428|NCT04634409|54788360|FG022|Overall Study|Death|0|||
28126429|NCT04634409|54788361|FG023|Overall Study|Death|0|||
28126430|NCT04634409|54788362|FG024|Overall Study|Death|0|||
28126431|NCT04634409|54788363|FG025|Overall Study|Death|0|||
28126432|NCT04634409|54788364|FG026|Overall Study|Death|0|||
28126433|NCT04634409|54788338|FG000|Overall Study|Adverse Event|0|||
28126434|NCT04634409|54788339|FG001|Overall Study|Adverse Event|0|||
28126435|NCT04634409|54788340|FG002|Overall Study|Adverse Event|1|||
28126436|NCT04634409|54788341|FG003|Overall Study|Adverse Event|0|||
28126437|NCT04634409|54788342|FG004|Overall Study|Adverse Event|0|||
28126438|NCT04634409|54788343|FG005|Overall Study|Adverse Event|1|||
28126439|NCT04634409|54788344|FG006|Overall Study|Adverse Event|0|||
28126440|NCT04634409|54788345|FG007|Overall Study|Adverse Event|0|||
28126441|NCT04634409|54788346|FG008|Overall Study|Adverse Event|0|||
28126442|NCT04634409|54788347|FG009|Overall Study|Adverse Event|0|||
28126443|NCT04634409|54788348|FG010|Overall Study|Adverse Event|0|||
28126444|NCT04634409|54788349|FG011|Overall Study|Adverse Event|0|||
28126445|NCT04634409|54788350|FG012|Overall Study|Adverse Event|0|||
28126446|NCT04634409|54788351|FG013|Overall Study|Adverse Event|0|||
28126447|NCT04634409|54788352|FG014|Overall Study|Adverse Event|0|||
28126448|NCT04634409|54788353|FG015|Overall Study|Adverse Event|0|||
28126449|NCT04634409|54788354|FG016|Overall Study|Adverse Event|0|||
28126450|NCT04634409|54788355|FG017|Overall Study|Adverse Event|0|||
27818253|NCT01469013|54276808|FG002|Part B (Extension Period)|Adverse Event|0|||
27818254|NCT01469013|54276809|FG003|Part B (Extension Period)|Adverse Event|0|||
28067490|NCT00296504|54722757|FG002|Interim Analysis|Site Closing|0|||
28067491|NCT00296504|54722758|FG003|Interim Analysis|Site Closing|0|||
28067492|NCT00296504|54722759|FG004|Interim Analysis|Site Closing|0|||
28067493|NCT00296504|54722760|FG005|Interim Analysis|Site Closing|1|||
28067494|NCT00296504|54722761|FG006|Interim Analysis|Site Closing|2|||
28067495|NCT00296504|54722762|FG007|Interim Analysis|Site Closing|0|||
28067496|NCT00296504|54722763|FG008|Interim Analysis|Site Closing|0|||
28067497|NCT00296504|54722755|FG000|Interim Analysis|Lack of Personnel at Site|1|||
28067498|NCT00296504|54722756|FG001|Interim Analysis|Lack of Personnel at Site|0|||
28067499|NCT00296504|54722757|FG002|Interim Analysis|Lack of Personnel at Site|0|||
28067500|NCT00296504|54722758|FG003|Interim Analysis|Lack of Personnel at Site|0|||
28067501|NCT00296504|54722759|FG004|Interim Analysis|Lack of Personnel at Site|0|||
28067502|NCT00296504|54722760|FG005|Interim Analysis|Lack of Personnel at Site|0|||
28126451|NCT04634409|54788356|FG018|Overall Study|Adverse Event|0|||
28126452|NCT04634409|54788357|FG019|Overall Study|Adverse Event|0|||
28126453|NCT04634409|54788358|FG020|Overall Study|Adverse Event|0|||
28126454|NCT04634409|54788359|FG021|Overall Study|Adverse Event|0|||
28126455|NCT04634409|54788360|FG022|Overall Study|Adverse Event|0|||
28126456|NCT04634409|54788361|FG023|Overall Study|Adverse Event|0|||
28126457|NCT04634409|54788362|FG024|Overall Study|Adverse Event|0|||
28126458|NCT04634409|54788363|FG025|Overall Study|Adverse Event|0|||
28126459|NCT04634409|54788364|FG026|Overall Study|Adverse Event|0|||
28126460|NCT04634409|54788338|FG000|Overall Study|Lost to Follow-up|3|||
28126461|NCT04634409|54788339|FG001|Overall Study|Lost to Follow-up|1|||
28126462|NCT04634409|54788340|FG002|Overall Study|Lost to Follow-up|1|||
28126463|NCT04634409|54788341|FG003|Overall Study|Lost to Follow-up|3|||
28126464|NCT04634409|54788342|FG004|Overall Study|Lost to Follow-up|1|||
28126465|NCT04634409|54788343|FG005|Overall Study|Lost to Follow-up|1|||
28126466|NCT04634409|54788344|FG006|Overall Study|Lost to Follow-up|1|||
28126467|NCT04634409|54788345|FG007|Overall Study|Lost to Follow-up|3|||
28126468|NCT04634409|54788346|FG008|Overall Study|Lost to Follow-up|3|||
28067503|NCT00296504|54722761|FG006|Interim Analysis|Lack of Personnel at Site|0|||
28067504|NCT00296504|54722762|FG007|Interim Analysis|Lack of Personnel at Site|0|||
28067505|NCT00296504|54722763|FG008|Interim Analysis|Lack of Personnel at Site|0|||
28067506|NCT00296504|54722755|FG000|Interim Analysis|Missed Schedule Date|1|||
28067507|NCT00296504|54722756|FG001|Interim Analysis|Missed Schedule Date|0|||
28067508|NCT00296504|54722757|FG002|Interim Analysis|Missed Schedule Date|0|||
28067509|NCT00296504|54722758|FG003|Interim Analysis|Missed Schedule Date|0|||
28067510|NCT00296504|54722759|FG004|Interim Analysis|Missed Schedule Date|0|||
28067511|NCT00296504|54722760|FG005|Interim Analysis|Missed Schedule Date|0|||
28067512|NCT00296504|54722761|FG006|Interim Analysis|Missed Schedule Date|0|||
28067513|NCT00296504|54722762|FG007|Interim Analysis|Missed Schedule Date|0|||
28067514|NCT00296504|54722763|FG008|Interim Analysis|Missed Schedule Date|0|||
28067515|NCT00296504|54722755|FG000|Interim Analysis|Inclusion in Other Protocol|0|||
28067516|NCT00296504|54722756|FG001|Interim Analysis|Inclusion in Other Protocol|0|||
28126469|NCT04634409|54788347|FG009|Overall Study|Lost to Follow-up|11|||
28126470|NCT04634409|54788348|FG010|Overall Study|Lost to Follow-up|8|||
28126471|NCT04634409|54788349|FG011|Overall Study|Lost to Follow-up|15|||
28126472|NCT04634409|54788350|FG012|Overall Study|Lost to Follow-up|3|||
28126473|NCT04634409|54788351|FG013|Overall Study|Lost to Follow-up|2|||
28126474|NCT04634409|54788352|FG014|Overall Study|Lost to Follow-up|7|||
28126475|NCT04634409|54788353|FG015|Overall Study|Lost to Follow-up|0|||
28126476|NCT04634409|54788354|FG016|Overall Study|Lost to Follow-up|0|||
28126477|NCT04634409|54788355|FG017|Overall Study|Lost to Follow-up|0|||
28126478|NCT04634409|54788356|FG018|Overall Study|Lost to Follow-up|0|||
28126479|NCT04634409|54788357|FG019|Overall Study|Lost to Follow-up|0|||
28126480|NCT04634409|54788358|FG020|Overall Study|Lost to Follow-up|0|||
28126481|NCT04634409|54788359|FG021|Overall Study|Lost to Follow-up|0|||
28126482|NCT04634409|54788360|FG022|Overall Study|Lost to Follow-up|0|||
28126483|NCT04634409|54788361|FG023|Overall Study|Lost to Follow-up|0|||
28126484|NCT04634409|54788362|FG024|Overall Study|Lost to Follow-up|0|||
28126485|NCT04634409|54788363|FG025|Overall Study|Lost to Follow-up|0|||
28126486|NCT04634409|54788364|FG026|Overall Study|Lost to Follow-up|0|||
28126487|NCT04634409|54788338|FG000|Overall Study|Withdrawal by Subject|3|||
28126488|NCT04634409|54788339|FG001|Overall Study|Withdrawal by Subject|1|||
28126489|NCT04634409|54788340|FG002|Overall Study|Withdrawal by Subject|6|||
28126490|NCT04634409|54788341|FG003|Overall Study|Withdrawal by Subject|4|||
28126491|NCT04634409|54788342|FG004|Overall Study|Withdrawal by Subject|2|||
28126492|NCT04634409|54788343|FG005|Overall Study|Withdrawal by Subject|0|||
28126493|NCT04634409|54788344|FG006|Overall Study|Withdrawal by Subject|0|||
28126494|NCT04634409|54788345|FG007|Overall Study|Withdrawal by Subject|2|||
28126495|NCT04634409|54788346|FG008|Overall Study|Withdrawal by Subject|3|||
28126496|NCT04634409|54788347|FG009|Overall Study|Withdrawal by Subject|2|||
28126497|NCT04634409|54788348|FG010|Overall Study|Withdrawal by Subject|3|||
28126498|NCT04634409|54788349|FG011|Overall Study|Withdrawal by Subject|2|||
28126499|NCT04634409|54788350|FG012|Overall Study|Withdrawal by Subject|2|||
28126500|NCT04634409|54788351|FG013|Overall Study|Withdrawal by Subject|1|||
28126501|NCT04634409|54788352|FG014|Overall Study|Withdrawal by Subject|5|||
28126502|NCT04634409|54788353|FG015|Overall Study|Withdrawal by Subject|0|||
28126503|NCT04634409|54788354|FG016|Overall Study|Withdrawal by Subject|0|||
28126504|NCT04634409|54788355|FG017|Overall Study|Withdrawal by Subject|1|||
28126505|NCT04634409|54788356|FG018|Overall Study|Withdrawal by Subject|0|||
28126506|NCT04634409|54788357|FG019|Overall Study|Withdrawal by Subject|0|||
28126507|NCT04634409|54788358|FG020|Overall Study|Withdrawal by Subject|0|||
28126508|NCT04634409|54788359|FG021|Overall Study|Withdrawal by Subject|0|||
28126509|NCT04634409|54788360|FG022|Overall Study|Withdrawal by Subject|0|||
28126510|NCT04634409|54788361|FG023|Overall Study|Withdrawal by Subject|1|||
28126511|NCT04634409|54788362|FG024|Overall Study|Withdrawal by Subject|0|||
28126512|NCT04634409|54788363|FG025|Overall Study|Withdrawal by Subject|0|||
28126513|NCT04634409|54788364|FG026|Overall Study|Withdrawal by Subject|0|||
28126514|NCT04634409|54788338|FG000|Overall Study|Other - As reported by Investigator|1|||
28126515|NCT04634409|54788339|FG001|Overall Study|Other - As reported by Investigator|0|||
28126516|NCT04634409|54788340|FG002|Overall Study|Other - As reported by Investigator|0|||
28067517|NCT00296504|54722757|FG002|Interim Analysis|Inclusion in Other Protocol|0|||
28126517|NCT04634409|54788341|FG003|Overall Study|Other - As reported by Investigator|0|||
28126518|NCT04634409|54788342|FG004|Overall Study|Other - As reported by Investigator|0|||
28126519|NCT04634409|54788343|FG005|Overall Study|Other - As reported by Investigator|0|||
28126520|NCT04634409|54788344|FG006|Overall Study|Other - As reported by Investigator|0|||
28126521|NCT04634409|54788345|FG007|Overall Study|Other - As reported by Investigator|6|||
28126522|NCT04634409|54788346|FG008|Overall Study|Other - As reported by Investigator|4|||
28126523|NCT04634409|54788347|FG009|Overall Study|Other - As reported by Investigator|0|||
28126524|NCT04634409|54788348|FG010|Overall Study|Other - As reported by Investigator|1|||
28126525|NCT04634409|54788349|FG011|Overall Study|Other - As reported by Investigator|2|||
28126526|NCT04634409|54788350|FG012|Overall Study|Other - As reported by Investigator|2|||
28126527|NCT04634409|54788351|FG013|Overall Study|Other - As reported by Investigator|1|||
28126528|NCT04634409|54788352|FG014|Overall Study|Other - As reported by Investigator|0|||
28126529|NCT04634409|54788353|FG015|Overall Study|Other - As reported by Investigator|0|||
28126530|NCT04634409|54788354|FG016|Overall Study|Other - As reported by Investigator|0|||
28126531|NCT04634409|54788355|FG017|Overall Study|Other - As reported by Investigator|0|||
28126532|NCT04634409|54788356|FG018|Overall Study|Other - As reported by Investigator|0|||
28126533|NCT04634409|54788357|FG019|Overall Study|Other - As reported by Investigator|0|||
28126534|NCT04634409|54788358|FG020|Overall Study|Other - As reported by Investigator|0|||
28126535|NCT04634409|54788359|FG021|Overall Study|Other - As reported by Investigator|0|||
28126536|NCT04634409|54788360|FG022|Overall Study|Other - As reported by Investigator|0|||
28126537|NCT04634409|54788361|FG023|Overall Study|Other - As reported by Investigator|0|||
28126538|NCT04634409|54788362|FG024|Overall Study|Other - As reported by Investigator|0|||
28126539|NCT04634409|54788363|FG025|Overall Study|Other - As reported by Investigator|0|||
28126540|NCT04634409|54788364|FG026|Overall Study|Other - As reported by Investigator|0|||
28126541|NCT00005780|54788442|FG000|Vaccine Administration Following EPOCH-R|Participant progressed before receiving the last vaccine.|1|||
28126542|NCT01978938|54788451|FG000|Overall Study|Lost to Follow-up|12|||
28126543|NCT01978938|54788452|FG001|Overall Study|Lost to Follow-up|6|||
28126544|NCT01978938|54788451|FG000|Overall Study|Withdrawal by Subject|8|||
28126545|NCT01978938|54788452|FG001|Overall Study|Withdrawal by Subject|4|||
28126546|NCT01978938|54788451|FG000|Overall Study|Adverse Event, non-fatal|2|||
28126547|NCT01978938|54788452|FG001|Overall Study|Adverse Event, non-fatal|1|||
28126548|NCT01978938|54788451|FG000|Overall Study|Participant noncompliance|1|||
28126549|NCT01978938|54788452|FG001|Overall Study|Participant noncompliance|1|||
28126550|NCT01978938|54788451|FG000|Overall Study|Did not meet inclusion criteria|0|||
28126551|NCT01978938|54788452|FG001|Overall Study|Did not meet inclusion criteria|1|||
28126552|NCT01978938|54788451|FG000|Overall Study|Previously scheduled procedure|0|||
28126553|NCT01978938|54788452|FG001|Overall Study|Previously scheduled procedure|1|||
28126554|NCT03041090|54788460|FG000|Overall Study|technical error|0|||
28126555|NCT03041090|54788461|FG001|Overall Study|technical error|3|||
28126556|NCT00116142|54788469|FG000|Overall Study|Adverse Event|8|||
28126557|NCT00116142|54788470|FG001|Overall Study|Adverse Event|7|||
28126558|NCT00116142|54788469|FG000|Overall Study|Protocol Violation|2|||
28126559|NCT00116142|54788470|FG001|Overall Study|Protocol Violation|1|||
28126560|NCT00116142|54788469|FG000|Overall Study|Withdrawal by Subject|5|||
28126561|NCT00116142|54788470|FG001|Overall Study|Withdrawal by Subject|5|||
28126562|NCT00116142|54788469|FG000|Overall Study|Physician Decision|3|||
28126563|NCT00116142|54788470|FG001|Overall Study|Physician Decision|1|||
28126564|NCT00116142|54788469|FG000|Overall Study|Delayed Radiation Therapy|1|||
28126565|NCT00116142|54788470|FG001|Overall Study|Delayed Radiation Therapy|0|||
28126566|NCT00116142|54788469|FG000|Overall Study|Patient could not tolerate docetaxel|0|||
28126567|NCT00116142|54788470|FG001|Overall Study|Patient could not tolerate docetaxel|2|||
28126568|NCT00116142|54788469|FG000|Overall Study|Patient stopped due to depression|0|||
28126569|NCT00116142|54788470|FG001|Overall Study|Patient stopped due to depression|1|||
28126570|NCT00116142|54788469|FG000|Overall Study|Patient stopped due to bilateral ruptured tendons|0|||
28126571|NCT00116142|54788470|FG001|Overall Study|Patient stopped due to bilateral ruptured tendons|1|||
28126572|NCT00116142|54788469|FG000|Overall Study|Patient didn't start due to diagnosis of colon cancer|0|||
28126573|NCT00116142|54788470|FG001|Overall Study|Patient didn't start due to diagnosis of colon cancer|1|||
28126574|NCT00116142|54788469|FG000|Overall Study|Patient didn't start due to low platelet counts|0|||
28126575|NCT00116142|54788470|FG001|Overall Study|Patient didn't start due to low platelet counts|1|||
28126576|NCT03135522|54788481|FG000|Overall Study|Adverse Event|1|||
28126577|NCT03135522|54788482|FG001|Overall Study|Adverse Event|0|||
28126578|NCT02875080|54788505|FG000|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2|||
28126579|NCT02875080|54788506|FG001|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
28126580|NCT02875080|54788507|FG002|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
28126581|NCT03129360|54788518|FG000|Overall Study|Did not meet entry criteria|0|||
28126582|NCT03129360|54788519|FG001|Overall Study|Did not meet entry criteria|2|||
28126583|NCT03129360|54788520|FG002|Overall Study|Did not meet entry criteria|1|||
28126584|NCT03129360|54788518|FG000|Overall Study|Excluded due to motion in scanner|1|||
28126585|NCT03129360|54788519|FG001|Overall Study|Excluded due to motion in scanner|0|||
28126586|NCT03129360|54788520|FG002|Overall Study|Excluded due to motion in scanner|0|||
28126587|NCT03165045|54788528|FG000|Visit 1|No registration after visit 1|9|||
28126588|NCT03165045|54788528|FG000|Visit 1|No treatment documented|10|||
28126589|NCT03165045|54788528|FG000|Visit 1|No visit 1|10|||
28126590|NCT03165045|54788528|FG000|Visit 2|Available CCQ score at visit 1 only|109|||
28126591|NCT03165045|54788528|FG000|Visit 2|No available total CCQ score at all|29|||
28126592|NCT03165045|54788528|FG000|Visit 2|Available total CCQ score at vist 2 only|44|||
28126593|NCT01928199|54788536|FG000|Overall Study|Lost to Follow-up|2|||
28126594|NCT01928199|54788537|FG001|Overall Study|Lost to Follow-up|1|||
28126595|NCT01928199|54788536|FG000|Overall Study|Withdrawal by Subject|3|||
28126596|NCT01928199|54788537|FG001|Overall Study|Withdrawal by Subject|5|||
28126597|NCT03128892|54788543|FG000|Overall Study|Withdrawal by Subject|2|||
28126598|NCT03128892|54788543|FG000|Overall Study|Physician Decision|1|||
28126599|NCT03039686|54788559|FG000|Double-blind Period|Administrative Reason by Sponsor|24|||
28126600|NCT03039686|54788560|FG001|Double-blind Period|Administrative Reason by Sponsor|25|||
28126601|NCT03039686|54788561|FG002|Double-blind Period|Administrative Reason by Sponsor|21|||
28126602|NCT03039686|54788559|FG000|Double-blind Period|Subject Request to Discontinue Study Treatment|1|||
28126603|NCT03039686|54788560|FG001|Double-blind Period|Subject Request to Discontinue Study Treatment|2|||
28126604|NCT03039686|54788561|FG002|Double-blind Period|Subject Request to Discontinue Study Treatment|0|||
28126605|NCT03039686|54788559|FG000|Double-blind Period|Withdrawal by Subject|2|||
28126606|NCT03039686|54788560|FG001|Double-blind Period|Withdrawal by Subject|2|||
28126607|NCT03039686|54788561|FG002|Double-blind Period|Withdrawal by Subject|1|||
28126608|NCT03039686|54788559|FG000|Double-blind Period|Death|0|||
28126609|NCT03039686|54788560|FG001|Double-blind Period|Death|0|||
28126610|NCT03039686|54788561|FG002|Double-blind Period|Death|1|||
28126611|NCT03039686|54788559|FG000|Open Label Period|Administrative Reason by Sponsor|0|||
28126612|NCT03039686|54788560|FG001|Open Label Period|Administrative Reason by Sponsor|34|||
28126613|NCT03039686|54788561|FG002|Open Label Period|Administrative Reason by Sponsor|41|||
28126614|NCT03039686|54788559|FG000|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
28126615|NCT03039686|54788560|FG001|Open Label Period|Subject Request to Discontinue Study Treatment|1|||
28126616|NCT03039686|54788561|FG002|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
28126617|NCT03039686|54788559|FG000|Open Label Period|Withdrawal by Subject|0|||
28126618|NCT03039686|54788560|FG001|Open Label Period|Withdrawal by Subject|3|||
28126619|NCT03039686|54788561|FG002|Open Label Period|Withdrawal by Subject|1|||
28126620|NCT01822275|54788579|FG000|Overall Study|Withdrawal by Subject|3|||
28126621|NCT01822275|54788579|FG000|Overall Study|Adverse Event|3|||
28126622|NCT01822275|54788579|FG000|Overall Study|Progression|14|||
28126623|NCT01822275|54788579|FG000|Overall Study|Physician Decision|2|||
28126624|NCT01656434|54788591|FG000|Overall Study|Adverse Event|199|||
28126625|NCT01656434|54788592|FG001|Overall Study|Adverse Event|63|||
28126626|NCT01656434|54788591|FG000|Overall Study|Enrollment terminated at trial site|2|||
28126627|NCT01656434|54788592|FG001|Overall Study|Enrollment terminated at trial site|0|||
28126628|NCT01656434|54788591|FG000|Overall Study|Lost to Follow-up|309|||
28126629|NCT01656434|54788592|FG001|Overall Study|Lost to Follow-up|76|||
28126630|NCT01656434|54788591|FG000|Overall Study|Site discontinued study participation|24|||
28126631|NCT01656434|54788592|FG001|Overall Study|Site discontinued study participation|9|||
28126632|NCT01656434|54788591|FG000|Overall Study|Screen failure|2|||
28126633|NCT01656434|54788592|FG001|Overall Study|Screen failure|0|||
28126634|NCT01656434|54788591|FG000|Overall Study|Protocol Violation|7|||
28126635|NCT01656434|54788592|FG001|Overall Study|Protocol Violation|0|||
28126636|NCT01656434|54788591|FG000|Overall Study|Pregnancy wish|18|||
28126637|NCT01656434|54788592|FG001|Overall Study|Pregnancy wish|6|||
28126638|NCT01656434|54788591|FG000|Overall Study|Pregnancy|45|||
28126639|NCT01656434|54788592|FG001|Overall Study|Pregnancy|10|||
28126640|NCT01656434|54788591|FG000|Overall Study|Physician Decision|7|||
28126641|NCT01656434|54788592|FG001|Overall Study|Physician Decision|2|||
28126642|NCT01656434|54788591|FG000|Overall Study|Non-compliance with study drug|48|||
28126643|NCT01656434|54788592|FG001|Overall Study|Non-compliance with study drug|9|||
28126644|NCT01656434|54788591|FG000|Overall Study|Study terminated by sponsor|1501|||
28126645|NCT01656434|54788592|FG001|Overall Study|Study terminated by sponsor|348|||
28126646|NCT01656434|54788591|FG000|Overall Study|Participant discontinued; drug related|13|||
28126647|NCT01656434|54788592|FG001|Overall Study|Participant discontinued; drug related|4|||
28126648|NCT01656434|54788591|FG000|Overall Study|Part. discontinued; unrelated to drug|55|||
28126649|NCT01656434|54788592|FG001|Overall Study|Part. discontinued; unrelated to drug|10|||
28126650|NCT01656434|54788591|FG000|Overall Study|Non-compliance with protocol|39|||
28126651|NCT01656434|54788592|FG001|Overall Study|Non-compliance with protocol|15|||
28126652|NCT01656434|54788591|FG000|Overall Study|Participant moved|40|||
28126653|NCT01656434|54788592|FG001|Overall Study|Participant moved|12|||
28126654|NCT01656434|54788591|FG000|Overall Study|Participant withdrew consent|28|||
28126655|NCT01656434|54788592|FG001|Overall Study|Participant withdrew consent|9|||
28126656|NCT01656434|54788591|FG000|Overall Study|Withdrawal by Subject|64|||
28126657|NCT01656434|54788592|FG001|Overall Study|Withdrawal by Subject|7|||
28126658|NCT02931396|54788600|FG000|Overall Study|Lost to Follow-up|3|||
28126659|NCT02931396|54788601|FG001|Overall Study|Lost to Follow-up|0|||
28126660|NCT02931396|54788600|FG000|Overall Study|Withdrawal by Subject|2|||
28126661|NCT02931396|54788601|FG001|Overall Study|Withdrawal by Subject|0|||
28126662|NCT03037580|54788609|FG000|Overall Study|Withdrawal by Subject|3|||
27831266|NCT01812707|54307684|FG003|Overall Study|Adverse Event|2|||
28126663|NCT03037580|54788610|FG001|Overall Study|Withdrawal by Subject|0|||
28126664|NCT03037580|54788609|FG000|Overall Study|Adverse Event|1|||
28126665|NCT03037580|54788610|FG001|Overall Study|Adverse Event|0|||
28126666|NCT03037580|54788609|FG000|Overall Study|Study Terminated by Sponsor|12|||
28126667|NCT03037580|54788610|FG001|Overall Study|Study Terminated by Sponsor|15|||
28126668|NCT03037580|54788609|FG000|Overall Study|Death|0|||
28126669|NCT03037580|54788610|FG001|Overall Study|Death|1|||
28126670|NCT01755195|54788616|FG000|Overall Study|Participant noncompliance|2|||
28126671|NCT01755195|54788616|FG000|Overall Study|Switched to alternative treatment|4|||
28126672|NCT01755195|54788616|FG000|Overall Study|Withdrawal by Subject|1|||
28126673|NCT01755195|54788616|FG000|Overall Study|Participant refused to start treatment|1|||
28126674|NCT01755195|54788616|FG000|Overall Study|Participant has been consented for another trial|1|||
28126675|NCT01755195|54788616|FG000|Overall Study|Refused further treatment|3|||
28126676|NCT01755195|54788616|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
28126677|NCT00897104|54788623|FG000|Overall Study|Lost to Follow-up|12|||
28126678|NCT00897104|54788624|FG001|Overall Study|Lost to Follow-up|17|||
28126679|NCT00897104|54788625|FG002|Overall Study|Lost to Follow-up|2|||
28126680|NCT00897104|54788623|FG000|Overall Study|Pregnancy|0|||
28126681|NCT00897104|54788624|FG001|Overall Study|Pregnancy|1|||
28126682|NCT00897104|54788625|FG002|Overall Study|Pregnancy|0|||
28126683|NCT00897104|54788623|FG000|Overall Study|Protocol Violation|0|||
28126684|NCT00897104|54788624|FG001|Overall Study|Protocol Violation|1|||
28126685|NCT00897104|54788625|FG002|Overall Study|Protocol Violation|0|||
28126686|NCT00897104|54788623|FG000|Overall Study|Withdrawal by Subject|23|||
28126687|NCT00897104|54788624|FG001|Overall Study|Withdrawal by Subject|27|||
28126688|NCT00897104|54788625|FG002|Overall Study|Withdrawal by Subject|3|||
28126689|NCT00897104|54788623|FG000|Overall Study|Abnormal Prestudy Labs|2|||
28126690|NCT00897104|54788624|FG001|Overall Study|Abnormal Prestudy Labs|0|||
28126691|NCT00897104|54788625|FG002|Overall Study|Abnormal Prestudy Labs|0|||
28126692|NCT00897104|54788623|FG000|Overall Study|Abnormal Baseline ECG|2|||
28126693|NCT00897104|54788624|FG001|Overall Study|Abnormal Baseline ECG|2|||
28126694|NCT00897104|54788625|FG002|Overall Study|Abnormal Baseline ECG|0|||
28126695|NCT00897104|54788623|FG000|Overall Study|Need for Concom. Med.|0|||
28126696|NCT00897104|54788624|FG001|Overall Study|Need for Concom. Med.|1|||
28126697|NCT00897104|54788625|FG002|Overall Study|Need for Concom. Med.|1|||
28126698|NCT00897104|54788623|FG000|Overall Study|Lack of Migraine Attack|20|||
28126699|NCT00897104|54788624|FG001|Overall Study|Lack of Migraine Attack|22|||
28126700|NCT00897104|54788625|FG002|Overall Study|Lack of Migraine Attack|1|||
28126701|NCT00897104|54788623|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
28126702|NCT00897104|54788624|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
28126703|NCT00897104|54788625|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
28126704|NCT00897104|54788623|FG000|Overall Study|Other|3|||
28126705|NCT00897104|54788624|FG001|Overall Study|Other|0|||
28126706|NCT00897104|54788625|FG002|Overall Study|Other|0|||
28126707|NCT00897104|54788623|FG000|Overall Study|Protocol Violation|1|||
28126708|NCT00897104|54788624|FG001|Overall Study|Protocol Violation|0|||
28126709|NCT00897104|54788625|FG002|Overall Study|Protocol Violation|0|||
28126710|NCT00897104|54788623|FG000|Overall Study|Withdrawal by Subject|0|||
28126711|NCT00897104|54788624|FG001|Overall Study|Withdrawal by Subject|0|||
28126712|NCT00897104|54788625|FG002|Overall Study|Withdrawal by Subject|1|||
28126713|NCT01339689|54788635|FG000|Overall Study|Adverse Event|1|||
28126714|NCT01339689|54788636|FG001|Overall Study|Adverse Event|2|||
28126715|NCT01339689|54788635|FG000|Overall Study|Lost to Follow-up|9|||
28126716|NCT01339689|54788636|FG001|Overall Study|Lost to Follow-up|3|||
27818255|NCT01469013|54276810|FG004|Part B (Extension Period)|Adverse Event|0|||
28126717|NCT01339689|54788635|FG000|Overall Study|Withdrawal by Subject|3|||
28126718|NCT01339689|54788636|FG001|Overall Study|Withdrawal by Subject|0|||
28126719|NCT01339689|54788635|FG000|Overall Study|Noncompliance|1|||
28126720|NCT01339689|54788636|FG001|Overall Study|Noncompliance|0|||
28126721|NCT01339689|54788635|FG000|Overall Study|Relocated out of area|0|||
28126722|NCT01339689|54788636|FG001|Overall Study|Relocated out of area|1|||
28126723|NCT01339689|54788635|FG000|Overall Study|Other|2|||
28126724|NCT01339689|54788636|FG001|Overall Study|Other|2|||
28126725|NCT01339689|54788635|FG000|Overall Study|multiple reasons|1|||
28126726|NCT01339689|54788636|FG001|Overall Study|multiple reasons|1|||
28126727|NCT03038126|54788644|FG000|Overall Study|Death|1|||
28126728|NCT03038126|54788645|FG001|Overall Study|Death|1|||
28126729|NCT03038126|54788644|FG000|Overall Study|Withdrawal by Subject|5|||
28126730|NCT03038126|54788645|FG001|Overall Study|Withdrawal by Subject|0|||
28126731|NCT03038126|54788644|FG000|Overall Study|Lost to Follow-up|0|||
28126732|NCT03038126|54788645|FG001|Overall Study|Lost to Follow-up|1|||
28126733|NCT03038126|54788644|FG000|Overall Study|Long Term Hospitalization|2|||
28126734|NCT03038126|54788645|FG001|Overall Study|Long Term Hospitalization|0|||
28126735|NCT03038126|54788644|FG000|Overall Study|Too Ill to Participate|1|||
28126736|NCT03038126|54788645|FG001|Overall Study|Too Ill to Participate|2|||
28126737|NCT00696878|54788663|FG000|Overall Study|Adverse Event|8|||
28126738|NCT00696878|54788663|FG000|Overall Study|Withdrawal by Subject|87|||
28126739|NCT00696878|54788663|FG000|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18|||
28126740|NCT00696878|54788663|FG000|Overall Study|Pregnant prior to Treat Cycle 3|304|||
28126741|NCT00696878|54788663|FG000|Overall Study|Trial stopped|32|||
28126742|NCT00696878|54788663|FG000|Overall Study|Other reason (not specified)|55|||
28126743|NCT00696800|54788669|FG000|Overall Study|Adverse Event|16|||
28126744|NCT00696800|54788670|FG001|Overall Study|Adverse Event|3|||
28126745|NCT00696800|54788669|FG000|Overall Study|Insufficient compliance with medication|2|||
28126746|NCT00696800|54788670|FG001|Overall Study|Insufficient compliance with medication|1|||
28126747|NCT00696800|54788669|FG000|Overall Study|Insufficient ovarian response on Day 8|4|||
28126748|NCT00696800|54788670|FG001|Overall Study|Insufficient ovarian response on Day 8|1|||
28126749|NCT00696800|54788669|FG000|Overall Study|Insufficient ovarian response|4|||
28126750|NCT00696800|54788670|FG001|Overall Study|Insufficient ovarian response|1|||
28126751|NCT00696800|54788669|FG000|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8|||
28126752|NCT00696800|54788670|FG001|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2|||
28126753|NCT00696800|54788669|FG000|Overall Study|Too high ovarian response|6|||
28126754|NCT00696800|54788670|FG001|Overall Study|Too high ovarian response|1|||
28126755|NCT00696800|54788669|FG000|Overall Study|No/too few/bad quality oocytes|4|||
28126756|NCT00696800|54788670|FG001|Overall Study|No/too few/bad quality oocytes|3|||
27818256|NCT01469013|54276811|FG005|Part B (Extension Period)|Adverse Event|2|||
27818257|NCT01469013|54276812|FG006|Part B (Extension Period)|Adverse Event|5|||
28126757|NCT00696800|54788669|FG000|Overall Study|No/abnormal fertilization|11|||
28126758|NCT00696800|54788670|FG001|Overall Study|No/abnormal fertilization|13|||
28126759|NCT00696800|54788669|FG000|Overall Study|No/too few/bad quality embryos|24|||
28126760|NCT00696800|54788670|FG001|Overall Study|No/too few/bad quality embryos|18|||
28126761|NCT00696800|54788669|FG000|Overall Study|Other Reasons|5|||
28126762|NCT00696800|54788670|FG001|Overall Study|Other Reasons|3|||
28126763|NCT00696800|54788669|FG000|Overall Study|Not treated|1|||
28126764|NCT00696800|54788670|FG001|Overall Study|Not treated|2|||
28126765|NCT00289874|54788678|FG000|Overall Study|Adverse Event|1|||
28126766|NCT00289874|54788679|FG001|Overall Study|Adverse Event|5|||
28126767|NCT00289874|54788678|FG000|Overall Study|Lost to Follow-up|1|||
28126768|NCT00289874|54788679|FG001|Overall Study|Lost to Follow-up|1|||
28126769|NCT00289874|54788678|FG000|Overall Study|Protocol Violation|3|||
27818258|NCT01469013|54276813|FG007|Part B (Extension Period)|Adverse Event|5|||
27818259|NCT01469013|54276814|FG008|Part B (Extension Period)|Adverse Event|3|||
27818260|NCT01469013|54276815|FG009|Part B (Extension Period)|Adverse Event|3|||
27818261|NCT01469013|54276816|FG010|Part B (Extension Period)|Adverse Event|1|||
27818262|NCT01469013|54276817|FG011|Part B (Extension Period)|Adverse Event|6|||
27818263|NCT01469013|54276818|FG012|Part B (Extension Period)|Adverse Event|3|||
27818264|NCT01469013|54276806|FG000|Part B (Extension Period)|Withdrawal by Subject|0|||
27818265|NCT01469013|54276807|FG001|Part B (Extension Period)|Withdrawal by Subject|0|||
27818266|NCT01469013|54276808|FG002|Part B (Extension Period)|Withdrawal by Subject|0|||
27818267|NCT01469013|54276809|FG003|Part B (Extension Period)|Withdrawal by Subject|0|||
27818268|NCT01469013|54276810|FG004|Part B (Extension Period)|Withdrawal by Subject|0|||
27818269|NCT01469013|54276811|FG005|Part B (Extension Period)|Withdrawal by Subject|0|||
27818270|NCT01469013|54276812|FG006|Part B (Extension Period)|Withdrawal by Subject|0|||
27818271|NCT01469013|54276813|FG007|Part B (Extension Period)|Withdrawal by Subject|0|||
28126770|NCT00289874|54788679|FG001|Overall Study|Protocol Violation|2|||
28126771|NCT00289874|54788678|FG000|Overall Study|Did not meet eligibility|1|||
28126772|NCT00289874|54788679|FG001|Overall Study|Did not meet eligibility|0|||
28126773|NCT00245570|54788685|FG000|Washout Between Periods III and IV|Adverse Event|0|||
28126774|NCT00245570|54788686|FG001|Washout Between Periods III and IV|Adverse Event|1|||
28126775|NCT00245570|54788687|FG002|Washout Between Periods III and IV|Adverse Event|0|||
28126776|NCT00245570|54788688|FG003|Washout Between Periods III and IV|Adverse Event|0|||
28126777|NCT00245570|54788689|FG004|Washout Between Periods III and IV|Adverse Event|0|||
27818272|NCT01469013|54276814|FG008|Part B (Extension Period)|Withdrawal by Subject|1|||
28126778|NCT00245570|54788690|FG005|Washout Between Periods III and IV|Adverse Event|0|||
28126779|NCT03512210|54788718|FG000|Step 1: MINMON Intervention|Lost to Follow-up|3|||
28126780|NCT03512210|54788718|FG000|Step 1: MINMON Intervention|Protocol Violation|1|||
28126781|NCT03512210|54788718|FG000|Step 2:Post-MINMON|Death|2|||
28126782|NCT03512210|54788718|FG000|Step 2:Post-MINMON|Lost to Follow-up|30|||
28126783|NCT03512210|54788718|FG000|Step 2:Post-MINMON|Withdrawal by Subject|2|||
28126784|NCT00383721|54788727|FG000|26-Week Double-Blind Treatment Period|Adverse Event|11|||
28126785|NCT00383721|54788728|FG001|26-Week Double-Blind Treatment Period|Adverse Event|5|||
27818273|NCT01469013|54276815|FG009|Part B (Extension Period)|Withdrawal by Subject|0|||
27818274|NCT01469013|54276816|FG010|Part B (Extension Period)|Withdrawal by Subject|1|||
27818275|NCT01469013|54276817|FG011|Part B (Extension Period)|Withdrawal by Subject|0|||
27818276|NCT01469013|54276818|FG012|Part B (Extension Period)|Withdrawal by Subject|3|||
28126786|NCT00383721|54788729|FG002|26-Week Double-Blind Treatment Period|Adverse Event|7|||
28126787|NCT00383721|54788730|FG003|26-Week Double-Blind Treatment Period|Adverse Event|14|||
28126788|NCT00383721|54788731|FG004|26-Week Double-Blind Treatment Period|Adverse Event|13|||
28126789|NCT00383721|54788727|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|1|||
28126790|NCT00383721|54788728|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
28126791|NCT00383721|54788729|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
28126792|NCT00383721|54788730|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
28126793|NCT00383721|54788731|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
28126794|NCT00383721|54788727|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
28126795|NCT00383721|54788728|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
28126796|NCT00383721|54788729|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
28126797|NCT00383721|54788730|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
28126798|NCT00383721|54788731|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|4|||
28126799|NCT00383721|54788727|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4|||
28126800|NCT00383721|54788728|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
28126801|NCT00383721|54788729|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15|||
28126802|NCT00383721|54788730|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
28126803|NCT00383721|54788731|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11|||
28126804|NCT00383721|54788727|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|5|||
28126805|NCT00383721|54788728|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
28126806|NCT00383721|54788729|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|6|||
28126807|NCT00383721|54788730|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|8|||
28126808|NCT00383721|54788731|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|9|||
28126809|NCT00383721|54788727|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7|||
28126810|NCT00383721|54788728|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
28126811|NCT00383721|54788729|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
28126812|NCT00383721|54788730|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
28126813|NCT00383721|54788731|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
28126814|NCT00383721|54788727|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
28126815|NCT00383721|54788728|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
28126816|NCT00383721|54788729|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11|||
28126817|NCT00383721|54788730|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4|||
28126818|NCT00383721|54788731|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13|||
28126819|NCT00383721|54788727|FG000|26-Week Double-Blind Treatment Period|Administrative|1|||
28126820|NCT00383721|54788728|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
28126821|NCT00383721|54788729|FG002|26-Week Double-Blind Treatment Period|Administrative|3|||
28126822|NCT00383721|54788730|FG003|26-Week Double-Blind Treatment Period|Administrative|3|||
28126823|NCT00383721|54788731|FG004|26-Week Double-Blind Treatment Period|Administrative|3|||
28126824|NCT00383721|54788727|FG000|26-Week Double-Blind Treatment Period|Ongoing|1|||
28126825|NCT00383721|54788728|FG001|26-Week Double-Blind Treatment Period|Ongoing|0|||
28126826|NCT00383721|54788729|FG002|26-Week Double-Blind Treatment Period|Ongoing|0|||
28126827|NCT00383721|54788730|FG003|26-Week Double-Blind Treatment Period|Ongoing|0|||
28126828|NCT00383721|54788731|FG004|26-Week Double-Blind Treatment Period|Ongoing|0|||
28126829|NCT00383721|54788727|FG000|26-Week Treatment Safety Extension|Adverse Event|6|||
28126830|NCT00383721|54788728|FG001|26-Week Treatment Safety Extension|Adverse Event|7|||
28126831|NCT00383721|54788729|FG002|26-Week Treatment Safety Extension|Adverse Event|10|||
28126832|NCT00383721|54788730|FG003|26-Week Treatment Safety Extension|Adverse Event|1|||
28126833|NCT00383721|54788731|FG004|26-Week Treatment Safety Extension|Adverse Event|0|||
28126834|NCT00383721|54788727|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
28126835|NCT00383721|54788728|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|2|||
28126836|NCT00383721|54788729|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|4|||
28126837|NCT00383721|54788730|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
28067518|NCT00296504|54722758|FG003|Interim Analysis|Inclusion in Other Protocol|1|||
28067519|NCT00296504|54722759|FG004|Interim Analysis|Inclusion in Other Protocol|0|||
28067520|NCT00296504|54722760|FG005|Interim Analysis|Inclusion in Other Protocol|0|||
27818277|NCT01493427|54276845|FG000|Overall Study|Adverse Event|10|||
27818278|NCT01493427|54276845|FG000|Overall Study|Personal Reasons|4|||
27818279|NCT01493427|54276845|FG000|Overall Study|Lost to Follow-up|2|||
27818280|NCT01493427|54276845|FG000|Overall Study|Inability to Follow Instructions|2|||
27818281|NCT01493427|54276845|FG000|Overall Study|Other|2|||
27818282|NCT01523457|54276851|FG000|Overall Study|Withdrawal by Subject|7|||
27818283|NCT01523457|54276852|FG001|Overall Study|Withdrawal by Subject|2|||
28126838|NCT00383721|54788731|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
28126839|NCT00383721|54788727|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
28126840|NCT00383721|54788728|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
28126841|NCT00383721|54788729|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
28126842|NCT00383721|54788730|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
28126843|NCT00383721|54788731|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
28126844|NCT00383721|54788727|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
28126845|NCT00383721|54788728|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4|||
28126846|NCT00383721|54788729|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
27849339|NCT01624259|54345531|FG001|Overall Study|Physician Decision|1|||
27849340|NCT01624259|54345530|FG000|Overall Study|Lost to Follow-up|2|||
27849341|NCT01624259|54345531|FG001|Overall Study|Lost to Follow-up|3|||
27849342|NCT01624259|54345530|FG000|Overall Study|Abnormal laboratory measure|3|||
27849343|NCT01624259|54345531|FG001|Overall Study|Abnormal laboratory measure|0|||
27849344|NCT02081417|54345541|FG000|Overall Study|Lost to Follow-up|26|||
27849345|NCT02081417|54345542|FG001|Overall Study|Lost to Follow-up|23|||
27849346|NCT02081417|54345541|FG000|Overall Study|Moved Away|1|||
27849347|NCT02081417|54345542|FG001|Overall Study|Moved Away|2|||
27849348|NCT02081417|54345541|FG000|Overall Study|Incarcerated|2|||
27849349|NCT02081417|54345542|FG001|Overall Study|Incarcerated|2|||
27849350|NCT02081417|54345541|FG000|Overall Study|Death|4|||
27849351|NCT02081417|54345542|FG001|Overall Study|Death|3|||
27849352|NCT02081417|54345541|FG000|Overall Study|Withdrawal by Subject|4|||
27849353|NCT02081417|54345542|FG001|Overall Study|Withdrawal by Subject|0|||
27849354|NCT02081417|54345541|FG000|Overall Study|Admitted to Residential Treatment|2|||
27849355|NCT02081417|54345542|FG001|Overall Study|Admitted to Residential Treatment|0|||
28067521|NCT00296504|54722761|FG006|Interim Analysis|Inclusion in Other Protocol|0|||
28067522|NCT00296504|54722762|FG007|Interim Analysis|Inclusion in Other Protocol|0|||
28067523|NCT00296504|54722763|FG008|Interim Analysis|Inclusion in Other Protocol|0|||
28067524|NCT00296504|54722755|FG000|Interim Analysis|Participant Stopped|0|||
27849356|NCT02081417|54345541|FG000|Overall Study|Did not start treatment|17|||
27849357|NCT02081417|54345542|FG001|Overall Study|Did not start treatment|21|||
27849358|NCT02081183|54345550|FG000|Overall Study|Lost to Follow-up|0|||
27849359|NCT02081183|54345551|FG001|Overall Study|Lost to Follow-up|1|||
27849360|NCT02081183|54345550|FG000|Overall Study|Protocol Violation|1|||
27849361|NCT02081183|54345551|FG001|Overall Study|Protocol Violation|0|||
27849362|NCT02081183|54345550|FG000|Overall Study|Other|3|||
27849363|NCT02081183|54345551|FG001|Overall Study|Other|3|||
27849364|NCT02080871|54345557|FG000|Overall Study|Death|1|||
27849365|NCT02080871|54345557|FG000|Overall Study|Lost to Follow-up|1|||
27849366|NCT02080481|54345563|FG000|Overall Study|Never received a block.|1|||
27849367|NCT02080481|54345564|FG001|Overall Study|Never received a block.|0|||
27849368|NCT02080403|54345572|FG000|Overall Study|Adverse Event|5|||
27849369|NCT02080403|54345573|FG001|Overall Study|Adverse Event|1|||
27849370|NCT02080403|54345572|FG000|Overall Study|Death|0|||
27849371|NCT02080403|54345573|FG001|Overall Study|Death|2|||
27849372|NCT02080403|54345572|FG000|Overall Study|Lost to Follow-up|2|||
27849373|NCT02080403|54345573|FG001|Overall Study|Lost to Follow-up|0|||
27849374|NCT02080403|54345572|FG000|Overall Study|Pregnancy|0|||
27849375|NCT02080403|54345573|FG001|Overall Study|Pregnancy|1|||
27849376|NCT02080403|54345572|FG000|Overall Study|Protocol Violation|3|||
27849377|NCT02080403|54345573|FG001|Overall Study|Protocol Violation|7|||
27849378|NCT02080403|54345572|FG000|Overall Study|Withdrawal by Subject|5|||
27849379|NCT02080403|54345573|FG001|Overall Study|Withdrawal by Subject|1|||
27849380|NCT02080091|54345579|FG000|Overall Study|Study Terminated|22|||
27849381|NCT02080091|54345579|FG000|Overall Study|Death|1|||
27849382|NCT02080091|54345579|FG000|Overall Study|Withdrawal by Subject|1|||
27849383|NCT02080091|54345579|FG000|Overall Study|Other|1|||
27849384|NCT02079077|54345585|FG000|Overall Study|Lost to Follow-up|5|||
27849385|NCT02079077|54345586|FG001|Overall Study|Lost to Follow-up|7|||
27849386|NCT02079077|54345585|FG000|Overall Study|Became STIs Positive|1|||
27849387|NCT02079077|54345586|FG001|Overall Study|Became STIs Positive|2|||
27849388|NCT02078219|54345614|FG000|Overall Study|Other|2|||
27849389|NCT02078219|54345615|FG001|Overall Study|Other|2|||
27849390|NCT02078219|54345616|FG002|Overall Study|Other|3|||
27849391|NCT02078219|54345617|FG003|Overall Study|Other|0|||
27849392|NCT02078219|54345618|FG004|Overall Study|Other|1|||
27849393|NCT02078219|54345614|FG000|Overall Study|Withdrawal by Subject|0|||
27849394|NCT02078219|54345615|FG001|Overall Study|Withdrawal by Subject|1|||
28067525|NCT00296504|54722756|FG001|Interim Analysis|Participant Stopped|0|||
28067526|NCT00296504|54722757|FG002|Interim Analysis|Participant Stopped|0|||
28067527|NCT00296504|54722758|FG003|Interim Analysis|Participant Stopped|0|||
27849395|NCT02078219|54345616|FG002|Overall Study|Withdrawal by Subject|0|||
27849396|NCT02078219|54345617|FG003|Overall Study|Withdrawal by Subject|1|||
27849397|NCT02078219|54345618|FG004|Overall Study|Withdrawal by Subject|1|||
27849398|NCT02078219|54345614|FG000|Overall Study|Protocol Violation|0|||
27940526|NCT00938470|54596809|FG000|Overall Study|Other Reason|0|||
27849399|NCT02078219|54345615|FG001|Overall Study|Protocol Violation|0|||
27849400|NCT02078219|54345616|FG002|Overall Study|Protocol Violation|0|||
27849401|NCT02078219|54345617|FG003|Overall Study|Protocol Violation|1|||
27849402|NCT02078219|54345618|FG004|Overall Study|Protocol Violation|0|||
27849403|NCT02078219|54345614|FG000|Overall Study|Death|0|||
27849404|NCT02078219|54345615|FG001|Overall Study|Death|0|||
27849405|NCT02078219|54345616|FG002|Overall Study|Death|0|||
27849406|NCT02078219|54345617|FG003|Overall Study|Death|1|||
27849407|NCT02078219|54345618|FG004|Overall Study|Death|0|||
27849408|NCT02078219|54345614|FG000|Overall Study|Adverse Event|1|||
28067528|NCT00296504|54722759|FG004|Interim Analysis|Participant Stopped|1|||
28126847|NCT00383721|54788730|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7|||
28126848|NCT00383721|54788731|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
28126849|NCT00383721|54788727|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
28126850|NCT00383721|54788728|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
28126851|NCT00383721|54788729|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
28126852|NCT00383721|54788730|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
28126853|NCT00383721|54788731|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
28126854|NCT00383721|54788727|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|2|||
28126855|NCT00383721|54788728|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
28126856|NCT00383721|54788729|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
28126857|NCT00383721|54788730|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
28126858|NCT00383721|54788731|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
28126859|NCT00383721|54788727|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
28126860|NCT00383721|54788728|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
28126861|NCT00383721|54788729|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
28126862|NCT00383721|54788730|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
28126863|NCT00383721|54788731|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
28126864|NCT00383721|54788727|FG000|26-Week Treatment Safety Extension|Administrative|1|||
28126865|NCT00383721|54788728|FG001|26-Week Treatment Safety Extension|Administrative|2|||
28126866|NCT00383721|54788729|FG002|26-Week Treatment Safety Extension|Administrative|3|||
28126867|NCT00383721|54788730|FG003|26-Week Treatment Safety Extension|Administrative|1|||
28126868|NCT00383721|54788731|FG004|26-Week Treatment Safety Extension|Administrative|0|||
28126869|NCT03035942|54788759|FG000|Overall Study|Adverse Event|8|||
28126870|NCT03035942|54788760|FG001|Overall Study|Adverse Event|4|||
28126871|NCT03035942|54788761|FG002|Overall Study|Adverse Event|5|||
28126872|NCT02616146|54788773|FG000|Overall Study|Adverse Event|64|||
28126873|NCT02616146|54788774|FG001|Overall Study|Adverse Event|24|||
28126874|NCT02616146|54788773|FG000|Overall Study|Lost to Follow-up|23|||
28126875|NCT02616146|54788774|FG001|Overall Study|Lost to Follow-up|13|||
28126876|NCT02616146|54788773|FG000|Overall Study|Non-compliance with study protocol|2|||
28126877|NCT02616146|54788774|FG001|Overall Study|Non-compliance with study protocol|0|||
28126878|NCT02616146|54788773|FG000|Overall Study|Non-compliance with study drug|4|||
28126879|NCT02616146|54788774|FG001|Overall Study|Non-compliance with study drug|2|||
28126880|NCT02616146|54788773|FG000|Overall Study|Pregnancy|2|||
28126881|NCT02616146|54788774|FG001|Overall Study|Pregnancy|2|||
28126882|NCT02616146|54788773|FG000|Overall Study|Pregnancy wish|3|||
28126883|NCT02616146|54788774|FG001|Overall Study|Pregnancy wish|0|||
28126884|NCT02616146|54788773|FG000|Overall Study|Protocol Violation|6|||
28126885|NCT02616146|54788774|FG001|Overall Study|Protocol Violation|3|||
28126886|NCT02616146|54788773|FG000|Overall Study|Study terminated by sponsor|1372|||
28126887|NCT02616146|54788774|FG001|Overall Study|Study terminated by sponsor|432|||
28126888|NCT02616146|54788773|FG000|Overall Study|Participant moved|4|||
28126889|NCT02616146|54788774|FG001|Overall Study|Participant moved|3|||
28126890|NCT02616146|54788773|FG000|Overall Study|Withdrawal by Subject|30|||
28126891|NCT02616146|54788774|FG001|Overall Study|Withdrawal by Subject|24|||
28126892|NCT02616146|54788773|FG000|Overall Study|Physician Decision|2|||
28126893|NCT02616146|54788774|FG001|Overall Study|Physician Decision|1|||
28126894|NCT04850313|54788782|FG000|Overall Study|Withdrawal by Subject|0|||
28126895|NCT04850313|54788783|FG001|Overall Study|Withdrawal by Subject|1|||
27818284|NCT01523301|54276860|FG000|Overall Study|Adverse Event|25|||
27818285|NCT01523301|54276861|FG001|Overall Study|Adverse Event|16|||
27818286|NCT01523301|54276860|FG000|Overall Study|Lack of Efficacy|0|||
27818287|NCT01523301|54276861|FG001|Overall Study|Lack of Efficacy|2|||
27818288|NCT01523301|54276860|FG000|Overall Study|Protocol Violation|3|||
27818289|NCT01523301|54276861|FG001|Overall Study|Protocol Violation|4|||
27818290|NCT01523301|54276860|FG000|Overall Study|Lost to Follow-up|1|||
27818291|NCT01523301|54276861|FG001|Overall Study|Lost to Follow-up|0|||
27818292|NCT01523301|54276860|FG000|Overall Study|Withdrawal by Subject|6|||
27818293|NCT01523301|54276861|FG001|Overall Study|Withdrawal by Subject|8|||
27818294|NCT01523301|54276860|FG000|Overall Study|Other Reason|0|||
27818295|NCT01523301|54276861|FG001|Overall Study|Other Reason|2|||
27818296|NCT01806506|54276869|FG000|Overall Study|Lost to Follow-up|2|||
27818297|NCT01806506|54276870|FG001|Overall Study|Lost to Follow-up|1|||
27818298|NCT01766336|54276878|FG000|Overall Study|Adverse Event|11|||
27818299|NCT01766336|54276879|FG001|Overall Study|Adverse Event|8|||
28126896|NCT03035864|54788791|FG000|Treatment Period|Adverse Event|1|||
28126897|NCT03035864|54788792|FG001|Treatment Period|Adverse Event|0|||
28126898|NCT03035864|54788791|FG000|Treatment Period|Other|3|||
28126899|NCT03035864|54788792|FG001|Treatment Period|Other|1|||
27849409|NCT02078219|54345615|FG001|Overall Study|Adverse Event|1|||
28126900|NCT03035864|54788791|FG000|Follow-up Period|Adverse Event|1|||
28126901|NCT03035864|54788792|FG001|Follow-up Period|Adverse Event|0|||
28126902|NCT03035864|54788791|FG000|Follow-up Period|Lost to Follow-up|6|||
28126903|NCT03035864|54788792|FG001|Follow-up Period|Lost to Follow-up|2|||
28126904|NCT03035864|54788791|FG000|Follow-up Period|Physician Decision|1|||
28126905|NCT03035864|54788792|FG001|Follow-up Period|Physician Decision|0|||
28126906|NCT03035864|54788791|FG000|Follow-up Period|Other|3|||
28126907|NCT03035864|54788792|FG001|Follow-up Period|Other|2|||
28126908|NCT02885181|54788810|FG000|Overall Study|Investigator's Discretion|0|||
28126909|NCT02885181|54788811|FG001|Overall Study|Investigator's Discretion|1|||
28126910|NCT02885181|54788812|FG002|Overall Study|Investigator's Discretion|0|||
28126911|NCT02885181|54788813|FG003|Overall Study|Investigator's Discretion|1|||
28126912|NCT02885181|54788810|FG000|Overall Study|Adverse Event|0|||
28126913|NCT02885181|54788811|FG001|Overall Study|Adverse Event|0|||
28126914|NCT02885181|54788812|FG002|Overall Study|Adverse Event|0|||
28126915|NCT02885181|54788813|FG003|Overall Study|Adverse Event|1|||
28126916|NCT02885181|54788810|FG000|Overall Study|Withdrawal by Subject|0|||
28126917|NCT02885181|54788811|FG001|Overall Study|Withdrawal by Subject|0|||
28126918|NCT02885181|54788812|FG002|Overall Study|Withdrawal by Subject|0|||
28126919|NCT02885181|54788813|FG003|Overall Study|Withdrawal by Subject|1|||
28126920|NCT02884089|54788827|FG000|Period 1|Dosing error|2|||
28126921|NCT02884089|54788828|FG001|Period 1|Dosing error|2|||
28126922|NCT02884089|54788829|FG002|Period 1|Dosing error|0|||
28126923|NCT02884089|54788830|FG003|Period 1|Dosing error|0|||
28126924|NCT02884089|54788827|FG000|Washout Period 1|Lost to Follow-up|0|||
28126925|NCT02884089|54788828|FG001|Washout Period 1|Lost to Follow-up|1|||
28126926|NCT02884089|54788829|FG002|Washout Period 1|Lost to Follow-up|0|||
28126927|NCT02884089|54788830|FG003|Washout Period 1|Lost to Follow-up|1|||
28126928|NCT02884089|54788827|FG000|Washout Period 1|Withdrawal by Subject|0|||
28126929|NCT02884089|54788828|FG001|Washout Period 1|Withdrawal by Subject|1|||
28126930|NCT02884089|54788829|FG002|Washout Period 1|Withdrawal by Subject|0|||
28126931|NCT02884089|54788830|FG003|Washout Period 1|Withdrawal by Subject|0|||
28126932|NCT02884089|54788827|FG000|Period 2|Adverse Event|1|||
28126933|NCT02884089|54788828|FG001|Period 2|Adverse Event|0|||
28126934|NCT02884089|54788829|FG002|Period 2|Adverse Event|0|||
28126935|NCT02884089|54788830|FG003|Period 2|Adverse Event|0|||
28126936|NCT02884089|54788827|FG000|Period 3|Withdrawal by Subject|0|||
28126937|NCT02884089|54788828|FG001|Period 3|Withdrawal by Subject|0|||
28126938|NCT02884089|54788829|FG002|Period 3|Withdrawal by Subject|1|||
28126939|NCT02884089|54788830|FG003|Period 3|Withdrawal by Subject|0|||
28126940|NCT02884089|54788827|FG000|Washout Period 3|Withdrawal by Subject|0|||
28126941|NCT02884089|54788828|FG001|Washout Period 3|Withdrawal by Subject|0|||
28126942|NCT02884089|54788829|FG002|Washout Period 3|Withdrawal by Subject|1|||
28126943|NCT02884089|54788830|FG003|Washout Period 3|Withdrawal by Subject|0|||
28126944|NCT02884089|54788827|FG000|Washout Period 3|Lost to Follow-up|0|||
28126945|NCT02884089|54788828|FG001|Washout Period 3|Lost to Follow-up|0|||
28126946|NCT02884089|54788829|FG002|Washout Period 3|Lost to Follow-up|0|||
28126947|NCT02884089|54788830|FG003|Washout Period 3|Lost to Follow-up|1|||
28126948|NCT02884089|54788827|FG000|Period 4|Withdrawal by Subject|0|||
28126949|NCT02884089|54788828|FG001|Period 4|Withdrawal by Subject|1|||
28126950|NCT02884089|54788829|FG002|Period 4|Withdrawal by Subject|0|||
28126951|NCT02884089|54788830|FG003|Period 4|Withdrawal by Subject|0|||
28126952|NCT02884089|54788827|FG000|Period 4|Lost to Follow-up|1|||
28126953|NCT02884089|54788828|FG001|Period 4|Lost to Follow-up|0|||
28126954|NCT02884089|54788829|FG002|Period 4|Lost to Follow-up|0|||
28126955|NCT02884089|54788830|FG003|Period 4|Lost to Follow-up|0|||
28126956|NCT02884089|54788827|FG000|Follow-up Visit|Withdrawal by Subject|1|||
28126957|NCT02884089|54788828|FG001|Follow-up Visit|Withdrawal by Subject|0|||
28126958|NCT02884089|54788829|FG002|Follow-up Visit|Withdrawal by Subject|0|||
28126959|NCT02884089|54788830|FG003|Follow-up Visit|Withdrawal by Subject|1|||
28126960|NCT02809677|54788840|FG000|Overall Study|Withdrawal by Subject|8|||
28126961|NCT02881047|54788845|FG000|Overall Study|Adverse Event|1|||
28126962|NCT02881047|54788845|FG000|Overall Study|Withdrawal by Subject|1|||
28126963|NCT03157089|54788851|FG000|Overall Study|Treated only with pembrolizumab|1|||
28126964|NCT03157089|54788852|FG001|Overall Study|Treated only with pembrolizumab|0|||
28126965|NCT03157089|54788851|FG000|Overall Study|Adverse Event|5|||
28126966|NCT03157089|54788852|FG001|Overall Study|Adverse Event|4|||
28126967|NCT03157089|54788851|FG000|Overall Study|Progressive disease|6|||
28126968|NCT03157089|54788852|FG001|Overall Study|Progressive disease|8|||
28126969|NCT03158727|54788861|FG000|Overall Study|Withdrawal by Subject|2|||
28126970|NCT03158727|54788862|FG001|Overall Study|Withdrawal by Subject|6|||
28126971|NCT03158727|54788861|FG000|Overall Study|Death|11|||
28126972|NCT03158727|54788862|FG001|Overall Study|Death|12|||
27849410|NCT02078219|54345616|FG002|Overall Study|Adverse Event|3|||
28126973|NCT03158727|54788861|FG000|Overall Study|Lost to Follow-up|1|||
28126974|NCT03158727|54788862|FG001|Overall Study|Lost to Follow-up|0|||
28126975|NCT03158727|54788861|FG000|Overall Study|Participant doesn't want to come back to the hospital for the visit|2|||
28126976|NCT03158727|54788862|FG001|Overall Study|Participant doesn't want to come back to the hospital for the visit|0|||
28126977|NCT03158727|54788861|FG000|Overall Study|Visit 11 not done by mistake|0|||
28126978|NCT03158727|54788862|FG001|Overall Study|Visit 11 not done by mistake|1|||
28126979|NCT03158727|54788861|FG000|Overall Study|Enrolled, not treated|1|||
28126980|NCT03158727|54788862|FG001|Overall Study|Enrolled, not treated|0|||
28126981|NCT00089895|54788870|FG000|Overall Study|Consent Withdrawn|11|||
28126982|NCT00089895|54788871|FG001|Overall Study|Consent Withdrawn|14|||
28126983|NCT00089895|54788870|FG000|Overall Study|Technical reason|7|||
28126984|NCT00089895|54788871|FG001|Overall Study|Technical reason|2|||
27940527|NCT00938470|54596810|FG001|Overall Study|Other Reason|1|||
27940528|NCT00938392|54596818|FG000|Overall Study|Adverse Event|0|||
28067529|NCT00296504|54722760|FG005|Interim Analysis|Participant Stopped|0|||
28126985|NCT00089895|54788870|FG000|Overall Study|Surgery|0|||
28126986|NCT00089895|54788871|FG001|Overall Study|Surgery|1|||
28126987|NCT00089895|54788870|FG000|Overall Study|Bleeding|0|||
28126988|NCT00089895|54788871|FG001|Overall Study|Bleeding|2|||
28126989|NCT00089895|54788870|FG000|Overall Study|Physician Decision|3|||
28126990|NCT00089895|54788871|FG001|Overall Study|Physician Decision|7|||
28126991|NCT00089895|54788870|FG000|Overall Study|Exclusion criteria met|6|||
28126992|NCT00089895|54788871|FG001|Overall Study|Exclusion criteria met|6|||
28126993|NCT00089895|54788870|FG000|Overall Study|Not otherwise specified|4|||
28126994|NCT00089895|54788871|FG001|Overall Study|Not otherwise specified|8|||
28126995|NCT00089895|54788870|FG000|Overall Study|Missing|4|||
28126996|NCT00089895|54788871|FG001|Overall Study|Missing|2|||
28126997|NCT02714218|54788880|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
28126998|NCT02714218|54788881|FG001|Pre-Treatment Period|Participant no longer meets study criteria|1|||
28126999|NCT02714218|54788882|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
28127000|NCT02714218|54788880|FG000|Pre-Treatment Period|Other reasons|0|||
28127001|NCT02714218|54788881|FG001|Pre-Treatment Period|Other reasons|1|||
28127002|NCT02714218|54788882|FG002|Pre-Treatment Period|Other reasons|0|||
28127003|NCT02714218|54788880|FG000|Treatment Period|Disease Progression|55|||
28127004|NCT02714218|54788881|FG001|Treatment Period|Disease Progression|52|||
28127005|NCT02714218|54788882|FG002|Treatment Period|Disease Progression|14|||
28127006|NCT02714218|54788880|FG000|Treatment Period|Study drug toxicity|46|||
28127007|NCT02714218|54788881|FG001|Treatment Period|Study drug toxicity|70|||
28127008|NCT02714218|54788882|FG002|Treatment Period|Study drug toxicity|6|||
28127009|NCT02714218|54788880|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
28127010|NCT02714218|54788881|FG001|Treatment Period|Adverse event unrelated to study drug|6|||
28127011|NCT02714218|54788882|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
28127012|NCT02714218|54788880|FG000|Treatment Period|Request to discontinue treatment|1|||
28127013|NCT02714218|54788881|FG001|Treatment Period|Request to discontinue treatment|4|||
28127014|NCT02714218|54788882|FG002|Treatment Period|Request to discontinue treatment|1|||
28127015|NCT02714218|54788880|FG000|Treatment Period|Participant withdrew consent|2|||
28127016|NCT02714218|54788881|FG001|Treatment Period|Participant withdrew consent|2|||
28127017|NCT02714218|54788882|FG002|Treatment Period|Participant withdrew consent|0|||
28127018|NCT02714218|54788880|FG000|Treatment Period|Maximum clinical benefit|4|||
28127019|NCT02714218|54788881|FG001|Treatment Period|Maximum clinical benefit|2|||
28127020|NCT02714218|54788882|FG002|Treatment Period|Maximum clinical benefit|0|||
28127021|NCT02714218|54788880|FG000|Treatment Period|Administrative reason by sponsor|2|||
28127022|NCT02714218|54788881|FG001|Treatment Period|Administrative reason by sponsor|1|||
28127023|NCT02714218|54788882|FG002|Treatment Period|Administrative reason by sponsor|0|||
28127024|NCT02714218|54788880|FG000|Treatment Period|Other reasons|6|||
28127025|NCT02714218|54788881|FG001|Treatment Period|Other reasons|6|||
28127026|NCT02714218|54788882|FG002|Treatment Period|Other reasons|0|||
28127027|NCT02714218|54788880|FG000|Treatment Period|Completed treatment as per protocol|36|||
28127028|NCT02714218|54788881|FG001|Treatment Period|Completed treatment as per protocol|27|||
28127029|NCT02714218|54788882|FG002|Treatment Period|Completed treatment as per protocol|3|||
28127030|NCT02714218|54788880|FG000|Treatment Period|Not reported|9|||
28127031|NCT02714218|54788881|FG001|Treatment Period|Not reported|6|||
28127032|NCT02714218|54788882|FG002|Treatment Period|Not reported|0|||
28127033|NCT03154047|54788889|FG000|Overall Study|Death|1|||
28127034|NCT03154047|54788889|FG000|Overall Study|Study terminated by sponsor|76|||
28067530|NCT00296504|54722761|FG006|Interim Analysis|Participant Stopped|0|||
28067531|NCT00296504|54722762|FG007|Interim Analysis|Participant Stopped|0|||
28067532|NCT00296504|54722763|FG008|Interim Analysis|Participant Stopped|0|||
28067533|NCT00296504|54722755|FG000|Interim Analysis|Physician and Participant Decision|0|||
28067534|NCT00296504|54722756|FG001|Interim Analysis|Physician and Participant Decision|0|||
28067535|NCT00296504|54722757|FG002|Interim Analysis|Physician and Participant Decision|0|||
28067536|NCT00296504|54722758|FG003|Interim Analysis|Physician and Participant Decision|0|||
28067537|NCT00296504|54722759|FG004|Interim Analysis|Physician and Participant Decision|0|||
28067538|NCT00296504|54722760|FG005|Interim Analysis|Physician and Participant Decision|1|||
28067539|NCT00296504|54722761|FG006|Interim Analysis|Physician and Participant Decision|0|||
28067540|NCT00296504|54722762|FG007|Interim Analysis|Physician and Participant Decision|0|||
28127035|NCT03154047|54788889|FG000|Overall Study|Withdrawal by Subject|3|||
28127036|NCT03156621|54788895|FG000|Open-Label Treatment Period (OLTP)|Adverse Event|0|||
28127037|NCT03156621|54788896|FG001|Open-Label Treatment Period (OLTP)|Adverse Event|2|||
28127038|NCT03156621|54788895|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
28127039|NCT03156621|54788896|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
28127040|NCT03156543|54788907|FG000|Overall Study|Withdrawal by Subject|1|||
28127041|NCT03156543|54788908|FG001|Overall Study|Withdrawal by Subject|0|||
28127042|NCT02713594|54788916|FG000|Overall Study|Withdrawal by Subject|32|||
28127043|NCT02713594|54788917|FG001|Overall Study|Withdrawal by Subject|22|||
28127044|NCT02713594|54788916|FG000|Overall Study|Lost to Follow-up|358|||
28127045|NCT02713594|54788917|FG001|Overall Study|Lost to Follow-up|374|||
28127046|NCT03152019|54788927|FG000|Overall Study|Adverse Event|0|||
28127047|NCT03152019|54788928|FG001|Overall Study|Adverse Event|1|||
28127048|NCT02714062|54788941|FG000|Overall Study|Adverse Event|0|||
28127049|NCT02714062|54788942|FG001|Overall Study|Adverse Event|0|||
28127050|NCT02714062|54788943|FG002|Overall Study|Adverse Event|2|||
28127051|NCT02714062|54788941|FG000|Overall Study|Withdrawal by Subject|1|||
28127052|NCT02714062|54788942|FG001|Overall Study|Withdrawal by Subject|0|||
28127053|NCT02714062|54788943|FG002|Overall Study|Withdrawal by Subject|1|||
28127054|NCT02714062|54788941|FG000|Overall Study|Protocol Violation|0|||
28127055|NCT02714062|54788942|FG001|Overall Study|Protocol Violation|1|||
28127056|NCT02714062|54788943|FG002|Overall Study|Protocol Violation|0|||
28127057|NCT03151395|54788953|FG000|Overall Study|Adverse Event|2|||
28127058|NCT03151395|54788953|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
28127059|NCT03151395|54788953|FG000|Overall Study|Subjects could not perform last visit before study completion date due to local COVID19 restrictions|3|||
28127060|NCT03151395|54788953|FG000|Overall Study|Unspecified reason|4|||
28127061|NCT02713828|54788959|FG000|Overall Study|Death|2|||
28127062|NCT02713828|54788960|FG001|Overall Study|Death|0|||
28127063|NCT02713828|54788959|FG000|Overall Study|Withdrawal by Subject|1|||
28127064|NCT02713828|54788960|FG001|Overall Study|Withdrawal by Subject|0|||
28127065|NCT02713828|54788959|FG000|Overall Study|study terminated but patient allowed to|2|||
28127066|NCT02713828|54788960|FG001|Overall Study|study terminated but patient allowed to|0|||
28127067|NCT02876328|54788989|FG000|Overall Study|Death|2|||
28127068|NCT02876328|54788990|FG001|Overall Study|Death|1|||
28127069|NCT02876328|54788991|FG002|Overall Study|Death|3|||
28127070|NCT02876328|54788992|FG003|Overall Study|Death|0|||
28127071|NCT02876328|54788993|FG004|Overall Study|Death|0|||
28127072|NCT02876328|54788994|FG005|Overall Study|Death|0|||
28127073|NCT02876328|54788995|FG006|Overall Study|Death|1|||
27940529|NCT00938392|54596819|FG001|Overall Study|Adverse Event|1|||
28127074|NCT02876328|54788996|FG007|Overall Study|Death|3|||
28127075|NCT02876328|54788997|FG008|Overall Study|Death|0|||
28127076|NCT02876328|54788998|FG009|Overall Study|Death|1|||
28127077|NCT02876328|54788999|FG010|Overall Study|Death|1|||
28127078|NCT02876328|54789000|FG011|Overall Study|Death|0|||
28127079|NCT02876328|54789001|FG012|Overall Study|Death|0|||
28127080|NCT02876328|54789002|FG013|Overall Study|Death|0|||
28127081|NCT02876328|54789003|FG014|Overall Study|Death|0|||
28127082|NCT02876328|54789004|FG015|Overall Study|Death|0|||
28127083|NCT02876328|54789005|FG016|Overall Study|Death|1|||
27818300|NCT01766336|54276878|FG000|Overall Study|Death|4|||
27818301|NCT01766336|54276879|FG001|Overall Study|Death|3|||
27818302|NCT01766336|54276878|FG000|Overall Study|Lost to Follow-up|1|||
28127084|NCT02876328|54789006|FG017|Overall Study|Death|1|||
28127085|NCT02876328|54789007|FG018|Overall Study|Death|0|||
28127086|NCT02876328|54789008|FG019|Overall Study|Death|0|||
28127087|NCT02876328|54789009|FG020|Overall Study|Death|0|||
28127088|NCT02876328|54789010|FG021|Overall Study|Death|1|||
28127089|NCT02876328|54789011|FG022|Overall Study|Death|0|||
28127090|NCT02876328|54789012|FG023|Overall Study|Death|0|||
28127091|NCT02876328|54788989|FG000|Overall Study|Withdrawal by Subject|0|||
28127092|NCT02876328|54788990|FG001|Overall Study|Withdrawal by Subject|2|||
28127093|NCT02876328|54788991|FG002|Overall Study|Withdrawal by Subject|3|||
28127094|NCT02876328|54788992|FG003|Overall Study|Withdrawal by Subject|3|||
28127095|NCT02876328|54788993|FG004|Overall Study|Withdrawal by Subject|0|||
28127096|NCT02876328|54788994|FG005|Overall Study|Withdrawal by Subject|1|||
28127097|NCT02876328|54788995|FG006|Overall Study|Withdrawal by Subject|0|||
27818303|NCT01766336|54276879|FG001|Overall Study|Lost to Follow-up|3|||
27818304|NCT01766336|54276878|FG000|Overall Study|Physician Decision|4|||
27818305|NCT01766336|54276879|FG001|Overall Study|Physician Decision|2|||
27818306|NCT01766336|54276878|FG000|Overall Study|Protocol Violation|0|||
27818307|NCT01766336|54276879|FG001|Overall Study|Protocol Violation|1|||
27818308|NCT01766336|54276878|FG000|Overall Study|Sponsor Decision|52|||
27818309|NCT01766336|54276879|FG001|Overall Study|Sponsor Decision|43|||
27818310|NCT01766336|54276878|FG000|Overall Study|Withdrawal by Subject|18|||
27818311|NCT01766336|54276879|FG001|Overall Study|Withdrawal by Subject|15|||
27818312|NCT01797536|54276889|FG000|Overall Study|Adverse Event|0|||
28127098|NCT02876328|54788996|FG007|Overall Study|Withdrawal by Subject|1|||
28127099|NCT02876328|54788997|FG008|Overall Study|Withdrawal by Subject|1|||
28127100|NCT02876328|54788998|FG009|Overall Study|Withdrawal by Subject|2|||
28127101|NCT02876328|54788999|FG010|Overall Study|Withdrawal by Subject|0|||
28127102|NCT02876328|54789000|FG011|Overall Study|Withdrawal by Subject|0|||
28127103|NCT02876328|54789001|FG012|Overall Study|Withdrawal by Subject|0|||
27818313|NCT01797536|54276890|FG001|Overall Study|Adverse Event|1|||
27818314|NCT01797536|54276891|FG002|Overall Study|Adverse Event|0|||
27818315|NCT01797536|54276892|FG003|Overall Study|Adverse Event|0|||
27818316|NCT01797302|54276905|FG000|Overall Study|Lost to Follow-up|16|||
27818317|NCT01797302|54276906|FG001|Overall Study|Lost to Follow-up|23|||
27818318|NCT01797302|54276907|FG002|Overall Study|Lost to Follow-up|22|||
27818319|NCT01797302|54276905|FG000|Overall Study|Withdrawal by Subject|1|||
27818320|NCT01797302|54276906|FG001|Overall Study|Withdrawal by Subject|3|||
27818321|NCT01797302|54276907|FG002|Overall Study|Withdrawal by Subject|4|||
28127104|NCT02876328|54789002|FG013|Overall Study|Withdrawal by Subject|0|||
27940530|NCT00938392|54596818|FG000|Overall Study|Withdrawal by Subject|0|||
28127105|NCT02876328|54789003|FG014|Overall Study|Withdrawal by Subject|0|||
28127106|NCT02876328|54789004|FG015|Overall Study|Withdrawal by Subject|0|||
27818322|NCT01805180|54276917|FG000|Lead-in Donor Phase|screen failure|1|||
27818323|NCT01805180|54276918|FG001|Lead-in Donor Phase|screen failure|0|||
28127107|NCT02876328|54789005|FG016|Overall Study|Withdrawal by Subject|1|||
27818324|NCT01805180|54276919|FG002|Lead-in Donor Phase|screen failure|0|||
27818325|NCT01804946|54276929|FG000|Overall Study|Protocol Violation|1|||
27818326|NCT01804946|54276930|FG001|Overall Study|Protocol Violation|0|||
27818327|NCT01804946|54276929|FG000|Overall Study|Adverse Event|0|||
27818328|NCT01804946|54276930|FG001|Overall Study|Adverse Event|1|||
27818329|NCT01804946|54276929|FG000|Overall Study|Insufficient data available|0|||
27818330|NCT01804946|54276930|FG001|Overall Study|Insufficient data available|1|||
27818331|NCT01804946|54276929|FG000|Overall Study|Do not meet inclusion criteria|1|||
27818332|NCT01804946|54276930|FG001|Overall Study|Do not meet inclusion criteria|2|||
27818333|NCT01737398|54276940|FG000|Overall Study|Adverse event or SAE|16|||
27818334|NCT01737398|54276941|FG001|Overall Study|Adverse event or SAE|1|||
27818335|NCT01737398|54276940|FG000|Overall Study|Stopping rule met|2|||
27818336|NCT01737398|54276941|FG001|Overall Study|Stopping rule met|1|||
28127108|NCT02876328|54789006|FG017|Overall Study|Withdrawal by Subject|3|||
28127109|NCT02876328|54789007|FG018|Overall Study|Withdrawal by Subject|0|||
28127110|NCT02876328|54789008|FG019|Overall Study|Withdrawal by Subject|0|||
28127111|NCT02876328|54789009|FG020|Overall Study|Withdrawal by Subject|1|||
28127112|NCT02876328|54789010|FG021|Overall Study|Withdrawal by Subject|0|||
28127113|NCT02876328|54789011|FG022|Overall Study|Withdrawal by Subject|0|||
28127114|NCT02876328|54789012|FG023|Overall Study|Withdrawal by Subject|0|||
28127115|NCT02876328|54788989|FG000|Overall Study|Missed 12 Month Visit|15|||
28127116|NCT02876328|54788990|FG001|Overall Study|Missed 12 Month Visit|10|||
28127117|NCT02876328|54788991|FG002|Overall Study|Missed 12 Month Visit|11|||
28127118|NCT02876328|54788992|FG003|Overall Study|Missed 12 Month Visit|6|||
28127119|NCT02876328|54788993|FG004|Overall Study|Missed 12 Month Visit|10|||
28127120|NCT02876328|54788994|FG005|Overall Study|Missed 12 Month Visit|14|||
28127121|NCT02876328|54788995|FG006|Overall Study|Missed 12 Month Visit|3|||
28127122|NCT02876328|54788996|FG007|Overall Study|Missed 12 Month Visit|8|||
28127123|NCT02876328|54788997|FG008|Overall Study|Missed 12 Month Visit|9|||
28127124|NCT02876328|54788998|FG009|Overall Study|Missed 12 Month Visit|5|||
28127125|NCT02876328|54788999|FG010|Overall Study|Missed 12 Month Visit|4|||
28127126|NCT02876328|54789000|FG011|Overall Study|Missed 12 Month Visit|1|||
28127127|NCT02876328|54789001|FG012|Overall Study|Missed 12 Month Visit|5|||
28127128|NCT02876328|54789002|FG013|Overall Study|Missed 12 Month Visit|4|||
28127129|NCT02876328|54789003|FG014|Overall Study|Missed 12 Month Visit|4|||
28127130|NCT02876328|54789004|FG015|Overall Study|Missed 12 Month Visit|4|||
28127131|NCT02876328|54789005|FG016|Overall Study|Missed 12 Month Visit|3|||
28127132|NCT02876328|54789006|FG017|Overall Study|Missed 12 Month Visit|6|||
28127133|NCT02876328|54789007|FG018|Overall Study|Missed 12 Month Visit|2|||
28127134|NCT02876328|54789008|FG019|Overall Study|Missed 12 Month Visit|2|||
28127135|NCT02876328|54789009|FG020|Overall Study|Missed 12 Month Visit|11|||
28127136|NCT02876328|54789010|FG021|Overall Study|Missed 12 Month Visit|7|||
28127137|NCT02876328|54789011|FG022|Overall Study|Missed 12 Month Visit|1|||
28127138|NCT02876328|54789012|FG023|Overall Study|Missed 12 Month Visit|0|||
28127139|NCT02875860|54789040|FG000|Overall Study|Withdrawal by Subject|0|||
28127140|NCT02875860|54789041|FG001|Overall Study|Withdrawal by Subject|1|||
28127141|NCT02875392|54789049|FG000|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|7|||
28127142|NCT02875392|54789050|FG001|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|8|||
28127143|NCT03127644|54789059|FG000|Overall Study|Study-specific withdrawal criteria|0|||
28127144|NCT03127644|54789060|FG001|Overall Study|Study-specific withdrawal criteria|0|||
28127145|NCT03127644|54789061|FG002|Overall Study|Study-specific withdrawal criteria|2|||
27818337|NCT01737398|54276940|FG000|Overall Study|Voluntary withdrawal|2|||
27818338|NCT01737398|54276941|FG001|Overall Study|Voluntary withdrawal|3|||
27818339|NCT01737398|54276940|FG000|Overall Study|Ineligibility|1|||
28067541|NCT00296504|54722763|FG008|Interim Analysis|Physician and Participant Decision|0|||
28067542|NCT00296504|54722755|FG000|Interim Analysis|Participant Stopped HIV Medications|0|||
28067543|NCT00296504|54722756|FG001|Interim Analysis|Participant Stopped HIV Medications|0|||
28067544|NCT00296504|54722757|FG002|Interim Analysis|Participant Stopped HIV Medications|0|||
27818340|NCT01737398|54276941|FG001|Overall Study|Ineligibility|0|||
27818341|NCT01737398|54276940|FG000|Overall Study|Liver transplant|1|||
28067545|NCT00296504|54722758|FG003|Interim Analysis|Participant Stopped HIV Medications|0|||
28067546|NCT00296504|54722759|FG004|Interim Analysis|Participant Stopped HIV Medications|0|||
28067547|NCT00296504|54722760|FG005|Interim Analysis|Participant Stopped HIV Medications|0|||
28067548|NCT00296504|54722761|FG006|Interim Analysis|Participant Stopped HIV Medications|1|||
28067549|NCT00296504|54722762|FG007|Interim Analysis|Participant Stopped HIV Medications|0|||
28067550|NCT00296504|54722763|FG008|Interim Analysis|Participant Stopped HIV Medications|0|||
28067551|NCT00296504|54722755|FG000|Interim Analysis|Study Ended|0|||
28067552|NCT00296504|54722756|FG001|Interim Analysis|Study Ended|0|||
28067553|NCT00296504|54722757|FG002|Interim Analysis|Study Ended|0|||
28067554|NCT00296504|54722758|FG003|Interim Analysis|Study Ended|0|||
28067555|NCT00296504|54722759|FG004|Interim Analysis|Study Ended|0|||
27818342|NCT01737398|54276941|FG001|Overall Study|Liver transplant|0|||
27818343|NCT01737398|54276940|FG000|Overall Study|Disease progression|2|||
28127146|NCT03965962|54789075|FG000|Overall Study|Adverse Event|1|||
28127147|NCT03965962|54789076|FG001|Overall Study|Adverse Event|0|||
28127148|NCT03965962|54789077|FG002|Overall Study|Adverse Event|0|||
28127149|NCT03965962|54789078|FG003|Overall Study|Adverse Event|0|||
28127150|NCT03965962|54789075|FG000|Overall Study|Protocol Violation|21|||
28127151|NCT03965962|54789076|FG001|Overall Study|Protocol Violation|4|||
27818344|NCT01737398|54276941|FG001|Overall Study|Disease progression|3|||
28127152|NCT03965962|54789077|FG002|Overall Study|Protocol Violation|10|||
28127153|NCT03965962|54789078|FG003|Overall Study|Protocol Violation|5|||
28127154|NCT03965962|54789075|FG000|Overall Study|Lost to Follow-up|0|||
28127155|NCT03965962|54789076|FG001|Overall Study|Lost to Follow-up|1|||
28127156|NCT03965962|54789077|FG002|Overall Study|Lost to Follow-up|0|||
28127157|NCT03965962|54789078|FG003|Overall Study|Lost to Follow-up|0|||
28127158|NCT03965962|54789075|FG000|Overall Study|Withdrawal by Subject|3|||
28127159|NCT03965962|54789076|FG001|Overall Study|Withdrawal by Subject|0|||
28127160|NCT03965962|54789077|FG002|Overall Study|Withdrawal by Subject|0|||
28127161|NCT03965962|54789078|FG003|Overall Study|Withdrawal by Subject|1|||
28127162|NCT03151551|54789090|FG000|Open-Label Treatment Period|Adverse Event|0|||
28127163|NCT03151551|54789091|FG001|Open-Label Treatment Period|Adverse Event|2|||
28127164|NCT03151551|54789090|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
28127165|NCT03151551|54789091|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
28127166|NCT03151551|54789090|FG000|Open-Label Treatment Period|Withdrawal by Subject|12|||
28127167|NCT03151551|54789091|FG001|Open-Label Treatment Period|Withdrawal by Subject|18|||
28127168|NCT03151551|54789090|FG000|Open-Label Treatment Period|Lack of Efficacy|1|||
28127169|NCT03151551|54789091|FG001|Open-Label Treatment Period|Lack of Efficacy|1|||
28127170|NCT03151551|54789090|FG000|Open-Label Treatment Period|Physician Decision|3|||
28127171|NCT03151551|54789091|FG001|Open-Label Treatment Period|Physician Decision|0|||
28127172|NCT03151551|54789090|FG000|Open-Label Treatment Period|Protocol Deviation|1|||
28127173|NCT03151551|54789091|FG001|Open-Label Treatment Period|Protocol Deviation|2|||
28127174|NCT03151551|54789090|FG000|Post-Treatment Follow-Up Period|Adverse Event|1|||
28127175|NCT03151551|54789091|FG001|Post-Treatment Follow-Up Period|Adverse Event|3|||
28127176|NCT03151551|54789090|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
27818345|NCT01737398|54276940|FG000|Overall Study|Sponsor's decision|2|||
27818346|NCT01737398|54276941|FG001|Overall Study|Sponsor's decision|0|||
28127177|NCT03151551|54789091|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
28127178|NCT03151551|54789090|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|20|||
28127179|NCT03151551|54789091|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|22|||
28127180|NCT03151551|54789090|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
28127181|NCT03151551|54789091|FG001|Post-Treatment Follow-Up Period|Physician Decision|1|||
27818347|NCT01795898|54276950|FG000|Overall Study|Adverse Event|27|||
27818348|NCT01795898|54276950|FG000|Overall Study|Lost to Follow-up|20|||
27818349|NCT01795898|54276950|FG000|Overall Study|Withdrawal of consent|6|||
27818350|NCT01795898|54276950|FG000|Overall Study|Diagnosed with metastasis|1|||
27818351|NCT01795898|54276950|FG000|Overall Study|No pain|1|||
28067556|NCT00296504|54722760|FG005|Interim Analysis|Study Ended|0|||
28127182|NCT03147495|54789101|FG000|Overall Study|Physician Decision|0|||
28127183|NCT03147495|54789102|FG001|Overall Study|Physician Decision|6|||
28127184|NCT03126786|54789110|FG000|Overall Study|Adverse Event|3|||
28127185|NCT03126786|54789111|FG001|Overall Study|Adverse Event|0|||
28127186|NCT03126786|54789110|FG000|Overall Study|Lost to Follow-up|0|||
28127187|NCT03126786|54789111|FG001|Overall Study|Lost to Follow-up|1|||
28127188|NCT03126786|54789110|FG000|Overall Study|Withdrawal by Subject|3|||
28127189|NCT03126786|54789111|FG001|Overall Study|Withdrawal by Subject|1|||
28127190|NCT03146403|54789119|FG000|Overall Study|Withdrawal by Subject|0|||
28067557|NCT00296504|54722761|FG006|Interim Analysis|Study Ended|1|||
28067558|NCT00296504|54722762|FG007|Interim Analysis|Study Ended|0|||
28067559|NCT00296504|54722763|FG008|Interim Analysis|Study Ended|0|||
28067560|NCT00296504|54722755|FG000|Interim Analysis|Participant Needed Interferon|0|||
28067561|NCT00296504|54722756|FG001|Interim Analysis|Participant Needed Interferon|0|||
28067562|NCT00296504|54722757|FG002|Interim Analysis|Participant Needed Interferon|0|||
28067563|NCT00296504|54722758|FG003|Interim Analysis|Participant Needed Interferon|0|||
28067564|NCT00296504|54722759|FG004|Interim Analysis|Participant Needed Interferon|0|||
28067565|NCT00296504|54722760|FG005|Interim Analysis|Participant Needed Interferon|0|||
28067566|NCT00296504|54722761|FG006|Interim Analysis|Participant Needed Interferon|0|||
28067567|NCT00296504|54722762|FG007|Interim Analysis|Participant Needed Interferon|1|||
28067568|NCT00296504|54722763|FG008|Interim Analysis|Participant Needed Interferon|0|||
28127191|NCT03146403|54789120|FG001|Overall Study|Withdrawal by Subject|3|||
28127192|NCT03146403|54789119|FG000|Overall Study|Lost to Follow-up|2|||
28127193|NCT03146403|54789120|FG001|Overall Study|Lost to Follow-up|0|||
28127194|NCT02713204|54789129|FG000|Baseline (Day 1) up to Week 12|Adverse Event|1|||
28127195|NCT02713204|54789130|FG001|Baseline (Day 1) up to Week 12|Adverse Event|0|||
28127196|NCT02713204|54789131|FG002|Baseline (Day 1) up to Week 12|Adverse Event|1|||
28127197|NCT02713204|54789132|FG003|Baseline (Day 1) up to Week 12|Adverse Event|0|||
27818352|NCT01795898|54276950|FG000|Overall Study|Death|1|||
27818353|NCT01795898|54276950|FG000|Overall Study|Withdrew consent & had adverse events|3|||
28127198|NCT02713204|54789133|FG004|Baseline (Day 1) up to Week 12|Adverse Event|0|||
28127199|NCT02713204|54789134|FG005|Baseline (Day 1) up to Week 12|Adverse Event|0|||
28127200|NCT02713204|54789135|FG006|Baseline (Day 1) up to Week 12|Adverse Event|0|||
28127201|NCT02713204|54789136|FG007|Baseline (Day 1) up to Week 12|Adverse Event|0|||
28127202|NCT02713204|54789129|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
28127203|NCT02713204|54789130|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
28127204|NCT02713204|54789131|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
28127205|NCT02713204|54789132|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
28127206|NCT02713204|54789133|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
28127207|NCT02713204|54789134|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
28127208|NCT02713204|54789135|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
28127209|NCT02713204|54789136|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
28127210|NCT02713204|54789129|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
28127211|NCT02713204|54789130|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
28127212|NCT02713204|54789131|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
28127213|NCT02713204|54789132|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
27818354|NCT01795898|54276950|FG000|Overall Study|Physician Decision|1|||
28127214|NCT02713204|54789133|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
28127215|NCT02713204|54789134|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
28127216|NCT02713204|54789135|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
28127217|NCT02713204|54789136|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
28127218|NCT02713204|54789129|FG000|From Week 12 up to Week 36|Adverse Event|1|||
28127219|NCT02713204|54789130|FG001|From Week 12 up to Week 36|Adverse Event|0|||
28127220|NCT02713204|54789131|FG002|From Week 12 up to Week 36|Adverse Event|0|||
28127221|NCT02713204|54789132|FG003|From Week 12 up to Week 36|Adverse Event|1|||
27818355|NCT01736696|54276961|FG000|Overall Study|Withdrawal by Subject|0|||
28127222|NCT02713204|54789133|FG004|From Week 12 up to Week 36|Adverse Event|1|||
28127223|NCT02713204|54789134|FG005|From Week 12 up to Week 36|Adverse Event|0|||
28127224|NCT02713204|54789135|FG006|From Week 12 up to Week 36|Adverse Event|2|||
28127225|NCT02713204|54789136|FG007|From Week 12 up to Week 36|Adverse Event|1|||
28127226|NCT02713204|54789129|FG000|From Week 12 up to Week 36|Death|0|||
28127227|NCT02713204|54789130|FG001|From Week 12 up to Week 36|Death|0|||
28127228|NCT02713204|54789131|FG002|From Week 12 up to Week 36|Death|0|||
28127229|NCT02713204|54789132|FG003|From Week 12 up to Week 36|Death|1|||
28127230|NCT02713204|54789133|FG004|From Week 12 up to Week 36|Death|0|||
28127231|NCT02713204|54789134|FG005|From Week 12 up to Week 36|Death|1|||
28127232|NCT02713204|54789135|FG006|From Week 12 up to Week 36|Death|0|||
28127233|NCT02713204|54789136|FG007|From Week 12 up to Week 36|Death|3|||
28127234|NCT02713204|54789129|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
28127235|NCT02713204|54789130|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
28127236|NCT02713204|54789131|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
28127237|NCT02713204|54789132|FG003|From Week 12 up to Week 36|Lost to Follow-up|2|||
28127238|NCT02713204|54789133|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
28127239|NCT02713204|54789134|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
28127240|NCT02713204|54789135|FG006|From Week 12 up to Week 36|Lost to Follow-up|0|||
28127241|NCT02713204|54789136|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
28127242|NCT02713204|54789129|FG000|From Week 12 up to Week 36|Participant Re-located|0|||
28127243|NCT02713204|54789130|FG001|From Week 12 up to Week 36|Participant Re-located|0|||
28127244|NCT02713204|54789131|FG002|From Week 12 up to Week 36|Participant Re-located|0|||
28127245|NCT02713204|54789132|FG003|From Week 12 up to Week 36|Participant Re-located|0|||
28127246|NCT02713204|54789133|FG004|From Week 12 up to Week 36|Participant Re-located|1|||
28127247|NCT02713204|54789134|FG005|From Week 12 up to Week 36|Participant Re-located|0|||
28127248|NCT02713204|54789135|FG006|From Week 12 up to Week 36|Participant Re-located|0|||
28127249|NCT02713204|54789136|FG007|From Week 12 up to Week 36|Participant Re-located|0|||
28127250|NCT03695172|54789156|FG000|Overall Study|Withdrawal by Subject|1|||
28127251|NCT03695172|54789157|FG001|Overall Study|Withdrawal by Subject|1|||
28127252|NCT03695172|54789158|FG002|Overall Study|Withdrawal by Subject|0|||
27818356|NCT01736696|54276962|FG001|Overall Study|Withdrawal by Subject|0|||
27818357|NCT01736696|54276963|FG002|Overall Study|Withdrawal by Subject|1|||
27818358|NCT01736696|54276964|FG003|Overall Study|Withdrawal by Subject|0|||
27818359|NCT01736696|54276965|FG004|Overall Study|Withdrawal by Subject|0|||
27818360|NCT01736696|54276966|FG005|Overall Study|Withdrawal by Subject|0|||
27818361|NCT01736696|54276967|FG006|Overall Study|Withdrawal by Subject|0|||
27818362|NCT01736540|54276991|FG000|Overall Study|Did not complete scan within 45 days|2|||
28127253|NCT03721107|54789170|FG000|Overall Study|Adverse Event|1|||
28127254|NCT03721107|54789171|FG001|Overall Study|Adverse Event|1|||
28127255|NCT03721107|54789172|FG002|Overall Study|Adverse Event|6|||
28127256|NCT03721107|54789173|FG003|Overall Study|Adverse Event|5|||
28127257|NCT03721107|54789170|FG000|Overall Study|Lost to Follow-up|2|||
28127258|NCT03721107|54789171|FG001|Overall Study|Lost to Follow-up|0|||
27818363|NCT01736540|54276991|FG000|Overall Study|Death|1|||
27818364|NCT01736540|54276991|FG000|Overall Study|Abnormal test procedure|1|||
27818365|NCT01736540|54276991|FG000|Overall Study|Withdrawal by Subject|5|||
27818366|NCT01736540|54276991|FG000|Overall Study|Protocol Violation|1|||
27818367|NCT01736540|54276991|FG000|Overall Study|Unable to tolerate MRI; claustrophobic|1|||
27818368|NCT01736540|54276991|FG000|Overall Study|No show for MRI appointment|1|||
27818369|NCT01736540|54276991|FG000|Overall Study|Unable to make MRI appointment|3|||
27818370|NCT01794338|54277004|FG000|Overall Study|Death|2|||
28127259|NCT03721107|54789172|FG002|Overall Study|Lost to Follow-up|3|||
28127260|NCT03721107|54789173|FG003|Overall Study|Lost to Follow-up|0|||
28127261|NCT03721107|54789170|FG000|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
28127262|NCT03721107|54789171|FG001|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
28127263|NCT03721107|54789172|FG002|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
28127264|NCT03721107|54789173|FG003|Overall Study|Inclusion/Exclusion Criteria not Met|1|||
28127265|NCT03721107|54789170|FG000|Overall Study|Physician Decision|0|||
28127266|NCT03721107|54789171|FG001|Overall Study|Physician Decision|1|||
28127267|NCT03721107|54789172|FG002|Overall Study|Physician Decision|0|||
28127268|NCT03721107|54789173|FG003|Overall Study|Physician Decision|0|||
28127269|NCT03721107|54789170|FG000|Overall Study|Pregnancy|0|||
28127270|NCT03721107|54789171|FG001|Overall Study|Pregnancy|0|||
28127271|NCT03721107|54789172|FG002|Overall Study|Pregnancy|1|||
28127272|NCT03721107|54789173|FG003|Overall Study|Pregnancy|0|||
28127273|NCT03721107|54789170|FG000|Overall Study|Withdrawal by Subject|1|||
28127274|NCT03721107|54789171|FG001|Overall Study|Withdrawal by Subject|1|||
28127275|NCT03721107|54789172|FG002|Overall Study|Withdrawal by Subject|5|||
28127276|NCT03721107|54789173|FG003|Overall Study|Withdrawal by Subject|5|||
28127277|NCT03721107|54789170|FG000|Overall Study|Other|1|||
28127278|NCT03721107|54789171|FG001|Overall Study|Other|0|||
28127279|NCT03721107|54789172|FG002|Overall Study|Other|0|||
28127280|NCT03721107|54789173|FG003|Overall Study|Other|1|||
28127281|NCT03052920|54789192|FG000|Overall Study|Withdrawal by Subject|1|||
28127282|NCT02930226|54789202|FG000|Overall Study|Technical Problems: Leak in plasma bag|0|||
28127283|NCT02930226|54789203|FG001|Overall Study|Technical Problems: Leak in plasma bag|0|||
28127284|NCT02930226|54789204|FG002|Overall Study|Technical Problems: Leak in plasma bag|0|||
28127285|NCT02930226|54789205|FG003|Overall Study|Technical Problems: Leak in plasma bag|0|||
28127286|NCT02930226|54789206|FG004|Overall Study|Technical Problems: Leak in plasma bag|1|||
28127287|NCT02930226|54789207|FG005|Overall Study|Technical Problems: Leak in plasma bag|0|||
28127288|NCT02722434|54789244|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
28127289|NCT02722434|54789245|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
28127290|NCT02722434|54789244|FG000|Overall Study|Withdrawal After Beginning Treatment|0|||
28127291|NCT02722434|54789245|FG001|Overall Study|Withdrawal After Beginning Treatment|3|||
28127292|NCT03539601|54789255|FG000|Overall Study|Withdraw by parent/guardian|1|||
28127293|NCT03539601|54789256|FG001|Overall Study|Withdraw by parent/guardian|0|||
27818371|NCT01794338|54277005|FG001|Overall Study|Death|0|||
27818372|NCT01794338|54277004|FG000|Overall Study|Lost to Follow-up|6|||
28127294|NCT03539601|54789257|FG002|Overall Study|Withdraw by parent/guardian|1|||
28127295|NCT03539601|54789258|FG003|Overall Study|Withdraw by parent/guardian|0|||
28127296|NCT03539601|54789255|FG000|Overall Study|Adverse Event|0|||
27818373|NCT01794338|54277005|FG001|Overall Study|Lost to Follow-up|9|||
28127297|NCT03539601|54789256|FG001|Overall Study|Adverse Event|2|||
28127298|NCT03539601|54789257|FG002|Overall Study|Adverse Event|0|||
28127299|NCT03539601|54789258|FG003|Overall Study|Adverse Event|0|||
28127300|NCT03539601|54789255|FG000|Overall Study|Lost to Follow-up|2|||
28127301|NCT03539601|54789256|FG001|Overall Study|Lost to Follow-up|4|||
28127302|NCT03539601|54789257|FG002|Overall Study|Lost to Follow-up|5|||
28127303|NCT03539601|54789258|FG003|Overall Study|Lost to Follow-up|0|||
28127304|NCT03539601|54789255|FG000|Overall Study|Withdrawal by Subject|2|||
28127305|NCT03539601|54789256|FG001|Overall Study|Withdrawal by Subject|0|||
28127306|NCT03539601|54789257|FG002|Overall Study|Withdrawal by Subject|0|||
28127307|NCT03539601|54789258|FG003|Overall Study|Withdrawal by Subject|1|||
28127308|NCT03539601|54789255|FG000|Overall Study|Randomized but not treated|1|||
28127309|NCT03539601|54789256|FG001|Overall Study|Randomized but not treated|1|||
28127310|NCT03539601|54789257|FG002|Overall Study|Randomized but not treated|0|||
28127311|NCT03539601|54789258|FG003|Overall Study|Randomized but not treated|0|||
28127312|NCT00700804|54789278|FG000|Overall Study|Withdrawal by Subject|1|||
28127313|NCT00700804|54789279|FG001|Overall Study|Withdrawal by Subject|2|||
28127314|NCT00700804|54789278|FG000|Overall Study|Protocol Violation|1|||
28127315|NCT00700804|54789279|FG001|Overall Study|Protocol Violation|1|||
28127316|NCT00700804|54789278|FG000|Overall Study|Loose Stools|1|||
28127317|NCT00700804|54789279|FG001|Overall Study|Loose Stools|1|||
28127318|NCT02903823|54789285|FG000|Overall Study|Physician Decision|5|||
28127319|NCT02903823|54789285|FG000|Overall Study|Could not advance catheter|1|||
28127320|NCT02903823|54789285|FG000|Overall Study|Catheter dislodgement|1|||
28127321|NCT00832455|54789314|FG000|Overall Study|Adverse Event|13|||
28127322|NCT00832455|54789314|FG000|Overall Study|Lost to Follow-up|26|||
28127323|NCT00832455|54789314|FG000|Overall Study|Protocol Violation|4|||
28127324|NCT00832455|54789314|FG000|Overall Study|Withdrawal by Subject|17|||
28127325|NCT00832455|54789314|FG000|Overall Study|Screening Failure|2|||
28127326|NCT00832455|54789314|FG000|Overall Study|Stopped Medication|4|||
28127327|NCT00832455|54789314|FG000|Overall Study|Parent misunderstood study|1|||
28127328|NCT00832455|54789314|FG000|Overall Study|Parent dissatisfied|1|||
28127329|NCT00832455|54789314|FG000|Overall Study|No improvement|3|||
28127330|NCT00832455|54789314|FG000|Overall Study|Patient moved|1|||
28127331|NCT00687531|54789327|FG000|Overall Study|Did not meet protocol eligibility|104|||
28127332|NCT00687531|54789327|FG000|Overall Study|Adverse Event|5|||
28127333|NCT00687531|54789327|FG000|Overall Study|Lost to Follow-up|26|||
28127334|NCT00423579|54789333|FG000|Overall Study|Lost to Follow-up|3|||
28127335|NCT00423579|54789334|FG001|Overall Study|Lost to Follow-up|0|||
28127336|NCT00423579|54789333|FG000|Overall Study|Protocol Violation|1|||
28127337|NCT00423579|54789334|FG001|Overall Study|Protocol Violation|3|||
28127338|NCT00423579|54789333|FG000|Overall Study|Diagnosis of diabetes|0|||
28127339|NCT00423579|54789334|FG001|Overall Study|Diagnosis of diabetes|1|||
28127340|NCT03268005|54789342|FG000|Overall Study|Death|2|||
27818374|NCT01609478|54277014|FG000|Overall Study|Adverse Event|3|||
28127341|NCT03268005|54789343|FG001|Overall Study|Death|1|||
28127342|NCT03268005|54789342|FG000|Overall Study|Lost to Follow-up|2|||
28127343|NCT03268005|54789343|FG001|Overall Study|Lost to Follow-up|2|||
28127344|NCT03268005|54789342|FG000|Overall Study|Withdrawal by Subject|11|||
28127345|NCT03268005|54789343|FG001|Overall Study|Withdrawal by Subject|11|||
27818375|NCT01609478|54277015|FG001|Overall Study|Adverse Event|1|||
28127346|NCT03149055|54789349|FG000|Overall Study|Not treated|4|||
28127347|NCT03137121|54789364|FG000|Overall Study|Withdrawal by Subject|0|||
28127348|NCT03137121|54789365|FG001|Overall Study|Withdrawal by Subject|1|||
28127349|NCT00700570|54789408|FG000|Overall Study|Adverse Event|2|||
28127350|NCT00700570|54789409|FG001|Overall Study|Adverse Event|6|||
28127351|NCT00700570|54789408|FG000|Overall Study|Discretion of Investigator or Sponsor|0|||
28127352|NCT00700570|54789409|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
28127353|NCT00700570|54789408|FG000|Overall Study|Disease Progression|8|||
28127354|NCT00700570|54789409|FG001|Overall Study|Disease Progression|11|||
28127355|NCT00700570|54789408|FG000|Overall Study|Withdrawal by Subject|1|||
28127356|NCT00700570|54789409|FG001|Overall Study|Withdrawal by Subject|6|||
28127357|NCT02874924|54789427|FG000|Overall Study|Adverse Event|2|||
28127358|NCT02874924|54789428|FG001|Overall Study|Adverse Event|0|||
28127359|NCT02874924|54789429|FG002|Overall Study|Adverse Event|0|||
28127360|NCT02874924|54789427|FG000|Overall Study|Withdrawal by Subject|1|||
28127361|NCT02874924|54789428|FG001|Overall Study|Withdrawal by Subject|0|||
28127362|NCT02874924|54789429|FG002|Overall Study|Withdrawal by Subject|0|||
28127363|NCT04425863|54789440|FG000|Overall Study|Death|0|||
28127364|NCT04425863|54789441|FG001|Overall Study|Death|0|||
28127365|NCT04425863|54789442|FG002|Overall Study|Death|1|||
28127366|NCT04360187|54789464|FG000|Double-Blind Treatment|Adverse Event|9|||
28127367|NCT04360187|54789465|FG001|Double-Blind Treatment|Adverse Event|11|||
28127368|NCT04360187|54789464|FG000|Double-Blind Treatment|Lack of Efficacy|7|||
28127369|NCT04360187|54789465|FG001|Double-Blind Treatment|Lack of Efficacy|2|||
28127370|NCT04360187|54789464|FG000|Double-Blind Treatment|Physician Decision|1|||
28127371|NCT04360187|54789465|FG001|Double-Blind Treatment|Physician Decision|0|||
28127372|NCT04360187|54789464|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
28127373|NCT04360187|54789465|FG001|Double-Blind Treatment|Withdrawal by Subject|2|||
28127374|NCT04360187|54789464|FG000|Double-Blind Treatment|Withdrawal By Parent/Guardian|2|||
28127375|NCT04360187|54789465|FG001|Double-Blind Treatment|Withdrawal By Parent/Guardian|0|||
28127376|NCT04360187|54789464|FG000|Follow-Up|Lost to Follow-up|1|||
28127377|NCT04360187|54789465|FG001|Follow-Up|Lost to Follow-up|0|||
28127378|NCT04498169|54789473|FG000|Study Completion|Adverse Event|1|||
28127379|NCT04498169|54789474|FG001|Study Completion|Adverse Event|1|||
28127380|NCT03695393|54789482|FG000|Overall Study|Death|3|||
28127381|NCT03695393|54789483|FG001|Overall Study|Death|1|||
28127382|NCT03695393|54789482|FG000|Overall Study|Lost to Follow-up|0|||
28127383|NCT03695393|54789483|FG001|Overall Study|Lost to Follow-up|1|||
28127384|NCT03694925|54789492|FG000|Overall Study|Inadequate laboratory testing|0|||
28127385|NCT03694925|54789493|FG001|Overall Study|Inadequate laboratory testing|3|||
28127386|NCT03694925|54789494|FG002|Overall Study|Inadequate laboratory testing|0|||
28127387|NCT04258020|54789506|FG000|Overall Study|Withdrawal by Subject|1|||
28127388|NCT04258020|54789507|FG001|Overall Study|Withdrawal by Subject|0|||
28127389|NCT04495283|54789516|FG000|Overall Study|Physician Decision|0|||
28127390|NCT04495283|54789517|FG001|Overall Study|Physician Decision|0|||
28127391|NCT04495283|54789518|FG002|Overall Study|Physician Decision|1|||
28127392|NCT04495283|54789516|FG000|Overall Study|Withdrawal by Subject|0|||
28127393|NCT04495283|54789517|FG001|Overall Study|Withdrawal by Subject|1|||
28127394|NCT04495283|54789518|FG002|Overall Study|Withdrawal by Subject|1|||
28127395|NCT04495283|54789516|FG000|Overall Study|Other|1|||
28127396|NCT04495283|54789517|FG001|Overall Study|Other|0|||
28127397|NCT04495283|54789518|FG002|Overall Study|Other|1|||
28127398|NCT03117738|54789531|FG000|Overall Study|Withdrawal by Subject|3|||
28127399|NCT03117738|54789532|FG001|Overall Study|Withdrawal by Subject|1|||
28127400|NCT03117738|54789531|FG000|Overall Study|Lost to Follow-up|1|||
28127401|NCT03117738|54789532|FG001|Overall Study|Lost to Follow-up|4|||
28127402|NCT04234464|54789540|FG000|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|1|||
28127403|NCT04234464|54789541|FG001|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|0|||
28127404|NCT03123588|54789549|FG000|Overall Study|Study Terminated by Sponsor|2|||
28127405|NCT03123588|54789550|FG001|Overall Study|Study Terminated by Sponsor|5|||
27818376|NCT01609478|54277016|FG002|Overall Study|Adverse Event|5|||
28127406|NCT03123588|54789549|FG000|Overall Study|Withdrawal by Subject|1|||
27818377|NCT01609478|54277014|FG000|Overall Study|Protocol Deviation|0|||
27818378|NCT01609478|54277015|FG001|Overall Study|Protocol Deviation|1|||
27818379|NCT01609478|54277016|FG002|Overall Study|Protocol Deviation|1|||
28127407|NCT03123588|54789550|FG001|Overall Study|Withdrawal by Subject|0|||
28127408|NCT03123588|54789549|FG000|Overall Study|Adverse Event|1|||
28127409|NCT03123588|54789550|FG001|Overall Study|Adverse Event|0|||
28127410|NCT03123588|54789549|FG000|Overall Study|Physician Decision|2|||
28127411|NCT03123588|54789550|FG001|Overall Study|Physician Decision|1|||
28127412|NCT03123354|54789557|FG000|Overall Study|Physician Decision|6|||
28127413|NCT04421027|54789563|FG000|Treatment Period|Adverse Event|5|||
28127414|NCT04421027|54789564|FG001|Treatment Period|Adverse Event|3|||
28127415|NCT04421027|54789565|FG002|Treatment Period|Adverse Event|0|||
28127416|NCT04421027|54789566|FG003|Treatment Period|Adverse Event|0|||
28127417|NCT04421027|54789563|FG000|Treatment Period|Death|98|||
28127418|NCT04421027|54789564|FG001|Treatment Period|Death|61|||
28127419|NCT04421027|54789565|FG002|Treatment Period|Death|0|||
28127420|NCT04421027|54789566|FG003|Treatment Period|Death|0|||
28127421|NCT04421027|54789563|FG000|Treatment Period|Lost to Follow-up|22|||
28127422|NCT04421027|54789564|FG001|Treatment Period|Lost to Follow-up|20|||
28127423|NCT04421027|54789565|FG002|Treatment Period|Lost to Follow-up|0|||
28127424|NCT04421027|54789566|FG003|Treatment Period|Lost to Follow-up|0|||
28127425|NCT04421027|54789563|FG000|Treatment Period|Other-Unknown|15|||
28127426|NCT04421027|54789564|FG001|Treatment Period|Other-Unknown|9|||
28127427|NCT04421027|54789565|FG002|Treatment Period|Other-Unknown|0|||
28127428|NCT04421027|54789566|FG003|Treatment Period|Other-Unknown|0|||
28127429|NCT04421027|54789563|FG000|Treatment Period|Physician Decision|1|||
28127430|NCT04421027|54789564|FG001|Treatment Period|Physician Decision|1|||
28127431|NCT04421027|54789565|FG002|Treatment Period|Physician Decision|0|||
28127432|NCT04421027|54789566|FG003|Treatment Period|Physician Decision|0|||
28127433|NCT04421027|54789563|FG000|Treatment Period|Withdrawal by Subject|7|||
28127434|NCT04421027|54789564|FG001|Treatment Period|Withdrawal by Subject|12|||
28127435|NCT04421027|54789565|FG002|Treatment Period|Withdrawal by Subject|0|||
28127436|NCT04421027|54789566|FG003|Treatment Period|Withdrawal by Subject|0|||
28127437|NCT04421027|54789563|FG000|Treatment Period|Randomized Not Dosed|9|||
28127438|NCT04421027|54789564|FG001|Treatment Period|Randomized Not Dosed|14|||
28127439|NCT04421027|54789565|FG002|Treatment Period|Randomized Not Dosed|0|||
28127440|NCT04421027|54789566|FG003|Treatment Period|Randomized Not Dosed|0|||
28127441|NCT04421027|54789563|FG000|Follow-Up Period|Adverse Event|0|||
28127442|NCT04421027|54789564|FG001|Follow-Up Period|Adverse Event|0|||
28127443|NCT04421027|54789565|FG002|Follow-Up Period|Adverse Event|0|||
28127444|NCT04421027|54789566|FG003|Follow-Up Period|Adverse Event|3|||
28127445|NCT04421027|54789563|FG000|Follow-Up Period|Death|0|||
28127446|NCT04421027|54789564|FG001|Follow-Up Period|Death|0|||
28127447|NCT04421027|54789565|FG002|Follow-Up Period|Death|16|||
28127448|NCT04421027|54789566|FG003|Follow-Up Period|Death|17|||
28127449|NCT04421027|54789563|FG000|Follow-Up Period|Lost to Follow-up|0|||
28127450|NCT04421027|54789564|FG001|Follow-Up Period|Lost to Follow-up|0|||
28127451|NCT04421027|54789565|FG002|Follow-Up Period|Lost to Follow-up|7|||
28127452|NCT04421027|54789566|FG003|Follow-Up Period|Lost to Follow-up|7|||
28127453|NCT04421027|54789563|FG000|Follow-Up Period|Protocol Deviation|0|||
28127454|NCT04421027|54789564|FG001|Follow-Up Period|Protocol Deviation|0|||
28127455|NCT04421027|54789565|FG002|Follow-Up Period|Protocol Deviation|1|||
28127456|NCT04421027|54789566|FG003|Follow-Up Period|Protocol Deviation|0|||
28127457|NCT04421027|54789563|FG000|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
28127458|NCT04421027|54789564|FG001|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
28127459|NCT04421027|54789565|FG002|Follow-Up Period|Still in hospital on ventilator at end of study|1|||
28127460|NCT04421027|54789566|FG003|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
28127461|NCT04421027|54789563|FG000|Follow-Up Period|Left message, participant did not call back|0|||
27818380|NCT01609478|54277014|FG000|Overall Study|Non-Compliance with study treatment|1|||
27818381|NCT01609478|54277015|FG001|Overall Study|Non-Compliance with study treatment|0|||
28127462|NCT04421027|54789564|FG001|Follow-Up Period|Left message, participant did not call back|0|||
28127463|NCT04421027|54789565|FG002|Follow-Up Period|Left message, participant did not call back|0|||
28127464|NCT04421027|54789566|FG003|Follow-Up Period|Left message, participant did not call back|1|||
28127465|NCT04421027|54789563|FG000|Follow-Up Period|Participant died|0|||
28127466|NCT04421027|54789564|FG001|Follow-Up Period|Participant died|0|||
28127467|NCT04421027|54789565|FG002|Follow-Up Period|Participant died|0|||
28127468|NCT04421027|54789566|FG003|Follow-Up Period|Participant died|1|||
28127469|NCT04421027|54789563|FG000|Follow-Up Period|Participant was alive but did not respond to calls|0|||
28127470|NCT04421027|54789564|FG001|Follow-Up Period|Participant was alive but did not respond to calls|0|||
28127471|NCT04421027|54789565|FG002|Follow-Up Period|Participant was alive but did not respond to calls|0|||
28127472|NCT04421027|54789566|FG003|Follow-Up Period|Participant was alive but did not respond to calls|1|||
28127473|NCT04419311|54789576|FG000|Overall Study|Lost to Follow-up|1|||
28127474|NCT04419311|54789577|FG001|Overall Study|Lost to Follow-up|0|||
28127475|NCT04411667|54789587|FG000|Overall Study|Physician Decision|1|||
28127476|NCT04411667|54789588|FG001|Overall Study|Physician Decision|0|||
28127477|NCT04358549|54789596|FG000|Overall Study|Adverse Event|0|||
28127478|NCT04358549|54789597|FG001|Overall Study|Adverse Event|1|||
28127479|NCT04358549|54789596|FG000|Overall Study|Death|1|||
28127480|NCT04358549|54789597|FG001|Overall Study|Death|0|||
28127481|NCT04358549|54789596|FG000|Overall Study|Lost to Follow-up|2|||
28127482|NCT04358549|54789597|FG001|Overall Study|Lost to Follow-up|1|||
28127483|NCT04358549|54789596|FG000|Overall Study|Withdrawal by Subject|6|||
28127484|NCT04358549|54789597|FG001|Overall Study|Withdrawal by Subject|6|||
28127485|NCT04358549|54789596|FG000|Overall Study|Start remdesivir|1|||
28127486|NCT04358549|54789597|FG001|Overall Study|Start remdesivir|0|||
28127487|NCT00700180|54789605|FG000|Overall Study|Death|99|||
28127488|NCT00700180|54789606|FG001|Overall Study|Death|114|||
27849411|NCT02078219|54345617|FG003|Overall Study|Adverse Event|1|||
27849412|NCT02078219|54345618|FG004|Overall Study|Adverse Event|0|||
27849413|NCT02076113|54345632|FG000|Overall Study|Lost to Follow-up|4|||
27849414|NCT02076113|54345633|FG001|Overall Study|Lost to Follow-up|1|||
27849415|NCT02076113|54345632|FG000|Overall Study|Withdrawal by Subject|2|||
28127489|NCT00700180|54789605|FG000|Overall Study|Alive on treatment|5|||
28127490|NCT00700180|54789606|FG001|Overall Study|Alive on treatment|3|||
28127491|NCT00700180|54789605|FG000|Overall Study|Alive in follow-up|46|||
28127492|NCT00700180|54789606|FG001|Overall Study|Alive in follow-up|27|||
28127493|NCT00700180|54789605|FG000|Overall Study|Lost to Follow-up|4|||
27849416|NCT02076113|54345633|FG001|Overall Study|Withdrawal by Subject|3|||
27849417|NCT02076113|54345632|FG000|Overall Study|Death|1|||
27849418|NCT02076113|54345633|FG001|Overall Study|Death|3|||
27849419|NCT02075255|54345645|FG000|Overall Study|Study specific withdrawal criteria|0|||
27849420|NCT02075255|54345646|FG001|Overall Study|Study specific withdrawal criteria|1|||
27940531|NCT00938392|54596819|FG001|Overall Study|Withdrawal by Subject|1|||
27940532|NCT00938392|54596818|FG000|Overall Study|Lost to Follow-up|2|||
27940533|NCT00938392|54596819|FG001|Overall Study|Lost to Follow-up|2|||
28127494|NCT00700180|54789606|FG001|Overall Study|Lost to Follow-up|5|||
28127495|NCT00238420|54789614|FG000|Overall Study|Protocol Violation|1|||
28127496|NCT00238420|54789615|FG001|Overall Study|Protocol Violation|1|||
28127497|NCT04492475|54789623|FG000|Overall Study|Enrolled but not treated|8|||
28127498|NCT04492475|54789624|FG001|Overall Study|Enrolled but not treated|8|||
28127499|NCT04492475|54789623|FG000|Overall Study|Withdrawal by Subject|4|||
28127500|NCT04492475|54789624|FG001|Overall Study|Withdrawal by Subject|0|||
28127501|NCT04492475|54789623|FG000|Overall Study|Became ineligible after enrollment|2|||
28127502|NCT04492475|54789624|FG001|Overall Study|Became ineligible after enrollment|0|||
28127503|NCT04486235|54789639|FG000|Overall Study|Pregnancy|1|||
28127504|NCT04486235|54789640|FG001|Overall Study|Pregnancy|0|||
27940534|NCT01022853|54596830|FG000|Overall Study|Progressive disease|2|||
28127505|NCT04486235|54789639|FG000|Overall Study|Lost to Follow-up|1|||
28127506|NCT04486235|54789640|FG001|Overall Study|Lost to Follow-up|0|||
28127507|NCT04358081|54789650|FG000|Treatment Phase of Study|Withdrawal by Subject|0|||
27849421|NCT02075255|54345647|FG002|Overall Study|Study specific withdrawal criteria|1|||
27849422|NCT02075255|54345645|FG000|Overall Study|Withdrawal by Subject|4|||
28127508|NCT04358081|54789651|FG001|Treatment Phase of Study|Withdrawal by Subject|1|||
28127509|NCT04358081|54789652|FG002|Treatment Phase of Study|Withdrawal by Subject|1|||
28127510|NCT04358081|54789650|FG000|Treatment Phase of Study|Adverse Event|1|||
28127511|NCT04358081|54789651|FG001|Treatment Phase of Study|Adverse Event|0|||
28127512|NCT04358081|54789652|FG002|Treatment Phase of Study|Adverse Event|1|||
28127513|NCT04358081|54789650|FG000|Treatment Phase of Study|Physician Decision|2|||
28127514|NCT04358081|54789651|FG001|Treatment Phase of Study|Physician Decision|0|||
28127515|NCT04358081|54789652|FG002|Treatment Phase of Study|Physician Decision|1|||
28127516|NCT04358081|54789650|FG000|Treatment Phase of Study|Protocol Violation|1|||
28127517|NCT04358081|54789651|FG001|Treatment Phase of Study|Protocol Violation|0|||
28127518|NCT04358081|54789652|FG002|Treatment Phase of Study|Protocol Violation|0|||
28127519|NCT04358081|54789650|FG000|Study Completion Phase|Death|0|||
28127520|NCT04358081|54789651|FG001|Study Completion Phase|Death|0|||
28127521|NCT04358081|54789652|FG002|Study Completion Phase|Death|1|||
28127522|NCT04358081|54789650|FG000|Study Completion Phase|Lost to Follow-up|1|||
27818382|NCT01609478|54277016|FG002|Overall Study|Non-Compliance with study treatment|0|||
27818383|NCT01609478|54277014|FG000|Overall Study|Physician Decision|1|||
28067569|NCT00296504|54722755|FG000|Interim Analysis|Ongoing|32|||
28127523|NCT04358081|54789651|FG001|Study Completion Phase|Lost to Follow-up|0|||
28127524|NCT04358081|54789652|FG002|Study Completion Phase|Lost to Follow-up|1|||
28127525|NCT04355663|54789665|FG000|Overall Study|Physician Decision|2|||
28127526|NCT04355663|54789666|FG001|Overall Study|Physician Decision|7|||
28127527|NCT04355663|54789667|FG002|Overall Study|Physician Decision|0|||
28127528|NCT04355663|54789665|FG000|Overall Study|Adverse Event|0|||
28127529|NCT04355663|54789666|FG001|Overall Study|Adverse Event|0|||
28127530|NCT04355663|54789667|FG002|Overall Study|Adverse Event|1|||
28127531|NCT04355663|54789665|FG000|Overall Study|Withdrawal by Subject|0|||
28127532|NCT04355663|54789666|FG001|Overall Study|Withdrawal by Subject|8|||
28067570|NCT00296504|54722756|FG001|Interim Analysis|Ongoing|12|||
28067571|NCT00296504|54722757|FG002|Interim Analysis|Ongoing|16|||
28067572|NCT00296504|54722758|FG003|Interim Analysis|Ongoing|22|||
28067573|NCT00296504|54722759|FG004|Interim Analysis|Ongoing|0|||
28067574|NCT00296504|54722760|FG005|Interim Analysis|Ongoing|0|||
28067575|NCT00296504|54722761|FG006|Interim Analysis|Ongoing|30|||
28067576|NCT00296504|54722762|FG007|Interim Analysis|Ongoing|1|||
28067577|NCT00296504|54722763|FG008|Interim Analysis|Ongoing|0|||
28067578|NCT00296504|54722755|FG000|Final Analysis|Withdrawal by Subject|0|||
28067579|NCT00296504|54722756|FG001|Final Analysis|Withdrawal by Subject|0|||
28067580|NCT00296504|54722757|FG002|Final Analysis|Withdrawal by Subject|0|||
28067581|NCT00296504|54722758|FG003|Final Analysis|Withdrawal by Subject|0|||
28067582|NCT00296504|54722759|FG004|Final Analysis|Withdrawal by Subject|0|||
28067583|NCT00296504|54722760|FG005|Final Analysis|Withdrawal by Subject|0|||
28067584|NCT00296504|54722761|FG006|Final Analysis|Withdrawal by Subject|0|||
28067585|NCT00296504|54722762|FG007|Final Analysis|Withdrawal by Subject|0|||
28067586|NCT00296504|54722763|FG008|Final Analysis|Withdrawal by Subject|1|||
28067587|NCT00296504|54722755|FG000|Final Analysis|Lost to Follow-up|0|||
28067588|NCT00296504|54722756|FG001|Final Analysis|Lost to Follow-up|0|||
28067589|NCT00296504|54722757|FG002|Final Analysis|Lost to Follow-up|0|||
28067590|NCT00296504|54722758|FG003|Final Analysis|Lost to Follow-up|0|||
28067591|NCT00296504|54722759|FG004|Final Analysis|Lost to Follow-up|0|||
28067592|NCT00296504|54722760|FG005|Final Analysis|Lost to Follow-up|0|||
28067593|NCT00296504|54722761|FG006|Final Analysis|Lost to Follow-up|0|||
28067594|NCT00296504|54722762|FG007|Final Analysis|Lost to Follow-up|0|||
28067595|NCT00296504|54722763|FG008|Final Analysis|Lost to Follow-up|5|||
28067596|NCT00296504|54722755|FG000|Final Analysis|Insufficient Viral Load Response|0|||
28127533|NCT04355663|54789667|FG002|Overall Study|Withdrawal by Subject|3|||
28127534|NCT04345367|54789677|FG000|Overall Study|Other|3|||
28127535|NCT04345367|54789678|FG001|Overall Study|Other|4|||
28127536|NCT04345367|54789677|FG000|Overall Study|Medication Error Without Associated Adverse Event|1|||
28067597|NCT00296504|54722756|FG001|Final Analysis|Insufficient Viral Load Response|0|||
28127537|NCT04345367|54789678|FG001|Overall Study|Medication Error Without Associated Adverse Event|0|||
28127538|NCT04345367|54789677|FG000|Overall Study|Withdrawal by Subject|11|||
28127539|NCT04345367|54789678|FG001|Overall Study|Withdrawal by Subject|11|||
28127540|NCT04345367|54789677|FG000|Overall Study|Protocol Violation|4|||
28127541|NCT04345367|54789678|FG001|Overall Study|Protocol Violation|3|||
28127542|NCT04345367|54789677|FG000|Overall Study|Lost to Follow-up|2|||
28127543|NCT04345367|54789678|FG001|Overall Study|Lost to Follow-up|4|||
28127544|NCT04345367|54789677|FG000|Overall Study|Lack of Efficacy|2|||
28127545|NCT04345367|54789678|FG001|Overall Study|Lack of Efficacy|0|||
28127546|NCT04345367|54789677|FG000|Overall Study|Death|2|||
28127547|NCT04345367|54789678|FG001|Overall Study|Death|0|||
28127548|NCT04345367|54789677|FG000|Overall Study|Adverse Event|10|||
28127549|NCT04345367|54789678|FG001|Overall Study|Adverse Event|9|||
28127550|NCT04404725|54789684|FG000|First Intervention|Withdrawal by Subject|0|||
28127551|NCT04404725|54789685|FG001|First Intervention|Withdrawal by Subject|2|||
28127552|NCT04404725|54789684|FG000|Second Intervention|Adverse Event|1|||
28127553|NCT04404725|54789685|FG001|Second Intervention|Adverse Event|1|||
28127554|NCT04404725|54789684|FG000|Second Intervention|Withdrawal by Subject|0|||
28127555|NCT04404725|54789685|FG001|Second Intervention|Withdrawal by Subject|1|||
28127556|NCT04343261|54789691|FG000|Overall Study|Adverse Event|1|||
28127557|NCT04343261|54789691|FG000|Overall Study|received inadequate amount of antibodies|7|||
28127558|NCT04336475|54789697|FG000|Overall Study|pain|1|||
28127559|NCT04336475|54789698|FG001|Overall Study|pain|0|||
28127560|NCT04336475|54789697|FG000|Overall Study|upper respiratory infection|1|||
28127561|NCT04336475|54789698|FG001|Overall Study|upper respiratory infection|0|||
28127562|NCT04336475|54789697|FG000|Overall Study|Lost to Follow-up|0|||
28127563|NCT04336475|54789698|FG001|Overall Study|Lost to Follow-up|2|||
28127564|NCT04335929|54789704|FG000|Overall Study|Lost to Follow-up|10|||
28127565|NCT04333199|54789711|FG000|Evaluated Patients|Lost to Follow-up|0|||
28127566|NCT04333199|54789712|FG001|Evaluated Patients|Lost to Follow-up|1|||
28127567|NCT04333199|54789713|FG002|Evaluated Patients|Lost to Follow-up|2|||
28127568|NCT04332419|54789722|FG000|Overall Study|Withdrawal by Subject|1|||
28127569|NCT04330157|54789726|FG000|Overall Study|Protocol Violation|4|||
28127570|NCT04330157|54789726|FG000|Overall Study|Not extubated within 24 h postoperatively|3|||
28127571|NCT04329923|54789741|FG000|Overall Study|Withdrawal by Subject|1|||
28127572|NCT04329923|54789742|FG001|Overall Study|Withdrawal by Subject|4|||
28127573|NCT04329923|54789743|FG002|Overall Study|Withdrawal by Subject|1|||
28127574|NCT04329923|54789744|FG003|Overall Study|Withdrawal by Subject|1|||
28127575|NCT04329923|54789745|FG004|Overall Study|Withdrawal by Subject|1|||
28127576|NCT04329923|54789746|FG005|Overall Study|Withdrawal by Subject|1|||
28127577|NCT04329923|54789741|FG000|Overall Study|early termination of study|0|||
28127578|NCT04329923|54789742|FG001|Overall Study|early termination of study|0|||
28127579|NCT04329923|54789743|FG002|Overall Study|early termination of study|0|||
28127580|NCT04329923|54789744|FG003|Overall Study|early termination of study|0|||
27818384|NCT01609478|54277015|FG001|Overall Study|Physician Decision|0|||
28127581|NCT04329923|54789745|FG004|Overall Study|early termination of study|1|||
28127582|NCT04329923|54789746|FG005|Overall Study|early termination of study|2|||
27818385|NCT01609478|54277016|FG002|Overall Study|Physician Decision|1|||
27818386|NCT01609478|54277014|FG000|Overall Study|Withdrawal by Subject|2|||
28127583|NCT04329923|54789741|FG000|Overall Study|positive SARS-COV2 PCR at baseline|0|||
28127584|NCT04329923|54789742|FG001|Overall Study|positive SARS-COV2 PCR at baseline|0|||
28127585|NCT04329923|54789743|FG002|Overall Study|positive SARS-COV2 PCR at baseline|0|||
28127586|NCT04329923|54789744|FG003|Overall Study|positive SARS-COV2 PCR at baseline|0|||
28127587|NCT04329923|54789745|FG004|Overall Study|positive SARS-COV2 PCR at baseline|0|||
28127588|NCT04329923|54789746|FG005|Overall Study|positive SARS-COV2 PCR at baseline|2|||
28127589|NCT04403399|54789762|FG000|Period 2|Physician Decision|0|||
28127590|NCT04403399|54789763|FG001|Period 2|Physician Decision|1|||
28127591|NCT04401293|54789771|FG000|Overall Study|Withdrawal by Subject|1|||
28127592|NCT04401293|54789772|FG001|Overall Study|Withdrawal by Subject|3|||
28127593|NCT04319159|54789780|FG000|Overall Study|Screening failure|13|||
28127594|NCT04319159|54789780|FG000|Overall Study|Re-screening due to COVID-19 implications|2|||
28127595|NCT04319159|54789780|FG000|Overall Study|Withdrawal by Subject|1|||
28127596|NCT04318535|54789786|FG000|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
28127597|NCT04318535|54789787|FG001|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1|||
28127598|NCT04318535|54789788|FG002|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
28127599|NCT04454567|54789799|FG000|Overall Study|Study Terminated by Sponsor|1|||
28127600|NCT04454567|54789800|FG001|Overall Study|Study Terminated by Sponsor|1|||
28127601|NCT04449341|54789808|FG000|Overall Study|Protocol Violation|1|||
28127602|NCT04449341|54789809|FG001|Overall Study|Protocol Violation|0|||
28127603|NCT04448561|54789817|FG000|Overall Study|Noncompliance|1|||
28127604|NCT04448561|54789818|FG001|Overall Study|Noncompliance|0|||
28127605|NCT04308239|54789834|FG000|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2|||
28127606|NCT04308239|54789835|FG001|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1|||
28127607|NCT04308239|54789834|FG000|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1|||
28127608|NCT04308239|54789835|FG001|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2|||
28127609|NCT04308239|54789834|FG000|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1|||
28127610|NCT04308239|54789835|FG001|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2|||
28127611|NCT04308239|54789834|FG000|Post-intervention Evaluation (1 Week)|testing error during evaluation|0|||
28127612|NCT04308239|54789835|FG001|Post-intervention Evaluation (1 Week)|testing error during evaluation|2|||
28127613|NCT04302545|54789847|FG000|Overall Study|Lost to Follow-up|3|||
28127614|NCT04302545|54789848|FG001|Overall Study|Lost to Follow-up|4|||
28127615|NCT04297241|54789865|FG000|Overall Study|Withdrawal by Subject|1|||
28127616|NCT04297241|54789865|FG000|Overall Study|Adverse Event|1|||
28127617|NCT04297241|54789865|FG000|Overall Study|Physician Decision|3|||
28127618|NCT04292171|54789881|FG000|Overall Study|Pharmacy error|2|||
28127619|NCT04292171|54789882|FG001|Overall Study|Pharmacy error|0|||
27818387|NCT01609478|54277015|FG001|Overall Study|Withdrawal by Subject|0|||
27818388|NCT01609478|54277016|FG002|Overall Study|Withdrawal by Subject|2|||
27818389|NCT01764854|54277028|FG000|Overall Study|Adverse Event|0|||
27818390|NCT01764854|54277029|FG001|Overall Study|Adverse Event|0|||
27818391|NCT01764854|54277030|FG002|Overall Study|Adverse Event|2|||
27818392|NCT01764854|54277031|FG003|Overall Study|Adverse Event|0|||
27818393|NCT01764854|54277028|FG000|Overall Study|Withdrawal by Subject|0|||
27818394|NCT01764854|54277029|FG001|Overall Study|Withdrawal by Subject|0|||
27818395|NCT01764854|54277030|FG002|Overall Study|Withdrawal by Subject|1|||
27818396|NCT01764854|54277031|FG003|Overall Study|Withdrawal by Subject|0|||
27818397|NCT01764854|54277028|FG000|Overall Study|relocation|0|||
27818398|NCT01764854|54277029|FG001|Overall Study|relocation|0|||
27818399|NCT01764854|54277030|FG002|Overall Study|relocation|2|||
27818400|NCT01764854|54277031|FG003|Overall Study|relocation|0|||
28067598|NCT00296504|54722757|FG002|Final Analysis|Insufficient Viral Load Response|0|||
28067599|NCT00296504|54722758|FG003|Final Analysis|Insufficient Viral Load Response|0|||
28067600|NCT00296504|54722759|FG004|Final Analysis|Insufficient Viral Load Response|0|||
28067601|NCT00296504|54722760|FG005|Final Analysis|Insufficient Viral Load Response|0|||
28067602|NCT00296504|54722761|FG006|Final Analysis|Insufficient Viral Load Response|0|||
28067603|NCT00296504|54722762|FG007|Final Analysis|Insufficient Viral Load Response|0|||
28067604|NCT00296504|54722763|FG008|Final Analysis|Insufficient Viral Load Response|6|||
28067605|NCT00296504|54722755|FG000|Final Analysis|Adverse Event|0|||
28067606|NCT00296504|54722756|FG001|Final Analysis|Adverse Event|0|||
28067607|NCT00296504|54722757|FG002|Final Analysis|Adverse Event|0|||
28067608|NCT00296504|54722758|FG003|Final Analysis|Adverse Event|0|||
28067609|NCT00296504|54722759|FG004|Final Analysis|Adverse Event|0|||
28067610|NCT00296504|54722760|FG005|Final Analysis|Adverse Event|0|||
28067611|NCT00296504|54722761|FG006|Final Analysis|Adverse Event|0|||
28067612|NCT00296504|54722762|FG007|Final Analysis|Adverse Event|0|||
28127620|NCT04292171|54789881|FG000|Overall Study|Delivered prior to procedure|0|||
28067613|NCT00296504|54722763|FG008|Final Analysis|Adverse Event|2|||
28127621|NCT04292171|54789882|FG001|Overall Study|Delivered prior to procedure|1|||
28127622|NCT04393493|54789890|FG000|First 4 Days of Intervention|Early improvement|5|||
28127623|NCT04393493|54789891|FG001|First 4 Days of Intervention|Early improvement|7|||
28127624|NCT04280705|54789901|FG000|Overall Study|Enrolled but not treated|4|||
28127625|NCT04280705|54789902|FG001|Overall Study|Enrolled but not treated|10|||
28127626|NCT04280705|54789901|FG000|Overall Study|Physician Decision|1|||
28127627|NCT04280705|54789902|FG001|Overall Study|Physician Decision|0|||
28127628|NCT04280705|54789901|FG000|Overall Study|Withdrawal by Subject|7|||
28127629|NCT04280705|54789902|FG001|Overall Study|Withdrawal by Subject|9|||
28127630|NCT04280705|54789901|FG000|Overall Study|Adverse Event|0|||
28127631|NCT04280705|54789902|FG001|Overall Study|Adverse Event|4|||
28127632|NCT04280705|54789901|FG000|Overall Study|Transferred to another hospital|1|||
28127633|NCT04280705|54789902|FG001|Overall Study|Transferred to another hospital|1|||
28127634|NCT02077166|54789915|FG000|Overall Study|Death|6|||
28127635|NCT02077166|54789916|FG001|Overall Study|Death|7|||
28127636|NCT02077166|54789917|FG002|Overall Study|Death|5|||
28127637|NCT02077166|54789918|FG003|Overall Study|Death|6|||
28127638|NCT02077166|54789919|FG004|Overall Study|Death|4|||
28127639|NCT02077166|54789920|FG005|Overall Study|Death|32|||
28127640|NCT02077166|54789921|FG006|Overall Study|Death|22|||
28127641|NCT02077166|54789915|FG000|Overall Study|Study Closure by Sponsor|3|||
28127642|NCT02077166|54789916|FG001|Overall Study|Study Closure by Sponsor|0|||
28127643|NCT02077166|54789917|FG002|Overall Study|Study Closure by Sponsor|2|||
28127644|NCT02077166|54789918|FG003|Overall Study|Study Closure by Sponsor|2|||
28127645|NCT02077166|54789919|FG004|Overall Study|Study Closure by Sponsor|2|||
28127646|NCT02077166|54789920|FG005|Overall Study|Study Closure by Sponsor|12|||
28127647|NCT02077166|54789921|FG006|Overall Study|Study Closure by Sponsor|4|||
28127648|NCT02077166|54789915|FG000|Overall Study|Lost to Follow-up|0|||
28127649|NCT02077166|54789916|FG001|Overall Study|Lost to Follow-up|0|||
28127650|NCT02077166|54789917|FG002|Overall Study|Lost to Follow-up|0|||
28127651|NCT02077166|54789918|FG003|Overall Study|Lost to Follow-up|0|||
28127652|NCT02077166|54789919|FG004|Overall Study|Lost to Follow-up|0|||
28067614|NCT00296504|54722755|FG000|Final Analysis|Pregnancy|0|||
28067615|NCT00296504|54722756|FG001|Final Analysis|Pregnancy|0|||
28067616|NCT00296504|54722757|FG002|Final Analysis|Pregnancy|0|||
28067617|NCT00296504|54722758|FG003|Final Analysis|Pregnancy|0|||
28067618|NCT00296504|54722759|FG004|Final Analysis|Pregnancy|0|||
28067619|NCT00296504|54722760|FG005|Final Analysis|Pregnancy|0|||
28067620|NCT00296504|54722761|FG006|Final Analysis|Pregnancy|0|||
28067621|NCT00296504|54722762|FG007|Final Analysis|Pregnancy|0|||
28067622|NCT00296504|54722763|FG008|Final Analysis|Pregnancy|4|||
28067623|NCT00296504|54722755|FG000|Final Analysis|Tuberculosis|0|||
28067624|NCT00296504|54722756|FG001|Final Analysis|Tuberculosis|0|||
28067625|NCT00296504|54722757|FG002|Final Analysis|Tuberculosis|0|||
28067626|NCT00296504|54722758|FG003|Final Analysis|Tuberculosis|0|||
28067627|NCT00296504|54722759|FG004|Final Analysis|Tuberculosis|0|||
28067628|NCT00296504|54722760|FG005|Final Analysis|Tuberculosis|0|||
28067629|NCT00296504|54722761|FG006|Final Analysis|Tuberculosis|0|||
28067630|NCT00296504|54722762|FG007|Final Analysis|Tuberculosis|0|||
28067631|NCT00296504|54722763|FG008|Final Analysis|Tuberculosis|1|||
28067632|NCT00296504|54722755|FG000|Final Analysis|Participant Moved to Another Country|0|||
28067633|NCT00296504|54722756|FG001|Final Analysis|Participant Moved to Another Country|0|||
28067634|NCT00296504|54722757|FG002|Final Analysis|Participant Moved to Another Country|0|||
28067635|NCT00296504|54722758|FG003|Final Analysis|Participant Moved to Another Country|0|||
28067636|NCT00296504|54722759|FG004|Final Analysis|Participant Moved to Another Country|0|||
28067637|NCT00296504|54722760|FG005|Final Analysis|Participant Moved to Another Country|0|||
28067638|NCT00296504|54722761|FG006|Final Analysis|Participant Moved to Another Country|0|||
28067639|NCT00296504|54722762|FG007|Final Analysis|Participant Moved to Another Country|0|||
28067640|NCT00296504|54722763|FG008|Final Analysis|Participant Moved to Another Country|1|||
28067641|NCT00296504|54722755|FG000|Final Analysis|Poor Adherence|0|||
28067642|NCT00296504|54722756|FG001|Final Analysis|Poor Adherence|0|||
28067643|NCT00296504|54722757|FG002|Final Analysis|Poor Adherence|0|||
28067644|NCT00296504|54722758|FG003|Final Analysis|Poor Adherence|0|||
28067645|NCT00296504|54722759|FG004|Final Analysis|Poor Adherence|0|||
28067646|NCT00296504|54722760|FG005|Final Analysis|Poor Adherence|0|||
28067647|NCT00296504|54722761|FG006|Final Analysis|Poor Adherence|0|||
28127653|NCT02077166|54789920|FG005|Overall Study|Lost to Follow-up|1|||
28127654|NCT02077166|54789921|FG006|Overall Study|Lost to Follow-up|0|||
28127655|NCT02077166|54789915|FG000|Overall Study|Withdrawal by Subject|3|||
28067648|NCT00296504|54722762|FG007|Final Analysis|Poor Adherence|0|||
28127656|NCT02077166|54789916|FG001|Overall Study|Withdrawal by Subject|0|||
28127657|NCT02077166|54789917|FG002|Overall Study|Withdrawal by Subject|1|||
28127658|NCT02077166|54789918|FG003|Overall Study|Withdrawal by Subject|1|||
28127659|NCT02077166|54789919|FG004|Overall Study|Withdrawal by Subject|1|||
28127660|NCT02077166|54789920|FG005|Overall Study|Withdrawal by Subject|3|||
28127661|NCT02077166|54789921|FG006|Overall Study|Withdrawal by Subject|0|||
28127662|NCT02077166|54789915|FG000|Overall Study|Other, Not Specified|0|||
28127663|NCT02077166|54789916|FG001|Overall Study|Other, Not Specified|0|||
28127664|NCT02077166|54789917|FG002|Overall Study|Other, Not Specified|1|||
28127665|NCT02077166|54789918|FG003|Overall Study|Other, Not Specified|0|||
28127666|NCT02077166|54789919|FG004|Overall Study|Other, Not Specified|1|||
28127667|NCT02077166|54789920|FG005|Overall Study|Other, Not Specified|7|||
28127668|NCT02077166|54789921|FG006|Overall Study|Other, Not Specified|8|||
28127669|NCT04273217|54789948|FG000|Overall Study|Lost to Follow-up|0|||
28127670|NCT04273217|54789949|FG001|Overall Study|Lost to Follow-up|0|||
28127671|NCT04273217|54789950|FG002|Overall Study|Lost to Follow-up|0|||
28127672|NCT04273217|54789951|FG003|Overall Study|Lost to Follow-up|0|||
28127673|NCT04273217|54789952|FG004|Overall Study|Lost to Follow-up|0|||
28127674|NCT04273217|54789953|FG005|Overall Study|Lost to Follow-up|1|||
28127675|NCT04273217|54789948|FG000|Overall Study|Participant non-compliance|0|||
28127676|NCT04273217|54789949|FG001|Overall Study|Participant non-compliance|0|||
28127677|NCT04273217|54789950|FG002|Overall Study|Participant non-compliance|0|||
28127678|NCT04273217|54789951|FG003|Overall Study|Participant non-compliance|0|||
28127679|NCT04273217|54789952|FG004|Overall Study|Participant non-compliance|1|||
28127680|NCT04273217|54789953|FG005|Overall Study|Participant non-compliance|0|||
28127681|NCT04273217|54789948|FG000|Overall Study|Positive urine drug screen|1|||
28127682|NCT04273217|54789949|FG001|Overall Study|Positive urine drug screen|0|||
28127683|NCT04273217|54789950|FG002|Overall Study|Positive urine drug screen|1|||
28127684|NCT04273217|54789951|FG003|Overall Study|Positive urine drug screen|0|||
28127685|NCT04273217|54789952|FG004|Overall Study|Positive urine drug screen|0|||
28127686|NCT04273217|54789953|FG005|Overall Study|Positive urine drug screen|1|||
28127687|NCT04384523|54789973|FG000|Overall Study|Lost to Follow-up|0|||
28127688|NCT04384523|54789974|FG001|Overall Study|Lost to Follow-up|0|||
28127689|NCT04384523|54789975|FG002|Overall Study|Lost to Follow-up|0|||
28127690|NCT04384523|54789976|FG003|Overall Study|Lost to Follow-up|0|||
28127691|NCT04384523|54789977|FG004|Overall Study|Lost to Follow-up|0|||
28127692|NCT04384523|54789978|FG005|Overall Study|Lost to Follow-up|1|||
28127693|NCT04384523|54789973|FG000|Overall Study|Protocol Violation|0|||
28127694|NCT04384523|54789974|FG001|Overall Study|Protocol Violation|1|||
28127695|NCT04384523|54789975|FG002|Overall Study|Protocol Violation|0|||
28127696|NCT04384523|54789976|FG003|Overall Study|Protocol Violation|0|||
28127697|NCT04384523|54789977|FG004|Overall Study|Protocol Violation|0|||
28127698|NCT04384523|54789978|FG005|Overall Study|Protocol Violation|0|||
28127699|NCT04384523|54789973|FG000|Overall Study|Withdrawal by Subject|1|||
28127700|NCT04384523|54789974|FG001|Overall Study|Withdrawal by Subject|0|||
28127701|NCT04384523|54789975|FG002|Overall Study|Withdrawal by Subject|0|||
28127702|NCT04384523|54789976|FG003|Overall Study|Withdrawal by Subject|0|||
28127703|NCT04384523|54789977|FG004|Overall Study|Withdrawal by Subject|0|||
28127704|NCT04384523|54789978|FG005|Overall Study|Withdrawal by Subject|0|||
28127705|NCT04382651|54790013|FG000|Overall Study|Death|26|||
28127706|NCT04382651|54790014|FG001|Overall Study|Death|23|||
28127707|NCT04382651|54790013|FG000|Overall Study|Lost to Follow-up|3|||
28127708|NCT04382651|54790014|FG001|Overall Study|Lost to Follow-up|4|||
28127709|NCT04382651|54790013|FG000|Overall Study|Withdrawal by Subject|2|||
28127710|NCT04382651|54790014|FG001|Overall Study|Withdrawal by Subject|0|||
28127711|NCT04382651|54790013|FG000|Overall Study|Physician Decision|0|||
28127712|NCT04382651|54790014|FG001|Overall Study|Physician Decision|1|||
28127713|NCT04238663|54790029|FG000|Overall Study|Lost to Follow-up|0|||
28127714|NCT04238663|54790030|FG001|Overall Study|Lost to Follow-up|1|||
28127715|NCT04238663|54790031|FG002|Overall Study|Lost to Follow-up|0|||
28127716|NCT03442088|54790039|FG000|Overall Study|Adverse Event|1|||
28127717|NCT03442088|54790039|FG000|Overall Study|Lack of Efficacy|2|||
27818401|NCT01764854|54277028|FG000|Overall Study|Protocol Violation|0|||
27818402|NCT01764854|54277029|FG001|Overall Study|Protocol Violation|0|||
27818403|NCT01764854|54277030|FG002|Overall Study|Protocol Violation|1|||
27818404|NCT01764854|54277031|FG003|Overall Study|Protocol Violation|2|||
27818405|NCT01764464|54277043|FG000|First Intervention|Withdrawal by Subject|1|||
27818406|NCT01764464|54277044|FG001|First Intervention|Withdrawal by Subject|0|||
27818407|NCT01764464|54277043|FG000|First Intervention|Lost to Follow-up|1|||
27818408|NCT01764464|54277044|FG001|First Intervention|Lost to Follow-up|0|||
27818409|NCT01764464|54277043|FG000|First Intervention|Adverse Event|0|||
27818410|NCT01764464|54277044|FG001|First Intervention|Adverse Event|2|||
27818411|NCT01764464|54277043|FG000|First Intervention|did not receive study drug|0|||
27818412|NCT01764464|54277044|FG001|First Intervention|did not receive study drug|1|||
27818413|NCT01764464|54277043|FG000|Second Intervention (Cross-over)|Adverse Event|2|||
27818414|NCT01764464|54277044|FG001|Second Intervention (Cross-over)|Adverse Event|0|||
28127718|NCT03442088|54790039|FG000|Overall Study|Lost to Follow-up|2|||
28127719|NCT04223687|54790045|FG000|Overall Study|Missing primary outcome|1|||
28127720|NCT04223687|54790046|FG001|Overall Study|Missing primary outcome|0|||
27818415|NCT01764386|54277052|FG000|Controlled Treatment Period (CTP)|Adverse Event|35|||
27818416|NCT01764386|54277053|FG001|Controlled Treatment Period (CTP)|Adverse Event|0|||
28127721|NCT03722576|54790052|FG000|Overall Study|Withdrawal by Subject|3|||
28127722|NCT03722576|54790052|FG000|Overall Study|Adverse Event|2|||
28127723|NCT03722576|54790052|FG000|Overall Study|Physician Decision|1|||
28127724|NCT03722576|54790052|FG000|Overall Study|Lost to Follow-up|1|||
28127725|NCT03693989|54790058|FG000|Overall Study|Protocol Violation|3|||
28127726|NCT03693989|54790059|FG001|Overall Study|Protocol Violation|4|||
28127727|NCT04206293|54790065|FG000|Overall Study|Consent withdrawal|1|||
28127728|NCT02727998|54790072|FG000|Overall Study|Lost to Follow-up|3|||
27818417|NCT01764386|54277052|FG000|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32|||
28127729|NCT02727998|54790073|FG001|Overall Study|Lost to Follow-up|3|||
28127730|NCT02727998|54790072|FG000|Overall Study|Withdrawal by Subject|0|||
28127731|NCT02727998|54790073|FG001|Overall Study|Withdrawal by Subject|1|||
28127732|NCT04366349|54790085|FG000|Overall Study|Withdrawal by Subject|1|||
28127733|NCT04366349|54790086|FG001|Overall Study|Withdrawal by Subject|0|||
28127734|NCT04366349|54790087|FG002|Overall Study|Withdrawal by Subject|0|||
28127735|NCT04366349|54790088|FG003|Overall Study|Withdrawal by Subject|0|||
28067649|NCT00296504|54722763|FG008|Final Analysis|Poor Adherence|1|||
28127736|NCT04366349|54790089|FG004|Overall Study|Withdrawal by Subject|0|||
28127737|NCT04366349|54790090|FG005|Overall Study|Withdrawal by Subject|0|||
27818418|NCT01764386|54277053|FG001|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0|||
27818419|NCT01764386|54277052|FG000|Controlled Treatment Period (CTP)|Lost to Follow-up|9|||
27818420|NCT01764386|54277053|FG001|Controlled Treatment Period (CTP)|Lost to Follow-up|5|||
28127738|NCT04179461|54790108|FG000|Overall Study|Lost to Follow-up|4|||
27818421|NCT01764386|54277052|FG000|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6|||
27818422|NCT01764386|54277053|FG001|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2|||
27818423|NCT01764386|54277052|FG000|Uncontrolled Treatment Period (UTP)|Adverse Event|2|||
27818424|NCT01764386|54277053|FG001|Uncontrolled Treatment Period (UTP)|Adverse Event|13|||
27818425|NCT01764386|54277052|FG000|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0|||
27818426|NCT01764386|54277053|FG001|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26|||
27818427|NCT01764386|54277052|FG000|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
27818428|NCT01764386|54277053|FG001|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
27818429|NCT01764386|54277052|FG000|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
27818430|NCT01764386|54277053|FG001|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
27818431|NCT01763918|54277064|FG000|Overall Study|Withdrawal by Subject|2|||
27818432|NCT01763918|54277065|FG001|Overall Study|Withdrawal by Subject|1|||
27818433|NCT01763918|54277066|FG002|Overall Study|Withdrawal by Subject|1|||
27818434|NCT01763918|54277067|FG003|Overall Study|Withdrawal by Subject|2|||
27818435|NCT01763918|54277064|FG000|Overall Study|Sponsor Decision|4|||
27818436|NCT01763918|54277065|FG001|Overall Study|Sponsor Decision|0|||
27818437|NCT01763918|54277066|FG002|Overall Study|Sponsor Decision|9|||
27818438|NCT01763918|54277067|FG003|Overall Study|Sponsor Decision|0|||
28127739|NCT04017611|54790112|FG000|Overall Study|Withdrawn prior to completion|1|||
28127740|NCT04172831|54790127|FG000|Overall Study|Adverse Event|21|||
28127741|NCT04172831|54790128|FG001|Overall Study|Adverse Event|9|||
28127742|NCT04172831|54790127|FG000|Overall Study|Lack of Efficacy|2|||
28127743|NCT04172831|54790128|FG001|Overall Study|Lack of Efficacy|8|||
28127744|NCT04172831|54790127|FG000|Overall Study|Physician Decision|0|||
28127745|NCT04172831|54790128|FG001|Overall Study|Physician Decision|1|||
28127746|NCT04172831|54790127|FG000|Overall Study|Withdrawal by Subject|12|||
28127747|NCT04172831|54790128|FG001|Overall Study|Withdrawal by Subject|11|||
28127748|NCT04172831|54790127|FG000|Overall Study|Lost to Follow-up|4|||
28127749|NCT04172831|54790128|FG001|Overall Study|Lost to Follow-up|9|||
28127750|NCT04172831|54790127|FG000|Overall Study|COVID-19 related crisis|3|||
28127751|NCT04172831|54790128|FG001|Overall Study|COVID-19 related crisis|3|||
27818439|NCT01763684|54277079|FG000|Overall Study|Study terminated early due to low enrollment|126|||
27818440|NCT01763684|54277080|FG001|Overall Study|Study terminated early due to low enrollment|127|||
28067650|NCT00313820|54722790|FG000|Assigned to Treatment|Other|1|||
28067651|NCT00313820|54722791|FG001|Assigned to Treatment|Other|0|||
28067652|NCT00313820|54722790|FG000|Pregabalin or Placebo Treatment Period|Adverse Event|9|||
28067653|NCT00313820|54722791|FG001|Pregabalin or Placebo Treatment Period|Adverse Event|4|||
28067654|NCT00313820|54722790|FG000|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0|||
28067655|NCT00313820|54722791|FG001|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1|||
28067656|NCT00313820|54722790|FG000|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0|||
28067657|NCT00313820|54722791|FG001|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7|||
28067658|NCT00313820|54722790|FG000|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6|||
28067659|NCT00313820|54722791|FG001|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4|||
28067660|NCT00313820|54722790|FG000|Pregabalin or Placebo Treatment Period|Other|2|||
28067661|NCT00313820|54722791|FG001|Pregabalin or Placebo Treatment Period|Other|3|||
28067662|NCT00462761|54722797|FG000|Overall Study|Adverse Event|6|||
28067663|NCT00462761|54722797|FG000|Overall Study|Withdrawal by Subject|9|||
28067664|NCT00462761|54722797|FG000|Overall Study|Physician Decision|5|||
28067665|NCT00462761|54722797|FG000|Overall Study|Disease progression|43|||
28067666|NCT00462761|54722797|FG000|Overall Study|Death|12|||
28067667|NCT00462761|54722797|FG000|Overall Study|Other|1|||
28067668|NCT00235872|54722829|FG000|Overall Study|Adverse Event|34|||
28127752|NCT04172831|54790127|FG000|Overall Study|Subject non-compliance|1|||
27818441|NCT01763684|54277079|FG000|Overall Study|Study surgery not performed|7|||
27818442|NCT01763684|54277080|FG001|Overall Study|Study surgery not performed|6|||
28127753|NCT04172831|54790128|FG001|Overall Study|Subject non-compliance|1|||
28127754|NCT04172831|54790127|FG000|Overall Study|Family emergency|1|||
28127755|NCT04172831|54790128|FG001|Overall Study|Family emergency|0|||
28127756|NCT04165031|54790145|FG000|Overall Study|Adverse Event|1|||
28127757|NCT04165031|54790146|FG001|Overall Study|Adverse Event|1|||
28127758|NCT04165031|54790147|FG002|Overall Study|Adverse Event|0|||
28127759|NCT04165031|54790148|FG003|Overall Study|Adverse Event|0|||
28127760|NCT04165031|54790149|FG004|Overall Study|Adverse Event|0|||
28127761|NCT04165031|54790150|FG005|Overall Study|Adverse Event|0|||
28127762|NCT04165031|54790145|FG000|Overall Study|Withdrawal by Subject|0|||
28127763|NCT04165031|54790146|FG001|Overall Study|Withdrawal by Subject|0|||
28127764|NCT04165031|54790147|FG002|Overall Study|Withdrawal by Subject|1|||
28127765|NCT04165031|54790148|FG003|Overall Study|Withdrawal by Subject|0|||
28127766|NCT04165031|54790149|FG004|Overall Study|Withdrawal by Subject|0|||
28127767|NCT04165031|54790150|FG005|Overall Study|Withdrawal by Subject|0|||
28127768|NCT02712424|54790167|FG000|Overall Study|Lost to Follow-up|34|||
28127769|NCT02712424|54790168|FG001|Overall Study|Lost to Follow-up|32|||
28127770|NCT02968004|54790176|FG000|Overall Study|Adverse Event|1|||
28127771|NCT02968004|54790177|FG001|Overall Study|Adverse Event|0|||
28127772|NCT02968004|54790176|FG000|Overall Study|Withdrawal by Subject|0|||
28127773|NCT02968004|54790177|FG001|Overall Study|Withdrawal by Subject|1|||
28127774|NCT03034772|54790185|FG000|Overall Study|Adverse Event|0|||
28127775|NCT03034772|54790186|FG001|Overall Study|Adverse Event|1|||
28127776|NCT03034772|54790185|FG000|Overall Study|Withdrawal by Subject|0|||
28127777|NCT03034772|54790186|FG001|Overall Study|Withdrawal by Subject|1|||
28127778|NCT03032198|54790192|FG000|Overall Study|Screen Fail|1|||
28127779|NCT02431364|54790201|FG000|Overall Study|Adverse Event|0|||
28127780|NCT02431364|54790202|FG001|Overall Study|Adverse Event|1|||
28127781|NCT02431364|54790203|FG002|Overall Study|Adverse Event|0|||
28127782|NCT02431364|54790204|FG003|Overall Study|Adverse Event|0|||
27818443|NCT01606748|54277088|FG000|Overall Study|Adverse Event|1|||
27818444|NCT01606748|54277089|FG001|Overall Study|Adverse Event|0|||
27818445|NCT01606748|54277088|FG000|Overall Study|Progressive Disease|1|||
27818446|NCT01606748|54277089|FG001|Overall Study|Progressive Disease|0|||
27818447|NCT01606748|54277088|FG000|Overall Study|Withdrawal by Subject|1|||
27818448|NCT01606748|54277089|FG001|Overall Study|Withdrawal by Subject|0|||
27818449|NCT01597622|54277107|FG000|Overall Study|Adverse Event|7|||
28127783|NCT02431364|54790205|FG004|Overall Study|Adverse Event|0|||
28127784|NCT02431364|54790201|FG000|Overall Study|Randomized but never treated|0|||
28127785|NCT02431364|54790202|FG001|Overall Study|Randomized but never treated|0|||
28127786|NCT02431364|54790203|FG002|Overall Study|Randomized but never treated|0|||
28127787|NCT02431364|54790204|FG003|Overall Study|Randomized but never treated|1|||
28127788|NCT02431364|54790205|FG004|Overall Study|Randomized but never treated|0|||
28127789|NCT03034460|54790223|FG000|Overall Study|Adverse Event|0|||
28127790|NCT03034460|54790224|FG001|Overall Study|Adverse Event|1|||
28067669|NCT00235872|54722829|FG000|Overall Study|Death|1|||
28067670|NCT00235872|54722829|FG000|Overall Study|Lost to Follow-up|1|||
28067671|NCT00235872|54722829|FG000|Overall Study|Withdrawal by Subject|50|||
28067672|NCT00235872|54722829|FG000|Overall Study|Administrative reason|61|||
28067673|NCT00461981|54722835|FG000|Overall Study|Lost to Follow-up|9|||
28067674|NCT00461981|54722836|FG001|Overall Study|Lost to Follow-up|6|||
28067675|NCT00461981|54722835|FG000|Overall Study|Withdrawal by Subject|2|||
28067676|NCT00461981|54722836|FG001|Overall Study|Withdrawal by Subject|3|||
28067677|NCT00296036|54722844|FG000|Overall Study|Withdrawal by Subject|1|||
28067678|NCT00296036|54722845|FG001|Overall Study|Withdrawal by Subject|0|||
28067679|NCT00296036|54722846|FG002|Overall Study|Withdrawal by Subject|2|||
28067680|NCT00296036|54722847|FG003|Overall Study|Withdrawal by Subject|1|||
28127791|NCT03034460|54790223|FG000|Overall Study|Withdrawal by Subject|2|||
28127792|NCT03034460|54790224|FG001|Overall Study|Withdrawal by Subject|2|||
28127793|NCT03034460|54790223|FG000|Overall Study|Personal Reasons|1|||
28127794|NCT03034460|54790224|FG001|Overall Study|Personal Reasons|0|||
28127795|NCT04162769|54790237|FG000|Double-blind Treatment (12-Week)|Adverse Event|2|||
28127796|NCT04162769|54790238|FG001|Double-blind Treatment (12-Week)|Adverse Event|5|||
27818450|NCT01597622|54277107|FG000|Overall Study|Lack of Efficacy|3|||
27818451|NCT01597622|54277107|FG000|Overall Study|Protocol Violation|1|||
28067681|NCT00296036|54722848|FG004|Overall Study|Withdrawal by Subject|2|||
27818452|NCT01597622|54277107|FG000|Overall Study|Lost to Follow-up|1|||
28127797|NCT04162769|54790239|FG002|Double-blind Treatment (12-Week)|Adverse Event|0|||
28127798|NCT04162769|54790240|FG003|Double-blind Treatment (12-Week)|Adverse Event|0|||
28127799|NCT04162769|54790237|FG000|Double-blind Treatment (12-Week)|Withdrawal by Subject|4|||
27818453|NCT01597622|54277107|FG000|Overall Study|Investigator Discretion|5|||
27818454|NCT01597622|54277107|FG000|Overall Study|Withdrawal by Subject|20|||
27818455|NCT01597622|54277107|FG000|Overall Study|Death|1|||
27818456|NCT01761266|54277113|FG000|Overall Study|Death|415|||
27818457|NCT01761266|54277114|FG001|Overall Study|Death|402|||
27818458|NCT01761266|54277113|FG000|Overall Study|Lost to Follow-up|8|||
27818459|NCT01761266|54277114|FG001|Overall Study|Lost to Follow-up|12|||
27818460|NCT01761266|54277113|FG000|Overall Study|Withdrawal by Subject|14|||
27818461|NCT01761266|54277114|FG001|Overall Study|Withdrawal by Subject|10|||
27818462|NCT01761266|54277113|FG000|Overall Study|Sponsor Decision|41|||
27818463|NCT01761266|54277114|FG001|Overall Study|Sponsor Decision|52|||
27818464|NCT01760954|54277127|FG000|Treatment Period (6 Months)|Withdrawal by Subject|8|||
27818465|NCT01760954|54277128|FG001|Treatment Period (6 Months)|Withdrawal by Subject|8|||
27818466|NCT01760954|54277129|FG002|Treatment Period (6 Months)|Withdrawal by Subject|4|||
27818467|NCT01760954|54277130|FG003|Treatment Period (6 Months)|Withdrawal by Subject|5|||
27818468|NCT01760954|54277127|FG000|Treatment Period (6 Months)|Adverse Event|5|||
27818469|NCT01760954|54277128|FG001|Treatment Period (6 Months)|Adverse Event|3|||
27818470|NCT01760954|54277129|FG002|Treatment Period (6 Months)|Adverse Event|4|||
27818471|NCT01760954|54277130|FG003|Treatment Period (6 Months)|Adverse Event|10|||
27818472|NCT01760954|54277127|FG000|Treatment Period (6 Months)|Lost to Follow-up|9|||
27818473|NCT01760954|54277128|FG001|Treatment Period (6 Months)|Lost to Follow-up|1|||
27818474|NCT01760954|54277129|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
27818475|NCT01760954|54277130|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
27818476|NCT01760954|54277127|FG000|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
27818477|NCT01760954|54277128|FG001|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
27818478|NCT01760954|54277129|FG002|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
27818479|NCT01760954|54277130|FG003|Treatment Period (6 Months)|Surgery or invasive intervention for end|2|||
27818480|NCT01760954|54277127|FG000|Treatment Period (6 Months)|Pregnancy|5|||
27818481|NCT01760954|54277128|FG001|Treatment Period (6 Months)|Pregnancy|0|||
27818482|NCT01760954|54277129|FG002|Treatment Period (6 Months)|Pregnancy|3|||
27818483|NCT01760954|54277130|FG003|Treatment Period (6 Months)|Pregnancy|2|||
27818484|NCT01760954|54277127|FG000|Treatment Period (6 Months)|Non-compliance|1|||
27818485|NCT01760954|54277128|FG001|Treatment Period (6 Months)|Non-compliance|4|||
27818486|NCT01760954|54277129|FG002|Treatment Period (6 Months)|Non-compliance|0|||
27818487|NCT01760954|54277130|FG003|Treatment Period (6 Months)|Non-compliance|3|||
27818488|NCT01760954|54277127|FG000|Treatment Period (6 Months)|Other|0|||
27818489|NCT01760954|54277128|FG001|Treatment Period (6 Months)|Other|3|||
27818490|NCT01760954|54277129|FG002|Treatment Period (6 Months)|Other|3|||
27818491|NCT01760954|54277130|FG003|Treatment Period (6 Months)|Other|1|||
27818492|NCT01760954|54277127|FG000|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1|||
28127800|NCT04162769|54790238|FG001|Double-blind Treatment (12-Week)|Withdrawal by Subject|3|||
28127801|NCT04162769|54790239|FG002|Double-blind Treatment (12-Week)|Withdrawal by Subject|2|||
28127802|NCT04162769|54790240|FG003|Double-blind Treatment (12-Week)|Withdrawal by Subject|0|||
28127803|NCT04162769|54790237|FG000|Double-blind Treatment (12-Week)|Physician Decision|1|||
28127804|NCT04162769|54790238|FG001|Double-blind Treatment (12-Week)|Physician Decision|0|||
28127805|NCT04162769|54790239|FG002|Double-blind Treatment (12-Week)|Physician Decision|0|||
28127806|NCT04162769|54790240|FG003|Double-blind Treatment (12-Week)|Physician Decision|0|||
28127807|NCT04162769|54790237|FG000|Double-blind Treatment (12-Week)|Lost to Follow-up|5|||
28127808|NCT04162769|54790238|FG001|Double-blind Treatment (12-Week)|Lost to Follow-up|1|||
28127809|NCT04162769|54790239|FG002|Double-blind Treatment (12-Week)|Lost to Follow-up|6|||
28127810|NCT04162769|54790240|FG003|Double-blind Treatment (12-Week)|Lost to Follow-up|0|||
28127811|NCT04162769|54790237|FG000|Double-blind Treatment (12-Week)|Protocol deviation|1|||
28127812|NCT04162769|54790238|FG001|Double-blind Treatment (12-Week)|Protocol deviation|1|||
28127813|NCT04162769|54790239|FG002|Double-blind Treatment (12-Week)|Protocol deviation|0|||
28127814|NCT04162769|54790240|FG003|Double-blind Treatment (12-Week)|Protocol deviation|0|||
28127815|NCT04162769|54790237|FG000|Double-blind Treatment (12-Week)|Other|0|||
28127816|NCT04162769|54790238|FG001|Double-blind Treatment (12-Week)|Other|1|||
28127817|NCT04162769|54790239|FG002|Double-blind Treatment (12-Week)|Other|1|||
28127818|NCT04162769|54790240|FG003|Double-blind Treatment (12-Week)|Other|0|||
27818493|NCT01760954|54277128|FG001|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6|||
27818494|NCT01760954|54277129|FG002|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
27818495|NCT01760954|54277130|FG003|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
27818496|NCT01760954|54277127|FG000|Treatment Period (6 Months)|Exclusionary Medication|1|||
27818497|NCT01760954|54277128|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
27818498|NCT01760954|54277129|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
27818499|NCT01760954|54277130|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
28127819|NCT04162769|54790237|FG000|OLE Period (52-Week)|Adverse Event|0|||
28127820|NCT04162769|54790238|FG001|OLE Period (52-Week)|Adverse Event|0|||
28127821|NCT04162769|54790239|FG002|OLE Period (52-Week)|Adverse Event|0|||
28127822|NCT04162769|54790240|FG003|OLE Period (52-Week)|Adverse Event|5|||
28127823|NCT04162769|54790237|FG000|OLE Period (52-Week)|Withdrawal by Subject|0|||
28127824|NCT04162769|54790238|FG001|OLE Period (52-Week)|Withdrawal by Subject|0|||
28127825|NCT04162769|54790239|FG002|OLE Period (52-Week)|Withdrawal by Subject|0|||
28127826|NCT04162769|54790240|FG003|OLE Period (52-Week)|Withdrawal by Subject|10|||
28127827|NCT04162769|54790237|FG000|OLE Period (52-Week)|Physician Decision|0|||
28127828|NCT04162769|54790238|FG001|OLE Period (52-Week)|Physician Decision|0|||
28127829|NCT04162769|54790239|FG002|OLE Period (52-Week)|Physician Decision|0|||
28127830|NCT04162769|54790240|FG003|OLE Period (52-Week)|Physician Decision|1|||
28127831|NCT04162769|54790237|FG000|OLE Period (52-Week)|Lost to Follow-up|0|||
28127832|NCT04162769|54790238|FG001|OLE Period (52-Week)|Lost to Follow-up|0|||
28127833|NCT04162769|54790239|FG002|OLE Period (52-Week)|Lost to Follow-up|0|||
28127834|NCT04162769|54790240|FG003|OLE Period (52-Week)|Lost to Follow-up|9|||
28127835|NCT04162769|54790237|FG000|OLE Period (52-Week)|Protocol deviation|0|||
28127836|NCT04162769|54790238|FG001|OLE Period (52-Week)|Protocol deviation|0|||
28127837|NCT04162769|54790239|FG002|OLE Period (52-Week)|Protocol deviation|0|||
28127838|NCT04162769|54790240|FG003|OLE Period (52-Week)|Protocol deviation|2|||
28127839|NCT04161131|54790251|FG000|Overall Study|Ineligible|2|||
28127840|NCT04161131|54790251|FG000|Overall Study|Lost to Follow-up|4|||
28127841|NCT04155047|54790257|FG000|Overall Study|Adverse Event|1|||
27849423|NCT02075255|54345646|FG001|Overall Study|Withdrawal by Subject|1|||
27849424|NCT02075255|54345647|FG002|Overall Study|Withdrawal by Subject|0|||
28127842|NCT04155047|54790258|FG001|Overall Study|Adverse Event|0|||
28127843|NCT04155047|54790257|FG000|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|1|||
28127844|NCT04155047|54790258|FG001|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|0|||
28127845|NCT04152083|54790266|FG000|Overall Study|Lost to Follow-up|2|||
28127846|NCT04152083|54790267|FG001|Overall Study|Lost to Follow-up|1|||
28127847|NCT04152083|54790266|FG000|Overall Study|Adverse Event|1|||
28127848|NCT04152083|54790267|FG001|Overall Study|Adverse Event|0|||
28127849|NCT04152083|54790266|FG000|Overall Study|Randomized but not treated|3|||
28127850|NCT04152083|54790267|FG001|Overall Study|Randomized but not treated|2|||
28127851|NCT02711956|54790288|FG000|Overall Study|Adverse Event|0|||
28127852|NCT02711956|54790289|FG001|Overall Study|Adverse Event|0|||
28127853|NCT02711956|54790290|FG002|Overall Study|Adverse Event|0|||
28127854|NCT02711956|54790291|FG003|Overall Study|Adverse Event|1|||
28127855|NCT02711956|54790292|FG004|Overall Study|Adverse Event|2|||
28127856|NCT02711956|54790293|FG005|Overall Study|Adverse Event|0|||
28127857|NCT02711956|54790294|FG006|Overall Study|Adverse Event|0|||
28127858|NCT02711956|54790295|FG007|Overall Study|Adverse Event|1|||
28127859|NCT02711956|54790296|FG008|Overall Study|Adverse Event|1|||
28127860|NCT02711956|54790297|FG009|Overall Study|Adverse Event|1|||
28127861|NCT02711956|54790298|FG010|Overall Study|Adverse Event|1|||
28127862|NCT02711956|54790299|FG011|Overall Study|Adverse Event|0|||
28127863|NCT02711956|54790300|FG012|Overall Study|Adverse Event|0|||
28127864|NCT02711956|54790301|FG013|Overall Study|Adverse Event|0|||
28127865|NCT02711956|54790302|FG014|Overall Study|Adverse Event|2|||
28127866|NCT02711956|54790288|FG000|Overall Study|Physician Decision|0|||
27849425|NCT02075255|54345645|FG000|Overall Study|Lost to Follow-up|0|||
28127867|NCT02711956|54790289|FG001|Overall Study|Physician Decision|0|||
28127868|NCT02711956|54790290|FG002|Overall Study|Physician Decision|0|||
28127869|NCT02711956|54790291|FG003|Overall Study|Physician Decision|2|||
28127870|NCT02711956|54790292|FG004|Overall Study|Physician Decision|0|||
28127871|NCT02711956|54790293|FG005|Overall Study|Physician Decision|0|||
28127872|NCT02711956|54790294|FG006|Overall Study|Physician Decision|0|||
28127873|NCT02711956|54790295|FG007|Overall Study|Physician Decision|0|||
28127874|NCT02711956|54790296|FG008|Overall Study|Physician Decision|0|||
28127875|NCT02711956|54790297|FG009|Overall Study|Physician Decision|0|||
28127876|NCT02711956|54790298|FG010|Overall Study|Physician Decision|0|||
28127877|NCT02711956|54790299|FG011|Overall Study|Physician Decision|0|||
28127878|NCT02711956|54790300|FG012|Overall Study|Physician Decision|0|||
28127879|NCT02711956|54790301|FG013|Overall Study|Physician Decision|0|||
28127880|NCT02711956|54790302|FG014|Overall Study|Physician Decision|0|||
28127881|NCT02711956|54790288|FG000|Overall Study|Withdrawal by Subject|0|||
28127882|NCT02711956|54790289|FG001|Overall Study|Withdrawal by Subject|0|||
28127883|NCT02711956|54790290|FG002|Overall Study|Withdrawal by Subject|0|||
28127884|NCT02711956|54790291|FG003|Overall Study|Withdrawal by Subject|0|||
28127885|NCT02711956|54790292|FG004|Overall Study|Withdrawal by Subject|0|||
28127886|NCT02711956|54790293|FG005|Overall Study|Withdrawal by Subject|0|||
28127887|NCT02711956|54790294|FG006|Overall Study|Withdrawal by Subject|1|||
28127888|NCT02711956|54790295|FG007|Overall Study|Withdrawal by Subject|0|||
28127889|NCT02711956|54790296|FG008|Overall Study|Withdrawal by Subject|0|||
28127890|NCT02711956|54790297|FG009|Overall Study|Withdrawal by Subject|0|||
28127891|NCT02711956|54790298|FG010|Overall Study|Withdrawal by Subject|0|||
28127892|NCT02711956|54790299|FG011|Overall Study|Withdrawal by Subject|1|||
28127893|NCT02711956|54790300|FG012|Overall Study|Withdrawal by Subject|6|||
28127894|NCT02711956|54790301|FG013|Overall Study|Withdrawal by Subject|0|||
28127895|NCT02711956|54790302|FG014|Overall Study|Withdrawal by Subject|1|||
28127896|NCT02711956|54790288|FG000|Overall Study|Clinical progression|1|||
28127897|NCT02711956|54790289|FG001|Overall Study|Clinical progression|0|||
28127898|NCT02711956|54790290|FG002|Overall Study|Clinical progression|0|||
28127899|NCT02711956|54790291|FG003|Overall Study|Clinical progression|0|||
28127900|NCT02711956|54790292|FG004|Overall Study|Clinical progression|0|||
28127901|NCT02711956|54790293|FG005|Overall Study|Clinical progression|0|||
28127902|NCT02711956|54790294|FG006|Overall Study|Clinical progression|1|||
28127903|NCT02711956|54790295|FG007|Overall Study|Clinical progression|0|||
28127904|NCT02711956|54790296|FG008|Overall Study|Clinical progression|1|||
28127905|NCT02711956|54790297|FG009|Overall Study|Clinical progression|0|||
28127906|NCT02711956|54790298|FG010|Overall Study|Clinical progression|0|||
28127907|NCT02711956|54790299|FG011|Overall Study|Clinical progression|2|||
28127908|NCT02711956|54790300|FG012|Overall Study|Clinical progression|4|||
28067682|NCT00296036|54722849|FG005|Overall Study|Withdrawal by Subject|1|||
28067683|NCT00296036|54722844|FG000|Overall Study|Protocol Violation|0|||
28067684|NCT00296036|54722845|FG001|Overall Study|Protocol Violation|0|||
28067685|NCT00296036|54722846|FG002|Overall Study|Protocol Violation|0|||
28067686|NCT00296036|54722847|FG003|Overall Study|Protocol Violation|0|||
28067687|NCT00296036|54722848|FG004|Overall Study|Protocol Violation|0|||
28067688|NCT00296036|54722849|FG005|Overall Study|Protocol Violation|3|||
28067689|NCT00089674|54722868|FG000|Overall Study|Physician Decision|4|||
28067690|NCT00089674|54722869|FG001|Overall Study|Physician Decision|2|||
28067691|NCT00089674|54722868|FG000|Overall Study|Adverse Event|23|||
28067692|NCT00089674|54722869|FG001|Overall Study|Adverse Event|29|||
28067693|NCT00089674|54722868|FG000|Overall Study|Withdrawal by Subject|143|||
28067694|NCT00089674|54722869|FG001|Overall Study|Withdrawal by Subject|127|||
28067695|NCT00089674|54722868|FG000|Overall Study|Death|43|||
28067696|NCT00089674|54722869|FG001|Overall Study|Death|43|||
28067697|NCT00089674|54722868|FG000|Overall Study|Disease progression|21|||
28067698|NCT00089674|54722869|FG001|Overall Study|Disease progression|23|||
28067699|NCT00089674|54722868|FG000|Overall Study|Ineligibility determined|8|||
28067700|NCT00089674|54722869|FG001|Overall Study|Ineligibility determined|10|||
28067701|NCT00089674|54722868|FG000|Overall Study|Lost to Follow-up|21|||
28067702|NCT00089674|54722869|FG001|Overall Study|Lost to Follow-up|17|||
28127909|NCT02711956|54790301|FG013|Overall Study|Clinical progression|1|||
28127910|NCT02711956|54790302|FG014|Overall Study|Clinical progression|1|||
28127911|NCT02711956|54790288|FG000|Overall Study|Radiographic progression|1|||
28127912|NCT02711956|54790289|FG001|Overall Study|Radiographic progression|1|||
28127913|NCT02711956|54790290|FG002|Overall Study|Radiographic progression|2|||
28127914|NCT02711956|54790291|FG003|Overall Study|Radiographic progression|0|||
28127915|NCT02711956|54790292|FG004|Overall Study|Radiographic progression|1|||
28127916|NCT02711956|54790293|FG005|Overall Study|Radiographic progression|0|||
28127917|NCT02711956|54790294|FG006|Overall Study|Radiographic progression|0|||
28127918|NCT02711956|54790295|FG007|Overall Study|Radiographic progression|0|||
28127919|NCT02711956|54790296|FG008|Overall Study|Radiographic progression|2|||
28127920|NCT02711956|54790297|FG009|Overall Study|Radiographic progression|1|||
28127921|NCT02711956|54790298|FG010|Overall Study|Radiographic progression|0|||
28127922|NCT02711956|54790299|FG011|Overall Study|Radiographic progression|5|||
28127923|NCT02711956|54790300|FG012|Overall Study|Radiographic progression|3|||
28127924|NCT02711956|54790301|FG013|Overall Study|Radiographic progression|0|||
28127925|NCT02711956|54790302|FG014|Overall Study|Radiographic progression|1|||
28127926|NCT02711956|54790288|FG000|Overall Study|PSA progression with clinical progression|0|||
28127927|NCT02711956|54790289|FG001|Overall Study|PSA progression with clinical progression|0|||
28127928|NCT02711956|54790290|FG002|Overall Study|PSA progression with clinical progression|0|||
28127929|NCT02711956|54790291|FG003|Overall Study|PSA progression with clinical progression|0|||
28127930|NCT02711956|54790292|FG004|Overall Study|PSA progression with clinical progression|1|||
28127931|NCT02711956|54790293|FG005|Overall Study|PSA progression with clinical progression|0|||
28127932|NCT02711956|54790294|FG006|Overall Study|PSA progression with clinical progression|0|||
28127933|NCT02711956|54790295|FG007|Overall Study|PSA progression with clinical progression|0|||
28127934|NCT02711956|54790296|FG008|Overall Study|PSA progression with clinical progression|0|||
28127935|NCT02711956|54790297|FG009|Overall Study|PSA progression with clinical progression|0|||
28127936|NCT02711956|54790298|FG010|Overall Study|PSA progression with clinical progression|0|||
28127937|NCT02711956|54790299|FG011|Overall Study|PSA progression with clinical progression|0|||
28127938|NCT02711956|54790300|FG012|Overall Study|PSA progression with clinical progression|1|||
28127939|NCT02711956|54790301|FG013|Overall Study|PSA progression with clinical progression|1|||
28127940|NCT02711956|54790302|FG014|Overall Study|PSA progression with clinical progression|0|||
28127941|NCT02711956|54790288|FG000|Overall Study|PSA progression with radiographic progression|0|||
28127942|NCT02711956|54790289|FG001|Overall Study|PSA progression with radiographic progression|1|||
28127943|NCT02711956|54790290|FG002|Overall Study|PSA progression with radiographic progression|0|||
28127944|NCT02711956|54790291|FG003|Overall Study|PSA progression with radiographic progression|0|||
28127945|NCT02711956|54790292|FG004|Overall Study|PSA progression with radiographic progression|0|||
28127946|NCT02711956|54790293|FG005|Overall Study|PSA progression with radiographic progression|2|||
28127947|NCT02711956|54790294|FG006|Overall Study|PSA progression with radiographic progression|2|||
28127948|NCT02711956|54790295|FG007|Overall Study|PSA progression with radiographic progression|1|||
28127949|NCT02711956|54790296|FG008|Overall Study|PSA progression with radiographic progression|0|||
28127950|NCT02711956|54790297|FG009|Overall Study|PSA progression with radiographic progression|1|||
28127951|NCT02711956|54790298|FG010|Overall Study|PSA progression with radiographic progression|0|||
28127952|NCT02711956|54790299|FG011|Overall Study|PSA progression with radiographic progression|1|||
28127953|NCT02711956|54790300|FG012|Overall Study|PSA progression with radiographic progression|2|||
28127954|NCT02711956|54790301|FG013|Overall Study|PSA progression with radiographic progression|3|||
28127955|NCT02711956|54790302|FG014|Overall Study|PSA progression with radiographic progression|3|||
28127956|NCT04149353|54790343|FG000|Overall Study|Study terminated|1|||
28127957|NCT02711800|54790348|FG000|Overall Study|Lost to Follow-up|1|||
28127958|NCT02711800|54790348|FG000|Overall Study|Withdrawal by Subject|1|||
28127959|NCT03031496|54790352|FG000|Period 1|Adverse Event|2|||
28127960|NCT03031496|54790353|FG001|Period 1|Adverse Event|0|||
28127961|NCT03031496|54790352|FG000|Period 1|Withdrawal by Subject|0|||
28127962|NCT03031496|54790353|FG001|Period 1|Withdrawal by Subject|2|||
28127963|NCT02659020|54790366|FG000|Overall Study|Adverse Event|0|||
28127964|NCT02659020|54790367|FG001|Overall Study|Adverse Event|0|||
28127965|NCT02659020|54790368|FG002|Overall Study|Adverse Event|0|||
28127966|NCT02659020|54790369|FG003|Overall Study|Adverse Event|2|||
28127967|NCT02659020|54790370|FG004|Overall Study|Adverse Event|0|||
28127968|NCT02659020|54790371|FG005|Overall Study|Adverse Event|0|||
28127969|NCT02659020|54790372|FG006|Overall Study|Adverse Event|2|||
28127970|NCT02659020|54790366|FG000|Overall Study|Lost to Follow-up|1|||
28127971|NCT02659020|54790367|FG001|Overall Study|Lost to Follow-up|2|||
28127972|NCT02659020|54790368|FG002|Overall Study|Lost to Follow-up|1|||
28127973|NCT02659020|54790369|FG003|Overall Study|Lost to Follow-up|6|||
28127974|NCT02659020|54790370|FG004|Overall Study|Lost to Follow-up|1|||
28127975|NCT02659020|54790371|FG005|Overall Study|Lost to Follow-up|5|||
28127976|NCT02659020|54790372|FG006|Overall Study|Lost to Follow-up|0|||
28127977|NCT02659020|54790366|FG000|Overall Study|Physician Decision|0|||
28127978|NCT02659020|54790367|FG001|Overall Study|Physician Decision|0|||
28127979|NCT02659020|54790368|FG002|Overall Study|Physician Decision|0|||
28127980|NCT02659020|54790369|FG003|Overall Study|Physician Decision|1|||
28127981|NCT02659020|54790370|FG004|Overall Study|Physician Decision|1|||
28127982|NCT02659020|54790371|FG005|Overall Study|Physician Decision|0|||
28127983|NCT02659020|54790372|FG006|Overall Study|Physician Decision|1|||
28127984|NCT02659020|54790366|FG000|Overall Study|Withdrawal by Subject|2|||
28127985|NCT02659020|54790367|FG001|Overall Study|Withdrawal by Subject|1|||
28127986|NCT02659020|54790368|FG002|Overall Study|Withdrawal by Subject|0|||
28127987|NCT02659020|54790369|FG003|Overall Study|Withdrawal by Subject|3|||
28127988|NCT02659020|54790370|FG004|Overall Study|Withdrawal by Subject|3|||
28127989|NCT02659020|54790371|FG005|Overall Study|Withdrawal by Subject|6|||
28127990|NCT02659020|54790372|FG006|Overall Study|Withdrawal by Subject|3|||
27849426|NCT02075255|54345646|FG001|Overall Study|Lost to Follow-up|0|||
27849427|NCT02075255|54345647|FG002|Overall Study|Lost to Follow-up|1|||
27849428|NCT02075255|54345645|FG000|Overall Study|Adverse Event|0|||
27849429|NCT02075255|54345646|FG001|Overall Study|Adverse Event|0|||
27849430|NCT02075255|54345647|FG002|Overall Study|Adverse Event|1|||
27849431|NCT02075255|54345645|FG000|Overall Study|Death|0|||
27849432|NCT02075255|54345646|FG001|Overall Study|Death|2|||
27849433|NCT02075255|54345647|FG002|Overall Study|Death|0|||
27849434|NCT02400671|54345818|FG000|Overall Study|Death|5|||
27849435|NCT02400671|54345819|FG001|Overall Study|Death|3|||
27849436|NCT02400671|54345820|FG002|Overall Study|Death|4|||
27849437|NCT02400671|54345818|FG000|Overall Study|Lost to Follow-up|20|||
27849438|NCT02400671|54345819|FG001|Overall Study|Lost to Follow-up|27|||
28067703|NCT00089674|54722868|FG000|Overall Study|Noncompliance|7|||
28067704|NCT00089674|54722869|FG001|Overall Study|Noncompliance|3|||
28067705|NCT00089674|54722868|FG000|Overall Study|Other|5|||
28067706|NCT00089674|54722869|FG001|Overall Study|Other|9|||
28067707|NCT00089674|54722868|FG000|Overall Study|Requirement for alternative therapy|14|||
28067708|NCT00089674|54722869|FG001|Overall Study|Requirement for alternative therapy|4|||
28067709|NCT00313586|54722879|FG000|Overall Study|Disease progression|14|||
28067710|NCT00313586|54722880|FG001|Overall Study|Disease progression|19|||
28067711|NCT00313586|54722881|FG002|Overall Study|Disease progression|10|||
28067712|NCT00313586|54722882|FG003|Overall Study|Disease progression|3|||
28067713|NCT00313586|54722879|FG000|Overall Study|Adverse Event|12|||
28067714|NCT00313586|54722880|FG001|Overall Study|Adverse Event|18|||
28067715|NCT00313586|54722881|FG002|Overall Study|Adverse Event|3|||
28067716|NCT00313586|54722882|FG003|Overall Study|Adverse Event|10|||
28067717|NCT00313586|54722879|FG000|Overall Study|Death|11|||
28067718|NCT00313586|54722880|FG001|Overall Study|Death|8|||
28067719|NCT00313586|54722881|FG002|Overall Study|Death|1|||
28067720|NCT00313586|54722882|FG003|Overall Study|Death|7|||
28127991|NCT02659020|54790366|FG000|Overall Study|Progressive Disease|0|||
28127992|NCT02659020|54790367|FG001|Overall Study|Progressive Disease|0|||
28127993|NCT02659020|54790368|FG002|Overall Study|Progressive Disease|0|||
28067721|NCT00313586|54722879|FG000|Overall Study|Withdrawal by Subject|13|||
28067722|NCT00313586|54722880|FG001|Overall Study|Withdrawal by Subject|6|||
28127994|NCT02659020|54790369|FG003|Overall Study|Progressive Disease|4|||
28127995|NCT02659020|54790370|FG004|Overall Study|Progressive Disease|1|||
28127996|NCT02659020|54790371|FG005|Overall Study|Progressive Disease|0|||
28127997|NCT02659020|54790372|FG006|Overall Study|Progressive Disease|2|||
28127998|NCT03482011|54790397|FG000|Induction Period (16 Weeks)|Adverse Event|1|||
28127999|NCT03482011|54790398|FG001|Induction Period (16 Weeks)|Adverse Event|3|||
27818500|NCT01760954|54277127|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
27818501|NCT01760954|54277128|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
27818502|NCT01760954|54277129|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
27818503|NCT01760954|54277130|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9|||
27818504|NCT01760954|54277127|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4|||
27818505|NCT01760954|54277128|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7|||
27818506|NCT01760954|54277129|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2|||
27818507|NCT01760954|54277130|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0|||
27818508|NCT01760954|54277127|FG000|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6|||
27818509|NCT01760954|54277128|FG001|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10|||
27818510|NCT01760954|54277129|FG002|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
27818511|NCT01760954|54277130|FG003|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
27818512|NCT01760954|54277127|FG000|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1|||
27849439|NCT02400671|54345820|FG002|Overall Study|Lost to Follow-up|24|||
27849440|NCT02400671|54345818|FG000|Overall Study|Withdrawal by Subject|2|||
28067723|NCT00313586|54722881|FG002|Overall Study|Withdrawal by Subject|6|||
28128000|NCT03482011|54790399|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
28128001|NCT03482011|54790400|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
28128002|NCT03482011|54790401|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
28128003|NCT03482011|54790402|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
28128004|NCT03482011|54790403|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
28128005|NCT03482011|54790404|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
28128006|NCT03482011|54790397|FG000|Induction Period (16 Weeks)|Lack of Efficacy|3|||
28128007|NCT03482011|54790398|FG001|Induction Period (16 Weeks)|Lack of Efficacy|1|||
28128008|NCT03482011|54790399|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
28128009|NCT03482011|54790400|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
28128010|NCT03482011|54790401|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
28128011|NCT03482011|54790402|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
28128012|NCT03482011|54790403|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
28128013|NCT03482011|54790404|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
28128014|NCT03482011|54790397|FG000|Induction Period (16 Weeks)|Lost to Follow-up|0|||
28128015|NCT03482011|54790398|FG001|Induction Period (16 Weeks)|Lost to Follow-up|1|||
28128016|NCT03482011|54790399|FG002|Induction Period (16 Weeks)|Lost to Follow-up|0|||
28128017|NCT03482011|54790400|FG003|Induction Period (16 Weeks)|Lost to Follow-up|0|||
28128018|NCT03482011|54790401|FG004|Induction Period (16 Weeks)|Lost to Follow-up|0|||
28128019|NCT03482011|54790402|FG005|Induction Period (16 Weeks)|Lost to Follow-up|0|||
28128020|NCT03482011|54790403|FG006|Induction Period (16 Weeks)|Lost to Follow-up|0|||
28128021|NCT03482011|54790404|FG007|Induction Period (16 Weeks)|Lost to Follow-up|0|||
28128022|NCT03482011|54790397|FG000|Induction Period (16 Weeks)|Screen Failure|0|||
28128023|NCT03482011|54790398|FG001|Induction Period (16 Weeks)|Screen Failure|1|||
28128024|NCT03482011|54790399|FG002|Induction Period (16 Weeks)|Screen Failure|0|||
28128025|NCT03482011|54790400|FG003|Induction Period (16 Weeks)|Screen Failure|0|||
28128026|NCT03482011|54790401|FG004|Induction Period (16 Weeks)|Screen Failure|0|||
28128027|NCT03482011|54790402|FG005|Induction Period (16 Weeks)|Screen Failure|0|||
28128028|NCT03482011|54790403|FG006|Induction Period (16 Weeks)|Screen Failure|0|||
28128029|NCT03482011|54790404|FG007|Induction Period (16 Weeks)|Screen Failure|0|||
28128030|NCT03482011|54790397|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
28128031|NCT03482011|54790398|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|5|||
28128032|NCT03482011|54790399|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
28128033|NCT03482011|54790400|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
27818513|NCT01760954|54277128|FG001|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4|||
27940535|NCT01022853|54596831|FG001|Overall Study|Progressive disease|3|||
28128034|NCT03482011|54790401|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
28128035|NCT03482011|54790402|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
28128036|NCT03482011|54790403|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
28128037|NCT03482011|54790404|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
28128038|NCT03482011|54790397|FG000|Maintenance Period (36 Weeks)|Adverse Event|0|||
28128039|NCT03482011|54790398|FG001|Maintenance Period (36 Weeks)|Adverse Event|0|||
28128040|NCT03482011|54790399|FG002|Maintenance Period (36 Weeks)|Adverse Event|0|||
28128041|NCT03482011|54790400|FG003|Maintenance Period (36 Weeks)|Adverse Event|0|||
28128042|NCT03482011|54790401|FG004|Maintenance Period (36 Weeks)|Adverse Event|0|||
28128043|NCT03482011|54790402|FG005|Maintenance Period (36 Weeks)|Adverse Event|1|||
28128044|NCT03482011|54790403|FG006|Maintenance Period (36 Weeks)|Adverse Event|1|||
28128045|NCT03482011|54790404|FG007|Maintenance Period (36 Weeks)|Adverse Event|4|||
28128046|NCT03482011|54790397|FG000|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
28128047|NCT03482011|54790398|FG001|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
28128048|NCT03482011|54790399|FG002|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
28067724|NCT00313586|54722882|FG003|Overall Study|Withdrawal by Subject|2|||
28067725|NCT00313586|54722879|FG000|Overall Study|Alternative therapy|3|||
28067726|NCT00313586|54722880|FG001|Overall Study|Alternative therapy|6|||
28067727|NCT00313586|54722881|FG002|Overall Study|Alternative therapy|2|||
28067728|NCT00313586|54722882|FG003|Overall Study|Alternative therapy|0|||
28067729|NCT00313586|54722879|FG000|Overall Study|Other complicating disease|2|||
28067730|NCT00313586|54722880|FG001|Overall Study|Other complicating disease|2|||
28067731|NCT00313586|54722881|FG002|Overall Study|Other complicating disease|0|||
28067732|NCT00313586|54722882|FG003|Overall Study|Other complicating disease|0|||
28128049|NCT03482011|54790400|FG003|Maintenance Period (36 Weeks)|Lack of Efficacy|2|||
28128050|NCT03482011|54790401|FG004|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
28128051|NCT03482011|54790402|FG005|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
28128052|NCT03482011|54790403|FG006|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
28128053|NCT03482011|54790404|FG007|Maintenance Period (36 Weeks)|Lack of Efficacy|9|||
28128054|NCT03482011|54790397|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
28128055|NCT03482011|54790398|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
28128056|NCT03482011|54790399|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
28128057|NCT03482011|54790400|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
28128058|NCT03482011|54790401|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|2|||
28128059|NCT03482011|54790402|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
28128060|NCT03482011|54790403|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
28128061|NCT03482011|54790404|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
28128062|NCT03482011|54790397|FG000|Maintenance Period (36 Weeks)|Physician Decision|0|||
28128063|NCT03482011|54790398|FG001|Maintenance Period (36 Weeks)|Physician Decision|0|||
28128064|NCT03482011|54790399|FG002|Maintenance Period (36 Weeks)|Physician Decision|0|||
28128065|NCT03482011|54790400|FG003|Maintenance Period (36 Weeks)|Physician Decision|1|||
28128066|NCT03482011|54790401|FG004|Maintenance Period (36 Weeks)|Physician Decision|0|||
28128067|NCT03482011|54790402|FG005|Maintenance Period (36 Weeks)|Physician Decision|1|||
28128068|NCT03482011|54790403|FG006|Maintenance Period (36 Weeks)|Physician Decision|1|||
28128069|NCT03482011|54790404|FG007|Maintenance Period (36 Weeks)|Physician Decision|1|||
28128070|NCT03482011|54790397|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
28128071|NCT03482011|54790398|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
28128072|NCT03482011|54790399|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
28128073|NCT03482011|54790400|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
28128074|NCT03482011|54790401|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
28128075|NCT03482011|54790402|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
28128076|NCT03482011|54790403|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
28128077|NCT03482011|54790404|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
28128078|NCT03482011|54790397|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
28128079|NCT03482011|54790398|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
28128080|NCT03482011|54790399|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
28128081|NCT03482011|54790400|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|2|||
28128082|NCT03482011|54790401|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
28128083|NCT03482011|54790402|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
28128084|NCT03482011|54790403|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
28128085|NCT03482011|54790404|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|5|||
28128086|NCT03482011|54790397|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
27940536|NCT01022853|54596832|FG002|Overall Study|Progressive disease|11|||
28128087|NCT03482011|54790398|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
28128088|NCT03482011|54790399|FG002|Follow-up Period (12 Weeks)|Adverse Event|0|||
28128089|NCT03482011|54790400|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
28128090|NCT03482011|54790401|FG004|Follow-up Period (12 Weeks)|Adverse Event|0|||
28128091|NCT03482011|54790402|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
28128092|NCT03482011|54790403|FG006|Follow-up Period (12 Weeks)|Adverse Event|1|||
28128093|NCT03482011|54790404|FG007|Follow-up Period (12 Weeks)|Adverse Event|4|||
28128094|NCT03482011|54790397|FG000|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
28128095|NCT03482011|54790398|FG001|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
28128096|NCT03482011|54790399|FG002|Follow-up Period (12 Weeks)|Lack of Efficacy|1|||
28128097|NCT03482011|54790400|FG003|Follow-up Period (12 Weeks)|Lack of Efficacy|3|||
28128098|NCT03482011|54790401|FG004|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
28128099|NCT03482011|54790402|FG005|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
28128100|NCT03482011|54790403|FG006|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
28128101|NCT03482011|54790404|FG007|Follow-up Period (12 Weeks)|Lack of Efficacy|6|||
28128102|NCT03482011|54790397|FG000|Follow-up Period (12 Weeks)|Physician Decision|0|||
28128103|NCT03482011|54790398|FG001|Follow-up Period (12 Weeks)|Physician Decision|0|||
28128104|NCT03482011|54790399|FG002|Follow-up Period (12 Weeks)|Physician Decision|0|||
28128105|NCT03482011|54790400|FG003|Follow-up Period (12 Weeks)|Physician Decision|0|||
28128106|NCT03482011|54790401|FG004|Follow-up Period (12 Weeks)|Physician Decision|0|||
28128107|NCT03482011|54790402|FG005|Follow-up Period (12 Weeks)|Physician Decision|0|||
28128108|NCT03482011|54790403|FG006|Follow-up Period (12 Weeks)|Physician Decision|0|||
28128109|NCT03482011|54790404|FG007|Follow-up Period (12 Weeks)|Physician Decision|1|||
28128110|NCT03482011|54790397|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
28128111|NCT03482011|54790398|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
28128112|NCT03482011|54790399|FG002|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
28128113|NCT03482011|54790400|FG003|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
28128114|NCT03482011|54790401|FG004|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
28128115|NCT03482011|54790402|FG005|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
28128116|NCT03482011|54790403|FG006|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
28128117|NCT03482011|54790404|FG007|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
28128118|NCT03481309|54790435|FG000|Washout (at Least 3 Days)|Withdrawal by Subject|1|||
28128119|NCT03481309|54790436|FG001|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
28128120|NCT03481309|54790437|FG002|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
28128121|NCT03481309|54790438|FG003|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
28128122|NCT03481309|54790439|FG004|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
28128123|NCT03481309|54790440|FG005|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
28128124|NCT03480841|54790448|FG000|Overall Study|Lost to Follow-up|2|||
28128125|NCT02709538|54790455|FG000|Overall Study|Adverse Event|13|||
28067733|NCT00313586|54722879|FG000|Overall Study|Did not achieve HI-major/better response|10|||
28067734|NCT00313586|54722880|FG001|Overall Study|Did not achieve HI-major/better response|7|||
28067735|NCT00313586|54722881|FG002|Overall Study|Did not achieve HI-major/better response|2|||
28067736|NCT00313586|54722882|FG003|Overall Study|Did not achieve HI-major/better response|1|||
28067737|NCT00313586|54722879|FG000|Overall Study|Physician Decision|2|||
28067738|NCT00313586|54722880|FG001|Overall Study|Physician Decision|1|||
28067739|NCT00313586|54722881|FG002|Overall Study|Physician Decision|0|||
28067740|NCT00313586|54722882|FG003|Overall Study|Physician Decision|0|||
28067741|NCT00313586|54722879|FG000|Overall Study|Absolute neutrophil count not recovered|2|||
28067742|NCT00313586|54722880|FG001|Overall Study|Absolute neutrophil count not recovered|1|||
28067743|NCT00313586|54722881|FG002|Overall Study|Absolute neutrophil count not recovered|0|||
28128126|NCT02709538|54790456|FG001|Overall Study|Adverse Event|2|||
28128127|NCT02709538|54790457|FG002|Overall Study|Adverse Event|3|||
28128128|NCT02709538|54790455|FG000|Overall Study|Lack of Efficacy|1|||
28128129|NCT02709538|54790456|FG001|Overall Study|Lack of Efficacy|0|||
28128130|NCT02709538|54790457|FG002|Overall Study|Lack of Efficacy|0|||
28128131|NCT02709538|54790455|FG000|Overall Study|Lost to Follow-up|24|||
28128132|NCT02709538|54790456|FG001|Overall Study|Lost to Follow-up|8|||
28128133|NCT02709538|54790457|FG002|Overall Study|Lost to Follow-up|4|||
28128134|NCT02709538|54790455|FG000|Overall Study|Physician Decision|1|||
28067744|NCT00313586|54722882|FG003|Overall Study|Absolute neutrophil count not recovered|0|||
28067745|NCT00313586|54722879|FG000|Overall Study|Lost insurance|0|||
28128135|NCT02709538|54790456|FG001|Overall Study|Physician Decision|0|||
27831267|NCT01812707|54307681|FG000|Overall Study|Poor compliance to protocol|1|||
28067746|NCT00313586|54722880|FG001|Overall Study|Lost insurance|1|||
28067747|NCT00313586|54722881|FG002|Overall Study|Lost insurance|0|||
28128136|NCT02709538|54790457|FG002|Overall Study|Physician Decision|0|||
28128137|NCT02709538|54790455|FG000|Overall Study|Withdrawal by Subject|40|||
28128138|NCT02709538|54790456|FG001|Overall Study|Withdrawal by Subject|7|||
28128139|NCT02709538|54790457|FG002|Overall Study|Withdrawal by Subject|4|||
28128140|NCT02709538|54790455|FG000|Overall Study|Non-compliance with study procedures|5|||
28128141|NCT02709538|54790456|FG001|Overall Study|Non-compliance with study procedures|0|||
28128142|NCT02709538|54790457|FG002|Overall Study|Non-compliance with study procedures|0|||
28128143|NCT02709538|54790455|FG000|Overall Study|Non-compliance with study drug|2|||
28128144|NCT02709538|54790456|FG001|Overall Study|Non-compliance with study drug|0|||
28128145|NCT02709538|54790457|FG002|Overall Study|Non-compliance with study drug|0|||
28128146|NCT02709538|54790455|FG000|Overall Study|Protocol deviation|10|||
28128147|NCT02709538|54790456|FG001|Overall Study|Protocol deviation|4|||
28128148|NCT02709538|54790457|FG002|Overall Study|Protocol deviation|4|||
28128149|NCT02709538|54790455|FG000|Overall Study|Withdrawal by Parent or Legal Guardian|1|||
28128150|NCT02709538|54790456|FG001|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
28128151|NCT02709538|54790457|FG002|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
28128152|NCT02709538|54790455|FG000|Overall Study|Other|16|||
28128153|NCT02709538|54790456|FG001|Overall Study|Other|7|||
28128154|NCT02709538|54790457|FG002|Overall Study|Other|5|||
28128155|NCT03789318|54790470|FG000|Overall Study|Adverse Event|0|||
28128156|NCT03789318|54790471|FG001|Overall Study|Adverse Event|0|||
28128157|NCT03789318|54790472|FG002|Overall Study|Adverse Event|1|||
28128158|NCT03789318|54790473|FG003|Overall Study|Adverse Event|1|||
28128159|NCT03789318|54790474|FG004|Overall Study|Adverse Event|0|||
28128160|NCT03789318|54790470|FG000|Overall Study|Lost to Follow-up|0|||
28128161|NCT03789318|54790471|FG001|Overall Study|Lost to Follow-up|0|||
28128162|NCT03789318|54790472|FG002|Overall Study|Lost to Follow-up|1|||
28128163|NCT03789318|54790473|FG003|Overall Study|Lost to Follow-up|0|||
28128164|NCT03789318|54790474|FG004|Overall Study|Lost to Follow-up|0|||
28128165|NCT03789318|54790470|FG000|Overall Study|Withdrawal by Subject|0|||
28128166|NCT03789318|54790471|FG001|Overall Study|Withdrawal by Subject|0|||
28128167|NCT03789318|54790472|FG002|Overall Study|Withdrawal by Subject|1|||
28128168|NCT03789318|54790473|FG003|Overall Study|Withdrawal by Subject|0|||
28128169|NCT03789318|54790474|FG004|Overall Study|Withdrawal by Subject|0|||
28128170|NCT00511134|54790492|FG000|Overall Study|Withdrawal by Subject|0|||
28128171|NCT00511134|54790493|FG001|Overall Study|Withdrawal by Subject|2|||
28128172|NCT01372384|54790499|FG000|Overall Study|Progression of disease|3|||
28128173|NCT03115476|54790506|FG000|LP0084-1369|Death|1|||
28128174|NCT03115476|54790507|FG001|LP0084-1369|Death|0|||
28128175|NCT03115476|54790508|FG002|LP0084-1369|Death|2|||
28128176|NCT03115476|54790506|FG000|LP0084-1369|Trial terminated by Sponsor|190|||
28128177|NCT03115476|54790507|FG001|LP0084-1369|Trial terminated by Sponsor|210|||
28128178|NCT03115476|54790508|FG002|LP0084-1369|Trial terminated by Sponsor|160|||
28128179|NCT03480763|54790518|FG000|Overall Study|Withdrawal by Subject|18|||
28128180|NCT03480763|54790519|FG001|Overall Study|Withdrawal by Subject|10|||
28128181|NCT03480763|54790518|FG000|Overall Study|Lost to Follow-up|4|||
28128182|NCT03480763|54790519|FG001|Overall Study|Lost to Follow-up|7|||
28128183|NCT03480763|54790518|FG000|Overall Study|non-study pneumococcal vaccine|1|||
28128184|NCT03480763|54790519|FG001|Overall Study|non-study pneumococcal vaccine|0|||
28128185|NCT03480763|54790518|FG000|Overall Study|oncological treatment|0|||
28128186|NCT03480763|54790519|FG001|Overall Study|oncological treatment|2|||
28128187|NCT03480763|54790518|FG000|Overall Study|pain with vaccination|1|||
27831268|NCT01812707|54307682|FG001|Overall Study|Poor compliance to protocol|0|||
27940537|NCT01022853|54596833|FG003|Overall Study|Progressive disease|7|||
28067748|NCT00313586|54722882|FG003|Overall Study|Lost insurance|0|||
28067749|NCT00313586|54722879|FG000|Overall Study|Moved|0|||
28067750|NCT00313586|54722880|FG001|Overall Study|Moved|1|||
28067751|NCT00313586|54722881|FG002|Overall Study|Moved|0|||
28067752|NCT00313586|54722882|FG003|Overall Study|Moved|0|||
28067753|NCT00313586|54722879|FG000|Overall Study|Death before starting treatment|1|||
28067754|NCT00313586|54722880|FG001|Overall Study|Death before starting treatment|0|||
28067755|NCT00313586|54722881|FG002|Overall Study|Death before starting treatment|0|||
28067756|NCT00313586|54722882|FG003|Overall Study|Death before starting treatment|0|||
28067757|NCT00312572|54722892|FG000|Overall Study|Adverse Event|10|||
28067758|NCT00312572|54722893|FG001|Overall Study|Adverse Event|16|||
28067759|NCT00312572|54722892|FG000|Overall Study|Lost to Follow-up|1|||
28067760|NCT00312572|54722893|FG001|Overall Study|Lost to Follow-up|1|||
28067761|NCT00312572|54722892|FG000|Overall Study|Administrative|4|||
28128188|NCT03480763|54790519|FG001|Overall Study|pain with vaccination|0|||
28128189|NCT03123120|54790533|FG000|Overall Study|Lost to Follow-up|0|||
28128190|NCT03123120|54790534|FG001|Overall Study|Lost to Follow-up|1|||
27940538|NCT01022853|54596834|FG004|Overall Study|Progressive disease|1|||
28128191|NCT03123120|54790533|FG000|Overall Study|Withdrawal by Subject|0|||
28128192|NCT03123120|54790534|FG001|Overall Study|Withdrawal by Subject|1|||
28128193|NCT01319994|54790544|FG000|Overall Study|Protocol Violation|7|||
28128194|NCT01319994|54790545|FG001|Overall Study|Protocol Violation|6|||
28128195|NCT03453151|54790555|FG000|Overall Study|Withdrawal by Subject|1|||
28128196|NCT03453151|54790555|FG000|Overall Study|Physician Decision|3|||
28128197|NCT02887248|54790559|FG000|Overall Study|Withdrawal by Subject|1|||
28128198|NCT02887248|54790559|FG000|Overall Study|Adverse Event|1|||
28128199|NCT02887248|54790559|FG000|Overall Study|Progressive Disease|1|||
28128200|NCT03452527|54790565|FG000|Overall Study|Withdrawal by Subject|1|||
28128201|NCT03452527|54790566|FG001|Overall Study|Withdrawal by Subject|1|||
28128202|NCT03452527|54790565|FG000|Overall Study|Study Terminated|2|||
28128203|NCT03452527|54790566|FG001|Overall Study|Study Terminated|3|||
28128204|NCT03028142|54790572|FG000|Overall Study|Adverse Event|1|||
28128205|NCT03028142|54790573|FG001|Overall Study|Adverse Event|1|||
28128206|NCT03028142|54790574|FG002|Overall Study|Adverse Event|0|||
28128207|NCT03028142|54790575|FG003|Overall Study|Adverse Event|0|||
28128208|NCT03028142|54790576|FG004|Overall Study|Adverse Event|0|||
28128209|NCT03028142|54790577|FG005|Overall Study|Adverse Event|1|||
28128210|NCT03028142|54790572|FG000|Overall Study|Withdrawal by Subject|0|||
28128211|NCT03028142|54790573|FG001|Overall Study|Withdrawal by Subject|0|||
28067762|NCT00312572|54722893|FG001|Overall Study|Administrative|2|||
28128212|NCT03028142|54790574|FG002|Overall Study|Withdrawal by Subject|0|||
28128213|NCT03028142|54790575|FG003|Overall Study|Withdrawal by Subject|0|||
28128214|NCT03028142|54790576|FG004|Overall Study|Withdrawal by Subject|1|||
28128215|NCT03028142|54790577|FG005|Overall Study|Withdrawal by Subject|0|||
28128216|NCT02708524|54790590|FG000|Overall Study|Adverse Event|0|||
28128217|NCT02708524|54790591|FG001|Overall Study|Adverse Event|1|||
28128218|NCT02708524|54790592|FG002|Overall Study|Adverse Event|0|||
28128219|NCT02708524|54790593|FG003|Overall Study|Adverse Event|0|||
28128220|NCT02708524|54790590|FG000|Overall Study|Lens Discomfort|1|||
28128221|NCT02708524|54790591|FG001|Overall Study|Lens Discomfort|0|||
28128222|NCT02708524|54790592|FG002|Overall Study|Lens Discomfort|1|||
28128223|NCT02708524|54790593|FG003|Overall Study|Lens Discomfort|0|||
28128224|NCT02708524|54790590|FG000|Overall Study|Lost to Follow-up|1|||
28128225|NCT02708524|54790591|FG001|Overall Study|Lost to Follow-up|1|||
28128226|NCT02708524|54790592|FG002|Overall Study|Lost to Follow-up|1|||
28128227|NCT02708524|54790593|FG003|Overall Study|Lost to Follow-up|0|||
28128228|NCT02708524|54790590|FG000|Overall Study|Protocol Violation|0|||
28128229|NCT02708524|54790591|FG001|Overall Study|Protocol Violation|1|||
28128230|NCT02708524|54790592|FG002|Overall Study|Protocol Violation|0|||
28128231|NCT02708524|54790593|FG003|Overall Study|Protocol Violation|0|||
28128232|NCT02708524|54790590|FG000|Overall Study|Withdrawal by Subject|1|||
28128233|NCT02708524|54790591|FG001|Overall Study|Withdrawal by Subject|1|||
28128234|NCT02708524|54790592|FG002|Overall Study|Withdrawal by Subject|0|||
28128235|NCT02708524|54790593|FG003|Overall Study|Withdrawal by Subject|0|||
28128236|NCT02708524|54790590|FG000|Overall Study|Dispensed incorrect study lens|0|||
28128237|NCT02708524|54790591|FG001|Overall Study|Dispensed incorrect study lens|1|||
28128238|NCT02708524|54790592|FG002|Overall Study|Dispensed incorrect study lens|1|||
28128239|NCT02708524|54790593|FG003|Overall Study|Dispensed incorrect study lens|0|||
28128240|NCT02708524|54790590|FG000|Overall Study|Did not wear lens at final visit|0|||
28128241|NCT02708524|54790591|FG001|Overall Study|Did not wear lens at final visit|1|||
28128242|NCT02708524|54790592|FG002|Overall Study|Did not wear lens at final visit|0|||
28067763|NCT00312572|54722892|FG000|Overall Study|Lack of Efficacy|1|||
28067764|NCT00312572|54722893|FG001|Overall Study|Lack of Efficacy|2|||
28067765|NCT00290888|54722903|FG000|Overall Study|Physician Decision|3|||
28067766|NCT00290888|54722904|FG001|Overall Study|Physician Decision|1|||
28067767|NCT00290732|54722913|FG000|Overall Study|Inability to instill drug intraductally.|0|||
28067768|NCT00290732|54722914|FG001|Overall Study|Inability to instill drug intraductally.|1|||
28067769|NCT00290732|54722915|FG002|Overall Study|Inability to instill drug intraductally.|1|||
28067770|NCT00290732|54722916|FG003|Overall Study|Inability to instill drug intraductally.|0|||
28067771|NCT00290732|54722917|FG004|Overall Study|Inability to instill drug intraductally.|0|||
28067772|NCT00312494|54722933|FG000|Overall Study|Randomized; not treated with study drug|9|||
28067773|NCT00312494|54722934|FG001|Overall Study|Randomized; not treated with study drug|10|||
28067774|NCT00312494|54722935|FG002|Overall Study|Randomized; not treated with study drug|5|||
28067775|NCT00312494|54722933|FG000|Overall Study|Adverse Event|33|||
28067776|NCT00312494|54722934|FG001|Overall Study|Adverse Event|15|||
28067777|NCT00312494|54722935|FG002|Overall Study|Adverse Event|11|||
28067778|NCT00312494|54722933|FG000|Overall Study|Lack of Efficacy|4|||
28067779|NCT00312494|54722934|FG001|Overall Study|Lack of Efficacy|6|||
28067780|NCT00312494|54722935|FG002|Overall Study|Lack of Efficacy|8|||
28067781|NCT00312494|54722933|FG000|Overall Study|Laboratory abnormality|1|||
28067782|NCT00312494|54722934|FG001|Overall Study|Laboratory abnormality|0|||
28067783|NCT00312494|54722935|FG002|Overall Study|Laboratory abnormality|0|||
28067784|NCT00312494|54722933|FG000|Overall Study|Lost to Follow-up|8|||
28067785|NCT00312494|54722934|FG001|Overall Study|Lost to Follow-up|8|||
28067786|NCT00312494|54722935|FG002|Overall Study|Lost to Follow-up|8|||
28067787|NCT00312494|54722933|FG000|Overall Study|Withdrawal by Subject|6|||
28067788|NCT00312494|54722934|FG001|Overall Study|Withdrawal by Subject|9|||
28067789|NCT00312494|54722935|FG002|Overall Study|Withdrawal by Subject|10|||
28067790|NCT00312494|54722933|FG000|Overall Study|Other|10|||
28067791|NCT00312494|54722934|FG001|Overall Study|Other|10|||
28067792|NCT00312494|54722935|FG002|Overall Study|Other|1|||
28128243|NCT02708524|54790593|FG003|Overall Study|Did not wear lens at final visit|0|||
28128244|NCT02708524|54790590|FG000|Overall Study|Subject lost study lens|1|||
28128245|NCT02708524|54790591|FG001|Overall Study|Subject lost study lens|0|||
28128246|NCT02708524|54790592|FG002|Overall Study|Subject lost study lens|0|||
28128247|NCT02708524|54790593|FG003|Overall Study|Subject lost study lens|0|||
28128248|NCT03418675|54790605|FG000|Overall Study|Lost to Follow-up|13|||
28128249|NCT03418675|54790606|FG001|Overall Study|Lost to Follow-up|10|||
28128250|NCT03418675|54790605|FG000|Overall Study|Adverse Event|2|||
28128251|NCT03418675|54790606|FG001|Overall Study|Adverse Event|0|||
28128252|NCT03417505|54790623|FG000|First Lens Type (30 Days)|Lost to Follow-up|1|||
28128253|NCT03417505|54790624|FG001|First Lens Type (30 Days)|Lost to Follow-up|1|||
28128254|NCT02953639|54790633|FG000|Overall Study|Adverse Event|2|||
28128255|NCT02953639|54790634|FG001|Overall Study|Adverse Event|0|||
28128256|NCT02953639|54790635|FG002|Overall Study|Adverse Event|1|||
28128257|NCT02953639|54790633|FG000|Overall Study|Lost to Follow-up|8|||
28128258|NCT02953639|54790634|FG001|Overall Study|Lost to Follow-up|4|||
28128259|NCT02953639|54790635|FG002|Overall Study|Lost to Follow-up|3|||
28128260|NCT02953639|54790633|FG000|Overall Study|Non-Compliance With Study Drug|0|||
28128261|NCT02953639|54790634|FG001|Overall Study|Non-Compliance With Study Drug|2|||
28128262|NCT02953639|54790635|FG002|Overall Study|Non-Compliance With Study Drug|1|||
28128263|NCT02953639|54790633|FG000|Overall Study|Multiple Reasons|1|||
28128264|NCT02953639|54790634|FG001|Overall Study|Multiple Reasons|0|||
28128265|NCT02953639|54790635|FG002|Overall Study|Multiple Reasons|1|||
28128266|NCT02953639|54790633|FG000|Overall Study|Physician Decision|1|||
28128267|NCT02953639|54790634|FG001|Overall Study|Physician Decision|0|||
28128268|NCT02953639|54790635|FG002|Overall Study|Physician Decision|0|||
28128269|NCT02953639|54790633|FG000|Overall Study|Withdrawal by Subject|7|||
28128270|NCT02953639|54790634|FG001|Overall Study|Withdrawal by Subject|8|||
28128271|NCT02953639|54790635|FG002|Overall Study|Withdrawal by Subject|10|||
28128272|NCT02953639|54790633|FG000|Overall Study|Completed or Discontinued information is missing|1|||
28128273|NCT02953639|54790634|FG001|Overall Study|Completed or Discontinued information is missing|0|||
28128274|NCT02953639|54790635|FG002|Overall Study|Completed or Discontinued information is missing|0|||
28128275|NCT04147715|54790657|FG000|Overall Study|Adverse Event|0|||
28128276|NCT04147715|54790658|FG001|Overall Study|Adverse Event|0|||
28128277|NCT04147715|54790659|FG002|Overall Study|Adverse Event|0|||
28128278|NCT04147715|54790660|FG003|Overall Study|Adverse Event|0|||
28128279|NCT04147715|54790661|FG004|Overall Study|Adverse Event|0|||
28128280|NCT04147715|54790662|FG005|Overall Study|Adverse Event|0|||
28128281|NCT04147715|54790663|FG006|Overall Study|Adverse Event|0|||
28128282|NCT04147715|54790664|FG007|Overall Study|Adverse Event|2|||
28128283|NCT04147715|54790665|FG008|Overall Study|Adverse Event|1|||
28128284|NCT04147715|54790666|FG009|Overall Study|Adverse Event|0|||
28128285|NCT04147715|54790667|FG010|Overall Study|Adverse Event|0|||
28128286|NCT04147715|54790668|FG011|Overall Study|Adverse Event|0|||
28128287|NCT02452554|54790755|FG000|Overall Study|Death|2|||
28128288|NCT02452554|54790756|FG001|Overall Study|Death|1|||
28128289|NCT02452554|54790757|FG002|Overall Study|Death|0|||
28128290|NCT02452554|54790758|FG003|Overall Study|Death|0|||
28128291|NCT02452554|54790759|FG004|Overall Study|Death|0|||
28128292|NCT02452554|54790760|FG005|Overall Study|Death|0|||
28128293|NCT02452554|54790755|FG000|Overall Study|Lack of Efficacy|13|||
28128294|NCT02452554|54790756|FG001|Overall Study|Lack of Efficacy|14|||
28128295|NCT02452554|54790757|FG002|Overall Study|Lack of Efficacy|9|||
28128296|NCT02452554|54790758|FG003|Overall Study|Lack of Efficacy|1|||
28128297|NCT02452554|54790759|FG004|Overall Study|Lack of Efficacy|5|||
28128298|NCT02452554|54790760|FG005|Overall Study|Lack of Efficacy|8|||
28128299|NCT02452554|54790755|FG000|Overall Study|Physician Decision|0|||
28128300|NCT02452554|54790756|FG001|Overall Study|Physician Decision|1|||
28128301|NCT02452554|54790757|FG002|Overall Study|Physician Decision|0|||
28128302|NCT02452554|54790758|FG003|Overall Study|Physician Decision|0|||
28128303|NCT02452554|54790759|FG004|Overall Study|Physician Decision|0|||
28128304|NCT02452554|54790760|FG005|Overall Study|Physician Decision|0|||
28128305|NCT02452554|54790755|FG000|Overall Study|Withdrawal by Subject|1|||
28128306|NCT02452554|54790756|FG001|Overall Study|Withdrawal by Subject|0|||
28128307|NCT02452554|54790757|FG002|Overall Study|Withdrawal by Subject|2|||
28128308|NCT02452554|54790758|FG003|Overall Study|Withdrawal by Subject|0|||
28128309|NCT02452554|54790759|FG004|Overall Study|Withdrawal by Subject|0|||
28128310|NCT02452554|54790760|FG005|Overall Study|Withdrawal by Subject|1|||
28128311|NCT02452554|54790755|FG000|Overall Study|Ineligible|0|||
28128312|NCT02452554|54790756|FG001|Overall Study|Ineligible|1|||
28128313|NCT02452554|54790757|FG002|Overall Study|Ineligible|0|||
28128314|NCT02452554|54790758|FG003|Overall Study|Ineligible|0|||
28128315|NCT02452554|54790759|FG004|Overall Study|Ineligible|0|||
28128316|NCT02452554|54790760|FG005|Overall Study|Ineligible|0|||
28128317|NCT02452554|54790755|FG000|Overall Study|Never Received Treatment|1|||
28128318|NCT02452554|54790756|FG001|Overall Study|Never Received Treatment|0|||
28128319|NCT02452554|54790757|FG002|Overall Study|Never Received Treatment|0|||
28128320|NCT02452554|54790758|FG003|Overall Study|Never Received Treatment|0|||
28128321|NCT02452554|54790759|FG004|Overall Study|Never Received Treatment|0|||
27818514|NCT01760954|54277129|FG002|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
28128322|NCT02452554|54790760|FG005|Overall Study|Never Received Treatment|0|||
28128323|NCT04009577|54790779|FG000|Core Study|Adverse Event|1|||
28128324|NCT04009577|54790780|FG001|Core Study|Adverse Event|0|||
28128325|NCT04009577|54790781|FG002|Core Study|Adverse Event|2|||
28128326|NCT04009577|54790782|FG003|Core Study|Adverse Event|4|||
27818515|NCT01760954|54277130|FG003|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
27818516|NCT01760954|54277127|FG000|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
27818517|NCT01760954|54277128|FG001|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
28128327|NCT04009577|54790779|FG000|Core Study|Withdrawal by Subject|0|||
28128328|NCT04009577|54790780|FG001|Core Study|Withdrawal by Subject|0|||
28128329|NCT04009577|54790781|FG002|Core Study|Withdrawal by Subject|2|||
28128330|NCT04009577|54790782|FG003|Core Study|Withdrawal by Subject|0|||
28128331|NCT04009577|54790779|FG000|Core Study|Other|0|||
28128332|NCT04009577|54790780|FG001|Core Study|Other|0|||
28128333|NCT04009577|54790781|FG002|Core Study|Other|0|||
28128334|NCT04009577|54790782|FG003|Core Study|Other|1|||
28128335|NCT04009577|54790779|FG000|Extension Phase|Adverse Event|0|||
28128336|NCT04009577|54790780|FG001|Extension Phase|Adverse Event|0|||
28128337|NCT04009577|54790781|FG002|Extension Phase|Adverse Event|0|||
28128338|NCT04009577|54790782|FG003|Extension Phase|Adverse Event|1|||
28128339|NCT04009577|54790779|FG000|Extension Phase|Inadequate therapeutic effect|0|||
28128340|NCT04009577|54790780|FG001|Extension Phase|Inadequate therapeutic effect|0|||
28128341|NCT04009577|54790781|FG002|Extension Phase|Inadequate therapeutic effect|1|||
28128342|NCT04009577|54790782|FG003|Extension Phase|Inadequate therapeutic effect|0|||
28128343|NCT04009577|54790779|FG000|Extension Phase|Withdrawal by Subject|0|||
28128344|NCT04009577|54790780|FG001|Extension Phase|Withdrawal by Subject|0|||
28128345|NCT04009577|54790781|FG002|Extension Phase|Withdrawal by Subject|1|||
28128346|NCT04009577|54790782|FG003|Extension Phase|Withdrawal by Subject|0|||
28128347|NCT04009577|54790779|FG000|Extension Phase|Not Treated|0|||
28128348|NCT04009577|54790780|FG001|Extension Phase|Not Treated|0|||
28128349|NCT04009577|54790781|FG002|Extension Phase|Not Treated|2|||
28128350|NCT04009577|54790782|FG003|Extension Phase|Not Treated|0|||
28128351|NCT04146467|54790810|FG000|Overall Study|Adverse Event|0|||
28128352|NCT04146467|54790811|FG001|Overall Study|Adverse Event|1|||
28128353|NCT04146467|54790810|FG000|Overall Study|Lost to Follow-up|0|||
28128354|NCT04146467|54790811|FG001|Overall Study|Lost to Follow-up|2|||
28128355|NCT02705716|54790822|FG000|Overall Study|Adverse Event|0|||
28128356|NCT02705716|54790823|FG001|Overall Study|Adverse Event|1|||
28128357|NCT02705716|54790822|FG000|Overall Study|Protocol Violation|3|||
28128358|NCT02705716|54790823|FG001|Overall Study|Protocol Violation|0|||
28128359|NCT02705716|54790822|FG000|Overall Study|Withdrawal of Consent|1|||
28128360|NCT02705716|54790823|FG001|Overall Study|Withdrawal of Consent|1|||
28128361|NCT04138043|54790831|FG000|Overall Study|Withdrawal by Subject|0|||
28128362|NCT04138043|54790832|FG001|Overall Study|Withdrawal by Subject|1|||
28128363|NCT03443713|54790851|FG000|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
28128364|NCT03443713|54790852|FG001|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
28128365|NCT03443713|54790853|FG002|First at Home Period (9-14 Days)|Withdrawal by Subject|1|||
28128366|NCT04133519|54790867|FG000|Overall Study|Withdrawal by Subject|5|||
28128367|NCT04133519|54790868|FG001|Overall Study|Withdrawal by Subject|4|||
28128368|NCT04133519|54790867|FG000|Overall Study|Protocol Violation|0|||
28128369|NCT04133519|54790868|FG001|Overall Study|Protocol Violation|1|||
28128370|NCT04133519|54790867|FG000|Overall Study|Never started treatment|1|||
28128371|NCT04133519|54790868|FG001|Overall Study|Never started treatment|1|||
27831269|NCT01812707|54307683|FG002|Overall Study|Poor compliance to protocol|0|||
28128372|NCT04007159|54790874|FG000|Induction Phase|(missed study visits)|16|||
28128373|NCT04007159|54790874|FG000|Induction Phase|Withdrawal by Subject|4|||
28128374|NCT04007159|54790874|FG000|Induction Phase|Adverse Event|2|||
28128375|NCT04007159|54790874|FG000|Challenge Phase|missed study visits|3|||
28128376|NCT03119688|54790885|FG000|Overall Study|Adverse Event|4|||
28128377|NCT03389893|54790904|FG000|Randomized Double Blind Period|Withdrawal by Subject|1|||
28128378|NCT03389893|54790905|FG001|Randomized Double Blind Period|Withdrawal by Subject|0|||
28128379|NCT03389893|54790906|FG002|Randomized Double Blind Period|Withdrawal by Subject|0|||
28128380|NCT03389893|54790907|FG003|Randomized Double Blind Period|Withdrawal by Subject|0|||
28128381|NCT03389893|54790904|FG000|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
28128382|NCT03389893|54790905|FG001|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
28128383|NCT03389893|54790906|FG002|Open Label Extension and Follow-Up|Lost to Follow-up|2|||
28128384|NCT03389893|54790907|FG003|Open Label Extension and Follow-Up|Lost to Follow-up|1|||
28128385|NCT03389893|54790904|FG000|Open Label Extension and Follow-Up|Physician Decision|0|||
28128386|NCT03389893|54790905|FG001|Open Label Extension and Follow-Up|Physician Decision|0|||
28128387|NCT03389893|54790906|FG002|Open Label Extension and Follow-Up|Physician Decision|1|||
28128388|NCT03389893|54790907|FG003|Open Label Extension and Follow-Up|Physician Decision|0|||
27818518|NCT01760954|54277129|FG002|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1|||
27818519|NCT01760954|54277130|FG003|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
27818520|NCT01760954|54277127|FG000|Post-treatment Follow-up (12 Months)|Other|13|||
27818521|NCT01760954|54277128|FG001|Post-treatment Follow-up (12 Months)|Other|8|||
27818522|NCT01760954|54277129|FG002|Post-treatment Follow-up (12 Months)|Other|9|||
28067793|NCT00312338|54722945|FG000|Overall Study|Adverse Event|7|||
28067794|NCT00312338|54722946|FG001|Overall Study|Adverse Event|2|||
28067795|NCT00312338|54722945|FG000|Overall Study|Lost to Follow-up|9|||
28067796|NCT00312338|54722946|FG001|Overall Study|Lost to Follow-up|1|||
28067797|NCT00312338|54722945|FG000|Overall Study|Withdrawal by Subject|4|||
28128389|NCT03389893|54790904|FG000|Open Label Extension and Follow-Up|Participant Moved|0|||
28128390|NCT03389893|54790905|FG001|Open Label Extension and Follow-Up|Participant Moved|0|||
28128391|NCT03389893|54790906|FG002|Open Label Extension and Follow-Up|Participant Moved|1|||
28128392|NCT03389893|54790907|FG003|Open Label Extension and Follow-Up|Participant Moved|0|||
28128393|NCT04128293|54790917|FG000|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
28128394|NCT04128293|54790918|FG001|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
28128395|NCT04128293|54790919|FG002|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
28128396|NCT04128293|54790920|FG003|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
28128397|NCT00787176|54790939|FG000|Overall Study|Low quality fetal heart rate tracing|7|||
28128398|NCT00787176|54790940|FG001|Overall Study|Low quality fetal heart rate tracing|3|||
28128399|NCT00787176|54790941|FG002|Overall Study|Low quality fetal heart rate tracing|6|||
28128400|NCT00787176|54790942|FG003|Overall Study|Low quality fetal heart rate tracing|5|||
28067798|NCT00312338|54722946|FG001|Overall Study|Withdrawal by Subject|0|||
28067799|NCT00312338|54722945|FG000|Overall Study|Subsequent infection|2|||
28067800|NCT00312338|54722946|FG001|Overall Study|Subsequent infection|0|||
28067801|NCT00290498|54722954|FG000|Overall Study|Death|2|||
28067802|NCT00290498|54722955|FG001|Overall Study|Death|0|||
28067803|NCT00290498|54722954|FG000|Overall Study|Physician Decision|1|||
28067804|NCT00290498|54722955|FG001|Overall Study|Physician Decision|0|||
28128401|NCT03691571|54790955|FG000|Overall Study|Withdrawal by Subject|9|||
28067805|NCT00290498|54722954|FG000|Overall Study|Withdrawal by Subject|1|||
28128402|NCT03691571|54790956|FG001|Overall Study|Withdrawal by Subject|2|||
28067806|NCT00290498|54722955|FG001|Overall Study|Withdrawal by Subject|0|||
28128403|NCT03113916|54790965|FG000|Overall Study|Withdrawal by Subject|9|||
28128404|NCT03113916|54790966|FG001|Overall Study|Withdrawal by Subject|7|||
28128405|NCT03113916|54790965|FG000|Overall Study|Pregnancy|1|||
28128406|NCT03113916|54790966|FG001|Overall Study|Pregnancy|3|||
28128407|NCT03113916|54790965|FG000|Overall Study|Lost to Follow-up|1|||
28128408|NCT03113916|54790966|FG001|Overall Study|Lost to Follow-up|2|||
28128409|NCT02925494|54790981|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
28128410|NCT02925494|54790982|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
28128411|NCT02925494|54790983|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
28128412|NCT02925494|54790984|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|23|||
28128413|NCT02925494|54790981|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
28128414|NCT02925494|54790982|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
28128415|NCT02925494|54790983|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|9|||
28128416|NCT02925494|54790984|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|10|||
28128417|NCT02925494|54790981|FG000|Post-Treatment Follow-Up Period|Other|1|||
28128418|NCT02925494|54790982|FG001|Post-Treatment Follow-Up Period|Other|4|||
28128419|NCT02925494|54790983|FG002|Post-Treatment Follow-Up Period|Other|3|||
28128420|NCT02925494|54790984|FG003|Post-Treatment Follow-Up Period|Other|6|||
28128421|NCT02925494|54790981|FG000|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1|||
28128422|NCT02925494|54790982|FG001|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
28128423|NCT02925494|54790983|FG002|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
28128424|NCT02925494|54790984|FG003|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6|||
28128425|NCT02925494|54790981|FG000|Post-Treatment Follow-Up Period|Pregnancy|1|||
28128426|NCT02925494|54790982|FG001|Post-Treatment Follow-Up Period|Pregnancy|0|||
28128427|NCT02925494|54790983|FG002|Post-Treatment Follow-Up Period|Pregnancy|1|||
28128428|NCT02925494|54790984|FG003|Post-Treatment Follow-Up Period|Pregnancy|2|||
28128429|NCT02925494|54790981|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
28128430|NCT02925494|54790982|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
28128431|NCT02925494|54790983|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
28128432|NCT02925494|54790984|FG003|Post-Treatment Follow-Up Period|Non-Compliance|2|||
28128433|NCT02925494|54790981|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
28128434|NCT02925494|54790982|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
28128435|NCT02925494|54790983|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
28128436|NCT02925494|54790984|FG003|Post-Treatment Follow-Up Period|Adverse Event|1|||
28128437|NCT04006145|54790997|FG000|Overall Study|Lost to Follow-up|0|||
28128438|NCT04006145|54790998|FG001|Overall Study|Lost to Follow-up|1|||
28128439|NCT04006145|54790997|FG000|Overall Study|Other|1|||
27818523|NCT01760954|54277130|FG003|Post-treatment Follow-up (12 Months)|Other|6|||
27818524|NCT01760876|54277140|FG000|Overall Study|Non-cardiac death (head injury)|1|||
27818525|NCT01760876|54277140|FG000|Overall Study|Carcinoma of prostate|1|||
27818526|NCT01760876|54277140|FG000|Overall Study|Impaired renal function|1|||
28128440|NCT04006145|54790998|FG001|Overall Study|Other|2|||
28128441|NCT03386773|54791006|FG000|Overall Study|Lost to Follow-up|24|||
28128442|NCT03386773|54791007|FG001|Overall Study|Lost to Follow-up|33|||
28128443|NCT03386773|54791006|FG000|Overall Study|Withdrawal by Subject|3|||
28128444|NCT03386773|54791007|FG001|Overall Study|Withdrawal by Subject|2|||
28128445|NCT04126343|54791019|FG000|Overall Study|Adverse Event|0|||
28128446|NCT04126343|54791020|FG001|Overall Study|Adverse Event|0|||
28128447|NCT04126343|54791021|FG002|Overall Study|Adverse Event|0|||
28128448|NCT04126343|54791022|FG003|Overall Study|Adverse Event|0|||
28128449|NCT04126343|54791023|FG004|Overall Study|Adverse Event|0|||
28128450|NCT04126343|54791024|FG005|Overall Study|Adverse Event|1|||
27818527|NCT01760876|54277140|FG000|Overall Study|Major depression|1|||
28128451|NCT04126343|54791019|FG000|Overall Study|Withdrawal by Subject|0|||
28128452|NCT04126343|54791020|FG001|Overall Study|Withdrawal by Subject|0|||
28128453|NCT04126343|54791021|FG002|Overall Study|Withdrawal by Subject|0|||
28128454|NCT04126343|54791022|FG003|Overall Study|Withdrawal by Subject|1|||
28128455|NCT04126343|54791023|FG004|Overall Study|Withdrawal by Subject|0|||
28128456|NCT04126343|54791024|FG005|Overall Study|Withdrawal by Subject|0|||
28128457|NCT04126343|54791019|FG000|Overall Study|Related to COVID-19 pandemic|3|||
28128458|NCT04126343|54791020|FG001|Overall Study|Related to COVID-19 pandemic|4|||
28128459|NCT04126343|54791021|FG002|Overall Study|Related to COVID-19 pandemic|3|||
28128460|NCT04126343|54791022|FG003|Overall Study|Related to COVID-19 pandemic|3|||
27818528|NCT01760876|54277140|FG000|Overall Study|Very poor baseline OCT quality|2|||
28128461|NCT04126343|54791023|FG004|Overall Study|Related to COVID-19 pandemic|3|||
27940539|NCT01022853|54596830|FG000|Overall Study|Dose-limiting toxicity|0|||
28128462|NCT04126343|54791024|FG005|Overall Study|Related to COVID-19 pandemic|3|||
28128463|NCT02952313|54791039|FG000|Primary Endpoint|Lost to Follow-up|4|||
28128464|NCT02952313|54791039|FG000|Primary Endpoint|Withdrawal by Subject|1|||
28128465|NCT02952313|54791039|FG000|Primary Endpoint|Lack of Efficacy|1|||
28128466|NCT02952313|54791039|FG000|Primary Endpoint|Missed visit|1|||
28128467|NCT02952313|54791039|FG000|Long-term Follow-up|Lost to Follow-up|12|||
28128468|NCT02952313|54791039|FG000|Long-term Follow-up|Did not reconsent for long-term FU|7|||
28128469|NCT02952313|54791039|FG000|Long-term Follow-up|Lack of Efficacy|6|||
28128470|NCT02952313|54791039|FG000|Long-term Follow-up|Withdrawal by Subject|5|||
28128471|NCT02952313|54791039|FG000|Long-term Follow-up|Physician Decision|1|||
28128472|NCT02952313|54791039|FG000|Long-term Follow-up|Death|1|||
28128473|NCT03119610|54791046|FG000|Overall Study|Adverse Event|1|||
28128474|NCT03119610|54791047|FG001|Overall Study|Adverse Event|0|||
28128475|NCT03119610|54791046|FG000|Overall Study|Lost to Follow-up|0|||
28128476|NCT03119610|54791047|FG001|Overall Study|Lost to Follow-up|1|||
28128477|NCT04005755|54791053|FG000|Overall Study|Adverse Event|6|||
28128478|NCT04005755|54791053|FG000|Overall Study|Physician Decision|3|||
28128479|NCT04005755|54791053|FG000|Overall Study|Administrative reason, temporary site closure due to COVID-19|4|||
28128480|NCT04005755|54791053|FG000|Overall Study|Withdrawal by Subject|3|||
28128481|NCT04005755|54791053|FG000|Overall Study|Lost to Follow-up|1|||
28128482|NCT03442777|54791060|FG000|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|8|||
28128483|NCT03442777|54791061|FG001|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|13|||
28128484|NCT03442777|54791062|FG002|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|7|||
28128485|NCT03401749|54791071|FG000|Overall Study|Lost to Follow-up|20|||
28128486|NCT03401749|54791072|FG001|Overall Study|Lost to Follow-up|16|||
28128487|NCT03401749|54791073|FG002|Overall Study|Lost to Follow-up|26|||
28128488|NCT03029624|54791081|FG000|Overall Study|Adverse Event|1|||
28128489|NCT03029624|54791081|FG000|Overall Study|Withdrawal by Subject|1|||
28128490|NCT03029624|54791081|FG000|Overall Study|Lack of Efficacy|1|||
28128491|NCT03029624|54791081|FG000|Overall Study|MRI need|2|||
28128492|NCT02952001|54791089|FG000|Overall Study|Adverse Event|3|||
28128493|NCT02952001|54791090|FG001|Overall Study|Adverse Event|0|||
28128494|NCT02952001|54791089|FG000|Overall Study|Prohibited therapy|10|||
28128495|NCT02952001|54791090|FG001|Overall Study|Prohibited therapy|3|||
28128496|NCT02952001|54791089|FG000|Overall Study|Due to Posterior Capsular Opacity|1|||
28128497|NCT02952001|54791090|FG001|Overall Study|Due to Posterior Capsular Opacity|0|||
28128498|NCT04123067|54791099|FG000|Overall Study|Lost to Follow-up|0|||
28128499|NCT04123067|54791100|FG001|Overall Study|Lost to Follow-up|1|||
28128500|NCT04117607|54791109|FG000|Overall Study|Early Termination|0|||
28128501|NCT04117607|54791110|FG001|Overall Study|Early Termination|1|||
28128502|NCT04117607|54791111|FG002|Overall Study|Early Termination|0|||
28128503|NCT04117607|54791112|FG003|Overall Study|Early Termination|0|||
28128504|NCT04117607|54791113|FG004|Overall Study|Early Termination|0|||
28128505|NCT04117607|54791114|FG005|Overall Study|Early Termination|0|||
28128506|NCT04117607|54791115|FG006|Overall Study|Early Termination|1|||
28128507|NCT04117607|54791116|FG007|Overall Study|Early Termination|0|||
28128508|NCT04117607|54791117|FG008|Overall Study|Early Termination|0|||
28128509|NCT04117607|54791118|FG009|Overall Study|Early Termination|0|||
28128510|NCT04117607|54791119|FG010|Overall Study|Early Termination|0|||
28128511|NCT04117607|54791120|FG011|Overall Study|Early Termination|0|||
28128512|NCT04117607|54791121|FG012|Overall Study|Early Termination|0|||
28128513|NCT04117607|54791122|FG013|Overall Study|Early Termination|0|||
28128514|NCT04112303|54791138|FG000|Overall Study|Death|1|||
28128515|NCT03998189|54791144|FG000|Overall Study|Lack of Efficacy|0|||
28128516|NCT03998189|54791145|FG001|Overall Study|Lack of Efficacy|1|||
28128517|NCT04099277|54791151|FG000|Overall Study|Physician Decision|1|||
28128518|NCT04099277|54791151|FG000|Overall Study|Withdrawal by Subject|1|||
28128519|NCT03990389|54791157|FG000|Overall Study|Lost to Follow-up|3|||
28128520|NCT03990389|54791158|FG001|Overall Study|Lost to Follow-up|0|||
28128521|NCT03988907|54791166|FG000|Overall Study|Unable to complete visit|0|||
28128522|NCT03988907|54791167|FG001|Overall Study|Unable to complete visit|1|||
28128523|NCT03987191|54791181|FG000|Overall Study|COVID-19 related research disruption|0|||
28128524|NCT03987191|54791182|FG001|Overall Study|COVID-19 related research disruption|2|||
28128525|NCT04098809|54791190|FG000|Overall Study|Withdrawal by Subject|1|||
28128526|NCT04098809|54791191|FG001|Overall Study|Withdrawal by Subject|3|||
28128527|NCT04098809|54791190|FG000|Overall Study|Physician Decision|2|||
28128528|NCT04098809|54791191|FG001|Overall Study|Physician Decision|1|||
28128529|NCT03122184|54791199|FG000|Overall Study|Lost to Follow-up|4|||
28128530|NCT03122184|54791200|FG001|Overall Study|Lost to Follow-up|6|||
28128531|NCT03122184|54791199|FG000|Overall Study|Withdrawal by Subject|3|||
28128532|NCT03122184|54791200|FG001|Overall Study|Withdrawal by Subject|0|||
28128533|NCT03122184|54791199|FG000|Overall Study|Terminated due to cognitive problem|1|||
28128534|NCT03122184|54791200|FG001|Overall Study|Terminated due to cognitive problem|0|||
28128535|NCT04091087|54791225|FG000|Overall Study|Not treated|1|||
28128536|NCT04091087|54791226|FG001|Overall Study|Not treated|0|||
28128537|NCT04091087|54791225|FG000|Overall Study|Adverse Event|4|||
28128538|NCT04091087|54791226|FG001|Overall Study|Adverse Event|4|||
28128539|NCT04091087|54791225|FG000|Overall Study|Protocol Violation|0|||
28128540|NCT04091087|54791226|FG001|Overall Study|Protocol Violation|1|||
28128541|NCT04091087|54791225|FG000|Overall Study|Withdrawal by Subject|5|||
28128542|NCT04091087|54791226|FG001|Overall Study|Withdrawal by Subject|2|||
28128543|NCT03400033|54791244|FG000|Overall Study|Withdrawal by Subject|1|||
28128544|NCT03400033|54791245|FG001|Overall Study|Withdrawal by Subject|2|||
28128545|NCT04089761|54791260|FG000|"Run In Phase"|Not eligible to proceed to the treatment phase|14|||
28128546|NCT04089761|54791260|FG000|"Run In Phase"|Lost to Follow-up|1|||
28128547|NCT04089761|54791260|FG000|"Treatment Phase"|No evaluable data|5|||
28128548|NCT04089761|54791260|FG000|"Treatment Phase"|Lost to Follow-up|1|||
28128549|NCT03118518|54791266|FG000|Overall Study|Early Exit after treatment|2|||
28128550|NCT03118518|54791267|FG001|Overall Study|Early Exit after treatment|8|||
28128551|NCT03118518|54791266|FG000|Overall Study|Early Exit after randomization but prior to treatment|4|||
28128552|NCT03118518|54791267|FG001|Overall Study|Early Exit after randomization but prior to treatment|3|||
28128553|NCT03984305|54791275|FG000|Overall Study|Sponsor Request due to Study Discontinuation|19|||
28128554|NCT03984305|54791276|FG001|Overall Study|Sponsor Request due to Study Discontinuation|15|||
28128555|NCT03984305|54791275|FG000|Overall Study|Withdrawal by Subject|3|||
28128556|NCT03984305|54791276|FG001|Overall Study|Withdrawal by Subject|3|||
28128557|NCT03984305|54791275|FG000|Overall Study|Lost to Follow-up|1|||
28128558|NCT03984305|54791276|FG001|Overall Study|Lost to Follow-up|0|||
28128559|NCT03397771|54791284|FG000|Overall Study|2 erroneously randomized, never treated|3|||
28128560|NCT03397771|54791285|FG001|Overall Study|2 erroneously randomized, never treated|1|||
28128561|NCT03397771|54791284|FG000|Overall Study|Withdrawal by Subject|1|||
28128562|NCT03397771|54791285|FG001|Overall Study|Withdrawal by Subject|3|||
28128563|NCT03397771|54791284|FG000|Overall Study|Protocol Violation|2|||
28128564|NCT03397771|54791285|FG001|Overall Study|Protocol Violation|2|||
28128565|NCT03397771|54791284|FG000|Overall Study|Adverse Event|2|||
28128566|NCT03397771|54791285|FG001|Overall Study|Adverse Event|1|||
28128567|NCT02876835|54791293|FG000|Treatment Period (51.1 Month)|Other|1|||
28128568|NCT02876835|54791294|FG001|Treatment Period (51.1 Month)|Other|0|||
28128569|NCT02876835|54791293|FG000|Treatment Period (51.1 Month)|Investigator Site Closed|6|||
28128570|NCT02876835|54791294|FG001|Treatment Period (51.1 Month)|Investigator Site Closed|13|||
28128571|NCT02876835|54791293|FG000|Treatment Period (51.1 Month)|Withdrawal by Subject|32|||
28128572|NCT02876835|54791294|FG001|Treatment Period (51.1 Month)|Withdrawal by Subject|23|||
28128573|NCT02876835|54791293|FG000|Treatment Period (51.1 Month)|Lost to Follow-up|25|||
28128574|NCT02876835|54791294|FG001|Treatment Period (51.1 Month)|Lost to Follow-up|29|||
28128575|NCT04086641|54791303|FG000|Foot 1 (Two Week Utilization)|COVID-19|1|||
28128576|NCT04086641|54791304|FG001|Foot 1 (Two Week Utilization)|COVID-19|2|||
28128577|NCT03503318|54791313|FG000|Overall Study|Death|1|||
28128578|NCT03503318|54791314|FG001|Overall Study|Death|0|||
28128579|NCT03503318|54791315|FG002|Overall Study|Death|4|||
28128580|NCT03503318|54791313|FG000|Overall Study|Adverse Event|3|||
28128581|NCT03503318|54791314|FG001|Overall Study|Adverse Event|4|||
28128582|NCT03503318|54791315|FG002|Overall Study|Adverse Event|2|||
28128583|NCT03503318|54791313|FG000|Overall Study|Withdrawal by Subject|12|||
28128584|NCT03503318|54791314|FG001|Overall Study|Withdrawal by Subject|17|||
28128585|NCT03503318|54791315|FG002|Overall Study|Withdrawal by Subject|16|||
28128586|NCT03503318|54791313|FG000|Overall Study|Protocol Violation|5|||
28128587|NCT03503318|54791314|FG001|Overall Study|Protocol Violation|0|||
28128588|NCT03503318|54791315|FG002|Overall Study|Protocol Violation|3|||
28128589|NCT03503318|54791313|FG000|Overall Study|Lost to Follow-up|17|||
28128590|NCT03503318|54791314|FG001|Overall Study|Lost to Follow-up|15|||
28128591|NCT03503318|54791315|FG002|Overall Study|Lost to Follow-up|12|||
28128592|NCT03503318|54791313|FG000|Overall Study|Other than specified|1|||
28128593|NCT03503318|54791314|FG001|Overall Study|Other than specified|3|||
28128594|NCT03503318|54791315|FG002|Overall Study|Other than specified|3|||
28128595|NCT03396913|54791325|FG000|Overall Study|Lost to Follow-up|0|||
28128596|NCT03396913|54791326|FG001|Overall Study|Lost to Follow-up|6|||
28128597|NCT03982433|54791332|FG000|Overall Study|Lost to Follow-up|1|||
28128598|NCT03396835|54791336|FG000|Overall Study|Withdrawn prior to completion|1|||
27818529|NCT01759862|54277146|FG000|Overall Study|Physician Decision|3|||
27818530|NCT01759862|54277147|FG001|Overall Study|Physician Decision|1|||
27818531|NCT01759862|54277146|FG000|Overall Study|Adverse Event|0|||
28128599|NCT03396835|54791336|FG000|Overall Study|Did not meet criteria for data analysis|1|||
28128600|NCT03122106|54791340|FG000|Overall Study|Not enough tissue|1|||
28128601|NCT03122106|54791340|FG000|Overall Study|Disease progression during screening|2|||
28128602|NCT03122106|54791340|FG000|Overall Study|Poor RNA quality for vaccine|1|||
28128603|NCT04084769|54791348|FG000|Overall Study|Protocol Violation|1|||
28128604|NCT04084769|54791349|FG001|Overall Study|Protocol Violation|3|||
27818532|NCT01759862|54277147|FG001|Overall Study|Adverse Event|1|||
27818533|NCT01606670|54277153|FG000|Overall Study|Adverse Event|6|||
27818534|NCT01606670|54277153|FG000|Overall Study|Lack of Efficacy|2|||
28128605|NCT04084769|54791350|FG002|Overall Study|Protocol Violation|0|||
28128606|NCT04084769|54791351|FG003|Overall Study|Protocol Violation|1|||
28128607|NCT04084769|54791348|FG000|Overall Study|Withdrawal by Subject|0|||
28128608|NCT04084769|54791349|FG001|Overall Study|Withdrawal by Subject|1|||
28128609|NCT04084769|54791350|FG002|Overall Study|Withdrawal by Subject|0|||
28128610|NCT04084769|54791351|FG003|Overall Study|Withdrawal by Subject|0|||
28128611|NCT04084769|54791348|FG000|Overall Study|Withdrawal by parent/guardian|1|||
28128612|NCT04084769|54791349|FG001|Overall Study|Withdrawal by parent/guardian|0|||
28128613|NCT04084769|54791350|FG002|Overall Study|Withdrawal by parent/guardian|0|||
28128614|NCT04084769|54791351|FG003|Overall Study|Withdrawal by parent/guardian|1|||
28128615|NCT04084769|54791348|FG000|Overall Study|Lost to Follow-up|2|||
28128616|NCT04084769|54791349|FG001|Overall Study|Lost to Follow-up|0|||
28128617|NCT04084769|54791350|FG002|Overall Study|Lost to Follow-up|0|||
28128618|NCT04084769|54791351|FG003|Overall Study|Lost to Follow-up|0|||
28128619|NCT03121950|54791368|FG000|Overall Study|Withdrawal by Subject|11|||
28128620|NCT03121950|54791369|FG001|Overall Study|Withdrawal by Subject|2|||
28128621|NCT03395353|54791377|FG000|Overall Study|Adverse Event|20|||
28128622|NCT03395353|54791377|FG000|Overall Study|Protocol Violation|1|||
28128623|NCT03395353|54791377|FG000|Overall Study|Lack of Efficacy|3|||
28128624|NCT03395353|54791377|FG000|Overall Study|Withdrawal by Subject|24|||
28128625|NCT03395353|54791377|FG000|Overall Study|Discontinued visit|1|||
28128626|NCT03395353|54791377|FG000|Overall Study|Refrain from visit due to COVID-19|1|||
28128627|NCT03395353|54791377|FG000|Overall Study|Physician Decision|4|||
28128628|NCT03395353|54791377|FG000|Overall Study|Early termination of overall study|33|||
28128629|NCT04082663|54791385|FG000|Overall Study|Adverse Event|6|||
28128630|NCT04082663|54791385|FG000|Overall Study|Lost to Follow-up|1|||
28128631|NCT03682367|54791391|FG000|Overall Study|Protocol Violation|2|||
28128632|NCT03682367|54791392|FG001|Overall Study|Protocol Violation|1|||
28128633|NCT03682367|54791391|FG000|Overall Study|Closed Study Early|0|||
28128634|NCT03682367|54791392|FG001|Overall Study|Closed Study Early|3|||
28128635|NCT03681353|54791398|FG000|Overall Study|Lost to Follow-up|2|||
28128636|NCT03681353|54791398|FG000|Overall Study|Withdrawal by Subject|3|||
28128637|NCT03681353|54791398|FG000|Overall Study|withdrawn by PI|2|||
28128638|NCT03394885|54791402|FG000|Overall Study|Adverse Event|4|||
28128639|NCT03394885|54791402|FG000|Overall Study|Lack of Efficacy|1|||
28128640|NCT03394885|54791402|FG000|Overall Study|Physician Decision|1|||
28128641|NCT03394885|54791402|FG000|Overall Study|Withdrawal by Subject|8|||
28128642|NCT03394885|54791402|FG000|Overall Study|Alternative Therapy|1|||
28128643|NCT02877927|54791408|FG000|Overall Study|Adverse Event|1|||
28128644|NCT02877927|54791409|FG001|Overall Study|Adverse Event|0|||
28128645|NCT02877927|54791408|FG000|Overall Study|Lost to Follow-up|37|||
28128646|NCT02877927|54791409|FG001|Overall Study|Lost to Follow-up|38|||
28128647|NCT02877927|54791408|FG000|Overall Study|Withdrawal by Subject|11|||
28128648|NCT02877927|54791409|FG001|Overall Study|Withdrawal by Subject|12|||
28128649|NCT02877927|54791408|FG000|Overall Study|Physician Decision|0|||
28128650|NCT02877927|54791409|FG001|Overall Study|Physician Decision|1|||
28128651|NCT02877927|54791408|FG000|Overall Study|Missed EOT/PTE Visit|5|||
28128652|NCT02877927|54791409|FG001|Overall Study|Missed EOT/PTE Visit|6|||
28128653|NCT02706886|54791424|FG000|Part A: SAD Period|Withdrawal by Subject|0|||
28128654|NCT02706886|54791425|FG001|Part A: SAD Period|Withdrawal by Subject|0|||
28128655|NCT02706886|54791426|FG002|Part A: SAD Period|Withdrawal by Subject|0|||
28128656|NCT02706886|54791427|FG003|Part A: SAD Period|Withdrawal by Subject|2|||
28128657|NCT02706886|54791428|FG004|Part A: SAD Period|Withdrawal by Subject|0|||
28128658|NCT02706886|54791429|FG005|Part A: SAD Period|Withdrawal by Subject|0|||
28128659|NCT02706886|54791430|FG006|Part A: SAD Period|Withdrawal by Subject|0|||
28128660|NCT02706886|54791431|FG007|Part A: SAD Period|Withdrawal by Subject|0|||
28067807|NCT00290498|54722954|FG000|Overall Study|Ineligible|3|||
28067808|NCT00290498|54722955|FG001|Overall Study|Ineligible|0|||
28067809|NCT00290498|54722954|FG000|Overall Study|Non-Compliance|1|||
28067810|NCT00290498|54722955|FG001|Overall Study|Non-Compliance|0|||
28067811|NCT00451451|54722966|FG000|Overall Study|Adverse Event|11|||
28067812|NCT00451451|54722967|FG001|Overall Study|Adverse Event|21|||
28067813|NCT00451451|54722968|FG002|Overall Study|Adverse Event|26|||
28067814|NCT00451451|54722969|FG003|Overall Study|Adverse Event|10|||
28067815|NCT00451451|54722966|FG000|Overall Study|Lost to Follow-up|11|||
28067816|NCT00451451|54722967|FG001|Overall Study|Lost to Follow-up|9|||
28067817|NCT00451451|54722968|FG002|Overall Study|Lost to Follow-up|8|||
28067818|NCT00451451|54722969|FG003|Overall Study|Lost to Follow-up|11|||
28128661|NCT02706886|54791432|FG008|Part A: SAD Period|Withdrawal by Subject|0|||
28128662|NCT04069715|54791486|FG000|Overall Study|Lost to Follow-up|1|||
28128663|NCT04069715|54791487|FG001|Overall Study|Lost to Follow-up|1|||
27818535|NCT01606670|54277153|FG000|Overall Study|Lost to Follow-up|3|||
27818536|NCT01606670|54277153|FG000|Overall Study|Withdrawal by Subject|3|||
28128664|NCT04069715|54791486|FG000|Overall Study|Physician Decision|1|||
28128665|NCT04069715|54791487|FG001|Overall Study|Physician Decision|1|||
28128666|NCT04069715|54791486|FG000|Overall Study|Withdrawal by Subject|3|||
28128667|NCT04069715|54791487|FG001|Overall Study|Withdrawal by Subject|3|||
28128668|NCT03681119|54791495|FG000|Overall Study|No specific reason|4|||
28128669|NCT03681119|54791496|FG001|Overall Study|No specific reason|0|||
28128670|NCT03681119|54791495|FG000|Overall Study|Sickness|2|||
28128671|NCT03681119|54791496|FG001|Overall Study|Sickness|0|||
28128672|NCT03111108|54791502|FG000|Overall Study|Death|0|||
28128673|NCT03111108|54791503|FG001|Overall Study|Death|1|||
28128674|NCT03111108|54791502|FG000|Overall Study|Withdrawal by Subject|1|||
28128675|NCT03111108|54791503|FG001|Overall Study|Withdrawal by Subject|0|||
28128676|NCT03677375|54791509|FG000|Overall Study|Incomplete procedure|8|||
28128677|NCT03677375|54791509|FG000|Overall Study|Adverse Event|3|||
28128678|NCT03677375|54791509|FG000|Overall Study|Physician Decision|1|||
28128679|NCT00702520|54791515|FG000|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
28128680|NCT00702520|54791516|FG001|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1|||
28128681|NCT00702520|54791517|FG002|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
28128682|NCT00702520|54791518|FG003|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
28128683|NCT00702520|54791515|FG000|Base Study P05788 - Embryo Transfer|No embryo transfer|3|||
28128684|NCT00702520|54791516|FG001|Base Study P05788 - Embryo Transfer|No embryo transfer|6|||
28128685|NCT00702520|54791517|FG002|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
28128686|NCT00702520|54791518|FG003|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
28128687|NCT00702520|54791515|FG000|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15|||
28128688|NCT00702520|54791516|FG001|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10|||
28128689|NCT00702520|54791517|FG002|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
28128690|NCT00702520|54791518|FG003|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
28128691|NCT04067141|54791528|FG000|First Intervention|Withdrawal by Subject|0|||
28128692|NCT04067141|54791529|FG001|First Intervention|Withdrawal by Subject|1|||
28128693|NCT04067141|54791528|FG000|Second Intervention|Adverse Event|0|||
28128694|NCT04067141|54791529|FG001|Second Intervention|Adverse Event|2|||
28128695|NCT02876601|54791539|FG000|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
28128696|NCT02876601|54791540|FG001|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
28128697|NCT02876601|54791541|FG002|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1|||
28128698|NCT02876601|54791542|FG003|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
28128699|NCT04054193|54791587|FG000|Cycle 1|Physician Decision|1|||
28128700|NCT04054193|54791587|FG000|Cycle 1|Consent withdrawn by parent/guardian|1|||
28128701|NCT04054193|54791587|FG000|Cycle 1|Allocated but not treated|3|||
28128702|NCT04054193|54791587|FG000|Cycles 2-3|Physician Decision|2|||
28128703|NCT04054193|54791587|FG000|Cycles 2-3|Consent withdrawn by parent/guardian|2|||
28128704|NCT04054193|54791587|FG000|Cycles 2-3|Various reasons|17|||
28128705|NCT03394027|54791595|FG000|Overall Study|Ineligible|3|||
28128706|NCT03394027|54791596|FG001|Overall Study|Ineligible|1|||
28128707|NCT03394027|54791597|FG002|Overall Study|Ineligible|3|||
28128708|NCT03394027|54791595|FG000|Overall Study|Participant declined to participate before treatment started|0|||
28128709|NCT03394027|54791596|FG001|Overall Study|Participant declined to participate before treatment started|0|||
28128710|NCT03394027|54791597|FG002|Overall Study|Participant declined to participate before treatment started|1|||
28128711|NCT03136107|54791623|FG000|Overall Study|Other (Not specified)|1|||
28128712|NCT02916056|54791631|FG000|Overall Study|Adverse Event|6|||
28128713|NCT02916056|54791631|FG000|Overall Study|Lost to Follow-up|1|||
28128714|NCT02916056|54791631|FG000|Overall Study|Other|12|||
28128715|NCT02916056|54791631|FG000|Overall Study|Protocol Violation|1|||
28128716|NCT02916056|54791631|FG000|Overall Study|Withdrawal by Subject|8|||
28128717|NCT02916056|54791631|FG000|Overall Study|Study Terminated by Sponsor|269|||
28128718|NCT04854642|54791635|FG000|Overall Study|Adverse Event|1|||
28128719|NCT04854642|54791636|FG001|Overall Study|Adverse Event|2|||
28128720|NCT04854642|54791635|FG000|Overall Study|Withdrawal by Subject|0|||
28128721|NCT04854642|54791636|FG001|Overall Study|Withdrawal by Subject|1|||
28128722|NCT03689712|54791646|FG000|Overall Study|Adverse Event|1|||
28128723|NCT03689712|54791647|FG001|Overall Study|Adverse Event|0|||
28128724|NCT03689712|54791646|FG000|Overall Study|Death|20|||
28128725|NCT03689712|54791647|FG001|Overall Study|Death|10|||
28128726|NCT03689712|54791646|FG000|Overall Study|Lost to Follow-up|6|||
28128727|NCT03689712|54791647|FG001|Overall Study|Lost to Follow-up|6|||
28128728|NCT03689712|54791646|FG000|Overall Study|Other|1|||
28128729|NCT03689712|54791647|FG001|Overall Study|Other|0|||
28128730|NCT03689712|54791646|FG000|Overall Study|Patient Non-Compliance|0|||
28128731|NCT03689712|54791647|FG001|Overall Study|Patient Non-Compliance|1|||
28128732|NCT03689712|54791646|FG000|Overall Study|Withdrawal by Subject|20|||
28128733|NCT03689712|54791647|FG001|Overall Study|Withdrawal by Subject|4|||
28128734|NCT03689712|54791646|FG000|Overall Study|Patients Continuing in Long Term Follow Up|88|||
28128735|NCT03689712|54791647|FG001|Overall Study|Patients Continuing in Long Term Follow Up|71|||
28128736|NCT03689712|54791646|FG000|Overall Study|Randomized but not Treated|13|||
28128737|NCT03689712|54791647|FG001|Overall Study|Randomized but not Treated|7|||
28128738|NCT03689712|54791646|FG000|Overall Study|Subject Dosing Suspended due to Product Issue|16|||
28128739|NCT03689712|54791647|FG001|Overall Study|Subject Dosing Suspended due to Product Issue|12|||
28128740|NCT03384745|54791659|FG000|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
28128741|NCT03384745|54791660|FG001|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
28128742|NCT03384745|54791661|FG002|Placebo Controlled Induction (W0 - W12)|Adverse Event|1|||
28128743|NCT03384745|54791662|FG003|Placebo Controlled Induction (W0 - W12)|Adverse Event|2|||
28128744|NCT03384745|54791663|FG004|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
28128745|NCT03384745|54791664|FG005|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
28128746|NCT03384745|54791659|FG000|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
28128747|NCT03384745|54791660|FG001|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
28128748|NCT03384745|54791661|FG002|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
28128749|NCT03384745|54791662|FG003|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
28128750|NCT03384745|54791663|FG004|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|3|||
28128751|NCT03384745|54791664|FG005|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|1|||
28128752|NCT03384745|54791659|FG000|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
28128753|NCT03384745|54791660|FG001|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
28128754|NCT03384745|54791661|FG002|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
28128755|NCT03384745|54791662|FG003|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
28128756|NCT03384745|54791663|FG004|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
28128757|NCT03384745|54791664|FG005|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
28128758|NCT03384745|54791659|FG000|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
28128759|NCT03384745|54791660|FG001|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
28128760|NCT03384745|54791661|FG002|Placebo Controlled Induction (W0 - W12)|Protocol Violation|1|||
28128761|NCT03384745|54791662|FG003|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
28128762|NCT03384745|54791663|FG004|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
28128763|NCT03384745|54791664|FG005|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
28128764|NCT03384745|54791659|FG000|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
28128765|NCT03384745|54791660|FG001|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
28128766|NCT03384745|54791661|FG002|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
28128767|NCT03384745|54791662|FG003|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
28128768|NCT03384745|54791663|FG004|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
28128769|NCT03384745|54791664|FG005|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
28128770|NCT03384745|54791659|FG000|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
28128771|NCT03384745|54791660|FG001|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
28128772|NCT03384745|54791661|FG002|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
28128773|NCT03384745|54791662|FG003|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
28128774|NCT03384745|54791663|FG004|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|1|||
28128775|NCT03384745|54791664|FG005|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
28128776|NCT03384745|54791659|FG000|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
28128777|NCT03384745|54791660|FG001|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
28128778|NCT03384745|54791661|FG002|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
28128779|NCT03384745|54791662|FG003|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
28128780|NCT03384745|54791663|FG004|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
28128781|NCT03384745|54791664|FG005|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
28128782|NCT03384745|54791659|FG000|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
28128783|NCT03384745|54791660|FG001|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
28128784|NCT03384745|54791661|FG002|Response Assess/Dose Hold (W24-W48)|Adverse Event|3|||
27818537|NCT01606670|54277153|FG000|Overall Study|Other Reason|2|||
27818538|NCT01793792|54277157|FG000|Overall Study|Death|5|||
28128785|NCT03384745|54791662|FG003|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
28128786|NCT03384745|54791663|FG004|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
28128787|NCT03384745|54791664|FG005|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
28128788|NCT03384745|54791659|FG000|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
28128789|NCT03384745|54791660|FG001|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
28128790|NCT03384745|54791661|FG002|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
28128791|NCT03384745|54791662|FG003|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
28128792|NCT03384745|54791663|FG004|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
28128793|NCT03384745|54791664|FG005|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
28128794|NCT03384745|54791659|FG000|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
28128795|NCT03384745|54791660|FG001|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
28128796|NCT03384745|54791661|FG002|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
28128797|NCT03384745|54791662|FG003|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|2|||
28128798|NCT03384745|54791663|FG004|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
28128799|NCT03384745|54791664|FG005|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
28128800|NCT03384745|54791659|FG000|Response Assess/Dose Hold (W24-W48)|Death|0|||
28128801|NCT03384745|54791660|FG001|Response Assess/Dose Hold (W24-W48)|Death|1|||
28128802|NCT03384745|54791661|FG002|Response Assess/Dose Hold (W24-W48)|Death|0|||
28128803|NCT03384745|54791662|FG003|Response Assess/Dose Hold (W24-W48)|Death|0|||
28128804|NCT03384745|54791663|FG004|Response Assess/Dose Hold (W24-W48)|Death|0|||
28128805|NCT03384745|54791664|FG005|Response Assess/Dose Hold (W24-W48)|Death|0|||
28128806|NCT03383887|54791684|FG000|Overall Study|Lost to Follow-up|0|||
28128807|NCT03383887|54791685|FG001|Overall Study|Lost to Follow-up|1|||
28128808|NCT03379753|54791693|FG000|Overall Study|Withdrawal by Subject|2|||
28128809|NCT03379753|54791694|FG001|Overall Study|Withdrawal by Subject|1|||
28128810|NCT03379753|54791693|FG000|Overall Study|not having correct procedure|1|||
28128811|NCT03379753|54791694|FG001|Overall Study|not having correct procedure|2|||
28128812|NCT03379753|54791693|FG000|Overall Study|No primary outcome|12|||
28128813|NCT03379753|54791694|FG001|Overall Study|No primary outcome|22|||
28128814|NCT03548064|54791708|FG000|Overall Study|Withdrawal by Subject|0|||
28128815|NCT03548064|54791709|FG001|Overall Study|Withdrawal by Subject|0|||
28128816|NCT03548064|54791710|FG002|Overall Study|Withdrawal by Subject|0|||
28128817|NCT03548064|54791711|FG003|Overall Study|Withdrawal by Subject|1|||
28128818|NCT03548064|54791712|FG004|Overall Study|Withdrawal by Subject|0|||
28128819|NCT03548064|54791713|FG005|Overall Study|Withdrawal by Subject|0|||
28128820|NCT03548064|54791714|FG006|Overall Study|Withdrawal by Subject|0|||
28128821|NCT03548064|54791715|FG007|Overall Study|Withdrawal by Subject|0|||
28128822|NCT03548064|54791708|FG000|Overall Study|Lost to Follow-up|0|||
28128823|NCT03548064|54791709|FG001|Overall Study|Lost to Follow-up|0|||
28128824|NCT03548064|54791710|FG002|Overall Study|Lost to Follow-up|0|||
28128825|NCT03548064|54791711|FG003|Overall Study|Lost to Follow-up|0|||
28128826|NCT03548064|54791712|FG004|Overall Study|Lost to Follow-up|2|||
28128827|NCT03548064|54791713|FG005|Overall Study|Lost to Follow-up|0|||
28128828|NCT03548064|54791714|FG006|Overall Study|Lost to Follow-up|0|||
28128829|NCT03548064|54791715|FG007|Overall Study|Lost to Follow-up|0|||
28128830|NCT03548064|54791708|FG000|Overall Study|Covid-19 Pandemic|0|||
28128831|NCT03548064|54791709|FG001|Overall Study|Covid-19 Pandemic|0|||
28128832|NCT03548064|54791710|FG002|Overall Study|Covid-19 Pandemic|0|||
28128833|NCT03548064|54791711|FG003|Overall Study|Covid-19 Pandemic|0|||
28128834|NCT03548064|54791712|FG004|Overall Study|Covid-19 Pandemic|10|||
28128835|NCT03548064|54791713|FG005|Overall Study|Covid-19 Pandemic|3|||
28128836|NCT03548064|54791714|FG006|Overall Study|Covid-19 Pandemic|0|||
28128837|NCT03548064|54791715|FG007|Overall Study|Covid-19 Pandemic|0|||
28128838|NCT03379675|54791742|FG000|Overall Study|Lost to Follow-up|0|||
28128839|NCT03379675|54791743|FG001|Overall Study|Lost to Follow-up|1|||
28128840|NCT03379675|54791744|FG002|Overall Study|Lost to Follow-up|0|||
28128841|NCT03379675|54791742|FG000|Overall Study|Adverse Event|2|||
28128842|NCT03379675|54791743|FG001|Overall Study|Adverse Event|0|||
28128843|NCT03379675|54791744|FG002|Overall Study|Adverse Event|0|||
28128844|NCT03379675|54791742|FG000|Overall Study|Withdrawal by Subject|2|||
28128845|NCT03379675|54791743|FG001|Overall Study|Withdrawal by Subject|1|||
28128846|NCT03379675|54791744|FG002|Overall Study|Withdrawal by Subject|2|||
28128847|NCT02930889|54791752|FG000|Overall Study|Lost to Follow-up|2|||
28128848|NCT02930889|54791752|FG000|Overall Study|Withdrawal by Subject|6|||
28128849|NCT02930889|54791752|FG000|Overall Study|Did not meet inclusion/exclusion criteria|8|||
28128850|NCT02875977|54791758|FG000|Overall Study|Lost to Follow-up|42|||
28128851|NCT02875977|54791759|FG001|Overall Study|Lost to Follow-up|29|||
28128852|NCT02703532|54791778|FG000|Overall Study|Withdrawal by Subject|0|||
28128853|NCT02703532|54791779|FG001|Overall Study|Withdrawal by Subject|1|||
28128854|NCT02703532|54791780|FG002|Overall Study|Withdrawal by Subject|0|||
28128855|NCT02703532|54791781|FG003|Overall Study|Withdrawal by Subject|1|||
28128856|NCT02703532|54791778|FG000|Overall Study|Lost to Follow-up|2|||
28128857|NCT02703532|54791779|FG001|Overall Study|Lost to Follow-up|0|||
28128858|NCT02703532|54791780|FG002|Overall Study|Lost to Follow-up|2|||
28128859|NCT02703532|54791781|FG003|Overall Study|Lost to Follow-up|0|||
28128860|NCT02930343|54791814|FG000|Overall Study|Lost to Follow-up|9|||
28128861|NCT02930343|54791815|FG001|Overall Study|Lost to Follow-up|7|||
28128862|NCT02703454|54791823|FG000|Overall Study|Not treated|1|||
28128863|NCT02703454|54791824|FG001|Overall Study|Not treated|3|||
28128864|NCT02703454|54791823|FG000|Overall Study|Withdrawal by Subject|4|||
28128865|NCT02703454|54791824|FG001|Overall Study|Withdrawal by Subject|3|||
28128866|NCT02703454|54791823|FG000|Overall Study|Lost to Follow-up|1|||
28128867|NCT02703454|54791824|FG001|Overall Study|Lost to Follow-up|2|||
28128868|NCT02703454|54791823|FG000|Overall Study|Study discontinuation|5|||
28128869|NCT02703454|54791824|FG001|Overall Study|Study discontinuation|8|||
28128870|NCT03103542|54791830|FG000|Overall Study|Physician Decision|2|||
28128871|NCT03103542|54791830|FG000|Overall Study|Adverse Event|2|||
28128872|NCT03103542|54791830|FG000|Overall Study|Other|2|||
28128873|NCT03103542|54791830|FG000|Overall Study|Withdrawal by Subject|1|||
28128874|NCT03376321|54791857|FG000|Overall Study|Other|5|||
28128875|NCT03376321|54791858|FG001|Overall Study|Other|1|||
28128876|NCT03376321|54791857|FG000|Overall Study|Withdrawal by Subject|8|||
28128877|NCT03376321|54791858|FG001|Overall Study|Withdrawal by Subject|14|||
28128878|NCT03376321|54791857|FG000|Overall Study|Lost to Follow-up|1|||
28128879|NCT03376321|54791858|FG001|Overall Study|Lost to Follow-up|7|||
28128880|NCT03376321|54791857|FG000|Overall Study|Death|4|||
28128881|NCT03376321|54791858|FG001|Overall Study|Death|0|||
28128882|NCT03376321|54791857|FG000|Overall Study|Randomized, not treated|5|||
28128883|NCT03376321|54791858|FG001|Overall Study|Randomized, not treated|3|||
27818539|NCT01793792|54277157|FG000|Overall Study|Lost to Follow-up|5|||
28067819|NCT00451451|54722966|FG000|Overall Study|Consent Withdrawn|14|||
28067820|NCT00451451|54722967|FG001|Overall Study|Consent Withdrawn|9|||
28067821|NCT00451451|54722968|FG002|Overall Study|Consent Withdrawn|17|||
28067822|NCT00451451|54722969|FG003|Overall Study|Consent Withdrawn|17|||
28128884|NCT03374995|54791866|FG000|Overall Study|Withdrawal by Subject|0|||
28128885|NCT03374995|54791867|FG001|Overall Study|Withdrawal by Subject|1|||
28128886|NCT02828982|54791873|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
28128887|NCT02828982|54791874|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
28128888|NCT03133767|54791884|FG000|Overall Study|Lost to Follow-up|38|||
28067823|NCT00451451|54722966|FG000|Overall Study|Investigator Decision|6|||
28067824|NCT00451451|54722967|FG001|Overall Study|Investigator Decision|2|||
28067825|NCT00451451|54722968|FG002|Overall Study|Investigator Decision|1|||
28067826|NCT00451451|54722969|FG003|Overall Study|Investigator Decision|2|||
28067827|NCT00451451|54722966|FG000|Overall Study|Subject Non-Compliance|8|||
27818540|NCT01793792|54277157|FG000|Overall Study|Withdrawal by Subject|1|||
27818541|NCT01793792|54277157|FG000|Overall Study|Device Not Implanted|1|||
28067828|NCT00451451|54722967|FG001|Overall Study|Subject Non-Compliance|4|||
28067829|NCT00451451|54722968|FG002|Overall Study|Subject Non-Compliance|3|||
28067830|NCT00451451|54722969|FG003|Overall Study|Subject Non-Compliance|3|||
28067831|NCT00451451|54722966|FG000|Overall Study|Death|1|||
28067832|NCT00451451|54722967|FG001|Overall Study|Death|0|||
28128889|NCT03133767|54791885|FG001|Overall Study|Lost to Follow-up|24|||
28128890|NCT03133767|54791884|FG000|Overall Study|Protocol Violation|0|||
28128891|NCT03133767|54791885|FG001|Overall Study|Protocol Violation|1|||
28128892|NCT03391765|54791895|FG000|Overall Study|Adverse Event|2|||
28128893|NCT03391765|54791896|FG001|Overall Study|Adverse Event|0|||
28128894|NCT03391765|54791897|FG002|Overall Study|Adverse Event|0|||
28067833|NCT00451451|54722968|FG002|Overall Study|Death|0|||
28128895|NCT03391765|54791898|FG003|Overall Study|Adverse Event|2|||
28128896|NCT03391765|54791895|FG000|Overall Study|Withdrew consent|5|||
28128897|NCT03391765|54791896|FG001|Overall Study|Withdrew consent|7|||
28128898|NCT03391765|54791897|FG002|Overall Study|Withdrew consent|2|||
28128899|NCT03391765|54791898|FG003|Overall Study|Withdrew consent|5|||
28128900|NCT03391765|54791895|FG000|Overall Study|Other, not specified|44|||
28128901|NCT03391765|54791896|FG001|Overall Study|Other, not specified|38|||
28128902|NCT03391765|54791897|FG002|Overall Study|Other, not specified|21|||
28128903|NCT03391765|54791898|FG003|Overall Study|Other, not specified|16|||
28128904|NCT02802228|54791910|FG000|Overall Study|Withdrawal by Subject|2|||
28128905|NCT02802228|54791911|FG001|Overall Study|Withdrawal by Subject|0|||
28128906|NCT02802228|54791910|FG000|Overall Study|Lost to Follow-up|1|||
28128907|NCT02802228|54791911|FG001|Overall Study|Lost to Follow-up|0|||
28128908|NCT02802228|54791910|FG000|Overall Study|Adverse Event|1|||
28128909|NCT02802228|54791911|FG001|Overall Study|Adverse Event|0|||
28128910|NCT02802228|54791910|FG000|Overall Study|Physician Decision|1|||
28128911|NCT02802228|54791911|FG001|Overall Study|Physician Decision|0|||
28128912|NCT03130257|54791920|FG000|Overall Study|Withdrawal by Subject|1|||
28128913|NCT03130257|54791921|FG001|Overall Study|Withdrawal by Subject|0|||
28128914|NCT03130257|54791922|FG002|Overall Study|Withdrawal by Subject|2|||
28128915|NCT03674177|54791934|FG000|Overall Study|Lost to Follow-up|2|||
28128916|NCT03674177|54791935|FG001|Overall Study|Lost to Follow-up|1|||
28128917|NCT03674177|54791936|FG002|Overall Study|Lost to Follow-up|0|||
28128918|NCT03674177|54791937|FG003|Overall Study|Lost to Follow-up|2|||
28128919|NCT03354637|54791963|FG000|Double-blind Period|Protocol Violation|2|||
28128920|NCT03354637|54791964|FG001|Double-blind Period|Protocol Violation|0|||
28128921|NCT03354637|54791965|FG002|Double-blind Period|Protocol Violation|0|||
28128922|NCT03354637|54791963|FG000|Double-blind Period|Adverse Event|1|||
28128923|NCT03354637|54791964|FG001|Double-blind Period|Adverse Event|2|||
28128924|NCT03354637|54791965|FG002|Double-blind Period|Adverse Event|0|||
28128925|NCT03354637|54791963|FG000|Double-blind Period|Lost to Follow-up|3|||
28128926|NCT03354637|54791964|FG001|Double-blind Period|Lost to Follow-up|4|||
28128927|NCT03354637|54791965|FG002|Double-blind Period|Lost to Follow-up|3|||
28128928|NCT03354637|54791963|FG000|Double-blind Period|Withdrawal by Subject|10|||
28128929|NCT03354637|54791964|FG001|Double-blind Period|Withdrawal by Subject|6|||
28067834|NCT00451451|54722969|FG003|Overall Study|Death|1|||
28067835|NCT00451451|54722966|FG000|Overall Study|Other Reasons for Not Completing Study|34|||
28067836|NCT00451451|54722967|FG001|Overall Study|Other Reasons for Not Completing Study|30|||
28067837|NCT00451451|54722968|FG002|Overall Study|Other Reasons for Not Completing Study|17|||
28067838|NCT00451451|54722969|FG003|Overall Study|Other Reasons for Not Completing Study|14|||
28067839|NCT03824912|54722984|FG000|Overall Study|Lost to Follow-up|18|||
28067840|NCT03824912|54722985|FG001|Overall Study|Lost to Follow-up|15|||
28067841|NCT03824912|54722986|FG002|Overall Study|Lost to Follow-up|8|||
28067842|NCT03824912|54722984|FG000|Overall Study|Negative Baseline Culture Result|118|||
28128930|NCT03354637|54791965|FG002|Double-blind Period|Withdrawal by Subject|4|||
28128931|NCT03354637|54791963|FG000|Double-blind Period|Incomplete Efficacy Data Collection|1|||
28128932|NCT03354637|54791964|FG001|Double-blind Period|Incomplete Efficacy Data Collection|1|||
28128933|NCT03354637|54791965|FG002|Double-blind Period|Incomplete Efficacy Data Collection|0|||
28128934|NCT03354637|54791963|FG000|Open Label Extension|Adverse Event|0|||
28128935|NCT03354637|54791964|FG001|Open Label Extension|Adverse Event|0|||
28128936|NCT03354637|54791965|FG002|Open Label Extension|Adverse Event|1|||
28128937|NCT03354637|54791963|FG000|Open Label Extension|Lost to Follow-up|0|||
28067843|NCT03824912|54722985|FG001|Overall Study|Negative Baseline Culture Result|112|||
28128938|NCT03354637|54791964|FG001|Open Label Extension|Lost to Follow-up|0|||
28128939|NCT03354637|54791965|FG002|Open Label Extension|Lost to Follow-up|2|||
28128940|NCT03354637|54791963|FG000|Open Label Extension|Withdrawal by Subject|0|||
28128941|NCT03354637|54791964|FG001|Open Label Extension|Withdrawal by Subject|0|||
28128942|NCT03354637|54791965|FG002|Open Label Extension|Withdrawal by Subject|5|||
28128943|NCT03354637|54791963|FG000|Open Label Extension|Study Terminated by Sponsor|0|||
28128944|NCT03354637|54791964|FG001|Open Label Extension|Study Terminated by Sponsor|0|||
28128945|NCT03354637|54791965|FG002|Open Label Extension|Study Terminated by Sponsor|17|||
28128946|NCT03354637|54791963|FG000|Open Label Extension|Subject Noncompliance|0|||
28128947|NCT03354637|54791964|FG001|Open Label Extension|Subject Noncompliance|0|||
28128948|NCT03354637|54791965|FG002|Open Label Extension|Subject Noncompliance|1|||
28128949|NCT03354637|54791963|FG000|Open Label Extension|Lack of Efficacy|0|||
28128950|NCT03354637|54791964|FG001|Open Label Extension|Lack of Efficacy|0|||
28128951|NCT03354637|54791965|FG002|Open Label Extension|Lack of Efficacy|1|||
28128952|NCT03354637|54791963|FG000|Open Label Extension|Physician Decision|0|||
28128953|NCT03354637|54791964|FG001|Open Label Extension|Physician Decision|0|||
28128954|NCT03354637|54791965|FG002|Open Label Extension|Physician Decision|1|||
28128955|NCT04053023|54791976|FG000|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1|||
28128956|NCT04053023|54791977|FG001|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0|||
28128957|NCT03352453|54791989|FG000|Overall Study|Miscellaneous Reasons|1|||
28128958|NCT03352453|54791990|FG001|Overall Study|Miscellaneous Reasons|2|||
28128959|NCT03352453|54791989|FG000|Overall Study|Lack of Efficacy|1|||
28128960|NCT03352453|54791990|FG001|Overall Study|Lack of Efficacy|0|||
28128961|NCT03352453|54791989|FG000|Overall Study|Withdrawal by Subject|8|||
28128962|NCT03352453|54791990|FG001|Overall Study|Withdrawal by Subject|14|||
28128963|NCT03352453|54791989|FG000|Overall Study|Study Terminated by Sponsor|2|||
28128964|NCT03352453|54791990|FG001|Overall Study|Study Terminated by Sponsor|1|||
28128965|NCT03352453|54791989|FG000|Overall Study|Protocol Deviation|1|||
28128966|NCT03352453|54791990|FG001|Overall Study|Protocol Deviation|0|||
28128967|NCT03352453|54791989|FG000|Overall Study|Lost to Follow-up|7|||
28128968|NCT03352453|54791990|FG001|Overall Study|Lost to Follow-up|6|||
28128969|NCT03352453|54791989|FG000|Overall Study|Adverse Event|2|||
28128970|NCT03352453|54791990|FG001|Overall Study|Adverse Event|9|||
28128971|NCT03128931|54791996|FG000|Overall Study|Physician Decision|1|||
28128972|NCT03128931|54791996|FG000|Overall Study|Equipment Issues|3|||
28128973|NCT03107052|54792003|FG000|Overall Study|Adverse Event|6|||
28128974|NCT03107052|54792004|FG001|Overall Study|Adverse Event|1|||
28128975|NCT03107052|54792005|FG002|Overall Study|Adverse Event|2|||
28067844|NCT03824912|54722986|FG002|Overall Study|Negative Baseline Culture Result|57|||
28128976|NCT03107052|54792003|FG000|Overall Study|Withdrawal by Subject|9|||
28128977|NCT03107052|54792004|FG001|Overall Study|Withdrawal by Subject|5|||
28128978|NCT03107052|54792005|FG002|Overall Study|Withdrawal by Subject|8|||
28128979|NCT03107052|54792003|FG000|Overall Study|Protocol Violation|6|||
28128980|NCT03107052|54792004|FG001|Overall Study|Protocol Violation|0|||
28128981|NCT03107052|54792005|FG002|Overall Study|Protocol Violation|3|||
28128982|NCT03107052|54792003|FG000|Overall Study|Lost to Follow-up|4|||
28067845|NCT03824912|54722984|FG000|Overall Study|Non-Compliance with Study Drug|0|||
28067846|NCT03824912|54722985|FG001|Overall Study|Non-Compliance with Study Drug|0|||
28067847|NCT03824912|54722986|FG002|Overall Study|Non-Compliance with Study Drug|1|||
28067848|NCT03824912|54722984|FG000|Overall Study|Protocol Violation|1|||
28067849|NCT03824912|54722985|FG001|Overall Study|Protocol Violation|4|||
28128983|NCT03107052|54792004|FG001|Overall Study|Lost to Follow-up|0|||
28128984|NCT03107052|54792005|FG002|Overall Study|Lost to Follow-up|1|||
28128985|NCT03107052|54792003|FG000|Overall Study|Lack of Efficacy|23|||
28128986|NCT03107052|54792004|FG001|Overall Study|Lack of Efficacy|7|||
28128987|NCT03107052|54792005|FG002|Overall Study|Lack of Efficacy|4|||
28128988|NCT03107052|54792003|FG000|Overall Study|Other than specified|4|||
28128989|NCT03107052|54792004|FG001|Overall Study|Other than specified|2|||
28128990|NCT03107052|54792005|FG002|Overall Study|Other than specified|0|||
28128991|NCT03107052|54792003|FG000|Overall Study|Study terminated due to futility|67|||
28128992|NCT03107052|54792004|FG001|Overall Study|Study terminated due to futility|31|||
28128993|NCT03107052|54792005|FG002|Overall Study|Study terminated due to futility|23|||
27818542|NCT01790984|54277163|FG000|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
28128994|NCT04050371|54792015|FG000|Overall Study|Withdrawal by Subject|1|||
28067850|NCT03824912|54722986|FG002|Overall Study|Protocol Violation|1|||
28067851|NCT03824912|54722984|FG000|Overall Study|Withdrawal by Subject|3|||
28067852|NCT03824912|54722985|FG001|Overall Study|Withdrawal by Subject|2|||
28067853|NCT03824912|54722986|FG002|Overall Study|Withdrawal by Subject|1|||
28128995|NCT04050371|54792016|FG001|Overall Study|Withdrawal by Subject|0|||
28128996|NCT04447287|54792025|FG000|Period 1: Run-in Period|Adverse Event|3|||
28128997|NCT04447287|54792026|FG001|Period 1: Run-in Period|Adverse Event|0|||
28128998|NCT04447287|54792027|FG002|Period 1: Run-in Period|Adverse Event|0|||
28128999|NCT04447287|54792025|FG000|Period 1: Run-in Period|Withdrawal by Subject|1|||
28129000|NCT04447287|54792026|FG001|Period 1: Run-in Period|Withdrawal by Subject|0|||
28129001|NCT04447287|54792027|FG002|Period 1: Run-in Period|Withdrawal by Subject|0|||
28129002|NCT04447287|54792025|FG000|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|1|||
28129003|NCT04447287|54792026|FG001|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
28129004|NCT04447287|54792027|FG002|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
28129005|NCT01879319|54792048|FG000|Overall Study|Withdrawal by Subject|1|||
28129006|NCT01879319|54792049|FG001|Overall Study|Withdrawal by Subject|0|||
28129007|NCT01879319|54792048|FG000|Overall Study|Lost to Follow-up|1|||
28129008|NCT01879319|54792049|FG001|Overall Study|Lost to Follow-up|5|||
28129009|NCT03102918|54792057|FG000|Overall Study|Protocol Violation|1|||
28129010|NCT03102918|54792058|FG001|Overall Study|Protocol Violation|0|||
28129011|NCT03128307|54792064|FG000|Overall Study|Lost to Follow-up|29|||
27818543|NCT01790984|54277164|FG001|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
27818544|NCT01790984|54277165|FG002|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
28129012|NCT03128307|54792064|FG000|Overall Study|Withdrawal by Subject|5|||
28129013|NCT03102762|54792070|FG000|Overall Study|Lost to Follow-up|1|||
28129014|NCT03102762|54792071|FG001|Overall Study|Lost to Follow-up|0|||
28129015|NCT01346475|54792084|FG000|First Intervention|Lost to Follow-up|4|||
28129016|NCT01346475|54792085|FG001|First Intervention|Lost to Follow-up|3|||
28129017|NCT01338636|54792091|FG000|Overall Study|Withdrawn due to lack of improvement|8|||
28129018|NCT00322218|54792097|FG000|Overall Study|Death|3|||
28129019|NCT00322218|54792098|FG001|Overall Study|Death|6|||
28129020|NCT02873754|54792104|FG000|Overall Study|Lost to Follow-up|5|||
28129021|NCT02873754|54792104|FG000|Overall Study|Couldn't complete study procedures|1|||
28129022|NCT03287414|54792110|FG000|Treatment Epoch|Adverse Event|0|||
28129023|NCT03287414|54792111|FG001|Treatment Epoch|Adverse Event|1|||
28129024|NCT03287414|54792110|FG000|Treatment Epoch|Study terminated by sponsor|2|||
28129025|NCT03287414|54792111|FG001|Treatment Epoch|Study terminated by sponsor|2|||
28129026|NCT03287414|54792110|FG000|Treatment Epoch|Subject/Guardian decision|4|||
28129027|NCT03287414|54792111|FG001|Treatment Epoch|Subject/Guardian decision|0|||
28129028|NCT03287414|54792110|FG000|Treatment Epoch|"Discontinued early with reason other selected"|1|||
28129029|NCT03287414|54792111|FG001|Treatment Epoch|"Discontinued early with reason other selected"|1|||
28129030|NCT03287414|54792110|FG000|Treatment Epoch|Withdrawal by Subject|1|||
28129031|NCT03287414|54792111|FG001|Treatment Epoch|Withdrawal by Subject|0|||
28129032|NCT03287414|54792110|FG000|PD/Safety Follow-up Epoch|Lost to Follow-up|1|||
28129033|NCT03287414|54792111|FG001|PD/Safety Follow-up Epoch|Lost to Follow-up|0|||
28129034|NCT03287414|54792110|FG000|PD/Safety Follow-up Epoch|Subject/Guardian decision|1|||
28129035|NCT03287414|54792111|FG001|PD/Safety Follow-up Epoch|Subject/Guardian decision|0|||
28129036|NCT03101592|54792141|FG000|Overall Study|participant files could not be located|111|||
28129037|NCT03101592|54792142|FG001|Overall Study|participant files could not be located|170|||
28129038|NCT03101592|54792143|FG002|Overall Study|participant files could not be located|118|||
28129039|NCT04046939|54792161|FG000|Primary Assessment Period|Adverse Event|1|||
28129040|NCT04046939|54792162|FG001|Primary Assessment Period|Adverse Event|0|||
28129041|NCT04046939|54792163|FG002|Primary Assessment Period|Adverse Event|0|||
28129042|NCT04046939|54792164|FG003|Primary Assessment Period|Adverse Event|0|||
28129043|NCT04046939|54792161|FG000|Primary Assessment Period|Withdrawal by Subject|1|||
28129044|NCT04046939|54792162|FG001|Primary Assessment Period|Withdrawal by Subject|0|||
28129045|NCT04046939|54792163|FG002|Primary Assessment Period|Withdrawal by Subject|1|||
28129046|NCT04046939|54792164|FG003|Primary Assessment Period|Withdrawal by Subject|0|||
27818545|NCT01790984|54277166|FG003|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
27818546|NCT01735994|54277191|FG000|Overall Study|Withdrawal by Subject|6|||
27818547|NCT01735994|54277192|FG001|Overall Study|Withdrawal by Subject|4|||
27818548|NCT01735994|54277191|FG000|Overall Study|Injury|2|||
27818549|NCT01735994|54277192|FG001|Overall Study|Injury|0|||
27818550|NCT01735994|54277191|FG000|Overall Study|Kicked off team|5|||
27818551|NCT01735994|54277192|FG001|Overall Study|Kicked off team|0|||
27818552|NCT01735994|54277191|FG000|Overall Study|Lost to Follow-up|50|||
27818553|NCT01735994|54277192|FG001|Overall Study|Lost to Follow-up|62|||
27818554|NCT01790828|54277198|FG000|Overall Study|Other|34|||
27818555|NCT01790594|54277204|FG000|Overall Study|Death|1|||
27818556|NCT01790594|54277205|FG001|Overall Study|Death|0|||
27818557|NCT01790594|54277206|FG002|Overall Study|Death|0|||
27818558|NCT01790594|54277204|FG000|Overall Study|Physician Decision|2|||
27818559|NCT01790594|54277205|FG001|Overall Study|Physician Decision|1|||
27818560|NCT01790594|54277206|FG002|Overall Study|Physician Decision|0|||
27818561|NCT01790594|54277204|FG000|Overall Study|Withdrawal by Subject|2|||
27818562|NCT01790594|54277205|FG001|Overall Study|Withdrawal by Subject|0|||
27818563|NCT01790594|54277206|FG002|Overall Study|Withdrawal by Subject|0|||
27818564|NCT01790594|54277204|FG000|Overall Study|Transplant was not done|0|||
27818565|NCT01790594|54277205|FG001|Overall Study|Transplant was not done|0|||
27818566|NCT01790594|54277206|FG002|Overall Study|Transplant was not done|3|||
27818567|NCT01790594|54277204|FG000|Overall Study|Terminated prior to week 76|0|||
27818568|NCT01790594|54277205|FG001|Overall Study|Terminated prior to week 76|2|||
27818569|NCT01790594|54277206|FG002|Overall Study|Terminated prior to week 76|0|||
27818570|NCT01790516|54277215|FG000|Overall Study|Physician Decision|1|||
27818571|NCT01790516|54277216|FG001|Overall Study|Physician Decision|0|||
27818572|NCT01790438|54277224|FG000|Overall Study|Adverse Event|3|||
28129047|NCT04046939|54792161|FG000|Primary Assessment Period|Physician Decision|0|||
28129048|NCT04046939|54792162|FG001|Primary Assessment Period|Physician Decision|0|||
28129049|NCT04046939|54792163|FG002|Primary Assessment Period|Physician Decision|1|||
28129050|NCT04046939|54792164|FG003|Primary Assessment Period|Physician Decision|0|||
28129051|NCT04046939|54792161|FG000|Eosinophil Recovery Period|Withdrawal by Subject|1|||
28129052|NCT04046939|54792162|FG001|Eosinophil Recovery Period|Withdrawal by Subject|0|||
28129053|NCT04046939|54792163|FG002|Eosinophil Recovery Period|Withdrawal by Subject|0|||
28129054|NCT04046939|54792164|FG003|Eosinophil Recovery Period|Withdrawal by Subject|1|||
28129055|NCT04042103|54792180|FG000|Overall Study|Lost to Follow-up|1|||
28129056|NCT04042103|54792180|FG000|Overall Study|Withdrawal by Subject|1|||
28129057|NCT02955797|54792188|FG000|Overall Study|Protocol Violation|1|||
28129058|NCT02955797|54792189|FG001|Overall Study|Protocol Violation|0|||
27818573|NCT01790438|54277225|FG001|Overall Study|Adverse Event|2|||
27818574|NCT01790438|54277224|FG000|Overall Study|Death|4|||
27818575|NCT01790438|54277225|FG001|Overall Study|Death|0|||
27818576|NCT01790438|54277224|FG000|Overall Study|Lost to Follow-up|5|||
28129059|NCT02955797|54792190|FG002|Overall Study|Protocol Violation|0|||
27818577|NCT01790438|54277225|FG001|Overall Study|Lost to Follow-up|2|||
27818578|NCT01790438|54277224|FG000|Overall Study|Withdrawal by Subject|13|||
27818579|NCT01790438|54277225|FG001|Overall Study|Withdrawal by Subject|2|||
27818580|NCT01790438|54277224|FG000|Overall Study|Physician Decision|3|||
27818581|NCT01790438|54277225|FG001|Overall Study|Physician Decision|1|||
28129060|NCT02955797|54792191|FG003|Overall Study|Protocol Violation|1|||
28129061|NCT02955797|54792188|FG000|Overall Study|Withdrawal by Subject|2|||
28129062|NCT02955797|54792189|FG001|Overall Study|Withdrawal by Subject|2|||
28129063|NCT02955797|54792190|FG002|Overall Study|Withdrawal by Subject|0|||
28129064|NCT02955797|54792191|FG003|Overall Study|Withdrawal by Subject|1|||
28129065|NCT02955797|54792188|FG000|Overall Study|Lost to Follow-up|0|||
28129066|NCT02955797|54792189|FG001|Overall Study|Lost to Follow-up|1|||
28129067|NCT02955797|54792190|FG002|Overall Study|Lost to Follow-up|0|||
28129068|NCT02955797|54792191|FG003|Overall Study|Lost to Follow-up|0|||
28129069|NCT03101514|54792204|FG000|Overall Study|Withdrawal by Subject|4|||
28129070|NCT03101514|54792204|FG000|Overall Study|Protocol Violation|2|||
28129071|NCT03101514|54792204|FG000|Overall Study|patient's information was incomplete|1|||
28129072|NCT02702518|54792210|FG000|Overall Study|Lost to Follow-up|3|||
28129073|NCT02702518|54792211|FG001|Overall Study|Lost to Follow-up|4|||
28129074|NCT04039503|54792221|FG000|Overall Study|Adverse Event|3|||
28129075|NCT04039503|54792222|FG001|Overall Study|Adverse Event|0|||
28129076|NCT04039503|54792223|FG002|Overall Study|Adverse Event|2|||
28129077|NCT04039503|54792224|FG003|Overall Study|Adverse Event|0|||
28129078|NCT04039503|54792221|FG000|Overall Study|Lost to Follow-up|0|||
28129079|NCT04039503|54792222|FG001|Overall Study|Lost to Follow-up|0|||
28129080|NCT04039503|54792223|FG002|Overall Study|Lost to Follow-up|1|||
28129081|NCT04039503|54792224|FG003|Overall Study|Lost to Follow-up|0|||
28129082|NCT04039503|54792221|FG000|Overall Study|Protocol Violation|0|||
28129083|NCT04039503|54792222|FG001|Overall Study|Protocol Violation|1|||
28129084|NCT04039503|54792223|FG002|Overall Study|Protocol Violation|2|||
28129085|NCT04039503|54792224|FG003|Overall Study|Protocol Violation|1|||
28129086|NCT04039503|54792221|FG000|Overall Study|Withdrawal by Subject|4|||
28129087|NCT04039503|54792222|FG001|Overall Study|Withdrawal by Subject|3|||
28129088|NCT04039503|54792223|FG002|Overall Study|Withdrawal by Subject|5|||
28129089|NCT04039503|54792224|FG003|Overall Study|Withdrawal by Subject|2|||
28129090|NCT03131895|54792261|FG000|Washout Period (at Least 5 Days)|Adverse Event|1|||
28129091|NCT03131895|54792262|FG001|Washout Period (at Least 5 Days)|Adverse Event|0|||
28129092|NCT03131895|54792263|FG002|Washout Period (at Least 5 Days)|Adverse Event|0|||
28129093|NCT03131895|54792264|FG003|Washout Period (at Least 5 Days)|Adverse Event|1|||
28129094|NCT03131895|54792261|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
28129095|NCT03131895|54792262|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
28129096|NCT03131895|54792263|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|2|||
28129097|NCT03131895|54792264|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
28129098|NCT03131895|54792261|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
28129099|NCT03131895|54792262|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|2|||
28129100|NCT03131895|54792263|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
28129101|NCT03131895|54792264|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
28129102|NCT03131895|54792261|FG000|Washout Period (at Least 5 Days)|Other|0|||
28129103|NCT03131895|54792262|FG001|Washout Period (at Least 5 Days)|Other|0|||
28129104|NCT03131895|54792263|FG002|Washout Period (at Least 5 Days)|Other|2|||
28129105|NCT03131895|54792264|FG003|Washout Period (at Least 5 Days)|Other|0|||
28129106|NCT03131895|54792261|FG000|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
28129107|NCT03131895|54792262|FG001|Intervention Period 2 (2 Days)|Lost to Follow-up|1|||
28129108|NCT03131895|54792263|FG002|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
28129109|NCT03131895|54792264|FG003|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
28129110|NCT03131895|54792261|FG000|Intervention Period 2 (2 Days)|Withdrawal by Subject|1|||
28129111|NCT03131895|54792262|FG001|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
28129112|NCT03131895|54792263|FG002|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
28129113|NCT03131895|54792264|FG003|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
28129114|NCT04039919|54792279|FG000|Treatment Period 1|Withdrawal by Subject|1|||
28129115|NCT04039919|54792280|FG001|Treatment Period 1|Withdrawal by Subject|0|||
28129116|NCT04039919|54792281|FG002|Treatment Period 1|Withdrawal by Subject|0|||
28129117|NCT04039919|54792282|FG003|Treatment Period 1|Withdrawal by Subject|0|||
28129118|NCT04039919|54792283|FG004|Treatment Period 1|Withdrawal by Subject|0|||
28129119|NCT04039919|54792279|FG000|Treatment Period 1|Sponsor's decision|0|||
28129120|NCT04039919|54792280|FG001|Treatment Period 1|Sponsor's decision|0|||
28129121|NCT04039919|54792281|FG002|Treatment Period 1|Sponsor's decision|0|||
28129122|NCT04039919|54792282|FG003|Treatment Period 1|Sponsor's decision|0|||
28129123|NCT04039919|54792283|FG004|Treatment Period 1|Sponsor's decision|16|||
28129124|NCT04039919|54792279|FG000|Treatment Period 5|Withdrawal by Subject|1|||
28129125|NCT04039919|54792280|FG001|Treatment Period 5|Withdrawal by Subject|0|||
28129126|NCT04039919|54792281|FG002|Treatment Period 5|Withdrawal by Subject|0|||
28129127|NCT04039919|54792282|FG003|Treatment Period 5|Withdrawal by Subject|0|||
28129128|NCT04039919|54792283|FG004|Treatment Period 5|Withdrawal by Subject|0|||
28129129|NCT04035473|54792319|FG000|Screening/Baseline|Death|0|||
28129130|NCT04035473|54792320|FG001|Screening/Baseline|Death|1|||
28129131|NCT04035473|54792319|FG000|Screening/Baseline|Adverse Event|0|||
28129132|NCT04035473|54792320|FG001|Screening/Baseline|Adverse Event|1|||
28129133|NCT04035473|54792319|FG000|Follow-up Period|Adverse Event|2|||
28129134|NCT04035473|54792320|FG001|Follow-up Period|Adverse Event|0|||
28129135|NCT04032977|54792328|FG000|Overall Study|Withdrawal by Subject|6|||
28129136|NCT04032977|54792329|FG001|Overall Study|Withdrawal by Subject|1|||
28129137|NCT04032977|54792328|FG000|Overall Study|Lost to Follow-up|2|||
28129138|NCT04032977|54792329|FG001|Overall Study|Lost to Follow-up|7|||
28129139|NCT04032977|54792328|FG000|Overall Study|Pregnancy|1|||
28129140|NCT04032977|54792329|FG001|Overall Study|Pregnancy|0|||
28129141|NCT04030247|54792335|FG000|Overall Study|Withdrawal by Subject|4|||
28129142|NCT04030247|54792335|FG000|Overall Study|Lost to Follow-up|13|||
28129143|NCT02915978|54792342|FG000|Overall Study|Adverse Event|2|||
28129144|NCT02915978|54792343|FG001|Overall Study|Adverse Event|1|||
28129145|NCT02915978|54792344|FG002|Overall Study|Adverse Event|0|||
28129146|NCT02701192|54792352|FG000|Overall Study|Protocol Violation|2|||
28129147|NCT02701192|54792352|FG000|Overall Study|Lost to Follow-up|4|||
28129148|NCT03101358|54792360|FG000|Overall Study|Non-compliance with study schedule|1|||
28129149|NCT03101358|54792361|FG001|Overall Study|Non-compliance with study schedule|0|||
28129150|NCT03101358|54792362|FG002|Overall Study|Non-compliance with study schedule|0|||
28129151|NCT03101358|54792363|FG003|Overall Study|Non-compliance with study schedule|1|||
28129152|NCT03101358|54792360|FG000|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
28129153|NCT03101358|54792361|FG001|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
28129154|NCT03101358|54792362|FG002|Overall Study|Decision to start another clinical trial. Not related to AE.|1|||
28129155|NCT03101358|54792363|FG003|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
28129156|NCT03101358|54792360|FG000|Overall Study|Physician Decision|1|||
28129157|NCT03101358|54792361|FG001|Overall Study|Physician Decision|0|||
28129158|NCT03101358|54792362|FG002|Overall Study|Physician Decision|0|||
28129159|NCT03101358|54792363|FG003|Overall Study|Physician Decision|3|||
28129160|NCT03101358|54792360|FG000|Overall Study|Adverse Event|0|||
28129161|NCT03101358|54792361|FG001|Overall Study|Adverse Event|0|||
28129162|NCT03101358|54792362|FG002|Overall Study|Adverse Event|1|||
28129163|NCT03101358|54792363|FG003|Overall Study|Adverse Event|0|||
28129164|NCT03101358|54792360|FG000|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
28129165|NCT03101358|54792361|FG001|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
28129166|NCT03101358|54792362|FG002|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
28129167|NCT03101358|54792363|FG003|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|1|||
28129168|NCT03101358|54792360|FG000|Overall Study|Lost to Follow-up|1|||
28129169|NCT03101358|54792361|FG001|Overall Study|Lost to Follow-up|0|||
28129170|NCT03101358|54792362|FG002|Overall Study|Lost to Follow-up|0|||
28129171|NCT03101358|54792363|FG003|Overall Study|Lost to Follow-up|1|||
28129172|NCT03657095|54792376|FG000|Overall Study|Withdrawal by Subject|1|||
28129173|NCT03657095|54792377|FG001|Overall Study|Withdrawal by Subject|1|||
28129174|NCT03657095|54792376|FG000|Overall Study|Adverse Event|0|||
28129175|NCT03657095|54792377|FG001|Overall Study|Adverse Event|3|||
28129176|NCT03657095|54792376|FG000|Overall Study|Study Terminated by Sponsor|58|||
28129177|NCT03657095|54792377|FG001|Overall Study|Study Terminated by Sponsor|49|||
28129178|NCT03100344|54792387|FG000|Overall Study|Adverse Event|0|||
28129179|NCT03100344|54792388|FG001|Overall Study|Adverse Event|3|||
28129180|NCT03100344|54792389|FG002|Overall Study|Adverse Event|2|||
28129181|NCT03100344|54792390|FG003|Overall Study|Adverse Event|3|||
28129182|NCT03100344|54792387|FG000|Overall Study|Lack of Efficacy|2|||
28129183|NCT03100344|54792388|FG001|Overall Study|Lack of Efficacy|0|||
28129184|NCT03100344|54792389|FG002|Overall Study|Lack of Efficacy|0|||
28129185|NCT03100344|54792390|FG003|Overall Study|Lack of Efficacy|0|||
28129186|NCT03100344|54792387|FG000|Overall Study|Protocol Violation|1|||
28129187|NCT03100344|54792388|FG001|Overall Study|Protocol Violation|0|||
28129188|NCT03100344|54792389|FG002|Overall Study|Protocol Violation|0|||
28129189|NCT03100344|54792390|FG003|Overall Study|Protocol Violation|0|||
28129190|NCT03100344|54792387|FG000|Overall Study|Withdrawal by Subject|10|||
28129191|NCT03100344|54792388|FG001|Overall Study|Withdrawal by Subject|7|||
28129192|NCT03100344|54792389|FG002|Overall Study|Withdrawal by Subject|4|||
28129193|NCT03100344|54792390|FG003|Overall Study|Withdrawal by Subject|8|||
28129194|NCT03100344|54792387|FG000|Overall Study|Lost to Follow-up|1|||
28129195|NCT03100344|54792388|FG001|Overall Study|Lost to Follow-up|1|||
28129196|NCT03100344|54792389|FG002|Overall Study|Lost to Follow-up|1|||
28129197|NCT03100344|54792390|FG003|Overall Study|Lost to Follow-up|1|||
28129198|NCT02951533|54792403|FG000|Part I (Week 0 Through Week 24)|Adverse Event|0|||
28129199|NCT02951533|54792404|FG001|Part I (Week 0 Through Week 24)|Adverse Event|16|||
28129200|NCT02951533|54792405|FG002|Part I (Week 0 Through Week 24)|Adverse Event|0|||
28129201|NCT02951533|54792403|FG000|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
28129202|NCT02951533|54792404|FG001|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
28129203|NCT02951533|54792405|FG002|Part I (Week 0 Through Week 24)|Lost to Follow-up|0|||
28129204|NCT02951533|54792403|FG000|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2|||
28129205|NCT02951533|54792404|FG001|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4|||
28129206|NCT02951533|54792405|FG002|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0|||
28129207|NCT02951533|54792403|FG000|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
28129208|NCT02951533|54792404|FG001|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1|||
28129209|NCT02951533|54792405|FG002|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
28129210|NCT02951533|54792403|FG000|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
28129211|NCT02951533|54792404|FG001|Part IIa (Week 24 Through Week 32)|Adverse Event|1|||
28129212|NCT02951533|54792405|FG002|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
28129213|NCT02951533|54792403|FG000|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1|||
28129214|NCT02951533|54792404|FG001|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
28129215|NCT02951533|54792405|FG002|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
28129216|NCT02951533|54792403|FG000|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
28129217|NCT02951533|54792404|FG001|Part IIb (Week 32 Through Week 56)|Adverse Event|2|||
28129218|NCT02951533|54792405|FG002|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
28129219|NCT02951533|54792403|FG000|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1|||
28129220|NCT02951533|54792404|FG001|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2|||
28129221|NCT02951533|54792405|FG002|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0|||
28129222|NCT02951533|54792403|FG000|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1|||
28129223|NCT02951533|54792404|FG001|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
28129224|NCT02951533|54792405|FG002|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
28129225|NCT02951533|54792403|FG000|Part III (Week 64 Through Week 100)|Lost to Follow-up|1|||
28129226|NCT02951533|54792404|FG001|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
28129227|NCT02951533|54792405|FG002|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
28129228|NCT02951533|54792403|FG000|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
28129229|NCT02951533|54792404|FG001|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0|||
28129230|NCT02951533|54792405|FG002|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
28129231|NCT02700412|54792422|FG000|Overall Study|Adverse Event|6|||
28129232|NCT02700412|54792422|FG000|Overall Study|Death|1|||
28129233|NCT02700412|54792422|FG000|Overall Study|Lack of Efficacy|19|||
28129234|NCT02700412|54792422|FG000|Overall Study|Protocol Violation|5|||
28129235|NCT02700412|54792422|FG000|Overall Study|Withdrawal by Subject|2|||
28129236|NCT03665441|54792428|FG000|Overall Study|survival follow up ongoing|23|||
28129237|NCT03665441|54792429|FG001|Overall Study|survival follow up ongoing|0|||
28129238|NCT03665441|54792428|FG000|Overall Study|Patients ongoing on treatment|9|||
28129239|NCT03665441|54792429|FG001|Overall Study|Patients ongoing on treatment|6|||
28129240|NCT03665441|54792428|FG000|Overall Study|Randomized but not treated|7|||
28129241|NCT03665441|54792429|FG001|Overall Study|Randomized but not treated|11|||
28129242|NCT02699866|54792435|FG000|Overall Study|Withdrawal by Subject|3|||
28129243|NCT02699866|54792435|FG000|Overall Study|Physician Decision|2|||
28129244|NCT02699866|54792435|FG000|Overall Study|Adverse Event|3|||
27818582|NCT01790438|54277224|FG000|Overall Study|Sponsor Decision|0|||
27818583|NCT01790438|54277225|FG001|Overall Study|Sponsor Decision|3|||
28067854|NCT03824912|54722984|FG000|Overall Study|Participation in another study|0|||
28067855|NCT03824912|54722985|FG001|Overall Study|Participation in another study|1|||
28067856|NCT03824912|54722986|FG002|Overall Study|Participation in another study|0|||
28067857|NCT00461123|54722996|FG000|Overall Study|Adverse Event|1|||
28067858|NCT00461123|54722997|FG001|Overall Study|Adverse Event|0|||
28067859|NCT00461123|54722996|FG000|Overall Study|Lost to Follow-up|1|||
28067860|NCT00461123|54722997|FG001|Overall Study|Lost to Follow-up|1|||
28067861|NCT00461123|54722996|FG000|Overall Study|Protocol Violation|3|||
28067862|NCT00461123|54722997|FG001|Overall Study|Protocol Violation|2|||
28067863|NCT00461123|54722996|FG000|Overall Study|Withdrawal by Subject|1|||
28067864|NCT00461123|54722997|FG001|Overall Study|Withdrawal by Subject|3|||
28067865|NCT00290342|54723005|FG000|Overall Study|Other|0|||
28067866|NCT00290342|54723006|FG001|Overall Study|Other|1|||
28067867|NCT00290342|54723005|FG000|Overall Study|Withdrawal by Subject|6|||
28067868|NCT00290342|54723006|FG001|Overall Study|Withdrawal by Subject|4|||
28067869|NCT00290342|54723005|FG000|Overall Study|Lost to Follow-up|1|||
28067870|NCT00290342|54723006|FG001|Overall Study|Lost to Follow-up|0|||
28067871|NCT00460811|54723017|FG000|Overall Study|Adverse Event|4|||
28067872|NCT00460811|54723018|FG001|Overall Study|Adverse Event|6|||
28067873|NCT00460811|54723019|FG002|Overall Study|Adverse Event|3|||
28067874|NCT00460811|54723020|FG003|Overall Study|Adverse Event|10|||
28067875|NCT00460811|54723021|FG004|Overall Study|Adverse Event|2|||
28067876|NCT00460811|54723017|FG000|Overall Study|Noncompliance|1|||
28067877|NCT00460811|54723018|FG001|Overall Study|Noncompliance|0|||
28067878|NCT00460811|54723019|FG002|Overall Study|Noncompliance|0|||
28067879|NCT00460811|54723020|FG003|Overall Study|Noncompliance|2|||
28067880|NCT00460811|54723021|FG004|Overall Study|Noncompliance|1|||
28067881|NCT00460811|54723017|FG000|Overall Study|Withdrawal by Subject|7|||
28067882|NCT00460811|54723018|FG001|Overall Study|Withdrawal by Subject|7|||
28067883|NCT00460811|54723019|FG002|Overall Study|Withdrawal by Subject|6|||
28129245|NCT03663569|54792439|FG000|Overall Study|Discontinuation of study|11|||
28129246|NCT03663569|54792439|FG000|Overall Study|Never taken Spiolto® Respimat®|1|||
28067884|NCT00460811|54723020|FG003|Overall Study|Withdrawal by Subject|3|||
28067885|NCT00460811|54723021|FG004|Overall Study|Withdrawal by Subject|11|||
28067886|NCT00460811|54723017|FG000|Overall Study|Physician Decision|1|||
28067887|NCT00460811|54723018|FG001|Overall Study|Physician Decision|0|||
28067888|NCT00460811|54723019|FG002|Overall Study|Physician Decision|0|||
28129247|NCT03663569|54792439|FG000|Overall Study|Deceased patient|6|||
28129248|NCT03663569|54792439|FG000|Overall Study|Lost to Follow-up|18|||
28129249|NCT03663569|54792439|FG000|Overall Study|Withdrawal of consent|5|||
28129250|NCT03663569|54792439|FG000|Overall Study|Patient's request|11|||
28067889|NCT00460811|54723020|FG003|Overall Study|Physician Decision|0|||
28067890|NCT00460811|54723021|FG004|Overall Study|Physician Decision|0|||
28067891|NCT00460811|54723017|FG000|Overall Study|Lost to Follow-up|3|||
28129251|NCT03663569|54792439|FG000|Overall Study|Adverse Event|4|||
28129252|NCT03663569|54792439|FG000|Overall Study|Not come to second visit|3|||
28129253|NCT03663569|54792439|FG000|Overall Study|Not meet inclusion / exclusion criterion|3|||
28129254|NCT03663569|54792439|FG000|Overall Study|Serious adverse event|1|||
28129255|NCT03596762|54792448|FG000|Overall Study|Protocol Violation|0|||
28129256|NCT03596762|54792449|FG001|Overall Study|Protocol Violation|0|||
28129257|NCT03596762|54792450|FG002|Overall Study|Protocol Violation|0|||
28129258|NCT03596762|54792451|FG003|Overall Study|Protocol Violation|0|||
28129259|NCT03596762|54792452|FG004|Overall Study|Protocol Violation|1|||
28129260|NCT03596762|54792448|FG000|Overall Study|Adverse Event|2|||
28129261|NCT03596762|54792449|FG001|Overall Study|Adverse Event|0|||
28129262|NCT03596762|54792450|FG002|Overall Study|Adverse Event|1|||
28129263|NCT03596762|54792451|FG003|Overall Study|Adverse Event|0|||
28129264|NCT03596762|54792452|FG004|Overall Study|Adverse Event|5|||
28129265|NCT03596762|54792448|FG000|Overall Study|Withdrawal by Subject|2|||
28129266|NCT03596762|54792449|FG001|Overall Study|Withdrawal by Subject|1|||
28129267|NCT03596762|54792450|FG002|Overall Study|Withdrawal by Subject|0|||
28129268|NCT03596762|54792451|FG003|Overall Study|Withdrawal by Subject|1|||
28129269|NCT03596762|54792452|FG004|Overall Study|Withdrawal by Subject|1|||
28129270|NCT03663179|54792470|FG000|Overall Study|Withdrawal by Subject|2|||
28129271|NCT03663179|54792471|FG001|Overall Study|Withdrawal by Subject|0|||
28129272|NCT03663179|54792470|FG000|Overall Study|Lost to Follow-up|1|||
28129273|NCT03663179|54792471|FG001|Overall Study|Lost to Follow-up|1|||
28129274|NCT03663179|54792470|FG000|Overall Study|Revealed exclusionary condition|1|||
28129275|NCT03663179|54792471|FG001|Overall Study|Revealed exclusionary condition|0|||
28129276|NCT03662789|54792479|FG000|Overall Study|Lost to Follow-up|1|||
28129277|NCT03662789|54792480|FG001|Overall Study|Lost to Follow-up|2|||
28129278|NCT03662789|54792479|FG000|Overall Study|Could not perform treadmill test|4|||
28129279|NCT03662789|54792480|FG001|Overall Study|Could not perform treadmill test|4|||
28129280|NCT03662789|54792479|FG000|Overall Study|Death|0|||
28129281|NCT03662789|54792480|FG001|Overall Study|Death|1|||
28129282|NCT03658889|54792488|FG000|Overall Study|Protocol Violation|2|||
28129283|NCT03658889|54792489|FG001|Overall Study|Protocol Violation|0|||
28129284|NCT03655691|54792497|FG000|Overall Study|Adverse Event|0|||
28129285|NCT03655691|54792498|FG001|Overall Study|Adverse Event|0|||
28129286|NCT03655691|54792499|FG002|Overall Study|Adverse Event|1|||
28129287|NCT03655691|54792497|FG000|Overall Study|Lost to Follow-up|1|||
28129288|NCT03655691|54792498|FG001|Overall Study|Lost to Follow-up|1|||
28129289|NCT03655691|54792499|FG002|Overall Study|Lost to Follow-up|2|||
28129290|NCT03655691|54792497|FG000|Overall Study|Protocol Violation|0|||
28129291|NCT03655691|54792498|FG001|Overall Study|Protocol Violation|1|||
28129292|NCT03655691|54792499|FG002|Overall Study|Protocol Violation|0|||
28129293|NCT03655691|54792497|FG000|Overall Study|Withdrawal by Subject|1|||
28129294|NCT03655691|54792498|FG001|Overall Study|Withdrawal by Subject|1|||
28067892|NCT00460811|54723018|FG001|Overall Study|Lost to Follow-up|2|||
28067893|NCT00460811|54723019|FG002|Overall Study|Lost to Follow-up|5|||
28067894|NCT00460811|54723020|FG003|Overall Study|Lost to Follow-up|3|||
28067895|NCT00460811|54723021|FG004|Overall Study|Lost to Follow-up|6|||
28067896|NCT00290186|54723040|FG000|Overall Study|Adverse Event|1|||
28067897|NCT00290186|54723041|FG001|Overall Study|Adverse Event|1|||
28067898|NCT00290186|54723040|FG000|Overall Study|Lost to Follow-up|3|||
28067899|NCT00290186|54723041|FG001|Overall Study|Lost to Follow-up|2|||
28067900|NCT00290186|54723040|FG000|Overall Study|Study was terminated prior to 3-month te|1|||
28067901|NCT00290186|54723041|FG001|Overall Study|Study was terminated prior to 3-month te|1|||
28067902|NCT00290186|54723040|FG000|Overall Study|Withdrawal by Subject|0|||
28067903|NCT00290186|54723041|FG001|Overall Study|Withdrawal by Subject|1|||
28067904|NCT00460655|54723051|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
28129295|NCT03655691|54792499|FG002|Overall Study|Withdrawal by Subject|0|||
28129296|NCT03658811|54792507|FG000|Overall Study|Lost to Follow-up|3|||
28129297|NCT03631355|54792517|FG000|Overall Study|Lost to Follow-up|1|||
28129298|NCT03631355|54792518|FG001|Overall Study|Lost to Follow-up|2|||
28129299|NCT03629249|54792527|FG000|Overall Study|Study terminated by sponsor|197|||
28129300|NCT03629249|54792528|FG001|Overall Study|Study terminated by sponsor|197|||
28129301|NCT03629249|54792529|FG002|Overall Study|Study terminated by sponsor|194|||
28129302|NCT03629249|54792527|FG000|Overall Study|Protocol deviation|0|||
28129303|NCT03629249|54792528|FG001|Overall Study|Protocol deviation|2|||
28129304|NCT03629249|54792529|FG002|Overall Study|Protocol deviation|5|||
28067905|NCT00460655|54723052|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
28067906|NCT00460655|54723053|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
28129305|NCT03629249|54792527|FG000|Overall Study|Subject decision|1|||
28129306|NCT03629249|54792528|FG001|Overall Study|Subject decision|1|||
28129307|NCT03629249|54792529|FG002|Overall Study|Subject decision|3|||
28129308|NCT03629249|54792527|FG000|Overall Study|Adverse Event|1|||
28129309|NCT03629249|54792528|FG001|Overall Study|Adverse Event|1|||
28129310|NCT03629249|54792529|FG002|Overall Study|Adverse Event|0|||
28129311|NCT03629249|54792527|FG000|Overall Study|Death|1|||
28129312|NCT03629249|54792528|FG001|Overall Study|Death|0|||
28129313|NCT03629249|54792529|FG002|Overall Study|Death|0|||
28129314|NCT03629249|54792527|FG000|Overall Study|Physician Decision|1|||
28129315|NCT03629249|54792528|FG001|Overall Study|Physician Decision|0|||
28129316|NCT03629249|54792529|FG002|Overall Study|Physician Decision|0|||
28129317|NCT03628781|54792539|FG000|Overall Study|Lost to Follow-up|16|||
28129318|NCT03628781|54792540|FG001|Overall Study|Lost to Follow-up|8|||
28129319|NCT03628781|54792539|FG000|Overall Study|Withdrawal by Subject|16|||
28129320|NCT03628781|54792540|FG001|Overall Study|Withdrawal by Subject|1|||
28129321|NCT03371251|54792552|FG000|Overall Study|Withdrawal by Subject|1|||
28129322|NCT03371251|54792553|FG001|Overall Study|Withdrawal by Subject|0|||
28129323|NCT03371251|54792554|FG002|Overall Study|Withdrawal by Subject|1|||
28129324|NCT03371251|54792555|FG003|Overall Study|Withdrawal by Subject|0|||
28129325|NCT03371251|54792556|FG004|Overall Study|Withdrawal by Subject|2|||
28129326|NCT03371251|54792557|FG005|Overall Study|Withdrawal by Subject|2|||
28129327|NCT03371251|54792552|FG000|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|1|||
28129328|NCT03371251|54792553|FG001|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
28129329|NCT03371251|54792554|FG002|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
28129330|NCT03371251|54792555|FG003|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
28129331|NCT03371251|54792556|FG004|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|2|||
28129332|NCT03371251|54792557|FG005|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|3|||
28129333|NCT03371251|54792552|FG000|Overall Study|Adverse Event|0|||
28129334|NCT03371251|54792553|FG001|Overall Study|Adverse Event|0|||
28129335|NCT03371251|54792554|FG002|Overall Study|Adverse Event|0|||
28129336|NCT03371251|54792555|FG003|Overall Study|Adverse Event|0|||
28129337|NCT03371251|54792556|FG004|Overall Study|Adverse Event|1|||
28129338|NCT03371251|54792557|FG005|Overall Study|Adverse Event|0|||
28129339|NCT03371251|54792552|FG000|Overall Study|Decision by Sponsor|0|||
28129340|NCT03371251|54792553|FG001|Overall Study|Decision by Sponsor|0|||
28129341|NCT03371251|54792554|FG002|Overall Study|Decision by Sponsor|0|||
27849441|NCT02400671|54345819|FG001|Overall Study|Withdrawal by Subject|2|||
27849442|NCT02400671|54345820|FG002|Overall Study|Withdrawal by Subject|0|||
27940540|NCT01022853|54596831|FG001|Overall Study|Dose-limiting toxicity|0|||
28067907|NCT00460655|54723054|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
28067908|NCT00460655|54723051|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3|||
28067909|NCT00460655|54723052|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
28067910|NCT00460655|54723053|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
28067911|NCT00460655|54723054|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
28067912|NCT00460655|54723051|FG000|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
28067913|NCT00460655|54723052|FG001|Double-Blind Phase (12 Weeks)|Protocol Violation|1|||
28067914|NCT00460655|54723053|FG002|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
28067915|NCT00460655|54723054|FG003|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
28067916|NCT00460655|54723051|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
28067917|NCT00460655|54723052|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
28067918|NCT00460655|54723053|FG002|Open-Label Phase (36 Weeks)|Adverse Event|1|||
28067919|NCT00460655|54723054|FG003|Open-Label Phase (36 Weeks)|Adverse Event|6|||
28067920|NCT00460655|54723051|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
28067921|NCT00460655|54723052|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
28067922|NCT00460655|54723053|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6|||
28067923|NCT00460655|54723054|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2|||
28067924|NCT00460655|54723051|FG000|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
28067925|NCT00460655|54723052|FG001|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
28067926|NCT00460655|54723053|FG002|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
28129342|NCT03371251|54792555|FG003|Overall Study|Decision by Sponsor|0|||
28129343|NCT03371251|54792556|FG004|Overall Study|Decision by Sponsor|2|||
28129344|NCT03371251|54792557|FG005|Overall Study|Decision by Sponsor|0|||
28129345|NCT03370471|54792576|FG000|Overall Study|Withdrawal by Subject|6|||
28129346|NCT03370471|54792577|FG001|Overall Study|Withdrawal by Subject|1|||
27849443|NCT00089999|54345830|FG000|Overall Study|Adverse Event|4|||
28129347|NCT03370471|54792576|FG000|Overall Study|Unable to access veins for blood draw|0|||
28129348|NCT03370471|54792577|FG001|Overall Study|Unable to access veins for blood draw|1|||
28129349|NCT03370471|54792576|FG000|Overall Study|Screen fail|1|||
28129350|NCT03370471|54792577|FG001|Overall Study|Screen fail|0|||
28129351|NCT03349645|54792585|FG000|Overall Study|Sponsor Terminated Study|75|||
28129352|NCT03349645|54792585|FG000|Overall Study|Withdrawal by Subject|4|||
28129353|NCT03349645|54792585|FG000|Overall Study|Protocol Violation|1|||
28129354|NCT03349645|54792585|FG000|Overall Study|Other|2|||
28129355|NCT03349333|54792589|FG000|Overall Study|Progression of Disease|36|||
28129356|NCT03349333|54792589|FG000|Overall Study|Adverse Event|11|||
28129357|NCT03349333|54792589|FG000|Overall Study|Other|6|||
28129358|NCT03349333|54792589|FG000|Overall Study|Withdrawal by Subject|5|||
28129359|NCT03349333|54792589|FG000|Overall Study|Conditions interfere with participation|2|||
28129360|NCT03349333|54792589|FG000|Overall Study|Physician Decision|2|||
28129361|NCT03349333|54792589|FG000|Overall Study|3-week lapse between pralatrexate doses|1|||
28129362|NCT03349333|54792589|FG000|Overall Study|Patients in treatment less than 24 month|8|||
28129363|NCT03349099|54792595|FG000|Overall Study|Physician Decision|3|||
28129364|NCT03349099|54792596|FG001|Overall Study|Physician Decision|4|||
28129365|NCT03349099|54792595|FG000|Overall Study|Stone migrated from the kidney|1|||
28129366|NCT03349099|54792596|FG001|Overall Study|Stone migrated from the kidney|0|||
28129367|NCT03348163|54792604|FG000|Overall Study|Withdrawal by Subject|2|||
28129368|NCT03348163|54792605|FG001|Overall Study|Withdrawal by Subject|0|||
28129369|NCT03347695|54792613|FG000|Overall Study|Death|0|||
28129370|NCT03347695|54792614|FG001|Overall Study|Death|4|||
28129371|NCT03347695|54792613|FG000|Overall Study|Lost to Follow-up|0|||
28129372|NCT03347695|54792614|FG001|Overall Study|Lost to Follow-up|1|||
28129373|NCT02892019|54792624|FG000|Overall Study|randomized but not treated|0|||
28129374|NCT02892019|54792625|FG001|Overall Study|randomized but not treated|1|||
28129375|NCT02892019|54792624|FG000|Overall Study|Withdrawal by Subject|0|||
28129376|NCT02892019|54792625|FG001|Overall Study|Withdrawal by Subject|1|||
28129377|NCT02892019|54792624|FG000|Overall Study|Adverse Event|1|||
28129378|NCT02892019|54792625|FG001|Overall Study|Adverse Event|1|||
28129379|NCT03365791|54792631|FG000|Overall Study|Adverse Event|5|||
28129380|NCT03365791|54792631|FG000|Overall Study|Death|1|||
28129381|NCT03365791|54792631|FG000|Overall Study|Lost to Follow-up|1|||
28129382|NCT03365791|54792631|FG000|Overall Study|Physician Decision|9|||
28129383|NCT03365791|54792631|FG000|Overall Study|Progressive disease|51|||
28129384|NCT03365791|54792631|FG000|Overall Study|Subject/guardian decision|5|||
28129385|NCT03365011|54792638|FG000|Overall Study|Withdrawal by Subject|1|||
28129386|NCT03365011|54792639|FG001|Overall Study|Withdrawal by Subject|2|||
28129387|NCT03627767|54792648|FG000|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|48|||
28129388|NCT03627767|54792649|FG001|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
28129389|NCT03627767|54792650|FG002|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
28129390|NCT03627767|54792651|FG003|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
28129391|NCT03627767|54792652|FG004|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
28129392|NCT03627767|54792648|FG000|Open-label (OL) Run-in Period (12 Weeks)|Death|1|||
28129393|NCT03627767|54792649|FG001|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
28129394|NCT03627767|54792650|FG002|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
28129395|NCT03627767|54792651|FG003|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
28129396|NCT03627767|54792652|FG004|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
28129397|NCT03627767|54792648|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|315|||
28129398|NCT03627767|54792649|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
28129399|NCT03627767|54792650|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
28129400|NCT03627767|54792651|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
28129401|NCT03627767|54792652|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
28129402|NCT03627767|54792648|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|13|||
28129403|NCT03627767|54792649|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
28129404|NCT03627767|54792650|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
28129405|NCT03627767|54792651|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
28129406|NCT03627767|54792652|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
28129407|NCT03627767|54792648|FG000|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|11|||
28129408|NCT03627767|54792649|FG001|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
28129409|NCT03627767|54792650|FG002|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
28129410|NCT03627767|54792651|FG003|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
28129411|NCT03627767|54792652|FG004|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
28129412|NCT03627767|54792648|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|40|||
28129413|NCT03627767|54792649|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
28129414|NCT03627767|54792650|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
28129415|NCT03627767|54792651|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
28129416|NCT03627767|54792652|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
28129417|NCT03627767|54792648|FG000|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|1|||
28129418|NCT03627767|54792649|FG001|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
28129419|NCT03627767|54792650|FG002|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
28129420|NCT03627767|54792651|FG003|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
28129421|NCT03627767|54792652|FG004|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
28129422|NCT03627767|54792648|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|2|||
28129423|NCT03627767|54792649|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
28129424|NCT03627767|54792650|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
28129425|NCT03627767|54792651|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
28129426|NCT03627767|54792652|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
28129427|NCT03627767|54792648|FG000|Open-label (OL) Run-in Period (12 Weeks)|Other|4|||
28129428|NCT03627767|54792649|FG001|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
28129429|NCT03627767|54792650|FG002|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
28129430|NCT03627767|54792651|FG003|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
28129431|NCT03627767|54792652|FG004|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
28129432|NCT03627767|54792648|FG000|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|2|||
28129433|NCT03627767|54792649|FG001|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
28129434|NCT03627767|54792650|FG002|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
28129435|NCT03627767|54792651|FG003|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
28129436|NCT03627767|54792652|FG004|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
28129437|NCT03627767|54792648|FG000|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
28129438|NCT03627767|54792649|FG001|Double-blind Treatment Period (40 Weeks)|Adverse Event|6|||
28129439|NCT03627767|54792650|FG002|Double-blind Treatment Period (40 Weeks)|Adverse Event|7|||
28129440|NCT03627767|54792651|FG003|Double-blind Treatment Period (40 Weeks)|Adverse Event|19|||
28129441|NCT03627767|54792652|FG004|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
28129442|NCT03627767|54792648|FG000|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
28129443|NCT03627767|54792649|FG001|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
28129444|NCT03627767|54792650|FG002|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|2|||
28129445|NCT03627767|54792651|FG003|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|3|||
28129446|NCT03627767|54792652|FG004|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
28129447|NCT03627767|54792648|FG000|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
28129448|NCT03627767|54792649|FG001|Double-blind Treatment Period (40 Weeks)|Protocol Violation|1|||
28129449|NCT03627767|54792650|FG002|Double-blind Treatment Period (40 Weeks)|Protocol Violation|5|||
27818584|NCT01790438|54277224|FG000|Overall Study|Protocol Required Discontinuation|7|||
27818585|NCT01790438|54277225|FG001|Overall Study|Protocol Required Discontinuation|1|||
27818586|NCT01735916|54277236|FG000|Overall Study|Subject not eligible to be randomized|11|||
27818587|NCT01735916|54277237|FG001|Overall Study|Subject not eligible to be randomized|0|||
27818588|NCT01735916|54277238|FG002|Overall Study|Subject not eligible to be randomized|0|||
27818589|NCT01735916|54277236|FG000|Overall Study|Early termination of study by sponsor|4|||
27940541|NCT01022853|54596832|FG002|Overall Study|Dose-limiting toxicity|0|||
27940542|NCT01022853|54596833|FG003|Overall Study|Dose-limiting toxicity|0|||
27818590|NCT01735916|54277237|FG001|Overall Study|Early termination of study by sponsor|19|||
27818591|NCT01735916|54277238|FG002|Overall Study|Early termination of study by sponsor|7|||
27818592|NCT01735916|54277236|FG000|Overall Study|Withdrawal by Subject|3|||
27818593|NCT01735916|54277237|FG001|Overall Study|Withdrawal by Subject|0|||
27818594|NCT01735916|54277238|FG002|Overall Study|Withdrawal by Subject|0|||
27818595|NCT01790126|54277248|FG000|Overall Study|PSA Progression|12|||
27818596|NCT01790126|54277249|FG001|Overall Study|PSA Progression|16|||
27818597|NCT01790126|54277250|FG002|Overall Study|PSA Progression|16|||
28129450|NCT03627767|54792651|FG003|Double-blind Treatment Period (40 Weeks)|Protocol Violation|2|||
28129451|NCT03627767|54792652|FG004|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
28129452|NCT03627767|54792648|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
28129453|NCT03627767|54792649|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|9|||
28129454|NCT03627767|54792650|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|6|||
28129455|NCT03627767|54792651|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|10|||
28129456|NCT03627767|54792652|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
28129457|NCT03627767|54792648|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
28129458|NCT03627767|54792649|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
28129459|NCT03627767|54792650|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|1|||
28129460|NCT03627767|54792651|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
28129461|NCT03627767|54792652|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
28129462|NCT03627767|54792648|FG000|Double-blind Treatment Period (40 Weeks)|Other|0|||
28129463|NCT03627767|54792649|FG001|Double-blind Treatment Period (40 Weeks)|Other|0|||
28129464|NCT03627767|54792650|FG002|Double-blind Treatment Period (40 Weeks)|Other|1|||
28129465|NCT03627767|54792651|FG003|Double-blind Treatment Period (40 Weeks)|Other|1|||
28129466|NCT03627767|54792652|FG004|Double-blind Treatment Period (40 Weeks)|Other|0|||
28129467|NCT03627767|54792648|FG000|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
28129468|NCT03627767|54792649|FG001|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
28129469|NCT03627767|54792650|FG002|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
28129470|NCT03627767|54792651|FG003|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
28129471|NCT03627767|54792652|FG004|Open-label Rescue Period (12 Weeks)|Adverse Event|9|||
28129472|NCT03627767|54792648|FG000|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
28129473|NCT03627767|54792649|FG001|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
28129474|NCT03627767|54792650|FG002|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
28129475|NCT03627767|54792651|FG003|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
28129476|NCT03627767|54792652|FG004|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|1|||
28129477|NCT03627767|54792648|FG000|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
28129478|NCT03627767|54792649|FG001|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
28129479|NCT03627767|54792650|FG002|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
28129480|NCT03627767|54792651|FG003|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
28129481|NCT03627767|54792652|FG004|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|9|||
28129482|NCT03627767|54792648|FG000|Open-label Rescue Period (12 Weeks)|Other|0|||
28129483|NCT03627767|54792649|FG001|Open-label Rescue Period (12 Weeks)|Other|0|||
28129484|NCT03627767|54792650|FG002|Open-label Rescue Period (12 Weeks)|Other|0|||
28129485|NCT03627767|54792651|FG003|Open-label Rescue Period (12 Weeks)|Other|0|||
28129486|NCT03627767|54792652|FG004|Open-label Rescue Period (12 Weeks)|Other|1|||
28129487|NCT03627065|54792663|FG000|Overall Study|Study Terminated by sponsor|1|||
28129488|NCT03627065|54792663|FG000|Overall Study|Withdrawal by Subject|2|||
28129489|NCT02142738|54792669|FG000|Overall Study|Adverse Event|13|||
28129490|NCT02142738|54792670|FG001|Overall Study|Adverse Event|9|||
28129491|NCT02142738|54792669|FG000|Overall Study|Death|92|||
28129492|NCT02142738|54792670|FG001|Overall Study|Death|112|||
28129493|NCT02142738|54792669|FG000|Overall Study|Lost to Follow-up|0|||
28129494|NCT02142738|54792670|FG001|Overall Study|Lost to Follow-up|3|||
28129495|NCT02142738|54792669|FG000|Overall Study|Withdrawal by Subject|6|||
28129496|NCT02142738|54792670|FG001|Overall Study|Withdrawal by Subject|7|||
28129497|NCT02142738|54792669|FG000|Overall Study|Follow up ended by sponsor|43|||
28129498|NCT02142738|54792670|FG001|Overall Study|Follow up ended by sponsor|20|||
28129499|NCT03617861|54792681|FG000|Second Intervention (1 Day)|Adverse Event|0|||
28129500|NCT03617861|54792682|FG001|Second Intervention (1 Day)|Adverse Event|0|||
28129501|NCT03617861|54792683|FG002|Second Intervention (1 Day)|Adverse Event|1|||
28129502|NCT03617861|54792684|FG003|Second Intervention (1 Day)|Adverse Event|0|||
28129503|NCT03614975|54792696|FG000|Overall Study|Physician Decision|7|||
28129504|NCT03614975|54792697|FG001|Overall Study|Physician Decision|5|||
28129505|NCT03614975|54792696|FG000|Overall Study|Withdrawal by Subject|2|||
28129506|NCT03614975|54792697|FG001|Overall Study|Withdrawal by Subject|2|||
28129507|NCT03614975|54792696|FG000|Overall Study|Specimens not in lab batch shipment|1|||
28129508|NCT03614975|54792697|FG001|Overall Study|Specimens not in lab batch shipment|1|||
28129509|NCT03613649|54792715|FG000|Second Treatment|Lost to Follow-up|0|||
28129510|NCT03613649|54792716|FG001|Second Treatment|Lost to Follow-up|0|||
28129511|NCT03613649|54792717|FG002|Second Treatment|Lost to Follow-up|1|||
27818598|NCT01790126|54277248|FG000|Overall Study|Other|5|||
28129512|NCT03613649|54792718|FG003|Second Treatment|Lost to Follow-up|0|||
28129513|NCT03613649|54792719|FG004|Second Treatment|Lost to Follow-up|0|||
28129514|NCT03613649|54792720|FG005|Second Treatment|Lost to Follow-up|0|||
28129515|NCT03613649|54792721|FG006|Second Treatment|Lost to Follow-up|0|||
28129516|NCT03613649|54792722|FG007|Second Treatment|Lost to Follow-up|0|||
28129517|NCT03613649|54792723|FG008|Second Treatment|Lost to Follow-up|0|||
28129518|NCT03613649|54792724|FG009|Second Treatment|Lost to Follow-up|0|||
28129519|NCT03613649|54792725|FG010|Second Treatment|Lost to Follow-up|0|||
28129520|NCT03613649|54792726|FG011|Second Treatment|Lost to Follow-up|0|||
28129521|NCT03613649|54792715|FG000|Second Treatment|Withdrawal by Subject|0|||
28129522|NCT03613649|54792716|FG001|Second Treatment|Withdrawal by Subject|0|||
28129523|NCT03613649|54792717|FG002|Second Treatment|Withdrawal by Subject|0|||
28129524|NCT03613649|54792718|FG003|Second Treatment|Withdrawal by Subject|0|||
28129525|NCT03613649|54792719|FG004|Second Treatment|Withdrawal by Subject|1|||
28129526|NCT03613649|54792720|FG005|Second Treatment|Withdrawal by Subject|0|||
28129527|NCT03613649|54792721|FG006|Second Treatment|Withdrawal by Subject|0|||
28129528|NCT03613649|54792722|FG007|Second Treatment|Withdrawal by Subject|0|||
28129529|NCT03613649|54792723|FG008|Second Treatment|Withdrawal by Subject|0|||
28129530|NCT03613649|54792724|FG009|Second Treatment|Withdrawal by Subject|0|||
28129531|NCT03613649|54792725|FG010|Second Treatment|Withdrawal by Subject|0|||
28129532|NCT03613649|54792726|FG011|Second Treatment|Withdrawal by Subject|0|||
28129533|NCT03613649|54792715|FG000|Third Treatment|Lost to Follow-up|0|||
28129534|NCT03613649|54792716|FG001|Third Treatment|Lost to Follow-up|0|||
28129535|NCT03613649|54792717|FG002|Third Treatment|Lost to Follow-up|0|||
28129536|NCT03613649|54792718|FG003|Third Treatment|Lost to Follow-up|0|||
28129537|NCT03613649|54792719|FG004|Third Treatment|Lost to Follow-up|1|||
28129538|NCT03613649|54792720|FG005|Third Treatment|Lost to Follow-up|0|||
28129539|NCT03613649|54792721|FG006|Third Treatment|Lost to Follow-up|0|||
28129540|NCT03613649|54792722|FG007|Third Treatment|Lost to Follow-up|0|||
28129541|NCT03613649|54792723|FG008|Third Treatment|Lost to Follow-up|0|||
28129542|NCT03613649|54792724|FG009|Third Treatment|Lost to Follow-up|0|||
28129543|NCT03613649|54792725|FG010|Third Treatment|Lost to Follow-up|0|||
28129544|NCT03613649|54792726|FG011|Third Treatment|Lost to Follow-up|1|||
28129545|NCT03613649|54792715|FG000|Third Treatment|Protocol Violation|0|||
28129546|NCT03613649|54792716|FG001|Third Treatment|Protocol Violation|0|||
28129547|NCT03613649|54792717|FG002|Third Treatment|Protocol Violation|0|||
28129548|NCT03613649|54792718|FG003|Third Treatment|Protocol Violation|0|||
28129549|NCT03613649|54792719|FG004|Third Treatment|Protocol Violation|0|||
28129550|NCT03613649|54792720|FG005|Third Treatment|Protocol Violation|0|||
28129551|NCT03613649|54792721|FG006|Third Treatment|Protocol Violation|1|||
28129552|NCT03613649|54792722|FG007|Third Treatment|Protocol Violation|0|||
28129553|NCT03613649|54792723|FG008|Third Treatment|Protocol Violation|0|||
28129554|NCT03613649|54792724|FG009|Third Treatment|Protocol Violation|0|||
28129555|NCT03613649|54792725|FG010|Third Treatment|Protocol Violation|0|||
28129556|NCT03613649|54792726|FG011|Third Treatment|Protocol Violation|1|||
28129557|NCT03613649|54792715|FG000|Fourth Treatment|Protocol Violation|1|||
28129558|NCT03613649|54792716|FG001|Fourth Treatment|Protocol Violation|0|||
28129559|NCT03613649|54792717|FG002|Fourth Treatment|Protocol Violation|0|||
28129560|NCT03613649|54792718|FG003|Fourth Treatment|Protocol Violation|0|||
28129561|NCT03613649|54792719|FG004|Fourth Treatment|Protocol Violation|1|||
28129562|NCT03613649|54792720|FG005|Fourth Treatment|Protocol Violation|0|||
28129563|NCT03613649|54792721|FG006|Fourth Treatment|Protocol Violation|0|||
28129564|NCT03613649|54792722|FG007|Fourth Treatment|Protocol Violation|0|||
28129565|NCT03613649|54792723|FG008|Fourth Treatment|Protocol Violation|0|||
28129566|NCT03613649|54792724|FG009|Fourth Treatment|Protocol Violation|0|||
28129567|NCT03613649|54792725|FG010|Fourth Treatment|Protocol Violation|0|||
28129568|NCT03613649|54792726|FG011|Fourth Treatment|Protocol Violation|0|||
28129569|NCT03613649|54792715|FG000|Fourth Treatment|Physician Decision|0|||
28129570|NCT03613649|54792716|FG001|Fourth Treatment|Physician Decision|0|||
28129571|NCT03613649|54792717|FG002|Fourth Treatment|Physician Decision|0|||
28129572|NCT03613649|54792718|FG003|Fourth Treatment|Physician Decision|0|||
28129573|NCT03613649|54792719|FG004|Fourth Treatment|Physician Decision|0|||
28129574|NCT03613649|54792720|FG005|Fourth Treatment|Physician Decision|0|||
28129575|NCT03613649|54792721|FG006|Fourth Treatment|Physician Decision|1|||
28129576|NCT03613649|54792722|FG007|Fourth Treatment|Physician Decision|0|||
28129577|NCT03613649|54792723|FG008|Fourth Treatment|Physician Decision|0|||
28129578|NCT03613649|54792724|FG009|Fourth Treatment|Physician Decision|0|||
28129579|NCT03613649|54792725|FG010|Fourth Treatment|Physician Decision|0|||
28129580|NCT03613649|54792726|FG011|Fourth Treatment|Physician Decision|0|||
28129581|NCT03096288|54792748|FG000|Overall Study|Withdrawal by Subject|0|||
28129582|NCT03096288|54792749|FG001|Overall Study|Withdrawal by Subject|1|||
28129583|NCT03096288|54792750|FG002|Overall Study|Withdrawal by Subject|0|||
28129584|NCT03096288|54792751|FG003|Overall Study|Withdrawal by Subject|1|||
28129585|NCT03611075|54792770|FG000|Overall Study|Physician Decision|0|||
28129586|NCT03611075|54792771|FG001|Overall Study|Physician Decision|1|||
28129587|NCT03611075|54792772|FG002|Overall Study|Physician Decision|1|||
28129588|NCT03611075|54792773|FG003|Overall Study|Physician Decision|0|||
28129589|NCT03611075|54792774|FG004|Overall Study|Physician Decision|0|||
28129590|NCT03611075|54792775|FG005|Overall Study|Physician Decision|0|||
28129591|NCT03611075|54792776|FG006|Overall Study|Physician Decision|0|||
28129592|NCT03611075|54792777|FG007|Overall Study|Physician Decision|0|||
28129593|NCT03611075|54792778|FG008|Overall Study|Physician Decision|0|||
28129594|NCT03611075|54792770|FG000|Overall Study|Lost to Follow-up|1|||
28129595|NCT03611075|54792771|FG001|Overall Study|Lost to Follow-up|0|||
28129596|NCT03611075|54792772|FG002|Overall Study|Lost to Follow-up|0|||
28129597|NCT03611075|54792773|FG003|Overall Study|Lost to Follow-up|2|||
28129598|NCT03611075|54792774|FG004|Overall Study|Lost to Follow-up|0|||
28129599|NCT03611075|54792775|FG005|Overall Study|Lost to Follow-up|0|||
28129600|NCT03611075|54792776|FG006|Overall Study|Lost to Follow-up|0|||
28129601|NCT03611075|54792777|FG007|Overall Study|Lost to Follow-up|0|||
28129602|NCT03611075|54792778|FG008|Overall Study|Lost to Follow-up|0|||
28129603|NCT03611075|54792770|FG000|Overall Study|Withdrawal by Subject|0|||
28129604|NCT03611075|54792771|FG001|Overall Study|Withdrawal by Subject|1|||
28129605|NCT03611075|54792772|FG002|Overall Study|Withdrawal by Subject|1|||
28129606|NCT03611075|54792773|FG003|Overall Study|Withdrawal by Subject|1|||
28129607|NCT03611075|54792774|FG004|Overall Study|Withdrawal by Subject|0|||
28129608|NCT03611075|54792775|FG005|Overall Study|Withdrawal by Subject|0|||
28129609|NCT03611075|54792776|FG006|Overall Study|Withdrawal by Subject|1|||
28129610|NCT03611075|54792777|FG007|Overall Study|Withdrawal by Subject|0|||
28129611|NCT03611075|54792778|FG008|Overall Study|Withdrawal by Subject|0|||
28129612|NCT03611075|54792770|FG000|Overall Study|Reason unknown|0|||
28129613|NCT03611075|54792771|FG001|Overall Study|Reason unknown|0|||
28129614|NCT03611075|54792772|FG002|Overall Study|Reason unknown|0|||
28129615|NCT03611075|54792773|FG003|Overall Study|Reason unknown|1|||
28129616|NCT03611075|54792774|FG004|Overall Study|Reason unknown|0|||
28129617|NCT03611075|54792775|FG005|Overall Study|Reason unknown|0|||
28129618|NCT03611075|54792776|FG006|Overall Study|Reason unknown|1|||
28129619|NCT03611075|54792777|FG007|Overall Study|Reason unknown|0|||
28129620|NCT03611075|54792778|FG008|Overall Study|Reason unknown|0|||
28129621|NCT03095508|54792823|FG000|Overall Study|Adverse Event|0|||
28129622|NCT03095508|54792824|FG001|Overall Study|Adverse Event|1|||
28129623|NCT03607487|54792834|FG000|Overall Study|Withdrawal by Subject|2|||
28129624|NCT03607487|54792835|FG001|Overall Study|Withdrawal by Subject|0|||
28129625|NCT03607487|54792836|FG002|Overall Study|Withdrawal by Subject|0|||
28129626|NCT03607487|54792837|FG003|Overall Study|Withdrawal by Subject|1|||
28129627|NCT03605693|54792851|FG000|Overall Study|Lost to Follow-up|4|||
28129628|NCT03605693|54792852|FG001|Overall Study|Lost to Follow-up|0|||
28129629|NCT03605693|54792851|FG000|Overall Study|Physician Decision|1|||
28129630|NCT03605693|54792852|FG001|Overall Study|Physician Decision|0|||
28129631|NCT03605303|54792858|FG000|Period 1|Study Terminated|2|||
28129632|NCT03605303|54792859|FG001|Period 1|Study Terminated|1|||
28129633|NCT03604523|54792867|FG000|Overall Study|Physician Decision|1|||
28129634|NCT03604523|54792868|FG001|Overall Study|Physician Decision|0|||
28129635|NCT03602339|54792874|FG000|Overall Study|Withdrawal by Subject|9|||
28129636|NCT03602339|54792874|FG000|Overall Study|Physician Decision|2|||
28129637|NCT03602339|54792874|FG000|Overall Study|Other reason|4|||
28129638|NCT03653429|54792883|FG000|Overall Study|Physician Decision|4|||
28129639|NCT03653429|54792884|FG001|Overall Study|Physician Decision|10|||
28129640|NCT03601715|54792893|FG000|Second Intervention|Lost to Follow-up|1|||
28129641|NCT03601715|54792894|FG001|Second Intervention|Lost to Follow-up|1|||
28129642|NCT03601715|54792895|FG002|Second Intervention|Lost to Follow-up|0|||
28129643|NCT03594227|54792907|FG000|Overall Study|Adverse Event|2|||
28129644|NCT03594227|54792908|FG001|Overall Study|Adverse Event|1|||
28129645|NCT03594227|54792909|FG002|Overall Study|Adverse Event|0|||
28129646|NCT03594227|54792910|FG003|Overall Study|Adverse Event|2|||
28129647|NCT03594227|54792907|FG000|Overall Study|Lost to Follow-up|1|||
28129648|NCT03594227|54792908|FG001|Overall Study|Lost to Follow-up|1|||
28129649|NCT03594227|54792909|FG002|Overall Study|Lost to Follow-up|1|||
28129650|NCT03594227|54792910|FG003|Overall Study|Lost to Follow-up|0|||
28129651|NCT03594227|54792907|FG000|Overall Study|Withdrawal by Subject|1|||
28129652|NCT03594227|54792908|FG001|Overall Study|Withdrawal by Subject|1|||
28129653|NCT03594227|54792909|FG002|Overall Study|Withdrawal by Subject|1|||
28129654|NCT03594227|54792910|FG003|Overall Study|Withdrawal by Subject|1|||
28129655|NCT03594227|54792907|FG000|Overall Study|Pregnancy|0|||
28129656|NCT03594227|54792908|FG001|Overall Study|Pregnancy|1|||
28129657|NCT03594227|54792909|FG002|Overall Study|Pregnancy|0|||
28129658|NCT03594227|54792910|FG003|Overall Study|Pregnancy|0|||
28129659|NCT03594227|54792907|FG000|Overall Study|Sponsor Decision|0|||
28129660|NCT03594227|54792908|FG001|Overall Study|Sponsor Decision|0|||
28129661|NCT03594227|54792909|FG002|Overall Study|Sponsor Decision|0|||
28129662|NCT03594227|54792910|FG003|Overall Study|Sponsor Decision|1|||
28129663|NCT03594227|54792907|FG000|Overall Study|Programmatic Analysis Non-completer|1|||
28129664|NCT03594227|54792908|FG001|Overall Study|Programmatic Analysis Non-completer|0|||
28129665|NCT03594227|54792909|FG002|Overall Study|Programmatic Analysis Non-completer|1|||
28129666|NCT03594227|54792910|FG003|Overall Study|Programmatic Analysis Non-completer|1|||
28129667|NCT03098550|54792934|FG000|Overall Study|Disease Progression|30|||
28129668|NCT03098550|54792935|FG001|Overall Study|Disease Progression|19|||
28129669|NCT03098550|54792936|FG002|Overall Study|Disease Progression|41|||
28129670|NCT03098550|54792934|FG000|Overall Study|Study Drug Toxicity|2|||
28129671|NCT03098550|54792935|FG001|Overall Study|Study Drug Toxicity|1|||
28129672|NCT03098550|54792936|FG002|Overall Study|Study Drug Toxicity|0|||
28129673|NCT03098550|54792934|FG000|Overall Study|Death|1|||
28129674|NCT03098550|54792935|FG001|Overall Study|Death|0|||
28129675|NCT03098550|54792936|FG002|Overall Study|Death|0|||
28129676|NCT03098550|54792934|FG000|Overall Study|Adverse Event unrelated to Study Drug|6|||
28129677|NCT03098550|54792935|FG001|Overall Study|Adverse Event unrelated to Study Drug|0|||
28129678|NCT03098550|54792936|FG002|Overall Study|Adverse Event unrelated to Study Drug|1|||
28129679|NCT03098550|54792934|FG000|Overall Study|Administrative reason by sponsor|0|||
28129680|NCT03098550|54792935|FG001|Overall Study|Administrative reason by sponsor|0|||
28129681|NCT03098550|54792936|FG002|Overall Study|Administrative reason by sponsor|1|||
28129682|NCT03098550|54792934|FG000|Overall Study|Other reasons|2|||
28129683|NCT03098550|54792935|FG001|Overall Study|Other reasons|0|||
28129684|NCT03098550|54792936|FG002|Overall Study|Other reasons|0|||
28129685|NCT03095118|54792948|FG000|Overall Study|Adverse Event|1|||
28129686|NCT03095118|54792948|FG000|Overall Study|Diagnosis not associated with monoclonal gammopathy|1|||
28129687|NCT03594071|54792952|FG000|Overall Study|Re-operation|3|||
28129688|NCT03594071|54792952|FG000|Overall Study|Missed visit|2|||
28129689|NCT02696902|54792959|FG000|Overall Study|Lost to Follow-up|0|||
28129690|NCT02696902|54792960|FG001|Overall Study|Lost to Follow-up|1|||
28129691|NCT02696902|54792961|FG002|Overall Study|Lost to Follow-up|1|||
28129692|NCT02696902|54792959|FG000|Overall Study|Withdrawal by Subject|0|||
28129693|NCT02696902|54792960|FG001|Overall Study|Withdrawal by Subject|0|||
28129694|NCT02696902|54792961|FG002|Overall Study|Withdrawal by Subject|1|||
28129695|NCT02696902|54792959|FG000|Overall Study|Death|19|||
28129696|NCT02696902|54792960|FG001|Overall Study|Death|3|||
28129697|NCT02696902|54792961|FG002|Overall Study|Death|24|||
28129698|NCT02696902|54792959|FG000|Overall Study|Participant not fit post-randomization|0|||
28129699|NCT02696902|54792960|FG001|Overall Study|Participant not fit post-randomization|0|||
28129700|NCT02696902|54792961|FG002|Overall Study|Participant not fit post-randomization|1|||
28129701|NCT02696902|54792959|FG000|Overall Study|Participant not eligible (negative PCR)|0|||
28129702|NCT02696902|54792960|FG001|Overall Study|Participant not eligible (negative PCR)|0|||
28129703|NCT02696902|54792961|FG002|Overall Study|Participant not eligible (negative PCR)|1|||
28129704|NCT02696902|54792959|FG000|Overall Study|Principal investigator's decision|1|||
28129705|NCT02696902|54792960|FG001|Overall Study|Principal investigator's decision|0|||
28129706|NCT02696902|54792961|FG002|Overall Study|Principal investigator's decision|0|||
28129707|NCT02696902|54792959|FG000|Overall Study|Sponsor's decision|1|||
28129708|NCT02696902|54792960|FG001|Overall Study|Sponsor's decision|0|||
28129709|NCT02696902|54792961|FG002|Overall Study|Sponsor's decision|0|||
28129710|NCT02696902|54792959|FG000|Overall Study|Transferred to other hospital|1|||
28129711|NCT02696902|54792960|FG001|Overall Study|Transferred to other hospital|0|||
28129712|NCT02696902|54792961|FG002|Overall Study|Transferred to other hospital|0|||
28129713|NCT02694562|54792971|FG000|Overall Study|Death|8|||
28129714|NCT02694562|54792971|FG000|Overall Study|Protocol Violation|4|||
28129715|NCT02694562|54792971|FG000|Overall Study|Lost to Follow-up|3|||
27849444|NCT00089999|54345831|FG001|Overall Study|Adverse Event|7|||
28129716|NCT02694562|54792971|FG000|Overall Study|Screen Failure|2|||
28129717|NCT02694562|54792971|FG000|Overall Study|Physician Decision|1|||
28129718|NCT02874534|54792977|FG000|Overall Study|Withdrawal by Subject|5|||
28129719|NCT02874534|54792978|FG001|Overall Study|Withdrawal by Subject|8|||
28129720|NCT02874534|54792977|FG000|Overall Study|Lost to Follow-up|2|||
28129721|NCT02874534|54792978|FG001|Overall Study|Lost to Follow-up|2|||
28129722|NCT02874534|54792977|FG000|Overall Study|Ongoing in study|1|||
28129723|NCT02874534|54792978|FG001|Overall Study|Ongoing in study|1|||
28129724|NCT03097614|54792984|FG000|Overall Study|Adverse Event|3|||
28129725|NCT03364309|54792991|FG000|Induction Period|Adverse Event|4|||
28129726|NCT03364309|54792992|FG001|Induction Period|Adverse Event|0|||
28129727|NCT03364309|54792993|FG002|Induction Period|Adverse Event|1|||
28129728|NCT03364309|54792994|FG003|Induction Period|Adverse Event|0|||
28129729|NCT03364309|54792995|FG004|Induction Period|Adverse Event|0|||
28129730|NCT03364309|54792996|FG005|Induction Period|Adverse Event|0|||
28129731|NCT03364309|54792997|FG006|Induction Period|Adverse Event|0|||
28129732|NCT03364309|54792998|FG007|Induction Period|Adverse Event|0|||
28129733|NCT03364309|54792999|FG008|Induction Period|Adverse Event|0|||
28129734|NCT03364309|54793000|FG009|Induction Period|Adverse Event|0|||
28129735|NCT03364309|54793001|FG010|Induction Period|Adverse Event|0|||
28129736|NCT03364309|54793002|FG011|Induction Period|Adverse Event|0|||
28129737|NCT03364309|54793003|FG012|Induction Period|Adverse Event|0|||
28129738|NCT03364309|54793004|FG013|Induction Period|Adverse Event|0|||
28129739|NCT03364309|54793005|FG014|Induction Period|Adverse Event|0|||
28129740|NCT03364309|54793006|FG015|Induction Period|Adverse Event|0|||
28129741|NCT03364309|54793007|FG016|Induction Period|Adverse Event|0|||
28129742|NCT03364309|54793008|FG017|Induction Period|Adverse Event|0|||
28129743|NCT03364309|54793009|FG018|Induction Period|Adverse Event|0|||
28129744|NCT03364309|54792991|FG000|Induction Period|Withdrawal by Subject|1|||
28129745|NCT03364309|54792992|FG001|Induction Period|Withdrawal by Subject|3|||
28129746|NCT03364309|54792993|FG002|Induction Period|Withdrawal by Subject|0|||
28129747|NCT03364309|54792994|FG003|Induction Period|Withdrawal by Subject|0|||
28129748|NCT03364309|54792995|FG004|Induction Period|Withdrawal by Subject|0|||
28129749|NCT03364309|54792996|FG005|Induction Period|Withdrawal by Subject|0|||
28129750|NCT03364309|54792997|FG006|Induction Period|Withdrawal by Subject|0|||
28129751|NCT03364309|54792998|FG007|Induction Period|Withdrawal by Subject|0|||
28129752|NCT03364309|54792999|FG008|Induction Period|Withdrawal by Subject|0|||
28129753|NCT03364309|54793000|FG009|Induction Period|Withdrawal by Subject|0|||
28129754|NCT03364309|54793001|FG010|Induction Period|Withdrawal by Subject|0|||
28129755|NCT03364309|54793002|FG011|Induction Period|Withdrawal by Subject|0|||
28129756|NCT03364309|54793003|FG012|Induction Period|Withdrawal by Subject|0|||
28129757|NCT03364309|54793004|FG013|Induction Period|Withdrawal by Subject|0|||
27940543|NCT01022853|54596834|FG004|Overall Study|Dose-limiting toxicity|1|||
28129758|NCT03364309|54793005|FG014|Induction Period|Withdrawal by Subject|0|||
28129759|NCT03364309|54793006|FG015|Induction Period|Withdrawal by Subject|0|||
28129760|NCT03364309|54793007|FG016|Induction Period|Withdrawal by Subject|0|||
28129761|NCT03364309|54793008|FG017|Induction Period|Withdrawal by Subject|0|||
28129762|NCT03364309|54793009|FG018|Induction Period|Withdrawal by Subject|0|||
28129763|NCT03364309|54792991|FG000|Induction Period|Lost to Follow-up|1|||
28129764|NCT03364309|54792992|FG001|Induction Period|Lost to Follow-up|0|||
28129765|NCT03364309|54792993|FG002|Induction Period|Lost to Follow-up|0|||
28129766|NCT03364309|54792994|FG003|Induction Period|Lost to Follow-up|0|||
28129767|NCT03364309|54792995|FG004|Induction Period|Lost to Follow-up|0|||
28129768|NCT03364309|54792996|FG005|Induction Period|Lost to Follow-up|0|||
28129769|NCT03364309|54792997|FG006|Induction Period|Lost to Follow-up|0|||
28129770|NCT03364309|54792998|FG007|Induction Period|Lost to Follow-up|0|||
28129771|NCT03364309|54792999|FG008|Induction Period|Lost to Follow-up|0|||
28129772|NCT03364309|54793000|FG009|Induction Period|Lost to Follow-up|0|||
27940544|NCT01022853|54596830|FG000|Overall Study|Withdrawal by Subject|0|||
28129773|NCT03364309|54793001|FG010|Induction Period|Lost to Follow-up|0|||
28129774|NCT03364309|54793002|FG011|Induction Period|Lost to Follow-up|0|||
28129775|NCT03364309|54793003|FG012|Induction Period|Lost to Follow-up|0|||
28129776|NCT03364309|54793004|FG013|Induction Period|Lost to Follow-up|0|||
28129777|NCT03364309|54793005|FG014|Induction Period|Lost to Follow-up|0|||
28129778|NCT03364309|54793006|FG015|Induction Period|Lost to Follow-up|0|||
28129779|NCT03364309|54793007|FG016|Induction Period|Lost to Follow-up|0|||
28129780|NCT03364309|54793008|FG017|Induction Period|Lost to Follow-up|0|||
28129781|NCT03364309|54793009|FG018|Induction Period|Lost to Follow-up|0|||
28129782|NCT03364309|54792991|FG000|Induction Period|Physician Decision|0|||
28129783|NCT03364309|54792992|FG001|Induction Period|Physician Decision|1|||
28129784|NCT03364309|54792993|FG002|Induction Period|Physician Decision|0|||
28129785|NCT03364309|54792994|FG003|Induction Period|Physician Decision|0|||
28129786|NCT03364309|54792995|FG004|Induction Period|Physician Decision|0|||
28129787|NCT03364309|54792996|FG005|Induction Period|Physician Decision|0|||
28129788|NCT03364309|54792997|FG006|Induction Period|Physician Decision|0|||
28129789|NCT03364309|54792998|FG007|Induction Period|Physician Decision|0|||
28129790|NCT03364309|54792999|FG008|Induction Period|Physician Decision|0|||
28129791|NCT03364309|54793000|FG009|Induction Period|Physician Decision|0|||
28129792|NCT03364309|54793001|FG010|Induction Period|Physician Decision|0|||
28129793|NCT03364309|54793002|FG011|Induction Period|Physician Decision|0|||
28129794|NCT03364309|54793003|FG012|Induction Period|Physician Decision|0|||
28129795|NCT03364309|54793004|FG013|Induction Period|Physician Decision|0|||
28129796|NCT03364309|54793005|FG014|Induction Period|Physician Decision|0|||
28129797|NCT03364309|54793006|FG015|Induction Period|Physician Decision|0|||
28129798|NCT03364309|54793007|FG016|Induction Period|Physician Decision|0|||
28129799|NCT03364309|54793008|FG017|Induction Period|Physician Decision|0|||
28129800|NCT03364309|54793009|FG018|Induction Period|Physician Decision|0|||
28129801|NCT03364309|54792991|FG000|Maintenance Period|Withdrawal by Subject|0|||
28129802|NCT03364309|54792992|FG001|Maintenance Period|Withdrawal by Subject|0|||
28129803|NCT03364309|54792993|FG002|Maintenance Period|Withdrawal by Subject|0|||
28129804|NCT03364309|54792994|FG003|Maintenance Period|Withdrawal by Subject|1|||
28129805|NCT03364309|54792995|FG004|Maintenance Period|Withdrawal by Subject|3|||
28129806|NCT03364309|54792996|FG005|Maintenance Period|Withdrawal by Subject|1|||
28129807|NCT03364309|54792997|FG006|Maintenance Period|Withdrawal by Subject|3|||
28129808|NCT03364309|54792998|FG007|Maintenance Period|Withdrawal by Subject|0|||
28129809|NCT03364309|54792999|FG008|Maintenance Period|Withdrawal by Subject|1|||
28129810|NCT03364309|54793000|FG009|Maintenance Period|Withdrawal by Subject|1|||
28129811|NCT03364309|54793001|FG010|Maintenance Period|Withdrawal by Subject|2|||
27818599|NCT01790126|54277249|FG001|Overall Study|Other|4|||
27818600|NCT01790126|54277250|FG002|Overall Study|Other|8|||
27818601|NCT01790126|54277248|FG000|Overall Study|Initiation of Non-Protocol Therapy|3|||
27818602|NCT01790126|54277249|FG001|Overall Study|Initiation of Non-Protocol Therapy|4|||
27818603|NCT01790126|54277250|FG002|Overall Study|Initiation of Non-Protocol Therapy|2|||
27818604|NCT01790126|54277248|FG000|Overall Study|Withdrawal by Physician|1|||
27818605|NCT01790126|54277249|FG001|Overall Study|Withdrawal by Physician|1|||
27818606|NCT01790126|54277250|FG002|Overall Study|Withdrawal by Physician|2|||
27818607|NCT01790126|54277248|FG000|Overall Study|Withdrawal by Subject|3|||
27818608|NCT01790126|54277249|FG001|Overall Study|Withdrawal by Subject|1|||
27818609|NCT01790126|54277250|FG002|Overall Study|Withdrawal by Subject|2|||
27818610|NCT01790126|54277248|FG000|Overall Study|Lost to Follow-up|1|||
27818611|NCT01790126|54277249|FG001|Overall Study|Lost to Follow-up|0|||
27818612|NCT01790126|54277250|FG002|Overall Study|Lost to Follow-up|1|||
27818613|NCT01790126|54277248|FG000|Overall Study|Adverse Event|0|||
27818614|NCT01790126|54277249|FG001|Overall Study|Adverse Event|2|||
27818615|NCT01790126|54277250|FG002|Overall Study|Adverse Event|0|||
27818616|NCT01790126|54277248|FG000|Overall Study|Death|2|||
27818617|NCT01790126|54277249|FG001|Overall Study|Death|0|||
27818618|NCT01790126|54277250|FG002|Overall Study|Death|0|||
27818619|NCT01790126|54277248|FG000|Overall Study|Radiographic Progression|3|||
27818620|NCT01790126|54277249|FG001|Overall Study|Radiographic Progression|1|||
27818621|NCT01790126|54277250|FG002|Overall Study|Radiographic Progression|0|||
27818622|NCT01734902|54277261|FG000|Overall Study|Other than listed|0|||
27818623|NCT01734902|54277262|FG001|Overall Study|Other than listed|2|||
27818624|NCT01790048|54277270|FG000|Overall Study|Incorrect Age|9|||
27818625|NCT01790048|54277271|FG001|Overall Study|Incorrect Age|14|||
27818626|NCT01790048|54277270|FG000|Overall Study|data entry error|0|||
27818627|NCT01790048|54277271|FG001|Overall Study|data entry error|1|||
27818628|NCT01790048|54277270|FG000|Overall Study|Other|0|||
27818629|NCT01790048|54277271|FG001|Overall Study|Other|2|||
27818630|NCT01790048|54277270|FG000|Overall Study|SAM at Enrollment|2|||
27818631|NCT01790048|54277271|FG001|Overall Study|SAM at Enrollment|0|||
27818632|NCT01790048|54277270|FG000|Overall Study|Measurement error|1|||
27818633|NCT01790048|54277271|FG001|Overall Study|Measurement error|0|||
27818634|NCT01789970|54277281|FG000|Open-label Titration Period|Adverse Event|68|||
27818635|NCT01789970|54277282|FG001|Open-label Titration Period|Adverse Event|0|||
27818636|NCT01789970|54277283|FG002|Open-label Titration Period|Adverse Event|0|||
27818637|NCT01789970|54277281|FG000|Open-label Titration Period|Lack of Efficacy|31|||
27818638|NCT01789970|54277282|FG001|Open-label Titration Period|Lack of Efficacy|0|||
27818639|NCT01789970|54277283|FG002|Open-label Titration Period|Lack of Efficacy|0|||
27818640|NCT01789970|54277281|FG000|Open-label Titration Period|Withdrawal by Subject|31|||
27818641|NCT01789970|54277282|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
27818642|NCT01789970|54277283|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
28129812|NCT03364309|54793002|FG011|Maintenance Period|Withdrawal by Subject|0|||
28129813|NCT03364309|54793003|FG012|Maintenance Period|Withdrawal by Subject|0|||
28129814|NCT03364309|54793004|FG013|Maintenance Period|Withdrawal by Subject|0|||
28129815|NCT03364309|54793005|FG014|Maintenance Period|Withdrawal by Subject|0|||
28129816|NCT03364309|54793006|FG015|Maintenance Period|Withdrawal by Subject|0|||
28129817|NCT03364309|54793007|FG016|Maintenance Period|Withdrawal by Subject|0|||
27818643|NCT01789970|54277281|FG000|Open-label Titration Period|Protocol Violation|18|||
27818644|NCT01789970|54277282|FG001|Open-label Titration Period|Protocol Violation|0|||
27818645|NCT01789970|54277283|FG002|Open-label Titration Period|Protocol Violation|0|||
27818646|NCT01789970|54277281|FG000|Open-label Titration Period|Lost to Follow-up|5|||
27818647|NCT01789970|54277282|FG001|Open-label Titration Period|Lost to Follow-up|0|||
28129818|NCT03364309|54793008|FG017|Maintenance Period|Withdrawal by Subject|0|||
28129819|NCT03364309|54793009|FG018|Maintenance Period|Withdrawal by Subject|0|||
28129820|NCT03364309|54792991|FG000|Maintenance Period|Adverse Event|0|||
28129821|NCT03364309|54792992|FG001|Maintenance Period|Adverse Event|0|||
28129822|NCT03364309|54792993|FG002|Maintenance Period|Adverse Event|0|||
28129823|NCT03364309|54792994|FG003|Maintenance Period|Adverse Event|0|||
28129824|NCT03364309|54792995|FG004|Maintenance Period|Adverse Event|2|||
28129825|NCT03364309|54792996|FG005|Maintenance Period|Adverse Event|0|||
28129826|NCT03364309|54792997|FG006|Maintenance Period|Adverse Event|3|||
28129827|NCT03364309|54792998|FG007|Maintenance Period|Adverse Event|0|||
28129828|NCT03364309|54792999|FG008|Maintenance Period|Adverse Event|1|||
28129829|NCT03364309|54793000|FG009|Maintenance Period|Adverse Event|0|||
28129830|NCT03364309|54793001|FG010|Maintenance Period|Adverse Event|2|||
28129831|NCT03364309|54793002|FG011|Maintenance Period|Adverse Event|0|||
28129832|NCT03364309|54793003|FG012|Maintenance Period|Adverse Event|0|||
28129833|NCT03364309|54793004|FG013|Maintenance Period|Adverse Event|0|||
27818648|NCT01789970|54277283|FG002|Open-label Titration Period|Lost to Follow-up|0|||
28129834|NCT03364309|54793005|FG014|Maintenance Period|Adverse Event|0|||
28129835|NCT03364309|54793006|FG015|Maintenance Period|Adverse Event|0|||
28129836|NCT03364309|54793007|FG016|Maintenance Period|Adverse Event|0|||
28129837|NCT03364309|54793008|FG017|Maintenance Period|Adverse Event|0|||
28129838|NCT03364309|54793009|FG018|Maintenance Period|Adverse Event|0|||
28129839|NCT03364309|54792991|FG000|Maintenance Period|Relapsed|0|||
28129840|NCT03364309|54792992|FG001|Maintenance Period|Relapsed|0|||
28129841|NCT03364309|54792993|FG002|Maintenance Period|Relapsed|0|||
28129842|NCT03364309|54792994|FG003|Maintenance Period|Relapsed|43|||
28129843|NCT03364309|54792995|FG004|Maintenance Period|Relapsed|7|||
28129844|NCT03364309|54792996|FG005|Maintenance Period|Relapsed|45|||
28129845|NCT03364309|54792997|FG006|Maintenance Period|Relapsed|10|||
28129846|NCT03364309|54792998|FG007|Maintenance Period|Relapsed|2|||
28129847|NCT03364309|54792999|FG008|Maintenance Period|Relapsed|0|||
28129848|NCT03364309|54793000|FG009|Maintenance Period|Relapsed|0|||
28129849|NCT03364309|54793001|FG010|Maintenance Period|Relapsed|0|||
28129850|NCT03364309|54793002|FG011|Maintenance Period|Relapsed|0|||
28129851|NCT03364309|54793003|FG012|Maintenance Period|Relapsed|0|||
28129852|NCT03364309|54793004|FG013|Maintenance Period|Relapsed|0|||
28129853|NCT03364309|54793005|FG014|Maintenance Period|Relapsed|0|||
28129854|NCT03364309|54793006|FG015|Maintenance Period|Relapsed|0|||
28129855|NCT03364309|54793007|FG016|Maintenance Period|Relapsed|0|||
28129856|NCT03364309|54793008|FG017|Maintenance Period|Relapsed|0|||
28129857|NCT03364309|54793009|FG018|Maintenance Period|Relapsed|0|||
28129858|NCT03364309|54792991|FG000|Maintenance Period|Lack of Efficacy|0|||
28129859|NCT03364309|54792992|FG001|Maintenance Period|Lack of Efficacy|0|||
28129860|NCT03364309|54792993|FG002|Maintenance Period|Lack of Efficacy|0|||
28129861|NCT03364309|54792994|FG003|Maintenance Period|Lack of Efficacy|0|||
28129862|NCT03364309|54792995|FG004|Maintenance Period|Lack of Efficacy|0|||
28129863|NCT03364309|54792996|FG005|Maintenance Period|Lack of Efficacy|0|||
28129864|NCT03364309|54792997|FG006|Maintenance Period|Lack of Efficacy|0|||
27818649|NCT01789970|54277281|FG000|Open-label Titration Period|Noncompliance to study drug admin|11|||
27818650|NCT01789970|54277282|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
27818651|NCT01789970|54277283|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
27818652|NCT01789970|54277281|FG000|Open-label Titration Period|Noncompliance with study rescue meds|2|||
27818653|NCT01789970|54277282|FG001|Open-label Titration Period|Noncompliance with study rescue meds|0|||
27818654|NCT01789970|54277283|FG002|Open-label Titration Period|Noncompliance with study rescue meds|0|||
27818655|NCT01789970|54277281|FG000|Open-label Titration Period|Noncompliance with study procedures|8|||
27818656|NCT01789970|54277282|FG001|Open-label Titration Period|Noncompliance with study procedures|0|||
27818657|NCT01789970|54277283|FG002|Open-label Titration Period|Noncompliance with study procedures|0|||
27818658|NCT01789970|54277281|FG000|Open-label Titration Period|Pregnancy|2|||
27818659|NCT01789970|54277282|FG001|Open-label Titration Period|Pregnancy|0|||
27818660|NCT01789970|54277283|FG002|Open-label Titration Period|Pregnancy|0|||
27818661|NCT01789970|54277281|FG000|Open-label Titration Period|Other|76|||
27818662|NCT01789970|54277282|FG001|Open-label Titration Period|Other|0|||
27818663|NCT01789970|54277283|FG002|Open-label Titration Period|Other|0|||
27818664|NCT01789970|54277281|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
27818665|NCT01789970|54277282|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
27818666|NCT01789970|54277283|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
27818667|NCT01789970|54277281|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
27818668|NCT01789970|54277282|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|9|||
27818669|NCT01789970|54277283|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|15|||
27818670|NCT01789970|54277281|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
27818671|NCT01789970|54277282|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
27818672|NCT01789970|54277283|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
27818673|NCT01789970|54277281|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
27818674|NCT01789970|54277282|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
28129865|NCT03364309|54792998|FG007|Maintenance Period|Lack of Efficacy|0|||
28129866|NCT03364309|54792999|FG008|Maintenance Period|Lack of Efficacy|1|||
28129867|NCT03364309|54793000|FG009|Maintenance Period|Lack of Efficacy|3|||
28129868|NCT03364309|54793001|FG010|Maintenance Period|Lack of Efficacy|2|||
28129869|NCT03364309|54793002|FG011|Maintenance Period|Lack of Efficacy|0|||
28129870|NCT03364309|54793003|FG012|Maintenance Period|Lack of Efficacy|0|||
28129871|NCT03364309|54793004|FG013|Maintenance Period|Lack of Efficacy|0|||
28129872|NCT03364309|54793005|FG014|Maintenance Period|Lack of Efficacy|0|||
28129873|NCT03364309|54793006|FG015|Maintenance Period|Lack of Efficacy|0|||
28129874|NCT03364309|54793007|FG016|Maintenance Period|Lack of Efficacy|0|||
28129875|NCT03364309|54793008|FG017|Maintenance Period|Lack of Efficacy|0|||
27818675|NCT01789970|54277283|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
27818676|NCT01789970|54277281|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
27818677|NCT01789970|54277282|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
27940545|NCT01022853|54596831|FG001|Overall Study|Withdrawal by Subject|1|||
28129876|NCT03364309|54793009|FG018|Maintenance Period|Lack of Efficacy|0|||
28129877|NCT03364309|54792991|FG000|Maintenance Period|Death|0|||
28129878|NCT03364309|54792992|FG001|Maintenance Period|Death|0|||
28129879|NCT03364309|54792993|FG002|Maintenance Period|Death|0|||
28129880|NCT03364309|54792994|FG003|Maintenance Period|Death|0|||
28129881|NCT03364309|54792995|FG004|Maintenance Period|Death|0|||
28129882|NCT03364309|54792996|FG005|Maintenance Period|Death|0|||
28129883|NCT03364309|54792997|FG006|Maintenance Period|Death|0|||
28129884|NCT03364309|54792998|FG007|Maintenance Period|Death|0|||
28129885|NCT03364309|54792999|FG008|Maintenance Period|Death|1|||
28129886|NCT03364309|54793000|FG009|Maintenance Period|Death|0|||
28129887|NCT03364309|54793001|FG010|Maintenance Period|Death|0|||
28129888|NCT03364309|54793002|FG011|Maintenance Period|Death|0|||
28129889|NCT03364309|54793003|FG012|Maintenance Period|Death|0|||
28129890|NCT03364309|54793004|FG013|Maintenance Period|Death|0|||
28129891|NCT03364309|54793005|FG014|Maintenance Period|Death|0|||
28129892|NCT03364309|54793006|FG015|Maintenance Period|Death|0|||
28129893|NCT03364309|54793007|FG016|Maintenance Period|Death|0|||
28129894|NCT03364309|54793008|FG017|Maintenance Period|Death|0|||
28129895|NCT03364309|54793009|FG018|Maintenance Period|Death|0|||
28129896|NCT03364309|54792991|FG000|Maintenance Period|Lost to Follow-up|0|||
28129897|NCT03364309|54792992|FG001|Maintenance Period|Lost to Follow-up|0|||
28129898|NCT03364309|54792993|FG002|Maintenance Period|Lost to Follow-up|0|||
28129899|NCT03364309|54792994|FG003|Maintenance Period|Lost to Follow-up|0|||
28129900|NCT03364309|54792995|FG004|Maintenance Period|Lost to Follow-up|0|||
28129901|NCT03364309|54792996|FG005|Maintenance Period|Lost to Follow-up|0|||
28129902|NCT03364309|54792997|FG006|Maintenance Period|Lost to Follow-up|0|||
28129903|NCT03364309|54792998|FG007|Maintenance Period|Lost to Follow-up|0|||
28129904|NCT03364309|54792999|FG008|Maintenance Period|Lost to Follow-up|1|||
27818678|NCT01789970|54277283|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7|||
27818679|NCT01789970|54277281|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
27818680|NCT01789970|54277282|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
27818681|NCT01789970|54277283|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
27818682|NCT01789970|54277281|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0|||
27818683|NCT01789970|54277282|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2|||
27818684|NCT01789970|54277283|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1|||
27818685|NCT01789970|54277281|FG000|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
27818686|NCT01789970|54277282|FG001|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
27818687|NCT01789970|54277283|FG002|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2|||
27818688|NCT01789970|54277281|FG000|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
27818689|NCT01789970|54277282|FG001|Double-blind Treatment Period (12 Weeks)|Pregnancy|1|||
27818690|NCT01789970|54277283|FG002|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
27818691|NCT01789970|54277281|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
28067927|NCT00460655|54723054|FG003|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1|||
28067928|NCT00460577|54723066|FG000|Overall Study|Protocol Violation|2|||
28067929|NCT00460577|54723067|FG001|Overall Study|Protocol Violation|6|||
28067930|NCT00289016|54723073|FG000|Overall Study|Disease Progression|29|||
28067931|NCT00289016|54723073|FG000|Overall Study|Death|2|||
28067932|NCT00289016|54723073|FG000|Overall Study|Unrelated Medical Condition or Accident|2|||
28067933|NCT00289016|54723073|FG000|Overall Study|Withdrawal by Subject|2|||
28067934|NCT00289016|54723073|FG000|Overall Study|Adverse Event|1|||
28067935|NCT00289016|54723073|FG000|Overall Study|Other|1|||
28067936|NCT00288860|54723079|FG000|Overall Study|Did not complete intake|4|||
28129905|NCT03364309|54793000|FG009|Maintenance Period|Lost to Follow-up|0|||
28129906|NCT03364309|54793001|FG010|Maintenance Period|Lost to Follow-up|0|||
28129907|NCT03364309|54793002|FG011|Maintenance Period|Lost to Follow-up|0|||
28129908|NCT03364309|54793003|FG012|Maintenance Period|Lost to Follow-up|0|||
28129909|NCT03364309|54793004|FG013|Maintenance Period|Lost to Follow-up|0|||
28067937|NCT00288860|54723080|FG001|Overall Study|Did not complete intake|8|||
28067938|NCT00288860|54723079|FG000|Overall Study|Death|4|||
28067939|NCT00288860|54723080|FG001|Overall Study|Death|3|||
28129910|NCT03364309|54793005|FG014|Maintenance Period|Lost to Follow-up|0|||
28129911|NCT03364309|54793006|FG015|Maintenance Period|Lost to Follow-up|0|||
28129912|NCT03364309|54793007|FG016|Maintenance Period|Lost to Follow-up|0|||
28129913|NCT03364309|54793008|FG017|Maintenance Period|Lost to Follow-up|0|||
28129914|NCT03364309|54793009|FG018|Maintenance Period|Lost to Follow-up|0|||
28129915|NCT03364309|54792991|FG000|Maintenance Period|Miscellaneous|0|||
28129916|NCT03364309|54792992|FG001|Maintenance Period|Miscellaneous|0|||
28129917|NCT03364309|54792993|FG002|Maintenance Period|Miscellaneous|0|||
27818692|NCT01789970|54277282|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
27818693|NCT01789970|54277283|FG002|Double-blind Treatment Period (12 Weeks)|Other|3|||
27818694|NCT01789970|54277281|FG000|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
27818695|NCT01789970|54277282|FG001|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1|||
27818696|NCT01789970|54277283|FG002|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
27818697|NCT01734434|54277301|FG000|Overall Study|Death Infant|3|||
27818698|NCT01734434|54277302|FG001|Overall Study|Death Infant|1|||
27818699|NCT01734434|54277303|FG002|Overall Study|Death Infant|17|||
27818700|NCT01734434|54277304|FG003|Overall Study|Death Infant|5|||
27818701|NCT01734434|54277301|FG000|Overall Study|Lost to Follow-up|2|||
27818702|NCT01734434|54277302|FG001|Overall Study|Lost to Follow-up|9|||
28129918|NCT03364309|54792994|FG003|Maintenance Period|Miscellaneous|0|||
28129919|NCT03364309|54792995|FG004|Maintenance Period|Miscellaneous|0|||
28129920|NCT03364309|54792996|FG005|Maintenance Period|Miscellaneous|0|||
27818703|NCT01734434|54277303|FG002|Overall Study|Lost to Follow-up|67|||
28129921|NCT03364309|54792997|FG006|Maintenance Period|Miscellaneous|0|||
28129922|NCT03364309|54792998|FG007|Maintenance Period|Miscellaneous|0|||
28129923|NCT03364309|54792999|FG008|Maintenance Period|Miscellaneous|1|||
28129924|NCT03364309|54793000|FG009|Maintenance Period|Miscellaneous|0|||
28129925|NCT03364309|54793001|FG010|Maintenance Period|Miscellaneous|0|||
28129926|NCT03364309|54793002|FG011|Maintenance Period|Miscellaneous|0|||
27818704|NCT01734434|54277304|FG003|Overall Study|Lost to Follow-up|11|||
27818705|NCT01734434|54277301|FG000|Overall Study|No Live Birth|1|||
27818706|NCT01734434|54277302|FG001|Overall Study|No Live Birth|2|||
27818707|NCT01734434|54277303|FG002|Overall Study|No Live Birth|32|||
27818708|NCT01734434|54277304|FG003|Overall Study|No Live Birth|6|||
27818709|NCT01734434|54277301|FG000|Overall Study|Withdrawal by Subject|4|||
27818710|NCT01734434|54277302|FG001|Overall Study|Withdrawal by Subject|0|||
27818711|NCT01734434|54277303|FG002|Overall Study|Withdrawal by Subject|8|||
27818712|NCT01734434|54277304|FG003|Overall Study|Withdrawal by Subject|1|||
27818713|NCT01734434|54277301|FG000|Overall Study|Signed Adult Version of Consent Form|0|||
27818714|NCT01734434|54277302|FG001|Overall Study|Signed Adult Version of Consent Form|0|||
27818715|NCT01734434|54277303|FG002|Overall Study|Signed Adult Version of Consent Form|1|||
27818716|NCT01734434|54277304|FG003|Overall Study|Signed Adult Version of Consent Form|0|||
27818717|NCT01734434|54277301|FG000|Overall Study|Subject Not Reachable|0|||
27818718|NCT01734434|54277302|FG001|Overall Study|Subject Not Reachable|0|||
27818719|NCT01734434|54277303|FG002|Overall Study|Subject Not Reachable|1|||
27818720|NCT01734434|54277304|FG003|Overall Study|Subject Not Reachable|0|||
27818721|NCT01734434|54277301|FG000|Overall Study|Treatment Defaulter|0|||
27818722|NCT01734434|54277302|FG001|Overall Study|Treatment Defaulter|0|||
27818723|NCT01734434|54277303|FG002|Overall Study|Treatment Defaulter|1|||
27818724|NCT01734434|54277304|FG003|Overall Study|Treatment Defaulter|0|||
27818725|NCT01734434|54277301|FG000|Overall Study|Wrong Version of Consent Form Signed|0|||
27818726|NCT01734434|54277302|FG001|Overall Study|Wrong Version of Consent Form Signed|0|||
27818727|NCT01734434|54277303|FG002|Overall Study|Wrong Version of Consent Form Signed|1|||
27818728|NCT01734434|54277304|FG003|Overall Study|Wrong Version of Consent Form Signed|0|||
27818729|NCT01734434|54277301|FG000|Overall Study|17 Yr Old Subject Signed Consent form|0|||
27818730|NCT01734434|54277302|FG001|Overall Study|17 Yr Old Subject Signed Consent form|0|||
27818731|NCT01734434|54277303|FG002|Overall Study|17 Yr Old Subject Signed Consent form|1|||
27818732|NCT01734434|54277304|FG003|Overall Study|17 Yr Old Subject Signed Consent form|0|||
27818733|NCT01788566|54277322|FG000|Overall Study|Death|4|||
28129927|NCT03364309|54793003|FG012|Maintenance Period|Miscellaneous|0|||
28129928|NCT03364309|54793004|FG013|Maintenance Period|Miscellaneous|0|||
28129929|NCT03364309|54793005|FG014|Maintenance Period|Miscellaneous|0|||
28129930|NCT03364309|54793006|FG015|Maintenance Period|Miscellaneous|0|||
28129931|NCT03364309|54793007|FG016|Maintenance Period|Miscellaneous|0|||
28129932|NCT03364309|54793008|FG017|Maintenance Period|Miscellaneous|0|||
28129933|NCT03364309|54793009|FG018|Maintenance Period|Miscellaneous|0|||
28129934|NCT03364309|54792991|FG000|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
28129935|NCT03364309|54792992|FG001|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
28129936|NCT03364309|54792993|FG002|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
27818734|NCT01788566|54277322|FG000|Overall Study|Adverse Event|1|||
27818735|NCT01788566|54277322|FG000|Overall Study|Clinical Progressive Disease|3|||
27818736|NCT01733732|54277328|FG000|Overall Study|Adverse Event|1|||
27818737|NCT01733732|54277329|FG001|Overall Study|Adverse Event|0|||
27818738|NCT01733732|54277328|FG000|Overall Study|Did not attend all study visits|1|||
27818739|NCT01733732|54277329|FG001|Overall Study|Did not attend all study visits|0|||
27818740|NCT01732874|54277347|FG000|Overall Study|Withdrawal by Subject|5|||
27818741|NCT01732874|54277348|FG001|Overall Study|Withdrawal by Subject|1|||
27818742|NCT01732874|54277347|FG000|Overall Study|Death of Infant|3|||
27818743|NCT01732874|54277348|FG001|Overall Study|Death of Infant|2|||
27818744|NCT01732796|54277357|FG000|Overall Study|Adverse Event|16|||
28129937|NCT03364309|54792994|FG003|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
27818745|NCT01732796|54277358|FG001|Overall Study|Adverse Event|16|||
28129938|NCT03364309|54792995|FG004|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
28129939|NCT03364309|54792996|FG005|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
28129940|NCT03364309|54792997|FG006|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
28129941|NCT03364309|54792998|FG007|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
28129942|NCT03364309|54792999|FG008|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
28129943|NCT03364309|54793000|FG009|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
28129944|NCT03364309|54793001|FG010|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
28129945|NCT03364309|54793002|FG011|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
28129946|NCT03364309|54793003|FG012|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
28129947|NCT03364309|54793004|FG013|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
28129948|NCT03364309|54793005|FG014|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
28129949|NCT03364309|54793006|FG015|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
28129950|NCT03364309|54793007|FG016|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
28129951|NCT03364309|54793008|FG017|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
28129952|NCT03364309|54793009|FG018|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
28129953|NCT03364309|54792991|FG000|Re-treatment (Maintenance) Period|Adverse Event|0|||
28129954|NCT03364309|54792992|FG001|Re-treatment (Maintenance) Period|Adverse Event|0|||
28129955|NCT03364309|54792993|FG002|Re-treatment (Maintenance) Period|Adverse Event|0|||
28129956|NCT03364309|54792994|FG003|Re-treatment (Maintenance) Period|Adverse Event|0|||
28129957|NCT03364309|54792995|FG004|Re-treatment (Maintenance) Period|Adverse Event|0|||
28129958|NCT03364309|54792996|FG005|Re-treatment (Maintenance) Period|Adverse Event|0|||
28129959|NCT03364309|54792997|FG006|Re-treatment (Maintenance) Period|Adverse Event|0|||
28129960|NCT03364309|54792998|FG007|Re-treatment (Maintenance) Period|Adverse Event|0|||
28129961|NCT03364309|54792999|FG008|Re-treatment (Maintenance) Period|Adverse Event|0|||
28129962|NCT03364309|54793000|FG009|Re-treatment (Maintenance) Period|Adverse Event|0|||
28129963|NCT03364309|54793001|FG010|Re-treatment (Maintenance) Period|Adverse Event|0|||
28129964|NCT03364309|54793002|FG011|Re-treatment (Maintenance) Period|Adverse Event|0|||
28129965|NCT03364309|54793003|FG012|Re-treatment (Maintenance) Period|Adverse Event|0|||
28129966|NCT03364309|54793004|FG013|Re-treatment (Maintenance) Period|Adverse Event|0|||
28129967|NCT03364309|54793005|FG014|Re-treatment (Maintenance) Period|Adverse Event|1|||
28129968|NCT03364309|54793006|FG015|Re-treatment (Maintenance) Period|Adverse Event|0|||
28129969|NCT03364309|54793007|FG016|Re-treatment (Maintenance) Period|Adverse Event|0|||
28129970|NCT03364309|54793008|FG017|Re-treatment (Maintenance) Period|Adverse Event|0|||
28129971|NCT03364309|54793009|FG018|Re-treatment (Maintenance) Period|Adverse Event|0|||
28129972|NCT03364309|54792991|FG000|Re-treatment (Maintenance) Period|Relapse|0|||
28129973|NCT03364309|54792992|FG001|Re-treatment (Maintenance) Period|Relapse|0|||
28129974|NCT03364309|54792993|FG002|Re-treatment (Maintenance) Period|Relapse|0|||
28129975|NCT03364309|54792994|FG003|Re-treatment (Maintenance) Period|Relapse|0|||
28129976|NCT03364309|54792995|FG004|Re-treatment (Maintenance) Period|Relapse|0|||
28129977|NCT03364309|54792996|FG005|Re-treatment (Maintenance) Period|Relapse|0|||
28129978|NCT03364309|54792997|FG006|Re-treatment (Maintenance) Period|Relapse|0|||
28129979|NCT03364309|54792998|FG007|Re-treatment (Maintenance) Period|Relapse|0|||
28129980|NCT03364309|54792999|FG008|Re-treatment (Maintenance) Period|Relapse|0|||
28129981|NCT03364309|54793000|FG009|Re-treatment (Maintenance) Period|Relapse|0|||
28129982|NCT03364309|54793001|FG010|Re-treatment (Maintenance) Period|Relapse|0|||
28129983|NCT03364309|54793002|FG011|Re-treatment (Maintenance) Period|Relapse|0|||
28129984|NCT03364309|54793003|FG012|Re-treatment (Maintenance) Period|Relapse|1|||
28129985|NCT03364309|54793004|FG013|Re-treatment (Maintenance) Period|Relapse|0|||
28129986|NCT03364309|54793005|FG014|Re-treatment (Maintenance) Period|Relapse|0|||
28129987|NCT03364309|54793006|FG015|Re-treatment (Maintenance) Period|Relapse|1|||
28129988|NCT03364309|54793007|FG016|Re-treatment (Maintenance) Period|Relapse|0|||
28129989|NCT03364309|54793008|FG017|Re-treatment (Maintenance) Period|Relapse|0|||
28129990|NCT03364309|54793009|FG018|Re-treatment (Maintenance) Period|Relapse|0|||
28129991|NCT03364309|54792991|FG000|Post-Treatment Followup Period|Withdrawal by Subject|0|||
28129992|NCT03364309|54792992|FG001|Post-Treatment Followup Period|Withdrawal by Subject|0|||
28129993|NCT03364309|54792993|FG002|Post-Treatment Followup Period|Withdrawal by Subject|0|||
28129994|NCT03364309|54792994|FG003|Post-Treatment Followup Period|Withdrawal by Subject|0|||
28129995|NCT03364309|54792995|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
28129996|NCT03364309|54792996|FG005|Post-Treatment Followup Period|Withdrawal by Subject|0|||
27818746|NCT01732796|54277359|FG002|Overall Study|Adverse Event|4|||
27818747|NCT01732796|54277357|FG000|Overall Study|Lack of Efficacy|21|||
27818748|NCT01732796|54277358|FG001|Overall Study|Lack of Efficacy|18|||
27818749|NCT01732796|54277359|FG002|Overall Study|Lack of Efficacy|5|||
27818750|NCT01732796|54277357|FG000|Overall Study|Lost to Follow-up|2|||
27818751|NCT01732796|54277358|FG001|Overall Study|Lost to Follow-up|0|||
27818752|NCT01732796|54277359|FG002|Overall Study|Lost to Follow-up|0|||
27818753|NCT01732796|54277357|FG000|Overall Study|Withdrawal by Subject|6|||
28129997|NCT03364309|54792997|FG006|Post-Treatment Followup Period|Withdrawal by Subject|0|||
28129998|NCT03364309|54792998|FG007|Post-Treatment Followup Period|Withdrawal by Subject|0|||
28129999|NCT03364309|54792999|FG008|Post-Treatment Followup Period|Withdrawal by Subject|0|||
28130000|NCT03364309|54793000|FG009|Post-Treatment Followup Period|Withdrawal by Subject|0|||
28130001|NCT03364309|54793001|FG010|Post-Treatment Followup Period|Withdrawal by Subject|0|||
28130002|NCT03364309|54793002|FG011|Post-Treatment Followup Period|Withdrawal by Subject|0|||
28130003|NCT03364309|54793003|FG012|Post-Treatment Followup Period|Withdrawal by Subject|0|||
28130004|NCT03364309|54793004|FG013|Post-Treatment Followup Period|Withdrawal by Subject|0|||
28130005|NCT03364309|54793005|FG014|Post-Treatment Followup Period|Withdrawal by Subject|0|||
28130006|NCT03364309|54793006|FG015|Post-Treatment Followup Period|Withdrawal by Subject|0|||
28130007|NCT03364309|54793007|FG016|Post-Treatment Followup Period|Withdrawal by Subject|3|||
28130008|NCT03364309|54793008|FG017|Post-Treatment Followup Period|Withdrawal by Subject|19|||
28130009|NCT03364309|54793009|FG018|Post-Treatment Followup Period|Withdrawal by Subject|1|||
28130010|NCT03364309|54792991|FG000|Post-Treatment Followup Period|Adverse Event|0|||
28130011|NCT03364309|54792992|FG001|Post-Treatment Followup Period|Adverse Event|0|||
28130012|NCT03364309|54792993|FG002|Post-Treatment Followup Period|Adverse Event|0|||
28130013|NCT03364309|54792994|FG003|Post-Treatment Followup Period|Adverse Event|0|||
28130014|NCT03364309|54792995|FG004|Post-Treatment Followup Period|Adverse Event|0|||
28130015|NCT03364309|54792996|FG005|Post-Treatment Followup Period|Adverse Event|0|||
28130016|NCT03364309|54792997|FG006|Post-Treatment Followup Period|Adverse Event|0|||
28130017|NCT03364309|54792998|FG007|Post-Treatment Followup Period|Adverse Event|0|||
28130018|NCT03364309|54792999|FG008|Post-Treatment Followup Period|Adverse Event|0|||
28130019|NCT03364309|54793000|FG009|Post-Treatment Followup Period|Adverse Event|0|||
27818754|NCT01732796|54277358|FG001|Overall Study|Withdrawal by Subject|8|||
27818755|NCT01732796|54277359|FG002|Overall Study|Withdrawal by Subject|2|||
27818756|NCT01732796|54277357|FG000|Overall Study|Other reason not defined above|1|||
28130020|NCT03364309|54793001|FG010|Post-Treatment Followup Period|Adverse Event|0|||
28130021|NCT03364309|54793002|FG011|Post-Treatment Followup Period|Adverse Event|0|||
28130022|NCT03364309|54793003|FG012|Post-Treatment Followup Period|Adverse Event|0|||
28130023|NCT03364309|54793004|FG013|Post-Treatment Followup Period|Adverse Event|0|||
28130024|NCT03364309|54793005|FG014|Post-Treatment Followup Period|Adverse Event|0|||
28130025|NCT03364309|54793006|FG015|Post-Treatment Followup Period|Adverse Event|0|||
28130026|NCT03364309|54793007|FG016|Post-Treatment Followup Period|Adverse Event|2|||
28130027|NCT03364309|54793008|FG017|Post-Treatment Followup Period|Adverse Event|6|||
28130028|NCT03364309|54793009|FG018|Post-Treatment Followup Period|Adverse Event|1|||
28130029|NCT03364309|54792991|FG000|Post-Treatment Followup Period|Lost to Follow-up|0|||
28130030|NCT03364309|54792992|FG001|Post-Treatment Followup Period|Lost to Follow-up|0|||
28130031|NCT03364309|54792993|FG002|Post-Treatment Followup Period|Lost to Follow-up|0|||
28130032|NCT03364309|54792994|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
28130033|NCT03364309|54792995|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
28130034|NCT03364309|54792996|FG005|Post-Treatment Followup Period|Lost to Follow-up|0|||
28130035|NCT03364309|54792997|FG006|Post-Treatment Followup Period|Lost to Follow-up|0|||
28130036|NCT03364309|54792998|FG007|Post-Treatment Followup Period|Lost to Follow-up|0|||
28130037|NCT03364309|54792999|FG008|Post-Treatment Followup Period|Lost to Follow-up|0|||
28130038|NCT03364309|54793000|FG009|Post-Treatment Followup Period|Lost to Follow-up|0|||
28130039|NCT03364309|54793001|FG010|Post-Treatment Followup Period|Lost to Follow-up|0|||
28130040|NCT03364309|54793002|FG011|Post-Treatment Followup Period|Lost to Follow-up|0|||
28130041|NCT03364309|54793003|FG012|Post-Treatment Followup Period|Lost to Follow-up|0|||
28130042|NCT03364309|54793004|FG013|Post-Treatment Followup Period|Lost to Follow-up|0|||
28130043|NCT03364309|54793005|FG014|Post-Treatment Followup Period|Lost to Follow-up|0|||
28130044|NCT03364309|54793006|FG015|Post-Treatment Followup Period|Lost to Follow-up|0|||
28130045|NCT03364309|54793007|FG016|Post-Treatment Followup Period|Lost to Follow-up|0|||
28130046|NCT03364309|54793008|FG017|Post-Treatment Followup Period|Lost to Follow-up|2|||
28130047|NCT03364309|54793009|FG018|Post-Treatment Followup Period|Lost to Follow-up|0|||
28130048|NCT03364309|54792991|FG000|Post-Treatment Followup Period|Miscellaneous|0|||
28130049|NCT03364309|54792992|FG001|Post-Treatment Followup Period|Miscellaneous|0|||
28130050|NCT03364309|54792993|FG002|Post-Treatment Followup Period|Miscellaneous|0|||
28130051|NCT03364309|54792994|FG003|Post-Treatment Followup Period|Miscellaneous|0|||
28130052|NCT03364309|54792995|FG004|Post-Treatment Followup Period|Miscellaneous|0|||
28130053|NCT03364309|54792996|FG005|Post-Treatment Followup Period|Miscellaneous|0|||
28130054|NCT03364309|54792997|FG006|Post-Treatment Followup Period|Miscellaneous|0|||
28130055|NCT03364309|54792998|FG007|Post-Treatment Followup Period|Miscellaneous|0|||
28130056|NCT03364309|54792999|FG008|Post-Treatment Followup Period|Miscellaneous|0|||
28130057|NCT03364309|54793000|FG009|Post-Treatment Followup Period|Miscellaneous|0|||
28130058|NCT03364309|54793001|FG010|Post-Treatment Followup Period|Miscellaneous|0|||
28130059|NCT03364309|54793002|FG011|Post-Treatment Followup Period|Miscellaneous|0|||
28130060|NCT03364309|54793003|FG012|Post-Treatment Followup Period|Miscellaneous|0|||
28130061|NCT03364309|54793004|FG013|Post-Treatment Followup Period|Miscellaneous|0|||
27818757|NCT01732796|54277358|FG001|Overall Study|Other reason not defined above|0|||
27818758|NCT01732796|54277359|FG002|Overall Study|Other reason not defined above|2|||
28067940|NCT00288860|54723079|FG000|Overall Study|Withdrawal by Subject|20|||
28067941|NCT00288860|54723080|FG001|Overall Study|Withdrawal by Subject|15|||
28130062|NCT03364309|54793005|FG014|Post-Treatment Followup Period|Miscellaneous|0|||
28130063|NCT03364309|54793006|FG015|Post-Treatment Followup Period|Miscellaneous|0|||
28130064|NCT03364309|54793007|FG016|Post-Treatment Followup Period|Miscellaneous|0|||
28130065|NCT03364309|54793008|FG017|Post-Treatment Followup Period|Miscellaneous|4|||
28130066|NCT03364309|54793009|FG018|Post-Treatment Followup Period|Miscellaneous|0|||
28130067|NCT03334903|54793035|FG000|Overall Study|Use of medical marijuana - determined ineligible later in study|1|||
28130068|NCT03334903|54793036|FG001|Overall Study|Use of medical marijuana - determined ineligible later in study|0|||
28067942|NCT00288860|54723079|FG000|Overall Study|Lost to Follow-up|74|||
28067943|NCT00288860|54723080|FG001|Overall Study|Lost to Follow-up|71|||
28067944|NCT00288704|54723092|FG000|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
28067945|NCT00288704|54723093|FG001|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1|||
28067946|NCT00288704|54723094|FG002|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
28067947|NCT00288704|54723092|FG000|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
28067948|NCT00288704|54723093|FG001|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1|||
28067949|NCT00288704|54723094|FG002|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
28067950|NCT00288704|54723092|FG000|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
28130069|NCT03334903|54793035|FG000|Overall Study|Protocol Violation|1|||
28130070|NCT03334903|54793036|FG001|Overall Study|Protocol Violation|3|||
28130071|NCT03334903|54793035|FG000|Overall Study|Surgery postponed|1|||
28130072|NCT03334903|54793036|FG001|Overall Study|Surgery postponed|0|||
28130073|NCT03334903|54793035|FG000|Overall Study|Adverse Event|1|||
28130074|NCT03334903|54793036|FG001|Overall Study|Adverse Event|1|||
28130075|NCT03334903|54793035|FG000|Overall Study|Withdrawal by Subject|0|||
28130076|NCT03334903|54793036|FG001|Overall Study|Withdrawal by Subject|1|||
28130077|NCT01353664|54793042|FG000|Overall Study|Other|3|||
28130078|NCT01353664|54793042|FG000|Overall Study|Disease Progression|16|||
28130079|NCT02694328|54793048|FG000|Overall Study|Adverse Event|27|||
28130080|NCT02694328|54793049|FG001|Overall Study|Adverse Event|33|||
28130081|NCT02694328|54793048|FG000|Overall Study|Withdrawal by Subject|27|||
28130082|NCT02694328|54793049|FG001|Overall Study|Withdrawal by Subject|23|||
28130083|NCT02694328|54793048|FG000|Overall Study|Lost to Follow-up|26|||
28067951|NCT00288704|54723093|FG001|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
28130084|NCT02694328|54793049|FG001|Overall Study|Lost to Follow-up|22|||
28130085|NCT02694328|54793048|FG000|Overall Study|Noncompliant with study drug|11|||
28130086|NCT02694328|54793049|FG001|Overall Study|Noncompliant with study drug|8|||
28130087|NCT02694328|54793048|FG000|Overall Study|Incarceration|1|||
28130088|NCT02694328|54793049|FG001|Overall Study|Incarceration|1|||
28130089|NCT02694328|54793048|FG000|Overall Study|Lack of Efficacy|1|||
28130090|NCT02694328|54793049|FG001|Overall Study|Lack of Efficacy|2|||
28130091|NCT02694328|54793048|FG000|Overall Study|Pregnancy|1|||
28130092|NCT02694328|54793049|FG001|Overall Study|Pregnancy|1|||
28130093|NCT02694328|54793048|FG000|Overall Study|Protocol Violation|6|||
28130094|NCT02694328|54793049|FG001|Overall Study|Protocol Violation|5|||
28130095|NCT02694328|54793048|FG000|Overall Study|Abnormal Laboratory Value|0|||
28130096|NCT02694328|54793049|FG001|Overall Study|Abnormal Laboratory Value|3|||
28130097|NCT03334747|54793064|FG000|Treatment Phase|Technical problems|0|||
28130098|NCT03334747|54793065|FG001|Treatment Phase|Technical problems|0|||
28130099|NCT03334747|54793066|FG002|Treatment Phase|Technical problems|0|||
28130100|NCT03334747|54793067|FG003|Treatment Phase|Technical problems|0|||
28130101|NCT03334747|54793068|FG004|Treatment Phase|Technical problems|1|||
28130102|NCT03334747|54793069|FG005|Treatment Phase|Technical problems|0|||
28130103|NCT03334747|54793070|FG006|Treatment Phase|Technical problems|0|||
28130104|NCT03334747|54793071|FG007|Treatment Phase|Technical problems|0|||
28130105|NCT03334747|54793072|FG008|Treatment Phase|Technical problems|0|||
28130106|NCT03334747|54793064|FG000|Treatment Phase|Subject/guardian decision|1|||
28130107|NCT03334747|54793065|FG001|Treatment Phase|Subject/guardian decision|0|||
28130108|NCT03334747|54793066|FG002|Treatment Phase|Subject/guardian decision|0|||
28130109|NCT03334747|54793067|FG003|Treatment Phase|Subject/guardian decision|0|||
28130110|NCT03334747|54793068|FG004|Treatment Phase|Subject/guardian decision|0|||
28130111|NCT03334747|54793069|FG005|Treatment Phase|Subject/guardian decision|1|||
28130112|NCT03334747|54793070|FG006|Treatment Phase|Subject/guardian decision|0|||
28130113|NCT03334747|54793071|FG007|Treatment Phase|Subject/guardian decision|0|||
28130114|NCT03334747|54793072|FG008|Treatment Phase|Subject/guardian decision|0|||
28130115|NCT03334747|54793064|FG000|Follow-Up Phase|Subject/guardian decision|0|||
28130116|NCT03334747|54793065|FG001|Follow-Up Phase|Subject/guardian decision|0|||
28130117|NCT03334747|54793066|FG002|Follow-Up Phase|Subject/guardian decision|0|||
28130118|NCT03334747|54793067|FG003|Follow-Up Phase|Subject/guardian decision|0|||
28130119|NCT03334747|54793068|FG004|Follow-Up Phase|Subject/guardian decision|0|||
28130120|NCT03334747|54793069|FG005|Follow-Up Phase|Subject/guardian decision|0|||
28130121|NCT03334747|54793070|FG006|Follow-Up Phase|Subject/guardian decision|1|||
28130122|NCT03334747|54793071|FG007|Follow-Up Phase|Subject/guardian decision|0|||
28130123|NCT03334747|54793072|FG008|Follow-Up Phase|Subject/guardian decision|1|||
28130124|NCT03346759|54793094|FG000|Enrollment to Baseline Data Collected|Lost to Follow-up|2|||
28130125|NCT03346759|54793095|FG001|Enrollment to Baseline Data Collected|Lost to Follow-up|3|||
28130126|NCT03346759|54793094|FG000|First Menstrual Cycle|Withdrawal by Subject|1|||
28130127|NCT03346759|54793095|FG001|First Menstrual Cycle|Withdrawal by Subject|0|||
28130128|NCT03346759|54793094|FG000|Second Menstrual Cycle|Lost to Follow-up|1|||
28130129|NCT03346759|54793095|FG001|Second Menstrual Cycle|Lost to Follow-up|0|||
28130130|NCT03361423|54793104|FG000|Overall Study|Withdrawal by Subject|4|||
28130131|NCT03361423|54793105|FG001|Overall Study|Withdrawal by Subject|3|||
28130132|NCT03361423|54793104|FG000|Overall Study|Did not treat|19|||
28130133|NCT03361423|54793105|FG001|Overall Study|Did not treat|18|||
28067952|NCT00288704|54723094|FG002|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1|||
28067953|NCT00288704|54723092|FG000|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
28067954|NCT00288704|54723093|FG001|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
28067955|NCT00288704|54723094|FG002|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1|||
28067956|NCT00288704|54723092|FG000|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
28067957|NCT00288704|54723093|FG001|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
28130134|NCT03361423|54793104|FG000|Overall Study|Started >60 minutes from migraine onset|0|||
28130135|NCT03361423|54793105|FG001|Overall Study|Started >60 minutes from migraine onset|1|||
28130136|NCT03361423|54793104|FG000|Overall Study|Missing data|4|||
28130137|NCT03361423|54793105|FG001|Overall Study|Missing data|1|||
28130138|NCT02693002|54793113|FG000|Overall Study|Withdrawal by Subject|1|||
28130139|NCT02693002|54793114|FG001|Overall Study|Withdrawal by Subject|0|||
28130140|NCT03093870|54793123|FG000|Overall Study|Withdrawal by Subject|2|||
28130141|NCT03093870|54793124|FG001|Overall Study|Withdrawal by Subject|6|||
28130142|NCT03093870|54793125|FG002|Overall Study|Withdrawal by Subject|5|||
28130143|NCT03093870|54793123|FG000|Overall Study|Death|1|||
28130144|NCT03093870|54793124|FG001|Overall Study|Death|35|||
28130145|NCT03093870|54793125|FG002|Overall Study|Death|35|||
28130146|NCT03093870|54793123|FG000|Overall Study|Radiographic disease progression|10|||
28130147|NCT03093870|54793124|FG001|Overall Study|Radiographic disease progression|0|||
28130148|NCT03093870|54793125|FG002|Overall Study|Radiographic disease progression|0|||
28130149|NCT03093870|54793123|FG000|Overall Study|Clinical disease progression|1|||
28130150|NCT03093870|54793124|FG001|Overall Study|Clinical disease progression|0|||
28130151|NCT03093870|54793125|FG002|Overall Study|Clinical disease progression|0|||
28130152|NCT03093870|54793123|FG000|Overall Study|Physician Decision|2|||
28130153|NCT03093870|54793124|FG001|Overall Study|Physician Decision|0|||
28130154|NCT03093870|54793125|FG002|Overall Study|Physician Decision|0|||
28130155|NCT03093870|54793123|FG000|Overall Study|Adverse Event|7|||
28130156|NCT03093870|54793124|FG001|Overall Study|Adverse Event|0|||
28130157|NCT03093870|54793125|FG002|Overall Study|Adverse Event|0|||
28130158|NCT03093870|54793123|FG000|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|1|||
28130159|NCT03093870|54793124|FG001|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
28130160|NCT03093870|54793125|FG002|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
28130161|NCT03093870|54793123|FG000|Overall Study|Lost to Follow-up|0|||
28130162|NCT03093870|54793124|FG001|Overall Study|Lost to Follow-up|0|||
28130163|NCT03093870|54793125|FG002|Overall Study|Lost to Follow-up|1|||
28130164|NCT03346057|54793148|FG000|Overall Study|Death|1|||
28130165|NCT03346057|54793149|FG001|Overall Study|Death|2|||
28130166|NCT03346057|54793150|FG002|Overall Study|Death|0|||
28130167|NCT03346057|54793151|FG003|Overall Study|Death|0|||
28130168|NCT03346057|54793148|FG000|Overall Study|Lost to Follow-up|0|||
28130169|NCT03346057|54793149|FG001|Overall Study|Lost to Follow-up|2|||
28130170|NCT03346057|54793150|FG002|Overall Study|Lost to Follow-up|1|||
28130171|NCT03346057|54793151|FG003|Overall Study|Lost to Follow-up|0|||
28130172|NCT03346057|54793148|FG000|Overall Study|Ineligible For Study - Not Treated|0|||
28130173|NCT03346057|54793149|FG001|Overall Study|Ineligible For Study - Not Treated|1|||
28130174|NCT03346057|54793150|FG002|Overall Study|Ineligible For Study - Not Treated|0|||
28130175|NCT03346057|54793151|FG003|Overall Study|Ineligible For Study - Not Treated|0|||
28130176|NCT03346057|54793148|FG000|Overall Study|Renal Insufficiency - Not Treated|1|||
28130177|NCT03346057|54793149|FG001|Overall Study|Renal Insufficiency - Not Treated|0|||
28130178|NCT03346057|54793150|FG002|Overall Study|Renal Insufficiency - Not Treated|0|||
28130179|NCT03346057|54793151|FG003|Overall Study|Renal Insufficiency - Not Treated|0|||
28130180|NCT03346057|54793148|FG000|Overall Study|Physician Decision|3|||
28130181|NCT03346057|54793149|FG001|Overall Study|Physician Decision|2|||
28130182|NCT03346057|54793150|FG002|Overall Study|Physician Decision|0|||
28130183|NCT03346057|54793151|FG003|Overall Study|Physician Decision|2|||
28130184|NCT03346057|54793148|FG000|Overall Study|Randomization Mistake - Not Treated|1|||
28130185|NCT03346057|54793149|FG001|Overall Study|Randomization Mistake - Not Treated|1|||
28130186|NCT03346057|54793150|FG002|Overall Study|Randomization Mistake - Not Treated|0|||
28130187|NCT03346057|54793151|FG003|Overall Study|Randomization Mistake - Not Treated|0|||
28130188|NCT03346057|54793148|FG000|Overall Study|Withdrawal by Subject|1|||
28130189|NCT03346057|54793149|FG001|Overall Study|Withdrawal by Subject|0|||
28130190|NCT03346057|54793150|FG002|Overall Study|Withdrawal by Subject|0|||
28130191|NCT03346057|54793151|FG003|Overall Study|Withdrawal by Subject|0|||
28130192|NCT03345979|54793163|FG000|Overall Study|Withdrawal by Subject|20|||
28130193|NCT03345979|54793164|FG001|Overall Study|Withdrawal by Subject|31|||
28130194|NCT03345979|54793163|FG000|Overall Study|Adverse Event|10|||
28130195|NCT03345979|54793164|FG001|Overall Study|Adverse Event|11|||
28130196|NCT03345979|54793163|FG000|Overall Study|Lost to Follow-up|8|||
28130197|NCT03345979|54793164|FG001|Overall Study|Lost to Follow-up|9|||
28130198|NCT03345979|54793163|FG000|Overall Study|Lack of Efficacy|4|||
28130199|NCT03345979|54793164|FG001|Overall Study|Lack of Efficacy|2|||
27940546|NCT01022853|54596832|FG002|Overall Study|Withdrawal by Subject|1|||
28130200|NCT03345979|54793163|FG000|Overall Study|Protocol Violation|1|||
28130201|NCT03345979|54793164|FG001|Overall Study|Protocol Violation|3|||
28130202|NCT03345979|54793163|FG000|Overall Study|Physician Decision|0|||
28130203|NCT03345979|54793164|FG001|Overall Study|Physician Decision|2|||
28130204|NCT02696434|54793172|FG000|Overall Study|Adverse Event|3|||
28130205|NCT02696434|54793173|FG001|Overall Study|Adverse Event|1|||
28130206|NCT02696434|54793172|FG000|Overall Study|Lost to Follow-up|5|||
28130207|NCT02696434|54793173|FG001|Overall Study|Lost to Follow-up|4|||
28130208|NCT02696434|54793172|FG000|Overall Study|Withdrawal by Subject|14|||
28130209|NCT02696434|54793173|FG001|Overall Study|Withdrawal by Subject|12|||
28130210|NCT02696434|54793172|FG000|Overall Study|Physician Decision|0|||
28130211|NCT02696434|54793173|FG001|Overall Study|Physician Decision|1|||
28130212|NCT03345901|54793179|FG000|Overall Study|The study was terminated|18|||
28130213|NCT02950831|54793184|FG000|Overall Study|Lost to Follow-up|1|||
28130214|NCT02950831|54793184|FG000|Overall Study|Withdrawal by Subject|3|||
28130215|NCT02950831|54793184|FG000|Overall Study|stimulation trail failure|5|||
28130216|NCT03593915|54793194|FG000|Overall Study|Adverse Event|0|||
28130217|NCT03593915|54793195|FG001|Overall Study|Adverse Event|0|||
28130218|NCT03593915|54793196|FG002|Overall Study|Adverse Event|0|||
28130219|NCT03593915|54793197|FG003|Overall Study|Adverse Event|1|||
28130220|NCT03593915|54793198|FG004|Overall Study|Adverse Event|0|||
28130221|NCT03593915|54793199|FG005|Overall Study|Adverse Event|0|||
28130222|NCT03593915|54793194|FG000|Overall Study|Physician Decision|0|||
28130223|NCT03593915|54793195|FG001|Overall Study|Physician Decision|0|||
28130224|NCT03593915|54793196|FG002|Overall Study|Physician Decision|0|||
28130225|NCT03593915|54793197|FG003|Overall Study|Physician Decision|0|||
28130226|NCT03593915|54793198|FG004|Overall Study|Physician Decision|0|||
28130227|NCT03593915|54793199|FG005|Overall Study|Physician Decision|1|||
28130228|NCT03593681|54793213|FG000|Overall Study|Inadequate sample collected|12|||
28130229|NCT03593681|54793213|FG000|Overall Study|Hysteroscope attempted but unable to find ostia|11|||
28130230|NCT03593681|54793213|FG000|Overall Study|Protocol Violation|3|||
28130231|NCT03593681|54793213|FG000|Overall Study|Withdrawal by Subject|3|||
28130232|NCT03593681|54793213|FG000|Overall Study|Procedure not attempted|3|||
28130233|NCT03593681|54793213|FG000|Overall Study|Adverse Event|2|||
28130234|NCT03593681|54793213|FG000|Overall Study|Physician Decision|1|||
28130235|NCT03592745|54793236|FG000|Overall Study|Adverse Event|0|||
28130236|NCT03592745|54793237|FG001|Overall Study|Adverse Event|2|||
28130237|NCT03592745|54793236|FG000|Overall Study|Lost to Follow-up|2|||
28130238|NCT03592745|54793237|FG001|Overall Study|Lost to Follow-up|0|||
28130239|NCT03592745|54793236|FG000|Overall Study|study temporary closure due to covid-19 pandemic|1|||
28130240|NCT03592745|54793237|FG001|Overall Study|study temporary closure due to covid-19 pandemic|1|||
28130241|NCT03592277|54793245|FG000|Overall Study|Withdrawal by Subject|6|||
28130242|NCT03592277|54793246|FG001|Overall Study|Withdrawal by Subject|8|||
28130243|NCT03401112|54793257|FG000|Overall Study|Adverse Event|1|||
28130244|NCT03401112|54793258|FG001|Overall Study|Adverse Event|2|||
28130245|NCT03401112|54793259|FG002|Overall Study|Adverse Event|3|||
28130246|NCT03401112|54793260|FG003|Overall Study|Adverse Event|2|||
28130247|NCT03401112|54793261|FG004|Overall Study|Adverse Event|0|||
28130248|NCT03401112|54793257|FG000|Overall Study|Lost to Follow-up|1|||
28130249|NCT03401112|54793258|FG001|Overall Study|Lost to Follow-up|0|||
28130250|NCT03401112|54793259|FG002|Overall Study|Lost to Follow-up|0|||
28130251|NCT03401112|54793260|FG003|Overall Study|Lost to Follow-up|0|||
28130252|NCT03401112|54793261|FG004|Overall Study|Lost to Follow-up|0|||
28130253|NCT03401112|54793257|FG000|Overall Study|Noncompliance|1|||
28130254|NCT03401112|54793258|FG001|Overall Study|Noncompliance|2|||
28130255|NCT03401112|54793259|FG002|Overall Study|Noncompliance|3|||
28130256|NCT03401112|54793260|FG003|Overall Study|Noncompliance|0|||
28130257|NCT03401112|54793261|FG004|Overall Study|Noncompliance|0|||
28130258|NCT03401112|54793257|FG000|Overall Study|Did not Meet Inclusion Criteria|1|||
28130259|NCT03401112|54793258|FG001|Overall Study|Did not Meet Inclusion Criteria|0|||
28130260|NCT03401112|54793259|FG002|Overall Study|Did not Meet Inclusion Criteria|0|||
28130261|NCT03401112|54793260|FG003|Overall Study|Did not Meet Inclusion Criteria|0|||
28130262|NCT03401112|54793261|FG004|Overall Study|Did not Meet Inclusion Criteria|0|||
28130263|NCT03401112|54793257|FG000|Overall Study|Withdrawal by Subject|0|||
28130264|NCT03401112|54793258|FG001|Overall Study|Withdrawal by Subject|3|||
28130265|NCT03401112|54793259|FG002|Overall Study|Withdrawal by Subject|2|||
28130266|NCT03401112|54793260|FG003|Overall Study|Withdrawal by Subject|1|||
28130267|NCT03401112|54793261|FG004|Overall Study|Withdrawal by Subject|0|||
28130268|NCT03401112|54793257|FG000|Overall Study|Physician Decision|0|||
28130269|NCT03401112|54793258|FG001|Overall Study|Physician Decision|0|||
28130270|NCT03401112|54793259|FG002|Overall Study|Physician Decision|0|||
28130271|NCT03401112|54793260|FG003|Overall Study|Physician Decision|2|||
28130272|NCT03401112|54793261|FG004|Overall Study|Physician Decision|0|||
28130273|NCT03401112|54793257|FG000|Overall Study|Study was Terminated by Sponsor|0|||
28130274|NCT03401112|54793258|FG001|Overall Study|Study was Terminated by Sponsor|0|||
28130275|NCT03401112|54793259|FG002|Overall Study|Study was Terminated by Sponsor|0|||
28130276|NCT03401112|54793260|FG003|Overall Study|Study was Terminated by Sponsor|1|||
27940547|NCT01022853|54596833|FG003|Overall Study|Withdrawal by Subject|1|||
28130277|NCT03401112|54793261|FG004|Overall Study|Study was Terminated by Sponsor|0|||
28130278|NCT03401112|54793257|FG000|Overall Study|Day 1 Assessment not Done|1|||
28130279|NCT03401112|54793258|FG001|Overall Study|Day 1 Assessment not Done|0|||
28130280|NCT03401112|54793259|FG002|Overall Study|Day 1 Assessment not Done|0|||
28130281|NCT03401112|54793260|FG003|Overall Study|Day 1 Assessment not Done|0|||
28130282|NCT03401112|54793261|FG004|Overall Study|Day 1 Assessment not Done|0|||
28130283|NCT03401112|54793257|FG000|Overall Study|Not Dosed|0|||
28130284|NCT03401112|54793258|FG001|Overall Study|Not Dosed|0|||
28130285|NCT03401112|54793259|FG002|Overall Study|Not Dosed|1|||
28130286|NCT03401112|54793260|FG003|Overall Study|Not Dosed|0|||
28130287|NCT03401112|54793261|FG004|Overall Study|Not Dosed|0|||
28130288|NCT03401112|54793257|FG000|Overall Study|Missed Clinical Visit|0|||
28130289|NCT03401112|54793258|FG001|Overall Study|Missed Clinical Visit|0|||
28130290|NCT03401112|54793259|FG002|Overall Study|Missed Clinical Visit|1|||
28130291|NCT03401112|54793260|FG003|Overall Study|Missed Clinical Visit|0|||
28130292|NCT03401112|54793261|FG004|Overall Study|Missed Clinical Visit|0|||
28130293|NCT03401112|54793257|FG000|Overall Study|Missed Doses|0|||
28130294|NCT03401112|54793258|FG001|Overall Study|Missed Doses|0|||
28130295|NCT03401112|54793259|FG002|Overall Study|Missed Doses|1|||
28130296|NCT03401112|54793260|FG003|Overall Study|Missed Doses|0|||
28130297|NCT03401112|54793261|FG004|Overall Study|Missed Doses|0|||
28130298|NCT02697916|54793290|FG000|Overall Study|Death|357|||
28130299|NCT02697916|54793291|FG001|Overall Study|Death|315|||
28130300|NCT02697916|54793290|FG000|Overall Study|Withdrawal by Subject|221|||
28130301|NCT02697916|54793291|FG001|Overall Study|Withdrawal by Subject|393|||
28130302|NCT03650387|54793297|FG000|Overall Study|Withdrawal by Subject|13|||
28130303|NCT03650387|54793297|FG000|Overall Study|Lost to Follow-up|12|||
28130304|NCT03650387|54793297|FG000|Overall Study|Adverse Event (Not related)|1|||
28130305|NCT03650387|54793297|FG000|Overall Study|Due to COVID-19 Pandemic|8|||
28130306|NCT03359473|54793323|FG000|Overall Study|Adverse Event|0|||
28130307|NCT03359473|54793324|FG001|Overall Study|Adverse Event|2|||
28130308|NCT03359473|54793325|FG002|Overall Study|Adverse Event|5|||
28130309|NCT03359473|54793326|FG003|Overall Study|Adverse Event|3|||
28130310|NCT03359473|54793323|FG000|Overall Study|Lost to Follow-up|0|||
28130311|NCT03359473|54793324|FG001|Overall Study|Lost to Follow-up|1|||
28130312|NCT03359473|54793325|FG002|Overall Study|Lost to Follow-up|0|||
28130313|NCT03359473|54793326|FG003|Overall Study|Lost to Follow-up|0|||
28130314|NCT03359473|54793323|FG000|Overall Study|Physician Decision|0|||
28130315|NCT03359473|54793324|FG001|Overall Study|Physician Decision|1|||
28130316|NCT03359473|54793325|FG002|Overall Study|Physician Decision|0|||
28130317|NCT03359473|54793326|FG003|Overall Study|Physician Decision|1|||
28130318|NCT03359473|54793323|FG000|Overall Study|Withdrawal by Subject|1|||
28130319|NCT03359473|54793324|FG001|Overall Study|Withdrawal by Subject|2|||
28130320|NCT03359473|54793325|FG002|Overall Study|Withdrawal by Subject|1|||
28130321|NCT03359473|54793326|FG003|Overall Study|Withdrawal by Subject|0|||
28130322|NCT03359473|54793323|FG000|Overall Study|Protocol-defined stopping criteria|1|||
28130323|NCT03359473|54793324|FG001|Overall Study|Protocol-defined stopping criteria|0|||
28130324|NCT03359473|54793325|FG002|Overall Study|Protocol-defined stopping criteria|0|||
28130325|NCT03359473|54793326|FG003|Overall Study|Protocol-defined stopping criteria|1|||
28130326|NCT03589469|54793339|FG000|Overall Study|Ongoing in study|58|||
28130327|NCT03589469|54793339|FG000|Overall Study|Withdrawal by Subject|6|||
28130328|NCT03589469|54793339|FG000|Overall Study|Physician Decision|1|||
28130329|NCT03589469|54793339|FG000|Overall Study|Death|77|||
28130330|NCT03589469|54793339|FG000|Overall Study|Lost to Follow-up|3|||
28130331|NCT03359395|54793345|FG000|First Intervention A / B|Withdrawal by Subject|1|||
28130332|NCT03359395|54793346|FG001|First Intervention A / B|Withdrawal by Subject|0|||
28130333|NCT03359395|54793345|FG000|First Intervention A / B|Lost to Follow-up|2|||
28130334|NCT03359395|54793346|FG001|First Intervention A / B|Lost to Follow-up|3|||
28130335|NCT03359395|54793345|FG000|Second Intervention B/A|Exclusion criteria|0|||
28130336|NCT03359395|54793346|FG001|Second Intervention B/A|Exclusion criteria|1|||
28130337|NCT03359395|54793345|FG000|Second Intervention B/A|Lost to Follow-up|3|||
28130338|NCT03359395|54793346|FG001|Second Intervention B/A|Lost to Follow-up|2|||
28130339|NCT03586427|54793357|FG000|Overall Study|Lost to Follow-up|0|||
28130340|NCT03586427|54793358|FG001|Overall Study|Lost to Follow-up|3|||
28130341|NCT03586427|54793359|FG002|Overall Study|Lost to Follow-up|1|||
28130342|NCT03586427|54793360|FG003|Overall Study|Lost to Follow-up|3|||
28130343|NCT03586427|54793361|FG004|Overall Study|Lost to Follow-up|3|||
28130344|NCT03586427|54793357|FG000|Overall Study|Withdrawal by Subject|0|||
28130345|NCT03586427|54793358|FG001|Overall Study|Withdrawal by Subject|1|||
28130346|NCT03586427|54793359|FG002|Overall Study|Withdrawal by Subject|2|||
28130347|NCT03586427|54793360|FG003|Overall Study|Withdrawal by Subject|1|||
28130348|NCT03586427|54793361|FG004|Overall Study|Withdrawal by Subject|1|||
28130349|NCT03586427|54793357|FG000|Overall Study|Adverse Event|0|||
28130350|NCT03586427|54793358|FG001|Overall Study|Adverse Event|0|||
28130351|NCT03586427|54793359|FG002|Overall Study|Adverse Event|1|||
28130352|NCT03586427|54793360|FG003|Overall Study|Adverse Event|0|||
28130353|NCT03586427|54793361|FG004|Overall Study|Adverse Event|0|||
28130354|NCT03586427|54793357|FG000|Overall Study|Protocol Violation|0|||
28130355|NCT03586427|54793358|FG001|Overall Study|Protocol Violation|0|||
28130356|NCT03586427|54793359|FG002|Overall Study|Protocol Violation|1|||
28130357|NCT03586427|54793360|FG003|Overall Study|Protocol Violation|0|||
28130358|NCT03586427|54793361|FG004|Overall Study|Protocol Violation|1|||
28130359|NCT03586427|54793357|FG000|Overall Study|Noncompliance with study drug|0|||
28130360|NCT03586427|54793358|FG001|Overall Study|Noncompliance with study drug|0|||
28130361|NCT03586427|54793359|FG002|Overall Study|Noncompliance with study drug|1|||
28130362|NCT03586427|54793360|FG003|Overall Study|Noncompliance with study drug|0|||
28130363|NCT03586427|54793361|FG004|Overall Study|Noncompliance with study drug|0|||
28130364|NCT03648983|54793378|FG000|Overall Study|Study was terminated due to PI departure|95|||
28130365|NCT02695420|54793387|FG000|Overall Study|Death|0|||
28130366|NCT02695420|54793388|FG001|Overall Study|Death|1|||
28130367|NCT02695420|54793389|FG002|Overall Study|Death|0|||
28130368|NCT02695420|54793390|FG003|Overall Study|Death|0|||
28130369|NCT03358147|54793408|FG000|Overall Study|Withdrawal by Subject|13|||
28130370|NCT03358147|54793409|FG001|Overall Study|Withdrawal by Subject|19|||
28130371|NCT03358147|54793410|FG002|Overall Study|Withdrawal by Subject|16|||
28130372|NCT03358147|54793411|FG003|Overall Study|Withdrawal by Subject|10|||
28130373|NCT03358147|54793412|FG004|Overall Study|Withdrawal by Subject|5|||
28130374|NCT03358147|54793408|FG000|Overall Study|Adverse Event|3|||
28130375|NCT03358147|54793409|FG001|Overall Study|Adverse Event|9|||
28130376|NCT03358147|54793410|FG002|Overall Study|Adverse Event|7|||
28130377|NCT03358147|54793411|FG003|Overall Study|Adverse Event|5|||
28130378|NCT03358147|54793412|FG004|Overall Study|Adverse Event|2|||
28130379|NCT03358147|54793408|FG000|Overall Study|Lost to Follow-up|4|||
28130380|NCT03358147|54793409|FG001|Overall Study|Lost to Follow-up|3|||
28130381|NCT03358147|54793410|FG002|Overall Study|Lost to Follow-up|7|||
28130382|NCT03358147|54793411|FG003|Overall Study|Lost to Follow-up|6|||
28130383|NCT03358147|54793412|FG004|Overall Study|Lost to Follow-up|4|||
28130384|NCT03358147|54793408|FG000|Overall Study|Major Protocol Deviation|11|||
28130385|NCT03358147|54793409|FG001|Overall Study|Major Protocol Deviation|3|||
28130386|NCT03358147|54793410|FG002|Overall Study|Major Protocol Deviation|2|||
28130387|NCT03358147|54793411|FG003|Overall Study|Major Protocol Deviation|3|||
28130388|NCT03358147|54793412|FG004|Overall Study|Major Protocol Deviation|1|||
28130389|NCT03358147|54793408|FG000|Overall Study|Protocol specified criteria|2|||
28130390|NCT03358147|54793409|FG001|Overall Study|Protocol specified criteria|3|||
28130391|NCT03358147|54793410|FG002|Overall Study|Protocol specified criteria|0|||
28130392|NCT03358147|54793411|FG003|Overall Study|Protocol specified criteria|3|||
28130393|NCT03358147|54793412|FG004|Overall Study|Protocol specified criteria|1|||
28130394|NCT03358147|54793408|FG000|Overall Study|Physician Decision|1|||
28130395|NCT03358147|54793409|FG001|Overall Study|Physician Decision|0|||
28130396|NCT03358147|54793410|FG002|Overall Study|Physician Decision|1|||
28130397|NCT03358147|54793411|FG003|Overall Study|Physician Decision|6|||
28130398|NCT03358147|54793412|FG004|Overall Study|Physician Decision|1|||
27849445|NCT00089999|54345830|FG000|Overall Study|Withdrawal by Subject|0|||
27849446|NCT00089999|54345831|FG001|Overall Study|Withdrawal by Subject|4|||
27849447|NCT00089999|54345830|FG000|Overall Study|Lost to Follow-up|2|||
27849448|NCT00089999|54345831|FG001|Overall Study|Lost to Follow-up|1|||
27849449|NCT00089999|54345830|FG000|Overall Study|Radiological Progression of Cancer|52|||
27849450|NCT00089999|54345831|FG001|Overall Study|Radiological Progression of Cancer|44|||
27849451|NCT00089999|54345830|FG000|Overall Study|Symptomatic Progression of Cancer|2|||
27849452|NCT00089999|54345831|FG001|Overall Study|Symptomatic Progression of Cancer|5|||
28130399|NCT03358147|54793408|FG000|Overall Study|Administrative reasons|0|||
28130400|NCT03358147|54793409|FG001|Overall Study|Administrative reasons|1|||
28130401|NCT03358147|54793410|FG002|Overall Study|Administrative reasons|0|||
27849453|NCT00089999|54345830|FG000|Overall Study|Death|3|||
27849454|NCT00089999|54345831|FG001|Overall Study|Death|3|||
28067958|NCT00288704|54723094|FG002|Open-Label Extension (OLE) Weeks 24-117|Death|2|||
28067959|NCT00288704|54723092|FG000|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
28067960|NCT00288704|54723093|FG001|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
28067961|NCT00288704|54723094|FG002|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15|||
28067962|NCT00288704|54723092|FG000|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
28067963|NCT00288704|54723093|FG001|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
28067964|NCT00288704|54723094|FG002|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1|||
28067965|NCT00288626|54723101|FG000|Overall Study|Death|3|||
28067966|NCT00288626|54723101|FG000|Overall Study|Withdrawal by Subject|4|||
28067967|NCT00087490|54723109|FG000|Overall Study|Death|6|||
28067968|NCT00087490|54723110|FG001|Overall Study|Death|4|||
28067969|NCT00087490|54723109|FG000|Overall Study|Adverse Event|3|||
28067970|NCT00087490|54723110|FG001|Overall Study|Adverse Event|8|||
28067971|NCT00087490|54723109|FG000|Overall Study|Lack of Efficacy|0|||
28067972|NCT00087490|54723110|FG001|Overall Study|Lack of Efficacy|2|||
28067973|NCT00087490|54723109|FG000|Overall Study|Protocol Violation or (/) Unspecified|214|||
28067974|NCT00087490|54723110|FG001|Overall Study|Protocol Violation or (/) Unspecified|201|||
28067975|NCT00087490|54723109|FG000|Overall Study|Lost to Follow-Up/participant withdrawal|28|||
28067976|NCT00087490|54723110|FG001|Overall Study|Lost to Follow-Up/participant withdrawal|36|||
28067977|NCT00087490|54723109|FG000|Overall Study|Randomized but not treated|7|||
28067978|NCT00087490|54723110|FG001|Overall Study|Randomized but not treated|18|||
28067979|NCT00087178|54723118|FG000|Overall Study|No follow up data|5|||
28067980|NCT00087178|54723119|FG001|Overall Study|No follow up data|15|||
28067981|NCT00087178|54723118|FG000|Overall Study|No clinical assessment|1|||
28067982|NCT00087178|54723119|FG001|Overall Study|No clinical assessment|2|||
28130402|NCT03358147|54793411|FG003|Overall Study|Administrative reasons|3|||
28130403|NCT03358147|54793412|FG004|Overall Study|Administrative reasons|0|||
28130404|NCT03358147|54793408|FG000|Overall Study|Lack of Efficacy|0|||
28130405|NCT03358147|54793409|FG001|Overall Study|Lack of Efficacy|1|||
28130406|NCT03358147|54793410|FG002|Overall Study|Lack of Efficacy|1|||
28130407|NCT03358147|54793411|FG003|Overall Study|Lack of Efficacy|0|||
28130408|NCT03358147|54793412|FG004|Overall Study|Lack of Efficacy|0|||
28160060|NCT02925923|54830166|FG001|Overall Study|blood samples hemolyzed|2|||
28160061|NCT02410343|54830174|FG000|Core Period (24 Weeks)|Adverse Event|1|||
28160062|NCT02410343|54830175|FG001|Core Period (24 Weeks)|Adverse Event|0|||
28160063|NCT02410343|54830174|FG000|Core Period (24 Weeks)|Early termination of study by sponsor|4|||
28160064|NCT02410343|54830175|FG001|Core Period (24 Weeks)|Early termination of study by sponsor|7|||
28160065|NCT02410343|54830174|FG000|Extension Period (12 Months)|Adverse Event|1|||
28160066|NCT02410343|54830175|FG001|Extension Period (12 Months)|Adverse Event|0|||
28160067|NCT02410343|54830174|FG000|Extension Period (12 Months)|Early termination of study by sponsor|0|||
28160068|NCT02410343|54830175|FG001|Extension Period (12 Months)|Early termination of study by sponsor|1|||
28160069|NCT03064841|54830182|FG000|Overall Study|Inclusion/exclusion criteria violation|4|||
28160070|NCT03064841|54830182|FG000|Overall Study|No glycated haemoglobinA1c measurement|11|||
28160071|NCT03064841|54830182|FG000|Overall Study|Screen failure|2|||
28160072|NCT02045303|54830188|FG000|Overall Study|Protocol Violation|2|||
28160073|NCT02045303|54830189|FG001|Overall Study|Protocol Violation|1|||
28160074|NCT02045303|54830190|FG002|Overall Study|Protocol Violation|0|||
28160075|NCT02045303|54830188|FG000|Overall Study|Withdrawal by Subject|0|||
28160076|NCT02045303|54830189|FG001|Overall Study|Withdrawal by Subject|2|||
27818759|NCT01732640|54277369|FG000|Overall Study|Adverse Event|0|||
27818760|NCT01732640|54277370|FG001|Overall Study|Adverse Event|1|||
28067983|NCT00087178|54723118|FG000|Overall Study|Patient not at risk for primary endpoint|0|||
28067984|NCT00087178|54723119|FG001|Overall Study|Patient not at risk for primary endpoint|1|||
28067985|NCT00288080|54723127|FG000|Overall Study|Withdrawal by Subject|1|||
28067986|NCT00288080|54723128|FG001|Overall Study|Withdrawal by Subject|3|||
28067987|NCT00288080|54723127|FG000|Overall Study|Protocol Violation|25|||
28067988|NCT00288080|54723128|FG001|Overall Study|Protocol Violation|20|||
28067989|NCT00287690|54723136|FG000|Overall Study|Protocol Violation|20|||
28067990|NCT00287690|54723137|FG001|Overall Study|Protocol Violation|26|||
28067991|NCT00286754|54723146|FG000|Overall Study|Adverse Event|2|||
28067992|NCT00286754|54723147|FG001|Overall Study|Adverse Event|2|||
28067993|NCT00286754|54723148|FG002|Overall Study|Adverse Event|3|||
28067994|NCT00286754|54723146|FG000|Overall Study|Withdrawal by Subject|6|||
28067995|NCT00286754|54723147|FG001|Overall Study|Withdrawal by Subject|2|||
28067996|NCT00286754|54723148|FG002|Overall Study|Withdrawal by Subject|0|||
28067997|NCT00286754|54723146|FG000|Overall Study|Lost to Follow-up|12|||
28067998|NCT00286754|54723147|FG001|Overall Study|Lost to Follow-up|14|||
28067999|NCT00286754|54723148|FG002|Overall Study|Lost to Follow-up|6|||
28068000|NCT00286754|54723146|FG000|Overall Study|Moved out of state|0|||
28068001|NCT00286754|54723147|FG001|Overall Study|Moved out of state|0|||
28068002|NCT00286754|54723148|FG002|Overall Study|Moved out of state|1|||
28068003|NCT00066742|54723162|FG000|Induction Chemoradiotherapy|Did not receive any protocol treatment|1|||
28068004|NCT00066742|54723162|FG000|Induction Chemoradiotherapy|Adverse Event|21|||
28068005|NCT00066742|54723162|FG000|Induction Chemoradiotherapy|Withdrawal by Subject|2|||
28068006|NCT00066742|54723162|FG000|Induction Chemoradiotherapy|not protocol specified|2|||
28068007|NCT00066742|54723162|FG000|Induction Chemoradiotherapy|Ineligible|3|||
28068008|NCT00066742|54723162|FG000|Consolidation Chemotherapy|not protocol specified|1|||
28068009|NCT00066742|54723162|FG000|Consolidation Chemotherapy|Ineligible|2|||
28068010|NCT00460265|54723170|FG000|Overall Study|Lost to Follow-up|14|||
28160077|NCT02045303|54830190|FG002|Overall Study|Withdrawal by Subject|0|||
28160078|NCT03434379|54830201|FG000|Global Period|Lost to Follow-up|3|||
28160079|NCT03434379|54830202|FG001|Global Period|Lost to Follow-up|1|||
28160080|NCT03434379|54830203|FG002|Global Period|Lost to Follow-up|0|||
28160081|NCT03434379|54830204|FG003|Global Period|Lost to Follow-up|0|||
28160082|NCT03434379|54830201|FG000|Global Period|Death|99|||
28160083|NCT03434379|54830202|FG001|Global Period|Death|179|||
28160084|NCT03434379|54830203|FG002|Global Period|Death|0|||
28160085|NCT03434379|54830204|FG003|Global Period|Death|0|||
28160086|NCT03434379|54830201|FG000|Global Period|Withdrawal by Subject|20|||
28160087|NCT03434379|54830202|FG001|Global Period|Withdrawal by Subject|20|||
28160088|NCT03434379|54830203|FG002|Global Period|Withdrawal by Subject|0|||
28160089|NCT03434379|54830204|FG003|Global Period|Withdrawal by Subject|0|||
28160090|NCT03434379|54830201|FG000|Global Period|On Study|43|||
28160091|NCT03434379|54830202|FG001|Global Period|On Study|136|||
28160092|NCT03434379|54830203|FG002|Global Period|On Study|0|||
28160093|NCT03434379|54830204|FG003|Global Period|On Study|0|||
27818761|NCT01732640|54277369|FG000|Overall Study|Death|0|||
28068011|NCT00460265|54723171|FG001|Overall Study|Lost to Follow-up|15|||
28160094|NCT03434379|54830201|FG000|China Extension Period|Lost to Follow-up|0|||
28068012|NCT00460265|54723170|FG000|Overall Study|Physician Decision|1|||
28068013|NCT00460265|54723171|FG001|Overall Study|Physician Decision|2|||
28068014|NCT00460265|54723170|FG000|Overall Study|Withdrawal by Subject|10|||
28160095|NCT03434379|54830202|FG001|China Extension Period|Lost to Follow-up|0|||
28068015|NCT00460265|54723171|FG001|Overall Study|Withdrawal by Subject|25|||
27818762|NCT01732640|54277370|FG001|Overall Study|Death|1|||
28130409|NCT03093402|54793428|FG000|Overall Study|Lost to Follow-up|1|||
28130410|NCT03093402|54793429|FG001|Overall Study|Lost to Follow-up|0|||
28130411|NCT03093402|54793430|FG002|Overall Study|Lost to Follow-up|0|||
28130412|NCT03093402|54793431|FG003|Overall Study|Lost to Follow-up|0|||
28130413|NCT03093402|54793428|FG000|Overall Study|Withdrawal by Subject|3|||
28130414|NCT03093402|54793429|FG001|Overall Study|Withdrawal by Subject|3|||
28130415|NCT03093402|54793430|FG002|Overall Study|Withdrawal by Subject|0|||
28130416|NCT03093402|54793431|FG003|Overall Study|Withdrawal by Subject|1|||
28130417|NCT03093402|54793428|FG000|Overall Study|Withdrew prior to dosing|2|||
28130418|NCT03093402|54793429|FG001|Overall Study|Withdrew prior to dosing|1|||
28130419|NCT03093402|54793430|FG002|Overall Study|Withdrew prior to dosing|2|||
28130420|NCT03093402|54793431|FG003|Overall Study|Withdrew prior to dosing|3|||
28130421|NCT03093402|54793428|FG000|Overall Study|Ineligible for study|1|||
28130422|NCT03093402|54793429|FG001|Overall Study|Ineligible for study|0|||
28130423|NCT03093402|54793430|FG002|Overall Study|Ineligible for study|0|||
28130424|NCT03093402|54793431|FG003|Overall Study|Ineligible for study|0|||
28130425|NCT03093402|54793428|FG000|Overall Study|Prescribed a prohibited concomitant medication|0|||
28130426|NCT03093402|54793429|FG001|Overall Study|Prescribed a prohibited concomitant medication|1|||
28130427|NCT03093402|54793430|FG002|Overall Study|Prescribed a prohibited concomitant medication|0|||
28130428|NCT03093402|54793431|FG003|Overall Study|Prescribed a prohibited concomitant medication|0|||
28130429|NCT03585959|54793441|FG000|Overall Study|Physician Decision|1|||
28130430|NCT03585959|54793441|FG000|Overall Study|Unsuccessful Procedure|2|||
28130431|NCT03584789|54793450|FG000|Overall Study|refused EHR permission|19|||
28130432|NCT03584789|54793451|FG001|Overall Study|refused EHR permission|28|||
28130433|NCT03584789|54793452|FG002|Overall Study|refused EHR permission|23|||
28130434|NCT03584789|54793450|FG000|Overall Study|patients tied to a provider who retired|0|||
28130435|NCT03584789|54793451|FG001|Overall Study|patients tied to a provider who retired|0|||
28130436|NCT03584789|54793452|FG002|Overall Study|patients tied to a provider who retired|3|||
28130437|NCT03343639|54793462|FG000|Overall Study|Withdrawal by Subject|10|||
28130438|NCT03343639|54793463|FG001|Overall Study|Withdrawal by Subject|6|||
28130439|NCT03343639|54793462|FG000|Overall Study|Lost to Follow-up|4|||
28130440|NCT03343639|54793463|FG001|Overall Study|Lost to Follow-up|5|||
28130441|NCT03343639|54793462|FG000|Overall Study|Protocol Violation|0|||
28130442|NCT03343639|54793463|FG001|Overall Study|Protocol Violation|1|||
28130443|NCT03647267|54793471|FG000|Overall Study|Lost to Follow-up|1|||
27818763|NCT01732484|54277380|FG000|Overall Study|Death|7|||
27818764|NCT01732484|54277380|FG000|Overall Study|Lost to Follow-up|14|||
27818765|NCT01732484|54277380|FG000|Overall Study|chronical illness|5|||
27818766|NCT01786148|54277388|FG000|Overall Study|Lost to Follow-up|21|||
28130444|NCT03647267|54793472|FG001|Overall Study|Lost to Follow-up|0|||
28130445|NCT03356977|54793480|FG000|Overall Study|Lost to Follow-up|3|||
28130446|NCT03356977|54793480|FG000|Overall Study|Withdrawal by parent/guardian|2|||
28130447|NCT02690974|54793484|FG000|Overall Study|Adverse Event|16|||
28130448|NCT02690974|54793484|FG000|Overall Study|Death|9|||
28130449|NCT02690974|54793484|FG000|Overall Study|Subject/guardian decision|4|||
28130450|NCT02690974|54793484|FG000|Overall Study|Lost to Follow-up|3|||
28130451|NCT02690974|54793484|FG000|Overall Study|Withdrawal of Informed Consent|3|||
28130452|NCT02690974|54793484|FG000|Overall Study|Physician Decision|2|||
28130453|NCT02690974|54793484|FG000|Overall Study|Non-compliance with study treatment|1|||
28130454|NCT02690974|54793484|FG000|Overall Study|Protocol-defined stopping criteria|1|||
28130455|NCT02690974|54793484|FG000|Overall Study|Protocol Deviation|1|||
28130456|NCT03093324|54793490|FG000|Overall Study|Adverse Event|4|||
28130457|NCT03093324|54793491|FG001|Overall Study|Adverse Event|15|||
28130458|NCT03093324|54793490|FG000|Overall Study|Lost to Follow-up|1|||
28130459|NCT03093324|54793491|FG001|Overall Study|Lost to Follow-up|0|||
28130460|NCT03093324|54793490|FG000|Overall Study|Protocol Deviation|2|||
28130461|NCT03093324|54793491|FG001|Overall Study|Protocol Deviation|2|||
28130462|NCT03093324|54793490|FG000|Overall Study|Withdrawal by Subject|2|||
28130463|NCT03093324|54793491|FG001|Overall Study|Withdrawal by Subject|2|||
28130464|NCT03584009|54793499|FG000|Overall Study|Death|25|||
27818767|NCT01786148|54277389|FG001|Overall Study|Lost to Follow-up|13|||
27818768|NCT01786148|54277388|FG000|Overall Study|Death|0|||
27818769|NCT01786148|54277389|FG001|Overall Study|Death|1|||
27818770|NCT01786148|54277388|FG000|Overall Study|Withdrawal by Subject|0|||
28130465|NCT03584009|54793500|FG001|Overall Study|Death|18|||
28130466|NCT03584009|54793499|FG000|Overall Study|Lost to Follow-up|0|||
28130467|NCT03584009|54793500|FG001|Overall Study|Lost to Follow-up|1|||
28130468|NCT03584009|54793499|FG000|Overall Study|Physician Decision|1|||
28130469|NCT03584009|54793500|FG001|Overall Study|Physician Decision|1|||
28130470|NCT03584009|54793499|FG000|Overall Study|Study Terminated by Sponsor|22|||
28130471|NCT03584009|54793500|FG001|Overall Study|Study Terminated by Sponsor|30|||
28130472|NCT03584009|54793499|FG000|Overall Study|Withdrawal by Subject|3|||
28130473|NCT03584009|54793500|FG001|Overall Study|Withdrawal by Subject|2|||
27818771|NCT01786148|54277389|FG001|Overall Study|Withdrawal by Subject|7|||
27818772|NCT01786148|54277388|FG000|Overall Study|Incarceration|1|||
28130474|NCT04167462|54793511|FG000|Overall Study|Other reasons|3|||
28130475|NCT04167462|54793512|FG001|Overall Study|Other reasons|2|||
28130476|NCT04167462|54793511|FG000|Overall Study|Withdrawal by Subject|6|||
28130477|NCT04167462|54793512|FG001|Overall Study|Withdrawal by Subject|7|||
28130478|NCT04167462|54793511|FG000|Overall Study|Adverse Event|4|||
28130479|NCT04167462|54793512|FG001|Overall Study|Adverse Event|0|||
28130480|NCT04167462|54793511|FG000|Overall Study|Pregnancy|1|||
28130481|NCT04167462|54793512|FG001|Overall Study|Pregnancy|0|||
28130482|NCT04167462|54793511|FG000|Overall Study|Lack of Efficacy|0|||
28130483|NCT04167462|54793512|FG001|Overall Study|Lack of Efficacy|1|||
28130484|NCT03583385|54793519|FG000|Treatment Period 1|Withdrawal by Subject|1|||
28130485|NCT03583385|54793520|FG001|Treatment Period 1|Withdrawal by Subject|1|||
28130486|NCT03583385|54793519|FG000|Treatment Period 2|Adverse Event|1|||
28130487|NCT03583385|54793520|FG001|Treatment Period 2|Adverse Event|0|||
28130488|NCT04350372|54793526|FG000|Overall Study|Death|1|||
28130489|NCT02949973|54793530|FG000|Overall Study|Physician Decision|1|||
28130490|NCT02948959|54793536|FG000|52 Weeks Treatment Period|Poor compliance to protocol|0|||
28130491|NCT02948959|54793537|FG001|52 Weeks Treatment Period|Poor compliance to protocol|2|||
28130492|NCT02948959|54793536|FG000|52 Weeks Treatment Period|Adverse Event|2|||
28130493|NCT02948959|54793537|FG001|52 Weeks Treatment Period|Adverse Event|5|||
28130494|NCT02948959|54793536|FG000|52 Weeks Treatment Period|Withdrawal by Subject|2|||
28130495|NCT02948959|54793537|FG001|52 Weeks Treatment Period|Withdrawal by Subject|2|||
28130496|NCT02948959|54793536|FG000|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|1|||
28130497|NCT02948959|54793537|FG001|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|6|||
28130498|NCT02948959|54793536|FG000|52 Weeks Treatment Period|Randomized by error|0|||
28130499|NCT02948959|54793537|FG001|52 Weeks Treatment Period|Randomized by error|5|||
28130500|NCT02948959|54793536|FG000|52 Weeks Treatment Period|Randomized and not treated|0|||
28130501|NCT02948959|54793537|FG001|52 Weeks Treatment Period|Randomized and not treated|3|||
28130502|NCT02948959|54793536|FG000|52 Weeks Treatment Period|Non-compliant to study treatment|0|||
28130503|NCT02948959|54793537|FG001|52 Weeks Treatment Period|Non-compliant to study treatment|1|||
28130504|NCT02948959|54793536|FG000|52 Weeks Treatment Period|Change of residence location|0|||
28130505|NCT02948959|54793537|FG001|52 Weeks Treatment Period|Change of residence location|1|||
28130506|NCT02948959|54793536|FG000|12 Weeks Follow-up Period|Adverse Event|0|||
28130507|NCT02948959|54793537|FG001|12 Weeks Follow-up Period|Adverse Event|2|||
28130508|NCT02948959|54793536|FG000|12 Weeks Follow-up Period|Poor compliance to protocol|1|||
28130509|NCT02948959|54793537|FG001|12 Weeks Follow-up Period|Poor compliance to protocol|2|||
28130510|NCT02948959|54793536|FG000|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
28130511|NCT02948959|54793537|FG001|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
28130512|NCT02948959|54793536|FG000|12 Weeks Follow-up Period|Randomized by error|0|||
28130513|NCT02948959|54793537|FG001|12 Weeks Follow-up Period|Randomized by error|3|||
28130514|NCT02948959|54793536|FG000|12 Weeks Follow-up Period|Change of residence location|0|||
28130515|NCT02948959|54793537|FG001|12 Weeks Follow-up Period|Change of residence location|2|||
28130516|NCT02948959|54793536|FG000|12 Weeks Follow-up Period|Study site closure|1|||
28130517|NCT02948959|54793537|FG001|12 Weeks Follow-up Period|Study site closure|0|||
28130518|NCT03582215|54793559|FG000|Overall Study|Adverse Event|1|||
28130519|NCT03582215|54793560|FG001|Overall Study|Adverse Event|0|||
28130520|NCT03582215|54793561|FG002|Overall Study|Adverse Event|0|||
28130521|NCT03582215|54793562|FG003|Overall Study|Adverse Event|0|||
28130522|NCT03582215|54793563|FG004|Overall Study|Adverse Event|0|||
28130523|NCT03582215|54793564|FG005|Overall Study|Adverse Event|0|||
28130524|NCT03582215|54793565|FG006|Overall Study|Adverse Event|2|||
28130525|NCT03582215|54793566|FG007|Overall Study|Adverse Event|2|||
28130526|NCT03089580|54793595|FG000|Overall Study|Lost to Follow-up|2|||
28130527|NCT03645395|54793605|FG000|Part 1 (Up to 6 Months)|Adverse Event|1|||
28130528|NCT03645395|54793606|FG001|Part 1 (Up to 6 Months)|Adverse Event|0|||
28130529|NCT03645395|54793607|FG002|Part 1 (Up to 6 Months)|Adverse Event|0|||
28130530|NCT03645395|54793608|FG003|Part 1 (Up to 6 Months)|Adverse Event|0|||
28130531|NCT03645395|54793605|FG000|Part 1 (Up to 6 Months)|Disease Progression|0|||
28130532|NCT03645395|54793606|FG001|Part 1 (Up to 6 Months)|Disease Progression|1|||
28130533|NCT03645395|54793607|FG002|Part 1 (Up to 6 Months)|Disease Progression|0|||
28130534|NCT03645395|54793608|FG003|Part 1 (Up to 6 Months)|Disease Progression|0|||
28130535|NCT03645395|54793605|FG000|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
28130536|NCT03645395|54793606|FG001|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
28130537|NCT03645395|54793607|FG002|Part 1 (Up to 6 Months)|Withdrawal by Subject|1|||
28130538|NCT03645395|54793608|FG003|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
28130539|NCT03645395|54793605|FG000|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|1|||
28130540|NCT03645395|54793606|FG001|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
28130541|NCT03645395|54793607|FG002|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
28130542|NCT03645395|54793608|FG003|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|0|||
28130543|NCT03342469|54793621|FG000|Overall Study|Withdrawal by Subject|0|||
28130544|NCT03342469|54793622|FG001|Overall Study|Withdrawal by Subject|1|||
28130545|NCT03342469|54793623|FG002|Overall Study|Withdrawal by Subject|0|||
28130546|NCT03342469|54793624|FG003|Overall Study|Withdrawal by Subject|0|||
28130547|NCT03581825|54793635|FG000|Period 1|Lens Discomfort|1|||
28130548|NCT03581825|54793636|FG001|Period 1|Lens Discomfort|0|||
28130549|NCT03581825|54793635|FG000|Period 2|Unsatisfactory Vision to Test|0|||
28130550|NCT03581825|54793636|FG001|Period 2|Unsatisfactory Vision to Test|1|||
28068016|NCT00460265|54723170|FG000|Overall Study|Ongoing|60|||
28068017|NCT00460265|54723171|FG001|Overall Study|Ongoing|47|||
28068018|NCT00460109|54723177|FG000|Overall Study|Death|1|||
28068019|NCT00065260|54723183|FG000|Overall Study|Death|0|||
28130551|NCT03342001|54793642|FG000|Overall Study|Adverse Event|1|||
28068020|NCT00065260|54723184|FG001|Overall Study|Death|1|||
28130552|NCT03342001|54793642|FG000|Overall Study|Lost to Follow-up|1|||
28130553|NCT03341923|54793646|FG000|Period 2, Second 14 Days of Wear|Adverse Event|0|||
28130554|NCT03341923|54793647|FG001|Period 2, Second 14 Days of Wear|Adverse Event|1|||
28068021|NCT00460031|54723190|FG000|Overall Study|Adverse Event|5|||
28068022|NCT00460031|54723190|FG000|Overall Study|Withdrawal by Subject|5|||
28068023|NCT00460031|54723190|FG000|Overall Study|Death|1|||
28068024|NCT00451217|54723198|FG000|Overall Study|Lost to Follow-up|0|||
28068025|NCT00451217|54723199|FG001|Overall Study|Lost to Follow-up|1|||
28068026|NCT00451217|54723200|FG002|Overall Study|Lost to Follow-up|1|||
28068027|NCT00451217|54723201|FG003|Overall Study|Lost to Follow-up|1|||
28068028|NCT00451217|54723198|FG000|Overall Study|Withdrawal by Subject|1|||
28068029|NCT00451217|54723199|FG001|Overall Study|Withdrawal by Subject|0|||
28068030|NCT00451217|54723200|FG002|Overall Study|Withdrawal by Subject|0|||
28068031|NCT00451217|54723201|FG003|Overall Study|Withdrawal by Subject|0|||
28068032|NCT00451217|54723198|FG000|Overall Study|Not Treated|1|||
28068033|NCT00451217|54723199|FG001|Overall Study|Not Treated|1|||
28068034|NCT00451217|54723200|FG002|Overall Study|Not Treated|3|||
28068035|NCT00451217|54723201|FG003|Overall Study|Not Treated|4|||
28068036|NCT00459953|54723213|FG000|Overall Study|not analyzed-household member in study|1|||
28068037|NCT00459953|54723214|FG001|Overall Study|not analyzed-household member in study|1|||
28068038|NCT00459875|54723220|FG000|Overall Study|Ineligible participant|1|||
28068039|NCT00459875|54723220|FG000|Overall Study|Adverse Event|2|||
28068040|NCT00311402|54723226|FG000|Overall Study|Adverse Event|118|||
28068041|NCT00311402|54723227|FG001|Overall Study|Adverse Event|105|||
28068042|NCT00311402|54723226|FG000|Overall Study|Lost to Follow-up|0|||
28068043|NCT00311402|54723227|FG001|Overall Study|Lost to Follow-up|3|||
28068044|NCT00311402|54723226|FG000|Overall Study|Withdrawal by Subject|17|||
28068045|NCT00311402|54723227|FG001|Overall Study|Withdrawal by Subject|18|||
28068046|NCT00311402|54723226|FG000|Overall Study|Lack of Efficacy|58|||
28130555|NCT03579719|54793655|FG000|Overall Study|Protocol deviation, pre-existent disease|1|||
28130556|NCT03341533|54793661|FG000|Overall Study|Withdrawal by Subject|1|||
28130557|NCT03341533|54793662|FG001|Overall Study|Withdrawal by Subject|1|||
28068047|NCT00311402|54723227|FG001|Overall Study|Lack of Efficacy|42|||
28068048|NCT00311402|54723226|FG000|Overall Study|Protocol Violation|7|||
28068049|NCT00311402|54723227|FG001|Overall Study|Protocol Violation|6|||
28068050|NCT00311402|54723226|FG000|Overall Study|IRB's rejection etc.|10|||
28068051|NCT00311402|54723227|FG001|Overall Study|IRB's rejection etc.|3|||
28068052|NCT00450749|54723236|FG000|Overall Study|Withdrawal by Subject|0|||
28068053|NCT00450749|54723237|FG001|Overall Study|Withdrawal by Subject|0|||
28068054|NCT00450749|54723238|FG002|Overall Study|Withdrawal by Subject|2|||
28130558|NCT03341533|54793661|FG000|Overall Study|Not eligible after randomization|2|||
28130559|NCT03341533|54793662|FG001|Overall Study|Not eligible after randomization|1|||
28130560|NCT02688088|54793668|FG000|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
28130561|NCT02688088|54793669|FG001|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|1|||
28130562|NCT02688088|54793670|FG002|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
28130563|NCT02688088|54793671|FG003|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
28130564|NCT02688088|54793672|FG004|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
28130565|NCT02688088|54793668|FG000|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
28130566|NCT02688088|54793669|FG001|Abemaciclib + Drug Cocktail - Period 2|Death|1|||
28130567|NCT02688088|54793670|FG002|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
28130568|NCT02688088|54793671|FG003|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
28130569|NCT02688088|54793672|FG004|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
28130570|NCT02688088|54793668|FG000|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
28130571|NCT02688088|54793669|FG001|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|3|||
28130572|NCT02688088|54793670|FG002|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
28130573|NCT02688088|54793671|FG003|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
28130574|NCT02688088|54793672|FG004|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
28130575|NCT02688088|54793668|FG000|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
28130576|NCT02688088|54793669|FG001|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|2|||
28130577|NCT02688088|54793670|FG002|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
27818773|NCT01786148|54277389|FG001|Overall Study|Incarceration|1|||
27818774|NCT01785602|54277401|FG000|Overall Study|Withdrawal by Subject|2|||
28130578|NCT02688088|54793671|FG003|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
28130579|NCT02688088|54793672|FG004|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
28130580|NCT02688088|54793668|FG000|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
28130581|NCT02688088|54793669|FG001|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
28130582|NCT02688088|54793670|FG002|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|7|||
28130583|NCT02688088|54793671|FG003|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
28130584|NCT02688088|54793672|FG004|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
28130585|NCT02688088|54793668|FG000|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
28130586|NCT02688088|54793669|FG001|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
28130587|NCT02688088|54793670|FG002|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|1|||
28130588|NCT02688088|54793671|FG003|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
28130589|NCT02688088|54793672|FG004|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
28130590|NCT02688088|54793668|FG000|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
28130591|NCT02688088|54793669|FG001|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
28130592|NCT02688088|54793670|FG002|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
28130593|NCT02688088|54793671|FG003|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|7|||
28130594|NCT02688088|54793672|FG004|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
28130595|NCT02688088|54793668|FG000|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
28130596|NCT02688088|54793669|FG001|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
28130597|NCT02688088|54793670|FG002|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
28130598|NCT02688088|54793671|FG003|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|1|||
28130599|NCT02688088|54793672|FG004|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
28130600|NCT02688088|54793668|FG000|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
28130601|NCT02688088|54793669|FG001|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
28130602|NCT02688088|54793670|FG002|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
28130603|NCT02688088|54793671|FG003|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
28130604|NCT02688088|54793672|FG004|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|18|||
28130605|NCT03641651|54793697|FG000|Overall Study|organizational issues at one study site|1|||
28130606|NCT03341299|54793701|FG000|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
28130607|NCT03341299|54793702|FG001|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
28130608|NCT03341299|54793703|FG002|Washout (A Minimum of 21 Hours)|Adverse Event|1|||
28130609|NCT03341299|54793704|FG003|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
28130610|NCT02949271|54793718|FG000|Overall Study|Lack of Efficacy|5|||
28130611|NCT02949271|54793719|FG001|Overall Study|Lack of Efficacy|4|||
28130612|NCT02949271|54793718|FG000|Overall Study|Lost to Follow-up|3|||
28130613|NCT02949271|54793719|FG001|Overall Study|Lost to Follow-up|6|||
28130614|NCT02949271|54793718|FG000|Overall Study|Physician Decision|5|||
28130615|NCT02949271|54793719|FG001|Overall Study|Physician Decision|5|||
28130616|NCT02949271|54793718|FG000|Overall Study|Protocol Violation|6|||
28130617|NCT02949271|54793719|FG001|Overall Study|Protocol Violation|3|||
28130618|NCT02949271|54793718|FG000|Overall Study|Withdrawal by Subject|1|||
28130619|NCT02949271|54793719|FG001|Overall Study|Withdrawal by Subject|0|||
28130620|NCT02949271|54793718|FG000|Overall Study|Delivered prior to intervention|7|||
28130621|NCT02949271|54793719|FG001|Overall Study|Delivered prior to intervention|9|||
28130622|NCT02949271|54793718|FG000|Overall Study|Outside the window for cervical dilation|2|||
28130623|NCT02949271|54793719|FG001|Overall Study|Outside the window for cervical dilation|3|||
28130624|NCT03640559|54793727|FG000|Overall Study|Physician Decision|1|||
28130625|NCT03640559|54793728|FG001|Overall Study|Physician Decision|1|||
28130626|NCT03640559|54793727|FG000|Overall Study|Withdrawal by Subject|1|||
28130627|NCT03640559|54793728|FG001|Overall Study|Withdrawal by Subject|0|||
28130628|NCT03339583|54793736|FG000|First Intervention (14 Days)|Adverse Event|1|||
28130629|NCT03339583|54793737|FG001|First Intervention (14 Days)|Adverse Event|0|||
28130630|NCT03339583|54793736|FG000|Second Intervention (14 Days)|unrelated acute exacerbation|0|||
28130631|NCT03339583|54793737|FG001|Second Intervention (14 Days)|unrelated acute exacerbation|1|||
28130632|NCT03339583|54793736|FG000|Second Intervention (14 Days)|Adverse Event|0|||
28130633|NCT03339583|54793737|FG001|Second Intervention (14 Days)|Adverse Event|1|||
28130634|NCT03339583|54793736|FG000|Follow-up (14 Days)|Physician Decision|6|||
28130635|NCT03339583|54793737|FG001|Follow-up (14 Days)|Physician Decision|3|||
28130636|NCT03639779|54793745|FG000|Overall Study|Lost to Follow-up|1|||
28130637|NCT03575975|54793754|FG000|Overall Study|Lost to Follow-up|1|||
28130638|NCT03575975|54793755|FG001|Overall Study|Lost to Follow-up|0|||
28130639|NCT03575975|54793756|FG002|Overall Study|Lost to Follow-up|0|||
28130640|NCT03636893|54793764|FG000|Overall Study|Death|0|||
28130641|NCT03636893|54793765|FG001|Overall Study|Death|1|||
28130642|NCT03636893|54793764|FG000|Overall Study|Protocol Violation|0|||
28130643|NCT03636893|54793765|FG001|Overall Study|Protocol Violation|3|||
28130644|NCT03636893|54793764|FG000|Overall Study|Withdrawal by Subject|1|||
28130645|NCT03636893|54793765|FG001|Overall Study|Withdrawal by Subject|2|||
28130646|NCT03636893|54793764|FG000|Overall Study|Refusal to surgery|4|||
28130647|NCT03636893|54793765|FG001|Overall Study|Refusal to surgery|3|||
28130648|NCT03636893|54793764|FG000|Overall Study|Early surgery (for acute bleeding)|3|||
28130649|NCT03636893|54793765|FG001|Overall Study|Early surgery (for acute bleeding)|0|||
28130650|NCT03636893|54793764|FG000|Overall Study|Adverse Event|1|||
28130651|NCT03636893|54793765|FG001|Overall Study|Adverse Event|1|||
28130652|NCT01353586|54793773|FG000|Overall Study|Procedure terminated prior to ablation|3|||
28130653|NCT01353586|54793774|FG001|Overall Study|Procedure terminated prior to ablation|0|||
28130654|NCT01353586|54793773|FG000|Overall Study|Never had insertion of study catheter|4|||
28130655|NCT01353586|54793774|FG001|Overall Study|Never had insertion of study catheter|1|||
28130656|NCT01353586|54793773|FG000|Overall Study|Neurological exam not done|0|||
28130657|NCT01353586|54793774|FG001|Overall Study|Neurological exam not done|1|||
28130658|NCT03091920|54793786|FG000|Overall Study|Adverse Event|0|||
28130659|NCT03091920|54793787|FG001|Overall Study|Adverse Event|1|||
28130660|NCT03091920|54793788|FG002|Overall Study|Adverse Event|0|||
28130661|NCT03338569|54793804|FG000|Overall Study|Physician Decision|8|||
28130662|NCT03338569|54793805|FG001|Overall Study|Physician Decision|3|||
28130663|NCT03338569|54793804|FG000|Overall Study|Withdrawal by Subject|0|||
28130664|NCT03338569|54793805|FG001|Overall Study|Withdrawal by Subject|1|||
28130665|NCT03338569|54793804|FG000|Overall Study|Lost to Follow-up|0|||
28130666|NCT03338569|54793805|FG001|Overall Study|Lost to Follow-up|1|||
28130667|NCT03338023|54793813|FG000|Overall Study|Withdrawal by Subject|3|||
28130668|NCT03338023|54793814|FG001|Overall Study|Withdrawal by Subject|4|||
28130669|NCT03338023|54793813|FG000|Overall Study|Protocol Violation|3|||
28130670|NCT03338023|54793814|FG001|Overall Study|Protocol Violation|3|||
28130671|NCT03338023|54793813|FG000|Overall Study|Lost to Follow-up|2|||
28130672|NCT03338023|54793814|FG001|Overall Study|Lost to Follow-up|1|||
28130673|NCT03338023|54793813|FG000|Overall Study|Physician Decision|1|||
28130674|NCT03338023|54793814|FG001|Overall Study|Physician Decision|2|||
28068055|NCT00450749|54723236|FG000|Overall Study|Noncompliant|0|||
28068056|NCT00450749|54723237|FG001|Overall Study|Noncompliant|1|||
28068057|NCT00450749|54723238|FG002|Overall Study|Noncompliant|0|||
28068058|NCT00292370|54723249|FG000|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12|||
28068059|NCT00292370|54723250|FG001|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
28068060|NCT00292370|54723251|FG002|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
28068061|NCT00292370|54723249|FG000|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22|||
28068062|NCT00292370|54723250|FG001|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
28068063|NCT00292370|54723251|FG002|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
28068064|NCT00292370|54723249|FG000|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8|||
28068065|NCT00292370|54723250|FG001|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
28068066|NCT00292370|54723251|FG002|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
28068067|NCT00292370|54723249|FG000|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4|||
28068068|NCT00292370|54723250|FG001|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
28068069|NCT00292370|54723251|FG002|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
28130675|NCT03337477|54793822|FG000|Overall Study|not categorized into the listed ones|11|||
28130676|NCT03337477|54793823|FG001|Overall Study|not categorized into the listed ones|9|||
28130677|NCT03337477|54793822|FG000|Overall Study|Withdrawal by Subject|0|||
28130678|NCT03337477|54793823|FG001|Overall Study|Withdrawal by Subject|1|||
28130679|NCT03337477|54793822|FG000|Overall Study|Death|0|||
28130680|NCT03337477|54793823|FG001|Overall Study|Death|1|||
28130681|NCT03337477|54793822|FG000|Overall Study|Lost to Follow-up|0|||
28130682|NCT03337477|54793823|FG001|Overall Study|Lost to Follow-up|2|||
28130683|NCT02687542|54793836|FG000|Overall Study|Medication error without associated AEs|0|||
28130684|NCT02687542|54793837|FG001|Overall Study|Medication error without associated AEs|0|||
28130685|NCT02687542|54793838|FG002|Overall Study|Medication error without associated AEs|0|||
28130686|NCT02687542|54793839|FG003|Overall Study|Medication error without associated AEs|0|||
28130687|NCT02687542|54793840|FG004|Overall Study|Medication error without associated AEs|1|||
28130688|NCT02687542|54793836|FG000|Overall Study|Lost to Follow-up|0|||
28130689|NCT02687542|54793837|FG001|Overall Study|Lost to Follow-up|0|||
28130690|NCT02687542|54793838|FG002|Overall Study|Lost to Follow-up|0|||
28130691|NCT02687542|54793839|FG003|Overall Study|Lost to Follow-up|0|||
28130692|NCT02687542|54793840|FG004|Overall Study|Lost to Follow-up|1|||
28130693|NCT02687542|54793836|FG000|Overall Study|Protocol Violation|0|||
28130694|NCT02687542|54793837|FG001|Overall Study|Protocol Violation|1|||
28130695|NCT02687542|54793838|FG002|Overall Study|Protocol Violation|0|||
28130696|NCT02687542|54793839|FG003|Overall Study|Protocol Violation|0|||
28130697|NCT02687542|54793840|FG004|Overall Study|Protocol Violation|0|||
28130698|NCT02687542|54793836|FG000|Overall Study|Other|5|||
28130699|NCT02687542|54793837|FG001|Overall Study|Other|9|||
28130700|NCT02687542|54793838|FG002|Overall Study|Other|10|||
28130701|NCT02687542|54793839|FG003|Overall Study|Other|6|||
28130702|NCT02687542|54793840|FG004|Overall Study|Other|5|||
28130703|NCT02687542|54793836|FG000|Overall Study|Adverse Event|3|||
28130704|NCT02687542|54793837|FG001|Overall Study|Adverse Event|1|||
28130705|NCT02687542|54793838|FG002|Overall Study|Adverse Event|3|||
28130706|NCT02687542|54793839|FG003|Overall Study|Adverse Event|2|||
28130707|NCT02687542|54793840|FG004|Overall Study|Adverse Event|9|||
28130708|NCT02687542|54793836|FG000|Overall Study|Withdrawal by Subject|0|||
28130709|NCT02687542|54793837|FG001|Overall Study|Withdrawal by Subject|1|||
28130710|NCT02687542|54793838|FG002|Overall Study|Withdrawal by Subject|1|||
28130711|NCT02687542|54793839|FG003|Overall Study|Withdrawal by Subject|2|||
28130712|NCT02687542|54793840|FG004|Overall Study|Withdrawal by Subject|4|||
28130713|NCT03336619|54793854|FG000|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|192|||
28130714|NCT03336619|54793855|FG001|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|204|||
28130715|NCT03336619|54793854|FG000|Overall Study|Withdrawal by Subject|17|||
28130716|NCT03336619|54793855|FG001|Overall Study|Withdrawal by Subject|16|||
28130717|NCT03336619|54793854|FG000|Overall Study|Adverse Event|2|||
28130718|NCT03336619|54793855|FG001|Overall Study|Adverse Event|5|||
28130719|NCT03336619|54793854|FG000|Overall Study|Physician Decision|3|||
28130720|NCT03336619|54793855|FG001|Overall Study|Physician Decision|0|||
28130721|NCT01353508|54793877|FG000|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
28130722|NCT01353508|54793878|FG001|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
28130723|NCT01353508|54793879|FG002|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
28130724|NCT01353508|54793880|FG003|Period 1 - First Intervention (7 Days)|Adverse Event|1|||
28130725|NCT01353508|54793877|FG000|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1|||
28130726|NCT01353508|54793878|FG001|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
28130727|NCT01353508|54793879|FG002|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
28130728|NCT01353508|54793880|FG003|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
28130729|NCT03636269|54793892|FG000|Period 1: Double-blind Phase|Adverse Event|13|||
28130730|NCT03636269|54793893|FG001|Period 1: Double-blind Phase|Adverse Event|7|||
28130731|NCT03636269|54793894|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
28130732|NCT03636269|54793892|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
28130733|NCT03636269|54793893|FG001|Period 1: Double-blind Phase|Lack of Efficacy|0|||
28130734|NCT03636269|54793894|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
28130735|NCT03636269|54793892|FG000|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|2|||
28130736|NCT03636269|54793893|FG001|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
28130737|NCT03636269|54793894|FG002|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
28130738|NCT03636269|54793892|FG000|Period 1: Double-blind Phase|Withdrawal by Subject|5|||
28130739|NCT03636269|54793893|FG001|Period 1: Double-blind Phase|Withdrawal by Subject|1|||
28130740|NCT03636269|54793894|FG002|Period 1: Double-blind Phase|Withdrawal by Subject|0|||
28130741|NCT03636269|54793892|FG000|Period 1: Double-blind Phase|Other|6|||
28130742|NCT03636269|54793893|FG001|Period 1: Double-blind Phase|Other|3|||
28130743|NCT03636269|54793894|FG002|Period 1: Double-blind Phase|Other|0|||
28130744|NCT03636269|54793892|FG000|Period 1: Double-blind Phase|Lost to Follow-up|1|||
28130745|NCT03636269|54793893|FG001|Period 1: Double-blind Phase|Lost to Follow-up|0|||
28130746|NCT03636269|54793894|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
28130747|NCT03636269|54793892|FG000|Period 1: Double-blind Phase|Subject non-compliance|1|||
28130748|NCT03636269|54793893|FG001|Period 1: Double-blind Phase|Subject non-compliance|2|||
28130749|NCT03636269|54793894|FG002|Period 1: Double-blind Phase|Subject non-compliance|0|||
28130750|NCT03636269|54793892|FG000|Period 2: Open-label Phase|Adverse Event|0|||
28130751|NCT03636269|54793893|FG001|Period 2: Open-label Phase|Adverse Event|0|||
28130752|NCT03636269|54793894|FG002|Period 2: Open-label Phase|Adverse Event|21|||
28130753|NCT03636269|54793892|FG000|Period 2: Open-label Phase|Lack of Efficacy|0|||
28130754|NCT03636269|54793893|FG001|Period 2: Open-label Phase|Lack of Efficacy|0|||
28130755|NCT03636269|54793894|FG002|Period 2: Open-label Phase|Lack of Efficacy|2|||
28130756|NCT03636269|54793892|FG000|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
28130757|NCT03636269|54793893|FG001|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
28130758|NCT03636269|54793894|FG002|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|2|||
28130759|NCT03636269|54793892|FG000|Period 2: Open-label Phase|Withdrawal by Subject|0|||
28130760|NCT03636269|54793893|FG001|Period 2: Open-label Phase|Withdrawal by Subject|0|||
28130761|NCT03636269|54793894|FG002|Period 2: Open-label Phase|Withdrawal by Subject|11|||
28130762|NCT03636269|54793892|FG000|Period 2: Open-label Phase|Administrative|0|||
28130763|NCT03636269|54793893|FG001|Period 2: Open-label Phase|Administrative|0|||
28130764|NCT03636269|54793894|FG002|Period 2: Open-label Phase|Administrative|36|||
28130765|NCT03636269|54793892|FG000|Period 2: Open-label Phase|Other|0|||
28130766|NCT03636269|54793893|FG001|Period 2: Open-label Phase|Other|0|||
28130767|NCT03636269|54793894|FG002|Period 2: Open-label Phase|Other|9|||
28130768|NCT03636269|54793892|FG000|Period 2: Open-label Phase|Sponsor stopping study|0|||
28130769|NCT03636269|54793893|FG001|Period 2: Open-label Phase|Sponsor stopping study|0|||
28130770|NCT03636269|54793894|FG002|Period 2: Open-label Phase|Sponsor stopping study|313|||
28130771|NCT02685202|54793903|FG000|Overall Study|Lost to Follow-up|9|||
28130772|NCT03087786|54793909|FG000|Overall Study|Withdrawal by Subject|2|||
28130773|NCT03087786|54793910|FG001|Overall Study|Withdrawal by Subject|0|||
28130774|NCT03635957|54793916|FG000|Run-In Period|Lost to Follow-up|1|||
28130775|NCT03635957|54793916|FG000|Pegloticase + IMM Period|Lack of Efficacy|3|||
28130776|NCT01353274|54793921|FG000|Overall Study|No case report form (CRF) collected|28|||
28130777|NCT02690194|54793928|FG000|Overall Study|Withdrawal by Subject|1|||
28130778|NCT02690194|54793929|FG001|Overall Study|Withdrawal by Subject|4|||
28130779|NCT02690194|54793930|FG002|Overall Study|Withdrawal by Subject|0|||
28130780|NCT02684344|54793940|FG000|Overall Study|Withdrawal by Subject|0|||
28130781|NCT02684344|54793941|FG001|Overall Study|Withdrawal by Subject|1|||
28130782|NCT02683876|54793949|FG000|Overall Study|samples damaged during shipping|2|||
28130783|NCT02683876|54793950|FG001|Overall Study|samples damaged during shipping|0|||
28130784|NCT03974100|54793960|FG000|TP1 - Day 1 to Week 52|Adverse Event|1|||
28130785|NCT03974100|54793961|FG001|TP1 - Day 1 to Week 52|Adverse Event|3|||
28130786|NCT03974100|54793962|FG002|TP1 - Day 1 to Week 52|Adverse Event|0|||
28130787|NCT03974100|54793963|FG003|TP1 - Day 1 to Week 52|Adverse Event|0|||
28130788|NCT03974100|54793964|FG004|TP1 - Day 1 to Week 52|Adverse Event|0|||
28130789|NCT03974100|54793960|FG000|TP1 - Day 1 to Week 52|Death|1|||
28130790|NCT03974100|54793961|FG001|TP1 - Day 1 to Week 52|Death|0|||
28130791|NCT03974100|54793962|FG002|TP1 - Day 1 to Week 52|Death|0|||
28130792|NCT03974100|54793963|FG003|TP1 - Day 1 to Week 52|Death|0|||
28130793|NCT03974100|54793964|FG004|TP1 - Day 1 to Week 52|Death|0|||
28130794|NCT03974100|54793960|FG000|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
28130795|NCT03974100|54793961|FG001|TP1 - Day 1 to Week 52|Lost to Follow-up|1|||
28130796|NCT03974100|54793962|FG002|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
28130797|NCT03974100|54793963|FG003|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
28130798|NCT03974100|54793964|FG004|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
28130799|NCT03974100|54793960|FG000|TP1 - Day 1 to Week 52|Physician Decision|0|||
28130800|NCT03974100|54793961|FG001|TP1 - Day 1 to Week 52|Physician Decision|2|||
28130801|NCT03974100|54793962|FG002|TP1 - Day 1 to Week 52|Physician Decision|0|||
28130802|NCT03974100|54793963|FG003|TP1 - Day 1 to Week 52|Physician Decision|0|||
28130803|NCT03974100|54793964|FG004|TP1 - Day 1 to Week 52|Physician Decision|0|||
28130804|NCT03974100|54793960|FG000|TP1 - Day 1 to Week 52|Subject decision|8|||
28130805|NCT03974100|54793961|FG001|TP1 - Day 1 to Week 52|Subject decision|9|||
28130806|NCT03974100|54793962|FG002|TP1 - Day 1 to Week 52|Subject decision|0|||
28130807|NCT03974100|54793963|FG003|TP1 - Day 1 to Week 52|Subject decision|0|||
28130808|NCT03974100|54793964|FG004|TP1 - Day 1 to Week 52|Subject decision|0|||
28130809|NCT03974100|54793960|FG000|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
28130810|NCT03974100|54793961|FG001|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
28130811|NCT03974100|54793962|FG002|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
28130812|NCT03974100|54793963|FG003|TP2- Week 52 to Week 78|Lost to Follow-up|1|||
28130813|NCT03974100|54793964|FG004|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
28130814|NCT03974100|54793960|FG000|TP2- Week 52 to Week 78|Subject decision|0|||
28130815|NCT03974100|54793961|FG001|TP2- Week 52 to Week 78|Subject decision|0|||
28130816|NCT03974100|54793962|FG002|TP2- Week 52 to Week 78|Subject decision|0|||
28130817|NCT03974100|54793963|FG003|TP2- Week 52 to Week 78|Subject decision|1|||
28130818|NCT03974100|54793964|FG004|TP2- Week 52 to Week 78|Subject decision|0|||
28130819|NCT02689804|54793978|FG000|Overall Study|Withdrawal by Subject|2|||
28130820|NCT02689804|54793979|FG001|Overall Study|Withdrawal by Subject|0|||
28130821|NCT02946931|54793988|FG000|Overall Study|Did not require collection of CRFs|588|||
28130822|NCT02946931|54793988|FG000|Overall Study|Other than listed|37|||
28130823|NCT02946931|54793988|FG000|Overall Study|Discharge from hospital|118|||
28130824|NCT02946931|54793988|FG000|Overall Study|Adverse Event|81|||
28130825|NCT02946931|54793988|FG000|Overall Study|CRFs not valid|1|||
28130826|NCT02946931|54793988|FG000|Overall Study|CRFs with missing information on the date of termination of PMS|6|||
28130827|NCT02689492|54793992|FG000|Overall Study|Lost to Follow-up|61|||
28130828|NCT02689492|54793992|FG000|Overall Study|Withdrawal by Subject|11|||
28130829|NCT02689492|54793992|FG000|Overall Study|Death|9|||
28130830|NCT02689492|54793992|FG000|Overall Study|Physician Decision|2|||
28130831|NCT02689492|54793992|FG000|Overall Study|Withdrawal/Loss To Follow-Up|1|||
28130832|NCT02689492|54793992|FG000|Overall Study|Withdrawal/ Physician's Decision|1|||
28130833|NCT02689492|54793992|FG000|Overall Study|Other than listed|1|||
28130834|NCT01374568|54794010|FG000|Overall Study|Lab unable to analyze BTM|0|||
28130835|NCT01374568|54794011|FG001|Overall Study|Lab unable to analyze BTM|2|||
28130836|NCT02682784|54794021|FG000|Overall Study|Withdrawal by Subject|0|||
28130837|NCT02682784|54794022|FG001|Overall Study|Withdrawal by Subject|2|||
28130838|NCT02682784|54794023|FG002|Overall Study|Withdrawal by Subject|1|||
28130839|NCT02682784|54794024|FG003|Overall Study|Withdrawal by Subject|2|||
28130840|NCT02682784|54794021|FG000|Overall Study|Physician Decision|1|||
28130841|NCT02682784|54794022|FG001|Overall Study|Physician Decision|0|||
28130842|NCT02682784|54794023|FG002|Overall Study|Physician Decision|1|||
28130843|NCT02682784|54794024|FG003|Overall Study|Physician Decision|1|||
28130844|NCT03387852|54794038|FG000|Overall Study|Adverse event (AE)|3|||
28130845|NCT03387852|54794039|FG001|Overall Study|Adverse event (AE)|0|||
28130846|NCT03387852|54794040|FG002|Overall Study|Adverse event (AE)|2|||
28130847|NCT03387852|54794041|FG003|Overall Study|Adverse event (AE)|0|||
28130848|NCT03387852|54794038|FG000|Overall Study|Loss of asthma control (LOAC)|28|||
28130849|NCT03387852|54794039|FG001|Overall Study|Loss of asthma control (LOAC)|16|||
28130850|NCT03387852|54794040|FG002|Overall Study|Loss of asthma control (LOAC)|20|||
28130851|NCT03387852|54794041|FG003|Overall Study|Loss of asthma control (LOAC)|14|||
28130852|NCT03387852|54794038|FG000|Overall Study|Withdrawal by participant|1|||
28130853|NCT03387852|54794039|FG001|Overall Study|Withdrawal by participant|1|||
28130854|NCT03387852|54794040|FG002|Overall Study|Withdrawal by participant|3|||
28130855|NCT03387852|54794041|FG003|Overall Study|Withdrawal by participant|2|||
28130856|NCT03387852|54794038|FG000|Overall Study|Other- Unspecified|1|||
28130857|NCT03387852|54794039|FG001|Overall Study|Other- Unspecified|1|||
28130858|NCT03387852|54794040|FG002|Overall Study|Other- Unspecified|2|||
28130859|NCT03387852|54794041|FG003|Overall Study|Other- Unspecified|1|||
28130860|NCT03387852|54794038|FG000|Overall Study|Poor compliance to protocol|0|||
27818775|NCT01785602|54277402|FG001|Overall Study|Withdrawal by Subject|0|||
28130861|NCT03387852|54794039|FG001|Overall Study|Poor compliance to protocol|0|||
28130862|NCT03387852|54794040|FG002|Overall Study|Poor compliance to protocol|0|||
28130863|NCT03387852|54794041|FG003|Overall Study|Poor compliance to protocol|1|||
28130864|NCT03387852|54794038|FG000|Overall Study|Randomized and not treated|0|||
28130865|NCT03387852|54794039|FG001|Overall Study|Randomized and not treated|0|||
28130866|NCT03387852|54794040|FG002|Overall Study|Randomized and not treated|0|||
27818776|NCT01785602|54277401|FG000|Overall Study|Lost to Follow-up|1|||
28130867|NCT03387852|54794041|FG003|Overall Study|Randomized and not treated|1|||
28130868|NCT02679274|54794054|FG000|Overall Study|Withdrawal by Subject|1|||
28130869|NCT02679274|54794055|FG001|Overall Study|Withdrawal by Subject|0|||
28130870|NCT04969861|54794063|FG000|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|1|||
28130871|NCT04969861|54794064|FG001|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|0|||
28130872|NCT02678416|54794072|FG000|Part 1|Withdrawal by Subject|1|||
28130873|NCT02678416|54794072|FG000|Part 2|Adverse Event|2|||
28130874|NCT02678416|54794072|FG000|Part 2|Withdrawal by Subject|1|||
28130875|NCT02680834|54794092|FG000|Overall Study|Physician Decision|5|||
28130876|NCT02680834|54794093|FG001|Overall Study|Physician Decision|2|||
28130877|NCT02680834|54794092|FG000|Overall Study|Withdrawal by Subject|6|||
28130878|NCT02680834|54794093|FG001|Overall Study|Withdrawal by Subject|0|||
28130879|NCT02680834|54794092|FG000|Overall Study|Lost to Follow-up|0|||
28130880|NCT02680834|54794093|FG001|Overall Study|Lost to Follow-up|1|||
28130881|NCT03343704|54794101|FG000|Overall Study|Refused to complete follow up|0|||
28130882|NCT03343704|54794102|FG001|Overall Study|Refused to complete follow up|1|||
28130883|NCT03343704|54794101|FG000|Overall Study|Death|0|||
28130884|NCT03343704|54794102|FG001|Overall Study|Death|1|||
28130885|NCT03343704|54794101|FG000|Overall Study|Reluctant to collect blood and received telephone follow up|1|||
28130886|NCT03343704|54794102|FG001|Overall Study|Reluctant to collect blood and received telephone follow up|0|||
28130887|NCT02680756|54794112|FG000|Overall Study|Adverse Event|10|||
28130888|NCT02680756|54794113|FG001|Overall Study|Adverse Event|2|||
28130889|NCT02680756|54794112|FG000|Overall Study|Lost to Follow-up|7|||
28130890|NCT02680756|54794113|FG001|Overall Study|Lost to Follow-up|6|||
28130891|NCT02680756|54794112|FG000|Overall Study|Withdrawal by Subject|5|||
28130892|NCT02680756|54794113|FG001|Overall Study|Withdrawal by Subject|5|||
28130893|NCT02680756|54794112|FG000|Overall Study|Physician Decision|4|||
28130894|NCT02680756|54794113|FG001|Overall Study|Physician Decision|1|||
28130895|NCT02680756|54794112|FG000|Overall Study|Hb ≤7.5 g/dL|0|||
28130896|NCT02680756|54794113|FG001|Overall Study|Hb ≤7.5 g/dL|2|||
28130897|NCT02680756|54794112|FG000|Overall Study|Blood transfusion for any reason|0|||
28130898|NCT02680756|54794113|FG001|Overall Study|Blood transfusion for any reason|1|||
28130899|NCT02680756|54794112|FG000|Overall Study|Death|1|||
28130900|NCT02680756|54794113|FG001|Overall Study|Death|0|||
28130901|NCT02680756|54794112|FG000|Overall Study|Protocol Violation|1|||
28130902|NCT02680756|54794113|FG001|Overall Study|Protocol Violation|0|||
28130903|NCT02680756|54794112|FG000|Overall Study|TSAT above 60% or a ferritin above 800 m|1|||
28130904|NCT02680756|54794113|FG001|Overall Study|TSAT above 60% or a ferritin above 800 m|0|||
28130905|NCT02680756|54794112|FG000|Overall Study|None of above or not recorded|3|||
28130906|NCT02680756|54794113|FG001|Overall Study|None of above or not recorded|2|||
28130907|NCT03086460|54794119|FG000|Study Participants|Lost to Follow-up|2|||
28130908|NCT03086460|54794119|FG000|Study Participants|Protocol Violation|1|||
28130909|NCT03086460|54794119|FG000|Study Participants|Withdrawal by Subject|6|||
28130910|NCT03086460|54794119|FG000|Treatment A|Lost to Follow-up|1|||
28130911|NCT03086460|54794119|FG000|Treatment A|Protocol Violation|1|||
28130912|NCT03086460|54794119|FG000|Treatment A|Withdrawal by Subject|2|||
28130913|NCT03086460|54794119|FG000|Treatment C|Withdrawal by Subject|2|||
28130914|NCT03086460|54794119|FG000|Treatment E|Lost to Follow-up|1|||
28130915|NCT03086460|54794119|FG000|Treatment E|Withdrawal by Subject|3|||
28130916|NCT02677714|54794145|FG000|Overall Study|Withdrawal by Subject|2|||
28130917|NCT02677714|54794146|FG001|Overall Study|Withdrawal by Subject|0|||
28130918|NCT02677324|54794152|FG000|Overall Study|Disease Progression|6|||
28130919|NCT02677324|54794152|FG000|Overall Study|Inability to Swallow pills|1|||
28130920|NCT02677324|54794152|FG000|Overall Study|Non-compliance|1|||
28130921|NCT02677324|54794152|FG000|Overall Study|Lack of Efficacy|1|||
28130922|NCT02677324|54794152|FG000|Overall Study|Medical insurance coverage|1|||
28130923|NCT02677324|54794152|FG000|Overall Study|Adverse Event|1|||
28130924|NCT02677324|54794152|FG000|Overall Study|IgM Myeloma diagnosis|1|||
28130925|NCT01971008|54794160|FG000|Overall Study|Protocol Violation|2|||
28130926|NCT01971008|54794161|FG001|Overall Study|Protocol Violation|1|||
28130927|NCT01374178|54794170|FG000|Washout Period of at Least 7 Days|Withdrawal by Subject|1|||
28130928|NCT01374178|54794171|FG001|Washout Period of at Least 7 Days|Withdrawal by Subject|0|||
28130929|NCT01374178|54794170|FG000|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2|||
28130930|NCT01374178|54794171|FG001|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0|||
28130931|NCT03025542|54794179|FG000|Overall Study|Adverse Event|0|||
28130932|NCT03025542|54794180|FG001|Overall Study|Adverse Event|2|||
28130933|NCT03025542|54794179|FG000|Overall Study|Lost to Follow-up|1|||
28130934|NCT03025542|54794180|FG001|Overall Study|Lost to Follow-up|0|||
28130935|NCT03025542|54794179|FG000|Overall Study|Withdrawal by Subject|1|||
28130936|NCT03025542|54794180|FG001|Overall Study|Withdrawal by Subject|0|||
28130937|NCT03022370|54794194|FG000|Overall Study|Death|6|||
28130938|NCT03022370|54794195|FG001|Overall Study|Death|12|||
28130939|NCT03022370|54794194|FG000|Overall Study|Lost to Follow-up|174|||
28130940|NCT03022370|54794195|FG001|Overall Study|Lost to Follow-up|109|||
28130941|NCT03021668|54794207|FG000|Overall Study|Physician Decision|0|||
28130942|NCT03021668|54794208|FG001|Overall Study|Physician Decision|1|||
28130943|NCT03020888|54794214|FG000|Overall Study|Physician Decision|4|||
28130944|NCT03020888|54794214|FG000|Overall Study|Withdrawal by Subject|6|||
28130945|NCT03020888|54794214|FG000|Overall Study|Insurance coverage|2|||
28130946|NCT03020888|54794214|FG000|Overall Study|Lost to Follow-up|1|||
28130947|NCT02250300|54794222|FG000|Expansion Phase|Death|6|||
28130948|NCT02250300|54794223|FG001|Expansion Phase|Death|7|||
28130949|NCT02250300|54794224|FG002|Expansion Phase|Death|0|||
28130950|NCT02250300|54794225|FG003|Expansion Phase|Death|0|||
28130951|NCT03020966|54794238|FG000|Overall Study|Withdrawal by Subject|2|||
28130952|NCT03020966|54794239|FG001|Overall Study|Withdrawal by Subject|0|||
28130953|NCT03020576|54794247|FG000|Overall Study|Withdrawal by Subject|1|||
28130954|NCT03020576|54794248|FG001|Overall Study|Withdrawal by Subject|2|||
28130955|NCT03017612|54794254|FG000|Overall Study|Adverse Event|2|||
28130956|NCT03635099|54794266|FG000|Period 1|Adverse Event|1|||
28130957|NCT03635099|54794267|FG001|Period 1|Adverse Event|0|||
28130958|NCT03635099|54794268|FG002|Period 1|Adverse Event|0|||
28130959|NCT03635099|54794269|FG003|Period 1|Adverse Event|1|||
28130960|NCT03635099|54794270|FG004|Period 1|Adverse Event|0|||
28130961|NCT03635099|54794271|FG005|Period 1|Adverse Event|0|||
28130962|NCT03635099|54794272|FG006|Period 1|Adverse Event|0|||
28130963|NCT03635099|54794273|FG007|Period 1|Adverse Event|0|||
28130964|NCT03635099|54794266|FG000|Period 1|Protocol Violation|0|||
28130965|NCT03635099|54794267|FG001|Period 1|Protocol Violation|0|||
28130966|NCT03635099|54794268|FG002|Period 1|Protocol Violation|1|||
28130967|NCT03635099|54794269|FG003|Period 1|Protocol Violation|0|||
28130968|NCT03635099|54794270|FG004|Period 1|Protocol Violation|0|||
28130969|NCT03635099|54794271|FG005|Period 1|Protocol Violation|0|||
28130970|NCT03635099|54794272|FG006|Period 1|Protocol Violation|0|||
28130971|NCT03635099|54794273|FG007|Period 1|Protocol Violation|0|||
28130972|NCT03635099|54794266|FG000|Period 1|Lost to Follow-up|0|||
28130973|NCT03635099|54794267|FG001|Period 1|Lost to Follow-up|0|||
28130974|NCT03635099|54794268|FG002|Period 1|Lost to Follow-up|1|||
28130975|NCT03635099|54794269|FG003|Period 1|Lost to Follow-up|2|||
28130976|NCT03635099|54794270|FG004|Period 1|Lost to Follow-up|1|||
28130977|NCT03635099|54794271|FG005|Period 1|Lost to Follow-up|0|||
28130978|NCT03635099|54794272|FG006|Period 1|Lost to Follow-up|1|||
28130979|NCT03635099|54794273|FG007|Period 1|Lost to Follow-up|2|||
28130980|NCT03635099|54794266|FG000|Period 1|Withdrawal by Subject|3|||
28130981|NCT03635099|54794267|FG001|Period 1|Withdrawal by Subject|3|||
28130982|NCT03635099|54794268|FG002|Period 1|Withdrawal by Subject|5|||
28130983|NCT03635099|54794269|FG003|Period 1|Withdrawal by Subject|2|||
28130984|NCT03635099|54794270|FG004|Period 1|Withdrawal by Subject|2|||
28130985|NCT03635099|54794271|FG005|Period 1|Withdrawal by Subject|0|||
28130986|NCT03635099|54794272|FG006|Period 1|Withdrawal by Subject|3|||
28130987|NCT03635099|54794273|FG007|Period 1|Withdrawal by Subject|0|||
28130988|NCT03635099|54794266|FG000|Period 1|History of suicidal ideation|0|||
28130989|NCT03635099|54794267|FG001|Period 1|History of suicidal ideation|0|||
28130990|NCT03635099|54794268|FG002|Period 1|History of suicidal ideation|1|||
28130991|NCT03635099|54794269|FG003|Period 1|History of suicidal ideation|0|||
28130992|NCT03635099|54794270|FG004|Period 1|History of suicidal ideation|0|||
28130993|NCT03635099|54794271|FG005|Period 1|History of suicidal ideation|0|||
28130994|NCT03635099|54794272|FG006|Period 1|History of suicidal ideation|0|||
28130995|NCT03635099|54794273|FG007|Period 1|History of suicidal ideation|0|||
28130996|NCT03635099|54794266|FG000|Period 1|pursue other treatment options|0|||
28130997|NCT03635099|54794267|FG001|Period 1|pursue other treatment options|0|||
28130998|NCT03635099|54794268|FG002|Period 1|pursue other treatment options|0|||
28130999|NCT03635099|54794269|FG003|Period 1|pursue other treatment options|0|||
28131000|NCT03635099|54794270|FG004|Period 1|pursue other treatment options|0|||
28131001|NCT03635099|54794271|FG005|Period 1|pursue other treatment options|1|||
28068070|NCT00292370|54723249|FG000|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0|||
28068071|NCT00292370|54723250|FG001|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3|||
28068072|NCT00292370|54723251|FG002|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2|||
28068073|NCT00292370|54723249|FG000|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0|||
28068074|NCT00292370|54723250|FG001|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1|||
28068075|NCT00292370|54723251|FG002|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5|||
28068076|NCT00065182|54723260|FG000|Overall Study|Adverse Event|24|||
28131002|NCT03635099|54794272|FG006|Period 1|pursue other treatment options|0|||
28131003|NCT03635099|54794273|FG007|Period 1|pursue other treatment options|0|||
28131004|NCT03635099|54794266|FG000|Not Eligible for Period 2|Pregnancy|0|||
28131005|NCT03635099|54794267|FG001|Not Eligible for Period 2|Pregnancy|0|||
27818777|NCT01785602|54277402|FG001|Overall Study|Lost to Follow-up|1|||
28131006|NCT03635099|54794268|FG002|Not Eligible for Period 2|Pregnancy|0|||
28131007|NCT03635099|54794269|FG003|Not Eligible for Period 2|Pregnancy|1|||
28131008|NCT03635099|54794270|FG004|Not Eligible for Period 2|Pregnancy|0|||
28131009|NCT03635099|54794271|FG005|Not Eligible for Period 2|Pregnancy|0|||
28131010|NCT03635099|54794272|FG006|Not Eligible for Period 2|Pregnancy|0|||
28131011|NCT03635099|54794273|FG007|Not Eligible for Period 2|Pregnancy|0|||
28131012|NCT03635099|54794266|FG000|Not Eligible for Period 2|Withdrawal by Subject|1|||
28131013|NCT03635099|54794267|FG001|Not Eligible for Period 2|Withdrawal by Subject|0|||
28131014|NCT03635099|54794268|FG002|Not Eligible for Period 2|Withdrawal by Subject|0|||
27818778|NCT01785602|54277401|FG000|Overall Study|Adverse Event|3|||
27818779|NCT01785602|54277402|FG001|Overall Study|Adverse Event|5|||
27818780|NCT01785602|54277401|FG000|Overall Study|Administrative problems|7|||
27818781|NCT01785602|54277402|FG001|Overall Study|Administrative problems|3|||
27940548|NCT01022853|54596834|FG004|Overall Study|Withdrawal by Subject|0|||
27940549|NCT01022853|54596830|FG000|Overall Study|Other not stated above|1|||
27940550|NCT01022853|54596831|FG001|Overall Study|Other not stated above|0|||
27940551|NCT01022853|54596832|FG002|Overall Study|Other not stated above|1|||
27940552|NCT01022853|54596833|FG003|Overall Study|Other not stated above|0|||
27818782|NCT01785524|54277410|FG000|Overall Study|Withdrawal by Subject|2|||
27818783|NCT01785524|54277411|FG001|Overall Study|Withdrawal by Subject|2|||
27818784|NCT01757288|54277420|FG000|Overall Study|Consent withdrawal|0|||
27818785|NCT01757288|54277421|FG001|Overall Study|Consent withdrawal|4|||
27818786|NCT01757288|54277422|FG002|Overall Study|Consent withdrawal|4|||
27818787|NCT01757288|54277420|FG000|Overall Study|Patient off study, IRB hold.|0|||
27818788|NCT01757288|54277421|FG001|Overall Study|Patient off study, IRB hold.|0|||
27818789|NCT01757288|54277422|FG002|Overall Study|Patient off study, IRB hold.|1|||
27818790|NCT01757288|54277420|FG000|Overall Study|Patient death prior to starting treatment|0|||
27818791|NCT01757288|54277421|FG001|Overall Study|Patient death prior to starting treatment|0|||
27818792|NCT01757288|54277422|FG002|Overall Study|Patient death prior to starting treatment|1|||
27818793|NCT01757288|54277420|FG000|Overall Study|Wrong medication administered|0|||
27818794|NCT01757288|54277421|FG001|Overall Study|Wrong medication administered|1|||
27818795|NCT01757288|54277422|FG002|Overall Study|Wrong medication administered|0|||
27818796|NCT01757288|54277420|FG000|Overall Study|Liver metastasis identified at CT simulation|0|||
27818797|NCT01757288|54277421|FG001|Overall Study|Liver metastasis identified at CT simulation|1|||
27818798|NCT01757288|54277422|FG002|Overall Study|Liver metastasis identified at CT simulation|0|||
27818799|NCT01757288|54277420|FG000|Overall Study|Not meeting protocol constraints|0|||
27818800|NCT01757288|54277421|FG001|Overall Study|Not meeting protocol constraints|1|||
27818801|NCT01757288|54277422|FG002|Overall Study|Not meeting protocol constraints|1|||
27818802|NCT01757288|54277420|FG000|Overall Study|Multiple missed appointments|0|||
27818803|NCT01757288|54277421|FG001|Overall Study|Multiple missed appointments|1|||
27818804|NCT01757288|54277422|FG002|Overall Study|Multiple missed appointments|0|||
27818805|NCT01757288|54277420|FG000|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
27818806|NCT01757288|54277421|FG001|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
27818807|NCT01757288|54277422|FG002|Overall Study|Mulitple hospitalization ( after first week of CRT)|1|||
27818808|NCT01757288|54277420|FG000|Overall Study|>2 weeks treatment break|0|||
27818809|NCT01757288|54277421|FG001|Overall Study|>2 weeks treatment break|0|||
27818810|NCT01757288|54277422|FG002|Overall Study|>2 weeks treatment break|1|||
27818811|NCT01756898|54277435|FG000|Overall Study|Adverse Event|7|||
28068077|NCT00065182|54723261|FG001|Overall Study|Adverse Event|17|||
28068078|NCT00065182|54723260|FG000|Overall Study|Lost to Follow-up|0|||
28068079|NCT00065182|54723261|FG001|Overall Study|Lost to Follow-up|4|||
28068080|NCT00065182|54723260|FG000|Overall Study|Protocol Violation|3|||
28068081|NCT00065182|54723261|FG001|Overall Study|Protocol Violation|4|||
28068082|NCT00065182|54723260|FG000|Overall Study|Serious adverse events (SAE)|1|||
28068083|NCT00065182|54723261|FG001|Overall Study|Serious adverse events (SAE)|0|||
28068084|NCT00065182|54723260|FG000|Overall Study|Sponsor Decision|11|||
28068085|NCT00065182|54723261|FG001|Overall Study|Sponsor Decision|7|||
28068086|NCT00065182|54723260|FG000|Overall Study|Withdrawal by Subject|8|||
28068087|NCT00065182|54723261|FG001|Overall Study|Withdrawal by Subject|3|||
28068088|NCT00065182|54723260|FG000|Overall Study|No clinical benefit|1|||
28068089|NCT00065182|54723261|FG001|Overall Study|No clinical benefit|0|||
28068090|NCT00065182|54723260|FG000|Overall Study|Death|0|||
28068091|NCT00065182|54723261|FG001|Overall Study|Death|1|||
28068092|NCT00065182|54723260|FG000|Overall Study|Decline in Status|0|||
28068093|NCT00065182|54723261|FG001|Overall Study|Decline in Status|1|||
28068094|NCT00064792|54723269|FG000|Overall Study|Withdrawal by Subject|2|||
28068095|NCT00064792|54723270|FG001|Overall Study|Withdrawal by Subject|0|||
28068096|NCT00064792|54723269|FG000|Overall Study|Adverse Event|3|||
28068097|NCT00064792|54723270|FG001|Overall Study|Adverse Event|0|||
28068098|NCT00450437|54723278|FG000|Overall Study|Withdrawal by Subject|10|||
28068099|NCT00450437|54723279|FG001|Overall Study|Withdrawal by Subject|2|||
28068100|NCT00450437|54723280|FG002|Overall Study|Withdrawal by Subject|0|||
28068101|NCT00450437|54723281|FG003|Overall Study|Withdrawal by Subject|1|||
28068102|NCT00450437|54723278|FG000|Overall Study|Lost to Follow-up|31|||
28068103|NCT00450437|54723279|FG001|Overall Study|Lost to Follow-up|12|||
28068104|NCT00450437|54723280|FG002|Overall Study|Lost to Follow-up|19|||
28068105|NCT00450437|54723281|FG003|Overall Study|Lost to Follow-up|9|||
28068106|NCT00450437|54723278|FG000|Overall Study|Protocol Violation|0|||
28068107|NCT00450437|54723279|FG001|Overall Study|Protocol Violation|1|||
28068108|NCT00450437|54723280|FG002|Overall Study|Protocol Violation|0|||
28068109|NCT00450437|54723281|FG003|Overall Study|Protocol Violation|1|||
28068110|NCT00450437|54723278|FG000|Overall Study|Inappropriate enrollment|4|||
28068111|NCT00450437|54723279|FG001|Overall Study|Inappropriate enrollment|1|||
28131015|NCT03635099|54794269|FG003|Not Eligible for Period 2|Withdrawal by Subject|0|||
28131016|NCT03635099|54794270|FG004|Not Eligible for Period 2|Withdrawal by Subject|0|||
28131017|NCT03635099|54794271|FG005|Not Eligible for Period 2|Withdrawal by Subject|0|||
28131018|NCT03635099|54794272|FG006|Not Eligible for Period 2|Withdrawal by Subject|0|||
28131019|NCT03635099|54794273|FG007|Not Eligible for Period 2|Withdrawal by Subject|0|||
28131020|NCT03635099|54794266|FG000|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
28131021|NCT03635099|54794267|FG001|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
28131022|NCT03635099|54794268|FG002|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
28131023|NCT03635099|54794269|FG003|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
28131024|NCT03635099|54794270|FG004|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
28131025|NCT03635099|54794271|FG005|Not Eligible for Period 2|Part II subjects did not have a period 2.|9|||
28131026|NCT03635099|54794272|FG006|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
28131027|NCT03635099|54794273|FG007|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
28131028|NCT03635099|54794266|FG000|Eligible for Period 2|Switch to higher dose at end of period 1|15|||
28131029|NCT03635099|54794267|FG001|Eligible for Period 2|Switch to higher dose at end of period 1|35|||
28131030|NCT03635099|54794268|FG002|Eligible for Period 2|Switch to higher dose at end of period 1|21|||
28131031|NCT03635099|54794269|FG003|Eligible for Period 2|Switch to higher dose at end of period 1|25|||
28131032|NCT03635099|54794270|FG004|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
28131033|NCT03635099|54794271|FG005|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
28131034|NCT03635099|54794272|FG006|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
28131035|NCT03635099|54794273|FG007|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
28131036|NCT03635099|54794266|FG000|Period 2|Adverse Event|0|||
28131037|NCT03635099|54794267|FG001|Period 2|Adverse Event|0|||
28131038|NCT03635099|54794268|FG002|Period 2|Adverse Event|1|||
28131039|NCT03635099|54794269|FG003|Period 2|Adverse Event|0|||
28131040|NCT03635099|54794270|FG004|Period 2|Adverse Event|1|||
28131041|NCT03635099|54794271|FG005|Period 2|Adverse Event|0|||
28131042|NCT03635099|54794272|FG006|Period 2|Adverse Event|0|||
28131043|NCT03635099|54794273|FG007|Period 2|Adverse Event|0|||
28131044|NCT03635099|54794266|FG000|Period 2|Lost to Follow-up|0|||
28131045|NCT03635099|54794267|FG001|Period 2|Lost to Follow-up|0|||
28131046|NCT03635099|54794268|FG002|Period 2|Lost to Follow-up|1|||
28131047|NCT03635099|54794269|FG003|Period 2|Lost to Follow-up|0|||
28131048|NCT03635099|54794270|FG004|Period 2|Lost to Follow-up|4|||
28131049|NCT03635099|54794271|FG005|Period 2|Lost to Follow-up|0|||
28131050|NCT03635099|54794272|FG006|Period 2|Lost to Follow-up|0|||
28131051|NCT03635099|54794273|FG007|Period 2|Lost to Follow-up|0|||
28131052|NCT03635099|54794266|FG000|Period 2|Withdrawal by Subject|0|||
28131053|NCT03635099|54794267|FG001|Period 2|Withdrawal by Subject|0|||
28131054|NCT03635099|54794268|FG002|Period 2|Withdrawal by Subject|7|||
28131055|NCT03635099|54794269|FG003|Period 2|Withdrawal by Subject|4|||
28131056|NCT03635099|54794270|FG004|Period 2|Withdrawal by Subject|7|||
28131057|NCT03635099|54794271|FG005|Period 2|Withdrawal by Subject|0|||
28131058|NCT03635099|54794272|FG006|Period 2|Withdrawal by Subject|0|||
28131059|NCT03635099|54794273|FG007|Period 2|Withdrawal by Subject|0|||
28131060|NCT02108652|54794299|FG000|Overall Study|Death|226|||
28131061|NCT02108652|54794299|FG000|Overall Study|Lost to Follow-up|2|||
28131062|NCT02108652|54794299|FG000|Overall Study|Withdrawal by Subject|8|||
28131063|NCT02108652|54794299|FG000|Overall Study|Ongoing at data cutoff 04 July 2016|74|||
28068112|NCT00450437|54723280|FG002|Overall Study|Inappropriate enrollment|3|||
28068113|NCT00450437|54723281|FG003|Overall Study|Inappropriate enrollment|0|||
28131064|NCT03634085|54794305|FG000|Overall Study|Adverse Event|1|||
28131065|NCT03634085|54794306|FG001|Overall Study|Adverse Event|0|||
28131066|NCT03634085|54794305|FG000|Overall Study|Withdrawal by Subject|0|||
28131067|NCT03634085|54794306|FG001|Overall Study|Withdrawal by Subject|2|||
28131068|NCT02676778|54794322|FG000|Overall Study|Disease Progression|7|||
28131069|NCT02676778|54794323|FG001|Overall Study|Disease Progression|3|||
28131070|NCT02676778|54794324|FG002|Overall Study|Disease Progression|1|||
28068114|NCT00450437|54723278|FG000|Overall Study|Administrative reason|0|||
28068115|NCT00450437|54723279|FG001|Overall Study|Administrative reason|0|||
28068116|NCT00450437|54723280|FG002|Overall Study|Administrative reason|1|||
28068117|NCT00450437|54723281|FG003|Overall Study|Administrative reason|0|||
28068118|NCT00450437|54723278|FG000|Overall Study|Unable to Classify|1|||
28068119|NCT00450437|54723279|FG001|Overall Study|Unable to Classify|0|||
28068120|NCT00450437|54723280|FG002|Overall Study|Unable to Classify|1|||
28068121|NCT00450437|54723281|FG003|Overall Study|Unable to Classify|0|||
28068122|NCT00286442|54723298|FG000|Overall Study|Hyperglycemic Rescue|19|||
28131071|NCT02676778|54794322|FG000|Overall Study|Couldn't Start Cycle After Planned Date|1|||
28068123|NCT00286442|54723299|FG001|Overall Study|Hyperglycemic Rescue|17|||
28131072|NCT02676778|54794323|FG001|Overall Study|Couldn't Start Cycle After Planned Date|1|||
28131073|NCT02676778|54794324|FG002|Overall Study|Couldn't Start Cycle After Planned Date|0|||
28131074|NCT02676778|54794322|FG000|Overall Study|Withdrawal by Subject|3|||
28131075|NCT02676778|54794323|FG001|Overall Study|Withdrawal by Subject|2|||
28131076|NCT02676778|54794324|FG002|Overall Study|Withdrawal by Subject|0|||
28131077|NCT02676778|54794322|FG000|Overall Study|Other|4|||
28131078|NCT02676778|54794323|FG001|Overall Study|Other|3|||
28131079|NCT02676778|54794324|FG002|Overall Study|Other|0|||
28131080|NCT02676778|54794322|FG000|Overall Study|Adverse Event|2|||
28131081|NCT02676778|54794323|FG001|Overall Study|Adverse Event|3|||
28131082|NCT02676778|54794324|FG002|Overall Study|Adverse Event|0|||
28131083|NCT02946385|54794339|FG000|Overall Study|Lost to Follow-up|0|||
28131084|NCT02946385|54794340|FG001|Overall Study|Lost to Follow-up|0|||
28131085|NCT02946385|54794341|FG002|Overall Study|Lost to Follow-up|3|||
28131086|NCT02946385|54794342|FG003|Overall Study|Lost to Follow-up|0|||
28131087|NCT02946385|54794343|FG004|Overall Study|Lost to Follow-up|2|||
28131088|NCT02946385|54794344|FG005|Overall Study|Lost to Follow-up|1|||
28131089|NCT02694718|54794364|FG000|Overall Study|Death|1|||
28131090|NCT02694718|54794364|FG000|Overall Study|Withdrawal by Subject|1|||
28068124|NCT00286442|54723300|FG002|Overall Study|Hyperglycemic Rescue|25|||
28131091|NCT02944513|54794370|FG000|Overall Study|Withdrawal by Subject|4|||
28131092|NCT02944513|54794371|FG001|Overall Study|Withdrawal by Subject|1|||
28131093|NCT03018938|54794386|FG000|Overall Study|Death|0|||
28131094|NCT03018938|54794387|FG001|Overall Study|Death|1|||
28131095|NCT03018938|54794386|FG000|Overall Study|Lost to Follow-up|21|||
28131096|NCT03018938|54794387|FG001|Overall Study|Lost to Follow-up|32|||
28131097|NCT03018938|54794386|FG000|Overall Study|Withdrawal by Subject|38|||
28131098|NCT03018938|54794387|FG001|Overall Study|Withdrawal by Subject|45|||
28131099|NCT03018938|54794386|FG000|Overall Study|Physician Decision|3|||
28131100|NCT03018938|54794387|FG001|Overall Study|Physician Decision|2|||
28131101|NCT03018938|54794386|FG000|Overall Study|Sponsor Decision|0|||
28131102|NCT03018938|54794387|FG001|Overall Study|Sponsor Decision|1|||
28131103|NCT03018938|54794386|FG000|Overall Study|Screen failure-After randomization|4|||
28131104|NCT03018938|54794387|FG001|Overall Study|Screen failure-After randomization|2|||
28131105|NCT03018938|54794386|FG000|Overall Study|Not recorded|0|||
28131106|NCT03018938|54794387|FG001|Overall Study|Not recorded|2|||
28131107|NCT02943577|54794395|FG000|Overall Study|Protocol Violation|0|||
28131108|NCT02943577|54794396|FG001|Overall Study|Protocol Violation|1|||
28131109|NCT02943577|54794395|FG000|Overall Study|Adverse Event|3|||
28131110|NCT02943577|54794396|FG001|Overall Study|Adverse Event|2|||
28068125|NCT00286442|54723298|FG000|Overall Study|Adverse Event|7|||
28068126|NCT00286442|54723299|FG001|Overall Study|Adverse Event|6|||
28068127|NCT00286442|54723300|FG002|Overall Study|Adverse Event|1|||
28068128|NCT00286442|54723298|FG000|Overall Study|Protocol Violation|2|||
28068129|NCT00286442|54723299|FG001|Overall Study|Protocol Violation|4|||
28068130|NCT00286442|54723300|FG002|Overall Study|Protocol Violation|2|||
28068131|NCT00286442|54723298|FG000|Overall Study|Lost to Follow-up|5|||
28068132|NCT00286442|54723299|FG001|Overall Study|Lost to Follow-up|2|||
28068133|NCT00286442|54723300|FG002|Overall Study|Lost to Follow-up|1|||
28068134|NCT00286442|54723298|FG000|Overall Study|Physician Decision|1|||
28068135|NCT00286442|54723299|FG001|Overall Study|Physician Decision|1|||
28068136|NCT00286442|54723300|FG002|Overall Study|Physician Decision|1|||
28068137|NCT00286442|54723298|FG000|Overall Study|Administrative Error|1|||
28068138|NCT00286442|54723299|FG001|Overall Study|Administrative Error|1|||
28068139|NCT00286442|54723300|FG002|Overall Study|Administrative Error|0|||
28068140|NCT00286442|54723298|FG000|Overall Study|Withdrawal by Subject|2|||
28068141|NCT00286442|54723299|FG001|Overall Study|Withdrawal by Subject|14|||
28068142|NCT00286442|54723300|FG002|Overall Study|Withdrawal by Subject|2|||
28068143|NCT00063934|54723308|FG000|Overall Study|Ineligible|1|||
28068144|NCT00458783|54723314|FG000|Overall Study|Protocol Violation|1228|||
28068145|NCT00458783|54723315|FG001|Overall Study|Protocol Violation|1220|||
28068146|NCT00063154|54723321|FG000|Overall Study|Disease progression|27|||
28068147|NCT00063154|54723321|FG000|Overall Study|Adverse Event|2|||
28068148|NCT00063154|54723321|FG000|Overall Study|Physician Decision|10|||
28068149|NCT00063154|54723321|FG000|Overall Study|Death|3|||
28068150|NCT00063154|54723321|FG000|Overall Study|Reason unspecified|1|||
28068151|NCT00063154|54723321|FG000|Overall Study|Did not receive treatment|8|||
28068152|NCT00311168|54723327|FG000|First Intervention|Withdrawal by Subject|2|||
28131111|NCT02943577|54794395|FG000|Overall Study|Lost to Follow-up|0|||
28131112|NCT02943577|54794396|FG001|Overall Study|Lost to Follow-up|1|||
28131113|NCT02943577|54794395|FG000|Overall Study|Withdrawal by Subject|1|||
28068153|NCT00311168|54723328|FG001|First Intervention|Withdrawal by Subject|2|||
28131114|NCT02943577|54794396|FG001|Overall Study|Withdrawal by Subject|1|||
28131115|NCT02943577|54794395|FG000|Overall Study|Pregnancy|1|||
28131116|NCT02943577|54794396|FG001|Overall Study|Pregnancy|0|||
28131117|NCT03016598|54794404|FG000|Overall Study|Lost to Follow-up|0|||
28131118|NCT03016598|54794405|FG001|Overall Study|Lost to Follow-up|2|||
28131119|NCT03017846|54794411|FG000|Overall Study|Lost to Follow-up|3|||
28131120|NCT03017846|54794411|FG000|Overall Study|Adverse Event|2|||
28131121|NCT03014180|54794417|FG000|Overall Study|Protocol Violation|2|||
28131122|NCT03011840|54794427|FG000|Overall Study|Not received PIL in post PIL phase|0|||
28131123|NCT03011840|54794428|FG001|Overall Study|Not received PIL in post PIL phase|21|||
28131124|NCT02942485|54794436|FG000|Overall Study|Lost to Follow-up|1|||
28131125|NCT02942485|54794437|FG001|Overall Study|Lost to Follow-up|0|||
28131126|NCT02942407|54794445|FG000|Overall Study|Lost to Follow-up|3|||
28131127|NCT02942407|54794446|FG001|Overall Study|Lost to Follow-up|2|||
28131128|NCT02942407|54794445|FG000|Overall Study|Withdrawal by Subject|7|||
28131129|NCT02942407|54794446|FG001|Overall Study|Withdrawal by Subject|9|||
28131130|NCT02942407|54794445|FG000|Overall Study|Death|16|||
28131131|NCT02942407|54794446|FG001|Overall Study|Death|13|||
28131132|NCT03009344|54794460|FG000|Overall Study|Lack of Efficacy|5|||
28131133|NCT03009344|54794460|FG000|Overall Study|Withdrawal by Subject|1|||
28131134|NCT03009344|54794460|FG000|Overall Study|Adverse Event|1|||
28068154|NCT00311168|54723327|FG000|First Intervention|Lost to Follow-up|1|||
28068155|NCT00311168|54723328|FG001|First Intervention|Lost to Follow-up|1|||
28131135|NCT03322423|54794464|FG000|Period 1|Subject no longer eligible|0|||
28131136|NCT03322423|54794465|FG001|Period 1|Subject no longer eligible|1|||
28068156|NCT00311168|54723327|FG000|First Intervention|Protocol Violation|1|||
28131137|NCT03322423|54794464|FG000|Period 1|Withdrawal by Subject|0|||
28131138|NCT03322423|54794465|FG001|Period 1|Withdrawal by Subject|1|||
28131139|NCT03322423|54794464|FG000|Period 1|Incorrect Lens Dispensed|1|||
28131140|NCT03322423|54794465|FG001|Period 1|Incorrect Lens Dispensed|0|||
28131141|NCT03322423|54794464|FG000|Period 1|Unsatisfactory Lens Fitting|1|||
28131142|NCT03322423|54794465|FG001|Period 1|Unsatisfactory Lens Fitting|0|||
28131143|NCT03322423|54794464|FG000|Period 2|Dispensed incorrect lens in left eye|0|||
28131144|NCT03322423|54794465|FG001|Period 2|Dispensed incorrect lens in left eye|1|||
28131145|NCT03322423|54794464|FG000|Period 2|Protocol Violation|1|||
28131146|NCT03322423|54794465|FG001|Period 2|Protocol Violation|0|||
28131147|NCT03322423|54794464|FG000|Period 2|Subject not eligible for Pytergiumectomy|0|||
28131148|NCT03322423|54794465|FG001|Period 2|Subject not eligible for Pytergiumectomy|1|||
28131149|NCT03007472|54794471|FG000|Overall Study|Did not have aidable contralateral thresholds at the time|2|||
28131150|NCT03007472|54794471|FG000|Overall Study|Death|2|||
28068157|NCT00311168|54723328|FG001|First Intervention|Protocol Violation|1|||
28068158|NCT00311168|54723327|FG000|First Intervention|Adverse Event|1|||
28068159|NCT00311168|54723328|FG001|First Intervention|Adverse Event|0|||
28068160|NCT00311168|54723327|FG000|First Intervention|Other|2|||
28068161|NCT00311168|54723328|FG001|First Intervention|Other|2|||
28131151|NCT03007472|54794471|FG000|Overall Study|Loss to Follow Up|1|||
28131152|NCT03321721|54794478|FG000|Overall Study|Lost to Follow-up|4|||
28131153|NCT03321721|54794479|FG001|Overall Study|Lost to Follow-up|8|||
28068162|NCT00311168|54723327|FG000|Second Intervention|Lost to Follow-up|9|||
28068163|NCT00311168|54723328|FG001|Second Intervention|Lost to Follow-up|2|||
27818812|NCT01756898|54277436|FG001|Overall Study|Adverse Event|1|||
27818813|NCT01756898|54277437|FG002|Overall Study|Adverse Event|0|||
27818814|NCT01756898|54277438|FG003|Overall Study|Adverse Event|0|||
27818815|NCT01756898|54277435|FG000|Overall Study|Lack of Efficacy|4|||
27818816|NCT01756898|54277436|FG001|Overall Study|Lack of Efficacy|7|||
27818817|NCT01756898|54277437|FG002|Overall Study|Lack of Efficacy|6|||
27818818|NCT01756898|54277438|FG003|Overall Study|Lack of Efficacy|6|||
27818819|NCT01756898|54277435|FG000|Overall Study|Lost to Follow-up|2|||
27818820|NCT01756898|54277436|FG001|Overall Study|Lost to Follow-up|4|||
27818821|NCT01756898|54277437|FG002|Overall Study|Lost to Follow-up|2|||
27818822|NCT01756898|54277438|FG003|Overall Study|Lost to Follow-up|3|||
27818823|NCT01756898|54277435|FG000|Overall Study|Protocol Violation|1|||
28068164|NCT00311168|54723327|FG000|Second Intervention|Withdrawal by Subject|0|||
28068165|NCT00311168|54723328|FG001|Second Intervention|Withdrawal by Subject|1|||
28068166|NCT00311168|54723327|FG000|Second Intervention|Other|1|||
28068167|NCT00311168|54723328|FG001|Second Intervention|Other|1|||
28068168|NCT00458705|54723336|FG000|Overall Study|Adverse Event|4|||
28131154|NCT03321721|54794480|FG002|Overall Study|Lost to Follow-up|11|||
28131155|NCT03015116|54794492|FG000|Overall Study|Lost to Follow-up|3|||
28131156|NCT03015116|54794493|FG001|Overall Study|Lost to Follow-up|0|||
28131157|NCT03015116|54794494|FG002|Overall Study|Lost to Follow-up|2|||
28131158|NCT03015116|54794492|FG000|Overall Study|Withdrawal by Subject|3|||
28131159|NCT03015116|54794493|FG001|Overall Study|Withdrawal by Subject|1|||
28131160|NCT03015116|54794494|FG002|Overall Study|Withdrawal by Subject|0|||
28131161|NCT03015116|54794492|FG000|Overall Study|Subject has New Medical Status|1|||
28131162|NCT03015116|54794493|FG001|Overall Study|Subject has New Medical Status|0|||
28131163|NCT03015116|54794494|FG002|Overall Study|Subject has New Medical Status|0|||
28131164|NCT03015116|54794492|FG000|Overall Study|Physician Decision|0|||
28131165|NCT03015116|54794493|FG001|Overall Study|Physician Decision|1|||
28131166|NCT03015116|54794494|FG002|Overall Study|Physician Decision|0|||
28131167|NCT03006458|54794504|FG000|First Intervention|Unsatisfied Vision|0|||
28131168|NCT03006458|54794505|FG001|First Intervention|Unsatisfied Vision|3|||
28131169|NCT03320941|54794516|FG000|Overall Study|subject/guardian decision|0|||
28131170|NCT03320941|54794517|FG001|Overall Study|subject/guardian decision|0|||
28131171|NCT03320941|54794518|FG002|Overall Study|subject/guardian decision|0|||
28131172|NCT03320941|54794519|FG003|Overall Study|subject/guardian decision|1|||
28131173|NCT03320941|54794520|FG004|Overall Study|subject/guardian decision|0|||
28131174|NCT03005288|54794534|FG000|Overall Study|Withdrawal by Subject|7|||
28131175|NCT03005288|54794535|FG001|Overall Study|Withdrawal by Subject|5|||
28131176|NCT03005288|54794534|FG000|Overall Study|Lost to Follow-up|0|||
28131177|NCT03005288|54794535|FG001|Overall Study|Lost to Follow-up|1|||
28131178|NCT03005288|54794534|FG000|Overall Study|Adverse Event|5|||
28131179|NCT03005288|54794535|FG001|Overall Study|Adverse Event|0|||
28131180|NCT03005288|54794534|FG000|Overall Study|Protocol deviation|0|||
28131181|NCT03005288|54794535|FG001|Overall Study|Protocol deviation|1|||
28131182|NCT03005288|54794534|FG000|Overall Study|Physician Decision|0|||
28131183|NCT03005288|54794535|FG001|Overall Study|Physician Decision|1|||
28131184|NCT03003494|54794541|FG000|Overall Study|Evaluable PF10 questionnaire at visit1|28|||
28131185|NCT03559699|54794545|FG000|Overall Study|Withdrawal by Subject|6|||
28131186|NCT03559699|54794545|FG000|Overall Study|Lost to Follow-up|1|||
27818824|NCT01756898|54277436|FG001|Overall Study|Protocol Violation|2|||
28068169|NCT00458705|54723336|FG000|Overall Study|Not Treated|1|||
28068170|NCT00062374|54723340|FG000|Overall Study|Not treated|12|||
28068171|NCT00285818|54723346|FG000|Overall Study|Withdrawal by Subject|3|||
28068172|NCT00285818|54723347|FG001|Overall Study|Withdrawal by Subject|2|||
28068173|NCT00285818|54723346|FG000|Overall Study|Lost to Follow-up|1|||
28068174|NCT00285818|54723347|FG001|Overall Study|Lost to Follow-up|0|||
28068175|NCT00285584|54723355|FG000|Month 3|Lost to Follow-up|3|||
28068176|NCT00285584|54723356|FG001|Month 3|Lost to Follow-up|3|||
28068177|NCT00285584|54723355|FG000|Month 3|Withdrawal by Subject|1|||
28068178|NCT00285584|54723356|FG001|Month 3|Withdrawal by Subject|0|||
28068179|NCT00285584|54723355|FG000|Month 6|Lost to Follow-up|0|||
28068180|NCT00285584|54723356|FG001|Month 6|Lost to Follow-up|1|||
28068181|NCT03807700|54723368|FG000|Overall Study|Withdrawal by Subject|2|||
28068182|NCT03807700|54723369|FG001|Overall Study|Withdrawal by Subject|1|||
28068183|NCT00291668|54723379|FG000|Overall Study|Lack of Efficacy|1|||
28068184|NCT00291668|54723380|FG001|Overall Study|Lack of Efficacy|0|||
28068185|NCT00291668|54723381|FG002|Overall Study|Lack of Efficacy|0|||
28068186|NCT00291668|54723379|FG000|Overall Study|SAE, non-fatal|1|||
28068187|NCT00291668|54723380|FG001|Overall Study|SAE, non-fatal|1|||
28068188|NCT00291668|54723381|FG002|Overall Study|SAE, non-fatal|1|||
28131187|NCT03085758|54794552|FG000|Overall Study|Death|26|||
28131188|NCT03085758|54794553|FG001|Overall Study|Death|24|||
28131189|NCT03085758|54794554|FG002|Overall Study|Death|53|||
28131190|NCT03085758|54794552|FG000|Overall Study|Lost to Follow-up|1|||
28131191|NCT03085758|54794553|FG001|Overall Study|Lost to Follow-up|1|||
27818825|NCT01756898|54277437|FG002|Overall Study|Protocol Violation|2|||
27818826|NCT01756898|54277438|FG003|Overall Study|Protocol Violation|1|||
28068189|NCT00291668|54723379|FG000|Overall Study|AE, non-serious non-fatal|1|||
28131192|NCT03085758|54794554|FG002|Overall Study|Lost to Follow-up|1|||
28068190|NCT00291668|54723380|FG001|Overall Study|AE, non-serious non-fatal|0|||
28131193|NCT03085758|54794552|FG000|Overall Study|Withdrawal by Subject|2|||
28131194|NCT03085758|54794553|FG001|Overall Study|Withdrawal by Subject|2|||
28131195|NCT03085758|54794554|FG002|Overall Study|Withdrawal by Subject|1|||
28131196|NCT03085758|54794552|FG000|Overall Study|Refusal to recall it up to day 90|0|||
28131197|NCT03085758|54794553|FG001|Overall Study|Refusal to recall it up to day 90|0|||
28131198|NCT03085758|54794554|FG002|Overall Study|Refusal to recall it up to day 90|1|||
28131199|NCT03085758|54794552|FG000|Overall Study|Pt seen by doctor in digestive surgery|0|||
28131200|NCT03085758|54794553|FG001|Overall Study|Pt seen by doctor in digestive surgery|1|||
27818827|NCT01756898|54277435|FG000|Overall Study|Withdrew Consent|5|||
27818828|NCT01756898|54277436|FG001|Overall Study|Withdrew Consent|3|||
27818829|NCT01756898|54277437|FG002|Overall Study|Withdrew Consent|5|||
27818830|NCT01756898|54277438|FG003|Overall Study|Withdrew Consent|6|||
27818831|NCT01756898|54277435|FG000|Overall Study|Other|0|||
27818832|NCT01756898|54277436|FG001|Overall Study|Other|2|||
27818833|NCT01756898|54277437|FG002|Overall Study|Other|2|||
27818834|NCT01756898|54277438|FG003|Overall Study|Other|0|||
27818835|NCT01731938|54277455|FG000|Preliminary Part I|Withdrawal by Subject|2|||
27818836|NCT01731938|54277456|FG001|Preliminary Part I|Withdrawal by Subject|2|||
27818837|NCT01731938|54277455|FG000|Preliminary Part I|Physician Decision|1|||
27818838|NCT01731938|54277456|FG001|Preliminary Part I|Physician Decision|0|||
27818839|NCT01731938|54277455|FG000|Preliminary Part I|Lost to Follow-up|0|||
27818840|NCT01731938|54277456|FG001|Preliminary Part I|Lost to Follow-up|3|||
27818841|NCT01731938|54277455|FG000|Preliminary Part I|Missed Week 6 visit|0|||
28131201|NCT03085758|54794554|FG002|Overall Study|Pt seen by doctor in digestive surgery|0|||
28131202|NCT03935880|54794578|FG000|Overall Study|Lost to Follow-up|0|||
28131203|NCT03935880|54794579|FG001|Overall Study|Lost to Follow-up|1|||
27818842|NCT01731938|54277456|FG001|Preliminary Part I|Missed Week 6 visit|3|||
27818843|NCT01731938|54277455|FG000|Primary Part II|Withdrawal by Subject|5|||
27818844|NCT01731938|54277456|FG001|Primary Part II|Withdrawal by Subject|4|||
28068191|NCT00291668|54723381|FG002|Overall Study|AE, non-serious non-fatal|0|||
28068192|NCT00291668|54723379|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
28068193|NCT00291668|54723380|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
28068194|NCT00291668|54723381|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
28068195|NCT00458393|54723391|FG000|Overall Study|Withdrawal by Subject|67|||
28068196|NCT00458393|54723392|FG001|Overall Study|Withdrawal by Subject|80|||
28068197|NCT00458393|54723391|FG000|Overall Study|Physician Decision|31|||
28068198|NCT00458393|54723392|FG001|Overall Study|Physician Decision|22|||
28068199|NCT00458393|54723391|FG000|Overall Study|Relocated|77|||
28068200|NCT00458393|54723392|FG001|Overall Study|Relocated|81|||
28068201|NCT00458393|54723391|FG000|Overall Study|Lost to Follow-up|115|||
28068202|NCT00458393|54723392|FG001|Overall Study|Lost to Follow-up|92|||
28068203|NCT00458393|54723391|FG000|Overall Study|Sites marked other on the form.|19|||
28068204|NCT00458393|54723392|FG001|Overall Study|Sites marked other on the form.|20|||
28068205|NCT00310856|54723403|FG000|Overall Study|Withdrawal by Subject|2|||
28068206|NCT00310856|54723404|FG001|Overall Study|Withdrawal by Subject|2|||
28068207|NCT00310856|54723405|FG002|Overall Study|Withdrawal by Subject|2|||
28068208|NCT00310856|54723403|FG000|Overall Study|Lost to Follow-up|1|||
28068209|NCT00310856|54723404|FG001|Overall Study|Lost to Follow-up|2|||
28068210|NCT00310856|54723405|FG002|Overall Study|Lost to Follow-up|6|||
28068211|NCT00310856|54723403|FG000|Overall Study|Inappropriate enrollment|1|||
28068212|NCT00310856|54723404|FG001|Overall Study|Inappropriate enrollment|1|||
28068213|NCT00310856|54723405|FG002|Overall Study|Inappropriate enrollment|0|||
28068214|NCT00310856|54723403|FG000|Overall Study|Unable to classify|1|||
28068215|NCT00310856|54723404|FG001|Overall Study|Unable to classify|0|||
28068216|NCT00310856|54723405|FG002|Overall Study|Unable to classify|0|||
28068217|NCT00283712|54723416|FG000|Overall Study|Death|0|||
28068218|NCT00283712|54723417|FG001|Overall Study|Death|1|||
28068219|NCT00048724|54723425|FG000|Overall Study|Adverse Event|53|||
28068220|NCT00048724|54723426|FG001|Overall Study|Adverse Event|12|||
28068221|NCT00048724|54723425|FG000|Overall Study|Withdrawal by Subject|34|||
28068222|NCT00048724|54723426|FG001|Overall Study|Withdrawal by Subject|54|||
28068223|NCT00048724|54723425|FG000|Overall Study|Lost to Follow-up|5|||
28068224|NCT00048724|54723426|FG001|Overall Study|Lost to Follow-up|5|||
27818845|NCT01731938|54277455|FG000|Primary Part II|Lost to Follow-up|4|||
27940553|NCT01022853|54596834|FG004|Overall Study|Other not stated above|0|||
28068225|NCT00048724|54723425|FG000|Overall Study|Protocol-defined Clinical Event|17|||
27940554|NCT01034709|54596851|FG000|Overall Study|Protocol Violation|9|||
28068226|NCT00048724|54723426|FG001|Overall Study|Protocol-defined Clinical Event|32|||
28068227|NCT00048724|54723425|FG000|Overall Study|Noncompliance With Protocol|4|||
28068228|NCT00048724|54723426|FG001|Overall Study|Noncompliance With Protocol|12|||
28131204|NCT03315793|54794587|FG000|Overall Study|Adverse Event|4|||
28131205|NCT03315793|54794588|FG001|Overall Study|Adverse Event|2|||
28131206|NCT03315793|54794587|FG000|Overall Study|Protocol Deviation|1|||
27818846|NCT01731938|54277456|FG001|Primary Part II|Lost to Follow-up|5|||
27818847|NCT01731938|54277455|FG000|Primary Part II|Death|2|||
28131207|NCT03315793|54794588|FG001|Overall Study|Protocol Deviation|0|||
28131208|NCT03315793|54794587|FG000|Overall Study|Difficult for regular visit|0|||
28131209|NCT03315793|54794588|FG001|Overall Study|Difficult for regular visit|1|||
28131210|NCT02676466|54794604|FG000|Overall Study|Death|0|||
27940555|NCT01034709|54596852|FG001|Overall Study|Protocol Violation|16|||
27940556|NCT00937768|54596860|FG000|Overall Study|Refused Further Treatment|3|||
28131211|NCT02676466|54794605|FG001|Overall Study|Death|2|||
28131212|NCT02676466|54794606|FG002|Overall Study|Death|1|||
28131213|NCT02676466|54794607|FG003|Overall Study|Death|0|||
28131214|NCT02676466|54794608|FG004|Overall Study|Death|0|||
28131215|NCT02676466|54794609|FG005|Overall Study|Death|0|||
28131216|NCT02676466|54794610|FG006|Overall Study|Death|0|||
28131217|NCT02676466|54794611|FG007|Overall Study|Death|0|||
28131218|NCT02676466|54794604|FG000|Overall Study|Withdrawal by Subject|4|||
28131219|NCT02676466|54794605|FG001|Overall Study|Withdrawal by Subject|3|||
28131220|NCT02676466|54794606|FG002|Overall Study|Withdrawal by Subject|1|||
28131221|NCT02676466|54794607|FG003|Overall Study|Withdrawal by Subject|0|||
28131222|NCT02676466|54794608|FG004|Overall Study|Withdrawal by Subject|3|||
28131223|NCT02676466|54794609|FG005|Overall Study|Withdrawal by Subject|1|||
28131224|NCT02676466|54794610|FG006|Overall Study|Withdrawal by Subject|1|||
28131225|NCT02676466|54794611|FG007|Overall Study|Withdrawal by Subject|1|||
28131226|NCT03314857|54794633|FG000|Overall Study|Death|4|||
28131227|NCT03314857|54794633|FG000|Overall Study|Physician Decision|1|||
28131228|NCT03633695|54794639|FG000|Overall Study|Lost to Follow-up|4|||
28131229|NCT03633695|54794640|FG001|Overall Study|Lost to Follow-up|5|||
28131230|NCT03633695|54794639|FG000|Overall Study|Discontinued|8|||
28131231|NCT03633695|54794640|FG001|Overall Study|Discontinued|4|||
28131232|NCT03314233|54794662|FG000|Overall Study|No longer eligible at time of delivery|1|||
28131233|NCT02675998|54794670|FG000|8-Week Treatment Period|Adverse Event|6|||
28131234|NCT02675998|54794671|FG001|8-Week Treatment Period|Adverse Event|5|||
28131235|NCT02675998|54794672|FG002|8-Week Treatment Period|Adverse Event|6|||
28131236|NCT02675998|54794673|FG003|8-Week Treatment Period|Adverse Event|0|||
28131237|NCT02675998|54794670|FG000|8-Week Treatment Period|Withdrawal by Subject|3|||
28131238|NCT02675998|54794671|FG001|8-Week Treatment Period|Withdrawal by Subject|3|||
28131239|NCT02675998|54794672|FG002|8-Week Treatment Period|Withdrawal by Subject|3|||
28131240|NCT02675998|54794673|FG003|8-Week Treatment Period|Withdrawal by Subject|0|||
28131241|NCT02675998|54794670|FG000|8-Week Treatment Period|Lack of Efficacy|2|||
28131242|NCT02675998|54794671|FG001|8-Week Treatment Period|Lack of Efficacy|5|||
28131243|NCT02675998|54794672|FG002|8-Week Treatment Period|Lack of Efficacy|3|||
28131244|NCT02675998|54794673|FG003|8-Week Treatment Period|Lack of Efficacy|0|||
28131245|NCT02675998|54794670|FG000|8-Week Treatment Period|Physician Decision|1|||
28131246|NCT02675998|54794671|FG001|8-Week Treatment Period|Physician Decision|0|||
28131247|NCT02675998|54794672|FG002|8-Week Treatment Period|Physician Decision|2|||
28131248|NCT02675998|54794673|FG003|8-Week Treatment Period|Physician Decision|0|||
28131249|NCT02675998|54794670|FG000|8-Week Treatment Period|GI side Effects|1|||
28131250|NCT02675998|54794671|FG001|8-Week Treatment Period|GI side Effects|4|||
28131251|NCT02675998|54794672|FG002|8-Week Treatment Period|GI side Effects|2|||
28131252|NCT02675998|54794673|FG003|8-Week Treatment Period|GI side Effects|0|||
28131253|NCT02675998|54794670|FG000|8-Week Treatment Period|Protocol Violation|1|||
28131254|NCT02675998|54794671|FG001|8-Week Treatment Period|Protocol Violation|1|||
28131255|NCT02675998|54794672|FG002|8-Week Treatment Period|Protocol Violation|1|||
28131256|NCT02675998|54794673|FG003|8-Week Treatment Period|Protocol Violation|0|||
28131257|NCT02675998|54794670|FG000|8-Week Treatment Period|Other|3|||
28131258|NCT02675998|54794671|FG001|8-Week Treatment Period|Other|1|||
27940557|NCT00937768|54596861|FG001|Overall Study|Refused Further Treatment|2|||
27940558|NCT00937768|54596860|FG000|Overall Study|Disease Progression|1|||
28131259|NCT02675998|54794672|FG002|8-Week Treatment Period|Other|2|||
28131260|NCT02675998|54794673|FG003|8-Week Treatment Period|Other|0|||
28131261|NCT02675998|54794670|FG000|4-Week Randomized Withdrawal Period|Lack of Efficacy|0|||
28131262|NCT02675998|54794671|FG001|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
28131263|NCT02675998|54794672|FG002|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
28131264|NCT02675998|54794673|FG003|4-Week Randomized Withdrawal Period|Lack of Efficacy|3|||
28131265|NCT02675998|54794670|FG000|4-Week Randomized Withdrawal Period|Adverse Event|0|||
28131266|NCT02675998|54794671|FG001|4-Week Randomized Withdrawal Period|Adverse Event|0|||
28131267|NCT02675998|54794672|FG002|4-Week Randomized Withdrawal Period|Adverse Event|1|||
28131268|NCT02675998|54794673|FG003|4-Week Randomized Withdrawal Period|Adverse Event|3|||
28131269|NCT02675998|54794670|FG000|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
28131270|NCT02675998|54794671|FG001|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
28131271|NCT02675998|54794672|FG002|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
28131272|NCT02675998|54794673|FG003|4-Week Randomized Withdrawal Period|Protocol Violation|1|||
28131273|NCT02675998|54794670|FG000|4-Week Randomized Withdrawal Period|Physician Decision|1|||
28131274|NCT02675998|54794671|FG001|4-Week Randomized Withdrawal Period|Physician Decision|0|||
28131275|NCT02675998|54794672|FG002|4-Week Randomized Withdrawal Period|Physician Decision|0|||
27940559|NCT00937768|54596861|FG001|Overall Study|Disease Progression|1|||
27940560|NCT00937768|54596860|FG000|Overall Study|Alternate Treatment|0|||
28131276|NCT02675998|54794673|FG003|4-Week Randomized Withdrawal Period|Physician Decision|0|||
28131277|NCT02675998|54794670|FG000|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
28131278|NCT02675998|54794671|FG001|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
28131279|NCT02675998|54794672|FG002|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
28131280|NCT02675998|54794673|FG003|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1|||
28131281|NCT02674204|54794689|FG000|Overall Study|Adverse Event|1|||
28131282|NCT02674204|54794690|FG001|Overall Study|Adverse Event|0|||
28131283|NCT02941627|54794696|FG000|Overall Study|Death|1|||
28131284|NCT02941627|54794696|FG000|Overall Study|Surgical failure|1|||
28131285|NCT02941627|54794696|FG000|Overall Study|cholesteatoma prevented implantation|1|||
27940561|NCT00937768|54596861|FG001|Overall Study|Alternate Treatment|1|||
27940562|NCT00937768|54596860|FG000|Overall Study|No Further Funding|4|||
27940563|NCT00937768|54596861|FG001|Overall Study|No Further Funding|4|||
27940564|NCT00940888|54596867|FG000|Overall Study|Unsuccessful Implant|4|||
27940565|NCT00940888|54596867|FG000|Overall Study|Death|461|||
27940566|NCT00940888|54596867|FG000|Overall Study|Withdrawn - Non-Death|364|||
27940567|NCT00940888|54596867|FG000|Overall Study|Lost to Follow-up|6|||
27940568|NCT01189266|54596874|FG000|Overall Study|Adverse Event|1|||
27940569|NCT01189266|54596875|FG001|Overall Study|Adverse Event|0|||
27940570|NCT01189266|54596876|FG002|Overall Study|Adverse Event|5|||
27940571|NCT01189266|54596874|FG000|Overall Study|Death|0|||
27940572|NCT01189266|54596875|FG001|Overall Study|Death|0|||
27940573|NCT01189266|54596876|FG002|Overall Study|Death|5|||
27940574|NCT01189266|54596874|FG000|Overall Study|Lack of Efficacy|4|||
27940575|NCT01189266|54596875|FG001|Overall Study|Lack of Efficacy|5|||
27940576|NCT01189266|54596876|FG002|Overall Study|Lack of Efficacy|44|||
27940577|NCT01189266|54596874|FG000|Overall Study|Physician Decision|0|||
27940578|NCT01189266|54596875|FG001|Overall Study|Physician Decision|0|||
27849455|NCT00089999|54345830|FG000|Overall Study|Poor General Condition|1|||
28131286|NCT03521934|54794708|FG000|Overall Study|Death|65|||
28131287|NCT03521934|54794709|FG001|Overall Study|Death|73|||
28131288|NCT03521934|54794708|FG000|Overall Study|Withdrawal by Subject|18|||
28131289|NCT03521934|54794709|FG001|Overall Study|Withdrawal by Subject|23|||
28131290|NCT03521934|54794708|FG000|Overall Study|Site Terminated by Sponsor|39|||
28131291|NCT03521934|54794709|FG001|Overall Study|Site Terminated by Sponsor|35|||
28131292|NCT03521934|54794708|FG000|Overall Study|Study Terminated by Sponsor|483|||
28131293|NCT03521934|54794709|FG001|Overall Study|Study Terminated by Sponsor|477|||
28131294|NCT03521934|54794708|FG000|Overall Study|Reason not Specified|3|||
28131295|NCT03521934|54794709|FG001|Overall Study|Reason not Specified|6|||
28131296|NCT03434353|54794720|FG000|Overall Study|Started commercial Hepatitis B virus therapy|10|||
28131297|NCT03434353|54794721|FG001|Overall Study|Started commercial Hepatitis B virus therapy|3|||
28131298|NCT03434353|54794722|FG002|Overall Study|Started commercial Hepatitis B virus therapy|11|||
28131299|NCT03434353|54794723|FG003|Overall Study|Started commercial Hepatitis B virus therapy|3|||
28131300|NCT03434353|54794724|FG004|Overall Study|Started commercial Hepatitis B virus therapy|17|||
28131301|NCT03434353|54794720|FG000|Overall Study|Withdrew consent|1|||
28131302|NCT03434353|54794721|FG001|Overall Study|Withdrew consent|0|||
28131303|NCT03434353|54794722|FG002|Overall Study|Withdrew consent|3|||
28131304|NCT03434353|54794723|FG003|Overall Study|Withdrew consent|0|||
27940579|NCT01189266|54596876|FG002|Overall Study|Physician Decision|1|||
27940580|NCT01189266|54596874|FG000|Overall Study|Protocol Violation|0|||
27940581|NCT01189266|54596875|FG001|Overall Study|Protocol Violation|1|||
27940582|NCT01189266|54596876|FG002|Overall Study|Protocol Violation|1|||
27940583|NCT01189266|54596874|FG000|Overall Study|Withdrawal by Subject|0|||
27940584|NCT01189266|54596875|FG001|Overall Study|Withdrawal by Subject|0|||
27940585|NCT01189266|54596876|FG002|Overall Study|Withdrawal by Subject|1|||
27849456|NCT00089999|54345831|FG001|Overall Study|Poor General Condition|0|||
28131305|NCT03434353|54794724|FG004|Overall Study|Withdrew consent|0|||
28131306|NCT03434353|54794720|FG000|Overall Study|Adverse Event|1|||
28131307|NCT03434353|54794721|FG001|Overall Study|Adverse Event|0|||
27940586|NCT01189266|54596874|FG000|Overall Study|Patient refuses further therapy|1|||
27940587|NCT01189266|54596875|FG001|Overall Study|Patient refuses further therapy|0|||
27940588|NCT01189266|54596876|FG002|Overall Study|Patient refuses further therapy|7|||
28068229|NCT00048724|54723425|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
28068230|NCT00048724|54723426|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
28068231|NCT00048724|54723425|FG000|Overall Study|Administrative|1|||
28068232|NCT00048724|54723426|FG001|Overall Study|Administrative|1|||
28068233|NCT00449033|54723434|FG000|Treatment Period|Adverse Event|117|||
28068234|NCT00449033|54723435|FG001|Treatment Period|Adverse Event|83|||
28068235|NCT00449033|54723434|FG000|Treatment Period|Death|21|||
28068236|NCT00449033|54723435|FG001|Treatment Period|Death|12|||
28131308|NCT03434353|54794722|FG002|Overall Study|Adverse Event|0|||
28131309|NCT03434353|54794723|FG003|Overall Study|Adverse Event|0|||
28131310|NCT03434353|54794724|FG004|Overall Study|Adverse Event|1|||
28131311|NCT03434353|54794720|FG000|Overall Study|Lost to Follow-up|2|||
28131312|NCT03434353|54794721|FG001|Overall Study|Lost to Follow-up|0|||
28131313|NCT03434353|54794722|FG002|Overall Study|Lost to Follow-up|0|||
28131314|NCT03434353|54794723|FG003|Overall Study|Lost to Follow-up|0|||
28131315|NCT03434353|54794724|FG004|Overall Study|Lost to Follow-up|0|||
28131316|NCT02914184|54794740|FG000|Overall Study|Lost to Follow-up|7|||
28131317|NCT02914184|54794741|FG001|Overall Study|Lost to Follow-up|10|||
28131318|NCT02914184|54794742|FG002|Overall Study|Lost to Follow-up|8|||
27940589|NCT01189266|54596874|FG000|Overall Study|No treatment|0|||
28068237|NCT00449033|54723434|FG000|Treatment Period|Lost to Follow-up|0|||
28131319|NCT02914184|54794743|FG003|Overall Study|Lost to Follow-up|7|||
28131320|NCT02914184|54794740|FG000|Overall Study|Withdrawal by Subject|4|||
28131321|NCT02914184|54794741|FG001|Overall Study|Withdrawal by Subject|2|||
28131322|NCT02914184|54794742|FG002|Overall Study|Withdrawal by Subject|7|||
28131323|NCT02914184|54794743|FG003|Overall Study|Withdrawal by Subject|3|||
28131324|NCT02914184|54794740|FG000|Overall Study|Other|1|||
28131325|NCT02914184|54794741|FG001|Overall Study|Other|0|||
28131326|NCT02914184|54794742|FG002|Overall Study|Other|0|||
28131327|NCT02914184|54794743|FG003|Overall Study|Other|0|||
28131328|NCT02914184|54794740|FG000|Overall Study|Migrated/moved from the study area|2|||
28131329|NCT02914184|54794741|FG001|Overall Study|Migrated/moved from the study area|1|||
27849457|NCT00089999|54345830|FG000|Overall Study|Clinical Progression|1|||
27849458|NCT00089999|54345831|FG001|Overall Study|Clinical Progression|2|||
27849459|NCT00089999|54345830|FG000|Overall Study|Physician Decision|2|||
27849460|NCT00089999|54345831|FG001|Overall Study|Physician Decision|2|||
27849461|NCT00089999|54345830|FG000|Overall Study|Patient Underwent Surgery|2|||
27849462|NCT00089999|54345831|FG001|Overall Study|Patient Underwent Surgery|0|||
27849463|NCT00089999|54345830|FG000|Overall Study|Skin Nodule Over Right Mastectomy|0|||
27849464|NCT00089999|54345831|FG001|Overall Study|Skin Nodule Over Right Mastectomy|1|||
27849465|NCT00089843|54345842|FG000|Overall Study|Withdrawal by Subject|1|||
28068238|NCT00449033|54723435|FG001|Treatment Period|Lost to Follow-up|2|||
28068239|NCT00449033|54723434|FG000|Treatment Period|Physician Decision|4|||
28068240|NCT00449033|54723435|FG001|Treatment Period|Physician Decision|5|||
28068241|NCT00449033|54723434|FG000|Treatment Period|Protocol Violation|8|||
28068242|NCT00449033|54723435|FG001|Treatment Period|Protocol Violation|7|||
28068243|NCT00449033|54723434|FG000|Treatment Period|Disease Progression|231|||
28068244|NCT00449033|54723435|FG001|Treatment Period|Disease Progression|288|||
28068245|NCT00449033|54723434|FG000|Treatment Period|Consent Withdrawn|36|||
28068246|NCT00449033|54723435|FG001|Treatment Period|Consent Withdrawn|20|||
28068247|NCT00449033|54723434|FG000|Treatment Period|Amended Protocol Criteria|22|||
28068248|NCT00449033|54723435|FG001|Treatment Period|Amended Protocol Criteria|18|||
28068249|NCT00449033|54723434|FG000|Treatment Period|Non-compliance|7|||
28068250|NCT00449033|54723435|FG001|Treatment Period|Non-compliance|8|||
28068251|NCT00449033|54723434|FG000|Treatment Period|Second Malignancy|0|||
28068252|NCT00449033|54723435|FG001|Treatment Period|Second Malignancy|1|||
28068253|NCT00449033|54723434|FG000|Treatment Period|Reason Missing|0|||
28068254|NCT00449033|54723435|FG001|Treatment Period|Reason Missing|4|||
28068255|NCT00449033|54723434|FG000|Treatment Period|Treatment Ongoing|6|||
28068256|NCT00449033|54723435|FG001|Treatment Period|Treatment Ongoing|4|||
28068257|NCT00449033|54723434|FG000|Follow-up Period|Death|299|||
28068258|NCT00449033|54723435|FG001|Follow-up Period|Death|311|||
28068259|NCT00449033|54723434|FG000|Follow-up Period|Lost to Follow-up|6|||
28068260|NCT00449033|54723435|FG001|Follow-up Period|Lost to Follow-up|10|||
28068261|NCT00449033|54723434|FG000|Follow-up Period|Reason Missing|120|||
28068262|NCT00449033|54723435|FG001|Follow-up Period|Reason Missing|113|||
28068263|NCT00448019|54723441|FG000|Overall Study|Withdrawal by Subject|3|||
28068264|NCT00448019|54723441|FG000|Overall Study|Disease progression|1|||
28068265|NCT00448019|54723441|FG000|Overall Study|Death|2|||
28068266|NCT00448019|54723441|FG000|Overall Study|Insurance Issues|1|||
28068267|NCT00457691|54723447|FG000|Overall Study|Adverse Event|4|||
28068268|NCT00457691|54723448|FG001|Overall Study|Adverse Event|1|||
28068269|NCT00457691|54723447|FG000|Overall Study|Death|163|||
28068270|NCT00457691|54723448|FG001|Overall Study|Death|148|||
28068271|NCT00457691|54723447|FG000|Overall Study|Protocol Violation|1|||
28068272|NCT00457691|54723448|FG001|Overall Study|Protocol Violation|3|||
28068273|NCT00457691|54723447|FG000|Overall Study|Lost to Follow-up|23|||
28068274|NCT00457691|54723448|FG001|Overall Study|Lost to Follow-up|14|||
28068275|NCT00457691|54723447|FG000|Overall Study|Study terminated by Sponsor|1|||
28068276|NCT00457691|54723448|FG001|Overall Study|Study terminated by Sponsor|1|||
28068277|NCT00457691|54723447|FG000|Overall Study|Subject refused (reason other than AE)|14|||
28068278|NCT00457691|54723448|FG001|Overall Study|Subject refused (reason other than AE)|19|||
28068279|NCT00457691|54723447|FG000|Overall Study|Disease progression, study terminated|180|||
28068280|NCT00457691|54723448|FG001|Overall Study|Disease progression, study terminated|196|||
28068281|NCT00457301|54723456|FG000|Overall Study|Withdrawal by Subject|3|||
28068282|NCT00457301|54723457|FG001|Overall Study|Withdrawal by Subject|3|||
28068283|NCT00457301|54723456|FG000|Overall Study|Censored out of the study|15|||
28068284|NCT00457301|54723457|FG001|Overall Study|Censored out of the study|14|||
28068285|NCT00457301|54723456|FG000|Overall Study|Death|5|||
27849466|NCT00089843|54345843|FG001|Overall Study|Withdrawal by Subject|4|||
27849467|NCT00089843|54345844|FG002|Overall Study|Withdrawal by Subject|5|||
28068286|NCT00457301|54723457|FG001|Overall Study|Death|7|||
28068287|NCT00456755|54723465|FG000|Overall Study|Lost to Follow-up|2|||
28068288|NCT00456755|54723466|FG001|Overall Study|Lost to Follow-up|1|||
28068289|NCT00447005|54723472|FG000|Overall Study|Adverse Event|1|||
28068290|NCT00447005|54723472|FG000|Overall Study|Lack of Efficacy|11|||
28068291|NCT00446849|54723476|FG000|Acute Phase|Lack of Efficacy|64|||
28068292|NCT00446849|54723476|FG000|Acute Phase|Protocol Violation|10|||
28068293|NCT00446849|54723476|FG000|Acute Phase|Consent withdrawn|4|||
28131330|NCT02914184|54794742|FG002|Overall Study|Migrated/moved from the study area|2|||
27849468|NCT00089843|54345845|FG003|Overall Study|Withdrawal by Subject|6|||
27940590|NCT01189266|54596875|FG001|Overall Study|No treatment|0|||
27940591|NCT01189266|54596876|FG002|Overall Study|No treatment|1|||
27940592|NCT01189032|54596888|FG000|Overall Study|Adverse Event|1|||
27849469|NCT00089843|54345842|FG000|Overall Study|Physician Decision|1|||
27849470|NCT00089843|54345843|FG001|Overall Study|Physician Decision|0|||
27849471|NCT00089843|54345844|FG002|Overall Study|Physician Decision|0|||
27849472|NCT00089843|54345845|FG003|Overall Study|Physician Decision|1|||
27849473|NCT00089297|54345855|FG000|Overall Study|Adverse Event|9|||
27849474|NCT00089297|54345855|FG000|Overall Study|Death|1|||
27849475|NCT00089297|54345855|FG000|Overall Study|Withdrawal by Subject|12|||
27849476|NCT00089297|54345855|FG000|Overall Study|Disease progression|2|||
27849477|NCT00089297|54345855|FG000|Overall Study|Ineligible|11|||
27849478|NCT00089297|54345855|FG000|Overall Study|Secondary malignancy|1|||
27849479|NCT00089297|54345855|FG000|Overall Study|IRB approval not ready|1|||
27849480|NCT00089297|54345855|FG000|Overall Study|Non-compliance|1|||
27849481|NCT00088907|54345897|FG000|Randomized Study (Step 1)|Lack of Efficacy|55|||
27849482|NCT00088907|54345898|FG001|Randomized Study (Step 1)|Lack of Efficacy|62|||
27849483|NCT00088907|54345897|FG000|Randomized Study (Step 1)|Adverse Event|14|||
27849484|NCT00088907|54345898|FG001|Randomized Study (Step 1)|Adverse Event|19|||
27849485|NCT00088907|54345897|FG000|Randomized Study (Step 1)|Death|11|||
27849486|NCT00088907|54345898|FG001|Randomized Study (Step 1)|Death|12|||
27849487|NCT00088907|54345897|FG000|Randomized Study (Step 1)|Withdrawal by Subject|10|||
27849488|NCT00088907|54345898|FG001|Randomized Study (Step 1)|Withdrawal by Subject|15|||
27849489|NCT00088907|54345897|FG000|Randomized Study (Step 1)|complicating disease|3|||
27849490|NCT00088907|54345898|FG001|Randomized Study (Step 1)|complicating disease|1|||
27849491|NCT00088907|54345897|FG000|Randomized Study (Step 1)|unknown/not specify|24|||
27849492|NCT00088907|54345898|FG001|Randomized Study (Step 1)|unknown/not specify|13|||
27849493|NCT00088907|54345897|FG000|Randomized Study (Step 1)|ineligible or not start protocol therapy|19|||
27849494|NCT00088907|54345898|FG001|Randomized Study (Step 1)|ineligible or not start protocol therapy|12|||
27849495|NCT00088907|54345897|FG000|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16|||
27849496|NCT00088907|54345898|FG001|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0|||
27849497|NCT00088907|54345897|FG000|Single Gefitinib Treatment (Step 2)|Death|1|||
27849498|NCT00088907|54345898|FG001|Single Gefitinib Treatment (Step 2)|Death|0|||
27849499|NCT00088907|54345897|FG000|Single Gefitinib Treatment (Step 2)|unknown/not specify|2|||
27849500|NCT00088907|54345898|FG001|Single Gefitinib Treatment (Step 2)|unknown/not specify|0|||
27849501|NCT00088907|54345897|FG000|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5|||
27849502|NCT00088907|54345898|FG001|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0|||
27849503|NCT00088829|54345905|FG000|Overall Study|PI left institution and study was close|22|||
27849504|NCT00088595|54345909|FG000|Overall Study|Adverse Event|11|||
27849505|NCT00088595|54345909|FG000|Overall Study|Withdrawal by Subject|8|||
27849506|NCT00088595|54345909|FG000|Overall Study|Ongoing (After Core)|7|||
27849507|NCT00088595|54345909|FG000|Overall Study|New Cancer Therapy|2|||
27849508|NCT00088205|54345923|FG000|Overall Study|Adverse Event|4|||
27849509|NCT00088205|54345923|FG000|Overall Study|Progressive Disease|51|||
27849510|NCT00088205|54345923|FG000|Overall Study|Physician Decision|1|||
27849511|NCT00088205|54345923|FG000|Overall Study|Death Due to Study Disease|4|||
27849512|NCT00085709|54346017|FG000|Overall Study|Adverse Event|8|||
27849513|NCT00085709|54346018|FG001|Overall Study|Adverse Event|0|||
27849514|NCT00085709|54346017|FG000|Overall Study|Death|8|||
27849515|NCT00085709|54346018|FG001|Overall Study|Death|2|||
27849516|NCT00085709|54346017|FG000|Overall Study|Refusal unrelated to adverse events|1|||
27849517|NCT00085709|54346018|FG001|Overall Study|Refusal unrelated to adverse events|2|||
27849518|NCT00085709|54346017|FG000|Overall Study|Progression|3|||
27849519|NCT00085709|54346018|FG001|Overall Study|Progression|4|||
27849520|NCT00085709|54346017|FG000|Overall Study|Not protocol specified|12|||
27849521|NCT00085709|54346018|FG001|Overall Study|Not protocol specified|22|||
27849522|NCT00085709|54346017|FG000|Overall Study|Not eligible|19|||
27849523|NCT00085709|54346018|FG001|Overall Study|Not eligible|19|||
27849524|NCT00085709|54346017|FG000|Overall Study|Withdrawal by Subject|2|||
27849525|NCT00085709|54346018|FG001|Overall Study|Withdrawal by Subject|1|||
27849526|NCT00085631|54346053|FG000|Overall Study|Missing Data|4|||
27849527|NCT00085631|54346054|FG001|Overall Study|Missing Data|11|||
27849528|NCT00085631|54346055|FG002|Overall Study|Missing Data|7|||
27849529|NCT00084929|54346071|FG000|Overall Study|ineligible - medical contraindication|1|||
27849530|NCT00084929|54346071|FG000|Overall Study|ineligible - Pre-scheduled procedure not|1|||
27849531|NCT00084929|54346071|FG000|Overall Study|Ineligible - Medical history|6|||
27849532|NCT00084929|54346071|FG000|Overall Study|Withdrawal by Subject|10|||
27849533|NCT00084929|54346071|FG000|Overall Study|Missing/incomplete CTC exam|9|||
27849534|NCT00084929|54346071|FG000|Overall Study|Missing Reference Standard (Colonoscopy)|42|||
27849535|NCT00084617|54346129|FG000|Overall Study|Withdrawal by Subject|7|||
27849536|NCT00084617|54346129|FG000|Overall Study|Lack of Efficacy|1|||
27849537|NCT00084617|54346129|FG000|Overall Study|Protocol Violation|1|||
27940593|NCT01189032|54596889|FG001|Overall Study|Adverse Event|3|||
27940594|NCT01189032|54596890|FG002|Overall Study|Adverse Event|4|||
27940595|NCT01189032|54596888|FG000|Overall Study|Lack of Efficacy|2|||
27940596|NCT01189032|54596889|FG001|Overall Study|Lack of Efficacy|3|||
28068294|NCT00446849|54723476|FG000|Acute Phase|Lost to Follow-up|2|||
27818848|NCT01731938|54277456|FG001|Primary Part II|Death|1|||
27818849|NCT01731938|54277455|FG000|Primary Part II|Missed Week 6 visit|2|||
27818850|NCT01731938|54277456|FG001|Primary Part II|Missed Week 6 visit|3|||
27818851|NCT01731470|54277463|FG000|Overall Study|Withdrawal by Subject|1|||
27818852|NCT01731470|54277463|FG000|Overall Study|Did not meet study criteria|1|||
27818853|NCT01756352|54277467|FG000|Overall Study|moved away and lost to followup|1|||
27818854|NCT01756274|54277471|FG000|Overall Study|Protocol Violation|2|||
27818855|NCT01756274|54277471|FG000|Overall Study|Laboratory error|1|||
27818856|NCT01731002|54277479|FG000|Overall Study|Adverse Event|0|||
27818857|NCT01731002|54277480|FG001|Overall Study|Adverse Event|2|||
27818858|NCT01731002|54277481|FG002|Overall Study|Adverse Event|2|||
27818859|NCT01731002|54277479|FG000|Overall Study|Non-Compliant|0|||
27818860|NCT01731002|54277480|FG001|Overall Study|Non-Compliant|1|||
27818861|NCT01731002|54277481|FG002|Overall Study|Non-Compliant|0|||
27818862|NCT01731002|54277479|FG000|Overall Study|Lost to Follow-up|1|||
27818863|NCT01731002|54277480|FG001|Overall Study|Lost to Follow-up|0|||
27818864|NCT01731002|54277481|FG002|Overall Study|Lost to Follow-up|0|||
27818865|NCT01731002|54277479|FG000|Overall Study|Test Agent Discontinuation|0|||
27818866|NCT01731002|54277480|FG001|Overall Study|Test Agent Discontinuation|1|||
27818867|NCT01731002|54277481|FG002|Overall Study|Test Agent Discontinuation|0|||
27849538|NCT00083915|54346243|FG000|Overall Study|Death|6|||
27818868|NCT01731002|54277479|FG000|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2|||
27818869|NCT01731002|54277480|FG001|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
27818870|NCT01731002|54277481|FG002|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
27818871|NCT01731002|54277479|FG000|Overall Study|Elevated IOP|1|||
27818872|NCT01731002|54277480|FG001|Overall Study|Elevated IOP|0|||
27818873|NCT01731002|54277481|FG002|Overall Study|Elevated IOP|0|||
27818874|NCT01731002|54277479|FG000|Overall Study|Inappropriate use of study medications|0|||
27818875|NCT01731002|54277480|FG001|Overall Study|Inappropriate use of study medications|0|||
27818876|NCT01731002|54277481|FG002|Overall Study|Inappropriate use of study medications|1|||
27818877|NCT01783886|54277492|FG000|Overall Study|Lost to Follow-up|0|||
27818878|NCT01783886|54277493|FG001|Overall Study|Lost to Follow-up|3|||
27818879|NCT01783886|54277494|FG002|Overall Study|Lost to Follow-up|0|||
27818880|NCT01783886|54277492|FG000|Overall Study|Protocol deviation|0|||
27818881|NCT01783886|54277493|FG001|Overall Study|Protocol deviation|0|||
27818882|NCT01783886|54277494|FG002|Overall Study|Protocol deviation|2|||
27849539|NCT00083915|54346244|FG001|Overall Study|Death|3|||
27849540|NCT00083915|54346243|FG000|Overall Study|Physician Decision|11|||
27849541|NCT00083915|54346244|FG001|Overall Study|Physician Decision|6|||
27849542|NCT00083915|54346243|FG000|Overall Study|Withdrawal by Subject|8|||
27849543|NCT00083915|54346244|FG001|Overall Study|Withdrawal by Subject|3|||
27849544|NCT00083915|54346243|FG000|Overall Study|disease progression|18|||
27849545|NCT00083915|54346244|FG001|Overall Study|disease progression|23|||
27849546|NCT00083915|54346243|FG000|Overall Study|Failure to collect|3|||
27849547|NCT00083915|54346244|FG001|Overall Study|Failure to collect|0|||
27849548|NCT00083915|54346243|FG000|Overall Study|No response|3|||
28068295|NCT00446849|54723476|FG000|Acute Phase|Physician Decision|1|||
28068296|NCT00446849|54723476|FG000|Acute Phase|noncompliance|1|||
28068297|NCT00446849|54723476|FG000|Maintenance Phase|Lack of Efficacy|40|||
28068298|NCT00446849|54723476|FG000|Maintenance Phase|Protocol Violation|7|||
28068299|NCT00446849|54723476|FG000|Maintenance Phase|Adverse Event|6|||
28068300|NCT00446849|54723476|FG000|Maintenance Phase|Consent withdrawn|5|||
28068301|NCT00446849|54723476|FG000|Maintenance Phase|Lost to Follow-up|3|||
28068302|NCT00446849|54723476|FG000|Maintenance Phase|Pregnancy|1|||
28068303|NCT00446849|54723476|FG000|Maintenance Phase|noncompliance|2|||
28068304|NCT00446849|54723476|FG000|Maintenance Phase|prohibited medication use|2|||
28068305|NCT00446849|54723476|FG000|Maintenance Phase|antibiotic use|1|||
27818883|NCT01783886|54277492|FG000|Overall Study|Withdrawal of consent by participant|1|||
27818884|NCT01783886|54277493|FG001|Overall Study|Withdrawal of consent by participant|3|||
27818885|NCT01783886|54277494|FG002|Overall Study|Withdrawal of consent by participant|4|||
27849549|NCT00083915|54346244|FG001|Overall Study|No response|1|||
27849550|NCT00083915|54346243|FG000|Overall Study|Insurance issues|1|||
27849551|NCT00083915|54346244|FG001|Overall Study|Insurance issues|1|||
27849552|NCT00632749|54347068|FG000|Overall Study|Progressive disease|3|||
27818886|NCT01783886|54277492|FG000|Overall Study|Adverse Event|4|||
27818887|NCT01783886|54277493|FG001|Overall Study|Adverse Event|5|||
27849553|NCT00632749|54347069|FG001|Overall Study|Progressive disease|2|||
27849554|NCT00632749|54347070|FG002|Overall Study|Progressive disease|2|||
28068306|NCT00446849|54723476|FG000|Maintenance Phase|study closure|1|||
27818888|NCT01783886|54277494|FG002|Overall Study|Adverse Event|4|||
28068307|NCT00446849|54723476|FG000|Maintenance Phase|hydrocodone use|1|||
28068308|NCT00446849|54723476|FG000|Maintenance Phase|concomitant medication use|1|||
28068309|NCT00446459|54723481|FG000|8 Months|Protocol Violation|12|||
28068310|NCT00446459|54723481|FG000|12 Months|Protocol Violation|4|||
28068311|NCT00446459|54723481|FG000|12 Months|14 subjects to MMF + Rituximab Study|14|||
28068312|NCT00456599|54723485|FG000|Overall Study|Non-compliance|1|||
28068313|NCT00456599|54723485|FG000|Overall Study|Withdrawal by Subject|2|||
28068314|NCT00456521|54723491|FG000|Overall Study|Adverse Event|150|||
28068315|NCT00456521|54723492|FG001|Overall Study|Adverse Event|25|||
28068316|NCT00456521|54723491|FG000|Overall Study|Withdrawal by Subject|43|||
28068317|NCT00456521|54723492|FG001|Overall Study|Withdrawal by Subject|24|||
28068318|NCT00456521|54723491|FG000|Overall Study|Lost to Follow-up|22|||
28068319|NCT00456521|54723492|FG001|Overall Study|Lost to Follow-up|17|||
28068320|NCT00456521|54723491|FG000|Overall Study|Lack of Efficacy|3|||
28068321|NCT00456521|54723492|FG001|Overall Study|Lack of Efficacy|6|||
28068322|NCT00456521|54723491|FG000|Overall Study|Protocol Violation|4|||
28068323|NCT00456521|54723492|FG001|Overall Study|Protocol Violation|0|||
28068324|NCT00456521|54723491|FG000|Overall Study|Pregnancy|1|||
28068325|NCT00456521|54723492|FG001|Overall Study|Pregnancy|1|||
28068326|NCT00456521|54723491|FG000|Overall Study|Drug non-compliance, moved, other|26|||
28068327|NCT00456521|54723492|FG001|Overall Study|Drug non-compliance, moved, other|11|||
28068328|NCT00456365|54723501|FG000|Overall Study|Lost to Follow-up|1|||
28068329|NCT00456365|54723502|FG001|Overall Study|Lost to Follow-up|3|||
28068330|NCT00456365|54723501|FG000|Overall Study|Withdrawal by Subject|4|||
28068331|NCT00456365|54723502|FG001|Overall Study|Withdrawal by Subject|7|||
28068332|NCT00456365|54723501|FG000|Overall Study|Pregnancy|1|||
28068333|NCT00456365|54723502|FG001|Overall Study|Pregnancy|1|||
28068334|NCT00456365|54723501|FG000|Overall Study|oncologic diagnosis|1|||
28068335|NCT00456365|54723502|FG001|Overall Study|oncologic diagnosis|1|||
28068336|NCT00455741|54723512|FG000|Overall Study|Physician Decision|0|||
28068337|NCT00455741|54723513|FG001|Overall Study|Physician Decision|1|||
28068338|NCT00445679|54723533|FG000|Overall Study|Adverse Event|22|||
28068339|NCT00445679|54723534|FG001|Overall Study|Adverse Event|12|||
28068340|NCT00445679|54723535|FG002|Overall Study|Adverse Event|30|||
28068341|NCT00445679|54723536|FG003|Overall Study|Adverse Event|19|||
28068342|NCT00445679|54723533|FG000|Overall Study|Failed to return|1|||
28068343|NCT00445679|54723534|FG001|Overall Study|Failed to return|3|||
28068344|NCT00445679|54723535|FG002|Overall Study|Failed to return|2|||
28068345|NCT00445679|54723536|FG003|Overall Study|Failed to return|2|||
28068346|NCT00445679|54723533|FG000|Overall Study|Physician Decision|0|||
28068347|NCT00445679|54723534|FG001|Overall Study|Physician Decision|0|||
28068348|NCT00445679|54723535|FG002|Overall Study|Physician Decision|1|||
28068349|NCT00445679|54723536|FG003|Overall Study|Physician Decision|0|||
28068350|NCT00445679|54723533|FG000|Overall Study|Lost to Follow-up|10|||
28068351|NCT00445679|54723534|FG001|Overall Study|Lost to Follow-up|6|||
28068352|NCT00445679|54723535|FG002|Overall Study|Lost to Follow-up|6|||
28068353|NCT00445679|54723536|FG003|Overall Study|Lost to Follow-up|5|||
28068354|NCT00445679|54723533|FG000|Overall Study|Compliance|3|||
28068355|NCT00445679|54723534|FG001|Overall Study|Compliance|2|||
28068356|NCT00445679|54723535|FG002|Overall Study|Compliance|1|||
28068357|NCT00445679|54723536|FG003|Overall Study|Compliance|2|||
28068358|NCT00445679|54723533|FG000|Overall Study|Withdrawal of Informed Consent|0|||
28068359|NCT00445679|54723534|FG001|Overall Study|Withdrawal of Informed Consent|0|||
28068360|NCT00445679|54723535|FG002|Overall Study|Withdrawal of Informed Consent|1|||
28068361|NCT00445679|54723536|FG003|Overall Study|Withdrawal of Informed Consent|0|||
28068362|NCT00445679|54723533|FG000|Overall Study|Protocol Violation|2|||
27818889|NCT01609556|54277518|FG000|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
27818890|NCT01609556|54277519|FG001|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
27818891|NCT01609556|54277520|FG002|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
27818892|NCT01609556|54277521|FG003|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
27818893|NCT01609556|54277522|FG004|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
27818894|NCT01609556|54277523|FG005|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
27818895|NCT01609556|54277524|FG006|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
27818896|NCT01609556|54277525|FG007|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
27818897|NCT01609556|54277526|FG008|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
27818898|NCT01609556|54277527|FG009|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
27818899|NCT01609556|54277528|FG010|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
27818900|NCT01609556|54277529|FG011|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
27818901|NCT01609556|54277530|FG012|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
27818902|NCT01609556|54277531|FG013|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
27818903|NCT01609556|54277532|FG014|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
28068363|NCT00445679|54723534|FG001|Overall Study|Protocol Violation|3|||
28068364|NCT00445679|54723535|FG002|Overall Study|Protocol Violation|3|||
28068365|NCT00445679|54723536|FG003|Overall Study|Protocol Violation|1|||
28068366|NCT00445679|54723533|FG000|Overall Study|Withdrawal by Subject|8|||
28068367|NCT00445679|54723534|FG001|Overall Study|Withdrawal by Subject|14|||
28068368|NCT00445679|54723535|FG002|Overall Study|Withdrawal by Subject|20|||
28068369|NCT00445679|54723536|FG003|Overall Study|Withdrawal by Subject|18|||
28068370|NCT00445679|54723533|FG000|Overall Study|Lack of Efficacy|2|||
28068371|NCT00445679|54723534|FG001|Overall Study|Lack of Efficacy|6|||
28068372|NCT00445679|54723535|FG002|Overall Study|Lack of Efficacy|2|||
28068373|NCT00445679|54723536|FG003|Overall Study|Lack of Efficacy|0|||
27818904|NCT01609556|54277533|FG015|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
27818905|NCT01609556|54277518|FG000|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
27818906|NCT01609556|54277519|FG001|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
27818907|NCT01609556|54277520|FG002|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
28068374|NCT00455429|54723550|FG000|Overall Study|Study Terminated by Sponsor|0|||
27818908|NCT01609556|54277521|FG003|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
27818909|NCT01609556|54277522|FG004|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8|||
27818910|NCT01609556|54277523|FG005|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13|||
27818911|NCT01609556|54277524|FG006|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5|||
27818912|NCT01609556|54277525|FG007|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4|||
27818913|NCT01609556|54277526|FG008|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
27818914|NCT01609556|54277527|FG009|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
27818915|NCT01609556|54277528|FG010|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6|||
27818916|NCT01609556|54277529|FG011|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
27818917|NCT01609556|54277530|FG012|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
27818918|NCT01609556|54277531|FG013|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
28068375|NCT00455429|54723551|FG001|Overall Study|Study Terminated by Sponsor|0|||
27849555|NCT00632749|54347071|FG003|Overall Study|Progressive disease|2|||
27849556|NCT00632749|54347072|FG004|Overall Study|Progressive disease|4|||
27818919|NCT01609556|54277532|FG014|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
27818920|NCT01609556|54277533|FG015|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
27849557|NCT00632749|54347073|FG005|Overall Study|Progressive disease|4|||
27849558|NCT00632749|54347074|FG006|Overall Study|Progressive disease|3|||
27849559|NCT00632749|54347075|FG007|Overall Study|Progressive disease|2|||
27849560|NCT00632749|54347076|FG008|Overall Study|Progressive disease|3|||
27849561|NCT00632749|54347077|FG009|Overall Study|Progressive disease|2|||
27849562|NCT00632749|54347078|FG010|Overall Study|Progressive disease|4|||
27849563|NCT00632749|54347079|FG011|Overall Study|Progressive disease|3|||
27849564|NCT00632749|54347080|FG012|Overall Study|Progressive disease|2|||
27849565|NCT00632749|54347081|FG013|Overall Study|Progressive disease|4|||
27849566|NCT00632749|54347068|FG000|Overall Study|Other Adverse event|1|||
27849567|NCT00632749|54347069|FG001|Overall Study|Other Adverse event|1|||
27849568|NCT00632749|54347070|FG002|Overall Study|Other Adverse event|1|||
27849569|NCT00632749|54347071|FG003|Overall Study|Other Adverse event|1|||
27849570|NCT00632749|54347072|FG004|Overall Study|Other Adverse event|2|||
27849571|NCT00632749|54347073|FG005|Overall Study|Other Adverse event|4|||
27849572|NCT00632749|54347074|FG006|Overall Study|Other Adverse event|1|||
27849573|NCT00632749|54347075|FG007|Overall Study|Other Adverse event|2|||
27849574|NCT00632749|54347076|FG008|Overall Study|Other Adverse event|2|||
27849575|NCT00632749|54347077|FG009|Overall Study|Other Adverse event|0|||
27849576|NCT00632749|54347078|FG010|Overall Study|Other Adverse event|1|||
27849577|NCT00632749|54347079|FG011|Overall Study|Other Adverse event|0|||
27849578|NCT00632749|54347080|FG012|Overall Study|Other Adverse event|1|||
27849579|NCT00632749|54347081|FG013|Overall Study|Other Adverse event|0|||
27849580|NCT00632749|54347068|FG000|Overall Study|Refuse to continue medication|0|||
27849581|NCT00632749|54347069|FG001|Overall Study|Refuse to continue medication|0|||
27849582|NCT00632749|54347070|FG002|Overall Study|Refuse to continue medication|0|||
27849583|NCT00632749|54347071|FG003|Overall Study|Refuse to continue medication|1|||
27849584|NCT00632749|54347072|FG004|Overall Study|Refuse to continue medication|0|||
27849585|NCT00632749|54347073|FG005|Overall Study|Refuse to continue medication|0|||
27849586|NCT00632749|54347074|FG006|Overall Study|Refuse to continue medication|0|||
27849587|NCT00632749|54347075|FG007|Overall Study|Refuse to continue medication|0|||
27849588|NCT00632749|54347076|FG008|Overall Study|Refuse to continue medication|0|||
27849589|NCT00632749|54347077|FG009|Overall Study|Refuse to continue medication|1|||
27849590|NCT00632749|54347078|FG010|Overall Study|Refuse to continue medication|0|||
27849591|NCT00632749|54347079|FG011|Overall Study|Refuse to continue medication|0|||
27849592|NCT00632749|54347080|FG012|Overall Study|Refuse to continue medication|0|||
27849593|NCT00632749|54347081|FG013|Overall Study|Refuse to continue medication|0|||
27849594|NCT00632749|54347068|FG000|Overall Study|Reason other than those specified above|0|||
27849595|NCT00632749|54347069|FG001|Overall Study|Reason other than those specified above|2|||
27849596|NCT00632749|54347070|FG002|Overall Study|Reason other than those specified above|0|||
27849597|NCT00632749|54347071|FG003|Overall Study|Reason other than those specified above|0|||
27849598|NCT00632749|54347072|FG004|Overall Study|Reason other than those specified above|1|||
27849599|NCT00632749|54347073|FG005|Overall Study|Reason other than those specified above|0|||
27849600|NCT00632749|54347074|FG006|Overall Study|Reason other than those specified above|1|||
27849601|NCT00632749|54347075|FG007|Overall Study|Reason other than those specified above|0|||
27849602|NCT00632749|54347076|FG008|Overall Study|Reason other than those specified above|0|||
27849603|NCT00632749|54347077|FG009|Overall Study|Reason other than those specified above|0|||
27849604|NCT00632749|54347078|FG010|Overall Study|Reason other than those specified above|2|||
27849605|NCT00632749|54347079|FG011|Overall Study|Reason other than those specified above|1|||
27849606|NCT00632749|54347080|FG012|Overall Study|Reason other than those specified above|0|||
27818921|NCT01609556|54277518|FG000|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
27818922|NCT01609556|54277519|FG001|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
27818923|NCT01609556|54277520|FG002|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
27818924|NCT01609556|54277521|FG003|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
27818925|NCT01609556|54277522|FG004|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
27818926|NCT01609556|54277523|FG005|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
27849607|NCT00632749|54347081|FG013|Overall Study|Reason other than those specified above|2|||
27849608|NCT00632359|54347151|FG000|Overall Study|Withdrawal by Subject|2|||
27849609|NCT00632203|54347158|FG000|Overall Study|Did not start study treatment|1|||
27849610|NCT00632203|54347159|FG001|Overall Study|Did not start study treatment|0|||
27849611|NCT03830333|54347180|FG000|Overall Study|Death|0|||
27849612|NCT03830333|54347181|FG001|Overall Study|Death|1|||
27849613|NCT03830333|54347180|FG000|Overall Study|Withdrawal by Subject|5|||
27849614|NCT03830333|54347181|FG001|Overall Study|Withdrawal by Subject|1|||
27849615|NCT03830333|54347180|FG000|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|3|||
27849616|NCT03830333|54347181|FG001|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|2|||
27849617|NCT00631969|54347267|FG000|Overall Study|Adverse Event|3|||
27849618|NCT00631969|54347268|FG001|Overall Study|Adverse Event|1|||
27849619|NCT00631969|54347267|FG000|Overall Study|Lack of Efficacy|2|||
27849620|NCT00631969|54347268|FG001|Overall Study|Lack of Efficacy|8|||
27849621|NCT00631969|54347267|FG000|Overall Study|Lost to Follow-up|2|||
27849622|NCT00631969|54347268|FG001|Overall Study|Lost to Follow-up|1|||
27818927|NCT01609556|54277524|FG006|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
27818928|NCT01609556|54277525|FG007|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
27818929|NCT01609556|54277526|FG008|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
27818930|NCT01609556|54277527|FG009|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
27818931|NCT01609556|54277528|FG010|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
27818932|NCT01609556|54277529|FG011|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
27818933|NCT01609556|54277530|FG012|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
27818934|NCT01609556|54277531|FG013|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
27818935|NCT01609556|54277532|FG014|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
27818936|NCT01609556|54277533|FG015|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
27818937|NCT01609556|54277518|FG000|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
27818938|NCT01609556|54277519|FG001|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
27818939|NCT01609556|54277520|FG002|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
27818940|NCT01609556|54277521|FG003|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
27818941|NCT01609556|54277522|FG004|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
27818942|NCT01609556|54277523|FG005|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
27818943|NCT01609556|54277524|FG006|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
27818944|NCT01609556|54277525|FG007|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
27818945|NCT01609556|54277526|FG008|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
27818946|NCT01609556|54277527|FG009|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
27818947|NCT01609556|54277528|FG010|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
27818948|NCT01609556|54277529|FG011|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
27818949|NCT01609556|54277530|FG012|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
27818950|NCT01609556|54277531|FG013|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
27818951|NCT01609556|54277532|FG014|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
27818952|NCT01609556|54277533|FG015|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
27818953|NCT01609556|54277518|FG000|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
27818954|NCT01609556|54277519|FG001|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
27818955|NCT01609556|54277520|FG002|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
27818956|NCT01609556|54277521|FG003|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
27818957|NCT01609556|54277522|FG004|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
27818958|NCT01609556|54277523|FG005|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1|||
27818959|NCT01609556|54277524|FG006|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
27818960|NCT01609556|54277525|FG007|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
27818961|NCT01609556|54277526|FG008|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
27818962|NCT01609556|54277527|FG009|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
27818963|NCT01609556|54277528|FG010|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
27818964|NCT01609556|54277529|FG011|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
27818965|NCT01609556|54277530|FG012|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
27818966|NCT01609556|54277531|FG013|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
27849623|NCT00631969|54347267|FG000|Overall Study|Protocol Violation|1|||
27849624|NCT00631969|54347268|FG001|Overall Study|Protocol Violation|1|||
27849625|NCT00631969|54347267|FG000|Overall Study|Consent Withdrawn|5|||
27849626|NCT00631969|54347268|FG001|Overall Study|Consent Withdrawn|7|||
27849627|NCT00631969|54347267|FG000|Overall Study|Noncompliant With Study Medication|0|||
27849628|NCT00631969|54347268|FG001|Overall Study|Noncompliant With Study Medication|1|||
27849629|NCT00631969|54347267|FG000|Overall Study|No Drug Exposure|2|||
27849630|NCT00631969|54347268|FG001|Overall Study|No Drug Exposure|2|||
27849631|NCT00631657|54347304|FG000|6-Month Treatment Period|Adverse Event|47|||
27849632|NCT00631657|54347305|FG001|6-Month Treatment Period|Adverse Event|0|||
27849633|NCT00631657|54347306|FG002|6-Month Treatment Period|Adverse Event|7|||
27849634|NCT00631657|54347304|FG000|6-Month Treatment Period|Withdrawal by Subject|14|||
27849635|NCT00631657|54347305|FG001|6-Month Treatment Period|Withdrawal by Subject|0|||
27849636|NCT00631657|54347306|FG002|6-Month Treatment Period|Withdrawal by Subject|5|||
27849637|NCT00631657|54347304|FG000|6-Month Treatment Period|Lack of Efficacy|34|||
27849638|NCT00631657|54347305|FG001|6-Month Treatment Period|Lack of Efficacy|0|||
27849639|NCT00631657|54347306|FG002|6-Month Treatment Period|Lack of Efficacy|25|||
27849640|NCT00631657|54347304|FG000|6-Month Treatment Period|Lost to Follow-up|7|||
27849641|NCT00631657|54347305|FG001|6-Month Treatment Period|Lost to Follow-up|0|||
27849642|NCT00631657|54347306|FG002|6-Month Treatment Period|Lost to Follow-up|2|||
27849643|NCT00631657|54347304|FG000|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21|||
27849644|NCT00631657|54347305|FG001|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0|||
27849645|NCT00631657|54347306|FG002|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6|||
27849646|NCT00631657|54347304|FG000|6-Month Treatment Period|Other|16|||
27849647|NCT00631657|54347305|FG001|6-Month Treatment Period|Other|0|||
27849648|NCT00631657|54347306|FG002|6-Month Treatment Period|Other|4|||
27849649|NCT00631657|54347304|FG000|6-Month Treatment Period|Not Treated|2|||
27849650|NCT00631657|54347305|FG001|6-Month Treatment Period|Not Treated|0|||
27849651|NCT00631657|54347306|FG002|6-Month Treatment Period|Not Treated|1|||
27849652|NCT00631657|54347304|FG000|7-Day Discontinuation Period|Not Treated|1|||
27849653|NCT00631657|54347305|FG001|7-Day Discontinuation Period|Not Treated|1|||
27849654|NCT00631657|54347306|FG002|7-Day Discontinuation Period|Not Treated|1|||
27849655|NCT00631657|54347304|FG000|7-Day Discontinuation Period|Other|1|||
27849656|NCT00631657|54347305|FG001|7-Day Discontinuation Period|Other|0|||
27849657|NCT00631657|54347306|FG002|7-Day Discontinuation Period|Other|0|||
27849658|NCT00631189|54347344|FG000|Initial Phase|Protocol Violation|347|||
27849659|NCT00631189|54347345|FG001|Initial Phase|Protocol Violation|0|||
27849660|NCT00631189|54347346|FG002|Initial Phase|Protocol Violation|0|||
27849661|NCT00631189|54347347|FG003|Initial Phase|Protocol Violation|0|||
27849662|NCT00631189|54347344|FG000|Initial Phase|Withdrawal by Subject|4|||
27849663|NCT00631189|54347345|FG001|Initial Phase|Withdrawal by Subject|0|||
27849664|NCT00631189|54347346|FG002|Initial Phase|Withdrawal by Subject|0|||
27849665|NCT00631189|54347347|FG003|Initial Phase|Withdrawal by Subject|0|||
27849666|NCT00631189|54347344|FG000|Treatment Phase|Withdrawal by Subject|0|||
27849667|NCT00631189|54347345|FG001|Treatment Phase|Withdrawal by Subject|2|||
27849668|NCT00631189|54347346|FG002|Treatment Phase|Withdrawal by Subject|1|||
27849669|NCT00631189|54347347|FG003|Treatment Phase|Withdrawal by Subject|1|||
27849670|NCT00631189|54347344|FG000|Treatment Phase|Protocol Violation|0|||
27849671|NCT00631189|54347345|FG001|Treatment Phase|Protocol Violation|1|||
27849672|NCT00631189|54347346|FG002|Treatment Phase|Protocol Violation|6|||
27849673|NCT00631189|54347347|FG003|Treatment Phase|Protocol Violation|2|||
27849674|NCT00631189|54347344|FG000|Treatment Phase|Adverse Event|0|||
27849675|NCT00631189|54347345|FG001|Treatment Phase|Adverse Event|3|||
27849676|NCT00631189|54347346|FG002|Treatment Phase|Adverse Event|2|||
27849677|NCT00631189|54347347|FG003|Treatment Phase|Adverse Event|4|||
27849678|NCT00631189|54347344|FG000|Treatment Phase|Lost to Follow-up|0|||
27849679|NCT00631189|54347345|FG001|Treatment Phase|Lost to Follow-up|1|||
27849680|NCT00631189|54347346|FG002|Treatment Phase|Lost to Follow-up|0|||
27849681|NCT00631189|54347347|FG003|Treatment Phase|Lost to Follow-up|0|||
27849682|NCT00631189|54347344|FG000|Treatment Phase|Pregnancy|0|||
27849683|NCT00631189|54347345|FG001|Treatment Phase|Pregnancy|0|||
27849684|NCT00631189|54347346|FG002|Treatment Phase|Pregnancy|1|||
27849685|NCT00631189|54347347|FG003|Treatment Phase|Pregnancy|0|||
27849686|NCT00631189|54347344|FG000|Treatment Phase|patient did not take pravastatin|0|||
27849687|NCT00631189|54347345|FG001|Treatment Phase|patient did not take pravastatin|0|||
27849688|NCT00631189|54347346|FG002|Treatment Phase|patient did not take pravastatin|1|||
27849689|NCT00631189|54347347|FG003|Treatment Phase|patient did not take pravastatin|0|||
27849690|NCT00630877|54347360|FG000|Overall Study|Adverse Event|11|||
27849691|NCT00630877|54347361|FG001|Overall Study|Adverse Event|8|||
27849692|NCT00630877|54347362|FG002|Overall Study|Adverse Event|7|||
27849693|NCT00630877|54347360|FG000|Overall Study|Withdrawal by Subject|3|||
27849694|NCT00630877|54347361|FG001|Overall Study|Withdrawal by Subject|4|||
27849695|NCT00630877|54347362|FG002|Overall Study|Withdrawal by Subject|0|||
27849696|NCT00630877|54347360|FG000|Overall Study|Lost to Follow-up|2|||
27849697|NCT00630877|54347361|FG001|Overall Study|Lost to Follow-up|0|||
27849698|NCT00630877|54347362|FG002|Overall Study|Lost to Follow-up|0|||
27849699|NCT00630877|54347360|FG000|Overall Study|Noncompliance|2|||
27849700|NCT00630877|54347361|FG001|Overall Study|Noncompliance|3|||
27849701|NCT00630877|54347362|FG002|Overall Study|Noncompliance|1|||
27849702|NCT00630877|54347360|FG000|Overall Study|Protocol violation|1|||
27849703|NCT00630877|54347361|FG001|Overall Study|Protocol violation|0|||
27849704|NCT00630877|54347362|FG002|Overall Study|Protocol violation|1|||
27849705|NCT00630877|54347360|FG000|Overall Study|Personal reasons|0|||
27849706|NCT00630877|54347361|FG001|Overall Study|Personal reasons|0|||
27849707|NCT00630877|54347362|FG002|Overall Study|Personal reasons|1|||
27849708|NCT02915783|54347374|FG000|Overall Study|Death|21|||
27849709|NCT02915783|54347374|FG000|Overall Study|Lost to Follow-up|1|||
27849710|NCT02915783|54347374|FG000|Overall Study|Withdrawal by Subject|2|||
27849711|NCT00630331|54347389|FG000|Overall Study|Death|2|||
27849712|NCT00630331|54347390|FG001|Overall Study|Death|1|||
27849713|NCT00630331|54347391|FG002|Overall Study|Death|1|||
27849714|NCT00630331|54347389|FG000|Overall Study|Adverse Event|1|||
27849715|NCT00630331|54347390|FG001|Overall Study|Adverse Event|0|||
27849716|NCT00630331|54347391|FG002|Overall Study|Adverse Event|0|||
27849717|NCT00630331|54347389|FG000|Overall Study|Withdrawal by Subject|12|||
28068376|NCT00455429|54723552|FG002|Overall Study|Study Terminated by Sponsor|0|||
28068377|NCT00455429|54723553|FG003|Overall Study|Study Terminated by Sponsor|3|||
28068378|NCT00455429|54723550|FG000|Overall Study|Lost to Follow-up|1|||
28068379|NCT00455429|54723551|FG001|Overall Study|Lost to Follow-up|0|||
28068380|NCT00455429|54723552|FG002|Overall Study|Lost to Follow-up|0|||
28068381|NCT00455429|54723553|FG003|Overall Study|Lost to Follow-up|3|||
28068382|NCT00455429|54723550|FG000|Overall Study|Withdrawal by Subject|0|||
28068383|NCT00455429|54723551|FG001|Overall Study|Withdrawal by Subject|1|||
28068384|NCT00455429|54723552|FG002|Overall Study|Withdrawal by Subject|1|||
27849718|NCT00630331|54347390|FG001|Overall Study|Withdrawal by Subject|7|||
27849719|NCT00630331|54347391|FG002|Overall Study|Withdrawal by Subject|5|||
27849720|NCT00630331|54347389|FG000|Overall Study|Lost to Follow-up|175|||
27849721|NCT00630331|54347390|FG001|Overall Study|Lost to Follow-up|143|||
28068385|NCT00455429|54723553|FG003|Overall Study|Withdrawal by Subject|0|||
28131331|NCT02914184|54794743|FG003|Overall Study|Migrated/moved from the study area|1|||
28131332|NCT03633227|54794757|FG000|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
28131333|NCT03633227|54794758|FG001|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
28131334|NCT03633227|54794757|FG000|Double Blind (DB), up to Week 48|Death|2|||
28131335|NCT03633227|54794758|FG001|Double Blind (DB), up to Week 48|Death|1|||
28131336|NCT03633227|54794757|FG000|Double Blind (DB), up to Week 48|Adverse Event|0|||
28131337|NCT03633227|54794758|FG001|Double Blind (DB), up to Week 48|Adverse Event|1|||
28131338|NCT03633227|54794757|FG000|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|2|||
28131339|NCT03633227|54794758|FG001|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|1|||
28131340|NCT03633227|54794757|FG000|Double Blind (DB), up to Week 48|Physician Decision|1|||
28131341|NCT03633227|54794758|FG001|Double Blind (DB), up to Week 48|Physician Decision|0|||
28131342|NCT03633227|54794757|FG000|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|1|||
28131343|NCT03633227|54794758|FG001|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|0|||
28131344|NCT03633227|54794757|FG000|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|1|||
28131345|NCT03633227|54794758|FG001|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|0|||
28131346|NCT03633227|54794757|FG000|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|0|||
28131347|NCT03633227|54794758|FG001|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|2|||
28131348|NCT03633227|54794757|FG000|DB Extension, Week 48 up to 3 Years|Death|0|||
28131349|NCT03633227|54794758|FG001|DB Extension, Week 48 up to 3 Years|Death|1|||
28131350|NCT03633227|54794757|FG000|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|3|||
28131351|NCT03633227|54794758|FG001|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|2|||
28131352|NCT03633227|54794757|FG000|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|1|||
28131353|NCT03633227|54794758|FG001|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|0|||
28131354|NCT03633227|54794757|FG000|DB Extension, Week 48 up to 3 Years|Physician Decision|0|||
28131355|NCT03633227|54794758|FG001|DB Extension, Week 48 up to 3 Years|Physician Decision|1|||
28131356|NCT02913326|54794771|FG000|Overall Study|Reason not listed|0|||
28131357|NCT02913326|54794772|FG001|Overall Study|Reason not listed|1|||
28131358|NCT02913326|54794771|FG000|Overall Study|Lost to Follow-up|0|||
28131359|NCT02913326|54794772|FG001|Overall Study|Lost to Follow-up|1|||
28131360|NCT02913326|54794771|FG000|Overall Study|Adverse Event|1|||
28131361|NCT02913326|54794772|FG001|Overall Study|Adverse Event|0|||
28131362|NCT02912468|54794780|FG000|Overall Study|Adverse Event|3|||
28131363|NCT02912468|54794781|FG001|Overall Study|Adverse Event|2|||
28131364|NCT02912468|54794780|FG000|Overall Study|Withdrawal by Subject|6|||
28131365|NCT02912468|54794781|FG001|Overall Study|Withdrawal by Subject|2|||
28131366|NCT02912468|54794780|FG000|Overall Study|Randomized and not treated|0|||
28131367|NCT02912468|54794781|FG001|Overall Study|Randomized and not treated|1|||
28131368|NCT04438499|54794788|FG000|Overall Study|Lack of Efficacy|2|||
28131369|NCT00002874|54794794|FG000|Overall Study|Withdrawal by Subject|1|||
28131370|NCT00002874|54794795|FG001|Overall Study|Withdrawal by Subject|1|||
28131371|NCT00002874|54794794|FG000|Overall Study|Protocol Violation|44|||
28131372|NCT00002874|54794795|FG001|Overall Study|Protocol Violation|34|||
28131373|NCT03001076|54794803|FG000|Overall Study|Withdrawal by patient|2|||
28131374|NCT03001076|54794804|FG001|Overall Study|Withdrawal by patient|0|||
28131375|NCT03001076|54794803|FG000|Overall Study|Other|1|||
28131376|NCT03001076|54794804|FG001|Overall Study|Other|0|||
28131377|NCT03001076|54794803|FG000|Overall Study|Adverse Event|3|||
28131378|NCT03001076|54794804|FG001|Overall Study|Adverse Event|3|||
28131379|NCT03001076|54794803|FG000|Overall Study|Sponsor decision|1|||
28131380|NCT03001076|54794804|FG001|Overall Study|Sponsor decision|0|||
28131381|NCT03001076|54794803|FG000|Overall Study|Lost to Follow-up|0|||
28131382|NCT03001076|54794804|FG001|Overall Study|Lost to Follow-up|2|||
28131383|NCT03555305|54794810|FG000|Period 1|Physician Decision|0|||
28131384|NCT03555305|54794811|FG001|Period 1|Physician Decision|1|||
28131385|NCT03555305|54794810|FG000|Period 1|Adverse Event|0|||
28131386|NCT03555305|54794811|FG001|Period 1|Adverse Event|1|||
28131387|NCT03553823|54794819|FG000|Overall Study|Physician Decision|0|||
28131388|NCT03553823|54794820|FG001|Overall Study|Physician Decision|1|||
28131389|NCT03000686|54794828|FG000|Part 1, Period 1 (1 Day)|Adverse Event|0|||
28131390|NCT03000686|54794829|FG001|Part 1, Period 1 (1 Day)|Adverse Event|1|||
28131391|NCT03000686|54794830|FG002|Part 1, Period 1 (1 Day)|Adverse Event|0|||
28131392|NCT03000686|54794831|FG003|Part 1, Period 1 (1 Day)|Adverse Event|0|||
28131393|NCT02493660|54794849|FG000|Overall Study|Physician Decision|0|||
28131394|NCT02493660|54794850|FG001|Overall Study|Physician Decision|1|||
28131395|NCT02493660|54794849|FG000|Overall Study|Adverse Event|4|||
28131396|NCT02493660|54794850|FG001|Overall Study|Adverse Event|2|||
28131397|NCT02493660|54794849|FG000|Overall Study|Withdrawal by Subject|2|||
28131398|NCT02493660|54794850|FG001|Overall Study|Withdrawal by Subject|3|||
28131399|NCT02493660|54794849|FG000|Overall Study|Subject unable to return for follow-up visits|2|||
28131400|NCT02493660|54794850|FG001|Overall Study|Subject unable to return for follow-up visits|0|||
28068386|NCT00455429|54723550|FG000|Overall Study|Lack of Efficacy|0|||
28131401|NCT02493660|54794849|FG000|Overall Study|Protocol Violation|0|||
28131402|NCT02493660|54794850|FG001|Overall Study|Protocol Violation|1|||
28068387|NCT00455429|54723551|FG001|Overall Study|Lack of Efficacy|1|||
28068388|NCT00455429|54723552|FG002|Overall Study|Lack of Efficacy|0|||
28068389|NCT00455429|54723553|FG003|Overall Study|Lack of Efficacy|1|||
28068390|NCT00455429|54723550|FG000|Overall Study|Adverse Event|0|||
28068391|NCT00455429|54723551|FG001|Overall Study|Adverse Event|1|||
28068392|NCT00455429|54723552|FG002|Overall Study|Adverse Event|0|||
28068393|NCT00455429|54723553|FG003|Overall Study|Adverse Event|3|||
28068394|NCT00455429|54723550|FG000|Overall Study|Randomly assigned but not treated|0|||
28068395|NCT00455429|54723551|FG001|Overall Study|Randomly assigned but not treated|0|||
28068396|NCT00455429|54723552|FG002|Overall Study|Randomly assigned but not treated|0|||
28068397|NCT00455429|54723553|FG003|Overall Study|Randomly assigned but not treated|2|||
28068398|NCT00455429|54723550|FG000|Overall Study|Personal Reason|1|||
28068399|NCT00455429|54723551|FG001|Overall Study|Personal Reason|0|||
28068400|NCT00455429|54723552|FG002|Overall Study|Personal Reason|0|||
28068401|NCT00455429|54723553|FG003|Overall Study|Personal Reason|0|||
28068402|NCT00455429|54723550|FG000|Overall Study|Non-compliance|0|||
28068403|NCT00455429|54723551|FG001|Overall Study|Non-compliance|0|||
28068404|NCT00455429|54723552|FG002|Overall Study|Non-compliance|0|||
28068405|NCT00455429|54723553|FG003|Overall Study|Non-compliance|1|||
28068406|NCT00455429|54723550|FG000|Overall Study|Other|0|||
28068407|NCT00455429|54723551|FG001|Overall Study|Other|2|||
28068408|NCT00455429|54723552|FG002|Overall Study|Other|0|||
28131403|NCT02493660|54794849|FG000|Overall Study|Death|0|||
28131404|NCT02493660|54794850|FG001|Overall Study|Death|1|||
28131405|NCT02493660|54794849|FG000|Overall Study|Lost to Follow-up|2|||
28131406|NCT02493660|54794850|FG001|Overall Study|Lost to Follow-up|4|||
28131407|NCT03552029|54794860|FG000|Overall Study|Death|3|||
28131408|NCT03552029|54794861|FG001|Overall Study|Death|0|||
28131409|NCT03552029|54794860|FG000|Overall Study|Adverse Event|1|||
28131410|NCT03552029|54794861|FG001|Overall Study|Adverse Event|0|||
28131411|NCT03552029|54794860|FG000|Overall Study|Lack of Efficacy|0|||
28131412|NCT03552029|54794861|FG001|Overall Study|Lack of Efficacy|2|||
28131413|NCT03552029|54794860|FG000|Overall Study|Physician Decision|0|||
28131414|NCT03552029|54794861|FG001|Overall Study|Physician Decision|1|||
28131415|NCT03552029|54794860|FG000|Overall Study|Study terminated by Sponsor|0|||
28131416|NCT03552029|54794861|FG001|Overall Study|Study terminated by Sponsor|1|||
28131417|NCT03552029|54794860|FG000|Overall Study|Other|0|||
28131418|NCT03552029|54794861|FG001|Overall Study|Other|2|||
28131419|NCT03521141|54794870|FG000|Overall Study|Death|1|||
28131420|NCT03521141|54794871|FG001|Overall Study|Death|0|||
28131421|NCT03521141|54794872|FG002|Overall Study|Death|1|||
28131422|NCT02997176|54794884|FG000|Overall Study|Adverse Event|0|||
28131423|NCT02997176|54794885|FG001|Overall Study|Adverse Event|0|||
28131424|NCT02997176|54794886|FG002|Overall Study|Adverse Event|0|||
28131425|NCT02997176|54794887|FG003|Overall Study|Adverse Event|8|||
28131426|NCT02997176|54794884|FG000|Overall Study|Progressive Disease|1|||
28131427|NCT02997176|54794885|FG001|Overall Study|Progressive Disease|0|||
28131428|NCT02997176|54794886|FG002|Overall Study|Progressive Disease|1|||
28068409|NCT00455429|54723553|FG003|Overall Study|Other|1|||
28068410|NCT00445601|54723568|FG000|Overall Study|Withdrawal by Subject|11|||
28131429|NCT02997176|54794887|FG003|Overall Study|Progressive Disease|1|||
28131430|NCT02997176|54794884|FG000|Overall Study|Death|0|||
28131431|NCT02997176|54794885|FG001|Overall Study|Death|0|||
28131432|NCT02997176|54794886|FG002|Overall Study|Death|1|||
28068411|NCT00445601|54723569|FG001|Overall Study|Withdrawal by Subject|11|||
28068412|NCT00445601|54723568|FG000|Overall Study|TURBT Complication|12|||
28068413|NCT00445601|54723569|FG001|Overall Study|TURBT Complication|8|||
28068414|NCT00445601|54723568|FG000|Overall Study|Incorrect Disease Status|6|||
28131433|NCT02997176|54794887|FG003|Overall Study|Death|1|||
28131434|NCT02997176|54794884|FG000|Overall Study|Withdrawal by Subject|0|||
28131435|NCT02997176|54794885|FG001|Overall Study|Withdrawal by Subject|2|||
28131436|NCT02997176|54794886|FG002|Overall Study|Withdrawal by Subject|0|||
28131437|NCT02997176|54794887|FG003|Overall Study|Withdrawal by Subject|1|||
28131438|NCT03000452|54794897|FG000|Treatment Period|Death|1|||
28131439|NCT03000452|54794897|FG000|Treatment Period|Progressive Disease (PD)|14|||
28131440|NCT03000452|54794897|FG000|Treatment Period|Physician Decision|1|||
28131441|NCT03000452|54794897|FG000|Treatment Period|Miscellaneous|2|||
28131442|NCT03000452|54794897|FG000|Follow-Up Period|Study Terminated by Sponsor|1|||
28131443|NCT03000452|54794897|FG000|Follow-Up Period|Death|3|||
28131444|NCT03000452|54794897|FG000|Follow-Up Period|Withdrawal by Subject|3|||
28131445|NCT01373164|54794906|FG000|Overall Study|Lost to Follow-up|0|||
28131446|NCT01373164|54794907|FG001|Overall Study|Lost to Follow-up|0|||
28131447|NCT01373164|54794908|FG002|Overall Study|Lost to Follow-up|1|||
28131448|NCT01373164|54794909|FG003|Overall Study|Lost to Follow-up|2|||
28131449|NCT01373164|54794910|FG004|Overall Study|Lost to Follow-up|0|||
28131450|NCT01373164|54794906|FG000|Overall Study|Withdrawal by Subject|0|||
28131451|NCT01373164|54794907|FG001|Overall Study|Withdrawal by Subject|1|||
28131452|NCT01373164|54794908|FG002|Overall Study|Withdrawal by Subject|0|||
28131453|NCT01373164|54794909|FG003|Overall Study|Withdrawal by Subject|10|||
28131454|NCT01373164|54794910|FG004|Overall Study|Withdrawal by Subject|2|||
28131455|NCT02999984|54794925|FG000|Overall Study|Treatment Failure|1|||
27818967|NCT01609556|54277532|FG014|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
27849722|NCT00630331|54347391|FG002|Overall Study|Lost to Follow-up|170|||
27849723|NCT00630331|54347389|FG000|Overall Study|Inappropriate enrollment|3|||
27849724|NCT00630331|54347390|FG001|Overall Study|Inappropriate enrollment|6|||
27849725|NCT00630331|54347391|FG002|Overall Study|Inappropriate enrollment|3|||
27849726|NCT00630331|54347389|FG000|Overall Study|Unable to classify|9|||
27849727|NCT00630331|54347390|FG001|Overall Study|Unable to classify|4|||
27849728|NCT00630331|54347391|FG002|Overall Study|Unable to classify|3|||
28068415|NCT00445601|54723569|FG001|Overall Study|Incorrect Disease Status|6|||
28068416|NCT00445601|54723568|FG000|Overall Study|Drug Delivery Issue|2|||
27818968|NCT01609556|54277533|FG015|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
27818969|NCT01609556|54277518|FG000|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
27818970|NCT01609556|54277519|FG001|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
27818971|NCT01609556|54277520|FG002|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
27818972|NCT01609556|54277521|FG003|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
27818973|NCT01609556|54277522|FG004|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
27849729|NCT00630331|54347389|FG000|Overall Study|Protocol Violation|4|||
28068417|NCT00445601|54723569|FG001|Overall Study|Drug Delivery Issue|2|||
28068418|NCT00445601|54723568|FG000|Overall Study|Adverse Event|2|||
28068419|NCT00445601|54723569|FG001|Overall Study|Adverse Event|0|||
28068420|NCT00445601|54723568|FG000|Overall Study|Death prior to TURBT|0|||
28068421|NCT00445601|54723569|FG001|Overall Study|Death prior to TURBT|1|||
28068422|NCT00444587|54723581|FG000|Overall Study|Death|2|||
28068423|NCT00444587|54723582|FG001|Overall Study|Death|1|||
28068424|NCT00444587|54723581|FG000|Overall Study|Progression of the disease|73|||
28068425|NCT00444587|54723582|FG001|Overall Study|Progression of the disease|8|||
28068426|NCT00444587|54723581|FG000|Overall Study|Refused treatment/did not cooperate|4|||
28068427|NCT00444587|54723582|FG001|Overall Study|Refused treatment/did not cooperate|1|||
28068428|NCT00444587|54723581|FG000|Overall Study|Investigator decision|3|||
28068429|NCT00444587|54723582|FG001|Overall Study|Investigator decision|0|||
28068430|NCT00444587|54723581|FG000|Overall Study|Protocol Violation|1|||
28068431|NCT00444587|54723582|FG001|Overall Study|Protocol Violation|0|||
28068432|NCT00444587|54723581|FG000|Overall Study|Missing|0|||
28068433|NCT00444587|54723582|FG001|Overall Study|Missing|5|||
28068434|NCT00455195|54723592|FG000|Double-blind Study AGLU02704|Adverse Event|2|||
28068435|NCT00455195|54723593|FG001|Double-blind Study AGLU02704|Adverse Event|1|||
28068436|NCT00455195|54723592|FG000|Double-blind Study AGLU02704|Death|1|||
28068437|NCT00455195|54723593|FG001|Double-blind Study AGLU02704|Death|0|||
28068438|NCT00455195|54723592|FG000|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
28068439|NCT00455195|54723593|FG001|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
28068440|NCT00455195|54723592|FG000|Double-blind Study AGLU02704|Unable to commit time to study|0|||
28068441|NCT00455195|54723593|FG001|Double-blind Study AGLU02704|Unable to commit time to study|1|||
28068442|NCT00235716|54723603|FG000|Overall Study|Death|26|||
28068443|NCT00235716|54723604|FG001|Overall Study|Death|39|||
28131456|NCT03550313|54794932|FG000|Overall Study|Adverse Event|0|||
28131457|NCT03550313|54794933|FG001|Overall Study|Adverse Event|1|||
28131458|NCT03550313|54794934|FG002|Overall Study|Adverse Event|0|||
27849730|NCT00630331|54347390|FG001|Overall Study|Protocol Violation|5|||
27849731|NCT00630331|54347391|FG002|Overall Study|Protocol Violation|6|||
28068444|NCT00235716|54723605|FG002|Overall Study|Death|32|||
28131459|NCT03550313|54794932|FG000|Overall Study|Lost to Follow-up|5|||
28131460|NCT03550313|54794933|FG001|Overall Study|Lost to Follow-up|7|||
28131461|NCT03550313|54794934|FG002|Overall Study|Lost to Follow-up|12|||
28068445|NCT00235716|54723606|FG003|Overall Study|Death|31|||
28068446|NCT00235716|54723603|FG000|Overall Study|Withdrawal by Subject|23|||
27849732|NCT00639509|54347443|FG000|Overall Study|Death|1|||
27818974|NCT01609556|54277523|FG005|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
27818975|NCT01609556|54277524|FG006|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
27818976|NCT01609556|54277525|FG007|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
28131462|NCT03550313|54794932|FG000|Overall Study|Study terminated by sponsor|44|||
28131463|NCT03550313|54794933|FG001|Overall Study|Study terminated by sponsor|37|||
28131464|NCT03550313|54794934|FG002|Overall Study|Study terminated by sponsor|48|||
28131465|NCT03550313|54794932|FG000|Overall Study|No longer met eligibility criteria|3|||
28131466|NCT03550313|54794933|FG001|Overall Study|No longer met eligibility criteria|5|||
28131467|NCT03550313|54794934|FG002|Overall Study|No longer met eligibility criteria|6|||
28131468|NCT03550313|54794932|FG000|Overall Study|Withdrawal by parent/guardian|20|||
28131469|NCT03550313|54794933|FG001|Overall Study|Withdrawal by parent/guardian|18|||
28131470|NCT03550313|54794934|FG002|Overall Study|Withdrawal by parent/guardian|26|||
28131471|NCT03550313|54794932|FG000|Overall Study|Other|4|||
28131472|NCT03550313|54794933|FG001|Overall Study|Other|2|||
28131473|NCT03550313|54794934|FG002|Overall Study|Other|2|||
28131474|NCT03550313|54794932|FG000|Overall Study|Randomized but not vaccinated|3|||
28131475|NCT03550313|54794933|FG001|Overall Study|Randomized but not vaccinated|23|||
28131476|NCT03550313|54794934|FG002|Overall Study|Randomized but not vaccinated|2|||
28131477|NCT03550313|54794932|FG000|Overall Study|Sites terminated due to quality issues|18|||
28131478|NCT03550313|54794933|FG001|Overall Study|Sites terminated due to quality issues|17|||
28131479|NCT03550313|54794934|FG002|Overall Study|Sites terminated due to quality issues|18|||
28131480|NCT03312907|54794946|FG000|Overall Study|Adverse Event|1|||
28131481|NCT03312907|54794947|FG001|Overall Study|Adverse Event|6|||
28131482|NCT03312907|54794948|FG002|Overall Study|Adverse Event|1|||
28131483|NCT03312907|54794946|FG000|Overall Study|Protocol Violation|2|||
28131484|NCT03312907|54794947|FG001|Overall Study|Protocol Violation|3|||
28131485|NCT03312907|54794948|FG002|Overall Study|Protocol Violation|4|||
28131486|NCT03312907|54794946|FG000|Overall Study|Lost to Follow-up|2|||
28131487|NCT03312907|54794947|FG001|Overall Study|Lost to Follow-up|3|||
28131488|NCT03312907|54794948|FG002|Overall Study|Lost to Follow-up|2|||
28131489|NCT03312907|54794946|FG000|Overall Study|Physician Decision|3|||
28131490|NCT03312907|54794947|FG001|Overall Study|Physician Decision|4|||
28131491|NCT03312907|54794948|FG002|Overall Study|Physician Decision|2|||
28131492|NCT03312907|54794946|FG000|Overall Study|Withdrawal by Subject|9|||
28131493|NCT03312907|54794947|FG001|Overall Study|Withdrawal by Subject|14|||
28131494|NCT03312907|54794948|FG002|Overall Study|Withdrawal by Subject|10|||
28131495|NCT02999672|54794958|FG000|Overall Study|Death|0|||
28131496|NCT02999672|54794959|FG001|Overall Study|Death|1|||
28131497|NCT02999672|54794958|FG000|Overall Study|Study Terminated by Sponsor|0|||
28131498|NCT02999672|54794959|FG001|Overall Study|Study Terminated by Sponsor|1|||
28131499|NCT02999672|54794958|FG000|Overall Study|Progressive Disease|9|||
28131500|NCT02999672|54794959|FG001|Overall Study|Progressive Disease|5|||
28131501|NCT02999672|54794958|FG000|Overall Study|Adverse Event|4|||
28131502|NCT02999672|54794959|FG001|Overall Study|Adverse Event|0|||
28131503|NCT01911676|54794969|FG000|Period 1 of Study|Withdrawal by Subject|4|||
28131504|NCT01911676|54794970|FG001|Period 1 of Study|Withdrawal by Subject|2|||
28131505|NCT01911676|54794971|FG002|Period 1 of Study|Withdrawal by Subject|1|||
28131506|NCT01911676|54794972|FG003|Period 1 of Study|Withdrawal by Subject|2|||
28131507|NCT01911676|54794969|FG000|Period 1 of Study|Physician Decision|2|||
28131508|NCT01911676|54794970|FG001|Period 1 of Study|Physician Decision|0|||
28131509|NCT01911676|54794971|FG002|Period 1 of Study|Physician Decision|0|||
28131510|NCT01911676|54794972|FG003|Period 1 of Study|Physician Decision|1|||
28131511|NCT01911676|54794969|FG000|Period 2 of Study|Physician Decision|2|||
28131512|NCT01911676|54794970|FG001|Period 2 of Study|Physician Decision|0|||
28131513|NCT01911676|54794971|FG002|Period 2 of Study|Physician Decision|0|||
28131514|NCT01911676|54794972|FG003|Period 2 of Study|Physician Decision|1|||
28131515|NCT01911676|54794969|FG000|Period 2 of Study|Lost to Follow-up|0|||
28131516|NCT01911676|54794970|FG001|Period 2 of Study|Lost to Follow-up|0|||
28131517|NCT01911676|54794971|FG002|Period 2 of Study|Lost to Follow-up|0|||
28131518|NCT01911676|54794972|FG003|Period 2 of Study|Lost to Follow-up|1|||
28131519|NCT03573323|54794989|FG000|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
28131520|NCT03573323|54794990|FG001|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
28131521|NCT03573323|54794989|FG000|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15|||
28131522|NCT03573323|54794990|FG001|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8|||
28131523|NCT03573323|54794989|FG000|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3|||
28131524|NCT03573323|54794990|FG001|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8|||
28131525|NCT03573323|54794989|FG000|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17|||
28068447|NCT00235716|54723604|FG001|Overall Study|Withdrawal by Subject|19|||
28131526|NCT03573323|54794990|FG001|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9|||
28131527|NCT03573323|54794989|FG000|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2|||
28131528|NCT03573323|54794990|FG001|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3|||
28131529|NCT03573323|54794989|FG000|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1|||
28131530|NCT03573323|54794990|FG001|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2|||
28131531|NCT03573323|54794989|FG000|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1|||
28131532|NCT03573323|54794990|FG001|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0|||
28131533|NCT03573323|54794989|FG000|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14|||
28131534|NCT03573323|54794990|FG001|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13|||
28131535|NCT03573323|54794989|FG000|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0|||
28131536|NCT03573323|54794990|FG001|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1|||
28131537|NCT03573323|54794989|FG000|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0|||
28131538|NCT03573323|54794990|FG001|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1|||
28131539|NCT03573323|54794989|FG000|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1|||
28131540|NCT03573323|54794990|FG001|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2|||
28131541|NCT03573323|54794989|FG000|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22|||
27818977|NCT01609556|54277526|FG008|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1|||
28068448|NCT00235716|54723605|FG002|Overall Study|Withdrawal by Subject|17|||
28068449|NCT00235716|54723606|FG003|Overall Study|Withdrawal by Subject|18|||
28068450|NCT00235716|54723603|FG000|Overall Study|Lost to Follow-up|12|||
28068451|NCT00235716|54723604|FG001|Overall Study|Lost to Follow-up|7|||
28068452|NCT00235716|54723605|FG002|Overall Study|Lost to Follow-up|14|||
28068453|NCT00235716|54723606|FG003|Overall Study|Lost to Follow-up|10|||
28068454|NCT00235716|54723603|FG000|Overall Study|Adverse Event|1|||
28068455|NCT00235716|54723604|FG001|Overall Study|Adverse Event|1|||
28068456|NCT00235716|54723605|FG002|Overall Study|Adverse Event|1|||
28068457|NCT00235716|54723606|FG003|Overall Study|Adverse Event|0|||
28068458|NCT00235716|54723603|FG000|Overall Study|Physician Decision|0|||
28068459|NCT00235716|54723604|FG001|Overall Study|Physician Decision|1|||
28068460|NCT00235716|54723605|FG002|Overall Study|Physician Decision|1|||
28068461|NCT00235716|54723606|FG003|Overall Study|Physician Decision|3|||
28068462|NCT00274742|54723622|FG000|Overall Study|Adverse Event|0|||
28068463|NCT00274742|54723623|FG001|Overall Study|Adverse Event|4|||
28068464|NCT00274742|54723624|FG002|Overall Study|Adverse Event|1|||
28068465|NCT00274742|54723625|FG003|Overall Study|Adverse Event|4|||
28068466|NCT00274742|54723626|FG004|Overall Study|Adverse Event|12|||
28068467|NCT00274742|54723627|FG005|Overall Study|Adverse Event|3|||
28068468|NCT00274742|54723622|FG000|Overall Study|Lost to Follow-up|0|||
28068469|NCT00274742|54723623|FG001|Overall Study|Lost to Follow-up|0|||
28068470|NCT00274742|54723624|FG002|Overall Study|Lost to Follow-up|0|||
28068471|NCT00274742|54723625|FG003|Overall Study|Lost to Follow-up|0|||
28068472|NCT00274742|54723626|FG004|Overall Study|Lost to Follow-up|1|||
28068473|NCT00274742|54723627|FG005|Overall Study|Lost to Follow-up|0|||
28068474|NCT00274742|54723622|FG000|Overall Study|End of Study|0|||
28068475|NCT00274742|54723623|FG001|Overall Study|End of Study|0|||
28068476|NCT00274742|54723624|FG002|Overall Study|End of Study|0|||
28068477|NCT00274742|54723625|FG003|Overall Study|End of Study|1|||
28068478|NCT00274742|54723626|FG004|Overall Study|End of Study|0|||
28068479|NCT00274742|54723627|FG005|Overall Study|End of Study|0|||
28068480|NCT00274742|54723622|FG000|Overall Study|Disease Progression|0|||
28068481|NCT00274742|54723623|FG001|Overall Study|Disease Progression|1|||
28068482|NCT00274742|54723624|FG002|Overall Study|Disease Progression|1|||
28068483|NCT00274742|54723625|FG003|Overall Study|Disease Progression|0|||
28068484|NCT00274742|54723626|FG004|Overall Study|Disease Progression|1|||
28068485|NCT00274742|54723627|FG005|Overall Study|Disease Progression|0|||
27940597|NCT01189032|54596890|FG002|Overall Study|Lack of Efficacy|0|||
28068486|NCT00274742|54723622|FG000|Overall Study|Other|0|||
28068487|NCT00274742|54723623|FG001|Overall Study|Other|3|||
28068488|NCT00274742|54723624|FG002|Overall Study|Other|0|||
28068489|NCT00274742|54723625|FG003|Overall Study|Other|0|||
28068490|NCT00274742|54723626|FG004|Overall Study|Other|2|||
28068491|NCT00274742|54723627|FG005|Overall Study|Other|0|||
28068492|NCT00262314|54723647|FG000|Overall Study|Changing physicians|38|||
28068493|NCT00262314|54723647|FG000|Overall Study|Death|12|||
28068494|NCT00262314|54723647|FG000|Overall Study|Patient's decision|92|||
28068495|NCT00262314|54723647|FG000|Overall Study|Other|95|||
28068496|NCT00262314|54723647|FG000|Overall Study|Lost to Follow-up|70|||
28131542|NCT03573323|54794990|FG001|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12|||
28131543|NCT03573323|54794989|FG000|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8|||
28131544|NCT03573323|54794990|FG001|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19|||
27818978|NCT01609556|54277527|FG009|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
27818979|NCT01609556|54277528|FG010|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
28131545|NCT03573323|54794989|FG000|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4|||
28131546|NCT03573323|54794990|FG001|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3|||
28131547|NCT03573323|54794989|FG000|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3|||
28131548|NCT03573323|54794990|FG001|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2|||
28131549|NCT03573323|54794989|FG000|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14|||
28131550|NCT03573323|54794990|FG001|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8|||
28131551|NCT03573323|54794989|FG000|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8|||
28131552|NCT03573323|54794990|FG001|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11|||
28131553|NCT03573323|54794989|FG000|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0|||
28131554|NCT03573323|54794990|FG001|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1|||
28131555|NCT03573323|54794989|FG000|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0|||
28131556|NCT03573323|54794990|FG001|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1|||
28131557|NCT03306043|54795016|FG000|Overall Study|Adverse Event|1|||
28131558|NCT03306043|54795016|FG000|Overall Study|Lost to Follow-up|1|||
28131559|NCT03306043|54795016|FG000|Overall Study|Withdrawal by Subject|2|||
28131560|NCT01069172|54795020|FG000|Overall Study|Withdrawal by Subject|1|||
28068497|NCT00262314|54723647|FG000|Overall Study|Administrative withdrawal|30|||
28068498|NCT00283400|54723655|FG000|Overall Study|Withdrawal by Subject|1|||
28068499|NCT00283400|54723656|FG001|Overall Study|Withdrawal by Subject|1|||
28068500|NCT00283400|54723657|FG002|Overall Study|Withdrawal by Subject|0|||
28131561|NCT01069172|54795021|FG001|Overall Study|Withdrawal by Subject|0|||
28131562|NCT02911688|54795030|FG000|Washout|Lost to Follow-up|1|||
28131563|NCT02911688|54795031|FG001|Washout|Lost to Follow-up|1|||
28068501|NCT00283400|54723658|FG003|Overall Study|Withdrawal by Subject|0|||
28068502|NCT00283400|54723655|FG000|Overall Study|Death|1|||
28068503|NCT00283400|54723656|FG001|Overall Study|Death|0|||
28068504|NCT00283400|54723657|FG002|Overall Study|Death|1|||
28068505|NCT00283400|54723658|FG003|Overall Study|Death|0|||
28068506|NCT00444275|54723671|FG000|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
28068507|NCT00444275|54723672|FG001|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
28068508|NCT00444275|54723673|FG002|Maintenance Treatment Phase|Didn'r receive the treatment|22|||
28068509|NCT00444275|54723674|FG003|Maintenance Treatment Phase|Didn'r receive the treatment|17|||
28068510|NCT00444275|54723675|FG004|Maintenance Treatment Phase|Didn'r receive the treatment|29|||
28068511|NCT00444275|54723671|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
28068512|NCT00444275|54723672|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
28068513|NCT00444275|54723673|FG002|Maintenance Treatment Phase|Lost to Follow-up|8|||
28068514|NCT00444275|54723674|FG003|Maintenance Treatment Phase|Lost to Follow-up|14|||
28068515|NCT00444275|54723675|FG004|Maintenance Treatment Phase|Lost to Follow-up|10|||
28068516|NCT00444275|54723671|FG000|Maintenance Treatment Phase|Adverse Event|0|||
28068517|NCT00444275|54723672|FG001|Maintenance Treatment Phase|Adverse Event|0|||
28068518|NCT00444275|54723673|FG002|Maintenance Treatment Phase|Adverse Event|3|||
28068519|NCT00444275|54723674|FG003|Maintenance Treatment Phase|Adverse Event|2|||
28068520|NCT00444275|54723675|FG004|Maintenance Treatment Phase|Adverse Event|13|||
28068521|NCT00444275|54723671|FG000|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
28068522|NCT00444275|54723672|FG001|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
28068523|NCT00444275|54723673|FG002|Maintenance Treatment Phase|Protocol specific criteria's development|1|||
28068524|NCT00444275|54723674|FG003|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
27818980|NCT01609556|54277529|FG011|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
28068525|NCT00444275|54723675|FG004|Maintenance Treatment Phase|Protocol specific criteria's development|6|||
28068526|NCT00444275|54723671|FG000|Maintenance Treatment Phase|Patient's wish|0|||
28068527|NCT00444275|54723672|FG001|Maintenance Treatment Phase|Patient's wish|0|||
28068528|NCT00444275|54723673|FG002|Maintenance Treatment Phase|Patient's wish|19|||
27818981|NCT01609556|54277530|FG012|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
27818982|NCT01609556|54277531|FG013|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
27818983|NCT01609556|54277532|FG014|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
27818984|NCT01609556|54277533|FG015|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
27818985|NCT01609556|54277518|FG000|Dose Escalation: Maximum 101.3 Weeks|Death|2|||
27818986|NCT01609556|54277519|FG001|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
27818987|NCT01609556|54277520|FG002|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
27818988|NCT01609556|54277521|FG003|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
27818989|NCT01609556|54277522|FG004|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
27818990|NCT01609556|54277523|FG005|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
27818991|NCT01609556|54277524|FG006|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
27818992|NCT01609556|54277525|FG007|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
27818993|NCT01609556|54277526|FG008|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
27818994|NCT01609556|54277527|FG009|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
27818995|NCT01609556|54277528|FG010|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
27818996|NCT01609556|54277529|FG011|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
27818997|NCT01609556|54277530|FG012|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
27818998|NCT01609556|54277531|FG013|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
27818999|NCT01609556|54277532|FG014|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
27819000|NCT01609556|54277533|FG015|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
27819001|NCT01609556|54277518|FG000|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
27819002|NCT01609556|54277519|FG001|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
27819003|NCT01609556|54277520|FG002|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
27819004|NCT01609556|54277521|FG003|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
27819005|NCT01609556|54277522|FG004|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
27819006|NCT01609556|54277523|FG005|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
27819007|NCT01609556|54277524|FG006|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
27819008|NCT01609556|54277525|FG007|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
27819009|NCT01609556|54277526|FG008|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
27819010|NCT01609556|54277527|FG009|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
27819011|NCT01609556|54277528|FG010|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
27819012|NCT01609556|54277529|FG011|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
27819013|NCT01609556|54277530|FG012|Dose Expansion: Maximum 124 Weeks|Adverse Event|4|||
27819014|NCT01609556|54277531|FG013|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
27819015|NCT01609556|54277532|FG014|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
28068529|NCT00444275|54723674|FG003|Maintenance Treatment Phase|Patient's wish|9|||
28068530|NCT00444275|54723675|FG004|Maintenance Treatment Phase|Patient's wish|20|||
28068531|NCT00444275|54723671|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
28068532|NCT00444275|54723672|FG001|Maintenance Treatment Phase|Protocol Violation|0|||
28068533|NCT00444275|54723673|FG002|Maintenance Treatment Phase|Protocol Violation|103|||
28068534|NCT00444275|54723674|FG003|Maintenance Treatment Phase|Protocol Violation|88|||
28068535|NCT00444275|54723675|FG004|Maintenance Treatment Phase|Protocol Violation|87|||
28068536|NCT00444275|54723671|FG000|Maintenance Treatment Phase|Ineffectiveness|0|||
28068537|NCT00444275|54723672|FG001|Maintenance Treatment Phase|Ineffectiveness|0|||
28068538|NCT00444275|54723673|FG002|Maintenance Treatment Phase|Ineffectiveness|5|||
28068539|NCT00444275|54723674|FG003|Maintenance Treatment Phase|Ineffectiveness|3|||
28068540|NCT00444275|54723675|FG004|Maintenance Treatment Phase|Ineffectiveness|14|||
28068541|NCT00454805|54723692|FG000|Overall Study|Withdrawal by Subject|9|||
28068542|NCT00454805|54723693|FG001|Overall Study|Withdrawal by Subject|2|||
28068543|NCT00454805|54723692|FG000|Overall Study|Death|0|||
28068544|NCT00454805|54723693|FG001|Overall Study|Death|2|||
28068545|NCT00454805|54723692|FG000|Overall Study|Disease progression|16|||
28068546|NCT00454805|54723693|FG001|Overall Study|Disease progression|19|||
28068547|NCT00454805|54723692|FG000|Overall Study|In order to begin radiotherapy|1|||
28068548|NCT00454805|54723693|FG001|Overall Study|In order to begin radiotherapy|0|||
28068549|NCT00283244|54723702|FG000|Overall Study|Adverse Event|0|||
28068550|NCT00283244|54723703|FG001|Overall Study|Adverse Event|8|||
28068551|NCT00283244|54723704|FG002|Overall Study|Adverse Event|11|||
28068552|NCT00283244|54723702|FG000|Overall Study|Death|4|||
28068553|NCT00283244|54723703|FG001|Overall Study|Death|3|||
28068554|NCT00283244|54723704|FG002|Overall Study|Death|2|||
28131564|NCT02911688|54795030|FG000|Washout|Withdrawal by Subject|0|||
27819016|NCT01609556|54277533|FG015|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
27819017|NCT01609556|54277518|FG000|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
27819018|NCT01609556|54277519|FG001|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
27819019|NCT01609556|54277520|FG002|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
27819020|NCT01609556|54277521|FG003|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
28068555|NCT00283244|54723702|FG000|Overall Study|Lack of Efficacy|8|||
28068556|NCT00283244|54723703|FG001|Overall Study|Lack of Efficacy|32|||
28068557|NCT00283244|54723704|FG002|Overall Study|Lack of Efficacy|26|||
28068558|NCT00283244|54723702|FG000|Overall Study|Withdrawal by Subject|1|||
28068559|NCT00283244|54723703|FG001|Overall Study|Withdrawal by Subject|2|||
28131565|NCT02911688|54795031|FG001|Washout|Withdrawal by Subject|1|||
28131566|NCT02670928|54795041|FG000|Overall Study|Adverse Event|3|||
28131567|NCT02670928|54795042|FG001|Overall Study|Adverse Event|1|||
28131568|NCT02670928|54795041|FG000|Overall Study|Withdrawal by Subject|4|||
28131569|NCT02670928|54795042|FG001|Overall Study|Withdrawal by Subject|0|||
28131570|NCT02670928|54795041|FG000|Overall Study|Lost to Follow-up|1|||
28131571|NCT02670928|54795042|FG001|Overall Study|Lost to Follow-up|0|||
28131572|NCT02670928|54795041|FG000|Overall Study|Miss 3 classes in a row in first 12 wks|2|||
28131573|NCT02670928|54795042|FG001|Overall Study|Miss 3 classes in a row in first 12 wks|0|||
28131574|NCT03305809|54795052|FG000|Overall Study|Adverse Event|2|||
28131575|NCT03305809|54795053|FG001|Overall Study|Adverse Event|2|||
28131576|NCT03305809|54795054|FG002|Overall Study|Adverse Event|6|||
28131577|NCT03305809|54795055|FG003|Overall Study|Adverse Event|6|||
28131578|NCT03305809|54795052|FG000|Overall Study|Death|0|||
28131579|NCT03305809|54795053|FG001|Overall Study|Death|0|||
28131580|NCT03305809|54795054|FG002|Overall Study|Death|1|||
28131581|NCT03305809|54795055|FG003|Overall Study|Death|1|||
28131582|NCT03305809|54795052|FG000|Overall Study|Lost to Follow-up|1|||
28131583|NCT03305809|54795053|FG001|Overall Study|Lost to Follow-up|2|||
28131584|NCT03305809|54795054|FG002|Overall Study|Lost to Follow-up|0|||
27940598|NCT01189032|54596888|FG000|Overall Study|Withdrawal by Subject|1|||
27940599|NCT01189032|54596889|FG001|Overall Study|Withdrawal by Subject|0|||
27940600|NCT01189032|54596890|FG002|Overall Study|Withdrawal by Subject|1|||
27940601|NCT01189032|54596888|FG000|Overall Study|Protocol Violation|1|||
27940602|NCT01189032|54596889|FG001|Overall Study|Protocol Violation|1|||
27940603|NCT01189032|54596890|FG002|Overall Study|Protocol Violation|1|||
27819021|NCT01609556|54277522|FG004|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
27819022|NCT01609556|54277523|FG005|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
27819023|NCT01609556|54277524|FG006|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
27819024|NCT01609556|54277525|FG007|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
27819025|NCT01609556|54277526|FG008|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
27819026|NCT01609556|54277527|FG009|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
27819027|NCT01609556|54277528|FG010|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
27819028|NCT01609556|54277529|FG011|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
27819029|NCT01609556|54277530|FG012|Dose Expansion: Maximum 124 Weeks|Disease Progression|32|||
27819030|NCT01609556|54277531|FG013|Dose Expansion: Maximum 124 Weeks|Disease Progression|13|||
27819031|NCT01609556|54277532|FG014|Dose Expansion: Maximum 124 Weeks|Disease Progression|20|||
27819032|NCT01609556|54277533|FG015|Dose Expansion: Maximum 124 Weeks|Disease Progression|27|||
27819033|NCT01609556|54277518|FG000|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
27819034|NCT01609556|54277519|FG001|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
27819035|NCT01609556|54277520|FG002|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
27819036|NCT01609556|54277521|FG003|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
27819037|NCT01609556|54277522|FG004|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
27819038|NCT01609556|54277523|FG005|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
27849733|NCT00638963|54347449|FG000|Overall Study|Withdrawal by Subject|1|||
27819039|NCT01609556|54277524|FG006|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
27849734|NCT00638963|54347450|FG001|Overall Study|Withdrawal by Subject|0|||
27940604|NCT01188798|54596900|FG000|Overall Study|Death|0|||
27940605|NCT01188798|54596901|FG001|Overall Study|Death|1|||
27940606|NCT01188798|54596900|FG000|Overall Study|Required additional transplant|1|||
27940607|NCT01188798|54596901|FG001|Overall Study|Required additional transplant|1|||
27940608|NCT01188798|54596900|FG000|Overall Study|Protocol closure|1|||
27849735|NCT00638183|54347456|FG000|Overall Study|Adverse Event|23|||
27849736|NCT00638183|54347456|FG000|Overall Study|Lack of Efficacy|14|||
27849737|NCT00638183|54347456|FG000|Overall Study|Physician Decision|9|||
27849738|NCT00638183|54347456|FG000|Overall Study|Lost to Follow-up|46|||
27849739|NCT00638183|54347456|FG000|Overall Study|Other reason not defined above|27|||
27849740|NCT00638027|54347462|FG000|Overall Study|Adverse Event|0|||
27849741|NCT00638027|54347463|FG001|Overall Study|Adverse Event|2|||
27849742|NCT00636155|54347469|FG000|Overall Study|Adverse Event|8|||
27849743|NCT00636155|54347469|FG000|Overall Study|Lack of Efficacy|1|||
27849744|NCT00636155|54347469|FG000|Overall Study|Withdrawal by Subject|3|||
27940609|NCT01188798|54596901|FG001|Overall Study|Protocol closure|1|||
27940610|NCT01183104|54596910|FG000|Overall Study|Adverse Event|8|||
28131585|NCT03305809|54795055|FG003|Overall Study|Lost to Follow-up|0|||
28131586|NCT03305809|54795052|FG000|Overall Study|Sponsor Decision|1|||
28131587|NCT03305809|54795053|FG001|Overall Study|Sponsor Decision|0|||
28131588|NCT03305809|54795054|FG002|Overall Study|Sponsor Decision|1|||
28131589|NCT03305809|54795055|FG003|Overall Study|Sponsor Decision|8|||
27940611|NCT01183104|54596911|FG001|Overall Study|Adverse Event|6|||
27940612|NCT01183104|54596910|FG000|Overall Study|Death|0|||
27940613|NCT01183104|54596911|FG001|Overall Study|Death|1|||
27940614|NCT01183104|54596910|FG000|Overall Study|Lost to Follow-up|14|||
27940615|NCT01183104|54596911|FG001|Overall Study|Lost to Follow-up|7|||
27940616|NCT01183104|54596910|FG000|Overall Study|Physician Decision|5|||
27940617|NCT01183104|54596911|FG001|Overall Study|Physician Decision|8|||
27940618|NCT01183104|54596910|FG000|Overall Study|Withdrawal by Subject|6|||
28131590|NCT03305809|54795052|FG000|Overall Study|Physician Decision|0|||
28131591|NCT03305809|54795053|FG001|Overall Study|Physician Decision|0|||
28131592|NCT03305809|54795054|FG002|Overall Study|Physician Decision|2|||
28131593|NCT03305809|54795055|FG003|Overall Study|Physician Decision|4|||
28131594|NCT03305809|54795052|FG000|Overall Study|Progressive Disease|0|||
28131595|NCT03305809|54795053|FG001|Overall Study|Progressive Disease|0|||
28131596|NCT03305809|54795054|FG002|Overall Study|Progressive Disease|1|||
27819040|NCT01609556|54277525|FG007|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
28131597|NCT03305809|54795055|FG003|Overall Study|Progressive Disease|0|||
28131598|NCT03305809|54795052|FG000|Overall Study|Protocol Violation|1|||
28131599|NCT03305809|54795053|FG001|Overall Study|Protocol Violation|0|||
28131600|NCT03305809|54795054|FG002|Overall Study|Protocol Violation|2|||
28131601|NCT03305809|54795055|FG003|Overall Study|Protocol Violation|3|||
28131602|NCT03305809|54795052|FG000|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
28131603|NCT03305809|54795053|FG001|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
28131604|NCT03305809|54795054|FG002|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
28131605|NCT03305809|54795055|FG003|Overall Study|Withdrawal due to Assessment Committee Decision|2|||
28131606|NCT03305809|54795052|FG000|Overall Study|Withdrawal by Subject|2|||
28131607|NCT03305809|54795053|FG001|Overall Study|Withdrawal by Subject|4|||
28131608|NCT03305809|54795054|FG002|Overall Study|Withdrawal by Subject|5|||
28131609|NCT03305809|54795055|FG003|Overall Study|Withdrawal by Subject|2|||
28131610|NCT03305809|54795052|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
28131611|NCT03305809|54795053|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
28131612|NCT03305809|54795054|FG002|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
28131613|NCT03305809|54795055|FG003|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
28131614|NCT02994056|54795068|FG000|Overall Study|Death|8|||
28131615|NCT02994056|54795068|FG000|Overall Study|Withdrew Consent|1|||
28131616|NCT03548051|54795087|FG000|Overall Study|Death|1|||
28131617|NCT03548051|54795088|FG001|Overall Study|Death|1|||
28131618|NCT03548051|54795087|FG000|Overall Study|Withdrawal by Subject|1|||
28131619|NCT03548051|54795088|FG001|Overall Study|Withdrawal by Subject|0|||
28131620|NCT03305731|54795094|FG000|Overall Study|Protocol Violation|1|||
28131621|NCT03305575|54795100|FG000|Overall Study|Physician Decision|1|||
28131622|NCT03305575|54795101|FG001|Overall Study|Physician Decision|0|||
27819041|NCT01609556|54277526|FG008|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
27819042|NCT01609556|54277527|FG009|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
27819043|NCT01609556|54277528|FG010|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
28131623|NCT02993822|54795111|FG000|Overall Study|Lack of Efficacy|1|||
28131624|NCT02993822|54795112|FG001|Overall Study|Lack of Efficacy|1|||
28131625|NCT02993822|54795113|FG002|Overall Study|Lack of Efficacy|0|||
28131626|NCT02993822|54795114|FG003|Overall Study|Lack of Efficacy|0|||
28131627|NCT02993822|54795111|FG000|Overall Study|Protocol Violation|1|||
28131628|NCT02993822|54795112|FG001|Overall Study|Protocol Violation|0|||
27819044|NCT01609556|54277529|FG011|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
27819045|NCT01609556|54277530|FG012|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
27940619|NCT01183104|54596911|FG001|Overall Study|Withdrawal by Subject|11|||
27940620|NCT01183104|54596910|FG000|Overall Study|Nonparticipation in Extension Study|39|||
27940621|NCT01183104|54596911|FG001|Overall Study|Nonparticipation in Extension Study|50|||
27940622|NCT01183104|54596910|FG000|Overall Study|Did not receive study drug|5|||
27940623|NCT01183104|54596911|FG001|Overall Study|Did not receive study drug|9|||
28131629|NCT02993822|54795113|FG002|Overall Study|Protocol Violation|0|||
28131630|NCT02993822|54795114|FG003|Overall Study|Protocol Violation|0|||
28131631|NCT02993822|54795111|FG000|Overall Study|Unable to attend follow-up due to illness|0|||
28131632|NCT02993822|54795112|FG001|Overall Study|Unable to attend follow-up due to illness|0|||
28131633|NCT02993822|54795113|FG002|Overall Study|Unable to attend follow-up due to illness|0|||
28131634|NCT02993822|54795114|FG003|Overall Study|Unable to attend follow-up due to illness|1|||
28131635|NCT02993822|54795111|FG000|Overall Study|Adverse Event|3|||
28131636|NCT02993822|54795112|FG001|Overall Study|Adverse Event|1|||
28131637|NCT02993822|54795113|FG002|Overall Study|Adverse Event|7|||
28131638|NCT02993822|54795114|FG003|Overall Study|Adverse Event|0|||
27819046|NCT01609556|54277531|FG013|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
27819047|NCT01609556|54277532|FG014|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
27819048|NCT01609556|54277533|FG015|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2|||
27819049|NCT01609556|54277518|FG000|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
28131639|NCT02993822|54795111|FG000|Overall Study|Withdrawal by Subject|4|||
28131640|NCT02993822|54795112|FG001|Overall Study|Withdrawal by Subject|2|||
28131641|NCT02993822|54795113|FG002|Overall Study|Withdrawal by Subject|2|||
28131642|NCT02993822|54795114|FG003|Overall Study|Withdrawal by Subject|3|||
28131643|NCT02993822|54795111|FG000|Overall Study|Lost to Follow-up|1|||
28131644|NCT02993822|54795112|FG001|Overall Study|Lost to Follow-up|0|||
28131645|NCT02993822|54795113|FG002|Overall Study|Lost to Follow-up|1|||
28131646|NCT02993822|54795114|FG003|Overall Study|Lost to Follow-up|0|||
28131647|NCT01068860|54795134|FG000|Overall Study|Withdrawal by Subject|0|||
28131648|NCT01068860|54795135|FG001|Overall Study|Withdrawal by Subject|0|||
28131649|NCT01068860|54795136|FG002|Overall Study|Withdrawal by Subject|0|||
28131650|NCT01068860|54795137|FG003|Overall Study|Withdrawal by Subject|0|||
28131651|NCT01068860|54795138|FG004|Overall Study|Withdrawal by Subject|0|||
28131652|NCT01068860|54795139|FG005|Overall Study|Withdrawal by Subject|2|||
28131653|NCT01068860|54795140|FG006|Overall Study|Withdrawal by Subject|0|||
28131654|NCT01068860|54795141|FG007|Overall Study|Withdrawal by Subject|0|||
28131655|NCT01068860|54795142|FG008|Overall Study|Withdrawal by Subject|0|||
28131656|NCT01068860|54795143|FG009|Overall Study|Withdrawal by Subject|3|||
28131657|NCT01068860|54795134|FG000|Overall Study|Administrative problems; misrandomized|0|||
28131658|NCT01068860|54795135|FG001|Overall Study|Administrative problems; misrandomized|0|||
28131659|NCT01068860|54795136|FG002|Overall Study|Administrative problems; misrandomized|0|||
28131660|NCT01068860|54795137|FG003|Overall Study|Administrative problems; misrandomized|1|||
28131661|NCT01068860|54795138|FG004|Overall Study|Administrative problems; misrandomized|0|||
28131662|NCT01068860|54795139|FG005|Overall Study|Administrative problems; misrandomized|0|||
28131663|NCT01068860|54795140|FG006|Overall Study|Administrative problems; misrandomized|0|||
28131664|NCT01068860|54795141|FG007|Overall Study|Administrative problems; misrandomized|0|||
28131665|NCT01068860|54795142|FG008|Overall Study|Administrative problems; misrandomized|0|||
28131666|NCT01068860|54795143|FG009|Overall Study|Administrative problems; misrandomized|1|||
28131667|NCT01068860|54795134|FG000|Overall Study|Lost to Follow-up|0|||
28131668|NCT01068860|54795135|FG001|Overall Study|Lost to Follow-up|1|||
28131669|NCT01068860|54795136|FG002|Overall Study|Lost to Follow-up|0|||
28131670|NCT01068860|54795137|FG003|Overall Study|Lost to Follow-up|0|||
28131671|NCT01068860|54795138|FG004|Overall Study|Lost to Follow-up|0|||
28131672|NCT01068860|54795139|FG005|Overall Study|Lost to Follow-up|0|||
28131673|NCT01068860|54795140|FG006|Overall Study|Lost to Follow-up|0|||
28131674|NCT01068860|54795141|FG007|Overall Study|Lost to Follow-up|0|||
28131675|NCT01068860|54795142|FG008|Overall Study|Lost to Follow-up|0|||
28131676|NCT01068860|54795143|FG009|Overall Study|Lost to Follow-up|0|||
28131677|NCT02989610|54795165|FG000|Overall Study|Withdrawal/Other reasons|39|||
28131678|NCT01372774|54795171|FG000|Overall Study|Withdrawal prior to treatment|4|||
28131679|NCT01372774|54795172|FG001|Overall Study|Withdrawal prior to treatment|5|||
28131680|NCT02670538|54795183|FG000|Overall Study|Withdrawal of Consent|8|||
28131681|NCT02670538|54795184|FG001|Overall Study|Withdrawal of Consent|6|||
27819050|NCT01609556|54277519|FG001|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
27940624|NCT01163292|54596919|FG000|Overall Study|Lack of Efficacy|9|||
27940625|NCT01163292|54596920|FG001|Overall Study|Lack of Efficacy|0|||
27819051|NCT01609556|54277520|FG002|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
28131682|NCT02670538|54795185|FG002|Overall Study|Withdrawal of Consent|5|||
28131683|NCT02670538|54795183|FG000|Overall Study|Lost to Follow-up|8|||
28131684|NCT02670538|54795184|FG001|Overall Study|Lost to Follow-up|12|||
28131685|NCT02670538|54795185|FG002|Overall Study|Lost to Follow-up|7|||
28131686|NCT02670538|54795183|FG000|Overall Study|Adverse Event|5|||
28131687|NCT02670538|54795184|FG001|Overall Study|Adverse Event|5|||
28131688|NCT02670538|54795185|FG002|Overall Study|Adverse Event|11|||
28131689|NCT02670538|54795183|FG000|Overall Study|Lack of Efficacy|7|||
28131690|NCT02670538|54795184|FG001|Overall Study|Lack of Efficacy|1|||
28131691|NCT02670538|54795185|FG002|Overall Study|Lack of Efficacy|2|||
28131692|NCT02670538|54795183|FG000|Overall Study|Protocol Violation|3|||
28131693|NCT02670538|54795184|FG001|Overall Study|Protocol Violation|4|||
28131694|NCT02670538|54795185|FG002|Overall Study|Protocol Violation|1|||
28131695|NCT02670538|54795183|FG000|Overall Study|Noncompliance with Study Drug|1|||
28131696|NCT02670538|54795184|FG001|Overall Study|Noncompliance with Study Drug|3|||
28131697|NCT02670538|54795185|FG002|Overall Study|Noncompliance with Study Drug|2|||
28131698|NCT02670538|54795183|FG000|Overall Study|Other Miscellaneous Reasons|0|||
28131699|NCT02670538|54795184|FG001|Overall Study|Other Miscellaneous Reasons|1|||
28131700|NCT02670538|54795185|FG002|Overall Study|Other Miscellaneous Reasons|2|||
28131701|NCT03547583|54795196|FG000|Overall Study|Adverse Event|16|||
28131702|NCT03547583|54795197|FG001|Overall Study|Adverse Event|11|||
28131703|NCT03547583|54795198|FG002|Overall Study|Adverse Event|10|||
28131704|NCT03547583|54795196|FG000|Overall Study|Death|11|||
28131705|NCT03547583|54795197|FG001|Overall Study|Death|7|||
28131706|NCT03547583|54795198|FG002|Overall Study|Death|4|||
28131707|NCT03547583|54795196|FG000|Overall Study|Lost to Follow-up|1|||
27819052|NCT01609556|54277521|FG003|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
27819053|NCT01609556|54277522|FG004|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
27819054|NCT01609556|54277523|FG005|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
27819055|NCT01609556|54277524|FG006|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
27819056|NCT01609556|54277525|FG007|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
27819057|NCT01609556|54277526|FG008|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
27819058|NCT01609556|54277527|FG009|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
27819059|NCT01609556|54277528|FG010|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
27819060|NCT01609556|54277529|FG011|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
27819061|NCT01609556|54277530|FG012|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1|||
27819062|NCT01609556|54277531|FG013|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
27819063|NCT01609556|54277532|FG014|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
28131708|NCT03547583|54795197|FG001|Overall Study|Lost to Follow-up|0|||
28131709|NCT03547583|54795198|FG002|Overall Study|Lost to Follow-up|0|||
28131710|NCT03547583|54795196|FG000|Overall Study|Non-compliance with study drug|0|||
28131711|NCT03547583|54795197|FG001|Overall Study|Non-compliance with study drug|0|||
28131712|NCT03547583|54795198|FG002|Overall Study|Non-compliance with study drug|1|||
27819064|NCT01609556|54277533|FG015|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
27819065|NCT01609556|54277518|FG000|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
27819066|NCT01609556|54277519|FG001|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
28131713|NCT03547583|54795196|FG000|Overall Study|Physician Decision|1|||
28131714|NCT03547583|54795197|FG001|Overall Study|Physician Decision|0|||
28131715|NCT03547583|54795198|FG002|Overall Study|Physician Decision|3|||
28131716|NCT03547583|54795196|FG000|Overall Study|Protocol Violation|2|||
27819067|NCT01609556|54277520|FG002|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
27819068|NCT01609556|54277521|FG003|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
27819069|NCT01609556|54277522|FG004|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
27819070|NCT01609556|54277523|FG005|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
27819071|NCT01609556|54277524|FG006|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
27819072|NCT01609556|54277525|FG007|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
27819073|NCT01609556|54277526|FG008|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
27819074|NCT01609556|54277527|FG009|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
27819075|NCT01609556|54277528|FG010|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
28131717|NCT03547583|54795197|FG001|Overall Study|Protocol Violation|1|||
28131718|NCT03547583|54795198|FG002|Overall Study|Protocol Violation|1|||
28131719|NCT03547583|54795196|FG000|Overall Study|Withdrawal by Subject|12|||
28131720|NCT03547583|54795197|FG001|Overall Study|Withdrawal by Subject|19|||
28131721|NCT03547583|54795198|FG002|Overall Study|Withdrawal by Subject|10|||
28131722|NCT03547583|54795196|FG000|Overall Study|Other|2|||
28131723|NCT03547583|54795197|FG001|Overall Study|Other|2|||
28131724|NCT03547583|54795198|FG002|Overall Study|Other|3|||
28131725|NCT02670382|54795209|FG000|Placebo lead-in Phase|Withdrawal by Subject|2|||
28131726|NCT02670382|54795210|FG001|Placebo lead-in Phase|Withdrawal by Subject|1|||
28131727|NCT02991482|54795220|FG000|Overall Study|Disease progression|56|||
28131728|NCT02991482|54795221|FG001|Overall Study|Disease progression|47|||
28131729|NCT02991482|54795220|FG000|Overall Study|Death|4|||
28131730|NCT02991482|54795221|FG001|Overall Study|Death|4|||
28131731|NCT02991482|54795220|FG000|Overall Study|Adverse Event|1|||
28131732|NCT02991482|54795221|FG001|Overall Study|Adverse Event|6|||
28131733|NCT02991482|54795220|FG000|Overall Study|Patient decision|1|||
28131734|NCT02991482|54795221|FG001|Overall Study|Patient decision|1|||
28131735|NCT02991482|54795220|FG000|Overall Study|Physician Decision|0|||
27819076|NCT01609556|54277529|FG011|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
28131736|NCT02991482|54795221|FG001|Overall Study|Physician Decision|6|||
28131737|NCT02991482|54795220|FG000|Overall Study|Clinical deterioration|1|||
28131738|NCT02991482|54795221|FG001|Overall Study|Clinical deterioration|0|||
28131739|NCT02991482|54795220|FG000|Overall Study|Patient feeling too unwell|1|||
28131740|NCT02991482|54795221|FG001|Overall Study|Patient feeling too unwell|0|||
28131741|NCT02991482|54795220|FG000|Overall Study|Worsening of performance status|0|||
28131742|NCT02991482|54795221|FG001|Overall Study|Worsening of performance status|1|||
28131743|NCT02991482|54795220|FG000|Overall Study|Death prior to study drug initiation|1|||
28131744|NCT02991482|54795221|FG001|Overall Study|Death prior to study drug initiation|0|||
28131745|NCT02991482|54795220|FG000|Overall Study|Consent withdrawal prior to study drug initiation|0|||
28131746|NCT02991482|54795221|FG001|Overall Study|Consent withdrawal prior to study drug initiation|1|||
28131747|NCT02674750|54795230|FG000|Overall Study|Death|4|||
28131748|NCT02674750|54795231|FG001|Overall Study|Death|5|||
28131749|NCT02674750|54795232|FG002|Overall Study|Death|8|||
28131750|NCT02674750|54795230|FG000|Overall Study|Lost to Follow-up|0|||
28131751|NCT02674750|54795231|FG001|Overall Study|Lost to Follow-up|8|||
28131752|NCT02674750|54795232|FG002|Overall Study|Lost to Follow-up|0|||
28131753|NCT02674750|54795230|FG000|Overall Study|Lack of Efficacy|1|||
28131754|NCT02674750|54795231|FG001|Overall Study|Lack of Efficacy|17|||
28131755|NCT02674750|54795232|FG002|Overall Study|Lack of Efficacy|3|||
28131756|NCT02674750|54795230|FG000|Overall Study|Withdrawal by Subject|0|||
28131757|NCT02674750|54795231|FG001|Overall Study|Withdrawal by Subject|7|||
28131758|NCT02674750|54795232|FG002|Overall Study|Withdrawal by Subject|1|||
28131759|NCT02674750|54795230|FG000|Overall Study|Other|0|||
28131760|NCT02674750|54795231|FG001|Overall Study|Other|8|||
28131761|NCT02674750|54795232|FG002|Overall Study|Other|0|||
28131762|NCT02987972|54795261|FG000|Overall Study|Adverse Event|1|||
28131763|NCT02987972|54795262|FG001|Overall Study|Adverse Event|1|||
28131764|NCT02987972|54795263|FG002|Overall Study|Adverse Event|0|||
28131765|NCT02987972|54795261|FG000|Overall Study|Death|1|||
28131766|NCT02987972|54795262|FG001|Overall Study|Death|0|||
28131767|NCT02987972|54795263|FG002|Overall Study|Death|0|||
28131768|NCT02987972|54795261|FG000|Overall Study|Lack of Efficacy|9|||
28131769|NCT02987972|54795262|FG001|Overall Study|Lack of Efficacy|12|||
28131770|NCT02987972|54795263|FG002|Overall Study|Lack of Efficacy|12|||
28131771|NCT02987972|54795261|FG000|Overall Study|Lost to Follow-up|7|||
28131772|NCT02987972|54795262|FG001|Overall Study|Lost to Follow-up|8|||
28131773|NCT02987972|54795263|FG002|Overall Study|Lost to Follow-up|4|||
28131774|NCT02987972|54795261|FG000|Overall Study|Physician Decision|1|||
28131775|NCT02987972|54795262|FG001|Overall Study|Physician Decision|6|||
27819077|NCT01609556|54277530|FG012|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1|||
27819078|NCT01609556|54277531|FG013|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4|||
27819079|NCT01609556|54277532|FG014|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2|||
27819080|NCT01609556|54277533|FG015|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5|||
27819081|NCT01609556|54277518|FG000|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
27819082|NCT01609556|54277519|FG001|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
27819083|NCT01609556|54277520|FG002|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
27819084|NCT01609556|54277521|FG003|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
27819085|NCT01609556|54277522|FG004|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
27819086|NCT01609556|54277523|FG005|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
27819087|NCT01609556|54277524|FG006|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
27819088|NCT01609556|54277525|FG007|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
27819089|NCT01609556|54277526|FG008|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
27819090|NCT01609556|54277527|FG009|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
27819091|NCT01609556|54277528|FG010|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
27819092|NCT01609556|54277529|FG011|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
27819093|NCT01609556|54277530|FG012|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
27849745|NCT00636155|54347469|FG000|Overall Study|Stem cell transplant|1|||
27849746|NCT00636155|54347469|FG000|Overall Study|Physician Decision|5|||
27849747|NCT00634907|54347475|FG000|Overall Study|Withdrawal by Subject|3|||
27849748|NCT00634907|54347476|FG001|Overall Study|Withdrawal by Subject|0|||
27849749|NCT00634907|54347475|FG000|Overall Study|Physician Decision|3|||
27849750|NCT00634907|54347476|FG001|Overall Study|Physician Decision|9|||
27849751|NCT00634907|54347475|FG000|Overall Study|Withdrawal by Subject|11|||
27849752|NCT00634907|54347476|FG001|Overall Study|Withdrawal by Subject|8|||
27849753|NCT00634751|54347490|FG000|Phase I: 200mg Sorafenib+2DOC|Death|1|||
27849754|NCT00634751|54347491|FG001|Phase I: 200mg Sorafenib+2DOC|Death|0|||
27849755|NCT00634751|54347492|FG002|Phase I: 200mg Sorafenib+2DOC|Death|0|||
28131776|NCT02987972|54795263|FG002|Overall Study|Physician Decision|0|||
28131777|NCT02987972|54795261|FG000|Overall Study|Protocol Violation|2|||
28131778|NCT02987972|54795262|FG001|Overall Study|Protocol Violation|1|||
28131779|NCT02987972|54795263|FG002|Overall Study|Protocol Violation|5|||
28131780|NCT02987972|54795261|FG000|Overall Study|Withdrawal by Subject|22|||
27819094|NCT01609556|54277531|FG013|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
27819095|NCT01609556|54277532|FG014|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
27819096|NCT01609556|54277533|FG015|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1|||
27819097|NCT01609556|54277518|FG000|Dose Expansion: Maximum 124 Weeks|Death|0|||
27819098|NCT01609556|54277519|FG001|Dose Expansion: Maximum 124 Weeks|Death|0|||
27819099|NCT01609556|54277520|FG002|Dose Expansion: Maximum 124 Weeks|Death|0|||
27819100|NCT01609556|54277521|FG003|Dose Expansion: Maximum 124 Weeks|Death|0|||
27819101|NCT01609556|54277522|FG004|Dose Expansion: Maximum 124 Weeks|Death|0|||
27819102|NCT01609556|54277523|FG005|Dose Expansion: Maximum 124 Weeks|Death|0|||
27819103|NCT01609556|54277524|FG006|Dose Expansion: Maximum 124 Weeks|Death|0|||
27819104|NCT01609556|54277525|FG007|Dose Expansion: Maximum 124 Weeks|Death|0|||
27819105|NCT01609556|54277526|FG008|Dose Expansion: Maximum 124 Weeks|Death|0|||
27819106|NCT01609556|54277527|FG009|Dose Expansion: Maximum 124 Weeks|Death|0|||
27819107|NCT01609556|54277528|FG010|Dose Expansion: Maximum 124 Weeks|Death|0|||
27819108|NCT01609556|54277529|FG011|Dose Expansion: Maximum 124 Weeks|Death|0|||
27819109|NCT01609556|54277530|FG012|Dose Expansion: Maximum 124 Weeks|Death|4|||
27819110|NCT01609556|54277531|FG013|Dose Expansion: Maximum 124 Weeks|Death|2|||
27819111|NCT01609556|54277532|FG014|Dose Expansion: Maximum 124 Weeks|Death|0|||
27819112|NCT01609556|54277533|FG015|Dose Expansion: Maximum 124 Weeks|Death|3|||
27819113|NCT01609556|54277518|FG000|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
27819114|NCT01609556|54277519|FG001|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
27819115|NCT01609556|54277520|FG002|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
27819116|NCT01609556|54277521|FG003|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
27819117|NCT01609556|54277522|FG004|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
27819118|NCT01609556|54277523|FG005|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
27819119|NCT01609556|54277524|FG006|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
27819120|NCT01609556|54277525|FG007|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
27819121|NCT01609556|54277526|FG008|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
28068560|NCT00283244|54723704|FG002|Overall Study|Withdrawal by Subject|2|||
28068561|NCT00283244|54723702|FG000|Overall Study|Physician Decision|0|||
28068562|NCT00283244|54723703|FG001|Overall Study|Physician Decision|0|||
28068563|NCT00283244|54723704|FG002|Overall Study|Physician Decision|1|||
28068564|NCT00283244|54723702|FG000|Overall Study|Medical illness (other complicating dz)|4|||
28068565|NCT00283244|54723703|FG001|Overall Study|Medical illness (other complicating dz)|3|||
28068566|NCT00283244|54723704|FG002|Overall Study|Medical illness (other complicating dz)|6|||
28068567|NCT00283244|54723702|FG000|Overall Study|Clinical deterioration|1|||
28068568|NCT00283244|54723703|FG001|Overall Study|Clinical deterioration|3|||
28068569|NCT00283244|54723704|FG002|Overall Study|Clinical deterioration|3|||
28068570|NCT00282464|54723715|FG000|Overall Study|Adverse Event|26|||
28068571|NCT00282464|54723716|FG001|Overall Study|Adverse Event|20|||
28068572|NCT00282464|54723715|FG000|Overall Study|Lack of Efficacy|8|||
28131781|NCT02987972|54795262|FG001|Overall Study|Withdrawal by Subject|17|||
28131782|NCT02987972|54795263|FG002|Overall Study|Withdrawal by Subject|21|||
28131783|NCT03305419|54795279|FG000|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
28131784|NCT03305419|54795280|FG001|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1|||
28131785|NCT03305419|54795281|FG002|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
28131786|NCT03305419|54795282|FG003|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
28131787|NCT03305419|54795283|FG004|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
28131788|NCT03305419|54795284|FG005|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
28131789|NCT03305419|54795285|FG006|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
27819122|NCT01609556|54277527|FG009|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
28068573|NCT00282464|54723716|FG001|Overall Study|Lack of Efficacy|8|||
28068574|NCT00282464|54723715|FG000|Overall Study|Lost to Follow-up|10|||
28068575|NCT00282464|54723716|FG001|Overall Study|Lost to Follow-up|10|||
28068576|NCT00282464|54723715|FG000|Overall Study|Withdrawal by Subject|24|||
28068577|NCT00282464|54723716|FG001|Overall Study|Withdrawal by Subject|10|||
28068578|NCT00282464|54723715|FG000|Overall Study|laboratory abnormality|1|||
28068579|NCT00282464|54723716|FG001|Overall Study|laboratory abnormality|2|||
28131790|NCT03305419|54795286|FG007|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
28131791|NCT03305419|54795279|FG000|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1|||
27819123|NCT01609556|54277528|FG010|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
27819124|NCT01609556|54277529|FG011|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
27819125|NCT01609556|54277530|FG012|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1|||
27819126|NCT01609556|54277531|FG013|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
27819127|NCT01609556|54277532|FG014|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
27819128|NCT01609556|54277533|FG015|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
27819129|NCT01763996|54277907|FG000|Treatment Period 2|Adverse Event|0|||
27819130|NCT01763996|54277908|FG001|Treatment Period 2|Adverse Event|1|||
27819131|NCT01468701|54278351|FG000|Overall Study|Not eligible|91|||
27819132|NCT01468701|54278352|FG001|Overall Study|Not eligible|140|||
27819133|NCT01468701|54278353|FG002|Overall Study|Not eligible|29|||
27819134|NCT01468701|54278354|FG003|Overall Study|Not eligible|12|||
28068580|NCT00282464|54723715|FG000|Overall Study|Protocol Violation|0|||
28068581|NCT00282464|54723716|FG001|Overall Study|Protocol Violation|7|||
28131792|NCT03305419|54795280|FG001|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
28131793|NCT03305419|54795281|FG002|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
28131794|NCT03305419|54795282|FG003|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
28131795|NCT03305419|54795283|FG004|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
28131796|NCT03305419|54795284|FG005|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
28131797|NCT03305419|54795285|FG006|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
28131798|NCT03305419|54795286|FG007|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
28131799|NCT03305419|54795279|FG000|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1|||
28131800|NCT03305419|54795280|FG001|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
28131801|NCT03305419|54795281|FG002|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
28131802|NCT03305419|54795282|FG003|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
28131803|NCT03305419|54795283|FG004|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
28131804|NCT03305419|54795284|FG005|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
28131805|NCT03305419|54795285|FG006|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
28131806|NCT03305419|54795286|FG007|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
28131807|NCT03305419|54795279|FG000|Part B (14 Days)|Adverse Event|0|||
28131808|NCT03305419|54795280|FG001|Part B (14 Days)|Adverse Event|0|||
28131809|NCT03305419|54795281|FG002|Part B (14 Days)|Adverse Event|0|||
28131810|NCT03305419|54795282|FG003|Part B (14 Days)|Adverse Event|0|||
28131811|NCT03305419|54795283|FG004|Part B (14 Days)|Adverse Event|1|||
28131812|NCT03305419|54795284|FG005|Part B (14 Days)|Adverse Event|2|||
28131813|NCT03305419|54795285|FG006|Part B (14 Days)|Adverse Event|4|||
28131814|NCT03305419|54795286|FG007|Part B (14 Days)|Adverse Event|0|||
28131815|NCT03305419|54795279|FG000|Part B (14 Days)|Physician Decision|0|||
28131816|NCT03305419|54795280|FG001|Part B (14 Days)|Physician Decision|0|||
28131817|NCT03305419|54795281|FG002|Part B (14 Days)|Physician Decision|0|||
28131818|NCT03305419|54795282|FG003|Part B (14 Days)|Physician Decision|0|||
28131819|NCT03305419|54795283|FG004|Part B (14 Days)|Physician Decision|2|||
27819135|NCT01468701|54278355|FG004|Overall Study|Not eligible|22|||
27819136|NCT01468701|54278356|FG005|Overall Study|Not eligible|2|||
27819137|NCT01468701|54278357|FG006|Overall Study|Not eligible|39|||
27819138|NCT01468701|54278358|FG007|Overall Study|Not eligible|1|||
27819139|NCT01468701|54278359|FG008|Overall Study|Not eligible|40|||
27819140|NCT01468701|54278360|FG009|Overall Study|Not eligible|126|||
27819141|NCT01468701|54278361|FG010|Overall Study|Not eligible|39|||
27819142|NCT01468701|54278362|FG011|Overall Study|Not eligible|33|||
27819143|NCT01468701|54278363|FG012|Overall Study|Not eligible|1|||
27819144|NCT01468701|54278364|FG013|Overall Study|Not eligible|19|||
27819145|NCT01468701|54278365|FG014|Overall Study|Not eligible|1|||
27819146|NCT01468701|54278366|FG015|Overall Study|Not eligible|32|||
27819147|NCT01468701|54278367|FG016|Overall Study|Not eligible|0|||
27819148|NCT01468701|54278351|FG000|Overall Study|Lost to Follow-up|306|||
27819149|NCT01468701|54278352|FG001|Overall Study|Lost to Follow-up|0|||
27819150|NCT01468701|54278353|FG002|Overall Study|Lost to Follow-up|0|||
27819151|NCT01468701|54278354|FG003|Overall Study|Lost to Follow-up|0|||
27819152|NCT01468701|54278355|FG004|Overall Study|Lost to Follow-up|0|||
27819153|NCT01468701|54278356|FG005|Overall Study|Lost to Follow-up|0|||
27819154|NCT01468701|54278357|FG006|Overall Study|Lost to Follow-up|0|||
27819155|NCT01468701|54278358|FG007|Overall Study|Lost to Follow-up|0|||
27819156|NCT01468701|54278359|FG008|Overall Study|Lost to Follow-up|215|||
27819157|NCT01468701|54278360|FG009|Overall Study|Lost to Follow-up|309|||
27819158|NCT01468701|54278361|FG010|Overall Study|Lost to Follow-up|224|||
27819159|NCT01468701|54278362|FG011|Overall Study|Lost to Follow-up|212|||
27940626|NCT01163292|54596919|FG000|Overall Study|Adverse Event|6|||
28131820|NCT03305419|54795284|FG005|Part B (14 Days)|Physician Decision|8|||
28131821|NCT03305419|54795285|FG006|Part B (14 Days)|Physician Decision|1|||
28131822|NCT03305419|54795286|FG007|Part B (14 Days)|Physician Decision|0|||
28131823|NCT01372618|54795309|FG000|Overall Study|PI Died. Study Terminated|9|||
28131824|NCT03304873|54795315|FG000|Overall Study|Lost to Follow-up|1|||
28131825|NCT03304873|54795316|FG001|Overall Study|Lost to Follow-up|8|||
28131826|NCT02669758|54795322|FG000|Overall Study|Withdrawal by Subject|43|||
27819160|NCT01468701|54278363|FG012|Overall Study|Lost to Follow-up|11|||
27819161|NCT01468701|54278364|FG013|Overall Study|Lost to Follow-up|164|||
27819162|NCT01468701|54278365|FG014|Overall Study|Lost to Follow-up|17|||
27819163|NCT01468701|54278366|FG015|Overall Study|Lost to Follow-up|127|||
27819164|NCT01468701|54278367|FG016|Overall Study|Lost to Follow-up|1|||
27819165|NCT01468701|54278351|FG000|Overall Study|Withdrawal by Subject|165|||
27819166|NCT01468701|54278352|FG001|Overall Study|Withdrawal by Subject|0|||
27819167|NCT01468701|54278353|FG002|Overall Study|Withdrawal by Subject|0|||
27819168|NCT01468701|54278354|FG003|Overall Study|Withdrawal by Subject|0|||
27819169|NCT01468701|54278355|FG004|Overall Study|Withdrawal by Subject|0|||
27819170|NCT01468701|54278356|FG005|Overall Study|Withdrawal by Subject|0|||
27819171|NCT01468701|54278357|FG006|Overall Study|Withdrawal by Subject|0|||
27819172|NCT01468701|54278358|FG007|Overall Study|Withdrawal by Subject|0|||
27819173|NCT01468701|54278359|FG008|Overall Study|Withdrawal by Subject|83|||
28131827|NCT02669758|54795322|FG000|Overall Study|Lost to Follow-up|19|||
28131828|NCT02669758|54795322|FG000|Overall Study|Adverse Event|16|||
28131829|NCT02669758|54795322|FG000|Overall Study|Non-Compliance with Study Drug|8|||
28131830|NCT02669758|54795322|FG000|Overall Study|Lack of Efficacy|5|||
28131831|NCT02669758|54795322|FG000|Overall Study|Pregnancy|1|||
28131832|NCT02669758|54795322|FG000|Overall Study|Study noncompliance|1|||
28131833|NCT02669758|54795322|FG000|Overall Study|Protocol Violation|1|||
28131834|NCT02987660|54795328|FG000|Overall Study|Study terminated by sponsor|10|||
28131835|NCT02987660|54795329|FG001|Overall Study|Study terminated by sponsor|10|||
28131836|NCT04528069|54795335|FG000|Overall Study|Adverse Event|1|||
28131837|NCT04528069|54795335|FG000|Overall Study|Lost to Follow-up|1|||
28131838|NCT04528069|54795335|FG000|Overall Study|Patient Unable to Come|1|||
28131839|NCT04528069|54795335|FG000|Overall Study|Patient Unable to Attend|1|||
28131840|NCT03303469|54795351|FG000|Overall Study|Lost to Follow-up|2|||
28131841|NCT02990000|54795357|FG000|Overall Study|Failed to provide data beyond baseline|36|||
28131842|NCT02990000|54795358|FG001|Overall Study|Failed to provide data beyond baseline|34|||
27819174|NCT01468701|54278360|FG009|Overall Study|Withdrawal by Subject|88|||
27819175|NCT01468701|54278361|FG010|Overall Study|Withdrawal by Subject|100|||
27819176|NCT01468701|54278362|FG011|Overall Study|Withdrawal by Subject|114|||
27819177|NCT01468701|54278363|FG012|Overall Study|Withdrawal by Subject|9|||
27819178|NCT01468701|54278364|FG013|Overall Study|Withdrawal by Subject|47|||
27819179|NCT01468701|54278365|FG014|Overall Study|Withdrawal by Subject|6|||
27819180|NCT01468701|54278366|FG015|Overall Study|Withdrawal by Subject|31|||
27819181|NCT01468701|54278367|FG016|Overall Study|Withdrawal by Subject|0|||
27819182|NCT01468701|54278351|FG000|Overall Study|Other reasons than listed|437|||
27819183|NCT01468701|54278352|FG001|Overall Study|Other reasons than listed|0|||
27819184|NCT01468701|54278353|FG002|Overall Study|Other reasons than listed|0|||
27819185|NCT01468701|54278354|FG003|Overall Study|Other reasons than listed|0|||
27819186|NCT01468701|54278355|FG004|Overall Study|Other reasons than listed|0|||
27819187|NCT01468701|54278356|FG005|Overall Study|Other reasons than listed|0|||
27819188|NCT01468701|54278357|FG006|Overall Study|Other reasons than listed|0|||
27819189|NCT01468701|54278358|FG007|Overall Study|Other reasons than listed|0|||
28131843|NCT01068626|54795366|FG000|Overall Study|Adverse Event|3|||
27819190|NCT01468701|54278359|FG008|Overall Study|Other reasons than listed|318|||
28131844|NCT01068626|54795367|FG001|Overall Study|Adverse Event|0|||
28131845|NCT01068626|54795366|FG000|Overall Study|Withdrawal by Subject|0|||
28131846|NCT01068626|54795367|FG001|Overall Study|Withdrawal by Subject|2|||
28131847|NCT02921750|54795375|FG000|Overall Study|Adverse Event|1|||
28131848|NCT02921750|54795376|FG001|Overall Study|Adverse Event|2|||
28131849|NCT02921750|54795375|FG000|Overall Study|Withdrawal by Subject|1|||
28131850|NCT02921750|54795376|FG001|Overall Study|Withdrawal by Subject|1|||
28131851|NCT02921750|54795375|FG000|Overall Study|Lost to Follow-up|3|||
27819191|NCT01468701|54278360|FG009|Overall Study|Other reasons than listed|658|||
27819192|NCT01468701|54278361|FG010|Overall Study|Other reasons than listed|433|||
27940627|NCT01163292|54596920|FG001|Overall Study|Adverse Event|0|||
27940628|NCT01163292|54596919|FG000|Overall Study|Initiation of biological therapy|0|||
27940629|NCT01163292|54596920|FG001|Overall Study|Initiation of biological therapy|15|||
27940630|NCT01163292|54596919|FG000|Overall Study|Sufficient response to adalimumab|8|||
27940631|NCT01163292|54596920|FG001|Overall Study|Sufficient response to adalimumab|0|||
27940632|NCT01163292|54596919|FG000|Overall Study|Refusal to receive adalimumab|7|||
27940633|NCT01163292|54596920|FG001|Overall Study|Refusal to receive adalimumab|0|||
27940634|NCT01163292|54596919|FG000|Overall Study|Economic reasons|6|||
27940635|NCT01163292|54596920|FG001|Overall Study|Economic reasons|0|||
28068582|NCT00282464|54723715|FG000|Overall Study|Patient moved|1|||
28068583|NCT00282464|54723716|FG001|Overall Study|Patient moved|0|||
28068584|NCT00282464|54723715|FG000|Overall Study|patient non-compliant|3|||
28068585|NCT00282464|54723716|FG001|Overall Study|patient non-compliant|0|||
28068586|NCT00282464|54723715|FG000|Overall Study|patient no show|0|||
28068587|NCT00282464|54723716|FG001|Overall Study|patient no show|1|||
28068588|NCT00282464|54723715|FG000|Overall Study|patient incarcerated|0|||
28068589|NCT00282464|54723716|FG001|Overall Study|patient incarcerated|1|||
28068590|NCT00282464|54723715|FG000|Overall Study|family crisis|0|||
28068591|NCT00282464|54723716|FG001|Overall Study|family crisis|1|||
28068592|NCT00282464|54723715|FG000|Overall Study|dispensed wrong kit|0|||
28131852|NCT02921750|54795376|FG001|Overall Study|Lost to Follow-up|3|||
28131853|NCT02921750|54795375|FG000|Overall Study|Wound healed|3|||
28131854|NCT02921750|54795376|FG001|Overall Study|Wound healed|3|||
28131855|NCT02921750|54795375|FG000|Overall Study|Serious Adverse Event|1|||
27819193|NCT01468701|54278362|FG011|Overall Study|Other reasons than listed|504|||
27819194|NCT01468701|54278363|FG012|Overall Study|Other reasons than listed|28|||
27819195|NCT01468701|54278364|FG013|Overall Study|Other reasons than listed|239|||
28068593|NCT00282464|54723716|FG001|Overall Study|dispensed wrong kit|1|||
28068594|NCT00282464|54723715|FG000|Overall Study|dropped due to missed visits|0|||
28068595|NCT00282464|54723716|FG001|Overall Study|dropped due to missed visits|1|||
28068596|NCT00273182|54723722|FG000|Overall Study|Death|450|||
28068597|NCT00273182|54723722|FG000|Overall Study|Lost to Follow-up|88|||
28068598|NCT00273182|54723722|FG000|Overall Study|Withdrawal by Subject|257|||
28068599|NCT00273182|54723722|FG000|Overall Study|Device/System Explant|154|||
28068600|NCT00273182|54723722|FG000|Overall Study|Site exit, system change, 36 m FU missed|36|||
28068601|NCT00209274|54723729|FG000|Overall Study|Missed visit|3|||
28068602|NCT00209274|54723730|FG001|Overall Study|Missed visit|2|||
28068603|NCT00209274|54723729|FG000|Overall Study|Death|32|||
28068604|NCT00209274|54723730|FG001|Overall Study|Death|15|||
28068605|NCT00209274|54723729|FG000|Overall Study|Withdrawal by Subject|30|||
28068606|NCT00209274|54723730|FG001|Overall Study|Withdrawal by Subject|15|||
28068607|NCT00209274|54723729|FG000|Overall Study|Randomized not treated (RNT)|6|||
28068608|NCT00209274|54723730|FG001|Overall Study|Randomized not treated (RNT)|15|||
28068609|NCT03841331|54723738|FG000|Overall Study|Withdrawal by Subject|4|||
28068610|NCT03841331|54723739|FG001|Overall Study|Withdrawal by Subject|9|||
28068611|NCT03841331|54723738|FG000|Overall Study|Lost to Follow-up|5|||
28068612|NCT03841331|54723739|FG001|Overall Study|Lost to Follow-up|1|||
28068613|NCT00262080|54723748|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
28068614|NCT00262080|54723749|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
28068615|NCT00262080|54723750|FG002|Double Blind Treatment Period|Lost to Follow-up|0|||
28068616|NCT00262080|54723748|FG000|Repeat Dose Treatment Period|Adverse Event|1|||
28068617|NCT00262080|54723749|FG001|Repeat Dose Treatment Period|Adverse Event|0|||
28068618|NCT00262080|54723750|FG002|Repeat Dose Treatment Period|Adverse Event|0|||
28068619|NCT00262080|54723748|FG000|Repeat Dose Treatment Period|Withdrawal by Subject|0|||
28068620|NCT00262080|54723749|FG001|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
28068621|NCT00262080|54723750|FG002|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
27940636|NCT01163292|54596919|FG000|Overall Study|No further visits|5|||
28068622|NCT00262080|54723748|FG000|Repeat Dose Treatment Period|Lost to Follow-up|2|||
28068623|NCT00262080|54723749|FG001|Repeat Dose Treatment Period|Lost to Follow-up|0|||
27940637|NCT01163292|54596920|FG001|Overall Study|No further visits|7|||
27940638|NCT00950248|54596928|FG000|Year 1: Baseline|Withdrawal by Subject|6|||
27940639|NCT00950248|54596929|FG001|Year 1: Baseline|Withdrawal by Subject|0|||
27940640|NCT00950248|54596930|FG002|Year 1: Baseline|Withdrawal by Subject|0|||
27940641|NCT00950248|54596928|FG000|Year 1: Baseline|worsening of symptoms|2|||
27940642|NCT00950248|54596929|FG001|Year 1: Baseline|worsening of symptoms|0|||
27940643|NCT00950248|54596930|FG002|Year 1: Baseline|worsening of symptoms|0|||
27940644|NCT00950248|54596928|FG000|Year 2&3 Treatment Randomization|worsening of symptoms|0|||
27940645|NCT00950248|54596929|FG001|Year 2&3 Treatment Randomization|worsening of symptoms|2|||
27940646|NCT00950248|54596930|FG002|Year 2&3 Treatment Randomization|worsening of symptoms|4|||
27940647|NCT00950248|54596928|FG000|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
27940648|NCT00950248|54596929|FG001|Year 2&3 Treatment Randomization|Withdrawal by Subject|3|||
27940649|NCT00950248|54596930|FG002|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
27940650|NCT00950248|54596928|FG000|Year 2&3 Treatment Randomization|Death|0|||
27940651|NCT00950248|54596929|FG001|Year 2&3 Treatment Randomization|Death|0|||
27940652|NCT00950248|54596930|FG002|Year 2&3 Treatment Randomization|Death|1|||
27940653|NCT00950248|54596928|FG000|Year 2&3 Treatment Randomization|MRI contraindication|0|||
27940654|NCT00950248|54596929|FG001|Year 2&3 Treatment Randomization|MRI contraindication|1|||
27940655|NCT00950248|54596930|FG002|Year 2&3 Treatment Randomization|MRI contraindication|0|||
27940656|NCT00950170|54596937|FG000|Overall Study|Parent/Legal Guardian Request|1|||
27940657|NCT00950170|54596937|FG000|Overall Study|Adverse Event|2|||
27940658|NCT00950170|54596937|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
27940659|NCT01227824|54596961|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|12|||
27940660|NCT01227824|54596962|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|7|||
27940661|NCT01227824|54596963|FG002|Double-blind Phase: 96 Weeks Duration|Adverse Event|0|||
27940662|NCT01227824|54596961|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22|||
27940663|NCT01227824|54596962|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25|||
27940664|NCT01227824|54596963|FG002|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0|||
27940665|NCT01227824|54596961|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18|||
27940666|NCT01227824|54596962|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16|||
28131856|NCT02921750|54795376|FG001|Overall Study|Serious Adverse Event|2|||
28131857|NCT02920970|54795385|FG000|First Intervention|Protocol Violation|0|||
28131858|NCT02920970|54795386|FG001|First Intervention|Protocol Violation|1|||
28131859|NCT02920970|54795385|FG000|First Intervention|Adverse Event|0|||
28131860|NCT02920970|54795386|FG001|First Intervention|Adverse Event|1|||
28131861|NCT02920970|54795385|FG000|Second Intervention|Poor Lens Fit|1|||
28131862|NCT02920970|54795386|FG001|Second Intervention|Poor Lens Fit|0|||
28131863|NCT01068158|54795396|FG000|Overall Study|Withdrawal by Subject|1|||
28131864|NCT01068158|54795397|FG001|Overall Study|Withdrawal by Subject|2|||
28131865|NCT01068158|54795396|FG000|Overall Study|Lost to Follow-up|7|||
28131866|NCT01068158|54795397|FG001|Overall Study|Lost to Follow-up|0|||
28131867|NCT01068158|54795396|FG000|Overall Study|Protocol Violation|0|||
28131868|NCT01068158|54795397|FG001|Overall Study|Protocol Violation|2|||
28131869|NCT03303079|54795406|FG000|Overall Study|Adverse Event|0|||
28131870|NCT03303079|54795407|FG001|Overall Study|Adverse Event|1|||
28131871|NCT03303079|54795408|FG002|Overall Study|Adverse Event|3|||
28131872|NCT03303079|54795406|FG000|Overall Study|Protocol Violation|5|||
28131873|NCT03303079|54795407|FG001|Overall Study|Protocol Violation|4|||
28131874|NCT03303079|54795408|FG002|Overall Study|Protocol Violation|7|||
28131875|NCT03303079|54795406|FG000|Overall Study|Withdrawal by Subject|2|||
28131876|NCT03303079|54795407|FG001|Overall Study|Withdrawal by Subject|4|||
28131877|NCT03303079|54795408|FG002|Overall Study|Withdrawal by Subject|2|||
28131878|NCT03303079|54795406|FG000|Overall Study|Other than specified|0|||
28131879|NCT03303079|54795407|FG001|Overall Study|Other than specified|2|||
28131880|NCT03303079|54795408|FG002|Overall Study|Other than specified|0|||
28131881|NCT01067846|54795418|FG000|Overall Study|Lost to Follow-up|17|||
28131882|NCT01067846|54795419|FG001|Overall Study|Lost to Follow-up|19|||
28131883|NCT01067846|54795418|FG000|Overall Study|Withdrawal by Subject|1|||
28131884|NCT01067846|54795419|FG001|Overall Study|Withdrawal by Subject|0|||
27940667|NCT01227824|54596963|FG002|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0|||
28131885|NCT01067846|54795418|FG000|Overall Study|participation in other tx study|1|||
28131886|NCT01067846|54795419|FG001|Overall Study|participation in other tx study|0|||
28131887|NCT03311659|54795425|FG000|Overall Study|Protocol Violation|1|||
28131888|NCT03874234|54795442|FG000|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
28131889|NCT03874234|54795443|FG001|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
28131890|NCT03874234|54795444|FG002|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
28131891|NCT03874234|54795445|FG003|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|1|||
28131892|NCT03874234|54795446|FG004|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
28131893|NCT03874234|54795447|FG005|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
28131894|NCT03874234|54795448|FG006|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
28131895|NCT03874234|54795449|FG007|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
28131896|NCT03874234|54795450|FG008|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
28131897|NCT03874234|54795451|FG009|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
28131898|NCT03874234|54795452|FG010|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
28131899|NCT03874234|54795453|FG011|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
28131900|NCT03874234|54795454|FG012|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
28131901|NCT03874234|54795442|FG000|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|1|||
28131902|NCT03874234|54795443|FG001|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
28131903|NCT03874234|54795444|FG002|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
28131904|NCT03874234|54795445|FG003|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
28131905|NCT03874234|54795446|FG004|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
28131906|NCT03874234|54795447|FG005|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
28131907|NCT03874234|54795448|FG006|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
28131908|NCT03874234|54795449|FG007|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
28131909|NCT03874234|54795450|FG008|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
28131910|NCT03874234|54795451|FG009|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
28131911|NCT03874234|54795452|FG010|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
28131912|NCT03874234|54795453|FG011|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
28131913|NCT03874234|54795454|FG012|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
28131914|NCT03874234|54795442|FG000|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
28131915|NCT03874234|54795443|FG001|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
28131916|NCT03874234|54795444|FG002|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
28131917|NCT03874234|54795445|FG003|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|1|||
28131918|NCT03874234|54795446|FG004|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
28131919|NCT03874234|54795447|FG005|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
28131920|NCT03874234|54795448|FG006|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
28131921|NCT03874234|54795449|FG007|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
28131922|NCT03874234|54795450|FG008|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
28131923|NCT03874234|54795451|FG009|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
28131924|NCT03874234|54795452|FG010|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
28131925|NCT03874234|54795453|FG011|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
28131926|NCT03874234|54795454|FG012|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
28131927|NCT03874234|54795442|FG000|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
28131928|NCT03874234|54795443|FG001|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
28131929|NCT03874234|54795444|FG002|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
28131930|NCT03874234|54795445|FG003|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
28131931|NCT03874234|54795446|FG004|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|1|||
28131932|NCT03874234|54795447|FG005|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
28131933|NCT03874234|54795448|FG006|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
28131934|NCT03874234|54795449|FG007|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
28131935|NCT03874234|54795450|FG008|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
28131936|NCT03874234|54795451|FG009|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
27819196|NCT01468701|54278365|FG014|Overall Study|Other reasons than listed|39|||
27819197|NCT01468701|54278366|FG015|Overall Study|Other reasons than listed|172|||
28131937|NCT03874234|54795452|FG010|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
28131938|NCT03874234|54795453|FG011|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
28131939|NCT03874234|54795454|FG012|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
28131940|NCT03874234|54795442|FG000|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
28131941|NCT03874234|54795443|FG001|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
28131942|NCT03874234|54795444|FG002|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
28131943|NCT03874234|54795445|FG003|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
28131944|NCT03874234|54795446|FG004|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
28131945|NCT03874234|54795447|FG005|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
28131946|NCT03874234|54795448|FG006|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
28131947|NCT03874234|54795449|FG007|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|1|||
28131948|NCT03874234|54795450|FG008|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
28131949|NCT03874234|54795451|FG009|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
28131950|NCT03874234|54795452|FG010|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
28131951|NCT03874234|54795453|FG011|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
28131952|NCT03874234|54795454|FG012|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
28131953|NCT03874234|54795442|FG000|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
28131954|NCT03874234|54795443|FG001|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
28131955|NCT03874234|54795444|FG002|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
27819198|NCT01468701|54278367|FG016|Overall Study|Other reasons than listed|0|||
27819199|NCT01468701|54278351|FG000|Overall Study|No end of study case report form|0|||
27819200|NCT01468701|54278352|FG001|Overall Study|No end of study case report form|0|||
27819201|NCT01468701|54278353|FG002|Overall Study|No end of study case report form|0|||
27819202|NCT01468701|54278354|FG003|Overall Study|No end of study case report form|0|||
27819203|NCT01468701|54278355|FG004|Overall Study|No end of study case report form|0|||
27819204|NCT01468701|54278356|FG005|Overall Study|No end of study case report form|0|||
27819205|NCT01468701|54278357|FG006|Overall Study|No end of study case report form|0|||
28068624|NCT00262080|54723750|FG002|Repeat Dose Treatment Period|Lost to Follow-up|2|||
28068625|NCT00262080|54723748|FG000|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
28068626|NCT00262080|54723749|FG001|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
28068627|NCT00262080|54723750|FG002|Repeat Dose Treatment Period|Decision to discontinue the study|2|||
28068628|NCT00262080|54723748|FG000|Repeat Dose Treatment Period|enrolled in EDEMA4|1|||
28068629|NCT00262080|54723749|FG001|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
28068630|NCT00262080|54723750|FG002|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
28131956|NCT03874234|54795445|FG003|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
28131957|NCT03874234|54795446|FG004|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
28131958|NCT03874234|54795447|FG005|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
28131959|NCT03874234|54795448|FG006|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
28131960|NCT03874234|54795449|FG007|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
28131961|NCT03874234|54795450|FG008|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
28131962|NCT03874234|54795451|FG009|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
28131963|NCT03874234|54795452|FG010|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
28131964|NCT03874234|54795453|FG011|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
28131965|NCT03874234|54795454|FG012|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
28131966|NCT03874234|54795442|FG000|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
28131967|NCT03874234|54795443|FG001|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
28131968|NCT03874234|54795444|FG002|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
28131969|NCT03874234|54795445|FG003|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
28131970|NCT03874234|54795446|FG004|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
28131971|NCT03874234|54795447|FG005|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
28131972|NCT03874234|54795448|FG006|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|1|||
28131973|NCT03874234|54795449|FG007|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
28131974|NCT03874234|54795450|FG008|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
27819206|NCT01468701|54278358|FG007|Overall Study|No end of study case report form|0|||
27819207|NCT01468701|54278359|FG008|Overall Study|No end of study case report form|4|||
27819208|NCT01468701|54278360|FG009|Overall Study|No end of study case report form|1|||
28068631|NCT00282308|54723760|FG000|Treatment Period|Lost to Follow-up|1|||
28068632|NCT00282308|54723761|FG001|Treatment Period|Lost to Follow-up|0|||
28068633|NCT00282308|54723762|FG002|Treatment Period|Lost to Follow-up|0|||
28068634|NCT00282308|54723760|FG000|Treatment Period|Subject/Guardian Decision to Withdraw|2|||
28068635|NCT00282308|54723761|FG001|Treatment Period|Subject/Guardian Decision to Withdraw|4|||
28068636|NCT00282308|54723762|FG002|Treatment Period|Subject/Guardian Decision to Withdraw|0|||
28068637|NCT00282308|54723760|FG000|Treatment Period|Adverse Event|0|||
28068638|NCT00282308|54723761|FG001|Treatment Period|Adverse Event|2|||
28068639|NCT00282308|54723762|FG002|Treatment Period|Adverse Event|0|||
28131975|NCT03874234|54795451|FG009|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
28131976|NCT03874234|54795452|FG010|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
28131977|NCT03874234|54795453|FG011|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
28131978|NCT03874234|54795454|FG012|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
28131979|NCT03874234|54795442|FG000|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
28131980|NCT03874234|54795443|FG001|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
28131981|NCT03874234|54795444|FG002|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
28131982|NCT03874234|54795445|FG003|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
28131983|NCT03874234|54795446|FG004|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|1|||
28131984|NCT03874234|54795447|FG005|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
28131985|NCT03874234|54795448|FG006|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
28131986|NCT03874234|54795449|FG007|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
28131987|NCT03874234|54795450|FG008|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
28131988|NCT03874234|54795451|FG009|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
28131989|NCT03874234|54795452|FG010|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
28131990|NCT03874234|54795453|FG011|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
28131991|NCT03874234|54795454|FG012|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
28131992|NCT02985398|54795490|FG000|Overall Study|Adverse Event|1|||
28131993|NCT02985398|54795490|FG000|Overall Study|Lost to Follow-up|4|||
28131994|NCT02985398|54795490|FG000|Overall Study|Withdrawal by Subject|8|||
28131995|NCT02985398|54795490|FG000|Overall Study|Study Burden|9|||
28131996|NCT03310723|54795496|FG000|Overall Study|Withdrawal by Subject|0|||
28131997|NCT03310723|54795497|FG001|Overall Study|Withdrawal by Subject|1|||
28131998|NCT03310723|54795496|FG000|Overall Study|Protocol Violation|0|||
28131999|NCT03310723|54795497|FG001|Overall Study|Protocol Violation|2|||
28132000|NCT02663674|54795505|FG000|Overall Study|Lost to Follow-up|5|||
28132001|NCT02663674|54795506|FG001|Overall Study|Lost to Follow-up|4|||
28132002|NCT02663674|54795505|FG000|Overall Study|Withdrawal by Subject|1|||
28132003|NCT02663674|54795506|FG001|Overall Study|Withdrawal by Subject|4|||
28132004|NCT02663674|54795505|FG000|Overall Study|Physician Decision|1|||
28132005|NCT02663674|54795506|FG001|Overall Study|Physician Decision|1|||
28132006|NCT02663674|54795505|FG000|Overall Study|Other Event (Health Related)|0|||
28132007|NCT02663674|54795506|FG001|Overall Study|Other Event (Health Related)|1|||
28132008|NCT02908880|54795512|FG000|Overall Study|Lost to Follow-up|4|||
28132009|NCT02908880|54795512|FG000|Overall Study|Explantation of the device|1|||
28132010|NCT02908880|54795512|FG000|Overall Study|Withdrawal by Subject|17|||
28132011|NCT02908880|54795512|FG000|Overall Study|Death|5|||
28132012|NCT03310411|54795516|FG000|Period 1|Adverse Event|0|||
28132013|NCT03310411|54795517|FG001|Period 1|Adverse Event|0|||
28132014|NCT03310411|54795518|FG002|Period 1|Adverse Event|0|||
28132015|NCT03310411|54795519|FG003|Period 1|Adverse Event|1|||
28132016|NCT03301831|54795537|FG000|Overall Study|Lost to Follow-up|5|||
28132017|NCT03301831|54795538|FG001|Overall Study|Lost to Follow-up|3|||
28132018|NCT03301831|54795537|FG000|Overall Study|Protocol Violation|4|||
28132019|NCT03301831|54795538|FG001|Overall Study|Protocol Violation|0|||
28132020|NCT03301831|54795537|FG000|Overall Study|Withdrawal by Subject|11|||
28132021|NCT03301831|54795538|FG001|Overall Study|Withdrawal by Subject|0|||
28132022|NCT02909504|54795544|FG000|Overall Study|Adverse Event|2|||
28132023|NCT02909504|54795544|FG000|Overall Study|Lack of Efficacy|3|||
28132024|NCT02909504|54795544|FG000|Overall Study|Withdrawal by Subject|4|||
28132025|NCT02909504|54795544|FG000|Overall Study|Pregnancy|1|||
28132026|NCT02909504|54795544|FG000|Overall Study|Subject moved|1|||
27940668|NCT01227824|54596961|FG000|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6|||
28132027|NCT02909504|54795544|FG000|Overall Study|Lost to Follow-up|1|||
28132028|NCT02199691|54795553|FG000|Overall Study|Protocol Violation|3|||
28132029|NCT02199691|54795554|FG001|Overall Study|Protocol Violation|3|||
28132030|NCT02199691|54795555|FG002|Overall Study|Protocol Violation|6|||
28132031|NCT02199691|54795556|FG003|Overall Study|Protocol Violation|7|||
28132032|NCT02199691|54795553|FG000|Overall Study|Withdrawal by Subject|5|||
28132033|NCT02199691|54795554|FG001|Overall Study|Withdrawal by Subject|3|||
28132034|NCT02199691|54795555|FG002|Overall Study|Withdrawal by Subject|12|||
28132035|NCT02199691|54795556|FG003|Overall Study|Withdrawal by Subject|13|||
28132036|NCT02199691|54795553|FG000|Overall Study|Lost to Follow-up|2|||
28132037|NCT02199691|54795554|FG001|Overall Study|Lost to Follow-up|1|||
28132038|NCT02199691|54795555|FG002|Overall Study|Lost to Follow-up|9|||
28132039|NCT02199691|54795556|FG003|Overall Study|Lost to Follow-up|10|||
28132040|NCT03299881|54795570|FG000|Overall Study|Study Termination|17|||
28132041|NCT03299881|54795571|FG001|Overall Study|Study Termination|13|||
28132042|NCT03299101|54795577|FG000|Overall Study|Lost to Follow-up|1|||
28132043|NCT03299101|54795577|FG000|Overall Study|Withdrawal by Subject|5|||
28132044|NCT03299101|54795577|FG000|Overall Study|Surgery was changed|3|||
28132045|NCT03299101|54795577|FG000|Overall Study|Not enough time to complete prehab|1|||
28132046|NCT02663128|54795583|FG000|Period 2|Physician Decision|0|||
28132047|NCT02663128|54795584|FG001|Period 2|Physician Decision|0|||
28132048|NCT02663128|54795585|FG002|Period 2|Physician Decision|0|||
28132049|NCT02663128|54795586|FG003|Period 2|Physician Decision|0|||
28132050|NCT02663128|54795587|FG004|Period 2|Physician Decision|1|||
28132051|NCT02663128|54795588|FG005|Period 2|Physician Decision|0|||
28132052|NCT03298867|54795599|FG000|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
27819209|NCT01468701|54278361|FG010|Overall Study|No end of study case report form|2|||
27819210|NCT01468701|54278362|FG011|Overall Study|No end of study case report form|3|||
27819211|NCT01468701|54278363|FG012|Overall Study|No end of study case report form|0|||
27819212|NCT01468701|54278364|FG013|Overall Study|No end of study case report form|1|||
27819213|NCT01468701|54278365|FG014|Overall Study|No end of study case report form|0|||
27819214|NCT01468701|54278366|FG015|Overall Study|No end of study case report form|0|||
27819215|NCT01468701|54278367|FG016|Overall Study|No end of study case report form|0|||
27819216|NCT01468701|54278351|FG000|Overall Study|Not being followed up|0|||
27819217|NCT01468701|54278352|FG001|Overall Study|Not being followed up|4963|||
27819218|NCT01468701|54278353|FG002|Overall Study|Not being followed up|1755|||
27819219|NCT01468701|54278354|FG003|Overall Study|Not being followed up|703|||
27819220|NCT01468701|54278355|FG004|Overall Study|Not being followed up|1714|||
27819221|NCT01468701|54278356|FG005|Overall Study|Not being followed up|126|||
27819222|NCT01468701|54278357|FG006|Overall Study|Not being followed up|1170|||
28068640|NCT00282308|54723760|FG000|Treatment Period|Not Treated with Study Drug|1|||
28068641|NCT00282308|54723761|FG001|Treatment Period|Not Treated with Study Drug|0|||
28068642|NCT00282308|54723762|FG002|Treatment Period|Not Treated with Study Drug|0|||
28068643|NCT00282308|54723760|FG000|Optional Extension Re-treatment Period|Adverse Event|0|||
28068644|NCT00282308|54723761|FG001|Optional Extension Re-treatment Period|Adverse Event|0|||
28068645|NCT00282308|54723762|FG002|Optional Extension Re-treatment Period|Adverse Event|4|||
28068646|NCT00282308|54723760|FG000|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
28068647|NCT00282308|54723761|FG001|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
28068648|NCT00282308|54723762|FG002|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1|||
28068649|NCT00282308|54723760|FG000|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
28068650|NCT00282308|54723761|FG001|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
28068651|NCT00282308|54723762|FG002|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1|||
28068652|NCT00282308|54723760|FG000|Safety Follow-up Period|Adverse Event|0|||
28068653|NCT00282308|54723761|FG001|Safety Follow-up Period|Adverse Event|0|||
28068654|NCT00282308|54723762|FG002|Safety Follow-up Period|Adverse Event|1|||
28068655|NCT00282308|54723760|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
28068656|NCT00282308|54723761|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
28068657|NCT00282308|54723762|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
28132053|NCT03298867|54795600|FG001|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
28068658|NCT00282308|54723760|FG000|Safety Follow-up Period|Physician Decision to Withdraw|0|||
28132054|NCT03298867|54795599|FG000|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
28132055|NCT03298867|54795600|FG001|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
28132056|NCT03298867|54795599|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|1|||
28132057|NCT03298867|54795600|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|9|||
28132058|NCT03298867|54795599|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|0|||
28132059|NCT03298867|54795600|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|1|||
28132060|NCT03298867|54795599|FG000|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|0|||
28132061|NCT03298867|54795600|FG001|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|1|||
28132062|NCT03298867|54795599|FG000|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|0|||
28132063|NCT03298867|54795600|FG001|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|2|||
28132064|NCT03298867|54795599|FG000|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|0|||
28132065|NCT03298867|54795600|FG001|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|1|||
28132066|NCT03298867|54795599|FG000|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|0|||
28132067|NCT03298867|54795600|FG001|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|2|||
28132068|NCT03298867|54795599|FG000|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|0|||
28132069|NCT03298867|54795600|FG001|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|1|||
27819223|NCT01468701|54278358|FG007|Overall Study|Not being followed up|4|||
27819224|NCT01468701|54278359|FG008|Overall Study|Not being followed up|0|||
27819225|NCT01468701|54278360|FG009|Overall Study|Not being followed up|0|||
27819226|NCT01468701|54278361|FG010|Overall Study|Not being followed up|0|||
27819227|NCT01468701|54278362|FG011|Overall Study|Not being followed up|0|||
27819228|NCT01468701|54278363|FG012|Overall Study|Not being followed up|0|||
28132070|NCT02906930|54795610|FG000|Overall Study|Withdrawal by Subject|0|||
27819229|NCT01468701|54278364|FG013|Overall Study|Not being followed up|0|||
27819230|NCT01468701|54278365|FG014|Overall Study|Not being followed up|0|||
27819231|NCT01468701|54278366|FG015|Overall Study|Not being followed up|0|||
27819232|NCT01468701|54278367|FG016|Overall Study|Not being followed up|0|||
27819233|NCT01492101|54278382|FG000|Overall Study|Death|323|||
27819234|NCT01492101|54278383|FG001|Overall Study|Death|322|||
27819235|NCT01492101|54278382|FG000|Overall Study|Withdrawal by Subject|14|||
28068659|NCT00282308|54723761|FG001|Safety Follow-up Period|Physician Decision to Withdraw|0|||
28068660|NCT00282308|54723762|FG002|Safety Follow-up Period|Physician Decision to Withdraw|1|||
28068661|NCT00282308|54723760|FG000|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
28068662|NCT00282308|54723761|FG001|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
28068663|NCT00282308|54723762|FG002|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12|||
28068664|NCT00282152|54723774|FG000|Overall Study|Withdrawal by Subject|1|||
28068665|NCT00282152|54723775|FG001|Overall Study|Withdrawal by Subject|0|||
28068666|NCT00281840|54723782|FG000|Overall Study|Adverse Event|12|||
28068667|NCT00281840|54723782|FG000|Overall Study|Physician Decision|6|||
28068668|NCT00281840|54723782|FG000|Overall Study|Withdrawal by Subject|3|||
27819236|NCT01492101|54278383|FG001|Overall Study|Withdrawal by Subject|18|||
27819237|NCT01492101|54278382|FG000|Overall Study|Lost to Follow-up|0|||
27819238|NCT01492101|54278383|FG001|Overall Study|Lost to Follow-up|2|||
27819239|NCT01468311|54278389|FG000|Overall Study|mobilization failure|1|||
27819240|NCT01468311|54278389|FG000|Overall Study|Withdrawal by Subject|1|||
27819241|NCT01730534|54278500|FG000|Overall Study|Withdrawal by Subject|97|||
27819242|NCT01730534|54278501|FG001|Overall Study|Withdrawal by Subject|127|||
27819243|NCT01730534|54278500|FG000|Overall Study|Lost to Follow-up|12|||
27819244|NCT01730534|54278501|FG001|Overall Study|Lost to Follow-up|18|||
27819245|NCT01783730|54278521|FG000|Overall Study|Failed to meet inclusion criteria|6|||
27819246|NCT01730378|54278527|FG000|Overall Study|Lost to Follow-up|1|||
27819247|NCT01730378|54278528|FG001|Overall Study|Lost to Follow-up|0|||
27819248|NCT01783496|54278541|FG000|Overall Study|Lost to Follow-up|0|||
27819249|NCT01783496|54278542|FG001|Overall Study|Lost to Follow-up|0|||
27819250|NCT01783496|54278543|FG002|Overall Study|Lost to Follow-up|0|||
27819251|NCT01783496|54278544|FG003|Overall Study|Lost to Follow-up|2|||
27819252|NCT01783496|54278545|FG004|Overall Study|Lost to Follow-up|0|||
27819253|NCT01783496|54278546|FG005|Overall Study|Lost to Follow-up|1|||
27819254|NCT01783496|54278541|FG000|Overall Study|Withdrawal by Subject|1|||
27819255|NCT01783496|54278542|FG001|Overall Study|Withdrawal by Subject|0|||
27819256|NCT01783496|54278543|FG002|Overall Study|Withdrawal by Subject|0|||
27819257|NCT01783496|54278544|FG003|Overall Study|Withdrawal by Subject|0|||
27819258|NCT01783496|54278545|FG004|Overall Study|Withdrawal by Subject|0|||
27819259|NCT01783496|54278546|FG005|Overall Study|Withdrawal by Subject|0|||
27819260|NCT01729208|54278571|FG000|Baseline|Physician Decision|5|||
27819261|NCT01729208|54278572|FG001|Baseline|Physician Decision|4|||
27819262|NCT01729208|54278571|FG000|12 Months Follow-up|Withdrawal by Subject|4|||
27819263|NCT01729208|54278572|FG001|12 Months Follow-up|Withdrawal by Subject|7|||
27819264|NCT01729208|54278571|FG000|12 Months Follow-up|Lost to Follow-up|3|||
27819265|NCT01729208|54278572|FG001|12 Months Follow-up|Lost to Follow-up|3|||
27819266|NCT01729208|54278571|FG000|24 Months Follow-up|Lost to Follow-up|3|||
27819267|NCT01729208|54278572|FG001|24 Months Follow-up|Lost to Follow-up|0|||
28132071|NCT02906930|54795611|FG001|Overall Study|Withdrawal by Subject|5|||
28132072|NCT02906930|54795612|FG002|Overall Study|Withdrawal by Subject|5|||
28132073|NCT02906930|54795613|FG003|Overall Study|Withdrawal by Subject|4|||
28132074|NCT02906930|54795610|FG000|Overall Study|Lost to Follow-up|5|||
28132075|NCT02906930|54795611|FG001|Overall Study|Lost to Follow-up|7|||
28132076|NCT02906930|54795612|FG002|Overall Study|Lost to Follow-up|5|||
28132077|NCT02906930|54795613|FG003|Overall Study|Lost to Follow-up|2|||
28132078|NCT02906930|54795610|FG000|Overall Study|Death|0|||
27819268|NCT01729208|54278571|FG000|36 Months Follow-up|Physician Decision|1|||
28068669|NCT00281840|54723782|FG000|Overall Study|Disease Progression|2|||
28068670|NCT00281840|54723782|FG000|Overall Study|exceed maximum delay in treatment|1|||
28068671|NCT00281840|54723782|FG000|Overall Study|Complicating Disease|1|||
28068672|NCT00281684|54723791|FG000|Overall Study|Lost to Follow-up|0|||
28068673|NCT00281684|54723792|FG001|Overall Study|Lost to Follow-up|0|||
28068674|NCT00281684|54723793|FG002|Overall Study|Lost to Follow-up|1|||
28068675|NCT00281684|54723794|FG003|Overall Study|Lost to Follow-up|0|||
28068676|NCT00281684|54723791|FG000|Overall Study|Withdrawal by Subject|1|||
28068677|NCT00281684|54723792|FG001|Overall Study|Withdrawal by Subject|0|||
28068678|NCT00281684|54723793|FG002|Overall Study|Withdrawal by Subject|0|||
28068679|NCT00281684|54723794|FG003|Overall Study|Withdrawal by Subject|0|||
28068680|NCT00272792|54723808|FG000|Part 1: Responsiveness|Lost to Follow-up|1|||
28068681|NCT00272792|54723809|FG001|Part 1: Responsiveness|Lost to Follow-up|0|||
28068682|NCT00272792|54723808|FG000|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0|||
28068683|NCT00272792|54723809|FG001|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2|||
28068684|NCT00272792|54723808|FG000|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1|||
28068685|NCT00272792|54723809|FG001|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0|||
28068686|NCT00272792|54723808|FG000|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0|||
28068687|NCT00272792|54723809|FG001|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1|||
28068688|NCT00048568|54723817|FG000|Double-Blind Period Days 1 to 169|Adverse Event|11|||
28068689|NCT00048568|54723818|FG001|Double-Blind Period Days 1 to 169|Adverse Event|3|||
28068690|NCT00048568|54723819|FG002|Double-Blind Period Days 1 to 169|Adverse Event|0|||
28068691|NCT00048568|54723817|FG000|Double-Blind Period Days 1 to 169|Lack of Efficacy|11|||
28068692|NCT00048568|54723818|FG001|Double-Blind Period Days 1 to 169|Lack of Efficacy|33|||
28132079|NCT02906930|54795611|FG001|Overall Study|Death|0|||
28132080|NCT02906930|54795612|FG002|Overall Study|Death|1|||
28132081|NCT02906930|54795613|FG003|Overall Study|Death|0|||
27819269|NCT01729208|54278572|FG001|36 Months Follow-up|Physician Decision|0|||
27819270|NCT01729208|54278571|FG000|36 Months Follow-up|Withdrawal by Subject|2|||
27819271|NCT01729208|54278572|FG001|36 Months Follow-up|Withdrawal by Subject|4|||
27819272|NCT01609010|54278589|FG000|Overall Study|Stable disease (SD)|22|||
28068693|NCT00048568|54723819|FG002|Double-Blind Period Days 1 to 169|Lack of Efficacy|0|||
28068694|NCT00048568|54723817|FG000|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
28132082|NCT02906930|54795610|FG000|Overall Study|Other|1|||
28132083|NCT02906930|54795611|FG001|Overall Study|Other|2|||
27819273|NCT01609010|54278590|FG001|Overall Study|Stable disease (SD)|16|||
27819274|NCT01609010|54278589|FG000|Overall Study|Progressive disease (PD)|8|||
27819275|NCT01609010|54278590|FG001|Overall Study|Progressive disease (PD)|10|||
27819276|NCT01609010|54278589|FG000|Overall Study|Adverse Event|3|||
27819277|NCT01609010|54278590|FG001|Overall Study|Adverse Event|6|||
27819278|NCT01609010|54278589|FG000|Overall Study|Withdrawal by Subject|2|||
27819279|NCT01609010|54278590|FG001|Overall Study|Withdrawal by Subject|2|||
27819280|NCT01609010|54278589|FG000|Overall Study|Other|2|||
27819281|NCT01609010|54278590|FG001|Overall Study|Other|0|||
27819282|NCT01609010|54278589|FG000|Overall Study|Other malignancy|1|||
27819283|NCT01609010|54278590|FG001|Overall Study|Other malignancy|0|||
27819284|NCT01609010|54278589|FG000|Overall Study|Pathology review|2|||
27819285|NCT01609010|54278590|FG001|Overall Study|Pathology review|1|||
27819286|NCT01609010|54278589|FG000|Overall Study|Protocol Violation|1|||
27819287|NCT01609010|54278590|FG001|Overall Study|Protocol Violation|1|||
27819288|NCT01609010|54278589|FG000|Overall Study|New cancer|1|||
27819289|NCT01609010|54278590|FG001|Overall Study|New cancer|0|||
27819290|NCT01609010|54278589|FG000|Overall Study|Lost to Follow-up|1|||
27819291|NCT01609010|54278590|FG001|Overall Study|Lost to Follow-up|1|||
27849756|NCT00634751|54347493|FG003|Phase I: 200mg Sorafenib+2DOC|Death|0|||
28068695|NCT00048568|54723818|FG001|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
28068696|NCT00048568|54723819|FG002|Double-Blind Period Days 1 to 169|Lost to Follow-up|0|||
28068697|NCT00048568|54723817|FG000|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7|||
28068698|NCT00048568|54723818|FG001|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4|||
28068699|NCT00048568|54723819|FG002|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0|||
28068700|NCT00048568|54723817|FG000|Double-Blind Period Days 1 to 169|Unknown Reasons|2|||
28068701|NCT00048568|54723818|FG001|Double-Blind Period Days 1 to 169|Unknown Reasons|4|||
28068702|NCT00048568|54723819|FG002|Double-Blind Period Days 1 to 169|Unknown Reasons|0|||
28068703|NCT00048568|54723817|FG000|Double-Blind Period Days 170 to 365|Death|1|||
28068704|NCT00048568|54723818|FG001|Double-Blind Period Days 170 to 365|Death|1|||
28068705|NCT00048568|54723819|FG002|Double-Blind Period Days 170 to 365|Death|0|||
28068706|NCT00048568|54723817|FG000|Double-Blind Period Days 170 to 365|Adverse Event|7|||
28068707|NCT00048568|54723818|FG001|Double-Blind Period Days 170 to 365|Adverse Event|1|||
28068708|NCT00048568|54723819|FG002|Double-Blind Period Days 170 to 365|Adverse Event|0|||
28068709|NCT00048568|54723817|FG000|Double-Blind Period Days 170 to 365|Lack of Efficacy|2|||
28068710|NCT00048568|54723818|FG001|Double-Blind Period Days 170 to 365|Lack of Efficacy|7|||
28068711|NCT00048568|54723819|FG002|Double-Blind Period Days 170 to 365|Lack of Efficacy|0|||
28132084|NCT02906930|54795612|FG002|Overall Study|Other|1|||
28132085|NCT02906930|54795613|FG003|Overall Study|Other|2|||
28132086|NCT02983604|54795627|FG000|Overall Study|Enrolled but not Treated|0|||
28132087|NCT02983604|54795628|FG001|Overall Study|Enrolled but not Treated|0|||
28132088|NCT02983604|54795629|FG002|Overall Study|Enrolled but not Treated|1|||
28132089|NCT02983604|54795630|FG003|Overall Study|Enrolled but not Treated|0|||
28132090|NCT02662582|54795642|FG000|Treatment Period 1 (14 Days)|Adverse Event|3|||
28132091|NCT02662582|54795643|FG001|Treatment Period 1 (14 Days)|Adverse Event|2|||
28132092|NCT02662582|54795642|FG000|Treatment Period 1 (14 Days)|Miscellaneous|0|||
28132093|NCT02662582|54795643|FG001|Treatment Period 1 (14 Days)|Miscellaneous|1|||
28132094|NCT02662582|54795642|FG000|Treatment Period 1 (14 Days)|Protocol Deviation|1|||
28132095|NCT02662582|54795643|FG001|Treatment Period 1 (14 Days)|Protocol Deviation|0|||
28132096|NCT02662582|54795642|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
28132097|NCT02662582|54795643|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
28132098|NCT02908100|54795653|FG000|Overall Study|Adverse Event|7|||
28132099|NCT02908100|54795654|FG001|Overall Study|Adverse Event|6|||
28132100|NCT02908100|54795655|FG002|Overall Study|Adverse Event|9|||
28132101|NCT02908100|54795653|FG000|Overall Study|Death|2|||
28132102|NCT02908100|54795654|FG001|Overall Study|Death|0|||
28132103|NCT02908100|54795655|FG002|Overall Study|Death|0|||
28132104|NCT02908100|54795653|FG000|Overall Study|Lack of Efficacy|2|||
28132105|NCT02908100|54795654|FG001|Overall Study|Lack of Efficacy|3|||
28132106|NCT02908100|54795655|FG002|Overall Study|Lack of Efficacy|3|||
28132107|NCT02908100|54795653|FG000|Overall Study|Lost to Follow-up|0|||
28132108|NCT02908100|54795654|FG001|Overall Study|Lost to Follow-up|1|||
28132109|NCT02908100|54795655|FG002|Overall Study|Lost to Follow-up|2|||
28132110|NCT02908100|54795653|FG000|Overall Study|Non-Compliance With Study Drug|1|||
28132111|NCT02908100|54795654|FG001|Overall Study|Non-Compliance With Study Drug|1|||
28132112|NCT02908100|54795655|FG002|Overall Study|Non-Compliance With Study Drug|2|||
28132113|NCT02908100|54795653|FG000|Overall Study|Non-Compliance With Contraceptive Method|1|||
27819292|NCT01608308|54278598|FG000|Overall Study|pretreatment medical and billing reasons|0|||
27819293|NCT01608308|54278599|FG001|Overall Study|pretreatment medical and billing reasons|2|||
27849757|NCT00634751|54347490|FG000|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
27819294|NCT01755416|54278630|FG000|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1|||
27819295|NCT01755416|54278631|FG001|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2|||
28068712|NCT00048568|54723817|FG000|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3|||
28068713|NCT00048568|54723818|FG001|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1|||
28132114|NCT02908100|54795654|FG001|Overall Study|Non-Compliance With Contraceptive Method|0|||
28132115|NCT02908100|54795655|FG002|Overall Study|Non-Compliance With Contraceptive Method|0|||
28132116|NCT02908100|54795653|FG000|Overall Study|Physician Decision|0|||
28132117|NCT02908100|54795654|FG001|Overall Study|Physician Decision|1|||
28132118|NCT02908100|54795655|FG002|Overall Study|Physician Decision|0|||
28132119|NCT02908100|54795653|FG000|Overall Study|Pregnancy|1|||
28132120|NCT02908100|54795654|FG001|Overall Study|Pregnancy|2|||
28132121|NCT02908100|54795655|FG002|Overall Study|Pregnancy|0|||
28132122|NCT02908100|54795653|FG000|Overall Study|Withdrawal by Subject|8|||
28132123|NCT02908100|54795654|FG001|Overall Study|Withdrawal by Subject|7|||
28132124|NCT02908100|54795655|FG002|Overall Study|Withdrawal by Subject|5|||
28132125|NCT02908100|54795653|FG000|Overall Study|Randomised in Error|1|||
28132126|NCT02908100|54795654|FG001|Overall Study|Randomised in Error|0|||
28132127|NCT02908100|54795655|FG002|Overall Study|Randomised in Error|0|||
28132128|NCT02982590|54795679|FG000|Overall Study|Lost to Follow-up|0|||
28132129|NCT02982590|54795680|FG001|Overall Study|Lost to Follow-up|1|||
28132130|NCT02982590|54795679|FG000|Overall Study|Death|4|||
28132131|NCT02982590|54795680|FG001|Overall Study|Death|0|||
28132132|NCT03310021|54795706|FG000|Overall Study|Withdrawal by Subject|0|||
28132133|NCT03310021|54795707|FG001|Overall Study|Withdrawal by Subject|0|||
28132134|NCT03310021|54795708|FG002|Overall Study|Withdrawal by Subject|0|||
28132135|NCT03310021|54795709|FG003|Overall Study|Withdrawal by Subject|0|||
28132136|NCT03310021|54795710|FG004|Overall Study|Withdrawal by Subject|0|||
28132137|NCT03310021|54795711|FG005|Overall Study|Withdrawal by Subject|0|||
28132138|NCT03310021|54795712|FG006|Overall Study|Withdrawal by Subject|1|||
28132139|NCT03310021|54795713|FG007|Overall Study|Withdrawal by Subject|0|||
28132140|NCT03310021|54795714|FG008|Overall Study|Withdrawal by Subject|0|||
28132141|NCT03310021|54795715|FG009|Overall Study|Withdrawal by Subject|0|||
28132142|NCT03310021|54795716|FG010|Overall Study|Withdrawal by Subject|0|||
28132143|NCT03310021|54795717|FG011|Overall Study|Withdrawal by Subject|0|||
28132144|NCT03310021|54795718|FG012|Overall Study|Withdrawal by Subject|0|||
28132145|NCT03310021|54795719|FG013|Overall Study|Withdrawal by Subject|0|||
28132146|NCT03310021|54795720|FG014|Overall Study|Withdrawal by Subject|0|||
28132147|NCT03310021|54795721|FG015|Overall Study|Withdrawal by Subject|0|||
28132148|NCT03310021|54795722|FG016|Overall Study|Withdrawal by Subject|0|||
28132149|NCT03310021|54795723|FG017|Overall Study|Withdrawal by Subject|0|||
28132150|NCT03310021|54795724|FG018|Overall Study|Withdrawal by Subject|0|||
28132151|NCT03310021|54795725|FG019|Overall Study|Withdrawal by Subject|0|||
28132152|NCT03310021|54795706|FG000|Overall Study|Lost to Follow-up|0|||
28132153|NCT03310021|54795707|FG001|Overall Study|Lost to Follow-up|0|||
28132154|NCT03310021|54795708|FG002|Overall Study|Lost to Follow-up|0|||
28132155|NCT03310021|54795709|FG003|Overall Study|Lost to Follow-up|0|||
28132156|NCT03310021|54795710|FG004|Overall Study|Lost to Follow-up|0|||
28132157|NCT03310021|54795711|FG005|Overall Study|Lost to Follow-up|0|||
28132158|NCT03310021|54795712|FG006|Overall Study|Lost to Follow-up|0|||
28132159|NCT03310021|54795713|FG007|Overall Study|Lost to Follow-up|0|||
28132160|NCT03310021|54795714|FG008|Overall Study|Lost to Follow-up|0|||
28132161|NCT03310021|54795715|FG009|Overall Study|Lost to Follow-up|0|||
28132162|NCT03310021|54795716|FG010|Overall Study|Lost to Follow-up|1|||
28132163|NCT03310021|54795717|FG011|Overall Study|Lost to Follow-up|0|||
28132164|NCT03310021|54795718|FG012|Overall Study|Lost to Follow-up|0|||
28132165|NCT03310021|54795719|FG013|Overall Study|Lost to Follow-up|0|||
28132166|NCT03310021|54795720|FG014|Overall Study|Lost to Follow-up|0|||
28132167|NCT03310021|54795721|FG015|Overall Study|Lost to Follow-up|0|||
28132168|NCT03310021|54795722|FG016|Overall Study|Lost to Follow-up|0|||
28132169|NCT03310021|54795723|FG017|Overall Study|Lost to Follow-up|0|||
28132170|NCT03310021|54795724|FG018|Overall Study|Lost to Follow-up|0|||
28132171|NCT03310021|54795725|FG019|Overall Study|Lost to Follow-up|0|||
28132172|NCT03333109|54795770|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
28132173|NCT03333109|54795771|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
28132174|NCT03333109|54795772|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
28132175|NCT03333109|54795770|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
28132176|NCT03333109|54795771|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
28132177|NCT03333109|54795772|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
28132178|NCT03333109|54795770|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|4|||
28132179|NCT03333109|54795771|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
28132180|NCT03333109|54795772|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|1|||
28132181|NCT03333109|54795770|FG000|Double-blind Treatment Period (DBTP)|Pregnancy|1|||
28132182|NCT03333109|54795771|FG001|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
28132183|NCT03333109|54795772|FG002|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
28132184|NCT03333109|54795770|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|9|||
28132185|NCT03333109|54795771|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
28132186|NCT03333109|54795772|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|5|||
28132187|NCT03333109|54795770|FG000|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
28132188|NCT03333109|54795771|FG001|Double-blind Treatment Period (DBTP)|Randomized but not treated|0|||
28132189|NCT03333109|54795772|FG002|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
28132190|NCT03333109|54795770|FG000|Safety Follow-up Period|Lost to Follow-up|6|||
28132191|NCT03333109|54795771|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
28132192|NCT03333109|54795772|FG002|Safety Follow-up Period|Lost to Follow-up|1|||
28132193|NCT03333109|54795770|FG000|Safety Follow-up Period|Withdrawal by Subject|7|||
28132194|NCT03333109|54795771|FG001|Safety Follow-up Period|Withdrawal by Subject|2|||
28132195|NCT03333109|54795772|FG002|Safety Follow-up Period|Withdrawal by Subject|12|||
28132196|NCT02940223|54795782|FG000|Overall Study|Failed Requirement|2|||
28132197|NCT02940223|54795783|FG001|Overall Study|Failed Requirement|0|||
28132198|NCT03296527|54795791|FG000|Overall Study|Adverse Event|15|||
28132199|NCT03296527|54795792|FG001|Overall Study|Adverse Event|33|||
28132200|NCT03296527|54795791|FG000|Overall Study|Protocol Deviation|4|||
28132201|NCT03296527|54795792|FG001|Overall Study|Protocol Deviation|0|||
28132202|NCT03296527|54795791|FG000|Overall Study|Subject withdrew consent|3|||
28132203|NCT03296527|54795792|FG001|Overall Study|Subject withdrew consent|1|||
28132204|NCT03296527|54795791|FG000|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|9|||
28132205|NCT03296527|54795792|FG001|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|14|||
28068714|NCT00048568|54723819|FG002|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0|||
28068715|NCT00048568|54723817|FG000|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
28068716|NCT00048568|54723818|FG001|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1|||
28068717|NCT00048568|54723819|FG002|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
28068718|NCT00048568|54723817|FG000|Double-Blind Period Days 170 to 365|Pregnancy|2|||
28068719|NCT00048568|54723818|FG001|Double-Blind Period Days 170 to 365|Pregnancy|0|||
28068720|NCT00048568|54723819|FG002|Double-Blind Period Days 170 to 365|Pregnancy|0|||
28068721|NCT00048568|54723817|FG000|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
28068722|NCT00048568|54723818|FG001|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
28068723|NCT00048568|54723819|FG002|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0|||
28068724|NCT00048568|54723817|FG000|Open-Label Period|Death|0|||
28068725|NCT00048568|54723818|FG001|Open-Label Period|Death|0|||
28068726|NCT00048568|54723819|FG002|Open-Label Period|Death|13|||
28132206|NCT03296527|54795791|FG000|Overall Study|Discontinuations due to withdrawal from trial|2|||
28132207|NCT03296527|54795792|FG001|Overall Study|Discontinuations due to withdrawal from trial|3|||
28132208|NCT03296527|54795791|FG000|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|0|||
28068727|NCT00048568|54723817|FG000|Open-Label Period|Adverse Event|0|||
28068728|NCT00048568|54723818|FG001|Open-Label Period|Adverse Event|0|||
27819296|NCT01755026|54278639|FG000|Overall Study|Adverse Event|1|||
27819297|NCT01755026|54278640|FG001|Overall Study|Adverse Event|0|||
27819298|NCT01755026|54278639|FG000|Overall Study|Withdrawal by Subject|1|||
27819299|NCT01755026|54278640|FG001|Overall Study|Withdrawal by Subject|1|||
27819300|NCT01491945|54278655|FG000|Overall Study|Death|30|||
27819301|NCT01491945|54278655|FG000|Overall Study|Withdrwan/LTF|16|||
27819302|NCT01491945|54278655|FG000|Overall Study|Conversion|4|||
27819303|NCT01491945|54278655|FG000|Overall Study|Missed Visit|1|||
27819304|NCT01728584|54278677|FG000|Overall Study|Adverse Event|1|||
27819305|NCT01728584|54278678|FG001|Overall Study|Adverse Event|0|||
28132209|NCT03296527|54795792|FG001|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|2|||
28132210|NCT03296527|54795791|FG000|Overall Study|Discontinuation due to liquid in uterus|1|||
28132211|NCT03296527|54795792|FG001|Overall Study|Discontinuation due to liquid in uterus|0|||
28132212|NCT03296527|54795791|FG000|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|1|||
27819306|NCT01728584|54278679|FG002|Overall Study|Adverse Event|0|||
27819307|NCT01728584|54278680|FG003|Overall Study|Adverse Event|0|||
27819308|NCT01728584|54278677|FG000|Overall Study|Physician Decision|4|||
28068729|NCT00048568|54723819|FG002|Open-Label Period|Adverse Event|49|||
28068730|NCT00048568|54723817|FG000|Open-Label Period|Lack of Efficacy|0|||
28068731|NCT00048568|54723818|FG001|Open-Label Period|Lack of Efficacy|0|||
28068732|NCT00048568|54723819|FG002|Open-Label Period|Lack of Efficacy|32|||
28068733|NCT00048568|54723817|FG000|Open-Label Period|Withdrawal by Subject|0|||
28068734|NCT00048568|54723818|FG001|Open-Label Period|Withdrawal by Subject|0|||
28068735|NCT00048568|54723819|FG002|Open-Label Period|Withdrawal by Subject|26|||
27819309|NCT01728584|54278678|FG001|Overall Study|Physician Decision|0|||
27819310|NCT01728584|54278679|FG002|Overall Study|Physician Decision|1|||
27819311|NCT01728584|54278680|FG003|Overall Study|Physician Decision|0|||
27819312|NCT01728584|54278677|FG000|Overall Study|Withdrawal by Subject|1|||
28068736|NCT00048568|54723817|FG000|Open-Label Period|Pregnancy|0|||
28132213|NCT03296527|54795792|FG001|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|0|||
28132214|NCT03295201|54795801|FG000|Overall Study|Lost to Follow-up|1|||
28132215|NCT03295201|54795802|FG001|Overall Study|Lost to Follow-up|1|||
28132216|NCT03295201|54795801|FG000|Overall Study|Hospital admission|0|||
28132217|NCT03295201|54795802|FG001|Overall Study|Hospital admission|1|||
28132218|NCT03293485|54795808|FG000|Overall Study|Death|1|||
28132219|NCT03293485|54795808|FG000|Overall Study|Screen Failure|2|||
28132220|NCT03293485|54795808|FG000|Overall Study|Withdrawal by Subject|2|||
28132221|NCT03309943|54795816|FG000|Overall Study|Withdrawal by Subject|0|||
28132222|NCT03309943|54795817|FG001|Overall Study|Withdrawal by Subject|1|||
28132223|NCT03309943|54795816|FG000|Overall Study|Inappropriate behavior towards staff|0|||
28132224|NCT03309943|54795817|FG001|Overall Study|Inappropriate behavior towards staff|1|||
28132225|NCT01732627|54795825|FG000|Overall Study|Withdrawal by Subject|1|||
28132226|NCT01732627|54795826|FG001|Overall Study|Withdrawal by Subject|0|||
28132227|NCT03307837|54795838|FG000|Overall Study|Withdrawal by Subject|0|||
28132228|NCT03307837|54795839|FG001|Overall Study|Withdrawal by Subject|0|||
28132229|NCT03307837|54795840|FG002|Overall Study|Withdrawal by Subject|1|||
28132230|NCT03307837|54795841|FG003|Overall Study|Withdrawal by Subject|0|||
28132231|NCT03307837|54795842|FG004|Overall Study|Withdrawal by Subject|0|||
28132232|NCT03307837|54795843|FG005|Overall Study|Withdrawal by Subject|1|||
28132233|NCT03307837|54795838|FG000|Overall Study|Lost to Follow-up|1|||
28132234|NCT03307837|54795839|FG001|Overall Study|Lost to Follow-up|1|||
28132235|NCT03307837|54795840|FG002|Overall Study|Lost to Follow-up|0|||
28132236|NCT03307837|54795841|FG003|Overall Study|Lost to Follow-up|0|||
28132237|NCT03307837|54795842|FG004|Overall Study|Lost to Follow-up|0|||
28132238|NCT03307837|54795843|FG005|Overall Study|Lost to Follow-up|1|||
28132239|NCT03331315|54795864|FG000|Overall Study|Physician Decision|18|||
28132240|NCT03331315|54795865|FG001|Overall Study|Physician Decision|14|||
28132241|NCT03329989|54795873|FG000|Overall Study|Withdrawal by Subject|9|||
28132242|NCT03329989|54795873|FG000|Overall Study|Lost to Follow-up|8|||
28132243|NCT03329989|54795873|FG000|Overall Study|Adverse Event|5|||
28132244|NCT03329989|54795873|FG000|Overall Study|Protocol Violation|1|||
28132245|NCT03287869|54795879|FG000|Overall Study|Adverse Event|14|||
28132246|NCT03287869|54795880|FG001|Overall Study|Adverse Event|12|||
28132247|NCT03287869|54795879|FG000|Overall Study|Lack of Efficacy|1|||
28132248|NCT03287869|54795880|FG001|Overall Study|Lack of Efficacy|0|||
28132249|NCT03287869|54795879|FG000|Overall Study|Lost to Follow-up|13|||
28132250|NCT03287869|54795880|FG001|Overall Study|Lost to Follow-up|19|||
28132251|NCT03287869|54795879|FG000|Overall Study|Non-Compliance With Study Drug|5|||
28132252|NCT03287869|54795880|FG001|Overall Study|Non-Compliance With Study Drug|9|||
28132253|NCT03287869|54795879|FG000|Overall Study|Progressive Disease|1|||
28132254|NCT03287869|54795880|FG001|Overall Study|Progressive Disease|0|||
28132255|NCT03287869|54795879|FG000|Overall Study|Protocol Deviation|2|||
28132256|NCT03287869|54795880|FG001|Overall Study|Protocol Deviation|1|||
28132257|NCT03287869|54795879|FG000|Overall Study|Withdrawal by Subject|36|||
28132258|NCT03287869|54795880|FG001|Overall Study|Withdrawal by Subject|43|||
28132259|NCT03287869|54795879|FG000|Overall Study|Early Closure of the Site|0|||
28132260|NCT03287869|54795880|FG001|Overall Study|Early Closure of the Site|1|||
28132261|NCT03287869|54795879|FG000|Overall Study|Physician Decision|5|||
28132262|NCT03287869|54795880|FG001|Overall Study|Physician Decision|5|||
28132263|NCT03287869|54795879|FG000|Overall Study|Reason not Specified|6|||
28132264|NCT03287869|54795880|FG001|Overall Study|Reason not Specified|3|||
28132265|NCT02661490|54795891|FG000|Overall Study|Lost to Follow-up|0|||
28132266|NCT02661490|54795892|FG001|Overall Study|Lost to Follow-up|1|||
28132267|NCT02661490|54795893|FG002|Overall Study|Lost to Follow-up|0|||
28132268|NCT02661490|54795894|FG003|Overall Study|Lost to Follow-up|0|||
28132269|NCT02661490|54795895|FG004|Overall Study|Lost to Follow-up|2|||
28132270|NCT02661490|54795891|FG000|Overall Study|Withdrawal by Subject|2|||
28132271|NCT02661490|54795892|FG001|Overall Study|Withdrawal by Subject|0|||
28132272|NCT02661490|54795893|FG002|Overall Study|Withdrawal by Subject|2|||
28132273|NCT02661490|54795894|FG003|Overall Study|Withdrawal by Subject|0|||
27819313|NCT01728584|54278678|FG001|Overall Study|Withdrawal by Subject|0|||
28132274|NCT02661490|54795895|FG004|Overall Study|Withdrawal by Subject|0|||
28132275|NCT02661490|54795891|FG000|Overall Study|Death|1|||
28132276|NCT02661490|54795892|FG001|Overall Study|Death|1|||
28132277|NCT02661490|54795893|FG002|Overall Study|Death|0|||
28132278|NCT02661490|54795894|FG003|Overall Study|Death|1|||
28132279|NCT02661490|54795895|FG004|Overall Study|Death|0|||
28132280|NCT02661490|54795891|FG000|Overall Study|Reason not Specified|0|||
28132281|NCT02661490|54795892|FG001|Overall Study|Reason not Specified|0|||
28132282|NCT02661490|54795893|FG002|Overall Study|Reason not Specified|0|||
28132283|NCT02661490|54795894|FG003|Overall Study|Reason not Specified|0|||
28132284|NCT02661490|54795895|FG004|Overall Study|Reason not Specified|1|||
28132285|NCT03287791|54795910|FG000|Overall Study|Insufficient Therapeutic Response|0|||
28132286|NCT03287791|54795911|FG001|Overall Study|Insufficient Therapeutic Response|0|||
28132287|NCT03287791|54795912|FG002|Overall Study|Insufficient Therapeutic Response|1|||
28068737|NCT00048568|54723818|FG001|Open-Label Period|Pregnancy|0|||
28068738|NCT00048568|54723819|FG002|Open-Label Period|Pregnancy|5|||
28068739|NCT00048568|54723817|FG000|Open-Label Period|No Longer Met Study Criteria|0|||
28068740|NCT00048568|54723818|FG001|Open-Label Period|No Longer Met Study Criteria|0|||
28068741|NCT00048568|54723819|FG002|Open-Label Period|No Longer Met Study Criteria|2|||
28068742|NCT00048568|54723817|FG000|Open-Label Period|Administrative Decision By Sponsor|0|||
28132288|NCT03287791|54795910|FG000|Overall Study|Adverse Event|0|||
28132289|NCT03287791|54795911|FG001|Overall Study|Adverse Event|4|||
28132290|NCT03287791|54795912|FG002|Overall Study|Adverse Event|3|||
28132291|NCT03287791|54795910|FG000|Overall Study|Withdrawal by Subject|12|||
28132292|NCT03287791|54795911|FG001|Overall Study|Withdrawal by Subject|12|||
28132293|NCT03287791|54795912|FG002|Overall Study|Withdrawal by Subject|17|||
28132294|NCT03287791|54795910|FG000|Overall Study|Missed more than 6 consecutive doses|3|||
28132295|NCT03287791|54795911|FG001|Overall Study|Missed more than 6 consecutive doses|2|||
27819314|NCT01728584|54278679|FG002|Overall Study|Withdrawal by Subject|0|||
27819315|NCT01728584|54278680|FG003|Overall Study|Withdrawal by Subject|0|||
27819316|NCT01728584|54278677|FG000|Overall Study|Screen failure|1|||
27819317|NCT01728584|54278678|FG001|Overall Study|Screen failure|0|||
27819318|NCT01728584|54278679|FG002|Overall Study|Screen failure|0|||
27819319|NCT01728584|54278680|FG003|Overall Study|Screen failure|0|||
27819320|NCT01728584|54278677|FG000|Overall Study|Other reason (not specified)|1|||
27819321|NCT01728584|54278678|FG001|Overall Study|Other reason (not specified)|0|||
27819322|NCT01728584|54278679|FG002|Overall Study|Other reason (not specified)|0|||
27819323|NCT01728584|54278680|FG003|Overall Study|Other reason (not specified)|1|||
27819324|NCT01522443|54278713|FG000|Overall Study|No longer receiving clinical benefit|36|||
27819325|NCT01522443|54278714|FG001|Overall Study|No longer receiving clinical benefit|28|||
27819326|NCT01522443|54278713|FG000|Overall Study|Adverse Event|10|||
27819327|NCT01522443|54278714|FG001|Overall Study|Adverse Event|15|||
27819328|NCT01522443|54278713|FG000|Overall Study|Withdrawal by Subject|5|||
27819329|NCT01522443|54278714|FG001|Overall Study|Withdrawal by Subject|8|||
27819330|NCT01522443|54278713|FG000|Overall Study|No study treatment given|1|||
27819331|NCT01522443|54278714|FG001|Overall Study|No study treatment given|1|||
27819332|NCT01522443|54278713|FG000|Overall Study|Other|1|||
27819333|NCT01522443|54278714|FG001|Overall Study|Other|3|||
27819334|NCT01468233|54278735|FG000|Treatment Period 1|Adverse Event|5|||
27819335|NCT01468233|54278736|FG001|Treatment Period 1|Adverse Event|3|||
27819336|NCT01468233|54278737|FG002|Treatment Period 1|Adverse Event|0|||
27819337|NCT01468233|54278738|FG003|Treatment Period 1|Adverse Event|0|||
27819338|NCT01468233|54278739|FG004|Treatment Period 1|Adverse Event|0|||
27819339|NCT01468233|54278740|FG005|Treatment Period 1|Adverse Event|0|||
27819340|NCT01468233|54278735|FG000|Treatment Period 1|Withdrawal by Subject|3|||
27819341|NCT01468233|54278736|FG001|Treatment Period 1|Withdrawal by Subject|4|||
27819342|NCT01468233|54278737|FG002|Treatment Period 1|Withdrawal by Subject|0|||
27819343|NCT01468233|54278738|FG003|Treatment Period 1|Withdrawal by Subject|0|||
27819344|NCT01468233|54278739|FG004|Treatment Period 1|Withdrawal by Subject|0|||
27819345|NCT01468233|54278740|FG005|Treatment Period 1|Withdrawal by Subject|0|||
27819346|NCT01468233|54278735|FG000|Treatment Period 1|Lost to Follow-up|3|||
27819347|NCT01468233|54278736|FG001|Treatment Period 1|Lost to Follow-up|0|||
27819348|NCT01468233|54278737|FG002|Treatment Period 1|Lost to Follow-up|0|||
27819349|NCT01468233|54278738|FG003|Treatment Period 1|Lost to Follow-up|0|||
27819350|NCT01468233|54278739|FG004|Treatment Period 1|Lost to Follow-up|0|||
27819351|NCT01468233|54278740|FG005|Treatment Period 1|Lost to Follow-up|0|||
27819352|NCT01468233|54278735|FG000|Treatment Period 1|Other|1|||
27819353|NCT01468233|54278736|FG001|Treatment Period 1|Other|1|||
27819354|NCT01468233|54278737|FG002|Treatment Period 1|Other|0|||
28068743|NCT00048568|54723818|FG001|Open-Label Period|Administrative Decision By Sponsor|0|||
28068744|NCT00048568|54723819|FG002|Open-Label Period|Administrative Decision By Sponsor|1|||
28068745|NCT00048568|54723817|FG000|Open-Label Period|Unknown Reasons|0|||
28068746|NCT00048568|54723818|FG001|Open-Label Period|Unknown Reasons|0|||
28132296|NCT03287791|54795912|FG002|Overall Study|Missed more than 6 consecutive doses|2|||
28132297|NCT03287791|54795910|FG000|Overall Study|Lost to Follow-up|8|||
27819355|NCT01468233|54278738|FG003|Treatment Period 1|Other|0|||
27819356|NCT01468233|54278739|FG004|Treatment Period 1|Other|0|||
27819357|NCT01468233|54278740|FG005|Treatment Period 1|Other|0|||
27819358|NCT01468233|54278735|FG000|Treatment Period 2|Adverse Event|0|||
27819359|NCT01468233|54278736|FG001|Treatment Period 2|Adverse Event|0|||
27819360|NCT01468233|54278737|FG002|Treatment Period 2|Adverse Event|3|||
28068747|NCT00048568|54723819|FG002|Open-Label Period|Unknown Reasons|25|||
28068748|NCT00048568|54723817|FG000|Open-Label Period|Lost to Follow-up|0|||
28132298|NCT03287791|54795911|FG001|Overall Study|Lost to Follow-up|14|||
28132299|NCT03287791|54795912|FG002|Overall Study|Lost to Follow-up|11|||
27819361|NCT01468233|54278738|FG003|Treatment Period 2|Adverse Event|0|||
27819362|NCT01468233|54278739|FG004|Treatment Period 2|Adverse Event|2|||
28132300|NCT03287791|54795910|FG000|Overall Study|Protocol Violation|7|||
28132301|NCT03287791|54795911|FG001|Overall Study|Protocol Violation|2|||
28132302|NCT03287791|54795912|FG002|Overall Study|Protocol Violation|1|||
28132303|NCT03287791|54795910|FG000|Overall Study|Participant was enrolled at 2 sites|1|||
28132304|NCT03287791|54795911|FG001|Overall Study|Participant was enrolled at 2 sites|0|||
28132305|NCT03287791|54795912|FG002|Overall Study|Participant was enrolled at 2 sites|1|||
28132306|NCT03287791|54795910|FG000|Overall Study|Too much time between 2 visits|0|||
28132307|NCT03287791|54795911|FG001|Overall Study|Too much time between 2 visits|1|||
28132308|NCT03287791|54795912|FG002|Overall Study|Too much time between 2 visits|0|||
28132309|NCT03287791|54795910|FG000|Overall Study|Non-compliance|0|||
28132310|NCT03287791|54795911|FG001|Overall Study|Non-compliance|1|||
28132311|NCT03287791|54795912|FG002|Overall Study|Non-compliance|0|||
28132312|NCT03287791|54795910|FG000|Overall Study|Did not meet inclusion criteria|1|||
28132313|NCT03287791|54795911|FG001|Overall Study|Did not meet inclusion criteria|0|||
28132314|NCT03287791|54795912|FG002|Overall Study|Did not meet inclusion criteria|0|||
28132315|NCT03287635|54795920|FG000|Overall Study|Lost to Follow-up|5|||
28132316|NCT03287635|54795920|FG000|Overall Study|Withdrawal by Subject|1|||
28132317|NCT03287635|54795920|FG000|Overall Study|Physician Decision|1|||
28132318|NCT03287089|54795926|FG000|Overall Study|Lost to Follow-up|0|||
28132319|NCT03287089|54795927|FG001|Overall Study|Lost to Follow-up|2|||
28132320|NCT03287089|54795926|FG000|Overall Study|Physician Decision|0|||
28132321|NCT03287089|54795927|FG001|Overall Study|Physician Decision|2|||
28132322|NCT03287089|54795926|FG000|Overall Study|Withdrawal by Subject|0|||
28132323|NCT03287089|54795927|FG001|Overall Study|Withdrawal by Subject|2|||
28132324|NCT03286543|54795935|FG000|Consented|Screen failure before randomization|2|||
28132325|NCT03286543|54795936|FG001|Consented|Screen failure before randomization|0|||
28132326|NCT03286543|54795937|FG002|Consented|Screen failure before randomization|0|||
28132327|NCT03286543|54795935|FG000|Consented|Screen failure before enrollment|4|||
28132328|NCT03286543|54795936|FG001|Consented|Screen failure before enrollment|0|||
28132329|NCT03286543|54795937|FG002|Consented|Screen failure before enrollment|0|||
28132330|NCT03286543|54795935|FG000|Consented|TKA cancelled after enrollment|1|||
28132331|NCT03286543|54795936|FG001|Consented|TKA cancelled after enrollment|0|||
28132332|NCT03286543|54795937|FG002|Consented|TKA cancelled after enrollment|0|||
28132333|NCT03286543|54795935|FG000|Consented|Withdrawn from study|12|||
28132334|NCT03286543|54795936|FG001|Consented|Withdrawn from study|0|||
27819363|NCT01468233|54278740|FG005|Treatment Period 2|Adverse Event|1|||
27819364|NCT01468233|54278735|FG000|Treatment Period 2|Lack of Efficacy|0|||
28132335|NCT03286543|54795937|FG002|Consented|Withdrawn from study|0|||
28132336|NCT03286543|54795935|FG000|Study Enrollment|TKA cancelled after enrollment|0|||
28132337|NCT03286543|54795936|FG001|Study Enrollment|TKA cancelled after enrollment|0|||
28132338|NCT03286543|54795937|FG002|Study Enrollment|TKA cancelled after enrollment|1|||
28132339|NCT03286543|54795935|FG000|Study Enrollment|Withdrawn from study|0|||
28132340|NCT03286543|54795936|FG001|Study Enrollment|Withdrawn from study|6|||
28132341|NCT03286543|54795937|FG002|Study Enrollment|Withdrawn from study|6|||
28132342|NCT03306433|54795943|FG000|Overall Study|Lost to Follow-up|3|||
28132343|NCT03306433|54795943|FG000|Overall Study|Patient did not have teeth extracted|1|||
27819365|NCT01468233|54278736|FG001|Treatment Period 2|Lack of Efficacy|0|||
27819366|NCT01468233|54278737|FG002|Treatment Period 2|Lack of Efficacy|9|||
27819367|NCT01468233|54278738|FG003|Treatment Period 2|Lack of Efficacy|2|||
27819368|NCT01468233|54278739|FG004|Treatment Period 2|Lack of Efficacy|0|||
27819369|NCT01468233|54278740|FG005|Treatment Period 2|Lack of Efficacy|1|||
27819370|NCT01468233|54278735|FG000|Treatment Period 2|Withdrawal by Subject|0|||
27819371|NCT01468233|54278736|FG001|Treatment Period 2|Withdrawal by Subject|0|||
27819372|NCT01468233|54278737|FG002|Treatment Period 2|Withdrawal by Subject|9|||
27819373|NCT01468233|54278738|FG003|Treatment Period 2|Withdrawal by Subject|1|||
27819374|NCT01468233|54278739|FG004|Treatment Period 2|Withdrawal by Subject|1|||
27819375|NCT01468233|54278740|FG005|Treatment Period 2|Withdrawal by Subject|1|||
27819376|NCT01468233|54278735|FG000|Treatment Period 2|Loss/absence of response (per protocol)|0|||
27819377|NCT01468233|54278736|FG001|Treatment Period 2|Loss/absence of response (per protocol)|0|||
27819378|NCT01468233|54278737|FG002|Treatment Period 2|Loss/absence of response (per protocol)|84|||
27819379|NCT01468233|54278738|FG003|Treatment Period 2|Loss/absence of response (per protocol)|25|||
27819380|NCT01468233|54278739|FG004|Treatment Period 2|Loss/absence of response (per protocol)|22|||
27819381|NCT01468233|54278740|FG005|Treatment Period 2|Loss/absence of response (per protocol)|20|||
28132344|NCT03306433|54795943|FG000|Overall Study|Teeth not sent to the lab or participant only had two teeth for extraction|3|||
28132345|NCT02940691|54795951|FG000|Overall Study|Lost to Follow-up|5|||
28132346|NCT02940691|54795951|FG000|Overall Study|Incarceration|1|||
28132347|NCT03306277|54795989|FG000|Overall Study|Death|1|||
28132348|NCT03306277|54795989|FG000|Overall Study|Adverse Event|1|||
28132349|NCT03306277|54795989|FG000|Overall Study|Withdrawal by Subject|1|||
28132350|NCT03130959|54796003|FG000|Overall Study|Disease progression|19|||
28132351|NCT03130959|54796004|FG001|Overall Study|Disease progression|7|||
28132352|NCT03130959|54796005|FG002|Overall Study|Disease progression|12|||
28132353|NCT03130959|54796006|FG003|Overall Study|Disease progression|7|||
28132354|NCT03130959|54796007|FG004|Overall Study|Disease progression|12|||
28132355|NCT03130959|54796008|FG005|Overall Study|Disease progression|3|||
28132356|NCT03130959|54796009|FG006|Overall Study|Disease progression|6|||
28132357|NCT03130959|54796010|FG007|Overall Study|Disease progression|3|||
28132358|NCT03130959|54796011|FG008|Overall Study|Disease progression|15|||
28132359|NCT03130959|54796012|FG009|Overall Study|Disease progression|8|||
28132360|NCT03130959|54796003|FG000|Overall Study|Study drug toxicity|2|||
28132361|NCT03130959|54796004|FG001|Overall Study|Study drug toxicity|2|||
28132362|NCT03130959|54796005|FG002|Overall Study|Study drug toxicity|1|||
28132363|NCT03130959|54796006|FG003|Overall Study|Study drug toxicity|2|||
28132364|NCT03130959|54796007|FG004|Overall Study|Study drug toxicity|1|||
28132365|NCT03130959|54796008|FG005|Overall Study|Study drug toxicity|1|||
28132366|NCT03130959|54796009|FG006|Overall Study|Study drug toxicity|3|||
28132367|NCT03130959|54796010|FG007|Overall Study|Study drug toxicity|0|||
28132368|NCT03130959|54796011|FG008|Overall Study|Study drug toxicity|3|||
27819382|NCT01468233|54278735|FG000|Treatment Period 2|Lost to Follow-up|0|||
27819383|NCT01468233|54278736|FG001|Treatment Period 2|Lost to Follow-up|0|||
27819384|NCT01468233|54278737|FG002|Treatment Period 2|Lost to Follow-up|3|||
27849758|NCT00634751|54347491|FG001|Phase I: 400mg Sorafenib BID+2DOC|Death|1|||
28132369|NCT03130959|54796012|FG009|Overall Study|Study drug toxicity|3|||
28132370|NCT03130959|54796003|FG000|Overall Study|Other reasons|0|||
28132371|NCT03130959|54796004|FG001|Overall Study|Other reasons|0|||
28132372|NCT03130959|54796005|FG002|Overall Study|Other reasons|0|||
28132373|NCT03130959|54796006|FG003|Overall Study|Other reasons|0|||
28132374|NCT03130959|54796007|FG004|Overall Study|Other reasons|0|||
28132375|NCT03130959|54796008|FG005|Overall Study|Other reasons|1|||
27819385|NCT01468233|54278738|FG003|Treatment Period 2|Lost to Follow-up|0|||
27849759|NCT00634751|54347492|FG002|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
28132376|NCT03130959|54796009|FG006|Overall Study|Other reasons|1|||
28132377|NCT03130959|54796010|FG007|Overall Study|Other reasons|0|||
28132378|NCT03130959|54796011|FG008|Overall Study|Other reasons|0|||
28132379|NCT03130959|54796012|FG009|Overall Study|Other reasons|0|||
28132380|NCT03130959|54796003|FG000|Overall Study|Subject request to discontinue therapy|0|||
28132381|NCT03130959|54796004|FG001|Overall Study|Subject request to discontinue therapy|0|||
28132382|NCT03130959|54796005|FG002|Overall Study|Subject request to discontinue therapy|1|||
28132383|NCT03130959|54796006|FG003|Overall Study|Subject request to discontinue therapy|1|||
27819386|NCT01468233|54278739|FG004|Treatment Period 2|Lost to Follow-up|2|||
27819387|NCT01468233|54278740|FG005|Treatment Period 2|Lost to Follow-up|0|||
27819388|NCT01468233|54278735|FG000|Treatment Period 2|Other|0|||
27819389|NCT01468233|54278736|FG001|Treatment Period 2|Other|0|||
27819390|NCT01468233|54278737|FG002|Treatment Period 2|Other|3|||
27819391|NCT01468233|54278738|FG003|Treatment Period 2|Other|0|||
27819392|NCT01468233|54278739|FG004|Treatment Period 2|Other|1|||
27819393|NCT01468233|54278740|FG005|Treatment Period 2|Other|0|||
27819394|NCT01468077|54278760|FG000|Overall Study|Adverse Event|2|||
27819395|NCT01468077|54278761|FG001|Overall Study|Adverse Event|2|||
27819396|NCT01468077|54278760|FG000|Overall Study|Lack of Efficacy|1|||
27819397|NCT01468077|54278761|FG001|Overall Study|Lack of Efficacy|1|||
27819398|NCT01468077|54278760|FG000|Overall Study|Physician Decision|1|||
27819399|NCT01468077|54278761|FG001|Overall Study|Physician Decision|0|||
27819400|NCT01522365|54278769|FG000|Overall Study|Withdrawal by Subject|1|||
27819401|NCT01522365|54278770|FG001|Overall Study|Withdrawal by Subject|1|||
28132384|NCT03130959|54796007|FG004|Overall Study|Subject request to discontinue therapy|0|||
28132385|NCT03130959|54796008|FG005|Overall Study|Subject request to discontinue therapy|0|||
28132386|NCT03130959|54796009|FG006|Overall Study|Subject request to discontinue therapy|1|||
28132387|NCT03130959|54796010|FG007|Overall Study|Subject request to discontinue therapy|1|||
28132388|NCT03130959|54796011|FG008|Overall Study|Subject request to discontinue therapy|0|||
28132389|NCT03130959|54796012|FG009|Overall Study|Subject request to discontinue therapy|0|||
28132390|NCT03130959|54796003|FG000|Overall Study|Not reported|0|||
28132391|NCT03130959|54796004|FG001|Overall Study|Not reported|0|||
28132392|NCT03130959|54796005|FG002|Overall Study|Not reported|0|||
28132393|NCT03130959|54796006|FG003|Overall Study|Not reported|1|||
28132394|NCT03130959|54796007|FG004|Overall Study|Not reported|0|||
28132395|NCT03130959|54796008|FG005|Overall Study|Not reported|1|||
28132396|NCT03130959|54796009|FG006|Overall Study|Not reported|0|||
28132397|NCT03130959|54796010|FG007|Overall Study|Not reported|0|||
28132398|NCT03130959|54796011|FG008|Overall Study|Not reported|0|||
28132399|NCT03130959|54796012|FG009|Overall Study|Not reported|1|||
28132400|NCT03130959|54796003|FG000|Overall Study|Adverse Event unrelated to drug|0|||
28132401|NCT03130959|54796004|FG001|Overall Study|Adverse Event unrelated to drug|0|||
28132402|NCT03130959|54796005|FG002|Overall Study|Adverse Event unrelated to drug|1|||
28132403|NCT03130959|54796006|FG003|Overall Study|Adverse Event unrelated to drug|1|||
28132404|NCT03130959|54796007|FG004|Overall Study|Adverse Event unrelated to drug|1|||
28132405|NCT03130959|54796008|FG005|Overall Study|Adverse Event unrelated to drug|0|||
28132406|NCT03130959|54796009|FG006|Overall Study|Adverse Event unrelated to drug|1|||
28132407|NCT03130959|54796010|FG007|Overall Study|Adverse Event unrelated to drug|0|||
28132408|NCT03130959|54796011|FG008|Overall Study|Adverse Event unrelated to drug|1|||
28132409|NCT03130959|54796012|FG009|Overall Study|Adverse Event unrelated to drug|1|||
28132410|NCT03130959|54796003|FG000|Overall Study|Participant withdrew consent|0|||
28132411|NCT03130959|54796004|FG001|Overall Study|Participant withdrew consent|1|||
27819402|NCT01522365|54278769|FG000|Overall Study|Lost to Follow-up|1|||
27819403|NCT01522365|54278770|FG001|Overall Study|Lost to Follow-up|1|||
28068749|NCT00048568|54723818|FG001|Open-Label Period|Lost to Follow-up|0|||
28068750|NCT00048568|54723819|FG002|Open-Label Period|Lost to Follow-up|7|||
28068751|NCT00262002|54723847|FG000|Overall Study|Adverse Event|2|||
28068752|NCT00262002|54723848|FG001|Overall Study|Adverse Event|1|||
28068753|NCT00262002|54723849|FG002|Overall Study|Adverse Event|0|||
28068754|NCT00262002|54723850|FG003|Overall Study|Adverse Event|0|||
28068755|NCT00262002|54723851|FG004|Overall Study|Adverse Event|0|||
28068756|NCT00262002|54723852|FG005|Overall Study|Adverse Event|1|||
28068757|NCT00262002|54723853|FG006|Overall Study|Adverse Event|0|||
28068758|NCT00262002|54723847|FG000|Overall Study|Withdrawal by Subject|4|||
28068759|NCT00262002|54723848|FG001|Overall Study|Withdrawal by Subject|2|||
28132412|NCT03130959|54796005|FG002|Overall Study|Participant withdrew consent|0|||
27819404|NCT01754402|54278780|FG000|Overall Study|Death|0|||
28132413|NCT03130959|54796006|FG003|Overall Study|Participant withdrew consent|2|||
28132414|NCT03130959|54796007|FG004|Overall Study|Participant withdrew consent|1|||
28132415|NCT03130959|54796008|FG005|Overall Study|Participant withdrew consent|0|||
27819405|NCT01754402|54278781|FG001|Overall Study|Death|0|||
28068760|NCT00262002|54723849|FG002|Overall Study|Withdrawal by Subject|0|||
28132416|NCT03130959|54796009|FG006|Overall Study|Participant withdrew consent|0|||
28132417|NCT03130959|54796010|FG007|Overall Study|Participant withdrew consent|0|||
28132418|NCT03130959|54796011|FG008|Overall Study|Participant withdrew consent|0|||
28132419|NCT03130959|54796012|FG009|Overall Study|Participant withdrew consent|2|||
28132420|NCT03130959|54796003|FG000|Overall Study|Administrative reason by sponsor|1|||
28132421|NCT03130959|54796004|FG001|Overall Study|Administrative reason by sponsor|0|||
28132422|NCT03130959|54796005|FG002|Overall Study|Administrative reason by sponsor|1|||
28068761|NCT00262002|54723850|FG003|Overall Study|Withdrawal by Subject|1|||
28068762|NCT00262002|54723851|FG004|Overall Study|Withdrawal by Subject|2|||
28068763|NCT00262002|54723852|FG005|Overall Study|Withdrawal by Subject|2|||
28068764|NCT00262002|54723853|FG006|Overall Study|Withdrawal by Subject|2|||
28068765|NCT00262002|54723847|FG000|Overall Study|Lost to Follow-up|2|||
28068766|NCT00262002|54723848|FG001|Overall Study|Lost to Follow-up|0|||
28068767|NCT00262002|54723849|FG002|Overall Study|Lost to Follow-up|0|||
28068768|NCT00262002|54723850|FG003|Overall Study|Lost to Follow-up|2|||
28068769|NCT00262002|54723851|FG004|Overall Study|Lost to Follow-up|0|||
28068770|NCT00262002|54723852|FG005|Overall Study|Lost to Follow-up|1|||
28068771|NCT00262002|54723853|FG006|Overall Study|Lost to Follow-up|0|||
28068772|NCT00262002|54723847|FG000|Overall Study|Inapropriate enrollment|0|||
28068773|NCT00262002|54723848|FG001|Overall Study|Inapropriate enrollment|1|||
28068774|NCT00262002|54723849|FG002|Overall Study|Inapropriate enrollment|0|||
28068775|NCT00262002|54723850|FG003|Overall Study|Inapropriate enrollment|0|||
28068776|NCT00262002|54723851|FG004|Overall Study|Inapropriate enrollment|0|||
28068777|NCT00262002|54723852|FG005|Overall Study|Inapropriate enrollment|0|||
28068778|NCT00262002|54723853|FG006|Overall Study|Inapropriate enrollment|0|||
28068779|NCT00262002|54723847|FG000|Overall Study|Protocol Violation|3|||
28068780|NCT00262002|54723848|FG001|Overall Study|Protocol Violation|2|||
28068781|NCT00262002|54723849|FG002|Overall Study|Protocol Violation|0|||
28068782|NCT00262002|54723850|FG003|Overall Study|Protocol Violation|2|||
28068783|NCT00262002|54723851|FG004|Overall Study|Protocol Violation|5|||
28068784|NCT00262002|54723852|FG005|Overall Study|Protocol Violation|3|||
28068785|NCT00262002|54723853|FG006|Overall Study|Protocol Violation|2|||
28068786|NCT00262002|54723847|FG000|Overall Study|Unable to classify|0|||
28068787|NCT00262002|54723848|FG001|Overall Study|Unable to classify|0|||
28068788|NCT00262002|54723849|FG002|Overall Study|Unable to classify|0|||
28068789|NCT00262002|54723850|FG003|Overall Study|Unable to classify|0|||
28068790|NCT00262002|54723851|FG004|Overall Study|Unable to classify|0|||
28068791|NCT00262002|54723852|FG005|Overall Study|Unable to classify|0|||
28068792|NCT00262002|54723853|FG006|Overall Study|Unable to classify|2|||
28068793|NCT00281528|54723921|FG000|Overall Study|Progressive Disease|28|||
28068794|NCT00281528|54723922|FG001|Overall Study|Progressive Disease|18|||
28068795|NCT00281528|54723923|FG002|Overall Study|Progressive Disease|27|||
28068796|NCT00281528|54723921|FG000|Overall Study|Unacceptable Toxicity-related to trt|21|||
28068797|NCT00281528|54723922|FG001|Overall Study|Unacceptable Toxicity-related to trt|24|||
28068798|NCT00281528|54723923|FG002|Overall Study|Unacceptable Toxicity-related to trt|32|||
28068799|NCT00281528|54723921|FG000|Overall Study|Adverse Event-unrelated to treatment|3|||
28068800|NCT00281528|54723922|FG001|Overall Study|Adverse Event-unrelated to treatment|0|||
28068801|NCT00281528|54723923|FG002|Overall Study|Adverse Event-unrelated to treatment|2|||
28068802|NCT00281528|54723921|FG000|Overall Study|Physician Decision|11|||
28068803|NCT00281528|54723922|FG001|Overall Study|Physician Decision|4|||
28068804|NCT00281528|54723923|FG002|Overall Study|Physician Decision|5|||
28068805|NCT00281528|54723921|FG000|Overall Study|Protocol Violation|1|||
28068806|NCT00281528|54723922|FG001|Overall Study|Protocol Violation|0|||
28068807|NCT00281528|54723923|FG002|Overall Study|Protocol Violation|1|||
28068808|NCT00281528|54723921|FG000|Overall Study|Withdrawal by Subject|5|||
28068809|NCT00281528|54723922|FG001|Overall Study|Withdrawal by Subject|5|||
28068810|NCT00281528|54723923|FG002|Overall Study|Withdrawal by Subject|7|||
28068811|NCT00281528|54723921|FG000|Overall Study|Other|6|||
28068812|NCT00281528|54723922|FG001|Overall Study|Other|3|||
28068813|NCT00281528|54723923|FG002|Overall Study|Other|5|||
28132423|NCT03130959|54796006|FG003|Overall Study|Administrative reason by sponsor|0|||
28068814|NCT00280748|54723931|FG000|Overall Study|Decline in performance|3|||
28068815|NCT00280748|54723931|FG000|Overall Study|Extra-cranial disease progression|1|||
28068816|NCT00271856|54723937|FG000|Overall Study|Withdrawal by Subject|1|||
28068817|NCT00271856|54723938|FG001|Overall Study|Withdrawal by Subject|7|||
28068818|NCT00271856|54723937|FG000|Overall Study|Lost to Follow-up|10|||
28068819|NCT00271856|54723938|FG001|Overall Study|Lost to Follow-up|11|||
28068820|NCT00061048|54723944|FG000|Overall Study|Adverse Event|2|||
28068821|NCT00061048|54723944|FG000|Overall Study|disease progression|20|||
28068822|NCT00270998|54723951|FG000|3 Month Follow-up|Adverse Event|1|||
28068823|NCT00270998|54723952|FG001|3 Month Follow-up|Adverse Event|0|||
28068824|NCT00270998|54723953|FG002|3 Month Follow-up|Adverse Event|0|||
28132424|NCT03130959|54796007|FG004|Overall Study|Administrative reason by sponsor|0|||
28132425|NCT03130959|54796008|FG005|Overall Study|Administrative reason by sponsor|0|||
28132426|NCT03130959|54796009|FG006|Overall Study|Administrative reason by sponsor|0|||
28132427|NCT03130959|54796010|FG007|Overall Study|Administrative reason by sponsor|0|||
28132428|NCT03130959|54796011|FG008|Overall Study|Administrative reason by sponsor|0|||
28132429|NCT03130959|54796012|FG009|Overall Study|Administrative reason by sponsor|0|||
28132430|NCT03130959|54796003|FG000|Overall Study|Lost to Follow-up|1|||
28132431|NCT03130959|54796004|FG001|Overall Study|Lost to Follow-up|0|||
28132432|NCT03130959|54796005|FG002|Overall Study|Lost to Follow-up|0|||
28132433|NCT03130959|54796006|FG003|Overall Study|Lost to Follow-up|0|||
28132434|NCT03130959|54796007|FG004|Overall Study|Lost to Follow-up|0|||
28132435|NCT03130959|54796008|FG005|Overall Study|Lost to Follow-up|0|||
28132436|NCT03130959|54796009|FG006|Overall Study|Lost to Follow-up|0|||
28132437|NCT03130959|54796010|FG007|Overall Study|Lost to Follow-up|0|||
28132438|NCT03130959|54796011|FG008|Overall Study|Lost to Follow-up|0|||
28132439|NCT03130959|54796012|FG009|Overall Study|Lost to Follow-up|0|||
28132440|NCT03124407|54796051|FG000|Overall Study|Lost to Follow-up|1|||
28132441|NCT03124407|54796052|FG001|Overall Study|Lost to Follow-up|0|||
28132442|NCT03124407|54796053|FG002|Overall Study|Lost to Follow-up|0|||
27819406|NCT01754402|54278782|FG002|Overall Study|Death|1|||
27819407|NCT01754402|54278780|FG000|Overall Study|Adverse Event|2|||
27819408|NCT01754402|54278781|FG001|Overall Study|Adverse Event|2|||
27819409|NCT01754402|54278782|FG002|Overall Study|Adverse Event|1|||
27819410|NCT01754402|54278780|FG000|Overall Study|Withdrawal by Subject|0|||
27819411|NCT01754402|54278781|FG001|Overall Study|Withdrawal by Subject|0|||
27819412|NCT01754402|54278782|FG002|Overall Study|Withdrawal by Subject|1|||
27819413|NCT01754402|54278780|FG000|Overall Study|Lack of Efficacy|0|||
27819414|NCT01754402|54278781|FG001|Overall Study|Lack of Efficacy|0|||
27819415|NCT01754402|54278782|FG002|Overall Study|Lack of Efficacy|1|||
27819416|NCT01783418|54278793|FG000|Overall Study|Withdrawal by Subject|1|||
27819417|NCT01783418|54278794|FG001|Overall Study|Withdrawal by Subject|0|||
27819418|NCT01521897|54278800|FG000|Overall Study|Protocol Violation|18|||
27819419|NCT01521897|54278800|FG000|Overall Study|Lost to Follow-up|5|||
27819420|NCT01782872|54278808|FG000|Overall Study|Protocol Violation|0|||
27819421|NCT01782872|54278809|FG001|Overall Study|Protocol Violation|0|||
27819422|NCT01782872|54278810|FG002|Overall Study|Protocol Violation|0|||
27819423|NCT01782872|54278811|FG003|Overall Study|Protocol Violation|1|||
27819424|NCT01782872|54278808|FG000|Overall Study|Withdrawal by Subject|0|||
27819425|NCT01782872|54278809|FG001|Overall Study|Withdrawal by Subject|1|||
27819426|NCT01782872|54278810|FG002|Overall Study|Withdrawal by Subject|0|||
27819427|NCT01782872|54278811|FG003|Overall Study|Withdrawal by Subject|0|||
27819428|NCT01490697|54278823|FG000|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1|||
27819429|NCT01490697|54278824|FG001|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2|||
27819430|NCT01728194|54278832|FG000|Overall Study|Lost to Follow-up|4|||
27819431|NCT01728194|54278833|FG001|Overall Study|Lost to Follow-up|3|||
27819432|NCT01728194|54278832|FG000|Overall Study|Physician Decision|4|||
27819433|NCT01728194|54278833|FG001|Overall Study|Physician Decision|0|||
27819434|NCT01728194|54278832|FG000|Overall Study|Withdrawal by Subject|7|||
27819435|NCT01728194|54278833|FG001|Overall Study|Withdrawal by Subject|3|||
27819436|NCT01728194|54278832|FG000|Overall Study|Perceived Medication Side Effects|4|||
27819437|NCT01728194|54278833|FG001|Overall Study|Perceived Medication Side Effects|0|||
28132443|NCT03124407|54796054|FG003|Overall Study|Lost to Follow-up|0|||
28132444|NCT03124407|54796051|FG000|Overall Study|Adverse Event|0|||
27819438|NCT01728194|54278832|FG000|Overall Study|Family Member Request|1|||
27819439|NCT01728194|54278833|FG001|Overall Study|Family Member Request|0|||
27819440|NCT01782482|54278841|FG000|Overall Study|Adverse Event|2|||
27819441|NCT01782482|54278842|FG001|Overall Study|Adverse Event|1|||
27819442|NCT01782482|54278841|FG000|Overall Study|Lost to Follow-up|2|||
27819443|NCT01782482|54278842|FG001|Overall Study|Lost to Follow-up|3|||
28132445|NCT03124407|54796052|FG001|Overall Study|Adverse Event|0|||
28132446|NCT03124407|54796053|FG002|Overall Study|Adverse Event|1|||
28132447|NCT03124407|54796054|FG003|Overall Study|Adverse Event|0|||
28132448|NCT02929407|54796068|FG000|Overall Study|Adverse Event|1|||
28132449|NCT03123939|54796072|FG000|Overall Study|Lack of Efficacy|6|||
28132450|NCT03123939|54796072|FG000|Overall Study|Death|5|||
28132451|NCT03123939|54796072|FG000|Overall Study|Physician Decision|2|||
28132452|NCT03123939|54796072|FG000|Overall Study|Subject/guardian decision|2|||
28132453|NCT03123939|54796072|FG000|Overall Study|Lost to Follow-up|1|||
28132454|NCT03123939|54796072|FG000|Overall Study|New therapy for study indication|1|||
28132455|NCT03123939|54796072|FG000|Overall Study|Protocol deviation|1|||
28132456|NCT03123939|54796072|FG000|Overall Study|Progressive disease|18|||
28132457|NCT03123939|54796072|FG000|Overall Study|Discontinued prior to CTL019 infusion due to death|4|||
28132458|NCT03123939|54796072|FG000|Overall Study|Discontinued prior to CTL019 infusion due to technical problems|1|||
28132459|NCT03123861|54796087|FG000|Overall Study|Protocol Violation|1|||
28132460|NCT03123861|54796088|FG001|Overall Study|Protocol Violation|1|||
28132461|NCT03123861|54796087|FG000|Overall Study|Withdrawal by Subject|2|||
28132462|NCT03123861|54796088|FG001|Overall Study|Withdrawal by Subject|2|||
28132463|NCT03123471|54796096|FG000|Placebo-controlled Phase|Adverse Event|3|||
28132464|NCT03123471|54796097|FG001|Placebo-controlled Phase|Adverse Event|8|||
28132465|NCT03123471|54796096|FG000|Placebo-controlled Phase|Lack of Efficacy|3|||
28132466|NCT03123471|54796097|FG001|Placebo-controlled Phase|Lack of Efficacy|4|||
28132467|NCT03123471|54796096|FG000|Placebo-controlled Phase|Withdrawal by Subject|6|||
28132468|NCT03123471|54796097|FG001|Placebo-controlled Phase|Withdrawal by Subject|16|||
28132469|NCT03123471|54796096|FG000|Placebo-controlled Phase|Non-compliance with Study Drug|3|||
28132470|NCT03123471|54796097|FG001|Placebo-controlled Phase|Non-compliance with Study Drug|0|||
28132471|NCT03123471|54796096|FG000|Placebo-controlled Phase|Lost to Follow-up|1|||
28132472|NCT03123471|54796097|FG001|Placebo-controlled Phase|Lost to Follow-up|3|||
28132473|NCT03123471|54796096|FG000|Placebo-controlled Phase|Protocol Deviation|2|||
28132474|NCT03123471|54796097|FG001|Placebo-controlled Phase|Protocol Deviation|1|||
28132475|NCT03123471|54796096|FG000|Placebo-controlled Phase|Miscellaneous|0|||
28132476|NCT03123471|54796097|FG001|Placebo-controlled Phase|Miscellaneous|1|||
28132477|NCT03123471|54796096|FG000|Apremilast Extension Phase|Lost to Follow-up|2|||
28132478|NCT03123471|54796097|FG001|Apremilast Extension Phase|Lost to Follow-up|5|||
28132479|NCT03123471|54796096|FG000|Apremilast Extension Phase|Adverse Event|1|||
28132480|NCT03123471|54796097|FG001|Apremilast Extension Phase|Adverse Event|5|||
28132481|NCT03123471|54796096|FG000|Apremilast Extension Phase|Lack of Efficacy|2|||
28132482|NCT03123471|54796097|FG001|Apremilast Extension Phase|Lack of Efficacy|8|||
28132483|NCT03123471|54796096|FG000|Apremilast Extension Phase|Withdrawal by Subject|3|||
28132484|NCT03123471|54796097|FG001|Apremilast Extension Phase|Withdrawal by Subject|7|||
28132485|NCT02661178|54796124|FG000|Part 1|Protocol Violation|1|||
28132486|NCT02661178|54796125|FG001|Part 1|Protocol Violation|0|||
28132487|NCT02661178|54796126|FG002|Part 1|Protocol Violation|0|||
28132488|NCT02661178|54796127|FG003|Part 1|Protocol Violation|0|||
28132489|NCT02661178|54796128|FG004|Part 1|Protocol Violation|0|||
28132490|NCT02661178|54796129|FG005|Part 1|Protocol Violation|0|||
28132491|NCT02661178|54796130|FG006|Part 1|Protocol Violation|0|||
28132492|NCT02661178|54796131|FG007|Part 1|Protocol Violation|0|||
28132493|NCT02661178|54796132|FG008|Part 1|Protocol Violation|0|||
28132494|NCT02661178|54796133|FG009|Part 1|Protocol Violation|0|||
28132495|NCT02661178|54796134|FG010|Part 1|Protocol Violation|0|||
28132496|NCT02661178|54796135|FG011|Part 1|Protocol Violation|0|||
28132497|NCT02661178|54796136|FG012|Part 1|Protocol Violation|0|||
28132498|NCT02661178|54796137|FG013|Part 1|Protocol Violation|0|||
28132499|NCT02661178|54796138|FG014|Part 1|Protocol Violation|0|||
28132500|NCT02660944|54796190|FG000|Overall Study|Adverse Event|3|||
28132501|NCT02660944|54796191|FG001|Overall Study|Adverse Event|4|||
28132502|NCT02660944|54796190|FG000|Overall Study|Physician Decision|3|||
28132503|NCT02660944|54796191|FG001|Overall Study|Physician Decision|1|||
28132504|NCT02660944|54796190|FG000|Overall Study|Withdrawal by Subject|5|||
28132505|NCT02660944|54796191|FG001|Overall Study|Withdrawal by Subject|3|||
28132506|NCT02660944|54796190|FG000|Overall Study|Lost to Follow-up|4|||
28132507|NCT02660944|54796191|FG001|Overall Study|Lost to Follow-up|1|||
28132508|NCT02660944|54796190|FG000|Overall Study|Subject schedule|0|||
28132509|NCT02660944|54796191|FG001|Overall Study|Subject schedule|1|||
28132510|NCT02660944|54796190|FG000|Overall Study|Exclusion criteria met|2|||
28132511|NCT02660944|54796191|FG001|Overall Study|Exclusion criteria met|0|||
28132512|NCT02975336|54796201|FG000|DBPC (52 Weeks)|Adverse Event|16|||
28132513|NCT02975336|54796202|FG001|DBPC (52 Weeks)|Adverse Event|17|||
28132514|NCT02975336|54796203|FG002|DBPC (52 Weeks)|Adverse Event|13|||
28132515|NCT02975336|54796204|FG003|DBPC (52 Weeks)|Adverse Event|18|||
28132516|NCT02975336|54796205|FG004|DBPC (52 Weeks)|Adverse Event|0|||
28132517|NCT02975336|54796206|FG005|DBPC (52 Weeks)|Adverse Event|0|||
28132518|NCT02975336|54796207|FG006|DBPC (52 Weeks)|Adverse Event|0|||
28132519|NCT02975336|54796208|FG007|DBPC (52 Weeks)|Adverse Event|0|||
28132520|NCT02975336|54796201|FG000|DBPC (52 Weeks)|Lost to Follow-up|2|||
28132521|NCT02975336|54796202|FG001|DBPC (52 Weeks)|Lost to Follow-up|1|||
28132522|NCT02975336|54796203|FG002|DBPC (52 Weeks)|Lost to Follow-up|2|||
28132523|NCT02975336|54796204|FG003|DBPC (52 Weeks)|Lost to Follow-up|4|||
28132524|NCT02975336|54796205|FG004|DBPC (52 Weeks)|Lost to Follow-up|0|||
28132525|NCT02975336|54796206|FG005|DBPC (52 Weeks)|Lost to Follow-up|0|||
28132526|NCT02975336|54796207|FG006|DBPC (52 Weeks)|Lost to Follow-up|0|||
28132527|NCT02975336|54796208|FG007|DBPC (52 Weeks)|Lost to Follow-up|0|||
28132528|NCT02975336|54796201|FG000|DBPC (52 Weeks)|Protocol Violation|4|||
28132529|NCT02975336|54796202|FG001|DBPC (52 Weeks)|Protocol Violation|1|||
28132530|NCT02975336|54796203|FG002|DBPC (52 Weeks)|Protocol Violation|3|||
28132531|NCT02975336|54796204|FG003|DBPC (52 Weeks)|Protocol Violation|1|||
28132532|NCT02975336|54796205|FG004|DBPC (52 Weeks)|Protocol Violation|0|||
28132533|NCT02975336|54796206|FG005|DBPC (52 Weeks)|Protocol Violation|0|||
28132534|NCT02975336|54796207|FG006|DBPC (52 Weeks)|Protocol Violation|0|||
28132535|NCT02975336|54796208|FG007|DBPC (52 Weeks)|Protocol Violation|0|||
28132536|NCT02975336|54796201|FG000|DBPC (52 Weeks)|Lack of Efficacy|4|||
28132537|NCT02975336|54796202|FG001|DBPC (52 Weeks)|Lack of Efficacy|4|||
28132538|NCT02975336|54796203|FG002|DBPC (52 Weeks)|Lack of Efficacy|2|||
28132539|NCT02975336|54796204|FG003|DBPC (52 Weeks)|Lack of Efficacy|3|||
28132540|NCT02975336|54796205|FG004|DBPC (52 Weeks)|Lack of Efficacy|0|||
28132541|NCT02975336|54796206|FG005|DBPC (52 Weeks)|Lack of Efficacy|0|||
28132542|NCT02975336|54796207|FG006|DBPC (52 Weeks)|Lack of Efficacy|0|||
28132543|NCT02975336|54796208|FG007|DBPC (52 Weeks)|Lack of Efficacy|0|||
28132544|NCT02975336|54796201|FG000|DBPC (52 Weeks)|Withdrawal by Subject|1|||
28132545|NCT02975336|54796202|FG001|DBPC (52 Weeks)|Withdrawal by Subject|0|||
28132546|NCT02975336|54796203|FG002|DBPC (52 Weeks)|Withdrawal by Subject|1|||
28132547|NCT02975336|54796204|FG003|DBPC (52 Weeks)|Withdrawal by Subject|3|||
28132548|NCT02975336|54796205|FG004|DBPC (52 Weeks)|Withdrawal by Subject|0|||
27819444|NCT01782482|54278841|FG000|Overall Study|Physician Decision|1|||
27819445|NCT01782482|54278842|FG001|Overall Study|Physician Decision|0|||
27819446|NCT01782482|54278841|FG000|Overall Study|Protocol Violation|1|||
27819447|NCT01782482|54278842|FG001|Overall Study|Protocol Violation|0|||
27819448|NCT01782482|54278841|FG000|Overall Study|Withdrawal by Subject|2|||
27819449|NCT01782482|54278842|FG001|Overall Study|Withdrawal by Subject|3|||
27819450|NCT01782482|54278841|FG000|Overall Study|Randomized in Error|2|||
27819451|NCT01782482|54278842|FG001|Overall Study|Randomized in Error|2|||
27819452|NCT01782482|54278841|FG000|Overall Study|Habitually wearing toric lens OS|0|||
27819453|NCT01782482|54278842|FG001|Overall Study|Habitually wearing toric lens OS|1|||
28132549|NCT02975336|54796206|FG005|DBPC (52 Weeks)|Withdrawal by Subject|0|||
28132550|NCT02975336|54796207|FG006|DBPC (52 Weeks)|Withdrawal by Subject|0|||
28132551|NCT02975336|54796208|FG007|DBPC (52 Weeks)|Withdrawal by Subject|0|||
28132552|NCT02975336|54796201|FG000|DBPC (52 Weeks)|Premature termination of the study|5|||
28132553|NCT02975336|54796202|FG001|DBPC (52 Weeks)|Premature termination of the study|6|||
28132554|NCT02975336|54796203|FG002|DBPC (52 Weeks)|Premature termination of the study|6|||
28132555|NCT02975336|54796204|FG003|DBPC (52 Weeks)|Premature termination of the study|4|||
28132556|NCT02975336|54796205|FG004|DBPC (52 Weeks)|Premature termination of the study|0|||
28132557|NCT02975336|54796206|FG005|DBPC (52 Weeks)|Premature termination of the study|0|||
27819454|NCT01466673|54278850|FG000|Overall Study|Non-compliance with study treatment|2|||
27819455|NCT01466673|54278851|FG001|Overall Study|Non-compliance with study treatment|0|||
27819456|NCT01466673|54278850|FG000|Overall Study|Lost to Follow-up|3|||
27819457|NCT01466673|54278851|FG001|Overall Study|Lost to Follow-up|5|||
27819458|NCT01466673|54278850|FG000|Overall Study|Adverse Event|2|||
27819459|NCT01466673|54278851|FG001|Overall Study|Adverse Event|1|||
27819460|NCT01753856|54278859|FG000|Overall Study|Adverse Event|1|||
28068825|NCT00270998|54723951|FG000|3 Month Follow-up|Lack of Efficacy|1|||
28068826|NCT00270998|54723952|FG001|3 Month Follow-up|Lack of Efficacy|2|||
28068827|NCT00270998|54723953|FG002|3 Month Follow-up|Lack of Efficacy|1|||
28068828|NCT00270998|54723951|FG000|3 Month Follow-up|Withdrawal by Subject|11|||
28068829|NCT00270998|54723952|FG001|3 Month Follow-up|Withdrawal by Subject|14|||
28068830|NCT00270998|54723953|FG002|3 Month Follow-up|Withdrawal by Subject|15|||
28068831|NCT00270998|54723951|FG000|3 Month Follow-up|Pessary did not fit|12|||
28068832|NCT00270998|54723952|FG001|3 Month Follow-up|Pessary did not fit|0|||
28068833|NCT00270998|54723953|FG002|3 Month Follow-up|Pessary did not fit|0|||
28068834|NCT00270998|54723951|FG000|3 Month Follow-up|Personal/family health|1|||
28068835|NCT00270998|54723952|FG001|3 Month Follow-up|Personal/family health|1|||
28132558|NCT02975336|54796207|FG006|DBPC (52 Weeks)|Premature termination of the study|0|||
28132559|NCT02975336|54796208|FG007|DBPC (52 Weeks)|Premature termination of the study|0|||
28132560|NCT02975336|54796201|FG000|LTE (104 Weeks)|Adverse Event|0|||
28132561|NCT02975336|54796202|FG001|LTE (104 Weeks)|Adverse Event|0|||
28132562|NCT02975336|54796203|FG002|LTE (104 Weeks)|Adverse Event|0|||
28132563|NCT02975336|54796204|FG003|LTE (104 Weeks)|Adverse Event|0|||
28132564|NCT02975336|54796205|FG004|LTE (104 Weeks)|Adverse Event|7|||
28068836|NCT00270998|54723953|FG002|3 Month Follow-up|Personal/family health|0|||
28068837|NCT00270998|54723951|FG000|3 Month Follow-up|Received/desired alternate treatment|13|||
28132565|NCT02975336|54796206|FG005|LTE (104 Weeks)|Adverse Event|4|||
28132566|NCT02975336|54796207|FG006|LTE (104 Weeks)|Adverse Event|2|||
28132567|NCT02975336|54796208|FG007|LTE (104 Weeks)|Adverse Event|0|||
28132568|NCT02975336|54796201|FG000|LTE (104 Weeks)|Lost to Follow-up|0|||
28132569|NCT02975336|54796202|FG001|LTE (104 Weeks)|Lost to Follow-up|0|||
27819461|NCT01753856|54278860|FG001|Overall Study|Adverse Event|0|||
27819462|NCT01753856|54278859|FG000|Overall Study|Withdrawal by Subject|0|||
27819463|NCT01753856|54278860|FG001|Overall Study|Withdrawal by Subject|2|||
27819464|NCT01753856|54278859|FG000|Overall Study|Sponsor Decision|2|||
27819465|NCT01753856|54278860|FG001|Overall Study|Sponsor Decision|0|||
27819466|NCT01464333|54278869|FG000|Overall Study|Adverse Event|34|||
27819467|NCT01464333|54278869|FG000|Overall Study|Lack of Efficacy|72|||
27819468|NCT01464333|54278869|FG000|Overall Study|Withdrawal by Subject|11|||
27819469|NCT01464333|54278869|FG000|Overall Study|Other|4|||
27819470|NCT01464333|54278869|FG000|Overall Study|No Hospital Visit|42|||
27819471|NCT01464255|54278875|FG000|Overall Study|unresolve corneal staining|0|||
27819472|NCT01464255|54278876|FG001|Overall Study|unresolve corneal staining|1|||
27819473|NCT01464021|54278883|FG000|Overall Study|Withdrawal by Subject|13|||
27819474|NCT01464021|54278883|FG000|Overall Study|Lost to Follow-up|1|||
27819475|NCT01464021|54278883|FG000|Overall Study|Lack of Efficacy|1|||
27819476|NCT01464021|54278883|FG000|Overall Study|various|11|||
27819477|NCT01753310|54278889|FG000|Overall Study|Entered into open label extension study|25|||
27819478|NCT01753310|54278890|FG001|Overall Study|Entered into open label extension study|22|||
27819479|NCT01753310|54278889|FG000|Overall Study|Adverse Event|1|||
27940669|NCT01227824|54596962|FG001|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3|||
27940670|NCT01227824|54596963|FG002|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0|||
27940671|NCT01227824|54596961|FG000|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6|||
27940672|NCT01227824|54596962|FG001|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4|||
27940673|NCT01227824|54596963|FG002|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0|||
27940674|NCT01227824|54596961|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22|||
27940675|NCT01227824|54596962|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10|||
27940676|NCT01227824|54596963|FG002|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0|||
28068838|NCT00270998|54723952|FG001|3 Month Follow-up|Received/desired alternate treatment|5|||
28068839|NCT00270998|54723953|FG002|3 Month Follow-up|Received/desired alternate treatment|2|||
28068840|NCT00270998|54723951|FG000|12 Month Follow-up|Lack of Efficacy|5|||
28068841|NCT00270998|54723952|FG001|12 Month Follow-up|Lack of Efficacy|4|||
28068842|NCT00270998|54723953|FG002|12 Month Follow-up|Lack of Efficacy|3|||
28068843|NCT00270998|54723951|FG000|12 Month Follow-up|Withdrawal by Subject|7|||
28068844|NCT00270998|54723952|FG001|12 Month Follow-up|Withdrawal by Subject|12|||
28068845|NCT00270998|54723953|FG002|12 Month Follow-up|Withdrawal by Subject|16|||
28068846|NCT00270998|54723951|FG000|12 Month Follow-up|Pessary did not fit|1|||
28068847|NCT00270998|54723952|FG001|12 Month Follow-up|Pessary did not fit|0|||
28068848|NCT00270998|54723953|FG002|12 Month Follow-up|Pessary did not fit|0|||
28132570|NCT02975336|54796203|FG002|LTE (104 Weeks)|Lost to Follow-up|0|||
27819480|NCT01753310|54278890|FG001|Overall Study|Adverse Event|0|||
27819481|NCT01753310|54278889|FG000|Overall Study|Lost to Follow-up|2|||
27819482|NCT01753310|54278890|FG001|Overall Study|Lost to Follow-up|0|||
27819483|NCT01753310|54278889|FG000|Overall Study|Subject decision|2|||
28068849|NCT00270998|54723951|FG000|12 Month Follow-up|Personal/family health|0|||
28068850|NCT00270998|54723952|FG001|12 Month Follow-up|Personal/family health|5|||
27940677|NCT01227824|54596961|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18|||
27940678|NCT01227824|54596962|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14|||
27940679|NCT01227824|54596963|FG002|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0|||
27940680|NCT01227824|54596961|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|3|||
27940681|NCT01227824|54596962|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
27940682|NCT01227824|54596963|FG002|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
27940683|NCT01227824|54596961|FG000|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
27940684|NCT01227824|54596962|FG001|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
27940685|NCT01227824|54596963|FG002|Open-label Phase: Median of 1267 Days|Adverse Event|4|||
27940686|NCT01227824|54596961|FG000|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
27940687|NCT01227824|54596962|FG001|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
27940688|NCT01227824|54596963|FG002|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5|||
27940689|NCT01227824|54596961|FG000|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
27940690|NCT01227824|54596962|FG001|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
27940691|NCT01227824|54596963|FG002|Open-label Phase: Median of 1267 Days|Protocol Violation|5|||
27940692|NCT01227824|54596961|FG000|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
27940693|NCT01227824|54596962|FG001|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
27940694|NCT01227824|54596963|FG002|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4|||
27940695|NCT01227824|54596961|FG000|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
28068851|NCT00270998|54723953|FG002|12 Month Follow-up|Personal/family health|1|||
28068852|NCT00270998|54723951|FG000|12 Month Follow-up|Received/desired alternate treatment|1|||
28068853|NCT00270998|54723952|FG001|12 Month Follow-up|Received/desired alternate treatment|4|||
28068854|NCT00270998|54723953|FG002|12 Month Follow-up|Received/desired alternate treatment|1|||
28068855|NCT00279812|54723969|FG000|Overall Study|Protocol Violation|1|||
28068856|NCT00279812|54723970|FG001|Overall Study|Protocol Violation|1|||
28068857|NCT00279812|54723971|FG002|Overall Study|Protocol Violation|0|||
28068858|NCT00279812|54723972|FG003|Overall Study|Protocol Violation|0|||
28068859|NCT00279812|54723973|FG004|Overall Study|Protocol Violation|1|||
28068860|NCT00279812|54723974|FG005|Overall Study|Protocol Violation|0|||
28068861|NCT00279812|54723969|FG000|Overall Study|Withdrawal by Subject|0|||
28068862|NCT00279812|54723970|FG001|Overall Study|Withdrawal by Subject|4|||
28068863|NCT00279812|54723971|FG002|Overall Study|Withdrawal by Subject|2|||
28068864|NCT00279812|54723972|FG003|Overall Study|Withdrawal by Subject|0|||
28068865|NCT00279812|54723973|FG004|Overall Study|Withdrawal by Subject|0|||
28068866|NCT00279812|54723974|FG005|Overall Study|Withdrawal by Subject|0|||
28068867|NCT00279812|54723969|FG000|Overall Study|Adverse Event|0|||
28068868|NCT00279812|54723970|FG001|Overall Study|Adverse Event|1|||
28068869|NCT00279812|54723971|FG002|Overall Study|Adverse Event|1|||
28068870|NCT00279812|54723972|FG003|Overall Study|Adverse Event|0|||
28068871|NCT00279812|54723973|FG004|Overall Study|Adverse Event|2|||
28068872|NCT00279812|54723974|FG005|Overall Study|Adverse Event|1|||
28068873|NCT00207714|54723993|FG000|Overall Study|Adverse Event|6|||
28068874|NCT00207714|54723994|FG001|Overall Study|Adverse Event|2|||
28068875|NCT00207714|54723995|FG002|Overall Study|Adverse Event|4|||
28068876|NCT00207714|54723996|FG003|Overall Study|Adverse Event|3|||
27940696|NCT01227824|54596962|FG001|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
28068877|NCT00207714|54723997|FG004|Overall Study|Adverse Event|1|||
28068878|NCT00207714|54723993|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
28068879|NCT00207714|54723994|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
28068880|NCT00207714|54723995|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
27940697|NCT01227824|54596963|FG002|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15|||
28068881|NCT00207714|54723996|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
28132571|NCT02975336|54796204|FG003|LTE (104 Weeks)|Lost to Follow-up|0|||
28132572|NCT02975336|54796205|FG004|LTE (104 Weeks)|Lost to Follow-up|0|||
28132573|NCT02975336|54796206|FG005|LTE (104 Weeks)|Lost to Follow-up|1|||
28132574|NCT02975336|54796207|FG006|LTE (104 Weeks)|Lost to Follow-up|0|||
28132575|NCT02975336|54796208|FG007|LTE (104 Weeks)|Lost to Follow-up|0|||
28132576|NCT02975336|54796201|FG000|LTE (104 Weeks)|Lack of Efficacy|0|||
28132577|NCT02975336|54796202|FG001|LTE (104 Weeks)|Lack of Efficacy|0|||
28132578|NCT02975336|54796203|FG002|LTE (104 Weeks)|Lack of Efficacy|0|||
28132579|NCT02975336|54796204|FG003|LTE (104 Weeks)|Lack of Efficacy|0|||
28132580|NCT02975336|54796205|FG004|LTE (104 Weeks)|Lack of Efficacy|0|||
28132581|NCT02975336|54796206|FG005|LTE (104 Weeks)|Lack of Efficacy|1|||
28132582|NCT02975336|54796207|FG006|LTE (104 Weeks)|Lack of Efficacy|2|||
28132583|NCT02975336|54796208|FG007|LTE (104 Weeks)|Lack of Efficacy|0|||
28132584|NCT02975336|54796201|FG000|LTE (104 Weeks)|Other|0|||
28068882|NCT00207714|54723997|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
28068883|NCT00207714|54723993|FG000|Overall Study|Other|3|||
28068884|NCT00207714|54723994|FG001|Overall Study|Other|2|||
28068885|NCT00207714|54723995|FG002|Overall Study|Other|5|||
28068886|NCT00207714|54723996|FG003|Overall Study|Other|1|||
28068887|NCT00207714|54723997|FG004|Overall Study|Other|0|||
28068888|NCT00207090|54724016|FG000|Overall Study|Study drug toxicity|3|||
28068889|NCT00207090|54724016|FG000|Overall Study|Chest wall mass larger|1|||
28068890|NCT00207090|54724016|FG000|Overall Study|Disease progression/relapse|2|||
28068891|NCT00207090|54724016|FG000|Overall Study|Physician Decision|1|||
28068892|NCT00059332|54724027|FG000|Overall Study|Withdrawal by Subject|2|||
28068893|NCT00059332|54724028|FG001|Overall Study|Withdrawal by Subject|1|||
28068894|NCT00059332|54724027|FG000|Overall Study|Lost to Follow-up|1|||
28068895|NCT00059332|54724028|FG001|Overall Study|Lost to Follow-up|1|||
28068896|NCT00233454|54724034|FG000|Overall Study|Death|6|||
28068897|NCT00047320|54724038|FG000|Overall Study|Lack of Efficacy|8|||
28068898|NCT00047320|54724038|FG000|Overall Study|Lost to Follow-up|1|||
28068899|NCT00047320|54724038|FG000|Overall Study|Physician Decision|8|||
28132585|NCT02975336|54796202|FG001|LTE (104 Weeks)|Other|0|||
28132586|NCT02975336|54796203|FG002|LTE (104 Weeks)|Other|0|||
28132587|NCT02975336|54796204|FG003|LTE (104 Weeks)|Other|0|||
28132588|NCT02975336|54796205|FG004|LTE (104 Weeks)|Other|55|||
27819484|NCT01753310|54278890|FG001|Overall Study|Subject decision|2|||
27819485|NCT01753310|54278889|FG000|Overall Study|Sponsor decision|1|||
28132589|NCT02975336|54796206|FG005|LTE (104 Weeks)|Other|63|||
28068900|NCT00047320|54724038|FG000|Overall Study|Withdrawal by Subject|9|||
28068901|NCT00047320|54724038|FG000|Overall Study|Ineligible|2|||
28068902|NCT00233064|54724044|FG000|Overall Study|Lost to Follow-up|7|||
28068903|NCT00233064|54724045|FG001|Overall Study|Lost to Follow-up|7|||
28132590|NCT02975336|54796207|FG006|LTE (104 Weeks)|Other|76|||
28132591|NCT02975336|54796208|FG007|LTE (104 Weeks)|Other|72|||
28132592|NCT03124563|54796224|FG000|Overall Study|Lost to Follow-up|1|||
28132593|NCT03124563|54796225|FG001|Overall Study|Lost to Follow-up|1|||
28132594|NCT03124563|54796224|FG000|Overall Study|Withdrawal by Subject|1|||
28132595|NCT03124563|54796225|FG001|Overall Study|Withdrawal by Subject|1|||
28132596|NCT03079869|54796233|FG000|Overall Study|Adverse Event|6|||
28132597|NCT03079869|54796234|FG001|Overall Study|Adverse Event|8|||
28132598|NCT03079869|54796233|FG000|Overall Study|Withdrawal by Subject|4|||
28132599|NCT03079869|54796234|FG001|Overall Study|Withdrawal by Subject|1|||
28132600|NCT03079869|54796233|FG000|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|3|||
28132601|NCT03079869|54796234|FG001|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|2|||
28132602|NCT03085914|54796247|FG000|Overall Study|Death|6|||
28132603|NCT03085914|54796248|FG001|Overall Study|Death|6|||
28132604|NCT03085914|54796249|FG002|Overall Study|Death|4|||
28132605|NCT03085914|54796250|FG003|Overall Study|Death|1|||
28132606|NCT03085914|54796251|FG004|Overall Study|Death|5|||
28132607|NCT03085914|54796252|FG005|Overall Study|Death|2|||
28132608|NCT03085914|54796253|FG006|Overall Study|Death|2|||
28132609|NCT03085914|54796247|FG000|Overall Study|Withdrawal by Subject|1|||
28132610|NCT03085914|54796248|FG001|Overall Study|Withdrawal by Subject|1|||
28132611|NCT03085914|54796249|FG002|Overall Study|Withdrawal by Subject|2|||
28132612|NCT03085914|54796250|FG003|Overall Study|Withdrawal by Subject|2|||
28132613|NCT03085914|54796251|FG004|Overall Study|Withdrawal by Subject|2|||
28132614|NCT03085914|54796252|FG005|Overall Study|Withdrawal by Subject|0|||
28132615|NCT03085914|54796253|FG006|Overall Study|Withdrawal by Subject|1|||
27940698|NCT01227824|54596961|FG000|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
27940699|NCT01227824|54596962|FG001|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
28068904|NCT00233064|54724044|FG000|Overall Study|Withdrawal by Subject|5|||
28068905|NCT00233064|54724045|FG001|Overall Study|Withdrawal by Subject|3|||
28068906|NCT00233064|54724044|FG000|Overall Study|Death|0|||
28068907|NCT00233064|54724045|FG001|Overall Study|Death|1|||
28068908|NCT00233064|54724044|FG000|Overall Study|Relocation|0|||
28068909|NCT00233064|54724045|FG001|Overall Study|Relocation|1|||
28068910|NCT00233064|54724044|FG000|Overall Study|Protocol Violation|1|||
28068911|NCT00233064|54724045|FG001|Overall Study|Protocol Violation|0|||
28068912|NCT00233064|54724044|FG000|Overall Study|Moved to Dom. Republic|1|||
28068913|NCT00233064|54724045|FG001|Overall Study|Moved to Dom. Republic|0|||
28068914|NCT00268892|54724055|FG000|Overall Study|Adverse Event|14|||
28068915|NCT00268892|54724056|FG001|Overall Study|Adverse Event|17|||
28068916|NCT00268892|54724057|FG002|Overall Study|Adverse Event|20|||
28068917|NCT00268892|54724055|FG000|Overall Study|Lack of Efficacy|1|||
28068918|NCT00268892|54724056|FG001|Overall Study|Lack of Efficacy|3|||
28068919|NCT00268892|54724057|FG002|Overall Study|Lack of Efficacy|0|||
28068920|NCT00268892|54724055|FG000|Overall Study|Withdrawal by Subject|14|||
28068921|NCT00268892|54724056|FG001|Overall Study|Withdrawal by Subject|15|||
28068922|NCT00268892|54724057|FG002|Overall Study|Withdrawal by Subject|13|||
28068923|NCT00268892|54724055|FG000|Overall Study|Physician Decision|0|||
28068924|NCT00268892|54724056|FG001|Overall Study|Physician Decision|1|||
28068925|NCT00268892|54724057|FG002|Overall Study|Physician Decision|0|||
28132616|NCT03085914|54796247|FG000|Overall Study|Lost to Follow-up|0|||
28132617|NCT03085914|54796248|FG001|Overall Study|Lost to Follow-up|0|||
28132618|NCT03085914|54796249|FG002|Overall Study|Lost to Follow-up|1|||
28132619|NCT03085914|54796250|FG003|Overall Study|Lost to Follow-up|0|||
28132620|NCT03085914|54796251|FG004|Overall Study|Lost to Follow-up|0|||
28132621|NCT03085914|54796252|FG005|Overall Study|Lost to Follow-up|1|||
28132622|NCT03085914|54796253|FG006|Overall Study|Lost to Follow-up|1|||
28132623|NCT03085914|54796247|FG000|Overall Study|Reason was not specified,|2|||
28132624|NCT03085914|54796248|FG001|Overall Study|Reason was not specified,|2|||
28068926|NCT00268892|54724055|FG000|Overall Study|Lost to Follow-up|5|||
28068927|NCT00268892|54724056|FG001|Overall Study|Lost to Follow-up|2|||
28068928|NCT00268892|54724057|FG002|Overall Study|Lost to Follow-up|4|||
28132625|NCT03085914|54796249|FG002|Overall Study|Reason was not specified,|2|||
28068929|NCT00268892|54724055|FG000|Overall Study|Protocol Violation|0|||
28068930|NCT00268892|54724056|FG001|Overall Study|Protocol Violation|1|||
28068931|NCT00268892|54724057|FG002|Overall Study|Protocol Violation|0|||
28068932|NCT00268892|54724055|FG000|Overall Study|Disease Progression|1|||
28068933|NCT00268892|54724056|FG001|Overall Study|Disease Progression|1|||
28068934|NCT00268892|54724057|FG002|Overall Study|Disease Progression|0|||
27849760|NCT00634751|54347493|FG003|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
27940700|NCT01227824|54596963|FG002|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8|||
27940701|NCT01227824|54596961|FG000|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
27940702|NCT01227824|54596962|FG001|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
27940703|NCT01227824|54596963|FG002|Open-label Phase: Median of 1267 Days|Physician Decision|3|||
27940704|NCT00949702|54596970|FG000|Overall Study|Death|40|||
27940705|NCT00949702|54596970|FG000|Overall Study|Disease progression|7|||
27940706|NCT00949702|54596970|FG000|Overall Study|Withdrawal of consent|1|||
27940707|NCT01034631|54596977|FG000|Phase I|Symptomatic Deterioration before Treatme|3|||
27940708|NCT01034631|54596978|FG001|Phase I|Symptomatic Deterioration before Treatme|0|||
27940709|NCT01034631|54596979|FG002|Phase I|Symptomatic Deterioration before Treatme|0|||
27940710|NCT01034631|54596977|FG000|Phase II|Not Evaluable per protocol|0|||
27940711|NCT01034631|54596978|FG001|Phase II|Not Evaluable per protocol|0|||
27940712|NCT01034631|54596979|FG002|Phase II|Not Evaluable per protocol|2|||
27940713|NCT01034631|54596977|FG000|Phase II|Determined Ineligible per protocol|0|||
27940714|NCT01034631|54596978|FG001|Phase II|Determined Ineligible per protocol|1|||
27940715|NCT01034631|54596979|FG002|Phase II|Determined Ineligible per protocol|0|||
27940716|NCT01227668|54596991|FG000|Phase 1 (Stabilization Phase)|Adverse Event|12|||
27940717|NCT01227668|54596992|FG001|Phase 1 (Stabilization Phase)|Adverse Event|0|||
27940718|NCT01227668|54596991|FG000|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7|||
27940719|NCT01227668|54596992|FG001|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0|||
27849761|NCT00634751|54347490|FG000|Pancreatic and Bilial Tract Cancer|Death|0|||
27849762|NCT00634751|54347491|FG001|Pancreatic and Bilial Tract Cancer|Death|0|||
27849763|NCT00634751|54347492|FG002|Pancreatic and Bilial Tract Cancer|Death|1|||
27940720|NCT01227668|54596991|FG000|Phase 1 (Stabilization Phase)|Lost to Follow-up|8|||
27940721|NCT01227668|54596992|FG001|Phase 1 (Stabilization Phase)|Lost to Follow-up|0|||
27940722|NCT01227668|54596991|FG000|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11|||
28132626|NCT03085914|54796250|FG003|Overall Study|Reason was not specified,|3|||
27940723|NCT01227668|54596992|FG001|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0|||
27940724|NCT01227668|54596991|FG000|Phase 1 (Stabilization Phase)|No longer meets study criteria|7|||
27940725|NCT01227668|54596992|FG001|Phase 1 (Stabilization Phase)|No longer meets study criteria|0|||
27940726|NCT01227668|54596991|FG000|Phase 1 (Stabilization Phase)|Lack of Efficacy|25|||
27940727|NCT01227668|54596992|FG001|Phase 1 (Stabilization Phase)|Lack of Efficacy|0|||
27940728|NCT01227668|54596991|FG000|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2|||
27940729|NCT01227668|54596992|FG001|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0|||
27940730|NCT01227668|54596991|FG000|Phase 2 (Randomization Phase)|Adverse Event|0|||
27940731|NCT01227668|54596992|FG001|Phase 2 (Randomization Phase)|Adverse Event|1|||
27940732|NCT01227668|54596991|FG000|Phase 2 (Randomization Phase)|Withdrawal by Subject|5|||
27940733|NCT01227668|54596992|FG001|Phase 2 (Randomization Phase)|Withdrawal by Subject|0|||
27940734|NCT01227668|54596991|FG000|Phase 2 (Randomization Phase)|Lost to Follow-up|1|||
27940735|NCT01227668|54596992|FG001|Phase 2 (Randomization Phase)|Lost to Follow-up|0|||
27940736|NCT01227668|54596991|FG000|Phase 2 (Randomization Phase)|Lack of Efficacy|13|||
27940737|NCT01227668|54596992|FG001|Phase 2 (Randomization Phase)|Lack of Efficacy|23|||
27940738|NCT01227668|54596991|FG000|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0|||
27940739|NCT01227668|54596992|FG001|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1|||
27940740|NCT01227512|54597004|FG000|Overall Study|Physician Decision|6|||
27940741|NCT01227512|54597005|FG001|Overall Study|Physician Decision|6|||
27940742|NCT01227512|54597004|FG000|Overall Study|Adverse Event|4|||
27940743|NCT01227512|54597005|FG001|Overall Study|Adverse Event|3|||
27940744|NCT01227512|54597004|FG000|Overall Study|Withdrawal by Subject|3|||
27940745|NCT01227512|54597005|FG001|Overall Study|Withdrawal by Subject|0|||
27940746|NCT01227512|54597004|FG000|Overall Study|Participant met withdrawal criteria|0|||
27940747|NCT01227512|54597005|FG001|Overall Study|Participant met withdrawal criteria|1|||
27940748|NCT01227278|54597015|FG000|Overall Study|Withdrawal by Subject|4|||
27940749|NCT01227278|54597016|FG001|Overall Study|Withdrawal by Subject|4|||
27849764|NCT00634751|54347493|FG003|Pancreatic and Bilial Tract Cancer|Death|1|||
27849765|NCT00634049|54347532|FG000|Overall Study|Never received study drug|1|||
27849766|NCT00634049|54347532|FG000|Overall Study|Died prior to receiving study drug|1|||
27849767|NCT00634049|54347532|FG000|Overall Study|Screening failure|1|||
28132627|NCT03085914|54796251|FG004|Overall Study|Reason was not specified,|3|||
28132628|NCT03085914|54796252|FG005|Overall Study|Reason was not specified,|3|||
27849768|NCT00632099|54347571|FG000|Overall Study|Lost to Follow-up|3|||
27849769|NCT00632099|54347572|FG001|Overall Study|Lost to Follow-up|3|||
27849770|NCT00632021|54347580|FG000|Overall Study|Withdrawal/death|4|||
27849771|NCT00632021|54347581|FG001|Overall Study|Withdrawal/death|7|||
27849772|NCT00631475|54347588|FG000|Overall Study|Death|18|||
27849773|NCT00631475|54347588|FG000|Overall Study|Adverse Event|14|||
27940750|NCT01227278|54597015|FG000|Overall Study|Death|0|||
27940751|NCT01227278|54597016|FG001|Overall Study|Death|2|||
28132629|NCT03085914|54796253|FG006|Overall Study|Reason was not specified,|6|||
27849774|NCT00631475|54347588|FG000|Overall Study|Withdrew consent|5|||
27849775|NCT00631475|54347588|FG000|Overall Study|Preparation for lung transplant|8|||
28132630|NCT03085914|54796247|FG000|Overall Study|Progressive Disease|0|||
28132631|NCT03085914|54796248|FG001|Overall Study|Progressive Disease|0|||
28132632|NCT03085914|54796249|FG002|Overall Study|Progressive Disease|2|||
28132633|NCT03085914|54796250|FG003|Overall Study|Progressive Disease|2|||
28132634|NCT03085914|54796251|FG004|Overall Study|Progressive Disease|1|||
28132635|NCT03085914|54796252|FG005|Overall Study|Progressive Disease|1|||
28132636|NCT03085914|54796253|FG006|Overall Study|Progressive Disease|1|||
28132637|NCT03085914|54796247|FG000|Overall Study|Study Terminated by the Sponsor|0|||
28132638|NCT03085914|54796248|FG001|Overall Study|Study Terminated by the Sponsor|0|||
28132639|NCT03085914|54796249|FG002|Overall Study|Study Terminated by the Sponsor|0|||
28132640|NCT03085914|54796250|FG003|Overall Study|Study Terminated by the Sponsor|1|||
28132641|NCT03085914|54796251|FG004|Overall Study|Study Terminated by the Sponsor|2|||
28132642|NCT03085914|54796252|FG005|Overall Study|Study Terminated by the Sponsor|1|||
27940752|NCT01227278|54597015|FG000|Overall Study|Other|1|||
27940753|NCT01227278|54597016|FG001|Overall Study|Other|2|||
27940754|NCT01034397|54597024|FG000|Overall Study|Lack of compliance|0|||
27940755|NCT01034397|54597025|FG001|Overall Study|Lack of compliance|1|||
27940756|NCT01034397|54597024|FG000|Overall Study|Lack of Efficacy|3|||
27940757|NCT01034397|54597025|FG001|Overall Study|Lack of Efficacy|0|||
27940758|NCT01034397|54597024|FG000|Overall Study|Adverse Event|4|||
27940759|NCT01034397|54597025|FG001|Overall Study|Adverse Event|0|||
28068935|NCT00268892|54724055|FG000|Overall Study|Trial Site Closed|4|||
28132643|NCT03085914|54796253|FG006|Overall Study|Study Terminated by the Sponsor|0|||
28132644|NCT03078582|54796281|FG000|Overall Study|Adverse Event|0|||
27940760|NCT01034397|54597024|FG000|Overall Study|Other|0|||
28068936|NCT00268892|54724056|FG001|Overall Study|Trial Site Closed|2|||
28068937|NCT00268892|54724057|FG002|Overall Study|Trial Site Closed|2|||
28068938|NCT00206076|54724067|FG000|Overall Study|Physician Decision|2|||
28068939|NCT00206076|54724068|FG001|Overall Study|Physician Decision|0|||
28068940|NCT00206076|54724067|FG000|Overall Study|Withdrawal by Subject|1|||
28068941|NCT00206076|54724068|FG001|Overall Study|Withdrawal by Subject|1|||
28068942|NCT00278954|54724076|FG000|Overall Study|Adverse Event|3|||
28068943|NCT00278954|54724076|FG000|Overall Study|Lost to Follow-up|1|||
28068944|NCT00278954|54724076|FG000|Overall Study|Withdrawal by Subject|1|||
28068945|NCT00278564|54724080|FG000|Overall Study|Lack of Efficacy|4|||
28068946|NCT00268346|54724086|FG000|Overall Study|Adverse Event|0|||
28068947|NCT00268346|54724087|FG001|Overall Study|Adverse Event|1|||
28068948|NCT00268346|54724086|FG000|Overall Study|Death|0|||
28068949|NCT00268346|54724087|FG001|Overall Study|Death|1|||
28068950|NCT00268346|54724086|FG000|Overall Study|Withdrawal by Subject|0|||
28068951|NCT00268346|54724087|FG001|Overall Study|Withdrawal by Subject|1|||
28068952|NCT00203892|54724096|FG000|Overall Study|Physician Decision|1|||
28068953|NCT00203892|54724097|FG001|Overall Study|Physician Decision|2|||
28068954|NCT00203892|54724098|FG002|Overall Study|Physician Decision|0|||
28068955|NCT00203892|54724096|FG000|Overall Study|Death|1|||
28132645|NCT03078582|54796282|FG001|Overall Study|Adverse Event|8|||
28132646|NCT03077724|54796290|FG000|Overall Study|Lost to Follow-up|5|||
28132647|NCT03077724|54796291|FG001|Overall Study|Lost to Follow-up|1|||
28132648|NCT03077724|54796290|FG000|Overall Study|Withdrawal by Subject|3|||
28132649|NCT03077724|54796291|FG001|Overall Study|Withdrawal by Subject|1|||
27940761|NCT01034397|54597025|FG001|Overall Study|Other|1|||
28068956|NCT00203892|54724097|FG001|Overall Study|Death|0|||
28068957|NCT00203892|54724098|FG002|Overall Study|Death|0|||
28068958|NCT00250718|54724106|FG000|Overall Study|Death|1|||
28068959|NCT00250718|54724106|FG000|Overall Study|Adverse Event|1|||
28068960|NCT00250718|54724106|FG000|Overall Study|Withdrawal by Subject|1|||
27940762|NCT01227044|54597042|FG000|Overall Study|Lost to Follow-up|5|||
28068961|NCT00276614|54724110|FG000|Overall Study|Progression of disease under study|3|||
28068962|NCT00276458|54724116|FG000|Overall Study|Adverse Event|0|||
28068963|NCT00276458|54724117|FG001|Overall Study|Adverse Event|2|||
28068964|NCT00276458|54724116|FG000|Overall Study|Lost to Follow-up|2|||
28068965|NCT00276458|54724117|FG001|Overall Study|Lost to Follow-up|2|||
28068966|NCT00276458|54724116|FG000|Overall Study|Protocol Violation|4|||
28132650|NCT00979212|54796299|FG000|Overall Study|Protocol Violation|1|||
28132651|NCT00979212|54796300|FG001|Overall Study|Protocol Violation|8|||
28132652|NCT00979212|54796299|FG000|Overall Study|No protocol therapy received|1|||
28132653|NCT00979212|54796300|FG001|Overall Study|No protocol therapy received|0|||
28132654|NCT03080454|54796306|FG000|Baseline|Adverse Event|2|||
28132655|NCT03080454|54796306|FG000|Anodal Doublestim (5 Days)|Adverse Event|1|||
27940763|NCT01227044|54597043|FG001|Overall Study|Lost to Follow-up|7|||
27940764|NCT01227044|54597042|FG000|Overall Study|Discontinued Intervention|1|||
27940765|NCT01227044|54597043|FG001|Overall Study|Discontinued Intervention|2|||
27940766|NCT01225952|54597052|FG000|Overall Study|Lost to Follow-up|1|||
27940767|NCT01225952|54597053|FG001|Overall Study|Lost to Follow-up|0|||
28132656|NCT03080454|54796306|FG000|Anodal FU (7 Days)|Lost to Follow-up|4|||
28132657|NCT02981342|54796330|FG000|Overall Study|Adverse Event|0|||
28132658|NCT02981342|54796331|FG001|Overall Study|Adverse Event|0|||
28132659|NCT02981342|54796332|FG002|Overall Study|Adverse Event|0|||
28132660|NCT02981342|54796333|FG003|Overall Study|Adverse Event|1|||
28132661|NCT02981342|54796330|FG000|Overall Study|Death|0|||
28132662|NCT02981342|54796331|FG001|Overall Study|Death|9|||
28132663|NCT02981342|54796332|FG002|Overall Study|Death|9|||
28132664|NCT02981342|54796333|FG003|Overall Study|Death|4|||
28132665|NCT02981342|54796330|FG000|Overall Study|Withdrawal by Subject|0|||
28132666|NCT02981342|54796331|FG001|Overall Study|Withdrawal by Subject|0|||
28132667|NCT02981342|54796332|FG002|Overall Study|Withdrawal by Subject|3|||
28132668|NCT02981342|54796333|FG003|Overall Study|Withdrawal by Subject|1|||
28132669|NCT02981342|54796330|FG000|Overall Study|Study closed by sponsor|0|||
28132670|NCT02981342|54796331|FG001|Overall Study|Study closed by sponsor|0|||
28132671|NCT02981342|54796332|FG002|Overall Study|Study closed by sponsor|1|||
27940768|NCT01225952|54597054|FG002|Overall Study|Lost to Follow-up|0|||
27940769|NCT01225952|54597052|FG000|Overall Study|Study Eye Explanted|0|||
27940770|NCT01225952|54597053|FG001|Overall Study|Study Eye Explanted|0|||
27940771|NCT01225952|54597054|FG002|Overall Study|Study Eye Explanted|1|||
27940772|NCT01225952|54597052|FG000|Overall Study|Withdrawal by Subject|4|||
28132672|NCT02981342|54796333|FG003|Overall Study|Study closed by sponsor|1|||
28132673|NCT02981342|54796330|FG000|Overall Study|Randomized, Never Treated|0|||
28132674|NCT02981342|54796331|FG001|Overall Study|Randomized, Never Treated|1|||
28132675|NCT02981342|54796332|FG002|Overall Study|Randomized, Never Treated|0|||
28132676|NCT02981342|54796333|FG003|Overall Study|Randomized, Never Treated|7|||
28132677|NCT02981342|54796330|FG000|Overall Study|Lost to Follow-up|0|||
27940773|NCT01225952|54597053|FG001|Overall Study|Withdrawal by Subject|4|||
27940774|NCT01225952|54597054|FG002|Overall Study|Withdrawal by Subject|5|||
27940775|NCT01225952|54597052|FG000|Overall Study|Surgical complications|1|||
28132678|NCT02981342|54796331|FG001|Overall Study|Lost to Follow-up|1|||
28132679|NCT02981342|54796332|FG002|Overall Study|Lost to Follow-up|0|||
28132680|NCT02981342|54796333|FG003|Overall Study|Lost to Follow-up|0|||
28132681|NCT02794246|54796345|FG000|Overall Study|Withdrawal by Subject|2|||
28132682|NCT02794246|54796345|FG000|Overall Study|Physician Decision|4|||
28132683|NCT03428100|54796353|FG000|Overall Study|Adverse Event|1|||
28132684|NCT03428100|54796354|FG001|Overall Study|Adverse Event|0|||
28132685|NCT03428100|54796355|FG002|Overall Study|Adverse Event|3|||
28132686|NCT03428100|54796356|FG003|Overall Study|Adverse Event|1|||
28132687|NCT03428100|54796353|FG000|Overall Study|Lack of Efficacy|16|||
28132688|NCT03428100|54796354|FG001|Overall Study|Lack of Efficacy|10|||
28132689|NCT03428100|54796355|FG002|Overall Study|Lack of Efficacy|7|||
28132690|NCT03428100|54796356|FG003|Overall Study|Lack of Efficacy|6|||
28132691|NCT03428100|54796353|FG000|Overall Study|Protocol Deviation|0|||
28132692|NCT03428100|54796354|FG001|Overall Study|Protocol Deviation|2|||
28132693|NCT03428100|54796355|FG002|Overall Study|Protocol Deviation|2|||
28132694|NCT03428100|54796356|FG003|Overall Study|Protocol Deviation|0|||
28132695|NCT03428100|54796353|FG000|Overall Study|Withdrawal by Subject|4|||
28132696|NCT03428100|54796354|FG001|Overall Study|Withdrawal by Subject|0|||
28132697|NCT03428100|54796355|FG002|Overall Study|Withdrawal by Subject|0|||
28132698|NCT03428100|54796356|FG003|Overall Study|Withdrawal by Subject|0|||
28132699|NCT03428100|54796353|FG000|Overall Study|Physician Decision|0|||
28132700|NCT03428100|54796354|FG001|Overall Study|Physician Decision|1|||
28132701|NCT03428100|54796355|FG002|Overall Study|Physician Decision|0|||
28132702|NCT03428100|54796356|FG003|Overall Study|Physician Decision|0|||
28132703|NCT02980874|54796378|FG000|Overall Study|Adverse Event|2|||
28132704|NCT02980874|54796379|FG001|Overall Study|Adverse Event|7|||
28132705|NCT02980874|54796378|FG000|Overall Study|Withdrawal by Subject|7|||
28132706|NCT02980874|54796379|FG001|Overall Study|Withdrawal by Subject|2|||
28132707|NCT02980874|54796378|FG000|Overall Study|Lost to Follow-up|5|||
28132708|NCT02980874|54796379|FG001|Overall Study|Lost to Follow-up|5|||
28132709|NCT02980874|54796378|FG000|Overall Study|Includes premature discontinuation due to study termination.|88|||
28132710|NCT02980874|54796379|FG001|Overall Study|Includes premature discontinuation due to study termination.|88|||
28132711|NCT02980874|54796378|FG000|Overall Study|Unknown study completion status|1|||
28132712|NCT02980874|54796379|FG001|Overall Study|Unknown study completion status|0|||
28132713|NCT01066052|54796387|FG000|Overall Study|Enrolled But Not Treated|3|||
28132714|NCT01066052|54796388|FG001|Overall Study|Enrolled But Not Treated|0|||
28132715|NCT03077646|54796396|FG000|Overall Study|Lost to Follow-up|29|||
28132716|NCT03077646|54796397|FG001|Overall Study|Lost to Follow-up|30|||
27819486|NCT01753310|54278890|FG001|Overall Study|Sponsor decision|0|||
27819487|NCT01753310|54278889|FG000|Overall Study|Withdrawal by Subject|1|||
27819488|NCT01753310|54278890|FG001|Overall Study|Withdrawal by Subject|0|||
27819489|NCT01463631|54278900|FG000|Overall Study|Withdrawal by Subject|0|||
27819490|NCT01463631|54278901|FG001|Overall Study|Withdrawal by Subject|0|||
27819491|NCT01463631|54278902|FG002|Overall Study|Withdrawal by Subject|0|||
27819492|NCT01463631|54278903|FG003|Overall Study|Withdrawal by Subject|1|||
27819493|NCT01463631|54278900|FG000|Overall Study|Death|0|||
27819494|NCT01463631|54278901|FG001|Overall Study|Death|0|||
27819495|NCT01463631|54278902|FG002|Overall Study|Death|1|||
27819496|NCT01463631|54278903|FG003|Overall Study|Death|0|||
27819497|NCT01463631|54278900|FG000|Overall Study|Progressive Disease|0|||
27819498|NCT01463631|54278901|FG001|Overall Study|Progressive Disease|0|||
27819499|NCT01463631|54278902|FG002|Overall Study|Progressive Disease|0|||
27819500|NCT01463631|54278903|FG003|Overall Study|Progressive Disease|5|||
27819501|NCT01521507|54278917|FG000|Stage 1: Randomized Design|Device did not fit, No Treatment|2|||
27819502|NCT01521507|54278918|FG001|Stage 1: Randomized Design|Device did not fit, No Treatment|0|||
27819503|NCT01521507|54278917|FG000|Stage 1: Randomized Design|Withdrawal by Subject|1|||
27819504|NCT01521507|54278918|FG001|Stage 1: Randomized Design|Withdrawal by Subject|3|||
27819505|NCT01521507|54278917|FG000|Stage 1: Randomized Design|Lost to Follow-up|0|||
27819506|NCT01521507|54278918|FG001|Stage 1: Randomized Design|Lost to Follow-up|2|||
27819507|NCT01521507|54278917|FG000|Stage 2: Observational Design|Device did not fit, No Treatment|0|||
27819508|NCT01521507|54278918|FG001|Stage 2: Observational Design|Device did not fit, No Treatment|1|||
27819509|NCT01521507|54278917|FG000|Stage 2: Observational Design|Withdrawal by Subject|3|||
27819510|NCT01521507|54278918|FG001|Stage 2: Observational Design|Withdrawal by Subject|1|||
28132717|NCT03077646|54796398|FG002|Overall Study|Lost to Follow-up|31|||
28132718|NCT02892149|54796408|FG000|Overall Study|Death|262|||
28132719|NCT02892149|54796409|FG001|Overall Study|Death|278|||
28132720|NCT02892149|54796408|FG000|Overall Study|Withdrawal by Subject|53|||
28132721|NCT02892149|54796409|FG001|Overall Study|Withdrawal by Subject|47|||
27819511|NCT01521507|54278917|FG000|Stage 2: Observational Design|Physician Decision|1|||
28132722|NCT02892149|54796408|FG000|Overall Study|Lost to Follow-up|37|||
28132723|NCT02892149|54796409|FG001|Overall Study|Lost to Follow-up|31|||
28132724|NCT04187092|54796417|FG000|Overall Study|Lost to Follow-up|1|||
28132725|NCT04187092|54796418|FG001|Overall Study|Lost to Follow-up|1|||
28132726|NCT04187092|54796417|FG000|Overall Study|Withdrawal by Subject|1|||
28132727|NCT04187092|54796418|FG001|Overall Study|Withdrawal by Subject|1|||
28132728|NCT04187092|54796417|FG000|Overall Study|Adverse Event|0|||
28132729|NCT04187092|54796418|FG001|Overall Study|Adverse Event|1|||
28132730|NCT02896127|54796426|FG000|COMPLETED WEEK 52|Adverse Event|9|||
28132731|NCT02896127|54796427|FG001|COMPLETED WEEK 52|Adverse Event|2|||
28132732|NCT02896127|54796426|FG000|COMPLETED WEEK 52|Lack of Efficacy|2|||
28132733|NCT02896127|54796427|FG001|COMPLETED WEEK 52|Lack of Efficacy|3|||
28132734|NCT02896127|54796426|FG000|COMPLETED WEEK 52|Lost to Follow-up|0|||
28132735|NCT02896127|54796427|FG001|COMPLETED WEEK 52|Lost to Follow-up|1|||
28132736|NCT02896127|54796426|FG000|COMPLETED WEEK 52|Physician Decision|1|||
28132737|NCT02896127|54796427|FG001|COMPLETED WEEK 52|Physician Decision|1|||
28132738|NCT02896127|54796426|FG000|COMPLETED WEEK 52|Pregnancy|2|||
28132739|NCT02896127|54796427|FG001|COMPLETED WEEK 52|Pregnancy|0|||
28132740|NCT02896127|54796426|FG000|COMPLETED WEEK 52|Withdrawal by Subject|12|||
28132741|NCT02896127|54796427|FG001|COMPLETED WEEK 52|Withdrawal by Subject|4|||
28132742|NCT02896127|54796426|FG000|COMPLETED WEEK 52|Technical problems|1|||
28132743|NCT02896127|54796427|FG001|COMPLETED WEEK 52|Technical problems|0|||
28132744|NCT02896127|54796426|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2|||
28132745|NCT02896127|54796427|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3|||
28132746|NCT02896127|54796426|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0|||
28132747|NCT02896127|54796427|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1|||
28132748|NCT02896127|54796426|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1|||
28132749|NCT02896127|54796427|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0|||
28132750|NCT02896127|54796426|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1|||
28132751|NCT02896127|54796427|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0|||
28132752|NCT02896127|54796426|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0|||
28132753|NCT02896127|54796427|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1|||
28132754|NCT03546647|54796433|FG000|Overall Study|Adverse Event|1|||
28132755|NCT03546647|54796434|FG001|Overall Study|Adverse Event|0|||
28132756|NCT03077412|54796443|FG000|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|1|||
28132757|NCT03077412|54796444|FG001|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|5|||
28132758|NCT03077412|54796445|FG002|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|3|||
28132759|NCT03077412|54796443|FG000|Overall Study|Protocol-Specified Disease Worsening|1|||
28132760|NCT03077412|54796444|FG001|Overall Study|Protocol-Specified Disease Worsening|3|||
28132761|NCT03077412|54796445|FG002|Overall Study|Protocol-Specified Disease Worsening|3|||
28132762|NCT03077412|54796443|FG000|Overall Study|Adverse Event|1|||
28132763|NCT03077412|54796444|FG001|Overall Study|Adverse Event|2|||
28132764|NCT03077412|54796445|FG002|Overall Study|Adverse Event|2|||
28132765|NCT03077412|54796443|FG000|Overall Study|Investigator's Discretion|0|||
28132766|NCT03077412|54796444|FG001|Overall Study|Investigator's Discretion|1|||
28132767|NCT03077412|54796445|FG002|Overall Study|Investigator's Discretion|1|||
28132768|NCT03077412|54796443|FG000|Overall Study|Withdrew Consent|0|||
28132769|NCT03077412|54796444|FG001|Overall Study|Withdrew Consent|2|||
28132770|NCT03077412|54796445|FG002|Overall Study|Withdrew Consent|0|||
28132771|NCT03544229|54796457|FG000|Overall Study|Adverse Event|1|||
28132772|NCT03544229|54796458|FG001|Overall Study|Adverse Event|0|||
28132773|NCT03544229|54796459|FG002|Overall Study|Adverse Event|1|||
28132774|NCT03544229|54796460|FG003|Overall Study|Adverse Event|0|||
28132775|NCT03544229|54796457|FG000|Overall Study|Protocol Deviation|0|||
27819512|NCT01521507|54278918|FG001|Stage 2: Observational Design|Physician Decision|0|||
27819513|NCT01521117|54278931|FG000|First Intervention (6 Weeks)|Adverse Event|5|||
27819514|NCT01521117|54278932|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
27819515|NCT01521117|54278931|FG000|First Intervention (6 Weeks)|Scheduling Issues|0|||
27819516|NCT01521117|54278932|FG001|First Intervention (6 Weeks)|Scheduling Issues|2|||
27819517|NCT01521117|54278931|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
27819518|NCT01521117|54278932|FG001|Second Intervention (6 Weeks)|Adverse Event|3|||
27819519|NCT01466595|54278940|FG000|Overall Study|Withdrawal by Subject|0|||
27819520|NCT01466595|54278941|FG001|Overall Study|Withdrawal by Subject|1|||
27819521|NCT01728116|54278958|FG000|Overall Study|Sponsor Terminated Study|106|||
27819522|NCT01728116|54278959|FG001|Overall Study|Sponsor Terminated Study|35|||
28132776|NCT03544229|54796458|FG001|Overall Study|Protocol Deviation|0|||
28132777|NCT03544229|54796459|FG002|Overall Study|Protocol Deviation|1|||
28132778|NCT03544229|54796460|FG003|Overall Study|Protocol Deviation|0|||
28132779|NCT03544229|54796457|FG000|Overall Study|Lost to Follow-up|3|||
28132780|NCT03544229|54796458|FG001|Overall Study|Lost to Follow-up|0|||
28132781|NCT03544229|54796459|FG002|Overall Study|Lost to Follow-up|0|||
28132782|NCT03544229|54796460|FG003|Overall Study|Lost to Follow-up|2|||
28132783|NCT03544229|54796457|FG000|Overall Study|Voluntary Withdrawal|2|||
28132784|NCT03544229|54796458|FG001|Overall Study|Voluntary Withdrawal|1|||
28132785|NCT03544229|54796459|FG002|Overall Study|Voluntary Withdrawal|3|||
28132786|NCT03544229|54796460|FG003|Overall Study|Voluntary Withdrawal|0|||
28132787|NCT03544229|54796457|FG000|Overall Study|Lack of Efficacy|0|||
28132788|NCT03544229|54796458|FG001|Overall Study|Lack of Efficacy|1|||
28132789|NCT03544229|54796459|FG002|Overall Study|Lack of Efficacy|0|||
28132790|NCT03544229|54796460|FG003|Overall Study|Lack of Efficacy|0|||
28132791|NCT03078816|54796470|FG000|Overall Study|Withdrawal by Subject|1|||
28132792|NCT03510455|54796474|FG000|Overall Study|Physician Decision|1|||
28132793|NCT03509675|54796482|FG000|First Intervention (7 Days)|Lost to Follow-up|3|||
28132794|NCT03509675|54796483|FG001|First Intervention (7 Days)|Lost to Follow-up|3|||
28132795|NCT03509675|54796482|FG000|First Intervention (7 Days)|Lack of Efficacy|2|||
28132796|NCT03509675|54796483|FG001|First Intervention (7 Days)|Lack of Efficacy|1|||
28132797|NCT03509675|54796482|FG000|Second Intervention )7 Days)|Withdrawal by Subject|1|||
28132798|NCT03509675|54796483|FG001|Second Intervention )7 Days)|Withdrawal by Subject|0|||
28132799|NCT03509675|54796482|FG000|Second Intervention )7 Days)|Lost Rinse B|1|||
28132800|NCT03509675|54796483|FG001|Second Intervention )7 Days)|Lost Rinse B|0|||
28132801|NCT03509207|54796489|FG000|Overall Study|Death|2|||
28132802|NCT03543137|54796493|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
28132803|NCT03543137|54796494|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
28132804|NCT03543137|54796493|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
28132805|NCT03543137|54796494|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
28132806|NCT03543137|54796493|FG000|Study Period 2: Up to Day 8|Adverse Event|0|||
28132807|NCT03543137|54796494|FG001|Study Period 2: Up to Day 8|Adverse Event|1|||
28132808|NCT02895347|54796504|FG000|Overall Study|Withdrawal by Subject|3|||
28132809|NCT02895347|54796505|FG001|Overall Study|Withdrawal by Subject|1|||
28132810|NCT03539549|54796512|FG000|Overall Study|Adverse Event|12|||
28132811|NCT03539549|54796512|FG000|Overall Study|Lost to Follow-up|1|||
28132812|NCT03539549|54796512|FG000|Overall Study|Death|2|||
28132813|NCT03539549|54796512|FG000|Overall Study|Progressive Disease|1|||
28132814|NCT03539549|54796512|FG000|Overall Study|Reason not Specified|1|||
28132815|NCT03506477|54796518|FG000|Overall Study|Withdrawal by Subject|1|||
27940776|NCT01225952|54597053|FG001|Overall Study|Surgical complications|0|||
27940777|NCT01225952|54597054|FG002|Overall Study|Surgical complications|0|||
27940778|NCT01034163|54597064|FG000|Overall Study|Treatment completed as per protocol|8|||
27940779|NCT01034163|54597065|FG001|Overall Study|Treatment completed as per protocol|7|||
27940780|NCT01034163|54597064|FG000|Overall Study|Withdrawal by Subject|8|||
27940781|NCT01034163|54597065|FG001|Overall Study|Withdrawal by Subject|2|||
27940782|NCT01034163|54597064|FG000|Overall Study|Protocol deviation|1|||
27940783|NCT01034163|54597065|FG001|Overall Study|Protocol deviation|0|||
28068967|NCT00276458|54724117|FG001|Overall Study|Protocol Violation|3|||
28068968|NCT00276380|54724125|FG000|Overall Study|Adverse Event|5|||
28068969|NCT00276380|54724126|FG001|Overall Study|Adverse Event|3|||
28068970|NCT00276380|54724125|FG000|Overall Study|Lost to Follow-up|1|||
28068971|NCT00276380|54724126|FG001|Overall Study|Lost to Follow-up|1|||
28068972|NCT00276380|54724125|FG000|Overall Study|Withdrawal by Subject|3|||
28068973|NCT00276380|54724126|FG001|Overall Study|Withdrawal by Subject|6|||
28068974|NCT00276380|54724125|FG000|Overall Study|Death|5|||
28068975|NCT00276380|54724126|FG001|Overall Study|Death|3|||
28132816|NCT03506477|54796519|FG001|Overall Study|Withdrawal by Subject|0|||
28132817|NCT03073980|54796528|FG000|Overall Study|Lost to Follow-up|10|||
27819523|NCT01728116|54278958|FG000|Overall Study|Withdrawal by Subject|16|||
27940784|NCT01034163|54597064|FG000|Overall Study|Disease progression|3|||
28068976|NCT00276380|54724125|FG000|Overall Study|Abnormal aPPT Levels|0|||
28132818|NCT03073980|54796529|FG001|Overall Study|Lost to Follow-up|2|||
28132819|NCT03073980|54796530|FG002|Overall Study|Lost to Follow-up|9|||
28132820|NCT03073980|54796528|FG000|Overall Study|No post-procedure data|0|||
28132821|NCT03073980|54796529|FG001|Overall Study|No post-procedure data|0|||
28068977|NCT00276380|54724126|FG001|Overall Study|Abnormal aPPT Levels|1|||
28068978|NCT00267956|54724135|FG000|Controlled Period|Adverse Event|4|||
27940785|NCT01034163|54597065|FG001|Overall Study|Disease progression|4|||
27940786|NCT01034163|54597064|FG000|Overall Study|Adverse Event|6|||
27940787|NCT01034163|54597065|FG001|Overall Study|Adverse Event|0|||
27940788|NCT01034163|54597064|FG000|Overall Study|Administrative problems|0|||
27940789|NCT01034163|54597065|FG001|Overall Study|Administrative problems|1|||
27940790|NCT01034163|54597064|FG000|Overall Study|Abnormal laboratory value|1|||
27940791|NCT01034163|54597065|FG001|Overall Study|Abnormal laboratory value|0|||
27940792|NCT01033851|54597073|FG000|Overall Study|Withdrawal by Subject|3|||
27940793|NCT01033851|54597074|FG001|Overall Study|Withdrawal by Subject|7|||
27940794|NCT01162122|54597082|FG000|Overall Study|Withdrawal by Subject|52|||
27940795|NCT01162122|54597083|FG001|Overall Study|Withdrawal by Subject|43|||
27940796|NCT01162122|54597082|FG000|Overall Study|Lost to Follow-up|73|||
27940797|NCT01162122|54597083|FG001|Overall Study|Lost to Follow-up|91|||
27940798|NCT01162122|54597082|FG000|Overall Study|Adverse Event|3|||
27940799|NCT01162122|54597083|FG001|Overall Study|Adverse Event|2|||
27940800|NCT01162122|54597082|FG000|Overall Study|Death|51|||
27940801|NCT01162122|54597083|FG001|Overall Study|Death|46|||
28068979|NCT00267956|54724136|FG001|Controlled Period|Adverse Event|1|||
28068980|NCT00267956|54724137|FG002|Controlled Period|Adverse Event|0|||
28068981|NCT00267956|54724138|FG003|Controlled Period|Adverse Event|0|||
28132822|NCT03073980|54796530|FG002|Overall Study|No post-procedure data|2|||
28132823|NCT03930186|54796542|FG000|Weeks 0 to 16|Adverse Event|6|||
28132824|NCT03930186|54796542|FG000|Weeks 0 to 16|Withdrawal by Subject|6|||
28132825|NCT03930186|54796542|FG000|Weeks 16 to 32|Adverse Event|1|||
28132826|NCT03930186|54796542|FG000|Weeks 16 to 32|Withdrawal by Subject|3|||
28132827|NCT03504917|54796548|FG000|Blinded Treatment Period|Protocol Violation|1|||
28132828|NCT03504917|54796549|FG001|Blinded Treatment Period|Protocol Violation|0|||
28132829|NCT03504917|54796548|FG000|Blinded Treatment Period|Withdrawal by Subject|12|||
28132830|NCT03504917|54796549|FG001|Blinded Treatment Period|Withdrawal by Subject|9|||
28132831|NCT03504917|54796548|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
28132832|NCT03504917|54796549|FG001|Blinded Treatment Period|Lack of Efficacy|1|||
28132833|NCT03504917|54796548|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
28132834|NCT03504917|54796549|FG001|Blinded Treatment Period|Lost to Follow-up|4|||
28132835|NCT03504917|54796548|FG000|Blinded Treatment Period|Adverse Event|4|||
28132836|NCT03504917|54796549|FG001|Blinded Treatment Period|Adverse Event|4|||
28132837|NCT03504917|54796548|FG000|Blinded Treatment Period|Physician Decision|1|||
28068982|NCT00267956|54724135|FG000|Controlled Period|Lack of Efficacy|4|||
28068983|NCT00267956|54724136|FG001|Controlled Period|Lack of Efficacy|2|||
28068984|NCT00267956|54724137|FG002|Controlled Period|Lack of Efficacy|0|||
28068985|NCT00267956|54724138|FG003|Controlled Period|Lack of Efficacy|0|||
28068986|NCT00267956|54724135|FG000|Controlled Period|Lost to Follow-up|2|||
28068987|NCT00267956|54724136|FG001|Controlled Period|Lost to Follow-up|0|||
28068988|NCT00267956|54724137|FG002|Controlled Period|Lost to Follow-up|0|||
28068989|NCT00267956|54724138|FG003|Controlled Period|Lost to Follow-up|0|||
28068990|NCT00267956|54724135|FG000|Controlled Period|Withdrew consent|3|||
28068991|NCT00267956|54724136|FG001|Controlled Period|Withdrew consent|1|||
28068992|NCT00267956|54724137|FG002|Controlled Period|Withdrew consent|0|||
28068993|NCT00267956|54724138|FG003|Controlled Period|Withdrew consent|0|||
28068994|NCT00267956|54724135|FG000|After Controlled Period|Adverse Event|0|||
28068995|NCT00267956|54724136|FG001|After Controlled Period|Adverse Event|0|||
28068996|NCT00267956|54724137|FG002|After Controlled Period|Adverse Event|2|||
28068997|NCT00267956|54724138|FG003|After Controlled Period|Adverse Event|1|||
28068998|NCT00267956|54724135|FG000|After Controlled Period|Lack of Efficacy|0|||
28068999|NCT00267956|54724136|FG001|After Controlled Period|Lack of Efficacy|0|||
28069000|NCT00267956|54724137|FG002|After Controlled Period|Lack of Efficacy|1|||
28069001|NCT00267956|54724138|FG003|After Controlled Period|Lack of Efficacy|1|||
28069002|NCT00267956|54724135|FG000|After Controlled Period|Lost to Follow-up|0|||
28069003|NCT00267956|54724136|FG001|After Controlled Period|Lost to Follow-up|0|||
28069004|NCT00267956|54724137|FG002|After Controlled Period|Lost to Follow-up|1|||
28069005|NCT00267956|54724138|FG003|After Controlled Period|Lost to Follow-up|0|||
28069006|NCT00267956|54724135|FG000|After Controlled Period|Withdrew consent|0|||
28132838|NCT03504917|54796549|FG001|Blinded Treatment Period|Physician Decision|0|||
28132839|NCT03504917|54796548|FG000|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|1|||
28160096|NCT03434379|54830203|FG002|China Extension Period|Lost to Follow-up|1|||
27940802|NCT01162122|54597082|FG000|Overall Study|Protocol Violation|2|||
27940803|NCT01162122|54597083|FG001|Overall Study|Protocol Violation|2|||
27940804|NCT01162122|54597082|FG000|Overall Study|Inappropriate enrollment|5|||
28069007|NCT00267956|54724136|FG001|After Controlled Period|Withdrew consent|0|||
28069008|NCT00267956|54724137|FG002|After Controlled Period|Withdrew consent|1|||
28069009|NCT00267956|54724138|FG003|After Controlled Period|Withdrew consent|0|||
28069010|NCT00267488|54724146|FG000|Overall Study|Sponsor Terminated Study|9|||
28069011|NCT00267488|54724146|FG000|Overall Study|Protocol Violation|1|||
28069012|NCT00267488|54724146|FG000|Overall Study|Other (Disease Progression)|1|||
28069013|NCT00058552|54724152|FG000|Overall Study|Died prior to receiving treatment|4|||
28069014|NCT00058552|54724153|FG001|Overall Study|Died prior to receiving treatment|2|||
28132840|NCT03504917|54796549|FG001|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|3|||
28132841|NCT03504917|54796548|FG000|Blinded Treatment Period|Study terminated by sponsor|39|||
28132842|NCT03504917|54796549|FG001|Blinded Treatment Period|Study terminated by sponsor|34|||
28132843|NCT03504917|54796548|FG000|Blinded Treatment Period|Non-compliance with study drug|0|||
28132844|NCT03504917|54796549|FG001|Blinded Treatment Period|Non-compliance with study drug|1|||
28132845|NCT03504917|54796548|FG000|Open Label Extension Treatment Period|The participant left the study site|0|||
28132846|NCT03504917|54796549|FG001|Open Label Extension Treatment Period|The participant left the study site|1|||
28132847|NCT03504917|54796548|FG000|Open Label Extension Treatment Period|Withdrawal by Subject|8|||
28132848|NCT03504917|54796549|FG001|Open Label Extension Treatment Period|Withdrawal by Subject|2|||
28132849|NCT03504917|54796548|FG000|Open Label Extension Treatment Period|Lost to Follow-up|1|||
28132850|NCT03504917|54796549|FG001|Open Label Extension Treatment Period|Lost to Follow-up|4|||
28132851|NCT03504917|54796548|FG000|Open Label Extension Treatment Period|Lack of Efficacy|3|||
28132852|NCT03504917|54796549|FG001|Open Label Extension Treatment Period|Lack of Efficacy|1|||
28132853|NCT03504917|54796548|FG000|Open Label Extension Treatment Period|Adverse Event|7|||
28132854|NCT03504917|54796549|FG001|Open Label Extension Treatment Period|Adverse Event|0|||
28132855|NCT03504917|54796548|FG000|Open Label Extension Treatment Period|Non-compliance with study drug|0|||
28132856|NCT03504917|54796549|FG001|Open Label Extension Treatment Period|Non-compliance with study drug|1|||
28132857|NCT03504917|54796548|FG000|Open Label Extension Treatment Period|Study terminated by sponsor|81|||
28132858|NCT03504917|54796549|FG001|Open Label Extension Treatment Period|Study terminated by sponsor|88|||
28132859|NCT03536663|54796561|FG000|Endexo|Protocol Violation|1|||
28132860|NCT03565211|54796570|FG000|Overall Study|Withdrawal by Subject|2|||
28132861|NCT03565211|54796570|FG000|Overall Study|Lost to Follow-up|1|||
28132862|NCT03565211|54796570|FG000|Overall Study|Adverse Event|44|||
28132863|NCT03565211|54796570|FG000|Overall Study|Personal issues|1|||
28132864|NCT03531905|54796577|FG000|Overall Study|Withdrawal by Subject|3|||
28132865|NCT03531905|54796578|FG001|Overall Study|Withdrawal by Subject|3|||
28132866|NCT03531905|54796579|FG002|Overall Study|Withdrawal by Subject|2|||
28132867|NCT03531905|54796577|FG000|Overall Study|Lost to Follow-up|2|||
28132868|NCT03531905|54796578|FG001|Overall Study|Lost to Follow-up|2|||
28132869|NCT03531905|54796579|FG002|Overall Study|Lost to Follow-up|1|||
28132870|NCT03531905|54796577|FG000|Overall Study|Participant was out of town|1|||
28132871|NCT03531905|54796578|FG001|Overall Study|Participant was out of town|0|||
28132872|NCT03531905|54796579|FG002|Overall Study|Participant was out of town|0|||
28132873|NCT03531905|54796577|FG000|Overall Study|Could not speak with the participant|1|||
28132874|NCT03531905|54796578|FG001|Overall Study|Could not speak with the participant|0|||
28132875|NCT03531905|54796579|FG002|Overall Study|Could not speak with the participant|0|||
28132876|NCT03531827|54796589|FG000|Overall Study|Adverse Event|2|||
28132877|NCT03531827|54796590|FG001|Overall Study|Adverse Event|0|||
28132878|NCT03531827|54796589|FG000|Overall Study|Progressive disease|1|||
28132879|NCT03531827|54796590|FG001|Overall Study|Progressive disease|0|||
28132880|NCT03530345|54796619|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
28132881|NCT03530345|54796620|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0|||
28132882|NCT03530345|54796619|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
28132883|NCT03530345|54796620|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
28132884|NCT03530345|54796619|FG000|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17|||
28132885|NCT03530345|54796620|FG001|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21|||
28132886|NCT03530345|54796619|FG000|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5|||
28132887|NCT03530345|54796620|FG001|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7|||
27849776|NCT00631163|54347609|FG000|Number of Participants in Year 1|Adverse Event|12|||
28132888|NCT03500159|54796634|FG000|Overall Study|Study Terminated|2|||
28132889|NCT03500159|54796635|FG001|Overall Study|Study Terminated|1|||
28132890|NCT03785340|54796643|FG000|Overall Study|Lost to Follow-up|2|||
28132891|NCT03785340|54796644|FG001|Overall Study|Lost to Follow-up|0|||
28132892|NCT03785340|54796643|FG000|Overall Study|Adverse Event|1|||
28132893|NCT03785340|54796644|FG001|Overall Study|Adverse Event|0|||
28132894|NCT03499067|54796650|FG000|First Intervention|Physician Decision|2|||
28132895|NCT03499067|54796651|FG001|First Intervention|Physician Decision|1|||
28132896|NCT03499067|54796650|FG000|First Intervention|Withdrawal by Subject|3|||
28132897|NCT03499067|54796651|FG001|First Intervention|Withdrawal by Subject|6|||
28132898|NCT03562481|54796659|FG000|First Intervention|Lost to Follow-up|1|||
28132899|NCT03562481|54796660|FG001|First Intervention|Lost to Follow-up|0|||
28132900|NCT03529409|54796686|FG000|Randomized|Lost to Follow-up|0|||
28132901|NCT03529409|54796687|FG001|Randomized|Lost to Follow-up|0|||
28132902|NCT03529409|54796688|FG002|Randomized|Lost to Follow-up|4|||
27940805|NCT01162122|54597083|FG001|Overall Study|Inappropriate enrollment|4|||
27940806|NCT01162122|54597082|FG000|Overall Study|Administrative reason|1|||
27940807|NCT01162122|54597083|FG001|Overall Study|Administrative reason|1|||
27940808|NCT01162122|54597082|FG000|Overall Study|Unable to classify|3|||
27940809|NCT01162122|54597083|FG001|Overall Study|Unable to classify|7|||
27940810|NCT01162122|54597082|FG000|Overall Study|Missing primary reason|1|||
27940811|NCT01162122|54597083|FG001|Overall Study|Missing primary reason|0|||
27940812|NCT01033071|54597095|FG000|Overall Study|Adverse Event|28|||
27940813|NCT01033071|54597096|FG001|Overall Study|Adverse Event|51|||
27940814|NCT01033071|54597097|FG002|Overall Study|Adverse Event|26|||
27940815|NCT01033071|54597095|FG000|Overall Study|Protocol Violation|0|||
27940816|NCT01033071|54597096|FG001|Overall Study|Protocol Violation|2|||
27940817|NCT01033071|54597097|FG002|Overall Study|Protocol Violation|1|||
27940818|NCT01033071|54597095|FG000|Overall Study|Lost to Follow-up|4|||
27940819|NCT01033071|54597096|FG001|Overall Study|Lost to Follow-up|5|||
27940820|NCT01033071|54597097|FG002|Overall Study|Lost to Follow-up|5|||
27940821|NCT01033071|54597095|FG000|Overall Study|Withdrawal by Subject|17|||
27940822|NCT01033071|54597096|FG001|Overall Study|Withdrawal by Subject|14|||
27940823|NCT01033071|54597097|FG002|Overall Study|Withdrawal by Subject|11|||
27940824|NCT01033071|54597095|FG000|Overall Study|Lack of Efficacy|0|||
27940825|NCT01033071|54597096|FG001|Overall Study|Lack of Efficacy|1|||
27940826|NCT01033071|54597097|FG002|Overall Study|Lack of Efficacy|1|||
28132903|NCT03529409|54796686|FG000|Randomized|Excluded|0|||
28132904|NCT03529409|54796687|FG001|Randomized|Excluded|0|||
28132905|NCT03529409|54796688|FG002|Randomized|Excluded|1|||
28132906|NCT03529409|54796686|FG000|Post-treatment Assessment|Death|1|||
27940827|NCT01033071|54597095|FG000|Overall Study|Other|6|||
27940828|NCT01033071|54597096|FG001|Overall Study|Other|4|||
27940829|NCT01033071|54597097|FG002|Overall Study|Other|3|||
27940830|NCT01032915|54597109|FG000|Overall Study|Adverse Event|2|||
27940831|NCT01032915|54597110|FG001|Overall Study|Adverse Event|2|||
27940832|NCT01032915|54597111|FG002|Overall Study|Adverse Event|1|||
27940833|NCT01032915|54597112|FG003|Overall Study|Adverse Event|1|||
27940834|NCT01032915|54597109|FG000|Overall Study|Abnormal test procedure result|0|||
27940835|NCT01032915|54597110|FG001|Overall Study|Abnormal test procedure result|0|||
27940836|NCT01032915|54597111|FG002|Overall Study|Abnormal test procedure result|1|||
27940837|NCT01032915|54597112|FG003|Overall Study|Abnormal test procedure result|0|||
28069015|NCT00058552|54724152|FG000|Overall Study|Disease progression|52|||
28069016|NCT00058552|54724153|FG001|Overall Study|Disease progression|44|||
28069017|NCT00058552|54724152|FG000|Overall Study|Adverse Event|4|||
28069018|NCT00058552|54724153|FG001|Overall Study|Adverse Event|2|||
28069019|NCT00058552|54724152|FG000|Overall Study|Withdrawal by Subject|3|||
28069020|NCT00058552|54724153|FG001|Overall Study|Withdrawal by Subject|5|||
28069021|NCT00058552|54724152|FG000|Overall Study|Physician Decision|2|||
28069022|NCT00058552|54724153|FG001|Overall Study|Physician Decision|5|||
28069023|NCT00058552|54724152|FG000|Overall Study|Clinical disease progression|0|||
28132907|NCT03529409|54796687|FG001|Post-treatment Assessment|Death|0|||
27940838|NCT01032915|54597109|FG000|Overall Study|Withdrawal by Subject|0|||
27940839|NCT01032915|54597110|FG001|Overall Study|Withdrawal by Subject|3|||
28069024|NCT00058552|54724153|FG001|Overall Study|Clinical disease progression|4|||
28069025|NCT00044512|54724161|FG000|Follow Up|Lost to Follow-up|2|||
28132908|NCT03529409|54796688|FG002|Post-treatment Assessment|Death|0|||
27940840|NCT01032915|54597111|FG002|Overall Study|Withdrawal by Subject|1|||
28132909|NCT03529409|54796686|FG000|Post-treatment Assessment|Lost to Follow-up|1|||
27940841|NCT01032915|54597112|FG003|Overall Study|Withdrawal by Subject|1|||
27940842|NCT01032915|54597109|FG000|Overall Study|Administrative reasons|5|||
27940843|NCT01032915|54597110|FG001|Overall Study|Administrative reasons|6|||
27940844|NCT01032915|54597111|FG002|Overall Study|Administrative reasons|4|||
27940845|NCT01032915|54597112|FG003|Overall Study|Administrative reasons|4|||
28069026|NCT03805438|54724165|FG000|Overall Study|Lack of Efficacy|1|||
28132910|NCT03529409|54796687|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
28132911|NCT03529409|54796688|FG002|Post-treatment Assessment|Lost to Follow-up|0|||
28160097|NCT03434379|54830204|FG003|China Extension Period|Lost to Follow-up|0|||
27940846|NCT01032915|54597109|FG000|Overall Study|Protocol Violation|1|||
27940847|NCT01032915|54597110|FG001|Overall Study|Protocol Violation|0|||
27940848|NCT01032915|54597111|FG002|Overall Study|Protocol Violation|0|||
28132912|NCT03529409|54796686|FG000|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|2|||
28132913|NCT03529409|54796687|FG001|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|4|||
28132914|NCT03529409|54796688|FG002|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|0|||
28132915|NCT03529409|54796686|FG000|Follow-up Assessment|Death|1|||
28132916|NCT03529409|54796687|FG001|Follow-up Assessment|Death|0|||
28132917|NCT03529409|54796688|FG002|Follow-up Assessment|Death|0|||
28132918|NCT03529409|54796686|FG000|Follow-up Assessment|Withdrawal by Subject|0|||
28132919|NCT03529409|54796687|FG001|Follow-up Assessment|Withdrawal by Subject|1|||
28132920|NCT03529409|54796688|FG002|Follow-up Assessment|Withdrawal by Subject|0|||
28132921|NCT03498287|54796697|FG000|Overall Study|Withdrawal by Subject|3|||
28132922|NCT03498287|54796698|FG001|Overall Study|Withdrawal by Subject|0|||
28132923|NCT03498287|54796697|FG000|Overall Study|Protocol Violation|0|||
28132924|NCT03498287|54796698|FG001|Overall Study|Protocol Violation|4|||
28132925|NCT03498287|54796697|FG000|Overall Study|Adverse Event|0|||
27940849|NCT01032915|54597112|FG003|Overall Study|Protocol Violation|1|||
28069027|NCT03805438|54724165|FG000|Overall Study|Protocol Violation|1|||
28132926|NCT03498287|54796698|FG001|Overall Study|Adverse Event|1|||
28132927|NCT03497429|54796706|FG000|Overall Study|Progressive disease|3|||
28132928|NCT03497429|54796707|FG001|Overall Study|Progressive disease|4|||
28132929|NCT03497429|54796706|FG000|Overall Study|Adverse Event|0|||
28132930|NCT03497429|54796707|FG001|Overall Study|Adverse Event|2|||
28132931|NCT03497039|54796715|FG000|Overall Study|Withdrawal by Subject|1|||
28132932|NCT03497039|54796716|FG001|Overall Study|Withdrawal by Subject|0|||
28132933|NCT03497039|54796715|FG000|Overall Study|Protocol Violation|0|||
28132934|NCT03497039|54796716|FG001|Overall Study|Protocol Violation|1|||
28132935|NCT03495869|54796735|FG000|Overall Study|Lost to Follow-up|4|||
28132936|NCT03495869|54796736|FG001|Overall Study|Lost to Follow-up|17|||
28132937|NCT03495869|54796737|FG002|Overall Study|Lost to Follow-up|8|||
28132938|NCT03495869|54796738|FG003|Overall Study|Lost to Follow-up|14|||
28132939|NCT03495869|54796735|FG000|Overall Study|Withdrawal by Subject|0|||
28069028|NCT00147537|54724173|FG000|Phase 1b|Death|0|||
28069029|NCT00147537|54724174|FG001|Phase 1b|Death|1|||
28069030|NCT00147537|54724175|FG002|Phase 1b|Death|2|||
28069031|NCT00147537|54724176|FG003|Phase 1b|Death|1|||
28069032|NCT00147537|54724177|FG004|Phase 1b|Death|2|||
28069033|NCT00147537|54724178|FG005|Phase 1b|Death|2|||
28069034|NCT00147537|54724179|FG006|Phase 1b|Death|1|||
28069035|NCT00147537|54724180|FG007|Phase 1b|Death|3|||
27819524|NCT01728116|54278959|FG001|Overall Study|Withdrawal by Subject|9|||
27819525|NCT01728116|54278958|FG000|Overall Study|Adverse Event|13|||
27819526|NCT01728116|54278959|FG001|Overall Study|Adverse Event|0|||
27819527|NCT01728116|54278958|FG000|Overall Study|Procedure/device failure|7|||
27819528|NCT01728116|54278959|FG001|Overall Study|Procedure/device failure|0|||
27819529|NCT01728116|54278958|FG000|Overall Study|Lost to Follow-up|9|||
27819530|NCT01728116|54278959|FG001|Overall Study|Lost to Follow-up|2|||
27819531|NCT01728116|54278958|FG000|Overall Study|Physician Decision|2|||
27819532|NCT01728116|54278959|FG001|Overall Study|Physician Decision|0|||
27819533|NCT01728116|54278958|FG000|Overall Study|Subject Non-Compliance|2|||
27819534|NCT01728116|54278959|FG001|Overall Study|Subject Non-Compliance|0|||
27819535|NCT01728116|54278958|FG000|Overall Study|Inter-current finding at procedure|1|||
28069036|NCT00147537|54724181|FG008|Phase 1b|Death|9|||
28069037|NCT00147537|54724182|FG009|Phase 1b|Death|0|||
28069038|NCT00147537|54724183|FG010|Phase 1b|Death|0|||
28069039|NCT00147537|54724173|FG000|Phase 1b|Lost to Follow-up|2|||
28069040|NCT00147537|54724174|FG001|Phase 1b|Lost to Follow-up|1|||
28069041|NCT00147537|54724175|FG002|Phase 1b|Lost to Follow-up|0|||
28069042|NCT00147537|54724176|FG003|Phase 1b|Lost to Follow-up|0|||
28069043|NCT00147537|54724177|FG004|Phase 1b|Lost to Follow-up|0|||
28069044|NCT00147537|54724178|FG005|Phase 1b|Lost to Follow-up|0|||
28069045|NCT00147537|54724179|FG006|Phase 1b|Lost to Follow-up|2|||
28069046|NCT00147537|54724180|FG007|Phase 1b|Lost to Follow-up|0|||
28069047|NCT00147537|54724181|FG008|Phase 1b|Lost to Follow-up|1|||
28069048|NCT00147537|54724182|FG009|Phase 1b|Lost to Follow-up|0|||
28132940|NCT03495869|54796736|FG001|Overall Study|Withdrawal by Subject|3|||
27940850|NCT01161498|54597124|FG000|Overall Study|Disease Progression|0|||
28069049|NCT00147537|54724183|FG010|Phase 1b|Lost to Follow-up|0|||
28069050|NCT00147537|54724173|FG000|Phase 1b|Other|0|||
28069051|NCT00147537|54724174|FG001|Phase 1b|Other|0|||
28069052|NCT00147537|54724175|FG002|Phase 1b|Other|2|||
28069053|NCT00147537|54724176|FG003|Phase 1b|Other|1|||
28069054|NCT00147537|54724177|FG004|Phase 1b|Other|1|||
28069055|NCT00147537|54724178|FG005|Phase 1b|Other|1|||
28069056|NCT00147537|54724179|FG006|Phase 1b|Other|14|||
28132941|NCT03495869|54796737|FG002|Overall Study|Withdrawal by Subject|0|||
28132942|NCT03495869|54796738|FG003|Overall Study|Withdrawal by Subject|3|||
28132943|NCT03495869|54796735|FG000|Overall Study|Dropped from study|0|||
28132944|NCT03495869|54796736|FG001|Overall Study|Dropped from study|7|||
28132945|NCT03495869|54796737|FG002|Overall Study|Dropped from study|2|||
28132946|NCT03495869|54796738|FG003|Overall Study|Dropped from study|4|||
28132947|NCT03071094|54796759|FG000|Overall Study|Death|1|||
28132948|NCT03071094|54796760|FG001|Overall Study|Death|1|||
28132949|NCT03071094|54796759|FG000|Overall Study|Adverse Event|1|||
28132950|NCT03071094|54796760|FG001|Overall Study|Adverse Event|0|||
28132951|NCT03559517|54796769|FG000|Overall Study|Withdrawal by Subject|1|||
28132952|NCT03559517|54796770|FG001|Overall Study|Withdrawal by Subject|0|||
28132953|NCT03559517|54796771|FG002|Overall Study|Withdrawal by Subject|0|||
28132954|NCT02509494|54796788|FG000|Overall Study|Lost to Follow-up|8|||
28132955|NCT02509494|54796789|FG001|Overall Study|Lost to Follow-up|47|||
28132956|NCT02509494|54796790|FG002|Overall Study|Lost to Follow-up|19|||
28132957|NCT02509494|54796791|FG003|Overall Study|Lost to Follow-up|6|||
28132958|NCT02509494|54796792|FG004|Overall Study|Lost to Follow-up|3|||
28132959|NCT02509494|54796793|FG005|Overall Study|Lost to Follow-up|3|||
28132960|NCT02509494|54796794|FG006|Overall Study|Lost to Follow-up|1|||
28132961|NCT02509494|54796795|FG007|Overall Study|Lost to Follow-up|3|||
28132962|NCT02509494|54796796|FG008|Overall Study|Lost to Follow-up|1|||
28132963|NCT02509494|54796788|FG000|Overall Study|Physician Decision|2|||
28132964|NCT02509494|54796789|FG001|Overall Study|Physician Decision|1|||
28132965|NCT02509494|54796790|FG002|Overall Study|Physician Decision|0|||
28132966|NCT02509494|54796791|FG003|Overall Study|Physician Decision|0|||
28132967|NCT02509494|54796792|FG004|Overall Study|Physician Decision|0|||
28132968|NCT02509494|54796793|FG005|Overall Study|Physician Decision|0|||
28132969|NCT02509494|54796794|FG006|Overall Study|Physician Decision|0|||
28132970|NCT02509494|54796795|FG007|Overall Study|Physician Decision|0|||
28132971|NCT02509494|54796796|FG008|Overall Study|Physician Decision|0|||
28132972|NCT02509494|54796788|FG000|Overall Study|Withdrawal by Subject|4|||
28132973|NCT02509494|54796789|FG001|Overall Study|Withdrawal by Subject|17|||
28132974|NCT02509494|54796790|FG002|Overall Study|Withdrawal by Subject|7|||
28132975|NCT02509494|54796791|FG003|Overall Study|Withdrawal by Subject|5|||
28132976|NCT02509494|54796792|FG004|Overall Study|Withdrawal by Subject|0|||
28132977|NCT02509494|54796793|FG005|Overall Study|Withdrawal by Subject|6|||
28132978|NCT02509494|54796794|FG006|Overall Study|Withdrawal by Subject|1|||
28132979|NCT02509494|54796795|FG007|Overall Study|Withdrawal by Subject|2|||
28132980|NCT02509494|54796796|FG008|Overall Study|Withdrawal by Subject|1|||
28132981|NCT02509494|54796788|FG000|Overall Study|Death|0|||
28132982|NCT02509494|54796789|FG001|Overall Study|Death|1|||
28132983|NCT02509494|54796790|FG002|Overall Study|Death|0|||
28132984|NCT02509494|54796791|FG003|Overall Study|Death|0|||
28132985|NCT02509494|54796792|FG004|Overall Study|Death|1|||
28132986|NCT02509494|54796793|FG005|Overall Study|Death|0|||
28132987|NCT02509494|54796794|FG006|Overall Study|Death|0|||
28132988|NCT02509494|54796795|FG007|Overall Study|Death|1|||
28132989|NCT02509494|54796796|FG008|Overall Study|Death|0|||
28132990|NCT02509494|54796788|FG000|Overall Study|Other|0|||
28132991|NCT02509494|54796789|FG001|Overall Study|Other|4|||
28132992|NCT02509494|54796790|FG002|Overall Study|Other|5|||
28132993|NCT02509494|54796791|FG003|Overall Study|Other|0|||
28132994|NCT02509494|54796792|FG004|Overall Study|Other|0|||
28132995|NCT02509494|54796793|FG005|Overall Study|Other|0|||
28132996|NCT02509494|54796794|FG006|Overall Study|Other|0|||
28132997|NCT02509494|54796795|FG007|Overall Study|Other|0|||
27940851|NCT01161498|54597125|FG001|Overall Study|Disease Progression|1|||
28132998|NCT02509494|54796796|FG008|Overall Study|Other|0|||
28132999|NCT02509494|54796788|FG000|Overall Study|Non-Compliance With Study Drug|1|||
28133000|NCT02509494|54796789|FG001|Overall Study|Non-Compliance With Study Drug|11|||
28133001|NCT02509494|54796790|FG002|Overall Study|Non-Compliance With Study Drug|7|||
28133002|NCT02509494|54796791|FG003|Overall Study|Non-Compliance With Study Drug|0|||
28133003|NCT02509494|54796792|FG004|Overall Study|Non-Compliance With Study Drug|1|||
28133004|NCT02509494|54796793|FG005|Overall Study|Non-Compliance With Study Drug|2|||
28133005|NCT02509494|54796794|FG006|Overall Study|Non-Compliance With Study Drug|1|||
28133006|NCT02509494|54796795|FG007|Overall Study|Non-Compliance With Study Drug|1|||
28133007|NCT02509494|54796796|FG008|Overall Study|Non-Compliance With Study Drug|0|||
28133008|NCT03493451|54796833|FG000|Overall Study|Death|11|||
28133009|NCT03493451|54796834|FG001|Overall Study|Death|26|||
28133010|NCT03493451|54796835|FG002|Overall Study|Death|3|||
28133011|NCT03493451|54796833|FG000|Overall Study|Lost to Follow-up|1|||
28133012|NCT03493451|54796834|FG001|Overall Study|Lost to Follow-up|4|||
28133013|NCT03493451|54796835|FG002|Overall Study|Lost to Follow-up|1|||
28133014|NCT03493451|54796833|FG000|Overall Study|Withdrawal by Subject|1|||
28133015|NCT03493451|54796834|FG001|Overall Study|Withdrawal by Subject|1|||
28133016|NCT03493451|54796835|FG002|Overall Study|Withdrawal by Subject|2|||
28133017|NCT03493451|54796833|FG000|Overall Study|Progressive Disease|1|||
28133018|NCT03493451|54796834|FG001|Overall Study|Progressive Disease|0|||
28133019|NCT03493451|54796835|FG002|Overall Study|Progressive Disease|0|||
28133020|NCT03493451|54796833|FG000|Overall Study|Transferred to long term extension study|8|||
28133021|NCT03493451|54796834|FG001|Overall Study|Transferred to long term extension study|13|||
28133022|NCT03493451|54796835|FG002|Overall Study|Transferred to long term extension study|5|||
28133023|NCT03492281|54796846|FG000|Overall Study|Withdrawal by Subject|21|||
28133024|NCT03492281|54796847|FG001|Overall Study|Withdrawal by Subject|14|||
28133025|NCT03492281|54796848|FG002|Overall Study|Withdrawal by Subject|13|||
28133026|NCT03492281|54796846|FG000|Overall Study|Lost to Follow-up|14|||
28133027|NCT03492281|54796847|FG001|Overall Study|Lost to Follow-up|15|||
28133028|NCT03492281|54796848|FG002|Overall Study|Lost to Follow-up|10|||
28133029|NCT03492281|54796846|FG000|Overall Study|Adverse Event|6|||
28133030|NCT03492281|54796847|FG001|Overall Study|Adverse Event|8|||
28133031|NCT03492281|54796848|FG002|Overall Study|Adverse Event|13|||
28133032|NCT03492281|54796846|FG000|Overall Study|Lack of Efficacy|3|||
28133033|NCT03492281|54796847|FG001|Overall Study|Lack of Efficacy|0|||
28133034|NCT03492281|54796848|FG002|Overall Study|Lack of Efficacy|1|||
28133035|NCT03492281|54796846|FG000|Overall Study|Physician Decision|1|||
28133036|NCT03492281|54796847|FG001|Overall Study|Physician Decision|0|||
28133037|NCT03492281|54796848|FG002|Overall Study|Physician Decision|3|||
28133038|NCT03492281|54796846|FG000|Overall Study|Protocol Violation|0|||
28133039|NCT03492281|54796847|FG001|Overall Study|Protocol Violation|2|||
28133040|NCT03492281|54796848|FG002|Overall Study|Protocol Violation|1|||
28133041|NCT03492281|54796846|FG000|Overall Study|Withdrawn Due to Sponsor|1|||
28133042|NCT03492281|54796847|FG001|Overall Study|Withdrawn Due to Sponsor|0|||
28133043|NCT03492281|54796848|FG002|Overall Study|Withdrawn Due to Sponsor|1|||
28133044|NCT03492281|54796846|FG000|Overall Study|Death|0|||
28133045|NCT03492281|54796847|FG001|Overall Study|Death|0|||
28133046|NCT03492281|54796848|FG002|Overall Study|Death|1|||
28133047|NCT03492281|54796846|FG000|Overall Study|Captured as Other in Database|8|||
28133048|NCT03492281|54796847|FG001|Overall Study|Captured as Other in Database|6|||
28133049|NCT03492281|54796848|FG002|Overall Study|Captured as Other in Database|3|||
28133050|NCT03070782|54796865|FG000|Overall Study|Adverse Event|3|||
28133051|NCT03070782|54796866|FG001|Overall Study|Adverse Event|0|||
28133052|NCT03070782|54796867|FG002|Overall Study|Adverse Event|3|||
28133053|NCT03070782|54796868|FG003|Overall Study|Adverse Event|1|||
28133054|NCT03070782|54796869|FG004|Overall Study|Adverse Event|6|||
28133055|NCT03070782|54796870|FG005|Overall Study|Adverse Event|2|||
28133056|NCT03070782|54796865|FG000|Overall Study|Withdrawal by Subject|2|||
28133057|NCT03070782|54796866|FG001|Overall Study|Withdrawal by Subject|1|||
28133058|NCT03070782|54796867|FG002|Overall Study|Withdrawal by Subject|1|||
28133059|NCT03070782|54796868|FG003|Overall Study|Withdrawal by Subject|0|||
28133060|NCT03070782|54796869|FG004|Overall Study|Withdrawal by Subject|4|||
28133061|NCT03070782|54796870|FG005|Overall Study|Withdrawal by Subject|3|||
28133062|NCT03070782|54796865|FG000|Overall Study|Reason Not Specified|2|||
28133063|NCT03070782|54796866|FG001|Overall Study|Reason Not Specified|0|||
28133064|NCT03070782|54796867|FG002|Overall Study|Reason Not Specified|0|||
28133065|NCT03070782|54796868|FG003|Overall Study|Reason Not Specified|1|||
28133066|NCT03070782|54796869|FG004|Overall Study|Reason Not Specified|2|||
28133067|NCT03070782|54796870|FG005|Overall Study|Reason Not Specified|1|||
28133068|NCT03070782|54796865|FG000|Overall Study|Ineligibility|0|||
28133069|NCT03070782|54796866|FG001|Overall Study|Ineligibility|0|||
28133070|NCT03070782|54796867|FG002|Overall Study|Ineligibility|0|||
28133071|NCT03070782|54796868|FG003|Overall Study|Ineligibility|1|||
28133072|NCT03070782|54796869|FG004|Overall Study|Ineligibility|0|||
28133073|NCT03070782|54796870|FG005|Overall Study|Ineligibility|1|||
28133074|NCT03070782|54796865|FG000|Overall Study|Pregnancy|0|||
28133075|NCT03070782|54796866|FG001|Overall Study|Pregnancy|0|||
28133076|NCT03070782|54796867|FG002|Overall Study|Pregnancy|0|||
28133077|NCT03070782|54796868|FG003|Overall Study|Pregnancy|1|||
28133078|NCT03070782|54796869|FG004|Overall Study|Pregnancy|0|||
27940852|NCT01180998|54597134|FG000|Overall Study|Poor Vision|0|||
28133079|NCT03070782|54796870|FG005|Overall Study|Pregnancy|0|||
28133080|NCT03070782|54796865|FG000|Overall Study|Investigator Judgement|0|||
28133081|NCT03070782|54796866|FG001|Overall Study|Investigator Judgement|0|||
28133082|NCT03070782|54796867|FG002|Overall Study|Investigator Judgement|0|||
28133083|NCT03070782|54796868|FG003|Overall Study|Investigator Judgement|1|||
27940853|NCT01180998|54597135|FG001|Overall Study|Poor Vision|2|||
28133084|NCT03070782|54796869|FG004|Overall Study|Investigator Judgement|0|||
28133085|NCT03070782|54796870|FG005|Overall Study|Investigator Judgement|0|||
27940854|NCT01180998|54597136|FG002|Overall Study|Poor Vision|2|||
28133086|NCT03525119|54796906|FG000|Overall Study|Adverse Event|0|||
28133087|NCT03525119|54796907|FG001|Overall Study|Adverse Event|1|||
28133088|NCT03525119|54796908|FG002|Overall Study|Adverse Event|0|||
28133089|NCT03525119|54796906|FG000|Overall Study|Lost to Follow-up|32|||
28133090|NCT03525119|54796907|FG001|Overall Study|Lost to Follow-up|33|||
28133091|NCT03525119|54796908|FG002|Overall Study|Lost to Follow-up|37|||
28133092|NCT03525119|54796906|FG000|Overall Study|Withdrawal by Subject|5|||
28133093|NCT03525119|54796907|FG001|Overall Study|Withdrawal by Subject|4|||
28133094|NCT03525119|54796908|FG002|Overall Study|Withdrawal by Subject|2|||
28133095|NCT03525119|54796906|FG000|Overall Study|Reason not Specified|2|||
28133096|NCT03525119|54796907|FG001|Overall Study|Reason not Specified|1|||
28133097|NCT03525119|54796908|FG002|Overall Study|Reason not Specified|2|||
28133098|NCT03525119|54796906|FG000|Overall Study|Randomized but not Vaccinated|1|||
28133099|NCT03525119|54796907|FG001|Overall Study|Randomized but not Vaccinated|0|||
28133100|NCT03525119|54796908|FG002|Overall Study|Randomized but not Vaccinated|2|||
28133101|NCT03558503|54796916|FG000|Overall Study|Adverse Event|1|||
28133102|NCT03558503|54796916|FG000|Overall Study|Death|1|||
28133103|NCT03558503|54796916|FG000|Overall Study|Refused to come in for the final 12-month assessment due to COVID-19|1|||
28133104|NCT03489863|54796922|FG000|Overall Study|Withdrawal by Subject|0|||
28133105|NCT03489863|54796923|FG001|Overall Study|Withdrawal by Subject|1|||
28133106|NCT03489551|54796929|FG000|Overall Study|Withdrawal by Subject|2|||
28133107|NCT03557801|54796936|FG000|Overall Study|Protocol Violation|1|||
28133108|NCT03557801|54796937|FG001|Overall Study|Protocol Violation|0|||
28133109|NCT03557801|54796938|FG002|Overall Study|Protocol Violation|0|||
28133110|NCT03557801|54796936|FG000|Overall Study|Withdrawal by Subject|1|||
28133111|NCT03557801|54796937|FG001|Overall Study|Withdrawal by Subject|0|||
28133112|NCT03557801|54796938|FG002|Overall Study|Withdrawal by Subject|3|||
28133113|NCT03557801|54796936|FG000|Overall Study|Lost to Follow-up|0|||
28133114|NCT03557801|54796937|FG001|Overall Study|Lost to Follow-up|1|||
28133115|NCT03557801|54796938|FG002|Overall Study|Lost to Follow-up|0|||
28133116|NCT04210180|54796946|FG000|Overall Study|Withdrawal by Subject|2|||
28133117|NCT03523871|54796950|FG000|Overall Study|Death|1|||
28133118|NCT03523715|54796956|FG000|Overall Study|Lost to Follow-up|11|||
28133119|NCT03523715|54796957|FG001|Overall Study|Lost to Follow-up|14|||
28133120|NCT03523715|54796956|FG000|Overall Study|Did not meet inclusion criteria|1|||
28133121|NCT03523715|54796957|FG001|Overall Study|Did not meet inclusion criteria|0|||
28133122|NCT03523715|54796956|FG000|Overall Study|Internally inconsistent reporting|0|||
28133123|NCT03523715|54796957|FG001|Overall Study|Internally inconsistent reporting|2|||
28133124|NCT03980730|54796965|FG000|Overall Study|Study Terminated by Sponsor|0|||
28133125|NCT03980730|54796966|FG001|Overall Study|Study Terminated by Sponsor|3|||
28133126|NCT03980730|54796965|FG000|Overall Study|Adverse Event|2|||
28133127|NCT03980730|54796966|FG001|Overall Study|Adverse Event|0|||
28133128|NCT03980730|54796965|FG000|Overall Study|Sponsor Request|0|||
28133129|NCT03980730|54796966|FG001|Overall Study|Sponsor Request|1|||
28133130|NCT03523091|54796974|FG000|Overall Study|Lower dose due to elevated post void residual (PVR)|1|||
28133131|NCT03523091|54796975|FG001|Overall Study|Lower dose due to elevated post void residual (PVR)|0|||
28133132|NCT03523091|54796974|FG000|Overall Study|Withdrawal by Subject|0|||
28133133|NCT03523091|54796975|FG001|Overall Study|Withdrawal by Subject|3|||
28133134|NCT03523091|54796974|FG000|Overall Study|Increase Botox dose|0|||
28133135|NCT03523091|54796975|FG001|Overall Study|Increase Botox dose|1|||
28133136|NCT03438383|54796996|FG000|Overall Study|Protocol Violation|9|||
28133137|NCT03438383|54796997|FG001|Overall Study|Protocol Violation|3|||
28133138|NCT03478787|54797005|FG000|Overall Study|Adverse Event|5|||
28133139|NCT03478787|54797006|FG001|Overall Study|Adverse Event|1|||
28133140|NCT03478787|54797005|FG000|Overall Study|Protocol Violation|3|||
28133141|NCT03478787|54797006|FG001|Overall Study|Protocol Violation|0|||
28133142|NCT03478787|54797005|FG000|Overall Study|Lack of Efficacy|7|||
28133143|NCT03478787|54797006|FG001|Overall Study|Lack of Efficacy|1|||
28133144|NCT03478787|54797005|FG000|Overall Study|Lost to Follow-up|9|||
28133145|NCT03478787|54797006|FG001|Overall Study|Lost to Follow-up|5|||
28133146|NCT03478787|54797005|FG000|Overall Study|Withdrawal by Subject|2|||
28133147|NCT03478787|54797006|FG001|Overall Study|Withdrawal by Subject|6|||
27940855|NCT01180998|54597134|FG000|Overall Study|Lost to Follow-up|0|||
28133148|NCT03478787|54797005|FG000|Overall Study|Other, Not Specified|3|||
28133149|NCT03478787|54797006|FG001|Overall Study|Other, Not Specified|0|||
28133150|NCT03488927|54797015|FG000|Overall Study|Withdrawal by Subject|44|||
28133151|NCT03488927|54797016|FG001|Overall Study|Withdrawal by Subject|118|||
28133152|NCT03488927|54797017|FG002|Overall Study|Withdrawal by Subject|217|||
28133153|NCT03488225|54797025|FG000|Overall Study|Off Protocol Therapy|2|||
28133154|NCT03488225|54797025|FG000|Overall Study|Stem Cell Transplant|2|||
28133155|NCT03437447|54797032|FG000|Treatment Period 1|Withdrawal by Subject|0|||
28133156|NCT03437447|54797033|FG001|Treatment Period 1|Withdrawal by Subject|0|||
28133157|NCT03437447|54797034|FG002|Treatment Period 1|Withdrawal by Subject|1|||
28133158|NCT03487445|54797057|FG000|Randomization|Not treated for administrative reasons|1|||
28133159|NCT03487445|54797058|FG001|Randomization|Not treated for administrative reasons|0|||
27819536|NCT01728116|54278959|FG001|Overall Study|Inter-current finding at procedure|0|||
27940856|NCT01180998|54597135|FG001|Overall Study|Lost to Follow-up|0|||
27940857|NCT01180998|54597136|FG002|Overall Study|Lost to Follow-up|1|||
27940858|NCT01180998|54597134|FG000|Overall Study|Protocol Violation|1|||
27940859|NCT01180998|54597135|FG001|Overall Study|Protocol Violation|2|||
27940860|NCT01180998|54597136|FG002|Overall Study|Protocol Violation|0|||
27940861|NCT01180998|54597134|FG000|Overall Study|Withdrawal by Subject|0|||
27940862|NCT01180998|54597135|FG001|Overall Study|Withdrawal by Subject|0|||
27940863|NCT01180998|54597136|FG002|Overall Study|Withdrawal by Subject|1|||
27940864|NCT01180998|54597134|FG000|Overall Study|Poor comfort|3|||
27940865|NCT01180998|54597135|FG001|Overall Study|Poor comfort|0|||
27940866|NCT01180998|54597136|FG002|Overall Study|Poor comfort|4|||
27940867|NCT01180998|54597134|FG000|Overall Study|Poor lens handling|0|||
27940868|NCT01180998|54597135|FG001|Overall Study|Poor lens handling|0|||
27940869|NCT01180998|54597136|FG002|Overall Study|Poor lens handling|2|||
27940870|NCT01029795|54597147|FG000|Overall Study|Entry Criteria Not Met|2|||
27940871|NCT01029795|54597148|FG001|Overall Study|Entry Criteria Not Met|1|||
27940872|NCT01029795|54597147|FG000|Overall Study|Physician Decision|2|||
27940873|NCT01029795|54597148|FG001|Overall Study|Physician Decision|1|||
27940874|NCT01029795|54597147|FG000|Overall Study|Sponsor Decision|11|||
27940875|NCT01029795|54597148|FG001|Overall Study|Sponsor Decision|17|||
27940876|NCT01029795|54597147|FG000|Overall Study|Withdrawal by Subject|1|||
28133160|NCT02109172|54797064|FG000|Overall Study|Withdrawal by Subject|1|||
28133161|NCT02109172|54797065|FG001|Overall Study|Withdrawal by Subject|0|||
28133162|NCT02109172|54797066|FG002|Overall Study|Withdrawal by Subject|0|||
28133163|NCT02109172|54797067|FG003|Overall Study|Withdrawal by Subject|1|||
28133164|NCT02109172|54797068|FG004|Overall Study|Withdrawal by Subject|0|||
28133165|NCT02109172|54797069|FG005|Overall Study|Withdrawal by Subject|0|||
28133166|NCT02109172|54797064|FG000|Overall Study|Adverse Event|0|||
28133167|NCT02109172|54797065|FG001|Overall Study|Adverse Event|0|||
28133168|NCT02109172|54797066|FG002|Overall Study|Adverse Event|1|||
28133169|NCT02109172|54797067|FG003|Overall Study|Adverse Event|0|||
28133170|NCT02109172|54797068|FG004|Overall Study|Adverse Event|0|||
28133171|NCT02109172|54797069|FG005|Overall Study|Adverse Event|1|||
28133172|NCT02109172|54797064|FG000|Overall Study|Death|0|||
28133173|NCT02109172|54797065|FG001|Overall Study|Death|0|||
28133174|NCT02109172|54797066|FG002|Overall Study|Death|0|||
28133175|NCT02109172|54797067|FG003|Overall Study|Death|0|||
28133176|NCT02109172|54797068|FG004|Overall Study|Death|1|||
28133177|NCT02109172|54797069|FG005|Overall Study|Death|0|||
28133178|NCT02974868|54797080|FG000|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
28133179|NCT02974868|54797081|FG001|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
28133180|NCT02974868|54797082|FG002|Initial 24-Week Treatment Period (TP)|Adverse Event|2|||
28133181|NCT02974868|54797083|FG003|Initial 24-Week Treatment Period (TP)|Adverse Event|4|||
28133182|NCT02974868|54797080|FG000|Initial 24-Week Treatment Period (TP)|others|3|||
28133183|NCT02974868|54797081|FG001|Initial 24-Week Treatment Period (TP)|others|8|||
28133184|NCT02974868|54797082|FG002|Initial 24-Week Treatment Period (TP)|others|1|||
28133185|NCT02974868|54797083|FG003|Initial 24-Week Treatment Period (TP)|others|8|||
28133186|NCT02974868|54797080|FG000|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2|||
28133187|NCT02974868|54797081|FG001|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1|||
28133188|NCT02974868|54797082|FG002|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11|||
28133189|NCT02974868|54797083|FG003|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6|||
28133190|NCT02974868|54797080|FG000|Cross-Over Extension (COE) Period|Withdrawal by Subject|2|||
28133191|NCT02974868|54797081|FG001|Cross-Over Extension (COE) Period|Withdrawal by Subject|1|||
28133192|NCT02974868|54797082|FG002|Cross-Over Extension (COE) Period|Withdrawal by Subject|3|||
28133193|NCT02974868|54797083|FG003|Cross-Over Extension (COE) Period|Withdrawal by Subject|0|||
28133194|NCT03486899|54797128|FG000|Overall Study|Lost to Follow-up|4|||
28133195|NCT03486899|54797129|FG001|Overall Study|Lost to Follow-up|1|||
28133196|NCT03486899|54797130|FG002|Overall Study|Lost to Follow-up|4|||
28133197|NCT03486899|54797131|FG003|Overall Study|Lost to Follow-up|3|||
28133198|NCT03486899|54797128|FG000|Overall Study|Death|1|||
28133199|NCT03486899|54797129|FG001|Overall Study|Death|0|||
28133200|NCT03486899|54797130|FG002|Overall Study|Death|0|||
28133201|NCT03486899|54797131|FG003|Overall Study|Death|1|||
28133202|NCT03486899|54797128|FG000|Overall Study|Adverse Event|0|||
27849777|NCT00631163|54347609|FG000|Number of Participants in Year 1|Withdrawal by Subject|8|||
27940877|NCT01029795|54597148|FG001|Overall Study|Withdrawal by Subject|3|||
27940878|NCT01032837|54597158|FG000|Overall Study|Adverse event/internal illness|0|||
27940879|NCT01032837|54597159|FG001|Overall Study|Adverse event/internal illness|1|||
27940880|NCT01032837|54597160|FG002|Overall Study|Adverse event/internal illness|0|||
27940881|NCT01032837|54597161|FG003|Overall Study|Adverse event/internal illness|1|||
27940882|NCT01032837|54597158|FG000|Overall Study|Withdrew consent|0|||
28133203|NCT03486899|54797129|FG001|Overall Study|Adverse Event|2|||
28133204|NCT03486899|54797130|FG002|Overall Study|Adverse Event|0|||
28133205|NCT03486899|54797131|FG003|Overall Study|Adverse Event|2|||
28133206|NCT03486899|54797128|FG000|Overall Study|Withdrawal by Subject|3|||
28133207|NCT03486899|54797129|FG001|Overall Study|Withdrawal by Subject|7|||
28133208|NCT03486899|54797130|FG002|Overall Study|Withdrawal by Subject|4|||
28133209|NCT03486899|54797131|FG003|Overall Study|Withdrawal by Subject|3|||
27849778|NCT00631163|54347609|FG000|Number of Participants in Year 1|Death|6|||
27849779|NCT00631163|54347609|FG000|Number of Participants in Year 1|Lost to Follow-up|1|||
27849780|NCT00631163|54347609|FG000|Number of Participants in Year 1|Patient's condition no longer requires study drug|1|||
27940883|NCT01032837|54597159|FG001|Overall Study|Withdrew consent|2|||
27940884|NCT01032837|54597160|FG002|Overall Study|Withdrew consent|0|||
27940885|NCT01032837|54597161|FG003|Overall Study|Withdrew consent|1|||
27940886|NCT01032837|54597158|FG000|Overall Study|Failed to return|0|||
27940887|NCT01032837|54597159|FG001|Overall Study|Failed to return|0|||
27940888|NCT01032837|54597160|FG002|Overall Study|Failed to return|1|||
27940889|NCT01032837|54597161|FG003|Overall Study|Failed to return|0|||
27940890|NCT01032837|54597158|FG000|Overall Study|Refused treatment|0|||
27940891|NCT01032837|54597159|FG001|Overall Study|Refused treatment|0|||
27940892|NCT01032837|54597160|FG002|Overall Study|Refused treatment|0|||
27940893|NCT01032837|54597161|FG003|Overall Study|Refused treatment|1|||
27940894|NCT01180296|54597173|FG000|Overall Study|Protocol Violation|1|||
27940895|NCT01180296|54597174|FG001|Overall Study|Protocol Violation|2|||
27940896|NCT01160640|54597184|FG000|Overall Study|Physician Decision|3|||
27940897|NCT01160640|54597185|FG001|Overall Study|Physician Decision|3|||
27940898|NCT01160640|54597184|FG000|Overall Study|Incarceration|1|||
27940899|NCT01160640|54597185|FG001|Overall Study|Incarceration|0|||
27940900|NCT01160640|54597184|FG000|Overall Study|Withdrawal by Subject|0|||
27940901|NCT01160640|54597185|FG001|Overall Study|Withdrawal by Subject|3|||
27940902|NCT01160484|54597193|FG000|Overall Study|Lack of Efficacy|9|||
27940903|NCT01160484|54597193|FG000|Overall Study|Adverse Event|6|||
27940904|NCT01160484|54597193|FG000|Overall Study|Withdrawal by Subject|2|||
27940905|NCT01160484|54597193|FG000|Overall Study|inclusion/exclusion criteria failure|1|||
28069057|NCT00147537|54724180|FG007|Phase 1b|Other|4|||
28069058|NCT00147537|54724181|FG008|Phase 1b|Other|4|||
28069059|NCT00147537|54724182|FG009|Phase 1b|Other|0|||
28069060|NCT00147537|54724183|FG010|Phase 1b|Other|0|||
28069061|NCT00147537|54724173|FG000|Phase 1b|Withdrawal by Subject|0|||
28069062|NCT00147537|54724174|FG001|Phase 1b|Withdrawal by Subject|0|||
28069063|NCT00147537|54724175|FG002|Phase 1b|Withdrawal by Subject|0|||
28069064|NCT00147537|54724176|FG003|Phase 1b|Withdrawal by Subject|0|||
28069065|NCT00147537|54724177|FG004|Phase 1b|Withdrawal by Subject|0|||
28069066|NCT00147537|54724178|FG005|Phase 1b|Withdrawal by Subject|0|||
28069067|NCT00147537|54724179|FG006|Phase 1b|Withdrawal by Subject|0|||
28069068|NCT00147537|54724180|FG007|Phase 1b|Withdrawal by Subject|0|||
28069069|NCT00147537|54724181|FG008|Phase 1b|Withdrawal by Subject|2|||
28069070|NCT00147537|54724182|FG009|Phase 1b|Withdrawal by Subject|0|||
28069071|NCT00147537|54724183|FG010|Phase 1b|Withdrawal by Subject|0|||
28069072|NCT00147537|54724173|FG000|Phase 1b|Randomized but not treated|0|||
28069073|NCT00147537|54724174|FG001|Phase 1b|Randomized but not treated|0|||
28069074|NCT00147537|54724175|FG002|Phase 1b|Randomized but not treated|0|||
28069075|NCT00147537|54724176|FG003|Phase 1b|Randomized but not treated|0|||
28069076|NCT00147537|54724177|FG004|Phase 1b|Randomized but not treated|0|||
28069077|NCT00147537|54724178|FG005|Phase 1b|Randomized but not treated|0|||
27940906|NCT01032291|54597200|FG000|Safety Lead-in|Adverse Event|1|||
27940907|NCT01032291|54597201|FG001|Safety Lead-in|Adverse Event|0|||
28069078|NCT00147537|54724179|FG006|Phase 1b|Randomized but not treated|1|||
28069079|NCT00147537|54724180|FG007|Phase 1b|Randomized but not treated|0|||
28069080|NCT00147537|54724181|FG008|Phase 1b|Randomized but not treated|1|||
28069081|NCT00147537|54724182|FG009|Phase 1b|Randomized but not treated|0|||
28069082|NCT00147537|54724183|FG010|Phase 1b|Randomized but not treated|0|||
28069083|NCT00147537|54724173|FG000|Phase 2|Death|0|||
27940908|NCT01032291|54597202|FG002|Safety Lead-in|Adverse Event|0|||
27940909|NCT01032291|54597200|FG000|Safety Lead-in|Death|1|||
27940910|NCT01032291|54597201|FG001|Safety Lead-in|Death|0|||
27940911|NCT01032291|54597202|FG002|Safety Lead-in|Death|0|||
27940912|NCT01032291|54597200|FG000|Proof of Concept|Adverse Event|0|||
27940913|NCT01032291|54597201|FG001|Proof of Concept|Adverse Event|5|||
27940914|NCT01032291|54597202|FG002|Proof of Concept|Adverse Event|1|||
27940915|NCT01032291|54597200|FG000|Proof of Concept|Death|0|||
27940916|NCT01032291|54597201|FG001|Proof of Concept|Death|1|||
27940917|NCT01032291|54597202|FG002|Proof of Concept|Death|2|||
28069084|NCT00147537|54724174|FG001|Phase 2|Death|0|||
28069085|NCT00147537|54724175|FG002|Phase 2|Death|0|||
28069086|NCT00147537|54724176|FG003|Phase 2|Death|0|||
28069087|NCT00147537|54724177|FG004|Phase 2|Death|0|||
28133210|NCT03486899|54797128|FG000|Overall Study|Other Reasons|0|||
28133211|NCT03486899|54797129|FG001|Overall Study|Other Reasons|1|||
28133212|NCT03486899|54797130|FG002|Overall Study|Other Reasons|0|||
28133213|NCT03486899|54797131|FG003|Overall Study|Other Reasons|1|||
28069088|NCT00147537|54724178|FG005|Phase 2|Death|0|||
28133214|NCT02918552|54797143|FG000|Overall Study|Failed Pharmacokinetics|1|||
28069089|NCT00147537|54724179|FG006|Phase 2|Death|0|||
28069090|NCT00147537|54724180|FG007|Phase 2|Death|0|||
28069091|NCT00147537|54724181|FG008|Phase 2|Death|0|||
28133215|NCT02918552|54797144|FG001|Overall Study|Failed Pharmacokinetics|0|||
28069092|NCT00147537|54724182|FG009|Phase 2|Death|85|||
28069093|NCT00147537|54724183|FG010|Phase 2|Death|31|||
28069094|NCT00147537|54724173|FG000|Phase 2|Lost to Follow-up|0|||
28069095|NCT00147537|54724174|FG001|Phase 2|Lost to Follow-up|0|||
28069096|NCT00147537|54724175|FG002|Phase 2|Lost to Follow-up|0|||
28069097|NCT00147537|54724176|FG003|Phase 2|Lost to Follow-up|0|||
28069098|NCT00147537|54724177|FG004|Phase 2|Lost to Follow-up|0|||
28069099|NCT00147537|54724178|FG005|Phase 2|Lost to Follow-up|0|||
28069100|NCT00147537|54724179|FG006|Phase 2|Lost to Follow-up|0|||
28069101|NCT00147537|54724180|FG007|Phase 2|Lost to Follow-up|0|||
28069102|NCT00147537|54724181|FG008|Phase 2|Lost to Follow-up|0|||
28069103|NCT00147537|54724182|FG009|Phase 2|Lost to Follow-up|12|||
28069104|NCT00147537|54724183|FG010|Phase 2|Lost to Follow-up|4|||
28069105|NCT00147537|54724173|FG000|Phase 2|Other|0|||
28069106|NCT00147537|54724174|FG001|Phase 2|Other|0|||
28069107|NCT00147537|54724175|FG002|Phase 2|Other|0|||
28069108|NCT00147537|54724176|FG003|Phase 2|Other|0|||
28069109|NCT00147537|54724177|FG004|Phase 2|Other|0|||
28069110|NCT00147537|54724178|FG005|Phase 2|Other|0|||
28069111|NCT00147537|54724179|FG006|Phase 2|Other|0|||
28069112|NCT00147537|54724180|FG007|Phase 2|Other|0|||
28069113|NCT00147537|54724181|FG008|Phase 2|Other|0|||
28069114|NCT00147537|54724182|FG009|Phase 2|Other|47|||
28069115|NCT00147537|54724183|FG010|Phase 2|Other|12|||
28069116|NCT00147537|54724173|FG000|Phase 2|Withdrawal by Subject|0|||
28069117|NCT00147537|54724174|FG001|Phase 2|Withdrawal by Subject|0|||
28069118|NCT00147537|54724175|FG002|Phase 2|Withdrawal by Subject|0|||
28069119|NCT00147537|54724176|FG003|Phase 2|Withdrawal by Subject|0|||
28069120|NCT00147537|54724177|FG004|Phase 2|Withdrawal by Subject|0|||
28069121|NCT00147537|54724178|FG005|Phase 2|Withdrawal by Subject|0|||
28069122|NCT00147537|54724179|FG006|Phase 2|Withdrawal by Subject|0|||
28069123|NCT00147537|54724180|FG007|Phase 2|Withdrawal by Subject|0|||
28069124|NCT00147537|54724181|FG008|Phase 2|Withdrawal by Subject|0|||
28069125|NCT00147537|54724182|FG009|Phase 2|Withdrawal by Subject|16|||
28069126|NCT00147537|54724183|FG010|Phase 2|Withdrawal by Subject|4|||
28069127|NCT00147537|54724173|FG000|Phase 2|Randomized but not treated|0|||
27940918|NCT01032291|54597200|FG000|Proof of Concept|Lack of Efficacy|0|||
27940919|NCT01032291|54597201|FG001|Proof of Concept|Lack of Efficacy|1|||
27940920|NCT01032291|54597202|FG002|Proof of Concept|Lack of Efficacy|0|||
27940921|NCT01032291|54597200|FG000|Proof of Concept|Never Received Study Drug|0|||
28069128|NCT00147537|54724174|FG001|Phase 2|Randomized but not treated|0|||
28069129|NCT00147537|54724175|FG002|Phase 2|Randomized but not treated|0|||
28069130|NCT00147537|54724176|FG003|Phase 2|Randomized but not treated|0|||
28069131|NCT00147537|54724177|FG004|Phase 2|Randomized but not treated|0|||
28069132|NCT00147537|54724178|FG005|Phase 2|Randomized but not treated|0|||
28069133|NCT00147537|54724179|FG006|Phase 2|Randomized but not treated|0|||
28069134|NCT00147537|54724180|FG007|Phase 2|Randomized but not treated|0|||
28069135|NCT00147537|54724181|FG008|Phase 2|Randomized but not treated|0|||
28069136|NCT00147537|54724182|FG009|Phase 2|Randomized but not treated|1|||
28069137|NCT00147537|54724183|FG010|Phase 2|Randomized but not treated|1|||
28069138|NCT00222729|54724228|FG000|Overall Study|Adverse Event|3|||
28069139|NCT00147225|54724238|FG000|Overall Study|Withdrawal by Subject|1|||
28069140|NCT00147225|54724239|FG001|Overall Study|Withdrawal by Subject|0|||
28133216|NCT02918552|54797143|FG000|Overall Study|Withdrawal by Subject|0|||
28133217|NCT02918552|54797144|FG001|Overall Study|Withdrawal by Subject|1|||
28133218|NCT02918552|54797143|FG000|Overall Study|Lost to Follow-up|0|||
28133219|NCT02918552|54797144|FG001|Overall Study|Lost to Follow-up|1|||
28133220|NCT03485495|54797152|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
28133221|NCT03485495|54797153|FG001|Overall Study|Non-compliance with inclusion criteria|0|||
28133222|NCT01065818|54797159|FG000|Overall Study|Withdrawal by Subject|1|||
28133223|NCT01065818|54797159|FG000|Overall Study|Not a candidate for surgery|1|||
28133224|NCT03483623|54797163|FG000|Overall Study|43 complete sets achieved|1|||
28133225|NCT02318277|54797175|FG000|Overall Study|Physician Decision|0|||
28133226|NCT02318277|54797176|FG001|Overall Study|Physician Decision|0|||
28133227|NCT02318277|54797177|FG002|Overall Study|Physician Decision|0|||
28133228|NCT02318277|54797178|FG003|Overall Study|Physician Decision|0|||
28133229|NCT02318277|54797179|FG004|Overall Study|Physician Decision|0|||
28133230|NCT02318277|54797180|FG005|Overall Study|Physician Decision|0|||
28133231|NCT02318277|54797181|FG006|Overall Study|Physician Decision|0|||
28133232|NCT02318277|54797182|FG007|Overall Study|Physician Decision|1|||
28133233|NCT02318277|54797175|FG000|Overall Study|Other|0|||
28133234|NCT02318277|54797176|FG001|Overall Study|Other|0|||
28133235|NCT02318277|54797177|FG002|Overall Study|Other|0|||
28133236|NCT02318277|54797178|FG003|Overall Study|Other|0|||
28133237|NCT02318277|54797179|FG004|Overall Study|Other|0|||
28133238|NCT02318277|54797180|FG005|Overall Study|Other|0|||
28133239|NCT02318277|54797181|FG006|Overall Study|Other|1|||
28133240|NCT02318277|54797182|FG007|Overall Study|Other|0|||
28133241|NCT02318277|54797175|FG000|Overall Study|Withdrawal by Subject|0|||
28133242|NCT02318277|54797176|FG001|Overall Study|Withdrawal by Subject|0|||
28133243|NCT02318277|54797177|FG002|Overall Study|Withdrawal by Subject|1|||
28133244|NCT02318277|54797178|FG003|Overall Study|Withdrawal by Subject|0|||
28133245|NCT02318277|54797179|FG004|Overall Study|Withdrawal by Subject|1|||
28133246|NCT02318277|54797180|FG005|Overall Study|Withdrawal by Subject|1|||
28133247|NCT02318277|54797181|FG006|Overall Study|Withdrawal by Subject|6|||
28133248|NCT02318277|54797182|FG007|Overall Study|Withdrawal by Subject|14|||
28133249|NCT02318277|54797175|FG000|Overall Study|Participant trial terminated by sponsor|0|||
28133250|NCT02318277|54797176|FG001|Overall Study|Participant trial terminated by sponsor|0|||
28133251|NCT02318277|54797177|FG002|Overall Study|Participant trial terminated by sponsor|1|||
28133252|NCT02318277|54797178|FG003|Overall Study|Participant trial terminated by sponsor|0|||
28133253|NCT02318277|54797179|FG004|Overall Study|Participant trial terminated by sponsor|1|||
28133254|NCT02318277|54797180|FG005|Overall Study|Participant trial terminated by sponsor|2|||
28133255|NCT02318277|54797181|FG006|Overall Study|Participant trial terminated by sponsor|5|||
28133256|NCT02318277|54797182|FG007|Overall Study|Participant trial terminated by sponsor|16|||
28133257|NCT02318277|54797175|FG000|Overall Study|Lost to Follow-up|1|||
28133258|NCT02318277|54797176|FG001|Overall Study|Lost to Follow-up|0|||
28133259|NCT02318277|54797177|FG002|Overall Study|Lost to Follow-up|1|||
28133260|NCT02318277|54797178|FG003|Overall Study|Lost to Follow-up|0|||
28133261|NCT02318277|54797179|FG004|Overall Study|Lost to Follow-up|0|||
28133262|NCT02318277|54797180|FG005|Overall Study|Lost to Follow-up|0|||
28133263|NCT02318277|54797181|FG006|Overall Study|Lost to Follow-up|3|||
28133264|NCT02318277|54797182|FG007|Overall Study|Lost to Follow-up|4|||
28133265|NCT02318277|54797175|FG000|Overall Study|Death|5|||
28133266|NCT02318277|54797176|FG001|Overall Study|Death|3|||
28133267|NCT02318277|54797177|FG002|Overall Study|Death|1|||
28133268|NCT02318277|54797178|FG003|Overall Study|Death|4|||
28133269|NCT02318277|54797179|FG004|Overall Study|Death|6|||
28133270|NCT02318277|54797180|FG005|Overall Study|Death|5|||
28133271|NCT02318277|54797181|FG006|Overall Study|Death|34|||
28133272|NCT02318277|54797182|FG007|Overall Study|Death|58|||
28133273|NCT02318277|54797175|FG000|Overall Study|Transitioned to Hospice|0|||
28133274|NCT02318277|54797176|FG001|Overall Study|Transitioned to Hospice|0|||
28133275|NCT02318277|54797177|FG002|Overall Study|Transitioned to Hospice|0|||
28133276|NCT02318277|54797178|FG003|Overall Study|Transitioned to Hospice|0|||
28133277|NCT02318277|54797179|FG004|Overall Study|Transitioned to Hospice|0|||
28133278|NCT02318277|54797180|FG005|Overall Study|Transitioned to Hospice|1|||
28133279|NCT02318277|54797181|FG006|Overall Study|Transitioned to Hospice|0|||
28133280|NCT02318277|54797182|FG007|Overall Study|Transitioned to Hospice|0|||
28133281|NCT01063868|54797227|FG000|Overall Study|Adverse Event|9|||
28133282|NCT01063868|54797228|FG001|Overall Study|Adverse Event|7|||
28133283|NCT01063868|54797227|FG000|Overall Study|Withdrawal by Subject|3|||
28133284|NCT01063868|54797228|FG001|Overall Study|Withdrawal by Subject|1|||
28133285|NCT01063868|54797227|FG000|Overall Study|Study Terminated By Sponsor|23|||
28133286|NCT01063868|54797228|FG001|Overall Study|Study Terminated By Sponsor|4|||
28133287|NCT02974088|54797236|FG000|Overall Study|Lost to Follow-up|0|||
28133288|NCT02974088|54797237|FG001|Overall Study|Lost to Follow-up|2|||
28133289|NCT02974088|54797236|FG000|Overall Study|Adverse Event|0|||
28133290|NCT02974088|54797237|FG001|Overall Study|Adverse Event|1|||
28133291|NCT02385045|54797243|FG000|Overall Study|Endoscopy could not be completed|4|||
28133292|NCT02974010|54797251|FG000|Overall Study|Lost to Follow-up|3|||
28133293|NCT02974010|54797252|FG001|Overall Study|Lost to Follow-up|1|||
28133294|NCT02974010|54797253|FG002|Overall Study|Lost to Follow-up|0|||
28133295|NCT02974010|54797254|FG003|Overall Study|Lost to Follow-up|0|||
28133296|NCT02974010|54797251|FG000|Overall Study|Withdrawal by Subject|2|||
28133297|NCT02974010|54797252|FG001|Overall Study|Withdrawal by Subject|1|||
28133298|NCT02974010|54797253|FG002|Overall Study|Withdrawal by Subject|0|||
28133299|NCT02974010|54797254|FG003|Overall Study|Withdrawal by Subject|0|||
28133300|NCT02974010|54797251|FG000|Overall Study|Adverse Event|0|||
28133301|NCT02974010|54797252|FG001|Overall Study|Adverse Event|1|||
28133302|NCT02974010|54797253|FG002|Overall Study|Adverse Event|0|||
27940922|NCT01032291|54597201|FG001|Proof of Concept|Never Received Study Drug|1|||
28069141|NCT00147225|54724240|FG002|Overall Study|Withdrawal by Subject|1|||
28069142|NCT00147225|54724241|FG003|Overall Study|Withdrawal by Subject|0|||
28069143|NCT00147225|54724242|FG004|Overall Study|Withdrawal by Subject|0|||
28069144|NCT00147225|54724243|FG005|Overall Study|Withdrawal by Subject|1|||
28069145|NCT00147225|54724238|FG000|Overall Study|Adverse Event|0|||
28069146|NCT00147225|54724239|FG001|Overall Study|Adverse Event|0|||
28069147|NCT00147225|54724240|FG002|Overall Study|Adverse Event|1|||
28069148|NCT00147225|54724241|FG003|Overall Study|Adverse Event|1|||
28069149|NCT00147225|54724242|FG004|Overall Study|Adverse Event|0|||
28069150|NCT00147225|54724243|FG005|Overall Study|Adverse Event|0|||
28069151|NCT00147225|54724238|FG000|Overall Study|Screen Failure|0|||
28069152|NCT00147225|54724239|FG001|Overall Study|Screen Failure|0|||
28069153|NCT00147225|54724240|FG002|Overall Study|Screen Failure|0|||
28069154|NCT00147225|54724241|FG003|Overall Study|Screen Failure|0|||
28069155|NCT00147225|54724242|FG004|Overall Study|Screen Failure|1|||
28069156|NCT00147225|54724243|FG005|Overall Study|Screen Failure|0|||
28069157|NCT00147225|54724238|FG000|Overall Study|Chemotherapy Changed|0|||
28069158|NCT00147225|54724239|FG001|Overall Study|Chemotherapy Changed|0|||
28069159|NCT00147225|54724240|FG002|Overall Study|Chemotherapy Changed|0|||
28069160|NCT00147225|54724241|FG003|Overall Study|Chemotherapy Changed|0|||
28069161|NCT00147225|54724242|FG004|Overall Study|Chemotherapy Changed|0|||
28069162|NCT00147225|54724243|FG005|Overall Study|Chemotherapy Changed|1|||
28069163|NCT00222105|54724257|FG000|Overall Study|Removed due to wrong diagnosis|1|||
28069164|NCT00222105|54724257|FG000|Overall Study|Withdrawal by Subject|1|||
28069165|NCT00222105|54724257|FG000|Overall Study|Adverse Event|8|||
28069166|NCT00222105|54724257|FG000|Overall Study|Treatment delays|2|||
28069167|NCT00222105|54724257|FG000|Overall Study|Death|2|||
28069168|NCT00146757|54724261|FG000|Overall Study|Death|1|||
28069169|NCT00146757|54724262|FG001|Overall Study|Death|0|||
28069170|NCT00146757|54724261|FG000|Overall Study|Adverse Event|1|||
28069171|NCT00146757|54724262|FG001|Overall Study|Adverse Event|0|||
28069172|NCT00267098|54724276|FG000|Overall Study|Death|0|||
28069173|NCT00267098|54724277|FG001|Overall Study|Death|0|||
28069174|NCT00267098|54724278|FG002|Overall Study|Death|57|||
28069175|NCT00267098|54724279|FG003|Overall Study|Death|66|||
28069176|NCT00267098|54724280|FG004|Overall Study|Death|14|||
28069177|NCT00267098|54724281|FG005|Overall Study|Death|23|||
28069178|NCT00267098|54724282|FG006|Overall Study|Death|28|||
28069179|NCT00267098|54724283|FG007|Overall Study|Death|9|||
28069180|NCT00267098|54724276|FG000|Overall Study|Lost to Follow-up|0|||
28069181|NCT00267098|54724277|FG001|Overall Study|Lost to Follow-up|0|||
28069182|NCT00267098|54724278|FG002|Overall Study|Lost to Follow-up|6|||
28069183|NCT00267098|54724279|FG003|Overall Study|Lost to Follow-up|5|||
28069184|NCT00267098|54724280|FG004|Overall Study|Lost to Follow-up|2|||
28069185|NCT00267098|54724281|FG005|Overall Study|Lost to Follow-up|3|||
28133303|NCT02974010|54797254|FG003|Overall Study|Adverse Event|0|||
28133304|NCT02974010|54797251|FG000|Overall Study|Completed day 42 but did not return for day 70|1|||
28160098|NCT03434379|54830201|FG000|China Extension Period|Death|0|||
27940923|NCT01032291|54597202|FG002|Proof of Concept|Never Received Study Drug|0|||
28069186|NCT00267098|54724282|FG006|Overall Study|Lost to Follow-up|1|||
28069187|NCT00267098|54724283|FG007|Overall Study|Lost to Follow-up|1|||
28069188|NCT00267098|54724276|FG000|Overall Study|Withdrawal by Subject|8|||
28069189|NCT00267098|54724277|FG001|Overall Study|Withdrawal by Subject|0|||
28069190|NCT00267098|54724278|FG002|Overall Study|Withdrawal by Subject|24|||
28069191|NCT00267098|54724279|FG003|Overall Study|Withdrawal by Subject|21|||
28069192|NCT00267098|54724280|FG004|Overall Study|Withdrawal by Subject|12|||
28069193|NCT00267098|54724281|FG005|Overall Study|Withdrawal by Subject|9|||
28069194|NCT00267098|54724282|FG006|Overall Study|Withdrawal by Subject|12|||
28069195|NCT00267098|54724283|FG007|Overall Study|Withdrawal by Subject|5|||
27940924|NCT01159938|54597216|FG000|First Study Period|Protocol Violation (Microalbuminuria)|0|||
27940925|NCT01159938|54597217|FG001|First Study Period|Protocol Violation (Microalbuminuria)|0|||
27940926|NCT01159938|54597218|FG002|First Study Period|Protocol Violation (Microalbuminuria)|1|||
27940927|NCT01159938|54597219|FG003|First Study Period|Protocol Violation (Microalbuminuria)|0|||
27940928|NCT01159938|54597220|FG004|First Study Period|Protocol Violation (Microalbuminuria)|0|||
27940929|NCT01029405|54597245|FG000|Overall Study|Withdrawal by Subject|0|||
27940930|NCT01029405|54597246|FG001|Overall Study|Withdrawal by Subject|1|||
27940931|NCT01029405|54597247|FG002|Overall Study|Withdrawal by Subject|2|||
27940932|NCT01029405|54597248|FG003|Overall Study|Withdrawal by Subject|0|||
27940933|NCT01029405|54597245|FG000|Overall Study|Protocol Violation|0|||
27940934|NCT01029405|54597246|FG001|Overall Study|Protocol Violation|0|||
27940935|NCT01029405|54597247|FG002|Overall Study|Protocol Violation|0|||
27940936|NCT01029405|54597248|FG003|Overall Study|Protocol Violation|1|||
27940937|NCT01029405|54597245|FG000|Overall Study|Adverse Event|0|||
27940938|NCT01029405|54597246|FG001|Overall Study|Adverse Event|0|||
27940939|NCT01029405|54597247|FG002|Overall Study|Adverse Event|1|||
27940940|NCT01029405|54597248|FG003|Overall Study|Adverse Event|1|||
27940941|NCT01029405|54597245|FG000|Overall Study|Lost to Follow-up|2|||
27940942|NCT01029405|54597246|FG001|Overall Study|Lost to Follow-up|1|||
27940943|NCT01029405|54597247|FG002|Overall Study|Lost to Follow-up|1|||
27940944|NCT01029405|54597248|FG003|Overall Study|Lost to Follow-up|2|||
27940945|NCT01029405|54597245|FG000|Overall Study|Other|0|||
27940946|NCT01029405|54597246|FG001|Overall Study|Other|1|||
27940947|NCT01029405|54597247|FG002|Overall Study|Other|0|||
27940948|NCT01029405|54597248|FG003|Overall Study|Other|1|||
27940949|NCT01021683|54597258|FG000|Overall Study|Lack of Efficacy|12|||
27940950|NCT01021683|54597258|FG000|Overall Study|Recovery of neutrophil count|51|||
27940951|NCT01021683|54597258|FG000|Overall Study|Other|8|||
27940952|NCT01021293|54597264|FG000|Overall Study|Serious Adverse Event|2|||
27940953|NCT01021293|54597265|FG001|Overall Study|Serious Adverse Event|1|||
27940954|NCT01021293|54597264|FG000|Overall Study|Adverse Event|2|||
27940955|NCT01021293|54597265|FG001|Overall Study|Adverse Event|1|||
27940956|NCT01021293|54597264|FG000|Overall Study|Withdrawal by Subject|1|||
27940957|NCT01021293|54597265|FG001|Overall Study|Withdrawal by Subject|3|||
27940958|NCT01021293|54597264|FG000|Overall Study|Migrated/moved from study area|6|||
27940959|NCT01021293|54597265|FG001|Overall Study|Migrated/moved from study area|18|||
27940960|NCT01021293|54597264|FG000|Overall Study|Lost to Follow-up|1|||
27940961|NCT01021293|54597265|FG001|Overall Study|Lost to Follow-up|1|||
27940962|NCT04625725|54597274|FG000|Overall Study|Death|4|||
27940963|NCT04625725|54597275|FG001|Overall Study|Death|4|||
27940964|NCT04625725|54597274|FG000|Overall Study|Lost to Follow-up|11|||
27940965|NCT04625725|54597275|FG001|Overall Study|Lost to Follow-up|8|||
27940966|NCT04625725|54597274|FG000|Overall Study|Physician Decision|1|||
27940967|NCT04625725|54597275|FG001|Overall Study|Physician Decision|0|||
27940968|NCT04625725|54597274|FG000|Overall Study|Withdrawal by Subject|56|||
27940969|NCT04625725|54597275|FG001|Overall Study|Withdrawal by Subject|32|||
28069196|NCT00267098|54724276|FG000|Overall Study|Physician Decision|5|||
28069197|NCT00267098|54724277|FG001|Overall Study|Physician Decision|0|||
28069198|NCT00267098|54724278|FG002|Overall Study|Physician Decision|7|||
28069199|NCT00267098|54724279|FG003|Overall Study|Physician Decision|11|||
28069200|NCT00267098|54724280|FG004|Overall Study|Physician Decision|5|||
28069201|NCT00267098|54724281|FG005|Overall Study|Physician Decision|4|||
28069202|NCT00267098|54724282|FG006|Overall Study|Physician Decision|3|||
28069203|NCT00267098|54724283|FG007|Overall Study|Physician Decision|0|||
28069204|NCT00267098|54724276|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|96|||
28069205|NCT00267098|54724277|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
28069206|NCT00267098|54724278|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
28069207|NCT00267098|54724279|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
28069208|NCT00267098|54724280|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
28069209|NCT00267098|54724281|FG005|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
28069210|NCT00267098|54724282|FG006|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
28069211|NCT00267098|54724283|FG007|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
28069212|NCT00267098|54724276|FG000|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
28069213|NCT00267098|54724277|FG001|Overall Study|Unsuccessful Implant Exit Per Protocol|51|||
28069214|NCT00267098|54724278|FG002|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
28069215|NCT00267098|54724279|FG003|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
27940970|NCT04625725|54597274|FG000|Overall Study|"Includes participants who discontinued early with reason other selected."|18|||
27940971|NCT04625725|54597275|FG001|Overall Study|"Includes participants who discontinued early with reason other selected."|10|||
27849781|NCT00631163|54347609|FG000|Number of Participants in Year 1|Administrative problems|6|||
27940972|NCT04625725|54597274|FG000|Overall Study|Ongoing in study|3409|||
27940973|NCT04625725|54597275|FG001|Overall Study|Ongoing in study|1700|||
27940974|NCT04625725|54597274|FG000|Overall Study|Protocol Deviation|1|||
27940975|NCT04625725|54597275|FG001|Overall Study|Protocol Deviation|0|||
28069216|NCT00267098|54724280|FG004|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
28069217|NCT00267098|54724281|FG005|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
27940976|NCT01021215|54597283|FG000|Overall Study|Lost to Follow-up|3|||
27940977|NCT01021215|54597284|FG001|Overall Study|Lost to Follow-up|0|||
27940978|NCT01021137|54597294|FG000|Overall Study|Lost to Follow-up|9|||
27940979|NCT01021137|54597295|FG001|Overall Study|Lost to Follow-up|4|||
27940980|NCT01021137|54597296|FG002|Overall Study|Lost to Follow-up|2|||
27940981|NCT01021137|54597297|FG003|Overall Study|Lost to Follow-up|6|||
27940982|NCT01021137|54597294|FG000|Overall Study|Withdrawal by Subject|1|||
27940983|NCT01021137|54597295|FG001|Overall Study|Withdrawal by Subject|0|||
27940984|NCT01021137|54597296|FG002|Overall Study|Withdrawal by Subject|0|||
27940985|NCT01021137|54597297|FG003|Overall Study|Withdrawal by Subject|3|||
27940986|NCT01020981|54597310|FG000|Overall Study|Did not return mailed survey|74|||
27940987|NCT01020981|54597311|FG001|Overall Study|Did not return mailed survey|58|||
27940988|NCT01020981|54597310|FG000|Overall Study|Survey returned undeliverable|8|||
27819537|NCT01728116|54278958|FG000|Overall Study|Incorrectly enrolled in Study|0|||
27819538|NCT01728116|54278959|FG001|Overall Study|Incorrectly enrolled in Study|1|||
27819539|NCT01728116|54278958|FG000|Overall Study|various not noted previously|5|||
27819540|NCT01728116|54278959|FG001|Overall Study|various not noted previously|0|||
27819541|NCT01465659|54278970|FG000|Completed 1 Cycle of Treatment|Death|0|||
27819542|NCT01465659|54278971|FG001|Completed 1 Cycle of Treatment|Death|1|||
27819543|NCT01465659|54278972|FG002|Completed 1 Cycle of Treatment|Death|0|||
27819544|NCT01465659|54278973|FG003|Completed 1 Cycle of Treatment|Death|0|||
27819545|NCT01465659|54278970|FG000|Completed 1 Cycle of Treatment|Adverse Event|0|||
27819546|NCT01465659|54278971|FG001|Completed 1 Cycle of Treatment|Adverse Event|0|||
27819547|NCT01465659|54278972|FG002|Completed 1 Cycle of Treatment|Adverse Event|0|||
28133305|NCT02974010|54797252|FG001|Overall Study|Completed day 42 but did not return for day 70|0|||
28133306|NCT02974010|54797253|FG002|Overall Study|Completed day 42 but did not return for day 70|1|||
28133307|NCT02974010|54797254|FG003|Overall Study|Completed day 42 but did not return for day 70|0|||
28133308|NCT02974010|54797251|FG000|Overall Study|Lack of Efficacy|0|||
28133309|NCT02974010|54797252|FG001|Overall Study|Lack of Efficacy|0|||
28133310|NCT02974010|54797253|FG002|Overall Study|Lack of Efficacy|1|||
28133311|NCT02974010|54797254|FG003|Overall Study|Lack of Efficacy|0|||
28133312|NCT02030938|54797264|FG000|Overall Study|Lost to Follow-up|4|||
28133313|NCT02030938|54797264|FG000|Overall Study|Withdrawal by Subject|1|||
28133314|NCT03122535|54797272|FG000|Overall Study|Lost to Follow-up|68|||
28133315|NCT03122535|54797273|FG001|Overall Study|Lost to Follow-up|68|||
28133316|NCT03122535|54797272|FG000|Overall Study|Physician Decision|3|||
28133317|NCT03122535|54797273|FG001|Overall Study|Physician Decision|3|||
28133318|NCT03122535|54797272|FG000|Overall Study|Withdrawal by Subject|2|||
28133319|NCT03122535|54797273|FG001|Overall Study|Withdrawal by Subject|2|||
28133320|NCT01061606|54797279|FG000|Overall Study|Adverse Event|1|||
28133321|NCT01061606|54797279|FG000|Overall Study|Death|1|||
28133322|NCT01061606|54797279|FG000|Overall Study|Disease Progression|4|||
28133323|NCT01061606|54797279|FG000|Overall Study|alternative therapy|2|||
28133324|NCT03122457|54797283|FG000|Overall Study|Withdrawal by Subject|6|||
28133325|NCT03482453|54797299|FG000|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
28133326|NCT03482453|54797300|FG001|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
28133327|NCT03482453|54797301|FG002|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
28133328|NCT03482453|54797302|FG003|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
28133329|NCT03482453|54797303|FG004|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
28133330|NCT03482453|54797304|FG005|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
28133331|NCT03482453|54797305|FG006|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
28133332|NCT03482453|54797306|FG007|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
28133333|NCT03482453|54797307|FG008|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
28133334|NCT03482453|54797308|FG009|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
28133335|NCT03482453|54797309|FG010|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1|||
28133336|NCT03482453|54797310|FG011|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
28133337|NCT03480425|54797346|FG000|Overall Study|Force transducer technical failure|1|||
28133338|NCT03472547|54797350|FG000|Overall Study|Withdrawal by Subject|30|||
28133339|NCT00799396|54797354|FG000|Clopidogrel Treatment|Adverse Event|6|||
27819548|NCT01465659|54278973|FG003|Completed 1 Cycle of Treatment|Adverse Event|1|||
27819549|NCT01465659|54278970|FG000|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
27819550|NCT01465659|54278971|FG001|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0|||
27819551|NCT01465659|54278972|FG002|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
28133340|NCT00799396|54797354|FG000|Clopidogrel Treatment|Physician Decision|5|||
27940989|NCT01020981|54597311|FG001|Overall Study|Survey returned undeliverable|32|||
27940990|NCT01020981|54597310|FG000|Overall Study|Participant declined to complete survey|2|||
28133341|NCT00799396|54797354|FG000|Clopidogrel Treatment|Withdrawal by Subject|2|||
28133342|NCT00799396|54797354|FG000|Clopidogrel Plus Aspirin|Adverse Event|2|||
28133343|NCT00799396|54797354|FG000|Clopidogrel Plus Aspirin|Physician Decision|4|||
28133344|NCT03469349|54797360|FG000|Overall Study|Withdrawal by Subject|1|||
28133345|NCT03469349|54797361|FG001|Overall Study|Withdrawal by Subject|3|||
28133346|NCT03469349|54797360|FG000|Overall Study|Progressive Disease|0|||
28133347|NCT03469349|54797361|FG001|Overall Study|Progressive Disease|1|||
28133348|NCT03469349|54797360|FG000|Overall Study|Lost to Follow-up|2|||
28133349|NCT03469349|54797361|FG001|Overall Study|Lost to Follow-up|2|||
28133350|NCT03469349|54797360|FG000|Overall Study|Adverse Event|2|||
28133351|NCT03469349|54797361|FG001|Overall Study|Adverse Event|4|||
28133352|NCT03467945|54797371|FG000|Treatment Period 2|Withdrawal by Subject|0|||
28133353|NCT03467945|54797372|FG001|Treatment Period 2|Withdrawal by Subject|1|||
28133354|NCT03467945|54797373|FG002|Treatment Period 2|Withdrawal by Subject|0|||
28133355|NCT03467945|54797374|FG003|Treatment Period 2|Withdrawal by Subject|0|||
28133356|NCT03467945|54797371|FG000|Treatment Period 3|Withdrawal by Subject|1|||
28133357|NCT03467945|54797372|FG001|Treatment Period 3|Withdrawal by Subject|0|||
28133358|NCT03467945|54797373|FG002|Treatment Period 3|Withdrawal by Subject|2|||
28133359|NCT03467945|54797374|FG003|Treatment Period 3|Withdrawal by Subject|1|||
28133360|NCT00069238|54797385|FG000|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9|||
28133361|NCT00069238|54797386|FG001|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
28133362|NCT00069238|54797387|FG002|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
28133363|NCT00069238|54797385|FG000|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
28133364|NCT00069238|54797386|FG001|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2|||
28133365|NCT00069238|54797387|FG002|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
28133366|NCT00069238|54797385|FG000|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
28133367|NCT00069238|54797386|FG001|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
28133368|NCT00069238|54797387|FG002|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2|||
28133369|NCT03435497|54797394|FG000|Overall Study|Lost to Follow-up|1|||
28133370|NCT03435497|54797395|FG001|Overall Study|Lost to Follow-up|0|||
28133371|NCT03435497|54797394|FG000|Overall Study|Death|1|||
28133372|NCT03435497|54797395|FG001|Overall Study|Death|0|||
28133373|NCT03435497|54797394|FG000|Overall Study|Withdrawal by Subject|0|||
28133374|NCT03435497|54797395|FG001|Overall Study|Withdrawal by Subject|4|||
28133375|NCT03435497|54797394|FG000|Overall Study|Wrong survey administered|0|||
28133376|NCT03435497|54797395|FG001|Overall Study|Wrong survey administered|2|||
28133377|NCT03073200|54797404|FG000|Double Blind Treatment Period|Protocol Violation|1|||
28133378|NCT03073200|54797405|FG001|Double Blind Treatment Period|Protocol Violation|0|||
28133379|NCT03073200|54797406|FG002|Double Blind Treatment Period|Protocol Violation|0|||
28133380|NCT03073200|54797407|FG003|Double Blind Treatment Period|Protocol Violation|0|||
28133381|NCT03073200|54797408|FG004|Double Blind Treatment Period|Protocol Violation|0|||
28133382|NCT03073200|54797409|FG005|Double Blind Treatment Period|Protocol Violation|0|||
28133383|NCT03073200|54797410|FG006|Double Blind Treatment Period|Protocol Violation|0|||
28133384|NCT03073200|54797411|FG007|Double Blind Treatment Period|Protocol Violation|0|||
28133385|NCT03073200|54797412|FG008|Double Blind Treatment Period|Protocol Violation|0|||
28133386|NCT03073200|54797413|FG009|Double Blind Treatment Period|Protocol Violation|0|||
28133387|NCT03073200|54797414|FG010|Double Blind Treatment Period|Protocol Violation|0|||
28133388|NCT03073200|54797415|FG011|Double Blind Treatment Period|Protocol Violation|0|||
28133389|NCT03073200|54797416|FG012|Double Blind Treatment Period|Protocol Violation|0|||
28133390|NCT03073200|54797417|FG013|Double Blind Treatment Period|Protocol Violation|0|||
28133391|NCT03073200|54797418|FG014|Double Blind Treatment Period|Protocol Violation|0|||
28133392|NCT03073200|54797404|FG000|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
28133393|NCT03073200|54797405|FG001|Double Blind Treatment Period|Withdrawal by Parent/Guardian|1|||
28133394|NCT03073200|54797406|FG002|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
27819552|NCT01465659|54278973|FG003|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
28133395|NCT03073200|54797407|FG003|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
28133396|NCT03073200|54797408|FG004|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
28133397|NCT03073200|54797409|FG005|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
28133398|NCT03073200|54797410|FG006|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
28133399|NCT03073200|54797411|FG007|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
27819553|NCT01465659|54278970|FG000|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
28133400|NCT03073200|54797412|FG008|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
28133401|NCT03073200|54797413|FG009|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
28133402|NCT03073200|54797414|FG010|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
28133403|NCT03073200|54797415|FG011|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
28133404|NCT03073200|54797416|FG012|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
28133405|NCT03073200|54797417|FG013|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
28133406|NCT03073200|54797418|FG014|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
28133407|NCT03073200|54797404|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
28133408|NCT03073200|54797405|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
28133409|NCT03073200|54797406|FG002|Double Blind Treatment Period|Withdrawal by Subject|0|||
28133410|NCT03073200|54797407|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
28133411|NCT03073200|54797408|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
28133412|NCT03073200|54797409|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
28133413|NCT03073200|54797410|FG006|Double Blind Treatment Period|Withdrawal by Subject|0|||
28133414|NCT03073200|54797411|FG007|Double Blind Treatment Period|Withdrawal by Subject|0|||
28133415|NCT03073200|54797412|FG008|Double Blind Treatment Period|Withdrawal by Subject|0|||
28133416|NCT03073200|54797413|FG009|Double Blind Treatment Period|Withdrawal by Subject|0|||
28133417|NCT03073200|54797414|FG010|Double Blind Treatment Period|Withdrawal by Subject|0|||
28133418|NCT03073200|54797415|FG011|Double Blind Treatment Period|Withdrawal by Subject|0|||
28133419|NCT03073200|54797416|FG012|Double Blind Treatment Period|Withdrawal by Subject|0|||
28133420|NCT03073200|54797417|FG013|Double Blind Treatment Period|Withdrawal by Subject|0|||
28133421|NCT03073200|54797418|FG014|Double Blind Treatment Period|Withdrawal by Subject|0|||
28133422|NCT03073200|54797404|FG000|Open-Label Maintenance Period|Lost to Follow-up|0|||
28133423|NCT03073200|54797405|FG001|Open-Label Maintenance Period|Lost to Follow-up|0|||
28133424|NCT03073200|54797406|FG002|Open-Label Maintenance Period|Lost to Follow-up|0|||
28133425|NCT03073200|54797407|FG003|Open-Label Maintenance Period|Lost to Follow-up|1|||
28133426|NCT03073200|54797408|FG004|Open-Label Maintenance Period|Lost to Follow-up|2|||
28133427|NCT03073200|54797409|FG005|Open-Label Maintenance Period|Lost to Follow-up|0|||
28133428|NCT03073200|54797410|FG006|Open-Label Maintenance Period|Lost to Follow-up|0|||
28133429|NCT03073200|54797411|FG007|Open-Label Maintenance Period|Lost to Follow-up|0|||
28133430|NCT03073200|54797412|FG008|Open-Label Maintenance Period|Lost to Follow-up|0|||
28133431|NCT03073200|54797413|FG009|Open-Label Maintenance Period|Lost to Follow-up|0|||
28133432|NCT03073200|54797414|FG010|Open-Label Maintenance Period|Lost to Follow-up|0|||
28133433|NCT03073200|54797415|FG011|Open-Label Maintenance Period|Lost to Follow-up|0|||
28133434|NCT03073200|54797416|FG012|Open-Label Maintenance Period|Lost to Follow-up|0|||
28133435|NCT03073200|54797417|FG013|Open-Label Maintenance Period|Lost to Follow-up|0|||
28133436|NCT03073200|54797418|FG014|Open-Label Maintenance Period|Lost to Follow-up|0|||
28133437|NCT03073200|54797404|FG000|Open-Label Maintenance Period|Participant moved to another city|0|||
28133438|NCT03073200|54797405|FG001|Open-Label Maintenance Period|Participant moved to another city|0|||
28133439|NCT03073200|54797406|FG002|Open-Label Maintenance Period|Participant moved to another city|0|||
28133440|NCT03073200|54797407|FG003|Open-Label Maintenance Period|Participant moved to another city|1|||
28133441|NCT03073200|54797408|FG004|Open-Label Maintenance Period|Participant moved to another city|0|||
28133442|NCT03073200|54797409|FG005|Open-Label Maintenance Period|Participant moved to another city|0|||
28133443|NCT03073200|54797410|FG006|Open-Label Maintenance Period|Participant moved to another city|0|||
28133444|NCT03073200|54797411|FG007|Open-Label Maintenance Period|Participant moved to another city|0|||
28133445|NCT03073200|54797412|FG008|Open-Label Maintenance Period|Participant moved to another city|0|||
28133446|NCT03073200|54797413|FG009|Open-Label Maintenance Period|Participant moved to another city|0|||
28133447|NCT03073200|54797414|FG010|Open-Label Maintenance Period|Participant moved to another city|0|||
28133448|NCT03073200|54797415|FG011|Open-Label Maintenance Period|Participant moved to another city|0|||
28133449|NCT03073200|54797416|FG012|Open-Label Maintenance Period|Participant moved to another city|0|||
28133450|NCT03073200|54797417|FG013|Open-Label Maintenance Period|Participant moved to another city|0|||
28133451|NCT03073200|54797418|FG014|Open-Label Maintenance Period|Participant moved to another city|0|||
28133452|NCT03073200|54797404|FG000|Open-Label Maintenance Period|Lack of Efficacy|0|||
28133453|NCT03073200|54797405|FG001|Open-Label Maintenance Period|Lack of Efficacy|0|||
28133454|NCT03073200|54797406|FG002|Open-Label Maintenance Period|Lack of Efficacy|0|||
28133455|NCT03073200|54797407|FG003|Open-Label Maintenance Period|Lack of Efficacy|0|||
28133456|NCT03073200|54797408|FG004|Open-Label Maintenance Period|Lack of Efficacy|1|||
28133457|NCT03073200|54797409|FG005|Open-Label Maintenance Period|Lack of Efficacy|0|||
28133458|NCT03073200|54797410|FG006|Open-Label Maintenance Period|Lack of Efficacy|0|||
28133459|NCT03073200|54797411|FG007|Open-Label Maintenance Period|Lack of Efficacy|0|||
28133460|NCT03073200|54797412|FG008|Open-Label Maintenance Period|Lack of Efficacy|0|||
28133461|NCT03073200|54797413|FG009|Open-Label Maintenance Period|Lack of Efficacy|0|||
28133462|NCT03073200|54797414|FG010|Open-Label Maintenance Period|Lack of Efficacy|0|||
28133463|NCT03073200|54797415|FG011|Open-Label Maintenance Period|Lack of Efficacy|0|||
28133464|NCT03073200|54797416|FG012|Open-Label Maintenance Period|Lack of Efficacy|0|||
28133465|NCT03073200|54797417|FG013|Open-Label Maintenance Period|Lack of Efficacy|0|||
28133466|NCT03073200|54797418|FG014|Open-Label Maintenance Period|Lack of Efficacy|0|||
28133467|NCT03073200|54797404|FG000|Open-Label Maintenance Period|Withdrawal by Subject|0|||
28133468|NCT03073200|54797405|FG001|Open-Label Maintenance Period|Withdrawal by Subject|0|||
28133469|NCT03073200|54797406|FG002|Open-Label Maintenance Period|Withdrawal by Subject|0|||
28133470|NCT03073200|54797407|FG003|Open-Label Maintenance Period|Withdrawal by Subject|2|||
28133471|NCT03073200|54797408|FG004|Open-Label Maintenance Period|Withdrawal by Subject|1|||
28133472|NCT03073200|54797409|FG005|Open-Label Maintenance Period|Withdrawal by Subject|0|||
28133473|NCT03073200|54797410|FG006|Open-Label Maintenance Period|Withdrawal by Subject|0|||
28133474|NCT03073200|54797411|FG007|Open-Label Maintenance Period|Withdrawal by Subject|0|||
28133475|NCT03073200|54797412|FG008|Open-Label Maintenance Period|Withdrawal by Subject|0|||
28133476|NCT03073200|54797413|FG009|Open-Label Maintenance Period|Withdrawal by Subject|0|||
28133477|NCT03073200|54797414|FG010|Open-Label Maintenance Period|Withdrawal by Subject|0|||
28133478|NCT03073200|54797415|FG011|Open-Label Maintenance Period|Withdrawal by Subject|0|||
28133479|NCT03073200|54797416|FG012|Open-Label Maintenance Period|Withdrawal by Subject|0|||
28133480|NCT03073200|54797417|FG013|Open-Label Maintenance Period|Withdrawal by Subject|0|||
28133481|NCT03073200|54797418|FG014|Open-Label Maintenance Period|Withdrawal by Subject|0|||
28133482|NCT03073200|54797404|FG000|Extension Period|Lost to Follow-up|0|||
28133483|NCT03073200|54797405|FG001|Extension Period|Lost to Follow-up|0|||
28133484|NCT03073200|54797406|FG002|Extension Period|Lost to Follow-up|0|||
28133485|NCT03073200|54797407|FG003|Extension Period|Lost to Follow-up|0|||
28133486|NCT03073200|54797408|FG004|Extension Period|Lost to Follow-up|0|||
28133487|NCT03073200|54797409|FG005|Extension Period|Lost to Follow-up|0|||
28133488|NCT03073200|54797410|FG006|Extension Period|Lost to Follow-up|1|||
28133489|NCT03073200|54797411|FG007|Extension Period|Lost to Follow-up|1|||
28133490|NCT03073200|54797412|FG008|Extension Period|Lost to Follow-up|0|||
28133491|NCT03073200|54797413|FG009|Extension Period|Lost to Follow-up|0|||
28133492|NCT03073200|54797414|FG010|Extension Period|Lost to Follow-up|0|||
28133493|NCT03073200|54797415|FG011|Extension Period|Lost to Follow-up|0|||
28133494|NCT03073200|54797416|FG012|Extension Period|Lost to Follow-up|0|||
28133495|NCT03073200|54797417|FG013|Extension Period|Lost to Follow-up|0|||
28133496|NCT03073200|54797418|FG014|Extension Period|Lost to Follow-up|0|||
28133497|NCT03073200|54797404|FG000|Extension Period|Sponsor Decision|0|||
28133498|NCT03073200|54797405|FG001|Extension Period|Sponsor Decision|0|||
28133499|NCT03073200|54797406|FG002|Extension Period|Sponsor Decision|0|||
28133500|NCT03073200|54797407|FG003|Extension Period|Sponsor Decision|0|||
28133501|NCT03073200|54797408|FG004|Extension Period|Sponsor Decision|0|||
28133502|NCT03073200|54797409|FG005|Extension Period|Sponsor Decision|0|||
28133503|NCT03073200|54797410|FG006|Extension Period|Sponsor Decision|0|||
28133504|NCT03073200|54797411|FG007|Extension Period|Sponsor Decision|0|||
28133505|NCT03073200|54797412|FG008|Extension Period|Sponsor Decision|1|||
28133506|NCT03073200|54797413|FG009|Extension Period|Sponsor Decision|0|||
28133507|NCT03073200|54797414|FG010|Extension Period|Sponsor Decision|0|||
28133508|NCT03073200|54797415|FG011|Extension Period|Sponsor Decision|0|||
28133509|NCT03073200|54797416|FG012|Extension Period|Sponsor Decision|0|||
28133510|NCT03073200|54797417|FG013|Extension Period|Sponsor Decision|0|||
28133511|NCT03073200|54797418|FG014|Extension Period|Sponsor Decision|0|||
28133512|NCT03073200|54797404|FG000|Extension Period|Withdrawal by Parent/Guardian|0|||
28133513|NCT03073200|54797405|FG001|Extension Period|Withdrawal by Parent/Guardian|0|||
28133514|NCT03073200|54797406|FG002|Extension Period|Withdrawal by Parent/Guardian|0|||
28133515|NCT03073200|54797407|FG003|Extension Period|Withdrawal by Parent/Guardian|0|||
28133516|NCT03073200|54797408|FG004|Extension Period|Withdrawal by Parent/Guardian|0|||
28133517|NCT03073200|54797409|FG005|Extension Period|Withdrawal by Parent/Guardian|0|||
28133518|NCT03073200|54797410|FG006|Extension Period|Withdrawal by Parent/Guardian|1|||
28133519|NCT03073200|54797411|FG007|Extension Period|Withdrawal by Parent/Guardian|3|||
28133520|NCT03073200|54797412|FG008|Extension Period|Withdrawal by Parent/Guardian|1|||
28133521|NCT03073200|54797413|FG009|Extension Period|Withdrawal by Parent/Guardian|0|||
28133522|NCT03073200|54797414|FG010|Extension Period|Withdrawal by Parent/Guardian|0|||
28160099|NCT03434379|54830202|FG001|China Extension Period|Death|0|||
28133523|NCT03073200|54797415|FG011|Extension Period|Withdrawal by Parent/Guardian|0|||
28133524|NCT03073200|54797416|FG012|Extension Period|Withdrawal by Parent/Guardian|0|||
28133525|NCT03073200|54797417|FG013|Extension Period|Withdrawal by Parent/Guardian|0|||
28133526|NCT03073200|54797418|FG014|Extension Period|Withdrawal by Parent/Guardian|0|||
28133527|NCT03073200|54797404|FG000|Extension Period|Withdrawal by Subject|0|||
28133528|NCT03073200|54797405|FG001|Extension Period|Withdrawal by Subject|0|||
28133529|NCT03073200|54797406|FG002|Extension Period|Withdrawal by Subject|0|||
28133530|NCT03073200|54797407|FG003|Extension Period|Withdrawal by Subject|0|||
28133531|NCT03073200|54797408|FG004|Extension Period|Withdrawal by Subject|0|||
28133532|NCT03073200|54797409|FG005|Extension Period|Withdrawal by Subject|0|||
28133533|NCT03073200|54797410|FG006|Extension Period|Withdrawal by Subject|1|||
28133534|NCT03073200|54797411|FG007|Extension Period|Withdrawal by Subject|2|||
28133535|NCT03073200|54797412|FG008|Extension Period|Withdrawal by Subject|0|||
28133536|NCT03073200|54797413|FG009|Extension Period|Withdrawal by Subject|0|||
28133537|NCT03073200|54797414|FG010|Extension Period|Withdrawal by Subject|0|||
28133538|NCT03073200|54797415|FG011|Extension Period|Withdrawal by Subject|0|||
28133539|NCT03073200|54797416|FG012|Extension Period|Withdrawal by Subject|0|||
28133540|NCT03073200|54797417|FG013|Extension Period|Withdrawal by Subject|0|||
28133541|NCT03073200|54797418|FG014|Extension Period|Withdrawal by Subject|0|||
28133542|NCT03073200|54797404|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
28133543|NCT03073200|54797405|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
28133544|NCT03073200|54797406|FG002|Randomized Withdrawal Period|Lost to Follow-up|0|||
28133545|NCT03073200|54797407|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
28133546|NCT03073200|54797408|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
28133547|NCT03073200|54797409|FG005|Randomized Withdrawal Period|Lost to Follow-up|0|||
28133548|NCT03073200|54797410|FG006|Randomized Withdrawal Period|Lost to Follow-up|0|||
28133549|NCT03073200|54797411|FG007|Randomized Withdrawal Period|Lost to Follow-up|0|||
28133550|NCT03073200|54797412|FG008|Randomized Withdrawal Period|Lost to Follow-up|0|||
28133551|NCT03073200|54797413|FG009|Randomized Withdrawal Period|Lost to Follow-up|0|||
28133552|NCT03073200|54797414|FG010|Randomized Withdrawal Period|Lost to Follow-up|0|||
28133553|NCT03073200|54797415|FG011|Randomized Withdrawal Period|Lost to Follow-up|1|||
28133554|NCT03073200|54797416|FG012|Randomized Withdrawal Period|Lost to Follow-up|0|||
28133555|NCT03073200|54797417|FG013|Randomized Withdrawal Period|Lost to Follow-up|0|||
28133556|NCT03073200|54797418|FG014|Randomized Withdrawal Period|Lost to Follow-up|0|||
28133557|NCT03073200|54797404|FG000|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
28133558|NCT03073200|54797405|FG001|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
28133559|NCT03073200|54797406|FG002|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
28133560|NCT03073200|54797407|FG003|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
28133561|NCT03073200|54797408|FG004|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
28133562|NCT03073200|54797409|FG005|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
28133563|NCT03073200|54797410|FG006|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
28133564|NCT03073200|54797411|FG007|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
28133565|NCT03073200|54797412|FG008|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
28133566|NCT03073200|54797413|FG009|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
28133567|NCT03073200|54797414|FG010|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
28133568|NCT03073200|54797415|FG011|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|1|||
28133569|NCT03073200|54797416|FG012|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
28133570|NCT03073200|54797417|FG013|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
28133571|NCT03073200|54797418|FG014|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
28133572|NCT03073200|54797404|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
28133573|NCT03073200|54797405|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
28133574|NCT03073200|54797406|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
28133575|NCT03073200|54797407|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
28133576|NCT03073200|54797408|FG004|Randomized Withdrawal Period|Withdrawal by Subject|0|||
28133577|NCT03073200|54797409|FG005|Randomized Withdrawal Period|Withdrawal by Subject|0|||
28133578|NCT03073200|54797410|FG006|Randomized Withdrawal Period|Withdrawal by Subject|0|||
28133579|NCT03073200|54797411|FG007|Randomized Withdrawal Period|Withdrawal by Subject|0|||
28133580|NCT03073200|54797412|FG008|Randomized Withdrawal Period|Withdrawal by Subject|0|||
28133581|NCT03073200|54797413|FG009|Randomized Withdrawal Period|Withdrawal by Subject|0|||
28133582|NCT03073200|54797414|FG010|Randomized Withdrawal Period|Withdrawal by Subject|1|||
28133583|NCT03073200|54797415|FG011|Randomized Withdrawal Period|Withdrawal by Subject|1|||
28133584|NCT03073200|54797416|FG012|Randomized Withdrawal Period|Withdrawal by Subject|0|||
28133585|NCT03073200|54797417|FG013|Randomized Withdrawal Period|Withdrawal by Subject|0|||
27819554|NCT01465659|54278971|FG001|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
27819555|NCT01465659|54278972|FG002|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
28133586|NCT03073200|54797418|FG014|Randomized Withdrawal Period|Withdrawal by Subject|0|||
27819556|NCT01465659|54278973|FG003|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
28133587|NCT03073200|54797404|FG000|Randomized Withdrawal Period|Adverse Event|0|||
28133588|NCT03073200|54797405|FG001|Randomized Withdrawal Period|Adverse Event|0|||
28133589|NCT03073200|54797406|FG002|Randomized Withdrawal Period|Adverse Event|0|||
28133590|NCT03073200|54797407|FG003|Randomized Withdrawal Period|Adverse Event|0|||
28133591|NCT03073200|54797408|FG004|Randomized Withdrawal Period|Adverse Event|0|||
28133592|NCT03073200|54797409|FG005|Randomized Withdrawal Period|Adverse Event|0|||
27819557|NCT01465659|54278970|FG000|Completed Follow for 1 Year|Death|6|||
27819558|NCT01465659|54278971|FG001|Completed Follow for 1 Year|Death|3|||
27819559|NCT01465659|54278972|FG002|Completed Follow for 1 Year|Death|2|||
28133593|NCT03073200|54797410|FG006|Randomized Withdrawal Period|Adverse Event|0|||
28133594|NCT03073200|54797411|FG007|Randomized Withdrawal Period|Adverse Event|0|||
28133595|NCT03073200|54797412|FG008|Randomized Withdrawal Period|Adverse Event|0|||
28133596|NCT03073200|54797413|FG009|Randomized Withdrawal Period|Adverse Event|0|||
28133597|NCT03073200|54797414|FG010|Randomized Withdrawal Period|Adverse Event|1|||
28133598|NCT03073200|54797415|FG011|Randomized Withdrawal Period|Adverse Event|0|||
28133599|NCT03073200|54797416|FG012|Randomized Withdrawal Period|Adverse Event|0|||
28133600|NCT03073200|54797417|FG013|Randomized Withdrawal Period|Adverse Event|0|||
28133601|NCT03073200|54797418|FG014|Randomized Withdrawal Period|Adverse Event|0|||
28133602|NCT03073200|54797404|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
28133603|NCT03073200|54797405|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
28133604|NCT03073200|54797406|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
28133605|NCT03073200|54797407|FG003|Post-Treatment Follow-Up Period|Adverse Event|0|||
28133606|NCT03073200|54797408|FG004|Post-Treatment Follow-Up Period|Adverse Event|0|||
28133607|NCT03073200|54797409|FG005|Post-Treatment Follow-Up Period|Adverse Event|0|||
28133608|NCT03073200|54797410|FG006|Post-Treatment Follow-Up Period|Adverse Event|0|||
27819560|NCT01465659|54278973|FG003|Completed Follow for 1 Year|Death|4|||
27819561|NCT01753076|54278988|FG000|Overall Study|Adverse Event|17|||
27819562|NCT01753076|54278989|FG001|Overall Study|Adverse Event|18|||
27819563|NCT01753076|54278988|FG000|Overall Study|Lack of Efficacy|3|||
27819564|NCT01753076|54278989|FG001|Overall Study|Lack of Efficacy|1|||
27819565|NCT01753076|54278988|FG000|Overall Study|Lost to Follow-up|2|||
27819566|NCT01753076|54278989|FG001|Overall Study|Lost to Follow-up|1|||
28133609|NCT03073200|54797411|FG007|Post-Treatment Follow-Up Period|Adverse Event|0|||
28133610|NCT03073200|54797412|FG008|Post-Treatment Follow-Up Period|Adverse Event|0|||
28133611|NCT03073200|54797413|FG009|Post-Treatment Follow-Up Period|Adverse Event|0|||
28133612|NCT03073200|54797414|FG010|Post-Treatment Follow-Up Period|Adverse Event|0|||
28133613|NCT03073200|54797415|FG011|Post-Treatment Follow-Up Period|Adverse Event|0|||
28133614|NCT03073200|54797416|FG012|Post-Treatment Follow-Up Period|Adverse Event|0|||
28133615|NCT03073200|54797417|FG013|Post-Treatment Follow-Up Period|Adverse Event|2|||
28133616|NCT03073200|54797418|FG014|Post-Treatment Follow-Up Period|Adverse Event|0|||
28133617|NCT03073200|54797404|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
28133618|NCT03073200|54797405|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
28133619|NCT03073200|54797406|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
27819567|NCT01753076|54278988|FG000|Overall Study|Physician Decision|4|||
27819568|NCT01753076|54278989|FG001|Overall Study|Physician Decision|2|||
27819569|NCT01753076|54278988|FG000|Overall Study|Withdrawal by Subject|14|||
27819570|NCT01753076|54278989|FG001|Overall Study|Withdrawal by Subject|24|||
27819571|NCT01753076|54278988|FG000|Overall Study|Other-Reached Protocol-defined Stopping|1|||
27819572|NCT01753076|54278989|FG001|Overall Study|Other-Reached Protocol-defined Stopping|0|||
27849782|NCT00631163|54347609|FG000|Number of Participants in Year 2|Withdrawal by Subject|2|||
27849783|NCT00631163|54347609|FG000|Number of Participants in Year 2|Adverse Event|1|||
27849784|NCT00631163|54347609|FG000|Number of Participants in Year 2|Protocol Violation|1|||
28133620|NCT03073200|54797407|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
28133621|NCT03073200|54797408|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
27819573|NCT01463007|54278997|FG000|Overall Study|Physician Decision|1|||
27819574|NCT01462929|54279005|FG000|Overall Study|Adverse Event|3|||
27819575|NCT01462929|54279006|FG001|Overall Study|Adverse Event|3|||
27819576|NCT01462929|54279007|FG002|Overall Study|Adverse Event|4|||
28133622|NCT03073200|54797409|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
27819577|NCT01462929|54279005|FG000|Overall Study|Withdrawal by Subject|2|||
27819578|NCT01462929|54279006|FG001|Overall Study|Withdrawal by Subject|1|||
27819579|NCT01462929|54279007|FG002|Overall Study|Withdrawal by Subject|0|||
27819580|NCT01462929|54279005|FG000|Overall Study|Lack of Efficacy|0|||
27819581|NCT01462929|54279006|FG001|Overall Study|Lack of Efficacy|0|||
27819582|NCT01462929|54279007|FG002|Overall Study|Lack of Efficacy|1|||
27819583|NCT01462695|54279017|FG000|Overall Study|Adverse Event|1|||
27819584|NCT01462695|54279018|FG001|Overall Study|Adverse Event|1|||
27819585|NCT01462695|54279017|FG000|Overall Study|Death|2|||
27819586|NCT01462695|54279018|FG001|Overall Study|Death|0|||
27819587|NCT01462695|54279017|FG000|Overall Study|Lack of Efficacy|6|||
27819588|NCT01462695|54279018|FG001|Overall Study|Lack of Efficacy|12|||
28133623|NCT03073200|54797410|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
28133624|NCT03073200|54797411|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
28133625|NCT03073200|54797412|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
28133626|NCT03073200|54797413|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
28133627|NCT03073200|54797414|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
28133628|NCT03073200|54797415|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
28133629|NCT03073200|54797416|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
28133630|NCT03073200|54797417|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
28133631|NCT03073200|54797418|FG014|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
28133632|NCT03073200|54797404|FG000|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
28133633|NCT03073200|54797405|FG001|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
28133634|NCT03073200|54797406|FG002|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
28133635|NCT03073200|54797407|FG003|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
28133636|NCT03073200|54797408|FG004|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
28133637|NCT03073200|54797409|FG005|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
28133638|NCT03073200|54797410|FG006|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
28133639|NCT03073200|54797411|FG007|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
28133640|NCT03073200|54797412|FG008|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
28133641|NCT03073200|54797413|FG009|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
28133642|NCT03073200|54797414|FG010|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
28133643|NCT03073200|54797415|FG011|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
28133644|NCT03073200|54797416|FG012|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
28133645|NCT03073200|54797417|FG013|Post-Treatment Follow-Up Period|Participant moved to another city|1|||
28133646|NCT03073200|54797418|FG014|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
28133647|NCT03073200|54797404|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
28133648|NCT03073200|54797405|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
28133649|NCT03073200|54797406|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
28133650|NCT03073200|54797407|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
28133651|NCT03073200|54797408|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
28133652|NCT03073200|54797409|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
28133653|NCT03073200|54797410|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
28133654|NCT03073200|54797411|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
28133655|NCT03073200|54797412|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
28069218|NCT00267098|54724282|FG006|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
28133656|NCT03073200|54797413|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
28133657|NCT03073200|54797414|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
27819589|NCT01462695|54279017|FG000|Overall Study|Physician Decision|5|||
27819590|NCT01462695|54279018|FG001|Overall Study|Physician Decision|0|||
27819591|NCT01462695|54279017|FG000|Overall Study|Withdrawal by Subject|2|||
28069219|NCT00267098|54724283|FG007|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
28069220|NCT00267098|54724276|FG000|Overall Study|Site closure|0|||
28069221|NCT00267098|54724277|FG001|Overall Study|Site closure|0|||
28069222|NCT00267098|54724278|FG002|Overall Study|Site closure|0|||
28069223|NCT00267098|54724279|FG003|Overall Study|Site closure|1|||
28069224|NCT00267098|54724280|FG004|Overall Study|Site closure|0|||
28069225|NCT00267098|54724281|FG005|Overall Study|Site closure|1|||
28069226|NCT00267098|54724282|FG006|Overall Study|Site closure|1|||
28069227|NCT00267098|54724283|FG007|Overall Study|Site closure|0|||
28069228|NCT00267098|54724276|FG000|Overall Study|Explanted Medtronic device|0|||
28133658|NCT03073200|54797415|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
28133659|NCT03073200|54797416|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
28133660|NCT03073200|54797417|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
28133661|NCT03073200|54797418|FG014|Post-Treatment Follow-Up Period|Protocol Violation|0|||
28133662|NCT03073200|54797404|FG000|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
28133663|NCT03073200|54797405|FG001|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
27819592|NCT01462695|54279018|FG001|Overall Study|Withdrawal by Subject|0|||
28133664|NCT03073200|54797406|FG002|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
28133665|NCT03073200|54797407|FG003|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
28133666|NCT03073200|54797408|FG004|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
28133667|NCT03073200|54797409|FG005|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
28133668|NCT03073200|54797410|FG006|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
28133669|NCT03073200|54797411|FG007|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
28133670|NCT03073200|54797412|FG008|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
28133671|NCT03073200|54797413|FG009|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
28133672|NCT03073200|54797414|FG010|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
28133673|NCT03073200|54797415|FG011|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
28133674|NCT03073200|54797416|FG012|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
27819593|NCT01462695|54279017|FG000|Overall Study|Inevaluable (did not receive study drug)|1|||
27819594|NCT01462695|54279018|FG001|Overall Study|Inevaluable (did not receive study drug)|0|||
28133675|NCT03073200|54797417|FG013|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
28133676|NCT03073200|54797418|FG014|Post-Treatment Follow-Up Period|Site terminated by sponsor|1|||
28133677|NCT03073200|54797404|FG000|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
28133678|NCT03073200|54797405|FG001|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
28133679|NCT03073200|54797406|FG002|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
28133680|NCT03073200|54797407|FG003|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
28133681|NCT03073200|54797408|FG004|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
28133682|NCT03073200|54797409|FG005|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
28133683|NCT03073200|54797410|FG006|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
28133684|NCT03073200|54797411|FG007|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
28133685|NCT03073200|54797412|FG008|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
28133686|NCT03073200|54797413|FG009|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
28133687|NCT03073200|54797414|FG010|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
28160100|NCT03434379|54830203|FG002|China Extension Period|Death|38|||
27819595|NCT01465347|54279024|FG000|Overall Study|Withdrawal by Subject|1|||
27819596|NCT01465347|54279025|FG001|Overall Study|Withdrawal by Subject|1|||
27819597|NCT01465347|54279024|FG000|Overall Study|Physician Decision|0|||
27819598|NCT01465347|54279025|FG001|Overall Study|Physician Decision|1|||
27819599|NCT01465347|54279024|FG000|Overall Study|Admitted to hospice|0|||
27819600|NCT01465347|54279025|FG001|Overall Study|Admitted to hospice|1|||
27819601|NCT01465191|54279037|FG000|Overall Study|Protocol Violation|6|||
27819602|NCT01465191|54279038|FG001|Overall Study|Protocol Violation|3|||
27819603|NCT01465191|54279039|FG002|Overall Study|Protocol Violation|3|||
27819604|NCT01465191|54279037|FG000|Overall Study|Lost to Follow-up|3|||
27819605|NCT01465191|54279038|FG001|Overall Study|Lost to Follow-up|6|||
27819606|NCT01465191|54279039|FG002|Overall Study|Lost to Follow-up|4|||
27819607|NCT01519947|54279054|FG000|Overall Study|Death|0|||
27819608|NCT01519947|54279055|FG001|Overall Study|Death|0|||
27819609|NCT01519947|54279056|FG002|Overall Study|Death|0|||
27819610|NCT01519947|54279057|FG003|Overall Study|Death|1|||
27819611|NCT01519947|54279054|FG000|Overall Study|Protocol Violation|0|||
27819612|NCT01519947|54279055|FG001|Overall Study|Protocol Violation|0|||
27819613|NCT01519947|54279056|FG002|Overall Study|Protocol Violation|2|||
27819614|NCT01519947|54279057|FG003|Overall Study|Protocol Violation|1|||
27819615|NCT01519947|54279054|FG000|Overall Study|Peritoneal Dialysis Needed|0|||
27819616|NCT01519947|54279055|FG001|Overall Study|Peritoneal Dialysis Needed|1|||
27819617|NCT01519947|54279056|FG002|Overall Study|Peritoneal Dialysis Needed|0|||
27819618|NCT01519947|54279057|FG003|Overall Study|Peritoneal Dialysis Needed|0|||
27819619|NCT01519947|54279054|FG000|Overall Study|Development of Anemia|0|||
27819620|NCT01519947|54279055|FG001|Overall Study|Development of Anemia|1|||
27819621|NCT01519947|54279056|FG002|Overall Study|Development of Anemia|0|||
27819622|NCT01519947|54279057|FG003|Overall Study|Development of Anemia|1|||
27819623|NCT01519947|54279054|FG000|Overall Study|Blood Transfusion|0|||
27819624|NCT01519947|54279055|FG001|Overall Study|Blood Transfusion|1|||
27819625|NCT01519947|54279056|FG002|Overall Study|Blood Transfusion|1|||
27819626|NCT01519947|54279057|FG003|Overall Study|Blood Transfusion|0|||
27819627|NCT01519947|54279054|FG000|Overall Study|Withdrawal by Subject|0|||
27819628|NCT01519947|54279055|FG001|Overall Study|Withdrawal by Subject|1|||
27819629|NCT01519947|54279056|FG002|Overall Study|Withdrawal by Subject|0|||
27819630|NCT01519947|54279057|FG003|Overall Study|Withdrawal by Subject|1|||
27819631|NCT01519947|54279054|FG000|Overall Study|Lost to Follow-up|0|||
27819632|NCT01519947|54279055|FG001|Overall Study|Lost to Follow-up|0|||
27819633|NCT01519947|54279056|FG002|Overall Study|Lost to Follow-up|3|||
28133688|NCT03073200|54797415|FG011|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
28133689|NCT03073200|54797416|FG012|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
28133690|NCT03073200|54797417|FG013|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|11|||
28133691|NCT03073200|54797418|FG014|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
28133692|NCT03073200|54797404|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
27819634|NCT01519947|54279057|FG003|Overall Study|Lost to Follow-up|2|||
27819635|NCT01519947|54279054|FG000|Overall Study|Poor Response|1|||
28133693|NCT03073200|54797405|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
28133694|NCT03073200|54797406|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
27819636|NCT01519947|54279055|FG001|Overall Study|Poor Response|0|||
27819637|NCT01519947|54279056|FG002|Overall Study|Poor Response|0|||
27819638|NCT01519947|54279057|FG003|Overall Study|Poor Response|1|||
27819639|NCT01519947|54279054|FG000|Overall Study|Adverse Event|1|||
28069229|NCT00267098|54724277|FG001|Overall Study|Explanted Medtronic device|0|||
28133695|NCT03073200|54797407|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
28133696|NCT03073200|54797408|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
28133697|NCT03073200|54797409|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
28133698|NCT03073200|54797410|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
28133699|NCT03073200|54797411|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
28133700|NCT03073200|54797412|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
28133701|NCT03073200|54797413|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
28133702|NCT03073200|54797414|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
28133703|NCT03073200|54797415|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
28133704|NCT03073200|54797416|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
28133705|NCT03073200|54797417|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|9|||
27819640|NCT01519947|54279055|FG001|Overall Study|Adverse Event|0|||
27819641|NCT01519947|54279056|FG002|Overall Study|Adverse Event|1|||
28069230|NCT00267098|54724278|FG002|Overall Study|Explanted Medtronic device|0|||
28069231|NCT00267098|54724279|FG003|Overall Study|Explanted Medtronic device|1|||
28069232|NCT00267098|54724280|FG004|Overall Study|Explanted Medtronic device|0|||
28069233|NCT00267098|54724281|FG005|Overall Study|Explanted Medtronic device|0|||
28069234|NCT00267098|54724282|FG006|Overall Study|Explanted Medtronic device|0|||
28069235|NCT00267098|54724283|FG007|Overall Study|Explanted Medtronic device|0|||
28069236|NCT00267098|54724276|FG000|Overall Study|Non-Medtronic LV Lead Implanted|0|||
28069237|NCT00267098|54724277|FG001|Overall Study|Non-Medtronic LV Lead Implanted|0|||
28069238|NCT00267098|54724278|FG002|Overall Study|Non-Medtronic LV Lead Implanted|0|||
28069239|NCT00267098|54724279|FG003|Overall Study|Non-Medtronic LV Lead Implanted|0|||
28069240|NCT00267098|54724280|FG004|Overall Study|Non-Medtronic LV Lead Implanted|2|||
28069241|NCT00267098|54724281|FG005|Overall Study|Non-Medtronic LV Lead Implanted|0|||
28069242|NCT00267098|54724282|FG006|Overall Study|Non-Medtronic LV Lead Implanted|0|||
28069243|NCT00267098|54724283|FG007|Overall Study|Non-Medtronic LV Lead Implanted|0|||
28069244|NCT00267098|54724276|FG000|Overall Study|Subject listed for heart transplant|0|||
28069245|NCT00267098|54724277|FG001|Overall Study|Subject listed for heart transplant|0|||
28069246|NCT00267098|54724278|FG002|Overall Study|Subject listed for heart transplant|0|||
28069247|NCT00267098|54724279|FG003|Overall Study|Subject listed for heart transplant|0|||
28069248|NCT00267098|54724280|FG004|Overall Study|Subject listed for heart transplant|0|||
28069249|NCT00267098|54724281|FG005|Overall Study|Subject listed for heart transplant|0|||
28069250|NCT00267098|54724282|FG006|Overall Study|Subject listed for heart transplant|1|||
28069251|NCT00267098|54724283|FG007|Overall Study|Subject listed for heart transplant|0|||
28069252|NCT00267098|54724276|FG000|Overall Study|Sponsor withdrew subject|0|||
28069253|NCT00267098|54724277|FG001|Overall Study|Sponsor withdrew subject|0|||
28069254|NCT00267098|54724278|FG002|Overall Study|Sponsor withdrew subject|0|||
28069255|NCT00267098|54724279|FG003|Overall Study|Sponsor withdrew subject|1|||
28069256|NCT00267098|54724280|FG004|Overall Study|Sponsor withdrew subject|0|||
28069257|NCT00267098|54724281|FG005|Overall Study|Sponsor withdrew subject|0|||
28069258|NCT00267098|54724282|FG006|Overall Study|Sponsor withdrew subject|0|||
28069259|NCT00267098|54724283|FG007|Overall Study|Sponsor withdrew subject|0|||
28069260|NCT00247676|54724306|FG000|Overall Study|Death|5|||
27819642|NCT01519947|54279057|FG003|Overall Study|Adverse Event|1|||
28069261|NCT00247676|54724306|FG000|Overall Study|Adverse Event|11|||
28069262|NCT00247676|54724306|FG000|Overall Study|Lack of Efficacy|15|||
27819643|NCT01462227|54279069|FG000|Second Assignment|Lost to Follow-up|1|||
27819644|NCT01462227|54279070|FG001|Second Assignment|Lost to Follow-up|0|||
28069263|NCT00247676|54724306|FG000|Overall Study|Other|3|||
28069264|NCT00247676|54724306|FG000|Overall Study|Withdrawal by Subject|2|||
28069265|NCT00267020|54724312|FG000|Overall Study|Adverse Event|22|||
28133706|NCT03073200|54797418|FG014|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
28133707|NCT03073200|54797404|FG000|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
28133708|NCT03073200|54797405|FG001|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
28133709|NCT03073200|54797406|FG002|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
28133710|NCT03073200|54797407|FG003|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
28133711|NCT03073200|54797408|FG004|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
28133712|NCT03073200|54797409|FG005|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
28133713|NCT03073200|54797410|FG006|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
28133714|NCT03073200|54797411|FG007|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
28133715|NCT03073200|54797412|FG008|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
28133716|NCT03073200|54797413|FG009|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
28133717|NCT03073200|54797414|FG010|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
28133718|NCT03073200|54797415|FG011|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
28133719|NCT03073200|54797416|FG012|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
28133720|NCT03073200|54797417|FG013|Post-Treatment Follow-Up Period|Other-determined by Investigator|2|||
28133721|NCT03073200|54797418|FG014|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
28133722|NCT03290781|54797447|FG000|Overall Study|Adverse Event|5|||
28133723|NCT03290781|54797448|FG001|Overall Study|Adverse Event|7|||
28133724|NCT03290781|54797449|FG002|Overall Study|Adverse Event|4|||
28133725|NCT03290781|54797450|FG003|Overall Study|Adverse Event|1|||
28133726|NCT03290781|54797451|FG004|Overall Study|Adverse Event|0|||
28133727|NCT03290781|54797452|FG005|Overall Study|Adverse Event|0|||
28069266|NCT00267020|54724313|FG001|Overall Study|Adverse Event|5|||
28133728|NCT03290781|54797453|FG006|Overall Study|Adverse Event|0|||
28133729|NCT03290781|54797447|FG000|Overall Study|Death|0|||
28133730|NCT03290781|54797448|FG001|Overall Study|Death|0|||
28133731|NCT03290781|54797449|FG002|Overall Study|Death|1|||
28133732|NCT03290781|54797450|FG003|Overall Study|Death|0|||
28133733|NCT03290781|54797451|FG004|Overall Study|Death|1|||
28069267|NCT00267020|54724312|FG000|Overall Study|Death|2|||
28069268|NCT00267020|54724313|FG001|Overall Study|Death|1|||
28069269|NCT00267020|54724312|FG000|Overall Study|Withdrawal by Subject|17|||
28069270|NCT00267020|54724313|FG001|Overall Study|Withdrawal by Subject|7|||
28069271|NCT00267020|54724312|FG000|Overall Study|Physician Decision|3|||
28069272|NCT00267020|54724313|FG001|Overall Study|Physician Decision|2|||
28069273|NCT00267020|54724312|FG000|Overall Study|Disease Progression|39|||
28069274|NCT00267020|54724313|FG001|Overall Study|Disease Progression|25|||
28069275|NCT00267020|54724312|FG000|Overall Study|Unrelated Complication|1|||
28069276|NCT00267020|54724313|FG001|Overall Study|Unrelated Complication|1|||
28069277|NCT00267020|54724312|FG000|Overall Study|Sponsor Request|1|||
28069278|NCT00267020|54724313|FG001|Overall Study|Sponsor Request|0|||
28069279|NCT00267020|54724312|FG000|Overall Study|Other|1|||
28069280|NCT00267020|54724313|FG001|Overall Study|Other|2|||
28069281|NCT00242216|54724321|FG000|Overall Study|Lost to Follow-up|12|||
28069282|NCT00242216|54724322|FG001|Overall Study|Lost to Follow-up|17|||
28069283|NCT00242216|54724321|FG000|Overall Study|Death|4|||
28069284|NCT00242216|54724322|FG001|Overall Study|Death|2|||
28069285|NCT00242216|54724321|FG000|Overall Study|Lack of Efficacy|1|||
28069286|NCT00242216|54724322|FG001|Overall Study|Lack of Efficacy|2|||
28069287|NCT00242216|54724321|FG000|Overall Study|no medicaiton dispensed|1|||
28069288|NCT00242216|54724322|FG001|Overall Study|no medicaiton dispensed|1|||
28069289|NCT00240110|54724330|FG000|Overall Study|Lost to Follow-up|6|||
28069290|NCT00240110|54724331|FG001|Overall Study|Lost to Follow-up|7|||
28069291|NCT00239720|54724341|FG000|Overall Study|Adverse Event|1|||
28133734|NCT03290781|54797452|FG005|Overall Study|Death|0|||
28133735|NCT03290781|54797453|FG006|Overall Study|Death|0|||
28133736|NCT03290781|54797447|FG000|Overall Study|Withdrawal by Subject|6|||
28069292|NCT00239720|54724342|FG001|Overall Study|Adverse Event|0|||
28069293|NCT00239720|54724341|FG000|Overall Study|Lost to Follow-up|0|||
28069294|NCT00239720|54724342|FG001|Overall Study|Lost to Follow-up|1|||
28069295|NCT00266864|54724350|FG000|Overall Study|Lost to Follow-up|4|||
28069296|NCT00266864|54724351|FG001|Overall Study|Lost to Follow-up|1|||
28069297|NCT00266864|54724350|FG000|Overall Study|Withdrawal by Subject|1|||
28069298|NCT00266864|54724351|FG001|Overall Study|Withdrawal by Subject|1|||
28069299|NCT00266708|54724359|FG000|Overall Study|No renal function|1|||
28133737|NCT03290781|54797448|FG001|Overall Study|Withdrawal by Subject|5|||
28133738|NCT03290781|54797449|FG002|Overall Study|Withdrawal by Subject|9|||
28133739|NCT03290781|54797450|FG003|Overall Study|Withdrawal by Subject|10|||
28133740|NCT03290781|54797451|FG004|Overall Study|Withdrawal by Subject|1|||
28133741|NCT03290781|54797452|FG005|Overall Study|Withdrawal by Subject|2|||
28133742|NCT03290781|54797453|FG006|Overall Study|Withdrawal by Subject|0|||
28133743|NCT03290781|54797447|FG000|Overall Study|Physician Decision|0|||
28069300|NCT00266708|54724360|FG001|Overall Study|No renal function|1|||
28069301|NCT00266708|54724359|FG000|Overall Study|Refused biopsy|3|||
28069302|NCT00266708|54724360|FG001|Overall Study|Refused biopsy|6|||
28069303|NCT00266708|54724359|FG000|Overall Study|Asthma|0|||
28069304|NCT00266708|54724360|FG001|Overall Study|Asthma|2|||
28069305|NCT00266630|54724368|FG000|Overall Study|Adverse Event|8|||
28069306|NCT00266630|54724369|FG001|Overall Study|Adverse Event|6|||
28133744|NCT03290781|54797448|FG001|Overall Study|Physician Decision|1|||
27819645|NCT01462227|54279071|FG002|Second Assignment|Lost to Follow-up|0|||
27819646|NCT01462227|54279072|FG003|Second Assignment|Lost to Follow-up|0|||
28069307|NCT00266630|54724368|FG000|Overall Study|Lack of Efficacy|1|||
28069308|NCT00266630|54724369|FG001|Overall Study|Lack of Efficacy|4|||
28069309|NCT00266630|54724368|FG000|Overall Study|Entry Criteria not met|1|||
28069310|NCT00266630|54724369|FG001|Overall Study|Entry Criteria not met|0|||
28133745|NCT03290781|54797449|FG002|Overall Study|Physician Decision|0|||
28069311|NCT00266630|54724368|FG000|Overall Study|Protocol Violation|1|||
27819647|NCT01462227|54279069|FG000|Second Assignment|Protocol Violation|0|||
28069312|NCT00266630|54724369|FG001|Overall Study|Protocol Violation|3|||
28133746|NCT03290781|54797450|FG003|Overall Study|Physician Decision|0|||
28133747|NCT03290781|54797451|FG004|Overall Study|Physician Decision|0|||
28133748|NCT03290781|54797452|FG005|Overall Study|Physician Decision|0|||
28133749|NCT03290781|54797453|FG006|Overall Study|Physician Decision|0|||
28133750|NCT03290781|54797447|FG000|Overall Study|Site Terminated by Sponsor|1|||
28133751|NCT03290781|54797448|FG001|Overall Study|Site Terminated by Sponsor|0|||
28133752|NCT03290781|54797449|FG002|Overall Study|Site Terminated by Sponsor|2|||
28133753|NCT03290781|54797450|FG003|Overall Study|Site Terminated by Sponsor|1|||
28133754|NCT03290781|54797451|FG004|Overall Study|Site Terminated by Sponsor|0|||
28133755|NCT03290781|54797452|FG005|Overall Study|Site Terminated by Sponsor|0|||
28133756|NCT03290781|54797453|FG006|Overall Study|Site Terminated by Sponsor|0|||
28133757|NCT03290781|54797447|FG000|Overall Study|Lost to Follow-up|0|||
28133758|NCT03290781|54797448|FG001|Overall Study|Lost to Follow-up|0|||
28133759|NCT03290781|54797449|FG002|Overall Study|Lost to Follow-up|0|||
28133760|NCT03290781|54797450|FG003|Overall Study|Lost to Follow-up|1|||
28133761|NCT03290781|54797451|FG004|Overall Study|Lost to Follow-up|0|||
28133762|NCT03290781|54797452|FG005|Overall Study|Lost to Follow-up|0|||
27819648|NCT01462227|54279070|FG001|Second Assignment|Protocol Violation|1|||
27819649|NCT01462227|54279071|FG002|Second Assignment|Protocol Violation|1|||
27819650|NCT01462227|54279072|FG003|Second Assignment|Protocol Violation|0|||
27819651|NCT01464879|54279080|FG000|Overall Study|Physician Decision|1|||
27819652|NCT01464879|54279080|FG000|Overall Study|Non-compliance|1|||
27819653|NCT01519869|54279090|FG000|Overall Study|Lost to Follow-up|1|||
27819654|NCT01519791|54279096|FG000|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2|||
27819655|NCT01519791|54279097|FG001|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1|||
27819656|NCT01519791|54279096|FG000|Overall Study|Protocol Violation|6|||
27819657|NCT01519791|54279097|FG001|Overall Study|Protocol Violation|19|||
27819658|NCT01519791|54279096|FG000|Overall Study|Other Reason|87|||
27819659|NCT01519791|54279097|FG001|Overall Study|Other Reason|222|||
27819660|NCT01519791|54279096|FG000|Overall Study|subjects randomized in error|2|||
27819661|NCT01519791|54279097|FG001|Overall Study|subjects randomized in error|0|||
27819662|NCT01519791|54279096|FG000|Overall Study|Lack of Efficacy|16|||
27819663|NCT01519791|54279097|FG001|Overall Study|Lack of Efficacy|20|||
27819664|NCT01519791|54279096|FG000|Overall Study|SAE, non-fatal|6|||
27819665|NCT01519791|54279097|FG001|Overall Study|SAE, non-fatal|22|||
27819666|NCT01519791|54279096|FG000|Overall Study|AE, serious fatal|0|||
27819667|NCT01519791|54279097|FG001|Overall Study|AE, serious fatal|1|||
28069313|NCT00266630|54724368|FG000|Overall Study|Physician Decision|1|||
28069314|NCT00266630|54724369|FG001|Overall Study|Physician Decision|2|||
28069315|NCT00266630|54724368|FG000|Overall Study|Withdrawal by Subject|10|||
28069316|NCT00266630|54724369|FG001|Overall Study|Withdrawal by Subject|2|||
28069317|NCT00266630|54724368|FG000|Overall Study|Lost to Follow-up|1|||
28069318|NCT00266630|54724369|FG001|Overall Study|Lost to Follow-up|0|||
28069319|NCT00266630|54724368|FG000|Overall Study|Other|19|||
28069320|NCT00266630|54724369|FG001|Overall Study|Other|11|||
28069321|NCT00129129|54724380|FG000|Primary Phase|Adverse Event|2|||
27819668|NCT01519791|54279096|FG000|Overall Study|SAE, fatal + SAE, non-fatal|0|||
28069322|NCT00129129|54724381|FG001|Primary Phase|Adverse Event|1|||
28069323|NCT00129129|54724382|FG002|Primary Phase|Adverse Event|0|||
28069324|NCT00129129|54724383|FG003|Primary Phase|Adverse Event|0|||
27819669|NCT01519791|54279097|FG001|Overall Study|SAE, fatal + SAE, non-fatal|1|||
27819670|NCT01519791|54279096|FG000|Overall Study|AE, non-serious non-fatal|12|||
28069325|NCT00129129|54724384|FG004|Primary Phase|Adverse Event|0|||
28133763|NCT03290781|54797453|FG006|Overall Study|Lost to Follow-up|0|||
28133764|NCT03290781|54797447|FG000|Overall Study|Protocol Deviation|2|||
28133765|NCT03290781|54797448|FG001|Overall Study|Protocol Deviation|0|||
28133766|NCT03290781|54797449|FG002|Overall Study|Protocol Deviation|0|||
27819671|NCT01519791|54279097|FG001|Overall Study|AE, non-serious non-fatal|31|||
27819672|NCT01519791|54279096|FG000|Overall Study|Withdrawal by Subject|15|||
27819673|NCT01519791|54279097|FG001|Overall Study|Withdrawal by Subject|37|||
27819674|NCT01519791|54279096|FG000|Overall Study|Lost to Follow-up|6|||
27819675|NCT01519791|54279097|FG001|Overall Study|Lost to Follow-up|14|||
27819676|NCT01461993|54279108|FG000|Overall Study|Withdrawal by Subject|60|||
27819677|NCT01461993|54279109|FG001|Overall Study|Withdrawal by Subject|53|||
27819678|NCT01461993|54279110|FG002|Overall Study|Withdrawal by Subject|16|||
27819679|NCT01461993|54279108|FG000|Overall Study|Lost to Follow-up|44|||
27819680|NCT01461993|54279109|FG001|Overall Study|Lost to Follow-up|48|||
27819681|NCT01461993|54279110|FG002|Overall Study|Lost to Follow-up|22|||
28133767|NCT03290781|54797450|FG003|Overall Study|Protocol Deviation|1|||
28133768|NCT03290781|54797451|FG004|Overall Study|Protocol Deviation|0|||
28133769|NCT03290781|54797452|FG005|Overall Study|Protocol Deviation|0|||
28133770|NCT03290781|54797453|FG006|Overall Study|Protocol Deviation|0|||
28133771|NCT03290781|54797447|FG000|Overall Study|Disease Relapse|32|||
28133772|NCT03290781|54797448|FG001|Overall Study|Disease Relapse|5|||
28133773|NCT03290781|54797449|FG002|Overall Study|Disease Relapse|38|||
28133774|NCT03290781|54797450|FG003|Overall Study|Disease Relapse|7|||
28133775|NCT03290781|54797451|FG004|Overall Study|Disease Relapse|3|||
28133776|NCT03290781|54797452|FG005|Overall Study|Disease Relapse|1|||
28133777|NCT03290781|54797453|FG006|Overall Study|Disease Relapse|4|||
28133778|NCT03290781|54797447|FG000|Overall Study|Other|3|||
28133779|NCT03290781|54797448|FG001|Overall Study|Other|0|||
28133780|NCT03290781|54797449|FG002|Overall Study|Other|2|||
28133781|NCT03290781|54797450|FG003|Overall Study|Other|2|||
28133782|NCT03290781|54797451|FG004|Overall Study|Other|0|||
28133783|NCT03290781|54797452|FG005|Overall Study|Other|0|||
28133784|NCT03290781|54797453|FG006|Overall Study|Other|0|||
28133785|NCT03466073|54797482|FG000|Overall Study|Death|1|||
28133786|NCT03466073|54797483|FG001|Overall Study|Death|0|||
28133787|NCT03466073|54797484|FG002|Overall Study|Death|0|||
28133788|NCT03466073|54797485|FG003|Overall Study|Death|0|||
28133789|NCT03466073|54797486|FG004|Overall Study|Death|0|||
28133790|NCT03466073|54797487|FG005|Overall Study|Death|1|||
28133791|NCT03412019|54797510|FG000|Overall Study|Withdrawal by Subject|1|||
28133792|NCT03412019|54797511|FG001|Overall Study|Withdrawal by Subject|1|||
28133793|NCT03070002|54797517|FG000|Follow up for 2 Years|Death|1|||
28133794|NCT02918318|54797525|FG000|Double-blind Induction Phase: 4 Weeks|Adverse Event|1|||
28133795|NCT02918318|54797526|FG001|Double-blind Induction Phase: 4 Weeks|Adverse Event|4|||
27819682|NCT01461993|54279108|FG000|Overall Study|Protocol Violation|10|||
27819683|NCT01461993|54279109|FG001|Overall Study|Protocol Violation|9|||
27819684|NCT01461993|54279110|FG002|Overall Study|Protocol Violation|7|||
27819685|NCT01461993|54279108|FG000|Overall Study|Adverse Event|9|||
27819686|NCT01461993|54279109|FG001|Overall Study|Adverse Event|11|||
27819687|NCT01461993|54279110|FG002|Overall Study|Adverse Event|3|||
27819688|NCT01461993|54279108|FG000|Overall Study|No longer met eligibility criteria|13|||
27819689|NCT01461993|54279109|FG001|Overall Study|No longer met eligibility criteria|18|||
27819690|NCT01461993|54279110|FG002|Overall Study|No longer met eligibility criteria|10|||
27819691|NCT01461993|54279108|FG000|Overall Study|Did not meet entrance criteria|2|||
27819692|NCT01461993|54279109|FG001|Overall Study|Did not meet entrance criteria|3|||
27819693|NCT01461993|54279110|FG002|Overall Study|Did not meet entrance criteria|0|||
27819694|NCT01461993|54279108|FG000|Overall Study|Other|13|||
27819695|NCT01461993|54279109|FG001|Overall Study|Other|15|||
27819696|NCT01461993|54279110|FG002|Overall Study|Other|6|||
27819697|NCT01782326|54279121|FG000|Planned Treatment Epoch|Subject/guardian decision|149|||
27819698|NCT01782326|54279122|FG001|Planned Treatment Epoch|Subject/guardian decision|151|||
27819699|NCT01782326|54279121|FG000|Planned Treatment Epoch|Death|29|||
27819700|NCT01782326|54279122|FG001|Planned Treatment Epoch|Death|30|||
27819701|NCT01782326|54279121|FG000|Planned Treatment Epoch|Physician Decision|18|||
27819702|NCT01782326|54279122|FG001|Planned Treatment Epoch|Physician Decision|16|||
27819703|NCT01782326|54279121|FG000|Planned Treatment Epoch|Protocol deviation|2|||
27819704|NCT01782326|54279122|FG001|Planned Treatment Epoch|Protocol deviation|3|||
27940991|NCT01020981|54597311|FG001|Overall Study|Participant declined to complete survey|0|||
27940992|NCT01020747|54597319|FG000|Overall Study|Withdrawal by Subject|1|||
27940993|NCT01020435|54597326|FG000|Overall Study|Lost to Follow-up|0|||
27940994|NCT01020435|54597327|FG001|Overall Study|Lost to Follow-up|1|||
27940995|NCT01031979|54597336|FG000|Overall Study|Lost to Follow-up|5|||
27940996|NCT01031979|54597337|FG001|Overall Study|Lost to Follow-up|4|||
27940997|NCT01020123|54597350|FG000|Main Period|Withdrawal by Subject|6|||
28133796|NCT02918318|54797527|FG002|Double-blind Induction Phase: 4 Weeks|Adverse Event|2|||
28133797|NCT02918318|54797528|FG003|Double-blind Induction Phase: 4 Weeks|Adverse Event|3|||
28133798|NCT02918318|54797529|FG004|Double-blind Induction Phase: 4 Weeks|Adverse Event|0|||
28133799|NCT02918318|54797525|FG000|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
28133800|NCT02918318|54797526|FG001|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
28133801|NCT02918318|54797527|FG002|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
28133802|NCT02918318|54797528|FG003|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2|||
27819705|NCT01782326|54279121|FG000|Planned Treatment Epoch|Lost to Follow-up|4|||
27819706|NCT01782326|54279122|FG001|Planned Treatment Epoch|Lost to Follow-up|4|||
27819707|NCT01782326|54279121|FG000|Planned Treatment Epoch|Technical problems|0|||
27819708|NCT01782326|54279122|FG001|Planned Treatment Epoch|Technical problems|4|||
27819709|NCT01782326|54279121|FG000|Double-blind Treatment|Adverse Event|129|||
27819710|NCT01782326|54279122|FG001|Double-blind Treatment|Adverse Event|145|||
28069326|NCT00129129|54724380|FG000|Primary Phase|Withdrawal by Subject|12|||
28133803|NCT02918318|54797529|FG004|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
28133804|NCT02918318|54797525|FG000|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
28133805|NCT02918318|54797526|FG001|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
28133806|NCT02918318|54797527|FG002|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
28133807|NCT02918318|54797528|FG003|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1|||
28133808|NCT02918318|54797529|FG004|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
28133809|NCT02918318|54797525|FG000|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
28133810|NCT02918318|54797526|FG001|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
28133811|NCT02918318|54797527|FG002|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
28133812|NCT02918318|54797528|FG003|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
28133813|NCT02918318|54797529|FG004|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
27849785|NCT00631163|54347609|FG000|Number of Participants in Year 2|Abnormal laboratory value|1|||
28133814|NCT02918318|54797525|FG000|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
28133815|NCT02918318|54797526|FG001|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
28133816|NCT02918318|54797527|FG002|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
28133817|NCT02918318|54797528|FG003|Double-blind Induction Phase: 4 Weeks|Non-compliance|1|||
28133818|NCT02918318|54797529|FG004|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
28133819|NCT02918318|54797525|FG000|Double-blind Induction Phase: 4 Weeks|Other|0|||
28133820|NCT02918318|54797526|FG001|Double-blind Induction Phase: 4 Weeks|Other|2|||
28133821|NCT02918318|54797527|FG002|Double-blind Induction Phase: 4 Weeks|Other|0|||
28133822|NCT02918318|54797528|FG003|Double-blind Induction Phase: 4 Weeks|Other|1|||
28133823|NCT02918318|54797529|FG004|Double-blind Induction Phase: 4 Weeks|Other|0|||
28133824|NCT02918318|54797525|FG000|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
28133825|NCT02918318|54797526|FG001|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
28133826|NCT02918318|54797527|FG002|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
28133827|NCT02918318|54797528|FG003|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2|||
28133828|NCT02918318|54797529|FG004|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
28133829|NCT02918318|54797525|FG000|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
28133830|NCT02918318|54797526|FG001|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
28133831|NCT02918318|54797527|FG002|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
28133832|NCT02918318|54797528|FG003|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
28133833|NCT02918318|54797529|FG004|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
28133834|NCT02918318|54797525|FG000|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
28133835|NCT02918318|54797526|FG001|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
28133836|NCT02918318|54797527|FG002|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
28133837|NCT02918318|54797528|FG003|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
28069327|NCT00129129|54724381|FG001|Primary Phase|Withdrawal by Subject|10|||
28069328|NCT00129129|54724382|FG002|Primary Phase|Withdrawal by Subject|0|||
28069329|NCT00129129|54724383|FG003|Primary Phase|Withdrawal by Subject|0|||
28069330|NCT00129129|54724384|FG004|Primary Phase|Withdrawal by Subject|0|||
28069331|NCT00129129|54724380|FG000|Primary Phase|Migration from study area|1|||
28069332|NCT00129129|54724381|FG001|Primary Phase|Migration from study area|3|||
28069333|NCT00129129|54724382|FG002|Primary Phase|Migration from study area|0|||
28069334|NCT00129129|54724383|FG003|Primary Phase|Migration from study area|0|||
28069335|NCT00129129|54724384|FG004|Primary Phase|Migration from study area|0|||
28069336|NCT00129129|54724380|FG000|Primary Phase|Lost to Follow-up|8|||
28069337|NCT00129129|54724381|FG001|Primary Phase|Lost to Follow-up|6|||
28069338|NCT00129129|54724382|FG002|Primary Phase|Lost to Follow-up|0|||
28069339|NCT00129129|54724383|FG003|Primary Phase|Lost to Follow-up|0|||
28069340|NCT00129129|54724384|FG004|Primary Phase|Lost to Follow-up|0|||
28069341|NCT00129129|54724380|FG000|Primary Phase|Other|2|||
28069342|NCT00129129|54724381|FG001|Primary Phase|Other|5|||
28069343|NCT00129129|54724382|FG002|Primary Phase|Other|0|||
28133838|NCT02918318|54797529|FG004|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
28133839|NCT02918318|54797525|FG000|Posttreatment Phase: Up to 24 Weeks|Other|0|||
28133840|NCT02918318|54797526|FG001|Posttreatment Phase: Up to 24 Weeks|Other|3|||
27819711|NCT01782326|54279121|FG000|Double-blind Treatment|Subject/guardian decision|111|||
28069344|NCT00129129|54724383|FG003|Primary Phase|Other|0|||
28133841|NCT02918318|54797527|FG002|Posttreatment Phase: Up to 24 Weeks|Other|1|||
28133842|NCT02918318|54797528|FG003|Posttreatment Phase: Up to 24 Weeks|Other|1|||
28133843|NCT02918318|54797529|FG004|Posttreatment Phase: Up to 24 Weeks|Other|0|||
28069345|NCT00129129|54724384|FG004|Primary Phase|Other|0|||
28133844|NCT02918318|54797525|FG000|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
28133845|NCT02918318|54797526|FG001|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
28133846|NCT02918318|54797527|FG002|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
28133847|NCT02918318|54797528|FG003|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
28133848|NCT02918318|54797529|FG004|Open Label Treatment Phase: 4 Weeks|Adverse Event|1|||
28133849|NCT02918318|54797525|FG000|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
28133850|NCT02918318|54797526|FG001|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
27819712|NCT01782326|54279122|FG001|Double-blind Treatment|Subject/guardian decision|125|||
27819713|NCT01782326|54279121|FG000|Double-blind Treatment|Lack of Efficacy|17|||
27819714|NCT01782326|54279122|FG001|Double-blind Treatment|Lack of Efficacy|22|||
27819715|NCT01782326|54279121|FG000|Double-blind Treatment|Physician Decision|13|||
27819716|NCT01782326|54279122|FG001|Double-blind Treatment|Physician Decision|16|||
28133851|NCT02918318|54797527|FG002|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
28133852|NCT02918318|54797528|FG003|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
27819717|NCT01782326|54279121|FG000|Double-blind Treatment|Protocol deviation|8|||
27819718|NCT01782326|54279122|FG001|Double-blind Treatment|Protocol deviation|7|||
28133853|NCT02918318|54797529|FG004|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1|||
28133854|NCT03411863|54797574|FG000|Overall Study|Withdrawal by Subject|3|||
28133855|NCT03411863|54797575|FG001|Overall Study|Withdrawal by Subject|1|||
28133856|NCT03411863|54797574|FG000|Overall Study|Physician Decision|0|||
28133857|NCT03411863|54797575|FG001|Overall Study|Physician Decision|1|||
28133858|NCT01065350|54797584|FG000|Overall Study|Received incorrect drug allocation|0|||
28133859|NCT01065350|54797585|FG001|Overall Study|Received incorrect drug allocation|1|||
28133860|NCT03434249|54797593|FG000|Overall Study|Adverse Event|1|||
28133861|NCT03434249|54797594|FG001|Overall Study|Adverse Event|0|||
28133862|NCT03434249|54797593|FG000|Overall Study|Lost to Follow-up|0|||
28133863|NCT03434249|54797594|FG001|Overall Study|Lost to Follow-up|1|||
28133864|NCT03434249|54797593|FG000|Overall Study|Non-compliance of family|2|||
28133865|NCT03434249|54797594|FG001|Overall Study|Non-compliance of family|1|||
27819719|NCT01782326|54279121|FG000|Double-blind Treatment|Technical problems|0|||
27819720|NCT01782326|54279122|FG001|Double-blind Treatment|Technical problems|5|||
27819721|NCT01439373|54279130|FG000|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0|||
27819722|NCT01439373|54279131|FG001|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1|||
27819723|NCT01439373|54279130|FG000|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2|||
27819724|NCT01439373|54279131|FG001|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0|||
27819725|NCT01461369|54279144|FG000|Overall Study|Lack of Efficacy|2|||
27819726|NCT01461369|54279145|FG001|Overall Study|Lack of Efficacy|0|||
27819727|NCT01461369|54279146|FG002|Overall Study|Lack of Efficacy|6|||
27819728|NCT01461369|54279144|FG000|Overall Study|Lost to Follow-up|0|||
27819729|NCT01461369|54279145|FG001|Overall Study|Lost to Follow-up|0|||
27819730|NCT01461369|54279146|FG002|Overall Study|Lost to Follow-up|3|||
28133866|NCT03434249|54797593|FG000|Overall Study|Difficulties in completing daily diary|2|||
28133867|NCT03434249|54797594|FG001|Overall Study|Difficulties in completing daily diary|1|||
28133868|NCT03114969|54797609|FG000|Overall Study|Lost to Follow-up|0|||
28133869|NCT03114969|54797610|FG001|Overall Study|Lost to Follow-up|0|||
28133870|NCT03114969|54797611|FG002|Overall Study|Lost to Follow-up|3|||
28133871|NCT03114969|54797612|FG003|Overall Study|Lost to Follow-up|2|||
28133872|NCT03114969|54797613|FG004|Overall Study|Lost to Follow-up|0|||
28133873|NCT03114969|54797614|FG005|Overall Study|Lost to Follow-up|0|||
28133874|NCT03114969|54797615|FG006|Overall Study|Lost to Follow-up|0|||
28133875|NCT03114969|54797616|FG007|Overall Study|Lost to Follow-up|0|||
27819731|NCT01461369|54279144|FG000|Overall Study|Adverse Event|9|||
27819732|NCT01461369|54279145|FG001|Overall Study|Adverse Event|12|||
27819733|NCT01461369|54279146|FG002|Overall Study|Adverse Event|4|||
27819734|NCT01461369|54279144|FG000|Overall Study|Protocol Violation|1|||
27819735|NCT01461369|54279145|FG001|Overall Study|Protocol Violation|2|||
28133876|NCT03114969|54797617|FG008|Overall Study|Lost to Follow-up|0|||
28133877|NCT03114969|54797609|FG000|Overall Study|Adverse Event|0|||
28133878|NCT03114969|54797610|FG001|Overall Study|Adverse Event|0|||
28133879|NCT03114969|54797611|FG002|Overall Study|Adverse Event|1|||
28133880|NCT03114969|54797612|FG003|Overall Study|Adverse Event|0|||
28133881|NCT03114969|54797613|FG004|Overall Study|Adverse Event|0|||
28133882|NCT03114969|54797614|FG005|Overall Study|Adverse Event|1|||
28133883|NCT03114969|54797615|FG006|Overall Study|Adverse Event|1|||
28133884|NCT03114969|54797616|FG007|Overall Study|Adverse Event|0|||
28133885|NCT03114969|54797617|FG008|Overall Study|Adverse Event|2|||
28133886|NCT02046096|54797646|FG000|Overall Study|Death|28|||
28133887|NCT02046096|54797647|FG001|Overall Study|Death|45|||
28133888|NCT02046096|54797646|FG000|Overall Study|Lost to Follow-up|9|||
28133889|NCT02046096|54797647|FG001|Overall Study|Lost to Follow-up|20|||
27819736|NCT01461369|54279146|FG002|Overall Study|Protocol Violation|2|||
27819737|NCT01461369|54279144|FG000|Overall Study|Withdrawal by Subject|1|||
28069346|NCT00129129|54724380|FG000|Fourth Dose Phase|Lost to Follow-up|4|||
28069347|NCT00129129|54724381|FG001|Fourth Dose Phase|Lost to Follow-up|0|||
28069348|NCT00129129|54724382|FG002|Fourth Dose Phase|Lost to Follow-up|0|||
28069349|NCT00129129|54724383|FG003|Fourth Dose Phase|Lost to Follow-up|2|||
28069350|NCT00129129|54724384|FG004|Fourth Dose Phase|Lost to Follow-up|2|||
28069351|NCT00129129|54724380|FG000|Fourth Dose Phase|Withdrawal by Subject|0|||
28069352|NCT00129129|54724381|FG001|Fourth Dose Phase|Withdrawal by Subject|0|||
28069353|NCT00129129|54724382|FG002|Fourth Dose Phase|Withdrawal by Subject|0|||
28069354|NCT00129129|54724383|FG003|Fourth Dose Phase|Withdrawal by Subject|0|||
28069355|NCT00129129|54724384|FG004|Fourth Dose Phase|Withdrawal by Subject|1|||
28069356|NCT00129129|54724380|FG000|Fourth Dose Phase|Migration from study area|0|||
28069357|NCT00129129|54724381|FG001|Fourth Dose Phase|Migration from study area|0|||
28069358|NCT00129129|54724382|FG002|Fourth Dose Phase|Migration from study area|0|||
28069359|NCT00129129|54724383|FG003|Fourth Dose Phase|Migration from study area|0|||
28069360|NCT00129129|54724384|FG004|Fourth Dose Phase|Migration from study area|2|||
28069361|NCT00129129|54724380|FG000|Fourth Dose Phase|Other|0|||
28069362|NCT00129129|54724381|FG001|Fourth Dose Phase|Other|0|||
28069363|NCT00129129|54724382|FG002|Fourth Dose Phase|Other|0|||
28069364|NCT00129129|54724383|FG003|Fourth Dose Phase|Other|1|||
28069365|NCT00129129|54724384|FG004|Fourth Dose Phase|Other|1|||
28069366|NCT00129129|54724380|FG000|Fourth Dose Phase|Protocol Violation|0|||
28069367|NCT00129129|54724381|FG001|Fourth Dose Phase|Protocol Violation|0|||
28069368|NCT00129129|54724382|FG002|Fourth Dose Phase|Protocol Violation|0|||
28069369|NCT00129129|54724383|FG003|Fourth Dose Phase|Protocol Violation|1|||
28069370|NCT00129129|54724384|FG004|Fourth Dose Phase|Protocol Violation|0|||
28069371|NCT00221403|54724407|FG000|Overall Study|Protocol Violation|1|||
28069372|NCT00221403|54724408|FG001|Overall Study|Protocol Violation|0|||
28069373|NCT00221403|54724409|FG002|Overall Study|Protocol Violation|0|||
28069374|NCT00221403|54724407|FG000|Overall Study|Physician Decision|1|||
28069375|NCT00221403|54724408|FG001|Overall Study|Physician Decision|0|||
28069376|NCT00221403|54724409|FG002|Overall Study|Physician Decision|0|||
28069377|NCT00221403|54724407|FG000|Overall Study|Withdrawal by Subject|0|||
28069378|NCT00221403|54724408|FG001|Overall Study|Withdrawal by Subject|3|||
28069379|NCT00221403|54724409|FG002|Overall Study|Withdrawal by Subject|0|||
28069380|NCT00221403|54724407|FG000|Overall Study|Lack of Efficacy|0|||
28069381|NCT00221403|54724408|FG001|Overall Study|Lack of Efficacy|1|||
28069382|NCT00221403|54724409|FG002|Overall Study|Lack of Efficacy|0|||
28069383|NCT00221403|54724407|FG000|Overall Study|Adverse Event|0|||
28069384|NCT00221403|54724408|FG001|Overall Study|Adverse Event|1|||
28069385|NCT00221403|54724409|FG002|Overall Study|Adverse Event|0|||
28069386|NCT00145977|54724419|FG000|Overall Study|Lack of Efficacy|0|||
28069387|NCT00145977|54724420|FG001|Overall Study|Lack of Efficacy|4|||
28069388|NCT00145977|54724419|FG000|Overall Study|Lost to Follow-up|1|||
28069389|NCT00145977|54724420|FG001|Overall Study|Lost to Follow-up|0|||
28069390|NCT00145977|54724419|FG000|Overall Study|Withdrawal by Subject|1|||
28069391|NCT00145977|54724420|FG001|Overall Study|Withdrawal by Subject|0|||
28133890|NCT02046096|54797646|FG000|Overall Study|Withdrawal by Subject|5|||
28133891|NCT02046096|54797647|FG001|Overall Study|Withdrawal by Subject|17|||
28133892|NCT02046096|54797646|FG000|Overall Study|Other endpoint|2|||
28133893|NCT02046096|54797647|FG001|Overall Study|Other endpoint|19|||
28133894|NCT03463577|54797661|FG000|Overall Study|Lost to Follow-up|238|||
28133895|NCT03463577|54797662|FG001|Overall Study|Lost to Follow-up|435|||
27819738|NCT01461369|54279145|FG001|Overall Study|Withdrawal by Subject|3|||
28133896|NCT03463577|54797663|FG002|Overall Study|Lost to Follow-up|0|||
28133897|NCT03463577|54797664|FG003|Overall Study|Lost to Follow-up|0|||
28133898|NCT03463577|54797665|FG004|Overall Study|Lost to Follow-up|0|||
28133899|NCT03463577|54797666|FG005|Overall Study|Lost to Follow-up|0|||
28133900|NCT03463577|54797661|FG000|Overall Study|With unknown pregnancy outcome|0|||
28133901|NCT03463577|54797662|FG001|Overall Study|With unknown pregnancy outcome|5|||
28133902|NCT03463577|54797663|FG002|Overall Study|With unknown pregnancy outcome|0|||
27819739|NCT01461369|54279146|FG002|Overall Study|Withdrawal by Subject|2|||
27819740|NCT01727258|54279157|FG000|Overall Study|Adverse Event|0|||
27819741|NCT01727258|54279158|FG001|Overall Study|Adverse Event|2|||
27819742|NCT01727258|54279159|FG002|Overall Study|Adverse Event|0|||
27819743|NCT01727258|54279157|FG000|Overall Study|Noncompliance with Study Drug|0|||
27819744|NCT01727258|54279158|FG001|Overall Study|Noncompliance with Study Drug|0|||
27819745|NCT01727258|54279159|FG002|Overall Study|Noncompliance with Study Drug|1|||
27819746|NCT01727258|54279157|FG000|Overall Study|Withdrawal by Subject|1|||
27819747|NCT01727258|54279158|FG001|Overall Study|Withdrawal by Subject|1|||
27819748|NCT01727258|54279159|FG002|Overall Study|Withdrawal by Subject|0|||
27849786|NCT00631007|54347626|FG000|Overall Study|Adverse Event|0|||
28133903|NCT03463577|54797664|FG003|Overall Study|With unknown pregnancy outcome|0|||
28133904|NCT03463577|54797665|FG004|Overall Study|With unknown pregnancy outcome|0|||
28133905|NCT03463577|54797666|FG005|Overall Study|With unknown pregnancy outcome|0|||
28133906|NCT03463577|54797661|FG000|Overall Study|Maternal death|2|||
28133907|NCT03463577|54797662|FG001|Overall Study|Maternal death|0|||
28133908|NCT03463577|54797663|FG002|Overall Study|Maternal death|0|||
28133909|NCT03463577|54797664|FG003|Overall Study|Maternal death|0|||
28133910|NCT03463577|54797665|FG004|Overall Study|Maternal death|0|||
28133911|NCT03463577|54797666|FG005|Overall Study|Maternal death|0|||
28133912|NCT03463577|54797661|FG000|Overall Study|Neonatal death|0|||
28133913|NCT03463577|54797662|FG001|Overall Study|Neonatal death|0|||
28133914|NCT03463577|54797663|FG002|Overall Study|Neonatal death|0|||
28133915|NCT03463577|54797664|FG003|Overall Study|Neonatal death|15|||
28133916|NCT03463577|54797665|FG004|Overall Study|Neonatal death|17|||
28133917|NCT03463577|54797666|FG005|Overall Study|Neonatal death|0|||
28133918|NCT03122145|54797682|FG000|Overall Study|Concurrent respiratory disease|3|||
28133919|NCT03122145|54797683|FG001|Overall Study|Concurrent respiratory disease|0|||
28133920|NCT03114657|54797691|FG000|Overall Study|Adverse Event|9|||
28133921|NCT03114657|54797692|FG001|Overall Study|Adverse Event|6|||
28133922|NCT03114657|54797691|FG000|Overall Study|Death|4|||
28133923|NCT03114657|54797692|FG001|Overall Study|Death|0|||
28133924|NCT03114657|54797691|FG000|Overall Study|Multiple Reasons|1|||
28133925|NCT03114657|54797692|FG001|Overall Study|Multiple Reasons|2|||
28133926|NCT03114657|54797691|FG000|Overall Study|Physician Decision|2|||
28133927|NCT03114657|54797692|FG001|Overall Study|Physician Decision|2|||
28133928|NCT03114657|54797691|FG000|Overall Study|Study Terminated By Sponsor|355|||
28133929|NCT03114657|54797692|FG001|Overall Study|Study Terminated By Sponsor|374|||
28133930|NCT03114657|54797691|FG000|Overall Study|Symptomatic Deterioration|0|||
28133931|NCT03114657|54797692|FG001|Overall Study|Symptomatic Deterioration|1|||
28133932|NCT03114657|54797691|FG000|Overall Study|Withdrawal by Subject|28|||
28133933|NCT03114657|54797692|FG001|Overall Study|Withdrawal by Subject|22|||
28133934|NCT02926950|54797701|FG000|Overall Study|Adverse Event|4|||
28133935|NCT02926950|54797702|FG001|Overall Study|Adverse Event|6|||
28133936|NCT02926950|54797701|FG000|Overall Study|At the participant's own request|21|||
28133937|NCT02926950|54797702|FG001|Overall Study|At the participant's own request|25|||
28133938|NCT02926950|54797701|FG000|Overall Study|Reason not Specified|17|||
28133939|NCT02926950|54797702|FG001|Overall Study|Reason not Specified|9|||
28133940|NCT02926950|54797701|FG000|Overall Study|Lost to Follow-up|7|||
28133941|NCT02926950|54797702|FG001|Overall Study|Lost to Follow-up|8|||
28133942|NCT03410693|54797711|FG000|Overall Study|Disc trt: Withdrawal by participant|6|||
28133943|NCT03410693|54797712|FG001|Overall Study|Disc trt: Withdrawal by participant|4|||
28133944|NCT03410693|54797711|FG000|Overall Study|Disc trt: Lost to follow up|0|||
27819749|NCT01727258|54279157|FG000|Overall Study|Lost to Follow-up|1|||
27819750|NCT01727258|54279158|FG001|Overall Study|Lost to Follow-up|0|||
27819751|NCT01727258|54279159|FG002|Overall Study|Lost to Follow-up|0|||
27819752|NCT01781390|54279170|FG000|Overall Study|Withdrawal of Consent|0|||
27819753|NCT01781390|54279171|FG001|Overall Study|Withdrawal of Consent|3|||
28133945|NCT03410693|54797712|FG001|Overall Study|Disc trt: Lost to follow up|1|||
27819754|NCT01781390|54279172|FG002|Overall Study|Withdrawal of Consent|1|||
28133946|NCT03410693|54797711|FG000|Overall Study|Disc trt: radiological progression|58|||
28133947|NCT03410693|54797712|FG001|Overall Study|Disc trt: radiological progression|50|||
28133948|NCT03410693|54797711|FG000|Overall Study|Disc trt: Other|1|||
28133949|NCT03410693|54797712|FG001|Overall Study|Disc trt: Other|0|||
28133950|NCT03410693|54797711|FG000|Overall Study|Study drug never administered|1|||
28133951|NCT03410693|54797712|FG001|Overall Study|Study drug never administered|6|||
28133952|NCT03410693|54797711|FG000|Overall Study|Discontinued (disc) treatment (trt): Death|6|||
28133953|NCT03410693|54797712|FG001|Overall Study|Discontinued (disc) treatment (trt): Death|4|||
28133954|NCT03410693|54797711|FG000|Overall Study|Disc trt: Adverse Event (AE)|13|||
28133955|NCT03410693|54797712|FG001|Overall Study|Disc trt: Adverse Event (AE)|9|||
28133956|NCT03410693|54797711|FG000|Overall Study|Disc trt: Physician decision|0|||
28133957|NCT03410693|54797712|FG001|Overall Study|Disc trt: Physician decision|5|||
28133958|NCT03410693|54797711|FG000|Overall Study|Disc trt: clinical progression|1|||
28133959|NCT03410693|54797712|FG001|Overall Study|Disc trt: clinical progression|5|||
28133960|NCT03410693|54797711|FG000|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|1|||
28133961|NCT03410693|54797712|FG001|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|4|||
28133962|NCT01064414|54797727|FG000|Core Period: Baseline to Week 26|Adverse Event|4|||
28133963|NCT01064414|54797728|FG001|Core Period: Baseline to Week 26|Adverse Event|4|||
28133964|NCT01064414|54797729|FG002|Core Period: Baseline to Week 26|Adverse Event|2|||
28133965|NCT01064414|54797727|FG000|Core Period: Baseline to Week 26|Death|0|||
28133966|NCT01064414|54797728|FG001|Core Period: Baseline to Week 26|Death|1|||
28133967|NCT01064414|54797729|FG002|Core Period: Baseline to Week 26|Death|0|||
28133968|NCT01064414|54797727|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
28133969|NCT01064414|54797728|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
28133970|NCT01064414|54797729|FG002|Core Period: Baseline to Week 26|Protocol Violation|1|||
28133971|NCT01064414|54797727|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
28133972|NCT01064414|54797728|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
28133973|NCT01064414|54797729|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
28133974|NCT01064414|54797727|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
28133975|NCT01064414|54797728|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
28133976|NCT01064414|54797729|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
28133977|NCT01064414|54797727|FG000|Core Period: Baseline to Week 26|Other|4|||
28133978|NCT01064414|54797728|FG001|Core Period: Baseline to Week 26|Other|7|||
28133979|NCT01064414|54797729|FG002|Core Period: Baseline to Week 26|Other|2|||
28133980|NCT01064414|54797727|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
28133981|NCT01064414|54797728|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
28133982|NCT01064414|54797729|FG002|Extension Period: Week 26 to Week 52|Adverse Event|2|||
28133983|NCT01064414|54797727|FG000|Extension Period: Week 26 to Week 52|Death|0|||
28133984|NCT01064414|54797728|FG001|Extension Period: Week 26 to Week 52|Death|1|||
28133985|NCT01064414|54797729|FG002|Extension Period: Week 26 to Week 52|Death|0|||
28133986|NCT01064414|54797727|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
28133987|NCT01064414|54797728|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
28133988|NCT01064414|54797729|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
28133989|NCT01064414|54797727|FG000|Extension Period: Week 26 to Week 52|Physician Decision|1|||
28133990|NCT01064414|54797728|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
28133991|NCT01064414|54797729|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
28133992|NCT01064414|54797727|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
28133993|NCT01064414|54797728|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
28133994|NCT01064414|54797729|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
28133995|NCT01064414|54797727|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
28133996|NCT01064414|54797728|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
28133997|NCT01064414|54797729|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
28133998|NCT01064414|54797727|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
28133999|NCT01064414|54797728|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
28134000|NCT01064414|54797729|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
28134001|NCT01064414|54797727|FG000|Extension Period: Week 26 to Week 52|Other|5|||
28134002|NCT01064414|54797728|FG001|Extension Period: Week 26 to Week 52|Other|2|||
28134003|NCT01064414|54797729|FG002|Extension Period: Week 26 to Week 52|Other|1|||
28134004|NCT03433703|54797740|FG000|Overall Study|Study terminated by Sponsor|2|||
28134005|NCT03463031|54797750|FG000|Overall Study|Withdrawal by Subject|4|||
28134006|NCT03463031|54797751|FG001|Overall Study|Withdrawal by Subject|2|||
28160101|NCT03434379|54830204|FG003|China Extension Period|Death|61|||
28134007|NCT03463031|54797750|FG000|Overall Study|Investigator/Sponsor Decision|0|||
28134008|NCT03463031|54797751|FG001|Overall Study|Investigator/Sponsor Decision|1|||
28134009|NCT03463031|54797750|FG000|Overall Study|Lost to Follow-up|1|||
28134010|NCT03463031|54797751|FG001|Overall Study|Lost to Follow-up|1|||
28134011|NCT03463031|54797750|FG000|Overall Study|Adverse Event|4|||
28069392|NCT00238238|54724429|FG000|Overall Study|Withdrawal by Subject|0|||
28069393|NCT00238238|54724430|FG001|Overall Study|Withdrawal by Subject|3|||
28069394|NCT00238238|54724431|FG002|Overall Study|Withdrawal by Subject|0|||
28069395|NCT00128661|54724441|FG000|Overall Study|Adverse Event|14|||
28069396|NCT00128661|54724442|FG001|Overall Study|Adverse Event|11|||
28069397|NCT00128661|54724441|FG000|Overall Study|Lost to Follow-up|10|||
28069398|NCT00128661|54724442|FG001|Overall Study|Lost to Follow-up|7|||
28069399|NCT00128661|54724441|FG000|Overall Study|Withdrawal by Subject|243|||
28069400|NCT00128661|54724442|FG001|Overall Study|Withdrawal by Subject|232|||
28069401|NCT00128661|54724441|FG000|Overall Study|Other|7|||
28069402|NCT00128661|54724442|FG001|Overall Study|Other|8|||
28069403|NCT00145509|54724450|FG000|Overall Study|Adverse Event|10|||
28069404|NCT00145509|54724451|FG001|Overall Study|Adverse Event|3|||
28069405|NCT00145509|54724450|FG000|Overall Study|Lack of Efficacy|3|||
27819755|NCT01781390|54279170|FG000|Overall Study|Lost to Follow-up|1|||
28134012|NCT03463031|54797751|FG001|Overall Study|Adverse Event|1|||
28134013|NCT03463031|54797750|FG000|Overall Study|Use of prohibited medication by subject|1|||
28134014|NCT03463031|54797751|FG001|Overall Study|Use of prohibited medication by subject|0|||
28134015|NCT03462641|54797759|FG000|Visit 1|Failed to complete dopaminergic PET scan|1|||
28134016|NCT03462641|54797760|FG001|Visit 1|Failed to complete dopaminergic PET scan|0|||
28134017|NCT03462641|54797759|FG000|Visit 2|Withdrawal by Subject|0|||
27819756|NCT01781390|54279171|FG001|Overall Study|Lost to Follow-up|1|||
27819757|NCT01781390|54279172|FG002|Overall Study|Lost to Follow-up|1|||
27819758|NCT01781390|54279170|FG000|Overall Study|Adverse Event|1|||
27819759|NCT01781390|54279171|FG001|Overall Study|Adverse Event|2|||
27819760|NCT01781390|54279172|FG002|Overall Study|Adverse Event|1|||
27819761|NCT01781390|54279170|FG000|Overall Study|Participants who were Randomized and Not Treated|1|||
27819762|NCT01781390|54279171|FG001|Overall Study|Participants who were Randomized and Not Treated|1|||
27819763|NCT01781390|54279172|FG002|Overall Study|Participants who were Randomized and Not Treated|1|||
27819764|NCT01781234|54279182|FG000|Overall Study|Adverse Event|2|||
27819765|NCT01781234|54279183|FG001|Overall Study|Adverse Event|0|||
27819766|NCT01781234|54279182|FG000|Overall Study|Protocol Violation|3|||
27819767|NCT01781234|54279183|FG001|Overall Study|Protocol Violation|0|||
27819768|NCT01781234|54279182|FG000|Overall Study|Withdrawal by Subject|4|||
27819769|NCT01781234|54279183|FG001|Overall Study|Withdrawal by Subject|3|||
27819770|NCT01752842|54279193|FG000|Overall Study|Adverse Event|3|||
27819771|NCT01752842|54279194|FG001|Overall Study|Adverse Event|0|||
27819772|NCT01752842|54279193|FG000|Overall Study|Withdrawal by Subject|0|||
27819773|NCT01752842|54279194|FG001|Overall Study|Withdrawal by Subject|2|||
27819774|NCT01461057|54279202|FG000|Overall Study|Death|10|||
27819775|NCT01461057|54279203|FG001|Overall Study|Death|9|||
27819776|NCT01461057|54279202|FG000|Overall Study|Withdrawal by Subject|2|||
28069406|NCT00145509|54724451|FG001|Overall Study|Lack of Efficacy|1|||
28069407|NCT00145509|54724450|FG000|Overall Study|Lost to Follow-up|5|||
28069408|NCT00145509|54724451|FG001|Overall Study|Lost to Follow-up|9|||
28069409|NCT00145509|54724450|FG000|Overall Study|Withdrew Consent|2|||
28069410|NCT00145509|54724451|FG001|Overall Study|Withdrew Consent|7|||
28069411|NCT00145509|54724450|FG000|Overall Study|Reason not provided|2|||
28069412|NCT00145509|54724451|FG001|Overall Study|Reason not provided|1|||
28069413|NCT00145119|54724457|FG000|Overall Study|Death|45|||
28134018|NCT03462641|54797760|FG001|Visit 2|Withdrawal by Subject|1|||
28134019|NCT02974634|54797770|FG000|Overall Study|Advanced disease|12|||
28134020|NCT02974634|54797771|FG001|Overall Study|Advanced disease|3|||
28134021|NCT02974634|54797770|FG000|Overall Study|Noncompliance|3|||
28134022|NCT02974634|54797771|FG001|Overall Study|Noncompliance|7|||
28134023|NCT02974634|54797770|FG000|Overall Study|intervention technology related issues|5|||
28134024|NCT02974634|54797771|FG001|Overall Study|intervention technology related issues|0|||
28134025|NCT02974634|54797770|FG000|Overall Study|Death|8|||
28134026|NCT02974634|54797771|FG001|Overall Study|Death|11|||
28134027|NCT01060670|54797780|FG000|Run In|screen failure|0|||
28134028|NCT01060670|54797781|FG001|Run In|screen failure|238|||
28134029|NCT02971670|54797793|FG000|Overall Study|Withdrawal by Subject|4|||
28134030|NCT02971670|54797794|FG001|Overall Study|Withdrawal by Subject|1|||
28134031|NCT02971670|54797795|FG002|Overall Study|Withdrawal by Subject|1|||
28134032|NCT02971670|54797796|FG003|Overall Study|Withdrawal by Subject|2|||
28134033|NCT02971202|54797809|FG000|Overall Study|Pregnancy|1|||
28134034|NCT02971202|54797810|FG001|Overall Study|Pregnancy|0|||
28134035|NCT02971202|54797811|FG002|Overall Study|Pregnancy|0|||
28134036|NCT02971202|54797809|FG000|Overall Study|screen fail after consent|1|||
28134037|NCT02971202|54797810|FG001|Overall Study|screen fail after consent|0|||
28134038|NCT02971202|54797811|FG002|Overall Study|screen fail after consent|1|||
28134039|NCT02926638|54797821|FG000|Overall Study|Progression|2|||
28134040|NCT02926638|54797822|FG001|Overall Study|Progression|5|||
28134041|NCT02926638|54797821|FG000|Overall Study|Ineligible|1|||
28134042|NCT02926638|54797822|FG001|Overall Study|Ineligible|0|||
28134043|NCT02926638|54797821|FG000|Overall Study|Not protocol specified|1|||
28134044|NCT02926638|54797822|FG001|Overall Study|Not protocol specified|0|||
28134045|NCT02903030|54797830|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
28134046|NCT02903030|54797831|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
28134047|NCT02969408|54797840|FG000|Overall Study|Adverse Event|2|||
28134048|NCT02969408|54797840|FG000|Overall Study|Withdrawal by Subject|8|||
28134049|NCT02969408|54797840|FG000|Overall Study|Lost to Follow-up|4|||
28134050|NCT02969408|54797840|FG000|Overall Study|Protocol Violation|1|||
28134051|NCT02969408|54797840|FG000|Overall Study|Other than specified|1|||
28134052|NCT03462563|54797846|FG000|Overall Study|Death|1|||
28134053|NCT03462563|54797847|FG001|Overall Study|Death|1|||
28134054|NCT03462563|54797846|FG000|Overall Study|Termination of study|2|||
28069414|NCT00220779|54724464|FG000|Overall Study|Adverse Event|1|||
28069415|NCT00220779|54724465|FG001|Overall Study|Adverse Event|0|||
28069416|NCT00220779|54724466|FG002|Overall Study|Adverse Event|0|||
28069417|NCT00220779|54724464|FG000|Overall Study|Withdrawal by Subject|1|||
28069418|NCT00220779|54724465|FG001|Overall Study|Withdrawal by Subject|4|||
28069419|NCT00220779|54724466|FG002|Overall Study|Withdrawal by Subject|1|||
28069420|NCT00220779|54724464|FG000|Overall Study|Non-compliance|1|||
28069421|NCT00220779|54724465|FG001|Overall Study|Non-compliance|0|||
28069422|NCT00220779|54724466|FG002|Overall Study|Non-compliance|0|||
28069423|NCT00220779|54724464|FG000|Overall Study|Too time consuming|1|||
28069424|NCT00220779|54724465|FG001|Overall Study|Too time consuming|0|||
28069425|NCT00220779|54724466|FG002|Overall Study|Too time consuming|0|||
28069426|NCT00220779|54724464|FG000|Overall Study|Pregnancy|0|||
28069427|NCT00220779|54724465|FG001|Overall Study|Pregnancy|0|||
28069428|NCT00220779|54724466|FG002|Overall Study|Pregnancy|2|||
28069429|NCT00220779|54724464|FG000|Overall Study|Lack of Efficacy|3|||
28069430|NCT00220779|54724465|FG001|Overall Study|Lack of Efficacy|0|||
28069431|NCT00220779|54724466|FG002|Overall Study|Lack of Efficacy|1|||
28069432|NCT00207740|54724478|FG000|Overall Study|Adverse Event|4|||
28069433|NCT00207740|54724479|FG001|Overall Study|Adverse Event|14|||
28069434|NCT00207740|54724480|FG002|Overall Study|Adverse Event|14|||
28069435|NCT00207740|54724481|FG003|Overall Study|Adverse Event|11|||
28134055|NCT03462563|54797847|FG001|Overall Study|Termination of study|1|||
28134056|NCT03462563|54797846|FG000|Overall Study|Adverse Event|1|||
28134057|NCT03462563|54797847|FG001|Overall Study|Adverse Event|3|||
28134058|NCT03462563|54797846|FG000|Overall Study|Unspecified reason|10|||
28134059|NCT03462563|54797847|FG001|Overall Study|Unspecified reason|12|||
28134060|NCT03462563|54797846|FG000|Overall Study|Physician Decision|1|||
28134061|NCT03462563|54797847|FG001|Overall Study|Physician Decision|0|||
28134062|NCT01060124|54797853|FG000|Overall Study|Other|16|||
28134063|NCT01060124|54797853|FG000|Overall Study|Adverse Event|14|||
28134064|NCT01060124|54797853|FG000|Overall Study|Withdrawal by Subject|7|||
28134065|NCT03461003|54797859|FG000|Overall Study|Lost to Follow-up|2|||
28134066|NCT03461003|54797860|FG001|Overall Study|Lost to Follow-up|2|||
28134067|NCT03461003|54797859|FG000|Overall Study|Withdrawal by Subject|3|||
28134068|NCT03461003|54797860|FG001|Overall Study|Withdrawal by Subject|1|||
28134069|NCT02904902|54797866|FG000|Overall Study|Withdrawal by Subject|1|||
28134070|NCT04425720|54797872|FG000|Overall Study|Withdrawal by Subject|0|||
27940998|NCT01020123|54597351|FG001|Main Period|Withdrawal by Subject|5|||
27940999|NCT01020123|54597352|FG002|Main Period|Withdrawal by Subject|3|||
27941000|NCT01020123|54597353|FG003|Main Period|Withdrawal by Subject|1|||
27941001|NCT01020123|54597354|FG004|Main Period|Withdrawal by Subject|6|||
27941002|NCT01020123|54597355|FG005|Main Period|Withdrawal by Subject|3|||
27941003|NCT01020123|54597356|FG006|Main Period|Withdrawal by Subject|2|||
27941004|NCT01020123|54597350|FG000|Main Period|Eligibility Criteria not fullfilled|0|||
27941005|NCT01020123|54597351|FG001|Main Period|Eligibility Criteria not fullfilled|1|||
27941006|NCT01020123|54597352|FG002|Main Period|Eligibility Criteria not fullfilled|0|||
27941007|NCT01020123|54597353|FG003|Main Period|Eligibility Criteria not fullfilled|0|||
27941008|NCT01020123|54597354|FG004|Main Period|Eligibility Criteria not fullfilled|1|||
27941009|NCT01020123|54597355|FG005|Main Period|Eligibility Criteria not fullfilled|0|||
27941010|NCT01020123|54597356|FG006|Main Period|Eligibility Criteria not fullfilled|0|||
27941011|NCT01020123|54597350|FG000|Main Period|Adverse Event|5|||
27941012|NCT01020123|54597351|FG001|Main Period|Adverse Event|2|||
28069436|NCT00207740|54724478|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
27819777|NCT01461057|54279203|FG001|Overall Study|Withdrawal by Subject|3|||
27819778|NCT01461057|54279202|FG000|Overall Study|Physician Decision|0|||
27819779|NCT01461057|54279203|FG001|Overall Study|Physician Decision|2|||
27819780|NCT01461057|54279202|FG000|Overall Study|Adverse Event|0|||
27819781|NCT01461057|54279203|FG001|Overall Study|Adverse Event|1|||
27819782|NCT01461057|54279202|FG000|Overall Study|Progression of Disease|1|||
27819783|NCT01461057|54279203|FG001|Overall Study|Progression of Disease|0|||
27819784|NCT01461057|54279202|FG000|Overall Study|Study Terminated by Sponsor|2|||
27819785|NCT01461057|54279203|FG001|Overall Study|Study Terminated by Sponsor|0|||
27819786|NCT01460901|54279209|FG000|Overall Study|Withdrawal by Subject|2|||
27819787|NCT01519635|54279218|FG000|Overall Study|Withdrawal by Subject|0|||
28069437|NCT00207740|54724479|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
28069438|NCT00207740|54724480|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
28069439|NCT00207740|54724481|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
28069440|NCT00207740|54724478|FG000|Overall Study|Lost to Follow-up|0|||
28069441|NCT00207740|54724479|FG001|Overall Study|Lost to Follow-up|2|||
28069442|NCT00207740|54724480|FG002|Overall Study|Lost to Follow-up|1|||
28069443|NCT00207740|54724481|FG003|Overall Study|Lost to Follow-up|1|||
28069444|NCT00207740|54724478|FG000|Overall Study|Death|0|||
28134071|NCT04425720|54797873|FG001|Overall Study|Withdrawal by Subject|20|||
28134072|NCT03459443|54797880|FG000|Overall Study|Lack of Efficacy|3|||
28134073|NCT03459443|54797880|FG000|Overall Study|Adverse Event|1|||
28134074|NCT03459443|54797880|FG000|Overall Study|Sponsor's decision to close the study|18|||
28134075|NCT02904512|54797886|FG000|Overall Study|Withdrawal by Subject|1|||
28134076|NCT02904512|54797887|FG001|Overall Study|Withdrawal by Subject|0|||
28134077|NCT02904512|54797886|FG000|Overall Study|Transferred to ICU|1|||
28134078|NCT02904512|54797887|FG001|Overall Study|Transferred to ICU|0|||
28134079|NCT02904512|54797886|FG000|Overall Study|Minor Bleeding at site of device insertion|1|||
28134080|NCT02904512|54797887|FG001|Overall Study|Minor Bleeding at site of device insertion|0|||
27819788|NCT01519635|54279219|FG001|Overall Study|Withdrawal by Subject|1|||
27819789|NCT01519635|54279218|FG000|Overall Study|No possibility to put a catheter|1|||
27819790|NCT01519635|54279219|FG001|Overall Study|No possibility to put a catheter|2|||
27819791|NCT01519323|54279225|FG000|Overall Study|Death|3|||
27819792|NCT01519323|54279226|FG001|Overall Study|Death|2|||
27819793|NCT01519323|54279225|FG000|Overall Study|Study terminated by sponsor|0|||
27819794|NCT01519323|54279226|FG001|Overall Study|Study terminated by sponsor|1|||
27819795|NCT01519245|54279234|FG000|Overall Study|Met exclusion criteria, not analysed|1|||
27819796|NCT01519245|54279235|FG001|Overall Study|Met exclusion criteria, not analysed|2|||
27819797|NCT01519167|54279245|FG000|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0|||
27819798|NCT01519167|54279246|FG001|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3|||
27819799|NCT01519167|54279245|FG000|Overall Study|Adverse Event|0|||
27819800|NCT01519167|54279246|FG001|Overall Study|Adverse Event|1|||
27819801|NCT01519167|54279245|FG000|Overall Study|Lack of Efficacy|0|||
27819802|NCT01519167|54279246|FG001|Overall Study|Lack of Efficacy|1|||
27819803|NCT01519167|54279245|FG000|Overall Study|Medical condition changes&deep sedation|0|||
27819804|NCT01519167|54279246|FG001|Overall Study|Medical condition changes&deep sedation|2|||
27819805|NCT01519167|54279245|FG000|Overall Study|Physician Decision|0|||
27819806|NCT01519167|54279246|FG001|Overall Study|Physician Decision|1|||
27819807|NCT01519089|54279487|FG000|Overall Study|Adverse Event|4|||
27819808|NCT01519089|54279488|FG001|Overall Study|Adverse Event|4|||
27819809|NCT01519089|54279487|FG000|Overall Study|Lack of Efficacy|0|||
27819810|NCT01519089|54279488|FG001|Overall Study|Lack of Efficacy|2|||
27819811|NCT01519089|54279487|FG000|Overall Study|Lost to Follow-up|1|||
28134081|NCT02904200|54797893|FG000|Overall Study|Withdrawal by Subject|1|||
28134082|NCT02904200|54797894|FG001|Overall Study|Withdrawal by Subject|0|||
28134083|NCT03432533|54797900|FG000|Overall Study|Lost to Follow-up|1|||
28134084|NCT03432533|54797901|FG001|Overall Study|Lost to Follow-up|2|||
28134085|NCT03432533|54797900|FG000|Overall Study|Withdrawal by Subject|14|||
28134086|NCT03432533|54797901|FG001|Overall Study|Withdrawal by Subject|9|||
28134087|NCT02901548|54797907|FG000|Overall Study|Withdrew after month 3 biopsy showed persistent cancer|4|||
28134088|NCT02903966|54797913|FG000|Part A (Day 1 to 43)|Adverse Event|1|||
28134089|NCT02903966|54797914|FG001|Part A (Day 1 to 43)|Adverse Event|0|||
28134090|NCT02903966|54797913|FG000|Part B (Day 44 to 112)|Lack of Efficacy|0|||
28134091|NCT02903966|54797914|FG001|Part B (Day 44 to 112)|Lack of Efficacy|1|||
28134092|NCT02903966|54797913|FG000|Part B (Day 44 to 112)|Withdrawal by Subject|0|||
28134093|NCT02903966|54797914|FG001|Part B (Day 44 to 112)|Withdrawal by Subject|1|||
27819812|NCT01519089|54279488|FG001|Overall Study|Lost to Follow-up|0|||
27819813|NCT01519089|54279487|FG000|Overall Study|Withdrawal by Subject|0|||
27819814|NCT01519089|54279488|FG001|Overall Study|Withdrawal by Subject|2|||
27819815|NCT01519089|54279487|FG000|Overall Study|Other|2|||
27819816|NCT01519089|54279488|FG001|Overall Study|Other|6|||
28134094|NCT03457727|54797930|FG000|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
27819817|NCT01519089|54279487|FG000|Overall Study|Not received study drug|0|||
27819818|NCT01519089|54279488|FG001|Overall Study|Not received study drug|1|||
28134095|NCT03457727|54797931|FG001|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
28134096|NCT03457727|54797932|FG002|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
28134097|NCT03457727|54797933|FG003|Part 2, Washout Period 1 (5 Days)|Adverse Event|1|||
28134098|NCT03431441|54797965|FG000|Overall Study|Withdrawal by Subject|2|||
28134099|NCT03431441|54797965|FG000|Overall Study|Adverse Event|2|||
28134100|NCT03431441|54797965|FG000|Overall Study|Dispensed Incorrect Replacement Lens|1|||
28134101|NCT03457103|54797971|FG000|Overall Study|illness/hospitalization|4|||
28134102|NCT03457103|54797972|FG001|Overall Study|illness/hospitalization|2|||
28134103|NCT03457103|54797971|FG000|Overall Study|Lost to Follow-up|2|||
28134104|NCT03457103|54797972|FG001|Overall Study|Lost to Follow-up|1|||
28134105|NCT03457103|54797971|FG000|Overall Study|Withdrawal by Subject|1|||
28134106|NCT03457103|54797972|FG001|Overall Study|Withdrawal by Subject|2|||
28134107|NCT03457103|54797971|FG000|Overall Study|financial/ insurance issues|1|||
28134108|NCT03457103|54797972|FG001|Overall Study|financial/ insurance issues|1|||
28134109|NCT03455543|54797980|FG000|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2|||
28134110|NCT03455543|54797981|FG001|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5|||
28134111|NCT03455543|54797982|FG002|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0|||
28134112|NCT03455543|54797980|FG000|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7|||
28134113|NCT03455543|54797981|FG001|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2|||
28134114|NCT03455543|54797982|FG002|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0|||
28134115|NCT03455543|54797980|FG000|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2|||
28134116|NCT03455543|54797981|FG001|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
27819819|NCT01518699|54279510|FG000|Period 2|Protocol Violation|1|||
27819820|NCT01518699|54279511|FG001|Period 2|Protocol Violation|1|||
27819821|NCT01518699|54279512|FG002|Period 2|Protocol Violation|0|||
28069445|NCT00207740|54724479|FG001|Overall Study|Death|0|||
28069446|NCT00207740|54724480|FG002|Overall Study|Death|0|||
28069447|NCT00207740|54724481|FG003|Overall Study|Death|1|||
28069448|NCT00207740|54724478|FG000|Overall Study|Sponsor Directive|22|||
28069449|NCT00207740|54724479|FG001|Overall Study|Sponsor Directive|15|||
28069450|NCT00207740|54724480|FG002|Overall Study|Sponsor Directive|16|||
28069451|NCT00207740|54724481|FG003|Overall Study|Sponsor Directive|21|||
28069452|NCT00207740|54724478|FG000|Overall Study|Other|2|||
28069453|NCT00207740|54724479|FG001|Overall Study|Other|10|||
28134117|NCT03455543|54797982|FG002|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
28134118|NCT03455543|54797980|FG000|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
28134119|NCT03455543|54797981|FG001|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
28134120|NCT03455543|54797982|FG002|Part B: Open-label Extension (24 Weeks)|Adverse Event|3|||
28134121|NCT03455543|54797980|FG000|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
28134122|NCT03455543|54797981|FG001|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
28134123|NCT03455543|54797982|FG002|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20|||
28069454|NCT00207740|54724480|FG002|Overall Study|Other|7|||
28069455|NCT00207740|54724481|FG003|Overall Study|Other|5|||
28069456|NCT00265382|54724495|FG000|Overall Study|Adverse Event|21|||
28069457|NCT00265382|54724495|FG000|Overall Study|Laboratory Abnormality|1|||
28069458|NCT00265382|54724495|FG000|Overall Study|Lost to Follow-up|3|||
28069459|NCT00265382|54724495|FG000|Overall Study|Lack of Efficacy|6|||
28069460|NCT00265382|54724495|FG000|Overall Study|Miscellaneous|6|||
28069461|NCT00265382|54724495|FG000|Overall Study|Withdrawal by Subject|13|||
28069462|NCT00265382|54724495|FG000|Overall Study|Study terminated by sponsor|94|||
28069463|NCT00265382|54724495|FG000|Overall Study|Death|1|||
28069464|NCT00206726|54724499|FG000|Overall Study|Delayed recovery of blood counts|1|||
28069465|NCT00206726|54724499|FG000|Overall Study|Progressive disease or relapsed disease|18|||
28069466|NCT00206726|54724499|FG000|Overall Study|Placed on new protocol|1|||
27819822|NCT01518699|54279513|FG003|Period 2|Protocol Violation|0|||
28069467|NCT00206726|54724499|FG000|Overall Study|Bone marrow transplant|1|||
28069468|NCT00206726|54724499|FG000|Overall Study|Adverse Event|17|||
28134124|NCT03455543|54797980|FG000|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
28134125|NCT03455543|54797981|FG001|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
28134126|NCT03455543|54797982|FG002|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7|||
28134127|NCT03455543|54797980|FG000|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
28134128|NCT03455543|54797981|FG001|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
28134129|NCT03455543|54797982|FG002|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4|||
28134130|NCT03455543|54797980|FG000|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
28134131|NCT03455543|54797981|FG001|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
28134132|NCT03455543|54797982|FG002|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2|||
28134133|NCT03455543|54797980|FG000|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
28134134|NCT03455543|54797981|FG001|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
28134135|NCT03455543|54797982|FG002|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1|||
28134136|NCT03068754|54797992|FG000|Randomized Treatment Period (RTP)|Adverse Event|1|||
27819823|NCT01518699|54279514|FG004|Period 2|Protocol Violation|0|||
27819824|NCT01518699|54279515|FG005|Period 2|Protocol Violation|0|||
27819825|NCT01518699|54279510|FG000|Period 2|Lost to Follow-up|0|||
27819826|NCT01518699|54279511|FG001|Period 2|Lost to Follow-up|1|||
27819827|NCT01518699|54279512|FG002|Period 2|Lost to Follow-up|0|||
27819828|NCT01518699|54279513|FG003|Period 2|Lost to Follow-up|0|||
27819829|NCT01518699|54279514|FG004|Period 2|Lost to Follow-up|0|||
27819830|NCT01518699|54279515|FG005|Period 2|Lost to Follow-up|0|||
27819831|NCT01518699|54279510|FG000|Period 2|Adverse Event|1|||
27819832|NCT01518699|54279511|FG001|Period 2|Adverse Event|0|||
27819833|NCT01518699|54279512|FG002|Period 2|Adverse Event|0|||
27819834|NCT01518699|54279513|FG003|Period 2|Adverse Event|0|||
27819835|NCT01518699|54279514|FG004|Period 2|Adverse Event|0|||
27819836|NCT01518699|54279515|FG005|Period 2|Adverse Event|0|||
27819837|NCT01518309|54279523|FG000|Overall Study|Adverse Event|6|||
27819838|NCT01518309|54279523|FG000|Overall Study|Death|6|||
27819839|NCT01518309|54279523|FG000|Overall Study|Lack of Efficacy|7|||
27819840|NCT01518309|54279523|FG000|Overall Study|Withdrawal by Subject|6|||
27819841|NCT01518309|54279523|FG000|Overall Study|Physician Decision|3|||
27819842|NCT01518309|54279523|FG000|Overall Study|Sponsor Decision|2|||
27819843|NCT01518309|54279523|FG000|Overall Study|Not in Predefined Categories|9|||
27819844|NCT01419717|54279527|FG000|Overall Study|Protocol-specified Criteria|62|||
27819845|NCT01419717|54279527|FG000|Overall Study|Adverse Event|19|||
27819846|NCT01419717|54279527|FG000|Overall Study|Death|17|||
27819847|NCT01419717|54279527|FG000|Overall Study|Withdrawal by Subject|10|||
27819848|NCT01419717|54279527|FG000|Overall Study|Disease Progression|9|||
27819849|NCT01419717|54279527|FG000|Overall Study|Other|4|||
27819850|NCT01419717|54279527|FG000|Overall Study|Lost to Follow-up|2|||
27819851|NCT01419717|54279527|FG000|Overall Study|Administrative Decision|1|||
27819852|NCT01419717|54279527|FG000|Overall Study|Noncompliance|1|||
27819853|NCT01458951|54279534|FG000|Overall Study|Other|1|||
28134137|NCT03068754|54797993|FG001|Randomized Treatment Period (RTP)|Adverse Event|3|||
27819854|NCT01458951|54279535|FG001|Overall Study|Other|0|||
27819855|NCT01458951|54279536|FG002|Overall Study|Other|0|||
27819856|NCT01458951|54279534|FG000|Overall Study|Protocol Violation|5|||
27819857|NCT01458951|54279535|FG001|Overall Study|Protocol Violation|1|||
27819858|NCT01458951|54279536|FG002|Overall Study|Protocol Violation|0|||
28134138|NCT03068754|54797994|FG002|Randomized Treatment Period (RTP)|Adverse Event|0|||
28134139|NCT03068754|54797995|FG003|Randomized Treatment Period (RTP)|Adverse Event|0|||
28134140|NCT03068754|54797992|FG000|Randomized Treatment Period (RTP)|Death|2|||
28134141|NCT03068754|54797993|FG001|Randomized Treatment Period (RTP)|Death|2|||
28134142|NCT03068754|54797994|FG002|Randomized Treatment Period (RTP)|Death|0|||
28134143|NCT03068754|54797995|FG003|Randomized Treatment Period (RTP)|Death|0|||
28134144|NCT03068754|54797992|FG000|Randomized Treatment Period (RTP)|Disease progression|1|||
28134145|NCT03068754|54797993|FG001|Randomized Treatment Period (RTP)|Disease progression|2|||
28134146|NCT03068754|54797994|FG002|Randomized Treatment Period (RTP)|Disease progression|0|||
27819859|NCT01458951|54279534|FG000|Overall Study|Withdrawal by Subject|2|||
28134147|NCT03068754|54797995|FG003|Randomized Treatment Period (RTP)|Disease progression|0|||
28134148|NCT03068754|54797992|FG000|Randomized Treatment Period (RTP)|Lost to Follow-up|1|||
28134149|NCT03068754|54797993|FG001|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
28134150|NCT03068754|54797994|FG002|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
27819860|NCT01458951|54279535|FG001|Overall Study|Withdrawal by Subject|0|||
28069469|NCT00206726|54724499|FG000|Overall Study|Death|4|||
28134151|NCT03068754|54797995|FG003|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
28134152|NCT03068754|54797992|FG000|Randomized Treatment Period (RTP)|Withdrawal by Subject|6|||
28134153|NCT03068754|54797993|FG001|Randomized Treatment Period (RTP)|Withdrawal by Subject|2|||
28134154|NCT03068754|54797994|FG002|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
28134155|NCT03068754|54797995|FG003|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
28134156|NCT03068754|54797992|FG000|Randomized Treatment Period (RTP)|Discontinued by Physician|1|||
28134157|NCT03068754|54797993|FG001|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
28134158|NCT03068754|54797994|FG002|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
28134159|NCT03068754|54797995|FG003|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
28134160|NCT03068754|54797992|FG000|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
28134161|NCT03068754|54797993|FG001|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1|||
28134162|NCT03068754|54797994|FG002|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
28134163|NCT03068754|54797995|FG003|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
28134164|NCT03068754|54797992|FG000|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55|||
28069470|NCT00206726|54724499|FG000|Overall Study|Protocol Violation|1|||
28069471|NCT00206726|54724499|FG000|Overall Study|Withdrawal by Subject|8|||
28069472|NCT00237692|54724507|FG000|Overall Study|Lost to Follow-up|9|||
28069473|NCT00237692|54724508|FG001|Overall Study|Lost to Follow-up|3|||
28069474|NCT00237692|54724509|FG002|Overall Study|Lost to Follow-up|5|||
28069475|NCT00237692|54724510|FG003|Overall Study|Lost to Follow-up|3|||
28069476|NCT00237692|54724507|FG000|Overall Study|Death|1|||
28069477|NCT00237692|54724508|FG001|Overall Study|Death|2|||
28069478|NCT00237692|54724509|FG002|Overall Study|Death|2|||
28069479|NCT00237692|54724510|FG003|Overall Study|Death|3|||
28069480|NCT00237692|54724507|FG000|Overall Study|Excluded - did not meet criteria|4|||
28069481|NCT00237692|54724508|FG001|Overall Study|Excluded - did not meet criteria|3|||
28069482|NCT00237692|54724509|FG002|Overall Study|Excluded - did not meet criteria|5|||
28069483|NCT00237692|54724510|FG003|Overall Study|Excluded - did not meet criteria|9|||
28069484|NCT00237692|54724507|FG000|Overall Study|Withdrawal by Subject|4|||
28134165|NCT03068754|54797993|FG001|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29|||
28134166|NCT03068754|54797994|FG002|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
28134167|NCT03068754|54797995|FG003|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
28134168|NCT03068754|54797992|FG000|Open Label Extension Period (OLE)|Adverse Event|0|||
28134169|NCT03068754|54797993|FG001|Open Label Extension Period (OLE)|Adverse Event|0|||
28134170|NCT03068754|54797994|FG002|Open Label Extension Period (OLE)|Adverse Event|0|||
28134171|NCT03068754|54797995|FG003|Open Label Extension Period (OLE)|Adverse Event|1|||
28134172|NCT03068754|54797992|FG000|Open Label Extension Period (OLE)|Death|0|||
28134173|NCT03068754|54797993|FG001|Open Label Extension Period (OLE)|Death|0|||
28134174|NCT03068754|54797994|FG002|Open Label Extension Period (OLE)|Death|0|||
28134175|NCT03068754|54797995|FG003|Open Label Extension Period (OLE)|Death|1|||
28134176|NCT03068754|54797992|FG000|Open Label Extension Period (OLE)|Disease progression|0|||
28134177|NCT03068754|54797993|FG001|Open Label Extension Period (OLE)|Disease progression|0|||
28134178|NCT03068754|54797994|FG002|Open Label Extension Period (OLE)|Disease progression|3|||
28134179|NCT03068754|54797995|FG003|Open Label Extension Period (OLE)|Disease progression|1|||
28134180|NCT03068754|54797992|FG000|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
28134181|NCT03068754|54797993|FG001|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
28134182|NCT03068754|54797994|FG002|Open Label Extension Period (OLE)|Withdrawal by Subject|5|||
28134183|NCT03068754|54797995|FG003|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
28134184|NCT03068754|54797992|FG000|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
28134185|NCT03068754|54797993|FG001|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
28134186|NCT03068754|54797994|FG002|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1|||
28134187|NCT03068754|54797995|FG003|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
28134188|NCT03068754|54797992|FG000|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
28134189|NCT03068754|54797993|FG001|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
28134190|NCT03068754|54797994|FG002|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12|||
28134191|NCT03068754|54797995|FG003|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3|||
28134192|NCT02965820|54798005|FG000|Period 2, Second 30 Days|Adverse Event|1|||
28134193|NCT02965820|54798006|FG001|Period 2, Second 30 Days|Adverse Event|1|||
28134194|NCT03430895|54798012|FG000|Overall Study|Not Treated|2|||
28134195|NCT03452189|54798016|FG000|First Intervention (3 Months)|Adverse Event|1|||
28134196|NCT03452189|54798017|FG001|First Intervention (3 Months)|Adverse Event|0|||
28134197|NCT03452189|54798016|FG000|First Intervention (3 Months)|insufficient samples of plasma and stool|4|||
28134198|NCT03452189|54798017|FG001|First Intervention (3 Months)|insufficient samples of plasma and stool|0|||
28134199|NCT03451721|54798023|FG000|Overall Study|Death|1|||
28134200|NCT00603954|54798029|FG000|Overall Study|Protocol Violation|1|||
28134201|NCT00603954|54798030|FG001|Overall Study|Protocol Violation|2|||
28134202|NCT03427619|54798037|FG000|Overall Study|Physician Decision|3|||
28134203|NCT03427619|54798037|FG000|Overall Study|Withdrawal by Subject|4|||
28134204|NCT03427619|54798037|FG000|Overall Study|Lost to Follow-up|5|||
28134205|NCT03427619|54798037|FG000|Overall Study|Administrative|4|||
28134206|NCT03427619|54798037|FG000|Overall Study|Other|2|||
28134207|NCT03427619|54798037|FG000|Overall Study|Unknown or Missing Completion Status|48|||
28134208|NCT03407729|54798043|FG000|Overall Study|Lost to Follow-up|2|||
28134209|NCT03407729|54798044|FG001|Overall Study|Lost to Follow-up|0|||
28134210|NCT03407729|54798043|FG000|Overall Study|Unable to schedule|0|||
28134211|NCT03407729|54798044|FG001|Overall Study|Unable to schedule|3|||
28134212|NCT02435433|54798055|FG000|Overall Study|Withdrawal by Subject|2|||
28134213|NCT02435433|54798056|FG001|Overall Study|Withdrawal by Subject|3|||
28134214|NCT02435433|54798057|FG002|Overall Study|Withdrawal by Subject|1|||
28134215|NCT02435433|54798058|FG003|Overall Study|Withdrawal by Subject|0|||
28134216|NCT02435433|54798059|FG004|Overall Study|Withdrawal by Subject|0|||
28134217|NCT02435433|54798055|FG000|Overall Study|Lost to Follow-up|2|||
28134218|NCT02435433|54798056|FG001|Overall Study|Lost to Follow-up|2|||
28134219|NCT02435433|54798057|FG002|Overall Study|Lost to Follow-up|4|||
28134220|NCT02435433|54798058|FG003|Overall Study|Lost to Follow-up|1|||
28134221|NCT02435433|54798059|FG004|Overall Study|Lost to Follow-up|0|||
28134222|NCT03120351|54798072|FG000|Overall Study|Physician Decision|1|||
28134223|NCT03120351|54798073|FG001|Overall Study|Physician Decision|1|||
28134224|NCT02354703|54798083|FG000|Overall Study|Withdrawal by Subject|1|||
28134225|NCT02354703|54798084|FG001|Overall Study|Withdrawal by Subject|1|||
28134226|NCT02354703|54798085|FG002|Overall Study|Withdrawal by Subject|1|||
28134227|NCT02354703|54798086|FG003|Overall Study|Withdrawal by Subject|1|||
28134228|NCT02354703|54798083|FG000|Overall Study|Lost to Follow-up|2|||
28134229|NCT02354703|54798084|FG001|Overall Study|Lost to Follow-up|7|||
28134230|NCT02354703|54798085|FG002|Overall Study|Lost to Follow-up|9|||
28134231|NCT02354703|54798086|FG003|Overall Study|Lost to Follow-up|2|||
28134232|NCT02354703|54798083|FG000|Overall Study|Adverse Event|0|||
28134233|NCT02354703|54798084|FG001|Overall Study|Adverse Event|0|||
28134234|NCT02354703|54798085|FG002|Overall Study|Adverse Event|1|||
28134235|NCT02354703|54798086|FG003|Overall Study|Adverse Event|0|||
28134236|NCT00384111|54798102|FG000|Overall Study|Disease Progression|3|||
28134237|NCT00384111|54798102|FG000|Overall Study|Adverse Event|1|||
28134238|NCT00384111|54798102|FG000|Overall Study|Investigator Decision|3|||
28134239|NCT00384111|54798102|FG000|Overall Study|Study Terminated by the Sponsor|19|||
28134240|NCT03113409|54798106|FG000|Overall Study|Withdrawal by Subject|5|||
28134241|NCT03113409|54798107|FG001|Overall Study|Withdrawal by Subject|0|||
28134242|NCT03113409|54798108|FG002|Overall Study|Withdrawal by Subject|0|||
28134243|NCT01319877|54798114|FG000|Overall Study|Lost to Follow-up|100|||
28134244|NCT01319877|54798115|FG001|Overall Study|Lost to Follow-up|37|||
28134245|NCT01319877|54798114|FG000|Overall Study|Physician Decision|2|||
28134246|NCT01319877|54798115|FG001|Overall Study|Physician Decision|0|||
28134247|NCT01319877|54798114|FG000|Overall Study|Disease Progression|2|||
28134248|NCT01319877|54798115|FG001|Overall Study|Disease Progression|2|||
28134249|NCT01319877|54798114|FG000|Overall Study|Withdrawal by Subject|0|||
28134250|NCT01319877|54798115|FG001|Overall Study|Withdrawal by Subject|1|||
28134251|NCT01319877|54798114|FG000|Overall Study|Reason Not Specified|4|||
28134252|NCT01319877|54798115|FG001|Overall Study|Reason Not Specified|5|||
28134253|NCT03427073|54798128|FG000|Overall Study|Disease Progression|1|||
28134254|NCT03427073|54798129|FG001|Overall Study|Disease Progression|1|||
28134255|NCT03427073|54798130|FG002|Overall Study|Disease Progression|1|||
28134256|NCT03427073|54798131|FG003|Overall Study|Disease Progression|3|||
28134257|NCT03427073|54798132|FG004|Overall Study|Disease Progression|3|||
28134258|NCT03427073|54798133|FG005|Overall Study|Disease Progression|4|||
28134259|NCT03427073|54798134|FG006|Overall Study|Disease Progression|2|||
28134260|NCT03427073|54798135|FG007|Overall Study|Disease Progression|3|||
28134261|NCT03427073|54798128|FG000|Overall Study|Physician Decision|0|||
28134262|NCT03427073|54798129|FG001|Overall Study|Physician Decision|0|||
28134263|NCT03427073|54798130|FG002|Overall Study|Physician Decision|0|||
27849787|NCT00631007|54347627|FG001|Overall Study|Adverse Event|2|||
28134264|NCT03427073|54798131|FG003|Overall Study|Physician Decision|0|||
28134265|NCT03427073|54798132|FG004|Overall Study|Physician Decision|0|||
28134266|NCT03427073|54798133|FG005|Overall Study|Physician Decision|0|||
28134267|NCT03427073|54798134|FG006|Overall Study|Physician Decision|1|||
28134268|NCT03427073|54798135|FG007|Overall Study|Physician Decision|1|||
28134269|NCT03066804|54798155|FG000|Overall Study|Physician Decision|0|||
28134270|NCT03066804|54798156|FG001|Overall Study|Physician Decision|4|||
28134271|NCT03066804|54798155|FG000|Overall Study|Death|23|||
28134272|NCT03066804|54798156|FG001|Overall Study|Death|17|||
28134273|NCT03066804|54798155|FG000|Overall Study|Withdrawal by Subject|19|||
28134274|NCT03066804|54798156|FG001|Overall Study|Withdrawal by Subject|25|||
28134275|NCT03066804|54798155|FG000|Overall Study|Lost to Follow-up|2|||
28134276|NCT03066804|54798156|FG001|Overall Study|Lost to Follow-up|0|||
28134277|NCT03066804|54798155|FG000|Overall Study|Adverse Event|2|||
28134278|NCT03066804|54798156|FG001|Overall Study|Adverse Event|3|||
28134279|NCT03066804|54798155|FG000|Overall Study|Technical problems|5|||
28134280|NCT03066804|54798156|FG001|Overall Study|Technical problems|1|||
28134281|NCT02954237|54798163|FG000|Overall Study|Withdrawal by Subject|25|||
28134282|NCT02954237|54798163|FG000|Overall Study|Missed visit|16|||
28134283|NCT02954237|54798163|FG000|Overall Study|Death|2|||
28134284|NCT04250337|54798169|FG000|Overall Study|Adverse Event|0|||
28134285|NCT04250337|54798170|FG001|Overall Study|Adverse Event|3|||
28134286|NCT04250337|54798169|FG000|Overall Study|Lack of Efficacy|1|||
28069485|NCT00237692|54724508|FG001|Overall Study|Withdrawal by Subject|6|||
28069486|NCT00237692|54724509|FG002|Overall Study|Withdrawal by Subject|10|||
28134287|NCT04250337|54798170|FG001|Overall Study|Lack of Efficacy|3|||
28134288|NCT04250337|54798169|FG000|Overall Study|Physician Decision|1|||
28134289|NCT04250337|54798170|FG001|Overall Study|Physician Decision|0|||
28134290|NCT04250337|54798169|FG000|Overall Study|Protocol Deviation|2|||
28134291|NCT04250337|54798170|FG001|Overall Study|Protocol Deviation|2|||
28134292|NCT04250337|54798169|FG000|Overall Study|Withdrawal by Subject|4|||
28134293|NCT04250337|54798170|FG001|Overall Study|Withdrawal by Subject|3|||
28134294|NCT03118947|54798177|FG000|Overall Study|Adverse Event|7|||
28134295|NCT03118947|54798177|FG000|Overall Study|Death|3|||
28134296|NCT03118947|54798177|FG000|Overall Study|Lack of Efficacy|4|||
28134297|NCT03118947|54798177|FG000|Overall Study|Non-compliance with study drug|1|||
28134298|NCT03118947|54798177|FG000|Overall Study|Protocol Violation|2|||
28134299|NCT03118947|54798177|FG000|Overall Study|Withdrawal by Subject|3|||
28134300|NCT03118947|54798177|FG000|Overall Study|Withdrawal by caregiver|3|||
28134301|NCT03118947|54798177|FG000|Overall Study|Change in patient's living situation|4|||
28134302|NCT03118947|54798177|FG000|Overall Study|Lost to Follow-up|2|||
28134303|NCT03953079|54798184|FG000|Core Study|Withdrawal by Subject|1|||
28134304|NCT03953079|54798185|FG001|Core Study|Withdrawal by Subject|2|||
28134305|NCT03953079|54798186|FG002|Core Study|Withdrawal by Subject|1|||
28134306|NCT03953079|54798184|FG000|Core Study|COVID-19|0|||
28134307|NCT03953079|54798185|FG001|Core Study|COVID-19|1|||
28069487|NCT00237692|54724510|FG003|Overall Study|Withdrawal by Subject|4|||
28069488|NCT00237458|54724520|FG000|Overall Study|Lack of Efficacy|1|||
28069489|NCT00237458|54724520|FG000|Overall Study|Adverse Event|1|||
28069490|NCT00237458|54724520|FG000|Overall Study|Withdrawal by Subject|1|||
28069491|NCT00265148|54724526|FG000|Overall Study|Adverse Event|2|||
28069492|NCT00265148|54724527|FG001|Overall Study|Adverse Event|2|||
28069493|NCT00265148|54724526|FG000|Overall Study|Lack of Efficacy|0|||
28069494|NCT00265148|54724527|FG001|Overall Study|Lack of Efficacy|2|||
28069495|NCT00265148|54724526|FG000|Overall Study|Protocol Violation|3|||
28134308|NCT03953079|54798186|FG002|Core Study|COVID-19|0|||
28134309|NCT03953079|54798184|FG000|Core Study|Difficulties leaving the house|0|||
28134310|NCT03953079|54798185|FG001|Core Study|Difficulties leaving the house|1|||
28134311|NCT03953079|54798186|FG002|Core Study|Difficulties leaving the house|0|||
28134312|NCT03953079|54798184|FG000|Extension Study|Withdrawal by Subject|1|||
28134313|NCT03953079|54798185|FG001|Extension Study|Withdrawal by Subject|0|||
28134314|NCT03953079|54798186|FG002|Extension Study|Withdrawal by Subject|0|||
28134315|NCT03953079|54798184|FG000|Extension Study|Received Rescue Treatment|5|||
28134316|NCT03953079|54798185|FG001|Extension Study|Received Rescue Treatment|6|||
28134317|NCT03953079|54798186|FG002|Extension Study|Received Rescue Treatment|5|||
28134318|NCT03885999|54798199|FG000|Overall Study|Adverse Event|1|||
28134319|NCT03108027|54798213|FG000|Period 1|Subject/Guardian Decision|0|||
28134320|NCT03108027|54798214|FG001|Period 1|Subject/Guardian Decision|0|||
28134321|NCT03108027|54798215|FG002|Period 1|Subject/Guardian Decision|0|||
28134322|NCT03108027|54798216|FG003|Period 1|Subject/Guardian Decision|2|||
28134323|NCT03108027|54798217|FG004|Period 1|Subject/Guardian Decision|0|||
28134324|NCT03108027|54798218|FG005|Period 1|Subject/Guardian Decision|0|||
28134325|NCT03108027|54798213|FG000|Period 3|Adverse Event|0|||
28134326|NCT03108027|54798214|FG001|Period 3|Adverse Event|1|||
28134327|NCT03108027|54798215|FG002|Period 3|Adverse Event|0|||
28134328|NCT03108027|54798216|FG003|Period 3|Adverse Event|0|||
28134329|NCT03108027|54798217|FG004|Period 3|Adverse Event|0|||
28134330|NCT03108027|54798218|FG005|Period 3|Adverse Event|0|||
28134331|NCT03107715|54798234|FG000|Overall Study|did not deliver at the home hospital|4|||
28134332|NCT03107715|54798235|FG001|Overall Study|did not deliver at the home hospital|6|||
27819861|NCT01458951|54279536|FG002|Overall Study|Withdrawal by Subject|2|||
27819862|NCT01458951|54279534|FG000|Overall Study|Adverse Event|7|||
27819863|NCT01458951|54279535|FG001|Overall Study|Adverse Event|0|||
27819864|NCT01458951|54279536|FG002|Overall Study|Adverse Event|2|||
28134333|NCT03107715|54798234|FG000|Overall Study|infant stillborn|0|||
28134334|NCT03107715|54798235|FG001|Overall Study|infant stillborn|1|||
28134335|NCT03567057|54798244|FG000|Overall Study|Adverse Event|56|||
28134336|NCT03567057|54798245|FG001|Overall Study|Adverse Event|53|||
28134337|NCT03567057|54798246|FG002|Overall Study|Adverse Event|28|||
28134338|NCT03567057|54798244|FG000|Overall Study|Withdrawal by Subject|22|||
28134339|NCT03567057|54798245|FG001|Overall Study|Withdrawal by Subject|24|||
28134340|NCT03567057|54798246|FG002|Overall Study|Withdrawal by Subject|13|||
28134341|NCT03567057|54798244|FG000|Overall Study|Lost to Follow-up|3|||
28134342|NCT03567057|54798245|FG001|Overall Study|Lost to Follow-up|5|||
28134343|NCT03567057|54798246|FG002|Overall Study|Lost to Follow-up|2|||
28134344|NCT03567057|54798244|FG000|Overall Study|COVID-19 pandemic|4|||
28134345|NCT03567057|54798245|FG001|Overall Study|COVID-19 pandemic|3|||
28134346|NCT03567057|54798246|FG002|Overall Study|COVID-19 pandemic|0|||
28134347|NCT03567057|54798244|FG000|Overall Study|Non-compliance with study drug|4|||
28134348|NCT03567057|54798245|FG001|Overall Study|Non-compliance with study drug|2|||
28134349|NCT03567057|54798246|FG002|Overall Study|Non-compliance with study drug|0|||
28134350|NCT03567057|54798244|FG000|Overall Study|Lack of Efficacy|3|||
28134351|NCT03567057|54798245|FG001|Overall Study|Lack of Efficacy|0|||
28134352|NCT03567057|54798246|FG002|Overall Study|Lack of Efficacy|1|||
28134353|NCT03567057|54798244|FG000|Overall Study|Death|1|||
28134354|NCT03567057|54798245|FG001|Overall Study|Death|0|||
28134355|NCT03567057|54798246|FG002|Overall Study|Death|0|||
28134356|NCT03567057|54798244|FG000|Overall Study|Physician Decision|1|||
28134357|NCT03567057|54798245|FG001|Overall Study|Physician Decision|0|||
28134358|NCT03567057|54798246|FG002|Overall Study|Physician Decision|0|||
28134359|NCT03567057|54798244|FG000|Overall Study|Unstable medical condition|1|||
28134360|NCT03567057|54798245|FG001|Overall Study|Unstable medical condition|0|||
28134361|NCT03567057|54798246|FG002|Overall Study|Unstable medical condition|0|||
28134362|NCT03567057|54798244|FG000|Overall Study|Medical history event|0|||
28134363|NCT03567057|54798245|FG001|Overall Study|Medical history event|0|||
28134364|NCT03567057|54798246|FG002|Overall Study|Medical history event|1|||
28134365|NCT03567057|54798244|FG000|Overall Study|Other|0|||
28134366|NCT03567057|54798245|FG001|Overall Study|Other|0|||
28134367|NCT03567057|54798246|FG002|Overall Study|Other|1|||
28134368|NCT04388787|54798254|FG000|Blinded Period|Patient could not follow instructions|1|||
28134369|NCT04388787|54798254|FG000|Unblinded Period|Patients became fatiged after a single round of testing with sham vs subthreshold|9|||
28134370|NCT03057600|54798266|FG000|Overall Study|Adverse Event|0|||
27819865|NCT01458951|54279534|FG000|Overall Study|Insufficient Clinical Response|17|||
27819866|NCT01458951|54279535|FG001|Overall Study|Insufficient Clinical Response|0|||
28134371|NCT03057600|54798267|FG001|Overall Study|Adverse Event|0|||
28134372|NCT03057600|54798268|FG002|Overall Study|Adverse Event|4|||
28134373|NCT03057600|54798269|FG003|Overall Study|Adverse Event|0|||
28134374|NCT03057600|54798266|FG000|Overall Study|Radiologic Disease Progression|8|||
28134375|NCT03057600|54798267|FG001|Overall Study|Radiologic Disease Progression|7|||
28134376|NCT03057600|54798268|FG002|Overall Study|Radiologic Disease Progression|13|||
28134377|NCT03057600|54798269|FG003|Overall Study|Radiologic Disease Progression|10|||
28134378|NCT03057600|54798266|FG000|Overall Study|Symptomatic Deterioration|0|||
28134379|NCT03057600|54798267|FG001|Overall Study|Symptomatic Deterioration|1|||
28134380|NCT03057600|54798268|FG002|Overall Study|Symptomatic Deterioration|1|||
28134381|NCT03057600|54798269|FG003|Overall Study|Symptomatic Deterioration|0|||
28134382|NCT03057600|54798266|FG000|Overall Study|Investigator Decision|0|||
28134383|NCT03057600|54798267|FG001|Overall Study|Investigator Decision|0|||
28134384|NCT03057600|54798268|FG002|Overall Study|Investigator Decision|1|||
28134385|NCT03057600|54798269|FG003|Overall Study|Investigator Decision|0|||
28134386|NCT03057600|54798266|FG000|Overall Study|Study Termination by Sponsor|0|||
28134387|NCT03057600|54798267|FG001|Overall Study|Study Termination by Sponsor|0|||
28134388|NCT03057600|54798268|FG002|Overall Study|Study Termination by Sponsor|0|||
28134389|NCT03057600|54798269|FG003|Overall Study|Study Termination by Sponsor|2|||
28134390|NCT03057600|54798266|FG000|Overall Study|Withdrawal by Subject|0|||
28134391|NCT03057600|54798267|FG001|Overall Study|Withdrawal by Subject|1|||
28134392|NCT03057600|54798268|FG002|Overall Study|Withdrawal by Subject|0|||
28134393|NCT03057600|54798269|FG003|Overall Study|Withdrawal by Subject|0|||
28134394|NCT03057600|54798266|FG000|Overall Study|Other, Not Specified|1|||
28134395|NCT03057600|54798267|FG001|Overall Study|Other, Not Specified|1|||
28134396|NCT03057600|54798268|FG002|Overall Study|Other, Not Specified|1|||
28134397|NCT03057600|54798269|FG003|Overall Study|Other, Not Specified|1|||
28134398|NCT03371823|54798299|FG000|Overall Study|Screen fail (did not meet inclusion criteria)|1|||
28134399|NCT03371823|54798300|FG001|Overall Study|Screen fail (did not meet inclusion criteria)|0|||
28134400|NCT02966301|54798315|FG000|Overall Study|Death|2|||
28134401|NCT02966301|54798315|FG000|Overall Study|Withdrawal by Subject|1|||
28134402|NCT03107091|54798319|FG000|Overall Study|Physician Decision|1|||
28134403|NCT03065400|54798333|FG000|Overall Study|Adverse Event|1|||
28134404|NCT03065400|54798333|FG000|Overall Study|Physician Decision|3|||
28134405|NCT03065400|54798333|FG000|Overall Study|Withdrawal by Subject|1|||
28134406|NCT03065400|54798333|FG000|Overall Study|Completed 6 cycles but did not meet criteria to continue past cycle 6|5|||
28134407|NCT03085095|54798339|FG000|Overall Study|Adverse Event|23|||
28134408|NCT03085095|54798340|FG001|Overall Study|Adverse Event|8|||
28134409|NCT03085095|54798339|FG000|Overall Study|Protocol Violation|0|||
28134410|NCT03085095|54798340|FG001|Overall Study|Protocol Violation|1|||
28134411|NCT03085095|54798339|FG000|Overall Study|Lost to Follow-up|2|||
28134412|NCT03085095|54798340|FG001|Overall Study|Lost to Follow-up|1|||
28134413|NCT03085095|54798339|FG000|Overall Study|Withdrawal by Subject|17|||
28134414|NCT03085095|54798340|FG001|Overall Study|Withdrawal by Subject|6|||
28134415|NCT03085095|54798339|FG000|Overall Study|Physician Decision|9|||
28134416|NCT03085095|54798340|FG001|Overall Study|Physician Decision|3|||
28134417|NCT03085095|54798339|FG000|Overall Study|Testosterone Suppression Level Not Met|7|||
28134418|NCT03085095|54798340|FG001|Overall Study|Testosterone Suppression Level Not Met|13|||
28134419|NCT03085095|54798339|FG000|Overall Study|Did not Receive Study Drug|2|||
28134420|NCT03085095|54798340|FG001|Overall Study|Did not Receive Study Drug|2|||
28134421|NCT03085095|54798339|FG000|Overall Study|Dosing Interruption (Logistical Reason)|1|||
28134422|NCT03085095|54798340|FG001|Overall Study|Dosing Interruption (Logistical Reason)|0|||
28134423|NCT04097301|54798349|FG000|Overall Study|Death|1|||
28134424|NCT04097301|54798349|FG000|Overall Study|Withdrawal by Subject|1|||
28134425|NCT04097301|54798349|FG000|Overall Study|Screening Failure|5|||
28134426|NCT02649855|54798358|FG000|Overall Study|Refused further treatment|2|||
28134427|NCT02649855|54798359|FG001|Overall Study|Refused further treatment|1|||
28134428|NCT02649855|54798360|FG002|Overall Study|Refused further treatment|1|||
28134429|NCT02649855|54798358|FG000|Overall Study|Withdrew consent|0|||
28134430|NCT02649855|54798359|FG001|Overall Study|Withdrew consent|1|||
28134431|NCT02649855|54798360|FG002|Overall Study|Withdrew consent|0|||
28134432|NCT02649855|54798358|FG000|Overall Study|Switched to alternative treatment|0|||
28134433|NCT02649855|54798359|FG001|Overall Study|Switched to alternative treatment|1|||
28134434|NCT02649855|54798360|FG002|Overall Study|Switched to alternative treatment|1|||
28134435|NCT02649855|54798358|FG000|Overall Study|Principal investigator discretion|0|||
28134436|NCT02649855|54798359|FG001|Overall Study|Principal investigator discretion|1|||
28134437|NCT02649855|54798360|FG002|Overall Study|Principal investigator discretion|1|||
28134438|NCT02649855|54798358|FG000|Overall Study|No treatment, per protocol|1|||
27819867|NCT01458951|54279536|FG002|Overall Study|Insufficient Clinical Response|11|||
28134439|NCT02649855|54798359|FG001|Overall Study|No treatment, per protocol|0|||
28134440|NCT02649855|54798360|FG002|Overall Study|No treatment, per protocol|0|||
28134441|NCT02649855|54798358|FG000|Overall Study|Initiate new treatment|1|||
28134442|NCT02649855|54798359|FG001|Overall Study|Initiate new treatment|0|||
28134443|NCT02649855|54798360|FG002|Overall Study|Initiate new treatment|0|||
28134444|NCT02276547|54798368|FG000|Overall Study|Death|2|||
27819868|NCT01458639|54279543|FG000|Overall Study|Physician Decision|4|||
27819869|NCT01458639|54279543|FG000|Overall Study|Equipment issue|1|||
27819870|NCT01458639|54279543|FG000|Overall Study|Inability to obtain subject blood sample|1|||
27819871|NCT01437423|54279547|FG000|Overall Study|Lost to Follow-up|12|||
27819872|NCT01437423|54279547|FG000|Overall Study|Off label usage|3|||
28134445|NCT02276547|54798368|FG000|Overall Study|Explant|2|||
28134446|NCT02966834|54798378|FG000|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
28134447|NCT02966834|54798379|FG001|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
28134448|NCT02966834|54798380|FG002|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
28134449|NCT02966834|54798381|FG003|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
28134450|NCT02966834|54798382|FG004|Main Study Period (Up to 12 Weeks)|Adverse Event|1|||
28134451|NCT02966834|54798383|FG005|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
28134452|NCT02966834|54798378|FG000|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|1|||
28134453|NCT02966834|54798379|FG001|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
28134454|NCT02966834|54798380|FG002|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
28134455|NCT02966834|54798381|FG003|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
28134456|NCT02966834|54798382|FG004|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
28134457|NCT02966834|54798383|FG005|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
28134458|NCT02966834|54798378|FG000|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
28134459|NCT02966834|54798379|FG001|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
28134460|NCT02966834|54798380|FG002|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|4|||
28134461|NCT02966834|54798381|FG003|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|8|||
28134462|NCT02966834|54798382|FG004|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
28134463|NCT02966834|54798383|FG005|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|5|||
28134464|NCT02966834|54798378|FG000|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
28134465|NCT02966834|54798379|FG001|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
28134466|NCT02966834|54798380|FG002|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
28134467|NCT02966834|54798381|FG003|Follow-up (Up to 4 Weeks)|Adverse Event|2|||
28134468|NCT02966834|54798382|FG004|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
28134469|NCT02966834|54798383|FG005|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
28134470|NCT02966834|54798378|FG000|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
28134471|NCT02966834|54798379|FG001|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
28134472|NCT02966834|54798380|FG002|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
28134473|NCT02966834|54798381|FG003|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|2|||
28134474|NCT02966834|54798382|FG004|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
28134475|NCT02966834|54798383|FG005|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
28134476|NCT02966834|54798378|FG000|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
28134477|NCT02966834|54798379|FG001|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
28134478|NCT02966834|54798380|FG002|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
28134479|NCT02966834|54798381|FG003|Follow-up (Up to 4 Weeks)|Protocol Violation|1|||
28134480|NCT02966834|54798382|FG004|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
28134481|NCT02966834|54798383|FG005|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
28134482|NCT03106077|54798432|FG000|Overall Study|Screen Failure|94|||
28134483|NCT03106077|54798433|FG001|Overall Study|Screen Failure|0|||
28134484|NCT03105297|54798438|FG000|Baseline Phase (Day 1)|Other|21|||
28134485|NCT03105297|54798438|FG000|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1|||
28134486|NCT03105297|54798438|FG000|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7|||
28134487|NCT03426995|54798468|FG000|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
28134488|NCT03426995|54798469|FG001|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
28134489|NCT03426995|54798470|FG002|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1|||
28134490|NCT03426995|54798471|FG003|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
28134491|NCT03426995|54798472|FG004|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
28134492|NCT03426995|54798473|FG005|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
28134493|NCT03426995|54798474|FG006|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
28134494|NCT03426995|54798475|FG007|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
28134495|NCT03426995|54798476|FG008|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
28134496|NCT03426995|54798477|FG009|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
28134497|NCT03426995|54798478|FG010|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
28134498|NCT03426995|54798479|FG011|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
28134499|NCT03426995|54798480|FG012|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
28134500|NCT03426995|54798481|FG013|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
28134501|NCT03426995|54798482|FG014|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
28134502|NCT03426995|54798483|FG015|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
28134503|NCT03426995|54798484|FG016|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
28134504|NCT03426995|54798485|FG017|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
28134505|NCT03426995|54798486|FG018|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
27819873|NCT01458249|54279578|FG000|Overall Study|Not treated|1|||
27819874|NCT01458249|54279578|FG000|Overall Study|Adverse Event|4|||
27819875|NCT01458249|54279578|FG000|Overall Study|Other|2|||
27819876|NCT01458249|54279578|FG000|Overall Study|Ongoing|1|||
27819877|NCT01458171|54279594|FG000|Overall Study|Adverse Event|1|||
28134506|NCT03426995|54798468|FG000|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
28134507|NCT03426995|54798469|FG001|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
28134508|NCT03426995|54798470|FG002|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
28134509|NCT03426995|54798471|FG003|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
28134510|NCT03426995|54798472|FG004|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
28134511|NCT03426995|54798473|FG005|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1|||
28134512|NCT03426995|54798474|FG006|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
28134513|NCT03426995|54798475|FG007|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
28134514|NCT03426995|54798476|FG008|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
28134515|NCT03426995|54798477|FG009|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
28134516|NCT03426995|54798478|FG010|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
28134517|NCT03426995|54798479|FG011|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
28134518|NCT03426995|54798480|FG012|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
28134519|NCT03426995|54798481|FG013|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
28134520|NCT03426995|54798482|FG014|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
28134521|NCT03426995|54798483|FG015|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
28134522|NCT03426995|54798484|FG016|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
28134523|NCT03426995|54798485|FG017|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
28134524|NCT03426995|54798486|FG018|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
28134525|NCT03426995|54798468|FG000|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
27819878|NCT01457703|54279611|FG000|Overall Study|Screen Failure|5|||
27819879|NCT01457703|54279612|FG001|Overall Study|Screen Failure|7|||
27819880|NCT01457703|54279611|FG000|Overall Study|Withdrawal by Subject|1|||
27819881|NCT01457703|54279612|FG001|Overall Study|Withdrawal by Subject|4|||
27819882|NCT01419015|54279630|FG000|Overall Study|Death|2|||
27819883|NCT01418937|54279651|FG000|Overall Study|Lost to Follow-up|5|||
28134526|NCT03426995|54798469|FG001|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
27819884|NCT01418937|54279651|FG000|Overall Study|Protocol Violation|1|||
27819885|NCT01418937|54279651|FG000|Overall Study|Pregnancy|1|||
27819886|NCT01418937|54279651|FG000|Overall Study|Withdrawal by Subject|1|||
27819887|NCT01417377|54279664|FG000|Overall Study|Lost to Follow-up|12|||
27819888|NCT01417377|54279664|FG000|Overall Study|Enrolled, but not treated|1|||
27819889|NCT01437267|54279711|FG000|Overall Study|Withdrawal by Subject|0|||
27819890|NCT01437267|54279712|FG001|Overall Study|Withdrawal by Subject|0|||
27819891|NCT01437267|54279713|FG002|Overall Study|Withdrawal by Subject|0|||
27819892|NCT01437267|54279714|FG003|Overall Study|Withdrawal by Subject|1|||
27819893|NCT01437267|54279715|FG004|Overall Study|Withdrawal by Subject|0|||
27819894|NCT01437267|54279716|FG005|Overall Study|Withdrawal by Subject|0|||
27819895|NCT01437267|54279711|FG000|Overall Study|Protocol Violation|0|||
27819896|NCT01437267|54279712|FG001|Overall Study|Protocol Violation|1|||
27819897|NCT01437267|54279713|FG002|Overall Study|Protocol Violation|0|||
27819898|NCT01437267|54279714|FG003|Overall Study|Protocol Violation|0|||
27819899|NCT01437267|54279715|FG004|Overall Study|Protocol Violation|0|||
27819900|NCT01437267|54279716|FG005|Overall Study|Protocol Violation|0|||
27819901|NCT01456221|54279745|FG000|Overall Study|Withdrawal by Subject|56|||
27819902|NCT01456221|54279746|FG001|Overall Study|Withdrawal by Subject|49|||
27819903|NCT01456221|54279745|FG000|Overall Study|Lost to Follow-up|1|||
27819904|NCT01456221|54279746|FG001|Overall Study|Lost to Follow-up|4|||
27819905|NCT01456221|54279745|FG000|Overall Study|Received medication|3|||
27819906|NCT01456221|54279746|FG001|Overall Study|Received medication|2|||
27819907|NCT01456221|54279745|FG000|Overall Study|Incomplete data|4|||
27819908|NCT01456221|54279746|FG001|Overall Study|Incomplete data|2|||
27819909|NCT01437111|54279752|FG000|Overall Study|Adverse Event|2|||
27819910|NCT01437111|54279752|FG000|Overall Study|Withdrawal by Subject|4|||
27819911|NCT01437111|54279752|FG000|Overall Study|Not reported|5|||
27819912|NCT01437111|54279752|FG000|Overall Study|Physician Decision|1|||
28134527|NCT03426995|54798470|FG002|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
28134528|NCT03426995|54798471|FG003|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
28134529|NCT03426995|54798472|FG004|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
28134530|NCT03426995|54798473|FG005|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
28134531|NCT03426995|54798474|FG006|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
27819913|NCT01437111|54279752|FG000|Overall Study|Lost to Follow-up|5|||
27819914|NCT01437111|54279752|FG000|Overall Study|Protocol Violation|1|||
27819915|NCT01436643|54279800|FG000|2-week Pre-treatment|Abnormal test result|0|||
27819916|NCT01436643|54279801|FG001|2-week Pre-treatment|Abnormal test result|0|||
27819917|NCT01436643|54279802|FG002|2-week Pre-treatment|Abnormal test result|0|||
28134532|NCT03426995|54798475|FG007|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
28134533|NCT03426995|54798476|FG008|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
27819918|NCT01436643|54279803|FG003|2-week Pre-treatment|Abnormal test result|1|||
27819919|NCT01436643|54279800|FG000|2-week Pre-treatment|Adverse Event|0|||
27819920|NCT01436643|54279801|FG001|2-week Pre-treatment|Adverse Event|0|||
28134534|NCT03426995|54798477|FG009|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
28134535|NCT03426995|54798478|FG010|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
28134536|NCT03426995|54798479|FG011|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
28134537|NCT03426995|54798480|FG012|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
28134538|NCT03426995|54798481|FG013|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
28134539|NCT03426995|54798482|FG014|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
27819921|NCT01436643|54279802|FG002|2-week Pre-treatment|Adverse Event|0|||
27819922|NCT01436643|54279803|FG003|2-week Pre-treatment|Adverse Event|5|||
27819923|NCT01436643|54279800|FG000|2-week Pre-treatment|Protocol Violation|0|||
27819924|NCT01436643|54279801|FG001|2-week Pre-treatment|Protocol Violation|0|||
27819925|NCT01436643|54279802|FG002|2-week Pre-treatment|Protocol Violation|0|||
27819926|NCT01436643|54279803|FG003|2-week Pre-treatment|Protocol Violation|4|||
27819927|NCT01436643|54279800|FG000|Core Phase (16 Weeks)|Adverse Event|0|||
27819928|NCT01436643|54279801|FG001|Core Phase (16 Weeks)|Adverse Event|3|||
27819929|NCT01436643|54279802|FG002|Core Phase (16 Weeks)|Adverse Event|1|||
27819930|NCT01436643|54279803|FG003|Core Phase (16 Weeks)|Adverse Event|0|||
28069496|NCT00265148|54724527|FG001|Overall Study|Protocol Violation|2|||
28069497|NCT00265148|54724526|FG000|Overall Study|Lost to Follow-up|0|||
28069498|NCT00265148|54724527|FG001|Overall Study|Lost to Follow-up|1|||
28069499|NCT00265148|54724526|FG000|Overall Study|Withdrawal by Subject|2|||
28069500|NCT00265148|54724527|FG001|Overall Study|Withdrawal by Subject|1|||
28069501|NCT00265148|54724526|FG000|Overall Study|Physician Decision|1|||
28069502|NCT00265148|54724527|FG001|Overall Study|Physician Decision|0|||
28069503|NCT00265148|54724526|FG000|Overall Study|Increasing frailty|0|||
28069504|NCT00265148|54724527|FG001|Overall Study|Increasing frailty|1|||
28069505|NCT00265148|54724526|FG000|Overall Study|Subject chose to change of the dose|1|||
28069506|NCT00265148|54724527|FG001|Overall Study|Subject chose to change of the dose|0|||
28134540|NCT03426995|54798483|FG015|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
27819931|NCT01436643|54279800|FG000|Core Phase (16 Weeks)|Abnormal Test result|0|||
27819932|NCT01436643|54279801|FG001|Core Phase (16 Weeks)|Abnormal Test result|0|||
28069507|NCT00043186|54724543|FG000|Overall Study|Physician Decision|0|||
28069508|NCT00043186|54724544|FG001|Overall Study|Physician Decision|0|||
28134541|NCT03426995|54798484|FG016|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
28134542|NCT03426995|54798485|FG017|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
28134543|NCT03426995|54798486|FG018|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
28134544|NCT03426995|54798468|FG000|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
28134545|NCT03426995|54798469|FG001|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
28134546|NCT03426995|54798470|FG002|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
28134547|NCT03426995|54798471|FG003|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
28134548|NCT03426995|54798472|FG004|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
28134549|NCT03426995|54798473|FG005|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
28134550|NCT03426995|54798474|FG006|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
28134551|NCT03426995|54798475|FG007|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
28134552|NCT03426995|54798476|FG008|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
28134553|NCT03426995|54798477|FG009|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
28134554|NCT03426995|54798478|FG010|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1|||
28134555|NCT03426995|54798479|FG011|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
28134556|NCT03426995|54798480|FG012|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
28134557|NCT03426995|54798481|FG013|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
28134558|NCT03426995|54798482|FG014|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
28134559|NCT03426995|54798483|FG015|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
28134560|NCT03426995|54798484|FG016|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
28134561|NCT03426995|54798485|FG017|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
27819933|NCT01436643|54279802|FG002|Core Phase (16 Weeks)|Abnormal Test result|1|||
27819934|NCT01436643|54279803|FG003|Core Phase (16 Weeks)|Abnormal Test result|0|||
28134562|NCT03426995|54798486|FG018|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
28134563|NCT03426995|54798468|FG000|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
28134564|NCT03426995|54798469|FG001|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
28134565|NCT03426995|54798470|FG002|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
28134566|NCT03426995|54798471|FG003|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
28134567|NCT03426995|54798472|FG004|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
28134568|NCT03426995|54798473|FG005|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
28134569|NCT03426995|54798474|FG006|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
28134570|NCT03426995|54798475|FG007|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1|||
28134571|NCT03426995|54798476|FG008|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
28134572|NCT03426995|54798477|FG009|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
28134573|NCT03426995|54798478|FG010|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
28134574|NCT03426995|54798479|FG011|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
28134575|NCT03426995|54798480|FG012|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
28134576|NCT03426995|54798481|FG013|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
28134577|NCT03426995|54798482|FG014|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
28134578|NCT03426995|54798483|FG015|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
28134579|NCT03426995|54798484|FG016|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
28134580|NCT03426995|54798485|FG017|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
28134581|NCT03426995|54798486|FG018|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
28134582|NCT03426995|54798468|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
28134583|NCT03426995|54798469|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
28134584|NCT03426995|54798470|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
28134585|NCT03426995|54798471|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
28134586|NCT03426995|54798472|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
28134587|NCT03426995|54798473|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
28134588|NCT03426995|54798474|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
28134589|NCT03426995|54798475|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
28134590|NCT03426995|54798476|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
28134591|NCT03426995|54798477|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
28134592|NCT03426995|54798478|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
28134593|NCT03426995|54798479|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
28134594|NCT03426995|54798480|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
28134595|NCT03426995|54798481|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
28134596|NCT03426995|54798482|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8|||
28134597|NCT03426995|54798483|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9|||
28134598|NCT03426995|54798484|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
28134599|NCT03426995|54798485|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
28134600|NCT03426995|54798486|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
28134601|NCT03426995|54798468|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
28134602|NCT03426995|54798469|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
28134603|NCT03426995|54798470|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
28134604|NCT03426995|54798471|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
28134605|NCT03426995|54798472|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
28134606|NCT03426995|54798473|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
28134607|NCT03426995|54798474|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
28134608|NCT03426995|54798475|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
28134609|NCT03426995|54798476|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
28134610|NCT03426995|54798477|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
28134611|NCT03426995|54798478|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
28134612|NCT03426995|54798479|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
28134613|NCT03426995|54798480|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
28134614|NCT03426995|54798481|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
28134615|NCT03426995|54798482|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1|||
28134616|NCT03426995|54798483|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3|||
28134617|NCT03426995|54798484|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
28134618|NCT03426995|54798485|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
28134619|NCT03426995|54798486|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
28134620|NCT03424265|54798535|FG000|Overall Study|screening failure|1|||
28134621|NCT03424265|54798536|FG001|Overall Study|screening failure|0|||
28134622|NCT03424265|54798535|FG000|Overall Study|Withdrawal by Subject|0|||
28134623|NCT03424265|54798536|FG001|Overall Study|Withdrawal by Subject|2|||
28134624|NCT03322566|54798545|FG000|Overall Study|Death|34|||
28134625|NCT03322566|54798546|FG001|Overall Study|Death|35|||
28134626|NCT03322566|54798547|FG002|Overall Study|Death|23|||
28134627|NCT03322566|54798545|FG000|Overall Study|Physician Decision|6|||
28134628|NCT03322566|54798546|FG001|Overall Study|Physician Decision|7|||
28134629|NCT03322566|54798547|FG002|Overall Study|Physician Decision|2|||
28134630|NCT03322566|54798545|FG000|Overall Study|Withdrawal by Subject|4|||
28134631|NCT03322566|54798546|FG001|Overall Study|Withdrawal by Subject|3|||
28134632|NCT03322566|54798547|FG002|Overall Study|Withdrawal by Subject|6|||
28134633|NCT03322566|54798545|FG000|Overall Study|Lost to Follow-up|0|||
28134634|NCT03322566|54798546|FG001|Overall Study|Lost to Follow-up|0|||
28134635|NCT03322566|54798547|FG002|Overall Study|Lost to Follow-up|1|||
28134636|NCT03322566|54798545|FG000|Overall Study|Study terminated by sponsor|1|||
28134637|NCT03322566|54798546|FG001|Overall Study|Study terminated by sponsor|0|||
28134638|NCT03322566|54798547|FG002|Overall Study|Study terminated by sponsor|1|||
28134639|NCT02969018|54798563|FG000|Overall Study|Adverse Event|2|||
28134640|NCT02969018|54798564|FG001|Overall Study|Adverse Event|4|||
28134641|NCT02969018|54798565|FG002|Overall Study|Adverse Event|1|||
27819935|NCT01436643|54279800|FG000|Core Phase (16 Weeks)|Protocol Violation|1|||
27819936|NCT01436643|54279801|FG001|Core Phase (16 Weeks)|Protocol Violation|1|||
28134642|NCT02969018|54798566|FG003|Overall Study|Adverse Event|2|||
28134643|NCT02969018|54798567|FG004|Overall Study|Adverse Event|0|||
28134644|NCT02969018|54798568|FG005|Overall Study|Adverse Event|1|||
28134645|NCT02969018|54798569|FG006|Overall Study|Adverse Event|2|||
28134646|NCT02969018|54798570|FG007|Overall Study|Adverse Event|0|||
28134647|NCT02969018|54798563|FG000|Overall Study|Lack of Efficacy|0|||
28134648|NCT02969018|54798564|FG001|Overall Study|Lack of Efficacy|1|||
28134649|NCT02969018|54798565|FG002|Overall Study|Lack of Efficacy|0|||
28134650|NCT02969018|54798566|FG003|Overall Study|Lack of Efficacy|0|||
28134651|NCT02969018|54798567|FG004|Overall Study|Lack of Efficacy|1|||
28134652|NCT02969018|54798568|FG005|Overall Study|Lack of Efficacy|1|||
28134653|NCT02969018|54798569|FG006|Overall Study|Lack of Efficacy|1|||
28134654|NCT02969018|54798570|FG007|Overall Study|Lack of Efficacy|1|||
28134655|NCT02969018|54798563|FG000|Overall Study|Lost to Follow-up|1|||
28134656|NCT02969018|54798564|FG001|Overall Study|Lost to Follow-up|2|||
28134657|NCT02969018|54798565|FG002|Overall Study|Lost to Follow-up|2|||
28134658|NCT02969018|54798566|FG003|Overall Study|Lost to Follow-up|0|||
28134659|NCT02969018|54798567|FG004|Overall Study|Lost to Follow-up|1|||
28134660|NCT02969018|54798568|FG005|Overall Study|Lost to Follow-up|1|||
28134661|NCT02969018|54798569|FG006|Overall Study|Lost to Follow-up|0|||
28134662|NCT02969018|54798570|FG007|Overall Study|Lost to Follow-up|1|||
28134663|NCT02969018|54798563|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
28134664|NCT02969018|54798564|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
28134665|NCT02969018|54798565|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
28134666|NCT02969018|54798566|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
28134667|NCT02969018|54798567|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
28134668|NCT02969018|54798568|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
28134669|NCT02969018|54798569|FG006|Overall Study|No Longer Meets Eligibility Criteria|1|||
28134670|NCT02969018|54798570|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
28134671|NCT02969018|54798563|FG000|Overall Study|Non-Compliance With Study Drug|1|||
28134672|NCT02969018|54798564|FG001|Overall Study|Non-Compliance With Study Drug|0|||
28134673|NCT02969018|54798565|FG002|Overall Study|Non-Compliance With Study Drug|0|||
28134674|NCT02969018|54798566|FG003|Overall Study|Non-Compliance With Study Drug|0|||
28134675|NCT02969018|54798567|FG004|Overall Study|Non-Compliance With Study Drug|0|||
28134676|NCT02969018|54798568|FG005|Overall Study|Non-Compliance With Study Drug|0|||
28134677|NCT02969018|54798569|FG006|Overall Study|Non-Compliance With Study Drug|0|||
28134678|NCT02969018|54798570|FG007|Overall Study|Non-Compliance With Study Drug|0|||
28134679|NCT02969018|54798563|FG000|Overall Study|Other|0|||
28134680|NCT02969018|54798564|FG001|Overall Study|Other|0|||
28134681|NCT02969018|54798565|FG002|Overall Study|Other|0|||
28134682|NCT02969018|54798566|FG003|Overall Study|Other|1|||
28134683|NCT02969018|54798567|FG004|Overall Study|Other|0|||
28134684|NCT02969018|54798568|FG005|Overall Study|Other|0|||
28134685|NCT02969018|54798569|FG006|Overall Study|Other|0|||
28134686|NCT02969018|54798570|FG007|Overall Study|Other|2|||
28134687|NCT02969018|54798563|FG000|Overall Study|Pregnancy|0|||
28134688|NCT02969018|54798564|FG001|Overall Study|Pregnancy|0|||
28134689|NCT02969018|54798565|FG002|Overall Study|Pregnancy|0|||
28134690|NCT02969018|54798566|FG003|Overall Study|Pregnancy|0|||
28134691|NCT02969018|54798567|FG004|Overall Study|Pregnancy|0|||
28134692|NCT02969018|54798568|FG005|Overall Study|Pregnancy|1|||
28134693|NCT02969018|54798569|FG006|Overall Study|Pregnancy|0|||
28134694|NCT02969018|54798570|FG007|Overall Study|Pregnancy|0|||
28134695|NCT02969018|54798563|FG000|Overall Study|Protocol Violation|0|||
28134696|NCT02969018|54798564|FG001|Overall Study|Protocol Violation|0|||
28134697|NCT02969018|54798565|FG002|Overall Study|Protocol Violation|1|||
28134698|NCT02969018|54798566|FG003|Overall Study|Protocol Violation|1|||
28134699|NCT02969018|54798567|FG004|Overall Study|Protocol Violation|0|||
28134700|NCT02969018|54798568|FG005|Overall Study|Protocol Violation|0|||
28134701|NCT02969018|54798569|FG006|Overall Study|Protocol Violation|0|||
28134702|NCT02969018|54798570|FG007|Overall Study|Protocol Violation|0|||
28134703|NCT02969018|54798563|FG000|Overall Study|Withdrawal by Subject|0|||
28134704|NCT02969018|54798564|FG001|Overall Study|Withdrawal by Subject|1|||
28134705|NCT02969018|54798565|FG002|Overall Study|Withdrawal by Subject|2|||
28134706|NCT02969018|54798566|FG003|Overall Study|Withdrawal by Subject|1|||
28134707|NCT02969018|54798567|FG004|Overall Study|Withdrawal by Subject|0|||
28134708|NCT02969018|54798568|FG005|Overall Study|Withdrawal by Subject|4|||
27819937|NCT01436643|54279802|FG002|Core Phase (16 Weeks)|Protocol Violation|1|||
27819938|NCT01436643|54279803|FG003|Core Phase (16 Weeks)|Protocol Violation|0|||
27819939|NCT01454739|54279901|FG000|Overall Study|Protocol Violation|2|||
27819940|NCT01454739|54279902|FG001|Overall Study|Protocol Violation|3|||
28134709|NCT02969018|54798569|FG006|Overall Study|Withdrawal by Subject|4|||
28134710|NCT02969018|54798570|FG007|Overall Study|Withdrawal by Subject|3|||
28134711|NCT01319721|54798593|FG000|Overall Study|Lost to Follow-up|1|||
28134712|NCT01319721|54798594|FG001|Overall Study|Lost to Follow-up|6|||
28134713|NCT02905032|54798603|FG000|Overall Study|Withdrawal by Subject|2|||
28134714|NCT02905032|54798604|FG001|Overall Study|Withdrawal by Subject|0|||
28134715|NCT02905032|54798605|FG002|Overall Study|Withdrawal by Subject|0|||
28134716|NCT02905032|54798603|FG000|Overall Study|Protocol Violation|6|||
28134717|NCT02905032|54798604|FG001|Overall Study|Protocol Violation|12|||
27819941|NCT01454739|54279901|FG000|Overall Study|Withdrawal by Subject|2|||
28134718|NCT02905032|54798605|FG002|Overall Study|Protocol Violation|0|||
28134719|NCT03259425|54798612|FG000|Overall Study|Disease progression to an extent that didn't allow surgery|1|||
28134720|NCT03101241|54798618|FG000|Overall Study|Intercurrent condition necessitating discontinuation|4|||
28134721|NCT03101241|54798619|FG001|Overall Study|Intercurrent condition necessitating discontinuation|2|||
28134722|NCT03101241|54798618|FG000|Overall Study|Participant withdrew consent|3|||
28134723|NCT03101241|54798619|FG001|Overall Study|Participant withdrew consent|1|||
28134724|NCT03101241|54798618|FG000|Overall Study|Investigator decision that withdrawal was in best interest of participant|2|||
28134725|NCT03101241|54798619|FG001|Overall Study|Investigator decision that withdrawal was in best interest of participant|0|||
27819942|NCT01454739|54279902|FG001|Overall Study|Withdrawal by Subject|6|||
27819943|NCT01454739|54279901|FG000|Overall Study|Other|3|||
27819944|NCT01454739|54279902|FG001|Overall Study|Other|5|||
27819945|NCT01454739|54279901|FG000|Overall Study|Physician Decision|0|||
27819946|NCT01454739|54279902|FG001|Overall Study|Physician Decision|5|||
27819947|NCT01454739|54279901|FG000|Overall Study|Lost to Follow-up|0|||
27819948|NCT01454739|54279902|FG001|Overall Study|Lost to Follow-up|1|||
27819949|NCT01454739|54279901|FG000|Overall Study|Adverse Event|0|||
27819950|NCT01454739|54279902|FG001|Overall Study|Adverse Event|1|||
27819951|NCT01416441|54279940|FG000|Overall Study|Lost to Follow-up|5|||
27941013|NCT01020123|54597352|FG002|Main Period|Adverse Event|2|||
27941014|NCT01020123|54597353|FG003|Main Period|Adverse Event|1|||
27941015|NCT01020123|54597354|FG004|Main Period|Adverse Event|1|||
27941016|NCT01020123|54597355|FG005|Main Period|Adverse Event|2|||
27941017|NCT01020123|54597356|FG006|Main Period|Adverse Event|1|||
27941018|NCT01020123|54597350|FG000|Main Period|Protocol Violation|4|||
27941019|NCT01020123|54597351|FG001|Main Period|Protocol Violation|4|||
28069509|NCT00043186|54724545|FG002|Overall Study|Physician Decision|3|||
28069510|NCT00043186|54724546|FG003|Overall Study|Physician Decision|0|||
28069511|NCT00043186|54724547|FG004|Overall Study|Physician Decision|1|||
28069512|NCT00043186|54724548|FG005|Overall Study|Physician Decision|0|||
28069513|NCT00043186|54724549|FG006|Overall Study|Physician Decision|0|||
28069514|NCT00043186|54724550|FG007|Overall Study|Physician Decision|1|||
28069515|NCT00043186|54724551|FG008|Overall Study|Physician Decision|1|||
28069516|NCT00043186|54724543|FG000|Overall Study|Adverse Event|2|||
28069517|NCT00043186|54724544|FG001|Overall Study|Adverse Event|2|||
28069518|NCT00043186|54724545|FG002|Overall Study|Adverse Event|2|||
28069519|NCT00043186|54724546|FG003|Overall Study|Adverse Event|3|||
28069520|NCT00043186|54724547|FG004|Overall Study|Adverse Event|2|||
28069521|NCT00043186|54724548|FG005|Overall Study|Adverse Event|1|||
28069522|NCT00043186|54724549|FG006|Overall Study|Adverse Event|2|||
28069523|NCT00043186|54724550|FG007|Overall Study|Adverse Event|1|||
28069524|NCT00043186|54724551|FG008|Overall Study|Adverse Event|3|||
28069525|NCT00043186|54724543|FG000|Overall Study|Withdrawal by Subject|11|||
28069526|NCT00043186|54724544|FG001|Overall Study|Withdrawal by Subject|8|||
28069527|NCT00043186|54724545|FG002|Overall Study|Withdrawal by Subject|11|||
28069528|NCT00043186|54724546|FG003|Overall Study|Withdrawal by Subject|13|||
28069529|NCT00043186|54724547|FG004|Overall Study|Withdrawal by Subject|14|||
28069530|NCT00043186|54724548|FG005|Overall Study|Withdrawal by Subject|6|||
28069531|NCT00043186|54724549|FG006|Overall Study|Withdrawal by Subject|12|||
28069532|NCT00043186|54724550|FG007|Overall Study|Withdrawal by Subject|9|||
28069533|NCT00043186|54724551|FG008|Overall Study|Withdrawal by Subject|10|||
28069534|NCT00043186|54724543|FG000|Overall Study|Death|0|||
28069535|NCT00043186|54724544|FG001|Overall Study|Death|0|||
28069536|NCT00043186|54724545|FG002|Overall Study|Death|1|||
28069537|NCT00043186|54724546|FG003|Overall Study|Death|0|||
28069538|NCT00043186|54724547|FG004|Overall Study|Death|0|||
28069539|NCT00043186|54724548|FG005|Overall Study|Death|0|||
28069540|NCT00043186|54724549|FG006|Overall Study|Death|2|||
28069541|NCT00043186|54724550|FG007|Overall Study|Death|0|||
28069542|NCT00043186|54724551|FG008|Overall Study|Death|0|||
28069543|NCT00043186|54724543|FG000|Overall Study|Disease progression|1|||
28069544|NCT00043186|54724544|FG001|Overall Study|Disease progression|0|||
28069545|NCT00043186|54724545|FG002|Overall Study|Disease progression|0|||
28069546|NCT00043186|54724546|FG003|Overall Study|Disease progression|3|||
28069547|NCT00043186|54724547|FG004|Overall Study|Disease progression|0|||
28069548|NCT00043186|54724548|FG005|Overall Study|Disease progression|0|||
28069549|NCT00043186|54724549|FG006|Overall Study|Disease progression|0|||
28069550|NCT00043186|54724550|FG007|Overall Study|Disease progression|4|||
27819952|NCT01416441|54279940|FG000|Overall Study|Adverse Event|6|||
27941020|NCT01020123|54597352|FG002|Main Period|Protocol Violation|2|||
27941021|NCT01020123|54597353|FG003|Main Period|Protocol Violation|5|||
28069551|NCT00043186|54724551|FG008|Overall Study|Disease progression|0|||
28069552|NCT00043186|54724543|FG000|Overall Study|Ineligibility determined|0|||
28069553|NCT00043186|54724544|FG001|Overall Study|Ineligibility determined|0|||
28069554|NCT00043186|54724545|FG002|Overall Study|Ineligibility determined|0|||
28069555|NCT00043186|54724546|FG003|Overall Study|Ineligibility determined|0|||
28069556|NCT00043186|54724547|FG004|Overall Study|Ineligibility determined|0|||
28069557|NCT00043186|54724548|FG005|Overall Study|Ineligibility determined|0|||
28069558|NCT00043186|54724549|FG006|Overall Study|Ineligibility determined|0|||
28069559|NCT00043186|54724550|FG007|Overall Study|Ineligibility determined|0|||
28069560|NCT00043186|54724551|FG008|Overall Study|Ineligibility determined|1|||
28069561|NCT00043186|54724543|FG000|Overall Study|Lost to Follow-up|3|||
28134726|NCT03101241|54798618|FG000|Overall Study|Lost to Follow-up|2|||
28134727|NCT03101241|54798619|FG001|Overall Study|Lost to Follow-up|0|||
28134728|NCT03101241|54798618|FG000|Overall Study|Lack of Efficacy|0|||
28134729|NCT03101241|54798619|FG001|Overall Study|Lack of Efficacy|1|||
28134730|NCT03101241|54798618|FG000|Overall Study|Lack of efficacy/subject withdrew consent|0|||
28134731|NCT03101241|54798619|FG001|Overall Study|Lack of efficacy/subject withdrew consent|1|||
28134732|NCT03061188|54798629|FG000|Went on to Cycle 2 and Beyond|Adverse Event|0|||
28134733|NCT03061188|54798630|FG001|Went on to Cycle 2 and Beyond|Adverse Event|0|||
28134734|NCT03061188|54798631|FG002|Went on to Cycle 2 and Beyond|Adverse Event|1|||
28134735|NCT03061188|54798632|FG003|Went on to Cycle 2 and Beyond|Adverse Event|1|||
28134736|NCT03061188|54798629|FG000|On Follow-up for 3 Years|Death|0|||
28134737|NCT03061188|54798630|FG001|On Follow-up for 3 Years|Death|3|||
28134738|NCT03061188|54798631|FG002|On Follow-up for 3 Years|Death|5|||
28134739|NCT03061188|54798632|FG003|On Follow-up for 3 Years|Death|2|||
28134740|NCT03061188|54798629|FG000|On Follow-up for 3 Years|Still in follow-up|0|||
28134741|NCT03061188|54798630|FG001|On Follow-up for 3 Years|Still in follow-up|0|||
28134742|NCT03061188|54798631|FG002|On Follow-up for 3 Years|Still in follow-up|0|||
28134743|NCT03061188|54798632|FG003|On Follow-up for 3 Years|Still in follow-up|3|||
28134744|NCT03449147|54798650|FG000|52-week Treatment Period|Death|0|||
28134745|NCT03449147|54798651|FG001|52-week Treatment Period|Death|1|||
28134746|NCT03449147|54798652|FG002|52-week Treatment Period|Death|0|||
28134747|NCT03449147|54798650|FG000|52-week Treatment Period|Lost to Follow-up|6|||
28134748|NCT03449147|54798651|FG001|52-week Treatment Period|Lost to Follow-up|2|||
28134749|NCT03449147|54798652|FG002|52-week Treatment Period|Lost to Follow-up|5|||
28134750|NCT03449147|54798650|FG000|52-week Treatment Period|Other|0|||
28134751|NCT03449147|54798651|FG001|52-week Treatment Period|Other|1|||
28134752|NCT03449147|54798652|FG002|52-week Treatment Period|Other|2|||
28134753|NCT03449147|54798650|FG000|52-week Treatment Period|Physician Decision|1|||
28134754|NCT03449147|54798651|FG001|52-week Treatment Period|Physician Decision|0|||
28134755|NCT03449147|54798652|FG002|52-week Treatment Period|Physician Decision|3|||
28134756|NCT03449147|54798650|FG000|52-week Treatment Period|Screen Failure|1|||
28134757|NCT03449147|54798651|FG001|52-week Treatment Period|Screen Failure|2|||
28134758|NCT03449147|54798652|FG002|52-week Treatment Period|Screen Failure|0|||
28134759|NCT03449147|54798650|FG000|52-week Treatment Period|Withdrawal by Subject|46|||
28134760|NCT03449147|54798651|FG001|52-week Treatment Period|Withdrawal by Subject|68|||
28134761|NCT03449147|54798652|FG002|52-week Treatment Period|Withdrawal by Subject|74|||
28134762|NCT03449147|54798650|FG000|12-Week Off-Treatment Durability Period|Withdrawal by Subject|1|||
28134763|NCT03449147|54798651|FG001|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
28134764|NCT03449147|54798652|FG002|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
28134765|NCT03449147|54798650|FG000|12-Week Off-Treatment Durability Period|Other|0|||
28134766|NCT03449147|54798651|FG001|12-Week Off-Treatment Durability Period|Other|1|||
28134767|NCT03449147|54798652|FG002|12-Week Off-Treatment Durability Period|Other|0|||
28134768|NCT03423173|54798668|FG000|Overall Study|Randomized but not vaccinated|1|||
28134769|NCT03423173|54798669|FG001|Overall Study|Randomized but not vaccinated|0|||
28134770|NCT03423173|54798670|FG002|Overall Study|Randomized but not vaccinated|2|||
28134771|NCT03423173|54798671|FG003|Overall Study|Randomized but not vaccinated|1|||
28134772|NCT03423173|54798668|FG000|Overall Study|Adverse Event|1|||
28134773|NCT03423173|54798669|FG001|Overall Study|Adverse Event|1|||
28134774|NCT03423173|54798670|FG002|Overall Study|Adverse Event|1|||
28134775|NCT03423173|54798671|FG003|Overall Study|Adverse Event|1|||
28134776|NCT03423173|54798668|FG000|Overall Study|Lost to Follow-up|10|||
28134777|NCT03423173|54798669|FG001|Overall Study|Lost to Follow-up|19|||
28134778|NCT03423173|54798670|FG002|Overall Study|Lost to Follow-up|17|||
28134779|NCT03423173|54798671|FG003|Overall Study|Lost to Follow-up|22|||
28134780|NCT03423173|54798668|FG000|Overall Study|Withdrawal of consent|4|||
28134781|NCT03423173|54798669|FG001|Overall Study|Withdrawal of consent|10|||
28134782|NCT03423173|54798670|FG002|Overall Study|Withdrawal of consent|4|||
28134783|NCT03423173|54798671|FG003|Overall Study|Withdrawal of consent|5|||
28134784|NCT03423173|54798668|FG000|Overall Study|Death|1|||
28134785|NCT03423173|54798669|FG001|Overall Study|Death|0|||
28134786|NCT03423173|54798670|FG002|Overall Study|Death|0|||
28134787|NCT03423173|54798671|FG003|Overall Study|Death|0|||
28134788|NCT03423173|54798668|FG000|Overall Study|Reason not Specified|2|||
28134789|NCT03423173|54798669|FG001|Overall Study|Reason not Specified|5|||
28134790|NCT03423173|54798670|FG002|Overall Study|Reason not Specified|3|||
28134791|NCT03423173|54798671|FG003|Overall Study|Reason not Specified|1|||
28134792|NCT03447821|54798684|FG000|Overall Study|Withdrawal by Subject|1|||
28134793|NCT03447821|54798685|FG001|Overall Study|Withdrawal by Subject|1|||
28134794|NCT03447821|54798686|FG002|Overall Study|Withdrawal by Subject|0|||
28134795|NCT03447821|54798684|FG000|Overall Study|Lost to Follow-up|0|||
28134796|NCT03447821|54798685|FG001|Overall Study|Lost to Follow-up|0|||
28134797|NCT03447821|54798686|FG002|Overall Study|Lost to Follow-up|1|||
28134798|NCT03447353|54798700|FG000|Overall Study|Failure at Screening Visit|2|||
28134799|NCT03447353|54798700|FG000|Overall Study|Lost to Follow-up|4|||
28134800|NCT03447353|54798700|FG000|Overall Study|Scheduling Conflicts|3|||
28134801|NCT03447353|54798700|FG000|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1|||
28134802|NCT03446885|54798710|FG000|Overall Study|Lost to Follow-up|1|||
28134803|NCT03446885|54798711|FG001|Overall Study|Lost to Follow-up|0|||
28134804|NCT03446885|54798710|FG000|Overall Study|Did not complete entire visit|1|||
28134805|NCT03446885|54798711|FG001|Overall Study|Did not complete entire visit|0|||
28134806|NCT00710970|54798719|FG000|Overall Study|Never took drug|3|||
28134807|NCT03421379|54798725|FG000|Period 1|Withdrawal by Subject|0|||
28134808|NCT03421379|54798726|FG001|Period 1|Withdrawal by Subject|1|||
28134809|NCT03421379|54798725|FG000|Period 1|Physician Decision|1|||
28134810|NCT03421379|54798726|FG001|Period 1|Physician Decision|1|||
28134811|NCT03421379|54798725|FG000|Period 1|Did not receive treatment|1|||
28134812|NCT03421379|54798726|FG001|Period 1|Did not receive treatment|2|||
28134813|NCT02900378|54798734|FG000|Randomization (Visit 2)|Adverse Event|14|||
28134814|NCT02900378|54798735|FG001|Randomization (Visit 2)|Adverse Event|11|||
28134815|NCT02900378|54798734|FG000|Randomization (Visit 2)|Death|1|||
28134816|NCT02900378|54798735|FG001|Randomization (Visit 2)|Death|4|||
28134817|NCT02900378|54798734|FG000|Randomization (Visit 2)|Lost to Follow-up|1|||
28134818|NCT02900378|54798735|FG001|Randomization (Visit 2)|Lost to Follow-up|0|||
28134819|NCT02900378|54798734|FG000|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
28134820|NCT02900378|54798735|FG001|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
28134821|NCT02900378|54798734|FG000|Randomization (Visit 2)|Protocol Deviation|1|||
28134822|NCT02900378|54798735|FG001|Randomization (Visit 2)|Protocol Deviation|7|||
28134823|NCT02900378|54798734|FG000|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5|||
28134824|NCT02900378|54798735|FG001|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3|||
28134825|NCT02900378|54798734|FG000|Randomization (Visit 2)|Withdrawal of Informed Consent|0|||
28134826|NCT02900378|54798735|FG001|Randomization (Visit 2)|Withdrawal of Informed Consent|2|||
28134827|NCT03058692|54798743|FG000|Overall Study|Lost to Follow-up|2|||
28134828|NCT03058692|54798744|FG001|Overall Study|Lost to Follow-up|1|||
28134829|NCT03058692|54798743|FG000|Overall Study|Withdrawal by Subject|1|||
28134830|NCT03058692|54798744|FG001|Overall Study|Withdrawal by Subject|1|||
28134831|NCT02964338|54798754|FG000|Overall Study|Sponsor terminated study for futility|12|||
28134832|NCT02964338|54798755|FG001|Overall Study|Sponsor terminated study for futility|15|||
28134833|NCT02964338|54798756|FG002|Overall Study|Sponsor terminated study for futility|14|||
28134834|NCT02964338|54798754|FG000|Overall Study|Lack of Efficacy|0|||
28134835|NCT02964338|54798755|FG001|Overall Study|Lack of Efficacy|3|||
28134836|NCT02964338|54798756|FG002|Overall Study|Lack of Efficacy|0|||
28134837|NCT02964338|54798754|FG000|Overall Study|Lost to Follow-up|1|||
28134838|NCT02964338|54798755|FG001|Overall Study|Lost to Follow-up|0|||
28134839|NCT02964338|54798756|FG002|Overall Study|Lost to Follow-up|3|||
28134840|NCT02964338|54798754|FG000|Overall Study|Protocol Violation|0|||
28134841|NCT02964338|54798755|FG001|Overall Study|Protocol Violation|1|||
28134842|NCT02964338|54798756|FG002|Overall Study|Protocol Violation|0|||
28134843|NCT02964338|54798754|FG000|Overall Study|Withdrawal by Subject|1|||
28134844|NCT02964338|54798755|FG001|Overall Study|Withdrawal by Subject|3|||
28134845|NCT02964338|54798756|FG002|Overall Study|Withdrawal by Subject|1|||
28134846|NCT02964338|54798754|FG000|Overall Study|Adverse Event|2|||
28134847|NCT02964338|54798755|FG001|Overall Study|Adverse Event|1|||
28134848|NCT02964338|54798756|FG002|Overall Study|Adverse Event|1|||
28134849|NCT02964338|54798754|FG000|Overall Study|Non-compliant with e-diary|0|||
28134850|NCT02964338|54798755|FG001|Overall Study|Non-compliant with e-diary|1|||
28134851|NCT02964338|54798756|FG002|Overall Study|Non-compliant with e-diary|0|||
28134852|NCT02964338|54798754|FG000|Overall Study|Did not meet criteria|1|||
28134853|NCT02964338|54798755|FG001|Overall Study|Did not meet criteria|0|||
28134854|NCT02964338|54798756|FG002|Overall Study|Did not meet criteria|0|||
28134855|NCT03056352|54798764|FG000|Overall Study|Lost to Follow-up|1|||
28134856|NCT02898662|54798770|FG000|Overall Study|Adverse Event|1|||
28134857|NCT02898662|54798771|FG001|Overall Study|Adverse Event|0|||
28134858|NCT02898662|54798770|FG000|Overall Study|Loss of asthma control|23|||
28134859|NCT02898662|54798771|FG001|Overall Study|Loss of asthma control|24|||
28134860|NCT02898662|54798770|FG000|Overall Study|Withdrawal by Subject|4|||
28134861|NCT02898662|54798771|FG001|Overall Study|Withdrawal by Subject|1|||
28134862|NCT02898662|54798770|FG000|Overall Study|Technical issue|0|||
28134863|NCT02898662|54798771|FG001|Overall Study|Technical issue|1|||
28134864|NCT02898662|54798770|FG000|Overall Study|Randomized in error|0|||
28134865|NCT02898662|54798771|FG001|Overall Study|Randomized in error|1|||
28134866|NCT02898662|54798770|FG000|Overall Study|Subject decision|1|||
28134867|NCT02898662|54798771|FG001|Overall Study|Subject decision|0|||
28134868|NCT02898662|54798770|FG000|Overall Study|Other|0|||
28134869|NCT02898662|54798771|FG001|Overall Study|Other|1|||
28134870|NCT03055338|54798780|FG000|Overall Study|Lost to Follow-up|9|||
28134871|NCT03055338|54798781|FG001|Overall Study|Lost to Follow-up|2|||
28134872|NCT03055338|54798782|FG002|Overall Study|Lost to Follow-up|3|||
28134873|NCT03055338|54798780|FG000|Overall Study|No Post-treatment Protocol Contact|0|||
28134874|NCT03055338|54798781|FG001|Overall Study|No Post-treatment Protocol Contact|1|||
28134875|NCT03055338|54798782|FG002|Overall Study|No Post-treatment Protocol Contact|0|||
28134876|NCT03055338|54798780|FG000|Overall Study|Physician Decision|0|||
28134877|NCT03055338|54798781|FG001|Overall Study|Physician Decision|0|||
28134878|NCT03055338|54798782|FG002|Overall Study|Physician Decision|2|||
28134879|NCT03055338|54798780|FG000|Overall Study|Withdrawal by Subject|9|||
28134880|NCT03055338|54798781|FG001|Overall Study|Withdrawal by Subject|8|||
28134881|NCT03055338|54798782|FG002|Overall Study|Withdrawal by Subject|7|||
28134882|NCT03913130|54798790|FG000|Overall Study|Sponsor Decision|1|||
28134883|NCT03419741|54798796|FG000|Overall Study|Adverse Event|1|||
28134884|NCT03419741|54798797|FG001|Overall Study|Adverse Event|0|||
28134885|NCT03419741|54798796|FG000|Overall Study|Withdrawal by Subject|1|||
28134886|NCT03419741|54798797|FG001|Overall Study|Withdrawal by Subject|2|||
28134887|NCT02896400|54798819|FG000|1 Month Follow-up|Lost to Follow-up|7|||
28134888|NCT02896400|54798820|FG001|1 Month Follow-up|Lost to Follow-up|7|||
28134889|NCT02896400|54798821|FG002|1 Month Follow-up|Lost to Follow-up|5|||
28134890|NCT02896400|54798822|FG003|1 Month Follow-up|Lost to Follow-up|8|||
28134891|NCT02896400|54798823|FG004|1 Month Follow-up|Lost to Follow-up|9|||
28134892|NCT02896400|54798824|FG005|1 Month Follow-up|Lost to Follow-up|6|||
28134893|NCT02896400|54798825|FG006|1 Month Follow-up|Lost to Follow-up|5|||
28134894|NCT02896400|54798826|FG007|1 Month Follow-up|Lost to Follow-up|6|||
28134895|NCT02896400|54798827|FG008|1 Month Follow-up|Lost to Follow-up|4|||
28134896|NCT02896400|54798828|FG009|1 Month Follow-up|Lost to Follow-up|7|||
28134897|NCT02896400|54798829|FG010|1 Month Follow-up|Lost to Follow-up|5|||
28134898|NCT02896400|54798830|FG011|1 Month Follow-up|Lost to Follow-up|5|||
28134899|NCT02896400|54798831|FG012|1 Month Follow-up|Lost to Follow-up|3|||
28134900|NCT02896400|54798832|FG013|1 Month Follow-up|Lost to Follow-up|4|||
28134901|NCT02896400|54798833|FG014|1 Month Follow-up|Lost to Follow-up|1|||
28134902|NCT02896400|54798834|FG015|1 Month Follow-up|Lost to Follow-up|2|||
28134903|NCT02896400|54798819|FG000|1 Month Follow-up|Death|0|||
28134904|NCT02896400|54798820|FG001|1 Month Follow-up|Death|0|||
28134905|NCT02896400|54798821|FG002|1 Month Follow-up|Death|0|||
28134906|NCT02896400|54798822|FG003|1 Month Follow-up|Death|0|||
28134907|NCT02896400|54798823|FG004|1 Month Follow-up|Death|0|||
28069562|NCT00043186|54724544|FG001|Overall Study|Lost to Follow-up|5|||
28069563|NCT00043186|54724545|FG002|Overall Study|Lost to Follow-up|1|||
28069564|NCT00043186|54724546|FG003|Overall Study|Lost to Follow-up|1|||
28069565|NCT00043186|54724547|FG004|Overall Study|Lost to Follow-up|1|||
28069566|NCT00043186|54724548|FG005|Overall Study|Lost to Follow-up|1|||
28069567|NCT00043186|54724549|FG006|Overall Study|Lost to Follow-up|1|||
28069568|NCT00043186|54724550|FG007|Overall Study|Lost to Follow-up|1|||
28069569|NCT00043186|54724551|FG008|Overall Study|Lost to Follow-up|2|||
28134908|NCT02896400|54798824|FG005|1 Month Follow-up|Death|0|||
28134909|NCT02896400|54798825|FG006|1 Month Follow-up|Death|0|||
28134910|NCT02896400|54798826|FG007|1 Month Follow-up|Death|0|||
28134911|NCT02896400|54798827|FG008|1 Month Follow-up|Death|0|||
28134912|NCT02896400|54798828|FG009|1 Month Follow-up|Death|0|||
28134913|NCT02896400|54798829|FG010|1 Month Follow-up|Death|0|||
28134914|NCT02896400|54798830|FG011|1 Month Follow-up|Death|0|||
28134915|NCT02896400|54798831|FG012|1 Month Follow-up|Death|0|||
28134916|NCT02896400|54798832|FG013|1 Month Follow-up|Death|0|||
28134917|NCT02896400|54798833|FG014|1 Month Follow-up|Death|0|||
28134918|NCT02896400|54798834|FG015|1 Month Follow-up|Death|1|||
28134919|NCT02896400|54798819|FG000|3 Month Follow-up|Lost to Follow-up|6|||
28069570|NCT00043186|54724543|FG000|Overall Study|Noncompliance|0|||
28134920|NCT02896400|54798820|FG001|3 Month Follow-up|Lost to Follow-up|3|||
28134921|NCT02896400|54798821|FG002|3 Month Follow-up|Lost to Follow-up|6|||
28134922|NCT02896400|54798822|FG003|3 Month Follow-up|Lost to Follow-up|11|||
28134923|NCT02896400|54798823|FG004|3 Month Follow-up|Lost to Follow-up|12|||
28134924|NCT02896400|54798824|FG005|3 Month Follow-up|Lost to Follow-up|6|||
28134925|NCT02896400|54798825|FG006|3 Month Follow-up|Lost to Follow-up|4|||
28134926|NCT02896400|54798826|FG007|3 Month Follow-up|Lost to Follow-up|3|||
28134927|NCT02896400|54798827|FG008|3 Month Follow-up|Lost to Follow-up|6|||
28134928|NCT02896400|54798828|FG009|3 Month Follow-up|Lost to Follow-up|5|||
28134929|NCT02896400|54798829|FG010|3 Month Follow-up|Lost to Follow-up|6|||
28134930|NCT02896400|54798830|FG011|3 Month Follow-up|Lost to Follow-up|6|||
28134931|NCT02896400|54798831|FG012|3 Month Follow-up|Lost to Follow-up|3|||
28134932|NCT02896400|54798832|FG013|3 Month Follow-up|Lost to Follow-up|5|||
28134933|NCT02896400|54798833|FG014|3 Month Follow-up|Lost to Follow-up|3|||
28134934|NCT02896400|54798834|FG015|3 Month Follow-up|Lost to Follow-up|2|||
28134935|NCT02896400|54798819|FG000|3 Month Follow-up|Death|0|||
28134936|NCT02896400|54798820|FG001|3 Month Follow-up|Death|0|||
28134937|NCT02896400|54798821|FG002|3 Month Follow-up|Death|0|||
28134938|NCT02896400|54798822|FG003|3 Month Follow-up|Death|0|||
28134939|NCT02896400|54798823|FG004|3 Month Follow-up|Death|0|||
28134940|NCT02896400|54798824|FG005|3 Month Follow-up|Death|0|||
28134941|NCT02896400|54798825|FG006|3 Month Follow-up|Death|0|||
28134942|NCT02896400|54798826|FG007|3 Month Follow-up|Death|0|||
28134943|NCT02896400|54798827|FG008|3 Month Follow-up|Death|0|||
28134944|NCT02896400|54798828|FG009|3 Month Follow-up|Death|0|||
28134945|NCT02896400|54798829|FG010|3 Month Follow-up|Death|0|||
28134946|NCT02896400|54798830|FG011|3 Month Follow-up|Death|0|||
28134947|NCT02896400|54798831|FG012|3 Month Follow-up|Death|0|||
28134948|NCT02896400|54798832|FG013|3 Month Follow-up|Death|1|||
28134949|NCT02896400|54798833|FG014|3 Month Follow-up|Death|1|||
28134950|NCT02896400|54798834|FG015|3 Month Follow-up|Death|0|||
28134951|NCT02896400|54798819|FG000|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
28134952|NCT02896400|54798820|FG001|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
28134953|NCT02896400|54798821|FG002|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
28134954|NCT02896400|54798822|FG003|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
28134955|NCT02896400|54798823|FG004|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
28134956|NCT02896400|54798824|FG005|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
28134957|NCT02896400|54798825|FG006|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
28134958|NCT02896400|54798826|FG007|Biochemical Verification at 3 Months|Lost to Follow-up|2|||
28134959|NCT02896400|54798827|FG008|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
28134960|NCT02896400|54798828|FG009|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
28134961|NCT02896400|54798829|FG010|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
28134962|NCT02896400|54798830|FG011|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
28134963|NCT02896400|54798831|FG012|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
28134964|NCT02896400|54798832|FG013|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
28134965|NCT02896400|54798833|FG014|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
28134966|NCT02896400|54798834|FG015|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
28134967|NCT02896400|54798819|FG000|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
28134968|NCT02896400|54798820|FG001|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
28134969|NCT02896400|54798821|FG002|Biochemical Verification at 3 Months|participant was not eligible for biochem|46|||
28134970|NCT02896400|54798822|FG003|Biochemical Verification at 3 Months|participant was not eligible for biochem|40|||
28134971|NCT02896400|54798823|FG004|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
28134972|NCT02896400|54798824|FG005|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
28134973|NCT02896400|54798825|FG006|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
28134974|NCT02896400|54798826|FG007|Biochemical Verification at 3 Months|participant was not eligible for biochem|47|||
28134975|NCT02896400|54798827|FG008|Biochemical Verification at 3 Months|participant was not eligible for biochem|44|||
28134976|NCT02896400|54798828|FG009|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
28134977|NCT02896400|54798829|FG010|Biochemical Verification at 3 Months|participant was not eligible for biochem|55|||
28134978|NCT02896400|54798830|FG011|Biochemical Verification at 3 Months|participant was not eligible for biochem|41|||
28134979|NCT02896400|54798831|FG012|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
28134980|NCT02896400|54798832|FG013|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
28134981|NCT02896400|54798833|FG014|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
28134982|NCT02896400|54798834|FG015|Biochemical Verification at 3 Months|participant was not eligible for biochem|56|||
28134983|NCT03405935|54798860|FG000|Overall Study|Adverse Event|3|||
28134984|NCT03405935|54798860|FG000|Overall Study|Death|2|||
28134985|NCT03405935|54798860|FG000|Overall Study|Withdrawal by Subject|1|||
28134986|NCT03405935|54798860|FG000|Overall Study|Lost to Follow-up|2|||
28134987|NCT03055260|54798866|FG000|Overall Study|Withdrawal by Subject|1|||
28134988|NCT03055260|54798867|FG001|Overall Study|Withdrawal by Subject|0|||
28134989|NCT03404843|54798875|FG000|Overall Study|Study difficulties unrelated to Tx|4|||
28134990|NCT03404843|54798876|FG001|Overall Study|Study difficulties unrelated to Tx|1|||
28134991|NCT03444155|54798900|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
28134992|NCT03444155|54798901|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
28134993|NCT02898116|54798907|FG000|Overall Study|Adverse Event|1|||
28134994|NCT02898116|54798907|FG000|Overall Study|Progressive disease|1|||
28134995|NCT03658304|54798911|FG000|Overall Study|participants still on follow up|8|||
28134996|NCT03422159|54798917|FG000|Overall Study|Exclusion due to terminal disease|2|||
28134997|NCT03422159|54798918|FG001|Overall Study|Exclusion due to terminal disease|1|||
28134998|NCT03403751|54798928|FG000|Overall Study|Death|5|||
28134999|NCT03403751|54798929|FG001|Overall Study|Death|6|||
28135000|NCT03403751|54798928|FG000|Overall Study|Discontinuation (includes missing from Day 29)|2|||
28135001|NCT03403751|54798929|FG001|Overall Study|Discontinuation (includes missing from Day 29)|2|||
28135002|NCT02297412|54798939|FG000|Overall Study|Canceled|1|||
28135003|NCT02297412|54798940|FG001|Overall Study|Canceled|1|||
28135004|NCT03418727|54798949|FG000|Overall Study|Adverse Event|1|||
28135005|NCT03418727|54798950|FG001|Overall Study|Adverse Event|2|||
28135006|NCT03418727|54798951|FG002|Overall Study|Adverse Event|0|||
28135007|NCT03418727|54798949|FG000|Overall Study|Withdrawal by Subject|0|||
28135008|NCT03418727|54798950|FG001|Overall Study|Withdrawal by Subject|0|||
28135009|NCT03418727|54798951|FG002|Overall Study|Withdrawal by Subject|2|||
28135010|NCT03418571|54798961|FG000|Overall Study|Consent withdrawn by legal guardian|1|||
28135011|NCT03418571|54798962|FG001|Overall Study|Consent withdrawn by legal guardian|0|||
28135012|NCT03402893|54798968|FG000|Overall Study|Withdrawal by Subject|1|||
28135013|NCT03442985|54798976|FG000|Overall Study|Sponsor Request|55|||
28135014|NCT03442985|54798977|FG001|Overall Study|Sponsor Request|60|||
28135015|NCT03442985|54798978|FG002|Overall Study|Sponsor Request|54|||
28135016|NCT03442985|54798976|FG000|Overall Study|Lost to Follow-up|5|||
28135017|NCT03442985|54798977|FG001|Overall Study|Lost to Follow-up|2|||
28135018|NCT03442985|54798978|FG002|Overall Study|Lost to Follow-up|7|||
28135019|NCT03442985|54798976|FG000|Overall Study|Withdrawal by Subject|2|||
28135020|NCT03442985|54798977|FG001|Overall Study|Withdrawal by Subject|3|||
28135021|NCT03442985|54798978|FG002|Overall Study|Withdrawal by Subject|4|||
28135022|NCT03442985|54798976|FG000|Overall Study|Adverse Event|0|||
28135023|NCT03442985|54798977|FG001|Overall Study|Adverse Event|1|||
28135024|NCT03442985|54798978|FG002|Overall Study|Adverse Event|0|||
28135025|NCT01318122|54798990|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
28135026|NCT01318122|54798991|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
28135027|NCT01318122|54798992|FG002|Enrolled - Long-Term Extension Study|Adverse Event|2|||
28135028|NCT01318122|54798993|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
28135029|NCT01318122|54798990|FG000|Enrolled - Long-Term Extension Study|Other|1|||
28135030|NCT01318122|54798991|FG001|Enrolled - Long-Term Extension Study|Other|0|||
28135031|NCT01318122|54798992|FG002|Enrolled - Long-Term Extension Study|Other|0|||
28135032|NCT01318122|54798993|FG003|Enrolled - Long-Term Extension Study|Other|0|||
28135033|NCT01318122|54798990|FG000|Entered - Long-Term Extension Study|Adverse Event|6|||
28135034|NCT01318122|54798991|FG001|Entered - Long-Term Extension Study|Adverse Event|6|||
28135035|NCT01318122|54798992|FG002|Entered - Long-Term Extension Study|Adverse Event|2|||
28135036|NCT01318122|54798993|FG003|Entered - Long-Term Extension Study|Adverse Event|4|||
28135037|NCT01318122|54798990|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|1|||
28135038|NCT01318122|54798991|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
28135039|NCT01318122|54798992|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
28135040|NCT01318122|54798993|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
28135041|NCT01318122|54798990|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
28135042|NCT01318122|54798991|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|3|||
28135043|NCT01318122|54798992|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
28135044|NCT01318122|54798993|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
28135045|NCT01318122|54798990|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
28135046|NCT01318122|54798991|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
28135047|NCT01318122|54798992|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
28135048|NCT01318122|54798993|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
28135049|NCT02954159|54799001|FG000|Overall Study|Study ended prematurely due to low enrol|1|||
28135050|NCT02954159|54799002|FG001|Overall Study|Study ended prematurely due to low enrol|0|||
28135051|NCT02954159|54799001|FG000|Overall Study|Withdrawal by Subject|0|||
28135052|NCT02954159|54799002|FG001|Overall Study|Withdrawal by Subject|1|||
28135053|NCT03442829|54799010|FG000|Overall Study|Scheduling clash|3|||
28135054|NCT03442829|54799011|FG001|Overall Study|Scheduling clash|1|||
28135055|NCT03442829|54799010|FG000|Overall Study|Illness unrelated to study|1|||
28135056|NCT03442829|54799011|FG001|Overall Study|Illness unrelated to study|1|||
28135057|NCT03442595|54799019|FG000|Overall Study|Lost to Follow-up|94|||
28135058|NCT03442595|54799020|FG001|Overall Study|Lost to Follow-up|0|||
28135059|NCT03440411|54799029|FG000|Overall Study|Adverse Event|0|||
28135060|NCT03440411|54799030|FG001|Overall Study|Adverse Event|0|||
28135061|NCT03440411|54799031|FG002|Overall Study|Adverse Event|1|||
28135062|NCT03440411|54799032|FG003|Overall Study|Adverse Event|0|||
28135063|NCT03440411|54799029|FG000|Overall Study|PD|2|||
28135064|NCT03440411|54799030|FG001|Overall Study|PD|1|||
28135065|NCT03440411|54799031|FG002|Overall Study|PD|1|||
28135066|NCT03440411|54799032|FG003|Overall Study|PD|1|||
28135067|NCT03440411|54799029|FG000|Overall Study|Withdrawal by Subject|1|||
28135068|NCT03440411|54799030|FG001|Overall Study|Withdrawal by Subject|0|||
28135069|NCT03440411|54799031|FG002|Overall Study|Withdrawal by Subject|0|||
28135070|NCT03440411|54799032|FG003|Overall Study|Withdrawal by Subject|0|||
28135071|NCT03440411|54799029|FG000|Overall Study|Closed study by sponsor|0|||
28135072|NCT03440411|54799030|FG001|Overall Study|Closed study by sponsor|0|||
28135073|NCT03440411|54799031|FG002|Overall Study|Closed study by sponsor|0|||
28135074|NCT03440411|54799032|FG003|Overall Study|Closed study by sponsor|1|||
28135075|NCT03438539|54799053|FG000|Overall Study|Lost to Follow-up|8|||
28135076|NCT03438539|54799054|FG001|Overall Study|Lost to Follow-up|4|||
28135077|NCT03438539|54799055|FG002|Overall Study|Lost to Follow-up|10|||
28135078|NCT03438539|54799056|FG003|Overall Study|Lost to Follow-up|9|||
28135079|NCT03438539|54799057|FG004|Overall Study|Lost to Follow-up|3|||
28135080|NCT03438539|54799058|FG005|Overall Study|Lost to Follow-up|8|||
28135081|NCT03400787|54799074|FG000|Overall Study|Lost to Follow-up|1|||
28135082|NCT03400787|54799075|FG001|Overall Study|Lost to Follow-up|0|||
28135083|NCT03400787|54799074|FG000|Overall Study|Death|1|||
28135084|NCT03400787|54799075|FG001|Overall Study|Death|0|||
28135085|NCT03400787|54799074|FG000|Overall Study|Protocol Violation|0|||
28135086|NCT03400787|54799075|FG001|Overall Study|Protocol Violation|2|||
28135087|NCT03400787|54799074|FG000|Overall Study|Unblinded before 3-month follow-upa-|0|||
28135088|NCT03400787|54799075|FG001|Overall Study|Unblinded before 3-month follow-upa-|6|||
28135089|NCT03417245|54799083|FG000|Overall Study|Adverse Event|1|||
28135090|NCT03417245|54799084|FG001|Overall Study|Adverse Event|0|||
28135091|NCT03417245|54799083|FG000|Overall Study|Protocol Violation|1|||
28135092|NCT03417245|54799084|FG001|Overall Study|Protocol Violation|0|||
28135093|NCT03417245|54799083|FG000|Overall Study|Withdrawal by Subject|1|||
28135094|NCT03417245|54799084|FG001|Overall Study|Withdrawal by Subject|1|||
28135095|NCT03389555|54799092|FG000|Overall Study|Protocol Violation|1|||
28135096|NCT03389555|54799093|FG001|Overall Study|Protocol Violation|3|||
28135097|NCT03389555|54799092|FG000|Overall Study|Death|1|||
28135098|NCT03389555|54799093|FG001|Overall Study|Death|0|||
28135099|NCT03395639|54799101|FG000|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
28135100|NCT03395639|54799102|FG001|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
28135101|NCT03395639|54799103|FG002|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|0|||
28135102|NCT03395639|54799101|FG000|Main Treatment Period (0 to 4 Months)|Adverse Event|1|||
28135103|NCT03395639|54799102|FG001|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
28135104|NCT03395639|54799103|FG002|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
28135105|NCT03395639|54799101|FG000|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
28135106|NCT03395639|54799102|FG001|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|1|||
28135107|NCT03395639|54799103|FG002|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
28135108|NCT03395639|54799101|FG000|Extension Period (4-13 Months)|Adverse Event|0|||
28135109|NCT03395639|54799102|FG001|Extension Period (4-13 Months)|Adverse Event|0|||
28135110|NCT03395639|54799103|FG002|Extension Period (4-13 Months)|Adverse Event|2|||
28135111|NCT03395639|54799101|FG000|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
28135112|NCT03395639|54799102|FG001|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
28135113|NCT03395639|54799103|FG002|Extension Period (4-13 Months)|Subject discontinued at PI discretion|1|||
28135114|NCT03353922|54799110|FG000|Overall Study|Withdrawal by Subject|1|||
28135115|NCT03353922|54799111|FG001|Overall Study|Withdrawal by Subject|0|||
28135116|NCT03353922|54799112|FG002|Overall Study|Withdrawal by Subject|1|||
27819953|NCT01416441|54279940|FG000|Overall Study|Sponsor Discontinued Trial Site|43|||
28135117|NCT03353922|54799113|FG003|Overall Study|Withdrawal by Subject|1|||
28135118|NCT03353922|54799114|FG004|Overall Study|Withdrawal by Subject|0|||
28135119|NCT03353922|54799115|FG005|Overall Study|Withdrawal by Subject|0|||
28135120|NCT03353922|54799110|FG000|Overall Study|Adverse Event|0|||
28135121|NCT03353922|54799111|FG001|Overall Study|Adverse Event|1|||
27819954|NCT01416441|54279940|FG000|Overall Study|Subject Met Withdrawal Criteria|10|||
28135122|NCT03353922|54799112|FG002|Overall Study|Adverse Event|0|||
28135123|NCT03353922|54799113|FG003|Overall Study|Adverse Event|0|||
28135124|NCT03353922|54799114|FG004|Overall Study|Adverse Event|0|||
28135125|NCT03353922|54799115|FG005|Overall Study|Adverse Event|0|||
28135126|NCT03395405|54799128|FG000|Overall Study|Death|0|||
28135127|NCT03395405|54799129|FG001|Overall Study|Death|2|||
28135128|NCT03395405|54799128|FG000|Overall Study|Lost to Follow-up|0|||
28135129|NCT03395405|54799129|FG001|Overall Study|Lost to Follow-up|1|||
28135130|NCT03395405|54799128|FG000|Overall Study|Protocol Violation|0|||
28135131|NCT03395405|54799129|FG001|Overall Study|Protocol Violation|1|||
28135132|NCT03395405|54799128|FG000|Overall Study|Withdrawal by Subject|3|||
28135133|NCT03395405|54799129|FG001|Overall Study|Withdrawal by Subject|1|||
28135134|NCT03395405|54799128|FG000|Overall Study|COVID-19 Pandemic|1|||
28135135|NCT03395405|54799129|FG001|Overall Study|COVID-19 Pandemic|0|||
28135136|NCT03387683|54799137|FG000|Overall Study|In receipt of disallowed medication|1|||
28135137|NCT03387683|54799138|FG001|Overall Study|In receipt of disallowed medication|0|||
28135138|NCT03387683|54799137|FG000|Overall Study|Did not receive treatment|1|||
28135139|NCT03387683|54799138|FG001|Overall Study|Did not receive treatment|0|||
28135140|NCT03387059|54799146|FG000|Overall Study|Study termination|5|||
28135141|NCT03387059|54799147|FG001|Overall Study|Study termination|4|||
28135142|NCT02942004|54799156|FG000|Overall Study|Withdrawal by Subject|0|||
28135143|NCT02942004|54799157|FG001|Overall Study|Withdrawal by Subject|2|||
28135144|NCT02942004|54799158|FG002|Overall Study|Withdrawal by Subject|3|||
28135145|NCT02942004|54799156|FG000|Overall Study|Lost to Follow-up|1|||
28135146|NCT02942004|54799157|FG001|Overall Study|Lost to Follow-up|1|||
28135147|NCT02942004|54799158|FG002|Overall Study|Lost to Follow-up|2|||
28135148|NCT02942004|54799156|FG000|Overall Study|Randomized but not dosed|3|||
28135149|NCT02942004|54799157|FG001|Overall Study|Randomized but not dosed|9|||
28135150|NCT02942004|54799158|FG002|Overall Study|Randomized but not dosed|4|||
28135151|NCT03394391|54799168|FG000|Overall Study|Lost to Follow-up|1|||
28135152|NCT03394391|54799169|FG001|Overall Study|Lost to Follow-up|2|||
28135153|NCT03386435|54799177|FG000|Overall Study|Protocol Violation|5|||
28135154|NCT03386435|54799178|FG001|Overall Study|Protocol Violation|7|||
28135155|NCT02726880|54799186|FG000|Overall Study|Withdrawal by Subject|2|||
28135156|NCT02726880|54799187|FG001|Overall Study|Withdrawal by Subject|0|||
28135157|NCT02726880|54799186|FG000|Overall Study|Lost to Follow-up|1|||
28135158|NCT02726880|54799187|FG001|Overall Study|Lost to Follow-up|3|||
28135159|NCT03275389|54799204|FG000|Overall Study|Lost to Follow-up|10|||
28135160|NCT03275389|54799205|FG001|Overall Study|Lost to Follow-up|10|||
28135161|NCT03275389|54799206|FG002|Overall Study|Lost to Follow-up|19|||
28135162|NCT03275389|54799207|FG003|Overall Study|Lost to Follow-up|12|||
28135163|NCT03275389|54799208|FG004|Overall Study|Lost to Follow-up|11|||
28135164|NCT03275389|54799209|FG005|Overall Study|Lost to Follow-up|12|||
28135165|NCT03275389|54799210|FG006|Overall Study|Lost to Follow-up|21|||
28135166|NCT03275389|54799211|FG007|Overall Study|Lost to Follow-up|15|||
28135167|NCT03275389|54799212|FG008|Overall Study|Lost to Follow-up|12|||
28135168|NCT03275389|54799213|FG009|Overall Study|Lost to Follow-up|14|||
28135169|NCT03275389|54799204|FG000|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
28135170|NCT03275389|54799205|FG001|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
28135171|NCT03275389|54799206|FG002|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
28135172|NCT03275389|54799207|FG003|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
28135173|NCT03275389|54799208|FG004|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
28135174|NCT03275389|54799209|FG005|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
28135175|NCT03275389|54799210|FG006|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
28135176|NCT03275389|54799211|FG007|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
28135177|NCT03275389|54799212|FG008|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
28135178|NCT03275389|54799213|FG009|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
28135179|NCT03275389|54799204|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
28135180|NCT03275389|54799205|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
28135181|NCT03275389|54799206|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
28135182|NCT03275389|54799207|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
28135183|NCT03275389|54799208|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
28135184|NCT03275389|54799209|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
28135185|NCT03275389|54799210|FG006|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
28135186|NCT03275389|54799211|FG007|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
28135187|NCT03275389|54799212|FG008|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
28135188|NCT03275389|54799213|FG009|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
28135189|NCT03275389|54799204|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
28135190|NCT03275389|54799205|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
28135191|NCT03275389|54799206|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
28135192|NCT03275389|54799207|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
28135193|NCT03275389|54799208|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
28135194|NCT03275389|54799209|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
28135195|NCT03275389|54799210|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
28135196|NCT03275389|54799211|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
28135197|NCT03275389|54799212|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
28135198|NCT03275389|54799213|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
28135199|NCT03275389|54799204|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
28135200|NCT03275389|54799205|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
28135201|NCT03275389|54799206|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
28135202|NCT03275389|54799207|FG003|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
28135203|NCT03275389|54799208|FG004|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
28135204|NCT03275389|54799209|FG005|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
28135205|NCT03275389|54799210|FG006|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
28135206|NCT03275389|54799211|FG007|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
28135207|NCT03275389|54799212|FG008|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
28135208|NCT03275389|54799213|FG009|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
28135209|NCT03275389|54799204|FG000|Overall Study|Other|0|||
28135210|NCT03275389|54799205|FG001|Overall Study|Other|4|||
28135211|NCT03275389|54799206|FG002|Overall Study|Other|3|||
28135212|NCT03275389|54799207|FG003|Overall Study|Other|2|||
28135213|NCT03275389|54799208|FG004|Overall Study|Other|2|||
28135214|NCT03275389|54799209|FG005|Overall Study|Other|2|||
28135215|NCT03275389|54799210|FG006|Overall Study|Other|0|||
28135216|NCT03275389|54799211|FG007|Overall Study|Other|0|||
28135217|NCT03275389|54799212|FG008|Overall Study|Other|1|||
28135218|NCT03275389|54799213|FG009|Overall Study|Other|0|||
28135219|NCT03414983|54799237|FG000|Pre-Treatment|Other reasons|1|||
28135220|NCT03414983|54799238|FG001|Pre-Treatment|Other reasons|0|||
28135221|NCT03414983|54799237|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
28135222|NCT03414983|54799238|FG001|Pre-Treatment|Participant no longer meets study criteria|3|||
28135223|NCT03414983|54799237|FG000|Pre-Treatment|Participant withdrew consent|1|||
28135224|NCT03414983|54799238|FG001|Pre-Treatment|Participant withdrew consent|3|||
28135225|NCT03414983|54799237|FG000|Treatment|Participant withdrew consent|4|||
28135226|NCT03414983|54799238|FG001|Treatment|Participant withdrew consent|3|||
28135227|NCT03414983|54799237|FG000|Treatment|Participant request to discontinue study treatment|8|||
28135228|NCT03414983|54799238|FG001|Treatment|Participant request to discontinue study treatment|10|||
28135229|NCT03414983|54799237|FG000|Treatment|Adverse Event Unrelated to Study Drug|5|||
28135230|NCT03414983|54799238|FG001|Treatment|Adverse Event Unrelated to Study Drug|2|||
28135231|NCT03414983|54799237|FG000|Treatment|Death|0|||
27819955|NCT01416441|54279940|FG000|Overall Study|Investigator Withdrew Subject|2|||
27819956|NCT01416441|54279940|FG000|Overall Study|Subject Withdrew Consent|12|||
27819957|NCT01416441|54279940|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|3|||
27819958|NCT01436253|54279949|FG000|Overall Study|Lost to Follow-up|182|||
28135232|NCT03414983|54799238|FG001|Treatment|Death|2|||
28135233|NCT03414983|54799237|FG000|Treatment|Study Drug Toxicity|11|||
28135234|NCT03414983|54799238|FG001|Treatment|Study Drug Toxicity|4|||
28135235|NCT03414983|54799237|FG000|Treatment|Disease Progression|72|||
28135236|NCT03414983|54799238|FG001|Treatment|Disease Progression|27|||
28135237|NCT03414983|54799237|FG000|Treatment|Not reported|1|||
28135238|NCT03414983|54799238|FG001|Treatment|Not reported|0|||
28135239|NCT03414983|54799237|FG000|Treatment|Other reasons|3|||
27819959|NCT01436253|54279949|FG000|Overall Study|Not meeting all eligibility criteria|117|||
27819960|NCT01454583|54280862|FG000|1st Year|Lost to Follow-up|1057|||
27819961|NCT01454583|54280863|FG001|1st Year|Lost to Follow-up|318|||
28135240|NCT03414983|54799238|FG001|Treatment|Other reasons|2|||
28135241|NCT03414983|54799237|FG000|Treatment|Completed treatment as per protocol|8|||
28135242|NCT03414983|54799238|FG001|Treatment|Completed treatment as per protocol|0|||
28135243|NCT03414983|54799237|FG000|Treatment|Poor/non-compliance|2|||
27819962|NCT01454583|54280864|FG002|1st Year|Lost to Follow-up|180|||
27819963|NCT01454583|54280862|FG000|2nd Year|Lost to Follow-up|3965|||
27819964|NCT01454583|54280863|FG001|2nd Year|Lost to Follow-up|1049|||
27819965|NCT01454583|54280864|FG002|2nd Year|Lost to Follow-up|737|||
27819966|NCT01454583|54280862|FG000|3rd Year|Lost to Follow-up|1959|||
27819967|NCT01454583|54280863|FG001|3rd Year|Lost to Follow-up|512|||
27819968|NCT01454583|54280864|FG002|3rd Year|Lost to Follow-up|297|||
27819969|NCT01436175|54280887|FG000|Overall Study|Adverse Event|111|||
28135244|NCT03414983|54799238|FG001|Treatment|Poor/non-compliance|0|||
28135245|NCT03414983|54799237|FG000|Treatment|Maximum clinical benefit|5|||
28135246|NCT03414983|54799238|FG001|Treatment|Maximum clinical benefit|9|||
28135247|NCT03414983|54799237|FG000|Treatment|Lost to Follow-up|0|||
28135248|NCT03414983|54799238|FG001|Treatment|Lost to Follow-up|1|||
28135249|NCT03414359|54799246|FG000|Overall Study|Lack of Efficacy|1|||
28135250|NCT03414359|54799247|FG001|Overall Study|Lack of Efficacy|1|||
28135251|NCT03414359|54799246|FG000|Overall Study|Protocol Violation|0|||
28135252|NCT03414359|54799247|FG001|Overall Study|Protocol Violation|1|||
28135253|NCT03285295|54799258|FG000|Alinity s HBsAg|Protocol Violation|11|||
28135254|NCT03285295|54799259|FG001|Alinity s HBsAg|Protocol Violation|0|||
28135255|NCT03285295|54799260|FG002|Alinity s HBsAg|Protocol Violation|0|||
28135256|NCT03285295|54799261|FG003|Alinity s HBsAg|Protocol Violation|0|||
28135257|NCT03285295|54799262|FG004|Alinity s HBsAg|Protocol Violation|0|||
28135258|NCT03285295|54799258|FG000|Alinity s HBsAg|No Result on Comparator Assay|17|||
28135259|NCT03285295|54799259|FG001|Alinity s HBsAg|No Result on Comparator Assay|0|||
28135260|NCT03285295|54799260|FG002|Alinity s HBsAg|No Result on Comparator Assay|0|||
28135261|NCT03285295|54799261|FG003|Alinity s HBsAg|No Result on Comparator Assay|0|||
28135262|NCT03285295|54799262|FG004|Alinity s HBsAg|No Result on Comparator Assay|0|||
28135263|NCT03285295|54799258|FG000|Alinity s HBsAg|No Results Generated|74|||
28135264|NCT03285295|54799259|FG001|Alinity s HBsAg|No Results Generated|6|||
28135265|NCT03285295|54799260|FG002|Alinity s HBsAg|No Results Generated|0|||
28135266|NCT03285295|54799261|FG003|Alinity s HBsAg|No Results Generated|0|||
28135267|NCT03285295|54799262|FG004|Alinity s HBsAg|No Results Generated|0|||
28135268|NCT03285295|54799258|FG000|Alinity s HTLV I/II|Protocol Violation|6|||
28135269|NCT03285295|54799259|FG001|Alinity s HTLV I/II|Protocol Violation|0|||
28135270|NCT03285295|54799260|FG002|Alinity s HTLV I/II|Protocol Violation|0|||
28135271|NCT03285295|54799261|FG003|Alinity s HTLV I/II|Protocol Violation|0|||
28135272|NCT03285295|54799262|FG004|Alinity s HTLV I/II|Protocol Violation|0|||
28135273|NCT03285295|54799258|FG000|Alinity s HTLV I/II|No Result on Comparator Assay|15|||
28135274|NCT03285295|54799259|FG001|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
28135275|NCT03285295|54799260|FG002|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
28135276|NCT03285295|54799261|FG003|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
28135277|NCT03285295|54799262|FG004|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
28135278|NCT03285295|54799258|FG000|Alinity s HTLV I/II|No Results Generated|70|||
28135279|NCT03285295|54799259|FG001|Alinity s HTLV I/II|No Results Generated|0|||
28135280|NCT03285295|54799260|FG002|Alinity s HTLV I/II|No Results Generated|0|||
28135281|NCT03285295|54799261|FG003|Alinity s HTLV I/II|No Results Generated|0|||
28135282|NCT03285295|54799262|FG004|Alinity s HTLV I/II|No Results Generated|0|||
28135283|NCT03285295|54799258|FG000|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4|||
28135284|NCT03285295|54799259|FG001|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
28135285|NCT03285295|54799260|FG002|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
28135286|NCT03285295|54799261|FG003|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
28135287|NCT03285295|54799262|FG004|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
28135288|NCT03285295|54799258|FG000|Alinity s Anti-HCV|Protocol Violation|12|||
28135289|NCT03285295|54799259|FG001|Alinity s Anti-HCV|Protocol Violation|0|||
28135290|NCT03285295|54799260|FG002|Alinity s Anti-HCV|Protocol Violation|0|||
28135291|NCT03285295|54799261|FG003|Alinity s Anti-HCV|Protocol Violation|0|||
28135292|NCT03285295|54799262|FG004|Alinity s Anti-HCV|Protocol Violation|0|||
28135293|NCT03285295|54799258|FG000|Alinity s Anti-HCV|No Results on Comparator Assay|13|||
28135294|NCT03285295|54799259|FG001|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
28135295|NCT03285295|54799260|FG002|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
28135296|NCT03285295|54799261|FG003|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
28135297|NCT03285295|54799262|FG004|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
28135298|NCT03285295|54799258|FG000|Alinity s Anti-HCV|No Results Generated|71|||
28135299|NCT03285295|54799259|FG001|Alinity s Anti-HCV|No Results Generated|0|||
28135300|NCT03285295|54799260|FG002|Alinity s Anti-HCV|No Results Generated|0|||
28135301|NCT03285295|54799261|FG003|Alinity s Anti-HCV|No Results Generated|0|||
28135302|NCT03285295|54799262|FG004|Alinity s Anti-HCV|No Results Generated|0|||
28135303|NCT03285295|54799258|FG000|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18|||
27819970|NCT01436175|54280887|FG000|Overall Study|Protocol Violation|49|||
27819971|NCT01436175|54280887|FG000|Overall Study|Withdrawal by Subject|108|||
27819972|NCT01436175|54280887|FG000|Overall Study|Lost to Follow-up|89|||
27819973|NCT01436175|54280887|FG000|Overall Study|Lack of Efficacy|24|||
28135304|NCT03285295|54799259|FG001|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
27819974|NCT01436175|54280887|FG000|Overall Study|Met blood pressure or pulse withdrawal|63|||
28135305|NCT03285295|54799260|FG002|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
28135306|NCT03285295|54799261|FG003|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
28135307|NCT03285295|54799262|FG004|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
28135308|NCT03285295|54799258|FG000|Alinity s HIV Ag/Ab Combo|Protocol Violation|11|||
28135309|NCT03285295|54799259|FG001|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
28135310|NCT03285295|54799260|FG002|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
28135311|NCT03285295|54799261|FG003|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
28135312|NCT03285295|54799262|FG004|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
28135313|NCT03285295|54799258|FG000|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16|||
28135314|NCT03285295|54799259|FG001|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
28135315|NCT03285295|54799260|FG002|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
28135316|NCT03285295|54799261|FG003|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
28135317|NCT03285295|54799262|FG004|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
28135318|NCT03285295|54799258|FG000|Alinity s HIV Ag/Ab Combo|No Results Generated|72|||
28135319|NCT03285295|54799259|FG001|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
28135320|NCT03285295|54799260|FG002|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
28135321|NCT03285295|54799261|FG003|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
28135322|NCT03285295|54799262|FG004|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
28135323|NCT03285295|54799258|FG000|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11|||
28135324|NCT03285295|54799259|FG001|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
28135325|NCT03285295|54799260|FG002|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
28135326|NCT03285295|54799261|FG003|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
28135327|NCT03285295|54799262|FG004|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
28135328|NCT03285295|54799258|FG000|Alinity s Anti-HBc|Protocol Violation|8|||
28135329|NCT03285295|54799259|FG001|Alinity s Anti-HBc|Protocol Violation|0|||
28135330|NCT03285295|54799260|FG002|Alinity s Anti-HBc|Protocol Violation|0|||
28135331|NCT03285295|54799261|FG003|Alinity s Anti-HBc|Protocol Violation|0|||
28135332|NCT03285295|54799262|FG004|Alinity s Anti-HBc|Protocol Violation|0|||
28135333|NCT03285295|54799258|FG000|Alinity s Anti-HBc|No Results on Comparator Assay|13|||
28135334|NCT03285295|54799259|FG001|Alinity s Anti-HBc|No Results on Comparator Assay|1|||
28135335|NCT03285295|54799260|FG002|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
28135336|NCT03285295|54799261|FG003|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
28135337|NCT03285295|54799262|FG004|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
28135338|NCT03285295|54799258|FG000|Alinity s Anti-HBc|No Results Generated|70|||
28135339|NCT03285295|54799259|FG001|Alinity s Anti-HBc|No Results Generated|0|||
28135340|NCT03285295|54799260|FG002|Alinity s Anti-HBc|No Results Generated|0|||
28135341|NCT03285295|54799261|FG003|Alinity s Anti-HBc|No Results Generated|0|||
28135342|NCT03285295|54799262|FG004|Alinity s Anti-HBc|No Results Generated|0|||
28135343|NCT03285295|54799258|FG000|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14|||
28135344|NCT03285295|54799259|FG001|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
28135345|NCT03285295|54799260|FG002|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
28135346|NCT03285295|54799261|FG003|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
28135347|NCT03285295|54799262|FG004|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
28135348|NCT03285295|54799258|FG000|Alinity s Chagas|Protocol Violation|76|||
28135349|NCT03285295|54799259|FG001|Alinity s Chagas|Protocol Violation|0|||
28135350|NCT03285295|54799260|FG002|Alinity s Chagas|Protocol Violation|0|||
28135351|NCT03285295|54799261|FG003|Alinity s Chagas|Protocol Violation|0|||
28135352|NCT03285295|54799262|FG004|Alinity s Chagas|Protocol Violation|0|||
28135353|NCT03285295|54799258|FG000|Alinity s Chagas|No Results on Comparator Assay|38|||
28135354|NCT03285295|54799259|FG001|Alinity s Chagas|No Results on Comparator Assay|0|||
28135355|NCT03285295|54799260|FG002|Alinity s Chagas|No Results on Comparator Assay|0|||
28135356|NCT03285295|54799261|FG003|Alinity s Chagas|No Results on Comparator Assay|0|||
28135357|NCT03285295|54799262|FG004|Alinity s Chagas|No Results on Comparator Assay|0|||
28135358|NCT03285295|54799258|FG000|Alinity s Chagas|No Results Generated|105|||
28135359|NCT03285295|54799259|FG001|Alinity s Chagas|No Results Generated|0|||
28135360|NCT03285295|54799260|FG002|Alinity s Chagas|No Results Generated|0|||
28135361|NCT03285295|54799261|FG003|Alinity s Chagas|No Results Generated|0|||
28135362|NCT03285295|54799262|FG004|Alinity s Chagas|No Results Generated|0|||
28135363|NCT03285295|54799258|FG000|Alinity s Chagas Follow-Up|Lost to Follow-up|13|||
27819975|NCT01436175|54280887|FG000|Overall Study|Other|826|||
27819976|NCT01453725|54280915|FG000|Overall Study|Adverse Event|3|||
27819977|NCT01453725|54280916|FG001|Overall Study|Adverse Event|3|||
27819978|NCT01453725|54280915|FG000|Overall Study|Lost to Follow-up|4|||
28135364|NCT03285295|54799259|FG001|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
28135365|NCT03285295|54799260|FG002|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
28135366|NCT03285295|54799261|FG003|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
28135367|NCT03285295|54799262|FG004|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
28135368|NCT02583048|54799294|FG000|Overall Study|Withdrawal by Subject|0|||
28135369|NCT02583048|54799295|FG001|Overall Study|Withdrawal by Subject|1|||
28135370|NCT02583048|54799296|FG002|Overall Study|Withdrawal by Subject|0|||
28135371|NCT02583048|54799294|FG000|Overall Study|Failed to meet eligibility criterion|0|||
27819979|NCT01453725|54280916|FG001|Overall Study|Lost to Follow-up|0|||
28135372|NCT02583048|54799295|FG001|Overall Study|Failed to meet eligibility criterion|0|||
28135373|NCT02583048|54799296|FG002|Overall Study|Failed to meet eligibility criterion|1|||
28135374|NCT02939599|54799309|FG000|Overall Study|Adverse Event|1|||
28135375|NCT02939599|54799310|FG001|Overall Study|Adverse Event|0|||
28135376|NCT02939599|54799309|FG000|Overall Study|Study Terminated By Sponsor|2|||
28135377|NCT02939599|54799310|FG001|Overall Study|Study Terminated By Sponsor|2|||
28135378|NCT01318512|54799317|FG000|Maintenance Period (6 Months)|Death|2|||
28135379|NCT01318512|54799317|FG000|Maintenance Period (6 Months)|Protocol Violation|9|||
28135380|NCT03274687|54799338|FG000|Overall Study|Protocol Violation|1|||
28135381|NCT03274687|54799339|FG001|Overall Study|Protocol Violation|1|||
28135382|NCT04651218|54799345|FG000|Overall Study|Withdrawal by Subject|0|||
28135383|NCT04651218|54799346|FG001|Overall Study|Withdrawal by Subject|2|||
28135384|NCT03274453|54799356|FG000|Overall Study|Lost to Follow-up|2|||
28135385|NCT03274453|54799357|FG001|Overall Study|Lost to Follow-up|5|||
28135386|NCT03274453|54799358|FG002|Overall Study|Lost to Follow-up|4|||
28135387|NCT03274453|54799359|FG003|Overall Study|Lost to Follow-up|1|||
28135388|NCT03274453|54799356|FG000|Overall Study|Physician Decision|2|||
28135389|NCT03274453|54799357|FG001|Overall Study|Physician Decision|0|||
28135390|NCT03274453|54799358|FG002|Overall Study|Physician Decision|0|||
28135391|NCT03274453|54799359|FG003|Overall Study|Physician Decision|3|||
28135392|NCT03274453|54799356|FG000|Overall Study|Surgery Cancelled|0|||
28135393|NCT03274453|54799357|FG001|Overall Study|Surgery Cancelled|1|||
28135394|NCT03274453|54799358|FG002|Overall Study|Surgery Cancelled|0|||
28135395|NCT03274453|54799359|FG003|Overall Study|Surgery Cancelled|0|||
28135396|NCT03273907|54799369|FG000|Overall Study|Death|1|||
28135397|NCT03273907|54799369|FG000|Overall Study|Lost to Follow-up|4|||
28135398|NCT03273907|54799369|FG000|Overall Study|Withdrawal by Subject|2|||
28135399|NCT03273907|54799369|FG000|Overall Study|COVID 19|2|||
28135400|NCT00659646|54799391|FG000|Overall Study|Protocol Violation|12|||
28135401|NCT00659646|54799392|FG001|Overall Study|Protocol Violation|8|||
28135402|NCT00659646|54799391|FG000|Overall Study|Adverse Event|1|||
28135403|NCT00659646|54799392|FG001|Overall Study|Adverse Event|0|||
28135404|NCT00659646|54799391|FG000|Overall Study|Lost to Follow-up|1|||
28135405|NCT00659646|54799392|FG001|Overall Study|Lost to Follow-up|0|||
28135406|NCT00659646|54799391|FG000|Overall Study|protocol noncompliance after randomized|1|||
28135407|NCT00659646|54799392|FG001|Overall Study|protocol noncompliance after randomized|0|||
28135408|NCT02236572|54799400|FG000|Overall Study|Withdrawal by Subject|1|||
28135409|NCT02236572|54799400|FG000|Overall Study|Protocol Violation|1|||
28135410|NCT02236572|54799400|FG000|Overall Study|Lost to Follow-up|1|||
28135411|NCT03054870|54799404|FG000|Day of Ventilation Imaging|Protocol Violation|4|||
28135412|NCT03054870|54799404|FG000|Day of Ventilation Imaging|Lost to Follow-up|1|||
28135413|NCT03414047|54799423|FG000|Overall Study|Adverse Event|0|||
28135414|NCT03414047|54799424|FG001|Overall Study|Adverse Event|0|||
28135415|NCT03414047|54799425|FG002|Overall Study|Adverse Event|1|||
28135416|NCT03414047|54799426|FG003|Overall Study|Adverse Event|1|||
28135417|NCT03414047|54799423|FG000|Overall Study|Physician Decision|1|||
28135418|NCT03414047|54799424|FG001|Overall Study|Physician Decision|0|||
28135419|NCT03414047|54799425|FG002|Overall Study|Physician Decision|0|||
28135420|NCT03414047|54799426|FG003|Overall Study|Physician Decision|1|||
28135421|NCT03414047|54799423|FG000|Overall Study|Withdrawal by Subject|1|||
28135422|NCT03414047|54799424|FG001|Overall Study|Withdrawal by Subject|0|||
28135423|NCT03414047|54799425|FG002|Overall Study|Withdrawal by Subject|2|||
28135424|NCT03414047|54799426|FG003|Overall Study|Withdrawal by Subject|0|||
28135425|NCT03351335|54799440|FG000|Overall Study|Failure to maintain inclusion/exclusion|0|||
27819980|NCT01453725|54280915|FG000|Overall Study|Non-compliance With Protocol|1|||
27819981|NCT01453725|54280916|FG001|Overall Study|Non-compliance With Protocol|2|||
27819982|NCT01453725|54280915|FG000|Overall Study|Protocol Violation|1|||
28135426|NCT03351335|54799441|FG001|Overall Study|Failure to maintain inclusion/exclusion|0|||
28135427|NCT03351335|54799442|FG002|Overall Study|Failure to maintain inclusion/exclusion|4|||
28135428|NCT03055806|54799454|FG000|Overall Study|Adverse Event|0|||
28135429|NCT03055806|54799455|FG001|Overall Study|Adverse Event|0|||
28135430|NCT03055806|54799456|FG002|Overall Study|Adverse Event|1|||
27819983|NCT01453725|54280916|FG001|Overall Study|Protocol Violation|0|||
28135431|NCT03055806|54799457|FG003|Overall Study|Adverse Event|1|||
28135432|NCT03055806|54799454|FG000|Overall Study|Lost to Follow-up|0|||
28135433|NCT03055806|54799455|FG001|Overall Study|Lost to Follow-up|3|||
28135434|NCT03055806|54799456|FG002|Overall Study|Lost to Follow-up|6|||
27819984|NCT01453725|54280915|FG000|Overall Study|Withdrawal by Subject|2|||
28135435|NCT03055806|54799457|FG003|Overall Study|Lost to Follow-up|7|||
28135436|NCT03055806|54799454|FG000|Overall Study|Physician Decision|1|||
28135437|NCT03055806|54799455|FG001|Overall Study|Physician Decision|0|||
28135438|NCT03055806|54799456|FG002|Overall Study|Physician Decision|0|||
28135439|NCT03055806|54799457|FG003|Overall Study|Physician Decision|1|||
28135440|NCT03055806|54799454|FG000|Overall Study|Protocol Violation|1|||
28135441|NCT03055806|54799455|FG001|Overall Study|Protocol Violation|0|||
28135442|NCT03055806|54799456|FG002|Overall Study|Protocol Violation|0|||
28135443|NCT03055806|54799457|FG003|Overall Study|Protocol Violation|0|||
28135444|NCT03055806|54799454|FG000|Overall Study|Withdrawal of consent to continue drug|1|||
28135445|NCT03055806|54799455|FG001|Overall Study|Withdrawal of consent to continue drug|1|||
28135446|NCT03055806|54799456|FG002|Overall Study|Withdrawal of consent to continue drug|2|||
28135447|NCT03055806|54799457|FG003|Overall Study|Withdrawal of consent to continue drug|0|||
28135448|NCT03055806|54799454|FG000|Overall Study|Withdrawal of consent to continue study|2|||
28135449|NCT03055806|54799455|FG001|Overall Study|Withdrawal of consent to continue study|3|||
28135450|NCT03055806|54799456|FG002|Overall Study|Withdrawal of consent to continue study|4|||
28135451|NCT03055806|54799457|FG003|Overall Study|Withdrawal of consent to continue study|6|||
28135452|NCT03055806|54799454|FG000|Overall Study|Partner not willing to try intercourse|1|||
28135453|NCT03055806|54799455|FG001|Overall Study|Partner not willing to try intercourse|0|||
28135454|NCT03055806|54799456|FG002|Overall Study|Partner not willing to try intercourse|0|||
28135455|NCT03055806|54799457|FG003|Overall Study|Partner not willing to try intercourse|0|||
28135456|NCT04620798|54799469|FG000|Overall Study|Lost to Follow-up|126|||
28135457|NCT04620798|54799470|FG001|Overall Study|Lost to Follow-up|138|||
28135458|NCT03052764|54799478|FG000|Double-Blind Treatment Period|Adverse Event|2|||
28135459|NCT03052764|54799479|FG001|Double-Blind Treatment Period|Adverse Event|0|||
28135460|NCT03052764|54799478|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
28135461|NCT03052764|54799479|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
28135462|NCT03052764|54799478|FG000|Double-Blind Treatment Period|Protocol Violation|2|||
28135463|NCT03052764|54799479|FG001|Double-Blind Treatment Period|Protocol Violation|1|||
28135464|NCT03052764|54799478|FG000|Double-Blind Treatment Period|Withdrawal by Subject|3|||
28135465|NCT03052764|54799479|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
28135466|NCT03052764|54799478|FG000|Double-Blind Treatment Period|Reason not Specified|2|||
28135467|NCT03052764|54799479|FG001|Double-Blind Treatment Period|Reason not Specified|1|||
28135468|NCT02951819|54799489|FG000|Overall Study|Death|9|||
28135469|NCT02951819|54799490|FG001|Overall Study|Death|7|||
28135470|NCT02951819|54799489|FG000|Overall Study|Withdrawal by Subject|3|||
28135471|NCT02951819|54799490|FG001|Overall Study|Withdrawal by Subject|0|||
28135472|NCT02951819|54799489|FG000|Overall Study|Adverse Event|1|||
28135473|NCT02951819|54799490|FG001|Overall Study|Adverse Event|0|||
28135474|NCT02951819|54799489|FG000|Overall Study|Lack of Efficacy|4|||
28135475|NCT02951819|54799490|FG001|Overall Study|Lack of Efficacy|0|||
28135476|NCT02951819|54799489|FG000|Overall Study|Lost to Follow-up|1|||
28135477|NCT02951819|54799490|FG001|Overall Study|Lost to Follow-up|0|||
28135478|NCT02951819|54799489|FG000|Overall Study|Progressive Disease|1|||
28135479|NCT02951819|54799490|FG001|Overall Study|Progressive Disease|0|||
28135480|NCT02951819|54799489|FG000|Overall Study|Other|9|||
28135481|NCT02951819|54799490|FG001|Overall Study|Other|0|||
28135482|NCT03383783|54799496|FG000|Overall Study|Withdrawal by Subject|2|||
28135483|NCT03334721|54799514|FG000|Overall Study|Withdrawal by Subject|1|||
28135484|NCT03334721|54799515|FG001|Overall Study|Withdrawal by Subject|0|||
28135485|NCT03334721|54799514|FG000|Overall Study|No longer met inclusion/exclusion criter|1|||
28135486|NCT03334721|54799515|FG001|Overall Study|No longer met inclusion/exclusion criter|0|||
28135487|NCT03515551|54799528|FG000|Overall Study|Death|4|||
28135488|NCT03515551|54799529|FG001|Overall Study|Death|1|||
28135489|NCT03515551|54799530|FG002|Overall Study|Death|2|||
28135490|NCT03515551|54799531|FG003|Overall Study|Death|2|||
28135491|NCT03515551|54799532|FG004|Overall Study|Death|2|||
28135492|NCT03515551|54799533|FG005|Overall Study|Death|4|||
28135493|NCT03515551|54799534|FG006|Overall Study|Death|1|||
28135494|NCT03515551|54799528|FG000|Overall Study|Lost to Follow-up|0|||
28135495|NCT03515551|54799529|FG001|Overall Study|Lost to Follow-up|0|||
28135496|NCT03515551|54799530|FG002|Overall Study|Lost to Follow-up|1|||
28135497|NCT03515551|54799531|FG003|Overall Study|Lost to Follow-up|0|||
28135498|NCT03515551|54799532|FG004|Overall Study|Lost to Follow-up|0|||
28135499|NCT03515551|54799533|FG005|Overall Study|Lost to Follow-up|0|||
28135500|NCT03515551|54799534|FG006|Overall Study|Lost to Follow-up|0|||
28135501|NCT03515551|54799528|FG000|Overall Study|Withdrawal by Subject|0|||
28135502|NCT03515551|54799529|FG001|Overall Study|Withdrawal by Subject|1|||
28135503|NCT03515551|54799530|FG002|Overall Study|Withdrawal by Subject|0|||
28135504|NCT03515551|54799531|FG003|Overall Study|Withdrawal by Subject|0|||
28135505|NCT03515551|54799532|FG004|Overall Study|Withdrawal by Subject|0|||
28135506|NCT03515551|54799533|FG005|Overall Study|Withdrawal by Subject|0|||
28135507|NCT03515551|54799534|FG006|Overall Study|Withdrawal by Subject|1|||
28135508|NCT03515551|54799528|FG000|Overall Study|Study ended by sponsor|0|||
28135509|NCT03515551|54799529|FG001|Overall Study|Study ended by sponsor|0|||
28135510|NCT03515551|54799530|FG002|Overall Study|Study ended by sponsor|2|||
28135511|NCT03515551|54799531|FG003|Overall Study|Study ended by sponsor|1|||
28135512|NCT03515551|54799532|FG004|Overall Study|Study ended by sponsor|3|||
28135513|NCT03515551|54799533|FG005|Overall Study|Study ended by sponsor|0|||
28135514|NCT03515551|54799534|FG006|Overall Study|Study ended by sponsor|3|||
28135515|NCT03515551|54799528|FG000|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
28135516|NCT03515551|54799529|FG001|Overall Study|Sequential enrollment in 30-100 mcg cohort|1|||
28135517|NCT03515551|54799530|FG002|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
28135518|NCT03515551|54799531|FG003|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
28135519|NCT03515551|54799532|FG004|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
28135520|NCT03515551|54799533|FG005|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
27819985|NCT01453725|54280916|FG001|Overall Study|Withdrawal by Subject|3|||
27819986|NCT01453725|54280915|FG000|Overall Study|Pregnancy Wish|0|||
27819987|NCT01453725|54280916|FG001|Overall Study|Pregnancy Wish|2|||
27819988|NCT01453725|54280915|FG000|Overall Study|Pregnancy|1|||
27819989|NCT01453725|54280916|FG001|Overall Study|Pregnancy|0|||
27819990|NCT01453725|54280915|FG000|Overall Study|Physician Decision|1|||
27819991|NCT01453725|54280916|FG001|Overall Study|Physician Decision|1|||
27819992|NCT01415349|54280955|FG000|Treatment Period 1|Adverse Event|0|||
27819993|NCT01415349|54280956|FG001|Treatment Period 1|Adverse Event|1|||
27819994|NCT01415349|54280955|FG000|Treatment Period 1|Withdrawal by Subject|0|||
27819995|NCT01415349|54280956|FG001|Treatment Period 1|Withdrawal by Subject|1|||
27819996|NCT01453023|54281010|FG000|Treatment Period (TP) 1|Protocol Violation|1|||
27819997|NCT01453023|54281011|FG001|Treatment Period (TP) 1|Protocol Violation|0|||
27819998|NCT01453023|54281010|FG000|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0|||
27819999|NCT01453023|54281011|FG001|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1|||
27820000|NCT01453023|54281010|FG000|Treatment Period 2|Protocol Violation|0|||
27820001|NCT01453023|54281011|FG001|Treatment Period 2|Protocol Violation|1|||
27820002|NCT01452789|54281019|FG000|Overall Study|Withdrawal by Subject|3|||
27820003|NCT01452789|54281020|FG001|Overall Study|Withdrawal by Subject|2|||
27820004|NCT01451931|54281029|FG000|Overall Study|Lost to Follow-up|17|||
27820005|NCT01451931|54281030|FG001|Overall Study|Lost to Follow-up|36|||
27820006|NCT01451931|54281031|FG002|Overall Study|Lost to Follow-up|21|||
27820007|NCT01451931|54281029|FG000|Overall Study|Withdrawal by Subject|16|||
27820008|NCT01451931|54281030|FG001|Overall Study|Withdrawal by Subject|22|||
27820009|NCT01451931|54281031|FG002|Overall Study|Withdrawal by Subject|22|||
27820010|NCT01414257|54281054|FG000|Overall Study|No Visit After First Day of Treatment|12|||
27820011|NCT01414257|54281054|FG000|Overall Study|Protocol Violation|10|||
27820012|NCT01434693|54281097|FG000|Overall Study|Adverse Event|1|||
27820013|NCT01434693|54281098|FG001|Overall Study|Adverse Event|0|||
27820014|NCT01434693|54281099|FG002|Overall Study|Adverse Event|0|||
27820015|NCT01434693|54281100|FG003|Overall Study|Adverse Event|0|||
27820016|NCT01434693|54281097|FG000|Overall Study|Withdrawal by Subject|1|||
27820017|NCT01434693|54281098|FG001|Overall Study|Withdrawal by Subject|0|||
27820018|NCT01434693|54281099|FG002|Overall Study|Withdrawal by Subject|1|||
27820019|NCT01434693|54281100|FG003|Overall Study|Withdrawal by Subject|1|||
27820020|NCT01434693|54281097|FG000|Overall Study|Lost to Follow-up|1|||
27820021|NCT01434693|54281098|FG001|Overall Study|Lost to Follow-up|0|||
27820022|NCT01434693|54281099|FG002|Overall Study|Lost to Follow-up|0|||
27820023|NCT01434693|54281100|FG003|Overall Study|Lost to Follow-up|0|||
27820024|NCT01451541|54281117|FG000|Overall Study|Adverse Event|4|||
27820025|NCT01451541|54281118|FG001|Overall Study|Adverse Event|3|||
27820026|NCT01451541|54281119|FG002|Overall Study|Adverse Event|6|||
27820027|NCT01451541|54281117|FG000|Overall Study|Lack of Efficacy|2|||
27820028|NCT01451541|54281118|FG001|Overall Study|Lack of Efficacy|0|||
27820029|NCT01451541|54281119|FG002|Overall Study|Lack of Efficacy|0|||
27820030|NCT01451541|54281117|FG000|Overall Study|Lost to Follow-up|4|||
27820031|NCT01451541|54281118|FG001|Overall Study|Lost to Follow-up|4|||
27820032|NCT01451541|54281119|FG002|Overall Study|Lost to Follow-up|7|||
27820033|NCT01451541|54281117|FG000|Overall Study|Withdrawal by Subject|15|||
27820034|NCT01451541|54281118|FG001|Overall Study|Withdrawal by Subject|8|||
27820035|NCT01451541|54281119|FG002|Overall Study|Withdrawal by Subject|6|||
27820036|NCT01451541|54281117|FG000|Overall Study|randomization error, noncompliance|11|||
27820037|NCT01451541|54281118|FG001|Overall Study|randomization error, noncompliance|10|||
27820038|NCT01451541|54281119|FG002|Overall Study|randomization error, noncompliance|8|||
27820039|NCT01450761|54281247|FG000|Randomization|Subject no longer meets study criteria|1|||
27820040|NCT01450761|54281248|FG001|Randomization|Subject no longer meets study criteria|2|||
27820041|NCT01450761|54281247|FG000|Randomization|Withdrawal by Subject|2|||
27820042|NCT01450761|54281248|FG001|Randomization|Withdrawal by Subject|0|||
27820043|NCT01450761|54281247|FG000|Randomization|Disease progression|0|||
27820044|NCT01450761|54281248|FG001|Randomization|Disease progression|2|||
27820045|NCT01450761|54281247|FG000|Randomization|Adverse Event unrelated to study drug|1|||
27820046|NCT01450761|54281248|FG001|Randomization|Adverse Event unrelated to study drug|0|||
27820047|NCT01450761|54281247|FG000|Randomization|Other|0|||
27820048|NCT01450761|54281248|FG001|Randomization|Other|1|||
27820049|NCT01450761|54281247|FG000|Lead-in Chemotherapy|Disease progression|33|||
27820050|NCT01450761|54281248|FG001|Lead-in Chemotherapy|Disease progression|32|||
27820051|NCT01450761|54281247|FG000|Lead-in Chemotherapy|Adverse event unrelated to study drug|21|||
27820052|NCT01450761|54281248|FG001|Lead-in Chemotherapy|Adverse event unrelated to study drug|19|||
27820053|NCT01450761|54281247|FG000|Lead-in Chemotherapy|Withdrawal by Subject|14|||
28135521|NCT03515551|54799534|FG006|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
28135522|NCT03380429|54799560|FG000|Overall Study|Physician Decision|0|||
27820054|NCT01450761|54281248|FG001|Lead-in Chemotherapy|Withdrawal by Subject|12|||
27820055|NCT01450761|54281247|FG000|Lead-in Chemotherapy|Study drug toxicity|6|||
28135523|NCT03380429|54799561|FG001|Overall Study|Physician Decision|1|||
28135524|NCT03380429|54799562|FG002|Overall Study|Physician Decision|0|||
28135525|NCT03380429|54799563|FG003|Overall Study|Physician Decision|1|||
28135526|NCT03380429|54799564|FG004|Overall Study|Physician Decision|1|||
28135527|NCT03380429|54799560|FG000|Overall Study|Withdrawal by Subject|3|||
28135528|NCT03380429|54799561|FG001|Overall Study|Withdrawal by Subject|3|||
28135529|NCT03380429|54799562|FG002|Overall Study|Withdrawal by Subject|5|||
28135530|NCT03380429|54799563|FG003|Overall Study|Withdrawal by Subject|2|||
28135531|NCT03380429|54799564|FG004|Overall Study|Withdrawal by Subject|1|||
28135532|NCT03380429|54799560|FG000|Overall Study|Lost to Follow-up|0|||
28135533|NCT03380429|54799561|FG001|Overall Study|Lost to Follow-up|2|||
28135534|NCT03380429|54799562|FG002|Overall Study|Lost to Follow-up|4|||
28135535|NCT03380429|54799563|FG003|Overall Study|Lost to Follow-up|3|||
28135536|NCT03380429|54799564|FG004|Overall Study|Lost to Follow-up|1|||
27820056|NCT01450761|54281248|FG001|Lead-in Chemotherapy|Study drug toxicity|10|||
27820057|NCT01450761|54281247|FG000|Lead-in Chemotherapy|No longer meets study criteria|3|||
27820058|NCT01450761|54281248|FG001|Lead-in Chemotherapy|No longer meets study criteria|7|||
27820059|NCT01450761|54281247|FG000|Lead-in Chemotherapy|Death|3|||
27820060|NCT01450761|54281248|FG001|Lead-in Chemotherapy|Death|3|||
27820061|NCT01450761|54281247|FG000|Lead-in Chemotherapy|Other|2|||
27820062|NCT01450761|54281248|FG001|Lead-in Chemotherapy|Other|2|||
27820063|NCT01450761|54281247|FG000|Lead-in Chemotherapy|Lost to Follow-up|2|||
27820064|NCT01450761|54281248|FG001|Lead-in Chemotherapy|Lost to Follow-up|0|||
27820065|NCT01450761|54281247|FG000|Treatment With Blinded Study Therapy|Disease progression|318|||
27820066|NCT01450761|54281248|FG001|Treatment With Blinded Study Therapy|Disease progression|415|||
27820067|NCT01450761|54281247|FG000|Treatment With Blinded Study Therapy|Study drug toxicity|87|||
27820068|NCT01450761|54281248|FG001|Treatment With Blinded Study Therapy|Study drug toxicity|9|||
28135537|NCT03380429|54799560|FG000|Overall Study|Protocol Violation|1|||
27820069|NCT01450761|54281247|FG000|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27|||
27820070|NCT01450761|54281248|FG001|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19|||
27820071|NCT01450761|54281247|FG000|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15|||
27820072|NCT01450761|54281248|FG001|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8|||
27820073|NCT01450761|54281247|FG000|Treatment With Blinded Study Therapy|Withdrawal by Subject|12|||
27820074|NCT01450761|54281248|FG001|Treatment With Blinded Study Therapy|Withdrawal by Subject|5|||
27820075|NCT01450761|54281247|FG000|Treatment With Blinded Study Therapy|Death|5|||
27820076|NCT01450761|54281248|FG001|Treatment With Blinded Study Therapy|Death|6|||
27820077|NCT01450761|54281247|FG000|Treatment With Blinded Study Therapy|Other/Unspecified|5|||
28069571|NCT00043186|54724544|FG001|Overall Study|Noncompliance|0|||
28069572|NCT00043186|54724545|FG002|Overall Study|Noncompliance|1|||
28069573|NCT00043186|54724546|FG003|Overall Study|Noncompliance|1|||
28069574|NCT00043186|54724547|FG004|Overall Study|Noncompliance|0|||
28069575|NCT00043186|54724548|FG005|Overall Study|Noncompliance|0|||
28069576|NCT00043186|54724549|FG006|Overall Study|Noncompliance|0|||
28069577|NCT00043186|54724550|FG007|Overall Study|Noncompliance|0|||
28069578|NCT00043186|54724551|FG008|Overall Study|Noncompliance|0|||
28069579|NCT00043186|54724543|FG000|Overall Study|Other|0|||
28069580|NCT00043186|54724544|FG001|Overall Study|Other|0|||
28069581|NCT00043186|54724545|FG002|Overall Study|Other|1|||
28069582|NCT00043186|54724546|FG003|Overall Study|Other|1|||
28069583|NCT00043186|54724547|FG004|Overall Study|Other|0|||
28069584|NCT00043186|54724548|FG005|Overall Study|Other|0|||
28069585|NCT00043186|54724549|FG006|Overall Study|Other|0|||
28069586|NCT00043186|54724550|FG007|Overall Study|Other|0|||
28069587|NCT00043186|54724551|FG008|Overall Study|Other|0|||
28069588|NCT00041470|54724572|FG000|Overall Study|Loss of Funding|38|||
28069589|NCT00206102|54724578|FG000|Overall Study|Adverse Event|119|||
28069590|NCT00206102|54724579|FG001|Overall Study|Adverse Event|82|||
28069591|NCT00206102|54724578|FG000|Overall Study|Protocol Violation|0|||
28069592|NCT00206102|54724579|FG001|Overall Study|Protocol Violation|2|||
28069593|NCT00206102|54724578|FG000|Overall Study|Lack of therapeutic response|16|||
28069594|NCT00206102|54724579|FG001|Overall Study|Lack of therapeutic response|11|||
28069595|NCT00206102|54724578|FG000|Overall Study|Lost to Follow-up|95|||
28069596|NCT00206102|54724579|FG001|Overall Study|Lost to Follow-up|66|||
28069597|NCT00206102|54724578|FG000|Overall Study|Withdrawal by Subject|118|||
28069598|NCT00206102|54724579|FG001|Overall Study|Withdrawal by Subject|101|||
28135538|NCT03380429|54799561|FG001|Overall Study|Protocol Violation|0|||
28135539|NCT03380429|54799562|FG002|Overall Study|Protocol Violation|1|||
28135540|NCT03380429|54799563|FG003|Overall Study|Protocol Violation|0|||
28135541|NCT03380429|54799564|FG004|Overall Study|Protocol Violation|1|||
28135542|NCT03380429|54799560|FG000|Overall Study|Lack of Efficacy|0|||
28135543|NCT03380429|54799561|FG001|Overall Study|Lack of Efficacy|0|||
28135544|NCT03380429|54799562|FG002|Overall Study|Lack of Efficacy|0|||
28135545|NCT03380429|54799563|FG003|Overall Study|Lack of Efficacy|2|||
28135546|NCT03380429|54799564|FG004|Overall Study|Lack of Efficacy|1|||
28135547|NCT03380429|54799560|FG000|Overall Study|Adverse Event|1|||
28135548|NCT03380429|54799561|FG001|Overall Study|Adverse Event|1|||
28135549|NCT03380429|54799562|FG002|Overall Study|Adverse Event|1|||
28135550|NCT03380429|54799563|FG003|Overall Study|Adverse Event|2|||
28135551|NCT03380429|54799564|FG004|Overall Study|Adverse Event|0|||
28135552|NCT03280615|54799583|FG000|Overall Study|Lost to Follow-up|1|||
28135553|NCT03280615|54799584|FG001|Overall Study|Lost to Follow-up|2|||
28135554|NCT03280615|54799583|FG000|Overall Study|Adverse Event|1|||
28135555|NCT03280615|54799584|FG001|Overall Study|Adverse Event|1|||
28135556|NCT03280615|54799583|FG000|Overall Study|Withdrawal by Subject|2|||
28135557|NCT03280615|54799584|FG001|Overall Study|Withdrawal by Subject|2|||
28135558|NCT03280537|54799592|FG000|Overall Study|Withdrawal by Subject|2|||
28135559|NCT03280537|54799593|FG001|Overall Study|Withdrawal by Subject|4|||
28135560|NCT03280381|54799601|FG000|Overall Study|Physician Decision|0|||
28135561|NCT03280381|54799602|FG001|Overall Study|Physician Decision|2|||
28135562|NCT03270085|54799611|FG000|Overall Study|Withdrawal by Subject|1|||
28135563|NCT03270085|54799612|FG001|Overall Study|Withdrawal by Subject|0|||
28135564|NCT03267511|54799622|FG000|Overall Study|Lost to Follow-up|0|||
28135565|NCT03267511|54799623|FG001|Overall Study|Lost to Follow-up|0|||
28135566|NCT03267511|54799624|FG002|Overall Study|Lost to Follow-up|0|||
28135567|NCT03267511|54799625|FG003|Overall Study|Lost to Follow-up|1|||
28135568|NCT03379259|54799652|FG000|Overall Study|Commenced new anti-cancer therapy|1|||
28135569|NCT03379259|54799653|FG001|Overall Study|Commenced new anti-cancer therapy|0|||
27820078|NCT01450761|54281248|FG001|Treatment With Blinded Study Therapy|Other/Unspecified|4|||
28135570|NCT03379259|54799654|FG002|Overall Study|Commenced new anti-cancer therapy|0|||
28135571|NCT03379259|54799655|FG003|Overall Study|Commenced new anti-cancer therapy|0|||
28135572|NCT03379259|54799656|FG004|Overall Study|Commenced new anti-cancer therapy|0|||
28135573|NCT03379259|54799657|FG005|Overall Study|Commenced new anti-cancer therapy|0|||
28135574|NCT03379259|54799652|FG000|Overall Study|Death|0|||
28135575|NCT03379259|54799653|FG001|Overall Study|Death|1|||
28135576|NCT03379259|54799654|FG002|Overall Study|Death|2|||
28135577|NCT03379259|54799655|FG003|Overall Study|Death|1|||
28135578|NCT03379259|54799656|FG004|Overall Study|Death|4|||
28135579|NCT03379259|54799657|FG005|Overall Study|Death|2|||
28135580|NCT03379259|54799652|FG000|Overall Study|Withdrawal by Subject|0|||
28135581|NCT03379259|54799653|FG001|Overall Study|Withdrawal by Subject|0|||
28135582|NCT03379259|54799654|FG002|Overall Study|Withdrawal by Subject|1|||
28135583|NCT03379259|54799655|FG003|Overall Study|Withdrawal by Subject|0|||
28135584|NCT03379259|54799656|FG004|Overall Study|Withdrawal by Subject|2|||
28135585|NCT03379259|54799657|FG005|Overall Study|Withdrawal by Subject|0|||
27820079|NCT01450761|54281247|FG000|Treatment With Blinded Study Therapy|Lost to Follow-up|2|||
27820080|NCT01450761|54281248|FG001|Treatment With Blinded Study Therapy|Lost to Follow-up|1|||
27820081|NCT01450761|54281247|FG000|Treatment With Blinded Study Therapy|Maximum clinical benefit|1|||
27820082|NCT01450761|54281248|FG001|Treatment With Blinded Study Therapy|Maximum clinical benefit|2|||
27820083|NCT01450761|54281247|FG000|Treatment With Blinded Study Therapy|No longer meets study criteria|1|||
27820084|NCT01450761|54281248|FG001|Treatment With Blinded Study Therapy|No longer meets study criteria|2|||
27820085|NCT01450761|54281247|FG000|Treatment With Blinded Study Therapy|Not reported|2|||
27820086|NCT01450761|54281248|FG001|Treatment With Blinded Study Therapy|Not reported|2|||
27820087|NCT01450761|54281247|FG000|Treatment With Blinded Study Therapy|Poor/non-compliance|1|||
27820088|NCT01450761|54281248|FG001|Treatment With Blinded Study Therapy|Poor/non-compliance|0|||
27820089|NCT01450761|54281247|FG000|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2|||
27820090|NCT01450761|54281248|FG001|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3|||
28135586|NCT03379259|54799652|FG000|Overall Study|Study terminated by sponsor|0|||
28135587|NCT03379259|54799653|FG001|Overall Study|Study terminated by sponsor|0|||
28135588|NCT03379259|54799654|FG002|Overall Study|Study terminated by sponsor|0|||
28135589|NCT03379259|54799655|FG003|Overall Study|Study terminated by sponsor|1|||
28135590|NCT03379259|54799656|FG004|Overall Study|Study terminated by sponsor|1|||
28135591|NCT03379259|54799657|FG005|Overall Study|Study terminated by sponsor|4|||
28135592|NCT03379259|54799652|FG000|Overall Study|Disease progression|0|||
28135593|NCT03379259|54799653|FG001|Overall Study|Disease progression|0|||
28135594|NCT03379259|54799654|FG002|Overall Study|Disease progression|0|||
28135595|NCT03379259|54799655|FG003|Overall Study|Disease progression|1|||
28135596|NCT03379259|54799656|FG004|Overall Study|Disease progression|0|||
28135597|NCT03379259|54799657|FG005|Overall Study|Disease progression|1|||
28135598|NCT03379259|54799652|FG000|Overall Study|Lost to Follow-up|0|||
27820091|NCT01433991|54281298|FG000|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|2|||
27820092|NCT01433991|54281299|FG001|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
27820093|NCT01433991|54281300|FG002|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
27820094|NCT01433991|54281301|FG003|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
27849788|NCT00631007|54347628|FG002|Overall Study|Adverse Event|0|||
27849789|NCT00631007|54347629|FG003|Overall Study|Adverse Event|2|||
27849790|NCT00631007|54347630|FG004|Overall Study|Adverse Event|3|||
28135599|NCT03379259|54799653|FG001|Overall Study|Lost to Follow-up|0|||
27849791|NCT00631007|54347631|FG005|Overall Study|Adverse Event|2|||
27849792|NCT00631007|54347626|FG000|Overall Study|Lost to Follow-up|2|||
27849793|NCT00631007|54347627|FG001|Overall Study|Lost to Follow-up|1|||
27849794|NCT00631007|54347628|FG002|Overall Study|Lost to Follow-up|2|||
28135600|NCT03379259|54799654|FG002|Overall Study|Lost to Follow-up|0|||
28135601|NCT03379259|54799655|FG003|Overall Study|Lost to Follow-up|0|||
28135602|NCT03379259|54799656|FG004|Overall Study|Lost to Follow-up|1|||
28135603|NCT03379259|54799657|FG005|Overall Study|Lost to Follow-up|0|||
28135604|NCT03379259|54799652|FG000|Overall Study|Deteriorating condition|0|||
28135605|NCT03379259|54799653|FG001|Overall Study|Deteriorating condition|0|||
28135606|NCT03379259|54799654|FG002|Overall Study|Deteriorating condition|0|||
28135607|NCT03379259|54799655|FG003|Overall Study|Deteriorating condition|0|||
28135608|NCT03379259|54799656|FG004|Overall Study|Deteriorating condition|1|||
28135609|NCT03379259|54799657|FG005|Overall Study|Deteriorating condition|0|||
28135610|NCT03328897|54799677|FG000|Randomized-treatment Epoch|Adverse Event|4|||
28135611|NCT03328897|54799678|FG001|Randomized-treatment Epoch|Adverse Event|1|||
27820095|NCT01433991|54281298|FG000|Treatment Phase (Combination Agent)|Adverse Event|1|||
28135612|NCT03328897|54799679|FG002|Randomized-treatment Epoch|Adverse Event|1|||
28135613|NCT03328897|54799677|FG000|Randomized-treatment Epoch|Lost to Follow-up|0|||
28135614|NCT03328897|54799678|FG001|Randomized-treatment Epoch|Lost to Follow-up|1|||
28135615|NCT03328897|54799679|FG002|Randomized-treatment Epoch|Lost to Follow-up|0|||
28135616|NCT03328897|54799677|FG000|Randomized-treatment Epoch|Pregnancy|3|||
28135617|NCT03328897|54799678|FG001|Randomized-treatment Epoch|Pregnancy|0|||
28135618|NCT03328897|54799679|FG002|Randomized-treatment Epoch|Pregnancy|0|||
28135619|NCT03328897|54799677|FG000|Randomized-treatment Epoch|Patient/guardian decision|8|||
28135620|NCT03328897|54799678|FG001|Randomized-treatment Epoch|Patient/guardian decision|3|||
28135621|NCT03328897|54799679|FG002|Randomized-treatment Epoch|Patient/guardian decision|1|||
28135622|NCT03328897|54799677|FG000|Randomized-treatment Epoch|Lack of Efficacy|1|||
28135623|NCT03328897|54799678|FG001|Randomized-treatment Epoch|Lack of Efficacy|0|||
28135624|NCT03328897|54799679|FG002|Randomized-treatment Epoch|Lack of Efficacy|0|||
28135625|NCT03328897|54799677|FG000|Follow-up Epoch|Adverse Event|4|||
28135626|NCT03328897|54799678|FG001|Follow-up Epoch|Adverse Event|0|||
28135627|NCT03328897|54799679|FG002|Follow-up Epoch|Adverse Event|1|||
28135628|NCT03328897|54799677|FG000|Follow-up Epoch|Lack of Efficacy|1|||
28135629|NCT03328897|54799678|FG001|Follow-up Epoch|Lack of Efficacy|1|||
28135630|NCT03328897|54799679|FG002|Follow-up Epoch|Lack of Efficacy|1|||
28135631|NCT03328897|54799677|FG000|Follow-up Epoch|Lost to Follow-up|0|||
28135632|NCT03328897|54799678|FG001|Follow-up Epoch|Lost to Follow-up|1|||
28135633|NCT03328897|54799679|FG002|Follow-up Epoch|Lost to Follow-up|0|||
28135634|NCT03328897|54799677|FG000|Follow-up Epoch|Pregnancy|1|||
28135635|NCT03328897|54799678|FG001|Follow-up Epoch|Pregnancy|0|||
28135636|NCT03328897|54799679|FG002|Follow-up Epoch|Pregnancy|0|||
28135637|NCT03328897|54799677|FG000|Follow-up Epoch|Patient/guardian decision|2|||
27820096|NCT01433991|54281299|FG001|Treatment Phase (Combination Agent)|Adverse Event|0|||
27849795|NCT00631007|54347629|FG003|Overall Study|Lost to Follow-up|4|||
27849796|NCT00631007|54347630|FG004|Overall Study|Lost to Follow-up|5|||
27849797|NCT00631007|54347631|FG005|Overall Study|Lost to Follow-up|3|||
27849798|NCT00631007|54347626|FG000|Overall Study|Physician Decision|1|||
27849799|NCT00631007|54347627|FG001|Overall Study|Physician Decision|0|||
27849800|NCT00631007|54347628|FG002|Overall Study|Physician Decision|1|||
28135638|NCT03328897|54799678|FG001|Follow-up Epoch|Patient/guardian decision|1|||
28135639|NCT03328897|54799679|FG002|Follow-up Epoch|Patient/guardian decision|0|||
28135640|NCT03266107|54799687|FG000|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1|||
28135641|NCT03266107|54799687|FG000|Enrollment to Procedure|Study stopped prior to Procedure|2|||
28135642|NCT03266107|54799687|FG000|3-Month Follow-up Visit|Lost to Follow-up|1|||
28135643|NCT03266107|54799687|FG000|12-Month Follow-up Visit|Lost to Follow-up|1|||
27849801|NCT00631007|54347629|FG003|Overall Study|Physician Decision|0|||
27849802|NCT00631007|54347630|FG004|Overall Study|Physician Decision|0|||
27849803|NCT00631007|54347631|FG005|Overall Study|Physician Decision|2|||
27941022|NCT01020123|54597354|FG004|Main Period|Protocol Violation|2|||
28135644|NCT03378635|54799696|FG000|Overall Study|Adverse Event|1|||
28135645|NCT03378635|54799697|FG001|Overall Study|Adverse Event|0|||
28135646|NCT03378635|54799698|FG002|Overall Study|Adverse Event|0|||
28135647|NCT03378635|54799696|FG000|Overall Study|Withdrawal by Subject|1|||
27820097|NCT01433991|54281300|FG002|Treatment Phase (Combination Agent)|Adverse Event|3|||
27820098|NCT01433991|54281301|FG003|Treatment Phase (Combination Agent)|Adverse Event|1|||
27820099|NCT01433991|54281298|FG000|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
27820100|NCT01433991|54281299|FG001|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
27820101|NCT01433991|54281300|FG002|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
27820102|NCT01433991|54281301|FG003|Treatment Phase (Combination Agent)|Lost to Follow-up|1|||
27820103|NCT01433991|54281298|FG000|Treatment Phase (Combination Agent)|Participant Choice|0|||
27820104|NCT01433991|54281299|FG001|Treatment Phase (Combination Agent)|Participant Choice|0|||
27820105|NCT01433991|54281300|FG002|Treatment Phase (Combination Agent)|Participant Choice|0|||
27820106|NCT01433991|54281301|FG003|Treatment Phase (Combination Agent)|Participant Choice|1|||
27820107|NCT01433991|54281298|FG000|Treatment Phase (Combination Agent)|Clinical progression|0|||
27820108|NCT01433991|54281299|FG001|Treatment Phase (Combination Agent)|Clinical progression|1|||
27820109|NCT01433991|54281300|FG002|Treatment Phase (Combination Agent)|Clinical progression|2|||
27820110|NCT01433991|54281301|FG003|Treatment Phase (Combination Agent)|Clinical progression|3|||
27820111|NCT01433991|54281298|FG000|Treatment Phase (Combination Agent)|Progressive disease|1|||
27820112|NCT01433991|54281299|FG001|Treatment Phase (Combination Agent)|Progressive disease|0|||
27820113|NCT01433991|54281300|FG002|Treatment Phase (Combination Agent)|Progressive disease|0|||
27820114|NCT01433991|54281301|FG003|Treatment Phase (Combination Agent)|Progressive disease|0|||
27820115|NCT01433991|54281298|FG000|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
27820116|NCT01433991|54281299|FG001|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
27820117|NCT01433991|54281300|FG002|Treatment Phase (Combination Agent)|Terminated by sponsor|1|||
27820118|NCT01433991|54281301|FG003|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
27820119|NCT01450683|54281317|FG000|Overall Study|Adverse Event|2|||
27820120|NCT01433055|54281323|FG000|Overall Study|Diagnosed with cancer unrelated to study|1|||
27820121|NCT01433055|54281324|FG001|Overall Study|Diagnosed with cancer unrelated to study|0|||
27820122|NCT01433055|54281323|FG000|Overall Study|Severely elevated triglycerides at entry|1|||
27820123|NCT01433055|54281324|FG001|Overall Study|Severely elevated triglycerides at entry|0|||
27820124|NCT01450137|54281332|FG000|Up to Week 12|Adverse Event|2|||
27820125|NCT01450137|54281333|FG001|Up to Week 12|Adverse Event|1|||
27820126|NCT01450137|54281332|FG000|Up to Week 12|Withdrawal by Subject|0|||
27820127|NCT01450137|54281333|FG001|Up to Week 12|Withdrawal by Subject|2|||
27820128|NCT01450137|54281332|FG000|Week 12 to Study End|Death|0|||
27820129|NCT01450137|54281333|FG001|Week 12 to Study End|Death|1|||
27820130|NCT01450137|54281332|FG000|Week 12 to Study End|Withdrawal by Subject|0|||
27820131|NCT01450137|54281333|FG001|Week 12 to Study End|Withdrawal by Subject|1|||
27820132|NCT01412229|54281339|FG000|Overall Study|Physician Decision|1|||
27820133|NCT01412151|54281344|FG000|Week 0 - 306 - Treatment Period|Death|1|||
27820134|NCT01412151|54281344|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1|||
27820135|NCT01412151|54281344|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3|||
27820136|NCT01412151|54281344|FG000|Week 306 - 310 - Washout Period|Withdrawal by Subject|2|||
28135648|NCT03378635|54799697|FG001|Overall Study|Withdrawal by Subject|0|||
28135649|NCT03378635|54799698|FG002|Overall Study|Withdrawal by Subject|0|||
28135650|NCT03326869|54799709|FG000|Overall Study|Study data has been lost to natural disa|1|||
28135651|NCT03326869|54799710|FG001|Overall Study|Study data has been lost to natural disa|1|||
27820137|NCT01432275|54281350|FG000|First BG Meter System (7 Days)|Adverse Event|0|||
27820138|NCT01432275|54281351|FG001|First BG Meter System (7 Days)|Adverse Event|2|||
27820139|NCT01432275|54281350|FG000|First BG Meter System (7 Days)|Withdrawal by Subject|0|||
27820140|NCT01432275|54281351|FG001|First BG Meter System (7 Days)|Withdrawal by Subject|1|||
27820141|NCT01432275|54281350|FG000|Second BG Meter System (7 Days)|Adverse Event|1|||
27820142|NCT01432275|54281351|FG001|Second BG Meter System (7 Days)|Adverse Event|1|||
27820143|NCT01432275|54281350|FG000|Second BG Meter System (7 Days)|Lost to Follow-up|1|||
27820144|NCT01432275|54281351|FG001|Second BG Meter System (7 Days)|Lost to Follow-up|0|||
27820145|NCT01432275|54281350|FG000|Second BG Meter System (7 Days)|Physician Decision|0|||
27820146|NCT01432275|54281351|FG001|Second BG Meter System (7 Days)|Physician Decision|1|||
27820147|NCT01432275|54281350|FG000|Second BG Meter System (7 Days)|Withdrawal by Subject|0|||
27820148|NCT01432275|54281351|FG001|Second BG Meter System (7 Days)|Withdrawal by Subject|1|||
27820149|NCT01432275|54281350|FG000|ADC With Calculator (10 Days)|Physician Decision|1|||
28135652|NCT03334409|54799722|FG000|Overall Study|Did not meet inclusion criteria|1|||
27820150|NCT01432275|54281351|FG001|ADC With Calculator (10 Days)|Physician Decision|1|||
27820151|NCT01432275|54281350|FG000|ADC With Calculator (10 Days)|Withdrawal by Subject|2|||
27820152|NCT01432275|54281351|FG001|ADC With Calculator (10 Days)|Withdrawal by Subject|0|||
27820153|NCT01432275|54281350|FG000|ADC With Calculator (10 Days)|Protocol Violation|0|||
27820154|NCT01432275|54281351|FG001|ADC With Calculator (10 Days)|Protocol Violation|1|||
27820155|NCT01411995|54281359|FG000|Overall Study|Failed IUD insertion|0|||
28135653|NCT03334409|54799723|FG001|Overall Study|Did not meet inclusion criteria|0|||
28135654|NCT02891915|54799731|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
27820156|NCT01411995|54281360|FG001|Overall Study|Failed IUD insertion|1|||
27820157|NCT01411917|54281368|FG000|Overall Study|Patient did not undergo scheduled surger|0|||
27941023|NCT01020123|54597355|FG005|Main Period|Protocol Violation|3|||
28069599|NCT00206102|54724578|FG000|Overall Study|Study-specific discontinuation criteria|18|||
28135655|NCT02891915|54799732|FG001|Overall Study|Enrolled but Treatment Not Administered|4|||
28135656|NCT02891915|54799731|FG000|Overall Study|Withdrawal by Subject|3|||
28135657|NCT02891915|54799732|FG001|Overall Study|Withdrawal by Subject|3|||
28135658|NCT02891915|54799731|FG000|Overall Study|Became Ineligible After Enrollment|2|||
28135659|NCT02891915|54799732|FG001|Overall Study|Became Ineligible After Enrollment|1|||
28135660|NCT02891915|54799731|FG000|Overall Study|Lost to Follow-up|1|||
28069600|NCT00206102|54724579|FG001|Overall Study|Study-specific discontinuation criteria|17|||
28069601|NCT00206102|54724578|FG000|Overall Study|None of those categories|42|||
28069602|NCT00206102|54724579|FG001|Overall Study|None of those categories|36|||
28069603|NCT00041080|54724587|FG000|Overall Study|Adverse Event|21|||
28069604|NCT00041080|54724588|FG001|Overall Study|Adverse Event|1|||
28069605|NCT00041080|54724587|FG000|Overall Study|Withdrawal by Subject|6|||
28069606|NCT00041080|54724588|FG001|Overall Study|Withdrawal by Subject|6|||
28069607|NCT00041080|54724587|FG000|Overall Study|Concommitant Illness/Other|1|||
28069608|NCT00041080|54724588|FG001|Overall Study|Concommitant Illness/Other|2|||
28069609|NCT00041080|54724587|FG000|Overall Study|Did not start therapy|1|||
28069610|NCT00041080|54724588|FG001|Overall Study|Did not start therapy|1|||
28069611|NCT00041080|54724587|FG000|Overall Study|Ineligible|1|||
28069612|NCT00041080|54724588|FG001|Overall Study|Ineligible|0|||
28069613|NCT00205712|54724596|FG000|Overall Study|Lost to Follow-up|0|||
28069614|NCT00205712|54724597|FG001|Overall Study|Lost to Follow-up|1|||
28069615|NCT00203294|54724607|FG000|Overall Study|Withdrawal by Subject|8|||
28069616|NCT00203294|54724608|FG001|Overall Study|Withdrawal by Subject|13|||
28135661|NCT02891915|54799732|FG001|Overall Study|Lost to Follow-up|4|||
28135662|NCT02891915|54799731|FG000|Overall Study|Physician Decision|1|||
28135663|NCT02891915|54799732|FG001|Overall Study|Physician Decision|0|||
28135664|NCT02891681|54799741|FG000|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
28135665|NCT02891681|54799742|FG001|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
28135666|NCT02891681|54799743|FG002|Overall Study|Did not complete all timepoints in Endocrine Cohort|1|||
28135667|NCT02891681|54799741|FG000|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2|||
28135668|NCT02891681|54799742|FG001|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
28135669|NCT02891681|54799743|FG002|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
28135670|NCT02891681|54799741|FG000|Overall Study|Taken off study after first imaging appointment|1|||
28135671|NCT02891681|54799742|FG001|Overall Study|Taken off study after first imaging appointment|0|||
28135672|NCT02891681|54799743|FG002|Overall Study|Taken off study after first imaging appointment|0|||
28135673|NCT04671342|54799751|FG000|Consented and Screened (Visit 1)|Screen Failure|3|||
28135674|NCT04671342|54799751|FG000|Consented and Screened (Visit 1)|Lost to Follow-up|4|||
28069617|NCT00264290|54724616|FG000|Intervention (8 Weeks)|Adverse Event|1|||
28069618|NCT00264290|54724617|FG001|Intervention (8 Weeks)|Adverse Event|0|||
28135675|NCT04671342|54799751|FG000|Consented and Screened (Visit 1)|Withdrawal by Subject|1|||
28135676|NCT04671342|54799751|FG000|Consented and Screened (Visit 1)|Withdrawn by sponsor due to recruitment consideration (CSA patients)|39|||
28069619|NCT00234494|54724627|FG000|Overall Study|Protocol Violation|2|||
28069620|NCT00234104|54724635|FG000|Overall Study|Adverse Event|4|||
28069621|NCT00234104|54724636|FG001|Overall Study|Adverse Event|0|||
28135677|NCT04671342|54799751|FG000|Completed Visit 2 With Evaluable Data|Unusable device data|58|||
27820158|NCT01411917|54281369|FG001|Overall Study|Patient did not undergo scheduled surger|1|||
27820159|NCT01411839|54281377|FG000|Overall Study|Lost to Follow-up|4|||
27820160|NCT01411839|54281378|FG001|Overall Study|Lost to Follow-up|3|||
27820161|NCT01411215|54281386|FG000|Overall Study|Adverse Event|1|||
27820162|NCT01411215|54281387|FG001|Overall Study|Adverse Event|2|||
28135678|NCT04671342|54799751|FG000|Completed Visit 2 With Evaluable Data|Unusable PSG data|1|||
28135679|NCT03046446|54799755|FG000|Overall Study|Lack of Efficacy|7|||
28135680|NCT03046446|54799755|FG000|Overall Study|Adverse Event|6|||
28135681|NCT03046446|54799755|FG000|Overall Study|Lost to Follow-up|3|||
28135682|NCT03046446|54799755|FG000|Overall Study|Withdrawal by Subject|14|||
28135683|NCT03046446|54799755|FG000|Overall Study|Withdrawn by Investigator/Sponsor|3|||
28135684|NCT03046446|54799755|FG000|Overall Study|Disease Progression (see caveats)|25|||
28135685|NCT03046446|54799755|FG000|Overall Study|Non OA related knee surgery|1|||
28135686|NCT03051217|54799762|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|2|||
28135687|NCT03051217|54799763|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
28135688|NCT03051217|54799764|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
28135689|NCT03051217|54799765|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
28135690|NCT03051217|54799766|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
28135691|NCT03051217|54799767|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
28135692|NCT03051217|54799768|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
28135693|NCT03051217|54799762|FG000|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
28135694|NCT03051217|54799763|FG001|Initial Period (Week 0 to Week 16)|Protocol Violation|1|||
28135695|NCT03051217|54799764|FG002|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
28135696|NCT03051217|54799765|FG003|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
28135697|NCT03051217|54799766|FG004|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
28135698|NCT03051217|54799767|FG005|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
28135699|NCT03051217|54799768|FG006|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
28135700|NCT03051217|54799762|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
28135701|NCT03051217|54799763|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
28135702|NCT03051217|54799764|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
28135703|NCT03051217|54799765|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
28135704|NCT03051217|54799766|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
28135705|NCT03051217|54799767|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
28135706|NCT03051217|54799768|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
27820163|NCT01411215|54281386|FG000|Overall Study|Lack of Efficacy|2|||
27820164|NCT01411215|54281387|FG001|Overall Study|Lack of Efficacy|4|||
27820165|NCT01411215|54281386|FG000|Overall Study|Lost to Follow-up|12|||
27820166|NCT01411215|54281387|FG001|Overall Study|Lost to Follow-up|18|||
27820167|NCT01411215|54281386|FG000|Overall Study|Did not meet entrance criteria|0|||
27820168|NCT01411215|54281387|FG001|Overall Study|Did not meet entrance criteria|1|||
27849804|NCT00631007|54347626|FG000|Overall Study|Persistent Hyperglycemia|2|||
28069622|NCT00234104|54724637|FG002|Overall Study|Adverse Event|3|||
28069623|NCT00234104|54724638|FG003|Overall Study|Adverse Event|5|||
28069624|NCT00234104|54724635|FG000|Overall Study|Protocol Violation|0|||
28069625|NCT00234104|54724636|FG001|Overall Study|Protocol Violation|0|||
28069626|NCT00234104|54724637|FG002|Overall Study|Protocol Violation|0|||
28069627|NCT00234104|54724638|FG003|Overall Study|Protocol Violation|1|||
28069628|NCT00234104|54724635|FG000|Overall Study|Physician Decision|0|||
28069629|NCT00234104|54724636|FG001|Overall Study|Physician Decision|1|||
28069630|NCT00234104|54724637|FG002|Overall Study|Physician Decision|2|||
28069631|NCT00234104|54724638|FG003|Overall Study|Physician Decision|2|||
28069632|NCT00263666|54724650|FG000|Overall Study|Adverse Event|6|||
28069633|NCT00263666|54724651|FG001|Overall Study|Adverse Event|8|||
28069634|NCT00263666|54724650|FG000|Overall Study|Lost to Follow-up|1|||
28069635|NCT00263666|54724651|FG001|Overall Study|Lost to Follow-up|2|||
28069636|NCT00263666|54724650|FG000|Overall Study|Withdrawal by Subject|0|||
28069637|NCT00263666|54724651|FG001|Overall Study|Withdrawal by Subject|1|||
28069638|NCT00195338|54724657|FG000|Overall Study|Lost to Follow-up|2|||
28069639|NCT00195338|54724657|FG000|Overall Study|Adverse Event|5|||
28069640|NCT00195338|54724657|FG000|Overall Study|Lack of Efficacy|1|||
28069641|NCT00195338|54724657|FG000|Overall Study|Early closure of the site|4|||
28135707|NCT03051217|54799762|FG000|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
28135708|NCT03051217|54799763|FG001|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
28135709|NCT03051217|54799764|FG002|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
28135710|NCT03051217|54799765|FG003|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
28135711|NCT03051217|54799766|FG004|Maintenance Period (Week 16 to Week 52)|Adverse Event|2|||
28135712|NCT03051217|54799767|FG005|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
28135713|NCT03051217|54799768|FG006|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
28135714|NCT03051217|54799762|FG000|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
28135715|NCT03051217|54799763|FG001|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
27820169|NCT01411215|54281386|FG000|Overall Study|Study terminated by sponsor|2|||
27820170|NCT01411215|54281387|FG001|Overall Study|Study terminated by sponsor|15|||
27820171|NCT01411215|54281386|FG000|Overall Study|Protocol Violation|3|||
27820172|NCT01411215|54281387|FG001|Overall Study|Protocol Violation|5|||
27820173|NCT01411215|54281386|FG000|Overall Study|Withdrawal by Subject|34|||
27820174|NCT01411215|54281387|FG001|Overall Study|Withdrawal by Subject|21|||
27820175|NCT01411215|54281386|FG000|Overall Study|Other|12|||
27820176|NCT01411215|54281387|FG001|Overall Study|Other|17|||
27820177|NCT01411215|54281386|FG000|Overall Study|Screen failure|0|||
27820178|NCT01411215|54281387|FG001|Overall Study|Screen failure|1|||
27820179|NCT01449279|54281393|FG000|Overall Study|Lack of Efficacy|5|||
27820180|NCT01449279|54281393|FG000|Overall Study|Toxicity|2|||
27820181|NCT01447719|54281397|FG000|Overall Study|Image acquisition failure|2|||
27820182|NCT01447719|54281397|FG000|Overall Study|Invalid image or not imaged|3|||
27820183|NCT01447719|54281397|FG000|Overall Study|Subject still living at end of study|79|||
27820184|NCT01447719|54281397|FG000|Overall Study|Withdrawal by Subject|2|||
27820185|NCT01447719|54281397|FG000|Overall Study|Family withdrew autopsy consent|7|||
27820186|NCT01431963|54281406|FG000|Overall Study|Adverse Event|18|||
27820187|NCT01431963|54281406|FG000|Overall Study|Lack of Efficacy|7|||
27820188|NCT01431963|54281406|FG000|Overall Study|Protocol Violation|1|||
27820189|NCT01431963|54281406|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
27820190|NCT01431963|54281406|FG000|Overall Study|Physician Decision|4|||
27820191|NCT01431963|54281406|FG000|Overall Study|Withdrawal by Subject|3|||
28069642|NCT00039130|54724661|FG000|Overall Study|Adverse Event|11|||
28069643|NCT00039130|54724661|FG000|Overall Study|Death|9|||
28069644|NCT00039130|54724661|FG000|Overall Study|Withdrawal by Subject|3|||
28069645|NCT00039130|54724661|FG000|Overall Study|Progression|2|||
27849805|NCT00631007|54347627|FG001|Overall Study|Persistent Hyperglycemia|2|||
27849806|NCT00631007|54347628|FG002|Overall Study|Persistent Hyperglycemia|5|||
27849807|NCT00631007|54347629|FG003|Overall Study|Persistent Hyperglycemia|1|||
27849808|NCT00631007|54347630|FG004|Overall Study|Persistent Hyperglycemia|2|||
27849809|NCT00631007|54347631|FG005|Overall Study|Persistent Hyperglycemia|5|||
27849810|NCT00631007|54347626|FG000|Overall Study|Withdrawal by Subject|4|||
27849811|NCT00631007|54347627|FG001|Overall Study|Withdrawal by Subject|5|||
28069646|NCT00039130|54724661|FG000|Overall Study|Subsequent treatment|2|||
28069647|NCT00039130|54724661|FG000|Overall Study|Physician Decision|3|||
28135716|NCT03051217|54799764|FG002|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
28135717|NCT03051217|54799765|FG003|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1|||
28135718|NCT03051217|54799766|FG004|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
28135719|NCT03051217|54799767|FG005|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
28135720|NCT03051217|54799768|FG006|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
28135721|NCT03051217|54799762|FG000|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
28135722|NCT03051217|54799763|FG001|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
28135723|NCT03051217|54799764|FG002|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
28135724|NCT03051217|54799765|FG003|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1|||
28135725|NCT03051217|54799766|FG004|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
28135726|NCT03051217|54799767|FG005|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
28135727|NCT03051217|54799768|FG006|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
28135728|NCT03051217|54799762|FG000|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
28135729|NCT03051217|54799763|FG001|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
28135730|NCT03051217|54799764|FG002|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
28135731|NCT03051217|54799765|FG003|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
28135732|NCT03051217|54799766|FG004|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1|||
28135733|NCT03051217|54799767|FG005|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
28135734|NCT03051217|54799768|FG006|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
28135735|NCT03051217|54799762|FG000|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
28135736|NCT03051217|54799763|FG001|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
28135737|NCT03051217|54799764|FG002|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
28135738|NCT03051217|54799765|FG003|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
28135739|NCT03051217|54799766|FG004|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
27820192|NCT01447407|54281414|FG000|Overall Study|Withdrawal by Subject|2|||
28069648|NCT00035932|54724668|FG000|Overall Study|Adverse Event|10|||
27820193|NCT01447407|54281415|FG001|Overall Study|Withdrawal by Subject|0|||
27820194|NCT01447407|54281416|FG002|Overall Study|Withdrawal by Subject|0|||
27820195|NCT01447407|54281417|FG003|Overall Study|Withdrawal by Subject|1|||
27849812|NCT00631007|54347628|FG002|Overall Study|Withdrawal by Subject|2|||
28069649|NCT00035932|54724669|FG001|Overall Study|Adverse Event|9|||
28069650|NCT00035932|54724670|FG002|Overall Study|Adverse Event|9|||
28069651|NCT00035932|54724668|FG000|Overall Study|Death|0|||
27820196|NCT01447407|54281414|FG000|Overall Study|Physician Decision|0|||
28069652|NCT00035932|54724669|FG001|Overall Study|Death|0|||
28069653|NCT00035932|54724670|FG002|Overall Study|Death|1|||
28135740|NCT03051217|54799767|FG005|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1|||
28135741|NCT03051217|54799768|FG006|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
27820197|NCT01447407|54281415|FG001|Overall Study|Physician Decision|0|||
27820198|NCT01447407|54281416|FG002|Overall Study|Physician Decision|1|||
27820199|NCT01447407|54281417|FG003|Overall Study|Physician Decision|1|||
27820200|NCT01446237|54281427|FG000|Overall Study|Adverse Event|1|||
27820201|NCT01446237|54281427|FG000|Overall Study|Lost to Follow-up|2|||
27820202|NCT01446237|54281427|FG000|Overall Study|Withdrawal by Subject|7|||
27820203|NCT01446159|54281575|FG000|Overall Study|Withdrawal by Subject|1|||
28135742|NCT03046056|54799794|FG000|Overall Study|Non-responder at Week 10|6|||
28135743|NCT03046056|54799795|FG001|Overall Study|Non-responder at Week 10|6|||
28135744|NCT03046056|54799796|FG002|Overall Study|Non-responder at Week 10|4|||
28135745|NCT03046056|54799794|FG000|Overall Study|Protocol-specified Disease Worsening|3|||
28135746|NCT03046056|54799795|FG001|Overall Study|Protocol-specified Disease Worsening|3|||
27820204|NCT01446159|54281576|FG001|Overall Study|Withdrawal by Subject|0|||
27820205|NCT01446159|54281577|FG002|Overall Study|Withdrawal by Subject|14|||
27820206|NCT01446159|54281578|FG003|Overall Study|Withdrawal by Subject|11|||
27849813|NCT00631007|54347629|FG003|Overall Study|Withdrawal by Subject|2|||
27849814|NCT00631007|54347630|FG004|Overall Study|Withdrawal by Subject|1|||
27941024|NCT01020123|54597356|FG006|Main Period|Protocol Violation|2|||
28135747|NCT03046056|54799796|FG002|Overall Study|Protocol-specified Disease Worsening|1|||
27820207|NCT01446159|54281575|FG000|Overall Study|Lost to Follow-up|0|||
27820208|NCT01446159|54281576|FG001|Overall Study|Lost to Follow-up|0|||
27820209|NCT01446159|54281577|FG002|Overall Study|Lost to Follow-up|1|||
27820210|NCT01446159|54281578|FG003|Overall Study|Lost to Follow-up|2|||
27820211|NCT01446159|54281575|FG000|Overall Study|Death|2|||
27849815|NCT00631007|54347631|FG005|Overall Study|Withdrawal by Subject|3|||
27820212|NCT01446159|54281576|FG001|Overall Study|Death|3|||
27820213|NCT01446159|54281577|FG002|Overall Study|Death|43|||
27820214|NCT01446159|54281578|FG003|Overall Study|Death|36|||
27820215|NCT01446159|54281575|FG000|Overall Study|Other|0|||
27820216|NCT01446159|54281576|FG001|Overall Study|Other|0|||
27820217|NCT01446159|54281577|FG002|Overall Study|Other|13|||
27820218|NCT01446159|54281578|FG003|Overall Study|Other|13|||
27820219|NCT01446003|54281614|FG000|Period 1|Protocol Violation|2|||
27820220|NCT01446003|54281615|FG001|Period 1|Protocol Violation|0|||
27820221|NCT01446003|54281614|FG000|Period 2|Adverse Event|1|||
27820222|NCT01446003|54281615|FG001|Period 2|Adverse Event|0|||
27820223|NCT01430559|54281632|FG000|Overall Study|Adverse Event|7|||
27820224|NCT01430559|54281633|FG001|Overall Study|Adverse Event|3|||
27820225|NCT01430559|54281632|FG000|Overall Study|Entry criteria not met|1|||
27820226|NCT01430559|54281633|FG001|Overall Study|Entry criteria not met|1|||
27820227|NCT01430559|54281632|FG000|Overall Study|Lost to Follow-up|1|||
27820228|NCT01430559|54281633|FG001|Overall Study|Lost to Follow-up|0|||
28135748|NCT03046056|54799794|FG000|Overall Study|Adverse Event|1|||
28135749|NCT03046056|54799795|FG001|Overall Study|Adverse Event|5|||
28135750|NCT03046056|54799796|FG002|Overall Study|Adverse Event|0|||
28135751|NCT03046056|54799794|FG000|Overall Study|Non-compliance With Study Drug|0|||
28135752|NCT03046056|54799795|FG001|Overall Study|Non-compliance With Study Drug|0|||
28135753|NCT03046056|54799796|FG002|Overall Study|Non-compliance With Study Drug|2|||
28135754|NCT03046056|54799794|FG000|Overall Study|Protocol Violation|1|||
27820229|NCT01430559|54281632|FG000|Overall Study|Medication error|1|||
27820230|NCT01430559|54281633|FG001|Overall Study|Medication error|0|||
27820231|NCT01430559|54281632|FG000|Overall Study|Withdrawal by Subject|3|||
27820232|NCT01430559|54281633|FG001|Overall Study|Withdrawal by Subject|2|||
27820233|NCT01430559|54281632|FG000|Overall Study|Protocol Violation|1|||
27820234|NCT01430559|54281633|FG001|Overall Study|Protocol Violation|0|||
27820235|NCT01430559|54281632|FG000|Overall Study|Other|3|||
27820236|NCT01430559|54281633|FG001|Overall Study|Other|3|||
27820237|NCT01430559|54281632|FG000|Overall Study|Randomized, Not Treated|3|||
27820238|NCT01430559|54281633|FG001|Overall Study|Randomized, Not Treated|3|||
27820239|NCT01410357|54281646|FG000|Overall Study|Death|2|||
27820240|NCT01410357|54281647|FG001|Overall Study|Death|1|||
27820241|NCT01410357|54281646|FG000|Overall Study|Withdrawal by Subject|1|||
27820242|NCT01410357|54281647|FG001|Overall Study|Withdrawal by Subject|2|||
27820243|NCT01410357|54281646|FG000|Overall Study|Lost to Follow-up|23|||
27820244|NCT01410357|54281647|FG001|Overall Study|Lost to Follow-up|21|||
27820245|NCT01409811|54281672|FG000|Overall Study|Insurance denial|1|||
27820246|NCT01445847|54281678|FG000|Overall Study|Protocol Violation|13|||
27820247|NCT01445847|54281679|FG001|Overall Study|Protocol Violation|14|||
27820248|NCT01445847|54281678|FG000|Overall Study|Missed Data|1|||
27820249|NCT01445847|54281679|FG001|Overall Study|Missed Data|0|||
27820250|NCT01445769|54281698|FG000|Overall Study|Consent Withdrawn|2|||
27820251|NCT01445769|54281698|FG000|Overall Study|Disease Progression|1|||
27820252|NCT01445769|54281698|FG000|Overall Study|Lost to Follow-up|5|||
27820253|NCT01445613|54281780|FG000|30-day Follow-up|Withdrawal by Subject|6|||
27820254|NCT01445613|54281780|FG000|30-day Follow-up|Physician Decision|3|||
27820255|NCT01445613|54281780|FG000|30-day Follow-up|Missed visit|23|||
28135755|NCT03046056|54799795|FG001|Overall Study|Protocol Violation|1|||
28135756|NCT03046056|54799796|FG002|Overall Study|Protocol Violation|0|||
27820256|NCT01445613|54281780|FG000|30-day Follow-up|Death|3|||
27820257|NCT01445613|54281780|FG000|1-year Follow-up|Withdrawal by Subject|12|||
27820258|NCT01445613|54281780|FG000|1-year Follow-up|Missed visit|29|||
27820259|NCT01445613|54281780|FG000|1-year Follow-up|Lost to Follow-up|2|||
27820260|NCT01445613|54281780|FG000|1-year Follow-up|Death|30|||
27820261|NCT01445613|54281780|FG000|1-year Follow-up|Physician Decision|2|||
27820262|NCT01445613|54281780|FG000|1-year Follow-up|Received a non-study stent|2|||
27820263|NCT01445535|54281884|FG000|Overall Study|Enrolled/taken off study, no drug avail.|0|||
27820264|NCT01445535|54281885|FG001|Overall Study|Enrolled/taken off study, no drug avail.|0|||
27820265|NCT01445535|54281886|FG002|Overall Study|Enrolled/taken off study, no drug avail.|0|||
27820266|NCT01445535|54281887|FG003|Overall Study|Enrolled/taken off study, no drug avail.|1|||
27820267|NCT01445535|54281884|FG000|Overall Study|Disease progression|1|||
27820268|NCT01445535|54281885|FG001|Overall Study|Disease progression|0|||
27820269|NCT01445535|54281886|FG002|Overall Study|Disease progression|1|||
27820270|NCT01445535|54281887|FG003|Overall Study|Disease progression|0|||
27820271|NCT01445535|54281884|FG000|Overall Study|PI discretion|0|||
27820272|NCT01445535|54281885|FG001|Overall Study|PI discretion|0|||
27820273|NCT01445535|54281886|FG002|Overall Study|PI discretion|0|||
27820274|NCT01445535|54281887|FG003|Overall Study|PI discretion|1|||
27820275|NCT01445301|54281901|FG000|Overall Study|Adverse Event|15|||
27820276|NCT01445301|54281902|FG001|Overall Study|Adverse Event|25|||
27820277|NCT01445301|54281903|FG002|Overall Study|Adverse Event|4|||
27820278|NCT01445301|54281901|FG000|Overall Study|Lack of Efficacy|0|||
27820279|NCT01445301|54281902|FG001|Overall Study|Lack of Efficacy|1|||
27820280|NCT01445301|54281903|FG002|Overall Study|Lack of Efficacy|0|||
27820281|NCT01445301|54281901|FG000|Overall Study|Protocol Violation|1|||
27820282|NCT01445301|54281902|FG001|Overall Study|Protocol Violation|0|||
27820283|NCT01445301|54281903|FG002|Overall Study|Protocol Violation|0|||
28135757|NCT03046056|54799794|FG000|Overall Study|Investigator's Discretion|0|||
28135758|NCT03046056|54799795|FG001|Overall Study|Investigator's Discretion|1|||
28135759|NCT03046056|54799796|FG002|Overall Study|Investigator's Discretion|0|||
28135760|NCT03046056|54799794|FG000|Overall Study|Withdrew Consent|1|||
28135761|NCT03046056|54799795|FG001|Overall Study|Withdrew Consent|0|||
28135762|NCT03046056|54799796|FG002|Overall Study|Withdrew Consent|0|||
28135763|NCT02849587|54799807|FG000|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
28135764|NCT02849587|54799808|FG001|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|3|||
28135765|NCT02849587|54799809|FG002|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
28135766|NCT02849587|54799807|FG000|Overall Study|Withdrawal by Subject|0|||
27820284|NCT01445301|54281901|FG000|Overall Study|Protocol-Defined Stopping Criteria|0|||
27820285|NCT01445301|54281902|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
27820286|NCT01445301|54281903|FG002|Overall Study|Protocol-Defined Stopping Criteria|1|||
27820287|NCT01445301|54281901|FG000|Overall Study|Physician Decision|0|||
27820288|NCT01445301|54281902|FG001|Overall Study|Physician Decision|2|||
27820289|NCT01445301|54281903|FG002|Overall Study|Physician Decision|0|||
27820290|NCT01445301|54281901|FG000|Overall Study|Withdrawal by Subject|5|||
27820291|NCT01445301|54281902|FG001|Overall Study|Withdrawal by Subject|6|||
27820292|NCT01445301|54281903|FG002|Overall Study|Withdrawal by Subject|4|||
27820293|NCT01409031|54281913|FG000|Overall Study|transferred to other hosp|1|||
27820294|NCT01409031|54281914|FG001|Overall Study|transferred to other hosp|0|||
27820295|NCT01430403|54281923|FG000|Overall Study|Lost to Follow-up|5|||
27820296|NCT01430403|54281924|FG001|Overall Study|Lost to Follow-up|5|||
27820297|NCT01430403|54281925|FG002|Overall Study|Lost to Follow-up|3|||
27820298|NCT01430403|54281923|FG000|Overall Study|Physician Decision|1|||
27820299|NCT01430403|54281924|FG001|Overall Study|Physician Decision|0|||
27820300|NCT01430403|54281925|FG002|Overall Study|Physician Decision|0|||
27820301|NCT01430403|54281923|FG000|Overall Study|Protocol Violation|2|||
27820302|NCT01430403|54281924|FG001|Overall Study|Protocol Violation|3|||
27820303|NCT01430403|54281925|FG002|Overall Study|Protocol Violation|2|||
27820304|NCT01430403|54281923|FG000|Overall Study|Withdrawal by Subject|9|||
27820305|NCT01430403|54281924|FG001|Overall Study|Withdrawal by Subject|1|||
27820306|NCT01430403|54281925|FG002|Overall Study|Withdrawal by Subject|3|||
27820307|NCT01429623|54281940|FG000|Overall Study|Death|1|||
27820308|NCT01429623|54281941|FG001|Overall Study|Death|0|||
27820309|NCT01429623|54281940|FG000|Overall Study|Adverse Event|7|||
27820310|NCT01429623|54281941|FG001|Overall Study|Adverse Event|14|||
27820311|NCT01429623|54281940|FG000|Overall Study|Withdrawal by Subject|19|||
27820312|NCT01429623|54281941|FG001|Overall Study|Withdrawal by Subject|13|||
27820313|NCT01429623|54281940|FG000|Overall Study|Physician Decision|2|||
27820314|NCT01429623|54281941|FG001|Overall Study|Physician Decision|3|||
28135767|NCT02849587|54799808|FG001|Overall Study|Withdrawal by Subject|1|||
28135768|NCT02849587|54799809|FG002|Overall Study|Withdrawal by Subject|0|||
27820315|NCT01429623|54281940|FG000|Overall Study|Protocol Violation|3|||
27820316|NCT01429623|54281941|FG001|Overall Study|Protocol Violation|2|||
27820317|NCT01429623|54281940|FG000|Overall Study|Assorted|1|||
27820318|NCT01429623|54281941|FG001|Overall Study|Assorted|2|||
27820319|NCT01429623|54281940|FG000|Overall Study|Conversion to Alzheimer's disease|14|||
27820320|NCT01429623|54281941|FG001|Overall Study|Conversion to Alzheimer's disease|21|||
27820321|NCT01429623|54281940|FG000|Overall Study|No post baseline data|4|||
27820322|NCT01429623|54281941|FG001|Overall Study|No post baseline data|4|||
27820323|NCT01408641|54281949|FG000|Overall Study|Physician Decision|1|||
27820324|NCT01408641|54281950|FG001|Overall Study|Physician Decision|0|||
27820325|NCT01429077|54281958|FG000|Overall Study|Lost to Follow-up|0|||
27820326|NCT01429077|54281959|FG001|Overall Study|Lost to Follow-up|3|||
27820327|NCT01428453|54281967|FG000|Overall Study|Adverse Event|2|||
27820328|NCT01428453|54281968|FG001|Overall Study|Adverse Event|7|||
27820329|NCT01428453|54281967|FG000|Overall Study|Protocol Violation|1|||
27820330|NCT01428453|54281968|FG001|Overall Study|Protocol Violation|0|||
28135769|NCT03347279|54799823|FG000|Overall Study|Withdrawal by Subject|8|||
28135770|NCT03347279|54799824|FG001|Overall Study|Withdrawal by Subject|15|||
28135771|NCT03347279|54799823|FG000|Overall Study|Death|0|||
28135772|NCT03347279|54799824|FG001|Overall Study|Death|2|||
28135773|NCT03347279|54799823|FG000|Overall Study|Lost to Follow-up|5|||
28135774|NCT03347279|54799824|FG001|Overall Study|Lost to Follow-up|2|||
28135775|NCT03347279|54799823|FG000|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
28135776|NCT03347279|54799824|FG001|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
28135777|NCT03262441|54799830|FG000|Overall Study|Withdrawal by Subject|1|||
28135778|NCT04580394|54799834|FG000|First Intervention|Incorrectly Randomized|1|||
28135779|NCT04580394|54799834|FG000|First Intervention|Physician Decision|1|||
27820331|NCT01428453|54281967|FG000|Overall Study|Lost to Follow-up|0|||
27820332|NCT01428453|54281968|FG001|Overall Study|Lost to Follow-up|1|||
27820333|NCT01428453|54281967|FG000|Overall Study|Withdrawal by Subject|3|||
27820334|NCT01428453|54281968|FG001|Overall Study|Withdrawal by Subject|1|||
27820335|NCT01408563|54281976|FG000|Overall Study|Ineligible after consent/ registration|2|||
27820336|NCT01442493|54281982|FG000|Overall Study|withdrawn from study|3|||
27820337|NCT01442493|54281983|FG001|Overall Study|withdrawn from study|2|||
27820338|NCT01442181|54281991|FG000|Overall Study|patient refused surgery|1|||
27820339|NCT01442181|54281992|FG001|Overall Study|patient refused surgery|0|||
27820340|NCT01442181|54281991|FG000|Overall Study|no insurance for surgery|1|||
27820341|NCT01442181|54281992|FG001|Overall Study|no insurance for surgery|0|||
28135780|NCT04580394|54799834|FG000|First Intervention|Lost to Follow-up|1|||
28135781|NCT04580394|54799834|FG000|Washout (One Week)|Withdrawal by Subject|1|||
28135782|NCT04580394|54799834|FG000|Washout (One Week)|Adverse Event|1|||
28135783|NCT04580394|54799834|FG000|Washout (One Week)|Withdrawal by Subject|2|||
28135784|NCT04580394|54799834|FG000|Third Intervention|Adverse Event|1|||
28135785|NCT04580394|54799834|FG000|Third Intervention|Withdrawal by Subject|1|||
28135786|NCT04580394|54799834|FG000|Washout (One Week)|Withdrawal by Subject|2|||
28135787|NCT02781727|54799846|FG000|Pre-dosing Period|Withdrawal by Subject|1|||
28135788|NCT02781727|54799847|FG001|Pre-dosing Period|Withdrawal by Subject|0|||
28135789|NCT02781727|54799846|FG000|Treatment Period|Withdrawal by Subject|1|||
28135790|NCT02781727|54799847|FG001|Treatment Period|Withdrawal by Subject|0|||
28135791|NCT02781727|54799846|FG000|Treatment Period|Lost to Follow-up|0|||
28135792|NCT02781727|54799847|FG001|Treatment Period|Lost to Follow-up|1|||
28135793|NCT01343082|54799853|FG000|The run-in Period|Not meeting criteria|3|||
28135794|NCT01343082|54799854|FG001|The run-in Period|Not meeting criteria|4|||
28135795|NCT01343082|54799855|FG002|The run-in Period|Not meeting criteria|5|||
28135796|NCT01343082|54799853|FG000|Treatment Period , Switched to DE-111|Adverse Event|1|||
28135797|NCT01343082|54799854|FG001|Treatment Period , Switched to DE-111|Adverse Event|4|||
28135798|NCT01343082|54799855|FG002|Treatment Period , Switched to DE-111|Adverse Event|3|||
28135799|NCT01343082|54799853|FG000|Treatment Period , Switched to DE-111|Lack of Efficacy|0|||
28135800|NCT01343082|54799854|FG001|Treatment Period , Switched to DE-111|Lack of Efficacy|1|||
28135801|NCT01343082|54799855|FG002|Treatment Period , Switched to DE-111|Lack of Efficacy|2|||
27820342|NCT01442181|54281991|FG000|Overall Study|low ejection factor|0|||
27820343|NCT01442181|54281992|FG001|Overall Study|low ejection factor|1|||
27820344|NCT01442181|54281991|FG000|Overall Study|Lost to Follow-up|1|||
27820345|NCT01442181|54281992|FG001|Overall Study|Lost to Follow-up|1|||
27820346|NCT01442181|54281991|FG000|Overall Study|patient in an additional study|1|||
28135802|NCT01343082|54799853|FG000|Treatment Period , Switched to DE-111|Physician Decision|0|||
28135803|NCT01343082|54799854|FG001|Treatment Period , Switched to DE-111|Physician Decision|2|||
28135804|NCT01343082|54799855|FG002|Treatment Period , Switched to DE-111|Physician Decision|2|||
27820347|NCT01442181|54281992|FG001|Overall Study|patient in an additional study|0|||
27820348|NCT01442181|54281991|FG000|Overall Study|atrial fibrillation not noted|0|||
27820349|NCT01442181|54281992|FG001|Overall Study|atrial fibrillation not noted|1|||
28135805|NCT01343082|54799853|FG000|Treatment Period , Switched to DE-111|Withdrawal by Subject|4|||
27820350|NCT01442103|54281999|FG000|Overall Study|Lost to Follow-up|2|||
27820351|NCT01428219|54282003|FG000|Overall Study|25 patients enrolled, 3 were not treated|3|||
27820352|NCT01428063|54282010|FG000|Overall Study|Lack of Efficacy|8|||
27820353|NCT01428063|54282011|FG001|Overall Study|Lack of Efficacy|4|||
27820354|NCT01428063|54282012|FG002|Overall Study|Lack of Efficacy|1|||
27820355|NCT01428063|54282010|FG000|Overall Study|Adverse Event|2|||
27820356|NCT01428063|54282011|FG001|Overall Study|Adverse Event|3|||
27820357|NCT01428063|54282012|FG002|Overall Study|Adverse Event|0|||
27820358|NCT01428063|54282010|FG000|Overall Study|Lost to Follow-up|0|||
28135806|NCT01343082|54799854|FG001|Treatment Period , Switched to DE-111|Withdrawal by Subject|2|||
28135807|NCT01343082|54799855|FG002|Treatment Period , Switched to DE-111|Withdrawal by Subject|5|||
28135808|NCT03374189|54799861|FG000|Overall Study|Lost to Follow-up|1|||
28135809|NCT03374189|54799862|FG001|Overall Study|Lost to Follow-up|0|||
28135810|NCT03261037|54799872|FG000|Overall Study|Withdrawal by Subject|2|||
28135811|NCT03261037|54799873|FG001|Overall Study|Withdrawal by Subject|13|||
28135812|NCT03261037|54799874|FG002|Overall Study|Withdrawal by Subject|0|||
27820359|NCT01428063|54282011|FG001|Overall Study|Lost to Follow-up|2|||
27820360|NCT01428063|54282012|FG002|Overall Study|Lost to Follow-up|0|||
27820361|NCT01428063|54282010|FG000|Overall Study|No longer meets study criteria|0|||
27820362|NCT01428063|54282011|FG001|Overall Study|No longer meets study criteria|1|||
27820363|NCT01428063|54282012|FG002|Overall Study|No longer meets study criteria|0|||
27820364|NCT01441635|54282176|FG000|Overall Study|Adverse Event|4|||
27820365|NCT01441635|54282177|FG001|Overall Study|Adverse Event|3|||
27820366|NCT01441635|54282178|FG002|Overall Study|Adverse Event|1|||
27820367|NCT01441635|54282179|FG003|Overall Study|Adverse Event|5|||
27820368|NCT01441635|54282180|FG004|Overall Study|Adverse Event|1|||
27820369|NCT01441635|54282181|FG005|Overall Study|Adverse Event|2|||
27820370|NCT01441635|54282182|FG006|Overall Study|Adverse Event|2|||
27820371|NCT01441635|54282183|FG007|Overall Study|Adverse Event|2|||
27820372|NCT01441635|54282184|FG008|Overall Study|Adverse Event|1|||
28135813|NCT03261037|54799875|FG003|Overall Study|Withdrawal by Subject|18|||
28135814|NCT03261037|54799872|FG000|Overall Study|Non-compliance with study procedures|0|||
28135815|NCT03261037|54799873|FG001|Overall Study|Non-compliance with study procedures|2|||
28135816|NCT03261037|54799874|FG002|Overall Study|Non-compliance with study procedures|0|||
28135817|NCT03261037|54799875|FG003|Overall Study|Non-compliance with study procedures|6|||
28135818|NCT03261037|54799872|FG000|Overall Study|Participant moving away and can no longer be in study|0|||
28135819|NCT03261037|54799873|FG001|Overall Study|Participant moving away and can no longer be in study|1|||
28135820|NCT03261037|54799874|FG002|Overall Study|Participant moving away and can no longer be in study|0|||
28135821|NCT03261037|54799875|FG003|Overall Study|Participant moving away and can no longer be in study|0|||
28135822|NCT03261037|54799872|FG000|Overall Study|Participant came out of study due to investigator discretion|0|||
28135823|NCT03261037|54799873|FG001|Overall Study|Participant came out of study due to investigator discretion|2|||
28135824|NCT03261037|54799874|FG002|Overall Study|Participant came out of study due to investigator discretion|0|||
28135825|NCT03261037|54799875|FG003|Overall Study|Participant came out of study due to investigator discretion|0|||
28135826|NCT03261037|54799872|FG000|Overall Study|Diagnosed but protocol deviation|1|||
28135827|NCT03261037|54799873|FG001|Overall Study|Diagnosed but protocol deviation|0|||
28135828|NCT03261037|54799874|FG002|Overall Study|Diagnosed but protocol deviation|0|||
28135829|NCT03261037|54799875|FG003|Overall Study|Diagnosed but protocol deviation|0|||
28135830|NCT03261037|54799872|FG000|Overall Study|Participant did not want to continue the study|0|||
28135831|NCT03261037|54799873|FG001|Overall Study|Participant did not want to continue the study|1|||
28135832|NCT03261037|54799874|FG002|Overall Study|Participant did not want to continue the study|0|||
28135833|NCT03261037|54799875|FG003|Overall Study|Participant did not want to continue the study|0|||
28135834|NCT03261037|54799872|FG000|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
28135835|NCT03261037|54799873|FG001|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
28135836|NCT03261037|54799874|FG002|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
28135837|NCT03261037|54799875|FG003|Overall Study|Participant did not want to continue the diagnostic procedures|1|||
28135838|NCT03261037|54799872|FG000|Overall Study|Participant presented clinical improvement|0|||
28135839|NCT03261037|54799873|FG001|Overall Study|Participant presented clinical improvement|2|||
28135840|NCT03261037|54799874|FG002|Overall Study|Participant presented clinical improvement|0|||
28135841|NCT03261037|54799875|FG003|Overall Study|Participant presented clinical improvement|0|||
28135842|NCT03261037|54799872|FG000|Overall Study|Technical difficulties|0|||
27820373|NCT01441635|54282185|FG009|Overall Study|Adverse Event|0|||
27820374|NCT01441635|54282176|FG000|Overall Study|Withdrawal by Subject|1|||
27820375|NCT01441635|54282177|FG001|Overall Study|Withdrawal by Subject|1|||
27820376|NCT01441635|54282178|FG002|Overall Study|Withdrawal by Subject|0|||
27820377|NCT01441635|54282179|FG003|Overall Study|Withdrawal by Subject|1|||
27820378|NCT01441635|54282180|FG004|Overall Study|Withdrawal by Subject|0|||
27820379|NCT01441635|54282181|FG005|Overall Study|Withdrawal by Subject|0|||
27820380|NCT01441635|54282182|FG006|Overall Study|Withdrawal by Subject|2|||
27820381|NCT01441635|54282183|FG007|Overall Study|Withdrawal by Subject|0|||
27820382|NCT01441635|54282184|FG008|Overall Study|Withdrawal by Subject|1|||
28135843|NCT03261037|54799873|FG001|Overall Study|Technical difficulties|0|||
28135844|NCT03261037|54799874|FG002|Overall Study|Technical difficulties|0|||
27820383|NCT01441635|54282185|FG009|Overall Study|Withdrawal by Subject|1|||
27820384|NCT01441635|54282176|FG000|Overall Study|Lost to Follow-up|0|||
27820385|NCT01441635|54282177|FG001|Overall Study|Lost to Follow-up|1|||
27820386|NCT01441635|54282178|FG002|Overall Study|Lost to Follow-up|1|||
27820387|NCT01441635|54282179|FG003|Overall Study|Lost to Follow-up|1|||
27820388|NCT01441635|54282180|FG004|Overall Study|Lost to Follow-up|1|||
27820389|NCT01441635|54282181|FG005|Overall Study|Lost to Follow-up|3|||
27820390|NCT01441635|54282182|FG006|Overall Study|Lost to Follow-up|1|||
27820391|NCT01441635|54282183|FG007|Overall Study|Lost to Follow-up|1|||
27820392|NCT01441635|54282184|FG008|Overall Study|Lost to Follow-up|0|||
27820393|NCT01441635|54282185|FG009|Overall Study|Lost to Follow-up|1|||
27820394|NCT01441635|54282176|FG000|Overall Study|Noncompliance|0|||
27820395|NCT01441635|54282177|FG001|Overall Study|Noncompliance|1|||
27820396|NCT01441635|54282178|FG002|Overall Study|Noncompliance|0|||
27820397|NCT01441635|54282179|FG003|Overall Study|Noncompliance|0|||
28069654|NCT00035932|54724668|FG000|Overall Study|Disease Progression / Relapse|1|||
28069655|NCT00035932|54724669|FG001|Overall Study|Disease Progression / Relapse|1|||
28135845|NCT03261037|54799875|FG003|Overall Study|Technical difficulties|1|||
28069656|NCT00035932|54724670|FG002|Overall Study|Disease Progression / Relapse|0|||
28069657|NCT00035932|54724668|FG000|Overall Study|Lost to Follow-up|4|||
28069658|NCT00035932|54724669|FG001|Overall Study|Lost to Follow-up|4|||
28069659|NCT00035932|54724670|FG002|Overall Study|Lost to Follow-up|3|||
28069660|NCT00035932|54724668|FG000|Overall Study|Noncompliance|6|||
28069661|NCT00035932|54724669|FG001|Overall Study|Noncompliance|7|||
28069662|NCT00035932|54724670|FG002|Overall Study|Noncompliance|6|||
28069663|NCT00035932|54724668|FG000|Overall Study|Protocol Violation While on Study|0|||
28069664|NCT00035932|54724669|FG001|Overall Study|Protocol Violation While on Study|1|||
28069665|NCT00035932|54724670|FG002|Overall Study|Protocol Violation While on Study|2|||
28069666|NCT00035932|54724668|FG000|Overall Study|Withdrawal by Subject|1|||
28069667|NCT00035932|54724669|FG001|Overall Study|Withdrawal by Subject|5|||
28069668|NCT00035932|54724670|FG002|Overall Study|Withdrawal by Subject|0|||
28069669|NCT00035932|54724668|FG000|Overall Study|Study Termination by Sponsor|1|||
28069670|NCT00035932|54724669|FG001|Overall Study|Study Termination by Sponsor|0|||
28069671|NCT00035932|54724670|FG002|Overall Study|Study Termination by Sponsor|0|||
28069672|NCT00035932|54724668|FG000|Overall Study|Lack of Efficacy|33|||
28069673|NCT00035932|54724669|FG001|Overall Study|Lack of Efficacy|33|||
28069674|NCT00035932|54724670|FG002|Overall Study|Lack of Efficacy|28|||
28069675|NCT00022516|54724685|FG000|Overall Study|Adverse Event|0|||
28069676|NCT00022516|54724686|FG001|Overall Study|Adverse Event|59|||
28069677|NCT00022516|54724685|FG000|Overall Study|Lack of Efficacy|0|||
28069678|NCT00022516|54724686|FG001|Overall Study|Lack of Efficacy|27|||
28069679|NCT00022516|54724685|FG000|Overall Study|Physician Decision|0|||
28069680|NCT00022516|54724686|FG001|Overall Study|Physician Decision|1|||
28069681|NCT00022516|54724685|FG000|Overall Study|Protocol Violation|1|||
28069682|NCT00022516|54724686|FG001|Overall Study|Protocol Violation|3|||
28069683|NCT00022516|54724685|FG000|Overall Study|Withdrawal by Subject|2|||
28069684|NCT00022516|54724686|FG001|Overall Study|Withdrawal by Subject|113|||
28069685|NCT00022516|54724685|FG000|Overall Study|Incomplete documentation|0|||
28069686|NCT00022516|54724686|FG001|Overall Study|Incomplete documentation|27|||
28069687|NCT00033514|54724694|FG000|Overall Study|Lost to Follow-up|1|||
28069688|NCT00033514|54724695|FG001|Overall Study|Lost to Follow-up|1|||
28069689|NCT00033514|54724694|FG000|Overall Study|Withdrawal by Subject|0|||
28069690|NCT00033514|54724695|FG001|Overall Study|Withdrawal by Subject|3|||
28069691|NCT00006916|54724702|FG000|Overall Study|Device not inserted|4|||
28069692|NCT00006916|54724702|FG000|Overall Study|Complication of device insertion|1|||
28069693|NCT00454649|54724716|FG000|Overall Study|Lack of Efficacy|2|||
28069694|NCT00454649|54724717|FG001|Overall Study|Lack of Efficacy|2|||
28069695|NCT00454649|54724718|FG002|Overall Study|Lack of Efficacy|10|||
28069696|NCT00454649|54724719|FG003|Overall Study|Lack of Efficacy|3|||
28069697|NCT00454649|54724720|FG004|Overall Study|Lack of Efficacy|0|||
28069698|NCT00454649|54724721|FG005|Overall Study|Lack of Efficacy|4|||
28069699|NCT00454649|54724722|FG006|Overall Study|Lack of Efficacy|5|||
28069700|NCT00454649|54724723|FG007|Overall Study|Lack of Efficacy|13|||
28069701|NCT00454649|54724724|FG008|Overall Study|Lack of Efficacy|10|||
28069702|NCT00454649|54724725|FG009|Overall Study|Lack of Efficacy|2|||
28069703|NCT00454649|54724716|FG000|Overall Study|Adverse Event|0|||
28069704|NCT00454649|54724717|FG001|Overall Study|Adverse Event|1|||
28069705|NCT00454649|54724718|FG002|Overall Study|Adverse Event|3|||
28135846|NCT03261037|54799872|FG000|Overall Study|Equipment failed to work|0|||
27820398|NCT01441635|54282180|FG004|Overall Study|Noncompliance|0|||
28069706|NCT00454649|54724719|FG003|Overall Study|Adverse Event|0|||
28069707|NCT00454649|54724720|FG004|Overall Study|Adverse Event|1|||
28069708|NCT00454649|54724721|FG005|Overall Study|Adverse Event|2|||
28069709|NCT00454649|54724722|FG006|Overall Study|Adverse Event|3|||
28069710|NCT00454649|54724723|FG007|Overall Study|Adverse Event|4|||
28069711|NCT00454649|54724724|FG008|Overall Study|Adverse Event|6|||
28069712|NCT00454649|54724725|FG009|Overall Study|Adverse Event|2|||
28069713|NCT00454649|54724716|FG000|Overall Study|Lost to Follow-up|0|||
28069714|NCT00454649|54724717|FG001|Overall Study|Lost to Follow-up|0|||
28069715|NCT00454649|54724718|FG002|Overall Study|Lost to Follow-up|1|||
27820399|NCT01441635|54282181|FG005|Overall Study|Noncompliance|0|||
27820400|NCT01441635|54282182|FG006|Overall Study|Noncompliance|1|||
28069716|NCT00454649|54724719|FG003|Overall Study|Lost to Follow-up|0|||
28069717|NCT00454649|54724720|FG004|Overall Study|Lost to Follow-up|0|||
28069718|NCT00454649|54724721|FG005|Overall Study|Lost to Follow-up|0|||
28069719|NCT00454649|54724722|FG006|Overall Study|Lost to Follow-up|1|||
27820401|NCT01441635|54282183|FG007|Overall Study|Noncompliance|0|||
27820402|NCT01441635|54282184|FG008|Overall Study|Noncompliance|0|||
27820403|NCT01441635|54282185|FG009|Overall Study|Noncompliance|0|||
27820404|NCT01441635|54282176|FG000|Overall Study|Surgery or Invasive Intervention|0|||
27820405|NCT01441635|54282177|FG001|Overall Study|Surgery or Invasive Intervention|0|||
27820406|NCT01441635|54282178|FG002|Overall Study|Surgery or Invasive Intervention|1|||
27820407|NCT01441635|54282179|FG003|Overall Study|Surgery or Invasive Intervention|0|||
27820408|NCT01441635|54282180|FG004|Overall Study|Surgery or Invasive Intervention|0|||
27820409|NCT01441635|54282181|FG005|Overall Study|Surgery or Invasive Intervention|0|||
28135847|NCT03261037|54799873|FG001|Overall Study|Equipment failed to work|0|||
28135848|NCT03261037|54799874|FG002|Overall Study|Equipment failed to work|0|||
27820410|NCT01441635|54282182|FG006|Overall Study|Surgery or Invasive Intervention|0|||
27820411|NCT01441635|54282183|FG007|Overall Study|Surgery or Invasive Intervention|0|||
27820412|NCT01441635|54282184|FG008|Overall Study|Surgery or Invasive Intervention|0|||
27820413|NCT01441635|54282185|FG009|Overall Study|Surgery or Invasive Intervention|0|||
27820414|NCT01441635|54282176|FG000|Overall Study|Received Exclusionary Medication|1|||
27820415|NCT01441635|54282177|FG001|Overall Study|Received Exclusionary Medication|0|||
27820416|NCT01441635|54282178|FG002|Overall Study|Received Exclusionary Medication|0|||
27820417|NCT01441635|54282179|FG003|Overall Study|Received Exclusionary Medication|0|||
27820418|NCT01441635|54282180|FG004|Overall Study|Received Exclusionary Medication|0|||
27820419|NCT01441635|54282181|FG005|Overall Study|Received Exclusionary Medication|0|||
27820420|NCT01441635|54282182|FG006|Overall Study|Received Exclusionary Medication|0|||
27820421|NCT01441635|54282183|FG007|Overall Study|Received Exclusionary Medication|0|||
27820422|NCT01441635|54282184|FG008|Overall Study|Received Exclusionary Medication|0|||
27820423|NCT01441635|54282185|FG009|Overall Study|Received Exclusionary Medication|0|||
27820424|NCT01441635|54282176|FG000|Overall Study|Other|0|||
27820425|NCT01441635|54282177|FG001|Overall Study|Other|0|||
27820426|NCT01441635|54282178|FG002|Overall Study|Other|0|||
27820427|NCT01441635|54282179|FG003|Overall Study|Other|0|||
27820428|NCT01441635|54282180|FG004|Overall Study|Other|0|||
27820429|NCT01441635|54282181|FG005|Overall Study|Other|0|||
27820430|NCT01441635|54282182|FG006|Overall Study|Other|0|||
27820431|NCT01441635|54282183|FG007|Overall Study|Other|1|||
28135849|NCT03261037|54799875|FG003|Overall Study|Equipment failed to work|1|||
28135850|NCT03261037|54799872|FG000|Overall Study|End of study for participant and no follow up|0|||
27820432|NCT01441635|54282184|FG008|Overall Study|Other|0|||
27820433|NCT01441635|54282185|FG009|Overall Study|Other|0|||
27820434|NCT01408485|54282207|FG000|Overall Study|Withdrawal by Subject|21|||
27820435|NCT01427907|54282213|FG000|Overall Study|Withdrawal by Subject|3|||
27820436|NCT01427907|54282214|FG001|Overall Study|Withdrawal by Subject|4|||
27820437|NCT01427751|54282222|FG000|Overall Study|Adverse Event|18|||
27820438|NCT01427751|54282223|FG001|Overall Study|Adverse Event|2|||
27820439|NCT01427751|54282222|FG000|Overall Study|No further treatment benefit expected|5|||
27820440|NCT01427751|54282223|FG001|Overall Study|No further treatment benefit expected|1|||
27820441|NCT01427751|54282222|FG000|Overall Study|Lost to Follow-up|3|||
27820442|NCT01427751|54282223|FG001|Overall Study|Lost to Follow-up|1|||
27820443|NCT01427751|54282222|FG000|Overall Study|Withdrawal of consent|2|||
27820444|NCT01427751|54282223|FG001|Overall Study|Withdrawal of consent|2|||
27820445|NCT01427751|54282222|FG000|Overall Study|Protocol Violation|6|||
27820446|NCT01427751|54282223|FG001|Overall Study|Protocol Violation|4|||
27820447|NCT01427751|54282222|FG000|Overall Study|Death|2|||
27820448|NCT01427751|54282223|FG001|Overall Study|Death|0|||
27820449|NCT01427751|54282222|FG000|Overall Study|Other miscellaneous reasons|6|||
27820450|NCT01427751|54282223|FG001|Overall Study|Other miscellaneous reasons|4|||
27820451|NCT01920061|54282249|FG000|Overall Study|Death|1|||
27820452|NCT01920061|54282250|FG001|Overall Study|Death|1|||
27820453|NCT01920061|54282251|FG002|Overall Study|Death|0|||
27820454|NCT01920061|54282252|FG003|Overall Study|Death|1|||
27820455|NCT01920061|54282253|FG004|Overall Study|Death|1|||
27820456|NCT01920061|54282254|FG005|Overall Study|Death|0|||
27820457|NCT01920061|54282255|FG006|Overall Study|Death|0|||
27820458|NCT01920061|54282256|FG007|Overall Study|Death|1|||
27820459|NCT01920061|54282257|FG008|Overall Study|Death|0|||
27820460|NCT01920061|54282258|FG009|Overall Study|Death|1|||
28135851|NCT03261037|54799873|FG001|Overall Study|End of study for participant and no follow up|0|||
27820461|NCT01920061|54282259|FG010|Overall Study|Death|0|||
27820462|NCT01920061|54282260|FG011|Overall Study|Death|1|||
27820463|NCT01920061|54282261|FG012|Overall Study|Death|0|||
27820464|NCT01920061|54282262|FG013|Overall Study|Death|2|||
27820465|NCT01920061|54282263|FG014|Overall Study|Death|0|||
27820466|NCT01920061|54282264|FG015|Overall Study|Death|0|||
27820467|NCT01920061|54282265|FG016|Overall Study|Death|0|||
27820468|NCT01920061|54282266|FG017|Overall Study|Death|0|||
27820469|NCT01920061|54282267|FG018|Overall Study|Death|1|||
27820470|NCT01920061|54282268|FG019|Overall Study|Death|0|||
27820471|NCT01920061|54282249|FG000|Overall Study|Lost to Follow-up|0|||
27820472|NCT01920061|54282250|FG001|Overall Study|Lost to Follow-up|2|||
27820473|NCT01920061|54282251|FG002|Overall Study|Lost to Follow-up|0|||
27820474|NCT01920061|54282252|FG003|Overall Study|Lost to Follow-up|0|||
27820475|NCT01920061|54282253|FG004|Overall Study|Lost to Follow-up|0|||
27820476|NCT01920061|54282254|FG005|Overall Study|Lost to Follow-up|0|||
27820477|NCT01920061|54282255|FG006|Overall Study|Lost to Follow-up|1|||
27820478|NCT01920061|54282256|FG007|Overall Study|Lost to Follow-up|0|||
27820479|NCT01920061|54282257|FG008|Overall Study|Lost to Follow-up|0|||
27820480|NCT01920061|54282258|FG009|Overall Study|Lost to Follow-up|0|||
27820481|NCT01920061|54282259|FG010|Overall Study|Lost to Follow-up|3|||
27820482|NCT01920061|54282260|FG011|Overall Study|Lost to Follow-up|0|||
27820483|NCT01920061|54282261|FG012|Overall Study|Lost to Follow-up|0|||
27820484|NCT01920061|54282262|FG013|Overall Study|Lost to Follow-up|0|||
27820485|NCT01920061|54282263|FG014|Overall Study|Lost to Follow-up|0|||
27820486|NCT01920061|54282264|FG015|Overall Study|Lost to Follow-up|0|||
28135852|NCT03261037|54799874|FG002|Overall Study|End of study for participant and no follow up|0|||
28135853|NCT03261037|54799875|FG003|Overall Study|End of study for participant and no follow up|1|||
28135854|NCT03261037|54799872|FG000|Overall Study|Participant was too weak to continue in study|1|||
28135855|NCT03261037|54799873|FG001|Overall Study|Participant was too weak to continue in study|0|||
28135856|NCT03261037|54799874|FG002|Overall Study|Participant was too weak to continue in study|0|||
28135857|NCT03261037|54799875|FG003|Overall Study|Participant was too weak to continue in study|0|||
28135858|NCT03372551|54799886|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
28135859|NCT03372551|54799887|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
28135860|NCT03326323|54799900|FG000|Overall Study|Unable to receive ANH protocol|3|||
28135861|NCT03259789|54799911|FG000|Overall Study|Adverse Event|3|||
28135862|NCT03259789|54799912|FG001|Overall Study|Adverse Event|2|||
28135863|NCT03259789|54799913|FG002|Overall Study|Adverse Event|1|||
28135864|NCT03259789|54799911|FG000|Overall Study|Withdrawal by Subject|9|||
28135865|NCT03259789|54799912|FG001|Overall Study|Withdrawal by Subject|5|||
28135866|NCT03259789|54799913|FG002|Overall Study|Withdrawal by Subject|1|||
28135867|NCT03259789|54799911|FG000|Overall Study|Lost to Follow-up|5|||
28135868|NCT03259789|54799912|FG001|Overall Study|Lost to Follow-up|9|||
28135869|NCT03259789|54799913|FG002|Overall Study|Lost to Follow-up|4|||
28135870|NCT03259789|54799911|FG000|Overall Study|Physician Decision|0|||
28135871|NCT03259789|54799912|FG001|Overall Study|Physician Decision|1|||
28135872|NCT03259789|54799913|FG002|Overall Study|Physician Decision|0|||
28135873|NCT03259555|54799924|FG000|Overall Study|Adverse Event|6|||
28135874|NCT03259555|54799925|FG001|Overall Study|Adverse Event|4|||
28135875|NCT03259555|54799924|FG000|Overall Study|Lack of Efficacy|6|||
28135876|NCT03259555|54799925|FG001|Overall Study|Lack of Efficacy|4|||
28135877|NCT03259555|54799924|FG000|Overall Study|Lost to Follow-up|0|||
28135878|NCT03259555|54799925|FG001|Overall Study|Lost to Follow-up|2|||
28135879|NCT03259555|54799924|FG000|Overall Study|Non-Compliance With Study Drug|1|||
28135880|NCT03259555|54799925|FG001|Overall Study|Non-Compliance With Study Drug|0|||
28135881|NCT03259555|54799924|FG000|Overall Study|Progressive Disease|0|||
28135882|NCT03259555|54799925|FG001|Overall Study|Progressive Disease|2|||
28135883|NCT03259555|54799924|FG000|Overall Study|Withdrawal by Subject|19|||
28135884|NCT03259555|54799925|FG001|Overall Study|Withdrawal by Subject|16|||
28135885|NCT03259555|54799924|FG000|Overall Study|Physician Decision|1|||
28135886|NCT03259555|54799925|FG001|Overall Study|Physician Decision|2|||
28135887|NCT03259555|54799924|FG000|Overall Study|Other|1|||
28135888|NCT03259555|54799925|FG001|Overall Study|Other|0|||
28135889|NCT03259087|54799936|FG000|Part 1 and Period 1 of Part 2|Adverse Event|0|||
28135890|NCT03259087|54799937|FG001|Part 1 and Period 1 of Part 2|Adverse Event|0|||
28135891|NCT03259087|54799938|FG002|Part 1 and Period 1 of Part 2|Adverse Event|0|||
28135892|NCT03259087|54799939|FG003|Part 1 and Period 1 of Part 2|Adverse Event|0|||
28135893|NCT03259087|54799940|FG004|Part 1 and Period 1 of Part 2|Adverse Event|1|||
28135894|NCT03259087|54799936|FG000|Period 2 of Part 2|Adverse Event|0|||
27820487|NCT01920061|54282265|FG016|Overall Study|Lost to Follow-up|0|||
27820488|NCT01920061|54282266|FG017|Overall Study|Lost to Follow-up|1|||
27820489|NCT01920061|54282267|FG018|Overall Study|Lost to Follow-up|4|||
28135895|NCT03259087|54799937|FG001|Period 2 of Part 2|Adverse Event|0|||
28135896|NCT03259087|54799938|FG002|Period 2 of Part 2|Adverse Event|0|||
28135897|NCT03259087|54799939|FG003|Period 2 of Part 2|Adverse Event|0|||
28135898|NCT03259087|54799940|FG004|Period 2 of Part 2|Adverse Event|1|||
28135899|NCT03257995|54799962|FG000|Overall Study|Adverse Event|0|||
28135900|NCT03257995|54799963|FG001|Overall Study|Adverse Event|1|||
28135901|NCT03257995|54799964|FG002|Overall Study|Adverse Event|0|||
28135902|NCT03257995|54799965|FG003|Overall Study|Adverse Event|0|||
28135903|NCT03257995|54799966|FG004|Overall Study|Adverse Event|0|||
27820490|NCT01920061|54282268|FG019|Overall Study|Lost to Follow-up|3|||
28135904|NCT03257995|54799967|FG005|Overall Study|Adverse Event|0|||
27820491|NCT01920061|54282249|FG000|Overall Study|Other|1|||
27820492|NCT01920061|54282250|FG001|Overall Study|Other|1|||
27820493|NCT01920061|54282251|FG002|Overall Study|Other|2|||
28135905|NCT03257995|54799962|FG000|Overall Study|Protocol deviation|0|||
28135906|NCT03257995|54799963|FG001|Overall Study|Protocol deviation|0|||
27820494|NCT01920061|54282252|FG003|Overall Study|Other|1|||
27820495|NCT01920061|54282253|FG004|Overall Study|Other|0|||
27820496|NCT01920061|54282254|FG005|Overall Study|Other|1|||
27820497|NCT01920061|54282255|FG006|Overall Study|Other|0|||
27820498|NCT01920061|54282256|FG007|Overall Study|Other|0|||
27820499|NCT01920061|54282257|FG008|Overall Study|Other|0|||
27820500|NCT01920061|54282258|FG009|Overall Study|Other|1|||
27820501|NCT01920061|54282259|FG010|Overall Study|Other|1|||
28135907|NCT03257995|54799964|FG002|Overall Study|Protocol deviation|0|||
28135908|NCT03257995|54799965|FG003|Overall Study|Protocol deviation|0|||
28135909|NCT03257995|54799966|FG004|Overall Study|Protocol deviation|0|||
28135910|NCT03257995|54799967|FG005|Overall Study|Protocol deviation|2|||
28135911|NCT03049488|54799985|FG000|Overall Study|Lost to Follow-up|1|||
28135912|NCT03049488|54799986|FG001|Overall Study|Lost to Follow-up|1|||
28135913|NCT03049488|54799987|FG002|Overall Study|Lost to Follow-up|0|||
28135914|NCT03049488|54799988|FG003|Overall Study|Lost to Follow-up|0|||
28135915|NCT03049488|54799989|FG004|Overall Study|Lost to Follow-up|0|||
28135916|NCT03049488|54799990|FG005|Overall Study|Lost to Follow-up|0|||
28135917|NCT03049488|54799985|FG000|Overall Study|Moved from Area|1|||
28135918|NCT03049488|54799986|FG001|Overall Study|Moved from Area|0|||
28135919|NCT03049488|54799987|FG002|Overall Study|Moved from Area|0|||
28135920|NCT03049488|54799988|FG003|Overall Study|Moved from Area|1|||
28135921|NCT03049488|54799989|FG004|Overall Study|Moved from Area|1|||
28135922|NCT03049488|54799990|FG005|Overall Study|Moved from Area|0|||
28135923|NCT03049488|54799985|FG000|Overall Study|Physician Decision|0|||
27849816|NCT00631007|54347626|FG000|Overall Study|Other|2|||
27849817|NCT00631007|54347627|FG001|Overall Study|Other|1|||
27849818|NCT00631007|54347628|FG002|Overall Study|Other|0|||
27849819|NCT00631007|54347629|FG003|Overall Study|Other|0|||
28135924|NCT03049488|54799986|FG001|Overall Study|Physician Decision|1|||
28135925|NCT03049488|54799987|FG002|Overall Study|Physician Decision|0|||
28135926|NCT03049488|54799988|FG003|Overall Study|Physician Decision|0|||
28135927|NCT03049488|54799989|FG004|Overall Study|Physician Decision|0|||
28135928|NCT03049488|54799990|FG005|Overall Study|Physician Decision|0|||
28135929|NCT03049488|54799985|FG000|Overall Study|Withdrawal by Subject|0|||
27941025|NCT01020123|54597350|FG000|Main Period|Lost to Follow-up|0|||
28069720|NCT00454649|54724723|FG007|Overall Study|Lost to Follow-up|0|||
28069721|NCT00454649|54724724|FG008|Overall Study|Lost to Follow-up|0|||
28069722|NCT00454649|54724725|FG009|Overall Study|Lost to Follow-up|0|||
28069723|NCT00454649|54724716|FG000|Overall Study|Other|1|||
28069724|NCT00454649|54724717|FG001|Overall Study|Other|1|||
28069725|NCT00454649|54724718|FG002|Overall Study|Other|5|||
28069726|NCT00454649|54724719|FG003|Overall Study|Other|3|||
28069727|NCT00454649|54724720|FG004|Overall Study|Other|0|||
28069728|NCT00454649|54724721|FG005|Overall Study|Other|0|||
28069729|NCT00454649|54724722|FG006|Overall Study|Other|0|||
28069730|NCT00454649|54724723|FG007|Overall Study|Other|0|||
28135930|NCT03049488|54799986|FG001|Overall Study|Withdrawal by Subject|0|||
28135931|NCT03049488|54799987|FG002|Overall Study|Withdrawal by Subject|0|||
28135932|NCT03049488|54799988|FG003|Overall Study|Withdrawal by Subject|1|||
27820502|NCT01920061|54282260|FG011|Overall Study|Other|2|||
27820503|NCT01920061|54282261|FG012|Overall Study|Other|1|||
27820504|NCT01920061|54282262|FG013|Overall Study|Other|4|||
27820505|NCT01920061|54282263|FG014|Overall Study|Other|0|||
27820506|NCT01920061|54282264|FG015|Overall Study|Other|1|||
27820507|NCT01920061|54282265|FG016|Overall Study|Other|1|||
27849820|NCT00631007|54347630|FG004|Overall Study|Other|1|||
27849821|NCT00631007|54347631|FG005|Overall Study|Other|0|||
27849822|NCT00630539|54347658|FG000|Overall Study|Adverse Event|1|||
27849823|NCT00630539|54347659|FG001|Overall Study|Adverse Event|3|||
27849824|NCT00630539|54347660|FG002|Overall Study|Adverse Event|1|||
27849825|NCT00630539|54347661|FG003|Overall Study|Adverse Event|2|||
27849826|NCT00630539|54347658|FG000|Overall Study|Withdrawal by Subject|0|||
27849827|NCT00630539|54347659|FG001|Overall Study|Withdrawal by Subject|1|||
27849828|NCT00630539|54347660|FG002|Overall Study|Withdrawal by Subject|0|||
27849829|NCT00630539|54347661|FG003|Overall Study|Withdrawal by Subject|1|||
27849830|NCT00630305|54347739|FG000|Overall Study|Withdrawal by Subject|1|||
27849831|NCT00630305|54347739|FG000|Overall Study|Inability to insert contact lens|1|||
28069731|NCT00454649|54724724|FG008|Overall Study|Other|3|||
28069732|NCT00454649|54724725|FG009|Overall Study|Other|1|||
28069733|NCT00454649|54724716|FG000|Overall Study|Withdrawal by Subject|0|||
28069734|NCT00454649|54724717|FG001|Overall Study|Withdrawal by Subject|0|||
28135933|NCT03049488|54799989|FG004|Overall Study|Withdrawal by Subject|1|||
28135934|NCT03049488|54799990|FG005|Overall Study|Withdrawal by Subject|0|||
27820508|NCT01920061|54282266|FG017|Overall Study|Other|0|||
27820509|NCT01920061|54282267|FG018|Overall Study|Other|1|||
27820510|NCT01920061|54282268|FG019|Overall Study|Other|1|||
27849832|NCT01926197|54347965|FG000|Overall Study|Withdrawn to receive chemotherapy|1|||
27849833|NCT01926197|54347966|FG001|Overall Study|Withdrawn to receive chemotherapy|0|||
27849834|NCT01926197|54347965|FG000|Overall Study|Withdrawn due to non-coverage by insurance|0|||
28069735|NCT00454649|54724718|FG002|Overall Study|Withdrawal by Subject|0|||
28069736|NCT00454649|54724719|FG003|Overall Study|Withdrawal by Subject|0|||
28069737|NCT00454649|54724720|FG004|Overall Study|Withdrawal by Subject|0|||
28135935|NCT03257371|54800005|FG000|Overall Study|Lost to Follow-up|1|||
28135936|NCT03242863|54800009|FG000|Study Week 1|Withdrawal by Subject|0|||
28135937|NCT03242863|54800010|FG001|Study Week 1|Withdrawal by Subject|1|||
28135938|NCT03242863|54800011|FG002|Study Week 1|Withdrawal by Subject|0|||
28135939|NCT03242863|54800012|FG003|Study Week 1|Withdrawal by Subject|0|||
28135940|NCT03242863|54800013|FG004|Study Week 1|Withdrawal by Subject|3|||
28135941|NCT03242863|54800014|FG005|Study Week 1|Withdrawal by Subject|0|||
28135942|NCT03044106|54800022|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
28135943|NCT03044106|54800023|FG001|Washout (1 Week)|Withdrawal by Subject|2|||
28135944|NCT03043560|54800049|FG000|Overall Study|Discontinued Intervention|1|||
28135945|NCT03043560|54800050|FG001|Overall Study|Discontinued Intervention|2|||
28135946|NCT03043560|54800049|FG000|Overall Study|Lost to Follow-up|0|||
28135947|NCT03043560|54800050|FG001|Overall Study|Lost to Follow-up|1|||
28135948|NCT03255733|54800076|FG000|Overall Study|Lost to Follow-up|4|||
28135949|NCT03255655|54800082|FG000|Overall Study|Lost to Follow-up|7|||
28135950|NCT03255655|54800083|FG001|Overall Study|Lost to Follow-up|4|||
28135951|NCT02899988|54800093|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
28135952|NCT02899988|54800094|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
28135953|NCT02899988|54800095|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
28135954|NCT02899988|54800096|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
28135955|NCT02899988|54800097|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
28135956|NCT02899988|54800098|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
28135957|NCT02899988|54800099|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
28135958|NCT02899988|54800100|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
28135959|NCT02899988|54800101|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
28135960|NCT02899988|54800102|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
28135961|NCT02899988|54800103|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
28135962|NCT02899988|54800093|FG000|Induction Period (16 Weeks)|Adverse Event|0|||
28135963|NCT02899988|54800094|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
28135964|NCT02899988|54800095|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
28135965|NCT02899988|54800096|FG003|Induction Period (16 Weeks)|Adverse Event|2|||
28135966|NCT02899988|54800097|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
27820511|NCT01920061|54282249|FG000|Overall Study|Participant refused further follow-up|0|||
27820512|NCT01920061|54282250|FG001|Overall Study|Participant refused further follow-up|0|||
27820513|NCT01920061|54282251|FG002|Overall Study|Participant refused further follow-up|0|||
27820514|NCT01920061|54282252|FG003|Overall Study|Participant refused further follow-up|0|||
27820515|NCT01920061|54282253|FG004|Overall Study|Participant refused further follow-up|1|||
27820516|NCT01920061|54282254|FG005|Overall Study|Participant refused further follow-up|1|||
27820517|NCT01920061|54282255|FG006|Overall Study|Participant refused further follow-up|0|||
27820518|NCT01920061|54282256|FG007|Overall Study|Participant refused further follow-up|0|||
27820519|NCT01920061|54282257|FG008|Overall Study|Participant refused further follow-up|1|||
27849835|NCT01926197|54347966|FG001|Overall Study|Withdrawn due to non-coverage by insurance|1|||
27849836|NCT00989963|54347991|FG000|Overall Study|Adverse Event|1|||
28135967|NCT02899988|54800098|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
28135968|NCT02899988|54800099|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
28135969|NCT02899988|54800100|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
28135970|NCT02899988|54800101|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
28135971|NCT02899988|54800102|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
28135972|NCT02899988|54800103|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
28135973|NCT02899988|54800093|FG000|Induction Period (16 Weeks)|Physician Decision|0|||
28135974|NCT02899988|54800094|FG001|Induction Period (16 Weeks)|Physician Decision|1|||
28135975|NCT02899988|54800095|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
28135976|NCT02899988|54800096|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
28135977|NCT02899988|54800097|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
28135978|NCT02899988|54800098|FG005|Induction Period (16 Weeks)|Physician Decision|0|||
28135979|NCT02899988|54800099|FG006|Induction Period (16 Weeks)|Physician Decision|0|||
28135980|NCT02899988|54800100|FG007|Induction Period (16 Weeks)|Physician Decision|0|||
28135981|NCT02899988|54800101|FG008|Induction Period (16 Weeks)|Physician Decision|0|||
28135982|NCT02899988|54800102|FG009|Induction Period (16 Weeks)|Physician Decision|0|||
28135983|NCT02899988|54800103|FG010|Induction Period (16 Weeks)|Physician Decision|0|||
28135984|NCT02899988|54800093|FG000|Maintenance Period (88 Weeks)|Adverse Event|0|||
28135985|NCT02899988|54800094|FG001|Maintenance Period (88 Weeks)|Adverse Event|0|||
28135986|NCT02899988|54800095|FG002|Maintenance Period (88 Weeks)|Adverse Event|0|||
27820520|NCT01920061|54282258|FG009|Overall Study|Participant refused further follow-up|0|||
27820521|NCT01920061|54282259|FG010|Overall Study|Participant refused further follow-up|1|||
27820522|NCT01920061|54282260|FG011|Overall Study|Participant refused further follow-up|0|||
27820523|NCT01920061|54282261|FG012|Overall Study|Participant refused further follow-up|1|||
27820524|NCT01920061|54282262|FG013|Overall Study|Participant refused further follow-up|0|||
28135987|NCT02899988|54800096|FG003|Maintenance Period (88 Weeks)|Adverse Event|0|||
28135988|NCT02899988|54800097|FG004|Maintenance Period (88 Weeks)|Adverse Event|1|||
28135989|NCT02899988|54800098|FG005|Maintenance Period (88 Weeks)|Adverse Event|2|||
28135990|NCT02899988|54800099|FG006|Maintenance Period (88 Weeks)|Adverse Event|1|||
28135991|NCT02899988|54800100|FG007|Maintenance Period (88 Weeks)|Adverse Event|2|||
28135992|NCT02899988|54800101|FG008|Maintenance Period (88 Weeks)|Adverse Event|2|||
28135993|NCT02899988|54800102|FG009|Maintenance Period (88 Weeks)|Adverse Event|2|||
28135994|NCT02899988|54800103|FG010|Maintenance Period (88 Weeks)|Adverse Event|1|||
28135995|NCT02899988|54800093|FG000|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
28135996|NCT02899988|54800094|FG001|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
28135997|NCT02899988|54800095|FG002|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
28135998|NCT02899988|54800096|FG003|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
28135999|NCT02899988|54800097|FG004|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
28136000|NCT02899988|54800098|FG005|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
28136001|NCT02899988|54800099|FG006|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
28136002|NCT02899988|54800100|FG007|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
28136003|NCT02899988|54800101|FG008|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
27820525|NCT01920061|54282263|FG014|Overall Study|Participant refused further follow-up|1|||
27820526|NCT01920061|54282264|FG015|Overall Study|Participant refused further follow-up|2|||
27820527|NCT01920061|54282265|FG016|Overall Study|Participant refused further follow-up|1|||
27820528|NCT01920061|54282266|FG017|Overall Study|Participant refused further follow-up|1|||
27820529|NCT01920061|54282267|FG018|Overall Study|Participant refused further follow-up|0|||
27820530|NCT01920061|54282268|FG019|Overall Study|Participant refused further follow-up|0|||
27820531|NCT01426425|54282331|FG000|Overall Study|Exited prior to EP study|22|||
27820532|NCT01426425|54282331|FG000|Overall Study|Inclusion/exclusion criteria not met|151|||
27820533|NCT01426425|54282331|FG000|Overall Study|Met inclusion/exclusion, not treated|2|||
27820534|NCT01426347|54282344|FG000|Overall Study|Lost to Follow-up|0|||
27820535|NCT01426347|54282345|FG001|Overall Study|Lost to Follow-up|3|||
28136004|NCT02899988|54800102|FG009|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
28136005|NCT02899988|54800103|FG010|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
28136006|NCT02899988|54800093|FG000|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
28136007|NCT02899988|54800094|FG001|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
28136008|NCT02899988|54800095|FG002|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
27820536|NCT01426347|54282344|FG000|Overall Study|Protocol Violation|2|||
27820537|NCT01426347|54282345|FG001|Overall Study|Protocol Violation|0|||
27820538|NCT01426347|54282344|FG000|Overall Study|Withdrawal by Subject|5|||
27820539|NCT01426347|54282345|FG001|Overall Study|Withdrawal by Subject|0|||
27820540|NCT01882465|54282351|FG000|Period 1|Lens Discomfort|0|||
27820541|NCT01882465|54282352|FG001|Period 1|Lens Discomfort|0|||
27820542|NCT01882465|54282353|FG002|Period 1|Lens Discomfort|0|||
27820543|NCT01882465|54282354|FG003|Period 1|Lens Discomfort|1|||
27820544|NCT01882465|54282355|FG004|Period 1|Lens Discomfort|0|||
28136009|NCT02899988|54800096|FG003|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
28136010|NCT02899988|54800097|FG004|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
28136011|NCT02899988|54800098|FG005|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
28136012|NCT02899988|54800099|FG006|Maintenance Period (88 Weeks)|Withdrawal by Subject|3|||
28136013|NCT02899988|54800100|FG007|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
28136014|NCT02899988|54800101|FG008|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
28136015|NCT02899988|54800102|FG009|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
28136016|NCT02899988|54800103|FG010|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
27820545|NCT01882465|54282356|FG005|Period 1|Lens Discomfort|0|||
27820546|NCT01882465|54282357|FG006|Period 1|Lens Discomfort|0|||
27820547|NCT01882465|54282351|FG000|Period 1|Withdrawal by Subject|0|||
27820548|NCT01882465|54282352|FG001|Period 1|Withdrawal by Subject|0|||
27820549|NCT01882465|54282353|FG002|Period 1|Withdrawal by Subject|0|||
27820550|NCT01882465|54282354|FG003|Period 1|Withdrawal by Subject|0|||
27820551|NCT01882465|54282355|FG004|Period 1|Withdrawal by Subject|0|||
27820552|NCT01882465|54282356|FG005|Period 1|Withdrawal by Subject|0|||
27820553|NCT01882465|54282357|FG006|Period 1|Withdrawal by Subject|1|||
27820554|NCT01882465|54282351|FG000|Period 2|Protocol Violation|0|||
27820555|NCT01882465|54282352|FG001|Period 2|Protocol Violation|0|||
27820556|NCT01882465|54282353|FG002|Period 2|Protocol Violation|0|||
27820557|NCT01882465|54282354|FG003|Period 2|Protocol Violation|0|||
27820558|NCT01882465|54282355|FG004|Period 2|Protocol Violation|1|||
27820559|NCT01882465|54282356|FG005|Period 2|Protocol Violation|0|||
27820560|NCT01882465|54282357|FG006|Period 2|Protocol Violation|0|||
27820561|NCT01426269|54282365|FG000|Period 1: 12 Weeks|Adverse Event|5|||
27820562|NCT01426269|54282366|FG001|Period 1: 12 Weeks|Adverse Event|0|||
28069738|NCT00454649|54724721|FG005|Overall Study|Withdrawal by Subject|1|||
28069739|NCT00454649|54724722|FG006|Overall Study|Withdrawal by Subject|0|||
28069740|NCT00454649|54724723|FG007|Overall Study|Withdrawal by Subject|2|||
28069741|NCT00454649|54724724|FG008|Overall Study|Withdrawal by Subject|1|||
28069742|NCT00454649|54724725|FG009|Overall Study|Withdrawal by Subject|0|||
28069743|NCT00454571|54724768|FG000|Overall Study|Adverse Event|2|||
28069744|NCT00454571|54724769|FG001|Overall Study|Adverse Event|0|||
28069745|NCT00454571|54724768|FG000|Overall Study|Physician Decision|0|||
28069746|NCT00454571|54724769|FG001|Overall Study|Physician Decision|1|||
28069747|NCT00454571|54724768|FG000|Overall Study|Protocol Violation|1|||
28069748|NCT00454571|54724769|FG001|Overall Study|Protocol Violation|0|||
28069749|NCT00454571|54724768|FG000|Overall Study|Withdrawal by Subject|10|||
28069750|NCT00454571|54724769|FG001|Overall Study|Withdrawal by Subject|5|||
28069751|NCT03837743|54724775|FG000|Overall Study|Adverse Event|1|||
28069752|NCT03837743|54724775|FG000|Overall Study|Withdrawal by Subject|2|||
28069753|NCT03836729|54724783|FG000|Treatment Period 2 (Up to Day 7)|Adverse Event|1|||
28069754|NCT00443729|54724793|FG000|Overall Study|Never Treated|0|||
28069755|NCT00443729|54724794|FG001|Overall Study|Never Treated|1|||
28069756|NCT00443729|54724793|FG000|Overall Study|Lack of Efficacy|4|||
28069757|NCT00443729|54724794|FG001|Overall Study|Lack of Efficacy|2|||
28069758|NCT00443729|54724793|FG000|Overall Study|Lost to Follow-up|0|||
28069759|NCT00443729|54724794|FG001|Overall Study|Lost to Follow-up|1|||
28069760|NCT00443729|54724793|FG000|Overall Study|Physician Decision|2|||
28069761|NCT00443729|54724794|FG001|Overall Study|Physician Decision|1|||
28136017|NCT02939131|54800137|FG000|Overall Study|Unable to get to clinic|6|||
28069762|NCT00443729|54724793|FG000|Overall Study|Protocol Violation|1|||
27820563|NCT01426269|54282367|FG002|Period 1: 12 Weeks|Adverse Event|0|||
27820564|NCT01426269|54282365|FG000|Period 1: 12 Weeks|Withdrawal by Subject|22|||
27820565|NCT01426269|54282366|FG001|Period 1: 12 Weeks|Withdrawal by Subject|0|||
27820566|NCT01426269|54282367|FG002|Period 1: 12 Weeks|Withdrawal by Subject|0|||
27820567|NCT01426269|54282365|FG000|Period 1: 12 Weeks|Protocol Violation|5|||
28069763|NCT00443729|54724794|FG001|Overall Study|Protocol Violation|1|||
28069764|NCT00443729|54724793|FG000|Overall Study|Withdrawal by Subject|3|||
28069765|NCT00443729|54724794|FG001|Overall Study|Withdrawal by Subject|1|||
27820568|NCT01426269|54282366|FG001|Period 1: 12 Weeks|Protocol Violation|0|||
28136018|NCT02939131|54800138|FG001|Overall Study|Unable to get to clinic|4|||
28136019|NCT02939131|54800137|FG000|Overall Study|Lost to Follow-up|2|||
28136020|NCT02939131|54800138|FG001|Overall Study|Lost to Follow-up|4|||
28136021|NCT02939131|54800137|FG000|Overall Study|severe debilitation|1|||
28136022|NCT02939131|54800138|FG001|Overall Study|severe debilitation|0|||
28136023|NCT02939131|54800137|FG000|Overall Study|Other|0|||
28136024|NCT02939131|54800138|FG001|Overall Study|Other|1|||
28136025|NCT02939131|54800137|FG000|Overall Study|not willing to adhere to protocol|2|||
28136026|NCT02939131|54800138|FG001|Overall Study|not willing to adhere to protocol|0|||
28136027|NCT03345407|54800152|FG000|Overall Study|Withdrawal by Subject|11|||
28136028|NCT03345407|54800153|FG001|Overall Study|Withdrawal by Subject|1|||
28136029|NCT03345407|54800154|FG002|Overall Study|Withdrawal by Subject|5|||
28136030|NCT03345407|54800155|FG003|Overall Study|Withdrawal by Subject|6|||
28136031|NCT03345407|54800156|FG004|Overall Study|Withdrawal by Subject|3|||
27820569|NCT01426269|54282367|FG002|Period 1: 12 Weeks|Protocol Violation|0|||
27820570|NCT01426269|54282365|FG000|Period 1: 12 Weeks|Lost to Follow-up|22|||
27820571|NCT01426269|54282366|FG001|Period 1: 12 Weeks|Lost to Follow-up|0|||
27820572|NCT01426269|54282367|FG002|Period 1: 12 Weeks|Lost to Follow-up|0|||
27820573|NCT01426269|54282365|FG000|Period 1: 12 Weeks|Pregnancy|1|||
27820574|NCT01426269|54282366|FG001|Period 1: 12 Weeks|Pregnancy|0|||
27820575|NCT01426269|54282367|FG002|Period 1: 12 Weeks|Pregnancy|0|||
27820576|NCT01426269|54282365|FG000|Eligibility for Period 2, Randomization|Did not qualify|42|||
27820577|NCT01426269|54282366|FG001|Eligibility for Period 2, Randomization|Did not qualify|0|||
27820578|NCT01426269|54282367|FG002|Eligibility for Period 2, Randomization|Did not qualify|0|||
27820579|NCT01426269|54282365|FG000|Eligibility for Period 2, Randomization|Qualified, opted out|8|||
27820580|NCT01426269|54282366|FG001|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
27820581|NCT01426269|54282367|FG002|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
27820582|NCT01426269|54282365|FG000|Period 2: 40 Weeks|Adverse Event|0|||
27820583|NCT01426269|54282366|FG001|Period 2: 40 Weeks|Adverse Event|1|||
27820584|NCT01426269|54282367|FG002|Period 2: 40 Weeks|Adverse Event|2|||
27820585|NCT01426269|54282365|FG000|Period 2: 40 Weeks|Withdrawal by Subject|0|||
27820586|NCT01426269|54282366|FG001|Period 2: 40 Weeks|Withdrawal by Subject|9|||
27820587|NCT01426269|54282367|FG002|Period 2: 40 Weeks|Withdrawal by Subject|11|||
27820588|NCT01426269|54282365|FG000|Period 2: 40 Weeks|Protocol Violation|0|||
27820589|NCT01426269|54282366|FG001|Period 2: 40 Weeks|Protocol Violation|5|||
27820590|NCT01426269|54282367|FG002|Period 2: 40 Weeks|Protocol Violation|5|||
27820591|NCT01426269|54282365|FG000|Period 2: 40 Weeks|Lost to Follow-up|0|||
27820592|NCT01426269|54282366|FG001|Period 2: 40 Weeks|Lost to Follow-up|8|||
27820593|NCT01426269|54282367|FG002|Period 2: 40 Weeks|Lost to Follow-up|6|||
27820594|NCT01426269|54282365|FG000|Period 2: 40 Weeks|Site closed|0|||
27820595|NCT01426269|54282366|FG001|Period 2: 40 Weeks|Site closed|6|||
27820596|NCT01426269|54282367|FG002|Period 2: 40 Weeks|Site closed|5|||
27820597|NCT01426269|54282365|FG000|Period 2: 40 Weeks|Relapsed|0|||
27820598|NCT01426269|54282366|FG001|Period 2: 40 Weeks|Relapsed|9|||
27820599|NCT01426269|54282367|FG002|Period 2: 40 Weeks|Relapsed|18|||
27820600|NCT01426113|54282380|FG000|Overall Study|Study Discontinued|1|||
28136032|NCT03345407|54800157|FG005|Overall Study|Withdrawal by Subject|6|||
28136033|NCT03345407|54800158|FG006|Overall Study|Withdrawal by Subject|16|||
28136034|NCT03345407|54800152|FG000|Overall Study|Physician Decision|3|||
28136035|NCT03345407|54800153|FG001|Overall Study|Physician Decision|1|||
28136036|NCT03345407|54800154|FG002|Overall Study|Physician Decision|0|||
28136037|NCT03345407|54800155|FG003|Overall Study|Physician Decision|0|||
28136038|NCT03345407|54800156|FG004|Overall Study|Physician Decision|1|||
28136039|NCT03345407|54800157|FG005|Overall Study|Physician Decision|2|||
28136040|NCT03345407|54800158|FG006|Overall Study|Physician Decision|3|||
28136041|NCT03345407|54800152|FG000|Overall Study|Lost to Follow-up|2|||
28136042|NCT03345407|54800153|FG001|Overall Study|Lost to Follow-up|0|||
28136043|NCT03345407|54800154|FG002|Overall Study|Lost to Follow-up|1|||
28136044|NCT03345407|54800155|FG003|Overall Study|Lost to Follow-up|0|||
27820601|NCT01426113|54282381|FG001|Overall Study|Study Discontinued|1|||
27820602|NCT01426113|54282380|FG000|Overall Study|Adverse Event|0|||
27820603|NCT01426113|54282381|FG001|Overall Study|Adverse Event|1|||
28136045|NCT03345407|54800156|FG004|Overall Study|Lost to Follow-up|1|||
28136046|NCT03345407|54800157|FG005|Overall Study|Lost to Follow-up|2|||
27820604|NCT01864603|54282389|FG000|Stage 2|DSMB design modification|86056|||
28136047|NCT03345407|54800158|FG006|Overall Study|Lost to Follow-up|3|||
27820605|NCT01864603|54282390|FG001|Stage 2|DSMB design modification|92558|||
27820606|NCT01892293|54282401|FG000|Overall Study|Apheresed but not treated|4|||
28136048|NCT03345407|54800152|FG000|Overall Study|Protocol-defined stopping criteria|9|||
28136049|NCT03345407|54800153|FG001|Overall Study|Protocol-defined stopping criteria|0|||
28136050|NCT03345407|54800154|FG002|Overall Study|Protocol-defined stopping criteria|0|||
28136051|NCT03345407|54800155|FG003|Overall Study|Protocol-defined stopping criteria|0|||
28136052|NCT03345407|54800156|FG004|Overall Study|Protocol-defined stopping criteria|2|||
28136053|NCT03345407|54800157|FG005|Overall Study|Protocol-defined stopping criteria|1|||
28136054|NCT03345407|54800158|FG006|Overall Study|Protocol-defined stopping criteria|1|||
28136055|NCT03345407|54800152|FG000|Overall Study|Protocol Violation|2|||
28136056|NCT03345407|54800153|FG001|Overall Study|Protocol Violation|0|||
28136057|NCT03345407|54800154|FG002|Overall Study|Protocol Violation|0|||
28136058|NCT03345407|54800155|FG003|Overall Study|Protocol Violation|0|||
28136059|NCT03345407|54800156|FG004|Overall Study|Protocol Violation|1|||
28136060|NCT03345407|54800157|FG005|Overall Study|Protocol Violation|0|||
28136061|NCT03345407|54800158|FG006|Overall Study|Protocol Violation|3|||
28136062|NCT03345407|54800152|FG000|Overall Study|Lack of Efficacy|1|||
28136063|NCT03345407|54800153|FG001|Overall Study|Lack of Efficacy|1|||
28136064|NCT03345407|54800154|FG002|Overall Study|Lack of Efficacy|1|||
28136065|NCT03345407|54800155|FG003|Overall Study|Lack of Efficacy|1|||
28136066|NCT03345407|54800156|FG004|Overall Study|Lack of Efficacy|1|||
27820607|NCT01393899|54282408|FG000|Overall Study|Study terminated by sponsor|1|||
27820608|NCT01393899|54282409|FG001|Overall Study|Study terminated by sponsor|0|||
27820609|NCT01393899|54282410|FG002|Overall Study|Study terminated by sponsor|1|||
27820610|NCT01393899|54282408|FG000|Overall Study|Other|1|||
27820611|NCT01393899|54282409|FG001|Overall Study|Other|0|||
27820612|NCT01393899|54282410|FG002|Overall Study|Other|0|||
27820613|NCT01393899|54282408|FG000|Overall Study|Withdrawal by Subject|2|||
27820614|NCT01393899|54282409|FG001|Overall Study|Withdrawal by Subject|2|||
27820615|NCT01393899|54282410|FG002|Overall Study|Withdrawal by Subject|1|||
27820616|NCT01393899|54282408|FG000|Overall Study|Lost to Follow-up|0|||
27820617|NCT01393899|54282409|FG001|Overall Study|Lost to Follow-up|0|||
27820618|NCT01393899|54282410|FG002|Overall Study|Lost to Follow-up|1|||
27820619|NCT01393899|54282408|FG000|Overall Study|Does not meet entrance criteria|1|||
27820620|NCT01393899|54282409|FG001|Overall Study|Does not meet entrance criteria|0|||
27820621|NCT01393899|54282410|FG002|Overall Study|Does not meet entrance criteria|1|||
27849837|NCT00989963|54347992|FG001|Overall Study|Adverse Event|1|||
27849838|NCT00989963|54347993|FG002|Overall Study|Adverse Event|1|||
28069766|NCT00443651|54724802|FG000|Overall Study|Death|1|||
28069767|NCT00443651|54724803|FG001|Overall Study|Death|5|||
28069768|NCT00443651|54724802|FG000|Overall Study|Adverse Event|5|||
28069769|NCT00443651|54724803|FG001|Overall Study|Adverse Event|6|||
28069770|NCT00443651|54724802|FG000|Overall Study|Lost to Follow-up|18|||
28069771|NCT00443651|54724803|FG001|Overall Study|Lost to Follow-up|12|||
28069772|NCT00443651|54724802|FG000|Overall Study|Patient's/Guardian's Decision|58|||
28069773|NCT00443651|54724803|FG001|Overall Study|Patient's/Guardian's Decision|30|||
28069774|NCT00443651|54724802|FG000|Overall Study|Physician Decision|13|||
28069775|NCT00443651|54724803|FG001|Overall Study|Physician Decision|4|||
28069776|NCT00443651|54724802|FG000|Overall Study|Pregnancy|0|||
28069777|NCT00443651|54724803|FG001|Overall Study|Pregnancy|1|||
28069778|NCT00443261|54724809|FG000|Overall Study|Death|1|||
28136067|NCT03345407|54800157|FG005|Overall Study|Lack of Efficacy|0|||
28136068|NCT03345407|54800158|FG006|Overall Study|Lack of Efficacy|3|||
28136069|NCT03345407|54800152|FG000|Overall Study|Adverse Event|4|||
28136070|NCT03345407|54800153|FG001|Overall Study|Adverse Event|0|||
28136071|NCT03345407|54800154|FG002|Overall Study|Adverse Event|5|||
27820622|NCT01393899|54282408|FG000|Overall Study|Lack of Efficacy|26|||
27820623|NCT01393899|54282409|FG001|Overall Study|Lack of Efficacy|21|||
27849839|NCT00989573|54348031|FG000|Overall Study|Adverse Event|8|||
27941026|NCT01020123|54597351|FG001|Main Period|Lost to Follow-up|2|||
27820624|NCT01393899|54282410|FG002|Overall Study|Lack of Efficacy|16|||
27820625|NCT01393899|54282408|FG000|Overall Study|Adverse Event|1|||
28069779|NCT00439517|54724815|FG000|Overall Study|Subject on treatment|1|||
28069780|NCT00439517|54724816|FG001|Overall Study|Subject on treatment|0|||
27820626|NCT01393899|54282409|FG001|Overall Study|Adverse Event|5|||
27820627|NCT01393899|54282410|FG002|Overall Study|Adverse Event|3|||
27820628|NCT01393743|54282422|FG000|Core Study|Adverse Event|5|||
27820629|NCT01393743|54282423|FG001|Core Study|Adverse Event|9|||
27820630|NCT01393743|54282424|FG002|Core Study|Adverse Event|0|||
27820631|NCT01393743|54282422|FG000|Core Study|Lost to Follow-up|1|||
27820632|NCT01393743|54282423|FG001|Core Study|Lost to Follow-up|1|||
27820633|NCT01393743|54282424|FG002|Core Study|Lost to Follow-up|0|||
27820634|NCT01393743|54282422|FG000|Core Study|Participant's Choice|2|||
27820635|NCT01393743|54282423|FG001|Core Study|Participant's Choice|3|||
27820636|NCT01393743|54282424|FG002|Core Study|Participant's Choice|0|||
27820637|NCT01393743|54282422|FG000|Core Study|Inadequate therapeutic effect|2|||
27820638|NCT01393743|54282423|FG001|Core Study|Inadequate therapeutic effect|0|||
27820639|NCT01393743|54282424|FG002|Core Study|Inadequate therapeutic effect|0|||
27820640|NCT01393743|54282422|FG000|Extension Phase|Adverse Event|0|||
27820641|NCT01393743|54282423|FG001|Extension Phase|Adverse Event|0|||
27820642|NCT01393743|54282424|FG002|Extension Phase|Adverse Event|12|||
27820643|NCT01393743|54282422|FG000|Extension Phase|Lost to Follow-up|0|||
27820644|NCT01393743|54282423|FG001|Extension Phase|Lost to Follow-up|0|||
27820645|NCT01393743|54282424|FG002|Extension Phase|Lost to Follow-up|2|||
27820646|NCT01393743|54282422|FG000|Extension Phase|Participant choice|0|||
27820647|NCT01393743|54282423|FG001|Extension Phase|Participant choice|0|||
27820648|NCT01393743|54282424|FG002|Extension Phase|Participant choice|16|||
27820649|NCT01393743|54282422|FG000|Extension Phase|Inadequate therapeutic effect|0|||
27820650|NCT01393743|54282423|FG001|Extension Phase|Inadequate therapeutic effect|0|||
27820651|NCT01393743|54282424|FG002|Extension Phase|Inadequate therapeutic effect|7|||
27820652|NCT01393743|54282422|FG000|Extension Phase|Withdrawal by Subject|0|||
27820653|NCT01393743|54282423|FG001|Extension Phase|Withdrawal by Subject|0|||
28069781|NCT00439517|54724815|FG000|Overall Study|Subject in survival follow-up|1|||
28069782|NCT00439517|54724816|FG001|Overall Study|Subject in survival follow-up|0|||
28069783|NCT00438815|54724822|FG000|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30|||
28069784|NCT00438815|54724822|FG000|Overall Study|3-month follow-up no longer required|12|||
28069785|NCT00438815|54724822|FG000|Overall Study|Noncompliance with protocol requirements|9|||
28069786|NCT00438815|54724822|FG000|Overall Study|Transitioned to commercial C1INH-nf|6|||
28069787|NCT00438815|54724822|FG000|Overall Study|Lost to Follow-up|6|||
28069788|NCT00438815|54724822|FG000|Overall Study|Withdrawal by Subject|6|||
28069789|NCT00438815|54724822|FG000|Overall Study|Death|1|||
28069790|NCT00438659|54724828|FG000|Overall Study|Discontinued Mometasone/Placebo|1|||
28069791|NCT00438659|54724829|FG001|Overall Study|Discontinued Mometasone/Placebo|2|||
28069792|NCT00438659|54724828|FG000|Overall Study|Cancel|5|||
28069793|NCT00438659|54724829|FG001|Overall Study|Cancel|2|||
27820654|NCT01393743|54282424|FG002|Extension Phase|Withdrawal by Subject|8|||
27820655|NCT01393743|54282422|FG000|Extension Phase|Pregnancy|0|||
27849840|NCT00989573|54348032|FG001|Overall Study|Adverse Event|12|||
27849841|NCT00989573|54348033|FG002|Overall Study|Adverse Event|4|||
27849842|NCT00989573|54348031|FG000|Overall Study|Physician Decision|0|||
27849843|NCT00989573|54348032|FG001|Overall Study|Physician Decision|2|||
27849844|NCT00989573|54348033|FG002|Overall Study|Physician Decision|0|||
27849845|NCT00989573|54348031|FG000|Overall Study|Protocol Violation|1|||
27849846|NCT00989573|54348032|FG001|Overall Study|Protocol Violation|1|||
27849847|NCT00989573|54348033|FG002|Overall Study|Protocol Violation|1|||
27849848|NCT00989573|54348031|FG000|Overall Study|Withdrawal by Subject|4|||
27849849|NCT00989573|54348032|FG001|Overall Study|Withdrawal by Subject|7|||
27849850|NCT00989573|54348033|FG002|Overall Study|Withdrawal by Subject|3|||
27849851|NCT04126213|54348107|FG000|Overall Study|Lost to Follow-up|9|||
27849852|NCT04126213|54348108|FG001|Overall Study|Lost to Follow-up|1|||
27849853|NCT04126213|54348109|FG002|Overall Study|Lost to Follow-up|5|||
27849854|NCT04126213|54348110|FG003|Overall Study|Lost to Follow-up|10|||
27849855|NCT04126213|54348111|FG004|Overall Study|Lost to Follow-up|4|||
27849856|NCT04126213|54348112|FG005|Overall Study|Lost to Follow-up|7|||
27849857|NCT04126213|54348107|FG000|Overall Study|Withdrawal by Subject|3|||
27849858|NCT04126213|54348108|FG001|Overall Study|Withdrawal by Subject|2|||
27849859|NCT04126213|54348109|FG002|Overall Study|Withdrawal by Subject|1|||
27849860|NCT04126213|54348110|FG003|Overall Study|Withdrawal by Subject|1|||
27849861|NCT04126213|54348111|FG004|Overall Study|Withdrawal by Subject|1|||
27849862|NCT04126213|54348112|FG005|Overall Study|Withdrawal by Subject|1|||
27820656|NCT01393743|54282423|FG001|Extension Phase|Pregnancy|0|||
27820657|NCT01393743|54282424|FG002|Extension Phase|Pregnancy|1|||
27820658|NCT01393743|54282422|FG000|Extension Phase|Other|0|||
27820659|NCT01393743|54282423|FG001|Extension Phase|Other|0|||
27820660|NCT01393743|54282424|FG002|Extension Phase|Other|14|||
27849863|NCT04126213|54348107|FG000|Overall Study|Other|0|||
27849864|NCT04126213|54348108|FG001|Overall Study|Other|0|||
27849865|NCT04126213|54348109|FG002|Overall Study|Other|2|||
27849866|NCT04126213|54348110|FG003|Overall Study|Other|2|||
27849867|NCT04126213|54348111|FG004|Overall Study|Other|0|||
27849868|NCT04126213|54348112|FG005|Overall Study|Other|1|||
27849869|NCT04126213|54348107|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
28069794|NCT00437645|54724838|FG000|Overall Study|Adverse Event|15|||
27820661|NCT01405911|54282443|FG000|Overall Study|Pre-treatment lab AE|0|||
27820662|NCT01405911|54282444|FG001|Overall Study|Pre-treatment lab AE|1|||
27820663|NCT01405911|54282445|FG002|Overall Study|Pre-treatment lab AE|0|||
27820664|NCT01405911|54282443|FG000|Overall Study|Lost to Follow-up|0|||
27820665|NCT01405911|54282444|FG001|Overall Study|Lost to Follow-up|1|||
27820666|NCT01405911|54282445|FG002|Overall Study|Lost to Follow-up|0|||
27820667|NCT01405911|54282443|FG000|Overall Study|Protocol Violation|1|||
27820668|NCT01405911|54282444|FG001|Overall Study|Protocol Violation|0|||
27820669|NCT01405911|54282445|FG002|Overall Study|Protocol Violation|0|||
27820670|NCT01405911|54282443|FG000|Overall Study|Withdrawal by Subject|3|||
27820671|NCT01405911|54282444|FG001|Overall Study|Withdrawal by Subject|1|||
27820672|NCT01405911|54282445|FG002|Overall Study|Withdrawal by Subject|1|||
27820673|NCT01425801|54282453|FG000|Period 1|Withdrawal by Subject|0|||
27820674|NCT01425801|54282454|FG001|Period 1|Withdrawal by Subject|0|||
27820675|NCT01425801|54282455|FG002|Period 1|Withdrawal by Subject|0|||
27820676|NCT01425801|54282456|FG003|Period 1|Withdrawal by Subject|0|||
27820677|NCT01425801|54282457|FG004|Period 1|Withdrawal by Subject|1|||
27820678|NCT01425801|54282458|FG005|Period 1|Withdrawal by Subject|0|||
27820679|NCT01425801|54282453|FG000|Period 2|Withdrawal by Subject|0|||
27820680|NCT01425801|54282454|FG001|Period 2|Withdrawal by Subject|0|||
27820681|NCT01425801|54282455|FG002|Period 2|Withdrawal by Subject|0|||
27820682|NCT01425801|54282456|FG003|Period 2|Withdrawal by Subject|0|||
27820683|NCT01425801|54282457|FG004|Period 2|Withdrawal by Subject|1|||
27820684|NCT01425801|54282458|FG005|Period 2|Withdrawal by Subject|0|||
27820685|NCT01425801|54282453|FG000|Period 3|Stability criteria not fullfilled|0|||
27820686|NCT01425801|54282454|FG001|Period 3|Stability criteria not fullfilled|0|||
27820687|NCT01425801|54282455|FG002|Period 3|Stability criteria not fullfilled|1|||
27820688|NCT01425801|54282456|FG003|Period 3|Stability criteria not fullfilled|0|||
27820689|NCT01425801|54282457|FG004|Period 3|Stability criteria not fullfilled|0|||
27820690|NCT01425801|54282458|FG005|Period 3|Stability criteria not fullfilled|0|||
27820691|NCT01425801|54282453|FG000|Period 4|Not able to maintain visit schedule|0|||
27820692|NCT01425801|54282454|FG001|Period 4|Not able to maintain visit schedule|0|||
27820693|NCT01425801|54282455|FG002|Period 4|Not able to maintain visit schedule|1|||
27820694|NCT01425801|54282456|FG003|Period 4|Not able to maintain visit schedule|0|||
27820695|NCT01425801|54282457|FG004|Period 4|Not able to maintain visit schedule|0|||
27820696|NCT01425801|54282458|FG005|Period 4|Not able to maintain visit schedule|0|||
27820697|NCT01425723|54282483|FG000|Overall Study|Lack of Efficacy|0|||
27820698|NCT01425723|54282484|FG001|Overall Study|Lack of Efficacy|1|||
27820699|NCT01425723|54282483|FG000|Overall Study|Withdrawal by Subject|1|||
27820700|NCT01425723|54282484|FG001|Overall Study|Withdrawal by Subject|4|||
27820701|NCT01425723|54282483|FG000|Overall Study|Lost to Follow-up|0|||
27820702|NCT01425723|54282484|FG001|Overall Study|Lost to Follow-up|3|||
27820703|NCT01425723|54282483|FG000|Overall Study|Physician Decision|2|||
27820704|NCT01425723|54282484|FG001|Overall Study|Physician Decision|0|||
27820705|NCT01425723|54282483|FG000|Overall Study|Other|1|||
27820706|NCT01425723|54282484|FG001|Overall Study|Other|10|||
27820707|NCT01424397|54282515|FG000|Period-2 (8 Days)|Withdrawal by Subject|0|||
27820708|NCT01424397|54282516|FG001|Period-2 (8 Days)|Withdrawal by Subject|0|||
27820709|NCT01424397|54282517|FG002|Period-2 (8 Days)|Withdrawal by Subject|1|||
27820710|NCT01424397|54282518|FG003|Period-2 (8 Days)|Withdrawal by Subject|0|||
27820711|NCT01424397|54282519|FG004|Period-2 (8 Days)|Withdrawal by Subject|0|||
27820712|NCT01424397|54282520|FG005|Period-2 (8 Days)|Withdrawal by Subject|0|||
27820713|NCT01424397|54282521|FG006|Period-2 (8 Days)|Withdrawal by Subject|0|||
27820714|NCT01424397|54282522|FG007|Period-2 (8 Days)|Withdrawal by Subject|0|||
27849870|NCT04126213|54348108|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
28069795|NCT00437645|54724839|FG001|Overall Study|Adverse Event|84|||
28069796|NCT00437645|54724838|FG000|Overall Study|Withdrawal by Subject|10|||
28136072|NCT03345407|54800155|FG003|Overall Study|Adverse Event|4|||
28136073|NCT03345407|54800156|FG004|Overall Study|Adverse Event|6|||
28136074|NCT03345407|54800157|FG005|Overall Study|Adverse Event|5|||
28136075|NCT03345407|54800158|FG006|Overall Study|Adverse Event|16|||
28069797|NCT00437645|54724839|FG001|Overall Study|Withdrawal by Subject|22|||
28069798|NCT00437645|54724838|FG000|Overall Study|Protocol Violation|3|||
28069799|NCT00437645|54724839|FG001|Overall Study|Protocol Violation|3|||
28069800|NCT00437645|54724838|FG000|Overall Study|Lost to Follow-up|2|||
28069801|NCT00437645|54724839|FG001|Overall Study|Lost to Follow-up|3|||
28136076|NCT03255187|54800182|FG000|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1|||
28136077|NCT03255187|54800183|FG001|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3|||
28136078|NCT03255187|54800182|FG000|Period From First to Second Follow-up|Withdrawal by Subject|0|||
27849871|NCT04126213|54348109|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
27820715|NCT01424397|54282523|FG008|Period-2 (8 Days)|Withdrawal by Subject|0|||
28069802|NCT00437645|54724838|FG000|Overall Study|Administrative problems|2|||
27820716|NCT01424397|54282524|FG009|Period-2 (8 Days)|Withdrawal by Subject|0|||
27820717|NCT01424397|54282525|FG010|Period-2 (8 Days)|Withdrawal by Subject|0|||
27820718|NCT01424397|54282526|FG011|Period-2 (8 Days)|Withdrawal by Subject|0|||
27820719|NCT01392963|54282542|FG000|Week 0 (First Intervention)|Lost to Follow-up|0|||
27820720|NCT01392963|54282543|FG001|Week 0 (First Intervention)|Lost to Follow-up|1|||
27820721|NCT01392963|54282542|FG000|Week 0 (First Intervention)|Withdrawal by Subject|0|||
27820722|NCT01392963|54282543|FG001|Week 0 (First Intervention)|Withdrawal by Subject|1|||
27820723|NCT01392963|54282542|FG000|Week 24 Follow-up|Lost to Follow-up|2|||
27820724|NCT01392963|54282543|FG001|Week 24 Follow-up|Lost to Follow-up|0|||
27820725|NCT01392573|54282553|FG000|Overall Study|Adverse Event|1|||
27820726|NCT01392573|54282554|FG001|Overall Study|Adverse Event|3|||
27820727|NCT01392573|54282553|FG000|Overall Study|Lack of Efficacy|1|||
27820728|NCT01392573|54282554|FG001|Overall Study|Lack of Efficacy|2|||
27820729|NCT01392573|54282553|FG000|Overall Study|Protocol Violation|0|||
27820730|NCT01392573|54282554|FG001|Overall Study|Protocol Violation|2|||
27820731|NCT01392573|54282553|FG000|Overall Study|Withdrawal Criteria|13|||
27820732|NCT01392573|54282554|FG001|Overall Study|Withdrawal Criteria|15|||
27820733|NCT01392573|54282553|FG000|Overall Study|Site closure|8|||
27820734|NCT01392573|54282554|FG001|Overall Study|Site closure|7|||
27820735|NCT01392573|54282553|FG000|Overall Study|Unclassified|9|||
27820736|NCT01392573|54282554|FG001|Overall Study|Unclassified|6|||
27820737|NCT01392495|54282560|FG000|Overall Study|Death|3|||
27820738|NCT01392495|54282560|FG000|Overall Study|Administrative problems|8|||
27820739|NCT01392495|54282560|FG000|Overall Study|Withdrawal by Subject|2|||
27820740|NCT01392495|54282560|FG000|Overall Study|Adverse Event|3|||
27820741|NCT01405053|54282568|FG000|Overall Study|Adverse Event|3|||
27820742|NCT01405053|54282569|FG001|Overall Study|Adverse Event|0|||
27820743|NCT01405053|54282568|FG000|Overall Study|Lost to Follow-up|0|||
27820744|NCT01405053|54282569|FG001|Overall Study|Lost to Follow-up|1|||
27820745|NCT01405053|54282568|FG000|Overall Study|Participant choice|2|||
27820746|NCT01405053|54282569|FG001|Overall Study|Participant choice|1|||
27820747|NCT01405053|54282568|FG000|Overall Study|Inadequate therapeutic effect|2|||
27820748|NCT01405053|54282569|FG001|Overall Study|Inadequate therapeutic effect|1|||
27820749|NCT01405053|54282568|FG000|Overall Study|Withdrawal by Subject|3|||
27820750|NCT01405053|54282569|FG001|Overall Study|Withdrawal by Subject|4|||
27820751|NCT01405053|54282568|FG000|Overall Study|Other|0|||
27820752|NCT01405053|54282569|FG001|Overall Study|Other|1|||
27820753|NCT01403805|54282577|FG000|Overall Study|Withdrawal by Subject|0|||
27820754|NCT01403805|54282578|FG001|Overall Study|Withdrawal by Subject|4|||
27820755|NCT01403805|54282577|FG000|Overall Study|Lost to Follow-up|0|||
27820756|NCT01403805|54282578|FG001|Overall Study|Lost to Follow-up|2|||
27820757|NCT01403805|54282577|FG000|Overall Study|Death|0|||
27820758|NCT01403805|54282578|FG001|Overall Study|Death|1|||
27820759|NCT01423617|54282590|FG000|Overall Study|Lost to Follow-up|0|||
27820760|NCT01423617|54282591|FG001|Overall Study|Lost to Follow-up|1|||
27820761|NCT01392183|54282599|FG000|First Drug Administration|Adverse Event|3|||
27820762|NCT01392183|54282600|FG001|First Drug Administration|Adverse Event|2|||
27820763|NCT01392183|54282599|FG000|First Drug Administration|Death|1|||
27820764|NCT01392183|54282600|FG001|First Drug Administration|Death|0|||
27820765|NCT01392183|54282599|FG000|First Drug Administration|Withdrawal by Subject|10|||
27820766|NCT01392183|54282600|FG001|First Drug Administration|Withdrawal by Subject|17|||
27820767|NCT01751906|54282610|FG000|Overall Study|Lost to Follow-up|151|||
27820768|NCT01751906|54282611|FG001|Overall Study|Lost to Follow-up|68|||
27820769|NCT01751906|54282610|FG000|Overall Study|Withdrawal by Subject|22|||
27820770|NCT01751906|54282611|FG001|Overall Study|Withdrawal by Subject|18|||
27820771|NCT01751906|54282610|FG000|Overall Study|Physician Decision|5|||
27820772|NCT01751906|54282611|FG001|Overall Study|Physician Decision|2|||
27820773|NCT01751906|54282610|FG000|Overall Study|Death|84|||
27820774|NCT01751906|54282611|FG001|Overall Study|Death|43|||
27820775|NCT01751906|54282610|FG000|Overall Study|Denied on premises for follow-up by law|1|||
27820776|NCT01751906|54282611|FG001|Overall Study|Denied on premises for follow-up by law|0|||
27820777|NCT01402947|54282619|FG000|First Intervention|Adverse Event|0|||
27820778|NCT01402947|54282620|FG001|First Intervention|Adverse Event|1|||
27820779|NCT01402869|54282629|FG000|Overall Study|Required Tooth Extraction|0|||
27820780|NCT01402869|54282630|FG001|Overall Study|Required Tooth Extraction|0|||
27820781|NCT01402869|54282631|FG002|Overall Study|Required Tooth Extraction|1|||
27820782|NCT01391793|54282641|FG000|Overall Study|Ineligible|3|||
27820783|NCT01391793|54282642|FG001|Overall Study|Ineligible|0|||
27820784|NCT01391793|54282641|FG000|Overall Study|Urine Culture Negative or Indeterminate|71|||
27820785|NCT01391793|54282642|FG001|Overall Study|Urine Culture Negative or Indeterminate|87|||
27820786|NCT01391793|54282641|FG000|Overall Study|No DMSA|73|||
27820787|NCT01391793|54282642|FG001|Overall Study|No DMSA|57|||
27820788|NCT01422915|54282648|FG000|Overall Study|Adverse Event|1|||
27820789|NCT01727024|54282653|FG000|Period 1|Lost to Follow-up|1|||
27820790|NCT01727024|54282654|FG001|Period 1|Lost to Follow-up|1|||
27820791|NCT01727024|54282653|FG000|Period 1|Withdrawal by Subject|2|||
27820792|NCT01727024|54282654|FG001|Period 1|Withdrawal by Subject|3|||
27820793|NCT01422213|54282663|FG000|Overall Study|Adverse Event|8|||
27820794|NCT01422213|54282664|FG001|Overall Study|Adverse Event|7|||
27820795|NCT01422213|54282665|FG002|Overall Study|Adverse Event|11|||
27820796|NCT01422213|54282663|FG000|Overall Study|Lack of Efficacy|10|||
27820797|NCT01422213|54282664|FG001|Overall Study|Lack of Efficacy|2|||
27820798|NCT01422213|54282665|FG002|Overall Study|Lack of Efficacy|2|||
27820799|NCT01422213|54282663|FG000|Overall Study|Non-compliance with study drug|0|||
27820800|NCT01422213|54282664|FG001|Overall Study|Non-compliance with study drug|1|||
27820801|NCT01422213|54282665|FG002|Overall Study|Non-compliance with study drug|0|||
27820802|NCT01422213|54282663|FG000|Overall Study|Protocol Violation|0|||
27820803|NCT01422213|54282664|FG001|Overall Study|Protocol Violation|2|||
27820804|NCT01422213|54282665|FG002|Overall Study|Protocol Violation|4|||
27820805|NCT01422213|54282663|FG000|Overall Study|Withdrawal of Consent|7|||
27820806|NCT01422213|54282664|FG001|Overall Study|Withdrawal of Consent|3|||
27820807|NCT01422213|54282665|FG002|Overall Study|Withdrawal of Consent|5|||
27820808|NCT01422213|54282663|FG000|Overall Study|Lost to Follow-up|3|||
27820809|NCT01422213|54282664|FG001|Overall Study|Lost to Follow-up|3|||
27820810|NCT01422213|54282665|FG002|Overall Study|Lost to Follow-up|5|||
27820811|NCT01422213|54282663|FG000|Overall Study|Administrative or Other Reason(s)|5|||
27820812|NCT01422213|54282664|FG001|Overall Study|Administrative or Other Reason(s)|4|||
27820813|NCT01422213|54282665|FG002|Overall Study|Administrative or Other Reason(s)|2|||
27820814|NCT01390857|54282673|FG000|Overall Study|Protocol Violation|2|||
27820815|NCT01390857|54282673|FG000|Overall Study|Lost to Follow-up|1|||
27820816|NCT01390857|54282673|FG000|Overall Study|No Visit after the First Visit|7|||
28069803|NCT00437645|54724839|FG001|Overall Study|Administrative problems|1|||
28069804|NCT00437645|54724838|FG000|Overall Study|Lack of Efficacy|2|||
28069805|NCT00437645|54724839|FG001|Overall Study|Lack of Efficacy|1|||
28069806|NCT00437645|54724838|FG000|Overall Study|Condition no longer requires study drug|1|||
28069807|NCT00437645|54724839|FG001|Overall Study|Condition no longer requires study drug|1|||
28069808|NCT00437489|54724847|FG000|Overall Study|Study terminated by sponsor|23|||
28069809|NCT00437489|54724848|FG001|Overall Study|Study terminated by sponsor|21|||
28069810|NCT00437489|54724847|FG000|Overall Study|Lost to Follow-up|0|||
28069811|NCT00437489|54724848|FG001|Overall Study|Lost to Follow-up|1|||
28069812|NCT00442559|54724856|FG000|Overall Study|Lost to Follow-up|32|||
28136079|NCT03255187|54800183|FG001|Period From First to Second Follow-up|Withdrawal by Subject|1|||
28136080|NCT02929329|54800191|FG000|Overall Study|Withdrawal by Subject|24|||
28136081|NCT02929329|54800192|FG001|Overall Study|Withdrawal by Subject|21|||
28136082|NCT02929329|54800191|FG000|Overall Study|Lost to Follow-up|26|||
28136083|NCT02929329|54800192|FG001|Overall Study|Lost to Follow-up|20|||
28136084|NCT02929329|54800191|FG000|Overall Study|Death|1054|||
28136085|NCT02929329|54800192|FG001|Overall Study|Death|1051|||
27820817|NCT01725386|54282679|FG000|Overall Study|Death|84|||
28069813|NCT00442559|54724857|FG001|Overall Study|Lost to Follow-up|34|||
28136086|NCT03240133|54800205|FG000|Overall Study|Withdrawal by Subject|0|||
28136087|NCT03240133|54800206|FG001|Overall Study|Withdrawal by Subject|1|||
28136088|NCT03240133|54800207|FG002|Overall Study|Withdrawal by Subject|0|||
28069814|NCT00442559|54724856|FG000|Overall Study|Protocol Violation|1|||
28069815|NCT00442559|54724857|FG001|Overall Study|Protocol Violation|1|||
28069816|NCT00442559|54724856|FG000|Overall Study|Withdrawal by Subject|1|||
28069817|NCT00442559|54724857|FG001|Overall Study|Withdrawal by Subject|0|||
28069818|NCT00441701|54724879|FG000|Overall Study|Adverse Event|3|||
28069819|NCT00441701|54724880|FG001|Overall Study|Adverse Event|2|||
28136089|NCT03240133|54800205|FG000|Overall Study|Adverse Event|1|||
27820818|NCT01725386|54282680|FG001|Overall Study|Death|40|||
27820819|NCT01725386|54282679|FG000|Overall Study|Lost to Follow-up|81|||
27820820|NCT01725386|54282680|FG001|Overall Study|Lost to Follow-up|6|||
28069820|NCT00441701|54724881|FG002|Overall Study|Adverse Event|1|||
28069821|NCT00441701|54724882|FG003|Overall Study|Adverse Event|0|||
28069822|NCT00441701|54724883|FG004|Overall Study|Adverse Event|2|||
27820821|NCT01725386|54282679|FG000|Overall Study|Withdrawal by Subject|10|||
27820822|NCT01725386|54282680|FG001|Overall Study|Withdrawal by Subject|0|||
27820823|NCT01402011|54282689|FG000|Delayed Treatment Period|Withdrawal by Subject|1|||
28136090|NCT03240133|54800206|FG001|Overall Study|Adverse Event|1|||
28136091|NCT03240133|54800207|FG002|Overall Study|Adverse Event|0|||
27820824|NCT01402011|54282690|FG001|Delayed Treatment Period|Withdrawal by Subject|0|||
27820825|NCT01402011|54282691|FG002|Delayed Treatment Period|Withdrawal by Subject|0|||
27820826|NCT01402011|54282689|FG000|Active Treatment Period|Withdrawal by Subject|1|||
27820827|NCT01402011|54282690|FG001|Active Treatment Period|Withdrawal by Subject|3|||
27820828|NCT01402011|54282691|FG002|Active Treatment Period|Withdrawal by Subject|0|||
27820829|NCT01402011|54282689|FG000|Nine Month Follow-up|Withdrawal by Subject|0|||
27820830|NCT01402011|54282690|FG001|Nine Month Follow-up|Withdrawal by Subject|1|||
27820831|NCT01402011|54282691|FG002|Nine Month Follow-up|Withdrawal by Subject|0|||
27820832|NCT01421667|54282706|FG000|Overall Study|Withdrawal by Subject|0|||
27820833|NCT01421667|54282707|FG001|Overall Study|Withdrawal by Subject|1|||
27820834|NCT01421667|54282708|FG002|Overall Study|Withdrawal by Subject|2|||
27820835|NCT01421667|54282709|FG003|Overall Study|Withdrawal by Subject|1|||
27820836|NCT01421667|54282706|FG000|Overall Study|Lost to Follow-up|0|||
27820837|NCT01421667|54282707|FG001|Overall Study|Lost to Follow-up|1|||
27820838|NCT01421667|54282708|FG002|Overall Study|Lost to Follow-up|0|||
27820839|NCT01421667|54282709|FG003|Overall Study|Lost to Follow-up|0|||
27820840|NCT01390779|54282727|FG000|Overall Study|Physician Decision|1|||
27820841|NCT01891669|54282741|FG000|Overall Study|Death|0|||
27820842|NCT01891669|54282742|FG001|Overall Study|Death|0|||
27820843|NCT01891669|54282743|FG002|Overall Study|Death|0|||
27820844|NCT01891669|54282744|FG003|Overall Study|Death|0|||
27820845|NCT01891669|54282745|FG004|Overall Study|Death|0|||
27820846|NCT01891669|54282746|FG005|Overall Study|Death|0|||
27820847|NCT01891669|54282747|FG006|Overall Study|Death|0|||
27820848|NCT01891669|54282748|FG007|Overall Study|Death|1|||
27820849|NCT01891669|54282749|FG008|Overall Study|Death|0|||
27820850|NCT01891669|54282750|FG009|Overall Study|Death|1|||
27820851|NCT01891669|54282741|FG000|Overall Study|Withdrawal by Subject|1|||
27820852|NCT01891669|54282742|FG001|Overall Study|Withdrawal by Subject|1|||
27820853|NCT01891669|54282743|FG002|Overall Study|Withdrawal by Subject|0|||
27820854|NCT01891669|54282744|FG003|Overall Study|Withdrawal by Subject|0|||
27820855|NCT01891669|54282745|FG004|Overall Study|Withdrawal by Subject|0|||
27820856|NCT01891669|54282746|FG005|Overall Study|Withdrawal by Subject|0|||
27820857|NCT01891669|54282747|FG006|Overall Study|Withdrawal by Subject|1|||
27820858|NCT01891669|54282748|FG007|Overall Study|Withdrawal by Subject|2|||
27820859|NCT01891669|54282749|FG008|Overall Study|Withdrawal by Subject|1|||
27820860|NCT01891669|54282750|FG009|Overall Study|Withdrawal by Subject|1|||
27820861|NCT01891669|54282741|FG000|Overall Study|Other|1|||
27820862|NCT01891669|54282742|FG001|Overall Study|Other|0|||
27820863|NCT01891669|54282743|FG002|Overall Study|Other|0|||
27820864|NCT01891669|54282744|FG003|Overall Study|Other|0|||
27820865|NCT01891669|54282745|FG004|Overall Study|Other|0|||
27820866|NCT01891669|54282746|FG005|Overall Study|Other|0|||
27820867|NCT01891669|54282747|FG006|Overall Study|Other|0|||
27820868|NCT01891669|54282748|FG007|Overall Study|Other|1|||
27820869|NCT01891669|54282749|FG008|Overall Study|Other|0|||
27820870|NCT01891669|54282750|FG009|Overall Study|Other|0|||
27820871|NCT01421511|54282783|FG000|Overall Study|Lost to Follow-up|11|||
27820872|NCT01421511|54282784|FG001|Overall Study|Lost to Follow-up|14|||
27820873|NCT01421511|54282783|FG000|Overall Study|Randomized but didn't receive study drug|1|||
27820874|NCT01421511|54282784|FG001|Overall Study|Randomized but didn't receive study drug|7|||
27820875|NCT01421511|54282783|FG000|Overall Study|Physician Decision|0|||
27820876|NCT01421511|54282784|FG001|Overall Study|Physician Decision|1|||
28136092|NCT03240133|54800205|FG000|Overall Study|Rash|1|||
28136093|NCT03240133|54800206|FG001|Overall Study|Rash|0|||
28069823|NCT00441701|54724884|FG005|Overall Study|Adverse Event|2|||
28069824|NCT00441701|54724885|FG006|Overall Study|Adverse Event|0|||
28069825|NCT00441701|54724886|FG007|Overall Study|Adverse Event|0|||
28069826|NCT00441701|54724887|FG008|Overall Study|Adverse Event|0|||
28069827|NCT00441701|54724888|FG009|Overall Study|Adverse Event|0|||
28069828|NCT00441701|54724879|FG000|Overall Study|Lack of Efficacy|2|||
28069829|NCT00441701|54724880|FG001|Overall Study|Lack of Efficacy|0|||
28136094|NCT03240133|54800207|FG002|Overall Study|Rash|0|||
28136095|NCT03240133|54800205|FG000|Overall Study|sponsor closure/completion of Part 1 of the study|1|||
28136096|NCT03240133|54800206|FG001|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
28136097|NCT03240133|54800207|FG002|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
28136098|NCT03240133|54800205|FG000|Overall Study|Intercurrent illness.|0|||
28136099|NCT03240133|54800206|FG001|Overall Study|Intercurrent illness.|1|||
28136100|NCT03240133|54800207|FG002|Overall Study|Intercurrent illness.|0|||
28136101|NCT03240133|54800205|FG000|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
28136102|NCT03240133|54800206|FG001|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
27820877|NCT01421511|54282783|FG000|Overall Study|Withdrawal by Subject|6|||
27820878|NCT01421511|54282784|FG001|Overall Study|Withdrawal by Subject|5|||
27820879|NCT01421511|54282783|FG000|Overall Study|Death|1|||
27820880|NCT01421511|54282784|FG001|Overall Study|Death|1|||
28069830|NCT00441701|54724881|FG002|Overall Study|Lack of Efficacy|2|||
27820881|NCT01864525|54282793|FG000|Overall Study|Adverse Event|1|||
27820882|NCT01864525|54282794|FG001|Overall Study|Adverse Event|0|||
27820883|NCT01421277|54282802|FG000|Overall Study|Lack of qualifying event|0|||
27820884|NCT01421277|54282803|FG001|Overall Study|Lack of qualifying event|61|||
27820885|NCT01421277|54282802|FG000|Overall Study|Incomplete baseline data|0|||
28069831|NCT00441701|54724882|FG003|Overall Study|Lack of Efficacy|2|||
27820886|NCT01421277|54282803|FG001|Overall Study|Incomplete baseline data|31|||
27820887|NCT01891357|54282809|FG000|Overall Study|Protocol Violation|3|||
27820888|NCT01420965|54282816|FG000|Overall Study|Withdrawal by Subject|1|||
27820889|NCT01420965|54282817|FG001|Overall Study|Withdrawal by Subject|0|||
27820890|NCT01420965|54282818|FG002|Overall Study|Withdrawal by Subject|0|||
27820891|NCT01420965|54282816|FG000|Overall Study|Adverse Event|0|||
27820892|NCT01420965|54282817|FG001|Overall Study|Adverse Event|1|||
27820893|NCT01420965|54282818|FG002|Overall Study|Adverse Event|0|||
27820894|NCT01390389|54282828|FG000|Overall Study|Withdrawal by Subject|2|||
27820895|NCT01390389|54282829|FG001|Overall Study|Withdrawal by Subject|0|||
27820896|NCT01390389|54282828|FG000|Overall Study|Screen Fail|2|||
27820897|NCT01390389|54282829|FG001|Overall Study|Screen Fail|1|||
27820898|NCT01401465|54282841|FG000|Treatment Period 1|Adverse Event|4|||
27820899|NCT01401465|54282842|FG001|Treatment Period 1|Adverse Event|1|||
27820900|NCT01401465|54282841|FG000|Treatment Period 1|Pregnancy|0|||
27820901|NCT01401465|54282842|FG001|Treatment Period 1|Pregnancy|1|||
27820902|NCT01401465|54282841|FG000|Treatment Period 1|Protocol Violation|5|||
27820903|NCT01401465|54282842|FG001|Treatment Period 1|Protocol Violation|0|||
27820904|NCT01401465|54282841|FG000|Treatment Period 1|Withdrawal by Subject|1|||
27820905|NCT01401465|54282842|FG001|Treatment Period 1|Withdrawal by Subject|4|||
27820906|NCT01401465|54282841|FG000|Treatment Period 1|Non-Compliance to Study Drug|1|||
27820907|NCT01401465|54282842|FG001|Treatment Period 1|Non-Compliance to Study Drug|0|||
27820908|NCT01401465|54282841|FG000|Treatment Period 1|Inability to Meet Continuation Criteria|3|||
27820909|NCT01401465|54282842|FG001|Treatment Period 1|Inability to Meet Continuation Criteria|9|||
27820910|NCT01401465|54282841|FG000|Treatment Period 1|Scheduling Difficulties|1|||
27820911|NCT01401465|54282842|FG001|Treatment Period 1|Scheduling Difficulties|1|||
27820912|NCT01401465|54282841|FG000|Treatment Period 2|Lost to Follow-up|0|||
27820913|NCT01401465|54282842|FG001|Treatment Period 2|Lost to Follow-up|1|||
27820914|NCT01401465|54282841|FG000|Treatment Period 2|Withdrawal by Subject|0|||
27820915|NCT01401465|54282842|FG001|Treatment Period 2|Withdrawal by Subject|1|||
27820916|NCT01401153|54282853|FG000|First Test Day|Learning disabilities; illness|1|||
27820917|NCT01401153|54282854|FG001|First Test Day|Learning disabilities; illness|10|||
27820918|NCT01401153|54282853|FG000|Second Test Day|illness|0|||
27820919|NCT01401153|54282854|FG001|Second Test Day|illness|5|||
27820920|NCT01890967|54282867|FG000|Overall Study|Adverse Event|3|||
27820921|NCT01890967|54282868|FG001|Overall Study|Adverse Event|3|||
27820922|NCT01890967|54282869|FG002|Overall Study|Adverse Event|3|||
27820923|NCT01890967|54282870|FG003|Overall Study|Adverse Event|2|||
27820924|NCT01890967|54282871|FG004|Overall Study|Adverse Event|1|||
27820925|NCT01890967|54282872|FG005|Overall Study|Adverse Event|7|||
27820926|NCT01890967|54282867|FG000|Overall Study|Death|1|||
27820927|NCT01890967|54282868|FG001|Overall Study|Death|0|||
27820928|NCT01890967|54282869|FG002|Overall Study|Death|0|||
27820929|NCT01890967|54282870|FG003|Overall Study|Death|0|||
27820930|NCT01890967|54282871|FG004|Overall Study|Death|0|||
27820931|NCT01890967|54282872|FG005|Overall Study|Death|0|||
27820932|NCT01890967|54282867|FG000|Overall Study|Lost to Follow-up|1|||
27820933|NCT01890967|54282868|FG001|Overall Study|Lost to Follow-up|1|||
27820934|NCT01890967|54282869|FG002|Overall Study|Lost to Follow-up|1|||
27820935|NCT01890967|54282870|FG003|Overall Study|Lost to Follow-up|1|||
27820936|NCT01890967|54282871|FG004|Overall Study|Lost to Follow-up|0|||
27820937|NCT01890967|54282872|FG005|Overall Study|Lost to Follow-up|1|||
27820938|NCT01890967|54282867|FG000|Overall Study|Protocol Violation|0|||
27820939|NCT01890967|54282868|FG001|Overall Study|Protocol Violation|3|||
27820940|NCT01890967|54282869|FG002|Overall Study|Protocol Violation|3|||
27820941|NCT01890967|54282870|FG003|Overall Study|Protocol Violation|2|||
27820942|NCT01890967|54282871|FG004|Overall Study|Protocol Violation|4|||
27820943|NCT01890967|54282872|FG005|Overall Study|Protocol Violation|1|||
27820944|NCT01890967|54282867|FG000|Overall Study|Sponsor Decision|2|||
27820945|NCT01890967|54282868|FG001|Overall Study|Sponsor Decision|0|||
27820946|NCT01890967|54282869|FG002|Overall Study|Sponsor Decision|1|||
27820947|NCT01890967|54282870|FG003|Overall Study|Sponsor Decision|3|||
27820948|NCT01890967|54282871|FG004|Overall Study|Sponsor Decision|2|||
27820949|NCT01890967|54282872|FG005|Overall Study|Sponsor Decision|3|||
27820950|NCT01890967|54282867|FG000|Overall Study|Withdrawal by Subject|3|||
27820951|NCT01890967|54282868|FG001|Overall Study|Withdrawal by Subject|4|||
27820952|NCT01890967|54282869|FG002|Overall Study|Withdrawal by Subject|2|||
27820953|NCT01890967|54282870|FG003|Overall Study|Withdrawal by Subject|3|||
27820954|NCT01890967|54282871|FG004|Overall Study|Withdrawal by Subject|3|||
27820955|NCT01890967|54282872|FG005|Overall Study|Withdrawal by Subject|1|||
27820956|NCT01400919|54282891|FG000|Overall Study|Withdrawal by Subject|4|||
27820957|NCT01400919|54282891|FG000|Overall Study|Lost to Follow-up|2|||
28136103|NCT03240133|54800207|FG002|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|1|||
28136104|NCT03372083|54800231|FG000|Overall Study|Adverse Event|3|||
28136105|NCT03372083|54800231|FG000|Overall Study|Physician Decision|1|||
28136106|NCT03372083|54800231|FG000|Overall Study|Withdrawal by Subject|1|||
28136107|NCT03044886|54800238|FG000|Overall Study|Lost to Follow-up|15|||
28136108|NCT03044886|54800239|FG001|Overall Study|Lost to Follow-up|10|||
28136109|NCT03044886|54800240|FG002|Overall Study|Lost to Follow-up|12|||
28136110|NCT02961764|54800250|FG000|Overall Study|Protocol Violation|0|||
28136111|NCT02961764|54800251|FG001|Overall Study|Protocol Violation|1|||
28136112|NCT02961764|54800250|FG000|Overall Study|Death|2|||
28136113|NCT02961764|54800251|FG001|Overall Study|Death|0|||
28136114|NCT02961764|54800250|FG000|Overall Study|Lost to Follow-up|35|||
28136115|NCT02961764|54800251|FG001|Overall Study|Lost to Follow-up|24|||
28136116|NCT02961764|54800250|FG000|Overall Study|Withdrawal by Subject|2|||
28136117|NCT02961764|54800251|FG001|Overall Study|Withdrawal by Subject|0|||
28136118|NCT03371459|54800257|FG000|Washout|Lost to Follow-up|0|||
28136119|NCT03371459|54800258|FG001|Washout|Lost to Follow-up|1|||
28136120|NCT02961920|54800266|FG000|Overall Study|did not achive stydy protocol schedule|1|||
28136121|NCT02961920|54800267|FG001|Overall Study|did not achive stydy protocol schedule|1|||
28136122|NCT03371381|54800273|FG000|Overall Study|Death|5|||
28136123|NCT03371381|54800273|FG000|Overall Study|Study terminated by sponsor|3|||
28136124|NCT03371381|54800273|FG000|Overall Study|Other|4|||
28136125|NCT03044730|54800277|FG000|3 Cycles of Pembro + Capecitab|Progressive Disease|1|||
28136126|NCT03044730|54800277|FG000|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1|||
28136127|NCT03044730|54800277|FG000|3 Cycles of Pembro + Capecitab|Death|1|||
28136128|NCT03044730|54800277|FG000|3 Cycles of Pembro + Capecitab|Adverse Event|1|||
27820958|NCT01400919|54282891|FG000|Overall Study|Missed visit|2|||
27820959|NCT01864291|54282895|FG000|Overall Study|need for revision surgery|2|||
27820960|NCT01400841|54282899|FG000|Initial Study Phase (6 Months)|Death|1|||
27820961|NCT01400841|54282899|FG000|Extended Study Phase (2 Years)|Adverse Event|2|||
27820962|NCT01863667|54282905|FG000|Overall Study|Adverse Event|1|||
27820963|NCT01863667|54282906|FG001|Overall Study|Adverse Event|0|||
27820964|NCT01863667|54282905|FG000|Overall Study|Study terminated by Sponsor|30|||
27820965|NCT01863667|54282906|FG001|Overall Study|Study terminated by Sponsor|30|||
27820966|NCT01863667|54282905|FG000|Overall Study|Withdrawal by Subject|2|||
27820967|NCT01863667|54282906|FG001|Overall Study|Withdrawal by Subject|2|||
27820968|NCT01614769|54282912|FG000|Period 1|Discontinued due to Hypoglycemia|0|||
27820969|NCT01614769|54282913|FG001|Period 1|Discontinued due to Hypoglycemia|0|||
27820970|NCT01614769|54282914|FG002|Period 1|Discontinued due to Hypoglycemia|0|||
27820971|NCT01614769|54282915|FG003|Period 1|Discontinued due to Hypoglycemia|1|||
28136129|NCT03044730|54800277|FG000|Cycles 4 and Beyond|Progressive Disease|9|||
27820972|NCT01614769|54282916|FG004|Period 1|Discontinued due to Hypoglycemia|0|||
27820973|NCT01614769|54282917|FG005|Period 1|Discontinued due to Hypoglycemia|1|||
27849872|NCT04126213|54348110|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
27849873|NCT04126213|54348111|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
28136130|NCT03044730|54800277|FG000|Cycles 4 and Beyond|Adverse Event|1|||
28136131|NCT03044730|54800277|FG000|On Follow-up for 2 Years|Still in follow-up|7|||
28136132|NCT03044730|54800277|FG000|On Follow-up for 2 Years|Lost to Follow-up|1|||
28136133|NCT03044730|54800277|FG000|On Follow-up for 2 Years|Death|17|||
27820974|NCT01614769|54282912|FG000|Period 1|Protocol Violation|0|||
27820975|NCT01614769|54282913|FG001|Period 1|Protocol Violation|0|||
27820976|NCT01614769|54282914|FG002|Period 1|Protocol Violation|0|||
27820977|NCT01614769|54282915|FG003|Period 1|Protocol Violation|1|||
27820978|NCT01614769|54282916|FG004|Period 1|Protocol Violation|0|||
27820979|NCT01614769|54282917|FG005|Period 1|Protocol Violation|0|||
27820980|NCT01614769|54282912|FG000|Period 1|Withdrawal by Subject|1|||
27820981|NCT01614769|54282913|FG001|Period 1|Withdrawal by Subject|0|||
27820982|NCT01614769|54282914|FG002|Period 1|Withdrawal by Subject|0|||
27820983|NCT01614769|54282915|FG003|Period 1|Withdrawal by Subject|0|||
27820984|NCT01614769|54282916|FG004|Period 1|Withdrawal by Subject|0|||
27820985|NCT01614769|54282917|FG005|Period 1|Withdrawal by Subject|0|||
28069832|NCT00441701|54724883|FG004|Overall Study|Lack of Efficacy|0|||
28069833|NCT00441701|54724884|FG005|Overall Study|Lack of Efficacy|1|||
28069834|NCT00441701|54724885|FG006|Overall Study|Lack of Efficacy|0|||
28069835|NCT00441701|54724886|FG007|Overall Study|Lack of Efficacy|0|||
28069836|NCT00441701|54724887|FG008|Overall Study|Lack of Efficacy|0|||
28069837|NCT00441701|54724888|FG009|Overall Study|Lack of Efficacy|0|||
28069838|NCT00441701|54724879|FG000|Overall Study|Withdrawal by Subject|0|||
28136134|NCT02961374|54800282|FG000|Overall Study|Adverse Event|4|||
28136135|NCT02951429|54800288|FG000|Overall Study|Adverse Event|3|||
28136136|NCT02951429|54800289|FG001|Overall Study|Adverse Event|7|||
28136137|NCT02951429|54800288|FG000|Overall Study|Death|28|||
28136138|NCT02951429|54800289|FG001|Overall Study|Death|36|||
28136139|NCT02951429|54800288|FG000|Overall Study|Lack of Efficacy|0|||
28136140|NCT02951429|54800289|FG001|Overall Study|Lack of Efficacy|1|||
28136141|NCT02951429|54800288|FG000|Overall Study|Lost to Follow-up|0|||
28136142|NCT02951429|54800289|FG001|Overall Study|Lost to Follow-up|1|||
28136143|NCT02951429|54800288|FG000|Overall Study|Lung Transplantation|9|||
28136144|NCT02951429|54800289|FG001|Overall Study|Lung Transplantation|6|||
28136145|NCT02951429|54800288|FG000|Overall Study|Other|1|||
27820986|NCT01614769|54282912|FG000|Period 3|Withdrawal by Subject|0|||
27820987|NCT01614769|54282913|FG001|Period 3|Withdrawal by Subject|0|||
28069839|NCT00441701|54724880|FG001|Overall Study|Withdrawal by Subject|2|||
28069840|NCT00441701|54724881|FG002|Overall Study|Withdrawal by Subject|1|||
28069841|NCT00441701|54724882|FG003|Overall Study|Withdrawal by Subject|1|||
28136146|NCT02951429|54800289|FG001|Overall Study|Other|3|||
27820988|NCT01614769|54282914|FG002|Period 3|Withdrawal by Subject|1|||
28136147|NCT02951429|54800288|FG000|Overall Study|Progressive Disease|1|||
28136148|NCT02951429|54800289|FG001|Overall Study|Progressive Disease|1|||
28136149|NCT02951429|54800288|FG000|Overall Study|Withdrawal by Subject|7|||
28136150|NCT02951429|54800289|FG001|Overall Study|Withdrawal by Subject|11|||
28136151|NCT02951429|54800288|FG000|Overall Study|Participant ongoing in the study|23|||
28136152|NCT02951429|54800289|FG001|Overall Study|Participant ongoing in the study|17|||
28136153|NCT03343067|54800302|FG000|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0|||
28136154|NCT03343067|54800303|FG001|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3|||
27820989|NCT01614769|54282915|FG003|Period 3|Withdrawal by Subject|0|||
27820990|NCT01614769|54282916|FG004|Period 3|Withdrawal by Subject|0|||
27820991|NCT01614769|54282917|FG005|Period 3|Withdrawal by Subject|0|||
27820992|NCT01614457|54282927|FG000|Overall Study|Non-Compliance|1|||
27820993|NCT01614457|54282928|FG001|Overall Study|Non-Compliance|0|||
27820994|NCT01614457|54282927|FG000|Overall Study|Pregnancy (Self or Partner)|1|||
27820995|NCT01614457|54282928|FG001|Overall Study|Pregnancy (Self or Partner)|0|||
27820996|NCT01863433|54282934|FG000|Overall Study|Protocol Violation|1|||
27820997|NCT01862029|54282938|FG000|Overall Study|Physician Decision|1|||
27820998|NCT01835431|54282945|FG000|Overall Study|Adverse Event|1|||
27820999|NCT01835431|54282946|FG001|Overall Study|Adverse Event|0|||
27821000|NCT01835431|54282945|FG000|Overall Study|other|0|||
27821001|NCT01835431|54282946|FG001|Overall Study|other|2|||
27821002|NCT01835431|54282945|FG000|Overall Study|Withdrawal by Subject|6|||
27821003|NCT01835431|54282946|FG001|Overall Study|Withdrawal by Subject|10|||
27821004|NCT01835431|54282945|FG000|Overall Study|Protocol Violation|1|||
28136155|NCT03343067|54800304|FG002|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1|||
28136156|NCT03103503|54800312|FG000|Overall Study|Death|64|||
28136157|NCT03103503|54800312|FG000|Overall Study|Physician Decision|57|||
28136158|NCT03103503|54800312|FG000|Overall Study|Withdrawal by Subject|10|||
28136159|NCT03103503|54800312|FG000|Overall Study|Plexa Lead or Pulse Generator Extraction|10|||
28136160|NCT03103503|54800312|FG000|Overall Study|Lost to Follow-up|3|||
28136161|NCT03103503|54800312|FG000|Overall Study|Study Closure|757|||
28136162|NCT02961218|54800318|FG000|Overall Study|Lost to Follow-up|0|||
28136163|NCT02961218|54800319|FG001|Overall Study|Lost to Follow-up|2|||
28136164|NCT02961218|54800318|FG000|Overall Study|Physician Decision|0|||
28136165|NCT02961218|54800319|FG001|Overall Study|Physician Decision|2|||
28136166|NCT02961218|54800318|FG000|Overall Study|Subject/Guardian Decision|3|||
27821005|NCT01835431|54282946|FG001|Overall Study|Protocol Violation|0|||
27821006|NCT01880593|54282954|FG000|Overall Study|Adverse Event|1|||
27821007|NCT01880593|54282955|FG001|Overall Study|Adverse Event|0|||
27821008|NCT01880593|54282954|FG000|Overall Study|Lack of Efficacy|1|||
27821009|NCT01880593|54282955|FG001|Overall Study|Lack of Efficacy|5|||
27821010|NCT01880593|54282954|FG000|Overall Study|Withdrawal by Subject|6|||
27821011|NCT01880593|54282955|FG001|Overall Study|Withdrawal by Subject|1|||
27821012|NCT01400451|54282964|FG000|Combination Treatment (or Intended)|Withdrawal by Subject|2|||
27821013|NCT01400451|54282965|FG001|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
28069842|NCT00441701|54724883|FG004|Overall Study|Withdrawal by Subject|0|||
28069843|NCT00441701|54724884|FG005|Overall Study|Withdrawal by Subject|0|||
28069844|NCT00441701|54724885|FG006|Overall Study|Withdrawal by Subject|0|||
28069845|NCT00441701|54724886|FG007|Overall Study|Withdrawal by Subject|0|||
28069846|NCT00441701|54724887|FG008|Overall Study|Withdrawal by Subject|0|||
28069847|NCT00441701|54724888|FG009|Overall Study|Withdrawal by Subject|0|||
28069848|NCT00441545|54724906|FG000|First Intervention|Adverse Event|6|||
28069849|NCT00441545|54724907|FG001|First Intervention|Adverse Event|5|||
28069850|NCT00441545|54724906|FG000|First Intervention|Protocol Violation|2|||
28069851|NCT00441545|54724907|FG001|First Intervention|Protocol Violation|2|||
28069852|NCT00441545|54724906|FG000|First Intervention|Withdrawal by Subject|3|||
28136167|NCT02961218|54800319|FG001|Overall Study|Subject/Guardian Decision|1|||
28136168|NCT02949947|54800329|FG000|Overall Study|Non Compliance|0|||
27821014|NCT01400451|54282966|FG002|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
28069853|NCT00441545|54724907|FG001|First Intervention|Withdrawal by Subject|3|||
28136169|NCT02949947|54800330|FG001|Overall Study|Non Compliance|1|||
28069854|NCT00441545|54724906|FG000|First Intervention|Kidney transplant|1|||
28069855|NCT00441545|54724907|FG001|First Intervention|Kidney transplant|1|||
28136170|NCT02949947|54800329|FG000|Overall Study|Insurance change|1|||
28136171|NCT02949947|54800330|FG001|Overall Study|Insurance change|0|||
27821015|NCT01400451|54282964|FG000|Combination Treatment (or Intended)|Drug Toxicity|0|||
27821016|NCT01400451|54282965|FG001|Combination Treatment (or Intended)|Drug Toxicity|1|||
27821017|NCT01400451|54282966|FG002|Combination Treatment (or Intended)|Drug Toxicity|0|||
27821018|NCT01400451|54282964|FG000|Combination Treatment (or Intended)|Adverse Event|1|||
27821019|NCT01400451|54282965|FG001|Combination Treatment (or Intended)|Adverse Event|0|||
27821020|NCT01400451|54282966|FG002|Combination Treatment (or Intended)|Adverse Event|0|||
27821021|NCT01400451|54282964|FG000|Combination Treatment (or Intended)|Disease Progression|3|||
28136172|NCT03341507|54800336|FG000|Overall Study|Cormack-Lehane grade 1 or 2a during conventional laryngoscopy|34|||
28136173|NCT01345058|54800342|FG000|Overall Study|Withdrawal by Subject|1|||
28136174|NCT01345058|54800343|FG001|Overall Study|Withdrawal by Subject|0|||
28136175|NCT01345058|54800342|FG000|Overall Study|Participant Reported Increase in Events|1|||
28136176|NCT01345058|54800343|FG001|Overall Study|Participant Reported Increase in Events|0|||
28136177|NCT01345058|54800342|FG000|Overall Study|Side Effects of Hair Loss and Itchiness|1|||
28136178|NCT01345058|54800343|FG001|Overall Study|Side Effects of Hair Loss and Itchiness|0|||
28136179|NCT01345058|54800342|FG000|Overall Study|Participant Stopped Taking Study Drug|1|||
28136180|NCT01345058|54800343|FG001|Overall Study|Participant Stopped Taking Study Drug|0|||
28136181|NCT01345058|54800342|FG000|Overall Study|Participant No-Show at Multiple Visits|1|||
28136182|NCT01345058|54800343|FG001|Overall Study|Participant No-Show at Multiple Visits|0|||
28136183|NCT01345292|54800352|FG000|Overall Study|Withdrawal by Subject|2|||
28136184|NCT01345292|54800353|FG001|Overall Study|Withdrawal by Subject|0|||
28136185|NCT01345292|54800354|FG002|Overall Study|Withdrawal by Subject|1|||
28136186|NCT03340961|54800366|FG000|Overall Study|Adverse Event|1|||
28136187|NCT03340961|54800367|FG001|Overall Study|Adverse Event|3|||
28136188|NCT03340961|54800368|FG002|Overall Study|Adverse Event|2|||
28136189|NCT03340961|54800369|FG003|Overall Study|Adverse Event|4|||
28136190|NCT03340961|54800366|FG000|Overall Study|Lost to Follow-up|0|||
28136191|NCT03340961|54800367|FG001|Overall Study|Lost to Follow-up|1|||
28136192|NCT03340961|54800368|FG002|Overall Study|Lost to Follow-up|0|||
28136193|NCT03340961|54800369|FG003|Overall Study|Lost to Follow-up|1|||
28136194|NCT03340961|54800366|FG000|Overall Study|Withdrawal by Subject|3|||
28136195|NCT03340961|54800367|FG001|Overall Study|Withdrawal by Subject|2|||
28136196|NCT03340961|54800368|FG002|Overall Study|Withdrawal by Subject|4|||
28136197|NCT03340961|54800369|FG003|Overall Study|Withdrawal by Subject|7|||
28136198|NCT03340961|54800366|FG000|Overall Study|Use of prohibited treatment|0|||
28136199|NCT03340961|54800367|FG001|Overall Study|Use of prohibited treatment|3|||
28136200|NCT03340961|54800368|FG002|Overall Study|Use of prohibited treatment|2|||
28136201|NCT03340961|54800369|FG003|Overall Study|Use of prohibited treatment|4|||
28136202|NCT03340961|54800366|FG000|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
28136203|NCT03340961|54800367|FG001|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
28136204|NCT03340961|54800368|FG002|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
28136205|NCT03340961|54800369|FG003|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
28136206|NCT03340961|54800366|FG000|Overall Study|Subject developed an exclusion criterion|0|||
28069856|NCT00441545|54724906|FG000|First Intervention|Lack of Efficacy|2|||
28069857|NCT00441545|54724907|FG001|First Intervention|Lack of Efficacy|0|||
28069858|NCT00441545|54724906|FG000|First Intervention|Subject exceeded safety criteria|0|||
28069859|NCT00441545|54724907|FG001|First Intervention|Subject exceeded safety criteria|1|||
28069860|NCT00441545|54724906|FG000|First Intervention|Subject met an exclusionary criteria|1|||
28069861|NCT00441545|54724907|FG001|First Intervention|Subject met an exclusionary criteria|0|||
28069862|NCT00441545|54724906|FG000|First Intervention|Extended hospitalization|1|||
28069863|NCT00441545|54724907|FG001|First Intervention|Extended hospitalization|0|||
28069864|NCT00441545|54724906|FG000|First Intervention|Site error|1|||
28069865|NCT00441545|54724907|FG001|First Intervention|Site error|0|||
28069866|NCT00441545|54724906|FG000|First Intervention|Sponsor's request|1|||
28136207|NCT03340961|54800367|FG001|Overall Study|Subject developed an exclusion criterion|1|||
27821022|NCT01400451|54282965|FG001|Combination Treatment (or Intended)|Disease Progression|1|||
28136208|NCT03340961|54800368|FG002|Overall Study|Subject developed an exclusion criterion|0|||
28136209|NCT03340961|54800369|FG003|Overall Study|Subject developed an exclusion criterion|0|||
28069867|NCT00441545|54724907|FG001|First Intervention|Sponsor's request|0|||
28069868|NCT00441545|54724906|FG000|Second Intervention|Adverse Event|5|||
28069869|NCT00441545|54724907|FG001|Second Intervention|Adverse Event|2|||
28069870|NCT00441545|54724906|FG000|Second Intervention|Protocol Violation|4|||
28069871|NCT00441545|54724907|FG001|Second Intervention|Protocol Violation|1|||
28069872|NCT00441545|54724906|FG000|Second Intervention|Withdrawal by Subject|1|||
28069873|NCT00441545|54724907|FG001|Second Intervention|Withdrawal by Subject|1|||
28069874|NCT00441545|54724906|FG000|Second Intervention|Kidney Transplant|1|||
28136210|NCT03340961|54800366|FG000|Overall Study|Protocol Violation|1|||
28136211|NCT03340961|54800367|FG001|Overall Study|Protocol Violation|0|||
28069875|NCT00441545|54724907|FG001|Second Intervention|Kidney Transplant|1|||
28069876|NCT00441545|54724906|FG000|Second Intervention|Lack of Efficacy|0|||
28069877|NCT00441545|54724907|FG001|Second Intervention|Lack of Efficacy|1|||
28069878|NCT00441545|54724906|FG000|Second Intervention|Subject exceeded safety criteria|1|||
28069879|NCT00441545|54724907|FG001|Second Intervention|Subject exceeded safety criteria|0|||
28069880|NCT00441545|54724906|FG000|Second Intervention|Subject moved|0|||
28069881|NCT00441545|54724907|FG001|Second Intervention|Subject moved|1|||
28136212|NCT03340961|54800368|FG002|Overall Study|Protocol Violation|1|||
28136213|NCT03340961|54800369|FG003|Overall Study|Protocol Violation|0|||
28136214|NCT03340961|54800366|FG000|Overall Study|Adverse Event|1|||
28136215|NCT03340961|54800367|FG001|Overall Study|Adverse Event|1|||
28136216|NCT03340961|54800368|FG002|Overall Study|Adverse Event|0|||
28136217|NCT03340961|54800369|FG003|Overall Study|Adverse Event|0|||
28136218|NCT03340961|54800366|FG000|Overall Study|Lack of Efficacy|0|||
28136219|NCT03340961|54800367|FG001|Overall Study|Lack of Efficacy|0|||
28136220|NCT03340961|54800368|FG002|Overall Study|Lack of Efficacy|0|||
28136221|NCT03340961|54800369|FG003|Overall Study|Lack of Efficacy|1|||
28136222|NCT03340025|54800381|FG000|Overall Study|Lost to Follow-up|2|||
28136223|NCT03340025|54800382|FG001|Overall Study|Lost to Follow-up|2|||
28136224|NCT03339713|54800390|FG000|Overall Study|Lost to Follow-up|2|||
28136225|NCT03339713|54800391|FG001|Overall Study|Lost to Follow-up|1|||
28136226|NCT03339713|54800390|FG000|Overall Study|Protocol Violation|1|||
28136227|NCT03339713|54800391|FG001|Overall Study|Protocol Violation|0|||
28136228|NCT03339713|54800390|FG000|Overall Study|Withdrawal by Subject|1|||
28136229|NCT03339713|54800391|FG001|Overall Study|Withdrawal by Subject|1|||
28136230|NCT03254485|54800403|FG000|Overall Study|Adverse Event|3|||
28136231|NCT03254485|54800404|FG001|Overall Study|Adverse Event|0|||
28136232|NCT03254485|54800405|FG002|Overall Study|Adverse Event|0|||
28136233|NCT03254485|54800406|FG003|Overall Study|Adverse Event|6|||
28136234|NCT03254485|54800403|FG000|Overall Study|Protocol Violation|6|||
28136235|NCT03254485|54800404|FG001|Overall Study|Protocol Violation|0|||
28136236|NCT03254485|54800405|FG002|Overall Study|Protocol Violation|0|||
28136237|NCT03254485|54800406|FG003|Overall Study|Protocol Violation|2|||
28136238|NCT03254485|54800403|FG000|Overall Study|Withdrawal by Subject|1|||
28136239|NCT03254485|54800404|FG001|Overall Study|Withdrawal by Subject|0|||
28136240|NCT03254485|54800405|FG002|Overall Study|Withdrawal by Subject|0|||
28136241|NCT03254485|54800406|FG003|Overall Study|Withdrawal by Subject|4|||
28136242|NCT03254485|54800403|FG000|Overall Study|Death|0|||
28136243|NCT03254485|54800404|FG001|Overall Study|Death|0|||
28136244|NCT03254485|54800405|FG002|Overall Study|Death|0|||
28136245|NCT03254485|54800406|FG003|Overall Study|Death|1|||
28136246|NCT03254485|54800403|FG000|Overall Study|Lost to Follow-up|1|||
28136247|NCT03254485|54800404|FG001|Overall Study|Lost to Follow-up|0|||
28136248|NCT03254485|54800405|FG002|Overall Study|Lost to Follow-up|0|||
28136249|NCT03254485|54800406|FG003|Overall Study|Lost to Follow-up|0|||
28136250|NCT03254485|54800403|FG000|Overall Study|Other|1|||
28136251|NCT03254485|54800404|FG001|Overall Study|Other|0|||
28136252|NCT03254485|54800405|FG002|Overall Study|Other|0|||
28069882|NCT00436553|54724916|FG000|Overall Study|Adverse Event|4|||
28069883|NCT00436553|54724917|FG001|Overall Study|Adverse Event|3|||
28136253|NCT03254485|54800406|FG003|Overall Study|Other|2|||
28136254|NCT03339401|54800429|FG000|Overall Study|Death|2|||
28136255|NCT03339401|54800430|FG001|Overall Study|Death|1|||
28136256|NCT03339401|54800429|FG000|Overall Study|Withdrawal by Subject|2|||
28136257|NCT03339401|54800430|FG001|Overall Study|Withdrawal by Subject|0|||
28136258|NCT03339401|54800429|FG000|Overall Study|Study terminated|4|||
28136259|NCT03339401|54800430|FG001|Overall Study|Study terminated|3|||
28136260|NCT03339401|54800429|FG000|Overall Study|Investigator Decision|1|||
28136261|NCT03339401|54800430|FG001|Overall Study|Investigator Decision|0|||
28136262|NCT03370289|54800436|FG000|Overall Study|Screen Failure|1|||
28136263|NCT03370289|54800436|FG000|Overall Study|Sample Size Sufficient|4|||
28136264|NCT01344824|54800440|FG000|Overall Study|Adverse Event|15|||
28136265|NCT01344824|54800440|FG000|Overall Study|Withdrawal by Subject|6|||
28136266|NCT01344824|54800440|FG000|Overall Study|Other complicating disease|1|||
28136267|NCT01344824|54800440|FG000|Overall Study|Progression|15|||
28136268|NCT03339245|54800447|FG000|Overall Study|Adverse Event|1|||
28136269|NCT03339245|54800448|FG001|Overall Study|Adverse Event|1|||
28136270|NCT03339245|54800447|FG000|Overall Study|Withdrawal by Subject|1|||
28136271|NCT03339245|54800448|FG001|Overall Study|Withdrawal by Subject|0|||
28136272|NCT03044574|54800456|FG000|Overall Study|Lost to Follow-up|37|||
28136273|NCT03044574|54800457|FG001|Overall Study|Lost to Follow-up|45|||
28136274|NCT02959892|54800465|FG000|Overall Study|PET tracer synthesis failure|1|||
28136275|NCT02959892|54800466|FG001|Overall Study|PET tracer synthesis failure|0|||
28136276|NCT02959892|54800465|FG000|Overall Study|Study termination|0|||
28136277|NCT02959892|54800466|FG001|Overall Study|Study termination|1|||
28136278|NCT03252145|54800474|FG000|Overall Study|Withdrawal by Subject|1|||
28136279|NCT03252145|54800475|FG001|Overall Study|Withdrawal by Subject|0|||
28136280|NCT03252145|54800474|FG000|Overall Study|Complicating Disease|1|||
28136281|NCT03252145|54800475|FG001|Overall Study|Complicating Disease|2|||
28136282|NCT02959814|54800481|FG000|Overall Study|Excluded based on diagnostic angiography|16|||
28136283|NCT02959814|54800481|FG000|Overall Study|Excluded based on anatomical criteria|2|||
28136284|NCT02959814|54800481|FG000|Overall Study|Protocol Violation|7|||
28136285|NCT02959814|54800481|FG000|Overall Study|FFR not measured|2|||
28136286|NCT02959814|54800481|FG000|Overall Study|In-procedure QFR not computed|6|||
28136287|NCT02959814|54800481|FG000|Overall Study|Excluded by FFR core-lab|24|||
28136288|NCT03666624|54800488|FG000|Overall Study|participant grieving over recent death of parent|1|||
28136289|NCT03666624|54800489|FG001|Overall Study|participant grieving over recent death of parent|0|||
28136290|NCT03368807|54800495|FG000|Period 1 (Blinded CGM)|Withdrawal by Subject|3|||
28136291|NCT03368807|54800495|FG000|Period 1 (Blinded CGM)|Protocol Violation|1|||
28136292|NCT03368807|54800495|FG000|Period 1 (Blinded CGM)|Sponsor Decision|1|||
28136293|NCT03368807|54800495|FG000|Period 1 (Blinded CGM)|Lost to Follow-up|1|||
28136294|NCT03338855|54800503|FG000|Overall Study|Withdrawn as birth control pill stopped|1|||
28136295|NCT03338855|54800504|FG001|Overall Study|Withdrawn as birth control pill stopped|0|||
28136296|NCT03367793|54800516|FG000|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
28136297|NCT03367793|54800517|FG001|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
28136298|NCT03367793|54800518|FG002|Treatment 2 Dispense to 2 Months Wear|Physician Decision|1|||
28136299|NCT03367793|54800519|FG003|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
28136300|NCT03367793|54800520|FG004|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
27821023|NCT01400451|54282966|FG002|Combination Treatment (or Intended)|Disease Progression|1|||
27821024|NCT01400451|54282964|FG000|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
27821025|NCT01400451|54282965|FG001|Combination Treatment (or Intended)|Dose-limiting toxicity|1|||
27821026|NCT01400451|54282966|FG002|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
27821027|NCT01400139|54282979|FG000|HYD Core Study|Adverse Event|210|||
27821028|NCT01400139|54282979|FG000|HYD Core Study|Lack of Efficacy|59|||
27821029|NCT01400139|54282979|FG000|HYD Core Study|Withdrawal by Subject|114|||
27821030|NCT01400139|54282979|FG000|HYD Core Study|Lost to Follow-up|39|||
27821031|NCT01400139|54282979|FG000|HYD Core Study|Confirmed or suspected diversion|20|||
27821032|NCT01400139|54282979|FG000|HYD Core Study|Administrative|56|||
27849874|NCT04126213|54348112|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
28136301|NCT03367793|54800521|FG005|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
28136302|NCT01347307|54800543|FG000|Overall Study|Death|0|||
28136303|NCT01347307|54800544|FG001|Overall Study|Death|4|||
28136304|NCT01347307|54800543|FG000|Overall Study|Physician Decision|0|||
28136305|NCT01347307|54800544|FG001|Overall Study|Physician Decision|1|||
28136306|NCT03247543|54800601|FG000|Overall Study|Adverse Event|3|||
28136307|NCT03247543|54800602|FG001|Overall Study|Adverse Event|6|||
28136308|NCT03247543|54800603|FG002|Overall Study|Adverse Event|4|||
28136309|NCT03247543|54800601|FG000|Overall Study|Lost to Follow-up|10|||
28136310|NCT03247543|54800602|FG001|Overall Study|Lost to Follow-up|7|||
28136311|NCT03247543|54800603|FG002|Overall Study|Lost to Follow-up|8|||
28136312|NCT03247543|54800601|FG000|Overall Study|Consent withdrawn by caregiver|2|||
28136313|NCT03247543|54800602|FG001|Overall Study|Consent withdrawn by caregiver|2|||
28136314|NCT03247543|54800603|FG002|Overall Study|Consent withdrawn by caregiver|9|||
28136315|NCT03247543|54800601|FG000|Overall Study|Withdrawal by Subject|0|||
28136316|NCT03247543|54800602|FG001|Overall Study|Withdrawal by Subject|0|||
28136317|NCT03247543|54800603|FG002|Overall Study|Withdrawal by Subject|1|||
28136318|NCT03247543|54800601|FG000|Overall Study|Failure to Follow study procedures|1|||
28136319|NCT03247543|54800602|FG001|Overall Study|Failure to Follow study procedures|3|||
28136320|NCT03247543|54800603|FG002|Overall Study|Failure to Follow study procedures|1|||
28136321|NCT03247543|54800601|FG000|Overall Study|Lack of Efficacy|1|||
28136322|NCT03247543|54800602|FG001|Overall Study|Lack of Efficacy|0|||
28136323|NCT03247543|54800603|FG002|Overall Study|Lack of Efficacy|0|||
28136324|NCT03247543|54800601|FG000|Overall Study|Non-compliance with study visits|0|||
28136325|NCT03247543|54800602|FG001|Overall Study|Non-compliance with study visits|1|||
28136326|NCT03247543|54800603|FG002|Overall Study|Non-compliance with study visits|0|||
28136327|NCT01347073|54800613|FG000|Overall Study|Adverse Event|1|||
28136328|NCT01347073|54800613|FG000|Overall Study|Liver Transplant|1|||
28136329|NCT01315236|54800625|FG000|Double-blind Phase|Death|1|||
28136330|NCT01315236|54800626|FG001|Double-blind Phase|Death|0|||
28136331|NCT01315236|54800625|FG000|Double-blind Phase|Adverse Event|1|||
28136332|NCT01315236|54800626|FG001|Double-blind Phase|Adverse Event|0|||
28136333|NCT01315236|54800625|FG000|Double-blind Phase|Withdrawal of Consent|1|||
28136334|NCT01315236|54800626|FG001|Double-blind Phase|Withdrawal of Consent|0|||
28136335|NCT01315236|54800625|FG000|Double-blind Phase|Lost to Follow-up|1|||
28136336|NCT01315236|54800626|FG001|Double-blind Phase|Lost to Follow-up|0|||
28136337|NCT01315236|54800625|FG000|Open-label Phase|Death|1|||
28136338|NCT01315236|54800626|FG001|Open-label Phase|Death|0|||
28136339|NCT01315236|54800625|FG000|Open-label Phase|Adverse Event|0|||
28136340|NCT01315236|54800626|FG001|Open-label Phase|Adverse Event|1|||
28136341|NCT01315236|54800625|FG000|Open-label Phase|Other|0|||
28136342|NCT01315236|54800626|FG001|Open-label Phase|Other|1|||
28136343|NCT01315236|54800625|FG000|12-Month Follow-up Period|Death|0|||
28136344|NCT01315236|54800626|FG001|12-Month Follow-up Period|Death|1|||
28136345|NCT01315236|54800625|FG000|12-Month Follow-up Period|Did not return to the site for Month 12|1|||
28136346|NCT01315236|54800626|FG001|12-Month Follow-up Period|Did not return to the site for Month 12|0|||
28136347|NCT03232567|54800638|FG000|Overall Study|Withdrawal by Subject|0|||
28136348|NCT03232567|54800639|FG001|Overall Study|Withdrawal by Subject|1|||
28136349|NCT03232567|54800640|FG002|Overall Study|Withdrawal by Subject|0|||
28136350|NCT03232567|54800641|FG003|Overall Study|Withdrawal by Subject|0|||
28136351|NCT01348490|54800662|FG000|Overall Study|Death|1|||
28136352|NCT01348490|54800662|FG000|Overall Study|Adverse Event|3|||
28136353|NCT01348490|54800662|FG000|Overall Study|Consent withdrawn|7|||
28136354|NCT01348490|54800662|FG000|Overall Study|Disease progression|3|||
28136355|NCT01348490|54800662|FG000|Overall Study|Lost to Follow-up|1|||
28136356|NCT01348490|54800662|FG000|Overall Study|Termination of clinical trial by sponsor|1|||
28136357|NCT01348490|54800662|FG000|Overall Study|Other Unspecified|8|||
28136358|NCT03040674|54800683|FG000|Overall Study|Lost to Follow-up|225|||
28136359|NCT03040674|54800683|FG000|Overall Study|Death|23|||
28136360|NCT03232333|54800688|FG000|Overall Study|Infection or Osteomyelitis|9|||
28136361|NCT03232333|54800688|FG000|Overall Study|Lost to Follow-up|4|||
28136362|NCT03232333|54800688|FG000|Overall Study|Withdrawal by Subject|2|||
28136363|NCT03364049|54800696|FG000|Overall Study|Death|6|||
28136364|NCT03364049|54800697|FG001|Overall Study|Death|4|||
28136365|NCT03364049|54800698|FG002|Overall Study|Death|5|||
28136366|NCT03364049|54800699|FG003|Overall Study|Death|14|||
28160102|NCT03434379|54830201|FG000|China Extension Period|Withdrawal by Subject|0|||
28160103|NCT03434379|54830202|FG001|China Extension Period|Withdrawal by Subject|0|||
28160104|NCT03434379|54830203|FG002|China Extension Period|Withdrawal by Subject|7|||
28160105|NCT03434379|54830204|FG003|China Extension Period|Withdrawal by Subject|6|||
28160106|NCT03434379|54830201|FG000|China Extension Period|On Study|0|||
28160107|NCT03434379|54830202|FG001|China Extension Period|On Study|0|||
28160108|NCT03434379|54830203|FG002|China Extension Period|On Study|15|||
28160109|NCT03434379|54830204|FG003|China Extension Period|On Study|66|||
28160110|NCT03064451|54830220|FG000|Overall Study|Lost to Follow-up|1|||
28160111|NCT03064451|54830220|FG000|Overall Study|Mapping Failure|4|||
28160112|NCT03064451|54830220|FG000|Overall Study|Exited prior to procedure|8|||
28136367|NCT03364049|54800696|FG000|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
28136368|NCT03364049|54800697|FG001|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|1|||
28136369|NCT03364049|54800698|FG002|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
28136370|NCT03364049|54800699|FG003|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
28136371|NCT03364049|54800696|FG000|Overall Study|Withdrawal by Subject|0|||
28136372|NCT03364049|54800697|FG001|Overall Study|Withdrawal by Subject|1|||
28136373|NCT03364049|54800698|FG002|Overall Study|Withdrawal by Subject|1|||
28136374|NCT03364049|54800699|FG003|Overall Study|Withdrawal by Subject|1|||
28136375|NCT03238963|54800711|FG000|Overall Study|Prohibited medication given due to hospital stay|1|||
28136376|NCT03238963|54800712|FG001|Overall Study|Prohibited medication given due to hospital stay|0|||
28136377|NCT03238963|54800711|FG000|Overall Study|Withdrawal by Subject|1|||
28136378|NCT03238963|54800712|FG001|Overall Study|Withdrawal by Subject|1|||
28136379|NCT03238963|54800711|FG000|Overall Study|Lost to Follow-up|1|||
28136380|NCT03238963|54800712|FG001|Overall Study|Lost to Follow-up|0|||
28136381|NCT03238963|54800711|FG000|Overall Study|Protocol Violation|1|||
28136382|NCT03238963|54800712|FG001|Overall Study|Protocol Violation|1|||
28136383|NCT03238963|54800711|FG000|Overall Study|Adverse Event|1|||
28136384|NCT03238963|54800712|FG001|Overall Study|Adverse Event|0|||
28136385|NCT03337139|54800720|FG000|Phase I|Withdrawal by Subject|10|||
28136386|NCT03337139|54800721|FG001|Phase I|Withdrawal by Subject|0|||
28136387|NCT03042312|54800729|FG000|Overall Study|Administrative Reason|1|||
28136388|NCT03042312|54800730|FG001|Overall Study|Administrative Reason|1|||
28136389|NCT03042312|54800729|FG000|Overall Study|Adverse Event|0|||
28136390|NCT03042312|54800730|FG001|Overall Study|Adverse Event|1|||
28136391|NCT03042312|54800729|FG000|Overall Study|Lost to Follow-up|1|||
28136392|NCT03042312|54800730|FG001|Overall Study|Lost to Follow-up|3|||
28136393|NCT03042312|54800729|FG000|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|4|||
28136394|NCT03042312|54800730|FG001|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|2|||
28136395|NCT03042312|54800729|FG000|Overall Study|Withdrawal by Subject|4|||
28136396|NCT03042312|54800730|FG001|Overall Study|Withdrawal by Subject|5|||
28136397|NCT03360071|54800738|FG000|Overall Study|Lost to Follow-up|1|||
28136398|NCT03360071|54800739|FG001|Overall Study|Lost to Follow-up|0|||
28136399|NCT02949011|54800748|FG000|Overall Study|Adverse Event|6|||
28136400|NCT02949011|54800749|FG001|Overall Study|Adverse Event|7|||
28136401|NCT02949011|54800750|FG002|Overall Study|Adverse Event|3|||
28136402|NCT02949011|54800748|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
28136403|NCT02949011|54800749|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
28136404|NCT02949011|54800750|FG002|Overall Study|Failed Inclusion/Exclusion Criteria|3|||
28136405|NCT02949011|54800748|FG000|Overall Study|Protocol Deviation|5|||
28136406|NCT02949011|54800749|FG001|Overall Study|Protocol Deviation|3|||
28136407|NCT02949011|54800750|FG002|Overall Study|Protocol Deviation|3|||
28136408|NCT02949011|54800748|FG000|Overall Study|Lack of Efficacy|0|||
28136409|NCT02949011|54800749|FG001|Overall Study|Lack of Efficacy|2|||
27821033|NCT01400139|54282979|FG000|HYD Core Study|Did not qualify for Maintenance Period|14|||
28069884|NCT00436553|54724918|FG002|Overall Study|Adverse Event|4|||
28069885|NCT00436553|54724916|FG000|Overall Study|Death|3|||
28069886|NCT00436553|54724917|FG001|Overall Study|Death|1|||
28069887|NCT00436553|54724918|FG002|Overall Study|Death|3|||
28069888|NCT00436553|54724916|FG000|Overall Study|Lost to Follow-up|0|||
28069889|NCT00436553|54724917|FG001|Overall Study|Lost to Follow-up|2|||
28069890|NCT00436553|54724918|FG002|Overall Study|Lost to Follow-up|0|||
28069891|NCT00436553|54724916|FG000|Overall Study|Protocol Violation|1|||
28069892|NCT00436553|54724917|FG001|Overall Study|Protocol Violation|0|||
28069893|NCT00436553|54724918|FG002|Overall Study|Protocol Violation|0|||
28069894|NCT00436553|54724916|FG000|Overall Study|Withdrawal by Subject|5|||
28069895|NCT00436553|54724917|FG001|Overall Study|Withdrawal by Subject|6|||
28069896|NCT00436553|54724918|FG002|Overall Study|Withdrawal by Subject|3|||
28069897|NCT00441467|54724926|FG000|Overall Study|Adverse Event|6|||
28136410|NCT02949011|54800750|FG002|Overall Study|Lack of Efficacy|0|||
28136411|NCT02949011|54800748|FG000|Overall Study|Withdrawal by Subject|13|||
28136412|NCT02949011|54800749|FG001|Overall Study|Withdrawal by Subject|13|||
28136413|NCT02949011|54800750|FG002|Overall Study|Withdrawal by Subject|21|||
28069898|NCT00441467|54724926|FG000|Overall Study|Withdrawal by Subject|3|||
28069899|NCT00441467|54724926|FG000|Overall Study|Progressive disease|9|||
28136414|NCT02949011|54800748|FG000|Overall Study|Lost to Follow-up|7|||
28136415|NCT02949011|54800749|FG001|Overall Study|Lost to Follow-up|5|||
28136416|NCT02949011|54800750|FG002|Overall Study|Lost to Follow-up|5|||
28136417|NCT02949011|54800748|FG000|Overall Study|Death|0|||
28136418|NCT02949011|54800749|FG001|Overall Study|Death|0|||
28136419|NCT02949011|54800750|FG002|Overall Study|Death|1|||
28136420|NCT02949011|54800748|FG000|Overall Study|Miscellaneous|2|||
28136421|NCT02949011|54800749|FG001|Overall Study|Miscellaneous|4|||
28136422|NCT02949011|54800750|FG002|Overall Study|Miscellaneous|6|||
27821034|NCT01400139|54282979|FG000|HYD Extension Period|Adverse Event|8|||
27821035|NCT01400139|54282979|FG000|HYD Extension Period|Withdrawal by Subject|5|||
27821036|NCT01400139|54282979|FG000|HYD Extension Period|Administrative|10|||
27821037|NCT01399905|54282987|FG000|Overall Study|Withdrawal by Subject|1|||
27821038|NCT01399905|54282988|FG001|Overall Study|Withdrawal by Subject|1|||
27821039|NCT01725308|54283002|FG000|Treatment Period I|Did Not Receive Drug|1|||
28136423|NCT03357731|54800762|FG000|Overall Study|Withdrew consent due to personal reasons|0|||
28136424|NCT03357731|54800763|FG001|Overall Study|Withdrew consent due to personal reasons|0|||
28136425|NCT03357731|54800764|FG002|Overall Study|Withdrew consent due to personal reasons|0|||
28136426|NCT03357731|54800765|FG003|Overall Study|Withdrew consent due to personal reasons|0|||
28136427|NCT03357731|54800766|FG004|Overall Study|Withdrew consent due to personal reasons|1|||
28136428|NCT03357731|54800767|FG005|Overall Study|Withdrew consent due to personal reasons|0|||
28136429|NCT03357731|54800762|FG000|Overall Study|Acute bradycardia and hypotension|0|||
28136430|NCT03357731|54800763|FG001|Overall Study|Acute bradycardia and hypotension|0|||
28136431|NCT03357731|54800764|FG002|Overall Study|Acute bradycardia and hypotension|0|||
28136432|NCT03357731|54800765|FG003|Overall Study|Acute bradycardia and hypotension|1|||
28136433|NCT03357731|54800766|FG004|Overall Study|Acute bradycardia and hypotension|0|||
28136434|NCT03357731|54800767|FG005|Overall Study|Acute bradycardia and hypotension|0|||
28136435|NCT03357731|54800762|FG000|Overall Study|Adverse Event|0|||
28136436|NCT03357731|54800763|FG001|Overall Study|Adverse Event|0|||
28136437|NCT03357731|54800764|FG002|Overall Study|Adverse Event|0|||
28136438|NCT03357731|54800765|FG003|Overall Study|Adverse Event|0|||
28136439|NCT03357731|54800766|FG004|Overall Study|Adverse Event|0|||
28136440|NCT03357731|54800767|FG005|Overall Study|Adverse Event|1|||
28136441|NCT03357731|54800762|FG000|Overall Study|Hypotension|0|||
28136442|NCT03357731|54800763|FG001|Overall Study|Hypotension|0|||
28136443|NCT03357731|54800764|FG002|Overall Study|Hypotension|1|||
28136444|NCT03357731|54800765|FG003|Overall Study|Hypotension|1|||
28136445|NCT03357731|54800766|FG004|Overall Study|Hypotension|0|||
28136446|NCT03357731|54800767|FG005|Overall Study|Hypotension|0|||
28136447|NCT03357731|54800762|FG000|Overall Study|Lost to Follow-up|0|||
28136448|NCT03357731|54800763|FG001|Overall Study|Lost to Follow-up|0|||
28136449|NCT03357731|54800764|FG002|Overall Study|Lost to Follow-up|0|||
28136450|NCT03357731|54800765|FG003|Overall Study|Lost to Follow-up|1|||
28136451|NCT03357731|54800766|FG004|Overall Study|Lost to Follow-up|0|||
28136452|NCT03357731|54800767|FG005|Overall Study|Lost to Follow-up|0|||
28136453|NCT03357341|54800777|FG000|Overall Study|Withdrawal by Subject|3|||
28136454|NCT03357341|54800778|FG001|Overall Study|Withdrawal by Subject|6|||
28136455|NCT03357341|54800777|FG000|Overall Study|Lost to Follow-up|4|||
28136456|NCT03357341|54800778|FG001|Overall Study|Lost to Follow-up|5|||
28136457|NCT03357341|54800777|FG000|Overall Study|Death|0|||
28136458|NCT03357341|54800778|FG001|Overall Study|Death|1|||
28136459|NCT03039738|54800787|FG000|Overall Study|Incomplete data sets|54|||
28136460|NCT03039738|54800788|FG001|Overall Study|Incomplete data sets|0|||
28136461|NCT02946515|54800805|FG000|Overall Study|Lost to Follow-up|2|||
28136462|NCT02946515|54800806|FG001|Overall Study|Lost to Follow-up|1|||
28136463|NCT03036852|54800818|FG000|Overall Study|Death|2|||
28136464|NCT03036852|54800818|FG000|Overall Study|Lack of Efficacy|2|||
28136465|NCT03036852|54800818|FG000|Overall Study|Adverse Event|1|||
28136466|NCT03036852|54800818|FG000|Overall Study|Lost to Follow-up|1|||
28136467|NCT02945657|54800829|FG000|Overall Study|Adverse Event|1|||
28136468|NCT02945657|54800829|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
28136469|NCT02948777|54800834|FG000|Overall Study|worsening of asthma symptoms resulting in oral prednisolone use.|1|||
28136470|NCT03324581|54800842|FG000|Overall Study|Adverse Event|18|||
28136471|NCT03324581|54800843|FG001|Overall Study|Adverse Event|11|||
28136472|NCT03324581|54800844|FG002|Overall Study|Adverse Event|7|||
28136473|NCT03324581|54800842|FG000|Overall Study|Lack of Efficacy|0|||
28136474|NCT03324581|54800843|FG001|Overall Study|Lack of Efficacy|1|||
27821040|NCT01725308|54283003|FG001|Treatment Period I|Did Not Receive Drug|0|||
27849875|NCT04128319|54348129|FG000|Overall Study|Death|3|||
28136475|NCT03324581|54800844|FG002|Overall Study|Lack of Efficacy|0|||
27941027|NCT01020123|54597352|FG002|Main Period|Lost to Follow-up|0|||
28136476|NCT03324581|54800842|FG000|Overall Study|Lost to Follow-up|5|||
28136477|NCT03324581|54800843|FG001|Overall Study|Lost to Follow-up|3|||
28136478|NCT03324581|54800844|FG002|Overall Study|Lost to Follow-up|6|||
28136479|NCT03324581|54800842|FG000|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
28136480|NCT03324581|54800843|FG001|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
27941028|NCT01020123|54597353|FG003|Main Period|Lost to Follow-up|0|||
28136481|NCT03324581|54800844|FG002|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|0|||
28136482|NCT03324581|54800842|FG000|Overall Study|Physician Decision|0|||
28136483|NCT03324581|54800843|FG001|Overall Study|Physician Decision|1|||
28136484|NCT03324581|54800844|FG002|Overall Study|Physician Decision|2|||
28136485|NCT03324581|54800842|FG000|Overall Study|Protocol Deviation|8|||
28136486|NCT03324581|54800843|FG001|Overall Study|Protocol Deviation|9|||
28136487|NCT03324581|54800844|FG002|Overall Study|Protocol Deviation|4|||
28136488|NCT03324581|54800842|FG000|Overall Study|Withdrawal by Subject|6|||
28136489|NCT03324581|54800843|FG001|Overall Study|Withdrawal by Subject|8|||
28136490|NCT03324581|54800844|FG002|Overall Study|Withdrawal by Subject|6|||
28136491|NCT03324581|54800842|FG000|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
28136492|NCT03324581|54800843|FG001|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|1|||
28136493|NCT03324581|54800844|FG002|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
28136494|NCT02943473|54800852|FG000|Overall Study|enrolled but not dosed|1|||
28136495|NCT02943473|54800852|FG000|Overall Study|screen failure|1|||
28136496|NCT02943473|54800852|FG000|Overall Study|Physician Decision|4|||
28136497|NCT03073733|54800859|FG000|Overall Study|Lost to Follow-up|1|||
28136498|NCT03073733|54800860|FG001|Overall Study|Lost to Follow-up|0|||
28136499|NCT03073733|54800861|FG002|Overall Study|Lost to Follow-up|0|||
28136500|NCT03073733|54800859|FG000|Overall Study|Physician Decision|0|||
28136501|NCT03073733|54800860|FG001|Overall Study|Physician Decision|1|||
28136502|NCT03073733|54800861|FG002|Overall Study|Physician Decision|0|||
28136503|NCT03073733|54800859|FG000|Overall Study|Withdrawal by Subject|0|||
28136504|NCT03073733|54800860|FG001|Overall Study|Withdrawal by Subject|0|||
28136505|NCT03073733|54800861|FG002|Overall Study|Withdrawal by Subject|1|||
28136506|NCT03320369|54800871|FG000|Overall Study|Adverse Event|1|||
28136507|NCT03320369|54800871|FG000|Overall Study|Withdrawal by Subject|2|||
28136508|NCT02650895|54800881|FG000|Overall Study|Withdrawal by Subject|0|||
28136509|NCT02650895|54800882|FG001|Overall Study|Withdrawal by Subject|1|||
28136510|NCT02650895|54800883|FG002|Overall Study|Withdrawal by Subject|0|||
28136511|NCT02650895|54800884|FG003|Overall Study|Withdrawal by Subject|0|||
28136512|NCT02650895|54800885|FG004|Overall Study|Withdrawal by Subject|0|||
28136513|NCT02650895|54800886|FG005|Overall Study|Withdrawal by Subject|0|||
28136514|NCT03320057|54800905|FG000|Overall Study|Lost to Follow-up|4|||
28136515|NCT03320057|54800906|FG001|Overall Study|Lost to Follow-up|17|||
27849876|NCT05038293|54348175|FG000|Overall Study|device was not operating properly for one subject.|1|||
28136516|NCT03320057|54800905|FG000|Overall Study|Did not take mifepristone or misoprostol|2|||
28136517|NCT03320057|54800906|FG001|Overall Study|Did not take mifepristone or misoprostol|0|||
28136518|NCT03316547|54800914|FG000|Overall Study|Death|3|||
28136519|NCT03316547|54800915|FG001|Overall Study|Death|1|||
28136520|NCT03316547|54800914|FG000|Overall Study|Lost to Follow-up|6|||
28136521|NCT03316547|54800915|FG001|Overall Study|Lost to Follow-up|6|||
28136522|NCT03316547|54800914|FG000|Overall Study|Withdrawal by Subject|3|||
28136523|NCT03316547|54800915|FG001|Overall Study|Withdrawal by Subject|2|||
28136524|NCT03316547|54800914|FG000|Overall Study|Transfer to another hospital|6|||
27941029|NCT01020123|54597354|FG004|Main Period|Lost to Follow-up|0|||
28136525|NCT03316547|54800915|FG001|Overall Study|Transfer to another hospital|4|||
28136526|NCT02227199|54800939|FG000|Overall Study|Physician Decision|0|||
28136527|NCT02227199|54800940|FG001|Overall Study|Physician Decision|0|||
28136528|NCT02227199|54800941|FG002|Overall Study|Physician Decision|1|||
28136529|NCT02227199|54800939|FG000|Overall Study|Adverse Event|0|||
28136530|NCT02227199|54800940|FG001|Overall Study|Adverse Event|0|||
28136531|NCT02227199|54800941|FG002|Overall Study|Adverse Event|3|||
28136532|NCT03315689|54800955|FG000|Double-blind Period = 28 Days|Withdrawal by Subject|1|||
28136533|NCT03315689|54800956|FG001|Double-blind Period = 28 Days|Withdrawal by Subject|0|||
28136534|NCT03315689|54800955|FG000|Open Label Extension = 52 Weeks|Withdrawal by Subject|0|||
28136535|NCT03315689|54800956|FG001|Open Label Extension = 52 Weeks|Withdrawal by Subject|2|||
28136536|NCT03315689|54800955|FG000|Open Label Extension = 52 Weeks|Lost to Follow-up|0|||
28136537|NCT03315689|54800956|FG001|Open Label Extension = 52 Weeks|Lost to Follow-up|1|||
28136538|NCT03314519|54800966|FG000|Overall Study|Protocol Violation|3|||
28136539|NCT03314519|54800967|FG001|Overall Study|Protocol Violation|2|||
28136540|NCT03313037|54800979|FG000|Overall Study|Protocol Violation|4|||
28136541|NCT03313037|54800980|FG001|Overall Study|Protocol Violation|1|||
28136542|NCT03313037|54800979|FG000|Overall Study|Other|1|||
28136543|NCT03313037|54800980|FG001|Overall Study|Other|1|||
28136544|NCT03313037|54800979|FG000|Overall Study|Withdrawal by Subject|4|||
28136545|NCT03313037|54800980|FG001|Overall Study|Withdrawal by Subject|3|||
28136546|NCT03313037|54800979|FG000|Overall Study|No longer meets eligibility criteria|1|||
28136547|NCT03313037|54800980|FG001|Overall Study|No longer meets eligibility criteria|7|||
28136548|NCT03313037|54800979|FG000|Overall Study|Lost to Follow-up|9|||
28136549|NCT03313037|54800980|FG001|Overall Study|Lost to Follow-up|8|||
28136550|NCT03313037|54800979|FG000|Overall Study|Randomized but not treated|1|||
28136551|NCT03313037|54800980|FG001|Overall Study|Randomized but not treated|0|||
28136552|NCT02420795|54800989|FG000|Overall Study|Withdrawal by Subject|1|||
28136553|NCT02420795|54800990|FG001|Overall Study|Withdrawal by Subject|0|||
28136554|NCT02420795|54800991|FG002|Overall Study|Withdrawal by Subject|0|||
28136555|NCT02420795|54800989|FG000|Overall Study|Adverse Event|1|||
28136556|NCT02420795|54800990|FG001|Overall Study|Adverse Event|0|||
28136557|NCT02420795|54800991|FG002|Overall Study|Adverse Event|0|||
28136558|NCT02420795|54800989|FG000|Overall Study|Progressive disease|2|||
28136559|NCT02420795|54800990|FG001|Overall Study|Progressive disease|2|||
28136560|NCT02420795|54800991|FG002|Overall Study|Progressive disease|4|||
28136561|NCT02420795|54800989|FG000|Overall Study|Death|0|||
28136562|NCT02420795|54800990|FG001|Overall Study|Death|0|||
28136563|NCT02420795|54800991|FG002|Overall Study|Death|1|||
28136564|NCT03334175|54801003|FG000|Overall Study|Lost to Follow-up|0|||
28136565|NCT03334175|54801004|FG001|Overall Study|Lost to Follow-up|1|||
28136566|NCT03333941|54801010|FG000|Overall Study|Lost to Follow-up|10|||
28136567|NCT03333941|54801010|FG000|Overall Study|Death|2|||
27821041|NCT01725308|54283004|FG002|Treatment Period I|Did Not Receive Drug|0|||
27821042|NCT01725308|54283002|FG000|Treatment Period I|Adverse Event|5|||
27821043|NCT01725308|54283003|FG001|Treatment Period I|Adverse Event|4|||
27821044|NCT01725308|54283004|FG002|Treatment Period I|Adverse Event|21|||
28136568|NCT03333941|54801010|FG000|Overall Study|Adverse Event|1|||
28136569|NCT02942771|54801019|FG000|Overall Study|Adverse Event|1|||
28136570|NCT02942771|54801020|FG001|Overall Study|Adverse Event|0|||
28136571|NCT02942771|54801021|FG002|Overall Study|Adverse Event|0|||
28136572|NCT02942771|54801022|FG003|Overall Study|Adverse Event|0|||
28136573|NCT02942771|54801023|FG004|Overall Study|Adverse Event|2|||
28136574|NCT02942771|54801019|FG000|Overall Study|Lost to Follow-up|1|||
27821045|NCT01725308|54283002|FG000|Treatment Period I|Insufficient Response|7|||
28136575|NCT02942771|54801020|FG001|Overall Study|Lost to Follow-up|0|||
28136576|NCT02942771|54801021|FG002|Overall Study|Lost to Follow-up|0|||
28136577|NCT02942771|54801022|FG003|Overall Study|Lost to Follow-up|0|||
28136578|NCT02942771|54801023|FG004|Overall Study|Lost to Follow-up|0|||
28136579|NCT02942771|54801019|FG000|Overall Study|Withdrawal by Subject|1|||
28136580|NCT02942771|54801020|FG001|Overall Study|Withdrawal by Subject|0|||
28136581|NCT02942771|54801021|FG002|Overall Study|Withdrawal by Subject|0|||
28136582|NCT02942771|54801022|FG003|Overall Study|Withdrawal by Subject|0|||
28136583|NCT02942771|54801023|FG004|Overall Study|Withdrawal by Subject|2|||
28136584|NCT03036150|54801037|FG000|Overall Study|Withdrawal by Subject|8|||
28136585|NCT03036150|54801038|FG001|Overall Study|Withdrawal by Subject|3|||
28136586|NCT03036150|54801037|FG000|Overall Study|Lost to Follow-up|2|||
28136587|NCT03036150|54801038|FG001|Overall Study|Lost to Follow-up|2|||
28136588|NCT03332771|54801048|FG000|Overall Study|Adverse Event|6|||
28136589|NCT03332771|54801049|FG001|Overall Study|Adverse Event|4|||
27821046|NCT01725308|54283003|FG001|Treatment Period I|Insufficient Response|0|||
28136590|NCT03332771|54801050|FG002|Overall Study|Adverse Event|1|||
28136591|NCT03332771|54801051|FG003|Overall Study|Adverse Event|3|||
27821047|NCT01725308|54283004|FG002|Treatment Period I|Insufficient Response|5|||
27821048|NCT01725308|54283002|FG000|Treatment Period I|Worsening of the Target Disease|8|||
27821049|NCT01725308|54283003|FG001|Treatment Period I|Worsening of the Target Disease|0|||
28136592|NCT03332771|54801048|FG000|Overall Study|Poor Compliance to Protocol|0|||
28136593|NCT03332771|54801049|FG001|Overall Study|Poor Compliance to Protocol|1|||
28136594|NCT03332771|54801050|FG002|Overall Study|Poor Compliance to Protocol|0|||
28136595|NCT03332771|54801051|FG003|Overall Study|Poor Compliance to Protocol|1|||
28136596|NCT03332771|54801048|FG000|Overall Study|Lost to Follow-up|2|||
28136597|NCT03332771|54801049|FG001|Overall Study|Lost to Follow-up|2|||
28136598|NCT03332771|54801050|FG002|Overall Study|Lost to Follow-up|1|||
28136599|NCT03332771|54801051|FG003|Overall Study|Lost to Follow-up|2|||
28136600|NCT03332771|54801048|FG000|Overall Study|At the Participant's own request|20|||
28136601|NCT03332771|54801049|FG001|Overall Study|At the Participant's own request|26|||
28136602|NCT03332771|54801050|FG002|Overall Study|At the Participant's own request|14|||
28136603|NCT03332771|54801051|FG003|Overall Study|At the Participant's own request|23|||
28136604|NCT03332771|54801048|FG000|Overall Study|Reason Not Specified|6|||
28136605|NCT03332771|54801049|FG001|Overall Study|Reason Not Specified|18|||
28136606|NCT03332771|54801050|FG002|Overall Study|Reason Not Specified|16|||
28136607|NCT03332771|54801051|FG003|Overall Study|Reason Not Specified|19|||
28136608|NCT03310775|54801063|FG000|Overall Study|Lost to Follow-up|2|||
28136609|NCT03310775|54801064|FG001|Overall Study|Lost to Follow-up|3|||
28136610|NCT03310775|54801063|FG000|Overall Study|aggravation of depression|0|||
28136611|NCT03310775|54801064|FG001|Overall Study|aggravation of depression|1|||
28136612|NCT03330119|54801076|FG000|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|166|||
28136613|NCT03330119|54801077|FG001|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|282|||
28136614|NCT03040986|54801085|FG000|Overall Study|Hospice|1|||
28136615|NCT03040986|54801086|FG001|Overall Study|Hospice|0|||
28136616|NCT03040986|54801085|FG000|Overall Study|Adverse Event|2|||
28136617|NCT03040986|54801086|FG001|Overall Study|Adverse Event|1|||
28136618|NCT03040986|54801085|FG000|Overall Study|Disease progression on study|3|||
28136619|NCT03040986|54801086|FG001|Overall Study|Disease progression on study|1|||
28136620|NCT03039192|54801096|FG000|Overall Study|Lost to Follow-up|4|||
28136621|NCT03039192|54801097|FG001|Overall Study|Lost to Follow-up|4|||
28136622|NCT03039192|54801096|FG000|Overall Study|Adverse event, serious fatal|0|||
28136623|NCT03039192|54801097|FG001|Overall Study|Adverse event, serious fatal|1|||
28136624|NCT03039192|54801096|FG000|Overall Study|Adverse event, non-fatal|0|||
28136625|NCT03039192|54801097|FG001|Overall Study|Adverse event, non-fatal|2|||
28136626|NCT03039192|54801096|FG000|Overall Study|Withdrawal by Subject|6|||
28136627|NCT03039192|54801097|FG001|Overall Study|Withdrawal by Subject|9|||
28136628|NCT03039192|54801096|FG000|Overall Study|Discontinued from treatment phase|19|||
28136629|NCT03039192|54801097|FG001|Overall Study|Discontinued from treatment phase|12|||
28136630|NCT03039192|54801096|FG000|Overall Study|Other|3|||
28136631|NCT03039192|54801097|FG001|Overall Study|Other|2|||
28136632|NCT03698279|54801109|FG000|Overall Study|Withdrawal by parent/guardian|1|||
28136633|NCT03698279|54801110|FG001|Overall Study|Withdrawal by parent/guardian|1|||
28136634|NCT03698279|54801111|FG002|Overall Study|Withdrawal by parent/guardian|1|||
28136635|NCT03698279|54801112|FG003|Overall Study|Withdrawal by parent/guardian|1|||
28136636|NCT03698279|54801113|FG004|Overall Study|Withdrawal by parent/guardian|0|||
28136637|NCT03698279|54801114|FG005|Overall Study|Withdrawal by parent/guardian|0|||
28136638|NCT03698279|54801109|FG000|Overall Study|Protocol deviation|1|||
28136639|NCT03698279|54801110|FG001|Overall Study|Protocol deviation|0|||
28136640|NCT03698279|54801111|FG002|Overall Study|Protocol deviation|1|||
28136641|NCT03698279|54801112|FG003|Overall Study|Protocol deviation|0|||
28136642|NCT03698279|54801113|FG004|Overall Study|Protocol deviation|0|||
28136643|NCT03698279|54801114|FG005|Overall Study|Protocol deviation|0|||
28136644|NCT03698279|54801109|FG000|Overall Study|Withdrawal by Subject|0|||
28136645|NCT03698279|54801110|FG001|Overall Study|Withdrawal by Subject|0|||
28136646|NCT03698279|54801111|FG002|Overall Study|Withdrawal by Subject|1|||
28136647|NCT03698279|54801112|FG003|Overall Study|Withdrawal by Subject|0|||
28136648|NCT03698279|54801113|FG004|Overall Study|Withdrawal by Subject|0|||
28136649|NCT03698279|54801114|FG005|Overall Study|Withdrawal by Subject|0|||
28136650|NCT03698279|54801109|FG000|Overall Study|Lost to Follow-up|3|||
28136651|NCT03698279|54801110|FG001|Overall Study|Lost to Follow-up|1|||
28136652|NCT03698279|54801111|FG002|Overall Study|Lost to Follow-up|4|||
28136653|NCT03698279|54801112|FG003|Overall Study|Lost to Follow-up|5|||
28136654|NCT03698279|54801113|FG004|Overall Study|Lost to Follow-up|0|||
28136655|NCT03698279|54801114|FG005|Overall Study|Lost to Follow-up|0|||
28136656|NCT01529034|54801133|FG000|Overall Study|Discontinued prior to study treatment|14|||
28136657|NCT01529034|54801133|FG000|Overall Study|Site closure|62|||
28136658|NCT01529034|54801133|FG000|Overall Study|Study termination|29|||
28136659|NCT01529034|54801133|FG000|Overall Study|Withdrawal by Subject|25|||
27941030|NCT01020123|54597355|FG005|Main Period|Lost to Follow-up|0|||
28136660|NCT01529034|54801133|FG000|Overall Study|No treated SCs within protocol window|13|||
28136661|NCT01529034|54801133|FG000|Overall Study|Noncompliance|8|||
28136662|NCT01529034|54801133|FG000|Overall Study|Caregiver no longer available|7|||
28136663|NCT01529034|54801133|FG000|Overall Study|Adverse Event|4|||
28136664|NCT01529034|54801133|FG000|Overall Study|Protocol Violation|4|||
28136665|NCT01529034|54801133|FG000|Overall Study|Lack of Efficacy|4|||
28136666|NCT01529034|54801133|FG000|Overall Study|Investigator no longer available|2|||
28136667|NCT01529034|54801133|FG000|Overall Study|Study drug not available|2|||
27821050|NCT01725308|54283004|FG002|Treatment Period I|Worsening of the Target Disease|2|||
27821051|NCT01725308|54283002|FG000|Treatment Period I|Changes in the Episodes|3|||
27821052|NCT01725308|54283003|FG001|Treatment Period I|Changes in the Episodes|0|||
27821053|NCT01725308|54283004|FG002|Treatment Period I|Changes in the Episodes|2|||
27821054|NCT01725308|54283002|FG000|Treatment Period I|Withdrawal of Consent|12|||
27821055|NCT01725308|54283003|FG001|Treatment Period I|Withdrawal of Consent|7|||
27821056|NCT01725308|54283004|FG002|Treatment Period I|Withdrawal of Consent|5|||
27821057|NCT01725308|54283002|FG000|Treatment Period I|Lost to Follow-up|3|||
27821058|NCT01725308|54283003|FG001|Treatment Period I|Lost to Follow-up|2|||
27821059|NCT01725308|54283004|FG002|Treatment Period I|Lost to Follow-up|2|||
27821060|NCT01725308|54283002|FG000|Treatment Period I|Protocol Deviations|3|||
27821061|NCT01725308|54283003|FG001|Treatment Period I|Protocol Deviations|1|||
27821062|NCT01725308|54283004|FG002|Treatment Period I|Protocol Deviations|1|||
27821063|NCT01725308|54283002|FG000|Treatment Period I|Miscellaneous|2|||
27821064|NCT01725308|54283003|FG001|Treatment Period I|Miscellaneous|0|||
27821065|NCT01725308|54283004|FG002|Treatment Period I|Miscellaneous|3|||
28136668|NCT03036072|54801140|FG000|Overall Study|Death|0|||
28136669|NCT03036072|54801141|FG001|Overall Study|Death|1|||
28136670|NCT03036072|54801140|FG000|Overall Study|Withdrawal by Subject|0|||
28136671|NCT03036072|54801141|FG001|Overall Study|Withdrawal by Subject|1|||
28136672|NCT03036072|54801140|FG000|Overall Study|Physician Decision|0|||
28136673|NCT03036072|54801141|FG001|Overall Study|Physician Decision|1|||
28136674|NCT03038880|54801150|FG000|Overall Study|Death|1|||
28136675|NCT03038880|54801151|FG001|Overall Study|Death|2|||
28136676|NCT03038880|54801152|FG002|Overall Study|Death|0|||
28136677|NCT03038880|54801150|FG000|Overall Study|Physician Decision|2|||
28136678|NCT03038880|54801151|FG001|Overall Study|Physician Decision|1|||
28136679|NCT03038880|54801152|FG002|Overall Study|Physician Decision|0|||
28136680|NCT03035916|54801163|FG000|Overall Study|Puncture failed|0|||
28136681|NCT03035916|54801164|FG001|Overall Study|Puncture failed|2|||
28136682|NCT03035916|54801165|FG002|Overall Study|Puncture failed|0|||
28136683|NCT01702571|54801175|FG000|Overall Study|Death|1067|||
28136684|NCT01702571|54801176|FG001|Overall Study|Death|76|||
28136685|NCT01702571|54801175|FG000|Overall Study|Lost to Follow-up|144|||
28136686|NCT01702571|54801176|FG001|Overall Study|Lost to Follow-up|10|||
28136687|NCT01702571|54801175|FG000|Overall Study|Adverse Event/Unacceptable Toxicity|4|||
28136688|NCT01702571|54801176|FG001|Overall Study|Adverse Event/Unacceptable Toxicity|0|||
28136689|NCT01702571|54801175|FG000|Overall Study|Investigator Decision|5|||
28136690|NCT01702571|54801176|FG001|Overall Study|Investigator Decision|0|||
28136691|NCT01702571|54801175|FG000|Overall Study|Not Classifiable|1|||
28136692|NCT01702571|54801176|FG001|Overall Study|Not Classifiable|0|||
28136693|NCT01702571|54801175|FG000|Overall Study|On Study Treatment At Lplv/Cohort 1|93|||
28136694|NCT01702571|54801176|FG001|Overall Study|On Study Treatment At Lplv/Cohort 1|0|||
28136695|NCT01702571|54801175|FG000|Overall Study|On Study Treatment At Lplv/Cohort 2|0|||
28136696|NCT01702571|54801176|FG001|Overall Study|On Study Treatment At Lplv/Cohort 2|1|||
28136697|NCT01702571|54801175|FG000|Overall Study|Progressive Disease|3|||
28136698|NCT01702571|54801176|FG001|Overall Study|Progressive Disease|0|||
28136699|NCT01702571|54801175|FG000|Overall Study|Protocol Violation|2|||
28136700|NCT01702571|54801176|FG001|Overall Study|Protocol Violation|0|||
28136701|NCT01702571|54801175|FG000|Overall Study|Safety FU Done < 3 Months Prior To CCOD|9|||
28136702|NCT01702571|54801176|FG001|Overall Study|Safety FU Done < 3 Months Prior To CCOD|1|||
28136703|NCT01702571|54801175|FG000|Overall Study|Termination By Sponsor|4|||
28136704|NCT01702571|54801176|FG001|Overall Study|Termination By Sponsor|0|||
28136705|NCT01702571|54801175|FG000|Overall Study|Withdrawal by Subject|177|||
28136706|NCT01702571|54801176|FG001|Overall Study|Withdrawal by Subject|29|||
28136707|NCT03231943|54801199|FG000|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
28136708|NCT03231943|54801200|FG001|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
27821066|NCT01725308|54283002|FG000|Treatment Period II|Did Not Meet Transition Criteria|0|||
27821067|NCT01725308|54283003|FG001|Treatment Period II|Did Not Meet Transition Criteria|3|||
27821068|NCT01725308|54283004|FG002|Treatment Period II|Did Not Meet Transition Criteria|4|||
28069900|NCT00436163|54724930|FG000|Overall Study|Lost to Follow-up|2|||
28069901|NCT00436163|54724930|FG000|Overall Study|Adverse Event|1|||
28069902|NCT00006604|54724942|FG000|Overall Study|Met study objective - no further FU|1|||
28069903|NCT00006604|54724943|FG001|Overall Study|Met study objective - no further FU|0|||
28069904|NCT00006604|54724944|FG002|Overall Study|Met study objective - no further FU|0|||
28069905|NCT00006604|54724945|FG003|Overall Study|Met study objective - no further FU|0|||
28069906|NCT00006604|54724946|FG004|Overall Study|Met study objective - no further FU|0|||
28069907|NCT00006604|54724947|FG005|Overall Study|Met study objective - no further FU|0|||
28136709|NCT03231943|54801201|FG002|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
28136710|NCT03231943|54801202|FG003|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
28136711|NCT03231943|54801203|FG004|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
28136712|NCT03231943|54801204|FG005|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
28136713|NCT03231943|54801205|FG006|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
27821069|NCT01725308|54283002|FG000|Treatment Period II|Did Not Receive Drug|4|||
27821070|NCT01725308|54283003|FG001|Treatment Period II|Did Not Receive Drug|0|||
28136714|NCT03231943|54801206|FG007|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
28136715|NCT03231943|54801207|FG008|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
28136716|NCT03231943|54801208|FG009|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
28136717|NCT03231943|54801209|FG010|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
28136718|NCT03231943|54801210|FG011|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
28136719|NCT03231943|54801211|FG012|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
28136720|NCT03231943|54801199|FG000|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
28136721|NCT03231943|54801200|FG001|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1|||
28136722|NCT03231943|54801201|FG002|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
28136723|NCT03231943|54801202|FG003|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
28136724|NCT03231943|54801203|FG004|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
28136725|NCT03231943|54801204|FG005|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
28136726|NCT03231943|54801205|FG006|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
28136727|NCT03231943|54801206|FG007|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
28136728|NCT03231943|54801207|FG008|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
28136729|NCT03231943|54801208|FG009|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
28136730|NCT03231943|54801209|FG010|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
28136731|NCT03231943|54801210|FG011|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
28136732|NCT03231943|54801211|FG012|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
28136733|NCT03231943|54801199|FG000|Part 1, Period 3 (up to Day 45)|Adverse Event|1|||
28136734|NCT03231943|54801200|FG001|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
28136735|NCT03231943|54801201|FG002|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
28136736|NCT03231943|54801202|FG003|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
28136737|NCT03231943|54801203|FG004|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
28136738|NCT03231943|54801204|FG005|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
28136739|NCT03231943|54801205|FG006|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
28136740|NCT03231943|54801206|FG007|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
27941031|NCT01020123|54597356|FG006|Main Period|Lost to Follow-up|0|||
27941032|NCT01020123|54597350|FG000|Main Period|Unclasified|2|||
28136741|NCT03231943|54801207|FG008|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
28136742|NCT03231943|54801208|FG009|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
28136743|NCT03231943|54801209|FG010|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
28136744|NCT03231943|54801210|FG011|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
28136745|NCT03231943|54801211|FG012|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
28136746|NCT03231943|54801199|FG000|Part 2|Adverse Event|0|||
28136747|NCT03231943|54801200|FG001|Part 2|Adverse Event|0|||
28136748|NCT03231943|54801201|FG002|Part 2|Adverse Event|0|||
28136749|NCT03231943|54801202|FG003|Part 2|Adverse Event|0|||
28136750|NCT03231943|54801203|FG004|Part 2|Adverse Event|0|||
28136751|NCT03231943|54801204|FG005|Part 2|Adverse Event|0|||
28136752|NCT03231943|54801205|FG006|Part 2|Adverse Event|0|||
28136753|NCT03231943|54801206|FG007|Part 2|Adverse Event|0|||
28136754|NCT03231943|54801207|FG008|Part 2|Adverse Event|0|||
28136755|NCT03231943|54801208|FG009|Part 2|Adverse Event|0|||
28136756|NCT03231943|54801209|FG010|Part 2|Adverse Event|1|||
28136757|NCT03231943|54801210|FG011|Part 2|Adverse Event|0|||
28136758|NCT03231943|54801211|FG012|Part 2|Adverse Event|0|||
28136759|NCT03231943|54801199|FG000|Part 2|Withdrawal by Subject|0|||
28136760|NCT03231943|54801200|FG001|Part 2|Withdrawal by Subject|0|||
28136761|NCT03231943|54801201|FG002|Part 2|Withdrawal by Subject|0|||
28136762|NCT03231943|54801202|FG003|Part 2|Withdrawal by Subject|0|||
28136763|NCT03231943|54801203|FG004|Part 2|Withdrawal by Subject|0|||
28136764|NCT03231943|54801204|FG005|Part 2|Withdrawal by Subject|0|||
28136765|NCT03231943|54801205|FG006|Part 2|Withdrawal by Subject|0|||
28136766|NCT03231943|54801206|FG007|Part 2|Withdrawal by Subject|0|||
28136767|NCT03231943|54801207|FG008|Part 2|Withdrawal by Subject|0|||
28136768|NCT03231943|54801208|FG009|Part 2|Withdrawal by Subject|0|||
28136769|NCT03231943|54801209|FG010|Part 2|Withdrawal by Subject|0|||
28136770|NCT03231943|54801210|FG011|Part 2|Withdrawal by Subject|1|||
28136771|NCT03231943|54801211|FG012|Part 2|Withdrawal by Subject|0|||
28136772|NCT01578239|54801243|FG000|Treatment Period|Progressive Disease|19|||
28136773|NCT01578239|54801244|FG001|Treatment Period|Progressive Disease|64|||
28136774|NCT01578239|54801243|FG000|Treatment Period|Physician Decision|17|||
28136775|NCT01578239|54801244|FG001|Treatment Period|Physician Decision|17|||
28136776|NCT01578239|54801243|FG000|Treatment Period|Adverse Event|13|||
28136777|NCT01578239|54801244|FG001|Treatment Period|Adverse Event|10|||
27821071|NCT01725308|54283004|FG002|Treatment Period II|Did Not Receive Drug|0|||
27821072|NCT01725308|54283002|FG000|Treatment Period II|Adverse Event|13|||
27821073|NCT01725308|54283003|FG001|Treatment Period II|Adverse Event|8|||
27821074|NCT01725308|54283004|FG002|Treatment Period II|Adverse Event|20|||
27821075|NCT01725308|54283002|FG000|Treatment Period II|Insufficient Response|2|||
27941033|NCT01020123|54597351|FG001|Main Period|Unclasified|0|||
27941034|NCT01020123|54597352|FG002|Main Period|Unclasified|1|||
27821076|NCT01725308|54283003|FG001|Treatment Period II|Insufficient Response|4|||
27821077|NCT01725308|54283004|FG002|Treatment Period II|Insufficient Response|6|||
27821078|NCT01725308|54283002|FG000|Treatment Period II|Worsening of the Target Disease|1|||
27821079|NCT01725308|54283003|FG001|Treatment Period II|Worsening of the Target Disease|4|||
27821080|NCT01725308|54283004|FG002|Treatment Period II|Worsening of the Target Disease|2|||
27821081|NCT01725308|54283002|FG000|Treatment Period II|Changes in the Episodes|1|||
27821082|NCT01725308|54283003|FG001|Treatment Period II|Changes in the Episodes|0|||
27821083|NCT01725308|54283004|FG002|Treatment Period II|Changes in the Episodes|5|||
27821084|NCT01725308|54283002|FG000|Treatment Period II|Withdrawal of Consent|28|||
27821085|NCT01725308|54283003|FG001|Treatment Period II|Withdrawal of Consent|2|||
27821086|NCT01725308|54283004|FG002|Treatment Period II|Withdrawal of Consent|16|||
27821087|NCT01725308|54283002|FG000|Treatment Period II|Lost to Follow-up|1|||
27821088|NCT01725308|54283003|FG001|Treatment Period II|Lost to Follow-up|5|||
27821089|NCT01725308|54283004|FG002|Treatment Period II|Lost to Follow-up|3|||
28136778|NCT01578239|54801243|FG000|Treatment Period|Non-compliance|2|||
28136779|NCT01578239|54801244|FG001|Treatment Period|Non-compliance|0|||
28136780|NCT01578239|54801243|FG000|Treatment Period|Withdrawal by Subject|10|||
28136781|NCT01578239|54801244|FG001|Treatment Period|Withdrawal by Subject|9|||
28136782|NCT01578239|54801243|FG000|Treatment Period|Other|6|||
28136783|NCT01578239|54801244|FG001|Treatment Period|Other|1|||
28136784|NCT01578239|54801243|FG000|Long-term Follow-Up Period|Death|69|||
28136785|NCT01578239|54801244|FG001|Long-term Follow-Up Period|Death|64|||
28136786|NCT01578239|54801243|FG000|Long-term Follow-Up Period|Consent withdrawal|4|||
28136787|NCT01578239|54801244|FG001|Long-term Follow-Up Period|Consent withdrawal|10|||
28136788|NCT01578239|54801243|FG000|Long-term Follow-Up Period|Lost to Follow-up|2|||
28136789|NCT01578239|54801244|FG001|Long-term Follow-Up Period|Lost to Follow-up|4|||
28136790|NCT01578239|54801243|FG000|Long-term Follow-Up Period|Other|2|||
28136791|NCT01578239|54801244|FG001|Long-term Follow-Up Period|Other|2|||
28136792|NCT03231709|54801252|FG000|Treatment Period 1|Reason not Specified|0|||
28136793|NCT03231709|54801253|FG001|Treatment Period 1|Reason not Specified|1|||
28136794|NCT03231709|54801252|FG000|Treatment Period 2|Pretreatment Event/Adverse Event|0|||
28136795|NCT03231709|54801253|FG001|Treatment Period 2|Pretreatment Event/Adverse Event|1|||
28136796|NCT03241927|54801263|FG000|Overall Study|study terminated|1|||
28136797|NCT03241927|54801264|FG001|Overall Study|study terminated|0|||
28136798|NCT03329885|54801276|FG000|Overall Study|Sponsor discontinued the study early|0|||
28136799|NCT03329885|54801277|FG001|Overall Study|Sponsor discontinued the study early|0|||
28136800|NCT03329885|54801278|FG002|Overall Study|Sponsor discontinued the study early|0|||
28136801|NCT03329885|54801279|FG003|Overall Study|Sponsor discontinued the study early|0|||
28136802|NCT03329885|54801280|FG004|Overall Study|Sponsor discontinued the study early|0|||
28136803|NCT03329885|54801281|FG005|Overall Study|Sponsor discontinued the study early|0|||
28136804|NCT03329885|54801282|FG006|Overall Study|Sponsor discontinued the study early|1|||
28136805|NCT03329885|54801283|FG007|Overall Study|Sponsor discontinued the study early|1|||
28136806|NCT03329885|54801284|FG008|Overall Study|Sponsor discontinued the study early|0|||
28136807|NCT02941523|54801306|FG000|Monotherapy|Withdrawal by Subject|0|||
28136808|NCT02941523|54801307|FG001|Monotherapy|Withdrawal by Subject|1|||
28136809|NCT02941523|54801306|FG000|Carboplatin Combination Therapy|Adverse Event|0|||
28136810|NCT02941523|54801307|FG001|Carboplatin Combination Therapy|Adverse Event|1|||
28136811|NCT02941523|54801306|FG000|Carboplatin Combination Therapy|Death|1|||
28136812|NCT02941523|54801307|FG001|Carboplatin Combination Therapy|Death|2|||
28136813|NCT02941523|54801306|FG000|Carboplatin Combination Therapy|Disease progression|2|||
28136814|NCT02941523|54801307|FG001|Carboplatin Combination Therapy|Disease progression|0|||
28136815|NCT02941523|54801306|FG000|Carboplatin Combination Therapy|Withdrawal by Subject|2|||
28136816|NCT02941523|54801307|FG001|Carboplatin Combination Therapy|Withdrawal by Subject|1|||
27821090|NCT01725308|54283002|FG000|Treatment Period II|Protocol Deviations|0|||
27821091|NCT01725308|54283003|FG001|Treatment Period II|Protocol Deviations|0|||
27821092|NCT01725308|54283004|FG002|Treatment Period II|Protocol Deviations|1|||
28136817|NCT02938585|54801325|FG000|Overall Study|Withdrawal by parent or guardian|0|||
28136818|NCT02938585|54801326|FG001|Overall Study|Withdrawal by parent or guardian|1|||
28136819|NCT02938585|54801327|FG002|Overall Study|Withdrawal by parent or guardian|0|||
28136820|NCT02938585|54801328|FG003|Overall Study|Withdrawal by parent or guardian|0|||
27821093|NCT01725308|54283002|FG000|Treatment Period II|Miscellaneous|5|||
28136821|NCT02938585|54801325|FG000|Overall Study|Withdrawal by Subject|0|||
28136822|NCT02938585|54801326|FG001|Overall Study|Withdrawal by Subject|0|||
27821094|NCT01725308|54283003|FG001|Treatment Period II|Miscellaneous|3|||
27821095|NCT01725308|54283004|FG002|Treatment Period II|Miscellaneous|7|||
27821096|NCT01724528|54283021|FG000|Overall Study|Death|3|||
27821097|NCT01724528|54283022|FG001|Overall Study|Death|0|||
28136823|NCT02938585|54801327|FG002|Overall Study|Withdrawal by Subject|0|||
27821098|NCT01724528|54283021|FG000|Overall Study|Withdrawal by Subject|0|||
28136824|NCT02938585|54801328|FG003|Overall Study|Withdrawal by Subject|5|||
28136825|NCT03229759|54801352|FG000|Overall Study|Screen Failure|30|||
28136826|NCT03228433|54801364|FG000|Overall Study|Lost to Follow-up|1|||
28136827|NCT03228433|54801365|FG001|Overall Study|Lost to Follow-up|0|||
28136828|NCT03228433|54801366|FG002|Overall Study|Lost to Follow-up|0|||
28136829|NCT03228433|54801367|FG003|Overall Study|Lost to Follow-up|0|||
28136830|NCT03228433|54801368|FG004|Overall Study|Lost to Follow-up|0|||
28136831|NCT03228433|54801369|FG005|Overall Study|Lost to Follow-up|0|||
27821099|NCT01724528|54283022|FG001|Overall Study|Withdrawal by Subject|2|||
27821100|NCT01724528|54283021|FG000|Overall Study|Protocol Violation|0|||
27821101|NCT01724528|54283022|FG001|Overall Study|Protocol Violation|1|||
27821102|NCT01724528|54283021|FG000|Overall Study|Patient refused to attend last visit|1|||
27821103|NCT01724528|54283022|FG001|Overall Study|Patient refused to attend last visit|0|||
27821104|NCT01779440|54283030|FG000|Overall Study|Withdrawal by Subject|3|||
27821105|NCT01779440|54283031|FG001|Overall Study|Withdrawal by Subject|5|||
27821106|NCT01750346|54283040|FG000|Overall Study|Adverse Event|1|||
27821107|NCT01750346|54283041|FG001|Overall Study|Adverse Event|0|||
27821108|NCT01750346|54283042|FG002|Overall Study|Adverse Event|0|||
28136832|NCT03228433|54801364|FG000|Overall Study|Positive alcohol test|0|||
28136833|NCT03228433|54801365|FG001|Overall Study|Positive alcohol test|0|||
28136834|NCT03228433|54801366|FG002|Overall Study|Positive alcohol test|0|||
28136835|NCT03228433|54801367|FG003|Overall Study|Positive alcohol test|1|||
28136836|NCT03228433|54801368|FG004|Overall Study|Positive alcohol test|0|||
27821109|NCT01750268|54283052|FG000|Overall Study|Lost to Follow-up|0|||
27821110|NCT01750268|54283053|FG001|Overall Study|Lost to Follow-up|2|||
27821111|NCT01750268|54283052|FG000|Overall Study|Physician Decision|0|||
27821112|NCT01750268|54283053|FG001|Overall Study|Physician Decision|3|||
27821113|NCT01750268|54283052|FG000|Overall Study|Withdrawal by Subject|2|||
27821114|NCT01750268|54283053|FG001|Overall Study|Withdrawal by Subject|0|||
27821115|NCT01880437|54283062|FG000|Overall Study|Death|12|||
27821116|NCT01880437|54283063|FG001|Overall Study|Death|4|||
27821117|NCT01880437|54283064|FG002|Overall Study|Death|17|||
28069908|NCT00006604|54724948|FG006|Overall Study|Met study objective - no further FU|0|||
28069909|NCT00006604|54724949|FG007|Overall Study|Met study objective - no further FU|0|||
28069910|NCT00006604|54724950|FG008|Overall Study|Met study objective - no further FU|0|||
28069911|NCT00006604|54724951|FG009|Overall Study|Met study objective - no further FU|0|||
28069912|NCT00006604|54724952|FG010|Overall Study|Met study objective - no further FU|0|||
28069913|NCT00006604|54724953|FG011|Overall Study|Met study objective - no further FU|0|||
28069914|NCT00006604|54724954|FG012|Overall Study|Met study objective - no further FU|0|||
28069915|NCT00006604|54724955|FG013|Overall Study|Met study objective - no further FU|0|||
28069916|NCT00006604|54724956|FG014|Overall Study|Met study objective - no further FU|1|||
28136837|NCT03228433|54801369|FG005|Overall Study|Positive alcohol test|0|||
28136838|NCT01496118|54801399|FG000|Overall Study|Disease progression|3|||
27941035|NCT01020123|54597353|FG003|Main Period|Unclasified|0|||
28136839|NCT01496118|54801400|FG001|Overall Study|Disease progression|2|||
28136840|NCT01496118|54801401|FG002|Overall Study|Disease progression|3|||
28136841|NCT01496118|54801402|FG003|Overall Study|Disease progression|1|||
28136842|NCT01496118|54801403|FG004|Overall Study|Disease progression|2|||
28136843|NCT01496118|54801404|FG005|Overall Study|Disease progression|2|||
28136844|NCT01496118|54801405|FG006|Overall Study|Disease progression|14|||
28136845|NCT01496118|54801406|FG007|Overall Study|Disease progression|10|||
28136846|NCT01496118|54801399|FG000|Overall Study|Physician Decision|0|||
28136847|NCT01496118|54801400|FG001|Overall Study|Physician Decision|0|||
28136848|NCT01496118|54801401|FG002|Overall Study|Physician Decision|0|||
28136849|NCT01496118|54801402|FG003|Overall Study|Physician Decision|0|||
28136850|NCT01496118|54801403|FG004|Overall Study|Physician Decision|1|||
28136851|NCT01496118|54801404|FG005|Overall Study|Physician Decision|0|||
28136852|NCT01496118|54801405|FG006|Overall Study|Physician Decision|3|||
28136853|NCT01496118|54801406|FG007|Overall Study|Physician Decision|6|||
28136854|NCT01496118|54801399|FG000|Overall Study|Adverse Event|1|||
28136855|NCT01496118|54801400|FG001|Overall Study|Adverse Event|1|||
28136856|NCT01496118|54801401|FG002|Overall Study|Adverse Event|0|||
28136857|NCT01496118|54801402|FG003|Overall Study|Adverse Event|0|||
28136858|NCT01496118|54801403|FG004|Overall Study|Adverse Event|0|||
28136859|NCT01496118|54801404|FG005|Overall Study|Adverse Event|0|||
28136860|NCT01496118|54801405|FG006|Overall Study|Adverse Event|6|||
28136861|NCT01496118|54801406|FG007|Overall Study|Adverse Event|10|||
28136862|NCT01496118|54801399|FG000|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
28136863|NCT01496118|54801400|FG001|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
28136864|NCT01496118|54801401|FG002|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
28136865|NCT01496118|54801402|FG003|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
28136866|NCT01496118|54801403|FG004|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
28136867|NCT01496118|54801404|FG005|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
28136868|NCT01496118|54801405|FG006|Overall Study|Conditions requiring other treatment not permitted by protocol|1|||
28136869|NCT01496118|54801406|FG007|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
28136870|NCT01496118|54801399|FG000|Overall Study|Death|0|||
28136871|NCT01496118|54801400|FG001|Overall Study|Death|0|||
28136872|NCT01496118|54801401|FG002|Overall Study|Death|0|||
28136873|NCT01496118|54801402|FG003|Overall Study|Death|0|||
28136874|NCT01496118|54801403|FG004|Overall Study|Death|0|||
28136875|NCT01496118|54801404|FG005|Overall Study|Death|0|||
28136876|NCT01496118|54801405|FG006|Overall Study|Death|1|||
28136877|NCT01496118|54801406|FG007|Overall Study|Death|1|||
27821118|NCT01880437|54283062|FG000|Overall Study|Study terminated by Sponsor|3|||
28136878|NCT01496118|54801399|FG000|Overall Study|Withdrawal by Subject|0|||
28136879|NCT01496118|54801400|FG001|Overall Study|Withdrawal by Subject|0|||
28136880|NCT01496118|54801401|FG002|Overall Study|Withdrawal by Subject|0|||
28136881|NCT01496118|54801402|FG003|Overall Study|Withdrawal by Subject|2|||
28136882|NCT01496118|54801403|FG004|Overall Study|Withdrawal by Subject|0|||
28136883|NCT01496118|54801404|FG005|Overall Study|Withdrawal by Subject|1|||
28136884|NCT01496118|54801405|FG006|Overall Study|Withdrawal by Subject|6|||
28136885|NCT01496118|54801406|FG007|Overall Study|Withdrawal by Subject|3|||
28136886|NCT02936869|54801426|FG000|Overall Study|Lost to Follow-up|1|||
28136887|NCT02936869|54801427|FG001|Overall Study|Lost to Follow-up|3|||
28136888|NCT02936869|54801426|FG000|Overall Study|Death|0|||
28136889|NCT02936869|54801427|FG001|Overall Study|Death|1|||
28136890|NCT02936869|54801426|FG000|Overall Study|Legal Case|0|||
28136891|NCT02936869|54801427|FG001|Overall Study|Legal Case|1|||
28136892|NCT02936869|54801426|FG000|Overall Study|Protocol Violation|1|||
28136893|NCT02936869|54801427|FG001|Overall Study|Protocol Violation|0|||
28136894|NCT03309605|54801442|FG000|Overall Study|Adverse Event|0|||
28136895|NCT03309605|54801443|FG001|Overall Study|Adverse Event|0|||
28136896|NCT03309605|54801444|FG002|Overall Study|Adverse Event|0|||
28136897|NCT03309605|54801445|FG003|Overall Study|Adverse Event|1|||
28136898|NCT03309605|54801446|FG004|Overall Study|Adverse Event|0|||
28136899|NCT03309605|54801447|FG005|Overall Study|Adverse Event|0|||
28136900|NCT03309605|54801448|FG006|Overall Study|Adverse Event|2|||
27821119|NCT01880437|54283063|FG001|Overall Study|Study terminated by Sponsor|0|||
27821120|NCT01880437|54283064|FG002|Overall Study|Study terminated by Sponsor|2|||
27821121|NCT01861717|54283074|FG000|Overall Study|Lost to Follow-up|1|||
27821122|NCT01861717|54283074|FG000|Overall Study|Withdrawal by Subject|1|||
28136901|NCT03309605|54801449|FG007|Overall Study|Adverse Event|1|||
28136902|NCT03309605|54801442|FG000|Overall Study|Withdrawal by Subject|0|||
27821123|NCT01834729|54283083|FG000|Overall Study|Did not return bowel diaries|0|||
27821124|NCT01834729|54283084|FG001|Overall Study|Did not return bowel diaries|0|||
27821125|NCT01834729|54283085|FG002|Overall Study|Did not return bowel diaries|3|||
27821126|NCT01834729|54283086|FG003|Overall Study|Did not return bowel diaries|0|||
27821127|NCT01834729|54283083|FG000|Overall Study|Withdrawal by Subject|1|||
27821128|NCT01834729|54283084|FG001|Overall Study|Withdrawal by Subject|1|||
27821129|NCT01834729|54283085|FG002|Overall Study|Withdrawal by Subject|0|||
28136903|NCT03309605|54801443|FG001|Overall Study|Withdrawal by Subject|0|||
28136904|NCT03309605|54801444|FG002|Overall Study|Withdrawal by Subject|0|||
28136905|NCT03309605|54801445|FG003|Overall Study|Withdrawal by Subject|0|||
28136906|NCT03309605|54801446|FG004|Overall Study|Withdrawal by Subject|1|||
28136907|NCT03309605|54801447|FG005|Overall Study|Withdrawal by Subject|0|||
28136908|NCT03309605|54801448|FG006|Overall Study|Withdrawal by Subject|1|||
28136909|NCT03309605|54801449|FG007|Overall Study|Withdrawal by Subject|1|||
28136910|NCT02936635|54801465|FG000|Overall Study|Adverse Event|43|||
27821130|NCT01834729|54283086|FG003|Overall Study|Withdrawal by Subject|0|||
27821131|NCT01834729|54283083|FG000|Overall Study|Adverse Event|0|||
27821132|NCT01834729|54283084|FG001|Overall Study|Adverse Event|0|||
27821133|NCT01834729|54283085|FG002|Overall Study|Adverse Event|0|||
27821134|NCT01834729|54283086|FG003|Overall Study|Adverse Event|2|||
27821135|NCT01860703|54283097|FG000|Overall Study|Adverse Event|1|||
27821136|NCT01860703|54283098|FG001|Overall Study|Adverse Event|4|||
27821137|NCT01860703|54283099|FG002|Overall Study|Adverse Event|0|||
27821138|NCT01860703|54283100|FG003|Overall Study|Adverse Event|2|||
27821139|NCT01860703|54283097|FG000|Overall Study|Withdrawal by Subject|0|||
27821140|NCT01860703|54283098|FG001|Overall Study|Withdrawal by Subject|1|||
27821141|NCT01860703|54283099|FG002|Overall Study|Withdrawal by Subject|0|||
27821142|NCT01860703|54283100|FG003|Overall Study|Withdrawal by Subject|0|||
27821143|NCT01860703|54283097|FG000|Overall Study|Personal reason|1|||
27821144|NCT01860703|54283098|FG001|Overall Study|Personal reason|0|||
28136911|NCT02936635|54801466|FG001|Overall Study|Adverse Event|25|||
28136912|NCT02936635|54801465|FG000|Overall Study|Progressive Disease|10|||
28136913|NCT02936635|54801466|FG001|Overall Study|Progressive Disease|18|||
28136914|NCT02936635|54801465|FG000|Overall Study|Sponsor Discretion|10|||
27821145|NCT01860703|54283099|FG002|Overall Study|Personal reason|1|||
28136915|NCT02936635|54801466|FG001|Overall Study|Sponsor Discretion|16|||
28136916|NCT02936635|54801465|FG000|Overall Study|Death|9|||
28136917|NCT02936635|54801466|FG001|Overall Study|Death|15|||
28136918|NCT02936635|54801465|FG000|Overall Study|Withdrawal by Subject|8|||
28136919|NCT02936635|54801466|FG001|Overall Study|Withdrawal by Subject|15|||
27821146|NCT01860703|54283100|FG003|Overall Study|Personal reason|0|||
27821147|NCT01399593|54283118|FG000|Overall Study|Physician Decision|1|||
27821148|NCT01399593|54283119|FG001|Overall Study|Physician Decision|0|||
28136920|NCT02936635|54801465|FG000|Overall Study|Physician Decision|2|||
28136921|NCT02936635|54801466|FG001|Overall Study|Physician Decision|9|||
28136922|NCT02936635|54801465|FG000|Overall Study|Lost to Follow-up|1|||
27821149|NCT01399593|54283118|FG000|Overall Study|Adverse Event|1|||
27821150|NCT01399593|54283119|FG001|Overall Study|Adverse Event|0|||
27821151|NCT01399593|54283118|FG000|Overall Study|Death|1|||
27821152|NCT01399593|54283119|FG001|Overall Study|Death|1|||
27821153|NCT01399593|54283118|FG000|Overall Study|Transplantectomy|0|||
27821154|NCT01399593|54283119|FG001|Overall Study|Transplantectomy|1|||
27821155|NCT01833169|54283125|FG000|Overall Study|Disease Progression|99|||
27821156|NCT01833169|54283125|FG000|Overall Study|Adverse Event|33|||
27821157|NCT01833169|54283125|FG000|Overall Study|Withdrawal by Subject|9|||
27821158|NCT01833169|54283125|FG000|Overall Study|Death|3|||
27821159|NCT01833169|54283125|FG000|Overall Study|Physician Decision|2|||
27821160|NCT01860079|54283131|FG000|Overall Study|Physician Decision|14|||
27821161|NCT01860079|54283132|FG001|Overall Study|Physician Decision|22|||
27821162|NCT01388985|54283140|FG000|Overall Study|Death|0|||
27821163|NCT01388985|54283141|FG001|Overall Study|Death|1|||
27821164|NCT01388985|54283140|FG000|Overall Study|Lost to Follow-up|30|||
27821165|NCT01388985|54283141|FG001|Overall Study|Lost to Follow-up|30|||
27821166|NCT01388985|54283140|FG000|Overall Study|Withdrawal by Subject|13|||
27821167|NCT01388985|54283141|FG001|Overall Study|Withdrawal by Subject|4|||
27821168|NCT01388985|54283140|FG000|Overall Study|Subject unavailable|1|||
27821169|NCT01388985|54283141|FG001|Overall Study|Subject unavailable|1|||
27821170|NCT01388985|54283140|FG000|Overall Study|Other (no reason)|0|||
27821171|NCT01388985|54283141|FG001|Overall Study|Other (no reason)|1|||
28136923|NCT02936635|54801466|FG001|Overall Study|Lost to Follow-up|2|||
28136924|NCT02936635|54801465|FG000|Overall Study|Protocol Violation|1|||
28136925|NCT02936635|54801466|FG001|Overall Study|Protocol Violation|0|||
28136926|NCT02936635|54801465|FG000|Overall Study|Lack of effect/Entry into other study|31|||
28136927|NCT02936635|54801466|FG001|Overall Study|Lack of effect/Entry into other study|65|||
28136928|NCT03227029|54801475|FG000|Overall Study|Child Wheezed (no treatment)|0|||
27821172|NCT01388985|54283140|FG000|Overall Study|Error of nurse|5|||
27821173|NCT01388985|54283141|FG001|Overall Study|Error of nurse|1|||
27821174|NCT01388907|54283149|FG000|Overall Study|Adverse Event|2|||
27821175|NCT01388907|54283150|FG001|Overall Study|Adverse Event|0|||
28136929|NCT03227029|54801476|FG001|Overall Study|Child Wheezed (no treatment)|1|||
28136930|NCT03227029|54801477|FG002|Overall Study|Child Wheezed (no treatment)|0|||
28136931|NCT03227029|54801475|FG000|Overall Study|No post RSV season visit due to COVID|3|||
28136932|NCT03227029|54801476|FG001|Overall Study|No post RSV season visit due to COVID|3|||
28136933|NCT03227029|54801477|FG002|Overall Study|No post RSV season visit due to COVID|2|||
28136934|NCT03227029|54801475|FG000|Overall Study|Not able to get to clinic|0|||
28136935|NCT03227029|54801476|FG001|Overall Study|Not able to get to clinic|0|||
28136936|NCT03227029|54801477|FG002|Overall Study|Not able to get to clinic|1|||
28136937|NCT03227029|54801475|FG000|Overall Study|Withdrawal by Subject|1|||
28136938|NCT03227029|54801476|FG001|Overall Study|Withdrawal by Subject|0|||
28136939|NCT03227029|54801477|FG002|Overall Study|Withdrawal by Subject|0|||
28136940|NCT03227029|54801475|FG000|Overall Study|Unable to receive treatment in time (no treatment)|0|||
28136941|NCT03227029|54801476|FG001|Overall Study|Unable to receive treatment in time (no treatment)|0|||
28136942|NCT03227029|54801477|FG002|Overall Study|Unable to receive treatment in time (no treatment)|1|||
28136943|NCT03329573|54801489|FG000|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
28136944|NCT03329573|54801490|FG001|Treatment Period 1 (Up to 5 Days)|Adverse Event|1|||
28136945|NCT03329573|54801491|FG002|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
28136946|NCT03329573|54801492|FG003|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
28136947|NCT03329573|54801489|FG000|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
27821176|NCT01388361|54283161|FG000|Overall Study|Adverse Event|0|||
27821177|NCT01388361|54283162|FG001|Overall Study|Adverse Event|5|||
27821178|NCT01388361|54283163|FG002|Overall Study|Adverse Event|1|||
27821179|NCT01388361|54283161|FG000|Overall Study|Protocol Violation|0|||
27821180|NCT01388361|54283162|FG001|Overall Study|Protocol Violation|0|||
27821181|NCT01388361|54283163|FG002|Overall Study|Protocol Violation|2|||
27821182|NCT01388361|54283161|FG000|Overall Study|Withdrawal criteria|12|||
27821183|NCT01388361|54283162|FG001|Overall Study|Withdrawal criteria|7|||
27821184|NCT01388361|54283163|FG002|Overall Study|Withdrawal criteria|10|||
27821185|NCT01388361|54283161|FG000|Overall Study|Unclassified|0|||
27821186|NCT01388361|54283162|FG001|Overall Study|Unclassified|0|||
27821187|NCT01388361|54283163|FG002|Overall Study|Unclassified|1|||
27821188|NCT01399125|54283173|FG000|Overall Study|Adverse Event|32|||
27821189|NCT01399125|54283174|FG001|Overall Study|Adverse Event|30|||
27821190|NCT01399125|54283173|FG000|Overall Study|Abnormal Lab values|0|||
27821191|NCT01399125|54283174|FG001|Overall Study|Abnormal Lab values|1|||
27821192|NCT01399125|54283173|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
27821193|NCT01399125|54283174|FG001|Overall Study|Unsatisfactory Therapeutic Effect|4|||
27821194|NCT01399125|54283173|FG000|Overall Study|Withdrawal by Subject|5|||
27821195|NCT01399125|54283174|FG001|Overall Study|Withdrawal by Subject|8|||
27821196|NCT01399125|54283173|FG000|Overall Study|Lost to Follow-up|2|||
27821197|NCT01399125|54283174|FG001|Overall Study|Lost to Follow-up|3|||
27821198|NCT01399125|54283173|FG000|Overall Study|Administrative Problems|7|||
27821199|NCT01399125|54283174|FG001|Overall Study|Administrative Problems|11|||
27821200|NCT01399125|54283173|FG000|Overall Study|Death|0|||
27821201|NCT01399125|54283174|FG001|Overall Study|Death|1|||
27821202|NCT01399125|54283173|FG000|Overall Study|Protocol Deviation|5|||
27821203|NCT01399125|54283174|FG001|Overall Study|Protocol Deviation|2|||
27821204|NCT01399047|54283182|FG000|Overall Study|Withdrawal by Subject|0|||
27821205|NCT01399047|54283183|FG001|Overall Study|Withdrawal by Subject|1|||
27821206|NCT01387737|54283193|FG000|Overall Study|Adverse Event|20|||
27821207|NCT01387737|54283194|FG001|Overall Study|Adverse Event|30|||
27821208|NCT01387737|54283193|FG000|Overall Study|Lack of Efficacy|1|||
27821209|NCT01387737|54283194|FG001|Overall Study|Lack of Efficacy|0|||
28136948|NCT03329573|54801490|FG001|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2|||
28136949|NCT03329573|54801491|FG002|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
28136950|NCT03329573|54801492|FG003|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
28136951|NCT03329573|54801489|FG000|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1|||
28136952|NCT03329573|54801490|FG001|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
28136953|NCT03329573|54801491|FG002|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
28136954|NCT03329573|54801492|FG003|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
28136955|NCT03329573|54801489|FG000|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
28136956|NCT03329573|54801490|FG001|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1|||
28136957|NCT03329573|54801491|FG002|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
28136958|NCT03329573|54801492|FG003|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
28136959|NCT03308825|54801523|FG000|Overall Study|Lost to Follow-up|2|||
28136960|NCT03308825|54801524|FG001|Overall Study|Lost to Follow-up|2|||
28136961|NCT03308825|54801525|FG002|Overall Study|Lost to Follow-up|1|||
28136962|NCT03308825|54801526|FG003|Overall Study|Lost to Follow-up|0|||
28136963|NCT03308825|54801523|FG000|Overall Study|Protocol Violation|0|||
28136964|NCT03308825|54801524|FG001|Overall Study|Protocol Violation|2|||
28136965|NCT03308825|54801525|FG002|Overall Study|Protocol Violation|0|||
28136966|NCT03308825|54801526|FG003|Overall Study|Protocol Violation|0|||
28136967|NCT03328325|54801540|FG000|Overall Study|Lost to Follow-up|4|||
28136968|NCT03328325|54801540|FG000|Overall Study|Physician Decision|1|||
28136969|NCT03328325|54801540|FG000|Overall Study|Withdrawal by Subject|3|||
28136970|NCT03328325|54801540|FG000|Overall Study|Early Study Termination due to COVID-19 pandemic|3|||
28136971|NCT03305081|54801550|FG000|Overall Study|Lost to Follow-up|10|||
28136972|NCT03305081|54801551|FG001|Overall Study|Lost to Follow-up|15|||
28136973|NCT03325673|54801569|FG000|Overall Study|Adverse Event|4|||
28136974|NCT03325673|54801570|FG001|Overall Study|Adverse Event|0|||
28136975|NCT03223909|54801579|FG000|Overall Study|Protocol Violation|48|||
28136976|NCT03223909|54801580|FG001|Overall Study|Protocol Violation|45|||
28136977|NCT03223909|54801581|FG002|Overall Study|Protocol Violation|16|||
28136978|NCT03733925|54801589|FG000|Overall Study|Lost to Follow-up|1|||
28136979|NCT03733925|54801589|FG000|Overall Study|Withdrawal by Subject|2|||
28136980|NCT03733925|54801589|FG000|Overall Study|Adverse Event|2|||
28136981|NCT03733925|54801589|FG000|Overall Study|Non-Compliance with Study Drug|1|||
28136982|NCT03649711|54801596|FG000|Overall Study|Adverse Event|0|||
28136983|NCT03649711|54801597|FG001|Overall Study|Adverse Event|1|||
27821210|NCT01387737|54283193|FG000|Overall Study|Physician Decision|3|||
28136984|NCT03649711|54801598|FG002|Overall Study|Adverse Event|0|||
28136985|NCT03649711|54801596|FG000|Overall Study|Kidney Transplant|1|||
28136986|NCT03649711|54801597|FG001|Overall Study|Kidney Transplant|0|||
28136987|NCT03649711|54801598|FG002|Overall Study|Kidney Transplant|0|||
28136988|NCT03303521|54801608|FG000|Overall Study|Withdrawal by Subject|2|||
28136989|NCT03303521|54801609|FG001|Overall Study|Withdrawal by Subject|0|||
27821211|NCT01387737|54283194|FG001|Overall Study|Physician Decision|10|||
27821212|NCT01387737|54283193|FG000|Overall Study|Withdrawal by Subject|27|||
27821213|NCT01387737|54283194|FG001|Overall Study|Withdrawal by Subject|31|||
27821214|NCT01387737|54283193|FG000|Overall Study|Clearly not eligible for the study|1|||
27821215|NCT01387737|54283194|FG001|Overall Study|Clearly not eligible for the study|3|||
27821216|NCT01387347|54283202|FG000|Overall Study|Lost to Follow-up|2|||
27821217|NCT01387347|54283203|FG001|Overall Study|Lost to Follow-up|1|||
27821218|NCT01859923|54283217|FG000|Overall Study|Adverse Event|0|||
28136990|NCT03303521|54801608|FG000|Overall Study|Death|1|||
28136991|NCT03303521|54801609|FG001|Overall Study|Death|0|||
28136992|NCT03303521|54801608|FG000|Overall Study|Kidney transplantation|0|||
28136993|NCT03303521|54801609|FG001|Overall Study|Kidney transplantation|1|||
28136994|NCT03303521|54801608|FG000|Overall Study|Investigational product discontinuation|0|||
27821219|NCT01859923|54283218|FG001|Overall Study|Adverse Event|0|||
27849877|NCT05038293|54348176|FG001|Overall Study|device was not operating properly for one subject.|0|||
28136995|NCT03303521|54801609|FG001|Overall Study|Investigational product discontinuation|1|||
28136996|NCT03303521|54801608|FG000|Overall Study|Transferred to non-study dialysis center|1|||
28136997|NCT03303521|54801609|FG001|Overall Study|Transferred to non-study dialysis center|0|||
28136998|NCT03303521|54801608|FG000|Overall Study|Non-comliance to study protocol|0|||
28136999|NCT03303521|54801609|FG001|Overall Study|Non-comliance to study protocol|1|||
28137000|NCT03303521|54801608|FG000|Overall Study|Adverse Event|1|||
28137001|NCT03303521|54801609|FG001|Overall Study|Adverse Event|0|||
28137002|NCT03214081|54801615|FG000|Overall Study|Case Report Forms Uncollected|9|||
28137003|NCT03214081|54801615|FG000|Overall Study|Protocol Deviation|54|||
27821220|NCT01859923|54283219|FG002|Overall Study|Adverse Event|1|||
27821221|NCT01859923|54283220|FG003|Overall Study|Adverse Event|1|||
27821222|NCT01832155|54283235|FG000|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1|||
27849878|NCT05038293|54348175|FG000|Overall Study|one subject was dropped due to a behavioral issue|1|||
27849879|NCT05038293|54348176|FG001|Overall Study|one subject was dropped due to a behavioral issue|0|||
27849880|NCT05013008|54348184|FG000|Overall Study|Exclusion from mBFAS|5|||
27849881|NCT05013008|54348185|FG001|Overall Study|Exclusion from mBFAS|25|||
27849882|NCT04753164|54348202|FG000|Overall Study|Adverse Event|0|||
28069917|NCT00006604|54724957|FG015|Overall Study|Met study objective - no further FU|1|||
28069918|NCT00006604|54724958|FG016|Overall Study|Met study objective - no further FU|0|||
28069919|NCT00006604|54724942|FG000|Overall Study|Randomization entry error-no RX, no FU|0|||
28069920|NCT00006604|54724943|FG001|Overall Study|Randomization entry error-no RX, no FU|0|||
28069921|NCT00006604|54724944|FG002|Overall Study|Randomization entry error-no RX, no FU|0|||
28069922|NCT00006604|54724945|FG003|Overall Study|Randomization entry error-no RX, no FU|0|||
28069923|NCT00006604|54724946|FG004|Overall Study|Randomization entry error-no RX, no FU|0|||
28069924|NCT00006604|54724947|FG005|Overall Study|Randomization entry error-no RX, no FU|0|||
28069925|NCT00006604|54724948|FG006|Overall Study|Randomization entry error-no RX, no FU|0|||
28069926|NCT00006604|54724949|FG007|Overall Study|Randomization entry error-no RX, no FU|0|||
28069927|NCT00006604|54724950|FG008|Overall Study|Randomization entry error-no RX, no FU|0|||
28137004|NCT02888171|54801621|FG000|Overall Study|Lost to Follow-up|2|||
28137005|NCT02888171|54801622|FG001|Overall Study|Lost to Follow-up|1|||
28137006|NCT02888171|54801621|FG000|Overall Study|Withdrawal by Subject|3|||
28137007|NCT02888171|54801622|FG001|Overall Study|Withdrawal by Subject|2|||
28137008|NCT02888171|54801621|FG000|Overall Study|Adverse Event|0|||
28137009|NCT02888171|54801622|FG001|Overall Study|Adverse Event|1|||
28137010|NCT02932891|54801628|FG000|Overall Study|Lost to Follow-up|2|||
28137011|NCT02932891|54801628|FG000|Overall Study|HPA Suppress|2|||
28137012|NCT03302975|54801632|FG000|Overall Study|Lost to Follow-up|4|||
28137013|NCT03212521|54801636|FG000|Overall Study|Adverse Event|1|||
28137014|NCT03212521|54801636|FG000|Overall Study|Lost to Follow-up|4|||
28137015|NCT03212521|54801636|FG000|Overall Study|Withdrawal by Subject|1|||
28137016|NCT03212521|54801636|FG000|Overall Study|Other|1|||
28137017|NCT03212365|54801642|FG000|Overall Study|Discharged prior to Xa level|12|||
27821223|NCT01832155|54283236|FG001|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0|||
27821224|NCT01832155|54283235|FG000|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1|||
27821225|NCT01832155|54283236|FG001|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0|||
27821226|NCT01879579|54283250|FG000|Overall Study|Phone incompatible with texting platform|3|||
27821227|NCT01879579|54283251|FG001|Overall Study|Phone incompatible with texting platform|0|||
27821228|NCT01879579|54283250|FG000|Overall Study|Did not enroll in texting platform|1|||
27821229|NCT01879579|54283251|FG001|Overall Study|Did not enroll in texting platform|0|||
27821230|NCT01879579|54283250|FG000|Overall Study|Did not initiate insulin treatment|1|||
27821231|NCT01879579|54283251|FG001|Overall Study|Did not initiate insulin treatment|0|||
27821232|NCT01879579|54283250|FG000|Overall Study|Phenotypic type 1 diabetes|0|||
27821233|NCT01879579|54283251|FG001|Overall Study|Phenotypic type 1 diabetes|1|||
27821234|NCT01879579|54283250|FG000|Overall Study|Discontinued insulin - possible allergy|0|||
27821235|NCT01879579|54283251|FG001|Overall Study|Discontinued insulin - possible allergy|1|||
27821236|NCT01386645|54283263|FG000|Overall Study|Physician Decision|0|||
27821237|NCT01386645|54283264|FG001|Overall Study|Physician Decision|0|||
27821238|NCT01386645|54283265|FG002|Overall Study|Physician Decision|1|||
27821239|NCT01386645|54283263|FG000|Overall Study|Withdrawal by Subject|0|||
27821240|NCT01386645|54283264|FG001|Overall Study|Withdrawal by Subject|1|||
27821241|NCT01386645|54283265|FG002|Overall Study|Withdrawal by Subject|1|||
27821242|NCT01387269|54283275|FG000|Overall Study|Death|38|||
27821243|NCT01387269|54283276|FG001|Overall Study|Death|20|||
27821244|NCT01387269|54283275|FG000|Overall Study|Other|8|||
27821245|NCT01387269|54283276|FG001|Overall Study|Other|7|||
27821246|NCT01387269|54283275|FG000|Overall Study|Unrelated AE|12|||
27821247|NCT01387269|54283276|FG001|Overall Study|Unrelated AE|3|||
27821248|NCT01387269|54283275|FG000|Overall Study|Withdrawal by patient|32|||
27821249|NCT01387269|54283276|FG001|Overall Study|Withdrawal by patient|10|||
27821250|NCT01387269|54283275|FG000|Overall Study|Study drug-related AE|1|||
27821251|NCT01387269|54283276|FG001|Overall Study|Study drug-related AE|0|||
27821252|NCT01387269|54283275|FG000|Overall Study|Lost to Follow-up|1|||
27821253|NCT01387269|54283276|FG001|Overall Study|Lost to Follow-up|0|||
27821254|NCT01859143|54283284|FG000|Overall Study|Lost to Follow-up|2|||
27821255|NCT01859143|54283285|FG001|Overall Study|Lost to Follow-up|0|||
27821256|NCT01878253|54283292|FG000|Overall Study|Death|1|||
27821257|NCT01878253|54283292|FG000|Overall Study|SIdus System Removal|3|||
27821258|NCT01878253|54283292|FG000|Overall Study|Withdrawal by Subject|1|||
27821259|NCT01878253|54283292|FG000|Overall Study|Lost to Follow-up|2|||
27821260|NCT01878253|54283292|FG000|Overall Study|Completed Study w/o Follow-up Data|2|||
27821261|NCT01878175|54283301|FG000|Overall Study|Developed contraindicated health problem|2|||
27821262|NCT01878097|54283308|FG000|Baseline|Surveys not fully completed|2497|||
27821263|NCT01878097|54283309|FG001|Baseline|Surveys not fully completed|1800|||
27821264|NCT01878097|54283308|FG000|Implementation Year 1|Surveys not fully completed|3202|||
27821265|NCT01878097|54283309|FG001|Implementation Year 1|Surveys not fully completed|2549|||
27821266|NCT01878097|54283308|FG000|Implementation Year 2|Surveys not fully completed|3281|||
27821267|NCT01878097|54283309|FG001|Implementation Year 2|Surveys not fully completed|2841|||
27821268|NCT01878097|54283308|FG000|Implementation Year 3|Surveys not fully completed|3494|||
27821269|NCT01878097|54283309|FG001|Implementation Year 3|Surveys not fully completed|2980|||
27821270|NCT01878097|54283308|FG000|Implementation Year 4|Surveys not fully completed|3604|||
27821271|NCT01878097|54283309|FG001|Implementation Year 4|Surveys not fully completed|3007|||
27821272|NCT01750190|54283317|FG000|Overall Study|Adverse Event|47|||
27821273|NCT01750190|54283318|FG001|Overall Study|Adverse Event|19|||
27821274|NCT01750190|54283317|FG000|Overall Study|Death|38|||
27821275|NCT01750190|54283318|FG001|Overall Study|Death|11|||
27821276|NCT01750190|54283317|FG000|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|2|||
27821277|NCT01750190|54283318|FG001|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|43|||
27849883|NCT04753164|54348203|FG001|Overall Study|Adverse Event|2|||
27849884|NCT04753164|54348202|FG000|Overall Study|Withdrawal by Subject|9|||
28137018|NCT03212365|54801643|FG001|Overall Study|Discharged prior to Xa level|8|||
28137019|NCT03212365|54801642|FG000|Overall Study|Bled requiring enoxaparin cessation|4|||
28137020|NCT03212365|54801643|FG001|Overall Study|Bled requiring enoxaparin cessation|2|||
28137021|NCT03212365|54801642|FG000|Overall Study|Refused study medication|3|||
28137022|NCT03212365|54801643|FG001|Overall Study|Refused study medication|0|||
28137023|NCT03212365|54801642|FG000|Overall Study|Initiated heparin infusion on floor|1|||
28137024|NCT03212365|54801643|FG001|Overall Study|Initiated heparin infusion on floor|1|||
28137025|NCT03212365|54801642|FG000|Overall Study|Unexpected return to OR|1|||
28137026|NCT03212365|54801643|FG001|Overall Study|Unexpected return to OR|1|||
27821278|NCT01750190|54283317|FG000|Overall Study|Lost to Follow-up|28|||
27821279|NCT01750190|54283318|FG001|Overall Study|Lost to Follow-up|7|||
27821280|NCT01750190|54283317|FG000|Overall Study|Physician Decision|16|||
27821281|NCT01750190|54283318|FG001|Overall Study|Physician Decision|17|||
27821282|NCT01750190|54283317|FG000|Overall Study|Protocol Violation|6|||
27821283|NCT01750190|54283318|FG001|Overall Study|Protocol Violation|5|||
27849885|NCT04753164|54348203|FG001|Overall Study|Withdrawal by Subject|7|||
28137027|NCT03212365|54801642|FG000|Overall Study|Medication distribution error|1|||
28137028|NCT03212365|54801643|FG001|Overall Study|Medication distribution error|0|||
28137029|NCT03212365|54801642|FG000|Overall Study|Required epidural placement|1|||
28137030|NCT03212365|54801643|FG001|Overall Study|Required epidural placement|0|||
28137031|NCT03212365|54801642|FG000|Overall Study|Withdrawal by Subject|0|||
28137032|NCT03212365|54801643|FG001|Overall Study|Withdrawal by Subject|1|||
28137033|NCT03212365|54801642|FG000|Overall Study|developed acute renal failure|0|||
28137034|NCT03212365|54801643|FG001|Overall Study|developed acute renal failure|1|||
28137035|NCT03273257|54801651|FG000|Overall Study|Death|0|||
28137036|NCT03273257|54801652|FG001|Overall Study|Death|1|||
27821284|NCT01750190|54283317|FG000|Overall Study|Study/Site Terminated by Sponsor|4|||
28137037|NCT03273257|54801651|FG000|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
28137038|NCT03273257|54801652|FG001|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
28137039|NCT03273257|54801651|FG000|Overall Study|Study terminated|3|||
28137040|NCT03273257|54801652|FG001|Overall Study|Study terminated|2|||
28137041|NCT04316741|54801660|FG000|Baseline Enrollment|Lost to Follow-up|1|||
28137042|NCT04316741|54801661|FG001|Baseline Enrollment|Lost to Follow-up|1|||
28137043|NCT04316741|54801660|FG000|Immediate Post-Test|Lost to Follow-up|5|||
28137044|NCT04316741|54801661|FG001|Immediate Post-Test|Lost to Follow-up|1|||
28137045|NCT04316741|54801660|FG000|1-month Post-test|Lost to Follow-up|7|||
28137046|NCT04316741|54801661|FG001|1-month Post-test|Lost to Follow-up|2|||
28137047|NCT04316741|54801660|FG000|3-month Follow-up|Lost to Follow-up|10|||
28137048|NCT04316741|54801661|FG001|3-month Follow-up|Lost to Follow-up|2|||
28137049|NCT03271307|54801671|FG000|Overall Study|Lost to Follow-up|0|||
28137050|NCT03271307|54801672|FG001|Overall Study|Lost to Follow-up|0|||
28137051|NCT03271307|54801673|FG002|Overall Study|Lost to Follow-up|0|||
28137052|NCT03271307|54801674|FG003|Overall Study|Lost to Follow-up|28|||
28137053|NCT03271307|54801675|FG004|Overall Study|Lost to Follow-up|91|||
27821285|NCT01750190|54283318|FG001|Overall Study|Study/Site Terminated by Sponsor|1|||
27821286|NCT01750190|54283317|FG000|Overall Study|Withdrawal by Subject|83|||
27821287|NCT01750190|54283318|FG001|Overall Study|Withdrawal by Subject|89|||
27821288|NCT01750190|54283317|FG000|Overall Study|Kidney Transplant|8|||
27821289|NCT01750190|54283318|FG001|Overall Study|Kidney Transplant|4|||
27821290|NCT01750190|54283317|FG000|Overall Study|Dialysis|22|||
27821291|NCT01750190|54283318|FG001|Overall Study|Dialysis|8|||
27821292|NCT01750190|54283317|FG000|Overall Study|Other than Specified|13|||
27821293|NCT01750190|54283318|FG001|Overall Study|Other than Specified|4|||
27821294|NCT01831765|54283327|FG000|Overall Study|Lack of Efficacy|1|||
27821295|NCT01831765|54283328|FG001|Overall Study|Lack of Efficacy|0|||
27821296|NCT01831765|54283329|FG002|Overall Study|Lack of Efficacy|0|||
27821297|NCT01831765|54283327|FG000|Overall Study|Other, sponsor withdrew subject|0|||
27821298|NCT01831765|54283328|FG001|Overall Study|Other, sponsor withdrew subject|1|||
27821299|NCT01831765|54283329|FG002|Overall Study|Other, sponsor withdrew subject|0|||
27821300|NCT01831765|54283327|FG000|Overall Study|Pregnancy|1|||
27821301|NCT01831765|54283328|FG001|Overall Study|Pregnancy|1|||
27821302|NCT01831765|54283329|FG002|Overall Study|Pregnancy|2|||
27821303|NCT01831765|54283327|FG000|Overall Study|Death|0|||
27821304|NCT01831765|54283328|FG001|Overall Study|Death|1|||
27821305|NCT01831765|54283329|FG002|Overall Study|Death|1|||
27821306|NCT01831765|54283327|FG000|Overall Study|Other, site closed|1|||
27821307|NCT01831765|54283328|FG001|Overall Study|Other, site closed|1|||
27821308|NCT01831765|54283329|FG002|Overall Study|Other, site closed|0|||
27821309|NCT01831765|54283327|FG000|Overall Study|Adverse Event|5|||
27821310|NCT01831765|54283328|FG001|Overall Study|Adverse Event|3|||
27821311|NCT01831765|54283329|FG002|Overall Study|Adverse Event|3|||
27821312|NCT01831765|54283327|FG000|Overall Study|Withdrawal by Subject|22|||
27821313|NCT01831765|54283328|FG001|Overall Study|Withdrawal by Subject|7|||
27821314|NCT01831765|54283329|FG002|Overall Study|Withdrawal by Subject|17|||
27821315|NCT01831765|54283327|FG000|Overall Study|Withdrawal criteria|12|||
27821316|NCT01831765|54283328|FG001|Overall Study|Withdrawal criteria|10|||
27821317|NCT01831765|54283329|FG002|Overall Study|Withdrawal criteria|16|||
27821318|NCT01831765|54283327|FG000|Overall Study|Lost to Follow-up|2|||
27821319|NCT01831765|54283328|FG001|Overall Study|Lost to Follow-up|3|||
27821320|NCT01831765|54283329|FG002|Overall Study|Lost to Follow-up|3|||
27821321|NCT01749800|54283342|FG000|Overall Study|not meeting inclusion criteria|3|||
27821322|NCT01749800|54283343|FG001|Overall Study|not meeting inclusion criteria|0|||
27821323|NCT01749800|54283344|FG002|Overall Study|not meeting inclusion criteria|0|||
28137054|NCT03271151|54801692|FG000|Overall Study|Lost to Follow-up|1|||
27821324|NCT01749800|54283342|FG000|Overall Study|Withdrawal by Subject|0|||
27821325|NCT01749800|54283343|FG001|Overall Study|Withdrawal by Subject|1|||
27821326|NCT01749800|54283344|FG002|Overall Study|Withdrawal by Subject|0|||
27821327|NCT01830595|54283352|FG000|First Period|Withdrawal by Subject|1|||
27821328|NCT01830595|54283353|FG001|First Period|Withdrawal by Subject|3|||
27821329|NCT01830595|54283352|FG000|Washout|Withdrawal by Subject|2|||
27821330|NCT01830595|54283353|FG001|Washout|Withdrawal by Subject|2|||
28137055|NCT03271151|54801693|FG001|Overall Study|Lost to Follow-up|3|||
28137056|NCT03271151|54801692|FG000|Overall Study|Withdrawal by Subject|1|||
28137057|NCT03271151|54801693|FG001|Overall Study|Withdrawal by Subject|0|||
28137058|NCT03245723|54801701|FG000|Overall Study|Bigeminy precluding hypoxia exposure|1|||
28137059|NCT03245723|54801702|FG001|Overall Study|Bigeminy precluding hypoxia exposure|0|||
28137060|NCT03245723|54801701|FG000|Overall Study|Claustrophobia from wearing the mask|1|||
28137061|NCT03245723|54801702|FG001|Overall Study|Claustrophobia from wearing the mask|0|||
28137062|NCT03245723|54801701|FG000|Overall Study|Having to abruptly stop the scan to use the restroom|2|||
27821331|NCT01748552|54283371|FG000|Intervention Period 2 and Washout|Physician Decision|0|||
28137063|NCT03245723|54801702|FG001|Overall Study|Having to abruptly stop the scan to use the restroom|0|||
28137064|NCT03245723|54801701|FG000|Overall Study|Image acquisition/reconstruction failure|1|||
28137065|NCT03245723|54801702|FG001|Overall Study|Image acquisition/reconstruction failure|1|||
28137066|NCT03301649|54801711|FG000|Overall Study|Need alternate therapy due to live lice|17|||
28137067|NCT03301649|54801712|FG001|Overall Study|Need alternate therapy due to live lice|25|||
28137068|NCT03301649|54801713|FG002|Overall Study|Need alternate therapy due to live lice|81|||
28137069|NCT03301649|54801711|FG000|Overall Study|Lost to Follow-up|11|||
28137070|NCT03301649|54801712|FG001|Overall Study|Lost to Follow-up|11|||
28137071|NCT03301649|54801713|FG002|Overall Study|Lost to Follow-up|3|||
28137072|NCT03301649|54801711|FG000|Overall Study|Protocol Violation|0|||
28137073|NCT03301649|54801712|FG001|Overall Study|Protocol Violation|1|||
28137074|NCT03301649|54801713|FG002|Overall Study|Protocol Violation|1|||
28137075|NCT03301649|54801711|FG000|Overall Study|Withdrawal by Subject|10|||
28137076|NCT03301649|54801712|FG001|Overall Study|Withdrawal by Subject|4|||
28137077|NCT03301649|54801713|FG002|Overall Study|Withdrawal by Subject|0|||
28137078|NCT03301649|54801711|FG000|Overall Study|Other than specified|5|||
28137079|NCT03301649|54801712|FG001|Overall Study|Other than specified|3|||
28137080|NCT03301649|54801713|FG002|Overall Study|Other than specified|0|||
28137081|NCT03222973|54801723|FG000|Part 1 (Week 0 to Week 72)|Adverse Event|3|||
28137082|NCT03222973|54801724|FG001|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
28137083|NCT03222973|54801725|FG002|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
27821332|NCT01748552|54283372|FG001|Intervention Period 2 and Washout|Physician Decision|0|||
27821333|NCT01748552|54283373|FG002|Intervention Period 2 and Washout|Physician Decision|1|||
27821334|NCT01748552|54283374|FG003|Intervention Period 2 and Washout|Physician Decision|0|||
27821335|NCT01748552|54283375|FG004|Intervention Period 2 and Washout|Physician Decision|0|||
28137084|NCT03222973|54801726|FG003|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
28137085|NCT03222973|54801723|FG000|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
28137086|NCT03222973|54801724|FG001|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
28137087|NCT03222973|54801725|FG002|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
28137088|NCT03222973|54801726|FG003|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
28137089|NCT03222973|54801723|FG000|Part 1 (Week 0 to Week 72)|Consent Withdrawn|12|||
28137090|NCT03222973|54801724|FG001|Part 1 (Week 0 to Week 72)|Consent Withdrawn|9|||
28137091|NCT03222973|54801725|FG002|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
28137092|NCT03222973|54801726|FG003|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
28137093|NCT03222973|54801723|FG000|Part 1 (Week 0 to Week 72)|Death|0|||
27849886|NCT04753164|54348202|FG000|Overall Study|Lost to Follow-up|6|||
28137094|NCT03222973|54801724|FG001|Part 1 (Week 0 to Week 72)|Death|1|||
28137095|NCT03222973|54801725|FG002|Part 1 (Week 0 to Week 72)|Death|0|||
28137096|NCT03222973|54801726|FG003|Part 1 (Week 0 to Week 72)|Death|0|||
28137097|NCT03222973|54801723|FG000|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
28137098|NCT03222973|54801724|FG001|Part 1 (Week 0 to Week 72)|Pregnancy|1|||
28137099|NCT03222973|54801725|FG002|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
28137100|NCT03222973|54801726|FG003|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
28137101|NCT03222973|54801723|FG000|Part 1 (Week 0 to Week 72)|Other|8|||
28137102|NCT03222973|54801724|FG001|Part 1 (Week 0 to Week 72)|Other|2|||
28137103|NCT03222973|54801725|FG002|Part 1 (Week 0 to Week 72)|Other|0|||
28137104|NCT03222973|54801726|FG003|Part 1 (Week 0 to Week 72)|Other|0|||
28137105|NCT03222973|54801723|FG000|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
28137106|NCT03222973|54801724|FG001|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
28137107|NCT03222973|54801725|FG002|Part 2 (Week 73 to Week 168)|Adverse Event|2|||
28137108|NCT03222973|54801726|FG003|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
28137109|NCT03222973|54801723|FG000|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
28137110|NCT03222973|54801724|FG001|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
28137111|NCT03222973|54801725|FG002|Part 2 (Week 73 to Week 168)|Consent Withdrawn|10|||
28137112|NCT03222973|54801726|FG003|Part 2 (Week 73 to Week 168)|Consent Withdrawn|11|||
28137113|NCT03222973|54801723|FG000|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
28137114|NCT03222973|54801724|FG001|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
28137115|NCT03222973|54801725|FG002|Part 2 (Week 73 to Week 168)|Investigator Decision|2|||
28137116|NCT03222973|54801726|FG003|Part 2 (Week 73 to Week 168)|Investigator Decision|1|||
28137117|NCT03222973|54801723|FG000|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
28137118|NCT03222973|54801724|FG001|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
28137119|NCT03222973|54801725|FG002|Part 2 (Week 73 to Week 168)|Pregnancy|2|||
28137120|NCT03222973|54801726|FG003|Part 2 (Week 73 to Week 168)|Pregnancy|1|||
28137121|NCT03222973|54801723|FG000|Part 2 (Week 73 to Week 168)|Other|0|||
28137122|NCT03222973|54801724|FG001|Part 2 (Week 73 to Week 168)|Other|0|||
28137123|NCT03222973|54801725|FG002|Part 2 (Week 73 to Week 168)|Other|84|||
28137124|NCT03222973|54801726|FG003|Part 2 (Week 73 to Week 168)|Other|100|||
28137125|NCT03222973|54801723|FG000|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
28137126|NCT03222973|54801724|FG001|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
28137127|NCT03222973|54801725|FG002|Part 2 (Week 73 to Week 168)|Participants Not Dosed|1|||
28137128|NCT03222973|54801726|FG003|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
28137129|NCT01144416|54801738|FG000|Intervention Period|Adverse Event|5|||
28137130|NCT01144416|54801739|FG001|Intervention Period|Adverse Event|6|||
28137131|NCT01144416|54801738|FG000|Intervention Period|Insufficient ovarian response|11|||
28137132|NCT01144416|54801739|FG001|Intervention Period|Insufficient ovarian response|17|||
28137133|NCT01144416|54801738|FG000|Intervention Period|Risk of OHSS|0|||
28137134|NCT01144416|54801739|FG001|Intervention Period|Risk of OHSS|1|||
28137135|NCT01144416|54801738|FG000|Intervention Period|Too high ovarian response|4|||
28137136|NCT01144416|54801739|FG001|Intervention Period|Too high ovarian response|2|||
28137137|NCT01144416|54801738|FG000|Intervention Period|No/too few/bad oocytes|7|||
28137138|NCT01144416|54801739|FG001|Intervention Period|No/too few/bad oocytes|5|||
28137139|NCT01144416|54801738|FG000|Intervention Period|No or abnormal fertilization|25|||
28137140|NCT01144416|54801739|FG001|Intervention Period|No or abnormal fertilization|10|||
28137141|NCT01144416|54801738|FG000|Intervention Period|No/too few/bad quality embryos|3|||
28137142|NCT01144416|54801739|FG001|Intervention Period|No/too few/bad quality embryos|3|||
28137143|NCT01144416|54801738|FG000|Intervention Period|Other|7|||
28137144|NCT01144416|54801739|FG001|Intervention Period|Other|5|||
28137145|NCT00335777|54801749|FG000|Enrolled and Dispensed Study Medication|Lost to Follow-up|5|||
28137146|NCT00335777|54801749|FG000|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6|||
28137147|NCT00335777|54801749|FG000|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18|||
27821336|NCT01748552|54283376|FG005|Intervention Period 2 and Washout|Physician Decision|0|||
28069928|NCT00006604|54724951|FG009|Overall Study|Randomization entry error-no RX, no FU|0|||
28069929|NCT00006604|54724952|FG010|Overall Study|Randomization entry error-no RX, no FU|0|||
28069930|NCT00006604|54724953|FG011|Overall Study|Randomization entry error-no RX, no FU|1|||
28069931|NCT00006604|54724954|FG012|Overall Study|Randomization entry error-no RX, no FU|0|||
28069932|NCT00006604|54724955|FG013|Overall Study|Randomization entry error-no RX, no FU|0|||
28069933|NCT00006604|54724956|FG014|Overall Study|Randomization entry error-no RX, no FU|0|||
28069934|NCT00006604|54724957|FG015|Overall Study|Randomization entry error-no RX, no FU|0|||
28069935|NCT00006604|54724958|FG016|Overall Study|Randomization entry error-no RX, no FU|0|||
28137148|NCT00335777|54801749|FG000|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1|||
28137149|NCT00335777|54801749|FG000|Treated 2 Headaches Per Protocol|Treated out of protocol for early and late|12|||
28137150|NCT01140048|54801754|FG000|Overall Study|Physician Decision|1|||
28137151|NCT01140048|54801754|FG000|Overall Study|Withdrawal by Subject|13|||
28137152|NCT01140048|54801754|FG000|Overall Study|Lost to Follow-up|31|||
28137153|NCT02889809|54801760|FG000|Overall Study|Withdrawal by Subject|30|||
28137154|NCT02889809|54801761|FG001|Overall Study|Withdrawal by Subject|21|||
28137155|NCT02889809|54801760|FG000|Overall Study|Lost to Follow-up|1|||
28137156|NCT02889809|54801761|FG001|Overall Study|Lost to Follow-up|1|||
28137157|NCT02889809|54801760|FG000|Overall Study|Site Closed|12|||
28137158|NCT02889809|54801761|FG001|Overall Study|Site Closed|11|||
28137159|NCT00972738|54801774|FG000|Overall Study|Adverse Event|7|||
28137160|NCT00972738|54801775|FG001|Overall Study|Adverse Event|1|||
28137161|NCT00972738|54801776|FG002|Overall Study|Adverse Event|8|||
28137162|NCT00972738|54801774|FG000|Overall Study|Protocol Violation|2|||
28137163|NCT00972738|54801775|FG001|Overall Study|Protocol Violation|1|||
28137164|NCT00972738|54801776|FG002|Overall Study|Protocol Violation|3|||
28137165|NCT00972738|54801774|FG000|Overall Study|Lost to Follow-up|1|||
28137166|NCT00972738|54801775|FG001|Overall Study|Lost to Follow-up|0|||
28137167|NCT00972738|54801776|FG002|Overall Study|Lost to Follow-up|1|||
28137168|NCT00972738|54801774|FG000|Overall Study|Lack of Efficacy|5|||
28137169|NCT00972738|54801775|FG001|Overall Study|Lack of Efficacy|1|||
28137170|NCT00972738|54801776|FG002|Overall Study|Lack of Efficacy|11|||
28137171|NCT00972738|54801774|FG000|Overall Study|Withdrawal by Subject|5|||
28137172|NCT00972738|54801775|FG001|Overall Study|Withdrawal by Subject|1|||
28137173|NCT00972738|54801776|FG002|Overall Study|Withdrawal by Subject|4|||
28137174|NCT00972738|54801774|FG000|Overall Study|Moved|0|||
28137175|NCT00972738|54801775|FG001|Overall Study|Moved|0|||
28137176|NCT00972738|54801776|FG002|Overall Study|Moved|1|||
28137177|NCT00972738|54801774|FG000|Overall Study|Other|1|||
28137178|NCT00972738|54801775|FG001|Overall Study|Other|2|||
28137179|NCT00972738|54801776|FG002|Overall Study|Other|1|||
28137180|NCT03243305|54801784|FG000|Overall Study|Lost to Follow-up|250|||
28137181|NCT03243305|54801784|FG000|Overall Study|Withdrawal by Subject|170|||
28137182|NCT03243305|54801784|FG000|Overall Study|Pregnancy|104|||
28137183|NCT03243305|54801784|FG000|Overall Study|Non-Compliance with Study Drug|38|||
28137184|NCT03243305|54801784|FG000|Overall Study|Adverse Event|23|||
28137185|NCT03243305|54801784|FG000|Overall Study|No sexually active|26|||
28137186|NCT03243305|54801784|FG000|Overall Study|Physician Decision|22|||
28137187|NCT03243305|54801784|FG000|Overall Study|Protocol Violation|22|||
28137188|NCT03243305|54801784|FG000|Overall Study|Study method no longer primary method|12|||
28137189|NCT03243305|54801784|FG000|Overall Study|Study Terminated by Sponsor|1|||
28137190|NCT03243305|54801784|FG000|Overall Study|Early terminations|267|||
28137191|NCT03222583|54801790|FG000|Overall Study|Withdrawal by Subject|3|||
28137192|NCT03222583|54801791|FG001|Overall Study|Withdrawal by Subject|3|||
28137193|NCT03222583|54801790|FG000|Overall Study|Lost to Follow-up|1|||
28137194|NCT03222583|54801791|FG001|Overall Study|Lost to Follow-up|0|||
28137195|NCT03222583|54801790|FG000|Overall Study|Other|1|||
28137196|NCT03222583|54801791|FG001|Overall Study|Other|3|||
28137197|NCT03295721|54801800|FG000|Overall Study|Adverse Event|1|||
28137198|NCT03295721|54801801|FG001|Overall Study|Adverse Event|0|||
28137199|NCT03295721|54801802|FG002|Overall Study|Adverse Event|0|||
28137200|NCT03295721|54801800|FG000|Overall Study|Lost to Follow-up|1|||
28137201|NCT03295721|54801801|FG001|Overall Study|Lost to Follow-up|1|||
28137202|NCT03295721|54801802|FG002|Overall Study|Lost to Follow-up|1|||
28137203|NCT03295721|54801800|FG000|Overall Study|Withdrawal by Subject|1|||
28137204|NCT03295721|54801801|FG001|Overall Study|Withdrawal by Subject|0|||
28137205|NCT03295721|54801802|FG002|Overall Study|Withdrawal by Subject|1|||
28137206|NCT03295721|54801800|FG000|Overall Study|Death|0|||
28137207|NCT03295721|54801801|FG001|Overall Study|Death|0|||
28137208|NCT03295721|54801802|FG002|Overall Study|Death|1|||
28137209|NCT00803790|54801813|FG000|Period 1|Adverse Event|0|||
28137210|NCT00803790|54801814|FG001|Period 1|Adverse Event|1|||
28137211|NCT00803790|54801815|FG002|Period 1|Adverse Event|0|||
28137212|NCT00803790|54801816|FG003|Period 1|Adverse Event|0|||
28137213|NCT00803790|54801813|FG000|Period 1|Lost to Follow-up|1|||
28137214|NCT00803790|54801814|FG001|Period 1|Lost to Follow-up|2|||
28137215|NCT00803790|54801815|FG002|Period 1|Lost to Follow-up|0|||
28137216|NCT00803790|54801816|FG003|Period 1|Lost to Follow-up|0|||
28137217|NCT00803790|54801813|FG000|Period 1|Withdrawal by Subject|8|||
28137218|NCT00803790|54801814|FG001|Period 1|Withdrawal by Subject|6|||
28137219|NCT00803790|54801815|FG002|Period 1|Withdrawal by Subject|0|||
28137220|NCT00803790|54801816|FG003|Period 1|Withdrawal by Subject|0|||
28137221|NCT00803790|54801813|FG000|Period 1|positive drug screen or personal reasons|0|||
28137222|NCT00803790|54801814|FG001|Period 1|positive drug screen or personal reasons|3|||
28137223|NCT00803790|54801815|FG002|Period 1|positive drug screen or personal reasons|0|||
28137224|NCT00803790|54801816|FG003|Period 1|positive drug screen or personal reasons|4|||
28137225|NCT00803790|54801813|FG000|Period 1|Protocol Violation|0|||
28137226|NCT00803790|54801814|FG001|Period 1|Protocol Violation|0|||
28137227|NCT00803790|54801815|FG002|Period 1|Protocol Violation|1|||
28137228|NCT00803790|54801816|FG003|Period 1|Protocol Violation|0|||
28137229|NCT00803790|54801813|FG000|Period 2|Adverse Event|0|||
28137230|NCT00803790|54801814|FG001|Period 2|Adverse Event|0|||
28137231|NCT00803790|54801815|FG002|Period 2|Adverse Event|1|||
28137232|NCT00803790|54801816|FG003|Period 2|Adverse Event|1|||
28137233|NCT00803790|54801813|FG000|Period 2|Withdrawal by Subject|1|||
28137234|NCT00803790|54801814|FG001|Period 2|Withdrawal by Subject|0|||
28137235|NCT00803790|54801815|FG002|Period 2|Withdrawal by Subject|0|||
28137236|NCT00803790|54801816|FG003|Period 2|Withdrawal by Subject|0|||
28137237|NCT00803790|54801813|FG000|Period 2|Positive Drug Screen or Personal Reasons|1|||
28137238|NCT00803790|54801814|FG001|Period 2|Positive Drug Screen or Personal Reasons|0|||
28137239|NCT00803790|54801815|FG002|Period 2|Positive Drug Screen or Personal Reasons|0|||
28137240|NCT00803790|54801816|FG003|Period 2|Positive Drug Screen or Personal Reasons|0|||
28137241|NCT00250458|54801864|FG000|Overall Study|Lost to Follow-up|4|||
28137242|NCT00250458|54801865|FG001|Overall Study|Lost to Follow-up|2|||
28137243|NCT00250458|54801864|FG000|Overall Study|Protocol Violation|0|||
28137244|NCT00250458|54801865|FG001|Overall Study|Protocol Violation|1|||
28137245|NCT00250458|54801864|FG000|Overall Study|Withdrawal by Subject|4|||
28137246|NCT00250458|54801865|FG001|Overall Study|Withdrawal by Subject|2|||
28137247|NCT00250458|54801864|FG000|Overall Study|Lack of Migraine Attack|20|||
28137248|NCT00250458|54801865|FG001|Overall Study|Lack of Migraine Attack|9|||
28137249|NCT00250458|54801864|FG000|Overall Study|Qualifying migraine but did not treat|3|||
28137250|NCT00250458|54801865|FG001|Overall Study|Qualifying migraine but did not treat|3|||
28137251|NCT00250458|54801864|FG000|Overall Study|Other|1|||
28137252|NCT00250458|54801865|FG001|Overall Study|Other|0|||
28137253|NCT01667133|54801883|FG000|Phase 1: Dose-escalation|Adverse Event|0|||
28137254|NCT01667133|54801884|FG001|Phase 1: Dose-escalation|Adverse Event|0|||
28137255|NCT01667133|54801885|FG002|Phase 1: Dose-escalation|Adverse Event|1|||
28137256|NCT01667133|54801886|FG003|Phase 1: Dose-escalation|Adverse Event|0|||
28137257|NCT01667133|54801887|FG004|Phase 1: Dose-escalation|Adverse Event|0|||
28137258|NCT01667133|54801888|FG005|Phase 1: Dose-escalation|Adverse Event|0|||
28137259|NCT01667133|54801889|FG006|Phase 1: Dose-escalation|Adverse Event|0|||
28137260|NCT01667133|54801890|FG007|Phase 1: Dose-escalation|Adverse Event|0|||
28137261|NCT01667133|54801891|FG008|Phase 1: Dose-escalation|Adverse Event|0|||
28137262|NCT01667133|54801892|FG009|Phase 1: Dose-escalation|Adverse Event|0|||
28137263|NCT01667133|54801893|FG010|Phase 1: Dose-escalation|Adverse Event|0|||
28137264|NCT01667133|54801894|FG011|Phase 1: Dose-escalation|Adverse Event|0|||
27821337|NCT01748552|54283377|FG006|Intervention Period 2 and Washout|Physician Decision|0|||
28137265|NCT01667133|54801883|FG000|Phase 1: Dose-escalation|Lack of Efficacy|0|||
28137266|NCT01667133|54801884|FG001|Phase 1: Dose-escalation|Lack of Efficacy|0|||
28137267|NCT01667133|54801885|FG002|Phase 1: Dose-escalation|Lack of Efficacy|1|||
28137268|NCT01667133|54801886|FG003|Phase 1: Dose-escalation|Lack of Efficacy|0|||
28137269|NCT01667133|54801887|FG004|Phase 1: Dose-escalation|Lack of Efficacy|0|||
28137270|NCT01667133|54801888|FG005|Phase 1: Dose-escalation|Lack of Efficacy|0|||
28137271|NCT01667133|54801889|FG006|Phase 1: Dose-escalation|Lack of Efficacy|0|||
28137272|NCT01667133|54801890|FG007|Phase 1: Dose-escalation|Lack of Efficacy|0|||
28137273|NCT01667133|54801891|FG008|Phase 1: Dose-escalation|Lack of Efficacy|0|||
28137274|NCT01667133|54801892|FG009|Phase 1: Dose-escalation|Lack of Efficacy|0|||
28137275|NCT01667133|54801893|FG010|Phase 1: Dose-escalation|Lack of Efficacy|0|||
28137276|NCT01667133|54801894|FG011|Phase 1: Dose-escalation|Lack of Efficacy|0|||
28137277|NCT01667133|54801883|FG000|Phase 1: Dose-escalation|Progressive Disease|0|||
28137278|NCT01667133|54801884|FG001|Phase 1: Dose-escalation|Progressive Disease|1|||
28137279|NCT01667133|54801885|FG002|Phase 1: Dose-escalation|Progressive Disease|2|||
28137280|NCT01667133|54801886|FG003|Phase 1: Dose-escalation|Progressive Disease|0|||
28137281|NCT01667133|54801887|FG004|Phase 1: Dose-escalation|Progressive Disease|1|||
28137282|NCT01667133|54801888|FG005|Phase 1: Dose-escalation|Progressive Disease|1|||
28137283|NCT01667133|54801889|FG006|Phase 1: Dose-escalation|Progressive Disease|1|||
28137284|NCT01667133|54801890|FG007|Phase 1: Dose-escalation|Progressive Disease|0|||
28137285|NCT01667133|54801891|FG008|Phase 1: Dose-escalation|Progressive Disease|0|||
28137286|NCT01667133|54801892|FG009|Phase 1: Dose-escalation|Progressive Disease|0|||
28137287|NCT01667133|54801893|FG010|Phase 1: Dose-escalation|Progressive Disease|0|||
28137288|NCT01667133|54801894|FG011|Phase 1: Dose-escalation|Progressive Disease|0|||
28137289|NCT01667133|54801883|FG000|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
28137290|NCT01667133|54801884|FG001|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
28137291|NCT01667133|54801885|FG002|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
28137292|NCT01667133|54801886|FG003|Phase 1: Dose-escalation|Withdrawal by Subject|1|||
28137293|NCT01667133|54801887|FG004|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
28137294|NCT01667133|54801888|FG005|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
28137295|NCT01667133|54801889|FG006|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
28137296|NCT01667133|54801890|FG007|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
28137297|NCT01667133|54801891|FG008|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
28137298|NCT01667133|54801892|FG009|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
28137299|NCT01667133|54801893|FG010|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
28137300|NCT01667133|54801894|FG011|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
28137301|NCT01667133|54801883|FG000|Phase 2: Dose-expansion|Adverse Event|0|||
28137302|NCT01667133|54801884|FG001|Phase 2: Dose-expansion|Adverse Event|0|||
28137303|NCT01667133|54801885|FG002|Phase 2: Dose-expansion|Adverse Event|0|||
28137304|NCT01667133|54801886|FG003|Phase 2: Dose-expansion|Adverse Event|0|||
28137305|NCT01667133|54801887|FG004|Phase 2: Dose-expansion|Adverse Event|0|||
28137306|NCT01667133|54801888|FG005|Phase 2: Dose-expansion|Adverse Event|0|||
28137307|NCT01667133|54801889|FG006|Phase 2: Dose-expansion|Adverse Event|0|||
28137308|NCT01667133|54801890|FG007|Phase 2: Dose-expansion|Adverse Event|2|||
28137309|NCT01667133|54801891|FG008|Phase 2: Dose-expansion|Adverse Event|1|||
28137310|NCT01667133|54801892|FG009|Phase 2: Dose-expansion|Adverse Event|1|||
28137311|NCT01667133|54801893|FG010|Phase 2: Dose-expansion|Adverse Event|0|||
27821338|NCT01748552|54283378|FG007|Intervention Period 2 and Washout|Physician Decision|0|||
27821339|NCT01748552|54283379|FG008|Intervention Period 2 and Washout|Physician Decision|0|||
27821340|NCT01748552|54283380|FG009|Intervention Period 2 and Washout|Physician Decision|0|||
27821341|NCT01748552|54283381|FG010|Intervention Period 2 and Washout|Physician Decision|0|||
27821342|NCT01748552|54283382|FG011|Intervention Period 2 and Washout|Physician Decision|0|||
27821343|NCT01748552|54283371|FG000|Intervention Period 2 and Washout|Contingency dose not tested|0|||
27821344|NCT01748552|54283372|FG001|Intervention Period 2 and Washout|Contingency dose not tested|0|||
27821345|NCT01748552|54283373|FG002|Intervention Period 2 and Washout|Contingency dose not tested|0|||
27821346|NCT01748552|54283374|FG003|Intervention Period 2 and Washout|Contingency dose not tested|0|||
27821347|NCT01748552|54283375|FG004|Intervention Period 2 and Washout|Contingency dose not tested|0|||
27821348|NCT01748552|54283376|FG005|Intervention Period 2 and Washout|Contingency dose not tested|0|||
27821349|NCT01748552|54283377|FG006|Intervention Period 2 and Washout|Contingency dose not tested|3|||
27821350|NCT01748552|54283378|FG007|Intervention Period 2 and Washout|Contingency dose not tested|3|||
27821351|NCT01748552|54283379|FG008|Intervention Period 2 and Washout|Contingency dose not tested|3|||
27821352|NCT01748552|54283380|FG009|Intervention Period 2 and Washout|Contingency dose not tested|0|||
27821353|NCT01748552|54283381|FG010|Intervention Period 2 and Washout|Contingency dose not tested|0|||
27821354|NCT01748552|54283382|FG011|Intervention Period 2 and Washout|Contingency dose not tested|0|||
27821355|NCT01748162|54283424|FG000|Overall Study|no additional croup episodes to evaluate|2|||
27821356|NCT01748162|54283425|FG001|Overall Study|no additional croup episodes to evaluate|2|||
27821357|NCT01748162|54283424|FG000|Overall Study|participant consented but did not begin|0|||
27821358|NCT01748162|54283425|FG001|Overall Study|participant consented but did not begin|1|||
27821359|NCT01748162|54283424|FG000|Overall Study|reasons not available|3|||
27821360|NCT01748162|54283425|FG001|Overall Study|reasons not available|2|||
27821361|NCT01724216|54283431|FG000|Overall Study|Scan was not completed|1|||
27821362|NCT01723904|54283435|FG000|Overall Study|Noncompliant|3|||
27821363|NCT01723904|54283435|FG000|Overall Study|Adverse Event|5|||
28137312|NCT01667133|54801894|FG011|Phase 2: Dose-expansion|Adverse Event|0|||
28137313|NCT01667133|54801883|FG000|Phase 2: Dose-expansion|Lack of Efficacy|0|||
27821364|NCT01723904|54283435|FG000|Overall Study|Unable to follow protocol/ judged by inv|3|||
27821365|NCT01747772|54283439|FG000|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9|||
28137314|NCT01667133|54801884|FG001|Phase 2: Dose-expansion|Lack of Efficacy|0|||
28137315|NCT01667133|54801885|FG002|Phase 2: Dose-expansion|Lack of Efficacy|0|||
28137316|NCT01667133|54801886|FG003|Phase 2: Dose-expansion|Lack of Efficacy|0|||
28137317|NCT01667133|54801887|FG004|Phase 2: Dose-expansion|Lack of Efficacy|0|||
28137318|NCT01667133|54801888|FG005|Phase 2: Dose-expansion|Lack of Efficacy|0|||
28137319|NCT01667133|54801889|FG006|Phase 2: Dose-expansion|Lack of Efficacy|0|||
28137320|NCT01667133|54801890|FG007|Phase 2: Dose-expansion|Lack of Efficacy|0|||
28137321|NCT01667133|54801891|FG008|Phase 2: Dose-expansion|Lack of Efficacy|0|||
28137322|NCT01667133|54801892|FG009|Phase 2: Dose-expansion|Lack of Efficacy|2|||
28137323|NCT01667133|54801893|FG010|Phase 2: Dose-expansion|Lack of Efficacy|0|||
28137324|NCT01667133|54801894|FG011|Phase 2: Dose-expansion|Lack of Efficacy|0|||
27821366|NCT01830127|54283449|FG000|Overall Study|Adverse Event|1|||
27941036|NCT01020123|54597354|FG004|Main Period|Unclasified|1|||
27941037|NCT01020123|54597355|FG005|Main Period|Unclasified|3|||
27941038|NCT01020123|54597356|FG006|Main Period|Unclasified|6|||
27941039|NCT01020123|54597350|FG000|Extention Period|Withdrawal by Subject|2|||
27941040|NCT01020123|54597351|FG001|Extention Period|Withdrawal by Subject|1|||
27941041|NCT01020123|54597352|FG002|Extention Period|Withdrawal by Subject|1|||
27941042|NCT01020123|54597353|FG003|Extention Period|Withdrawal by Subject|0|||
27941043|NCT01020123|54597354|FG004|Extention Period|Withdrawal by Subject|0|||
27941044|NCT01020123|54597355|FG005|Extention Period|Withdrawal by Subject|0|||
27941045|NCT01020123|54597356|FG006|Extention Period|Withdrawal by Subject|0|||
27941046|NCT01020123|54597350|FG000|Extention Period|Adverse Event|0|||
27941047|NCT01020123|54597351|FG001|Extention Period|Adverse Event|0|||
27941048|NCT01020123|54597352|FG002|Extention Period|Adverse Event|0|||
27941049|NCT01020123|54597353|FG003|Extention Period|Adverse Event|1|||
27941050|NCT01020123|54597354|FG004|Extention Period|Adverse Event|0|||
27941051|NCT01020123|54597355|FG005|Extention Period|Adverse Event|0|||
27821367|NCT01830127|54283450|FG001|Overall Study|Adverse Event|6|||
27941052|NCT01020123|54597356|FG006|Extention Period|Adverse Event|0|||
27941053|NCT01020123|54597350|FG000|Extention Period|Protocol Violation|1|||
27941054|NCT01020123|54597351|FG001|Extention Period|Protocol Violation|1|||
27941055|NCT01020123|54597352|FG002|Extention Period|Protocol Violation|1|||
27941056|NCT01020123|54597353|FG003|Extention Period|Protocol Violation|0|||
27941057|NCT01020123|54597354|FG004|Extention Period|Protocol Violation|0|||
27941058|NCT01020123|54597355|FG005|Extention Period|Protocol Violation|0|||
27941059|NCT01020123|54597356|FG006|Extention Period|Protocol Violation|1|||
27941060|NCT01020123|54597350|FG000|Extention Period|Lost to Follow-up|0|||
28137325|NCT01667133|54801883|FG000|Phase 2: Dose-expansion|Progressive Disease|0|||
27941061|NCT01020123|54597351|FG001|Extention Period|Lost to Follow-up|0|||
27941062|NCT01020123|54597352|FG002|Extention Period|Lost to Follow-up|0|||
27941063|NCT01020123|54597353|FG003|Extention Period|Lost to Follow-up|0|||
27941064|NCT01020123|54597354|FG004|Extention Period|Lost to Follow-up|0|||
27941065|NCT01020123|54597355|FG005|Extention Period|Lost to Follow-up|2|||
27941066|NCT01020123|54597356|FG006|Extention Period|Lost to Follow-up|0|||
27941067|NCT01028391|54597397|FG000|Overall Study|Adverse Event|4|||
27821368|NCT01830127|54283449|FG000|Overall Study|Lack of Efficacy|3|||
27821369|NCT01830127|54283450|FG001|Overall Study|Lack of Efficacy|0|||
27821370|NCT01830127|54283449|FG000|Overall Study|Withdrawal by Subject|1|||
27821371|NCT01830127|54283450|FG001|Overall Study|Withdrawal by Subject|1|||
27821372|NCT01830127|54283449|FG000|Overall Study|Other reason not defined above|0|||
27821373|NCT01830127|54283450|FG001|Overall Study|Other reason not defined above|2|||
27821374|NCT01614067|54283458|FG000|Overall Study|Pregnancy|1|||
27821375|NCT01614067|54283459|FG001|Overall Study|Pregnancy|0|||
27821376|NCT01614067|54283458|FG000|Overall Study|Physician Decision|6|||
27821377|NCT01614067|54283459|FG001|Overall Study|Physician Decision|5|||
27821378|NCT01614067|54283458|FG000|Overall Study|Withdrawal by Subject|0|||
27821379|NCT01614067|54283459|FG001|Overall Study|Withdrawal by Subject|1|||
27821380|NCT01614067|54283458|FG000|Overall Study|Study terminated early by sponsor and was unable to collect data|8|||
27941068|NCT01028391|54597398|FG001|Overall Study|Adverse Event|0|||
28137326|NCT01667133|54801884|FG001|Phase 2: Dose-expansion|Progressive Disease|0|||
28137327|NCT01667133|54801885|FG002|Phase 2: Dose-expansion|Progressive Disease|0|||
28137328|NCT01667133|54801886|FG003|Phase 2: Dose-expansion|Progressive Disease|0|||
28137329|NCT01667133|54801887|FG004|Phase 2: Dose-expansion|Progressive Disease|0|||
27821381|NCT01614067|54283459|FG001|Overall Study|Study terminated early by sponsor and was unable to collect data|9|||
27821382|NCT01777490|54283469|FG000|Overall Study|Dyad withdrew with data use prohibition|0|||
27821383|NCT01777490|54283470|FG001|Overall Study|Dyad withdrew with data use prohibition|0|||
27821384|NCT01777490|54283471|FG002|Overall Study|Dyad withdrew with data use prohibition|1|||
28137330|NCT01667133|54801888|FG005|Phase 2: Dose-expansion|Progressive Disease|0|||
28137331|NCT01667133|54801889|FG006|Phase 2: Dose-expansion|Progressive Disease|0|||
28137332|NCT01667133|54801890|FG007|Phase 2: Dose-expansion|Progressive Disease|0|||
28137333|NCT01667133|54801891|FG008|Phase 2: Dose-expansion|Progressive Disease|0|||
27821385|NCT01777490|54283472|FG003|Overall Study|Dyad withdrew with data use prohibition|1|||
27821386|NCT01397409|54283494|FG000|Stage 2|Adverse Event|0|||
27821387|NCT01397409|54283495|FG001|Stage 2|Adverse Event|0|||
27941069|NCT01028391|54597397|FG000|Overall Study|Lack of Efficacy|0|||
28069936|NCT00006604|54724942|FG000|Overall Study|Death|0|||
28069937|NCT00006604|54724943|FG001|Overall Study|Death|0|||
28069938|NCT00006604|54724944|FG002|Overall Study|Death|0|||
28069939|NCT00006604|54724945|FG003|Overall Study|Death|0|||
28069940|NCT00006604|54724946|FG004|Overall Study|Death|0|||
28069941|NCT00006604|54724947|FG005|Overall Study|Death|0|||
28069942|NCT00006604|54724948|FG006|Overall Study|Death|0|||
28069943|NCT00006604|54724949|FG007|Overall Study|Death|0|||
28069944|NCT00006604|54724950|FG008|Overall Study|Death|0|||
28069945|NCT00006604|54724951|FG009|Overall Study|Death|1|||
28069946|NCT00006604|54724952|FG010|Overall Study|Death|1|||
28069947|NCT00006604|54724953|FG011|Overall Study|Death|1|||
28069948|NCT00006604|54724954|FG012|Overall Study|Death|0|||
28069949|NCT00006604|54724955|FG013|Overall Study|Death|0|||
28069950|NCT00006604|54724956|FG014|Overall Study|Death|0|||
28069951|NCT00006604|54724957|FG015|Overall Study|Death|0|||
28069952|NCT00006604|54724958|FG016|Overall Study|Death|0|||
28069953|NCT00006604|54724942|FG000|Overall Study|Severe debilitation, unable to continue|0|||
28069954|NCT00006604|54724943|FG001|Overall Study|Severe debilitation, unable to continue|0|||
28137334|NCT01667133|54801892|FG009|Phase 2: Dose-expansion|Progressive Disease|0|||
28137335|NCT01667133|54801893|FG010|Phase 2: Dose-expansion|Progressive Disease|3|||
28137336|NCT01667133|54801894|FG011|Phase 2: Dose-expansion|Progressive Disease|5|||
28137337|NCT01667133|54801883|FG000|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
28137338|NCT01667133|54801884|FG001|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
28137339|NCT01667133|54801885|FG002|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
28137340|NCT01667133|54801886|FG003|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
28137341|NCT01667133|54801887|FG004|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
28137342|NCT01667133|54801888|FG005|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
28137343|NCT01667133|54801889|FG006|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
28137344|NCT01667133|54801890|FG007|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
28137345|NCT01667133|54801891|FG008|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
28137346|NCT01667133|54801892|FG009|Phase 2: Dose-expansion|Withdrawal by Subject|2|||
28137347|NCT01667133|54801893|FG010|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
28137348|NCT01667133|54801894|FG011|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
28137349|NCT01667133|54801883|FG000|Phase 2: Dose-expansion|Death|0|||
28137350|NCT01667133|54801884|FG001|Phase 2: Dose-expansion|Death|0|||
28137351|NCT01667133|54801885|FG002|Phase 2: Dose-expansion|Death|0|||
28137352|NCT01667133|54801886|FG003|Phase 2: Dose-expansion|Death|0|||
28137353|NCT01667133|54801887|FG004|Phase 2: Dose-expansion|Death|0|||
28137354|NCT01667133|54801888|FG005|Phase 2: Dose-expansion|Death|0|||
28137355|NCT01667133|54801889|FG006|Phase 2: Dose-expansion|Death|0|||
28137356|NCT01667133|54801890|FG007|Phase 2: Dose-expansion|Death|0|||
28137357|NCT01667133|54801891|FG008|Phase 2: Dose-expansion|Death|0|||
28137358|NCT01667133|54801892|FG009|Phase 2: Dose-expansion|Death|1|||
28137359|NCT01667133|54801893|FG010|Phase 2: Dose-expansion|Death|0|||
28137360|NCT01667133|54801894|FG011|Phase 2: Dose-expansion|Death|0|||
28137361|NCT01667133|54801883|FG000|Phase 2: Dose-expansion|Other|0|||
28137362|NCT01667133|54801884|FG001|Phase 2: Dose-expansion|Other|0|||
28137363|NCT01667133|54801885|FG002|Phase 2: Dose-expansion|Other|0|||
28137364|NCT01667133|54801886|FG003|Phase 2: Dose-expansion|Other|0|||
28137365|NCT01667133|54801887|FG004|Phase 2: Dose-expansion|Other|0|||
28137366|NCT01667133|54801888|FG005|Phase 2: Dose-expansion|Other|0|||
28137367|NCT01667133|54801889|FG006|Phase 2: Dose-expansion|Other|0|||
28137368|NCT01667133|54801890|FG007|Phase 2: Dose-expansion|Other|0|||
28137369|NCT01667133|54801891|FG008|Phase 2: Dose-expansion|Other|0|||
28137370|NCT01667133|54801892|FG009|Phase 2: Dose-expansion|Other|0|||
28137371|NCT01667133|54801893|FG010|Phase 2: Dose-expansion|Other|0|||
28137372|NCT01667133|54801894|FG011|Phase 2: Dose-expansion|Other|1|||
28137373|NCT01181778|54801955|FG000|Overall Study|Physician Decision|48|||
28137374|NCT00092118|54801963|FG000|Overall Study|Adverse Event|35|||
28137375|NCT00092118|54801964|FG001|Overall Study|Adverse Event|32|||
28137376|NCT00092118|54801963|FG000|Overall Study|Lack of Efficacy|12|||
28137377|NCT00092118|54801964|FG001|Overall Study|Lack of Efficacy|14|||
28137378|NCT00092118|54801963|FG000|Overall Study|Lost to Follow-up|4|||
28137379|NCT00092118|54801964|FG001|Overall Study|Lost to Follow-up|3|||
28137380|NCT00092118|54801963|FG000|Overall Study|Protocol Violation|23|||
28137381|NCT00092118|54801964|FG001|Overall Study|Protocol Violation|25|||
28137382|NCT00092118|54801963|FG000|Overall Study|Withdrawal by Subject|4|||
28137383|NCT00092118|54801964|FG001|Overall Study|Withdrawal by Subject|10|||
28137384|NCT00092118|54801963|FG000|Overall Study|Other|6|||
28137385|NCT00092118|54801964|FG001|Overall Study|Other|5|||
28137386|NCT03261947|54801975|FG000|Overall Study|Death|10|||
28137387|NCT03261947|54801976|FG001|Overall Study|Death|13|||
28137388|NCT03261947|54801977|FG002|Overall Study|Death|17|||
28137389|NCT03261947|54801978|FG003|Overall Study|Death|12|||
28137390|NCT03261947|54801979|FG004|Overall Study|Death|8|||
28137391|NCT03261947|54801975|FG000|Overall Study|Lost to Follow-up|0|||
28137392|NCT03261947|54801976|FG001|Overall Study|Lost to Follow-up|0|||
28137393|NCT03261947|54801977|FG002|Overall Study|Lost to Follow-up|2|||
28137394|NCT03261947|54801978|FG003|Overall Study|Lost to Follow-up|1|||
28137395|NCT03261947|54801979|FG004|Overall Study|Lost to Follow-up|0|||
28137396|NCT03261947|54801975|FG000|Overall Study|Withdrawal by Subject|0|||
27941070|NCT01028391|54597398|FG001|Overall Study|Lack of Efficacy|2|||
28137397|NCT03261947|54801976|FG001|Overall Study|Withdrawal by Subject|0|||
28137398|NCT03261947|54801977|FG002|Overall Study|Withdrawal by Subject|3|||
28137399|NCT03261947|54801978|FG003|Overall Study|Withdrawal by Subject|0|||
28137400|NCT03261947|54801979|FG004|Overall Study|Withdrawal by Subject|1|||
28137401|NCT03261947|54801975|FG000|Overall Study|Site Terminated by Sponsor|0|||
28137402|NCT03261947|54801976|FG001|Overall Study|Site Terminated by Sponsor|0|||
28137403|NCT03261947|54801977|FG002|Overall Study|Site Terminated by Sponsor|4|||
28137404|NCT03261947|54801978|FG003|Overall Study|Site Terminated by Sponsor|7|||
28137405|NCT03261947|54801979|FG004|Overall Study|Site Terminated by Sponsor|5|||
28137406|NCT03261947|54801975|FG000|Overall Study|Reason not Specified|2|||
28137407|NCT03261947|54801976|FG001|Overall Study|Reason not Specified|0|||
28137408|NCT03261947|54801977|FG002|Overall Study|Reason not Specified|4|||
28137409|NCT03261947|54801978|FG003|Overall Study|Reason not Specified|1|||
28137410|NCT03261947|54801979|FG004|Overall Study|Reason not Specified|3|||
28137411|NCT03034044|54801995|FG000|Overall Study|Enrolled, but not received Xyntha|1|||
28137412|NCT03098979|54802014|FG000|Overall Study|Adverse Event|1|||
28137413|NCT03098979|54802015|FG001|Overall Study|Adverse Event|0|||
28137414|NCT03098979|54802016|FG002|Overall Study|Adverse Event|1|||
28137415|NCT03098979|54802017|FG003|Overall Study|Adverse Event|4|||
28137416|NCT03098979|54802018|FG004|Overall Study|Adverse Event|6|||
28137417|NCT03098979|54802019|FG005|Overall Study|Adverse Event|1|||
28137418|NCT03098979|54802014|FG000|Overall Study|Withdrawal by Subject|2|||
28137419|NCT03098979|54802015|FG001|Overall Study|Withdrawal by Subject|1|||
28137420|NCT03098979|54802016|FG002|Overall Study|Withdrawal by Subject|1|||
28137421|NCT03098979|54802017|FG003|Overall Study|Withdrawal by Subject|1|||
28137422|NCT03098979|54802018|FG004|Overall Study|Withdrawal by Subject|2|||
27821388|NCT01397409|54283496|FG002|Stage 2|Adverse Event|0|||
27821389|NCT01397409|54283497|FG003|Stage 2|Adverse Event|0|||
27821390|NCT01397409|54283498|FG004|Stage 2|Adverse Event|6|||
27821391|NCT01397409|54283499|FG005|Stage 2|Adverse Event|3|||
27821392|NCT01397409|54283500|FG006|Stage 2|Adverse Event|0|||
27821393|NCT01397409|54283501|FG007|Stage 2|Adverse Event|0|||
27821394|NCT01397409|54283502|FG008|Stage 2|Adverse Event|0|||
28137423|NCT03098979|54802019|FG005|Overall Study|Withdrawal by Subject|1|||
28137424|NCT03098979|54802014|FG000|Overall Study|Death|1|||
28137425|NCT03098979|54802015|FG001|Overall Study|Death|0|||
27821395|NCT01397409|54283503|FG009|Stage 2|Adverse Event|0|||
27821396|NCT01397409|54283494|FG000|Stage 2|Personal Reasons|0|||
27821397|NCT01397409|54283495|FG001|Stage 2|Personal Reasons|0|||
27821398|NCT01397409|54283496|FG002|Stage 2|Personal Reasons|0|||
27821399|NCT01397409|54283497|FG003|Stage 2|Personal Reasons|0|||
27821400|NCT01397409|54283498|FG004|Stage 2|Personal Reasons|1|||
27821401|NCT01397409|54283499|FG005|Stage 2|Personal Reasons|0|||
27821402|NCT01397409|54283500|FG006|Stage 2|Personal Reasons|0|||
28137426|NCT03098979|54802016|FG002|Overall Study|Death|2|||
28137427|NCT03098979|54802017|FG003|Overall Study|Death|0|||
28137428|NCT03098979|54802018|FG004|Overall Study|Death|1|||
28137429|NCT03098979|54802019|FG005|Overall Study|Death|0|||
28137430|NCT03098979|54802014|FG000|Overall Study|Physician Decision|2|||
28137431|NCT03098979|54802015|FG001|Overall Study|Physician Decision|1|||
28137432|NCT03098979|54802016|FG002|Overall Study|Physician Decision|0|||
28137433|NCT03098979|54802017|FG003|Overall Study|Physician Decision|0|||
28137434|NCT03098979|54802018|FG004|Overall Study|Physician Decision|0|||
28137435|NCT03098979|54802019|FG005|Overall Study|Physician Decision|0|||
27821403|NCT01397409|54283501|FG007|Stage 2|Personal Reasons|0|||
27821404|NCT01397409|54283502|FG008|Stage 2|Personal Reasons|0|||
27821405|NCT01397409|54283503|FG009|Stage 2|Personal Reasons|0|||
27821406|NCT01397409|54283494|FG000|Stage 2|Other Miscellaneous Reasons|0|||
28069955|NCT00006604|54724944|FG002|Overall Study|Severe debilitation, unable to continue|0|||
28069956|NCT00006604|54724945|FG003|Overall Study|Severe debilitation, unable to continue|0|||
28069957|NCT00006604|54724946|FG004|Overall Study|Severe debilitation, unable to continue|0|||
28069958|NCT00006604|54724947|FG005|Overall Study|Severe debilitation, unable to continue|0|||
28069959|NCT00006604|54724948|FG006|Overall Study|Severe debilitation, unable to continue|3|||
28069960|NCT00006604|54724949|FG007|Overall Study|Severe debilitation, unable to continue|0|||
28069961|NCT00006604|54724950|FG008|Overall Study|Severe debilitation, unable to continue|0|||
28069962|NCT00006604|54724951|FG009|Overall Study|Severe debilitation, unable to continue|5|||
28069963|NCT00006604|54724952|FG010|Overall Study|Severe debilitation, unable to continue|0|||
28069964|NCT00006604|54724953|FG011|Overall Study|Severe debilitation, unable to continue|2|||
28069965|NCT00006604|54724954|FG012|Overall Study|Severe debilitation, unable to continue|1|||
28069966|NCT00006604|54724955|FG013|Overall Study|Severe debilitation, unable to continue|0|||
28069967|NCT00006604|54724956|FG014|Overall Study|Severe debilitation, unable to continue|2|||
28069968|NCT00006604|54724957|FG015|Overall Study|Severe debilitation, unable to continue|0|||
28069969|NCT00006604|54724958|FG016|Overall Study|Severe debilitation, unable to continue|0|||
28069970|NCT00006604|54724942|FG000|Overall Study|Subj/Parent not able to get to clinic|0|||
28069971|NCT00006604|54724943|FG001|Overall Study|Subj/Parent not able to get to clinic|0|||
28069972|NCT00006604|54724944|FG002|Overall Study|Subj/Parent not able to get to clinic|0|||
27821407|NCT01397409|54283495|FG001|Stage 2|Other Miscellaneous Reasons|0|||
27821408|NCT01397409|54283496|FG002|Stage 2|Other Miscellaneous Reasons|0|||
27821409|NCT01397409|54283497|FG003|Stage 2|Other Miscellaneous Reasons|0|||
27821410|NCT01397409|54283498|FG004|Stage 2|Other Miscellaneous Reasons|1|||
28069973|NCT00006604|54724945|FG003|Overall Study|Subj/Parent not able to get to clinic|1|||
28137436|NCT03098979|54802014|FG000|Overall Study|Non-compliance|0|||
28137437|NCT03098979|54802015|FG001|Overall Study|Non-compliance|0|||
28137438|NCT03098979|54802016|FG002|Overall Study|Non-compliance|0|||
27821411|NCT01397409|54283499|FG005|Stage 2|Other Miscellaneous Reasons|1|||
28137439|NCT03098979|54802017|FG003|Overall Study|Non-compliance|0|||
28137440|NCT03098979|54802018|FG004|Overall Study|Non-compliance|0|||
28137441|NCT03098979|54802019|FG005|Overall Study|Non-compliance|1|||
28137442|NCT03098979|54802014|FG000|Overall Study|Protocol Violation|0|||
28137443|NCT03098979|54802015|FG001|Overall Study|Protocol Violation|0|||
28137444|NCT03098979|54802016|FG002|Overall Study|Protocol Violation|0|||
28137445|NCT03098979|54802017|FG003|Overall Study|Protocol Violation|0|||
28137446|NCT03098979|54802018|FG004|Overall Study|Protocol Violation|0|||
28137447|NCT03098979|54802019|FG005|Overall Study|Protocol Violation|1|||
28137448|NCT03261167|54802035|FG000|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0|||
28137449|NCT03261167|54802036|FG001|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3|||
28137450|NCT03261167|54802035|FG000|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3|||
28137451|NCT03261167|54802036|FG001|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1|||
28137452|NCT03261167|54802035|FG000|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1|||
28137453|NCT03261167|54802036|FG001|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0|||
28137454|NCT03261167|54802035|FG000|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1|||
28137455|NCT03261167|54802036|FG001|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0|||
28137456|NCT03261167|54802035|FG000|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
28137457|NCT03261167|54802036|FG001|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
27821412|NCT01397409|54283500|FG006|Stage 2|Other Miscellaneous Reasons|0|||
27821413|NCT01397409|54283501|FG007|Stage 2|Other Miscellaneous Reasons|0|||
28137458|NCT03294941|54802050|FG000|Overall Study|Withdrawal by Subject|0|||
28137459|NCT03294941|54802051|FG001|Overall Study|Withdrawal by Subject|2|||
28137460|NCT03098433|54802058|FG000|Overall Study|Withdrawal by Subject|10|||
28137461|NCT03294317|54802063|FG000|Overall Study|Physician Decision|1|||
28137462|NCT03294317|54802063|FG000|Overall Study|Withdrawal by Subject|6|||
28137463|NCT03294317|54802063|FG000|Overall Study|Lost to Follow-up|1|||
28137464|NCT03294317|54802063|FG000|Overall Study|Did not meet inclusion/exclusion criteria|1|||
28137465|NCT03294317|54802063|FG000|Overall Study|Failed HB lead implant|8|||
28137466|NCT03294317|54802063|FG000|Overall Study|Received CRT instead|1|||
28137467|NCT03294317|54802063|FG000|Overall Study|Exited after lead revision|2|||
28137468|NCT03292913|54802069|FG000|Overall Study|Death|9|||
28137469|NCT03292913|54802070|FG001|Overall Study|Death|3|||
28137470|NCT03292913|54802069|FG000|Overall Study|Lost to Follow-up|49|||
28137471|NCT03292913|54802070|FG001|Overall Study|Lost to Follow-up|49|||
28137472|NCT03292913|54802069|FG000|Overall Study|Withdrawal by Subject|2|||
28137473|NCT03292913|54802070|FG001|Overall Study|Withdrawal by Subject|0|||
28137474|NCT03292913|54802069|FG000|Overall Study|Clinic closed due to COVID|22|||
28137475|NCT03292913|54802070|FG001|Overall Study|Clinic closed due to COVID|36|||
28137476|NCT03291587|54802082|FG000|Overall Study|Lost to Follow-up|62|||
28137477|NCT03291587|54802083|FG001|Overall Study|Lost to Follow-up|43|||
28137478|NCT03291587|54802082|FG000|Overall Study|Refused to Answer|5|||
28137479|NCT03291587|54802083|FG001|Overall Study|Refused to Answer|2|||
28137480|NCT03291587|54802082|FG000|Overall Study|Death|2|||
28137481|NCT03291587|54802083|FG001|Overall Study|Death|4|||
28137482|NCT03291587|54802082|FG000|Overall Study|Not interested in participating|8|||
28137483|NCT03291587|54802083|FG001|Overall Study|Not interested in participating|6|||
28137484|NCT03291587|54802082|FG000|Overall Study|Too busy to participate|4|||
28137485|NCT03291587|54802083|FG001|Overall Study|Too busy to participate|2|||
28137486|NCT03210961|54802114|FG000|Overall Study|Adverse Event|0|||
28137487|NCT03210961|54802115|FG001|Overall Study|Adverse Event|0|||
28137488|NCT03210961|54802116|FG002|Overall Study|Adverse Event|0|||
28137489|NCT03210961|54802117|FG003|Overall Study|Adverse Event|0|||
28137490|NCT03210961|54802118|FG004|Overall Study|Adverse Event|0|||
28137491|NCT03210961|54802119|FG005|Overall Study|Adverse Event|0|||
28137492|NCT03210961|54802120|FG006|Overall Study|Adverse Event|0|||
28137493|NCT03210961|54802121|FG007|Overall Study|Adverse Event|0|||
28137494|NCT03210961|54802122|FG008|Overall Study|Adverse Event|0|||
28137495|NCT03210961|54802123|FG009|Overall Study|Adverse Event|0|||
28137496|NCT03210961|54802124|FG010|Overall Study|Adverse Event|0|||
28137497|NCT03210961|54802125|FG011|Overall Study|Adverse Event|0|||
28137498|NCT03210961|54802126|FG012|Overall Study|Adverse Event|0|||
28137499|NCT03210961|54802127|FG013|Overall Study|Adverse Event|1|||
28137500|NCT03210961|54802128|FG014|Overall Study|Adverse Event|0|||
28137501|NCT03210961|54802114|FG000|Overall Study|Lost to Follow-up|0|||
28069974|NCT00006604|54724946|FG004|Overall Study|Subj/Parent not able to get to clinic|1|||
28069975|NCT00006604|54724947|FG005|Overall Study|Subj/Parent not able to get to clinic|0|||
28069976|NCT00006604|54724948|FG006|Overall Study|Subj/Parent not able to get to clinic|1|||
28069977|NCT00006604|54724949|FG007|Overall Study|Subj/Parent not able to get to clinic|0|||
28069978|NCT00006604|54724950|FG008|Overall Study|Subj/Parent not able to get to clinic|0|||
28069979|NCT00006604|54724951|FG009|Overall Study|Subj/Parent not able to get to clinic|1|||
28069980|NCT00006604|54724952|FG010|Overall Study|Subj/Parent not able to get to clinic|2|||
28137502|NCT03210961|54802115|FG001|Overall Study|Lost to Follow-up|0|||
28137503|NCT03210961|54802116|FG002|Overall Study|Lost to Follow-up|0|||
28137504|NCT03210961|54802117|FG003|Overall Study|Lost to Follow-up|0|||
28137505|NCT03210961|54802118|FG004|Overall Study|Lost to Follow-up|0|||
28137506|NCT03210961|54802119|FG005|Overall Study|Lost to Follow-up|0|||
28137507|NCT03210961|54802120|FG006|Overall Study|Lost to Follow-up|0|||
28137508|NCT03210961|54802121|FG007|Overall Study|Lost to Follow-up|0|||
28137509|NCT03210961|54802122|FG008|Overall Study|Lost to Follow-up|0|||
27941071|NCT01028391|54597397|FG000|Overall Study|Lost to Follow-up|3|||
28137510|NCT03210961|54802123|FG009|Overall Study|Lost to Follow-up|0|||
28137511|NCT03210961|54802124|FG010|Overall Study|Lost to Follow-up|0|||
28137512|NCT03210961|54802125|FG011|Overall Study|Lost to Follow-up|0|||
28137513|NCT03210961|54802126|FG012|Overall Study|Lost to Follow-up|0|||
28137514|NCT03210961|54802127|FG013|Overall Study|Lost to Follow-up|0|||
28137515|NCT03210961|54802128|FG014|Overall Study|Lost to Follow-up|1|||
28137516|NCT03210961|54802114|FG000|Overall Study|Withdrawal by Subject|0|||
28137517|NCT03210961|54802115|FG001|Overall Study|Withdrawal by Subject|0|||
28137518|NCT03210961|54802116|FG002|Overall Study|Withdrawal by Subject|0|||
28137519|NCT03210961|54802117|FG003|Overall Study|Withdrawal by Subject|0|||
28137520|NCT03210961|54802118|FG004|Overall Study|Withdrawal by Subject|0|||
28137521|NCT03210961|54802119|FG005|Overall Study|Withdrawal by Subject|0|||
28137522|NCT03210961|54802120|FG006|Overall Study|Withdrawal by Subject|0|||
28137523|NCT03210961|54802121|FG007|Overall Study|Withdrawal by Subject|0|||
28137524|NCT03210961|54802122|FG008|Overall Study|Withdrawal by Subject|0|||
28137525|NCT03210961|54802123|FG009|Overall Study|Withdrawal by Subject|0|||
28137526|NCT03210961|54802124|FG010|Overall Study|Withdrawal by Subject|0|||
28137527|NCT03210961|54802125|FG011|Overall Study|Withdrawal by Subject|0|||
28137528|NCT03210961|54802126|FG012|Overall Study|Withdrawal by Subject|0|||
28137529|NCT03210961|54802127|FG013|Overall Study|Withdrawal by Subject|0|||
28137530|NCT03210961|54802128|FG014|Overall Study|Withdrawal by Subject|1|||
28137531|NCT03210961|54802114|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
28137532|NCT03210961|54802115|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
28137533|NCT03210961|54802116|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
28137534|NCT03210961|54802117|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
28137535|NCT03210961|54802118|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
28137536|NCT03210961|54802119|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
28137537|NCT03210961|54802120|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
28137538|NCT03210961|54802121|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
28137539|NCT03210961|54802122|FG008|Overall Study|No Longer Meets Eligibility Criteria|0|||
28137540|NCT03210961|54802123|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
28137541|NCT03210961|54802124|FG010|Overall Study|No Longer Meets Eligibility Criteria|0|||
28137542|NCT03210961|54802125|FG011|Overall Study|No Longer Meets Eligibility Criteria|0|||
28137543|NCT03210961|54802126|FG012|Overall Study|No Longer Meets Eligibility Criteria|0|||
28137544|NCT03210961|54802127|FG013|Overall Study|No Longer Meets Eligibility Criteria|1|||
28137545|NCT03210961|54802128|FG014|Overall Study|No Longer Meets Eligibility Criteria|0|||
28137546|NCT03210961|54802114|FG000|Overall Study|Other|0|||
28069981|NCT00006604|54724953|FG011|Overall Study|Subj/Parent not able to get to clinic|1|||
28069982|NCT00006604|54724954|FG012|Overall Study|Subj/Parent not able to get to clinic|1|||
28069983|NCT00006604|54724955|FG013|Overall Study|Subj/Parent not able to get to clinic|1|||
28069984|NCT00006604|54724956|FG014|Overall Study|Subj/Parent not able to get to clinic|3|||
28069985|NCT00006604|54724957|FG015|Overall Study|Subj/Parent not able to get to clinic|0|||
28069986|NCT00006604|54724958|FG016|Overall Study|Subj/Parent not able to get to clinic|0|||
28069987|NCT00006604|54724942|FG000|Overall Study|Site closing|0|||
28069988|NCT00006604|54724943|FG001|Overall Study|Site closing|0|||
28069989|NCT00006604|54724944|FG002|Overall Study|Site closing|1|||
28069990|NCT00006604|54724945|FG003|Overall Study|Site closing|1|||
28069991|NCT00006604|54724946|FG004|Overall Study|Site closing|0|||
28069992|NCT00006604|54724947|FG005|Overall Study|Site closing|0|||
28137547|NCT03210961|54802115|FG001|Overall Study|Other|0|||
28137548|NCT03210961|54802116|FG002|Overall Study|Other|0|||
28069993|NCT00006604|54724948|FG006|Overall Study|Site closing|0|||
28069994|NCT00006604|54724949|FG007|Overall Study|Site closing|1|||
28069995|NCT00006604|54724950|FG008|Overall Study|Site closing|0|||
28069996|NCT00006604|54724951|FG009|Overall Study|Site closing|0|||
28137549|NCT03210961|54802117|FG003|Overall Study|Other|1|||
28137550|NCT03210961|54802118|FG004|Overall Study|Other|0|||
28137551|NCT03210961|54802119|FG005|Overall Study|Other|0|||
28137552|NCT03210961|54802120|FG006|Overall Study|Other|1|||
28137553|NCT03210961|54802121|FG007|Overall Study|Other|0|||
28137554|NCT03210961|54802122|FG008|Overall Study|Other|0|||
28137555|NCT03210961|54802123|FG009|Overall Study|Other|0|||
28137556|NCT03210961|54802124|FG010|Overall Study|Other|1|||
28137557|NCT03210961|54802125|FG011|Overall Study|Other|0|||
28137558|NCT03210961|54802126|FG012|Overall Study|Other|2|||
28137559|NCT03210961|54802127|FG013|Overall Study|Other|2|||
28137560|NCT03210961|54802128|FG014|Overall Study|Other|0|||
28137561|NCT03242759|54802181|FG000|Overall Study|Adverse Event|5|||
27821414|NCT01397409|54283502|FG008|Stage 2|Other Miscellaneous Reasons|0|||
27821415|NCT01397409|54283503|FG009|Stage 2|Other Miscellaneous Reasons|0|||
27821416|NCT01397409|54283494|FG000|Stage 3|Adverse Event|0|||
27821417|NCT01397409|54283495|FG001|Stage 3|Adverse Event|0|||
27821418|NCT01397409|54283496|FG002|Stage 3|Adverse Event|0|||
27821419|NCT01397409|54283497|FG003|Stage 3|Adverse Event|0|||
27821420|NCT01397409|54283498|FG004|Stage 3|Adverse Event|0|||
27821421|NCT01397409|54283499|FG005|Stage 3|Adverse Event|0|||
27821422|NCT01397409|54283500|FG006|Stage 3|Adverse Event|0|||
27821423|NCT01397409|54283501|FG007|Stage 3|Adverse Event|1|||
27821424|NCT01397409|54283502|FG008|Stage 3|Adverse Event|0|||
27821425|NCT01397409|54283503|FG009|Stage 3|Adverse Event|0|||
27821426|NCT01397409|54283494|FG000|Stage 3|Other Miscellaneous Reasons|0|||
27821427|NCT01397409|54283495|FG001|Stage 3|Other Miscellaneous Reasons|0|||
27821428|NCT01397409|54283496|FG002|Stage 3|Other Miscellaneous Reasons|0|||
27821429|NCT01397409|54283497|FG003|Stage 3|Other Miscellaneous Reasons|0|||
27821430|NCT01397409|54283498|FG004|Stage 3|Other Miscellaneous Reasons|0|||
27821431|NCT01397409|54283499|FG005|Stage 3|Other Miscellaneous Reasons|0|||
27821432|NCT01397409|54283500|FG006|Stage 3|Other Miscellaneous Reasons|0|||
27821433|NCT01397409|54283501|FG007|Stage 3|Other Miscellaneous Reasons|1|||
27821434|NCT01397409|54283502|FG008|Stage 3|Other Miscellaneous Reasons|0|||
27821435|NCT01397409|54283503|FG009|Stage 3|Other Miscellaneous Reasons|0|||
28137562|NCT03242759|54802182|FG001|Overall Study|Adverse Event|1|||
28137563|NCT03242759|54802181|FG000|Overall Study|Withdrawal by Subject|4|||
28137564|NCT03242759|54802182|FG001|Overall Study|Withdrawal by Subject|3|||
28137565|NCT03242759|54802181|FG000|Overall Study|Lost to Follow-up|3|||
27821436|NCT01397253|54283528|FG000|Overall Study|Reviewed by only 1 pharmacist|126|||
27821437|NCT01397253|54283529|FG001|Overall Study|Reviewed by only 1 pharmacist|149|||
28137566|NCT03242759|54802182|FG001|Overall Study|Lost to Follow-up|1|||
28137567|NCT03242759|54802181|FG000|Overall Study|Administrative problems|1|||
28137568|NCT03242759|54802182|FG001|Overall Study|Administrative problems|1|||
28137569|NCT03242759|54802181|FG000|Overall Study|Death|22|||
28137570|NCT03242759|54802182|FG001|Overall Study|Death|0|||
28137571|NCT03242759|54802181|FG000|Overall Study|Change visit schedule|0|||
28137572|NCT03242759|54802182|FG001|Overall Study|Change visit schedule|1|||
28137573|NCT03097029|54802188|FG000|Overall Study|Withdrawal by Subject|1|||
28137574|NCT03257813|54802194|FG000|Overall Study|Protocol Violation|6|||
28137575|NCT03257813|54802195|FG001|Overall Study|Protocol Violation|3|||
28137576|NCT03210259|54802206|FG000|12-Week Run-in Period|Adverse Event|1|||
28137577|NCT03210259|54802207|FG001|12-Week Run-in Period|Adverse Event|0|||
28137578|NCT03210259|54802208|FG002|12-Week Run-in Period|Adverse Event|0|||
28137579|NCT03210259|54802206|FG000|12-Week Run-in Period|Death|1|||
28137580|NCT03210259|54802207|FG001|12-Week Run-in Period|Death|0|||
28137581|NCT03210259|54802208|FG002|12-Week Run-in Period|Death|0|||
28137582|NCT03210259|54802206|FG000|12-Week Run-in Period|Withdrawal by Subject|9|||
28137583|NCT03210259|54802207|FG001|12-Week Run-in Period|Withdrawal by Subject|0|||
28137584|NCT03210259|54802208|FG002|12-Week Run-in Period|Withdrawal by Subject|0|||
28137585|NCT03210259|54802206|FG000|12-Week Run-in Period|Lost to Follow-up|4|||
28137586|NCT03210259|54802207|FG001|12-Week Run-in Period|Lost to Follow-up|0|||
28137587|NCT03210259|54802208|FG002|12-Week Run-in Period|Lost to Follow-up|0|||
28137588|NCT03210259|54802206|FG000|12-Week Run-in Period|Lack of Efficacy|6|||
28137589|NCT03210259|54802207|FG001|12-Week Run-in Period|Lack of Efficacy|0|||
28137590|NCT03210259|54802208|FG002|12-Week Run-in Period|Lack of Efficacy|0|||
28137591|NCT03210259|54802206|FG000|48-Week Randomized Responder Period|Missed study visit|0|||
27821438|NCT01777334|54283537|FG000|Overall Study|Adverse Event|18|||
27821439|NCT01777334|54283538|FG001|Overall Study|Adverse Event|14|||
27821440|NCT01777334|54283537|FG000|Overall Study|Lack of Efficacy|15|||
27821441|NCT01777334|54283538|FG001|Overall Study|Lack of Efficacy|29|||
27821442|NCT01777334|54283537|FG000|Overall Study|Protocol Violation|3|||
27821443|NCT01777334|54283538|FG001|Overall Study|Protocol Violation|7|||
28137592|NCT03210259|54802207|FG001|48-Week Randomized Responder Period|Missed study visit|1|||
28137593|NCT03210259|54802208|FG002|48-Week Randomized Responder Period|Missed study visit|2|||
28137594|NCT03210259|54802206|FG000|48-Week Randomized Responder Period|Lost to Follow-up|0|||
28137595|NCT03210259|54802207|FG001|48-Week Randomized Responder Period|Lost to Follow-up|3|||
27821444|NCT01777334|54283537|FG000|Overall Study|Lost to Follow-up|3|||
28137596|NCT03210259|54802208|FG002|48-Week Randomized Responder Period|Lost to Follow-up|8|||
28137597|NCT03210259|54802206|FG000|48-Week Randomized Responder Period|Pregnancy|0|||
28137598|NCT03210259|54802207|FG001|48-Week Randomized Responder Period|Pregnancy|1|||
28137599|NCT03210259|54802208|FG002|48-Week Randomized Responder Period|Pregnancy|0|||
28137600|NCT03210259|54802206|FG000|48-Week Randomized Responder Period|Physician Decision|0|||
28137601|NCT03210259|54802207|FG001|48-Week Randomized Responder Period|Physician Decision|0|||
27821445|NCT01777334|54283538|FG001|Overall Study|Lost to Follow-up|2|||
27821446|NCT01777334|54283537|FG000|Overall Study|Withdrawal by Subject|14|||
27821447|NCT01777334|54283538|FG001|Overall Study|Withdrawal by Subject|11|||
27821448|NCT01383993|54283547|FG000|Overall Study|Adverse Event|1|||
27821449|NCT01383993|54283548|FG001|Overall Study|Adverse Event|1|||
27821450|NCT01383993|54283549|FG002|Overall Study|Adverse Event|0|||
27821451|NCT01383993|54283547|FG000|Overall Study|Withdrawal by Subject|0|||
27821452|NCT01383993|54283548|FG001|Overall Study|Withdrawal by Subject|0|||
27821453|NCT01383993|54283549|FG002|Overall Study|Withdrawal by Subject|1|||
27821454|NCT01383993|54283547|FG000|Overall Study|Marketed voriconazole in post-therapy|2|||
27821455|NCT01383993|54283548|FG001|Overall Study|Marketed voriconazole in post-therapy|0|||
27821456|NCT01383993|54283549|FG002|Overall Study|Marketed voriconazole in post-therapy|0|||
27821457|NCT01396395|54283560|FG000|Overall Study|Withdrawal by Subject|10|||
27821458|NCT01396395|54283561|FG001|Overall Study|Withdrawal by Subject|12|||
27821459|NCT01396395|54283560|FG000|Overall Study|Protocol Violation|3|||
27821460|NCT01396395|54283561|FG001|Overall Study|Protocol Violation|1|||
27821461|NCT01396395|54283560|FG000|Overall Study|Adverse Event|10|||
27821462|NCT01396395|54283561|FG001|Overall Study|Adverse Event|2|||
27821463|NCT01396395|54283560|FG000|Overall Study|Lost to Follow-up|17|||
27821464|NCT01396395|54283561|FG001|Overall Study|Lost to Follow-up|11|||
27821465|NCT01396395|54283560|FG000|Overall Study|Other|0|||
27821466|NCT01396395|54283561|FG001|Overall Study|Other|1|||
27821467|NCT01396317|54283571|FG000|Overall Study|Adverse Event|1|||
27821468|NCT01396317|54283572|FG001|Overall Study|Adverse Event|0|||
27821469|NCT01396161|54283587|FG000|Overall Study|Withdrawal by Subject|0|||
27821470|NCT01396161|54283588|FG001|Overall Study|Withdrawal by Subject|0|||
27821471|NCT01396161|54283589|FG002|Overall Study|Withdrawal by Subject|0|||
27821472|NCT01396161|54283590|FG003|Overall Study|Withdrawal by Subject|0|||
27821473|NCT01396161|54283591|FG004|Overall Study|Withdrawal by Subject|1|||
27821474|NCT01396161|54283592|FG005|Overall Study|Withdrawal by Subject|0|||
27821475|NCT01396161|54283593|FG006|Overall Study|Withdrawal by Subject|0|||
27821476|NCT01396161|54283587|FG000|Overall Study|Other|0|||
27821477|NCT01396161|54283588|FG001|Overall Study|Other|0|||
27821478|NCT01396161|54283589|FG002|Overall Study|Other|0|||
27821479|NCT01396161|54283590|FG003|Overall Study|Other|0|||
27821480|NCT01396161|54283591|FG004|Overall Study|Other|0|||
27821481|NCT01396161|54283592|FG005|Overall Study|Other|0|||
27821482|NCT01396161|54283593|FG006|Overall Study|Other|1|||
27821483|NCT01396083|54283616|FG000|Overall Study|Adverse Event|2|||
27821484|NCT01396083|54283617|FG001|Overall Study|Adverse Event|28|||
27821485|NCT01396083|54283616|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
27821486|NCT01396083|54283617|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
27821487|NCT01396083|54283616|FG000|Overall Study|Consent withdrawn|4|||
27821488|NCT01396083|54283617|FG001|Overall Study|Consent withdrawn|5|||
27821489|NCT01396083|54283616|FG000|Overall Study|Protocol deviation(s)|0|||
27821490|NCT01396083|54283617|FG001|Overall Study|Protocol deviation(s)|1|||
27821491|NCT01396083|54283616|FG000|Overall Study|Abnormal laboratory value(s)|1|||
27821492|NCT01396083|54283617|FG001|Overall Study|Abnormal laboratory value(s)|0|||
27821493|NCT01396083|54283616|FG000|Overall Study|Administrative problems|1|||
28069997|NCT00006604|54724952|FG010|Overall Study|Site closing|0|||
28069998|NCT00006604|54724953|FG011|Overall Study|Site closing|1|||
28069999|NCT00006604|54724954|FG012|Overall Study|Site closing|1|||
28070000|NCT00006604|54724955|FG013|Overall Study|Site closing|1|||
28070001|NCT00006604|54724956|FG014|Overall Study|Site closing|0|||
28070002|NCT00006604|54724957|FG015|Overall Study|Site closing|0|||
28070003|NCT00006604|54724958|FG016|Overall Study|Site closing|1|||
28070004|NCT00006604|54724942|FG000|Overall Study|Withdrawal by Subject|1|||
28070005|NCT00006604|54724943|FG001|Overall Study|Withdrawal by Subject|0|||
28070006|NCT00006604|54724944|FG002|Overall Study|Withdrawal by Subject|2|||
28070007|NCT00006604|54724945|FG003|Overall Study|Withdrawal by Subject|0|||
28070008|NCT00006604|54724946|FG004|Overall Study|Withdrawal by Subject|1|||
28070009|NCT00006604|54724947|FG005|Overall Study|Withdrawal by Subject|2|||
28070010|NCT00006604|54724948|FG006|Overall Study|Withdrawal by Subject|2|||
28070011|NCT00006604|54724949|FG007|Overall Study|Withdrawal by Subject|0|||
28070012|NCT00006604|54724950|FG008|Overall Study|Withdrawal by Subject|1|||
28070013|NCT00006604|54724951|FG009|Overall Study|Withdrawal by Subject|3|||
28070014|NCT00006604|54724952|FG010|Overall Study|Withdrawal by Subject|2|||
28070015|NCT00006604|54724953|FG011|Overall Study|Withdrawal by Subject|0|||
28070016|NCT00006604|54724954|FG012|Overall Study|Withdrawal by Subject|1|||
28070017|NCT00006604|54724955|FG013|Overall Study|Withdrawal by Subject|2|||
28070018|NCT00006604|54724956|FG014|Overall Study|Withdrawal by Subject|1|||
28070019|NCT00006604|54724957|FG015|Overall Study|Withdrawal by Subject|0|||
28137602|NCT03210259|54802208|FG002|48-Week Randomized Responder Period|Physician Decision|1|||
28137603|NCT03210259|54802206|FG000|48-Week Randomized Responder Period|Withdrawal by Subject|0|||
28137604|NCT03210259|54802207|FG001|48-Week Randomized Responder Period|Withdrawal by Subject|5|||
28137605|NCT03210259|54802208|FG002|48-Week Randomized Responder Period|Withdrawal by Subject|17|||
28137606|NCT03210259|54802206|FG000|48-Week Randomized Responder Period|Adverse Event|0|||
28137607|NCT03210259|54802207|FG001|48-Week Randomized Responder Period|Adverse Event|1|||
28137608|NCT03210259|54802208|FG002|48-Week Randomized Responder Period|Adverse Event|1|||
28137609|NCT03257657|54802217|FG000|Overall Study|Lost to Follow-up|0|||
28137610|NCT03257657|54802218|FG001|Overall Study|Lost to Follow-up|3|||
28137611|NCT03257657|54802217|FG000|Overall Study|Withdrawn|0|||
28137612|NCT03257657|54802218|FG001|Overall Study|Withdrawn|1|||
28137613|NCT03257657|54802217|FG000|Overall Study|Noted not eligible right after enrolled|0|||
28137614|NCT03257657|54802218|FG001|Overall Study|Noted not eligible right after enrolled|1|||
28137615|NCT02496611|54802227|FG000|Overall Study|Lost to Follow-up|2|||
28137616|NCT02496611|54802228|FG001|Overall Study|Lost to Follow-up|1|||
28137617|NCT02496611|54802227|FG000|Overall Study|Withdrawal by Subject|5|||
28137618|NCT02496611|54802228|FG001|Overall Study|Withdrawal by Subject|2|||
28137619|NCT03237481|54802238|FG000|Overall Study|Lost to Follow-up|1|||
28137620|NCT03237481|54802239|FG001|Overall Study|Lost to Follow-up|0|||
28137621|NCT03237481|54802240|FG002|Overall Study|Lost to Follow-up|0|||
27821494|NCT01396083|54283617|FG001|Overall Study|Administrative problems|0|||
27821495|NCT01396083|54283616|FG000|Overall Study|Lost to Follow-up|1|||
27821496|NCT01396083|54283617|FG001|Overall Study|Lost to Follow-up|0|||
27821497|NCT01723826|54283627|FG000|Overall Study|Adverse Event|4|||
27821498|NCT01723826|54283628|FG001|Overall Study|Adverse Event|1|||
27821499|NCT01723826|54283629|FG002|Overall Study|Adverse Event|4|||
27821500|NCT01723826|54283630|FG003|Overall Study|Adverse Event|5|||
27821501|NCT01723826|54283627|FG000|Overall Study|Death according to AE eCRF|2|||
27821502|NCT01723826|54283628|FG001|Overall Study|Death according to AE eCRF|3|||
27821503|NCT01723826|54283629|FG002|Overall Study|Death according to AE eCRF|3|||
27821504|NCT01723826|54283630|FG003|Overall Study|Death according to AE eCRF|7|||
27821505|NCT01723826|54283627|FG000|Overall Study|Lost to Follow-up|1|||
27821506|NCT01723826|54283628|FG001|Overall Study|Lost to Follow-up|3|||
27821507|NCT01723826|54283629|FG002|Overall Study|Lost to Follow-up|1|||
27821508|NCT01723826|54283630|FG003|Overall Study|Lost to Follow-up|1|||
27821509|NCT01723826|54283627|FG000|Overall Study|Non-compliance|0|||
28070020|NCT00006604|54724958|FG016|Overall Study|Withdrawal by Subject|1|||
28070021|NCT00006604|54724942|FG000|Overall Study|Subj/parent not willing to adhere to req|0|||
27821510|NCT01723826|54283628|FG001|Overall Study|Non-compliance|1|||
27821511|NCT01723826|54283629|FG002|Overall Study|Non-compliance|3|||
27821512|NCT01723826|54283630|FG003|Overall Study|Non-compliance|3|||
27821513|NCT01723826|54283627|FG000|Overall Study|Non-compliance With Study Drug|0|||
27821514|NCT01723826|54283628|FG001|Overall Study|Non-compliance With Study Drug|1|||
27821515|NCT01723826|54283629|FG002|Overall Study|Non-compliance With Study Drug|0|||
27821516|NCT01723826|54283630|FG003|Overall Study|Non-compliance With Study Drug|0|||
27821517|NCT01723826|54283627|FG000|Overall Study|Other Reason|8|||
27821518|NCT01723826|54283628|FG001|Overall Study|Other Reason|6|||
27821519|NCT01723826|54283629|FG002|Overall Study|Other Reason|12|||
28137622|NCT03237481|54802238|FG000|Overall Study|Protocol Violation|1|||
27821520|NCT01723826|54283630|FG003|Overall Study|Other Reason|14|||
27821521|NCT01723826|54283627|FG000|Overall Study|Physician Decision|1|||
27821522|NCT01723826|54283628|FG001|Overall Study|Physician Decision|3|||
27821523|NCT01723826|54283629|FG002|Overall Study|Physician Decision|4|||
28070022|NCT00006604|54724943|FG001|Overall Study|Subj/parent not willing to adhere to req|0|||
28070023|NCT00006604|54724944|FG002|Overall Study|Subj/parent not willing to adhere to req|1|||
28070024|NCT00006604|54724945|FG003|Overall Study|Subj/parent not willing to adhere to req|3|||
28070025|NCT00006604|54724946|FG004|Overall Study|Subj/parent not willing to adhere to req|0|||
28070026|NCT00006604|54724947|FG005|Overall Study|Subj/parent not willing to adhere to req|0|||
28070027|NCT00006604|54724948|FG006|Overall Study|Subj/parent not willing to adhere to req|3|||
28070028|NCT00006604|54724949|FG007|Overall Study|Subj/parent not willing to adhere to req|1|||
28070029|NCT00006604|54724950|FG008|Overall Study|Subj/parent not willing to adhere to req|0|||
28070030|NCT00006604|54724951|FG009|Overall Study|Subj/parent not willing to adhere to req|6|||
28070031|NCT00006604|54724952|FG010|Overall Study|Subj/parent not willing to adhere to req|3|||
28137623|NCT03237481|54802239|FG001|Overall Study|Protocol Violation|0|||
28137624|NCT03237481|54802240|FG002|Overall Study|Protocol Violation|0|||
27821524|NCT01723826|54283630|FG003|Overall Study|Physician Decision|11|||
27821525|NCT01723826|54283627|FG000|Overall Study|Protocol Violation|1|||
27821526|NCT01723826|54283628|FG001|Overall Study|Protocol Violation|1|||
27821527|NCT01723826|54283629|FG002|Overall Study|Protocol Violation|3|||
27821528|NCT01723826|54283630|FG003|Overall Study|Protocol Violation|1|||
28070032|NCT00006604|54724953|FG011|Overall Study|Subj/parent not willing to adhere to req|0|||
28070033|NCT00006604|54724954|FG012|Overall Study|Subj/parent not willing to adhere to req|0|||
28137625|NCT03237481|54802238|FG000|Overall Study|Withdrawal by Subject|3|||
27821529|NCT01723826|54283627|FG000|Overall Study|Withdrawal by Subject|10|||
27821530|NCT01723826|54283628|FG001|Overall Study|Withdrawal by Subject|17|||
27821531|NCT01723826|54283629|FG002|Overall Study|Withdrawal by Subject|27|||
27821532|NCT01723826|54283630|FG003|Overall Study|Withdrawal by Subject|48|||
27821533|NCT01721954|54283642|FG000|Overall Study|Death|58|||
27821534|NCT01721954|54283643|FG001|Overall Study|Death|64|||
27821535|NCT01721954|54283642|FG000|Overall Study|Withdrawal by Subject|8|||
27821536|NCT01721954|54283643|FG001|Overall Study|Withdrawal by Subject|4|||
27821537|NCT01721954|54283642|FG000|Overall Study|Adverse Event|2|||
27821538|NCT01721954|54283643|FG001|Overall Study|Adverse Event|0|||
27821539|NCT01721954|54283642|FG000|Overall Study|Lost to Follow-up|2|||
28137626|NCT03237481|54802239|FG001|Overall Study|Withdrawal by Subject|2|||
28137627|NCT03237481|54802240|FG002|Overall Study|Withdrawal by Subject|1|||
28137628|NCT03222349|54802248|FG000|Overall Study|Treatment B not done|5|||
28137629|NCT03222349|54802249|FG001|Overall Study|Treatment B not done|0|||
28137630|NCT03222349|54802248|FG000|Overall Study|Lost to Follow-up|1|||
28137631|NCT03222349|54802249|FG001|Overall Study|Lost to Follow-up|2|||
28137632|NCT03222349|54802248|FG000|Overall Study|Withdrawal by Subject|1|||
27821540|NCT01721954|54283643|FG001|Overall Study|Lost to Follow-up|1|||
27821541|NCT01776554|54283651|FG000|Overall Study|Adverse Event|1|||
28070034|NCT00006604|54724955|FG013|Overall Study|Subj/parent not willing to adhere to req|2|||
28070035|NCT00006604|54724956|FG014|Overall Study|Subj/parent not willing to adhere to req|3|||
28137633|NCT03222349|54802249|FG001|Overall Study|Withdrawal by Subject|0|||
28070036|NCT00006604|54724957|FG015|Overall Study|Subj/parent not willing to adhere to req|3|||
28070037|NCT00006604|54724958|FG016|Overall Study|Subj/parent not willing to adhere to req|4|||
28070038|NCT00006604|54724942|FG000|Overall Study|Lost to Follow-up|0|||
28070039|NCT00006604|54724943|FG001|Overall Study|Lost to Follow-up|0|||
28070040|NCT00006604|54724944|FG002|Overall Study|Lost to Follow-up|0|||
28070041|NCT00006604|54724945|FG003|Overall Study|Lost to Follow-up|0|||
28137634|NCT03222349|54802248|FG000|Overall Study|Treatment A not done|0|||
28070042|NCT00006604|54724946|FG004|Overall Study|Lost to Follow-up|0|||
28070043|NCT00006604|54724947|FG005|Overall Study|Lost to Follow-up|0|||
28070044|NCT00006604|54724948|FG006|Overall Study|Lost to Follow-up|0|||
28070045|NCT00006604|54724949|FG007|Overall Study|Lost to Follow-up|1|||
28070046|NCT00006604|54724950|FG008|Overall Study|Lost to Follow-up|0|||
28070047|NCT00006604|54724951|FG009|Overall Study|Lost to Follow-up|2|||
28070048|NCT00006604|54724952|FG010|Overall Study|Lost to Follow-up|0|||
28070049|NCT00006604|54724953|FG011|Overall Study|Lost to Follow-up|0|||
28137635|NCT03222349|54802249|FG001|Overall Study|Treatment A not done|5|||
28137636|NCT03222349|54802248|FG000|Overall Study|Study terminated by sponsor|1|||
28137637|NCT03222349|54802249|FG001|Overall Study|Study terminated by sponsor|0|||
28137638|NCT02927925|54802262|FG000|Overall Study|Death|16|||
28137639|NCT02927925|54802262|FG000|Overall Study|Physician Decision|1|||
28137640|NCT02927925|54802262|FG000|Overall Study|Withdrawal by Subject|11|||
28137641|NCT02927925|54802262|FG000|Overall Study|Other|3|||
28137642|NCT02927925|54802262|FG000|Overall Study|Disease progression at clinical cutoff|1|||
28137643|NCT03208933|54802266|FG000|Overall Study|Death|3|||
28137644|NCT03208933|54802266|FG000|Overall Study|Withdrawal by Subject|3|||
28137645|NCT03208933|54802266|FG000|Overall Study|Adverse Event|1|||
28137646|NCT03208933|54802266|FG000|Overall Study|Lost to Follow-up|2|||
28137647|NCT03208933|54802266|FG000|Overall Study|Physician Decision|3|||
28137648|NCT03208933|54802266|FG000|Overall Study|Protocol Violation|1|||
28137649|NCT02499120|54802272|FG000|Overall Study|Death|45|||
28137650|NCT02499120|54802273|FG001|Overall Study|Death|42|||
28137651|NCT02499120|54802272|FG000|Overall Study|Lost to Follow-up|1|||
28137652|NCT02499120|54802273|FG001|Overall Study|Lost to Follow-up|2|||
28137653|NCT02499120|54802272|FG000|Overall Study|Participant refused further follow-up|1|||
28137654|NCT02499120|54802273|FG001|Overall Study|Participant refused further follow-up|0|||
28137655|NCT02499120|54802272|FG000|Overall Study|Withdrawal by Subject|2|||
28137656|NCT02499120|54802273|FG001|Overall Study|Withdrawal by Subject|5|||
28137657|NCT02499120|54802272|FG000|Overall Study|Other|1|||
27821542|NCT01776554|54283652|FG001|Overall Study|Adverse Event|0|||
28137658|NCT02499120|54802273|FG001|Overall Study|Other|0|||
28137659|NCT02499120|54802272|FG000|Overall Study|Ongoing on study|15|||
28137660|NCT02499120|54802273|FG001|Overall Study|Ongoing on study|11|||
27821543|NCT01776554|54283651|FG000|Overall Study|Withdrawal by Subject|3|||
27821544|NCT01776554|54283652|FG001|Overall Study|Withdrawal by Subject|8|||
28070050|NCT00006604|54724954|FG012|Overall Study|Lost to Follow-up|0|||
28137661|NCT03207763|54802281|FG000|Overall Study|Lost to Follow-up|1|||
27821545|NCT01776554|54283651|FG000|Overall Study|Lost to Follow-up|6|||
27821546|NCT01776554|54283652|FG001|Overall Study|Lost to Follow-up|9|||
28137662|NCT03207763|54802282|FG001|Overall Study|Lost to Follow-up|0|||
28070051|NCT00006604|54724955|FG013|Overall Study|Lost to Follow-up|0|||
28070052|NCT00006604|54724956|FG014|Overall Study|Lost to Follow-up|0|||
28070053|NCT00006604|54724957|FG015|Overall Study|Lost to Follow-up|1|||
28070054|NCT00006604|54724958|FG016|Overall Study|Lost to Follow-up|3|||
28070055|NCT00006604|54724942|FG000|Overall Study|Other Reason|0|||
27821547|NCT01776554|54283651|FG000|Overall Study|Administrative Reason|2|||
27821548|NCT01776554|54283652|FG001|Overall Study|Administrative Reason|5|||
27821549|NCT01776554|54283651|FG000|Overall Study|Protocol Violation|1|||
27821550|NCT01776554|54283652|FG001|Overall Study|Protocol Violation|0|||
27821551|NCT01776554|54283651|FG000|Overall Study|Unclassified|4|||
27821552|NCT01776554|54283652|FG001|Overall Study|Unclassified|1|||
27821553|NCT01776008|54283659|FG000|Overall Study|ineligible|2|||
27821554|NCT01746368|54283665|FG000|Overall Study|Lost to Follow-up|2|||
27821555|NCT01746368|54283666|FG001|Overall Study|Lost to Follow-up|0|||
27821556|NCT01746368|54283665|FG000|Overall Study|Withdrawal by Subject|0|||
27821557|NCT01746368|54283666|FG001|Overall Study|Withdrawal by Subject|1|||
27821558|NCT01381575|54283675|FG000|Overall Study|Serious Adverse Event|1|||
27821559|NCT01381575|54283676|FG001|Overall Study|Serious Adverse Event|0|||
28137663|NCT04766034|54802301|FG000|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
28137664|NCT04766034|54802302|FG001|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
28137665|NCT04766034|54802303|FG002|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
28137666|NCT04766034|54802304|FG003|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
28137667|NCT04766034|54802305|FG004|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|3752|||
28137668|NCT04766034|54802301|FG000|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
28137669|NCT04766034|54802302|FG001|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
28137670|NCT04766034|54802303|FG002|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
28137671|NCT04766034|54802304|FG003|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
28137672|NCT04766034|54802305|FG004|Aim 2 - Pre-Randomization Survey|Did not finish survey|120|||
28137673|NCT04766034|54802301|FG000|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|67|||
28137674|NCT04766034|54802302|FG001|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|86|||
27821560|NCT01381575|54283677|FG002|Overall Study|Serious Adverse Event|0|||
27821561|NCT01381575|54283675|FG000|Overall Study|Non-Serious Adverse Event|0|||
27821562|NCT01381575|54283676|FG001|Overall Study|Non-Serious Adverse Event|0|||
27821563|NCT01381575|54283677|FG002|Overall Study|Non-Serious Adverse Event|1|||
27821564|NCT01381575|54283675|FG000|Overall Study|Protocol Violation|0|||
27821565|NCT01381575|54283676|FG001|Overall Study|Protocol Violation|1|||
27821566|NCT01381575|54283677|FG002|Overall Study|Protocol Violation|1|||
27821567|NCT01381575|54283675|FG000|Overall Study|Withdrawal by Subject|15|||
27821568|NCT01381575|54283676|FG001|Overall Study|Withdrawal by Subject|9|||
27821569|NCT01381575|54283677|FG002|Overall Study|Withdrawal by Subject|7|||
27821570|NCT01381575|54283675|FG000|Overall Study|Migrated/moved from study area|2|||
27821571|NCT01381575|54283676|FG001|Overall Study|Migrated/moved from study area|12|||
27821572|NCT01381575|54283677|FG002|Overall Study|Migrated/moved from study area|2|||
27821573|NCT01381575|54283675|FG000|Overall Study|Lost to Follow-up|8|||
27821574|NCT01381575|54283676|FG001|Overall Study|Lost to Follow-up|17|||
27821575|NCT01381575|54283677|FG002|Overall Study|Lost to Follow-up|9|||
28070056|NCT00006604|54724943|FG001|Overall Study|Other Reason|0|||
28070057|NCT00006604|54724944|FG002|Overall Study|Other Reason|0|||
28070058|NCT00006604|54724945|FG003|Overall Study|Other Reason|0|||
28070059|NCT00006604|54724946|FG004|Overall Study|Other Reason|0|||
28137675|NCT04766034|54802303|FG002|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|75|||
28137676|NCT04766034|54802304|FG003|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|84|||
28137677|NCT04766034|54802305|FG004|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|0|||
28070060|NCT00006604|54724947|FG005|Overall Study|Other Reason|1|||
28070061|NCT00006604|54724948|FG006|Overall Study|Other Reason|0|||
28070062|NCT00006604|54724949|FG007|Overall Study|Other Reason|0|||
28070063|NCT00006604|54724950|FG008|Overall Study|Other Reason|0|||
28070064|NCT00006604|54724951|FG009|Overall Study|Other Reason|1|||
28070065|NCT00006604|54724952|FG010|Overall Study|Other Reason|0|||
28070066|NCT00006604|54724953|FG011|Overall Study|Other Reason|0|||
28070067|NCT00006604|54724954|FG012|Overall Study|Other Reason|0|||
28070068|NCT00006604|54724955|FG013|Overall Study|Other Reason|0|||
28070069|NCT00006604|54724956|FG014|Overall Study|Other Reason|0|||
28070070|NCT00006604|54724957|FG015|Overall Study|Other Reason|0|||
28070071|NCT00006604|54724958|FG016|Overall Study|Other Reason|0|||
27821576|NCT01858363|54283688|FG000|Overall Study|Death|35|||
27821577|NCT01858363|54283689|FG001|Overall Study|Death|9|||
27821578|NCT01858363|54283688|FG000|Overall Study|Withdrawal by Subject|28|||
28070072|NCT00006478|54724981|FG000|Overall Study|Vaccine could not be produced|1|||
28070073|NCT00006478|54724981|FG000|Overall Study|Physician Decision|6|||
28070074|NCT00436007|54724988|FG000|Overall Study|Withdrawal by Subject|5|||
28070075|NCT00436007|54724989|FG001|Overall Study|Withdrawal by Subject|3|||
28070076|NCT00436007|54724990|FG002|Overall Study|Withdrawal by Subject|4|||
28070077|NCT00436007|54724988|FG000|Overall Study|Lost to Follow-up|14|||
28137678|NCT04766034|54802301|FG000|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|206|||
28137679|NCT04766034|54802302|FG001|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|223|||
28137680|NCT04766034|54802303|FG002|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|155|||
28137681|NCT04766034|54802304|FG003|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|198|||
28137682|NCT04766034|54802305|FG004|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|0|||
28137683|NCT03237013|54802320|FG000|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43|||
28137684|NCT03237013|54802321|FG001|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30|||
28137685|NCT03237013|54802322|FG002|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37|||
28137686|NCT03236779|54802332|FG000|Overall Study|Lost to Follow-up|13|||
28137687|NCT03236779|54802333|FG001|Overall Study|Lost to Follow-up|21|||
28137688|NCT03096483|54802341|FG000|Overall Study|Withdrawal by site|1|||
28137689|NCT02932579|54802347|FG000|Overall Study|Withdrawal by Subject|4|||
28137690|NCT02932579|54802348|FG001|Overall Study|Withdrawal by Subject|1|||
28137691|NCT03207451|54802358|FG000|Overall Study|scheduling conflict|1|||
28137692|NCT03207451|54802359|FG001|Overall Study|scheduling conflict|0|||
28137693|NCT03207451|54802360|FG002|Overall Study|scheduling conflict|2|||
28137694|NCT03207451|54802361|FG003|Overall Study|scheduling conflict|2|||
28137695|NCT03207451|54802358|FG000|Overall Study|Adverse Event|0|||
28137696|NCT03207451|54802359|FG001|Overall Study|Adverse Event|0|||
28137697|NCT03207451|54802360|FG002|Overall Study|Adverse Event|0|||
28137698|NCT03207451|54802361|FG003|Overall Study|Adverse Event|1|||
28137699|NCT03350503|54802388|FG000|Overall Study|Adverse Event|5|||
28137700|NCT03350503|54802388|FG000|Overall Study|Withdrawal by Subject|5|||
27821579|NCT01858363|54283689|FG001|Overall Study|Withdrawal by Subject|14|||
27821580|NCT01858363|54283688|FG000|Overall Study|Lost to Follow-up|13|||
27821581|NCT01858363|54283689|FG001|Overall Study|Lost to Follow-up|3|||
27821582|NCT01877551|54283697|FG000|Overall Study|Physician Decision|0|||
27821583|NCT01877551|54283698|FG001|Overall Study|Physician Decision|1|||
27821584|NCT01396005|54283706|FG000|Overall Study|Withdrawal by Subject|0|||
27821585|NCT01396005|54283707|FG001|Overall Study|Withdrawal by Subject|1|||
27821586|NCT01396005|54283706|FG000|Overall Study|Non-compliance with protocol|0|||
27821587|NCT01396005|54283707|FG001|Overall Study|Non-compliance with protocol|1|||
27849887|NCT04753164|54348203|FG001|Overall Study|Lost to Follow-up|6|||
27849888|NCT04753164|54348202|FG000|Overall Study|Other|12|||
27849889|NCT04753164|54348203|FG001|Overall Study|Other|5|||
27849890|NCT04729101|54348211|FG000|Overall Study|Adverse Event|1|||
27849891|NCT04729101|54348212|FG001|Overall Study|Adverse Event|0|||
27849892|NCT04729101|54348211|FG000|Overall Study|Physician Decision|1|||
27941072|NCT01028391|54597398|FG001|Overall Study|Lost to Follow-up|4|||
28070078|NCT00436007|54724989|FG001|Overall Study|Lost to Follow-up|10|||
28070079|NCT00436007|54724990|FG002|Overall Study|Lost to Follow-up|13|||
28137701|NCT03350503|54802388|FG000|Overall Study|Continuation impossible due to move|4|||
28070080|NCT00436007|54724988|FG000|Overall Study|Physician Decision|0|||
28070081|NCT00436007|54724989|FG001|Overall Study|Physician Decision|0|||
28070082|NCT00436007|54724990|FG002|Overall Study|Physician Decision|2|||
28070083|NCT00436007|54724988|FG000|Overall Study|Death|0|||
28070084|NCT00436007|54724989|FG001|Overall Study|Death|1|||
28070085|NCT00436007|54724990|FG002|Overall Study|Death|3|||
28070086|NCT00436007|54724988|FG000|Overall Study|Other|0|||
28070087|NCT00436007|54724989|FG001|Overall Study|Other|0|||
28070088|NCT00436007|54724990|FG002|Overall Study|Other|1|||
28070089|NCT00435461|54725006|FG000|Overall Study|Visit changed to EarlyWithdrawn Visit|1|||
28137702|NCT03350503|54802388|FG000|Overall Study|Physician Decision|3|||
28137703|NCT03288779|54802411|FG000|Overall Study|Withdrawal by Subject|3|||
28137704|NCT03206749|54802418|FG000|Overall Study|Withdrawal of consent|5|||
28137705|NCT03206749|54802419|FG001|Overall Study|Withdrawal of consent|3|||
28137706|NCT03206749|54802420|FG002|Overall Study|Withdrawal of consent|6|||
28137707|NCT03206749|54802418|FG000|Overall Study|Lost to Follow-up|0|||
28137708|NCT03206749|54802419|FG001|Overall Study|Lost to Follow-up|0|||
27821588|NCT01877239|54283715|FG000|Overall Study|Adverse Event|4|||
28137709|NCT03206749|54802420|FG002|Overall Study|Lost to Follow-up|1|||
27821589|NCT01877239|54283715|FG000|Overall Study|Disease Remission|1|||
27821590|NCT01877239|54283715|FG000|Overall Study|Withdrawal by Subject|4|||
28070090|NCT00435461|54725007|FG001|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
28070091|NCT00435461|54725008|FG002|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
28070092|NCT00435461|54725006|FG000|Overall Study|Protocol Violation|6|||
28137710|NCT03255941|54802440|FG000|Overall Study|Not eligible or refused injection|37|||
28137711|NCT03255941|54802441|FG001|Overall Study|Not eligible or refused injection|44|||
28137712|NCT03255941|54802442|FG002|Overall Study|Not eligible or refused injection|5|||
28137713|NCT03255941|54802443|FG003|Overall Study|Not eligible or refused injection|6|||
27821591|NCT01877239|54283715|FG000|Overall Study|Other|2|||
27849893|NCT04729101|54348212|FG001|Overall Study|Physician Decision|0|||
28137714|NCT03255941|54802440|FG000|Overall Study|Did not complete exit interview|1|||
28137715|NCT03255941|54802441|FG001|Overall Study|Did not complete exit interview|2|||
28137716|NCT03255941|54802442|FG002|Overall Study|Did not complete exit interview|0|||
28137717|NCT03255941|54802443|FG003|Overall Study|Did not complete exit interview|0|||
28137718|NCT03255629|54802465|FG000|Overall Study|Adverse Event|1|||
28137719|NCT03255629|54802466|FG001|Overall Study|Adverse Event|0|||
28137720|NCT03255629|54802465|FG000|Overall Study|did not experience hypoglycemia|2|||
28137721|NCT03255629|54802466|FG001|Overall Study|did not experience hypoglycemia|1|||
28137722|NCT03031938|54802475|FG000|Overall Study|Death|1|||
28137723|NCT03031938|54802476|FG001|Overall Study|Death|0|||
28137724|NCT01137773|54802484|FG000|Overall Study|Death|3|||
28137725|NCT01137773|54802485|FG001|Overall Study|Death|3|||
28137726|NCT01137773|54802484|FG000|Overall Study|Lost to Follow-up|6|||
28137727|NCT01137773|54802485|FG001|Overall Study|Lost to Follow-up|0|||
28137728|NCT03094611|54802493|FG000|Overall Study|Lack of Efficacy|1|||
28137729|NCT03094611|54802493|FG000|Overall Study|Stem Cell Transplant|1|||
27849894|NCT04729101|54348211|FG000|Overall Study|Withdrawal by Subject|1|||
28137730|NCT04105725|54802517|FG000|Primary Intervention|Lost to Follow-up|0|||
28137731|NCT04105725|54802518|FG001|Primary Intervention|Lost to Follow-up|2|||
28137732|NCT04105725|54802517|FG000|Primary Intervention|Withdrawal by Subject|0|||
28137733|NCT04105725|54802518|FG001|Primary Intervention|Withdrawal by Subject|1|||
27849895|NCT04729101|54348212|FG001|Overall Study|Withdrawal by Subject|0|||
27849896|NCT04569968|54348242|FG000|Overall Study|Lost to Follow-up|2|||
27849897|NCT04569968|54348243|FG001|Overall Study|Lost to Follow-up|5|||
28137734|NCT04066023|54802527|FG000|Overall Study|Adverse Event|0|||
28137735|NCT04066023|54802528|FG001|Overall Study|Adverse Event|0|||
28137736|NCT04066023|54802529|FG002|Overall Study|Adverse Event|1|||
28137737|NCT04066023|54802527|FG000|Overall Study|Sponsor decision|3|||
28137738|NCT04066023|54802528|FG001|Overall Study|Sponsor decision|6|||
28137739|NCT04066023|54802529|FG002|Overall Study|Sponsor decision|2|||
28137740|NCT04066023|54802527|FG000|Overall Study|Physician Decision|0|||
28137741|NCT04066023|54802528|FG001|Overall Study|Physician Decision|0|||
28137742|NCT04066023|54802529|FG002|Overall Study|Physician Decision|1|||
28137743|NCT04066023|54802527|FG000|Overall Study|Lost to Follow-up|0|||
27849898|NCT04569968|54348242|FG000|Overall Study|Story of head and/or neck surgery|2|||
27849899|NCT04569968|54348243|FG001|Overall Study|Story of head and/or neck surgery|2|||
27849900|NCT04569968|54348242|FG000|Overall Study|Time of stroke onset|8|||
27849901|NCT04569968|54348243|FG001|Overall Study|Time of stroke onset|7|||
27821592|NCT01877239|54283715|FG000|Overall Study|Lack of Efficacy|4|||
27821593|NCT01877239|54283715|FG000|Overall Study|Data not available|35|||
27821594|NCT01877083|54283719|FG000|Treatment Phase|Disease Progression|10|||
27821595|NCT01877083|54283719|FG000|Treatment Phase|Clinical Progression|1|||
27821596|NCT01877083|54283719|FG000|Treatment Phase|Adverse Event|6|||
27821597|NCT01877083|54283719|FG000|Treatment Phase|Withdrawal by Subject|2|||
27821598|NCT01877083|54283719|FG000|Treatment Phase|Lost to Follow-up|1|||
27821599|NCT01877083|54283719|FG000|Extension Phase|Disease Progression|3|||
27821600|NCT01877083|54283719|FG000|Extension Phase|Adverse Event|2|||
27821601|NCT01380327|54283726|FG000|Overall Study|Lost to Follow-up|0|||
27941073|NCT01028391|54597397|FG000|Overall Study|Physician Decision|0|||
28137744|NCT04066023|54802528|FG001|Overall Study|Lost to Follow-up|1|||
28137745|NCT04066023|54802529|FG002|Overall Study|Lost to Follow-up|1|||
28137746|NCT04066023|54802527|FG000|Overall Study|Noncompliance|0|||
28137747|NCT04066023|54802528|FG001|Overall Study|Noncompliance|1|||
28137748|NCT04066023|54802529|FG002|Overall Study|Noncompliance|1|||
28137749|NCT03106987|54802541|FG000|Overall Study|Death|37|||
28137750|NCT03106987|54802542|FG001|Overall Study|Death|22|||
28137751|NCT03106987|54802543|FG002|Overall Study|Death|12|||
28137752|NCT03106987|54802544|FG003|Overall Study|Death|8|||
28137753|NCT03106987|54802541|FG000|Overall Study|Lost to Follow-up|2|||
28137754|NCT03106987|54802542|FG001|Overall Study|Lost to Follow-up|0|||
28137755|NCT03106987|54802543|FG002|Overall Study|Lost to Follow-up|2|||
28137756|NCT03106987|54802544|FG003|Overall Study|Lost to Follow-up|2|||
28137757|NCT03106987|54802541|FG000|Overall Study|Withdrawal by Subject|5|||
28137758|NCT03106987|54802542|FG001|Overall Study|Withdrawal by Subject|1|||
28137759|NCT03106987|54802543|FG002|Overall Study|Withdrawal by Subject|4|||
27821602|NCT01380327|54283727|FG001|Overall Study|Lost to Follow-up|1|||
27821603|NCT01380327|54283728|FG002|Overall Study|Lost to Follow-up|1|||
28137760|NCT03106987|54802544|FG003|Overall Study|Withdrawal by Subject|1|||
28137761|NCT02932267|54802554|FG000|Overall Study|Withdrawal by Subject|3|||
28137762|NCT02932267|54802554|FG000|Overall Study|Lost to Follow-up|4|||
28137763|NCT02932267|54802554|FG000|Overall Study|Pregnancy|1|||
28137764|NCT03217591|54802561|FG000|Overall Study|Adverse Event|1|||
28137765|NCT03217591|54802562|FG001|Overall Study|Adverse Event|2|||
27821604|NCT01380327|54283726|FG000|Overall Study|Protocol Violation|3|||
27849902|NCT04569968|54348242|FG000|Overall Study|Type of strokr|12|||
28137766|NCT03217591|54802563|FG002|Overall Study|Adverse Event|6|||
28137767|NCT03217591|54802561|FG000|Overall Study|Withdrawal by Subject|0|||
28137768|NCT03217591|54802562|FG001|Overall Study|Withdrawal by Subject|1|||
28137769|NCT03217591|54802563|FG002|Overall Study|Withdrawal by Subject|3|||
28137770|NCT03217591|54802561|FG000|Overall Study|Lost to Follow-up|1|||
28137771|NCT03217591|54802562|FG001|Overall Study|Lost to Follow-up|0|||
28137772|NCT03217591|54802563|FG002|Overall Study|Lost to Follow-up|0|||
28137773|NCT03217591|54802561|FG000|Overall Study|Protocol Violation|1|||
28137774|NCT03217591|54802562|FG001|Overall Study|Protocol Violation|0|||
28137775|NCT03217591|54802563|FG002|Overall Study|Protocol Violation|1|||
27821605|NCT01380327|54283727|FG001|Overall Study|Protocol Violation|2|||
27821606|NCT01380327|54283728|FG002|Overall Study|Protocol Violation|3|||
27821607|NCT01380327|54283726|FG000|Overall Study|Withdrawal by Subject|0|||
27821608|NCT01380327|54283727|FG001|Overall Study|Withdrawal by Subject|0|||
27821609|NCT01380327|54283728|FG002|Overall Study|Withdrawal by Subject|1|||
28137776|NCT03031782|54802572|FG000|Treatment Period 1|Lack of Efficacy|3|||
28137777|NCT03031782|54802573|FG001|Treatment Period 1|Lack of Efficacy|0|||
27821610|NCT01380327|54283726|FG000|Overall Study|Housing situation precluded ability to k|0|||
28137778|NCT03031782|54802574|FG002|Treatment Period 1|Lack of Efficacy|0|||
28137779|NCT03031782|54802575|FG003|Treatment Period 1|Lack of Efficacy|0|||
28137780|NCT03031782|54802576|FG004|Treatment Period 1|Lack of Efficacy|0|||
28137781|NCT03031782|54802572|FG000|Treatment Period 2|Physician Decision|0|||
28137782|NCT03031782|54802573|FG001|Treatment Period 2|Physician Decision|1|||
28137783|NCT03031782|54802574|FG002|Treatment Period 2|Physician Decision|0|||
28137784|NCT03031782|54802575|FG003|Treatment Period 2|Physician Decision|0|||
28137785|NCT03031782|54802576|FG004|Treatment Period 2|Physician Decision|3|||
28137786|NCT03031782|54802572|FG000|Treatment Period 2|Lack of Efficacy|0|||
28137787|NCT03031782|54802573|FG001|Treatment Period 2|Lack of Efficacy|1|||
28137788|NCT03031782|54802574|FG002|Treatment Period 2|Lack of Efficacy|0|||
28137789|NCT03031782|54802575|FG003|Treatment Period 2|Lack of Efficacy|0|||
28137790|NCT03031782|54802576|FG004|Treatment Period 2|Lack of Efficacy|1|||
28137791|NCT03031782|54802572|FG000|Treatment Period 2|Withdrawal by Subject|0|||
28137792|NCT03031782|54802573|FG001|Treatment Period 2|Withdrawal by Subject|3|||
28137793|NCT03031782|54802574|FG002|Treatment Period 2|Withdrawal by Subject|0|||
28137794|NCT03031782|54802575|FG003|Treatment Period 2|Withdrawal by Subject|0|||
28137795|NCT03031782|54802576|FG004|Treatment Period 2|Withdrawal by Subject|1|||
28137796|NCT03031782|54802572|FG000|Treatment Period 2|Adverse Event|0|||
28137797|NCT03031782|54802573|FG001|Treatment Period 2|Adverse Event|1|||
28137798|NCT03031782|54802574|FG002|Treatment Period 2|Adverse Event|2|||
28137799|NCT03031782|54802575|FG003|Treatment Period 2|Adverse Event|0|||
28137800|NCT03031782|54802576|FG004|Treatment Period 2|Adverse Event|0|||
28137801|NCT03031782|54802572|FG000|Treatment Period 3|Withdrawal by Subject|0|||
28137802|NCT03031782|54802573|FG001|Treatment Period 3|Withdrawal by Subject|0|||
28137803|NCT03031782|54802574|FG002|Treatment Period 3|Withdrawal by Subject|0|||
28137804|NCT03031782|54802575|FG003|Treatment Period 3|Withdrawal by Subject|1|||
28137805|NCT03031782|54802576|FG004|Treatment Period 3|Withdrawal by Subject|0|||
28137806|NCT03216265|54802593|FG000|Overall Study|Adverse Event|2|||
28137807|NCT03216265|54802594|FG001|Overall Study|Adverse Event|0|||
28137808|NCT03216265|54802595|FG002|Overall Study|Adverse Event|2|||
28137809|NCT03216265|54802593|FG000|Overall Study|Lost to Follow-up|0|||
28137810|NCT03216265|54802594|FG001|Overall Study|Lost to Follow-up|1|||
28137811|NCT03216265|54802595|FG002|Overall Study|Lost to Follow-up|0|||
28137812|NCT03216265|54802593|FG000|Overall Study|Withdrawal by Subject|0|||
28137813|NCT03216265|54802594|FG001|Overall Study|Withdrawal by Subject|0|||
28137814|NCT03216265|54802595|FG002|Overall Study|Withdrawal by Subject|1|||
28137815|NCT04486950|54802617|FG000|Overall Study|Lost to Follow-up|0|||
28137816|NCT04486950|54802618|FG001|Overall Study|Lost to Follow-up|0|||
28137817|NCT04486950|54802619|FG002|Overall Study|Lost to Follow-up|0|||
28137818|NCT04486950|54802620|FG003|Overall Study|Lost to Follow-up|0|||
28137819|NCT04486950|54802621|FG004|Overall Study|Lost to Follow-up|0|||
28137820|NCT04486950|54802622|FG005|Overall Study|Lost to Follow-up|1|||
28137821|NCT04486950|54802623|FG006|Overall Study|Lost to Follow-up|0|||
28137822|NCT04693416|54802645|FG000|Overall Study|Lost to Follow-up|13|||
28137823|NCT04693416|54802646|FG001|Overall Study|Lost to Follow-up|0|||
28137824|NCT00265941|54802654|FG000|Overall Study|Protocol Violation|22|||
28137825|NCT00265941|54802655|FG001|Overall Study|Protocol Violation|25|||
28137826|NCT00265941|54802654|FG000|Overall Study|Lost to Follow-up|1|||
28137827|NCT00265941|54802655|FG001|Overall Study|Lost to Follow-up|1|||
27821611|NCT01380327|54283727|FG001|Overall Study|Housing situation precluded ability to k|0|||
28137828|NCT03882957|54802669|FG000|Overall Study|Did not complete all three arms|1|||
28137829|NCT03201211|54802681|FG000|Overall Study|Adverse Event|1|||
28137830|NCT03201211|54802682|FG001|Overall Study|Adverse Event|0|||
28137831|NCT03201211|54802683|FG002|Overall Study|Adverse Event|0|||
28137832|NCT03201211|54802681|FG000|Overall Study|Protocol Violation|1|||
28137833|NCT03201211|54802682|FG001|Overall Study|Protocol Violation|0|||
28137834|NCT03201211|54802683|FG002|Overall Study|Protocol Violation|0|||
28137835|NCT03201211|54802681|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
28137836|NCT03201211|54802682|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
28137837|NCT03201211|54802683|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
28137838|NCT03201211|54802681|FG000|Overall Study|OTHER unknown reasons|0|||
28137839|NCT03201211|54802682|FG001|Overall Study|OTHER unknown reasons|1|||
28137840|NCT03201211|54802683|FG002|Overall Study|OTHER unknown reasons|0|||
28137841|NCT04633837|54802693|FG000|Overall Study|Participant outcomes data not collected due to technical errors.|5|||
28137842|NCT04633837|54802694|FG001|Overall Study|Participant outcomes data not collected due to technical errors.|0|||
28137843|NCT03929913|54802700|FG000|Overall Study|Death|4|||
28137844|NCT03929913|54802700|FG000|Overall Study|Lost to Follow-up|1|||
27821612|NCT01380327|54283728|FG002|Overall Study|Housing situation precluded ability to k|1|||
27821613|NCT01380327|54283726|FG000|Overall Study|Questionable onset of epilepsy|0|||
28137845|NCT03929913|54802700|FG000|Overall Study|Failed Procedure|2|||
28137846|NCT03029832|54802706|FG000|Overall Study|Safety Follow-Up Completed|2|||
28137847|NCT03029832|54802707|FG001|Overall Study|Safety Follow-Up Completed|0|||
28137848|NCT03029832|54802706|FG000|Overall Study|Death due to Disease Progression|1|||
28137849|NCT03029832|54802707|FG001|Overall Study|Death due to Disease Progression|0|||
28137850|NCT03029832|54802706|FG000|Overall Study|Study Terminated By Sponsor|1|||
28137851|NCT03029832|54802707|FG001|Overall Study|Study Terminated By Sponsor|1|||
28137852|NCT03089697|54802715|FG000|Overall Study|Adverse Event|1|||
28137853|NCT03089697|54802716|FG001|Overall Study|Adverse Event|2|||
28137854|NCT03089697|54802715|FG000|Overall Study|Withdrawal by Subject|1|||
28137855|NCT03089697|54802716|FG001|Overall Study|Withdrawal by Subject|0|||
28137856|NCT03199963|54802724|FG000|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
28137857|NCT03199963|54802725|FG001|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
28137858|NCT03199963|54802724|FG000|Blinded Phase - Overall Study|Lost to Follow-up|9|||
28137859|NCT03199963|54802725|FG001|Blinded Phase - Overall Study|Lost to Follow-up|2|||
28137860|NCT03199963|54802724|FG000|Blinded Phase - Overall Study|Adverse Event|10|||
28137861|NCT03199963|54802725|FG001|Blinded Phase - Overall Study|Adverse Event|5|||
28137862|NCT03199963|54802724|FG000|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|109|||
28137863|NCT03199963|54802725|FG001|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|54|||
28137864|NCT03199963|54802724|FG000|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|7|||
28137865|NCT03199963|54802725|FG001|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|5|||
28137866|NCT03199963|54802724|FG000|Optional Open-Label Phase - BHR-700|Adverse Event|0|||
28137867|NCT03199963|54802725|FG001|Optional Open-Label Phase - BHR-700|Adverse Event|1|||
28137868|NCT03257631|54802741|FG000|Overall Study|Death|8|||
28137869|NCT03257631|54802742|FG001|Overall Study|Death|5|||
28137870|NCT03257631|54802743|FG002|Overall Study|Death|13|||
28137871|NCT03257631|54802744|FG003|Overall Study|Death|5|||
28137872|NCT03257631|54802741|FG000|Overall Study|Progressive Disease|0|||
28137873|NCT03257631|54802742|FG001|Overall Study|Progressive Disease|0|||
28137874|NCT03257631|54802743|FG002|Overall Study|Progressive Disease|1|||
28137875|NCT03257631|54802744|FG003|Overall Study|Progressive Disease|0|||
28137876|NCT03257631|54802741|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
28137877|NCT03257631|54802742|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
28137878|NCT03257631|54802743|FG002|Overall Study|Withdrawal by Parent/Guardian|4|||
28137879|NCT03257631|54802744|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
28137880|NCT03257631|54802741|FG000|Overall Study|Lost to Follow-up|0|||
28137881|NCT03257631|54802742|FG001|Overall Study|Lost to Follow-up|0|||
28137882|NCT03257631|54802743|FG002|Overall Study|Lost to Follow-up|1|||
28137883|NCT03257631|54802744|FG003|Overall Study|Lost to Follow-up|0|||
27941074|NCT01028391|54597398|FG001|Overall Study|Physician Decision|1|||
28137884|NCT03257631|54802741|FG000|Overall Study|Still on Study|3|||
28137885|NCT03257631|54802742|FG001|Overall Study|Still on Study|2|||
28137886|NCT03257631|54802743|FG002|Overall Study|Still on Study|4|||
28137887|NCT03257631|54802744|FG003|Overall Study|Still on Study|4|||
28137888|NCT03883581|54802754|FG000|Overall Study|Withdrawal by Subject|4|||
28137889|NCT03029208|54802760|FG000|Overall Study|Withdrawal by Subject|2|||
28137890|NCT03029208|54802761|FG001|Overall Study|Withdrawal by Subject|3|||
28137891|NCT03029208|54802760|FG000|Overall Study|Lost to Follow-up|0|||
28137892|NCT03029208|54802761|FG001|Overall Study|Lost to Follow-up|1|||
28137893|NCT03198715|54802781|FG000|Overall Study|Death|0|||
28137894|NCT03198715|54802782|FG001|Overall Study|Death|0|||
28137895|NCT03198715|54802783|FG002|Overall Study|Death|1|||
28137896|NCT03198715|54802784|FG003|Overall Study|Death|0|||
28137897|NCT03198715|54802785|FG004|Overall Study|Death|2|||
28137898|NCT03198715|54802781|FG000|Overall Study|Other|0|||
28137899|NCT03198715|54802782|FG001|Overall Study|Other|1|||
28137900|NCT03198715|54802783|FG002|Overall Study|Other|1|||
28137901|NCT03198715|54802784|FG003|Overall Study|Other|0|||
28137902|NCT03198715|54802785|FG004|Overall Study|Other|0|||
28137903|NCT03197935|54802808|FG000|Overall Study|Death due to any cause|9|||
28137904|NCT03197935|54802809|FG001|Overall Study|Death due to any cause|7|||
28137905|NCT03197935|54802808|FG000|Overall Study|Lost to Follow-up|0|||
28137906|NCT03197935|54802809|FG001|Overall Study|Lost to Follow-up|3|||
28137907|NCT03197935|54802808|FG000|Overall Study|Physician Decision|0|||
28137908|NCT03197935|54802809|FG001|Overall Study|Physician Decision|1|||
27821614|NCT01380327|54283727|FG001|Overall Study|Questionable onset of epilepsy|0|||
27821615|NCT01380327|54283728|FG002|Overall Study|Questionable onset of epilepsy|1|||
27821616|NCT01829425|54283738|FG000|Overall Study|Withdrawal by Subject|4|||
27821617|NCT01829425|54283739|FG001|Overall Study|Withdrawal by Subject|3|||
27821618|NCT01829425|54283738|FG000|Overall Study|Lost to Follow-up|2|||
27821619|NCT01829425|54283739|FG001|Overall Study|Lost to Follow-up|1|||
27821620|NCT01394991|54283756|FG000|Overall Study|Adverse Event|0|||
27821621|NCT01394991|54283757|FG001|Overall Study|Adverse Event|4|||
27821622|NCT01394991|54283756|FG000|Overall Study|Lack of Efficacy|5|||
28137909|NCT03197935|54802808|FG000|Overall Study|Withdrawal by Subject|11|||
28137910|NCT03197935|54802809|FG001|Overall Study|Withdrawal by Subject|7|||
28137911|NCT03197935|54802808|FG000|Overall Study|On-Going in Study|147|||
28137912|NCT03197935|54802809|FG001|Overall Study|On-Going in Study|146|||
28137913|NCT03197935|54802808|FG000|Overall Study|Did not receive any study treatment|1|||
28137914|NCT03197935|54802809|FG001|Overall Study|Did not receive any study treatment|1|||
28137915|NCT03088917|54802816|FG000|Overall Study|In care/cured elsewhere|15|||
28137916|NCT03088917|54802816|FG000|Overall Study|Refuse re-evaluation|13|||
28137917|NCT03088917|54802816|FG000|Overall Study|Contact not established|13|||
28137918|NCT03088917|54802816|FG000|Overall Study|Severe comorbidity/short life expectancy|5|||
28137919|NCT03088917|54802816|FG000|Overall Study|Moved outside study region|50|||
28137920|NCT03087513|54802822|FG000|Second Intervention After 3 hr Washout|Equipment malfunction|2|||
28137921|NCT02917629|54802837|FG000|Overall Study|Withdrawal by Subject|0|||
28137922|NCT02917629|54802838|FG001|Overall Study|Withdrawal by Subject|1|||
28137923|NCT02927847|54802847|FG000|Overall Study|Lost to Follow-up|1|||
28137924|NCT02927847|54802848|FG001|Overall Study|Lost to Follow-up|0|||
28137925|NCT02927847|54802847|FG000|Overall Study|Withdrawal by Subject|4|||
28137926|NCT02927847|54802848|FG001|Overall Study|Withdrawal by Subject|2|||
28137927|NCT02927847|54802847|FG000|Overall Study|PI withdrawn due to missed visits|1|||
28137928|NCT02927847|54802848|FG001|Overall Study|PI withdrawn due to missed visits|1|||
28137929|NCT02960438|54802858|FG000|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
28137930|NCT02960438|54802859|FG001|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|1|||
28137931|NCT02960438|54802860|FG002|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
28137932|NCT02960438|54802861|FG003|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|5|||
28137933|NCT02960438|54802858|FG000|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|2|||
28137934|NCT02960438|54802859|FG001|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|1|||
28137935|NCT02960438|54802860|FG002|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|0|||
28137936|NCT02960438|54802861|FG003|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|3|||
28137937|NCT02960438|54802858|FG000|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|2|||
28137938|NCT02960438|54802859|FG001|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
28137939|NCT02960438|54802860|FG002|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
28137940|NCT02960438|54802861|FG003|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
28137941|NCT02960438|54802858|FG000|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
28137942|NCT02960438|54802859|FG001|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
28137943|NCT02960438|54802860|FG002|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
28137944|NCT02960438|54802861|FG003|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
28137945|NCT02960438|54802858|FG000|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
28137946|NCT02960438|54802859|FG001|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
28137947|NCT02960438|54802860|FG002|Treatment Phase (Double-blind): 24 Weeks|Other|1|||
28137948|NCT02960438|54802861|FG003|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
28137949|NCT02960438|54802858|FG000|Treatment Phase (Double-blind): 24 Weeks|Not Treated|2|||
28137950|NCT02960438|54802859|FG001|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
28137951|NCT02960438|54802860|FG002|Treatment Phase (Double-blind): 24 Weeks|Not Treated|0|||
28137952|NCT02960438|54802861|FG003|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
27821623|NCT01394991|54283757|FG001|Overall Study|Lack of Efficacy|7|||
27821624|NCT01394991|54283756|FG000|Overall Study|Lost to Follow-up|6|||
28137953|NCT02960438|54802858|FG000|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
28137954|NCT02960438|54802859|FG001|Extension Phase (Open-label): 80 Weeks|Adverse Event|2|||
28137955|NCT02960438|54802860|FG002|Extension Phase (Open-label): 80 Weeks|Adverse Event|4|||
28137956|NCT02960438|54802861|FG003|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
28137957|NCT02960438|54802858|FG000|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
28137958|NCT02960438|54802859|FG001|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
28137959|NCT02960438|54802860|FG002|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|1|||
27821625|NCT01394991|54283757|FG001|Overall Study|Lost to Follow-up|8|||
27821626|NCT01394991|54283756|FG000|Overall Study|Physician Decision|1|||
28137960|NCT02960438|54802861|FG003|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
28137961|NCT02960438|54802858|FG000|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
28137962|NCT02960438|54802859|FG001|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
28137963|NCT02960438|54802860|FG002|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|0|||
28137964|NCT02960438|54802861|FG003|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
28137965|NCT02960438|54802858|FG000|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
28137966|NCT02960438|54802859|FG001|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|5|||
28137967|NCT02960438|54802860|FG002|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
28137968|NCT02960438|54802861|FG003|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|6|||
28137969|NCT02960438|54802858|FG000|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
28137970|NCT02960438|54802859|FG001|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
28137971|NCT02960438|54802860|FG002|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
28137972|NCT02960438|54802861|FG003|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
28137973|NCT02960438|54802858|FG000|Extension Phase (Open-label): 80 Weeks|Other|0|||
28137974|NCT02960438|54802859|FG001|Extension Phase (Open-label): 80 Weeks|Other|0|||
28137975|NCT02960438|54802860|FG002|Extension Phase (Open-label): 80 Weeks|Other|1|||
28137976|NCT02960438|54802861|FG003|Extension Phase (Open-label): 80 Weeks|Other|1|||
28137977|NCT02957942|54802881|FG000|Overall Study|Withdrawal by Subject|0|||
28137978|NCT02957942|54802882|FG001|Overall Study|Withdrawal by Subject|1|||
28137979|NCT02957942|54802881|FG000|Overall Study|Practicing experiment protocol|0|||
28137980|NCT02957942|54802882|FG001|Overall Study|Practicing experiment protocol|6|||
28137981|NCT02959970|54802890|FG000|Overall Study|Adverse Event|1|||
28137982|NCT02959970|54802891|FG001|Overall Study|Adverse Event|0|||
28137983|NCT02959970|54802890|FG000|Overall Study|Withdrawal by Subject|0|||
28137984|NCT02959970|54802891|FG001|Overall Study|Withdrawal by Subject|2|||
28070093|NCT00435461|54725007|FG001|Overall Study|Protocol Violation|9|||
28070094|NCT00435461|54725008|FG002|Overall Study|Protocol Violation|10|||
28070095|NCT00435461|54725006|FG000|Overall Study|Participant randomized(inadequate score)|1|||
28070096|NCT00435461|54725007|FG001|Overall Study|Participant randomized(inadequate score)|0|||
28070097|NCT00435461|54725008|FG002|Overall Study|Participant randomized(inadequate score)|0|||
28070098|NCT00435461|54725006|FG000|Overall Study|Compliance less than 80 percent|1|||
28070099|NCT00435461|54725007|FG001|Overall Study|Compliance less than 80 percent|0|||
28070100|NCT00435461|54725008|FG002|Overall Study|Compliance less than 80 percent|0|||
28070101|NCT00435461|54725006|FG000|Overall Study|In error, two study medications switched|1|||
28070102|NCT00435461|54725007|FG001|Overall Study|In error, two study medications switched|0|||
28070103|NCT00435461|54725008|FG002|Overall Study|In error, two study medications switched|0|||
28070104|NCT00435461|54725006|FG000|Overall Study|Lack of Efficacy|2|||
28070105|NCT00435461|54725007|FG001|Overall Study|Lack of Efficacy|1|||
28070106|NCT00435461|54725008|FG002|Overall Study|Lack of Efficacy|0|||
28070107|NCT00435461|54725006|FG000|Overall Study|Withdrawal by Subject|1|||
28070108|NCT00435461|54725007|FG001|Overall Study|Withdrawal by Subject|0|||
28070109|NCT00435461|54725008|FG002|Overall Study|Withdrawal by Subject|2|||
28137985|NCT02959970|54802890|FG000|Overall Study|Lost to Follow-up|1|||
28137986|NCT02959970|54802891|FG001|Overall Study|Lost to Follow-up|5|||
28137987|NCT05300763|54802924|FG000|Overall Study|Adverse Event|0|||
28137988|NCT05300763|54802925|FG001|Overall Study|Adverse Event|1|||
28137989|NCT05300763|54802924|FG000|Overall Study|Major Protocol Deviation|1|||
28137990|NCT05300763|54802925|FG001|Overall Study|Major Protocol Deviation|0|||
28137991|NCT05300763|54802924|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
28137992|NCT05300763|54802925|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
28137993|NCT02925312|54802933|FG000|Overall Study|Lost to Follow-up|25|||
28137994|NCT02925312|54802934|FG001|Overall Study|Lost to Follow-up|0|||
28137995|NCT02925312|54802933|FG000|Overall Study|Adverse Event|2|||
28137996|NCT02925312|54802934|FG001|Overall Study|Adverse Event|0|||
28137997|NCT03196297|54802949|FG000|Main Period|Withdrawal by Subject|4|||
28137998|NCT03196297|54802949|FG000|Extension Period|Withdrawal by Subject|1|||
28137999|NCT03196297|54802949|FG000|Extension Period|Lack of Efficacy|2|||
28138000|NCT03192475|54802974|FG000|Overall Study|Death|0|||
28138001|NCT03192475|54802975|FG001|Overall Study|Death|1|||
28138002|NCT03192475|54802974|FG000|Overall Study|Lost to Follow-up|13|||
28138003|NCT03192475|54802975|FG001|Overall Study|Lost to Follow-up|8|||
28138004|NCT03189745|54802984|FG000|Overall Study|Conflict in work schedule of participant|1|||
28138005|NCT03189745|54802985|FG001|Overall Study|Conflict in work schedule of participant|1|||
28138006|NCT03188263|54802993|FG000|Overall Study|Withdrawal by Subject|3|||
28138007|NCT03188263|54802994|FG001|Overall Study|Withdrawal by Subject|0|||
28138008|NCT03188263|54802993|FG000|Overall Study|Physician Decision|1|||
28138009|NCT03188263|54802994|FG001|Overall Study|Physician Decision|0|||
28138010|NCT03188185|54803002|FG000|Stage 1|Adverse Event|4|||
28138011|NCT03188185|54803003|FG001|Stage 1|Adverse Event|12|||
28138012|NCT03188185|54803004|FG002|Stage 1|Adverse Event|0|||
28138013|NCT03188185|54803005|FG003|Stage 1|Adverse Event|0|||
28138014|NCT03188185|54803002|FG000|Stage 1|Lack of Efficacy|0|||
28138015|NCT03188185|54803003|FG001|Stage 1|Lack of Efficacy|2|||
28138016|NCT03188185|54803004|FG002|Stage 1|Lack of Efficacy|0|||
28138017|NCT03188185|54803005|FG003|Stage 1|Lack of Efficacy|0|||
28138018|NCT03188185|54803002|FG000|Stage 1|Lost to Follow-up|6|||
28138019|NCT03188185|54803003|FG001|Stage 1|Lost to Follow-up|1|||
28138020|NCT03188185|54803004|FG002|Stage 1|Lost to Follow-up|0|||
28138021|NCT03188185|54803005|FG003|Stage 1|Lost to Follow-up|0|||
28138022|NCT03188185|54803002|FG000|Stage 1|Withdrawal by Subject|9|||
28138023|NCT03188185|54803003|FG001|Stage 1|Withdrawal by Subject|0|||
28138024|NCT03188185|54803004|FG002|Stage 1|Withdrawal by Subject|0|||
28138025|NCT03188185|54803005|FG003|Stage 1|Withdrawal by Subject|0|||
28138026|NCT03188185|54803002|FG000|Stage 1|Identified as a professional patient|0|||
28138027|NCT03188185|54803003|FG001|Stage 1|Identified as a professional patient|1|||
28138028|NCT03188185|54803004|FG002|Stage 1|Identified as a professional patient|0|||
28138029|NCT03188185|54803005|FG003|Stage 1|Identified as a professional patient|0|||
28138030|NCT03188185|54803002|FG000|Stage 2|Adverse Event|0|||
28138031|NCT03188185|54803003|FG001|Stage 2|Adverse Event|0|||
28138032|NCT03188185|54803004|FG002|Stage 2|Adverse Event|2|||
28138033|NCT03188185|54803005|FG003|Stage 2|Adverse Event|4|||
28138034|NCT03188185|54803002|FG000|Stage 2|Lack of Efficacy|0|||
28138035|NCT03188185|54803003|FG001|Stage 2|Lack of Efficacy|0|||
28138036|NCT03188185|54803004|FG002|Stage 2|Lack of Efficacy|3|||
28138037|NCT03188185|54803005|FG003|Stage 2|Lack of Efficacy|0|||
28138038|NCT03188185|54803002|FG000|Stage 2|Lost to Follow-up|0|||
28138039|NCT03188185|54803003|FG001|Stage 2|Lost to Follow-up|0|||
28138040|NCT03188185|54803004|FG002|Stage 2|Lost to Follow-up|1|||
28138041|NCT03188185|54803005|FG003|Stage 2|Lost to Follow-up|0|||
28138042|NCT03188185|54803002|FG000|Stage 2|Physician Decision|0|||
28138043|NCT03188185|54803003|FG001|Stage 2|Physician Decision|0|||
28138044|NCT03188185|54803004|FG002|Stage 2|Physician Decision|0|||
28138045|NCT03188185|54803005|FG003|Stage 2|Physician Decision|1|||
28138046|NCT03188185|54803002|FG000|Stage 2|Withdrawal by Subject|0|||
28138047|NCT03188185|54803003|FG001|Stage 2|Withdrawal by Subject|0|||
28138048|NCT03188185|54803004|FG002|Stage 2|Withdrawal by Subject|3|||
28138049|NCT03188185|54803005|FG003|Stage 2|Withdrawal by Subject|1|||
28138050|NCT03186781|54803021|FG000|Overall Study|Lost to Follow-up|0|||
27821627|NCT01394991|54283757|FG001|Overall Study|Physician Decision|3|||
28138051|NCT03186781|54803022|FG001|Overall Study|Lost to Follow-up|0|||
28138052|NCT03186781|54803023|FG002|Overall Study|Lost to Follow-up|1|||
28138053|NCT03186781|54803024|FG003|Overall Study|Lost to Follow-up|0|||
28138054|NCT03186781|54803025|FG004|Overall Study|Lost to Follow-up|1|||
28138055|NCT03186781|54803026|FG005|Overall Study|Lost to Follow-up|0|||
28138056|NCT03186781|54803021|FG000|Overall Study|Moved from Area|0|||
28138057|NCT03186781|54803022|FG001|Overall Study|Moved from Area|0|||
28138058|NCT03186781|54803023|FG002|Overall Study|Moved from Area|0|||
28138059|NCT03186781|54803024|FG003|Overall Study|Moved from Area|0|||
28138060|NCT03186781|54803025|FG004|Overall Study|Moved from Area|1|||
28138061|NCT03186781|54803026|FG005|Overall Study|Moved from Area|0|||
28138062|NCT03186781|54803021|FG000|Overall Study|Withdrawal by Subject|0|||
28138063|NCT03186781|54803022|FG001|Overall Study|Withdrawal by Subject|0|||
28138064|NCT03186781|54803023|FG002|Overall Study|Withdrawal by Subject|0|||
28138065|NCT03186781|54803024|FG003|Overall Study|Withdrawal by Subject|0|||
28138066|NCT03186781|54803025|FG004|Overall Study|Withdrawal by Subject|1|||
28138067|NCT03186781|54803026|FG005|Overall Study|Withdrawal by Subject|0|||
28138068|NCT03184987|54803053|FG000|Overall Study|Withdrawal by Subject|0|||
28138069|NCT03184987|54803054|FG001|Overall Study|Withdrawal by Subject|1|||
28138070|NCT03184987|54803055|FG002|Overall Study|Withdrawal by Subject|2|||
28138071|NCT03184987|54803053|FG000|Overall Study|Physician Decision|0|||
28138072|NCT03184987|54803054|FG001|Overall Study|Physician Decision|0|||
28138073|NCT03184987|54803055|FG002|Overall Study|Physician Decision|1|||
28138074|NCT03184987|54803053|FG000|Overall Study|Adverse Event|1|||
28138075|NCT03184987|54803054|FG001|Overall Study|Adverse Event|0|||
28138076|NCT03184987|54803055|FG002|Overall Study|Adverse Event|1|||
28138077|NCT03184519|54803063|FG000|Overall Study|Lost to Follow-up|6|||
28138078|NCT03184519|54803063|FG000|Overall Study|Physician Decision|21|||
28138079|NCT03184441|54803067|FG000|Overall Study|Withdrawal by Subject|1|||
28138080|NCT03026166|54803076|FG000|Overall Study|Death|22|||
28138081|NCT03026166|54803077|FG001|Overall Study|Death|7|||
28138082|NCT03026166|54803076|FG000|Overall Study|Physician Decision|2|||
28138083|NCT03026166|54803077|FG001|Overall Study|Physician Decision|0|||
28138084|NCT03026166|54803076|FG000|Overall Study|Withdrawal by Subject|1|||
28138085|NCT03026166|54803077|FG001|Overall Study|Withdrawal by Subject|2|||
28138086|NCT03026166|54803076|FG000|Overall Study|Lost to Follow-up|1|||
28138087|NCT03026166|54803077|FG001|Overall Study|Lost to Follow-up|0|||
28138088|NCT03026166|54803076|FG000|Overall Study|Study Terminated by Sponsor|3|||
27821628|NCT01394991|54283756|FG000|Overall Study|Protocol Violation|1|||
27821629|NCT01394991|54283757|FG001|Overall Study|Protocol Violation|1|||
27821630|NCT01394991|54283756|FG000|Overall Study|Withdrawal by Subject|20|||
28138089|NCT03026166|54803077|FG001|Overall Study|Study Terminated by Sponsor|3|||
28138090|NCT03026166|54803076|FG000|Overall Study|Other|1|||
28138091|NCT03026166|54803077|FG001|Overall Study|Other|0|||
28138092|NCT03026088|54803083|FG000|Overall Study|Study termination|20|||
28138093|NCT03181789|54803091|FG000|Overall Study|Withdrawal by Subject|0|||
27821631|NCT01394991|54283757|FG001|Overall Study|Withdrawal by Subject|17|||
27821632|NCT01394991|54283756|FG000|Overall Study|Chemotherapy Termination|10|||
27821633|NCT01394991|54283757|FG001|Overall Study|Chemotherapy Termination|15|||
27821634|NCT01394991|54283756|FG000|Overall Study|Disease Progression|7|||
27821635|NCT01394991|54283757|FG001|Overall Study|Disease Progression|7|||
27821636|NCT01394991|54283756|FG000|Overall Study|Prematurely Termination of Trial|9|||
27821637|NCT01394991|54283757|FG001|Overall Study|Prematurely Termination of Trial|10|||
27821638|NCT01829347|54283765|FG000|VTI-210|Death|5|||
27821639|NCT01829347|54283766|FG001|VTI-210|Death|3|||
27821640|NCT01829347|54283765|FG000|VTI-210|Withdrawal by Subject|1|||
27821641|NCT01829347|54283766|FG001|VTI-210|Withdrawal by Subject|0|||
27821642|NCT01829347|54283765|FG000|VTI-210E|Death|2|||
27821643|NCT01829347|54283766|FG001|VTI-210E|Death|1|||
27821644|NCT01829347|54283765|FG000|VTI-210E|Study terminated prematurely|1|||
27821645|NCT01829347|54283766|FG001|VTI-210E|Study terminated prematurely|5|||
27941075|NCT01028391|54597397|FG000|Overall Study|Withdrawal by Subject|6|||
28070110|NCT00435461|54725006|FG000|Overall Study|Randomized in error|1|||
28070111|NCT00435461|54725007|FG001|Overall Study|Randomized in error|0|||
28070112|NCT00435461|54725008|FG002|Overall Study|Randomized in error|0|||
28070113|NCT00435461|54725006|FG000|Overall Study|Participant could not tolerate symptoms|0|||
28070114|NCT00435461|54725007|FG001|Overall Study|Participant could not tolerate symptoms|0|||
28070115|NCT00435461|54725008|FG002|Overall Study|Participant could not tolerate symptoms|1|||
28070116|NCT00435461|54725006|FG000|Overall Study|Participant could not swallow capsule|0|||
28070117|NCT00435461|54725007|FG001|Overall Study|Participant could not swallow capsule|0|||
28070118|NCT00435461|54725008|FG002|Overall Study|Participant could not swallow capsule|1|||
28070119|NCT00435461|54725006|FG000|Overall Study|Pregnancy|2|||
28070120|NCT00435461|54725007|FG001|Overall Study|Pregnancy|0|||
28070121|NCT00435461|54725008|FG002|Overall Study|Pregnancy|0|||
28070122|NCT00435461|54725006|FG000|Overall Study|Participant moved eDiary,studymedication|1|||
28070123|NCT00435461|54725007|FG001|Overall Study|Participant moved eDiary,studymedication|0|||
28070124|NCT00435461|54725008|FG002|Overall Study|Participant moved eDiary,studymedication|0|||
28070125|NCT00435461|54725006|FG000|Overall Study|Participant ended study one day early|1|||
28070126|NCT00435461|54725007|FG001|Overall Study|Participant ended study one day early|0|||
27941076|NCT01028391|54597398|FG001|Overall Study|Withdrawal by Subject|3|||
27821646|NCT01394523|54283775|FG000|Overall Study|Unable to place block|1|||
27821647|NCT01394523|54283776|FG001|Overall Study|Unable to place block|0|||
27941077|NCT01028391|54597397|FG000|Overall Study|Needed excluded medication|1|||
28070127|NCT00435461|54725008|FG002|Overall Study|Participant ended study one day early|0|||
28138094|NCT03181789|54803092|FG001|Overall Study|Withdrawal by Subject|1|||
28138095|NCT03181789|54803093|FG002|Overall Study|Withdrawal by Subject|1|||
28138096|NCT03181789|54803094|FG003|Overall Study|Withdrawal by Subject|0|||
28138097|NCT03181789|54803091|FG000|Overall Study|Lost to Follow-up|7|||
28138098|NCT03181789|54803092|FG001|Overall Study|Lost to Follow-up|1|||
28138099|NCT03181789|54803093|FG002|Overall Study|Lost to Follow-up|0|||
27821648|NCT01394523|54283777|FG002|Overall Study|Unable to place block|0|||
28138100|NCT03181789|54803094|FG003|Overall Study|Lost to Follow-up|0|||
28138101|NCT03181789|54803091|FG000|Overall Study|Participant unable to adhere to visit|0|||
28138102|NCT03181789|54803092|FG001|Overall Study|Participant unable to adhere to visit|1|||
28138103|NCT03181789|54803093|FG002|Overall Study|Participant unable to adhere to visit|0|||
28138104|NCT03181789|54803094|FG003|Overall Study|Participant unable to adhere to visit|0|||
28138105|NCT03259074|54803107|FG000|Overall Study|Adverse Event|9|||
28138106|NCT03259074|54803108|FG001|Overall Study|Adverse Event|12|||
28138107|NCT03259074|54803109|FG002|Overall Study|Adverse Event|8|||
28138108|NCT03259074|54803107|FG000|Overall Study|Death|1|||
27821649|NCT01857973|54283785|FG000|Overall Study|Subject did not meet required BG range|3|||
27821650|NCT01857973|54283785|FG000|Overall Study|drop out after 3 failed attempts|1|||
27821651|NCT01857973|54283785|FG000|Overall Study|Physician Decision|1|||
27821652|NCT01857583|54283793|FG000|Overall Study|Adverse Event|0|||
28070128|NCT00435461|54725006|FG000|Overall Study|Noncompliance with study requirements|1|||
28138109|NCT03259074|54803108|FG001|Overall Study|Death|1|||
28138110|NCT03259074|54803109|FG002|Overall Study|Death|3|||
28138111|NCT03259074|54803107|FG000|Overall Study|Lost to Follow-up|2|||
28138112|NCT03259074|54803108|FG001|Overall Study|Lost to Follow-up|4|||
28138113|NCT03259074|54803109|FG002|Overall Study|Lost to Follow-up|3|||
28138114|NCT03259074|54803107|FG000|Overall Study|New Therapy For Study Indication|1|||
28138115|NCT03259074|54803108|FG001|Overall Study|New Therapy For Study Indication|2|||
28138116|NCT03259074|54803109|FG002|Overall Study|New Therapy For Study Indication|2|||
28138117|NCT03259074|54803107|FG000|Overall Study|Physician Decision|4|||
28138118|NCT03259074|54803108|FG001|Overall Study|Physician Decision|12|||
28138119|NCT03259074|54803109|FG002|Overall Study|Physician Decision|10|||
28138120|NCT03259074|54803107|FG000|Overall Study|Pregnancy|1|||
28138121|NCT03259074|54803108|FG001|Overall Study|Pregnancy|1|||
28138122|NCT03259074|54803109|FG002|Overall Study|Pregnancy|0|||
28138123|NCT03259074|54803107|FG000|Overall Study|Progressive Disease|1|||
28138124|NCT03259074|54803108|FG001|Overall Study|Progressive Disease|0|||
28070129|NCT00435461|54725007|FG001|Overall Study|Noncompliance with study requirements|1|||
28138125|NCT03259074|54803109|FG002|Overall Study|Progressive Disease|0|||
28138126|NCT03259074|54803107|FG000|Overall Study|Protocol Deviation|1|||
28138127|NCT03259074|54803108|FG001|Overall Study|Protocol Deviation|1|||
28138128|NCT03259074|54803109|FG002|Overall Study|Protocol Deviation|3|||
28138129|NCT03259074|54803107|FG000|Overall Study|Subject/Guardian Decision|13|||
28138130|NCT03259074|54803108|FG001|Overall Study|Subject/Guardian Decision|16|||
28138131|NCT03259074|54803109|FG002|Overall Study|Subject/Guardian Decision|14|||
28138132|NCT03024606|54803119|FG000|Overall Study|Withdrawal by Subject|9|||
28138133|NCT03024606|54803120|FG001|Overall Study|Withdrawal by Subject|10|||
28138134|NCT03180619|54803129|FG000|Overall Study|Withdrew Consent|5|||
28138135|NCT03180619|54803130|FG001|Overall Study|Withdrew Consent|0|||
28138136|NCT03180619|54803131|FG002|Overall Study|Withdrew Consent|2|||
28138137|NCT03180619|54803129|FG000|Overall Study|Death|2|||
28138138|NCT03180619|54803130|FG001|Overall Study|Death|1|||
28138139|NCT03180619|54803131|FG002|Overall Study|Death|2|||
28138140|NCT03180619|54803129|FG000|Overall Study|Adverse Event|2|||
28138141|NCT03180619|54803130|FG001|Overall Study|Adverse Event|0|||
28138142|NCT03180619|54803131|FG002|Overall Study|Adverse Event|1|||
28138143|NCT03180619|54803129|FG000|Overall Study|Investigator's discretion|2|||
28138144|NCT03180619|54803130|FG001|Overall Study|Investigator's discretion|0|||
28138145|NCT03180619|54803131|FG002|Overall Study|Investigator's discretion|1|||
27849903|NCT04569968|54348243|FG001|Overall Study|Type of strokr|8|||
28070130|NCT00435461|54725008|FG002|Overall Study|Noncompliance with study requirements|1|||
28070131|NCT00435461|54725006|FG000|Overall Study|Adverse Event|1|||
28070132|NCT00435461|54725007|FG001|Overall Study|Adverse Event|2|||
28070133|NCT00435461|54725008|FG002|Overall Study|Adverse Event|6|||
28070134|NCT00435461|54725006|FG000|Overall Study|Non-Compliance of diary|2|||
28070135|NCT00435461|54725007|FG001|Overall Study|Non-Compliance of diary|0|||
28070136|NCT00435461|54725008|FG002|Overall Study|Non-Compliance of diary|1|||
28070137|NCT00435461|54725006|FG000|Overall Study|Lost to Follow-up|1|||
28070138|NCT00435461|54725007|FG001|Overall Study|Lost to Follow-up|1|||
28070139|NCT00435461|54725008|FG002|Overall Study|Lost to Follow-up|2|||
28070140|NCT00006436|54725016|FG000|Overall Study|Refused further treatment|2|||
28070141|NCT00006436|54725016|FG000|Overall Study|Declined to participate (before treatment started)|1|||
28070142|NCT00434759|54725025|FG000|Overall Study|Lack of Efficacy|5|||
28070143|NCT00434759|54725026|FG001|Overall Study|Lack of Efficacy|4|||
28070144|NCT00434759|54725025|FG000|Overall Study|Withdrawal by Subject|17|||
28070145|NCT00434759|54725026|FG001|Overall Study|Withdrawal by Subject|1|||
28070146|NCT00434759|54725025|FG000|Overall Study|family affairs|2|||
28138146|NCT02915874|54803148|FG000|Overall Study|Lost to Follow-up|5|||
28138147|NCT02915874|54803149|FG001|Overall Study|Lost to Follow-up|4|||
28138148|NCT02915874|54803148|FG000|Overall Study|Withdrawal by Subject|1|||
28138149|NCT02915874|54803149|FG001|Overall Study|Withdrawal by Subject|1|||
28138150|NCT02915874|54803148|FG000|Overall Study|Started New Anxiety Medication|0|||
28138151|NCT02915874|54803149|FG001|Overall Study|Started New Anxiety Medication|1|||
28138152|NCT03022578|54803155|FG000|Overall Study|Adverse Event|1|||
28138153|NCT03022578|54803155|FG000|Overall Study|Lack of Efficacy|2|||
28138154|NCT03022578|54803155|FG000|Overall Study|Withdrawal by Subject|1|||
28138155|NCT03022422|54803165|FG000|Overall Study|3 subjects consented but not vaccinated|0|||
28138156|NCT03022422|54803166|FG001|Overall Study|3 subjects consented but not vaccinated|0|||
28138157|NCT03022422|54803167|FG002|Overall Study|3 subjects consented but not vaccinated|3|||
28138158|NCT03022422|54803168|FG003|Overall Study|3 subjects consented but not vaccinated|0|||
28138159|NCT03022422|54803169|FG004|Overall Study|3 subjects consented but not vaccinated|0|||
28138160|NCT03022422|54803170|FG005|Overall Study|3 subjects consented but not vaccinated|0|||
28138161|NCT03023826|54803186|FG000|Period 1|Withdrawal by Subject|0|||
28138162|NCT03023826|54803187|FG001|Period 1|Withdrawal by Subject|0|||
28138163|NCT03023826|54803188|FG002|Period 1|Withdrawal by Subject|0|||
28138164|NCT03023826|54803189|FG003|Period 1|Withdrawal by Subject|0|||
28138165|NCT03023826|54803190|FG004|Period 1|Withdrawal by Subject|1|||
28138166|NCT03023826|54803191|FG005|Period 1|Withdrawal by Subject|0|||
28138167|NCT03166735|54803204|FG000|Overall Study|Not Treated|1|||
28138168|NCT03166735|54803205|FG001|Overall Study|Not Treated|0|||
28138169|NCT03166735|54803206|FG002|Overall Study|Not Treated|0|||
28138170|NCT03166735|54803207|FG003|Overall Study|Not Treated|0|||
28138171|NCT03166735|54803208|FG004|Overall Study|Not Treated|0|||
28138172|NCT03166735|54803204|FG000|Overall Study|follow-up not completed as planned|0|||
28138173|NCT03166735|54803205|FG001|Overall Study|follow-up not completed as planned|1|||
28138174|NCT03166735|54803206|FG002|Overall Study|follow-up not completed as planned|1|||
28138175|NCT03166735|54803207|FG003|Overall Study|follow-up not completed as planned|0|||
28138176|NCT03166735|54803208|FG004|Overall Study|follow-up not completed as planned|1|||
28138177|NCT03166735|54803204|FG000|Overall Study|Withdrawal by Subject|0|||
28138178|NCT03166735|54803205|FG001|Overall Study|Withdrawal by Subject|0|||
28138179|NCT03166735|54803206|FG002|Overall Study|Withdrawal by Subject|1|||
28138180|NCT03166735|54803207|FG003|Overall Study|Withdrawal by Subject|1|||
28138181|NCT03166735|54803208|FG004|Overall Study|Withdrawal by Subject|2|||
27849904|NCT04569968|54348242|FG000|Overall Study|Cooperation|8|||
28138182|NCT03166735|54803204|FG000|Overall Study|Lost to Follow-up|0|||
28138183|NCT03166735|54803205|FG001|Overall Study|Lost to Follow-up|2|||
28138184|NCT03166735|54803206|FG002|Overall Study|Lost to Follow-up|1|||
28138185|NCT03166735|54803207|FG003|Overall Study|Lost to Follow-up|0|||
28138186|NCT03166735|54803208|FG004|Overall Study|Lost to Follow-up|1|||
28138187|NCT03165955|54803221|FG000|Treatment|Withdrawal by Subject|3|||
28138188|NCT03165955|54803221|FG000|Treatment|Death|1|||
28138189|NCT03165955|54803221|FG000|Treatment|Adverse Event|1|||
28138190|NCT03165955|54803221|FG000|Treatment|Progressive disease|3|||
28138191|NCT03055494|54803227|FG000|Overall Study|Lost to Follow-up|6|||
28138192|NCT03055494|54803228|FG001|Overall Study|Lost to Follow-up|0|||
28138193|NCT03055494|54803227|FG000|Overall Study|Physician Decision|2|||
28138194|NCT03055494|54803228|FG001|Overall Study|Physician Decision|0|||
27821653|NCT01857583|54283794|FG001|Overall Study|Adverse Event|0|||
28138195|NCT03055494|54803227|FG000|Overall Study|Withdrawal by Subject|1|||
28138196|NCT03055494|54803228|FG001|Overall Study|Withdrawal by Subject|0|||
27821654|NCT01857583|54283795|FG002|Overall Study|Adverse Event|1|||
27821655|NCT01857583|54283796|FG003|Overall Study|Adverse Event|1|||
27821656|NCT01857583|54283793|FG000|Overall Study|Death|0|||
27821657|NCT01857583|54283794|FG001|Overall Study|Death|1|||
27821658|NCT01857583|54283795|FG002|Overall Study|Death|1|||
27821659|NCT01857583|54283796|FG003|Overall Study|Death|0|||
27821660|NCT01857583|54283793|FG000|Overall Study|Physician Decision|0|||
27821661|NCT01857583|54283794|FG001|Overall Study|Physician Decision|0|||
27821662|NCT01857583|54283795|FG002|Overall Study|Physician Decision|0|||
27821663|NCT01857583|54283796|FG003|Overall Study|Physician Decision|1|||
27821664|NCT01857583|54283793|FG000|Overall Study|Withdrawal by Subject|1|||
27821665|NCT01857583|54283794|FG001|Overall Study|Withdrawal by Subject|0|||
27821666|NCT01857583|54283795|FG002|Overall Study|Withdrawal by Subject|1|||
27821667|NCT01857583|54283796|FG003|Overall Study|Withdrawal by Subject|2|||
27821668|NCT01829191|54283808|FG000|Overall Study|Relocation|0|||
27821669|NCT01829191|54283809|FG001|Overall Study|Relocation|1|||
27821670|NCT01829191|54283808|FG000|Overall Study|Lens discomfort|0|||
27821671|NCT01829191|54283809|FG001|Overall Study|Lens discomfort|3|||
27821672|NCT01829191|54283808|FG000|Overall Study|Lens handling difficulty|1|||
27821673|NCT01829191|54283809|FG001|Overall Study|Lens handling difficulty|4|||
27821674|NCT01829191|54283808|FG000|Overall Study|Protocol Violation|4|||
27821675|NCT01829191|54283809|FG001|Overall Study|Protocol Violation|1|||
27821676|NCT01829191|54283808|FG000|Overall Study|Withdrawal by Subject|2|||
27821677|NCT01829191|54283809|FG001|Overall Study|Withdrawal by Subject|3|||
27821678|NCT01829191|54283808|FG000|Overall Study|Lost to Follow-up|0|||
27821679|NCT01829191|54283809|FG001|Overall Study|Lost to Follow-up|1|||
27821680|NCT01829191|54283808|FG000|Overall Study|Subject was fit for ortho - k|0|||
27821681|NCT01829191|54283809|FG001|Overall Study|Subject was fit for ortho - k|1|||
27821682|NCT00211185|54283814|FG000|Overall Study|Death|2|||
27821683|NCT00211185|54283814|FG000|Overall Study|Disease progression|7|||
27821684|NCT00211185|54283814|FG000|Overall Study|Withdrawal by Subject|6|||
27821685|NCT00211185|54283814|FG000|Overall Study|Physician Decision|5|||
27821686|NCT00210639|54283820|FG000|Overall Study|Lost to Follow-up|37|||
27821687|NCT00210639|54283821|FG001|Overall Study|Lost to Follow-up|29|||
28070147|NCT00434759|54725026|FG001|Overall Study|family affairs|0|||
28070148|NCT00440999|54725036|FG000|Overall Study|Adverse Event|0|||
28070149|NCT00440999|54725037|FG001|Overall Study|Adverse Event|2|||
28070150|NCT00440999|54725036|FG000|Overall Study|Lack of Efficacy|6|||
28070151|NCT00440999|54725037|FG001|Overall Study|Lack of Efficacy|7|||
28070152|NCT00440999|54725036|FG000|Overall Study|Lost to Follow-up|19|||
28070153|NCT00440999|54725037|FG001|Overall Study|Lost to Follow-up|12|||
28070154|NCT00440999|54725036|FG000|Overall Study|Protocol Violation|1|||
28070155|NCT00440999|54725037|FG001|Overall Study|Protocol Violation|0|||
28138197|NCT03055494|54803227|FG000|Overall Study|Adverse Event|0|||
27821688|NCT00210639|54283820|FG000|Overall Study|Withdrawal by Subject|8|||
27821689|NCT00210639|54283821|FG001|Overall Study|Withdrawal by Subject|1|||
27821690|NCT00210639|54283820|FG000|Overall Study|Other|18|||
27821691|NCT00210639|54283821|FG001|Overall Study|Other|12|||
27821692|NCT01829113|54283829|FG000|Overall Study|Disease Progression|37|||
27821693|NCT01829113|54283830|FG001|Overall Study|Disease Progression|48|||
27821694|NCT01829113|54283829|FG000|Overall Study|Adverse Event|14|||
27821695|NCT01829113|54283830|FG001|Overall Study|Adverse Event|10|||
28070156|NCT00440999|54725036|FG000|Overall Study|Withdrawal by Subject|2|||
28070157|NCT00440999|54725037|FG001|Overall Study|Withdrawal by Subject|5|||
28138198|NCT03055494|54803228|FG001|Overall Study|Adverse Event|1|||
28138199|NCT03055494|54803227|FG000|Overall Study|Non-compliance with study treatment|1|||
28138200|NCT03055494|54803228|FG001|Overall Study|Non-compliance with study treatment|0|||
27821696|NCT01829113|54283829|FG000|Overall Study|Withdrawal by Subject|17|||
27821697|NCT01829113|54283830|FG001|Overall Study|Withdrawal by Subject|10|||
27821698|NCT01829113|54283829|FG000|Overall Study|Death|4|||
27821699|NCT01829113|54283830|FG001|Overall Study|Death|6|||
27821700|NCT01829113|54283829|FG000|Overall Study|Sponsor Decision|1|||
27821701|NCT01829113|54283830|FG001|Overall Study|Sponsor Decision|1|||
28070158|NCT00440999|54725036|FG000|Overall Study|Subjets missed the visit|1|||
27821702|NCT01829113|54283829|FG000|Overall Study|No Study Treatment Received|3|||
27821703|NCT01829113|54283830|FG001|Overall Study|No Study Treatment Received|2|||
27821704|NCT01829113|54283829|FG000|Overall Study|Physician Decision|1|||
27821705|NCT01829113|54283830|FG001|Overall Study|Physician Decision|1|||
27821706|NCT01857271|54283838|FG000|Overall Study|Lost to Follow-up|1|||
27821707|NCT01745120|54283844|FG000|Overall Study|Investigator decision|1|||
27821708|NCT01745120|54283845|FG001|Overall Study|Investigator decision|0|||
27821709|NCT01828567|54283856|FG000|Overall Study|Lost to Follow-up|27|||
27821710|NCT01828567|54283857|FG001|Overall Study|Lost to Follow-up|9|||
27821711|NCT01828567|54283856|FG000|Overall Study|Excluded - did not meet criteria|4|||
27821712|NCT01828567|54283857|FG001|Overall Study|Excluded - did not meet criteria|1|||
27821713|NCT01721486|54283865|FG000|Overall Study|Protocol Violation|1|||
27821714|NCT01721486|54283866|FG001|Overall Study|Protocol Violation|0|||
28138201|NCT02914548|54803238|FG000|Overall Study|Adverse Event|15|||
28138202|NCT02914548|54803239|FG001|Overall Study|Adverse Event|7|||
28138203|NCT02914548|54803240|FG002|Overall Study|Adverse Event|15|||
28138204|NCT02914548|54803238|FG000|Overall Study|Physician Decision|2|||
28138205|NCT02914548|54803239|FG001|Overall Study|Physician Decision|2|||
28138206|NCT02914548|54803240|FG002|Overall Study|Physician Decision|0|||
28138207|NCT02914548|54803238|FG000|Overall Study|Protocol Violation|1|||
28138208|NCT02914548|54803239|FG001|Overall Study|Protocol Violation|0|||
28138209|NCT02914548|54803240|FG002|Overall Study|Protocol Violation|0|||
28138210|NCT02914548|54803238|FG000|Overall Study|Withdrawal by Subject|3|||
28138211|NCT02914548|54803239|FG001|Overall Study|Withdrawal by Subject|4|||
28138212|NCT02914548|54803240|FG002|Overall Study|Withdrawal by Subject|4|||
28138213|NCT02914548|54803238|FG000|Overall Study|>40% of body surface area|0|||
28138214|NCT02914548|54803239|FG001|Overall Study|>40% of body surface area|1|||
28138215|NCT02914548|54803240|FG002|Overall Study|>40% of body surface area|1|||
28138216|NCT03165721|54803256|FG000|Overall Study|Refused further treatment|3|||
28138217|NCT03165721|54803257|FG001|Overall Study|Refused further treatment|0|||
28138218|NCT03165721|54803258|FG002|Overall Study|Refused further treatment|0|||
28138219|NCT03165721|54803256|FG000|Overall Study|Physician Decision|1|||
28138220|NCT03165721|54803257|FG001|Overall Study|Physician Decision|0|||
28138221|NCT03165721|54803258|FG002|Overall Study|Physician Decision|0|||
28138222|NCT02187198|54803274|FG000|Overall Study|did not show up for appointment and did not return calls after week 9|1|||
28138223|NCT02187198|54803275|FG001|Overall Study|did not show up for appointment and did not return calls after week 9|0|||
28138224|NCT02187198|54803274|FG000|Overall Study|did not show up for appointment and did not return calls after week 11|0|||
28138225|NCT02187198|54803275|FG001|Overall Study|did not show up for appointment and did not return calls after week 11|1|||
28138226|NCT02642029|54803281|FG000|Washout 1 (≥ 36 Hours)|Adverse Event|1|||
28138227|NCT02642029|54803282|FG001|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
28138228|NCT02642029|54803283|FG002|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
28138229|NCT02642029|54803284|FG003|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
28138230|NCT02642029|54803285|FG004|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
28138231|NCT02642029|54803286|FG005|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
27821715|NCT01721486|54283865|FG000|Overall Study|Physician Decision|0|||
27821716|NCT01721486|54283866|FG001|Overall Study|Physician Decision|1|||
27821717|NCT01775930|54283872|FG000|Overall Study|Futility stopping boundary met|1|||
27941078|NCT01028391|54597398|FG001|Overall Study|Needed excluded medication|1|||
28138232|NCT02642029|54803281|FG000|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
28138233|NCT02642029|54803282|FG001|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|1|||
28138234|NCT02642029|54803283|FG002|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
28138235|NCT02642029|54803284|FG003|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
28138236|NCT02642029|54803285|FG004|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
28138237|NCT02642029|54803286|FG005|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
28138238|NCT02642029|54803281|FG000|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
28138239|NCT02642029|54803282|FG001|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
28138240|NCT02642029|54803283|FG002|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
28138241|NCT02642029|54803284|FG003|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
28138242|NCT02642029|54803285|FG004|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|1|||
28138243|NCT02642029|54803286|FG005|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
28138244|NCT02642029|54803281|FG000|Study Visit 2 (1 Day)|Adverse Event|1|||
28138245|NCT02642029|54803282|FG001|Study Visit 2 (1 Day)|Adverse Event|0|||
28138246|NCT02642029|54803283|FG002|Study Visit 2 (1 Day)|Adverse Event|0|||
28138247|NCT02642029|54803284|FG003|Study Visit 2 (1 Day)|Adverse Event|0|||
28138248|NCT02642029|54803285|FG004|Study Visit 2 (1 Day)|Adverse Event|0|||
27821718|NCT01856569|54283876|FG000|Overall Study|Other|1|||
27821719|NCT01856569|54283876|FG000|Overall Study|Changed Site/Structure|1|||
27941079|NCT01179672|54597406|FG000|Overall Study|Adverse Event|17|||
27941080|NCT01179672|54597407|FG001|Overall Study|Adverse Event|8|||
28138249|NCT02642029|54803286|FG005|Study Visit 2 (1 Day)|Adverse Event|0|||
28138250|NCT02642029|54803281|FG000|Washout 2 (≥ 36 Hours)|Adverse Event|1|||
28138251|NCT02642029|54803282|FG001|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
28138252|NCT02642029|54803283|FG002|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
28138253|NCT02642029|54803284|FG003|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
28138254|NCT02642029|54803285|FG004|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
28138255|NCT02642029|54803286|FG005|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
27821720|NCT01856569|54283876|FG000|Overall Study|Lost to Follow-up|3|||
27821721|NCT01856569|54283876|FG000|Overall Study|Did not met inclusion criteria|8|||
27821722|NCT01721408|54283882|FG000|Overall Study|Adverse Event|6|||
27821723|NCT01721408|54283883|FG001|Overall Study|Adverse Event|1|||
27821724|NCT01721408|54283882|FG000|Overall Study|Death|1|||
27821725|NCT01721408|54283883|FG001|Overall Study|Death|0|||
27821726|NCT01721408|54283882|FG000|Overall Study|Insufficient clinical response|15|||
27821727|NCT01721408|54283883|FG001|Overall Study|Insufficient clinical response|6|||
28138256|NCT02642029|54803281|FG000|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|1|||
28138257|NCT02642029|54803282|FG001|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
28138258|NCT02642029|54803283|FG002|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
28138259|NCT02642029|54803284|FG003|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
28138260|NCT02642029|54803285|FG004|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
28138261|NCT02642029|54803286|FG005|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
28138262|NCT03178669|54803299|FG000|Overall Study|Adverse Event|4|||
28138263|NCT03178669|54803300|FG001|Overall Study|Adverse Event|1|||
28138264|NCT03178669|54803301|FG002|Overall Study|Adverse Event|4|||
28138265|NCT03178669|54803302|FG003|Overall Study|Adverse Event|2|||
28138266|NCT03178669|54803303|FG004|Overall Study|Adverse Event|2|||
28138267|NCT03178669|54803299|FG000|Overall Study|Lack of Efficacy|0|||
28138268|NCT03178669|54803300|FG001|Overall Study|Lack of Efficacy|0|||
28138269|NCT03178669|54803301|FG002|Overall Study|Lack of Efficacy|2|||
28138270|NCT03178669|54803302|FG003|Overall Study|Lack of Efficacy|0|||
28138271|NCT03178669|54803303|FG004|Overall Study|Lack of Efficacy|1|||
28138272|NCT03178669|54803299|FG000|Overall Study|Physician Decision|0|||
28138273|NCT03178669|54803300|FG001|Overall Study|Physician Decision|0|||
28138274|NCT03178669|54803301|FG002|Overall Study|Physician Decision|0|||
28138275|NCT03178669|54803302|FG003|Overall Study|Physician Decision|0|||
28138276|NCT03178669|54803303|FG004|Overall Study|Physician Decision|1|||
28138277|NCT03178669|54803299|FG000|Overall Study|Withdrawal by Subject|1|||
28138278|NCT03178669|54803300|FG001|Overall Study|Withdrawal by Subject|0|||
28138279|NCT03178669|54803301|FG002|Overall Study|Withdrawal by Subject|1|||
28138280|NCT03178669|54803302|FG003|Overall Study|Withdrawal by Subject|1|||
28138281|NCT03178669|54803303|FG004|Overall Study|Withdrawal by Subject|0|||
28138282|NCT03178669|54803299|FG000|Overall Study|Lost to Follow-up|0|||
28138283|NCT03178669|54803300|FG001|Overall Study|Lost to Follow-up|0|||
28138284|NCT03178669|54803301|FG002|Overall Study|Lost to Follow-up|0|||
28138285|NCT03178669|54803302|FG003|Overall Study|Lost to Follow-up|1|||
28138286|NCT03178669|54803303|FG004|Overall Study|Lost to Follow-up|0|||
28138287|NCT03178201|54803315|FG000|Overall Study|Off study|5|||
28138288|NCT03021642|54803319|FG000|Washout Period (21 Days)|Adverse Event|1|||
27821728|NCT01721408|54283882|FG000|Overall Study|No longer willing to participate study|9|||
27821729|NCT01721408|54283883|FG001|Overall Study|No longer willing to participate study|10|||
27821730|NCT01721408|54283882|FG000|Overall Study|Protocol Violation|0|||
28070159|NCT00440999|54725037|FG001|Overall Study|Subjets missed the visit|0|||
28070160|NCT00440999|54725036|FG000|Overall Study|Mixed infection at entry|1|||
28070161|NCT00440999|54725037|FG001|Overall Study|Mixed infection at entry|0|||
28070162|NCT00440999|54725036|FG000|Overall Study|P. falciparum malaria|5|||
28070163|NCT00440999|54725037|FG001|Overall Study|P. falciparum malaria|14|||
28070164|NCT00440999|54725036|FG000|Overall Study|Subj left hosp without inform staff|0|||
28070165|NCT00440999|54725037|FG001|Overall Study|Subj left hosp without inform staff|1|||
28070166|NCT00434213|54725045|FG000|Overall Study|Adverse Event|12|||
28070167|NCT00434213|54725045|FG000|Overall Study|Lack of Efficacy|9|||
28070168|NCT00434213|54725045|FG000|Overall Study|Lost to Follow-up|14|||
28070169|NCT00434213|54725045|FG000|Overall Study|Withdrawal by Subject|7|||
28070170|NCT00434213|54725045|FG000|Overall Study|Protocol Violation|3|||
28070171|NCT00434213|54725045|FG000|Overall Study|Unable to comply with study visit window|2|||
28070172|NCT00434213|54725045|FG000|Overall Study|Application site reaction|1|||
28070173|NCT00434213|54725045|FG000|Overall Study|Non-compliant to study schedule|1|||
28070174|NCT00006184|54725051|FG000|Overall Study|Death|1|||
28070175|NCT00006184|54725052|FG001|Overall Study|Death|0|||
28070176|NCT00434057|54725058|FG000|Overall Study|Withdrawal by Subject|1|||
28070177|NCT00433199|54725064|FG000|Double-Blind Period|Adverse Event|0|||
28138289|NCT03021642|54803320|FG001|Washout Period (21 Days)|Adverse Event|1|||
28138290|NCT03021564|54803328|FG000|Overall Study|Death|84|||
28138291|NCT03021564|54803329|FG001|Overall Study|Death|466|||
28138292|NCT03021564|54803328|FG000|Overall Study|Lost to Follow-up|0|||
28138293|NCT03021564|54803329|FG001|Overall Study|Lost to Follow-up|2|||
28138294|NCT03023046|54803339|FG000|Overall Study|Withdrawal by Subject|1|||
28138295|NCT03019458|54803347|FG000|Overall Study|Death|0|||
28138296|NCT03019458|54803348|FG001|Overall Study|Death|1|||
28138297|NCT02923830|54803358|FG000|Overall Study|Physician Decision|13|||
28138298|NCT02923830|54803359|FG001|Overall Study|Physician Decision|15|||
27821731|NCT01721408|54283883|FG001|Overall Study|Protocol Violation|2|||
27821732|NCT01721408|54283882|FG000|Overall Study|Other|3|||
27821733|NCT01721408|54283883|FG001|Overall Study|Other|3|||
27821734|NCT01721408|54283882|FG000|Overall Study|Lost to Follow-up|1|||
27821735|NCT01721408|54283883|FG001|Overall Study|Lost to Follow-up|2|||
27821736|NCT01721408|54283882|FG000|Overall Study|Does not meet entrance criteria|1|||
28138299|NCT03021018|54803368|FG000|Overall Study|Adverse Event|1|||
28138300|NCT03021018|54803369|FG001|Overall Study|Adverse Event|0|||
28138301|NCT03021018|54803370|FG002|Overall Study|Adverse Event|0|||
28138302|NCT03021018|54803368|FG000|Overall Study|Fall with subsequent nasal fracture|1|||
28138303|NCT03021018|54803369|FG001|Overall Study|Fall with subsequent nasal fracture|0|||
28138304|NCT03021018|54803370|FG002|Overall Study|Fall with subsequent nasal fracture|0|||
28138305|NCT02509507|54803387|FG000|Overall Study|Death|21|||
28138306|NCT02509507|54803388|FG001|Overall Study|Death|3|||
28138307|NCT02509507|54803389|FG002|Overall Study|Death|22|||
28138308|NCT02509507|54803390|FG003|Overall Study|Death|13|||
27821737|NCT01721408|54283883|FG001|Overall Study|Does not meet entrance criteria|0|||
27821738|NCT01744496|54283891|FG000|Titration Period|Adverse Event|2|||
27821739|NCT01744496|54283892|FG001|Titration Period|Adverse Event|1|||
27821740|NCT01744496|54283891|FG000|Titration Period|Personal reasons|0|||
28138309|NCT02509507|54803391|FG004|Overall Study|Death|6|||
28138310|NCT02509507|54803392|FG005|Overall Study|Death|9|||
28138311|NCT02509507|54803393|FG006|Overall Study|Death|4|||
28138312|NCT02509507|54803394|FG007|Overall Study|Death|3|||
28138313|NCT02509507|54803395|FG008|Overall Study|Death|7|||
28138314|NCT02509507|54803387|FG000|Overall Study|Lost to Follow-up|0|||
28138315|NCT02509507|54803388|FG001|Overall Study|Lost to Follow-up|1|||
28138316|NCT02509507|54803389|FG002|Overall Study|Lost to Follow-up|0|||
28138317|NCT02509507|54803390|FG003|Overall Study|Lost to Follow-up|0|||
28138318|NCT02509507|54803391|FG004|Overall Study|Lost to Follow-up|0|||
28138319|NCT02509507|54803392|FG005|Overall Study|Lost to Follow-up|1|||
28138320|NCT02509507|54803393|FG006|Overall Study|Lost to Follow-up|0|||
28138321|NCT02509507|54803394|FG007|Overall Study|Lost to Follow-up|0|||
28138322|NCT02509507|54803395|FG008|Overall Study|Lost to Follow-up|0|||
28138323|NCT02509507|54803387|FG000|Overall Study|Withdrawal by Subject|2|||
28138324|NCT02509507|54803388|FG001|Overall Study|Withdrawal by Subject|0|||
28138325|NCT02509507|54803389|FG002|Overall Study|Withdrawal by Subject|1|||
28138326|NCT02509507|54803390|FG003|Overall Study|Withdrawal by Subject|4|||
28138327|NCT02509507|54803391|FG004|Overall Study|Withdrawal by Subject|0|||
28138328|NCT02509507|54803392|FG005|Overall Study|Withdrawal by Subject|3|||
28138329|NCT02509507|54803393|FG006|Overall Study|Withdrawal by Subject|3|||
28138330|NCT02509507|54803394|FG007|Overall Study|Withdrawal by Subject|0|||
28138331|NCT02509507|54803395|FG008|Overall Study|Withdrawal by Subject|0|||
28138332|NCT02509507|54803387|FG000|Overall Study|Continuing Study|0|||
28138333|NCT02509507|54803388|FG001|Overall Study|Continuing Study|1|||
28138334|NCT02509507|54803389|FG002|Overall Study|Continuing Study|1|||
28138335|NCT02509507|54803390|FG003|Overall Study|Continuing Study|5|||
28138336|NCT02509507|54803391|FG004|Overall Study|Continuing Study|4|||
28138337|NCT02509507|54803392|FG005|Overall Study|Continuing Study|5|||
28138338|NCT02509507|54803393|FG006|Overall Study|Continuing Study|3|||
28138339|NCT02509507|54803394|FG007|Overall Study|Continuing Study|2|||
28138340|NCT02509507|54803395|FG008|Overall Study|Continuing Study|3|||
28138341|NCT03176407|54803420|FG000|Overall Study|Protocol Violation|1|||
28138342|NCT03176407|54803420|FG000|Overall Study|human failure|1|||
28138343|NCT03176407|54803420|FG000|Overall Study|EGD showed esophageal varices=excl. crit|1|||
28138344|NCT03175549|54803428|FG000|Overall Study|Lost to Follow-up|2|||
28138345|NCT03175549|54803429|FG001|Overall Study|Lost to Follow-up|2|||
28138346|NCT03175549|54803428|FG000|Overall Study|Medication non-compliance|2|||
28138347|NCT03175549|54803429|FG001|Overall Study|Medication non-compliance|2|||
28138348|NCT03174925|54803437|FG000|Overall Study|Elastographic images not retrievable|2|||
28138349|NCT03174925|54803437|FG000|Overall Study|Elastography image not interpretable|1|||
28138350|NCT02924688|54803447|FG000|Overall Study|Adverse Event|9|||
27821741|NCT01744496|54283892|FG001|Titration Period|Personal reasons|1|||
28138351|NCT02924688|54803448|FG001|Overall Study|Adverse Event|3|||
28138352|NCT02924688|54803449|FG002|Overall Study|Adverse Event|2|||
28138353|NCT02924688|54803450|FG003|Overall Study|Adverse Event|2|||
28138354|NCT02924688|54803451|FG004|Overall Study|Adverse Event|3|||
28138355|NCT02924688|54803452|FG005|Overall Study|Adverse Event|2|||
28138356|NCT02924688|54803447|FG000|Overall Study|Lack of Efficacy|2|||
28138357|NCT02924688|54803448|FG001|Overall Study|Lack of Efficacy|3|||
27821742|NCT01744496|54283891|FG000|Maintenance Period|Adverse Event|1|||
28138358|NCT02924688|54803449|FG002|Overall Study|Lack of Efficacy|4|||
28138359|NCT02924688|54803450|FG003|Overall Study|Lack of Efficacy|2|||
28138360|NCT02924688|54803451|FG004|Overall Study|Lack of Efficacy|1|||
28138361|NCT02924688|54803452|FG005|Overall Study|Lack of Efficacy|1|||
28138362|NCT02924688|54803447|FG000|Overall Study|Protocol Violation|3|||
28138363|NCT02924688|54803448|FG001|Overall Study|Protocol Violation|7|||
28138364|NCT02924688|54803449|FG002|Overall Study|Protocol Violation|5|||
28138365|NCT02924688|54803450|FG003|Overall Study|Protocol Violation|6|||
28138366|NCT02924688|54803451|FG004|Overall Study|Protocol Violation|2|||
27821743|NCT01744496|54283892|FG001|Maintenance Period|Adverse Event|3|||
27821744|NCT01744496|54283891|FG000|Maintenance Period|Protocol Violation|1|||
27821745|NCT01744496|54283892|FG001|Maintenance Period|Protocol Violation|0|||
28138367|NCT02924688|54803452|FG005|Overall Study|Protocol Violation|2|||
28138368|NCT02924688|54803447|FG000|Overall Study|Protocol defined withdrawal criteria met|1|||
28138369|NCT02924688|54803448|FG001|Overall Study|Protocol defined withdrawal criteria met|0|||
28138370|NCT02924688|54803449|FG002|Overall Study|Protocol defined withdrawal criteria met|1|||
28138371|NCT02924688|54803450|FG003|Overall Study|Protocol defined withdrawal criteria met|1|||
28138372|NCT02924688|54803451|FG004|Overall Study|Protocol defined withdrawal criteria met|1|||
28138373|NCT02924688|54803452|FG005|Overall Study|Protocol defined withdrawal criteria met|0|||
28138374|NCT02924688|54803447|FG000|Overall Study|Lost to Follow-up|2|||
28138375|NCT02924688|54803448|FG001|Overall Study|Lost to Follow-up|4|||
28138376|NCT02924688|54803449|FG002|Overall Study|Lost to Follow-up|2|||
28138377|NCT02924688|54803450|FG003|Overall Study|Lost to Follow-up|4|||
28138378|NCT02924688|54803451|FG004|Overall Study|Lost to Follow-up|2|||
28138379|NCT02924688|54803452|FG005|Overall Study|Lost to Follow-up|4|||
28138380|NCT02924688|54803447|FG000|Overall Study|Physician Decision|2|||
28138381|NCT02924688|54803448|FG001|Overall Study|Physician Decision|1|||
28138382|NCT02924688|54803449|FG002|Overall Study|Physician Decision|0|||
28138383|NCT02924688|54803450|FG003|Overall Study|Physician Decision|1|||
28138384|NCT02924688|54803451|FG004|Overall Study|Physician Decision|1|||
28138385|NCT02924688|54803452|FG005|Overall Study|Physician Decision|1|||
28138386|NCT02924688|54803447|FG000|Overall Study|Withdrawal by Subject|14|||
28138387|NCT02924688|54803448|FG001|Overall Study|Withdrawal by Subject|13|||
28138388|NCT02924688|54803449|FG002|Overall Study|Withdrawal by Subject|9|||
28138389|NCT02924688|54803450|FG003|Overall Study|Withdrawal by Subject|12|||
28138390|NCT02924688|54803451|FG004|Overall Study|Withdrawal by Subject|13|||
28138391|NCT02924688|54803452|FG005|Overall Study|Withdrawal by Subject|14|||
28138392|NCT03011892|54803475|FG000|Double Blind (DB) Period|Adverse Event|0|||
28138393|NCT03011892|54803476|FG001|Double Blind (DB) Period|Adverse Event|1|||
27849905|NCT04569968|54348243|FG001|Overall Study|Cooperation|8|||
28138394|NCT03011892|54803477|FG002|Double Blind (DB) Period|Adverse Event|1|||
28138395|NCT03011892|54803478|FG003|Double Blind (DB) Period|Adverse Event|0|||
28138396|NCT03011892|54803479|FG004|Double Blind (DB) Period|Adverse Event|0|||
28138397|NCT03011892|54803480|FG005|Double Blind (DB) Period|Adverse Event|0|||
28138398|NCT03011892|54803481|FG006|Double Blind (DB) Period|Adverse Event|0|||
27821746|NCT01744496|54283891|FG000|Maintenance Period|Withdrawal by Subject|1|||
27821747|NCT01744496|54283892|FG001|Maintenance Period|Withdrawal by Subject|1|||
27821748|NCT01744496|54283891|FG000|Maintenance Period|Subject left town|1|||
27821749|NCT01744496|54283892|FG001|Maintenance Period|Subject left town|0|||
27821750|NCT01721330|54283900|FG000|Overall Study|Withdrawal by Subject|0|||
27821751|NCT01721330|54283901|FG001|Overall Study|Withdrawal by Subject|1|||
27821752|NCT01828021|54283917|FG000|Overall Study|Adverse Event|5|||
27821753|NCT01828021|54283917|FG000|Overall Study|Lack of Efficacy|17|||
28070178|NCT00433199|54725065|FG001|Double-Blind Period|Adverse Event|25|||
28070179|NCT00433199|54725064|FG000|Double-Blind Period|Lack of Efficacy|0|||
28070180|NCT00433199|54725065|FG001|Double-Blind Period|Lack of Efficacy|2|||
28070181|NCT00433199|54725064|FG000|Double-Blind Period|Lost to Follow-up|2|||
27821754|NCT01828021|54283917|FG000|Overall Study|Withdrawal by Subject|2|||
28070182|NCT00433199|54725065|FG001|Double-Blind Period|Lost to Follow-up|5|||
28070183|NCT00433199|54725064|FG000|Double-Blind Period|Withdrawal by Subject|8|||
28070184|NCT00433199|54725065|FG001|Double-Blind Period|Withdrawal by Subject|19|||
28070185|NCT00433199|54725064|FG000|Double-Blind Period|Protocol Violation|1|||
28070186|NCT00433199|54725065|FG001|Double-Blind Period|Protocol Violation|10|||
28138399|NCT03011892|54803482|FG007|Double Blind (DB) Period|Adverse Event|0|||
28138400|NCT03011892|54803483|FG008|Double Blind (DB) Period|Adverse Event|0|||
28138401|NCT03011892|54803484|FG009|Double Blind (DB) Period|Adverse Event|0|||
28138402|NCT03011892|54803485|FG010|Double Blind (DB) Period|Adverse Event|0|||
28138403|NCT03011892|54803486|FG011|Double Blind (DB) Period|Adverse Event|0|||
28138404|NCT03011892|54803475|FG000|Double Blind (DB) Period|Lack of Efficacy|1|||
28070187|NCT00433199|54725064|FG000|Double-Blind Period|Administrative|1|||
28070188|NCT00433199|54725065|FG001|Double-Blind Period|Administrative|5|||
28070189|NCT00433199|54725064|FG000|Open-Label Period|Adverse Event|0|||
28070190|NCT00433199|54725065|FG001|Open-Label Period|Adverse Event|19|||
28070191|NCT00433199|54725064|FG000|Open-Label Period|Lack of Efficacy|0|||
28070192|NCT00433199|54725065|FG001|Open-Label Period|Lack of Efficacy|2|||
28070193|NCT00433199|54725064|FG000|Open-Label Period|Lost to Follow-up|0|||
28070194|NCT00433199|54725065|FG001|Open-Label Period|Lost to Follow-up|3|||
28070195|NCT00433199|54725064|FG000|Open-Label Period|Withdrawal by Subject|0|||
28070196|NCT00433199|54725065|FG001|Open-Label Period|Withdrawal by Subject|7|||
28070197|NCT00433199|54725064|FG000|Open-Label Period|Protocol Violation|0|||
28070198|NCT00433199|54725065|FG001|Open-Label Period|Protocol Violation|2|||
28070199|NCT00433199|54725064|FG000|Open-Label Period|Administrative|0|||
28070200|NCT00433199|54725065|FG001|Open-Label Period|Administrative|1|||
28070201|NCT00006046|54725081|FG000|Overall Study|Adverse Event|3|||
28070202|NCT00006046|54725082|FG001|Overall Study|Adverse Event|0|||
28070203|NCT00006046|54725083|FG002|Overall Study|Adverse Event|0|||
28070204|NCT00006046|54725084|FG003|Overall Study|Adverse Event|0|||
28138405|NCT03011892|54803476|FG001|Double Blind (DB) Period|Lack of Efficacy|0|||
28138406|NCT03011892|54803477|FG002|Double Blind (DB) Period|Lack of Efficacy|0|||
27821755|NCT01828021|54283917|FG000|Overall Study|Ileal obstruction, unrelated|1|||
27821756|NCT01827943|54283921|FG000|Overall Study|Protocol Violation|8|||
27849906|NCT04569968|54348242|FG000|Overall Study|Age interval|17|||
28070205|NCT00006046|54725085|FG004|Overall Study|Adverse Event|0|||
28070206|NCT00006046|54725081|FG000|Overall Study|Disease Progression|2|||
28070207|NCT00006046|54725082|FG001|Overall Study|Disease Progression|0|||
28070208|NCT00006046|54725083|FG002|Overall Study|Disease Progression|0|||
28138407|NCT03011892|54803478|FG003|Double Blind (DB) Period|Lack of Efficacy|0|||
28070209|NCT00006046|54725084|FG003|Overall Study|Disease Progression|0|||
28138408|NCT03011892|54803479|FG004|Double Blind (DB) Period|Lack of Efficacy|0|||
28138409|NCT03011892|54803480|FG005|Double Blind (DB) Period|Lack of Efficacy|0|||
28138410|NCT03011892|54803481|FG006|Double Blind (DB) Period|Lack of Efficacy|0|||
28138411|NCT03011892|54803482|FG007|Double Blind (DB) Period|Lack of Efficacy|0|||
27821757|NCT01827943|54283921|FG000|Overall Study|Never treated because of an rapid progression|1|||
27821758|NCT00217971|54283927|FG000|Overall Study|Adverse Event|1|||
27821759|NCT00217971|54283928|FG001|Overall Study|Adverse Event|1|||
27821760|NCT00217971|54283927|FG000|Overall Study|Lost to Follow-up|15|||
27821761|NCT00217971|54283928|FG001|Overall Study|Lost to Follow-up|19|||
27821762|NCT00217971|54283927|FG000|Overall Study|Physician Decision|0|||
27821763|NCT00217971|54283928|FG001|Overall Study|Physician Decision|1|||
27821764|NCT00217971|54283927|FG000|Overall Study|Withdrawal by Subject|7|||
28138412|NCT03011892|54803483|FG008|Double Blind (DB) Period|Lack of Efficacy|0|||
28138413|NCT03011892|54803484|FG009|Double Blind (DB) Period|Lack of Efficacy|0|||
28138414|NCT03011892|54803485|FG010|Double Blind (DB) Period|Lack of Efficacy|0|||
28138415|NCT03011892|54803486|FG011|Double Blind (DB) Period|Lack of Efficacy|0|||
28138416|NCT03011892|54803475|FG000|Double Blind (DB) Period|Lost to Follow-up|0|||
28138417|NCT03011892|54803476|FG001|Double Blind (DB) Period|Lost to Follow-up|3|||
28138418|NCT03011892|54803477|FG002|Double Blind (DB) Period|Lost to Follow-up|2|||
28138419|NCT03011892|54803478|FG003|Double Blind (DB) Period|Lost to Follow-up|5|||
28138420|NCT03011892|54803479|FG004|Double Blind (DB) Period|Lost to Follow-up|0|||
28138421|NCT03011892|54803480|FG005|Double Blind (DB) Period|Lost to Follow-up|2|||
28138422|NCT03011892|54803481|FG006|Double Blind (DB) Period|Lost to Follow-up|0|||
28138423|NCT03011892|54803482|FG007|Double Blind (DB) Period|Lost to Follow-up|0|||
28138424|NCT03011892|54803483|FG008|Double Blind (DB) Period|Lost to Follow-up|0|||
28138425|NCT03011892|54803484|FG009|Double Blind (DB) Period|Lost to Follow-up|0|||
28138426|NCT03011892|54803485|FG010|Double Blind (DB) Period|Lost to Follow-up|0|||
28138427|NCT03011892|54803486|FG011|Double Blind (DB) Period|Lost to Follow-up|0|||
28138428|NCT03011892|54803475|FG000|Double Blind (DB) Period|Other|1|||
28138429|NCT03011892|54803476|FG001|Double Blind (DB) Period|Other|1|||
28138430|NCT03011892|54803477|FG002|Double Blind (DB) Period|Other|1|||
27821765|NCT00217971|54283928|FG001|Overall Study|Withdrawal by Subject|12|||
27941081|NCT01179672|54597406|FG000|Overall Study|Withdrawal by Subject|10|||
28138431|NCT03011892|54803478|FG003|Double Blind (DB) Period|Other|0|||
28138432|NCT03011892|54803479|FG004|Double Blind (DB) Period|Other|1|||
28138433|NCT03011892|54803480|FG005|Double Blind (DB) Period|Other|0|||
28138434|NCT03011892|54803481|FG006|Double Blind (DB) Period|Other|0|||
28138435|NCT03011892|54803482|FG007|Double Blind (DB) Period|Other|0|||
28138436|NCT03011892|54803483|FG008|Double Blind (DB) Period|Other|0|||
28138437|NCT03011892|54803484|FG009|Double Blind (DB) Period|Other|0|||
28138438|NCT03011892|54803485|FG010|Double Blind (DB) Period|Other|0|||
28138439|NCT03011892|54803486|FG011|Double Blind (DB) Period|Other|0|||
28138440|NCT03011892|54803475|FG000|Double Blind (DB) Period|Physician Decision|1|||
28138441|NCT03011892|54803476|FG001|Double Blind (DB) Period|Physician Decision|0|||
28138442|NCT03011892|54803477|FG002|Double Blind (DB) Period|Physician Decision|1|||
28138443|NCT03011892|54803478|FG003|Double Blind (DB) Period|Physician Decision|0|||
28138444|NCT03011892|54803479|FG004|Double Blind (DB) Period|Physician Decision|0|||
28138445|NCT03011892|54803480|FG005|Double Blind (DB) Period|Physician Decision|0|||
28138446|NCT03011892|54803481|FG006|Double Blind (DB) Period|Physician Decision|0|||
28138447|NCT03011892|54803482|FG007|Double Blind (DB) Period|Physician Decision|0|||
28138448|NCT03011892|54803483|FG008|Double Blind (DB) Period|Physician Decision|0|||
28138449|NCT03011892|54803484|FG009|Double Blind (DB) Period|Physician Decision|0|||
28138450|NCT03011892|54803485|FG010|Double Blind (DB) Period|Physician Decision|0|||
28138451|NCT03011892|54803486|FG011|Double Blind (DB) Period|Physician Decision|0|||
28138452|NCT03011892|54803475|FG000|Double Blind (DB) Period|Pregnancy|0|||
28138453|NCT03011892|54803476|FG001|Double Blind (DB) Period|Pregnancy|0|||
28138454|NCT03011892|54803477|FG002|Double Blind (DB) Period|Pregnancy|0|||
28138455|NCT03011892|54803478|FG003|Double Blind (DB) Period|Pregnancy|0|||
28138456|NCT03011892|54803479|FG004|Double Blind (DB) Period|Pregnancy|1|||
28138457|NCT03011892|54803480|FG005|Double Blind (DB) Period|Pregnancy|0|||
28138458|NCT03011892|54803481|FG006|Double Blind (DB) Period|Pregnancy|0|||
28138459|NCT03011892|54803482|FG007|Double Blind (DB) Period|Pregnancy|0|||
28138460|NCT03011892|54803483|FG008|Double Blind (DB) Period|Pregnancy|0|||
28138461|NCT03011892|54803484|FG009|Double Blind (DB) Period|Pregnancy|0|||
28138462|NCT03011892|54803485|FG010|Double Blind (DB) Period|Pregnancy|0|||
28138463|NCT03011892|54803486|FG011|Double Blind (DB) Period|Pregnancy|0|||
28138464|NCT03011892|54803475|FG000|Double Blind (DB) Period|Protocol Violation|1|||
28138465|NCT03011892|54803476|FG001|Double Blind (DB) Period|Protocol Violation|0|||
28138466|NCT03011892|54803477|FG002|Double Blind (DB) Period|Protocol Violation|0|||
28138467|NCT03011892|54803478|FG003|Double Blind (DB) Period|Protocol Violation|0|||
28138468|NCT03011892|54803479|FG004|Double Blind (DB) Period|Protocol Violation|0|||
28138469|NCT03011892|54803480|FG005|Double Blind (DB) Period|Protocol Violation|0|||
28138470|NCT03011892|54803481|FG006|Double Blind (DB) Period|Protocol Violation|0|||
28138471|NCT03011892|54803482|FG007|Double Blind (DB) Period|Protocol Violation|0|||
28138472|NCT03011892|54803483|FG008|Double Blind (DB) Period|Protocol Violation|0|||
28138473|NCT03011892|54803484|FG009|Double Blind (DB) Period|Protocol Violation|0|||
28138474|NCT03011892|54803485|FG010|Double Blind (DB) Period|Protocol Violation|0|||
28138475|NCT03011892|54803486|FG011|Double Blind (DB) Period|Protocol Violation|0|||
28138476|NCT03011892|54803475|FG000|Double Blind (DB) Period|Withdrawal by Subject|7|||
28138477|NCT03011892|54803476|FG001|Double Blind (DB) Period|Withdrawal by Subject|5|||
28138478|NCT03011892|54803477|FG002|Double Blind (DB) Period|Withdrawal by Subject|1|||
28138479|NCT03011892|54803478|FG003|Double Blind (DB) Period|Withdrawal by Subject|2|||
28138480|NCT03011892|54803479|FG004|Double Blind (DB) Period|Withdrawal by Subject|4|||
28138481|NCT03011892|54803480|FG005|Double Blind (DB) Period|Withdrawal by Subject|3|||
28138482|NCT03011892|54803481|FG006|Double Blind (DB) Period|Withdrawal by Subject|0|||
28138483|NCT03011892|54803482|FG007|Double Blind (DB) Period|Withdrawal by Subject|0|||
28138484|NCT03011892|54803483|FG008|Double Blind (DB) Period|Withdrawal by Subject|0|||
28138485|NCT03011892|54803484|FG009|Double Blind (DB) Period|Withdrawal by Subject|0|||
28138486|NCT03011892|54803485|FG010|Double Blind (DB) Period|Withdrawal by Subject|0|||
28138487|NCT03011892|54803486|FG011|Double Blind (DB) Period|Withdrawal by Subject|0|||
28138488|NCT03011892|54803475|FG000|Double Blind (DB) Period|Randomized but not treated|0|||
28138489|NCT03011892|54803476|FG001|Double Blind (DB) Period|Randomized but not treated|0|||
28138490|NCT03011892|54803477|FG002|Double Blind (DB) Period|Randomized but not treated|0|||
28138491|NCT03011892|54803478|FG003|Double Blind (DB) Period|Randomized but not treated|0|||
28138492|NCT03011892|54803479|FG004|Double Blind (DB) Period|Randomized but not treated|1|||
28138493|NCT03011892|54803480|FG005|Double Blind (DB) Period|Randomized but not treated|0|||
28138494|NCT03011892|54803481|FG006|Double Blind (DB) Period|Randomized but not treated|0|||
28138495|NCT03011892|54803482|FG007|Double Blind (DB) Period|Randomized but not treated|0|||
28138496|NCT03011892|54803483|FG008|Double Blind (DB) Period|Randomized but not treated|0|||
28138497|NCT03011892|54803484|FG009|Double Blind (DB) Period|Randomized but not treated|0|||
27821766|NCT00217971|54283927|FG000|Overall Study|non compliant|1|||
27821767|NCT00217971|54283928|FG001|Overall Study|non compliant|0|||
27821768|NCT00217581|54283934|FG000|Overall Study|Withdrawal by Subject|1|||
28138498|NCT03011892|54803485|FG010|Double Blind (DB) Period|Randomized but not treated|0|||
28138499|NCT03011892|54803486|FG011|Double Blind (DB) Period|Randomized but not treated|0|||
27821769|NCT01856257|54283942|FG000|Overall Study|Death|2|||
28138500|NCT03011892|54803475|FG000|Open Label (OL) Period|Lost to Follow-up|0|||
28138501|NCT03011892|54803476|FG001|Open Label (OL) Period|Lost to Follow-up|0|||
28138502|NCT03011892|54803477|FG002|Open Label (OL) Period|Lost to Follow-up|0|||
28138503|NCT03011892|54803478|FG003|Open Label (OL) Period|Lost to Follow-up|0|||
27821770|NCT01856257|54283943|FG001|Overall Study|Death|0|||
28138504|NCT03011892|54803479|FG004|Open Label (OL) Period|Lost to Follow-up|0|||
28138505|NCT03011892|54803480|FG005|Open Label (OL) Period|Lost to Follow-up|0|||
28138506|NCT03011892|54803481|FG006|Open Label (OL) Period|Lost to Follow-up|4|||
28138507|NCT03011892|54803482|FG007|Open Label (OL) Period|Lost to Follow-up|2|||
28138508|NCT03011892|54803483|FG008|Open Label (OL) Period|Lost to Follow-up|1|||
28138509|NCT03011892|54803484|FG009|Open Label (OL) Period|Lost to Follow-up|0|||
28138510|NCT03011892|54803485|FG010|Open Label (OL) Period|Lost to Follow-up|1|||
28138511|NCT03011892|54803486|FG011|Open Label (OL) Period|Lost to Follow-up|1|||
28138512|NCT03011892|54803475|FG000|Open Label (OL) Period|Withdrawal by Subject|0|||
28138513|NCT03011892|54803476|FG001|Open Label (OL) Period|Withdrawal by Subject|0|||
28138514|NCT03011892|54803477|FG002|Open Label (OL) Period|Withdrawal by Subject|0|||
28138515|NCT03011892|54803478|FG003|Open Label (OL) Period|Withdrawal by Subject|0|||
28138516|NCT03011892|54803479|FG004|Open Label (OL) Period|Withdrawal by Subject|0|||
28138517|NCT03011892|54803480|FG005|Open Label (OL) Period|Withdrawal by Subject|0|||
28138518|NCT03011892|54803481|FG006|Open Label (OL) Period|Withdrawal by Subject|3|||
28138519|NCT03011892|54803482|FG007|Open Label (OL) Period|Withdrawal by Subject|0|||
28138520|NCT03011892|54803483|FG008|Open Label (OL) Period|Withdrawal by Subject|1|||
28138521|NCT03011892|54803484|FG009|Open Label (OL) Period|Withdrawal by Subject|0|||
28138522|NCT03011892|54803485|FG010|Open Label (OL) Period|Withdrawal by Subject|1|||
28138523|NCT03011892|54803486|FG011|Open Label (OL) Period|Withdrawal by Subject|2|||
28138524|NCT03011892|54803475|FG000|Open Label (OL) Period|Reason not specified|0|||
28138525|NCT03011892|54803476|FG001|Open Label (OL) Period|Reason not specified|0|||
28138526|NCT03011892|54803477|FG002|Open Label (OL) Period|Reason not specified|0|||
28138527|NCT03011892|54803478|FG003|Open Label (OL) Period|Reason not specified|0|||
28138528|NCT03011892|54803479|FG004|Open Label (OL) Period|Reason not specified|0|||
28138529|NCT03011892|54803480|FG005|Open Label (OL) Period|Reason not specified|0|||
28138530|NCT03011892|54803481|FG006|Open Label (OL) Period|Reason not specified|0|||
28138531|NCT03011892|54803482|FG007|Open Label (OL) Period|Reason not specified|1|||
28138532|NCT03011892|54803483|FG008|Open Label (OL) Period|Reason not specified|0|||
28138533|NCT03011892|54803484|FG009|Open Label (OL) Period|Reason not specified|0|||
28138534|NCT03011892|54803485|FG010|Open Label (OL) Period|Reason not specified|0|||
28138535|NCT03011892|54803486|FG011|Open Label (OL) Period|Reason not specified|0|||
28138536|NCT03017742|54803513|FG000|Overall Study|Protocol Violation|36|||
28138537|NCT03017742|54803513|FG000|Overall Study|Withdrawal by Subject|37|||
28138538|NCT03012828|54803523|FG000|Overall Study|Lost to Follow-up|1|||
28138539|NCT03012828|54803524|FG001|Overall Study|Lost to Follow-up|0|||
28138540|NCT03012828|54803525|FG002|Overall Study|Lost to Follow-up|1|||
28138541|NCT03012828|54803526|FG003|Overall Study|Lost to Follow-up|0|||
28138542|NCT03012828|54803527|FG004|Overall Study|Lost to Follow-up|1|||
28138543|NCT03012828|54803528|FG005|Overall Study|Lost to Follow-up|0|||
28138544|NCT03012828|54803523|FG000|Overall Study|Withdrawal by Subject|0|||
28138545|NCT03012828|54803524|FG001|Overall Study|Withdrawal by Subject|0|||
28138546|NCT03012828|54803525|FG002|Overall Study|Withdrawal by Subject|1|||
28138547|NCT03012828|54803526|FG003|Overall Study|Withdrawal by Subject|0|||
28138548|NCT03012828|54803527|FG004|Overall Study|Withdrawal by Subject|0|||
28138549|NCT03012828|54803528|FG005|Overall Study|Withdrawal by Subject|1|||
28138550|NCT03012828|54803523|FG000|Overall Study|Non-compliance with protocol|0|||
28138551|NCT03012828|54803524|FG001|Overall Study|Non-compliance with protocol|0|||
28138552|NCT03012828|54803525|FG002|Overall Study|Non-compliance with protocol|0|||
28138553|NCT03012828|54803526|FG003|Overall Study|Non-compliance with protocol|0|||
28138554|NCT03012828|54803527|FG004|Overall Study|Non-compliance with protocol|1|||
28138555|NCT03012828|54803528|FG005|Overall Study|Non-compliance with protocol|0|||
28138556|NCT03012828|54803523|FG000|Overall Study|Delay to last visit would delay DBL|0|||
28138557|NCT03012828|54803524|FG001|Overall Study|Delay to last visit would delay DBL|0|||
28138558|NCT03012828|54803525|FG002|Overall Study|Delay to last visit would delay DBL|0|||
28138559|NCT03012828|54803526|FG003|Overall Study|Delay to last visit would delay DBL|0|||
28138560|NCT03012828|54803527|FG004|Overall Study|Delay to last visit would delay DBL|0|||
28138561|NCT03012828|54803528|FG005|Overall Study|Delay to last visit would delay DBL|1|||
28138562|NCT03010254|54803546|FG000|Overall Study|Adverse Event|0|||
28138563|NCT03010254|54803547|FG001|Overall Study|Adverse Event|1|||
28138564|NCT03010254|54803546|FG000|Overall Study|Lost to Follow-up|4|||
28138565|NCT03010254|54803547|FG001|Overall Study|Lost to Follow-up|0|||
28138566|NCT03010254|54803546|FG000|Overall Study|Withdrawal by Subject|1|||
28138567|NCT03010254|54803547|FG001|Overall Study|Withdrawal by Subject|1|||
28138568|NCT03010254|54803546|FG000|Overall Study|Other|2|||
28138569|NCT03010254|54803547|FG001|Overall Study|Other|3|||
28138570|NCT03008460|54803562|FG000|Overall Study|Protocol deviation|0|||
28138571|NCT03008460|54803563|FG001|Overall Study|Protocol deviation|2|||
28138572|NCT03008460|54803562|FG000|Overall Study|Study drug not dispensed|0|||
28138573|NCT03008460|54803563|FG001|Overall Study|Study drug not dispensed|1|||
28138574|NCT03008460|54803562|FG000|Overall Study|Adverse Event|0|||
28138575|NCT03008460|54803563|FG001|Overall Study|Adverse Event|1|||
28138576|NCT03008460|54803562|FG000|Overall Study|Withdrawal by Subject|5|||
28138577|NCT03008460|54803563|FG001|Overall Study|Withdrawal by Subject|6|||
28138578|NCT03008460|54803562|FG000|Overall Study|COVID-19 pandemic - consent withdrawn|1|||
28138579|NCT03008460|54803563|FG001|Overall Study|COVID-19 pandemic - consent withdrawn|0|||
28138580|NCT03008460|54803562|FG000|Overall Study|End of study visit outside permitted time window|0|||
28138581|NCT03008460|54803563|FG001|Overall Study|End of study visit outside permitted time window|1|||
28138582|NCT03008460|54803562|FG000|Overall Study|Lost to Follow-up|1|||
28138583|NCT03008460|54803563|FG001|Overall Study|Lost to Follow-up|3|||
28138584|NCT02914236|54803569|FG000|Overall Study|Lost to Follow-up|1|||
28138585|NCT03003390|54803575|FG000|Overall Study|Physician Decision|2|||
28138586|NCT03003390|54803576|FG001|Overall Study|Physician Decision|0|||
28138587|NCT03003390|54803575|FG000|Overall Study|Parent refused intervention|2|||
28138588|NCT03003390|54803576|FG001|Overall Study|Parent refused intervention|0|||
28138589|NCT03003000|54803590|FG000|Overall Study|Adverse Event|1|||
28138590|NCT03003000|54803591|FG001|Overall Study|Adverse Event|2|||
28138591|NCT03003000|54803592|FG002|Overall Study|Adverse Event|3|||
28138592|NCT03003000|54803590|FG000|Overall Study|Lack of Efficacy|1|||
28138593|NCT03003000|54803591|FG001|Overall Study|Lack of Efficacy|0|||
28138594|NCT03003000|54803592|FG002|Overall Study|Lack of Efficacy|0|||
28138595|NCT03003000|54803590|FG000|Overall Study|Non-compliant with protocol|0|||
28138596|NCT03003000|54803591|FG001|Overall Study|Non-compliant with protocol|1|||
28138597|NCT03003000|54803592|FG002|Overall Study|Non-compliant with protocol|1|||
28138598|NCT03003000|54803590|FG000|Overall Study|Refused to continue medication|2|||
28138599|NCT03003000|54803591|FG001|Overall Study|Refused to continue medication|0|||
28138600|NCT03003000|54803592|FG002|Overall Study|Refused to continue medication|0|||
28138601|NCT03003000|54803590|FG000|Overall Study|Other than listed|1|||
28138602|NCT03003000|54803591|FG001|Overall Study|Other than listed|1|||
28138603|NCT03003000|54803592|FG002|Overall Study|Other than listed|1|||
28138604|NCT03002610|54803603|FG000|Overall Study|Withdrawal by Subject|6|||
28138605|NCT03002610|54803604|FG001|Overall Study|Withdrawal by Subject|25|||
28138606|NCT03002610|54803605|FG002|Overall Study|Withdrawal by Subject|13|||
28138607|NCT03005106|54803613|FG000|Overall Study|Lost to Follow-up|16|||
28138608|NCT03005106|54803613|FG000|Overall Study|Adverse Event|1|||
28138609|NCT03005106|54803613|FG000|Overall Study|Physician Decision|1|||
28138610|NCT03005106|54803613|FG000|Overall Study|Death|2|||
28138611|NCT01004861|54803630|FG000|Overall Study|Disease progression|3|||
28138612|NCT01004861|54803631|FG001|Overall Study|Disease progression|4|||
28138613|NCT01004861|54803632|FG002|Overall Study|Disease progression|5|||
28138614|NCT01004861|54803633|FG003|Overall Study|Disease progression|4|||
28138615|NCT01004861|54803634|FG004|Overall Study|Disease progression|4|||
28138616|NCT01004861|54803635|FG005|Overall Study|Disease progression|4|||
28138617|NCT01004861|54803636|FG006|Overall Study|Disease progression|5|||
28138618|NCT01004861|54803637|FG007|Overall Study|Disease progression|1|||
28138619|NCT01004861|54803638|FG008|Overall Study|Disease progression|4|||
28138620|NCT01004861|54803639|FG009|Overall Study|Disease progression|7|||
28138621|NCT01004861|54803640|FG010|Overall Study|Disease progression|6|||
28138622|NCT01004861|54803641|FG011|Overall Study|Disease progression|3|||
28138623|NCT01004861|54803642|FG012|Overall Study|Disease progression|8|||
28138624|NCT01004861|54803630|FG000|Overall Study|Physician Decision|0|||
28138625|NCT01004861|54803631|FG001|Overall Study|Physician Decision|2|||
28138626|NCT01004861|54803632|FG002|Overall Study|Physician Decision|1|||
28138627|NCT01004861|54803633|FG003|Overall Study|Physician Decision|1|||
28138628|NCT01004861|54803634|FG004|Overall Study|Physician Decision|1|||
28138629|NCT01004861|54803635|FG005|Overall Study|Physician Decision|0|||
28138630|NCT01004861|54803636|FG006|Overall Study|Physician Decision|0|||
28138631|NCT01004861|54803637|FG007|Overall Study|Physician Decision|1|||
28138632|NCT01004861|54803638|FG008|Overall Study|Physician Decision|0|||
28138633|NCT01004861|54803639|FG009|Overall Study|Physician Decision|0|||
28138634|NCT01004861|54803640|FG010|Overall Study|Physician Decision|0|||
28138635|NCT01004861|54803641|FG011|Overall Study|Physician Decision|0|||
28138636|NCT01004861|54803642|FG012|Overall Study|Physician Decision|3|||
28138637|NCT01004861|54803630|FG000|Overall Study|Adverse Event|0|||
28138638|NCT01004861|54803631|FG001|Overall Study|Adverse Event|0|||
28138639|NCT01004861|54803632|FG002|Overall Study|Adverse Event|0|||
28138640|NCT01004861|54803633|FG003|Overall Study|Adverse Event|1|||
28138641|NCT01004861|54803634|FG004|Overall Study|Adverse Event|0|||
28138642|NCT01004861|54803635|FG005|Overall Study|Adverse Event|2|||
28138643|NCT01004861|54803636|FG006|Overall Study|Adverse Event|1|||
28138644|NCT01004861|54803637|FG007|Overall Study|Adverse Event|1|||
28138645|NCT01004861|54803638|FG008|Overall Study|Adverse Event|13|||
28138646|NCT01004861|54803639|FG009|Overall Study|Adverse Event|1|||
28138647|NCT01004861|54803640|FG010|Overall Study|Adverse Event|1|||
28138648|NCT01004861|54803641|FG011|Overall Study|Adverse Event|0|||
28138649|NCT01004861|54803642|FG012|Overall Study|Adverse Event|2|||
28138650|NCT01004861|54803630|FG000|Overall Study|Protocol Violation|0|||
28138651|NCT01004861|54803631|FG001|Overall Study|Protocol Violation|0|||
28138652|NCT01004861|54803632|FG002|Overall Study|Protocol Violation|0|||
28138653|NCT01004861|54803633|FG003|Overall Study|Protocol Violation|0|||
28138654|NCT01004861|54803634|FG004|Overall Study|Protocol Violation|1|||
28138655|NCT01004861|54803635|FG005|Overall Study|Protocol Violation|0|||
28138656|NCT01004861|54803636|FG006|Overall Study|Protocol Violation|0|||
28138657|NCT01004861|54803637|FG007|Overall Study|Protocol Violation|0|||
28138658|NCT01004861|54803638|FG008|Overall Study|Protocol Violation|0|||
28138659|NCT01004861|54803639|FG009|Overall Study|Protocol Violation|0|||
28138660|NCT01004861|54803640|FG010|Overall Study|Protocol Violation|0|||
28138661|NCT01004861|54803641|FG011|Overall Study|Protocol Violation|0|||
28138662|NCT01004861|54803642|FG012|Overall Study|Protocol Violation|0|||
28138663|NCT01004861|54803630|FG000|Overall Study|Lost to Follow-up|0|||
28138664|NCT01004861|54803631|FG001|Overall Study|Lost to Follow-up|0|||
28138665|NCT01004861|54803632|FG002|Overall Study|Lost to Follow-up|0|||
28138666|NCT01004861|54803633|FG003|Overall Study|Lost to Follow-up|0|||
28138667|NCT01004861|54803634|FG004|Overall Study|Lost to Follow-up|0|||
28138668|NCT01004861|54803635|FG005|Overall Study|Lost to Follow-up|0|||
28138669|NCT01004861|54803636|FG006|Overall Study|Lost to Follow-up|0|||
28138670|NCT01004861|54803637|FG007|Overall Study|Lost to Follow-up|1|||
28138671|NCT01004861|54803638|FG008|Overall Study|Lost to Follow-up|3|||
28138672|NCT01004861|54803639|FG009|Overall Study|Lost to Follow-up|0|||
28138673|NCT01004861|54803640|FG010|Overall Study|Lost to Follow-up|0|||
28138674|NCT01004861|54803641|FG011|Overall Study|Lost to Follow-up|1|||
28138675|NCT01004861|54803642|FG012|Overall Study|Lost to Follow-up|0|||
28138676|NCT01004861|54803630|FG000|Overall Study|Non-compliance|0|||
28138677|NCT01004861|54803631|FG001|Overall Study|Non-compliance|0|||
28138678|NCT01004861|54803632|FG002|Overall Study|Non-compliance|0|||
28138679|NCT01004861|54803633|FG003|Overall Study|Non-compliance|0|||
28138680|NCT01004861|54803634|FG004|Overall Study|Non-compliance|0|||
28138681|NCT01004861|54803635|FG005|Overall Study|Non-compliance|0|||
28138682|NCT01004861|54803636|FG006|Overall Study|Non-compliance|0|||
28138683|NCT01004861|54803637|FG007|Overall Study|Non-compliance|0|||
28138684|NCT01004861|54803638|FG008|Overall Study|Non-compliance|5|||
28138685|NCT01004861|54803639|FG009|Overall Study|Non-compliance|0|||
28138686|NCT01004861|54803640|FG010|Overall Study|Non-compliance|0|||
28138687|NCT01004861|54803641|FG011|Overall Study|Non-compliance|0|||
28138688|NCT01004861|54803642|FG012|Overall Study|Non-compliance|1|||
28138689|NCT01004861|54803630|FG000|Overall Study|Other|0|||
28138690|NCT01004861|54803631|FG001|Overall Study|Other|0|||
28138691|NCT01004861|54803632|FG002|Overall Study|Other|0|||
28138692|NCT01004861|54803633|FG003|Overall Study|Other|0|||
28138693|NCT01004861|54803634|FG004|Overall Study|Other|0|||
28138694|NCT01004861|54803635|FG005|Overall Study|Other|0|||
28138695|NCT01004861|54803636|FG006|Overall Study|Other|0|||
28138696|NCT01004861|54803637|FG007|Overall Study|Other|0|||
28138697|NCT01004861|54803638|FG008|Overall Study|Other|0|||
28138698|NCT01004861|54803639|FG009|Overall Study|Other|2|||
28138699|NCT01004861|54803640|FG010|Overall Study|Other|1|||
28138700|NCT01004861|54803641|FG011|Overall Study|Other|2|||
28138701|NCT01004861|54803642|FG012|Overall Study|Other|3|||
28138702|NCT01004861|54803630|FG000|Overall Study|Patient decision|0|||
28138703|NCT01004861|54803631|FG001|Overall Study|Patient decision|0|||
28138704|NCT01004861|54803632|FG002|Overall Study|Patient decision|0|||
28138705|NCT01004861|54803633|FG003|Overall Study|Patient decision|0|||
28138706|NCT01004861|54803634|FG004|Overall Study|Patient decision|1|||
28138707|NCT01004861|54803635|FG005|Overall Study|Patient decision|0|||
28138708|NCT01004861|54803636|FG006|Overall Study|Patient decision|1|||
28138709|NCT01004861|54803637|FG007|Overall Study|Patient decision|0|||
28138710|NCT01004861|54803638|FG008|Overall Study|Patient decision|7|||
28138711|NCT01004861|54803639|FG009|Overall Study|Patient decision|1|||
28138712|NCT01004861|54803640|FG010|Overall Study|Patient decision|1|||
28138713|NCT01004861|54803641|FG011|Overall Study|Patient decision|2|||
28138714|NCT01004861|54803642|FG012|Overall Study|Patient decision|3|||
28138715|NCT01004861|54803630|FG000|Overall Study|Transitioned to Phase 4 study|0|||
28138716|NCT01004861|54803631|FG001|Overall Study|Transitioned to Phase 4 study|0|||
28138717|NCT01004861|54803632|FG002|Overall Study|Transitioned to Phase 4 study|0|||
28138718|NCT01004861|54803633|FG003|Overall Study|Transitioned to Phase 4 study|0|||
28138719|NCT01004861|54803634|FG004|Overall Study|Transitioned to Phase 4 study|0|||
28138720|NCT01004861|54803635|FG005|Overall Study|Transitioned to Phase 4 study|0|||
28138721|NCT01004861|54803636|FG006|Overall Study|Transitioned to Phase 4 study|0|||
28138722|NCT01004861|54803637|FG007|Overall Study|Transitioned to Phase 4 study|0|||
28138723|NCT01004861|54803638|FG008|Overall Study|Transitioned to Phase 4 study|2|||
28138724|NCT01004861|54803639|FG009|Overall Study|Transitioned to Phase 4 study|0|||
28138725|NCT01004861|54803640|FG010|Overall Study|Transitioned to Phase 4 study|0|||
28138726|NCT01004861|54803641|FG011|Overall Study|Transitioned to Phase 4 study|0|||
28138727|NCT01004861|54803642|FG012|Overall Study|Transitioned to Phase 4 study|0|||
28138728|NCT01004861|54803630|FG000|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
28138729|NCT01004861|54803631|FG001|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
28138730|NCT01004861|54803632|FG002|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
28138731|NCT01004861|54803633|FG003|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
28138732|NCT01004861|54803634|FG004|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
28138733|NCT01004861|54803635|FG005|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
28138734|NCT01004861|54803636|FG006|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
28138735|NCT01004861|54803637|FG007|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
28138736|NCT01004861|54803638|FG008|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|1|||
28138737|NCT01004861|54803639|FG009|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
28138738|NCT01004861|54803640|FG010|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
28138739|NCT01004861|54803641|FG011|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
28138740|NCT01004861|54803642|FG012|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
28138741|NCT01004861|54803630|FG000|Overall Study|Patient withdrew|0|||
28138742|NCT01004861|54803631|FG001|Overall Study|Patient withdrew|0|||
28138743|NCT01004861|54803632|FG002|Overall Study|Patient withdrew|0|||
28138744|NCT01004861|54803633|FG003|Overall Study|Patient withdrew|0|||
28138745|NCT01004861|54803634|FG004|Overall Study|Patient withdrew|0|||
28138746|NCT01004861|54803635|FG005|Overall Study|Patient withdrew|0|||
28138747|NCT01004861|54803636|FG006|Overall Study|Patient withdrew|0|||
28138748|NCT01004861|54803637|FG007|Overall Study|Patient withdrew|0|||
28138749|NCT01004861|54803638|FG008|Overall Study|Patient withdrew|1|||
28138750|NCT01004861|54803639|FG009|Overall Study|Patient withdrew|0|||
28138751|NCT01004861|54803640|FG010|Overall Study|Patient withdrew|0|||
28138752|NCT01004861|54803641|FG011|Overall Study|Patient withdrew|0|||
28138753|NCT01004861|54803642|FG012|Overall Study|Patient withdrew|0|||
28138754|NCT01004861|54803630|FG000|Overall Study|Surgical resection|0|||
28138755|NCT01004861|54803631|FG001|Overall Study|Surgical resection|0|||
28138756|NCT01004861|54803632|FG002|Overall Study|Surgical resection|0|||
28138757|NCT01004861|54803633|FG003|Overall Study|Surgical resection|0|||
28138758|NCT01004861|54803634|FG004|Overall Study|Surgical resection|0|||
28138759|NCT01004861|54803635|FG005|Overall Study|Surgical resection|0|||
28138760|NCT01004861|54803636|FG006|Overall Study|Surgical resection|0|||
28138761|NCT01004861|54803637|FG007|Overall Study|Surgical resection|0|||
28138762|NCT01004861|54803638|FG008|Overall Study|Surgical resection|1|||
28138763|NCT01004861|54803639|FG009|Overall Study|Surgical resection|0|||
28070210|NCT00006046|54725085|FG004|Overall Study|Disease Progression|0|||
28070211|NCT00005908|54725097|FG000|Overall Study|Withdrawal by Subject|1|||
28070212|NCT00005908|54725098|FG001|Overall Study|Withdrawal by Subject|0|||
28070213|NCT00432965|54725109|FG000|Overall Study|Lost to Follow-up|22|||
28070214|NCT00432965|54725110|FG001|Overall Study|Lost to Follow-up|19|||
28070215|NCT00432965|54725109|FG000|Overall Study|Withdrawal by Subject|13|||
28070216|NCT00432965|54725110|FG001|Overall Study|Withdrawal by Subject|13|||
28070217|NCT00432965|54725109|FG000|Overall Study|Physician Decision|14|||
28070218|NCT00432965|54725110|FG001|Overall Study|Physician Decision|13|||
28070219|NCT00432965|54725109|FG000|Overall Study|Lack of Efficacy|8|||
28070220|NCT00432965|54725110|FG001|Overall Study|Lack of Efficacy|13|||
28070221|NCT00432965|54725109|FG000|Overall Study|Non-compliance|7|||
28070222|NCT00432965|54725110|FG001|Overall Study|Non-compliance|0|||
28070223|NCT00432965|54725109|FG000|Overall Study|Adverse Event|22|||
28070224|NCT00432965|54725110|FG001|Overall Study|Adverse Event|19|||
28070225|NCT00432965|54725109|FG000|Overall Study|Death|3|||
28138764|NCT01004861|54803640|FG010|Overall Study|Surgical resection|0|||
28138765|NCT01004861|54803641|FG011|Overall Study|Surgical resection|0|||
28138766|NCT01004861|54803642|FG012|Overall Study|Surgical resection|0|||
28138767|NCT01004861|54803630|FG000|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
28138768|NCT01004861|54803631|FG001|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
28138769|NCT01004861|54803632|FG002|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
28138770|NCT01004861|54803633|FG003|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
28138771|NCT01004861|54803634|FG004|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
28138772|NCT01004861|54803635|FG005|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
28138773|NCT01004861|54803636|FG006|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
28138774|NCT01004861|54803637|FG007|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
28138775|NCT01004861|54803638|FG008|Overall Study|Patient maintained complete response status throughout drug holiday|1|||
28138776|NCT01004861|54803639|FG009|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
28138777|NCT01004861|54803640|FG010|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
28138778|NCT01004861|54803641|FG011|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
28138779|NCT01004861|54803642|FG012|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
28138780|NCT01004861|54803630|FG000|Overall Study|Study termination by Sponsor|0|||
28138781|NCT01004861|54803631|FG001|Overall Study|Study termination by Sponsor|0|||
28138782|NCT01004861|54803632|FG002|Overall Study|Study termination by Sponsor|0|||
28138783|NCT01004861|54803633|FG003|Overall Study|Study termination by Sponsor|0|||
28138784|NCT01004861|54803634|FG004|Overall Study|Study termination by Sponsor|0|||
28138785|NCT01004861|54803635|FG005|Overall Study|Study termination by Sponsor|0|||
28138786|NCT01004861|54803636|FG006|Overall Study|Study termination by Sponsor|0|||
28138787|NCT01004861|54803637|FG007|Overall Study|Study termination by Sponsor|0|||
28138788|NCT01004861|54803638|FG008|Overall Study|Study termination by Sponsor|1|||
28138789|NCT01004861|54803639|FG009|Overall Study|Study termination by Sponsor|0|||
28138790|NCT01004861|54803640|FG010|Overall Study|Study termination by Sponsor|0|||
28138791|NCT01004861|54803641|FG011|Overall Study|Study termination by Sponsor|0|||
28138792|NCT01004861|54803642|FG012|Overall Study|Study termination by Sponsor|0|||
28138793|NCT03254459|54803689|FG000|Overall Study|Adverse Event|7|||
28138794|NCT03254459|54803690|FG001|Overall Study|Adverse Event|20|||
28138795|NCT03254459|54803689|FG000|Overall Study|Withdrawal by Subject Consent|3|||
28138796|NCT03254459|54803690|FG001|Overall Study|Withdrawal by Subject Consent|1|||
28138797|NCT03254459|54803689|FG000|Overall Study|Lost to Follow-up|0|||
28138798|NCT03254459|54803690|FG001|Overall Study|Lost to Follow-up|1|||
28138799|NCT03254459|54803689|FG000|Overall Study|Miscellaneous|0|||
28138800|NCT03254459|54803690|FG001|Overall Study|Miscellaneous|1|||
28138801|NCT02736617|54803696|FG000|Treatment|Adverse Event|1|||
28138802|NCT02736617|54803696|FG000|Treatment|Lack of Efficacy|1|||
28138803|NCT02736617|54803696|FG000|Treatment|Withdrawal by Subject|1|||
28138804|NCT02736617|54803696|FG000|Maintenance|Lack of Efficacy|4|||
28138805|NCT02736617|54803696|FG000|Maintenance|Physician Decision|1|||
28138806|NCT03251963|54803703|FG000|Overall Study|inappropriate Xa level timing|6|||
28138807|NCT03251963|54803704|FG001|Overall Study|inappropriate Xa level timing|3|||
28138808|NCT03251963|54803703|FG000|Overall Study|no peak Xa level drawn|2|||
28138809|NCT03251963|54803704|FG001|Overall Study|no peak Xa level drawn|0|||
28138810|NCT03251963|54803703|FG000|Overall Study|bled prior to Xa level|1|||
28138811|NCT03251963|54803704|FG001|Overall Study|bled prior to Xa level|2|||
28138812|NCT03287219|54803712|FG000|Overall Study|Protocol Violation|0|||
28138813|NCT03287219|54803713|FG001|Overall Study|Protocol Violation|2|||
28138814|NCT03286751|54803752|FG000|Washout Period 1|Withdrawal by Subject|0|||
28138815|NCT03286751|54803753|FG001|Washout Period 1|Withdrawal by Subject|0|||
28138816|NCT03286751|54803754|FG002|Washout Period 1|Withdrawal by Subject|0|||
28138817|NCT03286751|54803755|FG003|Washout Period 1|Withdrawal by Subject|0|||
28138818|NCT03286751|54803756|FG004|Washout Period 1|Withdrawal by Subject|1|||
28138819|NCT03286751|54803757|FG005|Washout Period 1|Withdrawal by Subject|0|||
28138820|NCT03286751|54803752|FG000|Washout Period 2|Personal Reasons|0|||
28138821|NCT03286751|54803753|FG001|Washout Period 2|Personal Reasons|1|||
28138822|NCT03286751|54803754|FG002|Washout Period 2|Personal Reasons|0|||
28138823|NCT03286751|54803755|FG003|Washout Period 2|Personal Reasons|0|||
28138824|NCT03286751|54803756|FG004|Washout Period 2|Personal Reasons|0|||
27941082|NCT01179672|54597407|FG001|Overall Study|Withdrawal by Subject|12|||
27941083|NCT01179672|54597406|FG000|Overall Study|Entry Criteria Not Met|0|||
28138825|NCT03286751|54803757|FG005|Washout Period 2|Personal Reasons|0|||
28138826|NCT03286751|54803752|FG000|Washout Period 5|Adverse Event|0|||
28138827|NCT03286751|54803753|FG001|Washout Period 5|Adverse Event|0|||
28138828|NCT03286751|54803754|FG002|Washout Period 5|Adverse Event|0|||
28138829|NCT03286751|54803755|FG003|Washout Period 5|Adverse Event|0|||
28138830|NCT03286751|54803756|FG004|Washout Period 5|Adverse Event|1|||
28138831|NCT03286751|54803757|FG005|Washout Period 5|Adverse Event|0|||
28138832|NCT03249935|54803771|FG000|Overall Study|Discharged from facility early|36|||
28138833|NCT03249935|54803771|FG000|Overall Study|Negative for chlamydia at enrollment|4|||
28138834|NCT03249935|54803771|FG000|Overall Study|Protocol Violation|5|||
28138835|NCT03285113|54803777|FG000|Overall Study|Unable to implant leads|2|||
28138836|NCT03000348|54803787|FG000|Overall Study|Adverse Event|1|||
28138837|NCT03000348|54803788|FG001|Overall Study|Adverse Event|1|||
28138838|NCT03000348|54803789|FG002|Overall Study|Adverse Event|1|||
28138839|NCT03000348|54803790|FG003|Overall Study|Adverse Event|1|||
28138840|NCT03000348|54803791|FG004|Overall Study|Adverse Event|1|||
28138841|NCT03000348|54803792|FG005|Overall Study|Adverse Event|1|||
28138842|NCT03000348|54803787|FG000|Overall Study|Lost to Follow-up|0|||
28138843|NCT03000348|54803788|FG001|Overall Study|Lost to Follow-up|0|||
28138844|NCT03000348|54803789|FG002|Overall Study|Lost to Follow-up|1|||
28138845|NCT03000348|54803790|FG003|Overall Study|Lost to Follow-up|0|||
28138846|NCT03000348|54803791|FG004|Overall Study|Lost to Follow-up|0|||
28138847|NCT03000348|54803792|FG005|Overall Study|Lost to Follow-up|0|||
28138848|NCT03000348|54803787|FG000|Overall Study|Withdrawal by Subject|0|||
28138849|NCT03000348|54803788|FG001|Overall Study|Withdrawal by Subject|1|||
28138850|NCT03000348|54803789|FG002|Overall Study|Withdrawal by Subject|0|||
28138851|NCT03000348|54803790|FG003|Overall Study|Withdrawal by Subject|0|||
28138852|NCT03000348|54803791|FG004|Overall Study|Withdrawal by Subject|0|||
28138853|NCT03000348|54803792|FG005|Overall Study|Withdrawal by Subject|0|||
28138854|NCT03000348|54803787|FG000|Overall Study|Consent|0|||
28138855|NCT03000348|54803788|FG001|Overall Study|Consent|0|||
28138856|NCT03000348|54803789|FG002|Overall Study|Consent|0|||
28138857|NCT03000348|54803790|FG003|Overall Study|Consent|0|||
28138858|NCT03000348|54803791|FG004|Overall Study|Consent|1|||
28138859|NCT03000348|54803792|FG005|Overall Study|Consent|0|||
28138860|NCT03000348|54803787|FG000|Overall Study|Failure to expectorate sputum|1|||
28138861|NCT03000348|54803788|FG001|Overall Study|Failure to expectorate sputum|0|||
28138862|NCT03000348|54803789|FG002|Overall Study|Failure to expectorate sputum|1|||
28138863|NCT03000348|54803790|FG003|Overall Study|Failure to expectorate sputum|0|||
28138864|NCT03000348|54803791|FG004|Overall Study|Failure to expectorate sputum|1|||
28138865|NCT03000348|54803792|FG005|Overall Study|Failure to expectorate sputum|0|||
28138866|NCT03000348|54803787|FG000|Overall Study|No gram negative|1|||
28138867|NCT03000348|54803788|FG001|Overall Study|No gram negative|2|||
28138868|NCT03000348|54803789|FG002|Overall Study|No gram negative|1|||
28138869|NCT03000348|54803790|FG003|Overall Study|No gram negative|1|||
28138870|NCT03000348|54803791|FG004|Overall Study|No gram negative|1|||
28138871|NCT03000348|54803792|FG005|Overall Study|No gram negative|1|||
28138872|NCT03000348|54803787|FG000|Overall Study|Patient had no transport|0|||
28138873|NCT03000348|54803788|FG001|Overall Study|Patient had no transport|0|||
28138874|NCT03000348|54803789|FG002|Overall Study|Patient had no transport|0|||
28138875|NCT03000348|54803790|FG003|Overall Study|Patient had no transport|1|||
28138876|NCT03000348|54803791|FG004|Overall Study|Patient had no transport|0|||
28138877|NCT03000348|54803792|FG005|Overall Study|Patient had no transport|0|||
28138878|NCT03000348|54803787|FG000|Overall Study|Dosing|0|||
28138879|NCT03000348|54803788|FG001|Overall Study|Dosing|0|||
28138880|NCT03000348|54803789|FG002|Overall Study|Dosing|0|||
28138881|NCT03000348|54803790|FG003|Overall Study|Dosing|0|||
28138882|NCT03000348|54803791|FG004|Overall Study|Dosing|1|||
28138883|NCT03000348|54803792|FG005|Overall Study|Dosing|0|||
28138884|NCT03283709|54803811|FG000|Overall Study|trial terminated|0|||
28138885|NCT03283709|54803812|FG001|Overall Study|trial terminated|1|||
28138886|NCT03247673|54803821|FG000|Overall Study|Withdrawal by Subject|1|||
28138887|NCT03247673|54803822|FG001|Overall Study|Withdrawal by Subject|0|||
28138888|NCT03247673|54803823|FG002|Overall Study|Withdrawal by Subject|3|||
28138889|NCT03247673|54803821|FG000|Overall Study|Lost to Follow-up|0|||
28138890|NCT03247673|54803822|FG001|Overall Study|Lost to Follow-up|0|||
28138891|NCT03247673|54803823|FG002|Overall Study|Lost to Follow-up|1|||
28138892|NCT03247517|54803834|FG000|Overall Study|Adverse Event|0|||
28138893|NCT03247517|54803835|FG001|Overall Study|Adverse Event|4|||
27849907|NCT04569968|54348243|FG001|Overall Study|Age interval|6|||
28070226|NCT00432965|54725110|FG001|Overall Study|Death|4|||
28070227|NCT00432965|54725109|FG000|Overall Study|Exclusionary Methods|1|||
28070228|NCT00432965|54725110|FG001|Overall Study|Exclusionary Methods|2|||
28070229|NCT00432965|54725109|FG000|Overall Study|Incomplete Data|4|||
28070230|NCT00432965|54725110|FG001|Overall Study|Incomplete Data|3|||
28070231|NCT00440297|54725118|FG000|Overall Study|Adverse Event|8|||
28070232|NCT00440297|54725119|FG001|Overall Study|Adverse Event|5|||
28070233|NCT00440297|54725118|FG000|Overall Study|Lost to Follow-up|1|||
28070234|NCT00440297|54725119|FG001|Overall Study|Lost to Follow-up|0|||
28070235|NCT00440297|54725118|FG000|Overall Study|Physician Decision|1|||
28070236|NCT00440297|54725119|FG001|Overall Study|Physician Decision|0|||
28070237|NCT00440297|54725118|FG000|Overall Study|Protocol Violation|11|||
28070238|NCT00440297|54725119|FG001|Overall Study|Protocol Violation|7|||
28070239|NCT00440297|54725118|FG000|Overall Study|Withdrawal by Subject|1|||
28070240|NCT00440297|54725119|FG001|Overall Study|Withdrawal by Subject|6|||
28070241|NCT00440297|54725118|FG000|Overall Study|Randomized by mistake|1|||
28070242|NCT00440297|54725119|FG001|Overall Study|Randomized by mistake|0|||
28070243|NCT00432809|54725128|FG000|1 Year Follow-up|Misses 9 and 12 month visit|2|||
28070244|NCT00432809|54725129|FG001|1 Year Follow-up|Misses 9 and 12 month visit|0|||
28070245|NCT00432809|54725130|FG002|1 Year Follow-up|Misses 9 and 12 month visit|0|||
28070246|NCT00432809|54725128|FG000|1 Year Follow-up|Withdrawal by Subject|7|||
28070247|NCT00432809|54725129|FG001|1 Year Follow-up|Withdrawal by Subject|0|||
28138894|NCT03247517|54803836|FG002|Overall Study|Adverse Event|2|||
28138895|NCT03247517|54803834|FG000|Overall Study|Lost to Follow-up|2|||
28138896|NCT03247517|54803835|FG001|Overall Study|Lost to Follow-up|6|||
28138897|NCT03247517|54803836|FG002|Overall Study|Lost to Follow-up|4|||
28138898|NCT03247517|54803834|FG000|Overall Study|Consent withdrawn by caregiver|1|||
28138899|NCT03247517|54803835|FG001|Overall Study|Consent withdrawn by caregiver|4|||
28138900|NCT03247517|54803836|FG002|Overall Study|Consent withdrawn by caregiver|7|||
28138901|NCT03247517|54803834|FG000|Overall Study|Assent/consent withdrawn by subject|2|||
28138902|NCT03247517|54803835|FG001|Overall Study|Assent/consent withdrawn by subject|3|||
28138903|NCT03247517|54803836|FG002|Overall Study|Assent/consent withdrawn by subject|1|||
28138904|NCT03247517|54803834|FG000|Overall Study|Protocol Violation|0|||
28138905|NCT03247517|54803835|FG001|Overall Study|Protocol Violation|2|||
28138906|NCT03247517|54803836|FG002|Overall Study|Protocol Violation|0|||
28138907|NCT03247517|54803834|FG000|Overall Study|Multiple reasons|3|||
28138908|NCT03247517|54803835|FG001|Overall Study|Multiple reasons|1|||
28138909|NCT03247517|54803836|FG002|Overall Study|Multiple reasons|0|||
28138910|NCT03283553|54803846|FG000|Patient Participant Flow|Death|5|||
28138911|NCT03283553|54803847|FG001|Patient Participant Flow|Death|10|||
28138912|NCT03283553|54803846|FG000|Patient Participant Flow|Withdrawal by Subject|4|||
28138913|NCT03283553|54803847|FG001|Patient Participant Flow|Withdrawal by Subject|2|||
28138914|NCT03283553|54803846|FG000|Patient Participant Flow|Lost to Follow-up|1|||
28070248|NCT00432809|54725130|FG002|1 Year Follow-up|Withdrawal by Subject|1|||
28070249|NCT00431951|54725142|FG000|Overall Study|Inability to follow study procedures|1|||
28070250|NCT00431951|54725143|FG001|Overall Study|Inability to follow study procedures|0|||
28070251|NCT00431951|54725144|FG002|Overall Study|Inability to follow study procedures|1|||
28070252|NCT00431951|54725145|FG003|Overall Study|Inability to follow study procedures|2|||
28070253|NCT00431951|54725142|FG000|Overall Study|Lost to Follow-up|0|||
28070254|NCT00431951|54725143|FG001|Overall Study|Lost to Follow-up|1|||
28070255|NCT00431951|54725144|FG002|Overall Study|Lost to Follow-up|0|||
28138915|NCT03283553|54803847|FG001|Patient Participant Flow|Lost to Follow-up|1|||
28138916|NCT03283553|54803846|FG000|Care Partner Participant Flow|Withdrawal by Subject|4|||
28138917|NCT03283553|54803847|FG001|Care Partner Participant Flow|Withdrawal by Subject|3|||
28138918|NCT03283553|54803846|FG000|Care Partner Participant Flow|Lost to Follow-up|1|||
28138919|NCT03283553|54803847|FG001|Care Partner Participant Flow|Lost to Follow-up|1|||
28138920|NCT03283553|54803846|FG000|Care Partner Participant Flow|Discontinued because patient death|5|||
28138921|NCT03283553|54803847|FG001|Care Partner Participant Flow|Discontinued because patient death|11|||
28138922|NCT03283319|54803861|FG000|Overall Study|Lost to Follow-up|5|||
28138923|NCT03283319|54803862|FG001|Overall Study|Lost to Follow-up|4|||
28138924|NCT03283319|54803863|FG002|Overall Study|Lost to Follow-up|5|||
28138925|NCT03283319|54803864|FG003|Overall Study|Lost to Follow-up|5|||
28138926|NCT03283319|54803865|FG004|Overall Study|Lost to Follow-up|4|||
28138927|NCT03283319|54803866|FG005|Overall Study|Lost to Follow-up|3|||
28138928|NCT03283319|54803861|FG000|Overall Study|Withdrawal by Subject|2|||
28138929|NCT03283319|54803862|FG001|Overall Study|Withdrawal by Subject|2|||
28138930|NCT03283319|54803863|FG002|Overall Study|Withdrawal by Subject|2|||
28138931|NCT03283319|54803864|FG003|Overall Study|Withdrawal by Subject|1|||
28138932|NCT03283319|54803865|FG004|Overall Study|Withdrawal by Subject|0|||
28138933|NCT03283319|54803866|FG005|Overall Study|Withdrawal by Subject|1|||
28138934|NCT03283319|54803861|FG000|Overall Study|BARDA regulatory agency or IRB decision|0|||
28138935|NCT03283319|54803862|FG001|Overall Study|BARDA regulatory agency or IRB decision|0|||
28138936|NCT03283319|54803863|FG002|Overall Study|BARDA regulatory agency or IRB decision|0|||
28138937|NCT03283319|54803864|FG003|Overall Study|BARDA regulatory agency or IRB decision|1|||
28138938|NCT03283319|54803865|FG004|Overall Study|BARDA regulatory agency or IRB decision|0|||
28138939|NCT03283319|54803866|FG005|Overall Study|BARDA regulatory agency or IRB decision|0|||
28138940|NCT03282227|54803880|FG000|Overall Study|Exposure Goals Achieved|60|||
28138941|NCT03282227|54803880|FG000|Overall Study|Non-compliance w/ protocol requirements|79|||
28138942|NCT03282227|54803880|FG000|Overall Study|Adverse Event|15|||
28070256|NCT00431951|54725145|FG003|Overall Study|Lost to Follow-up|0|||
28070257|NCT00431951|54725142|FG000|Overall Study|Withdrawal by Subject|0|||
28070258|NCT00431951|54725143|FG001|Overall Study|Withdrawal by Subject|1|||
28070259|NCT00431951|54725144|FG002|Overall Study|Withdrawal by Subject|0|||
28070260|NCT00431951|54725145|FG003|Overall Study|Withdrawal by Subject|0|||
28070261|NCT00431951|54725142|FG000|Overall Study|Adverse Event|0|||
28070262|NCT00431951|54725143|FG001|Overall Study|Adverse Event|0|||
28070263|NCT00431951|54725144|FG002|Overall Study|Adverse Event|1|||
28070264|NCT00431951|54725145|FG003|Overall Study|Adverse Event|0|||
28070265|NCT00004978|54725161|FG000|Overall Study|Death|107|||
28070266|NCT00004978|54725162|FG001|Overall Study|Death|116|||
28070267|NCT00004978|54725161|FG000|Overall Study|Lost to Follow-up|101|||
28070268|NCT00004978|54725162|FG001|Overall Study|Lost to Follow-up|108|||
28070269|NCT00004978|54725161|FG000|Overall Study|Withdrawal by Subject|17|||
28070270|NCT00004978|54725162|FG001|Overall Study|Withdrawal by Subject|26|||
28070271|NCT00004978|54725161|FG000|Overall Study|site closure - not in analysis cohort|19|||
28070272|NCT00004978|54725162|FG001|Overall Study|site closure - not in analysis cohort|20|||
28070273|NCT00430937|54725170|FG000|Overall Study|Adverse Event|3|||
28070274|NCT00430937|54725171|FG001|Overall Study|Adverse Event|8|||
28070275|NCT00430937|54725170|FG000|Overall Study|Death|0|||
28070276|NCT00430937|54725171|FG001|Overall Study|Death|1|||
28070277|NCT00430937|54725170|FG000|Overall Study|Lost to Follow-up|6|||
28070278|NCT00430937|54725171|FG001|Overall Study|Lost to Follow-up|6|||
28138943|NCT03282227|54803880|FG000|Overall Study|Lost to Follow-up|21|||
28138944|NCT03282227|54803880|FG000|Overall Study|Withdrawal by Subject|20|||
28138945|NCT03282227|54803880|FG000|Overall Study|Lack of Efficacy|12|||
28138946|NCT03282227|54803880|FG000|Overall Study|Sponsor decision|3|||
28138947|NCT03282227|54803880|FG000|Overall Study|Physician Decision|2|||
28138948|NCT03282227|54803880|FG000|Overall Study|Pregnancy|2|||
28138949|NCT03282227|54803880|FG000|Overall Study|Other|1|||
28138950|NCT03240575|54803888|FG000|Overall Study|Adverse Event|0|||
28138951|NCT03240575|54803889|FG001|Overall Study|Adverse Event|2|||
28138952|NCT03240575|54803890|FG002|Overall Study|Adverse Event|0|||
28138953|NCT03240575|54803891|FG003|Overall Study|Adverse Event|1|||
28138954|NCT03240575|54803888|FG000|Overall Study|Withdrawal by Subject|2|||
28138955|NCT03240575|54803889|FG001|Overall Study|Withdrawal by Subject|11|||
28138956|NCT03240575|54803890|FG002|Overall Study|Withdrawal by Subject|0|||
28138957|NCT03240575|54803891|FG003|Overall Study|Withdrawal by Subject|1|||
28138958|NCT03240575|54803888|FG000|Overall Study|Other|0|||
28138959|NCT03240575|54803889|FG001|Overall Study|Other|1|||
28138960|NCT03240575|54803890|FG002|Overall Study|Other|0|||
28138961|NCT03240575|54803891|FG003|Overall Study|Other|0|||
28138962|NCT03385265|54803903|FG000|Overall Study|Withdrawal by Subject|5|||
28138963|NCT03385265|54803904|FG001|Overall Study|Withdrawal by Subject|2|||
28138964|NCT03385265|54803905|FG002|Overall Study|Withdrawal by Subject|5|||
28138965|NCT03385265|54803906|FG003|Overall Study|Withdrawal by Subject|2|||
28138966|NCT03280121|54803918|FG000|Overall Study|Physician Decision|1|||
28138967|NCT03280121|54803918|FG000|Overall Study|Lost to Follow-up|1|||
28138968|NCT03280121|54803918|FG000|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4|||
28138969|NCT03233009|54803922|FG000|Overall Study|Lost to Follow-up|1|||
28138970|NCT04034225|54803937|FG000|Overall Study|Death|3|||
28138971|NCT04034225|54803937|FG000|Overall Study|Withdrawal by Subject|2|||
28138972|NCT04034225|54803937|FG000|Overall Study|Study termination by Sponsor|18|||
28138973|NCT04034225|54803937|FG000|Overall Study|Physician Decision|1|||
28138974|NCT04034225|54803937|FG000|Overall Study|Lack of Efficacy|1|||
28138975|NCT02999178|54803945|FG000|Overall Study|Adverse Event|85|||
28138976|NCT02999178|54803946|FG001|Overall Study|Adverse Event|62|||
28138977|NCT02999178|54803945|FG000|Overall Study|Protocol Violation|1|||
28138978|NCT02999178|54803946|FG001|Overall Study|Protocol Violation|2|||
28138979|NCT02999178|54803945|FG000|Overall Study|Lost to Follow-up|0|||
28138980|NCT02999178|54803946|FG001|Overall Study|Lost to Follow-up|2|||
28138981|NCT02999178|54803945|FG000|Overall Study|Withdrawal by Subject|21|||
28138982|NCT02999178|54803946|FG001|Overall Study|Withdrawal by Subject|21|||
28138983|NCT02999178|54803945|FG000|Overall Study|Other reason not defined above|7|||
28138984|NCT02999178|54803946|FG001|Overall Study|Other reason not defined above|13|||
28138985|NCT02959190|54803958|FG000|Open Label|Adverse Event|5|||
28138986|NCT02959190|54803959|FG001|Open Label|Adverse Event|7|||
28138987|NCT02959190|54803960|FG002|Open Label|Adverse Event|3|||
28138988|NCT02959190|54803961|FG003|Open Label|Adverse Event|4|||
28138989|NCT02959190|54803958|FG000|Open Label|Pregnancy|0|||
28138990|NCT02959190|54803959|FG001|Open Label|Pregnancy|1|||
28138991|NCT02959190|54803960|FG002|Open Label|Pregnancy|0|||
28138992|NCT02959190|54803961|FG003|Open Label|Pregnancy|0|||
28138993|NCT02959190|54803958|FG000|Open Label|Withdrawal by Subject|2|||
28138994|NCT02959190|54803959|FG001|Open Label|Withdrawal by Subject|8|||
28138995|NCT02959190|54803960|FG002|Open Label|Withdrawal by Subject|0|||
28138996|NCT02959190|54803961|FG003|Open Label|Withdrawal by Subject|0|||
28138997|NCT02959190|54803958|FG000|Open Label|Physician Decision|0|||
28138998|NCT02959190|54803959|FG001|Open Label|Physician Decision|0|||
28138999|NCT02959190|54803960|FG002|Open Label|Physician Decision|1|||
28139000|NCT02959190|54803961|FG003|Open Label|Physician Decision|0|||
28139001|NCT02959190|54803958|FG000|Open Label|Protocol Violation|0|||
28139002|NCT02959190|54803959|FG001|Open Label|Protocol Violation|0|||
28139003|NCT02959190|54803960|FG002|Open Label|Protocol Violation|0|||
28139004|NCT02959190|54803961|FG003|Open Label|Protocol Violation|2|||
28139005|NCT02959190|54803958|FG000|Post Treatment Follow Up|Adverse Event|1|||
28139006|NCT02959190|54803959|FG001|Post Treatment Follow Up|Adverse Event|1|||
28139007|NCT02959190|54803960|FG002|Post Treatment Follow Up|Adverse Event|0|||
28139008|NCT02959190|54803961|FG003|Post Treatment Follow Up|Adverse Event|0|||
28139009|NCT02959190|54803958|FG000|Post Treatment Follow Up|Withdrawal by Subject|2|||
28139010|NCT02959190|54803959|FG001|Post Treatment Follow Up|Withdrawal by Subject|0|||
28139011|NCT02959190|54803960|FG002|Post Treatment Follow Up|Withdrawal by Subject|1|||
28139012|NCT02959190|54803961|FG003|Post Treatment Follow Up|Withdrawal by Subject|0|||
28139013|NCT01344356|54803982|FG000|Overall Study|Physician Decision|0|||
28139014|NCT01344356|54803983|FG001|Overall Study|Physician Decision|3|||
28139015|NCT01344356|54803982|FG000|Overall Study|Lost to Follow-up|0|||
28139016|NCT01344356|54803983|FG001|Overall Study|Lost to Follow-up|6|||
28139017|NCT02956460|54804009|FG000|Lens 1|Lost to Follow-up|1|||
28139018|NCT02956460|54804010|FG001|Lens 1|Lost to Follow-up|0|||
28139019|NCT02999100|54804022|FG000|Part 1 (up to 15 Days)|Adverse Event|0|||
28139020|NCT02999100|54804023|FG001|Part 1 (up to 15 Days)|Adverse Event|1|||
28139021|NCT02999100|54804024|FG002|Part 1 (up to 15 Days)|Adverse Event|0|||
28139022|NCT02999100|54804025|FG003|Part 1 (up to 15 Days)|Adverse Event|0|||
28139023|NCT02999100|54804026|FG004|Part 1 (up to 15 Days)|Adverse Event|0|||
28139024|NCT02999100|54804027|FG005|Part 1 (up to 15 Days)|Adverse Event|0|||
28139025|NCT02999100|54804022|FG000|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
28139026|NCT02999100|54804023|FG001|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
28139027|NCT02999100|54804024|FG002|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
28139028|NCT02999100|54804025|FG003|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
28139029|NCT02999100|54804026|FG004|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
28139030|NCT02999100|54804027|FG005|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1|||
28139031|NCT02999100|54804022|FG000|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
28139032|NCT02999100|54804023|FG001|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
28139033|NCT02999100|54804024|FG002|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1|||
28139034|NCT02999100|54804025|FG003|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
28139035|NCT02999100|54804026|FG004|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
28139036|NCT02999100|54804027|FG005|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
28139037|NCT02749370|54804049|FG000|Overall Study|Withdrawal by Subject|11|||
28139038|NCT02749370|54804049|FG000|Overall Study|Lost to Follow-up|3|||
28139039|NCT03607994|54804055|FG000|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
28139040|NCT03607994|54804056|FG001|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
28139041|NCT02996682|54804064|FG000|Overall Study|Death|0|||
28139042|NCT02996682|54804065|FG001|Overall Study|Death|3|||
28139043|NCT02873702|54804073|FG000|Healing Period (up to Week 8)|Adverse Event|1|||
28139044|NCT02873702|54804074|FG001|Healing Period (up to Week 8)|Adverse Event|0|||
28139045|NCT02873702|54804075|FG002|Healing Period (up to Week 8)|Adverse Event|0|||
28139046|NCT02873702|54804076|FG003|Healing Period (up to Week 8)|Adverse Event|0|||
28139047|NCT02873702|54804073|FG000|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
28139048|NCT02873702|54804074|FG001|Healing Period (up to Week 8)|Withdrawal by Subject|1|||
28139049|NCT02873702|54804075|FG002|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
28139050|NCT02873702|54804076|FG003|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
28139051|NCT02873702|54804073|FG000|Maintenance Period (up to Month 6)|Adverse Event|0|||
28139052|NCT02873702|54804074|FG001|Maintenance Period (up to Month 6)|Adverse Event|0|||
28139053|NCT02873702|54804075|FG002|Maintenance Period (up to Month 6)|Adverse Event|1|||
28139054|NCT02873702|54804076|FG003|Maintenance Period (up to Month 6)|Adverse Event|0|||
28139055|NCT02873702|54804073|FG000|Maintenance Period (up to Month 6)|Relapse of EE|0|||
28139056|NCT02873702|54804074|FG001|Maintenance Period (up to Month 6)|Relapse of EE|0|||
28139057|NCT02873702|54804075|FG002|Maintenance Period (up to Month 6)|Relapse of EE|4|||
28139058|NCT02873702|54804076|FG003|Maintenance Period (up to Month 6)|Relapse of EE|1|||
28139059|NCT02873702|54804073|FG000|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
28139060|NCT02873702|54804074|FG001|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
28139061|NCT02873702|54804075|FG002|Maintenance Period (up to Month 6)|Withdrawal by Subject|2|||
28139062|NCT02873702|54804076|FG003|Maintenance Period (up to Month 6)|Withdrawal by Subject|1|||
28139063|NCT02911116|54804088|FG000|Overall Study|Insufficient Therapeutic Response|1|||
28139064|NCT02911116|54804089|FG001|Overall Study|Insufficient Therapeutic Response|0|||
28139065|NCT02911116|54804088|FG000|Overall Study|Lost to Follow-up|0|||
28139066|NCT02911116|54804089|FG001|Overall Study|Lost to Follow-up|1|||
28139067|NCT02998554|54804097|FG000|Overall Study|Adverse Event|8|||
28139068|NCT02998554|54804098|FG001|Overall Study|Adverse Event|3|||
28139069|NCT02998554|54804097|FG000|Overall Study|Protocol deviation|1|||
28139070|NCT02998554|54804098|FG001|Overall Study|Protocol deviation|0|||
28139071|NCT02998554|54804097|FG000|Overall Study|Withdrawal by Subject|2|||
27941084|NCT01179672|54597407|FG001|Overall Study|Entry Criteria Not Met|2|||
27941085|NCT01179672|54597406|FG000|Overall Study|Lost to Follow-up|0|||
27941086|NCT01179672|54597407|FG001|Overall Study|Lost to Follow-up|1|||
28139072|NCT02998554|54804098|FG001|Overall Study|Withdrawal by Subject|6|||
28139073|NCT02998554|54804097|FG000|Overall Study|Lost to Follow-up|0|||
28139074|NCT02998554|54804098|FG001|Overall Study|Lost to Follow-up|1|||
28139075|NCT02998554|54804097|FG000|Overall Study|Lack of Efficacy|0|||
28139076|NCT02998554|54804098|FG001|Overall Study|Lack of Efficacy|1|||
28139077|NCT02996448|54804106|FG000|Overall Study|Study terminated due to adverse effects|3|||
28139078|NCT02995980|54804111|FG000|Overall Study|Lost to Follow-up|14|||
28139079|NCT02872142|54804116|FG000|Overall Study|Adverse Event|2|||
28139080|NCT02872142|54804116|FG000|Overall Study|Death|1|||
28139081|NCT02872142|54804116|FG000|Overall Study|Participant Decision|3|||
28139082|NCT02994654|54804120|FG000|Overall Study|Lost to Follow-up|1|||
28139083|NCT02870972|54804130|FG000|Overall Study|Adverse Event|1|||
28139084|NCT02870972|54804131|FG001|Overall Study|Adverse Event|0|||
28139085|NCT02870972|54804132|FG002|Overall Study|Adverse Event|0|||
28139086|NCT02870972|54804133|FG003|Overall Study|Adverse Event|0|||
28139087|NCT02870972|54804134|FG004|Overall Study|Adverse Event|0|||
28139088|NCT03214367|54804154|FG000|Lead-in Period|Withdrawal by Subject|50|||
28139089|NCT03214367|54804155|FG001|Lead-in Period|Withdrawal by Subject|0|||
28139090|NCT03214367|54804156|FG002|Lead-in Period|Withdrawal by Subject|0|||
28139091|NCT03214367|54804157|FG003|Lead-in Period|Withdrawal by Subject|0|||
28139092|NCT03214367|54804158|FG004|Lead-in Period|Withdrawal by Subject|2|||
28139093|NCT03214367|54804159|FG005|Lead-in Period|Withdrawal by Subject|0|||
28139094|NCT03214367|54804160|FG006|Lead-in Period|Withdrawal by Subject|0|||
28139095|NCT03214367|54804161|FG007|Lead-in Period|Withdrawal by Subject|0|||
28139096|NCT03214367|54804154|FG000|Lead-in Period|Adverse Event|3|||
28139097|NCT03214367|54804155|FG001|Lead-in Period|Adverse Event|0|||
28139098|NCT03214367|54804156|FG002|Lead-in Period|Adverse Event|0|||
28139099|NCT03214367|54804157|FG003|Lead-in Period|Adverse Event|0|||
28139100|NCT03214367|54804158|FG004|Lead-in Period|Adverse Event|0|||
28139101|NCT03214367|54804159|FG005|Lead-in Period|Adverse Event|0|||
28139102|NCT03214367|54804160|FG006|Lead-in Period|Adverse Event|0|||
28139103|NCT03214367|54804161|FG007|Lead-in Period|Adverse Event|0|||
28139104|NCT03214367|54804154|FG000|Lead-in Period|Lost to Follow-up|12|||
28139105|NCT03214367|54804155|FG001|Lead-in Period|Lost to Follow-up|0|||
28139106|NCT03214367|54804156|FG002|Lead-in Period|Lost to Follow-up|0|||
28139107|NCT03214367|54804157|FG003|Lead-in Period|Lost to Follow-up|0|||
28139108|NCT03214367|54804158|FG004|Lead-in Period|Lost to Follow-up|0|||
27941087|NCT01179672|54597406|FG000|Overall Study|Protocol Violation|2|||
28139109|NCT03214367|54804159|FG005|Lead-in Period|Lost to Follow-up|0|||
28139110|NCT03214367|54804160|FG006|Lead-in Period|Lost to Follow-up|0|||
28139111|NCT03214367|54804161|FG007|Lead-in Period|Lost to Follow-up|0|||
28139112|NCT03214367|54804154|FG000|Lead-in Period|Sponsor Decision|11|||
28139113|NCT03214367|54804155|FG001|Lead-in Period|Sponsor Decision|0|||
28139114|NCT03214367|54804156|FG002|Lead-in Period|Sponsor Decision|0|||
28139115|NCT03214367|54804157|FG003|Lead-in Period|Sponsor Decision|0|||
27821771|NCT01856257|54283944|FG002|Overall Study|Death|0|||
28139116|NCT03214367|54804158|FG004|Lead-in Period|Sponsor Decision|0|||
28139117|NCT03214367|54804159|FG005|Lead-in Period|Sponsor Decision|0|||
28139118|NCT03214367|54804160|FG006|Lead-in Period|Sponsor Decision|0|||
28139119|NCT03214367|54804161|FG007|Lead-in Period|Sponsor Decision|0|||
28139120|NCT03214367|54804154|FG000|Lead-in Period|Physician Decision|12|||
28139121|NCT03214367|54804155|FG001|Lead-in Period|Physician Decision|0|||
28139122|NCT03214367|54804156|FG002|Lead-in Period|Physician Decision|0|||
28139123|NCT03214367|54804157|FG003|Lead-in Period|Physician Decision|0|||
28139124|NCT03214367|54804158|FG004|Lead-in Period|Physician Decision|0|||
28139125|NCT03214367|54804159|FG005|Lead-in Period|Physician Decision|0|||
28139126|NCT03214367|54804160|FG006|Lead-in Period|Physician Decision|0|||
28139127|NCT03214367|54804161|FG007|Lead-in Period|Physician Decision|0|||
28139128|NCT03214367|54804154|FG000|Lead-in Period|Protocol Violation|5|||
28139129|NCT03214367|54804155|FG001|Lead-in Period|Protocol Violation|0|||
28139130|NCT03214367|54804156|FG002|Lead-in Period|Protocol Violation|0|||
28139131|NCT03214367|54804157|FG003|Lead-in Period|Protocol Violation|0|||
28139132|NCT03214367|54804158|FG004|Lead-in Period|Protocol Violation|0|||
28139133|NCT03214367|54804159|FG005|Lead-in Period|Protocol Violation|0|||
28139134|NCT03214367|54804160|FG006|Lead-in Period|Protocol Violation|0|||
28139135|NCT03214367|54804161|FG007|Lead-in Period|Protocol Violation|0|||
28139136|NCT03214367|54804154|FG000|Lead-in Period|Treatment Interruption|1|||
28139137|NCT03214367|54804155|FG001|Lead-in Period|Treatment Interruption|0|||
28139138|NCT03214367|54804156|FG002|Lead-in Period|Treatment Interruption|0|||
28139139|NCT03214367|54804157|FG003|Lead-in Period|Treatment Interruption|0|||
28139140|NCT03214367|54804158|FG004|Lead-in Period|Treatment Interruption|0|||
28139141|NCT03214367|54804159|FG005|Lead-in Period|Treatment Interruption|0|||
28139142|NCT03214367|54804160|FG006|Lead-in Period|Treatment Interruption|0|||
28139143|NCT03214367|54804161|FG007|Lead-in Period|Treatment Interruption|0|||
28139144|NCT03214367|54804154|FG000|Treatment Period|Adverse Event|0|||
28139145|NCT03214367|54804155|FG001|Treatment Period|Adverse Event|1|||
28139146|NCT03214367|54804156|FG002|Treatment Period|Adverse Event|4|||
28139147|NCT03214367|54804157|FG003|Treatment Period|Adverse Event|2|||
28139148|NCT03214367|54804158|FG004|Treatment Period|Adverse Event|0|||
27821772|NCT01856257|54283945|FG003|Overall Study|Death|0|||
27821773|NCT01856257|54283942|FG000|Overall Study|Physician Decision|0|||
28139149|NCT03214367|54804159|FG005|Treatment Period|Adverse Event|0|||
28139150|NCT03214367|54804160|FG006|Treatment Period|Adverse Event|0|||
28139151|NCT03214367|54804161|FG007|Treatment Period|Adverse Event|0|||
28139152|NCT03214367|54804154|FG000|Treatment Period|Death|0|||
28139153|NCT03214367|54804155|FG001|Treatment Period|Death|1|||
28139154|NCT03214367|54804156|FG002|Treatment Period|Death|1|||
28139155|NCT03214367|54804157|FG003|Treatment Period|Death|1|||
28139156|NCT03214367|54804158|FG004|Treatment Period|Death|0|||
28139157|NCT03214367|54804159|FG005|Treatment Period|Death|0|||
28139158|NCT03214367|54804160|FG006|Treatment Period|Death|0|||
28139159|NCT03214367|54804161|FG007|Treatment Period|Death|0|||
28139160|NCT03214367|54804154|FG000|Treatment Period|Lost to Follow-up|0|||
28139161|NCT03214367|54804155|FG001|Treatment Period|Lost to Follow-up|5|||
28139162|NCT03214367|54804156|FG002|Treatment Period|Lost to Follow-up|3|||
28139163|NCT03214367|54804157|FG003|Treatment Period|Lost to Follow-up|2|||
28139164|NCT03214367|54804158|FG004|Treatment Period|Lost to Follow-up|0|||
28139165|NCT03214367|54804159|FG005|Treatment Period|Lost to Follow-up|2|||
28139166|NCT03214367|54804160|FG006|Treatment Period|Lost to Follow-up|1|||
28139167|NCT03214367|54804161|FG007|Treatment Period|Lost to Follow-up|0|||
28139168|NCT03214367|54804154|FG000|Treatment Period|Sponsor Decision|0|||
28139169|NCT03214367|54804155|FG001|Treatment Period|Sponsor Decision|3|||
28139170|NCT03214367|54804156|FG002|Treatment Period|Sponsor Decision|0|||
28139171|NCT03214367|54804157|FG003|Treatment Period|Sponsor Decision|0|||
28139172|NCT03214367|54804158|FG004|Treatment Period|Sponsor Decision|0|||
28139173|NCT03214367|54804159|FG005|Treatment Period|Sponsor Decision|0|||
28139174|NCT03214367|54804160|FG006|Treatment Period|Sponsor Decision|0|||
28139175|NCT03214367|54804161|FG007|Treatment Period|Sponsor Decision|0|||
28139176|NCT03214367|54804154|FG000|Treatment Period|Physician Decision|0|||
28139177|NCT03214367|54804155|FG001|Treatment Period|Physician Decision|1|||
28139178|NCT03214367|54804156|FG002|Treatment Period|Physician Decision|2|||
28139179|NCT03214367|54804157|FG003|Treatment Period|Physician Decision|0|||
28139180|NCT03214367|54804158|FG004|Treatment Period|Physician Decision|0|||
28139181|NCT03214367|54804159|FG005|Treatment Period|Physician Decision|0|||
28139182|NCT03214367|54804160|FG006|Treatment Period|Physician Decision|0|||
28139183|NCT03214367|54804161|FG007|Treatment Period|Physician Decision|0|||
28139184|NCT03214367|54804154|FG000|Treatment Period|Protocol Violation|0|||
28139185|NCT03214367|54804155|FG001|Treatment Period|Protocol Violation|3|||
28139186|NCT03214367|54804156|FG002|Treatment Period|Protocol Violation|0|||
28139187|NCT03214367|54804157|FG003|Treatment Period|Protocol Violation|0|||
28139188|NCT03214367|54804158|FG004|Treatment Period|Protocol Violation|0|||
28139189|NCT03214367|54804159|FG005|Treatment Period|Protocol Violation|0|||
28139190|NCT03214367|54804160|FG006|Treatment Period|Protocol Violation|0|||
28139191|NCT03214367|54804161|FG007|Treatment Period|Protocol Violation|0|||
28139192|NCT03214367|54804154|FG000|Treatment Period|Withdrawal by Subject|0|||
28139193|NCT03214367|54804155|FG001|Treatment Period|Withdrawal by Subject|20|||
28139194|NCT03214367|54804156|FG002|Treatment Period|Withdrawal by Subject|23|||
28139195|NCT03214367|54804157|FG003|Treatment Period|Withdrawal by Subject|14|||
28139196|NCT03214367|54804158|FG004|Treatment Period|Withdrawal by Subject|0|||
28139197|NCT03214367|54804159|FG005|Treatment Period|Withdrawal by Subject|1|||
28139198|NCT03214367|54804160|FG006|Treatment Period|Withdrawal by Subject|1|||
28139199|NCT03214367|54804161|FG007|Treatment Period|Withdrawal by Subject|1|||
28139200|NCT02994108|54804177|FG000|Intervention Messages|Withdrawal by Subject|2|||
28139201|NCT02994108|54804178|FG001|Intervention Messages|Withdrawal by Subject|0|||
28139202|NCT02994108|54804177|FG000|Phase 1 Assessment|Lost to Follow-up|5|||
28139203|NCT02994108|54804178|FG001|Phase 1 Assessment|Lost to Follow-up|3|||
28139204|NCT02994108|54804177|FG000|Phase 2 Assessment|Lost to Follow-up|8|||
28139205|NCT02994108|54804178|FG001|Phase 2 Assessment|Lost to Follow-up|7|||
28139206|NCT02994108|54804177|FG000|Phase 2 Assessment|Withdrawal by Subject|1|||
28139207|NCT02994108|54804178|FG001|Phase 2 Assessment|Withdrawal by Subject|0|||
28139208|NCT03231371|54804185|FG000|Overall Study|Withdrawal by Subject|1|||
28139209|NCT03231371|54804185|FG000|Overall Study|chose or were ineligible to have MRI|12|||
28139210|NCT02870348|54804189|FG000|Overall Study|Participants were discontinued and assessed for entry into post-marketing study (GTI1401-EXP)|4|||
28139211|NCT03239873|54804195|FG000|Overall Study|Lost to Follow-up|15|||
28139212|NCT03239873|54804196|FG001|Overall Study|Lost to Follow-up|16|||
28139213|NCT03239873|54804195|FG000|Overall Study|Physician Decision|1|||
28139214|NCT03239873|54804196|FG001|Overall Study|Physician Decision|0|||
28139215|NCT03239873|54804195|FG000|Overall Study|Withdrawal by Parent/Guardian|12|||
28139216|NCT03239873|54804196|FG001|Overall Study|Withdrawal by Parent/Guardian|11|||
28139217|NCT03239873|54804195|FG000|Overall Study|Withdrawal by Subject|2|||
28139218|NCT03239873|54804196|FG001|Overall Study|Withdrawal by Subject|0|||
28139219|NCT03239873|54804195|FG000|Overall Study|Contraindication to study medication|1|||
28139220|NCT03239873|54804196|FG001|Overall Study|Contraindication to study medication|0|||
28139221|NCT03239873|54804195|FG000|Overall Study|Protocol Violation|1|||
28139222|NCT03239873|54804196|FG001|Overall Study|Protocol Violation|0|||
28139223|NCT03213509|54804204|FG000|Overall Study|Did not consent for verbal autopsy|4|||
28139224|NCT03213509|54804205|FG001|Overall Study|Did not consent for verbal autopsy|5|||
28139225|NCT03239483|54804214|FG000|Overall Study|Lost to Follow-up|1|||
28139226|NCT03239483|54804215|FG001|Overall Study|Lost to Follow-up|0|||
28139227|NCT03239483|54804214|FG000|Overall Study|Withdrawal by Subject|1|||
28139228|NCT03239483|54804215|FG001|Overall Study|Withdrawal by Subject|0|||
28139229|NCT02868554|54804224|FG000|Overall Study|Lost to Follow-up|3|||
28139230|NCT02868554|54804225|FG001|Overall Study|Lost to Follow-up|0|||
28139231|NCT02868554|54804226|FG002|Overall Study|Lost to Follow-up|1|||
28139232|NCT01068912|54804237|FG000|Overall Study|Adverse Event|2|||
28139233|NCT01068912|54804238|FG001|Overall Study|Adverse Event|3|||
28139234|NCT01068912|54804239|FG002|Overall Study|Adverse Event|2|||
28139235|NCT01068912|54804237|FG000|Overall Study|Withdrawal by Subject|5|||
28139236|NCT01068912|54804238|FG001|Overall Study|Withdrawal by Subject|6|||
28139237|NCT01068912|54804239|FG002|Overall Study|Withdrawal by Subject|6|||
28139238|NCT01068912|54804237|FG000|Overall Study|Lost to Follow-up|3|||
28139239|NCT01068912|54804238|FG001|Overall Study|Lost to Follow-up|7|||
28139240|NCT01068912|54804239|FG002|Overall Study|Lost to Follow-up|3|||
28139241|NCT01068912|54804237|FG000|Overall Study|Protocol Violation|0|||
28139242|NCT01068912|54804238|FG001|Overall Study|Protocol Violation|2|||
28139243|NCT01068912|54804239|FG002|Overall Study|Protocol Violation|0|||
28139244|NCT01068912|54804237|FG000|Overall Study|aggravation influenza|1|||
28139245|NCT01068912|54804238|FG001|Overall Study|aggravation influenza|1|||
28139246|NCT01068912|54804239|FG002|Overall Study|aggravation influenza|1|||
28139247|NCT01068912|54804237|FG000|Overall Study|other underlying illness|0|||
28139248|NCT01068912|54804238|FG001|Overall Study|other underlying illness|3|||
28139249|NCT01068912|54804239|FG002|Overall Study|other underlying illness|3|||
28139250|NCT03229109|54804251|FG000|Overall Study|Withdrawal by Subject|0|||
28139251|NCT03229109|54804252|FG001|Overall Study|Withdrawal by Subject|0|||
28139252|NCT03229109|54804253|FG002|Overall Study|Withdrawal by Subject|0|||
28139253|NCT03229109|54804254|FG003|Overall Study|Withdrawal by Subject|1|||
28139254|NCT03212261|54804264|FG000|Overall Study|Became ineligible d/t tech|2|||
28139255|NCT03212261|54804264|FG000|Overall Study|Tech Trouble- No first study visit|1|||
28139256|NCT03212261|54804264|FG000|Overall Study|Lost to Follow-up|7|||
28139257|NCT03212261|54804264|FG000|Overall Study|Family Emergency|1|||
28139258|NCT03212261|54804264|FG000|Overall Study|Too busy/ No time|5|||
28139259|NCT02993250|54804271|FG000|Overall Study|Lost to Follow-up|0|||
28139260|NCT02993250|54804272|FG001|Overall Study|Lost to Follow-up|1|||
28070279|NCT00430937|54725170|FG000|Overall Study|Withdrawal by Subject|5|||
28070280|NCT00430937|54725171|FG001|Overall Study|Withdrawal by Subject|2|||
28070281|NCT00430937|54725170|FG000|Overall Study|Protocol Violation|3|||
28070282|NCT00430937|54725171|FG001|Overall Study|Protocol Violation|2|||
28070283|NCT00430937|54725170|FG000|Overall Study|Lack of Efficacy|6|||
28070284|NCT00430937|54725171|FG001|Overall Study|Lack of Efficacy|5|||
28070285|NCT00430937|54725170|FG000|Overall Study|Inappropriate enrollment|2|||
28070286|NCT00430937|54725171|FG001|Overall Study|Inappropriate enrollment|1|||
28070287|NCT00430937|54725170|FG000|Overall Study|Administrative reasons|1|||
28070288|NCT00430937|54725171|FG001|Overall Study|Administrative reasons|0|||
28070289|NCT00430937|54725170|FG000|Overall Study|Protocol discontinuation criteria met|1|||
28070290|NCT00430937|54725171|FG001|Overall Study|Protocol discontinuation criteria met|2|||
28070291|NCT00430937|54725170|FG000|Overall Study|Unable to classify|0|||
28070292|NCT00430937|54725171|FG001|Overall Study|Unable to classify|1|||
28070293|NCT00004888|54725179|FG000|Overall Study|Adverse Event|5|||
28070294|NCT00004888|54725180|FG001|Overall Study|Adverse Event|10|||
28070295|NCT00004888|54725179|FG000|Overall Study|Withdrawal by Subject|0|||
28070296|NCT00004888|54725180|FG001|Overall Study|Withdrawal by Subject|3|||
28070297|NCT00004888|54725179|FG000|Overall Study|Physician Decision|1|||
28070298|NCT00004888|54725180|FG001|Overall Study|Physician Decision|1|||
28139261|NCT02989194|54804281|FG000|Overall Study|Study on hold for safety and participant was withdrawn|1|||
28139262|NCT02989194|54804282|FG001|Overall Study|Study on hold for safety and participant was withdrawn|0|||
28139263|NCT02989194|54804283|FG002|Overall Study|Study on hold for safety and participant was withdrawn|0|||
28139264|NCT02989194|54804281|FG000|Overall Study|Lost to Follow-up|0|||
28070299|NCT00004888|54725179|FG000|Overall Study|Progressive Disease|4|||
28139265|NCT02989194|54804282|FG001|Overall Study|Lost to Follow-up|1|||
28139266|NCT02989194|54804283|FG002|Overall Study|Lost to Follow-up|0|||
28139267|NCT02989194|54804281|FG000|Overall Study|Withdrawal by Subject|0|||
28139268|NCT02989194|54804282|FG001|Overall Study|Withdrawal by Subject|1|||
28139269|NCT02989194|54804283|FG002|Overall Study|Withdrawal by Subject|0|||
28139270|NCT02990910|54804304|FG000|Overall Study|Lack of Efficacy|6|||
28139271|NCT02990910|54804305|FG001|Overall Study|Lack of Efficacy|10|||
28139272|NCT03227861|54804311|FG000|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4|||
28139273|NCT03227861|54804311|FG000|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
28139274|NCT03227861|54804311|FG000|Main Study Period (Week 0 to Week 48)|Adverse Event|1|||
28139275|NCT03227861|54804311|FG000|Main Study Period (Week 0 to Week 48)|Protocol Violation|1|||
28139276|NCT03227861|54804311|FG000|Main Study Period (Week 0 to Week 48)|Other|5|||
28139277|NCT03227861|54804311|FG000|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55|||
28139278|NCT03227861|54804311|FG000|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16|||
28139279|NCT03227861|54804311|FG000|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6|||
28139280|NCT03227861|54804311|FG000|Extension Period (Week 48 to Week 96)|Adverse Event|1|||
28139281|NCT03227861|54804311|FG000|Extension Period (Week 48 to Week 96)|Other|2|||
28139282|NCT01336712|54804317|FG000|Overall Study|Death|2|||
28139283|NCT01336712|54804317|FG000|Overall Study|Lack of Efficacy|1|||
28070300|NCT00004888|54725180|FG001|Overall Study|Progressive Disease|9|||
28070301|NCT00004888|54725179|FG000|Overall Study|Death without progressive disease|0|||
28070302|NCT00004888|54725180|FG001|Overall Study|Death without progressive disease|1|||
28070303|NCT00004888|54725179|FG000|Overall Study|Toxic death|1|||
28070304|NCT00004888|54725180|FG001|Overall Study|Toxic death|0|||
28070305|NCT00004732|54725188|FG000|Overall Study|Withdrawal by Subject|36|||
28070306|NCT00004732|54725189|FG001|Overall Study|Withdrawal by Subject|64|||
28070307|NCT00004732|54725188|FG000|Overall Study|Lost to Follow-up|33|||
28070308|NCT00004732|54725189|FG001|Overall Study|Lost to Follow-up|47|||
28070309|NCT00430781|54725200|FG000|Interim Analysis; 11 February 2008|Adverse Event|10|||
28070310|NCT00430781|54725201|FG001|Interim Analysis; 11 February 2008|Adverse Event|3|||
28070311|NCT00430781|54725202|FG002|Interim Analysis; 11 February 2008|Adverse Event|7|||
28070312|NCT00430781|54725200|FG000|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
28070313|NCT00430781|54725201|FG001|Interim Analysis; 11 February 2008|Lost to Follow-up|0|||
28070314|NCT00430781|54725202|FG002|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
28070315|NCT00430781|54725200|FG000|Interim Analysis; 11 February 2008|Protocol Violation|0|||
28070316|NCT00430781|54725201|FG001|Interim Analysis; 11 February 2008|Protocol Violation|1|||
28070317|NCT00430781|54725202|FG002|Interim Analysis; 11 February 2008|Protocol Violation|0|||
28070318|NCT00430781|54725200|FG000|Interim Analysis; 11 February 2008|Withdrawal by Subject|4|||
28070319|NCT00430781|54725201|FG001|Interim Analysis; 11 February 2008|Withdrawal by Subject|0|||
28070320|NCT00430781|54725202|FG002|Interim Analysis; 11 February 2008|Withdrawal by Subject|2|||
28139284|NCT03208127|54804321|FG000|Overall Study|Death|1|||
28139285|NCT02865122|54804328|FG000|Overall Study|Adverse Event|1|||
28139286|NCT02865122|54804329|FG001|Overall Study|Adverse Event|0|||
28139287|NCT02865122|54804330|FG002|Overall Study|Adverse Event|0|||
28139288|NCT02864498|54804341|FG000|Overall Study|Unacceptable Adverse Events (AEs)|0|||
28139289|NCT02864498|54804342|FG001|Overall Study|Unacceptable Adverse Events (AEs)|3|||
28139290|NCT02864498|54804343|FG002|Overall Study|Unacceptable Adverse Events (AEs)|1|||
28139291|NCT02864498|54804341|FG000|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|6|||
28139292|NCT02864498|54804342|FG001|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|10|||
28139293|NCT02864498|54804343|FG002|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|4|||
28139294|NCT02864498|54804341|FG000|Overall Study|Investigator Discretion|0|||
28139295|NCT02864498|54804342|FG001|Overall Study|Investigator Discretion|2|||
28139296|NCT02864498|54804343|FG002|Overall Study|Investigator Discretion|1|||
28139297|NCT02864498|54804341|FG000|Overall Study|Lost to Follow-up|8|||
28139298|NCT02864498|54804342|FG001|Overall Study|Lost to Follow-up|6|||
28139299|NCT02864498|54804343|FG002|Overall Study|Lost to Follow-up|3|||
28139300|NCT02864498|54804341|FG000|Overall Study|Lack of Efficacy|5|||
28139301|NCT02864498|54804342|FG001|Overall Study|Lack of Efficacy|3|||
28139302|NCT02864498|54804343|FG002|Overall Study|Lack of Efficacy|3|||
28139303|NCT02864498|54804341|FG000|Overall Study|Other - Subject discontinued following database lock.|1|||
28139304|NCT02864498|54804342|FG001|Overall Study|Other - Subject discontinued following database lock.|0|||
28139305|NCT02864498|54804343|FG002|Overall Study|Other - Subject discontinued following database lock.|0|||
28139306|NCT02864498|54804341|FG000|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
28139307|NCT02864498|54804342|FG001|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|1|||
28139308|NCT02864498|54804343|FG002|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
28139309|NCT02864498|54804341|FG000|Overall Study|Subject moved out of the country.|0|||
28139310|NCT02864498|54804342|FG001|Overall Study|Subject moved out of the country.|0|||
28139311|NCT02864498|54804343|FG002|Overall Study|Subject moved out of the country.|1|||
28139312|NCT03238781|54804354|FG000|Overall Study|Adverse Event|1|||
28139313|NCT03238781|54804355|FG001|Overall Study|Adverse Event|1|||
28139314|NCT03238781|54804356|FG002|Overall Study|Adverse Event|2|||
28139315|NCT03238781|54804354|FG000|Overall Study|Lost to Follow-up|2|||
28139316|NCT03238781|54804355|FG001|Overall Study|Lost to Follow-up|1|||
28139317|NCT03238781|54804356|FG002|Overall Study|Lost to Follow-up|2|||
28139318|NCT03238781|54804354|FG000|Overall Study|Withdrawal by Subject|23|||
28070321|NCT00430781|54725200|FG000|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1|||
28070322|NCT00430781|54725201|FG001|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
28070323|NCT00430781|54725202|FG002|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
28070324|NCT00430781|54725200|FG000|Interim Analysis; 11 February 2008|Disease Progression|16|||
28070325|NCT00430781|54725201|FG001|Interim Analysis; 11 February 2008|Disease Progression|30|||
28070326|NCT00430781|54725202|FG002|Interim Analysis; 11 February 2008|Disease Progression|22|||
28070327|NCT00430781|54725200|FG000|Interim Analysis; 11 February 2008|Death|0|||
28070328|NCT00430781|54725201|FG001|Interim Analysis; 11 February 2008|Death|1|||
28070329|NCT00430781|54725202|FG002|Interim Analysis; 11 February 2008|Death|0|||
28070330|NCT00430781|54725200|FG000|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2|||
28070331|NCT00430781|54725201|FG001|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
28070332|NCT00430781|54725202|FG002|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
28070333|NCT00430781|54725200|FG000|Interim Analysis; 11 February 2008|Physician Decision|2|||
28070334|NCT00430781|54725201|FG001|Interim Analysis; 11 February 2008|Physician Decision|3|||
28070335|NCT00430781|54725202|FG002|Interim Analysis; 11 February 2008|Physician Decision|3|||
28070336|NCT00430781|54725200|FG000|Interim Analysis; 11 February 2008|Ongoing|23|||
28070337|NCT00430781|54725201|FG001|Interim Analysis; 11 February 2008|Ongoing|20|||
28070338|NCT00430781|54725202|FG002|Interim Analysis; 11 February 2008|Ongoing|25|||
28070339|NCT00430781|54725200|FG000|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
28070340|NCT00430781|54725201|FG001|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
28070341|NCT00430781|54725202|FG002|Final Analysis; 31 July 2008|Lost to Follow-up|3|||
28070342|NCT00430781|54725200|FG000|Final Analysis; 31 July 2008|Protocol Violation|0|||
28070343|NCT00430781|54725201|FG001|Final Analysis; 31 July 2008|Protocol Violation|1|||
28139319|NCT03238781|54804355|FG001|Overall Study|Withdrawal by Subject|14|||
28139320|NCT03238781|54804356|FG002|Overall Study|Withdrawal by Subject|16|||
28139321|NCT03238781|54804354|FG000|Overall Study|Decision by sponsor|0|||
28070344|NCT00430781|54725202|FG002|Final Analysis; 31 July 2008|Protocol Violation|0|||
28070345|NCT00430781|54725200|FG000|Final Analysis; 31 July 2008|Withdrawal by Subject|0|||
28070346|NCT00430781|54725201|FG001|Final Analysis; 31 July 2008|Withdrawal by Subject|2|||
28070347|NCT00430781|54725202|FG002|Final Analysis; 31 July 2008|Withdrawal by Subject|7|||
28070348|NCT00430781|54725200|FG000|Final Analysis; 31 July 2008|Physician Decision|0|||
28070349|NCT00430781|54725201|FG001|Final Analysis; 31 July 2008|Physician Decision|6|||
28070350|NCT00430781|54725202|FG002|Final Analysis; 31 July 2008|Physician Decision|6|||
28070351|NCT00430781|54725200|FG000|Final Analysis; 31 July 2008|Other|0|||
28070352|NCT00430781|54725201|FG001|Final Analysis; 31 July 2008|Other|1|||
28070353|NCT00430781|54725202|FG002|Final Analysis; 31 July 2008|Other|0|||
28070354|NCT00430781|54725200|FG000|Final Analysis; 31 July 2008|Ongoing|0|||
28070355|NCT00430781|54725201|FG001|Final Analysis; 31 July 2008|Ongoing|29|||
28070356|NCT00430781|54725202|FG002|Final Analysis; 31 July 2008|Ongoing|32|||
28070357|NCT00430781|54725200|FG000|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5|||
28070358|NCT00430781|54725201|FG001|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
28070359|NCT00430781|54725202|FG002|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
28070360|NCT00430781|54725200|FG000|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
28070361|NCT00430781|54725201|FG001|End-of-Study Analysis; 28 July 2011|Protocol Violation|1|||
28070362|NCT00430781|54725202|FG002|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
28070363|NCT00430781|54725200|FG000|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
28070364|NCT00430781|54725201|FG001|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2|||
28070365|NCT00430781|54725202|FG002|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
28070366|NCT00430781|54725200|FG000|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
28070367|NCT00430781|54725201|FG001|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5|||
28070368|NCT00430781|54725202|FG002|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
28070369|NCT00430781|54725200|FG000|End-of-Study Analysis; 28 July 2011|Physician Decision|4|||
28070370|NCT00430781|54725201|FG001|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
28070371|NCT00430781|54725202|FG002|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
28070372|NCT00430781|54725200|FG000|End-of-Study Analysis; 28 July 2011|Other|4|||
28070373|NCT00430781|54725201|FG001|End-of-Study Analysis; 28 July 2011|Other|1|||
28070374|NCT00430781|54725202|FG002|End-of-Study Analysis; 28 July 2011|Other|0|||
28070375|NCT00429299|54725216|FG000|Overall Study|Disease Progression|1|||
28070376|NCT00429299|54725217|FG001|Overall Study|Disease Progression|1|||
28070377|NCT00429299|54725218|FG002|Overall Study|Disease Progression|0|||
28070378|NCT00429299|54725216|FG000|Overall Study|Adverse Event|2|||
28070379|NCT00429299|54725217|FG001|Overall Study|Adverse Event|5|||
28070380|NCT00429299|54725218|FG002|Overall Study|Adverse Event|1|||
28070381|NCT00429299|54725216|FG000|Overall Study|Protocol Violation|1|||
28070382|NCT00429299|54725217|FG001|Overall Study|Protocol Violation|0|||
28070383|NCT00429299|54725218|FG002|Overall Study|Protocol Violation|0|||
28070384|NCT00429299|54725216|FG000|Overall Study|Withdrawal by Subject|0|||
28070385|NCT00429299|54725217|FG001|Overall Study|Withdrawal by Subject|1|||
28070386|NCT00429299|54725218|FG002|Overall Study|Withdrawal by Subject|3|||
28070387|NCT00428597|54725228|FG000|Overall Study|Randomized but not treated|3|||
28070388|NCT00428597|54725229|FG001|Overall Study|Randomized but not treated|3|||
28070389|NCT00428597|54725228|FG000|Overall Study|Objective Progression or Relapse|19|||
28070390|NCT00428597|54725229|FG001|Overall Study|Objective Progression or Relapse|47|||
28070391|NCT00428597|54725228|FG000|Overall Study|Study Terminated by Sponsor|41|||
28070392|NCT00428597|54725229|FG001|Overall Study|Study Terminated by Sponsor|16|||
28070393|NCT00428597|54725228|FG000|Overall Study|Adverse Event|15|||
28070394|NCT00428597|54725229|FG001|Overall Study|Adverse Event|7|||
28070395|NCT00428597|54725228|FG000|Overall Study|Global Deterioration of Health Status|1|||
28070396|NCT00428597|54725229|FG001|Overall Study|Global Deterioration of Health Status|5|||
28070397|NCT00428597|54725228|FG000|Overall Study|Protocol Violation|2|||
28070398|NCT00428597|54725229|FG001|Overall Study|Protocol Violation|1|||
28070399|NCT00428597|54725228|FG000|Overall Study|Withdrawal by Subject|2|||
28070400|NCT00428597|54725229|FG001|Overall Study|Withdrawal by Subject|1|||
28070401|NCT00428597|54725228|FG000|Overall Study|Other|1|||
28070402|NCT00428597|54725229|FG001|Overall Study|Other|1|||
28070403|NCT00428597|54725228|FG000|Overall Study|Lost to Follow-up|0|||
28070404|NCT00428597|54725229|FG001|Overall Study|Lost to Follow-up|1|||
28070405|NCT00428597|54725228|FG000|Overall Study|Pregnancy|1|||
28070406|NCT00428597|54725229|FG001|Overall Study|Pregnancy|0|||
28070407|NCT00428597|54725228|FG000|Overall Study|Death|1|||
28070408|NCT00428597|54725229|FG001|Overall Study|Death|3|||
28070409|NCT00428441|54725235|FG000|Overall Study|Lost to Follow-up|1|||
28070410|NCT00144339|54725241|FG000|Overall Study|Adverse Event|746|||
28070411|NCT00144339|54725242|FG001|Overall Study|Adverse Event|627|||
28070412|NCT00144339|54725241|FG000|Overall Study|Protocol Violation|75|||
28070413|NCT00144339|54725242|FG001|Overall Study|Protocol Violation|48|||
28070414|NCT00144339|54725241|FG000|Overall Study|Withdrawal by Subject|403|||
28070415|NCT00144339|54725242|FG001|Overall Study|Withdrawal by Subject|300|||
28070416|NCT00144339|54725241|FG000|Overall Study|Lost to Follow-up|76|||
28070417|NCT00144339|54725242|FG001|Overall Study|Lost to Follow-up|64|||
28139322|NCT03238781|54804355|FG001|Overall Study|Decision by sponsor|1|||
28139323|NCT03238781|54804356|FG002|Overall Study|Decision by sponsor|0|||
28139324|NCT02097121|54804367|FG000|Overall Study|Other, not specified|4|||
28139325|NCT02097121|54804368|FG001|Overall Study|Other, not specified|2|||
28139326|NCT02097121|54804369|FG002|Overall Study|Other, not specified|3|||
28139327|NCT02097121|54804367|FG000|Overall Study|Lack of Efficacy|2|||
28139328|NCT02097121|54804368|FG001|Overall Study|Lack of Efficacy|1|||
28139329|NCT02097121|54804369|FG002|Overall Study|Lack of Efficacy|3|||
28139330|NCT02097121|54804367|FG000|Overall Study|Withdrawal by Subject|0|||
28139331|NCT02097121|54804368|FG001|Overall Study|Withdrawal by Subject|1|||
28139332|NCT02097121|54804369|FG002|Overall Study|Withdrawal by Subject|2|||
28139333|NCT02097121|54804367|FG000|Overall Study|Adverse Event|0|||
28139334|NCT02097121|54804368|FG001|Overall Study|Adverse Event|1|||
28139335|NCT02097121|54804369|FG002|Overall Study|Adverse Event|0|||
28139336|NCT02097121|54804367|FG000|Overall Study|Lost to Follow-up|1|||
28139337|NCT02097121|54804368|FG001|Overall Study|Lost to Follow-up|1|||
28139338|NCT02097121|54804369|FG002|Overall Study|Lost to Follow-up|2|||
28139339|NCT02747420|54804398|FG000|Overall Study|Lost to Follow-up|4|||
28139340|NCT02747420|54804399|FG001|Overall Study|Lost to Follow-up|2|||
28139341|NCT02747420|54804398|FG000|Overall Study|Withdrawal by Subject|3|||
28139342|NCT02747420|54804399|FG001|Overall Study|Withdrawal by Subject|2|||
28139343|NCT03238001|54804405|FG000|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2|||
28139344|NCT03238001|54804405|FG000|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2|||
28139345|NCT03238001|54804405|FG000|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16|||
28139346|NCT03238001|54804405|FG000|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2|||
28139347|NCT03238001|54804405|FG000|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3|||
28139348|NCT03238001|54804405|FG000|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3|||
28139349|NCT03238001|54804405|FG000|Visit 2 (Secondary Endpoint Cohort)|Study completion|1|||
28139350|NCT03238001|54804405|FG000|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4|||
28139351|NCT02747108|54804419|FG000|Overall Study|Death|2|||
28139352|NCT02747108|54804420|FG001|Overall Study|Death|2|||
28139353|NCT02747108|54804419|FG000|Overall Study|Withdrawal by Subject|1|||
28139354|NCT02747108|54804420|FG001|Overall Study|Withdrawal by Subject|0|||
28139355|NCT02747108|54804419|FG000|Overall Study|Protocol Violation|2|||
28139356|NCT02747108|54804420|FG001|Overall Study|Protocol Violation|0|||
28139357|NCT03226769|54804448|FG000|Overall Study|Withdrawal by Subject|0|||
28139358|NCT03226769|54804449|FG001|Overall Study|Withdrawal by Subject|1|||
28139359|NCT02864342|54804457|FG000|Overall Study|Eligibility Criteria Deviation|2|||
28139360|NCT02864342|54804458|FG001|Overall Study|Eligibility Criteria Deviation|3|||
28139361|NCT02864342|54804457|FG000|Overall Study|Withdrawal by Subject|4|||
28139362|NCT02864342|54804458|FG001|Overall Study|Withdrawal by Subject|2|||
28139363|NCT02864342|54804457|FG000|Overall Study|Device Technology Issue|6|||
28139364|NCT02864342|54804458|FG001|Overall Study|Device Technology Issue|7|||
28139365|NCT02864342|54804457|FG000|Overall Study|Death|0|||
28139366|NCT02864342|54804458|FG001|Overall Study|Death|1|||
28139367|NCT02864342|54804457|FG000|Overall Study|Did Not Start Treatment with Symbicort|0|||
28139368|NCT02864342|54804458|FG001|Overall Study|Did Not Start Treatment with Symbicort|1|||
28139369|NCT02864342|54804457|FG000|Overall Study|Lost to Follow-up|1|||
28139370|NCT02864342|54804458|FG001|Overall Study|Lost to Follow-up|5|||
28139371|NCT02864342|54804457|FG000|Overall Study|Lost Device|1|||
28139372|NCT02864342|54804458|FG001|Overall Study|Lost Device|0|||
28139373|NCT02864342|54804457|FG000|Overall Study|Adverse Event|1|||
28139374|NCT02864342|54804458|FG001|Overall Study|Adverse Event|0|||
28139375|NCT03237065|54804467|FG000|Overall Study|Adverse Event|0|||
28139376|NCT03237065|54804468|FG001|Overall Study|Adverse Event|2|||
28139377|NCT03237065|54804467|FG000|Overall Study|Protocol Violation|0|||
28139378|NCT03237065|54804468|FG001|Overall Study|Protocol Violation|1|||
28139379|NCT03237065|54804467|FG000|Overall Study|Withdrawal by Subject|3|||
28139380|NCT03237065|54804468|FG001|Overall Study|Withdrawal by Subject|0|||
28139381|NCT03237065|54804467|FG000|Overall Study|Lost to Follow-up|1|||
28139382|NCT03237065|54804468|FG001|Overall Study|Lost to Follow-up|0|||
28139383|NCT03237065|54804467|FG000|Overall Study|Unable to obtain venous access|0|||
28139384|NCT03237065|54804468|FG001|Overall Study|Unable to obtain venous access|1|||
27821774|NCT01856257|54283943|FG001|Overall Study|Physician Decision|0|||
28139385|NCT03171415|54804479|FG000|Overall Study|Lost to Follow-up|0|||
28139386|NCT03171415|54804480|FG001|Overall Study|Lost to Follow-up|0|||
28139387|NCT03171415|54804481|FG002|Overall Study|Lost to Follow-up|0|||
28139388|NCT03171415|54804482|FG003|Overall Study|Lost to Follow-up|0|||
28139389|NCT03171415|54804483|FG004|Overall Study|Lost to Follow-up|2|||
27821775|NCT01856257|54283944|FG002|Overall Study|Physician Decision|0|||
28139390|NCT03829241|54804508|FG000|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|16|||
28139391|NCT03829241|54804509|FG001|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|19|||
28139392|NCT03829241|54804508|FG000|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|5|||
28139393|NCT03829241|54804509|FG001|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|11|||
28139394|NCT03829241|54804508|FG000|Randomization Phase (Week 1 to Week 8)|Sponsor Request|0|||
28139395|NCT03829241|54804509|FG001|Randomization Phase (Week 1 to Week 8)|Sponsor Request|1|||
28139396|NCT03829241|54804508|FG000|Randomization Phase (Week 1 to Week 8)|Adverse Event|8|||
28139397|NCT03829241|54804509|FG001|Randomization Phase (Week 1 to Week 8)|Adverse Event|9|||
28139398|NCT03829241|54804508|FG000|Randomization Phase (Week 1 to Week 8)|Non compliance|2|||
28139399|NCT03829241|54804509|FG001|Randomization Phase (Week 1 to Week 8)|Non compliance|1|||
28139400|NCT03829241|54804508|FG000|Randomization Phase (Week 1 to Week 8)|Pregnancy|0|||
28139401|NCT03829241|54804509|FG001|Randomization Phase (Week 1 to Week 8)|Pregnancy|1|||
28139402|NCT03829241|54804508|FG000|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|20|||
28139403|NCT03829241|54804509|FG001|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|24|||
28139404|NCT03829241|54804508|FG000|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|9|||
28139405|NCT03829241|54804509|FG001|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|7|||
28139406|NCT03829241|54804508|FG000|Extension Phase (Week 9 up to Week 48)|Physician Decision|1|||
28139407|NCT03829241|54804509|FG001|Extension Phase (Week 9 up to Week 48)|Physician Decision|0|||
28139408|NCT03829241|54804508|FG000|Extension Phase (Week 9 up to Week 48)|Sponsor Request|117|||
28139409|NCT03829241|54804509|FG001|Extension Phase (Week 9 up to Week 48)|Sponsor Request|108|||
28139410|NCT03829241|54804508|FG000|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|0|||
28139411|NCT03829241|54804509|FG001|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|1|||
28139412|NCT03829241|54804508|FG000|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
28139413|NCT03829241|54804509|FG001|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
28139414|NCT03829241|54804508|FG000|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
28139415|NCT03829241|54804509|FG001|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
28139416|NCT03829241|54804508|FG000|Extension Phase (Week 9 up to Week 48)|Pregnancy|0|||
28139417|NCT03829241|54804509|FG001|Extension Phase (Week 9 up to Week 48)|Pregnancy|2|||
28139418|NCT03164551|54804521|FG000|Overall Study|Imaging discontinued prior completion|8|||
28139419|NCT03164551|54804522|FG001|Overall Study|Imaging discontinued prior completion|0|||
27821776|NCT01856257|54283945|FG003|Overall Study|Physician Decision|1|||
27941088|NCT01179672|54597407|FG001|Overall Study|Protocol Violation|2|||
27941089|NCT01179672|54597406|FG000|Overall Study|Physician Decision|1|||
28139420|NCT03164551|54804521|FG000|Overall Study|Participant was non-compliant|1|||
28139421|NCT03164551|54804522|FG001|Overall Study|Participant was non-compliant|0|||
28139422|NCT03164551|54804521|FG000|Overall Study|Cancellation of Fresh Embryo Transfer|12|||
28139423|NCT03164551|54804522|FG001|Overall Study|Cancellation of Fresh Embryo Transfer|14|||
28139424|NCT03164551|54804521|FG000|Overall Study|Other|8|||
28139425|NCT03164551|54804522|FG001|Overall Study|Other|2|||
28139426|NCT02863328|54804530|FG000|Overall Study|Lost to Follow-up|4|||
28139427|NCT02863328|54804531|FG001|Overall Study|Lost to Follow-up|10|||
28139428|NCT02863328|54804530|FG000|Overall Study|Withdrawal by Subject|7|||
28139429|NCT02863328|54804531|FG001|Overall Study|Withdrawal by Subject|12|||
28139430|NCT02863328|54804530|FG000|Overall Study|Died|0|||
28139431|NCT02863328|54804531|FG001|Overall Study|Died|1|||
28139432|NCT03040141|54804540|FG000|Overall Study|Death|1|||
28139433|NCT03040141|54804541|FG001|Overall Study|Death|2|||
28139434|NCT03040141|54804542|FG002|Overall Study|Death|3|||
28139435|NCT03040141|54804540|FG000|Overall Study|Withdrawal by Subject|3|||
28139436|NCT03040141|54804541|FG001|Overall Study|Withdrawal by Subject|1|||
28139437|NCT03040141|54804542|FG002|Overall Study|Withdrawal by Subject|1|||
28139438|NCT03040141|54804540|FG000|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
28139439|NCT03040141|54804541|FG001|Overall Study|Subject discharged to nursing home, not able to attend visits|1|||
28139440|NCT03040141|54804542|FG002|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
28139441|NCT03040141|54804540|FG000|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|0|||
28139442|NCT03040141|54804541|FG001|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
28139443|NCT03040141|54804542|FG002|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
28139444|NCT02937701|54804556|FG000|Day 1 to Week 22|Adverse Event|11|||
28139445|NCT02937701|54804557|FG001|Day 1 to Week 22|Adverse Event|14|||
28139446|NCT02937701|54804558|FG002|Day 1 to Week 22|Adverse Event|0|||
28139447|NCT02937701|54804559|FG003|Day 1 to Week 22|Adverse Event|0|||
28139448|NCT02937701|54804560|FG004|Day 1 to Week 22|Adverse Event|0|||
28139449|NCT02937701|54804556|FG000|Day 1 to Week 22|Protocol Specified Criteria|7|||
28139450|NCT02937701|54804557|FG001|Day 1 to Week 22|Protocol Specified Criteria|7|||
28139451|NCT02937701|54804558|FG002|Day 1 to Week 22|Protocol Specified Criteria|0|||
28139452|NCT02937701|54804559|FG003|Day 1 to Week 22|Protocol Specified Criteria|0|||
28139453|NCT02937701|54804560|FG004|Day 1 to Week 22|Protocol Specified Criteria|0|||
28139454|NCT02937701|54804556|FG000|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5|||
28139455|NCT02937701|54804557|FG001|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9|||
28139456|NCT02937701|54804558|FG002|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
28139457|NCT02937701|54804559|FG003|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
28139458|NCT02937701|54804560|FG004|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
28139459|NCT02937701|54804556|FG000|Day 1 to Week 22|Withdrawal by Subject|6|||
28139460|NCT02937701|54804557|FG001|Day 1 to Week 22|Withdrawal by Subject|6|||
28139461|NCT02937701|54804558|FG002|Day 1 to Week 22|Withdrawal by Subject|0|||
28139462|NCT02937701|54804559|FG003|Day 1 to Week 22|Withdrawal by Subject|0|||
28139463|NCT02937701|54804560|FG004|Day 1 to Week 22|Withdrawal by Subject|0|||
28139464|NCT02937701|54804556|FG000|Day 1 to Week 22|Death|1|||
28139465|NCT02937701|54804557|FG001|Day 1 to Week 22|Death|1|||
28139466|NCT02937701|54804558|FG002|Day 1 to Week 22|Death|0|||
28139467|NCT02937701|54804559|FG003|Day 1 to Week 22|Death|0|||
28139468|NCT02937701|54804560|FG004|Day 1 to Week 22|Death|0|||
28139469|NCT02937701|54804556|FG000|Day 1 to Week 22|Protocol Violation|1|||
28139470|NCT02937701|54804557|FG001|Day 1 to Week 22|Protocol Violation|1|||
28139471|NCT02937701|54804558|FG002|Day 1 to Week 22|Protocol Violation|0|||
28139472|NCT02937701|54804559|FG003|Day 1 to Week 22|Protocol Violation|0|||
28139473|NCT02937701|54804560|FG004|Day 1 to Week 22|Protocol Violation|0|||
28139474|NCT02937701|54804556|FG000|Day 1 to Week 22|Lost to Follow-up|1|||
28139475|NCT02937701|54804557|FG001|Day 1 to Week 22|Lost to Follow-up|1|||
28139476|NCT02937701|54804558|FG002|Day 1 to Week 22|Lost to Follow-up|0|||
27821777|NCT01856257|54283942|FG000|Overall Study|Withdrawal by Subject|1|||
28139477|NCT02937701|54804559|FG003|Day 1 to Week 22|Lost to Follow-up|0|||
28139478|NCT02937701|54804560|FG004|Day 1 to Week 22|Lost to Follow-up|0|||
28139479|NCT02937701|54804556|FG000|Day 1 to Week 22|Physician Decision|2|||
28139480|NCT02937701|54804557|FG001|Day 1 to Week 22|Physician Decision|0|||
28139481|NCT02937701|54804558|FG002|Day 1 to Week 22|Physician Decision|0|||
28139482|NCT02937701|54804559|FG003|Day 1 to Week 22|Physician Decision|0|||
28139483|NCT02937701|54804560|FG004|Day 1 to Week 22|Physician Decision|0|||
28139484|NCT02937701|54804556|FG000|Day 1 to Week 22|Other|1|||
28139485|NCT02937701|54804557|FG001|Day 1 to Week 22|Other|0|||
28139486|NCT02937701|54804558|FG002|Day 1 to Week 22|Other|0|||
28139487|NCT02937701|54804559|FG003|Day 1 to Week 22|Other|0|||
28139488|NCT02937701|54804560|FG004|Day 1 to Week 22|Other|0|||
28139489|NCT02937701|54804556|FG000|Week 22 to Week 50|Adverse Event|0|||
28139490|NCT02937701|54804557|FG001|Week 22 to Week 50|Adverse Event|0|||
28139491|NCT02937701|54804558|FG002|Week 22 to Week 50|Adverse Event|10|||
28139492|NCT02937701|54804559|FG003|Week 22 to Week 50|Adverse Event|3|||
28139493|NCT02937701|54804560|FG004|Week 22 to Week 50|Adverse Event|3|||
28139494|NCT02937701|54804556|FG000|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
28139495|NCT02937701|54804557|FG001|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
28139496|NCT02937701|54804558|FG002|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10|||
28139497|NCT02937701|54804559|FG003|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3|||
28139498|NCT02937701|54804560|FG004|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2|||
28139499|NCT02937701|54804556|FG000|Week 22 to Week 50|Withdrawal by Subject|0|||
28139500|NCT02937701|54804557|FG001|Week 22 to Week 50|Withdrawal by Subject|0|||
28139501|NCT02937701|54804558|FG002|Week 22 to Week 50|Withdrawal by Subject|8|||
28139502|NCT02937701|54804559|FG003|Week 22 to Week 50|Withdrawal by Subject|2|||
28139503|NCT02937701|54804560|FG004|Week 22 to Week 50|Withdrawal by Subject|1|||
28139504|NCT02937701|54804556|FG000|Week 22 to Week 50|Lost to Follow-up|0|||
28139505|NCT02937701|54804557|FG001|Week 22 to Week 50|Lost to Follow-up|0|||
28139506|NCT02937701|54804558|FG002|Week 22 to Week 50|Lost to Follow-up|2|||
28139507|NCT02937701|54804559|FG003|Week 22 to Week 50|Lost to Follow-up|0|||
28139508|NCT02937701|54804560|FG004|Week 22 to Week 50|Lost to Follow-up|1|||
28139509|NCT02937701|54804556|FG000|Week 22 to Week 50|Physician Decision|0|||
28139510|NCT02937701|54804557|FG001|Week 22 to Week 50|Physician Decision|0|||
28139511|NCT02937701|54804558|FG002|Week 22 to Week 50|Physician Decision|2|||
28139512|NCT02937701|54804559|FG003|Week 22 to Week 50|Physician Decision|0|||
28139513|NCT02937701|54804560|FG004|Week 22 to Week 50|Physician Decision|1|||
28139514|NCT02937701|54804556|FG000|Week 22 to Week 50|Other|0|||
28139515|NCT02937701|54804557|FG001|Week 22 to Week 50|Other|0|||
28139516|NCT02937701|54804558|FG002|Week 22 to Week 50|Other|0|||
28139517|NCT02937701|54804559|FG003|Week 22 to Week 50|Other|0|||
28139518|NCT02937701|54804560|FG004|Week 22 to Week 50|Other|1|||
28139519|NCT03169153|54804572|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
28139520|NCT03169153|54804573|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
28139521|NCT03169153|54804572|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|2|||
28139522|NCT03169153|54804573|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|3|||
28139523|NCT03169153|54804572|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
28139524|NCT03169153|54804573|FG001|Period 2, Second 30 Days of Wear|Adverse Event|2|||
28139525|NCT03169153|54804572|FG000|Period 2, Second 30 Days of Wear|Could not attend visit|1|||
28139526|NCT03169153|54804573|FG001|Period 2, Second 30 Days of Wear|Could not attend visit|0|||
28139527|NCT03168919|54804579|FG000|Overall Study|Withdrawal by Subject|2|||
28139528|NCT03205163|54804589|FG000|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1|||
28139529|NCT03205163|54804590|FG001|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0|||
28139530|NCT01759537|54804605|FG000|Overall Study|Death|1|||
28139531|NCT01759537|54804606|FG001|Overall Study|Death|1|||
28139532|NCT01759537|54804605|FG000|Overall Study|Pregnancy|1|||
28139533|NCT01759537|54804606|FG001|Overall Study|Pregnancy|1|||
28139534|NCT01759537|54804605|FG000|Overall Study|Lost to Follow-up|9|||
28139535|NCT01759537|54804606|FG001|Overall Study|Lost to Follow-up|9|||
28139536|NCT01759537|54804605|FG000|Overall Study|Accident involving jaw fracture|1|||
28139537|NCT01759537|54804606|FG001|Overall Study|Accident involving jaw fracture|1|||
28139538|NCT01759537|54804605|FG000|Overall Study|Subcrestal implant too coronal|1|||
28139539|NCT01759537|54804606|FG001|Overall Study|Subcrestal implant too coronal|1|||
28139540|NCT03204539|54804614|FG000|Overall Study|Loss of funding|0|||
28139541|NCT03204539|54804615|FG001|Overall Study|Loss of funding|1|||
27821778|NCT01856257|54283943|FG001|Overall Study|Withdrawal by Subject|1|||
28139542|NCT03502681|54804632|FG000|Overall Study|Adverse Event|1|||
28139543|NCT03502681|54804633|FG001|Overall Study|Adverse Event|1|||
28139544|NCT03502681|54804632|FG000|Overall Study|Disease Progression|2|||
28139545|NCT03502681|54804633|FG001|Overall Study|Disease Progression|1|||
28139546|NCT02860130|54804640|FG000|Overall Study|Adverse Event|2|||
28139547|NCT02860130|54804641|FG001|Overall Study|Adverse Event|3|||
28139548|NCT02860130|54804640|FG000|Overall Study|Protocol Violation|1|||
28139549|NCT02860130|54804641|FG001|Overall Study|Protocol Violation|1|||
28139550|NCT02860130|54804640|FG000|Overall Study|Withdrawal by Subject|0|||
28139551|NCT02860130|54804641|FG001|Overall Study|Withdrawal by Subject|2|||
28139552|NCT02860130|54804640|FG000|Overall Study|Physician Decision|2|||
28139553|NCT02860130|54804641|FG001|Overall Study|Physician Decision|2|||
28139554|NCT02860130|54804640|FG000|Overall Study|Other|2|||
28139555|NCT02860130|54804641|FG001|Overall Study|Other|1|||
28139556|NCT00788671|54804647|FG000|Overall Study|Death|2|||
28139557|NCT00788671|54804647|FG000|Overall Study|Unable to biopsy|1|||
28139558|NCT00788671|54804647|FG000|Overall Study|Withdrawal by Subject|4|||
28139559|NCT00788671|54804647|FG000|Overall Study|IUD expulsed|1|||
28139560|NCT00788671|54804647|FG000|Overall Study|Lost to follow up|2|||
28139561|NCT02986854|54804654|FG000|Overall Study|Withdrawal by Subject|0|||
28139562|NCT02986854|54804655|FG001|Overall Study|Withdrawal by Subject|1|||
28139563|NCT02986854|54804656|FG002|Overall Study|Withdrawal by Subject|1|||
28139564|NCT02986854|54804654|FG000|Overall Study|Lost to Follow-up|3|||
28139565|NCT02986854|54804655|FG001|Overall Study|Lost to Follow-up|11|||
28139566|NCT02986854|54804656|FG002|Overall Study|Lost to Follow-up|2|||
28139567|NCT02887183|54804666|FG000|Overall Study|Adverse Event|44|||
28139568|NCT02887183|54804666|FG000|Overall Study|Death|30|||
28139569|NCT02887183|54804666|FG000|Overall Study|Pregnancy|1|||
28139570|NCT02887183|54804666|FG000|Overall Study|Protocol Violation|6|||
28139571|NCT02887183|54804666|FG000|Overall Study|Technical Problems|2|||
28139572|NCT02887183|54804666|FG000|Overall Study|Lost to Follow-up|13|||
28139573|NCT02887183|54804666|FG000|Overall Study|Physician Decision|10|||
28139574|NCT02887183|54804666|FG000|Overall Study|Withdrawal by Subject|35|||
28139575|NCT03167359|54804670|FG000|Overall Study|Physician Decision|1|||
28139576|NCT03167359|54804670|FG000|Overall Study|Lost to Follow-up|1|||
28139577|NCT01068600|54804676|FG000|Overall Study|Withdrawal by Subject|5|||
28139578|NCT01068600|54804677|FG001|Overall Study|Withdrawal by Subject|6|||
28139579|NCT01068600|54804676|FG000|Overall Study|Adverse Event|3|||
28139580|NCT01068600|54804677|FG001|Overall Study|Adverse Event|3|||
28139581|NCT01068600|54804676|FG000|Overall Study|Abnormal laboratory value(s)|1|||
28139582|NCT01068600|54804677|FG001|Overall Study|Abnormal laboratory value(s)|0|||
28139583|NCT01068600|54804676|FG000|Overall Study|Lost to Follow-up|1|||
28139584|NCT01068600|54804677|FG001|Overall Study|Lost to Follow-up|2|||
28139585|NCT01068600|54804676|FG000|Overall Study|Protocol deviation|1|||
28139586|NCT01068600|54804677|FG001|Overall Study|Protocol deviation|1|||
28139587|NCT01068600|54804676|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
28139588|NCT01068600|54804677|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
28139589|NCT01068600|54804676|FG000|Overall Study|Administrative problems|0|||
28139590|NCT01068600|54804677|FG001|Overall Study|Administrative problems|1|||
28139591|NCT01067976|54804683|FG000|Overall Study|Study drug never administered|20|||
28139592|NCT01067976|54804683|FG000|Overall Study|Study prematurely discontinued|2|||
28070418|NCT00144339|54725241|FG000|Overall Study|Other|58|||
28070419|NCT00144339|54725242|FG001|Overall Study|Other|60|||
28070420|NCT00144027|54725250|FG000|Overall Study|Lost to Follow-up|1|||
28070421|NCT00144027|54725251|FG001|Overall Study|Lost to Follow-up|3|||
28070422|NCT00144027|54725250|FG000|Overall Study|Withdrawal by Subject|2|||
28070423|NCT00144027|54725251|FG001|Overall Study|Withdrawal by Subject|2|||
28070424|NCT00144027|54725250|FG000|Overall Study|did not complete baseline assessment|0|||
28070425|NCT00144027|54725251|FG001|Overall Study|did not complete baseline assessment|6|||
28070426|NCT00127803|54725261|FG000|Overall Study|Adverse Event|2|||
28070427|NCT00127803|54725262|FG001|Overall Study|Adverse Event|0|||
28070428|NCT00127803|54725263|FG002|Overall Study|Adverse Event|0|||
28070429|NCT00127803|54725264|FG003|Overall Study|Adverse Event|0|||
28070430|NCT00127803|54725261|FG000|Overall Study|Withdrawal by Subject|1|||
28070431|NCT00127803|54725262|FG001|Overall Study|Withdrawal by Subject|0|||
28070432|NCT00127803|54725263|FG002|Overall Study|Withdrawal by Subject|0|||
28070433|NCT00127803|54725264|FG003|Overall Study|Withdrawal by Subject|0|||
28070434|NCT00127803|54725261|FG000|Overall Study|Lost to Follow-up|0|||
28070435|NCT00127803|54725262|FG001|Overall Study|Lost to Follow-up|0|||
28070436|NCT00127803|54725263|FG002|Overall Study|Lost to Follow-up|0|||
28070437|NCT00127803|54725264|FG003|Overall Study|Lost to Follow-up|1|||
28070438|NCT00127413|54725278|FG000|Overall Study|Lost to Follow-up|6|||
28070439|NCT00127413|54725279|FG001|Overall Study|Lost to Follow-up|4|||
28070440|NCT00127413|54725280|FG002|Overall Study|Lost to Follow-up|8|||
28070441|NCT00127413|54725281|FG003|Overall Study|Lost to Follow-up|2|||
28070442|NCT00143403|54725293|FG000|Overall Study|Adverse Event|3|||
28070443|NCT00143403|54725294|FG001|Overall Study|Adverse Event|8|||
28070444|NCT00143403|54725293|FG000|Overall Study|Death|1|||
28070445|NCT00143403|54725294|FG001|Overall Study|Death|0|||
28070446|NCT00143403|54725293|FG000|Overall Study|Withdrawal by Subject|3|||
28070447|NCT00143403|54725294|FG001|Overall Study|Withdrawal by Subject|12|||
28070448|NCT00143403|54725293|FG000|Overall Study|Relapse|15|||
28070449|NCT00143403|54725294|FG001|Overall Study|Relapse|7|||
28139593|NCT02858492|54804705|FG000|Overall Study|Withdrawal by Subject|0|||
28139594|NCT02858492|54804706|FG001|Overall Study|Withdrawal by Subject|1|||
28139595|NCT02858492|54804707|FG002|Overall Study|Withdrawal by Subject|0|||
28139596|NCT02858492|54804708|FG003|Overall Study|Withdrawal by Subject|1|||
28139597|NCT02858492|54804705|FG000|Overall Study|Adverse Event|0|||
28139598|NCT02858492|54804706|FG001|Overall Study|Adverse Event|0|||
28139599|NCT02858492|54804707|FG002|Overall Study|Adverse Event|0|||
28139600|NCT02858492|54804708|FG003|Overall Study|Adverse Event|3|||
28139601|NCT02858492|54804705|FG000|Overall Study|Lack of Efficacy|0|||
28139602|NCT02858492|54804706|FG001|Overall Study|Lack of Efficacy|0|||
28139603|NCT02858492|54804707|FG002|Overall Study|Lack of Efficacy|0|||
28139604|NCT02858492|54804708|FG003|Overall Study|Lack of Efficacy|1|||
28139605|NCT02858492|54804705|FG000|Overall Study|Protocol defined stopping criteria|0|||
28139606|NCT02858492|54804706|FG001|Overall Study|Protocol defined stopping criteria|0|||
28139607|NCT02858492|54804707|FG002|Overall Study|Protocol defined stopping criteria|0|||
28139608|NCT02858492|54804708|FG003|Overall Study|Protocol defined stopping criteria|1|||
28139609|NCT01067508|54804722|FG000|Overall Study|Physician Decision|0|||
28139610|NCT01067508|54804723|FG001|Overall Study|Physician Decision|1|||
28139611|NCT01067508|54804722|FG000|Overall Study|Withdrawal by Subject|0|||
28139612|NCT01067508|54804723|FG001|Overall Study|Withdrawal by Subject|1|||
28139613|NCT01067352|54804732|FG000|Overall Study|Withdrawal by Subject|1|||
28139614|NCT01067352|54804733|FG001|Overall Study|Withdrawal by Subject|2|||
28139615|NCT01067352|54804734|FG002|Overall Study|Withdrawal by Subject|1|||
28139616|NCT01067352|54804732|FG000|Overall Study|Physician Decision|0|||
28139617|NCT01067352|54804733|FG001|Overall Study|Physician Decision|1|||
28139618|NCT01067352|54804734|FG002|Overall Study|Physician Decision|0|||
28139619|NCT02986074|54804742|FG000|First Trial Period|Adverse Event|1|||
28139620|NCT02986074|54804743|FG001|First Trial Period|Adverse Event|0|||
28139621|NCT02986074|54804744|FG002|First Trial Period|Adverse Event|0|||
28139622|NCT02986074|54804745|FG003|First Trial Period|Adverse Event|0|||
28139623|NCT02986074|54804742|FG000|Follow up Period|system explant|0|||
28139624|NCT02986074|54804743|FG001|Follow up Period|system explant|0|||
28139625|NCT02986074|54804744|FG002|Follow up Period|system explant|1|||
28139626|NCT02986074|54804745|FG003|Follow up Period|system explant|2|||
28139627|NCT02986074|54804742|FG000|Follow up Period|Physician Decision|0|||
28139628|NCT02986074|54804743|FG001|Follow up Period|Physician Decision|0|||
28139629|NCT02986074|54804744|FG002|Follow up Period|Physician Decision|0|||
28139630|NCT02986074|54804745|FG003|Follow up Period|Physician Decision|1|||
28139631|NCT02920242|54804753|FG000|Overall Study|Withdrawal by Subject|1|||
28139632|NCT02920242|54804754|FG001|Overall Study|Withdrawal by Subject|0|||
28139633|NCT02920242|54804755|FG002|Overall Study|Withdrawal by Subject|1|||
28139634|NCT02920242|54804753|FG000|Overall Study|Did not meet inc./exc. criteria|1|||
28139635|NCT02920242|54804754|FG001|Overall Study|Did not meet inc./exc. criteria|0|||
28139636|NCT02920242|54804755|FG002|Overall Study|Did not meet inc./exc. criteria|0|||
28139637|NCT02985996|54804768|FG000|Overall Study|Withdrawal by Subject|0|||
28139638|NCT02985996|54804769|FG001|Overall Study|Withdrawal by Subject|0|||
28139639|NCT02985996|54804770|FG002|Overall Study|Withdrawal by Subject|1|||
28139640|NCT02985996|54804771|FG003|Overall Study|Withdrawal by Subject|0|||
28139641|NCT02985996|54804772|FG004|Overall Study|Withdrawal by Subject|0|||
28139642|NCT02985996|54804768|FG000|Overall Study|Protocol Violation|0|||
28139643|NCT02985996|54804769|FG001|Overall Study|Protocol Violation|1|||
28139644|NCT02985996|54804770|FG002|Overall Study|Protocol Violation|0|||
28139645|NCT02985996|54804771|FG003|Overall Study|Protocol Violation|0|||
28139646|NCT02985996|54804772|FG004|Overall Study|Protocol Violation|0|||
28139647|NCT03225833|54804794|FG000|Overall Study|Adverse Event|0|||
28139648|NCT03225833|54804795|FG001|Overall Study|Adverse Event|1|||
28139649|NCT03225833|54804796|FG002|Overall Study|Adverse Event|2|||
28139650|NCT03225833|54804797|FG003|Overall Study|Adverse Event|0|||
28139651|NCT03225833|54804798|FG004|Overall Study|Adverse Event|0|||
28139652|NCT03225833|54804799|FG005|Overall Study|Adverse Event|2|||
28139653|NCT03225833|54804794|FG000|Overall Study|Withdrawal by Subject|1|||
28139654|NCT03225833|54804795|FG001|Overall Study|Withdrawal by Subject|0|||
28139655|NCT03225833|54804796|FG002|Overall Study|Withdrawal by Subject|0|||
28139656|NCT03225833|54804797|FG003|Overall Study|Withdrawal by Subject|0|||
28139657|NCT03225833|54804798|FG004|Overall Study|Withdrawal by Subject|1|||
28139658|NCT03225833|54804799|FG005|Overall Study|Withdrawal by Subject|0|||
28139659|NCT03225833|54804794|FG000|Overall Study|Termination of Study by Sponsor|4|||
28139660|NCT03225833|54804795|FG001|Overall Study|Termination of Study by Sponsor|0|||
28139661|NCT03225833|54804796|FG002|Overall Study|Termination of Study by Sponsor|0|||
27941090|NCT01179672|54597407|FG001|Overall Study|Physician Decision|1|||
27941091|NCT01030965|54597421|FG000|Overall Study|Lack of Efficacy|3|||
27941092|NCT01030965|54597422|FG001|Overall Study|Lack of Efficacy|2|||
28139662|NCT03225833|54804797|FG003|Overall Study|Termination of Study by Sponsor|0|||
28139663|NCT03225833|54804798|FG004|Overall Study|Termination of Study by Sponsor|0|||
28139664|NCT03225833|54804799|FG005|Overall Study|Termination of Study by Sponsor|7|||
28139665|NCT03225833|54804794|FG000|Overall Study|Sponsor Decision|0|||
28139666|NCT03225833|54804795|FG001|Overall Study|Sponsor Decision|0|||
28139667|NCT03225833|54804796|FG002|Overall Study|Sponsor Decision|0|||
28139668|NCT03225833|54804797|FG003|Overall Study|Sponsor Decision|0|||
28139669|NCT03225833|54804798|FG004|Overall Study|Sponsor Decision|0|||
28139670|NCT03225833|54804799|FG005|Overall Study|Sponsor Decision|1|||
28139671|NCT03203447|54804820|FG000|Overall Study|Withdrawal by Subject|2|||
28139672|NCT03203447|54804821|FG001|Overall Study|Withdrawal by Subject|1|||
28139673|NCT03203447|54804820|FG000|Overall Study|Lost to Follow-up|1|||
28139674|NCT03203447|54804821|FG001|Overall Study|Lost to Follow-up|10|||
28139675|NCT03203447|54804820|FG000|Overall Study|Includes premature discontinuation due to study termination and unknown|159|||
28139676|NCT03203447|54804821|FG001|Overall Study|Includes premature discontinuation due to study termination and unknown|152|||
28139677|NCT02858726|54804831|FG000|Overall Study|Adverse Event|4|||
28139678|NCT02858726|54804832|FG001|Overall Study|Adverse Event|4|||
28139679|NCT02858726|54804833|FG002|Overall Study|Adverse Event|9|||
28139680|NCT02858726|54804834|FG003|Overall Study|Adverse Event|1|||
28139681|NCT02858726|54804831|FG000|Overall Study|Physician Decision|0|||
28139682|NCT02858726|54804832|FG001|Overall Study|Physician Decision|0|||
28139683|NCT02858726|54804833|FG002|Overall Study|Physician Decision|1|||
28139684|NCT02858726|54804834|FG003|Overall Study|Physician Decision|0|||
28139685|NCT02858726|54804831|FG000|Overall Study|Protocol Violation|0|||
28139686|NCT02858726|54804832|FG001|Overall Study|Protocol Violation|0|||
28139687|NCT02858726|54804833|FG002|Overall Study|Protocol Violation|0|||
28139688|NCT02858726|54804834|FG003|Overall Study|Protocol Violation|1|||
28139689|NCT02858726|54804831|FG000|Overall Study|Study Terminated by Sponsor|0|||
28139690|NCT02858726|54804832|FG001|Overall Study|Study Terminated by Sponsor|0|||
28139691|NCT02858726|54804833|FG002|Overall Study|Study Terminated by Sponsor|0|||
28139692|NCT02858726|54804834|FG003|Overall Study|Study Terminated by Sponsor|1|||
28139693|NCT02858726|54804831|FG000|Overall Study|Withdrawal by Subject|1|||
28139694|NCT02858726|54804832|FG001|Overall Study|Withdrawal by Subject|2|||
28139695|NCT02858726|54804833|FG002|Overall Study|Withdrawal by Subject|1|||
28139696|NCT02858726|54804834|FG003|Overall Study|Withdrawal by Subject|0|||
28139697|NCT02858726|54804831|FG000|Overall Study|Noncompliance|0|||
28139698|NCT02858726|54804832|FG001|Overall Study|Noncompliance|1|||
28139699|NCT02858726|54804833|FG002|Overall Study|Noncompliance|0|||
28139700|NCT02858726|54804834|FG003|Overall Study|Noncompliance|0|||
28139701|NCT03203291|54804848|FG000|Overall Study|Withdrawal by Subject|1|||
28139702|NCT01068678|54804854|FG000|Overall Study|Lack of Efficacy|3|||
28139703|NCT01068678|54804855|FG001|Overall Study|Lack of Efficacy|2|||
28139704|NCT01068678|54804854|FG000|Overall Study|Protocol Violation|5|||
28139705|NCT01068678|54804855|FG001|Overall Study|Protocol Violation|1|||
28139706|NCT01068678|54804854|FG000|Overall Study|Withdrawal criteria|12|||
28139707|NCT01068678|54804855|FG001|Overall Study|Withdrawal criteria|6|||
28139708|NCT01068678|54804854|FG000|Overall Study|Unclassified|18|||
28139709|NCT01068678|54804855|FG001|Overall Study|Unclassified|15|||
28139710|NCT03202511|54804861|FG000|Overall Study|Withdrawal by Subject|1|||
28139711|NCT03202511|54804862|FG001|Overall Study|Withdrawal by Subject|0|||
28139712|NCT02919696|54804883|FG000|Overall Study|Adverse Event|1|||
28139713|NCT02919696|54804884|FG001|Overall Study|Adverse Event|2|||
28139714|NCT02919696|54804883|FG000|Overall Study|Withdrawal by Subject|2|||
28139715|NCT02919696|54804884|FG001|Overall Study|Withdrawal by Subject|1|||
28139716|NCT02919696|54804883|FG000|Overall Study|Sponsor Decision|1|||
28139717|NCT02919696|54804884|FG001|Overall Study|Sponsor Decision|1|||
28139718|NCT02919696|54804883|FG000|Overall Study|Never Treated|0|||
28139719|NCT02919696|54804884|FG001|Overall Study|Never Treated|1|||
28139720|NCT02935673|54804899|FG000|Overall Study|Adverse Event|0|||
28139721|NCT02935673|54804900|FG001|Overall Study|Adverse Event|1|||
28139722|NCT02935673|54804901|FG002|Overall Study|Adverse Event|0|||
28139723|NCT02935673|54804899|FG000|Overall Study|Withdrawal by Subject|1|||
28139724|NCT02935673|54804900|FG001|Overall Study|Withdrawal by Subject|2|||
28139725|NCT02935673|54804901|FG002|Overall Study|Withdrawal by Subject|0|||
28139726|NCT03201809|54804913|FG000|Overall Study|Lost to Follow-up|2|||
28139727|NCT03201809|54804914|FG001|Overall Study|Lost to Follow-up|0|||
28139728|NCT02985450|54804925|FG000|Overall Study|Lost to Follow-up|7|||
28139729|NCT02908464|54804934|FG000|Overall Study|Withdrawal by Subject|2|||
28139730|NCT02908464|54804935|FG001|Overall Study|Withdrawal by Subject|1|||
28139731|NCT02908464|54804934|FG000|Overall Study|Found ineligible after randomization|0|||
28139732|NCT02908464|54804935|FG001|Overall Study|Found ineligible after randomization|2|||
28139733|NCT02907216|54804944|FG000|Overall Study|No benefit to be obtained by continuing|0|||
28139734|NCT02907216|54804945|FG001|Overall Study|No benefit to be obtained by continuing|1|||
28139735|NCT02907216|54804944|FG000|Overall Study|Withdrawal by Subject|1|||
27941093|NCT01030965|54597423|FG002|Overall Study|Lack of Efficacy|0|||
27941094|NCT01030965|54597424|FG003|Overall Study|Lack of Efficacy|3|||
28139736|NCT02907216|54804945|FG001|Overall Study|Withdrawal by Subject|0|||
28139737|NCT02984982|54804953|FG000|Overall Study|Adverse Event|2|||
28139738|NCT02984982|54804954|FG001|Overall Study|Adverse Event|5|||
28139739|NCT02984982|54804953|FG000|Overall Study|Poor Compliance to Protocol|4|||
28139740|NCT02984982|54804954|FG001|Overall Study|Poor Compliance to Protocol|4|||
28139741|NCT02984982|54804953|FG000|Overall Study|Withdrawal by Subject|2|||
28139742|NCT02984982|54804954|FG001|Overall Study|Withdrawal by Subject|0|||
28139743|NCT02984982|54804953|FG000|Overall Study|Randomized but not treated|0|||
27941095|NCT01030965|54597421|FG000|Overall Study|Protocol Violation|1|||
28139744|NCT02984982|54804954|FG001|Overall Study|Randomized but not treated|1|||
28139745|NCT02981472|54804963|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
28139746|NCT02981472|54804964|FG001|Pre-Treatment Period|Participant withdrew consent|1|||
28139747|NCT02981472|54804963|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
28139748|NCT02981472|54804964|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
28139749|NCT02981472|54804963|FG000|Treatment Period|Adverse Event|6|||
28139750|NCT02981472|54804964|FG001|Treatment Period|Adverse Event|1|||
28139751|NCT02981472|54804963|FG000|Treatment Period|Participant withdrew consent|1|||
28139752|NCT02981472|54804964|FG001|Treatment Period|Participant withdrew consent|0|||
28139753|NCT02981472|54804963|FG000|Treatment Period|Lost to Follow-up|0|||
28139754|NCT02981472|54804964|FG001|Treatment Period|Lost to Follow-up|1|||
28139755|NCT02982720|54804976|FG000|Overall Study|Adverse Event|3|||
28139756|NCT02982720|54804976|FG000|Overall Study|Death|1|||
28139757|NCT00849667|54804983|FG000|Overall Study|Withdrawal by Subject|16|||
28139758|NCT00849667|54804984|FG001|Overall Study|Withdrawal by Subject|33|||
28139759|NCT00849667|54804985|FG002|Overall Study|Withdrawal by Subject|35|||
28139760|NCT00849667|54804983|FG000|Overall Study|Lost to Follow-up|8|||
28139761|NCT00849667|54804984|FG001|Overall Study|Lost to Follow-up|8|||
28139762|NCT00849667|54804985|FG002|Overall Study|Lost to Follow-up|8|||
28139763|NCT00849667|54804983|FG000|Overall Study|Adverse Event|1|||
28139764|NCT00849667|54804984|FG001|Overall Study|Adverse Event|2|||
28139765|NCT00849667|54804985|FG002|Overall Study|Adverse Event|0|||
28139766|NCT00849667|54804983|FG000|Overall Study|Other|18|||
28139767|NCT00849667|54804984|FG001|Overall Study|Other|19|||
28139768|NCT00849667|54804985|FG002|Overall Study|Other|18|||
27941096|NCT01030965|54597422|FG001|Overall Study|Protocol Violation|1|||
28139769|NCT00849667|54804983|FG000|Overall Study|Progressive disease|119|||
28139770|NCT00849667|54804984|FG001|Overall Study|Progressive disease|100|||
28139771|NCT00849667|54804985|FG002|Overall Study|Progressive disease|112|||
28139772|NCT00849667|54804983|FG000|Overall Study|Sponsor decision|208|||
28139773|NCT00849667|54804984|FG001|Overall Study|Sponsor decision|204|||
28139774|NCT00849667|54804985|FG002|Overall Study|Sponsor decision|190|||
28139775|NCT00849667|54804983|FG000|Overall Study|Investigator discretion|0|||
28139776|NCT00849667|54804984|FG001|Overall Study|Investigator discretion|0|||
28139777|NCT00849667|54804985|FG002|Overall Study|Investigator discretion|1|||
28139778|NCT03201419|54805004|FG000|Overall Study|Adverse Event|3|||
28139779|NCT03201419|54805005|FG001|Overall Study|Adverse Event|1|||
28139780|NCT03201419|54805006|FG002|Overall Study|Adverse Event|0|||
28139781|NCT03201419|54805007|FG003|Overall Study|Adverse Event|0|||
28139782|NCT03201419|54805008|FG004|Overall Study|Adverse Event|1|||
28139783|NCT03201419|54805009|FG005|Overall Study|Adverse Event|1|||
28139784|NCT03201419|54805010|FG006|Overall Study|Adverse Event|5|||
28139785|NCT03201419|54805011|FG007|Overall Study|Adverse Event|0|||
28139786|NCT03201419|54805012|FG008|Overall Study|Adverse Event|0|||
28139787|NCT03201419|54805004|FG000|Overall Study|Lost to Follow-up|1|||
28139788|NCT03201419|54805005|FG001|Overall Study|Lost to Follow-up|0|||
28139789|NCT03201419|54805006|FG002|Overall Study|Lost to Follow-up|0|||
28139790|NCT03201419|54805007|FG003|Overall Study|Lost to Follow-up|0|||
28139791|NCT03201419|54805008|FG004|Overall Study|Lost to Follow-up|0|||
28139792|NCT03201419|54805009|FG005|Overall Study|Lost to Follow-up|0|||
28139793|NCT03201419|54805010|FG006|Overall Study|Lost to Follow-up|0|||
28139794|NCT03201419|54805011|FG007|Overall Study|Lost to Follow-up|0|||
28139795|NCT03201419|54805012|FG008|Overall Study|Lost to Follow-up|0|||
28139796|NCT03201419|54805004|FG000|Overall Study|Protocol Deviation|0|||
28139797|NCT03201419|54805005|FG001|Overall Study|Protocol Deviation|0|||
28139798|NCT03201419|54805006|FG002|Overall Study|Protocol Deviation|0|||
28139799|NCT03201419|54805007|FG003|Overall Study|Protocol Deviation|0|||
28139800|NCT03201419|54805008|FG004|Overall Study|Protocol Deviation|0|||
28139801|NCT03201419|54805009|FG005|Overall Study|Protocol Deviation|0|||
28139802|NCT03201419|54805010|FG006|Overall Study|Protocol Deviation|1|||
28139803|NCT03201419|54805011|FG007|Overall Study|Protocol Deviation|0|||
28139804|NCT03201419|54805012|FG008|Overall Study|Protocol Deviation|0|||
28139805|NCT03201419|54805004|FG000|Overall Study|Withdrawal by Subject|4|||
28139806|NCT03201419|54805005|FG001|Overall Study|Withdrawal by Subject|2|||
27821779|NCT01856257|54283944|FG002|Overall Study|Withdrawal by Subject|0|||
27821780|NCT01856257|54283945|FG003|Overall Study|Withdrawal by Subject|0|||
27821781|NCT01856257|54283942|FG000|Overall Study|Donor complication|0|||
28139807|NCT03201419|54805006|FG002|Overall Study|Withdrawal by Subject|1|||
28139808|NCT03201419|54805007|FG003|Overall Study|Withdrawal by Subject|0|||
28139809|NCT03201419|54805008|FG004|Overall Study|Withdrawal by Subject|0|||
28139810|NCT03201419|54805009|FG005|Overall Study|Withdrawal by Subject|0|||
28139811|NCT03201419|54805010|FG006|Overall Study|Withdrawal by Subject|0|||
28139812|NCT03201419|54805011|FG007|Overall Study|Withdrawal by Subject|1|||
28139813|NCT03201419|54805012|FG008|Overall Study|Withdrawal by Subject|2|||
28139814|NCT03201419|54805004|FG000|Overall Study|Other|0|||
28139815|NCT03201419|54805005|FG001|Overall Study|Other|0|||
28139816|NCT03201419|54805006|FG002|Overall Study|Other|1|||
28139817|NCT03201419|54805007|FG003|Overall Study|Other|0|||
28139818|NCT03201419|54805008|FG004|Overall Study|Other|0|||
28139819|NCT03201419|54805009|FG005|Overall Study|Other|0|||
28139820|NCT03201419|54805010|FG006|Overall Study|Other|0|||
28139821|NCT03201419|54805011|FG007|Overall Study|Other|0|||
28139822|NCT03201419|54805012|FG008|Overall Study|Other|0|||
28139823|NCT01764633|54805048|FG000|Overall Study|Withdrawal by Subject|105|||
28139824|NCT01764633|54805049|FG001|Overall Study|Withdrawal by Subject|88|||
28139825|NCT01764633|54805048|FG000|Overall Study|Lost to Follow-up|13|||
28139826|NCT01764633|54805049|FG001|Overall Study|Lost to Follow-up|5|||
28139827|NCT02924389|54805057|FG000|Overall Study|Lost to Follow-up|1|||
28139828|NCT02924389|54805058|FG001|Overall Study|Lost to Follow-up|0|||
28139829|NCT02924389|54805057|FG000|Overall Study|Physician Decision|2|||
28139830|NCT02924389|54805058|FG001|Overall Study|Physician Decision|0|||
28139831|NCT02924389|54805057|FG000|Overall Study|Withdrawal by Subject|3|||
28139832|NCT02924389|54805058|FG001|Overall Study|Withdrawal by Subject|0|||
28139833|NCT02924389|54805057|FG000|Overall Study|Participant began ARVs prior to study intervention|2|||
28139834|NCT02924389|54805058|FG001|Overall Study|Participant began ARVs prior to study intervention|0|||
28139835|NCT03235349|54805065|FG000|Overall Study|Adverse Event|1|||
28139836|NCT03235349|54805065|FG000|Overall Study|Other|1|||
28139837|NCT03235115|54805069|FG000|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
28139838|NCT03235115|54805070|FG001|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
28139839|NCT03235115|54805071|FG002|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
28070450|NCT00143403|54725293|FG000|Overall Study|Protocol Violation|2|||
28070451|NCT00143403|54725294|FG001|Overall Study|Protocol Violation|2|||
28070452|NCT00143403|54725293|FG000|Overall Study|specified by site|4|||
28070453|NCT00143403|54725294|FG001|Overall Study|specified by site|9|||
28070454|NCT00143403|54725293|FG000|Overall Study|Randomized Not Treated|7|||
28070455|NCT00143403|54725294|FG001|Overall Study|Randomized Not Treated|8|||
28070456|NCT00220701|54725302|FG000|Overall Study|Lost to Follow-up|5|||
28070457|NCT00220701|54725303|FG001|Overall Study|Lost to Follow-up|4|||
28070458|NCT00127101|54725315|FG000|Base Protocol|Adverse Event|0|||
28070459|NCT00127101|54725316|FG001|Base Protocol|Adverse Event|2|||
28070460|NCT00127101|54725317|FG002|Base Protocol|Adverse Event|1|||
28070461|NCT00127101|54725318|FG003|Base Protocol|Adverse Event|0|||
28070462|NCT00127101|54725319|FG004|Base Protocol|Adverse Event|0|||
28070463|NCT00127101|54725320|FG005|Base Protocol|Adverse Event|0|||
28070464|NCT00127101|54725315|FG000|Base Protocol|Lack of Efficacy|1|||
28070465|NCT00127101|54725316|FG001|Base Protocol|Lack of Efficacy|0|||
28070466|NCT00127101|54725317|FG002|Base Protocol|Lack of Efficacy|0|||
28139840|NCT03235115|54805072|FG003|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
28139841|NCT03235115|54805073|FG004|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
28139842|NCT03235115|54805074|FG005|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1|||
28139843|NCT02923531|54805082|FG000|Overall Study|Adverse Event|4|||
28139844|NCT02923531|54805082|FG000|Overall Study|Clinical Deterioration|1|||
28139845|NCT02923531|54805082|FG000|Overall Study|Disease Progression|3|||
28139846|NCT02923531|54805082|FG000|Overall Study|Study Termination|1|||
28139847|NCT02934503|54805087|FG000|Overall Study|progression of disease|3|||
28139848|NCT02934503|54805087|FG000|Overall Study|Withdrawal by Subject|1|||
28139849|NCT02937545|54805093|FG000|Overall Study|Withdrawal by Subject|1|||
28139850|NCT02937545|54805094|FG001|Overall Study|Withdrawal by Subject|2|||
28139851|NCT02937545|54805095|FG002|Overall Study|Withdrawal by Subject|6|||
28139852|NCT02937545|54805096|FG003|Overall Study|Withdrawal by Subject|7|||
28139853|NCT02937545|54805093|FG000|Overall Study|Lost to Follow-up|1|||
28139854|NCT02937545|54805094|FG001|Overall Study|Lost to Follow-up|0|||
28139855|NCT02937545|54805095|FG002|Overall Study|Lost to Follow-up|0|||
28139856|NCT02937545|54805096|FG003|Overall Study|Lost to Follow-up|0|||
28139857|NCT03199391|54805107|FG000|Overall Study|Death|1|||
28139858|NCT03199391|54805107|FG000|Overall Study|Lost to Follow-up|3|||
28139859|NCT03199391|54805107|FG000|Overall Study|Adverse Event|2|||
28139860|NCT03199391|54805107|FG000|Overall Study|Withdrawal by Subject|10|||
28139861|NCT03198767|54805118|FG000|Overall Study|Protocol Violation|0|||
28139862|NCT03198767|54805119|FG001|Overall Study|Protocol Violation|0|||
28139863|NCT03198767|54805120|FG002|Overall Study|Protocol Violation|0|||
28139864|NCT03198767|54805121|FG003|Overall Study|Protocol Violation|6|||
28139865|NCT03198767|54805122|FG004|Overall Study|Protocol Violation|0|||
28139866|NCT03198767|54805123|FG005|Overall Study|Protocol Violation|0|||
28139867|NCT03198767|54805124|FG006|Overall Study|Protocol Violation|0|||
28139868|NCT03162055|54805141|FG000|Overall Study|Adverse Event|6|||
28139869|NCT03162055|54805142|FG001|Overall Study|Adverse Event|5|||
28139870|NCT03162055|54805141|FG000|Overall Study|Death|3|||
28139871|NCT03162055|54805142|FG001|Overall Study|Death|3|||
28139872|NCT03162055|54805141|FG000|Overall Study|Lost to Follow-up|0|||
28139873|NCT03162055|54805142|FG001|Overall Study|Lost to Follow-up|1|||
28139874|NCT03162055|54805141|FG000|Overall Study|Study-specific withdrawal criteria|22|||
28139875|NCT03162055|54805142|FG001|Overall Study|Study-specific withdrawal criteria|14|||
28139876|NCT03162055|54805141|FG000|Overall Study|Withdrawal by Subject|17|||
28139877|NCT03162055|54805142|FG001|Overall Study|Withdrawal by Subject|2|||
28139878|NCT03162055|54805141|FG000|Overall Study|Did not receive treatment|2|||
28139879|NCT03162055|54805142|FG001|Overall Study|Did not receive treatment|0|||
28139880|NCT03162055|54805141|FG000|Overall Study|Incorrect randomization|4|||
28139881|NCT03162055|54805142|FG001|Overall Study|Incorrect randomization|3|||
28139882|NCT03162055|54805141|FG000|Overall Study|Other|8|||
28139883|NCT03162055|54805142|FG001|Overall Study|Other|15|||
28139884|NCT02927145|54805155|FG000|Initial Recruitment|Withdrawal by Subject|0|||
28139885|NCT02927145|54805156|FG001|Initial Recruitment|Withdrawal by Subject|1|||
28139886|NCT02927145|54805157|FG002|Initial Recruitment|Withdrawal by Subject|1|||
28139887|NCT02927145|54805158|FG003|Initial Recruitment|Withdrawal by Subject|4|||
28139888|NCT02927145|54805159|FG004|Initial Recruitment|Withdrawal by Subject|1|||
28139889|NCT02927145|54805160|FG005|Initial Recruitment|Withdrawal by Subject|1|||
28139890|NCT02927145|54805161|FG006|Initial Recruitment|Withdrawal by Subject|0|||
28139891|NCT02927145|54805162|FG007|Initial Recruitment|Withdrawal by Subject|0|||
28139892|NCT02927145|54805163|FG008|Initial Recruitment|Withdrawal by Subject|2|||
28139893|NCT02927145|54805155|FG000|Initial Recruitment|Adverse Event|0|||
28139894|NCT02927145|54805156|FG001|Initial Recruitment|Adverse Event|0|||
28139895|NCT02927145|54805157|FG002|Initial Recruitment|Adverse Event|0|||
28139896|NCT02927145|54805158|FG003|Initial Recruitment|Adverse Event|0|||
28139897|NCT02927145|54805159|FG004|Initial Recruitment|Adverse Event|2|||
28139898|NCT02927145|54805160|FG005|Initial Recruitment|Adverse Event|0|||
28139899|NCT02927145|54805161|FG006|Initial Recruitment|Adverse Event|0|||
28139900|NCT02927145|54805162|FG007|Initial Recruitment|Adverse Event|0|||
28139901|NCT02927145|54805163|FG008|Initial Recruitment|Adverse Event|0|||
28139902|NCT02927145|54805155|FG000|Invitation for Additional Challenge|Pregnancy|0|||
28139903|NCT02927145|54805156|FG001|Invitation for Additional Challenge|Pregnancy|0|||
28139904|NCT02927145|54805157|FG002|Invitation for Additional Challenge|Pregnancy|0|||
28139905|NCT02927145|54805158|FG003|Invitation for Additional Challenge|Pregnancy|0|||
28139906|NCT02927145|54805159|FG004|Invitation for Additional Challenge|Pregnancy|0|||
28139907|NCT02927145|54805160|FG005|Invitation for Additional Challenge|Pregnancy|0|||
28139908|NCT02927145|54805161|FG006|Invitation for Additional Challenge|Pregnancy|1|||
28139909|NCT02927145|54805162|FG007|Invitation for Additional Challenge|Pregnancy|0|||
28139910|NCT02927145|54805163|FG008|Invitation for Additional Challenge|Pregnancy|0|||
28139911|NCT03688919|54805186|FG000|Overall Study|Lost to Follow-up|2|||
28139912|NCT03688919|54805187|FG001|Overall Study|Lost to Follow-up|1|||
28139913|NCT03688919|54805186|FG000|Overall Study|withdrawn by study team due to poor data validity|1|||
28139914|NCT03688919|54805187|FG001|Overall Study|withdrawn by study team due to poor data validity|0|||
28139915|NCT02888119|54805210|FG000|Overall Study|Lost to Follow-up|5|||
28139916|NCT02888119|54805211|FG001|Overall Study|Lost to Follow-up|4|||
28139917|NCT02888119|54805212|FG002|Overall Study|Lost to Follow-up|0|||
28139918|NCT03197129|54805221|FG000|Overall Study|did not answer the VPT: shyness|4|||
28139919|NCT03197129|54805222|FG001|Overall Study|did not answer the VPT: shyness|5|||
28139920|NCT03196973|54805231|FG000|Overall Study|Adverse Event|1|||
28139921|NCT03196973|54805232|FG001|Overall Study|Adverse Event|1|||
28139922|NCT03196973|54805233|FG002|Overall Study|Adverse Event|2|||
28139923|NCT03196973|54805231|FG000|Overall Study|Lack of Efficacy|2|||
28139924|NCT03196973|54805232|FG001|Overall Study|Lack of Efficacy|6|||
28139925|NCT03196973|54805233|FG002|Overall Study|Lack of Efficacy|1|||
28139926|NCT03196973|54805231|FG000|Overall Study|Lost to Follow-up|4|||
28139927|NCT03196973|54805232|FG001|Overall Study|Lost to Follow-up|3|||
28139928|NCT03196973|54805233|FG002|Overall Study|Lost to Follow-up|2|||
28139929|NCT03196973|54805231|FG000|Overall Study|Consent withdrawn|2|||
28139930|NCT03196973|54805232|FG001|Overall Study|Consent withdrawn|1|||
28139931|NCT03196973|54805233|FG002|Overall Study|Consent withdrawn|0|||
28139932|NCT03196973|54805231|FG000|Overall Study|Administration of a wrong kit of study medication|0|||
28139933|NCT03196973|54805232|FG001|Overall Study|Administration of a wrong kit of study medication|1|||
28139934|NCT03196973|54805233|FG002|Overall Study|Administration of a wrong kit of study medication|0|||
28139935|NCT03196505|54805243|FG000|Overall Study|Physician Decision|26|||
28139936|NCT03196505|54805244|FG001|Overall Study|Physician Decision|26|||
28139937|NCT03196349|54805253|FG000|Overall Study|Did not receive study drug|0|||
28139938|NCT03196349|54805254|FG001|Overall Study|Did not receive study drug|1|||
28139939|NCT03196349|54805255|FG002|Overall Study|Did not receive study drug|2|||
28139940|NCT03196349|54805253|FG000|Overall Study|No data entered|2|||
28139941|NCT03196349|54805254|FG001|Overall Study|No data entered|4|||
28139942|NCT03196349|54805255|FG002|Overall Study|No data entered|0|||
28139943|NCT03196349|54805253|FG000|Overall Study|Study Terminated early|15|||
28139944|NCT03196349|54805254|FG001|Overall Study|Study Terminated early|9|||
28139945|NCT03196349|54805255|FG002|Overall Study|Study Terminated early|11|||
28139946|NCT02886715|54805266|FG000|Overall Study|Non-Compliance With Study Drug|0|||
28139947|NCT02886715|54805267|FG001|Overall Study|Non-Compliance With Study Drug|2|||
28139948|NCT02886715|54805268|FG002|Overall Study|Non-Compliance With Study Drug|0|||
28139949|NCT02886715|54805266|FG000|Overall Study|Adverse Event|4|||
28139950|NCT02886715|54805267|FG001|Overall Study|Adverse Event|2|||
28139951|NCT02886715|54805268|FG002|Overall Study|Adverse Event|0|||
28139952|NCT02886715|54805266|FG000|Overall Study|Lack of Efficacy|0|||
28139953|NCT02886715|54805267|FG001|Overall Study|Lack of Efficacy|2|||
28139954|NCT02886715|54805268|FG002|Overall Study|Lack of Efficacy|1|||
28139955|NCT02886715|54805266|FG000|Overall Study|Lost to Follow-up|29|||
28139956|NCT02886715|54805267|FG001|Overall Study|Lost to Follow-up|26|||
28139957|NCT02886715|54805268|FG002|Overall Study|Lost to Follow-up|10|||
28139958|NCT02886715|54805266|FG000|Overall Study|Pregnancy|1|||
28139959|NCT02886715|54805267|FG001|Overall Study|Pregnancy|1|||
28139960|NCT02886715|54805268|FG002|Overall Study|Pregnancy|1|||
28139961|NCT02886715|54805266|FG000|Overall Study|Protocol Violation|3|||
28139962|NCT02886715|54805267|FG001|Overall Study|Protocol Violation|2|||
28139963|NCT02886715|54805268|FG002|Overall Study|Protocol Violation|1|||
28139964|NCT02886715|54805266|FG000|Overall Study|Withdrawal by Subject|20|||
28139965|NCT02886715|54805267|FG001|Overall Study|Withdrawal by Subject|18|||
28139966|NCT02886715|54805268|FG002|Overall Study|Withdrawal by Subject|5|||
28139967|NCT02886715|54805266|FG000|Overall Study|missing|7|||
28139968|NCT02886715|54805267|FG001|Overall Study|missing|2|||
28139969|NCT02886715|54805268|FG002|Overall Study|missing|2|||
28139970|NCT03085797|54805278|FG000|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1|||
28139971|NCT03085797|54805279|FG001|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0|||
28139972|NCT03085797|54805278|FG000|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16|||
28139973|NCT03085797|54805279|FG001|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17|||
28139974|NCT03085797|54805278|FG000|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0|||
28139975|NCT03085797|54805279|FG001|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1|||
28139976|NCT03157531|54805287|FG000|Overall Study|Death|2|||
28139977|NCT03157531|54805287|FG000|Overall Study|Lost to Follow-up|4|||
28139978|NCT03159091|54805293|FG000|Overall Study|Incorrect inclusion ineligible patient|5|||
28139979|NCT03159091|54805294|FG001|Overall Study|Incorrect inclusion ineligible patient|3|||
28139980|NCT03159091|54805293|FG000|Overall Study|Patient has taken no dose of study drug|0|||
28139981|NCT03159091|54805294|FG001|Overall Study|Patient has taken no dose of study drug|1|||
28139982|NCT03196193|54805302|FG000|Overall Study|Adverse Event|1|||
28139983|NCT03196193|54805303|FG001|Overall Study|Adverse Event|0|||
28139984|NCT03196193|54805302|FG000|Overall Study|Computed Tomography (CT) data missing|2|||
28139985|NCT03196193|54805303|FG001|Overall Study|Computed Tomography (CT) data missing|0|||
28139986|NCT03621761|54805312|FG000|Overall Study|Lost to Follow-up|1|||
28139987|NCT03621761|54805313|FG001|Overall Study|Lost to Follow-up|1|||
28139988|NCT03621761|54805314|FG002|Overall Study|Lost to Follow-up|2|||
28139989|NCT03621761|54805312|FG000|Overall Study|Withdrawal by Subject|2|||
28139990|NCT03621761|54805313|FG001|Overall Study|Withdrawal by Subject|1|||
28139991|NCT03621761|54805314|FG002|Overall Study|Withdrawal by Subject|1|||
28139992|NCT03621761|54805312|FG000|Overall Study|Became Ineligible|0|||
28139993|NCT03621761|54805313|FG001|Overall Study|Became Ineligible|2|||
28139994|NCT03621761|54805314|FG002|Overall Study|Became Ineligible|0|||
28139995|NCT03221387|54805322|FG000|Overall Study|Lost to Follow-up|1|||
28139996|NCT03221387|54805322|FG000|Overall Study|Lung transplant|1|||
28139997|NCT03318861|54805331|FG000|Overall Study|Death|1|||
28139998|NCT03318861|54805332|FG001|Overall Study|Death|2|||
28139999|NCT03318861|54805333|FG002|Overall Study|Death|2|||
28140000|NCT03318861|54805334|FG003|Overall Study|Death|1|||
28140001|NCT03318861|54805335|FG004|Overall Study|Death|1|||
28140002|NCT03318861|54805331|FG000|Overall Study|Still on Study|2|||
28140003|NCT03318861|54805332|FG001|Overall Study|Still on Study|1|||
28140004|NCT03318861|54805333|FG002|Overall Study|Still on Study|1|||
28140005|NCT03318861|54805334|FG003|Overall Study|Still on Study|2|||
28140006|NCT03318861|54805335|FG004|Overall Study|Still on Study|1|||
28140007|NCT03318861|54805331|FG000|Overall Study|Enrolled But Did Not Initiate KITE-585|0|||
28140008|NCT03318861|54805332|FG001|Overall Study|Enrolled But Did Not Initiate KITE-585|1|||
28140009|NCT03318861|54805333|FG002|Overall Study|Enrolled But Did Not Initiate KITE-585|0|||
28140010|NCT03318861|54805334|FG003|Overall Study|Enrolled But Did Not Initiate KITE-585|1|||
28140011|NCT03318861|54805335|FG004|Overall Study|Enrolled But Did Not Initiate KITE-585|1|||
28140012|NCT03084315|54805349|FG000|Overall Study|Lost to Follow-up|8|||
28140013|NCT03084315|54805350|FG001|Overall Study|Lost to Follow-up|7|||
28140014|NCT03084315|54805349|FG000|Overall Study|Withdrawal by Subject|2|||
28140015|NCT03084315|54805350|FG001|Overall Study|Withdrawal by Subject|2|||
28140016|NCT03187301|54805356|FG000|Titration Period|Adverse Event|0|||
28140017|NCT03187301|54805357|FG001|Titration Period|Adverse Event|0|||
28140018|NCT03187301|54805358|FG002|Titration Period|Adverse Event|0|||
28140019|NCT03187301|54805359|FG003|Titration Period|Adverse Event|0|||
28140020|NCT03187301|54805360|FG004|Titration Period|Adverse Event|0|||
28140021|NCT03187301|54805361|FG005|Titration Period|Adverse Event|0|||
28140022|NCT03187301|54805362|FG006|Titration Period|Adverse Event|5|||
28140023|NCT03187301|54805356|FG000|Titration Period|Withdrawal by Subject|0|||
28140024|NCT03187301|54805357|FG001|Titration Period|Withdrawal by Subject|0|||
28140025|NCT03187301|54805358|FG002|Titration Period|Withdrawal by Subject|0|||
28140026|NCT03187301|54805359|FG003|Titration Period|Withdrawal by Subject|0|||
28140027|NCT03187301|54805360|FG004|Titration Period|Withdrawal by Subject|0|||
28140028|NCT03187301|54805361|FG005|Titration Period|Withdrawal by Subject|0|||
28140029|NCT03187301|54805362|FG006|Titration Period|Withdrawal by Subject|1|||
28140030|NCT03187301|54805356|FG000|Titration Period|Exclusion Criteria Met|0|||
28140031|NCT03187301|54805357|FG001|Titration Period|Exclusion Criteria Met|0|||
28140032|NCT03187301|54805358|FG002|Titration Period|Exclusion Criteria Met|0|||
28140033|NCT03187301|54805359|FG003|Titration Period|Exclusion Criteria Met|0|||
28140034|NCT03187301|54805360|FG004|Titration Period|Exclusion Criteria Met|0|||
28140035|NCT03187301|54805361|FG005|Titration Period|Exclusion Criteria Met|0|||
28140036|NCT03187301|54805362|FG006|Titration Period|Exclusion Criteria Met|1|||
28140037|NCT03187301|54805356|FG000|Pre-Intervention|Withdrawal by Subject|1|||
28140038|NCT03187301|54805357|FG001|Pre-Intervention|Withdrawal by Subject|0|||
28140039|NCT03187301|54805358|FG002|Pre-Intervention|Withdrawal by Subject|0|||
28140040|NCT03187301|54805359|FG003|Pre-Intervention|Withdrawal by Subject|0|||
28140041|NCT03187301|54805360|FG004|Pre-Intervention|Withdrawal by Subject|0|||
28140042|NCT03187301|54805361|FG005|Pre-Intervention|Withdrawal by Subject|0|||
28140043|NCT03187301|54805362|FG006|Pre-Intervention|Withdrawal by Subject|0|||
28140044|NCT02946047|54805387|FG000|Overall Study|Adverse Event|1|||
28140045|NCT02946047|54805388|FG001|Overall Study|Adverse Event|0|||
28140046|NCT02946047|54805389|FG002|Overall Study|Adverse Event|0|||
28140047|NCT02946047|54805390|FG003|Overall Study|Adverse Event|0|||
28140048|NCT03077919|54805402|FG000|Overall Study|Lost to Follow-up|4|||
28140049|NCT03077919|54805403|FG001|Overall Study|Lost to Follow-up|1|||
28140050|NCT03220217|54805412|FG000|Overall Study|Withdrawal by Subject|0|||
28140051|NCT03220217|54805413|FG001|Overall Study|Withdrawal by Subject|1|||
28140052|NCT03220217|54805414|FG002|Overall Study|Withdrawal by Subject|0|||
28140053|NCT03220217|54805412|FG000|Overall Study|Subject Missed Procedure|0|||
28140054|NCT03220217|54805413|FG001|Overall Study|Subject Missed Procedure|0|||
28140055|NCT03220217|54805414|FG002|Overall Study|Subject Missed Procedure|1|||
28140056|NCT03192137|54805445|FG000|Overall Study|Adverse Event|10|||
28140057|NCT03192137|54805446|FG001|Overall Study|Adverse Event|11|||
28140058|NCT03192137|54805445|FG000|Overall Study|Physician Decision|1|||
28140059|NCT03192137|54805446|FG001|Overall Study|Physician Decision|0|||
28140060|NCT03192137|54805445|FG000|Overall Study|Lack of Efficacy|20|||
28140061|NCT03192137|54805446|FG001|Overall Study|Lack of Efficacy|37|||
28140062|NCT03192137|54805445|FG000|Overall Study|Withdrawal by Subject|3|||
28140063|NCT03192137|54805446|FG001|Overall Study|Withdrawal by Subject|3|||
28140064|NCT03192137|54805445|FG000|Overall Study|Protocol Violation|4|||
28140065|NCT03192137|54805446|FG001|Overall Study|Protocol Violation|3|||
28140066|NCT03192137|54805445|FG000|Overall Study|Surgery Cancelled|4|||
28140067|NCT03192137|54805446|FG001|Overall Study|Surgery Cancelled|1|||
28140068|NCT03192137|54805445|FG000|Overall Study|Other - Various Administrative Reasons|8|||
28140069|NCT03192137|54805446|FG001|Overall Study|Other - Various Administrative Reasons|3|||
28140070|NCT03881059|54805466|FG000|Treatment Period - Part A|Adverse Event|1|||
28140071|NCT03881059|54805467|FG001|Treatment Period - Part A|Adverse Event|3|||
28140072|NCT03881059|54805468|FG002|Treatment Period - Part A|Adverse Event|4|||
28140073|NCT03881059|54805466|FG000|Treatment Period - Part A|Randomized by mistake with study treatment|0|||
28140074|NCT03881059|54805467|FG001|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
28140075|NCT03881059|54805468|FG002|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
28140076|NCT03881059|54805466|FG000|Treatment Period - Part A|Withdrawal by Subject|5|||
28140077|NCT03881059|54805467|FG001|Treatment Period - Part A|Withdrawal by Subject|2|||
28140078|NCT03881059|54805468|FG002|Treatment Period - Part A|Withdrawal by Subject|3|||
28140079|NCT03881059|54805466|FG000|Treatment Period - Part A|Other reasons|2|||
28140080|NCT03881059|54805467|FG001|Treatment Period - Part A|Other reasons|1|||
28140081|NCT03881059|54805468|FG002|Treatment Period - Part A|Other reasons|0|||
28140082|NCT03881059|54805466|FG000|Treatment Period - Part B|Adverse Event|0|||
28140083|NCT03881059|54805467|FG001|Treatment Period - Part B|Adverse Event|0|||
28140084|NCT03881059|54805468|FG002|Treatment Period - Part B|Adverse Event|3|||
28140085|NCT03881059|54805466|FG000|Treatment Period - Part B|Death|0|||
28140086|NCT03881059|54805467|FG001|Treatment Period - Part B|Death|1|||
28140087|NCT03881059|54805468|FG002|Treatment Period - Part B|Death|1|||
28140088|NCT03881059|54805466|FG000|Treatment Period - Part B|Lack of Efficacy|1|||
28140089|NCT03881059|54805467|FG001|Treatment Period - Part B|Lack of Efficacy|1|||
28140090|NCT03881059|54805468|FG002|Treatment Period - Part B|Lack of Efficacy|0|||
27821782|NCT01856257|54283943|FG001|Overall Study|Donor complication|0|||
27821783|NCT01856257|54283944|FG002|Overall Study|Donor complication|0|||
28140091|NCT03881059|54805466|FG000|Treatment Period - Part B|Lost to Follow-up|1|||
28140092|NCT03881059|54805467|FG001|Treatment Period - Part B|Lost to Follow-up|1|||
28140093|NCT03881059|54805468|FG002|Treatment Period - Part B|Lost to Follow-up|0|||
28140094|NCT03881059|54805466|FG000|Treatment Period - Part B|Site terminated by sponsor|1|||
28140095|NCT03881059|54805467|FG001|Treatment Period - Part B|Site terminated by sponsor|0|||
28140096|NCT03881059|54805468|FG002|Treatment Period - Part B|Site terminated by sponsor|3|||
27821784|NCT01856257|54283945|FG003|Overall Study|Donor complication|1|||
27941097|NCT01030965|54597423|FG002|Overall Study|Protocol Violation|1|||
27941098|NCT01030965|54597424|FG003|Overall Study|Protocol Violation|1|||
27821785|NCT00215943|54283956|FG000|Overall Study|Disease Progression|3|||
28140097|NCT03881059|54805466|FG000|Treatment Period - Part B|Withdrawal by Subject|1|||
28140098|NCT03881059|54805467|FG001|Treatment Period - Part B|Withdrawal by Subject|0|||
28140099|NCT03881059|54805468|FG002|Treatment Period - Part B|Withdrawal by Subject|1|||
28140100|NCT03881059|54805466|FG000|Treatment Period - Part B|Other reasons|4|||
28140101|NCT03881059|54805467|FG001|Treatment Period - Part B|Other reasons|3|||
28140102|NCT03881059|54805468|FG002|Treatment Period - Part B|Other reasons|3|||
28140103|NCT02861534|54805483|FG000|Overall Study|Death|541|||
28140104|NCT02861534|54805484|FG001|Overall Study|Death|552|||
28140105|NCT02861534|54805483|FG000|Overall Study|Lost to Follow-up|14|||
28140106|NCT02861534|54805484|FG001|Overall Study|Lost to Follow-up|14|||
28140107|NCT02861534|54805483|FG000|Overall Study|Site Terminated by Sponsor|4|||
28140108|NCT02861534|54805484|FG001|Overall Study|Site Terminated by Sponsor|3|||
28140109|NCT02861534|54805483|FG000|Overall Study|Withdrawal by Subject|15|||
28140110|NCT02861534|54805484|FG001|Overall Study|Withdrawal by Subject|18|||
28140111|NCT03083847|54805525|FG000|Main|Physician Decision|0|||
28140112|NCT03083847|54805526|FG001|Main|Physician Decision|0|||
28140113|NCT03083847|54805527|FG002|Main|Physician Decision|0|||
28140114|NCT03083847|54805528|FG003|Main|Physician Decision|0|||
28140115|NCT03083847|54805529|FG004|Main|Physician Decision|0|||
28140116|NCT03083847|54805530|FG005|Main|Physician Decision|1|||
28140117|NCT03083847|54805531|FG006|Main|Physician Decision|0|||
28140118|NCT03083847|54805532|FG007|Main|Physician Decision|0|||
28140119|NCT03083847|54805533|FG008|Main|Physician Decision|0|||
28140120|NCT03083847|54805534|FG009|Main|Physician Decision|0|||
28140121|NCT03083847|54805525|FG000|Main|Pregnancy|0|||
28140122|NCT03083847|54805526|FG001|Main|Pregnancy|0|||
28140123|NCT03083847|54805527|FG002|Main|Pregnancy|0|||
28140124|NCT03083847|54805528|FG003|Main|Pregnancy|0|||
28140125|NCT03083847|54805529|FG004|Main|Pregnancy|0|||
28140126|NCT03083847|54805530|FG005|Main|Pregnancy|0|||
28140127|NCT03083847|54805531|FG006|Main|Pregnancy|0|||
28140128|NCT03083847|54805532|FG007|Main|Pregnancy|1|||
28140129|NCT03083847|54805533|FG008|Main|Pregnancy|0|||
28140130|NCT03083847|54805534|FG009|Main|Pregnancy|0|||
28140131|NCT03083847|54805525|FG000|Main|Adverse Event|0|||
28140132|NCT03083847|54805526|FG001|Main|Adverse Event|0|||
27821786|NCT00215943|54283957|FG001|Overall Study|Disease Progression|5|||
28140133|NCT03083847|54805527|FG002|Main|Adverse Event|0|||
28140134|NCT03083847|54805528|FG003|Main|Adverse Event|0|||
28140135|NCT03083847|54805529|FG004|Main|Adverse Event|0|||
28140136|NCT03083847|54805530|FG005|Main|Adverse Event|0|||
28140137|NCT03083847|54805531|FG006|Main|Adverse Event|0|||
28140138|NCT03083847|54805532|FG007|Main|Adverse Event|2|||
28140139|NCT03083847|54805533|FG008|Main|Adverse Event|0|||
28140140|NCT03083847|54805534|FG009|Main|Adverse Event|0|||
28140141|NCT03083847|54805525|FG000|Main|Withdrawal by Subject|0|||
28140142|NCT03083847|54805526|FG001|Main|Withdrawal by Subject|0|||
28070467|NCT00127101|54725318|FG003|Base Protocol|Lack of Efficacy|0|||
28070468|NCT00127101|54725319|FG004|Base Protocol|Lack of Efficacy|2|||
28070469|NCT00127101|54725320|FG005|Base Protocol|Lack of Efficacy|0|||
28070470|NCT00127101|54725315|FG000|Base Protocol|Withdrawal by Subject|1|||
28070471|NCT00127101|54725316|FG001|Base Protocol|Withdrawal by Subject|2|||
28070472|NCT00127101|54725317|FG002|Base Protocol|Withdrawal by Subject|1|||
28070473|NCT00127101|54725318|FG003|Base Protocol|Withdrawal by Subject|0|||
28070474|NCT00127101|54725319|FG004|Base Protocol|Withdrawal by Subject|0|||
28070475|NCT00127101|54725320|FG005|Base Protocol|Withdrawal by Subject|1|||
28070476|NCT00127101|54725315|FG000|Continuation Phase|Adverse Event|0|||
28070477|NCT00127101|54725316|FG001|Continuation Phase|Adverse Event|0|||
28070478|NCT00127101|54725317|FG002|Continuation Phase|Adverse Event|0|||
28070479|NCT00127101|54725318|FG003|Continuation Phase|Adverse Event|0|||
28070480|NCT00127101|54725319|FG004|Continuation Phase|Adverse Event|1|||
28070481|NCT00127101|54725320|FG005|Continuation Phase|Adverse Event|1|||
28070482|NCT00127101|54725315|FG000|Continuation Phase|Lack of Efficacy|0|||
28070483|NCT00127101|54725316|FG001|Continuation Phase|Lack of Efficacy|0|||
28070484|NCT00127101|54725317|FG002|Continuation Phase|Lack of Efficacy|0|||
28070485|NCT00127101|54725318|FG003|Continuation Phase|Lack of Efficacy|0|||
28070486|NCT00127101|54725319|FG004|Continuation Phase|Lack of Efficacy|0|||
28070487|NCT00127101|54725320|FG005|Continuation Phase|Lack of Efficacy|1|||
28070488|NCT00127101|54725315|FG000|Continuation Phase|Withdrawal by Subject|0|||
28070489|NCT00127101|54725316|FG001|Continuation Phase|Withdrawal by Subject|0|||
28070490|NCT00127101|54725317|FG002|Continuation Phase|Withdrawal by Subject|1|||
28070491|NCT00127101|54725318|FG003|Continuation Phase|Withdrawal by Subject|0|||
28070492|NCT00127101|54725319|FG004|Continuation Phase|Withdrawal by Subject|2|||
28070493|NCT00127101|54725320|FG005|Continuation Phase|Withdrawal by Subject|1|||
28070494|NCT00126555|54725334|FG000|Overall Study|Withdrawal by Subject|1|||
28070495|NCT00126555|54725334|FG000|Overall Study|Adverse Event|2|||
28070496|NCT00126555|54725334|FG000|Overall Study|Progressive Disease|3|||
28070497|NCT00004228|54725357|FG000|Overall Study|Adverse Event|0|||
28070498|NCT00004228|54725358|FG001|Overall Study|Adverse Event|1|||
28070499|NCT00004228|54725359|FG002|Overall Study|Adverse Event|0|||
28070500|NCT00004228|54725360|FG003|Overall Study|Adverse Event|0|||
28070501|NCT00004228|54725361|FG004|Overall Study|Adverse Event|1|||
28070502|NCT00004228|54725362|FG005|Overall Study|Adverse Event|0|||
28070503|NCT00004228|54725363|FG006|Overall Study|Adverse Event|0|||
28070504|NCT00004228|54725357|FG000|Overall Study|Death|0|||
28070505|NCT00004228|54725358|FG001|Overall Study|Death|1|||
28070506|NCT00004228|54725359|FG002|Overall Study|Death|2|||
28070507|NCT00004228|54725360|FG003|Overall Study|Death|0|||
28070508|NCT00004228|54725361|FG004|Overall Study|Death|1|||
28070509|NCT00004228|54725362|FG005|Overall Study|Death|0|||
28070510|NCT00004228|54725363|FG006|Overall Study|Death|0|||
28070511|NCT00004228|54725357|FG000|Overall Study|Lack of Efficacy|1|||
28070512|NCT00004228|54725358|FG001|Overall Study|Lack of Efficacy|6|||
28070513|NCT00004228|54725359|FG002|Overall Study|Lack of Efficacy|5|||
28070514|NCT00004228|54725360|FG003|Overall Study|Lack of Efficacy|3|||
28070515|NCT00004228|54725361|FG004|Overall Study|Lack of Efficacy|9|||
28070516|NCT00004228|54725362|FG005|Overall Study|Lack of Efficacy|8|||
28070517|NCT00004228|54725363|FG006|Overall Study|Lack of Efficacy|4|||
28070518|NCT00004228|54725357|FG000|Overall Study|Lost to Follow-up|0|||
28070519|NCT00004228|54725358|FG001|Overall Study|Lost to Follow-up|0|||
28070520|NCT00004228|54725359|FG002|Overall Study|Lost to Follow-up|1|||
28070521|NCT00004228|54725360|FG003|Overall Study|Lost to Follow-up|0|||
28070522|NCT00004228|54725361|FG004|Overall Study|Lost to Follow-up|0|||
28070523|NCT00004228|54725362|FG005|Overall Study|Lost to Follow-up|0|||
28070524|NCT00004228|54725363|FG006|Overall Study|Lost to Follow-up|0|||
28070525|NCT00004228|54725357|FG000|Overall Study|Physician Decision|1|||
28070526|NCT00004228|54725358|FG001|Overall Study|Physician Decision|0|||
28070527|NCT00004228|54725359|FG002|Overall Study|Physician Decision|3|||
28070528|NCT00004228|54725360|FG003|Overall Study|Physician Decision|2|||
28070529|NCT00004228|54725361|FG004|Overall Study|Physician Decision|1|||
28070530|NCT00004228|54725362|FG005|Overall Study|Physician Decision|1|||
28070531|NCT00004228|54725363|FG006|Overall Study|Physician Decision|1|||
28070532|NCT00004228|54725357|FG000|Overall Study|Protocol Violation|0|||
28070533|NCT00004228|54725358|FG001|Overall Study|Protocol Violation|5|||
28070534|NCT00004228|54725359|FG002|Overall Study|Protocol Violation|2|||
28070535|NCT00004228|54725360|FG003|Overall Study|Protocol Violation|1|||
28070536|NCT00004228|54725361|FG004|Overall Study|Protocol Violation|1|||
28070537|NCT00004228|54725362|FG005|Overall Study|Protocol Violation|2|||
28070538|NCT00004228|54725363|FG006|Overall Study|Protocol Violation|0|||
28070539|NCT00004228|54725357|FG000|Overall Study|Withdrawal by Subject|3|||
28070540|NCT00004228|54725358|FG001|Overall Study|Withdrawal by Subject|0|||
28070541|NCT00004228|54725359|FG002|Overall Study|Withdrawal by Subject|1|||
28070542|NCT00004228|54725360|FG003|Overall Study|Withdrawal by Subject|0|||
28070543|NCT00004228|54725361|FG004|Overall Study|Withdrawal by Subject|2|||
28070544|NCT00004228|54725362|FG005|Overall Study|Withdrawal by Subject|1|||
28070545|NCT00004228|54725363|FG006|Overall Study|Withdrawal by Subject|2|||
28070546|NCT00004228|54725357|FG000|Overall Study|Other|0|||
28140143|NCT03083847|54805527|FG002|Main|Withdrawal by Subject|0|||
27941099|NCT01030965|54597421|FG000|Overall Study|Adverse Event|0|||
27941100|NCT01030965|54597422|FG001|Overall Study|Adverse Event|1|||
27941101|NCT01030965|54597423|FG002|Overall Study|Adverse Event|2|||
27941102|NCT01030965|54597424|FG003|Overall Study|Adverse Event|1|||
27941103|NCT01030965|54597421|FG000|Overall Study|Protocol-defined Stopping Criteria|0|||
27941104|NCT01030965|54597422|FG001|Overall Study|Protocol-defined Stopping Criteria|1|||
27941105|NCT01030965|54597423|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
27941106|NCT01030965|54597424|FG003|Overall Study|Protocol-defined Stopping Criteria|0|||
28070547|NCT00004228|54725358|FG001|Overall Study|Other|0|||
28070548|NCT00004228|54725359|FG002|Overall Study|Other|1|||
28070549|NCT00004228|54725360|FG003|Overall Study|Other|0|||
28140144|NCT03083847|54805528|FG003|Main|Withdrawal by Subject|0|||
28140145|NCT03083847|54805529|FG004|Main|Withdrawal by Subject|0|||
28140146|NCT03083847|54805530|FG005|Main|Withdrawal by Subject|0|||
28140147|NCT03083847|54805531|FG006|Main|Withdrawal by Subject|1|||
28140148|NCT03083847|54805532|FG007|Main|Withdrawal by Subject|1|||
28140149|NCT03083847|54805533|FG008|Main|Withdrawal by Subject|0|||
28140150|NCT03083847|54805534|FG009|Main|Withdrawal by Subject|0|||
28140151|NCT03082677|54805562|FG000|Overall Study|Not Treated|2|||
28140152|NCT02858180|54805577|FG000|Overall Study|Lost to Follow-up|0|||
28140153|NCT02858180|54805578|FG001|Overall Study|Lost to Follow-up|2|||
28140154|NCT03082599|54805586|FG000|Overall Study|Lost to Follow-up|1|||
28140155|NCT03082599|54805587|FG001|Overall Study|Lost to Follow-up|0|||
28140156|NCT01346501|54805595|FG000|Overall Study|Initiated Other Biological Agents|3|||
28140157|NCT01346501|54805596|FG001|Overall Study|Initiated Other Biological Agents|1|||
28140158|NCT01346501|54805595|FG000|Overall Study|Other|8|||
28140159|NCT01346501|54805596|FG001|Overall Study|Other|12|||
28140160|NCT03160885|54805606|FG000|Initial Treatment Period|Not dosed|2|||
28140161|NCT03160885|54805607|FG001|Initial Treatment Period|Not dosed|0|||
28140162|NCT03160885|54805608|FG002|Initial Treatment Period|Not dosed|0|||
28140163|NCT03160885|54805609|FG003|Initial Treatment Period|Not dosed|0|||
28140164|NCT03160885|54805610|FG004|Initial Treatment Period|Not dosed|0|||
28140165|NCT03160885|54805611|FG005|Initial Treatment Period|Not dosed|0|||
28140166|NCT03160885|54805612|FG006|Initial Treatment Period|Not dosed|0|||
28140167|NCT03160885|54805606|FG000|Initial Treatment Period|Discontinued IMP before Week 16|33|||
28140168|NCT03160885|54805607|FG001|Initial Treatment Period|Discontinued IMP before Week 16|22|||
28140169|NCT03160885|54805608|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
28140170|NCT03160885|54805609|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
28140171|NCT03160885|54805610|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
28140172|NCT03160885|54805611|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
28140173|NCT03160885|54805612|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
28140174|NCT03160885|54805606|FG000|Open-label Treatment|Not dosed|0|||
28140175|NCT03160885|54805607|FG001|Open-label Treatment|Not dosed|0|||
28140176|NCT03160885|54805608|FG002|Open-label Treatment|Not dosed|0|||
28140177|NCT03160885|54805609|FG003|Open-label Treatment|Not dosed|0|||
28140178|NCT03160885|54805610|FG004|Open-label Treatment|Not dosed|0|||
27821787|NCT00215943|54283956|FG000|Overall Study|Alternate therapy|0|||
27821788|NCT00215943|54283957|FG001|Overall Study|Alternate therapy|1|||
27821789|NCT00215943|54283956|FG000|Overall Study|Adverse Event|3|||
27821790|NCT00215943|54283957|FG001|Overall Study|Adverse Event|6|||
28140179|NCT03160885|54805611|FG005|Open-label Treatment|Not dosed|0|||
28140180|NCT03160885|54805612|FG006|Open-label Treatment|Not dosed|2|||
28140181|NCT03160885|54805606|FG000|Open-label Treatment|Discontinued IMP|0|||
28140182|NCT03160885|54805607|FG001|Open-label Treatment|Discontinued IMP|0|||
27821791|NCT00215943|54283956|FG000|Overall Study|Other disease|0|||
27821792|NCT00215943|54283957|FG001|Overall Study|Other disease|1|||
28070550|NCT00004228|54725361|FG004|Overall Study|Other|0|||
28070551|NCT00004228|54725362|FG005|Overall Study|Other|0|||
28070552|NCT00004228|54725363|FG006|Overall Study|Other|0|||
28070553|NCT00004228|54725357|FG000|Overall Study|ineligible|4|||
28070554|NCT00004228|54725358|FG001|Overall Study|ineligible|2|||
28070555|NCT00004228|54725359|FG002|Overall Study|ineligible|4|||
28070556|NCT00004228|54725360|FG003|Overall Study|ineligible|1|||
28140183|NCT03160885|54805608|FG002|Open-label Treatment|Discontinued IMP|0|||
28140184|NCT03160885|54805609|FG003|Open-label Treatment|Discontinued IMP|0|||
28140185|NCT03160885|54805610|FG004|Open-label Treatment|Discontinued IMP|0|||
28140186|NCT03160885|54805611|FG005|Open-label Treatment|Discontinued IMP|0|||
28140187|NCT03160885|54805612|FG006|Open-label Treatment|Discontinued IMP|131|||
28140188|NCT03160885|54805606|FG000|Open-label Treatment|Completed Week 50|0|||
28140189|NCT03160885|54805607|FG001|Open-label Treatment|Completed Week 50|0|||
27821793|NCT00215943|54283956|FG000|Overall Study|Other complications|3|||
27941107|NCT01030965|54597421|FG000|Overall Study|Withdrawal by Subject|0|||
28070557|NCT00004228|54725361|FG004|Overall Study|ineligible|1|||
28070558|NCT00004228|54725362|FG005|Overall Study|ineligible|2|||
28070559|NCT00004228|54725363|FG006|Overall Study|ineligible|5|||
28140190|NCT03160885|54805608|FG002|Open-label Treatment|Completed Week 50|0|||
28140191|NCT03160885|54805609|FG003|Open-label Treatment|Completed Week 50|0|||
28140192|NCT03160885|54805610|FG004|Open-label Treatment|Completed Week 50|0|||
27849908|NCT04569968|54348242|FG000|Overall Study|Denial of participation to the study|0|||
27849909|NCT04569968|54348243|FG001|Overall Study|Denial of participation to the study|3|||
27849910|NCT04569968|54348242|FG000|Overall Study|Free of temporomandibular joint dysfunction|4|||
27849911|NCT04569968|54348243|FG001|Overall Study|Free of temporomandibular joint dysfunction|2|||
27849912|NCT04569968|54348242|FG000|Overall Study|Lack of incisor and/or canin tooth|5|||
27849913|NCT04569968|54348243|FG001|Overall Study|Lack of incisor and/or canin tooth|3|||
27849914|NCT04569968|54348242|FG000|Overall Study|Quarantine|1|||
27849915|NCT04569968|54348243|FG001|Overall Study|Quarantine|0|||
27849916|NCT04569968|54348242|FG000|Overall Study|Previous recruitment to the expiratory muscle training|2|||
27941108|NCT01030965|54597422|FG001|Overall Study|Withdrawal by Subject|1|||
27941109|NCT01030965|54597423|FG002|Overall Study|Withdrawal by Subject|0|||
28070560|NCT00003526|54725380|FG000|Overall Study|Not evaluable|6|||
28140193|NCT03160885|54805611|FG005|Open-label Treatment|Completed Week 50|0|||
28140194|NCT03160885|54805612|FG006|Open-label Treatment|Completed Week 50|4|||
28140195|NCT03160885|54805606|FG000|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
28140196|NCT03160885|54805607|FG001|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
28140197|NCT03160885|54805608|FG002|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
28140198|NCT03160885|54805609|FG003|Maintenance Treatment Period|Not dosed - transfer to open-label|1|||
28140199|NCT03160885|54805610|FG004|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
28140200|NCT03160885|54805611|FG005|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
28140201|NCT03160885|54805612|FG006|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
28140202|NCT03160885|54805606|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
28140203|NCT03160885|54805607|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
28140204|NCT03160885|54805608|FG002|Maintenance Treatment Period|Discontinued IMP|9|||
28140205|NCT03160885|54805609|FG003|Maintenance Treatment Period|Discontinued IMP|13|||
28140206|NCT03160885|54805610|FG004|Maintenance Treatment Period|Discontinued IMP|5|||
28140207|NCT03160885|54805611|FG005|Maintenance Treatment Period|Discontinued IMP|7|||
28140208|NCT03160885|54805612|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
28140209|NCT03160885|54805606|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
28070561|NCT00195260|54725386|FG000|Part 1: Dose Escalation|Adverse Event|0|||
28140210|NCT03160885|54805607|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
28140211|NCT03160885|54805608|FG002|Maintenance Treatment Period|Transfer to open-label treatment|29|||
28140212|NCT03160885|54805609|FG003|Maintenance Treatment Period|Transfer to open-label treatment|26|||
28140213|NCT03160885|54805610|FG004|Maintenance Treatment Period|Transfer to open-label treatment|26|||
28140214|NCT03160885|54805611|FG005|Maintenance Treatment Period|Transfer to open-label treatment|8|||
28140215|NCT03160885|54805612|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
28140216|NCT03160885|54805606|FG000|Maintenance Treatment Period|Completed Week 50|0|||
28140217|NCT03160885|54805607|FG001|Maintenance Treatment Period|Completed Week 50|0|||
28140218|NCT03160885|54805608|FG002|Maintenance Treatment Period|Completed Week 50|1|||
28140219|NCT03160885|54805609|FG003|Maintenance Treatment Period|Completed Week 50|0|||
28140220|NCT03160885|54805610|FG004|Maintenance Treatment Period|Completed Week 50|0|||
28140221|NCT03160885|54805611|FG005|Maintenance Treatment Period|Completed Week 50|0|||
28140222|NCT03160885|54805612|FG006|Maintenance Treatment Period|Completed Week 50|0|||
28140223|NCT03181451|54805632|FG000|Overall Study|Adverse Event|0|||
28140224|NCT03181451|54805633|FG001|Overall Study|Adverse Event|1|||
28140225|NCT03181451|54805634|FG002|Overall Study|Adverse Event|0|||
28140226|NCT03181451|54805632|FG000|Overall Study|Withdrawal by Subject|0|||
28140227|NCT03181451|54805633|FG001|Overall Study|Withdrawal by Subject|1|||
28140228|NCT03181451|54805634|FG002|Overall Study|Withdrawal by Subject|0|||
28140229|NCT00406783|54805646|FG000|Overall Study|Adverse Event|4|||
28140230|NCT00406783|54805647|FG001|Overall Study|Adverse Event|4|||
28140231|NCT00406783|54805646|FG000|Overall Study|Treatment Failure|2|||
28140232|NCT00406783|54805647|FG001|Overall Study|Treatment Failure|3|||
28140233|NCT00406783|54805646|FG000|Overall Study|Lost to Follow-up|3|||
28140234|NCT00406783|54805647|FG001|Overall Study|Lost to Follow-up|0|||
28140235|NCT00406783|54805646|FG000|Overall Study|Withdrawal by Subject|1|||
28140236|NCT00406783|54805647|FG001|Overall Study|Withdrawal by Subject|4|||
28140237|NCT00406783|54805646|FG000|Overall Study|Protocol Violation|4|||
28070562|NCT00195260|54725387|FG001|Part 1: Dose Escalation|Adverse Event|1|||
28070563|NCT00195260|54725388|FG002|Part 1: Dose Escalation|Adverse Event|0|||
28070564|NCT00195260|54725389|FG003|Part 1: Dose Escalation|Adverse Event|1|||
28070565|NCT00195260|54725390|FG004|Part 1: Dose Escalation|Adverse Event|1|||
28070566|NCT00195260|54725391|FG005|Part 1: Dose Escalation|Adverse Event|0|||
28070567|NCT00195260|54725392|FG006|Part 1: Dose Escalation|Adverse Event|3|||
28070568|NCT00195260|54725393|FG007|Part 1: Dose Escalation|Adverse Event|0|||
28140238|NCT00406783|54805647|FG001|Overall Study|Protocol Violation|4|||
28140239|NCT03179891|54805653|FG000|First Intervention|Withdrawal by Subject|1|||
28140240|NCT03179891|54805654|FG001|First Intervention|Withdrawal by Subject|1|||
28140241|NCT03179891|54805653|FG000|First Intervention|Unspecified reason|1|||
28140242|NCT03179891|54805654|FG001|First Intervention|Unspecified reason|0|||
28140243|NCT03179891|54805653|FG000|First Intervention|Protocol Violation|0|||
28140244|NCT03179891|54805654|FG001|First Intervention|Protocol Violation|1|||
28140245|NCT02973815|54805665|FG000|Post Intervention|Death|1|||
28140246|NCT02973815|54805666|FG001|Post Intervention|Death|0|||
28140247|NCT02973815|54805665|FG000|Post Intervention|Lost to Follow-up|7|||
28140248|NCT02973815|54805666|FG001|Post Intervention|Lost to Follow-up|24|||
28140249|NCT02973815|54805665|FG000|Follow-up|Lost to Follow-up|2|||
28140250|NCT02973815|54805666|FG001|Follow-up|Lost to Follow-up|0|||
28140251|NCT03160573|54805676|FG000|First Sequence (3 Weeks)|Withdrawal by Subject|1|||
28140252|NCT03160573|54805677|FG001|First Sequence (3 Weeks)|Withdrawal by Subject|3|||
28140253|NCT03160573|54805678|FG002|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
28140254|NCT03160573|54805679|FG003|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
28140255|NCT02736227|54805692|FG000|Overall Study|Withdrawal by Subject|0|||
28140256|NCT02736227|54805693|FG001|Overall Study|Withdrawal by Subject|0|||
28140257|NCT02736227|54805694|FG002|Overall Study|Withdrawal by Subject|1|||
28140258|NCT02736227|54805692|FG000|Overall Study|Physician Decision|0|||
28140259|NCT02736227|54805693|FG001|Overall Study|Physician Decision|0|||
28140260|NCT02736227|54805694|FG002|Overall Study|Physician Decision|5|||
28140261|NCT02736227|54805692|FG000|Overall Study|Non Compliant|0|||
28140262|NCT02736227|54805693|FG001|Overall Study|Non Compliant|0|||
28140263|NCT02736227|54805694|FG002|Overall Study|Non Compliant|2|||
28140264|NCT03176459|54805703|FG000|Overall Study|Lost to Follow-up|5|||
28140265|NCT03176459|54805704|FG001|Overall Study|Lost to Follow-up|7|||
28140266|NCT03155269|54805712|FG000|Overall Study|Withdrawal by Subject|4|||
28140267|NCT03155269|54805713|FG001|Overall Study|Withdrawal by Subject|5|||
28140268|NCT03155269|54805712|FG000|Overall Study|Lost to Follow-up|1|||
28140269|NCT03155269|54805713|FG001|Overall Study|Lost to Follow-up|2|||
28140270|NCT02906670|54805729|FG000|Cohort 1, QW|Radiological Progression|1|||
28140271|NCT02906670|54805730|FG001|Cohort 1, QW|Radiological Progression|0|||
28140272|NCT02906670|54805731|FG002|Cohort 1, QW|Radiological Progression|0|||
28140273|NCT02906670|54805732|FG003|Cohort 1, QW|Radiological Progression|0|||
28140274|NCT02906670|54805733|FG004|Cohort 1, QW|Radiological Progression|0|||
28140275|NCT02906670|54805734|FG005|Cohort 1, QW|Radiological Progression|0|||
28140276|NCT02906670|54805735|FG006|Cohort 1, QW|Radiological Progression|0|||
28140277|NCT02906670|54805736|FG007|Cohort 1, QW|Radiological Progression|0|||
28140278|NCT02906670|54805737|FG008|Cohort 1, QW|Radiological Progression|0|||
28140279|NCT02906670|54805738|FG009|Cohort 1, QW|Radiological Progression|0|||
28140280|NCT02906670|54805729|FG000|Cohort 2, QW|Radiological Progression|0|||
28140281|NCT02906670|54805730|FG001|Cohort 2, QW|Radiological Progression|1|||
28140282|NCT02906670|54805731|FG002|Cohort 2, QW|Radiological Progression|0|||
28140283|NCT02906670|54805732|FG003|Cohort 2, QW|Radiological Progression|0|||
28140284|NCT02906670|54805733|FG004|Cohort 2, QW|Radiological Progression|0|||
28140285|NCT02906670|54805734|FG005|Cohort 2, QW|Radiological Progression|0|||
28140286|NCT02906670|54805735|FG006|Cohort 2, QW|Radiological Progression|0|||
28140287|NCT02906670|54805736|FG007|Cohort 2, QW|Radiological Progression|0|||
28140288|NCT02906670|54805737|FG008|Cohort 2, QW|Radiological Progression|0|||
28070569|NCT00195260|54725394|FG008|Part 1: Dose Escalation|Adverse Event|0|||
28070570|NCT00195260|54725395|FG009|Part 1: Dose Escalation|Adverse Event|0|||
28070571|NCT00195260|54725396|FG010|Part 1: Dose Escalation|Adverse Event|0|||
28070572|NCT00195260|54725386|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
28070573|NCT00195260|54725387|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
28070574|NCT00195260|54725388|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
28070575|NCT00195260|54725389|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
28070576|NCT00195260|54725390|FG004|Part 1: Dose Escalation|Withdrawal by Subject|2|||
28070577|NCT00195260|54725391|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
28070578|NCT00195260|54725392|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
28070579|NCT00195260|54725393|FG007|Part 1: Dose Escalation|Withdrawal by Subject|1|||
28070580|NCT00195260|54725394|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
28070581|NCT00195260|54725395|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
28070582|NCT00195260|54725396|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
28070583|NCT00195260|54725386|FG000|Part 1: Dose Escalation|Death|0|||
28070584|NCT00195260|54725387|FG001|Part 1: Dose Escalation|Death|0|||
28140289|NCT02906670|54805738|FG009|Cohort 2, QW|Radiological Progression|0|||
28140290|NCT02906670|54805729|FG000|Cohort 3, QW|Radiological Progression|0|||
28140291|NCT02906670|54805730|FG001|Cohort 3, QW|Radiological Progression|0|||
28140292|NCT02906670|54805731|FG002|Cohort 3, QW|Radiological Progression|2|||
28140293|NCT02906670|54805732|FG003|Cohort 3, QW|Radiological Progression|0|||
28140294|NCT02906670|54805733|FG004|Cohort 3, QW|Radiological Progression|0|||
28140295|NCT02906670|54805734|FG005|Cohort 3, QW|Radiological Progression|0|||
28140296|NCT02906670|54805735|FG006|Cohort 3, QW|Radiological Progression|0|||
28140297|NCT02906670|54805736|FG007|Cohort 3, QW|Radiological Progression|0|||
28140298|NCT02906670|54805737|FG008|Cohort 3, QW|Radiological Progression|0|||
28140299|NCT02906670|54805738|FG009|Cohort 3, QW|Radiological Progression|0|||
28140300|NCT02906670|54805729|FG000|Cohort 3, QW|Lack of Clinical Benefit|0|||
28140301|NCT02906670|54805730|FG001|Cohort 3, QW|Lack of Clinical Benefit|0|||
28140302|NCT02906670|54805731|FG002|Cohort 3, QW|Lack of Clinical Benefit|2|||
28140303|NCT02906670|54805732|FG003|Cohort 3, QW|Lack of Clinical Benefit|0|||
28140304|NCT02906670|54805733|FG004|Cohort 3, QW|Lack of Clinical Benefit|0|||
28140305|NCT02906670|54805734|FG005|Cohort 3, QW|Lack of Clinical Benefit|0|||
28140306|NCT02906670|54805735|FG006|Cohort 3, QW|Lack of Clinical Benefit|0|||
28140307|NCT02906670|54805736|FG007|Cohort 3, QW|Lack of Clinical Benefit|0|||
28140308|NCT02906670|54805737|FG008|Cohort 3, QW|Lack of Clinical Benefit|0|||
28140309|NCT02906670|54805738|FG009|Cohort 3, QW|Lack of Clinical Benefit|0|||
28140310|NCT02906670|54805729|FG000|Cohort 4, Q2W|Radiological Progression|0|||
28140311|NCT02906670|54805730|FG001|Cohort 4, Q2W|Radiological Progression|0|||
28140312|NCT02906670|54805731|FG002|Cohort 4, Q2W|Radiological Progression|0|||
28140313|NCT02906670|54805732|FG003|Cohort 4, Q2W|Radiological Progression|0|||
28140314|NCT02906670|54805733|FG004|Cohort 4, Q2W|Radiological Progression|0|||
28140315|NCT02906670|54805734|FG005|Cohort 4, Q2W|Radiological Progression|1|||
28140316|NCT02906670|54805735|FG006|Cohort 4, Q2W|Radiological Progression|0|||
28140317|NCT02906670|54805736|FG007|Cohort 4, Q2W|Radiological Progression|0|||
28140318|NCT02906670|54805737|FG008|Cohort 4, Q2W|Radiological Progression|0|||
28140319|NCT02906670|54805738|FG009|Cohort 4, Q2W|Radiological Progression|0|||
28140320|NCT02906670|54805729|FG000|Cohort 4, Q2W|Clinical Progression|0|||
28140321|NCT02906670|54805730|FG001|Cohort 4, Q2W|Clinical Progression|0|||
28140322|NCT02906670|54805731|FG002|Cohort 4, Q2W|Clinical Progression|0|||
28140323|NCT02906670|54805732|FG003|Cohort 4, Q2W|Clinical Progression|0|||
28140324|NCT02906670|54805733|FG004|Cohort 4, Q2W|Clinical Progression|0|||
28140325|NCT02906670|54805734|FG005|Cohort 4, Q2W|Clinical Progression|2|||
28140326|NCT02906670|54805735|FG006|Cohort 4, Q2W|Clinical Progression|0|||
27821794|NCT00215943|54283957|FG001|Overall Study|Other complications|1|||
27821795|NCT01827319|54283963|FG000|Overall Study|Lost to Follow-up|3|||
27821796|NCT01827163|54283967|FG000|Overall Study|Hypersensitivity reaction to Paclitaxel|2|||
27821797|NCT01827163|54283967|FG000|Overall Study|Adverse Event|9|||
27821798|NCT00215553|54283978|FG000|Overall Study|Adverse Event|0|||
27821799|NCT00215553|54283979|FG001|Overall Study|Adverse Event|1|||
27821800|NCT00215553|54283980|FG002|Overall Study|Adverse Event|2|||
27821801|NCT00215553|54283981|FG003|Overall Study|Adverse Event|1|||
27821802|NCT00215553|54283982|FG004|Overall Study|Adverse Event|2|||
27821803|NCT00215553|54283983|FG005|Overall Study|Adverse Event|6|||
27821804|NCT00215553|54283984|FG006|Overall Study|Adverse Event|0|||
27821805|NCT00214461|54284004|FG000|Overall Study|Adverse Event|0|||
27821806|NCT00214461|54284005|FG001|Overall Study|Adverse Event|0|||
27821807|NCT00214461|54284006|FG002|Overall Study|Adverse Event|1|||
27821808|NCT00214461|54284007|FG003|Overall Study|Adverse Event|1|||
27821809|NCT00214461|54284004|FG000|Overall Study|Withdrawal by Subject|0|||
27821810|NCT00214461|54284005|FG001|Overall Study|Withdrawal by Subject|0|||
27821811|NCT00214461|54284006|FG002|Overall Study|Withdrawal by Subject|1|||
27821812|NCT00214461|54284007|FG003|Overall Study|Withdrawal by Subject|0|||
27821813|NCT00214383|54284019|FG000|Overall Study|Lost to Follow-up|16|||
27821814|NCT00214383|54284020|FG001|Overall Study|Lost to Follow-up|26|||
27821815|NCT00212355|54284026|FG000|Overall Study|Adverse Event|1|||
27821816|NCT00212355|54284026|FG000|Overall Study|Withdrawal by Subject|1|||
27821817|NCT00212355|54284026|FG000|Overall Study|A change of address|1|||
27821818|NCT00211887|54284033|FG000|Overall Study|Adverse Event|8|||
27821819|NCT00211887|54284034|FG001|Overall Study|Adverse Event|4|||
27821820|NCT00211887|54284035|FG002|Overall Study|Adverse Event|6|||
27821821|NCT00211887|54284033|FG000|Overall Study|Death|1|||
27821822|NCT00211887|54284034|FG001|Overall Study|Death|1|||
27821823|NCT00211887|54284035|FG002|Overall Study|Death|1|||
27821824|NCT00211887|54284033|FG000|Overall Study|Lost to Follow-up|28|||
27821825|NCT00211887|54284034|FG001|Overall Study|Lost to Follow-up|13|||
27821826|NCT00211887|54284035|FG002|Overall Study|Lost to Follow-up|9|||
27821827|NCT00211887|54284033|FG000|Overall Study|Non-medical reason|31|||
27821828|NCT00211887|54284034|FG001|Overall Study|Non-medical reason|14|||
27821829|NCT00211887|54284035|FG002|Overall Study|Non-medical reason|8|||
27821830|NCT00211887|54284033|FG000|Overall Study|Other medical reason|15|||
27821831|NCT00211887|54284034|FG001|Overall Study|Other medical reason|11|||
27821832|NCT00211887|54284035|FG002|Overall Study|Other medical reason|7|||
27821833|NCT00211887|54284033|FG000|Overall Study|Side effects|19|||
27821834|NCT00211887|54284034|FG001|Overall Study|Side effects|13|||
27821835|NCT00211887|54284035|FG002|Overall Study|Side effects|5|||
27821836|NCT01855945|54284055|FG000|Overall Study|Adverse Event|0|||
28140327|NCT02906670|54805736|FG007|Cohort 4, Q2W|Clinical Progression|0|||
28140328|NCT02906670|54805737|FG008|Cohort 4, Q2W|Clinical Progression|0|||
27821837|NCT01855945|54284056|FG001|Overall Study|Adverse Event|0|||
27821838|NCT01855945|54284057|FG002|Overall Study|Adverse Event|0|||
27821839|NCT01855945|54284058|FG003|Overall Study|Adverse Event|0|||
27821840|NCT01855945|54284059|FG004|Overall Study|Adverse Event|0|||
27821841|NCT01855945|54284060|FG005|Overall Study|Adverse Event|0|||
27821842|NCT01855945|54284061|FG006|Overall Study|Adverse Event|1|||
27821843|NCT01855945|54284062|FG007|Overall Study|Adverse Event|0|||
28140329|NCT02906670|54805738|FG009|Cohort 4, Q2W|Clinical Progression|0|||
28140330|NCT02906670|54805729|FG000|Cohort 5, Q2W|Radiological Progression|0|||
27941110|NCT01030965|54597424|FG003|Overall Study|Withdrawal by Subject|2|||
27941111|NCT01179516|54597437|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
27941112|NCT01179516|54597438|FG001|Overall Study|Pretreatment Event or Adverse Event|8|||
27941113|NCT01179516|54597439|FG002|Overall Study|Pretreatment Event or Adverse Event|12|||
27941114|NCT01179516|54597437|FG000|Overall Study|Lack of Efficacy|4|||
27941115|NCT01179516|54597438|FG001|Overall Study|Lack of Efficacy|2|||
27941116|NCT01179516|54597439|FG002|Overall Study|Lack of Efficacy|0|||
27941117|NCT01179516|54597437|FG000|Overall Study|Noncompliance with Study Drug|2|||
27941118|NCT01179516|54597438|FG001|Overall Study|Noncompliance with Study Drug|0|||
27941119|NCT01179516|54597439|FG002|Overall Study|Noncompliance with Study Drug|1|||
27941120|NCT01179516|54597437|FG000|Overall Study|Protocol Deviations|4|||
27941121|NCT01179516|54597438|FG001|Overall Study|Protocol Deviations|3|||
27941122|NCT01179516|54597439|FG002|Overall Study|Protocol Deviations|3|||
28070585|NCT00195260|54725388|FG002|Part 1: Dose Escalation|Death|0|||
28140331|NCT02906670|54805730|FG001|Cohort 5, Q2W|Radiological Progression|0|||
28140332|NCT02906670|54805731|FG002|Cohort 5, Q2W|Radiological Progression|0|||
28140333|NCT02906670|54805732|FG003|Cohort 5, Q2W|Radiological Progression|0|||
28140334|NCT02906670|54805733|FG004|Cohort 5, Q2W|Radiological Progression|0|||
28140335|NCT02906670|54805734|FG005|Cohort 5, Q2W|Radiological Progression|0|||
28140336|NCT02906670|54805735|FG006|Cohort 5, Q2W|Radiological Progression|4|||
28140337|NCT02906670|54805736|FG007|Cohort 5, Q2W|Radiological Progression|0|||
28140338|NCT02906670|54805737|FG008|Cohort 5, Q2W|Radiological Progression|0|||
28140339|NCT02906670|54805738|FG009|Cohort 5, Q2W|Radiological Progression|0|||
28140340|NCT02906670|54805729|FG000|Cohort 5, Q2W|Clinical Progression|0|||
27821844|NCT01855945|54284063|FG008|Overall Study|Adverse Event|0|||
28140341|NCT02906670|54805730|FG001|Cohort 5, Q2W|Clinical Progression|0|||
28140342|NCT02906670|54805731|FG002|Cohort 5, Q2W|Clinical Progression|0|||
28140343|NCT02906670|54805732|FG003|Cohort 5, Q2W|Clinical Progression|0|||
28140344|NCT02906670|54805733|FG004|Cohort 5, Q2W|Clinical Progression|0|||
28140345|NCT02906670|54805734|FG005|Cohort 5, Q2W|Clinical Progression|0|||
28140346|NCT02906670|54805735|FG006|Cohort 5, Q2W|Clinical Progression|1|||
28140347|NCT02906670|54805736|FG007|Cohort 5, Q2W|Clinical Progression|0|||
28140348|NCT02906670|54805737|FG008|Cohort 5, Q2W|Clinical Progression|0|||
28140349|NCT02906670|54805738|FG009|Cohort 5, Q2W|Clinical Progression|0|||
28140350|NCT02906670|54805729|FG000|Cohort 5, Q2W|Adverse Event|0|||
28140351|NCT02906670|54805730|FG001|Cohort 5, Q2W|Adverse Event|0|||
28140352|NCT02906670|54805731|FG002|Cohort 5, Q2W|Adverse Event|0|||
28140353|NCT02906670|54805732|FG003|Cohort 5, Q2W|Adverse Event|0|||
27941123|NCT01179516|54597437|FG000|Overall Study|Withdrawal of Consent|2|||
27941124|NCT01179516|54597438|FG001|Overall Study|Withdrawal of Consent|6|||
28070586|NCT00195260|54725389|FG003|Part 1: Dose Escalation|Death|0|||
28070587|NCT00195260|54725390|FG004|Part 1: Dose Escalation|Death|0|||
28140354|NCT02906670|54805733|FG004|Cohort 5, Q2W|Adverse Event|0|||
28070588|NCT00195260|54725391|FG005|Part 1: Dose Escalation|Death|0|||
28070589|NCT00195260|54725392|FG006|Part 1: Dose Escalation|Death|0|||
28070590|NCT00195260|54725393|FG007|Part 1: Dose Escalation|Death|1|||
28070591|NCT00195260|54725394|FG008|Part 1: Dose Escalation|Death|0|||
28070592|NCT00195260|54725395|FG009|Part 1: Dose Escalation|Death|0|||
28070593|NCT00195260|54725396|FG010|Part 1: Dose Escalation|Death|0|||
28070594|NCT00195260|54725386|FG000|Part 1: Dose Escalation|Disease Progression|3|||
28070595|NCT00195260|54725387|FG001|Part 1: Dose Escalation|Disease Progression|2|||
28070596|NCT00195260|54725388|FG002|Part 1: Dose Escalation|Disease Progression|5|||
28070597|NCT00195260|54725389|FG003|Part 1: Dose Escalation|Disease Progression|6|||
28070598|NCT00195260|54725390|FG004|Part 1: Dose Escalation|Disease Progression|4|||
28070599|NCT00195260|54725391|FG005|Part 1: Dose Escalation|Disease Progression|6|||
28070600|NCT00195260|54725392|FG006|Part 1: Dose Escalation|Disease Progression|7|||
28070601|NCT00195260|54725393|FG007|Part 1: Dose Escalation|Disease Progression|4|||
28070602|NCT00195260|54725394|FG008|Part 1: Dose Escalation|Disease Progression|0|||
28140355|NCT02906670|54805734|FG005|Cohort 5, Q2W|Adverse Event|0|||
28140356|NCT02906670|54805735|FG006|Cohort 5, Q2W|Adverse Event|1|||
28140357|NCT02906670|54805736|FG007|Cohort 5, Q2W|Adverse Event|0|||
28140358|NCT02906670|54805737|FG008|Cohort 5, Q2W|Adverse Event|0|||
28140359|NCT02906670|54805738|FG009|Cohort 5, Q2W|Adverse Event|0|||
28140360|NCT02906670|54805729|FG000|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
28140361|NCT02906670|54805730|FG001|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
28140362|NCT02906670|54805731|FG002|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
28140363|NCT02906670|54805732|FG003|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
28140364|NCT02906670|54805733|FG004|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
28140365|NCT02906670|54805734|FG005|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
28140366|NCT02906670|54805735|FG006|Cohort 5, Q2W|Lack of Clinical Benefit|1|||
28140367|NCT02906670|54805736|FG007|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
28140368|NCT02906670|54805737|FG008|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
28140369|NCT02906670|54805738|FG009|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
28140370|NCT02906670|54805729|FG000|Cohort 5P, Q2W|Radiological Progression|0|||
28140371|NCT02906670|54805730|FG001|Cohort 5P, Q2W|Radiological Progression|0|||
28140372|NCT02906670|54805731|FG002|Cohort 5P, Q2W|Radiological Progression|0|||
28140373|NCT02906670|54805732|FG003|Cohort 5P, Q2W|Radiological Progression|0|||
28140374|NCT02906670|54805733|FG004|Cohort 5P, Q2W|Radiological Progression|0|||
28140375|NCT02906670|54805734|FG005|Cohort 5P, Q2W|Radiological Progression|0|||
28140376|NCT02906670|54805735|FG006|Cohort 5P, Q2W|Radiological Progression|0|||
28140377|NCT02906670|54805736|FG007|Cohort 5P, Q2W|Radiological Progression|2|||
28140378|NCT02906670|54805737|FG008|Cohort 5P, Q2W|Radiological Progression|0|||
28140379|NCT02906670|54805738|FG009|Cohort 5P, Q2W|Radiological Progression|0|||
28140380|NCT02906670|54805729|FG000|Cohort 5P, Q2W|Adverse Event|0|||
28140381|NCT02906670|54805730|FG001|Cohort 5P, Q2W|Adverse Event|0|||
28140382|NCT02906670|54805731|FG002|Cohort 5P, Q2W|Adverse Event|0|||
28140383|NCT02906670|54805732|FG003|Cohort 5P, Q2W|Adverse Event|0|||
28140384|NCT02906670|54805733|FG004|Cohort 5P, Q2W|Adverse Event|0|||
28140385|NCT02906670|54805734|FG005|Cohort 5P, Q2W|Adverse Event|0|||
28140386|NCT02906670|54805735|FG006|Cohort 5P, Q2W|Adverse Event|0|||
28140387|NCT02906670|54805736|FG007|Cohort 5P, Q2W|Adverse Event|1|||
28140388|NCT02906670|54805737|FG008|Cohort 5P, Q2W|Adverse Event|0|||
27821845|NCT01855945|54284064|FG009|Overall Study|Adverse Event|0|||
28140389|NCT02906670|54805738|FG009|Cohort 5P, Q2W|Adverse Event|0|||
28140390|NCT02906670|54805729|FG000|Cohort 6P, Q2W|Radiological Progression|0|||
28140391|NCT02906670|54805730|FG001|Cohort 6P, Q2W|Radiological Progression|0|||
28140392|NCT02906670|54805731|FG002|Cohort 6P, Q2W|Radiological Progression|0|||
28140393|NCT02906670|54805732|FG003|Cohort 6P, Q2W|Radiological Progression|0|||
28140394|NCT02906670|54805733|FG004|Cohort 6P, Q2W|Radiological Progression|0|||
28140395|NCT02906670|54805734|FG005|Cohort 6P, Q2W|Radiological Progression|0|||
28140396|NCT02906670|54805735|FG006|Cohort 6P, Q2W|Radiological Progression|0|||
28140397|NCT02906670|54805736|FG007|Cohort 6P, Q2W|Radiological Progression|0|||
28140398|NCT02906670|54805737|FG008|Cohort 6P, Q2W|Radiological Progression|1|||
28140399|NCT02906670|54805738|FG009|Cohort 6P, Q2W|Radiological Progression|0|||
28140400|NCT02906670|54805729|FG000|Cohort 6P, Q2W|Clinical Progression|0|||
28140401|NCT02906670|54805730|FG001|Cohort 6P, Q2W|Clinical Progression|0|||
28140402|NCT02906670|54805731|FG002|Cohort 6P, Q2W|Clinical Progression|0|||
28140403|NCT02906670|54805732|FG003|Cohort 6P, Q2W|Clinical Progression|0|||
28140404|NCT02906670|54805733|FG004|Cohort 6P, Q2W|Clinical Progression|0|||
28140405|NCT02906670|54805734|FG005|Cohort 6P, Q2W|Clinical Progression|0|||
28140406|NCT02906670|54805735|FG006|Cohort 6P, Q2W|Clinical Progression|0|||
28140407|NCT02906670|54805736|FG007|Cohort 6P, Q2W|Clinical Progression|0|||
28140408|NCT02906670|54805737|FG008|Cohort 6P, Q2W|Clinical Progression|3|||
28140409|NCT02906670|54805738|FG009|Cohort 6P, Q2W|Clinical Progression|0|||
28140410|NCT02906670|54805729|FG000|Cohort 4P, QW|Radiological Progression|0|||
28140411|NCT02906670|54805730|FG001|Cohort 4P, QW|Radiological Progression|0|||
28140412|NCT02906670|54805731|FG002|Cohort 4P, QW|Radiological Progression|0|||
28140413|NCT02906670|54805732|FG003|Cohort 4P, QW|Radiological Progression|3|||
28140414|NCT02906670|54805733|FG004|Cohort 4P, QW|Radiological Progression|0|||
28140415|NCT02906670|54805734|FG005|Cohort 4P, QW|Radiological Progression|0|||
28070603|NCT00195260|54725395|FG009|Part 1: Dose Escalation|Disease Progression|0|||
28070604|NCT00195260|54725396|FG010|Part 1: Dose Escalation|Disease Progression|0|||
28070605|NCT00195260|54725386|FG000|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
28070606|NCT00195260|54725387|FG001|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
28070607|NCT00195260|54725388|FG002|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
28070608|NCT00195260|54725389|FG003|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
28070609|NCT00195260|54725390|FG004|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
28070610|NCT00195260|54725391|FG005|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
28070611|NCT00195260|54725392|FG006|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
28070612|NCT00195260|54725393|FG007|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
28070613|NCT00195260|54725394|FG008|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
28070614|NCT00195260|54725395|FG009|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
28070615|NCT00195260|54725396|FG010|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
28070616|NCT00195260|54725386|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
28070617|NCT00195260|54725387|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
28140416|NCT02906670|54805735|FG006|Cohort 4P, QW|Radiological Progression|0|||
28140417|NCT02906670|54805736|FG007|Cohort 4P, QW|Radiological Progression|0|||
28140418|NCT02906670|54805737|FG008|Cohort 4P, QW|Radiological Progression|0|||
28070618|NCT00195260|54725388|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
28070619|NCT00195260|54725389|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
28140419|NCT02906670|54805738|FG009|Cohort 4P, QW|Radiological Progression|0|||
28140420|NCT02906670|54805729|FG000|Cohort 7P, Q2W|Adverse Event|0|||
28140421|NCT02906670|54805730|FG001|Cohort 7P, Q2W|Adverse Event|0|||
28140422|NCT02906670|54805731|FG002|Cohort 7P, Q2W|Adverse Event|0|||
28140423|NCT02906670|54805732|FG003|Cohort 7P, Q2W|Adverse Event|0|||
28070620|NCT00195260|54725390|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
28070621|NCT00195260|54725391|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
28070622|NCT00195260|54725392|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
28070623|NCT00195260|54725393|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
28070624|NCT00195260|54725394|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21|||
28070625|NCT00195260|54725395|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29|||
28070626|NCT00195260|54725396|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15|||
28140424|NCT02906670|54805733|FG004|Cohort 7P, Q2W|Adverse Event|0|||
28140425|NCT02906670|54805734|FG005|Cohort 7P, Q2W|Adverse Event|0|||
28140426|NCT02906670|54805735|FG006|Cohort 7P, Q2W|Adverse Event|0|||
28140427|NCT02906670|54805736|FG007|Cohort 7P, Q2W|Adverse Event|0|||
28140428|NCT02906670|54805737|FG008|Cohort 7P, Q2W|Adverse Event|0|||
28140429|NCT02906670|54805738|FG009|Cohort 7P, Q2W|Adverse Event|1|||
28140430|NCT02906670|54805729|FG000|Cohort 7P, Q2W|Physician Decision|0|||
28140431|NCT02906670|54805730|FG001|Cohort 7P, Q2W|Physician Decision|0|||
28140432|NCT02906670|54805731|FG002|Cohort 7P, Q2W|Physician Decision|0|||
28140433|NCT02906670|54805732|FG003|Cohort 7P, Q2W|Physician Decision|0|||
28140434|NCT02906670|54805733|FG004|Cohort 7P, Q2W|Physician Decision|0|||
28140435|NCT02906670|54805734|FG005|Cohort 7P, Q2W|Physician Decision|0|||
28140436|NCT02906670|54805735|FG006|Cohort 7P, Q2W|Physician Decision|0|||
28140437|NCT02906670|54805736|FG007|Cohort 7P, Q2W|Physician Decision|0|||
28140438|NCT02906670|54805737|FG008|Cohort 7P, Q2W|Physician Decision|0|||
28140439|NCT02906670|54805738|FG009|Cohort 7P, Q2W|Physician Decision|1|||
28140440|NCT02906670|54805729|FG000|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
28140441|NCT02906670|54805730|FG001|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
28140442|NCT02906670|54805731|FG002|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
28140443|NCT02906670|54805732|FG003|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
28140444|NCT02906670|54805733|FG004|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
28140445|NCT02906670|54805734|FG005|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
28140446|NCT02906670|54805735|FG006|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
28140447|NCT02906670|54805736|FG007|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
28140448|NCT02906670|54805737|FG008|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
28140449|NCT02906670|54805738|FG009|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1|||
28140450|NCT02906670|54805729|FG000|Cohort 5P, QW|Radiological Progression|0|||
28140451|NCT02906670|54805730|FG001|Cohort 5P, QW|Radiological Progression|0|||
28140452|NCT02906670|54805731|FG002|Cohort 5P, QW|Radiological Progression|0|||
28140453|NCT02906670|54805732|FG003|Cohort 5P, QW|Radiological Progression|0|||
28140454|NCT02906670|54805733|FG004|Cohort 5P, QW|Radiological Progression|3|||
28140455|NCT02906670|54805734|FG005|Cohort 5P, QW|Radiological Progression|0|||
28140456|NCT02906670|54805735|FG006|Cohort 5P, QW|Radiological Progression|0|||
28140457|NCT02906670|54805736|FG007|Cohort 5P, QW|Radiological Progression|0|||
28140458|NCT02906670|54805737|FG008|Cohort 5P, QW|Radiological Progression|0|||
28140459|NCT02906670|54805738|FG009|Cohort 5P, QW|Radiological Progression|0|||
28140460|NCT02906358|54805790|FG000|Overall Study|Withdrawal by Subject|10|||
28140461|NCT02906358|54805791|FG001|Overall Study|Withdrawal by Subject|7|||
28140462|NCT02906358|54805790|FG000|Overall Study|Lost to Follow-up|12|||
28140463|NCT02906358|54805791|FG001|Overall Study|Lost to Follow-up|15|||
28140464|NCT02186834|54805797|FG000|Dose Escalation|Death|0|||
28140465|NCT02186834|54805798|FG001|Dose Escalation|Death|0|||
28140466|NCT02186834|54805799|FG002|Dose Escalation|Death|0|||
27849917|NCT04569968|54348243|FG001|Overall Study|Previous recruitment to the expiratory muscle training|0|||
28140467|NCT02186834|54805800|FG003|Dose Escalation|Death|1|||
28140468|NCT02186834|54805801|FG004|Dose Escalation|Death|0|||
28140469|NCT02186834|54805802|FG005|Dose Escalation|Death|0|||
28140470|NCT02186834|54805797|FG000|Treatment at RP2D|Died prior to treatment|0|||
28140471|NCT02186834|54805798|FG001|Treatment at RP2D|Died prior to treatment|0|||
28140472|NCT02186834|54805799|FG002|Treatment at RP2D|Died prior to treatment|0|||
28140473|NCT02186834|54805800|FG003|Treatment at RP2D|Died prior to treatment|0|||
27849918|NCT04569968|54348242|FG000|Overall Study|Repetitive stroke|8|||
27849919|NCT04569968|54348243|FG001|Overall Study|Repetitive stroke|0|||
27849920|NCT04569968|54348242|FG000|Overall Study|Insufficient mastication|1|||
27849921|NCT04569968|54348243|FG001|Overall Study|Insufficient mastication|0|||
27849922|NCT04569968|54348242|FG000|Overall Study|Infection|1|||
27849923|NCT04569968|54348243|FG001|Overall Study|Infection|0|||
27849924|NCT03385304|54348251|FG000|Overall Study|Death|19|||
27849925|NCT03385304|54348252|FG001|Overall Study|Death|7|||
28140474|NCT02186834|54805801|FG004|Treatment at RP2D|Died prior to treatment|0|||
28140475|NCT02186834|54805802|FG005|Treatment at RP2D|Died prior to treatment|1|||
28140476|NCT03144687|54805813|FG000|Overall Study|Death|0|||
28140477|NCT03144687|54805814|FG001|Overall Study|Death|2|||
28140478|NCT03144687|54805813|FG000|Overall Study|Lost to Follow-up|0|||
28140479|NCT03144687|54805814|FG001|Overall Study|Lost to Follow-up|1|||
28140480|NCT03144687|54805813|FG000|Overall Study|Physician Decision|0|||
28140481|NCT03144687|54805814|FG001|Overall Study|Physician Decision|1|||
28140482|NCT03144687|54805813|FG000|Overall Study|Withdrawal by Subject|1|||
27821846|NCT01855945|54284065|FG010|Overall Study|Adverse Event|0|||
27821847|NCT01855945|54284066|FG011|Overall Study|Adverse Event|0|||
27821848|NCT01855945|54284055|FG000|Overall Study|Death|0|||
27821849|NCT01855945|54284056|FG001|Overall Study|Death|0|||
27821850|NCT01855945|54284057|FG002|Overall Study|Death|0|||
27821851|NCT01855945|54284058|FG003|Overall Study|Death|0|||
27821852|NCT01855945|54284059|FG004|Overall Study|Death|0|||
27821853|NCT01855945|54284060|FG005|Overall Study|Death|0|||
27821854|NCT01855945|54284061|FG006|Overall Study|Death|2|||
27821855|NCT01855945|54284062|FG007|Overall Study|Death|0|||
27821856|NCT01855945|54284063|FG008|Overall Study|Death|0|||
27821857|NCT01855945|54284064|FG009|Overall Study|Death|0|||
27821858|NCT01855945|54284065|FG010|Overall Study|Death|0|||
27821859|NCT01855945|54284066|FG011|Overall Study|Death|0|||
27821860|NCT01855945|54284055|FG000|Overall Study|Lost to Follow-up|11|||
27821861|NCT01855945|54284056|FG001|Overall Study|Lost to Follow-up|10|||
27821862|NCT01855945|54284057|FG002|Overall Study|Lost to Follow-up|7|||
27821863|NCT01855945|54284058|FG003|Overall Study|Lost to Follow-up|3|||
27821864|NCT01855945|54284059|FG004|Overall Study|Lost to Follow-up|0|||
27821865|NCT01855945|54284060|FG005|Overall Study|Lost to Follow-up|3|||
27821866|NCT01855945|54284061|FG006|Overall Study|Lost to Follow-up|4|||
27821867|NCT01855945|54284062|FG007|Overall Study|Lost to Follow-up|7|||
27821868|NCT01855945|54284063|FG008|Overall Study|Lost to Follow-up|2|||
27821869|NCT01855945|54284064|FG009|Overall Study|Lost to Follow-up|0|||
27821870|NCT01855945|54284065|FG010|Overall Study|Lost to Follow-up|0|||
27821871|NCT01855945|54284066|FG011|Overall Study|Lost to Follow-up|2|||
27821872|NCT01855945|54284055|FG000|Overall Study|Other - Unclassified|1|||
27821873|NCT01855945|54284056|FG001|Overall Study|Other - Unclassified|1|||
28140483|NCT03144687|54805814|FG001|Overall Study|Withdrawal by Subject|3|||
28140484|NCT03144687|54805813|FG000|Overall Study|Not Reported|2|||
28140485|NCT03144687|54805814|FG001|Overall Study|Not Reported|0|||
28140486|NCT03080961|54805824|FG000|Overall Study|Withdrawal by Subject|3|||
28140487|NCT02905266|54805848|FG000|Treatment Phase Part 1|Participant Withdrew Consent|1|||
28140488|NCT02905266|54805849|FG001|Treatment Phase Part 1|Participant Withdrew Consent|0|||
28140489|NCT02905266|54805848|FG000|Treatment Phase Part 1|Disease Progression|6|||
28140490|NCT02905266|54805849|FG001|Treatment Phase Part 1|Disease Progression|7|||
28140491|NCT02905266|54805848|FG000|Treatment Phase Part 1|Study Drug Toxicity|22|||
28140492|NCT02905266|54805849|FG001|Treatment Phase Part 1|Study Drug Toxicity|16|||
28140493|NCT02905266|54805848|FG000|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1|||
28140494|NCT02905266|54805849|FG001|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0|||
28140495|NCT02905266|54805848|FG000|Transition From Part 1 to Part 2|Disease progression|2|||
28140496|NCT02905266|54805849|FG001|Transition From Part 1 to Part 2|Disease progression|1|||
28140497|NCT02905266|54805848|FG000|Transition From Part 1 to Part 2|Study drug toxicity|0|||
28140498|NCT02905266|54805849|FG001|Transition From Part 1 to Part 2|Study drug toxicity|4|||
28140499|NCT02905266|54805848|FG000|Transition From Part 1 to Part 2|Death|0|||
28140500|NCT02905266|54805849|FG001|Transition From Part 1 to Part 2|Death|1|||
27821874|NCT01855945|54284057|FG002|Overall Study|Other - Unclassified|1|||
27849926|NCT03385304|54348251|FG000|Overall Study|Lost to Follow-up|17|||
27849927|NCT03385304|54348252|FG001|Overall Study|Lost to Follow-up|14|||
28140501|NCT02905266|54805848|FG000|Transition From Part 1 to Part 2|Participant withdrew consent|0|||
28140502|NCT02905266|54805849|FG001|Transition From Part 1 to Part 2|Participant withdrew consent|1|||
27821875|NCT01855945|54284058|FG003|Overall Study|Other - Unclassified|0|||
27821876|NCT01855945|54284059|FG004|Overall Study|Other - Unclassified|0|||
27821877|NCT01855945|54284060|FG005|Overall Study|Other - Unclassified|0|||
27849928|NCT03385304|54348251|FG000|Overall Study|Withdrawal by Subject|3|||
27849929|NCT03385304|54348252|FG001|Overall Study|Withdrawal by Subject|2|||
28140503|NCT02905266|54805848|FG000|Transition From Part 1 to Part 2|Adverse Event|1|||
28140504|NCT02905266|54805849|FG001|Transition From Part 1 to Part 2|Adverse Event|1|||
28140505|NCT02905266|54805848|FG000|Maintenance Phase Part 2|Disease Progression|9|||
28140506|NCT02905266|54805849|FG001|Maintenance Phase Part 2|Disease Progression|2|||
28140507|NCT02905266|54805848|FG000|Maintenance Phase Part 2|Study Drug Toxicity|3|||
28140508|NCT02905266|54805849|FG001|Maintenance Phase Part 2|Study Drug Toxicity|4|||
28140509|NCT02905266|54805848|FG000|Maintenance Phase Part 2|Maximum Clinical Benefit|0|||
28140510|NCT02905266|54805849|FG001|Maintenance Phase Part 2|Maximum Clinical Benefit|2|||
28140511|NCT02982018|54805857|FG000|Overall Study|Incorrect Lens Dispensed|1|||
28140512|NCT02982018|54805858|FG001|Overall Study|Incorrect Lens Dispensed|0|||
28140513|NCT02982018|54805857|FG000|Overall Study|Protocol Violation|1|||
28140514|NCT02982018|54805858|FG001|Overall Study|Protocol Violation|1|||
28140515|NCT02982018|54805857|FG000|Overall Study|Adverse Event|1|||
28140516|NCT02982018|54805858|FG001|Overall Study|Adverse Event|1|||
28140517|NCT02982018|54805857|FG000|Overall Study|Lens Discomfort|2|||
28140518|NCT02982018|54805858|FG001|Overall Study|Lens Discomfort|0|||
28140519|NCT02982018|54805857|FG000|Overall Study|Withdrawal by Subject|0|||
28140520|NCT02982018|54805858|FG001|Overall Study|Withdrawal by Subject|1|||
28140521|NCT03080493|54805866|FG000|Overall Study|Did not provide NRS pain results|1|||
28140522|NCT03080493|54805867|FG001|Overall Study|Did not provide NRS pain results|0|||
28140523|NCT03080493|54805866|FG000|Overall Study|Adverse Event|0|||
28140524|NCT03080493|54805867|FG001|Overall Study|Adverse Event|1|||
28140525|NCT03080493|54805866|FG000|Overall Study|Randomization error (parity group)|0|||
28140526|NCT03080493|54805867|FG001|Overall Study|Randomization error (parity group)|1|||
28140527|NCT01339910|54805875|FG000|Overall Study|Withdrawal by Subject|1|||
28140528|NCT01339910|54805876|FG001|Overall Study|Withdrawal by Subject|0|||
28140529|NCT01339910|54805875|FG000|Overall Study|Physician Decision|1|||
28140530|NCT01339910|54805876|FG001|Overall Study|Physician Decision|0|||
28140531|NCT01339910|54805875|FG000|Overall Study|Disease relapse|1|||
28140532|NCT01339910|54805876|FG001|Overall Study|Disease relapse|4|||
28140533|NCT02981082|54805884|FG000|Overall Study|Withdrawal by Subject|2|||
28140534|NCT02981082|54805885|FG001|Overall Study|Withdrawal by Subject|0|||
28140535|NCT02981082|54805884|FG000|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|1|||
28140536|NCT02981082|54805885|FG001|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|0|||
28140537|NCT02981082|54805884|FG000|Overall Study|Adverse Event|0|||
28140538|NCT02981082|54805885|FG001|Overall Study|Adverse Event|1|||
28140539|NCT01066104|54805893|FG000|Overall Study|Adverse Event|1|||
28140540|NCT01066104|54805894|FG001|Overall Study|Adverse Event|1|||
28140541|NCT01066104|54805893|FG000|Overall Study|Protocol Violation|1|||
28140542|NCT01066104|54805894|FG001|Overall Study|Protocol Violation|0|||
28140543|NCT02736968|54805905|FG000|Overall Study|Lost to Follow-up|0|||
28140544|NCT02736968|54805906|FG001|Overall Study|Lost to Follow-up|0|||
28140545|NCT02736968|54805907|FG002|Overall Study|Lost to Follow-up|0|||
28140546|NCT02736968|54805908|FG003|Overall Study|Lost to Follow-up|0|||
28140547|NCT02736968|54805909|FG004|Overall Study|Lost to Follow-up|0|||
28140548|NCT02736968|54805910|FG005|Overall Study|Lost to Follow-up|0|||
28140549|NCT02736968|54805911|FG006|Overall Study|Lost to Follow-up|5|||
28140550|NCT02736968|54805912|FG007|Overall Study|Lost to Follow-up|2|||
28140551|NCT02736968|54805905|FG000|Overall Study|COVID-19 Pandemic|0|||
28140552|NCT02736968|54805906|FG001|Overall Study|COVID-19 Pandemic|0|||
28140553|NCT02736968|54805907|FG002|Overall Study|COVID-19 Pandemic|0|||
28140554|NCT02736968|54805908|FG003|Overall Study|COVID-19 Pandemic|0|||
28140555|NCT02736968|54805909|FG004|Overall Study|COVID-19 Pandemic|0|||
28140556|NCT02736968|54805910|FG005|Overall Study|COVID-19 Pandemic|0|||
28140557|NCT02736968|54805911|FG006|Overall Study|COVID-19 Pandemic|2|||
28140558|NCT02736968|54805912|FG007|Overall Study|COVID-19 Pandemic|0|||
28140559|NCT02736968|54805905|FG000|Overall Study|Withdrawal by Subject|0|||
27821878|NCT01855945|54284061|FG006|Overall Study|Other - Unclassified|2|||
27941125|NCT01179516|54597439|FG002|Overall Study|Withdrawal of Consent|10|||
27941126|NCT01179516|54597437|FG000|Overall Study|Lost to Follow-up|7|||
27941127|NCT01179516|54597438|FG001|Overall Study|Lost to Follow-up|7|||
28140560|NCT02736968|54805906|FG001|Overall Study|Withdrawal by Subject|0|||
28140561|NCT02736968|54805907|FG002|Overall Study|Withdrawal by Subject|0|||
28140562|NCT02736968|54805908|FG003|Overall Study|Withdrawal by Subject|0|||
28140563|NCT02736968|54805909|FG004|Overall Study|Withdrawal by Subject|0|||
28140564|NCT02736968|54805910|FG005|Overall Study|Withdrawal by Subject|0|||
28140565|NCT02736968|54805911|FG006|Overall Study|Withdrawal by Subject|1|||
28140566|NCT02736968|54805912|FG007|Overall Study|Withdrawal by Subject|0|||
28140567|NCT02980224|54805925|FG000|Overall Study|Adverse Event|4|||
28140568|NCT02980224|54805926|FG001|Overall Study|Adverse Event|1|||
28140569|NCT02980224|54805925|FG000|Overall Study|Withdrawal by Subject|0|||
28140570|NCT02980224|54805926|FG001|Overall Study|Withdrawal by Subject|2|||
28140571|NCT02591615|54805936|FG000|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
28140572|NCT02591615|54805937|FG001|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
28140573|NCT02591615|54805938|FG002|Arm B Pembro Lead in Phase|Withdrawal by Subject|1|||
28140574|NCT02591615|54805939|FG003|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
28140575|NCT02591615|54805936|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
28140576|NCT02591615|54805937|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|1|||
28140577|NCT02591615|54805938|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
28140578|NCT02591615|54805939|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
28140579|NCT02591615|54805936|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|1|||
28140580|NCT02591615|54805937|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
28140581|NCT02591615|54805938|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|0|||
28140582|NCT02591615|54805939|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
28140583|NCT02591615|54805936|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|1|||
28140584|NCT02591615|54805937|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|3|||
28140585|NCT02591615|54805938|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|4|||
28140586|NCT02591615|54805939|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|12|||
28140587|NCT02591615|54805936|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Death|1|||
28140588|NCT02591615|54805937|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
28140589|NCT02591615|54805938|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Death|0|||
28140590|NCT02591615|54805939|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
28140591|NCT02591615|54805936|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
28140592|NCT02591615|54805937|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|1|||
28140593|NCT02591615|54805938|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
28140594|NCT02591615|54805939|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
28140595|NCT02591615|54805936|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
27941128|NCT01179516|54597439|FG002|Overall Study|Lost to Follow-up|3|||
27941129|NCT01179516|54597437|FG000|Overall Study|Other|2|||
28140596|NCT02591615|54805937|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
28140597|NCT02591615|54805938|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
28140598|NCT02591615|54805939|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
28140599|NCT02591615|54805936|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|1|||
28140600|NCT02591615|54805937|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
28140601|NCT02591615|54805938|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
28140602|NCT02591615|54805939|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
28140603|NCT02591615|54805936|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
28140604|NCT02591615|54805937|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|2|||
28140605|NCT02591615|54805938|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
28140606|NCT02591615|54805939|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|1|||
28140607|NCT02591615|54805936|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|2|||
28140608|NCT02591615|54805937|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|6|||
28140609|NCT02591615|54805938|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
28140610|NCT02591615|54805939|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
28140611|NCT02591615|54805936|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
28140612|NCT02591615|54805937|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
28140613|NCT02591615|54805938|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
28140614|NCT02591615|54805939|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
28140615|NCT02591615|54805936|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
28140616|NCT02591615|54805937|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
28140617|NCT02591615|54805938|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|1|||
28140618|NCT02591615|54805939|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
27821879|NCT01855945|54284062|FG007|Overall Study|Other - Unclassified|1|||
27821880|NCT01855945|54284063|FG008|Overall Study|Other - Unclassified|0|||
28140619|NCT02591615|54805936|FG000|Maintenance MK-3475|Adverse Event|0|||
28140620|NCT02591615|54805937|FG001|Maintenance MK-3475|Adverse Event|3|||
28140621|NCT02591615|54805938|FG002|Maintenance MK-3475|Adverse Event|1|||
27821881|NCT01855945|54284064|FG009|Overall Study|Other - Unclassified|0|||
27821882|NCT01855945|54284065|FG010|Overall Study|Other - Unclassified|1|||
28140622|NCT02591615|54805939|FG003|Maintenance MK-3475|Adverse Event|2|||
28140623|NCT02591615|54805936|FG000|Maintenance MK-3475|Lack of Efficacy|0|||
28140624|NCT02591615|54805937|FG001|Maintenance MK-3475|Lack of Efficacy|9|||
28140625|NCT02591615|54805938|FG002|Maintenance MK-3475|Lack of Efficacy|0|||
28140626|NCT02591615|54805939|FG003|Maintenance MK-3475|Lack of Efficacy|8|||
28140627|NCT02591615|54805936|FG000|Maintenance MK-3475|Death|0|||
28140628|NCT02591615|54805937|FG001|Maintenance MK-3475|Death|1|||
28140629|NCT02591615|54805938|FG002|Maintenance MK-3475|Death|1|||
28140630|NCT02591615|54805939|FG003|Maintenance MK-3475|Death|0|||
28140631|NCT02591615|54805936|FG000|Maintenance MK-3475|Physician discretion|0|||
28140632|NCT02591615|54805937|FG001|Maintenance MK-3475|Physician discretion|0|||
28140633|NCT02591615|54805938|FG002|Maintenance MK-3475|Physician discretion|1|||
28140634|NCT02591615|54805939|FG003|Maintenance MK-3475|Physician discretion|0|||
28140635|NCT02591615|54805936|FG000|Maintenance MK-3475|Withdrew to hospice|0|||
28140636|NCT02591615|54805937|FG001|Maintenance MK-3475|Withdrew to hospice|1|||
28140637|NCT02591615|54805938|FG002|Maintenance MK-3475|Withdrew to hospice|0|||
28140638|NCT02591615|54805939|FG003|Maintenance MK-3475|Withdrew to hospice|0|||
28140639|NCT02591615|54805936|FG000|Maintenance MK-3475|In active treatment|2|||
28140640|NCT02591615|54805937|FG001|Maintenance MK-3475|In active treatment|0|||
28140641|NCT02591615|54805938|FG002|Maintenance MK-3475|In active treatment|0|||
28140642|NCT02591615|54805939|FG003|Maintenance MK-3475|In active treatment|1|||
28140643|NCT03077607|54805954|FG000|Period 1 (15 Days)|Adverse Event|1|||
28140644|NCT03077607|54805955|FG001|Period 1 (15 Days)|Adverse Event|0|||
28140645|NCT03077607|54805954|FG000|Period 1 (15 Days)|Death|1|||
28140646|NCT03077607|54805955|FG001|Period 1 (15 Days)|Death|0|||
28140647|NCT03077607|54805954|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1|||
28140648|NCT03077607|54805955|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0|||
28070627|NCT00195260|54725386|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
28070628|NCT00195260|54725387|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
28070629|NCT00195260|54725388|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
28070630|NCT00195260|54725389|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
28070631|NCT00195260|54725390|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
28070632|NCT00195260|54725391|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
28070633|NCT00195260|54725392|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
28070634|NCT00195260|54725393|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
28070635|NCT00195260|54725394|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5|||
28070636|NCT00195260|54725395|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3|||
28070637|NCT00195260|54725396|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2|||
28070638|NCT00195260|54725386|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
28070639|NCT00195260|54725387|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
28070640|NCT00195260|54725388|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
28070641|NCT00195260|54725389|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
28070642|NCT00195260|54725390|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
28070643|NCT00195260|54725391|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
28070644|NCT00195260|54725392|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
28070645|NCT00195260|54725393|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
28070646|NCT00195260|54725394|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1|||
28070647|NCT00195260|54725395|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2|||
28070648|NCT00195260|54725396|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3|||
28070649|NCT00195260|54725386|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
28070650|NCT00195260|54725387|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
28070651|NCT00195260|54725388|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
28070652|NCT00195260|54725389|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
28070653|NCT00195260|54725390|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
28070654|NCT00195260|54725391|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
28070655|NCT00195260|54725392|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
28070656|NCT00195260|54725393|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
28070657|NCT00195260|54725394|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6|||
28070658|NCT00195260|54725395|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4|||
28070659|NCT00195260|54725396|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3|||
28070660|NCT00031486|54725426|FG000|Overall Study|Adverse Event|1|||
28070661|NCT00031486|54725427|FG001|Overall Study|Adverse Event|0|||
28070662|NCT00031486|54725426|FG000|Overall Study|Lost to Follow-up|0|||
28070663|NCT00031486|54725427|FG001|Overall Study|Lost to Follow-up|1|||
28070664|NCT00031486|54725426|FG000|Overall Study|Withdrawal by Subject|3|||
28070665|NCT00031486|54725427|FG001|Overall Study|Withdrawal by Subject|2|||
28070666|NCT00031486|54725426|FG000|Overall Study|Death|0|||
28070667|NCT00031486|54725427|FG001|Overall Study|Death|3|||
28070668|NCT00031486|54725426|FG000|Overall Study|Non-compliant|0|||
28070669|NCT00031486|54725427|FG001|Overall Study|Non-compliant|4|||
28070670|NCT00031486|54725426|FG000|Overall Study|Did not meet eligibility requirement|2|||
28070671|NCT00031486|54725427|FG001|Overall Study|Did not meet eligibility requirement|1|||
28070672|NCT00031486|54725426|FG000|Overall Study|Other|1|||
28070673|NCT00031486|54725427|FG001|Overall Study|Other|1|||
28070674|NCT00003508|54725435|FG000|Overall Study|Not evaluable|5|||
28070675|NCT00003472|54725439|FG000|Overall Study|Not evaluable|3|||
28070676|NCT00003298|54725443|FG000|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1|||
28070677|NCT00003298|54725443|FG000|Step 1 (Neoadjuvant Therapy)|Adverse Event|3|||
28070678|NCT00003298|54725443|FG000|Surgery|Unresectable at surgery|3|||
28070679|NCT00003298|54725443|FG000|Surgery|Progression before surgery|2|||
28070680|NCT00003298|54725443|FG000|Surgery|Unevaluable and off study|2|||
28070681|NCT00003298|54725443|FG000|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7|||
28070682|NCT00003298|54725443|FG000|Re-register to Step 2 After Surgery|Positive margins|5|||
28070683|NCT00003298|54725443|FG000|Re-register to Step 2 After Surgery|Other complications|2|||
28070684|NCT00003298|54725443|FG000|Re-register to Step 2 After Surgery|Reason unknown|1|||
28070685|NCT00003298|54725443|FG000|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3|||
28070686|NCT00003298|54725443|FG000|Step 2 (Adjuvant Therapy)|Ineligible|1|||
28070687|NCT00003298|54725443|FG000|Step 2 (Adjuvant Therapy)|Death|1|||
28070688|NCT00003298|54725443|FG000|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1|||
28140649|NCT03077607|54805954|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
28140650|NCT03077607|54805955|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
28140651|NCT02977572|54805974|FG000|Overall Study|Exclusion criterion|2|||
28140652|NCT02977572|54805975|FG001|Overall Study|Exclusion criterion|2|||
28140653|NCT02746874|54805987|FG000|Overall Study|Withdrawal by Subject|0|||
28140654|NCT02746874|54805988|FG001|Overall Study|Withdrawal by Subject|1|||
28140655|NCT02746874|54805987|FG000|Overall Study|Surgery Date Changed|0|||
28140656|NCT02746874|54805988|FG001|Overall Study|Surgery Date Changed|2|||
28140657|NCT03217175|54805994|FG000|Overall Study|Physician Decision|4|||
28070689|NCT00003298|54725443|FG000|Step 2 (Adjuvant Therapy)|Excessive complication|1|||
28070690|NCT00003298|54725443|FG000|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2|||
28070691|NCT00002842|54725448|FG000|Overall Study|ineligible for surgical resection|27|||
28070692|NCT00143247|54725452|FG000|Overall Study|Death|8|||
28070693|NCT00143247|54725452|FG000|Overall Study|Adverse Event|19|||
28070694|NCT00143247|54725452|FG000|Overall Study|Lack of Efficacy|3|||
28070695|NCT00143247|54725452|FG000|Overall Study|Withdrawal by Subject|55|||
28070696|NCT00143247|54725452|FG000|Overall Study|Study terminated by sponsor|31|||
28070697|NCT00143247|54725452|FG000|Overall Study|Protocol Violation|15|||
28070698|NCT00143247|54725452|FG000|Overall Study|Lost to Follow-up|12|||
28070699|NCT00143247|54725452|FG000|Overall Study|following inaccurate lab adverse event|1|||
28140658|NCT03217175|54805995|FG001|Overall Study|Physician Decision|1|||
28140659|NCT01062126|54806001|FG000|Overall Study|Death|209|||
28140660|NCT01062126|54806001|FG000|Overall Study|All Withdrawals|324|||
28140661|NCT02522429|54806005|FG000|Overall Study|Lost to Follow-up|8|||
28140662|NCT02522429|54806005|FG000|Overall Study|Adverse Event|2|||
28140663|NCT02522429|54806005|FG000|Overall Study|Death|1|||
28140664|NCT02522429|54806005|FG000|Overall Study|Patient exceeded inclusion criteria after enrollment but prior to undergoing study procedures|1|||
28140665|NCT02974140|54806009|FG000|Overall Study|Adverse Event|2|||
28140666|NCT02974140|54806009|FG000|Overall Study|Lost to Follow-up|1|||
28140667|NCT02974140|54806009|FG000|Overall Study|Study Terminated by Sponsor|36|||
28140668|NCT02974842|54806016|FG000|Overall Study|Withdrawal by Subject|4|||
28140669|NCT02974842|54806016|FG000|Overall Study|Screen failures|4|||
28140670|NCT03172481|54806022|FG000|Double-blind|Withdrawal by Subject|1|||
28140671|NCT03172481|54806023|FG001|Double-blind|Withdrawal by Subject|0|||
28140672|NCT02855450|54806031|FG000|Overall Study|Adverse Event|1|||
28140673|NCT02855450|54806032|FG001|Overall Study|Adverse Event|0|||
28140674|NCT02855450|54806031|FG000|Overall Study|Lost to Follow-up|4|||
28140675|NCT02855450|54806032|FG001|Overall Study|Lost to Follow-up|0|||
28140676|NCT03172325|54806040|FG000|Overall Study|Adverse Event|2|||
27941130|NCT01179516|54597438|FG001|Overall Study|Other|0|||
27941131|NCT01179516|54597439|FG002|Overall Study|Other|2|||
27941132|NCT01018953|54597447|FG000|Overall Study|Adverse Event|2|||
27941133|NCT01018953|54597447|FG000|Overall Study|Withdrawal by Subject|1|||
27941134|NCT01018953|54597447|FG000|Overall Study|Study termination by sponsor|5|||
27941135|NCT01158924|54597454|FG000|Overall Study|Withdrawal by Subject|1|||
27941136|NCT01158924|54597455|FG001|Overall Study|Withdrawal by Subject|2|||
27941137|NCT01158924|54597454|FG000|Overall Study|Lost to Follow-up|0|||
27941138|NCT01158924|54597455|FG001|Overall Study|Lost to Follow-up|1|||
27941139|NCT01027845|54597463|FG000|Primary Vaccination Phase|Serious Adverse Event|2|||
27941140|NCT01027845|54597464|FG001|Primary Vaccination Phase|Serious Adverse Event|0|||
27941141|NCT01027845|54597465|FG002|Primary Vaccination Phase|Serious Adverse Event|0|||
27941142|NCT01027845|54597466|FG003|Primary Vaccination Phase|Serious Adverse Event|0|||
27941143|NCT01027845|54597463|FG000|Primary Vaccination Phase|Adverse Event|1|||
27941144|NCT01027845|54597464|FG001|Primary Vaccination Phase|Adverse Event|0|||
27941145|NCT01027845|54597465|FG002|Primary Vaccination Phase|Adverse Event|0|||
27941146|NCT01027845|54597466|FG003|Primary Vaccination Phase|Adverse Event|0|||
28140677|NCT03172325|54806041|FG001|Overall Study|Adverse Event|3|||
27941147|NCT01027845|54597463|FG000|Primary Vaccination Phase|Protocol Violation|1|||
27941148|NCT01027845|54597464|FG001|Primary Vaccination Phase|Protocol Violation|0|||
27941149|NCT01027845|54597465|FG002|Primary Vaccination Phase|Protocol Violation|0|||
28140678|NCT03172325|54806040|FG000|Overall Study|Positive PPD|1|||
28140679|NCT03172325|54806041|FG001|Overall Study|Positive PPD|0|||
27941150|NCT01027845|54597466|FG003|Primary Vaccination Phase|Protocol Violation|0|||
27941151|NCT01027845|54597463|FG000|Primary Vaccination Phase|Migrated/moved from study area|0|||
28140680|NCT03172325|54806040|FG000|Overall Study|Poor Compliance|1|||
28140681|NCT03172325|54806041|FG001|Overall Study|Poor Compliance|1|||
28140682|NCT03085017|54806049|FG000|Overall Study|Death|0|||
28140683|NCT03085017|54806050|FG001|Overall Study|Death|3|||
28140684|NCT03215771|54806056|FG000|Overall Study|Withdrawal by Subject|2|||
28140685|NCT03215771|54806056|FG000|Overall Study|Physician Decision|1|||
27941152|NCT01027845|54597464|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
27941153|NCT01027845|54597465|FG002|Primary Vaccination Phase|Migrated/moved from study area|0|||
27941154|NCT01027845|54597466|FG003|Primary Vaccination Phase|Migrated/moved from study area|0|||
27941155|NCT01027845|54597463|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
27941156|NCT01027845|54597464|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
27941157|NCT01027845|54597465|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
27941158|NCT01027845|54597466|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
27941159|NCT01027845|54597463|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
27941160|NCT01027845|54597464|FG001|Booster Vaccination Phase|Migrated/moved from study area|0|||
27941161|NCT01027845|54597465|FG002|Booster Vaccination Phase|Migrated/moved from study area|0|||
27941162|NCT01027845|54597466|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
27941163|NCT01017549|54597475|FG000|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1|||
27941164|NCT01017549|54597475|FG000|One-year Follow-up|Lost to Follow-up|2|||
28140686|NCT02745392|54806065|FG000|Overall Study|Lost to Follow-up|0|||
28140687|NCT02745392|54806066|FG001|Overall Study|Lost to Follow-up|1|||
27941165|NCT01017549|54597475|FG000|One-year Follow-up|Withdrawal by Subject|5|||
28140688|NCT02745392|54806067|FG002|Overall Study|Lost to Follow-up|0|||
28140689|NCT02745392|54806068|FG003|Overall Study|Lost to Follow-up|0|||
28140690|NCT03076515|54806080|FG000|Overall Study|DMC decision based on interim analysis|25|||
27941166|NCT01017549|54597475|FG000|5 Year Follow-up|Lost to Follow-up|9|||
27941167|NCT01017549|54597475|FG000|5 Year Follow-up|Mastectomy|3|||
27941168|NCT01030341|54597479|FG000|Overall Study|Withdrawal by Subject|1|||
27821883|NCT01855945|54284066|FG011|Overall Study|Other - Unclassified|0|||
27821884|NCT01855945|54284055|FG000|Overall Study|Withdrawal by Subject|4|||
27821885|NCT01855945|54284056|FG001|Overall Study|Withdrawal by Subject|0|||
28070700|NCT00143247|54725452|FG000|Overall Study|Other|12|||
28070701|NCT00125853|54725456|FG000|Wash-out (4 Weeks)|Lost to Follow-up|3|||
28070702|NCT00125853|54725457|FG001|Wash-out (4 Weeks)|Lost to Follow-up|7|||
28070703|NCT00219141|54725466|FG000|Overall Study|Adverse Event|4|||
28070704|NCT00219141|54725467|FG001|Overall Study|Adverse Event|10|||
28070705|NCT00219141|54725468|FG002|Overall Study|Adverse Event|5|||
28070706|NCT00219141|54725466|FG000|Overall Study|Lack of Efficacy|3|||
28070707|NCT00219141|54725467|FG001|Overall Study|Lack of Efficacy|2|||
28070708|NCT00219141|54725468|FG002|Overall Study|Lack of Efficacy|0|||
28070709|NCT00219141|54725466|FG000|Overall Study|Administrative problems|0|||
28140691|NCT03076515|54806081|FG001|Overall Study|DMC decision based on interim analysis|29|||
27941169|NCT01030341|54597479|FG000|Overall Study|Lost to Follow-up|2|||
27941170|NCT01026831|54597485|FG000|Overall Study|Adverse Event|4|||
28140692|NCT03170609|54806094|FG000|Overall Study|Death|0|||
28140693|NCT03170609|54806095|FG001|Overall Study|Death|0|||
27821886|NCT01855945|54284057|FG002|Overall Study|Withdrawal by Subject|4|||
27821887|NCT01855945|54284058|FG003|Overall Study|Withdrawal by Subject|1|||
27821888|NCT01855945|54284059|FG004|Overall Study|Withdrawal by Subject|1|||
27821889|NCT01855945|54284060|FG005|Overall Study|Withdrawal by Subject|0|||
27821890|NCT01855945|54284061|FG006|Overall Study|Withdrawal by Subject|1|||
28140694|NCT03170609|54806096|FG002|Overall Study|Death|1|||
28140695|NCT03170609|54806097|FG003|Overall Study|Death|0|||
28140696|NCT03170609|54806098|FG004|Overall Study|Death|0|||
28140697|NCT03170609|54806099|FG005|Overall Study|Death|0|||
28140698|NCT03170609|54806100|FG006|Overall Study|Death|0|||
28140699|NCT03170609|54806094|FG000|Overall Study|Withdrawal by Subject|1|||
28140700|NCT03170609|54806095|FG001|Overall Study|Withdrawal by Subject|2|||
28140701|NCT03170609|54806096|FG002|Overall Study|Withdrawal by Subject|0|||
28140702|NCT03170609|54806097|FG003|Overall Study|Withdrawal by Subject|0|||
28140703|NCT03170609|54806098|FG004|Overall Study|Withdrawal by Subject|0|||
28140704|NCT03170609|54806099|FG005|Overall Study|Withdrawal by Subject|0|||
28140705|NCT03170609|54806100|FG006|Overall Study|Withdrawal by Subject|1|||
28140706|NCT03170609|54806094|FG000|Overall Study|Lost to Follow-up|1|||
28140707|NCT03170609|54806095|FG001|Overall Study|Lost to Follow-up|0|||
28140708|NCT03170609|54806096|FG002|Overall Study|Lost to Follow-up|5|||
28140709|NCT03170609|54806097|FG003|Overall Study|Lost to Follow-up|2|||
28140710|NCT03170609|54806098|FG004|Overall Study|Lost to Follow-up|1|||
28140711|NCT03170609|54806099|FG005|Overall Study|Lost to Follow-up|1|||
28140712|NCT03170609|54806100|FG006|Overall Study|Lost to Follow-up|0|||
28140713|NCT03170609|54806094|FG000|Overall Study|Other|1|||
28140714|NCT03170609|54806095|FG001|Overall Study|Other|0|||
28140715|NCT03170609|54806096|FG002|Overall Study|Other|0|||
28140716|NCT03170609|54806097|FG003|Overall Study|Other|0|||
28140717|NCT03170609|54806098|FG004|Overall Study|Other|0|||
28140718|NCT03170609|54806099|FG005|Overall Study|Other|1|||
28140719|NCT03170609|54806100|FG006|Overall Study|Other|0|||
28140720|NCT01141712|54806116|FG000|Overall Study|Disease progression|3|||
28140721|NCT03219333|54806126|FG000|Overall Study|Withdrawal by Subject|8|||
28140722|NCT03219333|54806127|FG001|Overall Study|Withdrawal by Subject|3|||
28140723|NCT03219333|54806126|FG000|Overall Study|Lost to Follow-up|1|||
28140724|NCT03219333|54806127|FG001|Overall Study|Lost to Follow-up|0|||
28140725|NCT03219333|54806126|FG000|Overall Study|Death|94|||
28140726|NCT03219333|54806127|FG001|Overall Study|Death|44|||
28140727|NCT03219333|54806126|FG000|Overall Study|Includes 4 participants who were enrolled and never received study treatment.|2|||
28140728|NCT03219333|54806127|FG001|Overall Study|Includes 4 participants who were enrolled and never received study treatment.|2|||
27821891|NCT01855945|54284062|FG007|Overall Study|Withdrawal by Subject|0|||
28140729|NCT03168867|54806135|FG000|Overall Study|Withdrawal by Subject|1|||
28140730|NCT03168867|54806136|FG001|Overall Study|Withdrawal by Subject|5|||
28140731|NCT01064622|54806145|FG000|Randomized Phase II|Withdrawal by Subject|2|||
28140732|NCT01064622|54806146|FG001|Randomized Phase II|Withdrawal by Subject|2|||
28140733|NCT01064622|54806145|FG000|Randomized Phase II|Protocol Violation|0|||
28140734|NCT01064622|54806146|FG001|Randomized Phase II|Protocol Violation|1|||
28140735|NCT04163718|54806155|FG000|Overall Study|Study terminated|12|||
28140736|NCT01063764|54806159|FG000|1st Period (From Week 8 to Week 22)|Adverse Event|4|||
28140737|NCT01063764|54806159|FG000|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6|||
28140738|NCT01063764|54806159|FG000|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1|||
28140739|NCT01063764|54806159|FG000|2nd Period (Week 22 to the End of Study)|Adverse Event|3|||
28140740|NCT01063764|54806159|FG000|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9|||
28140741|NCT01063764|54806159|FG000|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7|||
28140742|NCT01063764|54806159|FG000|2nd Period (Week 22 to the End of Study)|Protocol Violation|1|||
28140743|NCT03075891|54806169|FG000|Overall Study|Withdrawal by Subject|3|||
28140744|NCT03075891|54806170|FG001|Overall Study|Withdrawal by Subject|6|||
28140745|NCT03075891|54806169|FG000|Overall Study|Lost to Follow-up|1|||
28140746|NCT03075891|54806170|FG001|Overall Study|Lost to Follow-up|0|||
28140747|NCT03075891|54806169|FG000|Overall Study|Pregnancy|3|||
28140748|NCT03075891|54806170|FG001|Overall Study|Pregnancy|1|||
28140749|NCT03075891|54806169|FG000|Overall Study|visits not performed (no time)|1|||
28140750|NCT03075891|54806170|FG001|Overall Study|visits not performed (no time)|0|||
28140751|NCT03075891|54806169|FG000|Overall Study|Drug abuse relapse issue|0|||
28140752|NCT03075891|54806170|FG001|Overall Study|Drug abuse relapse issue|1|||
28140753|NCT03075891|54806169|FG000|Overall Study|Participant requiring study withdrawal|0|||
28140754|NCT03075891|54806170|FG001|Overall Study|Participant requiring study withdrawal|1|||
28140755|NCT03075891|54806169|FG000|Overall Study|Adverse event, non-fatal|1|||
28140756|NCT03075891|54806170|FG001|Overall Study|Adverse event, non-fatal|4|||
28140757|NCT02013167|54806180|FG000|Overall Study|Withdrawal by Subject|15|||
28140758|NCT02013167|54806181|FG001|Overall Study|Withdrawal by Subject|14|||
28140759|NCT02013167|54806180|FG000|Overall Study|Sponsor Decision|1|||
28140760|NCT02013167|54806181|FG001|Overall Study|Sponsor Decision|3|||
28140761|NCT02013167|54806180|FG000|Overall Study|Lost to Follow-up|0|||
28140762|NCT02013167|54806181|FG001|Overall Study|Lost to Follow-up|1|||
28140763|NCT02013167|54806180|FG000|Overall Study|Death|85|||
28140764|NCT02013167|54806181|FG001|Overall Study|Death|160|||
28140765|NCT01063062|54806190|FG000|Overall Study|Patient withdrew consent|0|||
28140766|NCT01063062|54806191|FG001|Overall Study|Patient withdrew consent|1|||
28140767|NCT01063062|54806190|FG000|Overall Study|Adverse Event|2|||
28140768|NCT01063062|54806191|FG001|Overall Study|Adverse Event|4|||
28140769|NCT01063062|54806190|FG000|Overall Study|Protocol Violation|5|||
28140770|NCT01063062|54806191|FG001|Overall Study|Protocol Violation|4|||
28140771|NCT01063062|54806190|FG000|Overall Study|Investigator's request|1|||
28140772|NCT01063062|54806191|FG001|Overall Study|Investigator's request|0|||
28140773|NCT01063062|54806190|FG000|Overall Study|Lost to Follow-up|0|||
28140774|NCT01063062|54806191|FG001|Overall Study|Lost to Follow-up|2|||
28140775|NCT01063062|54806190|FG000|Overall Study|Miscellaneous reason|0|||
28140776|NCT01063062|54806191|FG001|Overall Study|Miscellaneous reason|1|||
28140777|NCT02973048|54806200|FG000|Overall Study|Epidural catheter insertion failure|1|||
28140778|NCT02973048|54806201|FG001|Overall Study|Epidural catheter insertion failure|0|||
28140779|NCT02973048|54806200|FG000|Overall Study|Withdrawal by Subject|0|||
28140780|NCT02973048|54806201|FG001|Overall Study|Withdrawal by Subject|3|||
28140781|NCT02932943|54806209|FG000|Overall Study|Lost to Follow-up|0|||
28140782|NCT02932943|54806210|FG001|Overall Study|Lost to Follow-up|2|||
28140783|NCT02932943|54806209|FG000|Overall Study|Adverse Event|2|||
28140784|NCT02932943|54806210|FG001|Overall Study|Adverse Event|2|||
28140785|NCT02932943|54806209|FG000|Overall Study|Withdrawal by Subject|3|||
28140786|NCT02932943|54806210|FG001|Overall Study|Withdrawal by Subject|3|||
28140787|NCT02972658|54806235|FG000|Overall Study|Adverse Event|0|||
28140788|NCT02972658|54806236|FG001|Overall Study|Adverse Event|3|||
28140789|NCT02972658|54806237|FG002|Overall Study|Adverse Event|0|||
28140790|NCT02972658|54806238|FG003|Overall Study|Adverse Event|2|||
28140791|NCT02972658|54806235|FG000|Overall Study|Other-determined by Investigator|1|||
28140792|NCT02972658|54806236|FG001|Overall Study|Other-determined by Investigator|1|||
28140793|NCT02972658|54806237|FG002|Overall Study|Other-determined by Investigator|0|||
28140794|NCT02972658|54806238|FG003|Overall Study|Other-determined by Investigator|0|||
27821892|NCT01855945|54284063|FG008|Overall Study|Withdrawal by Subject|0|||
27821893|NCT01855945|54284064|FG009|Overall Study|Withdrawal by Subject|2|||
27821894|NCT01855945|54284065|FG010|Overall Study|Withdrawal by Subject|4|||
28140795|NCT02972658|54806235|FG000|Overall Study|Death|0|||
28140796|NCT02972658|54806236|FG001|Overall Study|Death|0|||
28140797|NCT02972658|54806237|FG002|Overall Study|Death|0|||
28140798|NCT02972658|54806238|FG003|Overall Study|Death|1|||
28140799|NCT02972658|54806235|FG000|Overall Study|Lost to Follow-up|0|||
28140800|NCT02972658|54806236|FG001|Overall Study|Lost to Follow-up|1|||
28140801|NCT02972658|54806237|FG002|Overall Study|Lost to Follow-up|1|||
28140802|NCT02972658|54806238|FG003|Overall Study|Lost to Follow-up|2|||
28140803|NCT02972658|54806235|FG000|Overall Study|Progressive Disease|0|||
28140804|NCT02972658|54806236|FG001|Overall Study|Progressive Disease|1|||
28140805|NCT02972658|54806237|FG002|Overall Study|Progressive Disease|0|||
28140806|NCT02972658|54806238|FG003|Overall Study|Progressive Disease|1|||
28140807|NCT02972658|54806235|FG000|Overall Study|Withdrawal by Subject|4|||
28140808|NCT02972658|54806236|FG001|Overall Study|Withdrawal by Subject|4|||
28140809|NCT02972658|54806237|FG002|Overall Study|Withdrawal by Subject|1|||
28140810|NCT02972658|54806238|FG003|Overall Study|Withdrawal by Subject|6|||
28140811|NCT02972658|54806235|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
28140812|NCT02972658|54806236|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
28140813|NCT02972658|54806237|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
28140814|NCT02972658|54806238|FG003|Overall Study|Withdrawal due to Caregiver Circumstance|0|||
28140815|NCT02972658|54806235|FG000|Overall Study|Sponsor Decision|70|||
28140816|NCT02972658|54806236|FG001|Overall Study|Sponsor Decision|127|||
28140817|NCT02972658|54806237|FG002|Overall Study|Sponsor Decision|72|||
28140818|NCT02972658|54806238|FG003|Overall Study|Sponsor Decision|119|||
28140819|NCT02853032|54806250|FG000|Overall Study|Adverse Event|4|||
28140820|NCT02853032|54806251|FG001|Overall Study|Adverse Event|0|||
28140821|NCT02853032|54806250|FG000|Overall Study|Withdrawal by Subject|3|||
28140822|NCT02853032|54806251|FG001|Overall Study|Withdrawal by Subject|1|||
27821895|NCT01855945|54284066|FG011|Overall Study|Withdrawal by Subject|1|||
27821896|NCT01855789|54284129|FG000|1) Baseline up to Week 24|Adverse Event|37|||
28140823|NCT02853032|54806250|FG000|Overall Study|Requested to withdraw from all treatment|2|||
28140824|NCT02853032|54806251|FG001|Overall Study|Requested to withdraw from all treatment|2|||
28140825|NCT02232087|54806259|FG000|Overall Study|Withdrawal by Subject|2|||
28140826|NCT02232087|54806260|FG001|Overall Study|Withdrawal by Subject|0|||
28140827|NCT02232087|54806261|FG002|Overall Study|Withdrawal by Subject|0|||
28140828|NCT02232087|54806262|FG003|Overall Study|Withdrawal by Subject|0|||
28140829|NCT02232087|54806263|FG004|Overall Study|Withdrawal by Subject|0|||
28140830|NCT02232087|54806264|FG005|Overall Study|Withdrawal by Subject|1|||
27849930|NCT03385304|54348251|FG000|Overall Study|Incarceration|2|||
27849931|NCT03385304|54348252|FG001|Overall Study|Incarceration|3|||
27849932|NCT03325608|54348262|FG000|Overall Study|Lost to Follow-up|47|||
28140831|NCT02232087|54806259|FG000|Overall Study|poor inhalation technique|0|||
27849933|NCT03325608|54348263|FG001|Overall Study|Lost to Follow-up|47|||
27821897|NCT01855789|54284130|FG001|1) Baseline up to Week 24|Adverse Event|0|||
28140832|NCT02232087|54806260|FG001|Overall Study|poor inhalation technique|1|||
28140833|NCT02232087|54806261|FG002|Overall Study|poor inhalation technique|0|||
28140834|NCT02232087|54806262|FG003|Overall Study|poor inhalation technique|0|||
28140835|NCT02232087|54806263|FG004|Overall Study|poor inhalation technique|0|||
28140836|NCT02232087|54806264|FG005|Overall Study|poor inhalation technique|2|||
28140837|NCT02232087|54806259|FG000|Overall Study|protocol stop criteria|0|||
28140838|NCT02232087|54806260|FG001|Overall Study|protocol stop criteria|1|||
28140839|NCT02232087|54806261|FG002|Overall Study|protocol stop criteria|0|||
28140840|NCT02232087|54806262|FG003|Overall Study|protocol stop criteria|1|||
28140841|NCT02232087|54806263|FG004|Overall Study|protocol stop criteria|0|||
28140842|NCT02232087|54806264|FG005|Overall Study|protocol stop criteria|0|||
28140843|NCT02232087|54806259|FG000|Overall Study|Adverse Event|0|||
28140844|NCT02232087|54806260|FG001|Overall Study|Adverse Event|0|||
28140845|NCT02232087|54806261|FG002|Overall Study|Adverse Event|0|||
28140846|NCT02232087|54806262|FG003|Overall Study|Adverse Event|0|||
28140847|NCT02232087|54806263|FG004|Overall Study|Adverse Event|1|||
28140848|NCT02232087|54806264|FG005|Overall Study|Adverse Event|0|||
28140849|NCT03168425|54806285|FG000|Overall Study|Lost to Follow-up|5|||
28140850|NCT03168425|54806286|FG001|Overall Study|Lost to Follow-up|8|||
28140851|NCT03168425|54806285|FG000|Overall Study|unable to confirm post op opioids|2|||
28140852|NCT03168425|54806286|FG001|Overall Study|unable to confirm post op opioids|3|||
28140853|NCT00004445|54806293|FG000|Overall Study|Physician Decision|2|||
28140854|NCT00004445|54806293|FG000|Overall Study|Withdrawal by Subject|1|||
28140855|NCT02972502|54806303|FG000|Overall Study|Lost to Follow-up|3|||
28140856|NCT02972502|54806304|FG001|Overall Study|Lost to Follow-up|1|||
28140857|NCT02972502|54806303|FG000|Overall Study|Withdrawal by Subject|1|||
28140858|NCT02972502|54806304|FG001|Overall Study|Withdrawal by Subject|1|||
28140859|NCT02971800|54806310|FG000|Overall Study|Protocol Violation|1|||
28140860|NCT02971800|54806310|FG000|Overall Study|Withdrawal by Subject|1|||
28140861|NCT02971800|54806310|FG000|Overall Study|Exclusion criteria prior intervention|1|||
28140862|NCT02971800|54806310|FG000|Overall Study|Number evaluable participant already reached|4|||
28140863|NCT03163667|54806316|FG000|Overall Study|Death|15|||
28140864|NCT03163667|54806317|FG001|Overall Study|Death|27|||
28140865|NCT03163667|54806316|FG000|Overall Study|Study terminated by sponsor (after primary endpoint was met)|8|||
28140866|NCT03163667|54806317|FG001|Overall Study|Study terminated by sponsor (after primary endpoint was met)|19|||
28140867|NCT03167411|54806325|FG000|Overall Study|Adverse Event|0|||
28140868|NCT03167411|54806326|FG001|Overall Study|Adverse Event|1|||
28140869|NCT01952847|54806336|FG000|Overall Study|Ineligible|1|||
27821898|NCT01855789|54284131|FG002|1) Baseline up to Week 24|Adverse Event|0|||
27821899|NCT01855789|54284132|FG003|1) Baseline up to Week 24|Adverse Event|0|||
28140870|NCT01952847|54806337|FG001|Overall Study|Ineligible|0|||
28140871|NCT01952847|54806338|FG002|Overall Study|Ineligible|0|||
28140872|NCT01952847|54806339|FG003|Overall Study|Ineligible|0|||
28140873|NCT01952847|54806336|FG000|Overall Study|Lack of Insurance Coverage|0|||
28140874|NCT01952847|54806337|FG001|Overall Study|Lack of Insurance Coverage|1|||
28140875|NCT01952847|54806338|FG002|Overall Study|Lack of Insurance Coverage|0|||
28140876|NCT01952847|54806339|FG003|Overall Study|Lack of Insurance Coverage|0|||
28140877|NCT01952847|54806336|FG000|Overall Study|Withdrawal by Subject|1|||
28140878|NCT01952847|54806337|FG001|Overall Study|Withdrawal by Subject|1|||
27821900|NCT01855789|54284129|FG000|1) Baseline up to Week 24|Death|2|||
28140879|NCT01952847|54806338|FG002|Overall Study|Withdrawal by Subject|0|||
28140880|NCT01952847|54806339|FG003|Overall Study|Withdrawal by Subject|1|||
28140881|NCT01560585|54806351|FG000|Overall Study|Physician Decision|3|||
28140882|NCT03075501|54806358|FG000|Overall Study|Scheduling difficulties|15|||
28140883|NCT03075501|54806359|FG001|Overall Study|Scheduling difficulties|9|||
28140884|NCT02317991|54806366|FG000|Overall Study|Adverse Event|12|||
28140885|NCT02317991|54806366|FG000|Overall Study|Death|4|||
28140886|NCT02317991|54806366|FG000|Overall Study|Withdrawal by Subject|8|||
28140887|NCT02317991|54806366|FG000|Overall Study|Progressive Disease|41|||
28140888|NCT03075267|54806373|FG000|Overall Study|Protocol Violation|1|||
28140889|NCT03075267|54806374|FG001|Overall Study|Protocol Violation|0|||
28140890|NCT03075267|54806375|FG002|Overall Study|Protocol Violation|0|||
28140891|NCT03074331|54806383|FG000|Overall Study|Enrolled but Not Treated|1|||
28140892|NCT03074331|54806383|FG000|Overall Study|Lost to Follow-up|5|||
28140893|NCT03074331|54806383|FG000|Overall Study|Withdrew Consent|1|||
28140894|NCT02260193|54806390|FG000|Overall Study|Lack of Efficacy|0|||
28140895|NCT02260193|54806391|FG001|Overall Study|Lack of Efficacy|1|||
28140896|NCT02260193|54806392|FG002|Overall Study|Lack of Efficacy|6|||
28140897|NCT02260193|54806390|FG000|Overall Study|Adverse Event|3|||
28140898|NCT02260193|54806391|FG001|Overall Study|Adverse Event|4|||
28140899|NCT02260193|54806392|FG002|Overall Study|Adverse Event|1|||
28140900|NCT02260193|54806390|FG000|Overall Study|Protocol Violation|0|||
28140901|NCT02260193|54806391|FG001|Overall Study|Protocol Violation|4|||
27941171|NCT01026831|54597486|FG001|Overall Study|Adverse Event|3|||
27821901|NCT01855789|54284130|FG001|1) Baseline up to Week 24|Death|0|||
27821902|NCT01855789|54284131|FG002|1) Baseline up to Week 24|Death|0|||
28140902|NCT02260193|54806392|FG002|Overall Study|Protocol Violation|0|||
28140903|NCT02260193|54806390|FG000|Overall Study|Withdrawal by Subject|3|||
28140904|NCT02260193|54806391|FG001|Overall Study|Withdrawal by Subject|0|||
28140905|NCT02260193|54806392|FG002|Overall Study|Withdrawal by Subject|2|||
28140906|NCT02260193|54806390|FG000|Overall Study|Kidney Transplantation|0|||
27821903|NCT01855789|54284132|FG003|1) Baseline up to Week 24|Death|0|||
27821904|NCT01855789|54284129|FG000|1) Baseline up to Week 24|Lack of Efficacy|16|||
27821905|NCT01855789|54284130|FG001|1) Baseline up to Week 24|Lack of Efficacy|0|||
27821906|NCT01855789|54284131|FG002|1) Baseline up to Week 24|Lack of Efficacy|0|||
27821907|NCT01855789|54284132|FG003|1) Baseline up to Week 24|Lack of Efficacy|0|||
27821908|NCT01855789|54284129|FG000|1) Baseline up to Week 24|Lost to Follow-up|11|||
27821909|NCT01855789|54284130|FG001|1) Baseline up to Week 24|Lost to Follow-up|0|||
27821910|NCT01855789|54284131|FG002|1) Baseline up to Week 24|Lost to Follow-up|0|||
27821911|NCT01855789|54284132|FG003|1) Baseline up to Week 24|Lost to Follow-up|0|||
27821912|NCT01855789|54284129|FG000|1) Baseline up to Week 24|Protocol Violation|4|||
27821913|NCT01855789|54284130|FG001|1) Baseline up to Week 24|Protocol Violation|0|||
27821914|NCT01855789|54284131|FG002|1) Baseline up to Week 24|Protocol Violation|0|||
27821915|NCT01855789|54284132|FG003|1) Baseline up to Week 24|Protocol Violation|0|||
27821916|NCT01855789|54284129|FG000|1) Baseline up to Week 24|Withdrawal by Subject|31|||
27821917|NCT01855789|54284130|FG001|1) Baseline up to Week 24|Withdrawal by Subject|0|||
27821918|NCT01855789|54284131|FG002|1) Baseline up to Week 24|Withdrawal by Subject|0|||
27821919|NCT01855789|54284132|FG003|1) Baseline up to Week 24|Withdrawal by Subject|0|||
27821920|NCT01855789|54284129|FG000|1) Baseline up to Week 24|Physician Decision|4|||
27821921|NCT01855789|54284130|FG001|1) Baseline up to Week 24|Physician Decision|0|||
27821922|NCT01855789|54284131|FG002|1) Baseline up to Week 24|Physician Decision|0|||
27821923|NCT01855789|54284132|FG003|1) Baseline up to Week 24|Physician Decision|0|||
27821924|NCT01855789|54284129|FG000|1) Baseline up to Week 24|Pregnancy|1|||
27821925|NCT01855789|54284130|FG001|1) Baseline up to Week 24|Pregnancy|0|||
27821926|NCT01855789|54284131|FG002|1) Baseline up to Week 24|Pregnancy|0|||
27821927|NCT01855789|54284132|FG003|1) Baseline up to Week 24|Pregnancy|0|||
27821928|NCT01855789|54284129|FG000|1) Baseline up to Week 24|Participant Non-compliance|3|||
27821929|NCT01855789|54284130|FG001|1) Baseline up to Week 24|Participant Non-compliance|0|||
27821930|NCT01855789|54284131|FG002|1) Baseline up to Week 24|Participant Non-compliance|0|||
27821931|NCT01855789|54284132|FG003|1) Baseline up to Week 24|Participant Non-compliance|0|||
27821932|NCT01855789|54284129|FG000|1) Baseline up to Week 24|Sponsor Decision|3|||
27821933|NCT01855789|54284130|FG001|1) Baseline up to Week 24|Sponsor Decision|0|||
27821934|NCT01855789|54284131|FG002|1) Baseline up to Week 24|Sponsor Decision|0|||
27821935|NCT01855789|54284132|FG003|1) Baseline up to Week 24|Sponsor Decision|0|||
27821936|NCT01855789|54284129|FG000|1) Baseline up to Week 24|Other|4|||
27821937|NCT01855789|54284130|FG001|1) Baseline up to Week 24|Other|0|||
27821938|NCT01855789|54284131|FG002|1) Baseline up to Week 24|Other|0|||
27821939|NCT01855789|54284132|FG003|1) Baseline up to Week 24|Other|0|||
27821940|NCT01855789|54284129|FG000|2) Week 24 up to End of Study|Adverse Event|0|||
27821941|NCT01855789|54284130|FG001|2) Week 24 up to End of Study|Adverse Event|4|||
27821942|NCT01855789|54284131|FG002|2) Week 24 up to End of Study|Adverse Event|5|||
27821943|NCT01855789|54284132|FG003|2) Week 24 up to End of Study|Adverse Event|21|||
27821944|NCT01855789|54284129|FG000|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
27821945|NCT01855789|54284130|FG001|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
27821946|NCT01855789|54284131|FG002|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
27821947|NCT01855789|54284132|FG003|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1|||
28070710|NCT00219141|54725467|FG001|Overall Study|Administrative problems|1|||
28070711|NCT00219141|54725468|FG002|Overall Study|Administrative problems|0|||
28070712|NCT00219141|54725466|FG000|Overall Study|Lost to Follow-up|2|||
28070713|NCT00219141|54725467|FG001|Overall Study|Lost to Follow-up|4|||
28070714|NCT00219141|54725468|FG002|Overall Study|Lost to Follow-up|1|||
28070715|NCT00219141|54725466|FG000|Overall Study|Protocol Violation|3|||
28070716|NCT00219141|54725467|FG001|Overall Study|Protocol Violation|1|||
28070717|NCT00219141|54725468|FG002|Overall Study|Protocol Violation|1|||
28140907|NCT02260193|54806391|FG001|Overall Study|Kidney Transplantation|0|||
28140908|NCT02260193|54806392|FG002|Overall Study|Kidney Transplantation|1|||
28140909|NCT02849678|54806402|FG000|Overall Study|Protocol Violation|3|||
28140910|NCT02849678|54806403|FG001|Overall Study|Protocol Violation|6|||
28140911|NCT01596257|54806411|FG000|Overall Study|Inadequate Collection|23|||
28140912|NCT01596257|54806412|FG001|Overall Study|Inadequate Collection|19|||
28140913|NCT04577781|54806422|FG000|Overall Study|Adverse Event|2|||
28140914|NCT04577781|54806423|FG001|Overall Study|Adverse Event|2|||
28140915|NCT04577781|54806422|FG000|Overall Study|Physician Decision|1|||
28140916|NCT04577781|54806423|FG001|Overall Study|Physician Decision|0|||
28140917|NCT02737826|54806430|FG000|Phase II - Randomization + Taper|Withdrawal by Subject|0|||
28140918|NCT02737826|54806431|FG001|Phase II - Randomization + Taper|Withdrawal by Subject|12|||
28140919|NCT02737826|54806432|FG002|Phase II - Randomization + Taper|Withdrawal by Subject|14|||
28140920|NCT03070431|54806459|FG000|Overall Study|Withdrawal by Subject|2|||
27821948|NCT01855789|54284129|FG000|2) Week 24 up to End of Study|Lack of Efficacy|0|||
27821949|NCT01855789|54284130|FG001|2) Week 24 up to End of Study|Lack of Efficacy|2|||
27821950|NCT01855789|54284131|FG002|2) Week 24 up to End of Study|Lack of Efficacy|5|||
27821951|NCT01855789|54284132|FG003|2) Week 24 up to End of Study|Lack of Efficacy|16|||
28070718|NCT00219141|54725466|FG000|Overall Study|Withdrawal by Subject|1|||
28070719|NCT00219141|54725467|FG001|Overall Study|Withdrawal by Subject|3|||
28070720|NCT00219141|54725468|FG002|Overall Study|Withdrawal by Subject|5|||
28070721|NCT00219141|54725466|FG000|Overall Study|Condition no longer requires study drug|1|||
28070722|NCT00219141|54725467|FG001|Overall Study|Condition no longer requires study drug|0|||
28070723|NCT00219141|54725468|FG002|Overall Study|Condition no longer requires study drug|0|||
28070724|NCT00142935|54725479|FG000|Overall Study|Other reason|1|||
28070725|NCT00142935|54725480|FG001|Overall Study|Other reason|1|||
28070726|NCT00142935|54725481|FG002|Overall Study|Other reason|1|||
28070727|NCT00142935|54725479|FG000|Overall Study|Lost to Follow-up|2|||
28140921|NCT03070431|54806459|FG000|Overall Study|Lost to Follow-up|2|||
28140922|NCT01071395|54806470|FG000|Overall Study|Withdrawal by Subject|2|||
28140923|NCT01071395|54806471|FG001|Overall Study|Withdrawal by Subject|1|||
28140924|NCT01071395|54806470|FG000|Overall Study|Adverse Event|3|||
28140925|NCT01071395|54806471|FG001|Overall Study|Adverse Event|1|||
28140926|NCT02970942|54806481|FG000|Overall Study|Death|0|||
28140927|NCT02970942|54806482|FG001|Overall Study|Death|1|||
28140928|NCT02970942|54806483|FG002|Overall Study|Death|0|||
28140929|NCT02970942|54806484|FG003|Overall Study|Death|0|||
28140930|NCT02970942|54806481|FG000|Overall Study|Lost to Follow-up|1|||
28140931|NCT02970942|54806482|FG001|Overall Study|Lost to Follow-up|0|||
28140932|NCT02970942|54806483|FG002|Overall Study|Lost to Follow-up|2|||
28140933|NCT02970942|54806484|FG003|Overall Study|Lost to Follow-up|1|||
28140934|NCT02970942|54806481|FG000|Overall Study|Withdrawal by Subject|3|||
28140935|NCT02970942|54806482|FG001|Overall Study|Withdrawal by Subject|5|||
28140936|NCT02970942|54806483|FG002|Overall Study|Withdrawal by Subject|3|||
28140937|NCT02970942|54806484|FG003|Overall Study|Withdrawal by Subject|2|||
28140938|NCT03073005|54806498|FG000|Overall Study|Death|6|||
28140939|NCT03073005|54806499|FG001|Overall Study|Death|0|||
28140940|NCT03073005|54806500|FG002|Overall Study|Death|7|||
28140941|NCT03073005|54806501|FG003|Overall Study|Death|0|||
27821952|NCT01855789|54284129|FG000|2) Week 24 up to End of Study|Lost to Follow-up|0|||
27821953|NCT01855789|54284130|FG001|2) Week 24 up to End of Study|Lost to Follow-up|1|||
27821954|NCT01855789|54284131|FG002|2) Week 24 up to End of Study|Lost to Follow-up|1|||
27821955|NCT01855789|54284132|FG003|2) Week 24 up to End of Study|Lost to Follow-up|4|||
27821956|NCT01855789|54284129|FG000|2) Week 24 up to End of Study|Protocol Violation|0|||
27821957|NCT01855789|54284130|FG001|2) Week 24 up to End of Study|Protocol Violation|0|||
27821958|NCT01855789|54284131|FG002|2) Week 24 up to End of Study|Protocol Violation|0|||
28070728|NCT00142935|54725480|FG001|Overall Study|Lost to Follow-up|5|||
28070729|NCT00142935|54725481|FG002|Overall Study|Lost to Follow-up|5|||
28070730|NCT00142935|54725479|FG000|Overall Study|Death|0|||
28070731|NCT00142935|54725480|FG001|Overall Study|Death|2|||
28070732|NCT00142935|54725481|FG002|Overall Study|Death|1|||
28070733|NCT00233948|54725495|FG000|Overall Study|Adverse Event|1|||
28070734|NCT00233948|54725496|FG001|Overall Study|Adverse Event|0|||
28070735|NCT00233948|54725497|FG002|Overall Study|Adverse Event|0|||
28070736|NCT00233948|54725498|FG003|Overall Study|Adverse Event|0|||
28070737|NCT00233948|54725499|FG004|Overall Study|Adverse Event|0|||
27821959|NCT01855789|54284132|FG003|2) Week 24 up to End of Study|Protocol Violation|1|||
27821960|NCT01855789|54284129|FG000|2) Week 24 up to End of Study|Withdrawal by Subject|0|||
27821961|NCT01855789|54284130|FG001|2) Week 24 up to End of Study|Withdrawal by Subject|7|||
27821962|NCT01855789|54284131|FG002|2) Week 24 up to End of Study|Withdrawal by Subject|5|||
27821963|NCT01855789|54284132|FG003|2) Week 24 up to End of Study|Withdrawal by Subject|8|||
27821964|NCT01855789|54284129|FG000|2) Week 24 up to End of Study|Physician Decision|0|||
27821965|NCT01855789|54284130|FG001|2) Week 24 up to End of Study|Physician Decision|0|||
27821966|NCT01855789|54284131|FG002|2) Week 24 up to End of Study|Physician Decision|2|||
27821967|NCT01855789|54284132|FG003|2) Week 24 up to End of Study|Physician Decision|4|||
27821968|NCT01855789|54284129|FG000|2) Week 24 up to End of Study|Participant Non-compliance|0|||
27849934|NCT03325608|54348264|FG002|Overall Study|Lost to Follow-up|41|||
28070738|NCT00233948|54725500|FG005|Overall Study|Adverse Event|0|||
28070739|NCT00233480|54725517|FG000|Overall Study|Underwent status II heart transplant|0|||
28070740|NCT00233480|54725518|FG001|Overall Study|Underwent status II heart transplant|1|||
28070741|NCT03801928|54725532|FG000|Overall Study|Adverse Event|1|||
28140942|NCT03073005|54806498|FG000|Overall Study|caregiver withdrew bc of pt death|0|||
28140943|NCT03073005|54806499|FG001|Overall Study|caregiver withdrew bc of pt death|6|||
28140944|NCT03073005|54806500|FG002|Overall Study|caregiver withdrew bc of pt death|0|||
28140945|NCT03073005|54806501|FG003|Overall Study|caregiver withdrew bc of pt death|7|||
28070742|NCT03801928|54725533|FG001|Overall Study|Adverse Event|0|||
28140946|NCT03073005|54806498|FG000|Overall Study|Lost to Follow-up|2|||
28140947|NCT03073005|54806499|FG001|Overall Study|Lost to Follow-up|2|||
28140948|NCT03073005|54806500|FG002|Overall Study|Lost to Follow-up|1|||
28140949|NCT03073005|54806501|FG003|Overall Study|Lost to Follow-up|2|||
28140950|NCT03073005|54806498|FG000|Overall Study|Withdrawal by Subject|0|||
28140951|NCT03073005|54806499|FG001|Overall Study|Withdrawal by Subject|4|||
28140952|NCT03073005|54806500|FG002|Overall Study|Withdrawal by Subject|4|||
28140953|NCT03073005|54806501|FG003|Overall Study|Withdrawal by Subject|4|||
28140954|NCT02849171|54806514|FG000|Overall Study|Withdrawal by Subject|1|||
28140955|NCT02849171|54806514|FG000|Overall Study|Not treated|1|||
28140956|NCT02848664|54806527|FG000|Overall Study|Withdrawal by Subject|2|||
28140957|NCT02848664|54806527|FG000|Overall Study|Adverse Event|1|||
28140958|NCT02848664|54806527|FG000|Overall Study|no assistance for device training|1|||
27821969|NCT01855789|54284130|FG001|2) Week 24 up to End of Study|Participant Non-compliance|1|||
27821970|NCT01855789|54284131|FG002|2) Week 24 up to End of Study|Participant Non-compliance|0|||
27849935|NCT03325608|54348265|FG003|Overall Study|Lost to Follow-up|41|||
28140959|NCT02969382|54806537|FG000|Overall Study|Adverse Event|8|||
28140960|NCT02969382|54806538|FG001|Overall Study|Adverse Event|10|||
28140961|NCT02969382|54806537|FG000|Overall Study|Lack of Efficacy|4|||
28140962|NCT02969382|54806538|FG001|Overall Study|Lack of Efficacy|5|||
28140963|NCT02969382|54806537|FG000|Overall Study|Death|0|||
28140964|NCT02969382|54806538|FG001|Overall Study|Death|1|||
28140965|NCT02969382|54806537|FG000|Overall Study|PROTOCOL DEVIATION|0|||
28140966|NCT02969382|54806538|FG001|Overall Study|PROTOCOL DEVIATION|1|||
28140967|NCT02969382|54806537|FG000|Overall Study|Withdrawal by Subject|14|||
28140968|NCT02969382|54806538|FG001|Overall Study|Withdrawal by Subject|9|||
28140969|NCT01989104|54806549|FG000|Overall Study|Withdrawal by Subject|3|||
28140970|NCT01989104|54806550|FG001|Overall Study|Withdrawal by Subject|0|||
28140971|NCT01989104|54806551|FG002|Overall Study|Withdrawal by Subject|0|||
28140972|NCT01989104|54806552|FG003|Overall Study|Withdrawal by Subject|0|||
28140973|NCT01989104|54806553|FG004|Overall Study|Withdrawal by Subject|0|||
28140974|NCT02903238|54806565|FG000|Overall Study|Lost to Follow-up|4|||
28140975|NCT02847260|54806570|FG000|Overall Study|Adverse Event|3|||
28140976|NCT02847260|54806570|FG000|Overall Study|Withdrawal by Subject|2|||
28140977|NCT02847260|54806570|FG000|Overall Study|Clinical Deterioration|1|||
28140978|NCT02847260|54806570|FG000|Overall Study|Physician Decision|1|||
28140979|NCT02968563|54806576|FG000|Overall Study|Adverse Event|0|||
28140980|NCT02968563|54806577|FG001|Overall Study|Adverse Event|6|||
28140981|NCT02968563|54806576|FG000|Overall Study|Death|1|||
28140982|NCT02968563|54806577|FG001|Overall Study|Death|1|||
28140983|NCT02968563|54806576|FG000|Overall Study|Lost to Follow-up|0|||
28140984|NCT02968563|54806577|FG001|Overall Study|Lost to Follow-up|1|||
28140985|NCT02904096|54806585|FG000|Overall Study|Adverse Event|1|||
28140986|NCT02904096|54806586|FG001|Overall Study|Adverse Event|0|||
28140987|NCT02904096|54806585|FG000|Overall Study|Withdrawal by Subject|4|||
28140988|NCT02904096|54806586|FG001|Overall Study|Withdrawal by Subject|3|||
28140989|NCT02904096|54806585|FG000|Overall Study|Lost to Follow-up|10|||
28140990|NCT02904096|54806586|FG001|Overall Study|Lost to Follow-up|17|||
28140991|NCT02904096|54806585|FG000|Overall Study|Non-compliant|3|||
28140992|NCT02904096|54806586|FG001|Overall Study|Non-compliant|1|||
28140993|NCT02904096|54806585|FG000|Overall Study|Sponsor instructed|1|||
28140994|NCT02904096|54806586|FG001|Overall Study|Sponsor instructed|0|||
28140995|NCT03161405|54806596|FG000|Second Intervention Period (6 Days)|Positive urine drug screen|1|||
28140996|NCT01813929|54806605|FG000|Overall Study|Withdrawal by Subject|0|||
28140997|NCT01813929|54806606|FG001|Overall Study|Withdrawal by Subject|1|||
28140998|NCT02901054|54806616|FG000|Overall Study|Physician Decision|1|||
28140999|NCT02901054|54806616|FG000|Overall Study|Withdrawal by Subject|3|||
28141000|NCT03068715|54806622|FG000|Overall Study|No longer met inclusion criteria|1|||
28141001|NCT03068715|54806623|FG001|Overall Study|No longer met inclusion criteria|0|||
28141002|NCT02966340|54806631|FG000|Overall Study|Adverse Event|0|||
28141003|NCT02966340|54806632|FG001|Overall Study|Adverse Event|1|||
28141004|NCT02966340|54806631|FG000|Overall Study|Lost to Follow-up|0|||
28141005|NCT02966340|54806632|FG001|Overall Study|Lost to Follow-up|1|||
28141006|NCT02966340|54806631|FG000|Overall Study|Withdrawal by Subject|1|||
28141007|NCT02966340|54806632|FG001|Overall Study|Withdrawal by Subject|0|||
28141008|NCT02966340|54806631|FG000|Overall Study|data acquisition error|1|||
28141009|NCT02966340|54806632|FG001|Overall Study|data acquisition error|0|||
28141010|NCT02966340|54806631|FG000|Overall Study|startle non-responder|1|||
28141011|NCT02966340|54806632|FG001|Overall Study|startle non-responder|1|||
28141012|NCT03067311|54806640|FG000|Overall Study|Lost to Follow-up|1|||
28141013|NCT03067311|54806641|FG001|Overall Study|Lost to Follow-up|1|||
27849936|NCT03325608|54348262|FG000|Overall Study|Death|44|||
28141014|NCT03067311|54806640|FG000|Overall Study|Moved away|1|||
28141015|NCT03067311|54806641|FG001|Overall Study|Moved away|1|||
28141016|NCT04380519|54806650|FG000|Overall Study|Withdrawal by Subject|4|||
28141017|NCT04380519|54806651|FG001|Overall Study|Withdrawal by Subject|0|||
28141018|NCT04380519|54806652|FG002|Overall Study|Withdrawal by Subject|1|||
28141019|NCT04380519|54806650|FG000|Overall Study|Death|14|||
28141020|NCT04380519|54806651|FG001|Overall Study|Death|9|||
28141021|NCT04380519|54806652|FG002|Overall Study|Death|6|||
28141022|NCT04380519|54806650|FG000|Overall Study|Adverse Event|0|||
28141023|NCT04380519|54806651|FG001|Overall Study|Adverse Event|1|||
28141024|NCT04380519|54806652|FG002|Overall Study|Adverse Event|0|||
28141025|NCT04380519|54806650|FG000|Overall Study|relatives' decision|0|||
28141026|NCT04380519|54806651|FG001|Overall Study|relatives' decision|1|||
28141027|NCT04380519|54806652|FG002|Overall Study|relatives' decision|0|||
28141028|NCT02847182|54806662|FG000|Overall Study|Withdrawal by Subject|0|||
28141029|NCT02847182|54806663|FG001|Overall Study|Withdrawal by Subject|1|||
28141030|NCT02846558|54806679|FG000|Overall Study|Adverse Event|1|||
28141031|NCT02846558|54806680|FG001|Overall Study|Adverse Event|0|||
28141032|NCT02846558|54806681|FG002|Overall Study|Adverse Event|0|||
28141033|NCT02846558|54806682|FG003|Overall Study|Adverse Event|0|||
28141034|NCT02846558|54806679|FG000|Overall Study|Withdrawal by Subject|5|||
28141035|NCT02846558|54806680|FG001|Overall Study|Withdrawal by Subject|4|||
28141036|NCT02846558|54806681|FG002|Overall Study|Withdrawal by Subject|2|||
28141037|NCT02846558|54806682|FG003|Overall Study|Withdrawal by Subject|2|||
28141038|NCT02846558|54806679|FG000|Overall Study|Lost to Follow-up|2|||
28141039|NCT02846558|54806680|FG001|Overall Study|Lost to Follow-up|0|||
28141040|NCT02846558|54806681|FG002|Overall Study|Lost to Follow-up|0|||
28141041|NCT02846558|54806682|FG003|Overall Study|Lost to Follow-up|0|||
28141042|NCT04362813|54806701|FG000|Overall Study|Death|12|||
28141043|NCT04362813|54806702|FG001|Overall Study|Death|16|||
28141044|NCT04362813|54806701|FG000|Overall Study|Withdrawal by Subject|3|||
28141045|NCT04362813|54806702|FG001|Overall Study|Withdrawal by Subject|1|||
28141046|NCT04362813|54806701|FG000|Overall Study|Protocol Violation|0|||
28141047|NCT04362813|54806702|FG001|Overall Study|Protocol Violation|3|||
28141048|NCT04362813|54806701|FG000|Overall Study|Lost to Follow-up|1|||
28141049|NCT04362813|54806702|FG001|Overall Study|Lost to Follow-up|1|||
28141050|NCT04362813|54806701|FG000|Overall Study|Enrolled but did not receive treatment|2|||
28141051|NCT04362813|54806702|FG001|Overall Study|Enrolled but did not receive treatment|4|||
27849937|NCT03325608|54348263|FG001|Overall Study|Death|0|||
28141052|NCT02966028|54806711|FG000|Overall Study|Adverse Event|7|||
28141053|NCT02966028|54806712|FG001|Overall Study|Adverse Event|13|||
28141054|NCT02966028|54806713|FG002|Overall Study|Adverse Event|10|||
28141055|NCT02966028|54806711|FG000|Overall Study|Physician Decision|1|||
28141056|NCT02966028|54806712|FG001|Overall Study|Physician Decision|0|||
28141057|NCT02966028|54806713|FG002|Overall Study|Physician Decision|2|||
28141058|NCT02966028|54806711|FG000|Overall Study|Withdrawal by Subject|7|||
28141059|NCT02966028|54806712|FG001|Overall Study|Withdrawal by Subject|5|||
28141060|NCT02966028|54806713|FG002|Overall Study|Withdrawal by Subject|5|||
28141061|NCT02966028|54806711|FG000|Overall Study|Kidney transplant Changed dialysis units|9|||
28141062|NCT02966028|54806712|FG001|Overall Study|Kidney transplant Changed dialysis units|16|||
28141063|NCT02966028|54806713|FG002|Overall Study|Kidney transplant Changed dialysis units|14|||
27849938|NCT03325608|54348264|FG002|Overall Study|Death|41|||
27941172|NCT01026831|54597485|FG000|Overall Study|Lost to Follow-up|2|||
27941173|NCT01026831|54597486|FG001|Overall Study|Lost to Follow-up|0|||
27941174|NCT01026831|54597485|FG000|Overall Study|Physician Decision|1|||
28141064|NCT02925741|54806727|FG000|Overall Study|Withdrawal by Subject|11|||
27941175|NCT01026831|54597486|FG001|Overall Study|Physician Decision|1|||
28141065|NCT02925741|54806728|FG001|Overall Study|Withdrawal by Subject|0|||
27821971|NCT01855789|54284132|FG003|2) Week 24 up to End of Study|Participant Non-compliance|1|||
28141066|NCT02964312|54806737|FG000|Overall Study|Lost to Follow-up|28|||
28141067|NCT02964312|54806737|FG000|Overall Study|Withdrawal by Subject|11|||
28141068|NCT02964312|54806737|FG000|Overall Study|Lack of Efficacy|10|||
28141069|NCT02964312|54806737|FG000|Overall Study|Did not consent to long-term FU|14|||
28141070|NCT02964312|54806737|FG000|Overall Study|Death|1|||
28141071|NCT02899962|54806761|FG000|Open-label Phase|Adverse Event|2|||
28141072|NCT02899962|54806762|FG001|Open-label Phase|Adverse Event|0|||
28141073|NCT02899962|54806763|FG002|Open-label Phase|Adverse Event|0|||
28141074|NCT02899962|54806761|FG000|Open-label Phase|Lost to Follow-up|9|||
28141075|NCT02899962|54806762|FG001|Open-label Phase|Lost to Follow-up|0|||
28141076|NCT02899962|54806763|FG002|Open-label Phase|Lost to Follow-up|0|||
28141077|NCT02899962|54806761|FG000|Open-label Phase|Other reasons|9|||
28141078|NCT02899962|54806762|FG001|Open-label Phase|Other reasons|0|||
28141079|NCT02899962|54806763|FG002|Open-label Phase|Other reasons|0|||
28141080|NCT02899962|54806761|FG000|Open-label Phase|Withdrawal by Subject|7|||
27821972|NCT01855789|54284129|FG000|2) Week 24 up to End of Study|Sponsor Decision|0|||
28141081|NCT02899962|54806762|FG001|Open-label Phase|Withdrawal by Subject|0|||
27849939|NCT03325608|54348265|FG003|Overall Study|Death|0|||
28141082|NCT02899962|54806763|FG002|Open-label Phase|Withdrawal by Subject|0|||
28141083|NCT02899962|54806761|FG000|Maintenance Phase|Adverse Event|0|||
28141084|NCT02899962|54806762|FG001|Maintenance Phase|Adverse Event|2|||
28141085|NCT02899962|54806763|FG002|Maintenance Phase|Adverse Event|1|||
28141086|NCT02899962|54806761|FG000|Maintenance Phase|Death|0|||
28141087|NCT02899962|54806762|FG001|Maintenance Phase|Death|0|||
27821973|NCT01855789|54284130|FG001|2) Week 24 up to End of Study|Sponsor Decision|0|||
27821974|NCT01855789|54284131|FG002|2) Week 24 up to End of Study|Sponsor Decision|0|||
28141088|NCT02899962|54806763|FG002|Maintenance Phase|Death|1|||
28141089|NCT02899962|54806761|FG000|Maintenance Phase|Lack of Efficacy|0|||
28141090|NCT02899962|54806762|FG001|Maintenance Phase|Lack of Efficacy|20|||
28141091|NCT02899962|54806763|FG002|Maintenance Phase|Lack of Efficacy|16|||
28141092|NCT02899962|54806761|FG000|Maintenance Phase|Lost to Follow-up|0|||
28141093|NCT02899962|54806762|FG001|Maintenance Phase|Lost to Follow-up|12|||
28141094|NCT02899962|54806763|FG002|Maintenance Phase|Lost to Follow-up|14|||
28141095|NCT02899962|54806761|FG000|Maintenance Phase|Other reasons|0|||
28141096|NCT02899962|54806762|FG001|Maintenance Phase|Other reasons|9|||
28141097|NCT02899962|54806763|FG002|Maintenance Phase|Other reasons|13|||
28141098|NCT02899962|54806761|FG000|Maintenance Phase|Not achieve treatment success after Wk 4|0|||
28141099|NCT02899962|54806762|FG001|Maintenance Phase|Not achieve treatment success after Wk 4|3|||
28141100|NCT02899962|54806763|FG002|Maintenance Phase|Not achieve treatment success after Wk 4|2|||
28141101|NCT02899962|54806761|FG000|Maintenance Phase|Not clear/almost clear after rescue med|0|||
28141102|NCT02899962|54806762|FG001|Maintenance Phase|Not clear/almost clear after rescue med|65|||
28141103|NCT02899962|54806763|FG002|Maintenance Phase|Not clear/almost clear after rescue med|70|||
27821975|NCT01855789|54284132|FG003|2) Week 24 up to End of Study|Sponsor Decision|1|||
27821976|NCT01855789|54284129|FG000|2) Week 24 up to End of Study|Other|0|||
28141104|NCT02899962|54806761|FG000|Maintenance Phase|Withdrawal by Subject|0|||
27821977|NCT01855789|54284130|FG001|2) Week 24 up to End of Study|Other|0|||
28141105|NCT02899962|54806762|FG001|Maintenance Phase|Withdrawal by Subject|30|||
28141106|NCT02899962|54806763|FG002|Maintenance Phase|Withdrawal by Subject|36|||
28141107|NCT02899728|54806772|FG000|Overall Study|Withdrawal by Subject|1|||
28141108|NCT02899728|54806773|FG001|Overall Study|Withdrawal by Subject|1|||
28141109|NCT02899338|54806781|FG000|Overall Study|Adverse Event|1|||
28141110|NCT02899338|54806782|FG001|Overall Study|Adverse Event|2|||
28141111|NCT02899338|54806781|FG000|Overall Study|Withdrawal by Subject|2|||
28141112|NCT02899338|54806782|FG001|Overall Study|Withdrawal by Subject|0|||
28141113|NCT03066609|54806791|FG000|INDUCTION|Pregnancy|0|||
28141114|NCT03066609|54806792|FG001|INDUCTION|Pregnancy|0|||
28141115|NCT03066609|54806793|FG002|INDUCTION|Pregnancy|1|||
28141116|NCT03066609|54806794|FG003|INDUCTION|Pregnancy|0|||
28141117|NCT03066609|54806791|FG000|INDUCTION|Lack of Efficacy|0|||
28141118|NCT03066609|54806792|FG001|INDUCTION|Lack of Efficacy|0|||
28141119|NCT03066609|54806793|FG002|INDUCTION|Lack of Efficacy|1|||
28141120|NCT03066609|54806794|FG003|INDUCTION|Lack of Efficacy|0|||
28141121|NCT03066609|54806791|FG000|INDUCTION|Adverse Event|2|||
28141122|NCT03066609|54806792|FG001|INDUCTION|Adverse Event|2|||
28141123|NCT03066609|54806793|FG002|INDUCTION|Adverse Event|0|||
27821978|NCT01855789|54284131|FG002|2) Week 24 up to End of Study|Other|0|||
27821979|NCT01855789|54284132|FG003|2) Week 24 up to End of Study|Other|1|||
28141124|NCT03066609|54806794|FG003|INDUCTION|Adverse Event|0|||
28141125|NCT03066609|54806791|FG000|MAINTENANCE|Adverse Event|0|||
28141126|NCT03066609|54806792|FG001|MAINTENANCE|Adverse Event|0|||
28141127|NCT03066609|54806793|FG002|MAINTENANCE|Adverse Event|0|||
28141128|NCT03066609|54806794|FG003|MAINTENANCE|Adverse Event|1|||
28141129|NCT03066609|54806791|FG000|MAINTENANCE|Withdrawal by Subject|4|||
28141130|NCT03066609|54806792|FG001|MAINTENANCE|Withdrawal by Subject|2|||
28141131|NCT03066609|54806793|FG002|MAINTENANCE|Withdrawal by Subject|1|||
28141132|NCT03066609|54806794|FG003|MAINTENANCE|Withdrawal by Subject|1|||
28141133|NCT03066609|54806791|FG000|MAINTENANCE|Lost to Follow-up|0|||
28141134|NCT03066609|54806792|FG001|MAINTENANCE|Lost to Follow-up|1|||
28141135|NCT03066609|54806793|FG002|MAINTENANCE|Lost to Follow-up|1|||
28141136|NCT03066609|54806794|FG003|MAINTENANCE|Lost to Follow-up|0|||
28141137|NCT03066609|54806791|FG000|MAINTENANCE|Pregnancy|1|||
28141138|NCT03066609|54806792|FG001|MAINTENANCE|Pregnancy|0|||
28141139|NCT03066609|54806793|FG002|MAINTENANCE|Pregnancy|0|||
28141140|NCT03066609|54806794|FG003|MAINTENANCE|Pregnancy|0|||
28141141|NCT03066609|54806791|FG000|MAINTENANCE|Lack of Efficacy|2|||
28141142|NCT03066609|54806792|FG001|MAINTENANCE|Lack of Efficacy|1|||
28141143|NCT03066609|54806793|FG002|MAINTENANCE|Lack of Efficacy|0|||
28141144|NCT03066609|54806794|FG003|MAINTENANCE|Lack of Efficacy|1|||
28141145|NCT03066609|54806791|FG000|OVERALL STUDY|Adverse Event|2|||
28141146|NCT03066609|54806792|FG001|OVERALL STUDY|Adverse Event|2|||
28141147|NCT03066609|54806793|FG002|OVERALL STUDY|Adverse Event|0|||
28141148|NCT03066609|54806794|FG003|OVERALL STUDY|Adverse Event|1|||
28141149|NCT03066609|54806791|FG000|OVERALL STUDY|Withdrawal by Subject|4|||
28141150|NCT03066609|54806792|FG001|OVERALL STUDY|Withdrawal by Subject|2|||
28141151|NCT03066609|54806793|FG002|OVERALL STUDY|Withdrawal by Subject|1|||
28141152|NCT03066609|54806794|FG003|OVERALL STUDY|Withdrawal by Subject|2|||
28141153|NCT03066609|54806791|FG000|OVERALL STUDY|Lost to Follow-up|1|||
28141154|NCT03066609|54806792|FG001|OVERALL STUDY|Lost to Follow-up|1|||
28141155|NCT03066609|54806793|FG002|OVERALL STUDY|Lost to Follow-up|1|||
28141156|NCT03066609|54806794|FG003|OVERALL STUDY|Lost to Follow-up|1|||
28141157|NCT03066609|54806791|FG000|OVERALL STUDY|Pregnancy|1|||
28141158|NCT03066609|54806792|FG001|OVERALL STUDY|Pregnancy|0|||
28141159|NCT03066609|54806793|FG002|OVERALL STUDY|Pregnancy|1|||
28141160|NCT03066609|54806794|FG003|OVERALL STUDY|Pregnancy|0|||
28141161|NCT03066609|54806791|FG000|OVERALL STUDY|Lack of Efficacy|2|||
28141162|NCT03066609|54806792|FG001|OVERALL STUDY|Lack of Efficacy|1|||
28141163|NCT03066609|54806793|FG002|OVERALL STUDY|Lack of Efficacy|1|||
28141164|NCT03066609|54806794|FG003|OVERALL STUDY|Lack of Efficacy|1|||
28141165|NCT03066609|54806791|FG000|OVERALL STUDY|discontinued follow up|0|||
28141166|NCT03066609|54806792|FG001|OVERALL STUDY|discontinued follow up|2|||
27821980|NCT01610791|54284138|FG000|Overall Study|Lost to Follow-up|7|||
27821981|NCT01610791|54284138|FG000|Overall Study|Adverse Event|6|||
28141167|NCT03066609|54806793|FG002|OVERALL STUDY|discontinued follow up|0|||
28141168|NCT03066609|54806794|FG003|OVERALL STUDY|discontinued follow up|0|||
28141169|NCT02964234|54806811|FG000|Overall Study|Lost to Follow-up|22|||
28141170|NCT02964234|54806812|FG001|Overall Study|Lost to Follow-up|13|||
28141171|NCT01345188|54806818|FG000|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2|||
28141172|NCT01345188|54806818|FG000|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1|||
28141173|NCT03852459|54806827|FG000|Overall Study|Adverse Event|2|||
28141174|NCT03852459|54806828|FG001|Overall Study|Adverse Event|2|||
27821982|NCT01610791|54284138|FG000|Overall Study|Physician Decision|1|||
27821983|NCT01610791|54284138|FG000|Overall Study|Adverse event and Investigator decision|1|||
28141175|NCT03852459|54806827|FG000|Overall Study|Withdrawal by Subject|1|||
28141176|NCT03852459|54806828|FG001|Overall Study|Withdrawal by Subject|1|||
28141177|NCT02896296|54806834|FG000|Overall Study|Adverse Event|1|||
27821984|NCT01610791|54284138|FG000|Overall Study|Death|1|||
27821985|NCT01610791|54284138|FG000|Overall Study|Not determined|5|||
27821986|NCT01876381|54284142|FG000|Overall Study|Lack of Efficacy|5|||
27821987|NCT01876381|54284142|FG000|Overall Study|Physician Decision|1|||
27821988|NCT01876381|54284142|FG000|Overall Study|Withdrawal by Subject|1|||
27821989|NCT01855399|54284157|FG000|6 Month|Lost to Follow-up|12|||
27821990|NCT01855399|54284158|FG001|6 Month|Lost to Follow-up|9|||
27821991|NCT01855399|54284157|FG000|6 Month|Withdrawal by Subject|8|||
27821992|NCT01855399|54284158|FG001|6 Month|Withdrawal by Subject|6|||
27821993|NCT01855399|54284157|FG000|12 Month|Lost to Follow-up|7|||
27821994|NCT01855399|54284158|FG001|12 Month|Lost to Follow-up|11|||
27821995|NCT01875991|54284166|FG000|Overall Study|Withdrawal by Subject|6|||
27821996|NCT01875991|54284167|FG001|Overall Study|Withdrawal by Subject|6|||
27821997|NCT01875991|54284166|FG000|Overall Study|Sponsor Decision|1|||
27821998|NCT01875991|54284167|FG001|Overall Study|Sponsor Decision|0|||
28141178|NCT02896296|54806834|FG000|Overall Study|Lost to Follow-up|19|||
28141179|NCT02896296|54806834|FG000|Overall Study|Pregnancy|1|||
28141180|NCT02896296|54806834|FG000|Overall Study|Physician Decision|2|||
28141181|NCT02896296|54806834|FG000|Overall Study|Withdrawal by Subject|10|||
28141182|NCT02896296|54806834|FG000|Overall Study|Site closing|7|||
28141183|NCT02896296|54806834|FG000|Overall Study|Incarceration|1|||
28141184|NCT02896296|54806834|FG000|Overall Study|Relocation|1|||
28141185|NCT03740919|54806841|FG000|Lead-in Period|Lost to Follow-up|1|||
28141186|NCT03740919|54806842|FG001|Lead-in Period|Lost to Follow-up|0|||
28141187|NCT03740919|54806843|FG002|Lead-in Period|Lost to Follow-up|0|||
28141188|NCT03740919|54806844|FG003|Lead-in Period|Lost to Follow-up|0|||
28141189|NCT03740919|54806841|FG000|Lead-in Period|Physician Decision|2|||
28141190|NCT03740919|54806842|FG001|Lead-in Period|Physician Decision|0|||
28141191|NCT03740919|54806843|FG002|Lead-in Period|Physician Decision|0|||
28141192|NCT03740919|54806844|FG003|Lead-in Period|Physician Decision|0|||
28141193|NCT03740919|54806841|FG000|Lead-in Period|Protocol Violation|1|||
28141194|NCT03740919|54806842|FG001|Lead-in Period|Protocol Violation|0|||
28141195|NCT03740919|54806843|FG002|Lead-in Period|Protocol Violation|0|||
28141196|NCT03740919|54806844|FG003|Lead-in Period|Protocol Violation|0|||
28141197|NCT03740919|54806841|FG000|Lead-in Period|Withdrawal by Subject|10|||
28141198|NCT03740919|54806842|FG001|Lead-in Period|Withdrawal by Subject|0|||
28141199|NCT03740919|54806843|FG002|Lead-in Period|Withdrawal by Subject|0|||
28141200|NCT03740919|54806844|FG003|Lead-in Period|Withdrawal by Subject|0|||
28141201|NCT03740919|54806841|FG000|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|18|||
28141202|NCT03740919|54806842|FG001|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
28141203|NCT03740919|54806843|FG002|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
28141204|NCT03740919|54806844|FG003|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
28141205|NCT03740919|54806841|FG000|Lead-in Period|Study Task Too Burdensome|1|||
28141206|NCT03740919|54806842|FG001|Lead-in Period|Study Task Too Burdensome|0|||
28141207|NCT03740919|54806843|FG002|Lead-in Period|Study Task Too Burdensome|0|||
27941176|NCT01026831|54597485|FG000|Overall Study|Protocol Violation|0|||
28070743|NCT03801928|54725534|FG002|Overall Study|Adverse Event|1|||
27941177|NCT01026831|54597486|FG001|Overall Study|Protocol Violation|2|||
27941178|NCT01026831|54597485|FG000|Overall Study|Withdrawal by Subject|7|||
28141208|NCT03740919|54806844|FG003|Lead-in Period|Study Task Too Burdensome|0|||
28141209|NCT03740919|54806841|FG000|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|1|||
28141210|NCT03740919|54806842|FG001|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
28141211|NCT03740919|54806843|FG002|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
28141212|NCT03740919|54806844|FG003|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
28141213|NCT03740919|54806841|FG000|Lead-in Period|Withdrew Consent Due to Required Procedures|1|||
28141214|NCT03740919|54806842|FG001|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
28141215|NCT03740919|54806843|FG002|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
28141216|NCT03740919|54806844|FG003|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
28141217|NCT03740919|54806841|FG000|Treatment Period|Adverse Event|0|||
28141218|NCT03740919|54806842|FG001|Treatment Period|Adverse Event|0|||
28141219|NCT03740919|54806843|FG002|Treatment Period|Adverse Event|2|||
28141220|NCT03740919|54806844|FG003|Treatment Period|Adverse Event|0|||
28141221|NCT03740919|54806841|FG000|Treatment Period|Protocol Violation|0|||
28141222|NCT03740919|54806842|FG001|Treatment Period|Protocol Violation|1|||
28141223|NCT03740919|54806843|FG002|Treatment Period|Protocol Violation|0|||
28141224|NCT03740919|54806844|FG003|Treatment Period|Protocol Violation|0|||
28141225|NCT03740919|54806841|FG000|Treatment Period|Withdrawal by Subject|0|||
28141226|NCT03740919|54806842|FG001|Treatment Period|Withdrawal by Subject|7|||
28141227|NCT03740919|54806843|FG002|Treatment Period|Withdrawal by Subject|6|||
28141228|NCT03740919|54806844|FG003|Treatment Period|Withdrawal by Subject|2|||
28141229|NCT03740919|54806841|FG000|Treatment Period|Terminated by Sponsor|0|||
27821999|NCT01855243|54284179|FG000|Overall Study|develpoed diabetic ketoacidosis|1|||
27822000|NCT01855243|54284180|FG001|Overall Study|develpoed diabetic ketoacidosis|0|||
27822001|NCT01855243|54284181|FG002|Overall Study|develpoed diabetic ketoacidosis|0|||
27822002|NCT01825837|54284193|FG000|PART I|Withdrawal by Subject|0|||
27822003|NCT01825837|54284194|FG001|PART I|Withdrawal by Subject|0|||
27822004|NCT01825837|54284195|FG002|PART I|Withdrawal by Subject|0|||
27822005|NCT01825837|54284196|FG003|PART I|Withdrawal by Subject|6|||
27822006|NCT01825837|54284193|FG000|PART I|Patient non-compliance|0|||
27822007|NCT01825837|54284194|FG001|PART I|Patient non-compliance|0|||
27849940|NCT03325608|54348262|FG000|Overall Study|Death of Care Recipient|0|||
27849941|NCT03325608|54348263|FG001|Overall Study|Death of Care Recipient|44|||
27941179|NCT01026831|54597486|FG001|Overall Study|Withdrawal by Subject|5|||
28141230|NCT03740919|54806842|FG001|Treatment Period|Terminated by Sponsor|1|||
28141231|NCT03740919|54806843|FG002|Treatment Period|Terminated by Sponsor|0|||
28141232|NCT03740919|54806844|FG003|Treatment Period|Terminated by Sponsor|0|||
28141233|NCT03740919|54806841|FG000|Treatment Period|Issue with Insulin Pump|0|||
28141234|NCT03740919|54806842|FG001|Treatment Period|Issue with Insulin Pump|1|||
28141235|NCT03740919|54806843|FG002|Treatment Period|Issue with Insulin Pump|0|||
28141236|NCT03740919|54806844|FG003|Treatment Period|Issue with Insulin Pump|0|||
28141237|NCT03740919|54806841|FG000|Treatment Period|Due to COVID-19 Pandemic|0|||
28141238|NCT03740919|54806842|FG001|Treatment Period|Due to COVID-19 Pandemic|0|||
28141239|NCT03740919|54806843|FG002|Treatment Period|Due to COVID-19 Pandemic|3|||
28141240|NCT03740919|54806844|FG003|Treatment Period|Due to COVID-19 Pandemic|1|||
28141241|NCT03740919|54806841|FG000|Treatment Period|Failure of Inclusion Criteria|0|||
28141242|NCT03740919|54806842|FG001|Treatment Period|Failure of Inclusion Criteria|0|||
28141243|NCT03740919|54806843|FG002|Treatment Period|Failure of Inclusion Criteria|1|||
28141244|NCT03740919|54806844|FG003|Treatment Period|Failure of Inclusion Criteria|0|||
28141245|NCT03740919|54806841|FG000|Treatment Period|Not Completing Diary|0|||
28141246|NCT03740919|54806842|FG001|Treatment Period|Not Completing Diary|0|||
28141247|NCT03740919|54806843|FG002|Treatment Period|Not Completing Diary|1|||
27822008|NCT01825837|54284195|FG002|PART I|Patient non-compliance|0|||
27822009|NCT01825837|54284196|FG003|PART I|Patient non-compliance|1|||
28141248|NCT03740919|54806844|FG003|Treatment Period|Not Completing Diary|0|||
28141249|NCT03740919|54806841|FG000|Treatment Period|Insulin Painful to Participant|0|||
28141250|NCT03740919|54806842|FG001|Treatment Period|Insulin Painful to Participant|0|||
28141251|NCT03740919|54806843|FG002|Treatment Period|Insulin Painful to Participant|1|||
28141252|NCT03740919|54806844|FG003|Treatment Period|Insulin Painful to Participant|0|||
28141253|NCT01335685|54806859|FG000|Overall Study|Study Terminated by Sponsor|2|||
28141254|NCT01335685|54806860|FG001|Overall Study|Study Terminated by Sponsor|1|||
28141255|NCT01335685|54806861|FG002|Overall Study|Study Terminated by Sponsor|1|||
28141256|NCT01335685|54806862|FG003|Overall Study|Study Terminated by Sponsor|10|||
28141257|NCT01335685|54806863|FG004|Overall Study|Study Terminated by Sponsor|0|||
28141258|NCT01335685|54806864|FG005|Overall Study|Study Terminated by Sponsor|4|||
28141259|NCT01335685|54806865|FG006|Overall Study|Study Terminated by Sponsor|2|||
28141260|NCT01335685|54806866|FG007|Overall Study|Study Terminated by Sponsor|3|||
28141261|NCT01335685|54806859|FG000|Overall Study|Withdrawal by Subject|1|||
28141262|NCT01335685|54806860|FG001|Overall Study|Withdrawal by Subject|0|||
28141263|NCT01335685|54806861|FG002|Overall Study|Withdrawal by Subject|0|||
28141264|NCT01335685|54806862|FG003|Overall Study|Withdrawal by Subject|1|||
28141265|NCT01335685|54806863|FG004|Overall Study|Withdrawal by Subject|0|||
28141266|NCT01335685|54806864|FG005|Overall Study|Withdrawal by Subject|0|||
28141267|NCT01335685|54806865|FG006|Overall Study|Withdrawal by Subject|0|||
28141268|NCT01335685|54806866|FG007|Overall Study|Withdrawal by Subject|0|||
28141269|NCT01335685|54806859|FG000|Overall Study|Reason not Specified|0|||
28141270|NCT01335685|54806860|FG001|Overall Study|Reason not Specified|0|||
28141271|NCT01335685|54806861|FG002|Overall Study|Reason not Specified|1|||
28141272|NCT01335685|54806862|FG003|Overall Study|Reason not Specified|0|||
28141273|NCT01335685|54806863|FG004|Overall Study|Reason not Specified|0|||
28141274|NCT01335685|54806864|FG005|Overall Study|Reason not Specified|1|||
28141275|NCT01335685|54806865|FG006|Overall Study|Reason not Specified|0|||
28141276|NCT01335685|54806866|FG007|Overall Study|Reason not Specified|0|||
28141277|NCT02926209|54806889|FG000|Study Cohort|Poor Bowel Preparation|1|||
28141278|NCT02926209|54806890|FG001|Study Cohort|Poor Bowel Preparation|0|||
28141279|NCT03066999|54806899|FG000|Overall Study|abnormal urethraBladder neck contracture|0|||
28141280|NCT03066999|54806900|FG001|Overall Study|abnormal urethraBladder neck contracture|2|||
28141281|NCT02963922|54806914|FG000|Overall Study|Adverse Event|15|||
28141282|NCT02963922|54806915|FG001|Overall Study|Adverse Event|6|||
28141283|NCT02963922|54806914|FG000|Overall Study|Protocol deviation|6|||
28141284|NCT02963922|54806915|FG001|Overall Study|Protocol deviation|6|||
28141285|NCT02963922|54806914|FG000|Overall Study|Lack of Efficacy|1|||
28141286|NCT02963922|54806915|FG001|Overall Study|Lack of Efficacy|1|||
28141287|NCT02963922|54806914|FG000|Overall Study|Lost to Follow-up|2|||
28141288|NCT02963922|54806915|FG001|Overall Study|Lost to Follow-up|3|||
28141289|NCT02963922|54806914|FG000|Overall Study|Other|8|||
28141290|NCT02963922|54806915|FG001|Overall Study|Other|14|||
28141291|NCT02881567|54806921|FG000|Overall Study|Adverse Event|1|||
28141292|NCT02881567|54806921|FG000|Overall Study|Lost to Follow-up|3|||
28141293|NCT02881567|54806921|FG000|Overall Study|Consent withdrawn|1|||
28141294|NCT02881567|54806921|FG000|Overall Study|Investigator decision|1|||
28141295|NCT02881567|54806921|FG000|Overall Study|Study terminated by sponsor|9|||
28141296|NCT02881567|54806921|FG000|Overall Study|Reason not Specified|3|||
28141297|NCT02962674|54806925|FG000|Overall Study|Study terminated by sponsor prior to completion of all study protocol visits by enrolled subjects.|49|||
28141298|NCT02962908|54806935|FG000|Overall Study|Lost to Follow-up|0|||
28141299|NCT02962908|54806936|FG001|Overall Study|Lost to Follow-up|3|||
28141300|NCT02962908|54806937|FG002|Overall Study|Lost to Follow-up|0|||
28141301|NCT02962908|54806938|FG003|Overall Study|Lost to Follow-up|1|||
28141302|NCT02962908|54806935|FG000|Overall Study|Withdrawal by Subject|0|||
27849942|NCT03325608|54348264|FG002|Overall Study|Death of Care Recipient|0|||
28141303|NCT02962908|54806936|FG001|Overall Study|Withdrawal by Subject|3|||
28141304|NCT02962908|54806937|FG002|Overall Study|Withdrawal by Subject|0|||
28141305|NCT02962908|54806938|FG003|Overall Study|Withdrawal by Subject|2|||
28141306|NCT02962908|54806935|FG000|Overall Study|Protocol Violation|0|||
28141307|NCT02962908|54806936|FG001|Overall Study|Protocol Violation|1|||
28141308|NCT02962908|54806937|FG002|Overall Study|Protocol Violation|0|||
28141309|NCT02962908|54806938|FG003|Overall Study|Protocol Violation|0|||
28141310|NCT02962908|54806935|FG000|Overall Study|Physician Decision|0|||
28141311|NCT02962908|54806936|FG001|Overall Study|Physician Decision|1|||
28141312|NCT02962908|54806937|FG002|Overall Study|Physician Decision|0|||
28141313|NCT02962908|54806938|FG003|Overall Study|Physician Decision|0|||
28141314|NCT02962284|54806956|FG000|Overall Study|Death|2|||
28141315|NCT02962284|54806957|FG001|Overall Study|Death|0|||
28141316|NCT02962284|54806956|FG000|Overall Study|Progressive disease|2|||
28141317|NCT02962284|54806957|FG001|Overall Study|Progressive disease|3|||
28141318|NCT02962284|54806956|FG000|Overall Study|Withdrawal by Subject|1|||
28141319|NCT02962284|54806957|FG001|Overall Study|Withdrawal by Subject|0|||
28141320|NCT01344876|54806965|FG000|Overall Study|Adverse Event|0|||
28141321|NCT01344876|54806966|FG001|Overall Study|Adverse Event|0|||
28141322|NCT01344876|54806967|FG002|Overall Study|Adverse Event|0|||
28141323|NCT01344876|54806968|FG003|Overall Study|Adverse Event|0|||
28141324|NCT01344876|54806969|FG004|Overall Study|Adverse Event|1|||
28141325|NCT01344876|54806965|FG000|Overall Study|Withdrawal by Subject|0|||
28141326|NCT01344876|54806966|FG001|Overall Study|Withdrawal by Subject|0|||
28141327|NCT01344876|54806967|FG002|Overall Study|Withdrawal by Subject|1|||
28141328|NCT01344876|54806968|FG003|Overall Study|Withdrawal by Subject|0|||
28141329|NCT01344876|54806969|FG004|Overall Study|Withdrawal by Subject|0|||
28141330|NCT01344876|54806965|FG000|Overall Study|Definite progression of primary disease|1|||
28141331|NCT01344876|54806966|FG001|Overall Study|Definite progression of primary disease|0|||
28141332|NCT01344876|54806967|FG002|Overall Study|Definite progression of primary disease|0|||
28141333|NCT01344876|54806968|FG003|Overall Study|Definite progression of primary disease|3|||
28141334|NCT01344876|54806969|FG004|Overall Study|Definite progression of primary disease|0|||
28141335|NCT02846324|54806986|FG000|Overall Study|Other|1|||
28141336|NCT02846324|54806987|FG001|Overall Study|Other|0|||
28141337|NCT02846324|54806988|FG002|Overall Study|Other|0|||
28141338|NCT02846324|54806989|FG003|Overall Study|Other|0|||
28141339|NCT02846324|54806986|FG000|Overall Study|Withdrawal by Subject|1|||
28141340|NCT02846324|54806987|FG001|Overall Study|Withdrawal by Subject|0|||
28141341|NCT02846324|54806988|FG002|Overall Study|Withdrawal by Subject|4|||
28141342|NCT02846324|54806989|FG003|Overall Study|Withdrawal by Subject|0|||
28141343|NCT03161093|54807014|FG000|Overall Study|Protocol Violation|11|||
28141344|NCT03161093|54807015|FG001|Overall Study|Protocol Violation|14|||
28141345|NCT03161093|54807016|FG002|Overall Study|Protocol Violation|6|||
28141346|NCT03161093|54807017|FG003|Overall Study|Protocol Violation|13|||
28141347|NCT03161093|54807018|FG004|Overall Study|Protocol Violation|1|||
28141348|NCT03161093|54807019|FG005|Overall Study|Protocol Violation|0|||
27822010|NCT01825837|54284193|FG000|PART I|Treatment failure|0|||
27822011|NCT01825837|54284194|FG001|PART I|Treatment failure|0|||
27941180|NCT01016067|54597494|FG000|Overall Study|Lost to Follow-up|1|||
28141349|NCT03161093|54807014|FG000|Overall Study|Adverse Event|5|||
28141350|NCT03161093|54807015|FG001|Overall Study|Adverse Event|21|||
28141351|NCT03161093|54807016|FG002|Overall Study|Adverse Event|16|||
28141352|NCT03161093|54807017|FG003|Overall Study|Adverse Event|35|||
28141353|NCT03161093|54807018|FG004|Overall Study|Adverse Event|2|||
28141354|NCT03161093|54807019|FG005|Overall Study|Adverse Event|1|||
28141355|NCT03161093|54807014|FG000|Overall Study|Lack of Efficacy|9|||
28141356|NCT03161093|54807015|FG001|Overall Study|Lack of Efficacy|13|||
28141357|NCT03161093|54807016|FG002|Overall Study|Lack of Efficacy|9|||
28141358|NCT03161093|54807017|FG003|Overall Study|Lack of Efficacy|24|||
28141359|NCT03161093|54807018|FG004|Overall Study|Lack of Efficacy|4|||
28141360|NCT03161093|54807019|FG005|Overall Study|Lack of Efficacy|1|||
28141361|NCT03161093|54807014|FG000|Overall Study|Physician Decision|0|||
28141362|NCT03161093|54807015|FG001|Overall Study|Physician Decision|1|||
28141363|NCT03161093|54807016|FG002|Overall Study|Physician Decision|0|||
28141364|NCT03161093|54807017|FG003|Overall Study|Physician Decision|2|||
28141365|NCT03161093|54807018|FG004|Overall Study|Physician Decision|17|||
28141366|NCT03161093|54807019|FG005|Overall Study|Physician Decision|15|||
27822012|NCT01825837|54284195|FG002|PART I|Treatment failure|0|||
28141367|NCT03161093|54807014|FG000|Overall Study|Withdrawal by Subject|24|||
28141368|NCT03161093|54807015|FG001|Overall Study|Withdrawal by Subject|73|||
28141369|NCT03161093|54807016|FG002|Overall Study|Withdrawal by Subject|44|||
28141370|NCT03161093|54807017|FG003|Overall Study|Withdrawal by Subject|97|||
28141371|NCT03161093|54807018|FG004|Overall Study|Withdrawal by Subject|11|||
28141372|NCT03161093|54807019|FG005|Overall Study|Withdrawal by Subject|10|||
28141373|NCT03161093|54807014|FG000|Overall Study|Lost to Follow-up|3|||
28141374|NCT03161093|54807015|FG001|Overall Study|Lost to Follow-up|12|||
28141375|NCT03161093|54807016|FG002|Overall Study|Lost to Follow-up|4|||
28141376|NCT03161093|54807017|FG003|Overall Study|Lost to Follow-up|7|||
28141377|NCT03161093|54807018|FG004|Overall Study|Lost to Follow-up|8|||
28141378|NCT03161093|54807019|FG005|Overall Study|Lost to Follow-up|13|||
28141379|NCT03161093|54807014|FG000|Overall Study|Death|3|||
28141380|NCT03161093|54807015|FG001|Overall Study|Death|9|||
28141381|NCT03161093|54807016|FG002|Overall Study|Death|7|||
28141382|NCT03161093|54807017|FG003|Overall Study|Death|9|||
28141383|NCT03161093|54807018|FG004|Overall Study|Death|0|||
28141384|NCT03161093|54807019|FG005|Overall Study|Death|0|||
28141385|NCT03161093|54807014|FG000|Overall Study|Unknown - Not reported|0|||
28141386|NCT03161093|54807015|FG001|Overall Study|Unknown - Not reported|1|||
28141387|NCT03161093|54807016|FG002|Overall Study|Unknown - Not reported|0|||
28141388|NCT03161093|54807017|FG003|Overall Study|Unknown - Not reported|0|||
28141389|NCT03161093|54807018|FG004|Overall Study|Unknown - Not reported|0|||
28141390|NCT03161093|54807019|FG005|Overall Study|Unknown - Not reported|1|||
28141391|NCT02847650|54807040|FG000|Overall Study|Adverse Event|2|||
28141392|NCT02847650|54807041|FG001|Overall Study|Adverse Event|4|||
28141393|NCT02847650|54807040|FG000|Overall Study|Lost to Follow-up|1|||
28141394|NCT02847650|54807041|FG001|Overall Study|Lost to Follow-up|0|||
28141395|NCT02847650|54807040|FG000|Overall Study|Protocol Violation|0|||
28141396|NCT02847650|54807041|FG001|Overall Study|Protocol Violation|1|||
28141397|NCT02847650|54807040|FG000|Overall Study|Withdrawal by Subject|1|||
28141398|NCT02847650|54807041|FG001|Overall Study|Withdrawal by Subject|1|||
28141399|NCT02847494|54807049|FG000|Overall Study|Lost to Follow-up|8|||
28141400|NCT02847494|54807050|FG001|Overall Study|Lost to Follow-up|5|||
28141401|NCT02554253|54807058|FG000|Overall Study|ineligible after enrollment|1|||
28141402|NCT02554253|54807059|FG001|Overall Study|ineligible after enrollment|0|||
28141403|NCT02554253|54807058|FG000|Overall Study|converted to transcatheter procedure|0|||
28141404|NCT02554253|54807059|FG001|Overall Study|converted to transcatheter procedure|1|||
28141405|NCT02554253|54807058|FG000|Overall Study|received both drugs|0|||
28141406|NCT02554253|54807059|FG001|Overall Study|received both drugs|1|||
28141407|NCT03157583|54807066|FG000|Overall Study|Other (did not meet study criteria)|1|||
28141408|NCT02842736|54807084|FG000|Overall Study|Lost to Follow-up|13|||
28141409|NCT02842736|54807084|FG000|Overall Study|Intervention for menstrual bleeding|17|||
28141410|NCT02842736|54807084|FG000|Overall Study|Withdrawal by Subject|4|||
28141411|NCT02842736|54807084|FG000|Overall Study|Pregnancy|3|||
28141412|NCT02842736|54807084|FG000|Overall Study|Hysterectomy for fibroids|2|||
28141413|NCT02842736|54807084|FG000|Overall Study|Hysterectomy for uterine prolapse|1|||
28141414|NCT02842736|54807084|FG000|Overall Study|IUD: Mirena|1|||
28141415|NCT01307033|54807090|FG000|8-week Double-blind Period|Adverse Event|2|||
28141416|NCT01307033|54807091|FG001|8-week Double-blind Period|Adverse Event|0|||
28141417|NCT01307033|54807092|FG002|8-week Double-blind Period|Adverse Event|0|||
28141418|NCT01307033|54807093|FG003|8-week Double-blind Period|Adverse Event|0|||
28141419|NCT01307033|54807090|FG000|8-week Double-blind Period|Withdrawal by Subject|4|||
28141420|NCT01307033|54807091|FG001|8-week Double-blind Period|Withdrawal by Subject|1|||
28141421|NCT01307033|54807092|FG002|8-week Double-blind Period|Withdrawal by Subject|0|||
28141422|NCT01307033|54807093|FG003|8-week Double-blind Period|Withdrawal by Subject|0|||
28141423|NCT01307033|54807090|FG000|8-week Double-blind Period|Lack of Efficacy|1|||
28141424|NCT01307033|54807091|FG001|8-week Double-blind Period|Lack of Efficacy|0|||
28141425|NCT01307033|54807092|FG002|8-week Double-blind Period|Lack of Efficacy|0|||
28141426|NCT01307033|54807093|FG003|8-week Double-blind Period|Lack of Efficacy|0|||
28141427|NCT01307033|54807090|FG000|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
28141428|NCT01307033|54807091|FG001|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3|||
28141429|NCT01307033|54807092|FG002|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
28141430|NCT01307033|54807093|FG003|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
28141431|NCT01307033|54807090|FG000|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6|||
28141432|NCT01307033|54807091|FG001|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3|||
28141433|NCT01307033|54807092|FG002|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
28141434|NCT01307033|54807093|FG003|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
28141435|NCT01307033|54807090|FG000|44-week Open-label Extension|Adverse Event|0|||
28141436|NCT01307033|54807091|FG001|44-week Open-label Extension|Adverse Event|0|||
28141437|NCT01307033|54807092|FG002|44-week Open-label Extension|Adverse Event|2|||
28141438|NCT01307033|54807093|FG003|44-week Open-label Extension|Adverse Event|1|||
27822013|NCT01825837|54284196|FG003|PART I|Treatment failure|7|||
27941181|NCT01016067|54597495|FG001|Overall Study|Lost to Follow-up|2|||
28141439|NCT01307033|54807090|FG000|44-week Open-label Extension|Withdrawal by Subject|0|||
28141440|NCT01307033|54807091|FG001|44-week Open-label Extension|Withdrawal by Subject|0|||
28141441|NCT01307033|54807092|FG002|44-week Open-label Extension|Withdrawal by Subject|2|||
28141442|NCT01307033|54807093|FG003|44-week Open-label Extension|Withdrawal by Subject|1|||
28141443|NCT01307033|54807090|FG000|44-week Open-label Extension|Physician Decision|0|||
28141444|NCT01307033|54807091|FG001|44-week Open-label Extension|Physician Decision|0|||
28141445|NCT01307033|54807092|FG002|44-week Open-label Extension|Physician Decision|1|||
28141446|NCT01307033|54807093|FG003|44-week Open-label Extension|Physician Decision|0|||
28141447|NCT01307033|54807090|FG000|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
28141448|NCT01307033|54807091|FG001|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
28141449|NCT01307033|54807092|FG002|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
28141450|NCT01307033|54807093|FG003|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2|||
28141451|NCT01307033|54807090|FG000|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
28141452|NCT01307033|54807091|FG001|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
28141453|NCT01307033|54807092|FG002|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6|||
28141454|NCT01307033|54807093|FG003|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7|||
28141455|NCT01307033|54807090|FG000|44-week Open-label Extension|Death|0|||
28141456|NCT01307033|54807091|FG001|44-week Open-label Extension|Death|0|||
28141457|NCT01307033|54807092|FG002|44-week Open-label Extension|Death|0|||
28141458|NCT01307033|54807093|FG003|44-week Open-label Extension|Death|1|||
28141459|NCT02844920|54807105|FG000|Overall Study|Lost to Follow-up|2|||
28141460|NCT03158311|54807112|FG000|Overall Study|Subject/Guardian Decision|10|||
28141461|NCT03158311|54807113|FG001|Overall Study|Subject/Guardian Decision|6|||
28141462|NCT03158311|54807114|FG002|Overall Study|Subject/Guardian Decision|11|||
28141463|NCT03158311|54807112|FG000|Overall Study|Adverse Event|5|||
28141464|NCT03158311|54807113|FG001|Overall Study|Adverse Event|3|||
28141465|NCT03158311|54807114|FG002|Overall Study|Adverse Event|3|||
28141466|NCT03158311|54807112|FG000|Overall Study|Techinical Problems|3|||
28141467|NCT03158311|54807113|FG001|Overall Study|Techinical Problems|1|||
28141468|NCT03158311|54807114|FG002|Overall Study|Techinical Problems|5|||
28141469|NCT03158311|54807112|FG000|Overall Study|Physician Decision|2|||
28141470|NCT03158311|54807113|FG001|Overall Study|Physician Decision|3|||
28141471|NCT03158311|54807114|FG002|Overall Study|Physician Decision|7|||
28141472|NCT03158311|54807112|FG000|Overall Study|Lost to Follow-up|1|||
28141473|NCT03158311|54807113|FG001|Overall Study|Lost to Follow-up|1|||
28141474|NCT03158311|54807114|FG002|Overall Study|Lost to Follow-up|1|||
28141475|NCT03158311|54807112|FG000|Overall Study|Sponsor decision|1|||
27822014|NCT01825837|54284193|FG000|PART I|reason unspecified|0|||
27941182|NCT01016067|54597494|FG000|Overall Study|Physician Decision|1|||
28070744|NCT03801928|54725535|FG003|Overall Study|Adverse Event|2|||
28070745|NCT03801928|54725536|FG004|Overall Study|Adverse Event|0|||
28070746|NCT03801928|54725537|FG005|Overall Study|Adverse Event|2|||
28070747|NCT03801928|54725532|FG000|Overall Study|Lack of Efficacy|0|||
28070748|NCT03801928|54725533|FG001|Overall Study|Lack of Efficacy|0|||
28070749|NCT03801928|54725534|FG002|Overall Study|Lack of Efficacy|1|||
28070750|NCT03801928|54725535|FG003|Overall Study|Lack of Efficacy|0|||
28070751|NCT03801928|54725536|FG004|Overall Study|Lack of Efficacy|0|||
28070752|NCT03801928|54725537|FG005|Overall Study|Lack of Efficacy|0|||
28070753|NCT03801928|54725532|FG000|Overall Study|Lost to Follow-up|5|||
28141476|NCT03158311|54807113|FG001|Overall Study|Sponsor decision|0|||
28141477|NCT03158311|54807114|FG002|Overall Study|Sponsor decision|0|||
28141478|NCT03158311|54807112|FG000|Overall Study|Pregnancy|0|||
28141479|NCT03158311|54807113|FG001|Overall Study|Pregnancy|2|||
28141480|NCT03158311|54807114|FG002|Overall Study|Pregnancy|0|||
28141481|NCT03158311|54807112|FG000|Overall Study|Randomized in error|0|||
28141482|NCT03158311|54807113|FG001|Overall Study|Randomized in error|0|||
28141483|NCT03158311|54807114|FG002|Overall Study|Randomized in error|1|||
28141484|NCT01336621|54807126|FG000|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11|||
28141485|NCT01336621|54807126|FG000|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2|||
28141486|NCT01336621|54807126|FG000|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12|||
28141487|NCT01336621|54807126|FG000|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27|||
28141488|NCT01336621|54807126|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11|||
28141489|NCT01336621|54807126|FG000|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2|||
28141490|NCT01336621|54807126|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22|||
28141491|NCT01336621|54807126|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2|||
28141492|NCT01336621|54807126|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9|||
28141493|NCT01336621|54807126|FG000|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1|||
28141494|NCT01336621|54807126|FG000|SFUCP (up to 2.6 Years)|Adverse Event|1|||
28141495|NCT01336621|54807126|FG000|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3|||
28141496|NCT01336621|54807126|FG000|SFUCP (up to 2.6 Years)|Physician Decision|1|||
28141497|NCT01336621|54807126|FG000|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3|||
28141498|NCT00383435|54807138|FG000|26-Week Double-Blind Treatment Period|Adverse Event|10|||
27822015|NCT01825837|54284194|FG001|PART I|reason unspecified|0|||
27822016|NCT01825837|54284195|FG002|PART I|reason unspecified|0|||
27822017|NCT01825837|54284196|FG003|PART I|reason unspecified|3|||
27822018|NCT01825837|54284193|FG000|PART II|Withdrawal by Subject|3|||
27822019|NCT01825837|54284194|FG001|PART II|Withdrawal by Subject|3|||
27822020|NCT01825837|54284195|FG002|PART II|Withdrawal by Subject|7|||
28141499|NCT00383435|54807139|FG001|26-Week Double-Blind Treatment Period|Adverse Event|2|||
28141500|NCT00383435|54807140|FG002|26-Week Double-Blind Treatment Period|Adverse Event|8|||
28141501|NCT00383435|54807141|FG003|26-Week Double-Blind Treatment Period|Adverse Event|6|||
27822021|NCT01825837|54284196|FG003|PART II|Withdrawal by Subject|0|||
28141502|NCT00383435|54807142|FG004|26-Week Double-Blind Treatment Period|Adverse Event|8|||
28141503|NCT00383435|54807138|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
28141504|NCT00383435|54807139|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|2|||
28141505|NCT00383435|54807140|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
28141506|NCT00383435|54807141|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|5|||
28141507|NCT00383435|54807142|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
28141508|NCT00383435|54807138|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
28141509|NCT00383435|54807139|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
28141510|NCT00383435|54807140|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
28141511|NCT00383435|54807141|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
28141512|NCT00383435|54807142|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
28141513|NCT00383435|54807138|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7|||
28141514|NCT00383435|54807139|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
28141515|NCT00383435|54807140|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14|||
28141516|NCT00383435|54807141|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
28141517|NCT00383435|54807142|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17|||
28141518|NCT00383435|54807138|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|2|||
28141519|NCT00383435|54807139|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
28141520|NCT00383435|54807140|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
28141521|NCT00383435|54807141|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
28141522|NCT00383435|54807142|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
28141523|NCT00383435|54807138|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1|||
28141524|NCT00383435|54807139|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
28070754|NCT03801928|54725533|FG001|Overall Study|Lost to Follow-up|1|||
28070755|NCT03801928|54725534|FG002|Overall Study|Lost to Follow-up|1|||
28070756|NCT03801928|54725535|FG003|Overall Study|Lost to Follow-up|4|||
28070757|NCT03801928|54725536|FG004|Overall Study|Lost to Follow-up|4|||
28070758|NCT03801928|54725537|FG005|Overall Study|Lost to Follow-up|2|||
28070759|NCT03801928|54725532|FG000|Overall Study|Withdrawal by Subject|0|||
28070760|NCT03801928|54725533|FG001|Overall Study|Withdrawal by Subject|0|||
28070761|NCT03801928|54725534|FG002|Overall Study|Withdrawal by Subject|2|||
28070762|NCT03801928|54725535|FG003|Overall Study|Withdrawal by Subject|1|||
28070763|NCT03801928|54725536|FG004|Overall Study|Withdrawal by Subject|0|||
28070764|NCT03801928|54725537|FG005|Overall Study|Withdrawal by Subject|0|||
28070765|NCT03801928|54725532|FG000|Overall Study|Other|0|||
28070766|NCT03801928|54725533|FG001|Overall Study|Other|2|||
28141525|NCT00383435|54807140|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3|||
28141526|NCT00383435|54807141|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
28141527|NCT00383435|54807142|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
28141528|NCT00383435|54807138|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10|||
28141529|NCT00383435|54807139|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8|||
28141530|NCT00383435|54807140|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9|||
28141531|NCT00383435|54807141|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
28070767|NCT03801928|54725534|FG002|Overall Study|Other|0|||
28070768|NCT03801928|54725535|FG003|Overall Study|Other|1|||
28070769|NCT03801928|54725536|FG004|Overall Study|Other|0|||
28141532|NCT00383435|54807142|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
28141533|NCT00383435|54807138|FG000|26-Week Double-Blind Treatment Period|Administrative|5|||
28141534|NCT00383435|54807139|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
28141535|NCT00383435|54807140|FG002|26-Week Double-Blind Treatment Period|Administrative|1|||
28141536|NCT00383435|54807141|FG003|26-Week Double-Blind Treatment Period|Administrative|1|||
28141537|NCT00383435|54807142|FG004|26-Week Double-Blind Treatment Period|Administrative|1|||
28141538|NCT00383435|54807138|FG000|26-Week Treatment Safety Extension|Adverse Event|4|||
28141539|NCT00383435|54807139|FG001|26-Week Treatment Safety Extension|Adverse Event|2|||
28141540|NCT00383435|54807140|FG002|26-Week Treatment Safety Extension|Adverse Event|5|||
28141541|NCT00383435|54807141|FG003|26-Week Treatment Safety Extension|Adverse Event|5|||
28141542|NCT00383435|54807142|FG004|26-Week Treatment Safety Extension|Adverse Event|1|||
27822022|NCT01825837|54284193|FG000|PART II|Patient non-compliance|5|||
27822023|NCT01825837|54284194|FG001|PART II|Patient non-compliance|2|||
27822024|NCT01825837|54284195|FG002|PART II|Patient non-compliance|4|||
28141543|NCT00383435|54807138|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
27822025|NCT01825837|54284196|FG003|PART II|Patient non-compliance|0|||
28141544|NCT00383435|54807139|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
28141545|NCT00383435|54807140|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
28141546|NCT00383435|54807141|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
28141547|NCT00383435|54807142|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
28141548|NCT00383435|54807138|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
28141549|NCT00383435|54807139|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
28141550|NCT00383435|54807140|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
28141551|NCT00383435|54807141|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
28141552|NCT00383435|54807142|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
28141553|NCT00383435|54807138|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
28141554|NCT00383435|54807139|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
28141555|NCT00383435|54807140|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
28141556|NCT00383435|54807141|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
28141557|NCT00383435|54807142|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
28141558|NCT00383435|54807138|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
28141559|NCT00383435|54807139|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
28141560|NCT00383435|54807140|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|2|||
28141561|NCT00383435|54807141|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
28141562|NCT00383435|54807142|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
28141563|NCT00383435|54807138|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
28141564|NCT00383435|54807139|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
28141565|NCT00383435|54807140|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
28141566|NCT00383435|54807141|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
28141567|NCT00383435|54807142|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
28141568|NCT00383435|54807138|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
28141569|NCT00383435|54807139|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
28141570|NCT00383435|54807140|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
28141571|NCT00383435|54807141|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
28141572|NCT00383435|54807142|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
28141573|NCT00383435|54807138|FG000|26-Week Treatment Safety Extension|Administrative|1|||
28141574|NCT00383435|54807139|FG001|26-Week Treatment Safety Extension|Administrative|1|||
28141575|NCT00383435|54807140|FG002|26-Week Treatment Safety Extension|Administrative|0|||
28141576|NCT00383435|54807141|FG003|26-Week Treatment Safety Extension|Administrative|1|||
28141577|NCT00383435|54807142|FG004|26-Week Treatment Safety Extension|Administrative|0|||
28141578|NCT03157037|54807154|FG000|Overall Study|Death|1|||
28141579|NCT00381485|54807176|FG000|Open-Label Run-In Period|Adverse Event|9|||
28141580|NCT00381485|54807177|FG001|Open-Label Run-In Period|Adverse Event|0|||
28141581|NCT00381485|54807178|FG002|Open-Label Run-In Period|Adverse Event|0|||
28141582|NCT00381485|54807179|FG003|Open-Label Run-In Period|Adverse Event|0|||
28141583|NCT00381485|54807176|FG000|Open-Label Run-In Period|Did not meet protocol eligibility|76|||
28141584|NCT00381485|54807177|FG001|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
28141585|NCT00381485|54807178|FG002|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
28141586|NCT00381485|54807179|FG003|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
28141587|NCT00381485|54807176|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16|||
28141588|NCT00381485|54807177|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
28141589|NCT00381485|54807178|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
28141590|NCT00381485|54807179|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
28141591|NCT00381485|54807176|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1|||
28141592|NCT00381485|54807177|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
28141593|NCT00381485|54807178|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
28141594|NCT00381485|54807179|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
28141595|NCT00381485|54807176|FG000|Open-Label Run-In Period|Lost to Follow-up|3|||
28141596|NCT00381485|54807177|FG001|Open-Label Run-In Period|Lost to Follow-up|0|||
28141597|NCT00381485|54807178|FG002|Open-Label Run-In Period|Lost to Follow-up|0|||
28070770|NCT03801928|54725537|FG005|Overall Study|Other|1|||
28070771|NCT00263588|54725556|FG000|Overall Study|Death|54|||
28070772|NCT00263588|54725557|FG001|Overall Study|Death|90|||
28070773|NCT00263588|54725556|FG000|Overall Study|disease progression, coma, 1 unknown|10|||
28070774|NCT00263588|54725557|FG001|Overall Study|disease progression, coma, 1 unknown|11|||
28070775|NCT00263588|54725556|FG000|Overall Study|Lost to Follow-up|7|||
28070776|NCT00263588|54725557|FG001|Overall Study|Lost to Follow-up|10|||
28070777|NCT00263588|54725556|FG000|Overall Study|Withdrawal by Subject|3|||
28070778|NCT00263588|54725557|FG001|Overall Study|Withdrawal by Subject|4|||
28070779|NCT00263588|54725556|FG000|Overall Study|Protocol Violation|0|||
28070780|NCT00263588|54725557|FG001|Overall Study|Protocol Violation|1|||
28141598|NCT00381485|54807179|FG003|Open-Label Run-In Period|Lost to Follow-up|0|||
28141599|NCT00381485|54807176|FG000|Open-Label Run-In Period|Treatment failure|1|||
28141600|NCT00381485|54807177|FG001|Open-Label Run-In Period|Treatment failure|0|||
28070781|NCT00263588|54725556|FG000|Overall Study|Investigator decision|7|||
28070782|NCT00263588|54725557|FG001|Overall Study|Investigator decision|15|||
28141601|NCT00381485|54807178|FG002|Open-Label Run-In Period|Treatment failure|0|||
28141602|NCT00381485|54807179|FG003|Open-Label Run-In Period|Treatment failure|0|||
28141603|NCT00381485|54807176|FG000|Double-Blind Treatment Period|Adverse Event|0|||
28141604|NCT00381485|54807177|FG001|Double-Blind Treatment Period|Adverse Event|2|||
28141605|NCT00381485|54807178|FG002|Double-Blind Treatment Period|Adverse Event|2|||
28141606|NCT00381485|54807179|FG003|Double-Blind Treatment Period|Adverse Event|5|||
28141607|NCT00381485|54807176|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
28141608|NCT00381485|54807177|FG001|Double-Blind Treatment Period|Lack of Efficacy|8|||
28141609|NCT00381485|54807178|FG002|Double-Blind Treatment Period|Lack of Efficacy|11|||
28141610|NCT00381485|54807179|FG003|Double-Blind Treatment Period|Lack of Efficacy|13|||
28141611|NCT00381485|54807176|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
28141612|NCT00381485|54807177|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
28141613|NCT00381485|54807178|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
28141614|NCT00381485|54807179|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
28141615|NCT00381485|54807176|FG000|Double-Blind Treatment Period|Noncompliance with protocol|0|||
28141616|NCT00381485|54807177|FG001|Double-Blind Treatment Period|Noncompliance with protocol|9|||
28141617|NCT00381485|54807178|FG002|Double-Blind Treatment Period|Noncompliance with protocol|3|||
28141618|NCT00381485|54807179|FG003|Double-Blind Treatment Period|Noncompliance with protocol|3|||
28141619|NCT00381485|54807176|FG000|Double-Blind Treatment Period|Did not meet protocol eligibility|0|||
28141620|NCT00381485|54807177|FG001|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
28141621|NCT00381485|54807178|FG002|Double-Blind Treatment Period|Did not meet protocol eligibility|7|||
28141622|NCT00381485|54807179|FG003|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
28141623|NCT00381485|54807176|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0|||
28141624|NCT00381485|54807177|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2|||
28141625|NCT00381485|54807178|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1|||
28141626|NCT00381485|54807179|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4|||
28141627|NCT00381485|54807176|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
28141628|NCT00381485|54807177|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
28141629|NCT00381485|54807178|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
28141630|NCT00381485|54807179|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1|||
28141631|NCT00381485|54807176|FG000|Double-Blind Treatment Period|Administrative|0|||
28141632|NCT00381485|54807177|FG001|Double-Blind Treatment Period|Administrative|1|||
28141633|NCT00381485|54807178|FG002|Double-Blind Treatment Period|Administrative|0|||
28141634|NCT00381485|54807179|FG003|Double-Blind Treatment Period|Administrative|1|||
28141635|NCT02840474|54807190|FG000|Overall Study|Lost to Follow-up|1|||
28141636|NCT02840474|54807191|FG001|Overall Study|Lost to Follow-up|0|||
28141637|NCT03155945|54807199|FG000|Overall Study|Lost to Follow-up|0|||
28141638|NCT03155945|54807200|FG001|Overall Study|Lost to Follow-up|1|||
28141639|NCT03155945|54807199|FG000|Overall Study|Withdrawal by Subject|0|||
28141640|NCT03155945|54807200|FG001|Overall Study|Withdrawal by Subject|1|||
28141641|NCT03155945|54807199|FG000|Overall Study|Other Reason|0|||
28141642|NCT03155945|54807200|FG001|Overall Study|Other Reason|1|||
28141643|NCT03160703|54807210|FG000|Overall Study|Withdrawal by Subject|0|||
28141644|NCT03160703|54807211|FG001|Overall Study|Withdrawal by Subject|0|||
28141645|NCT03160703|54807212|FG002|Overall Study|Withdrawal by Subject|0|||
28141646|NCT03160703|54807213|FG003|Overall Study|Withdrawal by Subject|1|||
28141647|NCT03159611|54807225|FG000|Overall Study|Did Not Meet Inclusion Criteria|9|||
28141648|NCT03159611|54807226|FG001|Overall Study|Did Not Meet Inclusion Criteria|5|||
27822026|NCT01825837|54284193|FG000|PART II|Adverse Event|3|||
27822027|NCT01825837|54284194|FG001|PART II|Adverse Event|3|||
28141649|NCT03159611|54807225|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
27822028|NCT01825837|54284195|FG002|PART II|Adverse Event|1|||
28070783|NCT00263588|54725556|FG000|Overall Study|Sponsor terminated study|0|||
28070784|NCT00263588|54725557|FG001|Overall Study|Sponsor terminated study|1|||
28070785|NCT00213135|54725567|FG000|Overall Study|Adverse Event|9|||
28070786|NCT00213135|54725568|FG001|Overall Study|Adverse Event|5|||
28070787|NCT00213135|54725569|FG002|Overall Study|Adverse Event|5|||
28070788|NCT00213135|54725567|FG000|Overall Study|Lost to Follow-up|11|||
28070789|NCT00213135|54725568|FG001|Overall Study|Lost to Follow-up|8|||
28070790|NCT00213135|54725569|FG002|Overall Study|Lost to Follow-up|4|||
27822029|NCT01825837|54284196|FG003|PART II|Adverse Event|0|||
27822030|NCT01825837|54284193|FG000|PART II|Treatment failure|6|||
27822031|NCT01825837|54284194|FG001|PART II|Treatment failure|4|||
27941183|NCT01016067|54597495|FG001|Overall Study|Physician Decision|1|||
27822032|NCT01825837|54284195|FG002|PART II|Treatment failure|5|||
27822033|NCT01825837|54284196|FG003|PART II|Treatment failure|0|||
27941184|NCT01016067|54597494|FG000|Overall Study|Withdrew due to Relocation|0|||
27941185|NCT01016067|54597495|FG001|Overall Study|Withdrew due to Relocation|1|||
27822034|NCT01825837|54284193|FG000|PART II|reason unspecified|2|||
27822035|NCT01825837|54284194|FG001|PART II|reason unspecified|2|||
27822036|NCT01825837|54284195|FG002|PART II|reason unspecified|2|||
27941186|NCT01015833|54597503|FG000|Overall Study|Death|1|||
27941187|NCT01015833|54597504|FG001|Overall Study|Death|0|||
28141650|NCT03159611|54807226|FG001|Overall Study|Did Not Meet Exclusion Criteria|3|||
28141651|NCT03159611|54807225|FG000|Overall Study|Protocol Violation|7|||
28141652|NCT03159611|54807226|FG001|Overall Study|Protocol Violation|4|||
28141653|NCT03159611|54807225|FG000|Overall Study|Adverse Event|1|||
28141654|NCT03159611|54807226|FG001|Overall Study|Adverse Event|0|||
28141655|NCT03159611|54807225|FG000|Overall Study|Withdrawal by Subject|1|||
28141656|NCT03159611|54807226|FG001|Overall Study|Withdrawal by Subject|1|||
28141657|NCT03159611|54807225|FG000|Overall Study|Non-compliance with protocol requirement|3|||
28141658|NCT03159611|54807226|FG001|Overall Study|Non-compliance with protocol requirement|2|||
28141659|NCT03159611|54807225|FG000|Overall Study|Inability to perform procedures|1|||
28141660|NCT03159611|54807226|FG001|Overall Study|Inability to perform procedures|0|||
28141661|NCT03159455|54807238|FG000|Overall Study|Adverse Event|0|||
28141662|NCT03159455|54807239|FG001|Overall Study|Adverse Event|0|||
28141663|NCT03159455|54807240|FG002|Overall Study|Adverse Event|0|||
28141664|NCT03159455|54807241|FG003|Overall Study|Adverse Event|0|||
28141665|NCT03159455|54807242|FG004|Overall Study|Adverse Event|0|||
28141666|NCT03159455|54807243|FG005|Overall Study|Adverse Event|1|||
28141667|NCT02838134|54807263|FG000|Overall Study|Lost to Follow-up|1|||
28141668|NCT02838134|54807264|FG001|Overall Study|Lost to Follow-up|2|||
28141669|NCT02838134|54807263|FG000|Overall Study|logistic problems|1|||
28141670|NCT02838134|54807264|FG001|Overall Study|logistic problems|1|||
27822037|NCT01825837|54284196|FG003|PART II|reason unspecified|0|||
28141671|NCT03150589|54807272|FG000|Overall Study|Withdrawal by Subject|16|||
28070791|NCT00213135|54725567|FG000|Overall Study|Protocol Violation|4|||
28070792|NCT00213135|54725568|FG001|Overall Study|Protocol Violation|4|||
28070793|NCT00213135|54725569|FG002|Overall Study|Protocol Violation|10|||
28070794|NCT00213135|54725567|FG000|Overall Study|Death|1|||
28070795|NCT00213135|54725568|FG001|Overall Study|Death|1|||
28070796|NCT00213135|54725569|FG002|Overall Study|Death|2|||
28070797|NCT00213135|54725567|FG000|Overall Study|Disease progression|4|||
28070798|NCT00213135|54725568|FG001|Overall Study|Disease progression|5|||
28070799|NCT00213135|54725569|FG002|Overall Study|Disease progression|21|||
28070800|NCT00213135|54725567|FG000|Overall Study|Other|21|||
28070801|NCT00213135|54725568|FG001|Overall Study|Other|12|||
28070802|NCT00213135|54725569|FG002|Overall Study|Other|15|||
28070803|NCT00077974|54725577|FG000|Overall Study|Adverse Event|22|||
28070804|NCT00077974|54725577|FG000|Overall Study|Protocol Violation|1|||
28070805|NCT00077974|54725577|FG000|Overall Study|Withdrawal by Subject|3|||
28070806|NCT00077974|54725577|FG000|Overall Study|Lack of Efficacy|76|||
28070807|NCT00077974|54725577|FG000|Overall Study|Decision of Sponsor|2|||
28070808|NCT00124917|54725581|FG000|Overall Study|Physician Decision|3|||
28070809|NCT00141921|54725586|FG000|Overall Study|Remain on Study|28|||
28070810|NCT00141921|54725586|FG000|Overall Study|Withdrawal by Subject|42|||
28141672|NCT03150589|54807273|FG001|Overall Study|Withdrawal by Subject|9|||
28141673|NCT03150589|54807272|FG000|Overall Study|Adverse Event|7|||
28141674|NCT03150589|54807273|FG001|Overall Study|Adverse Event|6|||
28141675|NCT03150589|54807272|FG000|Overall Study|Protocol Violation|4|||
28141676|NCT03150589|54807273|FG001|Overall Study|Protocol Violation|3|||
28141677|NCT03150589|54807272|FG000|Overall Study|Lost to Follow-up|3|||
28141678|NCT03150589|54807273|FG001|Overall Study|Lost to Follow-up|3|||
28141679|NCT03150589|54807272|FG000|Overall Study|Death|2|||
28141680|NCT03150589|54807273|FG001|Overall Study|Death|3|||
28070811|NCT00141921|54725586|FG000|Overall Study|Lost to Follow-up|19|||
28070812|NCT00141921|54725586|FG000|Overall Study|Noncompliance|17|||
28070813|NCT00141921|54725586|FG000|Overall Study|Disease Progression|7|||
28070814|NCT00141921|54725586|FG000|Overall Study|Protocol Deviation|7|||
28141681|NCT03150589|54807272|FG000|Overall Study|IP non-compliance and other reasons|12|||
28141682|NCT03150589|54807273|FG001|Overall Study|IP non-compliance and other reasons|3|||
28141683|NCT02835092|54807282|FG000|Overall Study|Withdrawal by Subject|3|||
28141684|NCT02835092|54807283|FG001|Overall Study|Withdrawal by Subject|6|||
28141685|NCT02835092|54807284|FG002|Overall Study|Withdrawal by Subject|3|||
28141686|NCT02835092|54807282|FG000|Overall Study|Lost to Follow-up|0|||
28141687|NCT02835092|54807283|FG001|Overall Study|Lost to Follow-up|2|||
28141688|NCT02835092|54807284|FG002|Overall Study|Lost to Follow-up|0|||
28141689|NCT03145207|54807292|FG000|Overall Study|volunteer started taking allergy shots|1|||
28141690|NCT03145207|54807292|FG000|Overall Study|baseline blood pressure high|1|||
28141691|NCT02836652|54807309|FG000|Overall Study|Death|3|||
28141692|NCT02836652|54807310|FG001|Overall Study|Death|3|||
28141693|NCT02836652|54807309|FG000|Overall Study|Transplant/Explant|3|||
28141694|NCT02836652|54807310|FG001|Overall Study|Transplant/Explant|4|||
28141695|NCT02836652|54807309|FG000|Overall Study|Withdrawn|9|||
28141696|NCT02836652|54807310|FG001|Overall Study|Withdrawn|9|||
28141697|NCT02836652|54807309|FG000|Overall Study|Not on treatment regimen post-op day 15|3|||
28141698|NCT02836652|54807310|FG001|Overall Study|Not on treatment regimen post-op day 15|3|||
28141699|NCT02836496|54807318|FG000|Overall Study|Adverse Event|2|||
28141700|NCT02836496|54807319|FG001|Overall Study|Adverse Event|1|||
28141701|NCT02836496|54807318|FG000|Overall Study|Withdrawal by Subject|0|||
28141702|NCT02836496|54807319|FG001|Overall Study|Withdrawal by Subject|1|||
28141703|NCT04213807|54807328|FG000|Overall Study|Physician Decision|0|||
28141704|NCT04213807|54807329|FG001|Overall Study|Physician Decision|0|||
28141705|NCT04213807|54807330|FG002|Overall Study|Physician Decision|1|||
28141706|NCT00577577|54807349|FG000|Overall Study|Adverse Event|3|||
28141707|NCT00577577|54807350|FG001|Overall Study|Adverse Event|2|||
28141708|NCT00577577|54807349|FG000|Overall Study|Lost to Follow-up|1|||
28141709|NCT00577577|54807350|FG001|Overall Study|Lost to Follow-up|0|||
28141710|NCT00577577|54807349|FG000|Overall Study|Protocol Violation|0|||
28141711|NCT00577577|54807350|FG001|Overall Study|Protocol Violation|3|||
28141712|NCT00577577|54807349|FG000|Overall Study|Transportation|1|||
28141713|NCT00577577|54807350|FG001|Overall Study|Transportation|0|||
28141714|NCT02833844|54807358|FG000|Double-Blind Period|Withdrawal by Subject|2|||
28141715|NCT02833844|54807359|FG001|Double-Blind Period|Withdrawal by Subject|3|||
28141716|NCT02833844|54807358|FG000|Double-Blind Period|Protocol Violation|0|||
27822038|NCT01854697|54284209|FG000|Overall Study|Adverse Event|1|||
27822039|NCT01854697|54284210|FG001|Overall Study|Adverse Event|0|||
27822040|NCT01854697|54284211|FG002|Overall Study|Adverse Event|0|||
27822041|NCT01854697|54284212|FG003|Overall Study|Adverse Event|0|||
27822042|NCT01854697|54284213|FG004|Overall Study|Adverse Event|1|||
27822043|NCT01854697|54284209|FG000|Overall Study|Lost to Follow-up|4|||
27822044|NCT01854697|54284210|FG001|Overall Study|Lost to Follow-up|1|||
27822045|NCT01854697|54284211|FG002|Overall Study|Lost to Follow-up|1|||
28070815|NCT00141921|54725586|FG000|Overall Study|Adverse Event|5|||
28070816|NCT00141921|54725586|FG000|Overall Study|Administrative Decision|2|||
28070817|NCT00141921|54725586|FG000|Overall Study|Pregnancy|4|||
28070818|NCT00141921|54725586|FG000|Overall Study|Ineligibility Determined|2|||
28070819|NCT00141921|54725586|FG000|Overall Study|Other|8|||
28070820|NCT00029146|54725592|FG000|Overall Study|Lost to Follow-up|2|||
28070821|NCT00029146|54725593|FG001|Overall Study|Lost to Follow-up|1|||
28070822|NCT00026494|54725603|FG000|Overall Study|Withdrawal by Subject|1|||
28070823|NCT00026494|54725604|FG001|Overall Study|Withdrawal by Subject|0|||
28070824|NCT00026494|54725605|FG002|Overall Study|Withdrawal by Subject|1|||
28070825|NCT00026494|54725606|FG003|Overall Study|Withdrawal by Subject|0|||
28070826|NCT00026494|54725603|FG000|Overall Study|Patient non-compliance|1|||
28070827|NCT00026494|54725604|FG001|Overall Study|Patient non-compliance|0|||
28070828|NCT00026494|54725605|FG002|Overall Study|Patient non-compliance|0|||
28070829|NCT00026494|54725606|FG003|Overall Study|Patient non-compliance|0|||
28070830|NCT00026494|54725603|FG000|Overall Study|Patient not treated|0|||
28070831|NCT00026494|54725604|FG001|Overall Study|Patient not treated|0|||
28070832|NCT00026494|54725605|FG002|Overall Study|Patient not treated|2|||
28070833|NCT00026494|54725606|FG003|Overall Study|Patient not treated|0|||
28070834|NCT00026494|54725603|FG000|Overall Study|Clinical progression|0|||
28070835|NCT00026494|54725604|FG001|Overall Study|Clinical progression|0|||
28070836|NCT00026494|54725605|FG002|Overall Study|Clinical progression|3|||
28070837|NCT00026494|54725606|FG003|Overall Study|Clinical progression|0|||
28070838|NCT00023764|54725616|FG000|Overall Study|Other|1|||
27822046|NCT01854697|54284212|FG003|Overall Study|Lost to Follow-up|2|||
27822047|NCT01854697|54284213|FG004|Overall Study|Lost to Follow-up|0|||
27822048|NCT01854697|54284209|FG000|Overall Study|To enter another AbbVie study|1|||
27822049|NCT01854697|54284210|FG001|Overall Study|To enter another AbbVie study|0|||
27822050|NCT01854697|54284211|FG002|Overall Study|To enter another AbbVie study|0|||
27822051|NCT01854697|54284212|FG003|Overall Study|To enter another AbbVie study|0|||
27822052|NCT01854697|54284213|FG004|Overall Study|To enter another AbbVie study|1|||
27822053|NCT01854697|54284209|FG000|Overall Study|Withdrew Consent|0|||
27822054|NCT01854697|54284210|FG001|Overall Study|Withdrew Consent|1|||
27822055|NCT01854697|54284211|FG002|Overall Study|Withdrew Consent|0|||
27822056|NCT01854697|54284212|FG003|Overall Study|Withdrew Consent|1|||
28141717|NCT02833844|54807359|FG001|Double-Blind Period|Protocol Violation|4|||
28141718|NCT02833844|54807358|FG000|Open-Label Period|Death|0|||
28141719|NCT02833844|54807359|FG001|Open-Label Period|Death|2|||
28141720|NCT02833844|54807358|FG000|Open-Label Period|Lost to Follow-up|1|||
28141721|NCT02833844|54807359|FG001|Open-Label Period|Lost to Follow-up|0|||
28141722|NCT02833844|54807358|FG000|Open-Label Period|Withdrawal by Subject|1|||
28141723|NCT02833844|54807359|FG001|Open-Label Period|Withdrawal by Subject|0|||
28141724|NCT01341782|54807369|FG000|Overall Study|Adverse Event|1|||
28141725|NCT01341782|54807370|FG001|Overall Study|Adverse Event|1|||
28141726|NCT01341782|54807369|FG000|Overall Study|Withdrawal by Subject|6|||
28141727|NCT01341782|54807370|FG001|Overall Study|Withdrawal by Subject|5|||
28141728|NCT01341782|54807369|FG000|Overall Study|Missed 3 consecutive doses|0|||
28141729|NCT01341782|54807370|FG001|Overall Study|Missed 3 consecutive doses|4|||
28141730|NCT01341782|54807369|FG000|Overall Study|2 consecutive calcium values >11.5 mg/dL|0|||
28141731|NCT01341782|54807370|FG001|Overall Study|2 consecutive calcium values >11.5 mg/dL|1|||
28141732|NCT01341782|54807369|FG000|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
28141733|NCT01341782|54807370|FG001|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
28141734|NCT01341782|54807369|FG000|Overall Study|Other|5|||
28141735|NCT01341782|54807370|FG001|Overall Study|Other|0|||
28141736|NCT01341470|54807382|FG000|Overall Study|Sponsor decision|0|||
28141737|NCT01341470|54807383|FG001|Overall Study|Sponsor decision|0|||
28141738|NCT01341470|54807384|FG002|Overall Study|Sponsor decision|1|||
28141739|NCT01341470|54807385|FG003|Overall Study|Sponsor decision|1|||
28141740|NCT01341470|54807386|FG004|Overall Study|Sponsor decision|0|||
28141741|NCT01341470|54807387|FG005|Overall Study|Sponsor decision|1|||
27822057|NCT01854697|54284213|FG004|Overall Study|Withdrew Consent|0|||
28141742|NCT03143101|54807406|FG000|Overall Study|Withdrawal by Subject|0|||
28141743|NCT03143101|54807407|FG001|Overall Study|Withdrawal by Subject|1|||
28141744|NCT03143101|54807408|FG002|Overall Study|Withdrawal by Subject|0|||
27822058|NCT01854697|54284209|FG000|Overall Study|Other|0|||
27822059|NCT01854697|54284210|FG001|Overall Study|Other|1|||
27822060|NCT01854697|54284211|FG002|Overall Study|Other|1|||
27822061|NCT01854697|54284212|FG003|Overall Study|Other|0|||
27822062|NCT01854697|54284213|FG004|Overall Study|Other|0|||
27822063|NCT01824979|54284225|FG000|Overall Study|Withdrawal by Subject|5|||
27822064|NCT01824979|54284226|FG001|Overall Study|Withdrawal by Subject|0|||
27822065|NCT01824979|54284225|FG000|Overall Study|Physician Decision|2|||
27822066|NCT01824979|54284226|FG001|Overall Study|Physician Decision|0|||
27822067|NCT01824979|54284225|FG000|Overall Study|Protocol Violation|6|||
27822068|NCT01824979|54284226|FG001|Overall Study|Protocol Violation|13|||
27822069|NCT01824823|54284234|FG000|Overall Study|Lack of Efficacy|1|||
27822070|NCT01824823|54284235|FG001|Overall Study|Lack of Efficacy|1|||
27822071|NCT01824823|54284234|FG000|Overall Study|Off-treatment reason not submitted|1|||
27822072|NCT01824823|54284235|FG001|Overall Study|Off-treatment reason not submitted|0|||
27822073|NCT01875367|54284243|FG000|Overall Study|Not complete at least 2 questionaries|4|||
27822074|NCT01875367|54284244|FG001|Overall Study|Not complete at least 2 questionaries|2|||
27822075|NCT01875367|54284243|FG000|Overall Study|Not receive study treatment|1|||
27822076|NCT01875367|54284244|FG001|Overall Study|Not receive study treatment|0|||
27822077|NCT01853839|54284254|FG000|Overall Study|Violated inclusion criteria|2|||
27822078|NCT01853839|54284254|FG000|Overall Study|Not meet ITT population definition|58|||
27822079|NCT01853839|54284254|FG000|Overall Study|End of treatment visit too early|33|||
27822080|NCT01853839|54284254|FG000|Overall Study|Lost to follow-up or no valid BP measure|336|||
27822081|NCT01874665|54284264|FG000|Overall Study|Adverse Event|6|||
27822082|NCT01874665|54284265|FG001|Overall Study|Adverse Event|2|||
27822083|NCT01874665|54284264|FG000|Overall Study|Withdrawal by Subject|4|||
27822084|NCT01874665|54284265|FG001|Overall Study|Withdrawal by Subject|1|||
27822085|NCT01874665|54284264|FG000|Overall Study|Physician Decision|3|||
27822086|NCT01874665|54284265|FG001|Overall Study|Physician Decision|0|||
27822087|NCT01874665|54284264|FG000|Overall Study|Clinical Progressive Disease|4|||
27822088|NCT01874665|54284265|FG001|Overall Study|Clinical Progressive Disease|3|||
27822089|NCT01874665|54284264|FG000|Overall Study|Study Terminated by Sponsor|0|||
27822090|NCT01874665|54284265|FG001|Overall Study|Study Terminated by Sponsor|2|||
27822091|NCT01874665|54284264|FG000|Overall Study|Documented Progressive Disease|11|||
27822092|NCT01874665|54284265|FG001|Overall Study|Documented Progressive Disease|7|||
27822093|NCT01874665|54284264|FG000|Overall Study|Other|2|||
27822094|NCT01874665|54284265|FG001|Overall Study|Other|0|||
27822095|NCT01874431|54284280|FG000|Overall Study|Physician Decision|0|||
27822096|NCT01874431|54284281|FG001|Overall Study|Physician Decision|0|||
27822097|NCT01874431|54284282|FG002|Overall Study|Physician Decision|1|||
27822098|NCT01874431|54284283|FG003|Overall Study|Physician Decision|0|||
27822099|NCT01874431|54284284|FG004|Overall Study|Physician Decision|0|||
27822100|NCT01874431|54284285|FG005|Overall Study|Physician Decision|0|||
27822101|NCT01874431|54284286|FG006|Overall Study|Physician Decision|0|||
27822102|NCT01874431|54284287|FG007|Overall Study|Physician Decision|0|||
27822103|NCT01874431|54284280|FG000|Overall Study|Adverse Event|5|||
27822104|NCT01874431|54284281|FG001|Overall Study|Adverse Event|4|||
27822105|NCT01874431|54284282|FG002|Overall Study|Adverse Event|6|||
27822106|NCT01874431|54284283|FG003|Overall Study|Adverse Event|5|||
27822107|NCT01874431|54284284|FG004|Overall Study|Adverse Event|2|||
27822108|NCT01874431|54284285|FG005|Overall Study|Adverse Event|8|||
27822109|NCT01874431|54284286|FG006|Overall Study|Adverse Event|2|||
27822110|NCT01874431|54284287|FG007|Overall Study|Adverse Event|3|||
27822111|NCT01874431|54284280|FG000|Overall Study|Protocol Violation|1|||
27822112|NCT01874431|54284281|FG001|Overall Study|Protocol Violation|1|||
27822113|NCT01874431|54284282|FG002|Overall Study|Protocol Violation|1|||
27822114|NCT01874431|54284283|FG003|Overall Study|Protocol Violation|0|||
27822115|NCT01874431|54284284|FG004|Overall Study|Protocol Violation|3|||
27822116|NCT01874431|54284285|FG005|Overall Study|Protocol Violation|2|||
27822117|NCT01874431|54284286|FG006|Overall Study|Protocol Violation|1|||
27822118|NCT01874431|54284287|FG007|Overall Study|Protocol Violation|1|||
27822119|NCT01874431|54284280|FG000|Overall Study|Non-compliance|0|||
27822120|NCT01874431|54284281|FG001|Overall Study|Non-compliance|0|||
27822121|NCT01874431|54284282|FG002|Overall Study|Non-compliance|0|||
27822122|NCT01874431|54284283|FG003|Overall Study|Non-compliance|0|||
28070839|NCT00023764|54725616|FG000|Overall Study|Adverse Event|4|||
28141745|NCT03143101|54807406|FG000|Overall Study|Lost to Follow-up|2|||
28141746|NCT03143101|54807407|FG001|Overall Study|Lost to Follow-up|2|||
28141747|NCT03143101|54807408|FG002|Overall Study|Lost to Follow-up|0|||
28141748|NCT00871351|54807419|FG000|Overall Study|Withdrawal by Subject|1|||
28141749|NCT00871351|54807420|FG001|Overall Study|Withdrawal by Subject|0|||
28141750|NCT00871351|54807421|FG002|Overall Study|Withdrawal by Subject|0|||
28141751|NCT00871351|54807419|FG000|Overall Study|Adverse Event|3|||
28141752|NCT00871351|54807420|FG001|Overall Study|Adverse Event|1|||
28141753|NCT00871351|54807421|FG002|Overall Study|Adverse Event|0|||
28141754|NCT02745080|54807431|FG000|Overall Study|Adverse Event|13|||
28141755|NCT02745080|54807432|FG001|Overall Study|Adverse Event|21|||
28141756|NCT02745080|54807431|FG000|Overall Study|Lack of Efficacy|11|||
28141757|NCT02745080|54807432|FG001|Overall Study|Lack of Efficacy|23|||
28141758|NCT02745080|54807431|FG000|Overall Study|Lost to Follow-up|3|||
28141759|NCT02745080|54807432|FG001|Overall Study|Lost to Follow-up|3|||
28141760|NCT02745080|54807431|FG000|Overall Study|Physician Decision|3|||
28141761|NCT02745080|54807432|FG001|Overall Study|Physician Decision|0|||
28141762|NCT02745080|54807431|FG000|Overall Study|Protocol Violation|3|||
27822123|NCT01874431|54284284|FG004|Overall Study|Non-compliance|1|||
27822124|NCT01874431|54284285|FG005|Overall Study|Non-compliance|0|||
27822125|NCT01874431|54284286|FG006|Overall Study|Non-compliance|1|||
27822126|NCT01874431|54284287|FG007|Overall Study|Non-compliance|0|||
28141763|NCT02745080|54807432|FG001|Overall Study|Protocol Violation|1|||
28141764|NCT02745080|54807431|FG000|Overall Study|Withdrawal by Subject|22|||
28141765|NCT02745080|54807432|FG001|Overall Study|Withdrawal by Subject|41|||
28141766|NCT00521599|54807442|FG000|Overall Study|Adverse Event|5|||
28141767|NCT00521599|54807443|FG001|Overall Study|Adverse Event|7|||
28141768|NCT00521599|54807444|FG002|Overall Study|Adverse Event|6|||
28141769|NCT00521599|54807442|FG000|Overall Study|Treatment Failure|8|||
28141770|NCT00521599|54807443|FG001|Overall Study|Treatment Failure|9|||
28141771|NCT00521599|54807444|FG002|Overall Study|Treatment Failure|22|||
28141772|NCT00521599|54807442|FG000|Overall Study|Lost to Follow-up|2|||
28141773|NCT00521599|54807443|FG001|Overall Study|Lost to Follow-up|1|||
28141774|NCT00521599|54807444|FG002|Overall Study|Lost to Follow-up|2|||
28141775|NCT00521599|54807442|FG000|Overall Study|Withdrawal by Subject|3|||
28141776|NCT00521599|54807443|FG001|Overall Study|Withdrawal by Subject|5|||
28141777|NCT00521599|54807444|FG002|Overall Study|Withdrawal by Subject|1|||
28141778|NCT00521599|54807442|FG000|Overall Study|Withdrawal by subject treatment related|3|||
28141779|NCT00521599|54807443|FG001|Overall Study|Withdrawal by subject treatment related|1|||
28141780|NCT00521599|54807444|FG002|Overall Study|Withdrawal by subject treatment related|2|||
28141781|NCT00521599|54807442|FG000|Overall Study|Protocol Violation|2|||
28141782|NCT00521599|54807443|FG001|Overall Study|Protocol Violation|4|||
28141783|NCT00521599|54807444|FG002|Overall Study|Protocol Violation|2|||
27822127|NCT01874431|54284280|FG000|Overall Study|Logistical difficulties|0|||
27822128|NCT01874431|54284281|FG001|Overall Study|Logistical difficulties|0|||
27849943|NCT03325608|54348265|FG003|Overall Study|Death of Care Recipient|41|||
27849944|NCT03325608|54348262|FG000|Overall Study|Withdrawal by Subject|44|||
28141784|NCT00521599|54807442|FG000|Overall Study|Did not meet protocol eligibility|2|||
28141785|NCT00521599|54807443|FG001|Overall Study|Did not meet protocol eligibility|2|||
28141786|NCT00521599|54807444|FG002|Overall Study|Did not meet protocol eligibility|1|||
28141787|NCT00442897|54807455|FG000|Base Study (12 Week Follow-up)|Adverse Event|1|||
28141788|NCT00442897|54807456|FG001|Base Study (12 Week Follow-up)|Adverse Event|0|||
28141789|NCT00442897|54807455|FG000|Base Study (12 Week Follow-up)|Death|0|||
28141790|NCT00442897|54807456|FG001|Base Study (12 Week Follow-up)|Death|1|||
28141791|NCT00442897|54807455|FG000|Base Study (12 Week Follow-up)|Protocol Violation|7|||
28141792|NCT00442897|54807456|FG001|Base Study (12 Week Follow-up)|Protocol Violation|3|||
28141793|NCT00442897|54807455|FG000|Base Study (12 Week Follow-up)|Withdrawal by Subject|9|||
28141794|NCT00442897|54807456|FG001|Base Study (12 Week Follow-up)|Withdrawal by Subject|8|||
28141795|NCT00442897|54807455|FG000|24 Weeks Follow-up (3 Centers)|Adverse Event|1|||
28141796|NCT00442897|54807456|FG001|24 Weeks Follow-up (3 Centers)|Adverse Event|0|||
28141797|NCT00442897|54807455|FG000|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
28141798|NCT00442897|54807456|FG001|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
28141799|NCT00442897|54807455|FG000|24 Weeks Follow-up (3 Centers)|Protocol Violation|2|||
27822129|NCT01874431|54284282|FG002|Overall Study|Logistical difficulties|0|||
27822130|NCT01874431|54284283|FG003|Overall Study|Logistical difficulties|0|||
27822131|NCT01874431|54284284|FG004|Overall Study|Logistical difficulties|0|||
28141800|NCT00442897|54807456|FG001|24 Weeks Follow-up (3 Centers)|Protocol Violation|1|||
28141801|NCT00442897|54807455|FG000|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1|||
28141802|NCT00442897|54807456|FG001|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3|||
28141803|NCT02834390|54807464|FG000|Induction Phase|Progressive disease|0|||
28141804|NCT02834390|54807465|FG001|Induction Phase|Progressive disease|1|||
28141805|NCT02834390|54807464|FG000|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|2|||
28141806|NCT02834390|54807465|FG001|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|0|||
28141807|NCT02834390|54807464|FG000|Induction Phase|Relapse after CR, CRp, or CRi|0|||
28141808|NCT02834390|54807465|FG001|Induction Phase|Relapse after CR, CRp, or CRi|1|||
28141809|NCT02834390|54807464|FG000|Consolidation Phase|Physician Decision|1|||
28141810|NCT02834390|54807465|FG001|Consolidation Phase|Physician Decision|1|||
28141811|NCT03141151|54807473|FG000|Overall Study|Lost to Follow-up|3|||
28141812|NCT03141151|54807474|FG001|Overall Study|Lost to Follow-up|2|||
28141813|NCT03141151|54807473|FG000|Overall Study|Withdrawal by Subject|3|||
28141814|NCT03141151|54807474|FG001|Overall Study|Withdrawal by Subject|2|||
28141815|NCT01358708|54807482|FG000|Double-Blind Treatment Phase|Lost to Follow-up|2|||
28141816|NCT01358708|54807483|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
28141817|NCT01358708|54807482|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
28141818|NCT01358708|54807483|FG001|Double-Blind Treatment Phase|Protocol Violation|0|||
28141819|NCT01356602|54807496|FG000|Overall Study|Protocol Deviation|0|||
27822132|NCT01874431|54284285|FG005|Overall Study|Logistical difficulties|0|||
27822133|NCT01874431|54284286|FG006|Overall Study|Logistical difficulties|1|||
28141820|NCT01356602|54807497|FG001|Overall Study|Protocol Deviation|1|||
28141821|NCT01356602|54807498|FG002|Overall Study|Protocol Deviation|1|||
28141822|NCT01356602|54807496|FG000|Overall Study|Administrative Problems|1|||
28141823|NCT01356602|54807497|FG001|Overall Study|Administrative Problems|4|||
28141824|NCT01356602|54807498|FG002|Overall Study|Administrative Problems|5|||
28141825|NCT01356602|54807496|FG000|Overall Study|Lost to Follow-up|4|||
28141826|NCT01356602|54807497|FG001|Overall Study|Lost to Follow-up|5|||
28141827|NCT01356602|54807498|FG002|Overall Study|Lost to Follow-up|6|||
28141828|NCT01356602|54807496|FG000|Overall Study|Withdrawal by Subject|4|||
28141829|NCT01356602|54807497|FG001|Overall Study|Withdrawal by Subject|3|||
28141830|NCT01356602|54807498|FG002|Overall Study|Withdrawal by Subject|7|||
28141831|NCT01356602|54807496|FG000|Overall Study|Lack of Efficacy|0|||
28141832|NCT01356602|54807497|FG001|Overall Study|Lack of Efficacy|1|||
28141833|NCT01356602|54807498|FG002|Overall Study|Lack of Efficacy|4|||
28141834|NCT01356602|54807496|FG000|Overall Study|Adverse Event|0|||
28141835|NCT01356602|54807497|FG001|Overall Study|Adverse Event|1|||
28141836|NCT01356602|54807498|FG002|Overall Study|Adverse Event|1|||
28141837|NCT02830880|54807506|FG000|Overall Study|Adverse reaction to chemotherapy|1|||
28141838|NCT02830880|54807506|FG000|Overall Study|Death|1|||
28141839|NCT02830880|54807506|FG000|Overall Study|Physician Decision|1|||
28141840|NCT03141307|54807512|FG000|In-Hospital|Withdrawal by Subject|0|||
28141841|NCT03141307|54807513|FG001|In-Hospital|Withdrawal by Subject|2|||
28141842|NCT03141307|54807512|FG000|In-Hospital|Protocol Violation|4|||
28141843|NCT03141307|54807513|FG001|In-Hospital|Protocol Violation|0|||
28141844|NCT03141307|54807512|FG000|Follow-Up|Lost to Follow-up|97|||
28141845|NCT03141307|54807513|FG001|Follow-Up|Lost to Follow-up|54|||
28141846|NCT02825420|54807521|FG000|Overall Study|Death|30|||
28141847|NCT02825420|54807522|FG001|Overall Study|Death|12|||
28141848|NCT02825420|54807521|FG000|Overall Study|Progressive disease|6|||
28141849|NCT02825420|54807522|FG001|Overall Study|Progressive disease|1|||
28141850|NCT02825420|54807521|FG000|Overall Study|Lost to Follow-up|2|||
28141851|NCT02825420|54807522|FG001|Overall Study|Lost to Follow-up|2|||
28141852|NCT02825420|54807521|FG000|Overall Study|Withdrawal by Subject|1|||
28141853|NCT02825420|54807522|FG001|Overall Study|Withdrawal by Subject|1|||
28141854|NCT02825420|54807521|FG000|Overall Study|Protocol amendment not signed|1|||
28141855|NCT02825420|54807522|FG001|Overall Study|Protocol amendment not signed|1|||
28141856|NCT02825420|54807521|FG000|Overall Study|Physician Decision|1|||
28070840|NCT00023764|54725616|FG000|Overall Study|Withdrawal by Subject|1|||
28070841|NCT00023764|54725616|FG000|Overall Study|Progression of disease|6|||
28141857|NCT02825420|54807522|FG001|Overall Study|Physician Decision|0|||
28141858|NCT02825420|54807521|FG000|Overall Study|Did not receive PLD|2|||
28141859|NCT02825420|54807522|FG001|Overall Study|Did not receive PLD|0|||
28141860|NCT02829944|54807535|FG000|Overall Study|Physician Decision|0|||
28141861|NCT02829944|54807536|FG001|Overall Study|Physician Decision|1|||
28141862|NCT02829944|54807535|FG000|Overall Study|Screen Failure|2|||
28141863|NCT02829944|54807536|FG001|Overall Study|Screen Failure|2|||
28141864|NCT02829944|54807535|FG000|Overall Study|Inadequate Neuraxial Block|1|||
28141865|NCT02829944|54807536|FG001|Overall Study|Inadequate Neuraxial Block|1|||
28141866|NCT02829944|54807535|FG000|Overall Study|Withdrawal by Subject|2|||
28141867|NCT02829944|54807536|FG001|Overall Study|Withdrawal by Subject|1|||
28141868|NCT02829944|54807535|FG000|Overall Study|Catheter Displacement|1|||
28141869|NCT02829944|54807536|FG001|Overall Study|Catheter Displacement|0|||
28141870|NCT02829944|54807535|FG000|Overall Study|Catheter broke|0|||
28141871|NCT02829944|54807536|FG001|Overall Study|Catheter broke|1|||
28070842|NCT00023764|54725616|FG000|Overall Study|patient received other treatment|1|||
28070843|NCT00023764|54725616|FG000|Overall Study|delay in obtaining staging images|1|||
28070844|NCT00189488|54725623|FG000|Overall Study|Ineligibility determined|1|||
28070845|NCT00189488|54725624|FG001|Overall Study|Ineligibility determined|0|||
28070846|NCT00189488|54725623|FG000|Overall Study|Protocol deviation|2|||
28070847|NCT00189488|54725624|FG001|Overall Study|Protocol deviation|1|||
28070848|NCT00189488|54725623|FG000|Overall Study|Adverse Event|2|||
28070849|NCT00189488|54725624|FG001|Overall Study|Adverse Event|1|||
28141872|NCT02829944|54807535|FG000|Overall Study|Staff unavailable|0|||
28070850|NCT00189488|54725623|FG000|Overall Study|Withdrawal by Subject|2|||
28141873|NCT02829944|54807536|FG001|Overall Study|Staff unavailable|1|||
28141874|NCT02824562|54807544|FG000|Overall Study|Lost to Follow-up|3|||
28141875|NCT02824562|54807545|FG001|Overall Study|Lost to Follow-up|4|||
28141876|NCT02824562|54807544|FG000|Overall Study|Death|0|||
28141877|NCT02824562|54807545|FG001|Overall Study|Death|1|||
28141878|NCT02744066|54807553|FG000|Overall Study|Withdrawal by parent|0|||
28141879|NCT02744066|54807554|FG001|Overall Study|Withdrawal by parent|1|||
28141880|NCT02744066|54807553|FG000|Overall Study|Discharged from NICU prior to completion|0|||
28141881|NCT02744066|54807554|FG001|Overall Study|Discharged from NICU prior to completion|4|||
28141882|NCT01338818|54807562|FG000|Overall Study|Adverse Event|8|||
28141883|NCT01338818|54807562|FG000|Overall Study|Lack of Efficacy|5|||
28141884|NCT01338818|54807562|FG000|Overall Study|no longer require study drug|1|||
28141885|NCT01338818|54807562|FG000|Overall Study|Withdrawal by Subject|11|||
28141886|NCT01338818|54807562|FG000|Overall Study|Lost to Follow-up|4|||
28141887|NCT01338818|54807562|FG000|Overall Study|Administrative problems|3|||
28141888|NCT01338818|54807562|FG000|Overall Study|Protocol Deviation|4|||
28141889|NCT02823470|54807568|FG000|Overall Study|Adverse Event|1|||
28141890|NCT02823470|54807569|FG001|Overall Study|Adverse Event|0|||
28141891|NCT02823470|54807568|FG000|Overall Study|Study terminated by sponsor|8|||
28141892|NCT02823470|54807569|FG001|Overall Study|Study terminated by sponsor|15|||
28141893|NCT01371656|54807580|FG000|Overall Study|Death|7|||
28141894|NCT01371656|54807581|FG001|Overall Study|Death|4|||
28141895|NCT01371656|54807580|FG000|Overall Study|Physician Decision|46|||
28141896|NCT01371656|54807581|FG001|Overall Study|Physician Decision|7|||
28141897|NCT01371656|54807580|FG000|Overall Study|Withdrawal by Subject|7|||
28141898|NCT01371656|54807581|FG001|Overall Study|Withdrawal by Subject|0|||
28141899|NCT01371656|54807580|FG000|Overall Study|Ineligible|4|||
28141900|NCT01371656|54807581|FG001|Overall Study|Ineligible|3|||
28141901|NCT01354106|54807587|FG000|Overall Study|Withdrawal by Subject|2|||
28141902|NCT01354028|54807593|FG000|Overall Study|Physician Decision|0|||
28141903|NCT01354028|54807594|FG001|Overall Study|Physician Decision|2|||
28141904|NCT01354028|54807593|FG000|Overall Study|Discharged before study start|2|||
28141905|NCT01354028|54807594|FG001|Overall Study|Discharged before study start|2|||
28141906|NCT01354028|54807593|FG000|Overall Study|No quiet alert state|0|||
28141907|NCT01354028|54807594|FG001|Overall Study|No quiet alert state|1|||
28141908|NCT01354964|54807608|FG000|Overall Study|Lost to Follow-up|2|||
28141909|NCT01354964|54807609|FG001|Overall Study|Lost to Follow-up|0|||
28141910|NCT01354964|54807608|FG000|Overall Study|IV access issues|1|||
28141911|NCT01354964|54807609|FG001|Overall Study|IV access issues|1|||
28141912|NCT01354964|54807608|FG000|Overall Study|Physician Decision|1|||
28141913|NCT01354964|54807609|FG001|Overall Study|Physician Decision|0|||
28141914|NCT01354496|54807619|FG000|Period 1|Adverse Event|0|||
28141915|NCT01354496|54807620|FG001|Period 1|Adverse Event|0|||
28141916|NCT01354496|54807621|FG002|Period 1|Adverse Event|1|||
28141917|NCT01354496|54807622|FG003|Period 1|Adverse Event|0|||
28141918|NCT01354496|54807623|FG004|Period 1|Adverse Event|0|||
28141919|NCT01354496|54807624|FG005|Period 1|Adverse Event|0|||
28141920|NCT01354496|54807619|FG000|Period 1|Physician Decision|0|||
28141921|NCT01354496|54807620|FG001|Period 1|Physician Decision|0|||
28141922|NCT01354496|54807621|FG002|Period 1|Physician Decision|1|||
28070851|NCT00189488|54725624|FG001|Overall Study|Withdrawal by Subject|6|||
28141923|NCT01354496|54807622|FG003|Period 1|Physician Decision|0|||
28141924|NCT01354496|54807623|FG004|Period 1|Physician Decision|0|||
28141925|NCT01354496|54807624|FG005|Period 1|Physician Decision|0|||
28141926|NCT01354496|54807619|FG000|Period 2|Adverse Event|0|||
28141927|NCT01354496|54807620|FG001|Period 2|Adverse Event|0|||
28141928|NCT01354496|54807621|FG002|Period 2|Adverse Event|0|||
28141929|NCT01354496|54807622|FG003|Period 2|Adverse Event|1|||
28141930|NCT01354496|54807623|FG004|Period 2|Adverse Event|0|||
28070852|NCT00189488|54725623|FG000|Overall Study|Disease progression|2|||
28070853|NCT00189488|54725624|FG001|Overall Study|Disease progression|4|||
28070854|NCT00189488|54725623|FG000|Overall Study|Administrative Decision|0|||
28070855|NCT00189488|54725624|FG001|Overall Study|Administrative Decision|2|||
28070856|NCT00189488|54725623|FG000|Overall Study|Death|5|||
28070857|NCT00189488|54725624|FG001|Overall Study|Death|8|||
28070858|NCT00189488|54725623|FG000|Overall Study|Other|1|||
28070859|NCT00189488|54725624|FG001|Overall Study|Other|0|||
28070860|NCT00233402|54725633|FG000|Overall Study|No pathology data|12|||
28141931|NCT01354496|54807624|FG005|Period 2|Adverse Event|0|||
28141932|NCT01354496|54807619|FG000|Washout (at Least 14 Days)|Scheduling Conflict|0|||
28141933|NCT01354496|54807620|FG001|Washout (at Least 14 Days)|Scheduling Conflict|1|||
28141934|NCT01354496|54807621|FG002|Washout (at Least 14 Days)|Scheduling Conflict|0|||
28141935|NCT01354496|54807622|FG003|Washout (at Least 14 Days)|Scheduling Conflict|1|||
28141936|NCT01354496|54807623|FG004|Washout (at Least 14 Days)|Scheduling Conflict|0|||
28141937|NCT01354496|54807624|FG005|Washout (at Least 14 Days)|Scheduling Conflict|0|||
28141938|NCT02822222|54807647|FG000|Overall Study|Protocol requirement SBP<110 mmHg|1|||
28141939|NCT02822222|54807648|FG001|Overall Study|Protocol requirement SBP<110 mmHg|0|||
28141940|NCT02821910|54807660|FG000|Overall Study|Withdrawal by Subject|0|||
28141941|NCT02821910|54807661|FG001|Overall Study|Withdrawal by Subject|0|||
28141942|NCT02821910|54807662|FG002|Overall Study|Withdrawal by Subject|1|||
28141943|NCT02821910|54807663|FG003|Overall Study|Withdrawal by Subject|0|||
28141944|NCT02821910|54807664|FG004|Overall Study|Withdrawal by Subject|0|||
28141945|NCT02821910|54807665|FG005|Overall Study|Withdrawal by Subject|1|||
28141946|NCT02821910|54807660|FG000|Overall Study|Other than specified|1|||
28141947|NCT02821910|54807661|FG001|Overall Study|Other than specified|0|||
28141948|NCT02821910|54807662|FG002|Overall Study|Other than specified|1|||
28141949|NCT02821910|54807663|FG003|Overall Study|Other than specified|0|||
28141950|NCT02821910|54807664|FG004|Overall Study|Other than specified|0|||
28141951|NCT02821910|54807665|FG005|Overall Study|Other than specified|0|||
28141952|NCT02817776|54807679|FG000|Overall Study|Excluded|33|||
28141953|NCT02817776|54807679|FG000|Overall Study|Lost to Follow-up|20|||
28141954|NCT02817776|54807679|FG000|Overall Study|Withdrawal by Subject|33|||
28141955|NCT02817776|54807679|FG000|Overall Study|Death|2|||
28141956|NCT03138655|54807691|FG000|Overall Study|Adverse Event|2|||
28141957|NCT03138655|54807692|FG001|Overall Study|Adverse Event|1|||
28141958|NCT03138655|54807693|FG002|Overall Study|Adverse Event|2|||
28141959|NCT03138655|54807694|FG003|Overall Study|Adverse Event|1|||
28141960|NCT03138655|54807695|FG004|Overall Study|Adverse Event|1|||
28141961|NCT03138655|54807696|FG005|Overall Study|Adverse Event|4|||
28141962|NCT03138655|54807697|FG006|Overall Study|Adverse Event|2|||
28141963|NCT03138655|54807698|FG007|Overall Study|Adverse Event|2|||
28141964|NCT03138655|54807691|FG000|Overall Study|Withdrawal by Subject|0|||
28141965|NCT03138655|54807692|FG001|Overall Study|Withdrawal by Subject|1|||
28141966|NCT03138655|54807693|FG002|Overall Study|Withdrawal by Subject|0|||
28141967|NCT03138655|54807694|FG003|Overall Study|Withdrawal by Subject|0|||
28141968|NCT03138655|54807695|FG004|Overall Study|Withdrawal by Subject|0|||
28070861|NCT00233402|54725634|FG001|Overall Study|No pathology data|9|||
28070862|NCT00233402|54725633|FG000|Overall Study|No Ta/T1|89|||
28070863|NCT00233402|54725634|FG001|Overall Study|No Ta/T1|94|||
28070864|NCT00233402|54725633|FG000|Overall Study|Lost to follow up etc|3|||
28070865|NCT00233402|54725634|FG001|Overall Study|Lost to follow up etc|21|||
28070866|NCT00233324|54725646|FG000|Main Study|Death|68|||
28070867|NCT00233324|54725647|FG001|Main Study|Death|60|||
28070868|NCT00233324|54725648|FG002|Main Study|Death|62|||
28070869|NCT00233324|54725649|FG003|Main Study|Death|47|||
28070870|NCT00233324|54725646|FG000|Follow up at 18-22 Months Corrected Age|Death|5|||
28070871|NCT00233324|54725647|FG001|Follow up at 18-22 Months Corrected Age|Death|7|||
28070872|NCT00233324|54725648|FG002|Follow up at 18-22 Months Corrected Age|Death|5|||
28070873|NCT00233324|54725649|FG003|Follow up at 18-22 Months Corrected Age|Death|4|||
28070874|NCT00233324|54725646|FG000|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8|||
28141969|NCT03138655|54807696|FG005|Overall Study|Withdrawal by Subject|0|||
28141970|NCT03138655|54807697|FG006|Overall Study|Withdrawal by Subject|1|||
28141971|NCT03138655|54807698|FG007|Overall Study|Withdrawal by Subject|0|||
28141972|NCT03138655|54807691|FG000|Overall Study|Reason not Specified|1|||
28141973|NCT03138655|54807692|FG001|Overall Study|Reason not Specified|0|||
28141974|NCT03138655|54807693|FG002|Overall Study|Reason not Specified|0|||
28141975|NCT03138655|54807694|FG003|Overall Study|Reason not Specified|2|||
28141976|NCT03138655|54807695|FG004|Overall Study|Reason not Specified|1|||
28141977|NCT03138655|54807696|FG005|Overall Study|Reason not Specified|1|||
28141978|NCT03138655|54807697|FG006|Overall Study|Reason not Specified|0|||
28141979|NCT03138655|54807698|FG007|Overall Study|Reason not Specified|0|||
28141980|NCT02820038|54807724|FG000|Overall Study|Lost to Follow-up|7|||
28141981|NCT02820038|54807725|FG001|Overall Study|Lost to Follow-up|11|||
28141982|NCT02820038|54807726|FG002|Overall Study|Lost to Follow-up|2|||
28141983|NCT02820038|54807727|FG003|Overall Study|Lost to Follow-up|9|||
28070875|NCT00233324|54725647|FG001|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
28070876|NCT00233324|54725648|FG002|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13|||
28070877|NCT00233324|54725649|FG003|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
28070878|NCT00023452|54725668|FG000|Overall Study|Ineligible for Study|163|||
28070879|NCT00023452|54725669|FG001|Overall Study|Ineligible for Study|159|||
28070880|NCT00023452|54725668|FG000|Overall Study|Out of Window|129|||
28070881|NCT00023452|54725669|FG001|Overall Study|Out of Window|69|||
28141984|NCT02820038|54807724|FG000|Overall Study|Withdrawal by Subject|3|||
28141985|NCT02820038|54807725|FG001|Overall Study|Withdrawal by Subject|14|||
28141986|NCT02820038|54807726|FG002|Overall Study|Withdrawal by Subject|3|||
28141987|NCT02820038|54807727|FG003|Overall Study|Withdrawal by Subject|13|||
28141988|NCT02819804|54807738|FG000|Complete Cycle 1 (28 Days)|Progressive disease/no response|1|||
28141989|NCT02819726|54807745|FG000|Part A (All Participants)|Lost to Follow-up|0|||
28141990|NCT02819726|54807746|FG001|Part A (All Participants)|Lost to Follow-up|1|||
28141991|NCT02819726|54807747|FG002|Part A (All Participants)|Lost to Follow-up|0|||
28070882|NCT00023452|54725668|FG000|Overall Study|Death|2|||
28070883|NCT00023452|54725669|FG001|Overall Study|Death|0|||
28070884|NCT00023452|54725668|FG000|Overall Study|Withdrawal by Subject|66|||
28141992|NCT02819726|54807748|FG003|Part A (All Participants)|Lost to Follow-up|0|||
28141993|NCT02819726|54807745|FG000|Part A (All Participants)|Withdrawal by Subject|3|||
28141994|NCT02819726|54807746|FG001|Part A (All Participants)|Withdrawal by Subject|5|||
28141995|NCT02819726|54807747|FG002|Part A (All Participants)|Withdrawal by Subject|6|||
27941188|NCT01015833|54597503|FG000|Overall Study|Withdrawal by Subject|3|||
27941189|NCT01015833|54597504|FG001|Overall Study|Withdrawal by Subject|2|||
28141996|NCT02819726|54807748|FG003|Part A (All Participants)|Withdrawal by Subject|0|||
28141997|NCT02819726|54807745|FG000|Part A (All Participants)|Protocol non-compliance|3|||
28141998|NCT02819726|54807746|FG001|Part A (All Participants)|Protocol non-compliance|4|||
28141999|NCT02819726|54807747|FG002|Part A (All Participants)|Protocol non-compliance|5|||
28142000|NCT02819726|54807748|FG003|Part A (All Participants)|Protocol non-compliance|0|||
28142001|NCT02819726|54807745|FG000|Part B (All Participants)|Lost to Follow-up|1|||
28142002|NCT02819726|54807746|FG001|Part B (All Participants)|Lost to Follow-up|1|||
28142003|NCT02819726|54807747|FG002|Part B (All Participants)|Lost to Follow-up|2|||
28142004|NCT02819726|54807748|FG003|Part B (All Participants)|Lost to Follow-up|2|||
28142005|NCT02819726|54807745|FG000|Part B (All Participants)|Withdrawal by Subject|2|||
28142006|NCT02819726|54807746|FG001|Part B (All Participants)|Withdrawal by Subject|1|||
28142007|NCT02819726|54807747|FG002|Part B (All Participants)|Withdrawal by Subject|1|||
28142008|NCT02819726|54807748|FG003|Part B (All Participants)|Withdrawal by Subject|0|||
28142009|NCT02819726|54807745|FG000|Part B (All Participants)|Protocol non-compliance|0|||
28142010|NCT02819726|54807746|FG001|Part B (All Participants)|Protocol non-compliance|0|||
28142011|NCT02819726|54807747|FG002|Part B (All Participants)|Protocol non-compliance|1|||
28142012|NCT02819726|54807748|FG003|Part B (All Participants)|Protocol non-compliance|0|||
27941190|NCT01015833|54597503|FG000|Overall Study|Adverse Event|0|||
27941191|NCT01015833|54597504|FG001|Overall Study|Adverse Event|1|||
28070885|NCT00023452|54725669|FG001|Overall Study|Withdrawal by Subject|54|||
28070886|NCT00023452|54725668|FG000|Overall Study|Adverse Event|139|||
28070887|NCT00023452|54725669|FG001|Overall Study|Adverse Event|196|||
28070888|NCT00023452|54725668|FG000|Overall Study|Lost to Follow-up|293|||
28070889|NCT00023452|54725669|FG001|Overall Study|Lost to Follow-up|60|||
28070890|NCT00023452|54725668|FG000|Overall Study|Physician Decision|49|||
28070891|NCT00023452|54725669|FG001|Overall Study|Physician Decision|21|||
28070892|NCT00023452|54725668|FG000|Overall Study|Refused Treatment (continued follow-up)|225|||
28070893|NCT00023452|54725669|FG001|Overall Study|Refused Treatment (continued follow-up)|224|||
28142013|NCT02816138|54807756|FG000|Overall Study|Adverse Event|1|||
28142014|NCT02815670|54807760|FG000|Overall Study|Prematurely discontinued of the trial|1|||
28142015|NCT02809976|54807764|FG000|Overall Study|Lost to Follow-up|1|||
28142016|NCT02809976|54807764|FG000|Overall Study|Withdrawal by Subject|1|||
28142017|NCT02880865|54807770|FG000|Overall Study|Adverse Event|1|||
28142018|NCT02880865|54807771|FG001|Overall Study|Adverse Event|0|||
28142019|NCT02880865|54807770|FG000|Overall Study|Withdrawal by Subject|0|||
28142020|NCT02880865|54807771|FG001|Overall Study|Withdrawal by Subject|2|||
28142021|NCT02880865|54807770|FG000|Overall Study|Physician Decision|0|||
28142022|NCT02880865|54807771|FG001|Overall Study|Physician Decision|1|||
28142023|NCT01854385|54807798|FG000|Pre-Treatment|Withdrawal by Subject|4|||
28142024|NCT01854385|54807798|FG000|Pre-Treatment|Did not meet criteria based on headache number|15|||
28142025|NCT01854385|54807798|FG000|Pre-Treatment|Disqualified based on blood pressure requirement|3|||
28142026|NCT01854385|54807798|FG000|Pre-Treatment|Unable to come for study visits|1|||
28142027|NCT01854385|54807798|FG000|Treatment|Lost to Follow-up|1|||
28142028|NCT02809118|54807805|FG000|Overall Study|Withdrawal by Subject|0|||
28142029|NCT02809118|54807806|FG001|Overall Study|Withdrawal by Subject|1|||
28142030|NCT02809118|54807807|FG002|Overall Study|Withdrawal by Subject|1|||
28142031|NCT03604159|54807817|FG000|Overall Study|Lost to Follow-up|6|||
28142032|NCT03604159|54807818|FG001|Overall Study|Lost to Follow-up|7|||
28142033|NCT02808338|54807824|FG000|Screening|Screen Failure|10|||
28142034|NCT02808338|54807824|FG000|Overnight In-lab Polysomonography|Withdrawal by Subject|1|||
28142035|NCT02808338|54807824|FG000|Overnight In-lab Polysomonography|Reason not given|1|||
28142036|NCT02807948|54807835|FG000|Overall Study|Physician Decision|1|||
27822134|NCT01874431|54284287|FG007|Overall Study|Logistical difficulties|0|||
27822135|NCT01874431|54284280|FG000|Overall Study|Withdrawal by Subject|0|||
27822136|NCT01874431|54284281|FG001|Overall Study|Withdrawal by Subject|0|||
27822137|NCT01874431|54284282|FG002|Overall Study|Withdrawal by Subject|1|||
27822138|NCT01874431|54284283|FG003|Overall Study|Withdrawal by Subject|2|||
27941192|NCT01015833|54597503|FG000|Overall Study|Physician Decision|2|||
27941193|NCT01015833|54597504|FG001|Overall Study|Physician Decision|0|||
28070894|NCT00023452|54725668|FG000|Overall Study|Pregnant|53|||
28142037|NCT02807948|54807836|FG001|Overall Study|Physician Decision|0|||
28142038|NCT02879383|54807845|FG000|First 24 Weeks|Physician Decision|0|||
28142039|NCT02879383|54807846|FG001|First 24 Weeks|Physician Decision|1|||
28142040|NCT02879383|54807847|FG002|First 24 Weeks|Physician Decision|0|||
28142041|NCT02879383|54807848|FG003|First 24 Weeks|Physician Decision|0|||
28142042|NCT02049710|54807862|FG000|Overall Study|Lost to Follow-up|319|||
28142043|NCT02049710|54807863|FG001|Overall Study|Lost to Follow-up|324|||
28142044|NCT02806232|54807891|FG000|Overall Study|Lost to Follow-up|1|||
27822139|NCT01874431|54284284|FG004|Overall Study|Withdrawal by Subject|1|||
27822140|NCT01874431|54284285|FG005|Overall Study|Withdrawal by Subject|1|||
28070895|NCT00023452|54725669|FG001|Overall Study|Pregnant|20|||
28070896|NCT00023452|54725668|FG000|Overall Study|Other|204|||
28070897|NCT00023452|54725669|FG001|Overall Study|Other|69|||
28070898|NCT00022672|54725681|FG000|Main Phase: 24 Months|Adverse Event|6|||
28070899|NCT00022672|54725682|FG001|Main Phase: 24 Months|Adverse Event|0|||
28070900|NCT00022672|54725681|FG000|Main Phase: 24 Months|Death|0|||
28070901|NCT00022672|54725682|FG001|Main Phase: 24 Months|Death|3|||
28070902|NCT00022672|54725681|FG000|Main Phase: 24 Months|Insufficient Therapeutic Response|75|||
28070903|NCT00022672|54725682|FG001|Main Phase: 24 Months|Insufficient Therapeutic Response|91|||
28070904|NCT00022672|54725681|FG000|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0|||
28070905|NCT00022672|54725682|FG001|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1|||
28070906|NCT00022672|54725681|FG000|Main Phase: 24 Months|Other Protocol Violation|1|||
28070907|NCT00022672|54725682|FG001|Main Phase: 24 Months|Other Protocol Violation|0|||
28070908|NCT00022672|54725681|FG000|Main Phase: 24 Months|Refused Treatment|3|||
28070909|NCT00022672|54725682|FG001|Main Phase: 24 Months|Refused Treatment|4|||
28070910|NCT00022672|54725681|FG000|Main Phase: 24 Months|Failure to Return|1|||
28070911|NCT00022672|54725682|FG001|Main Phase: 24 Months|Failure to Return|1|||
28070912|NCT00022672|54725681|FG000|Main Phase: 24 Months|Other|1|||
28070913|NCT00022672|54725682|FG001|Main Phase: 24 Months|Other|0|||
28070914|NCT00022672|54725681|FG000|Extension Phase|Adverse Event|1|||
28070915|NCT00022672|54725682|FG001|Extension Phase|Adverse Event|3|||
28070916|NCT00022672|54725681|FG000|Extension Phase|Death|0|||
28070917|NCT00022672|54725682|FG001|Extension Phase|Death|1|||
28142045|NCT02806232|54807892|FG001|Overall Study|Lost to Follow-up|2|||
28142046|NCT02806232|54807893|FG002|Overall Study|Lost to Follow-up|1|||
28070918|NCT00022672|54725681|FG000|Extension Phase|Insufficient Therapeutic Response|1|||
28070919|NCT00022672|54725682|FG001|Extension Phase|Insufficient Therapeutic Response|44|||
28070920|NCT00022672|54725681|FG000|Extension Phase|Refused Treatment|0|||
28142047|NCT02806232|54807894|FG003|Overall Study|Lost to Follow-up|0|||
28142048|NCT02806232|54807895|FG004|Overall Study|Lost to Follow-up|0|||
28142049|NCT02806232|54807896|FG005|Overall Study|Lost to Follow-up|1|||
28142050|NCT02806232|54807897|FG006|Overall Study|Lost to Follow-up|0|||
28142051|NCT02806232|54807898|FG007|Overall Study|Lost to Follow-up|0|||
28070921|NCT00022672|54725682|FG001|Extension Phase|Refused Treatment|2|||
28142052|NCT02806232|54807899|FG008|Overall Study|Lost to Follow-up|0|||
28142053|NCT02806232|54807891|FG000|Overall Study|Withdrawal by Subject|0|||
28142054|NCT02806232|54807892|FG001|Overall Study|Withdrawal by Subject|2|||
28142055|NCT02806232|54807893|FG002|Overall Study|Withdrawal by Subject|0|||
28142056|NCT02806232|54807894|FG003|Overall Study|Withdrawal by Subject|0|||
28142057|NCT02806232|54807895|FG004|Overall Study|Withdrawal by Subject|2|||
28142058|NCT02806232|54807896|FG005|Overall Study|Withdrawal by Subject|1|||
28142059|NCT02806232|54807897|FG006|Overall Study|Withdrawal by Subject|0|||
28142060|NCT02806232|54807898|FG007|Overall Study|Withdrawal by Subject|0|||
28142061|NCT02806232|54807899|FG008|Overall Study|Withdrawal by Subject|0|||
28142062|NCT02807402|54807919|FG000|Overall Study|Failure to Return|1|||
28142063|NCT02807402|54807919|FG000|Overall Study|Death|3|||
28142064|NCT02807402|54807919|FG000|Overall Study|Other|2|||
28142065|NCT00392327|54807939|FG000|Overall Study|Death|1|||
28142066|NCT00392327|54807940|FG001|Overall Study|Death|0|||
28142067|NCT00392327|54807941|FG002|Overall Study|Death|1|||
28142068|NCT00392327|54807942|FG003|Overall Study|Death|0|||
28142069|NCT00392327|54807943|FG004|Overall Study|Death|0|||
28070922|NCT00022672|54725681|FG000|Extension Phase|Other|1|||
28070923|NCT00022672|54725682|FG001|Extension Phase|Other|1|||
28070924|NCT00076804|54725691|FG000|Overall Study|Death|9|||
28070925|NCT00076804|54725692|FG001|Overall Study|Death|20|||
28070926|NCT00076804|54725691|FG000|Overall Study|Lost to Follow-up|9|||
28070927|NCT00076804|54725692|FG001|Overall Study|Lost to Follow-up|9|||
28070928|NCT00076804|54725691|FG000|Overall Study|Withdrawal by Subject|10|||
28070929|NCT00076804|54725692|FG001|Overall Study|Withdrawal by Subject|8|||
28070930|NCT00076804|54725691|FG000|Overall Study|Early study Closure|32|||
28070931|NCT00076804|54725692|FG001|Overall Study|Early study Closure|32|||
28070932|NCT00141453|54725700|FG000|Overall Study|Protocol Violation|6|||
28070933|NCT00141453|54725701|FG001|Overall Study|Protocol Violation|5|||
28142070|NCT00392327|54807944|FG005|Overall Study|Death|0|||
28142071|NCT00392327|54807945|FG006|Overall Study|Death|0|||
28142072|NCT00392327|54807946|FG007|Overall Study|Death|0|||
28142073|NCT00392327|54807939|FG000|Overall Study|Lack of Efficacy|8|||
27822141|NCT01874431|54284286|FG006|Overall Study|Withdrawal by Subject|3|||
27822142|NCT01874431|54284287|FG007|Overall Study|Withdrawal by Subject|0|||
27822143|NCT01874431|54284280|FG000|Overall Study|Sponsor decision|0|||
27822144|NCT01874431|54284281|FG001|Overall Study|Sponsor decision|0|||
27822145|NCT01874431|54284282|FG002|Overall Study|Sponsor decision|0|||
27822146|NCT01874431|54284283|FG003|Overall Study|Sponsor decision|0|||
27822147|NCT01874431|54284284|FG004|Overall Study|Sponsor decision|1|||
27822148|NCT01874431|54284285|FG005|Overall Study|Sponsor decision|0|||
27822149|NCT01874431|54284286|FG006|Overall Study|Sponsor decision|0|||
27822150|NCT01874431|54284287|FG007|Overall Study|Sponsor decision|0|||
27822151|NCT01874431|54284280|FG000|Overall Study|Lost to Follow-up|0|||
27822152|NCT01874431|54284281|FG001|Overall Study|Lost to Follow-up|0|||
27822153|NCT01874431|54284282|FG002|Overall Study|Lost to Follow-up|1|||
27822154|NCT01874431|54284283|FG003|Overall Study|Lost to Follow-up|0|||
27822155|NCT01874431|54284284|FG004|Overall Study|Lost to Follow-up|0|||
27822156|NCT01874431|54284285|FG005|Overall Study|Lost to Follow-up|0|||
27822157|NCT01874431|54284286|FG006|Overall Study|Lost to Follow-up|0|||
27822158|NCT01874431|54284287|FG007|Overall Study|Lost to Follow-up|0|||
27822159|NCT01824355|54284305|FG000|Overall Study|Adverse Event|2|||
27822160|NCT01824355|54284305|FG000|Overall Study|unevaluable reference method results per|1|||
27822161|NCT01823341|54284313|FG000|Overall Study|Failed run-in|7|||
27822162|NCT01823341|54284313|FG000|Overall Study|Withdrawal by Subject|7|||
27822163|NCT01823341|54284313|FG000|Overall Study|Adverse Event|1|||
27822164|NCT01853137|54284322|FG000|Overall Study|Lost to Follow-up|4|||
27822165|NCT01853137|54284323|FG001|Overall Study|Lost to Follow-up|1|||
27822166|NCT01823107|54284330|FG000|Overall Study|Withdrawal by Subject|1|||
27822167|NCT01874275|54284336|FG000|Overall Study|Lost to Follow-up|1|||
27822168|NCT01874275|54284337|FG001|Overall Study|Lost to Follow-up|0|||
27822169|NCT01873729|54284349|FG000|Overall Study|Withdrawal by Subject|1|||
27822170|NCT01873495|54284353|FG000|Overall Study|Withdrawal by Subject|1|||
27822171|NCT01873495|54284353|FG000|Overall Study|Physician Decision|3|||
27822172|NCT01873495|54284353|FG000|Overall Study|Adverse Event|1|||
27822173|NCT01873495|54284353|FG000|Overall Study|Removed for Transplantation|1|||
27822174|NCT01873495|54284353|FG000|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1|||
27822175|NCT01852825|54284360|FG000|Overall Study|Withdrawal by Subject|2|||
27822176|NCT01852825|54284361|FG001|Overall Study|Withdrawal by Subject|0|||
27822177|NCT01852825|54284362|FG002|Overall Study|Withdrawal by Subject|0|||
27822178|NCT01822561|54284370|FG000|Overall Study|Withdrawal by Subject|2|||
27822179|NCT01852591|54284395|FG000|Overall Study|Withdrawal by Subject|2|||
27822180|NCT01852591|54284395|FG000|Overall Study|Not Evaluable at Time of Analysis|1|||
27822181|NCT01852045|54284402|FG000|Overall Study|Adverse Event|1|||
27822182|NCT01852045|54284403|FG001|Overall Study|Adverse Event|0|||
27822183|NCT01852045|54284404|FG002|Overall Study|Adverse Event|0|||
27822184|NCT01852045|54284402|FG000|Overall Study|Lack of Efficacy|3|||
27822185|NCT01852045|54284403|FG001|Overall Study|Lack of Efficacy|0|||
27822186|NCT01852045|54284404|FG002|Overall Study|Lack of Efficacy|0|||
27822187|NCT01852045|54284402|FG000|Overall Study|Lost to Follow-up|0|||
27822188|NCT01852045|54284403|FG001|Overall Study|Lost to Follow-up|1|||
27822189|NCT01852045|54284404|FG002|Overall Study|Lost to Follow-up|1|||
27822190|NCT01852045|54284402|FG000|Overall Study|Withdrawal by Subject|1|||
27822191|NCT01852045|54284403|FG001|Overall Study|Withdrawal by Subject|0|||
27822192|NCT01852045|54284404|FG002|Overall Study|Withdrawal by Subject|1|||
27822193|NCT01852045|54284402|FG000|Overall Study|Other Miscellaneous Reasons|1|||
27822194|NCT01852045|54284403|FG001|Overall Study|Other Miscellaneous Reasons|3|||
27822195|NCT01852045|54284404|FG002|Overall Study|Other Miscellaneous Reasons|2|||
27822196|NCT01821937|54284423|FG000|Overall Study|Adverse Event|0|||
27822197|NCT01821937|54284424|FG001|Overall Study|Adverse Event|3|||
27822198|NCT01821625|54284432|FG000|Overall Study|Withdrawal by Subject|2|||
27849945|NCT03325608|54348263|FG001|Overall Study|Withdrawal by Subject|44|||
27849946|NCT03325608|54348264|FG002|Overall Study|Withdrawal by Subject|30|||
27822199|NCT01821625|54284432|FG000|Overall Study|Lack of Efficacy|2|||
27822200|NCT01821625|54284432|FG000|Overall Study|Adverse Event|1|||
27822201|NCT01821625|54284432|FG000|Overall Study|Medical contraindication|1|||
27822202|NCT01821391|54284438|FG000|Overall Study|Adverse Event|1|||
27822203|NCT01821391|54284439|FG001|Overall Study|Adverse Event|0|||
27822204|NCT01873417|54284447|FG000|Overall Study|Did Not Receive Any Study Drug|4|||
27849947|NCT03325608|54348265|FG003|Overall Study|Withdrawal by Subject|30|||
27849948|NCT03183141|54348275|FG000|Overall Study|Withdrawal by Subject|2|||
28070934|NCT00076570|54725709|FG000|Overall Study|Drug intolerance|8|||
27822205|NCT01873417|54284447|FG000|Overall Study|Adverse Event|24|||
27822206|NCT01873417|54284447|FG000|Overall Study|Lost to Follow-up|2|||
27822207|NCT01873417|54284447|FG000|Overall Study|Withdrawal by Subject|2|||
27822208|NCT01873417|54284447|FG000|Overall Study|Physician Decision|3|||
27822209|NCT01872715|54284451|FG000|Overall Study|Adverse Event|1|||
27822210|NCT01872715|54284451|FG000|Overall Study|Protocol Violation|1|||
27822211|NCT01872715|54284451|FG000|Overall Study|Withdrawal by Subject|2|||
28142074|NCT00392327|54807940|FG001|Overall Study|Lack of Efficacy|8|||
28142075|NCT00392327|54807941|FG002|Overall Study|Lack of Efficacy|9|||
28142076|NCT00392327|54807942|FG003|Overall Study|Lack of Efficacy|6|||
28142077|NCT00392327|54807943|FG004|Overall Study|Lack of Efficacy|3|||
28142078|NCT00392327|54807944|FG005|Overall Study|Lack of Efficacy|3|||
28142079|NCT00392327|54807945|FG006|Overall Study|Lack of Efficacy|3|||
28142080|NCT00392327|54807946|FG007|Overall Study|Lack of Efficacy|3|||
28142081|NCT00392327|54807939|FG000|Overall Study|Physician Decision|3|||
28142082|NCT00392327|54807940|FG001|Overall Study|Physician Decision|5|||
28142083|NCT00392327|54807941|FG002|Overall Study|Physician Decision|2|||
28142084|NCT00392327|54807942|FG003|Overall Study|Physician Decision|2|||
28142085|NCT00392327|54807943|FG004|Overall Study|Physician Decision|0|||
28142086|NCT00392327|54807944|FG005|Overall Study|Physician Decision|1|||
28142087|NCT00392327|54807945|FG006|Overall Study|Physician Decision|5|||
28142088|NCT00392327|54807946|FG007|Overall Study|Physician Decision|3|||
28142089|NCT00392327|54807939|FG000|Overall Study|Protocol Violation|0|||
28142090|NCT00392327|54807940|FG001|Overall Study|Protocol Violation|0|||
28142091|NCT00392327|54807941|FG002|Overall Study|Protocol Violation|1|||
28142092|NCT00392327|54807942|FG003|Overall Study|Protocol Violation|0|||
28142093|NCT00392327|54807943|FG004|Overall Study|Protocol Violation|0|||
28142094|NCT00392327|54807944|FG005|Overall Study|Protocol Violation|0|||
28142095|NCT00392327|54807945|FG006|Overall Study|Protocol Violation|0|||
28142096|NCT00392327|54807946|FG007|Overall Study|Protocol Violation|0|||
28142097|NCT00392327|54807939|FG000|Overall Study|Withdrawal by Subject|3|||
28142098|NCT00392327|54807940|FG001|Overall Study|Withdrawal by Subject|2|||
28142099|NCT00392327|54807941|FG002|Overall Study|Withdrawal by Subject|4|||
28142100|NCT00392327|54807942|FG003|Overall Study|Withdrawal by Subject|6|||
28142101|NCT00392327|54807943|FG004|Overall Study|Withdrawal by Subject|0|||
28142102|NCT00392327|54807944|FG005|Overall Study|Withdrawal by Subject|1|||
28142103|NCT00392327|54807945|FG006|Overall Study|Withdrawal by Subject|1|||
28142104|NCT00392327|54807946|FG007|Overall Study|Withdrawal by Subject|5|||
28142105|NCT00392327|54807939|FG000|Overall Study|Ineligible|0|||
28142106|NCT00392327|54807940|FG001|Overall Study|Ineligible|4|||
28142107|NCT00392327|54807941|FG002|Overall Study|Ineligible|3|||
28142108|NCT00392327|54807942|FG003|Overall Study|Ineligible|2|||
28142109|NCT00392327|54807943|FG004|Overall Study|Ineligible|0|||
28142110|NCT00392327|54807944|FG005|Overall Study|Ineligible|0|||
28142111|NCT00392327|54807945|FG006|Overall Study|Ineligible|0|||
28142112|NCT00392327|54807946|FG007|Overall Study|Ineligible|0|||
28142113|NCT02960490|54807966|FG000|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|3|||
28142114|NCT02960490|54807967|FG001|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|2|||
28142115|NCT02960490|54807968|FG002|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
28142116|NCT02960490|54807969|FG003|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
28142117|NCT02960490|54807970|FG004|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
28142118|NCT02960490|54807971|FG005|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
28142119|NCT02960490|54807972|FG006|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
28142120|NCT02960490|54807973|FG007|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
28142121|NCT02960490|54807974|FG008|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
28142122|NCT02960490|54807975|FG009|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
28142123|NCT02960490|54807966|FG000|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
28142124|NCT02960490|54807967|FG001|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|1|||
28142125|NCT02960490|54807968|FG002|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
28142126|NCT02960490|54807969|FG003|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
28142127|NCT02960490|54807970|FG004|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
28142128|NCT02960490|54807971|FG005|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
28142129|NCT02960490|54807972|FG006|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
28142130|NCT02960490|54807973|FG007|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
28142131|NCT02960490|54807974|FG008|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
28142132|NCT02960490|54807975|FG009|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
28142133|NCT02960490|54807966|FG000|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|1|||
28142134|NCT02960490|54807967|FG001|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|2|||
28142135|NCT02960490|54807968|FG002|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
28142136|NCT02960490|54807969|FG003|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
28142137|NCT02960490|54807970|FG004|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
28142138|NCT02960490|54807971|FG005|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
28142139|NCT02960490|54807972|FG006|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
28142140|NCT02960490|54807973|FG007|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
28142141|NCT02960490|54807974|FG008|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
28142142|NCT02960490|54807975|FG009|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
28142143|NCT02960490|54807966|FG000|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
28142144|NCT02960490|54807967|FG001|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
28142145|NCT02960490|54807968|FG002|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
28142146|NCT02960490|54807969|FG003|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
28142147|NCT02960490|54807970|FG004|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
28142148|NCT02960490|54807971|FG005|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
28142149|NCT02960490|54807972|FG006|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
28142150|NCT02960490|54807973|FG007|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
28142151|NCT02960490|54807974|FG008|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
28142152|NCT02960490|54807975|FG009|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
28142153|NCT02960490|54807966|FG000|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
28142154|NCT02960490|54807967|FG001|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
28142155|NCT02960490|54807968|FG002|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
28142156|NCT02960490|54807969|FG003|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
28142157|NCT02960490|54807970|FG004|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
28142158|NCT02960490|54807971|FG005|Re-randomized Participants: 12 Weeks|Lack of Efficacy|2|||
28142159|NCT02960490|54807972|FG006|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
28142160|NCT02960490|54807973|FG007|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
28142161|NCT02960490|54807974|FG008|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
28142162|NCT02960490|54807975|FG009|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
28142163|NCT02960490|54807966|FG000|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
28142164|NCT02960490|54807967|FG001|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
28142165|NCT02960490|54807968|FG002|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
28142166|NCT02960490|54807969|FG003|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
28142167|NCT02960490|54807970|FG004|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
28142168|NCT02960490|54807971|FG005|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
28142169|NCT02960490|54807972|FG006|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
28142170|NCT02960490|54807973|FG007|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
28142171|NCT02960490|54807974|FG008|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
27822212|NCT01871545|54284467|FG000|Overall Study|Death|2|||
27822213|NCT01871545|54284468|FG001|Overall Study|Death|0|||
28142172|NCT02960490|54807975|FG009|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
28142173|NCT02960490|54807966|FG000|Re-randomized Participants: 12 Weeks|Other|0|||
28142174|NCT02960490|54807967|FG001|Re-randomized Participants: 12 Weeks|Other|0|||
28142175|NCT02960490|54807968|FG002|Re-randomized Participants: 12 Weeks|Other|0|||
28142176|NCT02960490|54807969|FG003|Re-randomized Participants: 12 Weeks|Other|1|||
28142177|NCT02960490|54807970|FG004|Re-randomized Participants: 12 Weeks|Other|0|||
28142178|NCT02960490|54807971|FG005|Re-randomized Participants: 12 Weeks|Other|0|||
28142179|NCT02960490|54807972|FG006|Re-randomized Participants: 12 Weeks|Other|0|||
28142180|NCT02960490|54807973|FG007|Re-randomized Participants: 12 Weeks|Other|0|||
28142181|NCT02960490|54807974|FG008|Re-randomized Participants: 12 Weeks|Other|0|||
28142182|NCT02960490|54807975|FG009|Re-randomized Participants: 12 Weeks|Other|0|||
28142183|NCT02960490|54807966|FG000|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
28142184|NCT02960490|54807967|FG001|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
28142185|NCT02960490|54807968|FG002|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
28142186|NCT02960490|54807969|FG003|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
28142187|NCT02960490|54807970|FG004|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
28142188|NCT02960490|54807971|FG005|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
28142189|NCT02960490|54807972|FG006|Extension Phase(Open-label): 80 Weeks|Adverse Event|3|||
28142190|NCT02960490|54807973|FG007|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
28142191|NCT02960490|54807974|FG008|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
28142192|NCT02960490|54807975|FG009|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
28142193|NCT02960490|54807966|FG000|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
27822214|NCT01871545|54284467|FG000|Overall Study|Lack of Efficacy|11|||
27822215|NCT01871545|54284468|FG001|Overall Study|Lack of Efficacy|2|||
27822216|NCT01871545|54284467|FG000|Overall Study|Physician Decision|4|||
27822217|NCT01871545|54284468|FG001|Overall Study|Physician Decision|0|||
27822218|NCT01871545|54284467|FG000|Overall Study|Withdrawal by Subject|0|||
27822219|NCT01871545|54284468|FG001|Overall Study|Withdrawal by Subject|1|||
27822220|NCT01613599|54284477|FG000|Overall Study|Death|9|||
28142194|NCT02960490|54807967|FG001|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
28142195|NCT02960490|54807968|FG002|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
28142196|NCT02960490|54807969|FG003|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
28142197|NCT02960490|54807970|FG004|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
28142198|NCT02960490|54807971|FG005|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
28142199|NCT02960490|54807972|FG006|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
28142200|NCT02960490|54807973|FG007|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|1|||
28142201|NCT02960490|54807974|FG008|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
28142202|NCT02960490|54807975|FG009|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
28142203|NCT02960490|54807966|FG000|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
28142204|NCT02960490|54807967|FG001|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
28142205|NCT02960490|54807968|FG002|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
28142206|NCT02960490|54807969|FG003|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
28142207|NCT02960490|54807970|FG004|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
28142208|NCT02960490|54807971|FG005|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
28142209|NCT02960490|54807972|FG006|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|4|||
28142210|NCT02960490|54807973|FG007|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
28142211|NCT02960490|54807974|FG008|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
28142212|NCT02960490|54807975|FG009|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|7|||
28142213|NCT02960490|54807966|FG000|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
28142214|NCT02960490|54807967|FG001|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
28142215|NCT02960490|54807968|FG002|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
28142216|NCT02960490|54807969|FG003|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
28142217|NCT02960490|54807970|FG004|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
28142218|NCT02960490|54807971|FG005|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
28142219|NCT02960490|54807972|FG006|Extension Phase(Open-label): 80 Weeks|Disease Progression|2|||
28142220|NCT02960490|54807973|FG007|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
28142221|NCT02960490|54807974|FG008|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
28142222|NCT02960490|54807975|FG009|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
28142223|NCT02960490|54807966|FG000|Extension Phase(Open-label): 80 Weeks|Other|0|||
28142224|NCT02960490|54807967|FG001|Extension Phase(Open-label): 80 Weeks|Other|0|||
28142225|NCT02960490|54807968|FG002|Extension Phase(Open-label): 80 Weeks|Other|0|||
28142226|NCT02960490|54807969|FG003|Extension Phase(Open-label): 80 Weeks|Other|0|||
28142227|NCT02960490|54807970|FG004|Extension Phase(Open-label): 80 Weeks|Other|0|||
27941194|NCT01015833|54597503|FG000|Overall Study|Symptomatic deterioration|0|||
28142228|NCT02960490|54807971|FG005|Extension Phase(Open-label): 80 Weeks|Other|0|||
28142229|NCT02960490|54807972|FG006|Extension Phase(Open-label): 80 Weeks|Other|0|||
28142230|NCT02960490|54807973|FG007|Extension Phase(Open-label): 80 Weeks|Other|1|||
28142231|NCT02960490|54807974|FG008|Extension Phase(Open-label): 80 Weeks|Other|0|||
28142232|NCT02960490|54807975|FG009|Extension Phase(Open-label): 80 Weeks|Other|0|||
28142233|NCT02804750|54807999|FG000|Period 1|Adverse Event|0|||
28142234|NCT02804750|54808000|FG001|Period 1|Adverse Event|2|||
28142235|NCT02804750|54807999|FG000|Period 1|Withdrawal by Subject|0|||
28142236|NCT02804750|54808000|FG001|Period 1|Withdrawal by Subject|1|||
28142237|NCT02804750|54807999|FG000|Period 2|Adverse Event|1|||
28142238|NCT02804750|54808000|FG001|Period 2|Adverse Event|0|||
28142239|NCT02804750|54807999|FG000|Period 3|Adverse Event|0|||
28142240|NCT02804750|54808000|FG001|Period 3|Adverse Event|2|||
28142241|NCT02804750|54807999|FG000|Period 4|Adverse Event|0|||
28142242|NCT02804750|54808000|FG001|Period 4|Adverse Event|5|||
28142243|NCT02959866|54808008|FG000|Overall Study|Withdrawal by Subject|1|||
28142244|NCT02748512|54808015|FG000|Overall Study|Lost to Follow-up|1|||
28142245|NCT02748512|54808016|FG001|Overall Study|Lost to Follow-up|1|||
28142246|NCT02748356|54808022|FG000|Overall Study|Withdrawal by Subject|1|||
28142247|NCT03439657|54808028|FG000|Overall Study|Adverse Event|2|||
28142248|NCT03439657|54808029|FG001|Overall Study|Adverse Event|3|||
28142249|NCT03439657|54808028|FG000|Overall Study|Lost to Follow-up|1|||
28142250|NCT03439657|54808029|FG001|Overall Study|Lost to Follow-up|0|||
28142251|NCT03439657|54808028|FG000|Overall Study|Protocol Violation|1|||
28142252|NCT03439657|54808029|FG001|Overall Study|Protocol Violation|1|||
28142253|NCT03439657|54808028|FG000|Overall Study|Consent withdrawal, not due to an Adverse Event|3|||
28142254|NCT03439657|54808029|FG001|Overall Study|Consent withdrawal, not due to an Adverse Event|0|||
28142255|NCT02803580|54808037|FG000|Overall Study|Death|13|||
28142256|NCT02803580|54808037|FG000|Overall Study|Lost to Follow-up|19|||
28142257|NCT02803580|54808037|FG000|Overall Study|Withdrawal by Subject|3|||
28142258|NCT02803580|54808037|FG000|Overall Study|Inclusion in clinical trial|1|||
28142259|NCT02878213|54808041|FG000|Overall Study|Withdrawal by Subject|2|||
27941195|NCT01015833|54597504|FG001|Overall Study|Symptomatic deterioration|1|||
27941196|NCT01015833|54597503|FG000|Overall Study|Other|5|||
27941197|NCT01015833|54597504|FG001|Overall Study|Other|1|||
28142260|NCT02878213|54808041|FG000|Overall Study|Adverse Event|1|||
28142261|NCT02802878|54808048|FG000|Overall Study|Withdrawal by Subject|3|||
28142262|NCT02802878|54808049|FG001|Overall Study|Withdrawal by Subject|3|||
28142263|NCT02802878|54808048|FG000|Overall Study|Protocol Violation|1|||
28142264|NCT02802878|54808049|FG001|Overall Study|Protocol Violation|0|||
28142265|NCT02801396|54808055|FG000|Period 1|Withdrawal by Subject|0|||
28142266|NCT02801396|54808056|FG001|Period 1|Withdrawal by Subject|0|||
28142267|NCT02801396|54808057|FG002|Period 1|Withdrawal by Subject|0|||
27941198|NCT01015833|54597503|FG000|Overall Study|Motor Vehicle Accidents|1|||
28142268|NCT02801396|54808058|FG003|Period 1|Withdrawal by Subject|0|||
28142269|NCT02801396|54808059|FG004|Period 1|Withdrawal by Subject|1|||
28142270|NCT02801396|54808060|FG005|Period 1|Withdrawal by Subject|0|||
28142271|NCT02800928|54808068|FG000|Overall Study|Withdrawal by Subject|1|||
28142272|NCT02800928|54808069|FG001|Overall Study|Withdrawal by Subject|1|||
28142273|NCT02800928|54808068|FG000|Overall Study|Protocol Violation|1|||
28142274|NCT02800928|54808069|FG001|Overall Study|Protocol Violation|1|||
28142275|NCT03148691|54808078|FG000|Overall Study|Protocol Violation|1|||
28142276|NCT03148691|54808079|FG001|Overall Study|Protocol Violation|2|||
28142277|NCT03148691|54808080|FG002|Overall Study|Protocol Violation|7|||
28142278|NCT03148691|54808078|FG000|Overall Study|Lost to Follow-up|0|||
28142279|NCT03148691|54808079|FG001|Overall Study|Lost to Follow-up|0|||
28142280|NCT03148691|54808080|FG002|Overall Study|Lost to Follow-up|1|||
27941199|NCT01015833|54597504|FG001|Overall Study|Motor Vehicle Accidents|0|||
28142281|NCT03148691|54808078|FG000|Overall Study|Other|1|||
28142282|NCT03148691|54808079|FG001|Overall Study|Other|0|||
28142283|NCT03148691|54808080|FG002|Overall Study|Other|0|||
28142284|NCT03148691|54808078|FG000|Overall Study|Withdrawal by Subject|1|||
28142285|NCT03148691|54808079|FG001|Overall Study|Withdrawal by Subject|0|||
28142286|NCT03148691|54808080|FG002|Overall Study|Withdrawal by Subject|0|||
28142287|NCT03148067|54808088|FG000|Overall Study|Lost to Follow-up|3|||
28142288|NCT03148067|54808088|FG000|Overall Study|Death|1|||
28142289|NCT03146741|54808102|FG000|Overall Study|Txp with non-HCV+ heart|4|||
28142290|NCT03146741|54808102|FG000|Overall Study|Listeted for MOT|2|||
28142291|NCT03146741|54808102|FG000|Overall Study|Physician Decision|2|||
28142292|NCT03146741|54808102|FG000|Overall Study|Awaiting txp|2|||
28142293|NCT03150719|54808108|FG000|Overall Study|Adverse Event|0|||
28142294|NCT03150719|54808109|FG001|Overall Study|Adverse Event|1|||
28142295|NCT03150719|54808108|FG000|Overall Study|Death|0|||
28142296|NCT03150719|54808109|FG001|Overall Study|Death|1|||
28142297|NCT03150719|54808108|FG000|Overall Study|Other|1|||
27941200|NCT01015833|54597503|FG000|Overall Study|Did not start treatment|1|||
28142298|NCT03150719|54808109|FG001|Overall Study|Other|0|||
28142299|NCT04039217|54808115|FG000|Overall Study|Lost to Follow-up|1|||
28142300|NCT00982111|54808125|FG000|Overall Study|Adverse Event|1|||
28142301|NCT00982111|54808126|FG001|Overall Study|Adverse Event|1|||
28142302|NCT00982111|54808125|FG000|Overall Study|Progressive Disease|46|||
28142303|NCT00982111|54808126|FG001|Overall Study|Progressive Disease|39|||
28142304|NCT00982111|54808125|FG000|Overall Study|Lost to Follow-up|9|||
28142305|NCT00982111|54808126|FG001|Overall Study|Lost to Follow-up|6|||
28142306|NCT00982111|54808125|FG000|Overall Study|New Anti-Cancer Therapy|5|||
28142307|NCT00982111|54808126|FG001|Overall Study|New Anti-Cancer Therapy|5|||
28142308|NCT00982111|54808125|FG000|Overall Study|Medical Decision|1|||
28142309|NCT00982111|54808126|FG001|Overall Study|Medical Decision|0|||
28142310|NCT00982111|54808125|FG000|Overall Study|Withdrawal by Subject|17|||
28142311|NCT00982111|54808126|FG001|Overall Study|Withdrawal by Subject|19|||
28142312|NCT00982111|54808125|FG000|Overall Study|Global Study End|0|||
28142313|NCT00982111|54808126|FG001|Overall Study|Global Study End|1|||
28142314|NCT00982111|54808125|FG000|Overall Study|Sponsor's Decision|0|||
28142315|NCT00982111|54808126|FG001|Overall Study|Sponsor's Decision|1|||
28142316|NCT02957682|54808135|FG000|Overall Study|Adverse Event|64|||
28142317|NCT02957682|54808136|FG001|Overall Study|Adverse Event|67|||
28142318|NCT02957682|54808135|FG000|Overall Study|Poor Compliance to Protocol|30|||
28142319|NCT02957682|54808136|FG001|Overall Study|Poor Compliance to Protocol|26|||
28142320|NCT02957682|54808135|FG000|Overall Study|Physician Decision|4|||
28142321|NCT02957682|54808136|FG001|Overall Study|Physician Decision|4|||
28142322|NCT02957682|54808135|FG000|Overall Study|Study Terminated by Sponsor|4|||
28142323|NCT02957682|54808136|FG001|Overall Study|Study Terminated by Sponsor|3|||
28142324|NCT02957682|54808135|FG000|Overall Study|Subject Moved|10|||
27822221|NCT01613599|54284477|FG000|Overall Study|Lost to Follow-up|5|||
27822222|NCT01613599|54284477|FG000|Overall Study|Withdrawal by Subject|8|||
27822223|NCT01613599|54284477|FG000|Overall Study|Reason not specified|3|||
27822224|NCT01850641|54284481|FG000|Overall Study|Physician Decision|1|||
28142325|NCT02957682|54808136|FG001|Overall Study|Subject Moved|16|||
28142326|NCT02957682|54808135|FG000|Overall Study|Withdrawal by Subject|64|||
28142327|NCT02957682|54808136|FG001|Overall Study|Withdrawal by Subject|33|||
28142328|NCT02957682|54808135|FG000|Overall Study|Related to IMP Administration|3|||
27822225|NCT01850641|54284481|FG000|Overall Study|Decrease in serum phosphorus|1|||
27822226|NCT01850641|54284481|FG000|Overall Study|Decrease in serum calcium|2|||
27822227|NCT01850641|54284481|FG000|Overall Study|Increase in serum ferritin|1|||
27822228|NCT01850563|54284487|FG000|Overall Study|Not eligible|3|||
27822229|NCT01850563|54284488|FG001|Overall Study|Not eligible|0|||
27822230|NCT01819129|54284501|FG000|Overall Study|Other, Subject wanted HbA1c to be > 7%|1|||
27822231|NCT01819129|54284502|FG001|Overall Study|Other, Subject wanted HbA1c to be > 7%|0|||
27822232|NCT01819129|54284501|FG000|Overall Study|Other, weight gain, hypoglycaemic events|1|||
27941201|NCT01015833|54597504|FG001|Overall Study|Did not start treatment|0|||
27941202|NCT01015677|54597522|FG000|Overall Study|Adverse Event|0|||
27941203|NCT01015677|54597523|FG001|Overall Study|Adverse Event|1|||
27941204|NCT01015677|54597524|FG002|Overall Study|Adverse Event|0|||
27941205|NCT01015677|54597522|FG000|Overall Study|Lack of Efficacy|0|||
27941206|NCT01015677|54597523|FG001|Overall Study|Lack of Efficacy|1|||
27941207|NCT01015677|54597524|FG002|Overall Study|Lack of Efficacy|0|||
27941208|NCT01015677|54597522|FG000|Overall Study|Protocol Violation|0|||
27941209|NCT01015677|54597523|FG001|Overall Study|Protocol Violation|1|||
27941210|NCT01015677|54597524|FG002|Overall Study|Protocol Violation|0|||
27941211|NCT01015677|54597522|FG000|Overall Study|Withdrawal by Subject|1|||
27941212|NCT01015677|54597523|FG001|Overall Study|Withdrawal by Subject|1|||
27941213|NCT01015677|54597524|FG002|Overall Study|Withdrawal by Subject|0|||
27941214|NCT01225211|54597564|FG000|Overall Study|Adverse Event|0|||
27941215|NCT01225211|54597565|FG001|Overall Study|Adverse Event|0|||
27941216|NCT01225211|54597566|FG002|Overall Study|Adverse Event|1|||
27941217|NCT01225211|54597567|FG003|Overall Study|Adverse Event|0|||
27941218|NCT01225211|54597568|FG004|Overall Study|Adverse Event|0|||
27941219|NCT01225211|54597569|FG005|Overall Study|Adverse Event|0|||
27941220|NCT01225211|54597570|FG006|Overall Study|Adverse Event|0|||
27941221|NCT01225211|54597571|FG007|Overall Study|Adverse Event|0|||
27941222|NCT01225211|54597572|FG008|Overall Study|Adverse Event|0|||
27941223|NCT01225211|54597573|FG009|Overall Study|Adverse Event|1|||
27941224|NCT01225211|54597564|FG000|Overall Study|Withdrawal by Subject|0|||
27941225|NCT01225211|54597565|FG001|Overall Study|Withdrawal by Subject|0|||
27941226|NCT01225211|54597566|FG002|Overall Study|Withdrawal by Subject|0|||
27941227|NCT01225211|54597567|FG003|Overall Study|Withdrawal by Subject|0|||
27941228|NCT01225211|54597568|FG004|Overall Study|Withdrawal by Subject|0|||
28142329|NCT02957682|54808136|FG001|Overall Study|Related to IMP Administration|6|||
28142330|NCT02957682|54808135|FG000|Overall Study|Non-disclosed|16|||
28142331|NCT02957682|54808136|FG001|Overall Study|Non-disclosed|12|||
28142332|NCT02957682|54808135|FG000|Overall Study|Discontinued After Randomization and Prior to Any Treatment|3|||
28142333|NCT02957682|54808136|FG001|Overall Study|Discontinued After Randomization and Prior to Any Treatment|2|||
28142334|NCT03057951|54808144|FG000|Overall Study|Adverse Event|553|||
28142335|NCT03057951|54808145|FG001|Overall Study|Adverse Event|575|||
28142336|NCT03057951|54808144|FG000|Overall Study|Protocol Violation|30|||
28142337|NCT03057951|54808145|FG001|Overall Study|Protocol Violation|24|||
28142338|NCT03057951|54808144|FG000|Overall Study|Lost to Follow-up|6|||
28142339|NCT03057951|54808145|FG001|Overall Study|Lost to Follow-up|16|||
27941229|NCT01225211|54597569|FG005|Overall Study|Withdrawal by Subject|0|||
27941230|NCT01225211|54597570|FG006|Overall Study|Withdrawal by Subject|1|||
27941231|NCT01225211|54597571|FG007|Overall Study|Withdrawal by Subject|0|||
27941232|NCT01225211|54597572|FG008|Overall Study|Withdrawal by Subject|1|||
27941233|NCT01225211|54597573|FG009|Overall Study|Withdrawal by Subject|3|||
27941234|NCT01225211|54597564|FG000|Overall Study|Other|0|||
27941235|NCT01225211|54597565|FG001|Overall Study|Other|0|||
27941236|NCT01225211|54597566|FG002|Overall Study|Other|0|||
27941237|NCT01225211|54597567|FG003|Overall Study|Other|0|||
28142340|NCT03057951|54808144|FG000|Overall Study|Patient refusal to continue, not due to AE|304|||
28142341|NCT03057951|54808145|FG001|Overall Study|Patient refusal to continue, not due to AE|284|||
28142342|NCT03057951|54808144|FG000|Overall Study|Study drug stopped, reason missing|6|||
28142343|NCT03057951|54808145|FG001|Overall Study|Study drug stopped, reason missing|1|||
27941238|NCT01225211|54597568|FG004|Overall Study|Other|0|||
27941239|NCT01225211|54597569|FG005|Overall Study|Other|0|||
27941240|NCT01225211|54597570|FG006|Overall Study|Other|0|||
27941241|NCT01225211|54597571|FG007|Overall Study|Other|0|||
27941242|NCT01225211|54597572|FG008|Overall Study|Other|0|||
27941243|NCT01225211|54597573|FG009|Overall Study|Other|1|||
27941244|NCT01224821|54597656|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
27941245|NCT01224821|54597656|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|38|||
27941246|NCT01224821|54597656|FG000|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3|||
27941247|NCT01224821|54597656|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
27941248|NCT01224821|54597656|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1|||
27941249|NCT01224821|54597656|FG000|Dosimetric and Therapeutic Treatment|Started Other Treatment|1|||
28142344|NCT03057951|54808144|FG000|Overall Study|Medical advice|6|||
28142345|NCT03057951|54808145|FG001|Overall Study|Medical advice|2|||
28142346|NCT03057951|54808144|FG000|Overall Study|Due to Covid-19 Pandemic|2|||
28142347|NCT03057951|54808145|FG001|Overall Study|Due to Covid-19 Pandemic|8|||
28142348|NCT03057951|54808144|FG000|Overall Study|Investigator decision|2|||
28142349|NCT03057951|54808145|FG001|Overall Study|Investigator decision|0|||
28142350|NCT03057951|54808144|FG000|Overall Study|Patient decision|5|||
28142351|NCT03057951|54808145|FG001|Overall Study|Patient decision|2|||
28142352|NCT03057951|54808144|FG000|Overall Study|Not attending study visits|3|||
28142353|NCT03057951|54808145|FG001|Overall Study|Not attending study visits|0|||
28142354|NCT03057951|54808144|FG000|Overall Study|Patient moved away|3|||
27941250|NCT01224821|54597656|FG000|Long-Term Follow-Up|Death|2|||
27941251|NCT01224821|54597656|FG000|Long-Term Follow-Up|Completion of 10 Year Follow-up|9|||
27941252|NCT01224431|54597673|FG000|Overall Study|not randomized|0|||
27941253|NCT01224431|54597674|FG001|Overall Study|not randomized|4|||
27941254|NCT01224431|54597673|FG000|Overall Study|no video record|0|||
27941255|NCT01224431|54597674|FG001|Overall Study|no video record|1|||
28142355|NCT03057951|54808145|FG001|Overall Study|Patient moved away|4|||
27822233|NCT01819129|54284502|FG001|Overall Study|Other, weight gain, hypoglycaemic events|0|||
27822234|NCT01819129|54284501|FG000|Overall Study|Other, Subject moved out of the country|0|||
28142356|NCT03057951|54808144|FG000|Overall Study|Other reason than stated above|23|||
27941256|NCT01223183|54597684|FG000|Imaging Day 1|Physician Decision|0|||
27941257|NCT01223183|54597685|FG001|Imaging Day 1|Physician Decision|1|||
27822235|NCT01819129|54284502|FG001|Overall Study|Other, Subject moved out of the country|1|||
27822236|NCT01819129|54284501|FG000|Overall Study|Withdrawal by Subject|15|||
28142357|NCT03057951|54808145|FG001|Overall Study|Other reason than stated above|29|||
28142358|NCT03057951|54808144|FG000|Overall Study|Not treated|2|||
28142359|NCT03057951|54808145|FG001|Overall Study|Not treated|1|||
28142360|NCT03146663|54808153|FG000|Overall Study|Did not receive study treatment|1|||
28142361|NCT03146663|54808154|FG001|Overall Study|Did not receive study treatment|1|||
28142362|NCT02956278|54808164|FG000|Overall Study|Withdrawal by Subject|6|||
28142363|NCT02956278|54808165|FG001|Overall Study|Withdrawal by Subject|2|||
28142364|NCT02956278|54808166|FG002|Overall Study|Withdrawal by Subject|0|||
28142365|NCT02957136|54808176|FG000|Overall Study|Withdrawal by Subject|2|||
28142366|NCT02957136|54808177|FG001|Overall Study|Withdrawal by Subject|1|||
28142367|NCT03150485|54808183|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
28142368|NCT03150485|54808184|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
27822237|NCT01819129|54284502|FG001|Overall Study|Withdrawal by Subject|15|||
28142369|NCT03150485|54808185|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
28142370|NCT03150485|54808186|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
28142371|NCT03150485|54808187|FG004|Overall Study|Unsatisfactory Lens Fitting|0|||
28142372|NCT03150485|54808188|FG005|Overall Study|Unsatisfactory Lens Fitting|0|||
28142373|NCT03134911|54808195|FG000|Overall Study|Screen failure|31|||
28142374|NCT03134911|54808195|FG000|Overall Study|Not meeting inclusion/exclusion criteria|3|||
28142375|NCT03134599|54808214|FG000|Week 1|Lost to Follow-up|0|||
28142376|NCT03134599|54808215|FG001|Week 1|Lost to Follow-up|0|||
27941258|NCT01223183|54597684|FG000|Washout Period (5-24 Days)|Lost to Follow-up|1|||
28142377|NCT03134599|54808216|FG002|Week 1|Lost to Follow-up|0|||
28142378|NCT03134599|54808217|FG003|Week 1|Lost to Follow-up|0|||
28142379|NCT03134599|54808218|FG004|Week 1|Lost to Follow-up|1|||
28142380|NCT03134599|54808219|FG005|Week 1|Lost to Follow-up|0|||
28142381|NCT03134599|54808214|FG000|Week 2|Lost to Follow-up|1|||
28142382|NCT03134599|54808215|FG001|Week 2|Lost to Follow-up|0|||
28142383|NCT03134599|54808216|FG002|Week 2|Lost to Follow-up|0|||
28142384|NCT03134599|54808217|FG003|Week 2|Lost to Follow-up|1|||
28142385|NCT03134599|54808218|FG004|Week 2|Lost to Follow-up|1|||
28142386|NCT03134599|54808219|FG005|Week 2|Lost to Follow-up|0|||
28142387|NCT03134599|54808214|FG000|Week 3|Lost to Follow-up|0|||
28142388|NCT03134599|54808215|FG001|Week 3|Lost to Follow-up|0|||
28142389|NCT03134599|54808216|FG002|Week 3|Lost to Follow-up|0|||
28142390|NCT03134599|54808217|FG003|Week 3|Lost to Follow-up|1|||
28142391|NCT03134599|54808218|FG004|Week 3|Lost to Follow-up|0|||
28142392|NCT03134599|54808219|FG005|Week 3|Lost to Follow-up|1|||
28142393|NCT03153137|54808229|FG000|Overall Study|Lost to Follow-up|1|||
28142394|NCT03153137|54808230|FG001|Overall Study|Lost to Follow-up|0|||
28142395|NCT03153137|54808229|FG000|Overall Study|Withdrawal by Subject|2|||
28142396|NCT03153137|54808230|FG001|Overall Study|Withdrawal by Subject|1|||
28142397|NCT03153137|54808229|FG000|Overall Study|Physician Decision|0|||
28142398|NCT03153137|54808230|FG001|Overall Study|Physician Decision|3|||
28142399|NCT03136861|54808243|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3|||
28142400|NCT03136861|54808244|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2|||
28142401|NCT03136861|54808245|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
28142402|NCT03136861|54808246|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
28142403|NCT03136861|54808247|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
28142404|NCT03136861|54808248|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
28142405|NCT03136861|54808249|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
28142406|NCT03136861|54808243|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
28142407|NCT03136861|54808244|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
28142408|NCT03136861|54808245|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
28142409|NCT03136861|54808246|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
28142410|NCT03136861|54808247|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
28142411|NCT03136861|54808248|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
28142412|NCT03136861|54808249|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
28142413|NCT03136861|54808243|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2|||
28142414|NCT03136861|54808244|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1|||
28142415|NCT03136861|54808245|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
28142416|NCT03136861|54808246|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
28142417|NCT03136861|54808247|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
28142418|NCT03136861|54808248|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
28142419|NCT03136861|54808249|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
28142420|NCT03136861|54808243|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
28142421|NCT03136861|54808244|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1|||
28142422|NCT03136861|54808245|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
28142423|NCT03136861|54808246|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
28142424|NCT03136861|54808247|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
28142425|NCT03136861|54808248|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
28142426|NCT03136861|54808249|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
28142427|NCT03136861|54808243|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
28142428|NCT03136861|54808244|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
28142429|NCT03136861|54808245|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
28142430|NCT03136861|54808246|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
28142431|NCT03136861|54808247|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
28142432|NCT03136861|54808248|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
28142433|NCT03136861|54808249|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
28142434|NCT03136861|54808243|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
28142435|NCT03136861|54808244|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
28142436|NCT03136861|54808245|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
28142437|NCT03136861|54808246|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
28142438|NCT03136861|54808247|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2|||
28142439|NCT03136861|54808248|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
28142440|NCT03136861|54808249|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
28142441|NCT03136861|54808243|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
28142442|NCT03136861|54808244|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
28142443|NCT03136861|54808245|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1|||
28142444|NCT03136861|54808246|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
28070935|NCT00076570|54725710|FG001|Overall Study|Drug intolerance|8|||
28070936|NCT00124449|54725718|FG000|6-month Double-Blind Treatment Period|Adverse Event|1|||
28070937|NCT00124449|54725719|FG001|6-month Double-Blind Treatment Period|Adverse Event|0|||
28070938|NCT00124449|54725718|FG000|6-month Double-Blind Treatment Period|Lack of Efficacy|3|||
28070939|NCT00124449|54725719|FG001|6-month Double-Blind Treatment Period|Lack of Efficacy|8|||
28070940|NCT00124449|54725718|FG000|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
28070941|NCT00124449|54725719|FG001|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
28070942|NCT00124449|54725718|FG000|6-month Double-Blind Treatment Period|Poor/Noncompliance|1|||
28070943|NCT00124449|54725719|FG001|6-month Double-Blind Treatment Period|Poor/Noncompliance|0|||
28142445|NCT03136861|54808247|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
28142446|NCT03136861|54808248|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
28142447|NCT03136861|54808249|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
28142448|NCT03136861|54808243|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
28142449|NCT03136861|54808244|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
28142450|NCT03136861|54808245|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1|||
28142451|NCT03136861|54808246|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
27849949|NCT03183141|54348276|FG001|Overall Study|Withdrawal by Subject|4|||
27849950|NCT03183141|54348275|FG000|Overall Study|Death|0|||
27849951|NCT03183141|54348276|FG001|Overall Study|Death|8|||
27849952|NCT02957539|54348285|FG000|Baseline to Week 16|Lost to Follow-up|8|||
27849953|NCT02957539|54348286|FG001|Baseline to Week 16|Lost to Follow-up|10|||
27849954|NCT02957539|54348287|FG002|Baseline to Week 16|Lost to Follow-up|16|||
27849955|NCT02957539|54348285|FG000|Baseline to Week 16|Withdrawal by Subject|14|||
27849956|NCT02957539|54348286|FG001|Baseline to Week 16|Withdrawal by Subject|4|||
27849957|NCT02957539|54348287|FG002|Baseline to Week 16|Withdrawal by Subject|5|||
27849958|NCT02957539|54348285|FG000|Week 16 to 32|Withdrawal by Subject|3|||
27849959|NCT02957539|54348286|FG001|Week 16 to 32|Withdrawal by Subject|3|||
27849960|NCT02957539|54348287|FG002|Week 16 to 32|Withdrawal by Subject|1|||
27849961|NCT02957539|54348285|FG000|Week 16 to 32|Lost to Follow-up|8|||
27849962|NCT02957539|54348286|FG001|Week 16 to 32|Lost to Follow-up|7|||
28142452|NCT03136861|54808247|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
28142453|NCT03136861|54808248|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
28142454|NCT03136861|54808249|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
28142455|NCT03316950|54808277|FG000|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|1|||
28142456|NCT03316950|54808278|FG001|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|2|||
28142457|NCT03316950|54808279|FG002|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|3|||
28142458|NCT03316950|54808280|FG003|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|0|||
28142459|NCT03316950|54808277|FG000|Initial Intervention (1 to 3 Months)|Physician Decision|2|||
28142460|NCT03316950|54808278|FG001|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
28142461|NCT03316950|54808279|FG002|Initial Intervention (1 to 3 Months)|Physician Decision|1|||
28142462|NCT03316950|54808280|FG003|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
28142463|NCT03316950|54808277|FG000|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
28142464|NCT03316950|54808278|FG001|Initial Intervention (1 to 3 Months)|Lost to Follow-up|2|||
28142465|NCT03316950|54808279|FG002|Initial Intervention (1 to 3 Months)|Lost to Follow-up|5|||
28142466|NCT03316950|54808280|FG003|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
27849963|NCT02957539|54348287|FG002|Week 16 to 32|Lost to Follow-up|5|||
27849964|NCT02957539|54348285|FG000|Week 32 to Week 52|Lost to Follow-up|11|||
27849965|NCT02957539|54348286|FG001|Week 32 to Week 52|Lost to Follow-up|16|||
27849966|NCT02957539|54348287|FG002|Week 32 to Week 52|Lost to Follow-up|27|||
27849967|NCT02957539|54348285|FG000|Week 32 to Week 52|Withdrawal by Subject|0|||
28070944|NCT00124449|54725718|FG000|6-month Double-Blind Treatment Period|Sponsor request|0|||
27849968|NCT02957539|54348286|FG001|Week 32 to Week 52|Withdrawal by Subject|1|||
28070945|NCT00124449|54725719|FG001|6-month Double-Blind Treatment Period|Sponsor request|1|||
28070946|NCT00124449|54725718|FG000|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0|||
28070947|NCT00124449|54725719|FG001|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1|||
28070948|NCT00124449|54725718|FG000|18-Month Untreated Observation Period|Adverse Event|0|||
28070949|NCT00124449|54725719|FG001|18-Month Untreated Observation Period|Adverse Event|1|||
28070950|NCT00124449|54725718|FG000|18-Month Untreated Observation Period|Lack of Efficacy|11|||
28070951|NCT00124449|54725719|FG001|18-Month Untreated Observation Period|Lack of Efficacy|12|||
28070952|NCT00124449|54725718|FG000|18-Month Untreated Observation Period|Lost to Follow-up|1|||
28142467|NCT03139279|54808294|FG000|Overall Study|Physician Decision|2|||
27822238|NCT01819129|54284501|FG000|Overall Study|Lost to Follow-up|5|||
27822239|NCT01819129|54284502|FG001|Overall Study|Lost to Follow-up|2|||
28142468|NCT03139279|54808295|FG001|Overall Study|Physician Decision|0|||
28142469|NCT03139279|54808294|FG000|Overall Study|Protocol Violation|5|||
28142470|NCT03139279|54808295|FG001|Overall Study|Protocol Violation|4|||
28142471|NCT03139279|54808294|FG000|Overall Study|Withdrawal by Subject|0|||
28142472|NCT03139279|54808295|FG001|Overall Study|Withdrawal by Subject|2|||
28142473|NCT01370642|54808304|FG000|Overall Study|Adverse Event|2|||
28142474|NCT01370642|54808305|FG001|Overall Study|Adverse Event|1|||
28142475|NCT01370642|54808306|FG002|Overall Study|Adverse Event|1|||
28142476|NCT01370642|54808304|FG000|Overall Study|Detectable HCV RNA|0|||
28142477|NCT01370642|54808305|FG001|Overall Study|Detectable HCV RNA|0|||
28142478|NCT01370642|54808306|FG002|Overall Study|Detectable HCV RNA|22|||
28142479|NCT01370642|54808304|FG000|Overall Study|Lost to Follow-up|0|||
28142480|NCT01370642|54808305|FG001|Overall Study|Lost to Follow-up|0|||
28142481|NCT01370642|54808306|FG002|Overall Study|Lost to Follow-up|1|||
27822240|NCT01819129|54284501|FG000|Overall Study|Lack of Efficacy|0|||
27822241|NCT01819129|54284502|FG001|Overall Study|Lack of Efficacy|1|||
27822242|NCT01819129|54284501|FG000|Overall Study|Adverse Event|1|||
27822243|NCT01819129|54284502|FG001|Overall Study|Adverse Event|4|||
27822244|NCT01819129|54284501|FG000|Overall Study|Death|1|||
27822245|NCT01819129|54284502|FG001|Overall Study|Death|1|||
27822246|NCT01819129|54284501|FG000|Overall Study|Withdrawal Criteria|20|||
27822247|NCT01819129|54284502|FG001|Overall Study|Withdrawal Criteria|15|||
27822248|NCT04022889|54284510|FG000|Stage 1: Period 1|Adverse Event|1|||
27822249|NCT04022889|54284511|FG001|Stage 1: Period 1|Adverse Event|0|||
27822250|NCT04022889|54284512|FG002|Stage 1: Period 1|Adverse Event|0|||
27822251|NCT04022889|54284510|FG000|Stage 1: Period 1|Platelet component did not meet input specifications|1|||
27822252|NCT04022889|54284511|FG001|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
27822253|NCT04022889|54284512|FG002|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
27822254|NCT04022889|54284510|FG000|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
27822255|NCT04022889|54284511|FG001|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
27822256|NCT04022889|54284512|FG002|Stage 1: Period 2|Site closure due to COVID-19 pandemic|0|||
27822257|NCT04022889|54284510|FG000|Stage 2|Screen Failure|0|||
28142482|NCT01370642|54808304|FG000|Overall Study|Physician Decision|4|||
28142483|NCT01370642|54808305|FG001|Overall Study|Physician Decision|1|||
28142484|NCT01370642|54808306|FG002|Overall Study|Physician Decision|2|||
28142485|NCT01370642|54808304|FG000|Overall Study|Withdrawal by Subject|2|||
28142486|NCT01370642|54808305|FG001|Overall Study|Withdrawal by Subject|4|||
28142487|NCT01370642|54808306|FG002|Overall Study|Withdrawal by Subject|3|||
28142488|NCT02873208|54808314|FG000|Overall Study|Withdrawal by Subject|36|||
28142489|NCT02873208|54808314|FG000|Overall Study|Lost to Follow-up|22|||
28142490|NCT02873208|54808314|FG000|Overall Study|Adverse Event|15|||
28142491|NCT02873208|54808314|FG000|Overall Study|Non-compliance with study drug|12|||
27822258|NCT04022889|54284511|FG001|Stage 2|Screen Failure|0|||
27822259|NCT04022889|54284512|FG002|Stage 2|Screen Failure|3|||
27822260|NCT04022889|54284510|FG000|Stage 2|Ineligible for apheresis donation|0|||
28142492|NCT02873208|54808314|FG000|Overall Study|Protocol Violation|8|||
28142493|NCT02873208|54808314|FG000|Overall Study|Pregnancy|2|||
28142494|NCT02873208|54808314|FG000|Overall Study|Incarceration|1|||
28142495|NCT02873208|54808314|FG000|Overall Study|Lack of Efficacy|1|||
28142496|NCT02873208|54808314|FG000|Overall Study|Physician Decision|1|||
28142497|NCT03138967|54808320|FG000|Overall Study|Death|0|||
28142498|NCT03138967|54808321|FG001|Overall Study|Death|1|||
28142499|NCT03138967|54808320|FG000|Overall Study|Physician Decision|1|||
28142500|NCT03138967|54808321|FG001|Overall Study|Physician Decision|3|||
28142501|NCT01547117|54808331|FG000|Overall Study|Physician Decision|0|||
28142502|NCT01547117|54808332|FG001|Overall Study|Physician Decision|1|||
28142503|NCT01547117|54808333|FG002|Overall Study|Physician Decision|1|||
28142504|NCT01547117|54808334|FG003|Overall Study|Physician Decision|3|||
28142505|NCT01547117|54808331|FG000|Overall Study|Withdrawal by Subject|1|||
28142506|NCT01547117|54808332|FG001|Overall Study|Withdrawal by Subject|2|||
27822261|NCT04022889|54284511|FG001|Stage 2|Ineligible for apheresis donation|0|||
27822262|NCT04022889|54284512|FG002|Stage 2|Ineligible for apheresis donation|2|||
27822263|NCT04022889|54284510|FG000|Stage 2|Adverse Event|0|||
27822264|NCT04022889|54284511|FG001|Stage 2|Adverse Event|0|||
27822265|NCT04022889|54284512|FG002|Stage 2|Adverse Event|2|||
27822266|NCT04022889|54284510|FG000|Stage 2|Protocol Violation|0|||
27822267|NCT04022889|54284511|FG001|Stage 2|Protocol Violation|0|||
27822268|NCT04022889|54284512|FG002|Stage 2|Protocol Violation|1|||
27822269|NCT04022889|54284510|FG000|Stage 2|Site closure due to COVID-19 pandemic|1|||
27822270|NCT04022889|54284511|FG001|Stage 2|Site closure due to COVID-19 pandemic|0|||
27822271|NCT04022889|54284512|FG002|Stage 2|Site closure due to COVID-19 pandemic|0|||
27822272|NCT01849783|54284544|FG000|Overall Study|Adverse Event|5|||
27822273|NCT01849783|54284544|FG000|Overall Study|Death|2|||
27822274|NCT01849783|54284544|FG000|Overall Study|Physician Decision|1|||
27822275|NCT01849783|54284544|FG000|Overall Study|Withdrawal by Subject|1|||
27822276|NCT01849783|54284544|FG000|Overall Study|Unable to comply|2|||
27822277|NCT01849783|54284544|FG000|Overall Study|Disease progression|11|||
27822278|NCT01611883|54284556|FG000|Overall Study|Adverse Event|1|||
27822279|NCT01611883|54284557|FG001|Overall Study|Adverse Event|1|||
27822280|NCT01848457|54284567|FG000|Overall Study|Death|1|||
27822281|NCT01848457|54284568|FG001|Overall Study|Death|0|||
27822282|NCT01848457|54284569|FG002|Overall Study|Death|0|||
27822283|NCT01848457|54284570|FG003|Overall Study|Death|0|||
27822284|NCT01817959|54284590|FG000|Overall Study|Graft loss|1|||
27822285|NCT01817959|54284591|FG001|Overall Study|Graft loss|1|||
27822286|NCT01817959|54284590|FG000|Overall Study|forbidden medication|1|||
27822287|NCT01817959|54284591|FG001|Overall Study|forbidden medication|1|||
27822288|NCT01817959|54284590|FG000|Overall Study|Adverse Event|1|||
27822289|NCT01817959|54284591|FG001|Overall Study|Adverse Event|0|||
27822290|NCT01817959|54284590|FG000|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
27822291|NCT01817959|54284591|FG001|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
27822292|NCT01817725|54284597|FG000|Overall Study|Withdrawal by Subject|1|||
27822293|NCT01870999|54284604|FG000|Overall Study|Adverse Event|0|||
27822294|NCT01870999|54284605|FG001|Overall Study|Adverse Event|4|||
27822295|NCT01870999|54284606|FG002|Overall Study|Adverse Event|1|||
27822296|NCT01870999|54284604|FG000|Overall Study|Subject met withdrawal criteria|3|||
27822297|NCT01870999|54284605|FG001|Overall Study|Subject met withdrawal criteria|2|||
27822298|NCT01870999|54284606|FG002|Overall Study|Subject met withdrawal criteria|0|||
27822299|NCT01870999|54284604|FG000|Overall Study|Subject withdrawn by Investigator|1|||
27822300|NCT01870999|54284605|FG001|Overall Study|Subject withdrawn by Investigator|0|||
27822301|NCT01870999|54284606|FG002|Overall Study|Subject withdrawn by Investigator|0|||
27822302|NCT01870999|54284604|FG000|Overall Study|Withdrawal by Subject|0|||
27822303|NCT01870999|54284605|FG001|Overall Study|Withdrawal by Subject|2|||
27822304|NCT01870999|54284606|FG002|Overall Study|Withdrawal by Subject|5|||
27822305|NCT01870999|54284604|FG000|Overall Study|Protocol Violation|0|||
27822306|NCT01870999|54284605|FG001|Overall Study|Protocol Violation|0|||
27822307|NCT01870999|54284606|FG002|Overall Study|Protocol Violation|1|||
27822308|NCT01870921|54284614|FG000|Overall Study|Subject decision|80|||
27822309|NCT01870921|54284614|FG000|Overall Study|Severe non-compliance to protocol|7|||
27822310|NCT01870921|54284614|FG000|Overall Study|Subject Lost to Follow up|2|||
27822311|NCT01870921|54284614|FG000|Overall Study|Other|1|||
27822312|NCT01848145|54284627|FG000|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1|||
27941259|NCT01223183|54597685|FG001|Washout Period (5-24 Days)|Lost to Follow-up|0|||
28142507|NCT01547117|54808333|FG002|Overall Study|Withdrawal by Subject|1|||
27822313|NCT01848145|54284627|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1|||
27822314|NCT01848145|54284627|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1|||
28142508|NCT01547117|54808334|FG003|Overall Study|Withdrawal by Subject|2|||
28142509|NCT03136159|54808362|FG000|Overall Study|chorioamnionitis|2|||
28142510|NCT03136159|54808363|FG001|Overall Study|chorioamnionitis|0|||
28142511|NCT03136159|54808362|FG000|Overall Study|vertical skin incision|1|||
27822315|NCT01848145|54284627|FG000|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1|||
27822316|NCT01848145|54284627|FG000|Subsequent Infusions: Weeks 3-8|Disease Progression|6|||
27822317|NCT01848145|54284627|FG000|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3|||
27822318|NCT01848145|54284627|FG000|Subsequent Infusions: Weeks 3-8|Death|1|||
27822319|NCT01847755|54284631|FG000|Overall Study|Adverse Event|2|||
27822320|NCT01847755|54284631|FG000|Overall Study|Withdrawal by Subject|2|||
27822321|NCT01847755|54284631|FG000|Overall Study|Physician Decision|1|||
28142512|NCT03136159|54808363|FG001|Overall Study|vertical skin incision|0|||
28142513|NCT03136159|54808362|FG000|Overall Study|additional dressing|1|||
28142514|NCT03136159|54808363|FG001|Overall Study|additional dressing|0|||
28142515|NCT03136159|54808362|FG000|Overall Study|never got dressing placed|1|||
28142516|NCT03136159|54808363|FG001|Overall Study|never got dressing placed|0|||
28142517|NCT01986933|54808374|FG000|Placebo-controlled (Part A)|Adverse Event|1|||
28142518|NCT01986933|54808375|FG001|Placebo-controlled (Part A)|Adverse Event|5|||
28142519|NCT01986933|54808376|FG002|Placebo-controlled (Part A)|Adverse Event|2|||
28142520|NCT01986933|54808377|FG003|Placebo-controlled (Part A)|Adverse Event|2|||
28142521|NCT01986933|54808378|FG004|Placebo-controlled (Part A)|Adverse Event|4|||
28142522|NCT01986933|54808374|FG000|Placebo-controlled (Part A)|Lack of Efficacy|3|||
28142523|NCT01986933|54808375|FG001|Placebo-controlled (Part A)|Lack of Efficacy|1|||
28142524|NCT01986933|54808376|FG002|Placebo-controlled (Part A)|Lack of Efficacy|1|||
28142525|NCT01986933|54808377|FG003|Placebo-controlled (Part A)|Lack of Efficacy|2|||
28142526|NCT01986933|54808378|FG004|Placebo-controlled (Part A)|Lack of Efficacy|1|||
28142527|NCT01986933|54808374|FG000|Placebo-controlled (Part A)|Withdrawal by Subject|5|||
28142528|NCT01986933|54808375|FG001|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
28142529|NCT01986933|54808376|FG002|Placebo-controlled (Part A)|Withdrawal by Subject|6|||
28142530|NCT01986933|54808377|FG003|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
28142531|NCT01986933|54808378|FG004|Placebo-controlled (Part A)|Withdrawal by Subject|7|||
28142532|NCT01986933|54808374|FG000|Placebo-controlled (Part A)|Lost to Follow-up|0|||
28142533|NCT01986933|54808375|FG001|Placebo-controlled (Part A)|Lost to Follow-up|1|||
28142534|NCT01986933|54808376|FG002|Placebo-controlled (Part A)|Lost to Follow-up|0|||
28142535|NCT01986933|54808377|FG003|Placebo-controlled (Part A)|Lost to Follow-up|1|||
27822322|NCT01847443|54284662|FG000|Study Period 1|Withdrawal by Subject|0|||
27822323|NCT01847443|54284663|FG001|Study Period 1|Withdrawal by Subject|1|||
27941260|NCT01223183|54597684|FG000|Washout Period (5-24 Days)|Physician Decision|1|||
27941261|NCT01223183|54597685|FG001|Washout Period (5-24 Days)|Physician Decision|0|||
27941262|NCT01223027|54597694|FG000|Overall Study|Adverse Event|20|||
27941263|NCT01223027|54597695|FG001|Overall Study|Adverse Event|10|||
27941264|NCT01223027|54597694|FG000|Overall Study|Death|42|||
27941265|NCT01223027|54597695|FG001|Overall Study|Death|42|||
27941266|NCT01223027|54597694|FG000|Overall Study|Lost to Follow-up|2|||
27941267|NCT01223027|54597695|FG001|Overall Study|Lost to Follow-up|1|||
27941268|NCT01223027|54597694|FG000|Overall Study|Physician Decision|4|||
27941269|NCT01223027|54597695|FG001|Overall Study|Physician Decision|8|||
28142536|NCT01986933|54808378|FG004|Placebo-controlled (Part A)|Lost to Follow-up|0|||
28142537|NCT01986933|54808374|FG000|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
28142538|NCT01986933|54808375|FG001|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
28142539|NCT01986933|54808376|FG002|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
28142540|NCT01986933|54808377|FG003|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
28142541|NCT01986933|54808378|FG004|Placebo-controlled (Part A)|Others (not classified above reasons)|2|||
28142542|NCT01986933|54808374|FG000|Active-to-active (Part B)|Adverse Event|0|||
28142543|NCT01986933|54808375|FG001|Active-to-active (Part B)|Adverse Event|2|||
28142544|NCT01986933|54808376|FG002|Active-to-active (Part B)|Adverse Event|0|||
28142545|NCT01986933|54808377|FG003|Active-to-active (Part B)|Adverse Event|1|||
28142546|NCT01986933|54808378|FG004|Active-to-active (Part B)|Adverse Event|3|||
28142547|NCT01986933|54808374|FG000|Active-to-active (Part B)|Lack of Efficacy|0|||
28142548|NCT01986933|54808375|FG001|Active-to-active (Part B)|Lack of Efficacy|3|||
28142549|NCT01986933|54808376|FG002|Active-to-active (Part B)|Lack of Efficacy|2|||
28142550|NCT01986933|54808377|FG003|Active-to-active (Part B)|Lack of Efficacy|0|||
27822324|NCT01847443|54284664|FG002|Study Period 1|Withdrawal by Subject|0|||
27822325|NCT01847443|54284665|FG003|Study Period 1|Withdrawal by Subject|0|||
27822326|NCT01847443|54284662|FG000|Washout Period Before Study Period 2|Adverse Event|1|||
28142551|NCT01986933|54808378|FG004|Active-to-active (Part B)|Lack of Efficacy|4|||
28142552|NCT01986933|54808374|FG000|Active-to-active (Part B)|Pregnancy|0|||
28142553|NCT01986933|54808375|FG001|Active-to-active (Part B)|Pregnancy|0|||
28142554|NCT01986933|54808376|FG002|Active-to-active (Part B)|Pregnancy|0|||
28142555|NCT01986933|54808377|FG003|Active-to-active (Part B)|Pregnancy|0|||
28142556|NCT01986933|54808378|FG004|Active-to-active (Part B)|Pregnancy|1|||
28142557|NCT01986933|54808374|FG000|Active-to-active (Part B)|Physician Decision|0|||
28142558|NCT01986933|54808375|FG001|Active-to-active (Part B)|Physician Decision|0|||
27822327|NCT01847443|54284663|FG001|Washout Period Before Study Period 2|Adverse Event|1|||
27822328|NCT01847443|54284664|FG002|Washout Period Before Study Period 2|Adverse Event|0|||
27822329|NCT01847443|54284665|FG003|Washout Period Before Study Period 2|Adverse Event|0|||
27822330|NCT01847443|54284662|FG000|Washout Period Before Study Period 2|Other reason|1|||
28142559|NCT01986933|54808376|FG002|Active-to-active (Part B)|Physician Decision|1|||
28142560|NCT01986933|54808377|FG003|Active-to-active (Part B)|Physician Decision|1|||
28142561|NCT01986933|54808378|FG004|Active-to-active (Part B)|Physician Decision|0|||
28142562|NCT01986933|54808374|FG000|Active-to-active (Part B)|Withdrawal by Subject|0|||
28142563|NCT01986933|54808375|FG001|Active-to-active (Part B)|Withdrawal by Subject|4|||
28142564|NCT01986933|54808376|FG002|Active-to-active (Part B)|Withdrawal by Subject|7|||
28142565|NCT01986933|54808377|FG003|Active-to-active (Part B)|Withdrawal by Subject|6|||
28142566|NCT01986933|54808378|FG004|Active-to-active (Part B)|Withdrawal by Subject|6|||
28142567|NCT01986933|54808374|FG000|Active-to-active (Part B)|Lost to Follow-up|0|||
28142568|NCT01986933|54808375|FG001|Active-to-active (Part B)|Lost to Follow-up|0|||
28142569|NCT01986933|54808376|FG002|Active-to-active (Part B)|Lost to Follow-up|0|||
28142570|NCT01986933|54808377|FG003|Active-to-active (Part B)|Lost to Follow-up|0|||
28142571|NCT01986933|54808378|FG004|Active-to-active (Part B)|Lost to Follow-up|1|||
28142572|NCT01986933|54808374|FG000|Active-to-active (Part B)|Others (not classified above reasons)|0|||
28142573|NCT01986933|54808375|FG001|Active-to-active (Part B)|Others (not classified above reasons)|1|||
28142574|NCT01986933|54808376|FG002|Active-to-active (Part B)|Others (not classified above reasons)|0|||
28142575|NCT01986933|54808377|FG003|Active-to-active (Part B)|Others (not classified above reasons)|1|||
28142576|NCT01986933|54808378|FG004|Active-to-active (Part B)|Others (not classified above reasons)|1|||
28142577|NCT01986933|54808374|FG000|Placebo-to-active (Part B)|Adverse Event|0|||
28142578|NCT01986933|54808375|FG001|Placebo-to-active (Part B)|Adverse Event|1|||
28142579|NCT01986933|54808376|FG002|Placebo-to-active (Part B)|Adverse Event|0|||
28142580|NCT01986933|54808377|FG003|Placebo-to-active (Part B)|Adverse Event|1|||
28142581|NCT01986933|54808378|FG004|Placebo-to-active (Part B)|Adverse Event|0|||
27822331|NCT01847443|54284663|FG001|Washout Period Before Study Period 2|Other reason|0|||
28142582|NCT01986933|54808374|FG000|Placebo-to-active (Part B)|Lack of Efficacy|0|||
28142583|NCT01986933|54808375|FG001|Placebo-to-active (Part B)|Lack of Efficacy|0|||
28142584|NCT01986933|54808376|FG002|Placebo-to-active (Part B)|Lack of Efficacy|0|||
28142585|NCT01986933|54808377|FG003|Placebo-to-active (Part B)|Lack of Efficacy|1|||
28142586|NCT01986933|54808378|FG004|Placebo-to-active (Part B)|Lack of Efficacy|0|||
28142587|NCT01986933|54808374|FG000|Placebo-to-active (Part B)|Protocol Violation|0|||
28142588|NCT01986933|54808375|FG001|Placebo-to-active (Part B)|Protocol Violation|0|||
28142589|NCT01986933|54808376|FG002|Placebo-to-active (Part B)|Protocol Violation|1|||
28142590|NCT01986933|54808377|FG003|Placebo-to-active (Part B)|Protocol Violation|0|||
28142591|NCT01986933|54808378|FG004|Placebo-to-active (Part B)|Protocol Violation|0|||
28142592|NCT01986933|54808374|FG000|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
28142593|NCT01986933|54808375|FG001|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
28142594|NCT01986933|54808376|FG002|Placebo-to-active (Part B)|Withdrawal by Subject|4|||
28142595|NCT01986933|54808377|FG003|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
28142596|NCT01986933|54808378|FG004|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
28142597|NCT01986933|54808374|FG000|Placebo-to-active (Part B)|Lost to Follow-up|0|||
28142598|NCT01986933|54808375|FG001|Placebo-to-active (Part B)|Lost to Follow-up|1|||
28142599|NCT01986933|54808376|FG002|Placebo-to-active (Part B)|Lost to Follow-up|0|||
28142600|NCT01986933|54808377|FG003|Placebo-to-active (Part B)|Lost to Follow-up|0|||
28142601|NCT01986933|54808378|FG004|Placebo-to-active (Part B)|Lost to Follow-up|0|||
28142602|NCT00394355|54808422|FG000|Overall Study|Adverse Event|10|||
28142603|NCT00394355|54808423|FG001|Overall Study|Adverse Event|6|||
28142604|NCT00394355|54808424|FG002|Overall Study|Adverse Event|7|||
28142605|NCT00394355|54808425|FG003|Overall Study|Adverse Event|8|||
28142606|NCT00394355|54808422|FG000|Overall Study|Did not meet protocol eligibility|1|||
28142607|NCT00394355|54808423|FG001|Overall Study|Did not meet protocol eligibility|5|||
28142608|NCT00394355|54808424|FG002|Overall Study|Did not meet protocol eligibility|4|||
28142609|NCT00394355|54808425|FG003|Overall Study|Did not meet protocol eligibility|2|||
28142610|NCT00394355|54808422|FG000|Overall Study|Subject withdrawal - unrelated to drug|12|||
28142611|NCT00394355|54808423|FG001|Overall Study|Subject withdrawal - unrelated to drug|14|||
27822332|NCT01847443|54284664|FG002|Washout Period Before Study Period 2|Other reason|0|||
28142612|NCT00394355|54808424|FG002|Overall Study|Subject withdrawal - unrelated to drug|10|||
28070953|NCT00124449|54725719|FG001|18-Month Untreated Observation Period|Lost to Follow-up|0|||
28070954|NCT00124449|54725718|FG000|18-Month Untreated Observation Period|Pregnancy|1|||
28070955|NCT00124449|54725719|FG001|18-Month Untreated Observation Period|Pregnancy|0|||
28070956|NCT00124449|54725718|FG000|18-Month Untreated Observation Period|Poor/Noncompliance|1|||
28070957|NCT00124449|54725719|FG001|18-Month Untreated Observation Period|Poor/Noncompliance|0|||
28070958|NCT00124449|54725718|FG000|18-Month Untreated Observation Period|Relocated|1|||
28070959|NCT00124449|54725719|FG001|18-Month Untreated Observation Period|Relocated|0|||
28070960|NCT00076336|54725728|FG000|Overall Study|Death|13|||
28070961|NCT00076336|54725729|FG001|Overall Study|Death|17|||
28070962|NCT00076336|54725728|FG000|Overall Study|Adverse Event|4|||
28070963|NCT00076336|54725729|FG001|Overall Study|Adverse Event|4|||
28070964|NCT00076336|54725728|FG000|Overall Study|Lost to Follow-up|4|||
28070965|NCT00076336|54725729|FG001|Overall Study|Lost to Follow-up|4|||
28070966|NCT00076336|54725728|FG000|Overall Study|Non-Compliance|2|||
28070967|NCT00076336|54725729|FG001|Overall Study|Non-Compliance|0|||
28070968|NCT00076336|54725728|FG000|Overall Study|Creatinine Clearance < 30 or Dialysis|0|||
28070969|NCT00076336|54725729|FG001|Overall Study|Creatinine Clearance < 30 or Dialysis|1|||
28142613|NCT00394355|54808425|FG003|Overall Study|Subject withdrawal - unrelated to drug|6|||
28142614|NCT00394355|54808422|FG000|Overall Study|Subject withdrawal - related to drug|1|||
28142615|NCT00394355|54808423|FG001|Overall Study|Subject withdrawal - related to drug|0|||
28142616|NCT00394355|54808424|FG002|Overall Study|Subject withdrawal - related to drug|0|||
28142617|NCT00394355|54808425|FG003|Overall Study|Subject withdrawal - related to drug|0|||
28142618|NCT00394355|54808422|FG000|Overall Study|Lost to Follow-up|7|||
28142619|NCT00394355|54808423|FG001|Overall Study|Lost to Follow-up|5|||
28142620|NCT00394355|54808424|FG002|Overall Study|Lost to Follow-up|4|||
28142621|NCT00394355|54808425|FG003|Overall Study|Lost to Follow-up|3|||
28142622|NCT00394355|54808422|FG000|Overall Study|Noncompliance with protocol|4|||
28142623|NCT00394355|54808423|FG001|Overall Study|Noncompliance with protocol|3|||
28142624|NCT00394355|54808424|FG002|Overall Study|Noncompliance with protocol|10|||
28142625|NCT00394355|54808425|FG003|Overall Study|Noncompliance with protocol|8|||
28142626|NCT00394355|54808422|FG000|Overall Study|Administrative|0|||
28142627|NCT00394355|54808423|FG001|Overall Study|Administrative|1|||
28142628|NCT00394355|54808424|FG002|Overall Study|Administrative|1|||
28142629|NCT00394355|54808425|FG003|Overall Study|Administrative|1|||
28142630|NCT00394355|54808422|FG000|Overall Study|Lack of Efficacy|0|||
28142631|NCT00394355|54808423|FG001|Overall Study|Lack of Efficacy|0|||
28142632|NCT00394355|54808424|FG002|Overall Study|Lack of Efficacy|2|||
28142633|NCT00394355|54808425|FG003|Overall Study|Lack of Efficacy|3|||
28142634|NCT02797808|54808437|FG000|Overall Study|Withdrawal by Subject|1|||
28142635|NCT02797808|54808438|FG001|Overall Study|Withdrawal by Subject|1|||
28142636|NCT02797808|54808437|FG000|Overall Study|Physician Decision|6|||
28142637|NCT02797808|54808438|FG001|Overall Study|Physician Decision|2|||
28142638|NCT02796560|54808446|FG000|Overall Study|Adverse Event|2|||
28142639|NCT02796560|54808447|FG001|Overall Study|Adverse Event|0|||
28142640|NCT02796560|54808446|FG000|Overall Study|Withdrawal by Subject|2|||
28142641|NCT02796560|54808447|FG001|Overall Study|Withdrawal by Subject|2|||
28142642|NCT00344487|54808453|FG000|Overall Study|immunologic failure|1|||
28142643|NCT02871492|54808462|FG000|Overall Study|Lost to Follow-up|6|||
28142644|NCT02871492|54808463|FG001|Overall Study|Lost to Follow-up|3|||
28142645|NCT02871492|54808464|FG002|Overall Study|Lost to Follow-up|5|||
28142646|NCT02871492|54808462|FG000|Overall Study|Withdrawal by Subject|0|||
28142647|NCT02871492|54808463|FG001|Overall Study|Withdrawal by Subject|0|||
28142648|NCT02871492|54808464|FG002|Overall Study|Withdrawal by Subject|1|||
28142649|NCT03143855|54808474|FG000|Overall Study|Withdrawal by Subject|4|||
28142650|NCT03143855|54808475|FG001|Overall Study|Withdrawal by Subject|3|||
28142651|NCT03143855|54808474|FG000|Overall Study|Protocol Violation|1|||
28142652|NCT03143855|54808475|FG001|Overall Study|Protocol Violation|0|||
28142653|NCT03143855|54808474|FG000|Overall Study|Participant experienced withdrawal|0|||
28142654|NCT03143855|54808475|FG001|Overall Study|Participant experienced withdrawal|1|||
28142655|NCT02878603|54808483|FG000|Overall Study|Lost to Follow-up|4|||
28142656|NCT02878603|54808484|FG001|Overall Study|Lost to Follow-up|1|||
28142657|NCT02878603|54808483|FG000|Overall Study|Withdrawal by Subject|1|||
28142658|NCT02878603|54808484|FG001|Overall Study|Withdrawal by Subject|1|||
28142659|NCT02878603|54808483|FG000|Overall Study|Death|1|||
28142660|NCT02878603|54808484|FG001|Overall Study|Death|0|||
28142661|NCT02878603|54808483|FG000|Overall Study|Physician Decision|0|||
28142662|NCT02878603|54808484|FG001|Overall Study|Physician Decision|3|||
28142663|NCT01370408|54808490|FG000|Overall Study|treatment failure|9|||
28142664|NCT03294109|54808496|FG000|Overall Study|Withdrawal by Subject|6|||
28142665|NCT03294109|54808497|FG001|Overall Study|Withdrawal by Subject|5|||
28142666|NCT03132805|54808516|FG000|Overall Study|Lost to Follow-up|142|||
28142667|NCT03132805|54808517|FG001|Overall Study|Lost to Follow-up|141|||
28142668|NCT03132805|54808518|FG002|Overall Study|Lost to Follow-up|113|||
28142669|NCT02793128|54808526|FG000|Overall Study|Death|4|||
28142670|NCT02793128|54808526|FG000|Overall Study|Withdrawal by Subject|2|||
28142671|NCT02793128|54808526|FG000|Overall Study|Physician Decision|1|||
28142672|NCT02793128|54808526|FG000|Overall Study|Comorbid conditions and noncompliance|1|||
28142673|NCT02793128|54808526|FG000|Overall Study|Patient elected nephroureterectomy|1|||
28142674|NCT03142451|54808540|FG000|Overall Study|Adverse Event|5|||
28070970|NCT00076336|54725728|FG000|Overall Study|Patient, Investigator, Sponsor request|8|||
28070971|NCT00076336|54725729|FG001|Overall Study|Patient, Investigator, Sponsor request|6|||
28070972|NCT00076336|54725728|FG000|Overall Study|Liver Transplantation|3|||
28070973|NCT00076336|54725729|FG001|Overall Study|Liver Transplantation|3|||
28070974|NCT00076336|54725728|FG000|Overall Study|Virologic Breakthrough|14|||
28070975|NCT00076336|54725729|FG001|Overall Study|Virologic Breakthrough|16|||
28070976|NCT00076336|54725728|FG000|Overall Study|Treatment failure|4|||
28070977|NCT00076336|54725729|FG001|Overall Study|Treatment failure|5|||
28070978|NCT00185588|54725739|FG000|Overall Study|Adverse Event|3|||
28070979|NCT00185588|54725740|FG001|Overall Study|Adverse Event|1|||
28070980|NCT00185588|54725741|FG002|Overall Study|Adverse Event|4|||
28070981|NCT00185588|54725742|FG003|Overall Study|Adverse Event|2|||
28070982|NCT00185588|54725739|FG000|Overall Study|Lost to Follow-up|0|||
28070983|NCT00185588|54725740|FG001|Overall Study|Lost to Follow-up|0|||
28070984|NCT00185588|54725741|FG002|Overall Study|Lost to Follow-up|1|||
28070985|NCT00185588|54725742|FG003|Overall Study|Lost to Follow-up|2|||
28070986|NCT00185588|54725739|FG000|Overall Study|Withdrawal by Subject|0|||
28070987|NCT00185588|54725740|FG001|Overall Study|Withdrawal by Subject|1|||
28070988|NCT00185588|54725741|FG002|Overall Study|Withdrawal by Subject|0|||
28070989|NCT00185588|54725742|FG003|Overall Study|Withdrawal by Subject|0|||
28070990|NCT00185588|54725739|FG000|Overall Study|Physician Decision|0|||
28070991|NCT00185588|54725740|FG001|Overall Study|Physician Decision|0|||
28070992|NCT00185588|54725741|FG002|Overall Study|Physician Decision|1|||
28070993|NCT00185588|54725742|FG003|Overall Study|Physician Decision|0|||
28070994|NCT00232544|54725754|FG000|Overall Study|Lost to Follow-up|20|||
28070995|NCT00232544|54725755|FG001|Overall Study|Lost to Follow-up|15|||
28070996|NCT00231842|54725761|FG000|Overall Study|Withdrawal by Subject|3|||
28070997|NCT00231842|54725761|FG000|Overall Study|Did not complete the last 3 cycle|8|||
28070998|NCT00076102|54725766|FG000|Overall Study|Clinical progression|1|||
28070999|NCT00076102|54725766|FG000|Overall Study|Progression in pre-existing brain tumor|1|||
28142675|NCT03142451|54808541|FG001|Overall Study|Adverse Event|2|||
28142676|NCT03142451|54808540|FG000|Overall Study|Lost to Follow-up|25|||
28142677|NCT03142451|54808541|FG001|Overall Study|Lost to Follow-up|8|||
28142678|NCT03142451|54808540|FG000|Overall Study|Participant request|24|||
28142679|NCT03142451|54808541|FG001|Overall Study|Participant request|12|||
28142680|NCT03142451|54808540|FG000|Overall Study|Protocol Violation|3|||
28142681|NCT03142451|54808541|FG001|Overall Study|Protocol Violation|1|||
28142682|NCT03142451|54808540|FG000|Overall Study|Other|1|||
28142683|NCT03142451|54808541|FG001|Overall Study|Other|1|||
28142684|NCT03141905|54808549|FG000|Overall Study|Death|3|||
28142685|NCT03141905|54808550|FG001|Overall Study|Death|2|||
28142686|NCT03141905|54808549|FG000|Overall Study|Withdrawal by Subject|1|||
28142687|NCT03141905|54808550|FG001|Overall Study|Withdrawal by Subject|0|||
28142688|NCT03141905|54808549|FG000|Overall Study|Lost to Follow-up|3|||
28142689|NCT03141905|54808550|FG001|Overall Study|Lost to Follow-up|7|||
28142690|NCT03141905|54808549|FG000|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|17|||
28142691|NCT03141905|54808550|FG001|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|10|||
28142692|NCT01370018|54808557|FG000|Overall Study|Did not meet criteria for analysis|1|||
28142693|NCT04034355|54808563|FG000|Overall Study|Study terminated by Sponsor|10|||
28142694|NCT04034355|54808564|FG001|Overall Study|Study terminated by Sponsor|17|||
28142695|NCT04034355|54808563|FG000|Overall Study|Withdrawal by Subject|12|||
28142696|NCT04034355|54808564|FG001|Overall Study|Withdrawal by Subject|11|||
28142697|NCT04034355|54808563|FG000|Overall Study|Site terminated by Sponsor|4|||
28142698|NCT04034355|54808564|FG001|Overall Study|Site terminated by Sponsor|5|||
28142699|NCT04034355|54808563|FG000|Overall Study|Adverse Event|2|||
28142700|NCT04034355|54808564|FG001|Overall Study|Adverse Event|0|||
28142701|NCT04034355|54808563|FG000|Overall Study|Death|1|||
28142702|NCT04034355|54808564|FG001|Overall Study|Death|1|||
28142703|NCT04034355|54808563|FG000|Overall Study|Not reported|2|||
28142704|NCT04034355|54808564|FG001|Overall Study|Not reported|0|||
28142705|NCT04034355|54808563|FG000|Overall Study|Lost to Follow-up|1|||
28142706|NCT04034355|54808564|FG001|Overall Study|Lost to Follow-up|0|||
28142707|NCT04034355|54808563|FG000|Overall Study|Physician Decision|1|||
28142708|NCT04034355|54808564|FG001|Overall Study|Physician Decision|0|||
28142709|NCT04034355|54808563|FG000|Overall Study|Protocol Violation|0|||
28071000|NCT00076102|54725766|FG000|Overall Study|plexiform neurofibroma surgery|1|||
28071001|NCT00076102|54725766|FG000|Overall Study|refusal of further therapy|2|||
28071002|NCT00231062|54725780|FG000|Overall Study|Physician Decision|6|||
28071003|NCT00184028|54725784|FG000|Overall Study|Death|1|||
28142710|NCT04034355|54808564|FG001|Overall Study|Protocol Violation|1|||
28142711|NCT04034355|54808563|FG000|Overall Study|Progressive disease|1|||
28142712|NCT04034355|54808564|FG001|Overall Study|Progressive disease|0|||
28071004|NCT00184028|54725784|FG000|Overall Study|Lack of Efficacy|4|||
28142713|NCT01336764|54808581|FG000|Overall Study|Withdrawal by Subject|5|||
28142714|NCT01336764|54808582|FG001|Overall Study|Withdrawal by Subject|5|||
28142715|NCT01336608|54808591|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102|||
28142716|NCT01336608|54808592|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
28142717|NCT01336608|54808593|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
28142718|NCT01336608|54808594|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
28142719|NCT01336608|54808591|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|9|||
28142720|NCT01336608|54808592|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
28142721|NCT01336608|54808593|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
28142722|NCT01336608|54808594|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
28142723|NCT01336608|54808591|FG000|2-week, Single-blind Run-In Period|Adverse Event|1|||
28142724|NCT01336608|54808592|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
28142725|NCT01336608|54808593|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
27941270|NCT01223027|54597694|FG000|Overall Study|Progressive Disease|167|||
27941271|NCT01223027|54597695|FG001|Overall Study|Progressive Disease|183|||
27941272|NCT01223027|54597694|FG000|Overall Study|Protocol Violation|2|||
27941273|NCT01223027|54597695|FG001|Overall Study|Protocol Violation|1|||
27941274|NCT01223027|54597694|FG000|Overall Study|Subject/guardian decicion|18|||
27941275|NCT01223027|54597695|FG001|Overall Study|Subject/guardian decicion|16|||
27941276|NCT01223027|54597694|FG000|Overall Study|New therapy for study indication|17|||
27941277|NCT01223027|54597695|FG001|Overall Study|New therapy for study indication|8|||
28142726|NCT01336608|54808594|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
28142727|NCT01336608|54808591|FG000|2-week, Single-blind Run-In Period|Physician Decision|1|||
28142728|NCT01336608|54808592|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
28142729|NCT01336608|54808593|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
28142730|NCT01336608|54808594|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
28142731|NCT01336608|54808591|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|2|||
28142732|NCT01336608|54808592|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
28142733|NCT01336608|54808593|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
28142734|NCT01336608|54808594|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
28142735|NCT01336608|54808591|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
28142736|NCT01336608|54808592|FG001|24-week, Double-blind Treatment Period|Adverse Event|8|||
28142737|NCT01336608|54808593|FG002|24-week, Double-blind Treatment Period|Adverse Event|6|||
28142738|NCT01336608|54808594|FG003|24-week, Double-blind Treatment Period|Adverse Event|7|||
28142739|NCT01336608|54808591|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
28142740|NCT01336608|54808592|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
28142741|NCT01336608|54808593|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
28142742|NCT01336608|54808594|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
28142743|NCT01336608|54808591|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
28142744|NCT01336608|54808592|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
28142745|NCT01336608|54808593|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
28142746|NCT01336608|54808594|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6|||
28142747|NCT01336608|54808591|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
28142748|NCT01336608|54808592|FG001|24-week, Double-blind Treatment Period|Protocol Violation|4|||
28142749|NCT01336608|54808593|FG002|24-week, Double-blind Treatment Period|Protocol Violation|3|||
28142750|NCT01336608|54808594|FG003|24-week, Double-blind Treatment Period|Protocol Violation|3|||
28142751|NCT01336608|54808591|FG000|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
28142752|NCT01336608|54808592|FG001|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
28142753|NCT01336608|54808593|FG002|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3|||
28142754|NCT01336608|54808594|FG003|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6|||
28142755|NCT01336608|54808591|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
27822333|NCT01847443|54284665|FG003|Washout Period Before Study Period 2|Other reason|0|||
27822334|NCT01847443|54284662|FG000|Washout Period Before Study Period 3|Other reason|1|||
27822335|NCT01847443|54284663|FG001|Washout Period Before Study Period 3|Other reason|0|||
27822336|NCT01847443|54284664|FG002|Washout Period Before Study Period 3|Other reason|0|||
27822337|NCT01847443|54284665|FG003|Washout Period Before Study Period 3|Other reason|0|||
27822338|NCT01847443|54284662|FG000|Washout Period Before Study Period 4|Withdrawal by Subject|1|||
27822339|NCT01847443|54284663|FG001|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
27822340|NCT01847443|54284664|FG002|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
27822341|NCT01847443|54284665|FG003|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
27822342|NCT01847443|54284662|FG000|Washout Period Before Study Period 4|Positive alcohol test|1|||
27822343|NCT01847443|54284663|FG001|Washout Period Before Study Period 4|Positive alcohol test|0|||
27822344|NCT01847443|54284664|FG002|Washout Period Before Study Period 4|Positive alcohol test|0|||
27822345|NCT01847443|54284665|FG003|Washout Period Before Study Period 4|Positive alcohol test|0|||
27822346|NCT01847209|54284684|FG000|Overall Study|Withdrawal by Subject|1|||
27822347|NCT01847209|54284684|FG000|Overall Study|No lung nodule found on intraop CT scan|1|||
27822348|NCT01846741|54284688|FG000|Baseline Visit|Subject did not meet entry criteria|2|||
27822349|NCT01870843|54284727|FG000|Overall Study|Adverse Event|10|||
28142756|NCT01336608|54808592|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
28142757|NCT01336608|54808593|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
28142758|NCT01336608|54808594|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
28142759|NCT01336608|54808591|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
28142760|NCT01336608|54808592|FG001|24-week, Double-blind Treatment Period|Physician Decision|3|||
28142761|NCT01336608|54808593|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
28142762|NCT01336608|54808594|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
28071005|NCT00184028|54725784|FG000|Overall Study|Adverse Event|2|||
28071006|NCT00184028|54725784|FG000|Overall Study|Withdrawal by Subject|1|||
28071007|NCT00184028|54725784|FG000|Overall Study|Non-compliance|2|||
28071008|NCT00183872|54725789|FG000|Overall Study|Death|3|||
28071009|NCT00183872|54725789|FG000|Overall Study|Adverse Event|9|||
28071010|NCT00183872|54725789|FG000|Overall Study|Withdrawal by Subject|2|||
28142763|NCT01336608|54808591|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
28142764|NCT01336608|54808592|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
28142765|NCT01336608|54808593|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
28071011|NCT00183872|54725789|FG000|Overall Study|Drug delayed more than 28 days|2|||
28071012|NCT03815175|54725793|FG000|Overall Study|Subject Lost to Follow-up|6|||
28071013|NCT03815175|54725793|FG000|Overall Study|Subject Withdrew Consent|48|||
27822350|NCT01870843|54284727|FG000|Overall Study|Lost to Follow-up|24|||
28142766|NCT01336608|54808594|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|1|||
28142767|NCT01346371|54808613|FG000|Overall Study|Lost to Follow-up|2|||
28142768|NCT01346371|54808614|FG001|Overall Study|Lost to Follow-up|0|||
28142769|NCT03644849|54808632|FG000|Overall Study|Lost to Follow-up|1|||
28142770|NCT03644849|54808633|FG001|Overall Study|Lost to Follow-up|3|||
28142771|NCT03131479|54808644|FG000|Overall Study|Adverse Event|0|||
27822351|NCT01870843|54284727|FG000|Overall Study|Death|1|||
28071014|NCT03815175|54725793|FG000|Overall Study|Subject Withdrawn by Physician/Site|10|||
28071015|NCT03815175|54725793|FG000|Overall Study|Death|86|||
28071016|NCT03815175|54725793|FG000|Overall Study|Improper/Duplicate SubjectEnrollment|1|||
28071017|NCT03815175|54725793|FG000|Overall Study|Subject Discontinued by Sponsor|2|||
28071018|NCT03815175|54725793|FG000|Overall Study|Other Status Change Reason|1|||
28071019|NCT03815175|54725793|FG000|Overall Study|Missed Visit|12|||
28071020|NCT00262028|54725806|FG000|Overall Study|Withdrawal by Subject|6|||
28142772|NCT03131479|54808645|FG001|Overall Study|Adverse Event|0|||
28142773|NCT03131479|54808646|FG002|Overall Study|Adverse Event|1|||
28142774|NCT03131479|54808647|FG003|Overall Study|Adverse Event|1|||
28142775|NCT03131479|54808648|FG004|Overall Study|Adverse Event|0|||
28142776|NCT03131479|54808644|FG000|Overall Study|Subject/Guardian Decision|0|||
28071021|NCT00262028|54725807|FG001|Overall Study|Withdrawal by Subject|3|||
28071022|NCT00262028|54725808|FG002|Overall Study|Withdrawal by Subject|6|||
27822352|NCT01870843|54284727|FG000|Overall Study|Withdrawal by Subject|18|||
27822353|NCT01816477|54284733|FG000|Overall Study|Withdrawal by Subject|13|||
27822354|NCT01816477|54284734|FG001|Overall Study|Withdrawal by Subject|1|||
27822355|NCT01816477|54284733|FG000|Overall Study|Unable to tolerate catheter placement|3|||
27822356|NCT01816477|54284734|FG001|Overall Study|Unable to tolerate catheter placement|0|||
28142777|NCT03131479|54808645|FG001|Overall Study|Subject/Guardian Decision|0|||
28071023|NCT00262028|54725809|FG003|Overall Study|Withdrawal by Subject|5|||
28071024|NCT00262028|54725810|FG004|Overall Study|Withdrawal by Subject|2|||
28142778|NCT03131479|54808646|FG002|Overall Study|Subject/Guardian Decision|0|||
28142779|NCT03131479|54808647|FG003|Overall Study|Subject/Guardian Decision|1|||
28142780|NCT03131479|54808648|FG004|Overall Study|Subject/Guardian Decision|0|||
28142781|NCT03602885|54808662|FG000|Overall Study|Lost to Follow-up|3|||
28142782|NCT03602885|54808663|FG001|Overall Study|Lost to Follow-up|0|||
28142783|NCT02880761|54808671|FG000|Overall Study|Death|6|||
28142784|NCT02880761|54808672|FG001|Overall Study|Death|8|||
28142785|NCT02880761|54808671|FG000|Overall Study|Withdrawal by Subject|3|||
28142786|NCT02880761|54808672|FG001|Overall Study|Withdrawal by Subject|6|||
28142787|NCT02880761|54808671|FG000|Overall Study|Protocol Violation|4|||
28142788|NCT02880761|54808672|FG001|Overall Study|Protocol Violation|3|||
28142789|NCT02880761|54808671|FG000|Overall Study|Lost to Follow-up|3|||
28142790|NCT02880761|54808672|FG001|Overall Study|Lost to Follow-up|4|||
28142791|NCT02930941|54808680|FG000|Overall Study|Lost to Follow-up|1|||
28142792|NCT02930941|54808681|FG001|Overall Study|Lost to Follow-up|2|||
28142793|NCT03137537|54808693|FG000|Overall Study|Adverse Event|0|||
28142794|NCT03137537|54808694|FG001|Overall Study|Adverse Event|1|||
28142795|NCT03137459|54808702|FG000|2-month Assessment|Withdrawal by Subject|13|||
28142796|NCT03137459|54808703|FG001|2-month Assessment|Withdrawal by Subject|3|||
28142797|NCT03137459|54808702|FG000|2-month Assessment|Unable to reach|42|||
28142798|NCT03137459|54808703|FG001|2-month Assessment|Unable to reach|32|||
28142799|NCT03137459|54808702|FG000|2-month Assessment|Refused assessment|7|||
28142800|NCT03137459|54808703|FG001|2-month Assessment|Refused assessment|5|||
28142801|NCT03137459|54808702|FG000|2-month Assessment|Acutely ill|6|||
28142802|NCT03137459|54808703|FG001|2-month Assessment|Acutely ill|2|||
28142803|NCT03137459|54808702|FG000|4-month Assessment|Death|4|||
28142804|NCT03137459|54808703|FG001|4-month Assessment|Death|2|||
28142805|NCT03137459|54808702|FG000|4-month Assessment|Withdrawal by Subject|4|||
28142806|NCT03137459|54808703|FG001|4-month Assessment|Withdrawal by Subject|2|||
28142807|NCT03137459|54808702|FG000|4-month Assessment|Unable to reach|44|||
28142808|NCT03137459|54808703|FG001|4-month Assessment|Unable to reach|29|||
28142809|NCT03137459|54808702|FG000|4-month Assessment|Refused assessment|24|||
28142810|NCT03137459|54808703|FG001|4-month Assessment|Refused assessment|10|||
28142811|NCT03137459|54808702|FG000|4-month Assessment|Acutely ill|2|||
28142812|NCT03137459|54808703|FG001|4-month Assessment|Acutely ill|3|||
28142813|NCT03137459|54808702|FG000|6-months|Lost to Follow-up|14|||
28142814|NCT03137459|54808703|FG001|6-months|Lost to Follow-up|11|||
28142815|NCT03137459|54808702|FG000|6-months|Death|0|||
28142816|NCT03137459|54808703|FG001|6-months|Death|2|||
28142817|NCT03137459|54808702|FG000|6-months|Refused assessment|6|||
28142818|NCT03137459|54808703|FG001|6-months|Refused assessment|3|||
28142819|NCT03137459|54808702|FG000|6-months|Acutely ill|1|||
27941278|NCT01223027|54597694|FG000|Overall Study|Study terminated by sponsor|2|||
28071025|NCT00262028|54725811|FG005|Overall Study|Withdrawal by Subject|3|||
28142820|NCT03137459|54808703|FG001|6-months|Acutely ill|1|||
28142821|NCT03131713|54808712|FG000|Overall Study|Lost to Follow-up|5|||
27822357|NCT01846507|54284740|FG000|Overall Study|Lost to Follow-up|4|||
27822358|NCT01846507|54284740|FG000|Overall Study|Protocol Violation|1|||
27822359|NCT01846507|54284740|FG000|Overall Study|Missing data|2|||
27822360|NCT01846039|54284746|FG000|Overall Study|Protocol Violation|1|||
27822361|NCT01846039|54284746|FG000|Overall Study|Subject Withdrew Consent|1|||
27822362|NCT01610167|54284753|FG000|Overall Study|Scheduling conflict.|0|||
27941279|NCT01223027|54597695|FG001|Overall Study|Study terminated by sponsor|8|||
27941280|NCT01015287|54597703|FG000|Overall Study|Death|21|||
27941281|NCT01015287|54597704|FG001|Overall Study|Death|16|||
28142822|NCT03131713|54808713|FG001|Overall Study|Lost to Follow-up|0|||
28142823|NCT02930005|54808721|FG000|Overall Study|Lost to Follow-up|1|||
28142824|NCT02930005|54808722|FG001|Overall Study|Lost to Follow-up|5|||
28142825|NCT03637491|54808732|FG000|Overall Study|Death|9|||
28142826|NCT03637491|54808733|FG001|Overall Study|Death|9|||
28142827|NCT03637491|54808734|FG002|Overall Study|Death|5|||
28142828|NCT03637491|54808735|FG003|Overall Study|Death|3|||
28142829|NCT03637491|54808732|FG000|Overall Study|Lost to Follow-up|0|||
28142830|NCT03637491|54808733|FG001|Overall Study|Lost to Follow-up|1|||
28142831|NCT03637491|54808734|FG002|Overall Study|Lost to Follow-up|0|||
28142832|NCT03637491|54808735|FG003|Overall Study|Lost to Follow-up|1|||
28142833|NCT03637491|54808732|FG000|Overall Study|Study Terminated By Sponsor|0|||
28142834|NCT03637491|54808733|FG001|Overall Study|Study Terminated By Sponsor|2|||
28142835|NCT03637491|54808734|FG002|Overall Study|Study Terminated By Sponsor|1|||
28142836|NCT03637491|54808735|FG003|Overall Study|Study Terminated By Sponsor|0|||
28142837|NCT03637491|54808732|FG000|Overall Study|Withdrawal by Subject|1|||
28142838|NCT03637491|54808733|FG001|Overall Study|Withdrawal by Subject|0|||
28142839|NCT03637491|54808734|FG002|Overall Study|Withdrawal by Subject|1|||
28142840|NCT03637491|54808735|FG003|Overall Study|Withdrawal by Subject|2|||
28142841|NCT03334539|54808769|FG000|Overall Study|Adverse Event|3|||
28142842|NCT03334539|54808770|FG001|Overall Study|Adverse Event|5|||
28142843|NCT03334539|54808771|FG002|Overall Study|Adverse Event|0|||
28142844|NCT03334539|54808769|FG000|Overall Study|Withdrawal by Subject|0|||
28142845|NCT03334539|54808770|FG001|Overall Study|Withdrawal by Subject|1|||
28142846|NCT03334539|54808771|FG002|Overall Study|Withdrawal by Subject|1|||
28142847|NCT03334539|54808769|FG000|Overall Study|Administrative Reasons|1|||
28142848|NCT03334539|54808770|FG001|Overall Study|Administrative Reasons|0|||
28142849|NCT03334539|54808771|FG002|Overall Study|Administrative Reasons|0|||
27941282|NCT01015287|54597703|FG000|Overall Study|Adverse Event|1|||
28142850|NCT03334539|54808769|FG000|Overall Study|Hypertension Not Controlled|0|||
28142851|NCT03334539|54808770|FG001|Overall Study|Hypertension Not Controlled|1|||
28142852|NCT03334539|54808771|FG002|Overall Study|Hypertension Not Controlled|0|||
28142853|NCT03137303|54808786|FG000|T1: 3-month Follow-up|Withdrawal by Subject|1|||
28142854|NCT03137303|54808787|FG001|T1: 3-month Follow-up|Withdrawal by Subject|4|||
28142855|NCT03137303|54808786|FG000|T1: 3-month Follow-up|Lost to Follow-up|5|||
28142856|NCT03137303|54808787|FG001|T1: 3-month Follow-up|Lost to Follow-up|6|||
28142857|NCT03137303|54808786|FG000|T2: 6-month Follow-up|Lost to Follow-up|5|||
28142858|NCT03137303|54808787|FG001|T2: 6-month Follow-up|Lost to Follow-up|5|||
28142859|NCT03137303|54808786|FG000|T3: 9-month Follow-up|Death|1|||
28142860|NCT03137303|54808787|FG001|T3: 9-month Follow-up|Death|0|||
28142861|NCT03137303|54808786|FG000|T3: 9-month Follow-up|Lost to Follow-up|4|||
28142862|NCT03137303|54808787|FG001|T3: 9-month Follow-up|Lost to Follow-up|4|||
28142863|NCT03137303|54808786|FG000|T4: 12-month Follow-up|Withdrawal by Subject|0|||
28142864|NCT03137303|54808787|FG001|T4: 12-month Follow-up|Withdrawal by Subject|1|||
28142865|NCT03137303|54808786|FG000|T4: 12-month Follow-up|Lost to Follow-up|7|||
28142866|NCT03137303|54808787|FG001|T4: 12-month Follow-up|Lost to Follow-up|4|||
28142867|NCT03296553|54808795|FG000|Overall Study|Withdrawal by Subject|1|||
28142868|NCT03296553|54808796|FG001|Overall Study|Withdrawal by Subject|1|||
28142869|NCT03296553|54808795|FG000|Overall Study|Death|1|||
28142870|NCT03296553|54808796|FG001|Overall Study|Death|0|||
28142871|NCT03131167|54808815|FG000|Overall Study|Other (Unspecified)|0|||
28142872|NCT03131167|54808816|FG001|Overall Study|Other (Unspecified)|0|||
28142873|NCT03131167|54808817|FG002|Overall Study|Other (Unspecified)|0|||
28142874|NCT03131167|54808818|FG003|Overall Study|Other (Unspecified)|0|||
28142875|NCT03131167|54808819|FG004|Overall Study|Other (Unspecified)|0|||
28142876|NCT03131167|54808820|FG005|Overall Study|Other (Unspecified)|1|||
28142877|NCT03131167|54808821|FG006|Overall Study|Other (Unspecified)|0|||
28142878|NCT03131167|54808822|FG007|Overall Study|Other (Unspecified)|0|||
28142879|NCT03131167|54808823|FG008|Overall Study|Other (Unspecified)|0|||
28142880|NCT03131167|54808824|FG009|Overall Study|Other (Unspecified)|0|||
28142881|NCT03131167|54808825|FG010|Overall Study|Other (Unspecified)|0|||
28142882|NCT03131167|54808826|FG011|Overall Study|Other (Unspecified)|0|||
28142883|NCT03131167|54808827|FG012|Overall Study|Other (Unspecified)|0|||
28142884|NCT03060447|54808858|FG000|Overall Study|Withdrawal by Subject|2|||
28142885|NCT03060447|54808859|FG001|Overall Study|Withdrawal by Subject|0|||
28142886|NCT01712789|54808871|FG000|Overall Study|Lack of Efficacy|2|||
28142887|NCT01712789|54808871|FG000|Overall Study|Lost to Follow-up|1|||
28142888|NCT01712789|54808871|FG000|Overall Study|Progressive Disease|504|||
28142889|NCT01712789|54808871|FG000|Overall Study|Death|57|||
28142890|NCT01712789|54808871|FG000|Overall Study|Adverse Event|52|||
28142891|NCT01712789|54808871|FG000|Overall Study|Miscellaneous|31|||
28142892|NCT01712789|54808871|FG000|Overall Study|Withdrawal by Subject|21|||
28142893|NCT01712789|54808871|FG000|Overall Study|Transition to Commercial Treatment|8|||
28142894|NCT01712789|54808871|FG000|Overall Study|Participants Did Not Receive Study Drug|6|||
28142895|NCT02978781|54808878|FG000|Part A|Adverse Event|1|||
28142896|NCT02978781|54808879|FG001|Part A|Adverse Event|1|||
28142897|NCT02978781|54808880|FG002|Part A|Adverse Event|0|||
28142898|NCT02978781|54808881|FG003|Part A|Adverse Event|0|||
28142899|NCT02978781|54808882|FG004|Part A|Adverse Event|0|||
28142900|NCT02978781|54808878|FG000|Part A|Withdrawal by Subject|0|||
28142901|NCT02978781|54808879|FG001|Part A|Withdrawal by Subject|1|||
28142902|NCT02978781|54808880|FG002|Part A|Withdrawal by Subject|0|||
28142903|NCT02978781|54808881|FG003|Part A|Withdrawal by Subject|0|||
28142904|NCT02978781|54808882|FG004|Part A|Withdrawal by Subject|0|||
28142905|NCT02978781|54808878|FG000|Part B|Withdrawal by Subject|0|||
28142906|NCT02978781|54808879|FG001|Part B|Withdrawal by Subject|0|||
28142907|NCT02978781|54808880|FG002|Part B|Withdrawal by Subject|0|||
28142908|NCT02978781|54808881|FG003|Part B|Withdrawal by Subject|1|||
28142909|NCT02978781|54808882|FG004|Part B|Withdrawal by Subject|0|||
28142910|NCT02978781|54808878|FG000|Part C|Adverse Event|0|||
28142911|NCT02978781|54808879|FG001|Part C|Adverse Event|0|||
28142912|NCT02978781|54808880|FG002|Part C|Adverse Event|0|||
28142913|NCT02978781|54808881|FG003|Part C|Adverse Event|0|||
28142914|NCT02978781|54808882|FG004|Part C|Adverse Event|2|||
28142915|NCT02978781|54808878|FG000|Part C|Withdrawal by Subject|0|||
28142916|NCT02978781|54808879|FG001|Part C|Withdrawal by Subject|0|||
28142917|NCT02978781|54808880|FG002|Part C|Withdrawal by Subject|0|||
28142918|NCT02978781|54808881|FG003|Part C|Withdrawal by Subject|0|||
28142919|NCT02978781|54808882|FG004|Part C|Withdrawal by Subject|1|||
28142920|NCT02978781|54808878|FG000|Part C|Tremor not improved due to Topamax discontinuation|0|||
28142921|NCT02978781|54808879|FG001|Part C|Tremor not improved due to Topamax discontinuation|0|||
28142922|NCT02978781|54808880|FG002|Part C|Tremor not improved due to Topamax discontinuation|0|||
28142923|NCT02978781|54808881|FG003|Part C|Tremor not improved due to Topamax discontinuation|0|||
28142924|NCT02978781|54808882|FG004|Part C|Tremor not improved due to Topamax discontinuation|1|||
28142925|NCT03074318|54808912|FG000|Overall Study|Adverse Event|0|||
28142926|NCT03074318|54808913|FG001|Overall Study|Adverse Event|1|||
28142927|NCT03074318|54808914|FG002|Overall Study|Adverse Event|1|||
28142928|NCT03074318|54808915|FG003|Overall Study|Adverse Event|1|||
28142929|NCT03074318|54808912|FG000|Overall Study|Death|1|||
28142930|NCT03074318|54808913|FG001|Overall Study|Death|0|||
28142931|NCT03074318|54808914|FG002|Overall Study|Death|0|||
28142932|NCT03074318|54808915|FG003|Overall Study|Death|0|||
28142933|NCT03074318|54808912|FG000|Overall Study|Withdrawal by Subject|1|||
28142934|NCT03074318|54808913|FG001|Overall Study|Withdrawal by Subject|2|||
28142935|NCT03074318|54808914|FG002|Overall Study|Withdrawal by Subject|2|||
28142936|NCT03074318|54808915|FG003|Overall Study|Withdrawal by Subject|4|||
28142937|NCT03074318|54808912|FG000|Overall Study|Trial Closure|2|||
28142938|NCT03074318|54808913|FG001|Overall Study|Trial Closure|2|||
28142939|NCT03074318|54808914|FG002|Overall Study|Trial Closure|3|||
27941283|NCT01015287|54597704|FG001|Overall Study|Adverse Event|0|||
27941284|NCT01015287|54597703|FG000|Overall Study|Sponsor Decision|3|||
27941285|NCT01015287|54597704|FG001|Overall Study|Sponsor Decision|7|||
27941286|NCT01015287|54597703|FG000|Overall Study|Physician Decision|19|||
27941287|NCT01015287|54597704|FG001|Overall Study|Physician Decision|21|||
27941288|NCT01015287|54597703|FG000|Overall Study|Withdrawal by Subject|14|||
27941289|NCT01015287|54597704|FG001|Overall Study|Withdrawal by Subject|19|||
27941290|NCT01015287|54597703|FG000|Overall Study|Entry Criteria not Met|11|||
27941291|NCT01015287|54597704|FG001|Overall Study|Entry Criteria not Met|14|||
27941292|NCT01015287|54597703|FG000|Overall Study|Lost to Follow-up|2|||
27941293|NCT01015287|54597704|FG001|Overall Study|Lost to Follow-up|1|||
27941294|NCT01015287|54597703|FG000|Overall Study|Protocol Violation|1|||
27941295|NCT01015287|54597704|FG001|Overall Study|Protocol Violation|1|||
27941296|NCT01015131|54597712|FG000|Overall Study|Physician Decision|1|||
27941297|NCT01015131|54597712|FG000|Overall Study|Protocol Violation|1|||
27941298|NCT01015131|54597712|FG000|Overall Study|Withdrawal by Subject|2|||
27941299|NCT01015131|54597712|FG000|Overall Study|Other Protocol Specified Criteria|4|||
27941300|NCT01222715|54597718|FG000|Overall Study|Adverse Event|0|||
27941301|NCT01222715|54597719|FG001|Overall Study|Adverse Event|4|||
27941302|NCT01222715|54597718|FG000|Overall Study|Death|0|||
27941303|NCT01222715|54597719|FG001|Overall Study|Death|1|||
27822363|NCT01610167|54284754|FG001|Overall Study|Scheduling conflict.|0|||
27822364|NCT01610167|54284755|FG002|Overall Study|Scheduling conflict.|2|||
27941304|NCT01222715|54597718|FG000|Overall Study|Lack of Efficacy|22|||
27941305|NCT01222715|54597719|FG001|Overall Study|Lack of Efficacy|14|||
28142940|NCT03074318|54808915|FG003|Overall Study|Trial Closure|11|||
28142941|NCT03135119|54808936|FG000|Overall Study|Lost to Follow-up|2|||
28142942|NCT03135119|54808937|FG001|Overall Study|Lost to Follow-up|0|||
28142943|NCT03135119|54808936|FG000|Overall Study|Physician Decision|1|||
28142944|NCT03135119|54808937|FG001|Overall Study|Physician Decision|1|||
28142945|NCT03135119|54808936|FG000|Overall Study|COVID-19 Shutdown|2|||
28142946|NCT03135119|54808937|FG001|Overall Study|COVID-19 Shutdown|2|||
28142947|NCT01369784|54808943|FG000|Overall Study|Protocol Violation|12|||
28142948|NCT03353675|54808947|FG000|Overall Study|Adverse Event|4|||
28142949|NCT03137069|54808957|FG000|Overall Study|Withdrawal by Subject|1|||
28142950|NCT03137069|54808958|FG001|Overall Study|Withdrawal by Subject|2|||
28142951|NCT03137069|54808959|FG002|Overall Study|Withdrawal by Subject|2|||
28142952|NCT03137069|54808960|FG003|Overall Study|Withdrawal by Subject|2|||
28142953|NCT03137069|54808961|FG004|Overall Study|Withdrawal by Subject|0|||
28142954|NCT03137069|54808962|FG005|Overall Study|Withdrawal by Subject|0|||
28142955|NCT03137069|54808957|FG000|Overall Study|Adverse Event|0|||
28142956|NCT03137069|54808958|FG001|Overall Study|Adverse Event|3|||
28142957|NCT03137069|54808959|FG002|Overall Study|Adverse Event|1|||
28142958|NCT03137069|54808960|FG003|Overall Study|Adverse Event|1|||
28142959|NCT03137069|54808961|FG004|Overall Study|Adverse Event|0|||
28142960|NCT03137069|54808962|FG005|Overall Study|Adverse Event|1|||
28142961|NCT03137069|54808957|FG000|Overall Study|Protocol Violation|0|||
28142962|NCT03137069|54808958|FG001|Overall Study|Protocol Violation|1|||
28142963|NCT03137069|54808959|FG002|Overall Study|Protocol Violation|0|||
28142964|NCT03137069|54808960|FG003|Overall Study|Protocol Violation|1|||
28142965|NCT03137069|54808961|FG004|Overall Study|Protocol Violation|1|||
28142966|NCT03137069|54808962|FG005|Overall Study|Protocol Violation|1|||
28142967|NCT03137069|54808957|FG000|Overall Study|Physician Decision|0|||
28142968|NCT03137069|54808958|FG001|Overall Study|Physician Decision|0|||
28142969|NCT03137069|54808959|FG002|Overall Study|Physician Decision|0|||
28142970|NCT03137069|54808960|FG003|Overall Study|Physician Decision|1|||
28142971|NCT03137069|54808961|FG004|Overall Study|Physician Decision|0|||
28142972|NCT03137069|54808962|FG005|Overall Study|Physician Decision|0|||
28142973|NCT03137069|54808957|FG000|Overall Study|Study Terminated by Sponsor|0|||
28142974|NCT03137069|54808958|FG001|Overall Study|Study Terminated by Sponsor|0|||
28142975|NCT03137069|54808959|FG002|Overall Study|Study Terminated by Sponsor|0|||
28142976|NCT03137069|54808960|FG003|Overall Study|Study Terminated by Sponsor|0|||
28142977|NCT03137069|54808961|FG004|Overall Study|Study Terminated by Sponsor|1|||
28142978|NCT03137069|54808962|FG005|Overall Study|Study Terminated by Sponsor|0|||
28142979|NCT03137069|54808957|FG000|Overall Study|Data Entry Error|0|||
28142980|NCT03137069|54808958|FG001|Overall Study|Data Entry Error|0|||
28142981|NCT03137069|54808959|FG002|Overall Study|Data Entry Error|0|||
28142982|NCT03137069|54808960|FG003|Overall Study|Data Entry Error|1|||
28142983|NCT03137069|54808961|FG004|Overall Study|Data Entry Error|0|||
28142984|NCT03137069|54808962|FG005|Overall Study|Data Entry Error|0|||
28142985|NCT02792504|54808980|FG000|Overall Study|Lost to Follow-up|24|||
28142986|NCT02792504|54808980|FG000|Overall Study|Violated inclusion/exclusion criteria|6|||
28142987|NCT03124459|54808990|FG000|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
28142988|NCT03124459|54808991|FG001|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
28142989|NCT03124459|54808992|FG002|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
28142990|NCT03124459|54808993|FG003|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
28142991|NCT03124459|54808994|FG004|Phase 2- Randomized Doubled-blind|Adverse Event|2|||
28142992|NCT03124459|54808995|FG005|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
28142993|NCT03124459|54808990|FG000|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
28142994|NCT03124459|54808991|FG001|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
28142995|NCT03124459|54808992|FG002|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
28142996|NCT03124459|54808993|FG003|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
28142997|NCT03124459|54808994|FG004|Phase 2- Randomized Doubled-blind|Lost to Follow-up|1|||
28142998|NCT03124459|54808995|FG005|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
28142999|NCT03124459|54808990|FG000|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
28143000|NCT03124459|54808991|FG001|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
28143001|NCT03124459|54808992|FG002|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
28143002|NCT03124459|54808993|FG003|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|11|||
28143003|NCT03124459|54808994|FG004|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|12|||
28143004|NCT03124459|54808995|FG005|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
28143005|NCT03124459|54808990|FG000|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
28143006|NCT03124459|54808991|FG001|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
28143007|NCT03124459|54808992|FG002|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
28143008|NCT03124459|54808993|FG003|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|1|||
28143009|NCT03124459|54808994|FG004|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|4|||
28143010|NCT03124459|54808995|FG005|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
28143011|NCT03124459|54808990|FG000|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
28143012|NCT03124459|54808991|FG001|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
28143013|NCT03124459|54808992|FG002|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
28143014|NCT03124459|54808993|FG003|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
28143015|NCT03124459|54808994|FG004|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
28143016|NCT03124459|54808995|FG005|Part 2- Open Label ACE-083|Study terminated by Sponsor|22|||
28143017|NCT03124459|54808990|FG000|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
28143018|NCT03124459|54808991|FG001|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
28143019|NCT03124459|54808992|FG002|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
28143020|NCT03124459|54808993|FG003|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
27822365|NCT01816243|54284763|FG000|Overall Study|Adverse Event|6|||
27822366|NCT01816243|54284763|FG000|Overall Study|Lost to Follow-up|1|||
27822367|NCT01816243|54284763|FG000|Overall Study|Lack of Efficacy|1|||
27822368|NCT01816243|54284763|FG000|Overall Study|Not eligible for the study|1|||
27822369|NCT01816243|54284763|FG000|Overall Study|Amputation|3|||
27822370|NCT01845805|54284769|FG000|Overall Study|Withdrawal by Subject|1|||
27822371|NCT01845805|54284770|FG001|Overall Study|Withdrawal by Subject|2|||
27822372|NCT01845805|54284769|FG000|Overall Study|Disease Progression|13|||
27822373|NCT01845805|54284770|FG001|Overall Study|Disease Progression|14|||
27822374|NCT01845805|54284769|FG000|Overall Study|Drug-related Toxicity|4|||
27822375|NCT01845805|54284770|FG001|Overall Study|Drug-related Toxicity|0|||
27822376|NCT01845025|54284778|FG000|Overall Study|Adverse Event|6|||
27822377|NCT01845025|54284779|FG001|Overall Study|Adverse Event|3|||
27822378|NCT01845025|54284778|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
27822379|NCT01845025|54284779|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
27822380|NCT01845025|54284778|FG000|Overall Study|Withdrawal by Subject|48|||
27822381|NCT01845025|54284779|FG001|Overall Study|Withdrawal by Subject|44|||
27822382|NCT01845025|54284778|FG000|Overall Study|Lost to Follow-up|13|||
27822383|NCT01845025|54284779|FG001|Overall Study|Lost to Follow-up|13|||
27822384|NCT01845025|54284778|FG000|Overall Study|Administrative problems|8|||
27822385|NCT01845025|54284779|FG001|Overall Study|Administrative problems|8|||
27822386|NCT01845025|54284778|FG000|Overall Study|Death|2|||
27822387|NCT01845025|54284779|FG001|Overall Study|Death|0|||
27822388|NCT01845025|54284778|FG000|Overall Study|Protocol deviation|3|||
27822389|NCT01845025|54284779|FG001|Overall Study|Protocol deviation|6|||
28071026|NCT00262028|54725812|FG006|Overall Study|Withdrawal by Subject|5|||
28071027|NCT00262028|54725813|FG007|Overall Study|Withdrawal by Subject|7|||
28071028|NCT00262028|54725814|FG008|Overall Study|Withdrawal by Subject|2|||
28071029|NCT00262028|54725806|FG000|Overall Study|Lost to Follow-up|7|||
28071030|NCT00262028|54725807|FG001|Overall Study|Lost to Follow-up|7|||
28071031|NCT00262028|54725808|FG002|Overall Study|Lost to Follow-up|5|||
28071032|NCT00262028|54725809|FG003|Overall Study|Lost to Follow-up|5|||
28071033|NCT00262028|54725810|FG004|Overall Study|Lost to Follow-up|4|||
28143021|NCT03124459|54808994|FG004|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
28143022|NCT03124459|54808995|FG005|Part 2- Open Label ACE-083|Withdrawal by Subject|1|||
28143023|NCT03134183|54809010|FG000|Overall Study|Withdrawal by Subject|1|||
28143024|NCT03134183|54809011|FG001|Overall Study|Withdrawal by Subject|1|||
28143025|NCT03136367|54809020|FG000|T1 Consultation|discontinued mistakenly included|2|||
28143026|NCT03136367|54809021|FG001|T1 Consultation|discontinued mistakenly included|6|||
28143027|NCT03136367|54809022|FG002|T1 Consultation|discontinued mistakenly included|1|||
28143028|NCT03136367|54809020|FG000|T1 Consultation|Discontinued other|0|||
28143029|NCT03136367|54809021|FG001|T1 Consultation|Discontinued other|1|||
28143030|NCT03136367|54809022|FG002|T1 Consultation|Discontinued other|0|||
28143031|NCT03136367|54809020|FG000|T2 Post-consultation|Withdrawal by Subject|1|||
27822390|NCT01845025|54284778|FG000|Overall Study|Missing|1|||
27822391|NCT01845025|54284779|FG001|Overall Study|Missing|1|||
27822392|NCT01870297|54284820|FG000|Overall Study|Adverse Event|0|||
28143032|NCT03136367|54809021|FG001|T2 Post-consultation|Withdrawal by Subject|1|||
28143033|NCT03136367|54809022|FG002|T2 Post-consultation|Withdrawal by Subject|5|||
28143034|NCT03136367|54809020|FG000|T2 Post-consultation|discontinued mistakenly included|2|||
28143035|NCT03136367|54809021|FG001|T2 Post-consultation|discontinued mistakenly included|2|||
27822393|NCT01870297|54284821|FG001|Overall Study|Adverse Event|0|||
27822394|NCT01870297|54284822|FG002|Overall Study|Adverse Event|0|||
27822395|NCT01870297|54284823|FG003|Overall Study|Adverse Event|0|||
27822396|NCT01870297|54284824|FG004|Overall Study|Adverse Event|2|||
27822397|NCT01870297|54284825|FG005|Overall Study|Adverse Event|0|||
28071034|NCT00262028|54725811|FG005|Overall Study|Lost to Follow-up|3|||
28071035|NCT00262028|54725812|FG006|Overall Study|Lost to Follow-up|3|||
27822398|NCT01870297|54284826|FG006|Overall Study|Adverse Event|0|||
27822399|NCT01870297|54284820|FG000|Overall Study|Lost to Follow-up|0|||
27822400|NCT01870297|54284821|FG001|Overall Study|Lost to Follow-up|1|||
28143036|NCT03136367|54809022|FG002|T2 Post-consultation|discontinued mistakenly included|17|||
28143037|NCT03136367|54809020|FG000|T2 Post-consultation|Discontinued other|0|||
28143038|NCT03136367|54809021|FG001|T2 Post-consultation|Discontinued other|2|||
28143039|NCT03136367|54809022|FG002|T2 Post-consultation|Discontinued other|6|||
28143040|NCT03136367|54809020|FG000|T2 Post-consultation|Discontinued transferred care|0|||
28143041|NCT03136367|54809021|FG001|T2 Post-consultation|Discontinued transferred care|0|||
28143042|NCT03136367|54809022|FG002|T2 Post-consultation|Discontinued transferred care|3|||
28143043|NCT03136367|54809020|FG000|T2 Post-consultation|Discontinued lost contact|0|||
28143044|NCT03136367|54809021|FG001|T2 Post-consultation|Discontinued lost contact|1|||
28143045|NCT03136367|54809022|FG002|T2 Post-consultation|Discontinued lost contact|0|||
27822401|NCT01870297|54284822|FG002|Overall Study|Lost to Follow-up|1|||
27822402|NCT01870297|54284823|FG003|Overall Study|Lost to Follow-up|0|||
28143046|NCT03136367|54809020|FG000|T3 1 Week After Surgery|Discontinued mistakenly included|5|||
27941306|NCT01222715|54597718|FG000|Overall Study|Physician Decision|12|||
27941307|NCT01222715|54597719|FG001|Overall Study|Physician Decision|2|||
27941308|NCT01222715|54597718|FG000|Overall Study|Refusal of further protocol therapy|0|||
27941309|NCT01222715|54597719|FG001|Overall Study|Refusal of further protocol therapy|4|||
27822403|NCT01870297|54284824|FG004|Overall Study|Lost to Follow-up|0|||
27822404|NCT01870297|54284825|FG005|Overall Study|Lost to Follow-up|0|||
27822405|NCT01870297|54284826|FG006|Overall Study|Lost to Follow-up|0|||
27822406|NCT01870297|54284820|FG000|Overall Study|Withdrawal by Subject|0|||
27822407|NCT01870297|54284821|FG001|Overall Study|Withdrawal by Subject|0|||
27822408|NCT01870297|54284822|FG002|Overall Study|Withdrawal by Subject|0|||
27822409|NCT01870297|54284823|FG003|Overall Study|Withdrawal by Subject|0|||
27849969|NCT02957539|54348287|FG002|Week 32 to Week 52|Withdrawal by Subject|0|||
27941310|NCT01222715|54597718|FG000|Overall Study|Pt cannot receive treatment for >9 wks|1|||
27941311|NCT01222715|54597719|FG001|Overall Study|Pt cannot receive treatment for >9 wks|1|||
28071036|NCT00262028|54725813|FG007|Overall Study|Lost to Follow-up|5|||
28071037|NCT00262028|54725814|FG008|Overall Study|Lost to Follow-up|6|||
28071038|NCT00262028|54725806|FG000|Overall Study|Administrative Reason|11|||
28071039|NCT00262028|54725807|FG001|Overall Study|Administrative Reason|14|||
28071040|NCT00262028|54725808|FG002|Overall Study|Administrative Reason|9|||
28071041|NCT00262028|54725809|FG003|Overall Study|Administrative Reason|12|||
28071042|NCT00262028|54725810|FG004|Overall Study|Administrative Reason|6|||
28143047|NCT03136367|54809021|FG001|T3 1 Week After Surgery|Discontinued mistakenly included|9|||
28143048|NCT03136367|54809022|FG002|T3 1 Week After Surgery|Discontinued mistakenly included|8|||
28143049|NCT03136367|54809020|FG000|T3 1 Week After Surgery|Discontinued transferred care|2|||
28143050|NCT03136367|54809021|FG001|T3 1 Week After Surgery|Discontinued transferred care|11|||
28143051|NCT03136367|54809022|FG002|T3 1 Week After Surgery|Discontinued transferred care|14|||
28143052|NCT03136367|54809020|FG000|T3 1 Week After Surgery|other discontinued|2|||
28143053|NCT03136367|54809021|FG001|T3 1 Week After Surgery|other discontinued|4|||
28143054|NCT03136367|54809022|FG002|T3 1 Week After Surgery|other discontinued|3|||
28143055|NCT03136367|54809020|FG000|T3 1 Week After Surgery|Withdrawal by Subject|0|||
28143056|NCT03136367|54809021|FG001|T3 1 Week After Surgery|Withdrawal by Subject|6|||
28071043|NCT00262028|54725811|FG005|Overall Study|Administrative Reason|7|||
28071044|NCT00262028|54725812|FG006|Overall Study|Administrative Reason|4|||
28071045|NCT00262028|54725813|FG007|Overall Study|Administrative Reason|6|||
28071046|NCT00262028|54725814|FG008|Overall Study|Administrative Reason|10|||
28071047|NCT00262028|54725806|FG000|Overall Study|Protocol Violation|0|||
28071048|NCT00262028|54725807|FG001|Overall Study|Protocol Violation|0|||
28071049|NCT00262028|54725808|FG002|Overall Study|Protocol Violation|0|||
28071050|NCT00262028|54725809|FG003|Overall Study|Protocol Violation|1|||
28071051|NCT00262028|54725810|FG004|Overall Study|Protocol Violation|0|||
28071052|NCT00262028|54725811|FG005|Overall Study|Protocol Violation|0|||
28071053|NCT00262028|54725812|FG006|Overall Study|Protocol Violation|0|||
28071054|NCT00262028|54725813|FG007|Overall Study|Protocol Violation|0|||
28071055|NCT00262028|54725814|FG008|Overall Study|Protocol Violation|0|||
28071056|NCT00262028|54725806|FG000|Overall Study|Unable to classify|0|||
28071057|NCT00262028|54725807|FG001|Overall Study|Unable to classify|3|||
28071058|NCT00262028|54725808|FG002|Overall Study|Unable to classify|0|||
28071059|NCT00262028|54725809|FG003|Overall Study|Unable to classify|0|||
28071060|NCT00262028|54725810|FG004|Overall Study|Unable to classify|0|||
28071061|NCT00262028|54725811|FG005|Overall Study|Unable to classify|0|||
28071062|NCT00262028|54725812|FG006|Overall Study|Unable to classify|0|||
28071063|NCT00262028|54725813|FG007|Overall Study|Unable to classify|0|||
28071064|NCT00262028|54725814|FG008|Overall Study|Unable to classify|1|||
28071065|NCT00183248|54725858|FG000|Overall Study|Lost to Follow-up|0|||
28071066|NCT00183248|54725859|FG001|Overall Study|Lost to Follow-up|1|||
28071067|NCT00183248|54725858|FG000|Overall Study|Focal glomerulosclerosis proteinuria|1|||
28071068|NCT00183248|54725859|FG001|Overall Study|Focal glomerulosclerosis proteinuria|0|||
28071069|NCT00183170|54725867|FG000|First Intervention|Did not complete study|1|||
28071070|NCT00183170|54725868|FG001|First Intervention|Did not complete study|0|||
28071071|NCT00183170|54725867|FG000|First Intervention|Did not meet targeted BrAC|1|||
28071072|NCT00183170|54725868|FG001|First Intervention|Did not meet targeted BrAC|0|||
28143057|NCT03136367|54809022|FG002|T3 1 Week After Surgery|Withdrawal by Subject|2|||
27822410|NCT01870297|54284824|FG004|Overall Study|Withdrawal by Subject|1|||
27941312|NCT01222715|54597718|FG000|Overall Study|Ineligible|0|||
28071073|NCT00183170|54725867|FG000|Washout 1 Week|Did not complete study|6|||
28071074|NCT00183170|54725868|FG001|Washout 1 Week|Did not complete study|8|||
28071075|NCT00183170|54725867|FG000|Second Intervention|Did not complete study|1|||
28071076|NCT00183170|54725868|FG001|Second Intervention|Did not complete study|0|||
28071077|NCT00183170|54725867|FG000|Second Intervention|Did not meet targeted BrAC|0|||
28071078|NCT00183170|54725868|FG001|Second Intervention|Did not meet targeted BrAC|2|||
28071079|NCT00230282|54725874|FG000|Fludarabine + Cyclophosphamide|Lost to Follow-up|4|||
28071080|NCT00230282|54725874|FG000|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1|||
27822411|NCT01870297|54284825|FG005|Overall Study|Withdrawal by Subject|1|||
27822412|NCT01870297|54284826|FG006|Overall Study|Withdrawal by Subject|1|||
27822413|NCT01870297|54284820|FG000|Overall Study|Sponsor Decision|0|||
27822414|NCT01870297|54284821|FG001|Overall Study|Sponsor Decision|6|||
27822415|NCT01870297|54284822|FG002|Overall Study|Sponsor Decision|0|||
27822416|NCT01870297|54284823|FG003|Overall Study|Sponsor Decision|0|||
27822417|NCT01870297|54284824|FG004|Overall Study|Sponsor Decision|0|||
27822418|NCT01870297|54284825|FG005|Overall Study|Sponsor Decision|0|||
27822419|NCT01870297|54284826|FG006|Overall Study|Sponsor Decision|1|||
28143058|NCT03136367|54809020|FG000|T3 1 Week After Surgery|Discontinued lost contact|1|||
28143059|NCT03136367|54809021|FG001|T3 1 Week After Surgery|Discontinued lost contact|2|||
28143060|NCT03136367|54809022|FG002|T3 1 Week After Surgery|Discontinued lost contact|4|||
28143061|NCT03136367|54809020|FG000|T4 12 Weeks After Surgery|Withdrawal by Subject|1|||
28143062|NCT03136367|54809021|FG001|T4 12 Weeks After Surgery|Withdrawal by Subject|3|||
28143063|NCT03136367|54809022|FG002|T4 12 Weeks After Surgery|Withdrawal by Subject|0|||
27822420|NCT01814761|54284853|FG000|Overall Study|Other Reasons|1|||
27822421|NCT01814761|54284854|FG001|Overall Study|Other Reasons|10|||
27822422|NCT01814761|54284853|FG000|Overall Study|Ocular Adverse Event|6|||
27822423|NCT01814761|54284854|FG001|Overall Study|Ocular Adverse Event|15|||
27822424|NCT01814761|54284853|FG000|Overall Study|Lost to Follow-up|1|||
27822425|NCT01814761|54284854|FG001|Overall Study|Lost to Follow-up|5|||
27822426|NCT01843933|54284862|FG000|Overall Study|Data lost|6|||
27822427|NCT01843933|54284863|FG001|Overall Study|Data lost|4|||
27822428|NCT01814371|54284871|FG000|Overall Study|Lost to Follow-up|30|||
28143064|NCT03136367|54809020|FG000|T4 12 Weeks After Surgery|Death|0|||
28143065|NCT03136367|54809021|FG001|T4 12 Weeks After Surgery|Death|1|||
28143066|NCT03136367|54809022|FG002|T4 12 Weeks After Surgery|Death|3|||
28143067|NCT03136367|54809020|FG000|T4 12 Weeks After Surgery|discontinued lost contact|1|||
28143068|NCT03136367|54809021|FG001|T4 12 Weeks After Surgery|discontinued lost contact|0|||
28143069|NCT03136367|54809022|FG002|T4 12 Weeks After Surgery|discontinued lost contact|0|||
28143070|NCT03136367|54809020|FG000|T4 12 Weeks After Surgery|discontinued transferred care|0|||
28143071|NCT03136367|54809021|FG001|T4 12 Weeks After Surgery|discontinued transferred care|1|||
28143072|NCT03136367|54809022|FG002|T4 12 Weeks After Surgery|discontinued transferred care|5|||
28143073|NCT03136367|54809020|FG000|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
28143074|NCT03136367|54809021|FG001|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
28143075|NCT03136367|54809022|FG002|T4 12 Weeks After Surgery|discontinued mistakenly included|1|||
28143076|NCT03136367|54809020|FG000|T5 1 Year After Surgery|discontinued mistakenly included|1|||
28143077|NCT03136367|54809021|FG001|T5 1 Year After Surgery|discontinued mistakenly included|1|||
28143078|NCT03136367|54809022|FG002|T5 1 Year After Surgery|discontinued mistakenly included|1|||
28143079|NCT03136367|54809020|FG000|T5 1 Year After Surgery|Withdrawal by Subject|1|||
28143080|NCT03136367|54809021|FG001|T5 1 Year After Surgery|Withdrawal by Subject|0|||
28143081|NCT03136367|54809022|FG002|T5 1 Year After Surgery|Withdrawal by Subject|0|||
28143082|NCT03136367|54809020|FG000|T5 1 Year After Surgery|Death|0|||
28143083|NCT03136367|54809021|FG001|T5 1 Year After Surgery|Death|0|||
28143084|NCT03136367|54809022|FG002|T5 1 Year After Surgery|Death|1|||
28143085|NCT03136367|54809020|FG000|T5 1 Year After Surgery|Discontinued lost contact|1|||
28143086|NCT03136367|54809021|FG001|T5 1 Year After Surgery|Discontinued lost contact|6|||
28143087|NCT03136367|54809022|FG002|T5 1 Year After Surgery|Discontinued lost contact|0|||
28143088|NCT03136367|54809020|FG000|T5 1 Year After Surgery|Lost to Follow-up|2|||
28143089|NCT03136367|54809021|FG001|T5 1 Year After Surgery|Lost to Follow-up|22|||
28143090|NCT03136367|54809022|FG002|T5 1 Year After Surgery|Lost to Follow-up|15|||
28143091|NCT03136367|54809020|FG000|T5 1 Year After Surgery|study ended before due|31|||
28143092|NCT03136367|54809021|FG001|T5 1 Year After Surgery|study ended before due|103|||
28143093|NCT03136367|54809022|FG002|T5 1 Year After Surgery|study ended before due|110|||
28143094|NCT03136367|54809020|FG000|T5 1 Year After Surgery|logistical issues prevented contact|0|||
28143095|NCT03136367|54809021|FG001|T5 1 Year After Surgery|logistical issues prevented contact|4|||
28143096|NCT03136367|54809022|FG002|T5 1 Year After Surgery|logistical issues prevented contact|2|||
28143097|NCT03124381|54809035|FG000|Overall Study|Lost to Follow-up|1|||
28143098|NCT03124381|54809036|FG001|Overall Study|Lost to Follow-up|1|||
28143099|NCT03124381|54809035|FG000|Overall Study|Withdrawal by Subject|6|||
28143100|NCT03124381|54809036|FG001|Overall Study|Withdrawal by Subject|3|||
28143101|NCT03124381|54809035|FG000|Overall Study|Protocol Violation|0|||
28143102|NCT03124381|54809036|FG001|Overall Study|Protocol Violation|1|||
28143103|NCT03124381|54809035|FG000|Overall Study|Adverse Event|1|||
28143104|NCT03124381|54809036|FG001|Overall Study|Adverse Event|1|||
28143105|NCT03124381|54809035|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
28143106|NCT03124381|54809036|FG001|Overall Study|Non-Compliance with Study Treatment|0|||
28143107|NCT03133793|54809046|FG000|Overall Study|Withdrawal by Subject|0|||
28143108|NCT03133793|54809047|FG001|Overall Study|Withdrawal by Subject|4|||
28143109|NCT03133793|54809048|FG002|Overall Study|Withdrawal by Subject|2|||
28143110|NCT03133793|54809049|FG003|Overall Study|Withdrawal by Subject|4|||
28143111|NCT03133793|54809046|FG000|Overall Study|Lost to Follow-up|1|||
28143112|NCT03133793|54809047|FG001|Overall Study|Lost to Follow-up|0|||
28143113|NCT03133793|54809048|FG002|Overall Study|Lost to Follow-up|2|||
28143114|NCT03133793|54809049|FG003|Overall Study|Lost to Follow-up|0|||
28143115|NCT03133793|54809046|FG000|Overall Study|Death|0|||
28143116|NCT03133793|54809047|FG001|Overall Study|Death|0|||
28143117|NCT03133793|54809048|FG002|Overall Study|Death|0|||
28143118|NCT03133793|54809049|FG003|Overall Study|Death|1|||
28143119|NCT02747238|54809065|FG000|Overall Study|Lack of Efficacy|0|||
28143120|NCT02747238|54809066|FG001|Overall Study|Lack of Efficacy|1|||
28143121|NCT02747238|54809065|FG000|Overall Study|Data lost|3|||
28143122|NCT02747238|54809066|FG001|Overall Study|Data lost|5|||
28143123|NCT03133481|54809074|FG000|Overall Study|FC Catheter fell out post operative day1|0|||
28143124|NCT03133481|54809075|FG001|Overall Study|FC Catheter fell out post operative day1|4|||
28143125|NCT02864316|54809083|FG000|Overall Study|Progressive Disease|2|||
28143126|NCT02864316|54809084|FG001|Overall Study|Progressive Disease|1|||
28143127|NCT02864316|54809083|FG000|Overall Study|Adverse Event|0|||
28143128|NCT02864316|54809084|FG001|Overall Study|Adverse Event|1|||
28143129|NCT02862600|54809090|FG000|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9|||
28143130|NCT02862600|54809090|FG000|Period 1--Perhexiline-low Target Range|Protocol Violation|3|||
28143131|NCT02862600|54809090|FG000|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1|||
28143132|NCT02862600|54809090|FG000|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7|||
28143133|NCT02864082|54809098|FG000|Overall Study|Adverse Event|1|||
28143134|NCT02864082|54809099|FG001|Overall Study|Adverse Event|1|||
28143135|NCT02864082|54809098|FG000|Overall Study|Lost to Follow-up|0|||
28143136|NCT02864082|54809099|FG001|Overall Study|Lost to Follow-up|1|||
28143137|NCT02864082|54809098|FG000|Overall Study|Withdrawal by Subject|2|||
28143138|NCT02864082|54809099|FG001|Overall Study|Withdrawal by Subject|2|||
28143139|NCT02792192|54809123|FG000|Overall Study|Death|1|||
28143140|NCT02792192|54809124|FG001|Overall Study|Death|0|||
28143141|NCT02792192|54809125|FG002|Overall Study|Death|0|||
28143142|NCT02792192|54809126|FG003|Overall Study|Death|0|||
28143143|NCT02792192|54809123|FG000|Overall Study|Informed Consent Withdrawn|4|||
28143144|NCT02792192|54809124|FG001|Overall Study|Informed Consent Withdrawn|0|||
28143145|NCT02792192|54809125|FG002|Overall Study|Informed Consent Withdrawn|0|||
28143146|NCT02792192|54809126|FG003|Overall Study|Informed Consent Withdrawn|0|||
28143147|NCT02792192|54809123|FG000|Overall Study|Physician Decision|1|||
27822429|NCT01814371|54284872|FG001|Overall Study|Lost to Follow-up|27|||
27822430|NCT01814137|54284946|FG000|Overall Study|Adverse Event|0|||
27822431|NCT01814137|54284947|FG001|Overall Study|Adverse Event|1|||
27822432|NCT01814137|54284946|FG000|Overall Study|Withdrawal by Subject|2|||
27822433|NCT01814137|54284947|FG001|Overall Study|Withdrawal by Subject|2|||
27822434|NCT01814137|54284946|FG000|Overall Study|Physician Decision|1|||
27822435|NCT01814137|54284947|FG001|Overall Study|Physician Decision|1|||
27822436|NCT01814137|54284946|FG000|Overall Study|Unclassified|2|||
27822437|NCT01814137|54284947|FG001|Overall Study|Unclassified|1|||
27849970|NCT02690077|54348300|FG000|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|5|||
27849971|NCT02690077|54348301|FG001|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|8|||
27849972|NCT02690077|54348300|FG000|Overall Study|Withdrawal by Subject|0|||
27849973|NCT02690077|54348301|FG001|Overall Study|Withdrawal by Subject|5|||
27849974|NCT02690077|54348300|FG000|Overall Study|Excluded by IRB|0|||
27849975|NCT02690077|54348301|FG001|Overall Study|Excluded by IRB|2|||
27849976|NCT02275780|54348309|FG000|Base Study: 96 Weeks|Adverse Event|6|||
27849977|NCT02275780|54348310|FG001|Base Study: 96 Weeks|Adverse Event|14|||
28071081|NCT00230282|54725874|FG000|Fludarabine + Cyclophosphamide|Change in diagnosis|1|||
28071082|NCT00230282|54725874|FG000|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2|||
28071083|NCT00261950|54725878|FG000|Overall Study|Lost to Follow-up|2|||
28071084|NCT00261950|54725878|FG000|Overall Study|Death|6|||
28071085|NCT00261950|54725878|FG000|Overall Study|Withdrawal by Subject|5|||
28071086|NCT00261950|54725878|FG000|Overall Study|Other|1|||
28071087|NCT00261950|54725878|FG000|Overall Study|Physician Decision|1|||
28143148|NCT02792192|54809124|FG001|Overall Study|Physician Decision|0|||
28143149|NCT02792192|54809125|FG002|Overall Study|Physician Decision|0|||
28143150|NCT02792192|54809126|FG003|Overall Study|Physician Decision|0|||
28143151|NCT02792192|54809123|FG000|Overall Study|Progressive Disease|0|||
28143152|NCT02792192|54809124|FG001|Overall Study|Progressive Disease|1|||
28143153|NCT02792192|54809125|FG002|Overall Study|Progressive Disease|0|||
28143154|NCT02792192|54809126|FG003|Overall Study|Progressive Disease|0|||
28143155|NCT02792192|54809123|FG000|Overall Study|Study Terminated By Sponsor|6|||
28143156|NCT02792192|54809124|FG001|Overall Study|Study Terminated By Sponsor|10|||
28143157|NCT02792192|54809125|FG002|Overall Study|Study Terminated By Sponsor|0|||
28143158|NCT02792192|54809126|FG003|Overall Study|Study Terminated By Sponsor|0|||
28143159|NCT02964507|54809145|FG000|Overall Study|Protocol specified Withdrawal criteria met|0|||
28143160|NCT02964507|54809146|FG001|Overall Study|Protocol specified Withdrawal criteria met|1|||
28143161|NCT02964507|54809147|FG002|Overall Study|Protocol specified Withdrawal criteria met|0|||
28143162|NCT02964507|54809148|FG003|Overall Study|Protocol specified Withdrawal criteria met|0|||
28143163|NCT02964507|54809149|FG004|Overall Study|Protocol specified Withdrawal criteria met|1|||
28143164|NCT02964507|54809150|FG005|Overall Study|Protocol specified Withdrawal criteria met|0|||
28143165|NCT02964507|54809151|FG006|Overall Study|Protocol specified Withdrawal criteria met|0|||
28143166|NCT02964507|54809152|FG007|Overall Study|Protocol specified Withdrawal criteria met|0|||
28143167|NCT02964507|54809145|FG000|Overall Study|Study terminated by Sponsor|9|||
28143168|NCT02964507|54809146|FG001|Overall Study|Study terminated by Sponsor|1|||
28143169|NCT02964507|54809147|FG002|Overall Study|Study terminated by Sponsor|9|||
28143170|NCT02964507|54809148|FG003|Overall Study|Study terminated by Sponsor|3|||
28143171|NCT02964507|54809149|FG004|Overall Study|Study terminated by Sponsor|3|||
28143172|NCT02964507|54809150|FG005|Overall Study|Study terminated by Sponsor|2|||
28143173|NCT02964507|54809151|FG006|Overall Study|Study terminated by Sponsor|0|||
28143174|NCT02964507|54809152|FG007|Overall Study|Study terminated by Sponsor|0|||
28143175|NCT02964507|54809145|FG000|Overall Study|Other|3|||
28143176|NCT02964507|54809146|FG001|Overall Study|Other|0|||
28143177|NCT02964507|54809147|FG002|Overall Study|Other|0|||
28143178|NCT02964507|54809148|FG003|Overall Study|Other|0|||
28143179|NCT02964507|54809149|FG004|Overall Study|Other|1|||
28143180|NCT02964507|54809150|FG005|Overall Study|Other|0|||
28143181|NCT02964507|54809151|FG006|Overall Study|Other|0|||
28071088|NCT00261950|54725878|FG000|Overall Study|Protocol specified Criteria|11|||
28071089|NCT00230048|54725884|FG000|Overall Study|Lost to Follow-up|13|||
28143182|NCT02964507|54809152|FG007|Overall Study|Other|0|||
28143183|NCT02964507|54809145|FG000|Overall Study|Death|11|||
28143184|NCT02964507|54809146|FG001|Overall Study|Death|9|||
28143185|NCT02964507|54809147|FG002|Overall Study|Death|12|||
27822438|NCT01813435|54284964|FG000|Overall Study|did not finish experimental regimen|1902|||
28071090|NCT00230048|54725885|FG001|Overall Study|Lost to Follow-up|18|||
28071091|NCT00229658|54725895|FG000|Overall Study|Administrative|2|||
28071092|NCT00229658|54725896|FG001|Overall Study|Administrative|1|||
28071093|NCT00229658|54725895|FG000|Overall Study|Investigator decision|13|||
28071094|NCT00229658|54725896|FG001|Overall Study|Investigator decision|10|||
27822439|NCT01813435|54284965|FG001|Overall Study|did not finish experimental regimen|770|||
27822440|NCT01813435|54284964|FG000|Overall Study|Lost to Follow-up|268|||
28071095|NCT00229658|54725895|FG000|Overall Study|Other|80|||
27822441|NCT01813435|54284965|FG001|Overall Study|Lost to Follow-up|237|||
28071096|NCT00229658|54725896|FG001|Overall Study|Other|60|||
28071097|NCT00229658|54725895|FG000|Overall Study|Lost to Follow-up|82|||
28071098|NCT00229658|54725896|FG001|Overall Study|Lost to Follow-up|55|||
28071099|NCT00229658|54725895|FG000|Overall Study|Serious Adverse Event|2|||
28071100|NCT00229658|54725896|FG001|Overall Study|Serious Adverse Event|2|||
28071101|NCT00229658|54725895|FG000|Overall Study|Withdrawal of consent|46|||
28071102|NCT00229658|54725896|FG001|Overall Study|Withdrawal of consent|39|||
28071103|NCT00182078|54725904|FG000|Overall Study|Withdrawal by Subject|1|||
28071104|NCT00182078|54725905|FG001|Overall Study|Withdrawal by Subject|0|||
27822442|NCT01813357|54284973|FG000|Overall Study|Lost to Follow-up|5|||
27822443|NCT01813357|54284974|FG001|Overall Study|Lost to Follow-up|6|||
27822444|NCT01812655|54284983|FG000|Overall Study|Protocol Violation|1|||
27822445|NCT01812655|54284984|FG001|Overall Study|Protocol Violation|1|||
27822446|NCT01812655|54284985|FG002|Overall Study|Protocol Violation|0|||
27822447|NCT01812109|54285006|FG000|Overall Study|research personnel delay|16|||
27822448|NCT01812109|54285006|FG000|Overall Study|NIRS Unattainable|17|||
28071105|NCT00181844|54725911|FG000|Signed Consent|Withdrawal by Subject|5|||
28071106|NCT00181844|54725911|FG000|Signed Consent|Did not meet entrance criteria|7|||
28071107|NCT00181844|54725911|FG000|Exposed to Study Medication|Adverse Event|10|||
28071108|NCT00181844|54725911|FG000|Exposed to Study Medication|Lack of Efficacy|2|||
28071109|NCT00181844|54725911|FG000|Exposed to Study Medication|Non-compliance|2|||
28071110|NCT00181844|54725911|FG000|Exposed to Study Medication|Withdrawal by Subject|1|||
28071111|NCT00181844|54725911|FG000|Exposed to Study Medication|Difficulty meeting study schedule|2|||
28071112|NCT00181766|54725915|FG000|Overall Study|Lost to Follow-up|6|||
28071113|NCT00181766|54725915|FG000|Overall Study|Adverse Event|4|||
28071114|NCT00181766|54725915|FG000|Overall Study|non-compliance|2|||
28071115|NCT00180674|54725919|FG000|Phase 1, Observation Period|Withdrawal by Subject|4|||
28071116|NCT00180674|54725919|FG000|Phase 2, Warfarin Treatment Period|Adverse Event|1|||
28071117|NCT00076024|54725930|FG000|Phase 1, Lead-in|Lack of Efficacy|4|||
28071118|NCT00076024|54725931|FG001|Phase 1, Lead-in|Lack of Efficacy|0|||
28071119|NCT00076024|54725932|FG002|Phase 1, Lead-in|Lack of Efficacy|0|||
28071120|NCT00076024|54725933|FG003|Phase 1, Lead-in|Lack of Efficacy|0|||
28071121|NCT00076024|54725930|FG000|Phase 1, Lead-in|Adverse Event|1|||
28071122|NCT00076024|54725931|FG001|Phase 1, Lead-in|Adverse Event|0|||
28071123|NCT00076024|54725932|FG002|Phase 1, Lead-in|Adverse Event|0|||
28071124|NCT00076024|54725933|FG003|Phase 1, Lead-in|Adverse Event|0|||
28071125|NCT00076024|54725930|FG000|Phase 1, Lead-in|Clinical progression|1|||
28071126|NCT00076024|54725931|FG001|Phase 1, Lead-in|Clinical progression|0|||
28071127|NCT00076024|54725932|FG002|Phase 1, Lead-in|Clinical progression|0|||
28071128|NCT00076024|54725933|FG003|Phase 1, Lead-in|Clinical progression|0|||
28143186|NCT02964507|54809148|FG003|Overall Study|Death|2|||
28143187|NCT02964507|54809149|FG004|Overall Study|Death|10|||
28143188|NCT02964507|54809150|FG005|Overall Study|Death|5|||
28143189|NCT02964507|54809151|FG006|Overall Study|Death|0|||
28143190|NCT02964507|54809152|FG007|Overall Study|Death|0|||
28143191|NCT02964507|54809145|FG000|Overall Study|Withdrawal by Subject|1|||
28143192|NCT02964507|54809146|FG001|Overall Study|Withdrawal by Subject|0|||
28143193|NCT02964507|54809147|FG002|Overall Study|Withdrawal by Subject|1|||
28143194|NCT02964507|54809148|FG003|Overall Study|Withdrawal by Subject|1|||
28071129|NCT00076024|54725930|FG000|Phase 2, Double-blind|Lack of Efficacy|0|||
27822449|NCT01811953|54285016|FG000|Overall Study|Adverse Event|0|||
28071130|NCT00076024|54725931|FG001|Phase 2, Double-blind|Lack of Efficacy|59|||
28071131|NCT00076024|54725932|FG002|Phase 2, Double-blind|Lack of Efficacy|40|||
28071132|NCT00076024|54725933|FG003|Phase 2, Double-blind|Lack of Efficacy|0|||
28143195|NCT02964507|54809149|FG004|Overall Study|Withdrawal by Subject|0|||
28143196|NCT02964507|54809150|FG005|Overall Study|Withdrawal by Subject|1|||
28143197|NCT02964507|54809151|FG006|Overall Study|Withdrawal by Subject|0|||
27822450|NCT01811953|54285017|FG001|Overall Study|Adverse Event|0|||
27822451|NCT01811953|54285018|FG002|Overall Study|Adverse Event|0|||
27822452|NCT01811953|54285019|FG003|Overall Study|Adverse Event|1|||
27822453|NCT01811953|54285020|FG004|Overall Study|Adverse Event|0|||
27822454|NCT01811953|54285021|FG005|Overall Study|Adverse Event|1|||
27822455|NCT01811953|54285016|FG000|Overall Study|Protocol Violation|0|||
28143198|NCT02964507|54809152|FG007|Overall Study|Withdrawal by Subject|0|||
28143199|NCT02964507|54809145|FG000|Overall Study|Physician Decision|2|||
28143200|NCT02964507|54809146|FG001|Overall Study|Physician Decision|0|||
28143201|NCT02964507|54809147|FG002|Overall Study|Physician Decision|3|||
28143202|NCT02964507|54809148|FG003|Overall Study|Physician Decision|0|||
28143203|NCT02964507|54809149|FG004|Overall Study|Physician Decision|1|||
28143204|NCT02964507|54809150|FG005|Overall Study|Physician Decision|0|||
28143205|NCT02964507|54809151|FG006|Overall Study|Physician Decision|0|||
28143206|NCT02964507|54809152|FG007|Overall Study|Physician Decision|0|||
28143207|NCT03170869|54809171|FG000|Overall Study|Protocol Violation|5|||
28143208|NCT03170869|54809171|FG000|Overall Study|Early study termination|3|||
28143209|NCT02440464|54809178|FG000|Overall Study|Withdrawal by Subject|3|||
28143210|NCT02440464|54809179|FG001|Overall Study|Withdrawal by Subject|2|||
28143211|NCT03103321|54809190|FG000|Overall Study|Protocol Violation|1|||
28143212|NCT03103321|54809191|FG001|Overall Study|Protocol Violation|1|||
28143213|NCT03103321|54809192|FG002|Overall Study|Protocol Violation|1|||
28143214|NCT03103321|54809193|FG003|Overall Study|Protocol Violation|0|||
28143215|NCT03131453|54809206|FG000|Overall Study|Study terminated by Sponsor|424|||
28143216|NCT03131453|54809207|FG001|Overall Study|Study terminated by Sponsor|222|||
28143217|NCT03131453|54809208|FG002|Overall Study|Study terminated by Sponsor|438|||
28143218|NCT03131453|54809206|FG000|Overall Study|Withdrawal by Subject|18|||
28143219|NCT03131453|54809207|FG001|Overall Study|Withdrawal by Subject|7|||
28143220|NCT03131453|54809208|FG002|Overall Study|Withdrawal by Subject|13|||
28143221|NCT03131453|54809206|FG000|Overall Study|Adverse Event|10|||
28143222|NCT03131453|54809207|FG001|Overall Study|Adverse Event|3|||
28143223|NCT03131453|54809208|FG002|Overall Study|Adverse Event|3|||
28143224|NCT03131453|54809206|FG000|Overall Study|Lost to Follow-up|1|||
28143225|NCT03131453|54809207|FG001|Overall Study|Lost to Follow-up|0|||
28143226|NCT03131453|54809208|FG002|Overall Study|Lost to Follow-up|1|||
28143227|NCT03131453|54809206|FG000|Overall Study|Physician Decision|1|||
28143228|NCT03131453|54809207|FG001|Overall Study|Physician Decision|0|||
28143229|NCT03131453|54809208|FG002|Overall Study|Physician Decision|1|||
28143230|NCT03131453|54809206|FG000|Overall Study|Non-compliance with study treatment|1|||
28143231|NCT03131453|54809207|FG001|Overall Study|Non-compliance with study treatment|0|||
28143232|NCT03131453|54809208|FG002|Overall Study|Non-compliance with study treatment|0|||
28143233|NCT03131453|54809206|FG000|Overall Study|Technical problems|1|||
28143234|NCT03131453|54809207|FG001|Overall Study|Technical problems|0|||
28143235|NCT03131453|54809208|FG002|Overall Study|Technical problems|0|||
28143236|NCT03131453|54809206|FG000|Overall Study|Protocol deviation|0|||
28143237|NCT03131453|54809207|FG001|Overall Study|Protocol deviation|1|||
28143238|NCT03131453|54809208|FG002|Overall Study|Protocol deviation|0|||
28143239|NCT02942277|54809236|FG000|Year 1|Withdrawal by Subject|0|||
28143240|NCT02942277|54809237|FG001|Year 1|Withdrawal by Subject|0|||
28143241|NCT02942277|54809238|FG002|Year 1|Withdrawal by Subject|0|||
28143242|NCT02942277|54809239|FG003|Year 1|Withdrawal by Subject|0|||
28143243|NCT02942277|54809240|FG004|Year 1|Withdrawal by Subject|1|||
28143244|NCT02942277|54809241|FG005|Year 1|Withdrawal by Subject|3|||
28143245|NCT02942277|54809242|FG006|Year 1|Withdrawal by Subject|0|||
28143246|NCT02942277|54809243|FG007|Year 1|Withdrawal by Subject|1|||
28143247|NCT02942277|54809244|FG008|Year 1|Withdrawal by Subject|0|||
28143248|NCT02942277|54809245|FG009|Year 1|Withdrawal by Subject|0|||
28143249|NCT02942277|54809246|FG010|Year 1|Withdrawal by Subject|3|||
28143250|NCT02942277|54809236|FG000|Year 1|Travel|0|||
28143251|NCT02942277|54809237|FG001|Year 1|Travel|1|||
28143252|NCT02942277|54809238|FG002|Year 1|Travel|0|||
28143253|NCT02942277|54809239|FG003|Year 1|Travel|0|||
28143254|NCT02942277|54809240|FG004|Year 1|Travel|4|||
28143255|NCT02942277|54809241|FG005|Year 1|Travel|5|||
28143256|NCT02942277|54809242|FG006|Year 1|Travel|0|||
28143257|NCT02942277|54809243|FG007|Year 1|Travel|0|||
28143258|NCT02942277|54809244|FG008|Year 1|Travel|0|||
28143259|NCT02942277|54809245|FG009|Year 1|Travel|0|||
28143260|NCT02942277|54809246|FG010|Year 1|Travel|8|||
28143261|NCT02942277|54809236|FG000|Year 1|Joined Army|0|||
28143262|NCT02942277|54809237|FG001|Year 1|Joined Army|1|||
28143263|NCT02942277|54809238|FG002|Year 1|Joined Army|0|||
28143264|NCT02942277|54809239|FG003|Year 1|Joined Army|0|||
28143265|NCT02942277|54809240|FG004|Year 1|Joined Army|0|||
28143266|NCT02942277|54809241|FG005|Year 1|Joined Army|0|||
28143267|NCT02942277|54809242|FG006|Year 1|Joined Army|0|||
28143268|NCT02942277|54809243|FG007|Year 1|Joined Army|0|||
28143269|NCT02942277|54809244|FG008|Year 1|Joined Army|0|||
28143270|NCT02942277|54809245|FG009|Year 1|Joined Army|0|||
28143271|NCT02942277|54809246|FG010|Year 1|Joined Army|0|||
28143272|NCT02942277|54809236|FG000|Year 1|Subject met withdrawal criteria|0|||
28143273|NCT02942277|54809237|FG001|Year 1|Subject met withdrawal criteria|0|||
28143274|NCT02942277|54809238|FG002|Year 1|Subject met withdrawal criteria|0|||
28143275|NCT02942277|54809239|FG003|Year 1|Subject met withdrawal criteria|1|||
28143276|NCT02942277|54809240|FG004|Year 1|Subject met withdrawal criteria|0|||
28143277|NCT02942277|54809241|FG005|Year 1|Subject met withdrawal criteria|0|||
28143278|NCT02942277|54809242|FG006|Year 1|Subject met withdrawal criteria|0|||
28143279|NCT02942277|54809243|FG007|Year 1|Subject met withdrawal criteria|0|||
28143280|NCT02942277|54809244|FG008|Year 1|Subject met withdrawal criteria|0|||
28143281|NCT02942277|54809245|FG009|Year 1|Subject met withdrawal criteria|0|||
28143282|NCT02942277|54809246|FG010|Year 1|Subject met withdrawal criteria|0|||
28143283|NCT02942277|54809236|FG000|Year 1|Lost to Follow-up|0|||
28143284|NCT02942277|54809237|FG001|Year 1|Lost to Follow-up|0|||
28143285|NCT02942277|54809238|FG002|Year 1|Lost to Follow-up|0|||
28143286|NCT02942277|54809239|FG003|Year 1|Lost to Follow-up|0|||
28143287|NCT02942277|54809240|FG004|Year 1|Lost to Follow-up|1|||
28143288|NCT02942277|54809241|FG005|Year 1|Lost to Follow-up|0|||
28143289|NCT02942277|54809242|FG006|Year 1|Lost to Follow-up|0|||
28143290|NCT02942277|54809243|FG007|Year 1|Lost to Follow-up|0|||
28143291|NCT02942277|54809244|FG008|Year 1|Lost to Follow-up|0|||
28143292|NCT02942277|54809245|FG009|Year 1|Lost to Follow-up|0|||
28143293|NCT02942277|54809246|FG010|Year 1|Lost to Follow-up|2|||
28143294|NCT02942277|54809236|FG000|Year 1|Protocol Violation|0|||
28143295|NCT02942277|54809237|FG001|Year 1|Protocol Violation|0|||
28143296|NCT02942277|54809238|FG002|Year 1|Protocol Violation|0|||
28143297|NCT02942277|54809239|FG003|Year 1|Protocol Violation|0|||
28143298|NCT02942277|54809240|FG004|Year 1|Protocol Violation|1|||
28143299|NCT02942277|54809241|FG005|Year 1|Protocol Violation|1|||
28143300|NCT02942277|54809242|FG006|Year 1|Protocol Violation|0|||
28143301|NCT02942277|54809243|FG007|Year 1|Protocol Violation|0|||
28143302|NCT02942277|54809244|FG008|Year 1|Protocol Violation|0|||
28143303|NCT02942277|54809245|FG009|Year 1|Protocol Violation|0|||
28143304|NCT02942277|54809246|FG010|Year 1|Protocol Violation|2|||
27822456|NCT01811953|54285017|FG001|Overall Study|Protocol Violation|0|||
27822457|NCT01811953|54285018|FG002|Overall Study|Protocol Violation|0|||
28143305|NCT02942277|54809236|FG000|Year 1|Pregnancy|0|||
28143306|NCT02942277|54809237|FG001|Year 1|Pregnancy|0|||
28143307|NCT02942277|54809238|FG002|Year 1|Pregnancy|0|||
28143308|NCT02942277|54809239|FG003|Year 1|Pregnancy|0|||
28143309|NCT02942277|54809240|FG004|Year 1|Pregnancy|0|||
28143310|NCT02942277|54809241|FG005|Year 1|Pregnancy|1|||
28143311|NCT02942277|54809242|FG006|Year 1|Pregnancy|0|||
28143312|NCT02942277|54809243|FG007|Year 1|Pregnancy|0|||
28143313|NCT02942277|54809244|FG008|Year 1|Pregnancy|0|||
28143314|NCT02942277|54809245|FG009|Year 1|Pregnancy|0|||
28143315|NCT02942277|54809246|FG010|Year 1|Pregnancy|0|||
28143316|NCT02942277|54809236|FG000|Year 2|Lost to Follow-up|0|||
28143317|NCT02942277|54809237|FG001|Year 2|Lost to Follow-up|0|||
28143318|NCT02942277|54809238|FG002|Year 2|Lost to Follow-up|0|||
28143319|NCT02942277|54809239|FG003|Year 2|Lost to Follow-up|0|||
28143320|NCT02942277|54809240|FG004|Year 2|Lost to Follow-up|2|||
28143321|NCT02942277|54809241|FG005|Year 2|Lost to Follow-up|1|||
28143322|NCT02942277|54809242|FG006|Year 2|Lost to Follow-up|0|||
28143323|NCT02942277|54809243|FG007|Year 2|Lost to Follow-up|0|||
28143324|NCT02942277|54809244|FG008|Year 2|Lost to Follow-up|0|||
28143325|NCT02942277|54809245|FG009|Year 2|Lost to Follow-up|0|||
27822458|NCT01811953|54285019|FG003|Overall Study|Protocol Violation|0|||
27822459|NCT01811953|54285020|FG004|Overall Study|Protocol Violation|1|||
28143326|NCT02942277|54809246|FG010|Year 2|Lost to Follow-up|0|||
28143327|NCT02942277|54809236|FG000|Year 2|Did not rescreen|0|||
27822460|NCT01811953|54285021|FG005|Overall Study|Protocol Violation|0|||
27822461|NCT01811563|54285037|FG000|Overall Study|Lost to Follow-up|5|||
28143328|NCT02942277|54809237|FG001|Year 2|Did not rescreen|0|||
28143329|NCT02942277|54809238|FG002|Year 2|Did not rescreen|1|||
28143330|NCT02942277|54809239|FG003|Year 2|Did not rescreen|1|||
28143331|NCT02942277|54809240|FG004|Year 2|Did not rescreen|9|||
28143332|NCT02942277|54809241|FG005|Year 2|Did not rescreen|6|||
28143333|NCT02942277|54809242|FG006|Year 2|Did not rescreen|0|||
28143334|NCT02942277|54809243|FG007|Year 2|Did not rescreen|1|||
28143335|NCT02942277|54809244|FG008|Year 2|Did not rescreen|0|||
28143336|NCT02942277|54809245|FG009|Year 2|Did not rescreen|0|||
28143337|NCT02942277|54809246|FG010|Year 2|Did not rescreen|21|||
28143338|NCT02942277|54809236|FG000|Year 2|Met withdrawal criteria|0|||
28143339|NCT02942277|54809237|FG001|Year 2|Met withdrawal criteria|0|||
28143340|NCT02942277|54809238|FG002|Year 2|Met withdrawal criteria|0|||
28143341|NCT02942277|54809239|FG003|Year 2|Met withdrawal criteria|0|||
28143342|NCT02942277|54809240|FG004|Year 2|Met withdrawal criteria|1|||
28143343|NCT02942277|54809241|FG005|Year 2|Met withdrawal criteria|2|||
28143344|NCT02942277|54809242|FG006|Year 2|Met withdrawal criteria|0|||
28143345|NCT02942277|54809243|FG007|Year 2|Met withdrawal criteria|0|||
28143346|NCT02942277|54809244|FG008|Year 2|Met withdrawal criteria|0|||
28143347|NCT02942277|54809245|FG009|Year 2|Met withdrawal criteria|0|||
28143348|NCT02942277|54809246|FG010|Year 2|Met withdrawal criteria|1|||
28143349|NCT02942277|54809236|FG000|Year 2|Travel|0|||
28143350|NCT02942277|54809237|FG001|Year 2|Travel|1|||
28143351|NCT02942277|54809238|FG002|Year 2|Travel|0|||
28143352|NCT02942277|54809239|FG003|Year 2|Travel|0|||
28143353|NCT02942277|54809240|FG004|Year 2|Travel|0|||
28143354|NCT02942277|54809241|FG005|Year 2|Travel|1|||
28071133|NCT00076024|54725930|FG000|Phase 2, Double-blind|Withdrawal by Subject|0|||
28071134|NCT00076024|54725931|FG001|Phase 2, Double-blind|Withdrawal by Subject|13|||
28071135|NCT00076024|54725932|FG002|Phase 2, Double-blind|Withdrawal by Subject|4|||
28071136|NCT00076024|54725933|FG003|Phase 2, Double-blind|Withdrawal by Subject|0|||
28071137|NCT00076024|54725930|FG000|Phase 2, Double-blind|Adverse Event|0|||
28071138|NCT00076024|54725931|FG001|Phase 2, Double-blind|Adverse Event|25|||
28071139|NCT00076024|54725932|FG002|Phase 2, Double-blind|Adverse Event|6|||
28071140|NCT00076024|54725933|FG003|Phase 2, Double-blind|Adverse Event|0|||
28071141|NCT00076024|54725930|FG000|Phase 2, Double-blind|Un-specified|0|||
28071142|NCT00076024|54725931|FG001|Phase 2, Double-blind|Un-specified|14|||
28071143|NCT00076024|54725932|FG002|Phase 2, Double-blind|Un-specified|6|||
28071144|NCT00076024|54725933|FG003|Phase 2, Double-blind|Un-specified|0|||
28071145|NCT00076024|54725930|FG000|Phase 2, Double-blind|Randomized but not treated|0|||
28071146|NCT00076024|54725931|FG001|Phase 2, Double-blind|Randomized but not treated|1|||
28071147|NCT00076024|54725932|FG002|Phase 2, Double-blind|Randomized but not treated|0|||
28071148|NCT00076024|54725933|FG003|Phase 2, Double-blind|Randomized but not treated|0|||
28143355|NCT02942277|54809242|FG006|Year 2|Travel|0|||
28143356|NCT02942277|54809243|FG007|Year 2|Travel|0|||
28143357|NCT02942277|54809244|FG008|Year 2|Travel|0|||
28143358|NCT02942277|54809245|FG009|Year 2|Travel|1|||
28143359|NCT02942277|54809246|FG010|Year 2|Travel|3|||
28143360|NCT02942277|54809236|FG000|Year 2|Non-compliant|0|||
28143361|NCT02942277|54809237|FG001|Year 2|Non-compliant|0|||
28143362|NCT02942277|54809238|FG002|Year 2|Non-compliant|0|||
28143363|NCT02942277|54809239|FG003|Year 2|Non-compliant|0|||
28071149|NCT00076024|54725930|FG000|Phase 2, Open-label|Adverse Event|0|||
28071150|NCT00076024|54725931|FG001|Phase 2, Open-label|Adverse Event|0|||
28071151|NCT00076024|54725932|FG002|Phase 2, Open-label|Adverse Event|0|||
28071152|NCT00076024|54725933|FG003|Phase 2, Open-label|Adverse Event|2|||
28071153|NCT00076024|54725930|FG000|Phase 2, Open-label|Lack of Efficacy|0|||
28071154|NCT00076024|54725931|FG001|Phase 2, Open-label|Lack of Efficacy|0|||
28071155|NCT00076024|54725932|FG002|Phase 2, Open-label|Lack of Efficacy|0|||
28071156|NCT00076024|54725933|FG003|Phase 2, Open-label|Lack of Efficacy|11|||
28071157|NCT00076024|54725930|FG000|Phase 2, Open-label|Withdrawal by Subject|0|||
28071158|NCT00076024|54725931|FG001|Phase 2, Open-label|Withdrawal by Subject|0|||
28071159|NCT00076024|54725932|FG002|Phase 2, Open-label|Withdrawal by Subject|0|||
28071160|NCT00076024|54725933|FG003|Phase 2, Open-label|Withdrawal by Subject|1|||
28143364|NCT02942277|54809240|FG004|Year 2|Non-compliant|1|||
28143365|NCT02942277|54809241|FG005|Year 2|Non-compliant|1|||
28143366|NCT02942277|54809242|FG006|Year 2|Non-compliant|0|||
28143367|NCT02942277|54809243|FG007|Year 2|Non-compliant|0|||
28143368|NCT02942277|54809244|FG008|Year 2|Non-compliant|0|||
28143369|NCT02942277|54809245|FG009|Year 2|Non-compliant|0|||
28071161|NCT00076024|54725930|FG000|Phase 2, Open-label|Other|0|||
28143370|NCT02942277|54809246|FG010|Year 2|Non-compliant|0|||
28143371|NCT02942277|54809236|FG000|Year 2|Withdrawal by Subject|0|||
28143372|NCT02942277|54809237|FG001|Year 2|Withdrawal by Subject|0|||
28143373|NCT02942277|54809238|FG002|Year 2|Withdrawal by Subject|0|||
28143374|NCT02942277|54809239|FG003|Year 2|Withdrawal by Subject|0|||
28143375|NCT02942277|54809240|FG004|Year 2|Withdrawal by Subject|0|||
28071162|NCT00076024|54725931|FG001|Phase 2, Open-label|Other|0|||
28071163|NCT00076024|54725932|FG002|Phase 2, Open-label|Other|0|||
28071164|NCT00076024|54725933|FG003|Phase 2, Open-label|Other|2|||
28071165|NCT00075478|54725944|FG000|Overall Study|not eligible|1|||
28071166|NCT00075478|54725945|FG001|Overall Study|not eligible|0|||
28071167|NCT00075478|54725944|FG000|Overall Study|Physician Decision|0|||
28071168|NCT00075478|54725945|FG001|Overall Study|Physician Decision|1|||
28143376|NCT02942277|54809241|FG005|Year 2|Withdrawal by Subject|0|||
28143377|NCT02942277|54809242|FG006|Year 2|Withdrawal by Subject|1|||
28143378|NCT02942277|54809243|FG007|Year 2|Withdrawal by Subject|0|||
28143379|NCT02942277|54809244|FG008|Year 2|Withdrawal by Subject|0|||
28143380|NCT02942277|54809245|FG009|Year 2|Withdrawal by Subject|0|||
28143381|NCT02942277|54809246|FG010|Year 2|Withdrawal by Subject|0|||
28143382|NCT02859324|54809297|FG000|Overall Study|Death|4|||
28071169|NCT00175916|54725951|FG000|Overall Study|Death|19|||
28071170|NCT00175916|54725951|FG000|Overall Study|Adverse Event|81|||
28071171|NCT00175916|54725951|FG000|Overall Study|Lack of Efficacy|354|||
28071172|NCT00175916|54725951|FG000|Overall Study|Lost to Follow-up|17|||
28071173|NCT00175916|54725951|FG000|Overall Study|Subject Choice|98|||
28071174|NCT00175916|54725951|FG000|Overall Study|Lack of compliance|8|||
28071175|NCT00175916|54725951|FG000|Overall Study|Patient cannot record seizures|1|||
28071176|NCT00175916|54725951|FG000|Overall Study|Sponsor decision|17|||
28143383|NCT02859324|54809298|FG001|Overall Study|Death|6|||
28143384|NCT02859324|54809299|FG002|Overall Study|Death|5|||
28143385|NCT02859324|54809297|FG000|Overall Study|Other reasons|3|||
28143386|NCT02859324|54809298|FG001|Overall Study|Other reasons|3|||
28143387|NCT02859324|54809299|FG002|Overall Study|Other reasons|0|||
28143388|NCT02143063|54809310|FG000|Overall Study|Lost to Follow-up|16|||
28143389|NCT02143063|54809311|FG001|Overall Study|Lost to Follow-up|28|||
28143390|NCT02143063|54809312|FG002|Overall Study|Lost to Follow-up|29|||
28143391|NCT02143063|54809310|FG000|Overall Study|Withdrawal by Subject|0|||
28143392|NCT02143063|54809311|FG001|Overall Study|Withdrawal by Subject|1|||
28143393|NCT02143063|54809312|FG002|Overall Study|Withdrawal by Subject|0|||
28143394|NCT02143063|54809310|FG000|Overall Study|Death|0|||
28143395|NCT02143063|54809311|FG001|Overall Study|Death|1|||
28143396|NCT02143063|54809312|FG002|Overall Study|Death|1|||
28143397|NCT02859246|54809320|FG000|Overall Study|Screen fails|3|||
28143398|NCT02859246|54809320|FG000|Overall Study|Adverse Event|1|||
28143399|NCT02859246|54809320|FG000|Overall Study|Withdrawal by Subject|1|||
28143400|NCT01083433|54809343|FG000|Overall Study|Lost to Follow-up|2|||
28143401|NCT01083433|54809344|FG001|Overall Study|Lost to Follow-up|1|||
28143402|NCT01083433|54809345|FG002|Overall Study|Lost to Follow-up|1|||
28143403|NCT01083433|54809343|FG000|Overall Study|Withdrawal by Subject|0|||
28143404|NCT01083433|54809344|FG001|Overall Study|Withdrawal by Subject|5|||
28143405|NCT01083433|54809345|FG002|Overall Study|Withdrawal by Subject|3|||
28143406|NCT01083433|54809343|FG000|Overall Study|Pregnancy|0|||
28143407|NCT01083433|54809344|FG001|Overall Study|Pregnancy|0|||
28143408|NCT01083433|54809345|FG002|Overall Study|Pregnancy|1|||
28143409|NCT02791490|54809359|FG000|Overall Study|Lost to Follow-up|1|||
28143410|NCT02791490|54809360|FG001|Overall Study|Lost to Follow-up|2|||
28143411|NCT02791490|54809359|FG000|Overall Study|Withdrawal by Subject|2|||
28143412|NCT02791490|54809360|FG001|Overall Study|Withdrawal by Subject|6|||
28143413|NCT02507973|54809375|FG000|Overall Study|Adverse Event|1|||
28143414|NCT02425644|54809383|FG000|Overall Study|Lost to Follow-up|2|||
27822462|NCT01811563|54285038|FG001|Overall Study|Lost to Follow-up|2|||
27822463|NCT01811563|54285037|FG000|Overall Study|Incorrect Randomization procedure|0|||
27822464|NCT01811563|54285038|FG001|Overall Study|Incorrect Randomization procedure|1|||
27822465|NCT01811485|54285047|FG000|Overall Study|Adverse Event|1|||
27822466|NCT01811485|54285048|FG001|Overall Study|Adverse Event|3|||
27822467|NCT01811485|54285049|FG002|Overall Study|Adverse Event|2|||
27822468|NCT01811485|54285047|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
27822469|NCT01811485|54285048|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
27822470|NCT01811485|54285049|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
27822471|NCT01811485|54285047|FG000|Overall Study|Administrative problems|1|||
27822472|NCT01811485|54285048|FG001|Overall Study|Administrative problems|0|||
27822473|NCT01811485|54285049|FG002|Overall Study|Administrative problems|0|||
27822474|NCT01811485|54285047|FG000|Overall Study|Protocol Deviation|0|||
27822475|NCT01811485|54285048|FG001|Overall Study|Protocol Deviation|1|||
27822476|NCT01811485|54285049|FG002|Overall Study|Protocol Deviation|0|||
27822477|NCT01810939|54285060|FG000|Part A Treatment Period|Non-compliance with Study Drug|1|||
27822478|NCT01810939|54285061|FG001|Part A Treatment Period|Non-compliance with Study Drug|0|||
27822479|NCT01810939|54285062|FG002|Part A Treatment Period|Non-compliance with Study Drug|0|||
28143415|NCT02425644|54809384|FG001|Overall Study|Lost to Follow-up|3|||
28143416|NCT02425644|54809383|FG000|Overall Study|Withdrawal by Subject|41|||
28143417|NCT02425644|54809384|FG001|Overall Study|Withdrawal by Subject|36|||
28143418|NCT02425644|54809383|FG000|Overall Study|Lack of Efficacy|3|||
27822480|NCT01810939|54285060|FG000|Part A Treatment Period|Protocol Violation|2|||
28071177|NCT00175916|54725951|FG000|Overall Study|Vigabatrin intake|1|||
28143419|NCT02425644|54809384|FG001|Overall Study|Lack of Efficacy|10|||
28143420|NCT02425644|54809383|FG000|Overall Study|Adverse Event|13|||
28143421|NCT02425644|54809384|FG001|Overall Study|Adverse Event|3|||
28071178|NCT00175916|54725951|FG000|Overall Study|Suicidal behaviour|1|||
28071179|NCT00175916|54725951|FG000|Overall Study|Withdrawal by Subject|1|||
28143422|NCT02425644|54809383|FG000|Overall Study|Death|0|||
27849978|NCT02275780|54348309|FG000|Base Study: 96 Weeks|Death|3|||
28143423|NCT02425644|54809384|FG001|Overall Study|Death|2|||
28143424|NCT02425644|54809383|FG000|Overall Study|Other|18|||
28143425|NCT02425644|54809384|FG001|Overall Study|Other|17|||
28143426|NCT02861664|54809396|FG000|Overall Study|Withdrawal of Consent|0|||
28143427|NCT02861664|54809397|FG001|Overall Study|Withdrawal of Consent|1|||
28143428|NCT01307787|54809405|FG000|Overall Study|Withdrawal by Subject|2|||
28143429|NCT01307787|54809406|FG001|Overall Study|Withdrawal by Subject|0|||
28143430|NCT03284853|54809419|FG000|Overall Study|Adverse Event|40|||
28143431|NCT03284853|54809420|FG001|Overall Study|Adverse Event|4|||
28143432|NCT03284853|54809419|FG000|Overall Study|Withdrawal by Subject|5|||
28143433|NCT03284853|54809420|FG001|Overall Study|Withdrawal by Subject|1|||
28143434|NCT03284853|54809419|FG000|Overall Study|Lost to Follow-up|1|||
28143435|NCT03284853|54809420|FG001|Overall Study|Lost to Follow-up|0|||
28143436|NCT03284853|54809419|FG000|Overall Study|Lack of Efficacy|1|||
28143437|NCT03284853|54809420|FG001|Overall Study|Lack of Efficacy|0|||
28143438|NCT03284853|54809419|FG000|Overall Study|Disallowed Concurrent Medication|1|||
28143439|NCT03284853|54809420|FG001|Overall Study|Disallowed Concurrent Medication|1|||
28143440|NCT03284853|54809419|FG000|Overall Study|Protocol Violation|3|||
28143441|NCT03284853|54809420|FG001|Overall Study|Protocol Violation|3|||
28071180|NCT00175916|54725951|FG000|Overall Study|Seizure - free|4|||
28143442|NCT03284853|54809419|FG000|Overall Study|Death|0|||
28143443|NCT03284853|54809420|FG001|Overall Study|Death|1|||
28143444|NCT03284853|54809419|FG000|Overall Study|Other - Reason not reported in CSR|4|||
28143445|NCT03284853|54809420|FG001|Overall Study|Other - Reason not reported in CSR|3|||
28143446|NCT03055221|54809426|FG000|Overall Study|Adverse Event|2|||
28071181|NCT00175916|54725951|FG000|Overall Study|Administrative reason|1|||
28071182|NCT00175916|54725951|FG000|Overall Study|Pregnancy|1|||
28071183|NCT00175916|54725951|FG000|Overall Study|Patient's request|2|||
28071184|NCT00175916|54725951|FG000|Overall Study|Treating physiciant's choice|1|||
28071185|NCT00175916|54725951|FG000|Overall Study|Moved overseas|1|||
28071186|NCT00175916|54725951|FG000|Overall Study|Loss of job and economic burden|1|||
28071187|NCT00175916|54725951|FG000|Overall Study|Site was closed|9|||
28071188|NCT00175916|54725951|FG000|Overall Study|Patient went to prison|1|||
28071189|NCT00075400|54725956|FG000|Overall Study|Ineligible: wrong primary|1|||
28071190|NCT00075400|54725956|FG000|Overall Study|Never treated|2|||
28071191|NCT00228566|54725965|FG000|Overall Study|Adverse Event|31|||
28071192|NCT00228566|54725965|FG000|Overall Study|Lack of Efficacy|14|||
28071193|NCT00228566|54725965|FG000|Overall Study|Lost to Follow-up|16|||
28071194|NCT00228566|54725965|FG000|Overall Study|Physician Decision|5|||
28071195|NCT00228566|54725965|FG000|Overall Study|Withdrawal by Subject|4|||
28071196|NCT00228566|54725965|FG000|Overall Study|Miscellaneous|1|||
28071197|NCT00074152|54725971|FG000|Overall Study|Death|21|||
28071198|NCT00074152|54725972|FG001|Overall Study|Death|9|||
28071199|NCT00074152|54725971|FG000|Overall Study|Lack of Efficacy|34|||
28071200|NCT00074152|54725972|FG001|Overall Study|Lack of Efficacy|24|||
28071201|NCT00261846|54725988|FG000|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
28071202|NCT00261846|54725989|FG001|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
28071203|NCT00261846|54725990|FG002|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12|||
28071204|NCT00261846|54725991|FG003|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
28071205|NCT00261846|54725992|FG004|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
28071206|NCT00261846|54725993|FG005|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
28071207|NCT00261846|54725994|FG006|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
28071208|NCT00261846|54725995|FG007|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
28071209|NCT00261846|54725996|FG008|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
28071210|NCT00261846|54725997|FG009|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
28071211|NCT00261846|54725998|FG010|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
28143447|NCT03055221|54809426|FG000|Overall Study|Withdrawal by Subject|4|||
28143448|NCT03055221|54809426|FG000|Overall Study|Death|6|||
28071212|NCT00261846|54725999|FG011|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
28071213|NCT00261846|54725988|FG000|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
28071214|NCT00261846|54725989|FG001|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
28071215|NCT00261846|54725990|FG002|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
28071216|NCT00261846|54725991|FG003|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
28071217|NCT00261846|54725992|FG004|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
28143449|NCT03055221|54809426|FG000|Overall Study|Physician Decision|1|||
28071218|NCT00261846|54725993|FG005|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
28071219|NCT00261846|54725994|FG006|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
28071220|NCT00261846|54725995|FG007|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
28071221|NCT00261846|54725996|FG008|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
28071222|NCT00261846|54725997|FG009|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
28071223|NCT00261846|54725998|FG010|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
28071224|NCT00261846|54725999|FG011|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
28071225|NCT00261846|54725988|FG000|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
28071226|NCT00261846|54725989|FG001|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
28071227|NCT00261846|54725990|FG002|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
28071228|NCT00261846|54725991|FG003|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9|||
28071229|NCT00261846|54725992|FG004|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8|||
28071230|NCT00261846|54725993|FG005|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1|||
28071231|NCT00261846|54725994|FG006|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
28071232|NCT00261846|54725995|FG007|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
28071233|NCT00261846|54725996|FG008|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
28071234|NCT00261846|54725997|FG009|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2|||
28071235|NCT00261846|54725998|FG010|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
28143450|NCT03055221|54809426|FG000|Overall Study|Study terminated by Sponsor|3|||
28143451|NCT04497415|54809452|FG000|Overall Study|Lost to Follow-up|43|||
28143452|NCT04497415|54809453|FG001|Overall Study|Lost to Follow-up|27|||
28143453|NCT03125941|54809461|FG000|Overall Study|did not receive intervention|1|||
28143454|NCT03125941|54809462|FG001|Overall Study|did not receive intervention|2|||
28143455|NCT02774889|54809470|FG000|Overall Study|Lost to Follow-up|2|||
28143456|NCT02774889|54809471|FG001|Overall Study|Lost to Follow-up|1|||
28143457|NCT03125629|54809479|FG000|Overall Study|Withdrawal by Subject|2|||
28143458|NCT03125629|54809479|FG000|Overall Study|Equipment malfunction|1|||
28143459|NCT03125395|54809491|FG000|Overall Study|Adverse Event|2|||
28071236|NCT00261846|54725999|FG011|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
28071237|NCT00261846|54725988|FG000|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
28071238|NCT00261846|54725989|FG001|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
28071239|NCT00261846|54725990|FG002|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
28071240|NCT00261846|54725991|FG003|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12|||
28071241|NCT00261846|54725992|FG004|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
28071242|NCT00261846|54725993|FG005|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
28071243|NCT00261846|54725994|FG006|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
28071244|NCT00261846|54725995|FG007|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
28071245|NCT00261846|54725996|FG008|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1|||
28071246|NCT00261846|54725997|FG009|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
28071247|NCT00261846|54725998|FG010|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
28143460|NCT03125395|54809491|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
28143461|NCT03125395|54809491|FG000|Overall Study|Physician Decision|2|||
28143462|NCT03125395|54809491|FG000|Overall Study|Commercial drug is available|5|||
28143463|NCT00261807|54809505|FG000|Overall Study|Lost to Follow-up|2|||
28143464|NCT00261807|54809505|FG000|Overall Study|Adverse Event|2|||
28143465|NCT00261807|54809505|FG000|Overall Study|Death|1|||
28143466|NCT00261807|54809505|FG000|Overall Study|Protocol Violation|2|||
28143467|NCT02820753|54809512|FG000|2 Month|Withdrawal by Subject|3|||
28143468|NCT02820753|54809513|FG001|2 Month|Withdrawal by Subject|3|||
28143469|NCT02820753|54809512|FG000|2 Month|Lost to Follow-up|24|||
28143470|NCT02820753|54809513|FG001|2 Month|Lost to Follow-up|26|||
28143471|NCT02820753|54809512|FG000|2 Month|Stopped per NIH Hold|51|||
28143472|NCT02820753|54809513|FG001|2 Month|Stopped per NIH Hold|13|||
28143473|NCT02820753|54809512|FG000|6 Month|Withdrawal by Subject|2|||
28143474|NCT02820753|54809513|FG001|6 Month|Withdrawal by Subject|2|||
28143475|NCT02820753|54809512|FG000|6 Month|Lost to Follow-up|20|||
28143476|NCT02820753|54809513|FG001|6 Month|Lost to Follow-up|27|||
28143477|NCT02820753|54809512|FG000|6 Month|Stopped per NIH Hold|81|||
28143478|NCT02820753|54809513|FG001|6 Month|Stopped per NIH Hold|81|||
28143479|NCT02820753|54809512|FG000|6 Month|Death|0|||
28143480|NCT02820753|54809513|FG001|6 Month|Death|1|||
28143481|NCT02861586|54809527|FG000|Overall Study|Withdrawal by Subject|1|||
28143482|NCT02861586|54809528|FG001|Overall Study|Withdrawal by Subject|2|||
28143483|NCT02861586|54809529|FG002|Overall Study|Withdrawal by Subject|0|||
28143484|NCT02861586|54809530|FG003|Overall Study|Withdrawal by Subject|0|||
28143485|NCT02861586|54809531|FG004|Overall Study|Withdrawal by Subject|0|||
28143486|NCT02861586|54809532|FG005|Overall Study|Withdrawal by Subject|1|||
28143487|NCT02861586|54809533|FG006|Overall Study|Withdrawal by Subject|1|||
28143488|NCT02861586|54809534|FG007|Overall Study|Withdrawal by Subject|0|||
28143489|NCT02861586|54809527|FG000|Overall Study|Lost to Follow-up|3|||
28143490|NCT02861586|54809528|FG001|Overall Study|Lost to Follow-up|1|||
28143491|NCT02861586|54809529|FG002|Overall Study|Lost to Follow-up|1|||
28143492|NCT02861586|54809530|FG003|Overall Study|Lost to Follow-up|0|||
28143493|NCT02861586|54809531|FG004|Overall Study|Lost to Follow-up|0|||
28143494|NCT02861586|54809532|FG005|Overall Study|Lost to Follow-up|3|||
28143495|NCT02861586|54809533|FG006|Overall Study|Lost to Follow-up|0|||
28143496|NCT02861586|54809534|FG007|Overall Study|Lost to Follow-up|0|||
28143497|NCT02861586|54809527|FG000|Overall Study|Adverse Event|0|||
28143498|NCT02861586|54809528|FG001|Overall Study|Adverse Event|0|||
28143499|NCT02861586|54809529|FG002|Overall Study|Adverse Event|0|||
28143500|NCT02861586|54809530|FG003|Overall Study|Adverse Event|0|||
28143501|NCT02861586|54809531|FG004|Overall Study|Adverse Event|0|||
28143502|NCT02861586|54809532|FG005|Overall Study|Adverse Event|1|||
28143503|NCT02861586|54809533|FG006|Overall Study|Adverse Event|0|||
28143504|NCT02861586|54809534|FG007|Overall Study|Adverse Event|0|||
28143505|NCT03120949|54809570|FG000|Overall Study|randomized in error|1|||
28143506|NCT03120949|54809571|FG001|Overall Study|randomized in error|0|||
28143507|NCT03120949|54809570|FG000|Overall Study|Death|13|||
28143508|NCT03120949|54809571|FG001|Overall Study|Death|13|||
28143509|NCT03120949|54809570|FG000|Overall Study|Lost to Follow-up|23|||
28143510|NCT03120949|54809571|FG001|Overall Study|Lost to Follow-up|13|||
28143511|NCT03120949|54809570|FG000|Overall Study|Withdrawal by Subject|139|||
28143512|NCT03120949|54809571|FG001|Overall Study|Withdrawal by Subject|124|||
28143513|NCT03120949|54809570|FG000|Overall Study|Covid-19|43|||
28143514|NCT03120949|54809571|FG001|Overall Study|Covid-19|34|||
28143515|NCT03120949|54809570|FG000|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|1|||
28143516|NCT03120949|54809571|FG001|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|3|||
28143517|NCT03120949|54809570|FG000|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|1|||
28143518|NCT03120949|54809571|FG001|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|0|||
28143519|NCT03120949|54809570|FG000|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|1|||
28143520|NCT03120949|54809571|FG001|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|0|||
28143521|NCT03120949|54809570|FG000|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|1|||
28143522|NCT03120949|54809571|FG001|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|0|||
28143523|NCT03120949|54809570|FG000|Overall Study|Site was closed|2|||
28143524|NCT03120949|54809571|FG001|Overall Study|Site was closed|3|||
28143525|NCT03120949|54809570|FG000|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|1|||
28143526|NCT03120949|54809571|FG001|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|0|||
28143527|NCT03120949|54809570|FG000|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|0|||
28143528|NCT03120949|54809571|FG001|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|1|||
28143529|NCT03120949|54809570|FG000|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|1|||
28143530|NCT03120949|54809571|FG001|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|0|||
28143531|NCT03120949|54809570|FG000|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|1|||
28143532|NCT03120949|54809571|FG001|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|0|||
28143533|NCT03120949|54809570|FG000|Overall Study|Other: Adverse Event|0|||
28143534|NCT03120949|54809571|FG001|Overall Study|Other: Adverse Event|1|||
28143535|NCT03120949|54809570|FG000|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|0|||
28143536|NCT03120949|54809571|FG001|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|1|||
28143537|NCT03120949|54809570|FG000|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|0|||
28143538|NCT03120949|54809571|FG001|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|2|||
27822481|NCT01810939|54285061|FG001|Part A Treatment Period|Protocol Violation|0|||
27822482|NCT01810939|54285062|FG002|Part A Treatment Period|Protocol Violation|0|||
27822483|NCT01810939|54285060|FG000|Part A Treatment Period|Adverse Event|10|||
28143539|NCT03120949|54809570|FG000|Overall Study|Subject Refusal To Attend Visit|0|||
28071248|NCT00261846|54725999|FG011|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
28071249|NCT00261846|54725988|FG000|Period 2: Part 2 (Efficacy)|Other|0|||
28071250|NCT00261846|54725989|FG001|Period 2: Part 2 (Efficacy)|Other|0|||
28143540|NCT03120949|54809571|FG001|Overall Study|Subject Refusal To Attend Visit|1|||
28143541|NCT03120949|54809570|FG000|Overall Study|Personal Reasons|0|||
28143542|NCT03120949|54809571|FG001|Overall Study|Personal Reasons|1|||
28143543|NCT03120949|54809570|FG000|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|0|||
28143544|NCT03120949|54809571|FG001|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|1|||
28143545|NCT03120949|54809570|FG000|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|0|||
28143546|NCT03120949|54809571|FG001|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|1|||
28143547|NCT03120949|54809570|FG000|Overall Study|Compliance With Medication|0|||
28143548|NCT03120949|54809571|FG001|Overall Study|Compliance With Medication|1|||
28071251|NCT00261846|54725990|FG002|Period 2: Part 2 (Efficacy)|Other|0|||
28071252|NCT00261846|54725991|FG003|Period 2: Part 2 (Efficacy)|Other|15|||
28071253|NCT00261846|54725992|FG004|Period 2: Part 2 (Efficacy)|Other|4|||
28071254|NCT00261846|54725993|FG005|Period 2: Part 2 (Efficacy)|Other|0|||
28071255|NCT00261846|54725994|FG006|Period 2: Part 2 (Efficacy)|Other|1|||
28071256|NCT00261846|54725995|FG007|Period 2: Part 2 (Efficacy)|Other|5|||
28071257|NCT00261846|54725996|FG008|Period 2: Part 2 (Efficacy)|Other|4|||
28071258|NCT00261846|54725997|FG009|Period 2: Part 2 (Efficacy)|Other|4|||
28071259|NCT00261846|54725998|FG010|Period 2: Part 2 (Efficacy)|Other|0|||
28071260|NCT00261846|54725999|FG011|Period 2: Part 2 (Efficacy)|Other|0|||
28071261|NCT00261846|54725988|FG000|Period 2: Part 2 (Efficacy)|Death|0|||
28071262|NCT00261846|54725989|FG001|Period 2: Part 2 (Efficacy)|Death|0|||
28071263|NCT00261846|54725990|FG002|Period 2: Part 2 (Efficacy)|Death|0|||
28143549|NCT03120949|54809570|FG000|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|0|||
28143550|NCT03120949|54809571|FG001|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|1|||
28071264|NCT00261846|54725991|FG003|Period 2: Part 2 (Efficacy)|Death|37|||
28071265|NCT00261846|54725992|FG004|Period 2: Part 2 (Efficacy)|Death|7|||
28071266|NCT00261846|54725993|FG005|Period 2: Part 2 (Efficacy)|Death|1|||
28071267|NCT00261846|54725994|FG006|Period 2: Part 2 (Efficacy)|Death|10|||
28071268|NCT00261846|54725995|FG007|Period 2: Part 2 (Efficacy)|Death|12|||
28143551|NCT03120949|54809570|FG000|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|0|||
28143552|NCT03120949|54809571|FG001|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|1|||
28143553|NCT03120949|54809570|FG000|Overall Study|Study Terminated By Principal Investigator|0|||
28143554|NCT03120949|54809571|FG001|Overall Study|Study Terminated By Principal Investigator|1|||
28143555|NCT03124537|54809590|FG000|Overall Study|Lost to Follow-up|3|||
28143556|NCT03124537|54809591|FG001|Overall Study|Lost to Follow-up|5|||
28143557|NCT03124537|54809590|FG000|Overall Study|App Crash, Incomplete Data|7|||
28071269|NCT00261846|54725996|FG008|Period 2: Part 2 (Efficacy)|Death|3|||
28071270|NCT00261846|54725997|FG009|Period 2: Part 2 (Efficacy)|Death|30|||
28071271|NCT00261846|54725998|FG010|Period 2: Part 2 (Efficacy)|Death|44|||
28071272|NCT00261846|54725999|FG011|Period 2: Part 2 (Efficacy)|Death|22|||
28071273|NCT00261846|54725988|FG000|Period 2: Part 2 (Efficacy)|Extension study|0|||
28071274|NCT00261846|54725989|FG001|Period 2: Part 2 (Efficacy)|Extension study|0|||
28143558|NCT03124537|54809591|FG001|Overall Study|App Crash, Incomplete Data|8|||
28143559|NCT03118297|54809599|FG000|Overall Study|Lost to Follow-up|0|||
28143560|NCT03118297|54809600|FG001|Overall Study|Lost to Follow-up|2|||
28143561|NCT03117361|54809606|FG000|Overall Study|Progressive disease|5|||
28143562|NCT03117361|54809606|FG000|Overall Study|Death|1|||
28143563|NCT03117361|54809606|FG000|Overall Study|Physician Decision|2|||
28143564|NCT03117361|54809606|FG000|Overall Study|On study treatment at the end of study|1|||
28143565|NCT03117361|54809606|FG000|Overall Study|Treatment-related adverse event|1|||
28143566|NCT01368614|54809610|FG000|Screening Period|Screen Failure|58|||
28143567|NCT01368614|54809611|FG001|Screening Period|Screen Failure|0|||
28143568|NCT01368614|54809612|FG002|Screening Period|Screen Failure|0|||
28143569|NCT01368614|54809613|FG003|Screening Period|Screen Failure|0|||
28143570|NCT01368614|54809610|FG000|Study Period|Withdrawal by Subject|0|||
28143571|NCT01368614|54809611|FG001|Study Period|Withdrawal by Subject|1|||
28143572|NCT01368614|54809612|FG002|Study Period|Withdrawal by Subject|1|||
28143573|NCT01368614|54809613|FG003|Study Period|Withdrawal by Subject|3|||
28143574|NCT01368614|54809610|FG000|Study Period|Lost to Follow-up|0|||
28143575|NCT01368614|54809611|FG001|Study Period|Lost to Follow-up|0|||
28143576|NCT01368614|54809612|FG002|Study Period|Lost to Follow-up|1|||
28143577|NCT01368614|54809613|FG003|Study Period|Lost to Follow-up|0|||
28143578|NCT03053427|54809623|FG000|Overall Study|Adverse Event|4|||
27822484|NCT01810939|54285061|FG001|Part A Treatment Period|Adverse Event|0|||
27822485|NCT01810939|54285062|FG002|Part A Treatment Period|Adverse Event|0|||
28143579|NCT03053427|54809624|FG001|Overall Study|Adverse Event|4|||
28143580|NCT03053427|54809623|FG000|Overall Study|Lack of Efficacy|1|||
28143581|NCT03053427|54809624|FG001|Overall Study|Lack of Efficacy|3|||
28143582|NCT03053427|54809623|FG000|Overall Study|Lost to Follow-up|2|||
28143583|NCT03053427|54809624|FG001|Overall Study|Lost to Follow-up|2|||
28071275|NCT00261846|54725990|FG002|Period 2: Part 2 (Efficacy)|Extension study|0|||
28143584|NCT03053427|54809623|FG000|Overall Study|Worsening of the target disease|0|||
28143585|NCT03053427|54809624|FG001|Overall Study|Worsening of the target disease|1|||
28143586|NCT03053427|54809623|FG000|Overall Study|Protocol Deviation|3|||
27822486|NCT01810939|54285060|FG000|Part A Treatment Period|Withdrawal by Subject|5|||
27822487|NCT01810939|54285061|FG001|Part A Treatment Period|Withdrawal by Subject|0|||
27822488|NCT01810939|54285062|FG002|Part A Treatment Period|Withdrawal by Subject|0|||
27822489|NCT01810939|54285060|FG000|Part A Treatment Period|Protocol-specified (eGFR)|2|||
27822490|NCT01810939|54285061|FG001|Part A Treatment Period|Protocol-specified (eGFR)|0|||
27822491|NCT01810939|54285062|FG002|Part A Treatment Period|Protocol-specified (eGFR)|0|||
27822492|NCT01810939|54285060|FG000|Part A Treatment Period|Protocol-specified (High K+)|3|||
27822493|NCT01810939|54285061|FG001|Part A Treatment Period|Protocol-specified (High K+)|0|||
27822494|NCT01810939|54285062|FG002|Part A Treatment Period|Protocol-specified (High K+)|0|||
27822495|NCT01810939|54285060|FG000|Part A Treatment Period|Protocol-specified (Low K+)|1|||
27822496|NCT01810939|54285061|FG001|Part A Treatment Period|Protocol-specified (Low K+)|0|||
28071276|NCT00261846|54725991|FG003|Period 2: Part 2 (Efficacy)|Extension study|61|||
28071277|NCT00261846|54725992|FG004|Period 2: Part 2 (Efficacy)|Extension study|27|||
28143587|NCT03053427|54809624|FG001|Overall Study|Protocol Deviation|3|||
28143588|NCT03053427|54809623|FG000|Overall Study|Withdrawal by Subject|3|||
28143589|NCT03053427|54809624|FG001|Overall Study|Withdrawal by Subject|2|||
28143590|NCT03053427|54809623|FG000|Overall Study|Miscellaneous|0|||
28143591|NCT03053427|54809624|FG001|Overall Study|Miscellaneous|1|||
28143592|NCT03052959|54809641|FG000|Overall Study|Lost to Follow-up|4|||
28143593|NCT03052959|54809642|FG001|Overall Study|Lost to Follow-up|5|||
28071278|NCT00261846|54725993|FG005|Period 2: Part 2 (Efficacy)|Extension study|0|||
28143594|NCT03120013|54809649|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
28143595|NCT03120013|54809650|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
27822497|NCT01810939|54285062|FG002|Part A Treatment Period|Protocol-specified (Low K+)|0|||
28071279|NCT00261846|54725994|FG006|Period 2: Part 2 (Efficacy)|Extension study|4|||
28071280|NCT00261846|54725995|FG007|Period 2: Part 2 (Efficacy)|Extension study|9|||
28071281|NCT00261846|54725996|FG008|Period 2: Part 2 (Efficacy)|Extension study|5|||
28071282|NCT00261846|54725997|FG009|Period 2: Part 2 (Efficacy)|Extension study|9|||
28071283|NCT00261846|54725998|FG010|Period 2: Part 2 (Efficacy)|Extension study|1|||
28071284|NCT00261846|54725999|FG011|Period 2: Part 2 (Efficacy)|Extension study|1|||
28143596|NCT01845649|54809658|FG000|Overall Study|Adverse Event|7|||
28143597|NCT01845649|54809659|FG001|Overall Study|Adverse Event|10|||
28143598|NCT01845649|54809658|FG000|Overall Study|Lack of Efficacy|1|||
28143599|NCT01845649|54809659|FG001|Overall Study|Lack of Efficacy|1|||
28143600|NCT01845649|54809658|FG000|Overall Study|Lost to Follow-up|2|||
28143601|NCT01845649|54809659|FG001|Overall Study|Lost to Follow-up|2|||
28143602|NCT01845649|54809658|FG000|Overall Study|Withdrew Consent|12|||
28143603|NCT01845649|54809659|FG001|Overall Study|Withdrew Consent|4|||
28143604|NCT01845649|54809658|FG000|Overall Study|Protocol Deviation|7|||
28071285|NCT00169442|54726044|FG000|Overall Study|Withdrawal by Subject|0|||
28143605|NCT01845649|54809659|FG001|Overall Study|Protocol Deviation|4|||
28143606|NCT01845649|54809658|FG000|Overall Study|Reason not Specified|2|||
28143607|NCT01845649|54809659|FG001|Overall Study|Reason not Specified|1|||
28143608|NCT01345929|54809667|FG000|Overall Study|Withdrawal by Subject|9|||
28143609|NCT01345929|54809668|FG001|Overall Study|Withdrawal by Subject|8|||
28143610|NCT01345929|54809667|FG000|Overall Study|Lost to Follow-up|9|||
28143611|NCT01345929|54809668|FG001|Overall Study|Lost to Follow-up|9|||
28143612|NCT01345929|54809667|FG000|Overall Study|Adverse Event|0|||
28143613|NCT01345929|54809668|FG001|Overall Study|Adverse Event|1|||
28143614|NCT01345929|54809667|FG000|Overall Study|Didn't meet eligibility criteria|2|||
28143615|NCT01345929|54809668|FG001|Overall Study|Didn't meet eligibility criteria|0|||
28143616|NCT01345929|54809667|FG000|Overall Study|40,000 CFU/ML|1|||
28143617|NCT01345929|54809668|FG001|Overall Study|40,000 CFU/ML|0|||
28143618|NCT01345929|54809667|FG000|Overall Study|Patient withdrawal|0|||
28143619|NCT01345929|54809668|FG001|Overall Study|Patient withdrawal|1|||
28143620|NCT01343901|54809674|FG000|Overall Study|Death|85|||
28143621|NCT01343901|54809674|FG000|Overall Study|Physician Decision|4|||
28143622|NCT01343901|54809674|FG000|Overall Study|Lost to Follow-up|12|||
28143623|NCT01343901|54809674|FG000|Overall Study|Management by another medical team|11|||
28143624|NCT01343901|54809674|FG000|Overall Study|Participant decision|1|||
28143625|NCT03053271|54809678|FG000|Overall Study|Did not meet randomization criteria|3|||
28143626|NCT03053271|54809678|FG000|Overall Study|Withdrawal by Subject|1|||
27849979|NCT02275780|54348310|FG001|Base Study: 96 Weeks|Death|1|||
27849980|NCT02275780|54348309|FG000|Base Study: 96 Weeks|Lack of Efficacy|21|||
28071286|NCT00169442|54726045|FG001|Overall Study|Withdrawal by Subject|0|||
28071287|NCT00169442|54726046|FG002|Overall Study|Withdrawal by Subject|1|||
28071288|NCT00169442|54726047|FG003|Overall Study|Withdrawal by Subject|0|||
28071289|NCT00169442|54726048|FG004|Overall Study|Withdrawal by Subject|0|||
28071290|NCT00169442|54726049|FG005|Overall Study|Withdrawal by Subject|0|||
28071291|NCT00169442|54726044|FG000|Overall Study|Migrated/moved from study area|0|||
28071292|NCT00169442|54726045|FG001|Overall Study|Migrated/moved from study area|0|||
28071293|NCT00169442|54726046|FG002|Overall Study|Migrated/moved from study area|0|||
28071294|NCT00169442|54726047|FG003|Overall Study|Migrated/moved from study area|0|||
28071295|NCT00169442|54726048|FG004|Overall Study|Migrated/moved from study area|0|||
28071296|NCT00169442|54726049|FG005|Overall Study|Migrated/moved from study area|2|||
28071297|NCT00169442|54726044|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
28071298|NCT00169442|54726045|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
28071299|NCT00169442|54726046|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
28071300|NCT00169442|54726047|FG003|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
28071301|NCT00169442|54726048|FG004|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
28071302|NCT00169442|54726049|FG005|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
28071303|NCT00169442|54726044|FG000|Overall Study|Lost to follow-up (compl. vaccination)|0|||
28071304|NCT00169442|54726045|FG001|Overall Study|Lost to follow-up (compl. vaccination)|1|||
28071305|NCT00169442|54726046|FG002|Overall Study|Lost to follow-up (compl. vaccination)|0|||
28071306|NCT00169442|54726047|FG003|Overall Study|Lost to follow-up (compl. vaccination)|0|||
28071307|NCT00169442|54726048|FG004|Overall Study|Lost to follow-up (compl. vaccination)|0|||
28071308|NCT00169442|54726049|FG005|Overall Study|Lost to follow-up (compl. vaccination)|0|||
28071309|NCT00261716|54726067|FG000|Overall Study|Withdrawal by Subject|6|||
28071310|NCT00261716|54726068|FG001|Overall Study|Withdrawal by Subject|8|||
28071311|NCT00261716|54726067|FG000|Overall Study|Lost to Follow-up|0|||
28071312|NCT00261716|54726068|FG001|Overall Study|Lost to Follow-up|2|||
28071313|NCT03809104|54726078|FG000|Overall Study|Withdrawal by Subject|3|||
28071314|NCT00203502|54726082|FG000|Overall Study|Death|1|||
28071315|NCT03799198|54726088|FG000|Overall Study|Lost to Follow-up|4|||
28071316|NCT03799198|54726089|FG001|Overall Study|Lost to Follow-up|8|||
28143627|NCT01343823|54809686|FG000|Overall Study|Study Terminated|1|||
28143628|NCT01343823|54809687|FG001|Overall Study|Study Terminated|0|||
28143629|NCT01343823|54809688|FG002|Overall Study|Study Terminated|0|||
28143630|NCT01343823|54809689|FG003|Overall Study|Study Terminated|1|||
28143631|NCT01343823|54809686|FG000|Overall Study|Withdrawal by Subject|1|||
28143632|NCT01343823|54809687|FG001|Overall Study|Withdrawal by Subject|0|||
28071317|NCT03799198|54726088|FG000|Overall Study|Death|0|||
28071318|NCT03799198|54726089|FG001|Overall Study|Death|1|||
28071319|NCT00232596|54726097|FG000|6-Week Titration Phase|Adverse Event|6|||
28071320|NCT00232596|54726098|FG001|6-Week Titration Phase|Adverse Event|19|||
28071321|NCT00232596|54726097|FG000|6-Week Titration Phase|Failed to Return|2|||
28071322|NCT00232596|54726098|FG001|6-Week Titration Phase|Failed to Return|1|||
28071323|NCT00232596|54726097|FG000|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1|||
28071324|NCT00232596|54726098|FG001|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2|||
28071325|NCT00232596|54726097|FG000|6-Week Titration Phase|Protocol Violation|1|||
28071326|NCT00232596|54726098|FG001|6-Week Titration Phase|Protocol Violation|3|||
28071327|NCT00232596|54726097|FG000|6-Week Titration Phase|Participant Request Unrelated to Study|1|||
28071328|NCT00232596|54726098|FG001|6-Week Titration Phase|Participant Request Unrelated to Study|0|||
28071329|NCT00232596|54726097|FG000|6-Week Titration Phase|Other|3|||
28071330|NCT00232596|54726098|FG001|6-Week Titration Phase|Other|3|||
27849981|NCT02275780|54348310|FG001|Base Study: 96 Weeks|Lack of Efficacy|32|||
27849982|NCT02275780|54348309|FG000|Base Study: 96 Weeks|Lost to Follow-up|28|||
27849983|NCT02275780|54348310|FG001|Base Study: 96 Weeks|Lost to Follow-up|24|||
27849984|NCT02275780|54348309|FG000|Base Study: 96 Weeks|Protocol Violation|1|||
27849985|NCT02275780|54348310|FG001|Base Study: 96 Weeks|Protocol Violation|6|||
27849986|NCT02275780|54348309|FG000|Base Study: 96 Weeks|Withdrawal by Subject|19|||
27849987|NCT02275780|54348310|FG001|Base Study: 96 Weeks|Withdrawal by Subject|22|||
27849988|NCT02275780|54348309|FG000|Base Study: 96 Weeks|Noncompliance with drug|9|||
27849989|NCT02275780|54348310|FG001|Base Study: 96 Weeks|Noncompliance with drug|6|||
27849990|NCT02275780|54348309|FG000|Base Study: 96 Weeks|Physician Decision|2|||
27849991|NCT02275780|54348310|FG001|Base Study: 96 Weeks|Physician Decision|4|||
27849992|NCT02275780|54348309|FG000|Base Study: 96 Weeks|Pregnancy|2|||
27849993|NCT02275780|54348310|FG001|Base Study: 96 Weeks|Pregnancy|1|||
27849994|NCT02275780|54348309|FG000|Base Study: 96 Weeks|Randomized not treated|2|||
27849995|NCT02275780|54348310|FG001|Base Study: 96 Weeks|Randomized not treated|1|||
27849996|NCT02275780|54348309|FG000|Extension Study: up to 192 Weeks|Ongoing|260|||
27849997|NCT02275780|54348310|FG001|Extension Study: up to 192 Weeks|Ongoing|233|||
27849998|NCT02158091|54348319|FG000|Overall Study|DLT|2|||
27849999|NCT02158091|54348320|FG001|Overall Study|DLT|1|||
27850000|NCT02158091|54348321|FG002|Overall Study|DLT|0|||
27850001|NCT00545077|54348331|FG000|Overall Study|Treatment not received|5|||
27850002|NCT00545077|54348332|FG001|Overall Study|Treatment not received|1|||
27850003|NCT00545077|54348331|FG000|Overall Study|Disease Progression|131|||
27850004|NCT00545077|54348332|FG001|Overall Study|Disease Progression|98|||
27850005|NCT00545077|54348331|FG000|Overall Study|Withdrawal by Subject|3|||
27850006|NCT00545077|54348332|FG001|Overall Study|Withdrawal by Subject|14|||
27850007|NCT00545077|54348331|FG000|Overall Study|Physician Decision|6|||
28071331|NCT00232596|54726097|FG000|6-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
28071332|NCT00232596|54726098|FG001|6-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
28071333|NCT00232596|54726097|FG000|12-Week Maintenance Phase|Adverse Event|7|||
28071334|NCT00232596|54726098|FG001|12-Week Maintenance Phase|Adverse Event|22|||
28071335|NCT00232596|54726097|FG000|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1|||
28071336|NCT00232596|54726098|FG001|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2|||
28071337|NCT00232596|54726097|FG000|12-Week Maintenance Phase|Protocol Violation|3|||
28071338|NCT00232596|54726098|FG001|12-Week Maintenance Phase|Protocol Violation|1|||
28071339|NCT00232596|54726097|FG000|12-Week Maintenance Phase|Other|1|||
28071340|NCT00232596|54726098|FG001|12-Week Maintenance Phase|Other|3|||
28071341|NCT00073918|54726116|FG000|Overall Study|Eligibility requirement not met - HAMA+|1|||
28071342|NCT00073918|54726116|FG000|Overall Study|Rapid disease progression|2|||
28071343|NCT00073918|54726116|FG000|Overall Study|Eligibility requirement not met-low CD20|1|||
28071344|NCT00231894|54726122|FG000|Overall Study|Withdrawal by Subject|1|||
28071345|NCT00231894|54726123|FG001|Overall Study|Withdrawal by Subject|1|||
28071346|NCT00203424|54726135|FG000|Treatment Period|Withdrawal by Subject|4|||
28071347|NCT00203424|54726135|FG000|Treatment Period|Adverse Event|5|||
28071348|NCT00203424|54726135|FG000|Treatment Period|progressive disease|2|||
28071349|NCT00203424|54726135|FG000|Follow-up Period|Withdrawal by Subject|1|||
28071350|NCT00203424|54726135|FG000|Follow-up Period|progressive disease|4|||
28071351|NCT00203424|54726135|FG000|Follow-up Period|Lost to Follow-up|1|||
28071352|NCT00203268|54726139|FG000|Early Treatment|only treated one headache|2|||
28071353|NCT00203268|54726139|FG000|Early Treatment|Lost to Follow-up|1|||
28071354|NCT00203268|54726139|FG000|Early Treatment|Withdrawal by Subject|1|||
28071355|NCT00168818|54726148|FG000|Overall Study|Adverse Event|23|||
28071356|NCT00168818|54726149|FG001|Overall Study|Adverse Event|29|||
28071357|NCT00168818|54726150|FG002|Overall Study|Adverse Event|31|||
28071358|NCT00168818|54726148|FG000|Overall Study|Protocol Violation|16|||
28071359|NCT00168818|54726149|FG001|Overall Study|Protocol Violation|11|||
28071360|NCT00168818|54726150|FG002|Overall Study|Protocol Violation|11|||
28071361|NCT00168818|54726148|FG000|Overall Study|Lost to Follow-up|13|||
28071362|NCT00168818|54726149|FG001|Overall Study|Lost to Follow-up|4|||
28071363|NCT00168818|54726150|FG002|Overall Study|Lost to Follow-up|15|||
28071364|NCT00168818|54726148|FG000|Overall Study|Withdrawal by Subject|43|||
27850008|NCT00545077|54348332|FG001|Overall Study|Physician Decision|3|||
27850009|NCT00545077|54348331|FG000|Overall Study|Lost to Follow-up|2|||
28071365|NCT00168818|54726149|FG001|Overall Study|Withdrawal by Subject|41|||
28071366|NCT00168818|54726150|FG002|Overall Study|Withdrawal by Subject|37|||
28143633|NCT01343823|54809688|FG002|Overall Study|Withdrawal by Subject|0|||
28143634|NCT01343823|54809689|FG003|Overall Study|Withdrawal by Subject|0|||
28143635|NCT01318083|54809702|FG000|Overall Study|Adverse Event|4|||
28143636|NCT01318083|54809703|FG001|Overall Study|Adverse Event|1|||
28143637|NCT01318083|54809704|FG002|Overall Study|Adverse Event|2|||
28143638|NCT01318083|54809702|FG000|Overall Study|Withdrawal by Subject|1|||
28143639|NCT01318083|54809703|FG001|Overall Study|Withdrawal by Subject|0|||
28143640|NCT01318083|54809704|FG002|Overall Study|Withdrawal by Subject|2|||
28143641|NCT01318083|54809702|FG000|Overall Study|Lack of Efficacy|0|||
28143642|NCT01318083|54809703|FG001|Overall Study|Lack of Efficacy|0|||
28143643|NCT01318083|54809704|FG002|Overall Study|Lack of Efficacy|1|||
28143644|NCT01318083|54809702|FG000|Overall Study|Treatment Complications|1|||
28143645|NCT01318083|54809703|FG001|Overall Study|Treatment Complications|0|||
28143646|NCT01318083|54809704|FG002|Overall Study|Treatment Complications|0|||
28143647|NCT01318083|54809702|FG000|Overall Study|Lack of Study Medication Compliance|0|||
28143648|NCT01318083|54809703|FG001|Overall Study|Lack of Study Medication Compliance|1|||
28143649|NCT01318083|54809704|FG002|Overall Study|Lack of Study Medication Compliance|0|||
28143650|NCT01376323|54809717|FG000|Overall Study|Adverse Event|1|||
28143651|NCT01376323|54809718|FG001|Overall Study|Adverse Event|0|||
28143652|NCT01376323|54809719|FG002|Overall Study|Adverse Event|0|||
28143653|NCT01376323|54809720|FG003|Overall Study|Adverse Event|2|||
28143654|NCT01376323|54809721|FG004|Overall Study|Adverse Event|0|||
28143655|NCT01376323|54809717|FG000|Overall Study|Lost to Follow-up|0|||
28143656|NCT01376323|54809718|FG001|Overall Study|Lost to Follow-up|0|||
28143657|NCT01376323|54809719|FG002|Overall Study|Lost to Follow-up|0|||
28143658|NCT01376323|54809720|FG003|Overall Study|Lost to Follow-up|2|||
28143659|NCT01376323|54809721|FG004|Overall Study|Lost to Follow-up|0|||
28143660|NCT01376323|54809717|FG000|Overall Study|Physician Decision|1|||
28143661|NCT01376323|54809718|FG001|Overall Study|Physician Decision|0|||
28143662|NCT01376323|54809719|FG002|Overall Study|Physician Decision|2|||
28143663|NCT01376323|54809720|FG003|Overall Study|Physician Decision|1|||
28143664|NCT01376323|54809721|FG004|Overall Study|Physician Decision|1|||
28143665|NCT01376323|54809717|FG000|Overall Study|Withdrawal by Subject|0|||
28143666|NCT01376323|54809718|FG001|Overall Study|Withdrawal by Subject|1|||
27822498|NCT01810939|54285060|FG000|Part B Placebo-Controlled Withdrawal|Physician Decision|0|||
28071367|NCT00168818|54726148|FG000|Overall Study|Other|22|||
28071368|NCT00168818|54726149|FG001|Overall Study|Other|24|||
28071369|NCT00168818|54726150|FG002|Overall Study|Other|30|||
28071370|NCT00168818|54726148|FG000|Treatment|Adverse Event|77|||
28071371|NCT00168818|54726149|FG001|Treatment|Adverse Event|89|||
28071372|NCT00168818|54726150|FG002|Treatment|Adverse Event|68|||
28071373|NCT00168818|54726148|FG000|Treatment|Protocol Violation|8|||
28071374|NCT00168818|54726149|FG001|Treatment|Protocol Violation|11|||
28071375|NCT00168818|54726150|FG002|Treatment|Protocol Violation|11|||
28071376|NCT00168818|54726148|FG000|Treatment|Lost to Follow-up|0|||
28071377|NCT00168818|54726149|FG001|Treatment|Lost to Follow-up|2|||
28071378|NCT00168818|54726150|FG002|Treatment|Lost to Follow-up|1|||
28071379|NCT00168818|54726148|FG000|Treatment|Withdrawal by Subject|25|||
28071380|NCT00168818|54726149|FG001|Treatment|Withdrawal by Subject|20|||
28071381|NCT00168818|54726150|FG002|Treatment|Withdrawal by Subject|22|||
28071382|NCT00168818|54726148|FG000|Treatment|Other|23|||
28071383|NCT00168818|54726149|FG001|Treatment|Other|29|||
28071384|NCT00168818|54726150|FG002|Treatment|Other|31|||
28071385|NCT00260832|54726160|FG000|Overall Study|Adverse Event|26|||
28071386|NCT00260832|54726161|FG001|Overall Study|Adverse Event|19|||
28071387|NCT00260832|54726160|FG000|Overall Study|Progression|116|||
28071388|NCT00260832|54726161|FG001|Overall Study|Progression|96|||
28071389|NCT00260832|54726160|FG000|Overall Study|Withdrawal by Subject|15|||
28143667|NCT01376323|54809719|FG002|Overall Study|Withdrawal by Subject|1|||
27822499|NCT01810939|54285061|FG001|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
28071390|NCT00260832|54726161|FG001|Overall Study|Withdrawal by Subject|17|||
28071391|NCT00260832|54726160|FG000|Overall Study|Physician Decision|15|||
28071392|NCT00260832|54726161|FG001|Overall Study|Physician Decision|9|||
28071393|NCT00260832|54726160|FG000|Overall Study|Death|43|||
28071394|NCT00260832|54726161|FG001|Overall Study|Death|62|||
28071395|NCT00260832|54726160|FG000|Overall Study|Other|10|||
28071396|NCT00260832|54726161|FG001|Overall Study|Other|7|||
28071397|NCT00260832|54726160|FG000|Overall Study|Protocol Violation|3|||
28071398|NCT00260832|54726161|FG001|Overall Study|Protocol Violation|1|||
28143668|NCT01376323|54809720|FG003|Overall Study|Withdrawal by Subject|0|||
28143669|NCT01376323|54809721|FG004|Overall Study|Withdrawal by Subject|0|||
28143670|NCT03725293|54809758|FG000|Overall Study|Physician Decision|9|||
28143671|NCT03725293|54809759|FG001|Overall Study|Physician Decision|6|||
28143672|NCT03725293|54809758|FG000|Overall Study|alternative vascular access needs|1|||
28071399|NCT00168038|54726167|FG000|Overall Study|Adverse Event|1|||
28143673|NCT03725293|54809759|FG001|Overall Study|alternative vascular access needs|2|||
28143674|NCT03725293|54809758|FG000|Overall Study|venous anatomy screen failures|2|||
28143675|NCT03725293|54809759|FG001|Overall Study|venous anatomy screen failures|1|||
28071400|NCT00168038|54726167|FG000|Overall Study|Therapy failure|1|||
28071401|NCT00167414|54726171|FG000|Overall Study|Death|10|||
28071402|NCT00166712|54726177|FG000|Overall Study|Death|0|||
28071403|NCT00166712|54726178|FG001|Overall Study|Death|1|||
28071404|NCT00166712|54726177|FG000|Overall Study|Adverse Event|1|||
28071405|NCT00166712|54726178|FG001|Overall Study|Adverse Event|0|||
28071406|NCT00166712|54726177|FG000|Overall Study|Withdrawal by Subject|1|||
28071407|NCT00166712|54726178|FG001|Overall Study|Withdrawal by Subject|2|||
28071408|NCT00166712|54726177|FG000|Overall Study|Physician Decision|0|||
28071409|NCT00166712|54726178|FG001|Overall Study|Physician Decision|2|||
28071410|NCT00073528|54726190|FG000|Overall Study|Death|488|||
28071411|NCT00073528|54726191|FG001|Overall Study|Death|473|||
28071412|NCT00073528|54726190|FG000|Overall Study|Lost to Follow-up|52|||
28071413|NCT00073528|54726191|FG001|Overall Study|Lost to Follow-up|45|||
28071414|NCT00073528|54726190|FG000|Overall Study|Withdrawal by Subject|50|||
28071415|NCT00073528|54726191|FG001|Overall Study|Withdrawal by Subject|45|||
28143676|NCT01368536|54809768|FG000|Overall Study|Adverse Event|5|||
28143677|NCT01368536|54809769|FG001|Overall Study|Adverse Event|6|||
28143678|NCT01368536|54809770|FG002|Overall Study|Adverse Event|8|||
28143679|NCT01368536|54809768|FG000|Overall Study|Abnormal laboratory value(s)|0|||
28071416|NCT00073528|54726190|FG000|Overall Study|Study terminated by Sponsor|10|||
28071417|NCT00073528|54726191|FG001|Overall Study|Study terminated by Sponsor|29|||
28071418|NCT00073528|54726190|FG000|Overall Study|Other|18|||
28071419|NCT00073528|54726191|FG001|Overall Study|Other|19|||
28071420|NCT00073528|54726190|FG000|Overall Study|Other|9|||
28071421|NCT00073528|54726191|FG001|Overall Study|Other|12|||
28071422|NCT00073528|54726190|FG000|Overall Study|Protocol Violation|3|||
28071423|NCT00073528|54726191|FG001|Overall Study|Protocol Violation|5|||
28071424|NCT03801148|54726201|FG000|Period 1 (2 Days)|Adverse Event|1|||
28071425|NCT03801148|54726202|FG001|Period 1 (2 Days)|Adverse Event|1|||
28071426|NCT03801148|54726203|FG002|Period 1 (2 Days)|Adverse Event|0|||
28071427|NCT03801148|54726204|FG003|Period 1 (2 Days)|Adverse Event|0|||
28071428|NCT03801148|54726201|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
28071429|NCT03801148|54726202|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
28071430|NCT03801148|54726203|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
28071431|NCT03801148|54726204|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|1|||
28143680|NCT01368536|54809769|FG001|Overall Study|Abnormal laboratory value(s)|1|||
28143681|NCT01368536|54809770|FG002|Overall Study|Abnormal laboratory value(s)|2|||
28143682|NCT01368536|54809768|FG000|Overall Study|Abnormal test procedure result(s)|0|||
28143683|NCT01368536|54809769|FG001|Overall Study|Abnormal test procedure result(s)|0|||
28143684|NCT01368536|54809770|FG002|Overall Study|Abnormal test procedure result(s)|1|||
28143685|NCT01368536|54809768|FG000|Overall Study|Unsatisfactory therapeutic effect|7|||
28143686|NCT01368536|54809769|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
28143687|NCT01368536|54809770|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
28143688|NCT01368536|54809768|FG000|Overall Study|No longer required study medication|0|||
28143689|NCT01368536|54809769|FG001|Overall Study|No longer required study medication|0|||
28143690|NCT01368536|54809770|FG002|Overall Study|No longer required study medication|1|||
28143691|NCT01368536|54809768|FG000|Overall Study|Withdrawal by Subject|2|||
28143692|NCT01368536|54809769|FG001|Overall Study|Withdrawal by Subject|5|||
28143693|NCT01368536|54809770|FG002|Overall Study|Withdrawal by Subject|4|||
28143694|NCT01368536|54809768|FG000|Overall Study|Lost to Follow-up|3|||
28143695|NCT01368536|54809769|FG001|Overall Study|Lost to Follow-up|3|||
28143696|NCT01368536|54809770|FG002|Overall Study|Lost to Follow-up|5|||
28143697|NCT01368536|54809768|FG000|Overall Study|Administrative problems|34|||
28143698|NCT01368536|54809769|FG001|Overall Study|Administrative problems|39|||
28071432|NCT03801148|54726201|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
28071433|NCT03801148|54726202|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
28071434|NCT03801148|54726203|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
28071435|NCT03801148|54726204|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
28071436|NCT03801148|54726201|FG000|Follow-Up (12 Days)|Lost to Follow-up|0|||
28143699|NCT01368536|54809770|FG002|Overall Study|Administrative problems|35|||
28143700|NCT01368536|54809768|FG000|Overall Study|Protocol deviation|0|||
28143701|NCT01368536|54809769|FG001|Overall Study|Protocol deviation|3|||
28143702|NCT01368536|54809770|FG002|Overall Study|Protocol deviation|1|||
28143703|NCT03051165|54809779|FG000|Overall Study|Withdrawal by Subject|1|||
28143704|NCT03051165|54809779|FG000|Overall Study|Early termination of study|12|||
28143705|NCT01319929|54809785|FG000|First Treatment Period (4 Weeks)|Adverse Event|2|||
27941313|NCT01222715|54597719|FG001|Overall Study|Ineligible|1|||
27941314|NCT01222715|54597718|FG000|Overall Study|Surgery or radiation therapy in 1st 6 wk|1|||
27941315|NCT01222715|54597719|FG001|Overall Study|Surgery or radiation therapy in 1st 6 wk|0|||
27941316|NCT01222403|54597727|FG000|Overall Study|Inappropriate enrollment|0|||
27941317|NCT01222403|54597728|FG001|Overall Study|Inappropriate enrollment|2|||
27941318|NCT01222247|54597736|FG000|Overall Study|Lost to Follow-up|2|||
27941319|NCT01222247|54597737|FG001|Overall Study|Lost to Follow-up|2|||
28143706|NCT01319929|54809786|FG001|First Treatment Period (4 Weeks)|Adverse Event|0|||
28143707|NCT01319929|54809785|FG000|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
28143708|NCT01319929|54809786|FG001|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
28143709|NCT01319929|54809785|FG000|First Treatment Period (4 Weeks)|Protocol Violation|0|||
28143710|NCT01319929|54809786|FG001|First Treatment Period (4 Weeks)|Protocol Violation|1|||
28143711|NCT01319929|54809785|FG000|Second Treatment Period (4 Weeks)|Adverse Event|1|||
28143712|NCT01319929|54809786|FG001|Second Treatment Period (4 Weeks)|Adverse Event|0|||
28143713|NCT01319929|54809785|FG000|Second Treatment Period (4 Weeks)|Sponsor Decision|0|||
28143714|NCT01319929|54809786|FG001|Second Treatment Period (4 Weeks)|Sponsor Decision|1|||
28143715|NCT03110185|54809795|FG000|Overall Study|Death|0|||
28143716|NCT03110185|54809796|FG001|Overall Study|Death|1|||
28143717|NCT03110185|54809795|FG000|Overall Study|Withdrawal by Subject|2|||
28143718|NCT03110185|54809796|FG001|Overall Study|Withdrawal by Subject|7|||
28143719|NCT03110185|54809795|FG000|Overall Study|Time Constraints|0|||
28143720|NCT03110185|54809796|FG001|Overall Study|Time Constraints|6|||
28143721|NCT03110185|54809795|FG000|Overall Study|Conflict with care|5|||
28143722|NCT03110185|54809796|FG001|Overall Study|Conflict with care|12|||
28143723|NCT03110185|54809795|FG000|Overall Study|Protocol Violation|1|||
28143724|NCT03110185|54809796|FG001|Overall Study|Protocol Violation|4|||
28143725|NCT03110185|54809795|FG000|Overall Study|MRI Incompatible|2|||
28143726|NCT03110185|54809796|FG001|Overall Study|MRI Incompatible|0|||
28143727|NCT03110185|54809795|FG000|Overall Study|Patient Refusal|0|||
28143728|NCT03110185|54809796|FG001|Overall Study|Patient Refusal|1|||
28143729|NCT02858076|54809807|FG000|Overall Study|Death|6|||
28143730|NCT02858076|54809808|FG001|Overall Study|Death|3|||
28143731|NCT02858076|54809807|FG000|Overall Study|Withdrawal by Subject|1|||
28143732|NCT02858076|54809808|FG001|Overall Study|Withdrawal by Subject|5|||
28143733|NCT02858076|54809807|FG000|Overall Study|Lost to Follow-up|2|||
28143734|NCT02858076|54809808|FG001|Overall Study|Lost to Follow-up|7|||
28143735|NCT02858076|54809807|FG000|Overall Study|Completed Out of Window|1|||
28143736|NCT02858076|54809808|FG001|Overall Study|Completed Out of Window|3|||
28143737|NCT04594759|54809816|FG000|Overall Study|Lost to Follow-up|3|||
28143738|NCT02856282|54809820|FG000|Overall Study|Withdrawal by Subject|1|||
28143739|NCT03833817|54809826|FG000|Overall Study|Withdrawal by Subject|3|||
28143740|NCT03833817|54809827|FG001|Overall Study|Withdrawal by Subject|3|||
28143741|NCT03833817|54809826|FG000|Overall Study|Lost to Follow-up|3|||
28143742|NCT03833817|54809827|FG001|Overall Study|Lost to Follow-up|3|||
28143743|NCT03119701|54809835|FG000|6-day Dosing|Death|4|||
28143744|NCT03119701|54809836|FG001|6-day Dosing|Death|1|||
28143745|NCT03119701|54809835|FG000|6-day Dosing|Adverse Event|3|||
28143746|NCT03119701|54809836|FG001|6-day Dosing|Adverse Event|0|||
28143747|NCT03119701|54809835|FG000|6-day Dosing|Physician Decision|0|||
27941320|NCT01014975|54597743|FG000|Overall Study|Withdrawal by Subject|1|||
27941321|NCT01014975|54597744|FG001|Overall Study|Withdrawal by Subject|0|||
28143748|NCT03119701|54809836|FG001|6-day Dosing|Physician Decision|1|||
28143749|NCT03119701|54809835|FG000|6-day Dosing|Withdrawal by Subject|0|||
28143750|NCT03119701|54809836|FG001|6-day Dosing|Withdrawal by Subject|1|||
28143751|NCT03119701|54809835|FG000|Mid-term (Final) Follow-up at D90|Death|3|||
28143752|NCT03119701|54809836|FG001|Mid-term (Final) Follow-up at D90|Death|1|||
28143753|NCT02679781|54809850|FG000|Overall Study|Lost to Follow-up|1|||
28143754|NCT02679781|54809851|FG001|Overall Study|Lost to Follow-up|2|||
28143755|NCT02679781|54809850|FG000|Overall Study|low cooperation, referral to treatment under general anesthesia|6|||
28143756|NCT02679781|54809851|FG001|Overall Study|low cooperation, referral to treatment under general anesthesia|1|||
28143757|NCT02624869|54809860|FG000|Overall Study|Lost to Follow-up|0|||
28143758|NCT02624869|54809861|FG001|Overall Study|Lost to Follow-up|0|||
27941322|NCT01014975|54597745|FG002|Overall Study|Withdrawal by Subject|1|||
27941323|NCT01014975|54597743|FG000|Overall Study|Death|3|||
27941324|NCT01014975|54597744|FG001|Overall Study|Death|3|||
27941325|NCT01014975|54597745|FG002|Overall Study|Death|4|||
27941326|NCT01014975|54597743|FG000|Overall Study|Lost to Follow-up|0|||
27941327|NCT01014975|54597744|FG001|Overall Study|Lost to Follow-up|0|||
28071437|NCT03801148|54726202|FG001|Follow-Up (12 Days)|Lost to Follow-up|1|||
28071438|NCT03801148|54726203|FG002|Follow-Up (12 Days)|Lost to Follow-up|1|||
28071439|NCT03801148|54726204|FG003|Follow-Up (12 Days)|Lost to Follow-up|0|||
28071440|NCT00072280|54726216|FG000|Treatment|Found ineligible|1|||
28071441|NCT00072280|54726217|FG001|Treatment|Found ineligible|2|||
28071442|NCT00072280|54726216|FG000|Follow-up|Early termination of study|2|||
28071443|NCT00072280|54726217|FG001|Follow-up|Early termination of study|2|||
28071444|NCT00071812|54726226|FG000|24-Week Double-Blind Period|Adverse Event|2|||
28071445|NCT00071812|54726227|FG001|24-Week Double-Blind Period|Adverse Event|3|||
28071446|NCT00071812|54726228|FG002|24-Week Double-Blind Period|Adverse Event|4|||
28071447|NCT00071812|54726229|FG003|24-Week Double-Blind Period|Adverse Event|4|||
28071448|NCT00071812|54726226|FG000|24-Week Double-Blind Period|Lack of Efficacy|3|||
28071449|NCT00071812|54726227|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
28071450|NCT00071812|54726228|FG002|24-Week Double-Blind Period|Lack of Efficacy|2|||
28071451|NCT00071812|54726229|FG003|24-Week Double-Blind Period|Lack of Efficacy|1|||
28071452|NCT00071812|54726226|FG000|24-Week Double-Blind Period|Lost to Follow-up|0|||
28143759|NCT02624869|54809862|FG002|Overall Study|Lost to Follow-up|1|||
28143760|NCT02624869|54809860|FG000|Overall Study|Withdrawal by Subject|1|||
28143761|NCT02624869|54809861|FG001|Overall Study|Withdrawal by Subject|3|||
28071453|NCT00071812|54726227|FG001|24-Week Double-Blind Period|Lost to Follow-up|1|||
28143762|NCT02624869|54809862|FG002|Overall Study|Withdrawal by Subject|1|||
28143763|NCT03110029|54809882|FG000|Overall Study|Withdrawal by Subject|1|||
28143764|NCT03110029|54809883|FG001|Overall Study|Withdrawal by Subject|1|||
28143765|NCT02747004|54809892|FG000|Overall Study|Withdrawal by Subject|8|||
27850010|NCT00545077|54348332|FG001|Overall Study|Lost to Follow-up|0|||
28143766|NCT02747004|54809893|FG001|Overall Study|Withdrawal by Subject|5|||
28143767|NCT02747004|54809894|FG002|Overall Study|Withdrawal by Subject|4|||
28143768|NCT02747004|54809892|FG000|Overall Study|Lost to Follow-up|1|||
28143769|NCT02747004|54809893|FG001|Overall Study|Lost to Follow-up|2|||
28143770|NCT02747004|54809894|FG002|Overall Study|Lost to Follow-up|2|||
28143771|NCT02747004|54809892|FG000|Overall Study|on study treatment/follow-up|48|||
28143772|NCT02747004|54809893|FG001|Overall Study|on study treatment/follow-up|42|||
27822500|NCT01810939|54285062|FG002|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
27822501|NCT01810939|54285060|FG000|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
27822502|NCT01810939|54285061|FG001|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1|||
28071454|NCT00071812|54726228|FG002|24-Week Double-Blind Period|Lost to Follow-up|1|||
28071455|NCT00071812|54726229|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
28071456|NCT00071812|54726226|FG000|24-Week Double-Blind Period|Withdrawal by Subject|5|||
28071457|NCT00071812|54726227|FG001|24-Week Double-Blind Period|Withdrawal by Subject|1|||
28071458|NCT00071812|54726228|FG002|24-Week Double-Blind Period|Withdrawal by Subject|1|||
28071459|NCT00071812|54726229|FG003|24-Week Double-Blind Period|Withdrawal by Subject|5|||
28071460|NCT00071812|54726226|FG000|24-Week Double-Blind Period|Protocol Violation|0|||
28071461|NCT00071812|54726227|FG001|24-Week Double-Blind Period|Protocol Violation|0|||
28071462|NCT00071812|54726228|FG002|24-Week Double-Blind Period|Protocol Violation|0|||
28071463|NCT00071812|54726229|FG003|24-Week Double-Blind Period|Protocol Violation|1|||
28071464|NCT00071812|54726226|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
28071465|NCT00071812|54726227|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
28071466|NCT00071812|54726228|FG002|24-Week Open-Label Extension Period|Adverse Event|0|||
28143773|NCT02747004|54809894|FG002|Overall Study|on study treatment/follow-up|41|||
28143774|NCT04207749|54809904|FG000|Overall Study|Lost to Follow-up|0|||
28143775|NCT04207749|54809905|FG001|Overall Study|Lost to Follow-up|2|||
28143776|NCT04207749|54809904|FG000|Overall Study|Protocol Violation|0|||
28143777|NCT04207749|54809905|FG001|Overall Study|Protocol Violation|1|||
28143778|NCT04207749|54809904|FG000|Overall Study|Withdrawal by Subject|3|||
28143779|NCT04207749|54809905|FG001|Overall Study|Withdrawal by Subject|0|||
28143780|NCT04207749|54809904|FG000|Overall Study|Unable to attend study visits due to COVID-19 pandemic|1|||
28143781|NCT04207749|54809905|FG001|Overall Study|Unable to attend study visits due to COVID-19 pandemic|4|||
28143782|NCT03043365|54809916|FG000|Weeks 0 to Week 8|Adverse Event|1|||
28143783|NCT03043365|54809917|FG001|Weeks 0 to Week 8|Adverse Event|3|||
28143784|NCT03043365|54809916|FG000|Weeks 0 to Week 8|Lost to Follow-up|2|||
28143785|NCT03043365|54809917|FG001|Weeks 0 to Week 8|Lost to Follow-up|0|||
28143786|NCT03043365|54809916|FG000|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1|||
28143787|NCT03043365|54809917|FG001|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0|||
28143788|NCT03108157|54809927|FG000|Overall Study|Protocol Violation|15|||
28143789|NCT03108157|54809928|FG001|Overall Study|Protocol Violation|4|||
28143790|NCT04421131|54809935|FG000|Overall Study|Lost to Follow-up|1|||
28143791|NCT04421131|54809935|FG000|Overall Study|Protocol Violation|2|||
28143792|NCT04421131|54809935|FG000|Overall Study|App crashed|5|||
28143793|NCT04167345|54809944|FG000|Overall Study|Other|1|||
28143794|NCT04167345|54809945|FG001|Overall Study|Other|1|||
28143795|NCT04167345|54809946|FG002|Overall Study|Other|0|||
28143796|NCT04167345|54809947|FG003|Overall Study|Other|0|||
28143797|NCT04167345|54809948|FG004|Overall Study|Other|0|||
28143798|NCT02854800|54809967|FG000|Overall Study|Protocol Violation|16|||
28143799|NCT02854800|54809968|FG001|Overall Study|Protocol Violation|11|||
28143800|NCT02854800|54809969|FG002|Overall Study|Protocol Violation|3|||
28143801|NCT02854800|54809967|FG000|Overall Study|Withdrawal by Subject|4|||
28143802|NCT02854800|54809968|FG001|Overall Study|Withdrawal by Subject|2|||
28143803|NCT02854800|54809969|FG002|Overall Study|Withdrawal by Subject|3|||
28143804|NCT02931539|54809982|FG000|Period 1: Treatment Phase|Investigator discretion|1|||
28143805|NCT02931539|54809983|FG001|Period 1: Treatment Phase|Investigator discretion|1|||
28143806|NCT02931539|54809984|FG002|Period 1: Treatment Phase|Investigator discretion|0|||
28143807|NCT02931539|54809982|FG000|Period 1: Treatment Phase|Adverse Event|5|||
28143808|NCT02931539|54809983|FG001|Period 1: Treatment Phase|Adverse Event|1|||
28143809|NCT02931539|54809984|FG002|Period 1: Treatment Phase|Adverse Event|0|||
28143810|NCT02931539|54809982|FG000|Period 1: Treatment Phase|Lost to Follow-up|1|||
28143811|NCT02931539|54809983|FG001|Period 1: Treatment Phase|Lost to Follow-up|2|||
28143812|NCT02931539|54809984|FG002|Period 1: Treatment Phase|Lost to Follow-up|0|||
28143813|NCT02931539|54809982|FG000|Period 1: Treatment Phase|Death|8|||
28143814|NCT02931539|54809983|FG001|Period 1: Treatment Phase|Death|24|||
28143815|NCT02931539|54809984|FG002|Period 1: Treatment Phase|Death|0|||
28143816|NCT02931539|54809982|FG000|Period 1: Treatment Phase|Withdrawal by Subject|16|||
28143817|NCT02931539|54809983|FG001|Period 1: Treatment Phase|Withdrawal by Subject|8|||
28143818|NCT02931539|54809984|FG002|Period 1: Treatment Phase|Withdrawal by Subject|0|||
28143819|NCT02931539|54809982|FG000|Period 1: Treatment Phase|Protocol Violation|6|||
28143820|NCT02931539|54809983|FG001|Period 1: Treatment Phase|Protocol Violation|0|||
28143821|NCT02931539|54809984|FG002|Period 1: Treatment Phase|Protocol Violation|0|||
28143822|NCT02931539|54809982|FG000|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|22|||
28143823|NCT02931539|54809983|FG001|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
28143824|NCT02931539|54809984|FG002|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
28143825|NCT02931539|54809982|FG000|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
28143826|NCT02931539|54809983|FG001|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
28143827|NCT02931539|54809984|FG002|Period 2: Maribavir Rescue Therapy|Sponsor decision|2|||
28143828|NCT04042077|54810001|FG000|Overall Study|Adverse Event|0|||
28143829|NCT04042077|54810002|FG001|Overall Study|Adverse Event|1|||
28143830|NCT04042077|54810001|FG000|Overall Study|Death|2|||
28143831|NCT04042077|54810002|FG001|Overall Study|Death|1|||
28143832|NCT04042077|54810001|FG000|Overall Study|Physician Decision|2|||
28143833|NCT04042077|54810002|FG001|Overall Study|Physician Decision|0|||
28143834|NCT04042077|54810001|FG000|Overall Study|Withdrawal by Subject|3|||
28143835|NCT04042077|54810002|FG001|Overall Study|Withdrawal by Subject|2|||
28143836|NCT04042077|54810001|FG000|Overall Study|Lack of Efficacy|0|||
28143837|NCT04042077|54810002|FG001|Overall Study|Lack of Efficacy|1|||
28143838|NCT02853318|54810023|FG000|Overall Study|Withdrawal by Subject|1|||
28143839|NCT03113071|54810033|FG000|Overall Study|Withdrawal by Subject|1|||
28143840|NCT03113071|54810034|FG001|Overall Study|Withdrawal by Subject|0|||
28143841|NCT03050307|54810042|FG000|Overall Study|Adverse Event|4|||
28143842|NCT03050307|54810043|FG001|Overall Study|Adverse Event|2|||
28143843|NCT03050307|54810042|FG000|Overall Study|Significant Protocol Deviation|0|||
28143844|NCT03050307|54810043|FG001|Overall Study|Significant Protocol Deviation|1|||
28143845|NCT03050307|54810042|FG000|Overall Study|Lost to Follow-up|0|||
28143846|NCT03050307|54810043|FG001|Overall Study|Lost to Follow-up|1|||
28143847|NCT03050307|54810042|FG000|Overall Study|Voluntary Withdrawal|3|||
28143848|NCT03050307|54810043|FG001|Overall Study|Voluntary Withdrawal|4|||
28143849|NCT03050307|54810042|FG000|Overall Study|Reason not Specified|1|||
28143850|NCT03050307|54810043|FG001|Overall Study|Reason not Specified|1|||
28143851|NCT03118765|54810069|FG000|Overall Study|Withdrawal by Subject|0|||
28143852|NCT03118765|54810070|FG001|Overall Study|Withdrawal by Subject|0|||
28143853|NCT03118765|54810071|FG002|Overall Study|Withdrawal by Subject|1|||
28143854|NCT03118765|54810072|FG003|Overall Study|Withdrawal by Subject|0|||
28143855|NCT03118765|54810073|FG004|Overall Study|Withdrawal by Subject|0|||
28143856|NCT03118765|54810069|FG000|Overall Study|Adverse Event|1|||
28143857|NCT03118765|54810070|FG001|Overall Study|Adverse Event|1|||
28143858|NCT03118765|54810071|FG002|Overall Study|Adverse Event|1|||
28143859|NCT03118765|54810072|FG003|Overall Study|Adverse Event|1|||
28143860|NCT03118765|54810073|FG004|Overall Study|Adverse Event|1|||
28143861|NCT03118765|54810069|FG000|Overall Study|Non compliance with Study Procedures|0|||
28143862|NCT03118765|54810070|FG001|Overall Study|Non compliance with Study Procedures|0|||
28143863|NCT03118765|54810071|FG002|Overall Study|Non compliance with Study Procedures|0|||
28143864|NCT03118765|54810072|FG003|Overall Study|Non compliance with Study Procedures|1|||
28143865|NCT03118765|54810073|FG004|Overall Study|Non compliance with Study Procedures|0|||
28143866|NCT03118765|54810069|FG000|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
28143867|NCT03118765|54810070|FG001|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
28143868|NCT03118765|54810071|FG002|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
28143869|NCT03118765|54810072|FG003|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
28143870|NCT03118765|54810073|FG004|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
28143871|NCT03118765|54810069|FG000|Overall Study|COPD Exacerbation|1|||
28143872|NCT03118765|54810070|FG001|Overall Study|COPD Exacerbation|0|||
28143873|NCT03118765|54810071|FG002|Overall Study|COPD Exacerbation|0|||
28143874|NCT03118765|54810072|FG003|Overall Study|COPD Exacerbation|1|||
28143875|NCT03118765|54810073|FG004|Overall Study|COPD Exacerbation|0|||
28143876|NCT03118765|54810069|FG000|Overall Study|Lost to Follow-up|1|||
28143877|NCT03118765|54810070|FG001|Overall Study|Lost to Follow-up|0|||
28143878|NCT03118765|54810071|FG002|Overall Study|Lost to Follow-up|1|||
28143879|NCT03118765|54810072|FG003|Overall Study|Lost to Follow-up|0|||
28143880|NCT03118765|54810073|FG004|Overall Study|Lost to Follow-up|0|||
28143881|NCT03118765|54810069|FG000|Overall Study|Sponsor Decision|1|||
28143882|NCT03118765|54810070|FG001|Overall Study|Sponsor Decision|0|||
28143883|NCT03118765|54810071|FG002|Overall Study|Sponsor Decision|1|||
28143884|NCT03118765|54810072|FG003|Overall Study|Sponsor Decision|0|||
28143885|NCT03118765|54810073|FG004|Overall Study|Sponsor Decision|1|||
28143886|NCT05222880|54810088|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
28143887|NCT05222880|54810088|FG000|Overall Study|Withdrew Consent during Study|1|||
28143888|NCT05222880|54810088|FG000|Overall Study|COVID-19 Related|1|||
28143889|NCT04810962|54810105|FG000|Overall Study|Adverse Event|0|||
28071467|NCT00071812|54726229|FG003|24-Week Open-Label Extension Period|Adverse Event|7|||
28071468|NCT00071812|54726226|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
28143890|NCT04810962|54810106|FG001|Overall Study|Adverse Event|1|||
28143891|NCT04810962|54810105|FG000|Overall Study|Lost to Follow-up|2|||
28143892|NCT04810962|54810106|FG001|Overall Study|Lost to Follow-up|1|||
28143893|NCT04810962|54810105|FG000|Overall Study|Physician Decision|1|||
28143894|NCT04810962|54810106|FG001|Overall Study|Physician Decision|0|||
28143895|NCT04810962|54810105|FG000|Overall Study|Withdrawal by Subject|1|||
28143896|NCT04810962|54810106|FG001|Overall Study|Withdrawal by Subject|3|||
28143897|NCT04810962|54810105|FG000|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|2|||
28143898|NCT04810962|54810106|FG001|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|1|||
28143899|NCT04606134|54810139|FG000|Overall Study|Adverse Event|0|||
28143900|NCT04606134|54810140|FG001|Overall Study|Adverse Event|1|||
28143901|NCT04426825|54810146|FG000|Overall Study|Continuing on study|6|||
28143902|NCT04426825|54810146|FG000|Overall Study|Death|17|||
28143903|NCT04399538|54810155|FG000|Double-Blind Treatment|Work schedule conflicts|0|||
28143904|NCT04399538|54810156|FG001|Double-Blind Treatment|Work schedule conflicts|0|||
28143905|NCT04399538|54810157|FG002|Double-Blind Treatment|Work schedule conflicts|0|||
28143906|NCT04399538|54810158|FG003|Double-Blind Treatment|Work schedule conflicts|1|||
28143907|NCT04399538|54810159|FG004|Double-Blind Treatment|Work schedule conflicts|1|||
28143908|NCT04399538|54810155|FG000|Double-Blind Treatment|Adverse Event|0|||
28143909|NCT04399538|54810156|FG001|Double-Blind Treatment|Adverse Event|0|||
28143910|NCT04399538|54810157|FG002|Double-Blind Treatment|Adverse Event|0|||
28143911|NCT04399538|54810158|FG003|Double-Blind Treatment|Adverse Event|0|||
27822503|NCT01810939|54285062|FG002|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
27822504|NCT01810939|54285060|FG000|Part B Placebo-Controlled Withdrawal|Adverse Event|0|||
27822505|NCT01810939|54285061|FG001|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
28143912|NCT04399538|54810159|FG004|Double-Blind Treatment|Adverse Event|1|||
28143913|NCT04399538|54810155|FG000|Follow-Up|Adverse Event|0|||
28143914|NCT04399538|54810156|FG001|Follow-Up|Adverse Event|0|||
27822506|NCT01810939|54285062|FG002|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
27822507|NCT01810939|54285060|FG000|Part B Placebo-Controlled Withdrawal|Death|0|||
27822508|NCT01810939|54285061|FG001|Part B Placebo-Controlled Withdrawal|Death|0|||
27822509|NCT01810939|54285062|FG002|Part B Placebo-Controlled Withdrawal|Death|1|||
27822510|NCT01810939|54285060|FG000|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
28071469|NCT00071812|54726227|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
27822511|NCT01810939|54285061|FG001|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
27822512|NCT01810939|54285062|FG002|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1|||
27822513|NCT01810939|54285060|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0|||
27822514|NCT01810939|54285061|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
27822515|NCT01810939|54285062|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
27822516|NCT01810939|54285060|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0|||
27822517|NCT01810939|54285061|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1|||
27822518|NCT01810939|54285062|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2|||
27822519|NCT01810939|54285060|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0|||
27822520|NCT01810939|54285061|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2|||
27822521|NCT01810939|54285062|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14|||
27822522|NCT01810939|54285060|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0|||
28071470|NCT00071812|54726228|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
28071471|NCT00071812|54726229|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|17|||
28071472|NCT00071812|54726226|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
28071473|NCT00071812|54726227|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
28071474|NCT00071812|54726228|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
28071475|NCT00071812|54726229|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
28071476|NCT00071812|54726226|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
28071477|NCT00071812|54726227|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
28071478|NCT00071812|54726228|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
28071479|NCT00071812|54726229|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|12|||
28071480|NCT00071812|54726226|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
28143915|NCT04399538|54810157|FG002|Follow-Up|Adverse Event|0|||
28143916|NCT04399538|54810158|FG003|Follow-Up|Adverse Event|0|||
28143917|NCT04399538|54810159|FG004|Follow-Up|Adverse Event|1|||
28143918|NCT04399538|54810155|FG000|Follow-Up|Withdrawal by Subject|0|||
28143919|NCT04399538|54810156|FG001|Follow-Up|Withdrawal by Subject|0|||
28071481|NCT00071812|54726227|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
28071482|NCT00071812|54726228|FG002|24-Week Open-Label Extension Period|Lack of Compliance|1|||
28071483|NCT00071812|54726229|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
28071484|NCT00071110|54726243|FG000|Overall Study|Protocol Violation|0|||
28071485|NCT00071110|54726244|FG001|Overall Study|Protocol Violation|4|||
28071486|NCT00071032|54726252|FG000|Overall Study|Lost to Follow-up|1|||
28143920|NCT04399538|54810157|FG002|Follow-Up|Withdrawal by Subject|0|||
28143921|NCT04399538|54810158|FG003|Follow-Up|Withdrawal by Subject|2|||
28071487|NCT00071032|54726253|FG001|Overall Study|Lost to Follow-up|1|||
28071488|NCT00071032|54726252|FG000|Overall Study|Withdrawal by Subject|8|||
28143922|NCT04399538|54810159|FG004|Follow-Up|Withdrawal by Subject|0|||
28143923|NCT03875235|54810177|FG000|Overall Study|Ongoing study treatment|63|||
28143924|NCT03875235|54810178|FG001|Overall Study|Ongoing study treatment|20|||
28143925|NCT03875235|54810177|FG000|Overall Study|Off treatment|77|||
28143926|NCT03875235|54810178|FG001|Overall Study|Off treatment|91|||
28143927|NCT03875235|54810177|FG000|Overall Study|Withdrawal by Subject|3|||
28143928|NCT03875235|54810178|FG001|Overall Study|Withdrawal by Subject|10|||
28143929|NCT03875235|54810177|FG000|Overall Study|Death|198|||
28143930|NCT03875235|54810178|FG001|Overall Study|Death|223|||
28143931|NCT03094832|54810214|FG000|Overall Study|Lost to Follow-up|0|||
28143932|NCT03094832|54810215|FG001|Overall Study|Lost to Follow-up|0|||
28143933|NCT03094832|54810216|FG002|Overall Study|Lost to Follow-up|0|||
28143934|NCT03094832|54810217|FG003|Overall Study|Lost to Follow-up|1|||
28143935|NCT03094832|54810218|FG004|Overall Study|Lost to Follow-up|1|||
28143936|NCT03094832|54810214|FG000|Overall Study|Death|1|||
28143937|NCT03094832|54810215|FG001|Overall Study|Death|0|||
28143938|NCT03094832|54810216|FG002|Overall Study|Death|0|||
28143939|NCT03094832|54810217|FG003|Overall Study|Death|0|||
28143940|NCT03094832|54810218|FG004|Overall Study|Death|0|||
28143941|NCT03094832|54810214|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
28143942|NCT03094832|54810215|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
28143943|NCT03094832|54810216|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
28143944|NCT03094832|54810217|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
28143945|NCT03094832|54810218|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
28143946|NCT03094832|54810214|FG000|Overall Study|Other|13|||
28143947|NCT03094832|54810215|FG001|Overall Study|Other|20|||
28143948|NCT03094832|54810216|FG002|Overall Study|Other|1|||
28143949|NCT03094832|54810217|FG003|Overall Study|Other|7|||
28143950|NCT03094832|54810218|FG004|Overall Study|Other|1|||
28143951|NCT03036579|54810232|FG000|2 Years|Lost to Follow-up|1|||
28143952|NCT03036579|54810233|FG001|2 Years|Lost to Follow-up|0|||
28143953|NCT03036579|54810232|FG000|3 Years|Lost to Follow-up|0|||
28143954|NCT03036579|54810233|FG001|3 Years|Lost to Follow-up|1|||
28143955|NCT02867761|54810241|FG000|Overall Study|Participant withdrawn by investigator|0|||
28143956|NCT02867761|54810242|FG001|Overall Study|Participant withdrawn by investigator|1|||
28143957|NCT02867761|54810241|FG000|Overall Study|Lost to Follow-up|25|||
28143958|NCT02867761|54810242|FG001|Overall Study|Lost to Follow-up|18|||
28143959|NCT02867761|54810241|FG000|Overall Study|Unable to complete protocol|3|||
28143960|NCT02867761|54810242|FG001|Overall Study|Unable to complete protocol|7|||
28071489|NCT00071032|54726253|FG001|Overall Study|Withdrawal by Subject|6|||
28071490|NCT00071032|54726252|FG000|Overall Study|Missing Primary Outcome|0|||
28071491|NCT00071032|54726253|FG001|Overall Study|Missing Primary Outcome|1|||
28071492|NCT00259610|54726264|FG000|Overall Study|Withdrawal by Subject|33|||
28071493|NCT00259610|54726265|FG001|Overall Study|Withdrawal by Subject|25|||
28071494|NCT00259610|54726266|FG002|Overall Study|Withdrawal by Subject|29|||
28071495|NCT00259610|54726267|FG003|Overall Study|Withdrawal by Subject|19|||
28071496|NCT00259610|54726264|FG000|Overall Study|Lost to Follow-up|19|||
28071497|NCT00259610|54726265|FG001|Overall Study|Lost to Follow-up|8|||
28071498|NCT00259610|54726266|FG002|Overall Study|Lost to Follow-up|18|||
28071499|NCT00259610|54726267|FG003|Overall Study|Lost to Follow-up|15|||
28071500|NCT00259610|54726264|FG000|Overall Study|Physician Decision|6|||
28071501|NCT00259610|54726265|FG001|Overall Study|Physician Decision|4|||
28143961|NCT02719990|54810257|FG000|Overall Study|Physician Decision|2|||
28143962|NCT02719990|54810257|FG000|Overall Study|Withdrawal by Subject|2|||
28143963|NCT02719990|54810257|FG000|Overall Study|Study Terminated By Sponsor|32|||
28143964|NCT02494583|54810264|FG000|Overall Study|Death|224|||
28071502|NCT00259610|54726266|FG002|Overall Study|Physician Decision|7|||
28071503|NCT00259610|54726267|FG003|Overall Study|Physician Decision|2|||
28071504|NCT00259610|54726264|FG000|Overall Study|Death|1|||
28143965|NCT02494583|54810265|FG001|Overall Study|Death|214|||
28143966|NCT02494583|54810266|FG002|Overall Study|Death|225|||
28143967|NCT02494583|54810264|FG000|Overall Study|Lost to Follow-up|1|||
28143968|NCT02494583|54810265|FG001|Overall Study|Lost to Follow-up|0|||
27850011|NCT00545077|54348331|FG000|Overall Study|Protocol Violation|1|||
28143969|NCT02494583|54810266|FG002|Overall Study|Lost to Follow-up|0|||
28143970|NCT02494583|54810264|FG000|Overall Study|Protocol Violation|1|||
28143971|NCT02494583|54810265|FG001|Overall Study|Protocol Violation|2|||
28143972|NCT02494583|54810266|FG002|Overall Study|Protocol Violation|0|||
28143973|NCT02494583|54810264|FG000|Overall Study|Screen Failure|0|||
28143974|NCT02494583|54810265|FG001|Overall Study|Screen Failure|1|||
28143975|NCT02494583|54810266|FG002|Overall Study|Screen Failure|0|||
28143976|NCT02494583|54810264|FG000|Overall Study|Transferred to Extension Study|15|||
28143977|NCT02494583|54810265|FG001|Overall Study|Transferred to Extension Study|15|||
28143978|NCT02494583|54810266|FG002|Overall Study|Transferred to Extension Study|6|||
28143979|NCT02494583|54810264|FG000|Overall Study|Did Not Continue on Extension Study|8|||
28143980|NCT02494583|54810265|FG001|Overall Study|Did Not Continue on Extension Study|10|||
28143981|NCT02494583|54810266|FG002|Overall Study|Did Not Continue on Extension Study|4|||
28143982|NCT02494583|54810264|FG000|Overall Study|Withdrawal by Subject|7|||
28143983|NCT02494583|54810265|FG001|Overall Study|Withdrawal by Subject|15|||
28143984|NCT02494583|54810266|FG002|Overall Study|Withdrawal by Subject|15|||
28143985|NCT02322814|54810281|FG000|Overall Study|Death|7|||
28143986|NCT02322814|54810282|FG001|Overall Study|Death|29|||
28143987|NCT02322814|54810283|FG002|Overall Study|Death|32|||
28143988|NCT02322814|54810284|FG003|Overall Study|Death|23|||
28143989|NCT02322814|54810285|FG004|Overall Study|Death|14|||
28143990|NCT02322814|54810281|FG000|Overall Study|Lost to Follow-up|1|||
28143991|NCT02322814|54810282|FG001|Overall Study|Lost to Follow-up|3|||
28143992|NCT02322814|54810283|FG002|Overall Study|Lost to Follow-up|3|||
28143993|NCT02322814|54810284|FG003|Overall Study|Lost to Follow-up|1|||
28143994|NCT02322814|54810285|FG004|Overall Study|Lost to Follow-up|0|||
28143995|NCT02322814|54810281|FG000|Overall Study|Various Reasons|2|||
28143996|NCT02322814|54810282|FG001|Overall Study|Various Reasons|0|||
28143997|NCT02322814|54810283|FG002|Overall Study|Various Reasons|1|||
28143998|NCT02322814|54810284|FG003|Overall Study|Various Reasons|1|||
28143999|NCT02322814|54810285|FG004|Overall Study|Various Reasons|0|||
28144000|NCT02322814|54810281|FG000|Overall Study|Progressive Disease|0|||
28144001|NCT02322814|54810282|FG001|Overall Study|Progressive Disease|0|||
28144002|NCT02322814|54810283|FG002|Overall Study|Progressive Disease|0|||
28144003|NCT02322814|54810284|FG003|Overall Study|Progressive Disease|1|||
28144004|NCT02322814|54810285|FG004|Overall Study|Progressive Disease|1|||
28144005|NCT02322814|54810281|FG000|Overall Study|Protocol Violation|1|||
28144006|NCT02322814|54810282|FG001|Overall Study|Protocol Violation|0|||
28144007|NCT02322814|54810283|FG002|Overall Study|Protocol Violation|0|||
28144008|NCT02322814|54810284|FG003|Overall Study|Protocol Violation|0|||
28144009|NCT02322814|54810285|FG004|Overall Study|Protocol Violation|0|||
28144010|NCT02322814|54810281|FG000|Overall Study|Study Terminated by Sponsor|0|||
28144011|NCT02322814|54810282|FG001|Overall Study|Study Terminated by Sponsor|7|||
28144012|NCT02322814|54810283|FG002|Overall Study|Study Terminated by Sponsor|9|||
28144013|NCT02322814|54810284|FG003|Overall Study|Study Terminated by Sponsor|5|||
28144014|NCT02322814|54810285|FG004|Overall Study|Study Terminated by Sponsor|13|||
28071505|NCT00259610|54726265|FG001|Overall Study|Death|1|||
28071506|NCT00259610|54726266|FG002|Overall Study|Death|2|||
28071507|NCT00259610|54726267|FG003|Overall Study|Death|0|||
28071508|NCT00259610|54726264|FG000|Overall Study|non medical reason|6|||
28071509|NCT00259610|54726265|FG001|Overall Study|non medical reason|2|||
28071510|NCT00259610|54726266|FG002|Overall Study|non medical reason|10|||
28071511|NCT00259610|54726267|FG003|Overall Study|non medical reason|3|||
28071512|NCT00259610|54726264|FG000|Overall Study|Adverse Event|3|||
28071513|NCT00259610|54726265|FG001|Overall Study|Adverse Event|4|||
28071514|NCT00259610|54726266|FG002|Overall Study|Adverse Event|5|||
28071515|NCT00259610|54726267|FG003|Overall Study|Adverse Event|2|||
28071516|NCT00259610|54726264|FG000|Overall Study|Serious Adverse Event|8|||
28071517|NCT00259610|54726265|FG001|Overall Study|Serious Adverse Event|2|||
28071518|NCT00259610|54726266|FG002|Overall Study|Serious Adverse Event|2|||
28144015|NCT02322814|54810281|FG000|Overall Study|Withdrawal by Subject|5|||
28144016|NCT02322814|54810282|FG001|Overall Study|Withdrawal by Subject|4|||
28144017|NCT02322814|54810283|FG002|Overall Study|Withdrawal by Subject|2|||
28144018|NCT02322814|54810284|FG003|Overall Study|Withdrawal by Subject|1|||
28144019|NCT02322814|54810285|FG004|Overall Study|Withdrawal by Subject|3|||
28144020|NCT01333033|54810307|FG000|Overall Study|Ineligible|0|||
28144021|NCT01333033|54810308|FG001|Overall Study|Ineligible|0|||
28144022|NCT01333033|54810309|FG002|Overall Study|Ineligible|0|||
28144023|NCT01333033|54810310|FG003|Overall Study|Ineligible|0|||
28144024|NCT01333033|54810311|FG004|Overall Study|Ineligible|6|||
28144025|NCT01333033|54810312|FG005|Overall Study|Ineligible|8|||
28071519|NCT00259610|54726267|FG003|Overall Study|Serious Adverse Event|2|||
28071520|NCT00165776|54726281|FG000|Overall Study|Lack of Efficacy|0|||
28071521|NCT00165776|54726282|FG001|Overall Study|Lack of Efficacy|0|||
28071522|NCT00165776|54726283|FG002|Overall Study|Lack of Efficacy|0|||
28144026|NCT01333033|54810307|FG000|Overall Study|Withdrawal by Subject|0|||
28144027|NCT01333033|54810308|FG001|Overall Study|Withdrawal by Subject|0|||
28144028|NCT01333033|54810309|FG002|Overall Study|Withdrawal by Subject|0|||
28071523|NCT00165776|54726284|FG003|Overall Study|Lack of Efficacy|1|||
28144029|NCT01333033|54810310|FG003|Overall Study|Withdrawal by Subject|0|||
28071524|NCT00165776|54726281|FG000|Overall Study|Withdrawal by Subject|4|||
28144030|NCT01333033|54810311|FG004|Overall Study|Withdrawal by Subject|4|||
28071525|NCT00165776|54726282|FG001|Overall Study|Withdrawal by Subject|1|||
28071526|NCT00165776|54726283|FG002|Overall Study|Withdrawal by Subject|2|||
28071527|NCT00165776|54726284|FG003|Overall Study|Withdrawal by Subject|0|||
28071528|NCT00165776|54726281|FG000|Overall Study|Worsening of Cervical Dystonia|0|||
28071529|NCT00165776|54726282|FG001|Overall Study|Worsening of Cervical Dystonia|0|||
28071530|NCT00165776|54726283|FG002|Overall Study|Worsening of Cervical Dystonia|0|||
28071531|NCT00165776|54726284|FG003|Overall Study|Worsening of Cervical Dystonia|1|||
28071532|NCT00165698|54726296|FG000|Overall Study|Adverse Event|2|||
28071533|NCT00165698|54726297|FG001|Overall Study|Adverse Event|10|||
28144031|NCT01333033|54810312|FG005|Overall Study|Withdrawal by Subject|2|||
28144032|NCT01333033|54810307|FG000|Overall Study|PET inevaluable|0|||
28144033|NCT01333033|54810308|FG001|Overall Study|PET inevaluable|0|||
28144034|NCT01333033|54810309|FG002|Overall Study|PET inevaluable|0|||
28144035|NCT01333033|54810310|FG003|Overall Study|PET inevaluable|0|||
28144036|NCT01333033|54810311|FG004|Overall Study|PET inevaluable|2|||
28144037|NCT01333033|54810312|FG005|Overall Study|PET inevaluable|4|||
28144038|NCT01333033|54810307|FG000|Overall Study|Adverse Event|0|||
28144039|NCT01333033|54810308|FG001|Overall Study|Adverse Event|0|||
28144040|NCT01333033|54810309|FG002|Overall Study|Adverse Event|0|||
28144041|NCT01333033|54810310|FG003|Overall Study|Adverse Event|0|||
28144042|NCT01333033|54810311|FG004|Overall Study|Adverse Event|2|||
28144043|NCT01333033|54810312|FG005|Overall Study|Adverse Event|1|||
28144044|NCT01333033|54810307|FG000|Overall Study|Progression|0|||
28144045|NCT01333033|54810308|FG001|Overall Study|Progression|0|||
28144046|NCT01333033|54810309|FG002|Overall Study|Progression|0|||
28144047|NCT01333033|54810310|FG003|Overall Study|Progression|0|||
28144048|NCT01333033|54810311|FG004|Overall Study|Progression|0|||
28144049|NCT01333033|54810312|FG005|Overall Study|Progression|1|||
28144050|NCT01333033|54810307|FG000|Overall Study|MD Decision|0|||
28144051|NCT01333033|54810308|FG001|Overall Study|MD Decision|0|||
28144052|NCT01333033|54810309|FG002|Overall Study|MD Decision|0|||
28144053|NCT01333033|54810310|FG003|Overall Study|MD Decision|0|||
28144054|NCT01333033|54810311|FG004|Overall Study|MD Decision|0|||
28144055|NCT01333033|54810312|FG005|Overall Study|MD Decision|2|||
28144056|NCT01192776|54810334|FG000|Overall Study|Death|8|||
27822523|NCT01810939|54285061|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2|||
27822524|NCT01810939|54285062|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1|||
27822525|NCT01810939|54285060|FG000|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
27822526|NCT01810939|54285061|FG001|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1|||
27822527|NCT01810939|54285062|FG002|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
27822528|NCT01810783|54285081|FG000|Overall Study|Adverse Event|32|||
28144057|NCT01192776|54810335|FG001|Overall Study|Death|15|||
28144058|NCT01192776|54810336|FG002|Overall Study|Death|18|||
28144059|NCT01192776|54810337|FG003|Overall Study|Death|15|||
28144060|NCT01192776|54810334|FG000|Overall Study|Lost to Follow-up|3|||
28144061|NCT01192776|54810335|FG001|Overall Study|Lost to Follow-up|6|||
28144062|NCT01192776|54810336|FG002|Overall Study|Lost to Follow-up|3|||
28144063|NCT01192776|54810337|FG003|Overall Study|Lost to Follow-up|5|||
28144064|NCT01367834|54810370|FG000|Overall Study|Withdrawal by Subject|2|||
28144065|NCT01367834|54810371|FG001|Overall Study|Withdrawal by Subject|2|||
28144066|NCT01367834|54810370|FG000|Overall Study|Study was ended.|0|||
28144067|NCT01367834|54810371|FG001|Overall Study|Study was ended.|1|||
28144068|NCT03106753|54810379|FG000|Overall Study|Withdrawal by Subject|0|||
28144069|NCT03106753|54810380|FG001|Overall Study|Withdrawal by Subject|1|||
28144070|NCT03045081|54810390|FG000|Overall Study|Withdrawal by Subject|6|||
28144071|NCT03045081|54810391|FG001|Overall Study|Withdrawal by Subject|11|||
28144072|NCT03107377|54810399|FG000|Overall Study|Adverse Event|3|||
28144073|NCT03107377|54810400|FG001|Overall Study|Adverse Event|3|||
28144074|NCT03107377|54810399|FG000|Overall Study|Protocol Violation|9|||
28144075|NCT03107377|54810400|FG001|Overall Study|Protocol Violation|12|||
28144076|NCT03107377|54810399|FG000|Overall Study|Physician Decision|3|||
28071534|NCT00165698|54726296|FG000|Overall Study|Lost to Follow-up|2|||
28071535|NCT00165698|54726297|FG001|Overall Study|Lost to Follow-up|2|||
28071536|NCT00165698|54726296|FG000|Overall Study|Withdrawal by Subject|2|||
28071537|NCT00165698|54726297|FG001|Overall Study|Withdrawal by Subject|1|||
28144077|NCT03107377|54810400|FG001|Overall Study|Physician Decision|6|||
28144078|NCT03107377|54810399|FG000|Overall Study|Pregnancy|7|||
28144079|NCT03107377|54810400|FG001|Overall Study|Pregnancy|7|||
28144080|NCT03107377|54810399|FG000|Overall Study|Withdrawal by Subject|16|||
28144081|NCT03107377|54810400|FG001|Overall Study|Withdrawal by Subject|22|||
28144082|NCT03107377|54810399|FG000|Overall Study|Lost to Follow-up|37|||
28144083|NCT03107377|54810400|FG001|Overall Study|Lost to Follow-up|34|||
28144084|NCT03107377|54810399|FG000|Overall Study|Other reason not specified|16|||
28144085|NCT03107377|54810400|FG001|Overall Study|Other reason not specified|15|||
28144086|NCT02545283|54810408|FG000|Overall Study|Lost to Follow-up|2|||
28071538|NCT00165698|54726296|FG000|Overall Study|Protocol Violation|1|||
27822529|NCT01810783|54285081|FG000|Overall Study|Withdrawal by Subject|22|||
27822530|NCT01810783|54285081|FG000|Overall Study|Lack of Efficacy|12|||
27822531|NCT01810783|54285081|FG000|Overall Study|Lost to Follow-up|10|||
27822532|NCT01810783|54285081|FG000|Overall Study|Protocol Violation|5|||
27822533|NCT01810783|54285081|FG000|Overall Study|Non-compliance with IMP|4|||
27822534|NCT01810783|54285081|FG000|Overall Study|Adminstrative or other reason(s)|23|||
27822535|NCT01810783|54285081|FG000|Overall Study|Enrolled, not treated|1|||
27822536|NCT01808209|54285102|FG000|Overall Study|Lost to Follow-up|0|||
27822537|NCT01808209|54285103|FG001|Overall Study|Lost to Follow-up|1|||
28071539|NCT00165698|54726297|FG001|Overall Study|Protocol Violation|0|||
28071540|NCT00165698|54726296|FG000|Overall Study|Not Taken/Lost the medicine|1|||
28071541|NCT00165698|54726297|FG001|Overall Study|Not Taken/Lost the medicine|2|||
28071542|NCT00225758|54726303|FG000|Overall Study|Adverse Event|4|||
28071543|NCT00259298|54726309|FG000|Overall Study|Withdrawal by Subject|1|||
28071544|NCT00259298|54726309|FG000|Overall Study|Physician Decision|2|||
28071545|NCT03789292|54726319|FG000|Treatment Period I (Week 0 to Week 26)|Adverse Event|7|||
28071546|NCT03789292|54726320|FG001|Treatment Period I (Week 0 to Week 26)|Adverse Event|8|||
28071547|NCT03789292|54726321|FG002|Treatment Period I (Week 0 to Week 26)|Adverse Event|0|||
28071548|NCT03789292|54726319|FG000|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|2|||
28071549|NCT03789292|54726320|FG001|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
28071550|NCT03789292|54726321|FG002|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
28071551|NCT03789292|54726319|FG000|Treatment Period I (Week 0 to Week 26)|Physician Decision|1|||
28071552|NCT03789292|54726320|FG001|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
28144087|NCT02545283|54810409|FG001|Overall Study|Lost to Follow-up|4|||
28144088|NCT02545283|54810408|FG000|Overall Study|Withdrawal by Subject|5|||
28144089|NCT02545283|54810409|FG001|Overall Study|Withdrawal by Subject|9|||
28144090|NCT02545283|54810408|FG000|Overall Study|Death|109|||
28144091|NCT02545283|54810409|FG001|Overall Study|Death|211|||
28144092|NCT02545283|54810408|FG000|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|0|||
28144093|NCT02545283|54810409|FG001|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|3|||
28144094|NCT02545283|54810408|FG000|Overall Study|Study Terminated By Sponsor|33|||
28144095|NCT02545283|54810409|FG001|Overall Study|Study Terminated By Sponsor|71|||
28144096|NCT03282565|54810420|FG000|Overall Study|COVID-19 Research Shutdown|0|||
28144097|NCT03282565|54810421|FG001|Overall Study|COVID-19 Research Shutdown|2|||
28144098|NCT03282565|54810422|FG002|Overall Study|COVID-19 Research Shutdown|2|||
28144099|NCT02875613|54810430|FG000|Overall Study|Withdrawal by Subject|1|||
28144100|NCT02815267|54810440|FG000|Double-Blind Phase|Adverse Event|0|||
28144101|NCT02815267|54810441|FG001|Double-Blind Phase|Adverse Event|3|||
28144102|NCT02815267|54810440|FG000|Double-Blind Phase|Lost to Follow-up|17|||
28144103|NCT02815267|54810441|FG001|Double-Blind Phase|Lost to Follow-up|9|||
28144104|NCT02815267|54810440|FG000|Double-Blind Phase|Withdrawal by Subject|11|||
28144105|NCT02815267|54810441|FG001|Double-Blind Phase|Withdrawal by Subject|10|||
28144106|NCT02815267|54810440|FG000|Double-Blind Phase|Protocol Violation|3|||
28144107|NCT02815267|54810441|FG001|Double-Blind Phase|Protocol Violation|2|||
28144108|NCT02815267|54810440|FG000|Double-Blind Phase|Site withdrawal|1|||
28144109|NCT02815267|54810441|FG001|Double-Blind Phase|Site withdrawal|6|||
28144110|NCT02815267|54810440|FG000|Double-Blind Phase|Received a disallowed medication|1|||
28144111|NCT02815267|54810441|FG001|Double-Blind Phase|Received a disallowed medication|1|||
28144112|NCT02815267|54810440|FG000|Open-Label Phase|Adverse Event|1|||
28144113|NCT02815267|54810441|FG001|Open-Label Phase|Adverse Event|1|||
28144114|NCT02815267|54810440|FG000|Open-Label Phase|Lost to Follow-up|23|||
27822538|NCT01807117|54285113|FG000|Overall Study|Physician Decision|2|||
28144115|NCT02815267|54810441|FG001|Open-Label Phase|Lost to Follow-up|9|||
28144116|NCT02815267|54810440|FG000|Open-Label Phase|Withdrawal by Subject|24|||
28144117|NCT02815267|54810441|FG001|Open-Label Phase|Withdrawal by Subject|13|||
28144118|NCT02815267|54810440|FG000|Open-Label Phase|Protocol Violation|0|||
28144119|NCT02815267|54810441|FG001|Open-Label Phase|Protocol Violation|1|||
28144120|NCT02815267|54810440|FG000|Open-Label Phase|Administrative|21|||
27822539|NCT01807117|54285113|FG000|Overall Study|Disease diagnosis not a study disease|1|||
27822540|NCT01806961|54285119|FG000|Overall Study|sponsor decision|16|||
27822541|NCT01613131|54285125|FG000|Overall Study|Withdrawal by Subject|3|||
27822542|NCT01613131|54285126|FG001|Overall Study|Withdrawal by Subject|5|||
28071553|NCT03789292|54726321|FG002|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
28144121|NCT02815267|54810441|FG001|Open-Label Phase|Administrative|12|||
28144122|NCT02815267|54810440|FG000|Open-Label Phase|Other|2|||
28144123|NCT02815267|54810441|FG001|Open-Label Phase|Other|5|||
28144124|NCT02930837|54810451|FG000|Overall Study|Adverse Event|6|||
28144125|NCT02930837|54810451|FG000|Overall Study|Lost to Follow-up|5|||
28144126|NCT02930837|54810451|FG000|Overall Study|Withdrawal by Subject|1|||
28144127|NCT01343277|54810457|FG000|Overall Study|Other|3|||
28144128|NCT01343277|54810458|FG001|Overall Study|Other|3|||
28144129|NCT01343277|54810457|FG000|Overall Study|Withdrawal by Subject|18|||
28144130|NCT01343277|54810458|FG001|Overall Study|Withdrawal by Subject|13|||
28144131|NCT01343277|54810457|FG000|Overall Study|Physician Decision|1|||
28144132|NCT01343277|54810458|FG001|Overall Study|Physician Decision|2|||
28144133|NCT01343277|54810457|FG000|Overall Study|Death|10|||
28144134|NCT01343277|54810458|FG001|Overall Study|Death|1|||
28144135|NCT01343277|54810457|FG000|Overall Study|Adverse Event|67|||
28144136|NCT01343277|54810458|FG001|Overall Study|Adverse Event|13|||
28144137|NCT01343277|54810457|FG000|Overall Study|Disease progression|270|||
28144138|NCT01343277|54810458|FG001|Overall Study|Disease progression|138|||
28144139|NCT01343277|54810457|FG000|Overall Study|Randomized not treated|6|||
28144140|NCT01343277|54810458|FG001|Overall Study|Randomized not treated|21|||
28144141|NCT01343277|54810457|FG000|Overall Study|Treatment ongoing|8|||
28144142|NCT01343277|54810458|FG001|Overall Study|Treatment ongoing|2|||
28144143|NCT01343277|54810457|FG000|Overall Study|Subsequent anticancer therapy|1|||
28144144|NCT01343277|54810458|FG001|Overall Study|Subsequent anticancer therapy|0|||
28144145|NCT03135899|54810472|FG000|Overall Study|Failed spirometry,unable to repeat visit|0|||
28144146|NCT03135899|54810473|FG001|Overall Study|Failed spirometry,unable to repeat visit|0|||
28144147|NCT03135899|54810474|FG002|Overall Study|Failed spirometry,unable to repeat visit|0|||
28144148|NCT03135899|54810475|FG003|Overall Study|Failed spirometry,unable to repeat visit|0|||
28144149|NCT03135899|54810476|FG004|Overall Study|Failed spirometry,unable to repeat visit|0|||
28144150|NCT03135899|54810477|FG005|Overall Study|Failed spirometry,unable to repeat visit|0|||
28144151|NCT03135899|54810478|FG006|Overall Study|Failed spirometry,unable to repeat visit|1|||
28144152|NCT03135899|54810479|FG007|Overall Study|Failed spirometry,unable to repeat visit|0|||
28144153|NCT03135899|54810472|FG000|Overall Study|Withdrawal by Subject|0|||
28144154|NCT03135899|54810473|FG001|Overall Study|Withdrawal by Subject|0|||
28144155|NCT03135899|54810474|FG002|Overall Study|Withdrawal by Subject|0|||
28144156|NCT03135899|54810475|FG003|Overall Study|Withdrawal by Subject|0|||
28144157|NCT03135899|54810476|FG004|Overall Study|Withdrawal by Subject|0|||
28144158|NCT03135899|54810477|FG005|Overall Study|Withdrawal by Subject|2|||
28144159|NCT03135899|54810478|FG006|Overall Study|Withdrawal by Subject|0|||
28144160|NCT03135899|54810479|FG007|Overall Study|Withdrawal by Subject|0|||
28144161|NCT02487979|54810493|FG000|Overall Study|Physician Decision|2|||
28144162|NCT02487979|54810493|FG000|Overall Study|Withdrawal by Subject|2|||
28144163|NCT02487979|54810493|FG000|Overall Study|Progressive Disease|17|||
28144164|NCT03103087|54810504|FG000|Overall Study|Did not receive any study drug|1|||
28144165|NCT03103087|54810505|FG001|Overall Study|Did not receive any study drug|0|||
28144166|NCT03103087|54810506|FG002|Overall Study|Did not receive any study drug|0|||
28144167|NCT03103087|54810504|FG000|Overall Study|Protocol Violation|1|||
28144168|NCT03103087|54810505|FG001|Overall Study|Protocol Violation|2|||
28144169|NCT03103087|54810506|FG002|Overall Study|Protocol Violation|1|||
28144170|NCT03103087|54810504|FG000|Overall Study|Lack of Efficacy|2|||
28144171|NCT03103087|54810505|FG001|Overall Study|Lack of Efficacy|1|||
28144172|NCT03103087|54810506|FG002|Overall Study|Lack of Efficacy|1|||
28144173|NCT03103087|54810504|FG000|Overall Study|Pregnancy|0|||
28144174|NCT03103087|54810505|FG001|Overall Study|Pregnancy|0|||
28144175|NCT03103087|54810506|FG002|Overall Study|Pregnancy|1|||
28144176|NCT03103087|54810504|FG000|Overall Study|Adverse Event|2|||
28144177|NCT03103087|54810505|FG001|Overall Study|Adverse Event|15|||
28144178|NCT03103087|54810506|FG002|Overall Study|Adverse Event|6|||
28144179|NCT03103087|54810504|FG000|Overall Study|Withdrawal by Subject|13|||
28144180|NCT03103087|54810505|FG001|Overall Study|Withdrawal by Subject|6|||
28144181|NCT03103087|54810506|FG002|Overall Study|Withdrawal by Subject|6|||
28144182|NCT03103087|54810504|FG000|Overall Study|Lost to Follow-up|4|||
28144183|NCT03103087|54810505|FG001|Overall Study|Lost to Follow-up|2|||
28144184|NCT03103087|54810506|FG002|Overall Study|Lost to Follow-up|7|||
28144185|NCT03103087|54810504|FG000|Overall Study|Other reason not reported|1|||
28144186|NCT03103087|54810505|FG001|Overall Study|Other reason not reported|3|||
28144187|NCT03103087|54810506|FG002|Overall Study|Other reason not reported|5|||
28144188|NCT03132467|54810516|FG000|Overall Study|Adverse Event|2|||
28144189|NCT03132467|54810516|FG000|Overall Study|Withdrawal by Subject|2|||
28144190|NCT03131999|54810523|FG000|Overall Study|Withdrawal by Subject|0|||
28144191|NCT03131999|54810524|FG001|Overall Study|Withdrawal by Subject|1|||
28144192|NCT02263885|54810539|FG000|Overall Study|Withdrawal by Subject|7|||
28144193|NCT02263885|54810539|FG000|Overall Study|Alternative Treatment|3|||
28144194|NCT02000219|54810544|FG000|14-Week Study Period|Physician Decision|1|||
28144195|NCT02000219|54810544|FG000|14-Week Study Period|Adverse Event|1|||
28144196|NCT02000219|54810544|FG000|14-Week Study Period|Underwent transplantation|1|||
28144197|NCT02000219|54810544|FG000|Continuation Period|Withdrawal by Subject|1|||
28144198|NCT02000219|54810544|FG000|Continuation Period|Had liver transplant|2|||
28144199|NCT02000219|54810544|FG000|Continuation Period|Non-compliance with study drug|2|||
28144200|NCT03101371|54810550|FG000|Overall Study|Physician Decision|0|||
28144201|NCT03101371|54810551|FG001|Overall Study|Physician Decision|1|||
28144202|NCT03101371|54810550|FG000|Overall Study|Lost to Follow-up|1|||
28144203|NCT03101371|54810551|FG001|Overall Study|Lost to Follow-up|4|||
28144204|NCT03101371|54810550|FG000|Overall Study|Did not meet eligibility criteria|2|||
28144205|NCT03101371|54810551|FG001|Overall Study|Did not meet eligibility criteria|1|||
28144206|NCT02850276|54810557|FG000|Overall Study|screen failure|43|||
28144207|NCT02850276|54810557|FG000|Overall Study|Withdrawal by Subject|14|||
28144208|NCT02850276|54810557|FG000|Overall Study|Physician Decision|2|||
28144209|NCT02850276|54810557|FG000|Overall Study|Lost to Follow-up|2|||
28144210|NCT02783768|54810562|FG000|Overall Study|Lost to Follow-up|1|||
28144211|NCT02783768|54810563|FG001|Overall Study|Lost to Follow-up|0|||
28144212|NCT03131687|54810575|FG000|Overall Study|Adverse Event|0|||
28144213|NCT03131687|54810576|FG001|Overall Study|Adverse Event|1|||
28144214|NCT03131687|54810577|FG002|Overall Study|Adverse Event|0|||
28144215|NCT03131687|54810578|FG003|Overall Study|Adverse Event|1|||
28144216|NCT03131687|54810579|FG004|Overall Study|Adverse Event|2|||
28144217|NCT03131687|54810580|FG005|Overall Study|Adverse Event|2|||
28144218|NCT03131687|54810575|FG000|Overall Study|Death|1|||
28144219|NCT03131687|54810576|FG001|Overall Study|Death|0|||
28144220|NCT03131687|54810577|FG002|Overall Study|Death|0|||
28144221|NCT03131687|54810578|FG003|Overall Study|Death|0|||
28144222|NCT03131687|54810579|FG004|Overall Study|Death|0|||
28144223|NCT03131687|54810580|FG005|Overall Study|Death|0|||
28144224|NCT03131687|54810575|FG000|Overall Study|Withdrawal by Subject|3|||
28144225|NCT03131687|54810576|FG001|Overall Study|Withdrawal by Subject|3|||
28144226|NCT03131687|54810577|FG002|Overall Study|Withdrawal by Subject|3|||
28071554|NCT03789292|54726319|FG000|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
28071555|NCT03789292|54726320|FG001|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
28071556|NCT03789292|54726321|FG002|Treatment Period I (Week 0 to Week 26)|Protocol Violation|0|||
28071557|NCT03789292|54726319|FG000|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|9|||
28144227|NCT03131687|54810578|FG003|Overall Study|Withdrawal by Subject|1|||
28144228|NCT03131687|54810579|FG004|Overall Study|Withdrawal by Subject|2|||
28144229|NCT03131687|54810580|FG005|Overall Study|Withdrawal by Subject|1|||
28144230|NCT03131687|54810575|FG000|Overall Study|Lost to Follow-up|1|||
28144231|NCT03131687|54810576|FG001|Overall Study|Lost to Follow-up|4|||
28144232|NCT03131687|54810577|FG002|Overall Study|Lost to Follow-up|0|||
28144233|NCT03131687|54810578|FG003|Overall Study|Lost to Follow-up|1|||
28144234|NCT03131687|54810579|FG004|Overall Study|Lost to Follow-up|4|||
28144235|NCT03131687|54810580|FG005|Overall Study|Lost to Follow-up|2|||
28144236|NCT03131687|54810575|FG000|Overall Study|Participant Started New Diabetic Drug|1|||
28144237|NCT03131687|54810576|FG001|Overall Study|Participant Started New Diabetic Drug|0|||
28144238|NCT03131687|54810577|FG002|Overall Study|Participant Started New Diabetic Drug|0|||
28144239|NCT03131687|54810578|FG003|Overall Study|Participant Started New Diabetic Drug|0|||
28144240|NCT03131687|54810579|FG004|Overall Study|Participant Started New Diabetic Drug|0|||
28144241|NCT03131687|54810580|FG005|Overall Study|Participant Started New Diabetic Drug|0|||
28144242|NCT03131687|54810575|FG000|Overall Study|Principle Investigator Decision|0|||
28144243|NCT03131687|54810576|FG001|Overall Study|Principle Investigator Decision|1|||
28144244|NCT03131687|54810577|FG002|Overall Study|Principle Investigator Decision|0|||
28144245|NCT03131687|54810578|FG003|Overall Study|Principle Investigator Decision|0|||
28144246|NCT03131687|54810579|FG004|Overall Study|Principle Investigator Decision|0|||
28071558|NCT03789292|54726320|FG001|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|8|||
28071559|NCT03789292|54726321|FG002|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|0|||
28144247|NCT03131687|54810580|FG005|Overall Study|Principle Investigator Decision|0|||
28071560|NCT03789292|54726319|FG000|Treatment Period I (Week 0 to Week 26)|Significant dose delay|1|||
28071561|NCT03789292|54726320|FG001|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
28071562|NCT03789292|54726321|FG002|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
28071563|NCT03789292|54726319|FG000|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
28071564|NCT03789292|54726320|FG001|Treatment Period I (Week 0 to Week 26)|Patient decision|2|||
28071565|NCT03789292|54726321|FG002|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
28071566|NCT03789292|54726319|FG000|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
28144248|NCT03131687|54810575|FG000|Overall Study|Inadvertent Enrollment|0|||
28144249|NCT03131687|54810576|FG001|Overall Study|Inadvertent Enrollment|0|||
28144250|NCT03131687|54810577|FG002|Overall Study|Inadvertent Enrollment|0|||
28144251|NCT03131687|54810578|FG003|Overall Study|Inadvertent Enrollment|1|||
28144252|NCT03131687|54810579|FG004|Overall Study|Inadvertent Enrollment|0|||
28144253|NCT03131687|54810580|FG005|Overall Study|Inadvertent Enrollment|0|||
28144254|NCT03101293|54810609|FG000|Washout Period (at Least 7 Days)|Positive drug urine screen|1|||
28144255|NCT03101293|54810610|FG001|Washout Period (at Least 7 Days)|Positive drug urine screen|0|||
28144256|NCT02850978|54810616|FG000|Overall Study|Uncollectable CRF|27|||
28144257|NCT02850978|54810616|FG000|Overall Study|No visit since the first visit|35|||
28144258|NCT02850978|54810616|FG000|Overall Study|Adverse Event|81|||
28144259|NCT02850978|54810616|FG000|Overall Study|Lack of Efficacy|40|||
28144260|NCT02850978|54810616|FG000|Overall Study|Improvement in condition|34|||
28144261|NCT02850978|54810616|FG000|Overall Study|Lost to Follow-up|121|||
28071567|NCT03789292|54726320|FG001|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
28071568|NCT03789292|54726321|FG002|Treatment Period II (Week 26 to Week 52)|Adverse Event|6|||
27850012|NCT00545077|54348332|FG001|Overall Study|Protocol Violation|0|||
27850013|NCT00545077|54348331|FG000|Overall Study|Adverse Event|0|||
27850014|NCT00545077|54348332|FG001|Overall Study|Adverse Event|31|||
27850015|NCT00545077|54348331|FG000|Overall Study|Death|0|||
27850016|NCT00545077|54348332|FG001|Overall Study|Death|8|||
27850017|NCT00130533|54348340|FG000|Overall Study|Withdrawal by Subject|33|||
28144262|NCT02850978|54810616|FG000|Overall Study|Reason not listed|88|||
28144263|NCT03135431|54810622|FG000|Overall Study|Study Surgeon not available|2|||
28144264|NCT03135431|54810623|FG001|Overall Study|Study Surgeon not available|0|||
28144265|NCT04534517|54810645|FG000|Overall Study|Adverse Event|1|||
28144266|NCT04534517|54810645|FG000|Overall Study|Withdrawal by Subject|1|||
27850018|NCT00130533|54348341|FG001|Overall Study|Withdrawal by Subject|6|||
27850019|NCT00130533|54348340|FG000|Overall Study|Adverse Event|34|||
28144267|NCT04534517|54810645|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
27850020|NCT00130533|54348341|FG001|Overall Study|Adverse Event|1|||
27850021|NCT00130533|54348340|FG000|Overall Study|Disease relapse|9|||
27850022|NCT00130533|54348341|FG001|Overall Study|Disease relapse|13|||
27850023|NCT00130533|54348340|FG000|Overall Study|Interruption of treatment > 3 weeks|11|||
28071569|NCT03789292|54726319|FG000|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
28071570|NCT03789292|54726320|FG001|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
28071571|NCT03789292|54726321|FG002|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|1|||
28071572|NCT03789292|54726319|FG000|Treatment Period II (Week 26 to Week 52)|Physician Decision|1|||
28071573|NCT03789292|54726320|FG001|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
28071574|NCT03789292|54726321|FG002|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
28071575|NCT03789292|54726319|FG000|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|9|||
28071576|NCT03789292|54726320|FG001|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
28144268|NCT04534517|54810645|FG000|Overall Study|COVID-19 Related|1|||
28071577|NCT03789292|54726321|FG002|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
28144269|NCT02831257|54810649|FG000|Overall Study|Lack of Efficacy|3|||
28144270|NCT02831257|54810649|FG000|Overall Study|Adverse Event|2|||
28144271|NCT02831257|54810649|FG000|Overall Study|Physician Decision|1|||
28144272|NCT02831257|54810649|FG000|Overall Study|Withdrawal by Subject|6|||
28144273|NCT03100825|54810653|FG000|Overall Study|Participant/Guardian Decision|7|||
28144274|NCT03100825|54810653|FG000|Overall Study|Physician Decision|1|||
28144275|NCT02250534|54810660|FG000|Overall Study|Lost to Follow-up|18|||
28144276|NCT02250534|54810661|FG001|Overall Study|Lost to Follow-up|28|||
28144277|NCT02250534|54810662|FG002|Overall Study|Lost to Follow-up|33|||
28144278|NCT02250534|54810660|FG000|Overall Study|Personal reasons|7|||
28144279|NCT02250534|54810661|FG001|Overall Study|Personal reasons|8|||
28144280|NCT02250534|54810662|FG002|Overall Study|Personal reasons|14|||
28144281|NCT02250534|54810660|FG000|Overall Study|Adverse Event|6|||
28144282|NCT02250534|54810661|FG001|Overall Study|Adverse Event|3|||
28144283|NCT02250534|54810662|FG002|Overall Study|Adverse Event|8|||
28144284|NCT02250534|54810660|FG000|Overall Study|incarcerated|2|||
28144285|NCT02250534|54810661|FG001|Overall Study|incarcerated|1|||
28144286|NCT02250534|54810662|FG002|Overall Study|incarcerated|2|||
28144287|NCT02250534|54810660|FG000|Overall Study|Withdrawal by Subject|0|||
28144288|NCT02250534|54810661|FG001|Overall Study|Withdrawal by Subject|1|||
28144289|NCT02250534|54810662|FG002|Overall Study|Withdrawal by Subject|2|||
28144290|NCT02250534|54810660|FG000|Overall Study|Death|0|||
28144291|NCT02250534|54810661|FG001|Overall Study|Death|1|||
28144292|NCT02250534|54810662|FG002|Overall Study|Death|1|||
28144293|NCT02250534|54810660|FG000|Overall Study|Physician Decision|1|||
28144294|NCT02250534|54810661|FG001|Overall Study|Physician Decision|3|||
28144295|NCT02250534|54810662|FG002|Overall Study|Physician Decision|1|||
28144296|NCT02250534|54810660|FG000|Overall Study|Protocol Violation|1|||
28144297|NCT02250534|54810661|FG001|Overall Study|Protocol Violation|0|||
28144298|NCT02250534|54810662|FG002|Overall Study|Protocol Violation|1|||
28144299|NCT02250534|54810660|FG000|Overall Study|Reason unknown|1|||
28144300|NCT02250534|54810661|FG001|Overall Study|Reason unknown|0|||
28144301|NCT02250534|54810662|FG002|Overall Study|Reason unknown|0|||
28144302|NCT02848326|54810676|FG000|Treatment Period|Adverse Event|5|||
28144303|NCT02848326|54810677|FG001|Treatment Period|Adverse Event|4|||
28144304|NCT02848326|54810678|FG002|Treatment Period|Adverse Event|11|||
28144305|NCT02848326|54810679|FG003|Treatment Period|Adverse Event|6|||
28144306|NCT02848326|54810680|FG004|Treatment Period|Adverse Event|5|||
28144307|NCT02848326|54810681|FG005|Treatment Period|Adverse Event|7|||
28144308|NCT02848326|54810676|FG000|Treatment Period|Withdrawal of Consent|20|||
28144309|NCT02848326|54810677|FG001|Treatment Period|Withdrawal of Consent|6|||
28144310|NCT02848326|54810678|FG002|Treatment Period|Withdrawal of Consent|9|||
28144311|NCT02848326|54810679|FG003|Treatment Period|Withdrawal of Consent|6|||
28144312|NCT02848326|54810680|FG004|Treatment Period|Withdrawal of Consent|9|||
28144313|NCT02848326|54810681|FG005|Treatment Period|Withdrawal of Consent|6|||
28144314|NCT02848326|54810676|FG000|Treatment Period|Lost to Follow-up|5|||
28144315|NCT02848326|54810677|FG001|Treatment Period|Lost to Follow-up|1|||
28144316|NCT02848326|54810678|FG002|Treatment Period|Lost to Follow-up|11|||
28144317|NCT02848326|54810679|FG003|Treatment Period|Lost to Follow-up|7|||
28071578|NCT03789292|54726319|FG000|Treatment Period II (Week 26 to Week 52)|Significant dose delay|1|||
28071579|NCT03789292|54726320|FG001|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
28071580|NCT03789292|54726321|FG002|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
28071581|NCT03789292|54726319|FG000|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|2|||
28144318|NCT02848326|54810680|FG004|Treatment Period|Lost to Follow-up|2|||
28071582|NCT03789292|54726320|FG001|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|1|||
28071583|NCT03789292|54726321|FG002|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|0|||
28071584|NCT03781336|54726337|FG000|Overall Study|Withdrawal by Subject|2|||
28071585|NCT03781336|54726338|FG001|Overall Study|Withdrawal by Subject|2|||
28071586|NCT03780400|54726344|FG000|Overall Study|Lost to Follow-up|5|||
28071587|NCT03780400|54726344|FG000|Overall Study|Withdrawal by Subject|2|||
28144319|NCT02848326|54810681|FG005|Treatment Period|Lost to Follow-up|3|||
28144320|NCT02848326|54810676|FG000|Treatment Period|Pregnancy|0|||
28144321|NCT02848326|54810677|FG001|Treatment Period|Pregnancy|0|||
28144322|NCT02848326|54810678|FG002|Treatment Period|Pregnancy|1|||
28144323|NCT02848326|54810679|FG003|Treatment Period|Pregnancy|1|||
28144324|NCT02848326|54810680|FG004|Treatment Period|Pregnancy|0|||
28144325|NCT02848326|54810681|FG005|Treatment Period|Pregnancy|1|||
28144326|NCT02848326|54810676|FG000|Treatment Period|Protocol Violation|4|||
28144327|NCT02848326|54810677|FG001|Treatment Period|Protocol Violation|3|||
28144328|NCT02848326|54810678|FG002|Treatment Period|Protocol Violation|4|||
28144329|NCT02848326|54810679|FG003|Treatment Period|Protocol Violation|2|||
28144330|NCT02848326|54810680|FG004|Treatment Period|Protocol Violation|3|||
28144331|NCT02848326|54810681|FG005|Treatment Period|Protocol Violation|3|||
28144332|NCT02848326|54810676|FG000|Treatment Period|Non-compliance with Study Drug|4|||
28144333|NCT02848326|54810677|FG001|Treatment Period|Non-compliance with Study Drug|0|||
28144334|NCT02848326|54810678|FG002|Treatment Period|Non-compliance with Study Drug|0|||
28144335|NCT02848326|54810679|FG003|Treatment Period|Non-compliance with Study Drug|1|||
28144336|NCT02848326|54810680|FG004|Treatment Period|Non-compliance with Study Drug|0|||
28144337|NCT02848326|54810681|FG005|Treatment Period|Non-compliance with Study Drug|0|||
28144338|NCT02848326|54810676|FG000|Safety Follow-up Period|Withdrawal of Consent|0|||
28144339|NCT02848326|54810677|FG001|Safety Follow-up Period|Withdrawal of Consent|1|||
28144340|NCT02848326|54810678|FG002|Safety Follow-up Period|Withdrawal of Consent|1|||
28144341|NCT02848326|54810679|FG003|Safety Follow-up Period|Withdrawal of Consent|0|||
28144342|NCT02848326|54810680|FG004|Safety Follow-up Period|Withdrawal of Consent|0|||
28144343|NCT02848326|54810681|FG005|Safety Follow-up Period|Withdrawal of Consent|2|||
28144344|NCT02848326|54810676|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
28144345|NCT02848326|54810677|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
28144346|NCT02848326|54810678|FG002|Safety Follow-up Period|Lost to Follow-up|2|||
28144347|NCT02848326|54810679|FG003|Safety Follow-up Period|Lost to Follow-up|0|||
28144348|NCT02848326|54810680|FG004|Safety Follow-up Period|Lost to Follow-up|1|||
28144349|NCT02848326|54810681|FG005|Safety Follow-up Period|Lost to Follow-up|3|||
28144350|NCT03128723|54810695|FG000|Overall Study|Withdrawal by Subject|2|||
28144351|NCT03128411|54810699|FG000|Treatment Phase|Adverse Event|21|||
28144352|NCT03128411|54810699|FG000|Treatment Phase|Physician Decision|1|||
28144353|NCT03128411|54810699|FG000|Treatment Phase|Other|2|||
28144354|NCT03128411|54810699|FG000|Long Term Follow-up Phase|Death|2|||
28144355|NCT02847858|54810705|FG000|Overall Study|Lost to Follow-up|401|||
28144356|NCT02847858|54810706|FG001|Overall Study|Lost to Follow-up|269|||
28144357|NCT03124199|54810717|FG000|Overall Study|Lost to Follow-up|4|||
28144358|NCT04465916|54810723|FG000|Overall Study|Withdrawal by Subject|0|||
28071588|NCT03780244|54726350|FG000|Overall Study|Lost to Follow-up|1|||
28071589|NCT03780244|54726351|FG001|Overall Study|Lost to Follow-up|0|||
28071590|NCT03785548|54726359|FG000|Overall Study|age > 80|1|||
28071591|NCT03785548|54726360|FG001|Overall Study|age > 80|0|||
28071592|NCT03785548|54726359|FG000|Overall Study|no Postop queries|1|||
28144359|NCT04465916|54810724|FG001|Overall Study|Withdrawal by Subject|1|||
28144360|NCT05090852|54810730|FG000|Overall Study|Physician Decision|5|||
28144361|NCT00075816|54810745|FG000|Overall Study|Did not undergo transplantation|14|||
28144362|NCT00075816|54810746|FG001|Overall Study|Did not undergo transplantation|11|||
28144363|NCT00109772|54810760|FG000|Double-blind Treatment|Adverse Event|14|||
28144364|NCT00109772|54810761|FG001|Double-blind Treatment|Adverse Event|5|||
28144365|NCT00109772|54810760|FG000|Double-blind Treatment|Lack of Efficacy|1|||
28144366|NCT00109772|54810761|FG001|Double-blind Treatment|Lack of Efficacy|0|||
28144367|NCT00109772|54810760|FG000|Double-blind Treatment|Withdrawal by Subject|2|||
28144368|NCT00109772|54810761|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
28144369|NCT00109772|54810760|FG000|Double-blind Treatment|Lost to Follow-up|2|||
28144370|NCT00109772|54810761|FG001|Double-blind Treatment|Lost to Follow-up|3|||
28071593|NCT03785548|54726360|FG001|Overall Study|no Postop queries|0|||
28071594|NCT00141297|54726368|FG000|Overall Study|Adverse Event|0|||
28071595|NCT00141297|54726369|FG001|Overall Study|Adverse Event|0|||
28071596|NCT00141297|54726370|FG002|Overall Study|Adverse Event|1|||
28071597|NCT00141297|54726371|FG003|Overall Study|Adverse Event|0|||
28071598|NCT00141297|54726372|FG004|Overall Study|Adverse Event|1|||
28144371|NCT00109772|54810760|FG000|Double-blind Treatment|Protocol Violation|0|||
28144372|NCT00109772|54810761|FG001|Double-blind Treatment|Protocol Violation|1|||
28144373|NCT00109772|54810760|FG000|Double-blind Treatment|Other|0|||
28071599|NCT00141297|54726373|FG005|Overall Study|Adverse Event|1|||
28144374|NCT00109772|54810761|FG001|Double-blind Treatment|Other|4|||
28144375|NCT00109772|54810760|FG000|Double-blind Treatment|Withdrew prior to treatment|3|||
28144376|NCT00109772|54810761|FG001|Double-blind Treatment|Withdrew prior to treatment|1|||
28144377|NCT00109772|54810760|FG000|Open-label Extension|Adverse Event|10|||
28144378|NCT00109772|54810761|FG001|Open-label Extension|Adverse Event|19|||
28144379|NCT00109772|54810760|FG000|Open-label Extension|Lack of Efficacy|19|||
28144380|NCT00109772|54810761|FG001|Open-label Extension|Lack of Efficacy|11|||
28144381|NCT00109772|54810760|FG000|Open-label Extension|Withdrawal by Subject|9|||
28144382|NCT00109772|54810761|FG001|Open-label Extension|Withdrawal by Subject|6|||
28144383|NCT00109772|54810760|FG000|Open-label Extension|Lost to Follow-up|1|||
28144384|NCT00109772|54810761|FG001|Open-label Extension|Lost to Follow-up|0|||
28144385|NCT00109772|54810760|FG000|Open-label Extension|Death|0|||
28144386|NCT00109772|54810761|FG001|Open-label Extension|Death|1|||
28144387|NCT00109772|54810760|FG000|Open-label Extension|Protocol Violation|2|||
28144388|NCT00109772|54810761|FG001|Open-label Extension|Protocol Violation|2|||
28144389|NCT00109772|54810760|FG000|Open-label Extension|Other|4|||
28144390|NCT00109772|54810761|FG001|Open-label Extension|Other|10|||
27822543|NCT01868893|54285132|FG000|Overall Study|Adverse Event|2|||
27941328|NCT01014975|54597745|FG002|Overall Study|Lost to Follow-up|1|||
28071600|NCT00141297|54726374|FG006|Overall Study|Adverse Event|0|||
28071601|NCT00141297|54726375|FG007|Overall Study|Adverse Event|1|||
28071602|NCT00141297|54726376|FG008|Overall Study|Adverse Event|1|||
28071603|NCT00141297|54726377|FG009|Overall Study|Adverse Event|0|||
28071604|NCT00141297|54726368|FG000|Overall Study|Death|1|||
28071605|NCT00141297|54726369|FG001|Overall Study|Death|0|||
28071606|NCT00141297|54726370|FG002|Overall Study|Death|0|||
28071607|NCT00141297|54726371|FG003|Overall Study|Death|0|||
28071608|NCT00141297|54726372|FG004|Overall Study|Death|0|||
28071609|NCT00141297|54726373|FG005|Overall Study|Death|0|||
28071610|NCT00141297|54726374|FG006|Overall Study|Death|0|||
28071611|NCT00141297|54726375|FG007|Overall Study|Death|0|||
28071612|NCT00141297|54726376|FG008|Overall Study|Death|1|||
28071613|NCT00141297|54726377|FG009|Overall Study|Death|0|||
28071614|NCT00141297|54726368|FG000|Overall Study|Withdrawal by Subject|0|||
28071615|NCT00141297|54726369|FG001|Overall Study|Withdrawal by Subject|0|||
28071616|NCT00141297|54726370|FG002|Overall Study|Withdrawal by Subject|0|||
28071617|NCT00141297|54726371|FG003|Overall Study|Withdrawal by Subject|0|||
28144391|NCT02783066|54810767|FG000|Overall Study|Withdrawal by Subject|13|||
28144392|NCT01371305|54810778|FG000|Overall Study|Adverse Event|0|||
28144393|NCT01371305|54810779|FG001|Overall Study|Adverse Event|0|||
28144394|NCT01371305|54810780|FG002|Overall Study|Adverse Event|0|||
28144395|NCT01371305|54810781|FG003|Overall Study|Adverse Event|2|||
28144396|NCT01371305|54810782|FG004|Overall Study|Adverse Event|1|||
28144397|NCT01371305|54810783|FG005|Overall Study|Adverse Event|0|||
28144398|NCT01371305|54810778|FG000|Overall Study|Study terminated by sponsor|0|||
28144399|NCT01371305|54810779|FG001|Overall Study|Study terminated by sponsor|0|||
28144400|NCT01371305|54810780|FG002|Overall Study|Study terminated by sponsor|0|||
28144401|NCT01371305|54810781|FG003|Overall Study|Study terminated by sponsor|0|||
28144402|NCT01371305|54810782|FG004|Overall Study|Study terminated by sponsor|3|||
28144403|NCT01371305|54810783|FG005|Overall Study|Study terminated by sponsor|1|||
28144404|NCT01371305|54810778|FG000|Overall Study|Subject request|0|||
28144405|NCT01371305|54810779|FG001|Overall Study|Subject request|0|||
28144406|NCT01371305|54810780|FG002|Overall Study|Subject request|0|||
28144407|NCT01371305|54810781|FG003|Overall Study|Subject request|0|||
28144408|NCT01371305|54810782|FG004|Overall Study|Subject request|0|||
28144409|NCT01371305|54810783|FG005|Overall Study|Subject request|1|||
28144410|NCT00109928|54810798|FG000|Overall Study|Adverse Event|2|||
28144411|NCT00109928|54810798|FG000|Overall Study|Progression|6|||
28144412|NCT00109928|54810798|FG000|Overall Study|Death|2|||
28144413|NCT00109928|54810798|FG000|Overall Study|not protocol specified|2|||
28071618|NCT00141297|54726372|FG004|Overall Study|Withdrawal by Subject|0|||
28071619|NCT00141297|54726373|FG005|Overall Study|Withdrawal by Subject|0|||
28071620|NCT00141297|54726374|FG006|Overall Study|Withdrawal by Subject|0|||
28071621|NCT00141297|54726375|FG007|Overall Study|Withdrawal by Subject|0|||
28144414|NCT00109928|54810798|FG000|Overall Study|not eligible|1|||
28144415|NCT00109850|54810803|FG000|Overall Study|Adverse Event|1|||
28144416|NCT00109850|54810803|FG000|Overall Study|Death|2|||
28144417|NCT00109850|54810803|FG000|Overall Study|Ineligible|1|||
28144418|NCT01342926|54810811|FG000|Overall Study|Adverse Event|5|||
28144419|NCT01342926|54810812|FG001|Overall Study|Adverse Event|8|||
28144420|NCT01342926|54810813|FG002|Overall Study|Adverse Event|10|||
28071622|NCT00141297|54726376|FG008|Overall Study|Withdrawal by Subject|1|||
28071623|NCT00141297|54726377|FG009|Overall Study|Withdrawal by Subject|0|||
28071624|NCT00141297|54726368|FG000|Overall Study|Other|0|||
28071625|NCT00141297|54726369|FG001|Overall Study|Other|0|||
28071626|NCT00141297|54726370|FG002|Overall Study|Other|0|||
28071627|NCT00141297|54726371|FG003|Overall Study|Other|1|||
28071628|NCT00141297|54726372|FG004|Overall Study|Other|5|||
28071629|NCT00141297|54726373|FG005|Overall Study|Other|0|||
28071630|NCT00141297|54726374|FG006|Overall Study|Other|0|||
28071631|NCT00141297|54726375|FG007|Overall Study|Other|0|||
28071632|NCT00141297|54726376|FG008|Overall Study|Other|2|||
28071633|NCT00141297|54726377|FG009|Overall Study|Other|0|||
28071634|NCT00141297|54726368|FG000|Overall Study|Progressive Disease|2|||
28071635|NCT00141297|54726369|FG001|Overall Study|Progressive Disease|3|||
28071636|NCT00141297|54726370|FG002|Overall Study|Progressive Disease|6|||
28071637|NCT00141297|54726371|FG003|Overall Study|Progressive Disease|2|||
28071638|NCT00141297|54726372|FG004|Overall Study|Progressive Disease|15|||
28071639|NCT00141297|54726373|FG005|Overall Study|Progressive Disease|2|||
28071640|NCT00141297|54726374|FG006|Overall Study|Progressive Disease|3|||
28071641|NCT00141297|54726375|FG007|Overall Study|Progressive Disease|3|||
28071642|NCT00141297|54726376|FG008|Overall Study|Progressive Disease|15|||
28071643|NCT00141297|54726377|FG009|Overall Study|Progressive Disease|6|||
28071644|NCT00141297|54726368|FG000|Overall Study|Transitioned|0|||
28071645|NCT00141297|54726369|FG001|Overall Study|Transitioned|0|||
28071646|NCT00141297|54726370|FG002|Overall Study|Transitioned|0|||
28071647|NCT00141297|54726371|FG003|Overall Study|Transitioned|0|||
28144421|NCT01342926|54810814|FG003|Overall Study|Adverse Event|7|||
28144422|NCT01342926|54810811|FG000|Overall Study|Lost to Follow-up|0|||
28144423|NCT01342926|54810812|FG001|Overall Study|Lost to Follow-up|1|||
28144424|NCT01342926|54810813|FG002|Overall Study|Lost to Follow-up|1|||
28144425|NCT01342926|54810814|FG003|Overall Study|Lost to Follow-up|0|||
28144426|NCT01342926|54810811|FG000|Overall Study|Investigator Discretion|2|||
28144427|NCT01342926|54810812|FG001|Overall Study|Investigator Discretion|2|||
28144428|NCT01342926|54810813|FG002|Overall Study|Investigator Discretion|0|||
28144429|NCT01342926|54810814|FG003|Overall Study|Investigator Discretion|0|||
28144430|NCT01342926|54810811|FG000|Overall Study|Withdrawal by Subject|2|||
28144431|NCT01342926|54810812|FG001|Overall Study|Withdrawal by Subject|4|||
28144432|NCT01342926|54810813|FG002|Overall Study|Withdrawal by Subject|3|||
28144433|NCT01342926|54810814|FG003|Overall Study|Withdrawal by Subject|5|||
28071648|NCT00141297|54726372|FG004|Overall Study|Transitioned|1|||
28071649|NCT00141297|54726373|FG005|Overall Study|Transitioned|0|||
28071650|NCT00141297|54726374|FG006|Overall Study|Transitioned|0|||
28071651|NCT00141297|54726375|FG007|Overall Study|Transitioned|0|||
28071652|NCT00141297|54726376|FG008|Overall Study|Transitioned|0|||
28071653|NCT00141297|54726377|FG009|Overall Study|Transitioned|0|||
28071654|NCT00141219|54726412|FG000|Overall Study|Protocol violations|5|||
28071655|NCT00141219|54726413|FG001|Overall Study|Protocol violations|4|||
28071656|NCT00141219|54726412|FG000|Overall Study|Adverse Event|8|||
28071657|NCT00141219|54726413|FG001|Overall Study|Adverse Event|6|||
28071658|NCT00141219|54726412|FG000|Overall Study|Lack of Efficacy|5|||
28071659|NCT00141219|54726413|FG001|Overall Study|Lack of Efficacy|4|||
28071660|NCT00141219|54726412|FG000|Overall Study|Withdrawal by Subject|6|||
28071661|NCT00141219|54726413|FG001|Overall Study|Withdrawal by Subject|2|||
28071662|NCT00162266|54726422|FG000|Double-Blind Period|Adverse Event|5|||
28071663|NCT00162266|54726423|FG001|Double-Blind Period|Adverse Event|9|||
28071664|NCT00162266|54726424|FG002|Double-Blind Period|Adverse Event|11|||
28071665|NCT00162266|54726425|FG003|Double-Blind Period|Adverse Event|0|||
28071666|NCT00162266|54726422|FG000|Double-Blind Period|Death|0|||
28071667|NCT00162266|54726423|FG001|Double-Blind Period|Death|1|||
28071668|NCT00162266|54726424|FG002|Double-Blind Period|Death|0|||
28071669|NCT00162266|54726425|FG003|Double-Blind Period|Death|0|||
28071670|NCT00162266|54726422|FG000|Double-Blind Period|Lost to Follow-up|1|||
28071671|NCT00162266|54726423|FG001|Double-Blind Period|Lost to Follow-up|2|||
28071672|NCT00162266|54726424|FG002|Double-Blind Period|Lost to Follow-up|0|||
28071673|NCT00162266|54726425|FG003|Double-Blind Period|Lost to Follow-up|0|||
28071674|NCT00162266|54726422|FG000|Double-Blind Period|Other Reason|1|||
28071675|NCT00162266|54726423|FG001|Double-Blind Period|Other Reason|0|||
28071676|NCT00162266|54726424|FG002|Double-Blind Period|Other Reason|1|||
28071677|NCT00162266|54726425|FG003|Double-Blind Period|Other Reason|0|||
28071678|NCT00162266|54726422|FG000|Double-Blind Period|Lack of Efficacy|13|||
28071679|NCT00162266|54726423|FG001|Double-Blind Period|Lack of Efficacy|17|||
28071680|NCT00162266|54726424|FG002|Double-Blind Period|Lack of Efficacy|30|||
28071681|NCT00162266|54726425|FG003|Double-Blind Period|Lack of Efficacy|0|||
28071682|NCT00162266|54726422|FG000|Double-Blind Period|Withdrawal by Subject|5|||
28071683|NCT00162266|54726423|FG001|Double-Blind Period|Withdrawal by Subject|2|||
28071684|NCT00162266|54726424|FG002|Double-Blind Period|Withdrawal by Subject|6|||
28071685|NCT00162266|54726425|FG003|Double-Blind Period|Withdrawal by Subject|0|||
28071686|NCT00162266|54726422|FG000|Open-Label Period|Death|0|||
28071687|NCT00162266|54726423|FG001|Open-Label Period|Death|0|||
28071688|NCT00162266|54726424|FG002|Open-Label Period|Death|0|||
28071689|NCT00162266|54726425|FG003|Open-Label Period|Death|7|||
28071690|NCT00162266|54726422|FG000|Open-Label Period|Adverse Event|0|||
28071691|NCT00162266|54726423|FG001|Open-Label Period|Adverse Event|0|||
28071692|NCT00162266|54726424|FG002|Open-Label Period|Adverse Event|0|||
28071693|NCT00162266|54726425|FG003|Open-Label Period|Adverse Event|46|||
28071694|NCT00162266|54726422|FG000|Open-Label Period|Lack of Efficacy|0|||
28144434|NCT01810016|54810827|FG000|Overall Study|Progressive disease|1|||
28144435|NCT01810016|54810828|FG001|Overall Study|Progressive disease|1|||
28071695|NCT00162266|54726423|FG001|Open-Label Period|Lack of Efficacy|0|||
28071696|NCT00162266|54726424|FG002|Open-Label Period|Lack of Efficacy|0|||
28071697|NCT00162266|54726425|FG003|Open-Label Period|Lack of Efficacy|26|||
28071698|NCT00162266|54726422|FG000|Open-Label Period|Lost to Follow-up|0|||
28071699|NCT00162266|54726423|FG001|Open-Label Period|Lost to Follow-up|0|||
28071700|NCT00162266|54726424|FG002|Open-Label Period|Lost to Follow-up|0|||
28071701|NCT00162266|54726425|FG003|Open-Label Period|Lost to Follow-up|3|||
28071702|NCT00162266|54726422|FG000|Open-Label Period|Withdrawal by Subject|0|||
28071703|NCT00162266|54726423|FG001|Open-Label Period|Withdrawal by Subject|0|||
28144436|NCT01810016|54810829|FG002|Overall Study|Progressive disease|0|||
28144437|NCT01810016|54810827|FG000|Overall Study|Death|0|||
27850024|NCT00130533|54348341|FG001|Overall Study|Interruption of treatment > 3 weeks|0|||
28071704|NCT00162266|54726424|FG002|Open-Label Period|Withdrawal by Subject|0|||
28071705|NCT00162266|54726425|FG003|Open-Label Period|Withdrawal by Subject|31|||
28071706|NCT00162266|54726422|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
28071707|NCT00162266|54726423|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
28071708|NCT00162266|54726424|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
28071709|NCT00162266|54726425|FG003|Open-Label Period|Administrative Reason By Sponsor|9|||
28071710|NCT00162266|54726422|FG000|Open-Label Period|Other Reasons|0|||
28071711|NCT00162266|54726423|FG001|Open-Label Period|Other Reasons|0|||
28071712|NCT00162266|54726424|FG002|Open-Label Period|Other Reasons|0|||
28071713|NCT00162266|54726425|FG003|Open-Label Period|Other Reasons|15|||
28071714|NCT00225212|54726477|FG000|Overall Study|Disease progression|2|||
28071715|NCT00225212|54726477|FG000|Overall Study|Death|1|||
28071716|NCT00225212|54726477|FG000|Overall Study|Adverse Event|2|||
28071717|NCT00225212|54726477|FG000|Overall Study|Intercurrent illness|1|||
28071718|NCT00162032|54726483|FG000|Overall Study|Lost to Follow-up|4|||
28071719|NCT00162032|54726484|FG001|Overall Study|Lost to Follow-up|2|||
28071720|NCT00162032|54726483|FG000|Overall Study|Reason not specified|1|||
28071721|NCT00162032|54726484|FG001|Overall Study|Reason not specified|0|||
28071722|NCT00258674|54726498|FG000|Overall Study|Death|32|||
28071723|NCT00258674|54726499|FG001|Overall Study|Death|53|||
28071724|NCT00258674|54726500|FG002|Overall Study|Death|34|||
28071725|NCT00258440|54726511|FG000|Overall Study|Withdrawal by Subject|0|||
28071726|NCT00258440|54726512|FG001|Overall Study|Withdrawal by Subject|0|||
28071727|NCT00258440|54726513|FG002|Overall Study|Withdrawal by Subject|1|||
28071728|NCT00224120|54726523|FG000|Overall Study|Adverse Event|10|||
28071729|NCT00224120|54726524|FG001|Overall Study|Adverse Event|4|||
28071730|NCT00224120|54726523|FG000|Overall Study|Protocol Violation|1|||
28071731|NCT00224120|54726524|FG001|Overall Study|Protocol Violation|0|||
28071732|NCT00224120|54726523|FG000|Overall Study|Withdrawal by Subject|5|||
27822544|NCT01868893|54285132|FG000|Overall Study|Commercial availability of study drug|17|||
27822545|NCT01868893|54285132|FG000|Overall Study|Neutropenia|1|||
28071733|NCT00224120|54726524|FG001|Overall Study|Withdrawal by Subject|10|||
28071734|NCT00224120|54726523|FG000|Overall Study|Lack of Efficacy|0|||
28071735|NCT00224120|54726524|FG001|Overall Study|Lack of Efficacy|2|||
28071736|NCT00224120|54726523|FG000|Overall Study|Lost to Follow-up|2|||
28071737|NCT00224120|54726524|FG001|Overall Study|Lost to Follow-up|3|||
28144438|NCT01810016|54810828|FG001|Overall Study|Death|0|||
28144439|NCT01810016|54810829|FG002|Overall Study|Death|1|||
28144440|NCT02843178|54810841|FG000|Overall Study|Lost to Follow-up|8|||
28144441|NCT02843178|54810842|FG001|Overall Study|Lost to Follow-up|8|||
28144442|NCT02843178|54810843|FG002|Overall Study|Lost to Follow-up|6|||
28144443|NCT02843178|54810844|FG003|Overall Study|Lost to Follow-up|3|||
28144444|NCT02843178|54810841|FG000|Overall Study|Withdrawal by Subject|0|||
28144445|NCT02843178|54810842|FG001|Overall Study|Withdrawal by Subject|0|||
28144446|NCT02843178|54810843|FG002|Overall Study|Withdrawal by Subject|1|||
28144447|NCT02843178|54810844|FG003|Overall Study|Withdrawal by Subject|1|||
28144448|NCT01722266|54810858|FG000|Overall Study|Withdrawal by Subject|1|||
28144449|NCT01722266|54810859|FG001|Overall Study|Withdrawal by Subject|2|||
28144450|NCT01722266|54810860|FG002|Overall Study|Withdrawal by Subject|0|||
28144451|NCT01722266|54810861|FG003|Overall Study|Withdrawal by Subject|0|||
28144452|NCT01722266|54810858|FG000|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
28144453|NCT01722266|54810859|FG001|Overall Study|Tolerated only 0.6 mg liraglutide|1|||
28144454|NCT01722266|54810860|FG002|Overall Study|Tolerated only 0.6 mg liraglutide|3|||
28144455|NCT01722266|54810861|FG003|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
28144456|NCT01722266|54810858|FG000|Overall Study|Dropped out due to Nausea|0|||
28144457|NCT01722266|54810859|FG001|Overall Study|Dropped out due to Nausea|0|||
28144458|NCT01722266|54810860|FG002|Overall Study|Dropped out due to Nausea|2|||
28144459|NCT01722266|54810861|FG003|Overall Study|Dropped out due to Nausea|0|||
28144460|NCT03123185|54810885|FG000|Overall Study|Withdrawal by Subject|0|||
28144461|NCT03123185|54810886|FG001|Overall Study|Withdrawal by Subject|0|||
27822546|NCT01868503|54285138|FG000|Overall Study|Withdrawal by Subject|1|||
28144462|NCT03123185|54810887|FG002|Overall Study|Withdrawal by Subject|0|||
28144463|NCT03123185|54810888|FG003|Overall Study|Withdrawal by Subject|0|||
28144464|NCT03123185|54810889|FG004|Overall Study|Withdrawal by Subject|0|||
27822547|NCT01868503|54285138|FG000|Overall Study|Protocol Violation|1|||
28071738|NCT00224120|54726523|FG000|Overall Study|Other|4|||
28071739|NCT00224120|54726524|FG001|Overall Study|Other|5|||
28071740|NCT00257660|54726532|FG000|Overall Study|Lack of Efficacy|5|||
28071741|NCT00257660|54726533|FG001|Overall Study|Lack of Efficacy|23|||
28071742|NCT00257660|54726532|FG000|Overall Study|Withdrawal by Subject|2|||
28071743|NCT00257660|54726533|FG001|Overall Study|Withdrawal by Subject|0|||
28144465|NCT03123185|54810890|FG005|Overall Study|Withdrawal by Subject|0|||
28144466|NCT03123185|54810891|FG006|Overall Study|Withdrawal by Subject|0|||
28071744|NCT00257660|54726532|FG000|Overall Study|Lost to Follow-up|1|||
28144467|NCT03123185|54810892|FG007|Overall Study|Withdrawal by Subject|0|||
28144468|NCT03123185|54810893|FG008|Overall Study|Withdrawal by Subject|0|||
27822548|NCT01868035|54285148|FG000|Overall Study|Lost to Follow-up|3|||
28071745|NCT00257660|54726533|FG001|Overall Study|Lost to Follow-up|0|||
28144469|NCT03123185|54810894|FG009|Overall Study|Withdrawal by Subject|0|||
28144470|NCT03123185|54810895|FG010|Overall Study|Withdrawal by Subject|0|||
28144471|NCT03123185|54810896|FG011|Overall Study|Withdrawal by Subject|0|||
28144472|NCT03123185|54810897|FG012|Overall Study|Withdrawal by Subject|1|||
28144473|NCT03123185|54810898|FG013|Overall Study|Withdrawal by Subject|0|||
28144474|NCT02842866|54810957|FG000|Overall Study|Serious Adverse Event|0|||
28144475|NCT02842866|54810958|FG001|Overall Study|Serious Adverse Event|1|||
28144476|NCT02842866|54810957|FG000|Overall Study|Protocol Violation|4|||
27941329|NCT01221623|54597755|FG000|Overall Study|Withdrawal by Subject|19|||
27941330|NCT01221623|54597756|FG001|Overall Study|Withdrawal by Subject|8|||
27941331|NCT01221623|54597755|FG000|Overall Study|Lost to Follow-up|7|||
27941332|NCT01221623|54597756|FG001|Overall Study|Lost to Follow-up|1|||
28071746|NCT00257660|54726532|FG000|Overall Study|PI & Subject Schedule Conflicts|1|||
28071747|NCT00257660|54726533|FG001|Overall Study|PI & Subject Schedule Conflicts|0|||
28071748|NCT00257660|54726532|FG000|Overall Study|No longer wanted to do blood draws|1|||
28071749|NCT00257660|54726533|FG001|Overall Study|No longer wanted to do blood draws|0|||
28071750|NCT00224042|54726541|FG000|Overall Study|Adverse Event|2|||
28071751|NCT00224042|54726542|FG001|Overall Study|Adverse Event|1|||
28071752|NCT00224042|54726541|FG000|Overall Study|Protocol Violation|0|||
28071753|NCT00224042|54726542|FG001|Overall Study|Protocol Violation|1|||
28071754|NCT00224042|54726541|FG000|Overall Study|Physician Decision|0|||
28071755|NCT00224042|54726542|FG001|Overall Study|Physician Decision|1|||
28071756|NCT00224042|54726541|FG000|Overall Study|Did not meet lab incusion criteria|2|||
28071757|NCT00224042|54726542|FG001|Overall Study|Did not meet lab incusion criteria|3|||
28071758|NCT00224042|54726541|FG000|Overall Study|Other|2|||
28071759|NCT00224042|54726542|FG001|Overall Study|Other|0|||
28071760|NCT00160706|54726548|FG000|Overall Study|Adverse Event|53|||
28071761|NCT00160706|54726548|FG000|Overall Study|Adverse Event and Other Reason|105|||
28071762|NCT00160706|54726548|FG000|Overall Study|Protocol Violation|3|||
28071763|NCT00160706|54726548|FG000|Overall Study|Withdrawal by Subject|41|||
28071764|NCT00160706|54726548|FG000|Overall Study|Withdrawal by Subject and Other|12|||
28071765|NCT00160706|54726548|FG000|Overall Study|Physician Decision|10|||
28071766|NCT00160706|54726548|FG000|Overall Study|Physician Decision and Other|3|||
28071767|NCT00160706|54726548|FG000|Overall Study|Lost to Follow-up|4|||
28071768|NCT00160706|54726548|FG000|Overall Study|Lost to Follow-up and Other|1|||
28071769|NCT00160706|54726548|FG000|Overall Study|Lack of Efficacy|42|||
28071770|NCT00160706|54726548|FG000|Overall Study|Lack of Efficacy and Other|1|||
28071771|NCT00160706|54726548|FG000|Overall Study|Other Reason|11|||
28071772|NCT00257192|54726554|FG000|Overall Study|Adverse Event|21|||
28071773|NCT00257192|54726555|FG001|Overall Study|Adverse Event|10|||
28071774|NCT00257192|54726554|FG000|Overall Study|Laboratory abnormality|1|||
28071775|NCT00257192|54726555|FG001|Overall Study|Laboratory abnormality|1|||
28071776|NCT00257192|54726554|FG000|Overall Study|Lost to Follow-up|3|||
28071777|NCT00257192|54726555|FG001|Overall Study|Lost to Follow-up|3|||
28071778|NCT00257192|54726554|FG000|Overall Study|Insufficient clinical response|18|||
28071779|NCT00257192|54726555|FG001|Overall Study|Insufficient clinical response|18|||
28071780|NCT00257192|54726554|FG000|Overall Study|Withdrawal by Subject|14|||
28071781|NCT00257192|54726555|FG001|Overall Study|Withdrawal by Subject|2|||
28071782|NCT00257192|54726554|FG000|Overall Study|Randomized but not treated|0|||
28071783|NCT00257192|54726555|FG001|Overall Study|Randomized but not treated|1|||
28071784|NCT00257192|54726554|FG000|Overall Study|Study terminated by sponsor|1|||
28071785|NCT00257192|54726555|FG001|Overall Study|Study terminated by sponsor|0|||
28071786|NCT00257192|54726554|FG000|Overall Study|Miscellaneous|0|||
28071787|NCT00257192|54726555|FG001|Overall Study|Miscellaneous|4|||
28071788|NCT00256724|54726563|FG000|Overall Study|Physician Decision|2|||
28071789|NCT00256724|54726564|FG001|Overall Study|Physician Decision|5|||
28071790|NCT00256724|54726563|FG000|Overall Study|Protocol Violation|3|||
27941333|NCT01221623|54597755|FG000|Overall Study|Adverse Event|6|||
27941334|NCT01221623|54597756|FG001|Overall Study|Adverse Event|3|||
27941335|NCT01221623|54597755|FG000|Overall Study|Death|1|||
27941336|NCT01221623|54597756|FG001|Overall Study|Death|0|||
27941337|NCT01221623|54597755|FG000|Overall Study|Other|5|||
27941338|NCT01221623|54597756|FG001|Overall Study|Other|2|||
27941339|NCT01014585|54597766|FG000|Overall Study|Adverse Event|0|||
27941340|NCT01014585|54597767|FG001|Overall Study|Adverse Event|2|||
27941341|NCT01014585|54597768|FG002|Overall Study|Adverse Event|0|||
27941342|NCT01014585|54597769|FG003|Overall Study|Adverse Event|3|||
28071791|NCT00256724|54726564|FG001|Overall Study|Protocol Violation|3|||
28071792|NCT00157820|54726573|FG000|Randomized|Physician Decision|4|||
28071793|NCT00157820|54726574|FG001|Randomized|Physician Decision|2|||
28071794|NCT00157820|54726575|FG002|Randomized|Physician Decision|3|||
27941343|NCT01014585|54597766|FG000|Overall Study|Withdrawal by Subject|2|||
27941344|NCT01014585|54597767|FG001|Overall Study|Withdrawal by Subject|0|||
27941345|NCT01014585|54597768|FG002|Overall Study|Withdrawal by Subject|1|||
28071795|NCT00157820|54726573|FG000|Randomized|Withdrawal by Subject|1|||
28071796|NCT00157820|54726574|FG001|Randomized|Withdrawal by Subject|2|||
28144477|NCT02842866|54810958|FG001|Overall Study|Protocol Violation|2|||
27941346|NCT01014585|54597769|FG003|Overall Study|Withdrawal by Subject|3|||
27941347|NCT01014585|54597766|FG000|Overall Study|Lost to Follow-up|0|||
27941348|NCT01014585|54597767|FG001|Overall Study|Lost to Follow-up|0|||
27941349|NCT01014585|54597768|FG002|Overall Study|Lost to Follow-up|0|||
27941350|NCT01014585|54597769|FG003|Overall Study|Lost to Follow-up|2|||
27941351|NCT01014585|54597766|FG000|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18|||
27941352|NCT01014585|54597767|FG001|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23|||
27941353|NCT01014585|54597768|FG002|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
27941354|NCT01014585|54597769|FG003|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
27941355|NCT01221233|54597781|FG000|Overall Study|Withdrawal by Subject|3|||
27941356|NCT01221233|54597782|FG001|Overall Study|Withdrawal by Subject|1|||
27941357|NCT01220609|54597788|FG000|Overall Study|Ineligible-Wrong primary cancer site|1|||
27941358|NCT01220609|54597788|FG000|Overall Study|Ineligible- Wrong cell type|1|||
27941359|NCT01220609|54597788|FG000|Overall Study|Ineligible-Never treated|1|||
27941360|NCT01220297|54597800|FG000|Overall Study|Death|2|||
27822549|NCT01868035|54285148|FG000|Overall Study|Withdrawal by Subject|1|||
27822550|NCT01868035|54285148|FG000|Overall Study|Progressive Disease|2|||
27941361|NCT01220297|54597800|FG000|Overall Study|Lost to Follow-up|1|||
27941362|NCT01219985|54597806|FG000|Overall Study|Physician Decision|20|||
27941363|NCT01218659|54597814|FG000|18-Month Randomized Period|Withdrawal by Subject|2|||
27941364|NCT01218659|54597815|FG001|18-Month Randomized Period|Withdrawal by Subject|3|||
27941365|NCT01218659|54597816|FG002|18-Month Randomized Period|Withdrawal by Subject|0|||
27941366|NCT01218659|54597814|FG000|18-Month Randomized Period|Did not receive study drug|0|||
27941367|NCT01218659|54597815|FG001|18-Month Randomized Period|Did not receive study drug|3|||
27941368|NCT01218659|54597816|FG002|18-Month Randomized Period|Did not receive study drug|0|||
27941369|NCT01218659|54597814|FG000|12-Month OLE|Withdrawal by Subject|0|||
27941370|NCT01218659|54597815|FG001|12-Month OLE|Withdrawal by Subject|0|||
28144478|NCT02842866|54810957|FG000|Overall Study|Lost to Follow-up|2|||
28144479|NCT02842866|54810958|FG001|Overall Study|Lost to Follow-up|0|||
28144480|NCT02842866|54810957|FG000|Overall Study|Withdrawal by Subject|1|||
28144481|NCT02842866|54810958|FG001|Overall Study|Withdrawal by Subject|0|||
28144482|NCT01316913|54810968|FG000|Overall Study|Adverse Event|17|||
28144483|NCT01316913|54810969|FG001|Overall Study|Adverse Event|20|||
28144484|NCT01316913|54810970|FG002|Overall Study|Adverse Event|15|||
28144485|NCT01316913|54810971|FG003|Overall Study|Adverse Event|11|||
28144486|NCT01316913|54810968|FG000|Overall Study|Lack of Efficacy|22|||
28144487|NCT01316913|54810969|FG001|Overall Study|Lack of Efficacy|12|||
28144488|NCT01316913|54810970|FG002|Overall Study|Lack of Efficacy|9|||
28144489|NCT01316913|54810971|FG003|Overall Study|Lack of Efficacy|13|||
28144490|NCT01316913|54810968|FG000|Overall Study|Protocol Violation|1|||
28144491|NCT01316913|54810969|FG001|Overall Study|Protocol Violation|4|||
27822551|NCT01868035|54285148|FG000|Overall Study|Non-compliance|1|||
27822552|NCT01609933|54285152|FG000|Overall Study|Adverse Event|1|||
27822553|NCT01609933|54285152|FG000|Overall Study|Withdrawal by Subject|3|||
27822554|NCT01843777|54285160|FG000|Overall Study|Withdrawal by Subject|1|||
27822555|NCT01843777|54285161|FG001|Overall Study|Withdrawal by Subject|0|||
27822556|NCT01842607|54285167|FG000|Overall Study|Adverse Event|11|||
27822557|NCT01842607|54285167|FG000|Overall Study|Lack of Efficacy|19|||
27822558|NCT01842607|54285167|FG000|Overall Study|Protocol Violation|8|||
27822559|NCT01842607|54285167|FG000|Overall Study|Protocol defined stopping criteria|2|||
27822560|NCT01842607|54285167|FG000|Overall Study|Lost to Follow-up|3|||
27822561|NCT01842607|54285167|FG000|Overall Study|Physician Decision|9|||
27822562|NCT01842607|54285167|FG000|Overall Study|Withdrawal by Subject|14|||
27822563|NCT01803607|54285173|FG000|Overall Study|Adverse Event|5|||
27850025|NCT00130533|54348340|FG000|Overall Study|Death|4|||
27941371|NCT01218659|54597816|FG002|12-Month OLE|Withdrawal by Subject|2|||
27941372|NCT01218659|54597814|FG000|12-Month OLE|Physician Decision|0|||
27941373|NCT01218659|54597815|FG001|12-Month OLE|Physician Decision|0|||
27941374|NCT01218659|54597816|FG002|12-Month OLE|Physician Decision|1|||
27941375|NCT01218659|54597814|FG000|12-Month OLE|Lost to Follow-up|0|||
28144492|NCT01316913|54810970|FG002|Overall Study|Protocol Violation|4|||
27822564|NCT01803607|54285174|FG001|Overall Study|Adverse Event|3|||
27822565|NCT01803607|54285173|FG000|Overall Study|Lack of Efficacy|0|||
27822566|NCT01803607|54285174|FG001|Overall Study|Lack of Efficacy|1|||
27850026|NCT00130533|54348341|FG001|Overall Study|Death|2|||
28144493|NCT01316913|54810971|FG003|Overall Study|Protocol Violation|1|||
28144494|NCT01316913|54810968|FG000|Overall Study|Protocol-defined Stopping Criteria|7|||
27822567|NCT01803607|54285173|FG000|Overall Study|Protocol Violation|3|||
27850027|NCT00130533|54348340|FG000|Overall Study|Protocol Violation|5|||
27850028|NCT00130533|54348341|FG001|Overall Study|Protocol Violation|1|||
27850029|NCT00130533|54348340|FG000|Overall Study|Lost to Follow-up|1|||
27850030|NCT00130533|54348341|FG001|Overall Study|Lost to Follow-up|1|||
27850031|NCT00130533|54348340|FG000|Overall Study|Sponsor´s decision|2|||
27850032|NCT00130533|54348341|FG001|Overall Study|Sponsor´s decision|0|||
27850033|NCT00130533|54348340|FG000|Overall Study|Second Primary Malignancy|0|||
27850034|NCT00130533|54348341|FG001|Overall Study|Second Primary Malignancy|1|||
27850035|NCT00130533|54348340|FG000|Overall Study|Other|12|||
27850036|NCT00130533|54348341|FG001|Overall Study|Other|5|||
27850037|NCT00129935|54348349|FG000|Overall Study|Adverse Event|18|||
27850038|NCT00129935|54348350|FG001|Overall Study|Adverse Event|56|||
27850039|NCT00129935|54348349|FG000|Overall Study|Death|1|||
27850040|NCT00129935|54348350|FG001|Overall Study|Death|1|||
27850041|NCT00129935|54348349|FG000|Overall Study|Withdrawal by Subject|7|||
27850042|NCT00129935|54348350|FG001|Overall Study|Withdrawal by Subject|20|||
27822568|NCT01803607|54285174|FG001|Overall Study|Protocol Violation|2|||
27822569|NCT01803607|54285173|FG000|Overall Study|Study terminated by sponsor|54|||
28071797|NCT00157820|54726575|FG002|Randomized|Withdrawal by Subject|3|||
28071798|NCT00157820|54726573|FG000|Randomized|Protocol Violation|2|||
28071799|NCT00157820|54726574|FG001|Randomized|Protocol Violation|1|||
28071800|NCT00157820|54726575|FG002|Randomized|Protocol Violation|2|||
28071801|NCT00157820|54726573|FG000|1st 8 Month|Death|7|||
28071802|NCT00157820|54726574|FG001|1st 8 Month|Death|8|||
28071803|NCT00157820|54726575|FG002|1st 8 Month|Death|3|||
27822570|NCT01803607|54285174|FG001|Overall Study|Study terminated by sponsor|56|||
27822571|NCT01803607|54285173|FG000|Overall Study|Withdrawal by Subject|6|||
27822572|NCT01803607|54285174|FG001|Overall Study|Withdrawal by Subject|5|||
27822573|NCT01867021|54285182|FG000|Overall Study|Adverse Event|0|||
27822574|NCT01867021|54285183|FG001|Overall Study|Adverse Event|1|||
27822575|NCT01867021|54285182|FG000|Overall Study|Not Eligible|0|||
27822576|NCT01867021|54285183|FG001|Overall Study|Not Eligible|1|||
27822577|NCT01867021|54285182|FG000|Overall Study|Death|1|||
27822578|NCT01867021|54285183|FG001|Overall Study|Death|0|||
27822579|NCT01867021|54285182|FG000|Overall Study|Lost to Follow-up|0|||
27822580|NCT01867021|54285183|FG001|Overall Study|Lost to Follow-up|2|||
27822581|NCT01867021|54285182|FG000|Overall Study|Withdrawal by Subject|1|||
27822582|NCT01867021|54285183|FG001|Overall Study|Withdrawal by Subject|6|||
27822583|NCT01866709|54285196|FG000|Overall Study|Adverse Event|1|||
27822584|NCT01866709|54285197|FG001|Overall Study|Adverse Event|0|||
27822585|NCT01841593|54285205|FG000|First Intervention (Days 1 to 7)|Protocol Violation|0|||
27850043|NCT00129935|54348349|FG000|Overall Study|Protocol Violation|0|||
27850044|NCT00129935|54348350|FG001|Overall Study|Protocol Violation|4|||
27850045|NCT00129935|54348349|FG000|Overall Study|Physician Decision|3|||
27850046|NCT00129935|54348350|FG001|Overall Study|Physician Decision|4|||
28071804|NCT00157820|54726573|FG000|1st 8 Month|Lost to Follow-up|1|||
28071805|NCT00157820|54726574|FG001|1st 8 Month|Lost to Follow-up|2|||
28071806|NCT00157820|54726575|FG002|1st 8 Month|Lost to Follow-up|1|||
28071807|NCT00157820|54726573|FG000|1st 8 Month|Premature cross-over|0|||
28071808|NCT00157820|54726574|FG001|1st 8 Month|Premature cross-over|2|||
28071809|NCT00157820|54726575|FG002|1st 8 Month|Premature cross-over|2|||
28071810|NCT00157820|54726573|FG000|2nd 8 Months|Death|3|||
28071811|NCT00157820|54726574|FG001|2nd 8 Months|Death|1|||
28071812|NCT00157820|54726575|FG002|2nd 8 Months|Death|3|||
28071813|NCT00157820|54726573|FG000|2nd 8 Months|Lost to Follow-up|1|||
28071814|NCT00157820|54726574|FG001|2nd 8 Months|Lost to Follow-up|5|||
28071815|NCT00157820|54726575|FG002|2nd 8 Months|Lost to Follow-up|2|||
28071816|NCT00157820|54726573|FG000|2nd 8 Months|Premature cross-over|1|||
28071817|NCT00157820|54726574|FG001|2nd 8 Months|Premature cross-over|7|||
28071818|NCT00157820|54726575|FG002|2nd 8 Months|Premature cross-over|9|||
28071819|NCT00223808|54726587|FG000|Overall Study|<5 hrs therapy before discharge|3|||
28071820|NCT00223808|54726588|FG001|Overall Study|<5 hrs therapy before discharge|5|||
28071821|NCT00223808|54726589|FG002|Overall Study|<5 hrs therapy before discharge|5|||
28071822|NCT00154310|54726599|FG000|Overall Study|Adverse Event|19|||
27850047|NCT00129935|54348349|FG000|Overall Study|Recurrence|1|||
27850048|NCT00129935|54348350|FG001|Overall Study|Recurrence|3|||
27850049|NCT00129935|54348349|FG000|Overall Study|Second primary|0|||
28071823|NCT00154310|54726600|FG001|Overall Study|Adverse Event|9|||
28071824|NCT00154310|54726599|FG000|Overall Study|Lack of Efficacy|5|||
28071825|NCT00154310|54726600|FG001|Overall Study|Lack of Efficacy|4|||
27822586|NCT01841593|54285206|FG001|First Intervention (Days 1 to 7)|Protocol Violation|1|||
27822587|NCT01841593|54285205|FG000|Second Intervention (Days 8 to 14)|Adverse Event|1|||
27822588|NCT01841593|54285206|FG001|Second Intervention (Days 8 to 14)|Adverse Event|0|||
27822589|NCT01866319|54285474|FG000|Overall Study|Adverse Event|12|||
27822590|NCT01866319|54285475|FG001|Overall Study|Adverse Event|5|||
27822591|NCT01866319|54285476|FG002|Overall Study|Adverse Event|9|||
28071826|NCT00154310|54726599|FG000|Overall Study|Protocol Violation|4|||
28071827|NCT00154310|54726600|FG001|Overall Study|Protocol Violation|2|||
28071828|NCT00154310|54726599|FG000|Overall Study|Withdrawal by Subject|9|||
28144495|NCT01316913|54810969|FG001|Overall Study|Protocol-defined Stopping Criteria|8|||
28144496|NCT01316913|54810970|FG002|Overall Study|Protocol-defined Stopping Criteria|11|||
28144497|NCT01316913|54810971|FG003|Overall Study|Protocol-defined Stopping Criteria|6|||
28144498|NCT01316913|54810968|FG000|Overall Study|Lost to Follow-up|0|||
28144499|NCT01316913|54810969|FG001|Overall Study|Lost to Follow-up|1|||
28144500|NCT01316913|54810970|FG002|Overall Study|Lost to Follow-up|0|||
28144501|NCT01316913|54810971|FG003|Overall Study|Lost to Follow-up|2|||
28144502|NCT01316913|54810968|FG000|Overall Study|Withdrawal by Subject|10|||
28144503|NCT01316913|54810969|FG001|Overall Study|Withdrawal by Subject|9|||
28144504|NCT01316913|54810970|FG002|Overall Study|Withdrawal by Subject|10|||
28144505|NCT01316913|54810971|FG003|Overall Study|Withdrawal by Subject|6|||
28144506|NCT02875067|54810982|FG000|Overall Study|Withdrawal by Subject|1|||
28144507|NCT02875067|54810982|FG000|Overall Study|Withdrawal by Termination of Study|5|||
28144508|NCT02781506|54810986|FG000|Overall Study|Adverse Event|5|||
28144509|NCT03132753|54810992|FG000|Baseline - 6 Month Follow-Up|Lost to Follow-up|27|||
28144510|NCT03132753|54810993|FG001|Baseline - 6 Month Follow-Up|Lost to Follow-up|32|||
28144511|NCT03132753|54810992|FG000|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6|||
28144512|NCT03132753|54810993|FG001|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2|||
28144513|NCT01468454|54810999|FG000|Overall Study|Did not have surgery after PET|9|||
28144514|NCT03067077|54811004|FG000|Overall Study|Did not receive surgery|4|||
28144515|NCT03067077|54811005|FG001|Overall Study|Did not receive surgery|5|||
28144516|NCT03067077|54811004|FG000|Overall Study|Lost to Follow-up|3|||
28144517|NCT03067077|54811005|FG001|Overall Study|Lost to Follow-up|2|||
28144518|NCT03096847|54811014|FG000|Overall Study|Other|2|||
28144519|NCT03096847|54811015|FG001|Overall Study|Other|1|||
28144520|NCT03096847|54811016|FG002|Overall Study|Other|2|||
28144521|NCT03096847|54811014|FG000|Overall Study|Lost to Follow-up|1|||
28071829|NCT00154310|54726600|FG001|Overall Study|Withdrawal by Subject|3|||
28071830|NCT00154310|54726599|FG000|Overall Study|Lost to Follow-up|0|||
28071831|NCT00154310|54726600|FG001|Overall Study|Lost to Follow-up|8|||
28071832|NCT00154310|54726599|FG000|Overall Study|Administrative problems|0|||
28071833|NCT00154310|54726600|FG001|Overall Study|Administrative problems|1|||
28071834|NCT00154310|54726599|FG000|Overall Study|Death|0|||
28071835|NCT00154310|54726600|FG001|Overall Study|Death|1|||
28071836|NCT03771664|54726608|FG000|Overall Study|Adverse Event|1|||
28071837|NCT03771664|54726609|FG001|Overall Study|Adverse Event|0|||
28071838|NCT03771664|54726608|FG000|Overall Study|Lost to Follow-up|1|||
28071839|NCT03771664|54726609|FG001|Overall Study|Lost to Follow-up|0|||
28071840|NCT03771664|54726608|FG000|Overall Study|Withdrawal by Participant|1|||
28071841|NCT03771664|54726609|FG001|Overall Study|Withdrawal by Participant|4|||
28071842|NCT03771664|54726608|FG000|Overall Study|Randomized but not Treated|0|||
28071843|NCT03771664|54726609|FG001|Overall Study|Randomized but not Treated|1|||
28071844|NCT03771352|54726615|FG000|Overall Study|Screen failure|2|||
28071845|NCT03771352|54726615|FG000|Overall Study|Withdrawal by Subject|2|||
28071846|NCT03770728|54726623|FG000|Overall Study|Adverse Event|1|||
28071847|NCT03770728|54726624|FG001|Overall Study|Adverse Event|0|||
28071848|NCT03770728|54726625|FG002|Overall Study|Adverse Event|1|||
28071849|NCT03770728|54726626|FG003|Overall Study|Adverse Event|0|||
28071850|NCT03770728|54726623|FG000|Overall Study|Poor compliance to protocol|0|||
28071851|NCT03770728|54726624|FG001|Overall Study|Poor compliance to protocol|0|||
28071852|NCT03770728|54726625|FG002|Overall Study|Poor compliance to protocol|1|||
28071853|NCT03770728|54726626|FG003|Overall Study|Poor compliance to protocol|0|||
28071854|NCT03770728|54726623|FG000|Overall Study|Withdrawal by Subject|13|||
28071855|NCT03770728|54726624|FG001|Overall Study|Withdrawal by Subject|8|||
28071856|NCT03770728|54726625|FG002|Overall Study|Withdrawal by Subject|9|||
28071857|NCT03770728|54726626|FG003|Overall Study|Withdrawal by Subject|13|||
28071858|NCT03770728|54726623|FG000|Overall Study|Other than specified|24|||
28071859|NCT03770728|54726624|FG001|Overall Study|Other than specified|23|||
28071860|NCT03770728|54726625|FG002|Overall Study|Other than specified|21|||
28071861|NCT03770728|54726626|FG003|Overall Study|Other than specified|22|||
28071862|NCT03769090|54726641|FG000|Overall Study|Randomized and did not receive randomized study treatment|1|||
28071863|NCT03769090|54726642|FG001|Overall Study|Randomized and did not receive randomized study treatment|2|||
28071864|NCT03769090|54726643|FG002|Overall Study|Randomized and did not receive randomized study treatment|2|||
28071865|NCT03769090|54726641|FG000|Overall Study|Withdrawal by Subject|52|||
28071866|NCT03769090|54726642|FG001|Overall Study|Withdrawal by Subject|62|||
28071867|NCT03769090|54726643|FG002|Overall Study|Withdrawal by Subject|74|||
28071868|NCT03769090|54726641|FG000|Overall Study|Death|4|||
28071869|NCT03769090|54726642|FG001|Overall Study|Death|2|||
28071870|NCT03769090|54726643|FG002|Overall Study|Death|2|||
28071871|NCT03769090|54726641|FG000|Overall Study|Adverse Event|7|||
28144522|NCT03096847|54811015|FG001|Overall Study|Lost to Follow-up|0|||
28144523|NCT03096847|54811016|FG002|Overall Study|Lost to Follow-up|1|||
28144524|NCT03096847|54811014|FG000|Overall Study|Death|6|||
28144525|NCT03096847|54811015|FG001|Overall Study|Death|0|||
28144526|NCT03096847|54811016|FG002|Overall Study|Death|2|||
28144527|NCT03096847|54811014|FG000|Overall Study|Protocol Violation|3|||
28144528|NCT03096847|54811015|FG001|Overall Study|Protocol Violation|0|||
28144529|NCT03096847|54811016|FG002|Overall Study|Protocol Violation|6|||
27822592|NCT01866319|54285474|FG000|Overall Study|Clinical progression|3|||
27822593|NCT01866319|54285475|FG001|Overall Study|Clinical progression|2|||
27822594|NCT01866319|54285476|FG002|Overall Study|Clinical progression|2|||
27822595|NCT01866319|54285474|FG000|Overall Study|Death|153|||
27822596|NCT01866319|54285475|FG001|Overall Study|Death|154|||
27822597|NCT01866319|54285476|FG002|Overall Study|Death|147|||
27822598|NCT01866319|54285474|FG000|Overall Study|Lost to Follow-up|6|||
27822599|NCT01866319|54285475|FG001|Overall Study|Lost to Follow-up|3|||
27822600|NCT01866319|54285476|FG002|Overall Study|Lost to Follow-up|8|||
27822601|NCT01866319|54285474|FG000|Overall Study|Physician Decision|1|||
27822602|NCT01866319|54285475|FG001|Overall Study|Physician Decision|0|||
27822603|NCT01866319|54285476|FG002|Overall Study|Physician Decision|1|||
27822604|NCT01866319|54285474|FG000|Overall Study|Protocol Violation|0|||
27822605|NCT01866319|54285475|FG001|Overall Study|Protocol Violation|0|||
27822606|NCT01866319|54285476|FG002|Overall Study|Protocol Violation|1|||
27822607|NCT01866319|54285474|FG000|Overall Study|Withdrawal by Subject|32|||
27822608|NCT01866319|54285475|FG001|Overall Study|Withdrawal by Subject|14|||
27822609|NCT01866319|54285476|FG002|Overall Study|Withdrawal by Subject|12|||
27822610|NCT01802515|54285503|FG000|Overall Study|Withdrawal by Subject|3|||
27822611|NCT01802515|54285504|FG001|Overall Study|Withdrawal by Subject|0|||
27822612|NCT01802515|54285505|FG002|Overall Study|Withdrawal by Subject|0|||
27822613|NCT01802437|54285515|FG000|Overall Study|Lost to Follow-up|1|||
27822614|NCT01802437|54285516|FG001|Overall Study|Lost to Follow-up|0|||
27822615|NCT01802437|54285515|FG000|Overall Study|Withdrawal by Subject|3|||
27822616|NCT01802437|54285516|FG001|Overall Study|Withdrawal by Subject|4|||
27822617|NCT01801735|54285623|FG000|Overall Study|Adverse Event|79|||
27822618|NCT01801735|54285623|FG000|Overall Study|Lack of Efficacy|28|||
27822619|NCT01801735|54285623|FG000|Overall Study|Withdrawal by Subject|27|||
27822620|NCT01801735|54285623|FG000|Overall Study|Protocol Violation|25|||
27822621|NCT01801735|54285623|FG000|Overall Study|Lost to Follow-up|15|||
27822622|NCT01801735|54285623|FG000|Overall Study|Non-compliance with Trial Drug|13|||
27822623|NCT01801735|54285623|FG000|Overall Study|Physician Decision|3|||
27822624|NCT01801735|54285623|FG000|Overall Study|Death|1|||
27822625|NCT01801735|54285623|FG000|Overall Study|Other, including site closure|19|||
27822626|NCT01840579|54286389|FG000|Overall Study|Status not recorded|0|||
27850050|NCT00129935|54348350|FG001|Overall Study|Second primary|1|||
27850051|NCT00129935|54348349|FG000|Overall Study|Other|3|||
28071872|NCT03769090|54726642|FG001|Overall Study|Adverse Event|7|||
28071873|NCT03769090|54726643|FG002|Overall Study|Adverse Event|8|||
28071874|NCT03769090|54726641|FG000|Overall Study|A single severe exacerbation event lasting >20 days|0|||
28144530|NCT03096847|54811014|FG000|Overall Study|Physician Decision|12|||
28144531|NCT03096847|54811015|FG001|Overall Study|Physician Decision|2|||
28144532|NCT03096847|54811016|FG002|Overall Study|Physician Decision|8|||
28144533|NCT03096847|54811014|FG000|Overall Study|Withdrawal by Subject|24|||
28144534|NCT03096847|54811015|FG001|Overall Study|Withdrawal by Subject|1|||
28144535|NCT03096847|54811016|FG002|Overall Study|Withdrawal by Subject|12|||
28144536|NCT03096847|54811014|FG000|Overall Study|Adverse Event|72|||
28144537|NCT03096847|54811015|FG001|Overall Study|Adverse Event|6|||
28144538|NCT03096847|54811016|FG002|Overall Study|Adverse Event|28|||
28144539|NCT03096847|54811014|FG000|Overall Study|Progressive disease|97|||
28144540|NCT03096847|54811015|FG001|Overall Study|Progressive disease|10|||
28144541|NCT03096847|54811016|FG002|Overall Study|Progressive disease|78|||
28144542|NCT03096847|54811014|FG000|Overall Study|Non-compliance with study medication|1|||
28144543|NCT03096847|54811015|FG001|Overall Study|Non-compliance with study medication|0|||
28071875|NCT03769090|54726642|FG001|Overall Study|A single severe exacerbation event lasting >20 days|1|||
28071876|NCT03769090|54726643|FG002|Overall Study|A single severe exacerbation event lasting >20 days|2|||
28071877|NCT03769090|54726641|FG000|Overall Study|>= 3 severe exacerbation events within a 3 month period|1|||
28071878|NCT03769090|54726642|FG001|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
28071879|NCT03769090|54726643|FG002|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
28071880|NCT03769090|54726641|FG000|Overall Study|>= 5 total severe exacerbation events|0|||
27822627|NCT01840579|54286390|FG001|Overall Study|Status not recorded|0|||
27822628|NCT01840579|54286391|FG002|Overall Study|Status not recorded|2|||
27850052|NCT00129935|54348350|FG001|Overall Study|Other|2|||
27850053|NCT00129935|54348349|FG000|Overall Study|Crossed to the other arm|2|||
28144544|NCT03096847|54811016|FG002|Overall Study|Non-compliance with study medication|0|||
28144545|NCT03096847|54811014|FG000|Overall Study|New therapy for study indication|1|||
27822629|NCT01840579|54286392|FG003|Overall Study|Status not recorded|3|||
27822630|NCT01840579|54286393|FG004|Overall Study|Status not recorded|4|||
27822631|NCT01840579|54286394|FG005|Overall Study|Status not recorded|3|||
27822632|NCT01840579|54286395|FG006|Overall Study|Status not recorded|0|||
27822633|NCT01840579|54286396|FG007|Overall Study|Status not recorded|3|||
28144546|NCT03096847|54811015|FG001|Overall Study|New therapy for study indication|0|||
28144547|NCT03096847|54811016|FG002|Overall Study|New therapy for study indication|1|||
28144548|NCT01365182|54811035|FG000|Overall Study|Withdrawal by Subject|10|||
28144549|NCT01365182|54811036|FG001|Overall Study|Withdrawal by Subject|13|||
28144550|NCT01365182|54811037|FG002|Overall Study|Withdrawal by Subject|12|||
28144551|NCT03128099|54811055|FG000|Overall Study|High dose task was too long|0|||
28144552|NCT03128099|54811056|FG001|Overall Study|High dose task was too long|4|||
28144553|NCT03128099|54811057|FG002|Overall Study|High dose task was too long|0|||
28144554|NCT03128099|54811055|FG000|Overall Study|Participant got a full time job.|1|||
28144555|NCT03128099|54811056|FG001|Overall Study|Participant got a full time job.|0|||
28144556|NCT03128099|54811057|FG002|Overall Study|Participant got a full time job.|0|||
28144557|NCT03128099|54811055|FG000|Overall Study|Became homeless and lost contact|1|||
28144558|NCT03128099|54811056|FG001|Overall Study|Became homeless and lost contact|0|||
28144559|NCT03128099|54811057|FG002|Overall Study|Became homeless and lost contact|0|||
28144560|NCT03128099|54811055|FG000|Overall Study|Did not complete all the assessments|0|||
28144561|NCT03128099|54811056|FG001|Overall Study|Did not complete all the assessments|0|||
28144562|NCT03128099|54811057|FG002|Overall Study|Did not complete all the assessments|1|||
28144563|NCT02886494|54811065|FG000|Overall Study|Adverse Event|1|||
28144564|NCT02886494|54811066|FG001|Overall Study|Adverse Event|0|||
28144565|NCT02886494|54811065|FG000|Overall Study|Withdrawal by Subject|12|||
28144566|NCT02886494|54811066|FG001|Overall Study|Withdrawal by Subject|3|||
28144567|NCT02886494|54811065|FG000|Overall Study|Protocol Violation|4|||
28144568|NCT02886494|54811066|FG001|Overall Study|Protocol Violation|1|||
28144569|NCT02846532|54811078|FG000|Overall Study|Lost to Follow-up|0|||
28144570|NCT02846532|54811079|FG001|Overall Study|Lost to Follow-up|1|||
28144571|NCT02846532|54811080|FG002|Overall Study|Lost to Follow-up|1|||
28144572|NCT02846532|54811078|FG000|Overall Study|Withdrawal by Subject|1|||
28144573|NCT02846532|54811079|FG001|Overall Study|Withdrawal by Subject|2|||
28144574|NCT02846532|54811080|FG002|Overall Study|Withdrawal by Subject|0|||
28144575|NCT00842348|54811099|FG000|Patients Randomised in Study 726|Did not enter Study 729|59|||
28144576|NCT00842348|54811100|FG001|Patients Randomised in Study 726|Did not enter Study 729|56|||
28144577|NCT00842348|54811099|FG000|Study 729|Disease progression/death|19|||
28144578|NCT00842348|54811100|FG001|Study 729|Disease progression/death|30|||
28144579|NCT00842348|54811099|FG000|Study 729|Adverse Event|1|||
28144580|NCT00842348|54811100|FG001|Study 729|Adverse Event|1|||
28144581|NCT00842348|54811099|FG000|Study 729|Protocol Violation|1|||
28144582|NCT00842348|54811100|FG001|Study 729|Protocol Violation|1|||
28144583|NCT00842348|54811099|FG000|Study 729|Withdrawal by Subject|2|||
28144584|NCT00842348|54811100|FG001|Study 729|Withdrawal by Subject|4|||
28144585|NCT00842348|54811099|FG000|Study 729|Due to Sponsor stopping the study|1|||
28144586|NCT00842348|54811100|FG001|Study 729|Due to Sponsor stopping the study|1|||
28144587|NCT00842348|54811099|FG000|Study 729|Due to non-availability of IP|0|||
28144588|NCT00842348|54811100|FG001|Study 729|Due to non-availability of IP|1|||
28144589|NCT00842348|54811099|FG000|Study 729|Sponsor's decision|1|||
28144590|NCT00842348|54811100|FG001|Study 729|Sponsor's decision|0|||
28144591|NCT00842348|54811099|FG000|Study 729|Surgical resection|1|||
28144592|NCT00842348|54811100|FG001|Study 729|Surgical resection|0|||
28144593|NCT03095599|54811112|FG000|Overall Study|Withdrawal by Subject|1|||
28144594|NCT03095599|54811113|FG001|Overall Study|Withdrawal by Subject|0|||
28144595|NCT03095599|54811112|FG000|Overall Study|Lost to Follow-up|1|||
28144596|NCT03095599|54811113|FG001|Overall Study|Lost to Follow-up|0|||
28144597|NCT03095599|54811112|FG000|Overall Study|Withdrawal prior to vaccination|1|||
28144598|NCT03095599|54811113|FG001|Overall Study|Withdrawal prior to vaccination|0|||
28144599|NCT03095521|54811123|FG000|Overall Study|Withdrawal by Subject|0|||
28144600|NCT03095521|54811124|FG001|Overall Study|Withdrawal by Subject|1|||
28144601|NCT03095521|54811123|FG000|Overall Study|Lost to Follow-up|0|||
28144602|NCT03095521|54811124|FG001|Overall Study|Lost to Follow-up|1|||
28144603|NCT03033875|54811133|FG000|Overall Study|Withdrawal by Subject|5|||
27822634|NCT01840579|54286397|FG008|Overall Study|Status not recorded|3|||
27822635|NCT01840579|54286398|FG009|Overall Study|Status not recorded|3|||
27822636|NCT01840579|54286389|FG000|Overall Study|Progressive disease|3|||
28144604|NCT03033875|54811134|FG001|Overall Study|Withdrawal by Subject|9|||
28144605|NCT03033875|54811135|FG002|Overall Study|Withdrawal by Subject|4|||
28144606|NCT03033875|54811133|FG000|Overall Study|Other|14|||
28144607|NCT03033875|54811134|FG001|Overall Study|Other|15|||
27822637|NCT01840579|54286390|FG001|Overall Study|Progressive disease|5|||
27822638|NCT01840579|54286391|FG002|Overall Study|Progressive disease|0|||
28144608|NCT03033875|54811135|FG002|Overall Study|Other|8|||
27822639|NCT01840579|54286392|FG003|Overall Study|Progressive disease|0|||
27822640|NCT01840579|54286393|FG004|Overall Study|Progressive disease|0|||
28144609|NCT01968785|54811153|FG000|Overall Study|Withdrawal by Subject|1|||
28144610|NCT01968785|54811154|FG001|Overall Study|Withdrawal by Subject|0|||
28144611|NCT03095287|54811160|FG000|Overall Study|Treatment Failure|1|||
28144612|NCT03095287|54811160|FG000|Overall Study|Adverse Event|1|||
28144613|NCT02839746|54811178|FG000|Overall Study|Not met selection criteria|12|||
28144614|NCT00033293|54811184|FG000|Overall Study|Death|0|||
28144615|NCT00033293|54811185|FG001|Overall Study|Death|1|||
28144616|NCT00033293|54811184|FG000|Overall Study|Lack of Efficacy|5|||
28144617|NCT00033293|54811185|FG001|Overall Study|Lack of Efficacy|8|||
28144618|NCT00033293|54811184|FG000|Overall Study|Lost to Follow-up|0|||
28144619|NCT00033293|54811185|FG001|Overall Study|Lost to Follow-up|1|||
28144620|NCT00033293|54811184|FG000|Overall Study|Physician Decision|3|||
28144621|NCT00033293|54811185|FG001|Overall Study|Physician Decision|1|||
28144622|NCT00033293|54811184|FG000|Overall Study|Withdrawal by Subject|1|||
28144623|NCT00033293|54811185|FG001|Overall Study|Withdrawal by Subject|0|||
28144624|NCT00033293|54811184|FG000|Overall Study|Could not be weaned from steroid therapy|1|||
28144625|NCT00033293|54811185|FG001|Overall Study|Could not be weaned from steroid therapy|1|||
28144626|NCT00033293|54811184|FG000|Overall Study|Treatment refused|0|||
28144627|NCT00033293|54811185|FG001|Overall Study|Treatment refused|6|||
28144628|NCT02836236|54811195|FG000|Overall Study|Randomized but Never Treated|1|||
28144629|NCT02836236|54811196|FG001|Overall Study|Randomized but Never Treated|0|||
28144630|NCT02836236|54811195|FG000|Overall Study|Withdrew Consent|2|||
28144631|NCT02836236|54811196|FG001|Overall Study|Withdrew Consent|0|||
28144632|NCT02836236|54811195|FG000|Overall Study|Adverse Event|0|||
28144633|NCT02836236|54811196|FG001|Overall Study|Adverse Event|1|||
28144634|NCT02836236|54811195|FG000|Overall Study|Investigator's Discretion|1|||
28144635|NCT02836236|54811196|FG001|Overall Study|Investigator's Discretion|0|||
28144636|NCT02836236|54811195|FG000|Overall Study|Still on Study|101|||
27941376|NCT01218659|54597815|FG001|12-Month OLE|Lost to Follow-up|0|||
28071881|NCT03769090|54726642|FG001|Overall Study|>= 5 total severe exacerbation events|1|||
28071882|NCT03769090|54726643|FG002|Overall Study|>= 5 total severe exacerbation events|1|||
28071883|NCT03769090|54726641|FG000|Overall Study|Protocol Violation|5|||
28071884|NCT03769090|54726642|FG001|Overall Study|Protocol Violation|6|||
28071885|NCT03769090|54726643|FG002|Overall Study|Protocol Violation|8|||
28071886|NCT03769090|54726641|FG000|Overall Study|Pregnancy|1|||
28144637|NCT02836236|54811196|FG001|Overall Study|Still on Study|49|||
28144638|NCT02039674|54811216|FG000|Overall Study|Adverse Event|0|||
28144639|NCT02039674|54811217|FG001|Overall Study|Adverse Event|0|||
28144640|NCT02039674|54811218|FG002|Overall Study|Adverse Event|0|||
28144641|NCT02039674|54811219|FG003|Overall Study|Adverse Event|1|||
28144642|NCT02039674|54811220|FG004|Overall Study|Adverse Event|0|||
28144643|NCT02039674|54811221|FG005|Overall Study|Adverse Event|0|||
28144644|NCT02039674|54811222|FG006|Overall Study|Adverse Event|0|||
28144645|NCT02039674|54811223|FG007|Overall Study|Adverse Event|0|||
28144646|NCT02039674|54811224|FG008|Overall Study|Adverse Event|2|||
28144647|NCT02039674|54811225|FG009|Overall Study|Adverse Event|1|||
28144648|NCT02039674|54811226|FG010|Overall Study|Adverse Event|0|||
28144649|NCT02039674|54811227|FG011|Overall Study|Adverse Event|2|||
28144650|NCT02039674|54811228|FG012|Overall Study|Adverse Event|3|||
28144651|NCT02039674|54811229|FG013|Overall Study|Adverse Event|1|||
28144652|NCT02039674|54811216|FG000|Overall Study|Death|2|||
28144653|NCT02039674|54811217|FG001|Overall Study|Death|0|||
28144654|NCT02039674|54811218|FG002|Overall Study|Death|2|||
28144655|NCT02039674|54811219|FG003|Overall Study|Death|3|||
28144656|NCT02039674|54811220|FG004|Overall Study|Death|0|||
28144657|NCT02039674|54811221|FG005|Overall Study|Death|0|||
28144658|NCT02039674|54811222|FG006|Overall Study|Death|1|||
28144659|NCT02039674|54811223|FG007|Overall Study|Death|0|||
28144660|NCT02039674|54811224|FG008|Overall Study|Death|2|||
28144661|NCT02039674|54811225|FG009|Overall Study|Death|0|||
28144662|NCT02039674|54811226|FG010|Overall Study|Death|1|||
28144663|NCT02039674|54811227|FG011|Overall Study|Death|3|||
28144664|NCT02039674|54811228|FG012|Overall Study|Death|2|||
28144665|NCT02039674|54811229|FG013|Overall Study|Death|8|||
28144666|NCT02039674|54811216|FG000|Overall Study|Excluded Medication|1|||
28144667|NCT02039674|54811217|FG001|Overall Study|Excluded Medication|1|||
28144668|NCT02039674|54811218|FG002|Overall Study|Excluded Medication|0|||
28144669|NCT02039674|54811219|FG003|Overall Study|Excluded Medication|1|||
28144670|NCT02039674|54811220|FG004|Overall Study|Excluded Medication|0|||
28144671|NCT02039674|54811221|FG005|Overall Study|Excluded Medication|1|||
28144672|NCT02039674|54811222|FG006|Overall Study|Excluded Medication|0|||
28071887|NCT03769090|54726642|FG001|Overall Study|Pregnancy|0|||
28071888|NCT03769090|54726643|FG002|Overall Study|Pregnancy|3|||
28071889|NCT03769090|54726641|FG000|Overall Study|Lost to Follow-up|19|||
28144673|NCT02039674|54811223|FG007|Overall Study|Excluded Medication|0|||
28144674|NCT02039674|54811224|FG008|Overall Study|Excluded Medication|2|||
28144675|NCT02039674|54811225|FG009|Overall Study|Excluded Medication|3|||
28144676|NCT02039674|54811226|FG010|Overall Study|Excluded Medication|5|||
28144677|NCT02039674|54811227|FG011|Overall Study|Excluded Medication|6|||
28071890|NCT03769090|54726642|FG001|Overall Study|Lost to Follow-up|25|||
28144678|NCT02039674|54811228|FG012|Overall Study|Excluded Medication|8|||
28144679|NCT02039674|54811229|FG013|Overall Study|Excluded Medication|3|||
28144680|NCT02039674|54811216|FG000|Overall Study|Lost to Follow-up|0|||
28144681|NCT02039674|54811217|FG001|Overall Study|Lost to Follow-up|0|||
28144682|NCT02039674|54811218|FG002|Overall Study|Lost to Follow-up|0|||
28144683|NCT02039674|54811219|FG003|Overall Study|Lost to Follow-up|0|||
28144684|NCT02039674|54811220|FG004|Overall Study|Lost to Follow-up|1|||
28144685|NCT02039674|54811221|FG005|Overall Study|Lost to Follow-up|1|||
28144686|NCT02039674|54811222|FG006|Overall Study|Lost to Follow-up|0|||
28144687|NCT02039674|54811223|FG007|Overall Study|Lost to Follow-up|0|||
28144688|NCT02039674|54811224|FG008|Overall Study|Lost to Follow-up|0|||
28144689|NCT02039674|54811225|FG009|Overall Study|Lost to Follow-up|0|||
28144690|NCT02039674|54811226|FG010|Overall Study|Lost to Follow-up|0|||
28144691|NCT02039674|54811227|FG011|Overall Study|Lost to Follow-up|2|||
28144692|NCT02039674|54811228|FG012|Overall Study|Lost to Follow-up|2|||
28144693|NCT02039674|54811229|FG013|Overall Study|Lost to Follow-up|1|||
28144694|NCT02039674|54811216|FG000|Overall Study|Physician Decision|0|||
28144695|NCT02039674|54811217|FG001|Overall Study|Physician Decision|0|||
28144696|NCT02039674|54811218|FG002|Overall Study|Physician Decision|0|||
28144697|NCT02039674|54811219|FG003|Overall Study|Physician Decision|0|||
28144698|NCT02039674|54811220|FG004|Overall Study|Physician Decision|0|||
28144699|NCT02039674|54811221|FG005|Overall Study|Physician Decision|0|||
28144700|NCT02039674|54811222|FG006|Overall Study|Physician Decision|0|||
28144701|NCT02039674|54811223|FG007|Overall Study|Physician Decision|0|||
28144702|NCT02039674|54811224|FG008|Overall Study|Physician Decision|0|||
28144703|NCT02039674|54811225|FG009|Overall Study|Physician Decision|0|||
28144704|NCT02039674|54811226|FG010|Overall Study|Physician Decision|0|||
28144705|NCT02039674|54811227|FG011|Overall Study|Physician Decision|1|||
28144706|NCT02039674|54811228|FG012|Overall Study|Physician Decision|1|||
28144707|NCT02039674|54811229|FG013|Overall Study|Physician Decision|0|||
28144708|NCT02039674|54811216|FG000|Overall Study|Progressive Disease|8|||
28144709|NCT02039674|54811217|FG001|Overall Study|Progressive Disease|8|||
28144710|NCT02039674|54811218|FG002|Overall Study|Progressive Disease|6|||
28144711|NCT02039674|54811219|FG003|Overall Study|Progressive Disease|7|||
28144712|NCT02039674|54811220|FG004|Overall Study|Progressive Disease|9|||
28144713|NCT02039674|54811221|FG005|Overall Study|Progressive Disease|10|||
28144714|NCT02039674|54811222|FG006|Overall Study|Progressive Disease|1|||
28144715|NCT02039674|54811223|FG007|Overall Study|Progressive Disease|3|||
28144716|NCT02039674|54811224|FG008|Overall Study|Progressive Disease|6|||
28144717|NCT02039674|54811225|FG009|Overall Study|Progressive Disease|4|||
28144718|NCT02039674|54811226|FG010|Overall Study|Progressive Disease|0|||
28144719|NCT02039674|54811227|FG011|Overall Study|Progressive Disease|34|||
28144720|NCT02039674|54811228|FG012|Overall Study|Progressive Disease|34|||
28144721|NCT02039674|54811229|FG013|Overall Study|Progressive Disease|18|||
28144722|NCT02039674|54811216|FG000|Overall Study|Withdrawal by Subject|1|||
28144723|NCT02039674|54811217|FG001|Overall Study|Withdrawal by Subject|2|||
28144724|NCT02039674|54811218|FG002|Overall Study|Withdrawal by Subject|3|||
28071891|NCT03769090|54726643|FG002|Overall Study|Lost to Follow-up|21|||
28071892|NCT03769090|54726641|FG000|Overall Study|Condition under investigation worsened|2|||
28071893|NCT03769090|54726642|FG001|Overall Study|Condition under investigation worsened|0|||
28071894|NCT03769090|54726643|FG002|Overall Study|Condition under investigation worsened|1|||
28071895|NCT03769090|54726641|FG000|Overall Study|Lack of Efficacy|1|||
28144725|NCT02039674|54811219|FG003|Overall Study|Withdrawal by Subject|0|||
28144726|NCT02039674|54811220|FG004|Overall Study|Withdrawal by Subject|1|||
28144727|NCT02039674|54811221|FG005|Overall Study|Withdrawal by Subject|0|||
28144728|NCT02039674|54811222|FG006|Overall Study|Withdrawal by Subject|0|||
28144729|NCT02039674|54811223|FG007|Overall Study|Withdrawal by Subject|0|||
28144730|NCT02039674|54811224|FG008|Overall Study|Withdrawal by Subject|0|||
28144731|NCT02039674|54811225|FG009|Overall Study|Withdrawal by Subject|1|||
28071896|NCT03769090|54726642|FG001|Overall Study|Lack of Efficacy|2|||
28071897|NCT03769090|54726643|FG002|Overall Study|Lack of Efficacy|2|||
28071898|NCT03769090|54726641|FG000|Overall Study|Other reasons|8|||
28144732|NCT02039674|54811226|FG010|Overall Study|Withdrawal by Subject|1|||
28144733|NCT02039674|54811227|FG011|Overall Study|Withdrawal by Subject|4|||
28144734|NCT02039674|54811228|FG012|Overall Study|Withdrawal by Subject|6|||
28144735|NCT02039674|54811229|FG013|Overall Study|Withdrawal by Subject|2|||
28144736|NCT02039674|54811216|FG000|Overall Study|Clinical Progression|0|||
28144737|NCT02039674|54811217|FG001|Overall Study|Clinical Progression|0|||
28144738|NCT02039674|54811218|FG002|Overall Study|Clinical Progression|0|||
28144739|NCT02039674|54811219|FG003|Overall Study|Clinical Progression|0|||
28071899|NCT03769090|54726642|FG001|Overall Study|Other reasons|12|||
28071900|NCT03769090|54726643|FG002|Overall Study|Other reasons|15|||
28071901|NCT03559270|54726667|FG000|Overall Study|Adverse Event|6|||
28071902|NCT03559270|54726668|FG001|Overall Study|Adverse Event|5|||
28071903|NCT03559270|54726669|FG002|Overall Study|Adverse Event|3|||
28071904|NCT03559270|54726670|FG003|Overall Study|Adverse Event|0|||
28071905|NCT03559270|54726667|FG000|Overall Study|Lack of Efficacy|34|||
28071906|NCT03559270|54726668|FG001|Overall Study|Lack of Efficacy|52|||
28071907|NCT03559270|54726669|FG002|Overall Study|Lack of Efficacy|37|||
28071908|NCT03559270|54726670|FG003|Overall Study|Lack of Efficacy|2|||
28071909|NCT03559270|54726667|FG000|Overall Study|Death|0|||
28071910|NCT03559270|54726668|FG001|Overall Study|Death|2|||
28144740|NCT02039674|54811220|FG004|Overall Study|Clinical Progression|0|||
28144741|NCT02039674|54811221|FG005|Overall Study|Clinical Progression|0|||
28144742|NCT02039674|54811222|FG006|Overall Study|Clinical Progression|1|||
28144743|NCT02039674|54811223|FG007|Overall Study|Clinical Progression|0|||
28144744|NCT02039674|54811224|FG008|Overall Study|Clinical Progression|0|||
28144745|NCT02039674|54811225|FG009|Overall Study|Clinical Progression|0|||
28144746|NCT02039674|54811226|FG010|Overall Study|Clinical Progression|0|||
28144747|NCT02039674|54811227|FG011|Overall Study|Clinical Progression|0|||
28144748|NCT02039674|54811228|FG012|Overall Study|Clinical Progression|1|||
28144749|NCT02039674|54811229|FG013|Overall Study|Clinical Progression|0|||
28144750|NCT02039674|54811216|FG000|Overall Study|Sponsor Decision|1|||
28144751|NCT02039674|54811217|FG001|Overall Study|Sponsor Decision|1|||
28144752|NCT02039674|54811218|FG002|Overall Study|Sponsor Decision|1|||
28144753|NCT02039674|54811219|FG003|Overall Study|Sponsor Decision|1|||
28144754|NCT02039674|54811220|FG004|Overall Study|Sponsor Decision|1|||
28144755|NCT02039674|54811221|FG005|Overall Study|Sponsor Decision|0|||
28144756|NCT02039674|54811222|FG006|Overall Study|Sponsor Decision|0|||
28144757|NCT02039674|54811223|FG007|Overall Study|Sponsor Decision|0|||
28144758|NCT02039674|54811224|FG008|Overall Study|Sponsor Decision|0|||
28144759|NCT02039674|54811225|FG009|Overall Study|Sponsor Decision|3|||
28144760|NCT02039674|54811226|FG010|Overall Study|Sponsor Decision|0|||
28144761|NCT02039674|54811227|FG011|Overall Study|Sponsor Decision|8|||
28144762|NCT02039674|54811228|FG012|Overall Study|Sponsor Decision|5|||
28144763|NCT02039674|54811229|FG013|Overall Study|Sponsor Decision|0|||
28144764|NCT02039674|54811216|FG000|Overall Study|Other|0|||
28144765|NCT02039674|54811217|FG001|Overall Study|Other|0|||
28144766|NCT02039674|54811218|FG002|Overall Study|Other|0|||
28144767|NCT02039674|54811219|FG003|Overall Study|Other|0|||
28144768|NCT02039674|54811220|FG004|Overall Study|Other|0|||
28144769|NCT02039674|54811221|FG005|Overall Study|Other|0|||
28144770|NCT02039674|54811222|FG006|Overall Study|Other|0|||
27822641|NCT01840579|54286394|FG005|Overall Study|Progressive disease|0|||
27822642|NCT01840579|54286395|FG006|Overall Study|Progressive disease|0|||
28144771|NCT02039674|54811223|FG007|Overall Study|Other|0|||
28144772|NCT02039674|54811224|FG008|Overall Study|Other|0|||
28144773|NCT02039674|54811225|FG009|Overall Study|Other|0|||
28144774|NCT02039674|54811226|FG010|Overall Study|Other|0|||
27822643|NCT01840579|54286396|FG007|Overall Study|Progressive disease|0|||
27822644|NCT01840579|54286397|FG008|Overall Study|Progressive disease|0|||
28071911|NCT03559270|54726669|FG002|Overall Study|Death|0|||
28071912|NCT03559270|54726670|FG003|Overall Study|Death|0|||
28071913|NCT03559270|54726667|FG000|Overall Study|Lost to Follow-up|16|||
28144775|NCT02039674|54811227|FG011|Overall Study|Other|0|||
28144776|NCT02039674|54811228|FG012|Overall Study|Other|1|||
28144777|NCT02039674|54811229|FG013|Overall Study|Other|0|||
28144778|NCT03126227|54811269|FG000|Overall Study|Adverse Event|43|||
28144779|NCT03126227|54811270|FG001|Overall Study|Adverse Event|4|||
28144780|NCT03126227|54811269|FG000|Overall Study|Death|0|||
28071914|NCT03559270|54726668|FG001|Overall Study|Lost to Follow-up|4|||
28144781|NCT03126227|54811270|FG001|Overall Study|Death|1|||
27822645|NCT01840579|54286398|FG009|Overall Study|Progressive disease|0|||
28144782|NCT03126227|54811269|FG000|Overall Study|Lost to Follow-up|0|||
28144783|NCT03126227|54811270|FG001|Overall Study|Lost to Follow-up|1|||
28144784|NCT03126227|54811269|FG000|Overall Study|Physician Decision|2|||
28144785|NCT03126227|54811270|FG001|Overall Study|Physician Decision|0|||
28144786|NCT03126227|54811269|FG000|Overall Study|Protocol Violation|1|||
28144787|NCT03126227|54811270|FG001|Overall Study|Protocol Violation|0|||
28144788|NCT03126227|54811269|FG000|Overall Study|Withdrawal by Subject|19|||
28144789|NCT03126227|54811270|FG001|Overall Study|Withdrawal by Subject|3|||
28144790|NCT03126227|54811269|FG000|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|8|||
28144791|NCT03126227|54811270|FG001|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|1|||
28144792|NCT03126227|54811269|FG000|Overall Study|Lack of dosing compliance|2|||
28144793|NCT03126227|54811270|FG001|Overall Study|Lack of dosing compliance|0|||
28144794|NCT03126227|54811269|FG000|Overall Study|Did not meet eligibility criteria subsequent to enrollment|2|||
28144795|NCT03126227|54811270|FG001|Overall Study|Did not meet eligibility criteria subsequent to enrollment|0|||
28144796|NCT03126227|54811269|FG000|Overall Study|Scheduling conflict|1|||
28144797|NCT03126227|54811270|FG001|Overall Study|Scheduling conflict|0|||
28144798|NCT03099187|54811278|FG000|Double-blind Treatment|Adverse Event|19|||
28144799|NCT03099187|54811279|FG001|Double-blind Treatment|Adverse Event|1|||
28144800|NCT03099187|54811280|FG002|Double-blind Treatment|Adverse Event|0|||
28144801|NCT03099187|54811281|FG003|Double-blind Treatment|Adverse Event|0|||
28144802|NCT03099187|54811278|FG000|Double-blind Treatment|Death|1|||
28144803|NCT03099187|54811279|FG001|Double-blind Treatment|Death|3|||
28144804|NCT03099187|54811280|FG002|Double-blind Treatment|Death|0|||
28144805|NCT03099187|54811281|FG003|Double-blind Treatment|Death|0|||
28144806|NCT03099187|54811278|FG000|Double-blind Treatment|Lack of Efficacy|1|||
28144807|NCT03099187|54811279|FG001|Double-blind Treatment|Lack of Efficacy|0|||
28144808|NCT03099187|54811280|FG002|Double-blind Treatment|Lack of Efficacy|0|||
28144809|NCT03099187|54811281|FG003|Double-blind Treatment|Lack of Efficacy|0|||
28144810|NCT03099187|54811278|FG000|Double-blind Treatment|Physician Decision|2|||
28144811|NCT03099187|54811279|FG001|Double-blind Treatment|Physician Decision|1|||
28144812|NCT03099187|54811280|FG002|Double-blind Treatment|Physician Decision|0|||
28144813|NCT03099187|54811281|FG003|Double-blind Treatment|Physician Decision|0|||
28144814|NCT03099187|54811278|FG000|Double-blind Treatment|Withdrawal by Subject|9|||
28144815|NCT03099187|54811279|FG001|Double-blind Treatment|Withdrawal by Subject|4|||
28144816|NCT03099187|54811280|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
28144817|NCT03099187|54811281|FG003|Double-blind Treatment|Withdrawal by Subject|0|||
28144818|NCT03099187|54811278|FG000|Double-blind Treatment|Lung transplantation|0|||
28144819|NCT03099187|54811279|FG001|Double-blind Treatment|Lung transplantation|1|||
28144820|NCT03099187|54811280|FG002|Double-blind Treatment|Lung transplantation|0|||
28144821|NCT03099187|54811281|FG003|Double-blind Treatment|Lung transplantation|0|||
28144822|NCT03099187|54811278|FG000|Double-blind Treatment|Non-compliance with study drug|0|||
28144823|NCT03099187|54811279|FG001|Double-blind Treatment|Non-compliance with study drug|2|||
28144824|NCT03099187|54811280|FG002|Double-blind Treatment|Non-compliance with study drug|0|||
28144825|NCT03099187|54811281|FG003|Double-blind Treatment|Non-compliance with study drug|0|||
28144826|NCT03099187|54811278|FG000|Double-blind Treatment|Disease progression|0|||
28144827|NCT03099187|54811279|FG001|Double-blind Treatment|Disease progression|1|||
28144828|NCT03099187|54811280|FG002|Double-blind Treatment|Disease progression|0|||
28144829|NCT03099187|54811281|FG003|Double-blind Treatment|Disease progression|0|||
28144830|NCT03099187|54811278|FG000|Double-blind Treatment|Randomization error|0|||
28144831|NCT03099187|54811279|FG001|Double-blind Treatment|Randomization error|2|||
27822646|NCT01840579|54286389|FG000|Overall Study|Ongoing in study|0|||
28144832|NCT03099187|54811280|FG002|Double-blind Treatment|Randomization error|0|||
27822647|NCT01840579|54286390|FG001|Overall Study|Ongoing in study|1|||
28144833|NCT03099187|54811281|FG003|Double-blind Treatment|Randomization error|0|||
28144834|NCT03099187|54811278|FG000|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
28144835|NCT03099187|54811279|FG001|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
28144836|NCT03099187|54811280|FG002|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
28144837|NCT03099187|54811281|FG003|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
28144838|NCT03099187|54811278|FG000|12-month Safety Follow-up|Adverse Event|0|||
28144839|NCT03099187|54811279|FG001|12-month Safety Follow-up|Adverse Event|0|||
28144840|NCT03099187|54811280|FG002|12-month Safety Follow-up|Adverse Event|5|||
28144841|NCT03099187|54811281|FG003|12-month Safety Follow-up|Adverse Event|12|||
28144842|NCT03099187|54811278|FG000|12-month Safety Follow-up|Death|0|||
28144843|NCT03099187|54811279|FG001|12-month Safety Follow-up|Death|0|||
28144844|NCT03099187|54811280|FG002|12-month Safety Follow-up|Death|7|||
28144845|NCT03099187|54811281|FG003|12-month Safety Follow-up|Death|9|||
28144846|NCT03099187|54811278|FG000|12-month Safety Follow-up|Lung transplantation|0|||
28144847|NCT03099187|54811279|FG001|12-month Safety Follow-up|Lung transplantation|0|||
28144848|NCT03099187|54811280|FG002|12-month Safety Follow-up|Lung transplantation|2|||
28144849|NCT03099187|54811281|FG003|12-month Safety Follow-up|Lung transplantation|1|||
28144850|NCT03099187|54811278|FG000|12-month Safety Follow-up|Lost to Follow-up|0|||
28144851|NCT03099187|54811279|FG001|12-month Safety Follow-up|Lost to Follow-up|0|||
28144852|NCT03099187|54811280|FG002|12-month Safety Follow-up|Lost to Follow-up|1|||
28144853|NCT03099187|54811281|FG003|12-month Safety Follow-up|Lost to Follow-up|0|||
28144854|NCT03099187|54811278|FG000|12-month Safety Follow-up|Symptomatic deterioration|0|||
28144855|NCT03099187|54811279|FG001|12-month Safety Follow-up|Symptomatic deterioration|0|||
27941377|NCT01218659|54597816|FG002|12-Month OLE|Lost to Follow-up|1|||
27941378|NCT01218659|54597814|FG000|12-Month OLE|Pregnancy|0|||
27941379|NCT01218659|54597815|FG001|12-Month OLE|Pregnancy|0|||
28071915|NCT03559270|54726669|FG002|Overall Study|Lost to Follow-up|12|||
27941380|NCT01218659|54597816|FG002|12-Month OLE|Pregnancy|1|||
27941381|NCT01218659|54597814|FG000|12-Month OLE|Lack of Efficacy|0|||
27941382|NCT01218659|54597815|FG001|12-Month OLE|Lack of Efficacy|0|||
27941383|NCT01218659|54597816|FG002|12-Month OLE|Lack of Efficacy|1|||
27941384|NCT01218659|54597814|FG000|12-Month OLE|Declined to participate in the OLE|0|||
27941385|NCT01218659|54597815|FG001|12-Month OLE|Declined to participate in the OLE|0|||
27941386|NCT01218659|54597816|FG002|12-Month OLE|Declined to participate in the OLE|4|||
27941387|NCT00940498|54597831|FG000|Overall Study|Death|2|||
27941388|NCT00940498|54597832|FG001|Overall Study|Death|0|||
27941389|NCT00940498|54597833|FG002|Overall Study|Death|0|||
27941390|NCT00940498|54597834|FG003|Overall Study|Death|1|||
28144856|NCT03099187|54811280|FG002|12-month Safety Follow-up|Symptomatic deterioration|1|||
28144857|NCT03099187|54811281|FG003|12-month Safety Follow-up|Symptomatic deterioration|1|||
28144858|NCT03099187|54811278|FG000|12-month Safety Follow-up|Withdrawal by Subject|0|||
28144859|NCT03099187|54811279|FG001|12-month Safety Follow-up|Withdrawal by Subject|0|||
28144860|NCT03099187|54811280|FG002|12-month Safety Follow-up|Withdrawal by Subject|3|||
28144861|NCT03099187|54811281|FG003|12-month Safety Follow-up|Withdrawal by Subject|2|||
28144862|NCT03099187|54811278|FG000|12-month Safety Follow-up|Due to hospitalization|0|||
28144863|NCT03099187|54811279|FG001|12-month Safety Follow-up|Due to hospitalization|0|||
28144864|NCT03099187|54811280|FG002|12-month Safety Follow-up|Due to hospitalization|0|||
28144865|NCT03099187|54811281|FG003|12-month Safety Follow-up|Due to hospitalization|1|||
28144866|NCT04535453|54811303|FG000|Overall Study|Death|0|||
28144867|NCT04535453|54811304|FG001|Overall Study|Death|1|||
28144868|NCT04535453|54811305|FG002|Overall Study|Death|0|||
28144869|NCT04535453|54811306|FG003|Overall Study|Death|0|||
28144870|NCT04535453|54811307|FG004|Overall Study|Death|0|||
28144871|NCT04535453|54811308|FG005|Overall Study|Death|0|||
28144872|NCT04535453|54811309|FG006|Overall Study|Death|0|||
28144873|NCT04535453|54811310|FG007|Overall Study|Death|0|||
28144874|NCT04535453|54811311|FG008|Overall Study|Death|0|||
28144875|NCT04535453|54811312|FG009|Overall Study|Death|0|||
28144876|NCT04535453|54811313|FG010|Overall Study|Death|0|||
28071916|NCT03559270|54726670|FG003|Overall Study|Lost to Follow-up|3|||
28071917|NCT03559270|54726667|FG000|Overall Study|Sponsor Decision|38|||
28071918|NCT03559270|54726668|FG001|Overall Study|Sponsor Decision|31|||
28071919|NCT03559270|54726669|FG002|Overall Study|Sponsor Decision|35|||
28071920|NCT03559270|54726670|FG003|Overall Study|Sponsor Decision|18|||
28071921|NCT03559270|54726667|FG000|Overall Study|Withdrawal by Subject|19|||
28071922|NCT03559270|54726668|FG001|Overall Study|Withdrawal by Subject|21|||
28071923|NCT03559270|54726669|FG002|Overall Study|Withdrawal by Subject|18|||
28144877|NCT04535453|54811314|FG011|Overall Study|Death|0|||
28144878|NCT04535453|54811303|FG000|Overall Study|Lost to Follow-up|1|||
28144879|NCT04535453|54811304|FG001|Overall Study|Lost to Follow-up|1|||
28144880|NCT04535453|54811305|FG002|Overall Study|Lost to Follow-up|1|||
28144881|NCT04535453|54811306|FG003|Overall Study|Lost to Follow-up|0|||
28144882|NCT04535453|54811307|FG004|Overall Study|Lost to Follow-up|3|||
27941391|NCT00940498|54597835|FG004|Overall Study|Death|5|||
27941392|NCT00940498|54597836|FG005|Overall Study|Death|0|||
28071924|NCT03559270|54726670|FG003|Overall Study|Withdrawal by Subject|7|||
28144883|NCT04535453|54811308|FG005|Overall Study|Lost to Follow-up|1|||
28144884|NCT04535453|54811309|FG006|Overall Study|Lost to Follow-up|0|||
28144885|NCT04535453|54811310|FG007|Overall Study|Lost to Follow-up|0|||
28071925|NCT03559270|54726667|FG000|Overall Study|Physician Decision|3|||
27941393|NCT00940498|54597837|FG006|Overall Study|Death|1|||
28071926|NCT03559270|54726668|FG001|Overall Study|Physician Decision|2|||
28144886|NCT04535453|54811311|FG008|Overall Study|Lost to Follow-up|1|||
28144887|NCT04535453|54811312|FG009|Overall Study|Lost to Follow-up|1|||
28144888|NCT04535453|54811313|FG010|Overall Study|Lost to Follow-up|0|||
28144889|NCT04535453|54811314|FG011|Overall Study|Lost to Follow-up|0|||
28144890|NCT04535453|54811303|FG000|Overall Study|Physician Decision|0|||
28144891|NCT04535453|54811304|FG001|Overall Study|Physician Decision|0|||
28144892|NCT04535453|54811305|FG002|Overall Study|Physician Decision|0|||
28144893|NCT04535453|54811306|FG003|Overall Study|Physician Decision|1|||
28144894|NCT04535453|54811307|FG004|Overall Study|Physician Decision|0|||
28144895|NCT04535453|54811308|FG005|Overall Study|Physician Decision|0|||
28144896|NCT04535453|54811309|FG006|Overall Study|Physician Decision|0|||
28144897|NCT04535453|54811310|FG007|Overall Study|Physician Decision|0|||
28144898|NCT04535453|54811311|FG008|Overall Study|Physician Decision|0|||
28144899|NCT04535453|54811312|FG009|Overall Study|Physician Decision|0|||
28144900|NCT04535453|54811313|FG010|Overall Study|Physician Decision|0|||
28144901|NCT04535453|54811314|FG011|Overall Study|Physician Decision|0|||
28144902|NCT04535453|54811303|FG000|Overall Study|Withdrawal by Subject|3|||
28144903|NCT04535453|54811304|FG001|Overall Study|Withdrawal by Subject|6|||
28144904|NCT04535453|54811305|FG002|Overall Study|Withdrawal by Subject|3|||
28144905|NCT04535453|54811306|FG003|Overall Study|Withdrawal by Subject|3|||
28144906|NCT04535453|54811307|FG004|Overall Study|Withdrawal by Subject|2|||
28144907|NCT04535453|54811308|FG005|Overall Study|Withdrawal by Subject|1|||
28144908|NCT04535453|54811309|FG006|Overall Study|Withdrawal by Subject|1|||
28144909|NCT04535453|54811310|FG007|Overall Study|Withdrawal by Subject|1|||
28144910|NCT04535453|54811311|FG008|Overall Study|Withdrawal by Subject|1|||
28144911|NCT04535453|54811312|FG009|Overall Study|Withdrawal by Subject|1|||
28144912|NCT04535453|54811313|FG010|Overall Study|Withdrawal by Subject|0|||
28144913|NCT04535453|54811314|FG011|Overall Study|Withdrawal by Subject|1|||
28144914|NCT04535453|54811303|FG000|Overall Study|Other|0|||
28144915|NCT04535453|54811304|FG001|Overall Study|Other|0|||
28144916|NCT04535453|54811305|FG002|Overall Study|Other|1|||
28144917|NCT04535453|54811306|FG003|Overall Study|Other|0|||
28144918|NCT04535453|54811307|FG004|Overall Study|Other|1|||
28144919|NCT04535453|54811308|FG005|Overall Study|Other|0|||
28144920|NCT04535453|54811309|FG006|Overall Study|Other|1|||
28144921|NCT04535453|54811310|FG007|Overall Study|Other|1|||
28144922|NCT04535453|54811311|FG008|Overall Study|Other|1|||
28144923|NCT04535453|54811312|FG009|Overall Study|Other|0|||
28144924|NCT04535453|54811313|FG010|Overall Study|Other|0|||
28144925|NCT04535453|54811314|FG011|Overall Study|Other|0|||
28144926|NCT04463069|54811357|FG000|Overall Study|Withdrawal by Subject|2|||
28144927|NCT04463069|54811358|FG001|Overall Study|Withdrawal by Subject|10|||
28144928|NCT04463069|54811357|FG000|Overall Study|Participants' parents refused to participate after learning the assignment results|0|||
28144929|NCT04463069|54811358|FG001|Overall Study|Participants' parents refused to participate after learning the assignment results|13|||
28144930|NCT03521687|54811364|FG000|Overall Study|Adverse Event|4|||
28144931|NCT03521687|54811364|FG000|Overall Study|Physician Decision|1|||
28144932|NCT03125915|54811372|FG000|1 Month Follow up|Lost to Follow-up|3|||
27850054|NCT00129935|54348350|FG001|Overall Study|Crossed to the other arm|1|||
27850055|NCT00129935|54348349|FG000|Overall Study|Incorrect study treatment|1|||
27850056|NCT00129935|54348350|FG001|Overall Study|Incorrect study treatment|0|||
27850057|NCT01647828|54348365|FG000|Overall Study|Death|3|||
28144933|NCT03125915|54811373|FG001|1 Month Follow up|Lost to Follow-up|3|||
28144934|NCT03125915|54811374|FG002|1 Month Follow up|Lost to Follow-up|2|||
28144935|NCT03125915|54811375|FG003|1 Month Follow up|Lost to Follow-up|3|||
28144936|NCT03125915|54811372|FG000|3 Month Follow-up|Lost to Follow-up|6|||
28144937|NCT03125915|54811373|FG001|3 Month Follow-up|Lost to Follow-up|4|||
28144938|NCT03125915|54811374|FG002|3 Month Follow-up|Lost to Follow-up|4|||
28144939|NCT03125915|54811375|FG003|3 Month Follow-up|Lost to Follow-up|2|||
28144940|NCT03125915|54811372|FG000|6 Month Follow-up|Lost to Follow-up|7|||
28144941|NCT03125915|54811373|FG001|6 Month Follow-up|Lost to Follow-up|3|||
28144942|NCT03125915|54811374|FG002|6 Month Follow-up|Lost to Follow-up|6|||
28144943|NCT03125915|54811375|FG003|6 Month Follow-up|Lost to Follow-up|3|||
28144944|NCT03122171|54811385|FG000|Overall Study|Withdrawal by Subject|1|||
28144945|NCT01427725|54811389|FG000|Overall Study|Lost to Follow-up|17|||
28144946|NCT01427725|54811389|FG000|Overall Study|Protocol Violation|1|||
28144947|NCT01427725|54811389|FG000|Overall Study|Drug not administered|1|||
28144948|NCT01427725|54811389|FG000|Overall Study|Failure to visit|7|||
28144949|NCT01427725|54811389|FG000|Overall Study|Adverse Event|46|||
28144950|NCT01427725|54811389|FG000|Overall Study|Failure to visit after administration|40|||
28144951|NCT01427725|54811389|FG000|Overall Study|Patient's rejection|27|||
28144952|NCT01427725|54811389|FG000|Overall Study|Transfer to a different hospital|17|||
28144953|NCT01427725|54811389|FG000|Overall Study|Lack of Efficacy|8|||
28144954|NCT01427725|54811389|FG000|Overall Study|Death|7|||
28144955|NCT01427725|54811389|FG000|Overall Study|Symptom improvement|6|||
28144956|NCT01427725|54811389|FG000|Overall Study|AE and Patient's rejection|5|||
28144957|NCT01427725|54811389|FG000|Overall Study|Physician Decision|5|||
28144958|NCT01427725|54811389|FG000|Overall Study|Exacerbation of underlying disease|5|||
28144959|NCT01427725|54811389|FG000|Overall Study|Oral feeding difficulty|5|||
28144960|NCT01427725|54811389|FG000|Overall Study|Lack of Efficacy and Patient's rejection|1|||
28144961|NCT01427725|54811389|FG000|Overall Study|Forgetting prescription|1|||
28144962|NCT01427725|54811389|FG000|Overall Study|Other|2|||
28144963|NCT02839200|54811400|FG000|Overall Study|Withdrawal by Subject|2|||
28144964|NCT02839200|54811401|FG001|Overall Study|Withdrawal by Subject|0|||
28144965|NCT02839200|54811402|FG002|Overall Study|Withdrawal by Subject|1|||
28144966|NCT02839200|54811403|FG003|Overall Study|Withdrawal by Subject|0|||
28144967|NCT02839200|54811404|FG004|Overall Study|Withdrawal by Subject|0|||
28144968|NCT02839200|54811405|FG005|Overall Study|Withdrawal by Subject|1|||
28144969|NCT02839200|54811400|FG000|Overall Study|Lost to Follow-up|2|||
28144970|NCT02839200|54811401|FG001|Overall Study|Lost to Follow-up|0|||
28144971|NCT02839200|54811402|FG002|Overall Study|Lost to Follow-up|0|||
28144972|NCT02839200|54811403|FG003|Overall Study|Lost to Follow-up|0|||
28144973|NCT02839200|54811404|FG004|Overall Study|Lost to Follow-up|1|||
28144974|NCT02839200|54811405|FG005|Overall Study|Lost to Follow-up|0|||
28144975|NCT02839200|54811400|FG000|Overall Study|Adverse Event|0|||
28144976|NCT02839200|54811401|FG001|Overall Study|Adverse Event|0|||
28144977|NCT02839200|54811402|FG002|Overall Study|Adverse Event|0|||
28144978|NCT02839200|54811403|FG003|Overall Study|Adverse Event|0|||
28144979|NCT02839200|54811404|FG004|Overall Study|Adverse Event|1|||
28144980|NCT02839200|54811405|FG005|Overall Study|Adverse Event|0|||
28144981|NCT02839200|54811400|FG000|Overall Study|Randomized in error|0|||
28144982|NCT02839200|54811401|FG001|Overall Study|Randomized in error|1|||
28144983|NCT02839200|54811402|FG002|Overall Study|Randomized in error|0|||
28144984|NCT02839200|54811403|FG003|Overall Study|Randomized in error|0|||
28144985|NCT02839200|54811404|FG004|Overall Study|Randomized in error|0|||
28144986|NCT02839200|54811405|FG005|Overall Study|Randomized in error|0|||
28144987|NCT03118739|54811421|FG000|Overall Study|Physician Decision|0|||
28144988|NCT03118739|54811422|FG001|Overall Study|Physician Decision|1|||
28144989|NCT03118739|54811421|FG000|Overall Study|Withdrawal by Subject|5|||
28144990|NCT03118739|54811422|FG001|Overall Study|Withdrawal by Subject|3|||
28144991|NCT03118739|54811421|FG000|Overall Study|Lost to Follow-up|2|||
28144992|NCT03118739|54811422|FG001|Overall Study|Lost to Follow-up|0|||
28144993|NCT03094195|54811431|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12|||
28144994|NCT03094195|54811432|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10|||
28144995|NCT03094195|54811433|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11|||
28144996|NCT03094195|54811434|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
28144997|NCT03094195|54811435|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
28144998|NCT03094195|54811436|FG005|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
28144999|NCT03094195|54811437|FG006|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
28145000|NCT03094195|54811438|FG007|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
28145001|NCT03094195|54811431|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
28145002|NCT03094195|54811432|FG001|Double-Blind Treatment Period (DB)|Adverse Event|2|||
28145003|NCT03094195|54811433|FG002|Double-Blind Treatment Period (DB)|Adverse Event|1|||
28145004|NCT03094195|54811434|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
28145005|NCT03094195|54811435|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
28145006|NCT03094195|54811436|FG005|Double-Blind Treatment Period (DB)|Adverse Event|0|||
28145007|NCT03094195|54811437|FG006|Double-Blind Treatment Period (DB)|Adverse Event|0|||
28145008|NCT03094195|54811438|FG007|Double-Blind Treatment Period (DB)|Adverse Event|0|||
28145009|NCT03094195|54811431|FG000|Double-Blind Treatment Period (DB)|Physician Decision|0|||
28145010|NCT03094195|54811432|FG001|Double-Blind Treatment Period (DB)|Physician Decision|0|||
28145011|NCT03094195|54811433|FG002|Double-Blind Treatment Period (DB)|Physician Decision|1|||
28145012|NCT03094195|54811434|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
28145013|NCT03094195|54811435|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
28145014|NCT03094195|54811436|FG005|Double-Blind Treatment Period (DB)|Physician Decision|0|||
28145015|NCT03094195|54811437|FG006|Double-Blind Treatment Period (DB)|Physician Decision|0|||
28145016|NCT03094195|54811438|FG007|Double-Blind Treatment Period (DB)|Physician Decision|0|||
28145017|NCT03094195|54811431|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
28145018|NCT03094195|54811432|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
28145019|NCT03094195|54811433|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
28145020|NCT03094195|54811434|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
28145021|NCT03094195|54811435|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
28145022|NCT03094195|54811436|FG005|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
28145023|NCT03094195|54811437|FG006|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
28145024|NCT03094195|54811438|FG007|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
28145025|NCT02835690|54811459|FG000|Overall Study|Death|12|||
28145026|NCT02835690|54811460|FG001|Overall Study|Death|11|||
28145027|NCT02835690|54811461|FG002|Overall Study|Death|13|||
28145028|NCT02835690|54811459|FG000|Overall Study|Transferred to Extension Study|2|||
28145029|NCT02835690|54811460|FG001|Overall Study|Transferred to Extension Study|2|||
28145030|NCT02835690|54811461|FG002|Overall Study|Transferred to Extension Study|1|||
28145031|NCT02835690|54811459|FG000|Overall Study|Did Not Continue on Extension Study|0|||
28145032|NCT02835690|54811460|FG001|Overall Study|Did Not Continue on Extension Study|0|||
28145033|NCT02835690|54811461|FG002|Overall Study|Did Not Continue on Extension Study|1|||
28145034|NCT02835690|54811459|FG000|Overall Study|Not Treated|0|||
28145035|NCT02835690|54811460|FG001|Overall Study|Not Treated|2|||
28145036|NCT02835690|54811461|FG002|Overall Study|Not Treated|0|||
28145037|NCT02837952|54811472|FG000|Overall Study|Adverse Event|0|||
28145038|NCT02837952|54811473|FG001|Overall Study|Adverse Event|1|||
28145039|NCT02837952|54811472|FG000|Overall Study|Withdrawal by Subject|4|||
28145040|NCT02837952|54811473|FG001|Overall Study|Withdrawal by Subject|5|||
28145041|NCT02837952|54811472|FG000|Overall Study|Medication Error|1|||
28145042|NCT02837952|54811473|FG001|Overall Study|Medication Error|0|||
28145043|NCT02832167|54811479|FG000|Treatment Period 1|Disease progression|90|||
28145044|NCT02832167|54811479|FG000|Treatment Period 1|Adverse event unrelated to study drug|12|||
28145045|NCT02832167|54811479|FG000|Treatment Period 1|Death|2|||
28145046|NCT02832167|54811479|FG000|Treatment Period 1|Study Drug Toxicity|6|||
28145047|NCT02832167|54811479|FG000|Treatment Period 1|Participant request to discontinue|9|||
28145048|NCT02832167|54811479|FG000|Treatment Period 1|No longer meet study criteria|1|||
28145049|NCT02832167|54811479|FG000|Treatment Period 1|Participant withdrew consent|3|||
28145050|NCT02832167|54811479|FG000|Treatment Period 1|Other reasons|6|||
28145051|NCT02832167|54811479|FG000|Transition From Period 1 to Period 2|Other reasons|1|||
28145052|NCT02832167|54811479|FG000|Transition From Period 1 to Period 2|Participant withdrew consent|1|||
28145053|NCT02832167|54811479|FG000|Transition From Period 1 to Period 2|Death|2|||
28145054|NCT02832167|54811479|FG000|Transition From Period 1 to Period 2|Lost to Follow-up|3|||
28145055|NCT02832167|54811479|FG000|Treatment Period 2|Disease progression|69|||
28145056|NCT02832167|54811479|FG000|Treatment Period 2|Adverse event unrelated to study drug|1|||
28145057|NCT02832167|54811479|FG000|Treatment Period 2|Maximum clinical benefit|1|||
28145058|NCT02832167|54811479|FG000|Treatment Period 2|Study Drug Toxicity|5|||
28145059|NCT02832167|54811479|FG000|Treatment Period 2|Participant request to discontinue|2|||
28145060|NCT02832167|54811479|FG000|Treatment Period 2|Participant withdrew consent|3|||
28145061|NCT02832167|54811479|FG000|Treatment Period 2|Other reasons|3|||
28145062|NCT02674529|54811485|FG000|Overall Study|Lost to Follow-up|1|||
28145063|NCT02674529|54811486|FG001|Overall Study|Lost to Follow-up|2|||
27822648|NCT01840579|54286391|FG002|Overall Study|Ongoing in study|0|||
28145064|NCT02674529|54811485|FG000|Overall Study|Withdrawal by Subject|2|||
28145065|NCT02674529|54811486|FG001|Overall Study|Withdrawal by Subject|1|||
28145066|NCT02674529|54811485|FG000|Overall Study|Physician Decision|0|||
28145067|NCT02674529|54811486|FG001|Overall Study|Physician Decision|1|||
28145068|NCT02674529|54811485|FG000|Overall Study|Protocol Violation|0|||
28145069|NCT02674529|54811486|FG001|Overall Study|Protocol Violation|1|||
28145070|NCT02626949|54811497|FG000|Randomization, Pre-Enrollment|did not attend the baseline interview|15|||
28145071|NCT02626949|54811498|FG001|Randomization, Pre-Enrollment|did not attend the baseline interview|11|||
28145072|NCT02626949|54811497|FG000|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|1|||
28145073|NCT02626949|54811498|FG001|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|3|||
28145074|NCT02626949|54811497|FG000|Enrolled|Lost to Follow-up|7|||
28145075|NCT02626949|54811498|FG001|Enrolled|Lost to Follow-up|6|||
28145076|NCT02626949|54811497|FG000|Enrolled|Withdrawal by Subject|3|||
28145077|NCT02626949|54811498|FG001|Enrolled|Withdrawal by Subject|2|||
28145078|NCT03116399|54811506|FG000|Overall Study|Death|8|||
28145079|NCT03116399|54811507|FG001|Overall Study|Death|3|||
28145080|NCT03116399|54811506|FG000|Overall Study|Lost to Follow-up|7|||
28145081|NCT03116399|54811507|FG001|Overall Study|Lost to Follow-up|11|||
28145082|NCT03116399|54811506|FG000|Overall Study|Investigator Decision|1|||
28145083|NCT03116399|54811507|FG001|Overall Study|Investigator Decision|1|||
28145084|NCT03116399|54811506|FG000|Overall Study|Withdrawal by Subject|24|||
28145085|NCT03116399|54811507|FG001|Overall Study|Withdrawal by Subject|9|||
28145086|NCT03097861|54811516|FG000|Overall Study|Adverse Event|3|||
28145087|NCT03097861|54811517|FG001|Overall Study|Adverse Event|8|||
28145088|NCT03097861|54811518|FG002|Overall Study|Adverse Event|4|||
28145089|NCT03097861|54811516|FG000|Overall Study|Investigator Decision|0|||
28145090|NCT03097861|54811517|FG001|Overall Study|Investigator Decision|1|||
28145091|NCT03097861|54811518|FG002|Overall Study|Investigator Decision|0|||
28145092|NCT03097861|54811516|FG000|Overall Study|Lost to Follow-up|0|||
28145093|NCT03097861|54811517|FG001|Overall Study|Lost to Follow-up|7|||
28145094|NCT03097861|54811518|FG002|Overall Study|Lost to Follow-up|1|||
28145095|NCT03097861|54811516|FG000|Overall Study|Withdrawal by Subject|1|||
28145096|NCT03097861|54811517|FG001|Overall Study|Withdrawal by Subject|5|||
28145097|NCT03097861|54811518|FG002|Overall Study|Withdrawal by Subject|3|||
28145098|NCT03097861|54811516|FG000|Overall Study|Reason not provided|3|||
28145099|NCT03097861|54811517|FG001|Overall Study|Reason not provided|1|||
28145100|NCT03097861|54811518|FG002|Overall Study|Reason not provided|1|||
28145101|NCT03910673|54811533|FG000|Overall Study|Adverse Event|0|||
28145102|NCT03910673|54811534|FG001|Overall Study|Adverse Event|0|||
28145103|NCT03910673|54811535|FG002|Overall Study|Adverse Event|0|||
28145104|NCT03910673|54811536|FG003|Overall Study|Adverse Event|2|||
28145105|NCT03910673|54811537|FG004|Overall Study|Adverse Event|0|||
28145106|NCT01816139|54811543|FG000|Overall Study|Adverse Event|6|||
28145107|NCT01816139|54811544|FG001|Overall Study|Adverse Event|8|||
28145108|NCT01816139|54811543|FG000|Overall Study|Lack of Efficacy|1|||
28145109|NCT01816139|54811544|FG001|Overall Study|Lack of Efficacy|2|||
28145110|NCT01816139|54811543|FG000|Overall Study|Lost to Follow-up|5|||
28145111|NCT01816139|54811544|FG001|Overall Study|Lost to Follow-up|3|||
28145112|NCT01816139|54811543|FG000|Overall Study|Withdrew Consent|6|||
28145113|NCT01816139|54811544|FG001|Overall Study|Withdrew Consent|4|||
28145114|NCT01816139|54811543|FG000|Overall Study|Protocol Violation|6|||
28145115|NCT01816139|54811544|FG001|Overall Study|Protocol Violation|3|||
28071927|NCT03559270|54726669|FG002|Overall Study|Physician Decision|1|||
28071928|NCT03559270|54726670|FG003|Overall Study|Physician Decision|0|||
28071929|NCT03559270|54726667|FG000|Overall Study|Pregnancy|0|||
28071930|NCT03559270|54726668|FG001|Overall Study|Pregnancy|1|||
28071931|NCT03559270|54726669|FG002|Overall Study|Pregnancy|0|||
28071932|NCT03559270|54726670|FG003|Overall Study|Pregnancy|0|||
28071933|NCT03559270|54726667|FG000|Overall Study|Protocol Violation|1|||
28071934|NCT03559270|54726668|FG001|Overall Study|Protocol Violation|0|||
28071935|NCT03559270|54726669|FG002|Overall Study|Protocol Violation|2|||
28071936|NCT03559270|54726670|FG003|Overall Study|Protocol Violation|0|||
28071937|NCT02685826|54726725|FG000|Overall Study|Adverse Event|2|||
28071938|NCT02685826|54726726|FG001|Overall Study|Adverse Event|0|||
28071939|NCT02685826|54726727|FG002|Overall Study|Adverse Event|1|||
28071940|NCT02685826|54726725|FG000|Overall Study|Progressive Disease|2|||
28145116|NCT01816139|54811543|FG000|Overall Study|Reason not Specified|4|||
28145117|NCT01816139|54811544|FG001|Overall Study|Reason not Specified|2|||
28145118|NCT02833350|54811587|FG000|Overall Study|Adverse Event|0|||
28145119|NCT02833350|54811588|FG001|Overall Study|Adverse Event|3|||
28145120|NCT02833350|54811589|FG002|Overall Study|Adverse Event|4|||
28145121|NCT02833350|54811590|FG003|Overall Study|Adverse Event|4|||
27822649|NCT01840579|54286392|FG003|Overall Study|Ongoing in study|0|||
28071941|NCT02685826|54726726|FG001|Overall Study|Progressive Disease|1|||
28145122|NCT02833350|54811591|FG004|Overall Study|Adverse Event|1|||
28145123|NCT02833350|54811592|FG005|Overall Study|Adverse Event|0|||
28145124|NCT02833350|54811593|FG006|Overall Study|Adverse Event|1|||
28145125|NCT02833350|54811587|FG000|Overall Study|Death|0|||
28145126|NCT02833350|54811588|FG001|Overall Study|Death|0|||
28071942|NCT02685826|54726727|FG002|Overall Study|Progressive Disease|0|||
28071943|NCT02685826|54726725|FG000|Overall Study|Withdrawal by Subject|2|||
28071944|NCT02685826|54726726|FG001|Overall Study|Withdrawal by Subject|0|||
28071945|NCT02685826|54726727|FG002|Overall Study|Withdrawal by Subject|0|||
28071946|NCT02685826|54726725|FG000|Overall Study|Full Clinical Hold by FDA|19|||
28071947|NCT02685826|54726726|FG001|Overall Study|Full Clinical Hold by FDA|9|||
28071948|NCT02685826|54726727|FG002|Overall Study|Full Clinical Hold by FDA|20|||
28071949|NCT00114777|54726738|FG000|Randomization to Month 36|Death|10|||
28071950|NCT00114777|54726739|FG001|Randomization to Month 36|Death|4|||
28071951|NCT00114777|54726740|FG002|Randomization to Month 36|Death|3|||
28071952|NCT00114777|54726738|FG000|Randomization to Month 36|No Longer Met Study Criteria|0|||
28071953|NCT00114777|54726739|FG001|Randomization to Month 36|No Longer Met Study Criteria|0|||
28071954|NCT00114777|54726740|FG002|Randomization to Month 36|No Longer Met Study Criteria|2|||
28071955|NCT00114777|54726738|FG000|Randomization to Month 36|Lack of Efficacy|19|||
28071956|NCT00114777|54726739|FG001|Randomization to Month 36|Lack of Efficacy|15|||
28071957|NCT00114777|54726740|FG002|Randomization to Month 36|Lack of Efficacy|17|||
28071958|NCT00114777|54726738|FG000|Randomization to Month 36|Poor or Non-Compliance|0|||
28071959|NCT00114777|54726739|FG001|Randomization to Month 36|Poor or Non-Compliance|0|||
28071960|NCT00114777|54726740|FG002|Randomization to Month 36|Poor or Non-Compliance|1|||
28071961|NCT00114777|54726738|FG000|Randomization to Month 36|Adverse Event|34|||
28071962|NCT00114777|54726739|FG001|Randomization to Month 36|Adverse Event|35|||
28071963|NCT00114777|54726740|FG002|Randomization to Month 36|Adverse Event|44|||
28071964|NCT00114777|54726738|FG000|Randomization to Month 36|Withdrawal by Subject|3|||
28071965|NCT00114777|54726739|FG001|Randomization to Month 36|Withdrawal by Subject|4|||
28071966|NCT00114777|54726740|FG002|Randomization to Month 36|Withdrawal by Subject|5|||
28071967|NCT00114777|54726738|FG000|Randomization to Month 36|Other|9|||
28071968|NCT00114777|54726739|FG001|Randomization to Month 36|Other|3|||
28071969|NCT00114777|54726740|FG002|Randomization to Month 36|Other|12|||
28071970|NCT00114777|54726738|FG000|Long-Term Extension to Month 84|Death|8|||
28071971|NCT00114777|54726739|FG001|Long-Term Extension to Month 84|Death|13|||
28071972|NCT00114777|54726740|FG002|Long-Term Extension to Month 84|Death|7|||
28071973|NCT00114777|54726738|FG000|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
28071974|NCT00114777|54726739|FG001|Long-Term Extension to Month 84|No Longer Met Study Criteria|0|||
28071975|NCT00114777|54726740|FG002|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
28071976|NCT00114777|54726738|FG000|Long-Term Extension to Month 84|Lack of Efficacy|1|||
28071977|NCT00114777|54726739|FG001|Long-Term Extension to Month 84|Lack of Efficacy|0|||
28071978|NCT00114777|54726740|FG002|Long-Term Extension to Month 84|Lack of Efficacy|1|||
28145127|NCT02833350|54811589|FG002|Overall Study|Death|1|||
28145128|NCT02833350|54811590|FG003|Overall Study|Death|0|||
27822650|NCT01840579|54286393|FG004|Overall Study|Ongoing in study|0|||
27822651|NCT01840579|54286394|FG005|Overall Study|Ongoing in study|0|||
28071979|NCT00114777|54726738|FG000|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
28071980|NCT00114777|54726739|FG001|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
28071981|NCT00114777|54726740|FG002|Long-Term Extension to Month 84|Poor or Non-Compliance|3|||
28145129|NCT02833350|54811591|FG004|Overall Study|Death|0|||
28071982|NCT00114777|54726738|FG000|Long-Term Extension to Month 84|Adverse Event|15|||
28071983|NCT00114777|54726739|FG001|Long-Term Extension to Month 84|Adverse Event|14|||
28071984|NCT00114777|54726740|FG002|Long-Term Extension to Month 84|Adverse Event|7|||
28071985|NCT00114777|54726738|FG000|Long-Term Extension to Month 84|Withdrawal by Subject|2|||
28071986|NCT00114777|54726739|FG001|Long-Term Extension to Month 84|Withdrawal by Subject|1|||
28071987|NCT00114777|54726740|FG002|Long-Term Extension to Month 84|Withdrawal by Subject|6|||
28071988|NCT00114777|54726738|FG000|Long-Term Extension to Month 84|Lost to Follow-up|0|||
28071989|NCT00114777|54726739|FG001|Long-Term Extension to Month 84|Lost to Follow-up|0|||
28071990|NCT00114777|54726740|FG002|Long-Term Extension to Month 84|Lost to Follow-up|2|||
28071991|NCT00114777|54726738|FG000|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
28071992|NCT00114777|54726739|FG001|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
28071993|NCT00114777|54726740|FG002|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1|||
28071994|NCT00114777|54726738|FG000|Long-Term Extension to Month 84|Other|2|||
28071995|NCT00114777|54726739|FG001|Long-Term Extension to Month 84|Other|0|||
28071996|NCT00114777|54726740|FG002|Long-Term Extension to Month 84|Other|2|||
28071997|NCT00139737|54726749|FG000|Overall Study|Withdrawal by Subject|190|||
28145130|NCT02833350|54811592|FG005|Overall Study|Death|0|||
28145131|NCT02833350|54811593|FG006|Overall Study|Death|0|||
28145132|NCT02833350|54811587|FG000|Overall Study|Lack of Efficacy|0|||
28145133|NCT02833350|54811588|FG001|Overall Study|Lack of Efficacy|2|||
28145134|NCT02833350|54811589|FG002|Overall Study|Lack of Efficacy|1|||
28145135|NCT02833350|54811590|FG003|Overall Study|Lack of Efficacy|4|||
28145136|NCT02833350|54811591|FG004|Overall Study|Lack of Efficacy|0|||
28145137|NCT02833350|54811592|FG005|Overall Study|Lack of Efficacy|1|||
28145138|NCT02833350|54811593|FG006|Overall Study|Lack of Efficacy|1|||
28145139|NCT02833350|54811587|FG000|Overall Study|Lost to Follow-up|0|||
28145140|NCT02833350|54811588|FG001|Overall Study|Lost to Follow-up|1|||
28145141|NCT02833350|54811589|FG002|Overall Study|Lost to Follow-up|0|||
28145142|NCT02833350|54811590|FG003|Overall Study|Lost to Follow-up|0|||
28145143|NCT02833350|54811591|FG004|Overall Study|Lost to Follow-up|0|||
28145144|NCT02833350|54811592|FG005|Overall Study|Lost to Follow-up|0|||
28145145|NCT02833350|54811593|FG006|Overall Study|Lost to Follow-up|1|||
28145146|NCT02833350|54811587|FG000|Overall Study|Withdrawal by Subject|3|||
28145147|NCT02833350|54811588|FG001|Overall Study|Withdrawal by Subject|3|||
28145148|NCT02833350|54811589|FG002|Overall Study|Withdrawal by Subject|2|||
28145149|NCT02833350|54811590|FG003|Overall Study|Withdrawal by Subject|0|||
28145150|NCT02833350|54811591|FG004|Overall Study|Withdrawal by Subject|2|||
28145151|NCT02833350|54811592|FG005|Overall Study|Withdrawal by Subject|0|||
28145152|NCT02833350|54811593|FG006|Overall Study|Withdrawal by Subject|2|||
28145153|NCT01343043|54811616|FG000|Overall Study|Disease progression before treatment|1|||
28145154|NCT01343043|54811617|FG001|Overall Study|Disease progression before treatment|0|||
28145155|NCT01343043|54811618|FG002|Overall Study|Disease progression before treatment|0|||
27850058|NCT01647828|54348366|FG001|Overall Study|Death|4|||
28145156|NCT01343043|54811619|FG003|Overall Study|Disease progression before treatment|0|||
28145157|NCT01343043|54811616|FG000|Overall Study|Withdrawal by Subject|1|||
28145158|NCT01343043|54811617|FG001|Overall Study|Withdrawal by Subject|0|||
28145159|NCT01343043|54811618|FG002|Overall Study|Withdrawal by Subject|0|||
28145160|NCT01343043|54811619|FG003|Overall Study|Withdrawal by Subject|0|||
28145161|NCT01343043|54811616|FG000|Overall Study|Death|1|||
28145162|NCT01343043|54811617|FG001|Overall Study|Death|1|||
28145163|NCT01343043|54811618|FG002|Overall Study|Death|0|||
28145164|NCT01343043|54811619|FG003|Overall Study|Death|1|||
28145165|NCT03548987|54811634|FG000|Run-in Period (Week 0 to Week 20)|Other|9|||
28145166|NCT03548987|54811635|FG001|Run-in Period (Week 0 to Week 20)|Other|0|||
28145167|NCT03548987|54811634|FG000|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|8|||
28145168|NCT03548987|54811635|FG001|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|0|||
28145169|NCT03548987|54811634|FG000|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|11|||
28145170|NCT03548987|54811635|FG001|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|0|||
28145171|NCT03548987|54811634|FG000|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|2|||
28145172|NCT03548987|54811635|FG001|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|0|||
28145173|NCT03548987|54811634|FG000|Run-in Period (Week 0 to Week 20)|Run-in failure|19|||
28145174|NCT03548987|54811635|FG001|Run-in Period (Week 0 to Week 20)|Run-in failure|0|||
28145175|NCT03548987|54811634|FG000|Run-in Period (Week 0 to Week 20)|Pregnancy|1|||
28145176|NCT03548987|54811635|FG001|Run-in Period (Week 0 to Week 20)|Pregnancy|0|||
28145177|NCT03548987|54811634|FG000|Run-in Period (Week 0 to Week 20)|Protocol Violation|1|||
28145178|NCT03548987|54811635|FG001|Run-in Period (Week 0 to Week 20)|Protocol Violation|0|||
28145179|NCT03548987|54811634|FG000|Run-in Period (Week 0 to Week 20)|Adverse Event|48|||
28145180|NCT03548987|54811635|FG001|Run-in Period (Week 0 to Week 20)|Adverse Event|0|||
28145181|NCT03548987|54811634|FG000|Maintenance Period (Week 20 to Week 68)|other|12|||
28145182|NCT03548987|54811635|FG001|Maintenance Period (Week 20 to Week 68)|other|23|||
28145183|NCT03548987|54811634|FG000|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|2|||
28145184|NCT03548987|54811635|FG001|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|1|||
28145185|NCT03548987|54811634|FG000|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
28145186|NCT03548987|54811635|FG001|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
28145187|NCT03548987|54811634|FG000|Maintenance Period (Week 20 to Week 68)|Pregnancy|2|||
28145188|NCT03548987|54811635|FG001|Maintenance Period (Week 20 to Week 68)|Pregnancy|0|||
28145189|NCT03548987|54811634|FG000|Maintenance Period (Week 20 to Week 68)|Protocol Violation|1|||
28145190|NCT03548987|54811635|FG001|Maintenance Period (Week 20 to Week 68)|Protocol Violation|0|||
28145191|NCT03548987|54811634|FG000|Maintenance Period (Week 20 to Week 68)|Adverse Event|13|||
28145192|NCT03548987|54811635|FG001|Maintenance Period (Week 20 to Week 68)|Adverse Event|6|||
28145193|NCT01358760|54811645|FG000|Overall Study|Adverse Event|3|||
28145194|NCT01358760|54811646|FG001|Overall Study|Adverse Event|4|||
28145195|NCT01358760|54811647|FG002|Overall Study|Adverse Event|3|||
28145196|NCT01358760|54811645|FG000|Overall Study|Lost to Follow-up|1|||
28145197|NCT01358760|54811646|FG001|Overall Study|Lost to Follow-up|1|||
28145198|NCT01358760|54811647|FG002|Overall Study|Lost to Follow-up|3|||
28145199|NCT01358760|54811645|FG000|Overall Study|Withdrawal by Subject|5|||
28145200|NCT01358760|54811646|FG001|Overall Study|Withdrawal by Subject|3|||
28145201|NCT01358760|54811647|FG002|Overall Study|Withdrawal by Subject|2|||
28145202|NCT01358760|54811645|FG000|Overall Study|Physician Decision|1|||
28145203|NCT01358760|54811646|FG001|Overall Study|Physician Decision|0|||
28145204|NCT01358760|54811647|FG002|Overall Study|Physician Decision|1|||
28145205|NCT01358760|54811645|FG000|Overall Study|Entry criteria not met/Non-compliance|12|||
28145206|NCT01358760|54811646|FG001|Overall Study|Entry criteria not met/Non-compliance|12|||
28145207|NCT01358760|54811647|FG002|Overall Study|Entry criteria not met/Non-compliance|16|||
28145208|NCT01341990|54811657|FG000|Overall Study|Adverse Event|0|||
28145209|NCT01341990|54811658|FG001|Overall Study|Adverse Event|1|||
28145210|NCT01341990|54811657|FG000|Overall Study|Torn Study Lens|1|||
28145211|NCT01341990|54811658|FG001|Overall Study|Torn Study Lens|0|||
28145212|NCT01341990|54811657|FG000|Overall Study|Withdrawal by Subject|2|||
28145213|NCT01341990|54811658|FG001|Overall Study|Withdrawal by Subject|0|||
28145214|NCT03048747|54811664|FG000|Overall Study|Adverse Event|2|||
28145215|NCT03048747|54811664|FG000|Overall Study|Participant Met Withdrawal Criteria|2|||
28145216|NCT03048747|54811664|FG000|Overall Study|Physician Decision|1|||
28145217|NCT01991067|54811726|FG000|Overall Study|Lost to Follow-up|6|||
28145218|NCT01991067|54811727|FG001|Overall Study|Lost to Follow-up|5|||
28145219|NCT01709331|54811733|FG000|Overall Study|Adverse Event|1|||
28145220|NCT03255083|54811741|FG000|Overall Study|Clinical progression|1|||
28145221|NCT03255083|54811742|FG001|Overall Study|Clinical progression|0|||
28145222|NCT03255083|54811743|FG002|Overall Study|Clinical progression|0|||
28145223|NCT03255083|54811744|FG003|Overall Study|Clinical progression|0|||
28145224|NCT03255083|54811741|FG000|Overall Study|Adverse Event|0|||
27822652|NCT01840579|54286395|FG006|Overall Study|Ongoing in study|0|||
28145225|NCT03255083|54811742|FG001|Overall Study|Adverse Event|1|||
28145226|NCT03255083|54811743|FG002|Overall Study|Adverse Event|0|||
28145227|NCT03255083|54811744|FG003|Overall Study|Adverse Event|0|||
28145228|NCT03255083|54811741|FG000|Overall Study|Progressive disease by RECIST version 1.1|4|||
28145229|NCT03255083|54811742|FG001|Overall Study|Progressive disease by RECIST version 1.1|1|||
28145230|NCT03255083|54811743|FG002|Overall Study|Progressive disease by RECIST version 1.1|2|||
28145231|NCT03255083|54811744|FG003|Overall Study|Progressive disease by RECIST version 1.1|1|||
28145232|NCT03255083|54811741|FG000|Overall Study|Withdrawal by Subject|1|||
28145233|NCT03255083|54811742|FG001|Overall Study|Withdrawal by Subject|1|||
28145234|NCT03255083|54811743|FG002|Overall Study|Withdrawal by Subject|1|||
28145235|NCT03255083|54811744|FG003|Overall Study|Withdrawal by Subject|0|||
28145236|NCT04552587|54811760|FG000|Overall Study|Lost to Follow-up|4|||
28145237|NCT01316055|54811776|FG000|Overall Study|Lost to Follow-up|1|||
28145238|NCT01316055|54811777|FG001|Overall Study|Lost to Follow-up|0|||
28145239|NCT01316055|54811778|FG002|Overall Study|Lost to Follow-up|0|||
28145240|NCT01340976|54811795|FG000|Overall Study|Physician Decision|2|||
28145241|NCT01340976|54811796|FG001|Overall Study|Physician Decision|0|||
28145242|NCT01340976|54811797|FG002|Overall Study|Physician Decision|1|||
28145243|NCT01340976|54811798|FG003|Overall Study|Physician Decision|1|||
28145244|NCT01340976|54811799|FG004|Overall Study|Physician Decision|1|||
28145245|NCT01340976|54811800|FG005|Overall Study|Physician Decision|0|||
28145246|NCT01340976|54811795|FG000|Overall Study|Death|0|||
28145247|NCT01340976|54811796|FG001|Overall Study|Death|1|||
28145248|NCT01340976|54811797|FG002|Overall Study|Death|0|||
28145249|NCT01340976|54811798|FG003|Overall Study|Death|0|||
28145250|NCT01340976|54811799|FG004|Overall Study|Death|0|||
28145251|NCT01340976|54811800|FG005|Overall Study|Death|0|||
28145252|NCT01340976|54811795|FG000|Overall Study|Dose Limiting Toxicity Stopping Rule|1|||
28145253|NCT01340976|54811796|FG001|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
28145254|NCT01340976|54811797|FG002|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
28145255|NCT01340976|54811798|FG003|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
28145256|NCT01340976|54811799|FG004|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
28145257|NCT01340976|54811800|FG005|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
28145258|NCT01340976|54811795|FG000|Overall Study|Withdrawal by Subject|0|||
28145259|NCT01340976|54811796|FG001|Overall Study|Withdrawal by Subject|0|||
28145260|NCT01340976|54811797|FG002|Overall Study|Withdrawal by Subject|0|||
28145261|NCT01340976|54811798|FG003|Overall Study|Withdrawal by Subject|1|||
28145262|NCT01340976|54811799|FG004|Overall Study|Withdrawal by Subject|1|||
28145263|NCT01340976|54811800|FG005|Overall Study|Withdrawal by Subject|0|||
28145264|NCT01340976|54811795|FG000|Overall Study|Other anemia treatment|1|||
28145265|NCT01340976|54811796|FG001|Overall Study|Other anemia treatment|0|||
28145266|NCT01340976|54811797|FG002|Overall Study|Other anemia treatment|2|||
28145267|NCT01340976|54811798|FG003|Overall Study|Other anemia treatment|1|||
28145268|NCT01340976|54811799|FG004|Overall Study|Other anemia treatment|0|||
28145269|NCT01340976|54811800|FG005|Overall Study|Other anemia treatment|1|||
28145270|NCT01340976|54811795|FG000|Overall Study|Adverse Event|0|||
28145271|NCT01340976|54811796|FG001|Overall Study|Adverse Event|1|||
28145272|NCT01340976|54811797|FG002|Overall Study|Adverse Event|0|||
28145273|NCT01340976|54811798|FG003|Overall Study|Adverse Event|0|||
28145274|NCT01340976|54811799|FG004|Overall Study|Adverse Event|0|||
28145275|NCT01340976|54811800|FG005|Overall Study|Adverse Event|0|||
28145276|NCT01680016|54811822|FG000|Overall Study|Adverse Event|0|||
28145277|NCT01680016|54811823|FG001|Overall Study|Adverse Event|0|||
28145278|NCT01680016|54811824|FG002|Overall Study|Adverse Event|1|||
28145279|NCT01680016|54811825|FG003|Overall Study|Adverse Event|4|||
28145280|NCT01680016|54811822|FG000|Overall Study|The Subject went out of The Trial|1|||
28145281|NCT01680016|54811823|FG001|Overall Study|The Subject went out of The Trial|0|||
28145282|NCT01680016|54811824|FG002|Overall Study|The Subject went out of The Trial|3|||
28145283|NCT01680016|54811825|FG003|Overall Study|The Subject went out of The Trial|0|||
28145284|NCT01680016|54811822|FG000|Overall Study|Protocol Violation|0|||
28145285|NCT01680016|54811823|FG001|Overall Study|Protocol Violation|1|||
28145286|NCT01680016|54811824|FG002|Overall Study|Protocol Violation|0|||
28145287|NCT01680016|54811825|FG003|Overall Study|Protocol Violation|0|||
28145288|NCT01680016|54811822|FG000|Overall Study|Withdrawal by Subject|5|||
28145289|NCT01680016|54811823|FG001|Overall Study|Withdrawal by Subject|7|||
28145290|NCT01680016|54811824|FG002|Overall Study|Withdrawal by Subject|1|||
28145291|NCT01680016|54811825|FG003|Overall Study|Withdrawal by Subject|1|||
28145292|NCT01340898|54811850|FG000|Primary Phase|Serious Adverse Events|0|||
28145293|NCT01340898|54811851|FG001|Primary Phase|Serious Adverse Events|0|||
28145294|NCT01340898|54811852|FG002|Primary Phase|Serious Adverse Events|1|||
28145295|NCT01340898|54811850|FG000|Primary Phase|Withdrawal by Subject|8|||
28145296|NCT01340898|54811851|FG001|Primary Phase|Withdrawal by Subject|7|||
28145297|NCT01340898|54811852|FG002|Primary Phase|Withdrawal by Subject|5|||
28145298|NCT01340898|54811850|FG000|Primary Phase|Migrated/moved from study area|4|||
28145299|NCT01340898|54811851|FG001|Primary Phase|Migrated/moved from study area|1|||
28145300|NCT01340898|54811852|FG002|Primary Phase|Migrated/moved from study area|0|||
28145301|NCT01340898|54811850|FG000|Primary Phase|Lost to Follow-up|4|||
28145302|NCT01340898|54811851|FG001|Primary Phase|Lost to Follow-up|1|||
28145303|NCT01340898|54811852|FG002|Primary Phase|Lost to Follow-up|0|||
28145304|NCT01340898|54811850|FG000|Booster Phase|Withdrawal by Subject|3|||
28145305|NCT01340898|54811851|FG001|Booster Phase|Withdrawal by Subject|0|||
28145306|NCT01340898|54811852|FG002|Booster Phase|Withdrawal by Subject|4|||
28145307|NCT01340898|54811850|FG000|Booster Phase|Migrated/moved from study area|3|||
28145308|NCT01340898|54811851|FG001|Booster Phase|Migrated/moved from study area|0|||
28145309|NCT01340898|54811852|FG002|Booster Phase|Migrated/moved from study area|0|||
28145310|NCT01340898|54811850|FG000|Booster Phase|Lost to Follow-up|4|||
28145311|NCT01340898|54811851|FG001|Booster Phase|Lost to Follow-up|2|||
28145312|NCT01340898|54811852|FG002|Booster Phase|Lost to Follow-up|3|||
28145313|NCT02744898|54811873|FG000|Overall Study|Progressive Disease|2|||
28145314|NCT02744898|54811873|FG000|Overall Study|Physician Decision|1|||
28145315|NCT02744898|54811873|FG000|Overall Study|Toxicity|1|||
28145316|NCT03097315|54811877|FG000|Overall Study|Withdrawal by Subject|1|||
27822653|NCT01840579|54286396|FG007|Overall Study|Ongoing in study|0|||
27822654|NCT01840579|54286397|FG008|Overall Study|Ongoing in study|0|||
27822655|NCT01840579|54286398|FG009|Overall Study|Ongoing in study|0|||
28071998|NCT00139737|54726749|FG000|Overall Study|Adverse Event|58|||
28071999|NCT00139737|54726749|FG000|Overall Study|Lack of Efficacy|40|||
28072000|NCT00139737|54726749|FG000|Overall Study|Lost to Follow-up|8|||
28072001|NCT00139737|54726749|FG000|Overall Study|Death|3|||
28072002|NCT00139737|54726749|FG000|Overall Study|Laboratory Abnormality|2|||
28072003|NCT00139737|54726749|FG000|Overall Study|Protocol Violation|18|||
28072004|NCT00139737|54726749|FG000|Overall Study|Withdrew During Screening Phase|8|||
28072005|NCT00139737|54726749|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
28072006|NCT00139737|54726749|FG000|Overall Study|Screened, Not Treated|13|||
28145317|NCT03039699|54811883|FG000|Overall Study|Incorrect inclusion|5|||
27822656|NCT01840579|54286389|FG000|Overall Study|Death|0|||
28145318|NCT03039699|54811884|FG001|Overall Study|Incorrect inclusion|4|||
28145319|NCT03039699|54811883|FG000|Overall Study|Lack of data to assess study endpoint|5|||
28145320|NCT03039699|54811884|FG001|Overall Study|Lack of data to assess study endpoint|3|||
28145321|NCT03039699|54811883|FG000|Overall Study|Bacterial infection|12|||
28145322|NCT03039699|54811884|FG001|Overall Study|Bacterial infection|28|||
28145323|NCT02833974|54811892|FG000|Overall Study|Lost to Follow-up|1|||
28145324|NCT02833974|54811893|FG001|Overall Study|Lost to Follow-up|0|||
28145325|NCT02833974|54811892|FG000|Overall Study|Adverse Event|0|||
28145326|NCT02833974|54811893|FG001|Overall Study|Adverse Event|3|||
28145327|NCT03093415|54811902|FG000|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17|||
28145328|NCT03093415|54811903|FG001|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36|||
28145329|NCT03093415|54811904|FG002|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0|||
28145330|NCT03093415|54811902|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40|||
28145331|NCT03093415|54811903|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
28145332|NCT03093415|54811904|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
28145333|NCT03093415|54811902|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28|||
28145334|NCT03093415|54811903|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6|||
28145335|NCT03093415|54811904|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0|||
28145336|NCT03093415|54811902|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
28145337|NCT03093415|54811903|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12|||
28145338|NCT03093415|54811904|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
28145339|NCT03093415|54811902|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18|||
28145340|NCT03093415|54811903|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12|||
28145341|NCT03093415|54811904|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0|||
28145342|NCT03093415|54811902|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
28145343|NCT03093415|54811903|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
28145344|NCT03093415|54811904|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0|||
28145345|NCT03093415|54811902|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15|||
28145346|NCT03093415|54811903|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32|||
28145347|NCT03093415|54811904|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0|||
28145348|NCT03093415|54811902|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5|||
28145349|NCT03093415|54811903|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3|||
28145350|NCT03093415|54811904|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0|||
28145351|NCT03093415|54811902|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4|||
27822657|NCT01840579|54286390|FG001|Overall Study|Death|0|||
28145352|NCT03093415|54811903|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2|||
28145353|NCT03093415|54811904|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0|||
28145354|NCT03093415|54811902|FG000|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9|||
28145355|NCT03093415|54811903|FG001|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3|||
28145356|NCT03093415|54811904|FG002|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0|||
28145357|NCT03093415|54811902|FG000|Enrollment to SVR12 Results|Lost to Follow-up|1|||
28145358|NCT03093415|54811903|FG001|Enrollment to SVR12 Results|Lost to Follow-up|8|||
28145359|NCT03093415|54811904|FG002|Enrollment to SVR12 Results|Lost to Follow-up|3|||
28145360|NCT01358526|54811914|FG000|Open-label Titration Period|Adverse Event|95|||
28145361|NCT01358526|54811915|FG001|Open-label Titration Period|Adverse Event|0|||
28145362|NCT01358526|54811916|FG002|Open-label Titration Period|Adverse Event|0|||
28145363|NCT01358526|54811914|FG000|Open-label Titration Period|Withdrawal by Subject|65|||
28145364|NCT01358526|54811915|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
28145365|NCT01358526|54811916|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
28145366|NCT01358526|54811914|FG000|Open-label Titration Period|Lost to Follow-up|25|||
28145367|NCT01358526|54811915|FG001|Open-label Titration Period|Lost to Follow-up|0|||
28145368|NCT01358526|54811916|FG002|Open-label Titration Period|Lost to Follow-up|0|||
28145369|NCT01358526|54811914|FG000|Open-label Titration Period|Lack of Efficacy|107|||
28145370|NCT01358526|54811915|FG001|Open-label Titration Period|Lack of Efficacy|0|||
28145371|NCT01358526|54811916|FG002|Open-label Titration Period|Lack of Efficacy|0|||
28145372|NCT01358526|54811914|FG000|Open-label Titration Period|Confirmed or suspected diversion|16|||
28145373|NCT01358526|54811915|FG001|Open-label Titration Period|Confirmed or suspected diversion|0|||
28145374|NCT01358526|54811916|FG002|Open-label Titration Period|Confirmed or suspected diversion|0|||
28145375|NCT01358526|54811914|FG000|Open-label Titration Period|Administrative|8|||
28145376|NCT01358526|54811915|FG001|Open-label Titration Period|Administrative|0|||
28145377|NCT01358526|54811916|FG002|Open-label Titration Period|Administrative|0|||
28145378|NCT01358526|54811914|FG000|Open-label Titration Period|Did not qualify|178|||
28145379|NCT01358526|54811915|FG001|Open-label Titration Period|Did not qualify|0|||
28145380|NCT01358526|54811916|FG002|Open-label Titration Period|Did not qualify|0|||
28145381|NCT01358526|54811914|FG000|Double-blind Phase|Adverse Event|0|||
28145382|NCT01358526|54811915|FG001|Double-blind Phase|Adverse Event|24|||
28145383|NCT01358526|54811916|FG002|Double-blind Phase|Adverse Event|23|||
28145384|NCT01358526|54811914|FG000|Double-blind Phase|Withdrawal by Subject|0|||
28145385|NCT01358526|54811915|FG001|Double-blind Phase|Withdrawal by Subject|10|||
28145386|NCT01358526|54811916|FG002|Double-blind Phase|Withdrawal by Subject|8|||
28145387|NCT01358526|54811914|FG000|Double-blind Phase|Lost to Follow-up|0|||
28145388|NCT01358526|54811915|FG001|Double-blind Phase|Lost to Follow-up|4|||
28145389|NCT01358526|54811916|FG002|Double-blind Phase|Lost to Follow-up|1|||
28145390|NCT01358526|54811914|FG000|Double-blind Phase|Lack of Efficacy|0|||
28145391|NCT01358526|54811915|FG001|Double-blind Phase|Lack of Efficacy|31|||
28145392|NCT01358526|54811916|FG002|Double-blind Phase|Lack of Efficacy|73|||
28145393|NCT01358526|54811914|FG000|Double-blind Phase|Confirmed or suspected diversion|0|||
28145394|NCT01358526|54811915|FG001|Double-blind Phase|Confirmed or suspected diversion|5|||
28145395|NCT01358526|54811916|FG002|Double-blind Phase|Confirmed or suspected diversion|6|||
28145396|NCT01358526|54811914|FG000|Double-blind Phase|Administrative|0|||
28145397|NCT01358526|54811915|FG001|Double-blind Phase|Administrative|6|||
28145398|NCT01358526|54811916|FG002|Double-blind Phase|Administrative|10|||
28145399|NCT02830776|54811923|FG000|Overall Study|Lost to Follow-up|1|||
28145400|NCT03039621|54811930|FG000|Overall Study|Violation of inclusion criteria|3|||
28145401|NCT03039621|54811931|FG001|Overall Study|Violation of inclusion criteria|2|||
28145402|NCT03039621|54811930|FG000|Overall Study|Non-compliance with protocol requirement|4|||
28145403|NCT03039621|54811931|FG001|Overall Study|Non-compliance with protocol requirement|5|||
28145404|NCT03039621|54811930|FG000|Overall Study|Necessity to use drugs forbidden by pro|4|||
28145405|NCT03039621|54811931|FG001|Overall Study|Necessity to use drugs forbidden by pro|7|||
28145406|NCT03039621|54811930|FG000|Overall Study|Violation of non-inclusion criteria|1|||
27822658|NCT01840579|54286391|FG002|Overall Study|Death|0|||
27822659|NCT01840579|54286392|FG003|Overall Study|Death|0|||
28145407|NCT03039621|54811931|FG001|Overall Study|Violation of non-inclusion criteria|2|||
28145408|NCT03041181|54811939|FG000|Overall Study|Disease Progression|1|||
28145409|NCT03041181|54811940|FG001|Overall Study|Disease Progression|2|||
28145410|NCT02828436|54811946|FG000|Period 1|Did Not Meet Inclusion Criteria|0|||
28145411|NCT02828436|54811947|FG001|Period 1|Did Not Meet Inclusion Criteria|3|||
28145412|NCT02828436|54811946|FG000|Period 1|Lost to Follow-up|0|||
28145413|NCT02828436|54811947|FG001|Period 1|Lost to Follow-up|1|||
28145414|NCT02828436|54811946|FG000|Period 2|Withdrawal by Subject|4|||
28145415|NCT02828436|54811947|FG001|Period 2|Withdrawal by Subject|0|||
28145416|NCT02828436|54811946|FG000|Period 2|Did Not Meet Inclusion Criteria|3|||
28145417|NCT02828436|54811947|FG001|Period 2|Did Not Meet Inclusion Criteria|0|||
28145418|NCT02828436|54811946|FG000|Period 2|Lost to Follow-up|1|||
28145419|NCT02828436|54811947|FG001|Period 2|Lost to Follow-up|0|||
28145420|NCT02828124|54811961|FG000|Overall Study|Disease Progression|1|||
28145421|NCT02828124|54811962|FG001|Overall Study|Disease Progression|2|||
28145422|NCT02828124|54811963|FG002|Overall Study|Disease Progression|1|||
28145423|NCT02828124|54811964|FG003|Overall Study|Disease Progression|4|||
28145424|NCT02828124|54811961|FG000|Overall Study|AE Unrelated to Study Drug|0|||
28145425|NCT02828124|54811962|FG001|Overall Study|AE Unrelated to Study Drug|0|||
28145426|NCT02828124|54811963|FG002|Overall Study|AE Unrelated to Study Drug|0|||
28145427|NCT02828124|54811964|FG003|Overall Study|AE Unrelated to Study Drug|1|||
27822660|NCT01840579|54286393|FG004|Overall Study|Death|0|||
27822661|NCT01840579|54286394|FG005|Overall Study|Death|1|||
27822662|NCT01840579|54286395|FG006|Overall Study|Death|0|||
27822663|NCT01840579|54286396|FG007|Overall Study|Death|0|||
27822664|NCT01840579|54286397|FG008|Overall Study|Death|0|||
27822665|NCT01840579|54286398|FG009|Overall Study|Death|0|||
27822666|NCT01840579|54286389|FG000|Overall Study|Adverse Event|0|||
27822667|NCT01840579|54286390|FG001|Overall Study|Adverse Event|1|||
27822668|NCT01840579|54286391|FG002|Overall Study|Adverse Event|0|||
28145428|NCT02828124|54811961|FG000|Overall Study|Subject Withdrew Consent|0|||
28145429|NCT02828124|54811962|FG001|Overall Study|Subject Withdrew Consent|0|||
28145430|NCT02828124|54811963|FG002|Overall Study|Subject Withdrew Consent|0|||
28145431|NCT02828124|54811964|FG003|Overall Study|Subject Withdrew Consent|1|||
28145432|NCT02829996|54811979|FG000|Overall Study|Withdrawal by Subject|1|||
28145433|NCT02829996|54811980|FG001|Overall Study|Withdrawal by Subject|0|||
28145434|NCT02829996|54811981|FG002|Overall Study|Withdrawal by Subject|0|||
28145435|NCT02829996|54811982|FG003|Overall Study|Withdrawal by Subject|0|||
28145436|NCT02829996|54811983|FG004|Overall Study|Withdrawal by Subject|0|||
28145437|NCT02827500|54811997|FG000|Overall Study|Death|7|||
28145438|NCT02827500|54811998|FG001|Overall Study|Death|3|||
28145439|NCT02827500|54811997|FG000|Overall Study|Lost to Follow-up|1|||
28145440|NCT02827500|54811998|FG001|Overall Study|Lost to Follow-up|1|||
28145441|NCT02827500|54811997|FG000|Overall Study|Withdrawal by Subject|3|||
28145442|NCT02827500|54811998|FG001|Overall Study|Withdrawal by Subject|1|||
28145443|NCT02827500|54811997|FG000|Overall Study|Missing primary endpoint data|3|||
28145444|NCT02827500|54811998|FG001|Overall Study|Missing primary endpoint data|1|||
28145445|NCT02827500|54811997|FG000|Overall Study|Other|5|||
28145446|NCT02827500|54811998|FG001|Overall Study|Other|1|||
28145447|NCT02826798|54812009|FG000|Overall Study|Withdrawal by Subject|0|||
28145448|NCT02826798|54812010|FG001|Overall Study|Withdrawal by Subject|1|||
28145449|NCT02826798|54812011|FG002|Overall Study|Withdrawal by Subject|0|||
28145450|NCT02826798|54812012|FG003|Overall Study|Withdrawal by Subject|1|||
28145451|NCT02826798|54812013|FG004|Overall Study|Withdrawal by Subject|0|||
28145452|NCT02829138|54812027|FG000|Overall Study|Withdrawal by Subject|1|||
28145453|NCT02829138|54812028|FG001|Overall Study|Withdrawal by Subject|0|||
28145454|NCT02825550|54812034|FG000|Overall Study|Physician Decision|1|||
28145455|NCT02744040|54812043|FG000|Overall Study|Withdrawal by Subject|3|||
28145456|NCT02744040|54812044|FG001|Overall Study|Withdrawal by Subject|2|||
28145457|NCT02744040|54812045|FG002|Overall Study|Withdrawal by Subject|2|||
28145458|NCT02744040|54812043|FG000|Overall Study|Physician Decision|0|||
28145459|NCT02744040|54812044|FG001|Overall Study|Physician Decision|8|||
28145460|NCT02744040|54812045|FG002|Overall Study|Physician Decision|13|||
28145461|NCT02744040|54812043|FG000|Overall Study|Lost to Follow-up|3|||
28145462|NCT02744040|54812044|FG001|Overall Study|Lost to Follow-up|1|||
28145463|NCT02744040|54812045|FG002|Overall Study|Lost to Follow-up|7|||
28145464|NCT02743962|54812055|FG000|Overall Study|Atrophic vaginitis diagnosed|1|||
28145465|NCT02743962|54812056|FG001|Overall Study|Atrophic vaginitis diagnosed|0|||
28145466|NCT03094416|54812065|FG000|Run-in|Screening failure|8|||
28145467|NCT03094416|54812065|FG000|Run-in|Sponsor Decision To Discontinue Due To Global Covid-19 Pandemic|8|||
28145468|NCT03094416|54812065|FG000|Run-in|Withdrawal by Subject|3|||
28145469|NCT03094416|54812065|FG000|Treatment Period|Withdrawal by Subject|2|||
28145470|NCT03041025|54812073|FG000|Overall Study|Adverse Event|0|||
28145471|NCT03041025|54812074|FG001|Overall Study|Adverse Event|0|||
28145472|NCT03041025|54812075|FG002|Overall Study|Adverse Event|1|||
28145473|NCT03041025|54812073|FG000|Overall Study|Lost to Follow-up|1|||
28145474|NCT03041025|54812074|FG001|Overall Study|Lost to Follow-up|0|||
28145475|NCT03041025|54812075|FG002|Overall Study|Lost to Follow-up|0|||
28145476|NCT03041025|54812073|FG000|Overall Study|Withdrawal by Subject|0|||
28145477|NCT03041025|54812074|FG001|Overall Study|Withdrawal by Subject|0|||
28145478|NCT03041025|54812075|FG002|Overall Study|Withdrawal by Subject|1|||
28145479|NCT01338870|54812092|FG000|Overall Study|Lost to Follow-up|0|||
28145480|NCT01338870|54812093|FG001|Overall Study|Lost to Follow-up|0|||
28145481|NCT01338870|54812094|FG002|Overall Study|Lost to Follow-up|1|||
28145482|NCT01338870|54812095|FG003|Overall Study|Lost to Follow-up|0|||
28145483|NCT01338870|54812096|FG004|Overall Study|Lost to Follow-up|1|||
28145484|NCT01338870|54812097|FG005|Overall Study|Lost to Follow-up|0|||
28145485|NCT01338870|54812092|FG000|Overall Study|Withdrawal by Subject|2|||
28145486|NCT01338870|54812093|FG001|Overall Study|Withdrawal by Subject|3|||
28145487|NCT01338870|54812094|FG002|Overall Study|Withdrawal by Subject|4|||
27822669|NCT01840579|54286392|FG003|Overall Study|Adverse Event|0|||
27822670|NCT01840579|54286393|FG004|Overall Study|Adverse Event|0|||
28145488|NCT01338870|54812095|FG003|Overall Study|Withdrawal by Subject|0|||
28145489|NCT01338870|54812096|FG004|Overall Study|Withdrawal by Subject|0|||
28145490|NCT01338870|54812097|FG005|Overall Study|Withdrawal by Subject|2|||
28145491|NCT01338870|54812092|FG000|Overall Study|Other|3|||
28145492|NCT01338870|54812093|FG001|Overall Study|Other|3|||
28145493|NCT01338870|54812094|FG002|Overall Study|Other|3|||
28145494|NCT01338870|54812095|FG003|Overall Study|Other|2|||
28145495|NCT01338870|54812096|FG004|Overall Study|Other|0|||
28145496|NCT01338870|54812097|FG005|Overall Study|Other|2|||
28145497|NCT01338870|54812092|FG000|Overall Study|Protocol Violation|0|||
28145498|NCT01338870|54812093|FG001|Overall Study|Protocol Violation|2|||
28145499|NCT01338870|54812094|FG002|Overall Study|Protocol Violation|2|||
28145500|NCT01338870|54812095|FG003|Overall Study|Protocol Violation|2|||
28145501|NCT01338870|54812096|FG004|Overall Study|Protocol Violation|1|||
28145502|NCT01338870|54812097|FG005|Overall Study|Protocol Violation|1|||
28145503|NCT01338870|54812092|FG000|Overall Study|Adverse Event|4|||
28145504|NCT01338870|54812093|FG001|Overall Study|Adverse Event|4|||
28145505|NCT01338870|54812094|FG002|Overall Study|Adverse Event|1|||
28145506|NCT01338870|54812095|FG003|Overall Study|Adverse Event|5|||
28145507|NCT01338870|54812096|FG004|Overall Study|Adverse Event|4|||
28145508|NCT01338870|54812097|FG005|Overall Study|Adverse Event|1|||
28145509|NCT02824224|54812113|FG000|Overall Study|Discontinued, IUS expulsion|0|||
28145510|NCT02824224|54812114|FG001|Overall Study|Discontinued, IUS expulsion|1|||
28145511|NCT02824224|54812113|FG000|Overall Study|Did not show up for allocation visit|2|||
28145512|NCT02824224|54812114|FG001|Overall Study|Did not show up for allocation visit|0|||
28145513|NCT01338792|54812120|FG000|Overall Study|Adverse Event|2|||
28145514|NCT01338792|54812120|FG000|Overall Study|Death|1|||
28145515|NCT01338792|54812120|FG000|Overall Study|Withdrawal by Subject|1|||
28145516|NCT01314105|54812126|FG000|Overall Study|Progressive Disease|6|||
28145517|NCT01314105|54812127|FG001|Overall Study|Progressive Disease|10|||
28145518|NCT01314105|54812126|FG000|Overall Study|Refused to continue taking medication|0|||
28145519|NCT01314105|54812127|FG001|Overall Study|Refused to continue taking medication|1|||
28145520|NCT01314105|54812126|FG000|Overall Study|Other Adverse Event|1|||
28145521|NCT01314105|54812127|FG001|Overall Study|Other Adverse Event|1|||
28145522|NCT03040713|54812135|FG000|Overall Study|Positive amyloid scan|3|||
28145523|NCT01966471|54812141|FG000|Overall Study|Death|44|||
28145524|NCT01966471|54812142|FG001|Overall Study|Death|56|||
28145525|NCT01966471|54812141|FG000|Overall Study|Lost to Follow-up|46|||
28145526|NCT01966471|54812142|FG001|Overall Study|Lost to Follow-up|39|||
28145527|NCT01966471|54812141|FG000|Overall Study|Various reasons|4|||
28145528|NCT01966471|54812142|FG001|Overall Study|Various reasons|4|||
28145529|NCT01966471|54812141|FG000|Overall Study|Physician Decision|7|||
28145530|NCT01966471|54812142|FG001|Overall Study|Physician Decision|5|||
28145531|NCT01966471|54812141|FG000|Overall Study|Study Terminated By Sponsor|758|||
28145532|NCT01966471|54812142|FG001|Overall Study|Study Terminated By Sponsor|773|||
28145533|NCT01966471|54812141|FG000|Overall Study|Withdrawal by Subject|59|||
28145534|NCT01966471|54812142|FG001|Overall Study|Withdrawal by Subject|51|||
28145535|NCT03227471|54812171|FG000|Overall Study|Withdrawal by Subject|0|||
28145536|NCT03227471|54812172|FG001|Overall Study|Withdrawal by Subject|0|||
28145537|NCT03227471|54812173|FG002|Overall Study|Withdrawal by Subject|0|||
28145538|NCT03227471|54812174|FG003|Overall Study|Withdrawal by Subject|0|||
28145539|NCT03227471|54812175|FG004|Overall Study|Withdrawal by Subject|1|||
28145540|NCT03227471|54812176|FG005|Overall Study|Withdrawal by Subject|0|||
28145541|NCT03227471|54812177|FG006|Overall Study|Withdrawal by Subject|0|||
28145542|NCT03227471|54812178|FG007|Overall Study|Withdrawal by Subject|0|||
28145543|NCT03227471|54812179|FG008|Overall Study|Withdrawal by Subject|0|||
28145544|NCT03227471|54812180|FG009|Overall Study|Withdrawal by Subject|0|||
28145545|NCT03227471|54812181|FG010|Overall Study|Withdrawal by Subject|0|||
28145546|NCT03227471|54812182|FG011|Overall Study|Withdrawal by Subject|0|||
28145547|NCT03227471|54812183|FG012|Overall Study|Withdrawal by Subject|1|||
28145548|NCT03227471|54812184|FG013|Overall Study|Withdrawal by Subject|0|||
28145549|NCT03227471|54812185|FG014|Overall Study|Withdrawal by Subject|0|||
28145550|NCT03227471|54812171|FG000|Overall Study|Randomized, Never Dosed|0|||
28145551|NCT03227471|54812172|FG001|Overall Study|Randomized, Never Dosed|0|||
28145552|NCT03227471|54812173|FG002|Overall Study|Randomized, Never Dosed|0|||
28145553|NCT03227471|54812174|FG003|Overall Study|Randomized, Never Dosed|0|||
28145554|NCT03227471|54812175|FG004|Overall Study|Randomized, Never Dosed|0|||
28145555|NCT03227471|54812176|FG005|Overall Study|Randomized, Never Dosed|0|||
28145556|NCT03227471|54812177|FG006|Overall Study|Randomized, Never Dosed|0|||
28145557|NCT03227471|54812178|FG007|Overall Study|Randomized, Never Dosed|0|||
28145558|NCT03227471|54812179|FG008|Overall Study|Randomized, Never Dosed|0|||
28145559|NCT03227471|54812180|FG009|Overall Study|Randomized, Never Dosed|0|||
28145560|NCT03227471|54812181|FG010|Overall Study|Randomized, Never Dosed|0|||
28145561|NCT03227471|54812182|FG011|Overall Study|Randomized, Never Dosed|0|||
28145562|NCT03227471|54812183|FG012|Overall Study|Randomized, Never Dosed|0|||
28145563|NCT03227471|54812184|FG013|Overall Study|Randomized, Never Dosed|0|||
28145564|NCT03227471|54812185|FG014|Overall Study|Randomized, Never Dosed|1|||
28145565|NCT01354314|54812250|FG000|Overall Study|Lost to Follow-up|1|||
28145566|NCT01354314|54812251|FG001|Overall Study|Lost to Follow-up|0|||
28145567|NCT01354314|54812252|FG002|Overall Study|Lost to Follow-up|1|||
28145568|NCT01354314|54812253|FG003|Overall Study|Lost to Follow-up|1|||
28145569|NCT01354314|54812250|FG000|Overall Study|Withdrawal by Subject|0|||
28145570|NCT01354314|54812251|FG001|Overall Study|Withdrawal by Subject|0|||
28145571|NCT01354314|54812252|FG002|Overall Study|Withdrawal by Subject|1|||
28145572|NCT01354314|54812253|FG003|Overall Study|Withdrawal by Subject|0|||
28145573|NCT01354314|54812250|FG000|Overall Study|Adverse Event|0|||
28145574|NCT01354314|54812251|FG001|Overall Study|Adverse Event|0|||
28145575|NCT01354314|54812252|FG002|Overall Study|Adverse Event|0|||
28145576|NCT01354314|54812253|FG003|Overall Study|Adverse Event|1|||
28145577|NCT01354314|54812250|FG000|Overall Study|Protocol Violation|1|||
28145578|NCT01354314|54812251|FG001|Overall Study|Protocol Violation|1|||
28145579|NCT01354314|54812252|FG002|Overall Study|Protocol Violation|0|||
28145580|NCT01354314|54812253|FG003|Overall Study|Protocol Violation|0|||
28145581|NCT01354314|54812250|FG000|Overall Study|Less than 90% Adherence|4|||
28145582|NCT01354314|54812251|FG001|Overall Study|Less than 90% Adherence|2|||
28145583|NCT01354314|54812252|FG002|Overall Study|Less than 90% Adherence|6|||
28145584|NCT01354314|54812253|FG003|Overall Study|Less than 90% Adherence|4|||
28145585|NCT03194321|54812265|FG000|Overall Study|Withdrawal by Subject|1|||
28145586|NCT03194321|54812265|FG000|Overall Study|Lost to Follow-up|1|||
28145587|NCT03194321|54812265|FG000|Overall Study|Travel for Follow-up|1|||
28145588|NCT01354938|54812269|FG000|Overall Study|Lost to Follow-up|1|||
28145589|NCT03092791|54812292|FG000|Overall Study|Lost to Follow-up|0|||
28145590|NCT03092791|54812293|FG001|Overall Study|Lost to Follow-up|0|||
28145591|NCT03092791|54812294|FG002|Overall Study|Lost to Follow-up|0|||
28145592|NCT03092791|54812295|FG003|Overall Study|Lost to Follow-up|0|||
28145593|NCT03092791|54812296|FG004|Overall Study|Lost to Follow-up|0|||
28145594|NCT03092791|54812297|FG005|Overall Study|Lost to Follow-up|0|||
28145595|NCT03092791|54812298|FG006|Overall Study|Lost to Follow-up|1|||
28145596|NCT03092791|54812299|FG007|Overall Study|Lost to Follow-up|0|||
28145597|NCT03092791|54812292|FG000|Overall Study|Withdrawal of Consent|0|||
28145598|NCT03092791|54812293|FG001|Overall Study|Withdrawal of Consent|0|||
28145599|NCT03092791|54812294|FG002|Overall Study|Withdrawal of Consent|0|||
28145600|NCT03092791|54812295|FG003|Overall Study|Withdrawal of Consent|0|||
28145601|NCT03092791|54812296|FG004|Overall Study|Withdrawal of Consent|4|||
28145602|NCT03092791|54812297|FG005|Overall Study|Withdrawal of Consent|12|||
28145603|NCT03092791|54812298|FG006|Overall Study|Withdrawal of Consent|6|||
28145604|NCT03092791|54812299|FG007|Overall Study|Withdrawal of Consent|4|||
28145605|NCT03092791|54812292|FG000|Overall Study|Study Termination|0|||
28145606|NCT03092791|54812293|FG001|Overall Study|Study Termination|0|||
28145607|NCT03092791|54812294|FG002|Overall Study|Study Termination|0|||
28145608|NCT03092791|54812295|FG003|Overall Study|Study Termination|0|||
28145609|NCT03092791|54812296|FG004|Overall Study|Study Termination|55|||
28145610|NCT03092791|54812297|FG005|Overall Study|Study Termination|46|||
28145611|NCT03092791|54812298|FG006|Overall Study|Study Termination|53|||
28145612|NCT03092791|54812299|FG007|Overall Study|Study Termination|55|||
28145613|NCT03092791|54812292|FG000|Overall Study|Death|0|||
28145614|NCT03092791|54812293|FG001|Overall Study|Death|0|||
28145615|NCT03092791|54812294|FG002|Overall Study|Death|0|||
28145616|NCT03092791|54812295|FG003|Overall Study|Death|0|||
28145617|NCT03092791|54812296|FG004|Overall Study|Death|0|||
28145618|NCT03092791|54812297|FG005|Overall Study|Death|1|||
28145619|NCT03092791|54812298|FG006|Overall Study|Death|0|||
28145620|NCT03092791|54812299|FG007|Overall Study|Death|1|||
28145621|NCT03092791|54812292|FG000|Overall Study|Reason Not Specified|0|||
28145622|NCT03092791|54812293|FG001|Overall Study|Reason Not Specified|0|||
28145623|NCT03092791|54812294|FG002|Overall Study|Reason Not Specified|0|||
28145624|NCT03092791|54812295|FG003|Overall Study|Reason Not Specified|0|||
28145625|NCT03092791|54812296|FG004|Overall Study|Reason Not Specified|1|||
28145626|NCT03092791|54812297|FG005|Overall Study|Reason Not Specified|1|||
28145627|NCT03092791|54812298|FG006|Overall Study|Reason Not Specified|0|||
28145628|NCT03092791|54812299|FG007|Overall Study|Reason Not Specified|0|||
28145629|NCT04283461|54812327|FG000|Overall Study|Enrolled in separate trial|0|||
28145630|NCT04283461|54812328|FG001|Overall Study|Enrolled in separate trial|0|||
28145631|NCT04283461|54812329|FG002|Overall Study|Enrolled in separate trial|8|||
28145632|NCT04283461|54812330|FG003|Overall Study|Enrolled in separate trial|13|||
28145633|NCT04283461|54812331|FG004|Overall Study|Enrolled in separate trial|12|||
28145634|NCT04283461|54812332|FG005|Overall Study|Enrolled in separate trial|0|||
28145635|NCT04283461|54812333|FG006|Overall Study|Enrolled in separate trial|0|||
28145636|NCT04283461|54812334|FG007|Overall Study|Enrolled in separate trial|8|||
28145637|NCT04283461|54812335|FG008|Overall Study|Enrolled in separate trial|0|||
28145638|NCT04283461|54812336|FG009|Overall Study|Enrolled in separate trial|0|||
28145639|NCT04283461|54812337|FG010|Overall Study|Enrolled in separate trial|0|||
27822671|NCT01840579|54286394|FG005|Overall Study|Adverse Event|0|||
28145640|NCT04283461|54812338|FG011|Overall Study|Enrolled in separate trial|7|||
28145641|NCT04283461|54812339|FG012|Overall Study|Enrolled in separate trial|0|||
28145642|NCT02505425|54812370|FG000|Overall Study|Lost to Follow-up|41|||
28145643|NCT02505425|54812371|FG001|Overall Study|Lost to Follow-up|61|||
28145644|NCT02505425|54812372|FG002|Overall Study|Lost to Follow-up|31|||
28145645|NCT02505425|54812373|FG003|Overall Study|Lost to Follow-up|19|||
28145646|NCT02505425|54812370|FG000|Overall Study|Withdrawal by Subject|39|||
28145647|NCT02505425|54812371|FG001|Overall Study|Withdrawal by Subject|9|||
28145648|NCT02505425|54812372|FG002|Overall Study|Withdrawal by Subject|19|||
28145649|NCT02505425|54812373|FG003|Overall Study|Withdrawal by Subject|7|||
28145650|NCT02505425|54812370|FG000|Overall Study|Death|8|||
28145651|NCT02505425|54812371|FG001|Overall Study|Death|12|||
28145652|NCT02505425|54812372|FG002|Overall Study|Death|0|||
28145653|NCT02505425|54812373|FG003|Overall Study|Death|0|||
28145654|NCT03089047|54812385|FG000|Overall Study|Lost to Follow-up|1|||
28145655|NCT03089047|54812386|FG001|Overall Study|Lost to Follow-up|0|||
28145656|NCT01371006|54812394|FG000|Overall Study|Adverse Event|1|||
28145657|NCT01371006|54812395|FG001|Overall Study|Adverse Event|0|||
28145658|NCT01371552|54812430|FG000|Part 1, First 3 Days|Inconvenience|0|||
28145659|NCT01371552|54812431|FG001|Part 1, First 3 Days|Inconvenience|0|||
28145660|NCT01371552|54812432|FG002|Part 1, First 3 Days|Inconvenience|1|||
28145661|NCT01371552|54812433|FG003|Part 1, First 3 Days|Inconvenience|0|||
28145662|NCT01371552|54812434|FG004|Part 1, First 3 Days|Inconvenience|0|||
28145663|NCT01371552|54812435|FG005|Part 1, First 3 Days|Inconvenience|0|||
28145664|NCT02819310|54812444|FG000|Overall Study|Withdrawal by Subject|37|||
28145665|NCT02819310|54812444|FG000|Overall Study|Lost to Follow-up|16|||
28145666|NCT02819310|54812444|FG000|Overall Study|Adverse Event|13|||
28145667|NCT02819310|54812444|FG000|Overall Study|Lack of Efficacy|5|||
28145668|NCT02819310|54812444|FG000|Overall Study|Physician Decision|8|||
27850059|NCT01647828|54348367|FG002|Overall Study|Death|4|||
27850060|NCT01647828|54348368|FG003|Overall Study|Death|5|||
27850061|NCT01647828|54348369|FG004|Overall Study|Death|6|||
27850062|NCT01647828|54348370|FG005|Overall Study|Death|3|||
27850063|NCT01647828|54348371|FG006|Overall Study|Death|10|||
27850064|NCT01647828|54348372|FG007|Overall Study|Death|60|||
27850065|NCT01647828|54348373|FG008|Overall Study|Death|71|||
27850066|NCT01647828|54348365|FG000|Overall Study|Withdrawal by Subject|2|||
27850067|NCT01647828|54348366|FG001|Overall Study|Withdrawal by Subject|0|||
27850068|NCT01647828|54348367|FG002|Overall Study|Withdrawal by Subject|0|||
27941394|NCT00940498|54597838|FG007|Overall Study|Death|0|||
27941395|NCT00940498|54597831|FG000|Overall Study|Lost to Follow-up|1|||
27941396|NCT00940498|54597832|FG001|Overall Study|Lost to Follow-up|1|||
27941397|NCT00940498|54597833|FG002|Overall Study|Lost to Follow-up|2|||
27941398|NCT00940498|54597834|FG003|Overall Study|Lost to Follow-up|0|||
27941399|NCT00940498|54597835|FG004|Overall Study|Lost to Follow-up|1|||
27941400|NCT00940498|54597836|FG005|Overall Study|Lost to Follow-up|0|||
27941401|NCT00940498|54597837|FG006|Overall Study|Lost to Follow-up|0|||
27941402|NCT00940498|54597838|FG007|Overall Study|Lost to Follow-up|1|||
27941403|NCT00940498|54597831|FG000|Overall Study|Disease Progression|0|||
27941404|NCT00940498|54597832|FG001|Overall Study|Disease Progression|0|||
27941405|NCT00940498|54597833|FG002|Overall Study|Disease Progression|1|||
27941406|NCT00940498|54597834|FG003|Overall Study|Disease Progression|1|||
27941407|NCT00940498|54597835|FG004|Overall Study|Disease Progression|0|||
27941408|NCT00940498|54597836|FG005|Overall Study|Disease Progression|1|||
28072007|NCT00122187|54726755|FG000|Overall Study|Withdrew because of resource limitations|2|||
28072008|NCT00122187|54726756|FG001|Overall Study|Withdrew because of resource limitations|2|||
28072009|NCT00139659|54726766|FG000|Overall Study|Adverse Event|12|||
28072010|NCT00139659|54726767|FG001|Overall Study|Adverse Event|1|||
28072011|NCT00139659|54726766|FG000|Overall Study|Lack of Efficacy|1|||
28072012|NCT00139659|54726767|FG001|Overall Study|Lack of Efficacy|1|||
28072013|NCT00139659|54726766|FG000|Overall Study|Lost to Follow-up|7|||
28072014|NCT00139659|54726767|FG001|Overall Study|Lost to Follow-up|3|||
28072015|NCT00139659|54726766|FG000|Overall Study|Reason not Specified|6|||
28072016|NCT00139659|54726767|FG001|Overall Study|Reason not Specified|3|||
28072017|NCT00139659|54726766|FG000|Overall Study|Withdrawal by Subject|14|||
28072018|NCT00139659|54726767|FG001|Overall Study|Withdrawal by Subject|10|||
28072019|NCT00137631|54726779|FG000|Overall Study|Lost to Follow-up|37|||
28072020|NCT00137631|54726780|FG001|Overall Study|Lost to Follow-up|41|||
28072021|NCT00114231|54726788|FG000|Overall Study|No consent|2|||
28072022|NCT00114231|54726789|FG001|Overall Study|No consent|0|||
28072023|NCT00114231|54726788|FG000|Overall Study|QARC requirement not met|1|||
28072024|NCT00114231|54726789|FG001|Overall Study|QARC requirement not met|0|||
28072025|NCT00114231|54726788|FG000|Overall Study|Suspected metastatic disease|1|||
28072026|NCT00114231|54726789|FG001|Overall Study|Suspected metastatic disease|0|||
28072027|NCT00114231|54726788|FG000|Overall Study|No adenocarcinoma|1|||
28072028|NCT00114231|54726789|FG001|Overall Study|No adenocarcinoma|0|||
28072029|NCT00114231|54726788|FG000|Overall Study|Low creatinine clearance|0|||
28145669|NCT02819310|54812444|FG000|Overall Study|Protocol Violation|30|||
27850069|NCT01647828|54348368|FG003|Overall Study|Withdrawal by Subject|1|||
28072030|NCT00114231|54726789|FG001|Overall Study|Low creatinine clearance|1|||
28072031|NCT00114231|54726788|FG000|Overall Study|Tumor size > 4cm|1|||
28072032|NCT00114231|54726789|FG001|Overall Study|Tumor size > 4cm|0|||
27941409|NCT00940498|54597837|FG006|Overall Study|Disease Progression|0|||
27941410|NCT00940498|54597838|FG007|Overall Study|Disease Progression|0|||
27941411|NCT00940498|54597831|FG000|Overall Study|Physician Decision|0|||
27941412|NCT00940498|54597832|FG001|Overall Study|Physician Decision|0|||
27941413|NCT00940498|54597833|FG002|Overall Study|Physician Decision|0|||
27941414|NCT00940498|54597834|FG003|Overall Study|Physician Decision|0|||
27941415|NCT00940498|54597835|FG004|Overall Study|Physician Decision|2|||
28145670|NCT03087643|54812450|FG000|Overall Study|Withdrawal by Subject|2|||
28145671|NCT03087643|54812451|FG001|Overall Study|Withdrawal by Subject|4|||
28145672|NCT03087643|54812450|FG000|Overall Study|Death|2|||
28145673|NCT03087643|54812451|FG001|Overall Study|Death|2|||
28145674|NCT02821962|54812459|FG000|Overall Study|Lost to Follow-up|2|||
28145675|NCT02821962|54812460|FG001|Overall Study|Lost to Follow-up|0|||
28145676|NCT03092479|54812468|FG000|Overall Study|Lost to Follow-up|3|||
28145677|NCT03092479|54812469|FG001|Overall Study|Lost to Follow-up|2|||
28145678|NCT03092479|54812468|FG000|Overall Study|Withdrawal by Subject|4|||
28145679|NCT03092479|54812469|FG001|Overall Study|Withdrawal by Subject|0|||
28145680|NCT03086551|54812477|FG000|First Intervention|Failure to meet inclusion criterion|1|||
28145681|NCT03086551|54812478|FG001|First Intervention|Failure to meet inclusion criterion|0|||
28145682|NCT03086551|54812477|FG000|First Intervention|Lost to Follow-up|0|||
28145683|NCT03086551|54812478|FG001|First Intervention|Lost to Follow-up|1|||
28145684|NCT03086551|54812477|FG000|Washout|Lost to Follow-up|1|||
28145685|NCT03086551|54812478|FG001|Washout|Lost to Follow-up|2|||
28145686|NCT03086551|54812477|FG000|Washout|Withdrawal by Subject|2|||
28145687|NCT03086551|54812478|FG001|Washout|Withdrawal by Subject|1|||
28145688|NCT03265249|54812486|FG000|Overall Study|Withdrawal by Subject|0|||
28145689|NCT03265249|54812487|FG001|Overall Study|Withdrawal by Subject|1|||
28145690|NCT02951767|54812493|FG000|Overall Study|Ongoing at data cutoff 04 July 2016|54|||
28145691|NCT02951767|54812493|FG000|Overall Study|Withdrawal by Subject|5|||
28145692|NCT02951767|54812493|FG000|Overall Study|Death|59|||
28145693|NCT02951767|54812493|FG000|Overall Study|Lost to Follow-up|1|||
28145694|NCT03093181|54812500|FG000|Overall Study|Withdrawal by Subject|2|||
28145695|NCT03093181|54812501|FG001|Overall Study|Withdrawal by Subject|1|||
28145696|NCT03093181|54812502|FG002|Overall Study|Withdrawal by Subject|2|||
28145697|NCT03093181|54812500|FG000|Overall Study|Other (Not specified)|1|||
28145698|NCT03093181|54812501|FG001|Overall Study|Other (Not specified)|0|||
28145699|NCT03093181|54812502|FG002|Overall Study|Other (Not specified)|0|||
28145700|NCT03093181|54812500|FG000|Overall Study|Adverse Event|0|||
28145701|NCT03093181|54812501|FG001|Overall Study|Adverse Event|1|||
28145702|NCT03093181|54812502|FG002|Overall Study|Adverse Event|0|||
28145703|NCT03093181|54812500|FG000|Overall Study|Other (Protocol violation)|0|||
28145704|NCT03093181|54812501|FG001|Overall Study|Other (Protocol violation)|0|||
28145705|NCT03093181|54812502|FG002|Overall Study|Other (Protocol violation)|1|||
28145706|NCT03091777|54812513|FG000|Overall Study|Pregnancy|2|||
28145707|NCT03091777|54812514|FG001|Overall Study|Pregnancy|1|||
28145708|NCT03091777|54812515|FG002|Overall Study|Pregnancy|0|||
28145709|NCT03091777|54812513|FG000|Overall Study|Adverse Event|2|||
28145710|NCT03091777|54812514|FG001|Overall Study|Adverse Event|1|||
28145711|NCT03091777|54812515|FG002|Overall Study|Adverse Event|4|||
28145712|NCT03091777|54812513|FG000|Overall Study|Withdrawal by Subject|4|||
28145713|NCT03091777|54812514|FG001|Overall Study|Withdrawal by Subject|2|||
28145714|NCT03091777|54812515|FG002|Overall Study|Withdrawal by Subject|6|||
28145715|NCT03091777|54812513|FG000|Overall Study|Protocol Violation|2|||
28145716|NCT03091777|54812514|FG001|Overall Study|Protocol Violation|1|||
28145717|NCT03091777|54812515|FG002|Overall Study|Protocol Violation|1|||
28145718|NCT03091777|54812513|FG000|Overall Study|Lost to Follow-up|12|||
28145719|NCT03091777|54812514|FG001|Overall Study|Lost to Follow-up|14|||
28145720|NCT03091777|54812515|FG002|Overall Study|Lost to Follow-up|7|||
28145721|NCT03091777|54812513|FG000|Overall Study|Lack of Efficacy|0|||
28145722|NCT03091777|54812514|FG001|Overall Study|Lack of Efficacy|0|||
28145723|NCT03091777|54812515|FG002|Overall Study|Lack of Efficacy|5|||
28145724|NCT03091777|54812513|FG000|Overall Study|Noncompliance with study drug|2|||
28145725|NCT03091777|54812514|FG001|Overall Study|Noncompliance with study drug|3|||
28145726|NCT03091777|54812515|FG002|Overall Study|Noncompliance with study drug|1|||
27941416|NCT00940498|54597836|FG005|Overall Study|Physician Decision|0|||
27941417|NCT00940498|54597837|FG006|Overall Study|Physician Decision|0|||
28145727|NCT03091777|54812513|FG000|Overall Study|Physician Decision|1|||
28145728|NCT03091777|54812514|FG001|Overall Study|Physician Decision|0|||
28145729|NCT03091777|54812515|FG002|Overall Study|Physician Decision|1|||
28145730|NCT03091777|54812513|FG000|Overall Study|Abnormal Laboratory Value|7|||
28145731|NCT03091777|54812514|FG001|Overall Study|Abnormal Laboratory Value|11|||
28145732|NCT03091777|54812515|FG002|Overall Study|Abnormal Laboratory Value|12|||
28145733|NCT02818998|54812526|FG000|Overall Study|Adverse Event|3|||
28145734|NCT02818998|54812527|FG001|Overall Study|Adverse Event|2|||
28145735|NCT02818998|54812528|FG002|Overall Study|Adverse Event|1|||
28145736|NCT02818998|54812526|FG000|Overall Study|Lost to Follow-up|4|||
28145737|NCT02818998|54812527|FG001|Overall Study|Lost to Follow-up|1|||
28145738|NCT02818998|54812528|FG002|Overall Study|Lost to Follow-up|2|||
27941418|NCT00940498|54597838|FG007|Overall Study|Physician Decision|0|||
28145739|NCT02818998|54812526|FG000|Overall Study|Withdrawal by sponsor|0|||
28145740|NCT02818998|54812527|FG001|Overall Study|Withdrawal by sponsor|1|||
28145741|NCT02818998|54812528|FG002|Overall Study|Withdrawal by sponsor|1|||
28145742|NCT02818998|54812526|FG000|Overall Study|Death|3|||
28145743|NCT02818998|54812527|FG001|Overall Study|Death|6|||
28145744|NCT02818998|54812528|FG002|Overall Study|Death|8|||
28145745|NCT02818998|54812526|FG000|Overall Study|Withdrawal by Subject|7|||
28145746|NCT02818998|54812527|FG001|Overall Study|Withdrawal by Subject|6|||
28145747|NCT02818998|54812528|FG002|Overall Study|Withdrawal by Subject|6|||
28145748|NCT02818998|54812526|FG000|Overall Study|Physician Decision|1|||
28145749|NCT02818998|54812527|FG001|Overall Study|Physician Decision|0|||
28145750|NCT02818998|54812528|FG002|Overall Study|Physician Decision|0|||
28145751|NCT02821416|54812538|FG000|Overall Study|Adverse Event|0|||
28145752|NCT02821416|54812539|FG001|Overall Study|Adverse Event|1|||
28145753|NCT02821416|54812538|FG000|Overall Study|Withdrawal by Subject|2|||
28145754|NCT02821416|54812539|FG001|Overall Study|Withdrawal by Subject|0|||
28145755|NCT02821416|54812538|FG000|Overall Study|Lost to Follow-up|1|||
28145756|NCT02821416|54812539|FG001|Overall Study|Lost to Follow-up|0|||
28145757|NCT03108521|54812548|FG000|Overall Study|Lost to Follow-up|3|||
28145758|NCT03108521|54812549|FG001|Overall Study|Lost to Follow-up|0|||
28145759|NCT03108521|54812548|FG000|Overall Study|Lack of Efficacy|2|||
28145760|NCT03108521|54812549|FG001|Overall Study|Lack of Efficacy|0|||
28145761|NCT03108521|54812548|FG000|Overall Study|Physician Decision|4|||
28145762|NCT03108521|54812549|FG001|Overall Study|Physician Decision|0|||
28145763|NCT03108521|54812548|FG000|Overall Study|Adverse Event|3|||
28145764|NCT03108521|54812549|FG001|Overall Study|Adverse Event|0|||
28145765|NCT02817828|54812572|FG000|Overall Study|Lost to Follow-up|41|||
28145766|NCT02817828|54812572|FG000|Overall Study|Adverse event not related to bleeding|104|||
28145767|NCT02817828|54812572|FG000|Overall Study|Adverse event related to bleeding|53|||
28145768|NCT02817828|54812572|FG000|Overall Study|Protocol Violation|11|||
28145769|NCT02817828|54812572|FG000|Overall Study|Pregnancy|7|||
28145770|NCT02817828|54812572|FG000|Overall Study|Pregnancy wish|15|||
28145771|NCT02817828|54812572|FG000|Overall Study|Withdrawal by Subject|78|||
28145772|NCT02817828|54812572|FG000|Overall Study|Other|26|||
28145773|NCT02817906|54812583|FG000|Overall Study|Adverse Event|3|||
28145774|NCT02817906|54812584|FG001|Overall Study|Adverse Event|0|||
28145775|NCT02817906|54812583|FG000|Overall Study|Lack of Efficacy|1|||
28145776|NCT02817906|54812584|FG001|Overall Study|Lack of Efficacy|0|||
28145777|NCT02817906|54812583|FG000|Overall Study|Protocol Violation|1|||
28145778|NCT02817906|54812584|FG001|Overall Study|Protocol Violation|1|||
28145779|NCT02817906|54812583|FG000|Overall Study|Study Terminated by Sponsor|2|||
28145780|NCT02817906|54812584|FG001|Overall Study|Study Terminated by Sponsor|2|||
28145781|NCT02817906|54812583|FG000|Overall Study|Withdrawal by Subject|7|||
28145782|NCT02817906|54812584|FG001|Overall Study|Withdrawal by Subject|0|||
28145783|NCT02817906|54812583|FG000|Overall Study|Other|2|||
28145784|NCT02817906|54812584|FG001|Overall Study|Other|2|||
28145785|NCT02817594|54812595|FG000|Overall Study|Withdrawal by Subject|1|||
28145786|NCT02817594|54812595|FG000|Overall Study|Other|1|||
28145787|NCT02817594|54812595|FG000|Overall Study|Did Not Receive Treatment|1|||
28145788|NCT02813694|54812605|FG000|Overall Study|Physician Decision|0|||
28145789|NCT02813694|54812606|FG001|Overall Study|Physician Decision|1|||
28145790|NCT02813694|54812605|FG000|Overall Study|Withdrawal by Subject|10|||
28145791|NCT02813694|54812606|FG001|Overall Study|Withdrawal by Subject|9|||
28145792|NCT02813694|54812605|FG000|Overall Study|Lost to Follow-up|1|||
28145793|NCT02813694|54812606|FG001|Overall Study|Lost to Follow-up|1|||
28145794|NCT02813694|54812605|FG000|Overall Study|Death|3|||
28145795|NCT02813694|54812606|FG001|Overall Study|Death|3|||
28145796|NCT02813694|54812605|FG000|Overall Study|Randomized- did not receive study drug|2|||
28145797|NCT02813694|54812606|FG001|Overall Study|Randomized- did not receive study drug|0|||
28145798|NCT02813694|54812605|FG000|Overall Study|Patient hospitalized|1|||
28145799|NCT02813694|54812606|FG001|Overall Study|Patient hospitalized|0|||
28145800|NCT03103919|54812614|FG000|Overall Study|Adverse Event|2|||
28145801|NCT03103919|54812615|FG001|Overall Study|Adverse Event|2|||
28145802|NCT02810964|54812625|FG000|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|1|||
28145803|NCT02810964|54812626|FG001|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|2|||
28145804|NCT02810964|54812625|FG000|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|1|||
28145805|NCT02810964|54812626|FG001|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|0|||
28145806|NCT02810964|54812625|FG000|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|0|||
28145807|NCT02810964|54812626|FG001|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|1|||
28145808|NCT02810964|54812625|FG000|Double-Blind Treatment Phase (16 Weeks)|Relocation|1|||
28145809|NCT02810964|54812626|FG001|Double-Blind Treatment Phase (16 Weeks)|Relocation|0|||
28145810|NCT03103763|54812635|FG000|Overall Study|Death|15|||
28145811|NCT03103763|54812636|FG001|Overall Study|Death|5|||
28145812|NCT03103763|54812637|FG002|Overall Study|Death|5|||
28145813|NCT03103763|54812635|FG000|Overall Study|Withdrawal by Subject|0|||
28145814|NCT03103763|54812636|FG001|Overall Study|Withdrawal by Subject|3|||
28145815|NCT03103763|54812637|FG002|Overall Study|Withdrawal by Subject|2|||
28145816|NCT03101267|54812661|FG000|Primary Study Period|Withdrawal by Subject|1|||
28145817|NCT03101267|54812662|FG001|Primary Study Period|Withdrawal by Subject|2|||
28145818|NCT03101267|54812663|FG002|Primary Study Period|Withdrawal by Subject|3|||
28145819|NCT03101267|54812661|FG000|Primary Study Period|Miscellaneous|2|||
28145820|NCT03101267|54812662|FG001|Primary Study Period|Miscellaneous|0|||
28145821|NCT03101267|54812663|FG002|Primary Study Period|Miscellaneous|0|||
28145822|NCT02810418|54812678|FG000|Arm A Dose Escalation|Adverse Event|2|||
28145823|NCT02810418|54812679|FG001|Arm A Dose Escalation|Adverse Event|1|||
28145824|NCT02810418|54812680|FG002|Arm A Dose Escalation|Adverse Event|0|||
28145825|NCT02810418|54812681|FG003|Arm A Dose Escalation|Adverse Event|0|||
28145826|NCT02810418|54812682|FG004|Arm A Dose Escalation|Adverse Event|0|||
28145827|NCT02810418|54812683|FG005|Arm A Dose Escalation|Adverse Event|0|||
28145828|NCT02810418|54812684|FG006|Arm A Dose Escalation|Adverse Event|0|||
28145829|NCT02810418|54812678|FG000|Dose Expansion|Adverse Event|0|||
28145830|NCT02810418|54812679|FG001|Dose Expansion|Adverse Event|1|||
28145831|NCT02810418|54812680|FG002|Dose Expansion|Adverse Event|1|||
28145832|NCT02810418|54812681|FG003|Dose Expansion|Adverse Event|0|||
28145833|NCT02810418|54812682|FG004|Dose Expansion|Adverse Event|0|||
28145834|NCT02810418|54812683|FG005|Dose Expansion|Adverse Event|0|||
28145835|NCT02810418|54812684|FG006|Dose Expansion|Adverse Event|0|||
28145836|NCT02810418|54812678|FG000|Dose Expansion|Physician Decision|0|||
28145837|NCT02810418|54812679|FG001|Dose Expansion|Physician Decision|0|||
28145838|NCT02810418|54812680|FG002|Dose Expansion|Physician Decision|2|||
28145839|NCT02810418|54812681|FG003|Dose Expansion|Physician Decision|0|||
28145840|NCT02810418|54812682|FG004|Dose Expansion|Physician Decision|0|||
28145841|NCT02810418|54812683|FG005|Dose Expansion|Physician Decision|0|||
28145842|NCT02810418|54812684|FG006|Dose Expansion|Physician Decision|0|||
28145843|NCT02810418|54812678|FG000|Arm B Dose Escalation|Adverse Event|0|||
28145844|NCT02810418|54812679|FG001|Arm B Dose Escalation|Adverse Event|0|||
28145845|NCT02810418|54812680|FG002|Arm B Dose Escalation|Adverse Event|0|||
28145846|NCT02810418|54812681|FG003|Arm B Dose Escalation|Adverse Event|0|||
28145847|NCT02810418|54812682|FG004|Arm B Dose Escalation|Adverse Event|1|||
28145848|NCT02810418|54812683|FG005|Arm B Dose Escalation|Adverse Event|2|||
28145849|NCT02810418|54812684|FG006|Arm B Dose Escalation|Adverse Event|0|||
28145850|NCT02810340|54812750|FG000|Overall Study|Withdrawal by Subject|1|||
28145851|NCT02810340|54812751|FG001|Overall Study|Withdrawal by Subject|0|||
28145852|NCT02810340|54812752|FG002|Overall Study|Withdrawal by Subject|0|||
28145853|NCT02810340|54812750|FG000|Overall Study|Incarceration|0|||
28145854|NCT02810340|54812751|FG001|Overall Study|Incarceration|1|||
28145855|NCT02810340|54812752|FG002|Overall Study|Incarceration|0|||
28145856|NCT02810340|54812750|FG000|Overall Study|Lost to Follow-up|0|||
28145857|NCT02810340|54812751|FG001|Overall Study|Lost to Follow-up|0|||
28145858|NCT02810340|54812752|FG002|Overall Study|Lost to Follow-up|1|||
28145859|NCT02817516|54812764|FG000|Overall Study|Other|0|||
28145860|NCT02817516|54812765|FG001|Overall Study|Other|0|||
28145861|NCT02817516|54812766|FG002|Overall Study|Other|1|||
28145862|NCT02817516|54812767|FG003|Overall Study|Other|0|||
28145863|NCT02928029|54812782|FG000|Overall Study|Withdrawal by Subject|0|||
28145864|NCT02928029|54812783|FG001|Overall Study|Withdrawal by Subject|1|||
28145865|NCT02928029|54812782|FG000|Overall Study|Radiological progression|1|||
28145866|NCT02928029|54812783|FG001|Overall Study|Radiological progression|0|||
28145867|NCT02928029|54812782|FG000|Overall Study|Clinical progression|1|||
28145868|NCT02928029|54812783|FG001|Overall Study|Clinical progression|2|||
28145869|NCT02928029|54812782|FG000|Overall Study|AE not related to clinical progression|1|||
28145870|NCT02928029|54812783|FG001|Overall Study|AE not related to clinical progression|1|||
28145871|NCT02806986|54812789|FG000|Treatment Stage 1|Adverse Event|1|||
28145872|NCT02806986|54812789|FG000|Treatment Stage 2|Adverse Event|3|||
28145873|NCT02806986|54812789|FG000|Treatment Stage 2|Withdrawal by Subject|2|||
28145874|NCT03095651|54812805|FG000|Overall Study|Lost to Follow-up|1|||
28145875|NCT03095651|54812806|FG001|Overall Study|Lost to Follow-up|1|||
28145876|NCT03095651|54812807|FG002|Overall Study|Lost to Follow-up|0|||
28145877|NCT03095651|54812808|FG003|Overall Study|Lost to Follow-up|1|||
28145878|NCT03095651|54812809|FG004|Overall Study|Lost to Follow-up|0|||
28145879|NCT03095651|54812810|FG005|Overall Study|Lost to Follow-up|0|||
28145880|NCT03095651|54812811|FG006|Overall Study|Lost to Follow-up|0|||
28145881|NCT03095651|54812812|FG007|Overall Study|Lost to Follow-up|0|||
28145882|NCT03095651|54812805|FG000|Overall Study|Withdrawal by Subject|0|||
28145883|NCT03095651|54812806|FG001|Overall Study|Withdrawal by Subject|0|||
28145884|NCT03095651|54812807|FG002|Overall Study|Withdrawal by Subject|0|||
28145885|NCT03095651|54812808|FG003|Overall Study|Withdrawal by Subject|0|||
28145886|NCT03095651|54812809|FG004|Overall Study|Withdrawal by Subject|0|||
28145887|NCT03095651|54812810|FG005|Overall Study|Withdrawal by Subject|1|||
28145888|NCT03095651|54812811|FG006|Overall Study|Withdrawal by Subject|0|||
28145889|NCT03095651|54812812|FG007|Overall Study|Withdrawal by Subject|0|||
28145890|NCT02808312|54812835|FG000|Overall Study|Enrolled but Never Treated|0|||
28145891|NCT02808312|54812836|FG001|Overall Study|Enrolled but Never Treated|0|||
28145892|NCT02808312|54812837|FG002|Overall Study|Enrolled but Never Treated|1|||
28145893|NCT02808312|54812838|FG003|Overall Study|Enrolled but Never Treated|0|||
28145894|NCT02808312|54812839|FG004|Overall Study|Enrolled but Never Treated|0|||
28145895|NCT03099161|54812859|FG000|Overall Study|Adverse Event|0|||
28145896|NCT03099161|54812860|FG001|Overall Study|Adverse Event|0|||
28145897|NCT03099161|54812861|FG002|Overall Study|Adverse Event|2|||
28145898|NCT03099161|54812859|FG000|Overall Study|Physician Decision|2|||
28145899|NCT03099161|54812860|FG001|Overall Study|Physician Decision|0|||
28145900|NCT03099161|54812861|FG002|Overall Study|Physician Decision|0|||
28145901|NCT03099161|54812859|FG000|Overall Study|Progressive Disease|1|||
28145902|NCT03099161|54812860|FG001|Overall Study|Progressive Disease|4|||
28145903|NCT03099161|54812861|FG002|Overall Study|Progressive Disease|1|||
28145904|NCT03095027|54812869|FG000|Period 2, Second Week of Wear|Adverse Event|1|||
28145905|NCT03095027|54812870|FG001|Period 2, Second Week of Wear|Adverse Event|0|||
28145906|NCT04227197|54812878|FG000|Randomization|Protocol Violation|1|||
28145907|NCT04227197|54812879|FG001|Randomization|Protocol Violation|0|||
28145908|NCT04227197|54812878|FG000|Randomization|Discontinued participation because uncomfortable sharing information|1|||
28145909|NCT04227197|54812879|FG001|Randomization|Discontinued participation because uncomfortable sharing information|0|||
28145910|NCT04227197|54812878|FG000|Primary Care Provider (PCP) Visit|Did not complete PCP visit|2|||
28145911|NCT04227197|54812879|FG001|Primary Care Provider (PCP) Visit|Did not complete PCP visit|0|||
28145912|NCT04227197|54812878|FG000|2-week Follow-up Survey for Caregivers|Not responsive|7|||
28145913|NCT04227197|54812879|FG001|2-week Follow-up Survey for Caregivers|Not responsive|5|||
28145914|NCT04227197|54812878|FG000|2-week Follow-up Survey for Caregivers|Lost to Follow-up|5|||
28145915|NCT04227197|54812879|FG001|2-week Follow-up Survey for Caregivers|Lost to Follow-up|0|||
28145916|NCT04227197|54812878|FG000|2-week Follow-up Survey for PCP's|Not responsive|20|||
28145917|NCT04227197|54812879|FG001|2-week Follow-up Survey for PCP's|Not responsive|25|||
28145918|NCT04227197|54812878|FG000|7-month Follow-up Survey for Caregivers|Lost to Follow-up|11|||
28145919|NCT04227197|54812879|FG001|7-month Follow-up Survey for Caregivers|Lost to Follow-up|3|||
28145920|NCT03080935|54812890|FG000|Overall Study|Death|34|||
28145921|NCT03080935|54812891|FG001|Overall Study|Death|50|||
28145922|NCT03080935|54812890|FG000|Overall Study|Lost to Follow-up|5|||
28145923|NCT03080935|54812891|FG001|Overall Study|Lost to Follow-up|4|||
28145924|NCT03080935|54812890|FG000|Overall Study|Withdrawal by Subject|11|||
28145925|NCT03080935|54812891|FG001|Overall Study|Withdrawal by Subject|15|||
28145926|NCT02921789|54812903|FG000|Overall Study|Adverse Event|0|||
28145927|NCT02921789|54812904|FG001|Overall Study|Adverse Event|1|||
28145928|NCT02921789|54812903|FG000|Overall Study|Lost to Follow-up|1|||
28145929|NCT02921789|54812904|FG001|Overall Study|Lost to Follow-up|0|||
28145930|NCT02921789|54812903|FG000|Overall Study|Protocol Deviation|2|||
28145931|NCT02921789|54812904|FG001|Overall Study|Protocol Deviation|0|||
28145932|NCT02921789|54812903|FG000|Overall Study|Withdrawal by Subject|2|||
28145933|NCT02921789|54812904|FG001|Overall Study|Withdrawal by Subject|1|||
28145934|NCT02921789|54812903|FG000|Overall Study|Miscellaneous|3|||
28145935|NCT02921789|54812904|FG001|Overall Study|Miscellaneous|2|||
28145936|NCT02564900|54812925|FG000|Dose Escalation|Progressive disease per RECIST|2|||
28145937|NCT02564900|54812926|FG001|Dose Escalation|Progressive disease per RECIST|3|||
28145938|NCT02564900|54812927|FG002|Dose Escalation|Progressive disease per RECIST|3|||
28145939|NCT02564900|54812928|FG003|Dose Escalation|Progressive disease per RECIST|3|||
28145940|NCT02564900|54812929|FG004|Dose Escalation|Progressive disease per RECIST|3|||
28145941|NCT02564900|54812930|FG005|Dose Escalation|Progressive disease per RECIST|1|||
28145942|NCT02564900|54812931|FG006|Dose Escalation|Progressive disease per RECIST|0|||
28145943|NCT02564900|54812932|FG007|Dose Escalation|Progressive disease per RECIST|0|||
28145944|NCT02564900|54812933|FG008|Dose Escalation|Progressive disease per RECIST|0|||
28145945|NCT02564900|54812934|FG009|Dose Escalation|Progressive disease per RECIST|0|||
28145946|NCT02564900|54812935|FG010|Dose Escalation|Progressive disease per RECIST|0|||
28145947|NCT02564900|54812936|FG011|Dose Escalation|Progressive disease per RECIST|0|||
28145948|NCT02564900|54812937|FG012|Dose Escalation|Progressive disease per RECIST|0|||
28145949|NCT02564900|54812938|FG013|Dose Escalation|Progressive disease per RECIST|0|||
28145950|NCT02564900|54812939|FG014|Dose Escalation|Progressive disease per RECIST|0|||
28145951|NCT02564900|54812925|FG000|Dose Escalation|Ongoing|1|||
28145952|NCT02564900|54812926|FG001|Dose Escalation|Ongoing|0|||
28145953|NCT02564900|54812927|FG002|Dose Escalation|Ongoing|0|||
28145954|NCT02564900|54812928|FG003|Dose Escalation|Ongoing|2|||
28145955|NCT02564900|54812929|FG004|Dose Escalation|Ongoing|2|||
28145956|NCT02564900|54812930|FG005|Dose Escalation|Ongoing|2|||
28145957|NCT02564900|54812931|FG006|Dose Escalation|Ongoing|0|||
28145958|NCT02564900|54812932|FG007|Dose Escalation|Ongoing|0|||
28145959|NCT02564900|54812933|FG008|Dose Escalation|Ongoing|0|||
28145960|NCT02564900|54812934|FG009|Dose Escalation|Ongoing|0|||
28145961|NCT02564900|54812935|FG010|Dose Escalation|Ongoing|0|||
28145962|NCT02564900|54812936|FG011|Dose Escalation|Ongoing|0|||
28145963|NCT02564900|54812937|FG012|Dose Escalation|Ongoing|0|||
28145964|NCT02564900|54812938|FG013|Dose Escalation|Ongoing|0|||
28145965|NCT02564900|54812939|FG014|Dose Escalation|Ongoing|0|||
28145966|NCT02564900|54812925|FG000|Dose Escalation|Adverse Event|0|||
28145967|NCT02564900|54812926|FG001|Dose Escalation|Adverse Event|0|||
28145968|NCT02564900|54812927|FG002|Dose Escalation|Adverse Event|0|||
28145969|NCT02564900|54812928|FG003|Dose Escalation|Adverse Event|1|||
28145970|NCT02564900|54812929|FG004|Dose Escalation|Adverse Event|1|||
28145971|NCT02564900|54812930|FG005|Dose Escalation|Adverse Event|3|||
28145972|NCT02564900|54812931|FG006|Dose Escalation|Adverse Event|0|||
28145973|NCT02564900|54812932|FG007|Dose Escalation|Adverse Event|0|||
28145974|NCT02564900|54812933|FG008|Dose Escalation|Adverse Event|0|||
28145975|NCT02564900|54812934|FG009|Dose Escalation|Adverse Event|0|||
28145976|NCT02564900|54812935|FG010|Dose Escalation|Adverse Event|0|||
28145977|NCT02564900|54812936|FG011|Dose Escalation|Adverse Event|0|||
28145978|NCT02564900|54812937|FG012|Dose Escalation|Adverse Event|0|||
28145979|NCT02564900|54812938|FG013|Dose Escalation|Adverse Event|0|||
28145980|NCT02564900|54812939|FG014|Dose Escalation|Adverse Event|0|||
28145981|NCT02564900|54812925|FG000|Dose Expansion|Progressive disease per RECIST|0|||
28145982|NCT02564900|54812926|FG001|Dose Expansion|Progressive disease per RECIST|0|||
28145983|NCT02564900|54812927|FG002|Dose Expansion|Progressive disease per RECIST|0|||
28145984|NCT02564900|54812928|FG003|Dose Expansion|Progressive disease per RECIST|0|||
28145985|NCT02564900|54812929|FG004|Dose Expansion|Progressive disease per RECIST|0|||
28145986|NCT02564900|54812930|FG005|Dose Expansion|Progressive disease per RECIST|0|||
28145987|NCT02564900|54812931|FG006|Dose Expansion|Progressive disease per RECIST|19|||
28145988|NCT02564900|54812932|FG007|Dose Expansion|Progressive disease per RECIST|17|||
28145989|NCT02564900|54812933|FG008|Dose Expansion|Progressive disease per RECIST|8|||
28145990|NCT02564900|54812934|FG009|Dose Expansion|Progressive disease per RECIST|16|||
28145991|NCT02564900|54812935|FG010|Dose Expansion|Progressive disease per RECIST|13|||
28145992|NCT02564900|54812936|FG011|Dose Expansion|Progressive disease per RECIST|19|||
28145993|NCT02564900|54812937|FG012|Dose Expansion|Progressive disease per RECIST|10|||
28145994|NCT02564900|54812938|FG013|Dose Expansion|Progressive disease per RECIST|13|||
28145995|NCT02564900|54812939|FG014|Dose Expansion|Progressive disease per RECIST|11|||
28145996|NCT02564900|54812925|FG000|Dose Expansion|Clinical progression|0|||
28145997|NCT02564900|54812926|FG001|Dose Expansion|Clinical progression|0|||
28145998|NCT02564900|54812927|FG002|Dose Expansion|Clinical progression|0|||
28145999|NCT02564900|54812928|FG003|Dose Expansion|Clinical progression|0|||
28146000|NCT02564900|54812929|FG004|Dose Expansion|Clinical progression|0|||
28146001|NCT02564900|54812930|FG005|Dose Expansion|Clinical progression|0|||
28146002|NCT02564900|54812931|FG006|Dose Expansion|Clinical progression|5|||
28146003|NCT02564900|54812932|FG007|Dose Expansion|Clinical progression|12|||
28146004|NCT02564900|54812933|FG008|Dose Expansion|Clinical progression|0|||
28146005|NCT02564900|54812934|FG009|Dose Expansion|Clinical progression|3|||
28146006|NCT02564900|54812935|FG010|Dose Expansion|Clinical progression|2|||
28146007|NCT02564900|54812936|FG011|Dose Expansion|Clinical progression|0|||
28146008|NCT02564900|54812937|FG012|Dose Expansion|Clinical progression|1|||
28146009|NCT02564900|54812938|FG013|Dose Expansion|Clinical progression|3|||
28146010|NCT02564900|54812939|FG014|Dose Expansion|Clinical progression|1|||
28146011|NCT02564900|54812925|FG000|Dose Expansion|Adverse Event|0|||
28146012|NCT02564900|54812926|FG001|Dose Expansion|Adverse Event|0|||
28146013|NCT02564900|54812927|FG002|Dose Expansion|Adverse Event|0|||
28146014|NCT02564900|54812928|FG003|Dose Expansion|Adverse Event|0|||
28146015|NCT02564900|54812929|FG004|Dose Expansion|Adverse Event|0|||
28146016|NCT02564900|54812930|FG005|Dose Expansion|Adverse Event|0|||
28146017|NCT02564900|54812931|FG006|Dose Expansion|Adverse Event|9|||
28146018|NCT02564900|54812932|FG007|Dose Expansion|Adverse Event|22|||
28146019|NCT02564900|54812933|FG008|Dose Expansion|Adverse Event|0|||
28146020|NCT02564900|54812934|FG009|Dose Expansion|Adverse Event|11|||
28146021|NCT02564900|54812935|FG010|Dose Expansion|Adverse Event|0|||
28146022|NCT02564900|54812936|FG011|Dose Expansion|Adverse Event|5|||
28146023|NCT02564900|54812937|FG012|Dose Expansion|Adverse Event|2|||
28146024|NCT02564900|54812938|FG013|Dose Expansion|Adverse Event|2|||
28146025|NCT02564900|54812939|FG014|Dose Expansion|Adverse Event|1|||
28146026|NCT02564900|54812925|FG000|Dose Expansion|Ongoing|0|||
28146027|NCT02564900|54812926|FG001|Dose Expansion|Ongoing|0|||
28146028|NCT02564900|54812927|FG002|Dose Expansion|Ongoing|0|||
28146029|NCT02564900|54812928|FG003|Dose Expansion|Ongoing|0|||
28146030|NCT02564900|54812929|FG004|Dose Expansion|Ongoing|0|||
28146031|NCT02564900|54812930|FG005|Dose Expansion|Ongoing|0|||
28146032|NCT02564900|54812931|FG006|Dose Expansion|Ongoing|9|||
28146033|NCT02564900|54812932|FG007|Dose Expansion|Ongoing|10|||
28146034|NCT02564900|54812933|FG008|Dose Expansion|Ongoing|11|||
28146035|NCT02564900|54812934|FG009|Dose Expansion|Ongoing|3|||
28146036|NCT02564900|54812935|FG010|Dose Expansion|Ongoing|0|||
28146037|NCT02564900|54812936|FG011|Dose Expansion|Ongoing|0|||
28146038|NCT02564900|54812937|FG012|Dose Expansion|Ongoing|4|||
28146039|NCT02564900|54812938|FG013|Dose Expansion|Ongoing|0|||
28146040|NCT02564900|54812939|FG014|Dose Expansion|Ongoing|6|||
28146041|NCT02564900|54812925|FG000|Dose Expansion|Death|0|||
28146042|NCT02564900|54812926|FG001|Dose Expansion|Death|0|||
27822672|NCT01840579|54286395|FG006|Overall Study|Adverse Event|0|||
27941419|NCT00940498|54597831|FG000|Overall Study|Not treated due to disease related pain|0|||
27941420|NCT00940498|54597832|FG001|Overall Study|Not treated due to disease related pain|0|||
28146043|NCT02564900|54812927|FG002|Dose Expansion|Death|0|||
28146044|NCT02564900|54812928|FG003|Dose Expansion|Death|0|||
28146045|NCT02564900|54812929|FG004|Dose Expansion|Death|0|||
28146046|NCT02564900|54812930|FG005|Dose Expansion|Death|0|||
28146047|NCT02564900|54812931|FG006|Dose Expansion|Death|1|||
28146048|NCT02564900|54812932|FG007|Dose Expansion|Death|0|||
28146049|NCT02564900|54812933|FG008|Dose Expansion|Death|0|||
27941421|NCT00940498|54597833|FG002|Overall Study|Not treated due to disease related pain|0|||
27941422|NCT00940498|54597834|FG003|Overall Study|Not treated due to disease related pain|0|||
28146050|NCT02564900|54812934|FG009|Dose Expansion|Death|0|||
28146051|NCT02564900|54812935|FG010|Dose Expansion|Death|1|||
28146052|NCT02564900|54812936|FG011|Dose Expansion|Death|0|||
28146053|NCT02564900|54812937|FG012|Dose Expansion|Death|1|||
28146054|NCT02564900|54812938|FG013|Dose Expansion|Death|1|||
28146055|NCT02564900|54812939|FG014|Dose Expansion|Death|0|||
28146056|NCT02564900|54812925|FG000|Dose Expansion|Withdrawal by Subject|0|||
28146057|NCT02564900|54812926|FG001|Dose Expansion|Withdrawal by Subject|0|||
28146058|NCT02564900|54812927|FG002|Dose Expansion|Withdrawal by Subject|0|||
28146059|NCT02564900|54812928|FG003|Dose Expansion|Withdrawal by Subject|0|||
28146060|NCT02564900|54812929|FG004|Dose Expansion|Withdrawal by Subject|0|||
28146061|NCT02564900|54812930|FG005|Dose Expansion|Withdrawal by Subject|0|||
28146062|NCT02564900|54812931|FG006|Dose Expansion|Withdrawal by Subject|4|||
28146063|NCT02564900|54812932|FG007|Dose Expansion|Withdrawal by Subject|0|||
28146064|NCT02564900|54812933|FG008|Dose Expansion|Withdrawal by Subject|0|||
28146065|NCT02564900|54812934|FG009|Dose Expansion|Withdrawal by Subject|0|||
28146066|NCT02564900|54812935|FG010|Dose Expansion|Withdrawal by Subject|1|||
28146067|NCT02564900|54812936|FG011|Dose Expansion|Withdrawal by Subject|0|||
28146068|NCT02564900|54812937|FG012|Dose Expansion|Withdrawal by Subject|0|||
28146069|NCT02564900|54812938|FG013|Dose Expansion|Withdrawal by Subject|1|||
28146070|NCT02564900|54812939|FG014|Dose Expansion|Withdrawal by Subject|1|||
28146071|NCT02564900|54812925|FG000|Dose Expansion|Other|0|||
28146072|NCT02564900|54812926|FG001|Dose Expansion|Other|0|||
28146073|NCT02564900|54812927|FG002|Dose Expansion|Other|0|||
28146074|NCT02564900|54812928|FG003|Dose Expansion|Other|0|||
28146075|NCT02564900|54812929|FG004|Dose Expansion|Other|0|||
28146076|NCT02564900|54812930|FG005|Dose Expansion|Other|0|||
28146077|NCT02564900|54812931|FG006|Dose Expansion|Other|1|||
28146078|NCT02564900|54812932|FG007|Dose Expansion|Other|0|||
28146079|NCT02564900|54812933|FG008|Dose Expansion|Other|1|||
28146080|NCT02564900|54812934|FG009|Dose Expansion|Other|0|||
28146081|NCT02564900|54812935|FG010|Dose Expansion|Other|0|||
28146082|NCT02564900|54812936|FG011|Dose Expansion|Other|0|||
28146083|NCT02564900|54812937|FG012|Dose Expansion|Other|0|||
28146084|NCT02564900|54812938|FG013|Dose Expansion|Other|0|||
28146085|NCT02564900|54812939|FG014|Dose Expansion|Other|1|||
28146086|NCT02564900|54812925|FG000|Dose Expansion|Did not receive treatment|0|||
28146087|NCT02564900|54812926|FG001|Dose Expansion|Did not receive treatment|0|||
28146088|NCT02564900|54812927|FG002|Dose Expansion|Did not receive treatment|0|||
28146089|NCT02564900|54812928|FG003|Dose Expansion|Did not receive treatment|0|||
28146090|NCT02564900|54812929|FG004|Dose Expansion|Did not receive treatment|0|||
28146091|NCT02564900|54812930|FG005|Dose Expansion|Did not receive treatment|0|||
28146092|NCT02564900|54812931|FG006|Dose Expansion|Did not receive treatment|1|||
28146093|NCT02564900|54812932|FG007|Dose Expansion|Did not receive treatment|1|||
28146094|NCT02564900|54812933|FG008|Dose Expansion|Did not receive treatment|0|||
28146095|NCT02564900|54812934|FG009|Dose Expansion|Did not receive treatment|0|||
28146096|NCT02564900|54812935|FG010|Dose Expansion|Did not receive treatment|0|||
28146097|NCT02564900|54812936|FG011|Dose Expansion|Did not receive treatment|0|||
28146098|NCT02564900|54812937|FG012|Dose Expansion|Did not receive treatment|0|||
28146099|NCT02564900|54812938|FG013|Dose Expansion|Did not receive treatment|0|||
28146100|NCT02564900|54812939|FG014|Dose Expansion|Did not receive treatment|1|||
28146101|NCT03364673|54812989|FG000|Overall Study|Withdrawal by Subject|2|||
28146102|NCT03364673|54812989|FG000|Overall Study|Injury unrelated to study|3|||
28146103|NCT03097289|54812993|FG000|Overall Study|Adverse Event|1|||
28146104|NCT03097289|54812993|FG000|Overall Study|Equipment failure|2|||
28146105|NCT03097289|54812993|FG000|Overall Study|Collected platelet product unusable|3|||
28146106|NCT02419742|54813015|FG000|Overall Study|Adverse Event|2|||
28146107|NCT02419742|54813016|FG001|Overall Study|Adverse Event|0|||
28146108|NCT02419742|54813015|FG000|Overall Study|Disease Progression|0|||
28146109|NCT02419742|54813016|FG001|Overall Study|Disease Progression|1|||
28146110|NCT02419742|54813015|FG000|Overall Study|Withdrew Consent|2|||
28146111|NCT02419742|54813016|FG001|Overall Study|Withdrew Consent|1|||
28146112|NCT02419742|54813015|FG000|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|1|||
28146113|NCT02419742|54813016|FG001|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|0|||
28146114|NCT02898077|54813024|FG000|Overall Study|Enrolled/randomized, but never treated|1|||
28146115|NCT02898077|54813025|FG001|Overall Study|Enrolled/randomized, but never treated|1|||
28146116|NCT02898077|54813024|FG000|Overall Study|Lost to Follow-up|4|||
28146117|NCT02898077|54813025|FG001|Overall Study|Lost to Follow-up|3|||
28146118|NCT02898077|54813024|FG000|Overall Study|Physician Decision|0|||
28146119|NCT02898077|54813025|FG001|Overall Study|Physician Decision|2|||
28146120|NCT02898077|54813024|FG000|Overall Study|Sponsor Decision|32|||
28146121|NCT02898077|54813025|FG001|Overall Study|Sponsor Decision|13|||
28146122|NCT02898077|54813024|FG000|Overall Study|Withdrawal by Subject|6|||
28146123|NCT02898077|54813025|FG001|Overall Study|Withdrawal by Subject|3|||
28146124|NCT02898077|54813024|FG000|Overall Study|Discontinued from treatment but refused follow-up|2|||
28146125|NCT02898077|54813025|FG001|Overall Study|Discontinued from treatment but refused follow-up|1|||
28146126|NCT02898077|54813024|FG000|Overall Study|Ended extension period|3|||
28146127|NCT02898077|54813025|FG001|Overall Study|Ended extension period|0|||
28146128|NCT03097133|54813033|FG000|Overall Study|Lost to Follow-up|3|||
28146129|NCT03097133|54813034|FG001|Overall Study|Lost to Follow-up|2|||
28146130|NCT03097133|54813033|FG000|Overall Study|Withdrawal by Subject|2|||
28146131|NCT03097133|54813034|FG001|Overall Study|Withdrawal by Subject|5|||
28146132|NCT03097133|54813033|FG000|Overall Study|Discontinued DB, not entered FU Phase|21|||
28072033|NCT00114231|54726788|FG000|Overall Study|Tumor fixed on digital exam|0|||
28146133|NCT03097133|54813034|FG001|Overall Study|Discontinued DB, not entered FU Phase|25|||
28146134|NCT03097133|54813033|FG000|Overall Study|Other|3|||
28146135|NCT03097133|54813034|FG001|Overall Study|Other|2|||
28146136|NCT03097133|54813033|FG000|Overall Study|Adverse Event|1|||
28146137|NCT03097133|54813034|FG001|Overall Study|Adverse Event|0|||
28146138|NCT03889639|54813048|FG000|Overall Study|Withdrawal by Subject|0|||
28146139|NCT03889639|54813049|FG001|Overall Study|Withdrawal by Subject|0|||
28146140|NCT03889639|54813050|FG002|Overall Study|Withdrawal by Subject|0|||
28146141|NCT03889639|54813051|FG003|Overall Study|Withdrawal by Subject|0|||
28146142|NCT03889639|54813052|FG004|Overall Study|Withdrawal by Subject|0|||
28146143|NCT03889639|54813053|FG005|Overall Study|Withdrawal by Subject|0|||
28146144|NCT03889639|54813054|FG006|Overall Study|Withdrawal by Subject|0|||
28146145|NCT03889639|54813055|FG007|Overall Study|Withdrawal by Subject|1|||
28146146|NCT03265145|54813078|FG000|Overall Study|Protocol Violation|2|||
28146147|NCT03265145|54813079|FG001|Overall Study|Protocol Violation|0|||
28146148|NCT03265145|54813078|FG000|Overall Study|Adverse Event|1|||
28146149|NCT03265145|54813079|FG001|Overall Study|Adverse Event|0|||
28072034|NCT00114231|54726789|FG001|Overall Study|Tumor fixed on digital exam|1|||
28072035|NCT00114231|54726788|FG000|Overall Study|No Absolute Neutrophil Count|2|||
28072036|NCT00114231|54726789|FG001|Overall Study|No Absolute Neutrophil Count|0|||
28072037|NCT00114231|54726788|FG000|Overall Study|Biopsy done after registration|1|||
28072038|NCT00114231|54726789|FG001|Overall Study|Biopsy done after registration|0|||
28072039|NCT00113919|54726794|FG000|Overall Study|Physician Decision|8|||
28072040|NCT00113919|54726794|FG000|Overall Study|Death|6|||
28072041|NCT00113841|54726800|FG000|Overall Study|Disease progression|0|||
28072042|NCT00113841|54726801|FG001|Overall Study|Disease progression|2|||
28072043|NCT00113841|54726800|FG000|Overall Study|Non-compliant|1|||
28072044|NCT00113841|54726801|FG001|Overall Study|Non-compliant|0|||
28072045|NCT00113607|54726809|FG000|Overall Study|Adverse Event|40|||
28072046|NCT00113607|54726810|FG001|Overall Study|Adverse Event|71|||
28072047|NCT00113607|54726809|FG000|Overall Study|Death|8|||
28072048|NCT00113607|54726810|FG001|Overall Study|Death|8|||
28072049|NCT00113607|54726809|FG000|Overall Study|Withdrawal by Subject|50|||
28072050|NCT00113607|54726810|FG001|Overall Study|Withdrawal by Subject|58|||
28072051|NCT00113607|54726809|FG000|Overall Study|Lost to Follow-up|0|||
28072052|NCT00113607|54726810|FG001|Overall Study|Lost to Follow-up|2|||
28146150|NCT03265145|54813078|FG000|Overall Study|Withdrawal by Subject|23|||
28146151|NCT03265145|54813079|FG001|Overall Study|Withdrawal by Subject|19|||
28146152|NCT03265145|54813078|FG000|Overall Study|Death|12|||
28146153|NCT03265145|54813079|FG001|Overall Study|Death|12|||
28146154|NCT03265145|54813078|FG000|Overall Study|Lost to Follow-up|13|||
28146155|NCT03265145|54813079|FG001|Overall Study|Lost to Follow-up|9|||
28072053|NCT00113607|54726809|FG000|Overall Study|Disease Progression|180|||
28146156|NCT03265145|54813078|FG000|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|0|||
28146157|NCT03265145|54813079|FG001|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|1|||
28146158|NCT03265145|54813078|FG000|Overall Study|Switched back to previous medication|1|||
28146159|NCT03265145|54813079|FG001|Overall Study|Switched back to previous medication|0|||
28146160|NCT03265145|54813078|FG000|Overall Study|Did not want to take medication|1|||
28146161|NCT03265145|54813079|FG001|Overall Study|Did not want to take medication|0|||
28146162|NCT03265145|54813078|FG000|Overall Study|Subject could not afford medication|0|||
28146163|NCT03265145|54813079|FG001|Overall Study|Subject could not afford medication|1|||
28146164|NCT03265145|54813078|FG000|Overall Study|Site closed|2|||
28146165|NCT03265145|54813079|FG001|Overall Study|Site closed|3|||
28146166|NCT03265145|54813078|FG000|Overall Study|Incorrectly randomized|16|||
28146167|NCT03265145|54813079|FG001|Overall Study|Incorrectly randomized|6|||
28146168|NCT03265145|54813078|FG000|Overall Study|Entered into Electronic Data Capture in error|0|||
28146169|NCT03265145|54813079|FG001|Overall Study|Entered into Electronic Data Capture in error|1|||
28146170|NCT03265145|54813078|FG000|Overall Study|Physician Decision|0|||
28146171|NCT03265145|54813079|FG001|Overall Study|Physician Decision|3|||
28146172|NCT03265145|54813078|FG000|Overall Study|Subject transferred to another facility|0|||
27822673|NCT01840579|54286396|FG007|Overall Study|Adverse Event|0|||
27822674|NCT01840579|54286397|FG008|Overall Study|Adverse Event|0|||
27822675|NCT01840579|54286398|FG009|Overall Study|Adverse Event|0|||
27822676|NCT01840579|54286389|FG000|Overall Study|Follow-up ended by Sponsor|0|||
27822677|NCT01840579|54286390|FG001|Overall Study|Follow-up ended by Sponsor|0|||
27822678|NCT01840579|54286391|FG002|Overall Study|Follow-up ended by Sponsor|0|||
27822679|NCT01840579|54286392|FG003|Overall Study|Follow-up ended by Sponsor|0|||
27822680|NCT01840579|54286393|FG004|Overall Study|Follow-up ended by Sponsor|0|||
27822681|NCT01840579|54286394|FG005|Overall Study|Follow-up ended by Sponsor|0|||
28072054|NCT00113607|54726810|FG001|Overall Study|Disease Progression|142|||
28146173|NCT03265145|54813079|FG001|Overall Study|Subject transferred to another facility|1|||
28146174|NCT05674344|54813090|FG000|Overall Study|Screen Fail|21|||
28146175|NCT05674344|54813090|FG000|Overall Study|Incomplete study procedures|3|||
28146176|NCT05419908|54813109|FG000|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|1|||
28146177|NCT05419908|54813110|FG001|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|0|||
28146178|NCT05419908|54813109|FG000|Overall Study|Serious Adverse Event|0|||
28146179|NCT05419908|54813110|FG001|Overall Study|Serious Adverse Event|2|||
28146180|NCT05419908|54813109|FG000|Overall Study|Withdrawal by Subject|2|||
28146181|NCT05419908|54813110|FG001|Overall Study|Withdrawal by Subject|0|||
28146182|NCT05419908|54813109|FG000|Overall Study|Miscellaneous|1|||
28146183|NCT05419908|54813110|FG001|Overall Study|Miscellaneous|1|||
28146184|NCT04424641|54813175|FG000|Overall Study|Death|1|||
28146185|NCT04424641|54813176|FG001|Overall Study|Death|2|||
28146186|NCT04424641|54813177|FG002|Overall Study|Death|3|||
28146187|NCT04424641|54813178|FG003|Overall Study|Death|0|||
28146188|NCT04424641|54813179|FG004|Overall Study|Death|3|||
28146189|NCT04424641|54813180|FG005|Overall Study|Death|0|||
28146190|NCT04424641|54813181|FG006|Overall Study|Death|1|||
28146191|NCT04424641|54813182|FG007|Overall Study|Death|2|||
28146192|NCT04424641|54813175|FG000|Overall Study|Sponsor decision|0|||
28146193|NCT04424641|54813176|FG001|Overall Study|Sponsor decision|2|||
28146194|NCT04424641|54813177|FG002|Overall Study|Sponsor decision|3|||
28146195|NCT04424641|54813178|FG003|Overall Study|Sponsor decision|7|||
28146196|NCT04424641|54813179|FG004|Overall Study|Sponsor decision|2|||
28146197|NCT04424641|54813180|FG005|Overall Study|Sponsor decision|2|||
28146198|NCT04424641|54813181|FG006|Overall Study|Sponsor decision|3|||
28146199|NCT04424641|54813182|FG007|Overall Study|Sponsor decision|4|||
28146200|NCT04424641|54813175|FG000|Overall Study|Withdrawal by Subject|0|||
28146201|NCT04424641|54813176|FG001|Overall Study|Withdrawal by Subject|0|||
28146202|NCT04424641|54813177|FG002|Overall Study|Withdrawal by Subject|0|||
28146203|NCT04424641|54813178|FG003|Overall Study|Withdrawal by Subject|0|||
28146204|NCT04424641|54813179|FG004|Overall Study|Withdrawal by Subject|1|||
28072055|NCT00113607|54726809|FG000|Overall Study|Complete Response (Confirmed)|14|||
28072056|NCT00113607|54726810|FG001|Overall Study|Complete Response (Confirmed)|24|||
28072057|NCT00113607|54726809|FG000|Overall Study|Other|43|||
28072058|NCT00113607|54726810|FG001|Overall Study|Other|32|||
28072059|NCT00113529|54726817|FG000|Overall Study|Adverse Event|4|||
28072060|NCT00113529|54726817|FG000|Overall Study|Lack of Efficacy|20|||
28072061|NCT00113529|54726817|FG000|Overall Study|Decision of sponsor|6|||
28072062|NCT00113529|54726817|FG000|Overall Study|Withdrawal by Subject|4|||
28146205|NCT04424641|54813180|FG005|Overall Study|Withdrawal by Subject|0|||
28146206|NCT04424641|54813181|FG006|Overall Study|Withdrawal by Subject|0|||
28146207|NCT04424641|54813182|FG007|Overall Study|Withdrawal by Subject|0|||
28146208|NCT04424641|54813175|FG000|Overall Study|Other|0|||
27822682|NCT01840579|54286395|FG006|Overall Study|Follow-up ended by Sponsor|2|||
28072063|NCT00134901|54726823|FG000|Overall Study|Lost to Follow-up|5|||
28072064|NCT00134901|54726824|FG001|Overall Study|Lost to Follow-up|5|||
28146209|NCT04424641|54813176|FG001|Overall Study|Other|0|||
28146210|NCT04424641|54813177|FG002|Overall Study|Other|1|||
28146211|NCT04424641|54813178|FG003|Overall Study|Other|0|||
28146212|NCT04424641|54813179|FG004|Overall Study|Other|0|||
28146213|NCT04424641|54813180|FG005|Overall Study|Other|0|||
28146214|NCT04424641|54813181|FG006|Overall Study|Other|0|||
28146215|NCT04424641|54813182|FG007|Overall Study|Other|0|||
28146216|NCT04276090|54813211|FG000|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|1|||
28146217|NCT04276090|54813212|FG001|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|0|||
28146218|NCT04105842|54813222|FG000|Overall Study|Withdrawal by Subject|2|||
28146219|NCT04088734|54813229|FG000|Overall Study|Other, Not Specified|5|||
28146220|NCT03868787|54813252|FG000|Overall Study|Withdrawal by Subject|2|||
28146221|NCT03868787|54813253|FG001|Overall Study|Withdrawal by Subject|1|||
28146222|NCT03457701|54813284|FG000|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
28146223|NCT03457701|54813285|FG001|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
28146224|NCT03457701|54813284|FG000|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|0|||
28146225|NCT03457701|54813285|FG001|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
28146226|NCT03317405|54813361|FG000|Overall Study|Withdrawal by Subject|1|||
28146227|NCT03317405|54813362|FG001|Overall Study|Withdrawal by Subject|0|||
28146228|NCT03317405|54813363|FG002|Overall Study|Withdrawal by Subject|0|||
28146229|NCT03317405|54813361|FG000|Overall Study|Physician Decision|0|||
28146230|NCT03317405|54813362|FG001|Overall Study|Physician Decision|0|||
28146231|NCT03317405|54813363|FG002|Overall Study|Physician Decision|1|||
28146232|NCT03317405|54813361|FG000|Overall Study|Surgery Rescheduled|0|||
28146233|NCT03317405|54813362|FG001|Overall Study|Surgery Rescheduled|1|||
28146234|NCT03317405|54813363|FG002|Overall Study|Surgery Rescheduled|0|||
28146235|NCT02694978|54813460|FG000|Overall Study|Adverse Event|10|||
28146236|NCT02694978|54813461|FG001|Overall Study|Adverse Event|9|||
28146237|NCT02694978|54813460|FG000|Overall Study|Withdrawal by Subject|22|||
28146238|NCT02694978|54813461|FG001|Overall Study|Withdrawal by Subject|19|||
28146239|NCT02694978|54813460|FG000|Overall Study|Lost to Follow-up|14|||
28146240|NCT02694978|54813461|FG001|Overall Study|Lost to Follow-up|17|||
28146241|NCT02694978|54813460|FG000|Overall Study|Death|4|||
28146242|NCT02694978|54813461|FG001|Overall Study|Death|1|||
28146243|NCT02694978|54813460|FG000|Overall Study|Other-Decision of Participant|6|||
28146244|NCT02694978|54813461|FG001|Overall Study|Other-Decision of Participant|1|||
28146245|NCT02694978|54813460|FG000|Overall Study|Other-Investigator's decision|1|||
28146246|NCT02694978|54813461|FG001|Overall Study|Other-Investigator's decision|0|||
28146247|NCT02694978|54813460|FG000|Overall Study|Other-Unable to be reached|0|||
28146248|NCT02694978|54813461|FG001|Overall Study|Other-Unable to be reached|1|||
28146249|NCT02694978|54813460|FG000|Overall Study|Other-Protocol noncompliant|2|||
28146250|NCT02694978|54813461|FG001|Overall Study|Other-Protocol noncompliant|1|||
28146251|NCT02694978|54813460|FG000|Overall Study|Other-Personal reasons|3|||
28146252|NCT02694978|54813461|FG001|Overall Study|Other-Personal reasons|3|||
28146253|NCT02694978|54813460|FG000|Overall Study|Other-Withdrew prior to dosing|9|||
28146254|NCT02694978|54813461|FG001|Overall Study|Other-Withdrew prior to dosing|8|||
28146255|NCT02563002|54813469|FG000|Overall Study|Death|62|||
28146256|NCT02563002|54813470|FG001|Overall Study|Death|75|||
28146257|NCT02563002|54813469|FG000|Overall Study|Lost to Follow-up|1|||
28146258|NCT02563002|54813470|FG001|Overall Study|Lost to Follow-up|0|||
28146259|NCT02563002|54813469|FG000|Overall Study|Withdrawal by Subject|0|||
28146260|NCT02563002|54813470|FG001|Overall Study|Withdrawal by Subject|9|||
28146261|NCT02563002|54813469|FG000|Overall Study|Ongoing|90|||
28146262|NCT02563002|54813470|FG001|Overall Study|Ongoing|70|||
28146263|NCT02454933|54813481|FG000|Overall Study|Progressive disease|7|||
28146264|NCT02454933|54813482|FG001|Overall Study|Progressive disease|5|||
28146265|NCT02454933|54813481|FG000|Overall Study|Adverse Event|1|||
28146266|NCT02454933|54813482|FG001|Overall Study|Adverse Event|1|||
28146267|NCT02454933|54813481|FG000|Overall Study|Withdrawal by Subject|0|||
28146268|NCT02454933|54813482|FG001|Overall Study|Withdrawal by Subject|2|||
28146269|NCT02430480|54813487|FG000|Overall Study|Death|1|||
28146270|NCT02430480|54813487|FG000|Overall Study|Anesthesia concerns|1|||
28146271|NCT02430480|54813487|FG000|Overall Study|Progressed on treatment|1|||
28146272|NCT01967888|54813501|FG000|Overall Study|Lost to Follow-up|6|||
28146273|NCT01967888|54813502|FG001|Overall Study|Lost to Follow-up|4|||
28146274|NCT01967888|54813501|FG000|Overall Study|Withdrawal by Subject|1|||
28146275|NCT01967888|54813502|FG001|Overall Study|Withdrawal by Subject|1|||
28146276|NCT01967888|54813501|FG000|Overall Study|Did Not Have Transplant|1|||
28146277|NCT01967888|54813502|FG001|Overall Study|Did Not Have Transplant|0|||
28146278|NCT01967888|54813501|FG000|Overall Study|Research visit not done, data recorded|1|||
28146279|NCT01967888|54813502|FG001|Overall Study|Research visit not done, data recorded|0|||
28146280|NCT01967888|54813501|FG000|Overall Study|Subject excluded after randomization|1|||
28146281|NCT01967888|54813502|FG001|Overall Study|Subject excluded after randomization|0|||
28146282|NCT01967888|54813501|FG000|Overall Study|Patient didn't proceed to pancreatectomy|0|||
28146283|NCT01967888|54813502|FG001|Overall Study|Patient didn't proceed to pancreatectomy|1|||
28146284|NCT01967888|54813501|FG000|Overall Study|Subject Unable To Comply With Final Day|0|||
28146285|NCT01967888|54813502|FG001|Overall Study|Subject Unable To Comply With Final Day|1|||
28146286|NCT01864018|54813510|FG000|Overall Study|Ineligible|3|||
28146287|NCT01864018|54813511|FG001|Overall Study|Ineligible|1|||
28146288|NCT01796197|54813522|FG000|Overall Study|Lost to Follow-up|1|||
28146289|NCT01796197|54813522|FG000|Overall Study|Lack of Efficacy|1|||
28146290|NCT01205048|54813528|FG000|Overall Study|Withdrawal by Subject|14|||
28146291|NCT01205048|54813528|FG000|Overall Study|Clinical Investigation Plan Violation|1|||
28146292|NCT01205048|54813528|FG000|Overall Study|Lost to Follow-up|4|||
28146293|NCT01205048|54813528|FG000|Overall Study|Other|2|||
28146294|NCT01052779|54813536|FG000|Overall Study|Adverse Event|1|||
28146295|NCT01052779|54813537|FG001|Overall Study|Adverse Event|4|||
28146296|NCT01052779|54813536|FG000|Overall Study|Withdrawal by Subject|1|||
28146297|NCT01052779|54813537|FG001|Overall Study|Withdrawal by Subject|2|||
28146298|NCT01052779|54813536|FG000|Overall Study|Other-Protocol Violation|1|||
28146299|NCT01052779|54813537|FG001|Overall Study|Other-Protocol Violation|1|||
28146300|NCT01052779|54813536|FG000|Overall Study|Other-Surgery|0|||
28146301|NCT01052779|54813537|FG001|Overall Study|Other-Surgery|2|||
28072065|NCT00134901|54726823|FG000|Overall Study|discontinued intervention|12|||
28072066|NCT00134901|54726824|FG001|Overall Study|discontinued intervention|10|||
28072067|NCT00122109|54726834|FG000|Overall Study|Did not meet criteria|6|||
28072068|NCT00122109|54726835|FG001|Overall Study|Did not meet criteria|7|||
28072069|NCT00113373|54726844|FG000|Overall Study|Ineligible: wrong primary|1|||
28072070|NCT00113373|54726844|FG000|Overall Study|Ineligible: second primary|1|||
28072071|NCT00113373|54726844|FG000|Overall Study|Never Treated|1|||
28072072|NCT00113295|54726855|FG000|Overall Study|Adverse Event|4|||
28072073|NCT00113295|54726856|FG001|Overall Study|Adverse Event|1|||
28072074|NCT00113295|54726855|FG000|Overall Study|Unrelated Medical Illness|1|||
28072075|NCT00113295|54726856|FG001|Overall Study|Unrelated Medical Illness|0|||
28072076|NCT00112905|54726864|FG000|Overall Study|Adverse Event|4|||
28072077|NCT00112905|54726864|FG000|Overall Study|Death|1|||
28072078|NCT00112905|54726864|FG000|Overall Study|Ineligibility|5|||
28072079|NCT00112905|54726864|FG000|Overall Study|Alternative treatment|1|||
28072080|NCT00112905|54726864|FG000|Overall Study|performance status was deteiorating|1|||
28072081|NCT00427895|54726872|FG000|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
28072082|NCT00427895|54726873|FG001|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
28146302|NCT01052779|54813536|FG000|Overall Study|Other-Missed Week 5 Visit|2|||
28146303|NCT01052779|54813537|FG001|Overall Study|Other-Missed Week 5 Visit|0|||
28146304|NCT00591370|54813547|FG000|Overall Study|Not Treated|2|||
28146305|NCT00389610|54813553|FG000|Overall Study|Disease Progression|0|||
28146306|NCT00389610|54813554|FG001|Overall Study|Disease Progression|19|||
28146307|NCT00389610|54813553|FG000|Overall Study|Death|0|||
28146308|NCT00389610|54813554|FG001|Overall Study|Death|1|||
28146309|NCT00389610|54813553|FG000|Overall Study|Physician Decision|0|||
28146310|NCT00389610|54813554|FG001|Overall Study|Physician Decision|1|||
28146311|NCT00389610|54813553|FG000|Overall Study|Withdrawal by Subject|0|||
28146312|NCT00389610|54813554|FG001|Overall Study|Withdrawal by Subject|1|||
28146313|NCT03064763|54813560|FG000|Overall Study|Ongoing in study|10|||
28146314|NCT03064763|54813560|FG000|Overall Study|Death|8|||
28146315|NCT02782676|54813564|FG000|Overall Study|Lost to Follow-up|0|||
28146316|NCT02782676|54813565|FG001|Overall Study|Lost to Follow-up|1|||
28146317|NCT02471339|54813573|FG000|Overall Study|Did not provide follow-up data|2|||
28146318|NCT02471339|54813574|FG001|Overall Study|Did not provide follow-up data|0|||
28146319|NCT00107978|54813582|FG000|Overall Study|Adverse Event|1|||
28146320|NCT00107978|54813583|FG001|Overall Study|Adverse Event|5|||
28146321|NCT00107978|54813582|FG000|Overall Study|Death|3|||
28146322|NCT00107978|54813583|FG001|Overall Study|Death|3|||
28146323|NCT00107978|54813582|FG000|Overall Study|Lost to Follow-up|20|||
28146324|NCT00107978|54813583|FG001|Overall Study|Lost to Follow-up|28|||
28146325|NCT00107978|54813582|FG000|Overall Study|Withdrawal by Subject|4|||
28146326|NCT00107978|54813583|FG001|Overall Study|Withdrawal by Subject|9|||
28146327|NCT00107978|54813582|FG000|Overall Study|Protocol Violation|0|||
28146328|NCT00107978|54813583|FG001|Overall Study|Protocol Violation|1|||
28146329|NCT00107978|54813582|FG000|Overall Study|Other|5|||
28146330|NCT00107978|54813583|FG001|Overall Study|Other|4|||
28146331|NCT02781818|54813592|FG000|Overall Study|Lost to Follow-up|4|||
28146332|NCT02781818|54813593|FG001|Overall Study|Lost to Follow-up|2|||
28146333|NCT02781818|54813594|FG002|Overall Study|Lost to Follow-up|1|||
28146334|NCT02927873|54813608|FG000|Overall Study|Lost to Follow-up|0|||
28146335|NCT02927873|54813609|FG001|Overall Study|Lost to Follow-up|1|||
28146336|NCT02927873|54813610|FG002|Overall Study|Lost to Follow-up|0|||
28146337|NCT02927873|54813611|FG003|Overall Study|Lost to Follow-up|0|||
28146338|NCT02927873|54813612|FG004|Overall Study|Lost to Follow-up|0|||
28146339|NCT02927873|54813613|FG005|Overall Study|Lost to Follow-up|0|||
28146340|NCT02927873|54813608|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
28146341|NCT02927873|54813609|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
28146342|NCT02927873|54813610|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
28146343|NCT02927873|54813611|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
28146344|NCT02927873|54813612|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
28146345|NCT02927873|54813613|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
28146346|NCT02927873|54813608|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
28146347|NCT02927873|54813609|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
28146348|NCT02927873|54813610|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
28146349|NCT02927873|54813611|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
28146350|NCT02927873|54813612|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
28146351|NCT02927873|54813613|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
28146352|NCT02927873|54813608|FG000|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
28146353|NCT02927873|54813609|FG001|Overall Study|PARENTS NOT ABLE TO COME TO SITE|1|||
28146354|NCT02927873|54813610|FG002|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
28146355|NCT02927873|54813611|FG003|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
28146356|NCT02927873|54813612|FG004|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
28146357|NCT02927873|54813613|FG005|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
28146358|NCT02927873|54813608|FG000|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|1|||
28146359|NCT02927873|54813609|FG001|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
28146360|NCT02927873|54813610|FG002|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
28146361|NCT02927873|54813611|FG003|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
28146362|NCT02927873|54813612|FG004|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
28146363|NCT02927873|54813613|FG005|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
28146364|NCT02927873|54813608|FG000|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|1|||
28146365|NCT02927873|54813609|FG001|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
28146366|NCT02927873|54813610|FG002|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
28146367|NCT02927873|54813611|FG003|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
28146368|NCT02927873|54813612|FG004|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
28146369|NCT02927873|54813613|FG005|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
28146370|NCT01220999|54813632|FG000|Overall Study|Progressive disease|0|||
28146371|NCT01220999|54813633|FG001|Overall Study|Progressive disease|0|||
28146372|NCT01220999|54813634|FG002|Overall Study|Progressive disease|1|||
28146373|NCT01220999|54813635|FG003|Overall Study|Progressive disease|0|||
28146374|NCT01220999|54813636|FG004|Overall Study|Progressive disease|0|||
28146375|NCT00142415|54813654|FG000|Overall Study|Physician Decision|0|||
28146376|NCT00142415|54813655|FG001|Overall Study|Physician Decision|0|||
28146377|NCT00142415|54813656|FG002|Overall Study|Physician Decision|0|||
28146378|NCT00142415|54813657|FG003|Overall Study|Physician Decision|0|||
28146379|NCT00142415|54813658|FG004|Overall Study|Physician Decision|1|||
28146380|NCT00142415|54813659|FG005|Overall Study|Physician Decision|2|||
28146381|NCT02781584|54813701|FG000|Pre-treatment Phase|Investigator's Discretion|0|||
28146382|NCT02781584|54813702|FG001|Pre-treatment Phase|Investigator's Discretion|0|||
27850070|NCT01647828|54348369|FG004|Overall Study|Withdrawal by Subject|0|||
27850071|NCT01647828|54348370|FG005|Overall Study|Withdrawal by Subject|0|||
27850072|NCT01647828|54348371|FG006|Overall Study|Withdrawal by Subject|1|||
27850073|NCT01647828|54348372|FG007|Overall Study|Withdrawal by Subject|0|||
27850074|NCT01647828|54348373|FG008|Overall Study|Withdrawal by Subject|2|||
27850075|NCT01647828|54348365|FG000|Overall Study|Study terminated by Sponsor|0|||
27941423|NCT00940498|54597835|FG004|Overall Study|Not treated due to disease related pain|1|||
27941424|NCT00940498|54597836|FG005|Overall Study|Not treated due to disease related pain|0|||
27941425|NCT00940498|54597837|FG006|Overall Study|Not treated due to disease related pain|0|||
28072083|NCT00427895|54726874|FG002|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
28072084|NCT00427895|54726875|FG003|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352|||
28072085|NCT00427895|54726876|FG004|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
28072086|NCT00427895|54726877|FG005|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
28072087|NCT00427895|54726878|FG006|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
28072088|NCT00427895|54726879|FG007|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
28072089|NCT00427895|54726872|FG000|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
28072090|NCT00427895|54726873|FG001|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
28072091|NCT00427895|54726874|FG002|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
28072092|NCT00427895|54726875|FG003|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
28072093|NCT00427895|54726876|FG004|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
28072094|NCT00427895|54726877|FG005|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
28072095|NCT00427895|54726878|FG006|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
28072096|NCT00427895|54726879|FG007|Vax 2/Year 3 to 4|Lost to Follow-up|1|||
28072097|NCT00427895|54726872|FG000|Vax 2/Year 3 to 4|Protocol Violation|0|||
28072098|NCT00427895|54726873|FG001|Vax 2/Year 3 to 4|Protocol Violation|0|||
28072099|NCT00427895|54726874|FG002|Vax 2/Year 3 to 4|Protocol Violation|0|||
28072100|NCT00427895|54726875|FG003|Vax 2/Year 3 to 4|Protocol Violation|0|||
28072101|NCT00427895|54726876|FG004|Vax 2/Year 3 to 4|Protocol Violation|0|||
28072102|NCT00427895|54726877|FG005|Vax 2/Year 3 to 4|Protocol Violation|0|||
28072103|NCT00427895|54726878|FG006|Vax 2/Year 3 to 4|Protocol Violation|0|||
28072104|NCT00427895|54726879|FG007|Vax 2/Year 3 to 4|Protocol Violation|1|||
28072105|NCT00427895|54726872|FG000|Vax 2/Year 3 to 4|Failed to Return|0|||
28072106|NCT00427895|54726873|FG001|Vax 2/Year 3 to 4|Failed to Return|0|||
28072107|NCT00427895|54726874|FG002|Vax 2/Year 3 to 4|Failed to Return|0|||
28072108|NCT00427895|54726875|FG003|Vax 2/Year 3 to 4|Failed to Return|0|||
28072109|NCT00427895|54726876|FG004|Vax 2/Year 3 to 4|Failed to Return|1|||
28072110|NCT00427895|54726877|FG005|Vax 2/Year 3 to 4|Failed to Return|0|||
28072111|NCT00427895|54726878|FG006|Vax 2/Year 3 to 4|Failed to Return|0|||
28072112|NCT00427895|54726879|FG007|Vax 2/Year 3 to 4|Failed to Return|0|||
28072113|NCT00427895|54726872|FG000|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
28072114|NCT00427895|54726873|FG001|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1|||
28072115|NCT00427895|54726874|FG002|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4|||
28072116|NCT00427895|54726875|FG003|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32|||
28072117|NCT00427895|54726876|FG004|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
28072118|NCT00427895|54726877|FG005|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
28072119|NCT00427895|54726878|FG006|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
28072120|NCT00427895|54726879|FG007|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
28072121|NCT00427895|54726872|FG000|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4|||
28072122|NCT00427895|54726873|FG001|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
28072123|NCT00427895|54726874|FG002|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3|||
28072124|NCT00427895|54726875|FG003|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2|||
28072125|NCT00427895|54726876|FG004|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
28072126|NCT00427895|54726877|FG005|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
28072127|NCT00427895|54726878|FG006|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
28072128|NCT00427895|54726879|FG007|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
28072129|NCT00427895|54726872|FG000|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
28072130|NCT00427895|54726873|FG001|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
28072131|NCT00427895|54726874|FG002|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
28072132|NCT00427895|54726875|FG003|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
28072133|NCT00427895|54726876|FG004|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
28072134|NCT00427895|54726877|FG005|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
28072135|NCT00427895|54726878|FG006|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
28072136|NCT00427895|54726879|FG007|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
28072137|NCT00427895|54726872|FG000|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
28146383|NCT02781584|54813703|FG002|Pre-treatment Phase|Investigator's Discretion|0|||
28146384|NCT02781584|54813704|FG003|Pre-treatment Phase|Investigator's Discretion|0|||
28146385|NCT02781584|54813705|FG004|Pre-treatment Phase|Investigator's Discretion|0|||
28146386|NCT02781584|54813706|FG005|Pre-treatment Phase|Investigator's Discretion|0|||
28146387|NCT02781584|54813707|FG006|Pre-treatment Phase|Investigator's Discretion|0|||
28146388|NCT02781584|54813708|FG007|Pre-treatment Phase|Investigator's Discretion|0|||
28146389|NCT02781584|54813709|FG008|Pre-treatment Phase|Investigator's Discretion|0|||
28146390|NCT02781584|54813710|FG009|Pre-treatment Phase|Investigator's Discretion|0|||
28146391|NCT02781584|54813711|FG010|Pre-treatment Phase|Investigator's Discretion|0|||
28146392|NCT02781584|54813712|FG011|Pre-treatment Phase|Investigator's Discretion|2|||
28146393|NCT02781584|54813713|FG012|Pre-treatment Phase|Investigator's Discretion|1|||
28146394|NCT02781584|54813701|FG000|Pre-treatment Phase|Adverse Event|0|||
28146395|NCT02781584|54813702|FG001|Pre-treatment Phase|Adverse Event|0|||
28146396|NCT02781584|54813703|FG002|Pre-treatment Phase|Adverse Event|0|||
28146397|NCT02781584|54813704|FG003|Pre-treatment Phase|Adverse Event|0|||
28146398|NCT02781584|54813705|FG004|Pre-treatment Phase|Adverse Event|0|||
28146399|NCT02781584|54813706|FG005|Pre-treatment Phase|Adverse Event|0|||
28146400|NCT02781584|54813707|FG006|Pre-treatment Phase|Adverse Event|0|||
28146401|NCT02781584|54813708|FG007|Pre-treatment Phase|Adverse Event|0|||
28146402|NCT02781584|54813709|FG008|Pre-treatment Phase|Adverse Event|0|||
28146403|NCT02781584|54813710|FG009|Pre-treatment Phase|Adverse Event|0|||
28146404|NCT02781584|54813711|FG010|Pre-treatment Phase|Adverse Event|0|||
28146405|NCT02781584|54813712|FG011|Pre-treatment Phase|Adverse Event|1|||
28146406|NCT02781584|54813713|FG012|Pre-treatment Phase|Adverse Event|0|||
28146407|NCT02781584|54813701|FG000|Treatment Phase|Withdrew Consent|0|||
28146408|NCT02781584|54813702|FG001|Treatment Phase|Withdrew Consent|0|||
28146409|NCT02781584|54813703|FG002|Treatment Phase|Withdrew Consent|0|||
28146410|NCT02781584|54813704|FG003|Treatment Phase|Withdrew Consent|0|||
28146411|NCT02781584|54813705|FG004|Treatment Phase|Withdrew Consent|0|||
28146412|NCT02781584|54813706|FG005|Treatment Phase|Withdrew Consent|1|||
28146413|NCT02781584|54813707|FG006|Treatment Phase|Withdrew Consent|0|||
28146414|NCT02781584|54813708|FG007|Treatment Phase|Withdrew Consent|0|||
28146415|NCT02781584|54813709|FG008|Treatment Phase|Withdrew Consent|0|||
28146416|NCT02781584|54813710|FG009|Treatment Phase|Withdrew Consent|0|||
28146417|NCT02781584|54813711|FG010|Treatment Phase|Withdrew Consent|1|||
28146418|NCT02781584|54813712|FG011|Treatment Phase|Withdrew Consent|2|||
28146419|NCT02781584|54813713|FG012|Treatment Phase|Withdrew Consent|0|||
28146420|NCT02781584|54813701|FG000|Treatment Phase|Adverse Event|0|||
28146421|NCT02781584|54813702|FG001|Treatment Phase|Adverse Event|0|||
28146422|NCT02781584|54813703|FG002|Treatment Phase|Adverse Event|0|||
28146423|NCT02781584|54813704|FG003|Treatment Phase|Adverse Event|0|||
28146424|NCT02781584|54813705|FG004|Treatment Phase|Adverse Event|0|||
28146425|NCT02781584|54813706|FG005|Treatment Phase|Adverse Event|0|||
28146426|NCT02781584|54813707|FG006|Treatment Phase|Adverse Event|0|||
28146427|NCT02781584|54813708|FG007|Treatment Phase|Adverse Event|1|||
28146428|NCT02781584|54813709|FG008|Treatment Phase|Adverse Event|0|||
28146429|NCT02781584|54813710|FG009|Treatment Phase|Adverse Event|0|||
28146430|NCT02781584|54813711|FG010|Treatment Phase|Adverse Event|0|||
28146431|NCT02781584|54813712|FG011|Treatment Phase|Adverse Event|0|||
28146432|NCT02781584|54813713|FG012|Treatment Phase|Adverse Event|0|||
28146433|NCT02776670|54813743|FG000|Overall Study|Adverse Event|0|||
27822683|NCT01840579|54286396|FG007|Overall Study|Follow-up ended by Sponsor|0|||
28146434|NCT02776670|54813744|FG001|Overall Study|Adverse Event|2|||
28146435|NCT02776670|54813743|FG000|Overall Study|Protocol Violation|0|||
28146436|NCT02776670|54813744|FG001|Overall Study|Protocol Violation|2|||
28146437|NCT02776670|54813743|FG000|Overall Study|Withdrawal by Subject|0|||
28146438|NCT02776670|54813744|FG001|Overall Study|Withdrawal by Subject|1|||
28146439|NCT02776670|54813743|FG000|Overall Study|Other - Reason not given|0|||
28146440|NCT02776670|54813744|FG001|Overall Study|Other - Reason not given|1|||
28146441|NCT01307423|54813753|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
28146442|NCT01307423|54813754|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
28146443|NCT01307423|54813755|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6|||
28146444|NCT01307423|54813756|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
28146445|NCT01307423|54813757|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
28146446|NCT01307423|54813758|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
28146447|NCT01307423|54813759|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
28146448|NCT01307423|54813760|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
28146449|NCT01307423|54813761|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
28146450|NCT01307423|54813753|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1|||
28146451|NCT01307423|54813754|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
28146452|NCT01307423|54813755|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
28146453|NCT01307423|54813756|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
28146454|NCT01307423|54813757|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
28146455|NCT01307423|54813758|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
28146456|NCT01307423|54813759|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
28146457|NCT01307423|54813760|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
28146458|NCT01307423|54813761|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
28146459|NCT01307423|54813753|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8|||
28146460|NCT01307423|54813754|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
28146461|NCT01307423|54813755|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10|||
28146462|NCT01307423|54813756|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
28146463|NCT01307423|54813757|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
28146464|NCT01307423|54813758|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
28146465|NCT01307423|54813759|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
28146466|NCT01307423|54813760|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
28146467|NCT01307423|54813761|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
28146468|NCT01307423|54813753|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
28146469|NCT01307423|54813754|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
28146470|NCT01307423|54813755|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
28146471|NCT01307423|54813756|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
28146472|NCT01307423|54813757|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
28146473|NCT01307423|54813758|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
28146474|NCT01307423|54813759|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
28146475|NCT01307423|54813760|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
28146476|NCT01307423|54813761|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
28146477|NCT01307423|54813753|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5|||
28146478|NCT01307423|54813754|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
28146479|NCT01307423|54813755|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
28146480|NCT01307423|54813756|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
28146481|NCT01307423|54813757|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
28146482|NCT01307423|54813758|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
28146483|NCT01307423|54813759|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
28146484|NCT01307423|54813760|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
28146485|NCT01307423|54813761|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
28146486|NCT01307423|54813753|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
28146487|NCT01307423|54813754|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
28146488|NCT01307423|54813755|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
28146489|NCT01307423|54813756|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
28146490|NCT01307423|54813757|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
28146491|NCT01307423|54813758|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
28146492|NCT01307423|54813759|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
28146493|NCT01307423|54813760|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
28146494|NCT01307423|54813761|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
28146495|NCT01307423|54813753|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
28146496|NCT01307423|54813754|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
28146497|NCT01307423|54813755|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
28146498|NCT01307423|54813756|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
28146499|NCT01307423|54813757|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
28146500|NCT01307423|54813758|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
28146501|NCT01307423|54813759|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
28146502|NCT01307423|54813760|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
28146503|NCT01307423|54813761|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
28146504|NCT01307423|54813753|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
28146505|NCT01307423|54813754|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
28146506|NCT01307423|54813755|FG002|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
28146507|NCT01307423|54813756|FG003|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
28146508|NCT01307423|54813757|FG004|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
28146509|NCT01307423|54813758|FG005|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
28146510|NCT01307423|54813759|FG006|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
28146511|NCT01307423|54813760|FG007|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
28146512|NCT01307423|54813761|FG008|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
28146513|NCT01307423|54813753|FG000|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
28146514|NCT01307423|54813754|FG001|Active Treatment Phase (Week 25-52)|Adverse Event|3|||
28146515|NCT01307423|54813755|FG002|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
28146516|NCT01307423|54813756|FG003|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
28146517|NCT01307423|54813757|FG004|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
28146518|NCT01307423|54813758|FG005|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
28146519|NCT01307423|54813759|FG006|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
28146520|NCT01307423|54813760|FG007|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
28146521|NCT01307423|54813761|FG008|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
28146522|NCT01307423|54813753|FG000|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
28146523|NCT01307423|54813754|FG001|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
28146524|NCT01307423|54813755|FG002|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
28146525|NCT01307423|54813756|FG003|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3|||
28146526|NCT01307423|54813757|FG004|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1|||
28146527|NCT01307423|54813758|FG005|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
28146528|NCT01307423|54813759|FG006|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
28146529|NCT01307423|54813760|FG007|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
28146530|NCT01307423|54813761|FG008|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
28146531|NCT01307423|54813753|FG000|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
28146532|NCT01307423|54813754|FG001|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
28146533|NCT01307423|54813755|FG002|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
28146534|NCT01307423|54813756|FG003|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
28146535|NCT01307423|54813757|FG004|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
28146536|NCT01307423|54813758|FG005|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1|||
28146537|NCT01307423|54813759|FG006|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
28146538|NCT01307423|54813760|FG007|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
28146539|NCT01307423|54813761|FG008|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
28146540|NCT01307423|54813753|FG000|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
28146541|NCT01307423|54813754|FG001|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11|||
28146542|NCT01307423|54813755|FG002|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2|||
28146543|NCT01307423|54813756|FG003|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
28146544|NCT01307423|54813757|FG004|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
28146545|NCT01307423|54813758|FG005|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
28146546|NCT01307423|54813759|FG006|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
28146547|NCT01307423|54813760|FG007|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
28146548|NCT01307423|54813761|FG008|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
28146549|NCT01307423|54813753|FG000|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
28072138|NCT00427895|54726873|FG001|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
28146550|NCT01307423|54813754|FG001|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
28146551|NCT01307423|54813755|FG002|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
28146552|NCT01307423|54813756|FG003|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2|||
28146553|NCT01307423|54813757|FG004|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
28072139|NCT00427895|54726874|FG002|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4|||
28072140|NCT00427895|54726875|FG003|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7|||
28072141|NCT00427895|54726876|FG004|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
28072142|NCT00427895|54726877|FG005|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
28072143|NCT00427895|54726878|FG006|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
28072144|NCT00427895|54726879|FG007|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
28072145|NCT00427895|54726872|FG000|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
28072146|NCT00427895|54726873|FG001|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
28072147|NCT00427895|54726874|FG002|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
28072148|NCT00427895|54726875|FG003|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2|||
28146554|NCT01307423|54813758|FG005|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
28146555|NCT01307423|54813759|FG006|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
28146556|NCT01307423|54813760|FG007|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
28146557|NCT01307423|54813761|FG008|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
28146558|NCT01307423|54813753|FG000|Active Treatment Phase (Week 25-52)|Other|0|||
28146559|NCT01307423|54813754|FG001|Active Treatment Phase (Week 25-52)|Other|0|||
28146560|NCT01307423|54813755|FG002|Active Treatment Phase (Week 25-52)|Other|0|||
28146561|NCT01307423|54813756|FG003|Active Treatment Phase (Week 25-52)|Other|1|||
28146562|NCT01307423|54813757|FG004|Active Treatment Phase (Week 25-52)|Other|0|||
28146563|NCT01307423|54813758|FG005|Active Treatment Phase (Week 25-52)|Other|0|||
28146564|NCT01307423|54813759|FG006|Active Treatment Phase (Week 25-52)|Other|0|||
28146565|NCT01307423|54813760|FG007|Active Treatment Phase (Week 25-52)|Other|0|||
28146566|NCT01307423|54813761|FG008|Active Treatment Phase (Week 25-52)|Other|0|||
28146567|NCT01307423|54813753|FG000|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
28146568|NCT01307423|54813754|FG001|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
28146569|NCT01307423|54813755|FG002|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
28146570|NCT01307423|54813756|FG003|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
28146571|NCT01307423|54813757|FG004|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
28146572|NCT01307423|54813758|FG005|Active Treatment Phase (Week 25-52)|Protocol Violation|1|||
28146573|NCT01307423|54813759|FG006|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
28146574|NCT01307423|54813760|FG007|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
28146575|NCT01307423|54813761|FG008|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
28146576|NCT01307423|54813753|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
28146577|NCT01307423|54813754|FG001|Long-term Safety Phase (Year 2)|Adverse Event|2|||
28146578|NCT01307423|54813755|FG002|Long-term Safety Phase (Year 2)|Adverse Event|7|||
28146579|NCT01307423|54813756|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
28146580|NCT01307423|54813757|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
28146581|NCT01307423|54813758|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
28146582|NCT01307423|54813759|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
28146583|NCT01307423|54813760|FG007|Long-term Safety Phase (Year 2)|Adverse Event|1|||
28146584|NCT01307423|54813761|FG008|Long-term Safety Phase (Year 2)|Adverse Event|1|||
28146585|NCT01307423|54813753|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
28146586|NCT01307423|54813754|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
28146587|NCT01307423|54813755|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|5|||
28146588|NCT01307423|54813756|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
28146589|NCT01307423|54813757|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
28146590|NCT01307423|54813758|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
28146591|NCT01307423|54813759|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
28146592|NCT01307423|54813760|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
28146593|NCT01307423|54813761|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|3|||
28146594|NCT01307423|54813753|FG000|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
28146595|NCT01307423|54813754|FG001|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
28146596|NCT01307423|54813755|FG002|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1|||
28146597|NCT01307423|54813756|FG003|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
28146598|NCT01307423|54813757|FG004|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
28146599|NCT01307423|54813758|FG005|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
28146600|NCT01307423|54813759|FG006|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
28146601|NCT01307423|54813760|FG007|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
28146602|NCT01307423|54813761|FG008|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
28146603|NCT01307423|54813753|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
28146604|NCT01307423|54813754|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13|||
28146605|NCT01307423|54813755|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12|||
28146606|NCT01307423|54813756|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
28146607|NCT01307423|54813757|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
28146608|NCT01307423|54813758|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
28146609|NCT01307423|54813759|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
28146610|NCT01307423|54813760|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
28146611|NCT01307423|54813761|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2|||
28146612|NCT01307423|54813753|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
28146613|NCT01307423|54813754|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
28146614|NCT01307423|54813755|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
28146615|NCT01307423|54813756|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
28072149|NCT00427895|54726876|FG004|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
28072150|NCT00427895|54726877|FG005|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
28072151|NCT00427895|54726878|FG006|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
28146616|NCT01307423|54813757|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
28146617|NCT01307423|54813758|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
28146618|NCT01307423|54813759|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
28146619|NCT01307423|54813760|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
28146620|NCT01307423|54813761|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
28146621|NCT01307423|54813753|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
28146622|NCT01307423|54813754|FG001|Long-term Safety Phase (Year 3)|Adverse Event|1|||
28146623|NCT01307423|54813755|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
28146624|NCT01307423|54813756|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
28146625|NCT01307423|54813757|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
28146626|NCT01307423|54813758|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
28146627|NCT01307423|54813759|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
28146628|NCT01307423|54813760|FG007|Long-term Safety Phase (Year 3)|Adverse Event|3|||
28146629|NCT01307423|54813761|FG008|Long-term Safety Phase (Year 3)|Adverse Event|4|||
28146630|NCT01307423|54813753|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
28146631|NCT01307423|54813754|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
28146632|NCT01307423|54813755|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
28146633|NCT01307423|54813756|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
28146634|NCT01307423|54813757|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
28146635|NCT01307423|54813758|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
28146636|NCT01307423|54813759|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
28146637|NCT01307423|54813760|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|1|||
28072152|NCT00427895|54726879|FG007|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
28072153|NCT00427895|54726872|FG000|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
28072154|NCT00427895|54726873|FG001|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3|||
28072155|NCT00427895|54726874|FG002|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2|||
28072156|NCT00427895|54726875|FG003|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
28072157|NCT00427895|54726876|FG004|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
28072158|NCT00427895|54726877|FG005|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
28072159|NCT00427895|54726878|FG006|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
28072160|NCT00427895|54726879|FG007|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
28072161|NCT00427895|54726872|FG000|Vax 1 Baseline/6-Month Follow-up|Other|0|||
28072162|NCT00427895|54726873|FG001|Vax 1 Baseline/6-Month Follow-up|Other|0|||
28072163|NCT00427895|54726874|FG002|Vax 1 Baseline/6-Month Follow-up|Other|1|||
28072164|NCT00427895|54726875|FG003|Vax 1 Baseline/6-Month Follow-up|Other|2|||
28072165|NCT00427895|54726876|FG004|Vax 1 Baseline/6-Month Follow-up|Other|0|||
28072166|NCT00427895|54726877|FG005|Vax 1 Baseline/6-Month Follow-up|Other|0|||
28072167|NCT00427895|54726878|FG006|Vax 1 Baseline/6-Month Follow-up|Other|0|||
28072168|NCT00427895|54726879|FG007|Vax 1 Baseline/6-Month Follow-up|Other|0|||
28146638|NCT01307423|54813761|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
28146639|NCT01307423|54813753|FG000|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
28146640|NCT01307423|54813754|FG001|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
28072169|NCT00427895|54726872|FG000|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
28146641|NCT01307423|54813755|FG002|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
28146642|NCT01307423|54813756|FG003|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
28146643|NCT01307423|54813757|FG004|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
28146644|NCT01307423|54813758|FG005|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
28146645|NCT01307423|54813759|FG006|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
28146646|NCT01307423|54813760|FG007|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
28146647|NCT01307423|54813761|FG008|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
28146648|NCT01307423|54813753|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
28146649|NCT01307423|54813754|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
28146650|NCT01307423|54813755|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8|||
28146651|NCT01307423|54813756|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
28146652|NCT01307423|54813757|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
28146653|NCT01307423|54813758|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
28146654|NCT01307423|54813759|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
28146655|NCT01307423|54813760|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
28146656|NCT01307423|54813761|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
28146657|NCT01307423|54813753|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
28146658|NCT01307423|54813754|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|2|||
28146659|NCT01307423|54813755|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|3|||
28146660|NCT01307423|54813756|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
28146661|NCT01307423|54813757|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
28146662|NCT01307423|54813758|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
28146663|NCT01307423|54813759|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
28146664|NCT01307423|54813760|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
28146665|NCT01307423|54813761|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
28146666|NCT01307423|54813753|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
28146667|NCT01307423|54813754|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
28146668|NCT01307423|54813755|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
28146669|NCT01307423|54813756|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
28146670|NCT01307423|54813757|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
28146671|NCT01307423|54813758|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
28146672|NCT01307423|54813759|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
28146673|NCT01307423|54813760|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
28146674|NCT01307423|54813761|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
28146675|NCT01307423|54813753|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
28146676|NCT01307423|54813754|FG001|Long-term Safety Phase (Year 4)|Adverse Event|2|||
28146677|NCT01307423|54813755|FG002|Long-term Safety Phase (Year 4)|Adverse Event|0|||
28146678|NCT01307423|54813756|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
28146679|NCT01307423|54813757|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
28146680|NCT01307423|54813758|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
28146681|NCT01307423|54813759|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
28146682|NCT01307423|54813760|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
28146683|NCT01307423|54813761|FG008|Long-term Safety Phase (Year 4)|Adverse Event|0|||
28146684|NCT01307423|54813753|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
28146685|NCT01307423|54813754|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
28146686|NCT01307423|54813755|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
28146687|NCT01307423|54813756|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
28146688|NCT01307423|54813757|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
28146689|NCT01307423|54813758|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
28146690|NCT01307423|54813759|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
28146691|NCT01307423|54813760|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
28146692|NCT01307423|54813761|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
28146693|NCT01307423|54813753|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
28146694|NCT01307423|54813754|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5|||
28146695|NCT01307423|54813755|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
28146696|NCT01307423|54813756|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
28146697|NCT01307423|54813757|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
28146698|NCT01307423|54813758|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
28146699|NCT01307423|54813759|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
28146700|NCT01307423|54813760|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1|||
28146701|NCT01307423|54813761|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
28146702|NCT01307423|54813753|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
28146703|NCT01307423|54813754|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
28146704|NCT01307423|54813755|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
28146705|NCT01307423|54813756|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
28146706|NCT01307423|54813757|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
28146707|NCT01307423|54813758|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
28146708|NCT01307423|54813759|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
28146709|NCT01307423|54813760|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
28146710|NCT01307423|54813761|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
28146711|NCT01307423|54813753|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
28146712|NCT01307423|54813754|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
28146713|NCT01307423|54813755|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
28146714|NCT01307423|54813756|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
28146715|NCT01307423|54813757|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
28146716|NCT01307423|54813758|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
28146717|NCT01307423|54813759|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
27822684|NCT01840579|54286397|FG008|Overall Study|Follow-up ended by Sponsor|0|||
27822685|NCT01840579|54286398|FG009|Overall Study|Follow-up ended by Sponsor|0|||
27822686|NCT01801111|54286477|FG000|Overall Study|Adverse Event|12|||
27822687|NCT01801111|54286477|FG000|Overall Study|Death|8|||
27822688|NCT01801111|54286477|FG000|Overall Study|Physician Decision|5|||
28146718|NCT01307423|54813760|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
28146719|NCT01307423|54813761|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
28146720|NCT01307423|54813753|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
28146721|NCT01307423|54813754|FG001|Long-term Safety Phase (Year 5)|Adverse Event|1|||
28146722|NCT01307423|54813755|FG002|Long-term Safety Phase (Year 5)|Adverse Event|1|||
28146723|NCT01307423|54813756|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
28146724|NCT01307423|54813757|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
28146725|NCT01307423|54813758|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
28146726|NCT01307423|54813759|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
28146727|NCT01307423|54813760|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
28146728|NCT01307423|54813761|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
28146729|NCT01307423|54813753|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
28146730|NCT01307423|54813754|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|2|||
28146731|NCT01307423|54813755|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|1|||
28146732|NCT01307423|54813756|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
28146733|NCT01307423|54813757|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
28146734|NCT01307423|54813758|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
28146735|NCT01307423|54813759|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
28146736|NCT01307423|54813760|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
28146737|NCT01307423|54813761|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
28146738|NCT01307423|54813753|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
28146739|NCT01307423|54813754|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6|||
28146740|NCT01307423|54813755|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
28146741|NCT01307423|54813756|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
28146742|NCT01307423|54813757|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
28146743|NCT01307423|54813758|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
28146744|NCT01307423|54813759|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
28146745|NCT01307423|54813760|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
28146746|NCT01307423|54813761|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
28146747|NCT01307423|54813753|FG000|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
28146748|NCT01307423|54813754|FG001|Long-term Safety Phase (Year 5)|Lost to Follow-up|1|||
28146749|NCT01307423|54813755|FG002|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
28146750|NCT01307423|54813756|FG003|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
28146751|NCT01307423|54813757|FG004|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
28146752|NCT01307423|54813758|FG005|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
28146753|NCT01307423|54813759|FG006|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
28146754|NCT01307423|54813760|FG007|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
28146755|NCT01307423|54813761|FG008|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
28146756|NCT01307423|54813753|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
27822689|NCT01801111|54286477|FG000|Overall Study|Other|1|||
27822690|NCT01801111|54286477|FG000|Overall Study|Withdrawal by Subject|4|||
27822691|NCT01801111|54286477|FG000|Overall Study|Study Terminated by Sponsor|27|||
28146757|NCT01307423|54813754|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
28146758|NCT01307423|54813755|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|2|||
28146759|NCT01307423|54813756|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
28146760|NCT01307423|54813757|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
28146761|NCT01307423|54813758|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
28146762|NCT01307423|54813759|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
28146763|NCT01307423|54813760|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
28146764|NCT01307423|54813761|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
28146765|NCT02778074|54813795|FG000|Overall Study|Lost to Follow-up|7|||
27822692|NCT01801111|54286477|FG000|Overall Study|Progressive Disease|81|||
27822693|NCT01773967|54286509|FG000|Overall Study|Lost to Follow-up|15|||
27822694|NCT01773967|54286510|FG001|Overall Study|Lost to Follow-up|13|||
28072170|NCT00427895|54726873|FG001|Vax 1/Year 1 Follow-up|Lost to Follow-up|5|||
28146766|NCT02778074|54813796|FG001|Overall Study|Lost to Follow-up|10|||
28146767|NCT02768792|54813811|FG000|Overall Study|Adverse Event|1|||
28146768|NCT02775344|54813817|FG000|Overall Study|No ovarian cyst identified|3|||
28146769|NCT02775344|54813818|FG001|Overall Study|No ovarian cyst identified|2|||
28146770|NCT02777918|54813826|FG000|Overall Study|Medical reasons|1|||
28146771|NCT02777918|54813827|FG001|Overall Study|Medical reasons|2|||
28146772|NCT02777918|54813826|FG000|Overall Study|Too busy / stressed|1|||
28146773|NCT02777918|54813827|FG001|Overall Study|Too busy / stressed|1|||
28146774|NCT02777918|54813826|FG000|Overall Study|Withdrawal by Subject|1|||
28146775|NCT02777918|54813827|FG001|Overall Study|Withdrawal by Subject|1|||
28146776|NCT02927795|54813833|FG000|Overall Study|Non-evaluable PF10 quest. at visit 2|19|||
28146777|NCT02927795|54813833|FG000|Overall Study|Not Treated|4|||
28146778|NCT02767856|54813839|FG000|Overall Study|Lost to Follow-up|9|||
28146779|NCT02767856|54813840|FG001|Overall Study|Lost to Follow-up|1|||
28146780|NCT02767856|54813839|FG000|Overall Study|Withdrawal by Subject|2|||
28146781|NCT02767856|54813840|FG001|Overall Study|Withdrawal by Subject|1|||
28146782|NCT03087851|54813849|FG000|Overall Study|Withdraw on medical grounds|0|||
28146783|NCT03087851|54813850|FG001|Overall Study|Withdraw on medical grounds|1|||
28146784|NCT03087851|54813851|FG002|Overall Study|Withdraw on medical grounds|2|||
28146785|NCT03092375|54813863|FG000|Overall Study|Lack of Efficacy|0|||
28146786|NCT03092375|54813864|FG001|Overall Study|Lack of Efficacy|1|||
28146787|NCT03092375|54813865|FG002|Overall Study|Lack of Efficacy|1|||
28146788|NCT03092375|54813866|FG003|Overall Study|Lack of Efficacy|0|||
28146789|NCT01995513|54813883|FG000|Open Label Treatment Period|Other|9|||
28146790|NCT01995513|54813884|FG001|Open Label Treatment Period|Other|0|||
28146791|NCT01995513|54813885|FG002|Open Label Treatment Period|Other|0|||
28146792|NCT01995513|54813883|FG000|Open Label Treatment Period|Withdrawal by Subject|14|||
28146793|NCT01995513|54813884|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
28146794|NCT01995513|54813885|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
28146795|NCT01995513|54813883|FG000|Open Label Treatment Period|Protocol Violation|1|||
28146796|NCT01995513|54813884|FG001|Open Label Treatment Period|Protocol Violation|0|||
28146797|NCT01995513|54813885|FG002|Open Label Treatment Period|Protocol Violation|0|||
27822695|NCT01773889|54286520|FG000|Overall Study|lack of funding|2|||
28072171|NCT00427895|54726874|FG002|Vax 1/Year 1 Follow-up|Lost to Follow-up|2|||
28072172|NCT00427895|54726875|FG003|Vax 1/Year 1 Follow-up|Lost to Follow-up|21|||
28072173|NCT00427895|54726876|FG004|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
28072174|NCT00427895|54726877|FG005|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
28072175|NCT00427895|54726878|FG006|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
28072176|NCT00427895|54726879|FG007|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
28072177|NCT00427895|54726872|FG000|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
28072178|NCT00427895|54726873|FG001|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
28072179|NCT00427895|54726874|FG002|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
28072180|NCT00427895|54726875|FG003|Vax 1/Year 1 Follow-up|Protocol Violation|1|||
28072181|NCT00427895|54726876|FG004|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
28072182|NCT00427895|54726877|FG005|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
28072183|NCT00427895|54726878|FG006|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
28072184|NCT00427895|54726879|FG007|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
28072185|NCT00427895|54726872|FG000|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3|||
28072186|NCT00427895|54726873|FG001|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6|||
28146798|NCT01995513|54813883|FG000|Open Label Treatment Period|Disease Progression|64|||
28146799|NCT01995513|54813884|FG001|Open Label Treatment Period|Disease Progression|0|||
28072187|NCT00427895|54726874|FG002|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5|||
28072188|NCT00427895|54726875|FG003|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4|||
28072189|NCT00427895|54726876|FG004|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
28072190|NCT00427895|54726877|FG005|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
28146800|NCT01995513|54813885|FG002|Open Label Treatment Period|Disease Progression|0|||
28146801|NCT01995513|54813883|FG000|Open Label Treatment Period|No PSA response at week 13|43|||
28146802|NCT01995513|54813884|FG001|Open Label Treatment Period|No PSA response at week 13|0|||
28146803|NCT01995513|54813885|FG002|Open Label Treatment Period|No PSA response at week 13|0|||
28146804|NCT01995513|54813883|FG000|Open Label Treatment Period|Adverse Event|35|||
28146805|NCT01995513|54813884|FG001|Open Label Treatment Period|Adverse Event|0|||
28146806|NCT01995513|54813885|FG002|Open Label Treatment Period|Adverse Event|0|||
28146807|NCT01995513|54813883|FG000|Open Label Treatment Period|Death|8|||
28146808|NCT01995513|54813884|FG001|Open Label Treatment Period|Death|0|||
28146809|NCT01995513|54813885|FG002|Open Label Treatment Period|Death|0|||
28146810|NCT01995513|54813883|FG000|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|84|||
28146811|NCT01995513|54813884|FG001|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0|||
28146812|NCT01995513|54813885|FG002|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0|||
28146813|NCT01995513|54813883|FG000|Double Blind Treatment Period|Adverse Event|0|||
28146814|NCT01995513|54813884|FG001|Double Blind Treatment Period|Adverse Event|12|||
28146815|NCT01995513|54813885|FG002|Double Blind Treatment Period|Adverse Event|5|||
28146816|NCT01995513|54813883|FG000|Double Blind Treatment Period|Other|0|||
28146817|NCT01995513|54813884|FG001|Double Blind Treatment Period|Other|1|||
28146818|NCT01995513|54813885|FG002|Double Blind Treatment Period|Other|2|||
28146819|NCT01995513|54813883|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
28146820|NCT01995513|54813884|FG001|Double Blind Treatment Period|Withdrawal by Subject|4|||
28146821|NCT01995513|54813885|FG002|Double Blind Treatment Period|Withdrawal by Subject|6|||
28146822|NCT01995513|54813883|FG000|Double Blind Treatment Period|Death|0|||
28146823|NCT01995513|54813884|FG001|Double Blind Treatment Period|Death|0|||
28146824|NCT01995513|54813885|FG002|Double Blind Treatment Period|Death|1|||
28146825|NCT01995513|54813883|FG000|Double Blind Treatment Period|Disease Progression|0|||
28146826|NCT01995513|54813884|FG001|Double Blind Treatment Period|Disease Progression|82|||
28146827|NCT01995513|54813885|FG002|Double Blind Treatment Period|Disease Progression|93|||
28146828|NCT01995513|54813883|FG000|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0|||
28146829|NCT01995513|54813884|FG001|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|27|||
28146830|NCT01995513|54813885|FG002|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|18|||
28146831|NCT02927171|54813897|FG000|Overall Study|Lost to Follow-up|0|||
28146832|NCT02927171|54813898|FG001|Overall Study|Lost to Follow-up|1|||
28146833|NCT03087617|54813908|FG000|Overall Study|Lost to Follow-up|32|||
28146834|NCT03087617|54813909|FG001|Overall Study|Lost to Follow-up|30|||
28146835|NCT03087617|54813910|FG002|Overall Study|Lost to Follow-up|30|||
28146836|NCT03087617|54813911|FG003|Overall Study|Lost to Follow-up|39|||
28146837|NCT00103610|54813923|FG000|Overall Study|Entered Rescue Procedure|10|||
28146838|NCT00103610|54813924|FG001|Overall Study|Entered Rescue Procedure|52|||
28146839|NCT00103610|54813923|FG000|Overall Study|Death|16|||
28146840|NCT00103610|54813924|FG001|Overall Study|Death|12|||
28146841|NCT00103610|54813923|FG000|Overall Study|Elective Withdrawal|4|||
28146842|NCT00103610|54813924|FG001|Overall Study|Elective Withdrawal|0|||
28146843|NCT00103610|54813923|FG000|Overall Study|Lost to Follow-up|3|||
28146844|NCT00103610|54813924|FG001|Overall Study|Lost to Follow-up|1|||
28146845|NCT00103610|54813923|FG000|Overall Study|Adverse Event|2|||
28146846|NCT00103610|54813924|FG001|Overall Study|Adverse Event|2|||
28146847|NCT00103610|54813923|FG000|Overall Study|Other|2|||
28146848|NCT00103610|54813924|FG001|Overall Study|Other|7|||
28146849|NCT00103610|54813923|FG000|Overall Study|Failed mobilization|1|||
28146850|NCT00103610|54813924|FG001|Overall Study|Failed mobilization|5|||
28146851|NCT00103610|54813923|FG000|Overall Study|Noncompliance|0|||
28146852|NCT00103610|54813924|FG001|Overall Study|Noncompliance|1|||
28146853|NCT03091439|54813933|FG000|Overall Study|Study Terminated by the Sponsor|1|||
28146854|NCT03091439|54813934|FG001|Overall Study|Study Terminated by the Sponsor|0|||
28146855|NCT03086447|54813942|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
28146856|NCT03086447|54813943|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
28146857|NCT03086447|54813942|FG000|Overall Study|Lost Lens|2|||
28146858|NCT03086447|54813943|FG001|Overall Study|Lost Lens|5|||
28146859|NCT03086447|54813942|FG000|Overall Study|Product quality complaint|0|||
28146860|NCT03086447|54813943|FG001|Overall Study|Product quality complaint|1|||
28146861|NCT03086447|54813942|FG000|Overall Study|Lens Damage|1|||
28146862|NCT03086447|54813943|FG001|Overall Study|Lens Damage|6|||
28146863|NCT03086447|54813942|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
28146864|NCT03086447|54813943|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
27850076|NCT01647828|54348366|FG001|Overall Study|Study terminated by Sponsor|0|||
27850077|NCT01647828|54348367|FG002|Overall Study|Study terminated by Sponsor|0|||
28146865|NCT03086447|54813942|FG000|Overall Study|Test Article No Longer Available|1|||
28146866|NCT03086447|54813943|FG001|Overall Study|Test Article No Longer Available|0|||
28146867|NCT03086447|54813942|FG000|Overall Study|Protocol Violation|2|||
28146868|NCT03086447|54813943|FG001|Overall Study|Protocol Violation|4|||
28146869|NCT03086447|54813942|FG000|Overall Study|Lost to Follow-up|0|||
27850078|NCT01647828|54348368|FG003|Overall Study|Study terminated by Sponsor|0|||
28146870|NCT03086447|54813943|FG001|Overall Study|Lost to Follow-up|1|||
28146871|NCT03086447|54813942|FG000|Overall Study|Adverse Event|3|||
28146872|NCT03086447|54813943|FG001|Overall Study|Adverse Event|0|||
28146873|NCT03086447|54813942|FG000|Overall Study|Lens Discomfort|2|||
28146874|NCT03086447|54813943|FG001|Overall Study|Lens Discomfort|1|||
28146875|NCT03083639|54813974|FG000|Washout Period (at Least 6 Days)|Pregnancy|0|||
28146876|NCT03083639|54813975|FG001|Washout Period (at Least 6 Days)|Pregnancy|1|||
28146877|NCT03083639|54813974|FG000|Washout Period (at Least 6 Days)|Lost to Follow-up|1|||
28146878|NCT03083639|54813975|FG001|Washout Period (at Least 6 Days)|Lost to Follow-up|0|||
28146879|NCT02927431|54813984|FG000|Overall Study|Withdrawal by Subject|0|||
28146880|NCT02927431|54813985|FG001|Overall Study|Withdrawal by Subject|0|||
28146881|NCT02927431|54813986|FG002|Overall Study|Withdrawal by Subject|1|||
28146882|NCT03083483|54813999|FG000|Overall Study|Adverse Event|1|||
28146883|NCT03083483|54814000|FG001|Overall Study|Adverse Event|1|||
28146884|NCT03083483|54814001|FG002|Overall Study|Adverse Event|1|||
28146885|NCT03083483|54813999|FG000|Overall Study|Lost to Follow-up|2|||
28146886|NCT03083483|54814000|FG001|Overall Study|Lost to Follow-up|1|||
28146887|NCT03083483|54814001|FG002|Overall Study|Lost to Follow-up|1|||
28146888|NCT03083483|54813999|FG000|Overall Study|technological issues|1|||
28146889|NCT03083483|54814000|FG001|Overall Study|technological issues|0|||
28146890|NCT03083483|54814001|FG002|Overall Study|technological issues|1|||
28146891|NCT03085927|54814013|FG000|Overall Study|Withdrawal by Subject|1|||
28146892|NCT03085927|54814014|FG001|Overall Study|Withdrawal by Subject|4|||
28146893|NCT03085927|54814013|FG000|Overall Study|Lost to Follow-up|3|||
28146894|NCT03085927|54814014|FG001|Overall Study|Lost to Follow-up|1|||
28146895|NCT03085927|54814013|FG000|Overall Study|Death|1|||
28146896|NCT03085927|54814014|FG001|Overall Study|Death|0|||
28146897|NCT03085927|54814013|FG000|Overall Study|Child Toxicity/Side Effects of Treatment|1|||
28146898|NCT03085927|54814014|FG001|Overall Study|Child Toxicity/Side Effects of Treatment|0|||
28146899|NCT03085927|54814013|FG000|Overall Study|Dyad Became Ineligible|0|||
28146900|NCT03085927|54814014|FG001|Overall Study|Dyad Became Ineligible|1|||
28146901|NCT04392583|54814022|FG000|Overall Study|Participant declined follow-up and subsequently withdrawn|1|||
28146902|NCT04497987|54814028|FG000|Overall Study|Adverse Event|1|||
28146903|NCT04497987|54814029|FG001|Overall Study|Adverse Event|0|||
28146904|NCT04497987|54814028|FG000|Overall Study|Death|21|||
28146905|NCT04497987|54814029|FG001|Overall Study|Death|13|||
28146906|NCT04497987|54814028|FG000|Overall Study|Lost to Follow-up|19|||
28146907|NCT04497987|54814029|FG001|Overall Study|Lost to Follow-up|17|||
28146908|NCT04497987|54814028|FG000|Overall Study|Other - as reported by the investigator|22|||
28146909|NCT04497987|54814029|FG001|Overall Study|Other - as reported by the investigator|16|||
28146910|NCT04497987|54814028|FG000|Overall Study|Physician Decision|1|||
28146911|NCT04497987|54814029|FG001|Overall Study|Physician Decision|0|||
28146912|NCT04497987|54814028|FG000|Overall Study|Withdrawal by Subject|35|||
28146913|NCT04497987|54814029|FG001|Overall Study|Withdrawal by Subject|21|||
28146914|NCT00974571|54814039|FG000|Overall Study|Adverse Event|31|||
28146915|NCT00974571|54814040|FG001|Overall Study|Adverse Event|4|||
28146916|NCT00974571|54814041|FG002|Overall Study|Adverse Event|27|||
28146917|NCT00974571|54814039|FG000|Overall Study|Lack of Efficacy|3|||
28146918|NCT00974571|54814040|FG001|Overall Study|Lack of Efficacy|2|||
28146919|NCT00974571|54814041|FG002|Overall Study|Lack of Efficacy|9|||
28146920|NCT00974571|54814039|FG000|Overall Study|Lost to Follow-up|2|||
28146921|NCT00974571|54814040|FG001|Overall Study|Lost to Follow-up|1|||
28146922|NCT00974571|54814041|FG002|Overall Study|Lost to Follow-up|2|||
28146923|NCT00974571|54814039|FG000|Overall Study|Protocol Violation|13|||
28146924|NCT00974571|54814040|FG001|Overall Study|Protocol Violation|4|||
28146925|NCT00974571|54814041|FG002|Overall Study|Protocol Violation|18|||
28146926|NCT00974571|54814039|FG000|Overall Study|Withdrawal by Subject|14|||
28146927|NCT00974571|54814040|FG001|Overall Study|Withdrawal by Subject|5|||
28146928|NCT00974571|54814041|FG002|Overall Study|Withdrawal by Subject|16|||
28146929|NCT00974571|54814039|FG000|Overall Study|Patient Moved|1|||
28146930|NCT00974571|54814040|FG001|Overall Study|Patient Moved|0|||
28146931|NCT00974571|54814041|FG002|Overall Study|Patient Moved|1|||
28146932|NCT00974571|54814039|FG000|Overall Study|Other|4|||
28146933|NCT00974571|54814040|FG001|Overall Study|Other|0|||
28146934|NCT00974571|54814041|FG002|Overall Study|Other|10|||
28146935|NCT02766608|54814054|FG000|Overall Study|Adverse Event|27|||
28146936|NCT02766608|54814055|FG001|Overall Study|Adverse Event|22|||
28146937|NCT02766608|54814056|FG002|Overall Study|Adverse Event|17|||
28146938|NCT02766608|54814057|FG003|Overall Study|Adverse Event|13|||
28146939|NCT02766608|54814058|FG004|Overall Study|Adverse Event|12|||
28146940|NCT02766608|54814054|FG000|Overall Study|Withdrawal by Subject|21|||
28146941|NCT02766608|54814055|FG001|Overall Study|Withdrawal by Subject|20|||
28146942|NCT02766608|54814056|FG002|Overall Study|Withdrawal by Subject|24|||
28146943|NCT02766608|54814057|FG003|Overall Study|Withdrawal by Subject|13|||
28146944|NCT02766608|54814058|FG004|Overall Study|Withdrawal by Subject|10|||
28146945|NCT02766608|54814054|FG000|Overall Study|Lack of Efficacy|16|||
28146946|NCT02766608|54814055|FG001|Overall Study|Lack of Efficacy|15|||
28146947|NCT02766608|54814056|FG002|Overall Study|Lack of Efficacy|32|||
27822696|NCT01839487|54286698|FG000|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1|||
28072191|NCT00427895|54726878|FG006|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
28072192|NCT00427895|54726879|FG007|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
28072193|NCT00427895|54726872|FG000|Vax 1/Year 1 Follow-up|Adverse Event|0|||
28072194|NCT00427895|54726873|FG001|Vax 1/Year 1 Follow-up|Adverse Event|1|||
28072195|NCT00427895|54726874|FG002|Vax 1/Year 1 Follow-up|Adverse Event|0|||
28072196|NCT00427895|54726875|FG003|Vax 1/Year 1 Follow-up|Adverse Event|0|||
28072197|NCT00427895|54726876|FG004|Vax 1/Year 1 Follow-up|Adverse Event|0|||
28072198|NCT00427895|54726877|FG005|Vax 1/Year 1 Follow-up|Adverse Event|0|||
28072199|NCT00427895|54726878|FG006|Vax 1/Year 1 Follow-up|Adverse Event|0|||
28072200|NCT00427895|54726879|FG007|Vax 1/Year 1 Follow-up|Adverse Event|0|||
28072201|NCT00427895|54726872|FG000|Vax 1/Year 1 Follow-up|Death|1|||
28072202|NCT00427895|54726873|FG001|Vax 1/Year 1 Follow-up|Death|0|||
28072203|NCT00427895|54726874|FG002|Vax 1/Year 1 Follow-up|Death|0|||
28072204|NCT00427895|54726875|FG003|Vax 1/Year 1 Follow-up|Death|0|||
28072205|NCT00427895|54726876|FG004|Vax 1/Year 1 Follow-up|Death|0|||
28072206|NCT00427895|54726877|FG005|Vax 1/Year 1 Follow-up|Death|0|||
28072207|NCT00427895|54726878|FG006|Vax 1/Year 1 Follow-up|Death|0|||
28072208|NCT00427895|54726879|FG007|Vax 1/Year 1 Follow-up|Death|0|||
28072209|NCT00427895|54726872|FG000|Vax 1/Year 1 Follow-up|Failed to Return|0|||
28072210|NCT00427895|54726873|FG001|Vax 1/Year 1 Follow-up|Failed to Return|0|||
28072211|NCT00427895|54726874|FG002|Vax 1/Year 1 Follow-up|Failed to Return|12|||
28072212|NCT00427895|54726875|FG003|Vax 1/Year 1 Follow-up|Failed to Return|5|||
28072213|NCT00427895|54726876|FG004|Vax 1/Year 1 Follow-up|Failed to Return|0|||
28072214|NCT00427895|54726877|FG005|Vax 1/Year 1 Follow-up|Failed to Return|0|||
28072215|NCT00427895|54726878|FG006|Vax 1/Year 1 Follow-up|Failed to Return|0|||
28072216|NCT00427895|54726879|FG007|Vax 1/Year 1 Follow-up|Failed to Return|0|||
28072217|NCT00427895|54726872|FG000|Vax 1/Year 1 Follow-up|Other|0|||
28072218|NCT00427895|54726873|FG001|Vax 1/Year 1 Follow-up|Other|0|||
28072219|NCT00427895|54726874|FG002|Vax 1/Year 1 Follow-up|Other|0|||
28072220|NCT00427895|54726875|FG003|Vax 1/Year 1 Follow-up|Other|2|||
28072221|NCT00427895|54726876|FG004|Vax 1/Year 1 Follow-up|Other|0|||
28072222|NCT00427895|54726877|FG005|Vax 1/Year 1 Follow-up|Other|0|||
28072223|NCT00427895|54726878|FG006|Vax 1/Year 1 Follow-up|Other|0|||
28072224|NCT00427895|54726879|FG007|Vax 1/Year 1 Follow-up|Other|0|||
28072225|NCT00427895|54726872|FG000|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188|||
28072226|NCT00427895|54726873|FG001|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207|||
28072227|NCT00427895|54726874|FG002|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159|||
28072228|NCT00427895|54726875|FG003|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469|||
28072229|NCT00427895|54726876|FG004|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
28072230|NCT00427895|54726877|FG005|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
28072231|NCT00427895|54726878|FG006|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
28072232|NCT00427895|54726879|FG007|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
28072233|NCT00425945|54726920|FG000|Overall Study|Concern about Supplement|2|||
28072234|NCT00425945|54726921|FG001|Overall Study|Concern about Supplement|0|||
28072235|NCT00425945|54726920|FG000|Overall Study|Inconvenience|0|||
28072236|NCT00425945|54726921|FG001|Overall Study|Inconvenience|2|||
28072237|NCT00425945|54726920|FG000|Overall Study|Lost to Follow-up|0|||
28072238|NCT00425945|54726921|FG001|Overall Study|Lost to Follow-up|2|||
28146948|NCT02766608|54814057|FG003|Overall Study|Lack of Efficacy|8|||
28146949|NCT02766608|54814058|FG004|Overall Study|Lack of Efficacy|2|||
28146950|NCT02766608|54814054|FG000|Overall Study|Lost to Follow-up|6|||
28146951|NCT02766608|54814055|FG001|Overall Study|Lost to Follow-up|3|||
28146952|NCT02766608|54814056|FG002|Overall Study|Lost to Follow-up|5|||
28072239|NCT00425945|54726920|FG000|Overall Study|Began hypertension medication|1|||
28072240|NCT00425945|54726921|FG001|Overall Study|Began hypertension medication|0|||
28072241|NCT00425945|54726920|FG000|Overall Study|Began cancer treatments|1|||
28072242|NCT00425945|54726921|FG001|Overall Study|Began cancer treatments|0|||
28072243|NCT00425945|54726920|FG000|Overall Study|Moved from area|0|||
28072244|NCT00425945|54726921|FG001|Overall Study|Moved from area|1|||
28072245|NCT00416195|54726931|FG000|Overall Study|Adverse Event|1|||
28072246|NCT00416195|54726932|FG001|Overall Study|Adverse Event|2|||
28072247|NCT00416195|54726931|FG000|Overall Study|Protocol Violation|1|||
28146953|NCT02766608|54814057|FG003|Overall Study|Lost to Follow-up|2|||
28146954|NCT02766608|54814058|FG004|Overall Study|Lost to Follow-up|2|||
28146955|NCT02766608|54814054|FG000|Overall Study|Physician Decision|3|||
28146956|NCT02766608|54814055|FG001|Overall Study|Physician Decision|2|||
28146957|NCT02766608|54814056|FG002|Overall Study|Physician Decision|3|||
28146958|NCT02766608|54814057|FG003|Overall Study|Physician Decision|1|||
28146959|NCT02766608|54814058|FG004|Overall Study|Physician Decision|2|||
28146960|NCT02766608|54814054|FG000|Overall Study|Protocol disc criteria|3|||
28146961|NCT02766608|54814055|FG001|Overall Study|Protocol disc criteria|3|||
28146962|NCT02766608|54814056|FG002|Overall Study|Protocol disc criteria|4|||
28146963|NCT02766608|54814057|FG003|Overall Study|Protocol disc criteria|0|||
28146964|NCT02766608|54814058|FG004|Overall Study|Protocol disc criteria|0|||
28146965|NCT02766608|54814054|FG000|Overall Study|Protocol Violation|0|||
28146966|NCT02766608|54814055|FG001|Overall Study|Protocol Violation|4|||
28146967|NCT02766608|54814056|FG002|Overall Study|Protocol Violation|4|||
28146968|NCT02766608|54814057|FG003|Overall Study|Protocol Violation|0|||
28146969|NCT02766608|54814058|FG004|Overall Study|Protocol Violation|1|||
28146970|NCT02766608|54814054|FG000|Overall Study|Administrative Reasons|3|||
28146971|NCT02766608|54814055|FG001|Overall Study|Administrative Reasons|1|||
28146972|NCT02766608|54814056|FG002|Overall Study|Administrative Reasons|1|||
28146973|NCT02766608|54814057|FG003|Overall Study|Administrative Reasons|0|||
28146974|NCT02766608|54814058|FG004|Overall Study|Administrative Reasons|0|||
28146975|NCT00960141|54814076|FG000|Overall Study|Adverse Event|4|||
28146976|NCT00960141|54814077|FG001|Overall Study|Adverse Event|8|||
28146977|NCT00960141|54814078|FG002|Overall Study|Adverse Event|2|||
28146978|NCT00960141|54814076|FG000|Overall Study|Lack of Efficacy|3|||
28146979|NCT00960141|54814077|FG001|Overall Study|Lack of Efficacy|4|||
28146980|NCT00960141|54814078|FG002|Overall Study|Lack of Efficacy|2|||
28146981|NCT00960141|54814076|FG000|Overall Study|Lost to Follow-up|1|||
28146982|NCT00960141|54814077|FG001|Overall Study|Lost to Follow-up|0|||
28146983|NCT00960141|54814078|FG002|Overall Study|Lost to Follow-up|0|||
28146984|NCT00960141|54814076|FG000|Overall Study|Protocol Violation|1|||
28146985|NCT00960141|54814077|FG001|Overall Study|Protocol Violation|3|||
28146986|NCT00960141|54814078|FG002|Overall Study|Protocol Violation|2|||
28146987|NCT00960141|54814076|FG000|Overall Study|Withdrawal by Subject|1|||
28146988|NCT00960141|54814077|FG001|Overall Study|Withdrawal by Subject|2|||
28146989|NCT00960141|54814078|FG002|Overall Study|Withdrawal by Subject|1|||
28146990|NCT02771522|54814086|FG000|Overall Study|Lost to Follow-up|3|||
28146991|NCT02771522|54814086|FG000|Overall Study|Withdrawal by Subject|2|||
28146992|NCT02771522|54814086|FG000|Overall Study|No white spot lesions|3|||
28146993|NCT00759655|54814095|FG000|Overall Study|Termination of the study by sponsor|1|||
28146994|NCT02771366|54814101|FG000|Period 1|Withdrawal by Subject|0|||
28146995|NCT02771366|54814102|FG001|Period 1|Withdrawal by Subject|2|||
28146996|NCT02771366|54814101|FG000|Period 2 (Crossover)|Withdrawal by Subject|2|||
28146997|NCT02771366|54814102|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
28146998|NCT03396471|54814109|FG000|Study Treatment - Up to 22 Months|Disease Progression|6|||
28146999|NCT03396471|54814109|FG000|Study Treatment - Up to 22 Months|Alternative Cancer Therapy|2|||
28147000|NCT03396471|54814109|FG000|Study Treatment - Up to 22 Months|AE / Side Effects / Complications|3|||
28147001|NCT03396471|54814109|FG000|Study Treatment - Up to 22 Months|Death|2|||
28147002|NCT03396471|54814109|FG000|Study Treatment - Up to 22 Months|Symptomatic Deterioration|1|||
28147003|NCT03396471|54814109|FG000|Follow up - Up to 2 Years|Death|9|||
28147004|NCT03396471|54814109|FG000|Follow up - Up to 2 Years|Patient lost to follow up|1|||
28147005|NCT03396471|54814109|FG000|Follow up - Up to 2 Years|Patient Refused to follow up|1|||
28147006|NCT03396471|54814109|FG000|Follow up - Up to 2 Years|study terminated|1|||
28147007|NCT03396471|54814109|FG000|Follow up - Up to 2 Years|Patient would like to seek treatments locally.|1|||
28147008|NCT03396471|54814109|FG000|Follow up - Up to 2 Years|Patient stopped protocol treatment due to lack of response to treatment regimen.|1|||
28147009|NCT00103142|54814115|FG000|Overall Study|Adverse Event|1|||
28147010|NCT00103142|54814116|FG001|Overall Study|Adverse Event|0|||
28147011|NCT00103142|54814115|FG000|Overall Study|Progression of disease|2|||
28147012|NCT00103142|54814116|FG001|Overall Study|Progression of disease|1|||
28147013|NCT00943683|54814126|FG000|Overall Study|Adverse Event|3|||
28147014|NCT00943683|54814127|FG001|Overall Study|Adverse Event|3|||
28147015|NCT00943683|54814126|FG000|Overall Study|Lost to Follow-up|1|||
28147016|NCT00943683|54814127|FG001|Overall Study|Lost to Follow-up|1|||
28147017|NCT00943683|54814126|FG000|Overall Study|Protocol Violation|1|||
28147018|NCT00943683|54814127|FG001|Overall Study|Protocol Violation|2|||
28147019|NCT00943683|54814126|FG000|Overall Study|Withdrawal by Subject|1|||
28147020|NCT00943683|54814127|FG001|Overall Study|Withdrawal by Subject|0|||
28147021|NCT00943683|54814126|FG000|Overall Study|Patient Moved|1|||
28147022|NCT00943683|54814127|FG001|Overall Study|Patient Moved|0|||
28147023|NCT00911547|54814137|FG000|Overall Study|Adverse Event|8|||
28147024|NCT00911547|54814138|FG001|Overall Study|Adverse Event|27|||
28147025|NCT00911547|54814139|FG002|Overall Study|Adverse Event|11|||
28147026|NCT00911547|54814140|FG003|Overall Study|Adverse Event|6|||
28147027|NCT00911547|54814137|FG000|Overall Study|Lost to Follow-up|0|||
28147028|NCT00911547|54814138|FG001|Overall Study|Lost to Follow-up|0|||
28147029|NCT00911547|54814139|FG002|Overall Study|Lost to Follow-up|2|||
28147030|NCT00911547|54814140|FG003|Overall Study|Lost to Follow-up|1|||
28147031|NCT00911547|54814137|FG000|Overall Study|Protocol Violation|0|||
28147032|NCT00911547|54814138|FG001|Overall Study|Protocol Violation|5|||
28147033|NCT00911547|54814139|FG002|Overall Study|Protocol Violation|5|||
28147034|NCT00911547|54814140|FG003|Overall Study|Protocol Violation|1|||
28147035|NCT00911547|54814137|FG000|Overall Study|Withdrawal by Subject|3|||
28147036|NCT00911547|54814138|FG001|Overall Study|Withdrawal by Subject|10|||
28147037|NCT00911547|54814139|FG002|Overall Study|Withdrawal by Subject|4|||
28147038|NCT00911547|54814140|FG003|Overall Study|Withdrawal by Subject|8|||
28147039|NCT00899379|54814155|FG000|Overall Study|Adverse Event|2|||
28147040|NCT00899379|54814156|FG001|Overall Study|Adverse Event|2|||
28147041|NCT00899379|54814157|FG002|Overall Study|Adverse Event|1|||
28147042|NCT00899379|54814158|FG003|Overall Study|Adverse Event|1|||
28147043|NCT00899379|54814159|FG004|Overall Study|Adverse Event|2|||
28147044|NCT00899379|54814155|FG000|Overall Study|Lack of Efficacy|0|||
28147045|NCT00899379|54814156|FG001|Overall Study|Lack of Efficacy|4|||
28147046|NCT00899379|54814157|FG002|Overall Study|Lack of Efficacy|3|||
28147047|NCT00899379|54814158|FG003|Overall Study|Lack of Efficacy|0|||
28147048|NCT00899379|54814159|FG004|Overall Study|Lack of Efficacy|1|||
28147049|NCT00899379|54814155|FG000|Overall Study|Lost to Follow-up|9|||
28147050|NCT00899379|54814156|FG001|Overall Study|Lost to Follow-up|3|||
28147051|NCT00899379|54814157|FG002|Overall Study|Lost to Follow-up|0|||
28147052|NCT00899379|54814158|FG003|Overall Study|Lost to Follow-up|6|||
28147053|NCT00899379|54814159|FG004|Overall Study|Lost to Follow-up|2|||
28147054|NCT00899379|54814155|FG000|Overall Study|Protocol Violation|0|||
28147055|NCT00899379|54814156|FG001|Overall Study|Protocol Violation|0|||
28147056|NCT00899379|54814157|FG002|Overall Study|Protocol Violation|1|||
27941426|NCT00940498|54597838|FG007|Overall Study|Not treated due to disease related pain|0|||
28072248|NCT00416195|54726932|FG001|Overall Study|Protocol Violation|1|||
28072249|NCT00416195|54726931|FG000|Overall Study|Other|0|||
28072250|NCT00416195|54726932|FG001|Overall Study|Other|1|||
28072251|NCT00121641|54726942|FG000|24-week Short-term Treatment Period|Lack of Efficacy|15|||
28072252|NCT00121641|54726943|FG001|24-week Short-term Treatment Period|Lack of Efficacy|21|||
28072253|NCT00121641|54726944|FG002|24-week Short-term Treatment Period|Lack of Efficacy|14|||
28072254|NCT00121641|54726945|FG003|24-week Short-term Treatment Period|Lack of Efficacy|25|||
28072255|NCT00121641|54726946|FG004|24-week Short-term Treatment Period|Lack of Efficacy|30|||
28072256|NCT00121641|54726942|FG000|24-week Short-term Treatment Period|Subject Withdrew Consent|9|||
28072257|NCT00121641|54726943|FG001|24-week Short-term Treatment Period|Subject Withdrew Consent|11|||
28072258|NCT00121641|54726944|FG002|24-week Short-term Treatment Period|Subject Withdrew Consent|5|||
28072259|NCT00121641|54726945|FG003|24-week Short-term Treatment Period|Subject Withdrew Consent|10|||
28072260|NCT00121641|54726946|FG004|24-week Short-term Treatment Period|Subject Withdrew Consent|3|||
28147057|NCT00899379|54814158|FG003|Overall Study|Protocol Violation|1|||
28147058|NCT00899379|54814159|FG004|Overall Study|Protocol Violation|0|||
28147059|NCT00899379|54814155|FG000|Overall Study|Withdrawal by Subject|2|||
28147060|NCT00899379|54814156|FG001|Overall Study|Withdrawal by Subject|4|||
28147061|NCT00899379|54814157|FG002|Overall Study|Withdrawal by Subject|2|||
28147062|NCT00899379|54814158|FG003|Overall Study|Withdrawal by Subject|3|||
28147063|NCT00899379|54814159|FG004|Overall Study|Withdrawal by Subject|6|||
28147064|NCT00899379|54814155|FG000|Overall Study|Pregnancy|0|||
28147065|NCT00899379|54814156|FG001|Overall Study|Pregnancy|0|||
28147066|NCT00899379|54814157|FG002|Overall Study|Pregnancy|1|||
28147067|NCT00899379|54814158|FG003|Overall Study|Pregnancy|0|||
28147068|NCT00899379|54814159|FG004|Overall Study|Pregnancy|1|||
28147069|NCT00899379|54814155|FG000|Overall Study|Patient Uncooperative|0|||
28147070|NCT00899379|54814156|FG001|Overall Study|Patient Uncooperative|1|||
28147071|NCT00899379|54814157|FG002|Overall Study|Patient Uncooperative|0|||
28147072|NCT00899379|54814158|FG003|Overall Study|Patient Uncooperative|1|||
28147073|NCT00899379|54814159|FG004|Overall Study|Patient Uncooperative|2|||
28147074|NCT00899379|54814155|FG000|Overall Study|Abnormal Baseline ECG|0|||
28147075|NCT00899379|54814156|FG001|Overall Study|Abnormal Baseline ECG|0|||
27822697|NCT01839487|54286699|FG001|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
27822698|NCT01839487|54286700|FG002|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
27822699|NCT01839487|54286701|FG003|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
28072261|NCT00121641|54726942|FG000|24-week Short-term Treatment Period|Adverse Event|3|||
28072262|NCT00121641|54726943|FG001|24-week Short-term Treatment Period|Adverse Event|3|||
28072263|NCT00121641|54726944|FG002|24-week Short-term Treatment Period|Adverse Event|4|||
28072264|NCT00121641|54726945|FG003|24-week Short-term Treatment Period|Adverse Event|0|||
28072265|NCT00121641|54726946|FG004|24-week Short-term Treatment Period|Adverse Event|2|||
28072266|NCT00121641|54726942|FG000|24-week Short-term Treatment Period|Lost to Follow-up|0|||
27941427|NCT00940342|54597865|FG000|Overall Study|Adverse Event|0|||
27941428|NCT00940342|54597866|FG001|Overall Study|Adverse Event|2|||
28072267|NCT00121641|54726943|FG001|24-week Short-term Treatment Period|Lost to Follow-up|2|||
28072268|NCT00121641|54726944|FG002|24-week Short-term Treatment Period|Lost to Follow-up|3|||
28072269|NCT00121641|54726945|FG003|24-week Short-term Treatment Period|Lost to Follow-up|4|||
28072270|NCT00121641|54726946|FG004|24-week Short-term Treatment Period|Lost to Follow-up|4|||
28072271|NCT00121641|54726942|FG000|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
28072272|NCT00121641|54726943|FG001|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
28072273|NCT00121641|54726944|FG002|24-week Short-term Treatment Period|Poor / Non-compliance|3|||
28072274|NCT00121641|54726945|FG003|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
28072275|NCT00121641|54726946|FG004|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
28072276|NCT00121641|54726942|FG000|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
28072277|NCT00121641|54726943|FG001|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
28072278|NCT00121641|54726944|FG002|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
28072279|NCT00121641|54726945|FG003|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
28072280|NCT00121641|54726946|FG004|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
28072281|NCT00121641|54726942|FG000|24-week Short-term Treatment Period|Other Reason|1|||
28072282|NCT00121641|54726943|FG001|24-week Short-term Treatment Period|Other Reason|0|||
28072283|NCT00121641|54726944|FG002|24-week Short-term Treatment Period|Other Reason|0|||
28072284|NCT00121641|54726945|FG003|24-week Short-term Treatment Period|Other Reason|0|||
28072285|NCT00121641|54726946|FG004|24-week Short-term Treatment Period|Other Reason|0|||
28072286|NCT00121641|54726942|FG000|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
28072287|NCT00121641|54726943|FG001|48-month Short Term + Long Term Period|Lack of Efficacy|27|||
27822700|NCT01839487|54286702|FG004|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
27822701|NCT01839487|54286703|FG005|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
27822702|NCT01839487|54286698|FG000|Run-in Phase (Maximum Exposure:295 Days)|Death|14|||
28072288|NCT00121641|54726944|FG002|48-month Short Term + Long Term Period|Lack of Efficacy|21|||
28072289|NCT00121641|54726945|FG003|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
28147076|NCT00899379|54814157|FG002|Overall Study|Abnormal Baseline ECG|0|||
28147077|NCT00899379|54814158|FG003|Overall Study|Abnormal Baseline ECG|1|||
28147078|NCT00899379|54814159|FG004|Overall Study|Abnormal Baseline ECG|0|||
28147079|NCT00899379|54814155|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
28147080|NCT00899379|54814156|FG001|Overall Study|No Longer Met Inc/Exc Criteria|1|||
28147081|NCT00899379|54814157|FG002|Overall Study|No Longer Met Inc/Exc Criteria|1|||
28147082|NCT00899379|54814158|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
28147083|NCT00899379|54814159|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
28147084|NCT00899379|54814155|FG000|Overall Study|Not Completed/Entered Extn|5|||
28147085|NCT00899379|54814156|FG001|Overall Study|Not Completed/Entered Extn|1|||
28147086|NCT00899379|54814157|FG002|Overall Study|Not Completed/Entered Extn|6|||
28147087|NCT00899379|54814158|FG003|Overall Study|Not Completed/Entered Extn|4|||
28147088|NCT00899379|54814159|FG004|Overall Study|Not Completed/Entered Extn|3|||
28147089|NCT00899379|54814155|FG000|Overall Study|Study Terminated|3|||
28147090|NCT00899379|54814156|FG001|Overall Study|Study Terminated|0|||
28147091|NCT00899379|54814157|FG002|Overall Study|Study Terminated|3|||
28147092|NCT00899379|54814158|FG003|Overall Study|Study Terminated|3|||
28147093|NCT00899379|54814159|FG004|Overall Study|Study Terminated|1|||
28147094|NCT00899379|54814155|FG000|Overall Study|Lost to Follow-up|3|||
28147095|NCT00899379|54814156|FG001|Overall Study|Lost to Follow-up|1|||
28147096|NCT00899379|54814157|FG002|Overall Study|Lost to Follow-up|0|||
28147097|NCT00899379|54814158|FG003|Overall Study|Lost to Follow-up|2|||
28147098|NCT00899379|54814159|FG004|Overall Study|Lost to Follow-up|5|||
28147099|NCT00899379|54814155|FG000|Overall Study|Withdrawal by Subject|4|||
28147100|NCT00899379|54814156|FG001|Overall Study|Withdrawal by Subject|7|||
28147101|NCT00899379|54814157|FG002|Overall Study|Withdrawal by Subject|4|||
28147102|NCT00899379|54814158|FG003|Overall Study|Withdrawal by Subject|7|||
28147103|NCT00899379|54814159|FG004|Overall Study|Withdrawal by Subject|2|||
28147104|NCT00899379|54814155|FG000|Overall Study|Pregnancy|1|||
28147105|NCT00899379|54814156|FG001|Overall Study|Pregnancy|0|||
28147106|NCT00899379|54814157|FG002|Overall Study|Pregnancy|0|||
28147107|NCT00899379|54814158|FG003|Overall Study|Pregnancy|0|||
28147108|NCT00899379|54814159|FG004|Overall Study|Pregnancy|0|||
28147109|NCT00899379|54814155|FG000|Overall Study|Patient Uncooperative|0|||
28147110|NCT00899379|54814156|FG001|Overall Study|Patient Uncooperative|0|||
28147111|NCT00899379|54814157|FG002|Overall Study|Patient Uncooperative|0|||
28147112|NCT00899379|54814158|FG003|Overall Study|Patient Uncooperative|1|||
28147113|NCT00899379|54814159|FG004|Overall Study|Patient Uncooperative|0|||
28147114|NCT00899379|54814155|FG000|Overall Study|Abnormal Prestudy Labs|0|||
28147115|NCT00899379|54814156|FG001|Overall Study|Abnormal Prestudy Labs|0|||
28147116|NCT00899379|54814157|FG002|Overall Study|Abnormal Prestudy Labs|0|||
28147117|NCT00899379|54814158|FG003|Overall Study|Abnormal Prestudy Labs|0|||
28147118|NCT00899379|54814159|FG004|Overall Study|Abnormal Prestudy Labs|2|||
28147119|NCT00899379|54814155|FG000|Overall Study|Abnormal Baseline ECG|0|||
28147120|NCT00899379|54814156|FG001|Overall Study|Abnormal Baseline ECG|0|||
28147121|NCT00899379|54814157|FG002|Overall Study|Abnormal Baseline ECG|1|||
28147122|NCT00899379|54814158|FG003|Overall Study|Abnormal Baseline ECG|1|||
28147123|NCT00899379|54814159|FG004|Overall Study|Abnormal Baseline ECG|0|||
28147124|NCT00899379|54814155|FG000|Overall Study|No Attack Pretreatment|3|||
28147125|NCT00899379|54814156|FG001|Overall Study|No Attack Pretreatment|5|||
28147126|NCT00899379|54814157|FG002|Overall Study|No Attack Pretreatment|5|||
28147127|NCT00899379|54814158|FG003|Overall Study|No Attack Pretreatment|6|||
28147128|NCT00899379|54814159|FG004|Overall Study|No Attack Pretreatment|4|||
28147129|NCT00899379|54814155|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
28147130|NCT00899379|54814156|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
28147131|NCT00899379|54814157|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
28147132|NCT00899379|54814158|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
28147133|NCT00899379|54814159|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
28147134|NCT00899379|54814155|FG000|Overall Study|Inc/Exc Criteria Not Met|0|||
28147135|NCT00899379|54814156|FG001|Overall Study|Inc/Exc Criteria Not Met|0|||
28147136|NCT00899379|54814157|FG002|Overall Study|Inc/Exc Criteria Not Met|1|||
28147137|NCT00899379|54814158|FG003|Overall Study|Inc/Exc Criteria Not Met|0|||
28147138|NCT00899379|54814159|FG004|Overall Study|Inc/Exc Criteria Not Met|0|||
28147139|NCT04326439|54814167|FG000|Overall Study|Withdrawal by Subject|1|||
28147140|NCT04326439|54814168|FG001|Overall Study|Withdrawal by Subject|0|||
28147141|NCT04326439|54814167|FG000|Overall Study|Proceeded to HSCT after Induction 2|0|||
28147142|NCT04326439|54814168|FG001|Overall Study|Proceeded to HSCT after Induction 2|2|||
28147143|NCT04326439|54814167|FG000|Overall Study|Relapse after Induction 2|0|||
28147144|NCT04326439|54814168|FG001|Overall Study|Relapse after Induction 2|1|||
28147145|NCT04326439|54814167|FG000|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|1|||
28147146|NCT04326439|54814168|FG001|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|0|||
28147147|NCT00145795|54814182|FG000|Overall Study|Adverse Event|1|||
28147148|NCT00145795|54814183|FG001|Overall Study|Adverse Event|0|||
28147149|NCT02771210|54814191|FG000|Period 1|Adverse Event|5|||
28147150|NCT02771210|54814192|FG001|Period 1|Adverse Event|3|||
28147151|NCT02771210|54814191|FG000|Period 1|Lack of Efficacy|3|||
28147152|NCT02771210|54814192|FG001|Period 1|Lack of Efficacy|6|||
28147153|NCT02771210|54814191|FG000|Period 1|Lost to Follow-up|2|||
28147154|NCT02771210|54814192|FG001|Period 1|Lost to Follow-up|0|||
28147155|NCT02771210|54814191|FG000|Period 1|Physician Decision|0|||
28147156|NCT02771210|54814192|FG001|Period 1|Physician Decision|1|||
28147157|NCT02771210|54814191|FG000|Period 1|Withdrawal by Subject|0|||
28147158|NCT02771210|54814192|FG001|Period 1|Withdrawal by Subject|3|||
28147159|NCT02771210|54814191|FG000|Period 1|Withdrawal of informed consent|1|||
28147160|NCT02771210|54814192|FG001|Period 1|Withdrawal of informed consent|5|||
28147161|NCT02771210|54814191|FG000|Period 2|Adverse Event|1|||
28147162|NCT02771210|54814192|FG001|Period 2|Adverse Event|0|||
28147163|NCT02771210|54814191|FG000|Period 2|Lack of Efficacy|0|||
28147164|NCT02771210|54814192|FG001|Period 2|Lack of Efficacy|1|||
28147165|NCT02771210|54814191|FG000|Period 2|Withdrawal by Subject|1|||
28147166|NCT02771210|54814192|FG001|Period 2|Withdrawal by Subject|0|||
28147167|NCT02771210|54814191|FG000|Period 2|Withdrawal of informed consent|0|||
28147168|NCT02771210|54814192|FG001|Period 2|Withdrawal of informed consent|2|||
28147169|NCT00898677|54814202|FG000|Overall Study|Adverse Event|0|||
28147170|NCT00898677|54814203|FG001|Overall Study|Adverse Event|0|||
28147171|NCT00898677|54814204|FG002|Overall Study|Adverse Event|1|||
28147172|NCT00898677|54814205|FG003|Overall Study|Adverse Event|0|||
28147173|NCT00898677|54814202|FG000|Overall Study|Lost to Follow-up|0|||
28147174|NCT00898677|54814203|FG001|Overall Study|Lost to Follow-up|0|||
28147175|NCT00898677|54814204|FG002|Overall Study|Lost to Follow-up|2|||
28147176|NCT00898677|54814205|FG003|Overall Study|Lost to Follow-up|0|||
28147177|NCT00898677|54814202|FG000|Overall Study|Protocol Violation|1|||
28147178|NCT00898677|54814203|FG001|Overall Study|Protocol Violation|1|||
28147179|NCT00898677|54814204|FG002|Overall Study|Protocol Violation|2|||
28147180|NCT00898677|54814205|FG003|Overall Study|Protocol Violation|0|||
28147181|NCT00898677|54814202|FG000|Overall Study|Withdrawal by Subject|0|||
28147182|NCT00898677|54814203|FG001|Overall Study|Withdrawal by Subject|0|||
28147183|NCT00898677|54814204|FG002|Overall Study|Withdrawal by Subject|0|||
28147184|NCT00898677|54814205|FG003|Overall Study|Withdrawal by Subject|1|||
28147185|NCT00898677|54814202|FG000|Overall Study|Not Treated: Adverse Event|0|||
28147186|NCT00898677|54814203|FG001|Overall Study|Not Treated: Adverse Event|2|||
28147187|NCT00898677|54814204|FG002|Overall Study|Not Treated: Adverse Event|1|||
28147188|NCT00898677|54814205|FG003|Overall Study|Not Treated: Adverse Event|0|||
28147189|NCT00898677|54814202|FG000|Overall Study|Not Treated: Lost to Follow-Up|0|||
28147190|NCT00898677|54814203|FG001|Overall Study|Not Treated: Lost to Follow-Up|5|||
28147191|NCT00898677|54814204|FG002|Overall Study|Not Treated: Lost to Follow-Up|5|||
28147192|NCT00898677|54814205|FG003|Overall Study|Not Treated: Lost to Follow-Up|2|||
28147193|NCT00898677|54814202|FG000|Overall Study|Not Treated: Pregnancy|0|||
28147194|NCT00898677|54814203|FG001|Overall Study|Not Treated: Pregnancy|0|||
28147195|NCT00898677|54814204|FG002|Overall Study|Not Treated: Pregnancy|1|||
28147196|NCT00898677|54814205|FG003|Overall Study|Not Treated: Pregnancy|0|||
28147197|NCT00898677|54814202|FG000|Overall Study|Not Treated: Protocol Violation|2|||
28147198|NCT00898677|54814203|FG001|Overall Study|Not Treated: Protocol Violation|0|||
28147199|NCT00898677|54814204|FG002|Overall Study|Not Treated: Protocol Violation|2|||
28147200|NCT00898677|54814205|FG003|Overall Study|Not Treated: Protocol Violation|0|||
28147201|NCT00898677|54814202|FG000|Overall Study|Not Treated: Withdraw by Subject|2|||
28147202|NCT00898677|54814203|FG001|Overall Study|Not Treated: Withdraw by Subject|16|||
28147203|NCT00898677|54814204|FG002|Overall Study|Not Treated: Withdraw by Subject|11|||
28147204|NCT00898677|54814205|FG003|Overall Study|Not Treated: Withdraw by Subject|3|||
27822703|NCT01839487|54286699|FG001|Run-in Phase (Maximum Exposure:295 Days)|Death|6|||
27822704|NCT01839487|54286700|FG002|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
27822705|NCT01839487|54286701|FG003|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
27822706|NCT01839487|54286702|FG004|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
28072290|NCT00121641|54726946|FG004|48-month Short Term + Long Term Period|Lack of Efficacy|25|||
27822707|NCT01839487|54286703|FG005|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
27822708|NCT01839487|54286698|FG000|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
27822709|NCT01839487|54286699|FG001|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1|||
27822710|NCT01839487|54286700|FG002|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
27822711|NCT01839487|54286701|FG003|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
27822712|NCT01839487|54286702|FG004|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
27822713|NCT01839487|54286703|FG005|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
27822714|NCT01839487|54286698|FG000|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1|||
27822715|NCT01839487|54286699|FG001|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
27822716|NCT01839487|54286700|FG002|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
28072291|NCT00121641|54726942|FG000|48-month Short Term + Long Term Period|Subject Withdrew Consent|25|||
28072292|NCT00121641|54726943|FG001|48-month Short Term + Long Term Period|Subject Withdrew Consent|28|||
28072293|NCT00121641|54726944|FG002|48-month Short Term + Long Term Period|Subject Withdrew Consent|17|||
28072294|NCT00121641|54726945|FG003|48-month Short Term + Long Term Period|Subject Withdrew Consent|24|||
28072295|NCT00121641|54726946|FG004|48-month Short Term + Long Term Period|Subject Withdrew Consent|10|||
28072296|NCT00121641|54726942|FG000|48-month Short Term + Long Term Period|Adverse Event|9|||
28072297|NCT00121641|54726943|FG001|48-month Short Term + Long Term Period|Adverse Event|10|||
28072298|NCT00121641|54726944|FG002|48-month Short Term + Long Term Period|Adverse Event|10|||
28147205|NCT00898677|54814202|FG000|Overall Study|Not Treated: Patient uncooperative|2|||
28147206|NCT00898677|54814203|FG001|Overall Study|Not Treated: Patient uncooperative|3|||
28147207|NCT00898677|54814204|FG002|Overall Study|Not Treated: Patient uncooperative|1|||
28147208|NCT00898677|54814205|FG003|Overall Study|Not Treated: Patient uncooperative|0|||
28147209|NCT00898677|54814202|FG000|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
28147210|NCT00898677|54814203|FG001|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
28147211|NCT00898677|54814204|FG002|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
28147212|NCT00898677|54814205|FG003|Overall Study|Not Treated: Abnormal Prestudy Labs|1|||
28147213|NCT00898677|54814202|FG000|Overall Study|Not Treated: Abnormal Baseline ECG|1|||
28147214|NCT00898677|54814203|FG001|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
28147215|NCT00898677|54814204|FG002|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
28147216|NCT00898677|54814205|FG003|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
28147217|NCT00898677|54814202|FG000|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
28147218|NCT00898677|54814203|FG001|Overall Study|Not Treated: No Longer Met Inc Criteria|3|||
28147219|NCT00898677|54814204|FG002|Overall Study|Not Treated: No Longer Met Inc Criteria|1|||
28147220|NCT00898677|54814205|FG003|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
28147221|NCT00898677|54814202|FG000|Overall Study|Not Treated: Lack of Migraine Attack|9|||
28147222|NCT00898677|54814203|FG001|Overall Study|Not Treated: Lack of Migraine Attack|39|||
28147223|NCT00898677|54814204|FG002|Overall Study|Not Treated: Lack of Migraine Attack|43|||
28147224|NCT00898677|54814205|FG003|Overall Study|Not Treated: Lack of Migraine Attack|12|||
28147225|NCT00898677|54814202|FG000|Overall Study|Not Treated: Other (Not Specified)|0|||
28147226|NCT00898677|54814203|FG001|Overall Study|Not Treated: Other (Not Specified)|0|||
28147227|NCT00898677|54814204|FG002|Overall Study|Not Treated: Other (Not Specified)|2|||
28147228|NCT00898677|54814205|FG003|Overall Study|Not Treated: Other (Not Specified)|0|||
28147229|NCT02770820|54814215|FG000|Overall Study|Death|1|||
28147230|NCT02770820|54814215|FG000|Overall Study|Physician Decision|2|||
28147231|NCT03082729|54814219|FG000|Overall Study|Lost to Follow-up|7|||
28147232|NCT03082729|54814219|FG000|Overall Study|Physician Decision|2|||
28147233|NCT03082729|54814219|FG000|Overall Study|Withdrawal by Subject|1|||
28147234|NCT03082729|54814219|FG000|Overall Study|Lack of Efficacy|9|||
28147235|NCT03082729|54814219|FG000|Overall Study|Adverse Event|4|||
28147236|NCT03082729|54814219|FG000|Overall Study|Protocol Violation|6|||
28147237|NCT03082729|54814219|FG000|Overall Study|Fear of study procedure|1|||
28147238|NCT03082729|54814219|FG000|Overall Study|Scheduling conflict|1|||
28147239|NCT02764190|54814231|FG000|Overall Study|Lost to Follow-up|17|||
28147240|NCT02764190|54814232|FG001|Overall Study|Lost to Follow-up|13|||
28147241|NCT03077659|54814241|FG000|Overall Study|Withdrawal by Subject|0|||
28147242|NCT03077659|54814242|FG001|Overall Study|Withdrawal by Subject|0|||
28147243|NCT03077659|54814243|FG002|Overall Study|Withdrawal by Subject|1|||
28147244|NCT02807883|54814254|FG000|Overall Study|Withdrawal by Subject|2|||
28147245|NCT03082261|54814258|FG000|Overall Study|Death|4|||
28147246|NCT03082261|54814258|FG000|Overall Study|Implant of dorsal root ganglion stimulation (DRG) device|1|||
28147247|NCT03082261|54814258|FG000|Overall Study|Insurance denial|1|||
28147248|NCT03082261|54814258|FG000|Overall Study|Peripheral lead added|1|||
28147249|NCT03082261|54814258|FG000|Overall Study|Withdrawal by Subject|40|||
28147250|NCT03082261|54814258|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|2|||
28147251|NCT03082261|54814258|FG000|Overall Study|Subject implanted with device other than study device|1|||
28147252|NCT03082261|54814258|FG000|Overall Study|Lost to Follow-up|14|||
28147253|NCT03082261|54814258|FG000|Overall Study|Subject moved to a different state|1|||
28147254|NCT03082261|54814258|FG000|Overall Study|Subject non-compliance|2|||
28147255|NCT03082261|54814258|FG000|Overall Study|Subject participation terminated by investigator|9|||
28147256|NCT03082261|54814258|FG000|Overall Study|Subject participation terminated by sponsor|4|||
28147257|NCT03082261|54814258|FG000|Overall Study|System explant|19|||
28147258|NCT03082261|54814258|FG000|Overall Study|Unable to place lead(s)|2|||
28147259|NCT03082261|54814258|FG000|Overall Study|Unsuccessful trial evaluation period|19|||
28147260|NCT00102440|54814265|FG000|Overall Study|Lost to Follow-up|25|||
28147261|NCT00102440|54814266|FG001|Overall Study|Lost to Follow-up|18|||
28147262|NCT00102440|54814267|FG002|Overall Study|Lost to Follow-up|21|||
28147263|NCT00102440|54814265|FG000|Overall Study|Adverse Event|16|||
28147264|NCT00102440|54814266|FG001|Overall Study|Adverse Event|23|||
28147265|NCT00102440|54814267|FG002|Overall Study|Adverse Event|8|||
28147266|NCT00102440|54814265|FG000|Overall Study|Gout Flare|10|||
28147267|NCT00102440|54814266|FG001|Overall Study|Gout Flare|28|||
28147268|NCT00102440|54814267|FG002|Overall Study|Gout Flare|9|||
28147269|NCT00102440|54814265|FG000|Overall Study|Personal Reason(s)|19|||
28147270|NCT00102440|54814266|FG001|Overall Study|Personal Reason(s)|13|||
28147271|NCT00102440|54814267|FG002|Overall Study|Personal Reason(s)|13|||
28147272|NCT00102440|54814265|FG000|Overall Study|Other|11|||
28147273|NCT00102440|54814266|FG001|Overall Study|Other|14|||
28147274|NCT00102440|54814267|FG002|Overall Study|Other|14|||
28147275|NCT00102440|54814265|FG000|Overall Study|Protocol Violation|7|||
28147276|NCT00102440|54814266|FG001|Overall Study|Protocol Violation|2|||
28147277|NCT00102440|54814267|FG002|Overall Study|Protocol Violation|1|||
28147278|NCT02762084|54814291|FG000|Overall Study|Withdrawal by Subject|1|||
28147279|NCT02762084|54814292|FG001|Overall Study|Withdrawal by Subject|0|||
28147280|NCT02762084|54814293|FG002|Overall Study|Withdrawal by Subject|0|||
28147281|NCT02762084|54814291|FG000|Overall Study|Adverse Event|0|||
28147282|NCT02762084|54814292|FG001|Overall Study|Adverse Event|0|||
28147283|NCT02762084|54814293|FG002|Overall Study|Adverse Event|1|||
28147284|NCT02763644|54814305|FG000|Overall Study|Patient/guardian decision|1|||
28147285|NCT02763644|54814306|FG001|Overall Study|Patient/guardian decision|0|||
28147286|NCT02763644|54814305|FG000|Overall Study|Death|1|||
28147287|NCT02763644|54814306|FG001|Overall Study|Death|1|||
28147288|NCT02763644|54814305|FG000|Overall Study|Adverse Event|1|||
28147289|NCT02763644|54814306|FG001|Overall Study|Adverse Event|1|||
28147290|NCT02807844|54814324|FG000|Overall Study|Physician Decision|0|||
28147291|NCT02807844|54814325|FG001|Overall Study|Physician Decision|0|||
28147292|NCT02807844|54814326|FG002|Overall Study|Physician Decision|0|||
28147293|NCT02807844|54814327|FG003|Overall Study|Physician Decision|0|||
28147294|NCT02807844|54814328|FG004|Overall Study|Physician Decision|0|||
28147295|NCT02807844|54814329|FG005|Overall Study|Physician Decision|0|||
28147296|NCT02807844|54814330|FG006|Overall Study|Physician Decision|3|||
28147297|NCT02807844|54814331|FG007|Overall Study|Physician Decision|0|||
28147298|NCT02807844|54814332|FG008|Overall Study|Physician Decision|1|||
28147299|NCT02807844|54814333|FG009|Overall Study|Physician Decision|2|||
28147300|NCT02807844|54814324|FG000|Overall Study|Death|0|||
28147301|NCT02807844|54814325|FG001|Overall Study|Death|0|||
28147302|NCT02807844|54814326|FG002|Overall Study|Death|2|||
28147303|NCT02807844|54814327|FG003|Overall Study|Death|4|||
28147304|NCT02807844|54814328|FG004|Overall Study|Death|1|||
28147305|NCT02807844|54814329|FG005|Overall Study|Death|2|||
28147306|NCT02807844|54814330|FG006|Overall Study|Death|1|||
28147307|NCT02807844|54814331|FG007|Overall Study|Death|2|||
28147308|NCT02807844|54814332|FG008|Overall Study|Death|0|||
28147309|NCT02807844|54814333|FG009|Overall Study|Death|1|||
28147310|NCT02807844|54814324|FG000|Overall Study|Withdrawal by Subject|0|||
28147311|NCT02807844|54814325|FG001|Overall Study|Withdrawal by Subject|0|||
28147312|NCT02807844|54814326|FG002|Overall Study|Withdrawal by Subject|2|||
28147313|NCT02807844|54814327|FG003|Overall Study|Withdrawal by Subject|1|||
28147314|NCT02807844|54814328|FG004|Overall Study|Withdrawal by Subject|1|||
28147315|NCT02807844|54814329|FG005|Overall Study|Withdrawal by Subject|0|||
28147316|NCT02807844|54814330|FG006|Overall Study|Withdrawal by Subject|1|||
28147317|NCT02807844|54814331|FG007|Overall Study|Withdrawal by Subject|0|||
28147318|NCT02807844|54814332|FG008|Overall Study|Withdrawal by Subject|0|||
28147319|NCT02807844|54814333|FG009|Overall Study|Withdrawal by Subject|0|||
28147320|NCT02807844|54814324|FG000|Overall Study|Progressive disease|5|||
28147321|NCT02807844|54814325|FG001|Overall Study|Progressive disease|12|||
28147322|NCT02807844|54814326|FG002|Overall Study|Progressive disease|8|||
28147323|NCT02807844|54814327|FG003|Overall Study|Progressive disease|8|||
28147324|NCT02807844|54814328|FG004|Overall Study|Progressive disease|3|||
28147325|NCT02807844|54814329|FG005|Overall Study|Progressive disease|8|||
28147326|NCT02807844|54814330|FG006|Overall Study|Progressive disease|14|||
28147327|NCT02807844|54814331|FG007|Overall Study|Progressive disease|17|||
28147328|NCT02807844|54814332|FG008|Overall Study|Progressive disease|19|||
28147329|NCT02807844|54814333|FG009|Overall Study|Progressive disease|15|||
28147330|NCT02807844|54814324|FG000|Overall Study|Adverse Event|1|||
28147331|NCT02807844|54814325|FG001|Overall Study|Adverse Event|0|||
28147332|NCT02807844|54814326|FG002|Overall Study|Adverse Event|0|||
28147333|NCT02807844|54814327|FG003|Overall Study|Adverse Event|0|||
28147334|NCT02807844|54814328|FG004|Overall Study|Adverse Event|1|||
28147335|NCT02807844|54814329|FG005|Overall Study|Adverse Event|1|||
28147336|NCT02807844|54814330|FG006|Overall Study|Adverse Event|1|||
28147337|NCT02807844|54814331|FG007|Overall Study|Adverse Event|1|||
28147338|NCT02807844|54814332|FG008|Overall Study|Adverse Event|1|||
28147339|NCT02807844|54814333|FG009|Overall Study|Adverse Event|2|||
28147340|NCT02763566|54814363|FG000|Overall Study|Lost to Follow-up|1|||
28147341|NCT02763566|54814364|FG001|Overall Study|Lost to Follow-up|4|||
28147342|NCT02763566|54814365|FG002|Overall Study|Lost to Follow-up|0|||
28147343|NCT02763566|54814366|FG003|Overall Study|Lost to Follow-up|1|||
28147344|NCT02763566|54814363|FG000|Overall Study|On study treatment at study conclusion|114|||
28147345|NCT02763566|54814364|FG001|Overall Study|On study treatment at study conclusion|34|||
28147346|NCT02763566|54814365|FG002|Overall Study|On study treatment at study conclusion|54|||
27822717|NCT01839487|54286701|FG003|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
28147347|NCT02763566|54814366|FG003|Overall Study|On study treatment at study conclusion|13|||
28147348|NCT02763566|54814363|FG000|Overall Study|Withdrawal by Subject|3|||
28147349|NCT02763566|54814364|FG001|Overall Study|Withdrawal by Subject|1|||
28147350|NCT02763566|54814365|FG002|Overall Study|Withdrawal by Subject|0|||
28147351|NCT02763566|54814366|FG003|Overall Study|Withdrawal by Subject|0|||
28147352|NCT02763254|54814380|FG000|Overall Study|Adverse Event|1|||
28147353|NCT02805972|54814386|FG000|Washout Period|Lost to Follow-up|3|||
28147354|NCT02805972|54814387|FG001|Washout Period|Lost to Follow-up|0|||
28147355|NCT03032523|54814405|FG000|Overall Study|Withdrawal by Subject|2|||
28147356|NCT03032523|54814406|FG001|Overall Study|Withdrawal by Subject|2|||
28147357|NCT03032523|54814405|FG000|Overall Study|Physician Decision|1|||
28147358|NCT03032523|54814406|FG001|Overall Study|Physician Decision|0|||
28147359|NCT03031899|54814413|FG000|Overall Study|Protocol Violation|1|||
28147360|NCT03031899|54814413|FG000|Overall Study|lesion disappeared after stopping habit|1|||
28147361|NCT03086369|54814426|FG000|Overall Study|Lost to Follow-up|1|||
28147362|NCT03086369|54814427|FG001|Overall Study|Lost to Follow-up|0|||
28147363|NCT03086369|54814428|FG002|Overall Study|Lost to Follow-up|0|||
28147364|NCT03086369|54814429|FG003|Overall Study|Lost to Follow-up|2|||
28147365|NCT03086369|54814430|FG004|Overall Study|Lost to Follow-up|1|||
28147366|NCT03086369|54814426|FG000|Overall Study|Physician Decision|0|||
28147367|NCT03086369|54814427|FG001|Overall Study|Physician Decision|0|||
28147368|NCT03086369|54814428|FG002|Overall Study|Physician Decision|0|||
28147369|NCT03086369|54814429|FG003|Overall Study|Physician Decision|1|||
28147370|NCT03086369|54814430|FG004|Overall Study|Physician Decision|2|||
28147371|NCT03086369|54814426|FG000|Overall Study|Withdrawal by Subject|0|||
27822718|NCT01839487|54286702|FG004|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
27822719|NCT01839487|54286703|FG005|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
27822720|NCT01839487|54286698|FG000|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
27822721|NCT01839487|54286699|FG001|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
27822722|NCT01839487|54286700|FG002|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12|||
27822723|NCT01839487|54286701|FG003|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9|||
27822724|NCT01839487|54286702|FG004|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4|||
27822725|NCT01839487|54286703|FG005|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8|||
27822726|NCT01839487|54286698|FG000|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
27822727|NCT01839487|54286699|FG001|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
28147372|NCT03086369|54814427|FG001|Overall Study|Withdrawal by Subject|0|||
28147373|NCT03086369|54814428|FG002|Overall Study|Withdrawal by Subject|0|||
28147374|NCT03086369|54814429|FG003|Overall Study|Withdrawal by Subject|5|||
28147375|NCT03086369|54814430|FG004|Overall Study|Withdrawal by Subject|3|||
28147376|NCT03086369|54814426|FG000|Overall Study|Progressive Disease|0|||
28147377|NCT03086369|54814427|FG001|Overall Study|Progressive Disease|0|||
28147378|NCT03086369|54814428|FG002|Overall Study|Progressive Disease|0|||
28147379|NCT03086369|54814429|FG003|Overall Study|Progressive Disease|1|||
28147380|NCT03086369|54814430|FG004|Overall Study|Progressive Disease|1|||
28147381|NCT00101582|54814446|FG000|Overall Study|Ineligibility determined|0|||
28147382|NCT00101582|54814447|FG001|Overall Study|Ineligibility determined|1|||
28147383|NCT00101582|54814446|FG000|Overall Study|Adverse Event|1|||
28147384|NCT00101582|54814447|FG001|Overall Study|Adverse Event|4|||
28147385|NCT00101582|54814446|FG000|Overall Study|Withdrawal by Subject|6|||
28147386|NCT00101582|54814447|FG001|Overall Study|Withdrawal by Subject|4|||
28147387|NCT00101582|54814446|FG000|Overall Study|Physician Decision|1|||
28147388|NCT00101582|54814447|FG001|Overall Study|Physician Decision|0|||
28147389|NCT00101582|54814446|FG000|Overall Study|Death|3|||
28147390|NCT00101582|54814447|FG001|Overall Study|Death|5|||
28147391|NCT00101582|54814446|FG000|Overall Study|Other|0|||
28147392|NCT00101582|54814447|FG001|Overall Study|Other|1|||
28147393|NCT03086135|54814478|FG000|Overall Study|Adverse Event|1|||
28147394|NCT03086135|54814478|FG000|Overall Study|Lost to Follow-up|2|||
28147395|NCT02762708|54814495|FG000|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
28147396|NCT02762708|54814496|FG001|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|2|||
28147397|NCT02762708|54814497|FG002|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
28147398|NCT02762708|54814498|FG003|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
28147399|NCT02760602|54814510|FG000|Overall Study|Withdrawal by Subject|1|||
28147400|NCT02760602|54814511|FG001|Overall Study|Withdrawal by Subject|0|||
28147401|NCT02760602|54814510|FG000|Overall Study|Terminated by sponsor|12|||
28147402|NCT02760602|54814511|FG001|Overall Study|Terminated by sponsor|13|||
28147403|NCT03852719|54814520|FG000|Overall Study|Still on study|50|||
28147404|NCT03852719|54814521|FG001|Overall Study|Still on study|48|||
28147405|NCT03852719|54814522|FG002|Overall Study|Still on study|47|||
28147406|NCT03852719|54814520|FG000|Overall Study|Withdrawal of consent|0|||
28147407|NCT03852719|54814521|FG001|Overall Study|Withdrawal of consent|1|||
28147408|NCT03852719|54814522|FG002|Overall Study|Withdrawal of consent|2|||
28147409|NCT03852719|54814520|FG000|Overall Study|Physician Decision|0|||
28147410|NCT03852719|54814521|FG001|Overall Study|Physician Decision|0|||
28147411|NCT03852719|54814522|FG002|Overall Study|Physician Decision|1|||
28147412|NCT03852719|54814520|FG000|Overall Study|Pregnancy|1|||
28147413|NCT03852719|54814521|FG001|Overall Study|Pregnancy|0|||
28147414|NCT03852719|54814522|FG002|Overall Study|Pregnancy|0|||
28147415|NCT00210249|54814530|FG000|Overall Study|Lost to Follow-up|5|||
28147416|NCT00210249|54814530|FG000|Overall Study|Protocol Violation|11|||
28147417|NCT03086057|54814538|FG000|Stage 1: PrEP Uptake|Incarcerated|3|||
28147418|NCT03086057|54814539|FG001|Stage 1: PrEP Uptake|Incarcerated|1|||
28147419|NCT03086057|54814540|FG002|Stage 1: PrEP Uptake|Incarcerated|0|||
28147420|NCT03086057|54814541|FG003|Stage 1: PrEP Uptake|Incarcerated|0|||
28147421|NCT03086057|54814538|FG000|Stage 1: PrEP Uptake|Withdrawal by Subject|1|||
27850079|NCT01647828|54348369|FG004|Overall Study|Study terminated by Sponsor|0|||
27941429|NCT00940342|54597867|FG002|Overall Study|Adverse Event|1|||
27941430|NCT00936910|54597875|FG000|Overall Study|Lack of Efficacy|3|||
27941431|NCT00940108|54597884|FG000|Overall Study|Adverse Event|2|||
27941432|NCT00940108|54597885|FG001|Overall Study|Adverse Event|4|||
27941433|NCT00940108|54597886|FG002|Overall Study|Adverse Event|0|||
27941434|NCT00940108|54597887|FG003|Overall Study|Adverse Event|2|||
28147422|NCT03086057|54814539|FG001|Stage 1: PrEP Uptake|Withdrawal by Subject|4|||
28147423|NCT03086057|54814540|FG002|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
28147424|NCT03086057|54814541|FG003|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
28147425|NCT03086057|54814538|FG000|Stage 1: PrEP Uptake|Lost to Follow-up|6|||
28147426|NCT03086057|54814539|FG001|Stage 1: PrEP Uptake|Lost to Follow-up|5|||
28147427|NCT03086057|54814540|FG002|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
28147428|NCT03086057|54814541|FG003|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
28147429|NCT03086057|54814538|FG000|Stage 1: PrEP Uptake|Death|1|||
28147430|NCT03086057|54814539|FG001|Stage 1: PrEP Uptake|Death|0|||
28147431|NCT03086057|54814540|FG002|Stage 1: PrEP Uptake|Death|0|||
28147432|NCT03086057|54814541|FG003|Stage 1: PrEP Uptake|Death|0|||
28147433|NCT03086057|54814538|FG000|Stage 2: PrEP Adherence|Incarcerated|0|||
28147434|NCT03086057|54814539|FG001|Stage 2: PrEP Adherence|Incarcerated|0|||
28147435|NCT03086057|54814540|FG002|Stage 2: PrEP Adherence|Incarcerated|2|||
28147436|NCT03086057|54814541|FG003|Stage 2: PrEP Adherence|Incarcerated|0|||
28147437|NCT03086057|54814538|FG000|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
28147438|NCT03086057|54814539|FG001|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
28147439|NCT03086057|54814540|FG002|Stage 2: PrEP Adherence|Withdrawal by Subject|1|||
28147440|NCT03086057|54814541|FG003|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
28147441|NCT03086057|54814538|FG000|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
28147442|NCT03086057|54814539|FG001|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
28147443|NCT03086057|54814540|FG002|Stage 2: PrEP Adherence|Lost to Follow-up|3|||
28147444|NCT03086057|54814541|FG003|Stage 2: PrEP Adherence|Lost to Follow-up|2|||
28147445|NCT02759120|54814553|FG000|Overall Study|Death|34|||
28147446|NCT02759120|54814554|FG001|Overall Study|Death|36|||
28147447|NCT02759120|54814553|FG000|Overall Study|Lost to Follow-up|4|||
28147448|NCT02759120|54814554|FG001|Overall Study|Lost to Follow-up|7|||
28147449|NCT02759120|54814553|FG000|Overall Study|Physician Decision|3|||
28147450|NCT02759120|54814554|FG001|Overall Study|Physician Decision|0|||
27850080|NCT01647828|54348370|FG005|Overall Study|Study terminated by Sponsor|0|||
27850081|NCT01647828|54348371|FG006|Overall Study|Study terminated by Sponsor|1|||
27850082|NCT01647828|54348372|FG007|Overall Study|Study terminated by Sponsor|26|||
27850083|NCT01647828|54348373|FG008|Overall Study|Study terminated by Sponsor|16|||
27850084|NCT01647828|54348365|FG000|Overall Study|Lost to Follow-up|0|||
27850085|NCT01647828|54348366|FG001|Overall Study|Lost to Follow-up|0|||
27850086|NCT01647828|54348367|FG002|Overall Study|Lost to Follow-up|0|||
27850087|NCT01647828|54348368|FG003|Overall Study|Lost to Follow-up|0|||
27850088|NCT01647828|54348369|FG004|Overall Study|Lost to Follow-up|0|||
27941435|NCT00940108|54597884|FG000|Overall Study|Withdrew Consent|2|||
28147451|NCT02759120|54814553|FG000|Overall Study|Withdrawal by Subject|28|||
28147452|NCT02759120|54814554|FG001|Overall Study|Withdrawal by Subject|15|||
27850089|NCT01647828|54348370|FG005|Overall Study|Lost to Follow-up|0|||
27850090|NCT01647828|54348371|FG006|Overall Study|Lost to Follow-up|0|||
28147453|NCT02759120|54814553|FG000|Overall Study|Moved out of area|3|||
28147454|NCT02759120|54814554|FG001|Overall Study|Moved out of area|4|||
28147455|NCT02759120|54814553|FG000|Overall Study|Lung transplant|3|||
28147456|NCT02759120|54814554|FG001|Overall Study|Lung transplant|5|||
28147457|NCT02759120|54814553|FG000|Overall Study|Other reason not completed|10|||
27850091|NCT01647828|54348372|FG007|Overall Study|Lost to Follow-up|2|||
28147458|NCT02759120|54814554|FG001|Overall Study|Other reason not completed|12|||
28147459|NCT00101192|54814560|FG000|Overall Study|Ineligible|6|||
28147460|NCT00101192|54814560|FG000|Overall Study|Inevaluable|1|||
28147461|NCT03031431|54814564|FG000|Overall Study|Infant removed by maternal request|1|||
28147462|NCT03029247|54814570|FG000|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|3|||
28147463|NCT03029247|54814571|FG001|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|0|||
28147464|NCT03029247|54814570|FG000|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
28147465|NCT03029247|54814571|FG001|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
28147466|NCT03029247|54814570|FG000|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|7|||
28147467|NCT03029247|54814571|FG001|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|4|||
28147468|NCT03029247|54814570|FG000|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
28147469|NCT03029247|54814571|FG001|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
27850092|NCT01647828|54348373|FG008|Overall Study|Lost to Follow-up|0|||
27941436|NCT00940108|54597885|FG001|Overall Study|Withdrew Consent|1|||
27941437|NCT00940108|54597886|FG002|Overall Study|Withdrew Consent|0|||
27941438|NCT00940108|54597887|FG003|Overall Study|Withdrew Consent|1|||
27941439|NCT00940108|54597884|FG000|Overall Study|Dose 2 contraindicated|1|||
27941440|NCT00940108|54597885|FG001|Overall Study|Dose 2 contraindicated|1|||
27941441|NCT00940108|54597886|FG002|Overall Study|Dose 2 contraindicated|0|||
27941442|NCT00940108|54597887|FG003|Overall Study|Dose 2 contraindicated|1|||
27941443|NCT00940108|54597884|FG000|Overall Study|Declined further vaccination|0|||
27941444|NCT00940108|54597885|FG001|Overall Study|Declined further vaccination|1|||
27941445|NCT00940108|54597886|FG002|Overall Study|Declined further vaccination|3|||
27941446|NCT00940108|54597887|FG003|Overall Study|Declined further vaccination|0|||
27941447|NCT00940108|54597884|FG000|Overall Study|Refused - pyrexia after Dose 1|0|||
27941448|NCT00940108|54597885|FG001|Overall Study|Refused - pyrexia after Dose 1|1|||
27941449|NCT00940108|54597886|FG002|Overall Study|Refused - pyrexia after Dose 1|0|||
27941450|NCT00940108|54597887|FG003|Overall Study|Refused - pyrexia after Dose 1|0|||
27941451|NCT00940108|54597884|FG000|Overall Study|Viral illness after Dose 1|0|||
27941452|NCT00940108|54597885|FG001|Overall Study|Viral illness after Dose 1|1|||
27941453|NCT00940108|54597886|FG002|Overall Study|Viral illness after Dose 1|0|||
27941454|NCT00940108|54597887|FG003|Overall Study|Viral illness after Dose 1|0|||
27941455|NCT00940108|54597884|FG000|Overall Study|Diagnosed with H1N1|0|||
27941456|NCT00940108|54597885|FG001|Overall Study|Diagnosed with H1N1|0|||
27941457|NCT00940108|54597886|FG002|Overall Study|Diagnosed with H1N1|0|||
27941458|NCT00940108|54597887|FG003|Overall Study|Diagnosed with H1N1|1|||
27941459|NCT00936598|54597899|FG000|Overall Study|Withdrawal by Subject|1|||
27941460|NCT00936598|54597900|FG001|Overall Study|Withdrawal by Subject|0|||
27941461|NCT00936598|54597899|FG000|Overall Study|Ineligible after consent|1|||
27941462|NCT00936598|54597900|FG001|Overall Study|Ineligible after consent|0|||
27941463|NCT01025817|54597908|FG000|Completed Study Medication|Adverse Event|66|||
27941464|NCT01025817|54597909|FG001|Completed Study Medication|Adverse Event|39|||
27941465|NCT01025817|54597908|FG000|Completed Study Medication|Protocol Deviation|9|||
27941466|NCT01025817|54597909|FG001|Completed Study Medication|Protocol Deviation|8|||
27941467|NCT01025817|54597908|FG000|Completed Study Medication|Withdrawal by Subject|8|||
27941468|NCT01025817|54597909|FG001|Completed Study Medication|Withdrawal by Subject|9|||
27941469|NCT01025817|54597908|FG000|Completed Study Medication|Administrative problems|7|||
27941470|NCT01025817|54597909|FG001|Completed Study Medication|Administrative problems|5|||
28072299|NCT00121641|54726945|FG003|48-month Short Term + Long Term Period|Adverse Event|5|||
28072300|NCT00121641|54726946|FG004|48-month Short Term + Long Term Period|Adverse Event|5|||
28072301|NCT00121641|54726942|FG000|48-month Short Term + Long Term Period|Lost to Follow-up|9|||
28072302|NCT00121641|54726943|FG001|48-month Short Term + Long Term Period|Lost to Follow-up|7|||
28072303|NCT00121641|54726944|FG002|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
28072304|NCT00121641|54726945|FG003|48-month Short Term + Long Term Period|Lost to Follow-up|11|||
28072305|NCT00121641|54726946|FG004|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
28072306|NCT00121641|54726942|FG000|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
28072307|NCT00121641|54726943|FG001|48-month Short Term + Long Term Period|Poor / Non-compliance|1|||
28072308|NCT00121641|54726944|FG002|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
27850093|NCT00989261|54348395|FG000|Overall Study|Still in follow up|12|||
27850094|NCT00989261|54348396|FG001|Overall Study|Still in follow up|21|||
27850095|NCT00989261|54348395|FG000|Overall Study|Withdrawal by Subject|0|||
27850096|NCT00989261|54348396|FG001|Overall Study|Withdrawal by Subject|1|||
27850097|NCT00989261|54348395|FG000|Overall Study|Lost to Follow-up|3|||
27850098|NCT00989261|54348396|FG001|Overall Study|Lost to Follow-up|0|||
27850099|NCT00988559|54348415|FG000|Overall Study|Withdrawal by Subject|1|||
27850100|NCT00988559|54348416|FG001|Overall Study|Withdrawal by Subject|1|||
27850101|NCT00988559|54348417|FG002|Overall Study|Withdrawal by Subject|0|||
27850102|NCT00988559|54348418|FG003|Overall Study|Withdrawal by Subject|1|||
27941471|NCT01025817|54597908|FG000|Completed Study Medication|Unsatisfactory therapeutic effect|7|||
27941472|NCT01025817|54597909|FG001|Completed Study Medication|Unsatisfactory therapeutic effect|0|||
27941473|NCT01025817|54597908|FG000|Completed Study Medication|Abnormal test procedure|4|||
27941474|NCT01025817|54597909|FG001|Completed Study Medication|Abnormal test procedure|0|||
27941475|NCT01025817|54597908|FG000|Completed Study Medication|Graft loss|2|||
27941476|NCT01025817|54597909|FG001|Completed Study Medication|Graft loss|5|||
27941477|NCT01025817|54597908|FG000|Completed Study Medication|Death|2|||
27941478|NCT01025817|54597909|FG001|Completed Study Medication|Death|2|||
27941479|NCT01025817|54597908|FG000|Completed Study Medication|Abnormal lab values|0|||
27941480|NCT01025817|54597909|FG001|Completed Study Medication|Abnormal lab values|2|||
27941481|NCT01025817|54597908|FG000|Completed Study Medication|Subject no longer required study drug|0|||
27941482|NCT01025817|54597909|FG001|Completed Study Medication|Subject no longer required study drug|1|||
27941483|NCT01025817|54597908|FG000|Completed Study Medication|Lost to Follow-up|0|||
27941484|NCT01025817|54597909|FG001|Completed Study Medication|Lost to Follow-up|1|||
27941485|NCT01025817|54597908|FG000|Completed Study|Withdrawal by Subject|8|||
27941486|NCT01025817|54597909|FG001|Completed Study|Withdrawal by Subject|16|||
27941487|NCT01025817|54597908|FG000|Completed Study|Death|6|||
27941488|NCT01025817|54597909|FG001|Completed Study|Death|5|||
27941489|NCT01025817|54597908|FG000|Completed Study|Missing|2|||
27941490|NCT01025817|54597909|FG001|Completed Study|Missing|0|||
27941491|NCT01025817|54597908|FG000|Completed Study|Lost to Follow-up|0|||
27941492|NCT01025817|54597909|FG001|Completed Study|Lost to Follow-up|1|||
27941493|NCT00939640|54597915|FG000|Overall Study|Physician Decision|1|||
27941494|NCT01218113|54597927|FG000|Overall Study|Withdrawal by Subject|1|||
27941495|NCT01218113|54597928|FG001|Overall Study|Withdrawal by Subject|0|||
27941496|NCT01218113|54597929|FG002|Overall Study|Withdrawal by Subject|1|||
27941497|NCT01218113|54597927|FG000|Overall Study|Lost to Follow-up|4|||
27941498|NCT01218113|54597928|FG001|Overall Study|Lost to Follow-up|1|||
27941499|NCT01218113|54597929|FG002|Overall Study|Lost to Follow-up|4|||
27941500|NCT01218113|54597927|FG000|Overall Study|Protocol Deviation Eligibility Criteria|0|||
27941501|NCT01218113|54597928|FG001|Overall Study|Protocol Deviation Eligibility Criteria|0|||
27941502|NCT01218113|54597929|FG002|Overall Study|Protocol Deviation Eligibility Criteria|1|||
27941503|NCT03873493|54597944|FG000|Overall Study|Withdrawal by Subject|1|||
27941504|NCT03873493|54597944|FG000|Overall Study|Death|9|||
27941505|NCT03873493|54597944|FG000|Overall Study|Lost to Follow-up|1|||
27941506|NCT03873493|54597944|FG000|Overall Study|Study Terminated by Sponsor|1|||
27941507|NCT03873493|54597944|FG000|Overall Study|Other|2|||
27941508|NCT00939484|54597964|FG000|Overall Study|Progression/Relapse|8|||
27941509|NCT00939484|54597965|FG001|Overall Study|Progression/Relapse|20|||
27941510|NCT00939484|54597966|FG002|Overall Study|Progression/Relapse|3|||
27941511|NCT01010217|54597981|FG000|Overall Study|Lost to Follow-up|4|||
27941512|NCT01010217|54597982|FG001|Overall Study|Lost to Follow-up|5|||
27941513|NCT01010217|54597983|FG002|Overall Study|Lost to Follow-up|1|||
27941514|NCT01010217|54597984|FG003|Overall Study|Lost to Follow-up|0|||
27941515|NCT01010217|54597985|FG004|Overall Study|Lost to Follow-up|0|||
27941516|NCT01010217|54597981|FG000|Overall Study|Withdrawal by Subject|1|||
27941517|NCT01010217|54597982|FG001|Overall Study|Withdrawal by Subject|0|||
28147470|NCT04313283|54814577|FG000|Overall Study|did not complete intervention|4|||
28147471|NCT02760368|54814584|FG000|Overall Study|Withdrawal by Subject|12|||
28147472|NCT02760368|54814585|FG001|Overall Study|Withdrawal by Subject|8|||
28147473|NCT02760368|54814586|FG002|Overall Study|Withdrawal by Subject|9|||
28147474|NCT02760368|54814584|FG000|Overall Study|Screen Failure|0|||
28147475|NCT02760368|54814585|FG001|Overall Study|Screen Failure|0|||
28147476|NCT02760368|54814586|FG002|Overall Study|Screen Failure|1|||
28147477|NCT02760368|54814584|FG000|Overall Study|Death|1|||
28147478|NCT02760368|54814585|FG001|Overall Study|Death|0|||
28147479|NCT02760368|54814586|FG002|Overall Study|Death|0|||
28147480|NCT02760368|54814584|FG000|Overall Study|Withdrawal by Sponsor|0|||
28147481|NCT02760368|54814585|FG001|Overall Study|Withdrawal by Sponsor|0|||
28147482|NCT02760368|54814586|FG002|Overall Study|Withdrawal by Sponsor|1|||
28147483|NCT02754440|54814598|FG000|Overall Study|Protocol Violation|3|||
28147484|NCT02754440|54814599|FG001|Overall Study|Protocol Violation|2|||
28147485|NCT02754440|54814600|FG002|Overall Study|Protocol Violation|2|||
28147486|NCT02754440|54814601|FG003|Overall Study|Protocol Violation|6|||
28147487|NCT02754440|54814598|FG000|Overall Study|Adverse Event|3|||
28147488|NCT02754440|54814599|FG001|Overall Study|Adverse Event|1|||
28147489|NCT02754440|54814600|FG002|Overall Study|Adverse Event|0|||
28147490|NCT02754440|54814601|FG003|Overall Study|Adverse Event|9|||
28147491|NCT02754440|54814598|FG000|Overall Study|Withdrawal by Subject|0|||
28147492|NCT02754440|54814599|FG001|Overall Study|Withdrawal by Subject|0|||
28147493|NCT02754440|54814600|FG002|Overall Study|Withdrawal by Subject|0|||
27941518|NCT01010217|54597983|FG002|Overall Study|Withdrawal by Subject|0|||
27941519|NCT01010217|54597984|FG003|Overall Study|Withdrawal by Subject|0|||
27941520|NCT01010217|54597985|FG004|Overall Study|Withdrawal by Subject|0|||
27941521|NCT01010217|54597981|FG000|Overall Study|Physician Decision|0|||
27941522|NCT01010217|54597982|FG001|Overall Study|Physician Decision|0|||
27941523|NCT01010217|54597983|FG002|Overall Study|Physician Decision|0|||
27941524|NCT01010217|54597984|FG003|Overall Study|Physician Decision|6|||
27941525|NCT01010217|54597985|FG004|Overall Study|Physician Decision|3|||
27941526|NCT01217957|54598002|FG000|Phase 1|Withdrawal by Patient|1|||
27941527|NCT01217957|54598003|FG001|Phase 1|Withdrawal by Patient|0|||
27941528|NCT01217957|54598004|FG002|Phase 1|Withdrawal by Patient|1|||
27941529|NCT01217957|54598005|FG003|Phase 1|Withdrawal by Patient|1|||
27941530|NCT01217957|54598006|FG004|Phase 1|Withdrawal by Patient|0|||
27941531|NCT01217957|54598002|FG000|Phase 2|Withdrawal by Patient|0|||
27941532|NCT01217957|54598003|FG001|Phase 2|Withdrawal by Patient|0|||
27941533|NCT01217957|54598004|FG002|Phase 2|Withdrawal by Patient|0|||
27941534|NCT01217957|54598005|FG003|Phase 2|Withdrawal by Patient|0|||
27941535|NCT01217957|54598006|FG004|Phase 2|Withdrawal by Patient|1|||
27941536|NCT00939094|54598029|FG000|Overall Study|Adverse Event|9|||
27941537|NCT00939094|54598030|FG001|Overall Study|Adverse Event|0|||
27941538|NCT00939094|54598029|FG000|Overall Study|Withdrawal by Subject|1|||
27941539|NCT00939094|54598030|FG001|Overall Study|Withdrawal by Subject|6|||
27941540|NCT00939094|54598029|FG000|Overall Study|Lost to Follow-up|1|||
27941541|NCT00939094|54598030|FG001|Overall Study|Lost to Follow-up|1|||
27941542|NCT00939094|54598029|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
27941543|NCT00939094|54598030|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
27941544|NCT00939094|54598029|FG000|Overall Study|Severe non-compliance to protocol|0|||
27941545|NCT00939094|54598030|FG001|Overall Study|Severe non-compliance to protocol|1|||
27941546|NCT00939094|54598029|FG000|Overall Study|Study stopped by sponsor|0|||
27941547|NCT00939094|54598030|FG001|Overall Study|Study stopped by sponsor|2|||
27941548|NCT00939094|54598029|FG000|Overall Study|Abnormal ECG findings|1|||
27941549|NCT00939094|54598030|FG001|Overall Study|Abnormal ECG findings|0|||
27941550|NCT01217801|54598038|FG000|Period 1|Protocol Violation|1|||
27941551|NCT01217801|54598039|FG001|Period 1|Protocol Violation|1|||
27941552|NCT01217801|54598038|FG000|Period 1|Withdrawal by Subject|0|||
27941553|NCT01217801|54598039|FG001|Period 1|Withdrawal by Subject|1|||
27941554|NCT00935818|54598047|FG000|Overall Study|Withdrawal by Subject|45|||
27941555|NCT00935818|54598048|FG001|Overall Study|Withdrawal by Subject|50|||
27941556|NCT00935818|54598047|FG000|Overall Study|Lost to Follow-up|40|||
27941557|NCT00935818|54598048|FG001|Overall Study|Lost to Follow-up|42|||
27941558|NCT00935818|54598047|FG000|Overall Study|Adverse Event|6|||
27941559|NCT00935818|54598048|FG001|Overall Study|Adverse Event|7|||
27941560|NCT00935818|54598047|FG000|Overall Study|Physician Decision|0|||
27941561|NCT00935818|54598048|FG001|Overall Study|Physician Decision|1|||
27941562|NCT01216319|54598054|FG000|Overall Study|Lost to Follow-up|2|||
27941563|NCT01216319|54598054|FG000|Overall Study|Unanticipated chemo for breast cancer|2|||
27941564|NCT00936208|54598060|FG000|Overall Study|Protocol Violation|37|||
27941565|NCT00936208|54598061|FG001|Overall Study|Protocol Violation|22|||
27941566|NCT01216163|54598070|FG000|Overall Study|Withdrawal by Subject|1|||
27941567|NCT01216163|54598071|FG001|Overall Study|Withdrawal by Subject|1|||
27941568|NCT01216163|54598072|FG002|Overall Study|Withdrawal by Subject|0|||
27941569|NCT00933244|54598083|FG000|Overall Study|Withdrawal by Subject|5|||
27941570|NCT00933244|54598084|FG001|Overall Study|Withdrawal by Subject|1|||
27941571|NCT00933244|54598085|FG002|Overall Study|Withdrawal by Subject|3|||
27941572|NCT00930046|54598095|FG000|Overall Study|Wound catheter malfunctioned|1|||
27941573|NCT00930046|54598096|FG001|Overall Study|Wound catheter malfunctioned|2|||
27941574|NCT00935584|54598104|FG000|Overall Study|Withdrawal by Subject|9|||
27941575|NCT00935584|54598105|FG001|Overall Study|Withdrawal by Subject|0|||
27941576|NCT00935584|54598104|FG000|Overall Study|Death|3|||
27941577|NCT00935584|54598105|FG001|Overall Study|Death|0|||
27941578|NCT00935584|54598104|FG000|Overall Study|Lost to Follow-up|8|||
27941579|NCT00935584|54598105|FG001|Overall Study|Lost to Follow-up|0|||
27941580|NCT00935584|54598104|FG000|Overall Study|No show|9|||
27941581|NCT00935584|54598105|FG001|Overall Study|No show|0|||
27941582|NCT00935584|54598104|FG000|Overall Study|Relocated|3|||
27941583|NCT00935584|54598105|FG001|Overall Study|Relocated|0|||
27941584|NCT00935584|54598104|FG000|Overall Study|Patient changed provider|3|||
27941585|NCT00935584|54598105|FG001|Overall Study|Patient changed provider|0|||
27941586|NCT00935584|54598104|FG000|Overall Study|Provider dropped out of study|14|||
27941587|NCT00935584|54598105|FG001|Overall Study|Provider dropped out of study|4|||
27941588|NCT01215851|54598115|FG000|Treatment Period|Adverse Event|1|||
27941589|NCT01215851|54598116|FG001|Treatment Period|Adverse Event|1|||
27941590|NCT01215851|54598117|FG002|Treatment Period|Adverse Event|1|||
27941591|NCT01215851|54598118|FG003|Treatment Period|Adverse Event|3|||
27941592|NCT01215851|54598119|FG004|Treatment Period|Adverse Event|0|||
27941593|NCT01215851|54598120|FG005|Treatment Period|Adverse Event|1|||
27941594|NCT01215851|54598115|FG000|Follow up Period|Lost to Follow-up|0|||
27941595|NCT01215851|54598116|FG001|Follow up Period|Lost to Follow-up|0|||
27941596|NCT01215851|54598117|FG002|Follow up Period|Lost to Follow-up|0|||
27941597|NCT01215851|54598118|FG003|Follow up Period|Lost to Follow-up|0|||
27941598|NCT01215851|54598119|FG004|Follow up Period|Lost to Follow-up|0|||
27941599|NCT01215851|54598120|FG005|Follow up Period|Lost to Follow-up|1|||
27941600|NCT00933166|54598135|FG000|Overall Study|Lost to Follow-up|4|||
27941601|NCT00933166|54598135|FG000|Overall Study|Lack of Efficacy|9|||
27941602|NCT00933166|54598135|FG000|Overall Study|Unavailable|4|||
27941603|NCT00933166|54598135|FG000|Overall Study|Withdrawal by Subject|1|||
27941604|NCT00935272|54598141|FG000|Overall Study|Lost to Follow-up|10|||
27941605|NCT00935272|54598142|FG001|Overall Study|Lost to Follow-up|3|||
27941606|NCT00935272|54598141|FG000|Overall Study|Withdrawal by Subject|8|||
27941607|NCT00935272|54598142|FG001|Overall Study|Withdrawal by Subject|2|||
27941608|NCT00935272|54598141|FG000|Overall Study|Physician Decision|1|||
27941609|NCT00935272|54598142|FG001|Overall Study|Physician Decision|0|||
27941610|NCT00935272|54598141|FG000|Overall Study|Protocol Violation|0|||
27941611|NCT00935272|54598142|FG001|Overall Study|Protocol Violation|1|||
27941612|NCT01010061|54598151|FG000|Overall Study|Adverse Events or Intercurrent Illness|33|||
27941613|NCT01010061|54598152|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
27941614|NCT01010061|54598151|FG000|Overall Study|Disease Progression|2|||
27941615|NCT01010061|54598152|FG001|Overall Study|Disease Progression|8|||
27941616|NCT01010061|54598151|FG000|Overall Study|Withdrew Consent|5|||
27941617|NCT01010061|54598152|FG001|Overall Study|Withdrew Consent|1|||
27941618|NCT01010061|54598151|FG000|Overall Study|Death|3|||
27941619|NCT01010061|54598152|FG001|Overall Study|Death|6|||
27941620|NCT01010061|54598151|FG000|Overall Study|Administrative/Other|0|||
27941621|NCT01010061|54598152|FG001|Overall Study|Administrative/Other|1|||
27941622|NCT01010061|54598151|FG000|Overall Study|Refused Treatment/Did Not Cooperate|2|||
27941623|NCT01010061|54598152|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
27941624|NCT01010061|54598151|FG000|Overall Study|Insufficient Therapeutic Response|1|||
27941625|NCT01010061|54598152|FG001|Overall Study|Insufficient Therapeutic Response|5|||
27941626|NCT01010061|54598151|FG000|Overall Study|Violation of Selection Criteria|0|||
27941627|NCT01010061|54598152|FG001|Overall Study|Violation of Selection Criteria|1|||
27941628|NCT01010061|54598151|FG000|Overall Study|Did Not Receive Treatment|2|||
27941629|NCT01010061|54598152|FG001|Overall Study|Did Not Receive Treatment|2|||
27941630|NCT00929734|54598172|FG000|Overall Study|Lost to Follow-up|2|||
27941631|NCT00929734|54598173|FG001|Overall Study|Lost to Follow-up|1|||
27941632|NCT00929734|54598172|FG000|Overall Study|Withdrawal by Subject|0|||
27941633|NCT00929734|54598173|FG001|Overall Study|Withdrawal by Subject|2|||
27941634|NCT01013883|54598181|FG000|Overall Study|Lost to Follow-up|2|||
27941635|NCT01013883|54598182|FG001|Overall Study|Lost to Follow-up|2|||
27941636|NCT01009983|54598188|FG000|Overall Study|necessary scans not completed|1|||
27941637|NCT01215227|54598202|FG000|Overall Study|Adverse Event|11|||
27941638|NCT01215227|54598203|FG001|Overall Study|Adverse Event|11|||
27941639|NCT01215227|54598204|FG002|Overall Study|Adverse Event|4|||
27941640|NCT01215227|54598205|FG003|Overall Study|Adverse Event|8|||
27941641|NCT01215227|54598206|FG004|Overall Study|Adverse Event|7|||
27941642|NCT01215227|54598207|FG005|Overall Study|Adverse Event|6|||
27941643|NCT01215227|54598202|FG000|Overall Study|Treatment Failure|8|||
27941644|NCT01215227|54598203|FG001|Overall Study|Treatment Failure|4|||
27941645|NCT01215227|54598204|FG002|Overall Study|Treatment Failure|1|||
27941646|NCT01215227|54598205|FG003|Overall Study|Treatment Failure|5|||
27941647|NCT01215227|54598206|FG004|Overall Study|Treatment Failure|1|||
27941648|NCT01215227|54598207|FG005|Overall Study|Treatment Failure|1|||
27941649|NCT01215227|54598202|FG000|Overall Study|Lost to Follow-up|1|||
27941650|NCT01215227|54598203|FG001|Overall Study|Lost to Follow-up|4|||
27941651|NCT01215227|54598204|FG002|Overall Study|Lost to Follow-up|1|||
27941652|NCT01215227|54598205|FG003|Overall Study|Lost to Follow-up|1|||
27941653|NCT01215227|54598206|FG004|Overall Study|Lost to Follow-up|1|||
27941654|NCT01215227|54598207|FG005|Overall Study|Lost to Follow-up|2|||
27941655|NCT01215227|54598202|FG000|Overall Study|Subject Withdrew Consent|16|||
27941656|NCT01215227|54598203|FG001|Overall Study|Subject Withdrew Consent|20|||
27941657|NCT01215227|54598204|FG002|Overall Study|Subject Withdrew Consent|7|||
27941658|NCT01215227|54598205|FG003|Overall Study|Subject Withdrew Consent|10|||
27941659|NCT01215227|54598206|FG004|Overall Study|Subject Withdrew Consent|11|||
27941660|NCT01215227|54598207|FG005|Overall Study|Subject Withdrew Consent|8|||
27941661|NCT01215227|54598202|FG000|Overall Study|Non-Compliance With Protocol|2|||
27941662|NCT01215227|54598203|FG001|Overall Study|Non-Compliance With Protocol|6|||
27941663|NCT01215227|54598204|FG002|Overall Study|Non-Compliance With Protocol|1|||
27941664|NCT01215227|54598205|FG003|Overall Study|Non-Compliance With Protocol|0|||
27941665|NCT01215227|54598206|FG004|Overall Study|Non-Compliance With Protocol|0|||
27941666|NCT01215227|54598207|FG005|Overall Study|Non-Compliance With Protocol|0|||
27941667|NCT01215227|54598202|FG000|Overall Study|Administrative|83|||
28147494|NCT02754440|54814601|FG003|Overall Study|Withdrawal by Subject|1|||
27850103|NCT00988559|54348415|FG000|Overall Study|Pregnancy|0|||
27941668|NCT01215227|54598203|FG001|Overall Study|Administrative|73|||
27941669|NCT01215227|54598204|FG002|Overall Study|Administrative|42|||
27941670|NCT01215227|54598205|FG003|Overall Study|Administrative|24|||
27941671|NCT01215227|54598206|FG004|Overall Study|Administrative|28|||
27941672|NCT01215227|54598207|FG005|Overall Study|Administrative|40|||
27941673|NCT01215227|54598202|FG000|Overall Study|Missing Status|0|||
27941674|NCT01215227|54598203|FG001|Overall Study|Missing Status|1|||
28147495|NCT02754440|54814598|FG000|Overall Study|Equipment failure|0|||
27941675|NCT01215227|54598204|FG002|Overall Study|Missing Status|0|||
27941676|NCT01215227|54598205|FG003|Overall Study|Missing Status|0|||
27941677|NCT01215227|54598206|FG004|Overall Study|Missing Status|0|||
27941678|NCT01215227|54598207|FG005|Overall Study|Missing Status|0|||
27941679|NCT01215227|54598202|FG000|Overall Study|Randomized but not treated|0|||
27941680|NCT01215227|54598203|FG001|Overall Study|Randomized but not treated|0|||
27941681|NCT01215227|54598204|FG002|Overall Study|Randomized but not treated|1|||
27941682|NCT01215227|54598205|FG003|Overall Study|Randomized but not treated|1|||
27941683|NCT01215227|54598206|FG004|Overall Study|Randomized but not treated|0|||
27941684|NCT01215227|54598207|FG005|Overall Study|Randomized but not treated|1|||
27941685|NCT01009515|54598221|FG000|Overall Study|Withdrawal by Subject|3|||
27941686|NCT01214915|54598225|FG000|Overall Study|Adverse Event|8|||
27941687|NCT01214915|54598225|FG000|Overall Study|Lack of Efficacy|3|||
27941688|NCT01009281|54598229|FG000|Overall Study|Administrative problems|7|||
27941689|NCT01009203|54598233|FG000|Overall Study|Withdrawal by Subject|1|||
27941690|NCT01009203|54598233|FG000|Overall Study|Adverse Event|5|||
27941691|NCT01009203|54598233|FG000|Overall Study|Treatment-unrelated death|1|||
27941692|NCT01009047|54598239|FG000|Overall Study|Adverse Event|5|||
27941693|NCT01009047|54598240|FG001|Overall Study|Adverse Event|0|||
27941694|NCT01009047|54598239|FG000|Overall Study|Lost to Follow-up|0|||
27941695|NCT01009047|54598240|FG001|Overall Study|Lost to Follow-up|2|||
27941696|NCT01009047|54598239|FG000|Overall Study|Lack of Efficacy|4|||
27941697|NCT01009047|54598240|FG001|Overall Study|Lack of Efficacy|11|||
27941698|NCT01009047|54598239|FG000|Overall Study|Withdrawal by consent|16|||
27941699|NCT01009047|54598240|FG001|Overall Study|Withdrawal by consent|11|||
27941700|NCT01009047|54598239|FG000|Overall Study|Other|3|||
27941701|NCT01009047|54598240|FG001|Overall Study|Other|2|||
27941702|NCT01025193|54598246|FG000|Overall Study|Protocol Violation|1|||
27941703|NCT01025193|54598246|FG000|Overall Study|Adverse Event|3|||
27941704|NCT01025037|54598254|FG000|Overall Study|Adverse Event|3|||
27941705|NCT01025037|54598254|FG000|Overall Study|Lost to Follow-up|7|||
27941706|NCT01025037|54598254|FG000|Overall Study|Withdrawal by Subject|1|||
27941707|NCT01214837|54598261|FG000|Overall Study|Death|0|||
27941708|NCT01214837|54598262|FG001|Overall Study|Death|0|||
27941709|NCT01214837|54598263|FG002|Overall Study|Death|1|||
27941710|NCT01214837|54598261|FG000|Overall Study|Adverse Event|1|||
27941711|NCT01214837|54598262|FG001|Overall Study|Adverse Event|2|||
27941712|NCT01214837|54598263|FG002|Overall Study|Adverse Event|1|||
27941713|NCT01214837|54598261|FG000|Overall Study|Withdrawal by Subject|27|||
27941714|NCT01214837|54598262|FG001|Overall Study|Withdrawal by Subject|36|||
27941715|NCT01214837|54598263|FG002|Overall Study|Withdrawal by Subject|28|||
27941716|NCT01214837|54598261|FG000|Overall Study|Lost to Follow-up|20|||
27941717|NCT01214837|54598262|FG001|Overall Study|Lost to Follow-up|15|||
27941718|NCT01214837|54598263|FG002|Overall Study|Lost to Follow-up|21|||
27941719|NCT01214837|54598261|FG000|Overall Study|Inappropriate Enrolment|0|||
27941720|NCT01214837|54598262|FG001|Overall Study|Inappropriate Enrolment|1|||
27941721|NCT01214837|54598263|FG002|Overall Study|Inappropriate Enrolment|2|||
27941722|NCT01214837|54598261|FG000|Overall Study|Administrative Reason|2|||
27941723|NCT01214837|54598262|FG001|Overall Study|Administrative Reason|6|||
27941724|NCT01214837|54598263|FG002|Overall Study|Administrative Reason|4|||
27941725|NCT01214837|54598261|FG000|Overall Study|Protocol Violation|3|||
27941726|NCT01214837|54598262|FG001|Overall Study|Protocol Violation|1|||
27941727|NCT01214837|54598263|FG002|Overall Study|Protocol Violation|5|||
27941728|NCT01214837|54598261|FG000|Overall Study|Unable to Classify|1|||
27941729|NCT01214837|54598262|FG001|Overall Study|Unable to Classify|3|||
27941730|NCT01214837|54598263|FG002|Overall Study|Unable to Classify|0|||
27941731|NCT01024959|54598272|FG000|Overall Study|ineligible|12|||
28072309|NCT00121641|54726945|FG003|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
27822728|NCT01839487|54286700|FG002|Phase 2 (Maximum Exposure:935 Days)|Death|46|||
27822729|NCT01839487|54286701|FG003|Phase 2 (Maximum Exposure:935 Days)|Death|49|||
27822730|NCT01839487|54286702|FG004|Phase 2 (Maximum Exposure:935 Days)|Death|71|||
27822731|NCT01839487|54286703|FG005|Phase 2 (Maximum Exposure:935 Days)|Death|32|||
27822732|NCT01839487|54286698|FG000|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
27822733|NCT01839487|54286699|FG001|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
27822734|NCT01839487|54286700|FG002|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2|||
28072310|NCT00121641|54726946|FG004|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
28072311|NCT00121641|54726942|FG000|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
28072312|NCT00121641|54726943|FG001|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3|||
28072313|NCT00121641|54726944|FG002|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
28072314|NCT00121641|54726945|FG003|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
28147496|NCT02754440|54814599|FG001|Overall Study|Equipment failure|5|||
27822735|NCT01839487|54286701|FG003|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
27822736|NCT01839487|54286702|FG004|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1|||
27941732|NCT01024959|54598272|FG000|Overall Study|results not evaluable|12|||
27941733|NCT01024959|54598272|FG000|Overall Study|missing results required for analysis|17|||
27941734|NCT03672175|54598284|FG000|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
27941735|NCT03672175|54598285|FG001|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
27941736|NCT03672175|54598286|FG002|Treatment Period (Days 1 to 14)|Withdrawal by Subject|4|||
27941737|NCT03672175|54598284|FG000|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
27822737|NCT01839487|54286703|FG005|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
27822738|NCT01839487|54286698|FG000|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
27822739|NCT01839487|54286699|FG001|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
27941738|NCT03672175|54598285|FG001|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
28072315|NCT00121641|54726946|FG004|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
27941739|NCT03672175|54598286|FG002|Treatment Period (Days 1 to 14)|Lost to Follow-up|3|||
27941740|NCT03672175|54598284|FG000|Treatment Period (Days 1 to 14)|Randomized but not Treated|3|||
27941741|NCT03672175|54598285|FG001|Treatment Period (Days 1 to 14)|Randomized but not Treated|6|||
27941742|NCT03672175|54598286|FG002|Treatment Period (Days 1 to 14)|Randomized but not Treated|2|||
27941743|NCT03672175|54598284|FG000|FU Period (Days 15 to 42)|Adverse Event|0|||
27941744|NCT03672175|54598285|FG001|FU Period (Days 15 to 42)|Adverse Event|0|||
27941745|NCT03672175|54598286|FG002|FU Period (Days 15 to 42)|Adverse Event|1|||
27941746|NCT03672175|54598284|FG000|FU Period (Days 15 to 42)|Lost to Follow-up|3|||
27941747|NCT03672175|54598285|FG001|FU Period (Days 15 to 42)|Lost to Follow-up|6|||
27941748|NCT03672175|54598286|FG002|FU Period (Days 15 to 42)|Lost to Follow-up|2|||
27941749|NCT03672175|54598284|FG000|FU Period (Days 15 to 42)|Withdrawal by Subject|1|||
27941750|NCT03672175|54598285|FG001|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
27941751|NCT03672175|54598286|FG002|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
28072316|NCT00121641|54726942|FG000|48-month Short Term + Long Term Period|Pregnancy|0|||
28072317|NCT00121641|54726943|FG001|48-month Short Term + Long Term Period|Pregnancy|1|||
28147497|NCT02754440|54814600|FG002|Overall Study|Equipment failure|5|||
28147498|NCT02754440|54814601|FG003|Overall Study|Equipment failure|7|||
28147499|NCT02754440|54814598|FG000|Overall Study|Subject issues not resulting in AE|0|||
28147500|NCT02754440|54814599|FG001|Overall Study|Subject issues not resulting in AE|0|||
28147501|NCT02754440|54814600|FG002|Overall Study|Subject issues not resulting in AE|0|||
28147502|NCT02754440|54814601|FG003|Overall Study|Subject issues not resulting in AE|12|||
28147503|NCT02753816|54814613|FG000|Overall Study|Protocol Violation|0|||
28147504|NCT02753816|54814614|FG001|Overall Study|Protocol Violation|1|||
28147505|NCT02753816|54814615|FG002|Overall Study|Protocol Violation|0|||
28147506|NCT02752802|54814623|FG000|Overall Study|Contrast Volume Not Collected|1|||
28072318|NCT00121641|54726944|FG002|48-month Short Term + Long Term Period|Pregnancy|0|||
27822740|NCT01839487|54286700|FG002|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
28072319|NCT00121641|54726945|FG003|48-month Short Term + Long Term Period|Pregnancy|1|||
28072320|NCT00121641|54726946|FG004|48-month Short Term + Long Term Period|Pregnancy|0|||
28072321|NCT00121641|54726942|FG000|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
28072322|NCT00121641|54726943|FG001|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2|||
28072323|NCT00121641|54726944|FG002|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
28072324|NCT00121641|54726945|FG003|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
28072325|NCT00121641|54726946|FG004|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
28147507|NCT02752802|54814624|FG001|Overall Study|Contrast Volume Not Collected|0|||
28147508|NCT02756078|54814641|FG000|Period 1|Unsatisfactory Lens Fitting|0|||
28147509|NCT02756078|54814642|FG001|Period 1|Unsatisfactory Lens Fitting|1|||
28147510|NCT02756078|54814641|FG000|Period 1|Lost to Follow-up|0|||
28147511|NCT02756078|54814642|FG001|Period 1|Lost to Follow-up|2|||
27850104|NCT00988559|54348416|FG001|Overall Study|Pregnancy|1|||
28147512|NCT02756078|54814641|FG000|Period 1|Protocol Violation|0|||
28147513|NCT02756078|54814642|FG001|Period 1|Protocol Violation|1|||
28147514|NCT02756078|54814641|FG000|Period 1|Adverse Event|1|||
28147515|NCT02756078|54814642|FG001|Period 1|Adverse Event|10|||
28147516|NCT02756078|54814641|FG000|Period 1|Withdrawal by Subject|6|||
28147517|NCT02756078|54814642|FG001|Period 1|Withdrawal by Subject|6|||
28147518|NCT02756078|54814641|FG000|Period 1|Lens Discomfort|2|||
28147519|NCT02756078|54814642|FG001|Period 1|Lens Discomfort|2|||
28147520|NCT02756078|54814641|FG000|Period 2|Adverse Event|3|||
28147521|NCT02756078|54814642|FG001|Period 2|Adverse Event|5|||
28147522|NCT02756078|54814641|FG000|Period 2|Unsatisfactory Lens Fitting|0|||
28147523|NCT02756078|54814642|FG001|Period 2|Unsatisfactory Lens Fitting|1|||
28147524|NCT02756078|54814641|FG000|Period 2|Withdrawal by Subject|3|||
28147525|NCT02756078|54814642|FG001|Period 2|Withdrawal by Subject|1|||
28147526|NCT03813147|54814650|FG000|Overall Study|Lack of Efficacy|4|||
28147527|NCT03813147|54814651|FG001|Overall Study|Lack of Efficacy|4|||
28147528|NCT03813147|54814650|FG000|Overall Study|Physician Decision|2|||
28147529|NCT03813147|54814651|FG001|Overall Study|Physician Decision|1|||
28147530|NCT02752958|54814657|FG000|Overall Study|Adverse Event|3|||
28147531|NCT02752958|54814657|FG000|Overall Study|Lost to Follow-up|1|||
28147532|NCT02752958|54814657|FG000|Overall Study|Protocol Violation|1|||
28147533|NCT02752958|54814657|FG000|Overall Study|Withdrawal by Subject|2|||
28147534|NCT02752958|54814657|FG000|Overall Study|Other (Reason not specified)|2|||
28147535|NCT02805660|54814670|FG000|Overall Study|Death|5|||
28147536|NCT02805660|54814671|FG001|Overall Study|Death|2|||
28147537|NCT02805660|54814672|FG002|Overall Study|Death|9|||
27822741|NCT01839487|54286701|FG003|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1|||
27822742|NCT01839487|54286702|FG004|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10|||
27822743|NCT01839487|54286703|FG005|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3|||
27822744|NCT01839487|54286698|FG000|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
28072326|NCT00121641|54726942|FG000|48-month Short Term + Long Term Period|Death|0|||
28072327|NCT00121641|54726943|FG001|48-month Short Term + Long Term Period|Death|0|||
28072328|NCT00121641|54726944|FG002|48-month Short Term + Long Term Period|Death|0|||
28072329|NCT00121641|54726945|FG003|48-month Short Term + Long Term Period|Death|1|||
28072330|NCT00121641|54726946|FG004|48-month Short Term + Long Term Period|Death|0|||
28072331|NCT00121641|54726942|FG000|48-month Short Term + Long Term Period|Missing|0|||
28072332|NCT00121641|54726943|FG001|48-month Short Term + Long Term Period|Missing|0|||
28072333|NCT00121641|54726944|FG002|48-month Short Term + Long Term Period|Missing|1|||
28072334|NCT00121641|54726945|FG003|48-month Short Term + Long Term Period|Missing|0|||
28072335|NCT00121641|54726946|FG004|48-month Short Term + Long Term Period|Missing|0|||
28147538|NCT02805660|54814673|FG003|Overall Study|Death|5|||
28147539|NCT02805660|54814674|FG004|Overall Study|Death|0|||
28147540|NCT02805660|54814675|FG005|Overall Study|Death|14|||
28147541|NCT02805660|54814676|FG006|Overall Study|Death|12|||
28147542|NCT02805660|54814670|FG000|Overall Study|Lost to Follow-up|0|||
28147543|NCT02805660|54814671|FG001|Overall Study|Lost to Follow-up|1|||
28147544|NCT02805660|54814672|FG002|Overall Study|Lost to Follow-up|1|||
28147545|NCT02805660|54814673|FG003|Overall Study|Lost to Follow-up|2|||
28147546|NCT02805660|54814674|FG004|Overall Study|Lost to Follow-up|0|||
28147547|NCT02805660|54814675|FG005|Overall Study|Lost to Follow-up|0|||
28147548|NCT02805660|54814676|FG006|Overall Study|Lost to Follow-up|0|||
28147549|NCT02805660|54814670|FG000|Overall Study|Withdrawal by Subject|0|||
28147550|NCT02805660|54814671|FG001|Overall Study|Withdrawal by Subject|0|||
28147551|NCT02805660|54814672|FG002|Overall Study|Withdrawal by Subject|0|||
28147552|NCT02805660|54814673|FG003|Overall Study|Withdrawal by Subject|3|||
28147553|NCT02805660|54814674|FG004|Overall Study|Withdrawal by Subject|1|||
28147554|NCT02805660|54814675|FG005|Overall Study|Withdrawal by Subject|0|||
28147555|NCT02805660|54814676|FG006|Overall Study|Withdrawal by Subject|2|||
28147556|NCT02805660|54814670|FG000|Overall Study|Study terminated by Sponsor|0|||
28147557|NCT02805660|54814671|FG001|Overall Study|Study terminated by Sponsor|0|||
28147558|NCT02805660|54814672|FG002|Overall Study|Study terminated by Sponsor|1|||
28147559|NCT02805660|54814673|FG003|Overall Study|Study terminated by Sponsor|4|||
28147560|NCT02805660|54814674|FG004|Overall Study|Study terminated by Sponsor|2|||
28147561|NCT02805660|54814675|FG005|Overall Study|Study terminated by Sponsor|3|||
28147562|NCT02805660|54814676|FG006|Overall Study|Study terminated by Sponsor|1|||
28147563|NCT02805660|54814670|FG000|Overall Study|Miscellaneous|0|||
28147564|NCT02805660|54814671|FG001|Overall Study|Miscellaneous|1|||
28147565|NCT02805660|54814672|FG002|Overall Study|Miscellaneous|0|||
28147566|NCT02805660|54814673|FG003|Overall Study|Miscellaneous|4|||
28147567|NCT02805660|54814674|FG004|Overall Study|Miscellaneous|0|||
27822745|NCT01839487|54286699|FG001|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
28072336|NCT00121641|54726942|FG000|48-month Short Term + Long Term Period|Other Reason|5|||
28072337|NCT00121641|54726943|FG001|48-month Short Term + Long Term Period|Other Reason|3|||
28072338|NCT00121641|54726944|FG002|48-month Short Term + Long Term Period|Other Reason|2|||
28072339|NCT00121641|54726945|FG003|48-month Short Term + Long Term Period|Other Reason|0|||
28072340|NCT00121641|54726946|FG004|48-month Short Term + Long Term Period|Other Reason|1|||
28072341|NCT00425555|54726962|FG000|Overall Study|Withdrawal by Subject|11|||
28072342|NCT00425555|54726963|FG001|Overall Study|Withdrawal by Subject|8|||
28072343|NCT00425555|54726962|FG000|Overall Study|Lost to Follow-up|0|||
28072344|NCT00425555|54726963|FG001|Overall Study|Lost to Follow-up|1|||
28072345|NCT00425555|54726962|FG000|Overall Study|Administrative problems|3|||
28072346|NCT00425555|54726963|FG001|Overall Study|Administrative problems|0|||
28072347|NCT00425555|54726962|FG000|Overall Study|Death|1|||
28072348|NCT00425555|54726963|FG001|Overall Study|Death|2|||
28072349|NCT00425555|54726962|FG000|Overall Study|New cancer therapy|2|||
28072350|NCT00425555|54726963|FG001|Overall Study|New cancer therapy|1|||
28072351|NCT00425555|54726962|FG000|Overall Study|Disease progression|36|||
28072352|NCT00425555|54726963|FG001|Overall Study|Disease progression|33|||
28072353|NCT00425555|54726962|FG000|Overall Study|Adverse Event|25|||
28072354|NCT00425555|54726963|FG001|Overall Study|Adverse Event|15|||
28072355|NCT00425555|54726962|FG000|Overall Study|Protocol Violation|1|||
28072356|NCT00425555|54726963|FG001|Overall Study|Protocol Violation|0|||
28072357|NCT00424775|54726972|FG000|Overall Study|Adverse Event|2|||
28072358|NCT00424775|54726973|FG001|Overall Study|Adverse Event|0|||
28072359|NCT00424775|54726972|FG000|Overall Study|Lack of Efficacy|1|||
28072360|NCT00424775|54726973|FG001|Overall Study|Lack of Efficacy|0|||
28072361|NCT00121485|54726979|FG000|Overall Study|Not implanted|1|||
28072362|NCT00121485|54726980|FG001|Overall Study|Not implanted|5|||
28072363|NCT00121485|54726979|FG000|Overall Study|Crossover|0|||
28072364|NCT00121485|54726980|FG001|Overall Study|Crossover|2|||
28072365|NCT01763866|54727011|FG000|Overall Study|Withdrawal by Subject|2|||
28072366|NCT01763866|54727012|FG001|Overall Study|Withdrawal by Subject|1|||
28072367|NCT01763866|54727013|FG002|Overall Study|Withdrawal by Subject|4|||
28072368|NCT01763866|54727014|FG003|Overall Study|Withdrawal by Subject|0|||
28072369|NCT01763866|54727015|FG004|Overall Study|Withdrawal by Subject|0|||
28072370|NCT01763866|54727016|FG005|Overall Study|Withdrawal by Subject|3|||
28072371|NCT01763866|54727017|FG006|Overall Study|Withdrawal by Subject|4|||
28072372|NCT01763866|54727018|FG007|Overall Study|Withdrawal by Subject|0|||
28072373|NCT01763866|54727019|FG008|Overall Study|Withdrawal by Subject|1|||
28072374|NCT01763866|54727020|FG009|Overall Study|Withdrawal by Subject|1|||
28147568|NCT02805660|54814675|FG005|Overall Study|Miscellaneous|6|||
28147569|NCT02805660|54814676|FG006|Overall Study|Miscellaneous|4|||
28147570|NCT02807376|54814707|FG000|Overall Study|Intra-operative exclusion criteria|3|||
28147571|NCT02807376|54814708|FG001|Overall Study|Intra-operative exclusion criteria|0|||
28147572|NCT02807376|54814707|FG000|Overall Study|Lost to Follow-up|0|||
28147573|NCT02807376|54814708|FG001|Overall Study|Lost to Follow-up|1|||
28147574|NCT02804178|54814727|FG000|Overall Study|Adverse Event|1|||
28147575|NCT02917941|54814731|FG000|Treatment Period|Adverse Event|11|||
28147576|NCT02917941|54814731|FG000|Treatment Period|Progressive Disease|11|||
28147577|NCT02917941|54814731|FG000|Treatment Period|Reason not Specified|2|||
28147578|NCT02917941|54814731|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
28147579|NCT02917941|54814731|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
28147580|NCT01333956|54814739|FG000|Overall Study|Lost to Follow-up|1|||
28147581|NCT01333956|54814740|FG001|Overall Study|Lost to Follow-up|2|||
28147582|NCT01333956|54814741|FG002|Overall Study|Lost to Follow-up|0|||
28147583|NCT01333956|54814742|FG003|Overall Study|Lost to Follow-up|1|||
28147584|NCT01333956|54814739|FG000|Overall Study|Unable to complete study procedure|1|||
28147585|NCT01333956|54814740|FG001|Overall Study|Unable to complete study procedure|0|||
28147586|NCT01333956|54814741|FG002|Overall Study|Unable to complete study procedure|0|||
28147587|NCT01333956|54814742|FG003|Overall Study|Unable to complete study procedure|1|||
28147588|NCT01333956|54814739|FG000|Overall Study|Withdrawal by Subject|0|||
28147589|NCT01333956|54814740|FG001|Overall Study|Withdrawal by Subject|2|||
28147590|NCT01333956|54814741|FG002|Overall Study|Withdrawal by Subject|1|||
28147591|NCT01333956|54814742|FG003|Overall Study|Withdrawal by Subject|0|||
28147592|NCT01333722|54814755|FG000|Overall Study|Lack of Efficacy|0|||
28147593|NCT01333722|54814756|FG001|Overall Study|Lack of Efficacy|2|||
28147594|NCT01333722|54814755|FG000|Overall Study|Withdrawal by Subject|0|||
28147595|NCT01333722|54814756|FG001|Overall Study|Withdrawal by Subject|1|||
28147596|NCT01370694|54814764|FG000|Overall Study|Switched to rituximab|4|||
28147597|NCT01370694|54814764|FG000|Overall Study|Progressive disease|2|||
28147598|NCT03315143|54814770|FG000|Overall Study|Death|240|||
28147599|NCT03315143|54814771|FG001|Overall Study|Death|246|||
28147600|NCT03315143|54814770|FG000|Overall Study|Withdrawal by Subject|57|||
28147601|NCT03315143|54814771|FG001|Overall Study|Withdrawal by Subject|68|||
28147602|NCT03315143|54814770|FG000|Overall Study|Site Terminated by Sponsor|256|||
28147603|NCT03315143|54814771|FG001|Overall Study|Site Terminated by Sponsor|282|||
28147604|NCT03315143|54814770|FG000|Overall Study|Study Terminated by Sponsor|4723|||
28147605|NCT03315143|54814771|FG001|Overall Study|Study Terminated by Sponsor|4664|||
27822746|NCT01839487|54286700|FG002|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
27822747|NCT01839487|54286701|FG003|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3|||
28147606|NCT03315143|54814770|FG000|Overall Study|Reason not Specified|16|||
28147607|NCT03315143|54814771|FG001|Overall Study|Reason not Specified|32|||
28147608|NCT02797080|54814777|FG000|Overall Study|Lost to Follow-up|1|||
28147609|NCT02797080|54814777|FG000|Overall Study|Withdrawal by Subject|1|||
28147610|NCT02915835|54814783|FG000|Overall Study|Physician Decision|1|||
28147611|NCT02915835|54814784|FG001|Overall Study|Physician Decision|0|||
28147612|NCT02915835|54814783|FG000|Overall Study|Withdrawal by Subject|0|||
28147613|NCT02915835|54814784|FG001|Overall Study|Withdrawal by Subject|1|||
28147614|NCT01370616|54814792|FG000|Overall Study|Adverse Event|11|||
28147615|NCT01370616|54814793|FG001|Overall Study|Adverse Event|16|||
28147616|NCT01370616|54814792|FG000|Overall Study|Death|1|||
28147617|NCT01370616|54814793|FG001|Overall Study|Death|0|||
28147618|NCT01370616|54814792|FG000|Overall Study|Lack of Efficacy|6|||
28147619|NCT01370616|54814793|FG001|Overall Study|Lack of Efficacy|2|||
28147620|NCT01370616|54814792|FG000|Overall Study|Lost to Follow-up|0|||
28147621|NCT01370616|54814793|FG001|Overall Study|Lost to Follow-up|3|||
28147622|NCT01370616|54814792|FG000|Overall Study|Physician Decision|6|||
28147623|NCT01370616|54814793|FG001|Overall Study|Physician Decision|6|||
28147624|NCT01370616|54814792|FG000|Overall Study|Progressive Disease|0|||
28072375|NCT01763866|54727021|FG010|Overall Study|Withdrawal by Subject|2|||
28147625|NCT01370616|54814793|FG001|Overall Study|Progressive Disease|1|||
28147626|NCT01370616|54814792|FG000|Overall Study|Recovery|1|||
28147627|NCT01370616|54814793|FG001|Overall Study|Recovery|0|||
28147628|NCT01370616|54814792|FG000|Overall Study|Technical Problems|3|||
28147629|NCT01370616|54814793|FG001|Overall Study|Technical Problems|5|||
28147630|NCT01370616|54814792|FG000|Overall Study|Withdrawal by Subject|34|||
28147631|NCT01370616|54814793|FG001|Overall Study|Withdrawal by Subject|34|||
28072376|NCT01763866|54727022|FG011|Overall Study|Withdrawal by Subject|2|||
28072377|NCT01763866|54727023|FG012|Overall Study|Withdrawal by Subject|2|||
28072378|NCT01763866|54727024|FG013|Overall Study|Withdrawal by Subject|0|||
28072379|NCT01763866|54727025|FG014|Overall Study|Withdrawal by Subject|6|||
28072380|NCT01763866|54727026|FG015|Overall Study|Withdrawal by Subject|3|||
28072381|NCT01763866|54727027|FG016|Overall Study|Withdrawal by Subject|0|||
28072382|NCT01763866|54727028|FG017|Overall Study|Withdrawal by Subject|1|||
28072383|NCT01763866|54727029|FG018|Overall Study|Withdrawal by Subject|1|||
28072384|NCT01763866|54727030|FG019|Overall Study|Withdrawal by Subject|1|||
28072385|NCT01763866|54727031|FG020|Overall Study|Withdrawal by Subject|2|||
28072386|NCT01763866|54727032|FG021|Overall Study|Withdrawal by Subject|1|||
28072387|NCT01763866|54727033|FG022|Overall Study|Withdrawal by Subject|2|||
28072388|NCT01763866|54727034|FG023|Overall Study|Withdrawal by Subject|1|||
28072389|NCT01763866|54727011|FG000|Overall Study|Decision by sponsor|0|||
28072390|NCT01763866|54727012|FG001|Overall Study|Decision by sponsor|0|||
28072391|NCT01763866|54727013|FG002|Overall Study|Decision by sponsor|1|||
28072392|NCT01763866|54727014|FG003|Overall Study|Decision by sponsor|0|||
28147632|NCT02916927|54814806|FG000|Overall Study|Discharged prior to study drug receipt|0|||
28072393|NCT01763866|54727015|FG004|Overall Study|Decision by sponsor|2|||
28147633|NCT02916927|54814807|FG001|Overall Study|Discharged prior to study drug receipt|2|||
28147634|NCT02916927|54814806|FG000|Overall Study|At radiology for 45 & 60 min time points|0|||
28072394|NCT01763866|54727016|FG005|Overall Study|Decision by sponsor|0|||
28072395|NCT01763866|54727017|FG006|Overall Study|Decision by sponsor|2|||
28072396|NCT01763866|54727018|FG007|Overall Study|Decision by sponsor|0|||
28072397|NCT01763866|54727019|FG008|Overall Study|Decision by sponsor|2|||
28072398|NCT01763866|54727020|FG009|Overall Study|Decision by sponsor|0|||
28072399|NCT01763866|54727021|FG010|Overall Study|Decision by sponsor|6|||
28072400|NCT01763866|54727022|FG011|Overall Study|Decision by sponsor|0|||
28072401|NCT01763866|54727023|FG012|Overall Study|Decision by sponsor|1|||
28072402|NCT01763866|54727024|FG013|Overall Study|Decision by sponsor|0|||
28072403|NCT01763866|54727025|FG014|Overall Study|Decision by sponsor|5|||
28072404|NCT01763866|54727026|FG015|Overall Study|Decision by sponsor|0|||
28072405|NCT01763866|54727027|FG016|Overall Study|Decision by sponsor|0|||
28072406|NCT01763866|54727028|FG017|Overall Study|Decision by sponsor|0|||
28072407|NCT01763866|54727029|FG018|Overall Study|Decision by sponsor|4|||
28072408|NCT01763866|54727030|FG019|Overall Study|Decision by sponsor|0|||
28072409|NCT01763866|54727031|FG020|Overall Study|Decision by sponsor|2|||
28072410|NCT01763866|54727032|FG021|Overall Study|Decision by sponsor|0|||
28072411|NCT01763866|54727033|FG022|Overall Study|Decision by sponsor|1|||
28147635|NCT02916927|54814807|FG001|Overall Study|At radiology for 45 & 60 min time points|1|||
28147636|NCT02916927|54814806|FG000|Overall Study|Withdrawal before first time point|1|||
28147637|NCT02916927|54814807|FG001|Overall Study|Withdrawal before first time point|0|||
28147638|NCT02916693|54814813|FG000|Overall Study|Lost to Follow-up|7|||
28147639|NCT02574455|54814823|FG000|Overall Study|Death|197|||
28147640|NCT02574455|54814824|FG001|Overall Study|Death|210|||
28147641|NCT02574455|54814823|FG000|Overall Study|Withdrawal of Consent|11|||
28147642|NCT02574455|54814824|FG001|Overall Study|Withdrawal of Consent|28|||
28147643|NCT02574455|54814823|FG000|Overall Study|Lost to Follow-up|4|||
28147644|NCT02574455|54814824|FG001|Overall Study|Lost to Follow-up|4|||
28147645|NCT02574455|54814823|FG000|Overall Study|Sponsor's Decision|55|||
28147646|NCT02574455|54814824|FG001|Overall Study|Sponsor's Decision|20|||
28147647|NCT02795832|54814836|FG000|Overall Study|Adverse Event|0|||
28147648|NCT02795832|54814837|FG001|Overall Study|Adverse Event|0|||
28147649|NCT02795832|54814838|FG002|Overall Study|Adverse Event|0|||
28147650|NCT02795832|54814839|FG003|Overall Study|Adverse Event|0|||
28147651|NCT02795832|54814840|FG004|Overall Study|Adverse Event|0|||
28147652|NCT02795832|54814841|FG005|Overall Study|Adverse Event|3|||
28147653|NCT02794974|54814865|FG000|Overall Study|Physician Decision|0|||
28147654|NCT02794974|54814866|FG001|Overall Study|Physician Decision|1|||
28147655|NCT02419417|54814883|FG000|Overall Study|Disease progression|5|||
28147656|NCT02419417|54814884|FG001|Overall Study|Disease progression|4|||
28147657|NCT02419417|54814885|FG002|Overall Study|Disease progression|13|||
28147658|NCT02419417|54814886|FG003|Overall Study|Disease progression|10|||
28147659|NCT02419417|54814887|FG004|Overall Study|Disease progression|10|||
28147660|NCT02419417|54814888|FG005|Overall Study|Disease progression|3|||
28147661|NCT02419417|54814889|FG006|Overall Study|Disease progression|4|||
28147662|NCT02419417|54814890|FG007|Overall Study|Disease progression|5|||
28147663|NCT02419417|54814891|FG008|Overall Study|Disease progression|13|||
28147664|NCT02419417|54814892|FG009|Overall Study|Disease progression|9|||
28147665|NCT02419417|54814893|FG010|Overall Study|Disease progression|0|||
28147666|NCT02419417|54814883|FG000|Overall Study|Study drug toxicity|0|||
28147667|NCT02419417|54814884|FG001|Overall Study|Study drug toxicity|0|||
28147668|NCT02419417|54814885|FG002|Overall Study|Study drug toxicity|0|||
28147669|NCT02419417|54814886|FG003|Overall Study|Study drug toxicity|0|||
28072412|NCT01763866|54727034|FG023|Overall Study|Decision by sponsor|0|||
28147670|NCT02419417|54814887|FG004|Overall Study|Study drug toxicity|1|||
28147671|NCT02419417|54814888|FG005|Overall Study|Study drug toxicity|0|||
28147672|NCT02419417|54814889|FG006|Overall Study|Study drug toxicity|0|||
28147673|NCT02419417|54814890|FG007|Overall Study|Study drug toxicity|0|||
28147674|NCT02419417|54814891|FG008|Overall Study|Study drug toxicity|0|||
28147675|NCT02419417|54814892|FG009|Overall Study|Study drug toxicity|0|||
28072413|NCT01763866|54727011|FG000|Overall Study|Lost to Follow-up|0|||
28072414|NCT01763866|54727012|FG001|Overall Study|Lost to Follow-up|0|||
28147676|NCT02419417|54814893|FG010|Overall Study|Study drug toxicity|0|||
28147677|NCT02419417|54814883|FG000|Overall Study|Adverse event unrelated to study drug|0|||
28147678|NCT02419417|54814884|FG001|Overall Study|Adverse event unrelated to study drug|0|||
28147679|NCT02419417|54814885|FG002|Overall Study|Adverse event unrelated to study drug|0|||
28072415|NCT01763866|54727013|FG002|Overall Study|Lost to Follow-up|0|||
28147680|NCT02419417|54814886|FG003|Overall Study|Adverse event unrelated to study drug|0|||
28147681|NCT02419417|54814887|FG004|Overall Study|Adverse event unrelated to study drug|2|||
28147682|NCT02419417|54814888|FG005|Overall Study|Adverse event unrelated to study drug|1|||
28147683|NCT02419417|54814889|FG006|Overall Study|Adverse event unrelated to study drug|0|||
28147684|NCT02419417|54814890|FG007|Overall Study|Adverse event unrelated to study drug|1|||
28072416|NCT01763866|54727014|FG003|Overall Study|Lost to Follow-up|0|||
28147685|NCT02419417|54814891|FG008|Overall Study|Adverse event unrelated to study drug|0|||
28147686|NCT02419417|54814892|FG009|Overall Study|Adverse event unrelated to study drug|0|||
28147687|NCT02419417|54814893|FG010|Overall Study|Adverse event unrelated to study drug|0|||
28147688|NCT02419417|54814883|FG000|Overall Study|Participant request to discontinue|0|||
28147689|NCT02419417|54814884|FG001|Overall Study|Participant request to discontinue|0|||
28147690|NCT02419417|54814885|FG002|Overall Study|Participant request to discontinue|0|||
28147691|NCT02419417|54814886|FG003|Overall Study|Participant request to discontinue|0|||
28147692|NCT02419417|54814887|FG004|Overall Study|Participant request to discontinue|0|||
28147693|NCT02419417|54814888|FG005|Overall Study|Participant request to discontinue|0|||
28147694|NCT02419417|54814889|FG006|Overall Study|Participant request to discontinue|0|||
28147695|NCT02419417|54814890|FG007|Overall Study|Participant request to discontinue|0|||
28147696|NCT02419417|54814891|FG008|Overall Study|Participant request to discontinue|0|||
28147697|NCT02419417|54814892|FG009|Overall Study|Participant request to discontinue|1|||
28147698|NCT02419417|54814893|FG010|Overall Study|Participant request to discontinue|0|||
28147699|NCT02419417|54814883|FG000|Overall Study|Withdrawal by Subject|0|||
28147700|NCT02419417|54814884|FG001|Overall Study|Withdrawal by Subject|0|||
28147701|NCT02419417|54814885|FG002|Overall Study|Withdrawal by Subject|0|||
28147702|NCT02419417|54814886|FG003|Overall Study|Withdrawal by Subject|0|||
28147703|NCT02419417|54814887|FG004|Overall Study|Withdrawal by Subject|0|||
28147704|NCT02419417|54814888|FG005|Overall Study|Withdrawal by Subject|0|||
28147705|NCT02419417|54814889|FG006|Overall Study|Withdrawal by Subject|0|||
28147706|NCT02419417|54814890|FG007|Overall Study|Withdrawal by Subject|0|||
28147707|NCT02419417|54814891|FG008|Overall Study|Withdrawal by Subject|0|||
28147708|NCT02419417|54814892|FG009|Overall Study|Withdrawal by Subject|0|||
28147709|NCT02419417|54814893|FG010|Overall Study|Withdrawal by Subject|1|||
28147710|NCT00777491|54814934|FG000|Overall Study|Protocol Violation|0|||
28147711|NCT00777491|54814935|FG001|Overall Study|Protocol Violation|2|||
28147712|NCT00777491|54814934|FG000|Overall Study|Did not receive any protocol treatment|2|||
28147713|NCT00777491|54814935|FG001|Overall Study|Did not receive any protocol treatment|0|||
28147714|NCT03077711|54814947|FG000|Overall Study|Lost to Follow-up|2|||
28147715|NCT03077711|54814948|FG001|Overall Study|Lost to Follow-up|2|||
28147716|NCT03077711|54814947|FG000|Overall Study|noncompliant taking medication|2|||
28147717|NCT03077711|54814948|FG001|Overall Study|noncompliant taking medication|0|||
28147718|NCT04311463|54814975|FG000|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
28147719|NCT04311463|54814976|FG001|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|0|||
28147720|NCT04311463|54814975|FG000|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
28147721|NCT04311463|54814976|FG001|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
28147722|NCT04311463|54814975|FG000|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|2|||
28147723|NCT04311463|54814976|FG001|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
28147724|NCT01370538|54814989|FG000|Overall Study|Voluntary Discontinuation by Subject|3|||
28147725|NCT01370538|54814990|FG001|Overall Study|Voluntary Discontinuation by Subject|2|||
28147726|NCT01370538|54814989|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
28072417|NCT01763866|54727015|FG004|Overall Study|Lost to Follow-up|0|||
28147727|NCT01370538|54814990|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
28147728|NCT01370538|54814989|FG000|Overall Study|Adverse Event|1|||
28147729|NCT01370538|54814990|FG001|Overall Study|Adverse Event|0|||
28147730|NCT01370538|54814989|FG000|Overall Study|Protocol Violation|8|||
28147731|NCT01370538|54814990|FG001|Overall Study|Protocol Violation|5|||
28147732|NCT01370538|54814989|FG000|Overall Study|Development of study specific withdrawal|1|||
28072418|NCT01763866|54727016|FG005|Overall Study|Lost to Follow-up|0|||
28072419|NCT01763866|54727017|FG006|Overall Study|Lost to Follow-up|1|||
28072420|NCT01763866|54727018|FG007|Overall Study|Lost to Follow-up|0|||
28072421|NCT01763866|54727019|FG008|Overall Study|Lost to Follow-up|0|||
28072422|NCT01763866|54727020|FG009|Overall Study|Lost to Follow-up|0|||
28072423|NCT01763866|54727021|FG010|Overall Study|Lost to Follow-up|0|||
28072424|NCT01763866|54727022|FG011|Overall Study|Lost to Follow-up|0|||
28072425|NCT01763866|54727023|FG012|Overall Study|Lost to Follow-up|1|||
28072426|NCT01763866|54727024|FG013|Overall Study|Lost to Follow-up|0|||
28072427|NCT01763866|54727025|FG014|Overall Study|Lost to Follow-up|1|||
28147733|NCT01370538|54814990|FG001|Overall Study|Development of study specific withdrawal|1|||
28147734|NCT01370538|54814989|FG000|Overall Study|Lost to follow up|6|||
28147735|NCT01370538|54814990|FG001|Overall Study|Lost to follow up|10|||
28147736|NCT03402841|54815009|FG000|Overall Study|Withdrawal by Subject|3|||
28147737|NCT03402841|54815009|FG000|Overall Study|Lost to Follow-up|2|||
28147738|NCT03402841|54815009|FG000|Overall Study|Death|146|||
28147739|NCT02881957|54815024|FG000|Overall Study|Comfort care|0|||
28147740|NCT02881957|54815025|FG001|Overall Study|Comfort care|1|||
28147741|NCT02881957|54815024|FG000|Overall Study|Concurrent trial enrollment|0|||
28147742|NCT02881957|54815025|FG001|Overall Study|Concurrent trial enrollment|1|||
28147743|NCT02881957|54815024|FG000|Overall Study|Discharged within 48 hours|0|||
28147744|NCT02881957|54815025|FG001|Overall Study|Discharged within 48 hours|1|||
28147745|NCT02881957|54815024|FG000|Overall Study|Withdrawal by Subject|2|||
28147746|NCT02881957|54815025|FG001|Overall Study|Withdrawal by Subject|1|||
28147747|NCT02881957|54815024|FG000|Overall Study|Protocol Violation|1|||
28147748|NCT02881957|54815025|FG001|Overall Study|Protocol Violation|0|||
28147749|NCT03022461|54815031|FG000|Overall Study|Death|3|||
28147750|NCT02750930|54815036|FG000|Overall Study|Study closed/terminated|8|||
28147751|NCT03078907|54815042|FG000|Overall Study|Adverse Event|2|||
28147752|NCT03078907|54815043|FG001|Overall Study|Adverse Event|0|||
28147753|NCT03078907|54815042|FG000|Overall Study|Other|1|||
28147754|NCT03078907|54815043|FG001|Overall Study|Other|0|||
28147755|NCT03078907|54815042|FG000|Overall Study|Protocol Violation|0|||
28147756|NCT03078907|54815043|FG001|Overall Study|Protocol Violation|1|||
28147757|NCT03249714|54815051|FG000|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
28147758|NCT03249714|54815052|FG001|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
28147759|NCT03249714|54815051|FG000|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
28147760|NCT03249714|54815052|FG001|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
28147761|NCT03249714|54815051|FG000|Double-blind Treatment (Core Part)|Lost to Follow-up|1|||
28147762|NCT03249714|54815052|FG001|Double-blind Treatment (Core Part)|Lost to Follow-up|0|||
28147763|NCT03249714|54815051|FG000|Open-label Treatment (Extension Part)|Adverse Event|2|||
28147764|NCT03249714|54815052|FG001|Open-label Treatment (Extension Part)|Adverse Event|0|||
28147765|NCT02925117|54815078|FG000|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
28147766|NCT02925117|54815079|FG001|Period 1 (Weeks 0 - 16)|Adverse Event|3|||
28147767|NCT02925117|54815080|FG002|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
28147768|NCT02925117|54815081|FG003|Period 1 (Weeks 0 - 16)|Adverse Event|2|||
28147769|NCT02925117|54815082|FG004|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
28147770|NCT02925117|54815083|FG005|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
28147771|NCT02925117|54815084|FG006|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
28147772|NCT02925117|54815085|FG007|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
28147773|NCT02925117|54815086|FG008|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
28147774|NCT02925117|54815087|FG009|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
28147775|NCT02925117|54815088|FG010|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
28147776|NCT02925117|54815089|FG011|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
28147777|NCT02925117|54815078|FG000|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10|||
28147778|NCT02925117|54815079|FG001|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
28147779|NCT02925117|54815080|FG002|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
28147780|NCT02925117|54815081|FG003|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
28147781|NCT02925117|54815082|FG004|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
28147782|NCT02925117|54815083|FG005|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
28147783|NCT02925117|54815084|FG006|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
28072428|NCT01763866|54727026|FG015|Overall Study|Lost to Follow-up|0|||
28072429|NCT01763866|54727027|FG016|Overall Study|Lost to Follow-up|0|||
28072430|NCT01763866|54727028|FG017|Overall Study|Lost to Follow-up|0|||
28072431|NCT01763866|54727029|FG018|Overall Study|Lost to Follow-up|1|||
28072432|NCT01763866|54727030|FG019|Overall Study|Lost to Follow-up|1|||
28072433|NCT01763866|54727031|FG020|Overall Study|Lost to Follow-up|0|||
28072434|NCT01763866|54727032|FG021|Overall Study|Lost to Follow-up|0|||
28072435|NCT01763866|54727033|FG022|Overall Study|Lost to Follow-up|0|||
28072436|NCT01763866|54727034|FG023|Overall Study|Lost to Follow-up|1|||
28072437|NCT01763866|54727011|FG000|Overall Study|Death|0|||
28072438|NCT01763866|54727012|FG001|Overall Study|Death|0|||
28147784|NCT02925117|54815085|FG007|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
28147785|NCT02925117|54815086|FG008|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
28072439|NCT01763866|54727013|FG002|Overall Study|Death|0|||
28147786|NCT02925117|54815087|FG009|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
28147787|NCT02925117|54815088|FG010|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
28072440|NCT01763866|54727014|FG003|Overall Study|Death|0|||
28072441|NCT01763866|54727015|FG004|Overall Study|Death|0|||
28072442|NCT01763866|54727016|FG005|Overall Study|Death|0|||
28147788|NCT02925117|54815089|FG011|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
28147789|NCT02925117|54815078|FG000|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2|||
28147790|NCT02925117|54815079|FG001|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1|||
28147791|NCT02925117|54815080|FG002|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
28147792|NCT02925117|54815081|FG003|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
28147793|NCT02925117|54815082|FG004|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
28147794|NCT02925117|54815083|FG005|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
28147795|NCT02925117|54815084|FG006|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
28147796|NCT02925117|54815085|FG007|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
28147797|NCT02925117|54815086|FG008|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
28147798|NCT02925117|54815087|FG009|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
28147799|NCT02925117|54815088|FG010|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
28147800|NCT02925117|54815089|FG011|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
28147801|NCT02925117|54815078|FG000|Period 1 (Weeks 0 - 16)|Other|5|||
28147802|NCT02925117|54815079|FG001|Period 1 (Weeks 0 - 16)|Other|4|||
28147803|NCT02925117|54815080|FG002|Period 1 (Weeks 0 - 16)|Other|1|||
28147804|NCT02925117|54815081|FG003|Period 1 (Weeks 0 - 16)|Other|1|||
28147805|NCT02925117|54815082|FG004|Period 1 (Weeks 0 - 16)|Other|0|||
28147806|NCT02925117|54815083|FG005|Period 1 (Weeks 0 - 16)|Other|0|||
28147807|NCT02925117|54815084|FG006|Period 1 (Weeks 0 - 16)|Other|0|||
28147808|NCT02925117|54815085|FG007|Period 1 (Weeks 0 - 16)|Other|0|||
28147809|NCT02925117|54815086|FG008|Period 1 (Weeks 0 - 16)|Other|0|||
28147810|NCT02925117|54815087|FG009|Period 1 (Weeks 0 - 16)|Other|0|||
28147811|NCT02925117|54815088|FG010|Period 1 (Weeks 0 - 16)|Other|0|||
28147812|NCT02925117|54815089|FG011|Period 1 (Weeks 0 - 16)|Other|0|||
28147813|NCT02925117|54815078|FG000|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
28147814|NCT02925117|54815079|FG001|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
28147815|NCT02925117|54815080|FG002|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
28147816|NCT02925117|54815081|FG003|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
28147817|NCT02925117|54815082|FG004|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
28147818|NCT02925117|54815083|FG005|Period 2 (Weeks 16 - 88)|Adverse Event|1|||
28147819|NCT02925117|54815084|FG006|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
28147820|NCT02925117|54815085|FG007|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
28147821|NCT02925117|54815086|FG008|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
28147822|NCT02925117|54815087|FG009|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
28147823|NCT02925117|54815088|FG010|Period 2 (Weeks 16 - 88)|Adverse Event|3|||
28147824|NCT02925117|54815089|FG011|Period 2 (Weeks 16 - 88)|Adverse Event|2|||
28147825|NCT02925117|54815078|FG000|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
28147826|NCT02925117|54815079|FG001|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
28147827|NCT02925117|54815080|FG002|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
28147828|NCT02925117|54815081|FG003|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
28147829|NCT02925117|54815082|FG004|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
28147830|NCT02925117|54815083|FG005|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1|||
28147831|NCT02925117|54815084|FG006|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4|||
28147832|NCT02925117|54815085|FG007|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3|||
28147833|NCT02925117|54815086|FG008|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
28147834|NCT02925117|54815087|FG009|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
28147835|NCT02925117|54815088|FG010|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
28147836|NCT02925117|54815089|FG011|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
28147837|NCT02925117|54815078|FG000|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
28147838|NCT02925117|54815079|FG001|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
28147839|NCT02925117|54815080|FG002|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
28147840|NCT02925117|54815081|FG003|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
28147841|NCT02925117|54815082|FG004|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
28147842|NCT02925117|54815083|FG005|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2|||
28147843|NCT02925117|54815084|FG006|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
28147844|NCT02925117|54815085|FG007|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
28147845|NCT02925117|54815086|FG008|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
28147846|NCT02925117|54815087|FG009|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
28147847|NCT02925117|54815088|FG010|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
28147848|NCT02925117|54815089|FG011|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
28147849|NCT02925117|54815078|FG000|Period 2 (Weeks 16 - 88)|Other|0|||
28147850|NCT02925117|54815079|FG001|Period 2 (Weeks 16 - 88)|Other|0|||
28147851|NCT02925117|54815080|FG002|Period 2 (Weeks 16 - 88)|Other|0|||
28147852|NCT02925117|54815081|FG003|Period 2 (Weeks 16 - 88)|Other|0|||
28147853|NCT02925117|54815082|FG004|Period 2 (Weeks 16 - 88)|Other|1|||
28147854|NCT02925117|54815083|FG005|Period 2 (Weeks 16 - 88)|Other|1|||
28147855|NCT02925117|54815084|FG006|Period 2 (Weeks 16 - 88)|Other|1|||
28147856|NCT02925117|54815085|FG007|Period 2 (Weeks 16 - 88)|Other|1|||
28147857|NCT02925117|54815086|FG008|Period 2 (Weeks 16 - 88)|Other|3|||
28147858|NCT02925117|54815087|FG009|Period 2 (Weeks 16 - 88)|Other|4|||
28147859|NCT02925117|54815088|FG010|Period 2 (Weeks 16 - 88)|Other|3|||
28147860|NCT02925117|54815089|FG011|Period 2 (Weeks 16 - 88)|Other|0|||
28147861|NCT03075163|54815113|FG000|Overall Study|not eligible for treatment limb|138|||
28147862|NCT03075163|54815114|FG001|Overall Study|not eligible for treatment limb|138|||
28147863|NCT03078751|54815122|FG000|Overall Study|Adverse Event|4|||
28147864|NCT03078751|54815123|FG001|Overall Study|Adverse Event|0|||
28147865|NCT03078751|54815122|FG000|Overall Study|Physician Decision|1|||
28147866|NCT03078751|54815123|FG001|Overall Study|Physician Decision|0|||
28147867|NCT03078751|54815122|FG000|Overall Study|Terminated by Sponsor = early terminated recruitment|0|||
28147868|NCT03078751|54815123|FG001|Overall Study|Terminated by Sponsor = early terminated recruitment|23|||
28147869|NCT03078751|54815122|FG000|Overall Study|Subject/guardian decision|8|||
28147870|NCT03078751|54815123|FG001|Overall Study|Subject/guardian decision|1|||
28147871|NCT03078751|54815122|FG000|Overall Study|Untreated|0|||
28147872|NCT03078751|54815123|FG001|Overall Study|Untreated|4|||
28147873|NCT02924883|54815131|FG000|Overall Study|Death|39|||
28147874|NCT02924883|54815132|FG001|Overall Study|Death|20|||
28147875|NCT02924883|54815131|FG000|Overall Study|Lost to Follow-up|1|||
28147876|NCT02924883|54815132|FG001|Overall Study|Lost to Follow-up|0|||
28147877|NCT02924883|54815131|FG000|Overall Study|Symptomatic Deterioration/ Clinical Progression|0|||
28147878|NCT02924883|54815132|FG001|Overall Study|Symptomatic Deterioration/ Clinical Progression|1|||
28147879|NCT02924883|54815131|FG000|Overall Study|Protocol Violation|1|||
28147880|NCT02924883|54815132|FG001|Overall Study|Protocol Violation|0|||
28147881|NCT02924883|54815131|FG000|Overall Study|Withdrawal by Subject|22|||
28147882|NCT02924883|54815132|FG001|Overall Study|Withdrawal by Subject|16|||
28147883|NCT02924883|54815131|FG000|Overall Study|Progressive Disease|1|||
28147884|NCT02924883|54815132|FG001|Overall Study|Progressive Disease|0|||
28147885|NCT02924883|54815131|FG000|Overall Study|Study Terminated by Sponsor|69|||
28147886|NCT02924883|54815132|FG001|Overall Study|Study Terminated by Sponsor|32|||
28147887|NCT01369680|54815155|FG000|Overall Study|Lost to Follow-up|0|||
28147888|NCT01369680|54815156|FG001|Overall Study|Lost to Follow-up|0|||
28147889|NCT01369680|54815157|FG002|Overall Study|Lost to Follow-up|1|||
28147890|NCT01369680|54815158|FG003|Overall Study|Lost to Follow-up|2|||
28147891|NCT03074149|54815190|FG000|Overall Study|Reason unknown|22|||
28147892|NCT03074149|54815191|FG001|Overall Study|Reason unknown|35|||
28147893|NCT03074149|54815190|FG000|Overall Study|Death|10|||
28147894|NCT03074149|54815191|FG001|Overall Study|Death|45|||
28147895|NCT02751320|54815199|FG000|Overall Study|Adverse Event|2|||
28147896|NCT02751320|54815199|FG000|Overall Study|Withdrawal by Subject|1|||
28147897|NCT02206035|54815227|FG000|Overall Study|Physician Decision|10|||
28147898|NCT02206035|54815228|FG001|Overall Study|Physician Decision|0|||
28147899|NCT02206035|54815229|FG002|Overall Study|Physician Decision|175|||
28147900|NCT02746471|54815236|FG000|Overall Study|Death|43|||
28147901|NCT02746471|54815236|FG000|Overall Study|Exited before 36 months|1119|||
28147902|NCT02591953|54815243|FG000|Overall Study|Lost to Follow-up|6|||
28147903|NCT02591953|54815244|FG001|Overall Study|Lost to Follow-up|6|||
28147904|NCT03073213|54815252|FG000|Multiple Dose Period|Protocol Violation|0|||
28147905|NCT03073213|54815253|FG001|Multiple Dose Period|Protocol Violation|0|||
28147906|NCT03073213|54815254|FG002|Multiple Dose Period|Protocol Violation|1|||
28147907|NCT03070483|54815263|FG000|Overall Study|Lost to Follow-up|2|||
28147908|NCT02231762|54815268|FG000|Combination Phase|Adverse Event|10|||
28147909|NCT02231762|54815269|FG001|Combination Phase|Adverse Event|0|||
28147910|NCT02231762|54815270|FG002|Combination Phase|Adverse Event|0|||
28147911|NCT02231762|54815271|FG003|Combination Phase|Adverse Event|0|||
28147912|NCT02231762|54815268|FG000|Combination Phase|Withdrawal by Subject|2|||
28147913|NCT02231762|54815269|FG001|Combination Phase|Withdrawal by Subject|0|||
28147914|NCT02231762|54815270|FG002|Combination Phase|Withdrawal by Subject|0|||
28147915|NCT02231762|54815271|FG003|Combination Phase|Withdrawal by Subject|0|||
28147916|NCT02231762|54815268|FG000|Combination Phase|Disease Progression|6|||
28147917|NCT02231762|54815269|FG001|Combination Phase|Disease Progression|0|||
28147918|NCT02231762|54815270|FG002|Combination Phase|Disease Progression|0|||
28147919|NCT02231762|54815271|FG003|Combination Phase|Disease Progression|0|||
28147920|NCT02231762|54815268|FG000|Combination Phase|Did not meet inclusion criteria|1|||
28147921|NCT02231762|54815269|FG001|Combination Phase|Did not meet inclusion criteria|0|||
28147922|NCT02231762|54815270|FG002|Combination Phase|Did not meet inclusion criteria|0|||
28147923|NCT02231762|54815271|FG003|Combination Phase|Did not meet inclusion criteria|0|||
28147924|NCT02231762|54815268|FG000|Combination Phase|Protocol Violation|1|||
28147925|NCT02231762|54815269|FG001|Combination Phase|Protocol Violation|0|||
28147926|NCT02231762|54815270|FG002|Combination Phase|Protocol Violation|0|||
28147927|NCT02231762|54815271|FG003|Combination Phase|Protocol Violation|0|||
28072443|NCT01763866|54727017|FG006|Overall Study|Death|0|||
28072444|NCT01763866|54727018|FG007|Overall Study|Death|0|||
28072445|NCT01763866|54727019|FG008|Overall Study|Death|0|||
28072446|NCT01763866|54727020|FG009|Overall Study|Death|0|||
28072447|NCT01763866|54727021|FG010|Overall Study|Death|0|||
28072448|NCT01763866|54727022|FG011|Overall Study|Death|0|||
28147928|NCT02231762|54815268|FG000|Maintenance Phase|Disease progression|0|||
28147929|NCT02231762|54815269|FG001|Maintenance Phase|Disease progression|3|||
28147930|NCT02231762|54815270|FG002|Maintenance Phase|Disease progression|4|||
28147931|NCT02231762|54815271|FG003|Maintenance Phase|Disease progression|3|||
28147932|NCT02231762|54815268|FG000|Maintenance Phase|Adverse Event|0|||
28147933|NCT02231762|54815269|FG001|Maintenance Phase|Adverse Event|0|||
28147934|NCT02231762|54815270|FG002|Maintenance Phase|Adverse Event|1|||
28147935|NCT02231762|54815271|FG003|Maintenance Phase|Adverse Event|2|||
28147936|NCT03023397|54815288|FG000|Run-In|Failed screening allergen challenge|1|||
28147937|NCT03023397|54815289|FG001|Run-In|Failed screening allergen challenge|0|||
28147938|NCT03023397|54815290|FG002|Run-In|Failed screening allergen challenge|0|||
28147939|NCT03023397|54815288|FG000|Run-In|Loss of funding after informed consent but before screening allergen challenge|1|||
28147940|NCT03023397|54815289|FG001|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
28072449|NCT01763866|54727023|FG012|Overall Study|Death|0|||
28072450|NCT01763866|54727024|FG013|Overall Study|Death|0|||
28072451|NCT01763866|54727025|FG014|Overall Study|Death|0|||
28072452|NCT01763866|54727026|FG015|Overall Study|Death|0|||
28072453|NCT01763866|54727027|FG016|Overall Study|Death|1|||
28072454|NCT01763866|54727028|FG017|Overall Study|Death|0|||
28072455|NCT01763866|54727029|FG018|Overall Study|Death|0|||
28072456|NCT01763866|54727030|FG019|Overall Study|Death|0|||
28072457|NCT01763866|54727031|FG020|Overall Study|Death|0|||
28072458|NCT01763866|54727032|FG021|Overall Study|Death|0|||
28072459|NCT01763866|54727033|FG022|Overall Study|Death|0|||
28072460|NCT01763866|54727034|FG023|Overall Study|Death|0|||
28147941|NCT03023397|54815290|FG002|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
28072461|NCT00132873|54727084|FG000|Overall Study|Adverse Event|3|||
28072462|NCT00132873|54727084|FG000|Overall Study|Lost to Follow-up|1|||
28147942|NCT04325906|54815301|FG000|Overall Study|Withdrawal by Subject|2|||
28147943|NCT04325906|54815302|FG001|Overall Study|Withdrawal by Subject|0|||
28147944|NCT03068455|54815310|FG000|Pre-treatment Period|Disease progression|0|||
28147945|NCT03068455|54815311|FG001|Pre-treatment Period|Disease progression|1|||
28147946|NCT03068455|54815310|FG000|Pre-treatment Period|Participant withdrew consent|1|||
28147947|NCT03068455|54815311|FG001|Pre-treatment Period|Participant withdrew consent|1|||
28147948|NCT03068455|54815310|FG000|Pre-treatment Period|Poor/non-compliance|0|||
28147949|NCT03068455|54815311|FG001|Pre-treatment Period|Poor/non-compliance|1|||
28147950|NCT03068455|54815310|FG000|Pre-treatment Period|Participant no longer meets study criteria|1|||
28147951|NCT03068455|54815311|FG001|Pre-treatment Period|Participant no longer meets study criteria|3|||
28147952|NCT03068455|54815310|FG000|Pre-treatment Period|Not reported|2|||
28072463|NCT00132873|54727084|FG000|Overall Study|Lack of Efficacy|1|||
28072464|NCT00132873|54727084|FG000|Overall Study|Withdrawal by Subject|3|||
28072465|NCT00132873|54727084|FG000|Overall Study|Planned Pregnancy|1|||
28072466|NCT00120627|54727090|FG000|Overall Study|Withdrawal by Subject|5|||
28072467|NCT00120627|54727091|FG001|Overall Study|Withdrawal by Subject|5|||
28072468|NCT03762616|54727106|FG000|Overall Study|Protocol Violation|2|||
28147953|NCT03068455|54815311|FG001|Pre-treatment Period|Not reported|1|||
28147954|NCT03068455|54815310|FG000|Treatment Period|Disease progression|166|||
28147955|NCT03068455|54815311|FG001|Treatment Period|Disease progression|208|||
28072469|NCT04246996|54727114|FG000|Overall Study|Physician Decision|1|||
28072470|NCT04246996|54727115|FG001|Overall Study|Physician Decision|1|||
28072471|NCT04246996|54727114|FG000|Overall Study|Did not meet eligibility criteria|1|||
28072472|NCT04246996|54727115|FG001|Overall Study|Did not meet eligibility criteria|4|||
28072473|NCT00424463|54727124|FG000|Overall Study|Adverse Event|2|||
28072474|NCT00424463|54727125|FG001|Overall Study|Adverse Event|3|||
28072475|NCT00424463|54727126|FG002|Overall Study|Adverse Event|2|||
28072476|NCT00424463|54727124|FG000|Overall Study|Physician Decision|0|||
28072477|NCT00424463|54727125|FG001|Overall Study|Physician Decision|2|||
28072478|NCT00424463|54727126|FG002|Overall Study|Physician Decision|2|||
28072479|NCT00424463|54727124|FG000|Overall Study|Withdrawal by Subject|4|||
28072480|NCT00424463|54727125|FG001|Overall Study|Withdrawal by Subject|2|||
28072481|NCT00424463|54727126|FG002|Overall Study|Withdrawal by Subject|5|||
28072482|NCT00424463|54727124|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
28072483|NCT00424463|54727125|FG001|Overall Study|Tracheotomy due to worsening of ALS|7|||
28147956|NCT03068455|54815310|FG000|Treatment Period|Study drug toxicity|317|||
28147957|NCT03068455|54815311|FG001|Treatment Period|Study drug toxicity|104|||
28147958|NCT03068455|54815310|FG000|Treatment Period|Adverse Event unrelated to study drug|15|||
28147959|NCT03068455|54815311|FG001|Treatment Period|Adverse Event unrelated to study drug|7|||
28072484|NCT00424463|54727126|FG002|Overall Study|Tracheotomy due to worsening of ALS|6|||
28072485|NCT00424463|54727124|FG000|Overall Study|Patient's convenience|0|||
28072486|NCT00424463|54727125|FG001|Overall Study|Patient's convenience|0|||
28072487|NCT00424463|54727126|FG002|Overall Study|Patient's convenience|1|||
28147960|NCT03068455|54815310|FG000|Treatment Period|Participant request to stop therapy|33|||
28147961|NCT03068455|54815311|FG001|Treatment Period|Participant request to stop therapy|20|||
28147962|NCT03068455|54815310|FG000|Treatment Period|Participant withdrew consent|5|||
28072488|NCT00424385|54727134|FG000|Cohort 0|Withdrawal by Subject|5|||
28072489|NCT00424385|54727134|FG000|Cohort 0|Physician Decision|1|||
28147963|NCT03068455|54815311|FG001|Treatment Period|Participant withdrew consent|10|||
28147964|NCT03068455|54815310|FG000|Treatment Period|Poor/non-compliance|3|||
28147965|NCT03068455|54815311|FG001|Treatment Period|Poor/non-compliance|0|||
28147966|NCT03068455|54815310|FG000|Treatment Period|Participant no longer meets study criteria|1|||
28147967|NCT03068455|54815311|FG001|Treatment Period|Participant no longer meets study criteria|3|||
28147968|NCT03068455|54815310|FG000|Treatment Period|Other reasons|12|||
28147969|NCT03068455|54815311|FG001|Treatment Period|Other reasons|4|||
28147970|NCT03067987|54815319|FG000|Overall Study|Lost to Follow-up|7|||
28147971|NCT03067987|54815320|FG001|Overall Study|Lost to Follow-up|10|||
28147972|NCT03067987|54815319|FG000|Overall Study|Protocol Violation|1|||
28147973|NCT03067987|54815320|FG001|Overall Study|Protocol Violation|2|||
28147974|NCT03067987|54815319|FG000|Overall Study|Withdrawal by Subject|2|||
28147975|NCT03067987|54815320|FG001|Overall Study|Withdrawal by Subject|1|||
28147976|NCT03197870|54815329|FG000|Overall Study|Adverse Event|9|||
28072490|NCT00424385|54727134|FG000|Cohort 1|Withdrawal by Subject|1|||
28147977|NCT03197870|54815330|FG001|Overall Study|Adverse Event|4|||
28147978|NCT03197870|54815331|FG002|Overall Study|Adverse Event|6|||
28147979|NCT03197870|54815329|FG000|Overall Study|Withdrawal by Subject|2|||
28147980|NCT03197870|54815330|FG001|Overall Study|Withdrawal by Subject|3|||
28072491|NCT00423917|54727140|FG000|Overall Study|Cancel|2|||
28072492|NCT00423917|54727140|FG000|Overall Study|Ineligible|1|||
28072493|NCT00845026|54727146|FG000|Study Period III|Adverse Event|23|||
28072494|NCT00845026|54727147|FG001|Study Period III|Adverse Event|19|||
28072495|NCT00845026|54727146|FG000|Study Period III|Perceived lack of efficacy|27|||
28072496|NCT00845026|54727147|FG001|Study Period III|Perceived lack of efficacy|15|||
28147981|NCT03197870|54815331|FG002|Overall Study|Withdrawal by Subject|0|||
28147982|NCT03197870|54815329|FG000|Overall Study|Lost to Follow-up|2|||
28147983|NCT03197870|54815330|FG001|Overall Study|Lost to Follow-up|2|||
28147984|NCT03197870|54815331|FG002|Overall Study|Lost to Follow-up|0|||
28147985|NCT03197870|54815329|FG000|Overall Study|data not available|1|||
28147986|NCT03197870|54815330|FG001|Overall Study|data not available|1|||
28147987|NCT03197870|54815331|FG002|Overall Study|data not available|0|||
28147988|NCT04889222|54815342|FG000|Overall Study|Did not meet eligibility criteria|8|||
28147989|NCT04889222|54815342|FG000|Overall Study|Failure to place intravenous or arterial line|3|||
28072497|NCT00845026|54727146|FG000|Study Period III|Withdrawal by Subject|19|||
28072498|NCT00845026|54727147|FG001|Study Period III|Withdrawal by Subject|15|||
28072499|NCT00845026|54727146|FG000|Study Period III|Entry Criteria not met|8|||
28072500|NCT00845026|54727147|FG001|Study Period III|Entry Criteria not met|11|||
28072501|NCT00845026|54727146|FG000|Study Period III|Lost to Follow-up|4|||
28072502|NCT00845026|54727147|FG001|Study Period III|Lost to Follow-up|5|||
28072503|NCT00845026|54727146|FG000|Study Period III|Protocol Violation|8|||
28072504|NCT00845026|54727147|FG001|Study Period III|Protocol Violation|1|||
28072505|NCT00845026|54727146|FG000|Study Period III|Scheduled conflict|3|||
28072506|NCT00845026|54727147|FG001|Study Period III|Scheduled conflict|1|||
28072507|NCT00845026|54727146|FG000|Study Period III|Subject is moving or has moved|2|||
28072508|NCT00845026|54727147|FG001|Study Period III|Subject is moving or has moved|4|||
28072509|NCT00845026|54727146|FG000|Study Period III|Transportation issues|1|||
28072510|NCT00845026|54727147|FG001|Study Period III|Transportation issues|1|||
28072511|NCT00845026|54727146|FG000|Study Period IV|Adverse Event|4|||
28072512|NCT00845026|54727147|FG001|Study Period IV|Adverse Event|0|||
28072513|NCT00845026|54727146|FG000|Study Period IV|Perceived lack of efficacy|2|||
28072514|NCT00845026|54727147|FG001|Study Period IV|Perceived lack of efficacy|1|||
28072515|NCT00845026|54727146|FG000|Study Period IV|Protocol Violation|3|||
28072516|NCT00845026|54727147|FG001|Study Period IV|Protocol Violation|1|||
28072517|NCT00845026|54727146|FG000|Study Period IV|Lost to Follow-up|1|||
28072518|NCT00845026|54727147|FG001|Study Period IV|Lost to Follow-up|0|||
28072519|NCT00845026|54727146|FG000|Study Period IV|Withdrawal by Subject|4|||
28072520|NCT00845026|54727147|FG001|Study Period IV|Withdrawal by Subject|1|||
28072521|NCT00845026|54727146|FG000|Study Period IV|Entry Criteria Not Met|1|||
28147990|NCT04889222|54815342|FG000|Overall Study|Did not proceed due to time constraints|5|||
28147991|NCT03067441|54815365|FG000|Overall Study|Withdrawal by Subject|16|||
28147992|NCT03067441|54815366|FG001|Overall Study|Withdrawal by Subject|34|||
28147993|NCT03067441|54815365|FG000|Overall Study|Lost to Follow-up|7|||
28147994|NCT03067441|54815366|FG001|Overall Study|Lost to Follow-up|5|||
28147995|NCT03067441|54815365|FG000|Overall Study|Adverse Event|7|||
27941752|NCT03672175|54598284|FG000|Extended FU Period (Days 43 to 182)|Adverse Event|5|||
28072522|NCT00845026|54727147|FG001|Study Period IV|Entry Criteria Not Met|0|||
28147996|NCT03067441|54815366|FG001|Overall Study|Adverse Event|14|||
28147997|NCT03067441|54815365|FG000|Overall Study|Study Terminated by Sponsor or Investigator|1|||
28147998|NCT03067441|54815366|FG001|Overall Study|Study Terminated by Sponsor or Investigator|0|||
28072523|NCT00845026|54727146|FG000|Study Period IV|Subject is moving or has moved|0|||
28072524|NCT00845026|54727147|FG001|Study Period IV|Subject is moving or has moved|1|||
28147999|NCT03067441|54815365|FG000|Overall Study|Physician Decision|1|||
28072525|NCT00845026|54727146|FG000|Study Period IV|Scheduling conflict|1|||
28072526|NCT00845026|54727147|FG001|Study Period IV|Scheduling conflict|0|||
28072527|NCT00691678|54727155|FG000|Overall Study|Adverse Event|5|||
28072528|NCT00691678|54727155|FG000|Overall Study|life events, pain|11|||
28072529|NCT00423605|54727159|FG000|Overall Study|Adverse Event|129|||
28072530|NCT00423605|54727159|FG000|Overall Study|Withdrawal by Subject|36|||
28148000|NCT03067441|54815366|FG001|Overall Study|Physician Decision|3|||
28148001|NCT03067441|54815365|FG000|Overall Study|Other|1|||
28148002|NCT03067441|54815366|FG001|Overall Study|Other|1|||
28148003|NCT02600923|54815375|FG000|Overall Study|Death|10|||
28148004|NCT02600923|54815375|FG000|Overall Study|Adverse Event|3|||
28148005|NCT02600923|54815375|FG000|Overall Study|Global deterioration of health status|2|||
28148006|NCT02600923|54815375|FG000|Overall Study|Insufficient clinical response|6|||
28148007|NCT02600923|54815375|FG000|Overall Study|Lost to Follow-up|1|||
28148008|NCT02600923|54815375|FG000|Overall Study|Withdrawal by Subject|5|||
28148009|NCT02600923|54815375|FG000|Overall Study|Objective progression or relapse|50|||
28148010|NCT02600923|54815375|FG000|Overall Study|Study terminated by Sponsor|53|||
28148011|NCT02600923|54815375|FG000|Overall Study|Not treated|1|||
28148012|NCT03070171|54815381|FG000|Treatment Period 2 + Washout|Other Adverse Event|0|||
28148013|NCT03070171|54815382|FG001|Treatment Period 2 + Washout|Other Adverse Event|1|||
28148014|NCT03070171|54815381|FG000|Treatment Period 4 + Washout|Withdrawal by Subject|0|||
28148015|NCT03070171|54815382|FG001|Treatment Period 4 + Washout|Withdrawal by Subject|1|||
28148016|NCT03644017|54815388|FG000|Overall Study|Access Abandonment|5|||
28148017|NCT03644017|54815388|FG000|Overall Study|Kidney Transplant|2|||
28148018|NCT00158054|54815394|FG000|Overall Study|Refused to continue|3|||
28148019|NCT00158054|54815395|FG001|Overall Study|Refused to continue|0|||
28148020|NCT00158054|54815394|FG000|Overall Study|Unavailable for follow up|7|||
28148021|NCT00158054|54815395|FG001|Overall Study|Unavailable for follow up|3|||
28148022|NCT01337960|54815404|FG000|Overall Study|Lost to Follow-up|1|||
28148023|NCT01337960|54815405|FG001|Overall Study|Lost to Follow-up|0|||
28148024|NCT01337960|54815406|FG002|Overall Study|Lost to Follow-up|0|||
28148025|NCT01337960|54815404|FG000|Overall Study|Withdrawal by Subject|1|||
28148026|NCT01337960|54815405|FG001|Overall Study|Withdrawal by Subject|0|||
28148027|NCT01337960|54815406|FG002|Overall Study|Withdrawal by Subject|0|||
28148028|NCT02750306|54815425|FG000|Overall Study|Withdrawal by Subject|5|||
28148029|NCT02750306|54815426|FG001|Overall Study|Withdrawal by Subject|2|||
28148030|NCT02750306|54815425|FG000|Overall Study|Protocol Violation|1|||
28148031|NCT02750306|54815426|FG001|Overall Study|Protocol Violation|0|||
28148032|NCT01816165|54815434|FG000|Overall Study|Adverse Event|1|||
28148033|NCT01816165|54815435|FG001|Overall Study|Adverse Event|0|||
28148034|NCT01816165|54815436|FG002|Overall Study|Adverse Event|0|||
28148035|NCT01816165|54815437|FG003|Overall Study|Adverse Event|0|||
28148036|NCT01677988|54815466|FG000|Overall Study|Lack of Efficacy|2|||
28148037|NCT02926573|54815473|FG000|Overall Study|Nausea|1|||
27941753|NCT03672175|54598285|FG001|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
28072531|NCT00423605|54727159|FG000|Overall Study|Lost to Follow-up|15|||
28148038|NCT02926573|54815474|FG001|Overall Study|Nausea|0|||
28148039|NCT02926573|54815473|FG000|Overall Study|Remain intubated|2|||
28148040|NCT02926573|54815474|FG001|Overall Study|Remain intubated|2|||
28148041|NCT02926573|54815473|FG000|Overall Study|Change in surgery plan|3|||
28148042|NCT02926573|54815474|FG001|Overall Study|Change in surgery plan|1|||
28148043|NCT02926573|54815473|FG000|Overall Study|Change to outpatient status|5|||
28148044|NCT02926573|54815474|FG001|Overall Study|Change to outpatient status|1|||
28148045|NCT02926573|54815473|FG000|Overall Study|Withdrawal by Subject|0|||
28148046|NCT02926573|54815474|FG001|Overall Study|Withdrawal by Subject|2|||
28072532|NCT00423605|54727159|FG000|Overall Study|Lack of Efficacy|38|||
28072533|NCT00423605|54727159|FG000|Overall Study|Sponsor Decision|3|||
28072534|NCT00423605|54727159|FG000|Overall Study|Physician Decision|8|||
28072535|NCT00423605|54727159|FG000|Overall Study|Protocol Violation|7|||
28072536|NCT00423605|54727159|FG000|Overall Study|Not one of the pre-specified options|5|||
28072537|NCT00003838|54727166|FG000|Overall Study|Death|0|||
28072538|NCT00003838|54727167|FG001|Overall Study|Death|12|||
28072539|NCT00003838|54727168|FG002|Overall Study|Death|7|||
28072540|NCT00003838|54727166|FG000|Overall Study|Lost to Follow-up|0|||
28072541|NCT00003838|54727167|FG001|Overall Study|Lost to Follow-up|1|||
28072542|NCT00003838|54727168|FG002|Overall Study|Lost to Follow-up|1|||
28148047|NCT02926573|54815473|FG000|Overall Study|Return to operating room|0|||
28148048|NCT02926573|54815474|FG001|Overall Study|Return to operating room|2|||
28148049|NCT02926573|54815473|FG000|Overall Study|Delirium|0|||
28148050|NCT02926573|54815474|FG001|Overall Study|Delirium|1|||
28148051|NCT00158860|54815482|FG000|Overall Study|Adverse Event|3|||
27941754|NCT03672175|54598286|FG002|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
28148052|NCT00158860|54815483|FG001|Overall Study|Adverse Event|6|||
28148053|NCT00158860|54815482|FG000|Overall Study|Lost to Follow-up|11|||
28148054|NCT00158860|54815483|FG001|Overall Study|Lost to Follow-up|17|||
28148055|NCT00158860|54815482|FG000|Overall Study|Protocol Violation|8|||
28148056|NCT00158860|54815483|FG001|Overall Study|Protocol Violation|23|||
28148057|NCT00158860|54815482|FG000|Overall Study|Withdrawal by Subject|7|||
28148058|NCT00158860|54815483|FG001|Overall Study|Withdrawal by Subject|17|||
28148059|NCT00158860|54815482|FG000|Overall Study|MOVING OUT OF STATE|1|||
28148060|NCT00158860|54815483|FG001|Overall Study|MOVING OUT OF STATE|0|||
28148061|NCT00158860|54815482|FG000|Overall Study|Pregnancy|3|||
28148062|NCT00158860|54815483|FG001|Overall Study|Pregnancy|3|||
28148063|NCT00158860|54815482|FG000|Overall Study|SPONSOR STOPPED STUDY|2|||
28148064|NCT00158860|54815483|FG001|Overall Study|SPONSOR STOPPED STUDY|2|||
28148065|NCT00158860|54815482|FG000|Overall Study|SPONSOR REQUEST|0|||
28148066|NCT00158860|54815483|FG001|Overall Study|SPONSOR REQUEST|1|||
28148067|NCT00158860|54815482|FG000|Overall Study|Lost to Follow up but returned per GSK|0|||
28148068|NCT00158860|54815483|FG001|Overall Study|Lost to Follow up but returned per GSK|1|||
28148069|NCT00158860|54815482|FG000|Overall Study|Closed per sponsor|0|||
28148070|NCT00158860|54815483|FG001|Overall Study|Closed per sponsor|1|||
28148071|NCT03067129|54815494|FG000|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
28148072|NCT03067129|54815495|FG001|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
28148073|NCT03067129|54815496|FG002|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
28148074|NCT03067129|54815497|FG003|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|1|||
28148075|NCT03067129|54815494|FG000|Overall Study|Withdrawal by Subject|0|||
28148076|NCT03067129|54815495|FG001|Overall Study|Withdrawal by Subject|0|||
28148077|NCT03067129|54815496|FG002|Overall Study|Withdrawal by Subject|1|||
28148078|NCT03067129|54815497|FG003|Overall Study|Withdrawal by Subject|2|||
28148079|NCT03067129|54815494|FG000|Overall Study|Lost to Follow-up|5|||
28148080|NCT03067129|54815495|FG001|Overall Study|Lost to Follow-up|5|||
28148081|NCT03067129|54815496|FG002|Overall Study|Lost to Follow-up|4|||
28148082|NCT03067129|54815497|FG003|Overall Study|Lost to Follow-up|3|||
28148083|NCT01679236|54815519|FG000|Overall Study|Lost to Follow-up|15|||
28148084|NCT01679236|54815520|FG001|Overall Study|Lost to Follow-up|15|||
28148085|NCT01679002|54815529|FG000|Overall Study|Adverse Event|1|||
28148086|NCT01679002|54815530|FG001|Overall Study|Adverse Event|1|||
28148087|NCT01679002|54815531|FG002|Overall Study|Adverse Event|0|||
28148088|NCT04409509|54815541|FG000|Overall Study|Failure to meet randomization requirement|1|||
28148089|NCT04409509|54815542|FG001|Overall Study|Failure to meet randomization requirement|0|||
28148090|NCT04409509|54815541|FG000|Overall Study|Adverse Event|0|||
28148091|NCT04409509|54815542|FG001|Overall Study|Adverse Event|1|||
28148092|NCT04409509|54815541|FG000|Overall Study|Death|11|||
28148093|NCT04409509|54815542|FG001|Overall Study|Death|10|||
28148094|NCT04409509|54815541|FG000|Overall Study|Non-compliance with study drug|0|||
28148095|NCT04409509|54815542|FG001|Overall Study|Non-compliance with study drug|1|||
28148096|NCT04409509|54815541|FG000|Overall Study|Lost to Follow-up|0|||
28148097|NCT04409509|54815542|FG001|Overall Study|Lost to Follow-up|3|||
28148098|NCT04409509|54815541|FG000|Overall Study|Withdrawal by Subject|0|||
28148099|NCT04409509|54815542|FG001|Overall Study|Withdrawal by Subject|3|||
28148100|NCT04409509|54815541|FG000|Overall Study|Randomized by mistake|0|||
28148101|NCT04409509|54815542|FG001|Overall Study|Randomized by mistake|1|||
28148102|NCT04409509|54815541|FG000|Overall Study|Other|1|||
28148103|NCT04409509|54815542|FG001|Overall Study|Other|1|||
28148104|NCT01678924|54815553|FG000|Overall Study|Adverse Event|1|||
28148105|NCT01678924|54815554|FG001|Overall Study|Adverse Event|1|||
28148106|NCT01678924|54815555|FG002|Overall Study|Adverse Event|0|||
28148107|NCT01678924|54815556|FG003|Overall Study|Adverse Event|1|||
28148108|NCT01678924|54815553|FG000|Overall Study|Lack of Efficacy|7|||
28148109|NCT01678924|54815554|FG001|Overall Study|Lack of Efficacy|2|||
28148110|NCT01678924|54815555|FG002|Overall Study|Lack of Efficacy|0|||
28148111|NCT01678924|54815556|FG003|Overall Study|Lack of Efficacy|5|||
28148112|NCT01678924|54815553|FG000|Overall Study|Lost to Follow-up|0|||
28148113|NCT01678924|54815554|FG001|Overall Study|Lost to Follow-up|4|||
28148114|NCT01678924|54815555|FG002|Overall Study|Lost to Follow-up|0|||
28148115|NCT01678924|54815556|FG003|Overall Study|Lost to Follow-up|2|||
28148116|NCT01678924|54815553|FG000|Overall Study|Personal Reasons|2|||
28148117|NCT01678924|54815554|FG001|Overall Study|Personal Reasons|2|||
28148118|NCT01678924|54815555|FG002|Overall Study|Personal Reasons|2|||
28148119|NCT01678924|54815556|FG003|Overall Study|Personal Reasons|7|||
28148120|NCT01678924|54815553|FG000|Overall Study|Withdrawal by Subject|0|||
28148121|NCT01678924|54815554|FG001|Overall Study|Withdrawal by Subject|3|||
28148122|NCT01678924|54815555|FG002|Overall Study|Withdrawal by Subject|0|||
28148123|NCT01678924|54815556|FG003|Overall Study|Withdrawal by Subject|2|||
28148124|NCT01678924|54815553|FG000|Overall Study|Unable to attend scheduled visits|0|||
28148125|NCT01678924|54815554|FG001|Overall Study|Unable to attend scheduled visits|0|||
28148126|NCT01678924|54815555|FG002|Overall Study|Unable to attend scheduled visits|0|||
28148127|NCT01678924|54815556|FG003|Overall Study|Unable to attend scheduled visits|1|||
28148128|NCT02925793|54815570|FG000|Overall Study|Adverse Event|3|||
28148129|NCT02925793|54815571|FG001|Overall Study|Adverse Event|3|||
28148130|NCT02925793|54815572|FG002|Overall Study|Adverse Event|6|||
28148131|NCT02925793|54815570|FG000|Overall Study|Withdrawal by Subject|16|||
28148132|NCT02925793|54815571|FG001|Overall Study|Withdrawal by Subject|15|||
28148133|NCT02925793|54815572|FG002|Overall Study|Withdrawal by Subject|13|||
28148134|NCT02925793|54815570|FG000|Overall Study|Investigator Discretion|0|||
28148135|NCT02925793|54815571|FG001|Overall Study|Investigator Discretion|1|||
28148136|NCT02925793|54815572|FG002|Overall Study|Investigator Discretion|1|||
28148137|NCT02925793|54815570|FG000|Overall Study|Lost to Follow-up|2|||
28148138|NCT02925793|54815571|FG001|Overall Study|Lost to Follow-up|3|||
28148139|NCT02925793|54815572|FG002|Overall Study|Lost to Follow-up|1|||
28148140|NCT02925793|54815570|FG000|Overall Study|Lack of Efficacy|2|||
28148141|NCT02925793|54815571|FG001|Overall Study|Lack of Efficacy|6|||
28148142|NCT02925793|54815572|FG002|Overall Study|Lack of Efficacy|4|||
28148143|NCT02925793|54815570|FG000|Overall Study|Other:|2|||
28148144|NCT02925793|54815571|FG001|Overall Study|Other:|1|||
28148145|NCT02925793|54815572|FG002|Overall Study|Other:|3|||
28148146|NCT03071263|54815582|FG000|Overall Study|Adverse Event|1|||
28148147|NCT03071263|54815583|FG001|Overall Study|Adverse Event|3|||
28148148|NCT03071263|54815582|FG000|Overall Study|Withdrawal by Subject|1|||
28148149|NCT03071263|54815583|FG001|Overall Study|Withdrawal by Subject|3|||
28148150|NCT03071263|54815582|FG000|Overall Study|Physician Decision|1|||
28148151|NCT03071263|54815583|FG001|Overall Study|Physician Decision|0|||
28148152|NCT03071263|54815582|FG000|Overall Study|Participant moved to another city|0|||
28148153|NCT03071263|54815583|FG001|Overall Study|Participant moved to another city|1|||
28148154|NCT00157196|54815595|FG000|Overall Study|Ongoing at data cut-off|9|||
28148155|NCT03066193|54815599|FG000|Overall Study|Withdrawal by Subject|1|||
28148156|NCT03922321|54815603|FG000|Overall Study|Participant Moved|1|||
28148157|NCT03922321|54815603|FG000|Overall Study|Unable to Come to Site Due to COVID 19|1|||
28148158|NCT01677910|54815610|FG000|Double-Blind Treatment Period|Adverse Event|6|||
28148159|NCT01677910|54815611|FG001|Double-Blind Treatment Period|Adverse Event|2|||
28148160|NCT01677910|54815612|FG002|Double-Blind Treatment Period|Adverse Event|3|||
28148161|NCT01677910|54815613|FG003|Double-Blind Treatment Period|Adverse Event|0|||
28148162|NCT01677910|54815610|FG000|Double-Blind Treatment Period|Physician Decision|0|||
28148163|NCT01677910|54815611|FG001|Double-Blind Treatment Period|Physician Decision|0|||
28148164|NCT01677910|54815612|FG002|Double-Blind Treatment Period|Physician Decision|1|||
28148165|NCT01677910|54815613|FG003|Double-Blind Treatment Period|Physician Decision|0|||
28148166|NCT01677910|54815610|FG000|Double-Blind Treatment Period|Withdrawal of consent|1|||
28148167|NCT01677910|54815611|FG001|Double-Blind Treatment Period|Withdrawal of consent|0|||
28148168|NCT01677910|54815612|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
28148169|NCT01677910|54815613|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
28148170|NCT01677910|54815610|FG000|Double-Blind Treatment Period|Reason Not Specified|0|||
28148171|NCT01677910|54815611|FG001|Double-Blind Treatment Period|Reason Not Specified|1|||
28148172|NCT01677910|54815612|FG002|Double-Blind Treatment Period|Reason Not Specified|0|||
28148173|NCT01677910|54815613|FG003|Double-Blind Treatment Period|Reason Not Specified|0|||
28148174|NCT01677910|54815610|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
28148175|NCT01677910|54815611|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
28148176|NCT01677910|54815612|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
28148177|NCT01677910|54815613|FG003|Open-Label Extension Period (OLE)|Physician Decision|4|||
28148178|NCT01677910|54815610|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
28148179|NCT01677910|54815611|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
28148180|NCT01677910|54815612|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
28148181|NCT01677910|54815613|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
28148182|NCT01677910|54815610|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
28148183|NCT01677910|54815611|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
28148184|NCT01677910|54815612|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
28148185|NCT01677910|54815613|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
28148186|NCT01677910|54815610|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
28148187|NCT01677910|54815611|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
28148188|NCT01677910|54815612|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
28072543|NCT00003838|54727166|FG000|Overall Study|Disease Progression|0|||
28148189|NCT01677910|54815613|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|5|||
28148190|NCT01677910|54815610|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
28148191|NCT01677910|54815611|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
28148192|NCT01677910|54815612|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
28148193|NCT01677910|54815613|FG003|Open-Label Extension Period (OLE)|Adverse Event|15|||
28148194|NCT01677910|54815610|FG000|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
28148195|NCT01677910|54815611|FG001|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
28148196|NCT01677910|54815612|FG002|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
28148197|NCT01677910|54815613|FG003|Open-Label Extension Period (OLE)|Lost to Follow-up|1|||
28148198|NCT03911713|54815628|FG000|Overall Study|Lost to Follow-up|0|||
28148199|NCT03911713|54815629|FG001|Overall Study|Lost to Follow-up|2|||
28148200|NCT03911713|54815630|FG002|Overall Study|Lost to Follow-up|0|||
28148201|NCT03911713|54815631|FG003|Overall Study|Lost to Follow-up|0|||
28148202|NCT03911713|54815632|FG004|Overall Study|Lost to Follow-up|0|||
28148203|NCT03911713|54815628|FG000|Overall Study|Other|0|||
28148204|NCT03911713|54815629|FG001|Overall Study|Other|0|||
28148205|NCT03911713|54815630|FG002|Overall Study|Other|0|||
28148206|NCT03911713|54815631|FG003|Overall Study|Other|1|||
28148207|NCT03911713|54815632|FG004|Overall Study|Other|0|||
28148208|NCT03911713|54815628|FG000|Overall Study|Randomized, Never Dosed|1|||
28148209|NCT03911713|54815629|FG001|Overall Study|Randomized, Never Dosed|0|||
28148210|NCT03911713|54815630|FG002|Overall Study|Randomized, Never Dosed|0|||
28148211|NCT03911713|54815631|FG003|Overall Study|Randomized, Never Dosed|1|||
28148212|NCT03911713|54815632|FG004|Overall Study|Randomized, Never Dosed|0|||
28148213|NCT03065023|54815650|FG000|Overall Study|Progressive Disease|0|||
28148214|NCT03065023|54815651|FG001|Overall Study|Progressive Disease|1|||
28148215|NCT03065023|54815652|FG002|Overall Study|Progressive Disease|0|||
28148216|NCT03065023|54815653|FG003|Overall Study|Progressive Disease|0|||
28148217|NCT03065023|54815654|FG004|Overall Study|Progressive Disease|0|||
28148218|NCT03065023|54815650|FG000|Overall Study|Death|2|||
28148219|NCT03065023|54815651|FG001|Overall Study|Death|0|||
28148220|NCT03065023|54815652|FG002|Overall Study|Death|1|||
28148221|NCT03065023|54815653|FG003|Overall Study|Death|1|||
28148222|NCT03065023|54815654|FG004|Overall Study|Death|0|||
28148223|NCT03065023|54815650|FG000|Overall Study|Lost to Follow-up|0|||
28148224|NCT03065023|54815651|FG001|Overall Study|Lost to Follow-up|1|||
28148225|NCT03065023|54815652|FG002|Overall Study|Lost to Follow-up|0|||
28148226|NCT03065023|54815653|FG003|Overall Study|Lost to Follow-up|0|||
28148227|NCT03065023|54815654|FG004|Overall Study|Lost to Follow-up|0|||
28148228|NCT03065023|54815650|FG000|Overall Study|Participant Decision|0|||
28148229|NCT03065023|54815651|FG001|Overall Study|Participant Decision|0|||
27941755|NCT03672175|54598284|FG000|Extended FU Period (Days 43 to 182)|Lost to Follow-up|6|||
28072544|NCT00003838|54727167|FG001|Overall Study|Disease Progression|12|||
28072545|NCT00003838|54727168|FG002|Overall Study|Disease Progression|0|||
28072546|NCT00423449|54727175|FG000|Overall Study|Clinical Adverse Event|1|||
28072547|NCT00423449|54727176|FG001|Overall Study|Clinical Adverse Event|0|||
28072548|NCT00423449|54727177|FG002|Overall Study|Clinical Adverse Event|1|||
28072549|NCT00423449|54727178|FG003|Overall Study|Clinical Adverse Event|8|||
28072550|NCT00423449|54727179|FG004|Overall Study|Clinical Adverse Event|2|||
28072551|NCT00423449|54727175|FG000|Overall Study|Death|1|||
28072552|NCT00423449|54727176|FG001|Overall Study|Death|0|||
28072553|NCT00423449|54727177|FG002|Overall Study|Death|2|||
28072554|NCT00423449|54727178|FG003|Overall Study|Death|1|||
28072555|NCT00423449|54727179|FG004|Overall Study|Death|1|||
28072556|NCT00423449|54727175|FG000|Overall Study|Progressive Disease|1|||
28148230|NCT03065023|54815652|FG002|Overall Study|Participant Decision|0|||
28148231|NCT03065023|54815653|FG003|Overall Study|Participant Decision|1|||
28072557|NCT00423449|54727176|FG001|Overall Study|Progressive Disease|3|||
28148232|NCT03065023|54815654|FG004|Overall Study|Participant Decision|0|||
28148233|NCT03065023|54815650|FG000|Overall Study|Withdrawal by Subject|0|||
28148234|NCT03065023|54815651|FG001|Overall Study|Withdrawal by Subject|0|||
28148235|NCT03065023|54815652|FG002|Overall Study|Withdrawal by Subject|0|||
28148236|NCT03065023|54815653|FG003|Overall Study|Withdrawal by Subject|1|||
28148237|NCT03065023|54815654|FG004|Overall Study|Withdrawal by Subject|0|||
28148238|NCT03614923|54815667|FG000|Overall Study|Withdrawal by Subject|2|||
28148239|NCT03614923|54815668|FG001|Overall Study|Withdrawal by Subject|1|||
28148240|NCT03614923|54815669|FG002|Overall Study|Withdrawal by Subject|1|||
28148241|NCT03614923|54815667|FG000|Overall Study|Adverse Event|0|||
28148242|NCT03614923|54815668|FG001|Overall Study|Adverse Event|2|||
28148243|NCT03614923|54815669|FG002|Overall Study|Adverse Event|1|||
28148244|NCT03614923|54815667|FG000|Overall Study|Lost to Follow-up|1|||
28148245|NCT03614923|54815668|FG001|Overall Study|Lost to Follow-up|0|||
28148246|NCT03614923|54815669|FG002|Overall Study|Lost to Follow-up|1|||
28148247|NCT03614923|54815667|FG000|Overall Study|Lack of Efficacy|2|||
28148248|NCT03614923|54815668|FG001|Overall Study|Lack of Efficacy|0|||
28148249|NCT03614923|54815669|FG002|Overall Study|Lack of Efficacy|1|||
28148250|NCT03614923|54815667|FG000|Overall Study|Non-compliance|0|||
28148251|NCT03614923|54815668|FG001|Overall Study|Non-compliance|1|||
28148252|NCT03614923|54815669|FG002|Overall Study|Non-compliance|0|||
28148253|NCT03614923|54815667|FG000|Overall Study|Other|0|||
28148254|NCT03614923|54815668|FG001|Overall Study|Other|1|||
28148255|NCT03614923|54815669|FG002|Overall Study|Other|1|||
28148256|NCT02915016|54815685|FG000|Overall Study|Lost to Follow-up|4|||
28148257|NCT02915016|54815686|FG001|Overall Study|Lost to Follow-up|2|||
28148258|NCT02915016|54815687|FG002|Overall Study|Lost to Follow-up|5|||
28148259|NCT02915016|54815688|FG003|Overall Study|Lost to Follow-up|3|||
28148260|NCT02915016|54815689|FG004|Overall Study|Lost to Follow-up|5|||
28148261|NCT02915016|54815690|FG005|Overall Study|Lost to Follow-up|2|||
28148262|NCT02915016|54815691|FG006|Overall Study|Lost to Follow-up|8|||
28148263|NCT02915016|54815692|FG007|Overall Study|Lost to Follow-up|2|||
28148264|NCT02915016|54815685|FG000|Overall Study|Physician Decision|0|||
28148265|NCT02915016|54815686|FG001|Overall Study|Physician Decision|0|||
28148266|NCT02915016|54815687|FG002|Overall Study|Physician Decision|1|||
28148267|NCT02915016|54815688|FG003|Overall Study|Physician Decision|0|||
28148268|NCT02915016|54815689|FG004|Overall Study|Physician Decision|0|||
28148269|NCT02915016|54815690|FG005|Overall Study|Physician Decision|1|||
28148270|NCT02915016|54815691|FG006|Overall Study|Physician Decision|2|||
28148271|NCT02915016|54815692|FG007|Overall Study|Physician Decision|0|||
28148272|NCT02915016|54815685|FG000|Overall Study|Withdrawal by Subject|2|||
28148273|NCT02915016|54815686|FG001|Overall Study|Withdrawal by Subject|0|||
28148274|NCT02915016|54815687|FG002|Overall Study|Withdrawal by Subject|1|||
28148275|NCT02915016|54815688|FG003|Overall Study|Withdrawal by Subject|0|||
28148276|NCT02915016|54815689|FG004|Overall Study|Withdrawal by Subject|1|||
28148277|NCT02915016|54815690|FG005|Overall Study|Withdrawal by Subject|3|||
28148278|NCT02915016|54815691|FG006|Overall Study|Withdrawal by Subject|1|||
28148279|NCT02915016|54815692|FG007|Overall Study|Withdrawal by Subject|1|||
28148280|NCT02915016|54815685|FG000|Overall Study|Elected not to continue|0|||
28148281|NCT02915016|54815686|FG001|Overall Study|Elected not to continue|0|||
28148282|NCT02915016|54815687|FG002|Overall Study|Elected not to continue|0|||
28148283|NCT02915016|54815688|FG003|Overall Study|Elected not to continue|1|||
28148284|NCT02915016|54815689|FG004|Overall Study|Elected not to continue|0|||
28148285|NCT02915016|54815690|FG005|Overall Study|Elected not to continue|0|||
28148286|NCT02915016|54815691|FG006|Overall Study|Elected not to continue|1|||
28148287|NCT02915016|54815692|FG007|Overall Study|Elected not to continue|0|||
28148288|NCT02915016|54815685|FG000|Overall Study|HIV infection|1|||
28148289|NCT02915016|54815686|FG001|Overall Study|HIV infection|1|||
28148290|NCT02915016|54815687|FG002|Overall Study|HIV infection|1|||
28148291|NCT02915016|54815688|FG003|Overall Study|HIV infection|0|||
28148292|NCT02915016|54815689|FG004|Overall Study|HIV infection|1|||
28148293|NCT02915016|54815690|FG005|Overall Study|HIV infection|0|||
28148294|NCT02915016|54815691|FG006|Overall Study|HIV infection|0|||
28148295|NCT02915016|54815692|FG007|Overall Study|HIV infection|0|||
28148296|NCT02915016|54815685|FG000|Overall Study|Participant unable to adhere|0|||
28148297|NCT02915016|54815686|FG001|Overall Study|Participant unable to adhere|0|||
28148298|NCT02915016|54815687|FG002|Overall Study|Participant unable to adhere|0|||
28148299|NCT02915016|54815688|FG003|Overall Study|Participant unable to adhere|0|||
28148300|NCT02915016|54815689|FG004|Overall Study|Participant unable to adhere|0|||
28148301|NCT02915016|54815690|FG005|Overall Study|Participant unable to adhere|0|||
28148302|NCT02915016|54815691|FG006|Overall Study|Participant unable to adhere|0|||
28148303|NCT02915016|54815692|FG007|Overall Study|Participant unable to adhere|1|||
28148304|NCT03323749|54815712|FG000|Double-blind Period|Lost to Follow-up|4|||
28148305|NCT03323749|54815713|FG001|Double-blind Period|Lost to Follow-up|5|||
28072558|NCT00423449|54727177|FG002|Overall Study|Progressive Disease|8|||
28072559|NCT00423449|54727178|FG003|Overall Study|Progressive Disease|11|||
28072560|NCT00423449|54727179|FG004|Overall Study|Progressive Disease|4|||
28072561|NCT00423449|54727175|FG000|Overall Study|Laboratory Adverse Event|0|||
28148306|NCT03323749|54815712|FG000|Double-blind Period|Adverse Event|3|||
28148307|NCT03323749|54815713|FG001|Double-blind Period|Adverse Event|1|||
28072562|NCT00423449|54727176|FG001|Overall Study|Laboratory Adverse Event|1|||
28072563|NCT00423449|54727177|FG002|Overall Study|Laboratory Adverse Event|2|||
28072564|NCT00423449|54727178|FG003|Overall Study|Laboratory Adverse Event|0|||
28072565|NCT00423449|54727179|FG004|Overall Study|Laboratory Adverse Event|0|||
28072566|NCT00423449|54727175|FG000|Overall Study|Other|0|||
28072567|NCT00423449|54727176|FG001|Overall Study|Other|0|||
28072568|NCT00423449|54727177|FG002|Overall Study|Other|0|||
28072569|NCT00423449|54727178|FG003|Overall Study|Other|1|||
28072570|NCT00423449|54727179|FG004|Overall Study|Other|0|||
28072571|NCT00423449|54727175|FG000|Overall Study|Protocol Violation|0|||
28072572|NCT00423449|54727176|FG001|Overall Study|Protocol Violation|0|||
28072573|NCT00423449|54727177|FG002|Overall Study|Protocol Violation|2|||
28072574|NCT00423449|54727178|FG003|Overall Study|Protocol Violation|1|||
28072575|NCT00423449|54727179|FG004|Overall Study|Protocol Violation|0|||
28072576|NCT00423293|54727192|FG000|Overall Study|Ineligible / No protocol treatment|11|||
28072577|NCT00423137|54727200|FG000|Overall Study|Lost to Follow-up|0|||
28072578|NCT00423137|54727201|FG001|Overall Study|Lost to Follow-up|0|||
28072579|NCT00423137|54727202|FG002|Overall Study|Lost to Follow-up|1|||
28072580|NCT00423137|54727203|FG003|Overall Study|Lost to Follow-up|0|||
28072581|NCT00423137|54727200|FG000|Overall Study|Protocol Violation|0|||
28072582|NCT00423137|54727201|FG001|Overall Study|Protocol Violation|0|||
28072583|NCT00423137|54727202|FG002|Overall Study|Protocol Violation|0|||
28072584|NCT00423137|54727203|FG003|Overall Study|Protocol Violation|1|||
28072585|NCT00423137|54727200|FG000|Overall Study|Adverse Event Study disease worse|1|||
28072586|NCT00423137|54727201|FG001|Overall Study|Adverse Event Study disease worse|0|||
28148308|NCT03323749|54815712|FG000|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|83|||
28148309|NCT03323749|54815713|FG001|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|88|||
28148310|NCT03323749|54815712|FG000|Open-Label Period|Adverse Event|3|||
28148311|NCT03323749|54815713|FG001|Open-Label Period|Adverse Event|10|||
28148312|NCT03323749|54815712|FG000|Open-Label Period|Withdrawal by Subject|7|||
28148313|NCT03323749|54815713|FG001|Open-Label Period|Withdrawal by Subject|5|||
28148314|NCT02208024|54815732|FG000|Overall Study|Withdrawal by Subject|1|||
28148315|NCT02660086|54815738|FG000|Overall Study- 12-month|Withdrawal by Subject|5|||
28148316|NCT02660086|54815739|FG001|Overall Study- 12-month|Withdrawal by Subject|5|||
28148317|NCT02660086|54815738|FG000|Overall Study- 12-month|Left full-time employment|12|||
28148318|NCT02660086|54815739|FG001|Overall Study- 12-month|Left full-time employment|20|||
28148319|NCT02660086|54815738|FG000|Overall Study- 12-month|Missed 12-month follow-up visit|8|||
28148320|NCT02660086|54815739|FG001|Overall Study- 12-month|Missed 12-month follow-up visit|4|||
28148321|NCT02660086|54815738|FG000|Overall Study- 12-month|Became ineligible: new job in cafeteria|1|||
28148322|NCT02660086|54815739|FG001|Overall Study- 12-month|Became ineligible: new job in cafeteria|0|||
28148323|NCT02660086|54815738|FG000|Overall Study: 24-month Follow-up|Left employment after 12 months|17|||
28148324|NCT02660086|54815739|FG001|Overall Study: 24-month Follow-up|Left employment after 12 months|8|||
28148325|NCT02660086|54815738|FG000|Overall Study: 24-month Follow-up|Missed 24-month follow-up|9|||
28148326|NCT02660086|54815739|FG001|Overall Study: 24-month Follow-up|Missed 24-month follow-up|16|||
28148327|NCT01678144|54815745|FG000|Stage 1: MAR Classic|Adverse Event|1|||
28148328|NCT00153920|54815749|FG000|Overall Study|Adverse Event|9|||
28148329|NCT00153920|54815749|FG000|Overall Study|Progressive Disease|9|||
28148330|NCT00153920|54815749|FG000|Overall Study|Physician Decision|3|||
28148331|NCT00153920|54815749|FG000|Overall Study|Lack of Response|3|||
28148332|NCT00153920|54815749|FG000|Overall Study|Death|2|||
28148333|NCT00153920|54815749|FG000|Overall Study|Withdrawal by Subject|1|||
28148334|NCT00153920|54815749|FG000|Overall Study|Non-Protocol Therapy|1|||
28148335|NCT00153920|54815749|FG000|Overall Study|Withdrawal of Consent before Trt|1|||
28148336|NCT00153920|54815749|FG000|Overall Study|Progressive Disease before Trt|1|||
28148337|NCT02660242|54815753|FG000|Glucose Tabs|Lost to Follow-up|1|||
28148338|NCT02660242|54815753|FG000|Glucagon Injection|Lost to Follow-up|1|||
28148339|NCT03072043|54815769|FG000|Overall Study|Death|0|||
28148340|NCT03072043|54815770|FG001|Overall Study|Death|0|||
28148341|NCT03072043|54815771|FG002|Overall Study|Death|3|||
28148342|NCT03072043|54815769|FG000|Overall Study|Adverse Event|0|||
28148343|NCT03072043|54815770|FG001|Overall Study|Adverse Event|0|||
28148344|NCT03072043|54815771|FG002|Overall Study|Adverse Event|2|||
28148345|NCT03072043|54815769|FG000|Overall Study|Withdrawal by Subject|0|||
28148346|NCT03072043|54815770|FG001|Overall Study|Withdrawal by Subject|0|||
28148347|NCT03072043|54815771|FG002|Overall Study|Withdrawal by Subject|4|||
28148348|NCT03069313|54815783|FG000|Overall Study|Adverse Event|5|||
28148349|NCT03068767|54815789|FG000|Overall Study|Lost to Follow-up|7|||
28148350|NCT03068767|54815790|FG001|Overall Study|Lost to Follow-up|3|||
28148351|NCT03068767|54815789|FG000|Overall Study|Protocol Violation|3|||
28148352|NCT03068767|54815790|FG001|Overall Study|Protocol Violation|0|||
28148353|NCT03020745|54815804|FG000|Part 2 (Up to 169 Days)|Adverse Event|0|||
28148354|NCT03020745|54815805|FG001|Part 2 (Up to 169 Days)|Adverse Event|0|||
28148355|NCT03020745|54815806|FG002|Part 2 (Up to 169 Days)|Adverse Event|0|||
28148356|NCT03020745|54815807|FG003|Part 2 (Up to 169 Days)|Adverse Event|0|||
28148357|NCT03020745|54815808|FG004|Part 2 (Up to 169 Days)|Adverse Event|0|||
28148358|NCT03020745|54815809|FG005|Part 2 (Up to 169 Days)|Adverse Event|0|||
28148359|NCT03020745|54815810|FG006|Part 2 (Up to 169 Days)|Adverse Event|0|||
28148360|NCT03020745|54815811|FG007|Part 2 (Up to 169 Days)|Adverse Event|0|||
28148361|NCT03020745|54815812|FG008|Part 2 (Up to 169 Days)|Adverse Event|1|||
28148362|NCT03020745|54815813|FG009|Part 2 (Up to 169 Days)|Adverse Event|0|||
28148363|NCT03020745|54815804|FG000|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
28148364|NCT03020745|54815805|FG001|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
28148365|NCT03020745|54815806|FG002|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
28148366|NCT03020745|54815807|FG003|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
28148367|NCT03020745|54815808|FG004|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
28148368|NCT03020745|54815809|FG005|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
28148369|NCT03020745|54815810|FG006|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
28148370|NCT03020745|54815811|FG007|Part 2 (Up to 169 Days)|Withdrawal by Subject|1|||
28148371|NCT03020745|54815812|FG008|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
28148372|NCT03020745|54815813|FG009|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
28148373|NCT03020745|54815804|FG000|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
27850105|NCT00988559|54348417|FG002|Overall Study|Pregnancy|1|||
28148374|NCT03020745|54815805|FG001|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
28148375|NCT03020745|54815806|FG002|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
28148376|NCT03020745|54815807|FG003|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
28148377|NCT03020745|54815808|FG004|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
28148378|NCT03020745|54815809|FG005|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
27850106|NCT00988559|54348418|FG003|Overall Study|Pregnancy|0|||
27822748|NCT01839487|54286702|FG004|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2|||
28148379|NCT03020745|54815810|FG006|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
28148380|NCT03020745|54815811|FG007|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
28148381|NCT03020745|54815812|FG008|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
28148382|NCT03020745|54815813|FG009|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
28148383|NCT03020745|54815804|FG000|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
28148384|NCT03020745|54815805|FG001|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
28148385|NCT03020745|54815806|FG002|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
28148386|NCT03020745|54815807|FG003|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
28148387|NCT03020745|54815808|FG004|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
28148388|NCT03020745|54815809|FG005|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
28148389|NCT03020745|54815810|FG006|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
28148390|NCT03020745|54815811|FG007|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
28148391|NCT03020745|54815812|FG008|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2|||
28148392|NCT03020745|54815813|FG009|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
28148393|NCT03019965|54815848|FG000|Overall Study|Withdrawal by Subject|1|||
28148394|NCT03019965|54815849|FG001|Overall Study|Withdrawal by Subject|0|||
28148395|NCT03019965|54815848|FG000|Overall Study|Protocol Violation|1|||
28148396|NCT03019965|54815849|FG001|Overall Study|Protocol Violation|3|||
28148397|NCT03019965|54815848|FG000|Overall Study|viral or fungal infection|3|||
28148398|NCT03019965|54815849|FG001|Overall Study|viral or fungal infection|4|||
28148399|NCT03019965|54815848|FG000|Overall Study|acute liver failure in the first 24 hours of randomization|4|||
28148400|NCT03019965|54815849|FG001|Overall Study|acute liver failure in the first 24 hours of randomization|5|||
28148401|NCT03019965|54815848|FG000|Overall Study|Physician Decision|1|||
27822749|NCT01839487|54286703|FG005|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
28148402|NCT03019965|54815849|FG001|Overall Study|Physician Decision|1|||
28148403|NCT01675882|54815868|FG000|Overall Study|Adverse Event|0|||
28148404|NCT01675882|54815869|FG001|Overall Study|Adverse Event|2|||
28148405|NCT01675882|54815870|FG002|Overall Study|Adverse Event|1|||
28148406|NCT01675882|54815871|FG003|Overall Study|Adverse Event|0|||
28148407|NCT01675882|54815868|FG000|Overall Study|Participant unwilling to continue|2|||
28148408|NCT01675882|54815869|FG001|Overall Study|Participant unwilling to continue|4|||
28148409|NCT01675882|54815870|FG002|Overall Study|Participant unwilling to continue|2|||
28148410|NCT01675882|54815871|FG003|Overall Study|Participant unwilling to continue|1|||
28148411|NCT01675882|54815868|FG000|Overall Study|Lost to Follow-up|0|||
28148412|NCT01675882|54815869|FG001|Overall Study|Lost to Follow-up|1|||
28148413|NCT01675882|54815870|FG002|Overall Study|Lost to Follow-up|0|||
28148414|NCT01675882|54815871|FG003|Overall Study|Lost to Follow-up|0|||
28148415|NCT01675882|54815868|FG000|Overall Study|Non-compliance|0|||
28148416|NCT01675882|54815869|FG001|Overall Study|Non-compliance|0|||
28148417|NCT01675882|54815870|FG002|Overall Study|Non-compliance|0|||
28148418|NCT01675882|54815871|FG003|Overall Study|Non-compliance|1|||
28148419|NCT03018249|54815883|FG000|Overall Study|Withdrawal by Subject|2|||
28148420|NCT03018249|54815884|FG001|Overall Study|Withdrawal by Subject|2|||
28148421|NCT02923245|54815902|FG000|Overall Study|ultrasound order was cancelled|2|||
28148422|NCT02923245|54815903|FG001|Overall Study|ultrasound order was cancelled|1|||
28148423|NCT00905606|54815919|FG000|Period 1|Adverse Event|0|||
28148424|NCT00905606|54815920|FG001|Period 1|Adverse Event|1|||
28148425|NCT00905606|54815919|FG000|Washout|Withdrawal by Subject|1|||
28148426|NCT00905606|54815920|FG001|Washout|Withdrawal by Subject|0|||
28148427|NCT01676896|54815927|FG000|Overall Study|Withdrawal by Subject|12|||
28148428|NCT01676896|54815928|FG001|Overall Study|Withdrawal by Subject|7|||
28148429|NCT01676896|54815929|FG002|Overall Study|Withdrawal by Subject|19|||
28148430|NCT03017235|54815939|FG000|Overall Study|Withdrawal by Subject|4|||
28148431|NCT03017235|54815940|FG001|Overall Study|Withdrawal by Subject|3|||
28148432|NCT03017235|54815939|FG000|Overall Study|Lost to Follow-up|2|||
28148433|NCT03017235|54815940|FG001|Overall Study|Lost to Follow-up|7|||
28148434|NCT03017235|54815939|FG000|Overall Study|Adverse Event|0|||
28148435|NCT03017235|54815940|FG001|Overall Study|Adverse Event|1|||
28148436|NCT03017235|54815939|FG000|Overall Study|Protocol Violation|2|||
28148437|NCT03017235|54815940|FG001|Overall Study|Protocol Violation|1|||
28148438|NCT03017235|54815939|FG000|Overall Study|Cancer, emergency, allergy, active UTI|4|||
28148439|NCT03017235|54815940|FG001|Overall Study|Cancer, emergency, allergy, active UTI|2|||
28148440|NCT03017079|54815948|FG000|Overall Study|Physician Decision|1|||
28148441|NCT03017079|54815949|FG001|Overall Study|Physician Decision|1|||
28148442|NCT03017079|54815948|FG000|Overall Study|Death|3|||
28148443|NCT03017079|54815949|FG001|Overall Study|Death|2|||
28148444|NCT03017079|54815948|FG000|Overall Study|Lack of Efficacy|2|||
28148445|NCT03017079|54815949|FG001|Overall Study|Lack of Efficacy|2|||
28148446|NCT03017079|54815948|FG000|Overall Study|Protocol Violation|0|||
28148447|NCT03017079|54815949|FG001|Overall Study|Protocol Violation|1|||
28148448|NCT03015363|54815962|FG000|Overall Study|Physician Decision|14|||
28148449|NCT03015363|54815962|FG000|Overall Study|Withdrawal by Subject|3|||
28148450|NCT02880371|54815974|FG000|Phase 1b|Lost to Follow-up|1|||
28148451|NCT02880371|54815975|FG001|Phase 1b|Lost to Follow-up|0|||
28148452|NCT02880371|54815976|FG002|Phase 1b|Lost to Follow-up|0|||
28148453|NCT02880371|54815977|FG003|Phase 1b|Lost to Follow-up|0|||
28148454|NCT02880371|54815978|FG004|Phase 1b|Lost to Follow-up|0|||
28148455|NCT02880371|54815979|FG005|Phase 1b|Lost to Follow-up|0|||
28148456|NCT02880371|54815980|FG006|Phase 1b|Lost to Follow-up|0|||
28148457|NCT02880371|54815981|FG007|Phase 1b|Lost to Follow-up|0|||
28148458|NCT02880371|54815974|FG000|Phase 1b|Participants terminated by Sponsor|1|||
28148459|NCT02880371|54815975|FG001|Phase 1b|Participants terminated by Sponsor|0|||
28148460|NCT02880371|54815976|FG002|Phase 1b|Participants terminated by Sponsor|0|||
28148461|NCT02880371|54815977|FG003|Phase 1b|Participants terminated by Sponsor|0|||
28148462|NCT02880371|54815978|FG004|Phase 1b|Participants terminated by Sponsor|0|||
28148463|NCT02880371|54815979|FG005|Phase 1b|Participants terminated by Sponsor|0|||
28148464|NCT02880371|54815980|FG006|Phase 1b|Participants terminated by Sponsor|0|||
28148465|NCT02880371|54815981|FG007|Phase 1b|Participants terminated by Sponsor|0|||
28148466|NCT02880371|54815974|FG000|Phase 1b|Withdrawal by Subject|0|||
28148467|NCT02880371|54815975|FG001|Phase 1b|Withdrawal by Subject|0|||
28148468|NCT02880371|54815976|FG002|Phase 1b|Withdrawal by Subject|1|||
28148469|NCT02880371|54815977|FG003|Phase 1b|Withdrawal by Subject|0|||
28148470|NCT02880371|54815978|FG004|Phase 1b|Withdrawal by Subject|0|||
28148471|NCT02880371|54815979|FG005|Phase 1b|Withdrawal by Subject|0|||
28148472|NCT02880371|54815980|FG006|Phase 1b|Withdrawal by Subject|0|||
28148473|NCT02880371|54815981|FG007|Phase 1b|Withdrawal by Subject|0|||
28148474|NCT02880371|54815974|FG000|Phase 1b|Death|4|||
28148475|NCT02880371|54815975|FG001|Phase 1b|Death|6|||
28148476|NCT02880371|54815976|FG002|Phase 1b|Death|5|||
28148477|NCT02880371|54815977|FG003|Phase 1b|Death|1|||
28148478|NCT02880371|54815978|FG004|Phase 1b|Death|0|||
28148479|NCT02880371|54815979|FG005|Phase 1b|Death|0|||
28148480|NCT02880371|54815980|FG006|Phase 1b|Death|0|||
28148481|NCT02880371|54815981|FG007|Phase 1b|Death|0|||
28148482|NCT02880371|54815974|FG000|Phase 1b|Enrolled but not Treated|0|||
28148483|NCT02880371|54815975|FG001|Phase 1b|Enrolled but not Treated|1|||
28148484|NCT02880371|54815976|FG002|Phase 1b|Enrolled but not Treated|0|||
28148485|NCT02880371|54815977|FG003|Phase 1b|Enrolled but not Treated|0|||
28148486|NCT02880371|54815978|FG004|Phase 1b|Enrolled but not Treated|0|||
28148487|NCT02880371|54815979|FG005|Phase 1b|Enrolled but not Treated|0|||
28148488|NCT02880371|54815980|FG006|Phase 1b|Enrolled but not Treated|0|||
28148489|NCT02880371|54815981|FG007|Phase 1b|Enrolled but not Treated|0|||
28148490|NCT02880371|54815974|FG000|Phase 2|Enrolled but not Treated|0|||
28148491|NCT02880371|54815975|FG001|Phase 2|Enrolled but not Treated|0|||
28148492|NCT02880371|54815976|FG002|Phase 2|Enrolled but not Treated|0|||
28148493|NCT02880371|54815977|FG003|Phase 2|Enrolled but not Treated|0|||
28148494|NCT02880371|54815978|FG004|Phase 2|Enrolled but not Treated|0|||
28148495|NCT02880371|54815979|FG005|Phase 2|Enrolled but not Treated|1|||
28148496|NCT02880371|54815980|FG006|Phase 2|Enrolled but not Treated|1|||
28148497|NCT02880371|54815981|FG007|Phase 2|Enrolled but not Treated|0|||
28148498|NCT02880371|54815974|FG000|Phase 2|Other|0|||
28148499|NCT02880371|54815975|FG001|Phase 2|Other|0|||
28148500|NCT02880371|54815976|FG002|Phase 2|Other|0|||
28148501|NCT02880371|54815977|FG003|Phase 2|Other|0|||
28148502|NCT02880371|54815978|FG004|Phase 2|Other|0|||
28148503|NCT02880371|54815979|FG005|Phase 2|Other|1|||
28148504|NCT02880371|54815980|FG006|Phase 2|Other|2|||
28148505|NCT02880371|54815981|FG007|Phase 2|Other|1|||
28148506|NCT02880371|54815974|FG000|Phase 2|Participants terminated by Sponsor|0|||
28148507|NCT02880371|54815975|FG001|Phase 2|Participants terminated by Sponsor|0|||
28148508|NCT02880371|54815976|FG002|Phase 2|Participants terminated by Sponsor|0|||
28148509|NCT02880371|54815977|FG003|Phase 2|Participants terminated by Sponsor|0|||
28148510|NCT02880371|54815978|FG004|Phase 2|Participants terminated by Sponsor|1|||
28148511|NCT02880371|54815979|FG005|Phase 2|Participants terminated by Sponsor|6|||
28148512|NCT02880371|54815980|FG006|Phase 2|Participants terminated by Sponsor|1|||
28148513|NCT02880371|54815981|FG007|Phase 2|Participants terminated by Sponsor|5|||
28148514|NCT02880371|54815974|FG000|Phase 2|Death|0|||
28148515|NCT02880371|54815975|FG001|Phase 2|Death|0|||
28148516|NCT02880371|54815976|FG002|Phase 2|Death|0|||
28148517|NCT02880371|54815977|FG003|Phase 2|Death|0|||
28148518|NCT02880371|54815978|FG004|Phase 2|Death|1|||
28148519|NCT02880371|54815979|FG005|Phase 2|Death|10|||
28148520|NCT02880371|54815980|FG006|Phase 2|Death|20|||
28148521|NCT02880371|54815981|FG007|Phase 2|Death|5|||
28148522|NCT02880371|54815974|FG000|Phase 2|Lost to Follow-up|0|||
28148523|NCT02880371|54815975|FG001|Phase 2|Lost to Follow-up|0|||
28148524|NCT02880371|54815976|FG002|Phase 2|Lost to Follow-up|0|||
28148525|NCT02880371|54815977|FG003|Phase 2|Lost to Follow-up|0|||
28148526|NCT02880371|54815978|FG004|Phase 2|Lost to Follow-up|0|||
28148527|NCT02880371|54815979|FG005|Phase 2|Lost to Follow-up|0|||
28072587|NCT00423137|54727202|FG002|Overall Study|Adverse Event Study disease worse|3|||
28072588|NCT00423137|54727203|FG003|Overall Study|Adverse Event Study disease worse|1|||
28072589|NCT00423137|54727200|FG000|Overall Study|Adverse Event Other|0|||
28072590|NCT00423137|54727201|FG001|Overall Study|Adverse Event Other|0|||
28072591|NCT00423137|54727202|FG002|Overall Study|Adverse Event Other|2|||
28072592|NCT00423137|54727203|FG003|Overall Study|Adverse Event Other|0|||
28072593|NCT00422903|54727218|FG000|Overall Study|Disease Progression|3|||
28072594|NCT00422903|54727219|FG001|Overall Study|Disease Progression|1|||
28072595|NCT00422903|54727218|FG000|Overall Study|Adverse Event|0|||
28072596|NCT00422903|54727219|FG001|Overall Study|Adverse Event|2|||
28072597|NCT00422903|54727218|FG000|Overall Study|Informed Consent Withdrawn|1|||
28072598|NCT00422903|54727219|FG001|Overall Study|Informed Consent Withdrawn|2|||
28072599|NCT00422669|54727228|FG000|Overall Study|The study was terminated early.|98|||
28072600|NCT00422669|54727229|FG001|Overall Study|The study was terminated early.|100|||
28072601|NCT00422669|54727230|FG002|Overall Study|The study was terminated early.|7|||
28072602|NCT00422591|54727236|FG000|Overall Study|Physician Decision|4|||
28072603|NCT00422591|54727236|FG000|Overall Study|Withdrawal by Subject|2|||
28072604|NCT00422513|54727242|FG000|Overall Study|Lack of Efficacy|4|||
28072605|NCT00422513|54727243|FG001|Overall Study|Lack of Efficacy|5|||
28072606|NCT00422513|54727242|FG000|Overall Study|Protocol Violation|23|||
28072607|NCT00422513|54727243|FG001|Overall Study|Protocol Violation|7|||
28072608|NCT00422513|54727242|FG000|Overall Study|Refused Treatment|4|||
28072609|NCT00422513|54727243|FG001|Overall Study|Refused Treatment|2|||
28072610|NCT00422513|54727242|FG000|Overall Study|Withdrawal by Subject|2|||
28148528|NCT02880371|54815980|FG006|Phase 2|Lost to Follow-up|3|||
28148529|NCT02880371|54815981|FG007|Phase 2|Lost to Follow-up|0|||
28148530|NCT02880371|54815974|FG000|Phase 2|Withdrawal by Subject|0|||
28148531|NCT02880371|54815975|FG001|Phase 2|Withdrawal by Subject|0|||
28148532|NCT02880371|54815976|FG002|Phase 2|Withdrawal by Subject|0|||
27822750|NCT01799941|54286730|FG000|Overall Study|Adverse Event|34|||
28072611|NCT00422513|54727243|FG001|Overall Study|Withdrawal by Subject|1|||
28148533|NCT02880371|54815977|FG003|Phase 2|Withdrawal by Subject|0|||
28148534|NCT02880371|54815978|FG004|Phase 2|Withdrawal by Subject|0|||
28148535|NCT02880371|54815979|FG005|Phase 2|Withdrawal by Subject|1|||
28148536|NCT02880371|54815980|FG006|Phase 2|Withdrawal by Subject|1|||
28148537|NCT02880371|54815981|FG007|Phase 2|Withdrawal by Subject|0|||
28148538|NCT02880371|54815974|FG000|Phase 2|End of Study page not completed by error|0|||
28148539|NCT02880371|54815975|FG001|Phase 2|End of Study page not completed by error|0|||
28148540|NCT02880371|54815976|FG002|Phase 2|End of Study page not completed by error|0|||
28148541|NCT02880371|54815977|FG003|Phase 2|End of Study page not completed by error|0|||
28148542|NCT02880371|54815978|FG004|Phase 2|End of Study page not completed by error|0|||
28148543|NCT02880371|54815979|FG005|Phase 2|End of Study page not completed by error|1|||
28148544|NCT02880371|54815980|FG006|Phase 2|End of Study page not completed by error|0|||
28148545|NCT02880371|54815981|FG007|Phase 2|End of Study page not completed by error|0|||
28148546|NCT02837029|54816004|FG000|Screening|Failed to meet screening requirements.|7|||
28148547|NCT02837029|54816005|FG001|Screening|Failed to meet screening requirements.|3|||
28148548|NCT02837029|54816006|FG002|Screening|Failed to meet screening requirements.|0|||
28148549|NCT02837029|54816004|FG000|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2|||
28148550|NCT02837029|54816005|FG001|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
28148551|NCT02837029|54816006|FG002|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
28148552|NCT02837029|54816004|FG000|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
28148553|NCT02837029|54816005|FG001|Cycle 1 (DLT Monitoring Period)|Adverse Event|2|||
28148554|NCT02837029|54816006|FG002|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
28148555|NCT02837029|54816004|FG000|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
28148556|NCT02837029|54816005|FG001|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1|||
28148557|NCT02837029|54816006|FG002|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
28148558|NCT02837029|54816004|FG000|Cycle 2 and Beyond|Adverse Event|1|||
28148559|NCT02837029|54816005|FG001|Cycle 2 and Beyond|Adverse Event|0|||
28148560|NCT02837029|54816006|FG002|Cycle 2 and Beyond|Adverse Event|0|||
28148561|NCT02837029|54816004|FG000|2 Year Follow-up|Death|6|||
28148562|NCT02837029|54816005|FG001|2 Year Follow-up|Death|7|||
28148563|NCT02837029|54816006|FG002|2 Year Follow-up|Death|0|||
28148564|NCT02642965|54816015|FG000|Overall Study|Lack of Efficacy|4|||
28148565|NCT02642965|54816015|FG000|Overall Study|Physician Decision|9|||
28148566|NCT03010527|54816022|FG000|Overall Study|Death|0|||
28148567|NCT03010527|54816023|FG001|Overall Study|Death|0|||
28148568|NCT03010527|54816024|FG002|Overall Study|Death|1|||
28148569|NCT03010527|54816022|FG000|Overall Study|Adverse Event|0|||
28148570|NCT03010527|54816023|FG001|Overall Study|Adverse Event|4|||
28148571|NCT03010527|54816024|FG002|Overall Study|Adverse Event|2|||
28148572|NCT03010527|54816022|FG000|Overall Study|Protocol Violation|0|||
28148573|NCT03010527|54816023|FG001|Overall Study|Protocol Violation|1|||
28148574|NCT03010527|54816024|FG002|Overall Study|Protocol Violation|0|||
28148575|NCT03010527|54816022|FG000|Overall Study|Lost to Follow-up|0|||
28148576|NCT03010527|54816023|FG001|Overall Study|Lost to Follow-up|2|||
28148577|NCT03010527|54816024|FG002|Overall Study|Lost to Follow-up|1|||
28148578|NCT03010527|54816022|FG000|Overall Study|Withdrawal by Subject|0|||
28148579|NCT03010527|54816023|FG001|Overall Study|Withdrawal by Subject|3|||
28148580|NCT03010527|54816024|FG002|Overall Study|Withdrawal by Subject|4|||
28148581|NCT03010527|54816022|FG000|Overall Study|WITHDRAWAL CRITERIA #9|0|||
28148582|NCT03010527|54816023|FG001|Overall Study|WITHDRAWAL CRITERIA #9|4|||
28148583|NCT03010527|54816024|FG002|Overall Study|WITHDRAWAL CRITERIA #9|6|||
28148584|NCT03010527|54816022|FG000|Overall Study|WITHDRAWAL CRITERIA #12|0|||
28148585|NCT03010527|54816023|FG001|Overall Study|WITHDRAWAL CRITERIA #12|4|||
28148586|NCT03010527|54816024|FG002|Overall Study|WITHDRAWAL CRITERIA #12|2|||
28148587|NCT03010527|54816022|FG000|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
28148588|NCT03010527|54816023|FG001|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|1|||
28148589|NCT03010527|54816024|FG002|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
28148590|NCT00794924|54816057|FG000|Overall Study|Lost to Follow-up|6|||
28148591|NCT00794924|54816058|FG001|Overall Study|Lost to Follow-up|8|||
28148592|NCT00794924|54816057|FG000|Overall Study|Withdrawal by Subject|48|||
28148593|NCT00794924|54816058|FG001|Overall Study|Withdrawal by Subject|60|||
28148594|NCT00794924|54816057|FG000|Overall Study|Adverse Event|6|||
28148595|NCT00794924|54816058|FG001|Overall Study|Adverse Event|2|||
28148596|NCT02914275|54816064|FG000|Overall Study|Lost to Follow-up|84|||
28148597|NCT02914275|54816065|FG001|Overall Study|Lost to Follow-up|29|||
28148598|NCT02914275|54816064|FG000|Overall Study|Withdrawal by Subject|26|||
28148599|NCT02914275|54816065|FG001|Overall Study|Withdrawal by Subject|10|||
28148600|NCT02914275|54816064|FG000|Overall Study|Protocol Violation|1|||
28148601|NCT02914275|54816065|FG001|Overall Study|Protocol Violation|1|||
28148602|NCT02914275|54816064|FG000|Overall Study|Physician Decision|3|||
28148603|NCT02914275|54816065|FG001|Overall Study|Physician Decision|1|||
28148604|NCT02914275|54816064|FG000|Overall Study|Other|4|||
28148605|NCT02914275|54816065|FG001|Overall Study|Other|1|||
28148606|NCT02914275|54816064|FG000|Overall Study|Excluded due to invalid informed consent|3|||
28148607|NCT02914275|54816065|FG001|Overall Study|Excluded due to invalid informed consent|0|||
28148608|NCT00792116|54816077|FG000|Overall Study|Lost to Follow-up|0|||
28148609|NCT00792116|54816078|FG001|Overall Study|Lost to Follow-up|1|||
28148610|NCT00792116|54816077|FG000|Overall Study|Discontnued intervention|1|||
28148611|NCT00792116|54816078|FG001|Overall Study|Discontnued intervention|0|||
28148612|NCT00489827|54816093|FG000|Overall Study|Intraoperative exclusion criteria|1|||
28148613|NCT00489827|54816094|FG001|Overall Study|Intraoperative exclusion criteria|1|||
28148614|NCT00489827|54816093|FG000|Overall Study|Intraoperative exclusion criteria|1|||
28148615|NCT00489827|54816094|FG001|Overall Study|Intraoperative exclusion criteria|1|||
28148616|NCT02604433|54816102|FG000|Overall Study|Withdrawal by Subject|37|||
28148617|NCT02604433|54816103|FG001|Overall Study|Withdrawal by Subject|16|||
28148618|NCT02604433|54816102|FG000|Overall Study|Adverse Event|4|||
28148619|NCT02604433|54816103|FG001|Overall Study|Adverse Event|0|||
28148620|NCT02604433|54816102|FG000|Overall Study|Other reasons|3|||
28148621|NCT02604433|54816103|FG001|Overall Study|Other reasons|5|||
28148622|NCT02604433|54816102|FG000|Overall Study|Death|4|||
28148623|NCT02604433|54816103|FG001|Overall Study|Death|1|||
28148624|NCT02604433|54816102|FG000|Overall Study|Transition to Rollover Protocol|169|||
28148625|NCT02604433|54816103|FG001|Overall Study|Transition to Rollover Protocol|82|||
28148626|NCT02604433|54816102|FG000|Overall Study|Physician Decision|1|||
28148627|NCT02604433|54816103|FG001|Overall Study|Physician Decision|1|||
28148628|NCT02604433|54816102|FG000|Overall Study|Lack of Efficacy|0|||
28148629|NCT02604433|54816103|FG001|Overall Study|Lack of Efficacy|1|||
28148630|NCT02659150|54816109|FG000|Subject Enrollment|Physician Decision|3|||
28148631|NCT02659150|54816109|FG000|Subject Enrollment|Withdrawal by Subject|2|||
28148632|NCT02659150|54816109|FG000|Baseline Imaging|Withdrawal by Subject|1|||
28148633|NCT02659150|54816109|FG000|Baseline Imaging|Physician Decision|1|||
28148634|NCT02659150|54816109|FG000|Study Drug Dosing|Adverse Event|1|||
28148635|NCT03006393|54816116|FG000|Overall Study|Withdrawal by Subject|1|||
28148636|NCT03006393|54816117|FG001|Overall Study|Withdrawal by Subject|1|||
28148637|NCT03006393|54816116|FG000|Overall Study|Pregnancy|0|||
28148638|NCT03006393|54816117|FG001|Overall Study|Pregnancy|1|||
28148639|NCT03006393|54816116|FG000|Overall Study|Lost to Follow-up|0|||
28148640|NCT03006393|54816117|FG001|Overall Study|Lost to Follow-up|1|||
28148641|NCT00882440|54816134|FG000|Overall Study|Adverse Event|2|||
28148642|NCT00882440|54816135|FG001|Overall Study|Adverse Event|2|||
28148643|NCT00882440|54816136|FG002|Overall Study|Adverse Event|2|||
28148644|NCT00882440|54816137|FG003|Overall Study|Adverse Event|1|||
28148645|NCT00882440|54816138|FG004|Overall Study|Adverse Event|1|||
28148646|NCT00882440|54816139|FG005|Overall Study|Adverse Event|4|||
28148647|NCT00882440|54816140|FG006|Overall Study|Adverse Event|2|||
28148648|NCT00882440|54816134|FG000|Overall Study|Lack of Efficacy|3|||
28148649|NCT00882440|54816135|FG001|Overall Study|Lack of Efficacy|5|||
28148650|NCT00882440|54816136|FG002|Overall Study|Lack of Efficacy|2|||
28148651|NCT00882440|54816137|FG003|Overall Study|Lack of Efficacy|0|||
28148652|NCT00882440|54816138|FG004|Overall Study|Lack of Efficacy|0|||
28072612|NCT00422513|54727242|FG000|Overall Study|early termination of the study|67|||
28148653|NCT00882440|54816139|FG005|Overall Study|Lack of Efficacy|3|||
28148654|NCT00882440|54816140|FG006|Overall Study|Lack of Efficacy|0|||
28148655|NCT00882440|54816134|FG000|Overall Study|Lost to Follow-up|2|||
28148656|NCT00882440|54816135|FG001|Overall Study|Lost to Follow-up|0|||
28148657|NCT00882440|54816136|FG002|Overall Study|Lost to Follow-up|1|||
28148658|NCT00882440|54816137|FG003|Overall Study|Lost to Follow-up|1|||
28148659|NCT00882440|54816138|FG004|Overall Study|Lost to Follow-up|1|||
28148660|NCT00882440|54816139|FG005|Overall Study|Lost to Follow-up|0|||
28148661|NCT00882440|54816140|FG006|Overall Study|Lost to Follow-up|1|||
28148662|NCT00882440|54816134|FG000|Overall Study|Protocol Violation|0|||
28148663|NCT00882440|54816135|FG001|Overall Study|Protocol Violation|0|||
28148664|NCT00882440|54816136|FG002|Overall Study|Protocol Violation|1|||
28148665|NCT00882440|54816137|FG003|Overall Study|Protocol Violation|1|||
28148666|NCT00882440|54816138|FG004|Overall Study|Protocol Violation|1|||
28148667|NCT00882440|54816139|FG005|Overall Study|Protocol Violation|0|||
28148668|NCT00882440|54816140|FG006|Overall Study|Protocol Violation|0|||
28148669|NCT00882440|54816134|FG000|Overall Study|Withdrawal by Subject|2|||
28148670|NCT00882440|54816135|FG001|Overall Study|Withdrawal by Subject|1|||
28072613|NCT00422513|54727243|FG001|Overall Study|early termination of the study|80|||
28072614|NCT00422513|54727242|FG000|Overall Study|Adverse Event|4|||
28148671|NCT00882440|54816136|FG002|Overall Study|Withdrawal by Subject|1|||
28148672|NCT00882440|54816137|FG003|Overall Study|Withdrawal by Subject|0|||
28148673|NCT00882440|54816138|FG004|Overall Study|Withdrawal by Subject|6|||
28148674|NCT00882440|54816139|FG005|Overall Study|Withdrawal by Subject|0|||
28148675|NCT00882440|54816140|FG006|Overall Study|Withdrawal by Subject|1|||
28148676|NCT00882440|54816134|FG000|Overall Study|Patient Uncooperative|2|||
28148677|NCT00882440|54816135|FG001|Overall Study|Patient Uncooperative|0|||
28148678|NCT00882440|54816136|FG002|Overall Study|Patient Uncooperative|0|||
28148679|NCT00882440|54816137|FG003|Overall Study|Patient Uncooperative|0|||
28148680|NCT00882440|54816138|FG004|Overall Study|Patient Uncooperative|1|||
28148681|NCT00882440|54816139|FG005|Overall Study|Patient Uncooperative|0|||
28148682|NCT00882440|54816140|FG006|Overall Study|Patient Uncooperative|0|||
28148683|NCT03005067|54816151|FG000|Overall Study|Withdrawal by Subject|3|||
28148684|NCT03005067|54816152|FG001|Overall Study|Withdrawal by Subject|2|||
28148685|NCT03005067|54816151|FG000|Overall Study|Adverse Event|4|||
28148686|NCT03005067|54816152|FG001|Overall Study|Adverse Event|3|||
28148687|NCT03005067|54816151|FG000|Overall Study|Other (reason not specified)|3|||
28148688|NCT03005067|54816152|FG001|Overall Study|Other (reason not specified)|1|||
28148689|NCT03005067|54816151|FG000|Overall Study|Protocol Violation|0|||
28148690|NCT03005067|54816152|FG001|Overall Study|Protocol Violation|1|||
28148691|NCT02658448|54816158|FG000|Overall Study|Lost to Follow-up|1|||
28148692|NCT03075761|54816164|FG000|Overall Study|Lost to Follow-up|1|||
28148693|NCT03075761|54816165|FG001|Overall Study|Lost to Follow-up|6|||
28148694|NCT03000075|54816179|FG000|Part A|Adverse Event|4|||
28148695|NCT03000075|54816180|FG001|Part A|Adverse Event|0|||
28148696|NCT03000075|54816181|FG002|Part A|Adverse Event|0|||
28148697|NCT03000075|54816182|FG003|Part A|Adverse Event|0|||
28148698|NCT03000075|54816183|FG004|Part A|Adverse Event|0|||
28148699|NCT03000075|54816184|FG005|Part A|Adverse Event|0|||
28148700|NCT03000075|54816185|FG006|Part A|Adverse Event|0|||
28148701|NCT03000075|54816179|FG000|Part B|Not dosed due to AE|0|||
28072615|NCT00422513|54727243|FG001|Overall Study|Adverse Event|4|||
28072616|NCT00422513|54727242|FG000|Overall Study|Death|3|||
28072617|NCT00422513|54727243|FG001|Overall Study|Death|7|||
28072618|NCT00202878|54727251|FG000|Overall Study|Death|964|||
28072619|NCT00202878|54727252|FG001|Overall Study|Death|968|||
28072620|NCT00202878|54727251|FG000|Overall Study|Only Vital Status Known|357|||
28072621|NCT00202878|54727252|FG001|Overall Study|Only Vital Status Known|356|||
28072622|NCT00202878|54727251|FG000|Overall Study|Lost to Follow-up|44|||
28072623|NCT00202878|54727252|FG001|Overall Study|Lost to Follow-up|49|||
28072624|NCT00202878|54727251|FG000|Overall Study|Site Closure|39|||
28072625|NCT00202878|54727252|FG001|Overall Study|Site Closure|36|||
28072626|NCT00202878|54727251|FG000|Overall Study|Withdrawal by Subject|795|||
28148702|NCT03000075|54816180|FG001|Part B|Not dosed due to AE|0|||
28072627|NCT00202878|54727252|FG001|Overall Study|Withdrawal by Subject|808|||
28072628|NCT00414011|54727258|FG000|Overall Study|Physician Decision|3|||
28148703|NCT03000075|54816181|FG002|Part B|Not dosed due to AE|0|||
28148704|NCT03000075|54816182|FG003|Part B|Not dosed due to AE|0|||
28148705|NCT03000075|54816183|FG004|Part B|Not dosed due to AE|0|||
28072629|NCT00414011|54727258|FG000|Overall Study|Withdrawal by Subject|2|||
28072630|NCT00231816|54727265|FG000|Overall Study|Adverse Event|1|||
28148706|NCT03000075|54816184|FG005|Part B|Not dosed due to AE|2|||
28148707|NCT03000075|54816185|FG006|Part B|Not dosed due to AE|1|||
28148708|NCT03000075|54816179|FG000|Part B|Adverse Event|0|||
28148709|NCT03000075|54816180|FG001|Part B|Adverse Event|0|||
28148710|NCT03000075|54816181|FG002|Part B|Adverse Event|0|||
27822751|NCT01799941|54286730|FG000|Overall Study|Withdrawal by Subject|21|||
27822752|NCT01799941|54286730|FG000|Overall Study|Death|2|||
28072631|NCT00231816|54727266|FG001|Overall Study|Adverse Event|0|||
28148711|NCT03000075|54816182|FG003|Part B|Adverse Event|0|||
28148712|NCT03000075|54816183|FG004|Part B|Adverse Event|1|||
28148713|NCT03000075|54816184|FG005|Part B|Adverse Event|0|||
28072632|NCT00231816|54727265|FG000|Overall Study|Lost to Follow-up|8|||
28148714|NCT03000075|54816185|FG006|Part B|Adverse Event|0|||
28148715|NCT03073109|54816203|FG000|Overall Study|Adverse Event|0|||
28148716|NCT03073109|54816204|FG001|Overall Study|Adverse Event|1|||
28148717|NCT03073109|54816203|FG000|Overall Study|Other|2|||
28148718|NCT03073109|54816204|FG001|Overall Study|Other|0|||
28148719|NCT03073109|54816203|FG000|Overall Study|Lost to Follow-up|8|||
28148720|NCT03073109|54816204|FG001|Overall Study|Lost to Follow-up|1|||
28148721|NCT02371889|54816226|FG000|Overall Study|Adverse medication effect|11|||
28148722|NCT02371889|54816227|FG001|Overall Study|Adverse medication effect|2|||
28148723|NCT02371889|54816226|FG000|Overall Study|Lost to Follow-up|6|||
28148724|NCT02371889|54816227|FG001|Overall Study|Lost to Follow-up|5|||
28148725|NCT02371889|54816226|FG000|Overall Study|Personal time constraints|2|||
28148726|NCT02371889|54816227|FG001|Overall Study|Personal time constraints|4|||
28148727|NCT02371889|54816226|FG000|Overall Study|Lack of Efficacy|0|||
28148728|NCT02371889|54816227|FG001|Overall Study|Lack of Efficacy|2|||
28148729|NCT02371889|54816226|FG000|Overall Study|Relapse|0|||
28148730|NCT02371889|54816227|FG001|Overall Study|Relapse|1|||
28148731|NCT03072875|54816237|FG000|Overall Study|Lost to Follow-up|1|||
28148732|NCT04250077|54816245|FG000|Overall Study|Withdrawal by Subject|0|||
28148733|NCT04250077|54816246|FG001|Overall Study|Withdrawal by Subject|1|||
28148734|NCT04250077|54816247|FG002|Overall Study|Withdrawal by Subject|0|||
28072633|NCT00231816|54727266|FG001|Overall Study|Lost to Follow-up|5|||
28072634|NCT00231816|54727265|FG000|Overall Study|Protocol Violation|2|||
28072635|NCT00231816|54727266|FG001|Overall Study|Protocol Violation|3|||
28072636|NCT00231816|54727265|FG000|Overall Study|Withdrawal by Subject|3|||
28072637|NCT00231816|54727266|FG001|Overall Study|Withdrawal by Subject|3|||
28072638|NCT00231816|54727265|FG000|Overall Study|Other|2|||
28072639|NCT00231816|54727266|FG001|Overall Study|Other|1|||
28072640|NCT00260208|54727275|FG000|Overall Study|Subject withdrew consent|11|||
28072641|NCT00260208|54727276|FG001|Overall Study|Subject withdrew consent|7|||
28148735|NCT04250077|54816245|FG000|Overall Study|Lost to Follow-up|2|||
28072642|NCT00260208|54727275|FG000|Overall Study|Lost to Follow-up|6|||
28072643|NCT00260208|54727276|FG001|Overall Study|Lost to Follow-up|1|||
28072644|NCT00260208|54727275|FG000|Overall Study|Death|12|||
28148736|NCT04250077|54816246|FG001|Overall Study|Lost to Follow-up|3|||
28148737|NCT04250077|54816247|FG002|Overall Study|Lost to Follow-up|0|||
28148738|NCT00859430|54816259|FG000|First Intervention|Withdrawal by Subject|0|||
28148739|NCT00859430|54816260|FG001|First Intervention|Withdrawal by Subject|1|||
28148740|NCT02913105|54816277|FG000|Overall Study|Adverse Event|11|||
28148741|NCT02913105|54816278|FG001|Overall Study|Adverse Event|0|||
28148742|NCT02913105|54816279|FG002|Overall Study|Adverse Event|4|||
28148743|NCT02913105|54816277|FG000|Overall Study|Non-Compliance With Study Drug|0|||
28148744|NCT02913105|54816278|FG001|Overall Study|Non-Compliance With Study Drug|0|||
28148745|NCT02913105|54816279|FG002|Overall Study|Non-Compliance With Study Drug|1|||
28148746|NCT02913105|54816277|FG000|Overall Study|Reason Not Specified|3|||
28148747|NCT02913105|54816278|FG001|Overall Study|Reason Not Specified|1|||
28148748|NCT02913105|54816279|FG002|Overall Study|Reason Not Specified|1|||
28148749|NCT02913105|54816277|FG000|Overall Study|Physician Decision|1|||
28148750|NCT02913105|54816278|FG001|Overall Study|Physician Decision|1|||
28148751|NCT02913105|54816279|FG002|Overall Study|Physician Decision|0|||
28148752|NCT02913105|54816277|FG000|Overall Study|Withdrawal by Subject|0|||
28148753|NCT02913105|54816278|FG001|Overall Study|Withdrawal by Subject|3|||
28148754|NCT02913105|54816279|FG002|Overall Study|Withdrawal by Subject|1|||
28148755|NCT00840632|54816297|FG000|First Intervention|Withdrawal by Subject|0|||
28148756|NCT00840632|54816298|FG001|First Intervention|Withdrawal by Subject|1|||
28148757|NCT00840632|54816297|FG000|Washout|Withdrawal by Subject|1|||
28148758|NCT00840632|54816298|FG001|Washout|Withdrawal by Subject|1|||
28148759|NCT01602562|54816315|FG000|Overall Study|Adverse Event|3|||
28148760|NCT01602562|54816316|FG001|Overall Study|Adverse Event|1|||
28148761|NCT01602562|54816315|FG000|Overall Study|Physician Decision|1|||
28148762|NCT01602562|54816316|FG001|Overall Study|Physician Decision|1|||
28148763|NCT01602562|54816315|FG000|Overall Study|Withdrawal by Subject|1|||
28148764|NCT01602562|54816316|FG001|Overall Study|Withdrawal by Subject|1|||
28148765|NCT01945775|54816325|FG000|Overall Study|Death|214|||
28148766|NCT01945775|54816326|FG001|Overall Study|Death|98|||
28148767|NCT01945775|54816325|FG000|Overall Study|Lost to Follow-up|12|||
28148768|NCT01945775|54816326|FG001|Overall Study|Lost to Follow-up|7|||
28148769|NCT01945775|54816325|FG000|Overall Study|Withdrawal by Subject|11|||
28148770|NCT01945775|54816326|FG001|Overall Study|Withdrawal by Subject|21|||
28148771|NCT01945775|54816325|FG000|Overall Study|Other|50|||
27822753|NCT01799941|54286730|FG000|Overall Study|Investigator Decision|4|||
27822754|NCT01799941|54286730|FG000|Overall Study|Lack of Efficacy|3|||
28148772|NCT01945775|54816326|FG001|Overall Study|Other|18|||
28148773|NCT03072719|54816354|FG000|Overall Study|Adverse Event|1|||
27822755|NCT01799941|54286730|FG000|Overall Study|Lost to Follow-up|17|||
28148774|NCT03072719|54816355|FG001|Overall Study|Adverse Event|1|||
28148775|NCT00835796|54816363|FG000|First Intervention|Withdrawal by Subject|0|||
28148776|NCT00835796|54816364|FG001|First Intervention|Withdrawal by Subject|1|||
27822756|NCT01799941|54286730|FG000|Overall Study|Other|15|||
28148777|NCT00835640|54816370|FG000|Second Intervention|Protocol Violation|1|||
28148778|NCT00835640|54816371|FG001|Second Intervention|Protocol Violation|0|||
28148779|NCT02942017|54816377|FG000|Overall Study|Adverse Event|0|||
28148780|NCT02942017|54816378|FG001|Overall Study|Adverse Event|1|||
28148781|NCT02942017|54816377|FG000|Overall Study|Withdrawal by Subject|0|||
28148782|NCT02942017|54816378|FG001|Overall Study|Withdrawal by Subject|1|||
28148783|NCT02942017|54816377|FG000|Overall Study|Lost to Follow-up|1|||
28148784|NCT02942017|54816378|FG001|Overall Study|Lost to Follow-up|1|||
28148785|NCT02942017|54816377|FG000|Overall Study|Randomized but not dosed|1|||
28072645|NCT00260208|54727276|FG001|Overall Study|Death|10|||
28072646|NCT00260208|54727275|FG000|Overall Study|Missing|18|||
28072647|NCT00260208|54727276|FG001|Overall Study|Missing|16|||
28072648|NCT00202644|54727284|FG000|Overall Study|Adverse Event|12|||
28072649|NCT00202644|54727285|FG001|Overall Study|Adverse Event|13|||
28072650|NCT00202644|54727284|FG000|Overall Study|Withdrawal by Subject|8|||
28072651|NCT00202644|54727285|FG001|Overall Study|Withdrawal by Subject|6|||
28072652|NCT00202644|54727284|FG000|Overall Study|Lack of Efficacy|6|||
28072653|NCT00202644|54727285|FG001|Overall Study|Lack of Efficacy|6|||
28072654|NCT00202644|54727284|FG000|Overall Study|Lost to Follow-up|0|||
28072655|NCT00202644|54727285|FG001|Overall Study|Lost to Follow-up|1|||
28072656|NCT00202644|54727284|FG000|Overall Study|Other|9|||
28072657|NCT00202644|54727285|FG001|Overall Study|Other|1|||
28072658|NCT01235962|54727295|FG000|Overall Study|Withdrawal by Subject|20|||
28148786|NCT02942017|54816378|FG001|Overall Study|Randomized but not dosed|3|||
28148787|NCT00835406|54816393|FG000|Period: First Intervention|Adverse Event|0|||
28148788|NCT00835406|54816394|FG001|Period: First Intervention|Adverse Event|1|||
28148789|NCT00835406|54816393|FG000|Period: First Intervention|Withdrawal by Subject|2|||
28148790|NCT00835406|54816394|FG001|Period: First Intervention|Withdrawal by Subject|0|||
28148791|NCT00835406|54816393|FG000|Period: Washout of 7 Days|Withdrawal by Subject|0|||
28072659|NCT01235962|54727296|FG001|Overall Study|Withdrawal by Subject|19|||
28072660|NCT01235962|54727297|FG002|Overall Study|Withdrawal by Subject|62|||
27850107|NCT00988559|54348415|FG000|Overall Study|Lost to Follow-up|0|||
28148792|NCT00835406|54816394|FG001|Period: Washout of 7 Days|Withdrawal by Subject|2|||
28148793|NCT00835172|54816400|FG000|Washout|Protocol Violation|0|||
28148794|NCT00835172|54816401|FG001|Washout|Protocol Violation|1|||
28148795|NCT01676116|54816407|FG000|Overall Study|Withdrawal criteria|2|||
28148796|NCT01676116|54816408|FG001|Overall Study|Withdrawal criteria|14|||
28148797|NCT01676116|54816407|FG000|Overall Study|Adverse Event|1|||
28148798|NCT01676116|54816408|FG001|Overall Study|Adverse Event|2|||
28148799|NCT01676116|54816407|FG000|Overall Study|Unclassified|4|||
28148800|NCT01676116|54816408|FG001|Overall Study|Unclassified|10|||
28148801|NCT01676116|54816407|FG000|Overall Study|Protocol Violation|9|||
28148802|NCT01676116|54816408|FG001|Overall Study|Protocol Violation|3|||
28148803|NCT00740480|54816414|FG000|Overall Study|Adverse Event|1|||
28148804|NCT00740480|54816414|FG000|Overall Study|Physician Decision|1|||
28148805|NCT02743520|54816417|FG000|Overall Study|Withdrawal by Subject|1|||
28148806|NCT03001557|54816436|FG000|Core Phase|Randomized but not treated|0|||
28148807|NCT03001557|54816437|FG001|Core Phase|Randomized but not treated|0|||
28148808|NCT03001557|54816438|FG002|Core Phase|Randomized but not treated|1|||
28148809|NCT03001557|54816439|FG003|Core Phase|Randomized but not treated|0|||
28148810|NCT03001557|54816440|FG004|Core Phase|Randomized but not treated|0|||
28148811|NCT03001557|54816441|FG005|Core Phase|Randomized but not treated|0|||
28148812|NCT03001557|54816442|FG006|Core Phase|Randomized but not treated|0|||
28148813|NCT03001557|54816443|FG007|Core Phase|Randomized but not treated|0|||
28148814|NCT03001557|54816436|FG000|Extension Phase|Adverse Event|0|||
28148815|NCT03001557|54816437|FG001|Extension Phase|Adverse Event|0|||
28148816|NCT03001557|54816438|FG002|Extension Phase|Adverse Event|0|||
28148817|NCT03001557|54816439|FG003|Extension Phase|Adverse Event|0|||
28148818|NCT03001557|54816440|FG004|Extension Phase|Adverse Event|0|||
28148819|NCT03001557|54816441|FG005|Extension Phase|Adverse Event|2|||
28148820|NCT03001557|54816442|FG006|Extension Phase|Adverse Event|0|||
28148821|NCT03001557|54816443|FG007|Extension Phase|Adverse Event|0|||
28148822|NCT03001557|54816436|FG000|Extension Phase|Withdrawal by Subject|0|||
28148823|NCT03001557|54816437|FG001|Extension Phase|Withdrawal by Subject|0|||
28148824|NCT03001557|54816438|FG002|Extension Phase|Withdrawal by Subject|0|||
28148825|NCT03001557|54816439|FG003|Extension Phase|Withdrawal by Subject|0|||
28148826|NCT03001557|54816440|FG004|Extension Phase|Withdrawal by Subject|0|||
28148827|NCT03001557|54816441|FG005|Extension Phase|Withdrawal by Subject|1|||
28148828|NCT03001557|54816442|FG006|Extension Phase|Withdrawal by Subject|5|||
28148829|NCT03001557|54816443|FG007|Extension Phase|Withdrawal by Subject|2|||
28148830|NCT03001557|54816436|FG000|Extension Phase|Lost to Follow-up|0|||
28148831|NCT03001557|54816437|FG001|Extension Phase|Lost to Follow-up|0|||
28148832|NCT03001557|54816438|FG002|Extension Phase|Lost to Follow-up|0|||
28148833|NCT03001557|54816439|FG003|Extension Phase|Lost to Follow-up|0|||
28148834|NCT03001557|54816440|FG004|Extension Phase|Lost to Follow-up|0|||
28148835|NCT03001557|54816441|FG005|Extension Phase|Lost to Follow-up|0|||
28148836|NCT03001557|54816442|FG006|Extension Phase|Lost to Follow-up|2|||
28148837|NCT03001557|54816443|FG007|Extension Phase|Lost to Follow-up|1|||
28148838|NCT03001557|54816436|FG000|Extension Phase|Administrative Reason|0|||
28148839|NCT03001557|54816437|FG001|Extension Phase|Administrative Reason|0|||
28148840|NCT03001557|54816438|FG002|Extension Phase|Administrative Reason|0|||
28148841|NCT03001557|54816439|FG003|Extension Phase|Administrative Reason|0|||
28148842|NCT03001557|54816440|FG004|Extension Phase|Administrative Reason|0|||
28148843|NCT03001557|54816441|FG005|Extension Phase|Administrative Reason|1|||
28148844|NCT03001557|54816442|FG006|Extension Phase|Administrative Reason|3|||
28148845|NCT03001557|54816443|FG007|Extension Phase|Administrative Reason|3|||
28148846|NCT03001557|54816436|FG000|Extension Phase|Loss of caregiver|0|||
28148847|NCT03001557|54816437|FG001|Extension Phase|Loss of caregiver|0|||
28148848|NCT03001557|54816438|FG002|Extension Phase|Loss of caregiver|0|||
28148849|NCT03001557|54816439|FG003|Extension Phase|Loss of caregiver|0|||
28148850|NCT03001557|54816440|FG004|Extension Phase|Loss of caregiver|0|||
28148851|NCT03001557|54816441|FG005|Extension Phase|Loss of caregiver|0|||
28148852|NCT03001557|54816442|FG006|Extension Phase|Loss of caregiver|1|||
28148853|NCT03001557|54816443|FG007|Extension Phase|Loss of caregiver|0|||
28148854|NCT03001557|54816436|FG000|Extension Phase|Others|0|||
28148855|NCT03001557|54816437|FG001|Extension Phase|Others|0|||
28148856|NCT03001557|54816438|FG002|Extension Phase|Others|0|||
28148857|NCT03001557|54816439|FG003|Extension Phase|Others|0|||
28148858|NCT03001557|54816440|FG004|Extension Phase|Others|0|||
28148859|NCT03001557|54816441|FG005|Extension Phase|Others|1|||
28148860|NCT03001557|54816442|FG006|Extension Phase|Others|3|||
28148861|NCT03001557|54816443|FG007|Extension Phase|Others|0|||
28148862|NCT00830336|54816480|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
28148863|NCT00830336|54816481|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
28148864|NCT00830258|54816487|FG000|First Intervention|Adverse Event|1|||
28148865|NCT00830258|54816488|FG001|First Intervention|Adverse Event|0|||
28148866|NCT00830258|54816487|FG000|Washout: 7 Days|Protocol Violation|1|||
28148867|NCT00830258|54816488|FG001|Washout: 7 Days|Protocol Violation|0|||
28148868|NCT03349775|54816494|FG000|Overall Study|Side Effects|1|||
28148869|NCT03349775|54816495|FG001|Overall Study|Side Effects|2|||
28148870|NCT03349775|54816494|FG000|Overall Study|Withdrawal by Subject|1|||
28148871|NCT03349775|54816495|FG001|Overall Study|Withdrawal by Subject|1|||
28148872|NCT03349775|54816494|FG000|Overall Study|No primary outcome measurements|0|||
28148873|NCT03349775|54816495|FG001|Overall Study|No primary outcome measurements|1|||
28148874|NCT00830024|54816503|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
28148875|NCT00830024|54816504|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
28148876|NCT00829868|54816510|FG000|Washout|Physician Decision|1|||
28148877|NCT00829868|54816511|FG001|Washout|Physician Decision|0|||
28148878|NCT00829790|54816517|FG000|Washout of 14 Days|Withdrawal by Subject|0|||
28148879|NCT00829790|54816518|FG001|Washout of 14 Days|Withdrawal by Subject|1|||
28148880|NCT03207815|54816524|FG000|Overall Study|Protocol Violation|3|||
28148881|NCT03207815|54816525|FG001|Overall Study|Protocol Violation|1|||
28148882|NCT03207815|54816524|FG000|Overall Study|Adverse Event|1|||
28148883|NCT03207815|54816525|FG001|Overall Study|Adverse Event|2|||
28148884|NCT03207815|54816524|FG000|Overall Study|Lost to Follow-up|1|||
28148885|NCT03207815|54816525|FG001|Overall Study|Lost to Follow-up|2|||
28148886|NCT03207815|54816524|FG000|Overall Study|Investigator's Discretion|1|||
28148887|NCT03207815|54816525|FG001|Overall Study|Investigator's Discretion|1|||
28148888|NCT03207815|54816524|FG000|Overall Study|Lack of Efficacy|0|||
28148889|NCT03207815|54816525|FG001|Overall Study|Lack of Efficacy|1|||
28148890|NCT03207815|54816524|FG000|Overall Study|Pregnancy/Partner Pregnancy|1|||
28148891|NCT03207815|54816525|FG001|Overall Study|Pregnancy/Partner Pregnancy|0|||
28148892|NCT03207815|54816524|FG000|Overall Study|Withdrew Consent|1|||
28148893|NCT03207815|54816525|FG001|Overall Study|Withdrew Consent|0|||
28148894|NCT02911935|54816533|FG000|Overall Study|Lost to Follow-up|5|||
28148895|NCT02911935|54816534|FG001|Overall Study|Lost to Follow-up|7|||
28148896|NCT00829712|54816542|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
28148897|NCT00829712|54816543|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
28148898|NCT03069989|54816558|FG000|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1|||
28148899|NCT03069989|54816559|FG001|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0|||
28148900|NCT02698163|54816586|FG000|Overall Study|Lost to Follow-up|0|||
28148901|NCT02698163|54816587|FG001|Overall Study|Lost to Follow-up|1|||
28148902|NCT03817190|54816595|FG000|Overall Study|Early Termination|13|||
28148903|NCT03817190|54816596|FG001|Overall Study|Early Termination|20|||
28148904|NCT03817190|54816595|FG000|Overall Study|Adverse Event|10|||
28148905|NCT03817190|54816596|FG001|Overall Study|Adverse Event|17|||
28148906|NCT03817190|54816595|FG000|Overall Study|Withdrawal by Subject|12|||
28148907|NCT03817190|54816596|FG001|Overall Study|Withdrawal by Subject|8|||
28148908|NCT03817190|54816595|FG000|Overall Study|Lost to Follow-up|11|||
28148909|NCT03817190|54816596|FG001|Overall Study|Lost to Follow-up|7|||
28148910|NCT03817190|54816595|FG000|Overall Study|Lack of Efficacy|7|||
28148911|NCT03817190|54816596|FG001|Overall Study|Lack of Efficacy|5|||
28148912|NCT03817190|54816595|FG000|Overall Study|Investigator Decision|5|||
28148913|NCT03817190|54816596|FG001|Overall Study|Investigator Decision|1|||
28148914|NCT03817190|54816595|FG000|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|0|||
28148915|NCT03817190|54816596|FG001|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|1|||
28148916|NCT03817190|54816595|FG000|Overall Study|Lack of Contact|1|||
28148917|NCT03817190|54816596|FG001|Overall Study|Lack of Contact|0|||
28148918|NCT03817190|54816595|FG000|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|1|||
28148919|NCT03817190|54816596|FG001|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|0|||
28148920|NCT03797222|54816615|FG000|Overall Study|Withdrawal by Subject|1|||
28148921|NCT02742818|54816625|FG000|Overall Study|Adverse Event|0|||
28148922|NCT02742818|54816626|FG001|Overall Study|Adverse Event|1|||
28148923|NCT02742818|54816625|FG000|Overall Study|Protocol Violation|0|||
28148924|NCT02742818|54816626|FG001|Overall Study|Protocol Violation|1|||
28148925|NCT03069365|54816634|FG000|Overall Study|Adverse Event|1|||
28148926|NCT03065933|54816638|FG000|Overall Study|study terminated|5|||
28148927|NCT04256629|54816648|FG000|Overall Study|Adverse Event|0|||
28148928|NCT04256629|54816649|FG001|Overall Study|Adverse Event|0|||
28148929|NCT04256629|54816650|FG002|Overall Study|Adverse Event|0|||
28148930|NCT04256629|54816651|FG003|Overall Study|Adverse Event|0|||
28148931|NCT04256629|54816652|FG004|Overall Study|Adverse Event|0|||
28148932|NCT04256629|54816653|FG005|Overall Study|Adverse Event|1|||
28148933|NCT04256629|54816648|FG000|Overall Study|Protocol Violation|0|||
28148934|NCT04256629|54816649|FG001|Overall Study|Protocol Violation|1|||
28148935|NCT04256629|54816650|FG002|Overall Study|Protocol Violation|0|||
28148936|NCT04256629|54816651|FG003|Overall Study|Protocol Violation|0|||
28148937|NCT04256629|54816652|FG004|Overall Study|Protocol Violation|0|||
28148938|NCT04256629|54816653|FG005|Overall Study|Protocol Violation|0|||
28148939|NCT01346293|54816663|FG000|Overall Study|Protocol Violation|30|||
28148940|NCT01346293|54816664|FG001|Overall Study|Protocol Violation|9|||
28148941|NCT01346293|54816663|FG000|Overall Study|Lost to Follow-up|21|||
28148942|NCT01346293|54816664|FG001|Overall Study|Lost to Follow-up|8|||
28148943|NCT01346293|54816663|FG000|Overall Study|Withdrawal by Subject|15|||
28148944|NCT01346293|54816664|FG001|Overall Study|Withdrawal by Subject|4|||
28148945|NCT01346293|54816663|FG000|Overall Study|Other|1|||
28148946|NCT01346293|54816664|FG001|Overall Study|Other|0|||
28148947|NCT03502187|54816675|FG000|Overall Study|Withdrawal by Subject|4|||
28148948|NCT03502187|54816676|FG001|Overall Study|Withdrawal by Subject|3|||
28148949|NCT03502187|54816677|FG002|Overall Study|Withdrawal by Subject|3|||
28148950|NCT03502187|54816675|FG000|Overall Study|Lost to Follow-up|5|||
28148951|NCT03502187|54816676|FG001|Overall Study|Lost to Follow-up|4|||
28148952|NCT03502187|54816677|FG002|Overall Study|Lost to Follow-up|5|||
28148953|NCT03058705|54816685|FG000|Overall Study|Withdrawal by Subject|2|||
28148954|NCT03058705|54816685|FG000|Overall Study|Physician Decision|2|||
28148955|NCT02998671|54816694|FG000|Period 1|Study Terminated By Sponsor|2|||
28148956|NCT02998671|54816695|FG001|Period 1|Study Terminated By Sponsor|1|||
28148957|NCT02998671|54816696|FG002|Period 1|Study Terminated By Sponsor|0|||
28148958|NCT02998671|54816697|FG003|Period 1|Study Terminated By Sponsor|0|||
28148959|NCT02998671|54816698|FG004|Period 1|Study Terminated By Sponsor|1|||
28148960|NCT02998671|54816694|FG000|Period 1|Withdrawal by Subject|1|||
28148961|NCT02998671|54816695|FG001|Period 1|Withdrawal by Subject|2|||
28148962|NCT02998671|54816696|FG002|Period 1|Withdrawal by Subject|0|||
28148963|NCT02998671|54816697|FG003|Period 1|Withdrawal by Subject|0|||
28148964|NCT02998671|54816698|FG004|Period 1|Withdrawal by Subject|2|||
28148965|NCT02998671|54816694|FG000|Period 1|Pregnancy|1|||
28148966|NCT02998671|54816695|FG001|Period 1|Pregnancy|0|||
28148967|NCT02998671|54816696|FG002|Period 1|Pregnancy|0|||
28148968|NCT02998671|54816697|FG003|Period 1|Pregnancy|0|||
28148969|NCT02998671|54816698|FG004|Period 1|Pregnancy|0|||
28148970|NCT02998671|54816694|FG000|Period 1|Adverse Event|0|||
28148971|NCT02998671|54816695|FG001|Period 1|Adverse Event|0|||
28148972|NCT02998671|54816696|FG002|Period 1|Adverse Event|0|||
28148973|NCT02998671|54816697|FG003|Period 1|Adverse Event|0|||
28148974|NCT02998671|54816698|FG004|Period 1|Adverse Event|1|||
28148975|NCT02998671|54816694|FG000|Period 2|Adverse Event|0|||
28148976|NCT02998671|54816695|FG001|Period 2|Adverse Event|1|||
28148977|NCT02998671|54816696|FG002|Period 2|Adverse Event|0|||
28148978|NCT02998671|54816697|FG003|Period 2|Adverse Event|0|||
28148979|NCT02998671|54816698|FG004|Period 2|Adverse Event|0|||
28148980|NCT02998671|54816694|FG000|Period 2|Study Terminated By Sponsor|3|||
28148981|NCT02998671|54816695|FG001|Period 2|Study Terminated By Sponsor|5|||
28148982|NCT02998671|54816696|FG002|Period 2|Study Terminated By Sponsor|1|||
28148983|NCT02998671|54816697|FG003|Period 2|Study Terminated By Sponsor|3|||
28148984|NCT02998671|54816698|FG004|Period 2|Study Terminated By Sponsor|0|||
28148985|NCT02998671|54816694|FG000|Period 2|Withdrawal by Subject|0|||
28148986|NCT02998671|54816695|FG001|Period 2|Withdrawal by Subject|1|||
28148987|NCT02998671|54816696|FG002|Period 2|Withdrawal by Subject|0|||
27822757|NCT01799239|54286758|FG000|Period 1 (7 Days)|Lack of Efficacy|1|||
28148988|NCT02998671|54816697|FG003|Period 2|Withdrawal by Subject|0|||
28148989|NCT02998671|54816698|FG004|Period 2|Withdrawal by Subject|0|||
28148990|NCT02998671|54816694|FG000|Period 2|Lost to Follow-up|0|||
28148991|NCT02998671|54816695|FG001|Period 2|Lost to Follow-up|0|||
28148992|NCT02998671|54816696|FG002|Period 2|Lost to Follow-up|0|||
28148993|NCT02998671|54816697|FG003|Period 2|Lost to Follow-up|1|||
28148994|NCT02998671|54816698|FG004|Period 2|Lost to Follow-up|0|||
28148995|NCT02660827|54816718|FG000|From Study to End of Continued Access|Withdrawal by Subject|21|||
28148996|NCT02660827|54816718|FG000|From Study to End of Continued Access|Withdrawal by Sponsor|2|||
28148997|NCT02660827|54816718|FG000|From Study to End of Continued Access|Adverse Event|3|||
28148998|NCT02660827|54816718|FG000|From Study to End of Continued Access|didn't participate continued access period|5|||
28148999|NCT02660827|54816718|FG000|Period 1: Study Period|Withdrawal by Subject|1|||
28149000|NCT02660827|54816718|FG000|Period 2: Continued Access Period|Withdrawal by Subject|20|||
28149001|NCT02660827|54816718|FG000|Period 2: Continued Access Period|Withdrawal by Sponsor|2|||
28149002|NCT02660827|54816718|FG000|Period 2: Continued Access Period|Adverse Event|3|||
28149003|NCT01069419|54816739|FG000|Overall Study|Adverse Event|233|||
28149004|NCT01069419|54816739|FG000|Overall Study|Lack of Efficacy|332|||
28149005|NCT01069419|54816739|FG000|Overall Study|Lost to Follow-up|49|||
28149006|NCT01069419|54816739|FG000|Overall Study|Remission of disease|11|||
28149007|NCT01069419|54816739|FG000|Overall Study|Withdrawal by Subject|34|||
28149008|NCT01069419|54816739|FG000|Overall Study|Other Reason|43|||
28149009|NCT01069419|54816739|FG000|Overall Study|Missing termination information|13|||
28149010|NCT01069341|54816743|FG000|Overall Study|Lost to Follow-up|1|||
28149011|NCT02996097|54816747|FG000|Overall Study|Lost to Follow-up|11|||
28149012|NCT02996097|54816748|FG001|Overall Study|Lost to Follow-up|11|||
28149013|NCT02992899|54816755|FG000|Overall Study|Withdrawal by Subject|1|||
27822758|NCT01799239|54286759|FG001|Period 1 (7 Days)|Lack of Efficacy|0|||
28149014|NCT02992899|54816756|FG001|Overall Study|Withdrawal by Subject|0|||
28149015|NCT02992899|54816755|FG000|Overall Study|Lost to Follow-up|1|||
28149016|NCT02992899|54816756|FG001|Overall Study|Lost to Follow-up|3|||
28149017|NCT01602484|54816764|FG000|Overall Study|Airway issues unrelated to study|0|||
28149018|NCT01602484|54816765|FG001|Overall Study|Airway issues unrelated to study|1|||
28149019|NCT02989389|54816785|FG000|Period 1|Lost to Follow-up|0|||
28149020|NCT02989389|54816786|FG001|Period 1|Lost to Follow-up|1|||
28149021|NCT02989389|54816787|FG002|Period 1|Lost to Follow-up|0|||
28149022|NCT02989389|54816788|FG003|Period 1|Lost to Follow-up|0|||
28149023|NCT02989389|54816789|FG004|Period 1|Lost to Follow-up|0|||
28149024|NCT02989389|54816790|FG005|Period 1|Lost to Follow-up|0|||
28149025|NCT02989389|54816791|FG006|Period 1|Lost to Follow-up|0|||
28149026|NCT02989389|54816792|FG007|Period 1|Lost to Follow-up|0|||
28149027|NCT02989389|54816793|FG008|Period 1|Lost to Follow-up|0|||
28149028|NCT02989389|54816794|FG009|Period 1|Lost to Follow-up|0|||
28149029|NCT02989389|54816785|FG000|Period 1|Physician Decision|0|||
28149030|NCT02989389|54816786|FG001|Period 1|Physician Decision|0|||
28149031|NCT02989389|54816787|FG002|Period 1|Physician Decision|0|||
28149032|NCT02989389|54816788|FG003|Period 1|Physician Decision|0|||
28149033|NCT02989389|54816789|FG004|Period 1|Physician Decision|0|||
28149034|NCT02989389|54816790|FG005|Period 1|Physician Decision|0|||
28149035|NCT02989389|54816791|FG006|Period 1|Physician Decision|0|||
28149036|NCT02989389|54816792|FG007|Period 1|Physician Decision|0|||
28149037|NCT02989389|54816793|FG008|Period 1|Physician Decision|1|||
28149038|NCT02989389|54816794|FG009|Period 1|Physician Decision|0|||
28149039|NCT02653300|54816834|FG000|Overall Study|Withdrawal by Subject|2|||
28149040|NCT01757665|54816840|FG000|Overall Study|Still on Study - Visit Completed|240|||
28149041|NCT01757665|54816841|FG001|Overall Study|Still on Study - Visit Completed|30|||
28149042|NCT01757665|54816840|FG000|Overall Study|Still on Study - Visit Pending|398|||
28149043|NCT01757665|54816841|FG001|Overall Study|Still on Study - Visit Pending|40|||
28149044|NCT01757665|54816840|FG000|Overall Study|Still on Study - Missed Visit|14|||
28149045|NCT01757665|54816841|FG001|Overall Study|Still on Study - Missed Visit|1|||
28149046|NCT01757665|54816840|FG000|Overall Study|Death|25|||
28149047|NCT01757665|54816841|FG001|Overall Study|Death|8|||
28149048|NCT01757665|54816840|FG000|Overall Study|Explant|1|||
28149049|NCT01757665|54816841|FG001|Overall Study|Explant|2|||
28149050|NCT01757665|54816840|FG000|Overall Study|Withdrawal by Subject|10|||
28149051|NCT01757665|54816841|FG001|Overall Study|Withdrawal by Subject|0|||
28149052|NCT01757665|54816840|FG000|Overall Study|Lost to Follow-up|1|||
28149053|NCT01757665|54816841|FG001|Overall Study|Lost to Follow-up|1|||
28149054|NCT01757665|54816840|FG000|Overall Study|Not Implanted with Device|5|||
28149055|NCT01757665|54816841|FG001|Overall Study|Not Implanted with Device|1|||
28149056|NCT00430508|54816866|FG000|Overall Study|Adverse Event|2|||
28072661|NCT01235962|54727298|FG003|Overall Study|Withdrawal by Subject|49|||
28072662|NCT01235962|54727295|FG000|Overall Study|Lost to Follow-up|21|||
28072663|NCT01235962|54727296|FG001|Overall Study|Lost to Follow-up|16|||
28072664|NCT01235962|54727297|FG002|Overall Study|Lost to Follow-up|47|||
28072665|NCT01235962|54727298|FG003|Overall Study|Lost to Follow-up|32|||
28072666|NCT01235962|54727295|FG000|Overall Study|Physician Decision|5|||
28072667|NCT01235962|54727296|FG001|Overall Study|Physician Decision|0|||
28072668|NCT01235962|54727297|FG002|Overall Study|Physician Decision|9|||
28072669|NCT01235962|54727298|FG003|Overall Study|Physician Decision|5|||
28072670|NCT00259740|54727318|FG000|Overall Study|Physician Decision|1|||
28149057|NCT00430508|54816867|FG001|Overall Study|Adverse Event|3|||
28149058|NCT00430508|54816868|FG002|Overall Study|Adverse Event|5|||
28149059|NCT00430508|54816869|FG003|Overall Study|Adverse Event|3|||
28149060|NCT00430508|54816866|FG000|Overall Study|Withdrawal by Subject|0|||
28149061|NCT00430508|54816867|FG001|Overall Study|Withdrawal by Subject|1|||
28149062|NCT00430508|54816868|FG002|Overall Study|Withdrawal by Subject|1|||
28149063|NCT00430508|54816869|FG003|Overall Study|Withdrawal by Subject|1|||
28149064|NCT00430508|54816866|FG000|Overall Study|responder at visit 4|0|||
28149065|NCT00430508|54816867|FG001|Overall Study|responder at visit 4|0|||
28149066|NCT00430508|54816868|FG002|Overall Study|responder at visit 4|2|||
28149067|NCT00430508|54816869|FG003|Overall Study|responder at visit 4|0|||
28072671|NCT00259740|54727319|FG001|Overall Study|Physician Decision|1|||
28072672|NCT00259740|54727318|FG000|Overall Study|Adverse Event|0|||
28072673|NCT00259740|54727319|FG001|Overall Study|Adverse Event|2|||
28072674|NCT00259740|54727318|FG000|Overall Study|Withdrawal by Subject|2|||
28072675|NCT00259740|54727319|FG001|Overall Study|Withdrawal by Subject|6|||
28072676|NCT00259740|54727318|FG000|Overall Study|Death|1|||
28072677|NCT00259740|54727319|FG001|Overall Study|Death|1|||
28072678|NCT00259740|54727318|FG000|Overall Study|Disease progression|19|||
28072679|NCT00259740|54727319|FG001|Overall Study|Disease progression|36|||
28072680|NCT00259740|54727318|FG000|Overall Study|Ongoing|17|||
28072681|NCT00259740|54727319|FG001|Overall Study|Ongoing|3|||
28072682|NCT00259740|54727318|FG000|Overall Study|Other|3|||
28072683|NCT00259740|54727319|FG001|Overall Study|Other|0|||
28072684|NCT00259740|54727318|FG000|Overall Study|Requirement for alternative therapy|0|||
28072685|NCT00259740|54727319|FG001|Overall Study|Requirement for alternative therapy|4|||
28072686|NCT00201006|54727328|FG000|Overall Study|Withdrawal by Subject|7|||
28149068|NCT00430508|54816866|FG000|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0|||
28149069|NCT00430508|54816867|FG001|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
28149070|NCT00430508|54816868|FG002|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2|||
28149071|NCT00430508|54816869|FG003|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
28149072|NCT00430508|54816866|FG000|Overall Study|Other|1|||
28149073|NCT00430508|54816867|FG001|Overall Study|Other|1|||
28149074|NCT00430508|54816868|FG002|Overall Study|Other|3|||
28149075|NCT00430508|54816869|FG003|Overall Study|Other|0|||
28149076|NCT02988219|54816877|FG000|Overall Study|Lack of Efficacy|1|||
28149077|NCT02988219|54816878|FG001|Overall Study|Lack of Efficacy|1|||
28149078|NCT02988219|54816877|FG000|Overall Study|Withdrawal by Subject|0|||
28149079|NCT02988219|54816878|FG001|Overall Study|Withdrawal by Subject|2|||
28149080|NCT01346059|54816886|FG000|Overall Study|Withdrawal by Subject|1|||
28149081|NCT01346059|54816887|FG001|Overall Study|Withdrawal by Subject|0|||
28149082|NCT01318915|54816893|FG000|Overall Study|Lost to Follow-up|1|||
28149083|NCT02987205|54816899|FG000|Overall Study|Adverse Event|1|||
28149084|NCT02987205|54816899|FG000|Overall Study|Withdrawal by Subject|3|||
28149085|NCT02926937|54816921|FG000|Overall Study|Adverse Event|0|||
28149086|NCT02926937|54816922|FG001|Overall Study|Adverse Event|1|||
28149087|NCT02926937|54816923|FG002|Overall Study|Adverse Event|1|||
28149088|NCT02926937|54816921|FG000|Overall Study|Poor Compliance to Protocol|1|||
28149089|NCT02926937|54816922|FG001|Overall Study|Poor Compliance to Protocol|0|||
28149090|NCT02926937|54816923|FG002|Overall Study|Poor Compliance to Protocol|0|||
28149091|NCT02926937|54816921|FG000|Overall Study|Lost to Follow-up|4|||
28149092|NCT02926937|54816922|FG001|Overall Study|Lost to Follow-up|5|||
28149093|NCT02926937|54816923|FG002|Overall Study|Lost to Follow-up|0|||
28149094|NCT02926937|54816921|FG000|Overall Study|At the Participant's own Request|11|||
28149095|NCT02926937|54816922|FG001|Overall Study|At the Participant's own Request|5|||
28149096|NCT02926937|54816923|FG002|Overall Study|At the Participant's own Request|8|||
28149097|NCT02926937|54816921|FG000|Overall Study|Reason not Specified|3|||
28149098|NCT02926937|54816922|FG001|Overall Study|Reason not Specified|4|||
28149099|NCT02926937|54816923|FG002|Overall Study|Reason not Specified|2|||
28149100|NCT04189588|54816934|FG000|Overall Study|Death|0|||
27850108|NCT00988559|54348416|FG001|Overall Study|Lost to Follow-up|0|||
28072687|NCT00201006|54727329|FG001|Overall Study|Withdrawal by Subject|2|||
28072688|NCT00201006|54727330|FG002|Overall Study|Withdrawal by Subject|3|||
28072689|NCT00201006|54727328|FG000|Overall Study|Adverse Event|1|||
28072690|NCT00201006|54727329|FG001|Overall Study|Adverse Event|0|||
28072691|NCT00201006|54727330|FG002|Overall Study|Adverse Event|1|||
28072692|NCT00200850|54727341|FG000|Overall Study|relocation|1|||
28072693|NCT00200850|54727342|FG001|Overall Study|relocation|0|||
28149101|NCT04189588|54816935|FG001|Overall Study|Death|1|||
28149102|NCT04189588|54816934|FG000|Overall Study|Lost to Follow-up|0|||
28149103|NCT04189588|54816935|FG001|Overall Study|Lost to Follow-up|1|||
28149104|NCT00151892|54816943|FG000|Overall Study|Lack of Efficacy|50|||
28149105|NCT00151892|54816944|FG001|Overall Study|Lack of Efficacy|57|||
28149106|NCT00151892|54816943|FG000|Overall Study|Patient request|10|||
28149107|NCT00151892|54816944|FG001|Overall Study|Patient request|7|||
28149108|NCT00151892|54816943|FG000|Overall Study|Lost to Follow-up|5|||
28072694|NCT00200850|54727343|FG002|Overall Study|relocation|1|||
28072695|NCT00200850|54727341|FG000|Overall Study|too busy|1|||
28149109|NCT00151892|54816944|FG001|Overall Study|Lost to Follow-up|10|||
28149110|NCT00151892|54816943|FG000|Overall Study|Adverse Event|6|||
28149111|NCT00151892|54816944|FG001|Overall Study|Adverse Event|3|||
28149112|NCT00151892|54816943|FG000|Overall Study|Protocol Violation|3|||
28149113|NCT00151892|54816944|FG001|Overall Study|Protocol Violation|3|||
28149114|NCT00151892|54816943|FG000|Overall Study|Non-compliance|0|||
28149115|NCT00151892|54816944|FG001|Overall Study|Non-compliance|1|||
28072696|NCT00200850|54727342|FG001|Overall Study|too busy|0|||
28072697|NCT00200850|54727343|FG002|Overall Study|too busy|0|||
28072698|NCT00200850|54727341|FG000|Overall Study|Pregnancy|0|||
28072699|NCT00200850|54727342|FG001|Overall Study|Pregnancy|0|||
28072700|NCT00200850|54727343|FG002|Overall Study|Pregnancy|1|||
28072701|NCT00200850|54727341|FG000|Overall Study|Poor adherence|0|||
28072702|NCT00200850|54727342|FG001|Overall Study|Poor adherence|0|||
28072703|NCT00200850|54727343|FG002|Overall Study|Poor adherence|1|||
28072704|NCT00200850|54727341|FG000|Overall Study|optic neuritis|0|||
28072705|NCT00200850|54727342|FG001|Overall Study|optic neuritis|0|||
28072706|NCT00200850|54727343|FG002|Overall Study|optic neuritis|1|||
28072707|NCT00200850|54727341|FG000|Overall Study|Adverse Event|1|||
28072708|NCT00200850|54727342|FG001|Overall Study|Adverse Event|1|||
28072709|NCT00200850|54727343|FG002|Overall Study|Adverse Event|2|||
28072710|NCT03812224|54727353|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
28072711|NCT03812224|54727354|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
28072712|NCT03812224|54727353|FG000|Double-blind Treatment Period|Decision by Sponsor|0|||
28072713|NCT03812224|54727354|FG001|Double-blind Treatment Period|Decision by Sponsor|1|||
28072714|NCT03812224|54727353|FG000|Open-label Treatment Period|Withdrawal by Subject|2|||
28072715|NCT03812224|54727354|FG001|Open-label Treatment Period|Withdrawal by Subject|2|||
28072716|NCT03812224|54727353|FG000|Open-label Treatment Period|Decision by Sponsor|0|||
28149116|NCT00151892|54816943|FG000|Overall Study|Pregnancy|0|||
28149117|NCT00151892|54816944|FG001|Overall Study|Pregnancy|1|||
28149118|NCT00151892|54816943|FG000|Overall Study|Did not return for a visit|1|||
28149119|NCT00151892|54816944|FG001|Overall Study|Did not return for a visit|0|||
28149120|NCT00151892|54816943|FG000|Overall Study|Used prohibited corticosteroids|1|||
28149121|NCT00151892|54816944|FG001|Overall Study|Used prohibited corticosteroids|0|||
28149122|NCT00151892|54816943|FG000|Overall Study|Lack of study medication at center|0|||
28072717|NCT03812224|54727354|FG001|Open-label Treatment Period|Decision by Sponsor|1|||
28149123|NCT00151892|54816944|FG001|Overall Study|Lack of study medication at center|1|||
28149124|NCT03055195|54816968|FG000|Overall Study|Lack of Efficacy|1|||
28149125|NCT03055195|54816969|FG001|Overall Study|Lack of Efficacy|0|||
28149126|NCT03055195|54816968|FG000|Overall Study|Withdrawal by Subject|6|||
28072718|NCT00231114|54727363|FG000|Randomized|Withdrawal by Subject|6|||
28072719|NCT00231114|54727364|FG001|Randomized|Withdrawal by Subject|3|||
28149127|NCT03055195|54816969|FG001|Overall Study|Withdrawal by Subject|7|||
28149128|NCT03055195|54816968|FG000|Overall Study|Study Terminated by Sponsor|2|||
28149129|NCT03055195|54816969|FG001|Overall Study|Study Terminated by Sponsor|6|||
28149130|NCT03055195|54816968|FG000|Overall Study|Protocol Violation|2|||
28149131|NCT03055195|54816969|FG001|Overall Study|Protocol Violation|1|||
28149132|NCT03055195|54816968|FG000|Overall Study|Physician Decision|1|||
28149133|NCT03055195|54816969|FG001|Overall Study|Physician Decision|0|||
28149134|NCT02921919|54816977|FG000|Overall Study|Other|5|||
28149135|NCT02921919|54816978|FG001|Overall Study|Other|6|||
28149136|NCT02921919|54816977|FG000|Overall Study|Lost to Follow-up|0|||
28149137|NCT02921919|54816978|FG001|Overall Study|Lost to Follow-up|1|||
28149138|NCT02921919|54816977|FG000|Overall Study|Withdrawal by Subject|5|||
27850109|NCT00988559|54348417|FG002|Overall Study|Lost to Follow-up|1|||
28149139|NCT02921919|54816978|FG001|Overall Study|Withdrawal by Subject|1|||
28149140|NCT02921919|54816977|FG000|Overall Study|Disease Progression|47|||
28149141|NCT02921919|54816978|FG001|Overall Study|Disease Progression|38|||
28149142|NCT02921919|54816977|FG000|Overall Study|Physician Decision|3|||
28149143|NCT02921919|54816978|FG001|Overall Study|Physician Decision|2|||
28149144|NCT02921919|54816977|FG000|Overall Study|Adverse Event|6|||
28149145|NCT02921919|54816978|FG001|Overall Study|Adverse Event|4|||
28149146|NCT02910219|54817000|FG000|Overall Study|Withdrawal by Subject|1|||
28149147|NCT02910219|54817001|FG001|Overall Study|Withdrawal by Subject|1|||
28149148|NCT01068717|54817007|FG000|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1|||
28149149|NCT01068717|54817008|FG001|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
28149150|NCT01068717|54817009|FG002|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
28149151|NCT01068717|54817010|FG003|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
28149152|NCT02921763|54817024|FG000|Overall Study|Adverse Event|4|||
28149153|NCT02921763|54817024|FG000|Overall Study|Lost to Follow-up|4|||
28149154|NCT02921763|54817024|FG000|Overall Study|Lack of Efficacy|3|||
28149155|NCT02921763|54817024|FG000|Overall Study|Protocol Violation|2|||
28149156|NCT02921763|54817024|FG000|Overall Study|Withdrawal by Subject|2|||
28149157|NCT02921763|54817024|FG000|Overall Study|Physician Decision|1|||
28149158|NCT02921763|54817024|FG000|Overall Study|No data obtained|2|||
28149159|NCT01318135|54817046|FG000|Enrolled - Long-Term Extension Study|Adverse Event|1|||
28149160|NCT01318135|54817047|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
28149161|NCT01318135|54817048|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
28149162|NCT01318135|54817049|FG003|Enrolled - Long-Term Extension Study|Adverse Event|0|||
28149163|NCT01318135|54817050|FG004|Enrolled - Long-Term Extension Study|Adverse Event|0|||
28149164|NCT01318135|54817051|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
28149165|NCT01318135|54817052|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
28149166|NCT01318135|54817053|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
28149167|NCT01318135|54817046|FG000|Enrolled - Long-Term Extension Study|Treatment Complications|1|||
28149168|NCT01318135|54817047|FG001|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
28149169|NCT01318135|54817048|FG002|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
28149170|NCT01318135|54817049|FG003|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
28149171|NCT01318135|54817050|FG004|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
28149172|NCT01318135|54817051|FG005|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
28149173|NCT01318135|54817052|FG006|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
28149174|NCT01318135|54817053|FG007|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
28149175|NCT01318135|54817046|FG000|Entered - Long-Term Extension Study|Adverse Event|9|||
28149176|NCT01318135|54817047|FG001|Entered - Long-Term Extension Study|Adverse Event|3|||
27850110|NCT00988559|54348418|FG003|Overall Study|Lost to Follow-up|0|||
27850111|NCT00988169|54348428|FG000|Overall Study|Withdrawal by Subject|1|||
28149177|NCT01318135|54817048|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
28149178|NCT01318135|54817049|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
28149179|NCT01318135|54817050|FG004|Entered - Long-Term Extension Study|Adverse Event|4|||
28149180|NCT01318135|54817051|FG005|Entered - Long-Term Extension Study|Adverse Event|2|||
28149181|NCT01318135|54817052|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
28149182|NCT01318135|54817053|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
28149183|NCT01318135|54817046|FG000|Entered - Long-Term Extension Study|Protocol Violation|1|||
28149184|NCT01318135|54817047|FG001|Entered - Long-Term Extension Study|Protocol Violation|1|||
28149185|NCT01318135|54817048|FG002|Entered - Long-Term Extension Study|Protocol Violation|0|||
28149186|NCT01318135|54817049|FG003|Entered - Long-Term Extension Study|Protocol Violation|0|||
28149187|NCT01318135|54817050|FG004|Entered - Long-Term Extension Study|Protocol Violation|1|||
28149188|NCT01318135|54817051|FG005|Entered - Long-Term Extension Study|Protocol Violation|0|||
28149189|NCT01318135|54817052|FG006|Entered - Long-Term Extension Study|Protocol Violation|0|||
28149190|NCT01318135|54817053|FG007|Entered - Long-Term Extension Study|Protocol Violation|0|||
28149191|NCT01318135|54817046|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
28149192|NCT01318135|54817047|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
28149193|NCT01318135|54817048|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
28149194|NCT01318135|54817049|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
28149195|NCT01318135|54817050|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
28149196|NCT01318135|54817051|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
28149197|NCT01318135|54817052|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
28149198|NCT01318135|54817053|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
28149199|NCT01318135|54817046|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
28149200|NCT01318135|54817047|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|7|||
28149201|NCT01318135|54817048|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
28149202|NCT01318135|54817049|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
28149203|NCT01318135|54817050|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
28149204|NCT01318135|54817051|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
28149205|NCT01318135|54817052|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
28149206|NCT01318135|54817053|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
28149207|NCT01318135|54817046|FG000|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
28149208|NCT01318135|54817047|FG001|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
28149209|NCT01318135|54817048|FG002|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
28149210|NCT01318135|54817049|FG003|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
28072720|NCT00231114|54727363|FG000|Treatment Period|Death: Motor Vehicle Accident|1|||
28072721|NCT00231114|54727364|FG001|Treatment Period|Death: Motor Vehicle Accident|0|||
28072722|NCT00231114|54727363|FG000|Post-Treatment Period|Lost to Follow-up|6|||
28072723|NCT00231114|54727364|FG001|Post-Treatment Period|Lost to Follow-up|1|||
28072724|NCT00231114|54727363|FG000|Post-Treatment Period|Physician Decision|1|||
28072725|NCT00231114|54727364|FG001|Post-Treatment Period|Physician Decision|0|||
28072726|NCT00231114|54727363|FG000|Post-Treatment Period|Withdrawal by Subject|1|||
28072727|NCT00231114|54727364|FG001|Post-Treatment Period|Withdrawal by Subject|0|||
28072728|NCT03543046|54727374|FG000|Overall Study|Adverse Event|1|||
28072729|NCT03543046|54727375|FG001|Overall Study|Adverse Event|1|||
28072730|NCT03543046|54727374|FG000|Overall Study|Physician Decision|1|||
28072731|NCT03543046|54727375|FG001|Overall Study|Physician Decision|1|||
28072732|NCT03543046|54727374|FG000|Overall Study|Protocol Violation|1|||
28072733|NCT03543046|54727375|FG001|Overall Study|Protocol Violation|0|||
28072734|NCT00259272|54727394|FG000|Overall Study|Adverse Event|2|||
28072735|NCT00259272|54727395|FG001|Overall Study|Adverse Event|1|||
28072736|NCT00259272|54727396|FG002|Overall Study|Adverse Event|0|||
28072737|NCT00259272|54727397|FG003|Overall Study|Adverse Event|3|||
28072738|NCT00259272|54727394|FG000|Overall Study|Lack of Efficacy|5|||
28072739|NCT00259272|54727395|FG001|Overall Study|Lack of Efficacy|1|||
28072740|NCT00259272|54727396|FG002|Overall Study|Lack of Efficacy|2|||
28072741|NCT00259272|54727397|FG003|Overall Study|Lack of Efficacy|6|||
28072742|NCT00259272|54727394|FG000|Overall Study|Physician Decision|1|||
28072743|NCT00259272|54727395|FG001|Overall Study|Physician Decision|2|||
28072744|NCT00259272|54727396|FG002|Overall Study|Physician Decision|1|||
28072745|NCT00259272|54727397|FG003|Overall Study|Physician Decision|3|||
28072746|NCT00259272|54727394|FG000|Overall Study|Protocol Violation|2|||
28072747|NCT00259272|54727395|FG001|Overall Study|Protocol Violation|0|||
28072748|NCT00259272|54727396|FG002|Overall Study|Protocol Violation|0|||
28072749|NCT00259272|54727397|FG003|Overall Study|Protocol Violation|1|||
28149211|NCT01318135|54817050|FG004|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
28149212|NCT01318135|54817051|FG005|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
28149213|NCT01318135|54817052|FG006|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
28149214|NCT01318135|54817053|FG007|Entered - Long-Term Extension Study|Use of Excluded Medications|1|||
28149215|NCT02922153|54817065|FG000|Overall Study|Death|8|||
28149216|NCT02922153|54817066|FG001|Overall Study|Death|1|||
28149217|NCT02922153|54817065|FG000|Overall Study|Lost to Follow-up|1|||
28149218|NCT02922153|54817066|FG001|Overall Study|Lost to Follow-up|0|||
28149219|NCT02922153|54817065|FG000|Overall Study|Physician Decision|1|||
28149220|NCT02922153|54817066|FG001|Overall Study|Physician Decision|1|||
28149221|NCT02920983|54817072|FG000|Dispense 1|Unacceptable Lens Fit|0|||
28149222|NCT02920983|54817073|FG001|Dispense 1|Unacceptable Lens Fit|0|||
28149223|NCT02920983|54817074|FG002|Dispense 1|Unacceptable Lens Fit|0|||
28149224|NCT02920983|54817075|FG003|Dispense 1|Unacceptable Lens Fit|0|||
28149225|NCT02920983|54817076|FG004|Dispense 1|Unacceptable Lens Fit|1|||
28149226|NCT02920983|54817077|FG005|Dispense 1|Unacceptable Lens Fit|0|||
28149227|NCT02920983|54817072|FG000|Dispense 2|Unscceptable lens fit|1|||
28149228|NCT02920983|54817073|FG001|Dispense 2|Unscceptable lens fit|0|||
28149229|NCT02920983|54817074|FG002|Dispense 2|Unscceptable lens fit|0|||
28149230|NCT02920983|54817075|FG003|Dispense 2|Unscceptable lens fit|0|||
28149231|NCT02920983|54817076|FG004|Dispense 2|Unscceptable lens fit|1|||
28149232|NCT02920983|54817077|FG005|Dispense 2|Unscceptable lens fit|0|||
28149233|NCT02920983|54817072|FG000|Dispense 3|Unacceptable Lens Fit|1|||
28149234|NCT02920983|54817073|FG001|Dispense 3|Unacceptable Lens Fit|1|||
28149235|NCT02920983|54817074|FG002|Dispense 3|Unacceptable Lens Fit|0|||
28149236|NCT02920983|54817075|FG003|Dispense 3|Unacceptable Lens Fit|0|||
28149237|NCT02920983|54817076|FG004|Dispense 3|Unacceptable Lens Fit|1|||
28149238|NCT02920983|54817077|FG005|Dispense 3|Unacceptable Lens Fit|0|||
28149239|NCT02654002|54817094|FG000|Overall Study|Adverse Event|0|||
28149240|NCT02654002|54817095|FG001|Overall Study|Adverse Event|0|||
28149241|NCT02654002|54817096|FG002|Overall Study|Adverse Event|0|||
28149242|NCT02654002|54817097|FG003|Overall Study|Adverse Event|0|||
28149243|NCT02654002|54817098|FG004|Overall Study|Adverse Event|0|||
28149244|NCT02654002|54817099|FG005|Overall Study|Adverse Event|0|||
28149245|NCT02654002|54817100|FG006|Overall Study|Adverse Event|1|||
28149246|NCT02654002|54817101|FG007|Overall Study|Adverse Event|0|||
28149247|NCT02654002|54817102|FG008|Overall Study|Adverse Event|0|||
28149248|NCT02654002|54817094|FG000|Overall Study|Withdrew Consent|0|||
28149249|NCT02654002|54817095|FG001|Overall Study|Withdrew Consent|0|||
28149250|NCT02654002|54817096|FG002|Overall Study|Withdrew Consent|0|||
28149251|NCT02654002|54817097|FG003|Overall Study|Withdrew Consent|0|||
28149252|NCT02654002|54817098|FG004|Overall Study|Withdrew Consent|0|||
28149253|NCT02654002|54817099|FG005|Overall Study|Withdrew Consent|1|||
28149254|NCT02654002|54817100|FG006|Overall Study|Withdrew Consent|0|||
28149255|NCT02654002|54817101|FG007|Overall Study|Withdrew Consent|1|||
28072750|NCT00259272|54727394|FG000|Overall Study|Sponsor Decision|0|||
28072751|NCT00259272|54727395|FG001|Overall Study|Sponsor Decision|1|||
28072752|NCT00259272|54727396|FG002|Overall Study|Sponsor Decision|0|||
28072753|NCT00259272|54727397|FG003|Overall Study|Sponsor Decision|0|||
28072754|NCT00259272|54727394|FG000|Overall Study|Withdrawal by Subject|4|||
28072755|NCT00259272|54727395|FG001|Overall Study|Withdrawal by Subject|2|||
28072756|NCT00259272|54727396|FG002|Overall Study|Withdrawal by Subject|2|||
28072757|NCT00259272|54727397|FG003|Overall Study|Withdrawal by Subject|7|||
28149256|NCT02654002|54817102|FG008|Overall Study|Withdrew Consent|0|||
28149257|NCT01675492|54817137|FG000|Overall Study|study completed early - product approval|42|||
28149258|NCT03924622|54817148|FG000|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|2|||
28149259|NCT03924622|54817149|FG001|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
28149260|NCT03924622|54817150|FG002|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
28149261|NCT03924622|54817151|FG003|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|4|||
28149262|NCT03924622|54817152|FG004|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
28149263|NCT03924622|54817153|FG005|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
28149264|NCT04044664|54817170|FG000|Stage 1|Adverse Event|3|||
28149265|NCT04044664|54817171|FG001|Stage 1|Adverse Event|3|||
28149266|NCT04044664|54817172|FG002|Stage 1|Adverse Event|1|||
28149267|NCT04044664|54817170|FG000|Stage 1|Lost to Follow-up|3|||
28149268|NCT04044664|54817171|FG001|Stage 1|Lost to Follow-up|2|||
28149269|NCT04044664|54817172|FG002|Stage 1|Lost to Follow-up|2|||
28072758|NCT00259272|54727394|FG000|Overall Study|Lost to Follow-up|1|||
28072759|NCT00259272|54727395|FG001|Overall Study|Lost to Follow-up|0|||
28149270|NCT04044664|54817170|FG000|Stage 1|Withdrawal by Subject|9|||
28149271|NCT04044664|54817171|FG001|Stage 1|Withdrawal by Subject|1|||
28149272|NCT04044664|54817172|FG002|Stage 1|Withdrawal by Subject|0|||
28149273|NCT04044664|54817170|FG000|Stage 1|noncompliance, personal reason|2|||
28072760|NCT00259272|54727396|FG002|Overall Study|Lost to Follow-up|0|||
28072761|NCT00259272|54727397|FG003|Overall Study|Lost to Follow-up|1|||
28072762|NCT00421889|54727430|FG000|Overall Study|Adverse Event|1|||
28072763|NCT00421889|54727431|FG001|Overall Study|Adverse Event|0|||
28149274|NCT04044664|54817171|FG001|Stage 1|noncompliance, personal reason|0|||
28149275|NCT04044664|54817172|FG002|Stage 1|noncompliance, personal reason|0|||
28149276|NCT04044664|54817170|FG000|Stage 1|randomization error|0|||
28149277|NCT04044664|54817171|FG001|Stage 1|randomization error|1|||
28149278|NCT04044664|54817172|FG002|Stage 1|randomization error|0|||
28149279|NCT04044664|54817170|FG000|Stage 2|Adverse Event|2|||
28149280|NCT04044664|54817171|FG001|Stage 2|Adverse Event|0|||
28149281|NCT04044664|54817172|FG002|Stage 2|Adverse Event|0|||
28149282|NCT04044664|54817170|FG000|Stage 2|Lost to Follow-up|3|||
28149283|NCT04044664|54817171|FG001|Stage 2|Lost to Follow-up|2|||
28149284|NCT04044664|54817172|FG002|Stage 2|Lost to Follow-up|1|||
28149285|NCT04044664|54817170|FG000|Stage 2|Withdrawal by Subject|3|||
28149286|NCT04044664|54817171|FG001|Stage 2|Withdrawal by Subject|0|||
28149287|NCT04044664|54817172|FG002|Stage 2|Withdrawal by Subject|0|||
28149288|NCT04044664|54817170|FG000|Stage 2|protocol deviation|1|||
28149289|NCT04044664|54817171|FG001|Stage 2|protocol deviation|0|||
28149290|NCT04044664|54817172|FG002|Stage 2|protocol deviation|0|||
28149291|NCT00150176|54817182|FG000|Overall Study|Adverse Event|16|||
28149292|NCT00150176|54817183|FG001|Overall Study|Adverse Event|53|||
28149293|NCT00150176|54817182|FG000|Overall Study|Relapse/Impending relapse, non-AE|10|||
28149294|NCT00150176|54817183|FG001|Overall Study|Relapse/Impending relapse, non-AE|39|||
28149295|NCT00150176|54817182|FG000|Overall Study|Withdrawal by Subject|19|||
28149296|NCT00150176|54817183|FG001|Overall Study|Withdrawal by Subject|12|||
28149297|NCT00150176|54817182|FG000|Overall Study|Lost to Follow-up|3|||
27941756|NCT03672175|54598285|FG001|Extended FU Period (Days 43 to 182)|Lost to Follow-up|8|||
27941757|NCT03672175|54598286|FG002|Extended FU Period (Days 43 to 182)|Lost to Follow-up|7|||
27941758|NCT03672175|54598284|FG000|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
27941759|NCT03672175|54598285|FG001|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|0|||
27941760|NCT03672175|54598286|FG002|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
27941761|NCT03672175|54598284|FG000|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
27822759|NCT01799239|54286758|FG000|Period 1 (7 Days)|Withdrawal by Subject|2|||
27822760|NCT01799239|54286759|FG001|Period 1 (7 Days)|Withdrawal by Subject|0|||
28149298|NCT00150176|54817183|FG001|Overall Study|Lost to Follow-up|3|||
28149299|NCT00150176|54817182|FG000|Overall Study|OTHER|11|||
28149300|NCT00150176|54817183|FG001|Overall Study|OTHER|13|||
28149301|NCT02985879|54817193|FG000|Overall Study|Adverse Event|7|||
28149302|NCT02985879|54817194|FG001|Overall Study|Adverse Event|9|||
28149303|NCT02985879|54817195|FG002|Overall Study|Adverse Event|7|||
28149304|NCT02985879|54817193|FG000|Overall Study|Withdrew consent|6|||
28149305|NCT02985879|54817194|FG001|Overall Study|Withdrew consent|8|||
28149306|NCT02985879|54817195|FG002|Overall Study|Withdrew consent|10|||
28149307|NCT02985879|54817193|FG000|Overall Study|Lost to Follow-up|1|||
28072764|NCT00421889|54727432|FG002|Overall Study|Adverse Event|1|||
28072765|NCT00421889|54727433|FG003|Overall Study|Adverse Event|1|||
28072766|NCT00421889|54727434|FG004|Overall Study|Adverse Event|1|||
28072767|NCT00421889|54727435|FG005|Overall Study|Adverse Event|4|||
28149308|NCT02985879|54817194|FG001|Overall Study|Lost to Follow-up|0|||
28149309|NCT02985879|54817195|FG002|Overall Study|Lost to Follow-up|2|||
28149310|NCT02985879|54817193|FG000|Overall Study|Other, not specified|62|||
28149311|NCT02985879|54817194|FG001|Overall Study|Other, not specified|58|||
28149312|NCT02985879|54817195|FG002|Overall Study|Other, not specified|58|||
28149313|NCT01067469|54817211|FG000|Overall Study|Withdrawal by Subject|0|||
28149314|NCT01067469|54817212|FG001|Overall Study|Withdrawal by Subject|1|||
28149315|NCT01067469|54817211|FG000|Overall Study|Disease Progression|0|||
28149316|NCT01067469|54817212|FG001|Overall Study|Disease Progression|1|||
28149317|NCT02985021|54817218|FG000|Overall Study|Inability to comply with study procedures|1|||
28149318|NCT01066923|54817226|FG000|Overall Study|Withdrawal by Subject|3|||
28149319|NCT01066923|54817227|FG001|Overall Study|Withdrawal by Subject|3|||
28149320|NCT01066923|54817228|FG002|Overall Study|Withdrawal by Subject|8|||
28149321|NCT01066923|54817229|FG003|Overall Study|Withdrawal by Subject|8|||
28149322|NCT02919267|54817254|FG000|Overall Study|Protocol Violation|0|||
28149323|NCT02919267|54817255|FG001|Overall Study|Protocol Violation|3|||
28149324|NCT02919267|54817256|FG002|Overall Study|Protocol Violation|3|||
28149325|NCT02919267|54817257|FG003|Overall Study|Protocol Violation|4|||
28072768|NCT00421889|54727436|FG006|Overall Study|Adverse Event|1|||
28072769|NCT00421889|54727437|FG007|Overall Study|Adverse Event|0|||
28072770|NCT00421889|54727438|FG008|Overall Study|Adverse Event|2|||
28072771|NCT00421889|54727430|FG000|Overall Study|Withdrawal by Subject|1|||
28072772|NCT00421889|54727431|FG001|Overall Study|Withdrawal by Subject|3|||
28072773|NCT00421889|54727432|FG002|Overall Study|Withdrawal by Subject|0|||
28072774|NCT00421889|54727433|FG003|Overall Study|Withdrawal by Subject|0|||
28072775|NCT00421889|54727434|FG004|Overall Study|Withdrawal by Subject|2|||
28072776|NCT00421889|54727435|FG005|Overall Study|Withdrawal by Subject|0|||
28072777|NCT00421889|54727436|FG006|Overall Study|Withdrawal by Subject|0|||
28072778|NCT00421889|54727437|FG007|Overall Study|Withdrawal by Subject|0|||
28072779|NCT00421889|54727438|FG008|Overall Study|Withdrawal by Subject|0|||
28072780|NCT00421889|54727430|FG000|Overall Study|Death|0|||
28072781|NCT00421889|54727431|FG001|Overall Study|Death|0|||
28072782|NCT00421889|54727432|FG002|Overall Study|Death|0|||
28149326|NCT01368900|54817267|FG000|Overall Study|Lost to Follow-up|7|||
28149327|NCT02910063|54817273|FG000|Phase 2|Withdrawal by Subject|3|||
28149328|NCT02910063|54817274|FG001|Phase 2|Withdrawal by Subject|0|||
28149329|NCT02910063|54817275|FG002|Phase 2|Withdrawal by Subject|0|||
28072783|NCT00421889|54727433|FG003|Overall Study|Death|0|||
28072784|NCT00421889|54727434|FG004|Overall Study|Death|1|||
28072785|NCT00421889|54727435|FG005|Overall Study|Death|1|||
28072786|NCT00421889|54727436|FG006|Overall Study|Death|0|||
28072787|NCT00421889|54727437|FG007|Overall Study|Death|0|||
28149330|NCT02910063|54817273|FG000|Phase 2|Lost to Follow-up|1|||
28149331|NCT02910063|54817274|FG001|Phase 2|Lost to Follow-up|0|||
28149332|NCT02910063|54817275|FG002|Phase 2|Lost to Follow-up|0|||
28149333|NCT02910063|54817273|FG000|Phase 2|Death|24|||
28072788|NCT00421889|54727438|FG008|Overall Study|Death|0|||
28072789|NCT00421889|54727430|FG000|Overall Study|Progressive disease|3|||
28149334|NCT02910063|54817274|FG001|Phase 2|Death|0|||
28149335|NCT02910063|54817275|FG002|Phase 2|Death|0|||
28149336|NCT02909907|54817286|FG000|Overall Study|Withdrawal by Subject|0|||
28149337|NCT02909907|54817287|FG001|Overall Study|Withdrawal by Subject|1|||
28149338|NCT02651194|54817293|FG000|Overall Study|Lost to Follow-up|3|||
28149339|NCT02651194|54817293|FG000|Overall Study|Other|2|||
28149340|NCT02907177|54817299|FG000|Overall Study|Death|0|||
28149341|NCT02907177|54817300|FG001|Overall Study|Death|1|||
28149342|NCT02907177|54817299|FG000|Overall Study|Physician Decision|3|||
28149343|NCT02907177|54817300|FG001|Overall Study|Physician Decision|3|||
28149344|NCT02907177|54817299|FG000|Overall Study|Withdrawal by Subject|15|||
28149345|NCT02907177|54817300|FG001|Overall Study|Withdrawal by Subject|7|||
28072790|NCT00421889|54727431|FG001|Overall Study|Progressive disease|2|||
28149346|NCT02907177|54817299|FG000|Overall Study|Sponsor's Decision|50|||
28149347|NCT02907177|54817300|FG001|Overall Study|Sponsor's Decision|57|||
28149348|NCT02652442|54817306|FG000|Centrifugation - Distance|Lost to Follow-up|1|||
28149349|NCT02906709|54817320|FG000|Phase A (Week 0 to Week 16)|Adverse Event|1|||
28072791|NCT00421889|54727432|FG002|Overall Study|Progressive disease|2|||
28072792|NCT00421889|54727433|FG003|Overall Study|Progressive disease|3|||
28072793|NCT00421889|54727434|FG004|Overall Study|Progressive disease|2|||
28149350|NCT02906709|54817321|FG001|Phase A (Week 0 to Week 16)|Adverse Event|2|||
28149351|NCT02906709|54817320|FG000|Phase A (Week 0 to Week 16)|Death|0|||
28149352|NCT02906709|54817321|FG001|Phase A (Week 0 to Week 16)|Death|1|||
28149353|NCT02906709|54817320|FG000|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3|||
28149354|NCT02906709|54817321|FG001|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0|||
28149355|NCT02906709|54817320|FG000|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2|||
28149356|NCT02906709|54817321|FG001|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0|||
28149357|NCT00318656|54817335|FG000|Overall Study|Took Avandamet instead of Glim/Met|0|||
28149358|NCT00318656|54817336|FG001|Overall Study|Took Avandamet instead of Glim/Met|1|||
28149359|NCT00318656|54817335|FG000|Overall Study|Did not receive any treatment|0|||
28149360|NCT00318656|54817336|FG001|Overall Study|Did not receive any treatment|1|||
28149361|NCT02908347|54817342|FG000|Overall Study|Adverse Event|0|||
28149362|NCT02908347|54817343|FG001|Overall Study|Adverse Event|1|||
28149363|NCT02908347|54817342|FG000|Overall Study|Lost to Follow-up|1|||
28149364|NCT02908347|54817343|FG001|Overall Study|Lost to Follow-up|0|||
28149365|NCT02983305|54817365|FG000|Overall Study|incomplete data|2|||
28149366|NCT02983305|54817366|FG001|Overall Study|incomplete data|0|||
28149367|NCT03663166|54817372|FG000|Overall Study|Withdrawal by Subject|1|||
28149368|NCT02983227|54817379|FG000|Overall Study|Adverse Event|21|||
28149369|NCT02983227|54817380|FG001|Overall Study|Adverse Event|3|||
28149370|NCT02983227|54817379|FG000|Overall Study|Death|3|||
28149371|NCT02983227|54817380|FG001|Overall Study|Death|0|||
28149372|NCT02983227|54817379|FG000|Overall Study|Lack of Efficacy|8|||
28149373|NCT02983227|54817380|FG001|Overall Study|Lack of Efficacy|1|||
28149374|NCT02983227|54817379|FG000|Overall Study|Lost to Follow-up|3|||
28149375|NCT02983227|54817380|FG001|Overall Study|Lost to Follow-up|0|||
28149376|NCT02983227|54817379|FG000|Overall Study|Multiple Reasons|2|||
28149377|NCT02983227|54817380|FG001|Overall Study|Multiple Reasons|1|||
28149378|NCT02983227|54817379|FG000|Overall Study|Physician Decision|3|||
28149379|NCT02983227|54817380|FG001|Overall Study|Physician Decision|1|||
28149380|NCT02983227|54817379|FG000|Overall Study|Withdrawal by Subject|19|||
28149381|NCT02983227|54817380|FG001|Overall Study|Withdrawal by Subject|8|||
28149382|NCT00301262|54817388|FG000|Double Blind Phase (DB)|Adverse Event|1|||
28149383|NCT00301262|54817389|FG001|Double Blind Phase (DB)|Adverse Event|0|||
28149384|NCT00301262|54817388|FG000|Double Blind Phase (DB)|Lack of Efficacy|0|||
28149385|NCT00301262|54817389|FG001|Double Blind Phase (DB)|Lack of Efficacy|1|||
28149386|NCT00301262|54817388|FG000|Double Blind Phase (DB)|Lost to Follow-up|3|||
28149387|NCT00301262|54817389|FG001|Double Blind Phase (DB)|Lost to Follow-up|3|||
28149388|NCT00301262|54817388|FG000|Double Blind Phase (DB)|Withdrawal by Subject|5|||
28149389|NCT00301262|54817389|FG001|Double Blind Phase (DB)|Withdrawal by Subject|5|||
28149390|NCT00301262|54817388|FG000|Double Blind Phase (DB)|Other|1|||
28149391|NCT00301262|54817389|FG001|Double Blind Phase (DB)|Other|4|||
28149392|NCT00301262|54817388|FG000|Open Label Phase (OL)|Adverse Event|1|||
28149393|NCT00301262|54817389|FG001|Open Label Phase (OL)|Adverse Event|0|||
28149394|NCT00301262|54817388|FG000|Open Label Phase (OL)|Lost to Follow-up|1|||
28149395|NCT00301262|54817389|FG001|Open Label Phase (OL)|Lost to Follow-up|2|||
28149396|NCT00301262|54817388|FG000|Open Label Phase (OL)|Other|2|||
28072794|NCT00421889|54727435|FG005|Overall Study|Progressive disease|21|||
28072795|NCT00421889|54727436|FG006|Overall Study|Progressive disease|3|||
28072796|NCT00421889|54727437|FG007|Overall Study|Progressive disease|1|||
28072797|NCT00421889|54727438|FG008|Overall Study|Progressive disease|5|||
28072798|NCT00421889|54727430|FG000|Overall Study|Patient/Investigator request|0|||
28072799|NCT00421889|54727431|FG001|Overall Study|Patient/Investigator request|0|||
28072800|NCT00421889|54727432|FG002|Overall Study|Patient/Investigator request|0|||
28072801|NCT00421889|54727433|FG003|Overall Study|Patient/Investigator request|0|||
28072802|NCT00421889|54727434|FG004|Overall Study|Patient/Investigator request|0|||
28072803|NCT00421889|54727435|FG005|Overall Study|Patient/Investigator request|9|||
28149397|NCT00301262|54817389|FG001|Open Label Phase (OL)|Other|0|||
28149398|NCT02905149|54817416|FG000|Overall Study|Lost to Follow-up|2|||
28149399|NCT02905149|54817417|FG001|Overall Study|Lost to Follow-up|0|||
28072804|NCT00421889|54727436|FG006|Overall Study|Patient/Investigator request|0|||
28149400|NCT02790606|54817423|FG000|Overall Study|Death|27|||
28149401|NCT02790606|54817423|FG000|Overall Study|Lost to Follow-up|4|||
28149402|NCT02790606|54817423|FG000|Overall Study|Physician Decision|3|||
28149403|NCT02790606|54817423|FG000|Overall Study|Withdrawal by Subject|1|||
28149404|NCT03077620|54817431|FG000|Overall Study|Unable to place lumbar catheter|1|||
28149405|NCT03077620|54817432|FG001|Overall Study|Unable to place lumbar catheter|0|||
28149406|NCT03077620|54817433|FG002|Overall Study|Unable to place lumbar catheter|1|||
28149407|NCT03077620|54817434|FG003|Overall Study|Unable to place lumbar catheter|0|||
28149408|NCT03077620|54817431|FG000|Overall Study|Withdrawal by Subject|0|||
28149409|NCT03077620|54817432|FG001|Overall Study|Withdrawal by Subject|1|||
28149410|NCT03077620|54817433|FG002|Overall Study|Withdrawal by Subject|0|||
28149411|NCT03077620|54817434|FG003|Overall Study|Withdrawal by Subject|0|||
28149412|NCT03077620|54817431|FG000|Overall Study|Physician Decision|0|||
28149413|NCT03077620|54817432|FG001|Overall Study|Physician Decision|0|||
28149414|NCT03077620|54817433|FG002|Overall Study|Physician Decision|1|||
28149415|NCT03077620|54817434|FG003|Overall Study|Physician Decision|0|||
28149416|NCT02982213|54817455|FG000|Overall Study|Did not complete follow up questionnaire|5|||
28149417|NCT02982213|54817456|FG001|Overall Study|Did not complete follow up questionnaire|1|||
28149418|NCT02649634|54817464|FG000|Overall Study|Withdrawal by Subject|3|||
28149419|NCT02649634|54817465|FG001|Overall Study|Withdrawal by Subject|5|||
28149420|NCT02649634|54817464|FG000|Overall Study|Lost to Follow-up|0|||
28149421|NCT02649634|54817465|FG001|Overall Study|Lost to Follow-up|1|||
28149422|NCT01066143|54817471|FG000|Overall Study|ineligible for the study|8|||
28149423|NCT02980107|54817477|FG000|Overall Study|Withdrawal by Subject|51|||
28149424|NCT02980107|54817478|FG001|Overall Study|Withdrawal by Subject|62|||
28149425|NCT02652130|54817484|FG000|Overall Study|Death|1|||
28149426|NCT02979639|54817488|FG000|Overall Study|Withdrawal based on medical judgement|1|||
28149427|NCT02979639|54817488|FG000|Overall Study|Lost to Follow-up|8|||
28149428|NCT02979639|54817488|FG000|Overall Study|Withdrawal by Subject|3|||
28149429|NCT02979639|54817488|FG000|Overall Study|Adverse Event|2|||
28149430|NCT01674634|54817492|FG000|Overall Study|Withdrawal by Subject|3|||
28149431|NCT01674634|54817492|FG000|Overall Study|Lost to Follow-up|3|||
28149432|NCT02979249|54817500|FG000|Overall Study|Lost to Follow-up|2|||
28149433|NCT02979249|54817500|FG000|Overall Study|Withdrawal by Subject|4|||
28149434|NCT02976519|54817511|FG000|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
28149435|NCT02976519|54817512|FG001|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1|||
28149436|NCT02976519|54817513|FG002|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
28149437|NCT02976519|54817514|FG003|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
28149438|NCT02976519|54817515|FG004|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
28149439|NCT02976519|54817516|FG005|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
28149440|NCT02976519|54817517|FG006|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
28149441|NCT02976519|54817511|FG000|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
28149442|NCT02976519|54817512|FG001|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
28149443|NCT02976519|54817513|FG002|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
28149444|NCT02976519|54817514|FG003|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1|||
28149445|NCT02976519|54817515|FG004|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
28149446|NCT02976519|54817516|FG005|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
28149447|NCT02976519|54817517|FG006|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
28149448|NCT02976519|54817511|FG000|Wash-out Period (Part 2 Only)|Reason not listed|0|||
28149449|NCT02976519|54817512|FG001|Wash-out Period (Part 2 Only)|Reason not listed|0|||
28149450|NCT02976519|54817513|FG002|Wash-out Period (Part 2 Only)|Reason not listed|0|||
28149451|NCT02976519|54817514|FG003|Wash-out Period (Part 2 Only)|Reason not listed|0|||
28149452|NCT02976519|54817515|FG004|Wash-out Period (Part 2 Only)|Reason not listed|0|||
28149453|NCT02976519|54817516|FG005|Wash-out Period (Part 2 Only)|Reason not listed|0|||
28149454|NCT02976519|54817517|FG006|Wash-out Period (Part 2 Only)|Reason not listed|1|||
28149455|NCT02976519|54817511|FG000|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
28149456|NCT02976519|54817512|FG001|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
28149457|NCT02976519|54817513|FG002|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
28149458|NCT02976519|54817514|FG003|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
28149459|NCT02976519|54817515|FG004|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
28149460|NCT02976519|54817516|FG005|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
28149461|NCT02976519|54817517|FG006|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1|||
28149462|NCT02976519|54817511|FG000|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
28149463|NCT02976519|54817512|FG001|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
28149464|NCT02976519|54817513|FG002|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
28149465|NCT02976519|54817514|FG003|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
28149466|NCT02976519|54817515|FG004|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
28149467|NCT02976519|54817516|FG005|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
28149468|NCT02976519|54817517|FG006|Treatment Period 2 (Part 2 Only)|Adverse Event|1|||
28149469|NCT02975973|54817622|FG000|Overall Study|Adverse Event|1|||
28149470|NCT02975973|54817623|FG001|Overall Study|Adverse Event|1|||
28149471|NCT02975973|54817624|FG002|Overall Study|Adverse Event|1|||
28149472|NCT02975973|54817625|FG003|Overall Study|Adverse Event|0|||
28149473|NCT01362322|54817637|FG000|Overall Study|Withdrawal by Subject|3|||
28149474|NCT01362322|54817638|FG001|Overall Study|Withdrawal by Subject|1|||
28149475|NCT01362322|54817637|FG000|Overall Study|Lost to Follow-up|2|||
28149476|NCT01362322|54817638|FG001|Overall Study|Lost to Follow-up|6|||
28149477|NCT02918877|54817646|FG000|Overall Study|Withdrawal by Subject|2|||
28149478|NCT02918877|54817647|FG001|Overall Study|Withdrawal by Subject|2|||
28149479|NCT02918877|54817646|FG000|Overall Study|Surgery cancelled|1|||
28149480|NCT02918877|54817647|FG001|Overall Study|Surgery cancelled|0|||
28149481|NCT02918877|54817646|FG000|Overall Study|Physician Decision|1|||
28149482|NCT02918877|54817647|FG001|Overall Study|Physician Decision|0|||
28149483|NCT02918877|54817646|FG000|Overall Study|Received intraoperative steroids|1|||
28149484|NCT02918877|54817647|FG001|Overall Study|Received intraoperative steroids|0|||
28149485|NCT02918877|54817646|FG000|Overall Study|Unable to obtain lab samples|1|||
28149486|NCT02918877|54817647|FG001|Overall Study|Unable to obtain lab samples|0|||
28149487|NCT02918877|54817646|FG000|Overall Study|Unsafe to perform BAL|0|||
28149488|NCT02918877|54817647|FG001|Overall Study|Unsafe to perform BAL|1|||
28149489|NCT01674712|54817658|FG000|Overall Study|Adverse Event|5|||
28149490|NCT01674712|54817659|FG001|Overall Study|Adverse Event|6|||
28149491|NCT01674712|54817660|FG002|Overall Study|Adverse Event|3|||
28149492|NCT01674712|54817661|FG003|Overall Study|Adverse Event|4|||
28149493|NCT01674712|54817662|FG004|Overall Study|Adverse Event|6|||
28149494|NCT01674712|54817658|FG000|Overall Study|Lost to Follow-up|1|||
28149495|NCT01674712|54817659|FG001|Overall Study|Lost to Follow-up|0|||
28149496|NCT01674712|54817660|FG002|Overall Study|Lost to Follow-up|0|||
28149497|NCT01674712|54817661|FG003|Overall Study|Lost to Follow-up|0|||
28149498|NCT01674712|54817662|FG004|Overall Study|Lost to Follow-up|0|||
28149499|NCT01674712|54817658|FG000|Overall Study|Protocol Violation|2|||
28149500|NCT01674712|54817659|FG001|Overall Study|Protocol Violation|0|||
28149501|NCT01674712|54817660|FG002|Overall Study|Protocol Violation|0|||
28149502|NCT01674712|54817661|FG003|Overall Study|Protocol Violation|0|||
28149503|NCT01674712|54817662|FG004|Overall Study|Protocol Violation|0|||
28149504|NCT01674712|54817658|FG000|Overall Study|Withdrawal by Subject|2|||
28149505|NCT01674712|54817659|FG001|Overall Study|Withdrawal by Subject|2|||
28149506|NCT01674712|54817660|FG002|Overall Study|Withdrawal by Subject|5|||
28149507|NCT01674712|54817661|FG003|Overall Study|Withdrawal by Subject|4|||
28149508|NCT01674712|54817662|FG004|Overall Study|Withdrawal by Subject|3|||
28149509|NCT01674712|54817658|FG000|Overall Study|Administrative|0|||
28149510|NCT01674712|54817659|FG001|Overall Study|Administrative|1|||
28149511|NCT01674712|54817660|FG002|Overall Study|Administrative|0|||
28149512|NCT01674712|54817661|FG003|Overall Study|Administrative|0|||
28149513|NCT01674712|54817662|FG004|Overall Study|Administrative|1|||
28149514|NCT01674712|54817658|FG000|Overall Study|Lack of Efficacy|0|||
28149515|NCT01674712|54817659|FG001|Overall Study|Lack of Efficacy|0|||
28149516|NCT01674712|54817660|FG002|Overall Study|Lack of Efficacy|1|||
28149517|NCT01674712|54817661|FG003|Overall Study|Lack of Efficacy|0|||
28149518|NCT01674712|54817662|FG004|Overall Study|Lack of Efficacy|1|||
28149519|NCT01368432|54817676|FG000|Overall Study|Lost to Follow-up|0|||
28149520|NCT01368432|54817677|FG001|Overall Study|Lost to Follow-up|1|||
28149521|NCT01063881|54817700|FG000|Overall Study|Adverse Event|12|||
28149522|NCT01063881|54817701|FG001|Overall Study|Adverse Event|2|||
28149523|NCT01063881|54817702|FG002|Overall Study|Adverse Event|0|||
28149524|NCT01063881|54817700|FG000|Overall Study|Lost to Follow-up|13|||
28149525|NCT01063881|54817701|FG001|Overall Study|Lost to Follow-up|7|||
28149526|NCT01063881|54817702|FG002|Overall Study|Lost to Follow-up|1|||
28149527|NCT01063881|54817700|FG000|Overall Study|Withdrawal by Subject|25|||
28149528|NCT01063881|54817701|FG001|Overall Study|Withdrawal by Subject|1|||
28149529|NCT01063881|54817702|FG002|Overall Study|Withdrawal by Subject|0|||
28149530|NCT01063881|54817700|FG000|Overall Study|Reason for not completed not specified|5|||
28149531|NCT01063881|54817701|FG001|Overall Study|Reason for not completed not specified|1|||
28149532|NCT01063881|54817702|FG002|Overall Study|Reason for not completed not specified|0|||
28149533|NCT01062555|54817719|FG000|Phase 1|Death|10|||
28149534|NCT01062555|54817720|FG001|Phase 1|Death|17|||
28149535|NCT01062555|54817721|FG002|Phase 1|Death|0|||
28149536|NCT01062555|54817722|FG003|Phase 1|Death|0|||
28149537|NCT01062555|54817719|FG000|Phase 1|Graft Failure|12|||
28149538|NCT01062555|54817720|FG001|Phase 1|Graft Failure|8|||
28149539|NCT01062555|54817721|FG002|Phase 1|Graft Failure|0|||
28149540|NCT01062555|54817722|FG003|Phase 1|Graft Failure|0|||
28149541|NCT01062555|54817719|FG000|Phase 1|Withdrawal by Subject|1|||
28149542|NCT01062555|54817720|FG001|Phase 1|Withdrawal by Subject|1|||
28149543|NCT01062555|54817721|FG002|Phase 1|Withdrawal by Subject|0|||
28149544|NCT01062555|54817722|FG003|Phase 1|Withdrawal by Subject|0|||
28149545|NCT01062555|54817719|FG000|Phase 2|Death|0|||
28149546|NCT01062555|54817720|FG001|Phase 2|Death|0|||
28149547|NCT01062555|54817721|FG002|Phase 2|Death|8|||
28149548|NCT01062555|54817722|FG003|Phase 2|Death|3|||
28149549|NCT01062555|54817719|FG000|Phase 2|Graft failure|0|||
28149550|NCT01062555|54817720|FG001|Phase 2|Graft failure|0|||
28149551|NCT01062555|54817721|FG002|Phase 2|Graft failure|7|||
28149552|NCT01062555|54817722|FG003|Phase 2|Graft failure|4|||
28149553|NCT01062555|54817719|FG000|Phase 2|Withdrawal by Subject|0|||
28149554|NCT01062555|54817720|FG001|Phase 2|Withdrawal by Subject|0|||
28149555|NCT01062555|54817721|FG002|Phase 2|Withdrawal by Subject|0|||
28149556|NCT01062555|54817722|FG003|Phase 2|Withdrawal by Subject|7|||
28149557|NCT01062555|54817719|FG000|Phase 2|Protocol Violation|0|||
28149558|NCT01062555|54817720|FG001|Phase 2|Protocol Violation|0|||
28149559|NCT01062555|54817721|FG002|Phase 2|Protocol Violation|0|||
28149560|NCT01062555|54817722|FG003|Phase 2|Protocol Violation|3|||
28149561|NCT01062555|54817719|FG000|Phase 2|Physician Decision|0|||
28149562|NCT01062555|54817720|FG001|Phase 2|Physician Decision|0|||
28149563|NCT01062555|54817721|FG002|Phase 2|Physician Decision|0|||
28149564|NCT01062555|54817722|FG003|Phase 2|Physician Decision|17|||
28149565|NCT01064817|54817734|FG000|Study Completion|Physician Decision|1|||
28149566|NCT01064817|54817735|FG001|Study Completion|Physician Decision|0|||
28149567|NCT01064817|54817734|FG000|Study Completion|Withdrawal by Subject|1|||
28149568|NCT01064817|54817735|FG001|Study Completion|Withdrawal by Subject|0|||
28149569|NCT01368276|54817743|FG000|Overall Study|Death|1|||
28149570|NCT01368276|54817744|FG001|Overall Study|Death|10|||
28149571|NCT01064739|54817750|FG000|Fixed Sodium Diet + Fava Beans|Adverse Event|1|||
28149572|NCT02741570|54817762|FG000|Pre-Treatment Period|Other reasons|0|||
28149573|NCT02741570|54817763|FG001|Pre-Treatment Period|Other reasons|3|||
28149574|NCT02741570|54817762|FG000|Pre-Treatment Period|Participant no longer meets study criteria|3|||
28149575|NCT02741570|54817763|FG001|Pre-Treatment Period|Participant no longer meets study criteria|6|||
28149576|NCT02741570|54817762|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
28149577|NCT02741570|54817763|FG001|Pre-Treatment Period|Poor/non-compliance|1|||
28149578|NCT02741570|54817762|FG000|Pre-Treatment Period|Lost to Follow-up|0|||
28149579|NCT02741570|54817763|FG001|Pre-Treatment Period|Lost to Follow-up|2|||
28149580|NCT02741570|54817762|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
28149581|NCT02741570|54817763|FG001|Pre-Treatment Period|Participant withdrew consent|18|||
28149582|NCT02741570|54817762|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
28149583|NCT02741570|54817763|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|2|||
28149584|NCT02741570|54817762|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
28149585|NCT02741570|54817763|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
28149586|NCT02741570|54817762|FG000|Pre-Treatment Period|Death|0|||
28149587|NCT02741570|54817763|FG001|Pre-Treatment Period|Death|1|||
28149588|NCT02741570|54817762|FG000|Pre-Treatment Period|Disease progression|0|||
28149589|NCT02741570|54817763|FG001|Pre-Treatment Period|Disease progression|1|||
28149590|NCT02741570|54817762|FG000|Treatment Period|Other reasons|47|||
28149591|NCT02741570|54817763|FG001|Treatment Period|Other reasons|8|||
28149592|NCT02741570|54817762|FG000|Treatment Period|Poor/non-compliance|0|||
28149593|NCT02741570|54817763|FG001|Treatment Period|Poor/non-compliance|1|||
28149594|NCT02741570|54817762|FG000|Treatment Period|Maximum clinical benefit|3|||
28149595|NCT02741570|54817763|FG001|Treatment Period|Maximum clinical benefit|5|||
28149596|NCT02741570|54817762|FG000|Treatment Period|Lost to Follow-up|1|||
28149597|NCT02741570|54817763|FG001|Treatment Period|Lost to Follow-up|3|||
28149598|NCT02741570|54817762|FG000|Treatment Period|Participant withdrew consent|9|||
28149599|NCT02741570|54817763|FG001|Treatment Period|Participant withdrew consent|13|||
28149600|NCT02741570|54817762|FG000|Treatment Period|Participant request to discontinue treatment|8|||
28149601|NCT02741570|54817763|FG001|Treatment Period|Participant request to discontinue treatment|23|||
28149602|NCT02741570|54817762|FG000|Treatment Period|Adverse event unrelated to study drug|41|||
28149603|NCT02741570|54817763|FG001|Treatment Period|Adverse event unrelated to study drug|25|||
28149604|NCT02741570|54817762|FG000|Treatment Period|Death|9|||
28149605|NCT02741570|54817763|FG001|Treatment Period|Death|7|||
28149606|NCT02741570|54817762|FG000|Treatment Period|Study drug toxicity|55|||
28149607|NCT02741570|54817763|FG001|Treatment Period|Study drug toxicity|45|||
28149608|NCT02741570|54817762|FG000|Treatment Period|Disease progression|295|||
28149609|NCT02741570|54817763|FG001|Treatment Period|Disease progression|304|||
28149610|NCT01061775|54817769|FG000|Overall Study|Physician Decision|2|||
28149611|NCT01061775|54817769|FG000|Overall Study|Lost to Follow-up|1|||
28149612|NCT02651116|54817776|FG000|Overall Study|Adverse Event|0|||
28149613|NCT02651116|54817777|FG001|Overall Study|Adverse Event|1|||
28149614|NCT02651116|54817776|FG000|Overall Study|No Longer Willing To Participate In Study|1|||
28149615|NCT02651116|54817777|FG001|Overall Study|No Longer Willing To Participate In Study|0|||
28149616|NCT01061385|54817785|FG000|Overall Study|Lost to Follow-up|1|||
28149617|NCT01061385|54817786|FG001|Overall Study|Lost to Follow-up|0|||
28149618|NCT01061385|54817785|FG000|Overall Study|subject decision not related to AE|0|||
28149619|NCT01061385|54817786|FG001|Overall Study|subject decision not related to AE|1|||
28149620|NCT02973477|54817795|FG000|First Intervention|Lost to Follow-up|0|||
28149621|NCT02973477|54817796|FG001|First Intervention|Lost to Follow-up|2|||
28149622|NCT02973477|54817795|FG000|Washout|Withdrawal by Subject|1|||
28149623|NCT02973477|54817796|FG001|Washout|Withdrawal by Subject|0|||
28149624|NCT02973477|54817795|FG000|Second Intervention|Lost to Follow-up|1|||
28149625|NCT02973477|54817796|FG001|Second Intervention|Lost to Follow-up|0|||
28149626|NCT02788656|54817810|FG000|Overall Study|Withdrawal by Subject|1|||
28149627|NCT02788656|54817811|FG001|Overall Study|Withdrawal by Subject|0|||
28149628|NCT00283868|54817819|FG000|Overall Study|Lost to Follow-up|7|||
28149629|NCT00283868|54817820|FG001|Overall Study|Lost to Follow-up|8|||
28149630|NCT02973087|54817826|FG000|Overall Study|Withdrawal by Subject|2|||
28149631|NCT02973087|54817827|FG001|Overall Study|Withdrawal by Subject|1|||
28149632|NCT02973087|54817826|FG000|Overall Study|Adverse Event|1|||
28149633|NCT02973087|54817827|FG001|Overall Study|Adverse Event|0|||
28149634|NCT02973087|54817826|FG000|Overall Study|other|1|||
28149635|NCT02973087|54817827|FG001|Overall Study|other|1|||
28149636|NCT00271544|54817847|FG000|Overall Study|Subjects did not receive a 4196 lead|7|||
28149637|NCT00271544|54817847|FG000|Overall Study|Model 4196 lead not attempted|9|||
28149638|NCT00271544|54817847|FG000|Overall Study|Implant not attempted|4|||
28149639|NCT05342532|54817865|FG000|Overall Study|Adverse Event|5|||
28149640|NCT05342532|54817866|FG001|Overall Study|Adverse Event|20|||
28149641|NCT05342532|54817865|FG000|Overall Study|Lost to Follow-up|10|||
28149642|NCT05342532|54817866|FG001|Overall Study|Lost to Follow-up|15|||
28149643|NCT02984943|54817872|FG000|Overall Study|Withdrawal by Subject|3|||
28149644|NCT02984943|54817872|FG000|Overall Study|Physician Decision|1|||
28149645|NCT02787408|54817876|FG000|Overall Study|Death|16|||
28149646|NCT02787408|54817876|FG000|Overall Study|Withdrawal by Subject|1|||
28149647|NCT02787408|54817876|FG000|Overall Study|Non-implanted patient exited post 6 month follow-up visit per protocol|1|||
28149648|NCT02971605|54817880|FG000|Overall Study|Withdrawal by Subject|1|||
28149649|NCT03054337|54817892|FG000|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
28149650|NCT03054337|54817893|FG001|Dose Adjustment and Maintenance Period|Investigator discretion|2|||
28149651|NCT03054337|54817894|FG002|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
28149652|NCT03054337|54817895|FG003|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
28149653|NCT03054337|54817896|FG004|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
28149654|NCT03054337|54817897|FG005|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
28149655|NCT01060059|54817930|FG000|Overall Study|Adverse Event|1|||
28149656|NCT01060059|54817931|FG001|Overall Study|Adverse Event|1|||
28149657|NCT01060059|54817930|FG000|Overall Study|Death|2|||
28149658|NCT01060059|54817931|FG001|Overall Study|Death|3|||
28149659|NCT01060059|54817930|FG000|Overall Study|Lost to Follow-up|18|||
28149660|NCT01060059|54817931|FG001|Overall Study|Lost to Follow-up|34|||
28149661|NCT01060059|54817930|FG000|Overall Study|entry criteria not met|4|||
28149662|NCT01060059|54817931|FG001|Overall Study|entry criteria not met|3|||
28149663|NCT01060059|54817930|FG000|Overall Study|Withdrawal by Subject|35|||
28149664|NCT01060059|54817931|FG001|Overall Study|Withdrawal by Subject|23|||
28149665|NCT01060059|54817930|FG000|Overall Study|lack of glycemic control|2|||
28149666|NCT01060059|54817931|FG001|Overall Study|lack of glycemic control|1|||
28149667|NCT01060059|54817930|FG000|Overall Study|lack of compliance|5|||
28149668|NCT01060059|54817931|FG001|Overall Study|lack of compliance|2|||
28149669|NCT02648932|54817945|FG000|Overall Study|No transplant|3|||
28149670|NCT02648932|54817946|FG001|Overall Study|No transplant|1|||
28149671|NCT02122458|54817959|FG000|Overall Study|Withdrawal by Subject|0|||
28149672|NCT02122458|54817960|FG001|Overall Study|Withdrawal by Subject|0|||
28149673|NCT02122458|54817961|FG002|Overall Study|Withdrawal by Subject|0|||
28149674|NCT02122458|54817962|FG003|Overall Study|Withdrawal by Subject|4|||
28149675|NCT02122458|54817963|FG004|Overall Study|Withdrawal by Subject|4|||
28149676|NCT02122458|54817964|FG005|Overall Study|Withdrawal by Subject|4|||
28149677|NCT02122458|54817965|FG006|Overall Study|Withdrawal by Subject|0|||
28149678|NCT02122458|54817959|FG000|Overall Study|Lost to Follow-up|1|||
28149679|NCT02122458|54817960|FG001|Overall Study|Lost to Follow-up|3|||
28149680|NCT02122458|54817961|FG002|Overall Study|Lost to Follow-up|0|||
28149681|NCT02122458|54817962|FG003|Overall Study|Lost to Follow-up|7|||
28149682|NCT02122458|54817963|FG004|Overall Study|Lost to Follow-up|5|||
28149683|NCT02122458|54817964|FG005|Overall Study|Lost to Follow-up|15|||
28149684|NCT02122458|54817965|FG006|Overall Study|Lost to Follow-up|1|||
28149685|NCT02122458|54817959|FG000|Overall Study|Did not qualify at initial testing or after chart review|1|||
28072805|NCT00421889|54727437|FG007|Overall Study|Patient/Investigator request|1|||
28072806|NCT00421889|54727438|FG008|Overall Study|Patient/Investigator request|3|||
28072807|NCT00421889|54727430|FG000|Overall Study|Lost to Follow-up|0|||
28072808|NCT00421889|54727431|FG001|Overall Study|Lost to Follow-up|0|||
28072809|NCT00421889|54727432|FG002|Overall Study|Lost to Follow-up|0|||
28072810|NCT00421889|54727433|FG003|Overall Study|Lost to Follow-up|0|||
28072811|NCT00421889|54727434|FG004|Overall Study|Lost to Follow-up|0|||
28072812|NCT00421889|54727435|FG005|Overall Study|Lost to Follow-up|0|||
28072813|NCT00421889|54727436|FG006|Overall Study|Lost to Follow-up|0|||
28072814|NCT00421889|54727437|FG007|Overall Study|Lost to Follow-up|0|||
28072815|NCT00421889|54727438|FG008|Overall Study|Lost to Follow-up|1|||
28072816|NCT00421733|54727465|FG000|Overall Study|Adverse Event|4|||
28072817|NCT00421733|54727466|FG001|Overall Study|Adverse Event|9|||
28072818|NCT00421733|54727467|FG002|Overall Study|Adverse Event|2|||
28072819|NCT00421733|54727465|FG000|Overall Study|Lost to Follow-up|1|||
28072820|NCT00421733|54727466|FG001|Overall Study|Lost to Follow-up|2|||
28072821|NCT00421733|54727467|FG002|Overall Study|Lost to Follow-up|4|||
28149686|NCT02122458|54817960|FG001|Overall Study|Did not qualify at initial testing or after chart review|0|||
28149687|NCT02122458|54817961|FG002|Overall Study|Did not qualify at initial testing or after chart review|0|||
28149688|NCT02122458|54817962|FG003|Overall Study|Did not qualify at initial testing or after chart review|0|||
28072822|NCT00421733|54727465|FG000|Overall Study|Withdrawal by Subject|1|||
28149689|NCT02122458|54817963|FG004|Overall Study|Did not qualify at initial testing or after chart review|0|||
28149690|NCT02122458|54817964|FG005|Overall Study|Did not qualify at initial testing or after chart review|0|||
28149691|NCT02122458|54817965|FG006|Overall Study|Did not qualify at initial testing or after chart review|0|||
28149692|NCT02122458|54817959|FG000|Overall Study|Adverse Event|1|||
28149693|NCT02122458|54817960|FG001|Overall Study|Adverse Event|0|||
28072823|NCT00421733|54727466|FG001|Overall Study|Withdrawal by Subject|2|||
28072824|NCT00421733|54727467|FG002|Overall Study|Withdrawal by Subject|7|||
28072825|NCT00421733|54727465|FG000|Overall Study|Death|0|||
28072826|NCT00421733|54727466|FG001|Overall Study|Death|3|||
28072827|NCT00421733|54727467|FG002|Overall Study|Death|0|||
28072828|NCT00421733|54727465|FG000|Overall Study|Required dialysis|1|||
28072829|NCT00421733|54727466|FG001|Overall Study|Required dialysis|0|||
28072830|NCT00421733|54727467|FG002|Overall Study|Required dialysis|0|||
28072831|NCT00421733|54727465|FG000|Overall Study|Administrative|2|||
28072832|NCT00421733|54727466|FG001|Overall Study|Administrative|0|||
28072833|NCT00421733|54727467|FG002|Overall Study|Administrative|0|||
28072834|NCT00421733|54727465|FG000|Overall Study|Did not satisfy entry criteria|1|||
28149694|NCT02122458|54817961|FG002|Overall Study|Adverse Event|0|||
28149695|NCT02122458|54817962|FG003|Overall Study|Adverse Event|0|||
28149696|NCT02122458|54817963|FG004|Overall Study|Adverse Event|0|||
28149697|NCT02122458|54817964|FG005|Overall Study|Adverse Event|0|||
28149698|NCT02122458|54817965|FG006|Overall Study|Adverse Event|0|||
28149699|NCT02122458|54817959|FG000|Overall Study|Experimental Error|0|||
28149700|NCT02122458|54817960|FG001|Overall Study|Experimental Error|0|||
28149701|NCT02122458|54817961|FG002|Overall Study|Experimental Error|0|||
28149702|NCT02122458|54817962|FG003|Overall Study|Experimental Error|0|||
28149703|NCT02122458|54817963|FG004|Overall Study|Experimental Error|3|||
28149704|NCT02122458|54817964|FG005|Overall Study|Experimental Error|0|||
28072835|NCT00421733|54727466|FG001|Overall Study|Did not satisfy entry criteria|3|||
28072836|NCT00421733|54727467|FG002|Overall Study|Did not satisfy entry criteria|2|||
28072837|NCT00421733|54727465|FG000|Overall Study|Sponsor request|1|||
28072838|NCT00421733|54727466|FG001|Overall Study|Sponsor request|0|||
28072839|NCT00421733|54727467|FG002|Overall Study|Sponsor request|3|||
28072840|NCT00421733|54727465|FG000|Overall Study|Protocol deviation|4|||
28072841|NCT00421733|54727466|FG001|Overall Study|Protocol deviation|7|||
28072842|NCT00421733|54727467|FG002|Overall Study|Protocol deviation|2|||
28072843|NCT00421343|54727479|FG000|Overall Study|Death|1|||
28072844|NCT00421343|54727479|FG000|Overall Study|Withdrawal by Subject|2|||
28072845|NCT00421343|54727479|FG000|Overall Study|Lost to Follow-up|3|||
28072846|NCT00230178|54727486|FG000|Overall Study|Adverse Event|1|||
28072847|NCT00230178|54727487|FG001|Overall Study|Adverse Event|5|||
28072848|NCT00230178|54727488|FG002|Overall Study|Adverse Event|2|||
28072849|NCT00230178|54727486|FG000|Overall Study|Withdrawal by Subject|0|||
28072850|NCT00230178|54727487|FG001|Overall Study|Withdrawal by Subject|0|||
28072851|NCT00230178|54727488|FG002|Overall Study|Withdrawal by Subject|1|||
28072852|NCT00230178|54727486|FG000|Overall Study|Various other reasons|3|||
28149705|NCT02122458|54817965|FG006|Overall Study|Experimental Error|0|||
28072853|NCT00230178|54727487|FG001|Overall Study|Various other reasons|2|||
28072854|NCT00230178|54727488|FG002|Overall Study|Various other reasons|4|||
28072855|NCT00413777|54727498|FG000|Fixed-dose Period|Lost to Follow-up|1|||
28072856|NCT00413777|54727499|FG001|Fixed-dose Period|Lost to Follow-up|1|||
28149706|NCT02122458|54817959|FG000|Overall Study|Deployed or Moved|0|||
28072857|NCT00413777|54727498|FG000|Fixed-dose Period|Adverse Event|2|||
28072858|NCT00413777|54727499|FG001|Fixed-dose Period|Adverse Event|1|||
28072859|NCT00413777|54727498|FG000|Fixed-dose Period|Met Withdrawal Criteria|1|||
28149707|NCT02122458|54817960|FG001|Overall Study|Deployed or Moved|0|||
28149708|NCT02122458|54817961|FG002|Overall Study|Deployed or Moved|0|||
28149709|NCT02122458|54817962|FG003|Overall Study|Deployed or Moved|0|||
28149710|NCT02122458|54817963|FG004|Overall Study|Deployed or Moved|1|||
28149711|NCT02122458|54817964|FG005|Overall Study|Deployed or Moved|0|||
28149712|NCT02122458|54817965|FG006|Overall Study|Deployed or Moved|0|||
28149713|NCT02122458|54817959|FG000|Overall Study|Scheduling Delays - Unable to Complete|0|||
28149714|NCT02122458|54817960|FG001|Overall Study|Scheduling Delays - Unable to Complete|1|||
28149715|NCT02122458|54817961|FG002|Overall Study|Scheduling Delays - Unable to Complete|0|||
28149716|NCT02122458|54817962|FG003|Overall Study|Scheduling Delays - Unable to Complete|4|||
28149717|NCT02122458|54817963|FG004|Overall Study|Scheduling Delays - Unable to Complete|1|||
28149718|NCT02122458|54817964|FG005|Overall Study|Scheduling Delays - Unable to Complete|1|||
28149719|NCT02122458|54817965|FG006|Overall Study|Scheduling Delays - Unable to Complete|0|||
28149720|NCT02122458|54817959|FG000|Overall Study|Noncompliance|0|||
28149721|NCT02122458|54817960|FG001|Overall Study|Noncompliance|1|||
28149722|NCT02122458|54817961|FG002|Overall Study|Noncompliance|0|||
28149723|NCT02122458|54817962|FG003|Overall Study|Noncompliance|0|||
28149724|NCT02122458|54817963|FG004|Overall Study|Noncompliance|0|||
28149725|NCT02122458|54817964|FG005|Overall Study|Noncompliance|0|||
28149726|NCT02122458|54817965|FG006|Overall Study|Noncompliance|0|||
28149727|NCT02903511|54817981|FG000|Overall Study|Withdrawal by Subject|1|||
28149728|NCT02903511|54817982|FG001|Overall Study|Withdrawal by Subject|0|||
28149729|NCT02903511|54817981|FG000|Overall Study|Lost to Follow-up|3|||
28149730|NCT02903511|54817982|FG001|Overall Study|Lost to Follow-up|2|||
28149731|NCT01368042|54817999|FG000|Overall Study|Death|14|||
28149732|NCT01368042|54817999|FG000|Overall Study|Protocol Violation|11|||
28149733|NCT01368042|54817999|FG000|Overall Study|Lost to Follow-up|4|||
28149734|NCT01368042|54817999|FG000|Overall Study|Transplanted|1|||
27822761|NCT01799239|54286758|FG000|Period 1 (7 Days)|Protocol Violation|0|||
27822762|NCT01799239|54286759|FG001|Period 1 (7 Days)|Protocol Violation|1|||
27822763|NCT01799239|54286758|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
27822764|NCT01799239|54286759|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
27822765|NCT01799239|54286758|FG000|Period 2 (7 Days)|Protocol Violation|1|||
27850112|NCT00988091|54348455|FG000|Double-blind Period|Withdrawal by Subject|15|||
27850113|NCT00988091|54348456|FG001|Double-blind Period|Withdrawal by Subject|13|||
27850114|NCT00988091|54348455|FG000|Double-blind Period|Lost to Follow-up|12|||
27850115|NCT00988091|54348456|FG001|Double-blind Period|Lost to Follow-up|14|||
27850116|NCT00988091|54348455|FG000|Double-blind Period|Other|8|||
27850117|NCT00988091|54348456|FG001|Double-blind Period|Other|8|||
27850118|NCT00988091|54348455|FG000|Double-blind Period|Adverse Event|6|||
27850119|NCT00988091|54348456|FG001|Double-blind Period|Adverse Event|9|||
27850120|NCT00988091|54348455|FG000|Double-blind Period|Use of exclusionary medication|2|||
27850121|NCT00988091|54348456|FG001|Double-blind Period|Use of exclusionary medication|3|||
27850122|NCT00988091|54348455|FG000|Open-label Period|Adverse Event|4|||
27850123|NCT00988091|54348456|FG001|Open-label Period|Adverse Event|7|||
27850124|NCT00988091|54348455|FG000|Open-label Period|Use of exclusionary medication|1|||
27850125|NCT00988091|54348456|FG001|Open-label Period|Use of exclusionary medication|1|||
27850126|NCT00988091|54348455|FG000|Open-label Period|Protocol Violation|1|||
27850127|NCT00988091|54348456|FG001|Open-label Period|Protocol Violation|1|||
27850128|NCT00988091|54348455|FG000|Open-label Period|Withdrawal by Subject|10|||
27850129|NCT00988091|54348456|FG001|Open-label Period|Withdrawal by Subject|16|||
27850130|NCT00988091|54348455|FG000|Open-label Period|Lost to Follow-up|3|||
27850131|NCT00988091|54348456|FG001|Open-label Period|Lost to Follow-up|5|||
27850132|NCT00988091|54348455|FG000|Open-label Period|Other|2|||
27850133|NCT00988091|54348456|FG001|Open-label Period|Other|3|||
27850134|NCT02623218|54348746|FG000|Overall Study|Lost to Follow-up|0|||
27850135|NCT02623218|54348747|FG001|Overall Study|Lost to Follow-up|1|||
27850136|NCT02623218|54348748|FG002|Overall Study|Lost to Follow-up|0|||
28072860|NCT00413777|54727499|FG001|Fixed-dose Period|Met Withdrawal Criteria|0|||
28072861|NCT00413777|54727498|FG000|Fixed-dose Period|Withdrew Consent|0|||
28072862|NCT00413777|54727499|FG001|Fixed-dose Period|Withdrew Consent|1|||
28072863|NCT00197028|54727507|FG000|Overall Study|Adverse Event|2|||
28072864|NCT00197028|54727508|FG001|Overall Study|Adverse Event|2|||
28072865|NCT00197028|54727507|FG000|Overall Study|Protocol Violation|2|||
28149735|NCT00126776|54818005|FG000|Overall Study|follow up complete on all patients|0|||
27822766|NCT01799239|54286759|FG001|Period 2 (7 Days)|Protocol Violation|0|||
27822767|NCT02999854|54286775|FG000|Active Study Phase (up to 18 Months)|Screen failures|7|||
27822768|NCT02999854|54286776|FG001|Active Study Phase (up to 18 Months)|Screen failures|2|||
27850137|NCT02623218|54348749|FG003|Overall Study|Lost to Follow-up|0|||
27850138|NCT02623218|54348750|FG004|Overall Study|Lost to Follow-up|0|||
27850139|NCT02622828|54348784|FG000|Overall Study|participant withdrew|3|||
27850140|NCT02621424|54348900|FG000|Overall Study|Withdrawal by Subject|1|||
28072866|NCT00197028|54727508|FG001|Overall Study|Protocol Violation|1|||
28072867|NCT00197028|54727507|FG000|Overall Study|Withdrawal by Subject|8|||
28072868|NCT00197028|54727508|FG001|Overall Study|Withdrawal by Subject|12|||
27850141|NCT02621424|54348901|FG001|Overall Study|Withdrawal by Subject|2|||
27850142|NCT02621034|54348929|FG000|Overall Study|Lost to Follow-up|3|||
27850143|NCT02621034|54348930|FG001|Overall Study|Lost to Follow-up|2|||
28072869|NCT00197028|54727507|FG000|Overall Study|Lost to Follow-up|1|||
28149736|NCT00126776|54818006|FG001|Overall Study|follow up complete on all patients|0|||
28149737|NCT01674010|54818010|FG000|Open Treatment Phase 1|Adverse Event|10|||
28149738|NCT01674010|54818011|FG001|Open Treatment Phase 1|Adverse Event|0|||
28149739|NCT01674010|54818012|FG002|Open Treatment Phase 1|Adverse Event|0|||
28149740|NCT01674010|54818010|FG000|Open Treatment Phase 1|Death|1|||
28149741|NCT01674010|54818011|FG001|Open Treatment Phase 1|Death|0|||
28149742|NCT01674010|54818012|FG002|Open Treatment Phase 1|Death|0|||
28149743|NCT01674010|54818010|FG000|Open Treatment Phase 1|Lost to Follow-up|19|||
28149744|NCT01674010|54818011|FG001|Open Treatment Phase 1|Lost to Follow-up|0|||
28149745|NCT01674010|54818012|FG002|Open Treatment Phase 1|Lost to Follow-up|0|||
28149746|NCT01674010|54818010|FG000|Open Treatment Phase 1|Physician Decision|9|||
28149747|NCT01674010|54818011|FG001|Open Treatment Phase 1|Physician Decision|0|||
28149748|NCT01674010|54818012|FG002|Open Treatment Phase 1|Physician Decision|0|||
28149749|NCT01674010|54818010|FG000|Open Treatment Phase 1|Protocol Violation|7|||
28149750|NCT01674010|54818011|FG001|Open Treatment Phase 1|Protocol Violation|0|||
28149751|NCT01674010|54818012|FG002|Open Treatment Phase 1|Protocol Violation|0|||
28149752|NCT01674010|54818010|FG000|Open Treatment Phase 1|Sponsor Decision|79|||
28149753|NCT01674010|54818011|FG001|Open Treatment Phase 1|Sponsor Decision|0|||
28149754|NCT01674010|54818012|FG002|Open Treatment Phase 1|Sponsor Decision|0|||
28149755|NCT01674010|54818010|FG000|Open Treatment Phase 1|Did not remain in a stable remission|30|||
28149756|NCT01674010|54818011|FG001|Open Treatment Phase 1|Did not remain in a stable remission|0|||
28149757|NCT01674010|54818012|FG002|Open Treatment Phase 1|Did not remain in a stable remission|0|||
28149758|NCT01674010|54818010|FG000|Open Treatment Phase 1|Withdrawal by Subject|25|||
28149759|NCT01674010|54818011|FG001|Open Treatment Phase 1|Withdrawal by Subject|0|||
28072870|NCT00197028|54727508|FG001|Overall Study|Lost to Follow-up|0|||
28072871|NCT00197028|54727507|FG000|Overall Study|Other|3|||
28072872|NCT00197028|54727508|FG001|Overall Study|Other|6|||
28072873|NCT00420641|54727517|FG000|Overall Study|Adverse Event|3|||
28072874|NCT00420641|54727518|FG001|Overall Study|Adverse Event|25|||
28072875|NCT00420641|54727519|FG002|Overall Study|Adverse Event|10|||
28072876|NCT00420641|54727517|FG000|Overall Study|Lost to Follow-up|2|||
28072877|NCT00420641|54727518|FG001|Overall Study|Lost to Follow-up|4|||
28072878|NCT00420641|54727519|FG002|Overall Study|Lost to Follow-up|2|||
28072879|NCT00420641|54727517|FG000|Overall Study|Protocol Violation|8|||
28072880|NCT00420641|54727518|FG001|Overall Study|Protocol Violation|8|||
28072881|NCT00420641|54727519|FG002|Overall Study|Protocol Violation|7|||
28072882|NCT00420641|54727517|FG000|Overall Study|Withdrawal by Subject|15|||
28072883|NCT00420641|54727518|FG001|Overall Study|Withdrawal by Subject|21|||
28072884|NCT00420641|54727519|FG002|Overall Study|Withdrawal by Subject|14|||
28072885|NCT00420641|54727517|FG000|Overall Study|Lack of Efficacy|6|||
28072886|NCT00420641|54727518|FG001|Overall Study|Lack of Efficacy|5|||
28072887|NCT00420641|54727519|FG002|Overall Study|Lack of Efficacy|4|||
28072888|NCT00420641|54727517|FG000|Overall Study|Non-compliance|7|||
28072889|NCT00420641|54727518|FG001|Overall Study|Non-compliance|5|||
28072890|NCT00420641|54727519|FG002|Overall Study|Non-compliance|4|||
28072891|NCT00420641|54727517|FG000|Overall Study|Other|4|||
28072892|NCT00420641|54727518|FG001|Overall Study|Other|4|||
28072893|NCT00420641|54727519|FG002|Overall Study|Other|3|||
28072894|NCT00257556|54727529|FG000|Overall Study|Adverse Event|1|||
28072895|NCT00257556|54727530|FG001|Overall Study|Adverse Event|4|||
28072896|NCT00257556|54727529|FG000|Overall Study|Physician Decision|6|||
28072897|NCT00257556|54727530|FG001|Overall Study|Physician Decision|0|||
28072898|NCT00257556|54727529|FG000|Overall Study|Did not meet hCG criterion|3|||
28072899|NCT00257556|54727530|FG001|Overall Study|Did not meet hCG criterion|0|||
28072900|NCT00257556|54727529|FG000|Overall Study|other reason|4|||
28072901|NCT00257556|54727530|FG001|Overall Study|other reason|6|||
28072902|NCT00228384|54727538|FG000|Overall Study|Death|9|||
28072903|NCT00228384|54727539|FG001|Overall Study|Death|3|||
28072904|NCT00228384|54727538|FG000|Overall Study|Lost to Follow-up|6|||
28072905|NCT00228384|54727539|FG001|Overall Study|Lost to Follow-up|10|||
28149760|NCT01674010|54818012|FG002|Open Treatment Phase 1|Withdrawal by Subject|0|||
28149761|NCT01674010|54818010|FG000|Randomization Phase 2|Adverse Event|0|||
28149762|NCT01674010|54818011|FG001|Randomization Phase 2|Adverse Event|1|||
28149763|NCT01674010|54818012|FG002|Randomization Phase 2|Adverse Event|1|||
28149764|NCT01674010|54818010|FG000|Randomization Phase 2|Lost to Follow-up|0|||
28072906|NCT00228384|54727538|FG000|Overall Study|Surgical Intervention (bypass)|5|||
28072907|NCT00228384|54727539|FG001|Overall Study|Surgical Intervention (bypass)|5|||
28072908|NCT00228384|54727538|FG000|Overall Study|Withdrawal by Subject|9|||
28072909|NCT00228384|54727539|FG001|Overall Study|Withdrawal by Subject|10|||
28072910|NCT00228384|54727538|FG000|Overall Study|Physician Decision|0|||
28072911|NCT00228384|54727539|FG001|Overall Study|Physician Decision|1|||
28072912|NCT00257166|54727547|FG000|Overall Study|Adverse Event|18|||
28072913|NCT00257166|54727548|FG001|Overall Study|Adverse Event|13|||
28149765|NCT01674010|54818011|FG001|Randomization Phase 2|Lost to Follow-up|1|||
28149766|NCT01674010|54818012|FG002|Randomization Phase 2|Lost to Follow-up|2|||
28149767|NCT01674010|54818010|FG000|Randomization Phase 2|Mood episode recurrence|0|||
28149768|NCT01674010|54818011|FG001|Randomization Phase 2|Mood episode recurrence|8|||
28149769|NCT01674010|54818012|FG002|Randomization Phase 2|Mood episode recurrence|2|||
28149770|NCT01674010|54818010|FG000|Randomization Phase 2|Physician Decision|0|||
28149771|NCT01674010|54818011|FG001|Randomization Phase 2|Physician Decision|0|||
28149772|NCT01674010|54818012|FG002|Randomization Phase 2|Physician Decision|2|||
28149773|NCT01674010|54818010|FG000|Randomization Phase 2|Pregnancy|0|||
28149774|NCT01674010|54818011|FG001|Randomization Phase 2|Pregnancy|1|||
28149775|NCT01674010|54818012|FG002|Randomization Phase 2|Pregnancy|1|||
28149776|NCT01674010|54818010|FG000|Randomization Phase 2|Protocol Violation|0|||
28149777|NCT01674010|54818011|FG001|Randomization Phase 2|Protocol Violation|1|||
28149778|NCT01674010|54818012|FG002|Randomization Phase 2|Protocol Violation|1|||
28149779|NCT01674010|54818010|FG000|Randomization Phase 2|Sponsor Decision|0|||
28149780|NCT01674010|54818011|FG001|Randomization Phase 2|Sponsor Decision|42|||
28149781|NCT01674010|54818012|FG002|Randomization Phase 2|Sponsor Decision|45|||
28149782|NCT01674010|54818010|FG000|Randomization Phase 2|Withdrawal by Subject|0|||
28149783|NCT01674010|54818011|FG001|Randomization Phase 2|Withdrawal by Subject|8|||
28149784|NCT01674010|54818012|FG002|Randomization Phase 2|Withdrawal by Subject|7|||
28149785|NCT01345669|54818022|FG000|Overall Study|Primary tumour recurrence|53|||
28149786|NCT01345669|54818023|FG001|Overall Study|Primary tumour recurrence|32|||
28149787|NCT01345669|54818022|FG000|Overall Study|Second primary tumour|4|||
28149788|NCT01345669|54818023|FG001|Overall Study|Second primary tumour|3|||
28149789|NCT01345669|54818022|FG000|Overall Study|Adverse Event|63|||
28149790|NCT01345669|54818023|FG001|Overall Study|Adverse Event|9|||
27850144|NCT02621034|54348931|FG002|Overall Study|Lost to Follow-up|5|||
27850145|NCT02620020|54349013|FG000|Overall Study|Adverse Event|8|||
27850146|NCT02620020|54349014|FG001|Overall Study|Adverse Event|4|||
27850147|NCT02620020|54349015|FG002|Overall Study|Adverse Event|3|||
27850148|NCT02620020|54349016|FG003|Overall Study|Adverse Event|5|||
27850149|NCT02620020|54349013|FG000|Overall Study|Lost to Follow-up|4|||
28149791|NCT01345669|54818022|FG000|Overall Study|Protocol Violation|3|||
28149792|NCT01345669|54818023|FG001|Overall Study|Protocol Violation|1|||
28149793|NCT01345669|54818022|FG000|Overall Study|Lost to Follow-up|1|||
28149794|NCT01345669|54818023|FG001|Overall Study|Lost to Follow-up|1|||
28149795|NCT01345669|54818022|FG000|Overall Study|Withdrawal by Subject|52|||
28149796|NCT01345669|54818023|FG001|Overall Study|Withdrawal by Subject|13|||
28149797|NCT01345669|54818022|FG000|Overall Study|Other Reasons|111|||
28149798|NCT01345669|54818023|FG001|Overall Study|Other Reasons|60|||
28149799|NCT05334212|54818029|FG000|Overall Study|Study terminated prematurely|7|||
28149800|NCT01673854|54818033|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7|||
28149801|NCT01673854|54818033|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6|||
28149802|NCT01673854|54818033|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2|||
28149803|NCT01673854|54818033|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1|||
28149804|NCT01673854|54818033|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1|||
28149805|NCT01673854|54818033|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1|||
28149806|NCT01673854|54818033|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2|||
28149807|NCT01673854|54818033|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7|||
28149808|NCT01673854|54818033|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12|||
28149809|NCT01673854|54818033|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5|||
28072914|NCT00257166|54727547|FG000|Overall Study|Laboratory abnormality|1|||
28072915|NCT00257166|54727548|FG001|Overall Study|Laboratory abnormality|0|||
28072916|NCT00257166|54727547|FG000|Overall Study|Lost to Follow-up|8|||
28072917|NCT00257166|54727548|FG001|Overall Study|Lost to Follow-up|1|||
28072918|NCT00257166|54727547|FG000|Overall Study|Withdrawal by Subject|9|||
28072919|NCT00257166|54727548|FG001|Overall Study|Withdrawal by Subject|2|||
28072920|NCT00257166|54727547|FG000|Overall Study|Other|16|||
28072921|NCT00257166|54727548|FG001|Overall Study|Other|21|||
28072922|NCT00257166|54727547|FG000|Overall Study|Randomized, but not treated|1|||
28072923|NCT00257166|54727548|FG001|Overall Study|Randomized, but not treated|0|||
28072924|NCT00227370|54727556|FG000|Overall Study|Withdrawal by Subject|1|||
28072925|NCT00227370|54727557|FG001|Overall Study|Withdrawal by Subject|2|||
28072926|NCT00227370|54727556|FG000|Overall Study|Death|3|||
28072927|NCT00227370|54727557|FG001|Overall Study|Death|4|||
28072928|NCT00227370|54727556|FG000|Overall Study|Adverse Event|6|||
28072929|NCT00227370|54727557|FG001|Overall Study|Adverse Event|11|||
28072930|NCT00227370|54727556|FG000|Overall Study|Physician Decision|9|||
28072931|NCT00227370|54727557|FG001|Overall Study|Physician Decision|6|||
28072932|NCT00227370|54727556|FG000|Overall Study|Other reasons|2|||
27850150|NCT02620020|54349014|FG001|Overall Study|Lost to Follow-up|8|||
28149810|NCT01673854|54818033|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1|||
27850151|NCT02620020|54349015|FG002|Overall Study|Lost to Follow-up|1|||
27850152|NCT02620020|54349016|FG003|Overall Study|Lost to Follow-up|4|||
27850153|NCT02620020|54349013|FG000|Overall Study|Physician Decision|7|||
27850154|NCT02620020|54349014|FG001|Overall Study|Physician Decision|4|||
27850155|NCT02620020|54349015|FG002|Overall Study|Physician Decision|3|||
27850156|NCT02620020|54349016|FG003|Overall Study|Physician Decision|4|||
27850157|NCT02620020|54349013|FG000|Overall Study|Protocol Violation|5|||
27850158|NCT02620020|54349014|FG001|Overall Study|Protocol Violation|2|||
27850159|NCT02620020|54349015|FG002|Overall Study|Protocol Violation|1|||
27850160|NCT02620020|54349016|FG003|Overall Study|Protocol Violation|1|||
27850161|NCT02620020|54349013|FG000|Overall Study|Withdrawal by Subject|20|||
27850162|NCT02620020|54349014|FG001|Overall Study|Withdrawal by Subject|16|||
27850163|NCT02620020|54349015|FG002|Overall Study|Withdrawal by Subject|17|||
27850164|NCT02620020|54349016|FG003|Overall Study|Withdrawal by Subject|12|||
27850165|NCT02620020|54349013|FG000|Overall Study|Death|0|||
27850166|NCT02620020|54349014|FG001|Overall Study|Death|1|||
28149811|NCT01673854|54818033|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Death|1|||
28149812|NCT01343407|54818037|FG000|Second Treatment Period (Part 2)|Adverse Event|0|||
28149813|NCT01343407|54818038|FG001|Second Treatment Period (Part 2)|Adverse Event|0|||
28149814|NCT01343407|54818039|FG002|Second Treatment Period (Part 2)|Adverse Event|1|||
28149815|NCT01343407|54818040|FG003|Second Treatment Period (Part 2)|Adverse Event|0|||
28149816|NCT01343407|54818041|FG004|Second Treatment Period (Part 2)|Adverse Event|0|||
28149817|NCT01343407|54818042|FG005|Second Treatment Period (Part 2)|Adverse Event|0|||
28149818|NCT01343407|54818037|FG000|Second Washout (Part 2)|Withdrawal by Subject|0|||
28149819|NCT01343407|54818038|FG001|Second Washout (Part 2)|Withdrawal by Subject|0|||
28149820|NCT01343407|54818039|FG002|Second Washout (Part 2)|Withdrawal by Subject|1|||
28149821|NCT01343407|54818040|FG003|Second Washout (Part 2)|Withdrawal by Subject|0|||
28149822|NCT01343407|54818041|FG004|Second Washout (Part 2)|Withdrawal by Subject|0|||
28149823|NCT01343407|54818042|FG005|Second Washout (Part 2)|Withdrawal by Subject|0|||
28149824|NCT01367886|54818050|FG000|Overall Study|Lost to Follow-up|4|||
28149825|NCT01367886|54818050|FG000|Overall Study|Lack of Efficacy|2|||
28149826|NCT01367886|54818050|FG000|Overall Study|Death|1|||
28149827|NCT01673698|54818057|FG000|Overall Study|Lost to Follow-up|51|||
28149828|NCT01673698|54818058|FG001|Overall Study|Lost to Follow-up|13|||
28149829|NCT02786004|54818067|FG000|Overall Study|Withdrawal by Subject|0|||
28149830|NCT02786004|54818068|FG001|Overall Study|Withdrawal by Subject|1|||
28149831|NCT03051607|54818076|FG000|Overall Study|Adverse Event|66|||
28149832|NCT01062399|54818085|FG000|Overall Study|Protocol Violation|0|||
28149833|NCT01062399|54818086|FG001|Overall Study|Protocol Violation|1|||
28149834|NCT01062399|54818087|FG002|Overall Study|Protocol Violation|0|||
28149835|NCT01062399|54818088|FG003|Overall Study|Protocol Violation|6|||
28149836|NCT01062399|54818089|FG004|Overall Study|Protocol Violation|4|||
28149837|NCT01317277|54818103|FG000|Overall Study|Lost to Follow-up|3|||
28149838|NCT01317277|54818104|FG001|Overall Study|Lost to Follow-up|1|||
28149839|NCT01317277|54818103|FG000|Overall Study|Lost MEMS|1|||
28149840|NCT01317277|54818104|FG001|Overall Study|Lost MEMS|1|||
28149841|NCT01317277|54818103|FG000|Overall Study|Unable to comply with intervention|1|||
28149842|NCT01317277|54818104|FG001|Overall Study|Unable to comply with intervention|0|||
28149843|NCT01317277|54818103|FG000|Overall Study|Withdrawal by Subject|1|||
28149844|NCT01317277|54818104|FG001|Overall Study|Withdrawal by Subject|0|||
28149845|NCT01317277|54818103|FG000|Overall Study|Adverse Event|1|||
28149846|NCT01317277|54818104|FG001|Overall Study|Adverse Event|0|||
28149847|NCT02740478|54818110|FG000|Overall Study|Withdrawal by Subject|1|||
27850167|NCT02620020|54349015|FG002|Overall Study|Death|0|||
27850168|NCT02620020|54349016|FG003|Overall Study|Death|0|||
27850169|NCT02549989|54349026|FG000|Overall Study|Adverse Event|4|||
27850170|NCT02549989|54349026|FG000|Overall Study|Death|1|||
27850171|NCT02549989|54349026|FG000|Overall Study|Lack of Efficacy|19|||
27850172|NCT02549989|54349026|FG000|Overall Study|Withdrawal by Subject|3|||
27850173|NCT00987935|54349185|FG000|Overall Study|Progressive disease|3|||
27850174|NCT00987935|54349186|FG001|Overall Study|Progressive disease|2|||
28149848|NCT02969655|54818116|FG000|Overall Study|Withdrawal by Subject|3|||
28149849|NCT02969655|54818117|FG001|Overall Study|Withdrawal by Subject|2|||
27850175|NCT00987935|54349187|FG002|Overall Study|Progressive disease|3|||
28149850|NCT02969655|54818116|FG000|Overall Study|Physician Decision|4|||
27850176|NCT00987935|54349188|FG003|Overall Study|Progressive disease|2|||
27850177|NCT00987935|54349189|FG004|Overall Study|Progressive disease|5|||
27850178|NCT00987935|54349190|FG005|Overall Study|Progressive disease|3|||
27850179|NCT00987935|54349191|FG006|Overall Study|Progressive disease|9|||
27850180|NCT00987935|54349192|FG007|Overall Study|Progressive disease|48|||
27850181|NCT00987935|54349193|FG008|Overall Study|Progressive disease|23|||
27850182|NCT00987935|54349185|FG000|Overall Study|Adverse Event|0|||
27850183|NCT00987935|54349186|FG001|Overall Study|Adverse Event|1|||
27850184|NCT00987935|54349187|FG002|Overall Study|Adverse Event|0|||
27850185|NCT00987935|54349188|FG003|Overall Study|Adverse Event|1|||
27850186|NCT00987935|54349189|FG004|Overall Study|Adverse Event|1|||
27850187|NCT00987935|54349190|FG005|Overall Study|Adverse Event|0|||
27850188|NCT00987935|54349191|FG006|Overall Study|Adverse Event|2|||
27850189|NCT00987935|54349192|FG007|Overall Study|Adverse Event|10|||
27850190|NCT00987935|54349193|FG008|Overall Study|Adverse Event|6|||
27850191|NCT00987935|54349185|FG000|Overall Study|Refused to continue taking trial med.|1|||
27850192|NCT00987935|54349186|FG001|Overall Study|Refused to continue taking trial med.|0|||
27850193|NCT00987935|54349187|FG002|Overall Study|Refused to continue taking trial med.|0|||
27850194|NCT00987935|54349188|FG003|Overall Study|Refused to continue taking trial med.|0|||
27850195|NCT00987935|54349189|FG004|Overall Study|Refused to continue taking trial med.|1|||
27850196|NCT00987935|54349190|FG005|Overall Study|Refused to continue taking trial med.|0|||
27850197|NCT00987935|54349191|FG006|Overall Study|Refused to continue taking trial med.|4|||
27850198|NCT00987935|54349192|FG007|Overall Study|Refused to continue taking trial med.|4|||
27850199|NCT00987935|54349193|FG008|Overall Study|Refused to continue taking trial med.|2|||
28072933|NCT00227370|54727557|FG001|Overall Study|Other reasons|1|||
28072934|NCT00191100|54727565|FG000|Overall Study|Adverse Event|18|||
28149851|NCT02969655|54818117|FG001|Overall Study|Physician Decision|3|||
28149852|NCT02969655|54818116|FG000|Overall Study|Protocol-specified withdrawal criteria|4|||
28149853|NCT02969655|54818117|FG001|Overall Study|Protocol-specified withdrawal criteria|2|||
28149854|NCT02969655|54818116|FG000|Overall Study|Adverse Event|10|||
28149855|NCT02969655|54818117|FG001|Overall Study|Adverse Event|8|||
28149856|NCT01317199|54818128|FG000|Dose-escalation Phase 1|Physician Decision|5|||
28149857|NCT01317199|54818129|FG001|Dose-escalation Phase 1|Physician Decision|0|||
28149858|NCT01317199|54818130|FG002|Dose-escalation Phase 1|Physician Decision|0|||
28149859|NCT01317199|54818131|FG003|Dose-escalation Phase 1|Physician Decision|0|||
28149860|NCT01317199|54818128|FG000|Dose-escalation Phase 1|Disease progression|1|||
28149861|NCT01317199|54818129|FG001|Dose-escalation Phase 1|Disease progression|0|||
28149862|NCT01317199|54818130|FG002|Dose-escalation Phase 1|Disease progression|0|||
28149863|NCT01317199|54818131|FG003|Dose-escalation Phase 1|Disease progression|0|||
28149864|NCT01317199|54818128|FG000|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1|||
28149865|NCT01317199|54818129|FG001|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
28149866|NCT01317199|54818130|FG002|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
28149867|NCT01317199|54818131|FG003|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
28149868|NCT01317199|54818128|FG000|Randomized Phase 2|Disease progression|0|||
28149869|NCT01317199|54818129|FG001|Randomized Phase 2|Disease progression|3|||
28149870|NCT01317199|54818130|FG002|Randomized Phase 2|Disease progression|7|||
28149871|NCT01317199|54818131|FG003|Randomized Phase 2|Disease progression|5|||
28149872|NCT01317199|54818128|FG000|Randomized Phase 2|Withdrawal by Subject|0|||
28149873|NCT01317199|54818129|FG001|Randomized Phase 2|Withdrawal by Subject|3|||
28149874|NCT01317199|54818130|FG002|Randomized Phase 2|Withdrawal by Subject|5|||
28149875|NCT01317199|54818131|FG003|Randomized Phase 2|Withdrawal by Subject|4|||
28149876|NCT01317199|54818128|FG000|Randomized Phase 2|Adverse Event|0|||
28149877|NCT01317199|54818129|FG001|Randomized Phase 2|Adverse Event|0|||
28149878|NCT01317199|54818130|FG002|Randomized Phase 2|Adverse Event|0|||
28149879|NCT01317199|54818131|FG003|Randomized Phase 2|Adverse Event|1|||
28149880|NCT01317199|54818128|FG000|Randomized Phase 2|Comorbidities|0|||
27850200|NCT00987935|54349185|FG000|Overall Study|Reason other than those specified above|0|||
27850201|NCT00987935|54349186|FG001|Overall Study|Reason other than those specified above|0|||
27850202|NCT00987935|54349187|FG002|Overall Study|Reason other than those specified above|0|||
28072935|NCT00191100|54727566|FG001|Overall Study|Adverse Event|1|||
28072936|NCT00191100|54727565|FG000|Overall Study|Lost to Follow-up|2|||
28072937|NCT00191100|54727566|FG001|Overall Study|Lost to Follow-up|0|||
28072938|NCT00191100|54727565|FG000|Overall Study|Patient Moved|0|||
28072939|NCT00191100|54727566|FG001|Overall Study|Patient Moved|1|||
28072940|NCT00191100|54727565|FG000|Overall Study|Withdrawal by Subject|9|||
28072941|NCT00191100|54727566|FG001|Overall Study|Withdrawal by Subject|3|||
28072942|NCT00191100|54727565|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
28072943|NCT00191100|54727566|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
28072944|NCT00191100|54727565|FG000|Overall Study|Clinical Relapse|2|||
28072945|NCT00191100|54727566|FG001|Overall Study|Clinical Relapse|1|||
28072946|NCT00191100|54727565|FG000|Overall Study|Lack of Efficacy, Progressive Disease|1|||
28072947|NCT00191100|54727566|FG001|Overall Study|Lack of Efficacy, Progressive Disease|2|||
28149881|NCT01317199|54818129|FG001|Randomized Phase 2|Comorbidities|2|||
27941762|NCT03672175|54598285|FG001|Extended FU Period (Days 43 to 182)|Reason not Specified|4|||
27941763|NCT03672175|54598286|FG002|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
27941764|NCT03672175|54598284|FG000|Extended FU Period (Days 43 to 182)|Physician Decision|4|||
27941765|NCT03672175|54598285|FG001|Extended FU Period (Days 43 to 182)|Physician Decision|0|||
27941766|NCT03672175|54598286|FG002|Extended FU Period (Days 43 to 182)|Physician Decision|2|||
27941767|NCT03672175|54598284|FG000|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|18|||
27941768|NCT03672175|54598285|FG001|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|24|||
27941769|NCT03672175|54598286|FG002|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|21|||
27941770|NCT01008423|54598314|FG000|Overall Study|Adverse Event|13|||
27941771|NCT01008423|54598315|FG001|Overall Study|Adverse Event|6|||
27941772|NCT01008423|54598314|FG000|Overall Study|Withdrawal by Subject|4|||
27941773|NCT01008423|54598315|FG001|Overall Study|Withdrawal by Subject|7|||
27941774|NCT01008423|54598314|FG000|Overall Study|Lost to Follow-up|0|||
27941775|NCT01008423|54598315|FG001|Overall Study|Lost to Follow-up|2|||
27941776|NCT01008423|54598314|FG000|Overall Study|Low Cortisol|0|||
27941777|NCT01008423|54598315|FG001|Overall Study|Low Cortisol|1|||
27941778|NCT01008423|54598314|FG000|Overall Study|Lack of Efficacy|0|||
27941779|NCT01008423|54598315|FG001|Overall Study|Lack of Efficacy|5|||
27941780|NCT01008423|54598314|FG000|Overall Study|Disease Extent 70 centimeters (cm)|1|||
27941781|NCT01008423|54598315|FG001|Overall Study|Disease Extent 70 centimeters (cm)|0|||
27941782|NCT01008423|54598314|FG000|Overall Study|Personal Conflict|1|||
27941783|NCT01008423|54598315|FG001|Overall Study|Personal Conflict|0|||
27941784|NCT01008423|54598314|FG000|Overall Study|Other|0|||
27822769|NCT02999854|54286775|FG000|Active Study Phase (up to 18 Months)|Discontinued before HSCT|8|||
27822770|NCT02999854|54286776|FG001|Active Study Phase (up to 18 Months)|Discontinued before HSCT|2|||
27822771|NCT02999854|54286775|FG000|Active Study Phase (up to 18 Months)|Death|7|||
27822772|NCT02999854|54286776|FG001|Active Study Phase (up to 18 Months)|Death|5|||
27822773|NCT02999854|54286775|FG000|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|1|||
27822774|NCT02999854|54286776|FG001|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|0|||
27822775|NCT02999854|54286775|FG000|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|1|||
27822776|NCT02999854|54286776|FG001|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|0|||
27822777|NCT02999854|54286775|FG000|Long Term Safety FU (up to 24 Months)|Death|1|||
27822778|NCT02999854|54286776|FG001|Long Term Safety FU (up to 24 Months)|Death|1|||
27822779|NCT02999854|54286775|FG000|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
27822780|NCT02999854|54286776|FG001|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
27822781|NCT02999854|54286775|FG000|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
27822782|NCT02999854|54286776|FG001|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
27822783|NCT04146363|54286909|FG000|Induction Period|Adverse Event|1|||
27822784|NCT04146363|54286910|FG001|Induction Period|Adverse Event|2|||
27822785|NCT04146363|54286911|FG002|Induction Period|Adverse Event|0|||
27822786|NCT04146363|54286912|FG003|Induction Period|Adverse Event|0|||
27822787|NCT04146363|54286913|FG004|Induction Period|Adverse Event|0|||
27822788|NCT04146363|54286914|FG005|Induction Period|Adverse Event|0|||
27822789|NCT04146363|54286915|FG006|Induction Period|Adverse Event|0|||
27822790|NCT04146363|54286916|FG007|Induction Period|Adverse Event|0|||
27822791|NCT04146363|54286917|FG008|Induction Period|Adverse Event|0|||
27941785|NCT01008423|54598315|FG001|Overall Study|Other|1|||
27850203|NCT00987935|54349188|FG003|Overall Study|Reason other than those specified above|0|||
27850204|NCT00987935|54349189|FG004|Overall Study|Reason other than those specified above|0|||
27850205|NCT00987935|54349190|FG005|Overall Study|Reason other than those specified above|0|||
27850206|NCT00987935|54349191|FG006|Overall Study|Reason other than those specified above|0|||
27850207|NCT00987935|54349192|FG007|Overall Study|Reason other than those specified above|0|||
27850208|NCT00987935|54349193|FG008|Overall Study|Reason other than those specified above|1|||
27850209|NCT01597050|54349221|FG000|Overall Study|Withdrawal by Subject|1|||
27850210|NCT01597050|54349222|FG001|Overall Study|Withdrawal by Subject|0|||
27850211|NCT00987623|54349239|FG000|Overall Study|Lost to Follow-up|2|||
27850212|NCT00987623|54349240|FG001|Overall Study|Lost to Follow-up|1|||
27850213|NCT00987623|54349239|FG000|Overall Study|Time/job conflict|2|||
27850214|NCT00987623|54349240|FG001|Overall Study|Time/job conflict|0|||
27850215|NCT00987623|54349239|FG000|Overall Study|Discomfort|1|||
27850216|NCT00987623|54349240|FG001|Overall Study|Discomfort|0|||
27850217|NCT00987623|54349239|FG000|Overall Study|Biomicroscopy|0|||
27850218|NCT00987623|54349240|FG001|Overall Study|Biomicroscopy|1|||
27850219|NCT00987623|54349239|FG000|Overall Study|Influenza|0|||
27850220|NCT00987623|54349240|FG001|Overall Study|Influenza|1|||
28072948|NCT00191100|54727565|FG000|Overall Study|Lack of Efficacy, Stable Disease|1|||
28072949|NCT00191100|54727566|FG001|Overall Study|Lack of Efficacy, Stable Disease|0|||
28072950|NCT00191100|54727565|FG000|Overall Study|Physician Decision|3|||
28072951|NCT00191100|54727566|FG001|Overall Study|Physician Decision|1|||
28072952|NCT00191100|54727565|FG000|Overall Study|Death from Study Drug Toxicity|2|||
28149882|NCT01317199|54818130|FG002|Randomized Phase 2|Comorbidities|2|||
28149883|NCT01317199|54818131|FG003|Randomized Phase 2|Comorbidities|2|||
28149884|NCT01317199|54818128|FG000|Randomized Phase 2|Rising PSA, not as defined by protocol|0|||
28149885|NCT01317199|54818129|FG001|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
28149886|NCT01317199|54818130|FG002|Randomized Phase 2|Rising PSA, not as defined by protocol|5|||
28149887|NCT01317199|54818131|FG003|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
28149888|NCT01317199|54818128|FG000|Randomized Phase 2|Disenrolled before treatment|0|||
28149889|NCT01317199|54818129|FG001|Randomized Phase 2|Disenrolled before treatment|1|||
28149890|NCT01317199|54818130|FG002|Randomized Phase 2|Disenrolled before treatment|1|||
28149891|NCT01317199|54818131|FG003|Randomized Phase 2|Disenrolled before treatment|2|||
28149892|NCT01317199|54818128|FG000|Randomized Phase 2|Patient stopped taking study drug|0|||
28149893|NCT01317199|54818129|FG001|Randomized Phase 2|Patient stopped taking study drug|0|||
27850221|NCT00987467|54349246|FG000|Overall Study|Lost to Follow-up|2|||
27850222|NCT04990440|54349254|FG000|Overall Study|Sponsor's Decision|0|||
27850223|NCT04990440|54349255|FG001|Overall Study|Sponsor's Decision|0|||
27850224|NCT04990440|54349256|FG002|Overall Study|Sponsor's Decision|1|||
28072953|NCT00191100|54727566|FG001|Overall Study|Death from Study Drug Toxicity|0|||
28072954|NCT00191100|54727565|FG000|Overall Study|Protocol Violation|1|||
28072955|NCT00191100|54727566|FG001|Overall Study|Protocol Violation|1|||
28072956|NCT00191100|54727565|FG000|Overall Study|Death from Other Cause|1|||
28072957|NCT00191100|54727566|FG001|Overall Study|Death from Other Cause|0|||
28072958|NCT00191100|54727565|FG000|Overall Study|Reason Not Specified|0|||
28149894|NCT01317199|54818130|FG002|Randomized Phase 2|Patient stopped taking study drug|0|||
27850225|NCT04829747|54349264|FG000|Overall Study|Protocol Violation|1|||
27850226|NCT04408924|54349290|FG000|Overall Study|On Study Treatment|3|||
28149895|NCT01317199|54818131|FG003|Randomized Phase 2|Patient stopped taking study drug|1|||
28149896|NCT01317199|54818128|FG000|Randomized Phase 2|Patient transferred to other facility|0|||
28149897|NCT01317199|54818129|FG001|Randomized Phase 2|Patient transferred to other facility|0|||
28149898|NCT01317199|54818130|FG002|Randomized Phase 2|Patient transferred to other facility|1|||
28149899|NCT01317199|54818131|FG003|Randomized Phase 2|Patient transferred to other facility|0|||
28149900|NCT02648698|54818150|FG000|Overall Study|Protocol Violation|1|||
28149901|NCT02648698|54818151|FG001|Overall Study|Protocol Violation|5|||
28149902|NCT02970669|54818159|FG000|Double-blind Period|Adverse Event|4|||
28149903|NCT02970669|54818160|FG001|Double-blind Period|Adverse Event|0|||
28149904|NCT02970669|54818159|FG000|Double-blind Period|Death|1|||
28149905|NCT02970669|54818160|FG001|Double-blind Period|Death|0|||
27850227|NCT04408924|54349290|FG000|Overall Study|Off Treatment on Post-Treatment-Discontinuation Follow-up|14|||
27850228|NCT04408924|54349290|FG000|Overall Study|Lost to Follow-up|1|||
27850229|NCT04408924|54349290|FG000|Overall Study|Withdrawal by Subject|7|||
27850230|NCT04258423|54349306|FG000|Overall Study|Study Closure|2|||
27850231|NCT04258423|54349307|FG001|Overall Study|Study Closure|2|||
27850232|NCT04178967|54349315|FG000|Induction Period|Adverse Event|4|||
27850233|NCT04178967|54349316|FG001|Induction Period|Adverse Event|6|||
27850234|NCT04178967|54349317|FG002|Induction Period|Adverse Event|0|||
28149906|NCT02970669|54818159|FG000|Double-blind Period|Study terminated by sponsor|1|||
28149907|NCT02970669|54818160|FG001|Double-blind Period|Study terminated by sponsor|2|||
28149908|NCT02970669|54818159|FG000|Double-blind Period|Physician Decision|0|||
28149909|NCT02970669|54818160|FG001|Double-blind Period|Physician Decision|2|||
28149910|NCT02970669|54818159|FG000|Double-blind Period|Withdrawal by Subject|2|||
28149911|NCT02970669|54818160|FG001|Double-blind Period|Withdrawal by Subject|2|||
28149912|NCT02970669|54818159|FG000|Open-label Period|Withdrawal by Subject|2|||
28149913|NCT02970669|54818160|FG001|Open-label Period|Withdrawal by Subject|2|||
27850235|NCT04178967|54349318|FG003|Induction Period|Adverse Event|0|||
27850236|NCT04178967|54349319|FG004|Induction Period|Adverse Event|0|||
27850237|NCT04178967|54349320|FG005|Induction Period|Adverse Event|0|||
27850238|NCT04178967|54349321|FG006|Induction Period|Adverse Event|0|||
27850239|NCT04178967|54349322|FG007|Induction Period|Adverse Event|0|||
27850240|NCT04178967|54349323|FG008|Induction Period|Adverse Event|0|||
27850241|NCT04178967|54349324|FG009|Induction Period|Adverse Event|0|||
27850242|NCT04178967|54349325|FG010|Induction Period|Adverse Event|0|||
27850243|NCT04178967|54349315|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
27850244|NCT04178967|54349316|FG001|Induction Period|Due to Epidemic/Pandemic|4|||
27850245|NCT04178967|54349317|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
27850246|NCT04178967|54349318|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
27850247|NCT04178967|54349319|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
27850248|NCT04178967|54349320|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
27850249|NCT04178967|54349321|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
27850250|NCT04178967|54349322|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
27850251|NCT04178967|54349323|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
27850252|NCT04178967|54349324|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
27850253|NCT04178967|54349325|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
27850254|NCT04178967|54349315|FG000|Induction Period|Lack of Efficacy|4|||
28149914|NCT02970669|54818159|FG000|Open-label Period|Adverse Event|1|||
28149915|NCT02970669|54818160|FG001|Open-label Period|Adverse Event|0|||
28149916|NCT02970669|54818159|FG000|Open-label Period|Physician Decision|1|||
28149917|NCT02970669|54818160|FG001|Open-label Period|Physician Decision|0|||
28149918|NCT02902965|54818168|FG000|Overall Study|Withdrawal by Subject|10|||
28149919|NCT02902809|54818173|FG000|Overall Study|Discontinuation of asthma program|28|||
28149920|NCT01362244|54818179|FG000|Overall Study|Adverse Event|3|||
28149921|NCT01362244|54818180|FG001|Overall Study|Adverse Event|5|||
28149922|NCT01362244|54818179|FG000|Overall Study|Lack of Efficacy|5|||
28149923|NCT01362244|54818180|FG001|Overall Study|Lack of Efficacy|11|||
28149924|NCT01362244|54818179|FG000|Overall Study|Lost to Follow-up|0|||
27822792|NCT04146363|54286918|FG009|Induction Period|Adverse Event|0|||
27822793|NCT04146363|54286919|FG010|Induction Period|Adverse Event|0|||
27822794|NCT04146363|54286909|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
27822795|NCT04146363|54286910|FG001|Induction Period|Due to Epidemic/Pandemic|2|||
27822796|NCT04146363|54286911|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
27822797|NCT04146363|54286912|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
27822798|NCT04146363|54286913|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
27822799|NCT04146363|54286914|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
27822800|NCT04146363|54286915|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
28149925|NCT01362244|54818180|FG001|Overall Study|Lost to Follow-up|2|||
28149926|NCT01362244|54818179|FG000|Overall Study|Protocol Violation|5|||
28149927|NCT01362244|54818180|FG001|Overall Study|Protocol Violation|1|||
28149928|NCT01362244|54818179|FG000|Overall Study|Withdrawal by Subject|2|||
28149929|NCT01362244|54818180|FG001|Overall Study|Withdrawal by Subject|1|||
27850255|NCT04178967|54349316|FG001|Induction Period|Lack of Efficacy|1|||
27850256|NCT04178967|54349317|FG002|Induction Period|Lack of Efficacy|0|||
27850257|NCT04178967|54349318|FG003|Induction Period|Lack of Efficacy|0|||
27850258|NCT04178967|54349319|FG004|Induction Period|Lack of Efficacy|0|||
27850259|NCT04178967|54349320|FG005|Induction Period|Lack of Efficacy|0|||
28149930|NCT01362244|54818179|FG000|Overall Study|Did not Meet Continuation Criteria|17|||
28149931|NCT01362244|54818180|FG001|Overall Study|Did not Meet Continuation Criteria|11|||
28149932|NCT01362244|54818179|FG000|Overall Study|Protocol Defined Stopping Criteria|0|||
28149933|NCT01362244|54818180|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
28149934|NCT02969187|54818188|FG000|Overall Study|Physician Decision|12|||
28149935|NCT02969187|54818189|FG001|Overall Study|Physician Decision|13|||
28149936|NCT03050359|54818199|FG000|Overall Study|Randomized But Not Treated|2|||
28149937|NCT03050359|54818200|FG001|Overall Study|Randomized But Not Treated|0|||
28149938|NCT03050359|54818199|FG000|Overall Study|Pretreatment Event/Adverse Event|5|||
28149939|NCT03050359|54818200|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
28149940|NCT03050359|54818199|FG000|Overall Study|Significant Protocol Deviation|2|||
28149941|NCT03050359|54818200|FG001|Overall Study|Significant Protocol Deviation|3|||
28149942|NCT03050359|54818199|FG000|Overall Study|Lost to Follow-up|2|||
28149943|NCT03050359|54818200|FG001|Overall Study|Lost to Follow-up|1|||
28149944|NCT03050359|54818199|FG000|Overall Study|Voluntary Withdrawal|4|||
28149945|NCT03050359|54818200|FG001|Overall Study|Voluntary Withdrawal|6|||
28149946|NCT03050359|54818199|FG000|Overall Study|Pregnancy|1|||
28149947|NCT03050359|54818200|FG001|Overall Study|Pregnancy|0|||
28149948|NCT03050359|54818199|FG000|Overall Study|Reason Not Specified|1|||
28149949|NCT03050359|54818200|FG001|Overall Study|Reason Not Specified|0|||
28149950|NCT02785770|54818208|FG000|Intervention Period 2 (1 Day)|Adverse Event|0|||
28149951|NCT02785770|54818209|FG001|Intervention Period 2 (1 Day)|Adverse Event|1|||
28149952|NCT02785770|54818210|FG002|Intervention Period 2 (1 Day)|Adverse Event|0|||
28149953|NCT02785770|54818211|FG003|Intervention Period 2 (1 Day)|Adverse Event|0|||
28149954|NCT02785770|54818208|FG000|Intervention Period 2 (1 Day)|Family related obligations|0|||
28149955|NCT02785770|54818209|FG001|Intervention Period 2 (1 Day)|Family related obligations|0|||
28149956|NCT02785770|54818210|FG002|Intervention Period 2 (1 Day)|Family related obligations|1|||
28149957|NCT02785770|54818211|FG003|Intervention Period 2 (1 Day)|Family related obligations|0|||
28149958|NCT02785770|54818208|FG000|Intervention Period 3 (1 Day)|Adverse Event|0|||
28149959|NCT02785770|54818209|FG001|Intervention Period 3 (1 Day)|Adverse Event|0|||
28149960|NCT02785770|54818210|FG002|Intervention Period 3 (1 Day)|Adverse Event|0|||
28149961|NCT02785770|54818211|FG003|Intervention Period 3 (1 Day)|Adverse Event|1|||
28149962|NCT02965833|54818224|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
28149963|NCT02965833|54818225|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
28149964|NCT02965833|54818224|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
28149965|NCT02965833|54818225|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
28149966|NCT02965833|54818224|FG000|Period 1, First 30 Days of Wear|Protocol Violation|1|||
28149967|NCT02965833|54818225|FG001|Period 1, First 30 Days of Wear|Protocol Violation|0|||
28149968|NCT02965833|54818224|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
28149969|NCT02965833|54818225|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
28149970|NCT02965833|54818224|FG000|Period 2, Second 30 Days of Wear|Protocol Violation|2|||
28149971|NCT02965833|54818225|FG001|Period 2, Second 30 Days of Wear|Protocol Violation|0|||
28149972|NCT02968173|54818231|FG000|Overall Study|Withdrawal by Subject|1|||
28149973|NCT02785458|54818238|FG000|1 Month|Withdrawal by Subject|2|||
28149974|NCT02785458|54818239|FG001|1 Month|Withdrawal by Subject|1|||
28149975|NCT02785458|54818238|FG000|1 Month|Lost to Follow-up|38|||
28149976|NCT02785458|54818239|FG001|1 Month|Lost to Follow-up|31|||
28149977|NCT02785458|54818238|FG000|1 Month|Deemed Ineligible|1|||
28149978|NCT02785458|54818239|FG001|1 Month|Deemed Ineligible|0|||
28149979|NCT02785458|54818238|FG000|1 Month|Completed Evaluation by Baseline|42|||
28149980|NCT02785458|54818239|FG001|1 Month|Completed Evaluation by Baseline|39|||
28149981|NCT02785458|54818238|FG000|1 Month|Partial Interview|0|||
28149982|NCT02785458|54818239|FG001|1 Month|Partial Interview|4|||
28149983|NCT02785458|54818238|FG000|3 Months|Withdrawal by Subject|3|||
28149984|NCT02785458|54818239|FG001|3 Months|Withdrawal by Subject|1|||
28149985|NCT02785458|54818238|FG000|3 Months|Lost to Follow-up|25|||
28149986|NCT02785458|54818239|FG001|3 Months|Lost to Follow-up|21|||
28149987|NCT02785458|54818238|FG000|3 Months|Completed Evaluation at 1 Month|100|||
28149988|NCT02785458|54818239|FG001|3 Months|Completed Evaluation at 1 Month|89|||
28149989|NCT02784834|54818245|FG000|Overall Study|Lack of Efficacy|1|||
28149990|NCT02966223|54818249|FG000|Overall Study|Physician Decision|3|||
28149991|NCT02966223|54818249|FG000|Overall Study|Withdrawal by Subject|11|||
28149992|NCT02966223|54818249|FG000|Overall Study|Lost to Follow-up|1|||
28149993|NCT03049735|54818256|FG000|Overall Study|Discontinued due to AE (not dosed)|0|||
28149994|NCT03049735|54818257|FG001|Overall Study|Discontinued due to AE (not dosed)|0|||
28149995|NCT03049735|54818258|FG002|Overall Study|Discontinued due to AE (not dosed)|1|||
28149996|NCT03049735|54818256|FG000|Overall Study|Other|5|||
28149997|NCT03049735|54818257|FG001|Overall Study|Other|3|||
28149998|NCT03049735|54818258|FG002|Overall Study|Other|1|||
28149999|NCT03049735|54818256|FG000|Overall Study|Lack of Efficacy|4|||
28150000|NCT03049735|54818257|FG001|Overall Study|Lack of Efficacy|0|||
28150001|NCT03049735|54818258|FG002|Overall Study|Lack of Efficacy|3|||
28150002|NCT03049735|54818256|FG000|Overall Study|Protocol deviation|1|||
28150003|NCT03049735|54818257|FG001|Overall Study|Protocol deviation|0|||
28150004|NCT03049735|54818258|FG002|Overall Study|Protocol deviation|0|||
28150005|NCT03049735|54818256|FG000|Overall Study|Pregnancy|0|||
28150006|NCT03049735|54818257|FG001|Overall Study|Pregnancy|0|||
28150007|NCT03049735|54818258|FG002|Overall Study|Pregnancy|1|||
28150008|NCT03049735|54818256|FG000|Overall Study|Adverse Event|7|||
28150009|NCT03049735|54818257|FG001|Overall Study|Adverse Event|18|||
28150010|NCT03049735|54818258|FG002|Overall Study|Adverse Event|5|||
28150011|NCT03049735|54818256|FG000|Overall Study|Withdrawal by Subject|10|||
28150012|NCT03049735|54818257|FG001|Overall Study|Withdrawal by Subject|3|||
28150013|NCT03049735|54818258|FG002|Overall Study|Withdrawal by Subject|7|||
28150014|NCT03049735|54818256|FG000|Overall Study|Lost to Follow-up|1|||
28150015|NCT03049735|54818257|FG001|Overall Study|Lost to Follow-up|5|||
28150016|NCT03049735|54818258|FG002|Overall Study|Lost to Follow-up|5|||
28150017|NCT01295944|54818266|FG000|Overall Study|Switched to alternative treatment|1|||
28150018|NCT01295944|54818266|FG000|Overall Study|Ineligible|9|||
28150019|NCT01295944|54818266|FG000|Overall Study|Withdrawal by Subject|4|||
28150020|NCT01295944|54818266|FG000|Overall Study|Participant chose to be treated in Peru|1|||
28150021|NCT01295944|54818266|FG000|Overall Study|Participant wanting a local endoscopy surgery to remove more tumor|1|||
28150022|NCT01295944|54818266|FG000|Overall Study|Participant was diagnosed with stage 1 infiltrated ductal carcinoma of the right breast(10/03/2013).|1|||
28150023|NCT01295944|54818266|FG000|Overall Study|Participant decided to pursue other treatment before beginning protocol treatment|1|||
28150024|NCT02965599|54818272|FG000|Overall Study|Protocol-defined stop criteria reached|1|||
28150025|NCT02965599|54818273|FG001|Overall Study|Protocol-defined stop criteria reached|0|||
28150026|NCT02898597|54818282|FG000|Overall Study|Protocol Violation|4|||
28150027|NCT02898597|54818283|FG001|Overall Study|Protocol Violation|2|||
28150028|NCT02898597|54818282|FG000|Overall Study|Lost to Follow-up|0|||
28150029|NCT02898597|54818283|FG001|Overall Study|Lost to Follow-up|9|||
28150030|NCT02898597|54818282|FG000|Overall Study|Death|0|||
28150031|NCT02898597|54818283|FG001|Overall Study|Death|1|||
28150032|NCT02899377|54818291|FG000|Overall Study|Adverse Event|1|||
28150033|NCT02899377|54818292|FG001|Overall Study|Adverse Event|0|||
28150034|NCT01316887|54818303|FG000|Overall Study|Adverse Event|13|||
28150035|NCT01316887|54818304|FG001|Overall Study|Adverse Event|21|||
28150036|NCT01316887|54818305|FG002|Overall Study|Adverse Event|17|||
28150037|NCT01316887|54818303|FG000|Overall Study|Lack of Efficacy|9|||
28150038|NCT01316887|54818304|FG001|Overall Study|Lack of Efficacy|3|||
28150039|NCT01316887|54818305|FG002|Overall Study|Lack of Efficacy|1|||
28150040|NCT01316887|54818303|FG000|Overall Study|Protocol Violation|2|||
28150041|NCT01316887|54818304|FG001|Overall Study|Protocol Violation|6|||
28150042|NCT01316887|54818305|FG002|Overall Study|Protocol Violation|6|||
28150043|NCT01316887|54818303|FG000|Overall Study|Protocol-defined Stopping Criteria|8|||
28150044|NCT01316887|54818304|FG001|Overall Study|Protocol-defined Stopping Criteria|37|||
28150045|NCT01316887|54818305|FG002|Overall Study|Protocol-defined Stopping Criteria|36|||
28150046|NCT01316887|54818303|FG000|Overall Study|Study Closed/Terminated|2|||
28150047|NCT01316887|54818304|FG001|Overall Study|Study Closed/Terminated|4|||
28150048|NCT01316887|54818305|FG002|Overall Study|Study Closed/Terminated|3|||
28150049|NCT01316887|54818303|FG000|Overall Study|Lost to Follow-up|1|||
28150050|NCT01316887|54818304|FG001|Overall Study|Lost to Follow-up|7|||
28150051|NCT01316887|54818305|FG002|Overall Study|Lost to Follow-up|5|||
28150052|NCT01316887|54818303|FG000|Overall Study|Withdrawal by Subject|8|||
28150053|NCT01316887|54818304|FG001|Overall Study|Withdrawal by Subject|16|||
28150054|NCT01316887|54818305|FG002|Overall Study|Withdrawal by Subject|15|||
28150055|NCT02897349|54818316|FG000|Overall Study|Lost to Follow-up|2|||
28150056|NCT02897349|54818317|FG001|Overall Study|Lost to Follow-up|2|||
28150057|NCT02897349|54818316|FG000|Overall Study|Adverse Event|3|||
28150058|NCT02897349|54818317|FG001|Overall Study|Adverse Event|3|||
28072959|NCT00191100|54727566|FG001|Overall Study|Reason Not Specified|1|||
28072960|NCT00189540|54727574|FG000|Overall Study|Withdrawal by Subject|3|||
28072961|NCT00189540|54727575|FG001|Overall Study|Withdrawal by Subject|0|||
28072962|NCT00189540|54727574|FG000|Overall Study|Death|4|||
28072963|NCT00189540|54727575|FG001|Overall Study|Death|1|||
28072964|NCT00257010|54727581|FG000|Overall Study|Lack of Efficacy|11|||
28072965|NCT00257010|54727581|FG000|Overall Study|Lost to Follow-up|53|||
28072966|NCT00257010|54727581|FG000|Overall Study|Withdrawal by Subject|34|||
28072967|NCT00257010|54727581|FG000|Overall Study|Adverse Event|10|||
28072968|NCT00257010|54727581|FG000|Overall Study|various|11|||
28072969|NCT00257010|54727581|FG000|Overall Study|no headache reported|9|||
28072970|NCT00256854|54727591|FG000|Overall Study|Withdrawal by Subject|2|||
28072971|NCT00256854|54727592|FG001|Overall Study|Withdrawal by Subject|3|||
28072972|NCT00256854|54727593|FG002|Overall Study|Withdrawal by Subject|0|||
28150059|NCT02897349|54818316|FG000|Overall Study|Other than listed above|0|||
28150060|NCT02897349|54818317|FG001|Overall Study|Other than listed above|1|||
28150061|NCT03047551|54818334|FG000|Overall Study|Did not receive TAS|1|||
28150062|NCT03047551|54818335|FG001|Overall Study|Did not receive TAS|0|||
28150063|NCT03047551|54818334|FG000|Overall Study|Physician Decision|1|||
28150064|NCT03047551|54818335|FG001|Overall Study|Physician Decision|0|||
28150065|NCT03047551|54818334|FG000|Overall Study|Withdrawal by Subject|0|||
28150066|NCT03047551|54818335|FG001|Overall Study|Withdrawal by Subject|1|||
28150067|NCT03047551|54818334|FG000|Overall Study|Probe malfunction|0|||
28150068|NCT03047551|54818335|FG001|Overall Study|Probe malfunction|1|||
28150069|NCT03047551|54818334|FG000|Overall Study|Ineligible|0|||
28150070|NCT03047551|54818335|FG001|Overall Study|Ineligible|1|||
28150071|NCT02964741|54818344|FG000|Overall Study|Protocol Violation|1|||
28150072|NCT02964741|54818345|FG001|Overall Study|Protocol Violation|0|||
28150073|NCT02964741|54818346|FG002|Overall Study|Protocol Violation|0|||
28150074|NCT02964741|54818344|FG000|Overall Study|Withdrawal by Subject|0|||
28150075|NCT02964741|54818345|FG001|Overall Study|Withdrawal by Subject|1|||
28150076|NCT02964741|54818346|FG002|Overall Study|Withdrawal by Subject|0|||
28150077|NCT02964741|54818344|FG000|Overall Study|claustrophobia|1|||
28150078|NCT02964741|54818345|FG001|Overall Study|claustrophobia|0|||
28150079|NCT02964741|54818346|FG002|Overall Study|claustrophobia|0|||
28150080|NCT01316419|54818352|FG000|Overall Study|Not treated|103|||
28150081|NCT01316419|54818352|FG000|Overall Study|Violated inclusion/exclusion criterion|143|||
28150082|NCT01316419|54818352|FG000|Overall Study|Lost to Follow-up|19|||
28150083|NCT02964039|54818359|FG000|Overall Study|Medical reason unrelated to study participation|1|||
28150084|NCT02964039|54818360|FG001|Overall Study|Medical reason unrelated to study participation|0|||
28150085|NCT02964039|54818361|FG002|Overall Study|Medical reason unrelated to study participation|3|||
28150086|NCT02964039|54818359|FG000|Overall Study|Research shutdown due to pandemic|2|||
28150087|NCT02964039|54818360|FG001|Overall Study|Research shutdown due to pandemic|0|||
28150088|NCT02964039|54818361|FG002|Overall Study|Research shutdown due to pandemic|1|||
28150089|NCT02964039|54818359|FG000|Overall Study|Withdrawal by Subject|0|||
28150090|NCT02964039|54818360|FG001|Overall Study|Withdrawal by Subject|1|||
28150091|NCT02964039|54818361|FG002|Overall Study|Withdrawal by Subject|0|||
28150092|NCT02964039|54818359|FG000|Overall Study|Lost to Follow-up|1|||
28150093|NCT02964039|54818360|FG001|Overall Study|Lost to Follow-up|0|||
28150094|NCT02964039|54818361|FG002|Overall Study|Lost to Follow-up|1|||
28150095|NCT02897115|54818371|FG000|Overall Study|Early termination of study by sponsor|11|||
28150096|NCT02897115|54818372|FG001|Overall Study|Early termination of study by sponsor|8|||
28150097|NCT02896569|54818380|FG000|Overall Study|Lost to Follow-up|2|||
28150098|NCT02896569|54818381|FG001|Overall Study|Lost to Follow-up|1|||
28150099|NCT02896569|54818380|FG000|Overall Study|Physician Decision|1|||
28150100|NCT02896569|54818381|FG001|Overall Study|Physician Decision|3|||
28150101|NCT02896569|54818380|FG000|Overall Study|Adverse Event|0|||
28150102|NCT02896569|54818381|FG001|Overall Study|Adverse Event|1|||
28150103|NCT02896569|54818380|FG000|Overall Study|Withdrawal by Subject|1|||
28150104|NCT02896569|54818381|FG001|Overall Study|Withdrawal by Subject|0|||
28150105|NCT04030195|54818390|FG000|Overall Study|Withdrawal by Subject|2|||
28150106|NCT04030195|54818391|FG001|Overall Study|Withdrawal by Subject|0|||
28150107|NCT04030195|54818392|FG002|Overall Study|Withdrawal by Subject|0|||
28150108|NCT01673620|54818403|FG000|Overall Study|Adverse Event|1|||
28150109|NCT01673620|54818404|FG001|Overall Study|Adverse Event|0|||
28150110|NCT03044197|54818418|FG000|Overall Study|Withdrawal by Subject|3|||
28150111|NCT03044197|54818419|FG001|Overall Study|Withdrawal by Subject|1|||
28150112|NCT03575325|54818438|FG000|Overall Study|Death|1|||
28150113|NCT03043651|54818453|FG000|Overall Study|Death|1|||
28150114|NCT03043651|54818453|FG000|Overall Study|Progressive Disease|2|||
28150115|NCT03043651|54818453|FG000|Overall Study|Adverse Event|2|||
28150116|NCT03043651|54818453|FG000|Overall Study|Withdrawal by Subject|4|||
28150117|NCT03043651|54818453|FG000|Overall Study|Study Terminated by Sponsor|39|||
28150118|NCT03536143|54818457|FG000|Overall Study|Early termination, Sponsor decision|1|||
28150119|NCT01344759|54818467|FG000|Overall Study|Patients failed to reach sedation level|0|||
28150120|NCT01344759|54818468|FG001|Overall Study|Patients failed to reach sedation level|2|||
28150121|NCT05027451|54818491|FG000|Overall Study|Lost to Follow-up|1|||
28150122|NCT05027451|54818492|FG001|Overall Study|Lost to Follow-up|1|||
28150123|NCT04757649|54818524|FG000|Overall Study|Withdrawal by Subject|1|||
28150124|NCT04757649|54818524|FG000|Overall Study|Adverse Event|1|||
28150125|NCT04621786|54818528|FG000|Overall Study|Lost to Follow-up|9|||
28150126|NCT04621786|54818528|FG000|Overall Study|Protocol Violation|3|||
28072973|NCT00256854|54727594|FG003|Overall Study|Withdrawal by Subject|0|||
28072974|NCT00256854|54727595|FG004|Overall Study|Withdrawal by Subject|0|||
28072975|NCT00256854|54727596|FG005|Overall Study|Withdrawal by Subject|0|||
28072976|NCT00256854|54727591|FG000|Overall Study|Lack of Efficacy|1|||
28072977|NCT00256854|54727592|FG001|Overall Study|Lack of Efficacy|0|||
28072978|NCT00256854|54727593|FG002|Overall Study|Lack of Efficacy|0|||
28072979|NCT00256854|54727594|FG003|Overall Study|Lack of Efficacy|0|||
28072980|NCT00256854|54727595|FG004|Overall Study|Lack of Efficacy|0|||
28072981|NCT00256854|54727596|FG005|Overall Study|Lack of Efficacy|0|||
28072982|NCT00256854|54727591|FG000|Overall Study|Protocol Violation|0|||
28072983|NCT00256854|54727592|FG001|Overall Study|Protocol Violation|1|||
28072984|NCT00256854|54727593|FG002|Overall Study|Protocol Violation|1|||
28072985|NCT00256854|54727594|FG003|Overall Study|Protocol Violation|1|||
28072986|NCT00256854|54727595|FG004|Overall Study|Protocol Violation|0|||
28072987|NCT00256854|54727596|FG005|Overall Study|Protocol Violation|0|||
28072988|NCT00256854|54727591|FG000|Overall Study|Adverse Event|0|||
28072989|NCT00256854|54727592|FG001|Overall Study|Adverse Event|0|||
28072990|NCT00256854|54727593|FG002|Overall Study|Adverse Event|2|||
28150127|NCT04549454|54818534|FG000|T1 to T2|Lost to Follow-up|22|||
28150128|NCT04549454|54818535|FG001|T1 to T2|Lost to Follow-up|26|||
28150129|NCT04549454|54818534|FG000|T1 to T3|Lost to Follow-up|31|||
28150130|NCT04549454|54818535|FG001|T1 to T3|Lost to Follow-up|36|||
28150131|NCT04089865|54818564|FG000|Overall Study|Withdrawal by Subject|2|||
28150132|NCT04089865|54818565|FG001|Overall Study|Withdrawal by Subject|2|||
28150133|NCT04089865|54818566|FG002|Overall Study|Withdrawal by Subject|7|||
28150134|NCT04089865|54818567|FG003|Overall Study|Withdrawal by Subject|2|||
28150135|NCT03519256|54818599|FG000|Overall Study|Disease recurrence|4|||
28150136|NCT03519256|54818600|FG001|Overall Study|Disease recurrence|4|||
28150137|NCT03519256|54818601|FG002|Overall Study|Disease recurrence|5|||
28150138|NCT03519256|54818602|FG003|Overall Study|Disease recurrence|2|||
28150139|NCT03519256|54818599|FG000|Overall Study|Study drug toxicity|0|||
28150140|NCT03519256|54818600|FG001|Overall Study|Study drug toxicity|2|||
28150141|NCT03519256|54818601|FG002|Overall Study|Study drug toxicity|5|||
28150142|NCT03519256|54818602|FG003|Overall Study|Study drug toxicity|2|||
28150143|NCT03519256|54818599|FG000|Overall Study|Adverse event unrelated to study drug|0|||
28150144|NCT03519256|54818600|FG001|Overall Study|Adverse event unrelated to study drug|1|||
28150145|NCT03519256|54818601|FG002|Overall Study|Adverse event unrelated to study drug|1|||
28150146|NCT03519256|54818602|FG003|Overall Study|Adverse event unrelated to study drug|0|||
28150147|NCT03519256|54818599|FG000|Overall Study|Participant request to discontinue study treatment|0|||
28150148|NCT03519256|54818600|FG001|Overall Study|Participant request to discontinue study treatment|0|||
28150149|NCT03519256|54818601|FG002|Overall Study|Participant request to discontinue study treatment|0|||
28150150|NCT03519256|54818602|FG003|Overall Study|Participant request to discontinue study treatment|2|||
28150151|NCT03519256|54818599|FG000|Overall Study|Other reasons|0|||
28150152|NCT03519256|54818600|FG001|Overall Study|Other reasons|0|||
28150153|NCT03519256|54818601|FG002|Overall Study|Other reasons|2|||
28150154|NCT03519256|54818602|FG003|Overall Study|Other reasons|0|||
28150155|NCT03519256|54818599|FG000|Overall Study|Disease progression|6|||
28150156|NCT03519256|54818600|FG001|Overall Study|Disease progression|3|||
28150157|NCT03519256|54818601|FG002|Overall Study|Disease progression|2|||
28150158|NCT03519256|54818602|FG003|Overall Study|Disease progression|1|||
28150159|NCT03519256|54818599|FG000|Overall Study|Lost to Follow-up|0|||
28150160|NCT03519256|54818600|FG001|Overall Study|Lost to Follow-up|1|||
28150161|NCT03519256|54818601|FG002|Overall Study|Lost to Follow-up|0|||
28150162|NCT03519256|54818602|FG003|Overall Study|Lost to Follow-up|0|||
28150163|NCT03343054|54818625|FG000|Dose Escalation Period (Up to 286 Days)|Progressive Disease|2|||
28150164|NCT03343054|54818626|FG001|Dose Escalation Period (Up to 286 Days)|Progressive Disease|6|||
28150165|NCT03343054|54818627|FG002|Dose Escalation Period (Up to 286 Days)|Progressive Disease|0|||
28150166|NCT03343054|54818625|FG000|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|1|||
28150167|NCT03343054|54818626|FG001|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
28150168|NCT03343054|54818627|FG002|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
28150169|NCT03343054|54818625|FG000|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
28150170|NCT03343054|54818626|FG001|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
28150171|NCT03343054|54818627|FG002|Dose Expansion Period (Up to 502 Days)|Progressive Disease|11|||
28150172|NCT03343054|54818625|FG000|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
28150173|NCT03343054|54818626|FG001|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
28150174|NCT03343054|54818627|FG002|Dose Expansion Period (Up to 502 Days)|Ongoing|8|||
28072991|NCT00256854|54727594|FG003|Overall Study|Adverse Event|2|||
28072992|NCT00256854|54727595|FG004|Overall Study|Adverse Event|0|||
28072993|NCT00256854|54727596|FG005|Overall Study|Adverse Event|1|||
28072994|NCT00256854|54727591|FG000|Overall Study|Not compliant with the study drug|0|||
28072995|NCT00256854|54727592|FG001|Overall Study|Not compliant with the study drug|0|||
28072996|NCT00256854|54727593|FG002|Overall Study|Not compliant with the study drug|0|||
28072997|NCT00256854|54727594|FG003|Overall Study|Not compliant with the study drug|0|||
28072998|NCT00256854|54727595|FG004|Overall Study|Not compliant with the study drug|1|||
28072999|NCT00256854|54727596|FG005|Overall Study|Not compliant with the study drug|0|||
28073000|NCT00189462|54727613|FG000|Overall Study|Lack of Efficacy|5|||
28073001|NCT00189462|54727614|FG001|Overall Study|Lack of Efficacy|1|||
28073002|NCT00189462|54727613|FG000|Overall Study|Lost to Follow-up|18|||
28073003|NCT00189462|54727614|FG001|Overall Study|Lost to Follow-up|20|||
28073004|NCT00256698|54727622|FG000|Overall Study|Withdrawal by Subject|7|||
28073005|NCT00256698|54727623|FG001|Overall Study|Withdrawal by Subject|7|||
28073006|NCT00256698|54727622|FG000|Overall Study|Adverse Event|13|||
28073007|NCT00256698|54727623|FG001|Overall Study|Adverse Event|6|||
28073008|NCT00256698|54727622|FG000|Overall Study|Protocol Violation|6|||
28150175|NCT03330847|54818639|FG000|Overall Study|Patients ongoing study|62|||
28150176|NCT03330847|54818640|FG001|Overall Study|Patients ongoing study|65|||
28150177|NCT03330847|54818641|FG002|Overall Study|Patients ongoing study|15|||
28150178|NCT02799602|54818667|FG000|Overall Study|Protocol Violation|1|||
28150179|NCT02799602|54818668|FG001|Overall Study|Protocol Violation|0|||
28150180|NCT02799602|54818667|FG000|Overall Study|Physician Decision|3|||
28073009|NCT00256698|54727623|FG001|Overall Study|Protocol Violation|5|||
28150181|NCT02799602|54818668|FG001|Overall Study|Physician Decision|7|||
28150182|NCT02799602|54818667|FG000|Overall Study|COVID-19 pandemic related other reason|0|||
28150183|NCT02799602|54818668|FG001|Overall Study|COVID-19 pandemic related other reason|1|||
28150184|NCT02799602|54818667|FG000|Overall Study|Lost to Follow-up|4|||
28150185|NCT02799602|54818668|FG001|Overall Study|Lost to Follow-up|1|||
28150186|NCT02799602|54818667|FG000|Overall Study|ADDITIONAL PRIMARY MALIGNANCY|11|||
28150187|NCT02799602|54818668|FG001|Overall Study|ADDITIONAL PRIMARY MALIGNANCY|6|||
28150188|NCT02799602|54818667|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|14|||
28150189|NCT02799602|54818668|FG001|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|12|||
28150190|NCT02799602|54818667|FG000|Overall Study|ADVERSE EVENT ASSOCIATED WITH CLINICAL DISEASE PROGRESSION|24|||
28150191|NCT02799602|54818668|FG001|Overall Study|ADVERSE EVENT ASSOCIATED WITH CLINICAL DISEASE PROGRESSION|26|||
28150192|NCT02799602|54818667|FG000|Overall Study|Withdrawal by Subject|25|||
28150193|NCT02799602|54818668|FG001|Overall Study|Withdrawal by Subject|37|||
28150194|NCT02799602|54818667|FG000|Overall Study|ADVERSE EVENT NOT ASSOCIATED WITH CLINICAL DISEASE PROGRESSION|48|||
28150195|NCT02799602|54818668|FG001|Overall Study|ADVERSE EVENT NOT ASSOCIATED WITH CLINICAL DISEASE PROGRESSION|27|||
28150196|NCT02799602|54818667|FG000|Overall Study|PROGRESSIVE DISEASE - RADIOLOGICAL PROGRESSION|84|||
28150197|NCT02799602|54818668|FG001|Overall Study|PROGRESSIVE DISEASE - RADIOLOGICAL PROGRESSION|132|||
28150198|NCT02799602|54818667|FG000|Overall Study|PROGRESSIVE DISEASE - CLINICAL PROGRESSION|127|||
28150199|NCT02799602|54818668|FG001|Overall Study|PROGRESSIVE DISEASE - CLINICAL PROGRESSION|272|||
28150200|NCT02799602|54818667|FG000|Overall Study|Death|8|||
28150201|NCT02799602|54818668|FG001|Overall Study|Death|5|||
28150202|NCT02799602|54818667|FG000|Overall Study|Other|3|||
28150203|NCT02799602|54818668|FG001|Overall Study|Other|3|||
28150204|NCT02799602|54818667|FG000|Overall Study|GCP violation|1|||
28150205|NCT02799602|54818668|FG001|Overall Study|GCP violation|0|||
28150206|NCT02243709|54818685|FG000|Phase 1|Lost to Follow-up|0|||
28150207|NCT02243709|54818686|FG001|Phase 1|Lost to Follow-up|1|||
28150208|NCT02243709|54818685|FG000|Phase 1|Withdrawal by Subject|1|||
28150209|NCT02243709|54818686|FG001|Phase 1|Withdrawal by Subject|0|||
28150210|NCT02243709|54818685|FG000|Phase 1|Protocol Violation|0|||
28150211|NCT02243709|54818686|FG001|Phase 1|Protocol Violation|1|||
28150212|NCT02243709|54818685|FG000|Phase 1|Adverse Event|0|||
28150213|NCT02243709|54818686|FG001|Phase 1|Adverse Event|1|||
28150214|NCT01891396|54818698|FG000|Overall Study|Withdrawal by Subject|4|||
28150215|NCT01891396|54818699|FG001|Overall Study|Withdrawal by Subject|4|||
28150216|NCT01891396|54818700|FG002|Overall Study|Withdrawal by Subject|3|||
28150217|NCT01891396|54818698|FG000|Overall Study|Lost to Follow-up|0|||
28150218|NCT01891396|54818699|FG001|Overall Study|Lost to Follow-up|1|||
28150219|NCT01891396|54818700|FG002|Overall Study|Lost to Follow-up|0|||
28150220|NCT01746225|54818715|FG000|Overall Study|Death|1|||
28150221|NCT01746225|54818716|FG001|Overall Study|Death|0|||
27822801|NCT04146363|54286916|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
27822802|NCT04146363|54286917|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
27822803|NCT04146363|54286918|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
27822804|NCT04146363|54286919|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
27822805|NCT04146363|54286909|FG000|Induction Period|Lack of Efficacy|7|||
27822806|NCT04146363|54286910|FG001|Induction Period|Lack of Efficacy|2|||
27822807|NCT04146363|54286911|FG002|Induction Period|Lack of Efficacy|0|||
27822808|NCT04146363|54286912|FG003|Induction Period|Lack of Efficacy|0|||
27822809|NCT04146363|54286913|FG004|Induction Period|Lack of Efficacy|0|||
27822810|NCT04146363|54286914|FG005|Induction Period|Lack of Efficacy|0|||
27822811|NCT04146363|54286915|FG006|Induction Period|Lack of Efficacy|0|||
27822812|NCT04146363|54286916|FG007|Induction Period|Lack of Efficacy|0|||
27822813|NCT04146363|54286917|FG008|Induction Period|Lack of Efficacy|0|||
27822814|NCT04146363|54286918|FG009|Induction Period|Lack of Efficacy|0|||
27822815|NCT04146363|54286919|FG010|Induction Period|Lack of Efficacy|0|||
27822816|NCT04146363|54286909|FG000|Induction Period|Lost to Follow-up|1|||
27822817|NCT04146363|54286910|FG001|Induction Period|Lost to Follow-up|4|||
27822818|NCT04146363|54286911|FG002|Induction Period|Lost to Follow-up|0|||
27822819|NCT04146363|54286912|FG003|Induction Period|Lost to Follow-up|0|||
27822820|NCT04146363|54286913|FG004|Induction Period|Lost to Follow-up|0|||
27822821|NCT04146363|54286914|FG005|Induction Period|Lost to Follow-up|0|||
28150222|NCT01746225|54818717|FG002|Overall Study|Death|1|||
28150223|NCT01746225|54818715|FG000|Overall Study|Withdrawal by Subject|5|||
28150224|NCT01746225|54818716|FG001|Overall Study|Withdrawal by Subject|15|||
28150225|NCT01746225|54818717|FG002|Overall Study|Withdrawal by Subject|19|||
28150226|NCT01746225|54818715|FG000|Overall Study|Physician Decision|14|||
27822822|NCT04146363|54286915|FG006|Induction Period|Lost to Follow-up|0|||
27822823|NCT04146363|54286916|FG007|Induction Period|Lost to Follow-up|0|||
27822824|NCT04146363|54286917|FG008|Induction Period|Lost to Follow-up|0|||
28150227|NCT01746225|54818716|FG001|Overall Study|Physician Decision|11|||
28150228|NCT01746225|54818717|FG002|Overall Study|Physician Decision|3|||
28150229|NCT01746225|54818715|FG000|Overall Study|Adverse Event|15|||
28150230|NCT01746225|54818716|FG001|Overall Study|Adverse Event|12|||
28150231|NCT01746225|54818717|FG002|Overall Study|Adverse Event|17|||
27822825|NCT04146363|54286918|FG009|Induction Period|Lost to Follow-up|0|||
27822826|NCT04146363|54286919|FG010|Induction Period|Lost to Follow-up|0|||
27822827|NCT04146363|54286909|FG000|Induction Period|Positive quantiferon test|0|||
27822828|NCT04146363|54286910|FG001|Induction Period|Positive quantiferon test|1|||
27822829|NCT04146363|54286911|FG002|Induction Period|Positive quantiferon test|0|||
27822830|NCT04146363|54286912|FG003|Induction Period|Positive quantiferon test|0|||
27822831|NCT04146363|54286913|FG004|Induction Period|Positive quantiferon test|0|||
28150232|NCT01746225|54818715|FG000|Overall Study|Continuing Treatment|5|||
28150233|NCT01746225|54818716|FG001|Overall Study|Continuing Treatment|8|||
28150234|NCT01746225|54818717|FG002|Overall Study|Continuing Treatment|3|||
28150235|NCT01471522|54818738|FG000|Overall Study|Withdrawal by Subject|28|||
28150236|NCT01471522|54818739|FG001|Overall Study|Withdrawal by Subject|22|||
28150237|NCT01471522|54818738|FG000|Overall Study|Lost to Follow-up|36|||
28150238|NCT01471522|54818739|FG001|Overall Study|Lost to Follow-up|26|||
28150239|NCT01191008|54818746|FG000|Overall Study|Protocol Violation|7|||
28150240|NCT01191008|54818746|FG000|Overall Study|Lost to Follow-up|8|||
28150241|NCT00821587|54818752|FG000|Overall Study|Physician Decision|0|||
28150242|NCT00821587|54818753|FG001|Overall Study|Physician Decision|1|||
28150243|NCT00645801|54818761|FG000|Overall Study|unclear if patient took all the medication.|1|||
28150244|NCT00645801|54818762|FG001|Overall Study|unclear if patient took all the medication.|0|||
28150245|NCT00645801|54818761|FG000|Overall Study|Lost to Follow-up|19|||
28150246|NCT00645801|54818762|FG001|Overall Study|Lost to Follow-up|15|||
28150247|NCT00424099|54818776|FG000|Overall Study|Adverse Event|0|||
28150248|NCT00424099|54818777|FG001|Overall Study|Adverse Event|1|||
28150249|NCT00424099|54818778|FG002|Overall Study|Adverse Event|1|||
28150250|NCT00424099|54818779|FG003|Overall Study|Adverse Event|0|||
28150251|NCT00424099|54818776|FG000|Overall Study|Death|0|||
28150252|NCT00424099|54818777|FG001|Overall Study|Death|1|||
28150253|NCT00424099|54818778|FG002|Overall Study|Death|0|||
28150254|NCT00424099|54818779|FG003|Overall Study|Death|0|||
28150255|NCT00424099|54818776|FG000|Overall Study|Illness|2|||
28073010|NCT00256698|54727622|FG000|Overall Study|Lost to Follow-up|1|||
28073011|NCT00256698|54727623|FG001|Overall Study|Lost to Follow-up|3|||
28073012|NCT00256698|54727622|FG000|Overall Study|disease progression|97|||
28073013|NCT00256698|54727623|FG001|Overall Study|disease progression|105|||
28073014|NCT00256698|54727622|FG000|Overall Study|still ongoing at data cut-off|41|||
28073015|NCT00256698|54727623|FG001|Overall Study|still ongoing at data cut-off|46|||
28073016|NCT00256698|54727622|FG000|Overall Study|withdrawn due to osteoporosis|1|||
28073017|NCT00256698|54727623|FG001|Overall Study|withdrawn due to osteoporosis|0|||
28073018|NCT00256698|54727622|FG000|Overall Study|Prematurely Discontinued|1|||
28073019|NCT00256698|54727623|FG001|Overall Study|Prematurely Discontinued|0|||
28073020|NCT00189306|54727629|FG000|Treatment Period|Withdrawal by Subject|2|||
28073021|NCT00189306|54727629|FG000|Treatment Period|Adverse Event|2|||
28073022|NCT00189306|54727629|FG000|Treatment Period|Protocol Violation|1|||
28073023|NCT00189306|54727629|FG000|Posttreatment Period|Death|1|||
28150256|NCT00424099|54818777|FG001|Overall Study|Illness|0|||
28073024|NCT00189306|54727629|FG000|Posttreatment Period|Withdrawal by Subject|2|||
28073025|NCT00189306|54727629|FG000|Posttreatment Period|Noncompliance|1|||
28150257|NCT00424099|54818778|FG002|Overall Study|Illness|1|||
28150258|NCT00424099|54818779|FG003|Overall Study|Illness|4|||
28150259|NCT00424099|54818776|FG000|Overall Study|Lost to Follow-up|0|||
28150260|NCT00424099|54818777|FG001|Overall Study|Lost to Follow-up|0|||
28150261|NCT00424099|54818778|FG002|Overall Study|Lost to Follow-up|3|||
28150262|NCT00424099|54818779|FG003|Overall Study|Lost to Follow-up|0|||
28073026|NCT00189306|54727629|FG000|Posttreatment Period|Target lesion excised|1|||
28073027|NCT00189306|54727629|FG000|Posttreatment Period|Protocol Violation|1|||
28073028|NCT00189306|54727629|FG000|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5|||
28073029|NCT00189306|54727629|FG000|Posttreatment Period|Local skin reaction/sign|1|||
28073030|NCT00189306|54727629|FG000|Long-Term Follow-up|Adverse Event|2|||
28073031|NCT00189306|54727629|FG000|Long-Term Follow-up|Death|4|||
28073032|NCT00189306|54727629|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
28073033|NCT00189306|54727629|FG000|Long-Term Follow-up|Intercurrent disease|2|||
28073034|NCT00189306|54727629|FG000|Long-Term Follow-up|Lost to Follow-up|9|||
28073035|NCT00189306|54727629|FG000|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20|||
28073036|NCT00187278|54727635|FG000|Overall Study|Protocol Violation|10|||
28073037|NCT00187278|54727636|FG001|Overall Study|Protocol Violation|13|||
28073038|NCT00256308|54727644|FG000|Overall Study|Death|2|||
28073039|NCT00255840|54727650|FG000|Overall Study|Lost to Follow-up|10|||
28073040|NCT00255840|54727651|FG001|Overall Study|Lost to Follow-up|14|||
28073041|NCT00255840|54727650|FG000|Overall Study|Discontinued intervention|53|||
28073042|NCT00255840|54727651|FG001|Overall Study|Discontinued intervention|56|||
28073043|NCT00224874|54727661|FG000|Overall Study|Withdrawal by Subject|0|||
28073044|NCT00224874|54727662|FG001|Overall Study|Withdrawal by Subject|0|||
28073045|NCT00224874|54727663|FG002|Overall Study|Withdrawal by Subject|1|||
28073046|NCT00224874|54727664|FG003|Overall Study|Withdrawal by Subject|0|||
28073047|NCT00186186|54727674|FG000|Overall Study|Lack of Efficacy|3|||
28073048|NCT00186186|54727674|FG000|Overall Study|Withdrawal by Subject|3|||
28073049|NCT00186186|54727674|FG000|Overall Study|Not reported as to reason|2|||
28073050|NCT00185640|54727679|FG000|Overall Study|Not Eligible|4|||
28073051|NCT00185640|54727679|FG000|Overall Study|Withdrawal by Subject|3|||
28073052|NCT00185640|54727679|FG000|Overall Study|Death|138|||
28073053|NCT03760666|54727686|FG000|Overall Study|Adverse Event|2|||
28073054|NCT03760666|54727687|FG001|Overall Study|Adverse Event|4|||
28073055|NCT03760666|54727688|FG002|Overall Study|Adverse Event|1|||
28073056|NCT03760666|54727686|FG000|Overall Study|AML Disease Progression|3|||
28073057|NCT03760666|54727687|FG001|Overall Study|AML Disease Progression|3|||
28073058|NCT03760666|54727688|FG002|Overall Study|AML Disease Progression|0|||
28073059|NCT03760666|54727686|FG000|Overall Study|Physician Decision|0|||
28073060|NCT03760666|54727687|FG001|Overall Study|Physician Decision|3|||
28073061|NCT03760666|54727688|FG002|Overall Study|Physician Decision|0|||
27941786|NCT01012947|54598326|FG000|Overall Study|Lost to Follow-up|131|||
27941787|NCT01012947|54598327|FG001|Overall Study|Lost to Follow-up|135|||
27941788|NCT01012947|54598328|FG002|Overall Study|Lost to Follow-up|130|||
27941789|NCT01012947|54598329|FG003|Overall Study|Lost to Follow-up|118|||
27941790|NCT01012947|54598330|FG004|Overall Study|Lost to Follow-up|142|||
27941791|NCT01214603|54598362|FG000|Overall Study|Adverse Event|0|||
27941792|NCT01214603|54598363|FG001|Overall Study|Adverse Event|0|||
27941793|NCT01214603|54598364|FG002|Overall Study|Adverse Event|1|||
28073062|NCT03760666|54727686|FG000|Overall Study|Withdrawal by Subject|0|||
28073063|NCT03760666|54727687|FG001|Overall Study|Withdrawal by Subject|1|||
28073064|NCT03760666|54727688|FG002|Overall Study|Withdrawal by Subject|0|||
28073065|NCT03760510|54727701|FG000|Overall Study|Not ventilated for 24 hours|105|||
28073066|NCT03760510|54727702|FG001|Overall Study|Not ventilated for 24 hours|97|||
28073067|NCT00224484|54727711|FG000|Overall Study|Serious Adverse Event|1|||
28073068|NCT00224484|54727712|FG001|Overall Study|Serious Adverse Event|1|||
28073069|NCT00224484|54727713|FG002|Overall Study|Serious Adverse Event|0|||
28073070|NCT00224484|54727711|FG000|Overall Study|Non-Serious Adverse Event|5|||
28073071|NCT00224484|54727712|FG001|Overall Study|Non-Serious Adverse Event|7|||
28073072|NCT00224484|54727713|FG002|Overall Study|Non-Serious Adverse Event|3|||
28073073|NCT00224484|54727711|FG000|Overall Study|Protocol Violation|2|||
28073074|NCT00224484|54727712|FG001|Overall Study|Protocol Violation|2|||
28073075|NCT00224484|54727713|FG002|Overall Study|Protocol Violation|0|||
28073076|NCT00224484|54727711|FG000|Overall Study|Withdrawal by Subject|49|||
28073077|NCT00224484|54727712|FG001|Overall Study|Withdrawal by Subject|18|||
28073078|NCT00224484|54727713|FG002|Overall Study|Withdrawal by Subject|16|||
28073079|NCT00224484|54727711|FG000|Overall Study|Migrated/moved from study area|18|||
28073080|NCT00224484|54727712|FG001|Overall Study|Migrated/moved from study area|5|||
28073081|NCT00224484|54727713|FG002|Overall Study|Migrated/moved from study area|5|||
28150263|NCT00424099|54818776|FG000|Overall Study|Hospitalized|1|||
28150264|NCT00424099|54818777|FG001|Overall Study|Hospitalized|2|||
27941794|NCT01214603|54598362|FG000|Overall Study|Death|1|||
27941795|NCT01214603|54598363|FG001|Overall Study|Death|0|||
27941796|NCT01214603|54598364|FG002|Overall Study|Death|0|||
27941797|NCT01214603|54598362|FG000|Overall Study|Progressive Disease|4|||
28073082|NCT00224484|54727711|FG000|Overall Study|Lost to Follow-up|66|||
28073083|NCT00224484|54727712|FG001|Overall Study|Lost to Follow-up|28|||
28073084|NCT00224484|54727713|FG002|Overall Study|Lost to Follow-up|36|||
28073085|NCT00224484|54727711|FG000|Overall Study|Reason not specified|5|||
28073086|NCT00224484|54727712|FG001|Overall Study|Reason not specified|4|||
28073087|NCT00224484|54727713|FG002|Overall Study|Reason not specified|2|||
28150265|NCT00424099|54818778|FG002|Overall Study|Hospitalized|1|||
28150266|NCT00424099|54818779|FG003|Overall Study|Hospitalized|3|||
28150267|NCT00424099|54818776|FG000|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
28150268|NCT00424099|54818777|FG001|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
28150269|NCT00424099|54818778|FG002|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
28150270|NCT00424099|54818779|FG003|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
28150271|NCT00424099|54818776|FG000|Overall Study|Withdrawal by Subject|1|||
28150272|NCT00424099|54818777|FG001|Overall Study|Withdrawal by Subject|9|||
28150273|NCT00424099|54818778|FG002|Overall Study|Withdrawal by Subject|4|||
28150274|NCT00424099|54818779|FG003|Overall Study|Withdrawal by Subject|6|||
28150275|NCT00424099|54818776|FG000|Overall Study|Physician Decision|0|||
28150276|NCT00424099|54818777|FG001|Overall Study|Physician Decision|0|||
28150277|NCT00424099|54818778|FG002|Overall Study|Physician Decision|1|||
28150278|NCT00424099|54818779|FG003|Overall Study|Physician Decision|0|||
28150279|NCT00424099|54818776|FG000|Overall Study|Missing|0|||
28150280|NCT00424099|54818777|FG001|Overall Study|Missing|0|||
28150281|NCT00424099|54818778|FG002|Overall Study|Missing|1|||
28150282|NCT00424099|54818779|FG003|Overall Study|Missing|0|||
28150283|NCT02988661|54818802|FG000|Overall Study|Death|2|||
28150284|NCT02988661|54818803|FG001|Overall Study|Death|18|||
28150285|NCT02988661|54818802|FG000|Overall Study|Lost to Follow-up|0|||
28150286|NCT02988661|54818803|FG001|Overall Study|Lost to Follow-up|33|||
28150287|NCT02988661|54818802|FG000|Overall Study|Withdrawal by Subject|0|||
28150288|NCT02988661|54818803|FG001|Overall Study|Withdrawal by Subject|6|||
28150289|NCT02988661|54818802|FG000|Overall Study|Unable to complete the 18-month survey|1|||
28150290|NCT02988661|54818803|FG001|Overall Study|Unable to complete the 18-month survey|27|||
28150291|NCT03738397|54818811|FG000|Overall Study|Adverse Event|3|||
28150292|NCT03738397|54818812|FG001|Overall Study|Adverse Event|7|||
28150293|NCT03738397|54818811|FG000|Overall Study|Withdrawal by Subject|8|||
28150294|NCT03738397|54818812|FG001|Overall Study|Withdrawal by Subject|11|||
28150295|NCT03738397|54818811|FG000|Overall Study|Lost to Follow-up|8|||
28150296|NCT03738397|54818812|FG001|Overall Study|Lost to Follow-up|5|||
28150297|NCT03738397|54818811|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
28150298|NCT03738397|54818812|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
28150299|NCT03738397|54818811|FG000|Overall Study|Other|4|||
28150300|NCT03738397|54818812|FG001|Overall Study|Other|6|||
28150301|NCT02960217|54818820|FG000|Maintenance Phase: Treatment Period 1|Adverse Event|1|||
28150302|NCT02960217|54818821|FG001|Maintenance Phase: Treatment Period 1|Adverse Event|0|||
28150303|NCT02960217|54818820|FG000|Maintenance Phase: Treatment Period 2|Adverse Event|0|||
28150304|NCT02960217|54818821|FG001|Maintenance Phase: Treatment Period 2|Adverse Event|1|||
28150305|NCT02960217|54818820|FG000|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0|||
28150306|NCT02960217|54818821|FG001|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1|||
28150307|NCT02960217|54818820|FG000|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1|||
28150308|NCT02960217|54818821|FG001|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0|||
28073088|NCT00254982|54727726|FG000|Overall Study|Other|2|||
28073089|NCT00254982|54727727|FG001|Overall Study|Other|1|||
28073090|NCT00254982|54727726|FG000|Overall Study|Lack of Efficacy|5|||
28073091|NCT00254982|54727727|FG001|Overall Study|Lack of Efficacy|3|||
28150309|NCT02960217|54818820|FG000|Maintenance Phase: Treatment Period 2|Other, Not Specified|0|||
28150310|NCT02960217|54818821|FG001|Maintenance Phase: Treatment Period 2|Other, Not Specified|1|||
28150311|NCT02960217|54818820|FG000|Open-Label Extension Phase|Adverse Event|1|||
28150312|NCT02960217|54818821|FG001|Open-Label Extension Phase|Adverse Event|0|||
28150313|NCT02960217|54818820|FG000|Open-Label Extension Phase|Sponsor Decision|18|||
28150314|NCT02960217|54818821|FG001|Open-Label Extension Phase|Sponsor Decision|11|||
28150315|NCT02960217|54818820|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
28073092|NCT00254982|54727726|FG000|Overall Study|Lost to Follow-up|5|||
28073093|NCT00254982|54727727|FG001|Overall Study|Lost to Follow-up|3|||
28073094|NCT00254982|54727726|FG000|Overall Study|Adverse Event|18|||
28150316|NCT02960217|54818821|FG001|Open-Label Extension Phase|Lack of Efficacy|1|||
28150317|NCT02960217|54818820|FG000|Open-Label Extension Phase|Other, Not Specified|0|||
28150318|NCT02960217|54818821|FG001|Open-Label Extension Phase|Other, Not Specified|1|||
28073095|NCT00254982|54727727|FG001|Overall Study|Adverse Event|16|||
28073096|NCT00254982|54727726|FG000|Overall Study|Withdrawal by Subject|1|||
28150319|NCT02959983|54818833|FG000|Overall Study|Protocol Violation|0|||
28150320|NCT02959983|54818834|FG001|Overall Study|Protocol Violation|1|||
28150321|NCT02959983|54818833|FG000|Overall Study|Lack of Efficacy|0|||
28150322|NCT02959983|54818834|FG001|Overall Study|Lack of Efficacy|1|||
28150323|NCT02959983|54818833|FG000|Overall Study|Lost to Follow-up|12|||
28150324|NCT02959983|54818834|FG001|Overall Study|Lost to Follow-up|9|||
28150325|NCT02959983|54818833|FG000|Overall Study|Other|1|||
28150326|NCT02959983|54818834|FG001|Overall Study|Other|1|||
28150327|NCT02959983|54818833|FG000|Overall Study|Physician Decision|1|||
28150328|NCT02959983|54818834|FG001|Overall Study|Physician Decision|0|||
28150329|NCT02959983|54818833|FG000|Overall Study|Adverse Event|5|||
28150330|NCT02959983|54818834|FG001|Overall Study|Adverse Event|1|||
28150331|NCT02959983|54818833|FG000|Overall Study|Withdrawal by Subject|7|||
28150332|NCT02959983|54818834|FG001|Overall Study|Withdrawal by Subject|12|||
28150333|NCT01344447|54818840|FG000|Overall Study|Adverse Event|1|||
28150334|NCT01344447|54818840|FG000|Overall Study|Protocol Violation|1|||
28150335|NCT01344447|54818840|FG000|Overall Study|Withdrawal by Subject|1|||
28150336|NCT01344447|54818840|FG000|Overall Study|The contrast was not seen|1|||
28150337|NCT01344447|54818840|FG000|Overall Study|Physician Decision|1|||
28150338|NCT01344447|54818840|FG000|Overall Study|MRA unsuccessful|1|||
28150339|NCT01344447|54818840|FG000|Overall Study|Bolus tracking failed|1|||
28150340|NCT01344447|54818840|FG000|Overall Study|Error of power injector|1|||
28150341|NCT03513068|54818850|FG000|Overall Study|Death|1|||
28150342|NCT03513068|54818851|FG001|Overall Study|Death|0|||
28150343|NCT03513068|54818850|FG000|Overall Study|Withdrawal by Subject|4|||
28150344|NCT03513068|54818851|FG001|Overall Study|Withdrawal by Subject|6|||
28150345|NCT01348425|54818859|FG000|Overall Study|Imaging was not taken.|1|||
28150346|NCT01348425|54818860|FG001|Overall Study|Imaging was not taken.|1|||
28150347|NCT03041701|54818868|FG000|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
28150348|NCT03041701|54818869|FG001|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
28150349|NCT03041701|54818870|FG002|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|0|||
28150350|NCT03041701|54818868|FG000|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
28150351|NCT03041701|54818869|FG001|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
28150352|NCT03041701|54818870|FG002|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|1|||
28150353|NCT02956629|54818887|FG000|Overall Study|Adverse Event|0|||
28150354|NCT02956629|54818888|FG001|Overall Study|Adverse Event|0|||
28150355|NCT02956629|54818889|FG002|Overall Study|Adverse Event|1|||
28150356|NCT02956629|54818890|FG003|Overall Study|Adverse Event|0|||
28150357|NCT02956629|54818891|FG004|Overall Study|Adverse Event|0|||
28150358|NCT02956629|54818892|FG005|Overall Study|Adverse Event|0|||
28150359|NCT02956629|54818887|FG000|Overall Study|Lost to Follow-up|2|||
28150360|NCT02956629|54818888|FG001|Overall Study|Lost to Follow-up|5|||
28150361|NCT02956629|54818889|FG002|Overall Study|Lost to Follow-up|3|||
28150362|NCT02956629|54818890|FG003|Overall Study|Lost to Follow-up|1|||
28150363|NCT02956629|54818891|FG004|Overall Study|Lost to Follow-up|0|||
28150364|NCT02956629|54818892|FG005|Overall Study|Lost to Follow-up|1|||
28150365|NCT02956629|54818887|FG000|Overall Study|Withdrawal by Subject|3|||
28150366|NCT02956629|54818888|FG001|Overall Study|Withdrawal by Subject|1|||
28150367|NCT02956629|54818889|FG002|Overall Study|Withdrawal by Subject|0|||
28150368|NCT02956629|54818890|FG003|Overall Study|Withdrawal by Subject|0|||
28150369|NCT02956629|54818891|FG004|Overall Study|Withdrawal by Subject|0|||
28150370|NCT02956629|54818892|FG005|Overall Study|Withdrawal by Subject|0|||
28150371|NCT01348347|54818909|FG000|Overall Study|Withdrawal by Subject|1|||
28150372|NCT01348347|54818910|FG001|Overall Study|Withdrawal by Subject|1|||
28150373|NCT01348347|54818911|FG002|Overall Study|Withdrawal by Subject|1|||
28150374|NCT01348347|54818909|FG000|Overall Study|Progressive disease|2|||
28150375|NCT01348347|54818910|FG001|Overall Study|Progressive disease|5|||
28150376|NCT01348347|54818911|FG002|Overall Study|Progressive disease|5|||
28150377|NCT02959671|54818920|FG000|Overall Study|Adverse Event|2|||
28150378|NCT02959671|54818920|FG000|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3|||
28150379|NCT01597258|54818924|FG000|Overall Study|No Drug Administration|1|||
28150380|NCT02958267|54818930|FG000|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1|||
28150381|NCT02958267|54818931|FG001|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0|||
28150382|NCT02958267|54818930|FG000|Enrollment to Actual Treatment Complete|Physician Decision|1|||
28150383|NCT02958267|54818931|FG001|Enrollment to Actual Treatment Complete|Physician Decision|0|||
28150384|NCT02958267|54818930|FG000|Follow-up Visits|Additional treatment pursued|2|||
27822832|NCT04146363|54286914|FG005|Induction Period|Positive quantiferon test|0|||
28150385|NCT02958267|54818931|FG001|Follow-up Visits|Additional treatment pursued|1|||
28150386|NCT01952574|54818941|FG000|Double-blind Treatment Phase|Withdrawal by Subject|9|||
28150387|NCT01952574|54818942|FG001|Double-blind Treatment Phase|Withdrawal by Subject|3|||
28150388|NCT01952574|54818943|FG002|Double-blind Treatment Phase|Withdrawal by Subject|3|||
28073097|NCT00254982|54727727|FG001|Overall Study|Withdrawal by Subject|1|||
28073098|NCT00254982|54727726|FG000|Overall Study|Inclusion/exclusion criteria violation|0|||
28073099|NCT00254982|54727727|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
28073100|NCT00254982|54727726|FG000|Overall Study|Protocol deviation|1|||
28150389|NCT01952574|54818944|FG003|Double-blind Treatment Phase|Withdrawal by Subject|4|||
28150390|NCT01952574|54818945|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
28150391|NCT01952574|54818946|FG005|Double-blind Treatment Phase|Withdrawal by Subject|0|||
28150392|NCT01952574|54818947|FG006|Double-blind Treatment Phase|Withdrawal by Subject|0|||
28150393|NCT01952574|54818941|FG000|Double-blind Treatment Phase|Sponsor Decision|6|||
28150394|NCT01952574|54818942|FG001|Double-blind Treatment Phase|Sponsor Decision|0|||
28150395|NCT01952574|54818943|FG002|Double-blind Treatment Phase|Sponsor Decision|5|||
27941798|NCT01214603|54598363|FG001|Overall Study|Progressive Disease|1|||
28073101|NCT00254982|54727727|FG001|Overall Study|Protocol deviation|1|||
28073102|NCT00254982|54727726|FG000|Overall Study|Diagnosis of Tuberculosis|1|||
28150396|NCT01952574|54818944|FG003|Double-blind Treatment Phase|Sponsor Decision|2|||
28150397|NCT01952574|54818945|FG004|Double-blind Treatment Phase|Sponsor Decision|0|||
28150398|NCT01952574|54818946|FG005|Double-blind Treatment Phase|Sponsor Decision|0|||
28150399|NCT01952574|54818947|FG006|Double-blind Treatment Phase|Sponsor Decision|0|||
28150400|NCT01952574|54818941|FG000|Double-blind Treatment Phase|Lost to Follow-up|2|||
28073103|NCT00254982|54727727|FG001|Overall Study|Diagnosis of Tuberculosis|1|||
28073104|NCT00254982|54727726|FG000|Overall Study|Malignancy|0|||
28073105|NCT00254982|54727727|FG001|Overall Study|Malignancy|2|||
28073106|NCT00254982|54727726|FG000|Overall Study|Opportunistic infection|1|||
28073107|NCT00254982|54727727|FG001|Overall Study|Opportunistic infection|0|||
28073108|NCT00254982|54727726|FG000|Overall Study|Abnormal liver function tests|2|||
28073109|NCT00254982|54727727|FG001|Overall Study|Abnormal liver function tests|1|||
28073110|NCT03759340|54727733|FG000|Overall Study|Adverse Event|2|||
28073111|NCT03759340|54727733|FG000|Overall Study|Lost to Follow-up|1|||
28150401|NCT01952574|54818942|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
28150402|NCT01952574|54818943|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
28150403|NCT01952574|54818944|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
28150404|NCT01952574|54818945|FG004|Double-blind Treatment Phase|Lost to Follow-up|0|||
28150405|NCT01952574|54818946|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
28150406|NCT01952574|54818947|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
28150407|NCT01952574|54818941|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
28150408|NCT01952574|54818942|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
28150409|NCT01952574|54818943|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
28150410|NCT01952574|54818944|FG003|Open-label Treatment Phase|Withdrawal by Subject|0|||
28150411|NCT01952574|54818945|FG004|Open-label Treatment Phase|Withdrawal by Subject|121|||
28150412|NCT01952574|54818946|FG005|Open-label Treatment Phase|Withdrawal by Subject|0|||
28150413|NCT01952574|54818947|FG006|Open-label Treatment Phase|Withdrawal by Subject|0|||
28150414|NCT01952574|54818941|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
28150415|NCT01952574|54818942|FG001|Open-label Treatment Phase|Decision by Sponsor|0|||
28150416|NCT01952574|54818943|FG002|Open-label Treatment Phase|Decision by Sponsor|0|||
28150417|NCT01952574|54818944|FG003|Open-label Treatment Phase|Decision by Sponsor|0|||
28150418|NCT01952574|54818945|FG004|Open-label Treatment Phase|Decision by Sponsor|17|||
28150419|NCT01952574|54818946|FG005|Open-label Treatment Phase|Decision by Sponsor|0|||
28150420|NCT01952574|54818947|FG006|Open-label Treatment Phase|Decision by Sponsor|0|||
27850260|NCT04178967|54349321|FG006|Induction Period|Lack of Efficacy|0|||
28150421|NCT01952574|54818941|FG000|Open-label Treatment Phase|Missing|0|||
28150422|NCT01952574|54818942|FG001|Open-label Treatment Phase|Missing|0|||
28150423|NCT01952574|54818943|FG002|Open-label Treatment Phase|Missing|0|||
28150424|NCT01952574|54818944|FG003|Open-label Treatment Phase|Missing|0|||
28150425|NCT01952574|54818945|FG004|Open-label Treatment Phase|Missing|4|||
28150426|NCT01952574|54818946|FG005|Open-label Treatment Phase|Missing|0|||
28150427|NCT01952574|54818947|FG006|Open-label Treatment Phase|Missing|0|||
28150428|NCT01952574|54818941|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
28150429|NCT01952574|54818942|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
28150430|NCT01952574|54818943|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
28150431|NCT01952574|54818944|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
28150432|NCT01952574|54818945|FG004|Open-label Treatment Phase|Lost to Follow-up|19|||
28150433|NCT01952574|54818946|FG005|Open-label Treatment Phase|Lost to Follow-up|0|||
28150434|NCT01952574|54818947|FG006|Open-label Treatment Phase|Lost to Follow-up|0|||
28150435|NCT01952574|54818941|FG000|Open-label Treatment Phase|Death|0|||
28150436|NCT01952574|54818942|FG001|Open-label Treatment Phase|Death|0|||
28150437|NCT01952574|54818943|FG002|Open-label Treatment Phase|Death|0|||
28150438|NCT01952574|54818944|FG003|Open-label Treatment Phase|Death|0|||
28150439|NCT01952574|54818945|FG004|Open-label Treatment Phase|Death|1|||
28150440|NCT01952574|54818946|FG005|Open-label Treatment Phase|Death|0|||
28150441|NCT01952574|54818947|FG006|Open-label Treatment Phase|Death|0|||
28150442|NCT01952574|54818941|FG000|Clinical Home Use Substudy|Withdrawal by Subject|0|||
28150443|NCT01952574|54818942|FG001|Clinical Home Use Substudy|Withdrawal by Subject|0|||
28150444|NCT01952574|54818943|FG002|Clinical Home Use Substudy|Withdrawal by Subject|0|||
28150445|NCT01952574|54818944|FG003|Clinical Home Use Substudy|Withdrawal by Subject|0|||
28150446|NCT01952574|54818945|FG004|Clinical Home Use Substudy|Withdrawal by Subject|0|||
28150447|NCT01952574|54818946|FG005|Clinical Home Use Substudy|Withdrawal by Subject|1|||
28150448|NCT01952574|54818947|FG006|Clinical Home Use Substudy|Withdrawal by Subject|0|||
28150449|NCT01952574|54818941|FG000|Clinical Home Use Substudy|Decision by Sponsor|0|||
28150450|NCT01952574|54818942|FG001|Clinical Home Use Substudy|Decision by Sponsor|0|||
28150451|NCT01952574|54818943|FG002|Clinical Home Use Substudy|Decision by Sponsor|0|||
28150452|NCT01952574|54818944|FG003|Clinical Home Use Substudy|Decision by Sponsor|0|||
28150453|NCT01952574|54818945|FG004|Clinical Home Use Substudy|Decision by Sponsor|0|||
28150454|NCT01952574|54818946|FG005|Clinical Home Use Substudy|Decision by Sponsor|2|||
28150455|NCT01952574|54818947|FG006|Clinical Home Use Substudy|Decision by Sponsor|1|||
28150456|NCT02959437|54818976|FG000|Overall Study|Death|33|||
28150457|NCT02959437|54818977|FG001|Overall Study|Death|3|||
28150458|NCT02959437|54818978|FG002|Overall Study|Death|0|||
28150459|NCT02959437|54818979|FG003|Overall Study|Death|0|||
28150460|NCT02959437|54818976|FG000|Overall Study|Lost to Follow-up|3|||
28150461|NCT02959437|54818977|FG001|Overall Study|Lost to Follow-up|1|||
28150462|NCT02959437|54818978|FG002|Overall Study|Lost to Follow-up|0|||
28150463|NCT02959437|54818979|FG003|Overall Study|Lost to Follow-up|0|||
28150464|NCT02959437|54818976|FG000|Overall Study|Withdrawal by Subject|11|||
28150465|NCT02959437|54818977|FG001|Overall Study|Withdrawal by Subject|3|||
28150466|NCT02959437|54818978|FG002|Overall Study|Withdrawal by Subject|0|||
28150467|NCT02959437|54818979|FG003|Overall Study|Withdrawal by Subject|0|||
28150468|NCT02959437|54818976|FG000|Overall Study|Progressive Disease|9|||
28150469|NCT02959437|54818977|FG001|Overall Study|Progressive Disease|1|||
28150470|NCT02959437|54818978|FG002|Overall Study|Progressive Disease|0|||
28150471|NCT02959437|54818979|FG003|Overall Study|Progressive Disease|0|||
28150472|NCT02959437|54818976|FG000|Overall Study|Study Terminated by Sponsor|4|||
28150473|NCT02959437|54818977|FG001|Overall Study|Study Terminated by Sponsor|0|||
28150474|NCT02959437|54818978|FG002|Overall Study|Study Terminated by Sponsor|0|||
28150475|NCT02959437|54818979|FG003|Overall Study|Study Terminated by Sponsor|0|||
28150476|NCT02959437|54818976|FG000|Overall Study|Other Unspecified|2|||
28150477|NCT02959437|54818977|FG001|Overall Study|Other Unspecified|0|||
28150478|NCT02959437|54818978|FG002|Overall Study|Other Unspecified|0|||
28150479|NCT02959437|54818979|FG003|Overall Study|Other Unspecified|0|||
28150480|NCT02957331|54818992|FG000|Overall Study|Protocol Violation|1|||
28150481|NCT02957331|54818993|FG001|Overall Study|Protocol Violation|0|||
28150482|NCT05212883|54818999|FG000|Overall Study|Invalid test result|125|||
28150483|NCT04995055|54819007|FG000|Period 1|COVID-19 Related|1|||
28150484|NCT04995055|54819008|FG001|Period 1|COVID-19 Related|0|||
28150485|NCT04995055|54819007|FG000|Period 1|Withdrawal by Subject|0|||
28150486|NCT04995055|54819008|FG001|Period 1|Withdrawal by Subject|1|||
28150487|NCT04995055|54819007|FG000|Period 1|Subject discontinued due to timing|4|||
28150488|NCT04995055|54819008|FG001|Period 1|Subject discontinued due to timing|4|||
28150489|NCT04778592|54819016|FG000|Overall Study|Adverse Event|1|||
28073112|NCT03759340|54727733|FG000|Overall Study|Withdrawal by Subject|15|||
28073113|NCT03759340|54727733|FG000|Overall Study|Study Terminated by Sponsor|38|||
28073114|NCT00224016|54727739|FG000|Titration Period|Withdrawal by Subject|0|||
28073115|NCT00224016|54727740|FG001|Titration Period|Withdrawal by Subject|1|||
28073116|NCT00224016|54727739|FG000|Titration Period|Lost to Follow-up|1|||
28073117|NCT00224016|54727740|FG001|Titration Period|Lost to Follow-up|0|||
28073118|NCT00224016|54727739|FG000|Maintenance Period|Withdrawal by Subject|2|||
28073119|NCT00224016|54727740|FG001|Maintenance Period|Withdrawal by Subject|0|||
28073120|NCT00224016|54727739|FG000|Maintenance Period|Lost to Follow-up|0|||
28073121|NCT00224016|54727740|FG001|Maintenance Period|Lost to Follow-up|1|||
28150490|NCT04778592|54819017|FG001|Overall Study|Adverse Event|2|||
28150491|NCT04778592|54819016|FG000|Overall Study|Withdrawal by Subject|1|||
28150492|NCT04778592|54819017|FG001|Overall Study|Withdrawal by Subject|2|||
28150493|NCT04743635|54819025|FG000|Overall Study|Lost to Follow-up|2|||
28150494|NCT04743635|54819026|FG001|Overall Study|Lost to Follow-up|0|||
28150495|NCT04712110|54819033|FG000|Overall Study|Lost to Follow-up|0|||
28150496|NCT04712110|54819034|FG001|Overall Study|Lost to Follow-up|1|||
28150497|NCT04712110|54819033|FG000|Overall Study|Withdrawal by Subject|0|||
28150498|NCT04712110|54819034|FG001|Overall Study|Withdrawal by Subject|4|||
28150499|NCT04712110|54819033|FG000|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|46|||
28150500|NCT04712110|54819034|FG001|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|14|||
28150501|NCT04476017|54819042|FG000|Part A (28 Days)|Withdrawal by Subject|1|||
28073122|NCT03757234|54727751|FG000|Overall Study|Adverse Event|0|||
28073123|NCT03757234|54727752|FG001|Overall Study|Adverse Event|0|||
28150502|NCT04476017|54819043|FG001|Part A (28 Days)|Withdrawal by Subject|0|||
27941799|NCT01214603|54598364|FG002|Overall Study|Progressive Disease|3|||
28150503|NCT04143594|54819058|FG000|Overall Study|Still on study|48|||
28150504|NCT04143594|54819059|FG001|Overall Study|Still on study|42|||
28150505|NCT04143594|54819060|FG002|Overall Study|Still on study|48|||
28150506|NCT04143594|54819061|FG003|Overall Study|Still on study|18|||
28150507|NCT04143594|54819058|FG000|Overall Study|Withdrew consent|0|||
28150508|NCT04143594|54819059|FG001|Overall Study|Withdrew consent|6|||
28150509|NCT04143594|54819060|FG002|Overall Study|Withdrew consent|1|||
28150510|NCT04143594|54819061|FG003|Overall Study|Withdrew consent|1|||
28150511|NCT04143594|54819058|FG000|Overall Study|Lost to Follow-up|2|||
28150512|NCT04143594|54819059|FG001|Overall Study|Lost to Follow-up|2|||
28150513|NCT04143594|54819060|FG002|Overall Study|Lost to Follow-up|3|||
28150514|NCT04143594|54819061|FG003|Overall Study|Lost to Follow-up|0|||
28150515|NCT04143594|54819058|FG000|Overall Study|Investigator's discretion|1|||
28150516|NCT04143594|54819059|FG001|Overall Study|Investigator's discretion|2|||
28150517|NCT04143594|54819060|FG002|Overall Study|Investigator's discretion|0|||
28150518|NCT04143594|54819061|FG003|Overall Study|Investigator's discretion|0|||
28150519|NCT04143594|54819058|FG000|Overall Study|Lack of Efficacy|0|||
28150520|NCT04143594|54819059|FG001|Overall Study|Lack of Efficacy|1|||
28150521|NCT04143594|54819060|FG002|Overall Study|Lack of Efficacy|0|||
28150522|NCT04143594|54819061|FG003|Overall Study|Lack of Efficacy|0|||
28150523|NCT04143594|54819058|FG000|Overall Study|Protocol Violation|0|||
28150524|NCT04143594|54819059|FG001|Overall Study|Protocol Violation|0|||
28150525|NCT04143594|54819060|FG002|Overall Study|Protocol Violation|0|||
28150526|NCT04143594|54819061|FG003|Overall Study|Protocol Violation|1|||
28150527|NCT03877510|54819074|FG000|Overall Study|Death|6|||
28150528|NCT03877510|54819074|FG000|Overall Study|Lost to Follow-up|2|||
28150529|NCT03877510|54819074|FG000|Overall Study|Non-compliance with study drug|2|||
28073124|NCT03757234|54727753|FG002|Overall Study|Adverse Event|0|||
28073125|NCT03757234|54727754|FG003|Overall Study|Adverse Event|0|||
28073126|NCT03757234|54727755|FG004|Overall Study|Adverse Event|1|||
28073127|NCT03757234|54727751|FG000|Overall Study|Lost to Follow-up|1|||
28073128|NCT03757234|54727752|FG001|Overall Study|Lost to Follow-up|0|||
28073129|NCT03757234|54727753|FG002|Overall Study|Lost to Follow-up|0|||
28073130|NCT03757234|54727754|FG003|Overall Study|Lost to Follow-up|0|||
28073131|NCT03757234|54727755|FG004|Overall Study|Lost to Follow-up|1|||
28073132|NCT03757234|54727751|FG000|Overall Study|Withdrawal by Subject|1|||
28073133|NCT03757234|54727752|FG001|Overall Study|Withdrawal by Subject|1|||
28073134|NCT03757234|54727753|FG002|Overall Study|Withdrawal by Subject|0|||
28073135|NCT03757234|54727754|FG003|Overall Study|Withdrawal by Subject|1|||
28073136|NCT03757234|54727755|FG004|Overall Study|Withdrawal by Subject|2|||
28073137|NCT03757234|54727751|FG000|Overall Study|Other|1|||
28073138|NCT03757234|54727752|FG001|Overall Study|Other|1|||
28073139|NCT03757234|54727753|FG002|Overall Study|Other|0|||
28073140|NCT03757234|54727754|FG003|Overall Study|Other|0|||
28073141|NCT03757234|54727755|FG004|Overall Study|Other|0|||
28073142|NCT00223080|54727769|FG000|Overall Study|Withdrawal by Subject|253|||
28073143|NCT00223080|54727770|FG001|Overall Study|Withdrawal by Subject|232|||
28073144|NCT00223080|54727769|FG000|Overall Study|Required contraindicated med|0|||
28073145|NCT00223080|54727770|FG001|Overall Study|Required contraindicated med|1|||
28073146|NCT00223080|54727769|FG000|Overall Study|Non-compliant|7|||
28073147|NCT00223080|54727770|FG001|Overall Study|Non-compliant|7|||
28073148|NCT00223080|54727769|FG000|Overall Study|Moved from study area|37|||
28073149|NCT00223080|54727770|FG001|Overall Study|Moved from study area|47|||
28073150|NCT00223080|54727769|FG000|Overall Study|Lost to Follow-up|259|||
28073151|NCT00223080|54727770|FG001|Overall Study|Lost to Follow-up|284|||
28073152|NCT00223080|54727769|FG000|Overall Study|Death|85|||
28073153|NCT00223080|54727770|FG001|Overall Study|Death|74|||
28073154|NCT00223080|54727769|FG000|Overall Study|Other|14|||
28073155|NCT00223080|54727770|FG001|Overall Study|Other|11|||
28073156|NCT00223080|54727769|FG000|Overall Study|Reason not provided|141|||
28073157|NCT00223080|54727770|FG001|Overall Study|Reason not provided|140|||
28073158|NCT00223080|54727769|FG000|Overall Study|Adverse Event|0|||
28073159|NCT00223080|54727770|FG001|Overall Study|Adverse Event|1|||
28073160|NCT00220740|54727778|FG000|Efficacy Period|Entered rescue treatment with placebo|23|||
28073161|NCT00220740|54727779|FG001|Efficacy Period|Entered rescue treatment with placebo|0|||
28073162|NCT00220740|54727778|FG000|Efficacy Period|Adverse Event|1|||
28073163|NCT00220740|54727779|FG001|Efficacy Period|Adverse Event|1|||
28073164|NCT00220740|54727778|FG000|Efficacy Period|Withdrawal by Subject|1|||
28150530|NCT03877510|54819074|FG000|Overall Study|Lack of Efficacy|14|||
28150531|NCT03877510|54819074|FG000|Overall Study|Adverse Event|20|||
28150532|NCT03877510|54819074|FG000|Overall Study|Withdrawal by Subject|22|||
28073165|NCT00220740|54727779|FG001|Efficacy Period|Withdrawal by Subject|0|||
28073166|NCT00220740|54727778|FG000|Efficacy Period|Protocol Violation|1|||
28150533|NCT03877510|54819074|FG000|Overall Study|Miscellaneous|1|||
28150534|NCT03846427|54819078|FG000|Overall Study|Death|13|||
28150535|NCT03846427|54819078|FG000|Overall Study|Withdrawal by Subject|3|||
28073167|NCT00220740|54727779|FG001|Efficacy Period|Protocol Violation|0|||
28073168|NCT00220740|54727778|FG000|Efficacy Period|Entered Rescue Treatment with IGIV-C|0|||
28073169|NCT00220740|54727779|FG001|Efficacy Period|Entered Rescue Treatment with IGIV-C|45|||
28073170|NCT00184002|54727787|FG000|Overall Study|Adverse Event|9|||
27822833|NCT04146363|54286915|FG006|Induction Period|Positive quantiferon test|0|||
27822834|NCT04146363|54286916|FG007|Induction Period|Positive quantiferon test|0|||
28073171|NCT00184002|54727787|FG000|Overall Study|Death|3|||
28073172|NCT00184002|54727787|FG000|Overall Study|Physician Decision|1|||
28073173|NCT00184002|54727787|FG000|Overall Study|Withdrawal by Subject|4|||
28073174|NCT00165672|54727793|FG000|Overall Study|Adverse Event|0|||
28073175|NCT00165672|54727794|FG001|Overall Study|Adverse Event|1|||
28073176|NCT00180414|54727802|FG000|Overall Study|Study cancellation due to lack of overall enrollments|4|||
28073177|NCT00180414|54727803|FG001|Overall Study|Study cancellation due to lack of overall enrollments|4|||
28073178|NCT00174252|54727809|FG000|Overall Study|Protocol Violation|2|||
28150536|NCT03846427|54819078|FG000|Overall Study|Physician Decision|1|||
28150537|NCT03706079|54819107|FG000|Predecessor Study|Death|0|||
28150538|NCT03706079|54819108|FG001|Predecessor Study|Death|2|||
28150539|NCT03706079|54819109|FG002|Predecessor Study|Death|0|||
28150540|NCT03706079|54819110|FG003|Predecessor Study|Death|1|||
28150541|NCT03706079|54819111|FG004|Predecessor Study|Death|0|||
28150542|NCT03706079|54819112|FG005|Predecessor Study|Death|0|||
28150543|NCT03706079|54819107|FG000|Predecessor Study|Lost to Follow-up|5|||
28150544|NCT03706079|54819108|FG001|Predecessor Study|Lost to Follow-up|2|||
28150545|NCT03706079|54819109|FG002|Predecessor Study|Lost to Follow-up|0|||
28150546|NCT03706079|54819110|FG003|Predecessor Study|Lost to Follow-up|0|||
28073179|NCT00169104|54727817|FG000|Overall Study|Withdrawal by Subject|2|||
28150547|NCT03706079|54819111|FG004|Predecessor Study|Lost to Follow-up|1|||
28150548|NCT03706079|54819112|FG005|Predecessor Study|Lost to Follow-up|0|||
28150549|NCT03706079|54819107|FG000|Predecessor Study|Withdrawal by Subject|8|||
28150550|NCT03706079|54819108|FG001|Predecessor Study|Withdrawal by Subject|15|||
28150551|NCT03706079|54819109|FG002|Predecessor Study|Withdrawal by Subject|0|||
28150552|NCT03706079|54819110|FG003|Predecessor Study|Withdrawal by Subject|5|||
28150553|NCT03706079|54819111|FG004|Predecessor Study|Withdrawal by Subject|2|||
28150554|NCT03706079|54819112|FG005|Predecessor Study|Withdrawal by Subject|0|||
28150555|NCT03706079|54819107|FG000|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
28150556|NCT03706079|54819108|FG001|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
28150557|NCT03706079|54819109|FG002|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
28150558|NCT03706079|54819110|FG003|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
28150559|NCT03706079|54819111|FG004|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
28150560|NCT03706079|54819112|FG005|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
28150561|NCT03706079|54819107|FG000|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
28150562|NCT03706079|54819108|FG001|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
27850261|NCT04178967|54349322|FG007|Induction Period|Lack of Efficacy|0|||
27822835|NCT04146363|54286917|FG008|Induction Period|Positive quantiferon test|0|||
27822836|NCT04146363|54286918|FG009|Induction Period|Positive quantiferon test|0|||
27822837|NCT04146363|54286919|FG010|Induction Period|Positive quantiferon test|0|||
27822838|NCT04146363|54286909|FG000|Induction Period|Protocol Deviation|5|||
27822839|NCT04146363|54286910|FG001|Induction Period|Protocol Deviation|6|||
28150563|NCT03706079|54819109|FG002|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
28150564|NCT03706079|54819110|FG003|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
28150565|NCT03706079|54819111|FG004|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
28150566|NCT03706079|54819112|FG005|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|1|||
28150567|NCT03706079|54819107|FG000|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|1|||
28150568|NCT03706079|54819108|FG001|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
27822840|NCT04146363|54286911|FG002|Induction Period|Protocol Deviation|0|||
28150569|NCT03706079|54819109|FG002|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|2|||
28150570|NCT03706079|54819110|FG003|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
28150571|NCT03706079|54819111|FG004|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
28150572|NCT03706079|54819112|FG005|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
28150573|NCT03706079|54819107|FG000|Long Term Extension (DESTINATION)|Pregnancy|1|||
28150574|NCT03706079|54819108|FG001|Long Term Extension (DESTINATION)|Pregnancy|0|||
28150575|NCT03706079|54819109|FG002|Long Term Extension (DESTINATION)|Pregnancy|0|||
28150576|NCT03706079|54819110|FG003|Long Term Extension (DESTINATION)|Pregnancy|0|||
28150577|NCT03706079|54819111|FG004|Long Term Extension (DESTINATION)|Pregnancy|0|||
28150578|NCT03706079|54819112|FG005|Long Term Extension (DESTINATION)|Pregnancy|0|||
28150579|NCT03706079|54819107|FG000|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
28150580|NCT03706079|54819108|FG001|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
28150581|NCT03706079|54819109|FG002|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
28150582|NCT03706079|54819110|FG003|Long Term Extension (DESTINATION)|Withdrawal by Subject|1|||
28150583|NCT03706079|54819111|FG004|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
28150584|NCT03706079|54819112|FG005|Long Term Extension (DESTINATION)|Withdrawal by Subject|0|||
28150585|NCT03706079|54819107|FG000|Long Term Extension (DESTINATION)|Lost to Follow-up|2|||
28150586|NCT03706079|54819108|FG001|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
28150587|NCT03706079|54819109|FG002|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
28150588|NCT03706079|54819110|FG003|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
28150589|NCT03706079|54819111|FG004|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
28150590|NCT03706079|54819112|FG005|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
28150591|NCT03706079|54819107|FG000|Long Term Extension (DESTINATION)|Death|8|||
28150592|NCT03706079|54819108|FG001|Long Term Extension (DESTINATION)|Death|2|||
28150593|NCT03706079|54819109|FG002|Long Term Extension (DESTINATION)|Death|2|||
28150594|NCT03706079|54819110|FG003|Long Term Extension (DESTINATION)|Death|1|||
28150595|NCT03706079|54819111|FG004|Long Term Extension (DESTINATION)|Death|0|||
28150596|NCT03706079|54819112|FG005|Long Term Extension (DESTINATION)|Death|0|||
28150597|NCT03657160|54819126|FG000|Overall Study|Adverse Event|5|||
28150598|NCT03657160|54819127|FG001|Overall Study|Adverse Event|6|||
28150599|NCT03657160|54819126|FG000|Overall Study|Protocol Deviation|3|||
28150600|NCT03657160|54819127|FG001|Overall Study|Protocol Deviation|0|||
28150601|NCT03657160|54819126|FG000|Overall Study|Withdrawal by Subject|18|||
28150602|NCT03657160|54819127|FG001|Overall Study|Withdrawal by Subject|16|||
28150603|NCT03657160|54819126|FG000|Overall Study|Site Termination|1|||
28150604|NCT03657160|54819127|FG001|Overall Study|Site Termination|0|||
28150605|NCT03657160|54819126|FG000|Overall Study|Unsatisfactory Therapeutic Response|5|||
28150606|NCT03657160|54819127|FG001|Overall Study|Unsatisfactory Therapeutic Response|3|||
28150607|NCT03657160|54819126|FG000|Overall Study|Death|33|||
28150608|NCT03657160|54819127|FG001|Overall Study|Death|26|||
28150609|NCT03657160|54819126|FG000|Overall Study|Death (COVID-19-Related)|1|||
28150610|NCT03657160|54819127|FG001|Overall Study|Death (COVID-19-Related)|0|||
28150611|NCT03657160|54819126|FG000|Overall Study|Reason Not Specified|5|||
28150612|NCT03657160|54819127|FG001|Overall Study|Reason Not Specified|5|||
28150613|NCT03657160|54819126|FG000|Overall Study|Other (COVID-19-Related)|0|||
28150614|NCT03657160|54819127|FG001|Overall Study|Other (COVID-19-Related)|1|||
28150615|NCT03635320|54819137|FG000|Overall Study|not implanted the device|1|||
28150616|NCT03635320|54819138|FG001|Overall Study|not implanted the device|2|||
28150617|NCT03635320|54819137|FG000|Overall Study|Withdrawal by Subject|11|||
28150618|NCT03635320|54819138|FG001|Overall Study|Withdrawal by Subject|6|||
28150619|NCT03508726|54819155|FG000|Overall Study|Withdrawal by Subject|0|||
28150620|NCT03508726|54819156|FG001|Overall Study|Withdrawal by Subject|1|||
28150621|NCT03499964|54819165|FG000|Overall Study|Lack of Efficacy|6|||
28150622|NCT03499964|54819166|FG001|Overall Study|Lack of Efficacy|26|||
28150623|NCT03499964|54819165|FG000|Overall Study|Adverse Event|1|||
28150624|NCT03499964|54819166|FG001|Overall Study|Adverse Event|0|||
28150625|NCT03499964|54819165|FG000|Overall Study|Death|1|||
28150626|NCT03499964|54819166|FG001|Overall Study|Death|0|||
27822841|NCT04146363|54286912|FG003|Induction Period|Protocol Deviation|0|||
27822842|NCT04146363|54286913|FG004|Induction Period|Protocol Deviation|0|||
27822843|NCT04146363|54286914|FG005|Induction Period|Protocol Deviation|0|||
27822844|NCT04146363|54286915|FG006|Induction Period|Protocol Deviation|0|||
27822845|NCT04146363|54286916|FG007|Induction Period|Protocol Deviation|0|||
27822846|NCT04146363|54286917|FG008|Induction Period|Protocol Deviation|0|||
27822847|NCT04146363|54286918|FG009|Induction Period|Protocol Deviation|0|||
28073180|NCT00169104|54727818|FG001|Overall Study|Withdrawal by Subject|0|||
28073181|NCT00169104|54727817|FG000|Overall Study|Protocol Violation|0|||
28073182|NCT00169104|54727818|FG001|Overall Study|Protocol Violation|1|||
28073183|NCT00169104|54727817|FG000|Overall Study|Physician Decision|0|||
28073184|NCT00169104|54727818|FG001|Overall Study|Physician Decision|1|||
28073185|NCT00163020|54727827|FG000|Overall Study|Lost to Follow-up|0|||
28073186|NCT00163020|54727828|FG001|Overall Study|Lost to Follow-up|2|||
28073187|NCT00252720|54727838|FG000|Overall Study|Withdrawal by Subject|95|||
28073188|NCT00252720|54727839|FG001|Overall Study|Withdrawal by Subject|97|||
28073189|NCT00252720|54727838|FG000|Overall Study|Death|7|||
28073190|NCT00252720|54727839|FG001|Overall Study|Death|8|||
28073191|NCT00252720|54727838|FG000|Overall Study|Moving|23|||
28073192|NCT00252720|54727839|FG001|Overall Study|Moving|42|||
28073193|NCT00252720|54727838|FG000|Overall Study|Mainly patients lost to follow-up|7|||
28073194|NCT00252720|54727839|FG001|Overall Study|Mainly patients lost to follow-up|18|||
28073195|NCT00167778|54727845|FG000|Overall Study|Withdrawal by Subject|1|||
28073196|NCT00167310|54727852|FG000|Overall Study|Protocol Violation|5|||
28073197|NCT00167310|54727853|FG001|Overall Study|Protocol Violation|3|||
28073198|NCT00167310|54727852|FG000|Overall Study|Withdrawal by Subject|3|||
28073199|NCT00167310|54727853|FG001|Overall Study|Withdrawal by Subject|7|||
28150627|NCT03499964|54819165|FG000|Overall Study|Withdrawal by Subject|2|||
28150628|NCT03499964|54819166|FG001|Overall Study|Withdrawal by Subject|1|||
28150629|NCT03499964|54819165|FG000|Overall Study|Lost to Follow-up|1|||
28150630|NCT03499964|54819166|FG001|Overall Study|Lost to Follow-up|0|||
28150631|NCT03345784|54819174|FG000|Overall Study|Withdrawal by Subject|2|||
28150632|NCT03345784|54819175|FG001|Overall Study|Withdrawal by Subject|1|||
28150633|NCT03279692|54819181|FG000|Overall Study|Withdrawal by Subject|1|||
28150634|NCT03001882|54819198|FG000|Overall Study|Death|1|||
28150635|NCT03001882|54819199|FG001|Overall Study|Death|0|||
28150636|NCT03001882|54819200|FG002|Overall Study|Death|0|||
28150637|NCT03001882|54819201|FG003|Overall Study|Death|3|||
28150638|NCT03001882|54819198|FG000|Overall Study|Participant withdrew consent|0|||
28150639|NCT03001882|54819199|FG001|Overall Study|Participant withdrew consent|1|||
28150640|NCT03001882|54819200|FG002|Overall Study|Participant withdrew consent|0|||
28150641|NCT03001882|54819201|FG003|Overall Study|Participant withdrew consent|5|||
28150642|NCT03001882|54819198|FG000|Overall Study|Other reasons|1|||
28150643|NCT03001882|54819199|FG001|Overall Study|Other reasons|2|||
28150644|NCT03001882|54819200|FG002|Overall Study|Other reasons|0|||
28150645|NCT03001882|54819201|FG003|Overall Study|Other reasons|5|||
28150646|NCT03001882|54819198|FG000|Overall Study|Administrative reason by sponsor|0|||
28150647|NCT03001882|54819199|FG001|Overall Study|Administrative reason by sponsor|0|||
28150648|NCT03001882|54819200|FG002|Overall Study|Administrative reason by sponsor|0|||
28150649|NCT03001882|54819201|FG003|Overall Study|Administrative reason by sponsor|1|||
28150650|NCT03001882|54819198|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
28150651|NCT03001882|54819199|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
28150652|NCT03001882|54819200|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
28150653|NCT03001882|54819201|FG003|Overall Study|Participant requested to discontinue study treatment|2|||
28150654|NCT03001882|54819198|FG000|Overall Study|Not reported|0|||
28150655|NCT03001882|54819199|FG001|Overall Study|Not reported|0|||
28150656|NCT03001882|54819200|FG002|Overall Study|Not reported|0|||
28150657|NCT03001882|54819201|FG003|Overall Study|Not reported|6|||
28150658|NCT03001882|54819198|FG000|Overall Study|Maximum clinical benefit|1|||
28150659|NCT03001882|54819199|FG001|Overall Study|Maximum clinical benefit|2|||
28150660|NCT03001882|54819200|FG002|Overall Study|Maximum clinical benefit|0|||
28150661|NCT03001882|54819201|FG003|Overall Study|Maximum clinical benefit|10|||
28150662|NCT03001882|54819198|FG000|Overall Study|AE unrelated to study drug|3|||
28150663|NCT03001882|54819199|FG001|Overall Study|AE unrelated to study drug|3|||
28150664|NCT03001882|54819200|FG002|Overall Study|AE unrelated to study drug|0|||
28150665|NCT03001882|54819201|FG003|Overall Study|AE unrelated to study drug|11|||
28150666|NCT03001882|54819198|FG000|Overall Study|Study Drug Toxicity|8|||
28150667|NCT03001882|54819199|FG001|Overall Study|Study Drug Toxicity|5|||
28150668|NCT03001882|54819200|FG002|Overall Study|Study Drug Toxicity|0|||
28150669|NCT03001882|54819201|FG003|Overall Study|Study Drug Toxicity|37|||
28150670|NCT03001882|54819198|FG000|Overall Study|Disease progression|15|||
27822848|NCT04146363|54286919|FG010|Induction Period|Protocol Deviation|0|||
27822849|NCT04146363|54286909|FG000|Induction Period|Withdrawal by Subject|6|||
28073200|NCT03754582|54727859|FG000|Treatment Phase|Adverse Event|0|||
28073201|NCT03754582|54727860|FG001|Treatment Phase|Adverse Event|1|||
28073202|NCT03754582|54727861|FG002|Treatment Phase|Adverse Event|0|||
28073203|NCT03754582|54727859|FG000|Follow-up Phase|Other|0|||
28150671|NCT03001882|54819199|FG001|Overall Study|Disease progression|14|||
28150672|NCT03001882|54819200|FG002|Overall Study|Disease progression|2|||
28150673|NCT03001882|54819201|FG003|Overall Study|Disease progression|90|||
28150674|NCT02985151|54819218|FG000|Original Randomization|Withdrawal by Subject|0|||
28150675|NCT02985151|54819219|FG001|Original Randomization|Withdrawal by Subject|1|||
28150676|NCT02603432|54819291|FG000|Overall Study|Ongoing|184|||
28150677|NCT02603432|54819292|FG001|Overall Study|Ongoing|144|||
28150678|NCT02603432|54819291|FG000|Overall Study|Adverse Event|1|||
28150679|NCT02603432|54819292|FG001|Overall Study|Adverse Event|0|||
28150680|NCT02603432|54819291|FG000|Overall Study|Death|144|||
28150681|NCT02603432|54819292|FG001|Overall Study|Death|177|||
28150682|NCT02603432|54819291|FG000|Overall Study|Lost to Follow-up|4|||
28150683|NCT02603432|54819292|FG001|Overall Study|Lost to Follow-up|6|||
28150684|NCT02603432|54819291|FG000|Overall Study|Progressive Disease|5|||
28150685|NCT02603432|54819292|FG001|Overall Study|Progressive Disease|5|||
28150686|NCT02603432|54819291|FG000|Overall Study|Withdrawal by Subject|9|||
28150687|NCT02603432|54819292|FG001|Overall Study|Withdrawal by Subject|17|||
28150688|NCT02603432|54819291|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
28150689|NCT02603432|54819292|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
28150690|NCT02603432|54819291|FG000|Overall Study|Other|0|||
28150691|NCT02603432|54819292|FG001|Overall Study|Other|1|||
28150692|NCT02582866|54819298|FG000|Overall Study|Death|1|||
28150693|NCT02582866|54819298|FG000|Overall Study|Lack of Efficacy|2|||
28150694|NCT02582866|54819298|FG000|Overall Study|Lost to Follow-up|2|||
28150695|NCT02582866|54819298|FG000|Overall Study|Withdrawal by Subject|7|||
28150696|NCT02582866|54819298|FG000|Overall Study|Investigator decision|5|||
27822850|NCT04146363|54286910|FG001|Induction Period|Withdrawal by Subject|3|||
27822851|NCT04146363|54286911|FG002|Induction Period|Withdrawal by Subject|0|||
28073204|NCT03754582|54727860|FG001|Follow-up Phase|Other|0|||
28073205|NCT03754582|54727861|FG002|Follow-up Phase|Other|1|||
28073206|NCT00161616|54727879|FG000|Overall Study|Withdrawal by Subject|6|||
28073207|NCT00161616|54727880|FG001|Overall Study|Withdrawal by Subject|5|||
28073208|NCT00161616|54727879|FG000|Overall Study|Physician Decision|1|||
28073209|NCT00161616|54727880|FG001|Overall Study|Physician Decision|0|||
28073210|NCT00161616|54727879|FG000|Overall Study|Death|1|||
28073211|NCT00161616|54727880|FG001|Overall Study|Death|1|||
28073212|NCT00161616|54727879|FG000|Overall Study|Lost to Follow-up|17|||
28073213|NCT00161616|54727880|FG001|Overall Study|Lost to Follow-up|13|||
28073214|NCT00161616|54727879|FG000|Overall Study|Protocol deviation|1|||
28073215|NCT00161616|54727880|FG001|Overall Study|Protocol deviation|0|||
28073216|NCT00252564|54727888|FG000|Overall Study|Adverse Event|17|||
28073217|NCT00252564|54727889|FG001|Overall Study|Adverse Event|13|||
28150697|NCT02582866|54819298|FG000|Overall Study|Participant wants to get pregnant|1|||
28150698|NCT02582866|54819298|FG000|Overall Study|Pregnancy|2|||
28150699|NCT02582866|54819298|FG000|Overall Study|Sponsor decision|1|||
28150700|NCT02582866|54819298|FG000|Overall Study|Withdrawal due to personal reasons|1|||
28150701|NCT02395666|54819304|FG000|Overall Study|Physician Decision|3|||
28150702|NCT02395666|54819305|FG001|Overall Study|Physician Decision|0|||
28150703|NCT02395666|54819304|FG000|Overall Study|Lost to Follow-up|1|||
28150704|NCT02395666|54819305|FG001|Overall Study|Lost to Follow-up|0|||
28150705|NCT02395666|54819304|FG000|Overall Study|Withdrawal by Subject|2|||
28150706|NCT02395666|54819305|FG001|Overall Study|Withdrawal by Subject|1|||
28150707|NCT02180867|54819322|FG000|Overall Study|Adverse Event|3|||
28150708|NCT02180867|54819323|FG001|Overall Study|Adverse Event|4|||
28150709|NCT02180867|54819324|FG002|Overall Study|Adverse Event|1|||
28150710|NCT02180867|54819325|FG003|Overall Study|Adverse Event|5|||
28150711|NCT02180867|54819326|FG004|Overall Study|Adverse Event|0|||
28150712|NCT02180867|54819327|FG005|Overall Study|Adverse Event|0|||
28150713|NCT02180867|54819328|FG006|Overall Study|Adverse Event|0|||
28150714|NCT02180867|54819322|FG000|Overall Study|Death|0|||
28150715|NCT02180867|54819323|FG001|Overall Study|Death|0|||
28150716|NCT02180867|54819324|FG002|Overall Study|Death|0|||
28150717|NCT02180867|54819325|FG003|Overall Study|Death|0|||
28150718|NCT02180867|54819326|FG004|Overall Study|Death|1|||
28150719|NCT02180867|54819327|FG005|Overall Study|Death|0|||
28073218|NCT00252564|54727888|FG000|Overall Study|Unrelated Complication|2|||
28073219|NCT00252564|54727889|FG001|Overall Study|Unrelated Complication|1|||
28073220|NCT00252564|54727888|FG000|Overall Study|Disease Progression|14|||
28073221|NCT00252564|54727889|FG001|Overall Study|Disease Progression|20|||
28073222|NCT00252564|54727888|FG000|Overall Study|Death|0|||
28073223|NCT00252564|54727889|FG001|Overall Study|Death|3|||
28073224|NCT00252564|54727888|FG000|Overall Study|Physician Decision|1|||
28073225|NCT00252564|54727889|FG001|Overall Study|Physician Decision|0|||
28073226|NCT00252564|54727888|FG000|Overall Study|Lost to Follow-up|1|||
28073227|NCT00252564|54727889|FG001|Overall Study|Lost to Follow-up|0|||
28073228|NCT00252564|54727888|FG000|Overall Study|Patient Request|4|||
28073229|NCT00252564|54727889|FG001|Overall Study|Patient Request|5|||
28073230|NCT00252564|54727888|FG000|Overall Study|Withdrawal by Subject|0|||
28073231|NCT00252564|54727889|FG001|Overall Study|Withdrawal by Subject|2|||
28073232|NCT00166296|54727897|FG000|Overall Study|Withdrawal by Subject|1|||
28073233|NCT00166296|54727898|FG001|Overall Study|Withdrawal by Subject|3|||
28073234|NCT00166296|54727897|FG000|Overall Study|Adverse Event|2|||
28073235|NCT00166296|54727898|FG001|Overall Study|Adverse Event|4|||
28073236|NCT00166296|54727897|FG000|Overall Study|Lost to Follow-up|4|||
28073237|NCT00166296|54727898|FG001|Overall Study|Lost to Follow-up|2|||
28073238|NCT00252174|54727907|FG000|Overall Study|Withdrawal by Subject|0|||
28073239|NCT00252174|54727908|FG001|Overall Study|Withdrawal by Subject|1|||
28073240|NCT00252174|54727909|FG002|Overall Study|Withdrawal by Subject|0|||
28073241|NCT00165984|54727917|FG000|Overall Study|Death|15|||
28073242|NCT00160680|54727926|FG000|Overall Study|Adverse Event|0|||
28073243|NCT00160680|54727927|FG001|Overall Study|Adverse Event|1|||
28073244|NCT00160680|54727926|FG000|Overall Study|Lack of Efficacy|2|||
28073245|NCT00160680|54727927|FG001|Overall Study|Lack of Efficacy|1|||
28073246|NCT00160680|54727926|FG000|Overall Study|Lost to Follow-up|3|||
28073247|NCT00160680|54727927|FG001|Overall Study|Lost to Follow-up|2|||
28073248|NCT00160680|54727926|FG000|Overall Study|Withdrawal by Subject|4|||
28073249|NCT00160680|54727927|FG001|Overall Study|Withdrawal by Subject|9|||
28073250|NCT00160524|54727933|FG000|Overall Study|Adverse Event|119|||
28073251|NCT00160524|54727933|FG000|Overall Study|Adverse Event and Other|94|||
28073252|NCT00160524|54727933|FG000|Overall Study|Protocol Violation|16|||
28073253|NCT00160524|54727933|FG000|Overall Study|Protocol Violation and Other|2|||
28073254|NCT00160524|54727933|FG000|Overall Study|Withdrawal by Subject|141|||
28073255|NCT00160524|54727933|FG000|Overall Study|Withdrawal by Subject and Other|17|||
28073256|NCT00160524|54727933|FG000|Overall Study|Physician Decision|27|||
28073257|NCT00160524|54727933|FG000|Overall Study|Physician Decision and Other|6|||
28073258|NCT00160524|54727933|FG000|Overall Study|Lost to Follow-up|13|||
28073259|NCT00160524|54727933|FG000|Overall Study|Lost to Follow-up and Other|1|||
28073260|NCT00160524|54727933|FG000|Overall Study|Lack of Efficacy|21|||
28073261|NCT00160524|54727933|FG000|Overall Study|Lack of Efficacy and Other|1|||
28073262|NCT00160524|54727933|FG000|Overall Study|Other|20|||
28073263|NCT00159822|54727937|FG000|Voriconazole Treatment Period|Lack of Efficacy|3|||
28073264|NCT00159822|54727937|FG000|Voriconazole Treatment Period|Adverse Event|9|||
28073265|NCT00159822|54727937|FG000|Voriconazole Treatment Period|Death|4|||
28073266|NCT00159822|54727937|FG000|Voriconazole Treatment Period|Protocol Violation|2|||
28073267|NCT00159822|54727937|FG000|Voriconazole Treatment Period|Lost to Follow-up|2|||
28073268|NCT00159822|54727937|FG000|Voriconazole Treatment Period|Withdrawal by Subject|2|||
28073269|NCT00159822|54727937|FG000|Post-treatment Follow-up Period|Death|1|||
28073270|NCT00159822|54727937|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|1|||
28073271|NCT00159822|54727937|FG000|Post-treatment Follow-up Period|Reason unspecified|1|||
28073272|NCT00158262|54727943|FG000|Overall Study|Lost to Follow-up|1|||
28073273|NCT00158262|54727944|FG001|Overall Study|Lost to Follow-up|1|||
28073274|NCT00157950|54727952|FG000|Overall Study|Death|1|||
28073275|NCT00157950|54727953|FG001|Overall Study|Death|0|||
28073276|NCT03745768|54727961|FG000|Overall Study|discontinued study|2|||
28073277|NCT03745768|54727962|FG001|Overall Study|discontinued study|0|||
28073278|NCT03745222|54727971|FG000|Overall Study|Withdrawal by Subject|0|||
28150720|NCT02180867|54819328|FG006|Overall Study|Death|0|||
28150721|NCT02180867|54819322|FG000|Overall Study|Lack of Efficacy|0|||
28150722|NCT02180867|54819323|FG001|Overall Study|Lack of Efficacy|2|||
28150723|NCT02180867|54819324|FG002|Overall Study|Lack of Efficacy|0|||
28150724|NCT02180867|54819325|FG003|Overall Study|Lack of Efficacy|1|||
28150725|NCT02180867|54819326|FG004|Overall Study|Lack of Efficacy|6|||
28073279|NCT03745222|54727972|FG001|Overall Study|Withdrawal by Subject|1|||
28150726|NCT02180867|54819327|FG005|Overall Study|Lack of Efficacy|0|||
28150727|NCT02180867|54819328|FG006|Overall Study|Lack of Efficacy|1|||
28073280|NCT03745222|54727973|FG002|Overall Study|Withdrawal by Subject|0|||
28073281|NCT03743038|54727981|FG000|Overall Study|Physician Decision|1|||
28073282|NCT00153816|54727993|FG000|Overall Study|Death|6|||
28073283|NCT00153816|54727994|FG001|Overall Study|Death|5|||
28073284|NCT00153816|54727995|FG002|Overall Study|Death|4|||
28073285|NCT00153816|54727996|FG003|Overall Study|Death|6|||
28073286|NCT00153816|54727997|FG004|Overall Study|Death|0|||
28073287|NCT00153816|54727998|FG005|Overall Study|Death|2|||
28073288|NCT00153816|54727993|FG000|Overall Study|Lost to Follow-up|7|||
28073289|NCT00153816|54727994|FG001|Overall Study|Lost to Follow-up|8|||
28073290|NCT00153816|54727995|FG002|Overall Study|Lost to Follow-up|5|||
28073291|NCT00153816|54727996|FG003|Overall Study|Lost to Follow-up|8|||
28073292|NCT00153816|54727997|FG004|Overall Study|Lost to Follow-up|7|||
28073293|NCT00153816|54727998|FG005|Overall Study|Lost to Follow-up|9|||
28073294|NCT00153816|54727993|FG000|Overall Study|Withdrawal by Subject|9|||
28073295|NCT00153816|54727994|FG001|Overall Study|Withdrawal by Subject|9|||
28073296|NCT00153816|54727995|FG002|Overall Study|Withdrawal by Subject|9|||
28073297|NCT00153816|54727996|FG003|Overall Study|Withdrawal by Subject|4|||
28073298|NCT00153816|54727997|FG004|Overall Study|Withdrawal by Subject|1|||
28073299|NCT00153816|54727998|FG005|Overall Study|Withdrawal by Subject|5|||
28073300|NCT00153816|54727993|FG000|Overall Study|Follow-up exam not done|8|||
28073301|NCT00153816|54727994|FG001|Overall Study|Follow-up exam not done|7|||
28073302|NCT00153816|54727995|FG002|Overall Study|Follow-up exam not done|11|||
28073303|NCT00153816|54727996|FG003|Overall Study|Follow-up exam not done|10|||
28073304|NCT00153816|54727997|FG004|Overall Study|Follow-up exam not done|8|||
28073305|NCT00153816|54727998|FG005|Overall Study|Follow-up exam not done|9|||
28073306|NCT00153816|54727993|FG000|Overall Study|Follow-up exam done, histology missing|2|||
28073307|NCT00153816|54727994|FG001|Overall Study|Follow-up exam done, histology missing|3|||
28073308|NCT00153816|54727995|FG002|Overall Study|Follow-up exam done, histology missing|3|||
28073309|NCT00153816|54727996|FG003|Overall Study|Follow-up exam done, histology missing|3|||
28073310|NCT00153816|54727997|FG004|Overall Study|Follow-up exam done, histology missing|1|||
28073311|NCT00153816|54727998|FG005|Overall Study|Follow-up exam done, histology missing|2|||
28073312|NCT00151476|54728015|FG000|FAP Identified Subjects|Protocol Violation|0|||
28073313|NCT00151476|54728016|FG001|FAP Identified Subjects|Protocol Violation|1|||
28073314|NCT00151476|54728015|FG000|FAP Analyzed Subjects|Lost to Follow-up|0|||
28073315|NCT00151476|54728016|FG001|FAP Analyzed Subjects|Lost to Follow-up|2|||
28073316|NCT00151476|54728015|FG000|FAP Analyzed Subjects|Other study participation|0|||
28073317|NCT00151476|54728016|FG001|FAP Analyzed Subjects|Other study participation|1|||
28073318|NCT00149994|54728025|FG000|Overall Study|Administrative problems:|1|||
28073319|NCT00149994|54728026|FG001|Overall Study|Administrative problems:|0|||
28073320|NCT00149994|54728025|FG000|Overall Study|Protocol Violation|0|||
28073321|NCT00149994|54728026|FG001|Overall Study|Protocol Violation|1|||
28073322|NCT00149214|54728034|FG000|Overall Study|Adverse Event|12|||
28073323|NCT00149214|54728035|FG001|Overall Study|Adverse Event|9|||
28150728|NCT02180867|54819322|FG000|Overall Study|Physician Decision|1|||
28150729|NCT02180867|54819323|FG001|Overall Study|Physician Decision|3|||
28150730|NCT02180867|54819324|FG002|Overall Study|Physician Decision|1|||
28150731|NCT02180867|54819325|FG003|Overall Study|Physician Decision|10|||
28150732|NCT02180867|54819326|FG004|Overall Study|Physician Decision|9|||
28150733|NCT02180867|54819327|FG005|Overall Study|Physician Decision|3|||
28150734|NCT02180867|54819328|FG006|Overall Study|Physician Decision|4|||
28150735|NCT02180867|54819322|FG000|Overall Study|Withdrawal by Subject|0|||
28150736|NCT02180867|54819323|FG001|Overall Study|Withdrawal by Subject|0|||
28150737|NCT02180867|54819324|FG002|Overall Study|Withdrawal by Subject|0|||
28150738|NCT02180867|54819325|FG003|Overall Study|Withdrawal by Subject|1|||
28150739|NCT02180867|54819326|FG004|Overall Study|Withdrawal by Subject|1|||
28150740|NCT02180867|54819327|FG005|Overall Study|Withdrawal by Subject|0|||
28150741|NCT02180867|54819328|FG006|Overall Study|Withdrawal by Subject|0|||
28150742|NCT02180867|54819322|FG000|Overall Study|Ineligible|1|||
28150743|NCT02180867|54819323|FG001|Overall Study|Ineligible|2|||
28150744|NCT02180867|54819324|FG002|Overall Study|Ineligible|0|||
28150745|NCT02180867|54819325|FG003|Overall Study|Ineligible|3|||
28150746|NCT02180867|54819326|FG004|Overall Study|Ineligible|5|||
28150747|NCT02180867|54819327|FG005|Overall Study|Ineligible|0|||
28150748|NCT02180867|54819328|FG006|Overall Study|Ineligible|0|||
28150749|NCT02180867|54819322|FG000|Overall Study|Repeat Eligibility Studies|0|||
28150750|NCT02180867|54819323|FG001|Overall Study|Repeat Eligibility Studies|0|||
28150751|NCT02180867|54819324|FG002|Overall Study|Repeat Eligibility Studies|0|||
28073324|NCT00149214|54728034|FG000|Overall Study|Withdrawal by Subject|4|||
28073325|NCT00149214|54728035|FG001|Overall Study|Withdrawal by Subject|1|||
28073326|NCT00149214|54728034|FG000|Overall Study|Physician Decision|3|||
28150752|NCT02180867|54819325|FG003|Overall Study|Repeat Eligibility Studies|0|||
28150753|NCT02180867|54819326|FG004|Overall Study|Repeat Eligibility Studies|1|||
28150754|NCT02180867|54819327|FG005|Overall Study|Repeat Eligibility Studies|0|||
28150755|NCT02180867|54819328|FG006|Overall Study|Repeat Eligibility Studies|0|||
28150756|NCT02180867|54819322|FG000|Overall Study|Refusal of further protocol therapy|1|||
28150757|NCT02180867|54819323|FG001|Overall Study|Refusal of further protocol therapy|0|||
28150758|NCT02180867|54819324|FG002|Overall Study|Refusal of further protocol therapy|2|||
28150759|NCT02180867|54819325|FG003|Overall Study|Refusal of further protocol therapy|6|||
28150760|NCT02180867|54819326|FG004|Overall Study|Refusal of further protocol therapy|4|||
28150761|NCT02180867|54819327|FG005|Overall Study|Refusal of further protocol therapy|0|||
28150762|NCT02180867|54819328|FG006|Overall Study|Refusal of further protocol therapy|0|||
28150763|NCT01734928|54819362|FG000|Randomization|Physician Decision|0|||
28150764|NCT01734928|54819363|FG001|Randomization|Physician Decision|1|||
28150765|NCT01734928|54819362|FG000|Randomization|clinical progression|0|||
28150766|NCT01734928|54819363|FG001|Randomization|clinical progression|1|||
28150767|NCT01734928|54819362|FG000|Randomization|progressive disease|0|||
28150768|NCT01734928|54819363|FG001|Randomization|progressive disease|2|||
28150769|NCT01734928|54819362|FG000|Randomization|Withdrew informed consent|0|||
28150770|NCT01734928|54819363|FG001|Randomization|Withdrew informed consent|4|||
28150771|NCT01734928|54819362|FG000|Randomization|Death|1|||
28150772|NCT01734928|54819363|FG001|Randomization|Death|0|||
28150773|NCT01734928|54819362|FG000|Randomization|Randomization error|1|||
28150774|NCT01734928|54819363|FG001|Randomization|Randomization error|0|||
28150775|NCT01734928|54819362|FG000|Randomization|Lost to Follow-up|1|||
28150776|NCT01734928|54819363|FG001|Randomization|Lost to Follow-up|0|||
28150777|NCT01734928|54819362|FG000|Treatment Period|Lost to Follow-up|0|||
28150778|NCT01734928|54819363|FG001|Treatment Period|Lost to Follow-up|2|||
28150779|NCT01734928|54819362|FG000|Treatment Period|Progressive Disease|167|||
28150780|NCT01734928|54819363|FG001|Treatment Period|Progressive Disease|165|||
28150781|NCT01734928|54819362|FG000|Treatment Period|Adverse Event|39|||
28150782|NCT01734928|54819363|FG001|Treatment Period|Adverse Event|52|||
28150783|NCT01734928|54819362|FG000|Treatment Period|Withdrawal of Consent|25|||
28150784|NCT01734928|54819363|FG001|Treatment Period|Withdrawal of Consent|22|||
28150785|NCT01734928|54819362|FG000|Treatment Period|Death|20|||
28150786|NCT01734928|54819363|FG001|Treatment Period|Death|9|||
28150787|NCT01734928|54819362|FG000|Treatment Period|Other Reasons|27|||
28150788|NCT01734928|54819363|FG001|Treatment Period|Other Reasons|19|||
28150789|NCT01734928|54819362|FG000|Treatment Period|Pregnancy|0|||
28150790|NCT01734928|54819363|FG001|Treatment Period|Pregnancy|1|||
28150791|NCT00667459|54819380|FG000|Overall Study|Death|0|||
28150792|NCT00667459|54819381|FG001|Overall Study|Death|2|||
28150793|NCT00667459|54819380|FG000|Overall Study|Lost to Follow-up|8|||
28150794|NCT00667459|54819381|FG001|Overall Study|Lost to Follow-up|43|||
28150795|NCT00453544|54819395|FG000|Overall Study|Withdrawal by Subject|1|||
28150796|NCT00453544|54819396|FG001|Overall Study|Withdrawal by Subject|0|||
28150797|NCT00453544|54819397|FG002|Overall Study|Withdrawal by Subject|0|||
28150798|NCT00453544|54819398|FG003|Overall Study|Withdrawal by Subject|0|||
28150799|NCT00453544|54819395|FG000|Overall Study|Primary outcome measure not completed|1|||
28150800|NCT00453544|54819396|FG001|Overall Study|Primary outcome measure not completed|1|||
28150801|NCT00453544|54819397|FG002|Overall Study|Primary outcome measure not completed|0|||
28150802|NCT00453544|54819398|FG003|Overall Study|Primary outcome measure not completed|1|||
28150803|NCT02646124|54819422|FG000|Overall Study|Lost to Follow-up|0|||
28150804|NCT02646124|54819423|FG001|Overall Study|Lost to Follow-up|2|||
28150805|NCT01597492|54819431|FG000|Overall Study|Withdrawal by Subject|1|||
28150806|NCT01597492|54819432|FG001|Overall Study|Withdrawal by Subject|2|||
28150807|NCT01597492|54819431|FG000|Overall Study|Adverse Event|3|||
28150808|NCT01597492|54819432|FG001|Overall Study|Adverse Event|0|||
28150809|NCT01597492|54819431|FG000|Overall Study|Lost to Follow-up|0|||
28150810|NCT01597492|54819432|FG001|Overall Study|Lost to Follow-up|2|||
28150811|NCT01597492|54819431|FG000|Overall Study|Other Reason|2|||
28150812|NCT01597492|54819432|FG001|Overall Study|Other Reason|0|||
28150813|NCT03423602|54819438|FG000|Overall Study|Death|1|||
28150814|NCT03423602|54819438|FG000|Overall Study|Lost to Follow-up|6|||
28150815|NCT03423602|54819438|FG000|Overall Study|Protocol Violation|1|||
28150816|NCT03423602|54819438|FG000|Overall Study|Withdrawal by Subject|4|||
28150817|NCT00109590|54819445|FG000|Overall Study|Lost to Follow-up|1|||
28150818|NCT00109590|54819446|FG001|Overall Study|Lost to Follow-up|0|||
28150819|NCT00109590|54819447|FG002|Overall Study|Lost to Follow-up|1|||
28150820|NCT00109590|54819445|FG000|Overall Study|Never Started Treatment|1|||
28150821|NCT00109590|54819446|FG001|Overall Study|Never Started Treatment|2|||
28150822|NCT00109590|54819447|FG002|Overall Study|Never Started Treatment|3|||
28150823|NCT02781558|54819471|FG000|Overall Study|Lost to Follow-up|2|||
28150824|NCT02781558|54819472|FG001|Overall Study|Lost to Follow-up|2|||
28150825|NCT02781558|54819471|FG000|Overall Study|Adverse Event|1|||
28150826|NCT02781558|54819472|FG001|Overall Study|Adverse Event|0|||
28150827|NCT03041311|54819481|FG000|Overall Study|Death|39|||
28150828|NCT03041311|54819482|FG001|Overall Study|Death|42|||
28150829|NCT03041311|54819481|FG000|Overall Study|Lost to Follow-up|0|||
28150830|NCT03041311|54819482|FG001|Overall Study|Lost to Follow-up|1|||
28150831|NCT03041311|54819481|FG000|Overall Study|Withdrawal by Subject|8|||
28150832|NCT03041311|54819482|FG001|Overall Study|Withdrawal by Subject|5|||
28150833|NCT03041311|54819481|FG000|Overall Study|Sponsor Terminated Study|2|||
28150834|NCT03041311|54819482|FG001|Overall Study|Sponsor Terminated Study|4|||
28150835|NCT03041311|54819481|FG000|Overall Study|Disease Progression|3|||
28150836|NCT03041311|54819482|FG001|Overall Study|Disease Progression|1|||
28150837|NCT03041311|54819481|FG000|Overall Study|Randomized in error, did not receive drug|2|||
28150838|NCT03041311|54819482|FG001|Overall Study|Randomized in error, did not receive drug|0|||
28150839|NCT02644096|54819498|FG000|Overall Study|Withdrawal by Subject|28|||
28150840|NCT02644096|54819499|FG001|Overall Study|Withdrawal by Subject|25|||
28150841|NCT02643628|54819507|FG000|Overall Study|Lost to Follow-up|1|||
28150842|NCT02643628|54819508|FG001|Overall Study|Lost to Follow-up|4|||
28150843|NCT02643628|54819507|FG000|Overall Study|Withdrawal by Subject|0|||
28150844|NCT02643628|54819508|FG001|Overall Study|Withdrawal by Subject|1|||
28150845|NCT02643628|54819507|FG000|Overall Study|Relocated out of state|0|||
28150846|NCT02643628|54819508|FG001|Overall Study|Relocated out of state|1|||
28150847|NCT02643472|54819518|FG000|Overall Study|Death|2|||
28150848|NCT02643472|54819519|FG001|Overall Study|Death|5|||
28150849|NCT02643472|54819518|FG000|Overall Study|Withdrawal by Subject|3|||
28150850|NCT02643472|54819519|FG001|Overall Study|Withdrawal by Subject|2|||
28150851|NCT02643472|54819518|FG000|Overall Study|Protocol Violation|0|||
28150852|NCT02643472|54819519|FG001|Overall Study|Protocol Violation|1|||
28150853|NCT02643472|54819518|FG000|Overall Study|Lost to Follow-up|22|||
28150854|NCT02643472|54819519|FG001|Overall Study|Lost to Follow-up|26|||
28150855|NCT02738840|54819527|FG000|Overall Study|MRI Scan not Performed|5|||
28150856|NCT02738840|54819527|FG000|Overall Study|Lost to Follow-up|1|||
28150857|NCT02738840|54819527|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
28150858|NCT02738840|54819527|FG000|Overall Study|Subject Did not Meet Screening Inclusion/Exclusion Criteria|1|||
28150859|NCT02643394|54819533|FG000|Overall Study|Protocol Violation|4|||
28150860|NCT02643394|54819534|FG001|Overall Study|Protocol Violation|5|||
28150861|NCT03538158|54819542|FG000|Overall Study|Lost to Follow-up|13|||
28150862|NCT03538158|54819543|FG001|Overall Study|Lost to Follow-up|7|||
28150863|NCT03538158|54819542|FG000|Overall Study|Withdrawal by Subject|2|||
28150864|NCT03538158|54819543|FG001|Overall Study|Withdrawal by Subject|1|||
28150865|NCT02643082|54819549|FG000|Period 1|Adverse Event|1|||
28150866|NCT02643082|54819550|FG001|Period 1|Adverse Event|0|||
28150867|NCT00353496|54819559|FG000|Overall Study|Adverse Event|1|||
28150868|NCT00353496|54819560|FG001|Overall Study|Adverse Event|0|||
28150869|NCT00353496|54819559|FG000|Overall Study|Protocol Violation|2|||
28150870|NCT00353496|54819560|FG001|Overall Study|Protocol Violation|2|||
28150871|NCT00353496|54819559|FG000|Overall Study|Withdrawal by Subject|3|||
28150872|NCT00353496|54819560|FG001|Overall Study|Withdrawal by Subject|4|||
28150873|NCT00353496|54819559|FG000|Overall Study|Physician Decision|6|||
28150874|NCT00353496|54819560|FG001|Overall Study|Physician Decision|9|||
28150875|NCT00353496|54819559|FG000|Overall Study|Not otherwise specified|4|||
28150876|NCT00353496|54819560|FG001|Overall Study|Not otherwise specified|2|||
28150877|NCT01361464|54819576|FG000|Overall Study|Death|1|||
28150878|NCT01361464|54819576|FG000|Overall Study|Withdrawal by Subject|2|||
28150879|NCT03486912|54819584|FG000|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
28150880|NCT03486912|54819585|FG001|Randomized (Pre-Treatment)|Withdrawal by Subject|1|||
28150881|NCT03486912|54819586|FG002|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
28150882|NCT03486912|54819587|FG003|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
28150883|NCT03486912|54819584|FG000|Treatment Period|Withdrawal by Subject|3|||
28150884|NCT03486912|54819585|FG001|Treatment Period|Withdrawal by Subject|3|||
28150885|NCT03486912|54819586|FG002|Treatment Period|Withdrawal by Subject|3|||
28150886|NCT03486912|54819587|FG003|Treatment Period|Withdrawal by Subject|2|||
28150887|NCT03486912|54819584|FG000|Treatment Period|Other Reasons|0|||
28150888|NCT03486912|54819585|FG001|Treatment Period|Other Reasons|2|||
28150889|NCT03486912|54819586|FG002|Treatment Period|Other Reasons|1|||
28150890|NCT03486912|54819587|FG003|Treatment Period|Other Reasons|1|||
28150891|NCT03486912|54819584|FG000|Treatment Period|Adverse Event|0|||
28150892|NCT03486912|54819585|FG001|Treatment Period|Adverse Event|1|||
28150893|NCT03486912|54819586|FG002|Treatment Period|Adverse Event|1|||
28150894|NCT03486912|54819587|FG003|Treatment Period|Adverse Event|0|||
28150895|NCT03486912|54819584|FG000|Treatment Period|Lost to Follow-up|1|||
28150896|NCT03486912|54819585|FG001|Treatment Period|Lost to Follow-up|0|||
28150897|NCT03486912|54819586|FG002|Treatment Period|Lost to Follow-up|0|||
28150898|NCT03486912|54819587|FG003|Treatment Period|Lost to Follow-up|2|||
28150899|NCT03345342|54819597|FG000|Open-Label Phase|Adverse Event|30|||
28150900|NCT03345342|54819598|FG001|Open-Label Phase|Adverse Event|0|||
28150901|NCT03345342|54819599|FG002|Open-Label Phase|Adverse Event|0|||
28150902|NCT03345342|54819600|FG003|Open-Label Phase|Adverse Event|0|||
28150903|NCT03345342|54819601|FG004|Open-Label Phase|Adverse Event|0|||
28150904|NCT03345342|54819597|FG000|Open-Label Phase|Death|1|||
28150905|NCT03345342|54819598|FG001|Open-Label Phase|Death|0|||
28150906|NCT03345342|54819599|FG002|Open-Label Phase|Death|0|||
28150907|NCT03345342|54819600|FG003|Open-Label Phase|Death|0|||
28150908|NCT03345342|54819601|FG004|Open-Label Phase|Death|0|||
28150909|NCT03345342|54819597|FG000|Open-Label Phase|Initiated Prohibited Medication|2|||
28150910|NCT03345342|54819598|FG001|Open-Label Phase|Initiated Prohibited Medication|0|||
28150911|NCT03345342|54819599|FG002|Open-Label Phase|Initiated Prohibited Medication|0|||
28150912|NCT03345342|54819600|FG003|Open-Label Phase|Initiated Prohibited Medication|0|||
28150913|NCT03345342|54819601|FG004|Open-Label Phase|Initiated Prohibited Medication|0|||
28150914|NCT03345342|54819597|FG000|Open-Label Phase|Lack of Efficacy|6|||
28150915|NCT03345342|54819598|FG001|Open-Label Phase|Lack of Efficacy|0|||
28150916|NCT03345342|54819599|FG002|Open-Label Phase|Lack of Efficacy|0|||
28150917|NCT03345342|54819600|FG003|Open-Label Phase|Lack of Efficacy|0|||
28150918|NCT03345342|54819601|FG004|Open-Label Phase|Lack of Efficacy|0|||
28150919|NCT03345342|54819597|FG000|Open-Label Phase|Lost to Follow-up|9|||
28150920|NCT03345342|54819598|FG001|Open-Label Phase|Lost to Follow-up|0|||
28150921|NCT03345342|54819599|FG002|Open-Label Phase|Lost to Follow-up|0|||
28150922|NCT03345342|54819600|FG003|Open-Label Phase|Lost to Follow-up|0|||
28150923|NCT03345342|54819601|FG004|Open-Label Phase|Lost to Follow-up|0|||
28150924|NCT03345342|54819597|FG000|Open-Label Phase|Non-Compliance with Study Drug|4|||
28150925|NCT03345342|54819598|FG001|Open-Label Phase|Non-Compliance with Study Drug|0|||
28150926|NCT03345342|54819599|FG002|Open-Label Phase|Non-Compliance with Study Drug|0|||
28150927|NCT03345342|54819600|FG003|Open-Label Phase|Non-Compliance with Study Drug|0|||
28150928|NCT03345342|54819601|FG004|Open-Label Phase|Non-Compliance with Study Drug|0|||
28150929|NCT03345342|54819597|FG000|Open-Label Phase|Physician Decision|4|||
28150930|NCT03345342|54819598|FG001|Open-Label Phase|Physician Decision|0|||
28150931|NCT03345342|54819599|FG002|Open-Label Phase|Physician Decision|0|||
28150932|NCT03345342|54819600|FG003|Open-Label Phase|Physician Decision|0|||
28150933|NCT03345342|54819601|FG004|Open-Label Phase|Physician Decision|0|||
28150934|NCT03345342|54819597|FG000|Open-Label Phase|Protocol Violation|8|||
28150935|NCT03345342|54819598|FG001|Open-Label Phase|Protocol Violation|0|||
28150936|NCT03345342|54819599|FG002|Open-Label Phase|Protocol Violation|0|||
28150937|NCT03345342|54819600|FG003|Open-Label Phase|Protocol Violation|0|||
28150938|NCT03345342|54819601|FG004|Open-Label Phase|Protocol Violation|0|||
28150939|NCT03345342|54819597|FG000|Open-Label Phase|Withdrawal by Subject|57|||
28150940|NCT03345342|54819598|FG001|Open-Label Phase|Withdrawal by Subject|0|||
28150941|NCT03345342|54819599|FG002|Open-Label Phase|Withdrawal by Subject|0|||
28150942|NCT03345342|54819600|FG003|Open-Label Phase|Withdrawal by Subject|0|||
28150943|NCT03345342|54819601|FG004|Open-Label Phase|Withdrawal by Subject|0|||
28150944|NCT03345342|54819597|FG000|Open-Label Phase|Other|15|||
28150945|NCT03345342|54819598|FG001|Open-Label Phase|Other|0|||
28150946|NCT03345342|54819599|FG002|Open-Label Phase|Other|0|||
28150947|NCT03345342|54819600|FG003|Open-Label Phase|Other|0|||
28150948|NCT03345342|54819601|FG004|Open-Label Phase|Other|0|||
28150949|NCT03345342|54819597|FG000|Double-Blind Phase|Adverse Event|0|||
28150950|NCT03345342|54819598|FG001|Double-Blind Phase|Adverse Event|1|||
28150951|NCT03345342|54819599|FG002|Double-Blind Phase|Adverse Event|6|||
28150952|NCT03345342|54819600|FG003|Double-Blind Phase|Adverse Event|0|||
28150953|NCT03345342|54819601|FG004|Double-Blind Phase|Adverse Event|0|||
28150954|NCT03345342|54819597|FG000|Double-Blind Phase|Death|0|||
28150955|NCT03345342|54819598|FG001|Double-Blind Phase|Death|2|||
28150956|NCT03345342|54819599|FG002|Double-Blind Phase|Death|1|||
28150957|NCT03345342|54819600|FG003|Double-Blind Phase|Death|0|||
28150958|NCT03345342|54819601|FG004|Double-Blind Phase|Death|0|||
28150959|NCT03345342|54819597|FG000|Double-Blind Phase|Initiated Prohibited Medication|0|||
28150960|NCT03345342|54819598|FG001|Double-Blind Phase|Initiated Prohibited Medication|0|||
28150961|NCT03345342|54819599|FG002|Double-Blind Phase|Initiated Prohibited Medication|2|||
28150962|NCT03345342|54819600|FG003|Double-Blind Phase|Initiated Prohibited Medication|0|||
28150963|NCT03345342|54819601|FG004|Double-Blind Phase|Initiated Prohibited Medication|0|||
28150964|NCT03345342|54819597|FG000|Double-Blind Phase|Lost to Follow-up|0|||
28150965|NCT03345342|54819598|FG001|Double-Blind Phase|Lost to Follow-up|1|||
28150966|NCT03345342|54819599|FG002|Double-Blind Phase|Lost to Follow-up|7|||
28150967|NCT03345342|54819600|FG003|Double-Blind Phase|Lost to Follow-up|0|||
27822852|NCT04146363|54286912|FG003|Induction Period|Withdrawal by Subject|0|||
27822853|NCT04146363|54286913|FG004|Induction Period|Withdrawal by Subject|0|||
27822854|NCT04146363|54286914|FG005|Induction Period|Withdrawal by Subject|0|||
28150968|NCT03345342|54819601|FG004|Double-Blind Phase|Lost to Follow-up|0|||
28150969|NCT03345342|54819597|FG000|Double-Blind Phase|Physician Decision|0|||
28150970|NCT03345342|54819598|FG001|Double-Blind Phase|Physician Decision|1|||
28150971|NCT03345342|54819599|FG002|Double-Blind Phase|Physician Decision|4|||
28150972|NCT03345342|54819600|FG003|Double-Blind Phase|Physician Decision|0|||
28150973|NCT03345342|54819601|FG004|Double-Blind Phase|Physician Decision|0|||
28150974|NCT03345342|54819597|FG000|Double-Blind Phase|Protocol Violation|0|||
28150975|NCT03345342|54819598|FG001|Double-Blind Phase|Protocol Violation|0|||
28150976|NCT03345342|54819599|FG002|Double-Blind Phase|Protocol Violation|1|||
28150977|NCT03345342|54819600|FG003|Double-Blind Phase|Protocol Violation|0|||
28150978|NCT03345342|54819601|FG004|Double-Blind Phase|Protocol Violation|0|||
28150979|NCT03345342|54819597|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
28150980|NCT03345342|54819598|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
28150981|NCT03345342|54819599|FG002|Double-Blind Phase|Withdrawal by Subject|38|||
28150982|NCT03345342|54819600|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
28150983|NCT03345342|54819601|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
28150984|NCT03345342|54819597|FG000|Double-Blind Phase|Other|0|||
28150985|NCT03345342|54819598|FG001|Double-Blind Phase|Other|1|||
28150986|NCT03345342|54819599|FG002|Double-Blind Phase|Other|3|||
28150987|NCT03345342|54819600|FG003|Double-Blind Phase|Other|0|||
28150988|NCT03345342|54819601|FG004|Double-Blind Phase|Other|0|||
28150989|NCT03345342|54819597|FG000|Follow-Up Phase|Adverse Event|0|||
28150990|NCT03345342|54819598|FG001|Follow-Up Phase|Adverse Event|0|||
28150991|NCT03345342|54819599|FG002|Follow-Up Phase|Adverse Event|0|||
28150992|NCT03345342|54819600|FG003|Follow-Up Phase|Adverse Event|0|||
28150993|NCT03345342|54819601|FG004|Follow-Up Phase|Adverse Event|4|||
28150994|NCT03345342|54819597|FG000|Follow-Up Phase|Lost to Follow-up|0|||
28150995|NCT03345342|54819598|FG001|Follow-Up Phase|Lost to Follow-up|0|||
28150996|NCT03345342|54819599|FG002|Follow-Up Phase|Lost to Follow-up|0|||
28150997|NCT03345342|54819600|FG003|Follow-Up Phase|Lost to Follow-up|0|||
28150998|NCT03345342|54819601|FG004|Follow-Up Phase|Lost to Follow-up|6|||
28150999|NCT03345342|54819597|FG000|Follow-Up Phase|Physician Decision|0|||
28151000|NCT03345342|54819598|FG001|Follow-Up Phase|Physician Decision|0|||
28151001|NCT03345342|54819599|FG002|Follow-Up Phase|Physician Decision|0|||
28151002|NCT03345342|54819600|FG003|Follow-Up Phase|Physician Decision|0|||
28151003|NCT03345342|54819601|FG004|Follow-Up Phase|Physician Decision|5|||
28151004|NCT03345342|54819597|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
28151005|NCT03345342|54819598|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
28151006|NCT03345342|54819599|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
28151007|NCT03345342|54819600|FG003|Follow-Up Phase|Withdrawal by Subject|5|||
28151008|NCT03345342|54819601|FG004|Follow-Up Phase|Withdrawal by Subject|15|||
28151009|NCT03345342|54819597|FG000|Follow-Up Phase|Other|0|||
28151010|NCT03345342|54819598|FG001|Follow-Up Phase|Other|0|||
28073327|NCT00149214|54728035|FG001|Overall Study|Physician Decision|3|||
28073328|NCT00149214|54728034|FG000|Overall Study|Sponsor Decision|0|||
28073329|NCT00149214|54728035|FG001|Overall Study|Sponsor Decision|1|||
28073330|NCT00149214|54728034|FG000|Overall Study|Progressive Disease|7|||
28073331|NCT00149214|54728035|FG001|Overall Study|Progressive Disease|3|||
28073332|NCT00114972|54728052|FG000|Overall Study|Withdrawal by Subject|40|||
28073333|NCT00114972|54728053|FG001|Overall Study|Withdrawal by Subject|7|||
28073334|NCT00114972|54728052|FG000|Overall Study|Lost to Follow-up|8|||
28073335|NCT00114972|54728053|FG001|Overall Study|Lost to Follow-up|5|||
28073336|NCT00129402|54728061|FG000|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
28073337|NCT00129402|54728062|FG001|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
28073338|NCT00129402|54728063|FG002|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
28073339|NCT00129402|54728064|FG003|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
28073340|NCT00129402|54728065|FG004|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
28073341|NCT00129402|54728066|FG005|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
28073342|NCT00129402|54728067|FG006|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
28073343|NCT00129402|54728061|FG000|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
28073344|NCT00129402|54728062|FG001|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
28073345|NCT00129402|54728063|FG002|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
28073346|NCT00129402|54728064|FG003|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
28073347|NCT00129402|54728065|FG004|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
28073348|NCT00129402|54728066|FG005|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1|||
28073349|NCT00129402|54728067|FG006|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
28073350|NCT00129402|54728061|FG000|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
28073351|NCT00129402|54728062|FG001|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
28073352|NCT00129402|54728063|FG002|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
28073353|NCT00129402|54728064|FG003|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1|||
28073354|NCT00129402|54728065|FG004|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
28073355|NCT00129402|54728066|FG005|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
28073356|NCT00129402|54728067|FG006|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
28073357|NCT00129402|54728061|FG000|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
28073358|NCT00129402|54728062|FG001|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
28151011|NCT03345342|54819599|FG002|Follow-Up Phase|Other|0|||
28151012|NCT03345342|54819600|FG003|Follow-Up Phase|Other|3|||
28073359|NCT00129402|54728063|FG002|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
28073360|NCT00129402|54728064|FG003|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
28073361|NCT00129402|54728065|FG004|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
28151013|NCT03345342|54819601|FG004|Follow-Up Phase|Other|1|||
28151014|NCT02642614|54819617|FG000|Overall Study|Adverse Event|1|||
28151015|NCT02642614|54819618|FG001|Overall Study|Adverse Event|1|||
28151016|NCT02642614|54819619|FG002|Overall Study|Adverse Event|2|||
28151017|NCT02642614|54819620|FG003|Overall Study|Adverse Event|2|||
28151018|NCT02642614|54819617|FG000|Overall Study|Lost to Follow-up|1|||
28151019|NCT02642614|54819618|FG001|Overall Study|Lost to Follow-up|0|||
28151020|NCT02642614|54819619|FG002|Overall Study|Lost to Follow-up|0|||
28151021|NCT02642614|54819620|FG003|Overall Study|Lost to Follow-up|0|||
28151022|NCT02642614|54819617|FG000|Overall Study|Withdrawal by Subject|1|||
28073362|NCT00129402|54728066|FG005|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
28073363|NCT00129402|54728067|FG006|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
28073364|NCT00129402|54728061|FG000|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
28073365|NCT00129402|54728062|FG001|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
28073366|NCT00129402|54728063|FG002|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2|||
28073367|NCT00129402|54728064|FG003|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
28073368|NCT00129402|54728065|FG004|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
28073369|NCT00129402|54728066|FG005|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
28151023|NCT02642614|54819618|FG001|Overall Study|Withdrawal by Subject|1|||
28151024|NCT02642614|54819619|FG002|Overall Study|Withdrawal by Subject|0|||
28151025|NCT02642614|54819620|FG003|Overall Study|Withdrawal by Subject|0|||
28151026|NCT02781324|54819635|FG000|Overall Study|Withdrawal by Subject|1|||
28151027|NCT02781324|54819636|FG001|Overall Study|Withdrawal by Subject|0|||
28151028|NCT02781324|54819635|FG000|Overall Study|Physician Decision|1|||
28151029|NCT02781324|54819636|FG001|Overall Study|Physician Decision|2|||
28151030|NCT03292146|54819646|FG000|Baseline to 12 Months|Relocation|1|||
28151031|NCT03292146|54819647|FG001|Baseline to 12 Months|Relocation|0|||
28151032|NCT03292146|54819646|FG000|Baseline to 12 Months|Seeking higher level of care for eating disorder|1|||
28151033|NCT03292146|54819647|FG001|Baseline to 12 Months|Seeking higher level of care for eating disorder|0|||
28151034|NCT03292146|54819646|FG000|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|0|||
28151035|NCT03292146|54819647|FG001|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|1|||
28151036|NCT03292146|54819646|FG000|12 Months to 24 Months|Planning pregnancy|2|||
28151037|NCT03292146|54819647|FG001|12 Months to 24 Months|Planning pregnancy|2|||
28151038|NCT03292146|54819646|FG000|12 Months to 24 Months|Personal reasons|1|||
28151039|NCT03292146|54819647|FG001|12 Months to 24 Months|Personal reasons|0|||
28151040|NCT03292146|54819646|FG000|12 Months to 24 Months|Lost to Follow-up|0|||
28151041|NCT03292146|54819647|FG001|12 Months to 24 Months|Lost to Follow-up|1|||
28151042|NCT01360996|54819656|FG000|Overall Study|Withdrawal by Subject|4|||
28151043|NCT01360996|54819657|FG001|Overall Study|Withdrawal by Subject|3|||
28151044|NCT01360996|54819658|FG002|Overall Study|Withdrawal by Subject|2|||
28151045|NCT01360996|54819656|FG000|Overall Study|Noncompliant|2|||
28151046|NCT01360996|54819657|FG001|Overall Study|Noncompliant|0|||
28151047|NCT01360996|54819658|FG002|Overall Study|Noncompliant|0|||
28073370|NCT00129402|54728067|FG006|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
28073371|NCT00129402|54728061|FG000|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
28073372|NCT00129402|54728062|FG001|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
28073373|NCT00129402|54728063|FG002|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3|||
28073374|NCT00129402|54728064|FG003|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
28073375|NCT00129402|54728065|FG004|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
28073376|NCT00129402|54728066|FG005|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1|||
28073377|NCT00129402|54728067|FG006|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
28151048|NCT01951885|54819667|FG000|Overall Study|ineligible due to a change in conditioning regimen|0|||
28151049|NCT01951885|54819668|FG001|Overall Study|ineligible due to a change in conditioning regimen|1|||
28073378|NCT00129402|54728061|FG000|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
28073379|NCT00129402|54728062|FG001|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
28073380|NCT00129402|54728063|FG002|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1|||
28073381|NCT00129402|54728064|FG003|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
28073382|NCT00129402|54728065|FG004|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
28073383|NCT00129402|54728066|FG005|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
28073384|NCT00129402|54728067|FG006|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
28073385|NCT00129402|54728061|FG000|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
28073386|NCT00129402|54728062|FG001|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
28073387|NCT00129402|54728063|FG002|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1|||
28073388|NCT00129402|54728064|FG003|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
28073389|NCT00129402|54728065|FG004|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
28073390|NCT00129402|54728066|FG005|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3|||
28073391|NCT00129402|54728067|FG006|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
28073392|NCT00129402|54728061|FG000|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
28073393|NCT00129402|54728062|FG001|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
28073394|NCT00129402|54728063|FG002|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
27850262|NCT04178967|54349323|FG008|Induction Period|Lack of Efficacy|0|||
28151050|NCT01951885|54819667|FG000|Overall Study|Adverse Event|1|||
28151051|NCT01951885|54819668|FG001|Overall Study|Adverse Event|0|||
28151052|NCT01951885|54819667|FG000|Overall Study|Withdrawal by Subject|0|||
28151053|NCT01951885|54819668|FG001|Overall Study|Withdrawal by Subject|1|||
28151054|NCT01951885|54819667|FG000|Overall Study|ineligible due to a change in donor|0|||
28151055|NCT01951885|54819668|FG001|Overall Study|ineligible due to a change in donor|1|||
28151056|NCT01951885|54819667|FG000|Overall Study|ineligible after experiencing cardiac issues|0|||
27941800|NCT01212185|54598375|FG000|Overall Study|Protocol Violation|2|||
27941801|NCT01212185|54598376|FG001|Overall Study|Protocol Violation|1|||
28073395|NCT00129402|54728064|FG003|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
28073396|NCT00129402|54728065|FG004|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
28073397|NCT00129402|54728066|FG005|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
28073398|NCT00129402|54728067|FG006|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
28073399|NCT00129402|54728061|FG000|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
28073400|NCT00129402|54728062|FG001|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
28073401|NCT00129402|54728063|FG002|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
28073402|NCT00129402|54728064|FG003|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
28073403|NCT00129402|54728065|FG004|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
28151057|NCT01951885|54819668|FG001|Overall Study|ineligible after experiencing cardiac issues|1|||
28151058|NCT02639338|54819676|FG000|Overall Study|Lost to Follow-up|2|||
28151059|NCT02639338|54819677|FG001|Overall Study|Lost to Follow-up|2|||
28151060|NCT02639338|54819676|FG000|Overall Study|Withdrew Consent|1|||
28151061|NCT02639338|54819677|FG001|Overall Study|Withdrew Consent|2|||
28151062|NCT02639338|54819676|FG000|Overall Study|Death|1|||
28151063|NCT02639338|54819677|FG001|Overall Study|Death|0|||
28151064|NCT02639338|54819676|FG000|Overall Study|Randomized but Not Treated|0|||
28151065|NCT02639338|54819677|FG001|Overall Study|Randomized but Not Treated|1|||
28151066|NCT01754857|54819683|FG000|Overall Study|Adverse Event|7|||
28151067|NCT01754857|54819683|FG000|Overall Study|Disease progression|3|||
28151068|NCT01754857|54819683|FG000|Overall Study|Physician Decision|2|||
28151069|NCT01754857|54819683|FG000|Overall Study|Withdrawal by Subject|3|||
28151070|NCT01754857|54819683|FG000|Overall Study|other complicating disease|1|||
28151071|NCT01754857|54819683|FG000|Overall Study|ineligible to continue onto maintenance|1|||
28151072|NCT01754857|54819683|FG000|Overall Study|Patient does not wish to be treated, but will continue to be followed for survival|1|||
28151073|NCT01754857|54819683|FG000|Overall Study|Patient decided not to begin maintenance therapy|1|||
28151074|NCT02900352|54819689|FG000|Overall Study|Lost to Follow-up|28|||
28151075|NCT02900352|54819690|FG001|Overall Study|Lost to Follow-up|17|||
28151076|NCT03040687|54819699|FG000|Overall Study|Withdrawal by Subject|1|||
28151077|NCT03040687|54819700|FG001|Overall Study|Withdrawal by Subject|0|||
28151078|NCT03040687|54819701|FG002|Overall Study|Withdrawal by Subject|0|||
28151079|NCT03042559|54819711|FG000|Overall Study|drop out|1|||
28151080|NCT03042559|54819712|FG001|Overall Study|drop out|1|||
28151081|NCT02780856|54819718|FG000|Overall Study|Lost to Follow-up|1|||
28151082|NCT00108732|54819747|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1|||
28151083|NCT00108732|54819747|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2|||
28151084|NCT00108732|54819747|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10|||
28151085|NCT00108732|54819747|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1|||
28151086|NCT00108732|54819747|FG000|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3|||
28151087|NCT00108732|54819747|FG000|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1|||
28151088|NCT00108732|54819747|FG000|Step 2 (Androgen Ablation and Vaccine)|Other|1|||
28151089|NCT00107952|54819753|FG000|Overall Study|Death|75|||
28151090|NCT00107952|54819754|FG001|Overall Study|Death|61|||
28151091|NCT00107952|54819753|FG000|Overall Study|Lost to Follow-up|0|||
28151092|NCT00107952|54819754|FG001|Overall Study|Lost to Follow-up|3|||
28151093|NCT00107952|54819753|FG000|Overall Study|Withdrawal by Subject|9|||
28151094|NCT00107952|54819754|FG001|Overall Study|Withdrawal by Subject|6|||
28151095|NCT00107952|54819753|FG000|Overall Study|Other|2|||
28151096|NCT00107952|54819754|FG001|Overall Study|Other|5|||
28151097|NCT00107952|54819753|FG000|Overall Study|Never received study treatment|9|||
28151098|NCT00107952|54819754|FG001|Overall Study|Never received study treatment|6|||
28151099|NCT01366638|54819772|FG000|Overall Study|Withdrawal by Subject|0|||
28151100|NCT01366638|54819773|FG001|Overall Study|Withdrawal by Subject|0|||
28151101|NCT01366638|54819774|FG002|Overall Study|Withdrawal by Subject|6|||
28151102|NCT01366638|54819772|FG000|Overall Study|Other|1|||
28151103|NCT01366638|54819773|FG001|Overall Study|Other|0|||
28151104|NCT01366638|54819774|FG002|Overall Study|Other|0|||
28151105|NCT02780700|54819782|FG000|Overall Study|Progressive disease|1|||
28151106|NCT04230122|54819820|FG000|Overall Study|Lost to Follow-up|1|||
28151107|NCT04230122|54819821|FG001|Overall Study|Lost to Follow-up|0|||
28151108|NCT02780388|54819832|FG000|Overall Study|Lost to Follow-up|0|||
28151109|NCT02780388|54819833|FG001|Overall Study|Lost to Follow-up|1|||
28151110|NCT02780388|54819834|FG002|Overall Study|Lost to Follow-up|0|||
28151111|NCT02780388|54819835|FG003|Overall Study|Lost to Follow-up|0|||
28151112|NCT02780388|54819836|FG004|Overall Study|Lost to Follow-up|0|||
28151113|NCT02780388|54819832|FG000|Overall Study|Withdrawal by Subject|1|||
28151114|NCT02780388|54819833|FG001|Overall Study|Withdrawal by Subject|1|||
28151115|NCT02780388|54819834|FG002|Overall Study|Withdrawal by Subject|0|||
28151116|NCT02780388|54819835|FG003|Overall Study|Withdrawal by Subject|0|||
28151117|NCT02780388|54819836|FG004|Overall Study|Withdrawal by Subject|0|||
28151118|NCT02224573|54819854|FG000|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|0|||
28151119|NCT02224573|54819855|FG001|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|1|||
28151120|NCT02224573|54819854|FG000|Treatment Phase|Started on Other IMP|1|||
28151121|NCT02224573|54819855|FG001|Treatment Phase|Started on Other IMP|0|||
28151122|NCT02224573|54819854|FG000|Treatment Phase|Participant Discontinued IMP|0|||
28151123|NCT02224573|54819855|FG001|Treatment Phase|Participant Discontinued IMP|1|||
28151124|NCT02224573|54819854|FG000|Treatment Phase|Lack of Efficacy|15|||
28151125|NCT02224573|54819855|FG001|Treatment Phase|Lack of Efficacy|8|||
28151126|NCT02224573|54819854|FG000|Treatment Phase|Began Commercial Product|1|||
28151127|NCT02224573|54819855|FG001|Treatment Phase|Began Commercial Product|0|||
28151128|NCT02224573|54819854|FG000|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
28151129|NCT02224573|54819855|FG001|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
28151130|NCT02224573|54819854|FG000|Treatment Phase|Met Withdrawal Criteria|5|||
28151131|NCT02224573|54819855|FG001|Treatment Phase|Met Withdrawal Criteria|7|||
28151132|NCT02224573|54819854|FG000|Treatment Phase|Participant Did Not Return for Visits|0|||
28151133|NCT02224573|54819855|FG001|Treatment Phase|Participant Did Not Return for Visits|1|||
28151134|NCT02224573|54819854|FG000|Treatment Phase|Continued Compassionate Use|1|||
28151135|NCT02224573|54819855|FG001|Treatment Phase|Continued Compassionate Use|0|||
28151136|NCT02224573|54819854|FG000|Treatment Phase|Lack of Efficiency|2|||
28151137|NCT02224573|54819855|FG001|Treatment Phase|Lack of Efficiency|1|||
28151138|NCT02224573|54819854|FG000|Treatment Phase|Participant with Protocol-Excluded Treatment|0|||
28151139|NCT02224573|54819855|FG001|Treatment Phase|Participant with Protocol-Excluded Treatment|1|||
28151140|NCT02224573|54819854|FG000|Treatment Phase|Participant Moved|2|||
28151141|NCT02224573|54819855|FG001|Treatment Phase|Participant Moved|0|||
28151142|NCT02224573|54819854|FG000|Treatment Phase|Withdrawal by Participant or Parent/Guardian|62|||
28151143|NCT02224573|54819855|FG001|Treatment Phase|Withdrawal by Participant or Parent/Guardian|48|||
28151144|NCT02224573|54819854|FG000|Treatment Phase|Refused Medication|1|||
28151145|NCT02224573|54819855|FG001|Treatment Phase|Refused Medication|1|||
28151146|NCT02224573|54819854|FG000|Treatment Phase|Adverse Event|26|||
28151147|NCT02224573|54819855|FG001|Treatment Phase|Adverse Event|38|||
28151148|NCT02224573|54819854|FG000|Treatment Phase|Placed in Group Home|0|||
28151149|NCT02224573|54819855|FG001|Treatment Phase|Placed in Group Home|1|||
28151150|NCT02224573|54819854|FG000|Treatment Phase|Pursued Other Trials|1|||
28151151|NCT02224573|54819855|FG001|Treatment Phase|Pursued Other Trials|0|||
28151152|NCT02224573|54819854|FG000|Treatment Phase|Withdrawn by the Investigator|23|||
28151153|NCT02224573|54819855|FG001|Treatment Phase|Withdrawn by the Investigator|11|||
28151154|NCT02224573|54819854|FG000|Treatment Phase|Lost to Follow-up|2|||
28151155|NCT02224573|54819855|FG001|Treatment Phase|Lost to Follow-up|1|||
28151156|NCT02224573|54819854|FG000|Taper Phase|Completed Incorrect Number of Taper Days|1|||
28151157|NCT02224573|54819855|FG001|Taper Phase|Completed Incorrect Number of Taper Days|0|||
28151158|NCT02224573|54819854|FG000|Taper Phase|Hospitalization/Dose Reduction|1|||
28151159|NCT02224573|54819855|FG001|Taper Phase|Hospitalization/Dose Reduction|0|||
28151160|NCT02224573|54819854|FG000|Taper Phase|Withdrawn by participants or parent/guardian|0|||
28151161|NCT02224573|54819855|FG001|Taper Phase|Withdrawn by participants or parent/guardian|3|||
27850263|NCT04178967|54349324|FG009|Induction Period|Lack of Efficacy|0|||
28073404|NCT00129402|54728066|FG005|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
28073405|NCT00129402|54728067|FG006|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1|||
28073406|NCT00129402|54728061|FG000|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
28073407|NCT00129402|54728062|FG001|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
28073408|NCT00129402|54728063|FG002|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
28073409|NCT00129402|54728064|FG003|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
28073410|NCT00129402|54728065|FG004|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
28073411|NCT00129402|54728066|FG005|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
28073412|NCT00129402|54728067|FG006|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3|||
28073413|NCT00129402|54728061|FG000|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
28151162|NCT02224573|54819854|FG000|Taper Phase|Adverse Event|1|||
28151163|NCT02224573|54819855|FG001|Taper Phase|Adverse Event|1|||
28151164|NCT01360840|54819865|FG000|Overall Study|Ongoing at data cut-off|10|||
28151165|NCT01360840|54819866|FG001|Overall Study|Ongoing at data cut-off|10|||
28151166|NCT01360840|54819867|FG002|Overall Study|Ongoing at data cut-off|9|||
28151167|NCT03350984|54819879|FG000|Overall Study|Death|1|||
28151168|NCT03350984|54819880|FG001|Overall Study|Death|0|||
28151169|NCT03350984|54819879|FG000|Overall Study|Lost to Follow-up|5|||
28151170|NCT03350984|54819880|FG001|Overall Study|Lost to Follow-up|6|||
28151171|NCT03350984|54819879|FG000|Overall Study|Protocol Violation|1|||
28151172|NCT03350984|54819880|FG001|Overall Study|Protocol Violation|2|||
28151173|NCT03350984|54819879|FG000|Overall Study|Physician Decision|1|||
28151174|NCT03350984|54819880|FG001|Overall Study|Physician Decision|0|||
28151175|NCT05176717|54819898|FG000|Overall Study|Sponsor Decision|1|||
28151176|NCT05176717|54819899|FG001|Overall Study|Sponsor Decision|2|||
28151177|NCT05176717|54819900|FG002|Overall Study|Sponsor Decision|2|||
28151178|NCT02770248|54819910|FG000|Overall Study|Adverse Event|0|||
28151179|NCT02770248|54819911|FG001|Overall Study|Adverse Event|1|||
28151180|NCT02770248|54819910|FG000|Overall Study|Randomized in error, prior to treatment|0|||
28151181|NCT02770248|54819911|FG001|Overall Study|Randomized in error, prior to treatment|1|||
28151182|NCT01344369|54819919|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
28151183|NCT01344369|54819920|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
28151184|NCT01344369|54819919|FG000|Washout of 28 Days|Physician Decision|0|||
28151185|NCT01344369|54819920|FG001|Washout of 28 Days|Physician Decision|1|||
28151186|NCT01344369|54819919|FG000|Second Intervention|Emesis within 2 x Tmax|0|||
28151187|NCT01344369|54819920|FG001|Second Intervention|Emesis within 2 x Tmax|1|||
28151188|NCT03179462|54819929|FG000|Overall Study|screening failure|1|||
28151189|NCT03179462|54819930|FG001|Overall Study|screening failure|2|||
28151190|NCT03179462|54819931|FG002|Overall Study|screening failure|0|||
28151191|NCT01314703|54819939|FG000|Overall Study|screen failure and closed enrollment|8|||
28151192|NCT01360762|54819944|FG000|Main Study Period (12-month Treatment)|Lost to Follow-up|7|||
28151193|NCT01360762|54819944|FG000|Main Study Period (12-month Treatment)|Death|5|||
28151194|NCT01360762|54819944|FG000|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1|||
28151195|NCT01360762|54819944|FG000|Main Study Period (12-month Treatment)|Patient relapsed|15|||
28151196|NCT01360762|54819944|FG000|Main Study Period (12-month Treatment)|Discontinuation|1|||
28151197|NCT01360762|54819944|FG000|Whole Study Period|Lost to Follow-up|10|||
28151198|NCT01360762|54819944|FG000|Whole Study Period|Death|7|||
28151199|NCT01360762|54819944|FG000|Whole Study Period|Patient relapsed|18|||
28151200|NCT01360762|54819944|FG000|Whole Study Period|Discontinuation of study drug for safety|1|||
28151201|NCT04382924|54819951|FG000|Overall Study|Death|2|||
28151202|NCT04382924|54819952|FG001|Overall Study|Death|5|||
28151203|NCT04382924|54819953|FG002|Overall Study|Death|4|||
28151204|NCT04382924|54819951|FG000|Overall Study|Protocol Violation|0|||
28151205|NCT04382924|54819952|FG001|Overall Study|Protocol Violation|1|||
28151206|NCT04382924|54819953|FG002|Overall Study|Protocol Violation|1|||
28151207|NCT04382924|54819951|FG000|Overall Study|Transferred to other hospital/declined in person visits|0|||
28151208|NCT04382924|54819952|FG001|Overall Study|Transferred to other hospital/declined in person visits|1|||
28151209|NCT04382924|54819953|FG002|Overall Study|Transferred to other hospital/declined in person visits|1|||
28151210|NCT04382924|54819951|FG000|Overall Study|Withdrawal by Subject|6|||
28151211|NCT04382924|54819952|FG001|Overall Study|Withdrawal by Subject|3|||
28151212|NCT04382924|54819953|FG002|Overall Study|Withdrawal by Subject|6|||
28151213|NCT03044431|54819967|FG000|Overall Study|Lost to Follow-up|59|||
28151214|NCT02770170|54819975|FG000|Overall Study|Withdrawal by Subject|0|||
28151215|NCT02770170|54819976|FG001|Overall Study|Withdrawal by Subject|0|||
28151216|NCT02770170|54819977|FG002|Overall Study|Withdrawal by Subject|0|||
28151217|NCT02770170|54819978|FG003|Overall Study|Withdrawal by Subject|2|||
28151218|NCT02770170|54819975|FG000|Overall Study|due to pregnancy|1|||
28151219|NCT02770170|54819976|FG001|Overall Study|due to pregnancy|0|||
28151220|NCT02770170|54819977|FG002|Overall Study|due to pregnancy|0|||
28151221|NCT02770170|54819978|FG003|Overall Study|due to pregnancy|0|||
28151222|NCT02770170|54819975|FG000|Overall Study|Lack of Efficacy|2|||
28151223|NCT02770170|54819976|FG001|Overall Study|Lack of Efficacy|0|||
28151224|NCT02770170|54819977|FG002|Overall Study|Lack of Efficacy|0|||
28151225|NCT02770170|54819978|FG003|Overall Study|Lack of Efficacy|1|||
28151226|NCT02770170|54819975|FG000|Overall Study|Adverse Event|4|||
28151227|NCT02770170|54819976|FG001|Overall Study|Adverse Event|3|||
28151228|NCT02770170|54819977|FG002|Overall Study|Adverse Event|5|||
28151229|NCT02770170|54819978|FG003|Overall Study|Adverse Event|3|||
28151230|NCT02770170|54819975|FG000|Overall Study|due to disease worsening|0|||
28151231|NCT02770170|54819976|FG001|Overall Study|due to disease worsening|0|||
28151232|NCT02770170|54819977|FG002|Overall Study|due to disease worsening|0|||
28151233|NCT02770170|54819978|FG003|Overall Study|due to disease worsening|1|||
28151234|NCT02769858|54819988|FG000|Overall Study|Withdrawal by Subject|2|||
28151235|NCT02769624|54819992|FG000|Overall Study|Lost to Follow-up|0|||
28151236|NCT02769624|54819993|FG001|Overall Study|Lost to Follow-up|1|||
28151237|NCT03446768|54820001|FG000|Overall Study|Withdrawal by Subject|0|||
28151238|NCT03446768|54820002|FG001|Overall Study|Withdrawal by Subject|1|||
28151239|NCT02676284|54820008|FG000|Overall Study|Withdrawal by Subject|1|||
28151240|NCT02769312|54820014|FG000|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
28151241|NCT02769312|54820015|FG001|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
28151242|NCT02769312|54820014|FG000|Double-Blind (0-2 Weeks)|Adverse Event|1|||
28151243|NCT02769312|54820015|FG001|Double-Blind (0-2 Weeks)|Adverse Event|0|||
28151244|NCT02769312|54820014|FG000|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1|||
28151245|NCT02769312|54820015|FG001|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0|||
28151246|NCT02769312|54820014|FG000|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0|||
28151247|NCT02769312|54820015|FG001|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1|||
28151248|NCT02769312|54820014|FG000|Follow-up|Lost to Follow-up|1|||
28151249|NCT02769312|54820015|FG001|Follow-up|Lost to Follow-up|1|||
28151250|NCT01673386|54820022|FG000|Overall Study|Study terminated by sponsor|16|||
28151251|NCT01673386|54820023|FG001|Overall Study|Study terminated by sponsor|22|||
28151252|NCT01673386|54820022|FG000|Overall Study|Adverse Event|5|||
28151253|NCT01673386|54820023|FG001|Overall Study|Adverse Event|2|||
28151254|NCT01673386|54820022|FG000|Overall Study|Progressive disease|4|||
28151255|NCT01673386|54820023|FG001|Overall Study|Progressive disease|1|||
28151256|NCT01673386|54820022|FG000|Overall Study|Withdrawal by Subject|0|||
28151257|NCT01673386|54820023|FG001|Overall Study|Withdrawal by Subject|2|||
28151258|NCT00103740|54820031|FG000|Period 1 - Core|Adverse Event|1|||
28151259|NCT00103740|54820032|FG001|Period 1 - Core|Adverse Event|0|||
27850264|NCT04178967|54349325|FG010|Induction Period|Lack of Efficacy|0|||
28151260|NCT00103740|54820031|FG000|Period 1 - Core|Protocol Violation|3|||
28151261|NCT00103740|54820032|FG001|Period 1 - Core|Protocol Violation|2|||
28151262|NCT00103740|54820031|FG000|Period 1 - Core|Patient withdrew consent|3|||
28151263|NCT00103740|54820032|FG001|Period 1 - Core|Patient withdrew consent|2|||
28151264|NCT00103740|54820031|FG000|Period 2 - Extended Observation Period|Lost to Follow-up|7|||
28073414|NCT00129402|54728062|FG001|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
28151265|NCT00103740|54820032|FG001|Period 2 - Extended Observation Period|Lost to Follow-up|6|||
28151266|NCT00103740|54820031|FG000|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21|||
28151267|NCT00103740|54820032|FG001|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13|||
28151268|NCT00103740|54820031|FG000|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5|||
28151269|NCT00103740|54820032|FG001|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6|||
28151270|NCT00103740|54820031|FG000|Period 2 - Extended Observation Period|Death|6|||
28151271|NCT00103740|54820032|FG001|Period 2 - Extended Observation Period|Death|2|||
28151272|NCT00103740|54820031|FG000|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30|||
28151273|NCT00103740|54820032|FG001|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9|||
28151274|NCT01281644|54820038|FG000|Overall Study|Lost to Follow-up|3|||
28151275|NCT01281644|54820038|FG000|Overall Study|Withdrawal by Subject|2|||
28151276|NCT02869893|54820044|FG000|Overall Study|participant aversion to IV|5|||
28151277|NCT02869893|54820044|FG000|Overall Study|participant fear of MRI scanner|2|||
28151278|NCT02872311|54820077|FG000|Overall Study|Death|2|||
28151279|NCT02872311|54820078|FG001|Overall Study|Death|0|||
28151280|NCT02872311|54820079|FG002|Overall Study|Death|0|||
28151281|NCT02872311|54820080|FG003|Overall Study|Death|0|||
28151282|NCT02872311|54820081|FG004|Overall Study|Death|0|||
28151283|NCT02872311|54820077|FG000|Overall Study|Lost to Follow-up|2|||
28151284|NCT02872311|54820078|FG001|Overall Study|Lost to Follow-up|0|||
28151285|NCT02872311|54820079|FG002|Overall Study|Lost to Follow-up|0|||
28151286|NCT02872311|54820080|FG003|Overall Study|Lost to Follow-up|0|||
28151287|NCT02872311|54820081|FG004|Overall Study|Lost to Follow-up|0|||
28151288|NCT02872311|54820077|FG000|Overall Study|Protocol Violation|0|||
28151289|NCT02872311|54820078|FG001|Overall Study|Protocol Violation|2|||
28151290|NCT02872311|54820079|FG002|Overall Study|Protocol Violation|1|||
28151291|NCT02872311|54820080|FG003|Overall Study|Protocol Violation|0|||
28151292|NCT02872311|54820081|FG004|Overall Study|Protocol Violation|0|||
28151293|NCT02871375|54820109|FG000|Period 1, First 14 Days of Wear|Inclusion criteria not met|0|||
28151294|NCT02871375|54820110|FG001|Period 1, First 14 Days of Wear|Inclusion criteria not met|1|||
28151295|NCT02867709|54820121|FG000|Treatment Period|Adverse Event|1|||
28151296|NCT02867709|54820122|FG001|Treatment Period|Adverse Event|1|||
28151297|NCT02867709|54820123|FG002|Treatment Period|Adverse Event|2|||
28151298|NCT02867709|54820121|FG000|Treatment Period|Withdrawal of Consent|7|||
28151299|NCT02867709|54820122|FG001|Treatment Period|Withdrawal of Consent|9|||
28151300|NCT02867709|54820123|FG002|Treatment Period|Withdrawal of Consent|8|||
28151301|NCT02867709|54820121|FG000|Treatment Period|Lost to Follow-up|17|||
28151302|NCT02867709|54820122|FG001|Treatment Period|Lost to Follow-up|20|||
28151303|NCT02867709|54820123|FG002|Treatment Period|Lost to Follow-up|20|||
28151304|NCT02867709|54820121|FG000|Treatment Period|Lack of Qualifying Event|42|||
28151305|NCT02867709|54820122|FG001|Treatment Period|Lack of Qualifying Event|55|||
28151306|NCT02867709|54820123|FG002|Treatment Period|Lack of Qualifying Event|42|||
27822855|NCT04146363|54286915|FG006|Induction Period|Withdrawal by Subject|0|||
28073415|NCT00129402|54728063|FG002|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
28073416|NCT00129402|54728064|FG003|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
28073417|NCT00129402|54728065|FG004|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
28073418|NCT00129402|54728066|FG005|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
28073419|NCT00129402|54728067|FG006|Start Period3 to End Period3(Week 34-53)|Subject moved|1|||
28073420|NCT00129402|54728061|FG000|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
28073421|NCT00129402|54728062|FG001|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
28073422|NCT00129402|54728063|FG002|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
28073423|NCT00129402|54728064|FG003|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
28073424|NCT00129402|54728065|FG004|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
28073425|NCT00129402|54728066|FG005|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
28073426|NCT00129402|54728067|FG006|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1|||
28073427|NCT03739528|54728077|FG000|Overall Study|Not treated|8|||
28073428|NCT03739528|54728078|FG001|Overall Study|Not treated|12|||
28073429|NCT03739528|54728077|FG000|Overall Study|Treatment and study discontinued|6|||
28073430|NCT03739528|54728078|FG001|Overall Study|Treatment and study discontinued|2|||
28073431|NCT03739528|54728077|FG000|Overall Study|Treatment discontinued + study completed|1|||
28151307|NCT02867709|54820121|FG000|Treatment Period|Protocol Violation|3|||
28151308|NCT02867709|54820122|FG001|Treatment Period|Protocol Violation|2|||
28151309|NCT02867709|54820123|FG002|Treatment Period|Protocol Violation|3|||
28151310|NCT02867709|54820121|FG000|Safety Follow-up Period|Withdrawal of Consent|1|||
28151311|NCT02867709|54820122|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
28151312|NCT02867709|54820123|FG002|Safety Follow-up Period|Withdrawal of Consent|6|||
28151313|NCT02867709|54820121|FG000|Safety Follow-up Period|Lost to Follow-up|10|||
28151314|NCT02867709|54820122|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
28151315|NCT02867709|54820123|FG002|Safety Follow-up Period|Lost to Follow-up|7|||
28151316|NCT02867709|54820121|FG000|Safety Follow-up Period|Pregnancy|0|||
28151317|NCT02867709|54820122|FG001|Safety Follow-up Period|Pregnancy|1|||
28151318|NCT02867709|54820123|FG002|Safety Follow-up Period|Pregnancy|0|||
28151319|NCT02867709|54820121|FG000|Safety Follow-up Period|Protocol Violation|0|||
28151320|NCT02867709|54820122|FG001|Safety Follow-up Period|Protocol Violation|1|||
28151321|NCT02867709|54820123|FG002|Safety Follow-up Period|Protocol Violation|1|||
28151322|NCT03044353|54820134|FG000|Overall Study|Adverse Event|0|||
28151323|NCT03044353|54820135|FG001|Overall Study|Adverse Event|1|||
28151324|NCT03044353|54820136|FG002|Overall Study|Adverse Event|0|||
28151325|NCT01361308|54820145|FG000|Overall Study|Withdrawal by Subject|9|||
28151326|NCT01361308|54820146|FG001|Overall Study|Withdrawal by Subject|13|||
28151327|NCT01361308|54820145|FG000|Overall Study|Physician Decision|3|||
28151328|NCT01361308|54820146|FG001|Overall Study|Physician Decision|3|||
28151329|NCT01361308|54820145|FG000|Overall Study|Lack of Efficacy|2|||
28151330|NCT01361308|54820146|FG001|Overall Study|Lack of Efficacy|0|||
28151331|NCT01361308|54820145|FG000|Overall Study|Protocol Violation|1|||
28151332|NCT01361308|54820146|FG001|Overall Study|Protocol Violation|0|||
28151333|NCT01361308|54820145|FG000|Overall Study|Lost to Follow-up|5|||
28151334|NCT01361308|54820146|FG001|Overall Study|Lost to Follow-up|4|||
28151335|NCT01361308|54820145|FG000|Overall Study|Adverse Event|8|||
28151336|NCT01361308|54820146|FG001|Overall Study|Adverse Event|4|||
28151337|NCT01361308|54820145|FG000|Overall Study|Eligibility Criteria Not Met|2|||
28151338|NCT01361308|54820146|FG001|Overall Study|Eligibility Criteria Not Met|3|||
28151339|NCT01361308|54820145|FG000|Overall Study|Failed C-SSRS|5|||
28151340|NCT01361308|54820146|FG001|Overall Study|Failed C-SSRS|2|||
28151341|NCT01361308|54820145|FG000|Overall Study|Other|0|||
28151342|NCT01361308|54820146|FG001|Overall Study|Other|1|||
28151343|NCT02872935|54820158|FG000|Overall Study|Other|0|||
28151344|NCT02872935|54820159|FG001|Overall Study|Other|1|||
28151345|NCT00103662|54820167|FG000|Overall Study|Entered Rescue Procedure|0|||
28151346|NCT00103662|54820168|FG001|Overall Study|Entered Rescue Procedure|7|||
28151347|NCT00103662|54820167|FG000|Overall Study|Death|7|||
27850265|NCT04178967|54349315|FG000|Induction Period|Protocol Violation|0|||
28151348|NCT00103662|54820168|FG001|Overall Study|Death|7|||
28151349|NCT00103662|54820167|FG000|Overall Study|Elective Withdrawal|5|||
28151350|NCT00103662|54820168|FG001|Overall Study|Elective Withdrawal|5|||
28151351|NCT00103662|54820167|FG000|Overall Study|Lost to Follow-up|0|||
28151352|NCT00103662|54820168|FG001|Overall Study|Lost to Follow-up|1|||
28151353|NCT00103662|54820167|FG000|Overall Study|Other|6|||
28151354|NCT00103662|54820168|FG001|Overall Study|Other|9|||
28151355|NCT00103662|54820167|FG000|Overall Study|Failed mobilization|0|||
28151356|NCT00103662|54820168|FG001|Overall Study|Failed mobilization|4|||
28073432|NCT03739528|54728078|FG001|Overall Study|Treatment discontinued + study completed|3|||
28073433|NCT00114738|54728087|FG000|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1|||
28073434|NCT00114738|54728088|FG001|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
28073435|NCT00114738|54728089|FG002|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
28073436|NCT00114738|54728087|FG000|Bortezomib Then Bortezomib + Induction|Progressive Disease|1|||
28073437|NCT00114738|54728088|FG001|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
28073438|NCT00114738|54728089|FG002|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
28073439|NCT00114738|54728087|FG000|Screening for Randomization|Neuropathy|17|||
28073440|NCT00114738|54728088|FG001|Screening for Randomization|Neuropathy|0|||
28073441|NCT00114738|54728089|FG002|Screening for Randomization|Neuropathy|0|||
28073442|NCT00114738|54728087|FG000|Screening for Randomization|Progressive disease|2|||
28073443|NCT00114738|54728088|FG001|Screening for Randomization|Progressive disease|0|||
28073444|NCT00114738|54728089|FG002|Screening for Randomization|Progressive disease|0|||
28073445|NCT00114738|54728087|FG000|Screening for Randomization|CNS Hemorrhage|1|||
28151357|NCT00103662|54820167|FG000|Overall Study|Intercurrent illness|1|||
28151358|NCT00103662|54820168|FG001|Overall Study|Intercurrent illness|0|||
28151359|NCT02865915|54820176|FG000|Overall Study|Pregnancy|1|||
28073446|NCT00114738|54728088|FG001|Screening for Randomization|CNS Hemorrhage|0|||
28073447|NCT00114738|54728089|FG002|Screening for Randomization|CNS Hemorrhage|0|||
28073448|NCT00114738|54728087|FG000|Screening for Randomization|Other|1|||
28073449|NCT00114738|54728088|FG001|Screening for Randomization|Other|0|||
28073450|NCT00114738|54728089|FG002|Screening for Randomization|Other|0|||
28073451|NCT00148122|54728096|FG000|Overall Study|Withdrawal by Subject|2|||
28073452|NCT00147498|54728104|FG000|Overall Study|Adverse Event|1|||
28073453|NCT00147498|54728105|FG001|Overall Study|Adverse Event|6|||
28073454|NCT00147498|54728106|FG002|Overall Study|Adverse Event|7|||
28073455|NCT00147498|54728107|FG003|Overall Study|Adverse Event|3|||
28073456|NCT00147498|54728104|FG000|Overall Study|Lack of Efficacy|1|||
28073457|NCT00147498|54728105|FG001|Overall Study|Lack of Efficacy|1|||
28073458|NCT00147498|54728106|FG002|Overall Study|Lack of Efficacy|1|||
28073459|NCT00147498|54728107|FG003|Overall Study|Lack of Efficacy|8|||
28151360|NCT02865915|54820177|FG001|Overall Study|Pregnancy|0|||
28151361|NCT02865915|54820176|FG000|Overall Study|Withdrawal by Subject|1|||
28151362|NCT02865915|54820177|FG001|Overall Study|Withdrawal by Subject|1|||
28151363|NCT02865915|54820176|FG000|Overall Study|Adverse Event|0|||
28151364|NCT02865915|54820177|FG001|Overall Study|Adverse Event|4|||
28151365|NCT02865915|54820176|FG000|Overall Study|Lost to Follow-up|0|||
28151366|NCT02865915|54820177|FG001|Overall Study|Lost to Follow-up|1|||
28151367|NCT02865915|54820176|FG000|Overall Study|Protocol Violation|0|||
28151368|NCT02865915|54820177|FG001|Overall Study|Protocol Violation|1|||
28151369|NCT02865915|54820176|FG000|Overall Study|Study terminated by sponsor|23|||
28151370|NCT02865915|54820177|FG001|Overall Study|Study terminated by sponsor|18|||
28151371|NCT02865915|54820176|FG000|Overall Study|Dosing group discontinued|0|||
28151372|NCT02865915|54820177|FG001|Overall Study|Dosing group discontinued|5|||
28151373|NCT00104676|54820185|FG000|Overall Study|Death|3|||
28151374|NCT00104676|54820186|FG001|Overall Study|Death|2|||
28151375|NCT00104676|54820185|FG000|Overall Study|Withdrawal by Subject|0|||
28151376|NCT00104676|54820186|FG001|Overall Study|Withdrawal by Subject|2|||
28151377|NCT00104676|54820185|FG000|Overall Study|treatment interruption|4|||
28151378|NCT00104676|54820186|FG001|Overall Study|treatment interruption|10|||
28151379|NCT00354835|54820194|FG000|Overall Study|Death|1|||
28151380|NCT00354835|54820195|FG001|Overall Study|Death|1|||
28151381|NCT00354835|54820194|FG000|Overall Study|Physician Decision|8|||
28151382|NCT00354835|54820195|FG001|Overall Study|Physician Decision|13|||
28151383|NCT00354835|54820194|FG000|Overall Study|Withdrawal by Subject|2|||
28151384|NCT00354835|54820195|FG001|Overall Study|Withdrawal by Subject|1|||
28151385|NCT00354835|54820194|FG000|Overall Study|Ineligible|17|||
28073460|NCT00147498|54728104|FG000|Overall Study|Laboratory abnormality|0|||
28073461|NCT00147498|54728105|FG001|Overall Study|Laboratory abnormality|0|||
28151386|NCT00354835|54820195|FG001|Overall Study|Ineligible|16|||
28151387|NCT00354835|54820194|FG000|Overall Study|Disease progression or relapse|15|||
28151388|NCT00354835|54820195|FG001|Overall Study|Disease progression or relapse|22|||
28151389|NCT00354835|54820194|FG000|Overall Study|Adverse Event|6|||
28151390|NCT00354835|54820195|FG001|Overall Study|Adverse Event|0|||
28151391|NCT00354835|54820194|FG000|Overall Study|Refusal of further therapy|3|||
28151392|NCT00354835|54820195|FG001|Overall Study|Refusal of further therapy|8|||
28151393|NCT02768298|54820218|FG000|Overall Study|Adverse Event|1|||
28151394|NCT02768298|54820219|FG001|Overall Study|Adverse Event|4|||
28151395|NCT02768298|54820218|FG000|Overall Study|Death|2|||
28151396|NCT02768298|54820219|FG001|Overall Study|Death|1|||
28151397|NCT02768298|54820218|FG000|Overall Study|Non-compliance with study treatment|0|||
28151398|NCT02768298|54820219|FG001|Overall Study|Non-compliance with study treatment|1|||
28151399|NCT02768298|54820218|FG000|Overall Study|Subject/guardian decision|1|||
28151400|NCT02768298|54820219|FG001|Overall Study|Subject/guardian decision|0|||
28151401|NCT02768298|54820218|FG000|Overall Study|Withdrawal of informed consent|0|||
28151402|NCT02768298|54820219|FG001|Overall Study|Withdrawal of informed consent|1|||
28151403|NCT02775864|54820229|FG000|Overall Study|Data ended end of 2010|1764|||
28151404|NCT02775864|54820230|FG001|Overall Study|Data ended end of 2010|2880|||
28151405|NCT02775864|54820231|FG002|Overall Study|Data ended end of 2010|1140|||
28151406|NCT02775864|54820232|FG003|Overall Study|Data ended end of 2010|1194|||
28151407|NCT02775864|54820229|FG000|Overall Study|Medicaid eligibility discontinued|1478|||
28151408|NCT02775864|54820230|FG001|Overall Study|Medicaid eligibility discontinued|2019|||
27822856|NCT04146363|54286916|FG007|Induction Period|Withdrawal by Subject|0|||
28151409|NCT02775864|54820231|FG002|Overall Study|Medicaid eligibility discontinued|720|||
28151410|NCT02775864|54820232|FG003|Overall Study|Medicaid eligibility discontinued|890|||
28151411|NCT02964273|54820245|FG000|Phase A: Double-blind Period (12 Months)|Adverse Events|1|||
28151412|NCT02964273|54820246|FG001|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
28151413|NCT02964273|54820247|FG002|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
27822857|NCT04146363|54286917|FG008|Induction Period|Withdrawal by Subject|0|||
27822858|NCT04146363|54286918|FG009|Induction Period|Withdrawal by Subject|0|||
27822859|NCT04146363|54286919|FG010|Induction Period|Withdrawal by Subject|0|||
27822860|NCT04146363|54286909|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
27822861|NCT04146363|54286910|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
27822862|NCT04146363|54286911|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
27822863|NCT04146363|54286912|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
27822864|NCT04146363|54286913|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
27822865|NCT04146363|54286914|FG005|Maintenance Blinded Treatment Period|Adverse Event|0|||
27822866|NCT04146363|54286915|FG006|Maintenance Blinded Treatment Period|Adverse Event|1|||
27822867|NCT04146363|54286916|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
27822868|NCT04146363|54286917|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
27822869|NCT04146363|54286918|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
27822870|NCT04146363|54286919|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
27822871|NCT04146363|54286909|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
27822872|NCT04146363|54286910|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
27822873|NCT04146363|54286911|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
28151414|NCT02964273|54820248|FG003|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
28151415|NCT02964273|54820245|FG000|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
28151416|NCT02964273|54820246|FG001|Phase A: Double-blind Period (12 Months)|Physician Decision|2|||
28151417|NCT02964273|54820247|FG002|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
28151418|NCT02964273|54820248|FG003|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
28151419|NCT02964273|54820245|FG000|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|3|||
28151420|NCT02964273|54820246|FG001|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|1|||
28151421|NCT02964273|54820247|FG002|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
28151422|NCT02964273|54820248|FG003|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
28151423|NCT02964273|54820245|FG000|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
28151424|NCT02964273|54820246|FG001|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
28151425|NCT02964273|54820247|FG002|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
28151426|NCT02964273|54820248|FG003|Phase B: Open-label Period (24 Months)|Adverse Events|2|||
28151427|NCT02964273|54820245|FG000|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
28151428|NCT02964273|54820246|FG001|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
27822874|NCT04146363|54286912|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
27850266|NCT04178967|54349316|FG001|Induction Period|Protocol Violation|6|||
27850267|NCT04178967|54349317|FG002|Induction Period|Protocol Violation|0|||
27941802|NCT01995175|54598382|FG000|Period 1 - From 0 up to 2 Years of Age|Withdrawal by Subject|35|||
28151429|NCT02964273|54820247|FG002|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|4|||
28151430|NCT02964273|54820248|FG003|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|3|||
27822875|NCT04146363|54286913|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
28151431|NCT02964273|54820245|FG000|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
28151432|NCT02964273|54820246|FG001|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
28151433|NCT02964273|54820247|FG002|Phase B: Open-label Period (24 Months)|Reason Not Specified|2|||
28151434|NCT02964273|54820248|FG003|Phase B: Open-label Period (24 Months)|Reason Not Specified|1|||
28151435|NCT02773446|54820267|FG000|First Admission|Withdrawal by Subject|0|||
28151436|NCT02773446|54820268|FG001|First Admission|Withdrawal by Subject|0|||
28151437|NCT02773446|54820269|FG002|First Admission|Withdrawal by Subject|0|||
28151438|NCT02773446|54820270|FG003|First Admission|Withdrawal by Subject|1|||
28151439|NCT02773446|54820271|FG004|First Admission|Withdrawal by Subject|0|||
28151440|NCT02773446|54820272|FG005|First Admission|Withdrawal by Subject|0|||
28151441|NCT02773446|54820267|FG000|First Admission|Lost to Follow-up|1|||
28151442|NCT02773446|54820268|FG001|First Admission|Lost to Follow-up|0|||
28151443|NCT02773446|54820269|FG002|First Admission|Lost to Follow-up|0|||
28151444|NCT02773446|54820270|FG003|First Admission|Lost to Follow-up|0|||
28151445|NCT02773446|54820271|FG004|First Admission|Lost to Follow-up|0|||
28151446|NCT02773446|54820272|FG005|First Admission|Lost to Follow-up|0|||
28151447|NCT02773368|54820291|FG000|Overall Study|Lost to Follow-up|4|||
28151448|NCT02773368|54820292|FG001|Overall Study|Lost to Follow-up|1|||
28151449|NCT02773368|54820291|FG000|Overall Study|Withdrawal by Subject|5|||
28151450|NCT02773368|54820292|FG001|Overall Study|Withdrawal by Subject|1|||
28151451|NCT02773368|54820291|FG000|Overall Study|Unclassified|1|||
28151452|NCT02773368|54820292|FG001|Overall Study|Unclassified|1|||
28151453|NCT02773368|54820291|FG000|Overall Study|Missing|0|||
28151454|NCT02773368|54820292|FG001|Overall Study|Missing|1|||
28151455|NCT01336647|54820301|FG000|Overall Study|Lost to Follow-up|4|||
28151456|NCT01336647|54820302|FG001|Overall Study|Lost to Follow-up|1|||
28151457|NCT01336647|54820303|FG002|Overall Study|Lost to Follow-up|3|||
28151458|NCT01336569|54820313|FG000|Overall Study|Lost to Follow-up|4|||
28151459|NCT02772978|54820317|FG000|Overall Study|Withdrawal by Subject|1|||
28151460|NCT02772978|54820318|FG001|Overall Study|Withdrawal by Subject|1|||
28151461|NCT00104052|54820323|FG000|Overall Study|Adverse Event|1|||
28151462|NCT00104052|54820323|FG000|Overall Study|Lack of Efficacy|26|||
28151463|NCT00104052|54820323|FG000|Overall Study|Discontinuation unrelated to treatment|2|||
28151464|NCT02777970|54820330|FG000|Overall Study|Lost to Follow-up|0|||
28151465|NCT02777970|54820331|FG001|Overall Study|Lost to Follow-up|1|||
28151466|NCT02777970|54820332|FG002|Overall Study|Lost to Follow-up|0|||
28151467|NCT02777970|54820330|FG000|Overall Study|Protocol Violation|1|||
27822876|NCT04146363|54286914|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
27822877|NCT04146363|54286915|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
27822878|NCT04146363|54286916|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
27822879|NCT04146363|54286917|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
27822880|NCT04146363|54286918|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
27822881|NCT04146363|54286919|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
28073462|NCT00147498|54728106|FG002|Overall Study|Laboratory abnormality|2|||
28073463|NCT00147498|54728107|FG003|Overall Study|Laboratory abnormality|0|||
28073464|NCT00147498|54728104|FG000|Overall Study|Participant defaulted|0|||
28073465|NCT00147498|54728105|FG001|Overall Study|Participant defaulted|1|||
28073466|NCT00147498|54728106|FG002|Overall Study|Participant defaulted|4|||
28073467|NCT00147498|54728107|FG003|Overall Study|Participant defaulted|3|||
28073468|NCT00147498|54728104|FG000|Overall Study|Other|1|||
28073469|NCT00147498|54728105|FG001|Overall Study|Other|1|||
28073470|NCT00147498|54728106|FG002|Overall Study|Other|3|||
28151468|NCT02777970|54820331|FG001|Overall Study|Protocol Violation|0|||
27822882|NCT04146363|54286909|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
27822883|NCT04146363|54286910|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
27822884|NCT04146363|54286911|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
27822885|NCT04146363|54286912|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
28073471|NCT00147498|54728107|FG003|Overall Study|Other|3|||
28073472|NCT00113568|54728117|FG000|Overall Study|Adverse Event|97|||
28151469|NCT02777970|54820332|FG002|Overall Study|Protocol Violation|0|||
28151470|NCT03037489|54820344|FG000|Overall Study|Adverse Event|4|||
27822886|NCT04146363|54286913|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
28073473|NCT00113568|54728117|FG000|Overall Study|Death|1|||
28073474|NCT00113568|54728117|FG000|Overall Study|Lack of Efficacy|30|||
28151471|NCT03037489|54820345|FG001|Overall Study|Adverse Event|0|||
28151472|NCT03037489|54820344|FG000|Overall Study|Withdrawal by Subject|3|||
28151473|NCT03037489|54820345|FG001|Overall Study|Withdrawal by Subject|0|||
28151474|NCT01336023|54820354|FG000|Week 0 to Week 26|Adverse Event|8|||
28151475|NCT01336023|54820355|FG001|Week 0 to Week 26|Adverse Event|10|||
28151476|NCT01336023|54820356|FG002|Week 0 to Week 26|Adverse Event|24|||
28151477|NCT01336023|54820354|FG000|Week 0 to Week 26|Lack of Efficacy|0|||
28151478|NCT01336023|54820355|FG001|Week 0 to Week 26|Lack of Efficacy|1|||
28151479|NCT01336023|54820356|FG002|Week 0 to Week 26|Lack of Efficacy|0|||
28151480|NCT01336023|54820354|FG000|Week 0 to Week 26|Protocol Violation|1|||
28151481|NCT01336023|54820355|FG001|Week 0 to Week 26|Protocol Violation|2|||
28151482|NCT01336023|54820356|FG002|Week 0 to Week 26|Protocol Violation|0|||
28151483|NCT01336023|54820354|FG000|Week 0 to Week 26|Withdrawal Criteria|34|||
28151484|NCT01336023|54820355|FG001|Week 0 to Week 26|Withdrawal Criteria|69|||
27822887|NCT04146363|54286914|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
27822888|NCT04146363|54286915|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
27822889|NCT04146363|54286916|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
27822890|NCT04146363|54286917|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
28151485|NCT01336023|54820356|FG002|Week 0 to Week 26|Withdrawal Criteria|40|||
28151486|NCT01336023|54820354|FG000|Week 0 to Week 26|Unclassified|5|||
28151487|NCT01336023|54820355|FG001|Week 0 to Week 26|Unclassified|16|||
28151488|NCT01336023|54820356|FG002|Week 0 to Week 26|Unclassified|9|||
28151489|NCT01336023|54820354|FG000|Week 27 to 52|Adverse Event|1|||
28151490|NCT01336023|54820355|FG001|Week 27 to 52|Adverse Event|5|||
28151491|NCT01336023|54820356|FG002|Week 27 to 52|Adverse Event|2|||
28151492|NCT01336023|54820354|FG000|Week 27 to 52|Protocol Violation|0|||
27822891|NCT04146363|54286918|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
27822892|NCT04146363|54286919|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
27822893|NCT04146363|54286909|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
28151493|NCT01336023|54820355|FG001|Week 27 to 52|Protocol Violation|2|||
28151494|NCT01336023|54820356|FG002|Week 27 to 52|Protocol Violation|1|||
28151495|NCT01336023|54820354|FG000|Week 27 to 52|Withdrawal Criteria|14|||
28151496|NCT01336023|54820355|FG001|Week 27 to 52|Withdrawal Criteria|19|||
28151497|NCT01336023|54820356|FG002|Week 27 to 52|Withdrawal Criteria|16|||
28151498|NCT01336023|54820354|FG000|Week 27 to 52|Unclassified|13|||
28151499|NCT01336023|54820355|FG001|Week 27 to 52|Unclassified|18|||
28151500|NCT01336023|54820356|FG002|Week 27 to 52|Unclassified|9|||
28151501|NCT03039283|54820364|FG000|Overall Study|Protocol Violation|2|||
28151502|NCT02863575|54820386|FG000|Overall Study|Participants Unable To Swallow Capsule|1|||
28151503|NCT02863575|54820387|FG001|Overall Study|Participants Unable To Swallow Capsule|0|||
28151504|NCT02863575|54820388|FG002|Overall Study|Participants Unable To Swallow Capsule|0|||
27822894|NCT04146363|54286910|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
27822895|NCT04146363|54286911|FG002|Maintenance Blinded Treatment Period|Physician Decision|1|||
28151505|NCT02863575|54820386|FG000|Overall Study|Withdrawal by Subject|0|||
28151506|NCT02863575|54820387|FG001|Overall Study|Withdrawal by Subject|1|||
28151507|NCT02863575|54820388|FG002|Overall Study|Withdrawal by Subject|1|||
28151508|NCT02863575|54820386|FG000|Overall Study|Adverse Event|0|||
28151509|NCT02863575|54820387|FG001|Overall Study|Adverse Event|1|||
28151510|NCT02863575|54820388|FG002|Overall Study|Adverse Event|0|||
28151511|NCT01227187|54820400|FG000|Overall Study|Physician Decision|0|||
28151512|NCT01227187|54820401|FG001|Overall Study|Physician Decision|0|||
28151513|NCT01227187|54820402|FG002|Overall Study|Physician Decision|0|||
28151514|NCT01227187|54820403|FG003|Overall Study|Physician Decision|1|||
28151515|NCT02638012|54820424|FG000|Overall Study|Lost to Follow-up|1|||
28151516|NCT00103506|54820430|FG000|Overall Study|Study closed by sponsor|34|||
27822896|NCT04146363|54286912|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
28073475|NCT00113568|54728117|FG000|Overall Study|Lost to Follow-up|156|||
28151517|NCT00103506|54820431|FG001|Overall Study|Study closed by sponsor|37|||
28151518|NCT00103506|54820430|FG000|Overall Study|Death|257|||
28151519|NCT00103506|54820431|FG001|Overall Study|Death|253|||
28151520|NCT00103506|54820430|FG000|Overall Study|Lost to Follow-up|13|||
27822897|NCT04146363|54286913|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
27822898|NCT04146363|54286914|FG005|Maintenance Blinded Treatment Period|Physician Decision|1|||
27822899|NCT04146363|54286915|FG006|Maintenance Blinded Treatment Period|Physician Decision|0|||
27822900|NCT04146363|54286916|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
27822901|NCT04146363|54286917|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
27822902|NCT04146363|54286918|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
27822903|NCT04146363|54286919|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
27822904|NCT04146363|54286909|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
27822905|NCT04146363|54286910|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
27822906|NCT04146363|54286911|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
27822907|NCT04146363|54286912|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
27822908|NCT04146363|54286913|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
27822909|NCT04146363|54286914|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
27822910|NCT04146363|54286915|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|3|||
27822911|NCT04146363|54286916|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|5|||
27822912|NCT04146363|54286917|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
27822913|NCT04146363|54286918|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
27822914|NCT04146363|54286919|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
27822915|NCT04146363|54286909|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
27822916|NCT04146363|54286910|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
27822917|NCT04146363|54286911|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
27822918|NCT04146363|54286912|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
27822919|NCT04146363|54286913|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
27822920|NCT04146363|54286914|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|7|||
27822921|NCT04146363|54286915|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|4|||
27822922|NCT04146363|54286916|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
27822923|NCT04146363|54286917|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
27822924|NCT04146363|54286918|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
27822925|NCT04146363|54286919|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
27822926|NCT04146363|54286909|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
27822927|NCT04146363|54286910|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
27822928|NCT04146363|54286911|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
27822929|NCT04146363|54286912|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
27822930|NCT04146363|54286913|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
27822931|NCT04146363|54286914|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
27822932|NCT04146363|54286915|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
27822933|NCT04146363|54286916|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
27822934|NCT04146363|54286917|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
27822935|NCT04146363|54286918|FG009|Maintenance Open Label Escape Arm|Adverse Event|4|||
27822936|NCT04146363|54286919|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
27822937|NCT04146363|54286909|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
27822938|NCT04146363|54286910|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
27822939|NCT04146363|54286911|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
28073476|NCT00113568|54728117|FG000|Overall Study|Protocol Violation|32|||
28151521|NCT00103506|54820431|FG001|Overall Study|Lost to Follow-up|13|||
28151522|NCT00103506|54820430|FG000|Overall Study|Withdrawal by Subject|18|||
28151523|NCT00103506|54820431|FG001|Overall Study|Withdrawal by Subject|21|||
28151524|NCT02765490|54820439|FG000|Overall Study|Lost to Follow-up|1|||
28151525|NCT02765490|54820440|FG001|Overall Study|Lost to Follow-up|1|||
28151526|NCT02765490|54820439|FG000|Overall Study|Other|0|||
28151527|NCT02765490|54820440|FG001|Overall Study|Other|1|||
28151528|NCT02765490|54820439|FG000|Overall Study|Death|0|||
28151529|NCT02765490|54820440|FG001|Overall Study|Death|1|||
27822940|NCT04146363|54286912|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
27822941|NCT04146363|54286913|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
28151530|NCT02762370|54820448|FG000|Overall Study|Protocol Violation|1|||
28151531|NCT02762370|54820449|FG001|Overall Study|Protocol Violation|0|||
28151532|NCT02639182|54820459|FG000|Overall Study|Disease Progression|50|||
28151533|NCT02639182|54820460|FG001|Overall Study|Disease Progression|49|||
28151534|NCT02639182|54820459|FG000|Overall Study|Adverse Event|7|||
28151535|NCT02639182|54820460|FG001|Overall Study|Adverse Event|5|||
28151536|NCT02639182|54820459|FG000|Overall Study|Physician Decision|3|||
27822942|NCT04146363|54286914|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
27822943|NCT04146363|54286915|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
27822944|NCT04146363|54286916|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
28151537|NCT02639182|54820460|FG001|Overall Study|Physician Decision|3|||
28151538|NCT02639182|54820459|FG000|Overall Study|Withdrew Consent|5|||
28151539|NCT02639182|54820460|FG001|Overall Study|Withdrew Consent|4|||
28151540|NCT02639182|54820459|FG000|Overall Study|Lost to Follow-up|0|||
28151541|NCT02639182|54820460|FG001|Overall Study|Lost to Follow-up|1|||
28151542|NCT02639182|54820459|FG000|Overall Study|Study Closure|1|||
28151543|NCT02639182|54820460|FG001|Overall Study|Study Closure|2|||
28151544|NCT02639182|54820459|FG000|Overall Study|Sponsor Ended Study|0|||
28151545|NCT02639182|54820460|FG001|Overall Study|Sponsor Ended Study|1|||
27822945|NCT04146363|54286917|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|11|||
27822946|NCT04146363|54286918|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|17|||
27822947|NCT04146363|54286919|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
27822948|NCT04146363|54286909|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
27822949|NCT04146363|54286910|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
28151546|NCT02639182|54820459|FG000|Overall Study|Randomized But Did Not Receive Study Drug|1|||
28151547|NCT02639182|54820460|FG001|Overall Study|Randomized But Did Not Receive Study Drug|1|||
28151548|NCT02863419|54820469|FG000|Overall Study|Lost to Follow-up|0|||
28151549|NCT02863419|54820470|FG001|Overall Study|Lost to Follow-up|1|||
28151550|NCT02863419|54820471|FG002|Overall Study|Lost to Follow-up|4|||
28151551|NCT02863419|54820469|FG000|Overall Study|Withdrawal by Subject|5|||
28151552|NCT02863419|54820470|FG001|Overall Study|Withdrawal by Subject|5|||
28151553|NCT02863419|54820471|FG002|Overall Study|Withdrawal by Subject|3|||
28151554|NCT02863419|54820469|FG000|Overall Study|Died|3|||
27822950|NCT04146363|54286911|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
27822951|NCT04146363|54286912|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
27822952|NCT04146363|54286913|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
28151555|NCT02863419|54820470|FG001|Overall Study|Died|4|||
28151556|NCT02863419|54820471|FG002|Overall Study|Died|1|||
28151557|NCT02765100|54820481|FG000|Overall Study|subject found ineligible after baseline|1|||
28151558|NCT02765100|54820482|FG001|Overall Study|subject found ineligible after baseline|1|||
28151559|NCT02765100|54820481|FG000|Overall Study|Lost to Follow-up|0|||
28151560|NCT02765100|54820482|FG001|Overall Study|Lost to Follow-up|1|||
28151561|NCT02761980|54820492|FG000|Overall Study|Adverse Event|4|||
27822953|NCT04146363|54286914|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
27941803|NCT01995175|54598382|FG000|Period 1 - From 0 up to 2 Years of Age|Lost to Follow-up|102|||
28073477|NCT00113568|54728117|FG000|Overall Study|Withdrawal by Subject|117|||
28073478|NCT00113568|54728117|FG000|Overall Study|Other|112|||
28073479|NCT00113490|54728123|FG000|Overall Study|Withdrawal by Subject|1|||
28073480|NCT00113490|54728124|FG001|Overall Study|Withdrawal by Subject|3|||
28073481|NCT00113490|54728123|FG000|Overall Study|Lost to Follow-up|1|||
28073482|NCT00113490|54728124|FG001|Overall Study|Lost to Follow-up|0|||
28073483|NCT00146640|54728132|FG000|Overall Study|Adverse Event|12|||
28151562|NCT02761980|54820493|FG001|Overall Study|Adverse Event|6|||
28151563|NCT02761980|54820494|FG002|Overall Study|Adverse Event|5|||
28151564|NCT02761980|54820495|FG003|Overall Study|Adverse Event|6|||
28073484|NCT00146640|54728133|FG001|Overall Study|Adverse Event|10|||
28073485|NCT00146640|54728132|FG000|Overall Study|Medical Reasons|3|||
28073486|NCT00146640|54728133|FG001|Overall Study|Medical Reasons|0|||
28073487|NCT00146640|54728132|FG000|Overall Study|Non-Medical Reasons|8|||
28151565|NCT02761980|54820492|FG000|Overall Study|Withdrawal by Subject|0|||
28151566|NCT02761980|54820493|FG001|Overall Study|Withdrawal by Subject|1|||
28151567|NCT02761980|54820494|FG002|Overall Study|Withdrawal by Subject|0|||
27941804|NCT01995175|54598382|FG000|Period 1 - From 0 up to 2 Years of Age|Other|67|||
27941805|NCT01995175|54598382|FG000|Period 1 - From 0 up to 2 Years of Age|Migrated / moved from the study area|49|||
28151568|NCT02761980|54820495|FG003|Overall Study|Withdrawal by Subject|0|||
28151569|NCT02761980|54820492|FG000|Overall Study|Other|0|||
28151570|NCT02761980|54820493|FG001|Overall Study|Other|0|||
28151571|NCT02761980|54820494|FG002|Overall Study|Other|1|||
28151572|NCT02761980|54820495|FG003|Overall Study|Other|0|||
27822954|NCT04146363|54286915|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
27822955|NCT04146363|54286916|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
27822956|NCT04146363|54286917|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
27822957|NCT04146363|54286918|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
27822958|NCT04146363|54286919|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
27822959|NCT04146363|54286909|FG000|Maintenance Open Label Escape Arm|Physician Decision|0|||
27822960|NCT04146363|54286910|FG001|Maintenance Open Label Escape Arm|Physician Decision|0|||
27822961|NCT04146363|54286911|FG002|Maintenance Open Label Escape Arm|Physician Decision|0|||
27822962|NCT04146363|54286912|FG003|Maintenance Open Label Escape Arm|Physician Decision|0|||
27822963|NCT04146363|54286913|FG004|Maintenance Open Label Escape Arm|Physician Decision|0|||
27822964|NCT04146363|54286914|FG005|Maintenance Open Label Escape Arm|Physician Decision|0|||
27822965|NCT04146363|54286915|FG006|Maintenance Open Label Escape Arm|Physician Decision|0|||
27822966|NCT04146363|54286916|FG007|Maintenance Open Label Escape Arm|Physician Decision|0|||
27822967|NCT04146363|54286917|FG008|Maintenance Open Label Escape Arm|Physician Decision|1|||
28151573|NCT02862171|54820514|FG000|Overall Study|Death|1|||
28151574|NCT02862171|54820514|FG000|Overall Study|Lost to Follow-up|13|||
28151575|NCT02862171|54820514|FG000|Overall Study|Withdrawal by Subject|57|||
28151576|NCT02862171|54820514|FG000|Overall Study|Non-compliance|4|||
28151577|NCT02862171|54820514|FG000|Overall Study|HIV-1 seroconversion|18|||
28151578|NCT02638948|54820522|FG000|Overall Study|Withdrawal by Subject|4|||
28151579|NCT02638948|54820523|FG001|Overall Study|Withdrawal by Subject|5|||
28151580|NCT02638948|54820524|FG002|Overall Study|Withdrawal by Subject|3|||
28151581|NCT02638948|54820525|FG003|Overall Study|Withdrawal by Subject|1|||
28151582|NCT02638948|54820522|FG000|Overall Study|Administrative Reason by Sponsor|0|||
28151583|NCT02638948|54820523|FG001|Overall Study|Administrative Reason by Sponsor|1|||
28151584|NCT02638948|54820524|FG002|Overall Study|Administrative Reason by Sponsor|0|||
28151585|NCT02638948|54820525|FG003|Overall Study|Administrative Reason by Sponsor|4|||
27822968|NCT04146363|54286918|FG009|Maintenance Open Label Escape Arm|Physician Decision|1|||
27822969|NCT04146363|54286919|FG010|Maintenance Open Label Escape Arm|Physician Decision|0|||
28151586|NCT02638948|54820522|FG000|Overall Study|Adverse Event|0|||
28151587|NCT02638948|54820523|FG001|Overall Study|Adverse Event|0|||
28151588|NCT02638948|54820524|FG002|Overall Study|Adverse Event|1|||
28151589|NCT02638948|54820525|FG003|Overall Study|Adverse Event|1|||
28151590|NCT02638948|54820522|FG000|Overall Study|Lack of Efficacy|1|||
27822970|NCT04146363|54286909|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
27850268|NCT04178967|54349318|FG003|Induction Period|Protocol Violation|0|||
28151591|NCT02638948|54820523|FG001|Overall Study|Lack of Efficacy|1|||
28151592|NCT02638948|54820524|FG002|Overall Study|Lack of Efficacy|0|||
28151593|NCT02638948|54820525|FG003|Overall Study|Lack of Efficacy|0|||
28151594|NCT02638948|54820522|FG000|Overall Study|Lost to Follow-up|0|||
28151595|NCT02638948|54820523|FG001|Overall Study|Lost to Follow-up|0|||
28151596|NCT02638948|54820524|FG002|Overall Study|Lost to Follow-up|1|||
28151597|NCT02638948|54820525|FG003|Overall Study|Lost to Follow-up|1|||
27850269|NCT04178967|54349319|FG004|Induction Period|Protocol Violation|0|||
27850270|NCT04178967|54349320|FG005|Induction Period|Protocol Violation|0|||
27850271|NCT04178967|54349321|FG006|Induction Period|Protocol Violation|0|||
27850272|NCT04178967|54349322|FG007|Induction Period|Protocol Violation|0|||
28151598|NCT02638948|54820522|FG000|Overall Study|Poor/Non-Compliance|0|||
28151599|NCT02638948|54820523|FG001|Overall Study|Poor/Non-Compliance|2|||
27850273|NCT04178967|54349323|FG008|Induction Period|Protocol Violation|0|||
27850274|NCT04178967|54349324|FG009|Induction Period|Protocol Violation|0|||
28151600|NCT02638948|54820524|FG002|Overall Study|Poor/Non-Compliance|1|||
28151601|NCT02638948|54820525|FG003|Overall Study|Poor/Non-Compliance|0|||
28151602|NCT02638948|54820522|FG000|Overall Study|Participant no longer met study criteria|0|||
28151603|NCT02638948|54820523|FG001|Overall Study|Participant no longer met study criteria|1|||
28151604|NCT02638948|54820524|FG002|Overall Study|Participant no longer met study criteria|0|||
28151605|NCT02638948|54820525|FG003|Overall Study|Participant no longer met study criteria|0|||
28151606|NCT02638948|54820522|FG000|Overall Study|Other than specified above|4|||
28151607|NCT02638948|54820523|FG001|Overall Study|Other than specified above|1|||
28151608|NCT02638948|54820524|FG002|Overall Study|Other than specified above|1|||
28151609|NCT02638948|54820525|FG003|Overall Study|Other than specified above|1|||
28151610|NCT00102960|54820541|FG000|Overall Study|Death|23|||
28151611|NCT00102960|54820542|FG001|Overall Study|Death|11|||
28151612|NCT00102960|54820543|FG002|Overall Study|Death|11|||
28151613|NCT00102960|54820541|FG000|Overall Study|Lost to Follow-up|6|||
27941806|NCT01995175|54598382|FG000|Period 2 - From 2 up to 6 Years of Age|Other|21|||
27941807|NCT01995175|54598382|FG000|Period 2 - From 2 up to 6 Years of Age|Lost to Follow-up|22|||
27822971|NCT04146363|54286910|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
27941808|NCT01995175|54598382|FG000|Period 2 - From 2 up to 6 Years of Age|Migrated/moved from the study area|6|||
27941809|NCT01995175|54598382|FG000|Period 2 - From 2 up to 6 Years of Age|Consent withdrawal, not due to a Serious Adverse Event|7|||
27941810|NCT01995175|54598382|FG000|Period 2 - From 2 up to 6 Years of Age|Protocol Violation|1|||
28151614|NCT00102960|54820542|FG001|Overall Study|Lost to Follow-up|12|||
28151615|NCT00102960|54820543|FG002|Overall Study|Lost to Follow-up|16|||
28151616|NCT00102960|54820541|FG000|Overall Study|Withdrawal by Subject|1|||
28151617|NCT00102960|54820542|FG001|Overall Study|Withdrawal by Subject|0|||
28151618|NCT00102960|54820543|FG002|Overall Study|Withdrawal by Subject|1|||
27941811|NCT02243605|54598462|FG000|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
27941812|NCT02243605|54598463|FG001|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
27941813|NCT02243605|54598462|FG000|Stage 1 - Interim Analysis Population|Adverse Event|1|||
27941814|NCT02243605|54598463|FG001|Stage 1 - Interim Analysis Population|Adverse Event|0|||
28151619|NCT02858895|54820555|FG000|Overall Study|Disease progression|31|||
28151620|NCT02858895|54820555|FG000|Overall Study|Death|2|||
27822972|NCT04146363|54286911|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
27822973|NCT04146363|54286912|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
28151621|NCT02858895|54820555|FG000|Overall Study|Adverse Event|1|||
28151622|NCT02858895|54820555|FG000|Overall Study|Withdrawal by Subject|3|||
28151623|NCT02858895|54820555|FG000|Overall Study|hospice,|1|||
28151624|NCT02858895|54820555|FG000|Overall Study|did not receive drug due to catheters misplaced|1|||
28151625|NCT02637856|54820566|FG000|Main Study (Baseline to Week 100)|Adverse Event|9|||
28151626|NCT02637856|54820567|FG001|Main Study (Baseline to Week 100)|Adverse Event|0|||
28151627|NCT02637856|54820566|FG000|Main Study (Baseline to Week 100)|Lost to Follow-up|5|||
28151628|NCT02637856|54820567|FG001|Main Study (Baseline to Week 100)|Lost to Follow-up|0|||
28151629|NCT02637856|54820566|FG000|Main Study (Baseline to Week 100)|Physician Decision|2|||
28151630|NCT02637856|54820567|FG001|Main Study (Baseline to Week 100)|Physician Decision|0|||
28151631|NCT02637856|54820566|FG000|Main Study (Baseline to Week 100)|Pregnancy|7|||
28151632|NCT02637856|54820567|FG001|Main Study (Baseline to Week 100)|Pregnancy|0|||
28151633|NCT02637856|54820566|FG000|Main Study (Baseline to Week 100)|Withdrawal by Subject|20|||
28151634|NCT02637856|54820567|FG001|Main Study (Baseline to Week 100)|Withdrawal by Subject|0|||
28151635|NCT02637856|54820566|FG000|Main Study (Baseline to Week 100)|Protocol Deviation|2|||
28151636|NCT02637856|54820567|FG001|Main Study (Baseline to Week 100)|Protocol Deviation|0|||
28151637|NCT02637856|54820566|FG000|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164|||
28151638|NCT02637856|54820567|FG001|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0|||
28151639|NCT02637856|54820566|FG000|Main Study (Baseline to Week 100)|Failed Drug Test|1|||
28151640|NCT02637856|54820567|FG001|Main Study (Baseline to Week 100)|Failed Drug Test|0|||
28151641|NCT02637856|54820566|FG000|Main Study (Baseline to Week 100)|Incarceration|1|||
28151642|NCT02637856|54820567|FG001|Main Study (Baseline to Week 100)|Incarceration|0|||
28151643|NCT02637856|54820566|FG000|Main Study (Baseline to Week 100)|Pregnancy Attempts|2|||
28151644|NCT02637856|54820567|FG001|Main Study (Baseline to Week 100)|Pregnancy Attempts|0|||
28151645|NCT02637856|54820566|FG000|Main Study (Baseline to Week 100)|Site Closing|6|||
28151646|NCT02637856|54820567|FG001|Main Study (Baseline to Week 100)|Site Closing|0|||
28151647|NCT02637856|54820566|FG000|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0|||
28151648|NCT02637856|54820567|FG001|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1|||
28151649|NCT02637856|54820566|FG000|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0|||
28151650|NCT02637856|54820567|FG001|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3|||
28151651|NCT02858037|54820573|FG000|Overall Study|Death|1|||
28151652|NCT02858037|54820573|FG000|Overall Study|Withdrawal by Subject|18|||
28151653|NCT02858037|54820573|FG000|Overall Study|Participant Relocated, no follow-up planned|26|||
28151654|NCT02858037|54820573|FG000|Overall Study|Lost to Follow-up|3|||
28151655|NCT02858037|54820573|FG000|Overall Study|Other|4|||
28151656|NCT02856555|54820580|FG000|Overall Study|Adverse Event|1|||
28151657|NCT02856555|54820581|FG001|Overall Study|Adverse Event|0|||
28151658|NCT02856555|54820582|FG002|Overall Study|Adverse Event|0|||
28151659|NCT02856555|54820580|FG000|Overall Study|Lost to Follow-up|1|||
28151660|NCT02856555|54820581|FG001|Overall Study|Lost to Follow-up|3|||
27822974|NCT04146363|54286913|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
28073488|NCT00146640|54728133|FG001|Overall Study|Non-Medical Reasons|4|||
28073489|NCT03737110|54728150|FG000|Run-in (RI) Period|Lack of Efficacy|3|||
28073490|NCT03737110|54728151|FG001|Run-in (RI) Period|Lack of Efficacy|0|||
28073491|NCT03737110|54728152|FG002|Run-in (RI) Period|Lack of Efficacy|0|||
28073492|NCT03737110|54728150|FG000|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|3|||
28073493|NCT03737110|54728151|FG001|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
28073494|NCT03737110|54728152|FG002|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
28073495|NCT03737110|54728150|FG000|Run-in (RI) Period|Adverse Event|4|||
28073496|NCT03737110|54728151|FG001|Run-in (RI) Period|Adverse Event|0|||
28073497|NCT03737110|54728152|FG002|Run-in (RI) Period|Adverse Event|0|||
28151661|NCT02856555|54820582|FG002|Overall Study|Lost to Follow-up|0|||
28151662|NCT02856555|54820580|FG000|Overall Study|Withdrawal by Subject|3|||
28151663|NCT02856555|54820581|FG001|Overall Study|Withdrawal by Subject|0|||
28151664|NCT02856555|54820582|FG002|Overall Study|Withdrawal by Subject|0|||
28151665|NCT02856555|54820580|FG000|Overall Study|Randomized but Never Treated|0|||
27822975|NCT04146363|54286914|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
27822976|NCT04146363|54286915|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
27822977|NCT04146363|54286916|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
27822978|NCT04146363|54286917|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|5|||
27822979|NCT04146363|54286918|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
27822980|NCT04146363|54286919|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
27822981|NCT04146363|54286909|FG000|Maintenance Open Label Escape Arm|Pregnancy|0|||
27822982|NCT04146363|54286910|FG001|Maintenance Open Label Escape Arm|Pregnancy|0|||
28151666|NCT02856555|54820581|FG001|Overall Study|Randomized but Never Treated|1|||
28151667|NCT02856555|54820582|FG002|Overall Study|Randomized but Never Treated|0|||
28151668|NCT02637232|54820620|FG000|Overall Study|Lost to Follow-up|42|||
28151669|NCT02637232|54820620|FG000|Overall Study|Adverse Event|11|||
28151670|NCT02637232|54820620|FG000|Overall Study|patient 's decision|2|||
28151671|NCT02855541|54820624|FG000|Overall Study|Change in health status|2|||
28151672|NCT02855541|54820624|FG000|Overall Study|Withdrawal by Subject|2|||
28151673|NCT02635984|54820630|FG000|Overall Study|Lost to Follow-up|2|||
27822983|NCT04146363|54286911|FG002|Maintenance Open Label Escape Arm|Pregnancy|0|||
27822984|NCT04146363|54286912|FG003|Maintenance Open Label Escape Arm|Pregnancy|0|||
27822985|NCT04146363|54286913|FG004|Maintenance Open Label Escape Arm|Pregnancy|0|||
27822986|NCT04146363|54286914|FG005|Maintenance Open Label Escape Arm|Pregnancy|0|||
27822987|NCT04146363|54286915|FG006|Maintenance Open Label Escape Arm|Pregnancy|0|||
27822988|NCT04146363|54286916|FG007|Maintenance Open Label Escape Arm|Pregnancy|0|||
27822989|NCT04146363|54286917|FG008|Maintenance Open Label Escape Arm|Pregnancy|0|||
27822990|NCT04146363|54286918|FG009|Maintenance Open Label Escape Arm|Pregnancy|1|||
27822991|NCT04146363|54286919|FG010|Maintenance Open Label Escape Arm|Pregnancy|0|||
27822992|NCT04146363|54286909|FG000|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
27822993|NCT04146363|54286910|FG001|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
27822994|NCT04146363|54286911|FG002|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
27822995|NCT04146363|54286912|FG003|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
27822996|NCT04146363|54286913|FG004|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
27822997|NCT04146363|54286914|FG005|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
27822998|NCT04146363|54286915|FG006|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
27822999|NCT04146363|54286916|FG007|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
27823000|NCT04146363|54286917|FG008|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
27823001|NCT04146363|54286918|FG009|Maintenance Open Label Escape Arm|EASI Scoring Error|2|||
27823002|NCT04146363|54286919|FG010|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
27823003|NCT01838941|54286944|FG000|Overall Study|Adverse Event|1|||
27823004|NCT01838941|54286944|FG000|Overall Study|Withdrawal by Subject|1|||
28073498|NCT03737110|54728150|FG000|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
28073499|NCT03737110|54728151|FG001|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|1|||
28073500|NCT03737110|54728152|FG002|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
28073501|NCT03737110|54728150|FG000|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
28073502|NCT03737110|54728151|FG001|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
28073503|NCT03737110|54728152|FG002|Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
28073504|NCT00146328|54728173|FG000|Overall Study|Adverse Event|39|||
28073505|NCT00146328|54728174|FG001|Overall Study|Adverse Event|48|||
28073506|NCT00146328|54728175|FG002|Overall Study|Adverse Event|79|||
28073507|NCT00146328|54728173|FG000|Overall Study|Protocol Violation|11|||
28073508|NCT00146328|54728174|FG001|Overall Study|Protocol Violation|6|||
28073509|NCT00146328|54728175|FG002|Overall Study|Protocol Violation|12|||
28073510|NCT00146328|54728173|FG000|Overall Study|Lost to Follow-up|7|||
28073511|NCT00146328|54728174|FG001|Overall Study|Lost to Follow-up|4|||
28073512|NCT00146328|54728175|FG002|Overall Study|Lost to Follow-up|7|||
28073513|NCT00146328|54728173|FG000|Overall Study|Withdrawal by Subject|16|||
28073514|NCT00146328|54728174|FG001|Overall Study|Withdrawal by Subject|16|||
28073515|NCT00146328|54728175|FG002|Overall Study|Withdrawal by Subject|22|||
28073516|NCT00146328|54728173|FG000|Overall Study|Virologic Failure/lack of efficacy|54|||
28073517|NCT00146328|54728174|FG001|Overall Study|Virologic Failure/lack of efficacy|72|||
28073518|NCT00146328|54728175|FG002|Overall Study|Virologic Failure/lack of efficacy|142|||
28073519|NCT00146328|54728173|FG000|Overall Study|Trial ended/site closed|8|||
28073520|NCT00146328|54728174|FG001|Overall Study|Trial ended/site closed|2|||
28073521|NCT00146328|54728175|FG002|Overall Study|Trial ended/site closed|19|||
28073522|NCT00146328|54728173|FG000|Overall Study|Patient decision to end|0|||
28073523|NCT00146328|54728174|FG001|Overall Study|Patient decision to end|1|||
27823005|NCT01773109|54286949|FG000|Overall Study|Symptomatic Progression|2|||
28073524|NCT00146328|54728175|FG002|Overall Study|Patient decision to end|6|||
28151674|NCT02635984|54820631|FG001|Overall Study|Lost to Follow-up|4|||
27823006|NCT01773109|54286949|FG000|Overall Study|Death|1|||
28073525|NCT00146328|54728173|FG000|Overall Study|Enroll into other trial|2|||
28073526|NCT00146328|54728174|FG001|Overall Study|Enroll into other trial|4|||
28073527|NCT00146328|54728175|FG002|Overall Study|Enroll into other trial|2|||
28073528|NCT00146328|54728173|FG000|Overall Study|Death|0|||
28073529|NCT00146328|54728174|FG001|Overall Study|Death|1|||
28073530|NCT00146328|54728175|FG002|Overall Study|Death|1|||
28073531|NCT00146328|54728173|FG000|Overall Study|Moved|2|||
28073532|NCT00146328|54728174|FG001|Overall Study|Moved|0|||
28073533|NCT00146328|54728175|FG002|Overall Study|Moved|0|||
28073534|NCT00146328|54728173|FG000|Overall Study|Interaction with other medication|2|||
28073535|NCT00146328|54728174|FG001|Overall Study|Interaction with other medication|0|||
28151675|NCT02635984|54820630|FG000|Overall Study|Study Arm Closed|1|||
28151676|NCT02635984|54820631|FG001|Overall Study|Study Arm Closed|0|||
27823007|NCT01772719|54286953|FG000|Overall Study|Withdrawal by Subject|3|||
27823008|NCT01772719|54286953|FG000|Overall Study|Adverse Event|2|||
27823009|NCT01772719|54286953|FG000|Overall Study|Protocol Violation|1|||
27823010|NCT01772719|54286953|FG000|Overall Study|Lost to Follow-up|1|||
27823011|NCT01798927|54286960|FG000|Overall Study|Withdrawal by Subject|1|||
27823012|NCT01276288|54287029|FG000|Overall Study|Adverse Event|1|||
27823013|NCT01276288|54287030|FG001|Overall Study|Adverse Event|1|||
27823014|NCT01276288|54287031|FG002|Overall Study|Adverse Event|0|||
27823015|NCT01276288|54287032|FG003|Overall Study|Adverse Event|0|||
27823016|NCT01276288|54287029|FG000|Overall Study|not treated|1|||
27823017|NCT01276288|54287030|FG001|Overall Study|not treated|0|||
27823018|NCT01276288|54287031|FG002|Overall Study|not treated|0|||
27823019|NCT01276288|54287032|FG003|Overall Study|not treated|0|||
27823020|NCT02702271|54287056|FG000|Overall Study|Death|36|||
27823021|NCT02702271|54287057|FG001|Overall Study|Death|7|||
27823022|NCT02702271|54287056|FG000|Overall Study|Lost to Follow-up|12|||
27823023|NCT02702271|54287057|FG001|Overall Study|Lost to Follow-up|0|||
27823024|NCT02702271|54287056|FG000|Overall Study|Withdrawal by Subject|8|||
27823025|NCT02702271|54287057|FG001|Overall Study|Withdrawal by Subject|1|||
27823026|NCT02702271|54287056|FG000|Overall Study|Physician Decision|2|||
27823027|NCT02702271|54287057|FG001|Overall Study|Physician Decision|0|||
27823028|NCT02702271|54287056|FG000|Overall Study|Unsuccessful Implant Attempt|5|||
27823029|NCT02702271|54287057|FG001|Overall Study|Unsuccessful Implant Attempt|1|||
27823030|NCT01276054|54287142|FG000|Overall Study|No one to oversee trial after P.I. left|2|||
27823031|NCT01276054|54287143|FG001|Overall Study|No one to oversee trial after P.I. left|2|||
27823032|NCT01798849|54287152|FG000|Overall Study|Physician Decision|0|||
27823033|NCT01798849|54287153|FG001|Overall Study|Physician Decision|0|||
27823034|NCT01798849|54287154|FG002|Overall Study|Physician Decision|1|||
27823035|NCT01797835|54287234|FG000|Overall Study|Lost to Follow-up|31|||
27823036|NCT01797835|54287235|FG001|Overall Study|Lost to Follow-up|27|||
27823037|NCT01275430|54287241|FG000|Overall Study|Adverse Event|1|||
27823038|NCT01275430|54287241|FG000|Overall Study|No Contrast Injection|6|||
27823039|NCT01275430|54287241|FG000|Overall Study|Device Malfunction|1|||
27823040|NCT01275430|54287241|FG000|Overall Study|Inability to achieve maximum p-wave|1|||
27823041|NCT01838551|54287246|FG000|Overall Study|Adverse Event|16|||
27823042|NCT01838551|54287246|FG000|Overall Study|Death|1|||
27823043|NCT01838551|54287246|FG000|Overall Study|Lack of Efficacy|10|||
27823044|NCT01838551|54287246|FG000|Overall Study|Physician Decision|4|||
27823045|NCT01838551|54287246|FG000|Overall Study|Withdrawal by Subject|10|||
27823046|NCT01838551|54287246|FG000|Overall Study|No reason reported (2); surgery (2), cancer (1), sponsor request (1), bad clinical condition (1)|7|||
27823047|NCT01797445|54287252|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
27823048|NCT01797445|54287253|FG001|Double-Blind Phase|Randomized but Not Treated|2|||
27823049|NCT01797445|54287252|FG000|Double-Blind Phase|Adverse Event|3|||
27823050|NCT01797445|54287253|FG001|Double-Blind Phase|Adverse Event|0|||
27823051|NCT01797445|54287252|FG000|Double-Blind Phase|Death|5|||
27823052|NCT01797445|54287253|FG001|Double-Blind Phase|Death|4|||
27823053|NCT01797445|54287252|FG000|Double-Blind Phase|Pregnancy|0|||
27823054|NCT01797445|54287253|FG001|Double-Blind Phase|Pregnancy|1|||
27823055|NCT01797445|54287252|FG000|Double-Blind Phase|Lack of Efficacy|1|||
27823056|NCT01797445|54287253|FG001|Double-Blind Phase|Lack of Efficacy|2|||
28151677|NCT01147653|54820639|FG000|Year 2|Withdrawal by Subject|2|||
27823057|NCT01797445|54287252|FG000|Double-Blind Phase|Investigator's Discretion|15|||
27823058|NCT01797445|54287253|FG001|Double-Blind Phase|Investigator's Discretion|17|||
27823059|NCT01797445|54287252|FG000|Double-Blind Phase|Noncompliance with Study Drug|5|||
27823060|NCT01797445|54287253|FG001|Double-Blind Phase|Noncompliance with Study Drug|1|||
27823061|NCT01797445|54287252|FG000|Double-Blind Phase|Protocol Violation|0|||
27823062|NCT01797445|54287253|FG001|Double-Blind Phase|Protocol Violation|1|||
27823063|NCT01797445|54287252|FG000|Double-Blind Phase|Withdrew Consent|20|||
27823064|NCT01797445|54287253|FG001|Double-Blind Phase|Withdrew Consent|35|||
28073536|NCT00146328|54728175|FG002|Overall Study|Interaction with other medication|1|||
28073537|NCT03733444|54728186|FG000|Overall Study|Adverse Event|8|||
28151678|NCT01147653|54820640|FG001|Year 2|Withdrawal by Subject|3|||
28151679|NCT02747043|54820661|FG000|Overall Study|Other|1|||
28151680|NCT02747043|54820662|FG001|Overall Study|Other|1|||
28073538|NCT03733444|54728187|FG001|Overall Study|Adverse Event|10|||
28073539|NCT03733444|54728188|FG002|Overall Study|Adverse Event|5|||
28073540|NCT03733444|54728186|FG000|Overall Study|Death|20|||
28073541|NCT03733444|54728187|FG001|Overall Study|Death|19|||
28073542|NCT03733444|54728188|FG002|Overall Study|Death|11|||
28073543|NCT03733444|54728186|FG000|Overall Study|Lost to Follow-up|3|||
28073544|NCT03733444|54728187|FG001|Overall Study|Lost to Follow-up|0|||
27850275|NCT04178967|54349325|FG010|Induction Period|Protocol Violation|0|||
27850276|NCT04178967|54349315|FG000|Induction Period|Withdrawal by Subject|6|||
27850277|NCT04178967|54349316|FG001|Induction Period|Withdrawal by Subject|4|||
27850278|NCT04178967|54349317|FG002|Induction Period|Withdrawal by Subject|0|||
27850279|NCT04178967|54349318|FG003|Induction Period|Withdrawal by Subject|0|||
27850280|NCT04178967|54349319|FG004|Induction Period|Withdrawal by Subject|0|||
27850281|NCT04178967|54349320|FG005|Induction Period|Withdrawal by Subject|0|||
28073545|NCT03733444|54728188|FG002|Overall Study|Lost to Follow-up|1|||
28073546|NCT03733444|54728186|FG000|Overall Study|Lack of Efficacy|0|||
28073547|NCT03733444|54728187|FG001|Overall Study|Lack of Efficacy|1|||
28073548|NCT03733444|54728188|FG002|Overall Study|Lack of Efficacy|1|||
28073549|NCT03733444|54728186|FG000|Overall Study|Physician Decision|2|||
28151681|NCT02747043|54820661|FG000|Overall Study|Adverse Event|3|||
28151682|NCT02747043|54820662|FG001|Overall Study|Adverse Event|1|||
28151683|NCT02747043|54820661|FG000|Overall Study|Withdrawal by Subject|1|||
28151684|NCT02747043|54820662|FG001|Overall Study|Withdrawal by Subject|1|||
28151685|NCT02747043|54820661|FG000|Overall Study|Physician Decision|1|||
28151686|NCT02747043|54820662|FG001|Overall Study|Physician Decision|1|||
28151687|NCT02747043|54820661|FG000|Overall Study|Protocol Violation|0|||
28151688|NCT02747043|54820662|FG001|Overall Study|Protocol Violation|1|||
28151689|NCT02747043|54820661|FG000|Overall Study|Disease progression|4|||
28151690|NCT02747043|54820662|FG001|Overall Study|Disease progression|0|||
28151691|NCT02637076|54820670|FG000|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
28151692|NCT02637076|54820671|FG001|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
28151693|NCT02637076|54820670|FG000|Overall Study|Withdrawal by Subject|0|||
28151694|NCT02637076|54820671|FG001|Overall Study|Withdrawal by Subject|4|||
28151695|NCT02854605|54820680|FG000|Overall Study|Adverse Event|1|||
27823065|NCT01797445|54287252|FG000|Double-Blind Phase|Lost to Follow-up|34|||
27823066|NCT01797445|54287253|FG001|Double-Blind Phase|Lost to Follow-up|26|||
27823067|NCT01797445|54287252|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
27823068|NCT01797445|54287253|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
27823069|NCT01611259|54287261|FG000|Overall Study|Physician Decision|1|||
27823070|NCT01611259|54287261|FG000|Overall Study|Lack of Efficacy|2|||
27823071|NCT01611259|54287261|FG000|Overall Study|Adverse Event|4|||
27823072|NCT01611259|54287261|FG000|Overall Study|Withdrawal by Subject|7|||
27823073|NCT01795495|54287268|FG000|Overall Study|Protocol Violation|1|||
27823074|NCT01795495|54287269|FG001|Overall Study|Protocol Violation|0|||
27823075|NCT01795495|54287270|FG002|Overall Study|Protocol Violation|1|||
28151696|NCT02854605|54820681|FG001|Overall Study|Adverse Event|5|||
28151697|NCT02854605|54820682|FG002|Overall Study|Adverse Event|2|||
28151698|NCT02854605|54820680|FG000|Overall Study|Lost to Follow-up|0|||
28151699|NCT02854605|54820681|FG001|Overall Study|Lost to Follow-up|2|||
28151700|NCT02854605|54820682|FG002|Overall Study|Lost to Follow-up|0|||
28151701|NCT02854605|54820680|FG000|Overall Study|Withdrew Consent|1|||
28151702|NCT02854605|54820681|FG001|Overall Study|Withdrew Consent|0|||
28151703|NCT02854605|54820682|FG002|Overall Study|Withdrew Consent|1|||
28151704|NCT02854605|54820680|FG000|Overall Study|Investigator's Discretion|1|||
28151705|NCT02854605|54820681|FG001|Overall Study|Investigator's Discretion|0|||
28151706|NCT02854605|54820682|FG002|Overall Study|Investigator's Discretion|0|||
28151707|NCT02854605|54820680|FG000|Overall Study|Protocol Violation|0|||
28151708|NCT02854605|54820681|FG001|Overall Study|Protocol Violation|0|||
28151709|NCT02854605|54820682|FG002|Overall Study|Protocol Violation|1|||
28151710|NCT02854527|54820700|FG000|Overall Study|Adverse Event|0|||
28151711|NCT02854527|54820701|FG001|Overall Study|Adverse Event|0|||
28151712|NCT02854527|54820702|FG002|Overall Study|Adverse Event|0|||
28151713|NCT02854527|54820703|FG003|Overall Study|Adverse Event|0|||
28151714|NCT02854527|54820704|FG004|Overall Study|Adverse Event|1|||
28151715|NCT02854527|54820705|FG005|Overall Study|Adverse Event|0|||
28151716|NCT02854527|54820706|FG006|Overall Study|Adverse Event|0|||
28151717|NCT02854527|54820707|FG007|Overall Study|Adverse Event|0|||
28151718|NCT02854527|54820708|FG008|Overall Study|Adverse Event|0|||
28151719|NCT02854527|54820709|FG009|Overall Study|Adverse Event|0|||
28151720|NCT02854527|54820700|FG000|Overall Study|Lost to Follow-up|0|||
28151721|NCT02854527|54820701|FG001|Overall Study|Lost to Follow-up|0|||
28151722|NCT02854527|54820702|FG002|Overall Study|Lost to Follow-up|0|||
27823076|NCT01795495|54287268|FG000|Overall Study|Physician Decision|0|||
27850282|NCT04178967|54349321|FG006|Induction Period|Withdrawal by Subject|0|||
27850283|NCT04178967|54349322|FG007|Induction Period|Withdrawal by Subject|0|||
28073550|NCT03733444|54728187|FG001|Overall Study|Physician Decision|1|||
28073551|NCT03733444|54728188|FG002|Overall Study|Physician Decision|0|||
28073552|NCT03733444|54728186|FG000|Overall Study|Protocol Violation|2|||
28151723|NCT02854527|54820703|FG003|Overall Study|Lost to Follow-up|1|||
28151724|NCT02854527|54820704|FG004|Overall Study|Lost to Follow-up|0|||
28151725|NCT02854527|54820705|FG005|Overall Study|Lost to Follow-up|0|||
28151726|NCT02854527|54820706|FG006|Overall Study|Lost to Follow-up|0|||
28151727|NCT02854527|54820707|FG007|Overall Study|Lost to Follow-up|0|||
28151728|NCT02854527|54820708|FG008|Overall Study|Lost to Follow-up|0|||
28151729|NCT02854527|54820709|FG009|Overall Study|Lost to Follow-up|0|||
28151730|NCT02853435|54820736|FG000|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
28151731|NCT02853435|54820737|FG001|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
28151732|NCT02853435|54820738|FG002|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
27823077|NCT01795495|54287269|FG001|Overall Study|Physician Decision|0|||
27823078|NCT01795495|54287270|FG002|Overall Study|Physician Decision|1|||
27823079|NCT01794949|54287280|FG000|Overall Study|Lost to Follow-up|1|||
27823080|NCT01794949|54287281|FG001|Overall Study|Lost to Follow-up|0|||
27823081|NCT01770379|54287290|FG000|Overall Study|Technical issues|1|||
27823082|NCT01770379|54287291|FG001|Overall Study|Technical issues|0|||
27823083|NCT01770379|54287292|FG002|Overall Study|Technical issues|0|||
27823084|NCT01770379|54287290|FG000|Overall Study|Withdrawal by Subject|7|||
27823085|NCT01770379|54287291|FG001|Overall Study|Withdrawal by Subject|10|||
28151733|NCT02853435|54820739|FG003|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
28151734|NCT02853435|54820740|FG004|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1|||
28151735|NCT02853435|54820741|FG005|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
28151736|NCT02635204|54820773|FG000|Overall Study|Adverse Event|1|||
28151737|NCT02635204|54820774|FG001|Overall Study|Adverse Event|0|||
28151738|NCT02635204|54820773|FG000|Overall Study|Lost to Follow-up|1|||
28151739|NCT02635204|54820774|FG001|Overall Study|Lost to Follow-up|1|||
28151740|NCT00102804|54820782|FG000|Overall Study|Progressive Disease (PD)|307|||
28151741|NCT00102804|54820783|FG001|Overall Study|Progressive Disease (PD)|196|||
28151742|NCT00102804|54820782|FG000|Overall Study|Withdrawal by Subject|46|||
28151743|NCT00102804|54820783|FG001|Overall Study|Withdrawal by Subject|7|||
28151744|NCT00102804|54820782|FG000|Overall Study|Adverse Event|37|||
28151745|NCT00102804|54820783|FG001|Overall Study|Adverse Event|3|||
28151746|NCT00102804|54820782|FG000|Overall Study|Physician Decision|24|||
28151747|NCT00102804|54820783|FG001|Overall Study|Physician Decision|6|||
28151748|NCT00102804|54820782|FG000|Overall Study|Death|5|||
28151749|NCT00102804|54820783|FG001|Overall Study|Death|6|||
28151750|NCT00102804|54820782|FG000|Overall Study|Enrollment Criteria Not Met|6|||
28151751|NCT00102804|54820783|FG001|Overall Study|Enrollment Criteria Not Met|0|||
28151752|NCT00102804|54820782|FG000|Overall Study|Lost to Follow-up|4|||
28151753|NCT00102804|54820783|FG001|Overall Study|Lost to Follow-up|1|||
28151754|NCT00102804|54820782|FG000|Overall Study|Protocol Violation|2|||
28151755|NCT00102804|54820783|FG001|Overall Study|Protocol Violation|1|||
28151756|NCT00102804|54820782|FG000|Overall Study|Satisfactory Response|2|||
28151757|NCT00102804|54820783|FG001|Overall Study|Satisfactory Response|0|||
28151758|NCT00102804|54820782|FG000|Overall Study|Sponsor Decision|1|||
28151759|NCT00102804|54820783|FG001|Overall Study|Sponsor Decision|0|||
28151760|NCT00102804|54820782|FG000|Overall Study|Alive, Receiving Treatment|7|||
28151761|NCT00102804|54820783|FG001|Overall Study|Alive, Receiving Treatment|2|||
28151762|NCT01814072|54820821|FG000|Overall Study|Lost to Follow-up|2|||
27823086|NCT01770379|54287292|FG002|Overall Study|Withdrawal by Subject|7|||
28151763|NCT01814072|54820822|FG001|Overall Study|Lost to Follow-up|2|||
28151764|NCT01814072|54820823|FG002|Overall Study|Lost to Follow-up|2|||
28151765|NCT01814072|54820824|FG003|Overall Study|Lost to Follow-up|0|||
28151766|NCT01814072|54820825|FG004|Overall Study|Lost to Follow-up|2|||
28151767|NCT01814072|54820826|FG005|Overall Study|Lost to Follow-up|3|||
28151768|NCT01814072|54820827|FG006|Overall Study|Lost to Follow-up|3|||
28151769|NCT01814072|54820828|FG007|Overall Study|Lost to Follow-up|1|||
28151770|NCT01814072|54820829|FG008|Overall Study|Lost to Follow-up|2|||
28151771|NCT01814072|54820830|FG009|Overall Study|Lost to Follow-up|3|||
28151772|NCT01814072|54820831|FG010|Overall Study|Lost to Follow-up|1|||
28151773|NCT01814072|54820832|FG011|Overall Study|Lost to Follow-up|2|||
28151774|NCT01814072|54820833|FG012|Overall Study|Lost to Follow-up|2|||
28151775|NCT01814072|54820834|FG013|Overall Study|Lost to Follow-up|1|||
28151776|NCT01814072|54820835|FG014|Overall Study|Lost to Follow-up|2|||
28151777|NCT01814072|54820836|FG015|Overall Study|Lost to Follow-up|1|||
28151778|NCT01814072|54820837|FG016|Overall Study|Lost to Follow-up|3|||
28151779|NCT01814072|54820838|FG017|Overall Study|Lost to Follow-up|1|||
28151780|NCT01814072|54820839|FG018|Overall Study|Lost to Follow-up|3|||
28151781|NCT01814072|54820840|FG019|Overall Study|Lost to Follow-up|3|||
28151782|NCT01814072|54820841|FG020|Overall Study|Lost to Follow-up|2|||
28151783|NCT01814072|54820842|FG021|Overall Study|Lost to Follow-up|1|||
28151784|NCT01814072|54820843|FG022|Overall Study|Lost to Follow-up|3|||
28151785|NCT01814072|54820844|FG023|Overall Study|Lost to Follow-up|1|||
28151786|NCT01814072|54820845|FG024|Overall Study|Lost to Follow-up|4|||
28151787|NCT01814072|54820846|FG025|Overall Study|Lost to Follow-up|1|||
28151788|NCT01814072|54820847|FG026|Overall Study|Lost to Follow-up|1|||
28151789|NCT01814072|54820848|FG027|Overall Study|Lost to Follow-up|2|||
28151790|NCT01814072|54820849|FG028|Overall Study|Lost to Follow-up|3|||
28151791|NCT01814072|54820850|FG029|Overall Study|Lost to Follow-up|3|||
28151792|NCT01814072|54820851|FG030|Overall Study|Lost to Follow-up|2|||
28151793|NCT01814072|54820852|FG031|Overall Study|Lost to Follow-up|0|||
28151794|NCT01814072|54820821|FG000|Overall Study|Withdrawal by Subject|2|||
27823087|NCT01770379|54287290|FG000|Overall Study|study terminated by sponsor|22|||
27823088|NCT01770379|54287291|FG001|Overall Study|study terminated by sponsor|23|||
28151795|NCT01814072|54820822|FG001|Overall Study|Withdrawal by Subject|0|||
28151796|NCT01814072|54820823|FG002|Overall Study|Withdrawal by Subject|1|||
28151797|NCT01814072|54820824|FG003|Overall Study|Withdrawal by Subject|0|||
28151798|NCT01814072|54820825|FG004|Overall Study|Withdrawal by Subject|2|||
28151799|NCT01814072|54820826|FG005|Overall Study|Withdrawal by Subject|3|||
28151800|NCT01814072|54820827|FG006|Overall Study|Withdrawal by Subject|1|||
28151801|NCT01814072|54820828|FG007|Overall Study|Withdrawal by Subject|0|||
28151802|NCT01814072|54820829|FG008|Overall Study|Withdrawal by Subject|1|||
28151803|NCT01814072|54820830|FG009|Overall Study|Withdrawal by Subject|2|||
28151804|NCT01814072|54820831|FG010|Overall Study|Withdrawal by Subject|0|||
28151805|NCT01814072|54820832|FG011|Overall Study|Withdrawal by Subject|0|||
28151806|NCT01814072|54820833|FG012|Overall Study|Withdrawal by Subject|1|||
27823089|NCT01770379|54287292|FG002|Overall Study|study terminated by sponsor|22|||
27823090|NCT01770379|54287290|FG000|Overall Study|Protocol Violation|0|||
27823091|NCT01770379|54287291|FG001|Overall Study|Protocol Violation|1|||
27823092|NCT01770379|54287292|FG002|Overall Study|Protocol Violation|1|||
27823093|NCT01770379|54287290|FG000|Overall Study|Physician Decision|0|||
27823094|NCT01770379|54287291|FG001|Overall Study|Physician Decision|1|||
27823095|NCT01770379|54287292|FG002|Overall Study|Physician Decision|2|||
27823096|NCT01770379|54287290|FG000|Overall Study|Lost to Follow-up|0|||
27823097|NCT01770379|54287291|FG001|Overall Study|Lost to Follow-up|0|||
27823098|NCT01770379|54287292|FG002|Overall Study|Lost to Follow-up|2|||
27823099|NCT01770379|54287290|FG000|Overall Study|Lack of Efficacy|8|||
27823100|NCT01770379|54287291|FG001|Overall Study|Lack of Efficacy|6|||
27823101|NCT01770379|54287292|FG002|Overall Study|Lack of Efficacy|6|||
27823102|NCT01770379|54287290|FG000|Overall Study|Adverse Event|1|||
27823103|NCT01770379|54287291|FG001|Overall Study|Adverse Event|3|||
27823104|NCT01770379|54287292|FG002|Overall Study|Adverse Event|2|||
27823105|NCT01986881|54287305|FG000|Overall Study|Death|228|||
28151807|NCT01814072|54820834|FG013|Overall Study|Withdrawal by Subject|1|||
28151808|NCT01814072|54820835|FG014|Overall Study|Withdrawal by Subject|1|||
28151809|NCT01814072|54820836|FG015|Overall Study|Withdrawal by Subject|1|||
27823106|NCT01986881|54287306|FG001|Overall Study|Death|233|||
28151810|NCT01814072|54820837|FG016|Overall Study|Withdrawal by Subject|0|||
28151811|NCT01814072|54820838|FG017|Overall Study|Withdrawal by Subject|0|||
28151812|NCT01814072|54820839|FG018|Overall Study|Withdrawal by Subject|0|||
28151813|NCT01814072|54820840|FG019|Overall Study|Withdrawal by Subject|2|||
27823107|NCT01986881|54287307|FG002|Overall Study|Death|247|||
27823108|NCT01986881|54287305|FG000|Overall Study|Lost to Follow-up|51|||
27823109|NCT01986881|54287306|FG001|Overall Study|Lost to Follow-up|44|||
27823110|NCT01986881|54287307|FG002|Overall Study|Lost to Follow-up|55|||
28151814|NCT01814072|54820841|FG020|Overall Study|Withdrawal by Subject|0|||
28151815|NCT01814072|54820842|FG021|Overall Study|Withdrawal by Subject|0|||
28151816|NCT01814072|54820843|FG022|Overall Study|Withdrawal by Subject|1|||
28151817|NCT01814072|54820844|FG023|Overall Study|Withdrawal by Subject|0|||
28151818|NCT01814072|54820845|FG024|Overall Study|Withdrawal by Subject|2|||
28151819|NCT01814072|54820846|FG025|Overall Study|Withdrawal by Subject|1|||
27823111|NCT01986881|54287305|FG000|Overall Study|Physician Decision|7|||
28151820|NCT01814072|54820847|FG026|Overall Study|Withdrawal by Subject|1|||
28151821|NCT01814072|54820848|FG027|Overall Study|Withdrawal by Subject|2|||
28151822|NCT01814072|54820849|FG028|Overall Study|Withdrawal by Subject|1|||
27823112|NCT01986881|54287306|FG001|Overall Study|Physician Decision|4|||
28151823|NCT01814072|54820850|FG029|Overall Study|Withdrawal by Subject|0|||
27823113|NCT01986881|54287307|FG002|Overall Study|Physician Decision|6|||
27823114|NCT01986881|54287305|FG000|Overall Study|Study Site Terminated by Sponsor|2|||
27823115|NCT01986881|54287306|FG001|Overall Study|Study Site Terminated by Sponsor|2|||
27823116|NCT01986881|54287307|FG002|Overall Study|Study Site Terminated by Sponsor|3|||
28073553|NCT03733444|54728187|FG001|Overall Study|Protocol Violation|1|||
28151824|NCT01814072|54820851|FG030|Overall Study|Withdrawal by Subject|0|||
28151825|NCT01814072|54820852|FG031|Overall Study|Withdrawal by Subject|0|||
28151826|NCT03038113|54820907|FG000|Overall Study|Withdrawal by Subject|0|||
28151827|NCT03038113|54820908|FG001|Overall Study|Withdrawal by Subject|0|||
28151828|NCT03038113|54820909|FG002|Overall Study|Withdrawal by Subject|1|||
28151829|NCT03038113|54820910|FG003|Overall Study|Withdrawal by Subject|0|||
28151830|NCT03038113|54820911|FG004|Overall Study|Withdrawal by Subject|0|||
28151831|NCT03038113|54820912|FG005|Overall Study|Withdrawal by Subject|0|||
28151832|NCT03038113|54820913|FG006|Overall Study|Withdrawal by Subject|0|||
28151833|NCT03038113|54820914|FG007|Overall Study|Withdrawal by Subject|0|||
28151834|NCT03038113|54820915|FG008|Overall Study|Withdrawal by Subject|0|||
28151835|NCT03038113|54820916|FG009|Overall Study|Withdrawal by Subject|0|||
28151836|NCT03038113|54820917|FG010|Overall Study|Withdrawal by Subject|0|||
28151837|NCT03038113|54820918|FG011|Overall Study|Withdrawal by Subject|0|||
28151838|NCT03038113|54820919|FG012|Overall Study|Withdrawal by Subject|0|||
28151839|NCT03038113|54820920|FG013|Overall Study|Withdrawal by Subject|1|||
27823117|NCT01986881|54287305|FG000|Overall Study|Withdrawal by Subject|41|||
27823118|NCT01986881|54287306|FG001|Overall Study|Withdrawal by Subject|60|||
28073554|NCT03733444|54728188|FG002|Overall Study|Protocol Violation|0|||
28073555|NCT03733444|54728186|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
28073556|NCT03733444|54728187|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
28073557|NCT03733444|54728188|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|2|||
28073558|NCT03733444|54728186|FG000|Overall Study|Study Terminated by Sponsor|203|||
28073559|NCT03733444|54728187|FG001|Overall Study|Study Terminated by Sponsor|209|||
28073560|NCT03733444|54728188|FG002|Overall Study|Study Terminated by Sponsor|221|||
28073561|NCT03733444|54728186|FG000|Overall Study|Withdrawal by Subject|19|||
28073562|NCT03733444|54728187|FG001|Overall Study|Withdrawal by Subject|18|||
28073563|NCT03733444|54728188|FG002|Overall Study|Withdrawal by Subject|16|||
28073564|NCT03733444|54728186|FG000|Overall Study|Miscellaneous|1|||
28073565|NCT03733444|54728187|FG001|Overall Study|Miscellaneous|0|||
27823119|NCT01986881|54287307|FG002|Overall Study|Withdrawal by Subject|45|||
28073566|NCT03733444|54728188|FG002|Overall Study|Miscellaneous|1|||
28151840|NCT03038113|54820907|FG000|Overall Study|Lost to Follow-up|0|||
28151841|NCT03038113|54820908|FG001|Overall Study|Lost to Follow-up|0|||
28151842|NCT03038113|54820909|FG002|Overall Study|Lost to Follow-up|0|||
28151843|NCT03038113|54820910|FG003|Overall Study|Lost to Follow-up|0|||
28151844|NCT03038113|54820911|FG004|Overall Study|Lost to Follow-up|0|||
28151845|NCT03038113|54820912|FG005|Overall Study|Lost to Follow-up|0|||
28151846|NCT03038113|54820913|FG006|Overall Study|Lost to Follow-up|1|||
28151847|NCT03038113|54820914|FG007|Overall Study|Lost to Follow-up|0|||
28151848|NCT03038113|54820915|FG008|Overall Study|Lost to Follow-up|0|||
28151849|NCT03038113|54820916|FG009|Overall Study|Lost to Follow-up|0|||
28151850|NCT03038113|54820917|FG010|Overall Study|Lost to Follow-up|0|||
28151851|NCT03038113|54820918|FG011|Overall Study|Lost to Follow-up|0|||
28151852|NCT03038113|54820919|FG012|Overall Study|Lost to Follow-up|0|||
28151853|NCT03038113|54820920|FG013|Overall Study|Lost to Follow-up|0|||
28151854|NCT00968149|54820969|FG000|Overall Study|Adverse Event|5|||
28151855|NCT00968149|54820970|FG001|Overall Study|Adverse Event|1|||
28151856|NCT00968149|54820969|FG000|Overall Study|Lack of Efficacy|0|||
28151857|NCT00968149|54820970|FG001|Overall Study|Lack of Efficacy|4|||
28151858|NCT00968149|54820969|FG000|Overall Study|Lost to Follow-up|0|||
28151859|NCT00968149|54820970|FG001|Overall Study|Lost to Follow-up|1|||
28151860|NCT00968149|54820969|FG000|Overall Study|Protocol Violation|4|||
28151861|NCT00968149|54820970|FG001|Overall Study|Protocol Violation|0|||
28151862|NCT00968149|54820969|FG000|Overall Study|Withdrawal by Subject|2|||
28151863|NCT00968149|54820970|FG001|Overall Study|Withdrawal by Subject|0|||
27941815|NCT02243605|54598462|FG000|Stage 2 - Final Analysis Population|Protocol Violation|5|||
27941816|NCT02243605|54598463|FG001|Stage 2 - Final Analysis Population|Protocol Violation|1|||
27941817|NCT02243605|54598462|FG000|Stage 2 - Final Analysis Population|Adverse Event|1|||
27941818|NCT02243605|54598463|FG001|Stage 2 - Final Analysis Population|Adverse Event|1|||
27941819|NCT02243605|54598462|FG000|Stage 2 - Final Analysis Population|Progression|0|||
27941820|NCT02243605|54598463|FG001|Stage 2 - Final Analysis Population|Progression|1|||
27941821|NCT01752907|54598480|FG000|Overall Study|Withdrawal by Subject|4|||
27941822|NCT01752907|54598481|FG001|Overall Study|Withdrawal by Subject|10|||
27941823|NCT01752907|54598480|FG000|Overall Study|Lost to Follow-up|2|||
27941824|NCT01752907|54598481|FG001|Overall Study|Lost to Follow-up|1|||
27941825|NCT01752907|54598480|FG000|Overall Study|Decision by Sponsor|6|||
28151864|NCT00963469|54820979|FG000|Overall Study|Adverse Event|15|||
28151865|NCT00963469|54820980|FG001|Overall Study|Adverse Event|11|||
28151866|NCT00963469|54820981|FG002|Overall Study|Adverse Event|1|||
28151867|NCT00963469|54820979|FG000|Overall Study|Lack of Efficacy|10|||
28151868|NCT00963469|54820980|FG001|Overall Study|Lack of Efficacy|7|||
28151869|NCT00963469|54820981|FG002|Overall Study|Lack of Efficacy|2|||
28151870|NCT00963469|54820979|FG000|Overall Study|Lost to Follow-up|1|||
28151871|NCT00963469|54820980|FG001|Overall Study|Lost to Follow-up|1|||
28151872|NCT00963469|54820981|FG002|Overall Study|Lost to Follow-up|0|||
28151873|NCT00963469|54820979|FG000|Overall Study|Protocol Violation|5|||
28151874|NCT00963469|54820980|FG001|Overall Study|Protocol Violation|5|||
28151875|NCT00963469|54820981|FG002|Overall Study|Protocol Violation|3|||
28151876|NCT00963469|54820979|FG000|Overall Study|Withdrawal by Subject|4|||
28151877|NCT00963469|54820980|FG001|Overall Study|Withdrawal by Subject|1|||
28151878|NCT00963469|54820981|FG002|Overall Study|Withdrawal by Subject|1|||
28151879|NCT00963469|54820979|FG000|Overall Study|Pre-randomization Adverse Event|1|||
28151880|NCT00963469|54820980|FG001|Overall Study|Pre-randomization Adverse Event|2|||
28151881|NCT00963469|54820981|FG002|Overall Study|Pre-randomization Adverse Event|0|||
28151882|NCT00963469|54820979|FG000|Overall Study|Moved|1|||
28151883|NCT00963469|54820980|FG001|Overall Study|Moved|0|||
28151884|NCT00963469|54820981|FG002|Overall Study|Moved|0|||
28151885|NCT00963469|54820979|FG000|Overall Study|Site closed (local pollen Season ended)|4|||
27823120|NCT01986881|54287305|FG000|Overall Study|Subject Moved|0|||
27823121|NCT01986881|54287306|FG001|Overall Study|Subject Moved|1|||
27941826|NCT01752907|54598481|FG001|Overall Study|Decision by Sponsor|9|||
28151886|NCT00963469|54820980|FG001|Overall Study|Site closed (local pollen Season ended)|1|||
28151887|NCT00963469|54820981|FG002|Overall Study|Site closed (local pollen Season ended)|3|||
27941827|NCT03439189|54598487|FG000|Overall Study|Protocol Violation|19|||
28151888|NCT00897949|54820992|FG000|Overall Study|Adverse Event|1|||
28151889|NCT00897949|54820993|FG001|Overall Study|Adverse Event|1|||
28151890|NCT00897949|54820994|FG002|Overall Study|Adverse Event|0|||
28151891|NCT00897949|54820992|FG000|Overall Study|Lost to Follow-up|0|||
28151892|NCT00897949|54820993|FG001|Overall Study|Lost to Follow-up|2|||
28151893|NCT00897949|54820994|FG002|Overall Study|Lost to Follow-up|1|||
28151894|NCT00897949|54820992|FG000|Overall Study|Protocol Violation|6|||
28151895|NCT00897949|54820993|FG001|Overall Study|Protocol Violation|3|||
28151896|NCT00897949|54820994|FG002|Overall Study|Protocol Violation|1|||
28151897|NCT00897949|54820992|FG000|Overall Study|Withdrawal by Subject|1|||
28151898|NCT00897949|54820993|FG001|Overall Study|Withdrawal by Subject|2|||
27823122|NCT01986881|54287307|FG002|Overall Study|Subject Moved|0|||
27823123|NCT01986881|54287305|FG000|Overall Study|Other|1|||
27823124|NCT01986881|54287306|FG001|Overall Study|Other|2|||
27823125|NCT01986881|54287307|FG002|Overall Study|Other|2|||
27823126|NCT01770145|54287338|FG000|Baseline|Adverse Event|20|||
27823127|NCT01770145|54287338|FG000|Baseline|Withdrawal by Subject|1|||
27823128|NCT01770145|54287338|FG000|Baseline|Lost to Follow-up|1|||
27823129|NCT01770145|54287338|FG000|Baseline|Unable to define optimal dose|4|||
28073567|NCT03733444|54728186|FG000|Overall Study|Not Treated|1|||
28073568|NCT03733444|54728187|FG001|Overall Study|Not Treated|2|||
28073569|NCT03733444|54728188|FG002|Overall Study|Not Treated|1|||
28073570|NCT03731182|54728208|FG000|Overall Study|Lost to Follow-up|2|||
28073571|NCT03731182|54728209|FG001|Overall Study|Lost to Follow-up|0|||
28073572|NCT03731182|54728208|FG000|Overall Study|Physician Decision|1|||
27823130|NCT01770145|54287338|FG000|Treatment|Adverse Event|3|||
27823131|NCT01770145|54287338|FG000|Treatment|Withdrawal by Subject|1|||
27941828|NCT03439189|54598487|FG000|Overall Study|Lack of Efficacy|63|||
28073573|NCT03731182|54728209|FG001|Overall Study|Physician Decision|0|||
27823132|NCT01609543|54287342|FG000|Overall Study|Disease Progression|28|||
28151899|NCT00897949|54820994|FG002|Overall Study|Withdrawal by Subject|0|||
28151900|NCT00897949|54820992|FG000|Overall Study|Patient Uncoorperative|0|||
27941829|NCT01211483|54598496|FG000|Phase 1b|Death|6|||
27941830|NCT01211483|54598497|FG001|Phase 1b|Death|0|||
28073574|NCT03731182|54728208|FG000|Overall Study|Withdrawal By Parent/Guardian|2|||
28151901|NCT00897949|54820993|FG001|Overall Study|Patient Uncoorperative|2|||
27823133|NCT01609543|54287342|FG000|Overall Study|Adverse Event|5|||
27823134|NCT01609543|54287342|FG000|Overall Study|Withdrawal by Subject|1|||
27823135|NCT01609543|54287342|FG000|Overall Study|Protocol Violation|1|||
27823136|NCT01609543|54287342|FG000|Overall Study|Death|7|||
27823137|NCT02003183|54287349|FG000|Overall Study|Lost to Follow-up|0|||
27823138|NCT02003183|54287350|FG001|Overall Study|Lost to Follow-up|2|||
27823139|NCT01986647|54287360|FG000|Overall Study|Lost to Follow-up|4|||
27823140|NCT01986647|54287361|FG001|Overall Study|Lost to Follow-up|1|||
27823141|NCT01986647|54287362|FG002|Overall Study|Lost to Follow-up|4|||
27823142|NCT01986647|54287363|FG003|Overall Study|Lost to Follow-up|4|||
27823143|NCT01986647|54287360|FG000|Overall Study|Withdrawal by Subject|1|||
28151902|NCT00897949|54820994|FG002|Overall Study|Patient Uncoorperative|1|||
28151903|NCT00897949|54820992|FG000|Overall Study|Lost to Follow-up|30|||
28151904|NCT00897949|54820993|FG001|Overall Study|Lost to Follow-up|23|||
28151905|NCT00897949|54820994|FG002|Overall Study|Lost to Follow-up|17|||
28151906|NCT00897949|54820992|FG000|Overall Study|Withdrawal by Subject|24|||
28151907|NCT00897949|54820993|FG001|Overall Study|Withdrawal by Subject|31|||
28151908|NCT00897949|54820994|FG002|Overall Study|Withdrawal by Subject|17|||
28151909|NCT00897949|54820992|FG000|Overall Study|Abnormal Prestudy Labs|2|||
28151910|NCT00897949|54820993|FG001|Overall Study|Abnormal Prestudy Labs|3|||
28151911|NCT00897949|54820994|FG002|Overall Study|Abnormal Prestudy Labs|4|||
28151912|NCT00897949|54820992|FG000|Overall Study|Abnormal Baseline ECG|2|||
28151913|NCT00897949|54820993|FG001|Overall Study|Abnormal Baseline ECG|2|||
28151914|NCT00897949|54820994|FG002|Overall Study|Abnormal Baseline ECG|4|||
28151915|NCT00897949|54820992|FG000|Overall Study|Need for Concom. Med.|0|||
28151916|NCT00897949|54820993|FG001|Overall Study|Need for Concom. Med.|1|||
28151917|NCT00897949|54820994|FG002|Overall Study|Need for Concom. Med.|1|||
28151918|NCT00897949|54820992|FG000|Overall Study|Lack of Migraine Attack|29|||
28151919|NCT00897949|54820993|FG001|Overall Study|Lack of Migraine Attack|30|||
28151920|NCT00897949|54820994|FG002|Overall Study|Lack of Migraine Attack|19|||
28151921|NCT00897949|54820992|FG000|Overall Study|Did not take study drug|9|||
28151922|NCT00897949|54820993|FG001|Overall Study|Did not take study drug|3|||
28151923|NCT00897949|54820994|FG002|Overall Study|Did not take study drug|4|||
28151924|NCT02760810|54821008|FG000|Overall Study|Protocol Violation|1|||
28151925|NCT02760654|54821014|FG000|Overall Study|Lost to Follow-up|3|||
28151926|NCT02760654|54821015|FG001|Overall Study|Lost to Follow-up|3|||
28151927|NCT02760654|54821014|FG000|Overall Study|Withdrawal by Subject|4|||
28151928|NCT02760654|54821015|FG001|Overall Study|Withdrawal by Subject|3|||
28151929|NCT00725491|54821023|FG000|Overall Study|Adverse Event|3|||
28151930|NCT00725491|54821024|FG001|Overall Study|Adverse Event|2|||
28151931|NCT00725491|54821023|FG000|Overall Study|Pregnancy|0|||
28151932|NCT00725491|54821024|FG001|Overall Study|Pregnancy|3|||
28151933|NCT00725491|54821023|FG000|Overall Study|Risk for hyperstimulation|2|||
28151934|NCT00725491|54821024|FG001|Overall Study|Risk for hyperstimulation|9|||
28151935|NCT00725491|54821023|FG000|Overall Study|No/too few oocytes/bad quality oocytes|1|||
28151936|NCT00725491|54821024|FG001|Overall Study|No/too few oocytes/bad quality oocytes|1|||
28151937|NCT00725491|54821023|FG000|Overall Study|Fertilization failure|0|||
28151938|NCT00725491|54821024|FG001|Overall Study|Fertilization failure|1|||
28151939|NCT00725491|54821023|FG000|Overall Study|No/too few embryos/ bad quality embryos|3|||
28151940|NCT00725491|54821024|FG001|Overall Study|No/too few embryos/ bad quality embryos|2|||
28151941|NCT02634580|54821034|FG000|Double-blind Treatment Period|Subject Request|1|||
28151942|NCT02634580|54821035|FG001|Double-blind Treatment Period|Subject Request|0|||
28151943|NCT02634580|54821036|FG002|Double-blind Treatment Period|Subject Request|1|||
27823144|NCT01986647|54287361|FG001|Overall Study|Withdrawal by Subject|3|||
27823145|NCT01986647|54287362|FG002|Overall Study|Withdrawal by Subject|2|||
27823146|NCT01986647|54287363|FG003|Overall Study|Withdrawal by Subject|3|||
27823147|NCT01986647|54287360|FG000|Overall Study|Health|5|||
27823148|NCT01986647|54287361|FG001|Overall Study|Health|3|||
28151944|NCT02634580|54821037|FG003|Double-blind Treatment Period|Subject Request|1|||
28151945|NCT02634580|54821034|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
28151946|NCT02634580|54821035|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
27823149|NCT01986647|54287362|FG002|Overall Study|Health|6|||
27823150|NCT01986647|54287363|FG003|Overall Study|Health|4|||
27823151|NCT02002091|54287379|FG000|Screening|Lost to Follow-up|10|||
27823152|NCT02002091|54287380|FG001|Screening|Lost to Follow-up|12|||
27823153|NCT02002091|54287379|FG000|Screening|Death|3|||
27823154|NCT02002091|54287380|FG001|Screening|Death|2|||
28151947|NCT02634580|54821036|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
28151948|NCT02634580|54821037|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
28151949|NCT02225366|54821048|FG000|Overall Study|Lack of Efficacy|1|||
28151950|NCT02225366|54821049|FG001|Overall Study|Lack of Efficacy|0|||
27823155|NCT01985321|54287417|FG000|Overall Study|Protocol Violation|4|||
27823156|NCT01985321|54287418|FG001|Overall Study|Protocol Violation|3|||
27823157|NCT01985321|54287417|FG000|Overall Study|Withdrawal by Subject|1|||
27823158|NCT01985321|54287418|FG001|Overall Study|Withdrawal by Subject|0|||
27823159|NCT01985321|54287417|FG000|Overall Study|Lost to Follow-up|5|||
27823160|NCT01985321|54287418|FG001|Overall Study|Lost to Follow-up|2|||
28073575|NCT03731182|54728209|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
28073576|NCT03730012|54728218|FG000|Overall Study|Adverse Event|0|||
28073577|NCT03730012|54728219|FG001|Overall Study|Adverse Event|1|||
28073578|NCT03730012|54728218|FG000|Overall Study|Lack of Efficacy|1|||
28073579|NCT03730012|54728219|FG001|Overall Study|Lack of Efficacy|5|||
28073580|NCT03730012|54728218|FG000|Overall Study|Withdrawal by Subject|0|||
28073581|NCT03730012|54728219|FG001|Overall Study|Withdrawal by Subject|1|||
28073582|NCT03730012|54728218|FG000|Overall Study|Miscellaneous|2|||
28073583|NCT03730012|54728219|FG001|Overall Study|Miscellaneous|1|||
28073584|NCT03728140|54728230|FG000|Overall Study|Abnormal embryo transfer operation|10|||
28073585|NCT03728140|54728231|FG001|Overall Study|Abnormal embryo transfer operation|7|||
28073586|NCT03725722|54728256|FG000|Overall Study|Lack of Efficacy|2|||
28073587|NCT03725722|54728257|FG001|Overall Study|Lack of Efficacy|1|||
28073588|NCT03725722|54728258|FG002|Overall Study|Lack of Efficacy|2|||
28073589|NCT03725722|54728259|FG003|Overall Study|Lack of Efficacy|0|||
28073590|NCT03725722|54728260|FG004|Overall Study|Lack of Efficacy|2|||
28073591|NCT03725722|54728256|FG000|Overall Study|Adverse Event|2|||
28073592|NCT03725722|54728257|FG001|Overall Study|Adverse Event|2|||
28073593|NCT03725722|54728258|FG002|Overall Study|Adverse Event|1|||
28073594|NCT03725722|54728259|FG003|Overall Study|Adverse Event|0|||
28073595|NCT03725722|54728260|FG004|Overall Study|Adverse Event|6|||
28073596|NCT03725722|54728256|FG000|Overall Study|Withdrawal by Subject|4|||
28073597|NCT03725722|54728257|FG001|Overall Study|Withdrawal by Subject|1|||
28073598|NCT03725722|54728258|FG002|Overall Study|Withdrawal by Subject|0|||
28151951|NCT00697255|54821057|FG000|Stage 1a|Insufficient ovarian response|1|||
28151952|NCT00697255|54821058|FG001|Stage 1a|Insufficient ovarian response|0|||
28151953|NCT00697255|54821057|FG000|Stage 1a|Multifollicular growth|1|||
28151954|NCT00697255|54821058|FG001|Stage 1a|Multifollicular growth|0|||
28151955|NCT00697255|54821057|FG000|Stage 1a|Not growing of dominant follicle|1|||
28151956|NCT00697255|54821058|FG001|Stage 1a|Not growing of dominant follicle|0|||
28151957|NCT00697255|54821057|FG000|Stage 1b|Not growing of dominant follicle|0|||
28151958|NCT00697255|54821058|FG001|Stage 1b|Not growing of dominant follicle|1|||
28151959|NCT00697255|54821057|FG000|Stage 1b|Insufficient ovarian response|0|||
28151960|NCT00697255|54821058|FG001|Stage 1b|Insufficient ovarian response|1|||
28151961|NCT02764320|54821066|FG000|Overall Study|Withdrawal by Subject|35|||
28151962|NCT02764320|54821067|FG001|Overall Study|Withdrawal by Subject|38|||
28151963|NCT02764320|54821066|FG000|Overall Study|Protocol Violation|11|||
28151964|NCT02764320|54821067|FG001|Overall Study|Protocol Violation|6|||
28151965|NCT02764320|54821066|FG000|Overall Study|Adverse Event|2|||
28151966|NCT02764320|54821067|FG001|Overall Study|Adverse Event|0|||
28151967|NCT02764320|54821066|FG000|Overall Study|Health Issues unable to continue|2|||
28151968|NCT02764320|54821067|FG001|Overall Study|Health Issues unable to continue|0|||
28151969|NCT02764320|54821066|FG000|Overall Study|Did not meet inclusion criteria|1|||
28151970|NCT02764320|54821067|FG001|Overall Study|Did not meet inclusion criteria|0|||
28151971|NCT02764320|54821066|FG000|Overall Study|Subject moved|0|||
28151972|NCT02764320|54821067|FG001|Overall Study|Subject moved|2|||
28073599|NCT03725722|54728259|FG003|Overall Study|Withdrawal by Subject|4|||
28073600|NCT03725722|54728260|FG004|Overall Study|Withdrawal by Subject|4|||
28073601|NCT03725722|54728256|FG000|Overall Study|Lost to Follow-up|3|||
28073602|NCT03725722|54728257|FG001|Overall Study|Lost to Follow-up|1|||
28073603|NCT03725722|54728258|FG002|Overall Study|Lost to Follow-up|2|||
28073604|NCT03725722|54728259|FG003|Overall Study|Lost to Follow-up|2|||
28073605|NCT03725722|54728260|FG004|Overall Study|Lost to Follow-up|1|||
28073606|NCT03725722|54728256|FG000|Overall Study|Personal reasons|0|||
28073607|NCT03725722|54728257|FG001|Overall Study|Personal reasons|0|||
28073608|NCT03725722|54728258|FG002|Overall Study|Personal reasons|1|||
28073609|NCT03725722|54728259|FG003|Overall Study|Personal reasons|0|||
28073610|NCT03725722|54728260|FG004|Overall Study|Personal reasons|1|||
28073611|NCT03725722|54728256|FG000|Overall Study|COVID-19 situation|0|||
28151973|NCT02764320|54821066|FG000|Overall Study|Overused medication unavailable|0|||
27823161|NCT01985321|54287417|FG000|Overall Study|Subject treated wrong type of sore|1|||
27941831|NCT01211483|54598498|FG002|Phase 1b|Death|0|||
28073612|NCT03725722|54728257|FG001|Overall Study|COVID-19 situation|1|||
28073613|NCT03725722|54728258|FG002|Overall Study|COVID-19 situation|0|||
28073614|NCT03725722|54728259|FG003|Overall Study|COVID-19 situation|0|||
28073615|NCT03725722|54728260|FG004|Overall Study|COVID-19 situation|0|||
28073616|NCT02966314|54728274|FG000|Overall Study|Lost to Follow-up|1|||
28151974|NCT02764320|54821067|FG001|Overall Study|Overused medication unavailable|1|||
28151975|NCT02764320|54821066|FG000|Overall Study|Seeking care outside site|0|||
28151976|NCT02764320|54821067|FG001|Overall Study|Seeking care outside site|1|||
28073617|NCT02966314|54728275|FG001|Overall Study|Lost to Follow-up|0|||
28073618|NCT03723070|54728281|FG000|Overall Study|Lost to Follow-up|2|||
27823162|NCT01985321|54287418|FG001|Overall Study|Subject treated wrong type of sore|0|||
27823163|NCT02000921|54287427|FG000|Overall Study|Withdrawal by Subject|3|||
27823164|NCT02000921|54287428|FG001|Overall Study|Withdrawal by Subject|10|||
27823165|NCT02000921|54287429|FG002|Overall Study|Withdrawal by Subject|5|||
28073619|NCT03723070|54728281|FG000|Overall Study|Physician Decision|1|||
28073620|NCT03723070|54728281|FG000|Overall Study|Ended the study at 1 month follow-up visit as per applicable protocol at that time|6|||
28073621|NCT03722524|54728289|FG000|Overall Study|Protocol Violation|86|||
28073622|NCT03722524|54728289|FG000|Overall Study|Adverse Event|7|||
28073623|NCT03722524|54728289|FG000|Overall Study|Lost to Follow-up|1|||
28073624|NCT03722524|54728289|FG000|Overall Study|Reason is not stated|1|||
28073625|NCT03722524|54728289|FG000|Overall Study|Physician Decision|1|||
28073626|NCT03722524|54728289|FG000|Overall Study|Patient's decision (refusal to continue participation)|3|||
28073627|NCT03722446|54728295|FG000|Overall Study|Protocol Violation|15|||
28073628|NCT03722446|54728296|FG001|Overall Study|Protocol Violation|2|||
28073629|NCT00146172|54728310|FG000|Overall Study|Adverse Event|0|||
28073630|NCT00146172|54728311|FG001|Overall Study|Adverse Event|0|||
28073631|NCT00146172|54728312|FG002|Overall Study|Adverse Event|1|||
28073632|NCT00146172|54728313|FG003|Overall Study|Adverse Event|1|||
28073633|NCT00146172|54728314|FG004|Overall Study|Adverse Event|0|||
28151977|NCT02764320|54821066|FG000|Overall Study|Technology barriers|0|||
28151978|NCT02764320|54821067|FG001|Overall Study|Technology barriers|1|||
28151979|NCT02851407|54821075|FG000|Overall Study|Withdrawal by parent/guardian|2|||
28151980|NCT02851407|54821076|FG001|Overall Study|Withdrawal by parent/guardian|7|||
28151981|NCT02851407|54821075|FG000|Overall Study|Protocol deviation|0|||
28151982|NCT02851407|54821076|FG001|Overall Study|Protocol deviation|1|||
28073634|NCT00146172|54728315|FG005|Overall Study|Adverse Event|2|||
28073635|NCT00146172|54728316|FG006|Overall Study|Adverse Event|3|||
28151983|NCT02851407|54821075|FG000|Overall Study|Transferred to another hospital to continue|1|||
28151984|NCT02851407|54821076|FG001|Overall Study|Transferred to another hospital to continue|0|||
28151985|NCT02851407|54821075|FG000|Overall Study|Other Death|30|||
28151986|NCT02851407|54821076|FG001|Overall Study|Other Death|20|||
28151987|NCT02851407|54821075|FG000|Overall Study|Adverse event, serious fatal|6|||
28151988|NCT02851407|54821076|FG001|Overall Study|Adverse event, serious fatal|8|||
28073636|NCT00146172|54728317|FG007|Overall Study|Adverse Event|10|||
28073637|NCT00146172|54728310|FG000|Overall Study|Lost to Follow-up|0|||
28073638|NCT00146172|54728311|FG001|Overall Study|Lost to Follow-up|0|||
28073639|NCT00146172|54728312|FG002|Overall Study|Lost to Follow-up|0|||
28073640|NCT00146172|54728313|FG003|Overall Study|Lost to Follow-up|0|||
28151989|NCT02851407|54821075|FG000|Overall Study|Consent withdrawn by participant|5|||
28151990|NCT02851407|54821076|FG001|Overall Study|Consent withdrawn by participant|3|||
28151991|NCT02851407|54821075|FG000|Overall Study|Screen failure|2|||
28151992|NCT02851407|54821076|FG001|Overall Study|Screen failure|1|||
28151993|NCT02851407|54821075|FG000|Overall Study|Disease relapse|9|||
28151994|NCT02851407|54821076|FG001|Overall Study|Disease relapse|6|||
28151995|NCT02851407|54821075|FG000|Overall Study|Physician Decision|7|||
28151996|NCT02851407|54821076|FG001|Overall Study|Physician Decision|6|||
28151997|NCT02851407|54821075|FG000|Overall Study|Transferred to hospital closer to home|0|||
28151998|NCT02851407|54821076|FG001|Overall Study|Transferred to hospital closer to home|1|||
28151999|NCT02851407|54821075|FG000|Overall Study|Enrolled in an investigational study|0|||
28152000|NCT02851407|54821076|FG001|Overall Study|Enrolled in an investigational study|1|||
28152001|NCT02851407|54821075|FG000|Overall Study|Early recovery|1|||
28152002|NCT02851407|54821076|FG001|Overall Study|Early recovery|0|||
28152003|NCT02851407|54821075|FG000|Overall Study|Adverse event, non-fatal|7|||
28152004|NCT02851407|54821076|FG001|Overall Study|Adverse event, non-fatal|5|||
28152005|NCT02851407|54821075|FG000|Overall Study|Lost to Follow-up|0|||
28152006|NCT02851407|54821076|FG001|Overall Study|Lost to Follow-up|2|||
28152007|NCT02636608|54821082|FG000|Overall Study|Failure to Return|4|||
28152008|NCT02636608|54821082|FG000|Overall Study|Insufficient Virological Response|1|||
28152009|NCT02636608|54821082|FG000|Overall Study|Death|3|||
27941832|NCT01211483|54598499|FG003|Phase 1b|Death|0|||
27941833|NCT01211483|54598496|FG000|Phase 1b|Withdrawal by Subject|1|||
27941834|NCT01211483|54598497|FG001|Phase 1b|Withdrawal by Subject|0|||
27941835|NCT01211483|54598498|FG002|Phase 1b|Withdrawal by Subject|0|||
28073641|NCT00146172|54728314|FG004|Overall Study|Lost to Follow-up|0|||
28073642|NCT00146172|54728315|FG005|Overall Study|Lost to Follow-up|0|||
28073643|NCT00146172|54728316|FG006|Overall Study|Lost to Follow-up|0|||
28073644|NCT00146172|54728317|FG007|Overall Study|Lost to Follow-up|1|||
28073645|NCT00146172|54728310|FG000|Overall Study|Disease Progression|2|||
28073646|NCT00146172|54728311|FG001|Overall Study|Disease Progression|4|||
28152010|NCT02636608|54821082|FG000|Overall Study|Other|2|||
28152011|NCT02636608|54821082|FG000|Overall Study|Did Not Receive Treatment|1|||
28152012|NCT02759562|54821091|FG000|Open-Label Treatment Period|Withdrew Consent|1|||
28152013|NCT02759562|54821092|FG001|Open-Label Treatment Period|Withdrew Consent|0|||
28152014|NCT02759562|54821091|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
28152015|NCT02759562|54821092|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
28073647|NCT00146172|54728312|FG002|Overall Study|Disease Progression|2|||
27823166|NCT02000921|54287427|FG000|Overall Study|Lost to Follow-up|2|||
27823167|NCT02000921|54287428|FG001|Overall Study|Lost to Follow-up|4|||
27823168|NCT02000921|54287429|FG002|Overall Study|Lost to Follow-up|5|||
27823169|NCT02000921|54287427|FG000|Overall Study|Physician Decision|0|||
27823170|NCT02000921|54287428|FG001|Overall Study|Physician Decision|2|||
27941836|NCT01211483|54598499|FG003|Phase 1b|Withdrawal by Subject|0|||
27941837|NCT01211483|54598496|FG000|Phase 2|Lost to Follow-up|0|||
27941838|NCT01211483|54598497|FG001|Phase 2|Lost to Follow-up|1|||
27941839|NCT01211483|54598498|FG002|Phase 2|Lost to Follow-up|1|||
27941840|NCT01211483|54598499|FG003|Phase 2|Lost to Follow-up|2|||
27941841|NCT01211483|54598496|FG000|Phase 2|Death|0|||
27941842|NCT01211483|54598497|FG001|Phase 2|Death|64|||
27941843|NCT01211483|54598498|FG002|Phase 2|Death|53|||
27941844|NCT01211483|54598499|FG003|Phase 2|Death|53|||
27941845|NCT01211483|54598496|FG000|Phase 2|Withdrawal by Subject|0|||
27941846|NCT01211483|54598497|FG001|Phase 2|Withdrawal by Subject|1|||
27941847|NCT01211483|54598498|FG002|Phase 2|Withdrawal by Subject|10|||
27941848|NCT01211483|54598499|FG003|Phase 2|Withdrawal by Subject|5|||
27941849|NCT01211483|54598496|FG000|Phase 2|Study terminated by Sponsor|0|||
27941850|NCT01211483|54598497|FG001|Phase 2|Study terminated by Sponsor|6|||
27941851|NCT01211483|54598498|FG002|Phase 2|Study terminated by Sponsor|8|||
27941852|NCT01211483|54598499|FG003|Phase 2|Study terminated by Sponsor|11|||
27941853|NCT01210001|54598516|FG000|Overall Study|Not treated|1|||
27941854|NCT01210001|54598517|FG001|Overall Study|Not treated|0|||
27941855|NCT01210001|54598518|FG002|Overall Study|Not treated|0|||
27941856|NCT01210001|54598516|FG000|Overall Study|Adverse Event|4|||
27941857|NCT01210001|54598517|FG001|Overall Study|Adverse Event|2|||
27941858|NCT01210001|54598518|FG002|Overall Study|Adverse Event|5|||
27941859|NCT01210001|54598516|FG000|Overall Study|Non compliant with protocol|2|||
27941860|NCT01210001|54598517|FG001|Overall Study|Non compliant with protocol|2|||
27823171|NCT02000921|54287429|FG002|Overall Study|Physician Decision|0|||
27823172|NCT01836523|54287475|FG000|Overall Study|Adverse Event|15|||
27823173|NCT01836523|54287476|FG001|Overall Study|Adverse Event|41|||
27823174|NCT01836523|54287477|FG002|Overall Study|Adverse Event|49|||
27823175|NCT01836523|54287478|FG003|Overall Study|Adverse Event|14|||
27823176|NCT01836523|54287475|FG000|Overall Study|Protocol Violation|6|||
27823177|NCT01836523|54287476|FG001|Overall Study|Protocol Violation|3|||
27823178|NCT01836523|54287477|FG002|Overall Study|Protocol Violation|2|||
27823179|NCT01836523|54287478|FG003|Overall Study|Protocol Violation|4|||
27823180|NCT01836523|54287475|FG000|Overall Study|Met Withdrawal Criteria|13|||
27823181|NCT01836523|54287476|FG001|Overall Study|Met Withdrawal Criteria|13|||
27823182|NCT01836523|54287477|FG002|Overall Study|Met Withdrawal Criteria|21|||
27823183|NCT01836523|54287478|FG003|Overall Study|Met Withdrawal Criteria|27|||
27823184|NCT01836523|54287475|FG000|Overall Study|Unclassified|17|||
27823185|NCT01836523|54287476|FG001|Overall Study|Unclassified|28|||
27823186|NCT01836523|54287477|FG002|Overall Study|Unclassified|19|||
27823187|NCT01836523|54287478|FG003|Overall Study|Unclassified|29|||
27823188|NCT01275196|54287490|FG000|Overall Study|Adverse Event|3|||
27823189|NCT01275196|54287491|FG001|Overall Study|Adverse Event|5|||
27823190|NCT01275196|54287490|FG000|Overall Study|Withdrawal by Subject|4|||
27823191|NCT01275196|54287491|FG001|Overall Study|Withdrawal by Subject|5|||
27823192|NCT01275196|54287490|FG000|Overall Study|Lost to Follow-up|1|||
27823193|NCT01275196|54287491|FG001|Overall Study|Lost to Follow-up|0|||
27823194|NCT01275196|54287490|FG000|Overall Study|Disease Progression|6|||
27823195|NCT01275196|54287491|FG001|Overall Study|Disease Progression|5|||
27823196|NCT01275196|54287490|FG000|Overall Study|Protocol Violation|1|||
27823197|NCT01275196|54287491|FG001|Overall Study|Protocol Violation|0|||
27823198|NCT01275196|54287490|FG000|Overall Study|Suboptimal response/treatment failure|5|||
27823199|NCT01275196|54287491|FG001|Overall Study|Suboptimal response/treatment failure|6|||
27823200|NCT01984697|54287504|FG000|Overall Study|Adverse Event|0|||
27823201|NCT01984697|54287505|FG001|Overall Study|Adverse Event|0|||
27823202|NCT01984697|54287506|FG002|Overall Study|Adverse Event|2|||
27823203|NCT01984697|54287507|FG003|Overall Study|Adverse Event|0|||
27823204|NCT01984697|54287508|FG004|Overall Study|Adverse Event|0|||
27823205|NCT01984697|54287504|FG000|Overall Study|Lost to Follow-up|14|||
27941861|NCT01210001|54598518|FG002|Overall Study|Non compliant with protocol|3|||
27941862|NCT01210001|54598516|FG000|Overall Study|Lost to Follow-up|4|||
27941863|NCT01210001|54598517|FG001|Overall Study|Lost to Follow-up|3|||
27941864|NCT01210001|54598518|FG002|Overall Study|Lost to Follow-up|2|||
27823206|NCT01984697|54287505|FG001|Overall Study|Lost to Follow-up|5|||
27823207|NCT01984697|54287506|FG002|Overall Study|Lost to Follow-up|10|||
27823208|NCT01984697|54287507|FG003|Overall Study|Lost to Follow-up|6|||
27823209|NCT01984697|54287508|FG004|Overall Study|Lost to Follow-up|21|||
27823210|NCT01984697|54287504|FG000|Overall Study|Physician Decision|3|||
27823211|NCT01984697|54287505|FG001|Overall Study|Physician Decision|0|||
27823212|NCT01984697|54287506|FG002|Overall Study|Physician Decision|0|||
27941865|NCT01210001|54598516|FG000|Overall Study|Patient refusal to continue,not due toAE|6|||
27941866|NCT01210001|54598517|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
27823213|NCT01984697|54287507|FG003|Overall Study|Physician Decision|1|||
27941867|NCT01210001|54598518|FG002|Overall Study|Patient refusal to continue,not due toAE|1|||
28073648|NCT00146172|54728313|FG003|Overall Study|Disease Progression|5|||
27941868|NCT01210001|54598516|FG000|Overall Study|Other reason not defined above|2|||
27941869|NCT01210001|54598517|FG001|Overall Study|Other reason not defined above|2|||
27941870|NCT01210001|54598518|FG002|Overall Study|Other reason not defined above|1|||
27941871|NCT01209689|54598559|FG000|Overall Study|Insufficient Therapeutic Response|7|||
27941872|NCT01209689|54598560|FG001|Overall Study|Insufficient Therapeutic Response|2|||
27941873|NCT01209689|54598559|FG000|Overall Study|Refused Treatment|8|||
27941874|NCT01209689|54598560|FG001|Overall Study|Refused Treatment|3|||
27941875|NCT01209689|54598559|FG000|Overall Study|Adverse Event|4|||
27941876|NCT01209689|54598560|FG001|Overall Study|Adverse Event|0|||
27941877|NCT01209689|54598559|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
27941878|NCT01209689|54598560|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
27941879|NCT01209689|54598559|FG000|Overall Study|Failure to Return|3|||
27941880|NCT01209689|54598560|FG001|Overall Study|Failure to Return|0|||
28073649|NCT00146172|54728314|FG004|Overall Study|Disease Progression|2|||
28073650|NCT00146172|54728315|FG005|Overall Study|Disease Progression|2|||
28073651|NCT00146172|54728316|FG006|Overall Study|Disease Progression|1|||
28073652|NCT00146172|54728317|FG007|Overall Study|Disease Progression|22|||
28073653|NCT00146172|54728310|FG000|Overall Study|Death|0|||
28073654|NCT00146172|54728311|FG001|Overall Study|Death|0|||
28073655|NCT00146172|54728312|FG002|Overall Study|Death|0|||
28073656|NCT00146172|54728313|FG003|Overall Study|Death|0|||
28073657|NCT00146172|54728314|FG004|Overall Study|Death|0|||
28073658|NCT00146172|54728315|FG005|Overall Study|Death|0|||
28073659|NCT00146172|54728316|FG006|Overall Study|Death|1|||
28073660|NCT00146172|54728317|FG007|Overall Study|Death|0|||
28073661|NCT00146172|54728310|FG000|Overall Study|Physician Decision|0|||
28073662|NCT00146172|54728311|FG001|Overall Study|Physician Decision|0|||
28073663|NCT00146172|54728312|FG002|Overall Study|Physician Decision|0|||
28073664|NCT00146172|54728313|FG003|Overall Study|Physician Decision|0|||
28073665|NCT00146172|54728314|FG004|Overall Study|Physician Decision|0|||
28073666|NCT00146172|54728315|FG005|Overall Study|Physician Decision|0|||
28073667|NCT00146172|54728316|FG006|Overall Study|Physician Decision|0|||
28073668|NCT00146172|54728317|FG007|Overall Study|Physician Decision|1|||
28073669|NCT00146172|54728310|FG000|Overall Study|Withdrawal by Subject|0|||
28073670|NCT00146172|54728311|FG001|Overall Study|Withdrawal by Subject|0|||
28073671|NCT00146172|54728312|FG002|Overall Study|Withdrawal by Subject|0|||
28073672|NCT00146172|54728313|FG003|Overall Study|Withdrawal by Subject|0|||
28073673|NCT00146172|54728314|FG004|Overall Study|Withdrawal by Subject|0|||
28073674|NCT00146172|54728315|FG005|Overall Study|Withdrawal by Subject|1|||
28073675|NCT00146172|54728316|FG006|Overall Study|Withdrawal by Subject|1|||
28073676|NCT00146172|54728317|FG007|Overall Study|Withdrawal by Subject|4|||
28073677|NCT00146172|54728310|FG000|Overall Study|Symptomatic Deterioration|1|||
28073678|NCT00146172|54728311|FG001|Overall Study|Symptomatic Deterioration|0|||
28073679|NCT00146172|54728312|FG002|Overall Study|Symptomatic Deterioration|1|||
28073680|NCT00146172|54728313|FG003|Overall Study|Symptomatic Deterioration|0|||
28073681|NCT00146172|54728314|FG004|Overall Study|Symptomatic Deterioration|1|||
28073682|NCT00146172|54728315|FG005|Overall Study|Symptomatic Deterioration|2|||
28073683|NCT00146172|54728316|FG006|Overall Study|Symptomatic Deterioration|0|||
28073684|NCT00146172|54728317|FG007|Overall Study|Symptomatic Deterioration|2|||
28073685|NCT00145626|54728345|FG000|Overall Study|Did not have NK infusions|2|||
28073686|NCT00145626|54728345|FG000|Overall Study|Turned 2 years old before treatment|1|||
28073687|NCT00145626|54728345|FG000|Overall Study|Death|1|||
28073688|NCT00145626|54728345|FG000|Overall Study|Withdrawal by Subject|1|||
27941881|NCT01209689|54598559|FG000|Overall Study|Sponsor's Decision to Stop the Study|68|||
27941882|NCT01209689|54598560|FG001|Overall Study|Sponsor's Decision to Stop the Study|17|||
28073689|NCT00153062|54728369|FG000|Overall Study|Death|360|||
28073690|NCT00153062|54728370|FG001|Overall Study|Death|352|||
28073691|NCT00153062|54728371|FG002|Overall Study|Death|369|||
28073692|NCT00153062|54728372|FG003|Overall Study|Death|365|||
28073693|NCT00153062|54728369|FG000|Overall Study|Withdrawal by Subject|14|||
28073694|NCT00153062|54728370|FG001|Overall Study|Withdrawal by Subject|30|||
28073695|NCT00153062|54728371|FG002|Overall Study|Withdrawal by Subject|27|||
28073696|NCT00153062|54728372|FG003|Overall Study|Withdrawal by Subject|28|||
27941883|NCT01209143|54598568|FG000|Overall Study|Adverse Event|2|||
28073697|NCT00153062|54728369|FG000|Overall Study|Lost to Follow-up|12|||
28073698|NCT00153062|54728370|FG001|Overall Study|Lost to Follow-up|20|||
28073699|NCT00153062|54728371|FG002|Overall Study|Lost to Follow-up|15|||
28073700|NCT00153062|54728372|FG003|Overall Study|Lost to Follow-up|16|||
28073701|NCT00153062|54728369|FG000|Overall Study|Adverse Event|0|||
28073702|NCT00153062|54728370|FG001|Overall Study|Adverse Event|1|||
28073703|NCT00153062|54728371|FG002|Overall Study|Adverse Event|1|||
28073704|NCT00153062|54728372|FG003|Overall Study|Adverse Event|0|||
28073705|NCT00153062|54728369|FG000|Overall Study|Protocol Violation|0|||
28073706|NCT00153062|54728370|FG001|Overall Study|Protocol Violation|2|||
28073707|NCT00153062|54728371|FG002|Overall Study|Protocol Violation|1|||
28073708|NCT00153062|54728372|FG003|Overall Study|Protocol Violation|1|||
27823214|NCT01984697|54287508|FG004|Overall Study|Physician Decision|0|||
27823215|NCT01984697|54287504|FG000|Overall Study|Protocol Violation|8|||
27823216|NCT01984697|54287505|FG001|Overall Study|Protocol Violation|5|||
27823217|NCT01984697|54287506|FG002|Overall Study|Protocol Violation|3|||
27823218|NCT01984697|54287507|FG003|Overall Study|Protocol Violation|2|||
27823219|NCT01984697|54287508|FG004|Overall Study|Protocol Violation|0|||
27823220|NCT01984697|54287504|FG000|Overall Study|Withdrawal by Subject|15|||
27941884|NCT01209143|54598569|FG001|Overall Study|Adverse Event|1|||
27941885|NCT01209143|54598568|FG000|Overall Study|Death|0|||
27941886|NCT01209143|54598569|FG001|Overall Study|Death|1|||
27941887|NCT01209143|54598568|FG000|Overall Study|Physician Decision|3|||
27941888|NCT01209143|54598569|FG001|Overall Study|Physician Decision|1|||
27941889|NCT01209143|54598568|FG000|Overall Study|Lost to Follow-up|1|||
27823221|NCT01984697|54287505|FG001|Overall Study|Withdrawal by Subject|21|||
27823222|NCT01984697|54287506|FG002|Overall Study|Withdrawal by Subject|13|||
27823223|NCT01984697|54287507|FG003|Overall Study|Withdrawal by Subject|11|||
27823224|NCT01984697|54287508|FG004|Overall Study|Withdrawal by Subject|13|||
27823225|NCT01984697|54287504|FG000|Overall Study|Missed last follow-up visit|1|||
27823226|NCT01984697|54287505|FG001|Overall Study|Missed last follow-up visit|0|||
27823227|NCT01984697|54287506|FG002|Overall Study|Missed last follow-up visit|0|||
27823228|NCT01984697|54287507|FG003|Overall Study|Missed last follow-up visit|0|||
27823229|NCT01984697|54287508|FG004|Overall Study|Missed last follow-up visit|0|||
27823230|NCT01984697|54287504|FG000|Overall Study|Death|0|||
27823231|NCT01984697|54287505|FG001|Overall Study|Death|0|||
27941890|NCT01209143|54598569|FG001|Overall Study|Lost to Follow-up|0|||
28152016|NCT02746575|54821099|FG000|Overall Study|Surgery cancelled or time chaned|13|||
28152017|NCT02746575|54821099|FG000|Overall Study|Received epidural|10|||
28152018|NCT02746575|54821099|FG000|Overall Study|Withdrawal by Subject|3|||
28152019|NCT02746575|54821099|FG000|Overall Study|Bradycardia/hypotension|9|||
28152020|NCT02746575|54821099|FG000|Overall Study|Study paused|8|||
28152021|NCT02746575|54821099|FG000|Overall Study|put on beta-blocker|3|||
28152022|NCT02746575|54821099|FG000|Overall Study|type of surgery|1|||
28152023|NCT02746575|54821099|FG000|Overall Study|typ of surgery|1|||
28152024|NCT02746575|54821099|FG000|Overall Study|PI unavailable|1|||
28152025|NCT02746575|54821099|FG000|Overall Study|Unknown history of CVA|1|||
28152026|NCT03625466|54821105|FG000|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
28152027|NCT03625466|54821106|FG001|Placebo-controlled Period (48 Weeks)|Adverse Event|1|||
28152028|NCT03625466|54821107|FG002|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
28152029|NCT03625466|54821105|FG000|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
28152030|NCT03625466|54821106|FG001|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
28152031|NCT03625466|54821107|FG002|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
28152032|NCT03625466|54821105|FG000|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
28152033|NCT03625466|54821106|FG001|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
28152034|NCT03625466|54821107|FG002|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
27823232|NCT01984697|54287506|FG002|Overall Study|Death|0|||
27823233|NCT01984697|54287507|FG003|Overall Study|Death|1|||
27823234|NCT01984697|54287508|FG004|Overall Study|Death|0|||
27823235|NCT01984697|54287504|FG000|Overall Study|Pregnancy|2|||
27823236|NCT01984697|54287505|FG001|Overall Study|Pregnancy|0|||
27823237|NCT01984697|54287506|FG002|Overall Study|Pregnancy|1|||
27823238|NCT01984697|54287507|FG003|Overall Study|Pregnancy|0|||
27823239|NCT01984697|54287508|FG004|Overall Study|Pregnancy|1|||
27823240|NCT02000531|54287522|FG000|Overall Study|Lost to Follow-up|1|||
27823241|NCT02000531|54287523|FG001|Overall Study|Lost to Follow-up|0|||
28073709|NCT00153062|54728369|FG000|Overall Study|No disposition data available|1|||
28073710|NCT00153062|54728370|FG001|Overall Study|No disposition data available|1|||
28073711|NCT00153062|54728371|FG002|Overall Study|No disposition data available|1|||
28073712|NCT00153062|54728372|FG003|Overall Study|No disposition data available|1|||
28073713|NCT00153062|54728369|FG000|Overall Study|Other|0|||
28073714|NCT00153062|54728370|FG001|Overall Study|Other|0|||
28073715|NCT00153062|54728371|FG002|Overall Study|Other|1|||
28073716|NCT00153062|54728372|FG003|Overall Study|Other|0|||
28152035|NCT02853123|54821114|FG000|Treatment Period 1|Adverse Event|0|||
28152036|NCT02853123|54821115|FG001|Treatment Period 1|Adverse Event|3|||
28152037|NCT02853123|54821114|FG000|Washout Period|Worsening of COPD|0|||
27823242|NCT02000531|54287522|FG000|Overall Study|Discontinued due to data cut-off|3|||
27941891|NCT01209143|54598568|FG000|Overall Study|Withdrawal by Subject|2|||
28073717|NCT00145470|54728384|FG000|Overall Study|Adverse Event|19|||
27823243|NCT02000531|54287523|FG001|Overall Study|Discontinued due to data cut-off|8|||
27823244|NCT01609231|54287531|FG000|Overall Study|Adverse Event|1|||
27823245|NCT01609231|54287532|FG001|Overall Study|Adverse Event|3|||
27823246|NCT01609231|54287531|FG000|Overall Study|Physician Decision|1|||
27823247|NCT01609231|54287532|FG001|Overall Study|Physician Decision|0|||
27941892|NCT01209143|54598569|FG001|Overall Study|Withdrawal by Subject|1|||
27941893|NCT01209143|54598568|FG000|Overall Study|Disease progression|11|||
27941894|NCT01209143|54598569|FG001|Overall Study|Disease progression|16|||
28152038|NCT02853123|54821115|FG001|Washout Period|Worsening of COPD|3|||
27823248|NCT01609231|54287531|FG000|Overall Study|Withdrawal by Subject|1|||
27823249|NCT01609231|54287532|FG001|Overall Study|Withdrawal by Subject|0|||
27823250|NCT01793935|54287540|FG000|Overall Study|Pregnancy|1|||
27823251|NCT01793935|54287541|FG001|Overall Study|Pregnancy|0|||
27823252|NCT01793935|54287540|FG000|Overall Study|Protocol Violation|2|||
27823253|NCT01793935|54287541|FG001|Overall Study|Protocol Violation|1|||
27823254|NCT01793935|54287540|FG000|Overall Study|Adverse Event|2|||
27823255|NCT01793935|54287541|FG001|Overall Study|Adverse Event|0|||
27823256|NCT01793935|54287540|FG000|Overall Study|Patient did not take study medication|1|||
27823257|NCT01793935|54287541|FG001|Overall Study|Patient did not take study medication|1|||
27823258|NCT01793935|54287540|FG000|Overall Study|Lost to Follow-up|0|||
27823259|NCT01793935|54287541|FG001|Overall Study|Lost to Follow-up|1|||
27823260|NCT02092025|54287547|FG000|Overall Study|Case Report Forms Uncollected|44|||
27823261|NCT02092025|54287547|FG000|Overall Study|Protocol Deviation|24|||
27823262|NCT01769443|54287553|FG000|Overall Study|Study closure|1|||
27823263|NCT01769443|54287554|FG001|Overall Study|Study closure|0|||
27823264|NCT01768117|54287561|FG000|Overall Study|Lost to Follow-up|1|||
27823265|NCT01768117|54287561|FG000|Overall Study|Withdrawal by Subject|2|||
27823266|NCT01768117|54287561|FG000|Overall Study|Protocol Violation|3|||
27823267|NCT01767493|54287565|FG000|Overall Study|screen failures|3|||
27823268|NCT01274182|54287572|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
27823269|NCT01274182|54287573|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
27823270|NCT01274182|54287574|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
27823271|NCT01274182|54287572|FG000|Overall Study|Adverse Event|4|||
27823272|NCT01274182|54287573|FG001|Overall Study|Adverse Event|5|||
27823273|NCT01274182|54287574|FG002|Overall Study|Adverse Event|3|||
27823274|NCT01274182|54287572|FG000|Overall Study|Withdrawal by Subject|5|||
27823275|NCT01274182|54287573|FG001|Overall Study|Withdrawal by Subject|5|||
27823276|NCT01274182|54287574|FG002|Overall Study|Withdrawal by Subject|3|||
27823277|NCT01274182|54287572|FG000|Overall Study|Lost to Follow-up|2|||
27823278|NCT01274182|54287573|FG001|Overall Study|Lost to Follow-up|3|||
27941895|NCT01023789|54598588|FG000|3 - Year Visit|Death|29|||
28152039|NCT02853123|54821114|FG000|Washout Period|Adverse Event|1|||
28152040|NCT02853123|54821115|FG001|Washout Period|Adverse Event|0|||
28152041|NCT02634346|54821125|FG000|Overall Study|Withdrawal by Subject|8|||
28152042|NCT02634346|54821126|FG001|Overall Study|Withdrawal by Subject|9|||
28152043|NCT02634346|54821127|FG002|Overall Study|Withdrawal by Subject|8|||
28152044|NCT02634346|54821125|FG000|Overall Study|Adverse Event|2|||
28152045|NCT02634346|54821126|FG001|Overall Study|Adverse Event|2|||
28152046|NCT02634346|54821127|FG002|Overall Study|Adverse Event|7|||
28152047|NCT02634346|54821125|FG000|Overall Study|Lack of Efficacy|1|||
28152048|NCT02634346|54821126|FG001|Overall Study|Lack of Efficacy|2|||
28152049|NCT02634346|54821127|FG002|Overall Study|Lack of Efficacy|8|||
28152050|NCT02634346|54821125|FG000|Overall Study|Lost to Follow-up|1|||
28152051|NCT02634346|54821126|FG001|Overall Study|Lost to Follow-up|0|||
28152052|NCT02634346|54821127|FG002|Overall Study|Lost to Follow-up|0|||
28152053|NCT02634346|54821125|FG000|Overall Study|Protocol Violation|0|||
28152054|NCT02634346|54821126|FG001|Overall Study|Protocol Violation|1|||
28152055|NCT02634346|54821127|FG002|Overall Study|Protocol Violation|0|||
28152056|NCT00849147|54821135|FG000|Overall Study|Withdrawal by Subject|1|||
28152057|NCT00849147|54821135|FG000|Overall Study|Protocol Violation|2|||
28152058|NCT00849147|54821135|FG000|Overall Study|Disease Relapse/Progression|2|||
28152059|NCT00101166|54821139|FG000|Overall Study|progressive disease|10|||
28152060|NCT02759016|54821145|FG000|Overall Study|Not treated with BI 836826|1|||
27941896|NCT01023789|54598588|FG000|3 - Year Visit|Withdrawal of consent|1|||
28152061|NCT02759016|54821146|FG001|Overall Study|Not treated with BI 836826|0|||
28152062|NCT02759016|54821145|FG000|Overall Study|Progressive disease|1|||
28152063|NCT02759016|54821146|FG001|Overall Study|Progressive disease|0|||
28152064|NCT02759016|54821145|FG000|Overall Study|SD, PR-MRDpos or PR-L|0|||
27823279|NCT01274182|54287574|FG002|Overall Study|Lost to Follow-up|1|||
27823280|NCT01274182|54287572|FG000|Overall Study|Protocol Violation|3|||
27941897|NCT01023789|54598588|FG000|3 - Year Visit|Lost to Follow-up|13|||
28152065|NCT02759016|54821146|FG001|Overall Study|SD, PR-MRDpos or PR-L|2|||
28152066|NCT02759016|54821145|FG000|Overall Study|Other not defined above|2|||
27823281|NCT01274182|54287573|FG001|Overall Study|Protocol Violation|2|||
27823282|NCT01274182|54287574|FG002|Overall Study|Protocol Violation|0|||
27823283|NCT01274182|54287572|FG000|Overall Study|Death|1|||
27823284|NCT01274182|54287573|FG001|Overall Study|Death|0|||
27823285|NCT01274182|54287574|FG002|Overall Study|Death|1|||
28152067|NCT02759016|54821146|FG001|Overall Study|Other not defined above|1|||
28152068|NCT02852967|54821158|FG000|Overall Study|Adverse Event|3|||
27823286|NCT01984229|54287588|FG000|Safety Follow-up Period|Adverse Event|1|||
27823287|NCT01984229|54287589|FG001|Safety Follow-up Period|Adverse Event|1|||
27850284|NCT04178967|54349323|FG008|Induction Period|Withdrawal by Subject|0|||
28152069|NCT02852967|54821159|FG001|Overall Study|Adverse Event|1|||
28152070|NCT02852967|54821160|FG002|Overall Study|Adverse Event|0|||
28152071|NCT02852967|54821161|FG003|Overall Study|Adverse Event|1|||
28152072|NCT02852967|54821162|FG004|Overall Study|Adverse Event|0|||
28152073|NCT02852967|54821158|FG000|Overall Study|Death|1|||
28152074|NCT02852967|54821159|FG001|Overall Study|Death|0|||
28152075|NCT02852967|54821160|FG002|Overall Study|Death|0|||
28152076|NCT02852967|54821161|FG003|Overall Study|Death|0|||
28152077|NCT02852967|54821162|FG004|Overall Study|Death|0|||
28152078|NCT02852967|54821158|FG000|Overall Study|Lost to Follow-up|1|||
28152079|NCT02852967|54821159|FG001|Overall Study|Lost to Follow-up|2|||
27823288|NCT01984229|54287588|FG000|Safety Follow-up Period|Lost to Follow-up|1|||
27941898|NCT01208207|54598595|FG000|Part I|Adverse Event|19|||
28152080|NCT02852967|54821160|FG002|Overall Study|Lost to Follow-up|3|||
28152081|NCT02852967|54821161|FG003|Overall Study|Lost to Follow-up|4|||
27823289|NCT01984229|54287589|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
27823290|NCT01835899|54287604|FG000|Overall Study|Adverse Event|0|||
27823291|NCT01835899|54287605|FG001|Overall Study|Adverse Event|0|||
27823292|NCT01835899|54287606|FG002|Overall Study|Adverse Event|1|||
27823293|NCT01835899|54287604|FG000|Overall Study|Other than stated above|0|||
27823294|NCT01835899|54287605|FG001|Overall Study|Other than stated above|1|||
27823295|NCT01835899|54287606|FG002|Overall Study|Other than stated above|0|||
27823296|NCT01766401|54287618|FG000|Overall Study|Adverse Event|7|||
27823297|NCT01766401|54287619|FG001|Overall Study|Adverse Event|22|||
27823298|NCT01766401|54287618|FG000|Overall Study|Lack of Efficacy|1|||
27823299|NCT01766401|54287619|FG001|Overall Study|Lack of Efficacy|2|||
27823300|NCT01766401|54287618|FG000|Overall Study|Protocol Violation|3|||
27823301|NCT01766401|54287619|FG001|Overall Study|Protocol Violation|8|||
27823302|NCT01766401|54287618|FG000|Overall Study|Withdrawal by Subject|15|||
27823303|NCT01766401|54287619|FG001|Overall Study|Withdrawal by Subject|12|||
27823304|NCT01766401|54287618|FG000|Overall Study|Lost to Follow-up|10|||
27823305|NCT01766401|54287619|FG001|Overall Study|Lost to Follow-up|11|||
27823306|NCT01766401|54287618|FG000|Overall Study|Pregnancy|1|||
27823307|NCT01766401|54287619|FG001|Overall Study|Pregnancy|1|||
27823308|NCT01272934|54287627|FG000|Overall Study|Adverse Event|0|||
27941899|NCT01208207|54598596|FG001|Part I|Adverse Event|2|||
27941900|NCT01208207|54598597|FG002|Part I|Adverse Event|6|||
28073718|NCT00145470|54728385|FG001|Overall Study|Adverse Event|25|||
28073719|NCT00145470|54728384|FG000|Overall Study|Lack of Efficacy|27|||
28073720|NCT00145470|54728385|FG001|Overall Study|Lack of Efficacy|13|||
28073721|NCT00145470|54728384|FG000|Overall Study|Withdrawal by Subject|36|||
28073722|NCT00145470|54728385|FG001|Overall Study|Withdrawal by Subject|34|||
28152082|NCT02852967|54821162|FG004|Overall Study|Lost to Follow-up|4|||
28152083|NCT02852967|54821158|FG000|Overall Study|Withdrawal by Subject|6|||
28152084|NCT02852967|54821159|FG001|Overall Study|Withdrawal by Subject|12|||
28152085|NCT02852967|54821160|FG002|Overall Study|Withdrawal by Subject|7|||
28152086|NCT02852967|54821161|FG003|Overall Study|Withdrawal by Subject|10|||
28073723|NCT00145470|54728384|FG000|Overall Study|Lost to Follow-up|21|||
28073724|NCT00145470|54728385|FG001|Overall Study|Lost to Follow-up|17|||
28073725|NCT00145470|54728384|FG000|Overall Study|Reason Not Reported|9|||
28073726|NCT00145470|54728385|FG001|Overall Study|Reason Not Reported|9|||
28073727|NCT00152516|54728391|FG000|Overall Study|Adverse Event|18|||
28073728|NCT00152516|54728391|FG000|Overall Study|Lack and Loss of Efficacy|30|||
28073729|NCT00152516|54728391|FG000|Overall Study|Lost to Follow-up|5|||
28073730|NCT00152516|54728391|FG000|Overall Study|Withdrawal by Subject|8|||
28073731|NCT00152516|54728391|FG000|Overall Study|Protocol Violation|3|||
28073732|NCT00152516|54728391|FG000|Overall Study|Other: Mother Refused To Cooperate|1|||
28073733|NCT00152516|54728391|FG000|Overall Study|Other: Given Commercial Drug in Error|2|||
28073734|NCT00152516|54728391|FG000|Overall Study|Other: Parents Withdrew Consent|2|||
28073735|NCT00152516|54728391|FG000|Overall Study|Other: Non-Compliance|2|||
28073736|NCT00152516|54728391|FG000|Overall Study|Other: Primary Care Physician's Decision|1|||
28073737|NCT00152516|54728391|FG000|Overall Study|Other: Moved Out Of State|1|||
28073738|NCT00152516|54728391|FG000|Overall Study|Other: Underwent Surgery for Epilepsy|1|||
28073739|NCT00152516|54728391|FG000|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1|||
28073740|NCT00145158|54728397|FG000|Overall Study|premature withdrawal|2|||
28073741|NCT00145158|54728398|FG001|Overall Study|premature withdrawal|3|||
28073742|NCT00150800|54728405|FG000|Overall Study|Adverse Event|89|||
28073743|NCT00150800|54728405|FG000|Overall Study|Death|18|||
28073744|NCT00150800|54728405|FG000|Overall Study|Lack of Efficacy|166|||
28073745|NCT00150800|54728405|FG000|Overall Study|Lost to Follow-up|58|||
28073746|NCT00150800|54728405|FG000|Overall Study|Subject's choice|90|||
28073747|NCT00150800|54728405|FG000|Overall Study|No compliance|18|||
28073748|NCT00150800|54728405|FG000|Overall Study|IP misshandling|1|||
28073749|NCT00150800|54728405|FG000|Overall Study|Site closure|24|||
28073750|NCT00150800|54728405|FG000|Overall Study|Protocol non-adherence|2|||
28073751|NCT00150800|54728405|FG000|Overall Study|Nobody to accompany patient|1|||
28073752|NCT00150800|54728405|FG000|Overall Study|Distance too long for patient|1|||
28073753|NCT00150800|54728405|FG000|Overall Study|Neurosurgery|2|||
28073754|NCT00150800|54728405|FG000|Overall Study|BRV monotherapy|1|||
28152087|NCT02852967|54821162|FG004|Overall Study|Withdrawal by Subject|10|||
28073755|NCT00150800|54728405|FG000|Overall Study|Visit refusal|3|||
28073756|NCT00150800|54728405|FG000|Overall Study|Sponsor's request|2|||
28073757|NCT00150800|54728405|FG000|Overall Study|Generalized Epilepsy|1|||
28152088|NCT02852967|54821158|FG000|Overall Study|SAE|0|||
27823309|NCT01272934|54287628|FG001|Overall Study|Adverse Event|1|||
27823310|NCT01272934|54287627|FG000|Overall Study|Abnormal Laboratory Value|0|||
27823311|NCT01272934|54287628|FG001|Overall Study|Abnormal Laboratory Value|1|||
27941901|NCT01208207|54598598|FG003|Part I|Adverse Event|0|||
28073758|NCT00150800|54728405|FG000|Overall Study|Moved from area/country|8|||
28073759|NCT00150800|54728405|FG000|Overall Study|PI retiring|2|||
28073760|NCT00150800|54728405|FG000|Overall Study|PI leaving site|2|||
28152089|NCT02852967|54821159|FG001|Overall Study|SAE|0|||
28152090|NCT02852967|54821160|FG002|Overall Study|SAE|0|||
27823312|NCT01983683|54287646|FG000|Overall Study|Withdrawal by Subject|14|||
28152091|NCT02852967|54821161|FG003|Overall Study|SAE|3|||
28152092|NCT02852967|54821162|FG004|Overall Study|SAE|0|||
28152093|NCT02852967|54821158|FG000|Overall Study|Elevated Liver Enzymes|2|||
28152094|NCT02852967|54821159|FG001|Overall Study|Elevated Liver Enzymes|0|||
28152095|NCT02852967|54821160|FG002|Overall Study|Elevated Liver Enzymes|0|||
28152096|NCT02852967|54821161|FG003|Overall Study|Elevated Liver Enzymes|2|||
27823313|NCT01983683|54287647|FG001|Overall Study|Withdrawal by Subject|18|||
27823314|NCT01983683|54287646|FG000|Overall Study|Death|11|||
27823315|NCT01983683|54287647|FG001|Overall Study|Death|15|||
27823316|NCT01983683|54287646|FG000|Overall Study|Physician Decision|8|||
27823317|NCT01983683|54287647|FG001|Overall Study|Physician Decision|9|||
27823318|NCT01983683|54287646|FG000|Overall Study|Lost to Follow-up|4|||
27823319|NCT01983683|54287647|FG001|Overall Study|Lost to Follow-up|8|||
27823320|NCT01983683|54287646|FG000|Overall Study|Sponsor Decision|1|||
27823321|NCT01983683|54287647|FG001|Overall Study|Sponsor Decision|1|||
27823322|NCT01998893|54287653|FG000|Overall Study|Adverse Event|2|||
28152097|NCT02852967|54821162|FG004|Overall Study|Elevated Liver Enzymes|2|||
28152098|NCT02852967|54821158|FG000|Overall Study|Physician Decision|0|||
28152099|NCT02852967|54821159|FG001|Overall Study|Physician Decision|0|||
28152100|NCT02852967|54821160|FG002|Overall Study|Physician Decision|0|||
28152101|NCT02852967|54821161|FG003|Overall Study|Physician Decision|1|||
28152102|NCT02852967|54821162|FG004|Overall Study|Physician Decision|0|||
28152103|NCT02852967|54821158|FG000|Overall Study|Lack of Efficacy|0|||
28152104|NCT02852967|54821159|FG001|Overall Study|Lack of Efficacy|1|||
28152105|NCT02852967|54821160|FG002|Overall Study|Lack of Efficacy|0|||
27823323|NCT01998893|54287653|FG000|Overall Study|Death|1|||
28152106|NCT02852967|54821161|FG003|Overall Study|Lack of Efficacy|0|||
28152107|NCT02852967|54821162|FG004|Overall Study|Lack of Efficacy|0|||
28152108|NCT02852967|54821158|FG000|Overall Study|Non-compliance|0|||
28152109|NCT02852967|54821159|FG001|Overall Study|Non-compliance|0|||
28152110|NCT02852967|54821160|FG002|Overall Study|Non-compliance|1|||
28152111|NCT02852967|54821161|FG003|Overall Study|Non-compliance|1|||
28152112|NCT02852967|54821162|FG004|Overall Study|Non-compliance|0|||
28152113|NCT02852967|54821158|FG000|Overall Study|Dispensing Drug Violation|0|||
28152114|NCT02852967|54821159|FG001|Overall Study|Dispensing Drug Violation|0|||
28152115|NCT02852967|54821160|FG002|Overall Study|Dispensing Drug Violation|1|||
28152116|NCT02852967|54821161|FG003|Overall Study|Dispensing Drug Violation|0|||
28152117|NCT02852967|54821162|FG004|Overall Study|Dispensing Drug Violation|0|||
27823324|NCT01998893|54287653|FG000|Overall Study|Lost to Follow-up|8|||
27823325|NCT01998893|54287653|FG000|Overall Study|Physician Decision|2|||
27823326|NCT01998893|54287653|FG000|Overall Study|Protocol Violation|2|||
27823327|NCT01998893|54287653|FG000|Overall Study|Withdrawal by Subject|1|||
27823328|NCT01998893|54287653|FG000|Overall Study|Transformation to high-grade lymphoma|1|||
27823329|NCT01791985|54287657|FG000|Overall Study|Adverse Event|7|||
27823330|NCT01791985|54287657|FG000|Overall Study|Withdrawal by Subject|1|||
27823331|NCT01998737|54287664|FG000|Overall Study|Corrupted database|23|||
27823332|NCT01998737|54287665|FG001|Overall Study|Corrupted database|0|||
27823333|NCT01791517|54287674|FG000|Phase I: Period 1|Withdrawal by Subject|0|||
27823334|NCT01791517|54287675|FG001|Phase I: Period 1|Withdrawal by Subject|1|||
27823335|NCT01791517|54287676|FG002|Phase I: Period 1|Withdrawal by Subject|1|||
27823336|NCT01791517|54287677|FG003|Phase I: Period 1|Withdrawal by Subject|0|||
27823337|NCT01791517|54287678|FG004|Phase I: Period 1|Withdrawal by Subject|1|||
27823338|NCT01791517|54287679|FG005|Phase I: Period 1|Withdrawal by Subject|1|||
27823339|NCT01791517|54287680|FG006|Phase I: Period 1|Withdrawal by Subject|0|||
27823340|NCT01791517|54287681|FG007|Phase I: Period 1|Withdrawal by Subject|0|||
28152118|NCT02852967|54821158|FG000|Overall Study|Inclusion/Exclusion Violation|1|||
28152119|NCT02852967|54821159|FG001|Overall Study|Inclusion/Exclusion Violation|0|||
28152120|NCT02852967|54821160|FG002|Overall Study|Inclusion/Exclusion Violation|0|||
28152121|NCT02852967|54821161|FG003|Overall Study|Inclusion/Exclusion Violation|0|||
28152122|NCT02852967|54821162|FG004|Overall Study|Inclusion/Exclusion Violation|0|||
28152123|NCT02762994|54821190|FG000|Overall Study|Withdrawal by Subject|0|||
28152124|NCT02762994|54821191|FG001|Overall Study|Withdrawal by Subject|1|||
28152125|NCT02762994|54821192|FG002|Overall Study|Withdrawal by Subject|2|||
28152126|NCT02762994|54821193|FG003|Overall Study|Withdrawal by Subject|0|||
28152127|NCT02762994|54821190|FG000|Overall Study|Protocol Violation|1|||
28152128|NCT02762994|54821191|FG001|Overall Study|Protocol Violation|0|||
28152129|NCT02762994|54821192|FG002|Overall Study|Protocol Violation|0|||
28152130|NCT02762994|54821193|FG003|Overall Study|Protocol Violation|2|||
28152131|NCT02852265|54821209|FG000|3-month Follow-up|Lost to Follow-up|1|||
28152132|NCT02852265|54821210|FG001|3-month Follow-up|Lost to Follow-up|1|||
28152133|NCT02633800|54821222|FG000|Overall Study|Death|3|||
28073761|NCT00150800|54728405|FG000|Overall Study|Patient insurance|1|||
27823341|NCT01791517|54287682|FG008|Phase I: Period 1|Withdrawal by Subject|0|||
27823342|NCT01791517|54287683|FG009|Phase I: Period 1|Withdrawal by Subject|0|||
27823343|NCT01791517|54287684|FG010|Phase I: Period 1|Withdrawal by Subject|0|||
27823344|NCT01791517|54287685|FG011|Phase I: Period 1|Withdrawal by Subject|0|||
27823345|NCT01791517|54287674|FG000|Phase I: Period 1|Adverse Event|0|||
27823346|NCT01791517|54287675|FG001|Phase I: Period 1|Adverse Event|0|||
27823347|NCT01791517|54287676|FG002|Phase I: Period 1|Adverse Event|1|||
27823348|NCT01791517|54287677|FG003|Phase I: Period 1|Adverse Event|1|||
27823349|NCT01791517|54287678|FG004|Phase I: Period 1|Adverse Event|0|||
27823350|NCT01791517|54287679|FG005|Phase I: Period 1|Adverse Event|0|||
27823351|NCT01791517|54287680|FG006|Phase I: Period 1|Adverse Event|0|||
28073762|NCT00150800|54728405|FG000|Overall Study|Surgical intervention|4|||
28073763|NCT00150800|54728405|FG000|Overall Study|Pregnancy planned|1|||
28073764|NCT00150800|54728405|FG000|Overall Study|PI discontinuation request|1|||
28073765|NCT00144300|54728412|FG000|Overall Study|Adverse Event|18|||
28073766|NCT00144300|54728413|FG001|Overall Study|Adverse Event|16|||
28073767|NCT00144300|54728412|FG000|Overall Study|Protocol Violation|1|||
28073768|NCT00144300|54728413|FG001|Overall Study|Protocol Violation|3|||
28152134|NCT02633800|54821223|FG001|Overall Study|Death|3|||
28152135|NCT02633800|54821222|FG000|Overall Study|Reason not provided|1|||
28152136|NCT02633800|54821223|FG001|Overall Study|Reason not provided|0|||
27823352|NCT01791517|54287681|FG007|Phase I: Period 1|Adverse Event|0|||
27823353|NCT01791517|54287682|FG008|Phase I: Period 1|Adverse Event|0|||
27823354|NCT01791517|54287683|FG009|Phase I: Period 1|Adverse Event|0|||
27823355|NCT01791517|54287684|FG010|Phase I: Period 1|Adverse Event|0|||
27823356|NCT01791517|54287685|FG011|Phase I: Period 1|Adverse Event|0|||
27823357|NCT01791517|54287674|FG000|Phase I: Period 1|Unsatisfactory Lens Fitting|1|||
27823358|NCT01791517|54287675|FG001|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
28152137|NCT02633800|54821222|FG000|Overall Study|Radiologic(al) progression|23|||
28152138|NCT02633800|54821223|FG001|Overall Study|Radiologic(al) progression|23|||
27823359|NCT01791517|54287676|FG002|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
28073769|NCT00144300|54728412|FG000|Overall Study|Lost to Follow-up|3|||
28073770|NCT00144300|54728413|FG001|Overall Study|Lost to Follow-up|0|||
27823360|NCT01791517|54287677|FG003|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
27823361|NCT01791517|54287678|FG004|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
27823362|NCT01791517|54287679|FG005|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
27823363|NCT01791517|54287680|FG006|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
27823364|NCT01791517|54287681|FG007|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
27823365|NCT01791517|54287682|FG008|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
27823366|NCT01791517|54287683|FG009|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
27823367|NCT01791517|54287684|FG010|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
27823368|NCT01791517|54287685|FG011|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
27823369|NCT01791517|54287674|FG000|Phase I: Period 1|Protocol Violation|0|||
27823370|NCT01791517|54287675|FG001|Phase I: Period 1|Protocol Violation|1|||
27823371|NCT01791517|54287676|FG002|Phase I: Period 1|Protocol Violation|0|||
27823372|NCT01791517|54287677|FG003|Phase I: Period 1|Protocol Violation|0|||
27823373|NCT01791517|54287678|FG004|Phase I: Period 1|Protocol Violation|0|||
27823374|NCT01791517|54287679|FG005|Phase I: Period 1|Protocol Violation|0|||
27823375|NCT01791517|54287680|FG006|Phase I: Period 1|Protocol Violation|0|||
27823376|NCT01791517|54287681|FG007|Phase I: Period 1|Protocol Violation|0|||
27823377|NCT01791517|54287682|FG008|Phase I: Period 1|Protocol Violation|0|||
27823378|NCT01791517|54287683|FG009|Phase I: Period 1|Protocol Violation|0|||
27823379|NCT01791517|54287684|FG010|Phase I: Period 1|Protocol Violation|0|||
27823380|NCT01791517|54287685|FG011|Phase I: Period 1|Protocol Violation|0|||
27823381|NCT01791517|54287674|FG000|Phase I: Period 1|Lost to Follow-up|0|||
27823382|NCT01791517|54287675|FG001|Phase I: Period 1|Lost to Follow-up|0|||
27823383|NCT01791517|54287676|FG002|Phase I: Period 1|Lost to Follow-up|0|||
27823384|NCT01791517|54287677|FG003|Phase I: Period 1|Lost to Follow-up|1|||
27823385|NCT01791517|54287678|FG004|Phase I: Period 1|Lost to Follow-up|0|||
27823386|NCT01791517|54287679|FG005|Phase I: Period 1|Lost to Follow-up|0|||
27823387|NCT01791517|54287680|FG006|Phase I: Period 1|Lost to Follow-up|1|||
27823388|NCT01791517|54287681|FG007|Phase I: Period 1|Lost to Follow-up|0|||
27823389|NCT01791517|54287682|FG008|Phase I: Period 1|Lost to Follow-up|1|||
28152139|NCT02633800|54821222|FG000|Overall Study|Clinical progression|3|||
28152140|NCT02633800|54821223|FG001|Overall Study|Clinical progression|6|||
28152141|NCT02633800|54821222|FG000|Overall Study|Study terminated by sponsor|6|||
28152142|NCT02633800|54821223|FG001|Overall Study|Study terminated by sponsor|5|||
27823390|NCT01791517|54287683|FG009|Phase I: Period 1|Lost to Follow-up|1|||
27823391|NCT01791517|54287684|FG010|Phase I: Period 1|Lost to Follow-up|0|||
27823392|NCT01791517|54287685|FG011|Phase I: Period 1|Lost to Follow-up|0|||
27823393|NCT01791517|54287674|FG000|Phase I: Period 1|Lens Handling DIfficulties|0|||
27823394|NCT01791517|54287675|FG001|Phase I: Period 1|Lens Handling DIfficulties|0|||
27823395|NCT01791517|54287676|FG002|Phase I: Period 1|Lens Handling DIfficulties|0|||
27823396|NCT01791517|54287677|FG003|Phase I: Period 1|Lens Handling DIfficulties|0|||
27823397|NCT01791517|54287678|FG004|Phase I: Period 1|Lens Handling DIfficulties|0|||
27823398|NCT01791517|54287679|FG005|Phase I: Period 1|Lens Handling DIfficulties|0|||
27823399|NCT01791517|54287680|FG006|Phase I: Period 1|Lens Handling DIfficulties|0|||
27823400|NCT01791517|54287681|FG007|Phase I: Period 1|Lens Handling DIfficulties|0|||
27823401|NCT01791517|54287682|FG008|Phase I: Period 1|Lens Handling DIfficulties|0|||
27823402|NCT01791517|54287683|FG009|Phase I: Period 1|Lens Handling DIfficulties|0|||
27823403|NCT01791517|54287684|FG010|Phase I: Period 1|Lens Handling DIfficulties|0|||
27823404|NCT01791517|54287685|FG011|Phase I: Period 1|Lens Handling DIfficulties|1|||
27823405|NCT01791517|54287674|FG000|Phase I: Period 2|Unsatisfactory Lens Fit|1|||
27823406|NCT01791517|54287675|FG001|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
27823407|NCT01791517|54287676|FG002|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
27823408|NCT01791517|54287677|FG003|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
27823409|NCT01791517|54287678|FG004|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
27823410|NCT01791517|54287679|FG005|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
27823411|NCT01791517|54287680|FG006|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
27823412|NCT01791517|54287681|FG007|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
27823413|NCT01791517|54287682|FG008|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
28073771|NCT00144300|54728412|FG000|Overall Study|Withdrawal by Subject|6|||
28073772|NCT00144300|54728413|FG001|Overall Study|Withdrawal by Subject|6|||
28073773|NCT00144300|54728412|FG000|Overall Study|Other reason (not specified)|1|||
28073774|NCT00144300|54728413|FG001|Overall Study|Other reason (not specified)|3|||
28073775|NCT00149630|54728421|FG000|Overall Study|Incarceration|2|||
28073776|NCT00149630|54728422|FG001|Overall Study|Incarceration|0|||
28073777|NCT00149630|54728421|FG000|Overall Study|Treatment Programs|4|||
28073778|NCT00149630|54728422|FG001|Overall Study|Treatment Programs|5|||
28073779|NCT00149630|54728421|FG000|Overall Study|Adverse Event|2|||
28152143|NCT02633800|54821222|FG000|Overall Study|Adverse event, non-fatal|7|||
28152144|NCT02633800|54821223|FG001|Overall Study|Adverse event, non-fatal|2|||
27823414|NCT01791517|54287683|FG009|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
27823415|NCT01791517|54287684|FG010|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
27823416|NCT01791517|54287685|FG011|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
27823417|NCT01791517|54287674|FG000|Phase I: Period 2|Protocol Violation|0|||
27823418|NCT01791517|54287675|FG001|Phase I: Period 2|Protocol Violation|0|||
27823419|NCT01791517|54287676|FG002|Phase I: Period 2|Protocol Violation|0|||
27823420|NCT01791517|54287677|FG003|Phase I: Period 2|Protocol Violation|1|||
27823421|NCT01791517|54287678|FG004|Phase I: Period 2|Protocol Violation|0|||
27823422|NCT01791517|54287679|FG005|Phase I: Period 2|Protocol Violation|0|||
27823423|NCT01791517|54287680|FG006|Phase I: Period 2|Protocol Violation|0|||
27823424|NCT01791517|54287681|FG007|Phase I: Period 2|Protocol Violation|0|||
27823425|NCT01791517|54287682|FG008|Phase I: Period 2|Protocol Violation|0|||
27823426|NCT01791517|54287683|FG009|Phase I: Period 2|Protocol Violation|0|||
27823427|NCT01791517|54287684|FG010|Phase I: Period 2|Protocol Violation|0|||
27823428|NCT01791517|54287685|FG011|Phase I: Period 2|Protocol Violation|0|||
27823429|NCT01791517|54287674|FG000|Phase I: Period 2|Withdrawal by Subject|0|||
27823430|NCT01791517|54287675|FG001|Phase I: Period 2|Withdrawal by Subject|0|||
27823431|NCT01791517|54287676|FG002|Phase I: Period 2|Withdrawal by Subject|0|||
27823432|NCT01791517|54287677|FG003|Phase I: Period 2|Withdrawal by Subject|0|||
27823433|NCT01791517|54287678|FG004|Phase I: Period 2|Withdrawal by Subject|0|||
27823434|NCT01791517|54287679|FG005|Phase I: Period 2|Withdrawal by Subject|0|||
27823435|NCT01791517|54287680|FG006|Phase I: Period 2|Withdrawal by Subject|0|||
27823436|NCT01791517|54287681|FG007|Phase I: Period 2|Withdrawal by Subject|0|||
27823437|NCT01791517|54287682|FG008|Phase I: Period 2|Withdrawal by Subject|0|||
27823438|NCT01791517|54287683|FG009|Phase I: Period 2|Withdrawal by Subject|1|||
28152145|NCT02633800|54821222|FG000|Overall Study|Withdrawal by Subject|0|||
27823439|NCT01791517|54287684|FG010|Phase I: Period 2|Withdrawal by Subject|1|||
27823440|NCT01791517|54287685|FG011|Phase I: Period 2|Withdrawal by Subject|0|||
27823441|NCT01791517|54287674|FG000|Phase I: Period 2|Unsatisfactory Visual Response|0|||
27823442|NCT01791517|54287675|FG001|Phase I: Period 2|Unsatisfactory Visual Response|0|||
27823443|NCT01791517|54287676|FG002|Phase I: Period 2|Unsatisfactory Visual Response|0|||
27823444|NCT01791517|54287677|FG003|Phase I: Period 2|Unsatisfactory Visual Response|0|||
27823445|NCT01791517|54287678|FG004|Phase I: Period 2|Unsatisfactory Visual Response|0|||
27941902|NCT01208207|54598599|FG004|Part I|Adverse Event|0|||
28073780|NCT00149630|54728422|FG001|Overall Study|Adverse Event|0|||
28073781|NCT00127842|54728432|FG000|Overall Study|Adverse Event|15|||
28152146|NCT02633800|54821223|FG001|Overall Study|Withdrawal by Subject|3|||
28152147|NCT02633800|54821222|FG000|Overall Study|Patient Request|1|||
28152148|NCT02633800|54821223|FG001|Overall Study|Patient Request|1|||
28073782|NCT00127842|54728432|FG000|Overall Study|Withdrawal by Subject|3|||
28073783|NCT00127842|54728432|FG000|Overall Study|Lost to Follow-up|1|||
28073784|NCT00127842|54728432|FG000|Overall Study|Lack of Efficacy|12|||
28073785|NCT00127842|54728432|FG000|Overall Study|Noncompliance|2|||
28073786|NCT00127842|54728432|FG000|Overall Study|Protocol Violation|1|||
28073787|NCT00127842|54728432|FG000|Overall Study|Other|5|||
28073788|NCT03720652|54728438|FG000|Overall Study|Withdrawal by Subject|2|||
28073789|NCT03720652|54728439|FG001|Overall Study|Withdrawal by Subject|7|||
28073790|NCT03720652|54728438|FG000|Overall Study|Lost to Follow-up|0|||
28073791|NCT03720652|54728439|FG001|Overall Study|Lost to Follow-up|4|||
28152149|NCT03829657|54821232|FG000|OL Treatment Period (Week 1 to Week 16)|Adverse Event|12|||
28152150|NCT03829657|54821233|FG001|OL Treatment Period (Week 1 to Week 16)|Adverse Event|4|||
28152151|NCT03829657|54821234|FG002|OL Treatment Period (Week 1 to Week 16)|Adverse Event|2|||
27823446|NCT01791517|54287679|FG005|Phase I: Period 2|Unsatisfactory Visual Response|0|||
27823447|NCT01791517|54287680|FG006|Phase I: Period 2|Unsatisfactory Visual Response|0|||
27823448|NCT01791517|54287681|FG007|Phase I: Period 2|Unsatisfactory Visual Response|0|||
27823449|NCT01791517|54287682|FG008|Phase I: Period 2|Unsatisfactory Visual Response|0|||
27823450|NCT01791517|54287683|FG009|Phase I: Period 2|Unsatisfactory Visual Response|0|||
27823451|NCT01791517|54287684|FG010|Phase I: Period 2|Unsatisfactory Visual Response|1|||
27823452|NCT01791517|54287685|FG011|Phase I: Period 2|Unsatisfactory Visual Response|0|||
28073792|NCT00112866|54728449|FG000|Overall Study|Protocol Violation|1|||
27823453|NCT01791517|54287674|FG000|Phase I: Period 2|Lens Discomfort|0|||
27823454|NCT01791517|54287675|FG001|Phase I: Period 2|Lens Discomfort|0|||
27823455|NCT01791517|54287676|FG002|Phase I: Period 2|Lens Discomfort|0|||
27823456|NCT01791517|54287677|FG003|Phase I: Period 2|Lens Discomfort|0|||
27823457|NCT01791517|54287678|FG004|Phase I: Period 2|Lens Discomfort|0|||
27823458|NCT01791517|54287679|FG005|Phase I: Period 2|Lens Discomfort|1|||
27823459|NCT01791517|54287680|FG006|Phase I: Period 2|Lens Discomfort|0|||
27823460|NCT01791517|54287681|FG007|Phase I: Period 2|Lens Discomfort|0|||
27823461|NCT01791517|54287682|FG008|Phase I: Period 2|Lens Discomfort|0|||
27823462|NCT01791517|54287683|FG009|Phase I: Period 2|Lens Discomfort|0|||
27823463|NCT01791517|54287684|FG010|Phase I: Period 2|Lens Discomfort|0|||
27823464|NCT01791517|54287685|FG011|Phase I: Period 2|Lens Discomfort|0|||
27823465|NCT01791517|54287674|FG000|Phase I: Period 2|Lost to Follow-up|0|||
27823466|NCT01791517|54287675|FG001|Phase I: Period 2|Lost to Follow-up|3|||
27823467|NCT01791517|54287676|FG002|Phase I: Period 2|Lost to Follow-up|2|||
27823468|NCT01791517|54287677|FG003|Phase I: Period 2|Lost to Follow-up|0|||
27823469|NCT01791517|54287678|FG004|Phase I: Period 2|Lost to Follow-up|0|||
27823470|NCT01791517|54287679|FG005|Phase I: Period 2|Lost to Follow-up|0|||
27823471|NCT01791517|54287680|FG006|Phase I: Period 2|Lost to Follow-up|0|||
27823472|NCT01791517|54287681|FG007|Phase I: Period 2|Lost to Follow-up|0|||
27823473|NCT01791517|54287682|FG008|Phase I: Period 2|Lost to Follow-up|0|||
27823474|NCT01791517|54287683|FG009|Phase I: Period 2|Lost to Follow-up|0|||
27823475|NCT01791517|54287684|FG010|Phase I: Period 2|Lost to Follow-up|0|||
27823476|NCT01791517|54287685|FG011|Phase I: Period 2|Lost to Follow-up|0|||
27823477|NCT01791517|54287674|FG000|Phase I: Period 3|Lens Discomfort|0|||
27823478|NCT01791517|54287675|FG001|Phase I: Period 3|Lens Discomfort|0|||
27823479|NCT01791517|54287676|FG002|Phase I: Period 3|Lens Discomfort|0|||
27823480|NCT01791517|54287677|FG003|Phase I: Period 3|Lens Discomfort|0|||
27823481|NCT01791517|54287678|FG004|Phase I: Period 3|Lens Discomfort|0|||
27823482|NCT01791517|54287679|FG005|Phase I: Period 3|Lens Discomfort|0|||
27823483|NCT01791517|54287680|FG006|Phase I: Period 3|Lens Discomfort|0|||
27823484|NCT01791517|54287681|FG007|Phase I: Period 3|Lens Discomfort|0|||
27823485|NCT01791517|54287682|FG008|Phase I: Period 3|Lens Discomfort|0|||
27823486|NCT01791517|54287683|FG009|Phase I: Period 3|Lens Discomfort|0|||
27823487|NCT01791517|54287684|FG010|Phase I: Period 3|Lens Discomfort|0|||
28073793|NCT00112866|54728450|FG001|Overall Study|Protocol Violation|0|||
28073794|NCT00112866|54728449|FG000|Overall Study|did not start treatment post-op|1|||
28073795|NCT00112866|54728450|FG001|Overall Study|did not start treatment post-op|2|||
28073796|NCT00127608|54728464|FG000|Overall Study|VZV DNA negative|1|||
28073797|NCT00149396|54728468|FG000|Overall Study|Death|15|||
28073798|NCT00149396|54728468|FG000|Overall Study|Withdrawal by Subject|1|||
28073799|NCT00149396|54728468|FG000|Overall Study|Subject noncompliance|2|||
28073800|NCT00149396|54728468|FG000|Overall Study|other treatment|5|||
28073801|NCT00223496|54728479|FG000|Overall Study|screen failure|9|||
28073802|NCT00223496|54728479|FG000|Overall Study|Lost to Follow-up|4|||
28073803|NCT00223496|54728479|FG000|Overall Study|Lack of Efficacy|6|||
28152152|NCT03829657|54821235|FG003|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
28152153|NCT03829657|54821236|FG004|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
28152154|NCT03829657|54821232|FG000|OL Treatment Period (Week 1 to Week 16)|Physician Decision|1|||
28152155|NCT03829657|54821233|FG001|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
28152156|NCT03829657|54821234|FG002|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
28152157|NCT03829657|54821235|FG003|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
28152158|NCT03829657|54821236|FG004|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
28073804|NCT00223496|54728479|FG000|Overall Study|Withdrawal by Subject|1|||
28073805|NCT00223496|54728479|FG000|Overall Study|Physician Decision|2|||
28073806|NCT00255944|54728485|FG000|Overall Study|Lost to Follow-up|797|||
27823488|NCT01791517|54287685|FG011|Phase I: Period 3|Lens Discomfort|1|||
27823489|NCT01791517|54287674|FG000|Phase I: Period 3|Lost to Follow-up|0|||
27823490|NCT01791517|54287675|FG001|Phase I: Period 3|Lost to Follow-up|1|||
27823491|NCT01791517|54287676|FG002|Phase I: Period 3|Lost to Follow-up|0|||
27823492|NCT01791517|54287677|FG003|Phase I: Period 3|Lost to Follow-up|0|||
27823493|NCT01791517|54287678|FG004|Phase I: Period 3|Lost to Follow-up|1|||
27823494|NCT01791517|54287679|FG005|Phase I: Period 3|Lost to Follow-up|0|||
27823495|NCT01791517|54287680|FG006|Phase I: Period 3|Lost to Follow-up|0|||
27823496|NCT01791517|54287681|FG007|Phase I: Period 3|Lost to Follow-up|0|||
28073807|NCT00255944|54728486|FG001|Overall Study|Lost to Follow-up|834|||
27823497|NCT01791517|54287682|FG008|Phase I: Period 3|Lost to Follow-up|0|||
27823498|NCT01791517|54287683|FG009|Phase I: Period 3|Lost to Follow-up|0|||
27823499|NCT01791517|54287684|FG010|Phase I: Period 3|Lost to Follow-up|0|||
27823500|NCT01791517|54287685|FG011|Phase I: Period 3|Lost to Follow-up|0|||
27823501|NCT01791517|54287674|FG000|Phase I: Period 3|Adverse Event|0|||
27823502|NCT01791517|54287675|FG001|Phase I: Period 3|Adverse Event|0|||
27823503|NCT01791517|54287676|FG002|Phase I: Period 3|Adverse Event|0|||
27823504|NCT01791517|54287677|FG003|Phase I: Period 3|Adverse Event|1|||
27823505|NCT01791517|54287678|FG004|Phase I: Period 3|Adverse Event|0|||
28073808|NCT00143598|54728494|FG000|Overall Study|Lost to Follow-up|23|||
27823506|NCT01791517|54287679|FG005|Phase I: Period 3|Adverse Event|0|||
28152159|NCT03829657|54821232|FG000|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|1|||
28152160|NCT03829657|54821233|FG001|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|3|||
28152161|NCT03829657|54821234|FG002|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|9|||
28152162|NCT03829657|54821235|FG003|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
28152163|NCT03829657|54821236|FG004|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
28152164|NCT03829657|54821232|FG000|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|6|||
28152165|NCT03829657|54821233|FG001|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|7|||
28152166|NCT03829657|54821234|FG002|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|5|||
27823507|NCT01791517|54287680|FG006|Phase I: Period 3|Adverse Event|0|||
27823508|NCT01791517|54287681|FG007|Phase I: Period 3|Adverse Event|0|||
27823509|NCT01791517|54287682|FG008|Phase I: Period 3|Adverse Event|0|||
27823510|NCT01791517|54287683|FG009|Phase I: Period 3|Adverse Event|0|||
27823511|NCT01791517|54287684|FG010|Phase I: Period 3|Adverse Event|0|||
27823512|NCT01791517|54287685|FG011|Phase I: Period 3|Adverse Event|0|||
27823513|NCT01791517|54287674|FG000|Phase II|Lost to Follow-up|1|||
27823514|NCT01791517|54287675|FG001|Phase II|Lost to Follow-up|0|||
27823515|NCT01791517|54287676|FG002|Phase II|Lost to Follow-up|1|||
27823516|NCT01791517|54287677|FG003|Phase II|Lost to Follow-up|0|||
27823517|NCT01791517|54287678|FG004|Phase II|Lost to Follow-up|1|||
27823518|NCT01791517|54287679|FG005|Phase II|Lost to Follow-up|2|||
27823519|NCT01791517|54287680|FG006|Phase II|Lost to Follow-up|0|||
28152167|NCT03829657|54821235|FG003|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
28152168|NCT03829657|54821236|FG004|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
28152169|NCT03829657|54821232|FG000|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|10|||
28152170|NCT03829657|54821233|FG001|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|6|||
28152171|NCT03829657|54821234|FG002|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|4|||
28152172|NCT03829657|54821235|FG003|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
28152173|NCT03829657|54821236|FG004|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
27823520|NCT01791517|54287681|FG007|Phase II|Lost to Follow-up|1|||
27823521|NCT01791517|54287682|FG008|Phase II|Lost to Follow-up|1|||
27941903|NCT01208207|54598600|FG005|Part I|Adverse Event|0|||
27823522|NCT01791517|54287683|FG009|Phase II|Lost to Follow-up|1|||
27823523|NCT01791517|54287684|FG010|Phase II|Lost to Follow-up|0|||
27823524|NCT01791517|54287685|FG011|Phase II|Lost to Follow-up|0|||
27823525|NCT01791517|54287674|FG000|Phase II|Withdrawal by Subject|1|||
27823526|NCT01791517|54287675|FG001|Phase II|Withdrawal by Subject|0|||
27823527|NCT01791517|54287676|FG002|Phase II|Withdrawal by Subject|0|||
27823528|NCT01791517|54287677|FG003|Phase II|Withdrawal by Subject|0|||
28152174|NCT03829657|54821232|FG000|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|3|||
28152175|NCT03829657|54821233|FG001|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
28152176|NCT03829657|54821234|FG002|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
28152177|NCT03829657|54821235|FG003|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
28152178|NCT03829657|54821236|FG004|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
28152179|NCT03829657|54821232|FG000|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
28152180|NCT03829657|54821233|FG001|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
28152181|NCT03829657|54821234|FG002|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
28152182|NCT03829657|54821235|FG003|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
28152183|NCT03829657|54821236|FG004|RW Treatment Period (Week 16 to Week 24)|Adverse Event|1|||
28152184|NCT03829657|54821232|FG000|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
28152185|NCT03829657|54821233|FG001|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
28152186|NCT03829657|54821234|FG002|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
28152187|NCT03829657|54821235|FG003|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|2|||
28152188|NCT03829657|54821236|FG004|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|3|||
28152189|NCT03829657|54821232|FG000|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
28152190|NCT03829657|54821233|FG001|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
28152191|NCT03829657|54821234|FG002|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
27823529|NCT01791517|54287678|FG004|Phase II|Withdrawal by Subject|0|||
27823530|NCT01791517|54287679|FG005|Phase II|Withdrawal by Subject|2|||
27823531|NCT01791517|54287680|FG006|Phase II|Withdrawal by Subject|0|||
27823532|NCT01791517|54287681|FG007|Phase II|Withdrawal by Subject|1|||
27823533|NCT01791517|54287682|FG008|Phase II|Withdrawal by Subject|0|||
28152192|NCT03829657|54821235|FG003|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
28152193|NCT03829657|54821236|FG004|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
28152194|NCT03829657|54821232|FG000|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
28152195|NCT03829657|54821233|FG001|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
28152196|NCT03829657|54821234|FG002|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
28152197|NCT03829657|54821235|FG003|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
28152198|NCT03829657|54821236|FG004|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|1|||
28152199|NCT03035227|54821247|FG000|Overall Study|study stopped due to PI leaving institut|1|||
28152200|NCT03035227|54821248|FG001|Overall Study|study stopped due to PI leaving institut|1|||
28152201|NCT00100932|54821258|FG000|Overall Study|Adverse Event|11|||
28152202|NCT00100932|54821259|FG001|Overall Study|Adverse Event|2|||
28152203|NCT00100932|54821258|FG000|Overall Study|Withdrawal by Subject|6|||
28152204|NCT00100932|54821259|FG001|Overall Study|Withdrawal by Subject|0|||
28152205|NCT00100932|54821258|FG000|Overall Study|Progressive Disease|44|||
28152206|NCT00100932|54821259|FG001|Overall Study|Progressive Disease|18|||
28152207|NCT00100932|54821258|FG000|Overall Study|Physician Decision|7|||
28152208|NCT00100932|54821259|FG001|Overall Study|Physician Decision|5|||
28152209|NCT00100932|54821258|FG000|Overall Study|Other|5|||
28152210|NCT00100932|54821259|FG001|Overall Study|Other|2|||
28152211|NCT03180307|54821267|FG000|Overall Study|Lost to Follow-up|2|||
28152212|NCT03180307|54821268|FG001|Overall Study|Lost to Follow-up|0|||
28152213|NCT03180307|54821267|FG000|Overall Study|Death|1|||
28152214|NCT03180307|54821268|FG001|Overall Study|Death|0|||
28152215|NCT03180307|54821267|FG000|Overall Study|Majority of which were disease too extensive and camera not used|3|||
28152216|NCT03180307|54821268|FG001|Overall Study|Majority of which were disease too extensive and camera not used|0|||
28152217|NCT02848833|54821272|FG000|Overall Study|subject who are duplicated|1|||
28152218|NCT02848833|54821272|FG000|Overall Study|have not taken the study drug|11|||
28152219|NCT02848833|54821272|FG000|Overall Study|follow-up failure|6|||
28152220|NCT02848833|54821272|FG000|Overall Study|Protocol Violation|119|||
28152221|NCT03361189|54821278|FG000|Overall Study|Received heart transplant|1|||
27823534|NCT01791517|54287683|FG009|Phase II|Withdrawal by Subject|0|||
27823535|NCT01791517|54287684|FG010|Phase II|Withdrawal by Subject|1|||
27823536|NCT01791517|54287685|FG011|Phase II|Withdrawal by Subject|0|||
27823537|NCT01791517|54287674|FG000|Phase II|Lack of Efficacy|0|||
27823538|NCT01791517|54287675|FG001|Phase II|Lack of Efficacy|0|||
27823539|NCT01791517|54287676|FG002|Phase II|Lack of Efficacy|0|||
27823540|NCT01791517|54287677|FG003|Phase II|Lack of Efficacy|0|||
27823541|NCT01791517|54287678|FG004|Phase II|Lack of Efficacy|1|||
27823542|NCT01791517|54287679|FG005|Phase II|Lack of Efficacy|0|||
27823543|NCT01791517|54287680|FG006|Phase II|Lack of Efficacy|0|||
27823544|NCT01791517|54287681|FG007|Phase II|Lack of Efficacy|0|||
27823545|NCT01791517|54287682|FG008|Phase II|Lack of Efficacy|0|||
27823546|NCT01791517|54287683|FG009|Phase II|Lack of Efficacy|0|||
27823547|NCT01791517|54287684|FG010|Phase II|Lack of Efficacy|0|||
27823548|NCT01791517|54287685|FG011|Phase II|Lack of Efficacy|0|||
27823549|NCT01791517|54287674|FG000|Phase II|Adverse Event|0|||
27823550|NCT01791517|54287675|FG001|Phase II|Adverse Event|0|||
27823551|NCT01791517|54287676|FG002|Phase II|Adverse Event|0|||
27823552|NCT01791517|54287677|FG003|Phase II|Adverse Event|0|||
27823553|NCT01791517|54287678|FG004|Phase II|Adverse Event|0|||
27823554|NCT01791517|54287679|FG005|Phase II|Adverse Event|0|||
27823555|NCT01791517|54287680|FG006|Phase II|Adverse Event|2|||
27823556|NCT01791517|54287681|FG007|Phase II|Adverse Event|1|||
27823557|NCT01791517|54287682|FG008|Phase II|Adverse Event|0|||
27823558|NCT01791517|54287683|FG009|Phase II|Adverse Event|1|||
27823559|NCT01791517|54287684|FG010|Phase II|Adverse Event|0|||
27823560|NCT01791517|54287685|FG011|Phase II|Adverse Event|0|||
27823561|NCT01791517|54287674|FG000|Phase II|Lens Handling Difficulties|0|||
27823562|NCT01791517|54287675|FG001|Phase II|Lens Handling Difficulties|0|||
27823563|NCT01791517|54287676|FG002|Phase II|Lens Handling Difficulties|0|||
27823564|NCT01791517|54287677|FG003|Phase II|Lens Handling Difficulties|0|||
27823565|NCT01791517|54287678|FG004|Phase II|Lens Handling Difficulties|0|||
27823566|NCT01791517|54287679|FG005|Phase II|Lens Handling Difficulties|0|||
27823567|NCT01791517|54287680|FG006|Phase II|Lens Handling Difficulties|0|||
27823568|NCT01791517|54287681|FG007|Phase II|Lens Handling Difficulties|0|||
27823569|NCT01791517|54287682|FG008|Phase II|Lens Handling Difficulties|1|||
27823570|NCT01791517|54287683|FG009|Phase II|Lens Handling Difficulties|0|||
27823571|NCT01791517|54287684|FG010|Phase II|Lens Handling Difficulties|0|||
27823572|NCT01791517|54287685|FG011|Phase II|Lens Handling Difficulties|0|||
27823573|NCT01791517|54287674|FG000|Phase II|Unsatisfactory Lens Fitting|0|||
27823574|NCT01791517|54287675|FG001|Phase II|Unsatisfactory Lens Fitting|0|||
27823575|NCT01791517|54287676|FG002|Phase II|Unsatisfactory Lens Fitting|0|||
27823576|NCT01791517|54287677|FG003|Phase II|Unsatisfactory Lens Fitting|0|||
27823577|NCT01791517|54287678|FG004|Phase II|Unsatisfactory Lens Fitting|0|||
28152222|NCT03361189|54821279|FG001|Overall Study|Received heart transplant|0|||
27823578|NCT01791517|54287679|FG005|Phase II|Unsatisfactory Lens Fitting|0|||
27850285|NCT04178967|54349324|FG009|Induction Period|Withdrawal by Subject|0|||
27941904|NCT01208207|54598601|FG006|Part I|Adverse Event|0|||
28152223|NCT03361189|54821278|FG000|Overall Study|Pacemake replacement|0|||
28152224|NCT03361189|54821279|FG001|Overall Study|Pacemake replacement|1|||
28152225|NCT00092131|54821287|FG000|Treatment Period I|Adverse Event|1|||
28152226|NCT00092131|54821288|FG001|Treatment Period I|Adverse Event|0|||
28152227|NCT00092131|54821287|FG000|Treatment Period II|Adverse Event|0|||
28152228|NCT00092131|54821288|FG001|Treatment Period II|Adverse Event|1|||
28152229|NCT02668783|54821296|FG000|Overall Study|Pregnancy|0|||
28152230|NCT02668783|54821297|FG001|Overall Study|Pregnancy|1|||
28152231|NCT02668783|54821296|FG000|Overall Study|Protocol Violation|2|||
27823579|NCT01791517|54287680|FG006|Phase II|Unsatisfactory Lens Fitting|0|||
27823580|NCT01791517|54287681|FG007|Phase II|Unsatisfactory Lens Fitting|0|||
27823581|NCT01791517|54287682|FG008|Phase II|Unsatisfactory Lens Fitting|0|||
27823582|NCT01791517|54287683|FG009|Phase II|Unsatisfactory Lens Fitting|1|||
27823583|NCT01791517|54287684|FG010|Phase II|Unsatisfactory Lens Fitting|0|||
27823584|NCT01791517|54287685|FG011|Phase II|Unsatisfactory Lens Fitting|0|||
27823585|NCT01791517|54287674|FG000|Phase II|Pre-Existing Ocular Issue|0|||
27823586|NCT01791517|54287675|FG001|Phase II|Pre-Existing Ocular Issue|0|||
27823587|NCT01791517|54287676|FG002|Phase II|Pre-Existing Ocular Issue|0|||
27941905|NCT01208207|54598595|FG000|Part I|Lack of Efficacy|21|||
28152232|NCT02668783|54821297|FG001|Overall Study|Protocol Violation|1|||
28152233|NCT02668783|54821296|FG000|Overall Study|Study terminated by sponsor|9|||
27823588|NCT01791517|54287677|FG003|Phase II|Pre-Existing Ocular Issue|0|||
27823589|NCT01791517|54287678|FG004|Phase II|Pre-Existing Ocular Issue|0|||
27823590|NCT01791517|54287679|FG005|Phase II|Pre-Existing Ocular Issue|0|||
27823591|NCT01791517|54287680|FG006|Phase II|Pre-Existing Ocular Issue|0|||
27823592|NCT01791517|54287681|FG007|Phase II|Pre-Existing Ocular Issue|0|||
27823593|NCT01791517|54287682|FG008|Phase II|Pre-Existing Ocular Issue|0|||
27823594|NCT01791517|54287683|FG009|Phase II|Pre-Existing Ocular Issue|0|||
27823595|NCT01791517|54287684|FG010|Phase II|Pre-Existing Ocular Issue|0|||
27823596|NCT01791517|54287685|FG011|Phase II|Pre-Existing Ocular Issue|1|||
27823597|NCT01998581|54287705|FG000|Overall Study|Refused repeat treatment|20|||
27823598|NCT01998581|54287706|FG001|Overall Study|Refused repeat treatment|4|||
27823599|NCT01998581|54287705|FG000|Overall Study|Protocol Violation|1|||
27823600|NCT01998581|54287706|FG001|Overall Study|Protocol Violation|0|||
27823601|NCT01998581|54287705|FG000|Overall Study|Withdrawal by Subject|8|||
27823602|NCT01998581|54287706|FG001|Overall Study|Withdrawal by Subject|1|||
27823603|NCT01998581|54287705|FG000|Overall Study|Lost to Follow-up|12|||
27823604|NCT01998581|54287706|FG001|Overall Study|Lost to Follow-up|4|||
27823605|NCT01998581|54287705|FG000|Overall Study|Adverse Event|1|||
27823606|NCT01998581|54287706|FG001|Overall Study|Adverse Event|1|||
27823607|NCT01998581|54287705|FG000|Overall Study|Other reasons|3|||
27823608|NCT01998581|54287706|FG001|Overall Study|Other reasons|2|||
27823609|NCT01998581|54287705|FG000|Overall Study|Randomized but withdrew before treatment|1|||
27823610|NCT01998581|54287706|FG001|Overall Study|Randomized but withdrew before treatment|0|||
27823611|NCT01983293|54287715|FG000|Overall Study|Withdrawal by Subject|29|||
27823612|NCT01983293|54287716|FG001|Overall Study|Withdrawal by Subject|15|||
27823613|NCT01983293|54287715|FG000|Overall Study|Missing 12-month visit|3|||
27823614|NCT01983293|54287716|FG001|Overall Study|Missing 12-month visit|3|||
27823615|NCT01983293|54287715|FG000|Overall Study|Missing NYHA/Patient Global Assessment|1|||
27823616|NCT01983293|54287716|FG001|Overall Study|Missing NYHA/Patient Global Assessment|1|||
27823617|NCT01791205|54287724|FG000|Phase II|Lack of Efficacy|6|||
27823618|NCT01791205|54287725|FG001|Phase II|Lack of Efficacy|0|||
27823619|NCT01791205|54287724|FG000|Phase II|Adverse Event|2|||
27823620|NCT01791205|54287725|FG001|Phase II|Adverse Event|0|||
27823621|NCT01791205|54287724|FG000|Phase II|Safety|1|||
27823622|NCT01791205|54287725|FG001|Phase II|Safety|0|||
27823623|NCT01791205|54287724|FG000|Phase II|Lost to Follow-up|1|||
27823624|NCT01791205|54287725|FG001|Phase II|Lost to Follow-up|0|||
27823625|NCT01791205|54287724|FG000|Phase II|Remission of disease|1|||
27823626|NCT01791205|54287725|FG001|Phase II|Remission of disease|0|||
27823627|NCT01791205|54287724|FG000|Phase II|Physician's decision|1|||
27823628|NCT01791205|54287725|FG001|Phase II|Physician's decision|0|||
27823629|NCT01272232|54287734|FG000|Weeks 0-56|Adverse Event|39|||
27823630|NCT01272232|54287735|FG001|Weeks 0-56|Adverse Event|18|||
27823631|NCT01272232|54287736|FG002|Weeks 0-56|Adverse Event|7|||
27823632|NCT01272232|54287734|FG000|Weeks 0-56|Lack of Efficacy|0|||
27823633|NCT01272232|54287735|FG001|Weeks 0-56|Lack of Efficacy|0|||
28152234|NCT02668783|54821297|FG001|Overall Study|Study terminated by sponsor|10|||
28152235|NCT02668783|54821296|FG000|Overall Study|Subject moved|1|||
28152236|NCT02668783|54821297|FG001|Overall Study|Subject moved|0|||
28152237|NCT02668783|54821296|FG000|Overall Study|Withdrawal by Subject|1|||
28152238|NCT02668783|54821297|FG001|Overall Study|Withdrawal by Subject|0|||
28152239|NCT00101010|54821303|FG000|Overall Study|Physician Decision|1|||
28152240|NCT02848599|54821309|FG000|Overall Study|Protocol Violation|7|||
28152241|NCT02848599|54821310|FG001|Overall Study|Protocol Violation|9|||
27823634|NCT01272232|54287736|FG002|Weeks 0-56|Lack of Efficacy|3|||
27823635|NCT01272232|54287734|FG000|Weeks 0-56|Protocol Violation|12|||
27823636|NCT01272232|54287735|FG001|Weeks 0-56|Protocol Violation|8|||
27823637|NCT01272232|54287736|FG002|Weeks 0-56|Protocol Violation|13|||
27823638|NCT01272232|54287734|FG000|Weeks 0-56|Withdrawal criteria|32|||
27823639|NCT01272232|54287735|FG001|Weeks 0-56|Withdrawal criteria|14|||
27823640|NCT01272232|54287736|FG002|Weeks 0-56|Withdrawal criteria|37|||
28152242|NCT00778999|54821341|FG000|Overall Study|Discontinuation: no embryo transfer|14|||
27823641|NCT01272232|54287734|FG000|Weeks 0-56|Unclassified|16|||
27823642|NCT01272232|54287735|FG001|Weeks 0-56|Unclassified|7|||
27823643|NCT01272232|54287736|FG002|Weeks 0-56|Unclassified|12|||
27823644|NCT01272232|54287734|FG000|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
27823645|NCT01272232|54287735|FG001|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
27823646|NCT01272232|54287736|FG002|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0|||
27823647|NCT01272232|54287734|FG000|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1|||
27823648|NCT01272232|54287735|FG001|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
27823649|NCT01272232|54287736|FG002|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
27823650|NCT01272232|54287734|FG000|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
27823651|NCT01272232|54287735|FG001|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0|||
27823652|NCT01272232|54287736|FG002|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
27823653|NCT01272232|54287734|FG000|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9|||
27823654|NCT01272232|54287735|FG001|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7|||
27823655|NCT01272232|54287736|FG002|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4|||
27823656|NCT01272232|54287734|FG000|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
27823657|NCT01272232|54287735|FG001|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
27823658|NCT01272232|54287736|FG002|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0|||
27823659|NCT01791127|54287744|FG000|Overall Study|Death|356|||
27823660|NCT01791127|54287744|FG000|Overall Study|Patient has withdrawn from study|293|||
27823661|NCT01791127|54287744|FG000|Overall Study|Lost to Follow-up|42|||
27823662|NCT01791127|54287744|FG000|Overall Study|All Siello leads are explanted|31|||
27823663|NCT01791127|54287744|FG000|Overall Study|Completion of 30 day safety registry|1|||
27823664|NCT01791127|54287744|FG000|Overall Study|Study terminated for EP Passion|749|||
27823665|NCT01997333|54287775|FG000|Randomization and Treatment|Disease Progression|70|||
27823666|NCT01997333|54287776|FG001|Randomization and Treatment|Disease Progression|159|||
27823667|NCT01997333|54287775|FG000|Randomization and Treatment|Adverse Event|10|||
27823668|NCT01997333|54287776|FG001|Randomization and Treatment|Adverse Event|32|||
27823669|NCT01997333|54287775|FG000|Randomization and Treatment|Physician Decision|0|||
27823670|NCT01997333|54287776|FG001|Randomization and Treatment|Physician Decision|4|||
27823671|NCT01997333|54287775|FG000|Randomization and Treatment|Withdrawal by Subject|6|||
27823672|NCT01997333|54287776|FG001|Randomization and Treatment|Withdrawal by Subject|3|||
27823673|NCT01997333|54287775|FG000|Randomization and Treatment|Did not receive treatment|17|||
27823674|NCT01997333|54287776|FG001|Randomization and Treatment|Did not receive treatment|5|||
27823675|NCT01997333|54287775|FG000|Survival Follow up|Withdrawal by Subject|15|||
27823676|NCT01997333|54287776|FG001|Survival Follow up|Withdrawal by Subject|6|||
27823677|NCT01997333|54287775|FG000|Survival Follow up|Lost to Follow-up|0|||
27823678|NCT01997333|54287776|FG001|Survival Follow up|Lost to Follow-up|6|||
27823679|NCT01997333|54287775|FG000|Survival Follow up|Various|1|||
27823680|NCT01997333|54287776|FG001|Survival Follow up|Various|2|||
27823681|NCT01982435|54287840|FG000|Overall Study|Adverse Event|1|||
27823682|NCT01982435|54287841|FG001|Overall Study|Adverse Event|0|||
27823683|NCT01620983|54287881|FG000|Overall Study|Lost to Follow-up|8|||
27823684|NCT01620983|54287882|FG001|Overall Study|Lost to Follow-up|4|||
28152243|NCT00778999|54821342|FG001|Overall Study|Discontinuation: no embryo transfer|14|||
27823685|NCT01620983|54287883|FG002|Overall Study|Lost to Follow-up|9|||
27823686|NCT01620983|54287881|FG000|Overall Study|Withdrawal by Subject|6|||
27823687|NCT01620983|54287882|FG001|Overall Study|Withdrawal by Subject|8|||
27823688|NCT01620983|54287883|FG002|Overall Study|Withdrawal by Subject|1|||
27823689|NCT01620983|54287881|FG000|Overall Study|Death|2|||
27823690|NCT01620983|54287882|FG001|Overall Study|Death|0|||
28073809|NCT00143598|54728495|FG001|Overall Study|Lost to Follow-up|21|||
28152244|NCT00778999|54821341|FG000|Overall Study|Did not receive recFSH|14|||
28152245|NCT00778999|54821342|FG001|Overall Study|Did not receive recFSH|20|||
28152246|NCT02631850|54821352|FG000|Treatment Period|Lost to Follow-up|0|||
28152247|NCT02631850|54821353|FG001|Treatment Period|Lost to Follow-up|1|||
28152248|NCT02631850|54821354|FG002|Treatment Period|Lost to Follow-up|0|||
28073810|NCT00143598|54728494|FG000|Overall Study|Withdrawal by Subject|33|||
28073811|NCT00143598|54728495|FG001|Overall Study|Withdrawal by Subject|37|||
28073812|NCT00143598|54728494|FG000|Overall Study|Death|36|||
28073813|NCT00143598|54728495|FG001|Overall Study|Death|36|||
28073814|NCT00126672|54728501|FG000|Overall Study|Adverse Event|4|||
28073815|NCT00126672|54728501|FG000|Overall Study|Lost to Follow-up|4|||
28073816|NCT00145574|54728508|FG000|Double Blind|Adverse Event|0|||
27823691|NCT01620983|54287883|FG002|Overall Study|Death|0|||
27823692|NCT01620983|54287881|FG000|Overall Study|Physician Decision|3|||
27823693|NCT01620983|54287882|FG001|Overall Study|Physician Decision|10|||
27823694|NCT01620983|54287883|FG002|Overall Study|Physician Decision|5|||
27823695|NCT01996709|54287893|FG000|Overall Study|Withdrawal by Subject|1|||
27823696|NCT01996709|54287894|FG001|Overall Study|Withdrawal by Subject|0|||
27823697|NCT01996709|54287893|FG000|Overall Study|Lost to Follow-up|3|||
27823698|NCT01996709|54287894|FG001|Overall Study|Lost to Follow-up|0|||
27823699|NCT01996709|54287893|FG000|Overall Study|Subject Non-Compliant|1|||
27823700|NCT01996709|54287894|FG001|Overall Study|Subject Non-Compliant|0|||
27823701|NCT01996709|54287893|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
27823702|NCT01996709|54287894|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
27823703|NCT01996319|54287919|FG000|Overall Study|Protocol Violation|1|||
27823704|NCT01996319|54287920|FG001|Overall Study|Protocol Violation|0|||
27823705|NCT01996319|54287919|FG000|Overall Study|Severe or moderate (COPD) Exacerbation|5|||
27823706|NCT01996319|54287920|FG001|Overall Study|Severe or moderate (COPD) Exacerbation|1|||
27823707|NCT01996319|54287919|FG000|Overall Study|Adverse Event|2|||
27823708|NCT01996319|54287920|FG001|Overall Study|Adverse Event|2|||
27823709|NCT01279486|54287926|FG000|Overall Study|Lost to Follow-up|1|||
27823710|NCT01279954|54287932|FG000|Overall Study|Lack of Efficacy|3|||
27823711|NCT01279954|54287933|FG001|Overall Study|Lack of Efficacy|4|||
27823712|NCT01278862|54287944|FG000|Overall Study|Lost to Follow-up|1|||
27823713|NCT01278862|54287945|FG001|Overall Study|Lost to Follow-up|1|||
27823714|NCT01278394|54287960|FG000|Overall Study|Lost to Follow-up|1|||
27823715|NCT01981187|54287964|FG000|Overall Study|Participant/guardian decision|2|||
27823716|NCT01981187|54287964|FG000|Overall Study|Physician Decision|1|||
27823717|NCT01981187|54287964|FG000|Overall Study|Disease progression|2|||
27823718|NCT01981187|54287964|FG000|Overall Study|Adverse Event|7|||
27823719|NCT01278160|54287970|FG000|Overall Study|Adverse Event|1|||
27823720|NCT01278160|54287971|FG001|Overall Study|Adverse Event|1|||
27823721|NCT01278160|54287970|FG000|Overall Study|Lost to Follow-up|0|||
27823722|NCT01278160|54287971|FG001|Overall Study|Lost to Follow-up|1|||
27823723|NCT01278160|54287970|FG000|Overall Study|Withdrawal by Subject|3|||
27823724|NCT01278160|54287971|FG001|Overall Study|Withdrawal by Subject|2|||
27823725|NCT01278160|54287970|FG000|Overall Study|Unclassified|1|||
27823726|NCT01278160|54287971|FG001|Overall Study|Unclassified|2|||
27823727|NCT01996241|54287979|FG000|Overall Study|Lost to Follow-up|252|||
27823728|NCT01996241|54287980|FG001|Overall Study|Lost to Follow-up|235|||
27823729|NCT02091869|54287990|FG000|Overall Study|Withdrawal by Subject|0|||
27823730|NCT02091869|54287991|FG001|Overall Study|Withdrawal by Subject|3|||
27823731|NCT01981109|54288006|FG000|Overall Study|Death|36|||
27823732|NCT01981109|54288006|FG000|Overall Study|Withdrawal by Subject|40|||
27823733|NCT01981109|54288006|FG000|Overall Study|Lost to Follow-up|9|||
27823734|NCT01981109|54288006|FG000|Overall Study|No Discontinuation Documentation|37|||
27823735|NCT01981109|54288006|FG000|Overall Study|Study Termination|100|||
27823736|NCT01981109|54288006|FG000|Overall Study|No data available|2|||
27823737|NCT00248794|54288014|FG000|Overall Study|Lost to Follow-up|6|||
27823738|NCT00248794|54288015|FG001|Overall Study|Lost to Follow-up|8|||
27823739|NCT00248794|54288016|FG002|Overall Study|Lost to Follow-up|3|||
27823740|NCT01995539|54288030|FG000|Overall Study|Screening Failure|1|||
27823741|NCT01995539|54288030|FG000|Overall Study|Withdrawal by Investigator|15|||
27823742|NCT01995539|54288030|FG000|Overall Study|Withdrawal by Subject|11|||
27823743|NCT01995539|54288030|FG000|Overall Study|Lost to Follow-up|5|||
27823744|NCT01995539|54288030|FG000|Overall Study|Subject missed visit 3,4, came in for V5|1|||
27823745|NCT01835587|54288038|FG000|Overall Study|Disease Recurrence or Relapse|0|||
27823746|NCT01835587|54288039|FG001|Overall Study|Disease Recurrence or Relapse|3|||
27823747|NCT01835587|54288040|FG002|Overall Study|Disease Recurrence or Relapse|0|||
27823748|NCT01835587|54288041|FG003|Overall Study|Disease Recurrence or Relapse|3|||
27823749|NCT01835587|54288038|FG000|Overall Study|Withdrawal by Subject|2|||
27823750|NCT01835587|54288039|FG001|Overall Study|Withdrawal by Subject|0|||
27823751|NCT01835587|54288040|FG002|Overall Study|Withdrawal by Subject|0|||
27823752|NCT01835587|54288041|FG003|Overall Study|Withdrawal by Subject|3|||
27823753|NCT01835587|54288038|FG000|Overall Study|Adverse Event|0|||
27823754|NCT01835587|54288039|FG001|Overall Study|Adverse Event|0|||
27823755|NCT01835587|54288040|FG002|Overall Study|Adverse Event|2|||
27823756|NCT01835587|54288041|FG003|Overall Study|Adverse Event|2|||
27823757|NCT01835587|54288038|FG000|Overall Study|Death|0|||
27823758|NCT01835587|54288039|FG001|Overall Study|Death|0|||
27823759|NCT01835587|54288040|FG002|Overall Study|Death|0|||
27823760|NCT01835587|54288041|FG003|Overall Study|Death|1|||
27823761|NCT01835587|54288038|FG000|Overall Study|Miscellaneous|0|||
27823762|NCT01835587|54288039|FG001|Overall Study|Miscellaneous|1|||
28073817|NCT00145574|54728509|FG001|Double Blind|Adverse Event|3|||
28073818|NCT00145574|54728510|FG002|Double Blind|Adverse Event|1|||
28073819|NCT00145574|54728508|FG000|Double Blind|Withdrawal by Subject|1|||
28152249|NCT02631850|54821355|FG003|Treatment Period|Lost to Follow-up|0|||
28152250|NCT02631850|54821352|FG000|Treatment Period|Protocol Violation|1|||
28152251|NCT02631850|54821353|FG001|Treatment Period|Protocol Violation|0|||
28152252|NCT02631850|54821354|FG002|Treatment Period|Protocol Violation|0|||
28152253|NCT02631850|54821355|FG003|Treatment Period|Protocol Violation|0|||
28152254|NCT02631850|54821352|FG000|Treatment Period|Withdrawal by Subject|0|||
28152255|NCT02631850|54821353|FG001|Treatment Period|Withdrawal by Subject|5|||
28152256|NCT02631850|54821354|FG002|Treatment Period|Withdrawal by Subject|2|||
27823763|NCT01835587|54288040|FG002|Overall Study|Miscellaneous|0|||
27823764|NCT01835587|54288041|FG003|Overall Study|Miscellaneous|0|||
27823765|NCT01736917|54288058|FG000|Overall Study|Adverse Event|1|||
27823766|NCT01736917|54288058|FG000|Overall Study|Protocol Violation|10|||
27823767|NCT01277302|54288067|FG000|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
27823768|NCT01277302|54288068|FG001|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
27823769|NCT01277302|54288069|FG002|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8|||
27823770|NCT01277302|54288067|FG000|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
27823771|NCT01277302|54288068|FG001|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
27823772|NCT01277302|54288069|FG002|7-Month Fixed Treatment Period|Lost to Follow-up|2|||
28073820|NCT00145574|54728509|FG001|Double Blind|Withdrawal by Subject|1|||
28073821|NCT00145574|54728510|FG002|Double Blind|Withdrawal by Subject|1|||
28073822|NCT00145574|54728508|FG000|Double Blind|required restricted medicine|0|||
28073823|NCT00145574|54728509|FG001|Double Blind|required restricted medicine|1|||
28073824|NCT00145574|54728510|FG002|Double Blind|required restricted medicine|0|||
28073825|NCT00145574|54728508|FG000|Open Label Long-term Extension|Adverse Event|0|||
28073826|NCT00145574|54728509|FG001|Open Label Long-term Extension|Adverse Event|0|||
28073827|NCT00145574|54728510|FG002|Open Label Long-term Extension|Adverse Event|5|||
27823773|NCT01277302|54288067|FG000|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
27823774|NCT01277302|54288068|FG001|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
27823775|NCT01277302|54288069|FG002|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1|||
27823776|NCT01277302|54288067|FG000|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
27823777|NCT01277302|54288068|FG001|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
27823778|NCT01277302|54288069|FG002|7-Month Fixed Treatment Period|Subject Non-compliance|1|||
27823779|NCT01277302|54288067|FG000|8-Month Alternate Dose Regimen Period|Death|0|||
27823780|NCT01277302|54288068|FG001|8-Month Alternate Dose Regimen Period|Death|1|||
27823781|NCT01277302|54288069|FG002|8-Month Alternate Dose Regimen Period|Death|0|||
27823782|NCT01277302|54288067|FG000|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
27823783|NCT01277302|54288068|FG001|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
27823784|NCT01277302|54288069|FG002|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3|||
27823785|NCT01277302|54288067|FG000|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3|||
27823786|NCT01277302|54288068|FG001|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0|||
27823787|NCT01277302|54288069|FG002|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1|||
27823788|NCT01277302|54288067|FG000|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0|||
27823789|NCT01277302|54288068|FG001|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2|||
27823790|NCT01277302|54288069|FG002|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1|||
27823791|NCT01277302|54288067|FG000|8-Month Alternate Dose Regimen Period|Relocation|1|||
27823792|NCT01277302|54288068|FG001|8-Month Alternate Dose Regimen Period|Relocation|0|||
27823793|NCT01277302|54288069|FG002|8-Month Alternate Dose Regimen Period|Relocation|1|||
27823794|NCT01980875|54288080|FG000|Overall Study|Withdrew Consent|1|||
27823795|NCT01980875|54288081|FG001|Overall Study|Withdrew Consent|1|||
28152257|NCT02631850|54821355|FG003|Treatment Period|Withdrawal by Subject|2|||
28152258|NCT02631850|54821352|FG000|Treatment Period|Adverse Event|1|||
28152259|NCT02631850|54821353|FG001|Treatment Period|Adverse Event|0|||
28152260|NCT02631850|54821354|FG002|Treatment Period|Adverse Event|2|||
28152261|NCT02631850|54821355|FG003|Treatment Period|Adverse Event|3|||
28152262|NCT02631850|54821352|FG000|Treatment Period|Family medical issue|1|||
27823796|NCT01980875|54288082|FG002|Overall Study|Withdrew Consent|1|||
28152263|NCT02631850|54821353|FG001|Treatment Period|Family medical issue|0|||
28152264|NCT02631850|54821354|FG002|Treatment Period|Family medical issue|0|||
28152265|NCT02631850|54821355|FG003|Treatment Period|Family medical issue|0|||
28152266|NCT02631850|54821352|FG000|6 Month Follow up|Lost to Follow-up|5|||
28152267|NCT02631850|54821353|FG001|6 Month Follow up|Lost to Follow-up|8|||
28152268|NCT02631850|54821354|FG002|6 Month Follow up|Lost to Follow-up|3|||
28152269|NCT02631850|54821355|FG003|6 Month Follow up|Lost to Follow-up|5|||
28152270|NCT02631850|54821352|FG000|6 Month Follow up|Withdrawal by Subject|1|||
28152271|NCT02631850|54821353|FG001|6 Month Follow up|Withdrawal by Subject|0|||
28152272|NCT02631850|54821354|FG002|6 Month Follow up|Withdrawal by Subject|0|||
28152273|NCT02631850|54821355|FG003|6 Month Follow up|Withdrawal by Subject|2|||
28152274|NCT02631850|54821352|FG000|6 Month Follow up|Adverse Event|1|||
28152275|NCT02631850|54821353|FG001|6 Month Follow up|Adverse Event|4|||
28152276|NCT02631850|54821354|FG002|6 Month Follow up|Adverse Event|1|||
28152277|NCT02631850|54821355|FG003|6 Month Follow up|Adverse Event|3|||
28152278|NCT02631850|54821352|FG000|6 Month Follow up|moved out of state, transportation issues, family medical issue|0|||
28152279|NCT02631850|54821353|FG001|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
27823797|NCT01980875|54288080|FG000|Overall Study|Study Terminated by Sponsor|7|||
27823798|NCT01980875|54288081|FG001|Overall Study|Study Terminated by Sponsor|24|||
27823799|NCT01980875|54288082|FG002|Overall Study|Study Terminated by Sponsor|22|||
27823800|NCT01980875|54288080|FG000|Overall Study|Lost to Follow-up|0|||
27823801|NCT01980875|54288081|FG001|Overall Study|Lost to Follow-up|0|||
28152280|NCT02631850|54821354|FG002|6 Month Follow up|moved out of state, transportation issues, family medical issue|2|||
28152281|NCT02631850|54821355|FG003|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
28152282|NCT00103038|54821366|FG000|Overall Study|Withdrawal by Subject|8|||
28152283|NCT00103038|54821366|FG000|Overall Study|Screen failure|3|||
27823802|NCT01980875|54288082|FG002|Overall Study|Lost to Follow-up|1|||
27823803|NCT01995461|54288090|FG000|Overall Study|Death|1|||
27823804|NCT01995461|54288090|FG000|Overall Study|Lost to Follow-up|2|||
28152284|NCT00103038|54821366|FG000|Overall Study|Death|1|||
28152285|NCT00103038|54821366|FG000|Overall Study|Physician Decision|1|||
28152286|NCT00620035|54821373|FG000|Overall Study|Adverse Event|106|||
28152287|NCT00620035|54821373|FG000|Overall Study|Withdrawal of Informed Consent|1|||
28152288|NCT00620035|54821373|FG000|Overall Study|Other Reason|38|||
28152289|NCT02763579|54821379|FG000|Overall Study|Death|101|||
28152290|NCT02763579|54821380|FG001|Overall Study|Death|132|||
28152291|NCT02763579|54821379|FG000|Overall Study|Lost to Follow-up|3|||
28152292|NCT02763579|54821380|FG001|Overall Study|Lost to Follow-up|1|||
28152293|NCT02763579|54821379|FG000|Overall Study|Withdrawal by Subject|18|||
28152294|NCT02763579|54821380|FG001|Overall Study|Withdrawal by Subject|9|||
28152295|NCT02763579|54821379|FG000|Overall Study|Physician Decision|2|||
28152296|NCT02763579|54821380|FG001|Overall Study|Physician Decision|0|||
28152297|NCT02763579|54821379|FG000|Overall Study|On-going in study|77|||
28152298|NCT02763579|54821380|FG001|Overall Study|On-going in study|60|||
28152299|NCT03034057|54821386|FG000|Overall Study|Withdrawal by Subject|10|||
28152300|NCT03034057|54821386|FG000|Overall Study|Protocol Violation|1|||
28152301|NCT03034057|54821386|FG000|Overall Study|Not defined|2|||
28152302|NCT03034057|54821386|FG000|Overall Study|Lost to Follow-up|19|||
27823805|NCT01995461|54288090|FG000|Overall Study|Withdrawal by Subject|2|||
27823806|NCT01980095|54288096|FG000|Overall Study|Lost to Follow-up|6|||
27823807|NCT01980095|54288097|FG001|Overall Study|Lost to Follow-up|7|||
27823808|NCT01980095|54288096|FG000|Overall Study|Withdrawal by Subject|2|||
27823809|NCT01980095|54288097|FG001|Overall Study|Withdrawal by Subject|3|||
27823810|NCT01980095|54288096|FG000|Overall Study|Poor compliance|5|||
27823811|NCT01980095|54288097|FG001|Overall Study|Poor compliance|0|||
27823812|NCT01980095|54288096|FG000|Overall Study|Safety issue|0|||
27823813|NCT01980095|54288097|FG001|Overall Study|Safety issue|1|||
27823814|NCT01980095|54288096|FG000|Overall Study|Study drug discontinued|1|||
27823815|NCT01980095|54288097|FG001|Overall Study|Study drug discontinued|0|||
27823816|NCT01980095|54288096|FG000|Overall Study|Randomized by mistake|1|||
27823817|NCT01980095|54288097|FG001|Overall Study|Randomized by mistake|0|||
27823818|NCT01980017|54288107|FG000|Overall Study|Lost to Follow-up|30|||
27823819|NCT01980017|54288108|FG001|Overall Study|Lost to Follow-up|21|||
27823820|NCT01980017|54288107|FG000|Overall Study|Death|0|||
27823821|NCT01980017|54288108|FG001|Overall Study|Death|1|||
27823822|NCT01978145|54288117|FG000|Treatment Period 1|Adverse Event|1|||
27850286|NCT04178967|54349325|FG010|Induction Period|Withdrawal by Subject|0|||
27823823|NCT01978145|54288118|FG001|Treatment Period 1|Adverse Event|9|||
27823824|NCT01978145|54288117|FG000|Treatment Period 1|Physician Decision|1|||
27823825|NCT01978145|54288118|FG001|Treatment Period 1|Physician Decision|0|||
27850287|NCT04178967|54349315|FG000|Induction Period|Lost to Follow-up|2|||
28152303|NCT03034057|54821386|FG000|Overall Study|Adverse Event|22|||
28152304|NCT03034057|54821386|FG000|Overall Study|Medication error without associated AE|1|||
28152305|NCT02757768|54821392|FG000|Overall Study|Randomized Never Received Study Drug|3|||
28152306|NCT02757768|54821393|FG001|Overall Study|Randomized Never Received Study Drug|4|||
28152307|NCT02757768|54821392|FG000|Overall Study|Adverse Event|5|||
28152308|NCT02757768|54821393|FG001|Overall Study|Adverse Event|3|||
28152309|NCT02757768|54821392|FG000|Overall Study|Lack of Efficacy|2|||
28152310|NCT02757768|54821393|FG001|Overall Study|Lack of Efficacy|1|||
28152311|NCT02757768|54821392|FG000|Overall Study|Lost to Follow-up|1|||
28152312|NCT02757768|54821393|FG001|Overall Study|Lost to Follow-up|0|||
28152313|NCT02757768|54821392|FG000|Overall Study|Protocol Deviation|2|||
28152314|NCT02757768|54821393|FG001|Overall Study|Protocol Deviation|9|||
28152315|NCT02757768|54821392|FG000|Overall Study|Withdrawal by Subject|16|||
28152316|NCT02757768|54821393|FG001|Overall Study|Withdrawal by Subject|9|||
28152317|NCT02757768|54821392|FG000|Overall Study|Miscellaneous|4|||
28152318|NCT02757768|54821393|FG001|Overall Study|Miscellaneous|2|||
28152319|NCT05225389|54821401|FG000|Overall Study|Three participants were discontinued by the Investigator on day 7 due to positive COVID-19 tests.|3|||
28152320|NCT02753946|54821407|FG000|Overall Study|Adverse Event|7|||
28152321|NCT02753946|54821408|FG001|Overall Study|Adverse Event|6|||
28152322|NCT02753946|54821407|FG000|Overall Study|Withdrawal by Subject|6|||
28152323|NCT02753946|54821408|FG001|Overall Study|Withdrawal by Subject|1|||
28152324|NCT02753946|54821407|FG000|Overall Study|Lack of Efficacy|1|||
27823826|NCT01978145|54288117|FG000|Treatment Period 1|Withdrawal by Subject|5|||
28152325|NCT02753946|54821408|FG001|Overall Study|Lack of Efficacy|0|||
28152326|NCT02753946|54821407|FG000|Overall Study|Physician Decision|0|||
28152327|NCT02753946|54821408|FG001|Overall Study|Physician Decision|2|||
28152328|NCT02756832|54821414|FG000|Overall Study|Lost for Observation after Baseline|6|||
28152329|NCT02756832|54821414|FG000|Overall Study|Lost for Observation|13|||
28152330|NCT02756832|54821414|FG000|Overall Study|Patient's Unwillingness|12|||
28152331|NCT02756832|54821414|FG000|Overall Study|Insufficient Efficacy|2|||
27823827|NCT01978145|54288118|FG001|Treatment Period 1|Withdrawal by Subject|4|||
28152332|NCT02756832|54821414|FG000|Overall Study|Sponsor Decision/Regulatory Requirement|1|||
28152333|NCT02756832|54821414|FG000|Overall Study|Reason not Specified|9|||
28152334|NCT02756832|54821414|FG000|Overall Study|Protocol Deviation|10|||
28152335|NCT00106080|54821420|FG000|Overall Study|Withdrew/Loss to follow-up|43|||
27823828|NCT01978145|54288117|FG000|Treatment Period 1|Par. reached defined stopping criteria|2|||
27823829|NCT01978145|54288118|FG001|Treatment Period 1|Par. reached defined stopping criteria|3|||
27823830|NCT01978145|54288117|FG000|Washout Period 1|Adverse Event|0|||
27823831|NCT01978145|54288118|FG001|Washout Period 1|Adverse Event|1|||
27823832|NCT01978145|54288117|FG000|Washout Period 1|Withdrawal by Subject|1|||
27823833|NCT01978145|54288118|FG001|Washout Period 1|Withdrawal by Subject|1|||
27823834|NCT01978145|54288117|FG000|Washout Period 1|Par. reached defined stopping criteria|0|||
27823835|NCT01978145|54288118|FG001|Washout Period 1|Par. reached defined stopping criteria|1|||
27823836|NCT01978145|54288117|FG000|Treatment Period 2|Adverse Event|3|||
27823837|NCT01978145|54288118|FG001|Treatment Period 2|Adverse Event|3|||
27823838|NCT01978145|54288117|FG000|Treatment Period 2|Protocol Violation|0|||
28152336|NCT00106080|54821421|FG001|Overall Study|Withdrew/Loss to follow-up|27|||
28152337|NCT02633020|54821429|FG000|Overall Study|Adverse Event|1|||
28152338|NCT02633020|54821430|FG001|Overall Study|Adverse Event|0|||
28152339|NCT00106626|54821440|FG000|Overall Study|Adverse Event|5|||
28152340|NCT00106626|54821441|FG001|Overall Study|Adverse Event|4|||
28152341|NCT00106626|54821442|FG002|Overall Study|Adverse Event|3|||
28152342|NCT00106626|54821443|FG003|Overall Study|Adverse Event|3|||
28152343|NCT00106626|54821440|FG000|Overall Study|Progressive Disease|4|||
28152344|NCT00106626|54821441|FG001|Overall Study|Progressive Disease|1|||
28152345|NCT00106626|54821442|FG002|Overall Study|Progressive Disease|9|||
28152346|NCT00106626|54821443|FG003|Overall Study|Progressive Disease|10|||
28152347|NCT00106626|54821440|FG000|Overall Study|Received radiation on new therapy|1|||
27823839|NCT01978145|54288118|FG001|Treatment Period 2|Protocol Violation|1|||
27823840|NCT01978145|54288117|FG000|Treatment Period 2|Lost to Follow-up|1|||
27823841|NCT01978145|54288118|FG001|Treatment Period 2|Lost to Follow-up|1|||
27823842|NCT01978145|54288117|FG000|Treatment Period 2|Withdrawal by Subject|7|||
27823843|NCT01978145|54288118|FG001|Treatment Period 2|Withdrawal by Subject|4|||
27823844|NCT01978145|54288117|FG000|Treatment Period 2|Par. reached defined stopping criteria|8|||
27823845|NCT01978145|54288118|FG001|Treatment Period 2|Par. reached defined stopping criteria|5|||
27823846|NCT01967537|54288124|FG000|Overall Study|Withdrawal by Subject|52|||
27823847|NCT01967537|54288124|FG000|Overall Study|Refuse treatment|2|||
27823848|NCT01967537|54288124|FG000|Overall Study|Lost to Follow-up|6|||
27823849|NCT01967225|54288132|FG000|Overall Study|Adverse Event|3|||
27823850|NCT01967225|54288133|FG001|Overall Study|Adverse Event|1|||
27823851|NCT01967225|54288132|FG000|Overall Study|Withdrawal by Subject|2|||
27823852|NCT01967225|54288133|FG001|Overall Study|Withdrawal by Subject|1|||
27823853|NCT01967225|54288132|FG000|Overall Study|Lack of Efficacy|1|||
27823854|NCT01967225|54288133|FG001|Overall Study|Lack of Efficacy|1|||
27823855|NCT01967225|54288132|FG000|Overall Study|Switching to other therapy|2|||
27823856|NCT01967225|54288133|FG001|Overall Study|Switching to other therapy|0|||
27823857|NCT01967225|54288132|FG000|Overall Study|Protocol driven decision point|1|||
28152348|NCT00106626|54821441|FG001|Overall Study|Received radiation on new therapy|0|||
28152349|NCT00106626|54821442|FG002|Overall Study|Received radiation on new therapy|0|||
27823858|NCT01967225|54288133|FG001|Overall Study|Protocol driven decision point|0|||
27823859|NCT01967225|54288132|FG000|Overall Study|Logistical difficulties|1|||
27823860|NCT01967225|54288133|FG001|Overall Study|Logistical difficulties|0|||
27823861|NCT01967225|54288132|FG000|Overall Study|Protocol Violation|2|||
27823862|NCT01967225|54288133|FG001|Overall Study|Protocol Violation|0|||
27823863|NCT01967147|54288143|FG000|Overall Study|Adverse Event|5|||
27823864|NCT01967147|54288144|FG001|Overall Study|Adverse Event|2|||
27823865|NCT01967147|54288143|FG000|Overall Study|Lack of Efficacy|1|||
27823866|NCT01967147|54288144|FG001|Overall Study|Lack of Efficacy|4|||
27823867|NCT01967147|54288143|FG000|Overall Study|Lost to Follow-up|1|||
27823868|NCT01967147|54288144|FG001|Overall Study|Lost to Follow-up|2|||
27823869|NCT01967147|54288143|FG000|Overall Study|Withdrawal by Subject|2|||
27823870|NCT01967147|54288144|FG001|Overall Study|Withdrawal by Subject|4|||
27823871|NCT01967147|54288143|FG000|Overall Study|Non-compliance with Study Drug|0|||
27823872|NCT01967147|54288144|FG001|Overall Study|Non-compliance with Study Drug|3|||
27823873|NCT01967147|54288143|FG000|Overall Study|Other|4|||
27823874|NCT01967147|54288144|FG001|Overall Study|Other|5|||
27823875|NCT01967069|54288153|FG000|Overall Study|Adverse Event|2|||
27823876|NCT01967069|54288154|FG001|Overall Study|Adverse Event|2|||
27823877|NCT01967069|54288153|FG000|Overall Study|Lost to Follow-up|5|||
27823878|NCT01967069|54288154|FG001|Overall Study|Lost to Follow-up|2|||
27823879|NCT01967069|54288153|FG000|Overall Study|Withdrawal by Subject|1|||
27823880|NCT01967069|54288154|FG001|Overall Study|Withdrawal by Subject|3|||
27823881|NCT01967069|54288153|FG000|Overall Study|Lack of Efficacy|0|||
27823882|NCT01967069|54288154|FG001|Overall Study|Lack of Efficacy|1|||
27823883|NCT01790503|54288171|FG000|Overall Study|Adverse Event|1|||
27823884|NCT01790503|54288172|FG001|Overall Study|Adverse Event|0|||
27823885|NCT01790503|54288173|FG002|Overall Study|Adverse Event|0|||
27823886|NCT01790503|54288174|FG003|Overall Study|Adverse Event|0|||
27823887|NCT01790503|54288175|FG004|Overall Study|Adverse Event|0|||
27823888|NCT01790503|54288176|FG005|Overall Study|Adverse Event|2|||
27823889|NCT01790503|54288177|FG006|Overall Study|Adverse Event|0|||
27823890|NCT01790503|54288178|FG007|Overall Study|Adverse Event|0|||
27823891|NCT01790503|54288179|FG008|Overall Study|Adverse Event|2|||
27941906|NCT01208207|54598596|FG001|Part I|Lack of Efficacy|3|||
28152350|NCT00106626|54821443|FG003|Overall Study|Received radiation on new therapy|0|||
28152351|NCT00106626|54821440|FG000|Overall Study|> 14 day delay in therapy start|0|||
28152352|NCT00106626|54821441|FG001|Overall Study|> 14 day delay in therapy start|1|||
28152353|NCT00106626|54821442|FG002|Overall Study|> 14 day delay in therapy start|0|||
28152354|NCT00106626|54821443|FG003|Overall Study|> 14 day delay in therapy start|0|||
28152355|NCT02632786|54821460|FG000|Overall Study|Adverse Event|2|||
28152356|NCT02632786|54821461|FG001|Overall Study|Adverse Event|1|||
28152357|NCT02632786|54821460|FG000|Overall Study|Death|3|||
27823892|NCT01790503|54288180|FG009|Overall Study|Adverse Event|4|||
27823893|NCT01790503|54288181|FG010|Overall Study|Adverse Event|7|||
27823894|NCT01790503|54288171|FG000|Overall Study|Withdrawal by Subject|0|||
27823895|NCT01790503|54288172|FG001|Overall Study|Withdrawal by Subject|0|||
27823896|NCT01790503|54288173|FG002|Overall Study|Withdrawal by Subject|1|||
27823897|NCT01790503|54288174|FG003|Overall Study|Withdrawal by Subject|1|||
27823898|NCT01790503|54288175|FG004|Overall Study|Withdrawal by Subject|1|||
27823899|NCT01790503|54288176|FG005|Overall Study|Withdrawal by Subject|2|||
27823900|NCT01790503|54288177|FG006|Overall Study|Withdrawal by Subject|1|||
27941907|NCT01208207|54598597|FG002|Part I|Lack of Efficacy|2|||
27823901|NCT01790503|54288178|FG007|Overall Study|Withdrawal by Subject|0|||
27823902|NCT01790503|54288179|FG008|Overall Study|Withdrawal by Subject|0|||
27823903|NCT01790503|54288180|FG009|Overall Study|Withdrawal by Subject|0|||
27823904|NCT01790503|54288181|FG010|Overall Study|Withdrawal by Subject|1|||
27823905|NCT01790503|54288171|FG000|Overall Study|Disease progression|2|||
27823906|NCT01790503|54288172|FG001|Overall Study|Disease progression|1|||
27823907|NCT01790503|54288173|FG002|Overall Study|Disease progression|0|||
27823908|NCT01790503|54288174|FG003|Overall Study|Disease progression|1|||
27823909|NCT01790503|54288175|FG004|Overall Study|Disease progression|2|||
27823910|NCT01790503|54288176|FG005|Overall Study|Disease progression|1|||
27823911|NCT01790503|54288177|FG006|Overall Study|Disease progression|0|||
27823912|NCT01790503|54288178|FG007|Overall Study|Disease progression|1|||
27823913|NCT01790503|54288179|FG008|Overall Study|Disease progression|0|||
27823914|NCT01790503|54288180|FG009|Overall Study|Disease progression|17|||
27823915|NCT01790503|54288181|FG010|Overall Study|Disease progression|7|||
27823916|NCT01790503|54288171|FG000|Overall Study|Protocol Violation|0|||
27823917|NCT01790503|54288172|FG001|Overall Study|Protocol Violation|0|||
27823918|NCT01790503|54288173|FG002|Overall Study|Protocol Violation|0|||
27823919|NCT01790503|54288174|FG003|Overall Study|Protocol Violation|0|||
27823920|NCT01790503|54288175|FG004|Overall Study|Protocol Violation|0|||
27823921|NCT01790503|54288176|FG005|Overall Study|Protocol Violation|0|||
27823922|NCT01790503|54288177|FG006|Overall Study|Protocol Violation|0|||
27823923|NCT01790503|54288178|FG007|Overall Study|Protocol Violation|0|||
27823924|NCT01790503|54288179|FG008|Overall Study|Protocol Violation|0|||
27823925|NCT01790503|54288180|FG009|Overall Study|Protocol Violation|1|||
27823926|NCT01790503|54288181|FG010|Overall Study|Protocol Violation|0|||
27823927|NCT01790503|54288171|FG000|Overall Study|Physician Decision|0|||
27823928|NCT01790503|54288172|FG001|Overall Study|Physician Decision|0|||
27823929|NCT01790503|54288173|FG002|Overall Study|Physician Decision|0|||
27823930|NCT01790503|54288174|FG003|Overall Study|Physician Decision|0|||
27823931|NCT01790503|54288175|FG004|Overall Study|Physician Decision|0|||
27823932|NCT01790503|54288176|FG005|Overall Study|Physician Decision|0|||
27823933|NCT01790503|54288177|FG006|Overall Study|Physician Decision|0|||
27823934|NCT01790503|54288178|FG007|Overall Study|Physician Decision|0|||
27823935|NCT01790503|54288179|FG008|Overall Study|Physician Decision|0|||
27823936|NCT01790503|54288180|FG009|Overall Study|Physician Decision|1|||
27823937|NCT01790503|54288181|FG010|Overall Study|Physician Decision|1|||
27823938|NCT01790503|54288171|FG000|Overall Study|Death|0|||
27823939|NCT01790503|54288172|FG001|Overall Study|Death|0|||
27823940|NCT01790503|54288173|FG002|Overall Study|Death|0|||
27823941|NCT01790503|54288174|FG003|Overall Study|Death|0|||
27823942|NCT01790503|54288175|FG004|Overall Study|Death|0|||
27823943|NCT01790503|54288176|FG005|Overall Study|Death|0|||
27823944|NCT01790503|54288177|FG006|Overall Study|Death|0|||
27823945|NCT01790503|54288178|FG007|Overall Study|Death|0|||
27823946|NCT01790503|54288179|FG008|Overall Study|Death|0|||
27823947|NCT01790503|54288180|FG009|Overall Study|Death|1|||
27823948|NCT01790503|54288181|FG010|Overall Study|Death|0|||
27823949|NCT01790503|54288171|FG000|Overall Study|Non Compliance|0|||
27823950|NCT01790503|54288172|FG001|Overall Study|Non Compliance|0|||
27823951|NCT01790503|54288173|FG002|Overall Study|Non Compliance|0|||
27823952|NCT01790503|54288174|FG003|Overall Study|Non Compliance|0|||
27823953|NCT01790503|54288175|FG004|Overall Study|Non Compliance|1|||
27823954|NCT01790503|54288176|FG005|Overall Study|Non Compliance|0|||
27823955|NCT01790503|54288177|FG006|Overall Study|Non Compliance|0|||
27941908|NCT01208207|54598598|FG003|Part I|Lack of Efficacy|0|||
27823956|NCT01790503|54288178|FG007|Overall Study|Non Compliance|0|||
27823957|NCT01790503|54288179|FG008|Overall Study|Non Compliance|0|||
27823958|NCT01790503|54288180|FG009|Overall Study|Non Compliance|0|||
27823959|NCT01790503|54288181|FG010|Overall Study|Non Compliance|0|||
27941909|NCT01208207|54598599|FG004|Part I|Lack of Efficacy|0|||
27823960|NCT01790503|54288171|FG000|Overall Study|Other|0|||
27823961|NCT01790503|54288172|FG001|Overall Study|Other|0|||
27823962|NCT01790503|54288173|FG002|Overall Study|Other|0|||
27823963|NCT01790503|54288174|FG003|Overall Study|Other|0|||
27823964|NCT01790503|54288175|FG004|Overall Study|Other|1|||
27823965|NCT01790503|54288176|FG005|Overall Study|Other|0|||
27823966|NCT01790503|54288177|FG006|Overall Study|Other|0|||
27823967|NCT01790503|54288178|FG007|Overall Study|Other|0|||
27823968|NCT01790503|54288179|FG008|Overall Study|Other|1|||
27823969|NCT01790503|54288180|FG009|Overall Study|Other|2|||
27823970|NCT01790503|54288181|FG010|Overall Study|Other|0|||
27823971|NCT01790113|54288220|FG000|Overall Study|Adverse Event|2|||
27823972|NCT01790113|54288221|FG001|Overall Study|Adverse Event|7|||
27823973|NCT01790113|54288220|FG000|Overall Study|Study ended due to FDA clearance|1|||
27823974|NCT01790113|54288221|FG001|Overall Study|Study ended due to FDA clearance|68|||
27823975|NCT01789567|54288227|FG000|Overall Study|Death|6|||
27823976|NCT01765543|54288231|FG000|Overall Study|Death|1|||
27823977|NCT01765543|54288231|FG000|Overall Study|Withdrawal by Subject|2|||
27823978|NCT01765153|54288241|FG000|Training Phase 1|Format of intervention differed|1|||
27823979|NCT01765153|54288242|FG001|Training Phase 1|Format of intervention differed|0|||
27823980|NCT01765153|54288241|FG000|Training Phase 1|Poor participation in intervention|0|||
27823981|NCT01765153|54288242|FG001|Training Phase 1|Poor participation in intervention|1|||
27823982|NCT01765153|54288241|FG000|Rest Phase 1|Withdrawal by Subject|0|||
27823983|NCT01765153|54288242|FG001|Rest Phase 1|Withdrawal by Subject|1|||
27823984|NCT01765153|54288241|FG000|Training Phase 2|Withdrawal by Subject|0|||
27823985|NCT01765153|54288242|FG001|Training Phase 2|Withdrawal by Subject|1|||
27823986|NCT01765153|54288241|FG000|Rest Phase 2|Lost to Follow-up|2|||
27823987|NCT01765153|54288242|FG001|Rest Phase 2|Lost to Follow-up|1|||
27823988|NCT00248170|54288254|FG000|Overall Study|Withdrawal by Subject|71|||
27823989|NCT00248170|54288255|FG001|Overall Study|Withdrawal by Subject|79|||
27823990|NCT00248170|54288254|FG000|Overall Study|Protocol Violation|35|||
27823991|NCT00248170|54288255|FG001|Overall Study|Protocol Violation|30|||
27823992|NCT00248170|54288254|FG000|Overall Study|Lost to Follow-up|28|||
27823993|NCT00248170|54288255|FG001|Overall Study|Lost to Follow-up|35|||
27823994|NCT00248170|54288254|FG000|Overall Study|Disease progression|196|||
27823995|NCT00248170|54288255|FG001|Overall Study|Disease progression|216|||
27823996|NCT00248170|54288254|FG000|Overall Study|Death|28|||
27823997|NCT00248170|54288255|FG001|Overall Study|Death|47|||
27823998|NCT00248170|54288254|FG000|Overall Study|Adverse Event|311|||
27823999|NCT00248170|54288255|FG001|Overall Study|Adverse Event|296|||
27824000|NCT00248170|54288254|FG000|Overall Study|Administrative problems|22|||
27824001|NCT00248170|54288255|FG001|Overall Study|Administrative problems|25|||
27824002|NCT00248170|54288254|FG000|Overall Study|Abnormal test procedure(s) result|49|||
27824003|NCT00248170|54288255|FG001|Overall Study|Abnormal test procedure(s) result|61|||
27824004|NCT00248170|54288254|FG000|Overall Study|Abnormal laboratory values|4|||
27824005|NCT00248170|54288255|FG001|Overall Study|Abnormal laboratory values|0|||
27824006|NCT00248170|54288254|FG000|Overall Study|Protocol deviation|17|||
27824007|NCT00248170|54288255|FG001|Overall Study|Protocol deviation|19|||
27824008|NCT01764997|54288266|FG000|Run-in Period|Adverse Event|15|||
27824009|NCT01764997|54288267|FG001|Run-in Period|Adverse Event|0|||
27824010|NCT01764997|54288268|FG002|Run-in Period|Adverse Event|0|||
27824011|NCT01764997|54288269|FG003|Run-in Period|Adverse Event|0|||
27824012|NCT01764997|54288270|FG004|Run-in Period|Adverse Event|0|||
27824013|NCT01764997|54288266|FG000|Run-in Period|Lack of Efficacy|5|||
27824014|NCT01764997|54288267|FG001|Run-in Period|Lack of Efficacy|0|||
27824015|NCT01764997|54288268|FG002|Run-in Period|Lack of Efficacy|0|||
27824016|NCT01764997|54288269|FG003|Run-in Period|Lack of Efficacy|0|||
28152358|NCT02632786|54821461|FG001|Overall Study|Death|2|||
27824017|NCT01764997|54288270|FG004|Run-in Period|Lack of Efficacy|0|||
27824018|NCT01764997|54288266|FG000|Run-in Period|Poor compliance to protocol|1|||
27824019|NCT01764997|54288267|FG001|Run-in Period|Poor compliance to protocol|0|||
27824020|NCT01764997|54288268|FG002|Run-in Period|Poor compliance to protocol|0|||
27824021|NCT01764997|54288269|FG003|Run-in Period|Poor compliance to protocol|0|||
27824022|NCT01764997|54288270|FG004|Run-in Period|Poor compliance to protocol|0|||
27824023|NCT01764997|54288266|FG000|Run-in Period|Other than specified above|17|||
27824024|NCT01764997|54288267|FG001|Run-in Period|Other than specified above|0|||
27824025|NCT01764997|54288268|FG002|Run-in Period|Other than specified above|0|||
27824026|NCT01764997|54288269|FG003|Run-in Period|Other than specified above|0|||
27824027|NCT01764997|54288270|FG004|Run-in Period|Other than specified above|0|||
27824028|NCT01764997|54288266|FG000|Study Drug Treatment Period|Adverse Event|0|||
28152359|NCT02632786|54821460|FG000|Overall Study|Physician Decision|5|||
28152360|NCT02632786|54821461|FG001|Overall Study|Physician Decision|4|||
28152361|NCT02632786|54821460|FG000|Overall Study|Withdrawal by Subject|1|||
28152362|NCT02632786|54821461|FG001|Overall Study|Withdrawal by Subject|0|||
28152363|NCT02755818|54821472|FG000|Overall Study|Withdrawal by Subject|0|||
27824029|NCT01764997|54288267|FG001|Study Drug Treatment Period|Adverse Event|1|||
27824030|NCT01764997|54288268|FG002|Study Drug Treatment Period|Adverse Event|0|||
27824031|NCT01764997|54288269|FG003|Study Drug Treatment Period|Adverse Event|0|||
27824032|NCT01764997|54288270|FG004|Study Drug Treatment Period|Adverse Event|24|||
27824033|NCT01764997|54288266|FG000|Study Drug Treatment Period|Lack of Efficacy|0|||
27824034|NCT01764997|54288267|FG001|Study Drug Treatment Period|Lack of Efficacy|0|||
27824035|NCT01764997|54288268|FG002|Study Drug Treatment Period|Lack of Efficacy|0|||
27824036|NCT01764997|54288269|FG003|Study Drug Treatment Period|Lack of Efficacy|0|||
27824037|NCT01764997|54288270|FG004|Study Drug Treatment Period|Lack of Efficacy|2|||
27824038|NCT01764997|54288266|FG000|Study Drug Treatment Period|Other than specified above|0|||
27824039|NCT01764997|54288267|FG001|Study Drug Treatment Period|Other than specified above|0|||
27824040|NCT01764997|54288268|FG002|Study Drug Treatment Period|Other than specified above|0|||
27824041|NCT01764997|54288269|FG003|Study Drug Treatment Period|Other than specified above|0|||
27824042|NCT01764997|54288270|FG004|Study Drug Treatment Period|Other than specified above|10|||
27824043|NCT01276756|54288282|FG000|Overall Study|Lost to Follow-up|2|||
27824044|NCT01276756|54288283|FG001|Overall Study|Lost to Follow-up|0|||
27824045|NCT01276756|54288282|FG000|Overall Study|Adverse Event|3|||
27824046|NCT01276756|54288283|FG001|Overall Study|Adverse Event|2|||
27824047|NCT00246376|54288294|FG000|Overall Study|Dropped/withdrew during dietary run-in|11|||
27824048|NCT00246376|54288295|FG001|Overall Study|Dropped/withdrew during dietary run-in|5|||
27824049|NCT00246376|54288296|FG002|Overall Study|Dropped/withdrew during dietary run-in|4|||
27824050|NCT00246376|54288297|FG003|Overall Study|Dropped/withdrew during dietary run-in|7|||
27824051|NCT00246376|54288298|FG004|Overall Study|Dropped/withdrew during dietary run-in|3|||
27824052|NCT00246376|54288294|FG000|Overall Study|Adverse Event|2|||
27824053|NCT00246376|54288295|FG001|Overall Study|Adverse Event|3|||
27824054|NCT00246376|54288296|FG002|Overall Study|Adverse Event|1|||
27824055|NCT00246376|54288297|FG003|Overall Study|Adverse Event|3|||
27824056|NCT00246376|54288298|FG004|Overall Study|Adverse Event|1|||
27824057|NCT00246376|54288294|FG000|Overall Study|Lost to Follow-up|2|||
27824058|NCT00246376|54288295|FG001|Overall Study|Lost to Follow-up|11|||
27824059|NCT00246376|54288296|FG002|Overall Study|Lost to Follow-up|11|||
27824060|NCT00246376|54288297|FG003|Overall Study|Lost to Follow-up|16|||
27824061|NCT00246376|54288298|FG004|Overall Study|Lost to Follow-up|13|||
27824062|NCT01764841|54288356|FG000|Overall Study|Logistical Difficulties|0|||
27824063|NCT01764841|54288357|FG001|Overall Study|Logistical Difficulties|1|||
27824064|NCT01764841|54288358|FG002|Overall Study|Logistical Difficulties|0|||
27824065|NCT01764841|54288359|FG003|Overall Study|Logistical Difficulties|0|||
27824066|NCT01764841|54288356|FG000|Overall Study|Death|3|||
27824067|NCT01764841|54288357|FG001|Overall Study|Death|0|||
27824068|NCT01764841|54288358|FG002|Overall Study|Death|1|||
27824069|NCT01764841|54288359|FG003|Overall Study|Death|4|||
27824070|NCT01764841|54288356|FG000|Overall Study|No Follow Up|1|||
27824071|NCT01764841|54288357|FG001|Overall Study|No Follow Up|0|||
27824072|NCT01764841|54288358|FG002|Overall Study|No Follow Up|1|||
27824073|NCT01764841|54288359|FG003|Overall Study|No Follow Up|0|||
27824074|NCT01764841|54288356|FG000|Overall Study|Protocol Violation|0|||
27824075|NCT01764841|54288357|FG001|Overall Study|Protocol Violation|1|||
27824076|NCT01764841|54288358|FG002|Overall Study|Protocol Violation|0|||
27824077|NCT01764841|54288359|FG003|Overall Study|Protocol Violation|0|||
27824078|NCT01764841|54288356|FG000|Overall Study|Withdrawal by Subject|16|||
27824079|NCT01764841|54288357|FG001|Overall Study|Withdrawal by Subject|24|||
27824080|NCT01764841|54288358|FG002|Overall Study|Withdrawal by Subject|11|||
27824081|NCT01764841|54288359|FG003|Overall Study|Withdrawal by Subject|15|||
27824082|NCT01764841|54288356|FG000|Overall Study|Lost to Follow-up|3|||
27824083|NCT01764841|54288357|FG001|Overall Study|Lost to Follow-up|0|||
27824084|NCT01764841|54288358|FG002|Overall Study|Lost to Follow-up|1|||
27824085|NCT01764841|54288359|FG003|Overall Study|Lost to Follow-up|0|||
27824086|NCT00245050|54288371|FG000|Overall Study|Adverse Event|3|||
27824087|NCT00245050|54288372|FG001|Overall Study|Adverse Event|2|||
27824088|NCT00243412|54288410|FG000|Overall Study|Death|0|||
27824089|NCT00243412|54288411|FG001|Overall Study|Death|1|||
27824090|NCT00243412|54288410|FG000|Overall Study|Adverse Event|4|||
27824091|NCT00243412|54288411|FG001|Overall Study|Adverse Event|2|||
27824092|NCT00243412|54288410|FG000|Overall Study|Lost to Follow-up|0|||
27824093|NCT00243412|54288411|FG001|Overall Study|Lost to Follow-up|1|||
27824094|NCT00243412|54288410|FG000|Overall Study|Physician Decision|1|||
27824095|NCT00243412|54288411|FG001|Overall Study|Physician Decision|1|||
27824096|NCT00243412|54288410|FG000|Overall Study|Withdrawal by Subject|4|||
27824097|NCT00243412|54288411|FG001|Overall Study|Withdrawal by Subject|5|||
27824098|NCT00243412|54288410|FG000|Overall Study|Other|1|||
27824099|NCT00243412|54288411|FG001|Overall Study|Other|1|||
27824100|NCT03805750|54288426|FG000|Second Intervention - 4 Weeks|Adverse Event|0|||
27824101|NCT03805750|54288427|FG001|Second Intervention - 4 Weeks|Adverse Event|2|||
27824102|NCT03804268|54288435|FG000|Overall Study|Adverse Event|2|||
27824103|NCT03804268|54288436|FG001|Overall Study|Adverse Event|2|||
27824104|NCT03804268|54288435|FG000|Overall Study|Withdrawal by Subject|2|||
27824105|NCT03804268|54288436|FG001|Overall Study|Withdrawal by Subject|0|||
27824106|NCT03804268|54288435|FG000|Overall Study|Lost to Follow-up|1|||
27824107|NCT03804268|54288436|FG001|Overall Study|Lost to Follow-up|0|||
27824108|NCT03804268|54288435|FG000|Overall Study|Physician Decision|2|||
27824109|NCT03804268|54288436|FG001|Overall Study|Physician Decision|0|||
27824110|NCT00243022|54288461|FG000|Overall Study|Withdrawal by Subject|1|||
27824111|NCT00243022|54288462|FG001|Overall Study|Withdrawal by Subject|0|||
27824112|NCT00243022|54288461|FG000|Overall Study|Death|1|||
27824113|NCT00243022|54288462|FG001|Overall Study|Death|0|||
27824114|NCT00243022|54288461|FG000|Overall Study|Difficult Travel Distance|0|||
27824115|NCT00243022|54288462|FG001|Overall Study|Difficult Travel Distance|1|||
27824116|NCT01736683|54288547|FG000|Overall Study|Disease Relapse|0|||
27824117|NCT01736683|54288548|FG001|Overall Study|Disease Relapse|0|||
27824118|NCT01736683|54288549|FG002|Overall Study|Disease Relapse|2|||
27824119|NCT01736683|54288550|FG003|Overall Study|Disease Relapse|1|||
27824120|NCT01736683|54288551|FG004|Overall Study|Disease Relapse|0|||
27824121|NCT01736683|54288547|FG000|Overall Study|Adverse Event|0|||
27824122|NCT01736683|54288548|FG001|Overall Study|Adverse Event|2|||
27824123|NCT01736683|54288549|FG002|Overall Study|Adverse Event|2|||
27824124|NCT01736683|54288550|FG003|Overall Study|Adverse Event|3|||
27824125|NCT01736683|54288551|FG004|Overall Study|Adverse Event|2|||
27824126|NCT01736683|54288547|FG000|Overall Study|Withdrawal by Subject|0|||
27824127|NCT01736683|54288548|FG001|Overall Study|Withdrawal by Subject|0|||
27824128|NCT01736683|54288549|FG002|Overall Study|Withdrawal by Subject|3|||
27824129|NCT01736683|54288550|FG003|Overall Study|Withdrawal by Subject|1|||
27824130|NCT01736683|54288551|FG004|Overall Study|Withdrawal by Subject|1|||
27824131|NCT01736683|54288547|FG000|Overall Study|Lack of Therapeutic Effect|7|||
27824132|NCT01736683|54288548|FG001|Overall Study|Lack of Therapeutic Effect|4|||
27824133|NCT01736683|54288549|FG002|Overall Study|Lack of Therapeutic Effect|13|||
27824134|NCT01736683|54288550|FG003|Overall Study|Lack of Therapeutic Effect|20|||
27824135|NCT01736683|54288551|FG004|Overall Study|Lack of Therapeutic Effect|1|||
27824136|NCT01736683|54288547|FG000|Overall Study|Progressive Disease|0|||
27824137|NCT01736683|54288548|FG001|Overall Study|Progressive Disease|0|||
27824138|NCT01736683|54288549|FG002|Overall Study|Progressive Disease|0|||
27824139|NCT01736683|54288550|FG003|Overall Study|Progressive Disease|1|||
27824140|NCT01736683|54288551|FG004|Overall Study|Progressive Disease|0|||
27824141|NCT01736683|54288547|FG000|Overall Study|Other|0|||
27824142|NCT01736683|54288548|FG001|Overall Study|Other|0|||
27824143|NCT01736683|54288549|FG002|Overall Study|Other|1|||
27824144|NCT01736683|54288550|FG003|Overall Study|Other|9|||
27824145|NCT01736683|54288551|FG004|Overall Study|Other|1|||
27824146|NCT01788943|54288567|FG000|Overall Study|Withdrawal by Subject|1|||
27824147|NCT01788943|54288568|FG001|Overall Study|Withdrawal by Subject|0|||
27824148|NCT01788163|54288595|FG000|Overall Study|Other|53|||
27824149|NCT01788163|54288596|FG001|Overall Study|Other|0|||
27824150|NCT01788163|54288597|FG002|Overall Study|Other|0|||
27824151|NCT01788163|54288598|FG003|Overall Study|Other|0|||
27824152|NCT01788163|54288599|FG004|Overall Study|Other|0|||
27824153|NCT01788163|54288600|FG005|Overall Study|Other|7|||
27824154|NCT01788163|54288601|FG006|Overall Study|Other|1|||
27824155|NCT01788163|54288602|FG007|Overall Study|Other|48|||
27824156|NCT01788163|54288603|FG008|Overall Study|Other|15|||
27824157|NCT01788163|54288595|FG000|Overall Study|Withdrawal by Subject|2|||
27824158|NCT01788163|54288596|FG001|Overall Study|Withdrawal by Subject|0|||
27824159|NCT01788163|54288597|FG002|Overall Study|Withdrawal by Subject|0|||
27824160|NCT01788163|54288598|FG003|Overall Study|Withdrawal by Subject|0|||
27824161|NCT01788163|54288599|FG004|Overall Study|Withdrawal by Subject|0|||
27824162|NCT01788163|54288600|FG005|Overall Study|Withdrawal by Subject|0|||
27824163|NCT01788163|54288601|FG006|Overall Study|Withdrawal by Subject|0|||
27941910|NCT01208207|54598600|FG005|Part I|Lack of Efficacy|0|||
28152364|NCT02755818|54821473|FG001|Overall Study|Withdrawal by Subject|0|||
28152365|NCT02755818|54821474|FG002|Overall Study|Withdrawal by Subject|0|||
28152366|NCT02755818|54821475|FG003|Overall Study|Withdrawal by Subject|2|||
28152367|NCT02755818|54821472|FG000|Overall Study|withdrawal by PI|0|||
28152368|NCT02755818|54821473|FG001|Overall Study|withdrawal by PI|0|||
28152369|NCT02755818|54821474|FG002|Overall Study|withdrawal by PI|1|||
27824164|NCT01788163|54288602|FG007|Overall Study|Withdrawal by Subject|0|||
27824165|NCT01788163|54288603|FG008|Overall Study|Withdrawal by Subject|1|||
27824166|NCT01787461|54288739|FG000|Overall Study|Adverse Event|4|||
27824167|NCT01787461|54288740|FG001|Overall Study|Adverse Event|3|||
27824168|NCT01787461|54288739|FG000|Overall Study|Lost to Follow-up|3|||
27824169|NCT01787461|54288740|FG001|Overall Study|Lost to Follow-up|2|||
27824170|NCT01787461|54288739|FG000|Overall Study|No longer met eligibility criteria|1|||
27824171|NCT01787461|54288740|FG001|Overall Study|No longer met eligibility criteria|0|||
27824172|NCT01787461|54288739|FG000|Overall Study|Withdrawal by Subject|3|||
27824173|NCT01787461|54288740|FG001|Overall Study|Withdrawal by Subject|4|||
27824174|NCT01787461|54288739|FG000|Overall Study|Protocol Violation|3|||
27824175|NCT01787461|54288740|FG001|Overall Study|Protocol Violation|0|||
27824176|NCT01786993|54288765|FG000|Overall Study|Death|6|||
27824177|NCT01786993|54288766|FG001|Overall Study|Death|7|||
27824178|NCT01786993|54288765|FG000|Overall Study|Withdrawal by Subject|3|||
27824179|NCT01786993|54288766|FG001|Overall Study|Withdrawal by Subject|2|||
27824180|NCT01786993|54288765|FG000|Overall Study|Lost to Follow-up|0|||
27824181|NCT01786993|54288766|FG001|Overall Study|Lost to Follow-up|1|||
27824182|NCT01786993|54288765|FG000|Overall Study|Subject Non-Compliance|1|||
27824183|NCT01786993|54288766|FG001|Overall Study|Subject Non-Compliance|0|||
27824184|NCT01786993|54288765|FG000|Overall Study|System Explant|1|||
27824185|NCT01786993|54288766|FG001|Overall Study|System Explant|0|||
27824186|NCT01786993|54288765|FG000|Overall Study|Hospice Admission|1|||
27824187|NCT01786993|54288766|FG001|Overall Study|Hospice Admission|0|||
27824188|NCT01966445|54288791|FG000|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
27824189|NCT01966445|54288792|FG001|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
27824190|NCT01966445|54288793|FG002|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
27824191|NCT01966445|54288794|FG003|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2|||
27824192|NCT01966445|54288795|FG004|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
27824193|NCT01966445|54288796|FG005|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1|||
27824194|NCT01966445|54288797|FG006|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
27824195|NCT01966445|54288791|FG000|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
27824196|NCT01966445|54288792|FG001|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
27824197|NCT01966445|54288793|FG002|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
27824198|NCT01966445|54288794|FG003|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
27824199|NCT01966445|54288795|FG004|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
27824200|NCT01966445|54288796|FG005|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
27941911|NCT01208207|54598601|FG006|Part I|Lack of Efficacy|0|||
28073828|NCT00145574|54728508|FG000|Open Label Long-term Extension|Lost to Follow-up|0|||
28152370|NCT02755818|54821475|FG003|Overall Study|withdrawal by PI|1|||
28152371|NCT03033745|54821490|FG000|Overall Study|Protocol Violation|0|||
28152372|NCT03033745|54821491|FG001|Overall Study|Protocol Violation|0|||
28152373|NCT03033745|54821492|FG002|Overall Study|Protocol Violation|1|||
28152374|NCT03033745|54821490|FG000|Overall Study|Adverse Event|1|||
28152375|NCT03033745|54821491|FG001|Overall Study|Adverse Event|0|||
28152376|NCT03033745|54821492|FG002|Overall Study|Adverse Event|1|||
28152377|NCT03033745|54821490|FG000|Overall Study|Withdrawal by Subject|0|||
28152378|NCT03033745|54821491|FG001|Overall Study|Withdrawal by Subject|1|||
28152379|NCT03033745|54821492|FG002|Overall Study|Withdrawal by Subject|0|||
28152380|NCT01672294|54821511|FG000|Overall Study|Withdrawal by Subject|4|||
28152381|NCT01672294|54821512|FG001|Overall Study|Withdrawal by Subject|4|||
28152382|NCT01672294|54821513|FG002|Overall Study|Withdrawal by Subject|4|||
28152383|NCT01672294|54821514|FG003|Overall Study|Withdrawal by Subject|4|||
28152384|NCT01672294|54821511|FG000|Overall Study|Excluded by study|1|||
28152385|NCT01672294|54821512|FG001|Overall Study|Excluded by study|1|||
28152386|NCT01672294|54821513|FG002|Overall Study|Excluded by study|0|||
28152387|NCT01672294|54821514|FG003|Overall Study|Excluded by study|0|||
28152388|NCT01672294|54821511|FG000|Overall Study|Lost to Follow-up|1|||
28152389|NCT01672294|54821512|FG001|Overall Study|Lost to Follow-up|16|||
28073829|NCT00145574|54728509|FG001|Open Label Long-term Extension|Lost to Follow-up|0|||
28073830|NCT00145574|54728510|FG002|Open Label Long-term Extension|Lost to Follow-up|1|||
28073831|NCT00145574|54728508|FG000|Open Label Long-term Extension|Withdrawal by Subject|0|||
28073832|NCT00145574|54728509|FG001|Open Label Long-term Extension|Withdrawal by Subject|0|||
28073833|NCT00145574|54728510|FG002|Open Label Long-term Extension|Withdrawal by Subject|4|||
28073834|NCT00145574|54728508|FG000|Open Label Long-term Extension|required restricted medicine|0|||
28073835|NCT00145574|54728509|FG001|Open Label Long-term Extension|required restricted medicine|0|||
28073836|NCT00145574|54728510|FG002|Open Label Long-term Extension|required restricted medicine|1|||
28073837|NCT00145496|54728525|FG000|Overall Study|Adverse Event|42|||
28073838|NCT00145496|54728526|FG001|Overall Study|Adverse Event|30|||
28073839|NCT00145496|54728525|FG000|Overall Study|Lack of Efficacy|12|||
28073840|NCT00145496|54728526|FG001|Overall Study|Lack of Efficacy|7|||
28073841|NCT00145496|54728525|FG000|Overall Study|Withdrawal by Subject|32|||
28073842|NCT00145496|54728526|FG001|Overall Study|Withdrawal by Subject|26|||
28073843|NCT00145496|54728525|FG000|Overall Study|Lost to Follow-up|12|||
28073844|NCT00145496|54728526|FG001|Overall Study|Lost to Follow-up|5|||
27824201|NCT01966445|54288797|FG006|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
27824202|NCT01966445|54288791|FG000|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
28073845|NCT00145496|54728525|FG000|Overall Study|Other|25|||
28073846|NCT00145496|54728526|FG001|Overall Study|Other|13|||
27824203|NCT01966445|54288792|FG001|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
27824204|NCT01966445|54288793|FG002|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
27824205|NCT01966445|54288794|FG003|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
27824206|NCT01966445|54288795|FG004|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2|||
27941912|NCT01208207|54598595|FG000|Part I|Lost to Follow-up|6|||
27941913|NCT01208207|54598596|FG001|Part I|Lost to Follow-up|1|||
27941914|NCT01208207|54598597|FG002|Part I|Lost to Follow-up|0|||
27941915|NCT01208207|54598598|FG003|Part I|Lost to Follow-up|0|||
27824207|NCT01966445|54288796|FG005|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
27824208|NCT01966445|54288797|FG006|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
27824209|NCT01966445|54288791|FG000|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
27824210|NCT01966445|54288792|FG001|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
27824211|NCT01966445|54288793|FG002|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
27824212|NCT01966445|54288794|FG003|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
27824213|NCT01966445|54288795|FG004|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
27824214|NCT01966445|54288796|FG005|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
27824215|NCT01966445|54288797|FG006|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3|||
27824216|NCT01966445|54288791|FG000|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
27824217|NCT01966445|54288792|FG001|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
27824218|NCT01966445|54288793|FG002|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
27824219|NCT01966445|54288794|FG003|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
27824220|NCT01966445|54288795|FG004|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
27824221|NCT01966445|54288796|FG005|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
27824222|NCT01966445|54288797|FG006|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2|||
27824223|NCT01763905|54288817|FG000|Overall Study|Withdrawal by Subject|1|||
27824224|NCT01763905|54288818|FG001|Overall Study|Withdrawal by Subject|1|||
27824225|NCT01763905|54288819|FG002|Overall Study|Withdrawal by Subject|0|||
27824226|NCT01763905|54288820|FG003|Overall Study|Withdrawal by Subject|1|||
27824227|NCT01763905|54288817|FG000|Overall Study|Decision by sponsor|5|||
27824228|NCT01763905|54288818|FG001|Overall Study|Decision by sponsor|0|||
27824229|NCT01763905|54288819|FG002|Overall Study|Decision by sponsor|8|||
27824230|NCT01763905|54288820|FG003|Overall Study|Decision by sponsor|0|||
27824231|NCT01763905|54288817|FG000|Overall Study|Lost to Follow-up|0|||
27824232|NCT01763905|54288818|FG001|Overall Study|Lost to Follow-up|0|||
27824233|NCT01763905|54288819|FG002|Overall Study|Lost to Follow-up|1|||
27824234|NCT01763905|54288820|FG003|Overall Study|Lost to Follow-up|0|||
27824235|NCT02091167|54288832|FG000|Overall Study|Lost to Follow-up|0|||
27824236|NCT02091167|54288833|FG001|Overall Study|Lost to Follow-up|2|||
27824237|NCT02091089|54288839|FG000|Overall Study|Lost to Follow-up|2|||
27824238|NCT01763203|54288854|FG000|Overall Study|Death|4|||
27824239|NCT01763203|54288855|FG001|Overall Study|Death|7|||
27824240|NCT01763203|54288854|FG000|Overall Study|Lost to Follow-up|12|||
27824241|NCT01763203|54288855|FG001|Overall Study|Lost to Follow-up|12|||
27824242|NCT01763203|54288854|FG000|Overall Study|Withdrawal by Subject|8|||
27824243|NCT01763203|54288855|FG001|Overall Study|Withdrawal by Subject|12|||
27824244|NCT01763203|54288854|FG000|Overall Study|Moved out of study region|7|||
27824245|NCT01763203|54288855|FG001|Overall Study|Moved out of study region|10|||
27824246|NCT01763203|54288854|FG000|Overall Study|Physician Decision|2|||
27824247|NCT01763203|54288855|FG001|Overall Study|Physician Decision|1|||
27824248|NCT01763047|54288872|FG000|Period 1|Test Article Not Available|4|||
27850288|NCT04178967|54349316|FG001|Induction Period|Lost to Follow-up|0|||
28152390|NCT01672294|54821513|FG002|Overall Study|Lost to Follow-up|7|||
28152391|NCT01672294|54821514|FG003|Overall Study|Lost to Follow-up|9|||
28152392|NCT02755116|54821526|FG000|Overall Study|surgery converted to open, pt admitted|3|||
28152393|NCT02755116|54821527|FG001|Overall Study|surgery converted to open, pt admitted|1|||
28152394|NCT02754492|54821537|FG000|Overall Study|Protocol Violation|2|||
28152395|NCT02754492|54821538|FG001|Overall Study|Protocol Violation|2|||
28152396|NCT02754492|54821539|FG002|Overall Study|Protocol Violation|0|||
28152397|NCT02754492|54821540|FG003|Overall Study|Protocol Violation|1|||
28152398|NCT02754492|54821537|FG000|Overall Study|Withdrawal by Subject|2|||
28152399|NCT02754492|54821538|FG001|Overall Study|Withdrawal by Subject|0|||
27824249|NCT01763047|54288873|FG001|Period 1|Test Article Not Available|1|||
27824250|NCT01763047|54288872|FG000|Period 1|Protocol Violation|4|||
27941916|NCT01208207|54598599|FG004|Part I|Lost to Follow-up|0|||
27941917|NCT01208207|54598600|FG005|Part I|Lost to Follow-up|0|||
27941918|NCT01208207|54598601|FG006|Part I|Lost to Follow-up|0|||
28152400|NCT02754492|54821539|FG002|Overall Study|Withdrawal by Subject|0|||
27824251|NCT01763047|54288873|FG001|Period 1|Protocol Violation|4|||
27824252|NCT01763047|54288872|FG000|Period 1|No Longer Meets Eligibility criteria|1|||
27824253|NCT01763047|54288873|FG001|Period 1|No Longer Meets Eligibility criteria|0|||
27824254|NCT01763047|54288872|FG000|Period 1|Adverse Event|0|||
27824255|NCT01763047|54288873|FG001|Period 1|Adverse Event|1|||
27824256|NCT01763047|54288872|FG000|Period 1|Unsatisfactory Visual Response|0|||
27824257|NCT01763047|54288873|FG001|Period 1|Unsatisfactory Visual Response|3|||
27824258|NCT01763047|54288872|FG000|Period 1|Lens Power Not Available|0|||
27824259|NCT01763047|54288873|FG001|Period 1|Lens Power Not Available|1|||
27824260|NCT01763047|54288872|FG000|Period 1|Study Site office Closed|0|||
27824261|NCT01763047|54288873|FG001|Period 1|Study Site office Closed|1|||
27824262|NCT01763047|54288872|FG000|Period 2|Lens Discomfort|1|||
27824263|NCT01763047|54288873|FG001|Period 2|Lens Discomfort|0|||
28073847|NCT00255164|54728535|FG000|Overall Study|Adverse Event|10|||
28073848|NCT00255164|54728536|FG001|Overall Study|Adverse Event|6|||
28073849|NCT00255164|54728537|FG002|Overall Study|Adverse Event|9|||
28073850|NCT00255164|54728535|FG000|Overall Study|Lost to Follow-up|4|||
28073851|NCT00255164|54728536|FG001|Overall Study|Lost to Follow-up|3|||
28073852|NCT00255164|54728537|FG002|Overall Study|Lost to Follow-up|4|||
28073853|NCT00255164|54728535|FG000|Overall Study|Withdrawal by Subject|18|||
28073854|NCT00255164|54728536|FG001|Overall Study|Withdrawal by Subject|17|||
28073855|NCT00255164|54728537|FG002|Overall Study|Withdrawal by Subject|8|||
28152401|NCT02754492|54821540|FG003|Overall Study|Withdrawal by Subject|0|||
28152402|NCT02754492|54821537|FG000|Overall Study|Equipment malfuntion|0|||
28152403|NCT02754492|54821538|FG001|Overall Study|Equipment malfuntion|0|||
28152404|NCT02754492|54821539|FG002|Overall Study|Equipment malfuntion|2|||
28152405|NCT02754492|54821540|FG003|Overall Study|Equipment malfuntion|5|||
28152406|NCT02754492|54821537|FG000|Overall Study|Adverse Event|0|||
28152407|NCT02754492|54821538|FG001|Overall Study|Adverse Event|0|||
28152408|NCT02754492|54821539|FG002|Overall Study|Adverse Event|0|||
28152409|NCT02754492|54821540|FG003|Overall Study|Adverse Event|13|||
27824264|NCT01763047|54288872|FG000|Period 2|No longer meets Eligibility Criteria|1|||
28073856|NCT00255164|54728535|FG000|Overall Study|Noncompliance|0|||
28073857|NCT00255164|54728536|FG001|Overall Study|Noncompliance|1|||
28073858|NCT00255164|54728537|FG002|Overall Study|Noncompliance|2|||
27824265|NCT01763047|54288873|FG001|Period 2|No longer meets Eligibility Criteria|0|||
27824266|NCT01763047|54288872|FG000|Period 2|Study Site office Closed|1|||
27824267|NCT01763047|54288873|FG001|Period 2|Study Site office Closed|1|||
28152410|NCT02754492|54821537|FG000|Overall Study|Venous access issues not resulting in AE|0|||
28152411|NCT02754492|54821538|FG001|Overall Study|Venous access issues not resulting in AE|0|||
28152412|NCT02754492|54821539|FG002|Overall Study|Venous access issues not resulting in AE|0|||
28152413|NCT02754492|54821540|FG003|Overall Study|Venous access issues not resulting in AE|4|||
28152414|NCT04068688|54821559|FG000|Overall Study|Lost to Follow-up|1|||
27824268|NCT01763047|54288872|FG000|Period 2|Unsatisfactory Visual Response|1|||
27824269|NCT01763047|54288873|FG001|Period 2|Unsatisfactory Visual Response|1|||
28073859|NCT00255164|54728535|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
28073860|NCT00255164|54728536|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
28073861|NCT00255164|54728537|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
28073862|NCT00255164|54728535|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
28073863|NCT00255164|54728536|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
28073864|NCT00255164|54728537|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
28073865|NCT00255164|54728535|FG000|Overall Study|Possible Barrett's Esophagus|1|||
28073866|NCT00255164|54728536|FG001|Overall Study|Possible Barrett's Esophagus|3|||
28073867|NCT00255164|54728537|FG002|Overall Study|Possible Barrett's Esophagus|8|||
28073868|NCT00255164|54728535|FG000|Overall Study|Esophageal Stricture|0|||
28073869|NCT00255164|54728536|FG001|Overall Study|Esophageal Stricture|0|||
28073870|NCT00255164|54728537|FG002|Overall Study|Esophageal Stricture|1|||
28073871|NCT00255164|54728535|FG000|Overall Study|Therapeutic Failure|11|||
28073872|NCT00255164|54728536|FG001|Overall Study|Therapeutic Failure|2|||
28073873|NCT00255164|54728537|FG002|Overall Study|Therapeutic Failure|3|||
28073874|NCT00126594|54728547|FG000|Overall Study|Ineligible|2|||
28073875|NCT00126594|54728548|FG001|Overall Study|Ineligible|0|||
28073876|NCT00126594|54728547|FG000|Overall Study|Withdrawal by Subject|0|||
28073877|NCT00126594|54728548|FG001|Overall Study|Withdrawal by Subject|4|||
28073878|NCT00126594|54728547|FG000|Overall Study|Physician Decision|1|||
28073879|NCT00126594|54728548|FG001|Overall Study|Physician Decision|3|||
28073880|NCT00126594|54728547|FG000|Overall Study|Adverse Event|7|||
28073881|NCT00126594|54728548|FG001|Overall Study|Adverse Event|5|||
28152415|NCT04068688|54821560|FG001|Overall Study|Lost to Follow-up|1|||
28152416|NCT04068688|54821561|FG002|Overall Study|Lost to Follow-up|0|||
28152417|NCT04068688|54821562|FG003|Overall Study|Lost to Follow-up|0|||
27824270|NCT01763047|54288872|FG000|Period 2|Protocol Violation|0|||
27941919|NCT01208207|54598595|FG000|Part I|Non-Compliance With Study Drug|1|||
28073882|NCT00126594|54728547|FG000|Overall Study|Non-compliance|0|||
28073883|NCT00126594|54728548|FG001|Overall Study|Non-compliance|1|||
27824271|NCT01763047|54288873|FG001|Period 2|Protocol Violation|2|||
27824272|NCT01763047|54288872|FG000|Period 2|Unsatisfactory lens Fitting|0|||
27824273|NCT01763047|54288873|FG001|Period 2|Unsatisfactory lens Fitting|1|||
27824274|NCT01977677|54288885|FG000|Overall Study|Unrelated Adverse Event|0|||
27824275|NCT01977677|54288886|FG001|Overall Study|Unrelated Adverse Event|0|||
27824276|NCT01977677|54288887|FG002|Overall Study|Unrelated Adverse Event|1|||
27824277|NCT01762345|54288895|FG000|Overall Study|Adverse Event|5|||
27824278|NCT01762345|54288895|FG000|Overall Study|Protocol Violation|2|||
27824279|NCT02090855|54288900|FG000|Overall Study|no evaluable Standard of Truth results|2|||
27824280|NCT01761565|54288907|FG000|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1|||
27824281|NCT01619579|54288917|FG000|Overall Study|Withdrawal by Subject|0|||
27824282|NCT01619579|54288918|FG001|Overall Study|Withdrawal by Subject|3|||
27824283|NCT01736215|54288924|FG000|Overall Study|Early termination of erythropoietin use|1|||
27824284|NCT01736215|54288924|FG000|Overall Study|Adverse Event|4|||
27824285|NCT01736215|54288924|FG000|Overall Study|Progressive disease stop chemotherapy|1|||
27824286|NCT01736215|54288924|FG000|Overall Study|Insufficient data to perform analysis|8|||
27824287|NCT01786603|54288930|FG000|Overall Study|Death|5|||
27824288|NCT01786603|54288931|FG001|Overall Study|Death|1|||
27824289|NCT01786603|54288930|FG000|Overall Study|Adverse Event|6|||
27824290|NCT01786603|54288931|FG001|Overall Study|Adverse Event|2|||
27824291|NCT01786603|54288930|FG000|Overall Study|Physician decision to withdraw|6|||
27824292|NCT01786603|54288931|FG001|Overall Study|Physician decision to withdraw|7|||
27824293|NCT01786603|54288930|FG000|Overall Study|Lost to Follow-up|1|||
27824294|NCT01786603|54288931|FG001|Overall Study|Lost to Follow-up|2|||
27824295|NCT01619423|54288954|FG000|Part 1 (Dose Escalation)|High basal Mn|0|||
27824296|NCT01619423|54288955|FG001|Part 1 (Dose Escalation)|High basal Mn|2|||
27824297|NCT01619423|54288956|FG002|Part 1 (Dose Escalation)|High basal Mn|0|||
27824298|NCT01619423|54288957|FG003|Part 1 (Dose Escalation)|High basal Mn|0|||
27824299|NCT01735279|54288970|FG000|Overall Study|Lost to Follow-up|11|||
27824300|NCT01735279|54288971|FG001|Overall Study|Lost to Follow-up|8|||
27824301|NCT01759381|54288979|FG000|Overall Study|Death|1|||
27824302|NCT01759381|54288980|FG001|Overall Study|Death|0|||
27824303|NCT01758523|54288999|FG000|Overall Study|Adverse Event|2|||
27824304|NCT01758523|54289000|FG001|Overall Study|Adverse Event|1|||
27824305|NCT01758523|54288999|FG000|Overall Study|Lack of Efficacy|4|||
27824306|NCT01758523|54289000|FG001|Overall Study|Lack of Efficacy|2|||
27824307|NCT01758523|54288999|FG000|Overall Study|Lost to Follow-up|3|||
27824308|NCT01758523|54289000|FG001|Overall Study|Lost to Follow-up|4|||
28152418|NCT04068688|54821563|FG004|Overall Study|Lost to Follow-up|5|||
28152419|NCT04068688|54821564|FG005|Overall Study|Lost to Follow-up|5|||
28152420|NCT04068688|54821565|FG006|Overall Study|Lost to Follow-up|0|||
28152421|NCT04068688|54821566|FG007|Overall Study|Lost to Follow-up|0|||
28152422|NCT04068688|54821567|FG008|Overall Study|Lost to Follow-up|1|||
28152423|NCT04068688|54821568|FG009|Overall Study|Lost to Follow-up|0|||
28152424|NCT04068688|54821559|FG000|Overall Study|Withdrawal by Subject|1|||
28152425|NCT04068688|54821560|FG001|Overall Study|Withdrawal by Subject|1|||
27824309|NCT01758523|54288999|FG000|Overall Study|Withdrawal by Subject|12|||
27824310|NCT01758523|54289000|FG001|Overall Study|Withdrawal by Subject|7|||
27824311|NCT01758289|54289023|FG000|Overall Study|Premature Study Termination|44|||
28152426|NCT04068688|54821561|FG002|Overall Study|Withdrawal by Subject|0|||
27824312|NCT01758289|54289023|FG000|Overall Study|Adverse Event|9|||
27824313|NCT01757821|54289047|FG000|Overall Study|Adverse Event|1|||
27824314|NCT01735201|54289076|FG000|Overall Study|Adverse Event|1|||
27824315|NCT01735201|54289077|FG001|Overall Study|Adverse Event|1|||
27824316|NCT01735201|54289078|FG002|Overall Study|Adverse Event|0|||
27824317|NCT01735201|54289079|FG003|Overall Study|Adverse Event|1|||
27824318|NCT01735201|54289080|FG004|Overall Study|Adverse Event|1|||
27824319|NCT01735201|54289081|FG005|Overall Study|Adverse Event|3|||
27824320|NCT01735201|54289082|FG006|Overall Study|Adverse Event|2|||
27824321|NCT01735201|54289083|FG007|Overall Study|Adverse Event|1|||
27824322|NCT01735201|54289076|FG000|Overall Study|Personal Reasons|1|||
27824323|NCT01735201|54289077|FG001|Overall Study|Personal Reasons|0|||
27824324|NCT01735201|54289078|FG002|Overall Study|Personal Reasons|0|||
27824325|NCT01735201|54289079|FG003|Overall Study|Personal Reasons|0|||
27824326|NCT01735201|54289080|FG004|Overall Study|Personal Reasons|0|||
27824327|NCT01735201|54289081|FG005|Overall Study|Personal Reasons|0|||
27824328|NCT01735201|54289082|FG006|Overall Study|Personal Reasons|0|||
27824329|NCT01735201|54289083|FG007|Overall Study|Personal Reasons|0|||
27824330|NCT01735201|54289076|FG000|Overall Study|Protocol Violation|1|||
27824331|NCT01735201|54289077|FG001|Overall Study|Protocol Violation|0|||
27824332|NCT01735201|54289078|FG002|Overall Study|Protocol Violation|0|||
27824333|NCT01735201|54289079|FG003|Overall Study|Protocol Violation|0|||
27824334|NCT01735201|54289080|FG004|Overall Study|Protocol Violation|0|||
28073884|NCT00126594|54728547|FG000|Overall Study|Disease Progression|29|||
28073885|NCT00126594|54728548|FG001|Overall Study|Disease Progression|24|||
28073886|NCT00126438|54728557|FG000|Overall Study|Withdrawal due to adverse event|1|||
28152427|NCT04068688|54821562|FG003|Overall Study|Withdrawal by Subject|0|||
28152428|NCT04068688|54821563|FG004|Overall Study|Withdrawal by Subject|0|||
28152429|NCT04068688|54821564|FG005|Overall Study|Withdrawal by Subject|0|||
28152430|NCT04068688|54821565|FG006|Overall Study|Withdrawal by Subject|0|||
28152431|NCT04068688|54821566|FG007|Overall Study|Withdrawal by Subject|0|||
28152432|NCT04068688|54821567|FG008|Overall Study|Withdrawal by Subject|0|||
28152433|NCT04068688|54821568|FG009|Overall Study|Withdrawal by Subject|0|||
28152434|NCT04068688|54821559|FG000|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
28152435|NCT04068688|54821560|FG001|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
28152436|NCT04068688|54821561|FG002|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
28152437|NCT04068688|54821562|FG003|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
28152438|NCT04068688|54821563|FG004|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
28152439|NCT04068688|54821564|FG005|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
28152440|NCT04068688|54821565|FG006|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
28152441|NCT04068688|54821566|FG007|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
28160113|NCT03064451|54830220|FG000|Overall Study|Withdrew consent: 3-month FU visit|1|||
27850289|NCT04178967|54349317|FG002|Induction Period|Lost to Follow-up|0|||
28073887|NCT00126438|54728558|FG001|Overall Study|Withdrawal due to adverse event|0|||
28073888|NCT00126438|54728557|FG000|Overall Study|Lost to Follow-up|22|||
28073889|NCT00126438|54728558|FG001|Overall Study|Lost to Follow-up|0|||
28073890|NCT00126438|54728557|FG000|Overall Study|Protocol Violation|8|||
28073891|NCT00126438|54728558|FG001|Overall Study|Protocol Violation|8|||
28073892|NCT00126438|54728557|FG000|Overall Study|Withdrawal by Subject|3|||
28073893|NCT00126438|54728558|FG001|Overall Study|Withdrawal by Subject|2|||
28073894|NCT00142584|54728566|FG000|Overall Study|Sponsor Termination of Study, etc.|72|||
28073895|NCT00142584|54728567|FG001|Overall Study|Sponsor Termination of Study, etc.|16|||
28073896|NCT00142584|54728566|FG000|Overall Study|Withdrawal by Subject|30|||
28073897|NCT00142584|54728567|FG001|Overall Study|Withdrawal by Subject|16|||
28073898|NCT00142584|54728566|FG000|Overall Study|Lost to Follow-up|22|||
28073899|NCT00142584|54728567|FG001|Overall Study|Lost to Follow-up|12|||
28073900|NCT00142584|54728566|FG000|Overall Study|Adverse Event|14|||
28073901|NCT00142584|54728567|FG001|Overall Study|Adverse Event|5|||
28073902|NCT00142584|54728566|FG000|Overall Study|Protocol Violation|4|||
28073903|NCT00142584|54728567|FG001|Overall Study|Protocol Violation|7|||
28073904|NCT00142584|54728566|FG000|Overall Study|Treatment Failure|2|||
28073905|NCT00142584|54728567|FG001|Overall Study|Treatment Failure|0|||
28073906|NCT00126126|54728577|FG000|Overall Study|Lost to Follow-up|0|||
28073907|NCT00126126|54728578|FG001|Overall Study|Lost to Follow-up|2|||
28073908|NCT00125268|54728586|FG000|Overall Study|Withdrawal by Subject|1|||
28073909|NCT00125268|54728587|FG001|Overall Study|Withdrawal by Subject|1|||
28073910|NCT00125190|54728593|FG000|Overall Study|Subject/Parent Decision|7|||
27850290|NCT04178967|54349318|FG003|Induction Period|Lost to Follow-up|0|||
28073911|NCT00125190|54728593|FG000|Overall Study|Non-compliance|2|||
28073912|NCT00125190|54728593|FG000|Overall Study|Adverse Event|1|||
28073913|NCT00125190|54728593|FG000|Overall Study|Other|1|||
28073914|NCT00125190|54728593|FG000|Overall Study|Lost to Follow-up|4|||
28073915|NCT00141726|54728598|FG000|Overall Study|Completed <50% Scheduled Dosing|3|||
28073916|NCT00111228|54728605|FG000|Overall Study|Withdrawal by Subject|5|||
27824335|NCT01735201|54289081|FG005|Overall Study|Protocol Violation|0|||
28073917|NCT00111228|54728606|FG001|Overall Study|Withdrawal by Subject|1|||
28073918|NCT00111228|54728607|FG002|Overall Study|Withdrawal by Subject|0|||
27824336|NCT01735201|54289082|FG006|Overall Study|Protocol Violation|0|||
27824337|NCT01735201|54289083|FG007|Overall Study|Protocol Violation|0|||
27824338|NCT01735201|54289076|FG000|Overall Study|Other Miscellaneous Reasons|0|||
27824339|NCT01735201|54289077|FG001|Overall Study|Other Miscellaneous Reasons|0|||
27824340|NCT01735201|54289078|FG002|Overall Study|Other Miscellaneous Reasons|0|||
27824341|NCT01735201|54289079|FG003|Overall Study|Other Miscellaneous Reasons|1|||
27824342|NCT01735201|54289080|FG004|Overall Study|Other Miscellaneous Reasons|0|||
27824343|NCT01735201|54289081|FG005|Overall Study|Other Miscellaneous Reasons|2|||
27824344|NCT01735201|54289082|FG006|Overall Study|Other Miscellaneous Reasons|1|||
27824345|NCT01735201|54289083|FG007|Overall Study|Other Miscellaneous Reasons|1|||
27824346|NCT01734811|54289103|FG000|Overall Study|Lost to Follow-up|2|||
27824347|NCT01734811|54289104|FG001|Overall Study|Lost to Follow-up|3|||
27824348|NCT01734811|54289103|FG000|Overall Study|Withdrawal by Subject|2|||
27824349|NCT01734811|54289104|FG001|Overall Study|Withdrawal by Subject|0|||
27824350|NCT01757275|54289112|FG000|Overall Study|Lost to Follow-up|1|||
27824351|NCT01757275|54289113|FG001|Overall Study|Lost to Follow-up|2|||
27824352|NCT01757275|54289112|FG000|Overall Study|Adverse Event|3|||
27824353|NCT01757275|54289113|FG001|Overall Study|Adverse Event|3|||
28152442|NCT04068688|54821567|FG008|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
28152443|NCT04068688|54821568|FG009|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
28152444|NCT01671748|54821596|FG000|4 Week run-in Phase|Withdrawal by Subject|1|||
28152445|NCT01671748|54821597|FG001|4 Week run-in Phase|Withdrawal by Subject|0|||
27824354|NCT01757275|54289112|FG000|Overall Study|Withdrawal by Subject|2|||
27824355|NCT01757275|54289113|FG001|Overall Study|Withdrawal by Subject|4|||
27824356|NCT01757275|54289112|FG000|Overall Study|Not treated|3|||
27824357|NCT01757275|54289113|FG001|Overall Study|Not treated|4|||
27824358|NCT01757197|54289128|FG000|Overall Study|Death|2|||
27824359|NCT01784965|54289152|FG000|Overall Study|Withdrawal by Subject|6|||
27824360|NCT01784965|54289153|FG001|Overall Study|Withdrawal by Subject|3|||
27824361|NCT01784965|54289152|FG000|Overall Study|Adverse Event|0|||
27824362|NCT01784965|54289153|FG001|Overall Study|Adverse Event|8|||
28152446|NCT01671748|54821596|FG000|4 Week run-in Phase|Adverse Event|1|||
28152447|NCT01671748|54821597|FG001|4 Week run-in Phase|Adverse Event|0|||
27824363|NCT01784419|54289161|FG000|Overall Study|Adverse Event|3|||
27824364|NCT01784029|54289168|FG000|Overall Study|Lost to Follow-up|19|||
27824365|NCT01784029|54289169|FG001|Overall Study|Lost to Follow-up|20|||
27824366|NCT01784029|54289170|FG002|Overall Study|Lost to Follow-up|22|||
28152448|NCT01671748|54821596|FG000|4 Week run-in Phase|Not eligible|9|||
28152449|NCT01671748|54821597|FG001|4 Week run-in Phase|Not eligible|0|||
27824367|NCT01733329|54289192|FG000|Overall Study|Protocol Violation|1|||
27824368|NCT01733329|54289193|FG001|Overall Study|Protocol Violation|1|||
27824369|NCT01733329|54289192|FG000|Overall Study|Uterine artery injury|1|||
27824370|NCT01733329|54289193|FG001|Overall Study|Uterine artery injury|0|||
27824371|NCT01783483|54289201|FG000|Overall Study|Death|3|||
28152450|NCT02657889|54821607|FG000|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
28152451|NCT02657889|54821608|FG001|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
28152452|NCT02657889|54821609|FG002|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
28152453|NCT02657889|54821610|FG003|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
28152454|NCT02657889|54821607|FG000|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|2|||
28152455|NCT02657889|54821608|FG001|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
28152456|NCT02657889|54821609|FG002|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
28152457|NCT02657889|54821610|FG003|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
28152458|NCT02657889|54821607|FG000|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
28152459|NCT02657889|54821608|FG001|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|1|||
28152460|NCT02657889|54821609|FG002|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
28152461|NCT02657889|54821610|FG003|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
28152462|NCT02657889|54821607|FG000|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
28152463|NCT02657889|54821608|FG001|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|1|||
28152464|NCT02657889|54821609|FG002|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
27824372|NCT01783483|54289202|FG001|Overall Study|Death|3|||
27824373|NCT01783483|54289201|FG000|Overall Study|Lost to Follow-up|14|||
27824374|NCT01783483|54289202|FG001|Overall Study|Lost to Follow-up|10|||
27824375|NCT01783483|54289201|FG000|Overall Study|Withdrawal by Subject|2|||
27824376|NCT01783483|54289202|FG001|Overall Study|Withdrawal by Subject|1|||
27824377|NCT01783483|54289201|FG000|Overall Study|Physician Decision|1|||
27824378|NCT01783483|54289202|FG001|Overall Study|Physician Decision|1|||
27824379|NCT01607593|54289221|FG000|Overall Study|Adverse Event|15|||
27824380|NCT01607593|54289221|FG000|Overall Study|Lack of Efficacy|16|||
27824381|NCT01607593|54289221|FG000|Overall Study|Lost to Follow-up|25|||
27824382|NCT01607593|54289221|FG000|Overall Study|Continuation|33|||
27824383|NCT01607593|54289221|FG000|Overall Study|Other|4|||
27824384|NCT01755637|54289234|FG000|Period 1|Adverse Event|0|||
27824385|NCT01755637|54289235|FG001|Period 1|Adverse Event|1|||
27824386|NCT01732549|54289253|FG000|Overall Study|Adverse Event|13|||
27824387|NCT01732549|54289254|FG001|Overall Study|Adverse Event|3|||
27824388|NCT01732549|54289253|FG000|Overall Study|Consent withdrawn|13|||
27824389|NCT01732549|54289254|FG001|Overall Study|Consent withdrawn|6|||
27824390|NCT01732549|54289253|FG000|Overall Study|Disease progression|37|||
27824391|NCT01732549|54289254|FG001|Overall Study|Disease progression|50|||
27824392|NCT01732549|54289253|FG000|Overall Study|Other|8|||
27824393|NCT01732549|54289254|FG001|Overall Study|Other|14|||
27824394|NCT01755091|54289273|FG000|Overall Study|Withdrawal by Subject|6|||
27824395|NCT01755091|54289274|FG001|Overall Study|Withdrawal by Subject|1|||
27824396|NCT01755091|54289275|FG002|Overall Study|Withdrawal by Subject|3|||
27824397|NCT01755091|54289273|FG000|Overall Study|Adverse Event|1|||
27824398|NCT01755091|54289274|FG001|Overall Study|Adverse Event|1|||
27824399|NCT01755091|54289275|FG002|Overall Study|Adverse Event|1|||
27824400|NCT01755091|54289273|FG000|Overall Study|Lost to Follow-up|1|||
27824401|NCT01755091|54289274|FG001|Overall Study|Lost to Follow-up|0|||
27824402|NCT01755091|54289275|FG002|Overall Study|Lost to Follow-up|1|||
27824403|NCT01755091|54289273|FG000|Overall Study|Physician Decision|1|||
27824404|NCT01755091|54289274|FG001|Overall Study|Physician Decision|1|||
27824405|NCT01755091|54289275|FG002|Overall Study|Physician Decision|2|||
27824406|NCT01754467|54289308|FG000|Overall Study|Lost to Follow-up|1|||
27824407|NCT01753999|54289312|FG000|Period 1 - Initial Assignment|Physician Decision|2|||
27824408|NCT01753999|54289313|FG001|Period 1 - Initial Assignment|Physician Decision|3|||
27824409|NCT01753999|54289312|FG000|Period 1 - Initial Assignment|Withdrawal by Subject|19|||
27824410|NCT01753999|54289313|FG001|Period 1 - Initial Assignment|Withdrawal by Subject|20|||
27824411|NCT01753999|54289312|FG000|Period 1 - Initial Assignment|Lost to Follow-up|18|||
27824412|NCT01753999|54289313|FG001|Period 1 - Initial Assignment|Lost to Follow-up|27|||
27824413|NCT01753999|54289312|FG000|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13|||
27824414|NCT01753999|54289313|FG001|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17|||
27824415|NCT01753999|54289312|FG000|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3|||
27824416|NCT01753999|54289313|FG001|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5|||
27824417|NCT01753999|54289312|FG000|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
27824418|NCT01753999|54289313|FG001|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
27824419|NCT01783015|54289333|FG000|Blinded Treatment|Adverse Event|0|||
27824420|NCT01783015|54289334|FG001|Blinded Treatment|Adverse Event|1|||
27824421|NCT01783015|54289335|FG002|Blinded Treatment|Adverse Event|0|||
27824422|NCT01783015|54289333|FG000|Blinded Treatment|Protocol Violation|0|||
27824423|NCT01783015|54289334|FG001|Blinded Treatment|Protocol Violation|1|||
27824424|NCT01783015|54289335|FG002|Blinded Treatment|Protocol Violation|0|||
27824425|NCT01783015|54289333|FG000|Blinded Treatment|Withdrawal by Subject|0|||
27824426|NCT01783015|54289334|FG001|Blinded Treatment|Withdrawal by Subject|1|||
27824427|NCT01783015|54289335|FG002|Blinded Treatment|Withdrawal by Subject|0|||
28073919|NCT00110994|54728617|FG000|Double-blind (DB) Treatment|Adverse Event|3|||
28073920|NCT00110994|54728618|FG001|Double-blind (DB) Treatment|Adverse Event|0|||
28073921|NCT00110994|54728617|FG000|Double-blind (DB) Treatment|Death|1|||
28073922|NCT00110994|54728618|FG001|Double-blind (DB) Treatment|Death|0|||
28073923|NCT00110994|54728617|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|0|||
28073924|NCT00110994|54728618|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|2|||
28073925|NCT00110994|54728617|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
28073926|NCT00110994|54728618|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|1|||
28073927|NCT00110994|54728617|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|34|||
27824428|NCT01783015|54289333|FG000|Blinded Treatment|Study Terminated by Sponsor|2|||
27824429|NCT01783015|54289334|FG001|Blinded Treatment|Study Terminated by Sponsor|0|||
27824430|NCT01783015|54289335|FG002|Blinded Treatment|Study Terminated by Sponsor|0|||
27824431|NCT01783015|54289333|FG000|Open Label Treatment|Study Terminated by Sponsor|0|||
27824432|NCT01783015|54289334|FG001|Open Label Treatment|Study Terminated by Sponsor|0|||
27824433|NCT01783015|54289335|FG002|Open Label Treatment|Study Terminated by Sponsor|6|||
27824434|NCT01782859|54289345|FG000|Overall Study|Protocol Violation|6|||
27824435|NCT01782859|54289346|FG001|Overall Study|Protocol Violation|6|||
27824436|NCT01782859|54289345|FG000|Overall Study|Withdrawal by Subject|0|||
27824437|NCT01782859|54289346|FG001|Overall Study|Withdrawal by Subject|1|||
27824438|NCT01782469|54289353|FG000|Overall Study|Lost to Follow-up|1|||
27824439|NCT01782313|54289357|FG000|Reached First Response/Completed 2 Cycle|Adverse Event|3|||
27824440|NCT01782313|54289357|FG000|Reached First Response/Completed 2 Cycle|Progressive Disease|3|||
27824441|NCT01782313|54289357|FG000|Treated Cycle 3|Progressive Disease|21|||
27824442|NCT01782313|54289357|FG000|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5|||
27824443|NCT01782313|54289357|FG000|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1|||
27824444|NCT01782313|54289357|FG000|Continued Treatment After 16 Weeks|Progressive Disease|6|||
27824445|NCT01782313|54289357|FG000|Continued Treatment After 16 Weeks|Withdrawal by Subject|1|||
27824446|NCT01782313|54289357|FG000|Survival Follow up|Lost to Follow-up|1|||
27824447|NCT01781611|54289380|FG000|Overall Study|Adverse Event|4|||
27824448|NCT01781611|54289381|FG001|Overall Study|Adverse Event|0|||
27824449|NCT01781299|54289398|FG000|Overall Study|Withdrawal by Subject|0|||
27824450|NCT01781299|54289399|FG001|Overall Study|Withdrawal by Subject|1|||
27824451|NCT01732471|54289405|FG000|Overall Study|Withdrawal by Subject|1|||
27824452|NCT01780987|54289424|FG000|Overall Study|Adverse Event|0|||
27824453|NCT01780987|54289425|FG001|Overall Study|Adverse Event|4|||
27824454|NCT01780987|54289424|FG000|Overall Study|Withdrawal by Subject|2|||
27824455|NCT01780987|54289425|FG001|Overall Study|Withdrawal by Subject|0|||
27824456|NCT01780987|54289424|FG000|Overall Study|Request of Changing Hospital|0|||
27824457|NCT01780987|54289425|FG001|Overall Study|Request of Changing Hospital|1|||
27824458|NCT01780987|54289424|FG000|Overall Study|Changing Residence|1|||
27824459|NCT01780987|54289425|FG001|Overall Study|Changing Residence|0|||
27824460|NCT01780987|54289424|FG000|Overall Study|Not Receiving any Study Medication|0|||
27824461|NCT01780987|54289425|FG001|Overall Study|Not Receiving any Study Medication|1|||
27824462|NCT01730053|54289514|FG000|Overall Study|Participant moved|0|||
27824463|NCT01730053|54289515|FG001|Overall Study|Participant moved|0|||
27824464|NCT01730053|54289516|FG002|Overall Study|Participant moved|1|||
27824465|NCT01730053|54289517|FG003|Overall Study|Participant moved|0|||
27824466|NCT01730053|54289518|FG004|Overall Study|Participant moved|0|||
27824467|NCT01730053|54289519|FG005|Overall Study|Participant moved|0|||
27824468|NCT01730053|54289514|FG000|Overall Study|Physician Decision|0|||
27824469|NCT01730053|54289515|FG001|Overall Study|Physician Decision|0|||
27824470|NCT01730053|54289516|FG002|Overall Study|Physician Decision|0|||
27824471|NCT01730053|54289517|FG003|Overall Study|Physician Decision|1|||
27824472|NCT01730053|54289518|FG004|Overall Study|Physician Decision|0|||
27824473|NCT01730053|54289519|FG005|Overall Study|Physician Decision|0|||
27824474|NCT01730053|54289514|FG000|Overall Study|Adverse Event|2|||
27824475|NCT01730053|54289515|FG001|Overall Study|Adverse Event|6|||
27824476|NCT01730053|54289516|FG002|Overall Study|Adverse Event|3|||
27824477|NCT01730053|54289517|FG003|Overall Study|Adverse Event|3|||
27824478|NCT01730053|54289518|FG004|Overall Study|Adverse Event|2|||
27824479|NCT01730053|54289519|FG005|Overall Study|Adverse Event|2|||
27824480|NCT01730053|54289514|FG000|Overall Study|Poor compliance to protocol|1|||
27824481|NCT01730053|54289515|FG001|Overall Study|Poor compliance to protocol|2|||
27824482|NCT01730053|54289516|FG002|Overall Study|Poor compliance to protocol|2|||
27824483|NCT01730053|54289517|FG003|Overall Study|Poor compliance to protocol|0|||
27824484|NCT01730053|54289518|FG004|Overall Study|Poor compliance to protocol|0|||
27824485|NCT01730053|54289519|FG005|Overall Study|Poor compliance to protocol|2|||
27824486|NCT01730053|54289514|FG000|Overall Study|Other than specified|2|||
27824487|NCT01730053|54289515|FG001|Overall Study|Other than specified|6|||
27824488|NCT01730053|54289516|FG002|Overall Study|Other than specified|5|||
27824489|NCT01730053|54289517|FG003|Overall Study|Other than specified|4|||
27824490|NCT01730053|54289518|FG004|Overall Study|Other than specified|7|||
27824491|NCT01730053|54289519|FG005|Overall Study|Other than specified|9|||
27824492|NCT01752985|54289554|FG000|Treatment Period|Subject request to discontinue treatment|1|||
27824493|NCT01752985|54289555|FG001|Treatment Period|Subject request to discontinue treatment|0|||
28073928|NCT00110994|54728618|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|41|||
28073929|NCT00110994|54728617|FG000|Double-blind (DB) Treatment|other reasons|2|||
28073930|NCT00110994|54728618|FG001|Double-blind (DB) Treatment|other reasons|3|||
28073931|NCT00110994|54728617|FG000|Active Follow-up|Disease progression/recurrence/replace|1|||
28073932|NCT00110994|54728618|FG001|Active Follow-up|Disease progression/recurrence/replace|0|||
27824494|NCT01752985|54289556|FG002|Treatment Period|Subject request to discontinue treatment|1|||
27824495|NCT01752985|54289554|FG000|Treatment Period|Subject no longer meets study criteria|0|||
27824496|NCT01752985|54289555|FG001|Treatment Period|Subject no longer meets study criteria|1|||
27824497|NCT01752985|54289556|FG002|Treatment Period|Subject no longer meets study criteria|1|||
27824498|NCT01752985|54289554|FG000|Treatment Period|Adverse Event|2|||
27824499|NCT01752985|54289555|FG001|Treatment Period|Adverse Event|1|||
27824500|NCT01752985|54289556|FG002|Treatment Period|Adverse Event|2|||
27824501|NCT01752985|54289554|FG000|Treatment Period|Withdrawal by Subject|1|||
27824502|NCT01752985|54289555|FG001|Treatment Period|Withdrawal by Subject|1|||
27824503|NCT01752985|54289556|FG002|Treatment Period|Withdrawal by Subject|0|||
27824504|NCT01752985|54289554|FG000|Treatment Period|Lost to Follow-up|0|||
27824505|NCT01752985|54289555|FG001|Treatment Period|Lost to Follow-up|0|||
27824506|NCT01752985|54289556|FG002|Treatment Period|Lost to Follow-up|1|||
27824507|NCT01751113|54289564|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
27824508|NCT01751113|54289565|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
27824509|NCT01751113|54289566|FG002|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
27824510|NCT01751113|54289567|FG003|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
27824511|NCT01751113|54289568|FG004|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
27824512|NCT01751113|54289569|FG005|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
27824513|NCT01751113|54289564|FG000|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
27824514|NCT01751113|54289565|FG001|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
27824515|NCT01751113|54289566|FG002|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
27824516|NCT01751113|54289567|FG003|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
27824517|NCT01751113|54289568|FG004|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
27824518|NCT01751113|54289569|FG005|Treatment Period 3 (4 Weeks)|Adverse Event|1|||
27824519|NCT01750879|54289589|FG000|Overall Study|Adverse Event|8|||
27824520|NCT01750879|54289590|FG001|Overall Study|Adverse Event|0|||
27824521|NCT01750879|54289589|FG000|Overall Study|Lack of Efficacy|1|||
27824522|NCT01750879|54289590|FG001|Overall Study|Lack of Efficacy|0|||
27824523|NCT01750879|54289589|FG000|Overall Study|Withdrawal by Subject|1|||
27824524|NCT01750879|54289590|FG001|Overall Study|Withdrawal by Subject|0|||
27824525|NCT01750879|54289589|FG000|Overall Study|Did not complete per protocol|0|||
27824526|NCT01750879|54289590|FG001|Overall Study|Did not complete per protocol|3|||
27824527|NCT01719380|54289616|FG000|Overall Study|Adverse Event|0|||
27941920|NCT01208207|54598596|FG001|Part I|Non-Compliance With Study Drug|0|||
28073933|NCT00110994|54728617|FG000|Active Follow-up|Other reasons|0|||
28073934|NCT00110994|54728618|FG001|Active Follow-up|Other reasons|2|||
28073935|NCT00110994|54728617|FG000|Long Term Follow-up|Death|19|||
28073936|NCT00110994|54728618|FG001|Long Term Follow-up|Death|17|||
28073937|NCT00144170|54728626|FG000|Overall Study|Adverse Event|84|||
28073938|NCT00144170|54728627|FG001|Overall Study|Adverse Event|41|||
28073939|NCT00144170|54728626|FG000|Overall Study|Protocol Violation|23|||
28073940|NCT00144170|54728627|FG001|Overall Study|Protocol Violation|16|||
28073941|NCT00144170|54728626|FG000|Overall Study|Lost to Follow-up|5|||
28073942|NCT00144170|54728627|FG001|Overall Study|Lost to Follow-up|10|||
28073943|NCT00144170|54728626|FG000|Overall Study|Withdrawal by Subject|29|||
28073944|NCT00144170|54728627|FG001|Overall Study|Withdrawal by Subject|13|||
28073945|NCT00144170|54728626|FG000|Overall Study|Other reason not defined above|211|||
28073946|NCT00144170|54728627|FG001|Overall Study|Other reason not defined above|316|||
28073947|NCT00255086|54728635|FG000|Overall Study|Adverse Event|1|||
28073948|NCT00255086|54728636|FG001|Overall Study|Adverse Event|1|||
28073949|NCT00255086|54728635|FG000|Overall Study|Protocol Violation|1|||
28073950|NCT00255086|54728636|FG001|Overall Study|Protocol Violation|1|||
28073951|NCT00110214|54728645|FG000|Overall Study|Never started treatment|21|||
27824528|NCT01719380|54289617|FG001|Overall Study|Adverse Event|0|||
27824529|NCT01719380|54289618|FG002|Overall Study|Adverse Event|1|||
27941921|NCT01208207|54598597|FG002|Part I|Non-Compliance With Study Drug|1|||
27941922|NCT01208207|54598598|FG003|Part I|Non-Compliance With Study Drug|0|||
28073952|NCT00110214|54728646|FG001|Overall Study|Never started treatment|20|||
28073953|NCT00110214|54728645|FG000|Overall Study|Disease progression or death|260|||
28073954|NCT00110214|54728646|FG001|Overall Study|Disease progression or death|151|||
28073955|NCT00110214|54728645|FG000|Overall Study|Adverse Event|115|||
28073956|NCT00110214|54728646|FG001|Overall Study|Adverse Event|192|||
28073957|NCT00110214|54728645|FG000|Overall Study|Refused further treatment|52|||
28073958|NCT00110214|54728646|FG001|Overall Study|Refused further treatment|65|||
28073959|NCT00110214|54728645|FG000|Overall Study|Other (not specified)|61|||
28073960|NCT00110214|54728646|FG001|Overall Study|Other (not specified)|75|||
28073961|NCT00124020|54728654|FG000|Overall Study|Death|67|||
28073962|NCT00124020|54728655|FG001|Overall Study|Death|71|||
28073963|NCT00124020|54728654|FG000|Overall Study|Withdrawal by Subject|13|||
28073964|NCT00124020|54728655|FG001|Overall Study|Withdrawal by Subject|11|||
28073965|NCT00124020|54728654|FG000|Overall Study|Lost to Follow-up|5|||
28073966|NCT00124020|54728655|FG001|Overall Study|Lost to Follow-up|8|||
28073967|NCT00124020|54728654|FG000|Overall Study|Other|1|||
28073968|NCT00124020|54728655|FG001|Overall Study|Other|1|||
28073969|NCT00124020|54728654|FG000|Overall Study|Transfer to another hospital|2|||
28073970|NCT00124020|54728655|FG001|Overall Study|Transfer to another hospital|0|||
27824530|NCT01719380|54289619|FG003|Overall Study|Adverse Event|2|||
27824531|NCT01719380|54289620|FG004|Overall Study|Adverse Event|0|||
27824532|NCT01719380|54289621|FG005|Overall Study|Adverse Event|1|||
27824533|NCT01719380|54289622|FG006|Overall Study|Adverse Event|0|||
27824534|NCT01719380|54289623|FG007|Overall Study|Adverse Event|1|||
27824535|NCT01719380|54289624|FG008|Overall Study|Adverse Event|4|||
27824536|NCT01719380|54289625|FG009|Overall Study|Adverse Event|3|||
27824537|NCT01719380|54289616|FG000|Overall Study|Death|0|||
27824538|NCT01719380|54289617|FG001|Overall Study|Death|1|||
27824539|NCT01719380|54289618|FG002|Overall Study|Death|0|||
27824540|NCT01719380|54289619|FG003|Overall Study|Death|0|||
27824541|NCT01719380|54289620|FG004|Overall Study|Death|0|||
27824542|NCT01719380|54289621|FG005|Overall Study|Death|0|||
27824543|NCT01719380|54289622|FG006|Overall Study|Death|0|||
27824544|NCT01719380|54289623|FG007|Overall Study|Death|0|||
27824545|NCT01719380|54289624|FG008|Overall Study|Death|3|||
27824546|NCT01719380|54289625|FG009|Overall Study|Death|3|||
27824547|NCT01719380|54289616|FG000|Overall Study|Participant/Guardian Decision|0|||
27824548|NCT01719380|54289617|FG001|Overall Study|Participant/Guardian Decision|0|||
27824549|NCT01719380|54289618|FG002|Overall Study|Participant/Guardian Decision|1|||
27824550|NCT01719380|54289619|FG003|Overall Study|Participant/Guardian Decision|0|||
27824551|NCT01719380|54289620|FG004|Overall Study|Participant/Guardian Decision|0|||
27824552|NCT01719380|54289621|FG005|Overall Study|Participant/Guardian Decision|0|||
27824553|NCT01719380|54289622|FG006|Overall Study|Participant/Guardian Decision|0|||
27824554|NCT01719380|54289623|FG007|Overall Study|Participant/Guardian Decision|0|||
28073971|NCT00215540|54728664|FG000|Overall Study|Withdrew from study medication|1|||
28073972|NCT00215540|54728665|FG001|Overall Study|Withdrew from study medication|0|||
28073973|NCT00215540|54728666|FG002|Overall Study|Withdrew from study medication|0|||
28073974|NCT00143390|54728676|FG000|Overall Study|Death|2|||
28073975|NCT00143390|54728677|FG001|Overall Study|Death|0|||
28073976|NCT00143390|54728676|FG000|Overall Study|Not meeting entry criteria|2|||
28073977|NCT00143390|54728677|FG001|Overall Study|Not meeting entry criteria|5|||
28073978|NCT00143390|54728676|FG000|Overall Study|Withdrawal by Subject|4|||
28073979|NCT00143390|54728677|FG001|Overall Study|Withdrawal by Subject|4|||
28073980|NCT00143390|54728676|FG000|Overall Study|Progressive disease|119|||
28073981|NCT00143390|54728677|FG001|Overall Study|Progressive disease|115|||
28073982|NCT00143390|54728676|FG000|Overall Study|Protocol Violation|2|||
28073983|NCT00143390|54728677|FG001|Overall Study|Protocol Violation|0|||
28073984|NCT00143390|54728676|FG000|Overall Study|Study termination|10|||
28073985|NCT00143390|54728677|FG001|Overall Study|Study termination|15|||
28073986|NCT00143390|54728676|FG000|Overall Study|Adverse Event|9|||
28073987|NCT00143390|54728677|FG001|Overall Study|Adverse Event|8|||
28073988|NCT00143390|54728676|FG000|Overall Study|Other|1|||
28073989|NCT00143390|54728677|FG001|Overall Study|Other|2|||
28073990|NCT00141102|54728685|FG000|Overall Study|Adverse Event|233|||
28073991|NCT00141102|54728686|FG001|Overall Study|Adverse Event|305|||
27824555|NCT01719380|54289624|FG008|Overall Study|Participant/Guardian Decision|2|||
27824556|NCT01719380|54289625|FG009|Overall Study|Participant/Guardian Decision|2|||
27824557|NCT01719380|54289616|FG000|Overall Study|Physician Decision|0|||
27824558|NCT01719380|54289617|FG001|Overall Study|Physician Decision|0|||
27824559|NCT01719380|54289618|FG002|Overall Study|Physician Decision|2|||
27824560|NCT01719380|54289619|FG003|Overall Study|Physician Decision|0|||
28073992|NCT00141102|54728685|FG000|Overall Study|Laboratory Abnormality|9|||
28073993|NCT00141102|54728686|FG001|Overall Study|Laboratory Abnormality|33|||
28073994|NCT00141102|54728685|FG000|Overall Study|Lack of Efficacy|21|||
28073995|NCT00141102|54728686|FG001|Overall Study|Lack of Efficacy|26|||
28073996|NCT00141102|54728685|FG000|Overall Study|Lost to Follow-up|29|||
27824561|NCT01719380|54289620|FG004|Overall Study|Physician Decision|0|||
28073997|NCT00141102|54728686|FG001|Overall Study|Lost to Follow-up|32|||
28073998|NCT00141102|54728685|FG000|Overall Study|Other|87|||
28073999|NCT00141102|54728686|FG001|Overall Study|Other|76|||
27824562|NCT01719380|54289621|FG005|Overall Study|Physician Decision|0|||
27824563|NCT01719380|54289622|FG006|Overall Study|Physician Decision|0|||
27824564|NCT01719380|54289623|FG007|Overall Study|Physician Decision|0|||
27824565|NCT01719380|54289624|FG008|Overall Study|Physician Decision|1|||
27824566|NCT01719380|54289625|FG009|Overall Study|Physician Decision|1|||
27824567|NCT01719380|54289616|FG000|Overall Study|Lack of Efficacy|2|||
27824568|NCT01719380|54289617|FG001|Overall Study|Lack of Efficacy|6|||
27824569|NCT01719380|54289618|FG002|Overall Study|Lack of Efficacy|5|||
27824570|NCT01719380|54289619|FG003|Overall Study|Lack of Efficacy|6|||
27824571|NCT01719380|54289620|FG004|Overall Study|Lack of Efficacy|3|||
27824572|NCT01719380|54289621|FG005|Overall Study|Lack of Efficacy|7|||
27824573|NCT01719380|54289622|FG006|Overall Study|Lack of Efficacy|10|||
27824574|NCT01719380|54289623|FG007|Overall Study|Lack of Efficacy|6|||
27824575|NCT01719380|54289624|FG008|Overall Study|Lack of Efficacy|39|||
27824576|NCT01719380|54289625|FG009|Overall Study|Lack of Efficacy|42|||
27824577|NCT01719380|54289616|FG000|Overall Study|Progressive Disease|0|||
27824578|NCT01719380|54289617|FG001|Overall Study|Progressive Disease|0|||
27824579|NCT01719380|54289618|FG002|Overall Study|Progressive Disease|0|||
27824580|NCT01719380|54289619|FG003|Overall Study|Progressive Disease|0|||
27824581|NCT01719380|54289620|FG004|Overall Study|Progressive Disease|0|||
27824582|NCT01719380|54289621|FG005|Overall Study|Progressive Disease|0|||
27824583|NCT01719380|54289622|FG006|Overall Study|Progressive Disease|0|||
27824584|NCT01719380|54289623|FG007|Overall Study|Progressive Disease|0|||
27824585|NCT01719380|54289624|FG008|Overall Study|Progressive Disease|1|||
27824586|NCT01719380|54289625|FG009|Overall Study|Progressive Disease|0|||
27824587|NCT01743560|54289675|FG000|Overall Study|Disease progression|26|||
27824588|NCT01743560|54289675|FG000|Overall Study|Adverse Event|8|||
27824589|NCT01743560|54289675|FG000|Overall Study|Death|3|||
27824590|NCT01743560|54289675|FG000|Overall Study|Withdrawal by Subject|2|||
27824591|NCT01743560|54289675|FG000|Overall Study|Protocol Violation|1|||
27824592|NCT01743560|54289675|FG000|Overall Study|>1 dose of study drug|3|||
27824593|NCT01743092|54289705|FG000|Overall Study|Lost to Follow-up|14|||
27824594|NCT01743092|54289706|FG001|Overall Study|Lost to Follow-up|15|||
27824595|NCT01780831|54289739|FG000|Overall Study|Withdrawal by Subject|0|||
27824596|NCT01780831|54289740|FG001|Overall Study|Withdrawal by Subject|0|||
27824597|NCT01780831|54289741|FG002|Overall Study|Withdrawal by Subject|4|||
27824598|NCT01780831|54289742|FG003|Overall Study|Withdrawal by Subject|0|||
27824599|NCT01780831|54289739|FG000|Overall Study|Lost to Follow-up|0|||
27824600|NCT01780831|54289740|FG001|Overall Study|Lost to Follow-up|0|||
27824601|NCT01780831|54289741|FG002|Overall Study|Lost to Follow-up|0|||
28074000|NCT00141102|54728685|FG000|Overall Study|Withdrawal by Subject|112|||
28074001|NCT00141102|54728686|FG001|Overall Study|Withdrawal by Subject|142|||
28074002|NCT00141102|54728685|FG000|Overall Study|Randomized But Did Not Receive Treatment|15|||
28074003|NCT00141102|54728686|FG001|Overall Study|Randomized But Did Not Receive Treatment|9|||
28074004|NCT00141102|54728685|FG000|Overall Study|Death|2|||
28074005|NCT00141102|54728686|FG001|Overall Study|Death|2|||
28074006|NCT00255008|54728697|FG000|Overall Study|Adverse Event|1|||
28152465|NCT02657889|54821610|FG003|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
28152466|NCT02657889|54821607|FG000|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
28152467|NCT02657889|54821608|FG001|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
28152468|NCT02657889|54821609|FG002|Phase 2: (Up to a Maximum of 54 Months)|Death|30|||
28152469|NCT02657889|54821610|FG003|Phase 2: (Up to a Maximum of 54 Months)|Death|42|||
28152470|NCT02657889|54821607|FG000|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
28152471|NCT02657889|54821608|FG001|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
28152472|NCT02657889|54821609|FG002|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|5|||
28152473|NCT02657889|54821610|FG003|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|2|||
28152474|NCT02657889|54821607|FG000|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
28152475|NCT02657889|54821608|FG001|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
28152476|NCT02657889|54821609|FG002|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|8|||
28152477|NCT02657889|54821610|FG003|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|2|||
28152478|NCT02657889|54821607|FG000|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
28152479|NCT02657889|54821608|FG001|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
27941923|NCT01208207|54598599|FG004|Part I|Non-Compliance With Study Drug|0|||
28074007|NCT00255008|54728698|FG001|Overall Study|Adverse Event|1|||
28152480|NCT02657889|54821609|FG002|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
27824602|NCT01780831|54289742|FG003|Overall Study|Lost to Follow-up|1|||
27824603|NCT01778023|54289801|FG000|Overall Study|Withdrawal by Subject|0|||
28074008|NCT00255008|54728699|FG002|Overall Study|Adverse Event|2|||
27824604|NCT01778023|54289802|FG001|Overall Study|Withdrawal by Subject|3|||
27824605|NCT01753297|54289810|FG000|Overall Study|Lost to Follow-up|7|||
27824606|NCT01753297|54289811|FG001|Overall Study|Lost to Follow-up|2|||
27824607|NCT01753297|54289810|FG000|Overall Study|Withdrawal by Subject|26|||
27824608|NCT01753297|54289811|FG001|Overall Study|Withdrawal by Subject|23|||
27941924|NCT01208207|54598600|FG005|Part I|Non-Compliance With Study Drug|0|||
27824609|NCT01753297|54289810|FG000|Overall Study|Adverse Event (up to Month 36)|1|||
27824610|NCT01753297|54289811|FG001|Overall Study|Adverse Event (up to Month 36)|1|||
27824611|NCT01753297|54289810|FG000|Overall Study|Death|0|||
27824612|NCT01753297|54289811|FG001|Overall Study|Death|2|||
27824613|NCT01753297|54289810|FG000|Overall Study|Did not attend end of study visit|7|||
27824614|NCT01753297|54289811|FG001|Overall Study|Did not attend end of study visit|8|||
27824615|NCT01777321|54289821|FG000|Overall Study|Withdrawal by Subject|0|||
27824616|NCT01777321|54289822|FG001|Overall Study|Withdrawal by Subject|1|||
27824617|NCT01729819|54289830|FG000|Overall Study|Adverse Event|2|||
27824618|NCT01729819|54289831|FG001|Overall Study|Adverse Event|4|||
27824619|NCT01729819|54289830|FG000|Overall Study|Lack of Efficacy|1|||
27824620|NCT01729819|54289831|FG001|Overall Study|Lack of Efficacy|0|||
27824621|NCT01729819|54289830|FG000|Overall Study|Lost to Follow-up|2|||
27824622|NCT01729819|54289831|FG001|Overall Study|Lost to Follow-up|0|||
27824623|NCT01729819|54289830|FG000|Overall Study|Other reason|1|||
27824624|NCT01729819|54289831|FG001|Overall Study|Other reason|0|||
27850291|NCT04178967|54349319|FG004|Induction Period|Lost to Follow-up|0|||
27850292|NCT04178967|54349320|FG005|Induction Period|Lost to Follow-up|0|||
28074009|NCT00255008|54728700|FG003|Overall Study|Adverse Event|0|||
28074010|NCT00255008|54728697|FG000|Overall Study|Lost to Follow-up|1|||
28074011|NCT00255008|54728698|FG001|Overall Study|Lost to Follow-up|0|||
28074012|NCT00255008|54728699|FG002|Overall Study|Lost to Follow-up|1|||
28074013|NCT00255008|54728700|FG003|Overall Study|Lost to Follow-up|2|||
28074014|NCT00255008|54728697|FG000|Overall Study|Did not meet viral reduction criteria|4|||
28074015|NCT00255008|54728698|FG001|Overall Study|Did not meet viral reduction criteria|5|||
28074016|NCT00255008|54728699|FG002|Overall Study|Did not meet viral reduction criteria|0|||
28074017|NCT00255008|54728700|FG003|Overall Study|Did not meet viral reduction criteria|1|||
28074018|NCT00255008|54728697|FG000|Overall Study|Withdrew consent|0|||
28074019|NCT00255008|54728698|FG001|Overall Study|Withdrew consent|0|||
28074020|NCT00255008|54728699|FG002|Overall Study|Withdrew consent|2|||
28074021|NCT00255008|54728700|FG003|Overall Study|Withdrew consent|0|||
28074022|NCT00255008|54728697|FG000|Overall Study|Sponsor request|18|||
28074023|NCT00255008|54728698|FG001|Overall Study|Sponsor request|3|||
28074024|NCT00255008|54728699|FG002|Overall Study|Sponsor request|8|||
28074025|NCT00255008|54728700|FG003|Overall Study|Sponsor request|17|||
28074026|NCT00255008|54728697|FG000|Overall Study|Adverse lab experience|1|||
28074027|NCT00255008|54728698|FG001|Overall Study|Adverse lab experience|0|||
28074028|NCT00255008|54728699|FG002|Overall Study|Adverse lab experience|0|||
28074029|NCT00255008|54728700|FG003|Overall Study|Adverse lab experience|0|||
28074030|NCT00255008|54728697|FG000|Overall Study|Other|7|||
28074031|NCT00255008|54728698|FG001|Overall Study|Other|0|||
28074032|NCT00255008|54728699|FG002|Overall Study|Other|3|||
28074033|NCT00255008|54728700|FG003|Overall Study|Other|2|||
28074034|NCT03714022|54728712|FG000|Overall Study|Adverse Event|1|||
28074035|NCT03714022|54728713|FG001|Overall Study|Adverse Event|0|||
28074036|NCT03714022|54728712|FG000|Overall Study|Consent withdrawal|0|||
28074037|NCT03714022|54728713|FG001|Overall Study|Consent withdrawal|1|||
28074038|NCT03714022|54728712|FG000|Overall Study|Lost to Follow-up|3|||
28074039|NCT03714022|54728713|FG001|Overall Study|Lost to Follow-up|2|||
28074040|NCT00143312|54728719|FG000|Overall Study|Death|11|||
28074041|NCT00143312|54728719|FG000|Overall Study|Adverse Event|2|||
28074042|NCT00143312|54728719|FG000|Overall Study|Lost to Follow-up|1|||
28074043|NCT00143312|54728719|FG000|Overall Study|Other|1|||
28074044|NCT00143312|54728719|FG000|Overall Study|Withdrawal by Subject|1|||
28074045|NCT00254540|54728725|FG000|Overall Study|Adverse Event|6|||
28074046|NCT00254540|54728726|FG001|Overall Study|Adverse Event|7|||
28074047|NCT00254540|54728725|FG000|Overall Study|Lack of Efficacy|13|||
28074048|NCT00254540|54728726|FG001|Overall Study|Lack of Efficacy|13|||
28074049|NCT00254540|54728725|FG000|Overall Study|Death|0|||
28074050|NCT00254540|54728726|FG001|Overall Study|Death|1|||
28074051|NCT00254540|54728725|FG000|Overall Study|Laboratory Test Abnormality|0|||
27941925|NCT01208207|54598601|FG006|Part I|Non-Compliance With Study Drug|0|||
28074052|NCT00254540|54728726|FG001|Overall Study|Laboratory Test Abnormality|1|||
28074053|NCT00139776|54728735|FG000|Period I|Did not enter Period II|575|||
28074054|NCT00139776|54728736|FG001|Period I|Did not enter Period II|0|||
28074055|NCT00139776|54728737|FG002|Period I|Did not enter Period II|0|||
28074056|NCT00139776|54728738|FG003|Period I|Did not enter Period II|0|||
28074057|NCT00139776|54728735|FG000|Period II|Not Randomized into Period III|0|||
28074058|NCT00139776|54728736|FG001|Period II|Not Randomized into Period III|322|||
28074059|NCT00139776|54728737|FG002|Period II|Not Randomized into Period III|0|||
28074060|NCT00139776|54728738|FG003|Period II|Not Randomized into Period III|0|||
28074061|NCT00139776|54728735|FG000|Period III|Adverse Event|0|||
27824625|NCT01729819|54289830|FG000|Overall Study|Protocol Violation|0|||
27824626|NCT01729819|54289831|FG001|Overall Study|Protocol Violation|1|||
27824627|NCT01729819|54289830|FG000|Overall Study|Withdrawal by Subject|0|||
27824628|NCT01729819|54289831|FG001|Overall Study|Withdrawal by Subject|2|||
27824629|NCT01776541|54289842|FG000|Overall Study|Administrative Reason|6|||
27850293|NCT04178967|54349321|FG006|Induction Period|Lost to Follow-up|0|||
28074062|NCT00139776|54728736|FG001|Period III|Adverse Event|0|||
27824630|NCT01776541|54289843|FG001|Overall Study|Administrative Reason|2|||
27824631|NCT01776541|54289842|FG000|Overall Study|Death|4|||
27824632|NCT01776541|54289843|FG001|Overall Study|Death|0|||
27824633|NCT01776541|54289842|FG000|Overall Study|Lost to Follow-up|27|||
27824634|NCT01776541|54289843|FG001|Overall Study|Lost to Follow-up|48|||
27824635|NCT01776541|54289842|FG000|Overall Study|Unclassified|5|||
27824636|NCT01776541|54289843|FG001|Overall Study|Unclassified|4|||
27824637|NCT01776541|54289842|FG000|Overall Study|Protocol Violation|2|||
27824638|NCT01776541|54289843|FG001|Overall Study|Protocol Violation|1|||
27824639|NCT01776541|54289842|FG000|Overall Study|Withdrawal by Subject|12|||
27824640|NCT01776541|54289843|FG001|Overall Study|Withdrawal by Subject|20|||
27824641|NCT01742078|54289872|FG000|Overall Study|Withdrawal by Subject|0|||
27824642|NCT01742078|54289873|FG001|Overall Study|Withdrawal by Subject|0|||
27824643|NCT01742078|54289874|FG002|Overall Study|Withdrawal by Subject|0|||
27824644|NCT01742078|54289875|FG003|Overall Study|Withdrawal by Subject|1|||
27824645|NCT01742078|54289876|FG004|Overall Study|Withdrawal by Subject|0|||
27824646|NCT01742078|54289877|FG005|Overall Study|Withdrawal by Subject|0|||
27824647|NCT01742078|54289878|FG006|Overall Study|Withdrawal by Subject|0|||
27824648|NCT01742078|54289879|FG007|Overall Study|Withdrawal by Subject|0|||
27824649|NCT01742078|54289880|FG008|Overall Study|Withdrawal by Subject|0|||
27824650|NCT01741688|54289902|FG000|Overall Study|Lack of insurance coverage|2|||
27824651|NCT01741688|54289902|FG000|Overall Study|Withdrawal by Subject|1|||
27824652|NCT01709084|54289909|FG000|Overall Study|Lost to Follow-up|4|||
27824653|NCT01709084|54289910|FG001|Overall Study|Lost to Follow-up|7|||
27824654|NCT01709084|54289909|FG000|Overall Study|Withdrawal by Subject|2|||
27824655|NCT01709084|54289910|FG001|Overall Study|Withdrawal by Subject|2|||
27824656|NCT01709084|54289909|FG000|Overall Study|Adverse Event|5|||
27824657|NCT01709084|54289910|FG001|Overall Study|Adverse Event|0|||
27824658|NCT01709084|54289909|FG000|Overall Study|Other|5|||
27824659|NCT01709084|54289910|FG001|Overall Study|Other|3|||
27824660|NCT01709084|54289909|FG000|Overall Study|Participant Reached a Virologic Endpoint|0|||
27824661|NCT01709084|54289910|FG001|Overall Study|Participant Reached a Virologic Endpoint|1|||
27824662|NCT01709084|54289909|FG000|Overall Study|Not Treated|0|||
27824663|NCT01709084|54289910|FG001|Overall Study|Not Treated|2|||
27824664|NCT01776307|54289919|FG000|Overall Study|Not dosed|0|||
27824665|NCT01776307|54289920|FG001|Overall Study|Not dosed|0|||
27824666|NCT01776307|54289921|FG002|Overall Study|Not dosed|1|||
27824667|NCT01729039|54289952|FG000|Overall Study|disqualified|2|||
27824668|NCT01729039|54289953|FG001|Overall Study|disqualified|5|||
27824669|NCT01729039|54289952|FG000|Overall Study|Withdrawal by Subject|8|||
27824670|NCT01729039|54289953|FG001|Overall Study|Withdrawal by Subject|7|||
27824671|NCT01775995|54289964|FG000|Overall Study|Lost to Follow-up|1|||
27824672|NCT01775995|54289965|FG001|Overall Study|Lost to Follow-up|1|||
27824673|NCT01741532|54289973|FG000|Overall Study|Adverse Event|4|||
27824674|NCT01741532|54289974|FG001|Overall Study|Adverse Event|0|||
28152481|NCT02657889|54821610|FG003|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
28152482|NCT02657889|54821607|FG000|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
28152483|NCT02657889|54821608|FG001|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
28152484|NCT02657889|54821609|FG002|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|6|||
28152485|NCT02657889|54821610|FG003|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|1|||
28152486|NCT02657889|54821607|FG000|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
28152487|NCT02657889|54821608|FG001|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
28152488|NCT02657889|54821609|FG002|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
28152489|NCT02657889|54821610|FG003|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|1|||
28152490|NCT02657889|54821607|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
28152491|NCT02657889|54821608|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
27824675|NCT01741532|54289973|FG000|Overall Study|Withdrawal by Subject|1|||
27824676|NCT01741532|54289974|FG001|Overall Study|Withdrawal by Subject|1|||
27824677|NCT01741532|54289973|FG000|Overall Study|Protocol Violation|0|||
27824678|NCT01741532|54289974|FG001|Overall Study|Protocol Violation|1|||
27824679|NCT01741532|54289973|FG000|Overall Study|Worsening of the disease|3|||
27824680|NCT01741532|54289974|FG001|Overall Study|Worsening of the disease|1|||
27824681|NCT01741532|54289973|FG000|Overall Study|Sponsor decision|1|||
27824682|NCT01741532|54289974|FG001|Overall Study|Sponsor decision|0|||
27824683|NCT01741532|54289973|FG000|Overall Study|Medical event|1|||
27824684|NCT01741532|54289974|FG001|Overall Study|Medical event|0|||
27824685|NCT01719224|54289984|FG000|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4|||
27824686|NCT01719224|54289985|FG001|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2|||
27824687|NCT01717976|54289996|FG000|Overall Study|Protocol Violation|0|||
27824688|NCT01717976|54289997|FG001|Overall Study|Protocol Violation|1|||
27824689|NCT01740440|54290003|FG000|Overall Study|Lost to Follow-up|3|||
27824690|NCT01740128|54290010|FG000|Overall Study|Pregnancy|0|||
27824691|NCT01740128|54290011|FG001|Overall Study|Pregnancy|1|||
27824692|NCT01740128|54290010|FG000|Overall Study|Protocol Violation|1|||
27824693|NCT01740128|54290011|FG001|Overall Study|Protocol Violation|2|||
27824694|NCT01740128|54290010|FG000|Overall Study|Lost to Follow-up|2|||
27824695|NCT01740128|54290011|FG001|Overall Study|Lost to Follow-up|2|||
27824696|NCT01740128|54290010|FG000|Overall Study|Withdrawal by Subject|1|||
27824697|NCT01740128|54290011|FG001|Overall Study|Withdrawal by Subject|0|||
27824698|NCT01740128|54290010|FG000|Overall Study|Insufficient protocol compliance|2|||
27824699|NCT01740128|54290011|FG001|Overall Study|Insufficient protocol compliance|2|||
27824700|NCT01976741|54290027|FG000|Overall Study|Withdrawal by Subject|1|||
27824701|NCT01976741|54290028|FG001|Overall Study|Withdrawal by Subject|0|||
27824702|NCT01976741|54290029|FG002|Overall Study|Withdrawal by Subject|1|||
27824703|NCT01976741|54290030|FG003|Overall Study|Withdrawal by Subject|1|||
27824704|NCT01976741|54290031|FG004|Overall Study|Withdrawal by Subject|0|||
27824705|NCT01976741|54290032|FG005|Overall Study|Withdrawal by Subject|0|||
27824706|NCT01976741|54290033|FG006|Overall Study|Withdrawal by Subject|1|||
27824707|NCT01976741|54290034|FG007|Overall Study|Withdrawal by Subject|4|||
27824708|NCT01976741|54290035|FG008|Overall Study|Withdrawal by Subject|0|||
27824709|NCT01976741|54290036|FG009|Overall Study|Withdrawal by Subject|0|||
27824710|NCT01976741|54290027|FG000|Overall Study|Adverse Event|0|||
27824711|NCT01976741|54290028|FG001|Overall Study|Adverse Event|0|||
27824712|NCT01976741|54290029|FG002|Overall Study|Adverse Event|2|||
27824713|NCT01976741|54290030|FG003|Overall Study|Adverse Event|0|||
27824714|NCT01976741|54290031|FG004|Overall Study|Adverse Event|0|||
27824715|NCT01976741|54290032|FG005|Overall Study|Adverse Event|0|||
27824716|NCT01976741|54290033|FG006|Overall Study|Adverse Event|3|||
27824717|NCT01976741|54290034|FG007|Overall Study|Adverse Event|8|||
27824718|NCT01976741|54290035|FG008|Overall Study|Adverse Event|1|||
27824719|NCT01976741|54290036|FG009|Overall Study|Adverse Event|4|||
27824720|NCT01727713|54290070|FG000|Overall Study|Lost to Follow-up|5|||
27824721|NCT01727713|54290070|FG000|Overall Study|Adverse Event|10|||
27824722|NCT01727713|54290070|FG000|Overall Study|Participant Met Withdrawal Criteria|5|||
27824723|NCT01727713|54290070|FG000|Overall Study|Withdrawal by Subject|13|||
27824724|NCT01727713|54290070|FG000|Overall Study|Protocol Deviation|2|||
27824725|NCT01965431|54290074|FG000|Overall Study|Adverse Event|0|||
27824726|NCT01965431|54290075|FG001|Overall Study|Adverse Event|1|||
27824727|NCT01965431|54290076|FG002|Overall Study|Adverse Event|0|||
27824728|NCT01965431|54290077|FG003|Overall Study|Adverse Event|0|||
27824729|NCT01965431|54290078|FG004|Overall Study|Adverse Event|0|||
27824730|NCT01965431|54290079|FG005|Overall Study|Adverse Event|0|||
27824731|NCT01965431|54290074|FG000|Overall Study|Other than stated above|6|||
27824732|NCT01965431|54290075|FG001|Overall Study|Other than stated above|5|||
27824733|NCT01965431|54290076|FG002|Overall Study|Other than stated above|6|||
27824734|NCT01965431|54290077|FG003|Overall Study|Other than stated above|6|||
27824735|NCT01965431|54290078|FG004|Overall Study|Other than stated above|6|||
27824736|NCT01965431|54290079|FG005|Overall Study|Other than stated above|6|||
27824737|NCT01976663|54290089|FG000|Overall Study|Completed 18 mos but no repeat treatment|24|||
27824738|NCT01976663|54290089|FG000|Overall Study|Personal Reasons|6|||
27824739|NCT01976663|54290089|FG000|Overall Study|Withdrawal by Subject|4|||
27824740|NCT01976663|54290089|FG000|Overall Study|Screen Failure|3|||
27824741|NCT01976663|54290089|FG000|Overall Study|Adverse Event|2|||
27824742|NCT01976663|54290089|FG000|Overall Study|Lost to Follow-up|3|||
27824743|NCT01775137|54290097|FG000|Overall Study|Death|1|||
27824744|NCT01775137|54290097|FG000|Overall Study|Protocol deviation|2|||
27824745|NCT01775137|54290097|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
27824746|NCT01775137|54290097|FG000|Overall Study|Adverse Event|1|||
27824747|NCT01775137|54290097|FG000|Overall Study|Withdrawal by participants|5|||
27824748|NCT01976507|54290104|FG000|Overall Study|Adverse Event|6|||
27824749|NCT01976507|54290104|FG000|Overall Study|ablation not done, drug not given|1|||
27824750|NCT01964963|54290108|FG000|Overall Study|Case Report Forms Uncollected|888|||
27824751|NCT01964963|54290108|FG000|Overall Study|Protocol Deviation|50|||
27824752|NCT01964963|54290108|FG000|Overall Study|Data Reliability was not Assured|5|||
27824753|NCT01964105|54290115|FG000|Overall Study|Lost to Follow-up|2|||
27824754|NCT01964105|54290116|FG001|Overall Study|Lost to Follow-up|13|||
27824755|NCT01964105|54290117|FG002|Overall Study|Lost to Follow-up|0|||
27824756|NCT01974323|54290127|FG000|Overall Study|Other Reasons|25|||
27824757|NCT01974323|54290128|FG001|Overall Study|Other Reasons|28|||
27824758|NCT01974323|54290127|FG000|Overall Study|Protocol Violation|2|||
27824759|NCT01974323|54290128|FG001|Overall Study|Protocol Violation|2|||
27824760|NCT01974323|54290127|FG000|Overall Study|Personal Reasons|15|||
27824761|NCT01974323|54290128|FG001|Overall Study|Personal Reasons|19|||
27824762|NCT01974323|54290127|FG000|Overall Study|Lost to Follow-up|45|||
27824763|NCT01974323|54290128|FG001|Overall Study|Lost to Follow-up|40|||
27824764|NCT01974323|54290127|FG000|Overall Study|Pregnancy|2|||
27824765|NCT01974323|54290128|FG001|Overall Study|Pregnancy|1|||
27824766|NCT01974323|54290127|FG000|Overall Study|Lack of Efficacy|1|||
27824767|NCT01974323|54290128|FG001|Overall Study|Lack of Efficacy|1|||
27824768|NCT01974323|54290127|FG000|Overall Study|Adverse Event|2|||
27824769|NCT01974323|54290128|FG001|Overall Study|Adverse Event|2|||
27824770|NCT01963403|54290136|FG000|Overall Study|Lost to Follow-up|2|||
27824771|NCT01963403|54290137|FG001|Overall Study|Lost to Follow-up|3|||
27824772|NCT01963403|54290136|FG000|Overall Study|Implant removal|0|||
27824773|NCT01963403|54290137|FG001|Overall Study|Implant removal|1|||
27824774|NCT01973387|54290147|FG000|Overall Study|Adverse Event|14|||
27824775|NCT01973387|54290148|FG001|Overall Study|Adverse Event|4|||
27824776|NCT01973387|54290147|FG000|Overall Study|Withdrawal by Subject|7|||
27824777|NCT01973387|54290148|FG001|Overall Study|Withdrawal by Subject|4|||
27824778|NCT01973387|54290147|FG000|Overall Study|Study terminated by sponsor|63|||
27824779|NCT01973387|54290148|FG001|Overall Study|Study terminated by sponsor|0|||
27824780|NCT01973387|54290147|FG000|Overall Study|Progressive disease or relapse|16|||
27824781|NCT01973387|54290148|FG001|Overall Study|Progressive disease or relapse|5|||
27824782|NCT01973387|54290147|FG000|Overall Study|Death|4|||
27824783|NCT01973387|54290148|FG001|Overall Study|Death|3|||
27824784|NCT01973387|54290147|FG000|Overall Study|Randomized, not treated|2|||
27824785|NCT01973387|54290148|FG001|Overall Study|Randomized, not treated|2|||
27824786|NCT01973231|54290156|FG000|Overall Study|Protocol Violation|1|||
27824787|NCT01973231|54290157|FG001|Overall Study|Protocol Violation|1|||
27824788|NCT01973231|54290156|FG000|Overall Study|Lost to Follow-up|1|||
27824789|NCT01973231|54290157|FG001|Overall Study|Lost to Follow-up|1|||
27824790|NCT01973231|54290156|FG000|Overall Study|unclassified|2|||
27824791|NCT01973231|54290157|FG001|Overall Study|unclassified|1|||
27824792|NCT01973231|54290156|FG000|Overall Study|Withdrawal by Subject|7|||
27824793|NCT01973231|54290157|FG001|Overall Study|Withdrawal by Subject|9|||
27824794|NCT01961687|54290163|FG000|Overall Study|Lost to Follow-up|19|||
27824795|NCT01961687|54290163|FG000|Overall Study|Re-operation|17|||
27824796|NCT01961687|54290163|FG000|Overall Study|Death|7|||
27824797|NCT01961687|54290163|FG000|Overall Study|Withdrawal by Subject|6|||
27824798|NCT01961687|54290163|FG000|Overall Study|Adverse Event|6|||
27824799|NCT01961687|54290163|FG000|Overall Study|Moved to area without study site|2|||
27824800|NCT01961687|54290163|FG000|Overall Study|Sponsor decision|2|||
27824801|NCT01961687|54290163|FG000|Overall Study|Physician Decision|1|||
27824802|NCT01961687|54290163|FG000|Overall Study|Unable to meet follow-up requirements|1|||
27824803|NCT01961609|54290225|FG000|Initiation|Missing|3|||
27824804|NCT01961609|54290226|FG001|Initiation|Missing|2|||
27824805|NCT01961609|54290227|FG002|Initiation|Missing|0|||
27824806|NCT01961609|54290228|FG003|Initiation|Missing|0|||
27824807|NCT01961609|54290225|FG000|Initiation|Protocol deviation|1|||
27824808|NCT01961609|54290226|FG001|Initiation|Protocol deviation|0|||
27824809|NCT01961609|54290227|FG002|Initiation|Protocol deviation|0|||
28152492|NCT02657889|54821609|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participant request|2|||
28152493|NCT02657889|54821610|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participant request|1|||
28152494|NCT02657889|54821607|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
28152495|NCT02657889|54821608|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
28152496|NCT02657889|54821609|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
28152497|NCT02657889|54821610|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|4|||
28152498|NCT03034915|54821625|FG000|Overall Study|Adverse Event|29|||
28152499|NCT03034915|54821626|FG001|Overall Study|Adverse Event|32|||
28152500|NCT03034915|54821627|FG002|Overall Study|Adverse Event|22|||
28152501|NCT03034915|54821625|FG000|Overall Study|Lost to Follow-up|5|||
28152502|NCT03034915|54821626|FG001|Overall Study|Lost to Follow-up|13|||
28152503|NCT03034915|54821627|FG002|Overall Study|Lost to Follow-up|3|||
28152504|NCT03034915|54821625|FG000|Overall Study|Withdrawal by Subject|29|||
28152505|NCT03034915|54821626|FG001|Overall Study|Withdrawal by Subject|46|||
28152506|NCT03034915|54821627|FG002|Overall Study|Withdrawal by Subject|41|||
28152507|NCT03034915|54821625|FG000|Overall Study|Protocol Deviation|2|||
28152508|NCT03034915|54821626|FG001|Overall Study|Protocol Deviation|14|||
28152509|NCT03034915|54821627|FG002|Overall Study|Protocol Deviation|7|||
27824810|NCT01961609|54290228|FG003|Initiation|Protocol deviation|0|||
27824811|NCT01961609|54290225|FG000|Initiation|Death|0|||
27824812|NCT01961609|54290226|FG001|Initiation|Death|1|||
28152510|NCT03034915|54821625|FG000|Overall Study|Lack of Efficacy|8|||
28152511|NCT03034915|54821626|FG001|Overall Study|Lack of Efficacy|16|||
27824813|NCT01961609|54290227|FG002|Initiation|Death|0|||
27824814|NCT01961609|54290228|FG003|Initiation|Death|0|||
27824815|NCT01961609|54290225|FG000|Initiation|Administrative problems|1|||
27824816|NCT01961609|54290226|FG001|Initiation|Administrative problems|0|||
27824817|NCT01961609|54290227|FG002|Initiation|Administrative problems|0|||
27824818|NCT01961609|54290228|FG003|Initiation|Administrative problems|0|||
27824819|NCT01961609|54290225|FG000|Initiation|Withdrawal by Subject|1|||
27824820|NCT01961609|54290226|FG001|Initiation|Withdrawal by Subject|2|||
27824821|NCT01961609|54290227|FG002|Initiation|Withdrawal by Subject|0|||
27824822|NCT01961609|54290228|FG003|Initiation|Withdrawal by Subject|0|||
27824823|NCT01961609|54290225|FG000|Initiation|Lack of Efficacy|2|||
27824824|NCT01961609|54290226|FG001|Initiation|Lack of Efficacy|1|||
27824825|NCT01961609|54290227|FG002|Initiation|Lack of Efficacy|0|||
27824826|NCT01961609|54290228|FG003|Initiation|Lack of Efficacy|0|||
27824827|NCT01961609|54290225|FG000|Initiation|Abnormal lab values|0|||
27824828|NCT01961609|54290226|FG001|Initiation|Abnormal lab values|1|||
27824829|NCT01961609|54290227|FG002|Initiation|Abnormal lab values|0|||
27824830|NCT01961609|54290228|FG003|Initiation|Abnormal lab values|0|||
27824831|NCT01961609|54290225|FG000|Initiation|Adverse Event|3|||
27824832|NCT01961609|54290226|FG001|Initiation|Adverse Event|5|||
28074063|NCT00139776|54728737|FG002|Period III|Adverse Event|22|||
28074064|NCT00139776|54728738|FG003|Period III|Adverse Event|23|||
28074065|NCT00139776|54728735|FG000|Period III|Other|0|||
28074066|NCT00139776|54728736|FG001|Period III|Other|0|||
28074067|NCT00139776|54728737|FG002|Period III|Other|23|||
28074068|NCT00139776|54728738|FG003|Period III|Other|34|||
28074069|NCT00139776|54728735|FG000|Period III|Lack of Efficacy|0|||
28074070|NCT00139776|54728736|FG001|Period III|Lack of Efficacy|0|||
28074071|NCT00139776|54728737|FG002|Period III|Lack of Efficacy|10|||
28074072|NCT00139776|54728738|FG003|Period III|Lack of Efficacy|24|||
28074073|NCT00139776|54728735|FG000|Period III|Lost to Follow-up|0|||
28074074|NCT00139776|54728736|FG001|Period III|Lost to Follow-up|0|||
28074075|NCT00139776|54728737|FG002|Period III|Lost to Follow-up|5|||
28074076|NCT00139776|54728738|FG003|Period III|Lost to Follow-up|4|||
28074077|NCT00139776|54728735|FG000|Period III|Withdrawal by Subject|0|||
28074078|NCT00139776|54728736|FG001|Period III|Withdrawal by Subject|0|||
28074079|NCT00139776|54728737|FG002|Period III|Withdrawal by Subject|16|||
28074080|NCT00139776|54728738|FG003|Period III|Withdrawal by Subject|21|||
28074081|NCT00413699|54728747|FG000|Initial Period|Death|25|||
28074082|NCT00413699|54728748|FG001|Initial Period|Death|30|||
28074083|NCT00413699|54728749|FG002|Initial Period|Death|0|||
28074084|NCT00413699|54728747|FG000|Initial Period|Lack of Efficacy|59|||
28074085|NCT00413699|54728748|FG001|Initial Period|Lack of Efficacy|115|||
28074086|NCT00413699|54728749|FG002|Initial Period|Lack of Efficacy|0|||
28074087|NCT00413699|54728747|FG000|Initial Period|Lost to Follow-up|31|||
28074088|NCT00413699|54728748|FG001|Initial Period|Lost to Follow-up|101|||
28074089|NCT00413699|54728749|FG002|Initial Period|Lost to Follow-up|0|||
28074090|NCT00413699|54728747|FG000|Initial Period|Protocol Violation|38|||
28074091|NCT00413699|54728748|FG001|Initial Period|Protocol Violation|89|||
28074092|NCT00413699|54728749|FG002|Initial Period|Protocol Violation|0|||
28074093|NCT00413699|54728747|FG000|Initial Period|Pregnancy|10|||
28074094|NCT00413699|54728748|FG001|Initial Period|Pregnancy|8|||
28074095|NCT00413699|54728749|FG002|Initial Period|Pregnancy|0|||
28074096|NCT00413699|54728747|FG000|Initial Period|Did not meet entrance criteria|2|||
28074097|NCT00413699|54728748|FG001|Initial Period|Did not meet entrance criteria|2|||
28074098|NCT00413699|54728749|FG002|Initial Period|Did not meet entrance criteria|0|||
28074099|NCT00413699|54728747|FG000|Initial Period|Medication error without adverse event|0|||
28074100|NCT00413699|54728748|FG001|Initial Period|Medication error without adverse event|1|||
28074101|NCT00413699|54728749|FG002|Initial Period|Medication error without adverse event|0|||
28074102|NCT00413699|54728747|FG000|Initial Period|Study terminated by Sponsor|0|||
28074103|NCT00413699|54728748|FG001|Initial Period|Study terminated by Sponsor|1|||
28074104|NCT00413699|54728749|FG002|Initial Period|Study terminated by Sponsor|0|||
28074105|NCT00413699|54728747|FG000|Initial Period|Other|67|||
28074106|NCT00413699|54728748|FG001|Initial Period|Other|211|||
28074107|NCT00413699|54728749|FG002|Initial Period|Other|0|||
28074108|NCT00413699|54728747|FG000|Initial Period|Adverse event related to study drug|178|||
28074109|NCT00413699|54728748|FG001|Initial Period|Adverse event related to study drug|527|||
28152512|NCT03034915|54821627|FG002|Overall Study|Lack of Efficacy|18|||
28152513|NCT03034915|54821625|FG000|Overall Study|Site closed|2|||
28152514|NCT03034915|54821626|FG001|Overall Study|Site closed|2|||
28074110|NCT00413699|54728749|FG002|Initial Period|Adverse event related to study drug|0|||
27824833|NCT01961609|54290227|FG002|Initiation|Adverse Event|0|||
28074111|NCT00413699|54728747|FG000|Initial Period|Adverse event not related to study drug|113|||
28074112|NCT00413699|54728748|FG001|Initial Period|Adverse event not related to study drug|248|||
28074113|NCT00413699|54728749|FG002|Initial Period|Adverse event not related to study drug|0|||
28074114|NCT00413699|54728747|FG000|Initial Period|Missing end of study page|0|||
28074115|NCT00413699|54728748|FG001|Initial Period|Missing end of study page|4|||
28074116|NCT00413699|54728749|FG002|Initial Period|Missing end of study page|0|||
28074117|NCT00413699|54728747|FG000|Initial Period|No longer willing to participate|116|||
28074118|NCT00413699|54728748|FG001|Initial Period|No longer willing to participate|368|||
28074119|NCT00413699|54728749|FG002|Initial Period|No longer willing to participate|0|||
28152515|NCT03034915|54821627|FG002|Overall Study|Site closed|4|||
27824834|NCT01961609|54290228|FG003|Initiation|Adverse Event|0|||
27850294|NCT04178967|54349322|FG007|Induction Period|Lost to Follow-up|0|||
28074120|NCT00413699|54728747|FG000|Extension Period|No Longer Willing to Participate|0|||
28152516|NCT03034915|54821625|FG000|Overall Study|Protocol-defined withdrawal criteria met|19|||
27824835|NCT01961609|54290225|FG000|Initiation|Randomized but not treated|1|||
28074121|NCT00413699|54728748|FG001|Extension Period|No Longer Willing to Participate|0|||
27824836|NCT01961609|54290226|FG001|Initiation|Randomized but not treated|1|||
27824837|NCT01961609|54290227|FG002|Initiation|Randomized but not treated|0|||
27824838|NCT01961609|54290228|FG003|Initiation|Randomized but not treated|0|||
27824839|NCT01961609|54290225|FG000|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1|||
27824840|NCT01961609|54290226|FG001|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
27824841|NCT01961609|54290227|FG002|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3|||
27824842|NCT01961609|54290228|FG003|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
27824843|NCT01961609|54290225|FG000|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3|||
27824844|NCT01961609|54290226|FG001|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
27824845|NCT01961609|54290227|FG002|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1|||
27824846|NCT01961609|54290228|FG003|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
27824847|NCT01961609|54290225|FG000|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
27824848|NCT01961609|54290226|FG001|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
27824849|NCT01961609|54290227|FG002|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
27824850|NCT01961609|54290228|FG003|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
27824851|NCT01961609|54290225|FG000|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13|||
27824852|NCT01961609|54290226|FG001|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4|||
27824853|NCT01961609|54290227|FG002|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10|||
27824854|NCT01961609|54290228|FG003|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0|||
27824855|NCT01961609|54290225|FG000|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
27824856|NCT01961609|54290226|FG001|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
27824857|NCT01961609|54290227|FG002|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3|||
27824858|NCT01961609|54290228|FG003|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0|||
27824859|NCT01961609|54290225|FG000|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
27824860|NCT01961609|54290226|FG001|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
27824861|NCT01961609|54290227|FG002|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1|||
27824862|NCT01961609|54290228|FG003|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
27824863|NCT01961609|54290225|FG000|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7|||
27824864|NCT01961609|54290226|FG001|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5|||
27824865|NCT01961609|54290227|FG002|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0|||
27824866|NCT01961609|54290228|FG003|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4|||
27824867|NCT01961609|54290225|FG000|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
27824868|NCT01961609|54290226|FG001|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
27824869|NCT01961609|54290227|FG002|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1|||
27824870|NCT01961609|54290228|FG003|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
27824871|NCT01961609|54290225|FG000|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1|||
27824872|NCT01961609|54290226|FG001|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
27824873|NCT01961609|54290227|FG002|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
27824874|NCT01961609|54290228|FG003|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
28152517|NCT03034915|54821626|FG001|Overall Study|Protocol-defined withdrawal criteria met|26|||
28152518|NCT03034915|54821627|FG002|Overall Study|Protocol-defined withdrawal criteria met|29|||
28152519|NCT03034915|54821625|FG000|Overall Study|Physician Decision|1|||
28152520|NCT03034915|54821626|FG001|Overall Study|Physician Decision|5|||
28152521|NCT03034915|54821627|FG002|Overall Study|Physician Decision|2|||
28152522|NCT02631538|54821639|FG000|Treatment Period (Up to Week 52)|Adverse Event|1|||
28152523|NCT02631538|54821640|FG001|Treatment Period (Up to Week 52)|Adverse Event|5|||
28152524|NCT02631538|54821641|FG002|Treatment Period (Up to Week 52)|Adverse Event|2|||
28152525|NCT02631538|54821642|FG003|Treatment Period (Up to Week 52)|Adverse Event|2|||
28152526|NCT02631538|54821639|FG000|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
28152527|NCT02631538|54821640|FG001|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
28152528|NCT02631538|54821641|FG002|Treatment Period (Up to Week 52)|Withdrawal by Subject|2|||
28152529|NCT02631538|54821642|FG003|Treatment Period (Up to Week 52)|Withdrawal by Subject|5|||
28152530|NCT02631538|54821639|FG000|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
28152531|NCT02631538|54821640|FG001|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
27824875|NCT01961609|54290225|FG000|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
27824876|NCT01961609|54290226|FG001|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1|||
27824877|NCT01961609|54290227|FG002|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
27824878|NCT01961609|54290228|FG003|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
27824879|NCT01961609|54290225|FG000|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
27824880|NCT01961609|54290226|FG001|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0|||
27824881|NCT01961609|54290227|FG002|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
27824882|NCT01961609|54290228|FG003|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1|||
27824883|NCT01961609|54290225|FG000|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1|||
27824884|NCT01961609|54290226|FG001|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
27824885|NCT01961609|54290227|FG002|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
27824886|NCT01961609|54290228|FG003|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2|||
27824887|NCT01774981|54290337|FG000|Overall Study|Adverse Event|0|||
27824888|NCT01774981|54290338|FG001|Overall Study|Adverse Event|0|||
27824889|NCT01774981|54290339|FG002|Overall Study|Adverse Event|0|||
27824890|NCT01774981|54290340|FG003|Overall Study|Adverse Event|0|||
27824891|NCT01774981|54290341|FG004|Overall Study|Adverse Event|0|||
27824892|NCT01774981|54290342|FG005|Overall Study|Adverse Event|1|||
27824893|NCT01774981|54290343|FG006|Overall Study|Adverse Event|0|||
27824894|NCT01774981|54290344|FG007|Overall Study|Adverse Event|0|||
27824895|NCT01774981|54290337|FG000|Overall Study|Withdrawal by Subject|0|||
27824896|NCT01774981|54290338|FG001|Overall Study|Withdrawal by Subject|0|||
27824897|NCT01774981|54290339|FG002|Overall Study|Withdrawal by Subject|0|||
27824898|NCT01774981|54290340|FG003|Overall Study|Withdrawal by Subject|0|||
27824899|NCT01774981|54290341|FG004|Overall Study|Withdrawal by Subject|0|||
27941926|NCT01208207|54598595|FG000|Part I|Physician Decision|0|||
28074122|NCT00413699|54728749|FG002|Extension Period|No Longer Willing to Participate|2|||
28074123|NCT00413699|54728747|FG000|Extension Period|Protocol Violation|0|||
28074124|NCT00413699|54728748|FG001|Extension Period|Protocol Violation|0|||
28074125|NCT00413699|54728749|FG002|Extension Period|Protocol Violation|1|||
28074126|NCT00413699|54728747|FG000|Extension Period|Adverse Event|0|||
28074127|NCT00413699|54728748|FG001|Extension Period|Adverse Event|0|||
28074128|NCT00413699|54728749|FG002|Extension Period|Adverse Event|2|||
28074129|NCT03713320|54728777|FG000|Randomized Period|Adverse Event|1|||
28074130|NCT03713320|54728778|FG001|Randomized Period|Adverse Event|5|||
28074131|NCT03713320|54728779|FG002|Randomized Period|Adverse Event|0|||
28074132|NCT03713320|54728777|FG000|Randomized Period|Physician Decision|1|||
28074133|NCT03713320|54728778|FG001|Randomized Period|Physician Decision|1|||
28074134|NCT03713320|54728779|FG002|Randomized Period|Physician Decision|0|||
28074135|NCT03713320|54728777|FG000|Randomized Period|Withdrawal by Subject|4|||
28074136|NCT03713320|54728778|FG001|Randomized Period|Withdrawal by Subject|0|||
28074137|NCT03713320|54728779|FG002|Randomized Period|Withdrawal by Subject|0|||
28074138|NCT03713320|54728777|FG000|Randomized Period|Participant decision|3|||
28074139|NCT03713320|54728778|FG001|Randomized Period|Participant decision|1|||
28152532|NCT02631538|54821641|FG002|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
28152533|NCT02631538|54821642|FG003|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
28152534|NCT02631538|54821639|FG000|Treatment Period (Up to Week 52)|Physician Decision|1|||
28152535|NCT02631538|54821640|FG001|Treatment Period (Up to Week 52)|Physician Decision|0|||
28152536|NCT02631538|54821641|FG002|Treatment Period (Up to Week 52)|Physician Decision|0|||
28152537|NCT02631538|54821642|FG003|Treatment Period (Up to Week 52)|Physician Decision|1|||
28152538|NCT02631538|54821639|FG000|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
28152539|NCT02631538|54821640|FG001|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
28152540|NCT02631538|54821641|FG002|Treatment Period (Up to Week 52)|Reached stopping criteria|1|||
28152541|NCT02631538|54821642|FG003|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
28152542|NCT02631538|54821639|FG000|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
28152543|NCT02631538|54821640|FG001|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
28152544|NCT02631538|54821641|FG002|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
28152545|NCT02631538|54821642|FG003|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
28152546|NCT02631148|54821665|FG000|Overall Study|8 were ineligible|8|||
28152547|NCT02631148|54821666|FG001|Overall Study|8 were ineligible|0|||
27824900|NCT01774981|54290342|FG005|Overall Study|Withdrawal by Subject|0|||
27824901|NCT01774981|54290343|FG006|Overall Study|Withdrawal by Subject|0|||
27824902|NCT01774981|54290344|FG007|Overall Study|Withdrawal by Subject|1|||
27824903|NCT01774981|54290337|FG000|Overall Study|Death|0|||
27824904|NCT01774981|54290338|FG001|Overall Study|Death|0|||
27824905|NCT01774981|54290339|FG002|Overall Study|Death|0|||
27824906|NCT01774981|54290340|FG003|Overall Study|Death|0|||
27824907|NCT01774981|54290341|FG004|Overall Study|Death|1|||
27824908|NCT01774981|54290342|FG005|Overall Study|Death|0|||
27824909|NCT01774981|54290343|FG006|Overall Study|Death|0|||
27824910|NCT01774981|54290344|FG007|Overall Study|Death|0|||
27824911|NCT01972841|54290373|FG000|Overall Study|Randomized but Never Received Treatment|2|||
27824912|NCT01972841|54290374|FG001|Overall Study|Randomized but Never Received Treatment|5|||
27824913|NCT01972841|54290375|FG002|Overall Study|Randomized but Never Received Treatment|4|||
27824914|NCT01972841|54290376|FG003|Overall Study|Randomized but Never Received Treatment|2|||
27824915|NCT01972841|54290377|FG004|Overall Study|Randomized but Never Received Treatment|6|||
27824916|NCT01972841|54290378|FG005|Overall Study|Randomized but Never Received Treatment|13|||
27824917|NCT01972841|54290373|FG000|Overall Study|Adverse Event|13|||
27824918|NCT01972841|54290374|FG001|Overall Study|Adverse Event|8|||
27824919|NCT01972841|54290375|FG002|Overall Study|Adverse Event|12|||
27824920|NCT01972841|54290376|FG003|Overall Study|Adverse Event|9|||
27824921|NCT01972841|54290377|FG004|Overall Study|Adverse Event|21|||
27824922|NCT01972841|54290378|FG005|Overall Study|Adverse Event|26|||
27824923|NCT01972841|54290373|FG000|Overall Study|Lack of Efficacy|1|||
27824924|NCT01972841|54290374|FG001|Overall Study|Lack of Efficacy|0|||
27824925|NCT01972841|54290375|FG002|Overall Study|Lack of Efficacy|0|||
27824926|NCT01972841|54290376|FG003|Overall Study|Lack of Efficacy|2|||
27824927|NCT01972841|54290377|FG004|Overall Study|Lack of Efficacy|4|||
27824928|NCT01972841|54290378|FG005|Overall Study|Lack of Efficacy|1|||
27824929|NCT01972841|54290373|FG000|Overall Study|Lost to Follow-up|4|||
27824930|NCT01972841|54290374|FG001|Overall Study|Lost to Follow-up|2|||
27824931|NCT01972841|54290375|FG002|Overall Study|Lost to Follow-up|4|||
27824932|NCT01972841|54290376|FG003|Overall Study|Lost to Follow-up|2|||
27824933|NCT01972841|54290377|FG004|Overall Study|Lost to Follow-up|9|||
27824934|NCT01972841|54290378|FG005|Overall Study|Lost to Follow-up|3|||
27824935|NCT01972841|54290373|FG000|Overall Study|Protocol Violation|2|||
27824936|NCT01972841|54290374|FG001|Overall Study|Protocol Violation|2|||
27824937|NCT01972841|54290375|FG002|Overall Study|Protocol Violation|3|||
27824938|NCT01972841|54290376|FG003|Overall Study|Protocol Violation|5|||
27824939|NCT01972841|54290377|FG004|Overall Study|Protocol Violation|9|||
27824940|NCT01972841|54290378|FG005|Overall Study|Protocol Violation|4|||
27824941|NCT01972841|54290373|FG000|Overall Study|Withdrawal by participants|21|||
27824942|NCT01972841|54290374|FG001|Overall Study|Withdrawal by participants|27|||
27824943|NCT01972841|54290375|FG002|Overall Study|Withdrawal by participants|23|||
27824944|NCT01972841|54290376|FG003|Overall Study|Withdrawal by participants|16|||
27824945|NCT01972841|54290377|FG004|Overall Study|Withdrawal by participants|33|||
27824946|NCT01972841|54290378|FG005|Overall Study|Withdrawal by participants|34|||
27824947|NCT01972841|54290373|FG000|Overall Study|Miscellaneous|0|||
27824948|NCT01972841|54290374|FG001|Overall Study|Miscellaneous|0|||
27824949|NCT01972841|54290375|FG002|Overall Study|Miscellaneous|4|||
27824950|NCT01972841|54290376|FG003|Overall Study|Miscellaneous|1|||
27824951|NCT01972841|54290377|FG004|Overall Study|Miscellaneous|0|||
27824952|NCT01972841|54290378|FG005|Overall Study|Miscellaneous|4|||
27824953|NCT01972841|54290373|FG000|Overall Study|Did not have end of treatment page|0|||
27824954|NCT01972841|54290374|FG001|Overall Study|Did not have end of treatment page|0|||
27824955|NCT01972841|54290375|FG002|Overall Study|Did not have end of treatment page|0|||
27824956|NCT01972841|54290376|FG003|Overall Study|Did not have end of treatment page|0|||
27824957|NCT01972841|54290377|FG004|Overall Study|Did not have end of treatment page|1|||
27824958|NCT01972841|54290378|FG005|Overall Study|Did not have end of treatment page|0|||
28152548|NCT02631148|54821665|FG000|Overall Study|Withdrawal by Subject|1|||
28152549|NCT02631148|54821666|FG001|Overall Study|Withdrawal by Subject|0|||
28152550|NCT02631148|54821665|FG000|Overall Study|PAH not available to study participant|1|||
28152551|NCT02631148|54821666|FG001|Overall Study|PAH not available to study participant|0|||
28152552|NCT02753400|54821674|FG000|Overall Study|Adverse Event|3|||
28152553|NCT02753400|54821675|FG001|Overall Study|Adverse Event|0|||
28152554|NCT02753400|54821674|FG000|Overall Study|Withdrawal by Subject|2|||
28152555|NCT02753400|54821675|FG001|Overall Study|Withdrawal by Subject|1|||
27824959|NCT01774903|54290392|FG000|Overall Study|Adverse Event|7|||
27824960|NCT01774903|54290392|FG000|Overall Study|Withdrawal by Subject|2|||
27824961|NCT01774903|54290392|FG000|Overall Study|Lack of Efficacy|1|||
27824962|NCT01774903|54290392|FG000|Overall Study|Ineligible to continue the trial|1|||
27824963|NCT01774591|54290399|FG000|Overall Study|Physician Decision|1|||
27824964|NCT01774591|54290400|FG001|Overall Study|Physician Decision|1|||
28152556|NCT03943147|54821692|FG000|Open-Label MMF Run-in (Part A)|Other reasons|4|||
28152557|NCT03943147|54821693|FG001|Open-Label MMF Run-in (Part A)|Other reasons|0|||
27824965|NCT01774591|54290399|FG000|Overall Study|Withdrawal by Subject|0|||
27824966|NCT01774591|54290400|FG001|Overall Study|Withdrawal by Subject|1|||
27824967|NCT01774591|54290399|FG000|Overall Study|Adverse Event|0|||
27824968|NCT01774591|54290400|FG001|Overall Study|Adverse Event|2|||
27824969|NCT01708915|54290410|FG000|Overall Study|Adverse Event|1|||
27824970|NCT01708915|54290411|FG001|Overall Study|Adverse Event|0|||
27824971|NCT01708915|54290412|FG002|Overall Study|Adverse Event|9|||
27824972|NCT01708915|54290413|FG003|Overall Study|Adverse Event|13|||
27824973|NCT01708915|54290410|FG000|Overall Study|Lack of Efficacy|84|||
27824974|NCT01708915|54290411|FG001|Overall Study|Lack of Efficacy|60|||
27824975|NCT01708915|54290412|FG002|Overall Study|Lack of Efficacy|35|||
27824976|NCT01708915|54290413|FG003|Overall Study|Lack of Efficacy|15|||
27824977|NCT01708915|54290410|FG000|Overall Study|Protocol Violation|0|||
27824978|NCT01708915|54290411|FG001|Overall Study|Protocol Violation|0|||
27824979|NCT01708915|54290412|FG002|Overall Study|Protocol Violation|0|||
27824980|NCT01708915|54290413|FG003|Overall Study|Protocol Violation|1|||
27824981|NCT01708915|54290410|FG000|Overall Study|Withdrawal by Subject|0|||
27824982|NCT01708915|54290411|FG001|Overall Study|Withdrawal by Subject|1|||
27824983|NCT01708915|54290412|FG002|Overall Study|Withdrawal by Subject|2|||
27824984|NCT01708915|54290413|FG003|Overall Study|Withdrawal by Subject|2|||
27824985|NCT01708915|54290410|FG000|Overall Study|Other reasons than stated above|1|||
27824986|NCT01708915|54290411|FG001|Overall Study|Other reasons than stated above|1|||
27824987|NCT01708915|54290412|FG002|Overall Study|Other reasons than stated above|0|||
27824988|NCT01708915|54290413|FG003|Overall Study|Other reasons than stated above|2|||
27824989|NCT01708291|54290425|FG000|Overall Study|fighting|2|||
27824990|NCT01708291|54290426|FG001|Overall Study|fighting|1|||
27824991|NCT01708057|54290432|FG000|Overall Study|Withdrawal due to study termination.|1|||
27824992|NCT01708057|54290433|FG001|Overall Study|Withdrawal due to study termination.|1|||
27824993|NCT01708057|54290434|FG002|Overall Study|Withdrawal due to study termination.|1|||
27824994|NCT01748071|54290451|FG000|Overall Study|Adverse Event|2|||
27824995|NCT01748071|54290452|FG001|Overall Study|Adverse Event|2|||
27824996|NCT01748071|54290453|FG002|Overall Study|Adverse Event|0|||
27824997|NCT01972529|54290465|FG000|Overall Study|Adverse Event|0|||
27824998|NCT01972529|54290466|FG001|Overall Study|Adverse Event|1|||
27824999|NCT01972529|54290467|FG002|Overall Study|Adverse Event|0|||
27825000|NCT01972529|54290468|FG003|Overall Study|Adverse Event|0|||
28152558|NCT03943147|54821692|FG000|Open-Label MMF Run-in (Part A)|Adverse Event|1|||
28152559|NCT03943147|54821693|FG001|Open-Label MMF Run-in (Part A)|Adverse Event|0|||
28152560|NCT03943147|54821692|FG000|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|1|||
27825001|NCT01972529|54290465|FG000|Overall Study|Lost to Follow-up|1|||
27825002|NCT01972529|54290466|FG001|Overall Study|Lost to Follow-up|0|||
28152561|NCT03943147|54821693|FG001|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|0|||
28152562|NCT03943147|54821692|FG000|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|1|||
28152563|NCT03943147|54821693|FG001|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|0|||
28152564|NCT03943147|54821692|FG000|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|3|||
28152565|NCT03943147|54821693|FG001|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|0|||
27825003|NCT01972529|54290467|FG002|Overall Study|Lost to Follow-up|0|||
27825004|NCT01972529|54290468|FG003|Overall Study|Lost to Follow-up|0|||
27825005|NCT01972529|54290465|FG000|Overall Study|Participant Choice|0|||
27825006|NCT01972529|54290466|FG001|Overall Study|Participant Choice|1|||
27825007|NCT01972529|54290467|FG002|Overall Study|Participant Choice|0|||
27825008|NCT01972529|54290468|FG003|Overall Study|Participant Choice|0|||
27825009|NCT01972529|54290465|FG000|Overall Study|Withdrawl of Consent|1|||
27825010|NCT01972529|54290466|FG001|Overall Study|Withdrawl of Consent|2|||
27825011|NCT01972529|54290467|FG002|Overall Study|Withdrawl of Consent|0|||
27825012|NCT01972529|54290468|FG003|Overall Study|Withdrawl of Consent|1|||
27941927|NCT01208207|54598596|FG001|Part I|Physician Decision|1|||
28074140|NCT03713320|54728779|FG002|Randomized Period|Participant decision|0|||
27941928|NCT01208207|54598597|FG002|Part I|Physician Decision|0|||
27941929|NCT01208207|54598598|FG003|Part I|Physician Decision|0|||
28074141|NCT03713320|54728777|FG000|Randomized Period|Study terminated by sponsor|6|||
28074142|NCT03713320|54728778|FG001|Randomized Period|Study terminated by sponsor|3|||
28074143|NCT03713320|54728779|FG002|Randomized Period|Study terminated by sponsor|0|||
28074144|NCT03713320|54728777|FG000|Cobomarsen Crossover Period|Physician Decision|0|||
28074145|NCT03713320|54728778|FG001|Cobomarsen Crossover Period|Physician Decision|0|||
28074146|NCT03713320|54728779|FG002|Cobomarsen Crossover Period|Physician Decision|2|||
28074147|NCT03713320|54728777|FG000|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
28074148|NCT03713320|54728778|FG001|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
28074149|NCT03713320|54728779|FG002|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|5|||
28074150|NCT03712930|54728786|FG000|Overall Study|Death|7|||
27941930|NCT01208207|54598599|FG004|Part I|Physician Decision|0|||
27941931|NCT01208207|54598600|FG005|Part I|Physician Decision|0|||
28074151|NCT03712930|54728786|FG000|Overall Study|Physician Decision|1|||
27941932|NCT01208207|54598601|FG006|Part I|Physician Decision|0|||
27825013|NCT01972529|54290465|FG000|Overall Study|Other|0|||
27825014|NCT01972529|54290466|FG001|Overall Study|Other|0|||
27825015|NCT01972529|54290467|FG002|Overall Study|Other|0|||
27825016|NCT01972529|54290468|FG003|Overall Study|Other|2|||
27825017|NCT01972529|54290465|FG000|Overall Study|Not treated|0|||
27825018|NCT01972529|54290466|FG001|Overall Study|Not treated|1|||
27825019|NCT01972529|54290467|FG002|Overall Study|Not treated|2|||
27825020|NCT01972529|54290468|FG003|Overall Study|Not treated|1|||
27825021|NCT01747915|54290482|FG000|Overall Study|Other|1|||
27825022|NCT01747915|54290483|FG001|Overall Study|Other|1|||
27941933|NCT01208207|54598595|FG000|Part I|Progressive Disease|1|||
27941934|NCT01208207|54598596|FG001|Part I|Progressive Disease|0|||
28074152|NCT03712930|54728786|FG000|Overall Study|Study Terminated by Sponsor|3|||
28074153|NCT03712930|54728786|FG000|Overall Study|Progressive Disease|2|||
28074154|NCT00420407|54728792|FG000|Overall Study|Lost to Follow-up|0|||
28074155|NCT00420407|54728793|FG001|Overall Study|Lost to Follow-up|3|||
28074156|NCT00420407|54728792|FG000|Overall Study|Physician Decision|2|||
28074157|NCT00420407|54728793|FG001|Overall Study|Physician Decision|1|||
28074158|NCT00420407|54728792|FG000|Overall Study|subject identified as detainee|1|||
28074159|NCT00420407|54728793|FG001|Overall Study|subject identified as detainee|0|||
28074160|NCT00420407|54728792|FG000|Overall Study|subject identified as Jehovah's witness|1|||
28074161|NCT00420407|54728793|FG001|Overall Study|subject identified as Jehovah's witness|0|||
28074162|NCT00420407|54728792|FG000|Overall Study|Withdrawal by Subject|0|||
28074163|NCT00420407|54728793|FG001|Overall Study|Withdrawal by Subject|2|||
28074164|NCT00420095|54728802|FG000|Overall Study|Adverse Event|1|||
28074165|NCT00420095|54728803|FG001|Overall Study|Adverse Event|0|||
28152566|NCT03943147|54821692|FG000|Blinded Treatment (Part B)|Study terminated by sponsor|3|||
28152567|NCT03943147|54821693|FG001|Blinded Treatment (Part B)|Study terminated by sponsor|0|||
28152568|NCT03730987|54821711|FG000|Overall Study|Lost to Follow-up|2|||
28152569|NCT03730987|54821712|FG001|Overall Study|Lost to Follow-up|0|||
28152570|NCT03730987|54821713|FG002|Overall Study|Lost to Follow-up|2|||
28152571|NCT03730987|54821714|FG003|Overall Study|Lost to Follow-up|0|||
28152572|NCT03556891|54821725|FG000|Overall Study|Adverse Event|4|||
28152573|NCT03556891|54821725|FG000|Overall Study|MRI Need|3|||
28152574|NCT03556891|54821725|FG000|Overall Study|Device Failure|1|||
28152575|NCT03556891|54821725|FG000|Overall Study|Death|1|||
28152576|NCT03556891|54821725|FG000|Overall Study|Lost to Follow-up|1|||
28152577|NCT03556891|54821725|FG000|Overall Study|Missing at random|1|||
28152578|NCT03556891|54821725|FG000|Overall Study|Missing due to COVID|1|||
28152579|NCT03556891|54821725|FG000|Overall Study|Protocol Violation|1|||
27825023|NCT01747915|54290484|FG002|Overall Study|Other|1|||
28074166|NCT00420095|54728802|FG000|Overall Study|Protocol Violation|1|||
28074167|NCT00420095|54728803|FG001|Overall Study|Protocol Violation|1|||
28074168|NCT00420095|54728802|FG000|Overall Study|Lost to Follow-up|1|||
28074169|NCT00420095|54728803|FG001|Overall Study|Lost to Follow-up|0|||
28152580|NCT02844543|54821729|FG000|Overall Study|Withdrawal by Subject|4|||
28152581|NCT02844543|54821729|FG000|Overall Study|Did not meet eligibility criteria|1|||
28152582|NCT03034135|54821733|FG000|Overall Study|Withdrawal by Subject|2|||
27941935|NCT01208207|54598597|FG002|Part I|Progressive Disease|0|||
27825024|NCT01747915|54290482|FG000|Overall Study|Adverse Event|8|||
27825025|NCT01747915|54290483|FG001|Overall Study|Adverse Event|5|||
27825026|NCT01747915|54290484|FG002|Overall Study|Adverse Event|2|||
27825027|NCT01747915|54290482|FG000|Overall Study|Death|0|||
27825028|NCT01747915|54290483|FG001|Overall Study|Death|0|||
27825029|NCT01747915|54290484|FG002|Overall Study|Death|1|||
27825030|NCT01747915|54290482|FG000|Overall Study|Lack of Efficacy|0|||
27825031|NCT01747915|54290483|FG001|Overall Study|Lack of Efficacy|1|||
27825032|NCT01747915|54290484|FG002|Overall Study|Lack of Efficacy|0|||
27825033|NCT01747915|54290482|FG000|Overall Study|Lost to Follow-up|1|||
27825034|NCT01747915|54290483|FG001|Overall Study|Lost to Follow-up|0|||
27825035|NCT01747915|54290484|FG002|Overall Study|Lost to Follow-up|0|||
27825036|NCT01747915|54290482|FG000|Overall Study|Withdrawal by Subject|4|||
27825037|NCT01747915|54290483|FG001|Overall Study|Withdrawal by Subject|4|||
27825038|NCT01747915|54290484|FG002|Overall Study|Withdrawal by Subject|1|||
27825039|NCT01747915|54290482|FG000|Overall Study|Protocol Violation|1|||
27825040|NCT01747915|54290483|FG001|Overall Study|Protocol Violation|0|||
27825041|NCT01747915|54290484|FG002|Overall Study|Protocol Violation|0|||
27825042|NCT01747915|54290482|FG000|Overall Study|Pregnancy|0|||
27825043|NCT01747915|54290483|FG001|Overall Study|Pregnancy|0|||
27825044|NCT01747915|54290484|FG002|Overall Study|Pregnancy|1|||
27825045|NCT01961297|54290494|FG000|Overall Study|unconfirmed diagnosis of SD|2|||
27825046|NCT01961297|54290495|FG001|Overall Study|unconfirmed diagnosis of SD|1|||
27825047|NCT01960907|54290503|FG000|Overall Study|Death|4|||
27825048|NCT01960907|54290504|FG001|Overall Study|Death|3|||
27825049|NCT01960907|54290503|FG000|Overall Study|Withdrawal by Subject|32|||
27825050|NCT01960907|54290504|FG001|Overall Study|Withdrawal by Subject|42|||
28152583|NCT01671280|54821737|FG000|Overall Study|Withdrawal by Subject|2|||
28152584|NCT01405963|54821743|FG000|Overall Study|Moved Away|2|||
28152585|NCT01405963|54821744|FG001|Overall Study|Moved Away|0|||
28152586|NCT01405963|54821743|FG000|Overall Study|Adverse Event|0|||
28152587|NCT01405963|54821744|FG001|Overall Study|Adverse Event|1|||
28152588|NCT01405963|54821743|FG000|Overall Study|Lost to Follow-up|0|||
27825051|NCT01747837|54290515|FG000|Overall Study|Lost to Follow-up|5|||
28074170|NCT00419393|54728809|FG000|Overall Study|Adverse Event|5|||
28074171|NCT00419393|54728809|FG000|Overall Study|Protocol Violation|5|||
28074172|NCT00419393|54728809|FG000|Overall Study|Withdrawal by Subject|7|||
28074173|NCT00419393|54728809|FG000|Overall Study|Other: Sponsor request|3|||
28074174|NCT00419393|54728809|FG000|Overall Study|Other: Subject had temporal lobectomy|1|||
28074175|NCT00419393|54728809|FG000|Overall Study|Other: Site closure|1|||
28074176|NCT00419393|54728809|FG000|Overall Study|Other: Other health problems|1|||
28074177|NCT00419393|54728809|FG000|Overall Study|Other: Investigator decision|1|||
28152589|NCT01405963|54821744|FG001|Overall Study|Lost to Follow-up|1|||
28152590|NCT02846415|54821753|FG000|Overall Study|Lost to Follow-up|2|||
28152591|NCT02846415|54821754|FG001|Overall Study|Lost to Follow-up|0|||
28152592|NCT02846415|54821753|FG000|Overall Study|Withdrawal by Subject|1|||
28152593|NCT02846415|54821754|FG001|Overall Study|Withdrawal by Subject|1|||
28152594|NCT02628418|54821773|FG000|Overall Study|Lost to Follow-up|1|||
28152595|NCT02628418|54821774|FG001|Overall Study|Lost to Follow-up|2|||
28152596|NCT02752776|54821802|FG000|Overall Study|Adverse Event|15|||
27825052|NCT01747837|54290516|FG001|Overall Study|Lost to Follow-up|2|||
28074178|NCT00419159|54728815|FG000|Overall Study|Adverse Event|7|||
27825053|NCT01747837|54290515|FG000|Overall Study|Death|4|||
27825054|NCT01747837|54290516|FG001|Overall Study|Death|4|||
28074179|NCT00419159|54728816|FG001|Overall Study|Adverse Event|15|||
28152597|NCT02752776|54821803|FG001|Overall Study|Adverse Event|23|||
27825055|NCT01971203|54290524|FG000|Overall Study|Protocol Violation|3|||
28152598|NCT02752776|54821804|FG002|Overall Study|Adverse Event|11|||
28152599|NCT02752776|54821802|FG000|Overall Study|Lack of Efficacy|2|||
28152600|NCT02752776|54821803|FG001|Overall Study|Lack of Efficacy|6|||
28152601|NCT02752776|54821804|FG002|Overall Study|Lack of Efficacy|14|||
28152602|NCT02752776|54821802|FG000|Overall Study|Lost to Follow-up|11|||
28152603|NCT02752776|54821803|FG001|Overall Study|Lost to Follow-up|12|||
28152604|NCT02752776|54821804|FG002|Overall Study|Lost to Follow-up|4|||
28152605|NCT02752776|54821802|FG000|Overall Study|Non-compliance with study treatment|0|||
28152606|NCT02752776|54821803|FG001|Overall Study|Non-compliance with study treatment|0|||
27825056|NCT01971203|54290525|FG001|Overall Study|Protocol Violation|2|||
28152607|NCT02752776|54821804|FG002|Overall Study|Non-compliance with study treatment|1|||
28152608|NCT02752776|54821802|FG000|Overall Study|Physician Decision|2|||
28152609|NCT02752776|54821803|FG001|Overall Study|Physician Decision|6|||
28152610|NCT02752776|54821804|FG002|Overall Study|Physician Decision|2|||
28152611|NCT02752776|54821802|FG000|Overall Study|Pregnancy|1|||
28152612|NCT02752776|54821803|FG001|Overall Study|Pregnancy|6|||
28152613|NCT02752776|54821804|FG002|Overall Study|Pregnancy|3|||
28152614|NCT02752776|54821802|FG000|Overall Study|Protocol Violation|10|||
28152615|NCT02752776|54821803|FG001|Overall Study|Protocol Violation|13|||
28152616|NCT02752776|54821804|FG002|Overall Study|Protocol Violation|6|||
28152617|NCT02752776|54821802|FG000|Overall Study|Subject/guardian decision|8|||
28152618|NCT02752776|54821803|FG001|Overall Study|Subject/guardian decision|6|||
28152619|NCT02752776|54821804|FG002|Overall Study|Subject/guardian decision|4|||
28152620|NCT02752776|54821802|FG000|Overall Study|Death|0|||
28152621|NCT02752776|54821803|FG001|Overall Study|Death|0|||
28152622|NCT02752776|54821804|FG002|Overall Study|Death|1|||
28152623|NCT02752776|54821802|FG000|Overall Study|Withdrawal by Subject|3|||
28152624|NCT02752776|54821803|FG001|Overall Study|Withdrawal by Subject|4|||
28152625|NCT02752776|54821804|FG002|Overall Study|Withdrawal by Subject|2|||
28152626|NCT01342965|54821816|FG000|Overall Study|Death|58|||
28152627|NCT01342965|54821817|FG001|Overall Study|Death|57|||
28152628|NCT01342965|54821816|FG000|Overall Study|Lost to Follow-up|5|||
28152629|NCT01342965|54821817|FG001|Overall Study|Lost to Follow-up|3|||
28152630|NCT01342965|54821816|FG000|Overall Study|Other Reasons- Unspecified|44|||
28152631|NCT01342965|54821817|FG001|Overall Study|Other Reasons- Unspecified|38|||
28152632|NCT01342965|54821816|FG000|Overall Study|Withdrawal by Subject|2|||
28152633|NCT01342965|54821817|FG001|Overall Study|Withdrawal by Subject|9|||
28152634|NCT02629822|54821823|FG000|Base Study|Lost to Follow-up|2|||
28152635|NCT02629822|54821823|FG000|Base Study|Non-Compliance With Study Drug|1|||
28152636|NCT02629822|54821823|FG000|Extension Study|Adverse Event|1|||
28152637|NCT02629822|54821823|FG000|Extension Study|Lost to Follow-up|1|||
28152638|NCT02840721|54821828|FG000|Treatment Period|Adverse Event|1|||
28152639|NCT02840721|54821828|FG000|Follow-Up|Lack of Efficacy|1|||
28152640|NCT02840721|54821828|FG000|Follow-Up|Withdrawal by Subject|4|||
28152641|NCT02840721|54821828|FG000|Follow-Up|Withdrawal of Consent|2|||
28152642|NCT03462706|54821836|FG000|Overall Study|Polyp was pedunculated|1|||
28152643|NCT03462706|54821837|FG001|Overall Study|Polyp was pedunculated|0|||
28152644|NCT03462706|54821838|FG002|Overall Study|Polyp was pedunculated|1|||
28152645|NCT03462706|54821839|FG003|Overall Study|Polyp was pedunculated|0|||
28152646|NCT03462706|54821836|FG000|Overall Study|Polyp was next to a cancer and not removed|0|||
28152647|NCT03462706|54821837|FG001|Overall Study|Polyp was next to a cancer and not removed|0|||
28152648|NCT03462706|54821838|FG002|Overall Study|Polyp was next to a cancer and not removed|0|||
28074180|NCT00419159|54728815|FG000|Overall Study|Abnormal laboratory value(s)|0|||
28074181|NCT00419159|54728816|FG001|Overall Study|Abnormal laboratory value(s)|2|||
28074182|NCT00419159|54728815|FG000|Overall Study|Subject's no longer requires study drug|0|||
28074183|NCT00419159|54728816|FG001|Overall Study|Subject's no longer requires study drug|1|||
28074184|NCT00419159|54728815|FG000|Overall Study|Protocol Violation|1|||
28074185|NCT00419159|54728816|FG001|Overall Study|Protocol Violation|0|||
28074186|NCT00419159|54728815|FG000|Overall Study|Withdrawal by Subject|10|||
28074187|NCT00419159|54728816|FG001|Overall Study|Withdrawal by Subject|3|||
28074188|NCT00419159|54728815|FG000|Overall Study|Lost to Follow-up|0|||
28074189|NCT00419159|54728816|FG001|Overall Study|Lost to Follow-up|1|||
28074190|NCT00419159|54728815|FG000|Overall Study|Death|2|||
28074191|NCT00419159|54728816|FG001|Overall Study|Death|2|||
28074192|NCT00419159|54728815|FG000|Overall Study|Disease progression|79|||
28074193|NCT00419159|54728816|FG001|Overall Study|Disease progression|76|||
28074194|NCT03717064|54728830|FG000|Period 2|Adverse Event|1|||
28074195|NCT03716050|54728842|FG000|Overall Study|Lost to Follow-up|0|||
28074196|NCT03716050|54728843|FG001|Overall Study|Lost to Follow-up|0|||
28074197|NCT03716050|54728844|FG002|Overall Study|Lost to Follow-up|1|||
28074198|NCT03716050|54728845|FG003|Overall Study|Lost to Follow-up|0|||
28074199|NCT03716050|54728846|FG004|Overall Study|Lost to Follow-up|0|||
28074200|NCT03716050|54728847|FG005|Overall Study|Lost to Follow-up|0|||
28074201|NCT03716050|54728848|FG006|Overall Study|Lost to Follow-up|0|||
28152649|NCT03462706|54821839|FG003|Overall Study|Polyp was next to a cancer and not removed|1|||
28152650|NCT02840253|54821849|FG000|Overall Study|Unsuccessful block|4|||
28152651|NCT02752074|54821855|FG000|Overall Study|Lost to Follow-up|1|||
28152652|NCT02752074|54821856|FG001|Overall Study|Lost to Follow-up|4|||
28152653|NCT02752074|54821855|FG000|Overall Study|Death|146|||
28152654|NCT02752074|54821856|FG001|Overall Study|Death|129|||
28152655|NCT02752074|54821855|FG000|Overall Study|Withdrawal by Subject|9|||
28152656|NCT02752074|54821856|FG001|Overall Study|Withdrawal by Subject|10|||
28152657|NCT02835495|54821864|FG000|Overall Study|Cancer diagnosis prior intervention|1|||
28152658|NCT02835495|54821865|FG001|Overall Study|Cancer diagnosis prior intervention|0|||
28152659|NCT02835495|54821864|FG000|Overall Study|Declined in-person follow-up visit|4|||
28152660|NCT02835495|54821865|FG001|Overall Study|Declined in-person follow-up visit|2|||
28152661|NCT02835339|54821875|FG000|Overall Study|Did not receive allocated intervention|13|||
28152662|NCT02835339|54821876|FG001|Overall Study|Did not receive allocated intervention|16|||
28152663|NCT02832063|54821884|FG000|Overall Study|Adverse Event|2|||
28152664|NCT02832063|54821885|FG001|Overall Study|Adverse Event|1|||
28152665|NCT02832063|54821884|FG000|Overall Study|Physician Decision|5|||
28152666|NCT02832063|54821885|FG001|Overall Study|Physician Decision|7|||
28152667|NCT02832063|54821884|FG000|Overall Study|Lost to Follow-up|15|||
28152668|NCT02832063|54821885|FG001|Overall Study|Lost to Follow-up|8|||
28152669|NCT02832063|54821884|FG000|Overall Study|Withdrawal by Subject|10|||
28152670|NCT02832063|54821885|FG001|Overall Study|Withdrawal by Subject|21|||
28152671|NCT02832063|54821884|FG000|Overall Study|Other|2|||
28152672|NCT02832063|54821885|FG001|Overall Study|Other|1|||
28160114|NCT03058679|54830226|FG000|Baseline to Week 6|Lost to Follow-up|3|||
28160115|NCT03058679|54830227|FG001|Baseline to Week 6|Lost to Follow-up|2|||
28160116|NCT03058679|54830226|FG000|Baseline to Week 6|Change in Crohn's disease medication|4|||
28160117|NCT03058679|54830227|FG001|Baseline to Week 6|Change in Crohn's disease medication|2|||
28160118|NCT03058679|54830226|FG000|Baseline to Week 6|Adverse Event|6|||
28160119|NCT03058679|54830227|FG001|Baseline to Week 6|Adverse Event|6|||
28160120|NCT03058679|54830226|FG000|Baseline to Week 6|Withdrawal by Subject|4|||
28160121|NCT03058679|54830227|FG001|Baseline to Week 6|Withdrawal by Subject|3|||
28160122|NCT03058679|54830226|FG000|Baseline to Week 6|Difficulty following the diet|0|||
28160123|NCT03058679|54830227|FG001|Baseline to Week 6|Difficulty following the diet|2|||
28160124|NCT03058679|54830226|FG000|Baseline to Week 6|Physician Decision|1|||
28074202|NCT03716050|54728849|FG007|Overall Study|Lost to Follow-up|0|||
28074203|NCT03716050|54728842|FG000|Overall Study|Physician Decision|0|||
28074204|NCT03716050|54728843|FG001|Overall Study|Physician Decision|0|||
28074205|NCT03716050|54728844|FG002|Overall Study|Physician Decision|0|||
28074206|NCT03716050|54728845|FG003|Overall Study|Physician Decision|1|||
28074207|NCT03716050|54728846|FG004|Overall Study|Physician Decision|0|||
28074208|NCT03716050|54728847|FG005|Overall Study|Physician Decision|0|||
28074209|NCT03716050|54728848|FG006|Overall Study|Physician Decision|0|||
28074210|NCT03716050|54728849|FG007|Overall Study|Physician Decision|0|||
28160125|NCT03058679|54830227|FG001|Baseline to Week 6|Physician Decision|0|||
28160126|NCT03058679|54830226|FG000|Week 6 to Week 12|Change in medication|5|||
28160127|NCT03058679|54830227|FG001|Week 6 to Week 12|Change in medication|7|||
28160128|NCT03058679|54830226|FG000|Week 6 to Week 12|Adverse Event|4|||
28074211|NCT03716050|54728842|FG000|Overall Study|Protocol Violation|0|||
28160129|NCT03058679|54830227|FG001|Week 6 to Week 12|Adverse Event|3|||
28160130|NCT03058679|54830226|FG000|Week 6 to Week 12|Withdrawal by Subject|9|||
28160131|NCT03058679|54830227|FG001|Week 6 to Week 12|Withdrawal by Subject|4|||
28074212|NCT03716050|54728843|FG001|Overall Study|Protocol Violation|0|||
28152673|NCT03125902|54821904|FG000|Overall Study|Death|52|||
28152674|NCT03125902|54821905|FG001|Overall Study|Death|123|||
28152675|NCT03125902|54821904|FG000|Overall Study|Lost to Follow-up|1|||
28152676|NCT03125902|54821905|FG001|Overall Study|Lost to Follow-up|0|||
28152677|NCT03125902|54821904|FG000|Overall Study|Mastectomy|0|||
28152678|NCT03125902|54821905|FG001|Overall Study|Mastectomy|1|||
28152679|NCT03125902|54821904|FG000|Overall Study|Physician Decision|1|||
28152680|NCT03125902|54821905|FG001|Overall Study|Physician Decision|0|||
28074213|NCT03716050|54728844|FG002|Overall Study|Protocol Violation|0|||
28074214|NCT03716050|54728845|FG003|Overall Study|Protocol Violation|1|||
28074215|NCT03716050|54728846|FG004|Overall Study|Protocol Violation|0|||
28074216|NCT03716050|54728847|FG005|Overall Study|Protocol Violation|0|||
28074217|NCT03716050|54728848|FG006|Overall Study|Protocol Violation|0|||
28074218|NCT03716050|54728849|FG007|Overall Study|Protocol Violation|2|||
28074219|NCT00413231|54728866|FG000|0 to 30-day Post Treatment|Death|5|||
28074220|NCT00413231|54728866|FG000|0 to 30-day Post Treatment|Intend to treat, but not implanted|3|||
28074221|NCT00413231|54728866|FG000|30-day to 365-day Post Treatment|Death|13|||
28152681|NCT03125902|54821904|FG000|Overall Study|Withdrawal by Subject|13|||
28152682|NCT03125902|54821905|FG001|Overall Study|Withdrawal by Subject|25|||
28152683|NCT03125902|54821904|FG000|Overall Study|Study is ongoing|153|||
28152684|NCT03125902|54821905|FG001|Overall Study|Study is ongoing|282|||
28152685|NCT04412707|54821914|FG000|Cycle 1|Death|0|||
28152686|NCT04412707|54821915|FG001|Cycle 1|Death|3|||
28074222|NCT00413231|54728866|FG000|365-day to 60-month Post Treatment|Death|36|||
28152687|NCT04412707|54821914|FG000|Cycle 1|Disease progression|1|||
28152688|NCT04412707|54821915|FG001|Cycle 1|Disease progression|2|||
28152689|NCT04412707|54821914|FG000|Cycle 2|Death|0|||
28152690|NCT04412707|54821915|FG001|Cycle 2|Death|1|||
28074223|NCT00413231|54728866|FG000|365-day to 60-month Post Treatment|Withdrawal by Subject|5|||
28074224|NCT00413231|54728866|FG000|365-day to 60-month Post Treatment|Lost to Follow-up|4|||
28074225|NCT00413231|54728866|FG000|365-day to 60-month Post Treatment|Exited after surgical conversion|1|||
28074226|NCT00413153|54728886|FG000|Overall Study|Withdrawal by Subject|1|||
28074227|NCT00413153|54728887|FG001|Overall Study|Withdrawal by Subject|1|||
28074228|NCT00413153|54728886|FG000|Overall Study|Adverse Event|1|||
28074229|NCT00413153|54728887|FG001|Overall Study|Adverse Event|0|||
28074230|NCT00412607|54728893|FG000|Overall Study|Withdrawal by Subject|9|||
28074231|NCT00412607|54728893|FG000|Overall Study|Lost to Follow-up|19|||
28152691|NCT04412707|54821914|FG000|Cycle 2|Disease progression|3|||
28152692|NCT04412707|54821915|FG001|Cycle 2|Disease progression|0|||
28152693|NCT04412707|54821914|FG000|Cycle 3 to End of Study (EOS)|Death|1|||
28152694|NCT04412707|54821915|FG001|Cycle 3 to End of Study (EOS)|Death|3|||
28152695|NCT04412707|54821914|FG000|Cycle 3 to End of Study (EOS)|Disease progression|4|||
28152696|NCT04412707|54821915|FG001|Cycle 3 to End of Study (EOS)|Disease progression|2|||
28152697|NCT04412707|54821914|FG000|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|4|||
28152698|NCT04412707|54821915|FG001|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|2|||
28152699|NCT04412707|54821914|FG000|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|1|||
28152700|NCT04412707|54821915|FG001|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|0|||
28152701|NCT01358721|54821934|FG000|Overall Study|Withdrawal by Subject|0|||
28152702|NCT01358721|54821935|FG001|Overall Study|Withdrawal by Subject|0|||
28152703|NCT01358721|54821936|FG002|Overall Study|Withdrawal by Subject|0|||
28152704|NCT01358721|54821937|FG003|Overall Study|Withdrawal by Subject|1|||
28152705|NCT01358721|54821934|FG000|Overall Study|Death|0|||
28152706|NCT01358721|54821935|FG001|Overall Study|Death|2|||
28152707|NCT01358721|54821936|FG002|Overall Study|Death|0|||
28152708|NCT01358721|54821937|FG003|Overall Study|Death|0|||
28152709|NCT01358721|54821934|FG000|Overall Study|Study Drug Toxicity|1|||
28152710|NCT01358721|54821935|FG001|Overall Study|Study Drug Toxicity|3|||
28152711|NCT01358721|54821936|FG002|Overall Study|Study Drug Toxicity|4|||
28152712|NCT01358721|54821937|FG003|Overall Study|Study Drug Toxicity|5|||
28152713|NCT01358721|54821934|FG000|Overall Study|SUBJ request to discontinue study TRT|0|||
28152714|NCT01358721|54821935|FG001|Overall Study|SUBJ request to discontinue study TRT|0|||
28152715|NCT01358721|54821936|FG002|Overall Study|SUBJ request to discontinue study TRT|0|||
28152716|NCT01358721|54821937|FG003|Overall Study|SUBJ request to discontinue study TRT|1|||
28152717|NCT01358721|54821934|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
28152718|NCT01358721|54821935|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
28152719|NCT01358721|54821936|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
28152720|NCT01358721|54821937|FG003|Overall Study|Subject No Longer Meets Study Criteria|1|||
28152721|NCT01358721|54821934|FG000|Overall Study|Adverse Event related to study drug|1|||
28152722|NCT01358721|54821935|FG001|Overall Study|Adverse Event related to study drug|0|||
28152723|NCT01358721|54821936|FG002|Overall Study|Adverse Event related to study drug|0|||
28152724|NCT01358721|54821937|FG003|Overall Study|Adverse Event related to study drug|1|||
28152725|NCT01358721|54821934|FG000|Overall Study|Disease Progression|19|||
28152726|NCT01358721|54821935|FG001|Overall Study|Disease Progression|15|||
28152727|NCT01358721|54821936|FG002|Overall Study|Disease Progression|17|||
28152728|NCT01358721|54821937|FG003|Overall Study|Disease Progression|15|||
28152729|NCT01358721|54821934|FG000|Overall Study|Out of State/Unmet Criteria|0|||
28152730|NCT01358721|54821935|FG001|Overall Study|Out of State/Unmet Criteria|0|||
28152731|NCT01358721|54821936|FG002|Overall Study|Out of State/Unmet Criteria|1|||
28152732|NCT01358721|54821937|FG003|Overall Study|Out of State/Unmet Criteria|0|||
28152733|NCT01341639|54821949|FG000|Infant Series|Protocol Violation|1|||
28074232|NCT00412607|54728893|FG000|Overall Study|Death|61|||
28074233|NCT00412607|54728893|FG000|Overall Study|Not meet inclusion/exclusion Criteria|15|||
28074234|NCT00419003|54728902|FG000|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
28074235|NCT00419003|54728903|FG001|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
28074236|NCT00419003|54728902|FG000|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1|||
28074237|NCT00419003|54728903|FG001|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0|||
28152734|NCT01341639|54821950|FG001|Infant Series|Protocol Violation|0|||
28152735|NCT01341639|54821949|FG000|Infant Series|Not Vaccinated|0|||
28152736|NCT01341639|54821950|FG001|Infant Series|Not Vaccinated|1|||
28152737|NCT01341639|54821949|FG000|Infant Series|Adverse Event|0|||
28152738|NCT01341639|54821950|FG001|Infant Series|Adverse Event|5|||
28152739|NCT01341639|54821949|FG000|Infant Series|Withdrawal by Subject|11|||
28152740|NCT01341639|54821950|FG001|Infant Series|Withdrawal by Subject|8|||
28152741|NCT01341639|54821949|FG000|Infant Series|Lost to Follow-up|0|||
28152742|NCT01341639|54821950|FG001|Infant Series|Lost to Follow-up|2|||
28152743|NCT01341639|54821949|FG000|Infant Series|Site 0048 Participants|17|||
28152744|NCT01341639|54821950|FG001|Infant Series|Site 0048 Participants|16|||
28152745|NCT01341639|54821949|FG000|Interim Period|Withdrawal by Subject|6|||
28152746|NCT01341639|54821950|FG001|Interim Period|Withdrawal by Subject|7|||
28152747|NCT01341639|54821949|FG000|Interim Period|Lost to Follow-up|2|||
28152748|NCT01341639|54821950|FG001|Interim Period|Lost to Follow-up|0|||
28152749|NCT01341639|54821949|FG000|Interim Period|Physician Decision|0|||
28152750|NCT01341639|54821950|FG001|Interim Period|Physician Decision|1|||
28152751|NCT01341639|54821949|FG000|Interim Period|Protocol Violation|0|||
28152752|NCT01341639|54821950|FG001|Interim Period|Protocol Violation|1|||
28152753|NCT01341639|54821949|FG000|Post-Treatment|Withdrawal by Subject|0|||
28152754|NCT01341639|54821950|FG001|Post-Treatment|Withdrawal by Subject|1|||
28152755|NCT01341639|54821949|FG000|Post-Treatment|Adverse Event|0|||
28152756|NCT01341639|54821950|FG001|Post-Treatment|Adverse Event|2|||
28152757|NCT02628028|54821964|FG000|Dosing Period|Withdrawal by Subject|0|||
28152758|NCT02628028|54821965|FG001|Dosing Period|Withdrawal by Subject|0|||
28152759|NCT02628028|54821966|FG002|Dosing Period|Withdrawal by Subject|1|||
28152760|NCT02628028|54821967|FG003|Dosing Period|Withdrawal by Subject|0|||
28152761|NCT02628028|54821968|FG004|Dosing Period|Withdrawal by Subject|2|||
28152762|NCT02628028|54821969|FG005|Dosing Period|Withdrawal by Subject|4|||
28152763|NCT02628028|54821970|FG006|Dosing Period|Withdrawal by Subject|1|||
28152764|NCT02628028|54821971|FG007|Dosing Period|Withdrawal by Subject|1|||
28152765|NCT02628028|54821964|FG000|Dosing Period|Adverse Event|0|||
28152766|NCT02628028|54821965|FG001|Dosing Period|Adverse Event|0|||
28074238|NCT00418691|54728915|FG000|Overall Study|Lost to Follow-up|1|||
28152767|NCT02628028|54821966|FG002|Dosing Period|Adverse Event|0|||
28152768|NCT02628028|54821967|FG003|Dosing Period|Adverse Event|0|||
28152769|NCT02628028|54821968|FG004|Dosing Period|Adverse Event|2|||
27941936|NCT01208207|54598598|FG003|Part I|Progressive Disease|0|||
28152770|NCT02628028|54821969|FG005|Dosing Period|Adverse Event|1|||
28152771|NCT02628028|54821970|FG006|Dosing Period|Adverse Event|3|||
28152772|NCT02628028|54821971|FG007|Dosing Period|Adverse Event|2|||
28152773|NCT02628028|54821964|FG000|Dosing Period|Death|0|||
28152774|NCT02628028|54821965|FG001|Dosing Period|Death|0|||
28152775|NCT02628028|54821966|FG002|Dosing Period|Death|0|||
28152776|NCT02628028|54821967|FG003|Dosing Period|Death|0|||
28152777|NCT02628028|54821968|FG004|Dosing Period|Death|0|||
28152778|NCT02628028|54821969|FG005|Dosing Period|Death|0|||
28152779|NCT02628028|54821970|FG006|Dosing Period|Death|0|||
28152780|NCT02628028|54821971|FG007|Dosing Period|Death|1|||
28152781|NCT02628028|54821964|FG000|Dosing Period|Lack of Efficacy|0|||
28152782|NCT02628028|54821965|FG001|Dosing Period|Lack of Efficacy|0|||
28152783|NCT02628028|54821966|FG002|Dosing Period|Lack of Efficacy|0|||
28152784|NCT02628028|54821967|FG003|Dosing Period|Lack of Efficacy|0|||
28152785|NCT02628028|54821968|FG004|Dosing Period|Lack of Efficacy|3|||
28152786|NCT02628028|54821969|FG005|Dosing Period|Lack of Efficacy|0|||
28152787|NCT02628028|54821970|FG006|Dosing Period|Lack of Efficacy|1|||
28152788|NCT02628028|54821971|FG007|Dosing Period|Lack of Efficacy|0|||
28152789|NCT02628028|54821964|FG000|Dosing Period|Study Terminated by Sponsor|0|||
28152790|NCT02628028|54821965|FG001|Dosing Period|Study Terminated by Sponsor|0|||
28152791|NCT02628028|54821966|FG002|Dosing Period|Study Terminated by Sponsor|0|||
28152792|NCT02628028|54821967|FG003|Dosing Period|Study Terminated by Sponsor|0|||
28152793|NCT02628028|54821968|FG004|Dosing Period|Study Terminated by Sponsor|7|||
28152794|NCT02628028|54821969|FG005|Dosing Period|Study Terminated by Sponsor|6|||
28152795|NCT02628028|54821970|FG006|Dosing Period|Study Terminated by Sponsor|7|||
28152796|NCT02628028|54821971|FG007|Dosing Period|Study Terminated by Sponsor|7|||
28152797|NCT02628028|54821964|FG000|Dosing Period|Physician Decision|0|||
28152798|NCT02628028|54821965|FG001|Dosing Period|Physician Decision|0|||
28152799|NCT02628028|54821966|FG002|Dosing Period|Physician Decision|0|||
28152800|NCT02628028|54821967|FG003|Dosing Period|Physician Decision|0|||
28152801|NCT02628028|54821968|FG004|Dosing Period|Physician Decision|0|||
28152802|NCT02628028|54821969|FG005|Dosing Period|Physician Decision|1|||
28152803|NCT02628028|54821970|FG006|Dosing Period|Physician Decision|0|||
28152804|NCT02628028|54821971|FG007|Dosing Period|Physician Decision|0|||
28152805|NCT02628028|54821964|FG000|Dosing Period|Site Terminated by Sponsor|0|||
28152806|NCT02628028|54821965|FG001|Dosing Period|Site Terminated by Sponsor|0|||
28152807|NCT02628028|54821966|FG002|Dosing Period|Site Terminated by Sponsor|0|||
28152808|NCT02628028|54821967|FG003|Dosing Period|Site Terminated by Sponsor|0|||
28152809|NCT02628028|54821968|FG004|Dosing Period|Site Terminated by Sponsor|0|||
28152810|NCT02628028|54821969|FG005|Dosing Period|Site Terminated by Sponsor|1|||
28152811|NCT02628028|54821970|FG006|Dosing Period|Site Terminated by Sponsor|1|||
28152812|NCT02628028|54821971|FG007|Dosing Period|Site Terminated by Sponsor|0|||
28152813|NCT02628028|54821964|FG000|Dosing Period|Lost to Follow-up|0|||
28152814|NCT02628028|54821965|FG001|Dosing Period|Lost to Follow-up|0|||
28152815|NCT02628028|54821966|FG002|Dosing Period|Lost to Follow-up|0|||
28152816|NCT02628028|54821967|FG003|Dosing Period|Lost to Follow-up|0|||
28152817|NCT02628028|54821968|FG004|Dosing Period|Lost to Follow-up|0|||
28152818|NCT02628028|54821969|FG005|Dosing Period|Lost to Follow-up|0|||
28152819|NCT02628028|54821970|FG006|Dosing Period|Lost to Follow-up|1|||
28152820|NCT02628028|54821971|FG007|Dosing Period|Lost to Follow-up|0|||
28152821|NCT02628028|54821964|FG000|Dosing Period|Other|0|||
28152822|NCT02628028|54821965|FG001|Dosing Period|Other|0|||
28152823|NCT02628028|54821966|FG002|Dosing Period|Other|0|||
28152824|NCT02628028|54821967|FG003|Dosing Period|Other|0|||
28152825|NCT02628028|54821968|FG004|Dosing Period|Other|2|||
28152826|NCT02628028|54821969|FG005|Dosing Period|Other|1|||
28152827|NCT02628028|54821970|FG006|Dosing Period|Other|2|||
28152828|NCT02628028|54821971|FG007|Dosing Period|Other|4|||
28152829|NCT02628028|54821964|FG000|Long-term Extension (LTE) Period|Adverse Event|0|||
28152830|NCT02628028|54821965|FG001|Long-term Extension (LTE) Period|Adverse Event|0|||
28152831|NCT02628028|54821966|FG002|Long-term Extension (LTE) Period|Adverse Event|0|||
28152832|NCT02628028|54821967|FG003|Long-term Extension (LTE) Period|Adverse Event|0|||
28152833|NCT02628028|54821968|FG004|Long-term Extension (LTE) Period|Adverse Event|0|||
28152834|NCT02628028|54821969|FG005|Long-term Extension (LTE) Period|Adverse Event|1|||
28152835|NCT02628028|54821970|FG006|Long-term Extension (LTE) Period|Adverse Event|0|||
28152836|NCT02628028|54821971|FG007|Long-term Extension (LTE) Period|Adverse Event|3|||
28152837|NCT02628028|54821964|FG000|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
28152838|NCT02628028|54821965|FG001|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
28152839|NCT02628028|54821966|FG002|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
28152840|NCT02628028|54821967|FG003|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
28152841|NCT02628028|54821968|FG004|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
28152842|NCT02628028|54821969|FG005|Long-term Extension (LTE) Period|Lack of Efficacy|2|||
28152843|NCT02628028|54821970|FG006|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
28152844|NCT02628028|54821971|FG007|Long-term Extension (LTE) Period|Lack of Efficacy|1|||
28152845|NCT02628028|54821964|FG000|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
28152846|NCT02628028|54821965|FG001|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
28152847|NCT02628028|54821966|FG002|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
28152848|NCT02628028|54821967|FG003|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
28152849|NCT02628028|54821968|FG004|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
28152850|NCT02628028|54821969|FG005|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52|||
28152851|NCT02628028|54821970|FG006|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
28152852|NCT02628028|54821971|FG007|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
28152853|NCT02628028|54821964|FG000|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
28152854|NCT02628028|54821965|FG001|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
28152855|NCT02628028|54821966|FG002|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
28152856|NCT02628028|54821967|FG003|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
28152857|NCT02628028|54821968|FG004|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
28152858|NCT02628028|54821969|FG005|Long-term Extension (LTE) Period|Withdrawal by Subject|2|||
28152859|NCT02628028|54821970|FG006|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
28152860|NCT02628028|54821971|FG007|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
28152861|NCT02628028|54821964|FG000|Long-term Extension (LTE) Period|Other|0|||
28152862|NCT02628028|54821965|FG001|Long-term Extension (LTE) Period|Other|0|||
28074239|NCT00418691|54728916|FG001|Overall Study|Lost to Follow-up|2|||
28074240|NCT00418691|54728917|FG002|Overall Study|Lost to Follow-up|3|||
28074241|NCT00418691|54728915|FG000|Overall Study|Started new medication voiding entry|0|||
28074242|NCT00418691|54728916|FG001|Overall Study|Started new medication voiding entry|0|||
28074243|NCT00418691|54728917|FG002|Overall Study|Started new medication voiding entry|1|||
28074244|NCT00418691|54728915|FG000|Overall Study|Progressive Disease|1|||
28074245|NCT00418691|54728916|FG001|Overall Study|Progressive Disease|0|||
28074246|NCT00418691|54728917|FG002|Overall Study|Progressive Disease|1|||
28074247|NCT00412373|54728927|FG000|Overall Study|Adverse Event|8|||
28152863|NCT02628028|54821966|FG002|Long-term Extension (LTE) Period|Other|0|||
28152864|NCT02628028|54821967|FG003|Long-term Extension (LTE) Period|Other|0|||
28152865|NCT02628028|54821968|FG004|Long-term Extension (LTE) Period|Other|0|||
28152866|NCT02628028|54821969|FG005|Long-term Extension (LTE) Period|Other|3|||
28152867|NCT02628028|54821970|FG006|Long-term Extension (LTE) Period|Other|4|||
28152868|NCT02628028|54821971|FG007|Long-term Extension (LTE) Period|Other|3|||
28152869|NCT03977701|54822003|FG000|Overall Study|COVID-19 pandemic|0|||
28152870|NCT03977701|54822004|FG001|Overall Study|COVID-19 pandemic|0|||
28152871|NCT03977701|54822005|FG002|Overall Study|COVID-19 pandemic|0|||
28152872|NCT03977701|54822006|FG003|Overall Study|COVID-19 pandemic|0|||
28152873|NCT03977701|54822007|FG004|Overall Study|COVID-19 pandemic|0|||
28152874|NCT03977701|54822008|FG005|Overall Study|COVID-19 pandemic|1|||
28152875|NCT03977701|54822009|FG006|Overall Study|COVID-19 pandemic|0|||
28152876|NCT03977701|54822010|FG007|Overall Study|COVID-19 pandemic|1|||
28152877|NCT03977701|54822011|FG008|Overall Study|COVID-19 pandemic|0|||
28152878|NCT03977701|54822012|FG009|Overall Study|COVID-19 pandemic|0|||
28152879|NCT02814526|54822051|FG000|Overall Study|Adverse Event|4|||
28152880|NCT02814526|54822052|FG001|Overall Study|Adverse Event|3|||
28152881|NCT02814526|54822051|FG000|Overall Study|Death|1|||
28152882|NCT02814526|54822052|FG001|Overall Study|Death|1|||
28152883|NCT02814526|54822051|FG000|Overall Study|Lost to Follow-up|3|||
28152884|NCT02814526|54822052|FG001|Overall Study|Lost to Follow-up|4|||
28152885|NCT02814526|54822051|FG000|Overall Study|non site physician decision|1|||
28152886|NCT02814526|54822052|FG001|Overall Study|non site physician decision|0|||
28152887|NCT02814526|54822051|FG000|Overall Study|participant noncompliance|1|||
28152888|NCT02814526|54822052|FG001|Overall Study|participant noncompliance|1|||
28152889|NCT02814526|54822051|FG000|Overall Study|Withdrawal by Subject|20|||
28152890|NCT02814526|54822052|FG001|Overall Study|Withdrawal by Subject|14|||
28152891|NCT02814526|54822051|FG000|Overall Study|safety risk|2|||
28152892|NCT02814526|54822052|FG001|Overall Study|safety risk|1|||
28152893|NCT02814526|54822051|FG000|Overall Study|early termination-study terminated|1|||
28152894|NCT02814526|54822052|FG001|Overall Study|early termination-study terminated|2|||
28152895|NCT02814526|54822051|FG000|Overall Study|Other|0|||
28152896|NCT02814526|54822052|FG001|Overall Study|Other|4|||
28152897|NCT02329834|54822060|FG000|Overall Study|Physician Decision|1|||
28152898|NCT02329834|54822061|FG001|Overall Study|Physician Decision|0|||
28152899|NCT01340937|54822072|FG000|Period 1: Infant Series|Other protocol criterion not met|0|||
28152900|NCT01340937|54822073|FG001|Period 1: Infant Series|Other protocol criterion not met|1|||
28152901|NCT01340937|54822074|FG002|Period 1: Infant Series|Other protocol criterion not met|1|||
28152902|NCT01340937|54822075|FG003|Period 1: Infant Series|Other protocol criterion not met|0|||
28152903|NCT01340937|54822072|FG000|Period 1: Infant Series|Adverse Event|0|||
28152904|NCT01340937|54822073|FG001|Period 1: Infant Series|Adverse Event|1|||
28152905|NCT01340937|54822074|FG002|Period 1: Infant Series|Adverse Event|4|||
28152906|NCT01340937|54822075|FG003|Period 1: Infant Series|Adverse Event|0|||
28152907|NCT01340937|54822072|FG000|Period 1: Infant Series|Death|2|||
28152908|NCT01340937|54822073|FG001|Period 1: Infant Series|Death|0|||
28152909|NCT01340937|54822074|FG002|Period 1: Infant Series|Death|2|||
28152910|NCT01340937|54822075|FG003|Period 1: Infant Series|Death|0|||
28152911|NCT01340937|54822072|FG000|Period 1: Infant Series|Lost to Follow-up|20|||
28152912|NCT01340937|54822073|FG001|Period 1: Infant Series|Lost to Follow-up|14|||
28152913|NCT01340937|54822074|FG002|Period 1: Infant Series|Lost to Follow-up|12|||
28152914|NCT01340937|54822075|FG003|Period 1: Infant Series|Lost to Follow-up|13|||
28152915|NCT01340937|54822072|FG000|Period 1: Infant Series|Physician Decision|2|||
28152916|NCT01340937|54822073|FG001|Period 1: Infant Series|Physician Decision|3|||
28152917|NCT01340937|54822074|FG002|Period 1: Infant Series|Physician Decision|1|||
28152918|NCT01340937|54822075|FG003|Period 1: Infant Series|Physician Decision|0|||
28152919|NCT01340937|54822072|FG000|Period 1: Infant Series|Protocol Violation|1|||
28152920|NCT01340937|54822073|FG001|Period 1: Infant Series|Protocol Violation|4|||
28152921|NCT01340937|54822074|FG002|Period 1: Infant Series|Protocol Violation|4|||
28152922|NCT01340937|54822075|FG003|Period 1: Infant Series|Protocol Violation|3|||
28152923|NCT01340937|54822072|FG000|Period 1: Infant Series|Withdrawal by Subject|33|||
28074248|NCT00412373|54728928|FG001|Overall Study|Adverse Event|13|||
28074249|NCT00412373|54728927|FG000|Overall Study|Lack of Efficacy|16|||
28152924|NCT01340937|54822073|FG001|Period 1: Infant Series|Withdrawal by Subject|32|||
28152925|NCT01340937|54822074|FG002|Period 1: Infant Series|Withdrawal by Subject|30|||
28152926|NCT01340937|54822075|FG003|Period 1: Infant Series|Withdrawal by Subject|15|||
28152927|NCT01340937|54822072|FG000|Period 1: Infant Series|Randomized but not vaccinated|0|||
27941937|NCT01208207|54598599|FG004|Part I|Progressive Disease|0|||
28152928|NCT01340937|54822073|FG001|Period 1: Infant Series|Randomized but not vaccinated|5|||
28152929|NCT01340937|54822074|FG002|Period 1: Infant Series|Randomized but not vaccinated|2|||
28152930|NCT01340937|54822075|FG003|Period 1: Infant Series|Randomized but not vaccinated|1|||
28152931|NCT01340937|54822072|FG000|Period 2: Interim Period|Withdrawal by Subject|28|||
28152932|NCT01340937|54822073|FG001|Period 2: Interim Period|Withdrawal by Subject|23|||
28152933|NCT01340937|54822074|FG002|Period 2: Interim Period|Withdrawal by Subject|17|||
28152934|NCT01340937|54822075|FG003|Period 2: Interim Period|Withdrawal by Subject|12|||
28152935|NCT01340937|54822072|FG000|Period 2: Interim Period|Adverse Event|1|||
28074250|NCT00412373|54728928|FG001|Overall Study|Lack of Efficacy|22|||
28074251|NCT00412373|54728927|FG000|Overall Study|Lost to Follow-up|7|||
28074252|NCT00412373|54728928|FG001|Overall Study|Lost to Follow-up|13|||
28074253|NCT00412373|54728927|FG000|Overall Study|Withdrawal by Subject|8|||
28074254|NCT00412373|54728928|FG001|Overall Study|Withdrawal by Subject|27|||
28074255|NCT00412373|54728927|FG000|Overall Study|Other|2|||
28074256|NCT00412373|54728928|FG001|Overall Study|Other|2|||
28074257|NCT00418379|54728937|FG000|Year 1|Adverse Event|9|||
28074258|NCT00418379|54728938|FG001|Year 1|Adverse Event|15|||
28074259|NCT00418379|54728939|FG002|Year 1|Adverse Event|3|||
28074260|NCT00418379|54728937|FG000|Year 1|Withdrawal by Subject|7|||
28074261|NCT00418379|54728938|FG001|Year 1|Withdrawal by Subject|8|||
28074262|NCT00418379|54728939|FG002|Year 1|Withdrawal by Subject|5|||
28152936|NCT01340937|54822073|FG001|Period 2: Interim Period|Adverse Event|0|||
28074263|NCT00418379|54728937|FG000|Year 1|Any other reason not above-mentioned|2|||
27825057|NCT01971203|54290524|FG000|Overall Study|Withdrawal by Subject|5|||
28074264|NCT00418379|54728938|FG001|Year 1|Any other reason not above-mentioned|5|||
28074265|NCT00418379|54728939|FG002|Year 1|Any other reason not above-mentioned|7|||
28074266|NCT00418379|54728937|FG000|Year 2|Adverse Event|5|||
28074267|NCT00418379|54728938|FG001|Year 2|Adverse Event|2|||
28074268|NCT00418379|54728939|FG002|Year 2|Adverse Event|1|||
28074269|NCT00418379|54728937|FG000|Year 2|Withdrawal by Subject|1|||
28074270|NCT00418379|54728938|FG001|Year 2|Withdrawal by Subject|1|||
28074271|NCT00418379|54728939|FG002|Year 2|Withdrawal by Subject|3|||
28074272|NCT00418379|54728937|FG000|Year 2|Any other reason not above-mentioned|2|||
28074273|NCT00418379|54728938|FG001|Year 2|Any other reason not above-mentioned|1|||
28074274|NCT00418379|54728939|FG002|Year 2|Any other reason not above-mentioned|6|||
28074275|NCT00418379|54728937|FG000|Year 3|Withdrawal by Subject|1|||
28074276|NCT00418379|54728938|FG001|Year 3|Withdrawal by Subject|1|||
28152937|NCT01340937|54822074|FG002|Period 2: Interim Period|Adverse Event|1|||
28152938|NCT01340937|54822075|FG003|Period 2: Interim Period|Adverse Event|0|||
28152939|NCT01340937|54822072|FG000|Period 2: Interim Period|Lost to Follow-up|29|||
28152940|NCT01340937|54822073|FG001|Period 2: Interim Period|Lost to Follow-up|48|||
28152941|NCT01340937|54822074|FG002|Period 2: Interim Period|Lost to Follow-up|53|||
28152942|NCT01340937|54822075|FG003|Period 2: Interim Period|Lost to Follow-up|23|||
28152943|NCT01340937|54822072|FG000|Period 2: Interim Period|Physician Decision|0|||
28152944|NCT01340937|54822073|FG001|Period 2: Interim Period|Physician Decision|1|||
28152945|NCT01340937|54822074|FG002|Period 2: Interim Period|Physician Decision|1|||
28152946|NCT01340937|54822075|FG003|Period 2: Interim Period|Physician Decision|0|||
28152947|NCT01340937|54822072|FG000|Period 2: Interim Period|Protocol Violation|5|||
28152948|NCT01340937|54822073|FG001|Period 2: Interim Period|Protocol Violation|3|||
27825058|NCT01971203|54290525|FG001|Overall Study|Withdrawal by Subject|6|||
27825059|NCT01971203|54290524|FG000|Overall Study|Adverse Event|1|||
28074277|NCT00418379|54728939|FG002|Year 3|Withdrawal by Subject|2|||
28074278|NCT00418379|54728937|FG000|Year 3|Any other reason not above-mentioned|2|||
28152949|NCT01340937|54822074|FG002|Period 2: Interim Period|Protocol Violation|6|||
27825060|NCT01971203|54290525|FG001|Overall Study|Adverse Event|0|||
27941938|NCT01208207|54598600|FG005|Part I|Progressive Disease|0|||
27941939|NCT01208207|54598601|FG006|Part I|Progressive Disease|0|||
28152950|NCT01340937|54822075|FG003|Period 2: Interim Period|Protocol Violation|3|||
28152951|NCT01340937|54822072|FG000|Period 2: Interim Period|Technical problems|4|||
28152952|NCT01340937|54822073|FG001|Period 2: Interim Period|Technical problems|4|||
28152953|NCT01340937|54822074|FG002|Period 2: Interim Period|Technical problems|6|||
28152954|NCT01340937|54822075|FG003|Period 2: Interim Period|Technical problems|3|||
28152955|NCT01340937|54822072|FG000|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
28152956|NCT01340937|54822073|FG001|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
28152957|NCT01340937|54822074|FG002|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
28152958|NCT01340937|54822075|FG003|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
28152959|NCT01340937|54822072|FG000|Period 3: Toddler Vaccinations|Lost to Follow-up|6|||
28152960|NCT01340937|54822073|FG001|Period 3: Toddler Vaccinations|Lost to Follow-up|14|||
28152961|NCT01340937|54822074|FG002|Period 3: Toddler Vaccinations|Lost to Follow-up|7|||
28152962|NCT01340937|54822075|FG003|Period 3: Toddler Vaccinations|Lost to Follow-up|8|||
28152963|NCT01340937|54822072|FG000|Period 3: Toddler Vaccinations|Protocol Violation|0|||
28152964|NCT01340937|54822073|FG001|Period 3: Toddler Vaccinations|Protocol Violation|0|||
28152965|NCT01340937|54822074|FG002|Period 3: Toddler Vaccinations|Protocol Violation|0|||
28152966|NCT01340937|54822075|FG003|Period 3: Toddler Vaccinations|Protocol Violation|1|||
28152967|NCT01340937|54822072|FG000|Period 3: Toddler Vaccinations|Technical problem|1|||
28152968|NCT01340937|54822073|FG001|Period 3: Toddler Vaccinations|Technical problem|1|||
28152969|NCT01340937|54822074|FG002|Period 3: Toddler Vaccinations|Technical problem|1|||
28152970|NCT01340937|54822075|FG003|Period 3: Toddler Vaccinations|Technical problem|0|||
28152971|NCT03029143|54822091|FG000|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|8|||
28152972|NCT03029143|54822092|FG001|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
28152973|NCT03029143|54822093|FG002|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
28152974|NCT03029143|54822091|FG000|Lead-in Period (6 Weeks)|Significant Protocol Deviation|12|||
28152975|NCT03029143|54822092|FG001|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
28152976|NCT03029143|54822093|FG002|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
28152977|NCT03029143|54822091|FG000|Lead-in Period (6 Weeks)|Lost to Follow-up|1|||
28152978|NCT03029143|54822092|FG001|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
28152979|NCT03029143|54822093|FG002|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
28152980|NCT03029143|54822091|FG000|Lead-in Period (6 Weeks)|Voluntary Withdrawal|6|||
28152981|NCT03029143|54822092|FG001|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
28152982|NCT03029143|54822093|FG002|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
28152983|NCT03029143|54822091|FG000|Lead-in Period (6 Weeks)|Randomized but not Treated|142|||
28152984|NCT03029143|54822092|FG001|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
28152985|NCT03029143|54822093|FG002|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
28152986|NCT03029143|54822091|FG000|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|0|||
28152987|NCT03029143|54822092|FG001|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|3|||
28152988|NCT03029143|54822093|FG002|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|9|||
28152989|NCT03029143|54822091|FG000|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|0|||
28152990|NCT03029143|54822092|FG001|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|1|||
28152991|NCT03029143|54822093|FG002|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|3|||
28152992|NCT03029143|54822091|FG000|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|0|||
28152993|NCT03029143|54822092|FG001|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|1|||
28152994|NCT03029143|54822093|FG002|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|3|||
28152995|NCT03029143|54822091|FG000|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|0|||
28152996|NCT03029143|54822092|FG001|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|10|||
28152997|NCT03029143|54822093|FG002|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|1|||
28152998|NCT03029143|54822091|FG000|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|0|||
28152999|NCT03029143|54822092|FG001|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|6|||
28153000|NCT03029143|54822093|FG002|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|7|||
28153001|NCT03029143|54822091|FG000|Randomized Treatment Period (24 Weeks)|Reason not Specified|0|||
28153002|NCT03029143|54822092|FG001|Randomized Treatment Period (24 Weeks)|Reason not Specified|2|||
28153003|NCT03029143|54822093|FG002|Randomized Treatment Period (24 Weeks)|Reason not Specified|1|||
28153004|NCT03028129|54822104|FG000|Overall Study|Adverse Event|13|||
28153005|NCT03028129|54822105|FG001|Overall Study|Adverse Event|2|||
28153006|NCT03028129|54822104|FG000|Overall Study|Lost to Follow-up|50|||
28153007|NCT03028129|54822105|FG001|Overall Study|Lost to Follow-up|38|||
28153008|NCT03028129|54822104|FG000|Overall Study|Physician Decision|0|||
28153009|NCT03028129|54822105|FG001|Overall Study|Physician Decision|1|||
28153010|NCT03028129|54822104|FG000|Overall Study|Protocol Violation|1|||
28153011|NCT03028129|54822105|FG001|Overall Study|Protocol Violation|1|||
28153012|NCT03028129|54822104|FG000|Overall Study|Withdrawal by Subject|62|||
28153013|NCT03028129|54822105|FG001|Overall Study|Withdrawal by Subject|45|||
28153014|NCT01309672|54822111|FG000|Overall Study|Lack of Efficacy|20|||
28153015|NCT01309672|54822111|FG000|Overall Study|Other|9|||
28153016|NCT01309672|54822111|FG000|Overall Study|Adverse Event|5|||
28153017|NCT01309672|54822111|FG000|Overall Study|Withdrawal by Subject|3|||
28153018|NCT03026257|54822122|FG000|Overall Study|Adverse Event|3|||
28153019|NCT03026257|54822123|FG001|Overall Study|Adverse Event|0|||
28153020|NCT03026257|54822124|FG002|Overall Study|Adverse Event|0|||
28153021|NCT03026257|54822125|FG003|Overall Study|Adverse Event|0|||
28153022|NCT03026257|54822126|FG004|Overall Study|Adverse Event|0|||
28153023|NCT03026257|54822127|FG005|Overall Study|Adverse Event|0|||
28153024|NCT03026257|54822122|FG000|Overall Study|Lost to Follow-up|1|||
28153025|NCT03026257|54822123|FG001|Overall Study|Lost to Follow-up|0|||
28153026|NCT03026257|54822124|FG002|Overall Study|Lost to Follow-up|0|||
28153027|NCT03026257|54822125|FG003|Overall Study|Lost to Follow-up|0|||
28153028|NCT03026257|54822126|FG004|Overall Study|Lost to Follow-up|0|||
28153029|NCT03026257|54822127|FG005|Overall Study|Lost to Follow-up|0|||
28153030|NCT03026257|54822122|FG000|Overall Study|Protocol Violation|1|||
28153031|NCT03026257|54822123|FG001|Overall Study|Protocol Violation|0|||
28153032|NCT03026257|54822124|FG002|Overall Study|Protocol Violation|0|||
28153033|NCT03026257|54822125|FG003|Overall Study|Protocol Violation|1|||
28153034|NCT03026257|54822126|FG004|Overall Study|Protocol Violation|1|||
28153035|NCT03026257|54822127|FG005|Overall Study|Protocol Violation|0|||
28153036|NCT03026257|54822122|FG000|Overall Study|Withdrawal by Subject|1|||
28153037|NCT03026257|54822123|FG001|Overall Study|Withdrawal by Subject|1|||
28153038|NCT03026257|54822124|FG002|Overall Study|Withdrawal by Subject|0|||
28153039|NCT03026257|54822125|FG003|Overall Study|Withdrawal by Subject|0|||
28153040|NCT03026257|54822126|FG004|Overall Study|Withdrawal by Subject|0|||
28074279|NCT00418379|54728938|FG001|Year 3|Any other reason not above-mentioned|1|||
28074280|NCT00418379|54728939|FG002|Year 3|Any other reason not above-mentioned|1|||
28074281|NCT00418379|54728937|FG000|Year 4|Adverse Event|0|||
28074282|NCT00418379|54728938|FG001|Year 4|Adverse Event|1|||
28074283|NCT00418379|54728939|FG002|Year 4|Adverse Event|0|||
28074284|NCT00418379|54728937|FG000|Year 4|Withdrawal by Subject|2|||
28074285|NCT00418379|54728938|FG001|Year 4|Withdrawal by Subject|3|||
28074286|NCT00418379|54728939|FG002|Year 4|Withdrawal by Subject|2|||
28074287|NCT00418379|54728937|FG000|Year 4|Any other reason not above-mentioned|1|||
28074288|NCT00418379|54728938|FG001|Year 4|Any other reason not above-mentioned|1|||
28074289|NCT00418379|54728939|FG002|Year 4|Any other reason not above-mentioned|0|||
28074290|NCT00418379|54728937|FG000|Year 5|Adverse Event|0|||
28074291|NCT00418379|54728938|FG001|Year 5|Adverse Event|1|||
28074292|NCT00418379|54728939|FG002|Year 5|Adverse Event|0|||
28074293|NCT00418379|54728937|FG000|Year 5|Any other reason not above-mentioned|2|||
28074294|NCT00418379|54728938|FG001|Year 5|Any other reason not above-mentioned|4|||
28074295|NCT00418379|54728939|FG002|Year 5|Any other reason not above-mentioned|3|||
28074296|NCT00418145|54728947|FG000|Overall Study|study terminated|6|||
28074297|NCT00417989|54728955|FG000|Overall Study|Withdrawal by Subject|13|||
28153041|NCT03026257|54822127|FG005|Overall Study|Withdrawal by Subject|0|||
28153042|NCT01670188|54822143|FG000|Overall Study|Death|0|||
28153043|NCT01670188|54822144|FG001|Overall Study|Death|1|||
28153044|NCT01933048|54822152|FG000|Overall Study|Lost to Follow-up|15|||
28153045|NCT01933048|54822153|FG001|Overall Study|Lost to Follow-up|18|||
28074298|NCT00417989|54728956|FG001|Overall Study|Withdrawal by Subject|13|||
28153046|NCT01933048|54822152|FG000|Overall Study|personal reasons|1|||
28153047|NCT01933048|54822153|FG001|Overall Study|personal reasons|1|||
28153048|NCT01933048|54822152|FG000|Overall Study|Protocol Violation|7|||
28153049|NCT01933048|54822153|FG001|Overall Study|Protocol Violation|8|||
28153050|NCT01933048|54822152|FG000|Overall Study|Physician Decision|1|||
28074299|NCT00417989|54728955|FG000|Overall Study|Lost to Follow-up|1|||
28074300|NCT00417989|54728956|FG001|Overall Study|Lost to Follow-up|6|||
28074301|NCT00417989|54728955|FG000|Overall Study|Protocol Violation|1|||
28074302|NCT00417989|54728956|FG001|Overall Study|Protocol Violation|0|||
28153051|NCT01933048|54822153|FG001|Overall Study|Physician Decision|0|||
27825061|NCT01605877|54290531|FG000|Overall Study|Withdrawal by Subject|1|||
27825062|NCT01970501|54290555|FG000|Overall Study|Discontinuation of study by sponsor|16|||
28153052|NCT01933048|54822152|FG000|Overall Study|unknown reasons|1|||
28153053|NCT01933048|54822153|FG001|Overall Study|unknown reasons|1|||
28153054|NCT02751450|54822164|FG000|Overall Study|Adverse Event|1|||
28153055|NCT02751450|54822165|FG001|Overall Study|Adverse Event|0|||
28153056|NCT01515748|54822175|FG000|Overall Study|Withdrawal by Subject|32|||
28153057|NCT01515748|54822176|FG001|Overall Study|Withdrawal by Subject|41|||
28153058|NCT01515748|54822175|FG000|Overall Study|Lost to Follow-up|2|||
28153059|NCT01515748|54822176|FG001|Overall Study|Lost to Follow-up|4|||
28153060|NCT01515748|54822175|FG000|Overall Study|Ongoing|86|||
28153061|NCT01515748|54822176|FG001|Overall Study|Ongoing|90|||
28153062|NCT01358175|54822186|FG000|Overall Study|Death|1|||
28153063|NCT01358175|54822187|FG001|Overall Study|Death|0|||
28153064|NCT01358175|54822188|FG002|Overall Study|Death|1|||
28153065|NCT01358175|54822186|FG000|Overall Study|Withdrawal by Subject|9|||
28153066|NCT01358175|54822187|FG001|Overall Study|Withdrawal by Subject|5|||
28153067|NCT01358175|54822188|FG002|Overall Study|Withdrawal by Subject|10|||
28153068|NCT01358175|54822186|FG000|Overall Study|Technical issues|0|||
28153069|NCT01358175|54822187|FG001|Overall Study|Technical issues|1|||
28153070|NCT01358175|54822188|FG002|Overall Study|Technical issues|0|||
28153071|NCT01358175|54822186|FG000|Overall Study|Pregnancy|0|||
28153072|NCT01358175|54822187|FG001|Overall Study|Pregnancy|1|||
28153073|NCT01358175|54822188|FG002|Overall Study|Pregnancy|0|||
28153074|NCT01358175|54822186|FG000|Overall Study|Physician Decision|1|||
28153075|NCT01358175|54822187|FG001|Overall Study|Physician Decision|0|||
28153076|NCT01358175|54822188|FG002|Overall Study|Physician Decision|0|||
28153077|NCT01358175|54822186|FG000|Overall Study|Non Compliance with Study Treatment|0|||
28153078|NCT01358175|54822187|FG001|Overall Study|Non Compliance with Study Treatment|1|||
28153079|NCT01358175|54822188|FG002|Overall Study|Non Compliance with Study Treatment|1|||
28153080|NCT01358175|54822186|FG000|Overall Study|Lost to Follow-up|1|||
28153081|NCT01358175|54822187|FG001|Overall Study|Lost to Follow-up|1|||
28153082|NCT01358175|54822188|FG002|Overall Study|Lost to Follow-up|3|||
28153083|NCT01358175|54822186|FG000|Overall Study|Lack of Efficacy|3|||
28153084|NCT01358175|54822187|FG001|Overall Study|Lack of Efficacy|8|||
28153085|NCT01358175|54822188|FG002|Overall Study|Lack of Efficacy|6|||
28153086|NCT01358175|54822186|FG000|Overall Study|Adverse Event|6|||
28153087|NCT01358175|54822187|FG001|Overall Study|Adverse Event|11|||
28153088|NCT01358175|54822188|FG002|Overall Study|Adverse Event|11|||
28153089|NCT04116229|54822202|FG000|Overall Study|Met exclusion criteria during screeneing on day of study visit.|2|||
28153090|NCT04116229|54822203|FG001|Overall Study|Met exclusion criteria during screeneing on day of study visit.|3|||
28153091|NCT04116229|54822202|FG000|Overall Study|Scheduling not possible.|0|||
28153092|NCT04116229|54822203|FG001|Overall Study|Scheduling not possible.|1|||
27825063|NCT01970501|54290556|FG001|Overall Study|Discontinuation of study by sponsor|14|||
28153093|NCT02833077|54822211|FG000|Overall Study|Adverse Event|1|||
28153094|NCT02833077|54822212|FG001|Overall Study|Adverse Event|2|||
28153095|NCT02833077|54822211|FG000|Overall Study|Lost to Follow-up|10|||
28153096|NCT02833077|54822212|FG001|Overall Study|Lost to Follow-up|1|||
28153097|NCT02833077|54822211|FG000|Overall Study|Personal Reasons|6|||
28153098|NCT02833077|54822212|FG001|Overall Study|Personal Reasons|4|||
28153099|NCT02833077|54822211|FG000|Overall Study|Protocol Deviation|0|||
28153100|NCT02833077|54822212|FG001|Overall Study|Protocol Deviation|1|||
28153101|NCT01355679|54822219|FG000|Overall Study|benign tumor types found at biopsy|2|||
28153102|NCT02832375|54822226|FG000|Overall Study|Lost to Follow-up|1|||
28153103|NCT02832375|54822227|FG001|Overall Study|Lost to Follow-up|0|||
28153104|NCT02832375|54822226|FG000|Overall Study|Withdrawal of Consent|1|||
28153105|NCT02832375|54822227|FG001|Overall Study|Withdrawal of Consent|0|||
28153106|NCT02925403|54822236|FG000|Overall Study|Lost to Follow-up|0|||
28153107|NCT02925403|54822237|FG001|Overall Study|Lost to Follow-up|1|||
28153108|NCT02626780|54822243|FG000|Overall Study|Withdrawal by Subject|3|||
28153109|NCT02831673|54822258|FG000|Overall Study|Adverse Event|6|||
28153110|NCT02831673|54822259|FG001|Overall Study|Adverse Event|4|||
28153111|NCT02831673|54822258|FG000|Overall Study|Lack of Efficacy|3|||
28153112|NCT02831673|54822259|FG001|Overall Study|Lack of Efficacy|1|||
28153113|NCT02831673|54822258|FG000|Overall Study|Protocol Violation|5|||
28153114|NCT02831673|54822259|FG001|Overall Study|Protocol Violation|4|||
28153115|NCT02831673|54822258|FG000|Overall Study|Protocol Withdrawal Criterion Met|1|||
28153116|NCT02831673|54822259|FG001|Overall Study|Protocol Withdrawal Criterion Met|6|||
28153117|NCT02831673|54822258|FG000|Overall Study|Lost to Follow-up|9|||
28153118|NCT02831673|54822259|FG001|Overall Study|Lost to Follow-up|6|||
28153119|NCT02831673|54822258|FG000|Overall Study|Physician Decision|6|||
28153120|NCT02831673|54822259|FG001|Overall Study|Physician Decision|3|||
28153121|NCT02831673|54822258|FG000|Overall Study|Withdrawal by Subject|6|||
28153122|NCT02831673|54822259|FG001|Overall Study|Withdrawal by Subject|4|||
28153123|NCT02831673|54822258|FG000|Overall Study|Ongoing at Week 48 primary analysis.|320|||
28153124|NCT02831673|54822259|FG001|Overall Study|Ongoing at Week 48 primary analysis.|330|||
28153125|NCT02830893|54822267|FG000|Overall Study|Relocation to out of the country|1|||
28153126|NCT02830893|54822268|FG001|Overall Study|Relocation to out of the country|0|||
28153127|NCT02830893|54822267|FG000|Overall Study|Lost to Follow-up|0|||
28153128|NCT02830893|54822268|FG001|Overall Study|Lost to Follow-up|2|||
28153129|NCT02830893|54822267|FG000|Overall Study|Discharged to SNF, no transportation.|0|||
28153130|NCT02830893|54822268|FG001|Overall Study|Discharged to SNF, no transportation.|1|||
28153131|NCT02625922|54822276|FG000|Overall Study|Non-availability of IMP|1|||
28153132|NCT02625922|54822277|FG001|Overall Study|Non-availability of IMP|1|||
28153133|NCT02625922|54822276|FG000|Overall Study|Systolic blood pressure < 125 mmHg|1|||
28153134|NCT02625922|54822277|FG001|Overall Study|Systolic blood pressure < 125 mmHg|1|||
28153135|NCT03350035|54822289|FG000|Overall Study|Lack of Efficacy|2|||
28153136|NCT03350035|54822290|FG001|Overall Study|Lack of Efficacy|0|||
28153137|NCT03350035|54822291|FG002|Overall Study|Lack of Efficacy|0|||
28153138|NCT03350035|54822289|FG000|Overall Study|Subject discharged to hospice|0|||
28153139|NCT03350035|54822290|FG001|Overall Study|Subject discharged to hospice|0|||
28153140|NCT03350035|54822291|FG002|Overall Study|Subject discharged to hospice|1|||
28153141|NCT01358331|54822325|FG000|Overall Study|Lost to Follow-up|0|||
28153142|NCT01358331|54822326|FG001|Overall Study|Lost to Follow-up|0|||
28153143|NCT01358331|54822327|FG002|Overall Study|Lost to Follow-up|0|||
28153144|NCT01358331|54822328|FG003|Overall Study|Lost to Follow-up|1|||
28153145|NCT01358331|54822329|FG004|Overall Study|Lost to Follow-up|0|||
28153146|NCT01358331|54822330|FG005|Overall Study|Lost to Follow-up|0|||
28153147|NCT01358331|54822325|FG000|Overall Study|Withdrawal by Subject|0|||
28153148|NCT01358331|54822326|FG001|Overall Study|Withdrawal by Subject|0|||
28153149|NCT01358331|54822327|FG002|Overall Study|Withdrawal by Subject|0|||
28153150|NCT01358331|54822328|FG003|Overall Study|Withdrawal by Subject|1|||
28153151|NCT01358331|54822329|FG004|Overall Study|Withdrawal by Subject|1|||
28153152|NCT01358331|54822330|FG005|Overall Study|Withdrawal by Subject|1|||
28153153|NCT01358331|54822325|FG000|Overall Study|Adverse Events|1|||
28153154|NCT01358331|54822326|FG001|Overall Study|Adverse Events|1|||
28153155|NCT01358331|54822327|FG002|Overall Study|Adverse Events|1|||
28153156|NCT01358331|54822328|FG003|Overall Study|Adverse Events|0|||
28153157|NCT01358331|54822329|FG004|Overall Study|Adverse Events|1|||
28153158|NCT01358331|54822330|FG005|Overall Study|Adverse Events|5|||
28153159|NCT01358331|54822325|FG000|Overall Study|Symptomatic Deterioration|0|||
28153160|NCT01358331|54822326|FG001|Overall Study|Symptomatic Deterioration|0|||
28153161|NCT01358331|54822327|FG002|Overall Study|Symptomatic Deterioration|0|||
28153162|NCT01358331|54822328|FG003|Overall Study|Symptomatic Deterioration|0|||
28153163|NCT01358331|54822329|FG004|Overall Study|Symptomatic Deterioration|1|||
28153164|NCT01358331|54822330|FG005|Overall Study|Symptomatic Deterioration|0|||
28153165|NCT01358331|54822325|FG000|Overall Study|Participants did not wish to continue|0|||
28153166|NCT01358331|54822326|FG001|Overall Study|Participants did not wish to continue|0|||
28153167|NCT01358331|54822327|FG002|Overall Study|Participants did not wish to continue|0|||
28153168|NCT01358331|54822328|FG003|Overall Study|Participants did not wish to continue|0|||
28153169|NCT01358331|54822329|FG004|Overall Study|Participants did not wish to continue|1|||
28153170|NCT01358331|54822330|FG005|Overall Study|Participants did not wish to continue|0|||
28153171|NCT01358331|54822325|FG000|Overall Study|Progress of disease under investigation|1|||
28153172|NCT01358331|54822326|FG001|Overall Study|Progress of disease under investigation|2|||
27825064|NCT01970501|54290555|FG000|Overall Study|Withdrawal by Subject|6|||
27825065|NCT01970501|54290556|FG001|Overall Study|Withdrawal by Subject|7|||
27825066|NCT01970501|54290555|FG000|Overall Study|Adverse Event|2|||
28153173|NCT01358331|54822327|FG002|Overall Study|Progress of disease under investigation|3|||
28153174|NCT01358331|54822328|FG003|Overall Study|Progress of disease under investigation|1|||
28153175|NCT01358331|54822329|FG004|Overall Study|Progress of disease under investigation|3|||
28153176|NCT01358331|54822330|FG005|Overall Study|Progress of disease under investigation|0|||
28153177|NCT02828241|54822346|FG000|Overall Study|Adverse Event|7|||
28153178|NCT02828241|54822347|FG001|Overall Study|Adverse Event|2|||
28153179|NCT02828241|54822346|FG000|Overall Study|Protocol Violation|1|||
28153180|NCT02828241|54822347|FG001|Overall Study|Protocol Violation|0|||
28153181|NCT01355523|54822356|FG000|Overall Study|Withdrawal by Subject|1|||
28153182|NCT01355523|54822357|FG001|Overall Study|Withdrawal by Subject|4|||
28153183|NCT01355523|54822356|FG000|Overall Study|Lost to Follow-up|0|||
28153184|NCT01355523|54822357|FG001|Overall Study|Lost to Follow-up|2|||
28153185|NCT01355523|54822356|FG000|Overall Study|Protocol Violation|0|||
28153186|NCT01355523|54822357|FG001|Overall Study|Protocol Violation|2|||
28153187|NCT01355523|54822356|FG000|Overall Study|Adverse Event|0|||
28153188|NCT01355523|54822357|FG001|Overall Study|Adverse Event|2|||
28153189|NCT02625220|54822363|FG000|Overall Study|Adverse Event|2|||
28153190|NCT02625220|54822363|FG000|Overall Study|Lost to Follow-up|2|||
27941940|NCT01208207|54598595|FG000|Part I|Protocol Violation|8|||
27941941|NCT01208207|54598596|FG001|Part I|Protocol Violation|0|||
27941942|NCT01208207|54598597|FG002|Part I|Protocol Violation|2|||
28153191|NCT02625220|54822363|FG000|Overall Study|Protocol Violation|1|||
28153192|NCT02625220|54822363|FG000|Overall Study|Study discontinued at site|2|||
27825067|NCT01970501|54290556|FG001|Overall Study|Adverse Event|4|||
28074303|NCT00417989|54728955|FG000|Overall Study|Death|0|||
28074304|NCT00417989|54728956|FG001|Overall Study|Death|1|||
28153193|NCT02826603|54822369|FG000|Overall Study|Adverse Event|17|||
28153194|NCT02826603|54822370|FG001|Overall Study|Adverse Event|9|||
28153195|NCT02826603|54822369|FG000|Overall Study|Lack of Efficacy|4|||
28153196|NCT02826603|54822370|FG001|Overall Study|Lack of Efficacy|9|||
28153197|NCT02826603|54822369|FG000|Overall Study|Lost to Follow-up|13|||
28153198|NCT02826603|54822370|FG001|Overall Study|Lost to Follow-up|12|||
28153199|NCT02826603|54822369|FG000|Overall Study|Noncompliance with treatment|0|||
28153200|NCT02826603|54822370|FG001|Overall Study|Noncompliance with treatment|2|||
28153201|NCT02826603|54822369|FG000|Overall Study|Physician Decision|1|||
28153202|NCT02826603|54822370|FG001|Overall Study|Physician Decision|7|||
28153203|NCT02826603|54822369|FG000|Overall Study|Pregnancy|1|||
28153204|NCT02826603|54822370|FG001|Overall Study|Pregnancy|2|||
28153205|NCT02826603|54822369|FG000|Overall Study|Protocol Violation|3|||
28153206|NCT02826603|54822370|FG001|Overall Study|Protocol Violation|3|||
28153207|NCT02826603|54822369|FG000|Overall Study|Withdrawal by Subject|20|||
28153208|NCT02826603|54822370|FG001|Overall Study|Withdrawal by Subject|19|||
28153209|NCT02826603|54822369|FG000|Overall Study|Death|2|||
28153210|NCT02826603|54822370|FG001|Overall Study|Death|0|||
28153211|NCT02826603|54822369|FG000|Overall Study|New therapy for study indication|0|||
28153212|NCT02826603|54822370|FG001|Overall Study|New therapy for study indication|1|||
28074305|NCT00417989|54728955|FG000|Overall Study|Physician Decision|5|||
28074306|NCT00417989|54728956|FG001|Overall Study|Physician Decision|2|||
28074307|NCT00412217|54728966|FG000|Overall Study|Insufficient Data Available|8|||
28074308|NCT00412217|54728967|FG001|Overall Study|Insufficient Data Available|3|||
28074309|NCT00412217|54728966|FG000|Overall Study|Death|5|||
28074310|NCT00412217|54728967|FG001|Overall Study|Death|4|||
28074311|NCT00412217|54728966|FG000|Overall Study|Disease Progression|2|||
28074312|NCT00412217|54728967|FG001|Overall Study|Disease Progression|3|||
28074313|NCT00412217|54728966|FG000|Overall Study|Investigator Decision|1|||
28074314|NCT00412217|54728967|FG001|Overall Study|Investigator Decision|0|||
28074315|NCT00412217|54728966|FG000|Overall Study|Withdrawal by Subject|2|||
28074316|NCT00412217|54728967|FG001|Overall Study|Withdrawal by Subject|0|||
28074317|NCT00412217|54728966|FG000|Overall Study|Lost to Follow-up|1|||
28074318|NCT00412217|54728967|FG001|Overall Study|Lost to Follow-up|4|||
28074319|NCT00412217|54728966|FG000|Overall Study|Study Terminated by Sponsor|26|||
28074320|NCT00412217|54728967|FG001|Overall Study|Study Terminated by Sponsor|33|||
28074321|NCT00412217|54728966|FG000|Overall Study|Other|1|||
28074322|NCT00412217|54728967|FG001|Overall Study|Other|1|||
28074323|NCT05000164|54728973|FG000|Overall Study|Adverse Event|1|||
28074324|NCT05000164|54728973|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
28074325|NCT05000164|54728973|FG000|Overall Study|Lens Discomfort|3|||
28074326|NCT05000164|54728973|FG000|Overall Study|Withdrew Consent during Study|2|||
28074327|NCT05000164|54728973|FG000|Overall Study|Subject Withdrawn by PI|2|||
28074328|NCT05000164|54728973|FG000|Overall Study|Other Fractured Test Article|1|||
28074329|NCT00123474|54728981|FG000|Randomized to Treatment|Randomized, never treated|1|||
28074330|NCT00123474|54728982|FG001|Randomized to Treatment|Randomized, never treated|4|||
28074331|NCT00123474|54728983|FG002|Randomized to Treatment|Randomized, never treated|2|||
28074332|NCT00123474|54728984|FG003|Randomized to Treatment|Randomized, never treated|1|||
28074333|NCT00123474|54728981|FG000|As Treated at Study Closure|not reported when site closed|1|||
28074334|NCT00123474|54728982|FG001|As Treated at Study Closure|not reported when site closed|0|||
28153213|NCT05270460|54822386|FG000|Overall Study|Adverse Event|0|||
27825068|NCT01970501|54290555|FG000|Overall Study|Death|1|||
27825069|NCT01970501|54290556|FG001|Overall Study|Death|3|||
28153214|NCT05270460|54822387|FG001|Overall Study|Adverse Event|1|||
28074335|NCT00123474|54728983|FG002|As Treated at Study Closure|not reported when site closed|1|||
28074336|NCT00123474|54728984|FG003|As Treated at Study Closure|not reported when site closed|0|||
28074337|NCT00123474|54728981|FG000|As Treated at Study Closure|Adverse Event|10|||
28153215|NCT05270460|54822388|FG002|Overall Study|Adverse Event|0|||
28153216|NCT05270460|54822386|FG000|Overall Study|Early Termination|0|||
28153217|NCT05270460|54822387|FG001|Overall Study|Early Termination|1|||
28153218|NCT05270460|54822388|FG002|Overall Study|Early Termination|0|||
28153219|NCT04622592|54822404|FG000|Overall Study|Death|0|||
28074338|NCT00123474|54728982|FG001|As Treated at Study Closure|Adverse Event|4|||
28153220|NCT04622592|54822405|FG001|Overall Study|Death|0|||
28153221|NCT04622592|54822406|FG002|Overall Study|Death|1|||
28153222|NCT04622592|54822407|FG003|Overall Study|Death|0|||
28153223|NCT04622592|54822408|FG004|Overall Study|Death|0|||
28153224|NCT04622592|54822409|FG005|Overall Study|Death|0|||
28153225|NCT04622592|54822410|FG006|Overall Study|Death|0|||
28153226|NCT04622592|54822411|FG007|Overall Study|Death|1|||
28153227|NCT04622592|54822404|FG000|Overall Study|Lost to Follow-up|0|||
28153228|NCT04622592|54822405|FG001|Overall Study|Lost to Follow-up|0|||
27825070|NCT01970501|54290555|FG000|Overall Study|Physician Decision|2|||
28074339|NCT00123474|54728983|FG002|As Treated at Study Closure|Adverse Event|10|||
28074340|NCT00123474|54728984|FG003|As Treated at Study Closure|Adverse Event|8|||
28074341|NCT00123474|54728981|FG000|As Treated at Study Closure|Disease Progression|35|||
28074342|NCT00123474|54728982|FG001|As Treated at Study Closure|Disease Progression|42|||
28074343|NCT00123474|54728983|FG002|As Treated at Study Closure|Disease Progression|29|||
28153229|NCT04622592|54822406|FG002|Overall Study|Lost to Follow-up|0|||
28153230|NCT04622592|54822407|FG003|Overall Study|Lost to Follow-up|3|||
28074344|NCT00123474|54728984|FG003|As Treated at Study Closure|Disease Progression|27|||
28074345|NCT00123474|54728981|FG000|As Treated at Study Closure|Investigator Request|12|||
28074346|NCT00123474|54728982|FG001|As Treated at Study Closure|Investigator Request|6|||
28153231|NCT04622592|54822408|FG004|Overall Study|Lost to Follow-up|1|||
28153232|NCT04622592|54822409|FG005|Overall Study|Lost to Follow-up|0|||
28153233|NCT04622592|54822410|FG006|Overall Study|Lost to Follow-up|2|||
28153234|NCT04622592|54822411|FG007|Overall Study|Lost to Follow-up|2|||
28153235|NCT04622592|54822404|FG000|Overall Study|Physician Decision|0|||
28153236|NCT04622592|54822405|FG001|Overall Study|Physician Decision|0|||
28153237|NCT04622592|54822406|FG002|Overall Study|Physician Decision|0|||
28153238|NCT04622592|54822407|FG003|Overall Study|Physician Decision|0|||
28153239|NCT04622592|54822408|FG004|Overall Study|Physician Decision|1|||
28153240|NCT04622592|54822409|FG005|Overall Study|Physician Decision|0|||
28153241|NCT04622592|54822410|FG006|Overall Study|Physician Decision|0|||
28153242|NCT04622592|54822411|FG007|Overall Study|Physician Decision|0|||
28153243|NCT04622592|54822404|FG000|Overall Study|Withdrawal by Subject|1|||
28153244|NCT04622592|54822405|FG001|Overall Study|Withdrawal by Subject|0|||
28153245|NCT04622592|54822406|FG002|Overall Study|Withdrawal by Subject|2|||
28153246|NCT04622592|54822407|FG003|Overall Study|Withdrawal by Subject|0|||
28153247|NCT04622592|54822408|FG004|Overall Study|Withdrawal by Subject|0|||
28153248|NCT04622592|54822409|FG005|Overall Study|Withdrawal by Subject|0|||
28153249|NCT04622592|54822410|FG006|Overall Study|Withdrawal by Subject|1|||
28153250|NCT04622592|54822411|FG007|Overall Study|Withdrawal by Subject|4|||
28153251|NCT04622592|54822404|FG000|Overall Study|Other than specified above|0|||
28153252|NCT04622592|54822405|FG001|Overall Study|Other than specified above|0|||
28153253|NCT04622592|54822406|FG002|Overall Study|Other than specified above|1|||
28153254|NCT04622592|54822407|FG003|Overall Study|Other than specified above|0|||
28153255|NCT04622592|54822408|FG004|Overall Study|Other than specified above|0|||
28153256|NCT04622592|54822409|FG005|Overall Study|Other than specified above|0|||
28153257|NCT04622592|54822410|FG006|Overall Study|Other than specified above|0|||
28153258|NCT04622592|54822411|FG007|Overall Study|Other than specified above|0|||
28153259|NCT04523220|54822432|FG000|Main Treatment Period|Physician Decision|1|||
28153260|NCT04523220|54822433|FG001|Main Treatment Period|Physician Decision|1|||
28153261|NCT04523220|54822434|FG002|Main Treatment Period|Physician Decision|0|||
28153262|NCT04523220|54822432|FG000|Main Treatment Period|Other|5|||
28153263|NCT04523220|54822433|FG001|Main Treatment Period|Other|2|||
28153264|NCT04523220|54822434|FG002|Main Treatment Period|Other|4|||
28153265|NCT04523220|54822432|FG000|Main Treatment Period|Subject Decision|5|||
28153266|NCT04523220|54822433|FG001|Main Treatment Period|Subject Decision|7|||
28153267|NCT04523220|54822434|FG002|Main Treatment Period|Subject Decision|3|||
28153268|NCT04523220|54822432|FG000|Main Treatment Period|Death|5|||
28153269|NCT04523220|54822433|FG001|Main Treatment Period|Death|11|||
28153270|NCT04523220|54822434|FG002|Main Treatment Period|Death|4|||
28153271|NCT04523220|54822432|FG000|Main Treatment Period|Adverse Event|11|||
28153272|NCT04523220|54822433|FG001|Main Treatment Period|Adverse Event|9|||
28153273|NCT04523220|54822434|FG002|Main Treatment Period|Adverse Event|9|||
28153274|NCT04523220|54822432|FG000|Main Treatment Period|Withdrawal by Subject|3|||
28153275|NCT04523220|54822433|FG001|Main Treatment Period|Withdrawal by Subject|3|||
28153276|NCT04523220|54822434|FG002|Main Treatment Period|Withdrawal by Subject|4|||
28153277|NCT04523220|54822432|FG000|Main Treatment Period|Study drug never adminstered|10|||
28153278|NCT04523220|54822433|FG001|Main Treatment Period|Study drug never adminstered|3|||
28153279|NCT04523220|54822434|FG002|Main Treatment Period|Study drug never adminstered|5|||
28153280|NCT04523220|54822432|FG000|Extension Treatment Period|Physician Decision|1|||
28153281|NCT04523220|54822433|FG001|Extension Treatment Period|Physician Decision|0|||
28153282|NCT04523220|54822434|FG002|Extension Treatment Period|Physician Decision|3|||
28153283|NCT04523220|54822432|FG000|Extension Treatment Period|Other|2|||
28153284|NCT04523220|54822433|FG001|Extension Treatment Period|Other|6|||
28153285|NCT04523220|54822434|FG002|Extension Treatment Period|Other|6|||
28153286|NCT04523220|54822432|FG000|Extension Treatment Period|Subject Decision|5|||
28153287|NCT04523220|54822433|FG001|Extension Treatment Period|Subject Decision|2|||
28153288|NCT04523220|54822434|FG002|Extension Treatment Period|Subject Decision|4|||
28153289|NCT04523220|54822432|FG000|Extension Treatment Period|Death|6|||
28153290|NCT04523220|54822433|FG001|Extension Treatment Period|Death|4|||
28153291|NCT04523220|54822434|FG002|Extension Treatment Period|Death|7|||
28153292|NCT04523220|54822432|FG000|Extension Treatment Period|Adverse Event|6|||
28153293|NCT04523220|54822433|FG001|Extension Treatment Period|Adverse Event|7|||
28153294|NCT04523220|54822434|FG002|Extension Treatment Period|Adverse Event|9|||
28153295|NCT04523220|54822432|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
28153296|NCT04523220|54822433|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
28153297|NCT04523220|54822434|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
28153298|NCT04523220|54822432|FG000|Extension Treatment Period|Study drug never administered|0|||
28153299|NCT04523220|54822433|FG001|Extension Treatment Period|Study drug never administered|1|||
28153300|NCT04523220|54822434|FG002|Extension Treatment Period|Study drug never administered|0|||
28153301|NCT04222088|54822465|FG000|Overall Study|Lost to Follow-up|5|||
28153302|NCT04222088|54822466|FG001|Overall Study|Lost to Follow-up|1|||
28153303|NCT04222088|54822465|FG000|Overall Study|Withdrawal by Subject|4|||
28153304|NCT04222088|54822466|FG001|Overall Study|Withdrawal by Subject|0|||
28153305|NCT03981614|54822475|FG000|Overall Study|Patient withdrawn prior to treatment|5|||
28153306|NCT03981614|54822476|FG001|Overall Study|Patient withdrawn prior to treatment|5|||
27825071|NCT01970501|54290556|FG001|Overall Study|Physician Decision|0|||
27941943|NCT01208207|54598598|FG003|Part I|Protocol Violation|0|||
28153307|NCT03981614|54822477|FG002|Overall Study|Patient withdrawn prior to treatment|1|||
28153308|NCT03978520|54822493|FG000|Overall Study|Adverse Event|2|||
28153309|NCT03978520|54822494|FG001|Overall Study|Adverse Event|5|||
28153310|NCT03978520|54822495|FG002|Overall Study|Adverse Event|3|||
28153311|NCT03978520|54822496|FG003|Overall Study|Adverse Event|5|||
28153312|NCT03978520|54822497|FG004|Overall Study|Adverse Event|6|||
28153313|NCT03978520|54822493|FG000|Overall Study|Withdrawal by Subject|10|||
28153314|NCT03978520|54822494|FG001|Overall Study|Withdrawal by Subject|4|||
28153315|NCT03978520|54822495|FG002|Overall Study|Withdrawal by Subject|5|||
28153316|NCT03978520|54822496|FG003|Overall Study|Withdrawal by Subject|6|||
27941944|NCT01208207|54598599|FG004|Part I|Protocol Violation|0|||
27941945|NCT01208207|54598600|FG005|Part I|Protocol Violation|0|||
28074347|NCT00123474|54728983|FG002|As Treated at Study Closure|Investigator Request|7|||
28074348|NCT00123474|54728984|FG003|As Treated at Study Closure|Investigator Request|5|||
28074349|NCT00123474|54728981|FG000|As Treated at Study Closure|non-specified|54|||
28074350|NCT00123474|54728982|FG001|As Treated at Study Closure|non-specified|47|||
28074351|NCT00123474|54728983|FG002|As Treated at Study Closure|non-specified|57|||
28074352|NCT00123474|54728984|FG003|As Treated at Study Closure|non-specified|60|||
28074353|NCT00123474|54728981|FG000|As Treated at Study Closure|Study Drug Toxicity|39|||
28074354|NCT00123474|54728982|FG001|As Treated at Study Closure|Study Drug Toxicity|45|||
28074355|NCT00123474|54728983|FG002|As Treated at Study Closure|Study Drug Toxicity|45|||
28074356|NCT00123474|54728984|FG003|As Treated at Study Closure|Study Drug Toxicity|51|||
28074357|NCT00123474|54728981|FG000|As Treated at Study Closure|Withdrawal by Subject|14|||
28074358|NCT00123474|54728982|FG001|As Treated at Study Closure|Withdrawal by Subject|19|||
28074359|NCT00123474|54728983|FG002|As Treated at Study Closure|Withdrawal by Subject|18|||
28153317|NCT03978520|54822497|FG004|Overall Study|Withdrawal by Subject|5|||
28153318|NCT03978520|54822493|FG000|Overall Study|Lost to Follow-up|2|||
28153319|NCT03978520|54822494|FG001|Overall Study|Lost to Follow-up|2|||
28153320|NCT03978520|54822495|FG002|Overall Study|Lost to Follow-up|2|||
28153321|NCT03978520|54822496|FG003|Overall Study|Lost to Follow-up|0|||
28153322|NCT03978520|54822497|FG004|Overall Study|Lost to Follow-up|1|||
28153323|NCT03978520|54822493|FG000|Overall Study|COVID-19 infection|0|||
28153324|NCT03978520|54822494|FG001|Overall Study|COVID-19 infection|1|||
28153325|NCT03978520|54822495|FG002|Overall Study|COVID-19 infection|0|||
28153326|NCT03978520|54822496|FG003|Overall Study|COVID-19 infection|0|||
28153327|NCT03978520|54822497|FG004|Overall Study|COVID-19 infection|0|||
28074360|NCT00123474|54728984|FG003|As Treated at Study Closure|Withdrawal by Subject|16|||
28153328|NCT03978520|54822493|FG000|Overall Study|Other, not specified|9|||
28153329|NCT03978520|54822494|FG001|Overall Study|Other, not specified|4|||
27825072|NCT01969799|54290564|FG000|Overall Study|Adverse Event|0|||
28074361|NCT00142298|54729025|FG000|Overall Study|Adverse Event|10|||
28074362|NCT00142298|54729026|FG001|Overall Study|Adverse Event|10|||
28074363|NCT00142298|54729027|FG002|Overall Study|Adverse Event|1|||
28074364|NCT00142298|54729028|FG003|Overall Study|Adverse Event|5|||
28074365|NCT00142298|54729029|FG004|Overall Study|Adverse Event|2|||
28074366|NCT00142298|54729030|FG005|Overall Study|Adverse Event|2|||
28074367|NCT00142298|54729031|FG006|Overall Study|Adverse Event|0|||
28074368|NCT00142298|54729032|FG007|Overall Study|Adverse Event|0|||
28074369|NCT00142298|54729033|FG008|Overall Study|Adverse Event|0|||
28153330|NCT03978520|54822495|FG002|Overall Study|Other, not specified|1|||
28153331|NCT03978520|54822496|FG003|Overall Study|Other, not specified|1|||
28153332|NCT03978520|54822497|FG004|Overall Study|Other, not specified|2|||
28153333|NCT03978520|54822493|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
28153334|NCT03978520|54822494|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
28153335|NCT03978520|54822495|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
28153336|NCT03978520|54822496|FG003|Overall Study|Sponsor decision based on interim analysis data review|33|||
28153337|NCT03978520|54822497|FG004|Overall Study|Sponsor decision based on interim analysis data review|24|||
28153338|NCT03929393|54822509|FG000|Overall Study|Death|1|||
28153339|NCT03929393|54822510|FG001|Overall Study|Death|0|||
28153340|NCT03929393|54822509|FG000|Overall Study|Time Commitment|2|||
28153341|NCT03929393|54822510|FG001|Overall Study|Time Commitment|5|||
28153342|NCT03929393|54822509|FG000|Overall Study|Motor Vehicle Accident|0|||
28153343|NCT03929393|54822510|FG001|Overall Study|Motor Vehicle Accident|1|||
28153344|NCT03929393|54822509|FG000|Overall Study|Difficulty Using Videoconferencing Technology|0|||
28153345|NCT03929393|54822510|FG001|Overall Study|Difficulty Using Videoconferencing Technology|1|||
28153346|NCT03929393|54822509|FG000|Overall Study|Other|1|||
28153347|NCT03929393|54822510|FG001|Overall Study|Other|3|||
28153348|NCT03874715|54822518|FG000|Overall Study|Adverse Event|2|||
28153349|NCT03874715|54822519|FG001|Overall Study|Adverse Event|0|||
28153350|NCT03874715|54822518|FG000|Overall Study|Poor compliance to protocol|5|||
28153351|NCT03874715|54822519|FG001|Overall Study|Poor compliance to protocol|1|||
28153352|NCT03874715|54822518|FG000|Overall Study|Withdrawal by Subject|1|||
28153353|NCT03874715|54822519|FG001|Overall Study|Withdrawal by Subject|0|||
28153354|NCT03874715|54822518|FG000|Overall Study|Other-unspecified|1|||
28153355|NCT03874715|54822519|FG001|Overall Study|Other-unspecified|0|||
28153356|NCT03502200|54822531|FG000|Overall Study|Adverse Event|1|||
28153357|NCT03502200|54822532|FG001|Overall Study|Adverse Event|0|||
28153358|NCT03502200|54822531|FG000|Overall Study|Lost to Follow-up|36|||
28153359|NCT03502200|54822532|FG001|Overall Study|Lost to Follow-up|38|||
28153360|NCT03502200|54822531|FG000|Overall Study|Study Team Decision|1|||
28153361|NCT03502200|54822532|FG001|Overall Study|Study Team Decision|1|||
28153362|NCT03502200|54822531|FG000|Overall Study|Withdrawal by Subject|5|||
28153363|NCT03502200|54822532|FG001|Overall Study|Withdrawal by Subject|7|||
28153364|NCT03502200|54822531|FG000|Overall Study|Death|0|||
28153365|NCT03502200|54822532|FG001|Overall Study|Death|2|||
28153366|NCT03492177|54822541|FG000|Overall Study|Adverse Event|1|||
28153367|NCT03492177|54822542|FG001|Overall Study|Adverse Event|0|||
28153368|NCT03492177|54822543|FG002|Overall Study|Adverse Event|0|||
28153369|NCT03492177|54822541|FG000|Overall Study|Death|3|||
28153370|NCT03492177|54822542|FG001|Overall Study|Death|0|||
28153371|NCT03492177|54822543|FG002|Overall Study|Death|3|||
28153372|NCT03492177|54822541|FG000|Overall Study|Lack of Efficacy|1|||
28153373|NCT03492177|54822542|FG001|Overall Study|Lack of Efficacy|2|||
28153374|NCT03492177|54822543|FG002|Overall Study|Lack of Efficacy|0|||
28153375|NCT03492177|54822541|FG000|Overall Study|Other|1|||
28153376|NCT03492177|54822542|FG001|Overall Study|Other|0|||
28153377|NCT03492177|54822543|FG002|Overall Study|Other|0|||
28153378|NCT03492177|54822541|FG000|Overall Study|Ongoing|16|||
28153379|NCT03492177|54822542|FG001|Overall Study|Ongoing|19|||
28153380|NCT03492177|54822543|FG002|Overall Study|Ongoing|17|||
28153381|NCT03361306|54822551|FG000|Overall Study|Death|5|||
28153382|NCT03361306|54822551|FG000|Overall Study|Still On Study (on study treatment)|3|||
28153383|NCT03361306|54822551|FG000|Overall Study|Still On Study (in follow up)|7|||
28153384|NCT03336242|54822557|FG000|Overall Study|Adverse Event|0|||
28153385|NCT03336242|54822558|FG001|Overall Study|Adverse Event|1|||
28153386|NCT03334435|54822569|FG000|Overall Study|Ongoing as of Week 52|70|||
28153387|NCT03334435|54822570|FG001|Overall Study|Ongoing as of Week 52|32|||
28153388|NCT03334435|54822571|FG002|Overall Study|Ongoing as of Week 52|379|||
28153389|NCT03334435|54822572|FG003|Overall Study|Ongoing as of Week 52|519|||
28153390|NCT03334435|54822573|FG004|Overall Study|Ongoing as of Week 52|146|||
28153391|NCT03334435|54822569|FG000|Overall Study|Lack of Efficacy|3|||
28153392|NCT03334435|54822570|FG001|Overall Study|Lack of Efficacy|5|||
28153393|NCT03334435|54822571|FG002|Overall Study|Lack of Efficacy|76|||
28153394|NCT03334435|54822572|FG003|Overall Study|Lack of Efficacy|140|||
28153395|NCT03334435|54822573|FG004|Overall Study|Lack of Efficacy|61|||
28153396|NCT03334435|54822569|FG000|Overall Study|Adverse Event|2|||
28153397|NCT03334435|54822570|FG001|Overall Study|Adverse Event|1|||
28153398|NCT03334435|54822571|FG002|Overall Study|Adverse Event|9|||
28153399|NCT03334435|54822572|FG003|Overall Study|Adverse Event|23|||
28153400|NCT03334435|54822573|FG004|Overall Study|Adverse Event|13|||
28153401|NCT03334435|54822569|FG000|Overall Study|Withdrawal by Subject|11|||
28153402|NCT03334435|54822570|FG001|Overall Study|Withdrawal by Subject|4|||
28153403|NCT03334435|54822571|FG002|Overall Study|Withdrawal by Subject|38|||
28153404|NCT03334435|54822572|FG003|Overall Study|Withdrawal by Subject|42|||
28153405|NCT03334435|54822573|FG004|Overall Study|Withdrawal by Subject|20|||
28153406|NCT03334435|54822569|FG000|Overall Study|Lost to Follow-up|3|||
28153407|NCT03334435|54822570|FG001|Overall Study|Lost to Follow-up|0|||
28153408|NCT03334435|54822571|FG002|Overall Study|Lost to Follow-up|2|||
28153409|NCT03334435|54822572|FG003|Overall Study|Lost to Follow-up|1|||
28153410|NCT03334435|54822573|FG004|Overall Study|Lost to Follow-up|1|||
28153411|NCT03334435|54822569|FG000|Overall Study|Death|0|||
28153412|NCT03334435|54822570|FG001|Overall Study|Death|0|||
28153413|NCT03334435|54822571|FG002|Overall Study|Death|0|||
28153414|NCT03334435|54822572|FG003|Overall Study|Death|1|||
28153415|NCT03334435|54822573|FG004|Overall Study|Death|0|||
28153416|NCT03334435|54822569|FG000|Overall Study|Other|0|||
28153417|NCT03334435|54822570|FG001|Overall Study|Other|1|||
28153418|NCT03334435|54822571|FG002|Overall Study|Other|3|||
28153419|NCT03334435|54822572|FG003|Overall Study|Other|2|||
28153420|NCT03334435|54822573|FG004|Overall Study|Other|1|||
28153421|NCT03277105|54822605|FG000|Overall Study|Death|77|||
28153422|NCT03277105|54822606|FG001|Overall Study|Death|73|||
28153423|NCT03277105|54822605|FG000|Overall Study|Lost to Follow-up|0|||
28153424|NCT03277105|54822606|FG001|Overall Study|Lost to Follow-up|3|||
28153425|NCT03277105|54822605|FG000|Overall Study|Withdrawal by Subject|10|||
28153426|NCT03277105|54822606|FG001|Overall Study|Withdrawal by Subject|9|||
28153427|NCT03277105|54822605|FG000|Overall Study|Other|1|||
28153428|NCT03277105|54822606|FG001|Overall Study|Other|3|||
28153429|NCT03277105|54822605|FG000|Overall Study|Ongoing|171|||
28153430|NCT03277105|54822606|FG001|Overall Study|Ongoing|175|||
28153431|NCT03201965|54822636|FG000|Overall Study|Death|5|||
28153432|NCT03201965|54822637|FG001|Overall Study|Death|27|||
28153433|NCT03201965|54822638|FG002|Overall Study|Death|27|||
28153434|NCT03201965|54822636|FG000|Overall Study|Lost to Follow-up|0|||
28153435|NCT03201965|54822637|FG001|Overall Study|Lost to Follow-up|1|||
28153436|NCT03201965|54822638|FG002|Overall Study|Lost to Follow-up|0|||
28153437|NCT03201965|54822636|FG000|Overall Study|Withdrawal by Subject|3|||
28153438|NCT03201965|54822637|FG001|Overall Study|Withdrawal by Subject|13|||
28153439|NCT03201965|54822638|FG002|Overall Study|Withdrawal by Subject|4|||
28153440|NCT03201965|54822636|FG000|Overall Study|Ongoing|20|||
28153441|NCT03201965|54822637|FG001|Overall Study|Ongoing|152|||
28153442|NCT03201965|54822638|FG002|Overall Study|Ongoing|164|||
28153443|NCT03143153|54822661|FG000|Pre-Treatment|Participant request to discontinue study treatment|0|||
28153444|NCT03143153|54822662|FG001|Pre-Treatment|Participant request to discontinue study treatment|0|||
28153445|NCT03143153|54822663|FG002|Pre-Treatment|Participant request to discontinue study treatment|2|||
28153446|NCT03143153|54822661|FG000|Pre-Treatment|Participant withdrew consent|0|||
28153447|NCT03143153|54822662|FG001|Pre-Treatment|Participant withdrew consent|1|||
28153448|NCT03143153|54822663|FG002|Pre-Treatment|Participant withdrew consent|12|||
28153449|NCT03143153|54822661|FG000|Pre-Treatment|Participant no longer meets study criteria|0|||
28153450|NCT03143153|54822662|FG001|Pre-Treatment|Participant no longer meets study criteria|4|||
28153451|NCT03143153|54822663|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
28153452|NCT03143153|54822661|FG000|Pre-Treatment|Other Reasons|1|||
28153453|NCT03143153|54822662|FG001|Pre-Treatment|Other Reasons|2|||
28153454|NCT03143153|54822663|FG002|Pre-Treatment|Other Reasons|1|||
28153455|NCT03143153|54822661|FG000|Pre-Treatment|Disease Progression|1|||
28153456|NCT03143153|54822662|FG001|Pre-Treatment|Disease Progression|1|||
28153457|NCT03143153|54822663|FG002|Pre-Treatment|Disease Progression|2|||
28153458|NCT03143153|54822661|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
28153459|NCT03143153|54822662|FG001|Pre-Treatment|Adverse event unrelated to study drug|3|||
28153460|NCT03143153|54822663|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
28153461|NCT03143153|54822661|FG000|Treatment|Disease progression|174|||
28153462|NCT03143153|54822662|FG001|Treatment|Disease progression|184|||
28153463|NCT03143153|54822663|FG002|Treatment|Disease progression|193|||
28153464|NCT03143153|54822661|FG000|Treatment|Study drug toxicity|59|||
28153465|NCT03143153|54822662|FG001|Treatment|Study drug toxicity|33|||
28153466|NCT03143153|54822663|FG002|Treatment|Study drug toxicity|40|||
28153467|NCT03143153|54822661|FG000|Treatment|Death|5|||
28153468|NCT03143153|54822662|FG001|Treatment|Death|3|||
28153469|NCT03143153|54822663|FG002|Treatment|Death|4|||
28153470|NCT03143153|54822661|FG000|Treatment|Adverse event unrelated to study drug|19|||
28153471|NCT03143153|54822662|FG001|Treatment|Adverse event unrelated to study drug|28|||
28153472|NCT03143153|54822663|FG002|Treatment|Adverse event unrelated to study drug|12|||
28153473|NCT03143153|54822661|FG000|Treatment|Participant request to discontinue study treatment|13|||
28153474|NCT03143153|54822662|FG001|Treatment|Participant request to discontinue study treatment|15|||
28074370|NCT00142298|54729034|FG009|Overall Study|Adverse Event|0|||
28074371|NCT00142298|54729025|FG000|Overall Study|Clinical disease progression|1|||
28074372|NCT00142298|54729026|FG001|Overall Study|Clinical disease progression|0|||
28153475|NCT03143153|54822663|FG002|Treatment|Participant request to discontinue study treatment|20|||
28153476|NCT03143153|54822661|FG000|Treatment|Participant withdrew consent|3|||
28153477|NCT03143153|54822662|FG001|Treatment|Participant withdrew consent|4|||
28153478|NCT03143153|54822663|FG002|Treatment|Participant withdrew consent|12|||
28153479|NCT03143153|54822661|FG000|Treatment|Pregnancy|1|||
28153480|NCT03143153|54822662|FG001|Treatment|Pregnancy|0|||
28153481|NCT03143153|54822663|FG002|Treatment|Pregnancy|0|||
28153482|NCT03143153|54822661|FG000|Treatment|Maximum clinical benefit|1|||
28153483|NCT03143153|54822662|FG001|Treatment|Maximum clinical benefit|3|||
28153484|NCT03143153|54822663|FG002|Treatment|Maximum clinical benefit|4|||
28153485|NCT03143153|54822661|FG000|Treatment|Completed treatment as per Protocol|13|||
28153486|NCT03143153|54822662|FG001|Treatment|Completed treatment as per Protocol|8|||
28074373|NCT00142298|54729027|FG002|Overall Study|Clinical disease progression|0|||
28074374|NCT00142298|54729028|FG003|Overall Study|Clinical disease progression|0|||
28074375|NCT00142298|54729029|FG004|Overall Study|Clinical disease progression|0|||
28074376|NCT00142298|54729030|FG005|Overall Study|Clinical disease progression|0|||
28074377|NCT00142298|54729031|FG006|Overall Study|Clinical disease progression|0|||
28074378|NCT00142298|54729032|FG007|Overall Study|Clinical disease progression|0|||
28074379|NCT00142298|54729033|FG008|Overall Study|Clinical disease progression|0|||
28074380|NCT00142298|54729034|FG009|Overall Study|Clinical disease progression|0|||
28153487|NCT03143153|54822663|FG002|Treatment|Completed treatment as per Protocol|0|||
28153488|NCT03143153|54822661|FG000|Treatment|Other reasons|12|||
28153489|NCT03143153|54822662|FG001|Treatment|Other reasons|7|||
28153490|NCT03143153|54822663|FG002|Treatment|Other reasons|15|||
28153491|NCT03143153|54822661|FG000|Treatment|Not reported|1|||
28153492|NCT03143153|54822662|FG001|Treatment|Not reported|0|||
28153493|NCT03143153|54822663|FG002|Treatment|Not reported|0|||
28153494|NCT02998528|54822674|FG000|Randomization Period|Adverse event unrelated to study drug|0|||
28153495|NCT02998528|54822675|FG001|Randomization Period|Adverse event unrelated to study drug|0|||
28153496|NCT02998528|54822676|FG002|Randomization Period|Adverse event unrelated to study drug|1|||
28153497|NCT02998528|54822674|FG000|Randomization Period|Participant withdrew consent|0|||
28153498|NCT02998528|54822675|FG001|Randomization Period|Participant withdrew consent|3|||
28153499|NCT02998528|54822676|FG002|Randomization Period|Participant withdrew consent|0|||
28153500|NCT02998528|54822674|FG000|Randomization Period|Participant no longer meets study criteria|1|||
28153501|NCT02998528|54822675|FG001|Randomization Period|Participant no longer meets study criteria|3|||
28153502|NCT02998528|54822676|FG002|Randomization Period|Participant no longer meets study criteria|2|||
28153503|NCT02998528|54822674|FG000|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
28153504|NCT02998528|54822675|FG001|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|7|||
28153505|NCT02998528|54822676|FG002|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
28153506|NCT02998528|54822674|FG000|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
28153507|NCT02998528|54822675|FG001|Neoadjuvant Treatment Period|Participant withdrew consent|4|||
28153508|NCT02998528|54822676|FG002|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
28153509|NCT02998528|54822674|FG000|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
28153510|NCT02998528|54822675|FG001|Neoadjuvant Treatment Period|Participant no longer meets study criteria|1|||
28153511|NCT02998528|54822676|FG002|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
28153512|NCT02998528|54822674|FG000|Neoadjuvant Treatment Period|Disease progression|3|||
28153513|NCT02998528|54822675|FG001|Neoadjuvant Treatment Period|Disease progression|2|||
28153514|NCT02998528|54822676|FG002|Neoadjuvant Treatment Period|Disease progression|1|||
28153515|NCT02998528|54822674|FG000|Neoadjuvant Treatment Period|Study drug toxicity|6|||
28153516|NCT02998528|54822675|FG001|Neoadjuvant Treatment Period|Study drug toxicity|14|||
28153517|NCT02998528|54822676|FG002|Neoadjuvant Treatment Period|Study drug toxicity|10|||
28153518|NCT02998528|54822674|FG000|Neoadjuvant Treatment Period|Death|1|||
28153519|NCT02998528|54822675|FG001|Neoadjuvant Treatment Period|Death|0|||
28153520|NCT02998528|54822676|FG002|Neoadjuvant Treatment Period|Death|0|||
28153521|NCT02998528|54822674|FG000|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
28153522|NCT02998528|54822675|FG001|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|3|||
28153523|NCT02998528|54822676|FG002|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
28153524|NCT02998528|54822674|FG000|Systemic Adjuvant Treatment Period|Disease progression|1|||
28153525|NCT02998528|54822675|FG001|Systemic Adjuvant Treatment Period|Disease progression|0|||
28153526|NCT02998528|54822676|FG002|Systemic Adjuvant Treatment Period|Disease progression|0|||
28153527|NCT02998528|54822674|FG000|Systemic Adjuvant Treatment Period|Study drug toxicity|4|||
27825073|NCT01969799|54290565|FG001|Overall Study|Adverse Event|1|||
28153528|NCT02998528|54822675|FG001|Systemic Adjuvant Treatment Period|Study drug toxicity|5|||
28153529|NCT02998528|54822676|FG002|Systemic Adjuvant Treatment Period|Study drug toxicity|1|||
28153530|NCT02998528|54822674|FG000|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
28153531|NCT02998528|54822675|FG001|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|0|||
28153532|NCT02998528|54822676|FG002|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
28153533|NCT02998528|54822674|FG000|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|3|||
28153534|NCT02998528|54822675|FG001|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
28153535|NCT02998528|54822676|FG002|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
28153536|NCT02998528|54822674|FG000|Systemic Adjuvant Treatment Period|Other reasons|0|||
28153537|NCT02998528|54822675|FG001|Systemic Adjuvant Treatment Period|Other reasons|0|||
28153538|NCT02998528|54822676|FG002|Systemic Adjuvant Treatment Period|Other reasons|1|||
28153539|NCT02919449|54822692|FG000|Overall Study|Withdrawal by Subject|1|||
28153540|NCT02919449|54822692|FG000|Overall Study|Investigator decision|1|||
28153541|NCT02913482|54822699|FG000|Overall Study|Death|0|||
28153542|NCT02913482|54822700|FG001|Overall Study|Death|2|||
28153543|NCT02913482|54822701|FG002|Overall Study|Death|2|||
28153544|NCT02913482|54822699|FG000|Overall Study|Progressive Disease|1|||
28153545|NCT02913482|54822700|FG001|Overall Study|Progressive Disease|1|||
27825074|NCT01969799|54290564|FG000|Overall Study|Death|16|||
27825075|NCT01969799|54290565|FG001|Overall Study|Death|11|||
27825076|NCT01969799|54290564|FG000|Overall Study|Lost to Follow-up|0|||
27941946|NCT01208207|54598601|FG006|Part I|Protocol Violation|0|||
28153546|NCT02913482|54822701|FG002|Overall Study|Progressive Disease|1|||
28153547|NCT02854436|54822711|FG000|Overall Study|Adverse Event|1|||
28153548|NCT02854436|54822711|FG000|Overall Study|Death|208|||
28153549|NCT02854436|54822711|FG000|Overall Study|Lost to Follow-up|5|||
28153550|NCT02854436|54822711|FG000|Overall Study|Withdrawal by Subject|12|||
28153551|NCT02854436|54822711|FG000|Overall Study|Other|45|||
28153552|NCT02854436|54822711|FG000|Overall Study|Ongoing|18|||
28153553|NCT02769832|54822715|FG000|Overall Study|Death|30|||
28153554|NCT02743494|54822722|FG000|Pre-treatment Period|Participant request to discontinue treatment|0|||
28153555|NCT02743494|54822723|FG001|Pre-treatment Period|Participant request to discontinue treatment|1|||
28153556|NCT02743494|54822722|FG000|Pre-treatment Period|Participant no longer meeting study criteria|0|||
28153557|NCT02743494|54822723|FG001|Pre-treatment Period|Participant no longer meeting study criteria|1|||
28153558|NCT02743494|54822722|FG000|Treatment Period|Completed treatment|229|||
28153559|NCT02743494|54822723|FG001|Treatment Period|Completed treatment|99|||
28153560|NCT02743494|54822722|FG000|Treatment Period|Disease recurrence|149|||
28153561|NCT02743494|54822723|FG001|Treatment Period|Disease recurrence|113|||
28153562|NCT02743494|54822722|FG000|Treatment Period|Study drug toxicity|57|||
28153563|NCT02743494|54822723|FG001|Treatment Period|Study drug toxicity|8|||
27941947|NCT01208207|54598595|FG000|Part I|Withdrawal by Subject|14|||
27941948|NCT01208207|54598596|FG001|Part I|Withdrawal by Subject|4|||
27941949|NCT01208207|54598597|FG002|Part I|Withdrawal by Subject|4|||
27941950|NCT01208207|54598598|FG003|Part I|Withdrawal by Subject|0|||
28153564|NCT02743494|54822722|FG000|Treatment Period|Death|1|||
27850295|NCT04178967|54349323|FG008|Induction Period|Lost to Follow-up|0|||
27850296|NCT04178967|54349324|FG009|Induction Period|Lost to Follow-up|0|||
28153565|NCT02743494|54822723|FG001|Treatment Period|Death|0|||
28153566|NCT02743494|54822722|FG000|Treatment Period|Adverse event unrelated to study drug|15|||
27941951|NCT01208207|54598599|FG004|Part I|Withdrawal by Subject|0|||
27941952|NCT01208207|54598600|FG005|Part I|Withdrawal by Subject|0|||
28153567|NCT02743494|54822723|FG001|Treatment Period|Adverse event unrelated to study drug|9|||
28153568|NCT02743494|54822722|FG000|Treatment Period|Participant request to discontinue treatment|30|||
28153569|NCT02743494|54822723|FG001|Treatment Period|Participant request to discontinue treatment|5|||
28153570|NCT02743494|54822722|FG000|Treatment Period|Participant withdrew consent|12|||
28153571|NCT02743494|54822723|FG001|Treatment Period|Participant withdrew consent|4|||
28153572|NCT02743494|54822722|FG000|Treatment Period|Lost to Follow-up|0|||
28153573|NCT02743494|54822723|FG001|Treatment Period|Lost to Follow-up|1|||
28153574|NCT02743494|54822722|FG000|Treatment Period|Poor/Non-compliance|1|||
28153575|NCT02743494|54822723|FG001|Treatment Period|Poor/Non-compliance|0|||
28153576|NCT02743494|54822722|FG000|Treatment Period|Other reasons|7|||
28153577|NCT02743494|54822723|FG001|Treatment Period|Other reasons|2|||
28153578|NCT02677896|54822731|FG000|Double Blind Period (up to 35 Months)|Death|113|||
28153579|NCT02677896|54822732|FG001|Double Blind Period (up to 35 Months)|Death|189|||
28153580|NCT02677896|54822731|FG000|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
28153581|NCT02677896|54822732|FG001|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
28153582|NCT02677896|54822731|FG000|Double Blind Period (up to 35 Months)|Progressive disease|3|||
28153583|NCT02677896|54822732|FG001|Double Blind Period (up to 35 Months)|Progressive disease|4|||
28153584|NCT02677896|54822731|FG000|Double Blind Period (up to 35 Months)|Withdrawal by Subject|41|||
28153585|NCT02677896|54822732|FG001|Double Blind Period (up to 35 Months)|Withdrawal by Subject|69|||
28153586|NCT02677896|54822731|FG000|Double Blind Period (up to 35 Months)|Miscellaneous|9|||
28153587|NCT02677896|54822732|FG001|Double Blind Period (up to 35 Months)|Miscellaneous|14|||
28153588|NCT02677896|54822731|FG000|Double Blind Period (up to 35 Months)|Continued in OLE|365|||
28153589|NCT02677896|54822732|FG001|Double Blind Period (up to 35 Months)|Continued in OLE|180|||
28153590|NCT02677896|54822731|FG000|Double Blind Period (up to 35 Months)|Followed-up for OS|31|||
28153591|NCT02677896|54822732|FG001|Double Blind Period (up to 35 Months)|Followed-up for OS|108|||
28153592|NCT02677896|54822731|FG000|Open-Label Extension (up to 25 Months)|Death|40|||
28153593|NCT02677896|54822732|FG001|Open-Label Extension (up to 25 Months)|Death|14|||
28153594|NCT02677896|54822731|FG000|Open-Label Extension (up to 25 Months)|Lost to Follow-up|2|||
28153595|NCT02677896|54822732|FG001|Open-Label Extension (up to 25 Months)|Lost to Follow-up|1|||
28153596|NCT02677896|54822731|FG000|Open-Label Extension (up to 25 Months)|Progressive disease|3|||
28153597|NCT02677896|54822732|FG001|Open-Label Extension (up to 25 Months)|Progressive disease|1|||
28153598|NCT02677896|54822731|FG000|Open-Label Extension (up to 25 Months)|Withdrawal by Subject|10|||
28153599|NCT02677896|54822732|FG001|Open-Label Extension (up to 25 Months)|Withdrawal by Subject|9|||
28153600|NCT02677896|54822731|FG000|Open-Label Extension (up to 25 Months)|Miscellaneous|0|||
28153601|NCT02677896|54822732|FG001|Open-Label Extension (up to 25 Months)|Miscellaneous|1|||
28153602|NCT02677896|54822731|FG000|Open-Label Extension (up to 25 Months)|OLE treatment ongoing|261|||
28153603|NCT02677896|54822732|FG001|Open-Label Extension (up to 25 Months)|OLE treatment ongoing|136|||
28153604|NCT02677896|54822731|FG000|Open-Label Extension (up to 25 Months)|Followed up for OS|49|||
28153605|NCT02677896|54822732|FG001|Open-Label Extension (up to 25 Months)|Followed up for OS|18|||
28153606|NCT02530970|54822743|FG000|Overall Study|Adverse Event|8|||
28153607|NCT02530970|54822743|FG000|Overall Study|Lost to Follow-up|88|||
28153608|NCT02530970|54822743|FG000|Overall Study|Physician Decision|5|||
28153609|NCT02530970|54822743|FG000|Overall Study|Withdrawal by Subject|14|||
28153610|NCT02530970|54822743|FG000|Overall Study|Death|6|||
28153611|NCT02530970|54822743|FG000|Overall Study|Hospitalization|1|||
28153612|NCT02530970|54822743|FG000|Overall Study|Insurance|2|||
28153613|NCT02530970|54822743|FG000|Overall Study|Explant|2|||
28153614|NCT02530970|54822743|FG000|Overall Study|Change in Provider|5|||
28153615|NCT02530970|54822743|FG000|Overall Study|Relocation|3|||
28153616|NCT02489318|54822749|FG000|Randomized|Withdrawal by Subject|0|||
28153617|NCT02489318|54822750|FG001|Randomized|Withdrawal by Subject|1|||
28153618|NCT02489318|54822749|FG000|Treated|Adverse Event|19|||
28153619|NCT02489318|54822750|FG001|Treated|Adverse Event|62|||
28153620|NCT02489318|54822749|FG000|Treated|Death|13|||
28153621|NCT02489318|54822750|FG001|Treated|Death|11|||
28153622|NCT02489318|54822749|FG000|Treated|Physician Decision|4|||
28153623|NCT02489318|54822750|FG001|Treated|Physician Decision|6|||
28153624|NCT02489318|54822749|FG000|Treated|Protocol Violation|1|||
28153625|NCT02489318|54822750|FG001|Treated|Protocol Violation|2|||
28153626|NCT02489318|54822749|FG000|Treated|Withdrawal by Subject|37|||
28153627|NCT02489318|54822750|FG001|Treated|Withdrawal by Subject|36|||
28153628|NCT02489318|54822749|FG000|Treated|Other: Progressive Disease|245|||
28153629|NCT02489318|54822750|FG001|Treated|Other: Progressive Disease|138|||
28153630|NCT02489318|54822749|FG000|Treated|Other|0|||
28153631|NCT02489318|54822750|FG001|Treated|Other|2|||
28153632|NCT02489318|54822749|FG000|Treated|Ongoing|0|||
27825077|NCT01969799|54290565|FG001|Overall Study|Lost to Follow-up|2|||
28153633|NCT02489318|54822750|FG001|Treated|Ongoing|267|||
28153634|NCT02418156|54822757|FG000|Overall Study|Lost to Follow-up|12|||
28153635|NCT02418156|54822757|FG000|Overall Study|Death|2|||
27941953|NCT01208207|54598601|FG006|Part I|Withdrawal by Subject|0|||
27941954|NCT01208207|54598595|FG000|Part II|Withdrawal by Subject|0|||
27941955|NCT01208207|54598596|FG001|Part II|Withdrawal by Subject|0|||
27941956|NCT01208207|54598597|FG002|Part II|Withdrawal by Subject|0|||
27941957|NCT01208207|54598598|FG003|Part II|Withdrawal by Subject|10|||
27941958|NCT01208207|54598599|FG004|Part II|Withdrawal by Subject|9|||
27941959|NCT01208207|54598600|FG005|Part II|Withdrawal by Subject|3|||
27941960|NCT01208207|54598601|FG006|Part II|Withdrawal by Subject|5|||
27941961|NCT01208207|54598595|FG000|Part II|Adverse Event|0|||
27941962|NCT01208207|54598596|FG001|Part II|Adverse Event|0|||
27941963|NCT01208207|54598597|FG002|Part II|Adverse Event|0|||
27941964|NCT01208207|54598598|FG003|Part II|Adverse Event|5|||
28153636|NCT02418156|54822757|FG000|Overall Study|Physician Decision|1|||
28153637|NCT02418156|54822757|FG000|Overall Study|Withdrawal by Subject|1|||
28074381|NCT00142298|54729025|FG000|Overall Study|Death|1|||
28074382|NCT00142298|54729026|FG001|Overall Study|Death|1|||
28074383|NCT00142298|54729027|FG002|Overall Study|Death|1|||
28074384|NCT00142298|54729028|FG003|Overall Study|Death|0|||
28074385|NCT00142298|54729029|FG004|Overall Study|Death|0|||
28074386|NCT00142298|54729030|FG005|Overall Study|Death|6|||
28074387|NCT00142298|54729031|FG006|Overall Study|Death|0|||
28074388|NCT00142298|54729032|FG007|Overall Study|Death|0|||
28074389|NCT00142298|54729033|FG008|Overall Study|Death|0|||
28074390|NCT00142298|54729034|FG009|Overall Study|Death|0|||
28074391|NCT00142298|54729025|FG000|Overall Study|Lack of Efficacy|44|||
28074392|NCT00142298|54729026|FG001|Overall Study|Lack of Efficacy|62|||
28074393|NCT00142298|54729027|FG002|Overall Study|Lack of Efficacy|9|||
28153638|NCT02418156|54822757|FG000|Overall Study|Subject refused to return|1|||
28153639|NCT02281084|54822786|FG000|Overall Study|Adverse Event|1|||
28153640|NCT02281084|54822787|FG001|Overall Study|Adverse Event|0|||
28153641|NCT02281084|54822788|FG002|Overall Study|Adverse Event|0|||
28153642|NCT02281084|54822789|FG003|Overall Study|Adverse Event|0|||
28153643|NCT02281084|54822786|FG000|Overall Study|Withdrawal by Subject|1|||
28153644|NCT02281084|54822787|FG001|Overall Study|Withdrawal by Subject|2|||
28153645|NCT02281084|54822788|FG002|Overall Study|Withdrawal by Subject|0|||
28153646|NCT02281084|54822789|FG003|Overall Study|Withdrawal by Subject|0|||
28153647|NCT02281084|54822786|FG000|Overall Study|Death|20|||
28153648|NCT02281084|54822787|FG001|Overall Study|Death|16|||
28153649|NCT02281084|54822788|FG002|Overall Study|Death|3|||
28153650|NCT02281084|54822789|FG003|Overall Study|Death|5|||
28153651|NCT02281084|54822786|FG000|Overall Study|Physician Decision|0|||
28153652|NCT02281084|54822787|FG001|Overall Study|Physician Decision|0|||
28153653|NCT02281084|54822788|FG002|Overall Study|Physician Decision|1|||
28153654|NCT02281084|54822789|FG003|Overall Study|Physician Decision|0|||
28153655|NCT02277444|54822799|FG000|Overall Study|Adverse Event|10|||
28153656|NCT02277444|54822799|FG000|Overall Study|Withdrawal by Subject|3|||
28153657|NCT02277444|54822799|FG000|Overall Study|Other|1|||
28153658|NCT02277444|54822799|FG000|Overall Study|Enrolled and not Treated|3|||
28153659|NCT02277444|54822799|FG000|Overall Study|Ongoing|113|||
28153660|NCT02257736|54822805|FG000|Overall Study|Progressive disease|365|||
28153661|NCT02257736|54822806|FG001|Overall Study|Progressive disease|327|||
28153662|NCT02257736|54822805|FG000|Overall Study|Adverse Event|45|||
28153663|NCT02257736|54822806|FG001|Overall Study|Adverse Event|56|||
28153664|NCT02257736|54822805|FG000|Overall Study|Withdrawal by Subject|21|||
28153665|NCT02257736|54822806|FG001|Overall Study|Withdrawal by Subject|38|||
28153666|NCT02257736|54822805|FG000|Overall Study|Death|11|||
28153667|NCT02257736|54822806|FG001|Overall Study|Death|6|||
28153668|NCT02257736|54822805|FG000|Overall Study|Physician Decision|5|||
28153669|NCT02257736|54822806|FG001|Overall Study|Physician Decision|9|||
28153670|NCT02257736|54822805|FG000|Overall Study|Non-Compliance with study drug|1|||
28153671|NCT02257736|54822806|FG001|Overall Study|Non-Compliance with study drug|2|||
28153672|NCT02257736|54822805|FG000|Overall Study|Protocol Violation|1|||
28153673|NCT02257736|54822806|FG001|Overall Study|Protocol Violation|0|||
28153674|NCT02257736|54822805|FG000|Overall Study|Other|1|||
28153675|NCT02257736|54822806|FG001|Overall Study|Other|7|||
28153676|NCT02257736|54822805|FG000|Overall Study|Randomized, not treated|1|||
28153677|NCT02257736|54822806|FG001|Overall Study|Randomized, not treated|2|||
28153678|NCT02252172|54822814|FG000|Overall Study|Lost to Follow-up|3|||
28153679|NCT02252172|54822815|FG001|Overall Study|Lost to Follow-up|1|||
28153680|NCT02252172|54822814|FG000|Overall Study|Ongoing|276|||
28153681|NCT02252172|54822815|FG001|Overall Study|Ongoing|298|||
28153682|NCT02136134|54822823|FG000|Overall Study|Death|35|||
28153683|NCT02136134|54822824|FG001|Overall Study|Death|29|||
28153684|NCT02136134|54822823|FG000|Overall Study|Withdrawal by Subject|14|||
28153685|NCT02136134|54822824|FG001|Overall Study|Withdrawal by Subject|4|||
28153686|NCT02136134|54822823|FG000|Overall Study|Other|3|||
28153687|NCT02136134|54822824|FG001|Overall Study|Other|3|||
28153688|NCT02136134|54822823|FG000|Overall Study|Ongoing|185|||
28153689|NCT02136134|54822824|FG001|Overall Study|Ongoing|207|||
28153690|NCT02136134|54822823|FG000|Overall Study|Subjects randomized but not treated|10|||
28153691|NCT02136134|54822824|FG001|Overall Study|Subjects randomized but not treated|8|||
28153692|NCT02076009|54822832|FG000|Overall Study|Death|44|||
28153693|NCT02076009|54822833|FG001|Overall Study|Death|30|||
28153694|NCT02076009|54822832|FG000|Overall Study|Withdrawal by Subject|9|||
28074394|NCT00142298|54729028|FG003|Overall Study|Lack of Efficacy|12|||
28074395|NCT00142298|54729029|FG004|Overall Study|Lack of Efficacy|1|||
28153695|NCT02076009|54822833|FG001|Overall Study|Withdrawal by Subject|3|||
28153696|NCT02076009|54822832|FG000|Overall Study|Lost to Follow-up|1|||
28153697|NCT02076009|54822833|FG001|Overall Study|Lost to Follow-up|1|||
28153698|NCT02076009|54822832|FG000|Overall Study|Progressive disease|1|||
28153699|NCT02076009|54822833|FG001|Overall Study|Progressive disease|0|||
28153700|NCT02076009|54822832|FG000|Overall Study|Ongoing|226|||
27825078|NCT01969799|54290564|FG000|Overall Study|Physician Decision|1|||
28074396|NCT00142298|54729030|FG005|Overall Study|Lack of Efficacy|0|||
28074397|NCT00142298|54729031|FG006|Overall Study|Lack of Efficacy|0|||
28074398|NCT00142298|54729032|FG007|Overall Study|Lack of Efficacy|1|||
28074399|NCT00142298|54729033|FG008|Overall Study|Lack of Efficacy|0|||
28074400|NCT00142298|54729034|FG009|Overall Study|Lack of Efficacy|0|||
28074401|NCT00142298|54729025|FG000|Overall Study|Non-compliance|15|||
28074402|NCT00142298|54729026|FG001|Overall Study|Non-compliance|13|||
28074403|NCT00142298|54729027|FG002|Overall Study|Non-compliance|0|||
28074404|NCT00142298|54729028|FG003|Overall Study|Non-compliance|6|||
28074405|NCT00142298|54729029|FG004|Overall Study|Non-compliance|1|||
28074406|NCT00142298|54729030|FG005|Overall Study|Non-compliance|0|||
28153701|NCT02076009|54822833|FG001|Overall Study|Ongoing|249|||
28153702|NCT02076009|54822832|FG000|Overall Study|Subjects randomized but not treated|2|||
28153703|NCT02076009|54822833|FG001|Overall Study|Subjects randomized but not treated|3|||
28153704|NCT02029443|54822857|FG000|Overall Study|Completed 30-Day safety follow-up visit|53|||
28153705|NCT02029443|54822858|FG001|Overall Study|Completed 30-Day safety follow-up visit|16|||
28153706|NCT02029443|54822859|FG002|Overall Study|Completed 30-Day safety follow-up visit|12|||
28153707|NCT02029443|54822860|FG003|Overall Study|Completed 30-Day safety follow-up visit|2|||
28153708|NCT02029443|54822861|FG004|Overall Study|Completed 30-Day safety follow-up visit|1|||
28153709|NCT02029443|54822857|FG000|Overall Study|Death|13|||
28153710|NCT02029443|54822858|FG001|Overall Study|Death|2|||
28153711|NCT02029443|54822859|FG002|Overall Study|Death|2|||
28153712|NCT02029443|54822860|FG003|Overall Study|Death|11|||
28153713|NCT02029443|54822861|FG004|Overall Study|Death|2|||
28153714|NCT02029443|54822857|FG000|Overall Study|Lost to Follow-up|1|||
28153715|NCT02029443|54822858|FG001|Overall Study|Lost to Follow-up|0|||
28153716|NCT02029443|54822859|FG002|Overall Study|Lost to Follow-up|1|||
28153717|NCT02029443|54822860|FG003|Overall Study|Lost to Follow-up|1|||
28153718|NCT02029443|54822861|FG004|Overall Study|Lost to Follow-up|0|||
28153719|NCT02029443|54822857|FG000|Overall Study|Started other anti-cancer therapy|17|||
28153720|NCT02029443|54822858|FG001|Overall Study|Started other anti-cancer therapy|4|||
28153721|NCT02029443|54822859|FG002|Overall Study|Started other anti-cancer therapy|7|||
28153722|NCT02029443|54822860|FG003|Overall Study|Started other anti-cancer therapy|9|||
28153723|NCT02029443|54822861|FG004|Overall Study|Started other anti-cancer therapy|3|||
28153724|NCT02029443|54822857|FG000|Overall Study|Withdrawal by Subject|3|||
28153725|NCT02029443|54822858|FG001|Overall Study|Withdrawal by Subject|1|||
28153726|NCT02029443|54822859|FG002|Overall Study|Withdrawal by Subject|1|||
28153727|NCT02029443|54822860|FG003|Overall Study|Withdrawal by Subject|1|||
28153728|NCT02029443|54822861|FG004|Overall Study|Withdrawal by Subject|0|||
28153729|NCT02029443|54822857|FG000|Overall Study|Other|6|||
28153730|NCT02029443|54822858|FG001|Overall Study|Other|6|||
28153731|NCT02029443|54822859|FG002|Overall Study|Other|4|||
28153732|NCT02029443|54822860|FG003|Overall Study|Other|2|||
28153733|NCT02029443|54822861|FG004|Overall Study|Other|0|||
28153734|NCT01946204|54822897|FG000|Overall Study|Death|38|||
28153735|NCT01946204|54822898|FG001|Overall Study|Death|59|||
28153736|NCT01946204|54822897|FG000|Overall Study|Withdrawal by Subject|37|||
28153737|NCT01946204|54822898|FG001|Overall Study|Withdrawal by Subject|50|||
28153738|NCT01946204|54822897|FG000|Overall Study|Lost to Follow-up|3|||
28153739|NCT01946204|54822898|FG001|Overall Study|Lost to Follow-up|7|||
28153740|NCT01946204|54822897|FG000|Overall Study|Ongoing|316|||
28153741|NCT01946204|54822898|FG001|Overall Study|Ongoing|687|||
28153742|NCT01946204|54822897|FG000|Overall Study|Other|7|||
28153743|NCT01946204|54822898|FG001|Overall Study|Other|3|||
28153744|NCT01850524|54822906|FG000|Overall Study|Lost to Follow-up|5|||
28153745|NCT01850524|54822907|FG001|Overall Study|Lost to Follow-up|10|||
28153746|NCT01850524|54822906|FG000|Overall Study|Withdrawal by Subject|24|||
28153747|NCT01850524|54822907|FG001|Overall Study|Withdrawal by Subject|22|||
28153748|NCT01850524|54822906|FG000|Overall Study|Reason not Specified|142|||
28153749|NCT01850524|54822907|FG001|Overall Study|Reason not Specified|141|||
28153750|NCT01776840|54822922|FG000|Overall Study|Lost to Follow-up|4|||
28153751|NCT01776840|54822923|FG001|Overall Study|Lost to Follow-up|4|||
28153752|NCT01776840|54822922|FG000|Overall Study|Withdrawal by Subject|42|||
28153753|NCT01776840|54822923|FG001|Overall Study|Withdrawal by Subject|22|||
28153754|NCT01776840|54822922|FG000|Overall Study|Ongoing|112|||
28153755|NCT01776840|54822923|FG001|Overall Study|Ongoing|129|||
28153756|NCT01615029|54822934|FG000|Overall Study|Adverse Event|0|||
27825079|NCT01969799|54290565|FG001|Overall Study|Physician Decision|0|||
27825080|NCT01969721|54290571|FG000|Overall Study|Adverse Event|3|||
27825081|NCT01969721|54290572|FG001|Overall Study|Adverse Event|8|||
28153757|NCT01615029|54822935|FG001|Overall Study|Adverse Event|0|||
28153758|NCT01615029|54822936|FG002|Overall Study|Adverse Event|0|||
28153759|NCT01615029|54822937|FG003|Overall Study|Adverse Event|0|||
28153760|NCT01615029|54822938|FG004|Overall Study|Adverse Event|1|||
28153761|NCT01615029|54822934|FG000|Overall Study|Death|0|||
28153762|NCT01615029|54822935|FG001|Overall Study|Death|0|||
28153763|NCT01615029|54822936|FG002|Overall Study|Death|0|||
28153764|NCT01615029|54822937|FG003|Overall Study|Death|0|||
28153765|NCT01615029|54822938|FG004|Overall Study|Death|1|||
28153766|NCT01615029|54822934|FG000|Overall Study|Lost to Follow-up|0|||
28153767|NCT01615029|54822935|FG001|Overall Study|Lost to Follow-up|0|||
28153768|NCT01615029|54822936|FG002|Overall Study|Lost to Follow-up|0|||
28153769|NCT01615029|54822937|FG003|Overall Study|Lost to Follow-up|0|||
27825082|NCT01969721|54290573|FG002|Overall Study|Adverse Event|3|||
28153770|NCT01615029|54822938|FG004|Overall Study|Lost to Follow-up|1|||
28153771|NCT01615029|54822934|FG000|Overall Study|Progressive disease|2|||
28153772|NCT01615029|54822935|FG001|Overall Study|Progressive disease|1|||
28153773|NCT01615029|54822936|FG002|Overall Study|Progressive disease|1|||
28153774|NCT01615029|54822937|FG003|Overall Study|Progressive disease|1|||
28153775|NCT01615029|54822938|FG004|Overall Study|Progressive disease|5|||
28074407|NCT00142298|54729031|FG006|Overall Study|Non-compliance|0|||
28074408|NCT00142298|54729032|FG007|Overall Study|Non-compliance|3|||
28074409|NCT00142298|54729033|FG008|Overall Study|Non-compliance|3|||
28074410|NCT00142298|54729034|FG009|Overall Study|Non-compliance|0|||
28153776|NCT01615029|54822934|FG000|Overall Study|Physician Decision|0|||
28153777|NCT01615029|54822935|FG001|Overall Study|Physician Decision|0|||
28153778|NCT01615029|54822936|FG002|Overall Study|Physician Decision|0|||
28153779|NCT01615029|54822937|FG003|Overall Study|Physician Decision|0|||
28153780|NCT01615029|54822938|FG004|Overall Study|Physician Decision|1|||
28153781|NCT01615029|54822934|FG000|Overall Study|Ongoing|1|||
28153782|NCT01615029|54822935|FG001|Overall Study|Ongoing|2|||
28153783|NCT01615029|54822936|FG002|Overall Study|Ongoing|3|||
28153784|NCT01615029|54822937|FG003|Overall Study|Ongoing|2|||
28074411|NCT00142298|54729025|FG000|Overall Study|Patient, Investigator,or Sponsor request|66|||
28074412|NCT00142298|54729026|FG001|Overall Study|Patient, Investigator,or Sponsor request|60|||
28074413|NCT00142298|54729027|FG002|Overall Study|Patient, Investigator,or Sponsor request|11|||
28074414|NCT00142298|54729028|FG003|Overall Study|Patient, Investigator,or Sponsor request|51|||
28074415|NCT00142298|54729029|FG004|Overall Study|Patient, Investigator,or Sponsor request|4|||
28153785|NCT01615029|54822938|FG004|Overall Study|Ongoing|23|||
28153786|NCT01609842|54822954|FG000|Concurrent Intervention Control|pharmacy data not available|2|||
28153787|NCT01609842|54822955|FG001|Concurrent Intervention Control|pharmacy data not available|0|||
28153788|NCT01569594|54822965|FG000|Overall Study|Physician Decision|4|||
28153789|NCT01569594|54822965|FG000|Overall Study|Death|13|||
28153790|NCT01569594|54822965|FG000|Overall Study|Lost to Follow-up|22|||
28153791|NCT01569594|54822965|FG000|Overall Study|Adverse Event|2|||
28153792|NCT01569594|54822965|FG000|Overall Study|Withdrawal by Subject|13|||
28153793|NCT01569594|54822965|FG000|Overall Study|Other|4|||
28153794|NCT01569594|54822965|FG000|Overall Study|No ECM used|9|||
28153795|NCT01314118|54822969|FG000|Overall Study|Adverse Event|9|||
28153796|NCT01314118|54822969|FG000|Overall Study|Progressive disease|27|||
28153797|NCT01314118|54822969|FG000|Overall Study|Physician Decision|11|||
28153798|NCT01314118|54822969|FG000|Overall Study|Death|4|||
28153799|NCT01314118|54822969|FG000|Overall Study|Protocol Violation|5|||
28153800|NCT01314118|54822969|FG000|Overall Study|Withdrawal by Subject|11|||
28153801|NCT01314118|54822969|FG000|Overall Study|Other|2|||
28153802|NCT01314118|54822969|FG000|Overall Study|Ongoing|62|||
28153803|NCT01207492|54822973|FG000|Overall Study|Still on study|1|||
28153804|NCT01207492|54822973|FG000|Overall Study|Withdrawal by Subject|9|||
28153805|NCT01207492|54822973|FG000|Overall Study|Physician Decision|1|||
28153806|NCT01207492|54822973|FG000|Overall Study|Progressive disease|3|||
28153807|NCT01207492|54822973|FG000|Overall Study|Toxicity|1|||
28153808|NCT01171898|54822981|FG000|Overall Study|Death|0|||
28153809|NCT01171898|54822982|FG001|Overall Study|Death|0|||
28153810|NCT01171898|54822983|FG002|Overall Study|Death|2|||
28153811|NCT01171898|54822984|FG003|Overall Study|Death|0|||
28153812|NCT01171898|54822981|FG000|Overall Study|Lost to Follow-up|0|||
28153813|NCT01171898|54822982|FG001|Overall Study|Lost to Follow-up|1|||
28153814|NCT01171898|54822983|FG002|Overall Study|Lost to Follow-up|1|||
28153815|NCT01171898|54822984|FG003|Overall Study|Lost to Follow-up|1|||
28153816|NCT01171898|54822981|FG000|Overall Study|Withdrawal by Subject|1|||
28153817|NCT01171898|54822982|FG001|Overall Study|Withdrawal by Subject|4|||
28153818|NCT01171898|54822983|FG002|Overall Study|Withdrawal by Subject|6|||
28153819|NCT01171898|54822984|FG003|Overall Study|Withdrawal by Subject|3|||
28153820|NCT01171898|54822981|FG000|Overall Study|Terminated by Sponsor|1|||
28153821|NCT01171898|54822982|FG001|Overall Study|Terminated by Sponsor|0|||
28153822|NCT01171898|54822983|FG002|Overall Study|Terminated by Sponsor|0|||
28153823|NCT01171898|54822984|FG003|Overall Study|Terminated by Sponsor|0|||
28153824|NCT01171898|54822981|FG000|Overall Study|Ongoing|1|||
28153825|NCT01171898|54822982|FG001|Overall Study|Ongoing|9|||
27825083|NCT01969721|54290574|FG003|Overall Study|Adverse Event|2|||
28153826|NCT01171898|54822983|FG002|Overall Study|Ongoing|3|||
28153827|NCT01171898|54822984|FG003|Overall Study|Ongoing|0|||
28153828|NCT01171898|54822981|FG000|Overall Study|Other|1|||
28153829|NCT01171898|54822982|FG001|Overall Study|Other|5|||
28153830|NCT01171898|54822983|FG002|Overall Study|Other|0|||
28153831|NCT01171898|54822984|FG003|Overall Study|Other|2|||
28153832|NCT00980538|54822997|FG000|Overall Study|Lost to Follow-up|20|||
28153833|NCT00980538|54822997|FG000|Overall Study|Sponsor's Decision|4|||
28153834|NCT00980538|54822997|FG000|Overall Study|Participant/Legal Representative Withdrew Consent/Assent|34|||
28153835|NCT00980538|54822997|FG000|Overall Study|Adverse Event/HIV-Related Event/Cutaneous Event/Rash|12|||
28153836|NCT00980538|54822997|FG000|Overall Study|Switch to Commercially Available Medication|25|||
27825084|NCT01969721|54290571|FG000|Overall Study|Lack of Efficacy|0|||
28153837|NCT00980538|54822997|FG000|Overall Study|Participant Non-Compliant|9|||
28153838|NCT00980538|54822997|FG000|Overall Study|Investigator no Longer Thinks Participant Benefits from the ETR Treatment|9|||
28153839|NCT00980538|54822997|FG000|Overall Study|Participant Ineligible to Continue the Trial|6|||
27825085|NCT01969721|54290572|FG001|Overall Study|Lack of Efficacy|0|||
27825086|NCT01969721|54290573|FG002|Overall Study|Lack of Efficacy|1|||
27825087|NCT01969721|54290574|FG003|Overall Study|Lack of Efficacy|0|||
28153840|NCT00980538|54822997|FG000|Overall Study|Other|60|||
28153841|NCT00980538|54822997|FG000|Overall Study|Other|1|||
28153842|NCT00593840|54823001|FG000|Overall Study|Withdrawal by Subject|1|||
28153843|NCT01329900|54823034|FG000|Overall Study|Elevated creatinine/renal function|1|||
28153844|NCT02825043|54823038|FG000|Overall Study|Lost to Follow-up|4|||
28153845|NCT02750592|54823053|FG000|Overall Study|Adverse Event|3|||
28153846|NCT02750592|54823053|FG000|Overall Study|Lack of Efficacy|2|||
28153847|NCT02624986|54823065|FG000|Overall Study|Death|0|||
28153848|NCT02624986|54823066|FG001|Overall Study|Death|1|||
27941965|NCT01208207|54598599|FG004|Part II|Adverse Event|9|||
27941966|NCT01208207|54598600|FG005|Part II|Adverse Event|4|||
27941967|NCT01208207|54598601|FG006|Part II|Adverse Event|2|||
27941968|NCT01208207|54598595|FG000|Part II|Lack of Efficacy|0|||
27941969|NCT01208207|54598596|FG001|Part II|Lack of Efficacy|0|||
27941970|NCT01208207|54598597|FG002|Part II|Lack of Efficacy|0|||
27941971|NCT01208207|54598598|FG003|Part II|Lack of Efficacy|6|||
27941972|NCT01208207|54598599|FG004|Part II|Lack of Efficacy|4|||
27941973|NCT01208207|54598600|FG005|Part II|Lack of Efficacy|3|||
27941974|NCT01208207|54598601|FG006|Part II|Lack of Efficacy|3|||
28153849|NCT02624986|54823067|FG002|Overall Study|Death|2|||
27941975|NCT01208207|54598595|FG000|Part II|Lost to Follow-up|0|||
27941976|NCT01208207|54598596|FG001|Part II|Lost to Follow-up|0|||
27941977|NCT01208207|54598597|FG002|Part II|Lost to Follow-up|0|||
27941978|NCT01208207|54598598|FG003|Part II|Lost to Follow-up|4|||
28153850|NCT02624986|54823068|FG003|Overall Study|Death|2|||
28153851|NCT02624986|54823069|FG004|Overall Study|Death|2|||
28153852|NCT02624986|54823070|FG005|Overall Study|Death|0|||
27825088|NCT01969721|54290571|FG000|Overall Study|Non compliant with protocol|1|||
27941979|NCT01208207|54598599|FG004|Part II|Lost to Follow-up|0|||
28153853|NCT02624986|54823071|FG006|Overall Study|Death|0|||
28153854|NCT02624986|54823072|FG007|Overall Study|Death|1|||
28153855|NCT02624986|54823065|FG000|Overall Study|Study Terminated by Sponsor|1|||
28153856|NCT02624986|54823066|FG001|Overall Study|Study Terminated by Sponsor|1|||
28153857|NCT02624986|54823067|FG002|Overall Study|Study Terminated by Sponsor|0|||
28153858|NCT02624986|54823068|FG003|Overall Study|Study Terminated by Sponsor|1|||
28153859|NCT02624986|54823069|FG004|Overall Study|Study Terminated by Sponsor|2|||
28153860|NCT02624986|54823070|FG005|Overall Study|Study Terminated by Sponsor|2|||
28153861|NCT02624986|54823071|FG006|Overall Study|Study Terminated by Sponsor|4|||
28153862|NCT02624986|54823072|FG007|Overall Study|Study Terminated by Sponsor|3|||
28153863|NCT02624986|54823065|FG000|Overall Study|Progressive Disease|0|||
28153864|NCT02624986|54823066|FG001|Overall Study|Progressive Disease|1|||
28153865|NCT02624986|54823067|FG002|Overall Study|Progressive Disease|0|||
28153866|NCT02624986|54823068|FG003|Overall Study|Progressive Disease|0|||
28153867|NCT02624986|54823069|FG004|Overall Study|Progressive Disease|0|||
28153868|NCT02624986|54823070|FG005|Overall Study|Progressive Disease|0|||
28153869|NCT02624986|54823071|FG006|Overall Study|Progressive Disease|0|||
28153870|NCT02624986|54823072|FG007|Overall Study|Progressive Disease|0|||
28153871|NCT02624986|54823065|FG000|Overall Study|Protocol Violation|1|||
28153872|NCT02624986|54823066|FG001|Overall Study|Protocol Violation|0|||
28153873|NCT02624986|54823067|FG002|Overall Study|Protocol Violation|0|||
28153874|NCT02624986|54823068|FG003|Overall Study|Protocol Violation|0|||
28153875|NCT02624986|54823069|FG004|Overall Study|Protocol Violation|0|||
28153876|NCT02624986|54823070|FG005|Overall Study|Protocol Violation|0|||
28153877|NCT02624986|54823071|FG006|Overall Study|Protocol Violation|0|||
28153878|NCT02624986|54823072|FG007|Overall Study|Protocol Violation|0|||
28153879|NCT02624986|54823065|FG000|Overall Study|Withdrawal by Subject|0|||
28153880|NCT02624986|54823066|FG001|Overall Study|Withdrawal by Subject|0|||
28153881|NCT02624986|54823067|FG002|Overall Study|Withdrawal by Subject|0|||
28153882|NCT02624986|54823068|FG003|Overall Study|Withdrawal by Subject|0|||
28153883|NCT02624986|54823069|FG004|Overall Study|Withdrawal by Subject|0|||
28153884|NCT02624986|54823070|FG005|Overall Study|Withdrawal by Subject|0|||
28153885|NCT02624986|54823071|FG006|Overall Study|Withdrawal by Subject|0|||
28153886|NCT02624986|54823072|FG007|Overall Study|Withdrawal by Subject|1|||
28153887|NCT02587598|54823105|FG000|Overall Study|Death|4|||
28153888|NCT02587598|54823106|FG001|Overall Study|Death|8|||
28153889|NCT02587598|54823107|FG002|Overall Study|Death|4|||
28153890|NCT02587598|54823108|FG003|Overall Study|Death|16|||
28153891|NCT02587598|54823109|FG004|Overall Study|Death|9|||
28153892|NCT02587598|54823110|FG005|Overall Study|Death|4|||
28153893|NCT02587598|54823111|FG006|Overall Study|Death|6|||
28153894|NCT02587598|54823112|FG007|Overall Study|Death|7|||
28153895|NCT02587598|54823113|FG008|Overall Study|Death|9|||
28153896|NCT02587598|54823114|FG009|Overall Study|Death|1|||
28153897|NCT02587598|54823115|FG010|Overall Study|Death|3|||
28153898|NCT02587598|54823105|FG000|Overall Study|Study Terminated by the Sponsor|0|||
28153899|NCT02587598|54823106|FG001|Overall Study|Study Terminated by the Sponsor|1|||
28153900|NCT02587598|54823107|FG002|Overall Study|Study Terminated by the Sponsor|0|||
28153901|NCT02587598|54823108|FG003|Overall Study|Study Terminated by the Sponsor|3|||
28153902|NCT02587598|54823109|FG004|Overall Study|Study Terminated by the Sponsor|0|||
28153903|NCT02587598|54823110|FG005|Overall Study|Study Terminated by the Sponsor|1|||
28153904|NCT02587598|54823111|FG006|Overall Study|Study Terminated by the Sponsor|0|||
28153905|NCT02587598|54823112|FG007|Overall Study|Study Terminated by the Sponsor|0|||
28153906|NCT02587598|54823113|FG008|Overall Study|Study Terminated by the Sponsor|0|||
28153907|NCT02587598|54823114|FG009|Overall Study|Study Terminated by the Sponsor|1|||
28153908|NCT02587598|54823115|FG010|Overall Study|Study Terminated by the Sponsor|6|||
28153909|NCT02587598|54823105|FG000|Overall Study|Reason for study withdrawal not specified|0|||
28153910|NCT02587598|54823106|FG001|Overall Study|Reason for study withdrawal not specified|1|||
28153911|NCT02587598|54823107|FG002|Overall Study|Reason for study withdrawal not specified|0|||
28153912|NCT02587598|54823108|FG003|Overall Study|Reason for study withdrawal not specified|0|||
28153913|NCT02587598|54823109|FG004|Overall Study|Reason for study withdrawal not specified|0|||
28153914|NCT02587598|54823110|FG005|Overall Study|Reason for study withdrawal not specified|0|||
28153915|NCT02587598|54823111|FG006|Overall Study|Reason for study withdrawal not specified|0|||
28153916|NCT02587598|54823112|FG007|Overall Study|Reason for study withdrawal not specified|0|||
28153917|NCT02587598|54823113|FG008|Overall Study|Reason for study withdrawal not specified|0|||
28153918|NCT02587598|54823114|FG009|Overall Study|Reason for study withdrawal not specified|0|||
28153919|NCT02587598|54823115|FG010|Overall Study|Reason for study withdrawal not specified|0|||
28153920|NCT02587598|54823105|FG000|Overall Study|Withdrawal by Subject|0|||
28153921|NCT02587598|54823106|FG001|Overall Study|Withdrawal by Subject|1|||
28153922|NCT02587598|54823107|FG002|Overall Study|Withdrawal by Subject|0|||
27850297|NCT04178967|54349325|FG010|Induction Period|Lost to Follow-up|0|||
27850298|NCT04178967|54349315|FG000|Induction Period|Participant Missed Study Visits|0|||
27941980|NCT01208207|54598600|FG005|Part II|Lost to Follow-up|2|||
28153923|NCT02587598|54823108|FG003|Overall Study|Withdrawal by Subject|2|||
28153924|NCT02587598|54823109|FG004|Overall Study|Withdrawal by Subject|3|||
28153925|NCT02587598|54823110|FG005|Overall Study|Withdrawal by Subject|1|||
28153926|NCT02587598|54823111|FG006|Overall Study|Withdrawal by Subject|0|||
28153927|NCT02587598|54823112|FG007|Overall Study|Withdrawal by Subject|0|||
28153928|NCT02587598|54823113|FG008|Overall Study|Withdrawal by Subject|0|||
28153929|NCT02587598|54823114|FG009|Overall Study|Withdrawal by Subject|1|||
28153930|NCT02587598|54823115|FG010|Overall Study|Withdrawal by Subject|2|||
28153931|NCT02587598|54823105|FG000|Overall Study|Physician Decision|0|||
27941981|NCT01208207|54598601|FG006|Part II|Lost to Follow-up|1|||
27941982|NCT01208207|54598595|FG000|Part II|Non-Compliance With Study Drug|0|||
28153932|NCT02587598|54823106|FG001|Overall Study|Physician Decision|0|||
27825089|NCT01969721|54290572|FG001|Overall Study|Non compliant with protocol|1|||
27941983|NCT01208207|54598596|FG001|Part II|Non-Compliance With Study Drug|0|||
27941984|NCT01208207|54598597|FG002|Part II|Non-Compliance With Study Drug|0|||
27941985|NCT01208207|54598598|FG003|Part II|Non-Compliance With Study Drug|4|||
27941986|NCT01208207|54598599|FG004|Part II|Non-Compliance With Study Drug|1|||
27941987|NCT01208207|54598600|FG005|Part II|Non-Compliance With Study Drug|1|||
27941988|NCT01208207|54598601|FG006|Part II|Non-Compliance With Study Drug|0|||
27941989|NCT01208207|54598595|FG000|Part II|Physician Decision|0|||
27941990|NCT01208207|54598596|FG001|Part II|Physician Decision|0|||
27941991|NCT01208207|54598597|FG002|Part II|Physician Decision|0|||
27941992|NCT01208207|54598598|FG003|Part II|Physician Decision|1|||
27941993|NCT01208207|54598599|FG004|Part II|Physician Decision|0|||
27941994|NCT01208207|54598600|FG005|Part II|Physician Decision|2|||
27941995|NCT01208207|54598601|FG006|Part II|Physician Decision|0|||
27941996|NCT01208207|54598595|FG000|Part II|Protocol Violation|0|||
27941997|NCT01208207|54598596|FG001|Part II|Protocol Violation|0|||
27941998|NCT01208207|54598597|FG002|Part II|Protocol Violation|0|||
27941999|NCT01208207|54598598|FG003|Part II|Protocol Violation|1|||
27942000|NCT01208207|54598599|FG004|Part II|Protocol Violation|0|||
27942001|NCT01208207|54598600|FG005|Part II|Protocol Violation|0|||
27942002|NCT01208207|54598601|FG006|Part II|Protocol Violation|0|||
27942003|NCT01208207|54598595|FG000|Part II|Technical Problems|0|||
27942004|NCT01208207|54598596|FG001|Part II|Technical Problems|0|||
27942005|NCT01208207|54598597|FG002|Part II|Technical Problems|0|||
27942006|NCT01208207|54598598|FG003|Part II|Technical Problems|1|||
27825090|NCT01969721|54290573|FG002|Overall Study|Non compliant with protocol|0|||
27825091|NCT01969721|54290574|FG003|Overall Study|Non compliant with protocol|2|||
27850299|NCT04178967|54349316|FG001|Induction Period|Participant Missed Study Visits|1|||
27850300|NCT04178967|54349317|FG002|Induction Period|Participant Missed Study Visits|0|||
27850301|NCT04178967|54349318|FG003|Induction Period|Participant Missed Study Visits|0|||
27850302|NCT04178967|54349319|FG004|Induction Period|Participant Missed Study Visits|0|||
27850303|NCT04178967|54349320|FG005|Induction Period|Participant Missed Study Visits|0|||
27850304|NCT04178967|54349321|FG006|Induction Period|Participant Missed Study Visits|0|||
27850305|NCT04178967|54349322|FG007|Induction Period|Participant Missed Study Visits|0|||
27850306|NCT04178967|54349323|FG008|Induction Period|Participant Missed Study Visits|0|||
27942007|NCT01208207|54598599|FG004|Part II|Technical Problems|0|||
27825092|NCT01969721|54290571|FG000|Overall Study|Other not defined above|0|||
27825093|NCT01969721|54290572|FG001|Overall Study|Other not defined above|2|||
27825094|NCT01969721|54290573|FG002|Overall Study|Other not defined above|0|||
27825095|NCT01969721|54290574|FG003|Overall Study|Other not defined above|0|||
27825096|NCT01969721|54290571|FG000|Overall Study|Discontinued during washout periods.|0|||
27825097|NCT01969721|54290572|FG001|Overall Study|Discontinued during washout periods.|1|||
27825098|NCT01969721|54290573|FG002|Overall Study|Discontinued during washout periods.|1|||
27825099|NCT01969721|54290574|FG003|Overall Study|Discontinued during washout periods.|2|||
27825100|NCT01969565|54290584|FG000|Overall Study|Withdrawal by Subject|1|||
27825101|NCT01968707|54290597|FG000|Overall Study|Did not meet treatment day baseline|49|||
27825102|NCT01968707|54290598|FG001|Overall Study|Did not meet treatment day baseline|12|||
27825103|NCT01968707|54290599|FG002|Overall Study|Did not meet treatment day baseline|41|||
27825104|NCT01968707|54290600|FG003|Overall Study|Did not meet treatment day baseline|44|||
27942008|NCT01208207|54598600|FG005|Part II|Technical Problems|1|||
27942009|NCT01208207|54598601|FG006|Part II|Technical Problems|0|||
27942010|NCT01012713|54598632|FG000|Overall Study|Lack of Efficacy|3|||
27825105|NCT01968707|54290601|FG004|Overall Study|Did not meet treatment day baseline|36|||
27942011|NCT01007253|54598637|FG000|Washout Period (2 Weeks) # 3|Physician Decision|1|||
27942012|NCT01007253|54598638|FG001|Washout Period (2 Weeks) # 3|Physician Decision|0|||
27942013|NCT01007253|54598639|FG002|Washout Period (2 Weeks) # 3|Physician Decision|0|||
27942014|NCT01007253|54598640|FG003|Washout Period (2 Weeks) # 3|Physician Decision|0|||
27942015|NCT01006707|54598650|FG000|Study Session 1|Lost to Follow-up|2|||
27942016|NCT01006707|54598651|FG001|Study Session 1|Lost to Follow-up|0|||
27942017|NCT01006707|54598652|FG002|Study Session 1|Lost to Follow-up|0|||
27942018|NCT01006707|54598650|FG000|Study Session 1|Could not tolerate withdrawal in scanner|3|||
27942019|NCT01006707|54598651|FG001|Study Session 1|Could not tolerate withdrawal in scanner|0|||
27942020|NCT01006707|54598652|FG002|Study Session 1|Could not tolerate withdrawal in scanner|0|||
27942021|NCT01006629|54598660|FG000|Overall Study|Adverse Event|1|||
27942022|NCT01006629|54598660|FG000|Overall Study|Parent refused to continue participation|1|||
27942023|NCT01006629|54598660|FG000|Overall Study|Parent unable to perform site visit|4|||
27942024|NCT01012323|54598664|FG000|Overall Study|Investigator Judgment|1|||
27942025|NCT01011933|54598668|FG000|Overall Study|Wrong cell type|1|||
27942026|NCT01011933|54598668|FG000|Overall Study|Improper pre-protocol Rx|1|||
27942027|NCT01011933|54598668|FG000|Overall Study|Inadequate pathology|1|||
27942028|NCT01011933|54598668|FG000|Overall Study|Never treated|1|||
27942029|NCT01011465|54598690|FG000|Overall Study|Withdrawal by Subject|2|||
27942030|NCT01011465|54598691|FG001|Overall Study|Withdrawal by Subject|1|||
27942031|NCT01011465|54598692|FG002|Overall Study|Withdrawal by Subject|0|||
27942032|NCT01011465|54598693|FG003|Overall Study|Withdrawal by Subject|0|||
27942033|NCT01011465|54598694|FG004|Overall Study|Withdrawal by Subject|1|||
27942034|NCT01011465|54598695|FG005|Overall Study|Withdrawal by Subject|0|||
27942035|NCT01011465|54598696|FG006|Overall Study|Withdrawal by Subject|1|||
27942036|NCT01011465|54598697|FG007|Overall Study|Withdrawal by Subject|0|||
27942037|NCT01011387|54598722|FG000|Overall Study|Withdrawal by Subject|3|||
27942038|NCT01011387|54598722|FG000|Overall Study|Adverse Event|2|||
27942039|NCT01011387|54598722|FG000|Overall Study|Protocol Violation|1|||
28153933|NCT02587598|54823107|FG002|Overall Study|Physician Decision|0|||
28153934|NCT02587598|54823108|FG003|Overall Study|Physician Decision|0|||
27825106|NCT01968707|54290602|FG005|Overall Study|Did not meet treatment day baseline|11|||
27825107|NCT01968707|54290603|FG006|Overall Study|Did not meet treatment day baseline|34|||
27942040|NCT01011309|54598729|FG000|Overall Study|Adverse Event|2|||
27942041|NCT01011309|54598730|FG001|Overall Study|Adverse Event|1|||
28074416|NCT00142298|54729030|FG005|Overall Study|Patient, Investigator,or Sponsor request|3|||
28074417|NCT00142298|54729031|FG006|Overall Study|Patient, Investigator,or Sponsor request|1|||
28074418|NCT00142298|54729032|FG007|Overall Study|Patient, Investigator,or Sponsor request|4|||
28074419|NCT00142298|54729033|FG008|Overall Study|Patient, Investigator,or Sponsor request|1|||
28074420|NCT00142298|54729034|FG009|Overall Study|Patient, Investigator,or Sponsor request|0|||
28074421|NCT00142298|54729025|FG000|Overall Study|Pregnancy|4|||
28074422|NCT00142298|54729026|FG001|Overall Study|Pregnancy|4|||
28074423|NCT00142298|54729027|FG002|Overall Study|Pregnancy|2|||
28074424|NCT00142298|54729028|FG003|Overall Study|Pregnancy|3|||
28074425|NCT00142298|54729029|FG004|Overall Study|Pregnancy|0|||
28074426|NCT00142298|54729030|FG005|Overall Study|Pregnancy|0|||
28074427|NCT00142298|54729031|FG006|Overall Study|Pregnancy|0|||
28074428|NCT00142298|54729032|FG007|Overall Study|Pregnancy|0|||
28074429|NCT00142298|54729033|FG008|Overall Study|Pregnancy|1|||
28074430|NCT00142298|54729034|FG009|Overall Study|Pregnancy|0|||
28153935|NCT02587598|54823109|FG004|Overall Study|Physician Decision|0|||
28153936|NCT02587598|54823110|FG005|Overall Study|Physician Decision|0|||
28153937|NCT02587598|54823111|FG006|Overall Study|Physician Decision|0|||
28153938|NCT02587598|54823112|FG007|Overall Study|Physician Decision|0|||
28153939|NCT02587598|54823113|FG008|Overall Study|Physician Decision|0|||
28153940|NCT02587598|54823114|FG009|Overall Study|Physician Decision|0|||
28153941|NCT02587598|54823115|FG010|Overall Study|Physician Decision|3|||
28153942|NCT02485574|54823151|FG000|Overall Study|dropped out because they failed to undergo CT scan at postoperative 12 months|4|||
28153943|NCT02624284|54823163|FG000|Overall Study|Withdrawal by Subject|3|||
28153944|NCT02624284|54823164|FG001|Overall Study|Withdrawal by Subject|6|||
28153945|NCT02624284|54823165|FG002|Overall Study|Withdrawal by Subject|3|||
28153946|NCT02624284|54823163|FG000|Overall Study|Protocol Violation|9|||
27942042|NCT01011309|54598731|FG002|Overall Study|Adverse Event|2|||
27942043|NCT01011309|54598729|FG000|Overall Study|Lack of Efficacy|0|||
28074431|NCT00142298|54729025|FG000|Overall Study|Virologic breakthrough|19|||
28074432|NCT00142298|54729026|FG001|Overall Study|Virologic breakthrough|23|||
27825108|NCT01968707|54290604|FG007|Overall Study|Did not meet treatment day baseline|35|||
28074433|NCT00142298|54729027|FG002|Overall Study|Virologic breakthrough|9|||
28153947|NCT02624284|54823164|FG001|Overall Study|Protocol Violation|10|||
28153948|NCT02624284|54823165|FG002|Overall Study|Protocol Violation|7|||
28074434|NCT00142298|54729028|FG003|Overall Study|Virologic breakthrough|7|||
28074435|NCT00142298|54729029|FG004|Overall Study|Virologic breakthrough|2|||
28074436|NCT00142298|54729030|FG005|Overall Study|Virologic breakthrough|3|||
28074437|NCT00142298|54729031|FG006|Overall Study|Virologic breakthrough|3|||
28074438|NCT00142298|54729032|FG007|Overall Study|Virologic breakthrough|0|||
28074439|NCT00142298|54729033|FG008|Overall Study|Virologic breakthrough|0|||
28074440|NCT00142298|54729034|FG009|Overall Study|Virologic breakthrough|0|||
28074441|NCT00142298|54729025|FG000|Overall Study|Other- not specified|0|||
28074442|NCT00142298|54729026|FG001|Overall Study|Other- not specified|3|||
28074443|NCT00142298|54729027|FG002|Overall Study|Other- not specified|0|||
28074444|NCT00142298|54729028|FG003|Overall Study|Other- not specified|1|||
28074445|NCT00142298|54729029|FG004|Overall Study|Other- not specified|0|||
28074446|NCT00142298|54729030|FG005|Overall Study|Other- not specified|0|||
28074447|NCT00142298|54729031|FG006|Overall Study|Other- not specified|0|||
28074448|NCT00142298|54729032|FG007|Overall Study|Other- not specified|0|||
28074449|NCT00142298|54729033|FG008|Overall Study|Other- not specified|0|||
28074450|NCT00142298|54729034|FG009|Overall Study|Other- not specified|0|||
28074451|NCT00142298|54729025|FG000|Overall Study|Lost to Follow-up|0|||
28074452|NCT00142298|54729026|FG001|Overall Study|Lost to Follow-up|0|||
28074453|NCT00142298|54729027|FG002|Overall Study|Lost to Follow-up|0|||
28074454|NCT00142298|54729028|FG003|Overall Study|Lost to Follow-up|0|||
28074455|NCT00142298|54729029|FG004|Overall Study|Lost to Follow-up|0|||
28074456|NCT00142298|54729030|FG005|Overall Study|Lost to Follow-up|0|||
28074457|NCT00142298|54729031|FG006|Overall Study|Lost to Follow-up|2|||
28074458|NCT00142298|54729032|FG007|Overall Study|Lost to Follow-up|0|||
28074459|NCT00142298|54729033|FG008|Overall Study|Lost to Follow-up|0|||
28074460|NCT00142298|54729034|FG009|Overall Study|Lost to Follow-up|0|||
28074461|NCT00142298|54729025|FG000|Overall Study|Treatment Failure|0|||
28074462|NCT00142298|54729026|FG001|Overall Study|Treatment Failure|0|||
28074463|NCT00142298|54729027|FG002|Overall Study|Treatment Failure|0|||
28074464|NCT00142298|54729028|FG003|Overall Study|Treatment Failure|0|||
28074465|NCT00142298|54729029|FG004|Overall Study|Treatment Failure|0|||
28074466|NCT00142298|54729030|FG005|Overall Study|Treatment Failure|2|||
28074467|NCT00142298|54729031|FG006|Overall Study|Treatment Failure|2|||
28074468|NCT00142298|54729032|FG007|Overall Study|Treatment Failure|0|||
28074469|NCT00142298|54729033|FG008|Overall Study|Treatment Failure|0|||
28074470|NCT00142298|54729034|FG009|Overall Study|Treatment Failure|0|||
28074471|NCT03709654|54729058|FG000|Overall Study|Lost to Follow-up|1|||
28074472|NCT03709654|54729059|FG001|Overall Study|Lost to Follow-up|1|||
28074473|NCT03709654|54729058|FG000|Overall Study|Withdrawal by Subject|1|||
28074474|NCT03709654|54729059|FG001|Overall Study|Withdrawal by Subject|1|||
28074475|NCT03709654|54729058|FG000|Overall Study|Adverse Event|1|||
28074476|NCT03709654|54729059|FG001|Overall Study|Adverse Event|0|||
28074477|NCT00412061|54729067|FG000|Double Blind Phase|Disease Progression|101|||
28074478|NCT00412061|54729068|FG001|Double Blind Phase|Disease Progression|154|||
28074479|NCT00412061|54729067|FG000|Double Blind Phase|Adverse Event|61|||
28074480|NCT00412061|54729068|FG001|Double Blind Phase|Adverse Event|16|||
28074481|NCT00412061|54729067|FG000|Double Blind Phase|Final Primary Analysis|26|||
28074482|NCT00412061|54729068|FG001|Double Blind Phase|Final Primary Analysis|14|||
28074483|NCT00412061|54729067|FG000|Double Blind Phase|Withdrawal by Subject|18|||
28074484|NCT00412061|54729068|FG001|Double Blind Phase|Withdrawal by Subject|20|||
28074485|NCT00412061|54729067|FG000|Double Blind Phase|Death|6|||
28074486|NCT00412061|54729068|FG001|Double Blind Phase|Death|3|||
28074487|NCT00412061|54729067|FG000|Double Blind Phase|Protocol Violation|3|||
28074488|NCT00412061|54729068|FG001|Double Blind Phase|Protocol Violation|4|||
28074489|NCT00412061|54729067|FG000|Double Blind Phase|New Cander Therapy|1|||
28074490|NCT00412061|54729068|FG001|Double Blind Phase|New Cander Therapy|1|||
28074491|NCT00412061|54729067|FG000|Double Blind Phase|Lost to Follow-up|0|||
28074492|NCT00412061|54729068|FG001|Double Blind Phase|Lost to Follow-up|1|||
28074493|NCT00412061|54729067|FG000|Open Label Phase|Disease Progression|0|||
28074494|NCT00412061|54729068|FG001|Open Label Phase|Disease Progression|86|||
28074495|NCT00412061|54729067|FG000|Open Label Phase|Adverse Event|0|||
28074496|NCT00412061|54729068|FG001|Open Label Phase|Adverse Event|46|||
28153949|NCT02624284|54823163|FG000|Overall Study|Revealed exclusionary condition|2|||
28074497|NCT00412061|54729067|FG000|Open Label Phase|Withdrawal by Subject|0|||
28074498|NCT00412061|54729068|FG001|Open Label Phase|Withdrawal by Subject|15|||
28074499|NCT00412061|54729067|FG000|Open Label Phase|Administrative Problems|0|||
28074500|NCT00412061|54729068|FG001|Open Label Phase|Administrative Problems|13|||
28153950|NCT02624284|54823164|FG001|Overall Study|Revealed exclusionary condition|2|||
28153951|NCT02624284|54823165|FG002|Overall Study|Revealed exclusionary condition|0|||
28153952|NCT02624284|54823163|FG000|Overall Study|Adverse Event|0|||
28153953|NCT02624284|54823164|FG001|Overall Study|Adverse Event|0|||
28074501|NCT00412061|54729067|FG000|Open Label Phase|Death|0|||
28074502|NCT00412061|54729068|FG001|Open Label Phase|Death|7|||
28074503|NCT00412061|54729067|FG000|Open Label Phase|Lost to Follow-up|0|||
28074504|NCT00412061|54729068|FG001|Open Label Phase|Lost to Follow-up|2|||
28153954|NCT02624284|54823165|FG002|Overall Study|Adverse Event|1|||
28153955|NCT02738450|54823177|FG000|Overall Study|Withdrawal by Subject|0|||
28153956|NCT02738450|54823178|FG001|Overall Study|Withdrawal by Subject|2|||
28153957|NCT02738450|54823179|FG002|Overall Study|Withdrawal by Subject|0|||
28153958|NCT02624050|54823190|FG000|Overall Study|Physician Decision|4|||
28153959|NCT02624050|54823191|FG001|Overall Study|Physician Decision|0|||
28153960|NCT02624050|54823190|FG000|Overall Study|Protocol Violation|2|||
28153961|NCT02624050|54823191|FG001|Overall Study|Protocol Violation|0|||
28153962|NCT01338987|54823207|FG000|Overall Study|enrolled on new protocol|0|||
28153963|NCT01338987|54823208|FG001|Overall Study|enrolled on new protocol|0|||
28153964|NCT01338987|54823209|FG002|Overall Study|enrolled on new protocol|1|||
28153965|NCT01338987|54823210|FG003|Overall Study|enrolled on new protocol|0|||
28153966|NCT01338987|54823211|FG004|Overall Study|enrolled on new protocol|0|||
28153967|NCT01338987|54823207|FG000|Overall Study|Disease progression on study|2|||
28153968|NCT01338987|54823208|FG001|Overall Study|Disease progression on study|1|||
28153969|NCT01338987|54823209|FG002|Overall Study|Disease progression on study|1|||
28153970|NCT01338987|54823210|FG003|Overall Study|Disease progression on study|0|||
28153971|NCT01338987|54823211|FG004|Overall Study|Disease progression on study|0|||
28153972|NCT03706430|54823225|FG000|Overall Study|No A-Line placed|5|||
28153973|NCT03706430|54823225|FG000|Overall Study|Subject had gel nail polish|1|||
28153974|NCT03706430|54823225|FG000|Overall Study|Nail length causing difficulties with sensor|1|||
28153975|NCT03706430|54823225|FG000|Overall Study|Cancelled Case|6|||
28153976|NCT03706430|54823225|FG000|Overall Study|Physician Decision|2|||
28153977|NCT02738138|54823247|FG000|Overall Study|Adverse Event|0|||
28153978|NCT02738138|54823248|FG001|Overall Study|Adverse Event|1|||
28153979|NCT02738138|54823247|FG000|Overall Study|Lost to Follow-up|2|||
28153980|NCT02738138|54823248|FG001|Overall Study|Lost to Follow-up|0|||
28153981|NCT02738138|54823247|FG000|Overall Study|Other - not further specified|1|||
28153982|NCT02738138|54823248|FG001|Overall Study|Other - not further specified|0|||
28153983|NCT01355289|54823257|FG000|Core Study|Adverse Event, Non-Fatal|1|||
28153984|NCT01355289|54823258|FG001|Core Study|Adverse Event, Non-Fatal|0|||
28153985|NCT01355289|54823259|FG002|Core Study|Adverse Event, Non-Fatal|0|||
28153986|NCT01355289|54823260|FG003|Core Study|Adverse Event, Non-Fatal|0|||
28153987|NCT01355289|54823261|FG004|Core Study|Adverse Event, Non-Fatal|0|||
28153988|NCT01355289|54823257|FG000|Core Study|Inadequate Therapeutic Effect|0|||
28153989|NCT01355289|54823258|FG001|Core Study|Inadequate Therapeutic Effect|0|||
28153990|NCT01355289|54823259|FG002|Core Study|Inadequate Therapeutic Effect|0|||
28153991|NCT01355289|54823260|FG003|Core Study|Inadequate Therapeutic Effect|1|||
28153992|NCT01355289|54823261|FG004|Core Study|Inadequate Therapeutic Effect|0|||
28153993|NCT01355289|54823257|FG000|Core Study|Other|0|||
28153994|NCT01355289|54823258|FG001|Core Study|Other|0|||
28153995|NCT01355289|54823259|FG002|Core Study|Other|0|||
28153996|NCT01355289|54823260|FG003|Core Study|Other|1|||
28153997|NCT01355289|54823261|FG004|Core Study|Other|0|||
28153998|NCT01355289|54823257|FG000|Open Label Extension|Adverse Event, Non-Fatal|0|||
28153999|NCT01355289|54823258|FG001|Open Label Extension|Adverse Event, Non-Fatal|0|||
28154000|NCT01355289|54823259|FG002|Open Label Extension|Adverse Event, Non-Fatal|0|||
28154001|NCT01355289|54823260|FG003|Open Label Extension|Adverse Event, Non-Fatal|0|||
28154002|NCT01355289|54823261|FG004|Open Label Extension|Adverse Event, Non-Fatal|1|||
28154003|NCT01355289|54823257|FG000|Open Label Extension|Lost to Follow-up|0|||
27850307|NCT04178967|54349324|FG009|Induction Period|Participant Missed Study Visits|0|||
27942044|NCT01011309|54598730|FG001|Overall Study|Lack of Efficacy|1|||
27942045|NCT01011309|54598731|FG002|Overall Study|Lack of Efficacy|0|||
27942046|NCT01011309|54598729|FG000|Overall Study|Protocol Violation|0|||
27942047|NCT01011309|54598730|FG001|Overall Study|Protocol Violation|1|||
27942048|NCT01011309|54598731|FG002|Overall Study|Protocol Violation|3|||
27942049|NCT01011153|54598742|FG000|Overall Study|Less than 78 cases completed|8|||
27942050|NCT01011153|54598743|FG001|Overall Study|Less than 78 cases completed|11|||
27942051|NCT01011153|54598744|FG002|Overall Study|Less than 78 cases completed|9|||
27942052|NCT00997893|54598776|FG000|Overall Study|Adverse Event|1|||
27942053|NCT00997893|54598777|FG001|Overall Study|Adverse Event|0|||
28074505|NCT00412061|54729067|FG000|Open Label Phase|New Cancer Therapy|0|||
28074506|NCT00412061|54729068|FG001|Open Label Phase|New Cancer Therapy|1|||
28074507|NCT00411671|54729086|FG000|Overall Study|Adverse Event|15|||
28074508|NCT00411671|54729086|FG000|Overall Study|Death|2|||
28074509|NCT00411671|54729086|FG000|Overall Study|Lost to Follow-up|3|||
28074510|NCT03835481|54729095|FG000|Double-blind Period|Other not stated below|0|||
28074511|NCT03835481|54729096|FG001|Double-blind Period|Other not stated below|0|||
28074512|NCT03835481|54729097|FG002|Double-blind Period|Other not stated below|0|||
28074513|NCT03835481|54729098|FG003|Double-blind Period|Other not stated below|1|||
28074514|NCT03835481|54729099|FG004|Double-blind Period|Other not stated below|1|||
28074515|NCT03835481|54729095|FG000|Double-blind Period|Termination of treatment by sponsor|0|||
28074516|NCT03835481|54729096|FG001|Double-blind Period|Termination of treatment by sponsor|0|||
28154004|NCT01355289|54823258|FG001|Open Label Extension|Lost to Follow-up|0|||
28154005|NCT01355289|54823259|FG002|Open Label Extension|Lost to Follow-up|0|||
28154006|NCT01355289|54823260|FG003|Open Label Extension|Lost to Follow-up|0|||
28154007|NCT01355289|54823261|FG004|Open Label Extension|Lost to Follow-up|1|||
28154008|NCT01355289|54823257|FG000|Open Label Extension|Inadequate Therapeutic Effect|0|||
28154009|NCT01355289|54823258|FG001|Open Label Extension|Inadequate Therapeutic Effect|0|||
28154010|NCT01355289|54823259|FG002|Open Label Extension|Inadequate Therapeutic Effect|0|||
28154011|NCT01355289|54823260|FG003|Open Label Extension|Inadequate Therapeutic Effect|0|||
28154012|NCT01355289|54823261|FG004|Open Label Extension|Inadequate Therapeutic Effect|29|||
28154013|NCT01355289|54823257|FG000|Open Label Extension|Other|0|||
28154014|NCT01355289|54823258|FG001|Open Label Extension|Other|0|||
28154015|NCT01355289|54823259|FG002|Open Label Extension|Other|0|||
28154016|NCT01355289|54823260|FG003|Open Label Extension|Other|0|||
28154017|NCT01355289|54823261|FG004|Open Label Extension|Other|3|||
28154018|NCT02737592|54823274|FG000|Overall Study|Withdrawal by Subject|1|||
28154019|NCT02737358|54823301|FG000|Overall Study|Withdrawal by Subject|7|||
28154020|NCT02737358|54823302|FG001|Overall Study|Withdrawal by Subject|12|||
28154021|NCT02737358|54823301|FG000|Overall Study|Lost to Follow-up|2|||
28154022|NCT02737358|54823302|FG001|Overall Study|Lost to Follow-up|3|||
28154023|NCT01354431|54823311|FG000|Pre-Treatment Period|Not reported|1|||
28154024|NCT01354431|54823312|FG001|Pre-Treatment Period|Not reported|0|||
28154025|NCT01354431|54823313|FG002|Pre-Treatment Period|Not reported|0|||
28154026|NCT01354431|54823311|FG000|Treatment Period|Disease Progression|50|||
28154027|NCT01354431|54823312|FG001|Treatment Period|Disease Progression|40|||
28154028|NCT01354431|54823313|FG002|Treatment Period|Disease Progression|44|||
28154029|NCT01354431|54823311|FG000|Treatment Period|Study Drug Toxicity|5|||
28154030|NCT01354431|54823312|FG001|Treatment Period|Study Drug Toxicity|8|||
28154031|NCT01354431|54823313|FG002|Treatment Period|Study Drug Toxicity|4|||
28154032|NCT01354431|54823311|FG000|Treatment Period|Death|0|||
28154033|NCT01354431|54823312|FG001|Treatment Period|Death|1|||
28154034|NCT01354431|54823313|FG002|Treatment Period|Death|0|||
28154035|NCT01354431|54823311|FG000|Treatment Period|AE unrelated to study drug|1|||
28154036|NCT01354431|54823312|FG001|Treatment Period|AE unrelated to study drug|2|||
28154037|NCT01354431|54823313|FG002|Treatment Period|AE unrelated to study drug|5|||
27825109|NCT01959581|54290637|FG000|Overall Study|Lost to Follow-up|5|||
27825110|NCT01746901|54290641|FG000|Naloxone Challenge Phase|Adverse Event|2|||
27825111|NCT01746901|54290642|FG001|Naloxone Challenge Phase|Adverse Event|0|||
27942054|NCT00997893|54598778|FG002|Overall Study|Adverse Event|0|||
27942055|NCT00997893|54598776|FG000|Overall Study|Unable to meet study timelines|1|||
27942056|NCT00997893|54598777|FG001|Overall Study|Unable to meet study timelines|0|||
27942057|NCT00997893|54598778|FG002|Overall Study|Unable to meet study timelines|0|||
27942058|NCT00997893|54598776|FG000|Overall Study|Pain/pain meds during Visit 4|0|||
27942059|NCT00997893|54598777|FG001|Overall Study|Pain/pain meds during Visit 4|1|||
28074517|NCT03835481|54729097|FG002|Double-blind Period|Termination of treatment by sponsor|0|||
28074518|NCT03835481|54729098|FG003|Double-blind Period|Termination of treatment by sponsor|0|||
28074519|NCT03835481|54729099|FG004|Double-blind Period|Termination of treatment by sponsor|35|||
28074520|NCT03835481|54729095|FG000|Double-blind Period|Withdrawal by Subject|0|||
28154038|NCT01354431|54823311|FG000|Treatment Period|Participant request to discontinue|2|||
28154039|NCT01354431|54823312|FG001|Treatment Period|Participant request to discontinue|2|||
28154040|NCT01354431|54823313|FG002|Treatment Period|Participant request to discontinue|1|||
28154041|NCT01354431|54823311|FG000|Treatment Period|Participant withdrew consent|0|||
28154042|NCT01354431|54823312|FG001|Treatment Period|Participant withdrew consent|1|||
28154043|NCT01354431|54823313|FG002|Treatment Period|Participant withdrew consent|0|||
28154044|NCT01354431|54823311|FG000|Treatment Period|Participant no longer meeting study criteria|1|||
28154045|NCT01354431|54823312|FG001|Treatment Period|Participant no longer meeting study criteria|0|||
28154046|NCT01354431|54823313|FG002|Treatment Period|Participant no longer meeting study criteria|0|||
28154047|NCT02736578|54823323|FG000|Overall Study|Adverse Event|1|||
28154048|NCT02736578|54823324|FG001|Overall Study|Adverse Event|0|||
28154049|NCT02622724|54823336|FG000|Overall Study|Death|51|||
28154050|NCT02622724|54823337|FG001|Overall Study|Death|53|||
28154051|NCT02622724|54823336|FG000|Overall Study|Lost to Follow-UP, withdrawal of consent|4|||
28154052|NCT02622724|54823337|FG001|Overall Study|Lost to Follow-UP, withdrawal of consent|7|||
28154053|NCT02622724|54823336|FG000|Overall Study|Early termination of study|38|||
28154054|NCT02622724|54823337|FG001|Overall Study|Early termination of study|43|||
28154055|NCT01354353|54823355|FG000|Overall Study|Adverse Event|1|||
28154056|NCT01354353|54823356|FG001|Overall Study|Adverse Event|0|||
28154057|NCT01354353|54823357|FG002|Overall Study|Adverse Event|0|||
28154058|NCT01354353|54823358|FG003|Overall Study|Adverse Event|4|||
28154059|NCT01354353|54823359|FG004|Overall Study|Adverse Event|0|||
28154060|NCT01354353|54823360|FG005|Overall Study|Adverse Event|5|||
28154061|NCT01354353|54823355|FG000|Overall Study|Entry Criteria Not Met|0|||
28154062|NCT01354353|54823356|FG001|Overall Study|Entry Criteria Not Met|0|||
28074521|NCT03835481|54729096|FG001|Double-blind Period|Withdrawal by Subject|0|||
28074522|NCT03835481|54729097|FG002|Double-blind Period|Withdrawal by Subject|1|||
28074523|NCT03835481|54729098|FG003|Double-blind Period|Withdrawal by Subject|0|||
28074524|NCT03835481|54729099|FG004|Double-blind Period|Withdrawal by Subject|5|||
28074525|NCT03835481|54729095|FG000|Double-blind Period|Lost to Follow-up|0|||
28074526|NCT03835481|54729096|FG001|Double-blind Period|Lost to Follow-up|0|||
28154063|NCT01354353|54823357|FG002|Overall Study|Entry Criteria Not Met|0|||
28154064|NCT01354353|54823358|FG003|Overall Study|Entry Criteria Not Met|1|||
28154065|NCT01354353|54823359|FG004|Overall Study|Entry Criteria Not Met|1|||
27825112|NCT01746901|54290643|FG002|Naloxone Challenge Phase|Adverse Event|0|||
27942060|NCT00997893|54598778|FG002|Overall Study|Pain/pain meds during Visit 4|0|||
27942061|NCT02905825|54598795|FG000|Overall Study|Protocol Violation|11|||
27825113|NCT01746901|54290644|FG003|Naloxone Challenge Phase|Adverse Event|0|||
27825114|NCT01746901|54290645|FG004|Naloxone Challenge Phase|Adverse Event|0|||
28154066|NCT01354353|54823360|FG005|Overall Study|Entry Criteria Not Met|0|||
28154067|NCT01354353|54823355|FG000|Overall Study|Physician Decision|0|||
28154068|NCT01354353|54823356|FG001|Overall Study|Physician Decision|1|||
28154069|NCT01354353|54823357|FG002|Overall Study|Physician Decision|1|||
28154070|NCT01354353|54823358|FG003|Overall Study|Physician Decision|0|||
28154071|NCT01354353|54823359|FG004|Overall Study|Physician Decision|0|||
28154072|NCT01354353|54823360|FG005|Overall Study|Physician Decision|0|||
28154073|NCT01354353|54823355|FG000|Overall Study|Withdrawal by Subject|2|||
28154074|NCT01354353|54823356|FG001|Overall Study|Withdrawal by Subject|0|||
28154075|NCT01354353|54823357|FG002|Overall Study|Withdrawal by Subject|1|||
28154076|NCT01354353|54823358|FG003|Overall Study|Withdrawal by Subject|0|||
28154077|NCT01354353|54823359|FG004|Overall Study|Withdrawal by Subject|0|||
28154078|NCT01354353|54823360|FG005|Overall Study|Withdrawal by Subject|1|||
28154079|NCT02622568|54823383|FG000|Overall Study|Lost to Follow-up|5|||
28154080|NCT02622568|54823384|FG001|Overall Study|Lost to Follow-up|5|||
28154081|NCT01354899|54823390|FG000|Overall Study|discharge from the hospital|2|||
28154082|NCT01354899|54823390|FG000|Overall Study|Protocol Violation|1|||
28154083|NCT01353963|54823394|FG000|Overall Study|Adverse Event|2|||
28154084|NCT02820597|54823403|FG000|Overall Study|Lost to Follow-up|12|||
28154085|NCT02822235|54823409|FG000|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144|||
28154086|NCT02822235|54823410|FG001|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107|||
28154087|NCT02822235|54823409|FG000|Cross-sectional Phase (Day 1)|Reason Not Specified|2|||
28154088|NCT02822235|54823410|FG001|Cross-sectional Phase (Day 1)|Reason Not Specified|0|||
28154089|NCT02822235|54823409|FG000|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0|||
28154090|NCT02822235|54823410|FG001|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1|||
28154091|NCT02822235|54823409|FG000|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4|||
28154092|NCT02822235|54823410|FG001|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0|||
28154093|NCT02822235|54823409|FG000|Prospective Phase (Day 1 up to Month 12)|Death|1|||
28154094|NCT02822235|54823410|FG001|Prospective Phase (Day 1 up to Month 12)|Death|0|||
28154095|NCT02822235|54823409|FG000|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6|||
28154096|NCT02822235|54823410|FG001|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1|||
28154097|NCT02817555|54823425|FG000|Overall Study|Death|1|||
28154098|NCT02817555|54823426|FG001|Overall Study|Death|3|||
28154099|NCT02817555|54823425|FG000|Overall Study|moved away|1|||
28154100|NCT02817555|54823426|FG001|Overall Study|moved away|0|||
28154101|NCT02817555|54823425|FG000|Overall Study|transplant|1|||
28154102|NCT02817555|54823426|FG001|Overall Study|transplant|1|||
28154103|NCT02817555|54823425|FG000|Overall Study|changed to Peritoneal Dialysis|0|||
28154104|NCT02817555|54823426|FG001|Overall Study|changed to Peritoneal Dialysis|1|||
28154105|NCT02817087|54823434|FG000|Overall Study|Withdrawal by Subject|2|||
28154106|NCT02817087|54823435|FG001|Overall Study|Withdrawal by Subject|0|||
28154107|NCT02813577|54823441|FG000|Overall Study|Study terminated|4|||
28154108|NCT02815293|54823448|FG000|Overall Study|Study termination by sponsor|10|||
28154109|NCT02815293|54823449|FG001|Overall Study|Study termination by sponsor|7|||
28154110|NCT02815293|54823450|FG002|Overall Study|Study termination by sponsor|0|||
28154111|NCT02815293|54823448|FG000|Overall Study|Participants not randomized|0|||
28154112|NCT02815293|54823449|FG001|Overall Study|Participants not randomized|0|||
28154113|NCT02815293|54823450|FG002|Overall Study|Participants not randomized|18|||
28154114|NCT02815293|54823448|FG000|Overall Study|Adverse Event|0|||
28154115|NCT02815293|54823449|FG001|Overall Study|Adverse Event|1|||
28154116|NCT02815293|54823450|FG002|Overall Study|Adverse Event|0|||
28154117|NCT02813421|54823458|FG000|Overall Study|Withdrawal by Subject|1|||
28154118|NCT02813421|54823459|FG001|Overall Study|Withdrawal by Subject|2|||
28154119|NCT02813421|54823458|FG000|Overall Study|Lost to Follow-up|1|||
28154120|NCT02813421|54823459|FG001|Overall Study|Lost to Follow-up|1|||
28154121|NCT03672188|54823480|FG000|Overall Study|Withdrawal by Subject|0|||
28154122|NCT03672188|54823481|FG001|Overall Study|Withdrawal by Subject|0|||
28154123|NCT03672188|54823482|FG002|Overall Study|Withdrawal by Subject|0|||
28154124|NCT03672188|54823483|FG003|Overall Study|Withdrawal by Subject|3|||
28154125|NCT03672188|54823484|FG004|Overall Study|Withdrawal by Subject|0|||
28154126|NCT03672188|54823485|FG005|Overall Study|Withdrawal by Subject|0|||
28154127|NCT03672188|54823486|FG006|Overall Study|Withdrawal by Subject|0|||
27825115|NCT01746901|54290646|FG005|Naloxone Challenge Phase|Adverse Event|0|||
28154128|NCT03672188|54823487|FG007|Overall Study|Withdrawal by Subject|0|||
28154129|NCT03672188|54823488|FG008|Overall Study|Withdrawal by Subject|0|||
28154130|NCT03672188|54823489|FG009|Overall Study|Withdrawal by Subject|0|||
28154131|NCT03672188|54823490|FG010|Overall Study|Withdrawal by Subject|0|||
28154132|NCT03672188|54823491|FG011|Overall Study|Withdrawal by Subject|0|||
28154133|NCT03672188|54823492|FG012|Overall Study|Withdrawal by Subject|0|||
28154134|NCT03672188|54823493|FG013|Overall Study|Withdrawal by Subject|0|||
28154135|NCT03672188|54823494|FG014|Overall Study|Withdrawal by Subject|0|||
28154136|NCT03672188|54823480|FG000|Overall Study|Death|0|||
28154137|NCT03672188|54823481|FG001|Overall Study|Death|0|||
28154138|NCT03672188|54823482|FG002|Overall Study|Death|0|||
28154139|NCT03672188|54823483|FG003|Overall Study|Death|0|||
28154140|NCT03672188|54823484|FG004|Overall Study|Death|0|||
28154141|NCT03672188|54823485|FG005|Overall Study|Death|0|||
28154142|NCT03672188|54823486|FG006|Overall Study|Death|0|||
28154143|NCT03672188|54823487|FG007|Overall Study|Death|0|||
28154144|NCT03672188|54823488|FG008|Overall Study|Death|0|||
28154145|NCT03672188|54823489|FG009|Overall Study|Death|0|||
28154146|NCT03672188|54823490|FG010|Overall Study|Death|0|||
28154147|NCT03672188|54823491|FG011|Overall Study|Death|0|||
28154148|NCT03672188|54823492|FG012|Overall Study|Death|1|||
28154149|NCT03672188|54823493|FG013|Overall Study|Death|0|||
28154150|NCT03672188|54823494|FG014|Overall Study|Death|0|||
28154151|NCT03672188|54823480|FG000|Overall Study|Lost to Follow-up|0|||
28154152|NCT03672188|54823481|FG001|Overall Study|Lost to Follow-up|0|||
28154153|NCT03672188|54823482|FG002|Overall Study|Lost to Follow-up|1|||
28154154|NCT03672188|54823483|FG003|Overall Study|Lost to Follow-up|0|||
28154155|NCT03672188|54823484|FG004|Overall Study|Lost to Follow-up|0|||
28154156|NCT03672188|54823485|FG005|Overall Study|Lost to Follow-up|0|||
28154157|NCT03672188|54823486|FG006|Overall Study|Lost to Follow-up|0|||
28154158|NCT03672188|54823487|FG007|Overall Study|Lost to Follow-up|0|||
28154159|NCT03672188|54823488|FG008|Overall Study|Lost to Follow-up|0|||
28154160|NCT03672188|54823489|FG009|Overall Study|Lost to Follow-up|0|||
28154161|NCT03672188|54823490|FG010|Overall Study|Lost to Follow-up|0|||
28154162|NCT03672188|54823491|FG011|Overall Study|Lost to Follow-up|0|||
28154163|NCT03672188|54823492|FG012|Overall Study|Lost to Follow-up|0|||
28154164|NCT03672188|54823493|FG013|Overall Study|Lost to Follow-up|0|||
28154165|NCT03672188|54823494|FG014|Overall Study|Lost to Follow-up|0|||
27825116|NCT01746901|54290647|FG006|Naloxone Challenge Phase|Adverse Event|0|||
27825117|NCT01746901|54290648|FG007|Naloxone Challenge Phase|Adverse Event|0|||
28074527|NCT03835481|54729097|FG002|Double-blind Period|Lost to Follow-up|0|||
28074528|NCT03835481|54729098|FG003|Double-blind Period|Lost to Follow-up|1|||
28074529|NCT03835481|54729099|FG004|Double-blind Period|Lost to Follow-up|0|||
28074530|NCT03835481|54729095|FG000|Double-blind Period|Protocol Violation|0|||
28074531|NCT03835481|54729096|FG001|Double-blind Period|Protocol Violation|2|||
28074532|NCT03835481|54729097|FG002|Double-blind Period|Protocol Violation|0|||
28074533|NCT03835481|54729098|FG003|Double-blind Period|Protocol Violation|1|||
28074534|NCT03835481|54729099|FG004|Double-blind Period|Protocol Violation|0|||
28074535|NCT03835481|54729095|FG000|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
28074536|NCT03835481|54729096|FG001|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
28074537|NCT03835481|54729097|FG002|Open Label Period (After Week 12)|Termination of treatment by Sponsor|23|||
28074538|NCT03835481|54729098|FG003|Open Label Period (After Week 12)|Termination of treatment by Sponsor|31|||
28074539|NCT03835481|54729099|FG004|Open Label Period (After Week 12)|Termination of treatment by Sponsor|35|||
28074540|NCT03835481|54729095|FG000|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
28074541|NCT03835481|54729096|FG001|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
28074542|NCT03835481|54729097|FG002|Open Label Period (After Week 12)|Withdrawal by Subject|7|||
28074543|NCT03835481|54729098|FG003|Open Label Period (After Week 12)|Withdrawal by Subject|9|||
28154166|NCT02620384|54823562|FG000|Overall Study|Adverse Event|2|||
28154167|NCT02620384|54823563|FG001|Overall Study|Adverse Event|1|||
28154168|NCT02620384|54823562|FG000|Overall Study|Discharged prior to 2nd dose|2|||
28154169|NCT02620384|54823563|FG001|Overall Study|Discharged prior to 2nd dose|5|||
28154170|NCT02620384|54823562|FG000|Overall Study|Drug shortage prevented 2nd dose|0|||
28154171|NCT02620384|54823563|FG001|Overall Study|Drug shortage prevented 2nd dose|1|||
28154172|NCT03915860|54823569|FG000|Overall Study|Adverse Event|3|||
28154173|NCT03915860|54823569|FG000|Overall Study|Withdrawal by Subject|6|||
28154174|NCT03915860|54823569|FG000|Overall Study|Lost to Follow-up|2|||
28154175|NCT03915860|54823569|FG000|Overall Study|Other than specified|3|||
28154176|NCT03786380|54823578|FG000|Overall Study|Adverse Event|1|||
28154177|NCT03786380|54823579|FG001|Overall Study|Adverse Event|0|||
28154178|NCT03786380|54823580|FG002|Overall Study|Adverse Event|0|||
28154179|NCT03786380|54823581|FG003|Overall Study|Adverse Event|3|||
28154180|NCT03786380|54823582|FG004|Overall Study|Adverse Event|1|||
28154181|NCT03786380|54823578|FG000|Overall Study|Lack of Efficacy|0|||
28154182|NCT03786380|54823579|FG001|Overall Study|Lack of Efficacy|0|||
28154183|NCT03786380|54823580|FG002|Overall Study|Lack of Efficacy|0|||
28154184|NCT03786380|54823581|FG003|Overall Study|Lack of Efficacy|0|||
28154185|NCT03786380|54823582|FG004|Overall Study|Lack of Efficacy|1|||
28154186|NCT03786380|54823578|FG000|Overall Study|Withdrawal by Subject|1|||
28154187|NCT03786380|54823579|FG001|Overall Study|Withdrawal by Subject|2|||
28154188|NCT03786380|54823580|FG002|Overall Study|Withdrawal by Subject|2|||
28154189|NCT03786380|54823581|FG003|Overall Study|Withdrawal by Subject|1|||
28154190|NCT03786380|54823582|FG004|Overall Study|Withdrawal by Subject|2|||
28154191|NCT03786380|54823578|FG000|Overall Study|Lost to Follow-up|3|||
28154192|NCT03786380|54823579|FG001|Overall Study|Lost to Follow-up|0|||
28154193|NCT03786380|54823580|FG002|Overall Study|Lost to Follow-up|1|||
28154194|NCT03786380|54823581|FG003|Overall Study|Lost to Follow-up|2|||
28154195|NCT03786380|54823582|FG004|Overall Study|Lost to Follow-up|0|||
28154196|NCT03786380|54823578|FG000|Overall Study|Physician Decision|0|||
28154197|NCT03786380|54823579|FG001|Overall Study|Physician Decision|0|||
28154198|NCT03786380|54823580|FG002|Overall Study|Physician Decision|1|||
28154199|NCT03786380|54823581|FG003|Overall Study|Physician Decision|0|||
28154200|NCT03786380|54823582|FG004|Overall Study|Physician Decision|0|||
28154201|NCT03786380|54823578|FG000|Overall Study|Study Terminated by the Sponsor|30|||
28154202|NCT03786380|54823579|FG001|Overall Study|Study Terminated by the Sponsor|20|||
27942062|NCT02905825|54598795|FG000|Overall Study|Device Malfunction|1|||
28154203|NCT03786380|54823580|FG002|Overall Study|Study Terminated by the Sponsor|50|||
28074544|NCT03835481|54729099|FG004|Open Label Period (After Week 12)|Withdrawal by Subject|1|||
28074545|NCT03835481|54729095|FG000|Open Label Period (After Week 12)|Lost to Follow-up|0|||
28074546|NCT03835481|54729096|FG001|Open Label Period (After Week 12)|Lost to Follow-up|0|||
28074547|NCT03835481|54729097|FG002|Open Label Period (After Week 12)|Lost to Follow-up|4|||
28074548|NCT03835481|54729098|FG003|Open Label Period (After Week 12)|Lost to Follow-up|3|||
28074549|NCT03835481|54729099|FG004|Open Label Period (After Week 12)|Lost to Follow-up|0|||
28154204|NCT03786380|54823581|FG003|Overall Study|Study Terminated by the Sponsor|57|||
28154205|NCT03786380|54823582|FG004|Overall Study|Study Terminated by the Sponsor|23|||
28154206|NCT03786380|54823578|FG000|Overall Study|Reason Not Specified|0|||
28154207|NCT03786380|54823579|FG001|Overall Study|Reason Not Specified|0|||
28154208|NCT03786380|54823580|FG002|Overall Study|Reason Not Specified|0|||
28154209|NCT03786380|54823581|FG003|Overall Study|Reason Not Specified|0|||
28074550|NCT03835481|54729095|FG000|Open Label Period (After Week 12)|Adverse Event|0|||
28074551|NCT03835481|54729096|FG001|Open Label Period (After Week 12)|Adverse Event|0|||
28154210|NCT03786380|54823582|FG004|Overall Study|Reason Not Specified|1|||
28154211|NCT02626000|54823594|FG000|Overall Study|Decision by Sponsor|1|||
28154212|NCT02626000|54823594|FG000|Overall Study|Death|29|||
28154213|NCT02736890|54823610|FG000|Crossover Next 12 Weeks|Lost to Follow-up|1|||
28154214|NCT02736890|54823611|FG001|Crossover Next 12 Weeks|Lost to Follow-up|2|||
28074552|NCT03835481|54729097|FG002|Open Label Period (After Week 12)|Adverse Event|1|||
28074553|NCT03835481|54729098|FG003|Open Label Period (After Week 12)|Adverse Event|1|||
28074554|NCT03835481|54729099|FG004|Open Label Period (After Week 12)|Adverse Event|0|||
28154215|NCT02736890|54823610|FG000|Crossover Next 12 Weeks|Withdrawal by Subject|1|||
28154216|NCT02736890|54823611|FG001|Crossover Next 12 Weeks|Withdrawal by Subject|0|||
28154217|NCT02779556|54823619|FG000|Baseline|Partial baseline interview completed|1|||
28154218|NCT02779556|54823620|FG001|Baseline|Partial baseline interview completed|0|||
28154219|NCT02779556|54823619|FG000|3 Months|Lost to Follow-up|40|||
28154220|NCT02779556|54823620|FG001|3 Months|Lost to Follow-up|29|||
28154221|NCT02779556|54823619|FG000|3 Months|Missed 3 month clinic visit|27|||
28154222|NCT02779556|54823620|FG001|3 Months|Missed 3 month clinic visit|19|||
28154223|NCT02779556|54823619|FG000|6 Month|Lost to Follow-up|33|||
28154224|NCT02779556|54823620|FG001|6 Month|Lost to Follow-up|39|||
28154225|NCT02779556|54823619|FG000|6 Month HbA1c|No value collected during window|69|||
28154226|NCT02779556|54823620|FG001|6 Month HbA1c|No value collected during window|50|||
28154227|NCT02779556|54823619|FG000|12 Month HbA1c|No value collected during window|138|||
28154228|NCT02779556|54823620|FG001|12 Month HbA1c|No value collected during window|102|||
28154229|NCT01669798|54823626|FG000|Overall Study|Physician Decision|5|||
28154230|NCT02334722|54823632|FG000|Overall Study|Lost to Follow-up|4|||
28154231|NCT02334722|54823633|FG001|Overall Study|Lost to Follow-up|0|||
28154232|NCT02334722|54823632|FG000|Overall Study|6 week questionnaire not completed|2|||
28154233|NCT02334722|54823633|FG001|Overall Study|6 week questionnaire not completed|0|||
28154234|NCT02334722|54823632|FG000|Overall Study|Unable to obtain medication|1|||
28154235|NCT02334722|54823633|FG001|Overall Study|Unable to obtain medication|1|||
28154236|NCT02334722|54823632|FG000|Overall Study|Withdrawal by Subject|0|||
28154237|NCT02334722|54823633|FG001|Overall Study|Withdrawal by Subject|3|||
28154238|NCT02334722|54823632|FG000|Overall Study|Adverse Event|0|||
28154239|NCT02334722|54823633|FG001|Overall Study|Adverse Event|2|||
28154240|NCT02334722|54823632|FG000|Overall Study|Physician Decision|0|||
28154241|NCT02334722|54823633|FG001|Overall Study|Physician Decision|1|||
28154242|NCT00812708|54823648|FG000|Overall Study|Device could not be implanted|2|||
28154243|NCT00812708|54823648|FG000|Overall Study|Lack of medical insurance|1|||
28154244|NCT00812708|54823648|FG000|Overall Study|Switched to another study|1|||
28154245|NCT00812708|54823648|FG000|Overall Study|Surgery cancelled due to uveitis|1|||
28154246|NCT00812708|54823648|FG000|Overall Study|Signed consent but later withdrew|3|||
28154247|NCT03761810|54823664|FG000|Overall Study|Adverse Event|12|||
28154248|NCT03761810|54823665|FG001|Overall Study|Adverse Event|0|||
28154249|NCT03761810|54823664|FG000|Overall Study|Lost to Follow-up|15|||
28154250|NCT03761810|54823665|FG001|Overall Study|Lost to Follow-up|7|||
28154251|NCT03761810|54823664|FG000|Overall Study|Pregnancy|1|||
28154252|NCT03761810|54823665|FG001|Overall Study|Pregnancy|0|||
28154253|NCT03761810|54823664|FG000|Overall Study|Withdrawal by Subject|14|||
28154254|NCT03761810|54823665|FG001|Overall Study|Withdrawal by Subject|5|||
28154255|NCT03761810|54823664|FG000|Overall Study|Physician Decision|1|||
28154256|NCT03761810|54823665|FG001|Overall Study|Physician Decision|0|||
28154257|NCT03761810|54823664|FG000|Overall Study|Withdrawal by Parent/Guardian|4|||
28154258|NCT03761810|54823665|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
28154259|NCT03761810|54823664|FG000|Overall Study|Other Than Specified|1|||
28154260|NCT03761810|54823665|FG001|Overall Study|Other Than Specified|0|||
28154261|NCT02811159|54823676|FG000|Treatment Course 1|Lost to Follow-up|1|||
28154262|NCT01889186|54823682|FG000|Overall Study|Adverse event- not related to progression|18|||
28154263|NCT01889186|54823683|FG001|Overall Study|Adverse event- not related to progression|5|||
28154264|NCT01889186|54823682|FG000|Overall Study|Adverse event- related to progression|7|||
28154265|NCT01889186|54823683|FG001|Overall Study|Adverse event- related to progression|2|||
28154266|NCT01889186|54823682|FG000|Overall Study|COVID-19 logistical restrictions|1|||
28154267|NCT01889186|54823683|FG001|Overall Study|COVID-19 logistical restrictions|0|||
28074555|NCT03835481|54729095|FG000|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
28074556|NCT03835481|54729096|FG001|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
28074557|NCT03835481|54729097|FG002|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
28074558|NCT03835481|54729098|FG003|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|1|||
28074559|NCT03835481|54729099|FG004|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
28074560|NCT03835481|54729095|FG000|Open Label Period (After Week 12)|Other not stated above|0|||
28074561|NCT03835481|54729096|FG001|Open Label Period (After Week 12)|Other not stated above|0|||
28074562|NCT03835481|54729097|FG002|Open Label Period (After Week 12)|Other not stated above|0|||
28074563|NCT03835481|54729098|FG003|Open Label Period (After Week 12)|Other not stated above|1|||
28074564|NCT03835481|54729099|FG004|Open Label Period (After Week 12)|Other not stated above|1|||
28074565|NCT03709576|54729146|FG000|Overall Study|progression prior to enrollment|1|||
28074566|NCT00122460|54729153|FG000|Overall Study|investigational study phase ongoing|7|||
28154268|NCT01889186|54823682|FG000|Overall Study|Investigator request|1|||
28154269|NCT01889186|54823683|FG001|Overall Study|Investigator request|1|||
28154270|NCT01889186|54823682|FG000|Overall Study|Progressive disease- Richter's|12|||
28154271|NCT01889186|54823683|FG001|Overall Study|Progressive disease- Richter's|7|||
28154272|NCT01889186|54823682|FG000|Overall Study|Progressive disease per protocol|46|||
28154273|NCT01889186|54823683|FG001|Overall Study|Progressive disease per protocol|17|||
28154274|NCT01889186|54823682|FG000|Overall Study|Stem cell transplant|2|||
28154275|NCT01889186|54823683|FG001|Overall Study|Stem cell transplant|1|||
28154276|NCT01889186|54823682|FG000|Overall Study|Withdrew consent|2|||
28154277|NCT01889186|54823683|FG001|Overall Study|Withdrew consent|3|||
28154278|NCT01889186|54823682|FG000|Overall Study|Other, not specified|18|||
28154279|NCT01889186|54823683|FG001|Overall Study|Other, not specified|15|||
28154280|NCT01510184|54823693|FG000|Overall Study|Sponsor discretion|28|||
28154281|NCT01510184|54823694|FG001|Overall Study|Sponsor discretion|28|||
28154282|NCT01510184|54823693|FG000|Overall Study|Death|1|||
28154283|NCT01510184|54823694|FG001|Overall Study|Death|2|||
28154284|NCT01510184|54823693|FG000|Overall Study|Withdrawal by Subject|1|||
28154285|NCT01510184|54823694|FG001|Overall Study|Withdrawal by Subject|4|||
28154286|NCT01510184|54823693|FG000|Overall Study|Other|0|||
28154287|NCT01510184|54823694|FG001|Overall Study|Other|1|||
28154288|NCT02809833|54823719|FG000|Overall Study|Death|3|||
28154289|NCT02809833|54823719|FG000|Overall Study|Intolerance|54|||
28154290|NCT02809833|54823719|FG000|Overall Study|Lack of Efficacy|89|||
28154291|NCT02809833|54823719|FG000|Overall Study|Remission/Treatment No Longer Needed|3|||
28154292|NCT02809833|54823719|FG000|Overall Study|Noncompliance|1|||
28154293|NCT02809833|54823719|FG000|Overall Study|Withdrawal by Subject|34|||
28154294|NCT02809833|54823719|FG000|Overall Study|Lost to Follow-up|35|||
28154295|NCT02809833|54823719|FG000|Overall Study|Adverse Event (AE)|24|||
28154296|NCT02809833|54823719|FG000|Overall Study|Other|5|||
28154297|NCT02809833|54823719|FG000|Overall Study|Missing Information|52|||
28154298|NCT02797262|54823725|FG000|Overall Study|Withdrawal by Subject|5|||
28154299|NCT02797262|54823726|FG001|Overall Study|Withdrawal by Subject|1|||
28154300|NCT02797262|54823725|FG000|Overall Study|Lost to Follow-up|10|||
28154301|NCT02797262|54823726|FG001|Overall Study|Lost to Follow-up|7|||
28074567|NCT00122460|54729154|FG001|Overall Study|investigational study phase ongoing|1|||
28074568|NCT00137436|54729160|FG000|Overall Study|Adverse Event|13|||
28074569|NCT00137436|54729160|FG000|Overall Study|Death|2|||
28074570|NCT00137436|54729160|FG000|Overall Study|Lack of Efficacy|17|||
28074571|NCT00137436|54729160|FG000|Overall Study|Withdrawal by Subject|6|||
28074572|NCT00137436|54729160|FG000|Overall Study|Other|5|||
28074573|NCT03834623|54729166|FG000|Overall Study|Progression|0|||
28074574|NCT03834623|54729167|FG001|Overall Study|Progression|1|||
28074575|NCT00410813|54729175|FG000|Overall Study|Adverse Event|6|||
28074576|NCT00410813|54729176|FG001|Overall Study|Adverse Event|11|||
28074577|NCT00410813|54729175|FG000|Overall Study|Progression|32|||
28074578|NCT00410813|54729176|FG001|Overall Study|Progression|21|||
28074579|NCT00410813|54729175|FG000|Overall Study|Not protocol specified|3|||
28074580|NCT00410813|54729176|FG001|Overall Study|Not protocol specified|4|||
28074581|NCT00410813|54729175|FG000|Overall Study|Ineligible|2|||
28074582|NCT00410813|54729176|FG001|Overall Study|Ineligible|4|||
28074583|NCT00410813|54729175|FG000|Overall Study|Death|0|||
28074584|NCT00410813|54729176|FG001|Overall Study|Death|2|||
28074585|NCT00405821|54729207|FG000|Overall Study|Death|5|||
28074586|NCT00405821|54729208|FG001|Overall Study|Death|7|||
28074587|NCT00405821|54729207|FG000|Overall Study|Lost to Follow-up|7|||
28154302|NCT02797262|54823725|FG000|Overall Study|Death|1|||
28154303|NCT02797262|54823726|FG001|Overall Study|Death|2|||
28154304|NCT02797262|54823725|FG000|Overall Study|Adverse Event|1|||
28154305|NCT02797262|54823726|FG001|Overall Study|Adverse Event|0|||
28154306|NCT02797262|54823725|FG000|Overall Study|COVID-19|2|||
28154307|NCT02797262|54823726|FG001|Overall Study|COVID-19|1|||
28154308|NCT02797262|54823725|FG000|Overall Study|Out-of-country|1|||
28154309|NCT02797262|54823726|FG001|Overall Study|Out-of-country|0|||
28154310|NCT02809053|54823734|FG000|Overall Study|Death|0|||
28154311|NCT02809053|54823735|FG001|Overall Study|Death|1|||
28154312|NCT02809053|54823734|FG000|Overall Study|Lost to Follow-up|3|||
28154313|NCT02809053|54823735|FG001|Overall Study|Lost to Follow-up|1|||
28154314|NCT02809053|54823734|FG000|Overall Study|Withdrawal by Subject|2|||
28154315|NCT02809053|54823735|FG001|Overall Study|Withdrawal by Subject|3|||
28154316|NCT02809053|54823734|FG000|Overall Study|Disease Progression|2|||
28154317|NCT02809053|54823735|FG001|Overall Study|Disease Progression|1|||
28154318|NCT02808975|54823743|FG000|Overall Study|Adverse Event|3|||
28154319|NCT02808975|54823744|FG001|Overall Study|Adverse Event|4|||
28154320|NCT02808975|54823743|FG000|Overall Study|Withdrew consent|9|||
28154321|NCT02808975|54823744|FG001|Overall Study|Withdrew consent|8|||
28154322|NCT02808975|54823743|FG000|Overall Study|Lost to Follow-up|4|||
28154323|NCT02808975|54823744|FG001|Overall Study|Lost to Follow-up|6|||
28154324|NCT02808975|54823743|FG000|Overall Study|Planned HS surgery performed prior Wk 13|1|||
28154325|NCT02808975|54823744|FG001|Overall Study|Planned HS surgery performed prior Wk 13|0|||
28154326|NCT02808975|54823743|FG000|Overall Study|Other, not specified|5|||
28074588|NCT00405821|54729208|FG001|Overall Study|Lost to Follow-up|7|||
28074589|NCT00405821|54729207|FG000|Overall Study|Protocol Violation|1|||
28074590|NCT00405821|54729208|FG001|Overall Study|Protocol Violation|0|||
28074591|NCT00405821|54729207|FG000|Overall Study|initiated ART|9|||
28074592|NCT00405821|54729208|FG001|Overall Study|initiated ART|8|||
28074593|NCT01446016|54729214|FG000|Overall Study|Lost to Follow-up|3|||
28074594|NCT01446016|54729214|FG000|Overall Study|Withdrawal by Subject|1|||
28074595|NCT01446016|54729214|FG000|Overall Study|Toxicity|3|||
28074596|NCT00137046|54729220|FG000|Overall Study|Death|2|||
27825118|NCT01746901|54290649|FG008|Naloxone Challenge Phase|Adverse Event|0|||
28074597|NCT00137046|54729221|FG001|Overall Study|Death|1|||
28074598|NCT00137046|54729220|FG000|Overall Study|Adverse Event|16|||
28074599|NCT00137046|54729221|FG001|Overall Study|Adverse Event|5|||
28074600|NCT00137046|54729220|FG000|Overall Study|Laboratory Abnormality|2|||
28074601|NCT00137046|54729221|FG001|Overall Study|Laboratory Abnormality|0|||
28074602|NCT00137046|54729220|FG000|Overall Study|Lack of Efficacy|13|||
28074603|NCT00137046|54729221|FG001|Overall Study|Lack of Efficacy|1|||
28074604|NCT00137046|54729220|FG000|Overall Study|Lost to Follow-up|8|||
28074605|NCT00137046|54729221|FG001|Overall Study|Lost to Follow-up|24|||
28074606|NCT00137046|54729220|FG000|Overall Study|Other|23|||
28074607|NCT00137046|54729221|FG001|Overall Study|Other|19|||
28074608|NCT00137046|54729220|FG000|Overall Study|Withdrawal by Subject|33|||
28074609|NCT00137046|54729221|FG001|Overall Study|Withdrawal by Subject|42|||
28074610|NCT00137046|54729220|FG000|Overall Study|Adverse Event 4 Days after Last Dose|1|||
28074611|NCT00137046|54729221|FG001|Overall Study|Adverse Event 4 Days after Last Dose|0|||
28074612|NCT00137046|54729220|FG000|Overall Study|Withdrew prior to study treatment|1|||
28074613|NCT00137046|54729221|FG001|Overall Study|Withdrew prior to study treatment|1|||
28074614|NCT00122382|54729233|FG000|Double-Blind Study|Adverse Event|9|||
28074615|NCT00122382|54729234|FG001|Double-Blind Study|Adverse Event|11|||
28074616|NCT00122382|54729235|FG002|Double-Blind Study|Adverse Event|0|||
28074617|NCT00122382|54729233|FG000|Double-Blind Study|Death|2|||
28074618|NCT00122382|54729234|FG001|Double-Blind Study|Death|2|||
28074619|NCT00122382|54729235|FG002|Double-Blind Study|Death|0|||
28074620|NCT00122382|54729233|FG000|Double-Blind Study|Lack of Efficacy|0|||
28074621|NCT00122382|54729234|FG001|Double-Blind Study|Lack of Efficacy|8|||
28074622|NCT00122382|54729235|FG002|Double-Blind Study|Lack of Efficacy|0|||
28074623|NCT00122382|54729233|FG000|Double-Blind Study|Lost to Follow-up|2|||
28074624|NCT00122382|54729234|FG001|Double-Blind Study|Lost to Follow-up|1|||
28074625|NCT00122382|54729235|FG002|Double-Blind Study|Lost to Follow-up|0|||
28074626|NCT00122382|54729233|FG000|Double-Blind Study|Pregnancy|2|||
28074627|NCT00122382|54729234|FG001|Double-Blind Study|Pregnancy|0|||
28074628|NCT00122382|54729235|FG002|Double-Blind Study|Pregnancy|0|||
28074629|NCT00122382|54729233|FG000|Double-Blind Study|Subject No Longer Meets Study Criteria|1|||
28074630|NCT00122382|54729234|FG001|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
28074631|NCT00122382|54729235|FG002|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
28074632|NCT00122382|54729233|FG000|Double-Blind Study|Withdrawal of Consent|7|||
28074633|NCT00122382|54729234|FG001|Double-Blind Study|Withdrawal of Consent|3|||
28074634|NCT00122382|54729235|FG002|Double-Blind Study|Withdrawal of Consent|0|||
28074635|NCT00122382|54729233|FG000|Double-Blind Study|Protocol Violation|1|||
28074636|NCT00122382|54729234|FG001|Double-Blind Study|Protocol Violation|0|||
28074637|NCT00122382|54729235|FG002|Double-Blind Study|Protocol Violation|0|||
28074638|NCT00122382|54729233|FG000|Double-Blind Study|Methotrexate Discontinued|0|||
28074639|NCT00122382|54729234|FG001|Double-Blind Study|Methotrexate Discontinued|1|||
28074640|NCT00122382|54729235|FG002|Double-Blind Study|Methotrexate Discontinued|0|||
28074641|NCT00122382|54729233|FG000|Double-Blind Study|Randomized but not treated|0|||
28074642|NCT00122382|54729234|FG001|Double-Blind Study|Randomized but not treated|2|||
28074643|NCT00122382|54729235|FG002|Double-Blind Study|Randomized but not treated|0|||
28074644|NCT00122382|54729233|FG000|Open-Label Study|Adverse Event|0|||
28074645|NCT00122382|54729234|FG001|Open-Label Study|Adverse Event|0|||
28074646|NCT00122382|54729235|FG002|Open-Label Study|Adverse Event|11|||
28074647|NCT00122382|54729233|FG000|Open-Label Study|Death|0|||
28074648|NCT00122382|54729234|FG001|Open-Label Study|Death|0|||
28074649|NCT00122382|54729235|FG002|Open-Label Study|Death|2|||
28074650|NCT00122382|54729233|FG000|Open-Label Study|Lack of Efficacy|0|||
28074651|NCT00122382|54729234|FG001|Open-Label Study|Lack of Efficacy|0|||
28074652|NCT00122382|54729235|FG002|Open-Label Study|Lack of Efficacy|3|||
28074653|NCT00122382|54729233|FG000|Open-Label Study|Lost to Follow-up|0|||
28074654|NCT00122382|54729234|FG001|Open-Label Study|Lost to Follow-up|0|||
28074655|NCT00122382|54729235|FG002|Open-Label Study|Lost to Follow-up|3|||
28154327|NCT02808975|54823744|FG001|Overall Study|Other, not specified|1|||
28154328|NCT02976038|54823750|FG000|Overall Study|Physician Decision|22|||
28154329|NCT02976038|54823750|FG000|Overall Study|Withdrawal by Subject|3|||
28154330|NCT02976038|54823750|FG000|Overall Study|Lost to Follow-up|2|||
28074656|NCT00122382|54729233|FG000|Open-Label Study|Pregnancy|0|||
28074657|NCT00122382|54729234|FG001|Open-Label Study|Pregnancy|0|||
28074658|NCT00122382|54729235|FG002|Open-Label Study|Pregnancy|2|||
28154331|NCT02976038|54823750|FG000|Overall Study|Adverse Event|1|||
28074659|NCT00122382|54729233|FG000|Open-Label Study|Poor/Non-Compliance|0|||
28074660|NCT00122382|54729234|FG001|Open-Label Study|Poor/Non-Compliance|0|||
28074661|NCT00122382|54729235|FG002|Open-Label Study|Poor/Non-Compliance|1|||
28074662|NCT00122382|54729233|FG000|Open-Label Study|Withdrawal of Consent|0|||
28074663|NCT00122382|54729234|FG001|Open-Label Study|Withdrawal of Consent|0|||
28074664|NCT00122382|54729235|FG002|Open-Label Study|Withdrawal of Consent|4|||
28154332|NCT02808819|54823775|FG000|Overall Study|eg. no treatment efficacy on asthma|5|||
28154333|NCT02808819|54823776|FG001|Overall Study|eg. no treatment efficacy on asthma|4|||
28074665|NCT01028716|54729253|FG000|Overall Study|Physician Decision|1|||
28074666|NCT00106704|54729260|FG000|Overall Study|Adverse Event|10|||
28074667|NCT00106704|54729261|FG001|Overall Study|Adverse Event|7|||
28074668|NCT00106704|54729260|FG000|Overall Study|Death|2|||
28074669|NCT00106704|54729261|FG001|Overall Study|Death|1|||
28074670|NCT00106704|54729260|FG000|Overall Study|Lack of Efficacy|67|||
28074671|NCT00106704|54729261|FG001|Overall Study|Lack of Efficacy|69|||
28074672|NCT00106704|54729260|FG000|Overall Study|Lost to Follow-up|7|||
28074673|NCT00106704|54729261|FG001|Overall Study|Lost to Follow-up|3|||
28074674|NCT00106704|54729260|FG000|Overall Study|Pregnancy|1|||
28074675|NCT00106704|54729261|FG001|Overall Study|Pregnancy|0|||
28074676|NCT00106704|54729260|FG000|Overall Study|Protocol Violation|4|||
28074677|NCT00106704|54729261|FG001|Overall Study|Protocol Violation|7|||
28154334|NCT02808819|54823775|FG000|Overall Study|Withdrawal by Subject|10|||
28154335|NCT02808819|54823776|FG001|Overall Study|Withdrawal by Subject|13|||
28074678|NCT00106704|54729260|FG000|Overall Study|Withdrawal by Subject|14|||
28154336|NCT02808819|54823775|FG000|Overall Study|Site terminated by sponsor|2|||
28154337|NCT02808819|54823776|FG001|Overall Study|Site terminated by sponsor|0|||
28154338|NCT02808819|54823775|FG000|Overall Study|Pregnancy|1|||
28154339|NCT02808819|54823776|FG001|Overall Study|Pregnancy|0|||
28154340|NCT02808819|54823775|FG000|Overall Study|Lost to Follow-up|1|||
28154341|NCT02808819|54823776|FG001|Overall Study|Lost to Follow-up|6|||
28154342|NCT02808819|54823775|FG000|Overall Study|Protocol Violation|0|||
28074679|NCT00106704|54729261|FG001|Overall Study|Withdrawal by Subject|21|||
28074680|NCT00106704|54729260|FG000|Overall Study|Patient moved|1|||
28074681|NCT00106704|54729261|FG001|Overall Study|Patient moved|0|||
28154343|NCT02808819|54823776|FG001|Overall Study|Protocol Violation|1|||
27942063|NCT01208051|54598804|FG000|Total Enrollment|Withdrawal by Subject|0|||
27942064|NCT01208051|54598805|FG001|Total Enrollment|Withdrawal by Subject|1|||
28074682|NCT00106704|54729260|FG000|Overall Study|Site terminated|0|||
28074683|NCT00106704|54729261|FG001|Overall Study|Site terminated|1|||
28074684|NCT00106704|54729260|FG000|Overall Study|Planned major surgery|1|||
28074685|NCT00106704|54729261|FG001|Overall Study|Planned major surgery|0|||
28074686|NCT00106704|54729260|FG000|Overall Study|Patient Received Glycemic Medication|22|||
28074687|NCT00106704|54729261|FG001|Overall Study|Patient Received Glycemic Medication|41|||
28074688|NCT00106704|54729260|FG000|Overall Study|Unable to re-enter US|1|||
28074689|NCT00106704|54729261|FG001|Overall Study|Unable to re-enter US|0|||
28074690|NCT00106704|54729260|FG000|Overall Study|Laboratory test|1|||
27825119|NCT01746901|54290641|FG000|Naloxone Challenge Phase|Did not meet entrance criteria|1|||
27825120|NCT01746901|54290642|FG001|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
27825121|NCT01746901|54290643|FG002|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
28154344|NCT02808819|54823775|FG000|Overall Study|Development of study-specific withdrawal criteria|8|||
28154345|NCT02808819|54823776|FG001|Overall Study|Development of study-specific withdrawal criteria|3|||
28154346|NCT02808819|54823775|FG000|Overall Study|Death|1|||
28154347|NCT02808819|54823776|FG001|Overall Study|Death|0|||
28154348|NCT02808819|54823775|FG000|Overall Study|Adverse Event|3|||
28154349|NCT02808819|54823776|FG001|Overall Study|Adverse Event|4|||
28154350|NCT02808429|54823786|FG000|Overall Study|Lost to Follow-up|1|||
28154351|NCT02808429|54823787|FG001|Overall Study|Lost to Follow-up|0|||
28154352|NCT02808429|54823788|FG002|Overall Study|Lost to Follow-up|0|||
28154353|NCT02808429|54823786|FG000|Overall Study|Protocol Violation|0|||
28154354|NCT02808429|54823787|FG001|Overall Study|Protocol Violation|1|||
28154355|NCT02808429|54823788|FG002|Overall Study|Protocol Violation|0|||
28154356|NCT02808429|54823786|FG000|Overall Study|Premature study termination by sponsor|2|||
28154357|NCT02808429|54823787|FG001|Overall Study|Premature study termination by sponsor|0|||
28154358|NCT02808429|54823788|FG002|Overall Study|Premature study termination by sponsor|1|||
28154359|NCT02808429|54823786|FG000|Overall Study|Relocation|0|||
28154360|NCT02808429|54823787|FG001|Overall Study|Relocation|0|||
28154361|NCT02808429|54823788|FG002|Overall Study|Relocation|1|||
28154362|NCT01594762|54823798|FG000|Overall Study|Withdrawal by Subject|1|||
28154363|NCT01594762|54823799|FG001|Overall Study|Withdrawal by Subject|0|||
28154364|NCT01594762|54823798|FG000|Overall Study|Lost to Follow-up|10|||
28154365|NCT01594762|54823799|FG001|Overall Study|Lost to Follow-up|10|||
28154366|NCT02615470|54823807|FG000|Overall Study|Lost to Follow-up|21|||
28154367|NCT02615470|54823808|FG001|Overall Study|Lost to Follow-up|32|||
28154368|NCT02806947|54823816|FG000|Overall Study|Withdrawal by Subject|5|||
28154369|NCT02806947|54823817|FG001|Overall Study|Withdrawal by Subject|1|||
28154370|NCT02806713|54823825|FG000|Overall Study|Urethral injury during procedure|1|||
28154371|NCT02806713|54823826|FG001|Overall Study|Urethral injury during procedure|0|||
28154372|NCT02806713|54823825|FG000|Overall Study|cancelled surgery|1|||
28154373|NCT02806713|54823826|FG001|Overall Study|cancelled surgery|2|||
28154374|NCT02807493|54823834|FG000|Overall Study|Adverse Event|5|||
28154375|NCT02807493|54823835|FG001|Overall Study|Adverse Event|2|||
28154376|NCT02807493|54823834|FG000|Overall Study|Lost to Follow-up|6|||
28154377|NCT02807493|54823835|FG001|Overall Study|Lost to Follow-up|0|||
28074691|NCT00106704|54729261|FG001|Overall Study|Laboratory test|1|||
28074692|NCT00105066|54729269|FG000|Overall Study|Adverse Event|2|||
28074693|NCT00105066|54729270|FG001|Overall Study|Adverse Event|5|||
28074694|NCT00104520|54729278|FG000|Overall Study|Unrelated adverse event|34|||
28074695|NCT00104520|54729279|FG001|Overall Study|Unrelated adverse event|47|||
28074696|NCT00104520|54729278|FG000|Overall Study|Study drug intolerance|0|||
28074697|NCT00104520|54729279|FG001|Overall Study|Study drug intolerance|1|||
28074698|NCT00104520|54729278|FG000|Overall Study|Related adverse event|13|||
28074699|NCT00104520|54729279|FG001|Overall Study|Related adverse event|15|||
28074700|NCT00104520|54729278|FG000|Overall Study|Lost to Follow-up|1|||
28074701|NCT00104520|54729279|FG001|Overall Study|Lost to Follow-up|0|||
28154378|NCT02807493|54823834|FG000|Overall Study|Physician Decision|4|||
28154379|NCT02807493|54823835|FG001|Overall Study|Physician Decision|1|||
28074702|NCT00104520|54729278|FG000|Overall Study|Noncompliance|0|||
28074703|NCT00104520|54729279|FG001|Overall Study|Noncompliance|2|||
28074704|NCT00104520|54729278|FG000|Overall Study|Personal/administrative|1|||
28154380|NCT02807493|54823834|FG000|Overall Study|Protocol Violation|7|||
28154381|NCT02807493|54823835|FG001|Overall Study|Protocol Violation|0|||
28154382|NCT02807493|54823834|FG000|Overall Study|Withdrawal by Subject|17|||
28154383|NCT02807493|54823835|FG001|Overall Study|Withdrawal by Subject|10|||
28154384|NCT02807493|54823834|FG000|Overall Study|Other withdrawal|17|||
28154385|NCT02807493|54823835|FG001|Overall Study|Other withdrawal|0|||
28154386|NCT02807493|54823834|FG000|Overall Study|C-Section Prior to Stage 2 of Labor|31|||
28154387|NCT02807493|54823835|FG001|Overall Study|C-Section Prior to Stage 2 of Labor|39|||
28154388|NCT02807259|54823843|FG000|Baseline (3 Months)|migration, refusal, not available|77|||
28154389|NCT02807259|54823844|FG001|Baseline (3 Months)|migration, refusal, not available|112|||
28154390|NCT02807259|54823843|FG000|Midline (3 Months)|migration, refusal, not available|30|||
28154391|NCT02807259|54823844|FG001|Midline (3 Months)|migration, refusal, not available|34|||
28074705|NCT00104520|54729279|FG001|Overall Study|Personal/administrative|1|||
28074706|NCT00104520|54729278|FG000|Overall Study|Other|1|||
28074707|NCT00104520|54729279|FG001|Overall Study|Other|5|||
28074708|NCT00135330|54729288|FG000|Overall Study|Adverse Event|2|||
28074709|NCT00135330|54729289|FG001|Overall Study|Adverse Event|5|||
28074710|NCT00135330|54729290|FG002|Overall Study|Adverse Event|1|||
28074711|NCT00135330|54729288|FG000|Overall Study|Lost to Follow-up|0|||
28074712|NCT00135330|54729289|FG001|Overall Study|Lost to Follow-up|2|||
28154392|NCT02807259|54823843|FG000|Endline (3 Months)|migration, refusal, not available|35|||
28154393|NCT02807259|54823844|FG001|Endline (3 Months)|migration, refusal, not available|87|||
28154394|NCT02802345|54823854|FG000|Overall Study|Not Treated|0|||
28154395|NCT02802345|54823855|FG001|Overall Study|Not Treated|1|||
28154396|NCT02802345|54823854|FG000|Overall Study|Adverse Event|28|||
28154397|NCT02802345|54823855|FG001|Overall Study|Adverse Event|20|||
28154398|NCT02802345|54823854|FG000|Overall Study|Withdrawal by Subject|3|||
28154399|NCT02802345|54823855|FG001|Overall Study|Withdrawal by Subject|3|||
28154400|NCT02802345|54823854|FG000|Overall Study|Protocol Violation|0|||
28154401|NCT02802345|54823855|FG001|Overall Study|Protocol Violation|1|||
28154402|NCT02802345|54823854|FG000|Overall Study|Other than listed|1|||
28154403|NCT02802345|54823855|FG001|Overall Study|Other than listed|5|||
28154404|NCT02801877|54823865|FG000|Overall Study|Lost to Follow-up|1|||
28154405|NCT02801877|54823866|FG001|Overall Study|Lost to Follow-up|1|||
28154406|NCT02801877|54823867|FG002|Overall Study|Lost to Follow-up|2|||
28154407|NCT02801877|54823868|FG003|Overall Study|Lost to Follow-up|0|||
28154408|NCT02801877|54823865|FG000|Overall Study|Never Started Treatment|2|||
28154409|NCT02801877|54823866|FG001|Overall Study|Never Started Treatment|0|||
28154410|NCT02801877|54823867|FG002|Overall Study|Never Started Treatment|4|||
28154411|NCT02801877|54823868|FG003|Overall Study|Never Started Treatment|0|||
28154412|NCT02805309|54823881|FG000|Overall Study|Lost to Follow-up|2|||
28154413|NCT02805309|54823882|FG001|Overall Study|Lost to Follow-up|2|||
28074713|NCT00135330|54729290|FG002|Overall Study|Lost to Follow-up|3|||
28074714|NCT00135330|54729288|FG000|Overall Study|Physician Decision|1|||
28074715|NCT00135330|54729289|FG001|Overall Study|Physician Decision|1|||
28074716|NCT00135330|54729290|FG002|Overall Study|Physician Decision|0|||
28074717|NCT00135330|54729288|FG000|Overall Study|Protocol Violation|4|||
28074718|NCT00135330|54729289|FG001|Overall Study|Protocol Violation|3|||
28074719|NCT00135330|54729290|FG002|Overall Study|Protocol Violation|3|||
28074720|NCT00135330|54729288|FG000|Overall Study|Patient Decision|5|||
28074721|NCT00135330|54729289|FG001|Overall Study|Patient Decision|1|||
28074722|NCT00135330|54729290|FG002|Overall Study|Patient Decision|4|||
28074723|NCT00135330|54729288|FG000|Overall Study|Sponsor Decision|0|||
28074724|NCT00135330|54729289|FG001|Overall Study|Sponsor Decision|1|||
28074725|NCT00135330|54729290|FG002|Overall Study|Sponsor Decision|0|||
28074726|NCT00134784|54729302|FG000|Overall Study|Withdrawal by Subject|2|||
28074727|NCT00134784|54729303|FG001|Overall Study|Withdrawal by Subject|2|||
28154414|NCT02805309|54823883|FG002|Overall Study|Lost to Follow-up|2|||
28154415|NCT02805309|54823881|FG000|Overall Study|Post-Randomization Exclusion|0|||
28074728|NCT00134784|54729304|FG002|Overall Study|Withdrawal by Subject|2|||
28074729|NCT00134784|54729305|FG003|Overall Study|Withdrawal by Subject|1|||
28154416|NCT02805309|54823882|FG001|Overall Study|Post-Randomization Exclusion|2|||
28154417|NCT02805309|54823883|FG002|Overall Study|Post-Randomization Exclusion|1|||
28154418|NCT02804763|54823895|FG000|Double-Blind Period (Week 1 to Week 24)|Adverse Event|1|||
28154419|NCT02804763|54823896|FG001|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
28154420|NCT02804763|54823897|FG002|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
28154421|NCT02804763|54823898|FG003|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
28154422|NCT02804763|54823895|FG000|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
28154423|NCT02804763|54823896|FG001|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
28154424|NCT02804763|54823897|FG002|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|1|||
28154425|NCT02804763|54823898|FG003|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|2|||
28154426|NCT02804763|54823895|FG000|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
28154427|NCT02804763|54823896|FG001|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|1|||
27825122|NCT01746901|54290644|FG003|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
28154428|NCT02804763|54823897|FG002|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
28154429|NCT02804763|54823898|FG003|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
28154430|NCT02804763|54823895|FG000|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|2|||
28154431|NCT02804763|54823896|FG001|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|0|||
28154432|NCT02804763|54823897|FG002|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
28154433|NCT02804763|54823898|FG003|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
28154434|NCT02804763|54823895|FG000|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|4|||
28154435|NCT02804763|54823896|FG001|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|0|||
28154436|NCT02804763|54823897|FG002|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
28154437|NCT02804763|54823898|FG003|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
28154438|NCT02804763|54823895|FG000|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
28154439|NCT02804763|54823896|FG001|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|1|||
28154440|NCT02804763|54823897|FG002|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
28074730|NCT00134082|54729312|FG000|Overall Study|Adverse Event|2|||
28074731|NCT00134082|54729312|FG000|Overall Study|Death|1|||
28074732|NCT03703336|54729318|FG000|Overall Study|Parent withdrew consent|29|||
28074733|NCT03703336|54729319|FG001|Overall Study|Parent withdrew consent|8|||
28074734|NCT03703336|54729318|FG000|Overall Study|Migration|3|||
28154441|NCT02804763|54823898|FG003|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
28154442|NCT02748057|54823914|FG000|Overall Study|Adverse Event|1|||
28154443|NCT02748057|54823915|FG001|Overall Study|Adverse Event|0|||
28154444|NCT02748057|54823914|FG000|Overall Study|Physician Decision|0|||
28074735|NCT03703336|54729319|FG001|Overall Study|Migration|3|||
28074736|NCT03703336|54729318|FG000|Overall Study|Protocol Violation|3|||
28074737|NCT03703336|54729319|FG001|Overall Study|Protocol Violation|1|||
28074738|NCT03703336|54729318|FG000|Overall Study|Physician Decision|2|||
28074739|NCT03703336|54729319|FG001|Overall Study|Physician Decision|0|||
28154445|NCT02748057|54823915|FG001|Overall Study|Physician Decision|1|||
28154446|NCT02748057|54823914|FG000|Overall Study|Protocol Violation|2|||
28154447|NCT02748057|54823915|FG001|Overall Study|Protocol Violation|1|||
28154448|NCT02748057|54823914|FG000|Overall Study|Participant Moved|1|||
28154449|NCT02748057|54823915|FG001|Overall Study|Participant Moved|0|||
28154450|NCT02748057|54823914|FG000|Overall Study|Withdrawal by Subject|1|||
28154451|NCT02748057|54823915|FG001|Overall Study|Withdrawal by Subject|0|||
28154452|NCT02748213|54823923|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
28154453|NCT02748213|54823924|FG001|Overall Study|Withdrawal Prior to Treatment|2|||
28154454|NCT02748213|54823923|FG000|Overall Study|Abnormal Laboratory Test|1|||
28154455|NCT02748213|54823924|FG001|Overall Study|Abnormal Laboratory Test|0|||
28154456|NCT02748213|54823923|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
28154457|NCT02748213|54823924|FG001|Overall Study|Adverse Event or Intercurrent Illness|11|||
28154458|NCT02748213|54823923|FG000|Overall Study|Death|5|||
28154459|NCT02748213|54823924|FG001|Overall Study|Death|3|||
27825123|NCT01746901|54290645|FG004|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
28074740|NCT03703336|54729318|FG000|Overall Study|Adverse Event|0|||
28074741|NCT03703336|54729319|FG001|Overall Study|Adverse Event|2|||
27825124|NCT01746901|54290646|FG005|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
28074742|NCT03703336|54729318|FG000|Overall Study|Lost to Follow-up|1|||
28154460|NCT02748213|54823923|FG000|Overall Study|Insufficient Therapeutic Response|56|||
28154461|NCT02748213|54823924|FG001|Overall Study|Insufficient Therapeutic Response|57|||
28074743|NCT03703336|54729319|FG001|Overall Study|Lost to Follow-up|0|||
28074744|NCT03702166|54729325|FG000|Overall Study|Lost to Follow-up|1|||
28074745|NCT03702166|54729325|FG000|Overall Study|Withdrawal by Subject|1|||
28074746|NCT00132678|54729332|FG000|Period II (Open-Label Oral Risperidone)|Death|0|||
28074747|NCT00132678|54729333|FG001|Period II (Open-Label Oral Risperidone)|Death|0|||
28074748|NCT00132678|54729334|FG002|Period II (Open-Label Oral Risperidone)|Death|1|||
28074749|NCT00132678|54729332|FG000|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
28154462|NCT02748213|54823923|FG000|Overall Study|Violation of Selection Criteria|2|||
28154463|NCT02748213|54823924|FG001|Overall Study|Violation of Selection Criteria|0|||
28154464|NCT02748213|54823923|FG000|Overall Study|Protocol Violation|6|||
28154465|NCT02748213|54823924|FG001|Overall Study|Protocol Violation|4|||
28154466|NCT02748213|54823923|FG000|Overall Study|Refused Treatment*|6|||
28154467|NCT02748213|54823924|FG001|Overall Study|Refused Treatment*|6|||
28154468|NCT02748213|54823923|FG000|Overall Study|Failure to Return|1|||
28154469|NCT02748213|54823924|FG001|Overall Study|Failure to Return|0|||
28154470|NCT02748213|54823923|FG000|Overall Study|Other|30|||
28154471|NCT02748213|54823924|FG001|Overall Study|Other|29|||
28154472|NCT02613910|54823930|FG000|Overall Study|Termination of study|1|||
28154473|NCT02802735|54823937|FG000|Overall Study|Withdrawal by Subject|0|||
28154474|NCT02802735|54823938|FG001|Overall Study|Withdrawal by Subject|1|||
28154475|NCT02802735|54823939|FG002|Overall Study|Withdrawal by Subject|0|||
28154476|NCT02802735|54823940|FG003|Overall Study|Withdrawal by Subject|0|||
28154477|NCT02802735|54823941|FG004|Overall Study|Withdrawal by Subject|0|||
28154478|NCT02799381|54823971|FG000|Overall Study|Withdrew consent|3|||
28154479|NCT02799381|54823972|FG001|Overall Study|Withdrew consent|2|||
28154480|NCT02799381|54823971|FG000|Overall Study|Adverse Event|0|||
28154481|NCT02799381|54823972|FG001|Overall Study|Adverse Event|1|||
27825125|NCT01746901|54290647|FG006|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
28074750|NCT00132678|54729333|FG001|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
28154482|NCT02799381|54823971|FG000|Overall Study|Participant did not take any study drug|1|||
28154483|NCT02799381|54823972|FG001|Overall Study|Participant did not take any study drug|0|||
28154484|NCT01333059|54823980|FG000|Overall Study|Physician Decision|3|||
28154485|NCT01333059|54823981|FG001|Overall Study|Physician Decision|3|||
28154486|NCT01333059|54823980|FG000|Overall Study|Protocol Violation|3|||
28154487|NCT01333059|54823981|FG001|Overall Study|Protocol Violation|0|||
28154488|NCT01370733|54823991|FG000|Overall Study|Withdrawal by Subject|8|||
28154489|NCT01370733|54823992|FG001|Overall Study|Withdrawal by Subject|8|||
28154490|NCT01370733|54823991|FG000|Overall Study|Lost to Follow-up|3|||
28154491|NCT01370733|54823992|FG001|Overall Study|Lost to Follow-up|0|||
28074751|NCT00132678|54729334|FG002|Period II (Open-Label Oral Risperidone)|Adverse Event|13|||
28074752|NCT00132678|54729332|FG000|Period II (Open-Label Oral Risperidone)|Non responder|0|||
28074753|NCT00132678|54729333|FG001|Period II (Open-Label Oral Risperidone)|Non responder|0|||
28074754|NCT00132678|54729334|FG002|Period II (Open-Label Oral Risperidone)|Non responder|6|||
28074755|NCT00132678|54729332|FG000|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
28074756|NCT00132678|54729333|FG001|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
28074757|NCT00132678|54729334|FG002|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7|||
28074758|NCT00132678|54729332|FG000|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
28074759|NCT00132678|54729333|FG001|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
28074760|NCT00132678|54729334|FG002|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14|||
28154492|NCT01370733|54823991|FG000|Overall Study|Adverse Event|2|||
28154493|NCT01370733|54823992|FG001|Overall Study|Adverse Event|4|||
28154494|NCT01370733|54823991|FG000|Overall Study|Lack of Efficacy|3|||
28154495|NCT01370733|54823992|FG001|Overall Study|Lack of Efficacy|5|||
28154496|NCT01370733|54823991|FG000|Overall Study|Physician Decision|0|||
28154497|NCT01370733|54823992|FG001|Overall Study|Physician Decision|2|||
28154498|NCT01370733|54823991|FG000|Overall Study|Protocol Violation|1|||
28154499|NCT01370733|54823992|FG001|Overall Study|Protocol Violation|3|||
28154500|NCT02613364|54824001|FG000|Overall Study|Other|19|||
28154501|NCT02613364|54824002|FG001|Overall Study|Other|29|||
28154502|NCT02613364|54824003|FG002|Overall Study|Other|17|||
28154503|NCT02613364|54824001|FG000|Overall Study|Too time consuming|21|||
28154504|NCT02613364|54824002|FG001|Overall Study|Too time consuming|26|||
28154505|NCT02613364|54824003|FG002|Overall Study|Too time consuming|26|||
28154506|NCT02613364|54824001|FG000|Overall Study|Withdrawal by Subject|13|||
28154507|NCT02613364|54824002|FG001|Overall Study|Withdrawal by Subject|18|||
28154508|NCT02613364|54824003|FG002|Overall Study|Withdrawal by Subject|17|||
28154509|NCT02613364|54824001|FG000|Overall Study|Medical|12|||
28154510|NCT02613364|54824002|FG001|Overall Study|Medical|13|||
28154511|NCT02613364|54824003|FG002|Overall Study|Medical|9|||
28154512|NCT02613364|54824001|FG000|Overall Study|Disliked Study Procedure|1|||
28154513|NCT02613364|54824002|FG001|Overall Study|Disliked Study Procedure|1|||
28154514|NCT02613364|54824003|FG002|Overall Study|Disliked Study Procedure|4|||
28154515|NCT02613364|54824001|FG000|Overall Study|Disliked Intervention|0|||
28154516|NCT02613364|54824002|FG001|Overall Study|Disliked Intervention|3|||
28154517|NCT02613364|54824003|FG002|Overall Study|Disliked Intervention|3|||
28154518|NCT01370655|54824023|FG000|Period 1|Adverse Event|2|||
28154519|NCT01370655|54824024|FG001|Period 1|Adverse Event|0|||
28154520|NCT01370655|54824025|FG002|Period 1|Adverse Event|0|||
28154521|NCT01370655|54824026|FG003|Period 1|Adverse Event|0|||
28154522|NCT01370655|54824027|FG004|Period 1|Adverse Event|0|||
27825126|NCT01746901|54290648|FG007|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
28154523|NCT01370655|54824028|FG005|Period 1|Adverse Event|0|||
28154524|NCT01370655|54824029|FG006|Period 1|Adverse Event|1|||
28154525|NCT01370655|54824030|FG007|Period 1|Adverse Event|0|||
28154526|NCT01370655|54824031|FG008|Period 1|Adverse Event|0|||
28154527|NCT01370655|54824032|FG009|Period 1|Adverse Event|0|||
28154528|NCT01370655|54824033|FG010|Period 1|Adverse Event|0|||
28154529|NCT01370655|54824034|FG011|Period 1|Adverse Event|0|||
28154530|NCT01370655|54824023|FG000|Period 2|Adverse Event|0|||
28154531|NCT01370655|54824024|FG001|Period 2|Adverse Event|0|||
28154532|NCT01370655|54824025|FG002|Period 2|Adverse Event|1|||
28154533|NCT01370655|54824026|FG003|Period 2|Adverse Event|0|||
28154534|NCT01370655|54824027|FG004|Period 2|Adverse Event|1|||
28154535|NCT01370655|54824028|FG005|Period 2|Adverse Event|0|||
28154536|NCT01370655|54824029|FG006|Period 2|Adverse Event|0|||
28154537|NCT01370655|54824030|FG007|Period 2|Adverse Event|1|||
28154538|NCT01370655|54824031|FG008|Period 2|Adverse Event|0|||
28154539|NCT01370655|54824032|FG009|Period 2|Adverse Event|0|||
28154540|NCT01370655|54824033|FG010|Period 2|Adverse Event|0|||
28154541|NCT01370655|54824034|FG011|Period 2|Adverse Event|0|||
28154542|NCT01370655|54824023|FG000|Period 2|met protocol specified stopping criteria|0|||
28154543|NCT01370655|54824024|FG001|Period 2|met protocol specified stopping criteria|0|||
28154544|NCT01370655|54824025|FG002|Period 2|met protocol specified stopping criteria|1|||
28154545|NCT01370655|54824026|FG003|Period 2|met protocol specified stopping criteria|0|||
28154546|NCT01370655|54824027|FG004|Period 2|met protocol specified stopping criteria|0|||
28154547|NCT01370655|54824028|FG005|Period 2|met protocol specified stopping criteria|0|||
28074761|NCT00132678|54729332|FG000|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
28074762|NCT00132678|54729333|FG001|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
28074763|NCT00132678|54729334|FG002|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16|||
28074764|NCT00132678|54729332|FG000|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
28074765|NCT00132678|54729333|FG001|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
28074766|NCT00132678|54729334|FG002|Period II (Open-Label Oral Risperidone)|Physician Decision|1|||
28074767|NCT00132678|54729332|FG000|Period III (Open-Label Stabilization)|Death|2|||
28074768|NCT00132678|54729333|FG001|Period III (Open-Label Stabilization)|Death|0|||
28074769|NCT00132678|54729334|FG002|Period III (Open-Label Stabilization)|Death|0|||
28074770|NCT00132678|54729332|FG000|Period III (Open-Label Stabilization)|Adverse Event|12|||
28074771|NCT00132678|54729333|FG001|Period III (Open-Label Stabilization)|Adverse Event|0|||
28074772|NCT00132678|54729334|FG002|Period III (Open-Label Stabilization)|Adverse Event|0|||
28074773|NCT00132678|54729332|FG000|Period III (Open-Label Stabilization)|Non responder|107|||
28074774|NCT00132678|54729333|FG001|Period III (Open-Label Stabilization)|Non responder|0|||
28154548|NCT01370655|54824029|FG006|Period 2|met protocol specified stopping criteria|1|||
28154549|NCT01370655|54824030|FG007|Period 2|met protocol specified stopping criteria|0|||
28154550|NCT01370655|54824031|FG008|Period 2|met protocol specified stopping criteria|1|||
28154551|NCT01370655|54824032|FG009|Period 2|met protocol specified stopping criteria|0|||
28154552|NCT01370655|54824033|FG010|Period 2|met protocol specified stopping criteria|1|||
28154553|NCT01370655|54824034|FG011|Period 2|met protocol specified stopping criteria|0|||
28154554|NCT01370655|54824023|FG000|Period 2|Withdrawal by Subject|0|||
28154555|NCT01370655|54824024|FG001|Period 2|Withdrawal by Subject|0|||
28154556|NCT01370655|54824025|FG002|Period 2|Withdrawal by Subject|0|||
28154557|NCT01370655|54824026|FG003|Period 2|Withdrawal by Subject|0|||
28154558|NCT01370655|54824027|FG004|Period 2|Withdrawal by Subject|0|||
28154559|NCT01370655|54824028|FG005|Period 2|Withdrawal by Subject|0|||
28154560|NCT01370655|54824029|FG006|Period 2|Withdrawal by Subject|0|||
28154561|NCT01370655|54824030|FG007|Period 2|Withdrawal by Subject|0|||
28154562|NCT01370655|54824031|FG008|Period 2|Withdrawal by Subject|1|||
28154563|NCT01370655|54824032|FG009|Period 2|Withdrawal by Subject|0|||
28154564|NCT01370655|54824033|FG010|Period 2|Withdrawal by Subject|0|||
28154565|NCT01370655|54824034|FG011|Period 2|Withdrawal by Subject|0|||
28154566|NCT02612194|54824047|FG000|Overall Study|Death|5|||
28154567|NCT02612194|54824048|FG001|Overall Study|Death|0|||
28154568|NCT02612194|54824049|FG002|Overall Study|Death|2|||
28154569|NCT02612194|54824047|FG000|Overall Study|Early Study Termination|1|||
28154570|NCT02612194|54824048|FG001|Overall Study|Early Study Termination|0|||
28154571|NCT02612194|54824049|FG002|Overall Study|Early Study Termination|0|||
28154572|NCT02798211|54824059|FG000|Period 1|Adverse Event|1|||
28154573|NCT02798211|54824060|FG001|Period 1|Adverse Event|1|||
28154574|NCT02798211|54824061|FG002|Period 1|Adverse Event|0|||
28154575|NCT02798211|54824062|FG003|Period 1|Adverse Event|0|||
28154576|NCT02798211|54824063|FG004|Period 1|Adverse Event|0|||
28154577|NCT02798211|54824064|FG005|Period 1|Adverse Event|0|||
28154578|NCT02798211|54824059|FG000|Period 1|Lost to Follow-up|2|||
28154579|NCT02798211|54824060|FG001|Period 1|Lost to Follow-up|1|||
28074775|NCT00132678|54729334|FG002|Period III (Open-Label Stabilization)|Non responder|0|||
28074776|NCT00132678|54729332|FG000|Period III (Open-Label Stabilization)|Ineligible to continue trial|5|||
28074777|NCT00132678|54729333|FG001|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
28074778|NCT00132678|54729334|FG002|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
28074779|NCT00132678|54729332|FG000|Period III (Open-Label Stabilization)|Lost to Follow-up|19|||
28074780|NCT00132678|54729333|FG001|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
28074781|NCT00132678|54729334|FG002|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
28074782|NCT00132678|54729332|FG000|Period III (Open-Label Stabilization)|Withdrawal by Subject|49|||
28074783|NCT00132678|54729333|FG001|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
28074784|NCT00132678|54729334|FG002|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
28074785|NCT00132678|54729332|FG000|Period III (Open-Label Stabilization)|Subject non-compliant|1|||
28074786|NCT00132678|54729333|FG001|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
28074787|NCT00132678|54729334|FG002|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
28074788|NCT00132678|54729332|FG000|Period III (Open-Label Stabilization)|Physician Decision|1|||
28074789|NCT00132678|54729333|FG001|Period III (Open-Label Stabilization)|Physician Decision|0|||
28074790|NCT00132678|54729334|FG002|Period III (Open-Label Stabilization)|Physician Decision|0|||
28074791|NCT00132678|54729332|FG000|Period III (Open-Label Stabilization)|Pregnancy|2|||
28154580|NCT02798211|54824061|FG002|Period 1|Lost to Follow-up|0|||
27825127|NCT01746901|54290649|FG008|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
27825128|NCT01746901|54290641|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
27825129|NCT01746901|54290642|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
27825130|NCT01746901|54290643|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
28154581|NCT02798211|54824062|FG003|Period 1|Lost to Follow-up|0|||
28154582|NCT02798211|54824063|FG004|Period 1|Lost to Follow-up|0|||
28154583|NCT02798211|54824064|FG005|Period 1|Lost to Follow-up|0|||
28154584|NCT02798211|54824059|FG000|Period 1|Protocol Violation|0|||
28154585|NCT02798211|54824060|FG001|Period 1|Protocol Violation|0|||
28154586|NCT02798211|54824061|FG002|Period 1|Protocol Violation|2|||
28154587|NCT02798211|54824062|FG003|Period 1|Protocol Violation|0|||
28154588|NCT02798211|54824063|FG004|Period 1|Protocol Violation|0|||
28154589|NCT02798211|54824064|FG005|Period 1|Protocol Violation|0|||
28154590|NCT02798211|54824059|FG000|Period 1|Withdrawal by Subject|1|||
28154591|NCT02798211|54824060|FG001|Period 1|Withdrawal by Subject|1|||
28154592|NCT02798211|54824061|FG002|Period 1|Withdrawal by Subject|0|||
28154593|NCT02798211|54824062|FG003|Period 1|Withdrawal by Subject|0|||
28154594|NCT02798211|54824063|FG004|Period 1|Withdrawal by Subject|0|||
28154595|NCT02798211|54824064|FG005|Period 1|Withdrawal by Subject|0|||
28154596|NCT02798211|54824059|FG000|Period 1|Death|0|||
28154597|NCT02798211|54824060|FG001|Period 1|Death|0|||
28154598|NCT02798211|54824061|FG002|Period 1|Death|1|||
28154599|NCT02798211|54824062|FG003|Period 1|Death|0|||
28154600|NCT02798211|54824063|FG004|Period 1|Death|0|||
28154601|NCT02798211|54824064|FG005|Period 1|Death|0|||
28154602|NCT02798211|54824059|FG000|Period 1|Withdrawal of Informed Consent|2|||
28154603|NCT02798211|54824060|FG001|Period 1|Withdrawal of Informed Consent|7|||
28154604|NCT02798211|54824061|FG002|Period 1|Withdrawal of Informed Consent|3|||
28154605|NCT02798211|54824062|FG003|Period 1|Withdrawal of Informed Consent|0|||
28154606|NCT02798211|54824063|FG004|Period 1|Withdrawal of Informed Consent|0|||
28154607|NCT02798211|54824064|FG005|Period 1|Withdrawal of Informed Consent|0|||
28154608|NCT02798211|54824059|FG000|Period 2|Withdrawal by Subject|2|||
28154609|NCT02798211|54824060|FG001|Period 2|Withdrawal by Subject|0|||
28154610|NCT02798211|54824061|FG002|Period 2|Withdrawal by Subject|0|||
28154611|NCT02798211|54824062|FG003|Period 2|Withdrawal by Subject|0|||
28154612|NCT02798211|54824063|FG004|Period 2|Withdrawal by Subject|2|||
27825131|NCT01746901|54290644|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
27825132|NCT01746901|54290645|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
27825133|NCT01746901|54290646|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
27825134|NCT01746901|54290647|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
27825135|NCT01746901|54290648|FG007|Drug Discrimination Phase: Day 1|Adverse Event|0|||
27825136|NCT01746901|54290649|FG008|Drug Discrimination Phase: Day 1|Adverse Event|0|||
27825137|NCT01746901|54290641|FG000|Drug Discrimination Phase: Day 2|Adverse Event|0|||
28154613|NCT02798211|54824064|FG005|Period 2|Withdrawal by Subject|2|||
28154614|NCT02798211|54824059|FG000|Period 2|Adverse Event|5|||
28154615|NCT02798211|54824060|FG001|Period 2|Adverse Event|0|||
28154616|NCT02798211|54824061|FG002|Period 2|Adverse Event|0|||
28154617|NCT02798211|54824062|FG003|Period 2|Adverse Event|0|||
28154618|NCT02798211|54824063|FG004|Period 2|Adverse Event|1|||
28154619|NCT02798211|54824064|FG005|Period 2|Adverse Event|0|||
28154620|NCT02798211|54824059|FG000|Period 2|Lack of Efficacy|1|||
28154621|NCT02798211|54824060|FG001|Period 2|Lack of Efficacy|0|||
28154622|NCT02798211|54824061|FG002|Period 2|Lack of Efficacy|0|||
28154623|NCT02798211|54824062|FG003|Period 2|Lack of Efficacy|1|||
28154624|NCT02798211|54824063|FG004|Period 2|Lack of Efficacy|0|||
28154625|NCT02798211|54824064|FG005|Period 2|Lack of Efficacy|1|||
28154626|NCT02798211|54824059|FG000|Period 2|Lost to Follow-up|3|||
28074792|NCT00132678|54729333|FG001|Period III (Open-Label Stabilization)|Pregnancy|0|||
28074793|NCT00132678|54729334|FG002|Period III (Open-Label Stabilization)|Pregnancy|0|||
28074794|NCT00132678|54729332|FG000|Period IV (Double-Blind Treatment)|Adverse Event|1|||
28074795|NCT00132678|54729333|FG001|Period IV (Double-Blind Treatment)|Adverse Event|1|||
28074796|NCT00132678|54729334|FG002|Period IV (Double-Blind Treatment)|Adverse Event|0|||
28074797|NCT00132678|54729332|FG000|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
28074798|NCT00132678|54729333|FG001|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
28154627|NCT02798211|54824060|FG001|Period 2|Lost to Follow-up|0|||
28154628|NCT02798211|54824061|FG002|Period 2|Lost to Follow-up|0|||
28154629|NCT02798211|54824062|FG003|Period 2|Lost to Follow-up|0|||
28154630|NCT02798211|54824063|FG004|Period 2|Lost to Follow-up|2|||
28154631|NCT02798211|54824064|FG005|Period 2|Lost to Follow-up|0|||
28154632|NCT02798211|54824059|FG000|Period 2|Physician Decision|1|||
28154633|NCT02798211|54824060|FG001|Period 2|Physician Decision|0|||
28154634|NCT02798211|54824061|FG002|Period 2|Physician Decision|0|||
28154635|NCT02798211|54824062|FG003|Period 2|Physician Decision|1|||
28154636|NCT02798211|54824063|FG004|Period 2|Physician Decision|1|||
28154637|NCT02798211|54824064|FG005|Period 2|Physician Decision|0|||
28154638|NCT02798211|54824059|FG000|Period 2|Pregnancy|0|||
28154639|NCT02798211|54824060|FG001|Period 2|Pregnancy|0|||
28154640|NCT02798211|54824061|FG002|Period 2|Pregnancy|0|||
28154641|NCT02798211|54824062|FG003|Period 2|Pregnancy|2|||
28154642|NCT02798211|54824063|FG004|Period 2|Pregnancy|0|||
28154643|NCT02798211|54824064|FG005|Period 2|Pregnancy|0|||
28154644|NCT02798211|54824059|FG000|Period 2|Technical problems|1|||
28154645|NCT02798211|54824060|FG001|Period 2|Technical problems|0|||
28154646|NCT02798211|54824061|FG002|Period 2|Technical problems|0|||
28154647|NCT02798211|54824062|FG003|Period 2|Technical problems|1|||
28154648|NCT02798211|54824063|FG004|Period 2|Technical problems|0|||
28154649|NCT02798211|54824064|FG005|Period 2|Technical problems|0|||
28154650|NCT02798211|54824059|FG000|Period 2|Withdrawal of Informed Consent|1|||
28154651|NCT02798211|54824060|FG001|Period 2|Withdrawal of Informed Consent|0|||
28154652|NCT02798211|54824061|FG002|Period 2|Withdrawal of Informed Consent|0|||
28154653|NCT02798211|54824062|FG003|Period 2|Withdrawal of Informed Consent|2|||
28154654|NCT02798211|54824063|FG004|Period 2|Withdrawal of Informed Consent|2|||
28154655|NCT02798211|54824064|FG005|Period 2|Withdrawal of Informed Consent|3|||
28154656|NCT02799069|54824079|FG000|Overall Study|Adverse Event|0|||
28154657|NCT02799069|54824080|FG001|Overall Study|Adverse Event|2|||
28154658|NCT02799069|54824081|FG002|Overall Study|Adverse Event|2|||
28154659|NCT02799069|54824079|FG000|Overall Study|Lack of Efficacy|2|||
28154660|NCT02799069|54824080|FG001|Overall Study|Lack of Efficacy|0|||
28154661|NCT02799069|54824081|FG002|Overall Study|Lack of Efficacy|0|||
28154662|NCT02799069|54824079|FG000|Overall Study|Lost to Follow-up|1|||
28154663|NCT02799069|54824080|FG001|Overall Study|Lost to Follow-up|1|||
28154664|NCT02799069|54824081|FG002|Overall Study|Lost to Follow-up|0|||
28154665|NCT02799069|54824079|FG000|Overall Study|Withdrawal by Subject|4|||
28154666|NCT02799069|54824080|FG001|Overall Study|Withdrawal by Subject|4|||
28154667|NCT02799069|54824081|FG002|Overall Study|Withdrawal by Subject|3|||
28154668|NCT02799069|54824079|FG000|Overall Study|Protocol Violation|1|||
28154669|NCT02799069|54824080|FG001|Overall Study|Protocol Violation|0|||
28154670|NCT02799069|54824081|FG002|Overall Study|Protocol Violation|2|||
28154671|NCT01669174|54824091|FG000|Overall Study|Subject withdrew consent|2|||
28154672|NCT01669174|54824092|FG001|Overall Study|Subject withdrew consent|2|||
28154673|NCT01669174|54824091|FG000|Overall Study|Lost to Follow-up|1|||
28154674|NCT01669174|54824092|FG001|Overall Study|Lost to Follow-up|0|||
28154675|NCT01669174|54824091|FG000|Overall Study|Adverse Event|2|||
28154676|NCT01669174|54824092|FG001|Overall Study|Adverse Event|2|||
28154677|NCT01669174|54824091|FG000|Overall Study|Administrative problems|1|||
28154678|NCT01669174|54824092|FG001|Overall Study|Administrative problems|2|||
28154679|NCT02798835|54824101|FG000|Overall Study|Protocol Violation|0|||
28154680|NCT02798835|54824102|FG001|Overall Study|Protocol Violation|0|||
28154681|NCT02798835|54824103|FG002|Overall Study|Protocol Violation|3|||
28154682|NCT02611882|54824114|FG000|Overall Study|Did not complete prostatectomy per protocol stipulation|33|||
28154683|NCT02611882|54824115|FG001|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
28154684|NCT02611882|54824116|FG002|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
28154685|NCT02796963|54824127|FG000|Overall Study|Lost to Follow-up|89|||
28154686|NCT02796963|54824128|FG001|Overall Study|Lost to Follow-up|76|||
28154687|NCT02796963|54824129|FG002|Overall Study|Lost to Follow-up|69|||
28154688|NCT02796963|54824130|FG003|Overall Study|Lost to Follow-up|72|||
28154689|NCT02796651|54824140|FG000|Overall Study|Adverse Event|6|||
28154690|NCT02796651|54824140|FG000|Overall Study|Lost to Follow-up|1|||
28154691|NCT02796651|54824140|FG000|Overall Study|Withdrawal by Subject|4|||
28154692|NCT02796651|54824140|FG000|Overall Study|Protocol Violation|4|||
28154693|NCT02796651|54824140|FG000|Overall Study|Lack of Efficacy|1|||
28154694|NCT02796651|54824140|FG000|Overall Study|Other|10|||
28154695|NCT02613208|54824155|FG000|Overall Study|Withdrawal by Subject|1|||
27825138|NCT01746901|54290642|FG001|Drug Discrimination Phase: Day 2|Adverse Event|2|||
27825139|NCT01746901|54290643|FG002|Drug Discrimination Phase: Day 2|Adverse Event|1|||
28154696|NCT02613208|54824155|FG000|Overall Study|Change of address|2|||
28154697|NCT02613208|54824155|FG000|Overall Study|Physician Decision|2|||
28154698|NCT02613208|54824155|FG000|Overall Study|Lost to Follow-up|5|||
28154699|NCT02613208|54824155|FG000|Overall Study|Death|37|||
28154700|NCT01668784|54824161|FG000|Randomized (Pre-treatment)|Disease Progression|0|||
28154701|NCT01668784|54824162|FG001|Randomized (Pre-treatment)|Disease Progression|1|||
28154702|NCT01668784|54824161|FG000|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0|||
28154703|NCT01668784|54824162|FG001|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3|||
28154704|NCT01668784|54824161|FG000|Randomized (Pre-treatment)|Withdrawal by Subject|1|||
28154705|NCT01668784|54824162|FG001|Randomized (Pre-treatment)|Withdrawal by Subject|8|||
28154706|NCT01668784|54824161|FG000|Randomized (Pre-treatment)|Poor/Non-Compliance|1|||
28154707|NCT01668784|54824162|FG001|Randomized (Pre-treatment)|Poor/Non-Compliance|0|||
28154708|NCT01668784|54824161|FG000|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2|||
28154709|NCT01668784|54824162|FG001|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1|||
28154710|NCT01668784|54824161|FG000|Randomized (Pre-treatment)|participant requested to be treated a local facility|0|||
28154711|NCT01668784|54824162|FG001|Randomized (Pre-treatment)|participant requested to be treated a local facility|1|||
28154712|NCT01668784|54824161|FG000|Treatment Period|Disease Progression|316|||
28154713|NCT01668784|54824162|FG001|Treatment Period|Disease Progression|293|||
28154714|NCT01668784|54824161|FG000|Treatment Period|Study Drug Toxicity|46|||
28154715|NCT01668784|54824162|FG001|Treatment Period|Study Drug Toxicity|53|||
28154716|NCT01668784|54824161|FG000|Treatment Period|Death|1|||
28154717|NCT01668784|54824162|FG001|Treatment Period|Death|1|||
28154718|NCT01668784|54824161|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
28154719|NCT01668784|54824162|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
28154720|NCT01668784|54824161|FG000|Treatment Period|Request to Discontinue Study Treatment|14|||
28154721|NCT01668784|54824162|FG001|Treatment Period|Request to Discontinue Study Treatment|21|||
28154722|NCT01668784|54824161|FG000|Treatment Period|Withdrawal by Subject|5|||
28154723|NCT01668784|54824162|FG001|Treatment Period|Withdrawal by Subject|3|||
28154724|NCT01668784|54824161|FG000|Treatment Period|Maximal Clinical Benefit|3|||
28154725|NCT01668784|54824162|FG001|Treatment Period|Maximal Clinical Benefit|3|||
28154726|NCT01668784|54824161|FG000|Treatment Period|Other|2|||
28154727|NCT01668784|54824162|FG001|Treatment Period|Other|8|||
28154728|NCT01668784|54824161|FG000|Treatment Period|Administrative Reason by Sponsor|5|||
28154729|NCT01668784|54824162|FG001|Treatment Period|Administrative Reason by Sponsor|1|||
28154730|NCT02750514|54824173|FG000|Track 1|Disease progression|20|||
28154731|NCT02750514|54824174|FG001|Track 1|Disease progression|1|||
28154732|NCT02750514|54824175|FG002|Track 1|Disease progression|0|||
28154733|NCT02750514|54824176|FG003|Track 1|Disease progression|1|||
28154734|NCT02750514|54824177|FG004|Track 1|Disease progression|0|||
28154735|NCT02750514|54824173|FG000|Track 1|Adverse event unrelated to study drug|1|||
28154736|NCT02750514|54824174|FG001|Track 1|Adverse event unrelated to study drug|0|||
28154737|NCT02750514|54824175|FG002|Track 1|Adverse event unrelated to study drug|0|||
28154738|NCT02750514|54824176|FG003|Track 1|Adverse event unrelated to study drug|0|||
27825140|NCT01746901|54290644|FG003|Drug Discrimination Phase: Day 2|Adverse Event|0|||
27942065|NCT01208051|54598806|FG002|Total Enrollment|Withdrawal by Subject|0|||
28154739|NCT02750514|54824177|FG004|Track 1|Adverse event unrelated to study drug|0|||
28154740|NCT02750514|54824173|FG000|Track 1|Study drug toxicity|4|||
28074799|NCT00132678|54729334|FG002|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0|||
28154741|NCT02750514|54824174|FG001|Track 1|Study drug toxicity|1|||
28154742|NCT02750514|54824175|FG002|Track 1|Study drug toxicity|0|||
28154743|NCT02750514|54824176|FG003|Track 1|Study drug toxicity|1|||
28074800|NCT00132678|54729332|FG000|Period IV (Double-Blind Treatment)|Lost to Follow-up|6|||
28074801|NCT00132678|54729333|FG001|Period IV (Double-Blind Treatment)|Lost to Follow-up|3|||
28074802|NCT00132678|54729334|FG002|Period IV (Double-Blind Treatment)|Lost to Follow-up|0|||
28074803|NCT00132678|54729332|FG000|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14|||
28074804|NCT00132678|54729333|FG001|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15|||
28074805|NCT00132678|54729334|FG002|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0|||
28074806|NCT00132678|54729332|FG000|Period IV (Double-Blind Treatment)|Physician Decision|10|||
28074807|NCT00132678|54729333|FG001|Period IV (Double-Blind Treatment)|Physician Decision|14|||
28154744|NCT02750514|54824177|FG004|Track 1|Study drug toxicity|0|||
28154745|NCT02750514|54824173|FG000|Track 1|Participant request to discontinue|1|||
28154746|NCT02750514|54824174|FG001|Track 1|Participant request to discontinue|0|||
28154747|NCT02750514|54824175|FG002|Track 1|Participant request to discontinue|0|||
28154748|NCT02750514|54824176|FG003|Track 1|Participant request to discontinue|0|||
28154749|NCT02750514|54824177|FG004|Track 1|Participant request to discontinue|0|||
28154750|NCT02750514|54824173|FG000|Track 1|Other reasons|1|||
28154751|NCT02750514|54824174|FG001|Track 1|Other reasons|0|||
28154752|NCT02750514|54824175|FG002|Track 1|Other reasons|0|||
28154753|NCT02750514|54824176|FG003|Track 1|Other reasons|0|||
28154754|NCT02750514|54824177|FG004|Track 1|Other reasons|0|||
28154755|NCT02750514|54824173|FG000|Track 2|Disease progression|4|||
28154756|NCT02750514|54824174|FG001|Track 2|Disease progression|5|||
28154757|NCT02750514|54824175|FG002|Track 2|Disease progression|2|||
28154758|NCT02750514|54824176|FG003|Track 2|Disease progression|5|||
28154759|NCT02750514|54824177|FG004|Track 2|Disease progression|0|||
28154760|NCT02750514|54824173|FG000|Track 2|Adverse event unrelated to study drug|1|||
28154761|NCT02750514|54824174|FG001|Track 2|Adverse event unrelated to study drug|0|||
28154762|NCT02750514|54824175|FG002|Track 2|Adverse event unrelated to study drug|0|||
28154763|NCT02750514|54824176|FG003|Track 2|Adverse event unrelated to study drug|0|||
28154764|NCT02750514|54824177|FG004|Track 2|Adverse event unrelated to study drug|0|||
27942066|NCT01208051|54598807|FG003|Total Enrollment|Withdrawal by Subject|0|||
27942067|NCT01208051|54598808|FG004|Total Enrollment|Withdrawal by Subject|2|||
27942068|NCT01208051|54598804|FG000|Total Enrollment|Brain metastases|0|||
27942069|NCT01208051|54598805|FG001|Total Enrollment|Brain metastases|0|||
27942070|NCT01208051|54598806|FG002|Total Enrollment|Brain metastases|1|||
27942071|NCT01208051|54598807|FG003|Total Enrollment|Brain metastases|0|||
27942072|NCT01208051|54598808|FG004|Total Enrollment|Brain metastases|0|||
27942073|NCT01207583|54598827|FG000|Overall Study|Withdrawal by Subject|0|||
27942074|NCT01207583|54598828|FG001|Overall Study|Withdrawal by Subject|3|||
28154765|NCT02750514|54824173|FG000|Track 2|Study drug toxicity|1|||
28154766|NCT02750514|54824174|FG001|Track 2|Study drug toxicity|2|||
28154767|NCT02750514|54824175|FG002|Track 2|Study drug toxicity|0|||
28154768|NCT02750514|54824176|FG003|Track 2|Study drug toxicity|2|||
28154769|NCT02750514|54824177|FG004|Track 2|Study drug toxicity|0|||
28154770|NCT02750514|54824173|FG000|Track 2|Participant withdrew consent|0|||
28154771|NCT02750514|54824174|FG001|Track 2|Participant withdrew consent|1|||
28154772|NCT02750514|54824175|FG002|Track 2|Participant withdrew consent|0|||
28154773|NCT02750514|54824176|FG003|Track 2|Participant withdrew consent|0|||
28154774|NCT02750514|54824177|FG004|Track 2|Participant withdrew consent|0|||
28154775|NCT02750514|54824173|FG000|Track 3|Disease progression|0|||
28154776|NCT02750514|54824174|FG001|Track 3|Disease progression|24|||
28154777|NCT02750514|54824175|FG002|Track 3|Disease progression|13|||
28154778|NCT02750514|54824176|FG003|Track 3|Disease progression|14|||
28154779|NCT02750514|54824177|FG004|Track 3|Disease progression|0|||
27942075|NCT01207583|54598829|FG002|Overall Study|Withdrawal by Subject|1|||
27942076|NCT01207583|54598827|FG000|Overall Study|Participant failed to return|1|||
27942077|NCT01207583|54598828|FG001|Overall Study|Participant failed to return|0|||
28154780|NCT02750514|54824173|FG000|Track 3|Adverse event unrelated to study drug|0|||
28154781|NCT02750514|54824174|FG001|Track 3|Adverse event unrelated to study drug|1|||
28154782|NCT02750514|54824175|FG002|Track 3|Adverse event unrelated to study drug|1|||
28154783|NCT02750514|54824176|FG003|Track 3|Adverse event unrelated to study drug|1|||
28154784|NCT02750514|54824177|FG004|Track 3|Adverse event unrelated to study drug|0|||
28154785|NCT02750514|54824173|FG000|Track 3|Study drug toxicity|0|||
28154786|NCT02750514|54824174|FG001|Track 3|Study drug toxicity|3|||
28154787|NCT02750514|54824175|FG002|Track 3|Study drug toxicity|0|||
28154788|NCT02750514|54824176|FG003|Track 3|Study drug toxicity|1|||
28154789|NCT02750514|54824177|FG004|Track 3|Study drug toxicity|0|||
28154790|NCT02750514|54824173|FG000|Track 3|Participant request to discontinue|0|||
28154791|NCT02750514|54824174|FG001|Track 3|Participant request to discontinue|2|||
28154792|NCT02750514|54824175|FG002|Track 3|Participant request to discontinue|0|||
28154793|NCT02750514|54824176|FG003|Track 3|Participant request to discontinue|0|||
28154794|NCT02750514|54824177|FG004|Track 3|Participant request to discontinue|0|||
28154795|NCT02750514|54824173|FG000|Track 3|Participant withdrew consent|0|||
28154796|NCT02750514|54824174|FG001|Track 3|Participant withdrew consent|3|||
28154797|NCT02750514|54824175|FG002|Track 3|Participant withdrew consent|1|||
28154798|NCT02750514|54824176|FG003|Track 3|Participant withdrew consent|0|||
28154799|NCT02750514|54824177|FG004|Track 3|Participant withdrew consent|0|||
28154800|NCT02750514|54824173|FG000|Track 3|Other reasons|0|||
28154801|NCT02750514|54824174|FG001|Track 3|Other reasons|3|||
28154802|NCT02750514|54824175|FG002|Track 3|Other reasons|0|||
28154803|NCT02750514|54824176|FG003|Track 3|Other reasons|0|||
28154804|NCT02750514|54824177|FG004|Track 3|Other reasons|0|||
28154805|NCT02750514|54824173|FG000|Track 4|Study drug toxicity|0|||
28154806|NCT02750514|54824174|FG001|Track 4|Study drug toxicity|6|||
28154807|NCT02750514|54824175|FG002|Track 4|Study drug toxicity|0|||
28154808|NCT02750514|54824176|FG003|Track 4|Study drug toxicity|5|||
28154809|NCT02750514|54824177|FG004|Track 4|Study drug toxicity|0|||
28154810|NCT02750514|54824173|FG000|Track 4|Participant request to discontinue|0|||
28154811|NCT02750514|54824174|FG001|Track 4|Participant request to discontinue|1|||
28154812|NCT02750514|54824175|FG002|Track 4|Participant request to discontinue|0|||
28154813|NCT02750514|54824176|FG003|Track 4|Participant request to discontinue|1|||
28154814|NCT02750514|54824177|FG004|Track 4|Participant request to discontinue|0|||
28154815|NCT02750514|54824173|FG000|Track 4|Participant withdrew consent|0|||
28154816|NCT02750514|54824174|FG001|Track 4|Participant withdrew consent|1|||
28154817|NCT02750514|54824175|FG002|Track 4|Participant withdrew consent|0|||
28154818|NCT02750514|54824176|FG003|Track 4|Participant withdrew consent|0|||
28154819|NCT02750514|54824177|FG004|Track 4|Participant withdrew consent|0|||
28154820|NCT02750514|54824173|FG000|Track 4|Other reasons|0|||
28154821|NCT02750514|54824174|FG001|Track 4|Other reasons|5|||
28154822|NCT02750514|54824175|FG002|Track 4|Other reasons|0|||
28154823|NCT02750514|54824176|FG003|Track 4|Other reasons|3|||
28154824|NCT02750514|54824177|FG004|Track 4|Other reasons|0|||
28154825|NCT02750514|54824173|FG000|Track 4|Disease progression|0|||
28154826|NCT02750514|54824174|FG001|Track 4|Disease progression|33|||
28154827|NCT02750514|54824175|FG002|Track 4|Disease progression|0|||
28154828|NCT02750514|54824176|FG003|Track 4|Disease progression|32|||
28154829|NCT02750514|54824177|FG004|Track 4|Disease progression|0|||
28154830|NCT02750514|54824173|FG000|Track 4|Adverse event unrelated to study drug|0|||
28154831|NCT02750514|54824174|FG001|Track 4|Adverse event unrelated to study drug|5|||
28154832|NCT02750514|54824175|FG002|Track 4|Adverse event unrelated to study drug|0|||
28154833|NCT02750514|54824176|FG003|Track 4|Adverse event unrelated to study drug|0|||
28154834|NCT02750514|54824177|FG004|Track 4|Adverse event unrelated to study drug|0|||
28154835|NCT02750514|54824173|FG000|Track 4|Death|0|||
28154836|NCT02750514|54824174|FG001|Track 4|Death|0|||
28154837|NCT02750514|54824175|FG002|Track 4|Death|0|||
28154838|NCT02750514|54824176|FG003|Track 4|Death|1|||
28154839|NCT02750514|54824177|FG004|Track 4|Death|0|||
28154840|NCT02750514|54824173|FG000|Track 5|Disease progression|0|||
28154841|NCT02750514|54824174|FG001|Track 5|Disease progression|0|||
28154842|NCT02750514|54824175|FG002|Track 5|Disease progression|0|||
28154843|NCT02750514|54824176|FG003|Track 5|Disease progression|0|||
28154844|NCT02750514|54824177|FG004|Track 5|Disease progression|34|||
28154845|NCT02750514|54824173|FG000|Track 5|Adverse event unrelated to study drug|0|||
28154846|NCT02750514|54824174|FG001|Track 5|Adverse event unrelated to study drug|0|||
28154847|NCT02750514|54824175|FG002|Track 5|Adverse event unrelated to study drug|0|||
28154848|NCT02750514|54824176|FG003|Track 5|Adverse event unrelated to study drug|0|||
28154849|NCT02750514|54824177|FG004|Track 5|Adverse event unrelated to study drug|2|||
28154850|NCT02750514|54824173|FG000|Track 5|Study drug toxicity|0|||
28154851|NCT02750514|54824174|FG001|Track 5|Study drug toxicity|0|||
28154852|NCT02750514|54824175|FG002|Track 5|Study drug toxicity|0|||
28154853|NCT02750514|54824176|FG003|Track 5|Study drug toxicity|0|||
28154854|NCT02750514|54824177|FG004|Track 5|Study drug toxicity|2|||
28154855|NCT02750514|54824173|FG000|Track 5|Participant request to discontinue|0|||
28154856|NCT02750514|54824174|FG001|Track 5|Participant request to discontinue|0|||
28154857|NCT02750514|54824175|FG002|Track 5|Participant request to discontinue|0|||
28154858|NCT02750514|54824176|FG003|Track 5|Participant request to discontinue|0|||
28154859|NCT02750514|54824177|FG004|Track 5|Participant request to discontinue|3|||
28154860|NCT02750514|54824173|FG000|Track 5|Other reasons|0|||
28154861|NCT02750514|54824174|FG001|Track 5|Other reasons|0|||
28154862|NCT02750514|54824175|FG002|Track 5|Other reasons|0|||
28154863|NCT02750514|54824176|FG003|Track 5|Other reasons|0|||
28154864|NCT02750514|54824177|FG004|Track 5|Other reasons|2|||
28154865|NCT02612428|54824199|FG000|VTL-308|Death|14|||
28154866|NCT02612428|54824200|FG001|VTL-308|Death|16|||
28154867|NCT02612428|54824199|FG000|VTL-308|Withdrawal by Subject|0|||
28154868|NCT02612428|54824200|FG001|VTL-308|Withdrawal by Subject|1|||
28154869|NCT02612428|54824199|FG000|VTL-308E|Death|9|||
28154870|NCT02612428|54824200|FG001|VTL-308E|Death|7|||
28154871|NCT02612428|54824199|FG000|VTL-308E|Lost to Follow-up|2|||
28154872|NCT02612428|54824200|FG001|VTL-308E|Lost to Follow-up|0|||
28154873|NCT03679884|54824211|FG000|Overall Study|Other|12|||
28154874|NCT03679884|54824212|FG001|Overall Study|Other|12|||
28154875|NCT03679884|54824213|FG002|Overall Study|Other|12|||
28154876|NCT03679884|54824214|FG003|Overall Study|Other|7|||
28154877|NCT03679884|54824215|FG004|Overall Study|Other|8|||
28154878|NCT03679884|54824211|FG000|Overall Study|Lack of Efficacy|15|||
28154879|NCT03679884|54824212|FG001|Overall Study|Lack of Efficacy|29|||
28154880|NCT03679884|54824213|FG002|Overall Study|Lack of Efficacy|13|||
28154881|NCT03679884|54824214|FG003|Overall Study|Lack of Efficacy|29|||
28154882|NCT03679884|54824215|FG004|Overall Study|Lack of Efficacy|10|||
28154883|NCT03679884|54824211|FG000|Overall Study|Death|1|||
28154884|NCT03679884|54824212|FG001|Overall Study|Death|0|||
28154885|NCT03679884|54824213|FG002|Overall Study|Death|0|||
28154886|NCT03679884|54824214|FG003|Overall Study|Death|0|||
28154887|NCT03679884|54824215|FG004|Overall Study|Death|0|||
28074808|NCT00132678|54729334|FG002|Period IV (Double-Blind Treatment)|Physician Decision|0|||
28074809|NCT00132678|54729332|FG000|Period IV (Double-Blind Treatment)|Subject Non-compliant|2|||
28074810|NCT00132678|54729333|FG001|Period IV (Double-Blind Treatment)|Subject Non-compliant|1|||
28074811|NCT00132678|54729334|FG002|Period IV (Double-Blind Treatment)|Subject Non-compliant|0|||
28074812|NCT00132678|54729332|FG000|Period IV (Double-Blind Treatment)|Pregnancy|0|||
28074813|NCT00132678|54729333|FG001|Period IV (Double-Blind Treatment)|Pregnancy|2|||
28074814|NCT00132678|54729334|FG002|Period IV (Double-Blind Treatment)|Pregnancy|0|||
28074815|NCT00101868|54729344|FG000|Overall Study|Death|10|||
28074816|NCT00101868|54729345|FG001|Overall Study|Death|10|||
28074817|NCT00101868|54729344|FG000|Overall Study|Withdrawal by Subject|8|||
28074818|NCT00101868|54729345|FG001|Overall Study|Withdrawal by Subject|9|||
28074819|NCT00101868|54729344|FG000|Overall Study|Protocol Violation|3|||
28074820|NCT00101868|54729345|FG001|Overall Study|Protocol Violation|0|||
28074821|NCT00101868|54729344|FG000|Overall Study|Lost to Follow-up|8|||
28074822|NCT00101868|54729345|FG001|Overall Study|Lost to Follow-up|13|||
28074823|NCT00101400|54729353|FG000|Survival Follow-Up|Alive|7|||
28074824|NCT03821064|54729357|FG000|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1|||
28074825|NCT00141518|54729364|FG000|Overall Study|Withdrew Consent Prior to Treatment|1|||
28074826|NCT00141518|54729365|FG001|Overall Study|Withdrew Consent Prior to Treatment|0|||
28074827|NCT00141518|54729366|FG002|Overall Study|Withdrew Consent Prior to Treatment|0|||
28074828|NCT00141518|54729364|FG000|Overall Study|Adverse Event|7|||
28074829|NCT00141518|54729365|FG001|Overall Study|Adverse Event|5|||
28074830|NCT00141518|54729366|FG002|Overall Study|Adverse Event|2|||
28074831|NCT00141518|54729364|FG000|Overall Study|Withdrawal by Subject|2|||
28074832|NCT00141518|54729365|FG001|Overall Study|Withdrawal by Subject|0|||
28074833|NCT00141518|54729366|FG002|Overall Study|Withdrawal by Subject|2|||
28074834|NCT00141518|54729364|FG000|Overall Study|Protocol Violation|1|||
28154888|NCT03679884|54824211|FG000|Overall Study|Adverse Event|2|||
28154889|NCT03679884|54824212|FG001|Overall Study|Adverse Event|10|||
28154890|NCT03679884|54824213|FG002|Overall Study|Adverse Event|9|||
28154891|NCT03679884|54824214|FG003|Overall Study|Adverse Event|6|||
28154892|NCT03679884|54824215|FG004|Overall Study|Adverse Event|6|||
28154893|NCT03679884|54824211|FG000|Overall Study|Withdrawal by Subject|12|||
28154894|NCT03679884|54824212|FG001|Overall Study|Withdrawal by Subject|23|||
28154895|NCT03679884|54824213|FG002|Overall Study|Withdrawal by Subject|8|||
28154896|NCT03679884|54824214|FG003|Overall Study|Withdrawal by Subject|8|||
28154897|NCT03679884|54824215|FG004|Overall Study|Withdrawal by Subject|9|||
28154898|NCT03679884|54824211|FG000|Overall Study|Lost to Follow-up|1|||
28154899|NCT03679884|54824212|FG001|Overall Study|Lost to Follow-up|4|||
28154900|NCT03679884|54824213|FG002|Overall Study|Lost to Follow-up|2|||
28154901|NCT03679884|54824214|FG003|Overall Study|Lost to Follow-up|0|||
28154902|NCT03679884|54824215|FG004|Overall Study|Lost to Follow-up|3|||
28154903|NCT01329978|54824230|FG000|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1|||
28154904|NCT01329978|54824231|FG001|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2|||
28154905|NCT01329978|54824232|FG002|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
28154906|NCT01329978|54824233|FG003|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
28154907|NCT01329978|54824234|FG004|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
28154908|NCT01329978|54824230|FG000|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
28154909|NCT01329978|54824231|FG001|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8|||
28154910|NCT01329978|54824232|FG002|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
28154911|NCT01329978|54824233|FG003|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
28154912|NCT01329978|54824234|FG004|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
28154913|NCT01329978|54824230|FG000|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
28154914|NCT01329978|54824231|FG001|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
28154915|NCT01329978|54824232|FG002|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3|||
28154916|NCT01329978|54824233|FG003|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
28154917|NCT01329978|54824234|FG004|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
28154918|NCT01329978|54824230|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
28154919|NCT01329978|54824231|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1|||
28154920|NCT01329978|54824232|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
28154921|NCT01329978|54824233|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
28154922|NCT01329978|54824234|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
28154923|NCT01329978|54824230|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
28154924|NCT01329978|54824231|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1|||
28154925|NCT01329978|54824232|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
28154926|NCT01329978|54824233|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
28154927|NCT01329978|54824234|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
28154928|NCT01329978|54824230|FG000|Rerandomization Treatment Period|Lost to Follow-up|0|||
28154929|NCT01329978|54824231|FG001|Rerandomization Treatment Period|Lost to Follow-up|0|||
28154930|NCT01329978|54824232|FG002|Rerandomization Treatment Period|Lost to Follow-up|0|||
28154931|NCT01329978|54824233|FG003|Rerandomization Treatment Period|Lost to Follow-up|5|||
28154932|NCT01329978|54824234|FG004|Rerandomization Treatment Period|Lost to Follow-up|3|||
28154933|NCT01329978|54824230|FG000|Rerandomization Treatment Period|Withdrawal by Subject|0|||
28154934|NCT01329978|54824231|FG001|Rerandomization Treatment Period|Withdrawal by Subject|0|||
28154935|NCT01329978|54824232|FG002|Rerandomization Treatment Period|Withdrawal by Subject|0|||
28154936|NCT01329978|54824233|FG003|Rerandomization Treatment Period|Withdrawal by Subject|0|||
28154937|NCT01329978|54824234|FG004|Rerandomization Treatment Period|Withdrawal by Subject|1|||
28154938|NCT01338012|54824246|FG000|Overall Study|Death|4|||
28154939|NCT01338012|54824246|FG000|Overall Study|Study terminated|4|||
28154940|NCT04905498|54824252|FG000|Overall Study|Lost to Follow-up|0|||
28154941|NCT04905498|54824253|FG001|Overall Study|Lost to Follow-up|2|||
28154942|NCT04905498|54824252|FG000|Overall Study|COVID lockdown|1|||
28154943|NCT04905498|54824253|FG001|Overall Study|COVID lockdown|0|||
28154944|NCT02607280|54824261|FG000|Overall Study|Adverse Event|4|||
28154945|NCT02607280|54824262|FG001|Overall Study|Adverse Event|0|||
28154946|NCT02607280|54824261|FG000|Overall Study|Decrease in CrCl <15|0|||
28154947|NCT02607280|54824262|FG001|Overall Study|Decrease in CrCl <15|1|||
28154948|NCT02202434|54824272|FG000|Overall Study|Death|70|||
28154949|NCT02202434|54824273|FG001|Overall Study|Death|39|||
28154950|NCT02202434|54824274|FG002|Overall Study|Death|13|||
28154951|NCT02202434|54824275|FG003|Overall Study|Death|27|||
28154952|NCT02202434|54824272|FG000|Overall Study|Lost to Follow-up|1|||
28154953|NCT02202434|54824273|FG001|Overall Study|Lost to Follow-up|1|||
28154954|NCT02202434|54824274|FG002|Overall Study|Lost to Follow-up|1|||
28154955|NCT02202434|54824275|FG003|Overall Study|Lost to Follow-up|0|||
28154956|NCT02202434|54824272|FG000|Overall Study|Physician Decision|2|||
28154957|NCT02202434|54824273|FG001|Overall Study|Physician Decision|3|||
28154958|NCT02202434|54824274|FG002|Overall Study|Physician Decision|0|||
28154959|NCT02202434|54824275|FG003|Overall Study|Physician Decision|0|||
28154960|NCT02202434|54824272|FG000|Overall Study|Withdrawal by Subject|13|||
28154961|NCT02202434|54824273|FG001|Overall Study|Withdrawal by Subject|14|||
28154962|NCT02202434|54824274|FG002|Overall Study|Withdrawal by Subject|1|||
28154963|NCT02202434|54824275|FG003|Overall Study|Withdrawal by Subject|4|||
28154964|NCT02202434|54824272|FG000|Overall Study|Completed Study|1|||
28154965|NCT02202434|54824273|FG001|Overall Study|Completed Study|0|||
28154966|NCT02202434|54824274|FG002|Overall Study|Completed Study|0|||
28154967|NCT02202434|54824275|FG003|Overall Study|Completed Study|0|||
28154968|NCT02202434|54824272|FG000|Overall Study|Visit Missed|21|||
28154969|NCT02202434|54824273|FG001|Overall Study|Visit Missed|12|||
28154970|NCT02202434|54824274|FG002|Overall Study|Visit Missed|0|||
28154971|NCT02202434|54824275|FG003|Overall Study|Visit Missed|5|||
28154972|NCT02202434|54824272|FG000|Overall Study|Other|1|||
28154973|NCT02202434|54824273|FG001|Overall Study|Other|0|||
28154974|NCT02202434|54824274|FG002|Overall Study|Other|0|||
28154975|NCT02202434|54824275|FG003|Overall Study|Other|1|||
28154976|NCT02784288|54824285|FG000|Overall Study|Patients neck dissection had spillage and therefore needed to come off protocol|1|||
28154977|NCT01230242|54824290|FG000|Overall Study|Physician Decision|2|||
28154978|NCT01230242|54824290|FG000|Overall Study|Withdrawal by Subject|1|||
28154979|NCT02608450|54824296|FG000|Overall Study|Lost to Follow-up|39|||
28154980|NCT02608450|54824297|FG001|Overall Study|Lost to Follow-up|32|||
28154981|NCT02608450|54824296|FG000|Overall Study|Withdrawal by Subject|21|||
28154982|NCT02608450|54824297|FG001|Overall Study|Withdrawal by Subject|15|||
28154983|NCT02608450|54824296|FG000|Overall Study|Adverse Event|3|||
28154984|NCT02608450|54824297|FG001|Overall Study|Adverse Event|6|||
28154985|NCT02608450|54824296|FG000|Overall Study|Withdrawal by parent|2|||
28154986|NCT02608450|54824297|FG001|Overall Study|Withdrawal by parent|3|||
28154987|NCT02608450|54824296|FG000|Overall Study|Lack of Efficacy|0|||
28154988|NCT02608450|54824297|FG001|Overall Study|Lack of Efficacy|3|||
28154989|NCT02608450|54824296|FG000|Overall Study|Noncompliance with study drug|0|||
28154990|NCT02608450|54824297|FG001|Overall Study|Noncompliance with study drug|2|||
28154991|NCT02608450|54824296|FG000|Overall Study|Physician Decision|0|||
28154992|NCT02608450|54824297|FG001|Overall Study|Physician Decision|1|||
28154993|NCT02608450|54824296|FG000|Overall Study|Pregnancy|0|||
28154994|NCT02608450|54824297|FG001|Overall Study|Pregnancy|1|||
28154995|NCT02608450|54824296|FG000|Overall Study|Progressive disease|1|||
28154996|NCT02608450|54824297|FG001|Overall Study|Progressive disease|0|||
28154997|NCT02608450|54824296|FG000|Overall Study|Multiple reasons|0|||
28154998|NCT02608450|54824297|FG001|Overall Study|Multiple reasons|2|||
28154999|NCT01668004|54824303|FG000|Overall Study|Adverse Event|7|||
28155000|NCT01668004|54824303|FG000|Overall Study|Withdrawal by Subject|2|||
28155001|NCT01668004|54824303|FG000|Overall Study|Lost to Follow-up|5|||
28155002|NCT01668004|54824303|FG000|Overall Study|Lack of Efficacy|9|||
28155003|NCT01668004|54824303|FG000|Overall Study|Non-compliance with treatment|2|||
28155004|NCT01667926|54824311|FG000|Overall Study|Withdrawal by Subject|1|||
28155005|NCT01667926|54824312|FG001|Overall Study|Withdrawal by Subject|2|||
28155006|NCT01667926|54824313|FG002|Overall Study|Withdrawal by Subject|2|||
28155007|NCT01667926|54824311|FG000|Overall Study|Physician Decision|0|||
28155008|NCT01667926|54824312|FG001|Overall Study|Physician Decision|0|||
28155009|NCT01667926|54824313|FG002|Overall Study|Physician Decision|1|||
28155010|NCT01667926|54824311|FG000|Overall Study|Time committment|0|||
28155011|NCT01667926|54824312|FG001|Overall Study|Time committment|0|||
28155012|NCT01667926|54824313|FG002|Overall Study|Time committment|2|||
28155013|NCT01667926|54824311|FG000|Overall Study|Inclusion/Exclusion Criteria|0|||
28155014|NCT01667926|54824312|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
28155015|NCT01667926|54824313|FG002|Overall Study|Inclusion/Exclusion Criteria|5|||
28155016|NCT01667926|54824311|FG000|Overall Study|Lost to Follow-up|1|||
28155017|NCT01667926|54824312|FG001|Overall Study|Lost to Follow-up|2|||
28155018|NCT01667926|54824313|FG002|Overall Study|Lost to Follow-up|1|||
28155019|NCT01667926|54824311|FG000|Overall Study|Side effects|3|||
28155020|NCT01667926|54824312|FG001|Overall Study|Side effects|0|||
28155021|NCT01667926|54824313|FG002|Overall Study|Side effects|0|||
28155022|NCT02604160|54824321|FG000|Overall Study|Protocol Violation|0|||
28155023|NCT02604160|54824322|FG001|Overall Study|Protocol Violation|1|||
28155024|NCT02604160|54824321|FG000|Overall Study|Physician Decision|0|||
28155025|NCT02604160|54824322|FG001|Overall Study|Physician Decision|1|||
28155026|NCT01359904|54824332|FG000|Overall Study|Withdrawal by Subject|1|||
28155027|NCT01359904|54824333|FG001|Overall Study|Withdrawal by Subject|0|||
28155028|NCT00157248|54824362|FG000|Overall Study|Adverse Event|36|||
28155029|NCT00157248|54824363|FG001|Overall Study|Adverse Event|25|||
28155030|NCT00157248|54824364|FG002|Overall Study|Adverse Event|13|||
28155031|NCT00157248|54824365|FG003|Overall Study|Adverse Event|33|||
28155032|NCT00157248|54824362|FG000|Overall Study|Protocol Violation|4|||
28155033|NCT00157248|54824363|FG001|Overall Study|Protocol Violation|0|||
28155034|NCT00157248|54824364|FG002|Overall Study|Protocol Violation|2|||
28155035|NCT00157248|54824365|FG003|Overall Study|Protocol Violation|2|||
28155036|NCT00157248|54824362|FG000|Overall Study|Lost to Follow-up|0|||
28155037|NCT00157248|54824363|FG001|Overall Study|Lost to Follow-up|1|||
28155038|NCT00157248|54824364|FG002|Overall Study|Lost to Follow-up|0|||
28155039|NCT00157248|54824365|FG003|Overall Study|Lost to Follow-up|0|||
28155040|NCT00157248|54824362|FG000|Overall Study|Withdrawal by Subject|1|||
28155041|NCT00157248|54824363|FG001|Overall Study|Withdrawal by Subject|4|||
28155042|NCT00157248|54824364|FG002|Overall Study|Withdrawal by Subject|3|||
28155043|NCT00157248|54824365|FG003|Overall Study|Withdrawal by Subject|3|||
28155044|NCT00157248|54824362|FG000|Overall Study|site closures, subject moving|7|||
28155045|NCT00157248|54824363|FG001|Overall Study|site closures, subject moving|7|||
28155046|NCT00157248|54824364|FG002|Overall Study|site closures, subject moving|3|||
28155047|NCT00157248|54824365|FG003|Overall Study|site closures, subject moving|9|||
28155048|NCT01328756|54824379|FG000|Overall Study|Protocol Violation|4|||
28155049|NCT01328756|54824379|FG000|Overall Study|Adverse Event|39|||
28155050|NCT01328756|54824379|FG000|Overall Study|Lack of Efficacy|5|||
28155051|NCT01328756|54824379|FG000|Overall Study|Withdrawal by Subject|41|||
28155052|NCT01328756|54824379|FG000|Overall Study|Lost to Follow-up|5|||
28155053|NCT01328756|54824379|FG000|Overall Study|Other|29|||
28155054|NCT03922308|54824386|FG000|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
28155055|NCT03922308|54824387|FG001|Overall Study|Not Meeting Confirmatory Inclusion Criteria|1|||
28155056|NCT03922308|54824388|FG002|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
28155057|NCT03922308|54824386|FG000|Overall Study|Lost to Follow-up|1|||
28155058|NCT03922308|54824387|FG001|Overall Study|Lost to Follow-up|0|||
28155059|NCT03922308|54824388|FG002|Overall Study|Lost to Follow-up|0|||
28155060|NCT03922308|54824386|FG000|Overall Study|Reason not Specified|0|||
28155061|NCT03922308|54824387|FG001|Overall Study|Reason not Specified|2|||
28155062|NCT03922308|54824388|FG002|Overall Study|Reason not Specified|1|||
28155063|NCT02607930|54824401|FG000|Double-Blinded Treatment Phase|Lost to Follow-up|25|||
28155064|NCT02607930|54824402|FG001|Double-Blinded Treatment Phase|Lost to Follow-up|19|||
28155065|NCT02607930|54824403|FG002|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
28155066|NCT02607930|54824404|FG003|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
28155067|NCT02607930|54824401|FG000|Double-Blinded Treatment Phase|Withdrew consent|14|||
28155068|NCT02607930|54824402|FG001|Double-Blinded Treatment Phase|Withdrew consent|18|||
28155069|NCT02607930|54824403|FG002|Double-Blinded Treatment Phase|Withdrew consent|0|||
28155070|NCT02607930|54824404|FG003|Double-Blinded Treatment Phase|Withdrew consent|0|||
28155071|NCT02607930|54824401|FG000|Double-Blinded Treatment Phase|Investigator's discretion|6|||
28155072|NCT02607930|54824402|FG001|Double-Blinded Treatment Phase|Investigator's discretion|3|||
28155073|NCT02607930|54824403|FG002|Double-Blinded Treatment Phase|Investigator's discretion|0|||
28155074|NCT02607930|54824404|FG003|Double-Blinded Treatment Phase|Investigator's discretion|0|||
28155075|NCT02607930|54824401|FG000|Double-Blinded Treatment Phase|Non-compliance with study drug|3|||
28155076|NCT02607930|54824402|FG001|Double-Blinded Treatment Phase|Non-compliance with study drug|5|||
28155077|NCT02607930|54824403|FG002|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
28155078|NCT02607930|54824404|FG003|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
28155079|NCT02607930|54824401|FG000|Double-Blinded Treatment Phase|Protocol Violation|2|||
28155080|NCT02607930|54824402|FG001|Double-Blinded Treatment Phase|Protocol Violation|3|||
28155081|NCT02607930|54824403|FG002|Double-Blinded Treatment Phase|Protocol Violation|0|||
28155082|NCT02607930|54824404|FG003|Double-Blinded Treatment Phase|Protocol Violation|0|||
28155083|NCT02607930|54824401|FG000|Double-Blinded Treatment Phase|Adverse Event|0|||
28155084|NCT02607930|54824402|FG001|Double-Blinded Treatment Phase|Adverse Event|4|||
28155085|NCT02607930|54824403|FG002|Double-Blinded Treatment Phase|Adverse Event|0|||
28155086|NCT02607930|54824404|FG003|Double-Blinded Treatment Phase|Adverse Event|0|||
28155087|NCT02607930|54824401|FG000|Double-Blinded Treatment Phase|Death|2|||
28155088|NCT02607930|54824402|FG001|Double-Blinded Treatment Phase|Death|1|||
28155089|NCT02607930|54824403|FG002|Double-Blinded Treatment Phase|Death|0|||
28155090|NCT02607930|54824404|FG003|Double-Blinded Treatment Phase|Death|0|||
28155091|NCT02607930|54824401|FG000|Double-Blinded Treatment Phase|Randomized but never treated|2|||
28155092|NCT02607930|54824402|FG001|Double-Blinded Treatment Phase|Randomized but never treated|0|||
28155093|NCT02607930|54824403|FG002|Double-Blinded Treatment Phase|Randomized but never treated|0|||
28155094|NCT02607930|54824404|FG003|Double-Blinded Treatment Phase|Randomized but never treated|0|||
28155095|NCT02607930|54824401|FG000|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
28155096|NCT02607930|54824402|FG001|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
28155097|NCT02607930|54824403|FG002|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|15|||
28155098|NCT02607930|54824404|FG003|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|10|||
28155099|NCT02607930|54824401|FG000|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
28155100|NCT02607930|54824402|FG001|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
28155101|NCT02607930|54824403|FG002|Open-Label B/F/TAF Extension Phase|Withdrew consent|10|||
28155102|NCT02607930|54824404|FG003|Open-Label B/F/TAF Extension Phase|Withdrew consent|13|||
28155103|NCT02607930|54824401|FG000|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
28155104|NCT02607930|54824402|FG001|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
28155105|NCT02607930|54824403|FG002|Open-Label B/F/TAF Extension Phase|Investigator's discretion|2|||
28155106|NCT02607930|54824404|FG003|Open-Label B/F/TAF Extension Phase|Investigator's discretion|5|||
28155107|NCT02607930|54824401|FG000|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
28155108|NCT02607930|54824402|FG001|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
28155109|NCT02607930|54824403|FG002|Open-Label B/F/TAF Extension Phase|Adverse Event|4|||
28155110|NCT02607930|54824404|FG003|Open-Label B/F/TAF Extension Phase|Adverse Event|2|||
28155111|NCT02607930|54824401|FG000|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
28155112|NCT02607930|54824402|FG001|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
28155113|NCT02607930|54824403|FG002|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
28155114|NCT02607930|54824404|FG003|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
28155115|NCT02607930|54824401|FG000|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
28155116|NCT02607930|54824402|FG001|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
28155117|NCT02607930|54824403|FG002|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
28155118|NCT02607930|54824404|FG003|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
28155119|NCT02607930|54824401|FG000|Open-Label B/F/TAF Extension Phase|Death|0|||
28155120|NCT02607930|54824402|FG001|Open-Label B/F/TAF Extension Phase|Death|0|||
28155121|NCT02607930|54824403|FG002|Open-Label B/F/TAF Extension Phase|Death|0|||
28155122|NCT02607930|54824404|FG003|Open-Label B/F/TAF Extension Phase|Death|1|||
28155123|NCT02607930|54824401|FG000|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
28155124|NCT02607930|54824402|FG001|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
28155125|NCT02607930|54824403|FG002|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|1|||
28155126|NCT02607930|54824404|FG003|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
28155127|NCT02101034|54824423|FG000|Overall Study|Enrolled but did not start treatment|0|||
28155128|NCT02101034|54824424|FG001|Overall Study|Enrolled but did not start treatment|0|||
28155129|NCT02101034|54824425|FG002|Overall Study|Enrolled but did not start treatment|1|||
28155130|NCT02101034|54824426|FG003|Overall Study|Enrolled but did not start treatment|0|||
28155131|NCT02101034|54824427|FG004|Overall Study|Enrolled but did not start treatment|0|||
28155132|NCT02736188|54824462|FG000|Overall Study|Discontinuation of Study by Sponsor|134|||
28155133|NCT02736188|54824462|FG000|Overall Study|Adverse Event|1|||
28155134|NCT02736188|54824462|FG000|Overall Study|Withdrawal by Subject|1|||
28155135|NCT02736188|54824462|FG000|Overall Study|Other|6|||
28155136|NCT00154284|54824470|FG000|Overall Study|Adverse Event|6|||
28155137|NCT00154284|54824471|FG001|Overall Study|Adverse Event|9|||
28155138|NCT00154284|54824470|FG000|Overall Study|Abnormal laboratory value(s)|0|||
28155139|NCT00154284|54824471|FG001|Overall Study|Abnormal laboratory value(s)|1|||
28155140|NCT00154284|54824470|FG000|Overall Study|Lack of Efficacy|1|||
28155141|NCT00154284|54824471|FG001|Overall Study|Lack of Efficacy|2|||
28155142|NCT00154284|54824470|FG000|Overall Study|Protocol Violation|0|||
28155143|NCT00154284|54824471|FG001|Overall Study|Protocol Violation|1|||
28155144|NCT02735096|54824479|FG000|Overall Study|No symptoms in clinic/personal leave|1|||
28155145|NCT00905346|54824492|FG000|Period 1|Withdrawal by Subject|1|||
28155146|NCT00905346|54824493|FG001|Period 1|Withdrawal by Subject|0|||
28155147|NCT01328444|54824506|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
28155148|NCT01328444|54824507|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
28155149|NCT01328444|54824508|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
28155150|NCT01328444|54824509|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
28155151|NCT01328444|54824510|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|5|||
28155152|NCT01328444|54824511|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
28155153|NCT01328444|54824506|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
28155154|NCT01328444|54824507|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
28155155|NCT01328444|54824508|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
28155156|NCT01328444|54824509|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
28155157|NCT01328444|54824510|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
28155158|NCT01328444|54824511|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
28155159|NCT01328444|54824506|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
28155160|NCT01328444|54824507|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
28155161|NCT01328444|54824508|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
28155162|NCT01328444|54824509|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
28155163|NCT01328444|54824510|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
28155164|NCT01328444|54824511|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
28155165|NCT01328444|54824506|FG000|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
28155166|NCT01328444|54824507|FG001|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1|||
28155167|NCT01328444|54824508|FG002|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
28155168|NCT01328444|54824509|FG003|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
28155169|NCT01328444|54824510|FG004|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2|||
28155170|NCT01328444|54824511|FG005|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
27825141|NCT01746901|54290645|FG004|Drug Discrimination Phase: Day 2|Adverse Event|0|||
27825142|NCT01746901|54290646|FG005|Drug Discrimination Phase: Day 2|Adverse Event|0|||
27825143|NCT01746901|54290647|FG006|Drug Discrimination Phase: Day 2|Adverse Event|0|||
27825144|NCT01746901|54290648|FG007|Drug Discrimination Phase: Day 2|Adverse Event|0|||
27942078|NCT01207583|54598829|FG002|Overall Study|Participant failed to return|0|||
28074835|NCT00141518|54729365|FG001|Overall Study|Protocol Violation|1|||
28074836|NCT00141518|54729366|FG002|Overall Study|Protocol Violation|2|||
28074837|NCT00141518|54729364|FG000|Overall Study|Lack of Efficacy|5|||
28074838|NCT00141518|54729365|FG001|Overall Study|Lack of Efficacy|0|||
28074839|NCT00141518|54729366|FG002|Overall Study|Lack of Efficacy|0|||
28074840|NCT00253448|54729376|FG000|Overall Study|Withdrawal by Subject|1|||
28074841|NCT00098748|54729383|FG000|Assigned to Study Treatment|Randomized, but not treated|0|||
28074842|NCT00098748|54729384|FG001|Assigned to Study Treatment|Randomized, but not treated|2|||
28074843|NCT00098748|54729385|FG002|Assigned to Study Treatment|Randomized, but not treated|2|||
28074844|NCT00098748|54729383|FG000|Received Study Treatment|Death|2|||
28074845|NCT00098748|54729384|FG001|Received Study Treatment|Death|1|||
28074846|NCT00098748|54729385|FG002|Received Study Treatment|Death|2|||
28155171|NCT01328444|54824506|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2|||
28155172|NCT01328444|54824507|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
28155173|NCT01328444|54824508|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
28155174|NCT01328444|54824509|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
28155175|NCT01328444|54824510|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
28155176|NCT01328444|54824511|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
28155177|NCT01328444|54824506|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
28155178|NCT01328444|54824507|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
28155179|NCT01328444|54824508|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
28155180|NCT01328444|54824509|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
28155181|NCT01328444|54824510|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
28155182|NCT01328444|54824511|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
28155183|NCT01328444|54824506|FG000|Washout Period (14 Days)|Adverse Event|1|||
28155184|NCT01328444|54824507|FG001|Washout Period (14 Days)|Adverse Event|1|||
28155185|NCT01328444|54824508|FG002|Washout Period (14 Days)|Adverse Event|0|||
28155186|NCT01328444|54824509|FG003|Washout Period (14 Days)|Adverse Event|1|||
28155187|NCT01328444|54824510|FG004|Washout Period (14 Days)|Adverse Event|1|||
28155188|NCT01328444|54824511|FG005|Washout Period (14 Days)|Adverse Event|2|||
28155189|NCT01328444|54824506|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
28155190|NCT01328444|54824507|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
28155191|NCT01328444|54824508|FG002|Washout Period (14 Days)|Lack of Efficacy|0|||
28155192|NCT01328444|54824509|FG003|Washout Period (14 Days)|Lack of Efficacy|0|||
28155193|NCT01328444|54824510|FG004|Washout Period (14 Days)|Lack of Efficacy|0|||
28155194|NCT01328444|54824511|FG005|Washout Period (14 Days)|Lack of Efficacy|1|||
28155195|NCT01328444|54824506|FG000|Washout Period (14 Days)|Withdrawal by Subject|0|||
28155196|NCT01328444|54824507|FG001|Washout Period (14 Days)|Withdrawal by Subject|0|||
28155197|NCT01328444|54824508|FG002|Washout Period (14 Days)|Withdrawal by Subject|0|||
28155198|NCT01328444|54824509|FG003|Washout Period (14 Days)|Withdrawal by Subject|0|||
28155199|NCT01328444|54824510|FG004|Washout Period (14 Days)|Withdrawal by Subject|0|||
28155200|NCT01328444|54824511|FG005|Washout Period (14 Days)|Withdrawal by Subject|1|||
28155201|NCT01328444|54824506|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|5|||
28155202|NCT01328444|54824507|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
28155203|NCT01328444|54824508|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
28155204|NCT01328444|54824509|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
28155205|NCT01328444|54824510|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
28155206|NCT01328444|54824511|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
28155207|NCT01328444|54824506|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5|||
28155208|NCT01328444|54824507|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
28155209|NCT01328444|54824508|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
28155210|NCT01328444|54824509|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
28155211|NCT01328444|54824510|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
28155212|NCT01328444|54824511|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4|||
28155213|NCT01328444|54824506|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
28155214|NCT01328444|54824507|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
28155215|NCT01328444|54824508|FG002|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
28155216|NCT01328444|54824509|FG003|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
28155217|NCT01328444|54824510|FG004|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
28155218|NCT01328444|54824511|FG005|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
28155219|NCT01328444|54824506|FG000|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
28155220|NCT01328444|54824507|FG001|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
28155221|NCT01328444|54824508|FG002|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
28155222|NCT01328444|54824509|FG003|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
28155223|NCT01328444|54824510|FG004|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
28155224|NCT01328444|54824511|FG005|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
28155225|NCT01328444|54824506|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
28155226|NCT01328444|54824507|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
28155227|NCT01328444|54824508|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
28155228|NCT01328444|54824509|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
28155229|NCT01328444|54824510|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
28155230|NCT01328444|54824511|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
28074847|NCT00098748|54729383|FG000|Received Study Treatment|Adverse Event|1|||
28074848|NCT00098748|54729384|FG001|Received Study Treatment|Adverse Event|2|||
28074849|NCT00098748|54729385|FG002|Received Study Treatment|Adverse Event|5|||
28074850|NCT00098748|54729383|FG000|Received Study Treatment|Lack of Efficacy|40|||
28074851|NCT00098748|54729384|FG001|Received Study Treatment|Lack of Efficacy|27|||
28074852|NCT00098748|54729385|FG002|Received Study Treatment|Lack of Efficacy|27|||
28074853|NCT00098748|54729383|FG000|Received Study Treatment|Other|2|||
28074854|NCT00098748|54729384|FG001|Received Study Treatment|Other|2|||
28074855|NCT00098748|54729385|FG002|Received Study Treatment|Other|6|||
28074856|NCT00098748|54729383|FG000|Received Study Treatment|Subject defaulted|3|||
28155231|NCT01328444|54824506|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
28155232|NCT01328444|54824507|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
28155233|NCT01328444|54824508|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
28155234|NCT01328444|54824509|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
28155235|NCT01328444|54824510|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
28155236|NCT01328444|54824511|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
28155237|NCT00887250|54824528|FG000|Overall Study|Adverse Event|3|||
28155238|NCT00887250|54824529|FG001|Overall Study|Adverse Event|0|||
28155239|NCT00887250|54824530|FG002|Overall Study|Adverse Event|7|||
28155240|NCT00887250|54824528|FG000|Overall Study|Lack of Efficacy|9|||
28155241|NCT00887250|54824529|FG001|Overall Study|Lack of Efficacy|6|||
28155242|NCT00887250|54824530|FG002|Overall Study|Lack of Efficacy|1|||
28155243|NCT00887250|54824528|FG000|Overall Study|Lost to Follow-up|2|||
28155244|NCT00887250|54824529|FG001|Overall Study|Lost to Follow-up|3|||
28155245|NCT00887250|54824530|FG002|Overall Study|Lost to Follow-up|1|||
28155246|NCT00887250|54824528|FG000|Overall Study|Protocol Violation|2|||
28155247|NCT00887250|54824529|FG001|Overall Study|Protocol Violation|2|||
28155248|NCT00887250|54824530|FG002|Overall Study|Protocol Violation|1|||
28155249|NCT00887250|54824528|FG000|Overall Study|Withdrawal by Subject|2|||
28155250|NCT00887250|54824529|FG001|Overall Study|Withdrawal by Subject|1|||
28155251|NCT00887250|54824530|FG002|Overall Study|Withdrawal by Subject|2|||
28155252|NCT00887250|54824528|FG000|Overall Study|Patient uncooperative|0|||
28155253|NCT00887250|54824529|FG001|Overall Study|Patient uncooperative|0|||
28155254|NCT00887250|54824530|FG002|Overall Study|Patient uncooperative|1|||
28155255|NCT02599402|54824535|FG000|Overall Study|Disease progression|153|||
28155256|NCT02599402|54824535|FG000|Overall Study|Study drug toxicity|201|||
28155257|NCT02599402|54824535|FG000|Overall Study|Death|26|||
28155258|NCT02599402|54824535|FG000|Overall Study|Adverse Event unrelated to study drug|23|||
28155259|NCT02599402|54824535|FG000|Overall Study|Participant request to discontinue study treatment|13|||
28155260|NCT02599402|54824535|FG000|Overall Study|Participant withdrew consent|5|||
28155261|NCT02599402|54824535|FG000|Overall Study|Lost to Follow-up|1|||
28155262|NCT02599402|54824535|FG000|Overall Study|Maximum Clinical Benefit|7|||
28155263|NCT02599402|54824535|FG000|Overall Study|Poor/non-compliance|1|||
28155264|NCT02599402|54824535|FG000|Overall Study|Pregnancy|1|||
28155265|NCT02599402|54824535|FG000|Overall Study|Participant no longer met study criteria|7|||
28155266|NCT02599402|54824535|FG000|Overall Study|Other Reasons|95|||
28155267|NCT02734862|54824575|FG000|Part A|Death|3|||
28155268|NCT02734862|54824576|FG001|Part A|Death|4|||
28155269|NCT02734862|54824577|FG002|Part A|Death|6|||
28155270|NCT02734862|54824575|FG000|Part A|Lost to Follow-up|2|||
28155271|NCT02734862|54824576|FG001|Part A|Lost to Follow-up|1|||
27942079|NCT01207583|54598827|FG000|Overall Study|Lost to Follow-up|0|||
27942080|NCT01207583|54598828|FG001|Overall Study|Lost to Follow-up|2|||
28155272|NCT02734862|54824577|FG002|Part A|Lost to Follow-up|1|||
28155273|NCT02734862|54824575|FG000|Part A|Withdrawal by Subject|1|||
28155274|NCT02734862|54824576|FG001|Part A|Withdrawal by Subject|1|||
28155275|NCT02734862|54824577|FG002|Part A|Withdrawal by Subject|2|||
27825145|NCT01746901|54290649|FG008|Drug Discrimination Phase: Day 2|Adverse Event|0|||
28074857|NCT00098748|54729384|FG001|Received Study Treatment|Subject defaulted|4|||
28074858|NCT00098748|54729385|FG002|Received Study Treatment|Subject defaulted|4|||
28074859|NCT00098748|54729383|FG000|Continued on Open-Label Treatment|Adverse Event|0|||
28155276|NCT02734862|54824575|FG000|Part A|Physician Decision|2|||
28155277|NCT02734862|54824576|FG001|Part A|Physician Decision|0|||
28155278|NCT02734862|54824577|FG002|Part A|Physician Decision|1|||
28155279|NCT02734862|54824575|FG000|Part A|Adverse Event|2|||
28155280|NCT02734862|54824576|FG001|Part A|Adverse Event|0|||
28155281|NCT02734862|54824577|FG002|Part A|Adverse Event|1|||
28155282|NCT02734862|54824575|FG000|Part A|Noncompliance|1|||
28155283|NCT02734862|54824576|FG001|Part A|Noncompliance|1|||
28155284|NCT02734862|54824577|FG002|Part A|Noncompliance|0|||
28155285|NCT02734862|54824575|FG000|Part A|Other|1|||
28155286|NCT02734862|54824576|FG001|Part A|Other|1|||
28155287|NCT02734862|54824577|FG002|Part A|Other|3|||
28155288|NCT02734862|54824575|FG000|Part B|Death|8|||
28155289|NCT02734862|54824576|FG001|Part B|Death|3|||
28155290|NCT02734862|54824577|FG002|Part B|Death|5|||
28155291|NCT02734862|54824575|FG000|Part B|Lost to Follow-up|2|||
28155292|NCT02734862|54824576|FG001|Part B|Lost to Follow-up|2|||
28155293|NCT02734862|54824577|FG002|Part B|Lost to Follow-up|0|||
28155294|NCT02734862|54824575|FG000|Part B|Withdrawal by Subject|3|||
28155295|NCT02734862|54824576|FG001|Part B|Withdrawal by Subject|1|||
28155296|NCT02734862|54824577|FG002|Part B|Withdrawal by Subject|0|||
28155297|NCT02734862|54824575|FG000|Part B|Other|0|||
28155298|NCT02734862|54824576|FG001|Part B|Other|1|||
28155299|NCT02734862|54824577|FG002|Part B|Other|0|||
28155300|NCT00858702|54824588|FG000|Overall Study|Lack of Efficacy|1|||
28155301|NCT00858702|54824589|FG001|Overall Study|Lack of Efficacy|0|||
28155302|NCT00858702|54824588|FG000|Overall Study|Protocol Violation|1|||
28155303|NCT00858702|54824589|FG001|Overall Study|Protocol Violation|1|||
28155304|NCT00858702|54824588|FG000|Overall Study|Other|2|||
28155305|NCT00858702|54824589|FG001|Overall Study|Other|1|||
28155306|NCT00858702|54824588|FG000|Overall Study|Withdrawal by Subject|1|||
28155307|NCT00858702|54824589|FG001|Overall Study|Withdrawal by Subject|0|||
28155308|NCT02598934|54824597|FG000|Overall Study|Adverse Event|11|||
28155309|NCT02598934|54824598|FG001|Overall Study|Adverse Event|13|||
28155310|NCT02598934|54824597|FG000|Overall Study|Failure to Return|3|||
28155311|NCT02598934|54824598|FG001|Overall Study|Failure to Return|3|||
27825146|NCT01746901|54290641|FG000|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
28074860|NCT00098748|54729384|FG001|Continued on Open-Label Treatment|Adverse Event|1|||
28074861|NCT00098748|54729385|FG002|Continued on Open-Label Treatment|Adverse Event|0|||
28074862|NCT00098748|54729383|FG000|Continued on Open-Label Treatment|Lack of Efficacy|1|||
28074863|NCT00098748|54729384|FG001|Continued on Open-Label Treatment|Lack of Efficacy|2|||
28074864|NCT00098748|54729385|FG002|Continued on Open-Label Treatment|Lack of Efficacy|0|||
28074865|NCT00098748|54729383|FG000|Continued on Open-Label Treatment|Other reason includes protocol violation|6|||
28074866|NCT00098748|54729384|FG001|Continued on Open-Label Treatment|Other reason includes protocol violation|7|||
28074867|NCT00098748|54729385|FG002|Continued on Open-Label Treatment|Other reason includes protocol violation|0|||
28155312|NCT02598934|54824597|FG000|Overall Study|Withdrawal by Subject|2|||
28155313|NCT02598934|54824598|FG001|Overall Study|Withdrawal by Subject|3|||
28155314|NCT02598934|54824597|FG000|Overall Study|Administrative|2|||
28155315|NCT02598934|54824598|FG001|Overall Study|Administrative|1|||
28155316|NCT02598934|54824597|FG000|Overall Study|Protocol Violation|1|||
28155317|NCT02598934|54824598|FG001|Overall Study|Protocol Violation|2|||
28155318|NCT02598622|54824606|FG000|Overall Study|Withdrawal by Subject|3|||
28155319|NCT02598622|54824607|FG001|Overall Study|Withdrawal by Subject|0|||
28155320|NCT02598622|54824606|FG000|Overall Study|Physician Decision|3|||
28155321|NCT02598622|54824607|FG001|Overall Study|Physician Decision|0|||
28155322|NCT00841698|54824615|FG000|First Intervention|Withdrawal by Subject|1|||
28155323|NCT00841698|54824616|FG001|First Intervention|Withdrawal by Subject|0|||
28155324|NCT00841542|54824622|FG000|Period 1|Adverse Event|1|||
28155325|NCT00841542|54824623|FG001|Period 1|Adverse Event|0|||
28155326|NCT00840216|54824645|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
28155327|NCT00840216|54824646|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
28155328|NCT00836706|54824656|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
28155329|NCT00836706|54824657|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
28155330|NCT00836472|54824663|FG000|Washout|Adverse Event|1|||
28155331|NCT00836472|54824664|FG001|Washout|Adverse Event|2|||
28155332|NCT00836472|54824663|FG000|Washout|Withdrawal by Subject|1|||
28155333|NCT00836472|54824664|FG001|Washout|Withdrawal by Subject|1|||
28155334|NCT02598388|54824680|FG000|Overall Study|Lost to Follow-up|1|||
28155335|NCT02598388|54824681|FG001|Overall Study|Lost to Follow-up|0|||
28155336|NCT02598388|54824682|FG002|Overall Study|Lost to Follow-up|1|||
28155337|NCT02598388|54824683|FG003|Overall Study|Lost to Follow-up|0|||
28155338|NCT02598388|54824684|FG004|Overall Study|Lost to Follow-up|5|||
28155339|NCT02598388|54824685|FG005|Overall Study|Lost to Follow-up|1|||
28155340|NCT02598388|54824686|FG006|Overall Study|Lost to Follow-up|2|||
28155341|NCT02598388|54824687|FG007|Overall Study|Lost to Follow-up|1|||
28155342|NCT02598388|54824688|FG008|Overall Study|Lost to Follow-up|0|||
28155343|NCT02598388|54824689|FG009|Overall Study|Lost to Follow-up|0|||
28155344|NCT02598388|54824690|FG010|Overall Study|Lost to Follow-up|1|||
28155345|NCT02598388|54824691|FG011|Overall Study|Lost to Follow-up|0|||
28155346|NCT02598388|54824680|FG000|Overall Study|Withdrawal by Subject|0|||
28155347|NCT02598388|54824681|FG001|Overall Study|Withdrawal by Subject|0|||
28155348|NCT02598388|54824682|FG002|Overall Study|Withdrawal by Subject|0|||
28155349|NCT02598388|54824683|FG003|Overall Study|Withdrawal by Subject|0|||
28155350|NCT02598388|54824684|FG004|Overall Study|Withdrawal by Subject|2|||
28155351|NCT02598388|54824685|FG005|Overall Study|Withdrawal by Subject|0|||
28155352|NCT02598388|54824686|FG006|Overall Study|Withdrawal by Subject|2|||
28155353|NCT02598388|54824687|FG007|Overall Study|Withdrawal by Subject|0|||
28155354|NCT02598388|54824688|FG008|Overall Study|Withdrawal by Subject|0|||
28155355|NCT02598388|54824689|FG009|Overall Study|Withdrawal by Subject|1|||
28155356|NCT02598388|54824690|FG010|Overall Study|Withdrawal by Subject|0|||
28155357|NCT02598388|54824691|FG011|Overall Study|Withdrawal by Subject|0|||
28155358|NCT02598388|54824680|FG000|Overall Study|Other|0|||
28155359|NCT02598388|54824681|FG001|Overall Study|Other|0|||
28155360|NCT02598388|54824682|FG002|Overall Study|Other|1|||
28155361|NCT02598388|54824683|FG003|Overall Study|Other|0|||
27825147|NCT01746901|54290642|FG001|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9|||
27825148|NCT01746901|54290643|FG002|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10|||
27942081|NCT01207583|54598829|FG002|Overall Study|Lost to Follow-up|0|||
28155362|NCT02598388|54824684|FG004|Overall Study|Other|3|||
28155363|NCT02598388|54824685|FG005|Overall Study|Other|0|||
28155364|NCT02598388|54824686|FG006|Overall Study|Other|1|||
28155365|NCT02598388|54824687|FG007|Overall Study|Other|0|||
28155366|NCT02598388|54824688|FG008|Overall Study|Other|0|||
28155367|NCT02598388|54824689|FG009|Overall Study|Other|0|||
28155368|NCT02598388|54824690|FG010|Overall Study|Other|0|||
28155369|NCT02598388|54824691|FG011|Overall Study|Other|0|||
28155370|NCT00835692|54824731|FG000|First Intervention|Withdrawal by Subject|1|||
27825149|NCT01746901|54290644|FG003|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
27825150|NCT01746901|54290645|FG004|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
27825151|NCT01746901|54290646|FG005|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
27825152|NCT01746901|54290647|FG006|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
27825153|NCT01746901|54290648|FG007|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
27825154|NCT01746901|54290649|FG008|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
27825155|NCT01746901|54290641|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
27825156|NCT01746901|54290642|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
27825157|NCT01746901|54290643|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
27825158|NCT01746901|54290644|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
27825159|NCT01746901|54290645|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
27825160|NCT01746901|54290646|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
27825161|NCT01746901|54290647|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
27825162|NCT01746901|54290648|FG007|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
27825163|NCT01746901|54290649|FG008|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
27825164|NCT01746901|54290641|FG000|Treatment Phase: First Intervention|Protocol Violation|0|||
27825165|NCT01746901|54290642|FG001|Treatment Phase: First Intervention|Protocol Violation|0|||
27825166|NCT01746901|54290643|FG002|Treatment Phase: First Intervention|Protocol Violation|0|||
27825167|NCT01746901|54290644|FG003|Treatment Phase: First Intervention|Protocol Violation|0|||
27825168|NCT01746901|54290645|FG004|Treatment Phase: First Intervention|Protocol Violation|0|||
27825169|NCT01746901|54290646|FG005|Treatment Phase: First Intervention|Protocol Violation|0|||
27825170|NCT01746901|54290647|FG006|Treatment Phase: First Intervention|Protocol Violation|1|||
27825171|NCT01746901|54290648|FG007|Treatment Phase: First Intervention|Protocol Violation|0|||
28074868|NCT00098748|54729383|FG000|Continued on Open-Label Treatment|Lost to Follow-up|1|||
28074869|NCT00098748|54729384|FG001|Continued on Open-Label Treatment|Lost to Follow-up|1|||
27825172|NCT01746901|54290649|FG008|Treatment Phase: First Intervention|Protocol Violation|0|||
28074870|NCT00098748|54729385|FG002|Continued on Open-Label Treatment|Lost to Follow-up|0|||
28074871|NCT00098748|54729383|FG000|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
28074872|NCT00098748|54729384|FG001|Continued on Open-Label Treatment|Withdrawal by Subject|4|||
28074873|NCT00098748|54729385|FG002|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
28074874|NCT00130520|54729393|FG000|Overall Study|Adverse Event|11|||
28155371|NCT00835692|54824732|FG001|First Intervention|Withdrawal by Subject|0|||
28155372|NCT00835536|54824745|FG000|Washout of 5 Weeks|Withdrawal by Subject|1|||
28074875|NCT00130520|54729393|FG000|Overall Study|Death|1|||
28074876|NCT00130520|54729393|FG000|Overall Study|Physician Decision|1|||
28074877|NCT00130520|54729393|FG000|Overall Study|Withdrawal by Subject|1|||
28074878|NCT00130520|54729393|FG000|Overall Study|Disease Progression|23|||
28155373|NCT00835536|54824746|FG001|Washout of 5 Weeks|Withdrawal by Subject|0|||
28155374|NCT03865316|54824750|FG000|Overall Study|Procedure Cancelled|4|||
28155375|NCT03865316|54824750|FG000|Overall Study|Equipment failure|4|||
28155376|NCT02598076|54824756|FG000|Overall Study|Lost to Follow-up|2|||
28155377|NCT02598076|54824757|FG001|Overall Study|Lost to Follow-up|3|||
28155378|NCT02602288|54824765|FG000|End of Treatment/3 Month Follow-up|Lost to Follow-up|14|||
28155379|NCT02602288|54824766|FG001|End of Treatment/3 Month Follow-up|Lost to Follow-up|10|||
28155380|NCT02602288|54824765|FG000|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
28074879|NCT00130520|54729393|FG000|Overall Study|Protocol non-compliance|1|||
28074880|NCT00130520|54729393|FG000|Overall Study|Did not meet re-treatment criteria|1|||
28074881|NCT00132132|54729399|FG000|Overall Study|Lost to Follow-up|7|||
28155381|NCT02602288|54824766|FG001|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
28155382|NCT02602288|54824765|FG000|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|9|||
28155383|NCT02602288|54824766|FG001|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|6|||
28155384|NCT02602288|54824765|FG000|12 Month Follow-up|Lost to Follow-up|0|||
28155385|NCT02602288|54824766|FG001|12 Month Follow-up|Lost to Follow-up|4|||
28155386|NCT02602288|54824765|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
28155387|NCT02602288|54824766|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
28155388|NCT02601820|54824772|FG000|Early On-Treatment (T2)|Missing T2 Record|51|||
28155389|NCT02601820|54824772|FG000|Late On-Treatment (T3)|missing T3 Record|49|||
28155390|NCT02601820|54824772|FG000|12 Weeks Post-Treatment (T4)|Missing T4 record|3|||
28155391|NCT02601820|54824772|FG000|1-Yr Post-Treatment (T5)|Missing T5 Record|88|||
28155392|NCT02807454|54824791|FG000|Overall Study|Adverse Event|1|||
28155393|NCT02807454|54824792|FG001|Overall Study|Adverse Event|0|||
28155394|NCT02807454|54824791|FG000|Overall Study|Withdrawal by Subject|0|||
28155395|NCT02807454|54824792|FG001|Overall Study|Withdrawal by Subject|1|||
28155396|NCT02807454|54824791|FG000|Overall Study|Progressive Disease|30|||
28155397|NCT02807454|54824792|FG001|Overall Study|Progressive Disease|3|||
28155398|NCT02807454|54824791|FG000|Overall Study|Other Reasons|1|||
28155399|NCT02807454|54824792|FG001|Overall Study|Other Reasons|1|||
28155400|NCT02597920|54824807|FG000|Overall Study|Worsening of other pre-existing disease|0|||
28155401|NCT02597920|54824808|FG001|Overall Study|Worsening of other pre-existing disease|1|||
28155402|NCT02597920|54824809|FG002|Overall Study|Worsening of other pre-existing disease|0|||
28155403|NCT02597920|54824807|FG000|Overall Study|Other adverse event|20|||
28155404|NCT02597920|54824808|FG001|Overall Study|Other adverse event|30|||
27825173|NCT01746901|54290641|FG000|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
28155405|NCT02597920|54824809|FG002|Overall Study|Other adverse event|0|||
28155406|NCT02597920|54824807|FG000|Overall Study|Lost to Follow-up|7|||
28155407|NCT02597920|54824808|FG001|Overall Study|Lost to Follow-up|9|||
28155408|NCT02597920|54824809|FG002|Overall Study|Lost to Follow-up|0|||
28155409|NCT02597920|54824807|FG000|Overall Study|Refuse to continue in the study|3|||
28155410|NCT02597920|54824808|FG001|Overall Study|Refuse to continue in the study|13|||
28155411|NCT02597920|54824809|FG002|Overall Study|Refuse to continue in the study|1|||
28155412|NCT02597920|54824807|FG000|Overall Study|Other than specified|10|||
28155413|NCT02597920|54824808|FG001|Overall Study|Other than specified|31|||
28155414|NCT02597920|54824809|FG002|Overall Study|Other than specified|5|||
28155415|NCT02597920|54824807|FG000|Overall Study|Other|1|||
28155416|NCT02597920|54824808|FG001|Overall Study|Other|0|||
28155417|NCT02597920|54824809|FG002|Overall Study|Other|0|||
28155418|NCT01235234|54824829|FG000|Overall Study|Adverse Event|2|||
28155419|NCT01235234|54824830|FG001|Overall Study|Adverse Event|2|||
28155420|NCT01235234|54824831|FG002|Overall Study|Adverse Event|1|||
28155421|NCT02597452|54824846|FG000|Overall Study|testing incomplete|30|||
28155422|NCT02597062|54824850|FG000|Overall Study|Ineligible|1|||
28155423|NCT00834756|54824856|FG000|First Intervention|Adverse Event|1|||
28155424|NCT00834756|54824857|FG001|First Intervention|Adverse Event|0|||
28155425|NCT00834756|54824856|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
28155426|NCT00834756|54824857|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
28155427|NCT00828854|54824861|FG000|Overall Study|Disease Progression|17|||
28155428|NCT00828854|54824861|FG000|Overall Study|Adverse Event|9|||
28155429|NCT00828854|54824861|FG000|Overall Study|Reason not Specified|1|||
28155430|NCT00834522|54824867|FG000|Washout|Adverse Event|1|||
28155431|NCT00834522|54824868|FG001|Washout|Adverse Event|0|||
28155432|NCT00834522|54824867|FG000|Washout|Withdrawal by Subject|2|||
28155433|NCT00834522|54824868|FG001|Washout|Withdrawal by Subject|1|||
28155434|NCT00834444|54824874|FG000|First Intervention|Adverse Event|1|||
28155435|NCT00834444|54824875|FG001|First Intervention|Adverse Event|0|||
28155436|NCT00834444|54824874|FG000|First Intervention|Intolerance to Venopuncture|0|||
28155437|NCT00834444|54824875|FG001|First Intervention|Intolerance to Venopuncture|1|||
28155438|NCT00834444|54824874|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
28155439|NCT00834444|54824875|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
28155440|NCT00834444|54824874|FG000|Second Intervention|Adverse Event|1|||
28155441|NCT00834444|54824875|FG001|Second Intervention|Adverse Event|0|||
28155442|NCT02605954|54824895|FG000|Overall Study|Adverse Event|5|||
28155443|NCT02605954|54824896|FG001|Overall Study|Adverse Event|1|||
28155444|NCT02605954|54824895|FG000|Overall Study|Investigator's Discretion|1|||
28155445|NCT02605954|54824896|FG001|Overall Study|Investigator's Discretion|0|||
28155446|NCT02605954|54824895|FG000|Overall Study|Non-Compliance with Study Drug|1|||
28155447|NCT02605954|54824896|FG001|Overall Study|Non-Compliance with Study Drug|0|||
28155448|NCT02605954|54824895|FG000|Overall Study|Withdrew Consent|2|||
28155449|NCT02605954|54824896|FG001|Overall Study|Withdrew Consent|2|||
28155450|NCT02605954|54824895|FG000|Overall Study|Lost to Follow-up|3|||
28155451|NCT02605954|54824896|FG001|Overall Study|Lost to Follow-up|0|||
28155452|NCT02605954|54824895|FG000|Overall Study|Randomized but not treated|0|||
28155453|NCT02605954|54824896|FG001|Overall Study|Randomized but not treated|1|||
28155454|NCT00724698|54824905|FG000|Overall Study|Adverse Event|9|||
28155455|NCT00724698|54824905|FG000|Overall Study|Failure of Therapy|4|||
28155456|NCT00724698|54824905|FG000|Overall Study|Poor Compliance|16|||
28155457|NCT00724698|54824905|FG000|Overall Study|Lost to Follow-up|36|||
28155458|NCT00724698|54824905|FG000|Overall Study|No Info|25|||
28155459|NCT00829998|54824910|FG000|Washout|Adverse Event|0|||
28155460|NCT00829998|54824911|FG001|Washout|Adverse Event|1|||
28155461|NCT00829764|54824922|FG000|First Intervention|Adverse Event|1|||
28155462|NCT00829764|54824923|FG001|First Intervention|Adverse Event|0|||
28155463|NCT00829764|54824922|FG000|First Intervention|Withdrawal by Subject|1|||
28155464|NCT00829764|54824923|FG001|First Intervention|Withdrawal by Subject|1|||
28155465|NCT00829530|54824945|FG000|First Intervention|Adverse Event|0|||
27942082|NCT01207427|54598853|FG000|Double-blind Treatment Period|Adverse Event|0|||
28155466|NCT00829530|54824946|FG001|First Intervention|Adverse Event|1|||
28155467|NCT00829530|54824945|FG000|First Intervention|Intolerance to Venopuncture|0|||
28155468|NCT00829530|54824946|FG001|First Intervention|Intolerance to Venopuncture|1|||
28155469|NCT00829530|54824945|FG000|Second Intervention|Intolerance to Venopuncture|1|||
28155470|NCT00829530|54824946|FG001|Second Intervention|Intolerance to Venopuncture|0|||
28155471|NCT01377194|54824953|FG000|Overall Study|Adverse Event|3|||
28155472|NCT01377194|54824954|FG001|Overall Study|Adverse Event|12|||
28155473|NCT01377194|54824955|FG002|Overall Study|Adverse Event|19|||
28155474|NCT01377194|54824953|FG000|Overall Study|Lack of Efficacy|3|||
28155475|NCT01377194|54824954|FG001|Overall Study|Lack of Efficacy|3|||
28155476|NCT01377194|54824955|FG002|Overall Study|Lack of Efficacy|3|||
28155477|NCT01377194|54824953|FG000|Overall Study|Protocol Violation|4|||
28155478|NCT01377194|54824954|FG001|Overall Study|Protocol Violation|10|||
28155479|NCT01377194|54824955|FG002|Overall Study|Protocol Violation|6|||
28155480|NCT01377194|54824953|FG000|Overall Study|Withdrawal by Subject|8|||
28155481|NCT01377194|54824954|FG001|Overall Study|Withdrawal by Subject|10|||
28155482|NCT01377194|54824955|FG002|Overall Study|Withdrawal by Subject|7|||
28155483|NCT01377194|54824953|FG000|Overall Study|Lost to Follow-up|14|||
28155484|NCT01377194|54824954|FG001|Overall Study|Lost to Follow-up|8|||
28155485|NCT01377194|54824955|FG002|Overall Study|Lost to Follow-up|11|||
28155486|NCT00829452|54824968|FG000|First Intervention|Withdrawal by Subject|0|||
28155487|NCT00829452|54824969|FG001|First Intervention|Withdrawal by Subject|1|||
28155488|NCT00829452|54824968|FG000|Washout of 42 Days|Withdrawal by Subject|0|||
28155489|NCT00829452|54824969|FG001|Washout of 42 Days|Withdrawal by Subject|1|||
28155490|NCT00829452|54824968|FG000|Second Intervention|Physician Decision|0|||
28155491|NCT00829452|54824969|FG001|Second Intervention|Physician Decision|1|||
28155492|NCT04600076|54824973|FG000|Overall Study|Lost to Follow-up|3|||
28155493|NCT02064387|54824989|FG000|Part 1 Max 23.5 Months Followup Duration|Death|0|||
28155494|NCT02064387|54824990|FG001|Part 1 Max 23.5 Months Followup Duration|Death|0|||
28155495|NCT02064387|54824991|FG002|Part 1 Max 23.5 Months Followup Duration|Death|0|||
28155496|NCT02064387|54824992|FG003|Part 1 Max 23.5 Months Followup Duration|Death|0|||
28155497|NCT02064387|54824993|FG004|Part 1 Max 23.5 Months Followup Duration|Death|0|||
28155498|NCT02064387|54824994|FG005|Part 1 Max 23.5 Months Followup Duration|Death|0|||
28155499|NCT02064387|54824995|FG006|Part 1 Max 23.5 Months Followup Duration|Death|0|||
28155500|NCT02064387|54824996|FG007|Part 1 Max 23.5 Months Followup Duration|Death|1|||
28155501|NCT02064387|54824997|FG008|Part 1 Max 23.5 Months Followup Duration|Death|0|||
28155502|NCT02064387|54824998|FG009|Part 1 Max 23.5 Months Followup Duration|Death|1|||
28155503|NCT02064387|54824999|FG010|Part 1 Max 23.5 Months Followup Duration|Death|0|||
28155504|NCT02064387|54825000|FG011|Part 1 Max 23.5 Months Followup Duration|Death|0|||
28155505|NCT02064387|54824989|FG000|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
28155506|NCT02064387|54824990|FG001|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
28155507|NCT02064387|54824991|FG002|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
28155508|NCT02064387|54824992|FG003|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
28155509|NCT02064387|54824993|FG004|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
28155510|NCT02064387|54824994|FG005|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
28155511|NCT02064387|54824995|FG006|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
28155512|NCT02064387|54824996|FG007|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1|||
28155513|NCT02064387|54824997|FG008|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
28155514|NCT02064387|54824998|FG009|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
28155515|NCT02064387|54824999|FG010|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
28155516|NCT02064387|54825000|FG011|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
28155517|NCT02064387|54824989|FG000|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
28155518|NCT02064387|54824990|FG001|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
28155519|NCT02064387|54824991|FG002|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
28155520|NCT02064387|54824992|FG003|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
28155521|NCT02064387|54824993|FG004|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
28155522|NCT02064387|54824994|FG005|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
28155523|NCT02064387|54824995|FG006|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
28155524|NCT02064387|54824996|FG007|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
28155525|NCT02064387|54824997|FG008|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1|||
28155526|NCT02064387|54824998|FG009|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
28155527|NCT02064387|54824999|FG010|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
28155528|NCT02064387|54825000|FG011|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
28155529|NCT02064387|54824989|FG000|Part 2 Max 35 Months Followup Duration|Death|0|||
28155530|NCT02064387|54824990|FG001|Part 2 Max 35 Months Followup Duration|Death|0|||
28155531|NCT02064387|54824991|FG002|Part 2 Max 35 Months Followup Duration|Death|0|||
28155532|NCT02064387|54824992|FG003|Part 2 Max 35 Months Followup Duration|Death|0|||
28155533|NCT02064387|54824993|FG004|Part 2 Max 35 Months Followup Duration|Death|0|||
28155534|NCT02064387|54824994|FG005|Part 2 Max 35 Months Followup Duration|Death|0|||
28155535|NCT02064387|54824995|FG006|Part 2 Max 35 Months Followup Duration|Death|0|||
28155536|NCT02064387|54824996|FG007|Part 2 Max 35 Months Followup Duration|Death|0|||
28155537|NCT02064387|54824997|FG008|Part 2 Max 35 Months Followup Duration|Death|0|||
28155538|NCT02064387|54824998|FG009|Part 2 Max 35 Months Followup Duration|Death|0|||
28155539|NCT02064387|54824999|FG010|Part 2 Max 35 Months Followup Duration|Death|5|||
28155540|NCT02064387|54825000|FG011|Part 2 Max 35 Months Followup Duration|Death|3|||
28155541|NCT02064387|54824989|FG000|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
28155542|NCT02064387|54824990|FG001|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
28155543|NCT02064387|54824991|FG002|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
28155544|NCT02064387|54824992|FG003|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
28155545|NCT02064387|54824993|FG004|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
28155546|NCT02064387|54824994|FG005|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
28155547|NCT02064387|54824995|FG006|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
28155548|NCT02064387|54824996|FG007|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
28155549|NCT02064387|54824997|FG008|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
28155550|NCT02064387|54824998|FG009|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
28155551|NCT02064387|54824999|FG010|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1|||
28155552|NCT02064387|54825000|FG011|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
28155553|NCT01328366|54825039|FG000|Overall Study|Death|1|||
28074882|NCT00132132|54729400|FG001|Overall Study|Lost to Follow-up|2|||
28074883|NCT00130442|54729408|FG000|Overall Study|Withdrawal by Subject|0|||
28074884|NCT00130442|54729409|FG001|Overall Study|Withdrawal by Subject|1|||
28074885|NCT00130442|54729408|FG000|Overall Study|did not meet criteria|1|||
28074886|NCT00130442|54729409|FG001|Overall Study|did not meet criteria|1|||
28074887|NCT00130208|54729419|FG000|Maintenance Period (26 Weeks)|Adverse Event|10|||
28074888|NCT00130208|54729420|FG001|Maintenance Period (26 Weeks)|Adverse Event|12|||
28074889|NCT00130208|54729419|FG000|Maintenance Period (26 Weeks)|Physician Decision|0|||
28074890|NCT00130208|54729420|FG001|Maintenance Period (26 Weeks)|Physician Decision|2|||
28155554|NCT01328366|54825039|FG000|Overall Study|Withdrawal by Subject|2|||
28155555|NCT01328366|54825039|FG000|Overall Study|Lost to Follow-up|7|||
28155556|NCT03256344|54825045|FG000|Overall Study|Death|6|||
28155557|NCT03256344|54825046|FG001|Overall Study|Death|22|||
28155558|NCT03256344|54825045|FG000|Overall Study|Withdrawal by Subject|3|||
28155559|NCT03256344|54825046|FG001|Overall Study|Withdrawal by Subject|3|||
28155560|NCT03256344|54825045|FG000|Overall Study|Sponsor Decision|1|||
28155561|NCT03256344|54825046|FG001|Overall Study|Sponsor Decision|0|||
28155562|NCT01370499|54825054|FG000|Overall Study|Adverse Event|38|||
28155563|NCT01370499|54825055|FG001|Overall Study|Adverse Event|12|||
28155564|NCT01370499|54825054|FG000|Overall Study|Lack of Efficacy|4|||
28155565|NCT01370499|54825055|FG001|Overall Study|Lack of Efficacy|2|||
28155566|NCT01370499|54825054|FG000|Overall Study|Lost to Follow-up|2|||
28155567|NCT01370499|54825055|FG001|Overall Study|Lost to Follow-up|1|||
28155568|NCT01370499|54825054|FG000|Overall Study|Physician Decision|3|||
27942083|NCT01207427|54598854|FG001|Double-blind Treatment Period|Adverse Event|1|||
27825174|NCT01746901|54290642|FG001|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
27942084|NCT01207427|54598855|FG002|Double-blind Treatment Period|Adverse Event|0|||
27942085|NCT01207427|54598853|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
27942086|NCT01207427|54598854|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
28155569|NCT01370499|54825055|FG001|Overall Study|Physician Decision|3|||
28155570|NCT01370499|54825054|FG000|Overall Study|Protocol Violation|5|||
28155571|NCT01370499|54825055|FG001|Overall Study|Protocol Violation|4|||
28155572|NCT01370499|54825054|FG000|Overall Study|Withdrawal by Subject|18|||
27825175|NCT01746901|54290643|FG002|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
28155573|NCT01370499|54825055|FG001|Overall Study|Withdrawal by Subject|7|||
28155574|NCT01370499|54825054|FG000|Overall Study|Sponsor Decision|41|||
28155575|NCT01370499|54825055|FG001|Overall Study|Sponsor Decision|15|||
28155576|NCT01370265|54825063|FG000|First Intervention|Adverse Event|1|||
28155577|NCT01370265|54825064|FG001|First Intervention|Adverse Event|1|||
28155578|NCT02792829|54825085|FG000|Treatment Period 2|Non compliance with alcohol prohibition|0|||
28155579|NCT02792829|54825086|FG001|Treatment Period 2|Non compliance with alcohol prohibition|1|||
28155580|NCT02792829|54825087|FG002|Treatment Period 2|Non compliance with alcohol prohibition|0|||
28155581|NCT02792829|54825088|FG003|Treatment Period 2|Non compliance with alcohol prohibition|0|||
28155582|NCT02792829|54825089|FG004|Treatment Period 2|Non compliance with alcohol prohibition|0|||
28155583|NCT02792829|54825090|FG005|Treatment Period 2|Non compliance with alcohol prohibition|0|||
28155584|NCT02792829|54825091|FG006|Treatment Period 2|Non compliance with alcohol prohibition|0|||
28155585|NCT02792829|54825092|FG007|Treatment Period 2|Non compliance with alcohol prohibition|0|||
28155586|NCT02792829|54825085|FG000|Treatment Period 2|Adverse Event|0|||
28155587|NCT02792829|54825086|FG001|Treatment Period 2|Adverse Event|0|||
28155588|NCT02792829|54825087|FG002|Treatment Period 2|Adverse Event|0|||
28155589|NCT02792829|54825088|FG003|Treatment Period 2|Adverse Event|0|||
28155590|NCT02792829|54825089|FG004|Treatment Period 2|Adverse Event|1|||
28155591|NCT02792829|54825090|FG005|Treatment Period 2|Adverse Event|0|||
28155592|NCT02792829|54825091|FG006|Treatment Period 2|Adverse Event|1|||
28155593|NCT02792829|54825092|FG007|Treatment Period 2|Adverse Event|1|||
28155594|NCT02792829|54825085|FG000|Treatment Period 2|Use of proscribed medications|0|||
28155595|NCT02792829|54825086|FG001|Treatment Period 2|Use of proscribed medications|0|||
28155596|NCT02792829|54825087|FG002|Treatment Period 2|Use of proscribed medications|0|||
28155597|NCT02792829|54825088|FG003|Treatment Period 2|Use of proscribed medications|0|||
28155598|NCT02792829|54825089|FG004|Treatment Period 2|Use of proscribed medications|0|||
28155599|NCT02792829|54825090|FG005|Treatment Period 2|Use of proscribed medications|0|||
28155600|NCT02792829|54825091|FG006|Treatment Period 2|Use of proscribed medications|0|||
28155601|NCT02792829|54825092|FG007|Treatment Period 2|Use of proscribed medications|1|||
28155602|NCT02867592|54825124|FG000|Overall Study|Adverse Event|3|||
28155603|NCT02867592|54825125|FG001|Overall Study|Adverse Event|0|||
28155604|NCT02867592|54825126|FG002|Overall Study|Adverse Event|2|||
27942087|NCT01207427|54598855|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
27942088|NCT01207427|54598853|FG000|Double-blind Treatment Period|Protocol Violation|2|||
28155605|NCT02867592|54825127|FG003|Overall Study|Adverse Event|1|||
28155606|NCT02867592|54825128|FG004|Overall Study|Adverse Event|1|||
28155607|NCT02867592|54825129|FG005|Overall Study|Adverse Event|5|||
28155608|NCT02867592|54825124|FG000|Overall Study|Death|0|||
28155609|NCT02867592|54825125|FG001|Overall Study|Death|0|||
28155610|NCT02867592|54825126|FG002|Overall Study|Death|0|||
28155611|NCT02867592|54825127|FG003|Overall Study|Death|1|||
28155612|NCT02867592|54825128|FG004|Overall Study|Death|0|||
28155613|NCT02867592|54825129|FG005|Overall Study|Death|1|||
28155614|NCT02867592|54825124|FG000|Overall Study|Lack of Efficacy|8|||
28155615|NCT02867592|54825125|FG001|Overall Study|Lack of Efficacy|10|||
28155616|NCT02867592|54825126|FG002|Overall Study|Lack of Efficacy|8|||
28155617|NCT02867592|54825127|FG003|Overall Study|Lack of Efficacy|8|||
28155618|NCT02867592|54825128|FG004|Overall Study|Lack of Efficacy|12|||
28155619|NCT02867592|54825129|FG005|Overall Study|Lack of Efficacy|17|||
28155620|NCT02867592|54825124|FG000|Overall Study|Physician Decision|1|||
28155621|NCT02867592|54825125|FG001|Overall Study|Physician Decision|2|||
28155622|NCT02867592|54825126|FG002|Overall Study|Physician Decision|2|||
28155623|NCT02867592|54825127|FG003|Overall Study|Physician Decision|0|||
28155624|NCT02867592|54825128|FG004|Overall Study|Physician Decision|5|||
28155625|NCT02867592|54825129|FG005|Overall Study|Physician Decision|1|||
28155626|NCT02867592|54825124|FG000|Overall Study|Protocol Violation|0|||
28155627|NCT02867592|54825125|FG001|Overall Study|Protocol Violation|0|||
28155628|NCT02867592|54825126|FG002|Overall Study|Protocol Violation|0|||
28155629|NCT02867592|54825127|FG003|Overall Study|Protocol Violation|0|||
28155630|NCT02867592|54825128|FG004|Overall Study|Protocol Violation|1|||
28155631|NCT02867592|54825129|FG005|Overall Study|Protocol Violation|1|||
28155632|NCT02867592|54825124|FG000|Overall Study|Withdrawal by Subject|0|||
28155633|NCT02867592|54825125|FG001|Overall Study|Withdrawal by Subject|1|||
28155634|NCT02867592|54825126|FG002|Overall Study|Withdrawal by Subject|0|||
28155635|NCT02867592|54825127|FG003|Overall Study|Withdrawal by Subject|1|||
28155636|NCT02867592|54825128|FG004|Overall Study|Withdrawal by Subject|3|||
28155637|NCT02867592|54825129|FG005|Overall Study|Withdrawal by Subject|3|||
28155638|NCT02867592|54825124|FG000|Overall Study|Ineligible|1|||
28155639|NCT02867592|54825125|FG001|Overall Study|Ineligible|1|||
27825176|NCT01746901|54290644|FG003|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
28155640|NCT02867592|54825126|FG002|Overall Study|Ineligible|0|||
28155641|NCT02867592|54825127|FG003|Overall Study|Ineligible|0|||
28155642|NCT02867592|54825128|FG004|Overall Study|Ineligible|2|||
28155643|NCT02867592|54825129|FG005|Overall Study|Ineligible|0|||
28155644|NCT02867592|54825124|FG000|Overall Study|No Treatment|1|||
28155645|NCT02867592|54825125|FG001|Overall Study|No Treatment|0|||
27825177|NCT01746901|54290645|FG004|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
27825178|NCT01746901|54290646|FG005|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
27825179|NCT01746901|54290647|FG006|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
28155646|NCT02867592|54825126|FG002|Overall Study|No Treatment|0|||
28155647|NCT02867592|54825127|FG003|Overall Study|No Treatment|0|||
28155648|NCT02867592|54825128|FG004|Overall Study|No Treatment|0|||
28155649|NCT02867592|54825129|FG005|Overall Study|No Treatment|0|||
28155650|NCT02867592|54825124|FG000|Overall Study|Still on Therapy|0|||
28155651|NCT02867592|54825125|FG001|Overall Study|Still on Therapy|0|||
28155652|NCT02867592|54825126|FG002|Overall Study|Still on Therapy|0|||
28155653|NCT02867592|54825127|FG003|Overall Study|Still on Therapy|0|||
28155654|NCT02867592|54825128|FG004|Overall Study|Still on Therapy|1|||
28155655|NCT02867592|54825129|FG005|Overall Study|Still on Therapy|0|||
28155656|NCT02867592|54825124|FG000|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
28155657|NCT02867592|54825125|FG001|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
28155658|NCT02867592|54825126|FG002|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
28155659|NCT02867592|54825127|FG003|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
28155660|NCT02867592|54825128|FG004|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
28155661|NCT02867592|54825129|FG005|Overall Study|Patient received concurrent anticancer or investigational therapy|1|||
28155662|NCT02867592|54825124|FG000|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
28155663|NCT02867592|54825125|FG001|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
27825180|NCT01746901|54290648|FG007|Treatment Phase: Second Intervention|Withdrawal by Subject|1|||
27825181|NCT01746901|54290649|FG008|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
27825182|NCT01746901|54290641|FG000|Treatment Phase: Third Intervention|Protocol Violation|0|||
27825183|NCT01746901|54290642|FG001|Treatment Phase: Third Intervention|Protocol Violation|0|||
27825184|NCT01746901|54290643|FG002|Treatment Phase: Third Intervention|Protocol Violation|0|||
27825185|NCT01746901|54290644|FG003|Treatment Phase: Third Intervention|Protocol Violation|0|||
27825186|NCT01746901|54290645|FG004|Treatment Phase: Third Intervention|Protocol Violation|0|||
28074891|NCT00130208|54729419|FG000|Maintenance Period (26 Weeks)|Withdrawal by Subject|8|||
28074892|NCT00130208|54729420|FG001|Maintenance Period (26 Weeks)|Withdrawal by Subject|11|||
28074893|NCT00130208|54729419|FG000|Maintenance Period (26 Weeks)|Lost to Follow-up|5|||
28074894|NCT00130208|54729420|FG001|Maintenance Period (26 Weeks)|Lost to Follow-up|4|||
28074895|NCT00130208|54729419|FG000|Maintenance Period (26 Weeks)|Other|1|||
28074896|NCT00130208|54729420|FG001|Maintenance Period (26 Weeks)|Other|1|||
28074897|NCT00130208|54729419|FG000|Washout Period (8 Weeks)|Adverse Event|3|||
28074898|NCT00130208|54729420|FG001|Washout Period (8 Weeks)|Adverse Event|6|||
28074899|NCT00130208|54729419|FG000|Washout Period (8 Weeks)|Withdrawal by Subject|2|||
28074900|NCT00130208|54729420|FG001|Washout Period (8 Weeks)|Withdrawal by Subject|4|||
28074901|NCT00130208|54729419|FG000|Washout Period (8 Weeks)|Lost to Follow-up|0|||
28074902|NCT00130208|54729420|FG001|Washout Period (8 Weeks)|Lost to Follow-up|1|||
28074903|NCT00130208|54729419|FG000|Washout Period (8 Weeks)|Other|1|||
28074904|NCT00130208|54729420|FG001|Washout Period (8 Weeks)|Other|1|||
28074905|NCT00253370|54729426|FG000|Overall Study|Adverse Event|18|||
28074906|NCT00253370|54729426|FG000|Overall Study|Disease progression|13|||
28074907|NCT00253370|54729426|FG000|Overall Study|Death|2|||
28074908|NCT00253370|54729426|FG000|Overall Study|Withdrawal by Subject|6|||
28074909|NCT00253370|54729426|FG000|Overall Study|Non-protocol therapy|1|||
28074910|NCT00253370|54729426|FG000|Overall Study|Physician Decision|1|||
28074911|NCT00253370|54729426|FG000|Overall Study|Protocol Violation|1|||
28074912|NCT00253370|54729426|FG000|Overall Study|Abdominal pain due to disease|1|||
28074913|NCT00140426|54729433|FG000|Overall Study|Withdrawal by Subject|0|||
28074914|NCT00140426|54729434|FG001|Overall Study|Withdrawal by Subject|3|||
28074915|NCT00121134|54729449|FG000|Overall Study|Progression of Disease|5|||
28074916|NCT00121134|54729450|FG001|Overall Study|Progression of Disease|3|||
27942089|NCT01207427|54598854|FG001|Double-blind Treatment Period|Protocol Violation|1|||
27942090|NCT01207427|54598855|FG002|Double-blind Treatment Period|Protocol Violation|1|||
28074917|NCT00121134|54729451|FG002|Overall Study|Progression of Disease|4|||
28074918|NCT00121134|54729452|FG003|Overall Study|Progression of Disease|2|||
28074919|NCT00121134|54729449|FG000|Overall Study|Toxicity|4|||
28074920|NCT00121134|54729450|FG001|Overall Study|Toxicity|7|||
28074921|NCT00121134|54729451|FG002|Overall Study|Toxicity|13|||
28074922|NCT00121134|54729452|FG003|Overall Study|Toxicity|5|||
28074923|NCT00121134|54729449|FG000|Overall Study|Physician Decision|6|||
28074924|NCT00121134|54729450|FG001|Overall Study|Physician Decision|4|||
28074925|NCT00121134|54729451|FG002|Overall Study|Physician Decision|4|||
28074926|NCT00121134|54729452|FG003|Overall Study|Physician Decision|1|||
28074927|NCT00121134|54729449|FG000|Overall Study|Treatment Delay|1|||
27825187|NCT01746901|54290646|FG005|Treatment Phase: Third Intervention|Protocol Violation|1|||
27825188|NCT01746901|54290647|FG006|Treatment Phase: Third Intervention|Protocol Violation|1|||
27825189|NCT01746901|54290648|FG007|Treatment Phase: Third Intervention|Protocol Violation|0|||
27825190|NCT01746901|54290649|FG008|Treatment Phase: Third Intervention|Protocol Violation|0|||
27825191|NCT01746901|54290641|FG000|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
27825192|NCT01746901|54290642|FG001|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
27825193|NCT01746901|54290643|FG002|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
27825194|NCT01746901|54290644|FG003|Treatment Phase: Fourth Intervention|Lost to Follow-up|1|||
28074928|NCT00121134|54729450|FG001|Overall Study|Treatment Delay|0|||
28074929|NCT00121134|54729451|FG002|Overall Study|Treatment Delay|0|||
28074930|NCT00121134|54729452|FG003|Overall Study|Treatment Delay|0|||
28155664|NCT02867592|54825126|FG002|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
28155665|NCT02867592|54825127|FG003|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|2|||
28155666|NCT02867592|54825128|FG004|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
28074931|NCT00121134|54729449|FG000|Overall Study|Intercurrent Illness|0|||
28074932|NCT00121134|54729450|FG001|Overall Study|Intercurrent Illness|0|||
28074933|NCT00121134|54729451|FG002|Overall Study|Intercurrent Illness|0|||
28074934|NCT00121134|54729452|FG003|Overall Study|Intercurrent Illness|1|||
28074935|NCT00121134|54729449|FG000|Overall Study|Patient Personal Reasons|0|||
28074936|NCT00121134|54729450|FG001|Overall Study|Patient Personal Reasons|1|||
28074937|NCT00121134|54729451|FG002|Overall Study|Patient Personal Reasons|0|||
27825195|NCT01746901|54290645|FG004|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
27942091|NCT01207427|54598853|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
28155667|NCT02867592|54825129|FG005|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
28155668|NCT00676494|54825145|FG000|Overall Study|Missed Visit|8|||
28155669|NCT00676494|54825145|FG000|Overall Study|Withdrawal by Subject|6|||
28155670|NCT02605642|54825150|FG000|Overall Study|Other|11|||
28155671|NCT02605642|54825151|FG001|Overall Study|Other|1|||
28155672|NCT02605642|54825150|FG000|Overall Study|Participant non-compliance|2|||
28155673|NCT02605642|54825151|FG001|Overall Study|Participant non-compliance|4|||
28155674|NCT02605642|54825150|FG000|Overall Study|Physician Decision|10|||
28155675|NCT02605642|54825151|FG001|Overall Study|Physician Decision|0|||
28155676|NCT02605642|54825150|FG000|Overall Study|Lost to Follow-up|12|||
28074938|NCT00121134|54729452|FG003|Overall Study|Patient Personal Reasons|0|||
28074939|NCT02657434|54729464|FG000|Overall Study|On-Going in Study|77|||
28074940|NCT02657434|54729465|FG001|Overall Study|On-Going in Study|91|||
28074941|NCT02657434|54729464|FG000|Overall Study|Death|177|||
28155677|NCT02605642|54825151|FG001|Overall Study|Lost to Follow-up|1|||
28155678|NCT02605642|54825150|FG000|Overall Study|Adverse Event|14|||
28155679|NCT02605642|54825151|FG001|Overall Study|Adverse Event|2|||
28074942|NCT02657434|54729465|FG001|Overall Study|Death|183|||
28074943|NCT02657434|54729464|FG000|Overall Study|Lost to Follow-up|2|||
28074944|NCT02657434|54729465|FG001|Overall Study|Lost to Follow-up|2|||
28074945|NCT02657434|54729464|FG000|Overall Study|Randomization by Error|2|||
28074946|NCT02657434|54729465|FG001|Overall Study|Randomization by Error|0|||
28074947|NCT02657434|54729464|FG000|Overall Study|Withdrawal by Subject|27|||
28074948|NCT02657434|54729465|FG001|Overall Study|Withdrawal by Subject|16|||
28074949|NCT02657434|54729464|FG000|Overall Study|Protocol Violation|1|||
28074950|NCT02657434|54729465|FG001|Overall Study|Protocol Violation|0|||
28074951|NCT00119262|54729474|FG000|Overall Study|Lack of Efficacy|0|||
28074952|NCT00119262|54729475|FG001|Overall Study|Lack of Efficacy|3|||
28074953|NCT00119262|54729474|FG000|Overall Study|Withdrawal by Subject|12|||
28074954|NCT00119262|54729475|FG001|Overall Study|Withdrawal by Subject|11|||
28074955|NCT00119262|54729474|FG000|Overall Study|Adverse Event|33|||
28074956|NCT00119262|54729475|FG001|Overall Study|Adverse Event|35|||
28074957|NCT00119262|54729474|FG000|Overall Study|other disease|0|||
28074958|NCT00119262|54729475|FG001|Overall Study|other disease|2|||
28074959|NCT00119262|54729474|FG000|Overall Study|ineligble|1|||
28074960|NCT00119262|54729475|FG001|Overall Study|ineligble|2|||
28074961|NCT00119262|54729474|FG000|Overall Study|others|0|||
28074962|NCT00119262|54729475|FG001|Overall Study|others|5|||
28074963|NCT03703882|54729483|FG000|Overall Study|Adverse Event|1|||
28074964|NCT03703882|54729484|FG001|Overall Study|Adverse Event|0|||
28074965|NCT03703882|54729483|FG000|Overall Study|Lost to Follow-up|0|||
28074966|NCT03703882|54729484|FG001|Overall Study|Lost to Follow-up|2|||
28074967|NCT03703882|54729483|FG000|Overall Study|Non-compliance with study drug|0|||
28074968|NCT03703882|54729484|FG001|Overall Study|Non-compliance with study drug|1|||
28155680|NCT02605642|54825150|FG000|Overall Study|Withdrawal by Subject|23|||
28155681|NCT02605642|54825151|FG001|Overall Study|Withdrawal by Subject|2|||
28155682|NCT02605642|54825150|FG000|Overall Study|Lack of response|24|||
28155683|NCT02605642|54825151|FG001|Overall Study|Lack of response|11|||
28155684|NCT02253810|54825159|FG000|Overall Study|Withdrawal by Subject|2|||
28155685|NCT02253810|54825160|FG001|Overall Study|Withdrawal by Subject|1|||
28155686|NCT02253810|54825159|FG000|Overall Study|Unknown concomitant procedure|3|||
28155687|NCT02253810|54825160|FG001|Overall Study|Unknown concomitant procedure|2|||
28155688|NCT03915470|54825181|FG000|Overall Study|Death|3|||
28155689|NCT03915470|54825182|FG001|Overall Study|Death|1|||
28155690|NCT03915470|54825181|FG000|Overall Study|Adverse Event|1|||
28155691|NCT03915470|54825182|FG001|Overall Study|Adverse Event|0|||
28155692|NCT03915470|54825181|FG000|Overall Study|Physician Decision|1|||
28155693|NCT03915470|54825182|FG001|Overall Study|Physician Decision|0|||
28155694|NCT03915470|54825181|FG000|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
28155695|NCT03915470|54825182|FG001|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
28155696|NCT02732912|54825193|FG000|Overall Study|Discharged before night|2|||
28155697|NCT02732912|54825194|FG001|Overall Study|Discharged before night|6|||
28155698|NCT02732912|54825193|FG000|Overall Study|Incomplete completion of questionnaire|2|||
28155699|NCT02732912|54825194|FG001|Overall Study|Incomplete completion of questionnaire|3|||
28155700|NCT02732912|54825193|FG000|Overall Study|No outcome; discharged or refused|6|||
28155701|NCT02732912|54825194|FG001|Overall Study|No outcome; discharged or refused|9|||
28155702|NCT02792517|54825200|FG000|Overall Study|Withdrawal by Subject|10|||
28155703|NCT02792517|54825200|FG000|Overall Study|Decision by Sponsor|7|||
28155704|NCT02792517|54825200|FG000|Overall Study|Lost to Follow-up|3|||
28155705|NCT01369485|54825235|FG000|Randomized Phase (Day 0 to Week 12)|Adverse Event|7|||
28155706|NCT01369485|54825236|FG001|Randomized Phase (Day 0 to Week 12)|Adverse Event|5|||
28155707|NCT01369485|54825235|FG000|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12|||
28155708|NCT01369485|54825236|FG001|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8|||
28155709|NCT01369485|54825235|FG000|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2|||
28155710|NCT01369485|54825236|FG001|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4|||
28155711|NCT01369485|54825235|FG000|Randomized Phase (Day 0 to Week 12)|expired patches|2|||
28155712|NCT01369485|54825236|FG001|Randomized Phase (Day 0 to Week 12)|expired patches|0|||
28155713|NCT01369485|54825235|FG000|Open Label Phase (Week 12 to Month 12)|Adverse Event|11|||
28155714|NCT01369485|54825236|FG001|Open Label Phase (Week 12 to Month 12)|Adverse Event|9|||
28155715|NCT01369485|54825235|FG000|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2|||
28155716|NCT01369485|54825236|FG001|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3|||
28155717|NCT01369485|54825235|FG000|Open Label Phase (Week 12 to Month 12)|Physician Decision|3|||
28155718|NCT01369485|54825236|FG001|Open Label Phase (Week 12 to Month 12)|Physician Decision|4|||
28155719|NCT01369485|54825235|FG000|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17|||
28155720|NCT01369485|54825236|FG001|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20|||
28155721|NCT01369485|54825235|FG000|Open Label Phase (Week 12 to Month 12)|Death|0|||
28155722|NCT01369485|54825236|FG001|Open Label Phase (Week 12 to Month 12)|Death|1|||
28155723|NCT01369485|54825235|FG000|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0|||
28155724|NCT01369485|54825236|FG001|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3|||
28155725|NCT02886572|54825263|FG000|Overall Study|Death|8|||
28155726|NCT02741700|54825276|FG000|Overall Study|Lost to Follow-up|17|||
28155727|NCT02741700|54825277|FG001|Overall Study|Lost to Follow-up|8|||
28155728|NCT02741700|54825276|FG000|Overall Study|Withdrawal by Subject|2|||
28155729|NCT02741700|54825277|FG001|Overall Study|Withdrawal by Subject|5|||
28155730|NCT02741700|54825276|FG000|Overall Study|Physician Decision|3|||
28155731|NCT02741700|54825277|FG001|Overall Study|Physician Decision|0|||
28155732|NCT02741700|54825276|FG000|Overall Study|Moved out of State|0|||
28155733|NCT02741700|54825277|FG001|Overall Study|Moved out of State|1|||
28155734|NCT02741700|54825276|FG000|Overall Study|Death|4|||
28155735|NCT02741700|54825277|FG001|Overall Study|Death|5|||
28155736|NCT00430950|54825285|FG000|Overall Study|Adverse Event|7|||
28155737|NCT00430950|54825286|FG001|Overall Study|Adverse Event|6|||
28155738|NCT00430950|54825285|FG000|Overall Study|Withdrawal by Subject|1|||
28155739|NCT00430950|54825286|FG001|Overall Study|Withdrawal by Subject|0|||
28155740|NCT00430950|54825285|FG000|Overall Study|concomitant medication,etc.|5|||
28155741|NCT00430950|54825286|FG001|Overall Study|concomitant medication,etc.|7|||
28155742|NCT02081391|54825294|FG000|12-hour Treatment|Withdrawal by Subject|3|||
28155743|NCT02081391|54825295|FG001|12-hour Treatment|Withdrawal by Subject|2|||
28155744|NCT02081391|54825296|FG002|12-hour Treatment|Withdrawal by Subject|0|||
28155745|NCT02081391|54825297|FG003|12-hour Treatment|Withdrawal by Subject|0|||
28155746|NCT02081391|54825294|FG000|12-hour Treatment|Physician Decision|4|||
28155747|NCT02081391|54825295|FG001|12-hour Treatment|Physician Decision|1|||
28155748|NCT02081391|54825296|FG002|12-hour Treatment|Physician Decision|0|||
28155749|NCT02081391|54825297|FG003|12-hour Treatment|Physician Decision|0|||
28155750|NCT02081391|54825294|FG000|12-hour Treatment|Lack of Efficacy|3|||
28155751|NCT02081391|54825295|FG001|12-hour Treatment|Lack of Efficacy|0|||
28155752|NCT02081391|54825296|FG002|12-hour Treatment|Lack of Efficacy|0|||
28155753|NCT02081391|54825297|FG003|12-hour Treatment|Lack of Efficacy|0|||
28155754|NCT02081391|54825294|FG000|12-hour Treatment|Adverse Event|4|||
28155755|NCT02081391|54825295|FG001|12-hour Treatment|Adverse Event|2|||
28155756|NCT02081391|54825296|FG002|12-hour Treatment|Adverse Event|0|||
28155757|NCT02081391|54825297|FG003|12-hour Treatment|Adverse Event|0|||
28155758|NCT02081391|54825294|FG000|12-hour Treatment|Recovery (opioid no longer needed)|2|||
28155759|NCT02081391|54825295|FG001|12-hour Treatment|Recovery (opioid no longer needed)|0|||
28155760|NCT02081391|54825296|FG002|12-hour Treatment|Recovery (opioid no longer needed)|1|||
28155761|NCT02081391|54825297|FG003|12-hour Treatment|Recovery (opioid no longer needed)|0|||
28155762|NCT02081391|54825294|FG000|12-hour Treatment|Further reasons|2|||
28155763|NCT02081391|54825295|FG001|12-hour Treatment|Further reasons|1|||
28155764|NCT02081391|54825296|FG002|12-hour Treatment|Further reasons|0|||
28155765|NCT02081391|54825297|FG003|12-hour Treatment|Further reasons|0|||
28155766|NCT02081391|54825294|FG000|24-hour Treatment and Trial Completion|Physician Decision|10|||
28155767|NCT02081391|54825295|FG001|24-hour Treatment and Trial Completion|Physician Decision|5|||
28155768|NCT02081391|54825296|FG002|24-hour Treatment and Trial Completion|Physician Decision|0|||
28155769|NCT02081391|54825297|FG003|24-hour Treatment and Trial Completion|Physician Decision|0|||
28155770|NCT02081391|54825294|FG000|24-hour Treatment and Trial Completion|Lack of Efficacy|1|||
28155771|NCT02081391|54825295|FG001|24-hour Treatment and Trial Completion|Lack of Efficacy|3|||
28155772|NCT02081391|54825296|FG002|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
28155773|NCT02081391|54825297|FG003|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
28155774|NCT02081391|54825294|FG000|24-hour Treatment and Trial Completion|Adverse Event|1|||
28155775|NCT02081391|54825295|FG001|24-hour Treatment and Trial Completion|Adverse Event|0|||
28155776|NCT02081391|54825296|FG002|24-hour Treatment and Trial Completion|Adverse Event|0|||
28155777|NCT02081391|54825297|FG003|24-hour Treatment and Trial Completion|Adverse Event|0|||
28155778|NCT02081391|54825294|FG000|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11|||
28155779|NCT02081391|54825295|FG001|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5|||
28155780|NCT02081391|54825296|FG002|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1|||
28155781|NCT02081391|54825297|FG003|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0|||
28155782|NCT02081391|54825294|FG000|24-hour Treatment and Trial Completion|Technical Problems|1|||
28155783|NCT02081391|54825295|FG001|24-hour Treatment and Trial Completion|Technical Problems|1|||
28155784|NCT02081391|54825296|FG002|24-hour Treatment and Trial Completion|Technical Problems|0|||
28155785|NCT02081391|54825297|FG003|24-hour Treatment and Trial Completion|Technical Problems|0|||
28155786|NCT02081391|54825294|FG000|24-hour Treatment and Trial Completion|Further reasons|3|||
28155787|NCT02081391|54825295|FG001|24-hour Treatment and Trial Completion|Further reasons|4|||
28155788|NCT02081391|54825296|FG002|24-hour Treatment and Trial Completion|Further reasons|0|||
28155789|NCT02081391|54825297|FG003|24-hour Treatment and Trial Completion|Further reasons|0|||
28155790|NCT00430092|54825320|FG000|Overall Study|Adverse Event|0|||
28155791|NCT00430092|54825321|FG001|Overall Study|Adverse Event|0|||
28155792|NCT00430092|54825322|FG002|Overall Study|Adverse Event|1|||
28155793|NCT00430092|54825320|FG000|Overall Study|Lack of Efficacy|5|||
28155794|NCT00430092|54825321|FG001|Overall Study|Lack of Efficacy|2|||
28155795|NCT00430092|54825322|FG002|Overall Study|Lack of Efficacy|54|||
28155796|NCT00430092|54825320|FG000|Overall Study|Lost to Follow-up|1|||
28155797|NCT00430092|54825321|FG001|Overall Study|Lost to Follow-up|0|||
28155798|NCT00430092|54825322|FG002|Overall Study|Lost to Follow-up|0|||
28155799|NCT00430092|54825320|FG000|Overall Study|Protocol Violation|0|||
28155800|NCT00430092|54825321|FG001|Overall Study|Protocol Violation|1|||
27942092|NCT01207427|54598854|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
27942093|NCT01207427|54598855|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
27942094|NCT04713553|54598868|FG000|Primary Study (2 Months)|Withdrawal by Subject|2|||
28155801|NCT00430092|54825322|FG002|Overall Study|Protocol Violation|1|||
28155802|NCT00430092|54825320|FG000|Overall Study|Withdrawal by Subject|0|||
28155803|NCT00430092|54825321|FG001|Overall Study|Withdrawal by Subject|1|||
28155804|NCT00430092|54825322|FG002|Overall Study|Withdrawal by Subject|1|||
28155805|NCT00425100|54825327|FG000|Overall Study|Adverse Event|36|||
28155806|NCT00425100|54825327|FG000|Overall Study|Lack of Efficacy|4|||
28155807|NCT00425100|54825327|FG000|Overall Study|Lost to Follow-up|2|||
28155808|NCT00425100|54825327|FG000|Overall Study|Protocol Violation|4|||
28155809|NCT00425100|54825327|FG000|Overall Study|Withdrawal by Subject|7|||
28155810|NCT00412932|54825332|FG000|Olmesartan (Olm) 20 mg|Adverse Event|1|||
28155811|NCT00412932|54825332|FG000|Olmesartan (Olm) 20 mg|Lack of Efficacy|2|||
28155812|NCT00412932|54825332|FG000|Olmesartan (Olm) 20 mg|Protocol Violation|1|||
28155813|NCT00412932|54825332|FG000|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2|||
28155814|NCT00412932|54825332|FG000|Olmesartan (Olm) 20 mg|Other|1|||
28155815|NCT00412932|54825332|FG000|Olmesartan 40 mg|Adverse Event|4|||
28155816|NCT00412932|54825332|FG000|Olmesartan 40 mg|Lack of Efficacy|3|||
28074969|NCT03703882|54729483|FG000|Overall Study|Physician Decision|0|||
28155817|NCT00412932|54825332|FG000|Olmesartan 40 mg|Withdrawal by Subject|1|||
28155818|NCT00412932|54825332|FG000|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3|||
28155819|NCT00412932|54825332|FG000|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3|||
28155820|NCT00412932|54825332|FG000|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1|||
28155821|NCT00412932|54825332|FG000|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
28155822|NCT02696031|54825338|FG000|Up to Week 24|Adverse Event|2|||
28074970|NCT03703882|54729484|FG001|Overall Study|Physician Decision|1|||
28074971|NCT03703882|54729483|FG000|Overall Study|Progressive disease|1|||
28074972|NCT03703882|54729484|FG001|Overall Study|Progressive disease|0|||
28074973|NCT03703882|54729483|FG000|Overall Study|Withdrawal by parent/guardian|1|||
28074974|NCT03703882|54729484|FG001|Overall Study|Withdrawal by parent/guardian|0|||
28155823|NCT02696031|54825339|FG001|Up to Week 24|Adverse Event|4|||
28155824|NCT02696031|54825340|FG002|Up to Week 24|Adverse Event|2|||
28155825|NCT02696031|54825341|FG003|Up to Week 24|Adverse Event|0|||
28155826|NCT02696031|54825342|FG004|Up to Week 24|Adverse Event|0|||
28155827|NCT02696031|54825343|FG005|Up to Week 24|Adverse Event|0|||
28074975|NCT03703882|54729483|FG000|Overall Study|Starting another treatment|0|||
28074976|NCT03703882|54729484|FG001|Overall Study|Starting another treatment|1|||
28074977|NCT03703882|54729483|FG000|Overall Study|noncompliance with study procedures|0|||
28074978|NCT03703882|54729484|FG001|Overall Study|noncompliance with study procedures|1|||
28155828|NCT02696031|54825338|FG000|Up to Week 24|Lack of Efficacy|2|||
28074979|NCT00131664|54729493|FG000|First Period (First 6 Months)|Lost to Follow-up|7|||
28074980|NCT00131664|54729494|FG001|First Period (First 6 Months)|Lost to Follow-up|3|||
28074981|NCT00131664|54729495|FG002|First Period (First 6 Months)|Lost to Follow-up|3|||
28074982|NCT00131664|54729496|FG003|First Period (First 6 Months)|Lost to Follow-up|0|||
28074983|NCT00131664|54729497|FG004|First Period (First 6 Months)|Lost to Follow-up|0|||
28074984|NCT00131664|54729498|FG005|First Period (First 6 Months)|Lost to Follow-up|0|||
28074985|NCT00131664|54729493|FG000|First Period (First 6 Months)|Death|0|||
27942095|NCT04713553|54598869|FG001|Primary Study (2 Months)|Withdrawal by Subject|3|||
27942096|NCT04713553|54598870|FG002|Primary Study (2 Months)|Withdrawal by Subject|0|||
27825196|NCT01746901|54290646|FG005|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
27825197|NCT01746901|54290647|FG006|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
27825198|NCT01746901|54290648|FG007|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
27825199|NCT01746901|54290649|FG008|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
27825200|NCT01746901|54290641|FG000|Treatment Phase: Fourth Intervention|Adverse Event|0|||
27825201|NCT01746901|54290642|FG001|Treatment Phase: Fourth Intervention|Adverse Event|0|||
27825202|NCT01746901|54290643|FG002|Treatment Phase: Fourth Intervention|Adverse Event|0|||
28074986|NCT00131664|54729494|FG001|First Period (First 6 Months)|Death|1|||
28074987|NCT00131664|54729495|FG002|First Period (First 6 Months)|Death|0|||
28074988|NCT00131664|54729496|FG003|First Period (First 6 Months)|Death|0|||
28074989|NCT00131664|54729497|FG004|First Period (First 6 Months)|Death|0|||
28074990|NCT00131664|54729498|FG005|First Period (First 6 Months)|Death|0|||
28074991|NCT00131664|54729493|FG000|First Period (First 6 Months)|Protocol Violation|2|||
28074992|NCT00131664|54729494|FG001|First Period (First 6 Months)|Protocol Violation|2|||
28074993|NCT00131664|54729495|FG002|First Period (First 6 Months)|Protocol Violation|1|||
28074994|NCT00131664|54729496|FG003|First Period (First 6 Months)|Protocol Violation|0|||
28074995|NCT00131664|54729497|FG004|First Period (First 6 Months)|Protocol Violation|0|||
28074996|NCT00131664|54729498|FG005|First Period (First 6 Months)|Protocol Violation|0|||
28074997|NCT00131664|54729493|FG000|First Period (First 6 Months)|Withdrawal by Subject|4|||
28074998|NCT00131664|54729494|FG001|First Period (First 6 Months)|Withdrawal by Subject|6|||
28074999|NCT00131664|54729495|FG002|First Period (First 6 Months)|Withdrawal by Subject|2|||
28075000|NCT00131664|54729496|FG003|First Period (First 6 Months)|Withdrawal by Subject|0|||
28075001|NCT00131664|54729497|FG004|First Period (First 6 Months)|Withdrawal by Subject|0|||
28075002|NCT00131664|54729498|FG005|First Period (First 6 Months)|Withdrawal by Subject|0|||
28075003|NCT00131664|54729493|FG000|First Period (First 6 Months)|Adverse Event|9|||
28155829|NCT02696031|54825339|FG001|Up to Week 24|Lack of Efficacy|1|||
28155830|NCT02696031|54825340|FG002|Up to Week 24|Lack of Efficacy|2|||
28155831|NCT02696031|54825341|FG003|Up to Week 24|Lack of Efficacy|0|||
27942097|NCT04713553|54598871|FG003|Primary Study (2 Months)|Withdrawal by Subject|0|||
28155832|NCT02696031|54825342|FG004|Up to Week 24|Lack of Efficacy|0|||
28155833|NCT02696031|54825343|FG005|Up to Week 24|Lack of Efficacy|0|||
28155834|NCT02696031|54825338|FG000|Up to Week 24|Lost to Follow-up|0|||
28155835|NCT02696031|54825339|FG001|Up to Week 24|Lost to Follow-up|1|||
28155836|NCT02696031|54825340|FG002|Up to Week 24|Lost to Follow-up|1|||
28155837|NCT02696031|54825341|FG003|Up to Week 24|Lost to Follow-up|0|||
27825203|NCT01746901|54290644|FG003|Treatment Phase: Fourth Intervention|Adverse Event|0|||
28075004|NCT00131664|54729494|FG001|First Period (First 6 Months)|Adverse Event|4|||
28075005|NCT00131664|54729495|FG002|First Period (First 6 Months)|Adverse Event|5|||
28155838|NCT02696031|54825342|FG004|Up to Week 24|Lost to Follow-up|0|||
28155839|NCT02696031|54825343|FG005|Up to Week 24|Lost to Follow-up|0|||
28155840|NCT02696031|54825338|FG000|Up to Week 24|Physician Decision|1|||
28155841|NCT02696031|54825339|FG001|Up to Week 24|Physician Decision|0|||
28155842|NCT02696031|54825340|FG002|Up to Week 24|Physician Decision|1|||
28155843|NCT02696031|54825341|FG003|Up to Week 24|Physician Decision|0|||
28155844|NCT02696031|54825342|FG004|Up to Week 24|Physician Decision|0|||
28155845|NCT02696031|54825343|FG005|Up to Week 24|Physician Decision|0|||
28155846|NCT02696031|54825338|FG000|Up to Week 24|Protocol Violation|1|||
28155847|NCT02696031|54825339|FG001|Up to Week 24|Protocol Violation|0|||
28155848|NCT02696031|54825340|FG002|Up to Week 24|Protocol Violation|0|||
28155849|NCT02696031|54825341|FG003|Up to Week 24|Protocol Violation|0|||
28155850|NCT02696031|54825342|FG004|Up to Week 24|Protocol Violation|0|||
28155851|NCT02696031|54825343|FG005|Up to Week 24|Protocol Violation|0|||
28155852|NCT02696031|54825338|FG000|Up to Week 24|Withdrawal by Subject|4|||
28155853|NCT02696031|54825339|FG001|Up to Week 24|Withdrawal by Subject|1|||
28155854|NCT02696031|54825340|FG002|Up to Week 24|Withdrawal by Subject|5|||
28155855|NCT02696031|54825341|FG003|Up to Week 24|Withdrawal by Subject|0|||
28155856|NCT02696031|54825342|FG004|Up to Week 24|Withdrawal by Subject|0|||
27825204|NCT01746901|54290645|FG004|Treatment Phase: Fourth Intervention|Adverse Event|0|||
28155857|NCT02696031|54825343|FG005|Up to Week 24|Withdrawal by Subject|0|||
28155858|NCT02696031|54825338|FG000|Up to Week 52|Adverse Event|4|||
28155859|NCT02696031|54825339|FG001|Up to Week 52|Adverse Event|5|||
28155860|NCT02696031|54825340|FG002|Up to Week 52|Adverse Event|3|||
28155861|NCT02696031|54825341|FG003|Up to Week 52|Adverse Event|0|||
27942098|NCT04713553|54598872|FG004|Primary Study (2 Months)|Withdrawal by Subject|1|||
27942099|NCT04713553|54598873|FG005|Primary Study (2 Months)|Withdrawal by Subject|0|||
27942100|NCT04713553|54598874|FG006|Primary Study (2 Months)|Withdrawal by Subject|0|||
27942101|NCT04713553|54598868|FG000|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
27942102|NCT04713553|54598869|FG001|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
27942103|NCT04713553|54598870|FG002|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
27942104|NCT04713553|54598871|FG003|Primary Study (2 Months)|Withdrawal by parent/guardian|1|||
27942105|NCT04713553|54598872|FG004|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
27942106|NCT04713553|54598873|FG005|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
27942107|NCT04713553|54598874|FG006|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
27942108|NCT04713553|54598868|FG000|Primary Study (2 Months)|Other|1|||
27942109|NCT04713553|54598869|FG001|Primary Study (2 Months)|Other|2|||
27942110|NCT04713553|54598870|FG002|Primary Study (2 Months)|Other|0|||
27942111|NCT04713553|54598871|FG003|Primary Study (2 Months)|Other|0|||
27942112|NCT04713553|54598872|FG004|Primary Study (2 Months)|Other|1|||
27942113|NCT04713553|54598873|FG005|Primary Study (2 Months)|Other|0|||
27942114|NCT04713553|54598874|FG006|Primary Study (2 Months)|Other|0|||
27942115|NCT04713553|54598868|FG000|Primary Study (2 Months)|Lost to Follow-up|1|||
27942116|NCT04713553|54598869|FG001|Primary Study (2 Months)|Lost to Follow-up|1|||
27942117|NCT04713553|54598870|FG002|Primary Study (2 Months)|Lost to Follow-up|2|||
27942118|NCT04713553|54598871|FG003|Primary Study (2 Months)|Lost to Follow-up|1|||
27942119|NCT04713553|54598872|FG004|Primary Study (2 Months)|Lost to Follow-up|0|||
27942120|NCT04713553|54598873|FG005|Primary Study (2 Months)|Lost to Follow-up|0|||
27942121|NCT04713553|54598874|FG006|Primary Study (2 Months)|Lost to Follow-up|0|||
27942122|NCT04713553|54598868|FG000|Primary Study (2 Months)|Inclusion criteria not met|0|||
27942123|NCT04713553|54598869|FG001|Primary Study (2 Months)|Inclusion criteria not met|0|||
27942124|NCT04713553|54598870|FG002|Primary Study (2 Months)|Inclusion criteria not met|1|||
27942125|NCT04713553|54598871|FG003|Primary Study (2 Months)|Inclusion criteria not met|0|||
27942126|NCT04713553|54598872|FG004|Primary Study (2 Months)|Inclusion criteria not met|0|||
27942127|NCT04713553|54598873|FG005|Primary Study (2 Months)|Inclusion criteria not met|0|||
27942128|NCT04713553|54598874|FG006|Primary Study (2 Months)|Inclusion criteria not met|0|||
27942129|NCT01206101|54598897|FG000|Overall Study|Adverse Event|1|||
28155862|NCT02696031|54825342|FG004|Up to Week 52|Adverse Event|0|||
28155863|NCT02696031|54825343|FG005|Up to Week 52|Adverse Event|0|||
28155864|NCT02696031|54825338|FG000|Up to Week 52|Lack of Efficacy|10|||
28155865|NCT02696031|54825339|FG001|Up to Week 52|Lack of Efficacy|7|||
28155866|NCT02696031|54825340|FG002|Up to Week 52|Lack of Efficacy|11|||
28155867|NCT02696031|54825341|FG003|Up to Week 52|Lack of Efficacy|0|||
28155868|NCT02696031|54825342|FG004|Up to Week 52|Lack of Efficacy|0|||
28155869|NCT02696031|54825343|FG005|Up to Week 52|Lack of Efficacy|0|||
28155870|NCT02696031|54825338|FG000|Up to Week 52|Lost to Follow-up|1|||
28155871|NCT02696031|54825339|FG001|Up to Week 52|Lost to Follow-up|1|||
28155872|NCT02696031|54825340|FG002|Up to Week 52|Lost to Follow-up|1|||
28155873|NCT02696031|54825341|FG003|Up to Week 52|Lost to Follow-up|0|||
28155874|NCT02696031|54825342|FG004|Up to Week 52|Lost to Follow-up|0|||
28155875|NCT02696031|54825343|FG005|Up to Week 52|Lost to Follow-up|0|||
28155876|NCT02696031|54825338|FG000|Up to Week 52|Physician Decision|1|||
28155877|NCT02696031|54825339|FG001|Up to Week 52|Physician Decision|1|||
28155878|NCT02696031|54825340|FG002|Up to Week 52|Physician Decision|2|||
27850308|NCT04178967|54349325|FG010|Induction Period|Participant Missed Study Visits|0|||
27850309|NCT04178967|54349315|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
27850310|NCT04178967|54349316|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
27850311|NCT04178967|54349317|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
27942130|NCT01206101|54598898|FG001|Overall Study|Adverse Event|0|||
27942131|NCT01206101|54598897|FG000|Overall Study|Physician Decision|0|||
27850312|NCT04178967|54349318|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
28155879|NCT02696031|54825341|FG003|Up to Week 52|Physician Decision|0|||
28155880|NCT02696031|54825342|FG004|Up to Week 52|Physician Decision|0|||
28155881|NCT02696031|54825343|FG005|Up to Week 52|Physician Decision|0|||
28155882|NCT02696031|54825338|FG000|Up to Week 52|Pregnancy|0|||
27942132|NCT01206101|54598898|FG001|Overall Study|Physician Decision|1|||
28155883|NCT02696031|54825339|FG001|Up to Week 52|Pregnancy|2|||
28155884|NCT02696031|54825340|FG002|Up to Week 52|Pregnancy|0|||
28075006|NCT00131664|54729496|FG003|First Period (First 6 Months)|Adverse Event|0|||
28075007|NCT00131664|54729497|FG004|First Period (First 6 Months)|Adverse Event|0|||
28155885|NCT02696031|54825341|FG003|Up to Week 52|Pregnancy|0|||
28155886|NCT02696031|54825342|FG004|Up to Week 52|Pregnancy|0|||
28155887|NCT02696031|54825343|FG005|Up to Week 52|Pregnancy|0|||
28155888|NCT02696031|54825338|FG000|Up to Week 52|Protocol Violation|1|||
28155889|NCT02696031|54825339|FG001|Up to Week 52|Protocol Violation|0|||
28155890|NCT02696031|54825340|FG002|Up to Week 52|Protocol Violation|0|||
28155891|NCT02696031|54825341|FG003|Up to Week 52|Protocol Violation|0|||
28155892|NCT02696031|54825342|FG004|Up to Week 52|Protocol Violation|0|||
28155893|NCT02696031|54825343|FG005|Up to Week 52|Protocol Violation|0|||
28155894|NCT02696031|54825338|FG000|Up to Week 52|Withdrawal by Subject|12|||
28155895|NCT02696031|54825339|FG001|Up to Week 52|Withdrawal by Subject|3|||
28155896|NCT02696031|54825340|FG002|Up to Week 52|Withdrawal by Subject|9|||
28155897|NCT02696031|54825341|FG003|Up to Week 52|Withdrawal by Subject|0|||
28155898|NCT02696031|54825342|FG004|Up to Week 52|Withdrawal by Subject|0|||
28155899|NCT02696031|54825343|FG005|Up to Week 52|Withdrawal by Subject|0|||
28155900|NCT02696031|54825338|FG000|Up to Week 104|Pregnancy|0|||
28155901|NCT02696031|54825339|FG001|Up to Week 104|Pregnancy|2|||
28155902|NCT02696031|54825340|FG002|Up to Week 104|Pregnancy|1|||
28155903|NCT02696031|54825341|FG003|Up to Week 104|Pregnancy|0|||
28155904|NCT02696031|54825342|FG004|Up to Week 104|Pregnancy|0|||
28155905|NCT02696031|54825343|FG005|Up to Week 104|Pregnancy|0|||
28155906|NCT02696031|54825338|FG000|Up to Week 104|Withdrawal by Subject|15|||
28155907|NCT02696031|54825339|FG001|Up to Week 104|Withdrawal by Subject|10|||
28155908|NCT02696031|54825340|FG002|Up to Week 104|Withdrawal by Subject|16|||
28155909|NCT02696031|54825341|FG003|Up to Week 104|Withdrawal by Subject|0|||
28155910|NCT02696031|54825342|FG004|Up to Week 104|Withdrawal by Subject|0|||
28155911|NCT02696031|54825343|FG005|Up to Week 104|Withdrawal by Subject|0|||
28155912|NCT02696031|54825338|FG000|Up to Week 104|Protocol Violation|1|||
28155913|NCT02696031|54825339|FG001|Up to Week 104|Protocol Violation|0|||
28155914|NCT02696031|54825340|FG002|Up to Week 104|Protocol Violation|0|||
28155915|NCT02696031|54825341|FG003|Up to Week 104|Protocol Violation|0|||
28155916|NCT02696031|54825342|FG004|Up to Week 104|Protocol Violation|0|||
28155917|NCT02696031|54825343|FG005|Up to Week 104|Protocol Violation|0|||
27825205|NCT01746901|54290646|FG005|Treatment Phase: Fourth Intervention|Adverse Event|1|||
27825206|NCT01746901|54290647|FG006|Treatment Phase: Fourth Intervention|Adverse Event|0|||
27942133|NCT01206101|54598897|FG000|Overall Study|Unclassified|1|||
28155918|NCT02696031|54825338|FG000|Up to Week 104|Physician Decision|1|||
28155919|NCT02696031|54825339|FG001|Up to Week 104|Physician Decision|2|||
28155920|NCT02696031|54825340|FG002|Up to Week 104|Physician Decision|3|||
28155921|NCT02696031|54825341|FG003|Up to Week 104|Physician Decision|0|||
28155922|NCT02696031|54825342|FG004|Up to Week 104|Physician Decision|0|||
28155923|NCT02696031|54825343|FG005|Up to Week 104|Physician Decision|0|||
28155924|NCT02696031|54825338|FG000|Up to Week 104|Lost to Follow-up|2|||
28155925|NCT02696031|54825339|FG001|Up to Week 104|Lost to Follow-up|3|||
28155926|NCT02696031|54825340|FG002|Up to Week 104|Lost to Follow-up|1|||
28155927|NCT02696031|54825341|FG003|Up to Week 104|Lost to Follow-up|0|||
28155928|NCT02696031|54825342|FG004|Up to Week 104|Lost to Follow-up|0|||
28155929|NCT02696031|54825343|FG005|Up to Week 104|Lost to Follow-up|0|||
28155930|NCT02696031|54825338|FG000|Up to Week 104|Lack of Efficacy|13|||
28155931|NCT02696031|54825339|FG001|Up to Week 104|Lack of Efficacy|12|||
28155932|NCT02696031|54825340|FG002|Up to Week 104|Lack of Efficacy|11|||
28155933|NCT02696031|54825341|FG003|Up to Week 104|Lack of Efficacy|0|||
28155934|NCT02696031|54825342|FG004|Up to Week 104|Lack of Efficacy|0|||
28155935|NCT02696031|54825343|FG005|Up to Week 104|Lack of Efficacy|0|||
28155936|NCT02696031|54825338|FG000|Up to Week 104|Adverse Event|7|||
28155937|NCT02696031|54825339|FG001|Up to Week 104|Adverse Event|11|||
28155938|NCT02696031|54825340|FG002|Up to Week 104|Adverse Event|5|||
28155939|NCT02696031|54825341|FG003|Up to Week 104|Adverse Event|0|||
28155940|NCT02696031|54825342|FG004|Up to Week 104|Adverse Event|0|||
28155941|NCT02696031|54825343|FG005|Up to Week 104|Adverse Event|0|||
28155942|NCT02696031|54825338|FG000|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
27850313|NCT04178967|54349319|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
28075008|NCT00131664|54729498|FG005|First Period (First 6 Months)|Adverse Event|0|||
28075009|NCT00131664|54729493|FG000|First Period (First 6 Months)|Clinically significant lab abnormalities|1|||
28075010|NCT00131664|54729494|FG001|First Period (First 6 Months)|Clinically significant lab abnormalities|2|||
28155943|NCT02696031|54825339|FG001|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|1|||
28155944|NCT02696031|54825340|FG002|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
28155945|NCT02696031|54825341|FG003|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
28155946|NCT02696031|54825342|FG004|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
28155947|NCT02696031|54825343|FG005|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
28155948|NCT02696031|54825338|FG000|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
28155949|NCT02696031|54825339|FG001|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
28155950|NCT02696031|54825340|FG002|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
28155951|NCT02696031|54825341|FG003|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|6|||
28155952|NCT02696031|54825342|FG004|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|8|||
28155953|NCT02696031|54825343|FG005|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|2|||
28155954|NCT02696031|54825338|FG000|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
28155955|NCT02696031|54825339|FG001|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
28155956|NCT02696031|54825340|FG002|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
27825207|NCT01746901|54290648|FG007|Treatment Phase: Fourth Intervention|Adverse Event|0|||
28155957|NCT02696031|54825341|FG003|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
28155958|NCT02696031|54825342|FG004|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
28155959|NCT02696031|54825343|FG005|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
28155960|NCT02696031|54825338|FG000|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
28075011|NCT00131664|54729495|FG002|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
28155961|NCT02696031|54825339|FG001|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
28155962|NCT02696031|54825340|FG002|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
28155963|NCT02696031|54825341|FG003|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|1|||
28155964|NCT02696031|54825342|FG004|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
28155965|NCT02696031|54825343|FG005|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
28155966|NCT02696031|54825338|FG000|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
28155967|NCT02696031|54825339|FG001|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
28155968|NCT02696031|54825340|FG002|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
28155969|NCT02696031|54825341|FG003|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
28155970|NCT02696031|54825342|FG004|Extension Phase From wk 104 to wk 208|Lost to Follow-up|1|||
28155971|NCT02696031|54825343|FG005|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
28155972|NCT02696031|54825338|FG000|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
28155973|NCT02696031|54825339|FG001|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
28075012|NCT00131664|54729496|FG003|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
28075013|NCT00131664|54729497|FG004|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
28075014|NCT00131664|54729498|FG005|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
28075015|NCT00131664|54729493|FG000|First Period (First 6 Months)|Administrative reasons|2|||
28075016|NCT00131664|54729494|FG001|First Period (First 6 Months)|Administrative reasons|0|||
28075017|NCT00131664|54729495|FG002|First Period (First 6 Months)|Administrative reasons|5|||
28155974|NCT02696031|54825340|FG002|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
28155975|NCT02696031|54825341|FG003|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
28155976|NCT02696031|54825342|FG004|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
28155977|NCT02696031|54825343|FG005|Extension Phase From wk 104 to wk 208|Lack of Efficacy|3|||
28155978|NCT02696031|54825338|FG000|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
28155979|NCT02696031|54825339|FG001|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
28155980|NCT02696031|54825340|FG002|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
28155981|NCT02696031|54825341|FG003|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
28155982|NCT02696031|54825342|FG004|Extension Phase From wk 104 to wk 208|Adverse Event|4|||
28155983|NCT02696031|54825343|FG005|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
28075018|NCT00131664|54729496|FG003|First Period (First 6 Months)|Administrative reasons|0|||
28155984|NCT00397254|54825352|FG000|Overall Study|Lost to Follow-up|2|||
28155985|NCT00397254|54825353|FG001|Overall Study|Lost to Follow-up|2|||
28155986|NCT01369641|54825357|FG000|Overall Study|Withdrawal by Subject|1|||
28075019|NCT00131664|54729497|FG004|First Period (First 6 Months)|Administrative reasons|0|||
28075020|NCT00131664|54729498|FG005|First Period (First 6 Months)|Administrative reasons|0|||
28075021|NCT00131664|54729493|FG000|Second Period (Additional Drug Added)|Lost to Follow-up|3|||
28075022|NCT00131664|54729494|FG001|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
28075023|NCT00131664|54729495|FG002|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
28075024|NCT00131664|54729496|FG003|Second Period (Additional Drug Added)|Lost to Follow-up|1|||
28075025|NCT00131664|54729497|FG004|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
28075026|NCT00131664|54729498|FG005|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
28075027|NCT00131664|54729493|FG000|Second Period (Additional Drug Added)|Protocol Violation|0|||
28075028|NCT00131664|54729494|FG001|Second Period (Additional Drug Added)|Protocol Violation|1|||
28075029|NCT00131664|54729495|FG002|Second Period (Additional Drug Added)|Protocol Violation|1|||
28075030|NCT00131664|54729496|FG003|Second Period (Additional Drug Added)|Protocol Violation|0|||
28075031|NCT00131664|54729497|FG004|Second Period (Additional Drug Added)|Protocol Violation|0|||
28075032|NCT00131664|54729498|FG005|Second Period (Additional Drug Added)|Protocol Violation|0|||
28075033|NCT00131664|54729493|FG000|Second Period (Additional Drug Added)|Withdrawal by Subject|2|||
28075034|NCT00131664|54729494|FG001|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
28155987|NCT00529152|54825361|FG000|Overall Study|Adverse Event|2|||
28155988|NCT00529152|54825361|FG000|Overall Study|Withdrawal by Subject|2|||
28155989|NCT00529152|54825361|FG000|Overall Study|Lost to Follow-up|1|||
28155990|NCT02605174|54825368|FG000|Overall Study|Adverse Event|0|||
28155991|NCT02605174|54825369|FG001|Overall Study|Adverse Event|0|||
28155992|NCT02605174|54825370|FG002|Overall Study|Adverse Event|1|||
27825208|NCT01746901|54290649|FG008|Treatment Phase: Fourth Intervention|Adverse Event|1|||
27825209|NCT01746901|54290641|FG000|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
27825210|NCT01746901|54290642|FG001|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
27825211|NCT01746901|54290643|FG002|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
27942134|NCT01206101|54598898|FG001|Overall Study|Unclassified|0|||
28075035|NCT00131664|54729495|FG002|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
28075036|NCT00131664|54729496|FG003|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
28155993|NCT02605174|54825371|FG003|Overall Study|Adverse Event|0|||
28155994|NCT02605174|54825372|FG004|Overall Study|Adverse Event|4|||
28155995|NCT02605174|54825373|FG005|Overall Study|Adverse Event|0|||
28155996|NCT02605174|54825374|FG006|Overall Study|Adverse Event|0|||
28155997|NCT02605174|54825368|FG000|Overall Study|Lost to Follow-up|20|||
28155998|NCT02605174|54825369|FG001|Overall Study|Lost to Follow-up|7|||
28155999|NCT02605174|54825370|FG002|Overall Study|Lost to Follow-up|27|||
28156000|NCT02605174|54825371|FG003|Overall Study|Lost to Follow-up|10|||
28156001|NCT02605174|54825372|FG004|Overall Study|Lost to Follow-up|20|||
28156002|NCT02605174|54825373|FG005|Overall Study|Lost to Follow-up|10|||
28156003|NCT02605174|54825374|FG006|Overall Study|Lost to Follow-up|29|||
28156004|NCT02605174|54825368|FG000|Overall Study|Protocol Violation|10|||
28156005|NCT02605174|54825369|FG001|Overall Study|Protocol Violation|4|||
28156006|NCT02605174|54825370|FG002|Overall Study|Protocol Violation|14|||
28156007|NCT02605174|54825371|FG003|Overall Study|Protocol Violation|6|||
28156008|NCT02605174|54825372|FG004|Overall Study|Protocol Violation|7|||
28156009|NCT02605174|54825373|FG005|Overall Study|Protocol Violation|7|||
28156010|NCT02605174|54825374|FG006|Overall Study|Protocol Violation|12|||
28156011|NCT02605174|54825368|FG000|Overall Study|Pregnancy|1|||
28156012|NCT02605174|54825369|FG001|Overall Study|Pregnancy|0|||
28156013|NCT02605174|54825370|FG002|Overall Study|Pregnancy|0|||
28156014|NCT02605174|54825371|FG003|Overall Study|Pregnancy|2|||
28156015|NCT02605174|54825372|FG004|Overall Study|Pregnancy|0|||
28156016|NCT02605174|54825373|FG005|Overall Study|Pregnancy|0|||
28156017|NCT02605174|54825374|FG006|Overall Study|Pregnancy|0|||
28156018|NCT02605174|54825368|FG000|Overall Study|Withdrawal by Subject|9|||
28156019|NCT02605174|54825369|FG001|Overall Study|Withdrawal by Subject|6|||
28156020|NCT02605174|54825370|FG002|Overall Study|Withdrawal by Subject|14|||
28156021|NCT02605174|54825371|FG003|Overall Study|Withdrawal by Subject|11|||
28156022|NCT02605174|54825372|FG004|Overall Study|Withdrawal by Subject|6|||
28156023|NCT02605174|54825373|FG005|Overall Study|Withdrawal by Subject|4|||
28156024|NCT02605174|54825374|FG006|Overall Study|Withdrawal by Subject|15|||
28156025|NCT02605174|54825368|FG000|Overall Study|Physician Decision|2|||
28156026|NCT02605174|54825369|FG001|Overall Study|Physician Decision|0|||
28075037|NCT00131664|54729497|FG004|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
28075038|NCT00131664|54729498|FG005|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
28075039|NCT00131664|54729493|FG000|Second Period (Additional Drug Added)|Adverse Event|0|||
28075040|NCT00131664|54729494|FG001|Second Period (Additional Drug Added)|Adverse Event|1|||
28075041|NCT00131664|54729495|FG002|Second Period (Additional Drug Added)|Adverse Event|0|||
28075042|NCT00131664|54729496|FG003|Second Period (Additional Drug Added)|Adverse Event|0|||
28075043|NCT00131664|54729497|FG004|Second Period (Additional Drug Added)|Adverse Event|0|||
28075044|NCT00131664|54729498|FG005|Second Period (Additional Drug Added)|Adverse Event|1|||
28075045|NCT00131664|54729493|FG000|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
28075046|NCT00131664|54729494|FG001|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
28075047|NCT00131664|54729495|FG002|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
28075048|NCT00131664|54729496|FG003|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1|||
28075049|NCT00131664|54729497|FG004|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
28075050|NCT00131664|54729498|FG005|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
28075051|NCT00131664|54729493|FG000|Second Period (Additional Drug Added)|Administrative reasons|4|||
28075052|NCT00131664|54729494|FG001|Second Period (Additional Drug Added)|Administrative reasons|2|||
28075053|NCT00131664|54729495|FG002|Second Period (Additional Drug Added)|Administrative reasons|0|||
28075054|NCT00131664|54729496|FG003|Second Period (Additional Drug Added)|Administrative reasons|0|||
28075055|NCT00131664|54729497|FG004|Second Period (Additional Drug Added)|Administrative reasons|1|||
28075056|NCT00131664|54729498|FG005|Second Period (Additional Drug Added)|Administrative reasons|0|||
28075057|NCT00131508|54729511|FG000|Overall Study|Disease progression|0|||
28075058|NCT00131508|54729512|FG001|Overall Study|Disease progression|2|||
28075059|NCT00131508|54729511|FG000|Overall Study|Non-Compliance|2|||
28075060|NCT00131508|54729512|FG001|Overall Study|Non-Compliance|4|||
28075061|NCT00131508|54729511|FG000|Overall Study|Withdrawal by Subject|1|||
28075062|NCT00131508|54729512|FG001|Overall Study|Withdrawal by Subject|2|||
28075063|NCT05050318|54729521|FG000|Overall Study|Protocol Deviation|1|||
28075064|NCT05050318|54729522|FG001|Overall Study|Protocol Deviation|0|||
28075065|NCT05050318|54729523|FG002|Overall Study|Protocol Deviation|0|||
28075066|NCT03699124|54729534|FG000|Overall Study|Adverse Event|6|||
28075067|NCT03699124|54729535|FG001|Overall Study|Adverse Event|5|||
28075068|NCT03699124|54729536|FG002|Overall Study|Adverse Event|2|||
28075069|NCT03699124|54729534|FG000|Overall Study|Death|0|||
28075070|NCT03699124|54729535|FG001|Overall Study|Death|2|||
28075071|NCT03699124|54729536|FG002|Overall Study|Death|0|||
28075072|NCT03699124|54729534|FG000|Overall Study|Lost to Follow-up|20|||
28075073|NCT03699124|54729535|FG001|Overall Study|Lost to Follow-up|16|||
28075074|NCT03699124|54729536|FG002|Overall Study|Lost to Follow-up|15|||
28075075|NCT03699124|54729534|FG000|Overall Study|Protocol Violation|1|||
28075076|NCT03699124|54729535|FG001|Overall Study|Protocol Violation|0|||
28075077|NCT03699124|54729536|FG002|Overall Study|Protocol Violation|0|||
28075078|NCT03699124|54729534|FG000|Overall Study|Withdrawal by Subject|13|||
28075079|NCT03699124|54729535|FG001|Overall Study|Withdrawal by Subject|14|||
28075080|NCT03699124|54729536|FG002|Overall Study|Withdrawal by Subject|13|||
28156027|NCT02605174|54825370|FG002|Overall Study|Physician Decision|0|||
28156028|NCT02605174|54825371|FG003|Overall Study|Physician Decision|0|||
28156029|NCT02605174|54825372|FG004|Overall Study|Physician Decision|0|||
28156030|NCT02605174|54825373|FG005|Overall Study|Physician Decision|0|||
28156031|NCT02605174|54825374|FG006|Overall Study|Physician Decision|3|||
27825212|NCT01746901|54290644|FG003|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
28156032|NCT02605174|54825368|FG000|Overall Study|Randomization Failure|22|||
28156033|NCT02605174|54825369|FG001|Overall Study|Randomization Failure|6|||
28156034|NCT02605174|54825370|FG002|Overall Study|Randomization Failure|20|||
28156035|NCT02605174|54825371|FG003|Overall Study|Randomization Failure|7|||
28156036|NCT02605174|54825372|FG004|Overall Study|Randomization Failure|16|||
28156037|NCT02605174|54825373|FG005|Overall Study|Randomization Failure|11|||
28156038|NCT02605174|54825374|FG006|Overall Study|Randomization Failure|30|||
28156039|NCT02604550|54825402|FG000|Overall Study|Lost to Follow-up|7|||
28156040|NCT02604550|54825403|FG001|Overall Study|Lost to Follow-up|6|||
27825213|NCT01746901|54290645|FG004|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
27825214|NCT01746901|54290646|FG005|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
27825215|NCT01746901|54290647|FG006|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
27825216|NCT01746901|54290648|FG007|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
27825217|NCT01746901|54290649|FG008|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
27825218|NCT01968551|54290688|FG000|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
27825219|NCT01968551|54290689|FG001|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
27850314|NCT04178967|54349320|FG005|Maintenance Blinded Treatment Period|Adverse Event|1|||
27942135|NCT01205165|54598904|FG000|Overall Study|Lost to Follow-up|2|||
27942136|NCT00997503|54598909|FG000|Overall Study|Death|53|||
28075081|NCT03699124|54729534|FG000|Overall Study|Other reasons|5|||
28075082|NCT03699124|54729535|FG001|Overall Study|Other reasons|3|||
27942137|NCT00997503|54598909|FG000|Overall Study|Withdrawal by Subject|76|||
28075083|NCT03699124|54729536|FG002|Overall Study|Other reasons|10|||
28075084|NCT05002972|54729544|FG000|Overall Study|Withdrawal by Subject|2|||
28075085|NCT04651114|54729548|FG000|Overall Study|Withdrawal by Subject|8|||
28075086|NCT04980040|54729552|FG000|Overall Study|Violated the Inclusion Criteria|260|||
28075087|NCT04980040|54729552|FG000|Overall Study|Violated the Administration & Dosage|225|||
28075088|NCT04980040|54729552|FG000|Overall Study|Lost to Safety-Follow-up|4|||
28075089|NCT04980040|54729552|FG000|Overall Study|Administered the study drug prior to signing the informed consent form|3|||
28156041|NCT02604550|54825402|FG000|Overall Study|Withdrawal by Subject|0|||
28156042|NCT02604550|54825403|FG001|Overall Study|Withdrawal by Subject|1|||
28156043|NCT02604550|54825402|FG000|Overall Study|Incomplete data using paper journal|18|||
28156044|NCT02604550|54825403|FG001|Overall Study|Incomplete data using paper journal|19|||
28156045|NCT02591290|54825409|FG000|Overall Study|Withdrawal by Subject|2|||
28156046|NCT02791893|54825415|FG000|Blinded Phase|Lost to Follow-up|2|||
28156047|NCT02791893|54825416|FG001|Blinded Phase|Lost to Follow-up|2|||
28156048|NCT02791893|54825415|FG000|Blinded Phase|Withdrawal by Subject|1|||
28156049|NCT02791893|54825416|FG001|Blinded Phase|Withdrawal by Subject|2|||
28156050|NCT02791893|54825415|FG000|Open Label Phase|Lost to Follow-up|3|||
28156051|NCT02791893|54825416|FG001|Open Label Phase|Lost to Follow-up|0|||
28075090|NCT00131352|54729558|FG000|Initial Treatment Period|Adverse Event|1|||
28156052|NCT02791893|54825415|FG000|Open Label Phase|Withdrawal by Subject|0|||
28156053|NCT02791893|54825416|FG001|Open Label Phase|Withdrawal by Subject|2|||
28156054|NCT00120042|54825425|FG000|Overall Study|all completed protocl|0|||
28156055|NCT00120042|54825426|FG001|Overall Study|all completed protocl|0|||
28156056|NCT00120042|54825427|FG002|Overall Study|all completed protocl|0|||
28156057|NCT02476851|54825434|FG000|Overall Study|Protocol Violation|1|||
28156058|NCT02476851|54825435|FG001|Overall Study|Protocol Violation|1|||
28156059|NCT02595970|54825441|FG000|Overall Study|Withdrawal by Subject|2|||
28156060|NCT02595970|54825441|FG000|Overall Study|Physician Decision|2|||
27942138|NCT00997503|54598909|FG000|Overall Study|Lost to Follow-up|33|||
28156061|NCT02595970|54825441|FG000|Overall Study|Protocol Violation|4|||
28156062|NCT02595970|54825441|FG000|Overall Study|Adverse Event|5|||
28156063|NCT02595970|54825441|FG000|Overall Study|Lack of Efficacy|7|||
28156064|NCT01866111|54825449|FG000|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|14|||
28156065|NCT01866111|54825450|FG001|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|13|||
28160132|NCT03058679|54830226|FG000|Week 6 to Week 12|Difficulty following the assigned diet|2|||
28160133|NCT03058679|54830227|FG001|Week 6 to Week 12|Difficulty following the assigned diet|3|||
27825220|NCT01968551|54290690|FG002|Open Label Phase (48 Weeks)|Randomized but Never Treated|0|||
27825221|NCT01968551|54290688|FG000|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
27825222|NCT01968551|54290689|FG001|Open Label Phase (48 Weeks)|Investigator's Discretion|1|||
27825223|NCT01968551|54290690|FG002|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
27825224|NCT01968551|54290688|FG000|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
27825225|NCT01968551|54290689|FG001|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
27825226|NCT01968551|54290690|FG002|Open Label Phase (48 Weeks)|Withdrew Consent|3|||
27825227|NCT01968551|54290688|FG000|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
27825228|NCT01968551|54290689|FG001|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
27825229|NCT01968551|54290690|FG002|Open Label Phase (48 Weeks)|Lost to Follow-up|2|||
27825230|NCT01968551|54290688|FG000|Extension Phase|Adverse Event|0|||
28075091|NCT00131352|54729559|FG001|Initial Treatment Period|Adverse Event|3|||
28075092|NCT00131352|54729558|FG000|Initial Treatment Period|Non-compliant|1|||
28075093|NCT00131352|54729559|FG001|Initial Treatment Period|Non-compliant|2|||
28075094|NCT00131352|54729558|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
28075095|NCT00131352|54729559|FG001|Initial Treatment Period|Withdrawal by Subject|1|||
28075096|NCT00131352|54729558|FG000|Initial Treatment Period|Lack of Efficacy|6|||
28075097|NCT00131352|54729559|FG001|Initial Treatment Period|Lack of Efficacy|4|||
28075098|NCT00131352|54729558|FG000|Initial Treatment Period|Other|0|||
28075099|NCT00131352|54729559|FG001|Initial Treatment Period|Other|2|||
28075100|NCT00131352|54729558|FG000|Repeat Treatment Period|Adverse Event|1|||
28075101|NCT00131352|54729559|FG001|Repeat Treatment Period|Adverse Event|0|||
28075102|NCT00131352|54729558|FG000|Repeat Treatment Period|Other|1|||
28075103|NCT00131352|54729559|FG001|Repeat Treatment Period|Other|0|||
28075104|NCT04633642|54729569|FG000|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|1|||
28075105|NCT04633642|54729570|FG001|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|2|||
28075106|NCT00136916|54729578|FG000|Overall Study|Never received study treatment|3|||
28075107|NCT00136916|54729579|FG001|Overall Study|Never received study treatment|5|||
28075108|NCT00136916|54729578|FG000|Overall Study|Death|1|||
28075109|NCT00136916|54729579|FG001|Overall Study|Death|3|||
28075110|NCT00136916|54729578|FG000|Overall Study|Adverse Event|27|||
28075111|NCT00136916|54729579|FG001|Overall Study|Adverse Event|8|||
28075112|NCT00136916|54729578|FG000|Overall Study|Laboratory abnormality|0|||
28075113|NCT00136916|54729579|FG001|Overall Study|Laboratory abnormality|1|||
28075114|NCT00136916|54729578|FG000|Overall Study|Lack of Efficacy|13|||
28075115|NCT00136916|54729579|FG001|Overall Study|Lack of Efficacy|3|||
28075116|NCT00136916|54729578|FG000|Overall Study|Lost to Follow-up|12|||
28075117|NCT00136916|54729579|FG001|Overall Study|Lost to Follow-up|14|||
28075118|NCT00136916|54729578|FG000|Overall Study|Withdrawal by Subject|44|||
28075119|NCT00136916|54729579|FG001|Overall Study|Withdrawal by Subject|46|||
28075120|NCT00136916|54729578|FG000|Overall Study|Other|22|||
28075121|NCT00136916|54729579|FG001|Overall Study|Other|24|||
28075122|NCT00136916|54729578|FG000|Overall Study|Discontinued in follow up period|3|||
28075123|NCT00136916|54729579|FG001|Overall Study|Discontinued in follow up period|0|||
28075124|NCT04633564|54729589|FG000|Period 1|Adverse Event|28|||
28075125|NCT04633564|54729590|FG001|Period 1|Adverse Event|19|||
28075126|NCT04633564|54729589|FG000|Period 1|Death|8|||
28075127|NCT04633564|54729590|FG001|Period 1|Death|7|||
28075128|NCT04633564|54729589|FG000|Period 1|Lost to Follow-up|3|||
27825231|NCT01968551|54290689|FG001|Extension Phase|Adverse Event|0|||
27850315|NCT04178967|54349321|FG006|Maintenance Blinded Treatment Period|Adverse Event|2|||
28075129|NCT04633564|54729590|FG001|Period 1|Lost to Follow-up|5|||
28075130|NCT04633564|54729589|FG000|Period 1|Physician Decision|4|||
28075131|NCT04633564|54729590|FG001|Period 1|Physician Decision|12|||
28075132|NCT04633564|54729589|FG000|Period 1|Protocol Violation|0|||
28156066|NCT01866111|54825451|FG002|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|20|||
28156067|NCT01866111|54825452|FG003|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|30|||
28156068|NCT01866111|54825449|FG000|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|65|||
28156069|NCT01866111|54825450|FG001|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|67|||
28156070|NCT01866111|54825451|FG002|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|63|||
28156071|NCT01866111|54825452|FG003|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|52|||
27942139|NCT00997503|54598909|FG000|Overall Study|Adverse Event|3|||
27942140|NCT00997503|54598909|FG000|Overall Study|Physician Decision|10|||
27942141|NCT00997503|54598909|FG000|Overall Study|Missed 12-month follow-up|85|||
27942142|NCT00997503|54598909|FG000|Overall Study|Other reason|13|||
28075133|NCT04633564|54729590|FG001|Period 1|Protocol Violation|1|||
28075134|NCT04633564|54729589|FG000|Period 1|Withdrawal by Subject|10|||
28075135|NCT04633564|54729590|FG001|Period 1|Withdrawal by Subject|8|||
28075136|NCT04633564|54729589|FG000|Period 1|Progressive disease|47|||
27942143|NCT01204775|54598918|FG000|Overall Study|Poor/non-compliance|0|||
28075137|NCT04633564|54729590|FG001|Period 1|Progressive disease|51|||
28075138|NCT04633564|54729589|FG000|Period 1|Terminated by Sponsor|8|||
28075139|NCT04633564|54729590|FG001|Period 1|Terminated by Sponsor|6|||
28075140|NCT04633564|54729589|FG000|Period 2|Adverse Event|3|||
28075141|NCT04633564|54729590|FG001|Period 2|Adverse Event|4|||
28075142|NCT04633564|54729589|FG000|Period 2|Death|0|||
27942144|NCT01204775|54598919|FG001|Overall Study|Poor/non-compliance|1|||
27942145|NCT01204775|54598918|FG000|Overall Study|Withdrawal by Subject|1|||
27942146|NCT01204775|54598919|FG001|Overall Study|Withdrawal by Subject|0|||
27942147|NCT00997035|54598927|FG000|3-week Followup Visit|Lost to Follow-up|9|||
27942148|NCT00997035|54598928|FG001|3-week Followup Visit|Lost to Follow-up|6|||
27942149|NCT00997035|54598927|FG000|3-month Follow-up Visit|Lost to Follow-up|12|||
27942150|NCT00997035|54598928|FG001|3-month Follow-up Visit|Lost to Follow-up|6|||
27942151|NCT01204697|54598946|FG000|Overall Study|Death|26|||
27942152|NCT01204697|54598947|FG001|Overall Study|Death|27|||
27942153|NCT01204697|54598946|FG000|Overall Study|Lost to Follow-up|3|||
27942154|NCT01204697|54598947|FG001|Overall Study|Lost to Follow-up|4|||
27942155|NCT01204697|54598946|FG000|Overall Study|Withdrawal by Subject|2|||
27942156|NCT01204697|54598947|FG001|Overall Study|Withdrawal by Subject|4|||
27942157|NCT01204697|54598946|FG000|Overall Study|Randomized, but not treated|0|||
27942158|NCT01204697|54598947|FG001|Overall Study|Randomized, but not treated|1|||
27942159|NCT01001325|54598955|FG000|Overall Study|Lost to Follow-up|16|||
27942160|NCT01001325|54598956|FG001|Overall Study|Lost to Follow-up|10|||
27942161|NCT01001325|54598955|FG000|Overall Study|Protocol Violation|2|||
27942162|NCT01001325|54598956|FG001|Overall Study|Protocol Violation|0|||
27942163|NCT01203917|54598962|FG000|Overall Study|Death|29|||
27942164|NCT01203917|54598962|FG000|Overall Study|Lost to Follow-up|2|||
27825232|NCT01968551|54290690|FG002|Extension Phase|Adverse Event|2|||
27942165|NCT01203917|54598962|FG000|Overall Study|Withdrawal by Subject|3|||
27942166|NCT01203917|54598962|FG000|Overall Study|Due to objective disease progression|1|||
27942167|NCT01203917|54598962|FG000|Overall Study|Due to EGFR M+I patient|1|||
27942168|NCT01202903|54598968|FG000|Overall Study|Administrative Probelms|1|||
27942169|NCT01202903|54598969|FG001|Overall Study|Administrative Probelms|4|||
27942170|NCT01202903|54598968|FG000|Overall Study|Protocol Violation|0|||
27942171|NCT01202903|54598969|FG001|Overall Study|Protocol Violation|1|||
27942172|NCT01202903|54598968|FG000|Overall Study|Death|1|||
28156072|NCT02595502|54825462|FG000|Period 1|Adverse Event|0|||
28156073|NCT02595502|54825463|FG001|Period 1|Adverse Event|1|||
28156074|NCT02595502|54825462|FG000|Period 1|Withdrawal by Subject|1|||
28156075|NCT02595502|54825463|FG001|Period 1|Withdrawal by Subject|0|||
28156076|NCT02595502|54825462|FG000|Period 1|Lost to Follow-up|0|||
28156077|NCT02595502|54825463|FG001|Period 1|Lost to Follow-up|1|||
28156078|NCT02595502|54825462|FG000|Period 2|Adverse Event|1|||
28156079|NCT02595502|54825463|FG001|Period 2|Adverse Event|1|||
28156080|NCT02595502|54825462|FG000|Period 2|Received incorrect lens at Period 1|0|||
28156081|NCT02595502|54825463|FG001|Period 2|Received incorrect lens at Period 1|1|||
28156082|NCT02595502|54825462|FG000|Period 3|Protocol Violation|0|||
28156083|NCT02595502|54825463|FG001|Period 3|Protocol Violation|1|||
28156084|NCT02595502|54825462|FG000|Period 3|Lost to Follow-up|1|||
28156085|NCT02595502|54825463|FG001|Period 3|Lost to Follow-up|0|||
28156086|NCT02595502|54825462|FG000|Period 3|Received Incorrect Treatment at period 3|0|||
28156087|NCT02595502|54825463|FG001|Period 3|Received Incorrect Treatment at period 3|1|||
28156088|NCT01369329|54825472|FG000|Overall Study|Withdrawal by Subject|8|||
28156089|NCT01369329|54825473|FG001|Overall Study|Withdrawal by Subject|6|||
28156090|NCT01369329|54825474|FG002|Overall Study|Withdrawal by Subject|10|||
28156091|NCT01369329|54825472|FG000|Overall Study|Lost to Follow-up|2|||
28156092|NCT01369329|54825473|FG001|Overall Study|Lost to Follow-up|2|||
27825233|NCT01968551|54290688|FG000|Extension Phase|Death|0|||
27825234|NCT01968551|54290689|FG001|Extension Phase|Death|1|||
27825235|NCT01968551|54290690|FG002|Extension Phase|Death|0|||
27825236|NCT01968551|54290688|FG000|Extension Phase|Withdrew Consent|0|||
28156093|NCT01369329|54825474|FG002|Overall Study|Lost to Follow-up|2|||
28156094|NCT01369329|54825472|FG000|Overall Study|Other|2|||
28156095|NCT01369329|54825473|FG001|Overall Study|Other|3|||
28156096|NCT01369329|54825474|FG002|Overall Study|Other|2|||
28156097|NCT02791659|54825484|FG000|Overall Study|Protocol Violation|0|||
28156098|NCT02791659|54825485|FG001|Overall Study|Protocol Violation|1|||
28156099|NCT02594098|54825493|FG000|Overall Study|Lack of Efficacy|17|||
28156100|NCT02594098|54825494|FG001|Overall Study|Lack of Efficacy|6|||
28156101|NCT02594098|54825493|FG000|Overall Study|Withdrawal by Subject|1|||
28156102|NCT02594098|54825494|FG001|Overall Study|Withdrawal by Subject|3|||
28156103|NCT02594098|54825493|FG000|Overall Study|Terminated participation|6|||
28156104|NCT02594098|54825494|FG001|Overall Study|Terminated participation|2|||
28156105|NCT02594098|54825493|FG000|Overall Study|Seek alternative treatment|2|||
28156106|NCT02594098|54825494|FG001|Overall Study|Seek alternative treatment|1|||
28156107|NCT02594098|54825493|FG000|Overall Study|Other|0|||
28156108|NCT02594098|54825494|FG001|Overall Study|Other|1|||
28156109|NCT02593864|54825502|FG000|Overall Study|Withdrawal by Subject|3|||
28156110|NCT02593864|54825502|FG000|Overall Study|Lost to Follow-up|3|||
28156111|NCT02590588|54825506|FG000|Overall Study|Adverse Event|1|||
28156112|NCT01434602|54825515|FG000|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
28156113|NCT01434602|54825516|FG001|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|1|||
28156114|NCT01434602|54825517|FG002|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
28156115|NCT01434602|54825518|FG003|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
28156116|NCT01434602|54825519|FG004|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
28156117|NCT01434602|54825515|FG000|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
28156118|NCT01434602|54825516|FG001|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
28156119|NCT01434602|54825517|FG002|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
28156120|NCT01434602|54825518|FG003|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|1|||
28156121|NCT01434602|54825519|FG004|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
28156122|NCT01434602|54825515|FG000|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
28156123|NCT01434602|54825516|FG001|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
28156124|NCT01434602|54825517|FG002|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
28156125|NCT01434602|54825518|FG003|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|1|||
28156126|NCT01434602|54825519|FG004|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
28156127|NCT01434602|54825515|FG000|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
28156128|NCT01434602|54825516|FG001|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
28156129|NCT01434602|54825517|FG002|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
28156130|NCT01434602|54825518|FG003|Phase II Recommended Phase 2 Dose|Started new therapy|1|||
28156131|NCT01434602|54825519|FG004|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
28156132|NCT01434602|54825515|FG000|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
28156133|NCT01434602|54825516|FG001|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
27825237|NCT01968551|54290689|FG001|Extension Phase|Withdrew Consent|0|||
28156134|NCT01434602|54825517|FG002|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
28156135|NCT01434602|54825518|FG003|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|1|||
28156136|NCT01434602|54825519|FG004|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
28156137|NCT01434602|54825515|FG000|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
28156138|NCT01434602|54825516|FG001|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
28156139|NCT01434602|54825517|FG002|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
28156140|NCT01434602|54825518|FG003|Phase II Recommended Phase 2 Dose|Transfer of care|1|||
28156141|NCT01434602|54825519|FG004|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
28156142|NCT01434602|54825515|FG000|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
28156143|NCT01434602|54825516|FG001|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
28156144|NCT01434602|54825517|FG002|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
28156145|NCT01434602|54825518|FG003|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
27825238|NCT01968551|54290690|FG002|Extension Phase|Withdrew Consent|1|||
27825239|NCT01968551|54290688|FG000|Extension Phase|Lost to Follow-up|1|||
27825240|NCT01968551|54290689|FG001|Extension Phase|Lost to Follow-up|0|||
28156146|NCT01434602|54825519|FG004|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|1|||
27825241|NCT01968551|54290690|FG002|Extension Phase|Lost to Follow-up|1|||
27825242|NCT01707992|54290705|FG000|Placebo-Controlled Phase (24 Months)|Adverse Event|8|||
27942173|NCT01202903|54598969|FG001|Overall Study|Death|0|||
28156147|NCT01434602|54825515|FG000|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
28156148|NCT01434602|54825516|FG001|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
28156149|NCT01434602|54825517|FG002|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
28156150|NCT01434602|54825518|FG003|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
28156151|NCT01434602|54825519|FG004|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
28156152|NCT01434602|54825515|FG000|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
28156153|NCT01434602|54825516|FG001|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
28156154|NCT01434602|54825517|FG002|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
28156155|NCT01434602|54825518|FG003|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|1|||
28156156|NCT01434602|54825519|FG004|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
28156157|NCT01434602|54825515|FG000|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
28156158|NCT01434602|54825516|FG001|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
28156159|NCT01434602|54825517|FG002|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
28156160|NCT01434602|54825518|FG003|Phase II Recommended Phase 2 Dose|Refused further treatment|2|||
28156161|NCT01434602|54825519|FG004|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
28156162|NCT01767129|54825541|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
28156163|NCT01767129|54825542|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
28156164|NCT02791269|54825551|FG000|Overall Study|Lost to Follow-up|0|||
28156165|NCT02791269|54825552|FG001|Overall Study|Lost to Follow-up|1|||
28156166|NCT02696564|54825562|FG000|Overall Study|Death|1|||
28156167|NCT02696564|54825563|FG001|Overall Study|Death|2|||
28156168|NCT02696564|54825562|FG000|Overall Study|Withdrawal by Subject|3|||
28156169|NCT02696564|54825563|FG001|Overall Study|Withdrawal by Subject|2|||
28156170|NCT02696564|54825562|FG000|Overall Study|Lost to Follow-up|3|||
28156171|NCT02696564|54825563|FG001|Overall Study|Lost to Follow-up|3|||
28156172|NCT02696564|54825562|FG000|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|3|||
28156173|NCT02696564|54825563|FG001|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|1|||
28156174|NCT02696564|54825562|FG000|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
28156175|NCT02696564|54825563|FG001|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
28156176|NCT02696564|54825562|FG000|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
28156177|NCT02696564|54825563|FG001|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
28156178|NCT02696564|54825562|FG000|Overall Study|Participant diagnosed with lung cancer|1|||
28156179|NCT02696564|54825563|FG001|Overall Study|Participant diagnosed with lung cancer|0|||
28156180|NCT02696564|54825562|FG000|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|0|||
28156181|NCT02696564|54825563|FG001|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|2|||
28156182|NCT02640950|54825569|FG000|Overall Study|Adverse Event|1|||
28156183|NCT02640950|54825569|FG000|Overall Study|Withdrawal by Subject|1|||
28156184|NCT02593786|54825577|FG000|Overall Study|Disease progression|12|||
28156185|NCT02593786|54825578|FG001|Overall Study|Disease progression|16|||
28156186|NCT02593786|54825579|FG002|Overall Study|Disease progression|10|||
27942174|NCT01202903|54598968|FG000|Overall Study|Lost to Follow-up|1|||
28156187|NCT02593786|54825580|FG003|Overall Study|Disease progression|7|||
28156188|NCT02593786|54825577|FG000|Overall Study|Study drug toxicity|1|||
28156189|NCT02593786|54825578|FG001|Overall Study|Study drug toxicity|0|||
28156190|NCT02593786|54825579|FG002|Overall Study|Study drug toxicity|0|||
28156191|NCT02593786|54825580|FG003|Overall Study|Study drug toxicity|0|||
28156192|NCT02593786|54825577|FG000|Overall Study|Adverse event unrelated to study drug|1|||
28156193|NCT02593786|54825578|FG001|Overall Study|Adverse event unrelated to study drug|1|||
28156194|NCT02593786|54825579|FG002|Overall Study|Adverse event unrelated to study drug|1|||
28156195|NCT02593786|54825580|FG003|Overall Study|Adverse event unrelated to study drug|0|||
28156196|NCT02593786|54825577|FG000|Overall Study|Participant request to discontinue study therapy|0|||
28156197|NCT02593786|54825578|FG001|Overall Study|Participant request to discontinue study therapy|2|||
28156198|NCT02593786|54825579|FG002|Overall Study|Participant request to discontinue study therapy|0|||
28156199|NCT02593786|54825580|FG003|Overall Study|Participant request to discontinue study therapy|0|||
28156200|NCT02593786|54825577|FG000|Overall Study|Other reasons|1|||
28156201|NCT02593786|54825578|FG001|Overall Study|Other reasons|1|||
28156202|NCT02593786|54825579|FG002|Overall Study|Other reasons|0|||
28156203|NCT02593786|54825580|FG003|Overall Study|Other reasons|5|||
28156204|NCT04829331|54825619|FG000|Overall Study|Lost to Follow-up|1|||
28156205|NCT04829331|54825620|FG001|Overall Study|Lost to Follow-up|0|||
28156206|NCT04602546|54825635|FG000|Overall Study|Training|2|||
28156207|NCT04602546|54825636|FG001|Overall Study|Training|2|||
28156208|NCT04602546|54825637|FG002|Overall Study|Training|1|||
28156209|NCT04602546|54825638|FG003|Overall Study|Training|2|||
28156210|NCT04602546|54825639|FG004|Overall Study|Training|0|||
28156211|NCT04602546|54825635|FG000|Overall Study|Randomized with disqualified data|2|||
28156212|NCT04602546|54825636|FG001|Overall Study|Randomized with disqualified data|0|||
28156213|NCT04602546|54825637|FG002|Overall Study|Randomized with disqualified data|2|||
27942175|NCT01202903|54598969|FG001|Overall Study|Lost to Follow-up|1|||
28156214|NCT04602546|54825638|FG003|Overall Study|Randomized with disqualified data|5|||
28156215|NCT04602546|54825639|FG004|Overall Study|Randomized with disqualified data|3|||
28156216|NCT04102189|54825669|FG000|Overall Study|Withdrawal by Subject|1|||
28156217|NCT04102189|54825670|FG001|Overall Study|Withdrawal by Subject|2|||
28156218|NCT04102189|54825669|FG000|Overall Study|Withdrawal by parent/guardian|0|||
28156219|NCT04102189|54825670|FG001|Overall Study|Withdrawal by parent/guardian|1|||
28156220|NCT04102189|54825669|FG000|Overall Study|Lost to Follow-up|1|||
28156221|NCT04102189|54825670|FG001|Overall Study|Lost to Follow-up|0|||
28156222|NCT04004988|54825685|FG000|Period 1|Physician Decision|2|||
28156223|NCT04004988|54825686|FG001|Period 1|Physician Decision|0|||
28156224|NCT04004988|54825685|FG000|Period 1|Withdrawal by Subject|0|||
28156225|NCT04004988|54825686|FG001|Period 1|Withdrawal by Subject|1|||
28156226|NCT04004988|54825685|FG000|Period 1|Adverse Event|1|||
28156227|NCT04004988|54825686|FG001|Period 1|Adverse Event|2|||
28156228|NCT03898700|54825693|FG000|Overall Study|Withdrawal by Subject|2|||
28156229|NCT03693300|54825699|FG000|Overall Study|Patients ongoing study|43|||
28156230|NCT03693300|54825700|FG001|Overall Study|Patients ongoing study|1|||
27825243|NCT01707992|54290706|FG001|Placebo-Controlled Phase (24 Months)|Adverse Event|13|||
27825244|NCT01707992|54290707|FG002|Placebo-Controlled Phase (24 Months)|Adverse Event|9|||
27942176|NCT01202903|54598968|FG000|Overall Study|Lack of Efficacy|1|||
27942177|NCT01202903|54598969|FG001|Overall Study|Lack of Efficacy|3|||
28075143|NCT04633564|54729590|FG001|Period 2|Death|2|||
28075144|NCT04633564|54729589|FG000|Period 2|Lost to Follow-up|0|||
28075145|NCT04633564|54729590|FG001|Period 2|Lost to Follow-up|1|||
28075146|NCT04633564|54729589|FG000|Period 2|Physician Decision|2|||
28075147|NCT04633564|54729590|FG001|Period 2|Physician Decision|4|||
28075148|NCT04633564|54729589|FG000|Period 2|Withdrawal by Subject|5|||
28075149|NCT04633564|54729590|FG001|Period 2|Withdrawal by Subject|1|||
28075150|NCT04633564|54729589|FG000|Period 2|Progressive Disease|74|||
28075151|NCT04633564|54729590|FG001|Period 2|Progressive Disease|82|||
28075152|NCT04633564|54729589|FG000|Period 2|Terminated by Sponsor|9|||
28075153|NCT04633564|54729590|FG001|Period 2|Terminated by Sponsor|3|||
28075154|NCT04960228|54729598|FG000|Overall Study|Withdrawal by Subject|216|||
28075155|NCT04960228|54729599|FG001|Overall Study|Withdrawal by Subject|35|||
28075156|NCT04960228|54729598|FG000|Overall Study|Failed attention check|69|||
28075157|NCT04960228|54729599|FG001|Overall Study|Failed attention check|148|||
28156231|NCT03586973|54825719|FG000|Overall Study|Death|15|||
28156232|NCT03586973|54825720|FG001|Overall Study|Death|8|||
28156233|NCT03586973|54825719|FG000|Overall Study|Site Terminated by Sponsor|3|||
28156234|NCT03586973|54825720|FG001|Overall Study|Site Terminated by Sponsor|6|||
28156235|NCT03586973|54825719|FG000|Overall Study|Withdrawal by Subject|1|||
28156236|NCT03586973|54825720|FG001|Overall Study|Withdrawal by Subject|0|||
28156237|NCT03586973|54825719|FG000|Overall Study|Lost to Follow-up|1|||
28156238|NCT03586973|54825720|FG001|Overall Study|Lost to Follow-up|0|||
28156239|NCT03383692|54825728|FG000|Overall Study|Progressive disease as per RECIST|3|||
28156240|NCT03383692|54825729|FG001|Overall Study|Progressive disease as per RECIST|3|||
28156241|NCT03383692|54825728|FG000|Overall Study|Clinical progression|0|||
28156242|NCT03383692|54825729|FG001|Overall Study|Clinical progression|1|||
28156243|NCT03383692|54825728|FG000|Overall Study|Adverse Event|3|||
28156244|NCT03383692|54825729|FG001|Overall Study|Adverse Event|0|||
28156245|NCT02968849|54825739|FG000|Overall Study|Death|8|||
28156246|NCT02968849|54825740|FG001|Overall Study|Death|10|||
28156247|NCT02968849|54825739|FG000|Overall Study|Lost to Follow-up|31|||
28156248|NCT02968849|54825740|FG001|Overall Study|Lost to Follow-up|29|||
28156249|NCT02968849|54825739|FG000|Overall Study|Withdrawal by Subject|73|||
28156250|NCT02968849|54825740|FG001|Overall Study|Withdrawal by Subject|64|||
28156251|NCT02968849|54825739|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
28156252|NCT02968849|54825740|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
28156253|NCT02968849|54825739|FG000|Overall Study|Physician Decision|6|||
28156254|NCT02968849|54825740|FG001|Overall Study|Physician Decision|9|||
28156255|NCT02968849|54825739|FG000|Overall Study|Other|16|||
28156256|NCT02968849|54825740|FG001|Overall Study|Other|10|||
28156257|NCT02669212|54825751|FG000|Overall Study|Lost to Follow-up|1|||
28156258|NCT02669212|54825752|FG001|Overall Study|Lost to Follow-up|0|||
28156259|NCT02669212|54825751|FG000|Overall Study|Medical Condition|3|||
27825245|NCT01707992|54290708|FG003|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
28156260|NCT02669212|54825752|FG001|Overall Study|Medical Condition|4|||
28156261|NCT02669212|54825751|FG000|Overall Study|Withdrawal by Subject|0|||
28156262|NCT02669212|54825752|FG001|Overall Study|Withdrawal by Subject|2|||
28156263|NCT02669212|54825751|FG000|Overall Study|Excluded - determined NOT post-infectious|0|||
28075158|NCT04960228|54729598|FG000|Overall Study|Flagged for response quality by Dynata|3|||
28075159|NCT04960228|54729599|FG001|Overall Study|Flagged for response quality by Dynata|3|||
28075160|NCT04619992|54729607|FG000|Overall Study|Withdrawal by Subject|1|||
28075161|NCT04619992|54729608|FG001|Overall Study|Withdrawal by Subject|0|||
28075162|NCT00136604|54729619|FG000|Overall Study|Lost to Follow-up|1|||
28075163|NCT00136604|54729620|FG001|Overall Study|Lost to Follow-up|0|||
28075164|NCT00136604|54729621|FG002|Overall Study|Lost to Follow-up|0|||
28075165|NCT00136604|54729622|FG003|Overall Study|Lost to Follow-up|0|||
28075166|NCT00136604|54729623|FG004|Overall Study|Lost to Follow-up|1|||
28075167|NCT00136604|54729619|FG000|Overall Study|Migrated/moved from study area|0|||
28075168|NCT00136604|54729620|FG001|Overall Study|Migrated/moved from study area|1|||
28075169|NCT00136604|54729621|FG002|Overall Study|Migrated/moved from study area|0|||
28075170|NCT00136604|54729622|FG003|Overall Study|Migrated/moved from study area|0|||
28075171|NCT00136604|54729623|FG004|Overall Study|Migrated/moved from study area|0|||
28075172|NCT00135512|54729639|FG000|Overall Study|Adverse Event|56|||
28075173|NCT00135512|54729639|FG000|Overall Study|Lack of Efficacy|25|||
28075174|NCT00135512|54729639|FG000|Overall Study|Other|42|||
28075175|NCT00130728|54729645|FG000|Overall Study|Death|258|||
28075176|NCT00130728|54729646|FG001|Overall Study|Death|258|||
28075177|NCT00130728|54729645|FG000|Overall Study|Lost to Follow-up|4|||
28075178|NCT00130728|54729646|FG001|Overall Study|Lost to Follow-up|0|||
28075179|NCT00130728|54729645|FG000|Overall Study|Withdrawal by Subject|0|||
28075180|NCT00130728|54729646|FG001|Overall Study|Withdrawal by Subject|2|||
28075181|NCT00129974|54729652|FG000|Overall Study|Other|1|||
28075182|NCT04947436|54729659|FG000|Overall Study|Lost to Follow-up|3|||
28075183|NCT04947436|54729660|FG001|Overall Study|Lost to Follow-up|7|||
28156264|NCT02669212|54825752|FG001|Overall Study|Excluded - determined NOT post-infectious|4|||
28156265|NCT02536664|54825774|FG000|Overall Study|Inadequate completion of documentation|2|||
28156266|NCT02536664|54825775|FG001|Overall Study|Inadequate completion of documentation|4|||
28156267|NCT02536664|54825774|FG000|Overall Study|Progression|13|||
28156268|NCT02536664|54825775|FG001|Overall Study|Progression|18|||
28156269|NCT02536664|54825774|FG000|Overall Study|Death due to lymphoma|2|||
28156270|NCT02536664|54825775|FG001|Overall Study|Death due to lymphoma|1|||
28156271|NCT02536664|54825774|FG000|Overall Study|Death due to other reason|3|||
28156272|NCT02536664|54825775|FG001|Overall Study|Death due to other reason|2|||
28156273|NCT02536664|54825774|FG000|Overall Study|Intolerability|8|||
28156274|NCT02536664|54825775|FG001|Overall Study|Intolerability|6|||
28156275|NCT02536664|54825774|FG000|Overall Study|Withdrawal by Subject|8|||
28156276|NCT02536664|54825775|FG001|Overall Study|Withdrawal by Subject|5|||
28156277|NCT02536664|54825774|FG000|Overall Study|Other|18|||
28156278|NCT02536664|54825775|FG001|Overall Study|Other|24|||
28156279|NCT02536664|54825774|FG000|Overall Study|Missing|53|||
28156280|NCT02536664|54825775|FG001|Overall Study|Missing|20|||
28156281|NCT02426892|54825781|FG000|Overall Study|Adverse Event|2|||
28156282|NCT02426892|54825781|FG000|Overall Study|Lack of Efficacy|17|||
28156283|NCT02426892|54825781|FG000|Overall Study|Withdrawal by Subject|1|||
28156284|NCT02312687|54825785|FG000|Overall Study|Other, Not Specified|1|||
28156285|NCT02304367|54825789|FG000|Overall Study|Lack of Response to Bruosumab|1|||
28156286|NCT02304367|54825789|FG000|Overall Study|Sponsor Decision|3|||
28156287|NCT02304367|54825789|FG000|Overall Study|Death|2|||
28156288|NCT02304367|54825789|FG000|Overall Study|Physician Decision|1|||
28156289|NCT02304367|54825789|FG000|Overall Study|Unable to Return Due to Corona Virus Pandemic|1|||
28156290|NCT02107703|54825802|FG000|Overall Study|Withdrawal by Subject|36|||
28156291|NCT02107703|54825803|FG001|Overall Study|Withdrawal by Subject|19|||
28156292|NCT02107703|54825802|FG000|Overall Study|Lost to Follow-up|6|||
28156293|NCT02107703|54825803|FG001|Overall Study|Lost to Follow-up|4|||
28156294|NCT02107703|54825802|FG000|Overall Study|On study treatment/follow up|319|||
28156295|NCT02107703|54825803|FG001|Overall Study|On study treatment/follow up|152|||
28156296|NCT02054520|54825818|FG000|Overall Study|Adverse Event|1|||
28156297|NCT02054520|54825819|FG001|Overall Study|Adverse Event|4|||
28075184|NCT04947436|54729661|FG002|Overall Study|Lost to Follow-up|5|||
28075185|NCT04947436|54729659|FG000|Overall Study|Death|1|||
28075186|NCT04947436|54729660|FG001|Overall Study|Death|1|||
28156298|NCT02054520|54825820|FG002|Overall Study|Adverse Event|2|||
27825246|NCT01707992|54290709|FG004|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
27825247|NCT01707992|54290710|FG005|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
27825248|NCT01707992|54290705|FG000|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10|||
27825249|NCT01707992|54290706|FG001|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3|||
27825250|NCT01707992|54290707|FG002|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2|||
27825251|NCT01707992|54290708|FG003|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
27825252|NCT01707992|54290709|FG004|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
27825253|NCT01707992|54290710|FG005|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
28075187|NCT04947436|54729661|FG002|Overall Study|Death|1|||
28156299|NCT02054520|54825821|FG003|Overall Study|Adverse Event|1|||
28156300|NCT02054520|54825822|FG004|Overall Study|Adverse Event|1|||
28156301|NCT02054520|54825823|FG005|Overall Study|Adverse Event|0|||
28156302|NCT02054520|54825818|FG000|Overall Study|Lack of Efficacy|7|||
28156303|NCT02054520|54825819|FG001|Overall Study|Lack of Efficacy|0|||
28156304|NCT02054520|54825820|FG002|Overall Study|Lack of Efficacy|2|||
28156305|NCT02054520|54825821|FG003|Overall Study|Lack of Efficacy|1|||
28156306|NCT02054520|54825822|FG004|Overall Study|Lack of Efficacy|3|||
28156307|NCT02054520|54825823|FG005|Overall Study|Lack of Efficacy|2|||
28156308|NCT02054520|54825818|FG000|Overall Study|Withdrawal by Subject|1|||
28156309|NCT02054520|54825819|FG001|Overall Study|Withdrawal by Subject|0|||
28156310|NCT02054520|54825820|FG002|Overall Study|Withdrawal by Subject|0|||
28156311|NCT02054520|54825821|FG003|Overall Study|Withdrawal by Subject|2|||
28156312|NCT02054520|54825822|FG004|Overall Study|Withdrawal by Subject|1|||
28156313|NCT02054520|54825823|FG005|Overall Study|Withdrawal by Subject|0|||
28156314|NCT02054520|54825818|FG000|Overall Study|Physician Decision|0|||
28156315|NCT02054520|54825819|FG001|Overall Study|Physician Decision|1|||
28156316|NCT02054520|54825820|FG002|Overall Study|Physician Decision|0|||
28156317|NCT02054520|54825821|FG003|Overall Study|Physician Decision|1|||
28156318|NCT02054520|54825822|FG004|Overall Study|Physician Decision|0|||
28156319|NCT02054520|54825823|FG005|Overall Study|Physician Decision|1|||
28156320|NCT02054520|54825818|FG000|Overall Study|Study terminated by Sponsor|0|||
28156321|NCT02054520|54825819|FG001|Overall Study|Study terminated by Sponsor|0|||
28156322|NCT02054520|54825820|FG002|Overall Study|Study terminated by Sponsor|2|||
28156323|NCT02054520|54825821|FG003|Overall Study|Study terminated by Sponsor|1|||
28156324|NCT02054520|54825822|FG004|Overall Study|Study terminated by Sponsor|0|||
28156325|NCT02054520|54825823|FG005|Overall Study|Study terminated by Sponsor|0|||
28156326|NCT01546987|54825852|FG000|Overall Study|Protocol Violation|3|||
28156327|NCT01546987|54825853|FG001|Overall Study|Protocol Violation|4|||
28156328|NCT00261443|54825876|FG000|1: Confirmation of Partial Nonresponse|Adverse Event|33|||
28156329|NCT00261443|54825877|FG001|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
28156330|NCT00261443|54825878|FG002|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
27825254|NCT01707992|54290705|FG000|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88|||
28075188|NCT00119106|54729671|FG000|Overall Study|HIV infected at baseline|179|||
28075189|NCT00119106|54729672|FG001|Overall Study|HIV infected at baseline|178|||
28075190|NCT00135356|54729688|FG000|Overall Study|Adverse Event|6|||
28075191|NCT00135356|54729689|FG001|Overall Study|Adverse Event|2|||
28075192|NCT00135356|54729688|FG000|Overall Study|Lack of Efficacy|2|||
28075193|NCT00135356|54729689|FG001|Overall Study|Lack of Efficacy|0|||
28075194|NCT00135356|54729688|FG000|Overall Study|Lost to Follow-up|3|||
28075195|NCT00135356|54729689|FG001|Overall Study|Lost to Follow-up|1|||
28156331|NCT00261443|54825876|FG000|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93|||
28156332|NCT00261443|54825877|FG001|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
27825255|NCT01707992|54290706|FG001|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68|||
27825256|NCT01707992|54290707|FG002|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154|||
27825257|NCT01707992|54290708|FG003|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
27825258|NCT01707992|54290709|FG004|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
27825259|NCT01707992|54290710|FG005|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
28075196|NCT00135356|54729688|FG000|Overall Study|Surgery for abdominal fat|1|||
28075197|NCT00135356|54729689|FG001|Overall Study|Surgery for abdominal fat|0|||
28075198|NCT00135356|54729688|FG000|Overall Study|Change in antiviral regimen|0|||
28075199|NCT00135356|54729689|FG001|Overall Study|Change in antiviral regimen|1|||
28156333|NCT00261443|54825878|FG002|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
27825260|NCT01707992|54290705|FG000|Placebo-Controlled Phase (24 Months)|Protocol Violation|1|||
28075200|NCT00135356|54729688|FG000|Overall Study|Poor/noncompliance|1|||
28075201|NCT00135356|54729689|FG001|Overall Study|Poor/noncompliance|1|||
28156334|NCT00261443|54825876|FG000|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111|||
28156335|NCT00261443|54825877|FG001|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
28156336|NCT00261443|54825878|FG002|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
28075202|NCT00135356|54729688|FG000|Overall Study|No longer meets study criteria|2|||
28075203|NCT00135356|54729689|FG001|Overall Study|No longer meets study criteria|0|||
28156337|NCT00261443|54825876|FG000|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23|||
28156338|NCT00261443|54825877|FG001|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
28156339|NCT00261443|54825878|FG002|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
28156340|NCT00261443|54825876|FG000|1: Confirmation of Partial Nonresponse|Pregnancy|1|||
28156341|NCT00261443|54825877|FG001|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
28156342|NCT00261443|54825878|FG002|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
28156343|NCT00261443|54825876|FG000|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307|||
28156344|NCT00261443|54825877|FG001|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
28156345|NCT00261443|54825878|FG002|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
28156346|NCT00261443|54825876|FG000|1: Confirmation of Partial Nonresponse|Other Reasons|16|||
28156347|NCT00261443|54825877|FG001|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
28075204|NCT00135356|54729688|FG000|Overall Study|Withdrawal by Subject|2|||
28075205|NCT00135356|54729689|FG001|Overall Study|Withdrawal by Subject|4|||
28075206|NCT00118716|54729697|FG000|Overall Study|Adverse Event|2|||
28075207|NCT00118716|54729698|FG001|Overall Study|Adverse Event|7|||
28075208|NCT00118716|54729697|FG000|Overall Study|Protocol Violation|5|||
28156348|NCT00261443|54825878|FG002|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
28156349|NCT00261443|54825876|FG000|2: Stability & Maintenance of Stability|Lack of Efficacy|43|||
28075209|NCT00118716|54729698|FG001|Overall Study|Protocol Violation|4|||
28156350|NCT00261443|54825877|FG001|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
28156351|NCT00261443|54825878|FG002|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
28156352|NCT00261443|54825876|FG000|2: Stability & Maintenance of Stability|Adverse Event|93|||
28156353|NCT00261443|54825877|FG001|2: Stability & Maintenance of Stability|Adverse Event|0|||
28156354|NCT00261443|54825878|FG002|2: Stability & Maintenance of Stability|Adverse Event|0|||
28156355|NCT00261443|54825876|FG000|2: Stability & Maintenance of Stability|Withdrawal by Subject|65|||
28156356|NCT00261443|54825877|FG001|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
28156357|NCT00261443|54825878|FG002|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
28156358|NCT00261443|54825876|FG000|2: Stability & Maintenance of Stability|Lost to Follow-up|59|||
28156359|NCT00261443|54825877|FG001|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
28156360|NCT00261443|54825878|FG002|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
28156361|NCT00261443|54825876|FG000|2: Stability & Maintenance of Stability|Poor/Noncompliance|33|||
28156362|NCT00261443|54825877|FG001|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
28156363|NCT00261443|54825878|FG002|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
28156364|NCT00261443|54825876|FG000|2: Stability & Maintenance of Stability|Pregnancy|1|||
28156365|NCT00261443|54825877|FG001|2: Stability & Maintenance of Stability|Pregnancy|0|||
28156366|NCT00261443|54825878|FG002|2: Stability & Maintenance of Stability|Pregnancy|0|||
28156367|NCT00261443|54825876|FG000|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32|||
28156368|NCT00261443|54825877|FG001|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
28156369|NCT00261443|54825878|FG002|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
28156370|NCT00261443|54825876|FG000|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1|||
28156371|NCT00261443|54825877|FG001|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
28156372|NCT00261443|54825878|FG002|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
28156373|NCT00261443|54825876|FG000|2: Stability & Maintenance of Stability|Other Reasons|13|||
28156374|NCT00261443|54825877|FG001|2: Stability & Maintenance of Stability|Other Reasons|0|||
28156375|NCT00261443|54825878|FG002|2: Stability & Maintenance of Stability|Other Reasons|0|||
28156376|NCT00261443|54825876|FG000|3: Assessment of Relapse|Lack of Efficacy|0|||
28156377|NCT00261443|54825877|FG001|3: Assessment of Relapse|Lack of Efficacy|31|||
28156378|NCT00261443|54825878|FG002|3: Assessment of Relapse|Lack of Efficacy|14|||
28156379|NCT00261443|54825876|FG000|3: Assessment of Relapse|Adverse Event|0|||
28156380|NCT00261443|54825877|FG001|3: Assessment of Relapse|Adverse Event|15|||
28156381|NCT00261443|54825878|FG002|3: Assessment of Relapse|Adverse Event|19|||
28156382|NCT00261443|54825876|FG000|3: Assessment of Relapse|Withdrawal by Subject|0|||
28156383|NCT00261443|54825877|FG001|3: Assessment of Relapse|Withdrawal by Subject|14|||
28156384|NCT00261443|54825878|FG002|3: Assessment of Relapse|Withdrawal by Subject|15|||
28156385|NCT00261443|54825876|FG000|3: Assessment of Relapse|Death|0|||
28156386|NCT00261443|54825877|FG001|3: Assessment of Relapse|Death|0|||
28156387|NCT00261443|54825878|FG002|3: Assessment of Relapse|Death|1|||
28156388|NCT00261443|54825876|FG000|3: Assessment of Relapse|Lost to Follow-up|0|||
28156389|NCT00261443|54825877|FG001|3: Assessment of Relapse|Lost to Follow-up|7|||
28156390|NCT00261443|54825878|FG002|3: Assessment of Relapse|Lost to Follow-up|6|||
27942178|NCT01202903|54598968|FG000|Overall Study|Adverse Event|3|||
28075210|NCT00118716|54729697|FG000|Overall Study|Withdrawal by Subject|0|||
28075211|NCT00118716|54729698|FG001|Overall Study|Withdrawal by Subject|1|||
28075212|NCT00118716|54729697|FG000|Overall Study|Exacerbation|2|||
28156391|NCT00261443|54825876|FG000|3: Assessment of Relapse|Poor/Noncompliance|0|||
28156392|NCT00261443|54825877|FG001|3: Assessment of Relapse|Poor/Noncompliance|5|||
28156393|NCT00261443|54825878|FG002|3: Assessment of Relapse|Poor/Noncompliance|3|||
28156394|NCT00261443|54825876|FG000|3: Assessment of Relapse|Pregnancy|0|||
28156395|NCT00261443|54825877|FG001|3: Assessment of Relapse|Pregnancy|2|||
28156396|NCT00261443|54825878|FG002|3: Assessment of Relapse|Pregnancy|1|||
28156397|NCT00261443|54825876|FG000|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0|||
28156398|NCT00261443|54825877|FG001|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2|||
28156399|NCT00261443|54825878|FG002|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1|||
28156400|NCT00261443|54825876|FG000|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
28156401|NCT00261443|54825877|FG001|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
28156402|NCT00261443|54825878|FG002|3: Assessment of Relapse|Administrative Reason By Sponsor|2|||
28156403|NCT00261443|54825876|FG000|3: Assessment of Relapse|Other Reasons|0|||
28156404|NCT00261443|54825877|FG001|3: Assessment of Relapse|Other Reasons|4|||
28156405|NCT00261443|54825878|FG002|3: Assessment of Relapse|Other Reasons|3|||
28156406|NCT00261443|54825876|FG000|4: Extension Phase|Adverse Event|0|||
28156407|NCT00261443|54825877|FG001|4: Extension Phase|Adverse Event|1|||
28156408|NCT00261443|54825878|FG002|4: Extension Phase|Adverse Event|0|||
28156409|NCT00261443|54825876|FG000|4: Extension Phase|Withdrawal by Subject|0|||
28156410|NCT00261443|54825877|FG001|4: Extension Phase|Withdrawal by Subject|1|||
28156411|NCT00261443|54825878|FG002|4: Extension Phase|Withdrawal by Subject|2|||
28156412|NCT00261443|54825876|FG000|4: Extension Phase|Lost to Follow-up|0|||
28156413|NCT00261443|54825877|FG001|4: Extension Phase|Lost to Follow-up|1|||
28156414|NCT00261443|54825878|FG002|4: Extension Phase|Lost to Follow-up|0|||
28156415|NCT02593318|54825895|FG000|Overall Study|Withdrawal by Subject|1|||
28156416|NCT02593318|54825896|FG001|Overall Study|Withdrawal by Subject|1|||
28156417|NCT00304070|54825911|FG000|Overall Study|Death|0|||
28156418|NCT00304070|54825912|FG001|Overall Study|Death|0|||
28156419|NCT00304070|54825913|FG002|Overall Study|Death|3|||
28156420|NCT00304070|54825911|FG000|Overall Study|Lost to Follow-up|0|||
28156421|NCT00304070|54825912|FG001|Overall Study|Lost to Follow-up|0|||
28156422|NCT00304070|54825913|FG002|Overall Study|Lost to Follow-up|1|||
28156423|NCT00304070|54825911|FG000|Overall Study|Physician Decision|0|||
28156424|NCT00304070|54825912|FG001|Overall Study|Physician Decision|0|||
28156425|NCT00304070|54825913|FG002|Overall Study|Physician Decision|3|||
28156426|NCT00304070|54825911|FG000|Overall Study|Withdrawal by Subject|0|||
28156427|NCT00304070|54825912|FG001|Overall Study|Withdrawal by Subject|0|||
28156428|NCT00304070|54825913|FG002|Overall Study|Withdrawal by Subject|1|||
28156429|NCT00304070|54825911|FG000|Overall Study|Progressive Disease|3|||
28156430|NCT00304070|54825912|FG001|Overall Study|Progressive Disease|7|||
28156431|NCT00304070|54825913|FG002|Overall Study|Progressive Disease|4|||
28156432|NCT02343302|54825927|FG000|Overall Study|Physician Decision|1|||
28156433|NCT02343302|54825928|FG001|Overall Study|Physician Decision|1|||
28156434|NCT02590432|54825936|FG000|Open-label Treatment Period|Adverse Event|97|||
28156435|NCT02590432|54825937|FG001|Open-label Treatment Period|Adverse Event|79|||
28156436|NCT02590432|54825938|FG002|Open-label Treatment Period|Adverse Event|0|||
28156437|NCT02590432|54825939|FG003|Open-label Treatment Period|Adverse Event|0|||
28156438|NCT02590432|54825940|FG004|Open-label Treatment Period|Adverse Event|0|||
28156439|NCT02590432|54825941|FG005|Open-label Treatment Period|Adverse Event|0|||
28156440|NCT02590432|54825942|FG006|Open-label Treatment Period|Adverse Event|0|||
28156441|NCT02590432|54825943|FG007|Open-label Treatment Period|Adverse Event|0|||
28156442|NCT02590432|54825944|FG008|Open-label Treatment Period|Adverse Event|0|||
28156443|NCT02590432|54825936|FG000|Open-label Treatment Period|Lack of Efficacy|14|||
28156444|NCT02590432|54825937|FG001|Open-label Treatment Period|Lack of Efficacy|5|||
28156445|NCT02590432|54825938|FG002|Open-label Treatment Period|Lack of Efficacy|0|||
28156446|NCT02590432|54825939|FG003|Open-label Treatment Period|Lack of Efficacy|0|||
28156447|NCT02590432|54825940|FG004|Open-label Treatment Period|Lack of Efficacy|0|||
28156448|NCT02590432|54825941|FG005|Open-label Treatment Period|Lack of Efficacy|0|||
27942179|NCT01202903|54598969|FG001|Overall Study|Adverse Event|3|||
27942180|NCT01202903|54598968|FG000|Overall Study|Withdrawal by Subject|4|||
28075213|NCT00118716|54729698|FG001|Overall Study|Exacerbation|2|||
28075214|NCT00118716|54729697|FG000|Overall Study|Discontinued by sponsor|1|||
28075215|NCT00118716|54729698|FG001|Overall Study|Discontinued by sponsor|1|||
28075216|NCT00118716|54729697|FG000|Overall Study|Non-compliance|1|||
28075217|NCT00118716|54729698|FG001|Overall Study|Non-compliance|3|||
28075218|NCT00118716|54729697|FG000|Overall Study|misrandomized|1|||
28156449|NCT02590432|54825942|FG006|Open-label Treatment Period|Lack of Efficacy|0|||
28156450|NCT02590432|54825943|FG007|Open-label Treatment Period|Lack of Efficacy|0|||
28156451|NCT02590432|54825944|FG008|Open-label Treatment Period|Lack of Efficacy|0|||
28075219|NCT00118716|54729698|FG001|Overall Study|misrandomized|1|||
28075220|NCT00118716|54729697|FG000|Overall Study|Expired drug use|1|||
28156452|NCT02590432|54825936|FG000|Open-label Treatment Period|Withdrawal of Consent|43|||
28156453|NCT02590432|54825937|FG001|Open-label Treatment Period|Withdrawal of Consent|28|||
28156454|NCT02590432|54825938|FG002|Open-label Treatment Period|Withdrawal of Consent|0|||
28156455|NCT02590432|54825939|FG003|Open-label Treatment Period|Withdrawal of Consent|0|||
28156456|NCT02590432|54825940|FG004|Open-label Treatment Period|Withdrawal of Consent|0|||
28156457|NCT02590432|54825941|FG005|Open-label Treatment Period|Withdrawal of Consent|0|||
28156458|NCT02590432|54825942|FG006|Open-label Treatment Period|Withdrawal of Consent|0|||
28156459|NCT02590432|54825943|FG007|Open-label Treatment Period|Withdrawal of Consent|0|||
28156460|NCT02590432|54825944|FG008|Open-label Treatment Period|Withdrawal of Consent|0|||
28156461|NCT02590432|54825936|FG000|Open-label Treatment Period|Lost to Follow-up|51|||
28156462|NCT02590432|54825937|FG001|Open-label Treatment Period|Lost to Follow-up|29|||
28156463|NCT02590432|54825938|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
28156464|NCT02590432|54825939|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
28156465|NCT02590432|54825940|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
28156466|NCT02590432|54825941|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
28156467|NCT02590432|54825942|FG006|Open-label Treatment Period|Lost to Follow-up|0|||
28156468|NCT02590432|54825943|FG007|Open-label Treatment Period|Lost to Follow-up|0|||
28156469|NCT02590432|54825944|FG008|Open-label Treatment Period|Lost to Follow-up|0|||
28156470|NCT02590432|54825936|FG000|Open-label Treatment Period|Protocol Violation|10|||
28156471|NCT02590432|54825937|FG001|Open-label Treatment Period|Protocol Violation|4|||
28156472|NCT02590432|54825938|FG002|Open-label Treatment Period|Protocol Violation|0|||
28156473|NCT02590432|54825939|FG003|Open-label Treatment Period|Protocol Violation|0|||
28075221|NCT00118716|54729698|FG001|Overall Study|Expired drug use|2|||
28156474|NCT02590432|54825940|FG004|Open-label Treatment Period|Protocol Violation|0|||
28156475|NCT02590432|54825941|FG005|Open-label Treatment Period|Protocol Violation|0|||
28156476|NCT02590432|54825942|FG006|Open-label Treatment Period|Protocol Violation|0|||
28156477|NCT02590432|54825943|FG007|Open-label Treatment Period|Protocol Violation|0|||
28156478|NCT02590432|54825944|FG008|Open-label Treatment Period|Protocol Violation|0|||
28156479|NCT02590432|54825936|FG000|Open-label Treatment Period|Non-compliance with Study Drug|7|||
28156480|NCT02590432|54825937|FG001|Open-label Treatment Period|Non-compliance with Study Drug|1|||
28156481|NCT02590432|54825938|FG002|Open-label Treatment Period|Non-compliance with Study Drug|0|||
28156482|NCT02590432|54825939|FG003|Open-label Treatment Period|Non-compliance with Study Drug|0|||
28156483|NCT02590432|54825940|FG004|Open-label Treatment Period|Non-compliance with Study Drug|0|||
28156484|NCT02590432|54825941|FG005|Open-label Treatment Period|Non-compliance with Study Drug|0|||
28075222|NCT00118716|54729697|FG000|Overall Study|Investigator discretion|0|||
28075223|NCT00118716|54729698|FG001|Overall Study|Investigator discretion|1|||
28075224|NCT04584346|54729706|FG000|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|0|||
28075225|NCT04584346|54729707|FG001|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|1|||
28075226|NCT00118482|54729717|FG000|Overall Study|Lost to Follow-up|7|||
28075227|NCT00118482|54729718|FG001|Overall Study|Lost to Follow-up|7|||
28075228|NCT00118482|54729717|FG000|Overall Study|Withdrawal by Subject|23|||
28075229|NCT00118482|54729718|FG001|Overall Study|Withdrawal by Subject|22|||
28156485|NCT02590432|54825942|FG006|Open-label Treatment Period|Non-compliance with Study Drug|0|||
28156486|NCT02590432|54825943|FG007|Open-label Treatment Period|Non-compliance with Study Drug|0|||
28156487|NCT02590432|54825944|FG008|Open-label Treatment Period|Non-compliance with Study Drug|0|||
28075230|NCT00129272|54729726|FG000|Overall Study|Lost to Follow-up|12|||
28075231|NCT00129272|54729727|FG001|Overall Study|Lost to Follow-up|11|||
28075232|NCT00129272|54729726|FG000|Overall Study|Withdrawal by Subject|5|||
28075233|NCT00129272|54729727|FG001|Overall Study|Withdrawal by Subject|11|||
28075234|NCT04899232|54729736|FG000|Screening Period|Physician Decision|1|||
28075235|NCT04899232|54729737|FG001|Screening Period|Physician Decision|0|||
28075236|NCT04899232|54729738|FG002|Screening Period|Physician Decision|0|||
28156488|NCT02590432|54825936|FG000|Open-label Treatment Period|Other Miscellaneous Reasons|10|||
28156489|NCT02590432|54825937|FG001|Open-label Treatment Period|Other Miscellaneous Reasons|6|||
28156490|NCT02590432|54825938|FG002|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
28156491|NCT02590432|54825939|FG003|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
28156492|NCT02590432|54825940|FG004|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
28156493|NCT02590432|54825941|FG005|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
28156494|NCT02590432|54825942|FG006|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
28156495|NCT02590432|54825943|FG007|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
28156496|NCT02590432|54825944|FG008|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
28156497|NCT02590432|54825936|FG000|Double-blind Treatment Period|Adverse Event|0|||
28156498|NCT02590432|54825937|FG001|Double-blind Treatment Period|Adverse Event|0|||
28156499|NCT02590432|54825938|FG002|Double-blind Treatment Period|Adverse Event|14|||
28156500|NCT02590432|54825939|FG003|Double-blind Treatment Period|Adverse Event|12|||
28156501|NCT02590432|54825940|FG004|Double-blind Treatment Period|Adverse Event|6|||
28156502|NCT02590432|54825941|FG005|Double-blind Treatment Period|Adverse Event|22|||
28156503|NCT02590432|54825942|FG006|Double-blind Treatment Period|Adverse Event|20|||
28156504|NCT02590432|54825943|FG007|Double-blind Treatment Period|Adverse Event|0|||
28156505|NCT02590432|54825944|FG008|Double-blind Treatment Period|Adverse Event|0|||
28156506|NCT02590432|54825936|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
28156507|NCT02590432|54825937|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
28156508|NCT02590432|54825938|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
28156509|NCT02590432|54825939|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
28156510|NCT02590432|54825940|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
28156511|NCT02590432|54825941|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
28156512|NCT02590432|54825942|FG006|Double-blind Treatment Period|Lack of Efficacy|0|||
28156513|NCT02590432|54825943|FG007|Double-blind Treatment Period|Lack of Efficacy|0|||
28156514|NCT02590432|54825944|FG008|Double-blind Treatment Period|Lack of Efficacy|0|||
28156515|NCT02590432|54825936|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
28156516|NCT02590432|54825937|FG001|Double-blind Treatment Period|Withdrawal of Consent|0|||
28156517|NCT02590432|54825938|FG002|Double-blind Treatment Period|Withdrawal of Consent|1|||
28156518|NCT02590432|54825939|FG003|Double-blind Treatment Period|Withdrawal of Consent|3|||
28156519|NCT02590432|54825940|FG004|Double-blind Treatment Period|Withdrawal of Consent|3|||
28156520|NCT02590432|54825941|FG005|Double-blind Treatment Period|Withdrawal of Consent|1|||
28156521|NCT02590432|54825942|FG006|Double-blind Treatment Period|Withdrawal of Consent|1|||
28156522|NCT02590432|54825943|FG007|Double-blind Treatment Period|Withdrawal of Consent|0|||
28156523|NCT02590432|54825944|FG008|Double-blind Treatment Period|Withdrawal of Consent|0|||
28156524|NCT02590432|54825936|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
28156525|NCT02590432|54825937|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
28156526|NCT02590432|54825938|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
28156527|NCT02590432|54825939|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
28156528|NCT02590432|54825940|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
28156529|NCT02590432|54825941|FG005|Double-blind Treatment Period|Lost to Follow-up|2|||
28156530|NCT02590432|54825942|FG006|Double-blind Treatment Period|Lost to Follow-up|0|||
28156531|NCT02590432|54825943|FG007|Double-blind Treatment Period|Lost to Follow-up|0|||
28156532|NCT02590432|54825944|FG008|Double-blind Treatment Period|Lost to Follow-up|0|||
28156533|NCT02590432|54825936|FG000|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
28156534|NCT02590432|54825937|FG001|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
28156535|NCT02590432|54825938|FG002|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
28156536|NCT02590432|54825939|FG003|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
27825261|NCT01707992|54290706|FG001|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
27825262|NCT01707992|54290707|FG002|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
27825263|NCT01707992|54290708|FG003|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
27825264|NCT01707992|54290709|FG004|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
27825265|NCT01707992|54290710|FG005|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
27825266|NCT01707992|54290705|FG000|Placebo-Controlled Phase (24 Months)|Pregnancy|12|||
27825267|NCT01707992|54290706|FG001|Placebo-Controlled Phase (24 Months)|Pregnancy|5|||
27825268|NCT01707992|54290707|FG002|Placebo-Controlled Phase (24 Months)|Pregnancy|9|||
27825269|NCT01707992|54290708|FG003|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
27825270|NCT01707992|54290709|FG004|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
28075237|NCT04899232|54729736|FG000|Screening Period|Withdrawal by Subject|1|||
28075238|NCT04899232|54729737|FG001|Screening Period|Withdrawal by Subject|0|||
28075239|NCT04899232|54729738|FG002|Screening Period|Withdrawal by Subject|0|||
28075240|NCT04899232|54729736|FG000|Screening Period|Participant discharged before receiving intervention|3|||
28075241|NCT04899232|54729737|FG001|Screening Period|Participant discharged before receiving intervention|0|||
28075242|NCT04899232|54729738|FG002|Screening Period|Participant discharged before receiving intervention|0|||
28075243|NCT04559698|54729757|FG000|Overall Study|Lost to Follow-up|14|||
28156537|NCT02590432|54825940|FG004|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
28156538|NCT02590432|54825941|FG005|Double-blind Treatment Period|Non-compliance with Study Drug|1|||
28156539|NCT02590432|54825942|FG006|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
28156540|NCT02590432|54825943|FG007|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
28156541|NCT02590432|54825944|FG008|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
28156542|NCT02590432|54825936|FG000|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
28156543|NCT02590432|54825937|FG001|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
28156544|NCT02590432|54825938|FG002|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
28156545|NCT02590432|54825939|FG003|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
28156546|NCT02590432|54825940|FG004|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
28075244|NCT04559698|54729758|FG001|Overall Study|Lost to Follow-up|15|||
28156547|NCT02590432|54825941|FG005|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
27825271|NCT01707992|54290710|FG005|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
27850316|NCT04178967|54349322|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
27850317|NCT04178967|54349323|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
28075245|NCT04559698|54729757|FG000|Overall Study|Withdrawal by Subject|0|||
28075246|NCT04559698|54729758|FG001|Overall Study|Withdrawal by Subject|1|||
27825272|NCT01707992|54290705|FG000|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10|||
28156548|NCT02590432|54825942|FG006|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
28156549|NCT02590432|54825943|FG007|Dose-reduced Open Label Treatment Period|Adverse Event|12|||
28156550|NCT02590432|54825944|FG008|Dose-reduced Open Label Treatment Period|Adverse Event|15|||
28156551|NCT02590432|54825936|FG000|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
28156552|NCT02590432|54825937|FG001|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
28156553|NCT02590432|54825938|FG002|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
28156554|NCT02590432|54825939|FG003|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
28156555|NCT02590432|54825940|FG004|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
28156556|NCT02590432|54825941|FG005|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
28156557|NCT02590432|54825942|FG006|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
28156558|NCT02590432|54825943|FG007|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1|||
28156559|NCT02590432|54825944|FG008|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
28156560|NCT02590432|54825936|FG000|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
28156561|NCT02590432|54825937|FG001|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
28156562|NCT02590432|54825938|FG002|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
28156563|NCT02590432|54825939|FG003|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
28156564|NCT02590432|54825940|FG004|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
28156565|NCT02590432|54825941|FG005|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
28156566|NCT02590432|54825942|FG006|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
28156567|NCT02590432|54825943|FG007|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3|||
28156568|NCT02590432|54825944|FG008|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1|||
28156569|NCT02590432|54825936|FG000|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
28156570|NCT02590432|54825937|FG001|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
28156571|NCT02590432|54825938|FG002|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
28156572|NCT02590432|54825939|FG003|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
28156573|NCT02590432|54825940|FG004|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
28156574|NCT02590432|54825941|FG005|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
28156575|NCT02590432|54825942|FG006|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
28156576|NCT02590432|54825943|FG007|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
28156577|NCT02590432|54825944|FG008|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1|||
28156578|NCT02590432|54825936|FG000|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
28156579|NCT02590432|54825937|FG001|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
28156580|NCT02590432|54825938|FG002|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
28156581|NCT02590432|54825939|FG003|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
28156582|NCT02590432|54825940|FG004|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
28156583|NCT02590432|54825941|FG005|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
28156584|NCT02590432|54825942|FG006|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
28156585|NCT02590432|54825943|FG007|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
28156586|NCT02590432|54825944|FG008|Dose-reduced Open Label Treatment Period|Protocol Violation|1|||
28156587|NCT02590432|54825936|FG000|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
28156588|NCT02590432|54825937|FG001|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
28156589|NCT02590432|54825938|FG002|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
28156590|NCT02590432|54825939|FG003|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
28156591|NCT02590432|54825940|FG004|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
28156592|NCT02590432|54825941|FG005|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
28156593|NCT02590432|54825942|FG006|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
28156594|NCT02590432|54825943|FG007|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1|||
28156595|NCT02590432|54825944|FG008|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
28156596|NCT02590432|54825936|FG000|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
28156597|NCT02590432|54825937|FG001|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
28156598|NCT02590432|54825938|FG002|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
28156599|NCT02590432|54825939|FG003|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
28156600|NCT02590432|54825940|FG004|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
28075247|NCT00133952|54729766|FG000|Overall Study|Adverse Event|1|||
28075248|NCT00133952|54729767|FG001|Overall Study|Adverse Event|2|||
28156601|NCT02590432|54825941|FG005|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
28156602|NCT02590432|54825942|FG006|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
28156603|NCT02590432|54825943|FG007|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1|||
28156604|NCT02590432|54825944|FG008|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
28156605|NCT02590354|54825956|FG000|Phase 1|Active hepatitis B or C infection|1|||
28156606|NCT02590354|54825956|FG000|Phase 1|Confirmed neutrophil count <1200/µl|1|||
28156607|NCT02590354|54825956|FG000|Phase 1|Detectable level of HIV DNA or caRNA|75|||
28156608|NCT02590354|54825956|FG000|Phase 1|Subject does not want to participate|20|||
28156609|NCT02590354|54825956|FG000|Phase 1|Lost to Follow-up|1|||
28156610|NCT02590354|54825956|FG000|Phase 2 - Treatment Interruption|Lost to Follow-up|2|||
28156611|NCT01667224|54825963|FG000|Overall Study|Withdrawal by Subject|3|||
28156612|NCT01667224|54825964|FG001|Overall Study|Withdrawal by Subject|1|||
28156613|NCT01667224|54825963|FG000|Overall Study|Protocol Violation|1|||
28156614|NCT01667224|54825964|FG001|Overall Study|Protocol Violation|1|||
28156615|NCT03923738|54825972|FG000|Period 1|Adverse Event|1|||
28156616|NCT03923738|54825972|FG000|Period 1|Withdrawal by Subject|1|||
28156617|NCT02588248|54825980|FG000|Overall Study|Physician Decision|4|||
28156618|NCT02588248|54825981|FG001|Overall Study|Physician Decision|3|||
28156619|NCT01328054|54825992|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0|||
28156620|NCT01328054|54825993|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2|||
28156621|NCT01328054|54825992|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0|||
28156622|NCT01328054|54825993|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1|||
28156623|NCT01328054|54825992|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0|||
28156624|NCT01328054|54825993|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2|||
28156625|NCT01849250|54826016|FG000|Overall Study|Withdrawal by Subject|1|||
28156626|NCT01849250|54826017|FG001|Overall Study|Withdrawal by Subject|0|||
28156627|NCT01849250|54826016|FG000|Overall Study|Not Evaluable|5|||
28156628|NCT01849250|54826017|FG001|Overall Study|Not Evaluable|3|||
28156629|NCT01849250|54826016|FG000|Overall Study|Screen Failure|1|||
28156630|NCT01849250|54826017|FG001|Overall Study|Screen Failure|0|||
28156631|NCT02791191|54826027|FG000|Overall Study|Adverse Event|2|||
28156632|NCT02791191|54826028|FG001|Overall Study|Adverse Event|4|||
28156633|NCT02791191|54826029|FG002|Overall Study|Adverse Event|5|||
28156634|NCT02791191|54826027|FG000|Overall Study|Lack of Efficacy|0|||
28156635|NCT02791191|54826028|FG001|Overall Study|Lack of Efficacy|1|||
28156636|NCT02791191|54826029|FG002|Overall Study|Lack of Efficacy|0|||
28156637|NCT02791191|54826027|FG000|Overall Study|Study Drug Non-Compliance|0|||
28156638|NCT02791191|54826028|FG001|Overall Study|Study Drug Non-Compliance|2|||
28156639|NCT02791191|54826029|FG002|Overall Study|Study Drug Non-Compliance|0|||
28156640|NCT02791191|54826027|FG000|Overall Study|Site Closed by Sponsor|1|||
28156641|NCT02791191|54826028|FG001|Overall Study|Site Closed by Sponsor|1|||
28156642|NCT02791191|54826029|FG002|Overall Study|Site Closed by Sponsor|3|||
28156643|NCT02791191|54826027|FG000|Overall Study|Progressive Disease|1|||
28156644|NCT02791191|54826028|FG001|Overall Study|Progressive Disease|0|||
28156645|NCT02791191|54826029|FG002|Overall Study|Progressive Disease|0|||
28075249|NCT00133952|54729766|FG000|Overall Study|Death|3|||
28075250|NCT00133952|54729767|FG001|Overall Study|Death|2|||
28075251|NCT00133952|54729766|FG000|Overall Study|Lost to Follow-up|9|||
28075252|NCT00133952|54729767|FG001|Overall Study|Lost to Follow-up|14|||
28075253|NCT00133952|54729766|FG000|Overall Study|Protocol Entry Criteria Exclusion|4|||
28075254|NCT00133952|54729767|FG001|Overall Study|Protocol Entry Criteria Exclusion|1|||
28075255|NCT00133952|54729766|FG000|Overall Study|Protocol Violation|1|||
28075256|NCT00133952|54729767|FG001|Overall Study|Protocol Violation|1|||
28075257|NCT00133952|54729766|FG000|Overall Study|Withdrawal by Subject|20|||
28075258|NCT00133952|54729767|FG001|Overall Study|Withdrawal by Subject|4|||
28075259|NCT00133952|54729766|FG000|Overall Study|Physician Decision|4|||
28075260|NCT00133952|54729767|FG001|Overall Study|Physician Decision|3|||
28075261|NCT00133952|54729766|FG000|Overall Study|Sponsor Decision|0|||
27850318|NCT04178967|54349324|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
28075262|NCT00133952|54729767|FG001|Overall Study|Sponsor Decision|1|||
28075263|NCT00118092|54729773|FG000|Overall Study|Withdrawal by Subject|1|||
28075264|NCT00118092|54729773|FG000|Overall Study|Protocol Violation|1|||
28156646|NCT02791191|54826027|FG000|Overall Study|Study Terminated by Sponsor|29|||
28156647|NCT02791191|54826028|FG001|Overall Study|Study Terminated by Sponsor|101|||
28156648|NCT02791191|54826029|FG002|Overall Study|Study Terminated by Sponsor|109|||
28156649|NCT02791191|54826027|FG000|Overall Study|Withdrawal by Subject|3|||
28156650|NCT02791191|54826028|FG001|Overall Study|Withdrawal by Subject|1|||
28075265|NCT04555096|54729780|FG000|Overall Study|Death|4|||
28075266|NCT04555096|54729781|FG001|Overall Study|Death|4|||
28156651|NCT02791191|54826029|FG002|Overall Study|Withdrawal by Subject|3|||
28156652|NCT02791191|54826027|FG000|Overall Study|Subject Withdrew Caregiver Circumstances|2|||
28156653|NCT02791191|54826028|FG001|Overall Study|Subject Withdrew Caregiver Circumstances|1|||
28156654|NCT02791191|54826029|FG002|Overall Study|Subject Withdrew Caregiver Circumstances|0|||
28156655|NCT02114697|54826052|FG000|Overall Study|Study terminated|5|||
28156656|NCT02114697|54826053|FG001|Overall Study|Study terminated|4|||
28156657|NCT01330017|54826064|FG000|Overall Study|Adverse Event|0|||
28156658|NCT01330017|54826065|FG001|Overall Study|Adverse Event|1|||
28156659|NCT01330017|54826066|FG002|Overall Study|Adverse Event|1|||
28156660|NCT01330017|54826067|FG003|Overall Study|Adverse Event|4|||
27942181|NCT01202903|54598969|FG001|Overall Study|Withdrawal by Subject|4|||
27942182|NCT01001169|54598977|FG000|Overall Study|Withdrawal by Subject|2|||
27942183|NCT01001169|54598978|FG001|Overall Study|Withdrawal by Subject|1|||
27942184|NCT01202747|54598992|FG000|Overall Study|Withdrawal by Subject|1|||
27942185|NCT00996801|54599002|FG000|Overall Study|Adverse Event|6|||
28075267|NCT04555096|54729780|FG000|Overall Study|Withdrawal by Subject|1|||
28075268|NCT04555096|54729781|FG001|Overall Study|Withdrawal by Subject|0|||
28075269|NCT04555096|54729780|FG000|Overall Study|Other|0|||
28075270|NCT04555096|54729781|FG001|Overall Study|Other|1|||
28075271|NCT00097500|54729789|FG000|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
28075272|NCT00097500|54729790|FG001|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
28075273|NCT00097500|54729789|FG000|On-drug Period (Week 0 to Week 52)|Adverse Event|5|||
28075274|NCT00097500|54729790|FG001|On-drug Period (Week 0 to Week 52)|Adverse Event|0|||
28075275|NCT00097500|54729789|FG000|On-drug Period (Week 0 to Week 52)|Physician Decision|0|||
28075276|NCT00097500|54729790|FG001|On-drug Period (Week 0 to Week 52)|Physician Decision|1|||
28075277|NCT00097500|54729789|FG000|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0|||
28156661|NCT01330017|54826068|FG004|Overall Study|Adverse Event|0|||
28075278|NCT00097500|54729790|FG001|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1|||
28156662|NCT01330017|54826064|FG000|Overall Study|Withdrawal by Subject|0|||
28156663|NCT01330017|54826065|FG001|Overall Study|Withdrawal by Subject|0|||
28156664|NCT01330017|54826066|FG002|Overall Study|Withdrawal by Subject|1|||
28156665|NCT01330017|54826067|FG003|Overall Study|Withdrawal by Subject|0|||
28156666|NCT01330017|54826068|FG004|Overall Study|Withdrawal by Subject|1|||
28156667|NCT01330017|54826064|FG000|Overall Study|Lost to Follow-up|0|||
28156668|NCT01330017|54826065|FG001|Overall Study|Lost to Follow-up|0|||
28156669|NCT01330017|54826066|FG002|Overall Study|Lost to Follow-up|1|||
27825273|NCT01707992|54290706|FG001|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4|||
28075279|NCT00097500|54729789|FG000|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2|||
27825274|NCT01707992|54290707|FG002|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9|||
28156670|NCT01330017|54826067|FG003|Overall Study|Lost to Follow-up|0|||
28156671|NCT01330017|54826068|FG004|Overall Study|Lost to Follow-up|0|||
28156672|NCT01330017|54826064|FG000|Overall Study|Protocol Violation|0|||
28156673|NCT01330017|54826065|FG001|Overall Study|Protocol Violation|0|||
28156674|NCT01330017|54826066|FG002|Overall Study|Protocol Violation|0|||
28156675|NCT01330017|54826067|FG003|Overall Study|Protocol Violation|1|||
28156676|NCT01330017|54826068|FG004|Overall Study|Protocol Violation|0|||
28156677|NCT01330017|54826064|FG000|Overall Study|Unknown Reason|5|||
28156678|NCT01330017|54826065|FG001|Overall Study|Unknown Reason|3|||
28156679|NCT01330017|54826066|FG002|Overall Study|Unknown Reason|5|||
28156680|NCT01330017|54826067|FG003|Overall Study|Unknown Reason|7|||
28156681|NCT01330017|54826068|FG004|Overall Study|Unknown Reason|2|||
28156682|NCT00150462|54826091|FG000|Overall Study|Disease Progression or Relapse|3|||
28156683|NCT00150462|54826092|FG001|Overall Study|Disease Progression or Relapse|1|||
28156684|NCT00150462|54826093|FG002|Overall Study|Disease Progression or Relapse|2|||
28156685|NCT00150462|54826094|FG003|Overall Study|Disease Progression or Relapse|1|||
28156686|NCT00150462|54826095|FG004|Overall Study|Disease Progression or Relapse|2|||
28156687|NCT00150462|54826096|FG005|Overall Study|Disease Progression or Relapse|2|||
28156688|NCT00150462|54826097|FG006|Overall Study|Disease Progression or Relapse|3|||
28156689|NCT00150462|54826098|FG007|Overall Study|Disease Progression or Relapse|5|||
28156690|NCT00150462|54826099|FG008|Overall Study|Disease Progression or Relapse|5|||
28156691|NCT00150462|54826100|FG009|Overall Study|Disease Progression or Relapse|3|||
28156692|NCT00150462|54826101|FG010|Overall Study|Disease Progression or Relapse|2|||
28156693|NCT00150462|54826091|FG000|Overall Study|Withdrawal by Subject|0|||
28156694|NCT00150462|54826092|FG001|Overall Study|Withdrawal by Subject|1|||
28156695|NCT00150462|54826093|FG002|Overall Study|Withdrawal by Subject|1|||
28156696|NCT00150462|54826094|FG003|Overall Study|Withdrawal by Subject|0|||
28156697|NCT00150462|54826095|FG004|Overall Study|Withdrawal by Subject|1|||
28156698|NCT00150462|54826096|FG005|Overall Study|Withdrawal by Subject|2|||
28156699|NCT00150462|54826097|FG006|Overall Study|Withdrawal by Subject|0|||
28156700|NCT00150462|54826098|FG007|Overall Study|Withdrawal by Subject|1|||
28156701|NCT00150462|54826099|FG008|Overall Study|Withdrawal by Subject|0|||
28156702|NCT00150462|54826100|FG009|Overall Study|Withdrawal by Subject|1|||
28156703|NCT00150462|54826101|FG010|Overall Study|Withdrawal by Subject|0|||
28156704|NCT00150462|54826091|FG000|Overall Study|Death|0|||
28156705|NCT00150462|54826092|FG001|Overall Study|Death|1|||
28156706|NCT00150462|54826093|FG002|Overall Study|Death|0|||
28156707|NCT00150462|54826094|FG003|Overall Study|Death|0|||
28156708|NCT00150462|54826095|FG004|Overall Study|Death|0|||
28156709|NCT00150462|54826096|FG005|Overall Study|Death|0|||
28156710|NCT00150462|54826097|FG006|Overall Study|Death|0|||
28156711|NCT00150462|54826098|FG007|Overall Study|Death|0|||
28156712|NCT00150462|54826099|FG008|Overall Study|Death|1|||
28156713|NCT00150462|54826100|FG009|Overall Study|Death|0|||
28156714|NCT00150462|54826101|FG010|Overall Study|Death|0|||
28156715|NCT00150462|54826091|FG000|Overall Study|Adverse Event|0|||
28156716|NCT00150462|54826092|FG001|Overall Study|Adverse Event|0|||
28156717|NCT00150462|54826093|FG002|Overall Study|Adverse Event|0|||
28156718|NCT00150462|54826094|FG003|Overall Study|Adverse Event|1|||
28156719|NCT00150462|54826095|FG004|Overall Study|Adverse Event|0|||
28156720|NCT00150462|54826096|FG005|Overall Study|Adverse Event|0|||
27825275|NCT01707992|54290708|FG003|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
27825276|NCT01707992|54290709|FG004|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
27825277|NCT01707992|54290710|FG005|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
27942186|NCT00996801|54599003|FG001|Overall Study|Adverse Event|4|||
28156721|NCT00150462|54826097|FG006|Overall Study|Adverse Event|0|||
28156722|NCT00150462|54826098|FG007|Overall Study|Adverse Event|2|||
28156723|NCT00150462|54826099|FG008|Overall Study|Adverse Event|0|||
28075280|NCT00097500|54729790|FG001|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1|||
28156724|NCT00150462|54826100|FG009|Overall Study|Adverse Event|1|||
28156725|NCT00150462|54826101|FG010|Overall Study|Adverse Event|0|||
28156726|NCT00150462|54826091|FG000|Overall Study|Physician Decision|0|||
28156727|NCT00150462|54826092|FG001|Overall Study|Physician Decision|0|||
28156728|NCT00150462|54826093|FG002|Overall Study|Physician Decision|1|||
28156729|NCT00150462|54826094|FG003|Overall Study|Physician Decision|1|||
28156730|NCT00150462|54826095|FG004|Overall Study|Physician Decision|0|||
28156731|NCT00150462|54826096|FG005|Overall Study|Physician Decision|0|||
28156732|NCT00150462|54826097|FG006|Overall Study|Physician Decision|0|||
28156733|NCT00150462|54826098|FG007|Overall Study|Physician Decision|0|||
28156734|NCT00150462|54826099|FG008|Overall Study|Physician Decision|0|||
28156735|NCT00150462|54826100|FG009|Overall Study|Physician Decision|0|||
28075281|NCT00097500|54729789|FG000|Off-drug Period (Week 52 to Week 64)|Physician Decision|0|||
28156736|NCT00150462|54826101|FG010|Overall Study|Physician Decision|0|||
28156737|NCT00150462|54826091|FG000|Overall Study|Other|0|||
28156738|NCT00150462|54826092|FG001|Overall Study|Other|0|||
28075282|NCT00097500|54729790|FG001|Off-drug Period (Week 52 to Week 64)|Physician Decision|1|||
28075283|NCT00097500|54729789|FG000|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3|||
28075284|NCT00097500|54729790|FG001|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2|||
28075285|NCT04551898|54729800|FG000|Overall Study|Participant randomized but did not receive study drug|0|||
28075286|NCT04551898|54729801|FG001|Overall Study|Participant randomized but did not receive study drug|1|||
28075287|NCT04551898|54729802|FG002|Overall Study|Participant randomized but did not receive study drug|3|||
28075288|NCT04551898|54729803|FG003|Overall Study|Participant randomized but did not receive study drug|1|||
28075289|NCT04551898|54729800|FG000|Overall Study|Withdrawal by Subject|5|||
28075290|NCT04551898|54729801|FG001|Overall Study|Withdrawal by Subject|1|||
28075291|NCT04551898|54729802|FG002|Overall Study|Withdrawal by Subject|2|||
28075292|NCT04551898|54729803|FG003|Overall Study|Withdrawal by Subject|2|||
28075293|NCT04551898|54729800|FG000|Overall Study|Lost to Follow-up|2|||
28075294|NCT04551898|54729801|FG001|Overall Study|Lost to Follow-up|1|||
28075295|NCT04551898|54729802|FG002|Overall Study|Lost to Follow-up|2|||
28075296|NCT04551898|54729803|FG003|Overall Study|Lost to Follow-up|2|||
28075297|NCT04551898|54729800|FG000|Overall Study|Death|1|||
28075298|NCT04551898|54729801|FG001|Overall Study|Death|0|||
28075299|NCT04551898|54729802|FG002|Overall Study|Death|0|||
28075300|NCT04551898|54729803|FG003|Overall Study|Death|0|||
28075301|NCT04551898|54729800|FG000|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
28075302|NCT04551898|54729801|FG001|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
28075303|NCT04551898|54729802|FG002|Overall Study|Incorrectly randomized and screen failed due to administrative error|1|||
28075304|NCT04551898|54729803|FG003|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
28075305|NCT04849780|54729821|FG000|Period 1|Covid-19 Related|1|||
28156739|NCT00150462|54826093|FG002|Overall Study|Other|0|||
28156740|NCT00150462|54826094|FG003|Overall Study|Other|0|||
28156741|NCT00150462|54826095|FG004|Overall Study|Other|0|||
28156742|NCT00150462|54826096|FG005|Overall Study|Other|0|||
28075306|NCT04849780|54729822|FG001|Period 1|Covid-19 Related|0|||
28156743|NCT00150462|54826097|FG006|Overall Study|Other|0|||
28156744|NCT00150462|54826098|FG007|Overall Study|Other|0|||
28156745|NCT00150462|54826099|FG008|Overall Study|Other|0|||
28156746|NCT00150462|54826100|FG009|Overall Study|Other|1|||
28156747|NCT00150462|54826101|FG010|Overall Study|Other|1|||
28156748|NCT01368081|54826141|FG000|Overall Study|Adverse Event|4|||
28156749|NCT01368081|54826142|FG001|Overall Study|Adverse Event|4|||
28156750|NCT01368081|54826143|FG002|Overall Study|Adverse Event|3|||
28156751|NCT01368081|54826144|FG003|Overall Study|Adverse Event|2|||
28156752|NCT01368081|54826145|FG004|Overall Study|Adverse Event|2|||
28156753|NCT01368081|54826146|FG005|Overall Study|Adverse Event|5|||
28156754|NCT01368081|54826147|FG006|Overall Study|Adverse Event|6|||
28156755|NCT01368081|54826148|FG007|Overall Study|Adverse Event|2|||
28156756|NCT01368081|54826149|FG008|Overall Study|Adverse Event|3|||
28156757|NCT01368081|54826150|FG009|Overall Study|Adverse Event|5|||
28156758|NCT01368081|54826151|FG010|Overall Study|Adverse Event|6|||
28156759|NCT01368081|54826152|FG011|Overall Study|Adverse Event|1|||
28156760|NCT01368081|54826153|FG012|Overall Study|Adverse Event|3|||
28156761|NCT01368081|54826141|FG000|Overall Study|Lack of Efficacy|0|||
28156762|NCT01368081|54826142|FG001|Overall Study|Lack of Efficacy|1|||
28156763|NCT01368081|54826143|FG002|Overall Study|Lack of Efficacy|0|||
28156764|NCT01368081|54826144|FG003|Overall Study|Lack of Efficacy|1|||
28156765|NCT01368081|54826145|FG004|Overall Study|Lack of Efficacy|0|||
28156766|NCT01368081|54826146|FG005|Overall Study|Lack of Efficacy|0|||
28156767|NCT01368081|54826147|FG006|Overall Study|Lack of Efficacy|0|||
28156768|NCT01368081|54826148|FG007|Overall Study|Lack of Efficacy|2|||
28156769|NCT01368081|54826149|FG008|Overall Study|Lack of Efficacy|0|||
27825278|NCT01707992|54290705|FG000|Placebo-Controlled Phase (24 Months)|Death|2|||
27825279|NCT01707992|54290706|FG001|Placebo-Controlled Phase (24 Months)|Death|1|||
27825280|NCT01707992|54290707|FG002|Placebo-Controlled Phase (24 Months)|Death|1|||
27825281|NCT01707992|54290708|FG003|Placebo-Controlled Phase (24 Months)|Death|0|||
27825282|NCT01707992|54290709|FG004|Placebo-Controlled Phase (24 Months)|Death|0|||
28075307|NCT04849780|54729821|FG000|Period 1|Subject no longer meet eligibility criteria|3|||
28075308|NCT04849780|54729822|FG001|Period 1|Subject no longer meet eligibility criteria|0|||
28075309|NCT04849780|54729821|FG000|Period 2|Subject no longer meet eligibility criteria|2|||
28075310|NCT04849780|54729822|FG001|Period 2|Subject no longer meet eligibility criteria|0|||
28075311|NCT04823494|54729836|FG000|Overall Study|Programming software malfunction.|1|||
28075312|NCT04823494|54729837|FG001|Overall Study|Programming software malfunction.|0|||
28075313|NCT04823494|54729836|FG000|Overall Study|Withdrawal by Subject|1|||
28075314|NCT04823494|54729837|FG001|Overall Study|Withdrawal by Subject|0|||
28156770|NCT01368081|54826150|FG009|Overall Study|Lack of Efficacy|0|||
28156771|NCT01368081|54826151|FG010|Overall Study|Lack of Efficacy|0|||
28156772|NCT01368081|54826152|FG011|Overall Study|Lack of Efficacy|0|||
27942187|NCT00996801|54599004|FG002|Overall Study|Adverse Event|12|||
27825283|NCT01707992|54290710|FG005|Placebo-Controlled Phase (24 Months)|Death|0|||
27825284|NCT01707992|54290705|FG000|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2|||
27825285|NCT01707992|54290706|FG001|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1|||
27825286|NCT01707992|54290707|FG002|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6|||
28156773|NCT01368081|54826153|FG012|Overall Study|Lack of Efficacy|0|||
28156774|NCT01368081|54826141|FG000|Overall Study|Protocol Violation|0|||
28156775|NCT01368081|54826142|FG001|Overall Study|Protocol Violation|0|||
28156776|NCT01368081|54826143|FG002|Overall Study|Protocol Violation|0|||
28156777|NCT01368081|54826144|FG003|Overall Study|Protocol Violation|0|||
28156778|NCT01368081|54826145|FG004|Overall Study|Protocol Violation|0|||
28156779|NCT01368081|54826146|FG005|Overall Study|Protocol Violation|1|||
28156780|NCT01368081|54826147|FG006|Overall Study|Protocol Violation|0|||
28156781|NCT01368081|54826148|FG007|Overall Study|Protocol Violation|1|||
28156782|NCT01368081|54826149|FG008|Overall Study|Protocol Violation|0|||
28156783|NCT01368081|54826150|FG009|Overall Study|Protocol Violation|0|||
28156784|NCT01368081|54826151|FG010|Overall Study|Protocol Violation|0|||
28156785|NCT01368081|54826152|FG011|Overall Study|Protocol Violation|0|||
28156786|NCT01368081|54826153|FG012|Overall Study|Protocol Violation|0|||
28156787|NCT01368081|54826141|FG000|Overall Study|Lost to Follow-up|0|||
28156788|NCT01368081|54826142|FG001|Overall Study|Lost to Follow-up|0|||
28156789|NCT01368081|54826143|FG002|Overall Study|Lost to Follow-up|0|||
28156790|NCT01368081|54826144|FG003|Overall Study|Lost to Follow-up|0|||
28156791|NCT01368081|54826145|FG004|Overall Study|Lost to Follow-up|0|||
28156792|NCT01368081|54826146|FG005|Overall Study|Lost to Follow-up|0|||
28156793|NCT01368081|54826147|FG006|Overall Study|Lost to Follow-up|0|||
28156794|NCT01368081|54826148|FG007|Overall Study|Lost to Follow-up|0|||
28156795|NCT01368081|54826149|FG008|Overall Study|Lost to Follow-up|0|||
28156796|NCT01368081|54826150|FG009|Overall Study|Lost to Follow-up|0|||
27831270|NCT01812707|54307684|FG003|Overall Study|Poor compliance to protocol|0|||
28156797|NCT01368081|54826151|FG010|Overall Study|Lost to Follow-up|0|||
28156798|NCT01368081|54826152|FG011|Overall Study|Lost to Follow-up|0|||
28156799|NCT01368081|54826153|FG012|Overall Study|Lost to Follow-up|1|||
28156800|NCT01368081|54826141|FG000|Overall Study|Withdrawal by Subject|4|||
28156801|NCT01368081|54826142|FG001|Overall Study|Withdrawal by Subject|4|||
28156802|NCT01368081|54826143|FG002|Overall Study|Withdrawal by Subject|1|||
28156803|NCT01368081|54826144|FG003|Overall Study|Withdrawal by Subject|1|||
28156804|NCT01368081|54826145|FG004|Overall Study|Withdrawal by Subject|0|||
28156805|NCT01368081|54826146|FG005|Overall Study|Withdrawal by Subject|3|||
28156806|NCT01368081|54826147|FG006|Overall Study|Withdrawal by Subject|4|||
28156807|NCT01368081|54826148|FG007|Overall Study|Withdrawal by Subject|2|||
28156808|NCT01368081|54826149|FG008|Overall Study|Withdrawal by Subject|5|||
28156809|NCT01368081|54826150|FG009|Overall Study|Withdrawal by Subject|4|||
28156810|NCT01368081|54826151|FG010|Overall Study|Withdrawal by Subject|3|||
28156811|NCT01368081|54826152|FG011|Overall Study|Withdrawal by Subject|2|||
28156812|NCT01368081|54826153|FG012|Overall Study|Withdrawal by Subject|0|||
28156813|NCT01368081|54826141|FG000|Overall Study|Other reason not defined above|2|||
28156814|NCT01368081|54826142|FG001|Overall Study|Other reason not defined above|0|||
28156815|NCT01368081|54826143|FG002|Overall Study|Other reason not defined above|0|||
28156816|NCT01368081|54826144|FG003|Overall Study|Other reason not defined above|1|||
27825287|NCT01707992|54290708|FG003|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
27825288|NCT01707992|54290709|FG004|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
28156817|NCT01368081|54826145|FG004|Overall Study|Other reason not defined above|0|||
28156818|NCT01368081|54826146|FG005|Overall Study|Other reason not defined above|1|||
28156819|NCT01368081|54826147|FG006|Overall Study|Other reason not defined above|2|||
28156820|NCT01368081|54826148|FG007|Overall Study|Other reason not defined above|0|||
28156821|NCT01368081|54826149|FG008|Overall Study|Other reason not defined above|0|||
28156822|NCT01368081|54826150|FG009|Overall Study|Other reason not defined above|1|||
28156823|NCT01368081|54826151|FG010|Overall Study|Other reason not defined above|0|||
28156824|NCT01368081|54826152|FG011|Overall Study|Other reason not defined above|0|||
28156825|NCT01368081|54826153|FG012|Overall Study|Other reason not defined above|3|||
28156826|NCT00303498|54826183|FG000|Run-In-Phase (10 Weeks)|Adverse Event|5|||
28156827|NCT00303498|54826184|FG001|Run-In-Phase (10 Weeks)|Adverse Event|1|||
28156828|NCT00303498|54826183|FG000|Run-In-Phase (10 Weeks)|Physician Decision|0|||
28156829|NCT00303498|54826184|FG001|Run-In-Phase (10 Weeks)|Physician Decision|1|||
28156830|NCT00303498|54826183|FG000|Run-In-Phase (10 Weeks)|Withdrawal by Subject|5|||
28156831|NCT00303498|54826184|FG001|Run-In-Phase (10 Weeks)|Withdrawal by Subject|0|||
28156832|NCT00303498|54826183|FG000|Run-In-Phase (10 Weeks)|Sponsor Decision|6|||
28156833|NCT00303498|54826184|FG001|Run-In-Phase (10 Weeks)|Sponsor Decision|3|||
28156834|NCT00303498|54826183|FG000|Run-In-Phase (10 Weeks)|Other|4|||
28156835|NCT00303498|54826184|FG001|Run-In-Phase (10 Weeks)|Other|1|||
28156836|NCT00303498|54826183|FG000|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|3|||
28156837|NCT00303498|54826184|FG001|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|2|||
28156838|NCT00303498|54826183|FG000|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|1|||
28156839|NCT00303498|54826184|FG001|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|0|||
28156840|NCT00303498|54826183|FG000|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|1|||
28156841|NCT00303498|54826184|FG001|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|0|||
28156842|NCT00303498|54826183|FG000|Maintenance Phase (24 Weeks)|Death|1|||
28156843|NCT00303498|54826184|FG001|Maintenance Phase (24 Weeks)|Death|0|||
28156844|NCT00303498|54826183|FG000|Maintenance Phase (24 Weeks)|Adverse Event|2|||
28156845|NCT00303498|54826184|FG001|Maintenance Phase (24 Weeks)|Adverse Event|1|||
28156846|NCT00303498|54826183|FG000|Maintenance Phase (24 Weeks)|Physician Decision|1|||
28156847|NCT00303498|54826184|FG001|Maintenance Phase (24 Weeks)|Physician Decision|0|||
28156848|NCT00303498|54826183|FG000|Maintenance Phase (24 Weeks)|Withdrawal by Subject|3|||
28156849|NCT00303498|54826184|FG001|Maintenance Phase (24 Weeks)|Withdrawal by Subject|4|||
28156850|NCT00303498|54826183|FG000|Maintenance Phase (24 Weeks)|Sponsor Decision|4|||
28156851|NCT00303498|54826184|FG001|Maintenance Phase (24 Weeks)|Sponsor Decision|0|||
28156852|NCT00303498|54826183|FG000|Maintenance Phase (24 Weeks)|Other|1|||
28156853|NCT00303498|54826184|FG001|Maintenance Phase (24 Weeks)|Other|0|||
28156854|NCT00303498|54826183|FG000|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|1|||
28156855|NCT00303498|54826184|FG001|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|2|||
28156856|NCT00303498|54826183|FG000|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|0|||
28156857|NCT00303498|54826184|FG001|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|1|||
28156858|NCT02588092|54826200|FG000|Overall Study|Death|4|||
28156859|NCT02588092|54826201|FG001|Overall Study|Death|3|||
28156860|NCT02588092|54826202|FG002|Overall Study|Death|3|||
28156861|NCT02588092|54826203|FG003|Overall Study|Death|3|||
28156862|NCT02588092|54826204|FG004|Overall Study|Death|2|||
28156863|NCT02588092|54826205|FG005|Overall Study|Death|2|||
28156864|NCT02588092|54826206|FG006|Overall Study|Death|2|||
28156865|NCT02588092|54826207|FG007|Overall Study|Death|1|||
28156866|NCT02588092|54826208|FG008|Overall Study|Death|5|||
28156867|NCT02588092|54826209|FG009|Overall Study|Death|2|||
28156868|NCT02588092|54826200|FG000|Overall Study|Withdrawal by Subject|0|||
28156869|NCT02588092|54826201|FG001|Overall Study|Withdrawal by Subject|0|||
28156870|NCT02588092|54826202|FG002|Overall Study|Withdrawal by Subject|0|||
28156871|NCT02588092|54826203|FG003|Overall Study|Withdrawal by Subject|0|||
28156872|NCT02588092|54826204|FG004|Overall Study|Withdrawal by Subject|0|||
28156873|NCT02588092|54826205|FG005|Overall Study|Withdrawal by Subject|1|||
28156874|NCT02588092|54826206|FG006|Overall Study|Withdrawal by Subject|1|||
28156875|NCT02588092|54826207|FG007|Overall Study|Withdrawal by Subject|2|||
28156876|NCT02588092|54826208|FG008|Overall Study|Withdrawal by Subject|0|||
28156877|NCT02588092|54826209|FG009|Overall Study|Withdrawal by Subject|0|||
28156878|NCT02588092|54826200|FG000|Overall Study|Started Another Treatment|0|||
28156879|NCT02588092|54826201|FG001|Overall Study|Started Another Treatment|0|||
28156880|NCT02588092|54826202|FG002|Overall Study|Started Another Treatment|0|||
28156881|NCT02588092|54826203|FG003|Overall Study|Started Another Treatment|0|||
28156882|NCT02588092|54826204|FG004|Overall Study|Started Another Treatment|1|||
28156883|NCT02588092|54826205|FG005|Overall Study|Started Another Treatment|0|||
28156884|NCT02588092|54826206|FG006|Overall Study|Started Another Treatment|0|||
28156885|NCT02588092|54826207|FG007|Overall Study|Started Another Treatment|1|||
28156886|NCT02588092|54826208|FG008|Overall Study|Started Another Treatment|0|||
28156887|NCT02588092|54826209|FG009|Overall Study|Started Another Treatment|0|||
28156888|NCT02588092|54826200|FG000|Overall Study|Sponsor Decision|0|||
28156889|NCT02588092|54826201|FG001|Overall Study|Sponsor Decision|0|||
28156890|NCT02588092|54826202|FG002|Overall Study|Sponsor Decision|0|||
28156891|NCT02588092|54826203|FG003|Overall Study|Sponsor Decision|0|||
28156892|NCT02588092|54826204|FG004|Overall Study|Sponsor Decision|0|||
28156893|NCT02588092|54826205|FG005|Overall Study|Sponsor Decision|0|||
28156894|NCT02588092|54826206|FG006|Overall Study|Sponsor Decision|0|||
28156895|NCT02588092|54826207|FG007|Overall Study|Sponsor Decision|0|||
28156896|NCT02588092|54826208|FG008|Overall Study|Sponsor Decision|1|||
28156897|NCT02588092|54826209|FG009|Overall Study|Sponsor Decision|1|||
28156898|NCT01367847|54826237|FG000|Overall Study|Withdrawal by Subject|2|||
28156899|NCT01367847|54826238|FG001|Overall Study|Withdrawal by Subject|2|||
28156900|NCT00150618|54826250|FG000|Overall Study|Adverse Event|2|||
28156901|NCT00150618|54826251|FG001|Overall Study|Adverse Event|2|||
28156902|NCT00150618|54826252|FG002|Overall Study|Adverse Event|6|||
28156903|NCT00150618|54826253|FG003|Overall Study|Adverse Event|9|||
28156904|NCT00150618|54826254|FG004|Overall Study|Adverse Event|5|||
28156905|NCT00150618|54826250|FG000|Overall Study|Withdrawal by Subject|6|||
28156906|NCT00150618|54826251|FG001|Overall Study|Withdrawal by Subject|8|||
28156907|NCT00150618|54826252|FG002|Overall Study|Withdrawal by Subject|8|||
28156908|NCT00150618|54826253|FG003|Overall Study|Withdrawal by Subject|4|||
28156909|NCT00150618|54826254|FG004|Overall Study|Withdrawal by Subject|5|||
28156910|NCT00150618|54826250|FG000|Overall Study|Lost to Follow-up|4|||
28156911|NCT00150618|54826251|FG001|Overall Study|Lost to Follow-up|1|||
28156912|NCT00150618|54826252|FG002|Overall Study|Lost to Follow-up|5|||
28156913|NCT00150618|54826253|FG003|Overall Study|Lost to Follow-up|8|||
28156914|NCT00150618|54826254|FG004|Overall Study|Lost to Follow-up|4|||
28156915|NCT00150618|54826250|FG000|Overall Study|Protocol Violation|1|||
28156916|NCT00150618|54826251|FG001|Overall Study|Protocol Violation|0|||
28156917|NCT00150618|54826252|FG002|Overall Study|Protocol Violation|0|||
28156918|NCT00150618|54826253|FG003|Overall Study|Protocol Violation|0|||
28156919|NCT00150618|54826254|FG004|Overall Study|Protocol Violation|1|||
28156920|NCT00150618|54826250|FG000|Overall Study|Lack of Efficacy|1|||
28156921|NCT00150618|54826251|FG001|Overall Study|Lack of Efficacy|4|||
28156922|NCT00150618|54826252|FG002|Overall Study|Lack of Efficacy|7|||
28156923|NCT00150618|54826253|FG003|Overall Study|Lack of Efficacy|4|||
28156924|NCT00150618|54826254|FG004|Overall Study|Lack of Efficacy|6|||
28156925|NCT00150618|54826250|FG000|Overall Study|No study meds|0|||
28156926|NCT00150618|54826251|FG001|Overall Study|No study meds|0|||
28156927|NCT00150618|54826252|FG002|Overall Study|No study meds|0|||
28156928|NCT00150618|54826253|FG003|Overall Study|No study meds|0|||
28156929|NCT00150618|54826254|FG004|Overall Study|No study meds|2|||
28156930|NCT00150618|54826250|FG000|Overall Study|Physician Decision|0|||
28156931|NCT00150618|54826251|FG001|Overall Study|Physician Decision|2|||
28156932|NCT00150618|54826252|FG002|Overall Study|Physician Decision|0|||
27825289|NCT01707992|54290710|FG005|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
28156933|NCT00150618|54826253|FG003|Overall Study|Physician Decision|0|||
28156934|NCT00150618|54826254|FG004|Overall Study|Physician Decision|1|||
28156935|NCT00150618|54826250|FG000|Overall Study|Lack of compliance|2|||
28156936|NCT00150618|54826251|FG001|Overall Study|Lack of compliance|1|||
28156937|NCT00150618|54826252|FG002|Overall Study|Lack of compliance|1|||
28156938|NCT00150618|54826253|FG003|Overall Study|Lack of compliance|0|||
28156939|NCT00150618|54826254|FG004|Overall Study|Lack of compliance|1|||
28156940|NCT00150618|54826250|FG000|Overall Study|Abnormal ECG|1|||
28156941|NCT00150618|54826251|FG001|Overall Study|Abnormal ECG|0|||
28156942|NCT00150618|54826252|FG002|Overall Study|Abnormal ECG|0|||
28156943|NCT00150618|54826253|FG003|Overall Study|Abnormal ECG|0|||
28156944|NCT00150618|54826254|FG004|Overall Study|Abnormal ECG|0|||
28156945|NCT00150618|54826250|FG000|Overall Study|Sponsor's decision|0|||
28156946|NCT00150618|54826251|FG001|Overall Study|Sponsor's decision|0|||
28156947|NCT00150618|54826252|FG002|Overall Study|Sponsor's decision|0|||
28156948|NCT00150618|54826253|FG003|Overall Study|Sponsor's decision|1|||
28156949|NCT00150618|54826254|FG004|Overall Study|Sponsor's decision|0|||
28156950|NCT02587234|54826268|FG000|Overall Study|Withdrawal by Subject|1|||
28156951|NCT02587234|54826269|FG001|Overall Study|Withdrawal by Subject|1|||
28156952|NCT02587234|54826268|FG000|Overall Study|Lost to Follow-up|0|||
28156953|NCT02587234|54826269|FG001|Overall Study|Lost to Follow-up|2|||
28156954|NCT01359046|54826277|FG000|Overall Study|Did not receive allocated intervention|6|||
28156955|NCT01359046|54826278|FG001|Overall Study|Did not receive allocated intervention|6|||
28156956|NCT01359046|54826277|FG000|Overall Study|Physician Decision|1|||
28156957|NCT01359046|54826278|FG001|Overall Study|Physician Decision|11|||
28156958|NCT02741310|54826286|FG000|Overall Study|Sponsor Decision|2|||
28156959|NCT02741310|54826287|FG001|Overall Study|Sponsor Decision|2|||
28156960|NCT01367457|54826304|FG000|Overall Study|Death|2|||
28156961|NCT01367457|54826305|FG001|Overall Study|Death|0|||
28156962|NCT01367457|54826306|FG002|Overall Study|Death|0|||
28156963|NCT01367457|54826304|FG000|Overall Study|Investigator's decision|2|||
28156964|NCT01367457|54826305|FG001|Overall Study|Investigator's decision|0|||
28156965|NCT01367457|54826306|FG002|Overall Study|Investigator's decision|0|||
28156966|NCT01367457|54826304|FG000|Overall Study|Clinical decline (CD)|2|||
28156967|NCT01367457|54826305|FG001|Overall Study|Clinical decline (CD)|0|||
28156968|NCT01367457|54826306|FG002|Overall Study|Clinical decline (CD)|0|||
28156969|NCT01367457|54826304|FG000|Overall Study|Progression and death|8|||
28156970|NCT01367457|54826305|FG001|Overall Study|Progression and death|0|||
28156971|NCT01367457|54826306|FG002|Overall Study|Progression and death|0|||
28156972|NCT01367457|54826304|FG000|Overall Study|Toxicity|16|||
28156973|NCT01367457|54826305|FG001|Overall Study|Toxicity|0|||
28156974|NCT01367457|54826306|FG002|Overall Study|Toxicity|0|||
28156975|NCT01367457|54826304|FG000|Overall Study|Progression|137|||
28156976|NCT01367457|54826305|FG001|Overall Study|Progression|0|||
28156977|NCT01367457|54826306|FG002|Overall Study|Progression|0|||
28156978|NCT01367457|54826304|FG000|Overall Study|Patient asks for rest + slow progression|1|||
28156979|NCT01367457|54826305|FG001|Overall Study|Patient asks for rest + slow progression|0|||
28156980|NCT01367457|54826306|FG002|Overall Study|Patient asks for rest + slow progression|0|||
28156981|NCT01367457|54826304|FG000|Overall Study|Investigator's opinion, stable disease|1|||
28156982|NCT01367457|54826305|FG001|Overall Study|Investigator's opinion, stable disease|0|||
28156983|NCT01367457|54826306|FG002|Overall Study|Investigator's opinion, stable disease|0|||
28156984|NCT01367457|54826304|FG000|Overall Study|Bleeding from cavernous haemangioma|1|||
28156985|NCT01367457|54826305|FG001|Overall Study|Bleeding from cavernous haemangioma|0|||
28156986|NCT01367457|54826306|FG002|Overall Study|Bleeding from cavernous haemangioma|0|||
28156987|NCT01367457|54826304|FG000|Overall Study|3 yr Temsirolimus treatment (no disease)|1|||
28156988|NCT01367457|54826305|FG001|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
28156989|NCT01367457|54826306|FG002|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
28156990|NCT01367457|54826304|FG000|Overall Study|low grade toxicities + stable disease|1|||
28156991|NCT01367457|54826305|FG001|Overall Study|low grade toxicities + stable disease|0|||
28156992|NCT01367457|54826306|FG002|Overall Study|low grade toxicities + stable disease|0|||
28156993|NCT01367457|54826304|FG000|Overall Study|Choledocolithiasis and pancreatitis|1|||
28156994|NCT01367457|54826305|FG001|Overall Study|Choledocolithiasis and pancreatitis|0|||
28156995|NCT01367457|54826306|FG002|Overall Study|Choledocolithiasis and pancreatitis|0|||
28156996|NCT01367457|54826304|FG000|Overall Study|Withdrawal by Subject|1|||
28156997|NCT01367457|54826305|FG001|Overall Study|Withdrawal by Subject|0|||
28156998|NCT01367457|54826306|FG002|Overall Study|Withdrawal by Subject|0|||
28156999|NCT01367457|54826304|FG000|Overall Study|CD, associated leukaemia|1|||
28157000|NCT01367457|54826305|FG001|Overall Study|CD, associated leukaemia|0|||
28157001|NCT01367457|54826306|FG002|Overall Study|CD, associated leukaemia|0|||
28157002|NCT01367457|54826304|FG000|Overall Study|Uncontrolled pain|1|||
28157003|NCT01367457|54826305|FG001|Overall Study|Uncontrolled pain|0|||
28157004|NCT01367457|54826306|FG002|Overall Study|Uncontrolled pain|0|||
28157005|NCT01367457|54826304|FG000|Overall Study|Overall status worsens to grade 4|1|||
28157006|NCT01367457|54826305|FG001|Overall Study|Overall status worsens to grade 4|0|||
28157007|NCT01367457|54826306|FG002|Overall Study|Overall status worsens to grade 4|0|||
28157008|NCT01367457|54826304|FG000|Overall Study|Stabilisation + frequent infections|1|||
28157009|NCT01367457|54826305|FG001|Overall Study|Stabilisation + frequent infections|0|||
28157010|NCT01367457|54826306|FG002|Overall Study|Stabilisation + frequent infections|0|||
28157011|NCT01367457|54826304|FG000|Overall Study|No clinical benefit|1|||
28157012|NCT01367457|54826305|FG001|Overall Study|No clinical benefit|0|||
28157013|NCT01367457|54826306|FG002|Overall Study|No clinical benefit|0|||
28157014|NCT01367457|54826304|FG000|Overall Study|Intestinal obstruction with necrosis|1|||
28157015|NCT01367457|54826305|FG001|Overall Study|Intestinal obstruction with necrosis|0|||
28157016|NCT01367457|54826306|FG002|Overall Study|Intestinal obstruction with necrosis|0|||
28157017|NCT01367457|54826304|FG000|Overall Study|Overall decline|1|||
28157018|NCT01367457|54826305|FG001|Overall Study|Overall decline|0|||
28075315|NCT04823494|54729836|FG000|Overall Study|Devices lost|0|||
28075316|NCT04823494|54729837|FG001|Overall Study|Devices lost|1|||
28075317|NCT04542694|54729847|FG000|Overall Study|The need for prohibited therapy|2|||
28075318|NCT04542694|54729848|FG001|Overall Study|The need for prohibited therapy|0|||
28075319|NCT04542694|54729847|FG000|Overall Study|Adverse Event|1|||
28075320|NCT04542694|54729848|FG001|Overall Study|Adverse Event|0|||
28075321|NCT04542694|54729847|FG000|Overall Study|Protocol Violation|1|||
28075322|NCT04542694|54729848|FG001|Overall Study|Protocol Violation|0|||
28075323|NCT00117312|54729858|FG000|Overall Study|Testosterone >1.0 ng/mL|9|||
28157019|NCT01367457|54826306|FG002|Overall Study|Overall decline|0|||
28157020|NCT01367457|54826304|FG000|Overall Study|Rejection of treatment|1|||
28157021|NCT01367457|54826305|FG001|Overall Study|Rejection of treatment|0|||
28157022|NCT01367457|54826306|FG002|Overall Study|Rejection of treatment|0|||
28157023|NCT01367457|54826304|FG000|Overall Study|Lost to Follow-up|1|||
28157024|NCT01367457|54826305|FG001|Overall Study|Lost to Follow-up|0|||
28157025|NCT01367457|54826306|FG002|Overall Study|Lost to Follow-up|0|||
28157026|NCT01367457|54826304|FG000|Overall Study|Death from septic shock|1|||
28157027|NCT01367457|54826305|FG001|Overall Study|Death from septic shock|0|||
28157028|NCT01367457|54826306|FG002|Overall Study|Death from septic shock|0|||
28157029|NCT01367457|54826304|FG000|Overall Study|CD, Suspected disease progression (DP)|1|||
28157030|NCT01367457|54826305|FG001|Overall Study|CD, Suspected disease progression (DP)|0|||
28157031|NCT01367457|54826306|FG002|Overall Study|CD, Suspected disease progression (DP)|0|||
28157032|NCT01367457|54826304|FG000|Overall Study|Patient's Wish|1|||
28157033|NCT01367457|54826305|FG001|Overall Study|Patient's Wish|0|||
28157034|NCT01367457|54826306|FG002|Overall Study|Patient's Wish|0|||
28157035|NCT01367457|54826304|FG000|Overall Study|Palliative. Overall decline|1|||
27825290|NCT01707992|54290705|FG000|Placebo-Controlled Phase (24 Months)|Other than specified|11|||
27825291|NCT01707992|54290706|FG001|Placebo-Controlled Phase (24 Months)|Other than specified|9|||
28157036|NCT01367457|54826305|FG001|Overall Study|Palliative. Overall decline|0|||
28157037|NCT01367457|54826306|FG002|Overall Study|Palliative. Overall decline|0|||
28157038|NCT01367457|54826304|FG000|Overall Study|Suspected DP/suspected active infection|1|||
28157039|NCT01367457|54826305|FG001|Overall Study|Suspected DP/suspected active infection|0|||
28157040|NCT01367457|54826306|FG002|Overall Study|Suspected DP/suspected active infection|0|||
28157041|NCT00235326|54826316|FG000|Overall Study|Lost to Follow-up|746|||
28157042|NCT00235326|54826317|FG001|Overall Study|Lost to Follow-up|1400|||
28157043|NCT00162942|54826327|FG000|Overall Study|Adverse Event|10|||
28157044|NCT00162942|54826328|FG001|Overall Study|Adverse Event|6|||
28157045|NCT00162942|54826327|FG000|Overall Study|Death|1|||
28157046|NCT00162942|54826328|FG001|Overall Study|Death|0|||
28157047|NCT00162942|54826327|FG000|Overall Study|Withdrawal by Subject|3|||
28157048|NCT00162942|54826328|FG001|Overall Study|Withdrawal by Subject|6|||
28157049|NCT00162942|54826327|FG000|Overall Study|Physician Decision|1|||
28157050|NCT00162942|54826328|FG001|Overall Study|Physician Decision|0|||
28157051|NCT00162942|54826327|FG000|Overall Study|Enter Open-Label Study|76|||
28157052|NCT00162942|54826328|FG001|Overall Study|Enter Open-Label Study|35|||
28157053|NCT00162942|54826327|FG000|Overall Study|Alternate Therapy|6|||
28157054|NCT00162942|54826328|FG001|Overall Study|Alternate Therapy|2|||
28157055|NCT00162942|54826327|FG000|Overall Study|Lack of Efficacy|1|||
28157056|NCT00162942|54826328|FG001|Overall Study|Lack of Efficacy|0|||
28157057|NCT00162942|54826327|FG000|Overall Study|Flare During Active Treatment|7|||
28075324|NCT00117312|54729859|FG001|Overall Study|Testosterone >1.0 ng/mL|9|||
28075325|NCT00117312|54729860|FG002|Overall Study|Testosterone >1.0 ng/mL|5|||
28075326|NCT00117312|54729861|FG003|Overall Study|Testosterone >1.0 ng/mL|9|||
28075327|NCT00117312|54729858|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
28157058|NCT00162942|54826328|FG001|Overall Study|Flare During Active Treatment|3|||
28075328|NCT00117312|54729859|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
28075329|NCT00117312|54729860|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
28075330|NCT00117312|54729861|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
28075331|NCT00117312|54729858|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
28075332|NCT00117312|54729859|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
28075333|NCT00117312|54729860|FG002|Overall Study|Prostate-specific antigen increase >=25%|5|||
28157059|NCT00162942|54826327|FG000|Overall Study|2 or more consecutive treatments missed|1|||
27942188|NCT00996801|54599005|FG003|Overall Study|Adverse Event|17|||
28157060|NCT00162942|54826328|FG001|Overall Study|2 or more consecutive treatments missed|0|||
28157061|NCT02786901|54826358|FG000|Overall Study|Adverse Event|1|||
28157062|NCT02786901|54826359|FG001|Overall Study|Adverse Event|1|||
28157063|NCT02786901|54826360|FG002|Overall Study|Adverse Event|2|||
28157064|NCT02786901|54826358|FG000|Overall Study|Physician Decision|1|||
28157065|NCT02786901|54826359|FG001|Overall Study|Physician Decision|0|||
28157066|NCT02786901|54826360|FG002|Overall Study|Physician Decision|0|||
28157067|NCT02786901|54826358|FG000|Overall Study|Rescue Therapy Use|71|||
28157068|NCT02786901|54826359|FG001|Overall Study|Rescue Therapy Use|49|||
28157069|NCT02786901|54826360|FG002|Overall Study|Rescue Therapy Use|33|||
28157070|NCT02786901|54826358|FG000|Overall Study|Subject Request/Lost to Follow up|1|||
28157071|NCT02786901|54826359|FG001|Overall Study|Subject Request/Lost to Follow up|5|||
28157072|NCT02786901|54826360|FG002|Overall Study|Subject Request/Lost to Follow up|5|||
28157073|NCT02786901|54826358|FG000|Overall Study|Disallowed medication|1|||
28157074|NCT02786901|54826359|FG001|Overall Study|Disallowed medication|1|||
28157075|NCT02786901|54826360|FG002|Overall Study|Disallowed medication|0|||
28157076|NCT02786901|54826358|FG000|Overall Study|Randomized in error|2|||
28157077|NCT02786901|54826359|FG001|Overall Study|Randomized in error|0|||
28157078|NCT02786901|54826360|FG002|Overall Study|Randomized in error|1|||
28157079|NCT02137239|54826370|FG000|Overall Study|Discontinued Study Treatment|0|||
28075334|NCT00117312|54729861|FG003|Overall Study|Prostate-specific antigen increase >=25%|3|||
28075335|NCT00117312|54729858|FG000|Overall Study|Other|0|||
28075336|NCT00117312|54729859|FG001|Overall Study|Other|1|||
28075337|NCT00117312|54729860|FG002|Overall Study|Other|3|||
28075338|NCT00117312|54729861|FG003|Overall Study|Other|1|||
28075339|NCT00117312|54729858|FG000|Overall Study|Patient choice|0|||
28075340|NCT00117312|54729859|FG001|Overall Study|Patient choice|0|||
28075341|NCT00117312|54729860|FG002|Overall Study|Patient choice|2|||
28075342|NCT00117312|54729861|FG003|Overall Study|Patient choice|1|||
28075343|NCT00117312|54729858|FG000|Overall Study|Adverse Event|0|||
28075344|NCT00117312|54729859|FG001|Overall Study|Adverse Event|2|||
28075345|NCT00117312|54729860|FG002|Overall Study|Adverse Event|0|||
28075346|NCT00117312|54729861|FG003|Overall Study|Adverse Event|0|||
28157080|NCT02137239|54826371|FG001|Overall Study|Discontinued Study Treatment|3|||
28075347|NCT00117312|54729858|FG000|Overall Study|Protocol Violation|0|||
28075348|NCT00117312|54729859|FG001|Overall Study|Protocol Violation|1|||
28157081|NCT02137239|54826370|FG000|Overall Study|Withdrew Consent|1|||
28157082|NCT02137239|54826371|FG001|Overall Study|Withdrew Consent|1|||
28157083|NCT02137239|54826370|FG000|Overall Study|Adverse Event|2|||
28157084|NCT02137239|54826371|FG001|Overall Study|Adverse Event|2|||
28157085|NCT02741076|54826390|FG000|Overall Study|Adverse Event|0|||
28157086|NCT02741076|54826391|FG001|Overall Study|Adverse Event|1|||
28157087|NCT02741076|54826392|FG002|Overall Study|Adverse Event|1|||
28157088|NCT02741076|54826393|FG003|Overall Study|Adverse Event|0|||
28157089|NCT02741076|54826390|FG000|Overall Study|Lack of Efficacy|1|||
28157090|NCT02741076|54826391|FG001|Overall Study|Lack of Efficacy|0|||
28157091|NCT02741076|54826392|FG002|Overall Study|Lack of Efficacy|0|||
28157092|NCT02741076|54826393|FG003|Overall Study|Lack of Efficacy|0|||
28157093|NCT02741076|54826390|FG000|Overall Study|Withdrawal by Subject|0|||
28157094|NCT02741076|54826391|FG001|Overall Study|Withdrawal by Subject|1|||
28157095|NCT02741076|54826392|FG002|Overall Study|Withdrawal by Subject|0|||
28075349|NCT00117312|54729860|FG002|Overall Study|Protocol Violation|3|||
28075350|NCT00117312|54729861|FG003|Overall Study|Protocol Violation|0|||
28157096|NCT02741076|54826393|FG003|Overall Study|Withdrawal by Subject|0|||
28157097|NCT02741076|54826390|FG000|Overall Study|Sponsor Request|2|||
28157098|NCT02741076|54826391|FG001|Overall Study|Sponsor Request|3|||
28157099|NCT02741076|54826392|FG002|Overall Study|Sponsor Request|0|||
28157100|NCT02741076|54826393|FG003|Overall Study|Sponsor Request|1|||
28157101|NCT02741076|54826390|FG000|Overall Study|No additional information available|0|||
28157102|NCT02741076|54826391|FG001|Overall Study|No additional information available|0|||
28157103|NCT02741076|54826392|FG002|Overall Study|No additional information available|1|||
28157104|NCT02741076|54826393|FG003|Overall Study|No additional information available|1|||
28157105|NCT01666444|54826406|FG000|Overall Study|Did not initiate treatment|2|||
28157106|NCT01666444|54826407|FG001|Overall Study|Did not initiate treatment|1|||
27942189|NCT00996801|54599006|FG004|Overall Study|Adverse Event|31|||
28075351|NCT00117312|54729858|FG000|Overall Study|PSA decrease <=50%|0|||
28075352|NCT00117312|54729859|FG001|Overall Study|PSA decrease <=50%|2|||
28075353|NCT00117312|54729860|FG002|Overall Study|PSA decrease <=50%|2|||
28075354|NCT00117312|54729861|FG003|Overall Study|PSA decrease <=50%|4|||
28075355|NCT00117312|54729858|FG000|Overall Study|PSA increase >= 10ng/mL|0|||
28075356|NCT00117312|54729859|FG001|Overall Study|PSA increase >= 10ng/mL|1|||
28075357|NCT00117312|54729860|FG002|Overall Study|PSA increase >= 10ng/mL|1|||
28075358|NCT00117312|54729861|FG003|Overall Study|PSA increase >= 10ng/mL|0|||
28075359|NCT00117312|54729858|FG000|Overall Study|Hepatic abnormality|0|||
28075360|NCT00117312|54729859|FG001|Overall Study|Hepatic abnormality|1|||
28075361|NCT00117312|54729860|FG002|Overall Study|Hepatic abnormality|0|||
28157107|NCT05159622|54826415|FG000|Overall Study|Lost to Follow-up|4|||
28157108|NCT05159622|54826416|FG001|Overall Study|Lost to Follow-up|5|||
28157109|NCT01665430|54826428|FG000|Overall Study|Adverse Event|1|||
28157110|NCT01665430|54826428|FG000|Overall Study|Withdrawal by Subject|6|||
28157111|NCT01665430|54826428|FG000|Overall Study|Other Unspecified|2|||
28157112|NCT02739594|54826434|FG000|Overall Study|Undesired Event|3|||
28157113|NCT02739594|54826435|FG001|Overall Study|Undesired Event|4|||
28157114|NCT02739594|54826434|FG000|Overall Study|Violation of Eligibility Criteria|1|||
28157115|NCT02739594|54826435|FG001|Overall Study|Violation of Eligibility Criteria|2|||
28157116|NCT02739594|54826434|FG000|Overall Study|Protocol Violation|5|||
28157117|NCT02739594|54826435|FG001|Overall Study|Protocol Violation|6|||
28157118|NCT02739594|54826434|FG000|Overall Study|Death|4|||
28157119|NCT02739594|54826435|FG001|Overall Study|Death|2|||
28157120|NCT02739594|54826434|FG000|Overall Study|Renal Insufficiency|4|||
28157121|NCT02739594|54826435|FG001|Overall Study|Renal Insufficiency|6|||
28157122|NCT02739594|54826434|FG000|Overall Study|Administrative Reasons|1|||
28157123|NCT02739594|54826435|FG001|Overall Study|Administrative Reasons|3|||
28157124|NCT02739594|54826434|FG000|Overall Study|Withdrawal by Subject|1|||
28157125|NCT02739594|54826435|FG001|Overall Study|Withdrawal by Subject|1|||
28157126|NCT02739594|54826434|FG000|Overall Study|Lost to Follow-up|0|||
28157127|NCT02739594|54826435|FG001|Overall Study|Lost to Follow-up|1|||
28157128|NCT02739594|54826434|FG000|Overall Study|Elevated Serum Creatinine|0|||
28157129|NCT02739594|54826435|FG001|Overall Study|Elevated Serum Creatinine|1|||
28157130|NCT02739594|54826434|FG000|Overall Study|Other|6|||
28157131|NCT02739594|54826435|FG001|Overall Study|Other|2|||
28157132|NCT03989232|54826444|FG000|Overall Study|Lost to Follow-up|3|||
28157133|NCT03989232|54826445|FG001|Overall Study|Lost to Follow-up|10|||
28157134|NCT03989232|54826444|FG000|Overall Study|Withdrawal by Subject|6|||
28157135|NCT03989232|54826445|FG001|Overall Study|Withdrawal by Subject|6|||
28157136|NCT03989232|54826444|FG000|Overall Study|Death|1|||
28157137|NCT03989232|54826445|FG001|Overall Study|Death|2|||
28157138|NCT02585830|54826451|FG000|Overall Study|Withdrawal by Subject|3|||
28157139|NCT02584504|54826458|FG000|Double-blind Treatment|Participant withdrew consent|0|||
28157140|NCT02584504|54826459|FG001|Double-blind Treatment|Participant withdrew consent|0|||
27942190|NCT00996801|54599007|FG005|Overall Study|Adverse Event|3|||
28157141|NCT02584504|54826460|FG002|Double-blind Treatment|Participant withdrew consent|1|||
28157142|NCT02584504|54826458|FG000|Double-blind Treatment|Adverse Event|0|||
28157143|NCT02584504|54826459|FG001|Double-blind Treatment|Adverse Event|1|||
28157144|NCT02584504|54826460|FG002|Double-blind Treatment|Adverse Event|0|||
28157145|NCT02584504|54826458|FG000|Double-blind Treatment|Family Matter|0|||
28157146|NCT02584504|54826459|FG001|Double-blind Treatment|Family Matter|1|||
28157147|NCT02584504|54826460|FG002|Double-blind Treatment|Family Matter|0|||
28157148|NCT02584504|54826458|FG000|Open-label Treatment|Participant withdrew consent|0|||
28157149|NCT02584504|54826459|FG001|Open-label Treatment|Participant withdrew consent|0|||
28157150|NCT02584504|54826460|FG002|Open-label Treatment|Participant withdrew consent|4|||
28157151|NCT02584504|54826458|FG000|Open-label Treatment|Adverse Event|2|||
28157152|NCT02584504|54826459|FG001|Open-label Treatment|Adverse Event|2|||
28157153|NCT02584504|54826460|FG002|Open-label Treatment|Adverse Event|3|||
28075362|NCT00117312|54729861|FG003|Overall Study|Hepatic abnormality|1|||
28075363|NCT00117312|54729858|FG000|Overall Study|Withdrawal by Subject|0|||
28075364|NCT00117312|54729859|FG001|Overall Study|Withdrawal by Subject|2|||
28075365|NCT00117312|54729860|FG002|Overall Study|Withdrawal by Subject|0|||
28075366|NCT00117312|54729861|FG003|Overall Study|Withdrawal by Subject|0|||
28075367|NCT00129116|54729876|FG000|Primary Phase|Lost to Follow-up|1|||
28075368|NCT00129116|54729877|FG001|Primary Phase|Lost to Follow-up|1|||
28157154|NCT02584504|54826458|FG000|Open-label Treatment|Physician Decision|0|||
28157155|NCT02584504|54826459|FG001|Open-label Treatment|Physician Decision|1|||
28157156|NCT02584504|54826460|FG002|Open-label Treatment|Physician Decision|0|||
28157157|NCT02584504|54826458|FG000|Open-label Treatment|Entered but not treated|0|||
28157158|NCT02584504|54826459|FG001|Open-label Treatment|Entered but not treated|1|||
28157159|NCT02584504|54826460|FG002|Open-label Treatment|Entered but not treated|1|||
28157160|NCT04605094|54826487|FG000|Overall Study|Adverse Event|2|||
28157161|NCT04605094|54826488|FG001|Overall Study|Adverse Event|2|||
28157162|NCT04605094|54826487|FG000|Overall Study|Lost to Follow-up|1|||
28157163|NCT04605094|54826488|FG001|Overall Study|Lost to Follow-up|4|||
28157164|NCT04605094|54826487|FG000|Overall Study|Physician Decision|2|||
28157165|NCT04605094|54826488|FG001|Overall Study|Physician Decision|2|||
28157166|NCT04605094|54826487|FG000|Overall Study|Study terminated by Sponsor|31|||
28157167|NCT04605094|54826488|FG001|Overall Study|Study terminated by Sponsor|33|||
28157168|NCT04605094|54826487|FG000|Overall Study|Withdrawal by Subject|22|||
28157169|NCT04605094|54826488|FG001|Overall Study|Withdrawal by Subject|19|||
28157170|NCT04605094|54826487|FG000|Overall Study|Other|1|||
28157171|NCT04605094|54826488|FG001|Overall Study|Other|1|||
28157172|NCT04354155|54826495|FG000|Overall Study|Withdrawal by Subject|1|||
27942191|NCT00996801|54599002|FG000|Overall Study|Lack of Efficacy|3|||
28157173|NCT04354155|54826495|FG000|Overall Study|Did not meet criteria for study intervention|1|||
28157174|NCT02586064|54826501|FG000|Overall Study|Other Obligations|6|||
28075369|NCT00129116|54729878|FG002|Primary Phase|Lost to Follow-up|0|||
28075370|NCT00129116|54729879|FG003|Primary Phase|Lost to Follow-up|1|||
28075371|NCT00129116|54729880|FG004|Primary Phase|Lost to Follow-up|1|||
28157175|NCT02586064|54826502|FG001|Overall Study|Other Obligations|6|||
28157176|NCT02586064|54826501|FG000|Overall Study|Other|3|||
28157177|NCT02586064|54826502|FG001|Overall Study|Other|7|||
28157178|NCT02586064|54826501|FG000|Overall Study|Never Started|3|||
27942192|NCT00996801|54599003|FG001|Overall Study|Lack of Efficacy|0|||
27942193|NCT00996801|54599004|FG002|Overall Study|Lack of Efficacy|1|||
27942194|NCT00996801|54599005|FG003|Overall Study|Lack of Efficacy|3|||
28075372|NCT00129116|54729876|FG000|Primary Phase|Protocol Violation|0|||
28157179|NCT02586064|54826502|FG001|Overall Study|Never Started|3|||
28157180|NCT02586064|54826501|FG000|Overall Study|Lost Interest|1|||
28157181|NCT02586064|54826502|FG001|Overall Study|Lost Interest|4|||
28157182|NCT02586064|54826501|FG000|Overall Study|Miscellaneous Life Issues|0|||
28157183|NCT02586064|54826502|FG001|Overall Study|Miscellaneous Life Issues|5|||
28157184|NCT02586064|54826501|FG000|Overall Study|Infrequent Attendance|2|||
28157185|NCT02586064|54826502|FG001|Overall Study|Infrequent Attendance|1|||
28157186|NCT02586064|54826501|FG000|Overall Study|Timed Out|2|||
28157187|NCT02586064|54826502|FG001|Overall Study|Timed Out|0|||
28157188|NCT02586064|54826501|FG000|Overall Study|AUD relapse|0|||
28157189|NCT02586064|54826502|FG001|Overall Study|AUD relapse|2|||
28157190|NCT02586064|54826501|FG000|Overall Study|Legal Issue|1|||
28157191|NCT02586064|54826502|FG001|Overall Study|Legal Issue|0|||
28157192|NCT03810495|54826511|FG000|Overall Study|Lost to Follow-up|2|||
28157193|NCT03810495|54826511|FG000|Overall Study|Withdrawal by Subject|1|||
28157194|NCT02782923|54826515|FG000|Overall Study|Lost to Follow-up|15|||
28157195|NCT03760458|54826524|FG000|Main Study (Through Week 48)|Withdrawal by Subject|1|||
27825292|NCT01707992|54290707|FG002|Placebo-Controlled Phase (24 Months)|Other than specified|10|||
28157196|NCT03760458|54826525|FG001|Main Study (Through Week 48)|Withdrawal by Subject|1|||
28157197|NCT03760458|54826526|FG002|Main Study (Through Week 48)|Withdrawal by Subject|0|||
28157198|NCT03760458|54826527|FG003|Main Study (Through Week 48)|Withdrawal by Subject|0|||
28157199|NCT03760458|54826528|FG004|Main Study (Through Week 48)|Withdrawal by Subject|0|||
28157200|NCT02066415|54826543|FG000|Overall Study|Decision by Sponsor|5|||
28157201|NCT02066415|54826544|FG001|Overall Study|Decision by Sponsor|4|||
28075373|NCT00129116|54729877|FG001|Primary Phase|Protocol Violation|1|||
28075374|NCT00129116|54729878|FG002|Primary Phase|Protocol Violation|0|||
28075375|NCT00129116|54729879|FG003|Primary Phase|Protocol Violation|0|||
28075376|NCT00129116|54729880|FG004|Primary Phase|Protocol Violation|0|||
28075377|NCT00129116|54729876|FG000|Primary Phase|Adverse Event|1|||
28075378|NCT00129116|54729877|FG001|Primary Phase|Adverse Event|1|||
28075379|NCT00129116|54729878|FG002|Primary Phase|Adverse Event|0|||
28075380|NCT00129116|54729879|FG003|Primary Phase|Adverse Event|0|||
28075381|NCT00129116|54729880|FG004|Primary Phase|Adverse Event|0|||
28075382|NCT00129116|54729876|FG000|Primary Phase|Withdrawal by Subject|0|||
28075383|NCT00129116|54729877|FG001|Primary Phase|Withdrawal by Subject|1|||
28075384|NCT00129116|54729878|FG002|Primary Phase|Withdrawal by Subject|0|||
28075385|NCT00129116|54729879|FG003|Primary Phase|Withdrawal by Subject|0|||
28075386|NCT00129116|54729880|FG004|Primary Phase|Withdrawal by Subject|0|||
28075387|NCT00129116|54729876|FG000|Primary Phase|Other|0|||
28075388|NCT00129116|54729877|FG001|Primary Phase|Other|0|||
28075389|NCT00129116|54729878|FG002|Primary Phase|Other|1|||
28075390|NCT00129116|54729879|FG003|Primary Phase|Other|0|||
28075391|NCT00129116|54729880|FG004|Primary Phase|Other|0|||
28075392|NCT00129116|54729876|FG000|Booster Phase|Lost to Follow-up|2|||
28075393|NCT00129116|54729877|FG001|Booster Phase|Lost to Follow-up|0|||
28157202|NCT02066415|54826545|FG002|Overall Study|Decision by Sponsor|2|||
28157203|NCT02066415|54826543|FG000|Overall Study|Withdrawal by Subject|9|||
28157204|NCT02066415|54826544|FG001|Overall Study|Withdrawal by Subject|1|||
28157205|NCT02066415|54826545|FG002|Overall Study|Withdrawal by Subject|4|||
28157206|NCT02066415|54826543|FG000|Overall Study|Lost to Follow-up|7|||
28157207|NCT02066415|54826544|FG001|Overall Study|Lost to Follow-up|2|||
28157208|NCT02066415|54826545|FG002|Overall Study|Lost to Follow-up|2|||
28157209|NCT02583256|54826557|FG000|Overall Study|Withdrawal by Subject|0|||
28157210|NCT02583256|54826558|FG001|Overall Study|Withdrawal by Subject|1|||
28157211|NCT02583256|54826559|FG002|Overall Study|Withdrawal by Subject|1|||
28157212|NCT02583256|54826560|FG003|Overall Study|Withdrawal by Subject|0|||
28157213|NCT02583256|54826557|FG000|Overall Study|Lost to Follow-up|1|||
28157214|NCT02583256|54826558|FG001|Overall Study|Lost to Follow-up|1|||
28157215|NCT02583256|54826559|FG002|Overall Study|Lost to Follow-up|0|||
28157216|NCT02583256|54826560|FG003|Overall Study|Lost to Follow-up|1|||
28157217|NCT02583256|54826557|FG000|Overall Study|Administrative/Other|2|||
27825293|NCT01707992|54290708|FG003|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
28075394|NCT00129116|54729878|FG002|Booster Phase|Lost to Follow-up|0|||
28075395|NCT00129116|54729879|FG003|Booster Phase|Lost to Follow-up|0|||
28075396|NCT00129116|54729880|FG004|Booster Phase|Lost to Follow-up|1|||
28075397|NCT00117156|54729892|FG000|Overall Study|Adverse Event|9|||
28075398|NCT00117156|54729892|FG000|Overall Study|Physician Decision|1|||
28075399|NCT00117156|54729892|FG000|Overall Study|Trt for Pre-Exist Second Primary|1|||
28075400|NCT00096954|54729898|FG000|Overall Study|Adverse Event|3|||
28075401|NCT00096954|54729899|FG001|Overall Study|Adverse Event|1|||
28157218|NCT02583256|54826558|FG001|Overall Study|Administrative/Other|0|||
28157219|NCT02583256|54826559|FG002|Overall Study|Administrative/Other|1|||
28157220|NCT02583256|54826560|FG003|Overall Study|Administrative/Other|2|||
28157221|NCT01981551|54826581|FG000|Overall Study|Refused further treatment|8|||
28157222|NCT01981551|54826581|FG000|Overall Study|Adverse Event|1|||
28157223|NCT02584660|54826587|FG000|Overall Study|Adverse Event|4|||
28157224|NCT02584660|54826588|FG001|Overall Study|Adverse Event|0|||
28157225|NCT02584660|54826587|FG000|Overall Study|Lost to Follow-up|3|||
28157226|NCT02584660|54826588|FG001|Overall Study|Lost to Follow-up|4|||
28157227|NCT02584660|54826587|FG000|Overall Study|Protocol Violation|0|||
28157228|NCT02584660|54826588|FG001|Overall Study|Protocol Violation|1|||
28157229|NCT02584660|54826587|FG000|Overall Study|Withdrawal by Subject|0|||
28157230|NCT02584660|54826588|FG001|Overall Study|Withdrawal by Subject|2|||
28075402|NCT00096954|54729898|FG000|Overall Study|Withdrawal by Subject|9|||
28075403|NCT00096954|54729899|FG001|Overall Study|Withdrawal by Subject|8|||
28075404|NCT00096954|54729898|FG000|Overall Study|Physician Decision|1|||
28075405|NCT00096954|54729899|FG001|Overall Study|Physician Decision|1|||
28075406|NCT00096954|54729898|FG000|Overall Study|Sponsors Decision|1|||
28075407|NCT00096954|54729899|FG001|Overall Study|Sponsors Decision|1|||
28075408|NCT00096954|54729898|FG000|Overall Study|Pregnancy|1|||
28075409|NCT00096954|54729899|FG001|Overall Study|Pregnancy|1|||
28075410|NCT00096954|54729898|FG000|Overall Study|Initiation of immunotherapy|1|||
28075411|NCT00096954|54729899|FG001|Overall Study|Initiation of immunotherapy|0|||
28075412|NCT00096954|54729898|FG000|Overall Study|Non-compliance|0|||
28075413|NCT00096954|54729899|FG001|Overall Study|Non-compliance|3|||
28075414|NCT00096954|54729898|FG000|Overall Study|Lost to Follow-up|8|||
28075415|NCT00096954|54729899|FG001|Overall Study|Lost to Follow-up|5|||
28075416|NCT00096486|54729909|FG000|Overall Study|Withdrawal by Subject|0|||
28075417|NCT00096486|54729910|FG001|Overall Study|Withdrawal by Subject|0|||
28075418|NCT00096486|54729911|FG002|Overall Study|Withdrawal by Subject|1|||
28075419|NCT00096486|54729912|FG003|Overall Study|Withdrawal by Subject|1|||
28075420|NCT00096486|54729909|FG000|Overall Study|Not Treated|0|||
28075421|NCT00096486|54729910|FG001|Overall Study|Not Treated|0|||
28075422|NCT00096486|54729911|FG002|Overall Study|Not Treated|1|||
28075423|NCT00096486|54729912|FG003|Overall Study|Not Treated|1|||
28075424|NCT00116844|54729924|FG000|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
28075425|NCT00116844|54729925|FG001|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
28075426|NCT00116844|54729924|FG000|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0|||
28075427|NCT00116844|54729925|FG001|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1|||
28075428|NCT00116844|54729924|FG000|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5|||
28075429|NCT00116844|54729925|FG001|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0|||
28075430|NCT00116844|54729924|FG000|Period 1: Treatment Period 1 (60 Days)|Other|1|||
28075431|NCT00116844|54729925|FG001|Period 1: Treatment Period 1 (60 Days)|Other|1|||
28075432|NCT00116844|54729924|FG000|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1|||
28075433|NCT00116844|54729925|FG001|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0|||
28075434|NCT00116844|54729924|FG000|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2|||
28075435|NCT00116844|54729925|FG001|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1|||
28075436|NCT00116844|54729924|FG000|Period 1: Treatment Period 2 (60 Days)|Other|0|||
28075437|NCT00116844|54729925|FG001|Period 1: Treatment Period 2 (60 Days)|Other|2|||
28075438|NCT00116844|54729924|FG000|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0|||
28075439|NCT00116844|54729925|FG001|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1|||
28157231|NCT02584660|54826587|FG000|Overall Study|Other|0|||
28157232|NCT02584660|54826588|FG001|Overall Study|Other|1|||
28157233|NCT02582632|54826610|FG000|Overall Study|Other|1|||
28157234|NCT02178722|54826619|FG000|Overall Study|Withdrawal by Subject|0|||
28157235|NCT02178722|54826620|FG001|Overall Study|Withdrawal by Subject|0|||
28157236|NCT02178722|54826621|FG002|Overall Study|Withdrawal by Subject|0|||
28157237|NCT02178722|54826622|FG003|Overall Study|Withdrawal by Subject|2|||
28157238|NCT02178722|54826623|FG004|Overall Study|Withdrawal by Subject|33|||
28157239|NCT02178722|54826619|FG000|Overall Study|Death|2|||
28157240|NCT02178722|54826620|FG001|Overall Study|Death|13|||
28157241|NCT02178722|54826621|FG002|Overall Study|Death|12|||
28075440|NCT00116844|54729924|FG000|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
28075441|NCT00116844|54729925|FG001|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
28075442|NCT00128492|54729933|FG000|Overall Study|AE unrelated to study|2|||
28075443|NCT00128492|54729934|FG001|Overall Study|AE unrelated to study|9|||
28075444|NCT00128492|54729933|FG000|Overall Study|Study drug intolerance (AE)|2|||
28075445|NCT00128492|54729934|FG001|Overall Study|Study drug intolerance (AE)|8|||
28075446|NCT00128492|54729933|FG000|Overall Study|AE related to study|1|||
27825294|NCT01707992|54290709|FG004|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
27825295|NCT01707992|54290710|FG005|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
28157242|NCT02178722|54826622|FG003|Overall Study|Death|12|||
28157243|NCT02178722|54826623|FG004|Overall Study|Death|205|||
28157244|NCT02178722|54826619|FG000|Overall Study|Lost to Follow-up|0|||
28075447|NCT00128492|54729934|FG001|Overall Study|AE related to study|4|||
28075448|NCT00128492|54729933|FG000|Overall Study|Death|1|||
28075449|NCT00128492|54729934|FG001|Overall Study|Death|0|||
28075450|NCT00128492|54729933|FG000|Overall Study|Lost to Follow-up|1|||
28075451|NCT00128492|54729934|FG001|Overall Study|Lost to Follow-up|5|||
28075452|NCT00128492|54729933|FG000|Overall Study|Noncompliance|0|||
28075453|NCT00128492|54729934|FG001|Overall Study|Noncompliance|5|||
28075454|NCT00128492|54729933|FG000|Overall Study|Personal or administrative|10|||
28075455|NCT00128492|54729934|FG001|Overall Study|Personal or administrative|22|||
28075456|NCT00128492|54729933|FG000|Overall Study|Withdrawal by Subject|3|||
28075457|NCT00128492|54729934|FG001|Overall Study|Withdrawal by Subject|5|||
28075458|NCT00128492|54729933|FG000|Overall Study|Pregnancy|0|||
28075459|NCT00128492|54729934|FG001|Overall Study|Pregnancy|1|||
28075460|NCT00132314|54729942|FG000|Overall Study|Lost to Follow-up|70|||
28075461|NCT00132314|54729943|FG001|Overall Study|Lost to Follow-up|62|||
28157245|NCT02178722|54826620|FG001|Overall Study|Lost to Follow-up|0|||
28157246|NCT02178722|54826621|FG002|Overall Study|Lost to Follow-up|0|||
28157247|NCT02178722|54826622|FG003|Overall Study|Lost to Follow-up|2|||
28157248|NCT02178722|54826623|FG004|Overall Study|Lost to Follow-up|11|||
28157249|NCT02178722|54826619|FG000|Overall Study|Study terminated by Sponsor|2|||
28157250|NCT02178722|54826620|FG001|Overall Study|Study terminated by Sponsor|7|||
28157251|NCT02178722|54826621|FG002|Overall Study|Study terminated by Sponsor|6|||
27825296|NCT01707992|54290705|FG000|Active Treatment Phase (24 Months)|Adverse Event|0|||
27942195|NCT00996801|54599006|FG004|Overall Study|Lack of Efficacy|0|||
28075462|NCT00132314|54729942|FG000|Overall Study|Lacked SSN|1|||
28075463|NCT00132314|54729943|FG001|Overall Study|Lacked SSN|3|||
28157252|NCT02178722|54826622|FG003|Overall Study|Study terminated by Sponsor|4|||
28157253|NCT02178722|54826623|FG004|Overall Study|Study terminated by Sponsor|128|||
28157254|NCT02178722|54826619|FG000|Overall Study|Physician Decision|0|||
28157255|NCT02178722|54826620|FG001|Overall Study|Physician Decision|0|||
28157256|NCT02178722|54826621|FG002|Overall Study|Physician Decision|0|||
28157257|NCT02178722|54826622|FG003|Overall Study|Physician Decision|0|||
28157258|NCT02178722|54826623|FG004|Overall Study|Physician Decision|3|||
28157259|NCT02178722|54826619|FG000|Overall Study|Other|0|||
28157260|NCT02178722|54826620|FG001|Overall Study|Other|0|||
28157261|NCT02178722|54826621|FG002|Overall Study|Other|0|||
28157262|NCT02178722|54826622|FG003|Overall Study|Other|0|||
28157263|NCT02178722|54826623|FG004|Overall Study|Other|2|||
28157264|NCT00972309|54826640|FG000|Overall Study|Switched to alternative treatment|0|||
28157265|NCT00972309|54826641|FG001|Overall Study|Switched to alternative treatment|2|||
28075464|NCT00132314|54729942|FG000|Overall Study|Refused intervention at baseline|2|||
28075465|NCT00132314|54729943|FG001|Overall Study|Refused intervention at baseline|7|||
28075466|NCT04539262|54729957|FG000|Overall Study|Adverse Event|0|||
28075467|NCT04539262|54729958|FG001|Overall Study|Adverse Event|0|||
28075468|NCT04539262|54729959|FG002|Overall Study|Adverse Event|1|||
28075469|NCT04539262|54729960|FG003|Overall Study|Adverse Event|0|||
28075470|NCT04539262|54729961|FG004|Overall Study|Adverse Event|0|||
28075471|NCT04539262|54729962|FG005|Overall Study|Adverse Event|0|||
28075472|NCT04539262|54729963|FG006|Overall Study|Adverse Event|0|||
28075473|NCT04539262|54729964|FG007|Overall Study|Adverse Event|0|||
28075474|NCT04539262|54729957|FG000|Overall Study|Withdrew Consent|0|||
28075475|NCT04539262|54729958|FG001|Overall Study|Withdrew Consent|0|||
28075476|NCT04539262|54729959|FG002|Overall Study|Withdrew Consent|0|||
28075477|NCT04539262|54729960|FG003|Overall Study|Withdrew Consent|1|||
28075478|NCT04539262|54729961|FG004|Overall Study|Withdrew Consent|0|||
28075479|NCT04539262|54729962|FG005|Overall Study|Withdrew Consent|0|||
28075480|NCT04539262|54729963|FG006|Overall Study|Withdrew Consent|0|||
28075481|NCT04539262|54729964|FG007|Overall Study|Withdrew Consent|0|||
28075482|NCT04539262|54729957|FG000|Overall Study|Randomized, Not treated|0|||
28075483|NCT04539262|54729958|FG001|Overall Study|Randomized, Not treated|1|||
28157266|NCT00972309|54826640|FG000|Overall Study|Refused further treatment|0|||
28157267|NCT00972309|54826641|FG001|Overall Study|Refused further treatment|1|||
28157268|NCT00972309|54826640|FG000|Overall Study|Late determination of ineligibility|0|||
28157269|NCT00972309|54826641|FG001|Overall Study|Late determination of ineligibility|1|||
28157270|NCT00972309|54826640|FG000|Overall Study|Second malignancy|1|||
28157271|NCT00972309|54826641|FG001|Overall Study|Second malignancy|1|||
28157272|NCT00972309|54826640|FG000|Overall Study|Visa issues|0|||
28157273|NCT00972309|54826641|FG001|Overall Study|Visa issues|1|||
28157274|NCT00972309|54826640|FG000|Overall Study|Secondary cancer (SCC)|0|||
28075484|NCT04539262|54729959|FG002|Overall Study|Randomized, Not treated|0|||
28157275|NCT00972309|54826641|FG001|Overall Study|Secondary cancer (SCC)|1|||
28157276|NCT00972309|54826640|FG000|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|0|||
28157277|NCT00972309|54826641|FG001|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|1|||
28157278|NCT00972309|54826640|FG000|Overall Study|Lost to Follow-up|1|||
28157279|NCT00972309|54826641|FG001|Overall Study|Lost to Follow-up|1|||
28157280|NCT00972309|54826640|FG000|Overall Study|Disease progression on study|10|||
28157281|NCT00972309|54826641|FG001|Overall Study|Disease progression on study|4|||
28157282|NCT02582242|54826660|FG000|Overall Study|Adverse Event|4|||
28157283|NCT02582242|54826661|FG001|Overall Study|Adverse Event|3|||
28157284|NCT02582242|54826660|FG000|Overall Study|Protocol Violation|3|||
28157285|NCT02582242|54826661|FG001|Overall Study|Protocol Violation|1|||
28157286|NCT02582242|54826660|FG000|Overall Study|Lost to Follow-up|0|||
27942196|NCT00996801|54599007|FG005|Overall Study|Lack of Efficacy|1|||
28157287|NCT02582242|54826661|FG001|Overall Study|Lost to Follow-up|1|||
28157288|NCT02582242|54826660|FG000|Overall Study|Withdrawal by Subject|11|||
28157289|NCT02582242|54826661|FG001|Overall Study|Withdrawal by Subject|11|||
28157290|NCT02582242|54826660|FG000|Overall Study|Unclassified|2|||
28157291|NCT02582242|54826661|FG001|Overall Study|Unclassified|1|||
28157292|NCT00663351|54826669|FG000|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|10|||
28157293|NCT00663351|54826670|FG001|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|19|||
28157294|NCT00663351|54826669|FG000|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|29|||
28157295|NCT00663351|54826670|FG001|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|10|||
28157296|NCT00663351|54826669|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|8|||
28157297|NCT00663351|54826670|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|15|||
28157298|NCT00663351|54826669|FG000|Post-Approval Study (Year 6 to Year 10)|Death|18|||
28157299|NCT00663351|54826670|FG001|Post-Approval Study (Year 6 to Year 10)|Death|7|||
28157300|NCT00663351|54826669|FG000|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|13|||
28157301|NCT00663351|54826670|FG001|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|7|||
28157302|NCT00663351|54826669|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|44|||
28157303|NCT00663351|54826670|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|32|||
28157304|NCT00616941|54826679|FG000|Overall Study|Progressive Disease|1|||
28157305|NCT00616941|54826680|FG001|Overall Study|Progressive Disease|2|||
28157306|NCT00616941|54826681|FG002|Overall Study|Progressive Disease|1|||
28157307|NCT00616941|54826679|FG000|Overall Study|Adverse Event|0|||
28157308|NCT00616941|54826680|FG001|Overall Study|Adverse Event|1|||
28157309|NCT00616941|54826681|FG002|Overall Study|Adverse Event|1|||
28157310|NCT00616941|54826679|FG000|Overall Study|Subject Non-compliance|0|||
28157311|NCT00616941|54826680|FG001|Overall Study|Subject Non-compliance|0|||
28157312|NCT00616941|54826681|FG002|Overall Study|Subject Non-compliance|1|||
28157313|NCT00616941|54826679|FG000|Overall Study|Unrelated Medical Illness/Complication|0|||
28157314|NCT00616941|54826680|FG001|Overall Study|Unrelated Medical Illness/Complication|2|||
28157315|NCT00616941|54826681|FG002|Overall Study|Unrelated Medical Illness/Complication|0|||
28157316|NCT00616941|54826679|FG000|Overall Study|Vaccination Suspended|0|||
28157317|NCT00616941|54826680|FG001|Overall Study|Vaccination Suspended|0|||
28157318|NCT00616941|54826681|FG002|Overall Study|Vaccination Suspended|3|||
28157319|NCT02581930|54826689|FG000|Overall Study|Withdrawal by Subject|1|||
28157320|NCT02581930|54826689|FG000|Overall Study|patient declined further treatment|1|||
28157321|NCT00105560|54826693|FG000|Overall Study|Lost to Follow-up|1|||
28157322|NCT02577718|54826706|FG000|Overall Study|Death|6|||
27825297|NCT01707992|54290706|FG001|Active Treatment Phase (24 Months)|Adverse Event|0|||
28075485|NCT04539262|54729960|FG003|Overall Study|Randomized, Not treated|0|||
28075486|NCT04539262|54729961|FG004|Overall Study|Randomized, Not treated|0|||
28075487|NCT04539262|54729962|FG005|Overall Study|Randomized, Not treated|0|||
28157323|NCT02577718|54826706|FG000|Overall Study|Withdrawal by Subject|2|||
28157324|NCT00520533|54826712|FG000|Overall Study|Death|1|||
28157325|NCT00520533|54826712|FG000|Overall Study|Suspension of the study for safety reasons|1|||
28157326|NCT00520533|54826712|FG000|Overall Study|Withdrawal by Subject|1|||
28157327|NCT00520533|54826712|FG000|Overall Study|Physician Decision|1|||
28157328|NCT01664104|54826721|FG000|Overall Study|Adverse Event|6|||
28157329|NCT01664104|54826721|FG000|Overall Study|Lack of Efficacy|2|||
28157330|NCT01664104|54826721|FG000|Overall Study|Withdrawal by Subject|1|||
28157331|NCT01664104|54826721|FG000|Overall Study|Lost to Follow-up|4|||
28157332|NCT01664104|54826721|FG000|Overall Study|Other|1|||
28157333|NCT01664104|54826721|FG000|Overall Study|Unknown: Reason Unrelated to TCZ|2|||
28157334|NCT02739984|54826729|FG000|Overall Study|Sponsor Decision|1|||
28157335|NCT02739984|54826730|FG001|Overall Study|Sponsor Decision|0|||
28157336|NCT02739984|54826729|FG000|Overall Study|Withdrawal by Subject|1|||
28157337|NCT02739984|54826730|FG001|Overall Study|Withdrawal by Subject|1|||
28157338|NCT02739984|54826729|FG000|Overall Study|Death|0|||
28157339|NCT02739984|54826730|FG001|Overall Study|Death|1|||
28157340|NCT02739984|54826729|FG000|Overall Study|Lost to Follow-up|3|||
28157341|NCT02739984|54826730|FG001|Overall Study|Lost to Follow-up|0|||
28157342|NCT00496730|54826738|FG000|Overall Study|Lost to Follow-up|4|||
28157343|NCT00496730|54826739|FG001|Overall Study|Lost to Follow-up|3|||
28157344|NCT00496730|54826738|FG000|Overall Study|Withdrawal by Subject|2|||
28157345|NCT00496730|54826739|FG001|Overall Study|Withdrawal by Subject|2|||
28157346|NCT02739828|54826745|FG000|Overall Study|Adverse Event|1|||
28157347|NCT02739828|54826745|FG000|Overall Study|Lost to Follow-up|4|||
28157348|NCT04435808|54826751|FG000|Overall Study|Study stopped by DSMB|0|||
28157349|NCT04435808|54826752|FG001|Overall Study|Study stopped by DSMB|1|||
28157350|NCT01664494|54826775|FG000|Overall Study|Withdrawal by Subject|27|||
28157351|NCT01664494|54826775|FG000|Overall Study|Death|18|||
28157352|NCT01664494|54826775|FG000|Overall Study|Other|49|||
28157353|NCT01664494|54826775|FG000|Overall Study|Lost to Follow-up|99|||
28157354|NCT02577016|54826781|FG000|Overall Study|Adverse Event|2|||
28157355|NCT02577016|54826782|FG001|Overall Study|Adverse Event|1|||
28157356|NCT02577016|54826781|FG000|Overall Study|Physician Decision|0|||
28157357|NCT02577016|54826782|FG001|Overall Study|Physician Decision|1|||
28157358|NCT05101252|54826790|FG000|Overall Study|Unsatisfactory Test Article|1|||
28157359|NCT05101252|54826791|FG001|Overall Study|Unsatisfactory Test Article|0|||
28157360|NCT05101252|54826790|FG000|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
27850319|NCT04178967|54349325|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
27850320|NCT04178967|54349315|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
27942197|NCT00996801|54599002|FG000|Overall Study|Lost to Follow-up|0|||
27942198|NCT00996801|54599003|FG001|Overall Study|Lost to Follow-up|0|||
27942199|NCT00996801|54599004|FG002|Overall Study|Lost to Follow-up|0|||
27942200|NCT00996801|54599005|FG003|Overall Study|Lost to Follow-up|3|||
27942201|NCT00996801|54599006|FG004|Overall Study|Lost to Follow-up|3|||
27942202|NCT00996801|54599007|FG005|Overall Study|Lost to Follow-up|2|||
27942203|NCT00996801|54599002|FG000|Overall Study|Physician Decision|0|||
27942204|NCT00996801|54599003|FG001|Overall Study|Physician Decision|0|||
27942205|NCT00996801|54599004|FG002|Overall Study|Physician Decision|0|||
27942206|NCT00996801|54599005|FG003|Overall Study|Physician Decision|1|||
27942207|NCT00996801|54599006|FG004|Overall Study|Physician Decision|0|||
28157361|NCT05101252|54826791|FG001|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
28157362|NCT05101252|54826790|FG000|Overall Study|Withdrew Consent during study|0|||
28157363|NCT05101252|54826791|FG001|Overall Study|Withdrew Consent during study|1|||
28157364|NCT05101252|54826790|FG000|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
28157365|NCT05101252|54826791|FG001|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
28157366|NCT03316586|54826797|FG000|Overall Study|Adverse Event|2|||
28157367|NCT03316586|54826797|FG000|Overall Study|Physician Decision|3|||
28157368|NCT03316586|54826797|FG000|Overall Study|Lack of Efficacy|10|||
28157369|NCT03316586|54826797|FG000|Overall Study|still on treatment|1|||
28157370|NCT03316586|54826797|FG000|Overall Study|Patient needed radiation therapy|1|||
28157371|NCT03316586|54826797|FG000|Overall Study|Physician Decision to send patient for breast surgery|1|||
28157372|NCT02994927|54826803|FG000|Overall Study|Withdrawal by parent/guardian|0|||
28157373|NCT02994927|54826804|FG001|Overall Study|Withdrawal by parent/guardian|1|||
28157374|NCT02994927|54826803|FG000|Overall Study|Did not meet eligibility criteria|0|||
28157375|NCT02994927|54826804|FG001|Overall Study|Did not meet eligibility criteria|1|||
27942208|NCT00996801|54599007|FG005|Overall Study|Physician Decision|0|||
27942209|NCT00996801|54599002|FG000|Overall Study|Progressive Disease|0|||
27942210|NCT00996801|54599003|FG001|Overall Study|Progressive Disease|1|||
27942211|NCT00996801|54599004|FG002|Overall Study|Progressive Disease|0|||
27942212|NCT00996801|54599005|FG003|Overall Study|Progressive Disease|0|||
27942213|NCT00996801|54599006|FG004|Overall Study|Progressive Disease|0|||
27942214|NCT00996801|54599007|FG005|Overall Study|Progressive Disease|0|||
27942215|NCT00996801|54599002|FG000|Overall Study|Protocol Violation|3|||
27942216|NCT00996801|54599003|FG001|Overall Study|Protocol Violation|4|||
27942217|NCT00996801|54599004|FG002|Overall Study|Protocol Violation|1|||
27942218|NCT00996801|54599005|FG003|Overall Study|Protocol Violation|2|||
27942219|NCT00996801|54599006|FG004|Overall Study|Protocol Violation|3|||
27942220|NCT00996801|54599007|FG005|Overall Study|Protocol Violation|4|||
27942221|NCT00996801|54599002|FG000|Overall Study|Study Terminated by Sponsor|0|||
27942222|NCT00996801|54599003|FG001|Overall Study|Study Terminated by Sponsor|1|||
28157376|NCT02994927|54826803|FG000|Overall Study|Physician Decision|4|||
27942223|NCT00996801|54599004|FG002|Overall Study|Study Terminated by Sponsor|0|||
27942224|NCT00996801|54599005|FG003|Overall Study|Study Terminated by Sponsor|0|||
27942225|NCT00996801|54599006|FG004|Overall Study|Study Terminated by Sponsor|46|||
27942226|NCT00996801|54599007|FG005|Overall Study|Study Terminated by Sponsor|0|||
27942227|NCT00996801|54599002|FG000|Overall Study|Withdrawal by Subject|8|||
27942228|NCT00996801|54599003|FG001|Overall Study|Withdrawal by Subject|6|||
27942229|NCT00996801|54599004|FG002|Overall Study|Withdrawal by Subject|9|||
27942230|NCT00996801|54599005|FG003|Overall Study|Withdrawal by Subject|5|||
28157377|NCT02994927|54826804|FG001|Overall Study|Physician Decision|3|||
28157378|NCT02994927|54826803|FG000|Overall Study|Death|4|||
28157379|NCT02994927|54826804|FG001|Overall Study|Death|2|||
27942231|NCT00996801|54599006|FG004|Overall Study|Withdrawal by Subject|5|||
27942232|NCT00996801|54599007|FG005|Overall Study|Withdrawal by Subject|9|||
27942233|NCT00996489|54599023|FG000|Overall Study|Device failure|45|||
27942234|NCT00996489|54599023|FG000|Overall Study|Discontinued|116|||
28157380|NCT02994927|54826803|FG000|Overall Study|Adverse Event|2|||
28157381|NCT02994927|54826804|FG001|Overall Study|Adverse Event|1|||
28157382|NCT02994927|54826803|FG000|Overall Study|Withdrawal by Subject|3|||
28157383|NCT02994927|54826804|FG001|Overall Study|Withdrawal by Subject|6|||
28157384|NCT02994927|54826803|FG000|Overall Study|Lost to Follow-up|2|||
28157385|NCT02994927|54826804|FG001|Overall Study|Lost to Follow-up|1|||
27850321|NCT04178967|54349316|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
28157386|NCT00107991|54826810|FG000|Eligibility Assessment|Disease not severe enough|7|||
28157387|NCT00107991|54826810|FG000|Eligibility Assessment|Unwilling to participate|7|||
28157388|NCT00107991|54826810|FG000|Eligibility Assessment|Positive purified protein derivative|4|||
28157389|NCT00107991|54826810|FG000|Eligibility Assessment|Abnormal labs|2|||
28157390|NCT00107991|54826810|FG000|Eligibility Assessment|Ongoing treatment with antibiotics|1|||
28157391|NCT00107991|54826810|FG000|Eligibility Assessment|chronic uncontrolled asthma|1|||
28157392|NCT00107991|54826810|FG000|Eligibility Assessment|hx of alcohol abuse in past 12 months|1|||
28157393|NCT00107991|54826810|FG000|12 Week Treatment Period|Lack of Efficacy|2|||
28157394|NCT00107991|54826810|FG000|12 Week Treatment Period|Adverse Event|1|||
28157395|NCT00107991|54826810|FG000|12 Week Treatment Period|Protocol Violation|1|||
28157396|NCT00107991|54826810|FG000|12 Week Treatment Period|Incarcerated|1|||
28157397|NCT00107991|54826810|FG000|18-Week Post Treatment Assessment|Adverse Event|2|||
28157398|NCT00492856|54826814|FG000|Induction|Adverse Event|2|||
28157399|NCT00492856|54826815|FG001|Induction|Adverse Event|0|||
28157400|NCT00492856|54826816|FG002|Induction|Adverse Event|0|||
28157401|NCT00492856|54826817|FG003|Induction|Adverse Event|0|||
28157402|NCT00492856|54826814|FG000|Induction|Withdrawal by Subject|1|||
28157403|NCT00492856|54826815|FG001|Induction|Withdrawal by Subject|0|||
28157404|NCT00492856|54826816|FG002|Induction|Withdrawal by Subject|0|||
28157405|NCT00492856|54826817|FG003|Induction|Withdrawal by Subject|0|||
28157406|NCT00492856|54826814|FG000|Induction|Death|3|||
28157407|NCT00492856|54826815|FG001|Induction|Death|0|||
28157408|NCT00492856|54826816|FG002|Induction|Death|0|||
28157409|NCT00492856|54826817|FG003|Induction|Death|0|||
28157410|NCT00492856|54826814|FG000|Consolidation|Adverse Event|6|||
28157411|NCT00492856|54826815|FG001|Consolidation|Adverse Event|0|||
28157412|NCT00492856|54826816|FG002|Consolidation|Adverse Event|0|||
28157413|NCT00492856|54826817|FG003|Consolidation|Adverse Event|0|||
28157414|NCT00492856|54826814|FG000|Consolidation|Not protocol specified|2|||
28157415|NCT00492856|54826815|FG001|Consolidation|Not protocol specified|0|||
28157416|NCT00492856|54826816|FG002|Consolidation|Not protocol specified|0|||
28157417|NCT00492856|54826817|FG003|Consolidation|Not protocol specified|0|||
28157418|NCT00492856|54826814|FG000|Consolidation|Lost to Follow-up|1|||
28157419|NCT00492856|54826815|FG001|Consolidation|Lost to Follow-up|0|||
28157420|NCT00492856|54826816|FG002|Consolidation|Lost to Follow-up|0|||
28157421|NCT00492856|54826817|FG003|Consolidation|Lost to Follow-up|0|||
28157422|NCT00492856|54826814|FG000|Post-consolidation|Adverse Event|0|||
28157423|NCT00492856|54826815|FG001|Post-consolidation|Adverse Event|4|||
28157424|NCT00492856|54826816|FG002|Post-consolidation|Adverse Event|0|||
28157425|NCT00492856|54826817|FG003|Post-consolidation|Adverse Event|1|||
27850322|NCT04178967|54349317|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
28157426|NCT00492856|54826814|FG000|Post-consolidation|Withdrawal by Subject|0|||
28157427|NCT00492856|54826815|FG001|Post-consolidation|Withdrawal by Subject|4|||
28157428|NCT00492856|54826816|FG002|Post-consolidation|Withdrawal by Subject|0|||
28157429|NCT00492856|54826817|FG003|Post-consolidation|Withdrawal by Subject|0|||
28157430|NCT00492856|54826814|FG000|Post-consolidation|Death|0|||
28157431|NCT00492856|54826815|FG001|Post-consolidation|Death|1|||
28157432|NCT00492856|54826816|FG002|Post-consolidation|Death|0|||
28157433|NCT00492856|54826817|FG003|Post-consolidation|Death|0|||
28157434|NCT00492856|54826814|FG000|Post-consolidation|Not protocol specified|0|||
28157435|NCT00492856|54826815|FG001|Post-consolidation|Not protocol specified|1|||
28157436|NCT00492856|54826816|FG002|Post-consolidation|Not protocol specified|0|||
28075488|NCT04539262|54729963|FG006|Overall Study|Randomized, Not treated|1|||
28157437|NCT00492856|54826817|FG003|Post-consolidation|Not protocol specified|0|||
28157438|NCT00492856|54826814|FG000|Post-consolidation|Lost to Follow-up|0|||
28157439|NCT00492856|54826815|FG001|Post-consolidation|Lost to Follow-up|2|||
28157440|NCT00492856|54826816|FG002|Post-consolidation|Lost to Follow-up|0|||
28157441|NCT00492856|54826817|FG003|Post-consolidation|Lost to Follow-up|0|||
28157442|NCT00492856|54826814|FG000|Post-consolidation|Observation Arm|0|||
28157443|NCT00492856|54826815|FG001|Post-consolidation|Observation Arm|0|||
28157444|NCT00492856|54826816|FG002|Post-consolidation|Observation Arm|27|||
28157445|NCT00492856|54826817|FG003|Post-consolidation|Observation Arm|0|||
28157446|NCT02782377|54826829|FG000|Overall Study|Physician Decision|5|||
28157447|NCT02410629|54826836|FG000|Overall Study|Family cannot commit to the study|2|||
28157448|NCT02410629|54826837|FG001|Overall Study|Family cannot commit to the study|1|||
27942235|NCT01000311|54599029|FG000|Overall Study|Adverse Event|2|||
28157449|NCT02410629|54826836|FG000|Overall Study|Subject returned to work|1|||
28157450|NCT02410629|54826837|FG001|Overall Study|Subject returned to work|0|||
28157451|NCT02410629|54826836|FG000|Overall Study|Subject moved back to home country|0|||
28157452|NCT02410629|54826837|FG001|Overall Study|Subject moved back to home country|1|||
28157453|NCT02410629|54826836|FG000|Overall Study|Subject underwent heart surgery|0|||
28157454|NCT02410629|54826837|FG001|Overall Study|Subject underwent heart surgery|1|||
28157455|NCT02252211|54826845|FG000|Overall Study|Adverse Event|0|||
27942236|NCT01000311|54599030|FG001|Overall Study|Adverse Event|5|||
27942237|NCT01000311|54599029|FG000|Overall Study|Withdrawal by Subject|16|||
28157456|NCT02252211|54826846|FG001|Overall Study|Adverse Event|1|||
28157457|NCT02252211|54826847|FG002|Overall Study|Adverse Event|0|||
28157458|NCT02252211|54826845|FG000|Overall Study|Progressive disease|3|||
28157459|NCT02252211|54826846|FG001|Overall Study|Progressive disease|2|||
28157460|NCT02252211|54826847|FG002|Overall Study|Progressive disease|0|||
28157461|NCT02252211|54826845|FG000|Overall Study|Withdrawal by Subject|1|||
28157462|NCT02252211|54826846|FG001|Overall Study|Withdrawal by Subject|0|||
28157463|NCT02252211|54826847|FG002|Overall Study|Withdrawal by Subject|0|||
28157464|NCT02252211|54826845|FG000|Overall Study|Serious Adverse Event During Screening|1|||
28157465|NCT02252211|54826846|FG001|Overall Study|Serious Adverse Event During Screening|0|||
28157466|NCT02252211|54826847|FG002|Overall Study|Serious Adverse Event During Screening|1|||
28157467|NCT02776683|54826854|FG000|Pre-switch Period|Protocol Violation|1|||
28157468|NCT02776683|54826855|FG001|Pre-switch Period|Protocol Violation|0|||
28157469|NCT02776683|54826854|FG000|Pre-switch Period|Adverse Event|21|||
28157470|NCT02776683|54826855|FG001|Pre-switch Period|Adverse Event|0|||
28157471|NCT02776683|54826854|FG000|Pre-switch Period|Withdrawal by Subject|9|||
28157472|NCT02776683|54826855|FG001|Pre-switch Period|Withdrawal by Subject|0|||
28157473|NCT02776683|54826854|FG000|Pre-switch Period|Physician Decision|7|||
28157474|NCT02776683|54826855|FG001|Pre-switch Period|Physician Decision|0|||
28157475|NCT02776683|54826854|FG000|Pre-switch Period|Progressive disease|39|||
28157476|NCT02776683|54826855|FG001|Pre-switch Period|Progressive disease|0|||
28157477|NCT02776683|54826854|FG000|Pre-switch Period|Other than listed|3|||
28157478|NCT02776683|54826855|FG001|Pre-switch Period|Other than listed|0|||
28157479|NCT02776683|54826854|FG000|Post-switch Period|Adverse Event|0|||
28157480|NCT02776683|54826855|FG001|Post-switch Period|Adverse Event|3|||
28157481|NCT02776683|54826854|FG000|Post-switch Period|Withdrawal by Subject|0|||
28157482|NCT02776683|54826855|FG001|Post-switch Period|Withdrawal by Subject|2|||
28157483|NCT02776683|54826854|FG000|Post-switch Period|Physician Decision|0|||
28157484|NCT02776683|54826855|FG001|Post-switch Period|Physician Decision|3|||
28157485|NCT02776683|54826854|FG000|Post-switch Period|Progressive disease|0|||
28157486|NCT02776683|54826855|FG001|Post-switch Period|Progressive disease|20|||
28157487|NCT02776683|54826854|FG000|Post-switch Period|Other than listed|0|||
28157488|NCT02776683|54826855|FG001|Post-switch Period|Other than listed|15|||
28157489|NCT02731742|54826863|FG000|Overall Study|Death|1|||
28157490|NCT02731742|54826864|FG001|Overall Study|Death|2|||
28157491|NCT02731742|54826865|FG002|Overall Study|Death|5|||
28157492|NCT02731742|54826866|FG003|Overall Study|Death|0|||
28157493|NCT02731742|54826863|FG000|Overall Study|Physician Decision|0|||
27942238|NCT01000311|54599030|FG001|Overall Study|Withdrawal by Subject|24|||
28157494|NCT02731742|54826864|FG001|Overall Study|Physician Decision|0|||
28157495|NCT02731742|54826865|FG002|Overall Study|Physician Decision|0|||
28157496|NCT02731742|54826866|FG003|Overall Study|Physician Decision|1|||
28157497|NCT02731742|54826863|FG000|Overall Study|Study Terminated by Sponsor|2|||
28157498|NCT02731742|54826864|FG001|Overall Study|Study Terminated by Sponsor|1|||
28157499|NCT02731742|54826865|FG002|Overall Study|Study Terminated by Sponsor|1|||
28157500|NCT02731742|54826866|FG003|Overall Study|Study Terminated by Sponsor|1|||
28157501|NCT00104871|54826889|FG000|Overall Study|Not evaluable|1|||
28157502|NCT03487796|54826897|FG000|Overall Study|Lost to Follow-up|18|||
28157503|NCT03487796|54826898|FG001|Overall Study|Lost to Follow-up|6|||
28157504|NCT02148705|54826913|FG000|Overall Study|Death|2|||
28157505|NCT02148705|54826914|FG001|Overall Study|Death|0|||
28157506|NCT02148705|54826915|FG002|Overall Study|Death|0|||
28157507|NCT02148705|54826913|FG000|Overall Study|Lost to Follow-up|13|||
28157508|NCT02148705|54826914|FG001|Overall Study|Lost to Follow-up|4|||
28157509|NCT02148705|54826915|FG002|Overall Study|Lost to Follow-up|10|||
28157510|NCT02148705|54826913|FG000|Overall Study|Withdrawal by Subject|3|||
28157511|NCT02148705|54826914|FG001|Overall Study|Withdrawal by Subject|0|||
28157512|NCT02148705|54826915|FG002|Overall Study|Withdrawal by Subject|2|||
28157513|NCT02148705|54826913|FG000|Overall Study|Not Treated|0|||
28157514|NCT02148705|54826914|FG001|Overall Study|Not Treated|1|||
28157515|NCT02148705|54826915|FG002|Overall Study|Not Treated|5|||
28157516|NCT03446612|54826925|FG000|Overall Study|Protocol defined stopping criteria|0|||
28157517|NCT03446612|54826926|FG001|Overall Study|Protocol defined stopping criteria|1|||
28157518|NCT02730728|54826937|FG000|Overall Study|Withdrawal by Subject|0|||
28157519|NCT02730728|54826938|FG001|Overall Study|Withdrawal by Subject|1|||
28157520|NCT02730728|54826939|FG002|Overall Study|Withdrawal by Subject|0|||
28157521|NCT02730728|54826937|FG000|Overall Study|Lack of Efficacy|0|||
28157522|NCT02730728|54826938|FG001|Overall Study|Lack of Efficacy|1|||
28157523|NCT02730728|54826939|FG002|Overall Study|Lack of Efficacy|1|||
28157524|NCT00104637|54826947|FG000|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1|||
28157525|NCT00104637|54826948|FG001|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0|||
28157526|NCT02768103|54826957|FG000|Overall Study|1 participant did not fit in the fMRI|1|||
28157527|NCT02767323|54826966|FG000|Overall Study|Withdrawal by Subject|17|||
28157528|NCT02767323|54826967|FG001|Overall Study|Withdrawal by Subject|5|||
28157529|NCT02767323|54826968|FG002|Overall Study|Withdrawal by Subject|13|||
28157530|NCT02767323|54826969|FG003|Overall Study|Withdrawal by Subject|0|||
28157531|NCT02767323|54826966|FG000|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
28157532|NCT02767323|54826967|FG001|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|20|||
28157533|NCT02767323|54826968|FG002|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
28157534|NCT02767323|54826969|FG003|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|0|||
28157535|NCT04304950|54826984|FG000|Overall Study|Lost to Follow-up|1|||
28157536|NCT04304950|54826985|FG001|Overall Study|Lost to Follow-up|1|||
28157537|NCT02780115|54826999|FG000|Overall Study|Withdrawal by Subject|0|||
28157538|NCT02780115|54827000|FG001|Overall Study|Withdrawal by Subject|1|||
28157539|NCT02780115|54827001|FG002|Overall Study|Withdrawal by Subject|1|||
28157540|NCT02780115|54827002|FG003|Overall Study|Withdrawal by Subject|0|||
28157541|NCT02780115|54827003|FG004|Overall Study|Withdrawal by Subject|0|||
28157542|NCT02780115|54826999|FG000|Overall Study|Adverse Event|0|||
28157543|NCT02780115|54827000|FG001|Overall Study|Adverse Event|0|||
28157544|NCT02780115|54827001|FG002|Overall Study|Adverse Event|0|||
28157545|NCT02780115|54827002|FG003|Overall Study|Adverse Event|1|||
28157546|NCT02780115|54827003|FG004|Overall Study|Adverse Event|1|||
28157547|NCT02766777|54827015|FG000|Overall Study|Adverse Event|12|||
28157548|NCT02766777|54827015|FG000|Overall Study|Lost to Follow-up|16|||
28157549|NCT02766777|54827015|FG000|Overall Study|Non-Compliance With Study Drug|1|||
28157550|NCT02766777|54827015|FG000|Overall Study|Protocol Violation|1|||
28157551|NCT02766777|54827015|FG000|Overall Study|Withdrawal by Subject|4|||
28157552|NCT00157014|54827023|FG000|Overall Study|Death|4|||
28157553|NCT00157014|54827024|FG001|Overall Study|Death|2|||
28157554|NCT00157014|54827025|FG002|Overall Study|Death|1|||
28157555|NCT00157014|54827026|FG003|Overall Study|Death|1|||
28157556|NCT00157014|54827023|FG000|Overall Study|Physician Decision|0|||
28157557|NCT00157014|54827024|FG001|Overall Study|Physician Decision|1|||
28157558|NCT00157014|54827025|FG002|Overall Study|Physician Decision|0|||
28157559|NCT00157014|54827026|FG003|Overall Study|Physician Decision|0|||
28157560|NCT00157014|54827023|FG000|Overall Study|Medications withdrawn on family request|0|||
28157561|NCT00157014|54827024|FG001|Overall Study|Medications withdrawn on family request|1|||
28157562|NCT00157014|54827025|FG002|Overall Study|Medications withdrawn on family request|0|||
27942239|NCT01000311|54599029|FG000|Overall Study|Lost to Follow-up|15|||
28157563|NCT00157014|54827026|FG003|Overall Study|Medications withdrawn on family request|0|||
28157564|NCT00157014|54827023|FG000|Overall Study|Patient withdrawn by investigator|1|||
28157565|NCT00157014|54827024|FG001|Overall Study|Patient withdrawn by investigator|0|||
28157566|NCT00157014|54827025|FG002|Overall Study|Patient withdrawn by investigator|0|||
28157567|NCT00157014|54827026|FG003|Overall Study|Patient withdrawn by investigator|0|||
28157568|NCT00157014|54827023|FG000|Overall Study|Patient unable to return in nursing home|1|||
28157569|NCT00157014|54827024|FG001|Overall Study|Patient unable to return in nursing home|0|||
28157570|NCT00157014|54827025|FG002|Overall Study|Patient unable to return in nursing home|0|||
28157571|NCT00157014|54827026|FG003|Overall Study|Patient unable to return in nursing home|0|||
28157572|NCT00157014|54827023|FG000|Overall Study|Patient would not receive transplant|0|||
28157573|NCT00157014|54827024|FG001|Overall Study|Patient would not receive transplant|1|||
28157574|NCT00157014|54827025|FG002|Overall Study|Patient would not receive transplant|0|||
28157575|NCT00157014|54827026|FG003|Overall Study|Patient would not receive transplant|0|||
28157576|NCT00157014|54827023|FG000|Overall Study|Withdrawal by Subject|1|||
28157577|NCT00157014|54827024|FG001|Overall Study|Withdrawal by Subject|0|||
28075489|NCT04539262|54729964|FG007|Overall Study|Randomized, Not treated|0|||
28075490|NCT03702010|54729987|FG000|Follow-up (30days)|Lack of Efficacy|2|||
28075491|NCT03702010|54729988|FG001|Follow-up (30days)|Lack of Efficacy|2|||
28075492|NCT04538170|54730002|FG000|Overall Study|Withdrawal by Subject|104|||
28075493|NCT04538170|54730003|FG001|Overall Study|Withdrawal by Subject|210|||
28075494|NCT04537234|54730015|FG000|Overall Study|Withdrawal by Subject|2|||
28157578|NCT00157014|54827025|FG002|Overall Study|Withdrawal by Subject|0|||
28157579|NCT00157014|54827026|FG003|Overall Study|Withdrawal by Subject|0|||
28157580|NCT02778867|54827038|FG000|Phase 1|Withdrawal by Subject|2|||
28157581|NCT02778867|54827039|FG001|Phase 1|Withdrawal by Subject|3|||
28157582|NCT02778867|54827040|FG002|Phase 1|Withdrawal by Subject|0|||
28157583|NCT02778867|54827041|FG003|Phase 1|Withdrawal by Subject|0|||
28157584|NCT02778867|54827038|FG000|Phase 2|Withdrawal by Subject|0|||
28157585|NCT02778867|54827039|FG001|Phase 2|Withdrawal by Subject|0|||
28157586|NCT02778867|54827040|FG002|Phase 2|Withdrawal by Subject|1|||
28075495|NCT04537234|54730016|FG001|Overall Study|Withdrawal by Subject|0|||
28075496|NCT04537078|54730024|FG000|Overall Study|Protocol Violation|3|||
28075497|NCT04537078|54730025|FG001|Overall Study|Protocol Violation|2|||
28075498|NCT04537078|54730024|FG000|Overall Study|Lost to Follow-up|1|||
28075499|NCT04537078|54730025|FG001|Overall Study|Lost to Follow-up|0|||
28075500|NCT04537078|54730024|FG000|Overall Study|Withdrawal by Subject|0|||
28075501|NCT04537078|54730025|FG001|Overall Study|Withdrawal by Subject|1|||
28075502|NCT04532164|54730038|FG000|Overall Study|Adverse Event|1|||
28075503|NCT04532164|54730038|FG000|Overall Study|Protocol Violation|5|||
28075504|NCT04532164|54730038|FG000|Overall Study|Lost to Follow-up|1|||
28075505|NCT04532164|54730038|FG000|Overall Study|Found to be Ineligible|3|||
28075506|NCT04532164|54730038|FG000|Overall Study|Withdrawal by Subject|14|||
28075507|NCT00116688|54730045|FG000|Overall Study|Protocol deviation|1|||
28075508|NCT00116688|54730046|FG001|Overall Study|Protocol deviation|0|||
28075509|NCT00116688|54730045|FG000|Overall Study|Noncompliance|3|||
28075510|NCT00116688|54730046|FG001|Overall Study|Noncompliance|1|||
28075511|NCT00116688|54730045|FG000|Overall Study|Adverse Event|11|||
28075512|NCT00116688|54730046|FG001|Overall Study|Adverse Event|0|||
28075513|NCT00116688|54730045|FG000|Overall Study|Withdrawal by Subject|26|||
28157587|NCT02778867|54827041|FG003|Phase 2|Withdrawal by Subject|0|||
28157588|NCT02778867|54827038|FG000|Phase 2|Physician Decision|0|||
28157589|NCT02778867|54827039|FG001|Phase 2|Physician Decision|0|||
28157590|NCT02778867|54827040|FG002|Phase 2|Physician Decision|0|||
28157591|NCT02778867|54827041|FG003|Phase 2|Physician Decision|1|||
28157592|NCT02778867|54827038|FG000|Phase 2|Adverse Event|0|||
28157593|NCT02778867|54827039|FG001|Phase 2|Adverse Event|0|||
28075514|NCT00116688|54730046|FG001|Overall Study|Withdrawal by Subject|2|||
28075515|NCT00116688|54730045|FG000|Overall Study|Requirement for alternative therapy|11|||
28075516|NCT00116688|54730046|FG001|Overall Study|Requirement for alternative therapy|1|||
28075517|NCT00116688|54730045|FG000|Overall Study|Physician Decision|7|||
28075518|NCT00116688|54730046|FG001|Overall Study|Physician Decision|0|||
28157594|NCT02778867|54827040|FG002|Phase 2|Adverse Event|0|||
28157595|NCT02778867|54827041|FG003|Phase 2|Adverse Event|1|||
28157596|NCT02778555|54827054|FG000|Overall Study|Withdrawal by Subject|55|||
28157597|NCT02778555|54827055|FG001|Overall Study|Withdrawal by Subject|32|||
28157598|NCT02778555|54827056|FG002|Overall Study|Withdrawal by Subject|107|||
28157599|NCT02778399|54827070|FG000|Up to Week 12 Treatment Period|Adverse Event|1|||
28157600|NCT02778399|54827071|FG001|Up to Week 12 Treatment Period|Adverse Event|2|||
28157601|NCT02778399|54827072|FG002|Up to Week 12 Treatment Period|Adverse Event|3|||
28157602|NCT02778399|54827073|FG003|Up to Week 12 Treatment Period|Adverse Event|2|||
28157603|NCT02778399|54827074|FG004|Up to Week 12 Treatment Period|Adverse Event|3|||
28157604|NCT02778399|54827075|FG005|Up to Week 12 Treatment Period|Adverse Event|3|||
28157605|NCT02778399|54827070|FG000|Up to Week 12 Treatment Period|Withdrawal by Subject|5|||
28157606|NCT02778399|54827071|FG001|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
28157607|NCT02778399|54827072|FG002|Up to Week 12 Treatment Period|Withdrawal by Subject|1|||
28157608|NCT02778399|54827073|FG003|Up to Week 12 Treatment Period|Withdrawal by Subject|4|||
28157609|NCT02778399|54827074|FG004|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
28157610|NCT02778399|54827075|FG005|Up to Week 12 Treatment Period|Withdrawal by Subject|3|||
28157611|NCT02778399|54827070|FG000|Up to Week 12 Treatment Period|Protocol Violation|0|||
28157612|NCT02778399|54827071|FG001|Up to Week 12 Treatment Period|Protocol Violation|0|||
28157613|NCT02778399|54827072|FG002|Up to Week 12 Treatment Period|Protocol Violation|0|||
28157614|NCT02778399|54827073|FG003|Up to Week 12 Treatment Period|Protocol Violation|0|||
28157615|NCT02778399|54827074|FG004|Up to Week 12 Treatment Period|Protocol Violation|1|||
28157616|NCT02778399|54827075|FG005|Up to Week 12 Treatment Period|Protocol Violation|0|||
28157617|NCT02778399|54827070|FG000|Up to Week 12 Treatment Period|Lost to Follow-up|3|||
28157618|NCT02778399|54827071|FG001|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
28157619|NCT02778399|54827072|FG002|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
28157620|NCT02778399|54827073|FG003|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
28157621|NCT02778399|54827074|FG004|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
28157622|NCT02778399|54827075|FG005|Up to Week 12 Treatment Period|Lost to Follow-up|2|||
28157623|NCT02778399|54827070|FG000|Up to Week 12 Treatment Period|other - reason not stated|0|||
28157624|NCT02778399|54827071|FG001|Up to Week 12 Treatment Period|other - reason not stated|0|||
28157625|NCT02778399|54827072|FG002|Up to Week 12 Treatment Period|other - reason not stated|0|||
28157626|NCT02778399|54827073|FG003|Up to Week 12 Treatment Period|other - reason not stated|1|||
28157627|NCT02778399|54827074|FG004|Up to Week 12 Treatment Period|other - reason not stated|2|||
28157628|NCT02778399|54827075|FG005|Up to Week 12 Treatment Period|other - reason not stated|0|||
28157629|NCT02778399|54827070|FG000|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
28157630|NCT02778399|54827071|FG001|Week 12 to Week 24 Treatment Period|Adverse Event|0|||
28157631|NCT02778399|54827072|FG002|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
28157632|NCT02778399|54827073|FG003|Week 12 to Week 24 Treatment Period|Adverse Event|1|||
28157633|NCT02778399|54827074|FG004|Week 12 to Week 24 Treatment Period|Adverse Event|3|||
28157634|NCT02778399|54827075|FG005|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
28157635|NCT02778399|54827070|FG000|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
28157636|NCT02778399|54827071|FG001|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
28157637|NCT02778399|54827072|FG002|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|0|||
28157638|NCT02778399|54827073|FG003|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
28157639|NCT02778399|54827074|FG004|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
28157640|NCT02778399|54827075|FG005|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
28157641|NCT02778399|54827070|FG000|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
28157642|NCT02778399|54827071|FG001|Week 12 to Week 24 Treatment Period|Protocol Violation|1|||
28157643|NCT02778399|54827072|FG002|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
28157644|NCT02778399|54827073|FG003|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
28157645|NCT02778399|54827074|FG004|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
28157646|NCT02778399|54827075|FG005|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
28157647|NCT02778399|54827070|FG000|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
28157648|NCT02778399|54827071|FG001|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
28157649|NCT02778399|54827072|FG002|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
28157650|NCT02778399|54827073|FG003|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
28157651|NCT02778399|54827074|FG004|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
28157652|NCT02778399|54827075|FG005|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
28157653|NCT02778399|54827070|FG000|Week 12 to Week 24 Treatment Period|Pregnancy|1|||
28157654|NCT02778399|54827071|FG001|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
28157655|NCT02778399|54827072|FG002|Week 12 to Week 24 Treatment Period|Pregnancy|2|||
28157656|NCT02778399|54827073|FG003|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
28157657|NCT02778399|54827074|FG004|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
28157658|NCT02778399|54827075|FG005|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
28157659|NCT02778399|54827070|FG000|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
28157660|NCT02778399|54827071|FG001|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
28157661|NCT02778399|54827072|FG002|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
28157662|NCT02778399|54827073|FG003|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
28157663|NCT02778399|54827074|FG004|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
28157664|NCT02778399|54827075|FG005|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
28157665|NCT03656744|54827124|FG000|Overall Study|Adverse Event|1|||
28157666|NCT03656744|54827125|FG001|Overall Study|Adverse Event|4|||
28157667|NCT03656744|54827126|FG002|Overall Study|Adverse Event|1|||
28157668|NCT03656744|54827124|FG000|Overall Study|Protocol Violation|1|||
28157669|NCT03656744|54827125|FG001|Overall Study|Protocol Violation|0|||
28157670|NCT03656744|54827126|FG002|Overall Study|Protocol Violation|0|||
28157671|NCT03656744|54827124|FG000|Overall Study|Lost to Follow-up|2|||
28157672|NCT03656744|54827125|FG001|Overall Study|Lost to Follow-up|2|||
28157673|NCT03656744|54827126|FG002|Overall Study|Lost to Follow-up|0|||
28157674|NCT03656744|54827124|FG000|Overall Study|Withdrawal by Subject|0|||
28157675|NCT03656744|54827125|FG001|Overall Study|Withdrawal by Subject|1|||
28157676|NCT03656744|54827126|FG002|Overall Study|Withdrawal by Subject|0|||
28157677|NCT03656744|54827124|FG000|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|1|||
28157678|NCT03656744|54827125|FG001|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
28157679|NCT03656744|54827126|FG002|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
28157680|NCT02739360|54827134|FG000|Overall Study|Adverse Event|1|||
28157681|NCT02739360|54827134|FG000|Overall Study|Study terminated by Sponsor|2|||
28157682|NCT01822522|54827144|FG000|Overall Study|Adverse Event|1|||
28157683|NCT01822522|54827145|FG001|Overall Study|Adverse Event|1|||
28157684|NCT01822522|54827146|FG002|Overall Study|Adverse Event|1|||
28157685|NCT01822522|54827147|FG003|Overall Study|Adverse Event|0|||
28157686|NCT01822522|54827148|FG004|Overall Study|Adverse Event|0|||
28157687|NCT01822522|54827149|FG005|Overall Study|Adverse Event|1|||
28157688|NCT01822522|54827144|FG000|Overall Study|Death|3|||
28157689|NCT01822522|54827145|FG001|Overall Study|Death|0|||
28157690|NCT01822522|54827146|FG002|Overall Study|Death|2|||
28157691|NCT01822522|54827147|FG003|Overall Study|Death|0|||
27850323|NCT04178967|54349318|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
27850324|NCT04178967|54349319|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
27850325|NCT04178967|54349320|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
27850326|NCT04178967|54349321|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
27850327|NCT04178967|54349322|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
28157692|NCT01822522|54827148|FG004|Overall Study|Death|0|||
28157693|NCT01822522|54827149|FG005|Overall Study|Death|0|||
28157694|NCT01822522|54827144|FG000|Overall Study|Lost to Follow-up|0|||
28157695|NCT01822522|54827145|FG001|Overall Study|Lost to Follow-up|0|||
28157696|NCT01822522|54827146|FG002|Overall Study|Lost to Follow-up|1|||
28157697|NCT01822522|54827147|FG003|Overall Study|Lost to Follow-up|1|||
27850328|NCT04178967|54349323|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
27850329|NCT04178967|54349324|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
27942240|NCT01000311|54599030|FG001|Overall Study|Lost to Follow-up|24|||
28157698|NCT01822522|54827148|FG004|Overall Study|Lost to Follow-up|0|||
28157699|NCT01822522|54827149|FG005|Overall Study|Lost to Follow-up|1|||
28157700|NCT01822522|54827144|FG000|Overall Study|Withdrawal by Subject|0|||
28157701|NCT01822522|54827145|FG001|Overall Study|Withdrawal by Subject|0|||
28157702|NCT01822522|54827146|FG002|Overall Study|Withdrawal by Subject|0|||
28157703|NCT01822522|54827147|FG003|Overall Study|Withdrawal by Subject|1|||
28157704|NCT01822522|54827148|FG004|Overall Study|Withdrawal by Subject|0|||
28157705|NCT01822522|54827149|FG005|Overall Study|Withdrawal by Subject|0|||
28157706|NCT01822522|54827144|FG000|Overall Study|Lack of Efficacy|0|||
28157707|NCT01822522|54827145|FG001|Overall Study|Lack of Efficacy|0|||
28157708|NCT01822522|54827146|FG002|Overall Study|Lack of Efficacy|0|||
28157709|NCT01822522|54827147|FG003|Overall Study|Lack of Efficacy|0|||
28157710|NCT01822522|54827148|FG004|Overall Study|Lack of Efficacy|0|||
28157711|NCT01822522|54827149|FG005|Overall Study|Lack of Efficacy|2|||
27825298|NCT01707992|54290707|FG002|Active Treatment Phase (24 Months)|Adverse Event|0|||
27825299|NCT01707992|54290708|FG003|Active Treatment Phase (24 Months)|Adverse Event|4|||
27825300|NCT01707992|54290709|FG004|Active Treatment Phase (24 Months)|Adverse Event|1|||
27825301|NCT01707992|54290710|FG005|Active Treatment Phase (24 Months)|Adverse Event|0|||
27825302|NCT01707992|54290705|FG000|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
27825303|NCT01707992|54290706|FG001|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
27825304|NCT01707992|54290707|FG002|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
27825305|NCT01707992|54290708|FG003|Active Treatment Phase (24 Months)|Lack of Efficacy|3|||
27825306|NCT01707992|54290709|FG004|Active Treatment Phase (24 Months)|Lack of Efficacy|1|||
27825307|NCT01707992|54290710|FG005|Active Treatment Phase (24 Months)|Lack of Efficacy|2|||
28157712|NCT00102687|54827193|FG000|Initial Period|Withdrawal by Subject|6|||
28157713|NCT00102687|54827194|FG001|Initial Period|Withdrawal by Subject|3|||
28157714|NCT00102687|54827195|FG002|Initial Period|Withdrawal by Subject|5|||
28157715|NCT00102687|54827196|FG003|Initial Period|Withdrawal by Subject|0|||
28157716|NCT00102687|54827197|FG004|Initial Period|Withdrawal by Subject|0|||
28157717|NCT00102687|54827193|FG000|Initial Period|Adverse Event|4|||
28157718|NCT00102687|54827194|FG001|Initial Period|Adverse Event|7|||
28157719|NCT00102687|54827195|FG002|Initial Period|Adverse Event|9|||
28157720|NCT00102687|54827196|FG003|Initial Period|Adverse Event|0|||
28157721|NCT00102687|54827197|FG004|Initial Period|Adverse Event|0|||
28157722|NCT00102687|54827193|FG000|Initial Period|Transformation to AML (blast > 30%)|1|||
28157723|NCT00102687|54827194|FG001|Initial Period|Transformation to AML (blast > 30%)|3|||
28157724|NCT00102687|54827195|FG002|Initial Period|Transformation to AML (blast > 30%)|0|||
28157725|NCT00102687|54827196|FG003|Initial Period|Transformation to AML (blast > 30%)|0|||
28157726|NCT00102687|54827197|FG004|Initial Period|Transformation to AML (blast > 30%)|0|||
28157727|NCT00102687|54827193|FG000|Initial Period|Protocol Violation|0|||
28157728|NCT00102687|54827194|FG001|Initial Period|Protocol Violation|0|||
27825308|NCT01707992|54290705|FG000|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
27825309|NCT01707992|54290706|FG001|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
27825310|NCT01707992|54290707|FG002|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
27825311|NCT01707992|54290708|FG003|Active Treatment Phase (24 Months)|Withdrawal by Subject|58|||
27825312|NCT01707992|54290709|FG004|Active Treatment Phase (24 Months)|Withdrawal by Subject|220|||
27825313|NCT01707992|54290710|FG005|Active Treatment Phase (24 Months)|Withdrawal by Subject|32|||
27825314|NCT01707992|54290705|FG000|Active Treatment Phase (24 Months)|Pregnancy|0|||
27825315|NCT01707992|54290706|FG001|Active Treatment Phase (24 Months)|Pregnancy|0|||
27825316|NCT01707992|54290707|FG002|Active Treatment Phase (24 Months)|Pregnancy|0|||
27825317|NCT01707992|54290708|FG003|Active Treatment Phase (24 Months)|Pregnancy|2|||
27825318|NCT01707992|54290709|FG004|Active Treatment Phase (24 Months)|Pregnancy|5|||
28157729|NCT00102687|54827195|FG002|Initial Period|Protocol Violation|2|||
28157730|NCT00102687|54827196|FG003|Initial Period|Protocol Violation|0|||
28157731|NCT00102687|54827197|FG004|Initial Period|Protocol Violation|0|||
28157732|NCT00102687|54827193|FG000|Initial Period|Physician Decision|2|||
28157733|NCT00102687|54827194|FG001|Initial Period|Physician Decision|9|||
28157734|NCT00102687|54827195|FG002|Initial Period|Physician Decision|6|||
28157735|NCT00102687|54827196|FG003|Initial Period|Physician Decision|0|||
28157736|NCT00102687|54827197|FG004|Initial Period|Physician Decision|0|||
28157737|NCT00102687|54827193|FG000|Initial Period|Sponsor's decision|0|||
28157738|NCT00102687|54827194|FG001|Initial Period|Sponsor's decision|1|||
28157739|NCT00102687|54827195|FG002|Initial Period|Sponsor's decision|1|||
28157740|NCT00102687|54827196|FG003|Initial Period|Sponsor's decision|0|||
28157741|NCT00102687|54827197|FG004|Initial Period|Sponsor's decision|0|||
28157742|NCT00102687|54827193|FG000|Initial Period|Failed Treatments (relapse,disease prog)|4|||
28157743|NCT00102687|54827194|FG001|Initial Period|Failed Treatments (relapse,disease prog)|4|||
28157744|NCT00102687|54827195|FG002|Initial Period|Failed Treatments (relapse,disease prog)|2|||
28157745|NCT00102687|54827196|FG003|Initial Period|Failed Treatments (relapse,disease prog)|0|||
28157746|NCT00102687|54827197|FG004|Initial Period|Failed Treatments (relapse,disease prog)|0|||
28157747|NCT00102687|54827193|FG000|Initial Period|Death|1|||
28157748|NCT00102687|54827194|FG001|Initial Period|Death|1|||
27942241|NCT01000311|54599029|FG000|Overall Study|Protocol Violation|1|||
28157749|NCT00102687|54827195|FG002|Initial Period|Death|1|||
28157750|NCT00102687|54827196|FG003|Initial Period|Death|0|||
28157751|NCT00102687|54827197|FG004|Initial Period|Death|0|||
28157752|NCT00102687|54827193|FG000|Maintenance Period|Withdrawal by Subject|4|||
28157753|NCT00102687|54827194|FG001|Maintenance Period|Withdrawal by Subject|0|||
28157754|NCT00102687|54827195|FG002|Maintenance Period|Withdrawal by Subject|2|||
28157755|NCT00102687|54827196|FG003|Maintenance Period|Withdrawal by Subject|3|||
28157756|NCT00102687|54827197|FG004|Maintenance Period|Withdrawal by Subject|1|||
28157757|NCT00102687|54827193|FG000|Maintenance Period|Adverse Event|1|||
28157758|NCT00102687|54827194|FG001|Maintenance Period|Adverse Event|0|||
28157759|NCT00102687|54827195|FG002|Maintenance Period|Adverse Event|0|||
28157760|NCT00102687|54827196|FG003|Maintenance Period|Adverse Event|1|||
28157761|NCT00102687|54827197|FG004|Maintenance Period|Adverse Event|3|||
28157762|NCT00102687|54827193|FG000|Maintenance Period|Transformation to AML (blast > 30%)|0|||
28157763|NCT00102687|54827194|FG001|Maintenance Period|Transformation to AML (blast > 30%)|1|||
28157764|NCT00102687|54827195|FG002|Maintenance Period|Transformation to AML (blast > 30%)|0|||
28157765|NCT00102687|54827196|FG003|Maintenance Period|Transformation to AML (blast > 30%)|2|||
28157766|NCT00102687|54827197|FG004|Maintenance Period|Transformation to AML (blast > 30%)|0|||
28157767|NCT00102687|54827193|FG000|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
28157768|NCT00102687|54827194|FG001|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
28157769|NCT00102687|54827195|FG002|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
28157770|NCT00102687|54827196|FG003|Maintenance Period|Failed Treatment (relapse,disease prog)|3|||
28157771|NCT00102687|54827197|FG004|Maintenance Period|Failed Treatment (relapse,disease prog)|4|||
28157772|NCT00102687|54827193|FG000|Maintenance Period|Death|0|||
28157773|NCT00102687|54827194|FG001|Maintenance Period|Death|0|||
28157774|NCT00102687|54827195|FG002|Maintenance Period|Death|0|||
28157775|NCT00102687|54827196|FG003|Maintenance Period|Death|1|||
28157776|NCT00102687|54827197|FG004|Maintenance Period|Death|1|||
28157777|NCT00102687|54827193|FG000|Maintenance Period|Physician Decision|1|||
28157778|NCT00102687|54827194|FG001|Maintenance Period|Physician Decision|2|||
28157779|NCT00102687|54827195|FG002|Maintenance Period|Physician Decision|3|||
28157780|NCT00102687|54827196|FG003|Maintenance Period|Physician Decision|0|||
28157781|NCT00102687|54827197|FG004|Maintenance Period|Physician Decision|4|||
28157782|NCT00102531|54827215|FG000|Overall Study|Adverse Event|0|||
28157783|NCT00102531|54827216|FG001|Overall Study|Adverse Event|1|||
28157784|NCT00102531|54827215|FG000|Overall Study|Disease Progression|5|||
28157785|NCT00102531|54827216|FG001|Overall Study|Disease Progression|9|||
28157786|NCT00102531|54827215|FG000|Overall Study|Physician Decision|0|||
28157787|NCT00102531|54827216|FG001|Overall Study|Physician Decision|1|||
28157788|NCT02771145|54827222|FG000|Overall Study|Adverse Event|3|||
28157789|NCT02771145|54827222|FG000|Overall Study|Lost to Follow-up|1|||
28157790|NCT02578186|54827242|FG000|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
28157791|NCT02578186|54827243|FG001|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
28157792|NCT02578186|54827242|FG000|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
28157793|NCT02578186|54827243|FG001|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
28157794|NCT00103311|54827251|FG000|Overall Study|Lost to Follow-up|1|||
28157795|NCT00103311|54827252|FG001|Overall Study|Lost to Follow-up|0|||
28157796|NCT00103311|54827251|FG000|Overall Study|Withdrawal by Subject|2|||
28157797|NCT00103311|54827252|FG001|Overall Study|Withdrawal by Subject|1|||
28157798|NCT00103311|54827251|FG000|Overall Study|Adverse Event|1|||
28157799|NCT00103311|54827252|FG001|Overall Study|Adverse Event|0|||
28157800|NCT02576938|54827265|FG000|Overall Study|Adverse Event|5|||
28157801|NCT02576938|54827266|FG001|Overall Study|Adverse Event|3|||
28157802|NCT02576938|54827267|FG002|Overall Study|Adverse Event|6|||
28157803|NCT02576938|54827265|FG000|Overall Study|Protocol Violation|1|||
28157804|NCT02576938|54827266|FG001|Overall Study|Protocol Violation|1|||
28075519|NCT00116688|54730045|FG000|Overall Study|Lost to Follow-up|3|||
28075520|NCT00116688|54730046|FG001|Overall Study|Lost to Follow-up|0|||
28075521|NCT00116688|54730045|FG000|Overall Study|Death|15|||
28075522|NCT00116688|54730046|FG001|Overall Study|Death|0|||
28075523|NCT00116688|54730045|FG000|Overall Study|Protocol-specified criteria|3|||
28075524|NCT00116688|54730046|FG001|Overall Study|Protocol-specified criteria|0|||
28075525|NCT00116688|54730045|FG000|Overall Study|Pregnancy|1|||
28075526|NCT00116688|54730046|FG001|Overall Study|Pregnancy|0|||
28075527|NCT00116688|54730045|FG000|Overall Study|Other|11|||
28157805|NCT02576938|54827267|FG002|Overall Study|Protocol Violation|1|||
28157806|NCT02576938|54827265|FG000|Overall Study|Withdrawal by Subject|3|||
28157807|NCT02576938|54827266|FG001|Overall Study|Withdrawal by Subject|2|||
28157808|NCT02576938|54827267|FG002|Overall Study|Withdrawal by Subject|4|||
28157809|NCT02576938|54827265|FG000|Overall Study|Lack of Efficacy|9|||
28075528|NCT00116688|54730046|FG001|Overall Study|Other|0|||
28157810|NCT02576938|54827266|FG001|Overall Study|Lack of Efficacy|4|||
28157811|NCT02576938|54827267|FG002|Overall Study|Lack of Efficacy|0|||
28157812|NCT02576938|54827265|FG000|Overall Study|Lost to Follow-up|2|||
28157813|NCT02576938|54827266|FG001|Overall Study|Lost to Follow-up|0|||
28157814|NCT02576938|54827267|FG002|Overall Study|Lost to Follow-up|1|||
28157815|NCT02576938|54827265|FG000|Overall Study|Physician Decision|0|||
28157816|NCT02576938|54827266|FG001|Overall Study|Physician Decision|1|||
28157817|NCT02576938|54827267|FG002|Overall Study|Physician Decision|0|||
28075529|NCT04531540|54730052|FG000|Overall Study|Adverse Event|1|||
28157818|NCT02576938|54827265|FG000|Overall Study|Met Exclusion Criteria|0|||
28157819|NCT02576938|54827266|FG001|Overall Study|Met Exclusion Criteria|1|||
28157820|NCT02576938|54827267|FG002|Overall Study|Met Exclusion Criteria|0|||
28157821|NCT02576860|54827279|FG000|Overall Study|Adverse Event|6|||
28157822|NCT02576860|54827280|FG001|Overall Study|Adverse Event|6|||
28157823|NCT02576860|54827279|FG000|Overall Study|Lost to Follow-up|5|||
28157824|NCT02576860|54827280|FG001|Overall Study|Lost to Follow-up|7|||
28157825|NCT02576860|54827279|FG000|Overall Study|Physician Decision|0|||
28157826|NCT02576860|54827280|FG001|Overall Study|Physician Decision|1|||
28157827|NCT02576860|54827279|FG000|Overall Study|Protocol Violation|0|||
28157828|NCT02576860|54827280|FG001|Overall Study|Protocol Violation|2|||
28157829|NCT02576860|54827279|FG000|Overall Study|Withdrawal by Subject|13|||
28157830|NCT02576860|54827280|FG001|Overall Study|Withdrawal by Subject|8|||
28157831|NCT02576860|54827279|FG000|Overall Study|Disallowed medication|1|||
28157832|NCT02576860|54827280|FG001|Overall Study|Disallowed medication|0|||
28157833|NCT02572570|54827287|FG000|Overall Study|Study Terminated|27|||
28157834|NCT00709202|54827296|FG000|Overall Study|Withdrawal by Subject|6|||
28157835|NCT00709202|54827297|FG001|Overall Study|Withdrawal by Subject|6|||
28157836|NCT00709124|54827306|FG000|Overall Study|Death|3|||
28157837|NCT00709124|54827307|FG001|Overall Study|Death|1|||
28075530|NCT04531540|54730052|FG000|Overall Study|Protocol Violation|3|||
28075531|NCT04531540|54730052|FG000|Overall Study|Withdrawal by Subject|4|||
28075532|NCT04531540|54730052|FG000|Overall Study|Found to be Ineligible|1|||
28075533|NCT04799782|54730056|FG000|Washout|Physician Decision|2|||
28075534|NCT04799782|54730057|FG001|Washout|Physician Decision|0|||
28075535|NCT04799782|54730056|FG000|Washout|Withdrawal by Subject|0|||
28075536|NCT04799782|54730057|FG001|Washout|Withdrawal by Subject|2|||
28075537|NCT04799782|54730056|FG000|Washout|Lost to Follow-up|0|||
28075538|NCT04799782|54730057|FG001|Washout|Lost to Follow-up|1|||
28075539|NCT03697252|54730065|FG000|Overall Study|Adverse Event|3|||
28157838|NCT00709124|54827306|FG000|Overall Study|encephalopathy; can't do assessment|1|||
28157839|NCT00709124|54827307|FG001|Overall Study|encephalopathy; can't do assessment|0|||
28157840|NCT02738580|54827319|FG000|Overall Study|Adverse Event|1|||
28157841|NCT02738580|54827320|FG001|Overall Study|Adverse Event|0|||
28157842|NCT02738580|54827319|FG000|Overall Study|Lack of Efficacy|3|||
28157843|NCT02738580|54827320|FG001|Overall Study|Lack of Efficacy|2|||
28157844|NCT02738580|54827319|FG000|Overall Study|Withdrawal by Subject|0|||
28157845|NCT02738580|54827320|FG001|Overall Study|Withdrawal by Subject|1|||
28157846|NCT02738580|54827319|FG000|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0|||
28157847|NCT02738580|54827320|FG001|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1|||
28157848|NCT02571244|54827328|FG000|Overall Study|Lost to Follow-up|0|||
28157849|NCT02571244|54827329|FG001|Overall Study|Lost to Follow-up|1|||
28157850|NCT02571244|54827328|FG000|Overall Study|Unable to reach out post discharge|3|||
28157851|NCT02571244|54827329|FG001|Overall Study|Unable to reach out post discharge|0|||
28157852|NCT02573350|54827340|FG000|Overall Study|Lost to Follow-up|2|||
28157853|NCT02573350|54827341|FG001|Overall Study|Lost to Follow-up|1|||
28157854|NCT02573350|54827340|FG000|Overall Study|Adverse Event|3|||
28157855|NCT02573350|54827341|FG001|Overall Study|Adverse Event|4|||
28157856|NCT02573350|54827340|FG000|Overall Study|Subject met Withdrawal Criteria|1|||
28157857|NCT02573350|54827341|FG001|Overall Study|Subject met Withdrawal Criteria|1|||
28157858|NCT02573350|54827340|FG000|Overall Study|Subject was Withdrawn from Participation by the Investigator|3|||
28157859|NCT02573350|54827341|FG001|Overall Study|Subject was Withdrawn from Participation by the Investigator|1|||
28157860|NCT02573350|54827340|FG000|Overall Study|Subject withdrew consent to participate|6|||
28157861|NCT02573350|54827341|FG001|Overall Study|Subject withdrew consent to participate|1|||
28157862|NCT02573350|54827340|FG000|Overall Study|Protocol Deviation|1|||
28157863|NCT02573350|54827341|FG001|Overall Study|Protocol Deviation|1|||
28157864|NCT01376804|54827350|FG000|Treatment Period|Withdrawal by Subject|1|||
28157865|NCT01376804|54827350|FG000|Treatment Period|Adverse Event|6|||
28157866|NCT01376804|54827350|FG000|Treatment Period|Patient did not receive study drug|1|||
28157867|NCT02574520|54827358|FG000|Overall Study|Not dosed|2|||
28157868|NCT02574520|54827359|FG001|Overall Study|Not dosed|0|||
28157869|NCT02574520|54827360|FG002|Overall Study|Not dosed|5|||
28157870|NCT02574520|54827361|FG003|Overall Study|Not dosed|4|||
28157871|NCT02574520|54827358|FG000|Overall Study|Adverse Event|0|||
28157872|NCT02574520|54827359|FG001|Overall Study|Adverse Event|0|||
28157873|NCT02574520|54827360|FG002|Overall Study|Adverse Event|0|||
28157874|NCT02574520|54827361|FG003|Overall Study|Adverse Event|1|||
28157875|NCT02574520|54827358|FG000|Overall Study|Withdrawal by Subject|0|||
28157876|NCT02574520|54827359|FG001|Overall Study|Withdrawal by Subject|0|||
28157877|NCT02574520|54827360|FG002|Overall Study|Withdrawal by Subject|0|||
28157878|NCT02574520|54827361|FG003|Overall Study|Withdrawal by Subject|1|||
27942242|NCT01000311|54599030|FG001|Overall Study|Protocol Violation|2|||
27942243|NCT01000311|54599029|FG000|Overall Study|Inappropriate enrollment|2|||
27942244|NCT01000311|54599030|FG001|Overall Study|Inappropriate enrollment|0|||
27942245|NCT01000311|54599029|FG000|Overall Study|Administrative reason|9|||
27942246|NCT01000311|54599030|FG001|Overall Study|Administrative reason|15|||
27942247|NCT01003899|54599036|FG000|Overall Study|Other Adverse Event|8|||
27942248|NCT01003899|54599036|FG000|Overall Study|Not entered|4|||
27942249|NCT01003899|54599036|FG000|Overall Study|Not treated|1|||
27942250|NCT01003899|54599036|FG000|Overall Study|Progressive disease|34|||
27942251|NCT01000155|54599040|FG000|Overall Study|Withdrawal by Subject|1|||
27942252|NCT01000155|54599040|FG000|Overall Study|Adverse Event|1|||
27942253|NCT00999921|54599046|FG000|Overall Study|Lost to Follow-up|10|||
27942254|NCT00999921|54599047|FG001|Overall Study|Lost to Follow-up|19|||
27942255|NCT01002573|54599058|FG000|Overall Study|Subject did not receive at least 1 dose|11|||
27942256|NCT01002573|54599059|FG001|Overall Study|Subject did not receive at least 1 dose|7|||
27942257|NCT00999687|54599065|FG000|First Intervention|Withdrawal by Subject|1|||
27942258|NCT00999687|54599065|FG000|Second Intervention|Withdrawal by Subject|2|||
27942259|NCT00999687|54599065|FG000|Second Intervention|Lack of Efficacy|1|||
27942260|NCT00996333|54599071|FG000|Overall Study|Screen failure|1|||
27942261|NCT00996333|54599071|FG000|Overall Study|Withdrawal by Subject|1|||
27942262|NCT00996333|54599071|FG000|Overall Study|Death|4|||
27942263|NCT00996333|54599071|FG000|Overall Study|Adverse Event|1|||
27942264|NCT00996333|54599071|FG000|Overall Study|Physician Decision|1|||
27942265|NCT00996333|54599071|FG000|Overall Study|Other|5|||
27942266|NCT00995865|54599078|FG000|Overall Study|Protocol Violation|2|||
27942267|NCT00995865|54599079|FG001|Overall Study|Protocol Violation|0|||
27942268|NCT00995865|54599080|FG002|Overall Study|Protocol Violation|0|||
27942269|NCT00995865|54599078|FG000|Overall Study|Lost to Follow-up|0|||
28157879|NCT02574520|54827358|FG000|Overall Study|Other|0|||
28157880|NCT02574520|54827359|FG001|Overall Study|Other|0|||
28157881|NCT02574520|54827360|FG002|Overall Study|Other|0|||
28157882|NCT02574520|54827361|FG003|Overall Study|Other|2|||
28157883|NCT00709592|54827373|FG000|Overall Study|Unable to proceed to transplant|0|||
27942270|NCT00995865|54599079|FG001|Overall Study|Lost to Follow-up|0|||
27942271|NCT00995865|54599080|FG002|Overall Study|Lost to Follow-up|1|||
27942272|NCT00995709|54599096|FG000|Overall Study|Adverse Event|4|||
27942273|NCT00995709|54599097|FG001|Overall Study|Adverse Event|2|||
27942274|NCT00995709|54599098|FG002|Overall Study|Adverse Event|0|||
28157884|NCT00709592|54827374|FG001|Overall Study|Unable to proceed to transplant|1|||
28157885|NCT02570152|54827380|FG000|Overall Study|Protocol Violation|2|||
28157886|NCT02570152|54827380|FG000|Overall Study|Migrated/moved from study area|13|||
28157887|NCT02570074|54827386|FG000|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1|||
28157888|NCT02570074|54827387|FG001|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0|||
28157889|NCT02569996|54827405|FG000|Overall Study|Adverse Event|6|||
27942275|NCT00995709|54599096|FG000|Overall Study|Lack of Efficacy|0|||
28075540|NCT03697252|54730066|FG001|Overall Study|Adverse Event|2|||
27825319|NCT01707992|54290710|FG005|Active Treatment Phase (24 Months)|Pregnancy|2|||
27825320|NCT01707992|54290705|FG000|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
27825321|NCT01707992|54290706|FG001|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
28075541|NCT03697252|54730065|FG000|Overall Study|Withdrawal by Subject|14|||
28075542|NCT03697252|54730066|FG001|Overall Study|Withdrawal by Subject|14|||
27825322|NCT01707992|54290707|FG002|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
28075543|NCT03697252|54730065|FG000|Overall Study|Lost to Follow-up|0|||
28075544|NCT03697252|54730066|FG001|Overall Study|Lost to Follow-up|1|||
28075545|NCT03697252|54730065|FG000|Overall Study|Physician Decision|1|||
28075546|NCT03697252|54730066|FG001|Overall Study|Physician Decision|1|||
28075547|NCT03697252|54730065|FG000|Overall Study|Other|0|||
28075548|NCT03697252|54730066|FG001|Overall Study|Other|1|||
28075549|NCT03701074|54730074|FG000|Overall Study|Physician Decision|1|||
28075550|NCT03701074|54730075|FG001|Overall Study|Physician Decision|0|||
28157890|NCT02569996|54827405|FG000|Overall Study|Physician Decision|3|||
28157891|NCT02569996|54827405|FG000|Overall Study|Progression of the disease|18|||
28157892|NCT02569996|54827405|FG000|Overall Study|New anti-lymphoma treatment|1|||
28157893|NCT02569996|54827405|FG000|Overall Study|Non-compliance|9|||
28075551|NCT04728802|54730083|FG000|Overall Study|Withdrawal by Subject|4|||
28075552|NCT04728802|54730084|FG001|Overall Study|Withdrawal by Subject|20|||
28157894|NCT02569996|54827405|FG000|Overall Study|Withdrawal by Subject|5|||
27825323|NCT01707992|54290708|FG003|Active Treatment Phase (24 Months)|Lost to Follow-up|5|||
28157895|NCT02569996|54827405|FG000|Overall Study|Lost to Follow-up|5|||
27825324|NCT01707992|54290709|FG004|Active Treatment Phase (24 Months)|Lost to Follow-up|11|||
27942276|NCT00995709|54599097|FG001|Overall Study|Lack of Efficacy|1|||
28157896|NCT02569996|54827405|FG000|Overall Study|Complete remission|7|||
28157897|NCT02569996|54827405|FG000|Overall Study|Unknown reason|1|||
28157898|NCT02572882|54827409|FG000|Overall Study|Withdrawal by Subject|1|||
28157899|NCT02572882|54827409|FG000|Overall Study|Participant received kidney transplant|1|||
28157900|NCT00708500|54827439|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
28157901|NCT00708500|54827440|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3|||
28157902|NCT00708500|54827441|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
28157903|NCT00708500|54827439|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1|||
28157904|NCT00708500|54827440|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
28157905|NCT00708500|54827441|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
27825325|NCT01707992|54290710|FG005|Active Treatment Phase (24 Months)|Lost to Follow-up|1|||
27825326|NCT01707992|54290705|FG000|Active Treatment Phase (24 Months)|Death|0|||
27825327|NCT01707992|54290706|FG001|Active Treatment Phase (24 Months)|Death|0|||
28157906|NCT00708500|54827439|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
28157907|NCT00708500|54827440|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1|||
28157908|NCT00708500|54827441|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
28157909|NCT00708500|54827439|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
28157910|NCT00708500|54827440|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2|||
28157911|NCT00708500|54827441|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
28157912|NCT00708500|54827439|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
28157913|NCT00708500|54827440|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
28157914|NCT00708500|54827441|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1|||
28157915|NCT00708500|54827439|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1|||
28157916|NCT00708500|54827440|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10|||
28157917|NCT00708500|54827441|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19|||
28157918|NCT00708500|54827439|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49|||
28157919|NCT00708500|54827440|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36|||
28157920|NCT00708500|54827441|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29|||
28157921|NCT00708500|54827439|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
28157922|NCT00708500|54827440|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1|||
28157923|NCT00708500|54827441|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
28160134|NCT03382821|54830235|FG000|Overall Study|Did not receive allocated intervention.|0|||
27825328|NCT01707992|54290707|FG002|Active Treatment Phase (24 Months)|Death|0|||
27825329|NCT01707992|54290708|FG003|Active Treatment Phase (24 Months)|Death|2|||
27825330|NCT01707992|54290709|FG004|Active Treatment Phase (24 Months)|Death|0|||
28157924|NCT00708500|54827439|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3|||
28157925|NCT00708500|54827440|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1|||
28157926|NCT00708500|54827441|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4|||
28157927|NCT00708500|54827439|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2|||
28157928|NCT00708500|54827440|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0|||
28157929|NCT00708500|54827441|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1|||
28157930|NCT00708500|54827439|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0|||
28157931|NCT00708500|54827440|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2|||
28157932|NCT00708500|54827441|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1|||
28157933|NCT00708500|54827439|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0|||
28157934|NCT00708500|54827440|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
28157935|NCT00708500|54827441|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
28157936|NCT00708500|54827439|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
28157937|NCT00708500|54827440|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1|||
28157938|NCT00708500|54827441|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
28157939|NCT00708500|54827439|FG000|FOLLOWUP|Adverse Event|0|||
28157940|NCT00708500|54827440|FG001|FOLLOWUP|Adverse Event|1|||
28157941|NCT00708500|54827441|FG002|FOLLOWUP|Adverse Event|0|||
28157942|NCT00708500|54827439|FG000|FOLLOWUP|Lost to Follow-up|1|||
27825331|NCT01707992|54290710|FG005|Active Treatment Phase (24 Months)|Death|0|||
28075553|NCT04728802|54730083|FG000|Overall Study|Physician Decision|7|||
28157943|NCT00708500|54827440|FG001|FOLLOWUP|Lost to Follow-up|6|||
28157944|NCT00708500|54827441|FG002|FOLLOWUP|Lost to Follow-up|4|||
28157945|NCT00708500|54827439|FG000|FOLLOWUP|Subject withdrawal unrelated to Tx|3|||
28157946|NCT00708500|54827440|FG001|FOLLOWUP|Subject withdrawal unrelated to Tx|4|||
28157947|NCT00708500|54827441|FG002|FOLLOWUP|Subject withdrawal unrelated to Tx|5|||
28157948|NCT00708500|54827439|FG000|FOLLOWUP|Subject withdrew consent|31|||
28157949|NCT00708500|54827440|FG001|FOLLOWUP|Subject withdrew consent|4|||
28157950|NCT00708500|54827441|FG002|FOLLOWUP|Subject withdrew consent|5|||
28157951|NCT00708500|54827439|FG000|FOLLOWUP|Non-compliance with protocol|5|||
28157952|NCT00708500|54827440|FG001|FOLLOWUP|Non-compliance with protocol|0|||
28157953|NCT00708500|54827441|FG002|FOLLOWUP|Non-compliance with protocol|1|||
28157954|NCT00708734|54827458|FG000|Overall Study|scheduling conflict|2|||
28157955|NCT00708734|54827458|FG000|Overall Study|moved|1|||
28157956|NCT00708734|54827458|FG000|Overall Study|leg injury|1|||
28157957|NCT00708734|54827458|FG000|Overall Study|knee replacement|1|||
28157958|NCT00708734|54827458|FG000|Overall Study|vertigo|1|||
28157959|NCT00708734|54827458|FG000|Overall Study|leg fracture|1|||
28157960|NCT04834362|54827464|FG000|Overall Study|Death|1|||
28157961|NCT04834362|54827465|FG001|Overall Study|Death|2|||
28157962|NCT00101907|54827477|FG000|Overall Study|Adverse Event|1|||
28157963|NCT00101907|54827478|FG001|Overall Study|Adverse Event|0|||
28157964|NCT00101907|54827479|FG002|Overall Study|Adverse Event|0|||
28157965|NCT00101907|54827480|FG003|Overall Study|Adverse Event|0|||
27825332|NCT01707992|54290705|FG000|Active Treatment Phase (24 Months)|Other than specified|0|||
28075554|NCT04728802|54730084|FG001|Overall Study|Physician Decision|7|||
28075555|NCT04728802|54730083|FG000|Overall Study|Protocol Violation|10|||
28075556|NCT04728802|54730084|FG001|Overall Study|Protocol Violation|4|||
28075557|NCT04728802|54730083|FG000|Overall Study|Transfer|1|||
28075558|NCT04728802|54730084|FG001|Overall Study|Transfer|0|||
28075559|NCT04728802|54730083|FG000|Overall Study|Death|4|||
28075560|NCT04728802|54730084|FG001|Overall Study|Death|5|||
28075561|NCT04728802|54730083|FG000|Overall Study|Other|3|||
28075562|NCT04728802|54730084|FG001|Overall Study|Other|0|||
28075563|NCT04715932|54730092|FG000|Overall Study|Lost to Follow-up|1|||
28075564|NCT04715932|54730093|FG001|Overall Study|Lost to Follow-up|0|||
28157966|NCT00101907|54827481|FG004|Overall Study|Adverse Event|0|||
28157967|NCT00101907|54827482|FG005|Overall Study|Adverse Event|0|||
28157968|NCT00101907|54827477|FG000|Overall Study|Death|0|||
28157969|NCT00101907|54827478|FG001|Overall Study|Death|1|||
28157970|NCT00101907|54827479|FG002|Overall Study|Death|0|||
28157971|NCT00101907|54827480|FG003|Overall Study|Death|0|||
27825333|NCT01707992|54290706|FG001|Active Treatment Phase (24 Months)|Other than specified|0|||
28075565|NCT00130832|54730101|FG000|Overall Study|Adverse Event|1|||
28075566|NCT00130832|54730102|FG001|Overall Study|Adverse Event|1|||
27825334|NCT01707992|54290707|FG002|Active Treatment Phase (24 Months)|Other than specified|0|||
28075567|NCT00130832|54730101|FG000|Overall Study|Lost to Follow-up|1|||
28075568|NCT00130832|54730102|FG001|Overall Study|Lost to Follow-up|2|||
28075569|NCT00130832|54730101|FG000|Overall Study|Protocol Violation|6|||
28157972|NCT00101907|54827481|FG004|Overall Study|Death|3|||
28075570|NCT00130832|54730102|FG001|Overall Study|Protocol Violation|8|||
28075571|NCT00130832|54730101|FG000|Overall Study|Withdrawal by Subject|6|||
28075572|NCT00130832|54730102|FG001|Overall Study|Withdrawal by Subject|1|||
28075573|NCT00130832|54730101|FG000|Overall Study|Moved|2|||
28075574|NCT00130832|54730102|FG001|Overall Study|Moved|2|||
28075575|NCT00130832|54730101|FG000|Overall Study|Other|0|||
28075576|NCT00130832|54730102|FG001|Overall Study|Other|3|||
28075577|NCT00096018|54730110|FG000|Overall Study|Became Ineligible (not treated)|0|||
28075578|NCT00096018|54730111|FG001|Overall Study|Became Ineligible (not treated)|3|||
28075579|NCT00096018|54730110|FG000|Overall Study|Miscellaneous (not treated)|0|||
28075580|NCT00096018|54730111|FG001|Overall Study|Miscellaneous (not treated)|2|||
28075581|NCT00096018|54730110|FG000|Overall Study|Adverse Event|0|||
28075582|NCT00096018|54730111|FG001|Overall Study|Adverse Event|5|||
28157973|NCT00101907|54827482|FG005|Overall Study|Death|0|||
28157974|NCT00101907|54827477|FG000|Overall Study|Physician Decision|0|||
28157975|NCT00101907|54827478|FG001|Overall Study|Physician Decision|0|||
28157976|NCT00101907|54827479|FG002|Overall Study|Physician Decision|0|||
28157977|NCT00101907|54827480|FG003|Overall Study|Physician Decision|1|||
28157978|NCT00101907|54827481|FG004|Overall Study|Physician Decision|1|||
28157979|NCT00101907|54827482|FG005|Overall Study|Physician Decision|0|||
28157980|NCT00101907|54827477|FG000|Overall Study|Withdrawal by Subject|1|||
28157981|NCT00101907|54827478|FG001|Overall Study|Withdrawal by Subject|0|||
28157982|NCT00101907|54827479|FG002|Overall Study|Withdrawal by Subject|1|||
28157983|NCT00101907|54827480|FG003|Overall Study|Withdrawal by Subject|0|||
28157984|NCT00101907|54827481|FG004|Overall Study|Withdrawal by Subject|1|||
28157985|NCT00101907|54827482|FG005|Overall Study|Withdrawal by Subject|0|||
28157986|NCT02565784|54827503|FG000|First Treatment|Adverse Event|1|||
28157987|NCT02565784|54827503|FG000|First Treatment|Withdrawal by Subject|1|||
28157988|NCT02565784|54827503|FG000|Second Treatment|Withdrawal by Subject|2|||
28157989|NCT04650204|54827537|FG000|Overall Study|Study was Terminated|2|||
28157990|NCT04650204|54827538|FG001|Overall Study|Study was Terminated|1|||
28157991|NCT02761629|54827546|FG000|Overall Study|Adverse Event/Intercurrent Illness|7|||
28157992|NCT02761629|54827547|FG001|Overall Study|Adverse Event/Intercurrent Illness|5|||
28157993|NCT02761629|54827546|FG000|Overall Study|Insufficient Therapeutic Response|2|||
28157994|NCT02761629|54827547|FG001|Overall Study|Insufficient Therapeutic Response|7|||
28157995|NCT02761629|54827546|FG000|Overall Study|Failure to Return|2|||
28157996|NCT02761629|54827547|FG001|Overall Study|Failure to Return|4|||
28157997|NCT02761629|54827546|FG000|Overall Study|Did not Cooperate/Refused Treatment|2|||
28157998|NCT02761629|54827547|FG001|Overall Study|Did not Cooperate/Refused Treatment|4|||
28157999|NCT02761629|54827546|FG000|Overall Study|Protocol Violation|2|||
28158000|NCT02761629|54827547|FG001|Overall Study|Protocol Violation|2|||
28158001|NCT02761629|54827546|FG000|Overall Study|Withdrawal by Subject|0|||
28158002|NCT02761629|54827547|FG001|Overall Study|Withdrawal by Subject|3|||
28158003|NCT02761629|54827546|FG000|Overall Study|Other|0|||
28158004|NCT02761629|54827547|FG001|Overall Study|Other|2|||
28158005|NCT02761629|54827546|FG000|Overall Study|Lost to Follow-up|4|||
28158006|NCT02761629|54827547|FG001|Overall Study|Lost to Follow-up|1|||
28158007|NCT02761629|54827546|FG000|Overall Study|Randomized But Not Treated|8|||
28158008|NCT02761629|54827547|FG001|Overall Study|Randomized But Not Treated|4|||
28158009|NCT02760927|54827553|FG000|Overall Study|Tube Slippage from Device|1|||
28158010|NCT00101439|54827559|FG000|Period 2|Withdrawal by Subject|0|||
28158011|NCT00101439|54827560|FG001|Period 2|Withdrawal by Subject|2|||
28158012|NCT04033068|54827570|FG000|Overall Study|Withdrawal by Subject|0|||
28158013|NCT04033068|54827571|FG001|Overall Study|Withdrawal by Subject|0|||
28158014|NCT04033068|54827572|FG002|Overall Study|Withdrawal by Subject|1|||
28158015|NCT04033068|54827573|FG003|Overall Study|Withdrawal by Subject|0|||
28158016|NCT04033068|54827570|FG000|Overall Study|Lost to Follow-up|0|||
28158017|NCT04033068|54827571|FG001|Overall Study|Lost to Follow-up|1|||
28158018|NCT04033068|54827572|FG002|Overall Study|Lost to Follow-up|0|||
28158019|NCT04033068|54827573|FG003|Overall Study|Lost to Follow-up|0|||
28158020|NCT04033068|54827570|FG000|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
28158021|NCT04033068|54827571|FG001|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
28158022|NCT04033068|54827572|FG002|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
28158023|NCT04033068|54827573|FG003|Overall Study|Inclusion / exclusion criteria not fulfilled|1|||
28158024|NCT02762565|54827583|FG000|Overall Study|Missing iBE data: a result of incomplete data transfer from the iBE|11|||
28158025|NCT02757963|54827596|FG000|Overall Study|Adverse Event|3|||
28158026|NCT02757963|54827596|FG000|Overall Study|Reached Stopping Criteria|1054|||
28158027|NCT02757963|54827596|FG000|Overall Study|Lost to Follow-up|5|||
28158028|NCT02757963|54827596|FG000|Overall Study|Physician Decision|1|||
28158029|NCT02757963|54827596|FG000|Overall Study|Withdrawal by Subject|34|||
28158030|NCT03111732|54827611|FG000|Overall Study|Enrolled in different study|1|||
28158031|NCT03111732|54827611|FG000|Overall Study|Progressive disease|3|||
28158032|NCT03111732|54827611|FG000|Overall Study|Withdrawal by Subject|1|||
28158033|NCT01663714|54827620|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
28158034|NCT01663714|54827620|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|11|||
28158035|NCT01663714|54827620|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16|||
28158036|NCT01663714|54827620|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
28158037|NCT01663714|54827620|FG000|Long-Term Follow-Up|Death|4|||
28158038|NCT01663714|54827620|FG000|Long-Term Follow-Up|Non-compliance|1|||
28158039|NCT01663636|54827642|FG000|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25|||
28158040|NCT01663636|54827643|FG001|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31|||
28158041|NCT03065244|54827651|FG000|Overall Study|Lost to Follow-up|1|||
28158042|NCT03065244|54827652|FG001|Overall Study|Lost to Follow-up|1|||
28158043|NCT03065244|54827651|FG000|Overall Study|Diagnosed with a different disease|1|||
28158044|NCT03065244|54827652|FG001|Overall Study|Diagnosed with a different disease|1|||
28158045|NCT03065244|54827651|FG000|Overall Study|Protocol Violation|0|||
28158046|NCT03065244|54827652|FG001|Overall Study|Protocol Violation|1|||
28158047|NCT03065244|54827651|FG000|Overall Study|Withdrawal by Subject|1|||
28158048|NCT03065244|54827652|FG001|Overall Study|Withdrawal by Subject|1|||
28158049|NCT00100815|54827658|FG000|Overall Study|Progression|24|||
28158050|NCT00100815|54827658|FG000|Overall Study|Adverse Event|18|||
28158051|NCT00100815|54827658|FG000|Overall Study|Death|4|||
28158052|NCT00100815|54827658|FG000|Overall Study|Other|3|||
28158053|NCT00708422|54827664|FG000|Overall Study|Adverse Event|3|||
28158054|NCT00708422|54827665|FG001|Overall Study|Adverse Event|1|||
28158055|NCT00708422|54827664|FG000|Overall Study|Withdrawal by Subject|1|||
28158056|NCT00708422|54827665|FG001|Overall Study|Withdrawal by Subject|0|||
28158057|NCT02760069|54827674|FG000|Overall Study|Withdrawal by Subject|0|||
28158058|NCT02760069|54827675|FG001|Overall Study|Withdrawal by Subject|1|||
28158059|NCT02760069|54827676|FG002|Overall Study|Withdrawal by Subject|1|||
28158060|NCT00707486|54827684|FG000|Overall Study|Withdrawal by Subject|1|||
28158061|NCT02759055|54827692|FG000|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1927|||
28158062|NCT02759055|54827693|FG001|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1508|||
28158063|NCT02756637|54827701|FG000|Overall Study|Not eligible for initial SWOG study|10|||
28158064|NCT02756637|54827702|FG001|Overall Study|Not eligible for initial SWOG study|10|||
28158065|NCT02756637|54827701|FG000|Overall Study|No available NLR value|44|||
28158066|NCT02756637|54827702|FG001|Overall Study|No available NLR value|44|||
28158067|NCT02756637|54827701|FG000|Overall Study|Did not complete curative therapy|33|||
28158068|NCT02756637|54827702|FG001|Overall Study|Did not complete curative therapy|0|||
28158069|NCT00708032|54827710|FG000|Overall Study|Adverse Event|0|||
28158070|NCT00708032|54827711|FG001|Overall Study|Adverse Event|2|||
28158071|NCT00708032|54827710|FG000|Overall Study|Lost to Follow-up|1|||
28158072|NCT00708032|54827711|FG001|Overall Study|Lost to Follow-up|2|||
28158073|NCT00708032|54827710|FG000|Overall Study|Pregnancy|0|||
28158074|NCT00708032|54827711|FG001|Overall Study|Pregnancy|1|||
28158075|NCT00708032|54827710|FG000|Overall Study|Poor vision|0|||
28158076|NCT00708032|54827711|FG001|Overall Study|Poor vision|6|||
28158077|NCT00708032|54827710|FG000|Overall Study|Visit out of range at month 12|4|||
28158078|NCT00708032|54827711|FG001|Overall Study|Visit out of range at month 12|1|||
28158079|NCT00708032|54827710|FG000|Overall Study|Did not meet protocol criteria|1|||
28158080|NCT00708032|54827711|FG001|Overall Study|Did not meet protocol criteria|2|||
28158081|NCT00708032|54827710|FG000|Overall Study|Protocol Violation|4|||
28158082|NCT00708032|54827711|FG001|Overall Study|Protocol Violation|1|||
28158083|NCT00708032|54827710|FG000|Overall Study|Withdrawal by Subject|0|||
28158084|NCT00708032|54827711|FG001|Overall Study|Withdrawal by Subject|1|||
28158085|NCT00707174|54827719|FG000|Overall Study|Adverse Event|1|||
28158086|NCT00707174|54827720|FG001|Overall Study|Adverse Event|6|||
28158087|NCT00707174|54827719|FG000|Overall Study|Withdrawal by Subject|4|||
28158088|NCT00707174|54827720|FG001|Overall Study|Withdrawal by Subject|1|||
28158089|NCT02756403|54827730|FG000|Overall Study|Unable to swallow medication|0|||
28158090|NCT02756403|54827731|FG001|Overall Study|Unable to swallow medication|1|||
28158091|NCT02756403|54827732|FG002|Overall Study|Unable to swallow medication|1|||
28158092|NCT02756403|54827733|FG003|Overall Study|Unable to swallow medication|1|||
28158093|NCT02756403|54827730|FG000|Overall Study|Did not complete Procedure|0|||
28158094|NCT02756403|54827731|FG001|Overall Study|Did not complete Procedure|1|||
28158095|NCT02756403|54827732|FG002|Overall Study|Did not complete Procedure|0|||
28158096|NCT02756403|54827733|FG003|Overall Study|Did not complete Procedure|0|||
28158097|NCT02756403|54827730|FG000|Overall Study|Changed Mind About Procedure|0|||
28158098|NCT02756403|54827731|FG001|Overall Study|Changed Mind About Procedure|0|||
28158099|NCT02756403|54827732|FG002|Overall Study|Changed Mind About Procedure|1|||
28158100|NCT02756403|54827733|FG003|Overall Study|Changed Mind About Procedure|0|||
28158101|NCT02756403|54827730|FG000|Overall Study|Protocol Violation|0|||
28158102|NCT02756403|54827731|FG001|Overall Study|Protocol Violation|1|||
28158103|NCT02756403|54827732|FG002|Overall Study|Protocol Violation|0|||
28158104|NCT02756403|54827733|FG003|Overall Study|Protocol Violation|1|||
28158105|NCT02753595|54827745|FG000|Overall Study|Sponsor termination|2|||
28158106|NCT02753595|54827746|FG001|Overall Study|Sponsor termination|2|||
28158107|NCT00707954|54827769|FG000|Overall Study|Physician Decision|0|||
28158108|NCT00707954|54827770|FG001|Overall Study|Physician Decision|0|||
28158109|NCT00707954|54827771|FG002|Overall Study|Physician Decision|0|||
28158110|NCT00707954|54827772|FG003|Overall Study|Physician Decision|0|||
28158111|NCT00707954|54827773|FG004|Overall Study|Physician Decision|1|||
28158112|NCT02561962|54827794|FG000|Overall Study|Ongoing in study|1|||
28158113|NCT02561962|54827795|FG001|Overall Study|Ongoing in study|0|||
28158114|NCT02561962|54827796|FG002|Overall Study|Ongoing in study|0|||
28158115|NCT02561962|54827797|FG003|Overall Study|Ongoing in study|1|||
28158116|NCT02561962|54827798|FG004|Overall Study|Ongoing in study|0|||
28158117|NCT02561962|54827799|FG005|Overall Study|Ongoing in study|1|||
28158118|NCT02561962|54827800|FG006|Overall Study|Ongoing in study|0|||
28158119|NCT02561962|54827801|FG007|Overall Study|Ongoing in study|4|||
28158120|NCT02561962|54827802|FG008|Overall Study|Ongoing in study|1|||
27942277|NCT00995709|54599098|FG002|Overall Study|Lack of Efficacy|4|||
27942278|NCT00995709|54599096|FG000|Overall Study|Withdrawal by Subject|0|||
27942279|NCT00995709|54599097|FG001|Overall Study|Withdrawal by Subject|4|||
27942280|NCT00995709|54599098|FG002|Overall Study|Withdrawal by Subject|1|||
27942281|NCT00995709|54599096|FG000|Overall Study|Lost to Follow-up|1|||
27942282|NCT00995709|54599097|FG001|Overall Study|Lost to Follow-up|0|||
27942283|NCT00995709|54599098|FG002|Overall Study|Lost to Follow-up|0|||
28075583|NCT00096018|54730110|FG000|Overall Study|Death|0|||
28075584|NCT00096018|54730111|FG001|Overall Study|Death|1|||
28075585|NCT00096018|54730110|FG000|Overall Study|Withdrawal by Subject|0|||
28075586|NCT00096018|54730111|FG001|Overall Study|Withdrawal by Subject|2|||
28075587|NCT00096018|54730110|FG000|Overall Study|Miscellaneous|2|||
28075588|NCT00096018|54730111|FG001|Overall Study|Miscellaneous|1|||
28075589|NCT04713748|54730117|FG000|Overall Study|Not enough kits allocated|35|||
28075590|NCT04702984|54730121|FG000|Overall Study|Adverse Event Unrelated to the Study Device|1|||
28075591|NCT04701658|54730127|FG000|Overall Study|Lost to Follow-up|6|||
28075592|NCT00128102|54730133|FG000|Overall Study|Site Discontinued|3|||
28075593|NCT00128102|54730134|FG001|Overall Study|Site Discontinued|6|||
28075594|NCT00128102|54730133|FG000|Overall Study|Other|0|||
28075595|NCT00128102|54730134|FG001|Overall Study|Other|1|||
28075596|NCT00128102|54730133|FG000|Overall Study|Progressive Disease|255|||
28075597|NCT00128102|54730134|FG001|Overall Study|Progressive Disease|285|||
28075598|NCT00128102|54730133|FG000|Overall Study|Adverse Event|34|||
28075599|NCT00128102|54730134|FG001|Overall Study|Adverse Event|11|||
28075600|NCT00128102|54730133|FG000|Overall Study|Death|12|||
28075601|NCT00128102|54730134|FG001|Overall Study|Death|13|||
28075602|NCT00128102|54730133|FG000|Overall Study|Physician Decision|3|||
27942284|NCT00995709|54599096|FG000|Overall Study|Death|0|||
27942285|NCT00995709|54599097|FG001|Overall Study|Death|1|||
27942286|NCT00995709|54599098|FG002|Overall Study|Death|0|||
27942287|NCT00995709|54599096|FG000|Overall Study|Protocol Violation|2|||
27942288|NCT00995709|54599097|FG001|Overall Study|Protocol Violation|1|||
27942289|NCT00995709|54599098|FG002|Overall Study|Protocol Violation|0|||
27825335|NCT01707992|54290708|FG003|Active Treatment Phase (24 Months)|Other than specified|1|||
28075603|NCT00128102|54730134|FG001|Overall Study|Physician Decision|3|||
27942290|NCT00998985|54599120|FG000|Overall Study|Withdrawal by Subject|0|||
27942291|NCT00998985|54599121|FG001|Overall Study|Withdrawal by Subject|0|||
28075604|NCT00128102|54730133|FG000|Overall Study|Withdrawal by Subject|19|||
28075605|NCT00128102|54730134|FG001|Overall Study|Withdrawal by Subject|11|||
27942292|NCT00998985|54599122|FG002|Overall Study|Withdrawal by Subject|0|||
27942293|NCT00998985|54599123|FG003|Overall Study|Withdrawal by Subject|0|||
27942294|NCT00998985|54599124|FG004|Overall Study|Withdrawal by Subject|0|||
27942295|NCT00998985|54599125|FG005|Overall Study|Withdrawal by Subject|0|||
27942296|NCT00998985|54599126|FG006|Overall Study|Withdrawal by Subject|0|||
27942297|NCT00998985|54599127|FG007|Overall Study|Withdrawal by Subject|0|||
27942298|NCT00998985|54599128|FG008|Overall Study|Withdrawal by Subject|1|||
27942299|NCT00998985|54599129|FG009|Overall Study|Withdrawal by Subject|0|||
27942300|NCT00998985|54599130|FG010|Overall Study|Withdrawal by Subject|0|||
27942301|NCT00998985|54599131|FG011|Overall Study|Withdrawal by Subject|0|||
27942302|NCT00998985|54599132|FG012|Overall Study|Withdrawal by Subject|0|||
27942303|NCT00998985|54599133|FG013|Overall Study|Withdrawal by Subject|0|||
27942304|NCT00998985|54599120|FG000|Overall Study|Protocol Violation|0|||
27942305|NCT00998985|54599121|FG001|Overall Study|Protocol Violation|0|||
27942306|NCT00998985|54599122|FG002|Overall Study|Protocol Violation|0|||
27942307|NCT00998985|54599123|FG003|Overall Study|Protocol Violation|0|||
27942308|NCT00998985|54599124|FG004|Overall Study|Protocol Violation|0|||
27942309|NCT00998985|54599125|FG005|Overall Study|Protocol Violation|1|||
27942310|NCT00998985|54599126|FG006|Overall Study|Protocol Violation|0|||
27942311|NCT00998985|54599127|FG007|Overall Study|Protocol Violation|0|||
27942312|NCT00998985|54599128|FG008|Overall Study|Protocol Violation|0|||
27942313|NCT00998985|54599129|FG009|Overall Study|Protocol Violation|0|||
27942314|NCT00998985|54599130|FG010|Overall Study|Protocol Violation|0|||
27942315|NCT00998985|54599131|FG011|Overall Study|Protocol Violation|0|||
27942316|NCT00998985|54599132|FG012|Overall Study|Protocol Violation|0|||
27942317|NCT00998985|54599133|FG013|Overall Study|Protocol Violation|0|||
27850330|NCT04178967|54349325|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
27850331|NCT04178967|54349315|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
27942318|NCT00995553|54599180|FG000|Overall Study|Withdrawal by Subject|2|||
27942319|NCT00995553|54599181|FG001|Overall Study|Withdrawal by Subject|6|||
28158121|NCT02561962|54827794|FG000|Overall Study|Withdrawal by Subject|1|||
28158122|NCT02561962|54827795|FG001|Overall Study|Withdrawal by Subject|0|||
28158123|NCT02561962|54827796|FG002|Overall Study|Withdrawal by Subject|0|||
28158124|NCT02561962|54827797|FG003|Overall Study|Withdrawal by Subject|0|||
28158125|NCT02561962|54827798|FG004|Overall Study|Withdrawal by Subject|1|||
27825336|NCT01707992|54290709|FG004|Active Treatment Phase (24 Months)|Other than specified|5|||
28158126|NCT02561962|54827799|FG005|Overall Study|Withdrawal by Subject|1|||
28158127|NCT02561962|54827800|FG006|Overall Study|Withdrawal by Subject|2|||
28158128|NCT02561962|54827801|FG007|Overall Study|Withdrawal by Subject|1|||
28158129|NCT02561962|54827802|FG008|Overall Study|Withdrawal by Subject|0|||
28158130|NCT02561962|54827794|FG000|Overall Study|Decision by sponsor|0|||
28158131|NCT02561962|54827795|FG001|Overall Study|Decision by sponsor|0|||
28158132|NCT02561962|54827796|FG002|Overall Study|Decision by sponsor|0|||
28158133|NCT02561962|54827797|FG003|Overall Study|Decision by sponsor|0|||
28158134|NCT02561962|54827798|FG004|Overall Study|Decision by sponsor|1|||
28158135|NCT02561962|54827799|FG005|Overall Study|Decision by sponsor|1|||
28158136|NCT02561962|54827800|FG006|Overall Study|Decision by sponsor|0|||
28158137|NCT02561962|54827801|FG007|Overall Study|Decision by sponsor|3|||
28158138|NCT02561962|54827802|FG008|Overall Study|Decision by sponsor|0|||
28075606|NCT00128102|54730133|FG000|Overall Study|Protocol Violation|2|||
28075607|NCT00128102|54730134|FG001|Overall Study|Protocol Violation|2|||
28075608|NCT04668274|54730140|FG000|Part 1 Study Period 1|Adverse Event|3|||
28075609|NCT04668274|54730141|FG001|Part 1 Study Period 1|Adverse Event|0|||
28075610|NCT04668274|54730142|FG002|Part 1 Study Period 1|Adverse Event|0|||
28158139|NCT02561962|54827794|FG000|Overall Study|Lost to Follow-up|0|||
28158140|NCT02561962|54827795|FG001|Overall Study|Lost to Follow-up|0|||
28158141|NCT02561962|54827796|FG002|Overall Study|Lost to Follow-up|0|||
28158142|NCT02561962|54827797|FG003|Overall Study|Lost to Follow-up|0|||
28158143|NCT02561962|54827798|FG004|Overall Study|Lost to Follow-up|0|||
27942320|NCT00991887|54599189|FG000|Overall Study|Lost to Follow-up|2|||
28075611|NCT04668274|54730143|FG003|Part 1 Study Period 1|Adverse Event|0|||
28075612|NCT04668274|54730140|FG000|Part 1 Study Period 1|Withdrawal by Subject|2|||
28075613|NCT04668274|54730141|FG001|Part 1 Study Period 1|Withdrawal by Subject|0|||
28075614|NCT04668274|54730142|FG002|Part 1 Study Period 1|Withdrawal by Subject|0|||
28158144|NCT02561962|54827799|FG005|Overall Study|Lost to Follow-up|1|||
28158145|NCT02561962|54827800|FG006|Overall Study|Lost to Follow-up|0|||
28075615|NCT04668274|54730143|FG003|Part 1 Study Period 1|Withdrawal by Subject|0|||
28158146|NCT02561962|54827801|FG007|Overall Study|Lost to Follow-up|0|||
28158147|NCT02561962|54827802|FG008|Overall Study|Lost to Follow-up|0|||
28158148|NCT02565706|54827826|FG000|Overall Study|Withdrawal by Subject|5|||
28158149|NCT02565706|54827827|FG001|Overall Study|Withdrawal by Subject|7|||
28158150|NCT02565706|54827828|FG002|Overall Study|Withdrawal by Subject|7|||
28158151|NCT02565706|54827829|FG003|Overall Study|Withdrawal by Subject|11|||
28075616|NCT04668274|54730140|FG000|Part 1 Study Period 2|Other|0|||
28075617|NCT04668274|54730141|FG001|Part 1 Study Period 2|Other|1|||
28075618|NCT04668274|54730142|FG002|Part 1 Study Period 2|Other|0|||
28075619|NCT04668274|54730143|FG003|Part 1 Study Period 2|Other|0|||
28075620|NCT04668274|54730140|FG000|Part 1 Study Period 3|Adverse Event|0|||
28075621|NCT04668274|54730141|FG001|Part 1 Study Period 3|Adverse Event|0|||
28075622|NCT04668274|54730142|FG002|Part 1 Study Period 3|Adverse Event|1|||
28075623|NCT04668274|54730143|FG003|Part 1 Study Period 3|Adverse Event|0|||
28075624|NCT04668274|54730140|FG000|Part 1 Study Period 3|Other|0|||
28075625|NCT04668274|54730141|FG001|Part 1 Study Period 3|Other|0|||
28158152|NCT02565706|54827826|FG000|Overall Study|Lost to Follow-up|72|||
28158153|NCT02565706|54827827|FG001|Overall Study|Lost to Follow-up|75|||
28075626|NCT04668274|54730142|FG002|Part 1 Study Period 3|Other|2|||
28158154|NCT02565706|54827828|FG002|Overall Study|Lost to Follow-up|82|||
28075627|NCT04668274|54730143|FG003|Part 1 Study Period 3|Other|0|||
27825337|NCT01707992|54290710|FG005|Active Treatment Phase (24 Months)|Other than specified|2|||
27942321|NCT00991887|54599190|FG001|Overall Study|Lost to Follow-up|1|||
27942322|NCT01002339|54599199|FG000|Overall Study|Withdrawal by Subject|0|||
27942323|NCT01002339|54599200|FG001|Overall Study|Withdrawal by Subject|1|||
28158155|NCT02565706|54827829|FG003|Overall Study|Lost to Follow-up|74|||
28158156|NCT00706628|54827848|FG000|Overall Study|Other Adverse Event|16|||
28158157|NCT00706628|54827849|FG001|Overall Study|Other Adverse Event|5|||
28158158|NCT00706628|54827850|FG002|Overall Study|Other Adverse Event|5|||
28158159|NCT00706628|54827851|FG003|Overall Study|Other Adverse Event|2|||
28158160|NCT00706628|54827848|FG000|Overall Study|Non compliant with protocol|0|||
28158161|NCT00706628|54827849|FG001|Overall Study|Non compliant with protocol|1|||
28158162|NCT00706628|54827850|FG002|Overall Study|Non compliant with protocol|0|||
28158163|NCT00706628|54827851|FG003|Overall Study|Non compliant with protocol|0|||
28158164|NCT00706628|54827848|FG000|Overall Study|Consent withdrawn|6|||
28158165|NCT00706628|54827849|FG001|Overall Study|Consent withdrawn|1|||
28158166|NCT00706628|54827850|FG002|Overall Study|Consent withdrawn|3|||
28158167|NCT00706628|54827851|FG003|Overall Study|Consent withdrawn|0|||
28158168|NCT00706628|54827848|FG000|Overall Study|Progressive disease|20|||
28158169|NCT00706628|54827849|FG001|Overall Study|Progressive disease|13|||
28158170|NCT00706628|54827850|FG002|Overall Study|Progressive disease|8|||
28158171|NCT00706628|54827851|FG003|Overall Study|Progressive disease|1|||
28158172|NCT00706628|54827848|FG000|Overall Study|Other than those stated above|4|||
28158173|NCT00706628|54827849|FG001|Overall Study|Other than those stated above|0|||
27942324|NCT01002339|54599201|FG002|Overall Study|Withdrawal by Subject|0|||
27942325|NCT01002339|54599199|FG000|Overall Study|Incorrect treatment assignment|0|||
27942326|NCT01002339|54599200|FG001|Overall Study|Incorrect treatment assignment|0|||
27942327|NCT01002339|54599201|FG002|Overall Study|Incorrect treatment assignment|1|||
27942328|NCT01002339|54599199|FG000|Overall Study|Protocol Violation|0|||
27942329|NCT01002339|54599200|FG001|Overall Study|Protocol Violation|0|||
27942330|NCT01002339|54599201|FG002|Overall Study|Protocol Violation|2|||
27942331|NCT01002339|54599199|FG000|Overall Study|Lung cancer detected before transplant|0|||
27942332|NCT01002339|54599200|FG001|Overall Study|Lung cancer detected before transplant|0|||
27942333|NCT01002339|54599201|FG002|Overall Study|Lung cancer detected before transplant|1|||
27942334|NCT01002339|54599199|FG000|Overall Study|Randomized. Not transplanted|0|||
27942335|NCT01002339|54599200|FG001|Overall Study|Randomized. Not transplanted|0|||
27942336|NCT01002339|54599201|FG002|Overall Study|Randomized. Not transplanted|1|||
27942337|NCT01002105|54599211|FG000|Overall Study|Lost to Follow-up|10|||
27942338|NCT01002105|54599212|FG001|Overall Study|Lost to Follow-up|16|||
28075628|NCT04668274|54730140|FG000|Part 2 Study Period 4|Other|0|||
28075629|NCT04668274|54730141|FG001|Part 2 Study Period 4|Other|0|||
28075630|NCT04668274|54730142|FG002|Part 2 Study Period 4|Other|0|||
28075631|NCT04668274|54730143|FG003|Part 2 Study Period 4|Other|1|||
28075632|NCT04406194|54730158|FG000|Period 1|Withdrawal by Subject|0|||
28075633|NCT04406194|54730159|FG001|Period 1|Withdrawal by Subject|1|||
28075634|NCT03822884|54730174|FG000|Overall Study|Withdrawal by Subject|0|||
28075635|NCT03822884|54730175|FG001|Overall Study|Withdrawal by Subject|0|||
28075636|NCT03822884|54730176|FG002|Overall Study|Withdrawal by Subject|0|||
28075637|NCT03822884|54730177|FG003|Overall Study|Withdrawal by Subject|0|||
28075638|NCT03822884|54730178|FG004|Overall Study|Withdrawal by Subject|1|||
28075639|NCT03822884|54730179|FG005|Overall Study|Withdrawal by Subject|0|||
28075640|NCT03822416|54730189|FG000|Overall Study|Lost to Follow-up|1|||
28158174|NCT00706628|54827850|FG002|Overall Study|Other than those stated above|0|||
28158175|NCT00706628|54827851|FG003|Overall Study|Other than those stated above|0|||
28158176|NCT00706628|54827848|FG000|Overall Study|Not treated|1|||
28158177|NCT00706628|54827849|FG001|Overall Study|Not treated|1|||
28075641|NCT03822416|54730190|FG001|Overall Study|Lost to Follow-up|0|||
28158178|NCT00706628|54827850|FG002|Overall Study|Not treated|0|||
28158179|NCT00706628|54827851|FG003|Overall Study|Not treated|0|||
28158180|NCT02561806|54827866|FG000|Induction Period|Adverse Event|0|||
28158181|NCT02561806|54827867|FG001|Induction Period|Adverse Event|2|||
28158182|NCT02561806|54827866|FG000|Induction Period|Lack of Efficacy|1|||
28158183|NCT02561806|54827867|FG001|Induction Period|Lack of Efficacy|0|||
28158184|NCT02561806|54827866|FG000|Induction Period|Withdrawal by Subject|0|||
28158185|NCT02561806|54827867|FG001|Induction Period|Withdrawal by Subject|2|||
28158186|NCT02561806|54827866|FG000|Induction Period|Site staff became unblinded|1|||
28158187|NCT02561806|54827867|FG001|Induction Period|Site staff became unblinded|0|||
28158188|NCT02561806|54827866|FG000|Induction Period|Randomized but not treated|0|||
28158189|NCT02561806|54827867|FG001|Induction Period|Randomized but not treated|1|||
28158190|NCT02561806|54827866|FG000|Maintenance Period|Adverse Event|2|||
28158191|NCT02561806|54827867|FG001|Maintenance Period|Adverse Event|1|||
28158192|NCT02561806|54827866|FG000|Maintenance Period|Lack of Efficacy|3|||
28158193|NCT02561806|54827867|FG001|Maintenance Period|Lack of Efficacy|1|||
28158194|NCT02561806|54827866|FG000|Maintenance Period|Lost to Follow-up|2|||
28158195|NCT02561806|54827867|FG001|Maintenance Period|Lost to Follow-up|2|||
28158196|NCT02561806|54827866|FG000|Maintenance Period|Protocol Violation|1|||
28158197|NCT02561806|54827867|FG001|Maintenance Period|Protocol Violation|0|||
28158198|NCT02561806|54827866|FG000|Maintenance Period|Withdrawal by Subject|5|||
28158199|NCT02561806|54827867|FG001|Maintenance Period|Withdrawal by Subject|3|||
28158200|NCT02561806|54827866|FG000|Maintenance Period|Site staff became unblinded|0|||
28158201|NCT02561806|54827867|FG001|Maintenance Period|Site staff became unblinded|1|||
28158202|NCT02561806|54827866|FG000|Post-Treatment Follow-up|Lost to Follow-up|1|||
28158203|NCT02561806|54827867|FG001|Post-Treatment Follow-up|Lost to Follow-up|1|||
28158204|NCT02561806|54827866|FG000|Post-Treatment Follow-up|Withdrawal by Subject|1|||
28158205|NCT02561806|54827867|FG001|Post-Treatment Follow-up|Withdrawal by Subject|0|||
28158206|NCT02561572|54827890|FG000|Overall Study|Inadequate time before surgery|2|||
28158207|NCT02561572|54827891|FG001|Overall Study|Inadequate time before surgery|1|||
28158208|NCT02561572|54827890|FG000|Overall Study|Protocol Violation|0|||
28158209|NCT02561572|54827891|FG001|Overall Study|Protocol Violation|1|||
28158210|NCT02180217|54827900|FG000|Overall Study|Adverse Event|3|||
28158211|NCT02180217|54827901|FG001|Overall Study|Adverse Event|2|||
28158212|NCT02180217|54827902|FG002|Overall Study|Adverse Event|22|||
28158213|NCT02180217|54827900|FG000|Overall Study|Death|1|||
28158214|NCT02180217|54827901|FG001|Overall Study|Death|1|||
28158215|NCT02180217|54827902|FG002|Overall Study|Death|0|||
28158216|NCT02180217|54827900|FG000|Overall Study|Withdrawal by Subject|1|||
28158217|NCT02180217|54827901|FG001|Overall Study|Withdrawal by Subject|1|||
28158218|NCT02180217|54827902|FG002|Overall Study|Withdrawal by Subject|4|||
28158219|NCT02180217|54827900|FG000|Overall Study|Subject/Guardian decision|5|||
28158220|NCT02180217|54827901|FG001|Overall Study|Subject/Guardian decision|3|||
28158221|NCT02180217|54827902|FG002|Overall Study|Subject/Guardian decision|6|||
28158222|NCT02180217|54827900|FG000|Overall Study|Physician Decision|1|||
28158223|NCT02180217|54827901|FG001|Overall Study|Physician Decision|1|||
28158224|NCT02180217|54827902|FG002|Overall Study|Physician Decision|6|||
28158225|NCT02180217|54827900|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
28158226|NCT02180217|54827901|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
28158227|NCT02180217|54827902|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
28158228|NCT02560558|54827919|FG000|Overall Study|Adverse Event|1|||
28158229|NCT02560558|54827920|FG001|Overall Study|Adverse Event|0|||
28158230|NCT02560558|54827919|FG000|Overall Study|Death|0|||
28158231|NCT02560558|54827920|FG001|Overall Study|Death|2|||
28158232|NCT02560558|54827919|FG000|Overall Study|Lost to Follow-up|0|||
28158233|NCT02560558|54827920|FG001|Overall Study|Lost to Follow-up|4|||
28158234|NCT02560558|54827919|FG000|Overall Study|Protocol Violation|3|||
28158235|NCT02560558|54827920|FG001|Overall Study|Protocol Violation|0|||
28158236|NCT02560558|54827919|FG000|Overall Study|Withdrawal by Subject|3|||
28158237|NCT02560558|54827920|FG001|Overall Study|Withdrawal by Subject|0|||
28158238|NCT02568046|54827928|FG000|Overall Study|Adverse Event|0|||
28158239|NCT02568046|54827929|FG001|Overall Study|Adverse Event|1|||
28158240|NCT02568046|54827928|FG000|Overall Study|Death|2|||
28158241|NCT02568046|54827929|FG001|Overall Study|Death|0|||
28158242|NCT02568046|54827928|FG000|Overall Study|Progressive Disease|1|||
28158243|NCT02568046|54827929|FG001|Overall Study|Progressive Disease|0|||
28158244|NCT02568046|54827928|FG000|Overall Study|Withdrawal by Subject|2|||
28158245|NCT02568046|54827929|FG001|Overall Study|Withdrawal by Subject|1|||
28158246|NCT02568046|54827928|FG000|Overall Study|Other Events|0|||
27825338|NCT01707992|54290705|FG000|Active Treatment Phase (24 Months)|Noncompliance|0|||
28158247|NCT02568046|54827929|FG001|Overall Study|Other Events|1|||
28158248|NCT02567656|54827941|FG000|Overall Study|Premature discontinuation due to PD|1|||
28158249|NCT02567656|54827942|FG001|Overall Study|Premature discontinuation due to PD|1|||
27825339|NCT01707992|54290706|FG001|Active Treatment Phase (24 Months)|Noncompliance|0|||
28158250|NCT02567656|54827943|FG002|Overall Study|Premature discontinuation due to PD|2|||
28158251|NCT02567656|54827944|FG003|Overall Study|Premature discontinuation due to PD|0|||
28158252|NCT02567656|54827945|FG004|Overall Study|Premature discontinuation due to PD|0|||
28158253|NCT02567656|54827946|FG005|Overall Study|Premature discontinuation due to PD|0|||
28158254|NCT02560012|54827960|FG000|Overall Study|Study Terminated|2|||
28158255|NCT02567266|54827967|FG000|Overall Study|Withdrawal by Subject|10|||
28158256|NCT02567266|54827968|FG001|Overall Study|Withdrawal by Subject|7|||
28158257|NCT02567266|54827969|FG002|Overall Study|Withdrawal by Subject|6|||
28158258|NCT02567266|54827967|FG000|Overall Study|Lost to Follow-up|13|||
28158259|NCT02567266|54827968|FG001|Overall Study|Lost to Follow-up|8|||
28158260|NCT02567266|54827969|FG002|Overall Study|Lost to Follow-up|10|||
28158261|NCT02567188|54827977|FG000|Overall Study|Death|10|||
28158262|NCT02567188|54827977|FG000|Overall Study|Terminated Mircera Treatment|9|||
28158263|NCT02567188|54827977|FG000|Overall Study|Lost to Follow-up|5|||
28158264|NCT02567188|54827977|FG000|Overall Study|Adverse Event|1|||
28158265|NCT02567188|54827977|FG000|Overall Study|Withdrawal by Subject|1|||
28158266|NCT02567188|54827977|FG000|Overall Study|Refused Treatment/ Did not Cooperate|1|||
28158267|NCT02567188|54827977|FG000|Overall Study|Moved and Changed Clinic|1|||
28158268|NCT02567188|54827977|FG000|Overall Study|Started Hemodialysis|2|||
28158269|NCT02567188|54827977|FG000|Overall Study|Protocol Violation|5|||
28158270|NCT00706238|54827982|FG000|Overall Study|Disease progression|4|||
28158271|NCT00706238|54827982|FG000|Overall Study|Other|1|||
28158272|NCT04649164|54827989|FG000|Overall Study|Withdrawal by Subject|1|||
28158273|NCT04649164|54827990|FG001|Overall Study|Withdrawal by Subject|1|||
28158274|NCT04649164|54827991|FG002|Overall Study|Withdrawal by Subject|2|||
28158275|NCT04649164|54827989|FG000|Overall Study|Participant's care recipient expired|0|||
28158276|NCT04649164|54827990|FG001|Overall Study|Participant's care recipient expired|0|||
28158277|NCT04649164|54827991|FG002|Overall Study|Participant's care recipient expired|2|||
28158278|NCT02753127|54828001|FG000|Overall Study|Lost to Follow-up|13|||
28158279|NCT02753127|54828002|FG001|Overall Study|Lost to Follow-up|11|||
28158280|NCT02753127|54828001|FG000|Overall Study|Withdrawal by Subject|37|||
28158281|NCT02753127|54828002|FG001|Overall Study|Withdrawal by Subject|47|||
28158282|NCT02753127|54828001|FG000|Overall Study|Other|3|||
28158283|NCT02753127|54828002|FG001|Overall Study|Other|8|||
28158284|NCT02753127|54828001|FG000|Overall Study|Hospice|0|||
28158285|NCT02753127|54828002|FG001|Overall Study|Hospice|2|||
28158286|NCT00706004|54828034|FG000|Overall Study|Did not meet eligibility criteria|2|||
28158287|NCT02724644|54828041|FG000|Overall Study|Adverse Event|7|||
28158288|NCT02724644|54828042|FG001|Overall Study|Adverse Event|1|||
28158289|NCT02724644|54828041|FG000|Overall Study|Lost to Follow-up|6|||
28158290|NCT02724644|54828042|FG001|Overall Study|Lost to Follow-up|2|||
28158291|NCT02724644|54828041|FG000|Overall Study|Withdrawal by Subject|7|||
28158292|NCT02724644|54828042|FG001|Overall Study|Withdrawal by Subject|1|||
28158293|NCT02724644|54828041|FG000|Overall Study|Administrative|1|||
28158294|NCT02724644|54828042|FG001|Overall Study|Administrative|0|||
27942339|NCT01002105|54599211|FG000|Overall Study|non compliance|5|||
28158295|NCT02725268|54828052|FG000|Overall Study|Death|58|||
28158296|NCT02725268|54828053|FG001|Overall Study|Death|59|||
28158297|NCT02725268|54828054|FG002|Overall Study|Death|30|||
28158298|NCT02725268|54828055|FG003|Overall Study|Death|16|||
28158299|NCT02725268|54828052|FG000|Overall Study|Lost to Follow-up|4|||
28158300|NCT02725268|54828053|FG001|Overall Study|Lost to Follow-up|3|||
28158301|NCT02725268|54828054|FG002|Overall Study|Lost to Follow-up|0|||
28158302|NCT02725268|54828055|FG003|Overall Study|Lost to Follow-up|1|||
28158303|NCT02725268|54828052|FG000|Overall Study|Site Terminated by Sponsor|0|||
28158304|NCT02725268|54828053|FG001|Overall Study|Site Terminated by Sponsor|1|||
28158305|NCT02725268|54828054|FG002|Overall Study|Site Terminated by Sponsor|0|||
28158306|NCT02725268|54828055|FG003|Overall Study|Site Terminated by Sponsor|0|||
28158307|NCT02725268|54828052|FG000|Overall Study|Withdrawal by Subject|8|||
28158308|NCT02725268|54828053|FG001|Overall Study|Withdrawal by Subject|6|||
28158309|NCT02725268|54828054|FG002|Overall Study|Withdrawal by Subject|8|||
28158310|NCT02725268|54828055|FG003|Overall Study|Withdrawal by Subject|1|||
27942340|NCT01002105|54599212|FG001|Overall Study|non compliance|3|||
28158311|NCT02725268|54828052|FG000|Overall Study|Reason not Specified|2|||
28158312|NCT02725268|54828053|FG001|Overall Study|Reason not Specified|1|||
28158313|NCT02725268|54828054|FG002|Overall Study|Reason not Specified|0|||
28158314|NCT02725268|54828055|FG003|Overall Study|Reason not Specified|0|||
28158315|NCT02724956|54828067|FG000|Overall Study|Physician Decision|1|||
28158316|NCT02724956|54828068|FG001|Overall Study|Physician Decision|0|||
28158317|NCT02724956|54828067|FG000|Overall Study|Lack of Efficacy|0|||
28158318|NCT02724956|54828068|FG001|Overall Study|Lack of Efficacy|1|||
28158319|NCT02724956|54828067|FG000|Overall Study|Withdrawal by Subject|0|||
28158320|NCT02724956|54828068|FG001|Overall Study|Withdrawal by Subject|1|||
28158321|NCT00705536|54828076|FG000|Start Period 1|Withdrawal by Subject|0|||
28158322|NCT00705536|54828077|FG001|Start Period 1|Withdrawal by Subject|0|||
28158323|NCT00705536|54828078|FG002|Start Period 1|Withdrawal by Subject|0|||
28158324|NCT00705536|54828079|FG003|Start Period 1|Withdrawal by Subject|1|||
28158325|NCT02724020|54828101|FG000|Overall Study|Death|16|||
28158326|NCT02724020|54828102|FG001|Overall Study|Death|18|||
28158327|NCT02724020|54828103|FG002|Overall Study|Death|19|||
28158328|NCT02724020|54828101|FG000|Overall Study|Lost to Follow-up|0|||
28158329|NCT02724020|54828102|FG001|Overall Study|Lost to Follow-up|3|||
28158330|NCT02724020|54828103|FG002|Overall Study|Lost to Follow-up|0|||
28158331|NCT02724020|54828101|FG000|Overall Study|Site Terminated by Sponsor|15|||
28158332|NCT02724020|54828102|FG001|Overall Study|Site Terminated by Sponsor|8|||
28158333|NCT02724020|54828103|FG002|Overall Study|Site Terminated by Sponsor|8|||
28158334|NCT02724020|54828101|FG000|Overall Study|Withdrawal by Subject|1|||
28158335|NCT02724020|54828102|FG001|Overall Study|Withdrawal by Subject|3|||
28075642|NCT03822416|54730189|FG000|Overall Study|Withdrawal by Subject|0|||
28075643|NCT03822416|54730190|FG001|Overall Study|Withdrawal by Subject|1|||
28075644|NCT04405570|54730200|FG000|Overall Study|Adverse Event|0|||
28075645|NCT04405570|54730201|FG001|Overall Study|Adverse Event|1|||
28075646|NCT04405570|54730202|FG002|Overall Study|Adverse Event|1|||
28075647|NCT04405570|54730203|FG003|Overall Study|Adverse Event|1|||
28075648|NCT04405570|54730200|FG000|Overall Study|Lost to Follow-up|0|||
28075649|NCT04405570|54730201|FG001|Overall Study|Lost to Follow-up|1|||
28075650|NCT04405570|54730202|FG002|Overall Study|Lost to Follow-up|0|||
28075651|NCT04405570|54730203|FG003|Overall Study|Lost to Follow-up|0|||
28075652|NCT04405570|54730200|FG000|Overall Study|Physician Decision|0|||
28075653|NCT04405570|54730201|FG001|Overall Study|Physician Decision|0|||
28075654|NCT04405570|54730202|FG002|Overall Study|Physician Decision|1|||
28075655|NCT04405570|54730203|FG003|Overall Study|Physician Decision|0|||
28158336|NCT02724020|54828103|FG002|Overall Study|Withdrawal by Subject|5|||
28158337|NCT02660034|54828125|FG000|Overall Study|Progressive Disease (Radiographic)|3|||
28158338|NCT02660034|54828126|FG001|Overall Study|Progressive Disease (Radiographic)|1|||
28158339|NCT02660034|54828127|FG002|Overall Study|Progressive Disease (Radiographic)|0|||
28158340|NCT02660034|54828128|FG003|Overall Study|Progressive Disease (Radiographic)|1|||
28158341|NCT02660034|54828129|FG004|Overall Study|Progressive Disease (Radiographic)|0|||
28158342|NCT02660034|54828130|FG005|Overall Study|Progressive Disease (Radiographic)|0|||
28158343|NCT02660034|54828131|FG006|Overall Study|Progressive Disease (Radiographic)|0|||
28158344|NCT02660034|54828132|FG007|Overall Study|Progressive Disease (Radiographic)|0|||
27942341|NCT01002105|54599211|FG000|Overall Study|condition worsened|4|||
28075656|NCT04405570|54730200|FG000|Overall Study|Withdrawal by Subject|0|||
28075657|NCT04405570|54730201|FG001|Overall Study|Withdrawal by Subject|1|||
28075658|NCT04405570|54730202|FG002|Overall Study|Withdrawal by Subject|1|||
28075659|NCT04405570|54730203|FG003|Overall Study|Withdrawal by Subject|0|||
28158345|NCT02660034|54828133|FG008|Overall Study|Progressive Disease (Radiographic)|0|||
27942342|NCT01002105|54599212|FG001|Overall Study|condition worsened|2|||
28075660|NCT04405570|54730200|FG000|Overall Study|Randomized not dosed|0|||
28075661|NCT04405570|54730201|FG001|Overall Study|Randomized not dosed|2|||
28075662|NCT04405570|54730202|FG002|Overall Study|Randomized not dosed|0|||
28075663|NCT04405570|54730203|FG003|Overall Study|Randomized not dosed|0|||
28075664|NCT00127712|54730218|FG000|Overall Study|Adverse Event|3|||
28075665|NCT00127712|54730219|FG001|Overall Study|Adverse Event|0|||
27942343|NCT02605993|54599225|FG000|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
28075666|NCT00127712|54730218|FG000|Overall Study|Lack of GI access to continue|2|||
28075667|NCT00127712|54730219|FG001|Overall Study|Lack of GI access to continue|0|||
28077069|NCT00403481|54731778|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1|||
28158346|NCT02660034|54828134|FG009|Overall Study|Progressive Disease (Radiographic)|0|||
27942344|NCT02605993|54599226|FG001|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
28158347|NCT02660034|54828135|FG010|Overall Study|Progressive Disease (Radiographic)|0|||
28158348|NCT02660034|54828136|FG011|Overall Study|Progressive Disease (Radiographic)|0|||
28158349|NCT02660034|54828137|FG012|Overall Study|Progressive Disease (Radiographic)|0|||
28158350|NCT02660034|54828138|FG013|Overall Study|Progressive Disease (Radiographic)|0|||
28158351|NCT02660034|54828125|FG000|Overall Study|Progressive Disease (Clinical)|7|||
28158352|NCT02660034|54828126|FG001|Overall Study|Progressive Disease (Clinical)|8|||
28158353|NCT02660034|54828127|FG002|Overall Study|Progressive Disease (Clinical)|3|||
28158354|NCT02660034|54828128|FG003|Overall Study|Progressive Disease (Clinical)|9|||
28158355|NCT02660034|54828129|FG004|Overall Study|Progressive Disease (Clinical)|3|||
28158356|NCT02660034|54828130|FG005|Overall Study|Progressive Disease (Clinical)|0|||
28158357|NCT02660034|54828131|FG006|Overall Study|Progressive Disease (Clinical)|0|||
28158358|NCT02660034|54828132|FG007|Overall Study|Progressive Disease (Clinical)|0|||
28158359|NCT02660034|54828133|FG008|Overall Study|Progressive Disease (Clinical)|0|||
28158360|NCT02660034|54828134|FG009|Overall Study|Progressive Disease (Clinical)|0|||
28158361|NCT02660034|54828135|FG010|Overall Study|Progressive Disease (Clinical)|0|||
28158362|NCT02660034|54828136|FG011|Overall Study|Progressive Disease (Clinical)|0|||
28158363|NCT02660034|54828137|FG012|Overall Study|Progressive Disease (Clinical)|0|||
28158364|NCT02660034|54828138|FG013|Overall Study|Progressive Disease (Clinical)|0|||
28158365|NCT02660034|54828125|FG000|Overall Study|Lost to Follow-up|0|||
28158366|NCT02660034|54828126|FG001|Overall Study|Lost to Follow-up|0|||
28158367|NCT02660034|54828127|FG002|Overall Study|Lost to Follow-up|1|||
28158368|NCT02660034|54828128|FG003|Overall Study|Lost to Follow-up|1|||
28158369|NCT02660034|54828129|FG004|Overall Study|Lost to Follow-up|0|||
28158370|NCT02660034|54828130|FG005|Overall Study|Lost to Follow-up|0|||
28158371|NCT02660034|54828131|FG006|Overall Study|Lost to Follow-up|0|||
28158372|NCT02660034|54828132|FG007|Overall Study|Lost to Follow-up|0|||
28158373|NCT02660034|54828133|FG008|Overall Study|Lost to Follow-up|0|||
28158374|NCT02660034|54828134|FG009|Overall Study|Lost to Follow-up|1|||
28158375|NCT02660034|54828135|FG010|Overall Study|Lost to Follow-up|1|||
28158376|NCT02660034|54828136|FG011|Overall Study|Lost to Follow-up|1|||
27825340|NCT01707992|54290707|FG002|Active Treatment Phase (24 Months)|Noncompliance|0|||
28158377|NCT02660034|54828137|FG012|Overall Study|Lost to Follow-up|0|||
28158378|NCT02660034|54828138|FG013|Overall Study|Lost to Follow-up|0|||
28158379|NCT02660034|54828125|FG000|Overall Study|Participant moved into special access scheme|1|||
28158380|NCT02660034|54828126|FG001|Overall Study|Participant moved into special access scheme|2|||
28158381|NCT02660034|54828127|FG002|Overall Study|Participant moved into special access scheme|0|||
28158382|NCT02660034|54828128|FG003|Overall Study|Participant moved into special access scheme|0|||
28158383|NCT02660034|54828129|FG004|Overall Study|Participant moved into special access scheme|0|||
28158384|NCT02660034|54828130|FG005|Overall Study|Participant moved into special access scheme|0|||
28158385|NCT02660034|54828131|FG006|Overall Study|Participant moved into special access scheme|0|||
28158386|NCT02660034|54828132|FG007|Overall Study|Participant moved into special access scheme|0|||
28158387|NCT02660034|54828133|FG008|Overall Study|Participant moved into special access scheme|0|||
28158388|NCT02660034|54828134|FG009|Overall Study|Participant moved into special access scheme|0|||
28158389|NCT02660034|54828135|FG010|Overall Study|Participant moved into special access scheme|0|||
28158390|NCT02660034|54828136|FG011|Overall Study|Participant moved into special access scheme|0|||
28158391|NCT02660034|54828137|FG012|Overall Study|Participant moved into special access scheme|0|||
28158392|NCT02660034|54828138|FG013|Overall Study|Participant moved into special access scheme|0|||
28158393|NCT02660034|54828125|FG000|Overall Study|Adverse Event|1|||
28158394|NCT02660034|54828126|FG001|Overall Study|Adverse Event|0|||
28158395|NCT02660034|54828127|FG002|Overall Study|Adverse Event|0|||
28158396|NCT02660034|54828128|FG003|Overall Study|Adverse Event|0|||
28158397|NCT02660034|54828129|FG004|Overall Study|Adverse Event|0|||
28158398|NCT02660034|54828130|FG005|Overall Study|Adverse Event|0|||
28158399|NCT02660034|54828131|FG006|Overall Study|Adverse Event|0|||
28158400|NCT02660034|54828132|FG007|Overall Study|Adverse Event|0|||
28158401|NCT02660034|54828133|FG008|Overall Study|Adverse Event|0|||
28158402|NCT02660034|54828134|FG009|Overall Study|Adverse Event|0|||
28158403|NCT02660034|54828135|FG010|Overall Study|Adverse Event|0|||
28158404|NCT02660034|54828136|FG011|Overall Study|Adverse Event|0|||
28158405|NCT02660034|54828137|FG012|Overall Study|Adverse Event|0|||
28158406|NCT02660034|54828138|FG013|Overall Study|Adverse Event|0|||
28158407|NCT02660034|54828125|FG000|Overall Study|Sponsor Decision|0|||
28158408|NCT02660034|54828126|FG001|Overall Study|Sponsor Decision|1|||
28158409|NCT02660034|54828127|FG002|Overall Study|Sponsor Decision|2|||
27825341|NCT01707992|54290708|FG003|Active Treatment Phase (24 Months)|Noncompliance|0|||
27825342|NCT01707992|54290709|FG004|Active Treatment Phase (24 Months)|Noncompliance|4|||
27825343|NCT01707992|54290710|FG005|Active Treatment Phase (24 Months)|Noncompliance|2|||
27825344|NCT01707992|54290705|FG000|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
27825345|NCT01707992|54290706|FG001|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
27825346|NCT01707992|54290707|FG002|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
27825347|NCT01707992|54290708|FG003|Active Treatment Phase (24 Months)|Study terminated by sponsor|809|||
27825348|NCT01707992|54290709|FG004|Active Treatment Phase (24 Months)|Study terminated by sponsor|243|||
28158410|NCT02660034|54828128|FG003|Overall Study|Sponsor Decision|2|||
28158411|NCT02660034|54828129|FG004|Overall Study|Sponsor Decision|3|||
28158412|NCT02660034|54828130|FG005|Overall Study|Sponsor Decision|0|||
28158413|NCT02660034|54828131|FG006|Overall Study|Sponsor Decision|0|||
28158414|NCT02660034|54828132|FG007|Overall Study|Sponsor Decision|0|||
28158415|NCT02660034|54828133|FG008|Overall Study|Sponsor Decision|0|||
28158416|NCT02660034|54828134|FG009|Overall Study|Sponsor Decision|0|||
28158417|NCT02660034|54828135|FG010|Overall Study|Sponsor Decision|0|||
28158418|NCT02660034|54828136|FG011|Overall Study|Sponsor Decision|0|||
28158419|NCT02660034|54828137|FG012|Overall Study|Sponsor Decision|0|||
28158420|NCT02660034|54828138|FG013|Overall Study|Sponsor Decision|1|||
28158421|NCT02660034|54828125|FG000|Overall Study|Withdrawal by Subject|0|||
28158422|NCT02660034|54828126|FG001|Overall Study|Withdrawal by Subject|0|||
28158423|NCT02660034|54828127|FG002|Overall Study|Withdrawal by Subject|0|||
28158424|NCT02660034|54828128|FG003|Overall Study|Withdrawal by Subject|0|||
28158425|NCT02660034|54828129|FG004|Overall Study|Withdrawal by Subject|0|||
28158426|NCT02660034|54828130|FG005|Overall Study|Withdrawal by Subject|0|||
28158427|NCT02660034|54828131|FG006|Overall Study|Withdrawal by Subject|1|||
28158428|NCT02660034|54828132|FG007|Overall Study|Withdrawal by Subject|1|||
28158429|NCT02660034|54828133|FG008|Overall Study|Withdrawal by Subject|1|||
28158430|NCT02660034|54828134|FG009|Overall Study|Withdrawal by Subject|0|||
28158431|NCT02660034|54828135|FG010|Overall Study|Withdrawal by Subject|0|||
28158432|NCT02660034|54828136|FG011|Overall Study|Withdrawal by Subject|1|||
28158433|NCT02660034|54828137|FG012|Overall Study|Withdrawal by Subject|2|||
28158434|NCT02660034|54828138|FG013|Overall Study|Withdrawal by Subject|0|||
28158435|NCT02660034|54828125|FG000|Overall Study|Death|0|||
28158436|NCT02660034|54828126|FG001|Overall Study|Death|0|||
28158437|NCT02660034|54828127|FG002|Overall Study|Death|0|||
28158438|NCT02660034|54828128|FG003|Overall Study|Death|0|||
28158439|NCT02660034|54828129|FG004|Overall Study|Death|0|||
28158440|NCT02660034|54828130|FG005|Overall Study|Death|13|||
28158441|NCT02660034|54828131|FG006|Overall Study|Death|14|||
28158442|NCT02660034|54828132|FG007|Overall Study|Death|10|||
28158443|NCT02660034|54828133|FG008|Overall Study|Death|9|||
28158444|NCT02660034|54828134|FG009|Overall Study|Death|21|||
28158445|NCT02660034|54828135|FG010|Overall Study|Death|17|||
28158446|NCT02660034|54828136|FG011|Overall Study|Death|15|||
28158447|NCT02660034|54828137|FG012|Overall Study|Death|18|||
28158448|NCT02660034|54828138|FG013|Overall Study|Death|7|||
28158449|NCT02660034|54828125|FG000|Overall Study|Physician Decision|0|||
28158450|NCT02660034|54828126|FG001|Overall Study|Physician Decision|0|||
28158451|NCT02660034|54828127|FG002|Overall Study|Physician Decision|0|||
28158452|NCT02660034|54828128|FG003|Overall Study|Physician Decision|0|||
28158453|NCT02660034|54828129|FG004|Overall Study|Physician Decision|0|||
28158454|NCT02660034|54828130|FG005|Overall Study|Physician Decision|0|||
28158455|NCT02660034|54828131|FG006|Overall Study|Physician Decision|0|||
28158456|NCT02660034|54828132|FG007|Overall Study|Physician Decision|0|||
28158457|NCT02660034|54828133|FG008|Overall Study|Physician Decision|0|||
28158458|NCT02660034|54828134|FG009|Overall Study|Physician Decision|0|||
28158459|NCT02660034|54828135|FG010|Overall Study|Physician Decision|0|||
28158460|NCT02660034|54828136|FG011|Overall Study|Physician Decision|0|||
28158461|NCT02660034|54828137|FG012|Overall Study|Physician Decision|0|||
28158462|NCT02660034|54828138|FG013|Overall Study|Physician Decision|1|||
28158463|NCT02660034|54828125|FG000|Overall Study|Participants transferred to LTE|0|||
28158464|NCT02660034|54828126|FG001|Overall Study|Participants transferred to LTE|0|||
28158465|NCT02660034|54828127|FG002|Overall Study|Participants transferred to LTE|0|||
28158466|NCT02660034|54828128|FG003|Overall Study|Participants transferred to LTE|0|||
28158467|NCT02660034|54828129|FG004|Overall Study|Participants transferred to LTE|0|||
28158468|NCT02660034|54828130|FG005|Overall Study|Participants transferred to LTE|10|||
28158469|NCT02660034|54828131|FG006|Overall Study|Participants transferred to LTE|8|||
28158470|NCT02660034|54828132|FG007|Overall Study|Participants transferred to LTE|8|||
28158471|NCT02660034|54828133|FG008|Overall Study|Participants transferred to LTE|10|||
28158472|NCT02660034|54828134|FG009|Overall Study|Participants transferred to LTE|1|||
28158473|NCT02660034|54828135|FG010|Overall Study|Participants transferred to LTE|2|||
28158474|NCT02660034|54828136|FG011|Overall Study|Participants transferred to LTE|4|||
28158475|NCT02660034|54828137|FG012|Overall Study|Participants transferred to LTE|1|||
28158476|NCT02660034|54828138|FG013|Overall Study|Participants transferred to LTE|1|||
28158477|NCT02193867|54828181|FG000|Overall Study|Death|2|||
28158478|NCT02193867|54828181|FG000|Overall Study|Sponsor Study Termination|2|||
28158479|NCT02200770|54828209|FG000|Randomized-controlled Period (RCP)|Adverse Event|0|||
28158480|NCT02200770|54828210|FG001|Randomized-controlled Period (RCP)|Adverse Event|2|||
28158481|NCT02200770|54828209|FG000|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
28158482|NCT02200770|54828210|FG001|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
28158483|NCT02200770|54828209|FG000|Randomized-controlled Period (RCP)|Participants randomized, but not treated|0|||
28158484|NCT02200770|54828210|FG001|Randomized-controlled Period (RCP)|Participants randomized, but not treated|1|||
28158485|NCT02200770|54828209|FG000|Randomized-controlled Period (RCP)|Other|1|||
28158486|NCT02200770|54828210|FG001|Randomized-controlled Period (RCP)|Other|2|||
28158487|NCT02200770|54828209|FG000|Open-label Period (OLP)|Adverse Event|1|||
28158488|NCT02200770|54828210|FG001|Open-label Period (OLP)|Adverse Event|2|||
28158489|NCT02200770|54828209|FG000|Open-label Period (OLP)|Death|1|||
28158490|NCT02200770|54828210|FG001|Open-label Period (OLP)|Death|2|||
28158491|NCT02200770|54828209|FG000|Open-label Period (OLP)|Lost to Follow-up|0|||
28158492|NCT02200770|54828210|FG001|Open-label Period (OLP)|Lost to Follow-up|1|||
28158493|NCT02200770|54828209|FG000|Open-label Period (OLP)|Withdrawal by Subject|0|||
28158494|NCT02200770|54828210|FG001|Open-label Period (OLP)|Withdrawal by Subject|14|||
28158495|NCT02200770|54828209|FG000|Open-label Period (OLP)|Other|6|||
28158496|NCT02200770|54828210|FG001|Open-label Period (OLP)|Other|15|||
28158497|NCT01186848|54828232|FG000|Overall Study|Lost to Follow-up|4|||
28158498|NCT01186848|54828232|FG000|Overall Study|Withdrawal by Subject|2|||
28158499|NCT01186848|54828232|FG000|Overall Study|Adverse Event|2|||
28158500|NCT01024608|54828240|FG000|Overall Study|Adverse Event|1|||
28158501|NCT01024608|54828241|FG001|Overall Study|Adverse Event|0|||
28158502|NCT01024608|54828240|FG000|Overall Study|Withdrawal by Subject|1|||
28158503|NCT01024608|54828241|FG001|Overall Study|Withdrawal by Subject|0|||
28158504|NCT01024608|54828240|FG000|Overall Study|Lost to Follow-up|0|||
28158505|NCT01024608|54828241|FG001|Overall Study|Lost to Follow-up|1|||
28158506|NCT01024608|54828240|FG000|Overall Study|Protocol Violation|0|||
28158507|NCT01024608|54828241|FG001|Overall Study|Protocol Violation|3|||
28158508|NCT01024608|54828240|FG000|Overall Study|Never received study treatment|2|||
28158509|NCT01024608|54828241|FG001|Overall Study|Never received study treatment|0|||
28158510|NCT00910650|54828247|FG000|Overall Study|Death|2|||
28158511|NCT03996876|54828282|FG000|Overall Study|Incomplete Data|2|||
28158512|NCT03996876|54828283|FG001|Overall Study|Incomplete Data|4|||
28158513|NCT01460160|54828290|FG000|Treatment Phase|Lack of Efficacy|3|||
28158514|NCT01460160|54828290|FG000|Treatment Phase|Study Drug Toxicity|2|||
28158515|NCT01460160|54828290|FG000|Treatment Phase|Adverse Event|8|||
28158516|NCT01460160|54828290|FG000|Treatment Phase|Withdrawal by Subject|4|||
28158517|NCT01460160|54828290|FG000|Treatment Phase|Death|2|||
28158518|NCT01460160|54828290|FG000|Treatment Phase|Other reasons|9|||
28158519|NCT01460160|54828290|FG000|Follow-up Phase|Withdrawal by Subject|4|||
28158520|NCT01460160|54828290|FG000|Follow-up Phase|Death|14|||
28158521|NCT01460160|54828290|FG000|Follow-up Phase|Lost to Follow-up|7|||
28158522|NCT01460160|54828290|FG000|Follow-up Phase|Follow-up no longer required per protocol|70|||
28158523|NCT01460160|54828290|FG000|Follow-up Phase|Other and not reported reasons|5|||
28158524|NCT01170702|54828298|FG000|Overall Study|Exclusion criteria met after consent|1|||
28158525|NCT01170702|54828299|FG001|Overall Study|Exclusion criteria met after consent|2|||
28158526|NCT01170702|54828300|FG002|Overall Study|Exclusion criteria met after consent|0|||
28158527|NCT01170702|54828301|FG003|Overall Study|Exclusion criteria met after consent|2|||
28158528|NCT02723864|54828340|FG000|Overall Study|Refused further treatment|1|||
28158529|NCT02723864|54828341|FG001|Overall Study|Refused further treatment|0|||
28158530|NCT02723864|54828342|FG002|Overall Study|Refused further treatment|0|||
28158531|NCT02723864|54828343|FG003|Overall Study|Refused further treatment|0|||
28158532|NCT02723864|54828344|FG004|Overall Study|Refused further treatment|1|||
28158533|NCT02723864|54828345|FG005|Overall Study|Refused further treatment|2|||
28158534|NCT02723864|54828346|FG006|Overall Study|Refused further treatment|0|||
28158535|NCT02723864|54828340|FG000|Overall Study|Exceed treatment hold time|0|||
28158536|NCT02723864|54828341|FG001|Overall Study|Exceed treatment hold time|1|||
28158537|NCT02723864|54828342|FG002|Overall Study|Exceed treatment hold time|0|||
28158538|NCT02723864|54828343|FG003|Overall Study|Exceed treatment hold time|0|||
28158539|NCT02723864|54828344|FG004|Overall Study|Exceed treatment hold time|0|||
28158540|NCT02723864|54828345|FG005|Overall Study|Exceed treatment hold time|0|||
28158541|NCT02723864|54828346|FG006|Overall Study|Exceed treatment hold time|0|||
28158542|NCT02723864|54828340|FG000|Overall Study|Clinical progression|0|||
28158543|NCT02723864|54828341|FG001|Overall Study|Clinical progression|0|||
28158544|NCT02723864|54828342|FG002|Overall Study|Clinical progression|1|||
28158545|NCT02723864|54828343|FG003|Overall Study|Clinical progression|0|||
28158546|NCT02723864|54828344|FG004|Overall Study|Clinical progression|0|||
27825349|NCT01707992|54290710|FG005|Active Treatment Phase (24 Months)|Study terminated by sponsor|174|||
27825350|NCT01707992|54290705|FG000|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
28158547|NCT02723864|54828345|FG005|Overall Study|Clinical progression|3|||
28158548|NCT02723864|54828346|FG006|Overall Study|Clinical progression|1|||
28158549|NCT02723864|54828340|FG000|Overall Study|Physician Decision|0|||
28158550|NCT02723864|54828341|FG001|Overall Study|Physician Decision|0|||
28158551|NCT02723864|54828342|FG002|Overall Study|Physician Decision|0|||
28158552|NCT02723864|54828343|FG003|Overall Study|Physician Decision|0|||
28158553|NCT02723864|54828344|FG004|Overall Study|Physician Decision|0|||
28158554|NCT02723864|54828345|FG005|Overall Study|Physician Decision|0|||
28158555|NCT02723864|54828346|FG006|Overall Study|Physician Decision|1|||
28158556|NCT02723864|54828340|FG000|Overall Study|Changes in patient condition|0|||
28158557|NCT02723864|54828341|FG001|Overall Study|Changes in patient condition|0|||
28158558|NCT02723864|54828342|FG002|Overall Study|Changes in patient condition|0|||
28158559|NCT02723864|54828343|FG003|Overall Study|Changes in patient condition|0|||
28158560|NCT02723864|54828344|FG004|Overall Study|Changes in patient condition|0|||
28158561|NCT02723864|54828345|FG005|Overall Study|Changes in patient condition|1|||
28158562|NCT02723864|54828346|FG006|Overall Study|Changes in patient condition|0|||
28158563|NCT02723864|54828340|FG000|Overall Study|Patient choice|0|||
28158564|NCT02723864|54828341|FG001|Overall Study|Patient choice|0|||
28158565|NCT02723864|54828342|FG002|Overall Study|Patient choice|0|||
28158566|NCT02723864|54828343|FG003|Overall Study|Patient choice|0|||
28158567|NCT02723864|54828344|FG004|Overall Study|Patient choice|0|||
28158568|NCT02723864|54828345|FG005|Overall Study|Patient choice|1|||
28158569|NCT02723864|54828346|FG006|Overall Study|Patient choice|0|||
28158570|NCT02723864|54828340|FG000|Overall Study|Adverse Event|0|||
28158571|NCT02723864|54828341|FG001|Overall Study|Adverse Event|0|||
28158572|NCT02723864|54828342|FG002|Overall Study|Adverse Event|0|||
28158573|NCT02723864|54828343|FG003|Overall Study|Adverse Event|0|||
28158574|NCT02723864|54828344|FG004|Overall Study|Adverse Event|0|||
28158575|NCT02723864|54828345|FG005|Overall Study|Adverse Event|1|||
28158576|NCT02723864|54828346|FG006|Overall Study|Adverse Event|0|||
28158577|NCT02723864|54828340|FG000|Overall Study|Started new treatment|0|||
28158578|NCT02723864|54828341|FG001|Overall Study|Started new treatment|0|||
28158579|NCT02723864|54828342|FG002|Overall Study|Started new treatment|0|||
28158580|NCT02723864|54828343|FG003|Overall Study|Started new treatment|0|||
28158581|NCT02723864|54828344|FG004|Overall Study|Started new treatment|0|||
28158582|NCT02723864|54828345|FG005|Overall Study|Started new treatment|1|||
28158583|NCT02723864|54828346|FG006|Overall Study|Started new treatment|0|||
28158584|NCT02723864|54828340|FG000|Overall Study|Switched to alternative treatment|0|||
28158585|NCT02723864|54828341|FG001|Overall Study|Switched to alternative treatment|0|||
28158586|NCT02723864|54828342|FG002|Overall Study|Switched to alternative treatment|0|||
27942345|NCT02605993|54599227|FG002|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|1|||
28158587|NCT02723864|54828343|FG003|Overall Study|Switched to alternative treatment|0|||
28158588|NCT02723864|54828344|FG004|Overall Study|Switched to alternative treatment|0|||
28158589|NCT02723864|54828345|FG005|Overall Study|Switched to alternative treatment|1|||
28075668|NCT04404010|54730227|FG000|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|1|||
28075669|NCT04404010|54730228|FG001|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|0|||
28075670|NCT04401202|54730238|FG000|Overall Study|Lost to Follow-up|2|||
28158590|NCT02723864|54828346|FG006|Overall Study|Switched to alternative treatment|0|||
28075671|NCT04401202|54730239|FG001|Overall Study|Lost to Follow-up|2|||
28075672|NCT04401202|54730238|FG000|Overall Study|Adverse Event|0|||
28075673|NCT04401202|54730239|FG001|Overall Study|Adverse Event|1|||
28075674|NCT04401202|54730238|FG000|Overall Study|Hospitalized|4|||
28075675|NCT04401202|54730239|FG001|Overall Study|Hospitalized|1|||
28075676|NCT00096356|54730248|FG000|Overall Study|Adverse Event|11|||
28075677|NCT00096356|54730249|FG001|Overall Study|Adverse Event|9|||
28075678|NCT00096356|54730248|FG000|Overall Study|Physician Decision|5|||
28075679|NCT00096356|54730249|FG001|Overall Study|Physician Decision|3|||
28158591|NCT02723864|54828340|FG000|Overall Study|Late determination of ineligibility|0|||
27825351|NCT01707992|54290706|FG001|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
28075680|NCT00096356|54730248|FG000|Overall Study|Withdrawal by Subject|17|||
28075681|NCT00096356|54730249|FG001|Overall Study|Withdrawal by Subject|23|||
28075682|NCT00096356|54730248|FG000|Overall Study|Lack of Efficacy|1|||
27825352|NCT01707992|54290707|FG002|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
27825353|NCT01707992|54290708|FG003|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
27825354|NCT01707992|54290709|FG004|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4|||
28075683|NCT00096356|54730249|FG001|Overall Study|Lack of Efficacy|0|||
28075684|NCT00096356|54730248|FG000|Overall Study|multiple reasons|10|||
28075685|NCT00096356|54730249|FG001|Overall Study|multiple reasons|18|||
28075686|NCT04358068|54730258|FG000|Overall Study|Did not initiate study treatment|2|||
28075687|NCT04358068|54730259|FG001|Overall Study|Did not initiate study treatment|2|||
28075688|NCT03694210|54730265|FG000|Overall Study|Death|1|||
28075689|NCT03694210|54730265|FG000|Overall Study|Screen Failure|7|||
28075690|NCT04339972|54730273|FG000|Overall Study|Scheduling Issues|3|||
28075691|NCT04339972|54730274|FG001|Overall Study|Scheduling Issues|3|||
28075692|NCT04339972|54730273|FG000|Overall Study|dropout|1|||
28075693|NCT04339972|54730274|FG001|Overall Study|dropout|1|||
28158592|NCT02723864|54828341|FG001|Overall Study|Late determination of ineligibility|0|||
28075694|NCT04339972|54730273|FG000|Overall Study|Technical issues|1|||
28075695|NCT04339972|54730274|FG001|Overall Study|Technical issues|0|||
28158593|NCT02723864|54828342|FG002|Overall Study|Late determination of ineligibility|0|||
27825355|NCT01707992|54290710|FG005|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
27825356|NCT01946165|54290727|FG000|Overall Study|Physician Decision|2|||
28075696|NCT04339972|54730273|FG000|Overall Study|Claustraphobia|0|||
28158594|NCT02723864|54828343|FG003|Overall Study|Late determination of ineligibility|0|||
28158595|NCT02723864|54828344|FG004|Overall Study|Late determination of ineligibility|0|||
28158596|NCT02723864|54828345|FG005|Overall Study|Late determination of ineligibility|1|||
28158597|NCT02723864|54828346|FG006|Overall Study|Late determination of ineligibility|0|||
28158598|NCT00705146|54828385|FG000|Overall Study|Lost to Follow-up|1|||
28158599|NCT00705146|54828386|FG001|Overall Study|Lost to Follow-up|1|||
28158600|NCT03203642|54828394|FG000|Overall Study|Adverse Event|3|||
28158601|NCT03203642|54828395|FG001|Overall Study|Adverse Event|1|||
28158602|NCT03203642|54828394|FG000|Overall Study|Withdrawal by Subject|6|||
28158603|NCT03203642|54828395|FG001|Overall Study|Withdrawal by Subject|6|||
28158604|NCT03203642|54828394|FG000|Overall Study|Lost to Follow-up|2|||
28158605|NCT03203642|54828395|FG001|Overall Study|Lost to Follow-up|1|||
28158606|NCT03203642|54828394|FG000|Overall Study|Termination of the study by sponsor|1|||
28158607|NCT03203642|54828395|FG001|Overall Study|Termination of the study by sponsor|1|||
28158608|NCT03203642|54828394|FG000|Overall Study|Participant moved|0|||
28158609|NCT03203642|54828395|FG001|Overall Study|Participant moved|1|||
28158610|NCT03203642|54828394|FG000|Overall Study|Investigator's decision|3|||
28158611|NCT03203642|54828395|FG001|Overall Study|Investigator's decision|0|||
28158612|NCT03203642|54828394|FG000|Overall Study|Other than above specified|0|||
28158613|NCT03203642|54828395|FG001|Overall Study|Other than above specified|1|||
28158614|NCT02737722|54828405|FG000|Overall Study|Physician Decision|0|||
28158615|NCT02737722|54828406|FG001|Overall Study|Physician Decision|0|||
28158616|NCT02737722|54828407|FG002|Overall Study|Physician Decision|1|||
28158617|NCT02737722|54828408|FG003|Overall Study|Physician Decision|0|||
28158618|NCT03792750|54828418|FG000|Overall Study|Death|3|||
28158619|NCT02750709|54828423|FG000|Treatment Period 1|Adverse Event|0|||
28158620|NCT02750709|54828424|FG001|Treatment Period 1|Adverse Event|0|||
28158621|NCT02750709|54828425|FG002|Treatment Period 1|Adverse Event|0|||
28158622|NCT02750709|54828426|FG003|Treatment Period 1|Adverse Event|0|||
28158623|NCT02750709|54828427|FG004|Treatment Period 1|Adverse Event|0|||
28158624|NCT02750709|54828428|FG005|Treatment Period 1|Adverse Event|1|||
28158625|NCT02723786|54828436|FG000|Overall Study|Lost to Follow-up|1|||
28158626|NCT02723084|54828455|FG000|Overall Study|Withdrawal by Subject|1|||
28158627|NCT02723084|54828456|FG001|Overall Study|Withdrawal by Subject|1|||
28158628|NCT02723084|54828455|FG000|Overall Study|Lost to Follow-up|3|||
28158629|NCT02723084|54828456|FG001|Overall Study|Lost to Follow-up|0|||
28158630|NCT02750943|54828464|FG000|Overall Study|Lost to Follow-up|1|||
28158631|NCT02750943|54828465|FG001|Overall Study|Lost to Follow-up|2|||
28158632|NCT02750943|54828464|FG000|Overall Study|Withdrawal by Subject|5|||
28158633|NCT02750943|54828465|FG001|Overall Study|Withdrawal by Subject|7|||
28158634|NCT04730349|54828482|FG000|Overall Study|Participant withdrew consent|1|||
28158635|NCT04730349|54828483|FG001|Overall Study|Participant withdrew consent|0|||
28158636|NCT04730349|54828482|FG000|Overall Study|Disease progression|6|||
28158637|NCT04730349|54828483|FG001|Overall Study|Disease progression|4|||
28158638|NCT04730349|54828482|FG000|Overall Study|Study drug toxicity|0|||
28158639|NCT04730349|54828483|FG001|Overall Study|Study drug toxicity|1|||
28158640|NCT04307394|54828502|FG000|Overall Study|Lost to Follow-up|3|||
28158641|NCT04307394|54828502|FG000|Overall Study|Withdrawal by Subject|2|||
28158642|NCT03940742|54828528|FG000|Overall Study|Lost to Follow-up|0|||
28158643|NCT03940742|54828529|FG001|Overall Study|Lost to Follow-up|0|||
28158644|NCT03940742|54828530|FG002|Overall Study|Lost to Follow-up|0|||
28158645|NCT03940742|54828531|FG003|Overall Study|Lost to Follow-up|1|||
28158646|NCT03917654|54828553|FG000|Year 1|Withdrawal by Subject|1|||
28158647|NCT03917654|54828554|FG001|Year 1|Withdrawal by Subject|0|||
27825357|NCT01946165|54290728|FG001|Overall Study|Physician Decision|0|||
28158648|NCT03917654|54828555|FG002|Year 1|Withdrawal by Subject|0|||
28158649|NCT03917654|54828556|FG003|Year 1|Withdrawal by Subject|0|||
28158650|NCT03917654|54828557|FG004|Year 1|Withdrawal by Subject|0|||
28158651|NCT03917654|54828558|FG005|Year 1|Withdrawal by Subject|1|||
28158652|NCT03917654|54828559|FG006|Year 1|Withdrawal by Subject|6|||
28158653|NCT03917654|54828560|FG007|Year 1|Withdrawal by Subject|2|||
28158654|NCT03917654|54828561|FG008|Year 1|Withdrawal by Subject|5|||
28158655|NCT03917654|54828562|FG009|Year 1|Withdrawal by Subject|3|||
28158656|NCT03917654|54828563|FG010|Year 1|Withdrawal by Subject|1|||
28158657|NCT03917654|54828564|FG011|Year 1|Withdrawal by Subject|0|||
28158658|NCT03917654|54828553|FG000|Year 1|Travel|0|||
28158659|NCT03917654|54828554|FG001|Year 1|Travel|1|||
28158660|NCT03917654|54828555|FG002|Year 1|Travel|1|||
28158661|NCT03917654|54828556|FG003|Year 1|Travel|0|||
28158662|NCT03917654|54828557|FG004|Year 1|Travel|4|||
28158663|NCT03917654|54828558|FG005|Year 1|Travel|4|||
28158664|NCT03917654|54828559|FG006|Year 1|Travel|10|||
28158665|NCT03917654|54828560|FG007|Year 1|Travel|8|||
28158666|NCT03917654|54828561|FG008|Year 1|Travel|2|||
28158667|NCT03917654|54828562|FG009|Year 1|Travel|5|||
28158668|NCT03917654|54828563|FG010|Year 1|Travel|3|||
28158669|NCT03917654|54828564|FG011|Year 1|Travel|3|||
28158670|NCT03917654|54828553|FG000|Year 1|Subject moved away from site|0|||
28158671|NCT03917654|54828554|FG001|Year 1|Subject moved away from site|1|||
28158672|NCT03917654|54828555|FG002|Year 1|Subject moved away from site|0|||
28158673|NCT03917654|54828556|FG003|Year 1|Subject moved away from site|0|||
27943482|NCT01147068|54600393|FG003|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
28075697|NCT04339972|54730274|FG001|Overall Study|Claustraphobia|1|||
27942346|NCT02605993|54599228|FG003|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
28158674|NCT03917654|54828557|FG004|Year 1|Subject moved away from site|0|||
27825358|NCT01946165|54290727|FG000|Overall Study|Withdrawal by Subject|0|||
27825359|NCT01946165|54290728|FG001|Overall Study|Withdrawal by Subject|2|||
27942347|NCT00995085|54599238|FG000|Overall Study|Withdrawal by Subject|5|||
27942348|NCT00603733|54599244|FG000|Active Phase ITT|Adverse Event|8|||
27825360|NCT01707667|54290737|FG000|Period 1|expulsion of colonic sensor catheter|1|||
27942349|NCT00603733|54599245|FG001|Active Phase ITT|Adverse Event|7|||
28075698|NCT00096278|54730282|FG000|Overall Study|No follow-up data|15|||
28075699|NCT00096278|54730283|FG001|Overall Study|No follow-up data|18|||
28075700|NCT00096278|54730282|FG000|Overall Study|Patient not at risk for primary endpoint|3|||
28158675|NCT03917654|54828558|FG005|Year 1|Subject moved away from site|0|||
28158676|NCT03917654|54828559|FG006|Year 1|Subject moved away from site|1|||
27825361|NCT01707667|54290738|FG001|Period 1|expulsion of colonic sensor catheter|0|||
27825362|NCT01959503|54290746|FG000|Overall Study|Death|2|||
27825363|NCT01959503|54290747|FG001|Overall Study|Death|1|||
27825364|NCT01959503|54290746|FG000|Overall Study|Randomized but not treated|1|||
27825365|NCT01959503|54290747|FG001|Overall Study|Randomized but not treated|1|||
27825366|NCT01605799|54290755|FG000|Overall Study|Withdrawal by Subject|2|||
27825367|NCT01605799|54290756|FG001|Overall Study|Withdrawal by Subject|1|||
27825368|NCT01706575|54290762|FG000|Overall Study|Participant Withdrew Consent|4|||
27825369|NCT01706575|54290762|FG000|Overall Study|Lost to Follow-up|2|||
27825370|NCT01706575|54290762|FG000|Overall Study|Started but not Treated|6|||
27825371|NCT01959425|54290768|FG000|Overall Study|Withdrawal by Subject|5|||
27825372|NCT01959425|54290769|FG001|Overall Study|Withdrawal by Subject|4|||
27942350|NCT00603733|54599244|FG000|Active Phase ITT|Withdrawal by Subject|0|||
27942351|NCT00603733|54599245|FG001|Active Phase ITT|Withdrawal by Subject|3|||
27825373|NCT01959425|54290768|FG000|Overall Study|Lost to Follow-up|1|||
27942352|NCT00603733|54599244|FG000|Active Phase ITT|Lost to Follow-up|0|||
27942353|NCT00603733|54599245|FG001|Active Phase ITT|Lost to Follow-up|1|||
28158677|NCT03917654|54828560|FG007|Year 1|Subject moved away from site|2|||
28158678|NCT03917654|54828561|FG008|Year 1|Subject moved away from site|1|||
28158679|NCT03917654|54828562|FG009|Year 1|Subject moved away from site|0|||
28158680|NCT03917654|54828563|FG010|Year 1|Subject moved away from site|0|||
28158681|NCT03917654|54828564|FG011|Year 1|Subject moved away from site|3|||
28158682|NCT03917654|54828553|FG000|Year 1|Spouse/Family member request|0|||
28158683|NCT03917654|54828554|FG001|Year 1|Spouse/Family member request|0|||
28158684|NCT03917654|54828555|FG002|Year 1|Spouse/Family member request|1|||
28158685|NCT03917654|54828556|FG003|Year 1|Spouse/Family member request|0|||
28158686|NCT03917654|54828557|FG004|Year 1|Spouse/Family member request|1|||
28158687|NCT03917654|54828558|FG005|Year 1|Spouse/Family member request|0|||
28158688|NCT03917654|54828559|FG006|Year 1|Spouse/Family member request|0|||
28158689|NCT03917654|54828560|FG007|Year 1|Spouse/Family member request|2|||
28158690|NCT03917654|54828561|FG008|Year 1|Spouse/Family member request|0|||
28158691|NCT03917654|54828562|FG009|Year 1|Spouse/Family member request|0|||
28158692|NCT03917654|54828563|FG010|Year 1|Spouse/Family member request|0|||
28158693|NCT03917654|54828564|FG011|Year 1|Spouse/Family member request|1|||
28158694|NCT03917654|54828553|FG000|Year 1|Death|0|||
28158695|NCT03917654|54828554|FG001|Year 1|Death|0|||
28158696|NCT03917654|54828555|FG002|Year 1|Death|0|||
28158697|NCT03917654|54828556|FG003|Year 1|Death|0|||
28158698|NCT03917654|54828557|FG004|Year 1|Death|0|||
28158699|NCT03917654|54828558|FG005|Year 1|Death|0|||
28158700|NCT03917654|54828559|FG006|Year 1|Death|0|||
28158701|NCT03917654|54828560|FG007|Year 1|Death|0|||
28158702|NCT03917654|54828561|FG008|Year 1|Death|1|||
28158703|NCT03917654|54828562|FG009|Year 1|Death|1|||
28158704|NCT03917654|54828563|FG010|Year 1|Death|0|||
28158705|NCT03917654|54828564|FG011|Year 1|Death|0|||
28158706|NCT03917654|54828553|FG000|Year 1|Lost to Follow-up|0|||
28158707|NCT03917654|54828554|FG001|Year 1|Lost to Follow-up|0|||
28158708|NCT03917654|54828555|FG002|Year 1|Lost to Follow-up|0|||
28158709|NCT03917654|54828556|FG003|Year 1|Lost to Follow-up|0|||
28158710|NCT03917654|54828557|FG004|Year 1|Lost to Follow-up|0|||
28158711|NCT03917654|54828558|FG005|Year 1|Lost to Follow-up|0|||
28158712|NCT03917654|54828559|FG006|Year 1|Lost to Follow-up|2|||
28158713|NCT03917654|54828560|FG007|Year 1|Lost to Follow-up|0|||
28158714|NCT03917654|54828561|FG008|Year 1|Lost to Follow-up|0|||
28158715|NCT03917654|54828562|FG009|Year 1|Lost to Follow-up|0|||
28158716|NCT03917654|54828563|FG010|Year 1|Lost to Follow-up|0|||
28158717|NCT03917654|54828564|FG011|Year 1|Lost to Follow-up|0|||
28158718|NCT03917654|54828553|FG000|Year 1|Missed visits|0|||
28158719|NCT03917654|54828554|FG001|Year 1|Missed visits|0|||
28158720|NCT03917654|54828555|FG002|Year 1|Missed visits|0|||
28158721|NCT03917654|54828556|FG003|Year 1|Missed visits|0|||
28158722|NCT03917654|54828557|FG004|Year 1|Missed visits|0|||
28158723|NCT03917654|54828558|FG005|Year 1|Missed visits|0|||
28158724|NCT03917654|54828559|FG006|Year 1|Missed visits|0|||
28158725|NCT03917654|54828560|FG007|Year 1|Missed visits|0|||
27825374|NCT01959425|54290769|FG001|Overall Study|Lost to Follow-up|0|||
27825375|NCT01959425|54290768|FG000|Overall Study|Discontinued Subjects|6|||
27825376|NCT01959425|54290769|FG001|Overall Study|Discontinued Subjects|4|||
27825377|NCT01725529|54290778|FG000|Overall Study|Adverse Event|1|||
27942354|NCT00603733|54599244|FG000|Active Phase ITT|Did not meet inclusion/exclusion|1|||
28158726|NCT03917654|54828561|FG008|Year 1|Missed visits|0|||
28158727|NCT03917654|54828562|FG009|Year 1|Missed visits|0|||
28158728|NCT03917654|54828563|FG010|Year 1|Missed visits|1|||
28158729|NCT03917654|54828564|FG011|Year 1|Missed visits|1|||
28158730|NCT03917654|54828553|FG000|Year 1|Pregnancy|0|||
28158731|NCT03917654|54828554|FG001|Year 1|Pregnancy|0|||
28158732|NCT03917654|54828555|FG002|Year 1|Pregnancy|0|||
28158733|NCT03917654|54828556|FG003|Year 1|Pregnancy|0|||
28158734|NCT03917654|54828557|FG004|Year 1|Pregnancy|0|||
28158735|NCT03917654|54828558|FG005|Year 1|Pregnancy|0|||
28158736|NCT03917654|54828559|FG006|Year 1|Pregnancy|0|||
28158737|NCT03917654|54828560|FG007|Year 1|Pregnancy|1|||
28158738|NCT03917654|54828561|FG008|Year 1|Pregnancy|0|||
28158739|NCT03917654|54828562|FG009|Year 1|Pregnancy|1|||
28158740|NCT03917654|54828563|FG010|Year 1|Pregnancy|0|||
28158741|NCT03917654|54828564|FG011|Year 1|Pregnancy|0|||
28158742|NCT03917654|54828553|FG000|Year 2|Travel|1|||
28158743|NCT03917654|54828554|FG001|Year 2|Travel|0|||
28158744|NCT03917654|54828555|FG002|Year 2|Travel|0|||
28158745|NCT03917654|54828556|FG003|Year 2|Travel|0|||
28158746|NCT03917654|54828557|FG004|Year 2|Travel|1|||
28158747|NCT03917654|54828558|FG005|Year 2|Travel|1|||
28158748|NCT03917654|54828559|FG006|Year 2|Travel|2|||
28158749|NCT03917654|54828560|FG007|Year 2|Travel|1|||
28158750|NCT03917654|54828561|FG008|Year 2|Travel|0|||
28158751|NCT03917654|54828562|FG009|Year 2|Travel|1|||
27850332|NCT04178967|54349316|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
28158752|NCT03917654|54828563|FG010|Year 2|Travel|0|||
28158753|NCT03917654|54828564|FG011|Year 2|Travel|1|||
28158754|NCT03917654|54828553|FG000|Year 2|Married|1|||
28158755|NCT03917654|54828554|FG001|Year 2|Married|0|||
28158756|NCT03917654|54828555|FG002|Year 2|Married|0|||
28158757|NCT03917654|54828556|FG003|Year 2|Married|0|||
28158758|NCT03917654|54828557|FG004|Year 2|Married|0|||
28158759|NCT03917654|54828558|FG005|Year 2|Married|0|||
28158760|NCT03917654|54828559|FG006|Year 2|Married|1|||
28158761|NCT03917654|54828560|FG007|Year 2|Married|1|||
28158762|NCT03917654|54828561|FG008|Year 2|Married|0|||
28158763|NCT03917654|54828562|FG009|Year 2|Married|0|||
28158764|NCT03917654|54828563|FG010|Year 2|Married|0|||
28158765|NCT03917654|54828564|FG011|Year 2|Married|0|||
28158766|NCT03917654|54828553|FG000|Year 2|Subject moved away from site|1|||
28158767|NCT03917654|54828554|FG001|Year 2|Subject moved away from site|0|||
28158768|NCT03917654|54828555|FG002|Year 2|Subject moved away from site|0|||
28158769|NCT03917654|54828556|FG003|Year 2|Subject moved away from site|0|||
28158770|NCT03917654|54828557|FG004|Year 2|Subject moved away from site|1|||
28158771|NCT03917654|54828558|FG005|Year 2|Subject moved away from site|0|||
28158772|NCT03917654|54828559|FG006|Year 2|Subject moved away from site|2|||
28158773|NCT03917654|54828560|FG007|Year 2|Subject moved away from site|3|||
28158774|NCT03917654|54828561|FG008|Year 2|Subject moved away from site|0|||
28158775|NCT03917654|54828562|FG009|Year 2|Subject moved away from site|2|||
28158776|NCT03917654|54828563|FG010|Year 2|Subject moved away from site|0|||
28158777|NCT03917654|54828564|FG011|Year 2|Subject moved away from site|1|||
28158778|NCT03917654|54828553|FG000|Year 2|Year 2 Screening failure|0|||
28158779|NCT03917654|54828554|FG001|Year 2|Year 2 Screening failure|1|||
28158780|NCT03917654|54828555|FG002|Year 2|Year 2 Screening failure|0|||
28158781|NCT03917654|54828556|FG003|Year 2|Year 2 Screening failure|0|||
28158782|NCT03917654|54828557|FG004|Year 2|Year 2 Screening failure|2|||
28158783|NCT03917654|54828558|FG005|Year 2|Year 2 Screening failure|0|||
28158784|NCT03917654|54828559|FG006|Year 2|Year 2 Screening failure|4|||
28158785|NCT03917654|54828560|FG007|Year 2|Year 2 Screening failure|3|||
28158786|NCT03917654|54828561|FG008|Year 2|Year 2 Screening failure|10|||
27825378|NCT01725529|54290779|FG001|Overall Study|Adverse Event|0|||
27825379|NCT01725529|54290780|FG002|Overall Study|Adverse Event|0|||
27825380|NCT01725529|54290778|FG000|Overall Study|Lost to Follow-up|2|||
28158787|NCT03917654|54828562|FG009|Year 2|Year 2 Screening failure|2|||
28158788|NCT03917654|54828563|FG010|Year 2|Year 2 Screening failure|1|||
28158789|NCT03917654|54828564|FG011|Year 2|Year 2 Screening failure|1|||
28158790|NCT03917654|54828553|FG000|Year 2|Death|0|||
28158791|NCT03917654|54828554|FG001|Year 2|Death|0|||
27825381|NCT01725529|54290779|FG001|Overall Study|Lost to Follow-up|1|||
28158792|NCT03917654|54828555|FG002|Year 2|Death|0|||
28158793|NCT03917654|54828556|FG003|Year 2|Death|0|||
28158794|NCT03917654|54828557|FG004|Year 2|Death|0|||
28158795|NCT03917654|54828558|FG005|Year 2|Death|1|||
28158796|NCT03917654|54828559|FG006|Year 2|Death|0|||
28158797|NCT03917654|54828560|FG007|Year 2|Death|0|||
28158798|NCT03917654|54828561|FG008|Year 2|Death|1|||
28158799|NCT03917654|54828562|FG009|Year 2|Death|1|||
28158800|NCT03917654|54828563|FG010|Year 2|Death|0|||
28158801|NCT03917654|54828564|FG011|Year 2|Death|0|||
28158802|NCT03917654|54828553|FG000|Year 2|Withdrawal by Subject|0|||
28158803|NCT03917654|54828554|FG001|Year 2|Withdrawal by Subject|0|||
28158804|NCT03917654|54828555|FG002|Year 2|Withdrawal by Subject|0|||
28158805|NCT03917654|54828556|FG003|Year 2|Withdrawal by Subject|0|||
28158806|NCT03917654|54828557|FG004|Year 2|Withdrawal by Subject|0|||
28158807|NCT03917654|54828558|FG005|Year 2|Withdrawal by Subject|0|||
28158808|NCT03917654|54828559|FG006|Year 2|Withdrawal by Subject|3|||
28158809|NCT03917654|54828560|FG007|Year 2|Withdrawal by Subject|0|||
28158810|NCT03917654|54828561|FG008|Year 2|Withdrawal by Subject|2|||
28158811|NCT03917654|54828562|FG009|Year 2|Withdrawal by Subject|5|||
28158812|NCT03917654|54828563|FG010|Year 2|Withdrawal by Subject|0|||
28158813|NCT03917654|54828564|FG011|Year 2|Withdrawal by Subject|0|||
28158814|NCT03917654|54828553|FG000|Year 2|Spouse/family member request|0|||
28158815|NCT03917654|54828554|FG001|Year 2|Spouse/family member request|0|||
28158816|NCT03917654|54828555|FG002|Year 2|Spouse/family member request|0|||
28158817|NCT03917654|54828556|FG003|Year 2|Spouse/family member request|0|||
28158818|NCT03917654|54828557|FG004|Year 2|Spouse/family member request|0|||
28158819|NCT03917654|54828558|FG005|Year 2|Spouse/family member request|0|||
28158820|NCT03917654|54828559|FG006|Year 2|Spouse/family member request|1|||
28158821|NCT03917654|54828560|FG007|Year 2|Spouse/family member request|0|||
28158822|NCT03917654|54828561|FG008|Year 2|Spouse/family member request|0|||
27942355|NCT00603733|54599245|FG001|Active Phase ITT|Did not meet inclusion/exclusion|3|||
27942356|NCT00603733|54599244|FG000|Active Phase ITT|Lack of Efficacy|1|||
27825382|NCT01725529|54290780|FG002|Overall Study|Lost to Follow-up|1|||
27850333|NCT04178967|54349317|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
28158823|NCT03917654|54828562|FG009|Year 2|Spouse/family member request|0|||
28158824|NCT03917654|54828563|FG010|Year 2|Spouse/family member request|0|||
28158825|NCT03917654|54828564|FG011|Year 2|Spouse/family member request|0|||
27825383|NCT01725529|54290778|FG000|Overall Study|Protocol Violation|0|||
27942357|NCT00603733|54599245|FG001|Active Phase ITT|Lack of Efficacy|2|||
27825384|NCT01725529|54290779|FG001|Overall Study|Protocol Violation|1|||
27825385|NCT01725529|54290780|FG002|Overall Study|Protocol Violation|1|||
27825386|NCT01725529|54290778|FG000|Overall Study|Withdrawal by Subject|12|||
27825387|NCT01725529|54290779|FG001|Overall Study|Withdrawal by Subject|14|||
28075701|NCT00096278|54730283|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
27825388|NCT01725529|54290780|FG002|Overall Study|Withdrawal by Subject|8|||
27825389|NCT01605097|54290788|FG000|Overall Study|Protocol Violation|1|||
28158826|NCT03917654|54828553|FG000|Year 2|Lost to Follow-up|0|||
28158827|NCT03917654|54828554|FG001|Year 2|Lost to Follow-up|0|||
28158828|NCT03917654|54828555|FG002|Year 2|Lost to Follow-up|0|||
28158829|NCT03917654|54828556|FG003|Year 2|Lost to Follow-up|0|||
28158830|NCT03917654|54828557|FG004|Year 2|Lost to Follow-up|0|||
28158831|NCT03917654|54828558|FG005|Year 2|Lost to Follow-up|0|||
28158832|NCT03917654|54828559|FG006|Year 2|Lost to Follow-up|1|||
28158833|NCT03917654|54828560|FG007|Year 2|Lost to Follow-up|0|||
28158834|NCT03917654|54828561|FG008|Year 2|Lost to Follow-up|1|||
28158835|NCT03917654|54828562|FG009|Year 2|Lost to Follow-up|0|||
28158836|NCT03917654|54828563|FG010|Year 2|Lost to Follow-up|0|||
28158837|NCT03917654|54828564|FG011|Year 2|Lost to Follow-up|1|||
28158838|NCT03917654|54828553|FG000|Year 2|Adverse Event|0|||
28158839|NCT03917654|54828554|FG001|Year 2|Adverse Event|0|||
28158840|NCT03917654|54828555|FG002|Year 2|Adverse Event|0|||
28158841|NCT03917654|54828556|FG003|Year 2|Adverse Event|0|||
28158842|NCT03917654|54828557|FG004|Year 2|Adverse Event|0|||
28158843|NCT03917654|54828558|FG005|Year 2|Adverse Event|0|||
28158844|NCT03917654|54828559|FG006|Year 2|Adverse Event|0|||
28158845|NCT03917654|54828560|FG007|Year 2|Adverse Event|0|||
28158846|NCT03917654|54828561|FG008|Year 2|Adverse Event|0|||
27825390|NCT01605019|54290795|FG000|Overall Study|pt did not meet transplant endpoint|3|||
27825391|NCT01605019|54290796|FG001|Overall Study|pt did not meet transplant endpoint|0|||
27825392|NCT01705717|54290804|FG000|Overall Study|Adverse Event|2|||
27825393|NCT01705717|54290805|FG001|Overall Study|Adverse Event|2|||
27942358|NCT00603733|54599244|FG000|Active Phase ITT|Subject moved, site closed|1|||
27942359|NCT00603733|54599245|FG001|Active Phase ITT|Subject moved, site closed|1|||
27942360|NCT00603733|54599244|FG000|Run-In Phase - 4 Weeks|Adverse Event|2|||
27942361|NCT00603733|54599245|FG001|Run-In Phase - 4 Weeks|Adverse Event|1|||
27942362|NCT00603733|54599244|FG000|Run-In Phase - 4 Weeks|Withdrawal by Subject|4|||
28158847|NCT03917654|54828562|FG009|Year 2|Adverse Event|1|||
27942363|NCT00603733|54599245|FG001|Run-In Phase - 4 Weeks|Withdrawal by Subject|1|||
27942364|NCT00603733|54599244|FG000|Run-In Phase - 4 Weeks|Lost to Follow-up|1|||
27942365|NCT00603733|54599245|FG001|Run-In Phase - 4 Weeks|Lost to Follow-up|0|||
28075702|NCT00095940|54730298|FG000|Lapatinib Continuation/Phase II|Disease Progression|1|||
28075703|NCT00095940|54730299|FG001|Lapatinib Continuation/Phase II|Disease Progression|1|||
28075704|NCT00095940|54730300|FG002|Lapatinib Continuation/Phase II|Disease Progression|15|||
27942366|NCT00603733|54599244|FG000|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5|||
28075705|NCT00095940|54730301|FG003|Lapatinib Continuation/Phase II|Disease Progression|0|||
28075706|NCT00095940|54730302|FG004|Lapatinib Continuation/Phase II|Disease Progression|0|||
28075707|NCT00095940|54730303|FG005|Lapatinib Continuation/Phase II|Disease Progression|13|||
28075708|NCT00095940|54730304|FG006|Lapatinib Continuation/Phase II|Disease Progression|2|||
28075709|NCT00095940|54730305|FG007|Lapatinib Continuation/Phase II|Disease Progression|1|||
28075710|NCT00095940|54730306|FG008|Lapatinib Continuation/Phase II|Disease Progression|12|||
28158848|NCT03917654|54828563|FG010|Year 2|Adverse Event|0|||
28158849|NCT03917654|54828564|FG011|Year 2|Adverse Event|0|||
28158850|NCT03060577|54828610|FG000|Overall Study|Withdrawal by Subject|25|||
28158851|NCT03060577|54828611|FG001|Overall Study|Withdrawal by Subject|5|||
27825394|NCT01705717|54290804|FG000|Overall Study|Lack of Efficacy|0|||
28158852|NCT03060577|54828610|FG000|Overall Study|Physician Decision|4|||
28158853|NCT03060577|54828611|FG001|Overall Study|Physician Decision|3|||
28158854|NCT03060577|54828610|FG000|Overall Study|Lost to Follow-up|3|||
28158855|NCT03060577|54828611|FG001|Overall Study|Lost to Follow-up|0|||
28158856|NCT03060577|54828610|FG000|Overall Study|Death|7|||
28158857|NCT03060577|54828611|FG001|Overall Study|Death|1|||
28158858|NCT03060577|54828610|FG000|Overall Study|Adverse Event|9|||
28158859|NCT03060577|54828611|FG001|Overall Study|Adverse Event|1|||
28158860|NCT03060577|54828610|FG000|Overall Study|Inclusion/Exclusion|1|||
28158861|NCT03060577|54828611|FG001|Overall Study|Inclusion/Exclusion|0|||
28158862|NCT03060577|54828610|FG000|Overall Study|Other|8|||
27850334|NCT04178967|54349318|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
27850335|NCT04178967|54349319|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
27850336|NCT04178967|54349320|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
27850337|NCT04178967|54349321|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
27850338|NCT04178967|54349322|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
27850339|NCT04178967|54349323|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
27850340|NCT04178967|54349324|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
28158863|NCT03060577|54828611|FG001|Overall Study|Other|2|||
28158864|NCT02872714|54828622|FG000|Overall Study|Progressive Disease|1|||
28158865|NCT02872714|54828623|FG001|Overall Study|Progressive Disease|2|||
28158866|NCT02872714|54828624|FG002|Overall Study|Progressive Disease|0|||
28158867|NCT02872714|54828625|FG003|Overall Study|Progressive Disease|0|||
28158868|NCT02872714|54828626|FG004|Overall Study|Progressive Disease|0|||
28158869|NCT02872714|54828622|FG000|Overall Study|Death|87|||
28158870|NCT02872714|54828623|FG001|Overall Study|Death|36|||
28158871|NCT02872714|54828624|FG002|Overall Study|Death|8|||
28158872|NCT02872714|54828625|FG003|Overall Study|Death|81|||
28158873|NCT02872714|54828626|FG004|Overall Study|Death|2|||
28158874|NCT02872714|54828622|FG000|Overall Study|Lost to Follow-up|2|||
28158875|NCT02872714|54828623|FG001|Overall Study|Lost to Follow-up|1|||
28158876|NCT02872714|54828624|FG002|Overall Study|Lost to Follow-up|0|||
28158877|NCT02872714|54828625|FG003|Overall Study|Lost to Follow-up|3|||
28158878|NCT02872714|54828626|FG004|Overall Study|Lost to Follow-up|0|||
28158879|NCT02872714|54828622|FG000|Overall Study|Physician Decision|0|||
28158880|NCT02872714|54828623|FG001|Overall Study|Physician Decision|0|||
28158881|NCT02872714|54828624|FG002|Overall Study|Physician Decision|0|||
28158882|NCT02872714|54828625|FG003|Overall Study|Physician Decision|1|||
28158883|NCT02872714|54828626|FG004|Overall Study|Physician Decision|0|||
28158884|NCT02872714|54828622|FG000|Overall Study|Withdrawal by Subject|1|||
28158885|NCT02872714|54828623|FG001|Overall Study|Withdrawal by Subject|3|||
28158886|NCT02872714|54828624|FG002|Overall Study|Withdrawal by Subject|0|||
28158887|NCT02872714|54828625|FG003|Overall Study|Withdrawal by Subject|2|||
27850341|NCT04178967|54349325|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
27850342|NCT04178967|54349315|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
27850343|NCT04178967|54349316|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
27850344|NCT04178967|54349317|FG002|Maintenance Blinded Treatment Period|Physician Decision|0|||
27850345|NCT04178967|54349318|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
27825395|NCT01705717|54290805|FG001|Overall Study|Lack of Efficacy|1|||
27825396|NCT01705717|54290804|FG000|Overall Study|Other|0|||
28158888|NCT02872714|54828626|FG004|Overall Study|Withdrawal by Subject|0|||
27825397|NCT01705717|54290805|FG001|Overall Study|Other|2|||
27825398|NCT01744483|54290813|FG000|Overall Study|Death|9|||
28158889|NCT02872714|54828622|FG000|Overall Study|Captured as Other|2|||
27850346|NCT04178967|54349319|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
27850347|NCT04178967|54349320|FG005|Maintenance Blinded Treatment Period|Physician Decision|0|||
27850348|NCT04178967|54349321|FG006|Maintenance Blinded Treatment Period|Physician Decision|1|||
27850349|NCT04178967|54349322|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
27850350|NCT04178967|54349323|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
27850351|NCT04178967|54349324|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
27850352|NCT04178967|54349325|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
27850353|NCT04178967|54349315|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
27850354|NCT04178967|54349316|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
27850355|NCT04178967|54349317|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
27850356|NCT04178967|54349318|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
27850357|NCT04178967|54349319|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
27850358|NCT04178967|54349320|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
27850359|NCT04178967|54349321|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
27850360|NCT04178967|54349322|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|4|||
28158890|NCT02872714|54828623|FG001|Overall Study|Captured as Other|0|||
28158891|NCT02872714|54828624|FG002|Overall Study|Captured as Other|0|||
28158892|NCT02872714|54828625|FG003|Overall Study|Captured as Other|1|||
28158893|NCT02872714|54828626|FG004|Overall Study|Captured as Other|0|||
28075711|NCT00095940|54730298|FG000|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
28075712|NCT00095940|54730299|FG001|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
28075713|NCT00095940|54730300|FG002|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
28075714|NCT00095940|54730301|FG003|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
28075715|NCT00095940|54730302|FG004|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
28075716|NCT00095940|54730303|FG005|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
28075717|NCT00095940|54730304|FG006|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
28075718|NCT00095940|54730305|FG007|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
28075719|NCT00095940|54730306|FG008|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
28075720|NCT00095940|54730298|FG000|Lapatinib Continuation/Phase II|Adverse Event|0|||
28075721|NCT00095940|54730299|FG001|Lapatinib Continuation/Phase II|Adverse Event|0|||
28075722|NCT00095940|54730300|FG002|Lapatinib Continuation/Phase II|Adverse Event|0|||
28075723|NCT00095940|54730301|FG003|Lapatinib Continuation/Phase II|Adverse Event|0|||
28075724|NCT00095940|54730302|FG004|Lapatinib Continuation/Phase II|Adverse Event|0|||
28075725|NCT00095940|54730303|FG005|Lapatinib Continuation/Phase II|Adverse Event|0|||
28075726|NCT00095940|54730304|FG006|Lapatinib Continuation/Phase II|Adverse Event|0|||
28075727|NCT00095940|54730305|FG007|Lapatinib Continuation/Phase II|Adverse Event|1|||
28075728|NCT00095940|54730306|FG008|Lapatinib Continuation/Phase II|Adverse Event|0|||
28075729|NCT00114218|54730324|FG000|Overall Study|Wrong Cell Type|2|||
28075730|NCT00114218|54730324|FG000|Overall Study|Wrong Primary|1|||
27825399|NCT01744483|54290814|FG001|Overall Study|Death|4|||
27825400|NCT01744483|54290815|FG002|Overall Study|Death|11|||
27825401|NCT01744483|54290813|FG000|Overall Study|Lost to Follow-up|8|||
27825402|NCT01744483|54290814|FG001|Overall Study|Lost to Follow-up|9|||
27825403|NCT01744483|54290815|FG002|Overall Study|Lost to Follow-up|11|||
27825404|NCT01744483|54290813|FG000|Overall Study|Protocol Violation|1|||
27825405|NCT01744483|54290814|FG001|Overall Study|Protocol Violation|2|||
27850361|NCT04178967|54349323|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
27850362|NCT04178967|54349324|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
28075731|NCT00114218|54730324|FG000|Overall Study|Never Treated|1|||
28075732|NCT00095628|54730328|FG000|Overall Study|Disease progression prior to treatment|1|||
28075733|NCT04380142|54730334|FG000|LD/CD Stabilization Period|Adverse Event|3|||
28075734|NCT04380142|54730335|FG001|LD/CD Stabilization Period|Adverse Event|0|||
28075735|NCT04380142|54730336|FG002|LD/CD Stabilization Period|Adverse Event|0|||
28075736|NCT04380142|54730334|FG000|LD/CD Stabilization Period|Withdrawal by Subject|4|||
28075737|NCT04380142|54730335|FG001|LD/CD Stabilization Period|Withdrawal by Subject|0|||
28075738|NCT04380142|54730336|FG002|LD/CD Stabilization Period|Withdrawal by Subject|0|||
28075739|NCT04380142|54730334|FG000|LD/CD Stabilization Period|Lost to Follow-up|1|||
28075740|NCT04380142|54730335|FG001|LD/CD Stabilization Period|Lost to Follow-up|0|||
28075741|NCT04380142|54730336|FG002|LD/CD Stabilization Period|Lost to Follow-up|0|||
28075742|NCT04380142|54730334|FG000|LD/CD Stabilization Period|Lack of Efficacy|1|||
28075743|NCT04380142|54730335|FG001|LD/CD Stabilization Period|Lack of Efficacy|0|||
28075744|NCT04380142|54730336|FG002|LD/CD Stabilization Period|Lack of Efficacy|0|||
28075745|NCT04380142|54730334|FG000|LD/CD Stabilization Period|Difficulty With Drug Delivery System|2|||
28075746|NCT04380142|54730335|FG001|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
28075747|NCT04380142|54730336|FG002|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
28075748|NCT04380142|54730334|FG000|LD/CD Stabilization Period|Other, Not Specified|18|||
28075749|NCT04380142|54730335|FG001|LD/CD Stabilization Period|Other, Not Specified|0|||
28075750|NCT04380142|54730336|FG002|LD/CD Stabilization Period|Other, Not Specified|0|||
28075751|NCT04380142|54730334|FG000|Double-Blind Treatment Period|Adverse Event|0|||
28075752|NCT04380142|54730335|FG001|Double-Blind Treatment Period|Adverse Event|1|||
28075753|NCT04380142|54730336|FG002|Double-Blind Treatment Period|Adverse Event|14|||
28075754|NCT04380142|54730334|FG000|Double-Blind Treatment Period|Withdrew Consent|0|||
28075755|NCT04380142|54730335|FG001|Double-Blind Treatment Period|Withdrew Consent|3|||
28075756|NCT04380142|54730336|FG002|Double-Blind Treatment Period|Withdrew Consent|6|||
28075757|NCT04380142|54730334|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
28075758|NCT04380142|54730335|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
28075759|NCT04380142|54730336|FG002|Double-Blind Treatment Period|Lack of Efficacy|2|||
28075760|NCT04380142|54730334|FG000|Double-Blind Treatment Period|Difficulty With Drug Delivery System|0|||
28075761|NCT04380142|54730335|FG001|Double-Blind Treatment Period|Difficulty With Drug Delivery System|1|||
28075762|NCT04380142|54730336|FG002|Double-Blind Treatment Period|Difficulty With Drug Delivery System|3|||
28075763|NCT04380142|54730334|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
28075764|NCT04380142|54730335|FG001|Double-Blind Treatment Period|Other, Not Specified|0|||
28075765|NCT04380142|54730336|FG002|Double-Blind Treatment Period|Other, Not Specified|1|||
28075766|NCT04380142|54730334|FG000|Double-Blind Treatment Period|Did Not Receive Study Drug|0|||
28075767|NCT04380142|54730335|FG001|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
28075768|NCT04380142|54730336|FG002|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
28075769|NCT04335136|54730346|FG000|Overall Study|Death|8|||
28075770|NCT04335136|54730347|FG001|Overall Study|Death|4|||
28075771|NCT04335136|54730346|FG000|Overall Study|Lost to Follow-up|2|||
28075772|NCT04335136|54730347|FG001|Overall Study|Lost to Follow-up|0|||
28075773|NCT04335136|54730346|FG000|Overall Study|Protocol Violation|1|||
28075774|NCT04335136|54730347|FG001|Overall Study|Protocol Violation|0|||
28075775|NCT04335136|54730346|FG000|Overall Study|Withdrawal by Subject|1|||
28075776|NCT04335136|54730347|FG001|Overall Study|Withdrawal by Subject|1|||
28075777|NCT04335136|54730346|FG000|Overall Study|Health-threatening condition|0|||
28075778|NCT04335136|54730347|FG001|Overall Study|Health-threatening condition|1|||
28075779|NCT04335136|54730346|FG000|Overall Study|Adverse Event|0|||
28075780|NCT04335136|54730347|FG001|Overall Study|Adverse Event|1|||
28075781|NCT04335136|54730346|FG000|Overall Study|Erroneously randomized|2|||
28075782|NCT04335136|54730347|FG001|Overall Study|Erroneously randomized|0|||
28075783|NCT04171414|54730353|FG000|Overall Study|Death|1|||
28075784|NCT04171414|54730353|FG000|Overall Study|Withdrawal by Subject|1|||
28075785|NCT04167670|54730360|FG000|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|1|||
28075786|NCT04167670|54730361|FG001|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|7|||
28075787|NCT04167670|54730362|FG002|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|4|||
28075788|NCT04167670|54730360|FG000|Overall Study|Significant protocol deviation|3|||
28075789|NCT04167670|54730361|FG001|Overall Study|Significant protocol deviation|1|||
28075790|NCT04167670|54730362|FG002|Overall Study|Significant protocol deviation|0|||
28075791|NCT04167670|54730360|FG000|Overall Study|Lost to Follow-up|0|||
28075792|NCT04167670|54730361|FG001|Overall Study|Lost to Follow-up|3|||
28075793|NCT04167670|54730362|FG002|Overall Study|Lost to Follow-up|3|||
28075794|NCT04167670|54730360|FG000|Overall Study|Voluntary Withdrawal|0|||
28075795|NCT04167670|54730361|FG001|Overall Study|Voluntary Withdrawal|1|||
27942367|NCT00603733|54599245|FG001|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10|||
27942368|NCT00603733|54599244|FG000|Run-In Phase - 4 Weeks|Lack of Efficacy|2|||
27942369|NCT00603733|54599245|FG001|Run-In Phase - 4 Weeks|Lack of Efficacy|1|||
27942370|NCT00603733|54599244|FG000|Maintenance Phase ITT|Adverse Event|3|||
27942371|NCT00603733|54599245|FG001|Maintenance Phase ITT|Adverse Event|6|||
27942372|NCT00603733|54599244|FG000|Maintenance Phase ITT|Withdrawal by Subject|1|||
28075796|NCT04167670|54730362|FG002|Overall Study|Voluntary Withdrawal|1|||
28075797|NCT04167670|54730360|FG000|Overall Study|Withdrawal of Consent|4|||
28075798|NCT04167670|54730361|FG001|Overall Study|Withdrawal of Consent|1|||
28075799|NCT04167670|54730362|FG002|Overall Study|Withdrawal of Consent|3|||
28075800|NCT04167670|54730360|FG000|Overall Study|Miscellaneous|7|||
28075801|NCT04167670|54730361|FG001|Overall Study|Miscellaneous|5|||
28075802|NCT04167670|54730362|FG002|Overall Study|Miscellaneous|3|||
27825406|NCT01744483|54290815|FG002|Overall Study|Protocol Violation|1|||
27942373|NCT00603733|54599245|FG001|Maintenance Phase ITT|Withdrawal by Subject|0|||
28075803|NCT00113516|54730370|FG000|Part 1|Adverse Event|6|||
27850363|NCT04178967|54349325|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
28075804|NCT00113516|54730371|FG001|Part 1|Adverse Event|0|||
28075805|NCT00113516|54730370|FG000|Part 1|Death|3|||
28075806|NCT00113516|54730371|FG001|Part 1|Death|0|||
28075807|NCT00113516|54730370|FG000|Part 1|Other|3|||
28075808|NCT00113516|54730371|FG001|Part 1|Other|0|||
28075809|NCT00113516|54730370|FG000|Part 1|Withdrawal by Subject|2|||
28075810|NCT00113516|54730371|FG001|Part 1|Withdrawal by Subject|0|||
28075811|NCT00113516|54730370|FG000|Part 1|Lack of Efficacy|2|||
28075812|NCT00113516|54730371|FG001|Part 1|Lack of Efficacy|0|||
28075813|NCT00113516|54730370|FG000|Part 1|Did Not Meet Entrance Criteria|1|||
28075814|NCT00113516|54730371|FG001|Part 1|Did Not Meet Entrance Criteria|0|||
28075815|NCT00113516|54730370|FG000|Part 1|Laboratory Abnormality|1|||
28075816|NCT00113516|54730371|FG001|Part 1|Laboratory Abnormality|0|||
28075817|NCT00113516|54730370|FG000|Part 1|Ongoing|1|||
28075818|NCT00113516|54730371|FG001|Part 1|Ongoing|0|||
28075819|NCT00113516|54730370|FG000|Part 1|Missing|65|||
28075820|NCT00113516|54730371|FG001|Part 1|Missing|0|||
28075821|NCT00113516|54730370|FG000|Part 2|Adverse Event|0|||
28075822|NCT00113516|54730371|FG001|Part 2|Adverse Event|16|||
28075823|NCT00113516|54730370|FG000|Part 2|Death|0|||
28075824|NCT00113516|54730371|FG001|Part 2|Death|5|||
28075825|NCT00113516|54730370|FG000|Part 2|Lack of Efficacy|0|||
28075826|NCT00113516|54730371|FG001|Part 2|Lack of Efficacy|37|||
28075827|NCT00113516|54730370|FG000|Part 2|Withdrawal by Subject|0|||
28075828|NCT00113516|54730371|FG001|Part 2|Withdrawal by Subject|3|||
28158894|NCT02787005|54828646|FG000|Overall Study|Adverse Event|24|||
28158895|NCT02787005|54828647|FG001|Overall Study|Adverse Event|9|||
28158896|NCT02787005|54828648|FG002|Overall Study|Adverse Event|9|||
28075829|NCT00113516|54730370|FG000|Part 2|Other|0|||
28075830|NCT00113516|54730371|FG001|Part 2|Other|3|||
28075831|NCT00113516|54730370|FG000|Part 2|Laboratory Abnormality|0|||
28075832|NCT00113516|54730371|FG001|Part 2|Laboratory Abnormality|1|||
28075833|NCT00113516|54730370|FG000|Part 2|Ongoing|0|||
27825407|NCT01744483|54290813|FG000|Overall Study|Withdrawal by Subject|4|||
28158897|NCT02787005|54828649|FG003|Overall Study|Adverse Event|7|||
28075834|NCT00113516|54730371|FG001|Part 2|Ongoing|1|||
28158898|NCT02787005|54828650|FG004|Overall Study|Adverse Event|2|||
28158899|NCT02787005|54828646|FG000|Overall Study|Death|100|||
28158900|NCT02787005|54828647|FG001|Overall Study|Death|53|||
28158901|NCT02787005|54828648|FG002|Overall Study|Death|48|||
28158902|NCT02787005|54828649|FG003|Overall Study|Death|69|||
28158903|NCT02787005|54828650|FG004|Overall Study|Death|38|||
28158904|NCT02787005|54828646|FG000|Overall Study|Sponsor Decision|7|||
28158905|NCT02787005|54828647|FG001|Overall Study|Sponsor Decision|4|||
28158906|NCT02787005|54828648|FG002|Overall Study|Sponsor Decision|0|||
28158907|NCT02787005|54828649|FG003|Overall Study|Sponsor Decision|4|||
28158908|NCT02787005|54828650|FG004|Overall Study|Sponsor Decision|5|||
28158909|NCT02787005|54828646|FG000|Overall Study|Withdrawal by Subject|2|||
28158910|NCT02787005|54828647|FG001|Overall Study|Withdrawal by Subject|1|||
28158911|NCT02787005|54828648|FG002|Overall Study|Withdrawal by Subject|1|||
28158912|NCT02787005|54828649|FG003|Overall Study|Withdrawal by Subject|0|||
28158913|NCT02787005|54828650|FG004|Overall Study|Withdrawal by Subject|1|||
28158914|NCT02787005|54828646|FG000|Overall Study|Screen Failure|0|||
28158915|NCT02787005|54828647|FG001|Overall Study|Screen Failure|2|||
28158916|NCT02787005|54828648|FG002|Overall Study|Screen Failure|0|||
28158917|NCT02787005|54828649|FG003|Overall Study|Screen Failure|0|||
28158918|NCT02787005|54828650|FG004|Overall Study|Screen Failure|1|||
28158919|NCT02787005|54828646|FG000|Overall Study|Lost to Follow-up|0|||
28158920|NCT02787005|54828647|FG001|Overall Study|Lost to Follow-up|0|||
28158921|NCT02787005|54828648|FG002|Overall Study|Lost to Follow-up|0|||
28158922|NCT02787005|54828649|FG003|Overall Study|Lost to Follow-up|1|||
28158923|NCT02787005|54828650|FG004|Overall Study|Lost to Follow-up|0|||
28158924|NCT02601313|54828684|FG000|Overall Study|Death|2|||
28158925|NCT02601313|54828685|FG001|Overall Study|Death|16|||
28158926|NCT02601313|54828686|FG002|Overall Study|Death|4|||
28158927|NCT02601313|54828684|FG000|Overall Study|Enrolled, did not initiate CTE/KTE-X19|0|||
28158928|NCT02601313|54828685|FG001|Overall Study|Enrolled, did not initiate CTE/KTE-X19|5|||
28158929|NCT02601313|54828686|FG002|Overall Study|Enrolled, did not initiate CTE/KTE-X19|2|||
28158930|NCT02601313|54828684|FG000|Overall Study|Enrolled, did not initiate KTE-X19|0|||
28158931|NCT02601313|54828685|FG001|Overall Study|Enrolled, did not initiate KTE-X19|1|||
28158932|NCT02601313|54828686|FG002|Overall Study|Enrolled, did not initiate KTE-X19|1|||
27825408|NCT01744483|54290814|FG001|Overall Study|Withdrawal by Subject|6|||
27825409|NCT01744483|54290815|FG002|Overall Study|Withdrawal by Subject|2|||
28158933|NCT02601313|54828684|FG000|Overall Study|Still on study|0|||
28158934|NCT02601313|54828685|FG001|Overall Study|Still on study|52|||
27825410|NCT01744483|54290813|FG000|Overall Study|No ICU Admit|5|||
27942374|NCT00603733|54599244|FG000|Maintenance Phase ITT|Protocol Violation|1|||
27825411|NCT01744483|54290814|FG001|Overall Study|No ICU Admit|1|||
27825412|NCT01744483|54290815|FG002|Overall Study|No ICU Admit|2|||
27825413|NCT01744483|54290813|FG000|Overall Study|Routed to OSH|2|||
28075835|NCT04142242|54730383|FG000|Overall Study|Non-compliance with the protocol|1|||
28075836|NCT04142242|54730384|FG001|Overall Study|Non-compliance with the protocol|0|||
28075837|NCT04142242|54730385|FG002|Overall Study|Non-compliance with the protocol|0|||
28075838|NCT04142242|54730386|FG003|Overall Study|Non-compliance with the protocol|0|||
28075839|NCT04142242|54730387|FG004|Overall Study|Non-compliance with the protocol|0|||
28075840|NCT04142242|54730388|FG005|Overall Study|Non-compliance with the protocol|1|||
28075841|NCT04142242|54730383|FG000|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0|||
28075842|NCT04142242|54730384|FG001|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|1|||
28075843|NCT04142242|54730385|FG002|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0|||
28075844|NCT04142242|54730386|FG003|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0|||
28158935|NCT02601313|54828686|FG002|Overall Study|Still on study|10|||
28158936|NCT02601313|54828684|FG000|Overall Study|Enrolled, did not initiate AC|4|||
28158937|NCT02601313|54828685|FG001|Overall Study|Enrolled, did not initiate AC|0|||
28158938|NCT02601313|54828686|FG002|Overall Study|Enrolled, did not initiate AC|0|||
28158939|NCT02514083|54828694|FG000|Overall Study|Adverse Event|1|||
28158940|NCT02395848|54828698|FG000|Overall Study|Lost to Follow-up|2|||
28158941|NCT02061761|54828715|FG000|Overall Study|Disease progression|2|||
28158942|NCT02061761|54828716|FG001|Overall Study|Disease progression|8|||
28158943|NCT02061761|54828717|FG002|Overall Study|Disease progression|4|||
28158944|NCT02061761|54828718|FG003|Overall Study|Disease progression|5|||
28158945|NCT02061761|54828719|FG004|Overall Study|Disease progression|9|||
28158946|NCT02061761|54828720|FG005|Overall Study|Disease progression|3|||
28158947|NCT02061761|54828721|FG006|Overall Study|Disease progression|1|||
28158948|NCT02061761|54828722|FG007|Overall Study|Disease progression|2|||
28158949|NCT02061761|54828723|FG008|Overall Study|Disease progression|28|||
28158950|NCT02061761|54828715|FG000|Overall Study|Study Drug toxicity|0|||
28158951|NCT02061761|54828716|FG001|Overall Study|Study Drug toxicity|0|||
28158952|NCT02061761|54828717|FG002|Overall Study|Study Drug toxicity|0|||
28158953|NCT02061761|54828718|FG003|Overall Study|Study Drug toxicity|0|||
28158954|NCT02061761|54828719|FG004|Overall Study|Study Drug toxicity|0|||
28158955|NCT02061761|54828720|FG005|Overall Study|Study Drug toxicity|1|||
28158956|NCT02061761|54828721|FG006|Overall Study|Study Drug toxicity|0|||
28158957|NCT02061761|54828722|FG007|Overall Study|Study Drug toxicity|2|||
28158958|NCT02061761|54828723|FG008|Overall Study|Study Drug toxicity|6|||
27825414|NCT01744483|54290814|FG001|Overall Study|Routed to OSH|0|||
27825415|NCT01744483|54290815|FG002|Overall Study|Routed to OSH|1|||
28075845|NCT04142242|54730387|FG004|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0|||
28075846|NCT04142242|54730388|FG005|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0|||
28075847|NCT04142242|54730383|FG000|Overall Study|Ongoing|0|||
28075848|NCT04142242|54730384|FG001|Overall Study|Ongoing|0|||
28075849|NCT04142242|54730385|FG002|Overall Study|Ongoing|31|||
28075850|NCT04142242|54730386|FG003|Overall Study|Ongoing|39|||
28075851|NCT04142242|54730387|FG004|Overall Study|Ongoing|0|||
28075852|NCT04142242|54730388|FG005|Overall Study|Ongoing|0|||
28075853|NCT04140292|54730416|FG000|Overall Study|Restriction on outpatient visits due to COVID-19.|4|||
28075854|NCT04140292|54730417|FG001|Overall Study|Restriction on outpatient visits due to COVID-19.|16|||
28075855|NCT04138810|54730426|FG000|Overall Study|Withdrawal by Subject|0|||
28075856|NCT04138810|54730427|FG001|Overall Study|Withdrawal by Subject|1|||
28075857|NCT04138810|54730426|FG000|Overall Study|Subject cancelled surgery|1|||
28075858|NCT04138810|54730427|FG001|Overall Study|Subject cancelled surgery|0|||
28075859|NCT00127166|54730435|FG000|Period I|Protocol Violation|0|||
28075860|NCT00127166|54730436|FG001|Period I|Protocol Violation|2|||
28075861|NCT00127166|54730435|FG000|Period I|Withdrawal by Subject|2|||
28075862|NCT00127166|54730436|FG001|Period I|Withdrawal by Subject|0|||
28075863|NCT00127166|54730435|FG000|Period I|Patient did not meet inclusion criteria|1|||
28075864|NCT00127166|54730436|FG001|Period I|Patient did not meet inclusion criteria|0|||
28158959|NCT02061761|54828715|FG000|Overall Study|Adverse event unrelated to study Drug|1|||
28158960|NCT02061761|54828716|FG001|Overall Study|Adverse event unrelated to study Drug|0|||
28158961|NCT02061761|54828717|FG002|Overall Study|Adverse event unrelated to study Drug|0|||
28158962|NCT02061761|54828718|FG003|Overall Study|Adverse event unrelated to study Drug|1|||
28158963|NCT02061761|54828719|FG004|Overall Study|Adverse event unrelated to study Drug|0|||
28158964|NCT02061761|54828720|FG005|Overall Study|Adverse event unrelated to study Drug|0|||
28158965|NCT02061761|54828721|FG006|Overall Study|Adverse event unrelated to study Drug|0|||
28158966|NCT02061761|54828722|FG007|Overall Study|Adverse event unrelated to study Drug|0|||
28158967|NCT02061761|54828723|FG008|Overall Study|Adverse event unrelated to study Drug|0|||
28158968|NCT02061761|54828715|FG000|Overall Study|Participant request to discontinue study treatment|0|||
28158969|NCT02061761|54828716|FG001|Overall Study|Participant request to discontinue study treatment|0|||
28158970|NCT02061761|54828717|FG002|Overall Study|Participant request to discontinue study treatment|2|||
28158971|NCT02061761|54828718|FG003|Overall Study|Participant request to discontinue study treatment|2|||
28158972|NCT02061761|54828719|FG004|Overall Study|Participant request to discontinue study treatment|0|||
28158973|NCT02061761|54828720|FG005|Overall Study|Participant request to discontinue study treatment|1|||
28158974|NCT02061761|54828721|FG006|Overall Study|Participant request to discontinue study treatment|0|||
28158975|NCT02061761|54828722|FG007|Overall Study|Participant request to discontinue study treatment|0|||
28075865|NCT00127166|54730435|FG000|Washout Period|Patient did not meet inclusion criteria|0|||
28158976|NCT02061761|54828723|FG008|Overall Study|Participant request to discontinue study treatment|2|||
28158977|NCT02061761|54828715|FG000|Overall Study|Withdrawal by Subject|0|||
28075866|NCT00127166|54730436|FG001|Washout Period|Patient did not meet inclusion criteria|1|||
28075867|NCT00127166|54730435|FG000|Period II|Withdrawal by Subject|2|||
27942375|NCT00603733|54599245|FG001|Maintenance Phase ITT|Protocol Violation|1|||
28075868|NCT00127166|54730436|FG001|Period II|Withdrawal by Subject|0|||
28158978|NCT02061761|54828716|FG001|Overall Study|Withdrawal by Subject|0|||
28158979|NCT02061761|54828717|FG002|Overall Study|Withdrawal by Subject|0|||
28158980|NCT02061761|54828718|FG003|Overall Study|Withdrawal by Subject|0|||
28158981|NCT02061761|54828719|FG004|Overall Study|Withdrawal by Subject|0|||
28158982|NCT02061761|54828720|FG005|Overall Study|Withdrawal by Subject|0|||
28158983|NCT02061761|54828721|FG006|Overall Study|Withdrawal by Subject|0|||
28158984|NCT02061761|54828722|FG007|Overall Study|Withdrawal by Subject|0|||
28158985|NCT02061761|54828723|FG008|Overall Study|Withdrawal by Subject|2|||
28158986|NCT02061761|54828715|FG000|Overall Study|Maximum clinical benefit|0|||
28158987|NCT02061761|54828716|FG001|Overall Study|Maximum clinical benefit|0|||
28075869|NCT00127166|54730435|FG000|Period II|Patient did not perform Visit 6 exercise|1|||
28075870|NCT00127166|54730436|FG001|Period II|Patient did not perform Visit 6 exercise|0|||
28075871|NCT00125138|54730446|FG000|Overall Study|Adverse Event|1|||
28075872|NCT00125138|54730447|FG001|Overall Study|Adverse Event|0|||
28075873|NCT00125138|54730448|FG002|Overall Study|Adverse Event|3|||
28075874|NCT00125138|54730449|FG003|Overall Study|Adverse Event|2|||
28075875|NCT00125138|54730446|FG000|Overall Study|Withdrawal by Subject|2|||
28075876|NCT00125138|54730447|FG001|Overall Study|Withdrawal by Subject|3|||
28075877|NCT00125138|54730448|FG002|Overall Study|Withdrawal by Subject|1|||
28075878|NCT00125138|54730449|FG003|Overall Study|Withdrawal by Subject|1|||
28075879|NCT00125138|54730446|FG000|Overall Study|Lack of Efficacy|0|||
28075880|NCT00125138|54730447|FG001|Overall Study|Lack of Efficacy|0|||
28075881|NCT00125138|54730448|FG002|Overall Study|Lack of Efficacy|0|||
28075882|NCT00125138|54730449|FG003|Overall Study|Lack of Efficacy|1|||
28075883|NCT00125138|54730446|FG000|Overall Study|Sponsor decision-pt moved to assist care|0|||
28075884|NCT00125138|54730447|FG001|Overall Study|Sponsor decision-pt moved to assist care|0|||
28075885|NCT00125138|54730448|FG002|Overall Study|Sponsor decision-pt moved to assist care|0|||
28075886|NCT00125138|54730449|FG003|Overall Study|Sponsor decision-pt moved to assist care|1|||
28075887|NCT04132336|54730466|FG000|Overall Study|Investigator Decision|0|||
28075888|NCT04132336|54730467|FG001|Overall Study|Investigator Decision|1|||
28075889|NCT04132336|54730468|FG002|Overall Study|Investigator Decision|0|||
28075890|NCT04132336|54730469|FG003|Overall Study|Investigator Decision|0|||
28075891|NCT04132336|54730470|FG004|Overall Study|Investigator Decision|0|||
28075892|NCT04132336|54730471|FG005|Overall Study|Investigator Decision|0|||
28075893|NCT04132336|54730472|FG006|Overall Study|Investigator Decision|0|||
28075894|NCT04131556|54730488|FG000|Overall Study|Adverse Event|1|||
28075895|NCT04131556|54730488|FG000|Overall Study|Withdrawal by Subject|1|||
28075896|NCT04295356|54730497|FG000|Overall Study|Physician Decision|1|||
28075897|NCT04295356|54730498|FG001|Overall Study|Physician Decision|0|||
28075898|NCT04295356|54730497|FG000|Overall Study|Lost to Follow-up|0|||
28075899|NCT04295356|54730498|FG001|Overall Study|Lost to Follow-up|3|||
28075900|NCT04295356|54730497|FG000|Overall Study|Protocol Violation|0|||
28075901|NCT04295356|54730498|FG001|Overall Study|Protocol Violation|1|||
28075902|NCT03691948|54730506|FG000|Overall Study|Lost to Follow-up|1|||
28075903|NCT03691948|54730507|FG001|Overall Study|Lost to Follow-up|3|||
28075904|NCT04126174|54730514|FG000|Overall Study|Lost to Follow-up|3|||
28075905|NCT04126174|54730515|FG001|Overall Study|Lost to Follow-up|3|||
28075906|NCT04124926|54730523|FG000|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|3|||
28075907|NCT04124926|54730524|FG001|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|7|||
28075908|NCT04124926|54730525|FG002|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
28075909|NCT04124926|54730526|FG003|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
28075910|NCT04124926|54730527|FG004|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
28075911|NCT04124926|54730523|FG000|Healing Phase|Protocol Violation|0|||
28075912|NCT04124926|54730524|FG001|Healing Phase|Protocol Violation|1|||
28075913|NCT04124926|54730525|FG002|Healing Phase|Protocol Violation|0|||
28075914|NCT04124926|54730526|FG003|Healing Phase|Protocol Violation|0|||
28075915|NCT04124926|54730527|FG004|Healing Phase|Protocol Violation|0|||
28075916|NCT04124926|54730523|FG000|Healing Phase|Lost to Follow-up|5|||
28075917|NCT04124926|54730524|FG001|Healing Phase|Lost to Follow-up|4|||
28075918|NCT04124926|54730525|FG002|Healing Phase|Lost to Follow-up|0|||
28075919|NCT04124926|54730526|FG003|Healing Phase|Lost to Follow-up|0|||
28075920|NCT04124926|54730527|FG004|Healing Phase|Lost to Follow-up|0|||
28075921|NCT04124926|54730523|FG000|Healing Phase|Voluntary Withdrawal|10|||
28075922|NCT04124926|54730524|FG001|Healing Phase|Voluntary Withdrawal|7|||
28075923|NCT04124926|54730525|FG002|Healing Phase|Voluntary Withdrawal|0|||
28075924|NCT04124926|54730526|FG003|Healing Phase|Voluntary Withdrawal|0|||
28075925|NCT04124926|54730527|FG004|Healing Phase|Voluntary Withdrawal|0|||
28075926|NCT04124926|54730523|FG000|Healing Phase|Withdrawal of Consent|5|||
27825416|NCT01744093|54290825|FG000|Overall Study|Withdrawal by Subject|6|||
27825417|NCT01744093|54290826|FG001|Overall Study|Withdrawal by Subject|1|||
27825418|NCT01725451|54290840|FG000|Period 1|Withdrawal by Subject|1|||
27825419|NCT01725451|54290841|FG001|Period 1|Withdrawal by Subject|0|||
27825420|NCT01725451|54290842|FG002|Period 1|Withdrawal by Subject|0|||
27825421|NCT01725451|54290843|FG003|Period 1|Withdrawal by Subject|0|||
27825422|NCT01725451|54290840|FG000|Washout From Period 3|Protocol Violation|0|||
27825423|NCT01725451|54290841|FG001|Washout From Period 3|Protocol Violation|0|||
27825424|NCT01725451|54290842|FG002|Washout From Period 3|Protocol Violation|1|||
27825425|NCT01725451|54290843|FG003|Washout From Period 3|Protocol Violation|0|||
27825426|NCT01725451|54290840|FG000|Washout From Period 3|Adverse Event|0|||
27825427|NCT01725451|54290841|FG001|Washout From Period 3|Adverse Event|1|||
27850364|NCT04178967|54349315|FG000|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
28075927|NCT04124926|54730524|FG001|Healing Phase|Withdrawal of Consent|3|||
28075928|NCT04124926|54730525|FG002|Healing Phase|Withdrawal of Consent|0|||
27825428|NCT01725451|54290842|FG002|Washout From Period 3|Adverse Event|0|||
27825429|NCT01725451|54290843|FG003|Washout From Period 3|Adverse Event|0|||
27825430|NCT01725451|54290840|FG000|Period 4|Adverse Event|0|||
27825431|NCT01725451|54290841|FG001|Period 4|Adverse Event|0|||
27825432|NCT01725451|54290842|FG002|Period 4|Adverse Event|1|||
27825433|NCT01725451|54290843|FG003|Period 4|Adverse Event|0|||
27825434|NCT01707290|54290860|FG000|Overall Study|Adverse event (AE)|1|||
27825435|NCT01707290|54290861|FG001|Overall Study|Adverse event (AE)|0|||
27825436|NCT01707290|54290860|FG000|Overall Study|Physician Decision|1|||
27825437|NCT01707290|54290861|FG001|Overall Study|Physician Decision|0|||
27825438|NCT01707290|54290860|FG000|Overall Study|Lost to Follow-up|3|||
27825439|NCT01707290|54290861|FG001|Overall Study|Lost to Follow-up|0|||
27825440|NCT01707290|54290860|FG000|Overall Study|Withdrawal of Consent (Not Due to AE)|4|||
27825441|NCT01707290|54290861|FG001|Overall Study|Withdrawal of Consent (Not Due to AE)|0|||
27825442|NCT01707290|54290860|FG000|Overall Study|Commercial drug available|60|||
27825443|NCT01707290|54290861|FG001|Overall Study|Commercial drug available|1|||
28075929|NCT04124926|54730526|FG003|Healing Phase|Withdrawal of Consent|0|||
28075930|NCT04124926|54730527|FG004|Healing Phase|Withdrawal of Consent|0|||
28075931|NCT04124926|54730523|FG000|Healing Phase|Miscellaneous|8|||
28075932|NCT04124926|54730524|FG001|Healing Phase|Miscellaneous|7|||
28075933|NCT04124926|54730525|FG002|Healing Phase|Miscellaneous|0|||
28075934|NCT04124926|54730526|FG003|Healing Phase|Miscellaneous|0|||
28075935|NCT04124926|54730527|FG004|Healing Phase|Miscellaneous|0|||
28075936|NCT04124926|54730523|FG000|Healing Phase|Randomized but not Treated|0|||
28158988|NCT02061761|54828717|FG002|Overall Study|Maximum clinical benefit|0|||
28158989|NCT02061761|54828718|FG003|Overall Study|Maximum clinical benefit|1|||
28158990|NCT02061761|54828719|FG004|Overall Study|Maximum clinical benefit|0|||
28158991|NCT02061761|54828720|FG005|Overall Study|Maximum clinical benefit|0|||
28158992|NCT02061761|54828721|FG006|Overall Study|Maximum clinical benefit|0|||
28158993|NCT02061761|54828722|FG007|Overall Study|Maximum clinical benefit|0|||
28158994|NCT02061761|54828723|FG008|Overall Study|Maximum clinical benefit|6|||
28158995|NCT02061761|54828715|FG000|Overall Study|Participant no longer meets study criteria|0|||
28158996|NCT02061761|54828716|FG001|Overall Study|Participant no longer meets study criteria|0|||
28158997|NCT02061761|54828717|FG002|Overall Study|Participant no longer meets study criteria|0|||
28158998|NCT02061761|54828718|FG003|Overall Study|Participant no longer meets study criteria|0|||
28158999|NCT02061761|54828719|FG004|Overall Study|Participant no longer meets study criteria|0|||
28159000|NCT02061761|54828720|FG005|Overall Study|Participant no longer meets study criteria|0|||
28159001|NCT02061761|54828721|FG006|Overall Study|Participant no longer meets study criteria|0|||
28159002|NCT02061761|54828722|FG007|Overall Study|Participant no longer meets study criteria|0|||
28159003|NCT02061761|54828723|FG008|Overall Study|Participant no longer meets study criteria|1|||
28159004|NCT02061761|54828715|FG000|Overall Study|Other reasons|0|||
28159005|NCT02061761|54828716|FG001|Overall Study|Other reasons|0|||
28159006|NCT02061761|54828717|FG002|Overall Study|Other reasons|0|||
28159007|NCT02061761|54828718|FG003|Overall Study|Other reasons|0|||
28159008|NCT02061761|54828719|FG004|Overall Study|Other reasons|2|||
28159009|NCT02061761|54828720|FG005|Overall Study|Other reasons|0|||
28159010|NCT02061761|54828721|FG006|Overall Study|Other reasons|0|||
28159011|NCT02061761|54828722|FG007|Overall Study|Other reasons|0|||
28159012|NCT02061761|54828723|FG008|Overall Study|Other reasons|6|||
28159013|NCT01927068|54828751|FG000|Overall Study|Death|37|||
28159014|NCT01927068|54828752|FG001|Overall Study|Death|3|||
28159015|NCT01927068|54828751|FG000|Overall Study|Withdrawal by Subject|50|||
28159016|NCT01927068|54828752|FG001|Overall Study|Withdrawal by Subject|3|||
28159017|NCT01927068|54828751|FG000|Overall Study|Lost to Follow-up|10|||
28159018|NCT01927068|54828752|FG001|Overall Study|Lost to Follow-up|2|||
28159019|NCT01927068|54828751|FG000|Overall Study|Physician Decision|9|||
28159020|NCT01927068|54828752|FG001|Overall Study|Physician Decision|0|||
28159021|NCT01927068|54828751|FG000|Overall Study|Missed last follow-up visit|2|||
27825444|NCT01707290|54290860|FG000|Overall Study|Other unspecified|17|||
28159022|NCT01927068|54828752|FG001|Overall Study|Missed last follow-up visit|0|||
28159023|NCT01309230|54828761|FG000|Overall Study|Withdrawal by Subject|0|||
28159024|NCT01309230|54828762|FG001|Overall Study|Withdrawal by Subject|2|||
28159025|NCT01309230|54828761|FG000|Overall Study|Observation arm closed|0|||
28159026|NCT01309230|54828762|FG001|Overall Study|Observation arm closed|2|||
28159027|NCT00819832|54828774|FG000|Overall Study|Sponsor Termination of Study|3|||
27825445|NCT01707290|54290861|FG001|Overall Study|Other unspecified|0|||
27825446|NCT01717040|54290872|FG000|Overall Study|Lost to Follow-up|2|||
27825447|NCT01717040|54290873|FG001|Overall Study|Lost to Follow-up|3|||
27825448|NCT01717040|54290872|FG000|Overall Study|Lack of Efficacy|1|||
27825449|NCT01717040|54290873|FG001|Overall Study|Lack of Efficacy|1|||
28159028|NCT00819832|54828775|FG001|Overall Study|Sponsor Termination of Study|0|||
27825450|NCT01717040|54290872|FG000|Overall Study|Adverse Event|1|||
27825451|NCT01717040|54290873|FG001|Overall Study|Adverse Event|0|||
28075937|NCT04124926|54730524|FG001|Healing Phase|Randomized but not Treated|3|||
28075938|NCT04124926|54730525|FG002|Healing Phase|Randomized but not Treated|0|||
28075939|NCT04124926|54730526|FG003|Healing Phase|Randomized but not Treated|0|||
28075940|NCT04124926|54730527|FG004|Healing Phase|Randomized but not Treated|0|||
28075941|NCT04124926|54730523|FG000|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
28075942|NCT04124926|54730524|FG001|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
27825452|NCT01717040|54290872|FG000|Overall Study|Required Medication Change|0|||
27825453|NCT01717040|54290873|FG001|Overall Study|Required Medication Change|1|||
27825454|NCT01717040|54290872|FG000|Overall Study|New Substance Use Disorder|1|||
27825455|NCT01717040|54290873|FG001|Overall Study|New Substance Use Disorder|0|||
27942376|NCT00603733|54599244|FG000|Maintenance Phase ITT|Lost to Follow-up|0|||
28075943|NCT04124926|54730525|FG002|Maintenance Phase|Pretreatment Event, AE, or SAE|3|||
28075944|NCT04124926|54730526|FG003|Maintenance Phase|Pretreatment Event, AE, or SAE|5|||
28159029|NCT00819832|54828776|FG002|Overall Study|Sponsor Termination of Study|0|||
28159030|NCT00819832|54828777|FG003|Overall Study|Sponsor Termination of Study|0|||
28159031|NCT00819832|54828778|FG004|Overall Study|Sponsor Termination of Study|0|||
28159032|NCT00819832|54828779|FG005|Overall Study|Sponsor Termination of Study|0|||
28159033|NCT00704522|54828795|FG000|Overall Study|Lack of Efficacy|65|||
28159034|NCT00704522|54828796|FG001|Overall Study|Lack of Efficacy|17|||
28159035|NCT00704522|54828795|FG000|Overall Study|Failure to appear again at hospital|56|||
28159036|NCT00704522|54828796|FG001|Overall Study|Failure to appear again at hospital|10|||
28159037|NCT00704522|54828795|FG000|Overall Study|Withdrawal by Subject|17|||
28159038|NCT00704522|54828796|FG001|Overall Study|Withdrawal by Subject|8|||
28159039|NCT00704522|54828795|FG000|Overall Study|Adverse Event|9|||
28159040|NCT00704522|54828796|FG001|Overall Study|Adverse Event|1|||
28159041|NCT00704522|54828795|FG000|Overall Study|Undefined causes|9|||
28159042|NCT00704522|54828796|FG001|Overall Study|Undefined causes|7|||
28159043|NCT00704522|54828795|FG000|Overall Study|No information on therapy end|27|||
28159044|NCT00704522|54828796|FG001|Overall Study|No information on therapy end|2|||
28159045|NCT02723630|54828807|FG000|Intervention Period 1|Adverse Event|1|||
28159046|NCT02723630|54828808|FG001|Intervention Period 1|Adverse Event|0|||
28159047|NCT02723630|54828809|FG002|Intervention Period 1|Adverse Event|0|||
28159048|NCT02723630|54828810|FG003|Intervention Period 1|Adverse Event|0|||
28159049|NCT02723630|54828811|FG004|Intervention Period 1|Adverse Event|0|||
28159050|NCT02723630|54828812|FG005|Intervention Period 1|Adverse Event|0|||
28075945|NCT04124926|54730527|FG004|Maintenance Phase|Pretreatment Event, AE, or SAE|4|||
28075946|NCT04124926|54730523|FG000|Maintenance Phase|Protocol Violation|0|||
28075947|NCT04124926|54730524|FG001|Maintenance Phase|Protocol Violation|0|||
28075948|NCT04124926|54730525|FG002|Maintenance Phase|Protocol Violation|3|||
28075949|NCT04124926|54730526|FG003|Maintenance Phase|Protocol Violation|0|||
28075950|NCT04124926|54730527|FG004|Maintenance Phase|Protocol Violation|0|||
28075951|NCT04124926|54730523|FG000|Maintenance Phase|Lost to Follow-up|0|||
28075952|NCT04124926|54730524|FG001|Maintenance Phase|Lost to Follow-up|0|||
28075953|NCT04124926|54730525|FG002|Maintenance Phase|Lost to Follow-up|7|||
28075954|NCT04124926|54730526|FG003|Maintenance Phase|Lost to Follow-up|8|||
28075955|NCT04124926|54730527|FG004|Maintenance Phase|Lost to Follow-up|9|||
28159051|NCT02723630|54828807|FG000|Intervention Period 3|consumption of restricted item|0|||
28159052|NCT02723630|54828808|FG001|Intervention Period 3|consumption of restricted item|1|||
28159053|NCT02723630|54828809|FG002|Intervention Period 3|consumption of restricted item|0|||
28075956|NCT04124926|54730523|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
28075957|NCT04124926|54730524|FG001|Maintenance Phase|Voluntary Withdrawal|0|||
28159054|NCT02723630|54828810|FG003|Intervention Period 3|consumption of restricted item|0|||
28159055|NCT02723630|54828811|FG004|Intervention Period 3|consumption of restricted item|0|||
28159056|NCT02723630|54828812|FG005|Intervention Period 3|consumption of restricted item|0|||
28159057|NCT04089735|54828855|FG000|Overall Study|Adverse Event|1|||
28159058|NCT04089735|54828856|FG001|Overall Study|Adverse Event|0|||
28159059|NCT04089735|54828857|FG002|Overall Study|Adverse Event|1|||
28159060|NCT04089735|54828858|FG003|Overall Study|Adverse Event|1|||
28159061|NCT04089735|54828859|FG004|Overall Study|Adverse Event|0|||
28159062|NCT04089735|54828860|FG005|Overall Study|Adverse Event|0|||
28159063|NCT04089735|54828855|FG000|Overall Study|Physician Decision|0|||
28159064|NCT04089735|54828856|FG001|Overall Study|Physician Decision|3|||
28159065|NCT04089735|54828857|FG002|Overall Study|Physician Decision|0|||
28159066|NCT04089735|54828858|FG003|Overall Study|Physician Decision|0|||
28159067|NCT04089735|54828859|FG004|Overall Study|Physician Decision|0|||
28159068|NCT04089735|54828860|FG005|Overall Study|Physician Decision|0|||
28159069|NCT04089735|54828855|FG000|Overall Study|Withdrawal by Subject|0|||
28159070|NCT04089735|54828856|FG001|Overall Study|Withdrawal by Subject|0|||
28159071|NCT04089735|54828857|FG002|Overall Study|Withdrawal by Subject|1|||
28159072|NCT04089735|54828858|FG003|Overall Study|Withdrawal by Subject|0|||
28159073|NCT04089735|54828859|FG004|Overall Study|Withdrawal by Subject|0|||
27825456|NCT01743469|54290900|FG000|Active Treatment Phase|Adverse Event|10|||
28159074|NCT04089735|54828860|FG005|Overall Study|Withdrawal by Subject|0|||
27825457|NCT01743469|54290901|FG001|Active Treatment Phase|Adverse Event|5|||
27825458|NCT01743469|54290902|FG002|Active Treatment Phase|Adverse Event|8|||
27825459|NCT01743469|54290903|FG003|Active Treatment Phase|Adverse Event|1|||
27825460|NCT01743469|54290900|FG000|Active Treatment Phase|Disease Progression|40|||
27825461|NCT01743469|54290901|FG001|Active Treatment Phase|Disease Progression|47|||
28159075|NCT04089735|54828855|FG000|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
28159076|NCT04089735|54828856|FG001|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|3|||
28160135|NCT03382821|54830236|FG001|Overall Study|Did not receive allocated intervention.|3|||
28159077|NCT04089735|54828857|FG002|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
28159078|NCT04089735|54828858|FG003|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|5|||
27825462|NCT01743469|54290902|FG002|Active Treatment Phase|Disease Progression|30|||
27825463|NCT01743469|54290903|FG003|Active Treatment Phase|Disease Progression|20|||
27825464|NCT01743469|54290900|FG000|Active Treatment Phase|Withdrawal by Subject|2|||
27850365|NCT04178967|54349316|FG001|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
28075958|NCT04124926|54730525|FG002|Maintenance Phase|Voluntary Withdrawal|3|||
28075959|NCT04124926|54730526|FG003|Maintenance Phase|Voluntary Withdrawal|6|||
28075960|NCT04124926|54730527|FG004|Maintenance Phase|Voluntary Withdrawal|5|||
28075961|NCT04124926|54730523|FG000|Maintenance Phase|Pregnancy|0|||
28075962|NCT04124926|54730524|FG001|Maintenance Phase|Pregnancy|0|||
28075963|NCT04124926|54730525|FG002|Maintenance Phase|Pregnancy|0|||
28075964|NCT04124926|54730526|FG003|Maintenance Phase|Pregnancy|1|||
28075965|NCT04124926|54730527|FG004|Maintenance Phase|Pregnancy|0|||
28075966|NCT04124926|54730523|FG000|Maintenance Phase|Lack of Efficacy|0|||
28075967|NCT04124926|54730524|FG001|Maintenance Phase|Lack of Efficacy|0|||
28075968|NCT04124926|54730525|FG002|Maintenance Phase|Lack of Efficacy|0|||
28075969|NCT04124926|54730526|FG003|Maintenance Phase|Lack of Efficacy|0|||
28075970|NCT04124926|54730527|FG004|Maintenance Phase|Lack of Efficacy|1|||
27825465|NCT01743469|54290901|FG001|Active Treatment Phase|Withdrawal by Subject|3|||
27825466|NCT01743469|54290902|FG002|Active Treatment Phase|Withdrawal by Subject|0|||
27825467|NCT01743469|54290903|FG003|Active Treatment Phase|Withdrawal by Subject|0|||
27825468|NCT01743469|54290900|FG000|Active Treatment Phase|Missing|1|||
28075971|NCT04124926|54730523|FG000|Maintenance Phase|Withdrawal of Consent|0|||
28075972|NCT04124926|54730524|FG001|Maintenance Phase|Withdrawal of Consent|0|||
28075973|NCT04124926|54730525|FG002|Maintenance Phase|Withdrawal of Consent|5|||
28075974|NCT04124926|54730526|FG003|Maintenance Phase|Withdrawal of Consent|5|||
28075975|NCT04124926|54730527|FG004|Maintenance Phase|Withdrawal of Consent|5|||
28075976|NCT04124926|54730523|FG000|Maintenance Phase|Miscellaneous|0|||
28075977|NCT04124926|54730524|FG001|Maintenance Phase|Miscellaneous|0|||
28075978|NCT04124926|54730525|FG002|Maintenance Phase|Miscellaneous|1|||
28075979|NCT04124926|54730526|FG003|Maintenance Phase|Miscellaneous|2|||
28075980|NCT04124926|54730527|FG004|Maintenance Phase|Miscellaneous|4|||
28075981|NCT04124926|54730523|FG000|Maintenance Phase|Randomized but not Treated|0|||
28075982|NCT04124926|54730524|FG001|Maintenance Phase|Randomized but not Treated|0|||
28075983|NCT04124926|54730525|FG002|Maintenance Phase|Randomized but not Treated|2|||
28075984|NCT04124926|54730526|FG003|Maintenance Phase|Randomized but not Treated|2|||
28075985|NCT04124926|54730527|FG004|Maintenance Phase|Randomized but not Treated|0|||
28075986|NCT04274686|54730539|FG000|Overall Study|Physician Decision|1|||
28075987|NCT04274686|54730540|FG001|Overall Study|Physician Decision|0|||
28075988|NCT04113694|54730548|FG000|Overall Study|Adverse Event|2|||
27825469|NCT01743469|54290901|FG001|Active Treatment Phase|Missing|0|||
27825470|NCT01743469|54290902|FG002|Active Treatment Phase|Missing|0|||
28075989|NCT04113694|54730548|FG000|Overall Study|Lost to Follow-up|2|||
28075990|NCT04113694|54730548|FG000|Overall Study|Withdrawal by Subject|6|||
28075991|NCT04113694|54730548|FG000|Overall Study|Withdrawal due to not meeting inclusion and exclusion criteria|1|||
28075992|NCT04105972|54730557|FG000|Overall Study|Adverse Event|2|||
28075993|NCT04105972|54730558|FG001|Overall Study|Adverse Event|1|||
28075994|NCT04102540|54730564|FG000|Overall Study|Withdrawn by PI|2|||
28160136|NCT02557516|54830247|FG000|Overall Study|Adverse Event|1|||
27825471|NCT01743469|54290903|FG003|Active Treatment Phase|Missing|0|||
27825472|NCT01743469|54290900|FG000|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
27825473|NCT01743469|54290901|FG001|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
27825474|NCT01743469|54290902|FG002|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
27825475|NCT01743469|54290903|FG003|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
27825476|NCT01743469|54290900|FG000|Follow-up Period - Post-Treatment|Death|43|||
27825477|NCT01743469|54290901|FG001|Follow-up Period - Post-Treatment|Death|47|||
27825478|NCT01743469|54290902|FG002|Follow-up Period - Post-Treatment|Death|22|||
28075995|NCT04102540|54730564|FG000|Overall Study|Lost to Follow-up|6|||
28075996|NCT00124982|54730570|FG000|Short-term Period|Death|1|||
28075997|NCT00124982|54730571|FG001|Short-term Period|Death|1|||
28075998|NCT00124982|54730572|FG002|Short-term Period|Death|0|||
28075999|NCT00124982|54730570|FG000|Short-term Period|Adverse Event|17|||
28076000|NCT00124982|54730571|FG001|Short-term Period|Adverse Event|22|||
28076001|NCT00124982|54730572|FG002|Short-term Period|Adverse Event|0|||
28159079|NCT04089735|54828859|FG004|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|1|||
28159080|NCT04089735|54828860|FG005|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|6|||
28159081|NCT01876784|54828876|FG000|Overall Study|Withdrawal by Subject|17|||
28159082|NCT01876784|54828877|FG001|Overall Study|Withdrawal by Subject|2|||
28159083|NCT01876784|54828876|FG000|Overall Study|Adverse Event|15|||
28159084|NCT01876784|54828877|FG001|Overall Study|Adverse Event|2|||
28159085|NCT01876784|54828876|FG000|Overall Study|Protocol Violation|1|||
28159086|NCT01876784|54828877|FG001|Overall Study|Protocol Violation|0|||
28159087|NCT01876784|54828876|FG000|Overall Study|Disease progression|37|||
28159088|NCT01876784|54828877|FG001|Overall Study|Disease progression|67|||
28076002|NCT00124982|54730570|FG000|Short-term Period|Lack of Efficacy|32|||
28076003|NCT00124982|54730571|FG001|Short-term Period|Lack of Efficacy|73|||
28076004|NCT00124982|54730572|FG002|Short-term Period|Lack of Efficacy|0|||
28076005|NCT00124982|54730570|FG000|Short-term Period|Lost to Follow-up|8|||
28076006|NCT00124982|54730571|FG001|Short-term Period|Lost to Follow-up|5|||
28076007|NCT00124982|54730572|FG002|Short-term Period|Lost to Follow-up|0|||
28076008|NCT00124982|54730570|FG000|Short-term Period|Withdrawal of Consent|7|||
28076009|NCT00124982|54730571|FG001|Short-term Period|Withdrawal of Consent|9|||
28076010|NCT00124982|54730572|FG002|Short-term Period|Withdrawal of Consent|0|||
28159089|NCT01876784|54828876|FG000|Overall Study|Lost to Follow-up|0|||
28159090|NCT01876784|54828877|FG001|Overall Study|Lost to Follow-up|1|||
28159091|NCT01876784|54828876|FG000|Overall Study|Death|1|||
28159092|NCT01876784|54828877|FG001|Overall Study|Death|0|||
28076011|NCT00124982|54730570|FG000|Short-term Period|Poor/Non-compliance|3|||
28159093|NCT01876784|54828876|FG000|Overall Study|Randomized but not treated|2|||
28159094|NCT01876784|54828877|FG001|Overall Study|Randomized but not treated|1|||
28076012|NCT00124982|54730571|FG001|Short-term Period|Poor/Non-compliance|1|||
28076013|NCT00124982|54730572|FG002|Short-term Period|Poor/Non-compliance|0|||
28076014|NCT00124982|54730570|FG000|Short-term Period|No Longer Meets Study Criteria|1|||
28076015|NCT00124982|54730571|FG001|Short-term Period|No Longer Meets Study Criteria|2|||
28076016|NCT00124982|54730572|FG002|Short-term Period|No Longer Meets Study Criteria|0|||
28076017|NCT00124982|54730570|FG000|Short-term Period|Participant Decision|1|||
28076018|NCT00124982|54730571|FG001|Short-term Period|Participant Decision|0|||
28076019|NCT00124982|54730572|FG002|Short-term Period|Participant Decision|0|||
28159095|NCT01876784|54828876|FG000|Overall Study|Other than specified above|5|||
28159096|NCT01876784|54828877|FG001|Overall Study|Other than specified above|6|||
28159097|NCT01876784|54828876|FG000|Overall Study|Ongoing|41|||
28159098|NCT01876784|54828877|FG001|Overall Study|Ongoing|40|||
28159099|NCT04205162|54828885|FG000|Overall Study|Lost to Follow-up|1|||
28159100|NCT04205162|54828886|FG001|Overall Study|Lost to Follow-up|0|||
28159101|NCT04205162|54828885|FG000|Overall Study|Withdrawal by Subject|2|||
28159102|NCT04205162|54828886|FG001|Overall Study|Withdrawal by Subject|0|||
28159103|NCT04205162|54828885|FG000|Overall Study|University closure due to COVID-19|1|||
28159104|NCT04205162|54828886|FG001|Overall Study|University closure due to COVID-19|0|||
28159105|NCT01329939|54828897|FG000|Overall Study|Lost to Follow-up|3|||
28076020|NCT00124982|54730570|FG000|Short-term Period|Participant Chose Own Doctor|0|||
28076021|NCT00124982|54730571|FG001|Short-term Period|Participant Chose Own Doctor|1|||
28076022|NCT00124982|54730572|FG002|Short-term Period|Participant Chose Own Doctor|0|||
28076023|NCT00124982|54730570|FG000|Short-term Period|Investigator Decision-No Specific AE|1|||
28159106|NCT01329939|54828898|FG001|Overall Study|Lost to Follow-up|0|||
28159107|NCT01329939|54828899|FG002|Overall Study|Lost to Follow-up|1|||
28159108|NCT01329939|54828900|FG003|Overall Study|Lost to Follow-up|2|||
28159109|NCT01329939|54828897|FG000|Overall Study|Withdrawal by Subject|0|||
28159110|NCT01329939|54828898|FG001|Overall Study|Withdrawal by Subject|1|||
28159111|NCT01329939|54828899|FG002|Overall Study|Withdrawal by Subject|0|||
28159112|NCT01329939|54828900|FG003|Overall Study|Withdrawal by Subject|0|||
28159113|NCT01329939|54828897|FG000|Overall Study|Adverse Event|0|||
28159114|NCT01329939|54828898|FG001|Overall Study|Adverse Event|0|||
28159115|NCT01329939|54828899|FG002|Overall Study|Adverse Event|0|||
28159116|NCT01329939|54828900|FG003|Overall Study|Adverse Event|3|||
28076024|NCT00124982|54730571|FG001|Short-term Period|Investigator Decision-No Specific AE|0|||
28076025|NCT00124982|54730572|FG002|Short-term Period|Investigator Decision-No Specific AE|0|||
28159117|NCT02499900|54828912|FG000|Core Study Period|Other|1|||
27825479|NCT01743469|54290903|FG003|Follow-up Period - Post-Treatment|Death|16|||
28076026|NCT00124982|54730570|FG000|Short-term Period|Participant Had Lymphopenia|1|||
28159118|NCT02499900|54828913|FG001|Core Study Period|Other|4|||
28159119|NCT02499900|54828912|FG000|Core Study Period|Lost to Follow-up|1|||
28159120|NCT02499900|54828913|FG001|Core Study Period|Lost to Follow-up|2|||
28159121|NCT02499900|54828912|FG000|Core Study Period|Per sponsor request|0|||
28160137|NCT02557516|54830248|FG001|Overall Study|Adverse Event|0|||
28159122|NCT02499900|54828913|FG001|Core Study Period|Per sponsor request|1|||
28159123|NCT02499900|54828912|FG000|Core Study Period|Pregnancy|1|||
28159124|NCT02499900|54828913|FG001|Core Study Period|Pregnancy|0|||
28159125|NCT02499900|54828912|FG000|Core Study Period|Protocol Violation|3|||
28159126|NCT02499900|54828913|FG001|Core Study Period|Protocol Violation|0|||
28159127|NCT02499900|54828912|FG000|Core Study Period|Withdrawal by Subject|11|||
28159128|NCT02499900|54828913|FG001|Core Study Period|Withdrawal by Subject|10|||
28159129|NCT02499900|54828912|FG000|Core Study Period|Adverse Event|18|||
28159130|NCT02499900|54828913|FG001|Core Study Period|Adverse Event|14|||
28159131|NCT02499900|54828912|FG000|Core Study Period|Death|0|||
28159132|NCT02499900|54828913|FG001|Core Study Period|Death|1|||
27942377|NCT00603733|54599245|FG001|Maintenance Phase ITT|Lost to Follow-up|1|||
27942378|NCT00603733|54599244|FG000|Maintenance Phase ITT|Lack of Efficacy|2|||
27942379|NCT00603733|54599245|FG001|Maintenance Phase ITT|Lack of Efficacy|2|||
27942380|NCT00603733|54599244|FG000|Maintenance Phase ITT|Physician Decision|0|||
28159133|NCT02499900|54828912|FG000|Completed Core, Continued Into Extension|Physician Decision|1|||
27942381|NCT00603733|54599245|FG001|Maintenance Phase ITT|Physician Decision|1|||
27825480|NCT01743469|54290900|FG000|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
27825481|NCT01743469|54290901|FG001|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
27825482|NCT01743469|54290902|FG002|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
28076027|NCT00124982|54730571|FG001|Short-term Period|Participant Had Lymphopenia|0|||
28076028|NCT00124982|54730572|FG002|Short-term Period|Participant Had Lymphopenia|0|||
28076029|NCT00124982|54730570|FG000|Long-term Period|Death|0|||
28076030|NCT00124982|54730571|FG001|Long-term Period|Death|0|||
28159134|NCT02499900|54828913|FG001|Completed Core, Continued Into Extension|Physician Decision|0|||
28159135|NCT02499900|54828912|FG000|Completed Core, Continued Into Extension|Withdrawal by Subject|0|||
28159136|NCT02499900|54828913|FG001|Completed Core, Continued Into Extension|Withdrawal by Subject|2|||
28159137|NCT02499900|54828912|FG000|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1|||
28159138|NCT02499900|54828913|FG001|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0|||
28159139|NCT02499900|54828912|FG000|Completed Core, Continued Into Extension|Personal motivation|1|||
28159140|NCT02499900|54828913|FG001|Completed Core, Continued Into Extension|Personal motivation|0|||
28159141|NCT02499900|54828912|FG000|Extension Study Period|Adverse Event|2|||
28159142|NCT02499900|54828913|FG001|Extension Study Period|Adverse Event|4|||
28159143|NCT02499900|54828912|FG000|Extension Study Period|Withdrawal by Subject|5|||
28159144|NCT02499900|54828913|FG001|Extension Study Period|Withdrawal by Subject|2|||
28159145|NCT02499900|54828912|FG000|Extension Study Period|Physician Decision|2|||
28159146|NCT02499900|54828913|FG001|Extension Study Period|Physician Decision|5|||
28159147|NCT02499900|54828912|FG000|Extension Study Period|Pregnancy|1|||
28159148|NCT02499900|54828913|FG001|Extension Study Period|Pregnancy|2|||
28076031|NCT00124982|54730572|FG002|Long-term Period|Death|1|||
28076032|NCT00124982|54730570|FG000|Long-term Period|Adverse Event|0|||
28076033|NCT00124982|54730571|FG001|Long-term Period|Adverse Event|0|||
28076034|NCT00124982|54730572|FG002|Long-term Period|Adverse Event|17|||
28076035|NCT00124982|54730570|FG000|Long-term Period|Lack of Efficacy|0|||
28076036|NCT00124982|54730571|FG001|Long-term Period|Lack of Efficacy|0|||
28076037|NCT00124982|54730572|FG002|Long-term Period|Lack of Efficacy|46|||
28076038|NCT00124982|54730570|FG000|Long-term Period|Lost to Follow-up|0|||
28076039|NCT00124982|54730571|FG001|Long-term Period|Lost to Follow-up|0|||
28076040|NCT00124982|54730572|FG002|Long-term Period|Lost to Follow-up|4|||
28076041|NCT00124982|54730570|FG000|Long-term Period|Withdrawal by Subject|0|||
28076042|NCT00124982|54730571|FG001|Long-term Period|Withdrawal by Subject|0|||
28076043|NCT00124982|54730572|FG002|Long-term Period|Withdrawal by Subject|16|||
28076044|NCT00124982|54730570|FG000|Long-term Period|Pregnancy|0|||
28076045|NCT00124982|54730571|FG001|Long-term Period|Pregnancy|0|||
28076046|NCT00124982|54730572|FG002|Long-term Period|Pregnancy|1|||
28076047|NCT00124982|54730570|FG000|Long-term Period|Poor/Non-compliance|0|||
28076048|NCT00124982|54730571|FG001|Long-term Period|Poor/Non-compliance|0|||
28076049|NCT00124982|54730572|FG002|Long-term Period|Poor/Non-compliance|2|||
28076050|NCT00124982|54730570|FG000|Long-term Period|Administrative Reason by Sponsor|0|||
28076051|NCT00124982|54730571|FG001|Long-term Period|Administrative Reason by Sponsor|0|||
28076052|NCT00124982|54730572|FG002|Long-term Period|Administrative Reason by Sponsor|1|||
28076053|NCT00124982|54730570|FG000|Long-term Period|Neurologist Recommendation|0|||
28076054|NCT00124982|54730571|FG001|Long-term Period|Neurologist Recommendation|0|||
28076055|NCT00124982|54730572|FG002|Long-term Period|Neurologist Recommendation|1|||
28076056|NCT04263142|54730586|FG000|Part 2 Period 1 (Day 1)|Adverse Event|0|||
28076057|NCT04263142|54730587|FG001|Part 2 Period 1 (Day 1)|Adverse Event|0|||
28076058|NCT04263142|54730588|FG002|Part 2 Period 1 (Day 1)|Adverse Event|0|||
28076059|NCT04263142|54730589|FG003|Part 2 Period 1 (Day 1)|Adverse Event|0|||
27825483|NCT01743469|54290903|FG003|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
27825484|NCT01743001|54290915|FG000|Overall Study|Physician Decision|1|||
28076060|NCT04263142|54730590|FG004|Part 2 Period 1 (Day 1)|Adverse Event|1|||
27942382|NCT00603733|54599244|FG000|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3|||
27825485|NCT01743001|54290916|FG001|Overall Study|Physician Decision|0|||
27825486|NCT01743001|54290915|FG000|Overall Study|Pregnancy|1|||
28076061|NCT04263142|54730586|FG000|Part 2 Period 2 (Day 1)|Physician Decision|0|||
28076062|NCT04263142|54730587|FG001|Part 2 Period 2 (Day 1)|Physician Decision|0|||
28076063|NCT04263142|54730588|FG002|Part 2 Period 2 (Day 1)|Physician Decision|0|||
27825487|NCT01743001|54290916|FG001|Overall Study|Pregnancy|0|||
27825488|NCT01743001|54290915|FG000|Overall Study|Death|1|||
28076064|NCT04263142|54730589|FG003|Part 2 Period 2 (Day 1)|Physician Decision|0|||
28076065|NCT04263142|54730590|FG004|Part 2 Period 2 (Day 1)|Physician Decision|1|||
28076066|NCT04095286|54730603|FG000|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
28076067|NCT04095286|54730604|FG001|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1|||
28159149|NCT02499900|54828912|FG000|Extension Study Period|Lost to Follow-up|2|||
28076068|NCT04095286|54730605|FG002|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
28076069|NCT04095286|54730606|FG003|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
27942383|NCT00603733|54599245|FG001|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5|||
27825489|NCT01743001|54290916|FG001|Overall Study|Death|0|||
27825490|NCT01704079|54290935|FG000|Overall Study|Withdrawal by Subject|5|||
27943483|NCT01147068|54600394|FG004|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
27825491|NCT01704079|54290936|FG001|Overall Study|Withdrawal by Subject|7|||
28076070|NCT04095286|54730607|FG004|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
28076071|NCT04095286|54730608|FG005|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
28076072|NCT04095286|54730603|FG000|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1|||
28076073|NCT04095286|54730604|FG001|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
28076074|NCT04095286|54730605|FG002|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
28076075|NCT04095286|54730606|FG003|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
28076076|NCT04095286|54730607|FG004|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
28076077|NCT04095286|54730608|FG005|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
28159150|NCT02499900|54828913|FG001|Extension Study Period|Lost to Follow-up|5|||
28159151|NCT02499900|54828912|FG000|Extension Study Period|Other|0|||
28159152|NCT02499900|54828913|FG001|Extension Study Period|Other|2|||
28159153|NCT03505749|54828927|FG000|Overall Study|Lost to Follow-up|7|||
28159154|NCT03505749|54828928|FG001|Overall Study|Lost to Follow-up|11|||
28159155|NCT03505749|54828927|FG000|Overall Study|Withdrawal by Subject|6|||
28159156|NCT03505749|54828928|FG001|Overall Study|Withdrawal by Subject|0|||
28159157|NCT03505749|54828927|FG000|Overall Study|Discharged from treatment|3|||
28159158|NCT03505749|54828928|FG001|Overall Study|Discharged from treatment|6|||
28159159|NCT03710642|54828952|FG000|Overall Study|Adverse Event|5|||
28159160|NCT03710642|54828953|FG001|Overall Study|Adverse Event|1|||
28159161|NCT03710642|54828952|FG000|Overall Study|non-site physician recommendation|1|||
28159162|NCT03710642|54828953|FG001|Overall Study|non-site physician recommendation|0|||
28159163|NCT03710642|54828952|FG000|Overall Study|Participant unwilling or unable to participate|1|||
28159164|NCT03710642|54828953|FG001|Overall Study|Participant unwilling or unable to participate|1|||
28159165|NCT03710642|54828952|FG000|Overall Study|"other is selected as the reason for study termination"|1|||
28159166|NCT03710642|54828953|FG001|Overall Study|"other is selected as the reason for study termination"|3|||
28159167|NCT03710642|54828952|FG000|Overall Study|NA-no code provided|1|||
28159168|NCT03710642|54828953|FG001|Overall Study|NA-no code provided|0|||
28159169|NCT03710642|54828952|FG000|Overall Study|Withdrawal by Subject|1|||
28159170|NCT03710642|54828953|FG001|Overall Study|Withdrawal by Subject|0|||
28159171|NCT00705224|54828959|FG000|Overall Study|Adverse Event|1|||
27825492|NCT01704079|54290935|FG000|Overall Study|Lost to Follow-up|2|||
27825493|NCT01704079|54290936|FG001|Overall Study|Lost to Follow-up|5|||
27825494|NCT01704079|54290935|FG000|Overall Study|Adverse Event|4|||
28076078|NCT04095286|54730603|FG000|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
28076079|NCT04095286|54730604|FG001|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
28076080|NCT04095286|54730605|FG002|Period 1 (4 Days) + Washout (7days)|Adverse Event|1|||
28076081|NCT04095286|54730606|FG003|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
28159172|NCT00705224|54828959|FG000|Overall Study|Lack of Efficacy|2|||
27825495|NCT01704079|54290936|FG001|Overall Study|Adverse Event|7|||
28159173|NCT00705224|54828959|FG000|Overall Study|Withdrawal by Subject|3|||
28076082|NCT04095286|54730607|FG004|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
28076083|NCT04095286|54730608|FG005|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
28076084|NCT04095286|54730603|FG000|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
28076085|NCT04095286|54730604|FG001|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
28076086|NCT04095286|54730605|FG002|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2|||
28076087|NCT04095286|54730606|FG003|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
28076088|NCT04095286|54730607|FG004|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
28076089|NCT04095286|54730608|FG005|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
28076090|NCT04095286|54730603|FG000|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
28159174|NCT00705224|54828959|FG000|Overall Study|Lost to Follow-up|5|||
28159175|NCT02722148|54828966|FG000|Overall Study|Lost to Follow-up|2|||
28159176|NCT02722148|54828966|FG000|Overall Study|Non compliant with treatment regimen|3|||
28159177|NCT00704132|54828972|FG000|Overall Study|Clinical Adverse Experience|1|||
28159178|NCT00704132|54828973|FG001|Overall Study|Clinical Adverse Experience|0|||
28159179|NCT00704132|54828972|FG000|Overall Study|Lack of Efficacy|0|||
28159180|NCT00704132|54828973|FG001|Overall Study|Lack of Efficacy|1|||
28159181|NCT00704132|54828972|FG000|Overall Study|Withdrawal by Subject|0|||
28159182|NCT00704132|54828973|FG001|Overall Study|Withdrawal by Subject|1|||
28159183|NCT01329549|54828988|FG000|Overall Study|Withdrawal by Subject|1|||
28159184|NCT01329549|54828988|FG000|Overall Study|Adverse Event|1|||
28159185|NCT02736474|54828994|FG000|Overall Study|Lost to Follow-up|0|||
28159186|NCT02736474|54828995|FG001|Overall Study|Lost to Follow-up|1|||
28159187|NCT00702650|54829017|FG000|Overall Study|Withdrawal by Subject|9|||
28159188|NCT00702650|54829017|FG000|Overall Study|Non-Compliance of Study Drug|3|||
28159189|NCT00702650|54829017|FG000|Overall Study|Lost to Follow-up|2|||
28159190|NCT00702650|54829017|FG000|Overall Study|Non-Compliance with Site Directives|1|||
28159191|NCT00702650|54829017|FG000|Overall Study|Sponsor Request|1|||
28159192|NCT00702650|54829017|FG000|Overall Study|Screening Testosterone Levels >300 ng/dL|1|||
28159193|NCT00702650|54829017|FG000|Overall Study|Adverse Event|3|||
28159194|NCT03230916|54829032|FG000|Overall Study|Withdrawal by Subject|0|||
28159195|NCT03230916|54829033|FG001|Overall Study|Withdrawal by Subject|0|||
28159196|NCT03230916|54829034|FG002|Overall Study|Withdrawal by Subject|0|||
28159197|NCT03230916|54829035|FG003|Overall Study|Withdrawal by Subject|0|||
28159198|NCT03230916|54829036|FG004|Overall Study|Withdrawal by Subject|0|||
28159199|NCT03230916|54829037|FG005|Overall Study|Withdrawal by Subject|1|||
28159200|NCT03230916|54829038|FG006|Overall Study|Withdrawal by Subject|0|||
28159201|NCT03230916|54829039|FG007|Overall Study|Withdrawal by Subject|0|||
28076091|NCT04095286|54730604|FG001|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
28076092|NCT04095286|54730605|FG002|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
28076093|NCT04095286|54730606|FG003|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
28076094|NCT04095286|54730607|FG004|Period 2 (4 Days) + Washout (7days)|Adverse Event|1|||
28076095|NCT04095286|54730608|FG005|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
28076096|NCT04093414|54730618|FG000|3 Month Follow up|Physician Decision|0|||
28076097|NCT04093414|54730619|FG001|3 Month Follow up|Physician Decision|1|||
28076098|NCT04093414|54730618|FG000|6month Follow up|Physician Decision|1|||
28076099|NCT04093414|54730619|FG001|6month Follow up|Physician Decision|3|||
28076100|NCT04093258|54730625|FG000|Period 2|Subject no longer meets the eligibility criteria|1|||
28076101|NCT04093258|54730626|FG001|Period 2|Subject no longer meets the eligibility criteria|0|||
28159202|NCT03230916|54829040|FG008|Overall Study|Withdrawal by Subject|0|||
28159203|NCT03230916|54829041|FG009|Overall Study|Withdrawal by Subject|0|||
28159204|NCT03230916|54829042|FG010|Overall Study|Withdrawal by Subject|0|||
28159205|NCT01337115|54829085|FG000|Overall Study|Protocol Violation|2|||
28159206|NCT01337115|54829086|FG001|Overall Study|Protocol Violation|0|||
28159207|NCT03761784|54829096|FG000|Overall Study|Adverse Event|4|||
27942384|NCT04631107|54599251|FG000|First Intervention (1 Night)|ineligible participant was inadvertently randomized but not treated|1|||
27942385|NCT04631107|54599251|FG000|Second Intervention (1 Night)|Adverse Event|1|||
28159208|NCT03761784|54829097|FG001|Overall Study|Adverse Event|0|||
28159209|NCT03761784|54829096|FG000|Overall Study|Lost to Follow-up|10|||
28159210|NCT03761784|54829097|FG001|Overall Study|Lost to Follow-up|7|||
28159211|NCT03761784|54829096|FG000|Overall Study|Pregnancy|1|||
28159212|NCT03761784|54829097|FG001|Overall Study|Pregnancy|0|||
28159213|NCT03761784|54829096|FG000|Overall Study|Protocol Violation|2|||
27942386|NCT04631107|54599251|FG000|Second Intervention (1 Night)|Withdrawal by Subject|1|||
27942387|NCT04631107|54599251|FG000|Third Intervention (1 Night)|Withdrawal by Subject|2|||
27942388|NCT00995007|54599261|FG000|Overall Study|Withdrew consent|1|||
27942389|NCT00995007|54599262|FG001|Overall Study|Withdrew consent|0|||
27942390|NCT00995007|54599261|FG000|Overall Study|Refused further treatment|8|||
28159214|NCT03761784|54829097|FG001|Overall Study|Protocol Violation|0|||
27825496|NCT01704079|54290935|FG000|Overall Study|Protocol Violation|1|||
28159215|NCT03761784|54829096|FG000|Overall Study|Withdrawal by Parent or Guardian|4|||
28160138|NCT02557516|54830249|FG002|Overall Study|Adverse Event|2|||
27825497|NCT01704079|54290936|FG001|Overall Study|Protocol Violation|0|||
27942391|NCT00995007|54599262|FG001|Overall Study|Refused further treatment|2|||
27850366|NCT04178967|54349317|FG002|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
27850367|NCT04178967|54349318|FG003|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
28159216|NCT03761784|54829097|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
28159217|NCT03761784|54829096|FG000|Overall Study|Withdrawal by Subject|9|||
28159218|NCT03761784|54829097|FG001|Overall Study|Withdrawal by Subject|4|||
28159219|NCT03761784|54829096|FG000|Overall Study|Physician Decision|1|||
28159220|NCT03761784|54829097|FG001|Overall Study|Physician Decision|0|||
28159221|NCT03761784|54829096|FG000|Overall Study|Other Than Specified|1|||
28159222|NCT03761784|54829097|FG001|Overall Study|Other Than Specified|0|||
28159223|NCT03195894|54829105|FG000|Overall Study|"An example is Started other treatment."|4|||
28159224|NCT03195894|54829106|FG001|Overall Study|"An example is Started other treatment."|5|||
28159225|NCT03195894|54829105|FG000|Overall Study|Withdrawal by Subject|15|||
28159226|NCT03195894|54829106|FG001|Overall Study|Withdrawal by Subject|4|||
28159227|NCT03195894|54829105|FG000|Overall Study|Lost to Follow-up|14|||
28159228|NCT03195894|54829106|FG001|Overall Study|Lost to Follow-up|19|||
28159229|NCT01337973|54829118|FG000|Overall Study|Lost to Follow-up|2|||
28159230|NCT01337973|54829119|FG001|Overall Study|Lost to Follow-up|4|||
28159231|NCT01337973|54829120|FG002|Overall Study|Lost to Follow-up|3|||
28159232|NCT01337973|54829118|FG000|Overall Study|Death|1|||
28159233|NCT01337973|54829119|FG001|Overall Study|Death|2|||
28159234|NCT01337973|54829120|FG002|Overall Study|Death|1|||
28159235|NCT01337973|54829118|FG000|Overall Study|Withdrawal by Subject|10|||
28159236|NCT01337973|54829119|FG001|Overall Study|Withdrawal by Subject|8|||
28159237|NCT01337973|54829120|FG002|Overall Study|Withdrawal by Subject|4|||
28159238|NCT01337973|54829118|FG000|Overall Study|missing data on primary outcome|3|||
28159239|NCT01337973|54829119|FG001|Overall Study|missing data on primary outcome|1|||
28159240|NCT01337973|54829120|FG002|Overall Study|missing data on primary outcome|3|||
28159241|NCT02929056|54829130|FG000|Overall Study|Lost to Follow-up|0|||
28159242|NCT02929056|54829131|FG001|Overall Study|Lost to Follow-up|1|||
28159243|NCT00157755|54829150|FG000|Overall Study|Death|2|||
28159244|NCT00157755|54829151|FG001|Overall Study|Death|3|||
28159245|NCT00157755|54829152|FG002|Overall Study|Death|3|||
28159246|NCT00157755|54829153|FG003|Overall Study|Death|2|||
28159247|NCT00157755|54829154|FG004|Overall Study|Death|0|||
28159248|NCT00157755|54829155|FG005|Overall Study|Death|0|||
27942392|NCT00995007|54599261|FG000|Overall Study|Toxicity|8|||
27942393|NCT00995007|54599262|FG001|Overall Study|Toxicity|0|||
27825498|NCT01704079|54290935|FG000|Overall Study|Subject noncompliance|2|||
27850368|NCT04178967|54349319|FG004|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
27850369|NCT04178967|54349320|FG005|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
27850370|NCT04178967|54349321|FG006|Maintenance Blinded Treatment Period|Sponsor Decision|4|||
27850371|NCT04178967|54349322|FG007|Maintenance Blinded Treatment Period|Sponsor Decision|6|||
27850372|NCT04178967|54349323|FG008|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
27850373|NCT04178967|54349324|FG009|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
27850374|NCT04178967|54349325|FG010|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
27850375|NCT04178967|54349315|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
27850376|NCT04178967|54349316|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
27850377|NCT04178967|54349317|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
27850378|NCT04178967|54349318|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
27850379|NCT04178967|54349319|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
28076102|NCT04253236|54730634|FG000|Overall Study|Adverse Event|1|||
28076103|NCT04253236|54730635|FG001|Overall Study|Adverse Event|0|||
28076104|NCT04253236|54730634|FG000|Overall Study|Safety Concerns|1|||
28076105|NCT04253236|54730635|FG001|Overall Study|Safety Concerns|0|||
28076106|NCT04253236|54730634|FG000|Overall Study|Study Terminated by Sponsor|1|||
28076107|NCT04253236|54730635|FG001|Overall Study|Study Terminated by Sponsor|0|||
28076108|NCT04087720|54730641|FG000|Overall Study|Withdrawal by Subject|2|||
28076109|NCT04087720|54730641|FG000|Overall Study|Withdrawal by Subject - COVID-19 Concerns|3|||
28076110|NCT04086472|54730650|FG000|Overall Study|Lost to Follow-up|1|||
28076111|NCT04086472|54730651|FG001|Overall Study|Lost to Follow-up|0|||
28076112|NCT04086472|54730652|FG002|Overall Study|Lost to Follow-up|0|||
28076113|NCT04086472|54730653|FG003|Overall Study|Lost to Follow-up|0|||
28076114|NCT04086472|54730654|FG004|Overall Study|Lost to Follow-up|1|||
28076115|NCT04086472|54730650|FG000|Overall Study|Physician Decision|0|||
28076116|NCT04086472|54730651|FG001|Overall Study|Physician Decision|1|||
28076117|NCT04086472|54730652|FG002|Overall Study|Physician Decision|1|||
28076118|NCT04086472|54730653|FG003|Overall Study|Physician Decision|0|||
28076119|NCT04086472|54730654|FG004|Overall Study|Physician Decision|0|||
28076120|NCT04086472|54730650|FG000|Overall Study|Withdrawal by Subject|1|||
28076121|NCT04086472|54730651|FG001|Overall Study|Withdrawal by Subject|1|||
28076122|NCT04086472|54730652|FG002|Overall Study|Withdrawal by Subject|1|||
28076123|NCT04086472|54730653|FG003|Overall Study|Withdrawal by Subject|0|||
28076124|NCT04086472|54730654|FG004|Overall Study|Withdrawal by Subject|0|||
28076125|NCT04086472|54730650|FG000|Overall Study|Various reasons|2|||
28076126|NCT04086472|54730651|FG001|Overall Study|Various reasons|0|||
28076127|NCT04086472|54730652|FG002|Overall Study|Various reasons|0|||
28076128|NCT04086472|54730653|FG003|Overall Study|Various reasons|3|||
28076129|NCT04086472|54730654|FG004|Overall Study|Various reasons|1|||
28076130|NCT04249336|54730670|FG000|Overall Study|Lost to Follow-up|3|||
28076131|NCT04249336|54730671|FG001|Overall Study|Lost to Follow-up|3|||
28076132|NCT04249336|54730672|FG002|Overall Study|Lost to Follow-up|3|||
28076133|NCT04249336|54730673|FG003|Overall Study|Lost to Follow-up|3|||
28076134|NCT04245202|54730685|FG000|Overall Study|Lack of Efficacy|10|||
28076135|NCT04245202|54730686|FG001|Overall Study|Lack of Efficacy|1|||
28076136|NCT04079842|54730693|FG000|Overall Study|Request of subject|2|||
28076137|NCT04079842|54730693|FG000|Overall Study|Unable to draw Arterial samples|1|||
28076138|NCT04078126|54730697|FG000|Washout|Study put on hold due to COVID-19|0|||
28076139|NCT04078126|54730698|FG001|Washout|Study put on hold due to COVID-19|2|||
28076140|NCT04078126|54730697|FG000|Period 2|Study put on hold due to COVID-19|1|||
28076141|NCT04078126|54730698|FG001|Period 2|Study put on hold due to COVID-19|1|||
28076142|NCT04073368|54730708|FG000|Overall Study|Adverse Event|2|||
28076143|NCT04073368|54730709|FG001|Overall Study|Adverse Event|0|||
28076144|NCT04073368|54730710|FG002|Overall Study|Adverse Event|1|||
28076145|NCT04073368|54730711|FG003|Overall Study|Adverse Event|1|||
28076146|NCT04073368|54730708|FG000|Overall Study|Withdrawal by Subject|2|||
28076147|NCT04073368|54730709|FG001|Overall Study|Withdrawal by Subject|2|||
28076148|NCT04073368|54730710|FG002|Overall Study|Withdrawal by Subject|1|||
28076149|NCT04073368|54730711|FG003|Overall Study|Withdrawal by Subject|1|||
28076150|NCT04073368|54730708|FG000|Overall Study|Lost to Follow-up|1|||
28076151|NCT04073368|54730709|FG001|Overall Study|Lost to Follow-up|1|||
28076152|NCT04073368|54730710|FG002|Overall Study|Lost to Follow-up|1|||
27850380|NCT04178967|54349320|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|3|||
27850381|NCT04178967|54349321|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
27942394|NCT00994461|54599280|FG000|Overall Study|Adverse Event|2|||
27942395|NCT00994461|54599281|FG001|Overall Study|Adverse Event|1|||
28076153|NCT04073368|54730711|FG003|Overall Study|Lost to Follow-up|0|||
28076154|NCT04073368|54730708|FG000|Overall Study|Protocol Violation|0|||
28076155|NCT04073368|54730709|FG001|Overall Study|Protocol Violation|1|||
28076156|NCT04073368|54730710|FG002|Overall Study|Protocol Violation|0|||
28076157|NCT04073368|54730711|FG003|Overall Study|Protocol Violation|0|||
28159249|NCT00157755|54829150|FG000|Overall Study|Lost to Follow-up|0|||
27825499|NCT01704079|54290936|FG001|Overall Study|Subject noncompliance|3|||
27825500|NCT01704079|54290935|FG000|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0|||
27825501|NCT01704079|54290936|FG001|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1|||
27825502|NCT01703845|54290944|FG000|Overall Study|Adverse Event|1|||
27825503|NCT01703845|54290945|FG001|Overall Study|Adverse Event|0|||
27825504|NCT01703845|54290944|FG000|Overall Study|Protocol Violation|1|||
27825505|NCT01703845|54290945|FG001|Overall Study|Protocol Violation|0|||
27825506|NCT01703845|54290944|FG000|Overall Study|other than stated above|1|||
27825507|NCT01703845|54290945|FG001|Overall Study|other than stated above|0|||
27825508|NCT01724359|54290953|FG000|Overall Study|Adverse Event|10|||
27825509|NCT01724359|54290953|FG000|Overall Study|Death|1|||
27825510|NCT01724359|54290953|FG000|Overall Study|Other|20|||
27825511|NCT01703221|54290962|FG000|Phase A (Up to 24 Weeks)|Adverse Event|2|||
27825512|NCT01703221|54290963|FG001|Phase A (Up to 24 Weeks)|Adverse Event|4|||
27825513|NCT01703221|54290964|FG002|Phase A (Up to 24 Weeks)|Adverse Event|0|||
27825514|NCT01703221|54290962|FG000|Phase A (Up to 24 Weeks)|Lack of Efficacy|2|||
27825515|NCT01703221|54290963|FG001|Phase A (Up to 24 Weeks)|Lack of Efficacy|0|||
27825516|NCT01703221|54290964|FG002|Phase A (Up to 24 Weeks)|Lack of Efficacy|1|||
27825517|NCT01703221|54290962|FG000|Phase A (Up to 24 Weeks)|Physician Decision|1|||
27825518|NCT01703221|54290963|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
27825519|NCT01703221|54290964|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
27825520|NCT01703221|54290962|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2|||
27825521|NCT01703221|54290963|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
27825522|NCT01703221|54290964|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
27825523|NCT01703221|54290962|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
28159250|NCT00157755|54829151|FG001|Overall Study|Lost to Follow-up|0|||
28159251|NCT00157755|54829152|FG002|Overall Study|Lost to Follow-up|1|||
28159252|NCT00157755|54829153|FG003|Overall Study|Lost to Follow-up|0|||
28159253|NCT00157755|54829154|FG004|Overall Study|Lost to Follow-up|0|||
28159254|NCT00157755|54829155|FG005|Overall Study|Lost to Follow-up|0|||
28159255|NCT00157755|54829150|FG000|Overall Study|Withdrawal by Subject|0|||
28159256|NCT00157755|54829151|FG001|Overall Study|Withdrawal by Subject|0|||
28159257|NCT00157755|54829152|FG002|Overall Study|Withdrawal by Subject|1|||
28159258|NCT00157755|54829153|FG003|Overall Study|Withdrawal by Subject|1|||
28159259|NCT00157755|54829154|FG004|Overall Study|Withdrawal by Subject|1|||
28159260|NCT00157755|54829155|FG005|Overall Study|Withdrawal by Subject|2|||
28159261|NCT00157755|54829150|FG000|Overall Study|Explant due to infection|0|||
27850382|NCT04178967|54349322|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
27850383|NCT04178967|54349323|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
27850384|NCT04178967|54349324|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
27850385|NCT04178967|54349325|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
27850386|NCT04178967|54349315|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
27850387|NCT04178967|54349316|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
27850388|NCT04178967|54349317|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
27850389|NCT04178967|54349318|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
27850390|NCT04178967|54349319|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
27850391|NCT04178967|54349320|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
28159262|NCT00157755|54829151|FG001|Overall Study|Explant due to infection|0|||
27825524|NCT01703221|54290963|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
27825525|NCT01703221|54290964|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
27825526|NCT01703221|54290962|FG000|Phase B - (Week 25 to 52)|Withdrawal by Subject|2|||
27825527|NCT01703221|54290963|FG001|Phase B - (Week 25 to 52)|Withdrawal by Subject|1|||
27942396|NCT00994461|54599282|FG002|Overall Study|Adverse Event|0|||
28076158|NCT04073368|54730708|FG000|Overall Study|Subject noncompliance|7|||
28076159|NCT04073368|54730709|FG001|Overall Study|Subject noncompliance|4|||
28076160|NCT04073368|54730710|FG002|Overall Study|Subject noncompliance|0|||
28076161|NCT04073368|54730711|FG003|Overall Study|Subject noncompliance|0|||
28076162|NCT04380688|54730723|FG000|Overall Study|Death|2|||
28076163|NCT04380688|54730724|FG001|Overall Study|Death|2|||
28076164|NCT04380688|54730723|FG000|Overall Study|Lost to Follow-up|2|||
28076165|NCT04380688|54730724|FG001|Overall Study|Lost to Follow-up|4|||
28159263|NCT00157755|54829152|FG002|Overall Study|Explant due to infection|1|||
28159264|NCT00157755|54829153|FG003|Overall Study|Explant due to infection|0|||
28159265|NCT00157755|54829154|FG004|Overall Study|Explant due to infection|0|||
28159266|NCT00157755|54829155|FG005|Overall Study|Explant due to infection|0|||
28076166|NCT04380688|54730723|FG000|Overall Study|Withdrawal by Subject|3|||
28076167|NCT04380688|54730724|FG001|Overall Study|Withdrawal by Subject|3|||
28076168|NCT00124748|54730732|FG000|Overall Study|Adverse Event|8|||
28076169|NCT00124748|54730733|FG001|Overall Study|Adverse Event|39|||
28076170|NCT00124748|54730732|FG000|Overall Study|Abnormal laboratory Value|2|||
28076171|NCT00124748|54730733|FG001|Overall Study|Abnormal laboratory Value|2|||
28076172|NCT00124748|54730732|FG000|Overall Study|Abnormal Procedure|0|||
28076173|NCT00124748|54730733|FG001|Overall Study|Abnormal Procedure|1|||
28076174|NCT00124748|54730732|FG000|Overall Study|Lack of Efficacy|20|||
28076175|NCT00124748|54730733|FG001|Overall Study|Lack of Efficacy|41|||
28076176|NCT00124748|54730732|FG000|Overall Study|No longer requires study drug|1|||
28076177|NCT00124748|54730733|FG001|Overall Study|No longer requires study drug|1|||
28159267|NCT00157755|54829150|FG000|Overall Study|Medical reason|0|||
28159268|NCT00157755|54829151|FG001|Overall Study|Medical reason|0|||
28159269|NCT00157755|54829152|FG002|Overall Study|Medical reason|1|||
28159270|NCT00157755|54829153|FG003|Overall Study|Medical reason|1|||
28159271|NCT00157755|54829154|FG004|Overall Study|Medical reason|0|||
28159272|NCT00157755|54829155|FG005|Overall Study|Medical reason|0|||
28159273|NCT00157755|54829150|FG000|Overall Study|Study site closure|0|||
28159274|NCT00157755|54829151|FG001|Overall Study|Study site closure|1|||
28159275|NCT00157755|54829152|FG002|Overall Study|Study site closure|0|||
28159276|NCT00157755|54829153|FG003|Overall Study|Study site closure|0|||
28159277|NCT00157755|54829154|FG004|Overall Study|Study site closure|0|||
28159278|NCT00157755|54829155|FG005|Overall Study|Study site closure|0|||
28159279|NCT00157755|54829150|FG000|Overall Study|Subject non-compliance|0|||
28159280|NCT00157755|54829151|FG001|Overall Study|Subject non-compliance|0|||
28159281|NCT00157755|54829152|FG002|Overall Study|Subject non-compliance|0|||
28159282|NCT00157755|54829153|FG003|Overall Study|Subject non-compliance|0|||
28159283|NCT00157755|54829154|FG004|Overall Study|Subject non-compliance|0|||
28076178|NCT00124748|54730732|FG000|Overall Study|Protocol Violation|3|||
28076179|NCT00124748|54730733|FG001|Overall Study|Protocol Violation|1|||
28076180|NCT00124748|54730732|FG000|Overall Study|Withdrawal by Subject|5|||
28076181|NCT00124748|54730733|FG001|Overall Study|Withdrawal by Subject|15|||
28076182|NCT00124748|54730732|FG000|Overall Study|Lost to Follow-up|2|||
28076183|NCT00124748|54730733|FG001|Overall Study|Lost to Follow-up|7|||
28159284|NCT00157755|54829155|FG005|Overall Study|Subject non-compliance|1|||
28159285|NCT00157755|54829150|FG000|Overall Study|Study completion|0|||
28159286|NCT00157755|54829151|FG001|Overall Study|Study completion|0|||
28159287|NCT00157755|54829152|FG002|Overall Study|Study completion|0|||
28159288|NCT00157755|54829153|FG003|Overall Study|Study completion|0|||
28076184|NCT00124748|54730732|FG000|Overall Study|Administrative Problem(Study Terminated)|101|||
28159289|NCT00157755|54829154|FG004|Overall Study|Study completion|1|||
28159290|NCT00157755|54829155|FG005|Overall Study|Study completion|2|||
28159291|NCT02723006|54829164|FG000|Overall Study|Withdrawal by Subject|0|||
28159292|NCT02723006|54829165|FG001|Overall Study|Withdrawal by Subject|1|||
28159293|NCT02723006|54829166|FG002|Overall Study|Withdrawal by Subject|1|||
28159294|NCT02723006|54829164|FG000|Overall Study|Study Terminated by Sponsor|1|||
28159295|NCT02723006|54829165|FG001|Overall Study|Study Terminated by Sponsor|6|||
28159296|NCT02723006|54829166|FG002|Overall Study|Study Terminated by Sponsor|6|||
28159297|NCT04003389|54829177|FG000|Overall Study|Adverse Event|27|||
28159298|NCT04003389|54829178|FG001|Overall Study|Adverse Event|34|||
28159299|NCT04003389|54829179|FG002|Overall Study|Adverse Event|28|||
28159300|NCT04003389|54829177|FG000|Overall Study|Lost to Follow-up|39|||
28159301|NCT04003389|54829178|FG001|Overall Study|Lost to Follow-up|30|||
28159302|NCT04003389|54829179|FG002|Overall Study|Lost to Follow-up|33|||
28159303|NCT04003389|54829177|FG000|Overall Study|Protocol Violation|1|||
28159304|NCT04003389|54829178|FG001|Overall Study|Protocol Violation|6|||
28159305|NCT04003389|54829179|FG002|Overall Study|Protocol Violation|5|||
28159306|NCT04003389|54829177|FG000|Overall Study|Withdrawal by Subject|119|||
28159307|NCT04003389|54829178|FG001|Overall Study|Withdrawal by Subject|79|||
28159308|NCT04003389|54829179|FG002|Overall Study|Withdrawal by Subject|85|||
28159309|NCT04003389|54829177|FG000|Overall Study|Miscellaneous|14|||
28159310|NCT04003389|54829178|FG001|Overall Study|Miscellaneous|11|||
28159311|NCT04003389|54829179|FG002|Overall Study|Miscellaneous|14|||
28159312|NCT04003389|54829177|FG000|Overall Study|Participant did not receive study drug|1|||
28159313|NCT04003389|54829178|FG001|Overall Study|Participant did not receive study drug|0|||
28159314|NCT04003389|54829179|FG002|Overall Study|Participant did not receive study drug|0|||
28076185|NCT00124748|54730733|FG001|Overall Study|Administrative Problem(Study Terminated)|174|||
28076186|NCT00124748|54730732|FG000|Overall Study|Death|1|||
28076187|NCT00124748|54730733|FG001|Overall Study|Death|3|||
28076188|NCT04070326|54730741|FG000|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|1|||
28076189|NCT04070326|54730742|FG001|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|0|||
28076190|NCT03689452|54730752|FG000|Overall Study|Lost to Follow-up|1|||
28159315|NCT00702962|54829189|FG000|Overall Study|Progressive disease|0|||
28159316|NCT00702962|54829190|FG001|Overall Study|Progressive disease|1|||
28076191|NCT03689452|54730753|FG001|Overall Study|Lost to Follow-up|1|||
28076192|NCT04067050|54730761|FG000|One Month|Lost to Follow-up|4|||
28076193|NCT04067050|54730762|FG001|One Month|Lost to Follow-up|0|||
28076194|NCT04067050|54730761|FG000|Two Month|Lost to Follow-up|1|||
28076195|NCT04067050|54730762|FG001|Two Month|Lost to Follow-up|0|||
28076196|NCT04067050|54730761|FG000|Two Month|Adverse Event|1|||
28076197|NCT04067050|54730762|FG001|Two Month|Adverse Event|0|||
28076198|NCT04060654|54730768|FG000|Overall Study|Withdrawal by Subject|1|||
28076199|NCT04060654|54730768|FG000|Overall Study|Lost to Follow-up|5|||
28076200|NCT00096200|54730775|FG000|Overall Study|Adverse Event|0|||
28159317|NCT00702962|54829189|FG000|Overall Study|Hospitalized for other health disorder|1|||
28159318|NCT00702962|54829190|FG001|Overall Study|Hospitalized for other health disorder|0|||
28159319|NCT01379508|54829202|FG000|Treatment to Week 104|Adverse Event|2|||
28159320|NCT01379508|54829203|FG001|Treatment to Week 104|Adverse Event|0|||
28076201|NCT00096200|54730776|FG001|Overall Study|Adverse Event|4|||
28076202|NCT00096200|54730777|FG002|Overall Study|Adverse Event|0|||
28159321|NCT01379508|54829204|FG002|Treatment to Week 104|Adverse Event|5|||
28076203|NCT00096200|54730775|FG000|Overall Study|Withdrawal by Subject|1|||
28076204|NCT00096200|54730776|FG001|Overall Study|Withdrawal by Subject|2|||
28076205|NCT00096200|54730777|FG002|Overall Study|Withdrawal by Subject|0|||
28076206|NCT00096200|54730775|FG000|Overall Study|Ineligible pathology|0|||
28076207|NCT00096200|54730776|FG001|Overall Study|Ineligible pathology|1|||
28159322|NCT01379508|54829205|FG003|Treatment to Week 104|Adverse Event|0|||
28159323|NCT01379508|54829202|FG000|Treatment to Week 104|Abnormal lab value|1|||
28159324|NCT01379508|54829203|FG001|Treatment to Week 104|Abnormal lab value|0|||
28159325|NCT01379508|54829204|FG002|Treatment to Week 104|Abnormal lab value|0|||
28159326|NCT01379508|54829205|FG003|Treatment to Week 104|Abnormal lab value|0|||
28159327|NCT01379508|54829202|FG000|Treatment to Week 104|Abnormal test procedure result(s)|1|||
28159328|NCT01379508|54829203|FG001|Treatment to Week 104|Abnormal test procedure result(s)|0|||
28159329|NCT01379508|54829204|FG002|Treatment to Week 104|Abnormal test procedure result(s)|0|||
28159330|NCT01379508|54829205|FG003|Treatment to Week 104|Abnormal test procedure result(s)|0|||
28159331|NCT01379508|54829202|FG000|Treatment to Week 104|Withdrawal by Subject|6|||
28159332|NCT01379508|54829203|FG001|Treatment to Week 104|Withdrawal by Subject|1|||
28159333|NCT01379508|54829204|FG002|Treatment to Week 104|Withdrawal by Subject|4|||
28159334|NCT01379508|54829205|FG003|Treatment to Week 104|Withdrawal by Subject|0|||
28076208|NCT00096200|54730777|FG002|Overall Study|Ineligible pathology|0|||
28076209|NCT04059094|54730790|FG000|Overall Study|Adverse Event|0|||
28076210|NCT04059094|54730791|FG001|Overall Study|Adverse Event|0|||
28076211|NCT04059094|54730792|FG002|Overall Study|Adverse Event|0|||
28076212|NCT04059094|54730793|FG003|Overall Study|Adverse Event|0|||
28076213|NCT04059094|54730794|FG004|Overall Study|Adverse Event|1|||
28076214|NCT04059094|54730790|FG000|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
28076215|NCT04059094|54730791|FG001|Overall Study|Not willing to travel due to COVID-19 pandemic|2|||
28076216|NCT04059094|54730792|FG002|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
28076217|NCT04059094|54730793|FG003|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
28159335|NCT01379508|54829202|FG000|Treatment to Week 104|Lost to Follow-up|5|||
28159336|NCT01379508|54829203|FG001|Treatment to Week 104|Lost to Follow-up|0|||
28159337|NCT01379508|54829204|FG002|Treatment to Week 104|Lost to Follow-up|3|||
28159338|NCT01379508|54829205|FG003|Treatment to Week 104|Lost to Follow-up|0|||
27825528|NCT01703221|54290964|FG002|Phase B - (Week 25 to 52)|Withdrawal by Subject|0|||
28076218|NCT04059094|54730794|FG004|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
28076219|NCT00096044|54730810|FG000|Overall Study|Withdrawal by Subject|9|||
28076220|NCT00096044|54730810|FG000|Overall Study|Adverse Event|21|||
28076221|NCT00096044|54730810|FG000|Overall Study|Disease Progression|4|||
28076222|NCT03689374|54730816|FG000|Run-in Period (12 Weeks)|Run-in failure|526|||
28076223|NCT03689374|54730817|FG001|Run-in Period (12 Weeks)|Run-in failure|0|||
28076224|NCT03689374|54730818|FG002|Run-in Period (12 Weeks)|Run-in failure|0|||
28076225|NCT03689374|54730816|FG000|Treatment Period (Week 0 to 52)|Withdrawal by Subject|0|||
28076226|NCT03689374|54730817|FG001|Treatment Period (Week 0 to 52)|Withdrawal by Subject|10|||
28076227|NCT03689374|54730818|FG002|Treatment Period (Week 0 to 52)|Withdrawal by Subject|38|||
28076228|NCT03689374|54730816|FG000|Treatment Period (Week 0 to 52)|Lost to Follow-up|0|||
28076229|NCT03689374|54730817|FG001|Treatment Period (Week 0 to 52)|Lost to Follow-up|3|||
28076230|NCT03689374|54730818|FG002|Treatment Period (Week 0 to 52)|Lost to Follow-up|4|||
28076231|NCT03689374|54730816|FG000|Treatment Period (Week 0 to 52)|Death|0|||
28076232|NCT03689374|54730817|FG001|Treatment Period (Week 0 to 52)|Death|11|||
28076233|NCT03689374|54730818|FG002|Treatment Period (Week 0 to 52)|Death|1|||
28076234|NCT00113360|54730824|FG000|Overall Study|Adverse Event|3|||
28076235|NCT00113360|54730824|FG000|Overall Study|Subject required surgery|1|||
28076236|NCT00113360|54730824|FG000|Overall Study|Did not meet eligibility criteria|3|||
28076237|NCT00123734|54730828|FG000|Overall Study|Death|3|||
28076238|NCT00123734|54730828|FG000|Overall Study|Lost to Follow-up|3|||
28076239|NCT00123734|54730828|FG000|Overall Study|Dropout|1|||
28076240|NCT00123734|54730828|FG000|Overall Study|Withdrawal by Subject|1|||
28076241|NCT00112736|54730838|FG000|Overall Study|1 pt never had had RX due rapid decline|1|||
28076242|NCT00112736|54730839|FG001|Overall Study|1 pt never had had RX due rapid decline|0|||
28076243|NCT00123422|54730854|FG000|Overall Study|Physician Decision|2|||
28076244|NCT00123422|54730855|FG001|Overall Study|Physician Decision|2|||
28076245|NCT00123422|54730856|FG002|Overall Study|Physician Decision|6|||
28076246|NCT00123422|54730854|FG000|Overall Study|Withdrawal by Subject|1|||
28076247|NCT00123422|54730855|FG001|Overall Study|Withdrawal by Subject|2|||
28076248|NCT00123422|54730856|FG002|Overall Study|Withdrawal by Subject|2|||
28076249|NCT00123422|54730854|FG000|Overall Study|Lost to Follow-up|1|||
28076250|NCT00123422|54730855|FG001|Overall Study|Lost to Follow-up|2|||
28076251|NCT00123422|54730856|FG002|Overall Study|Lost to Follow-up|2|||
28076252|NCT04052620|54730866|FG000|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|1|||
28076253|NCT04052620|54730867|FG001|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|0|||
28076254|NCT04052620|54730866|FG000|Overall Study|Withdrawal by Subject|1|||
28076255|NCT04052620|54730867|FG001|Overall Study|Withdrawal by Subject|0|||
28076256|NCT04052620|54730866|FG000|Overall Study|Lost to Follow-up|1|||
28076257|NCT04052620|54730867|FG001|Overall Study|Lost to Follow-up|1|||
28076258|NCT04052620|54730866|FG000|Overall Study|Adverse Event|1|||
28076259|NCT04052620|54730867|FG001|Overall Study|Adverse Event|0|||
28076260|NCT04052620|54730866|FG000|Overall Study|Subject did not meet study Criteria|0|||
28076261|NCT04052620|54730867|FG001|Overall Study|Subject did not meet study Criteria|1|||
28076262|NCT04052620|54730866|FG000|Overall Study|Screened failure, randomized by mistake|0|||
28076263|NCT04052620|54730867|FG001|Overall Study|Screened failure, randomized by mistake|1|||
28076264|NCT04052620|54730866|FG000|Overall Study|Personal reasons|2|||
28076265|NCT04052620|54730867|FG001|Overall Study|Personal reasons|4|||
28076266|NCT04052620|54730866|FG000|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|1|||
28076267|NCT04052620|54730867|FG001|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|0|||
28076268|NCT00112580|54730875|FG000|Overall Study|Adverse Event|1|||
28076269|NCT00112580|54730876|FG001|Overall Study|Adverse Event|2|||
28076270|NCT00112580|54730875|FG000|Overall Study|Disease progression|5|||
28076271|NCT00112580|54730876|FG001|Overall Study|Disease progression|16|||
28076272|NCT00112580|54730875|FG000|Overall Study|Participant withdrew consent|2|||
28076273|NCT00112580|54730876|FG001|Overall Study|Participant withdrew consent|1|||
28076274|NCT04238650|54730883|FG000|Overall Study|Withdrawal by Subject|0|||
27850392|NCT04178967|54349321|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
27850393|NCT04178967|54349322|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
28076275|NCT04238650|54730884|FG001|Overall Study|Withdrawal by Subject|1|||
28076276|NCT00095576|54730892|FG000|Overall Study|Adverse Event|5|||
28076277|NCT00095576|54730893|FG001|Overall Study|Adverse Event|3|||
28076278|NCT00095576|54730892|FG000|Overall Study|Lost to Follow-up|233|||
28076279|NCT00095576|54730893|FG001|Overall Study|Lost to Follow-up|229|||
28076280|NCT00095576|54730892|FG000|Overall Study|Protocol Violation|1|||
28076281|NCT00095576|54730893|FG001|Overall Study|Protocol Violation|0|||
28076282|NCT00095576|54730892|FG000|Overall Study|Withdrawal by Subject|34|||
28076283|NCT00095576|54730893|FG001|Overall Study|Withdrawal by Subject|47|||
28160139|NCT02557516|54830250|FG003|Overall Study|Adverse Event|1|||
28076284|NCT00095576|54730892|FG000|Overall Study|Option to switch to a rollover study|1097|||
28076285|NCT00095576|54730893|FG001|Overall Study|Option to switch to a rollover study|1099|||
28076286|NCT00095576|54730892|FG000|Overall Study|Site terminated|75|||
28076287|NCT00095576|54730893|FG001|Overall Study|Site terminated|67|||
28076288|NCT00095576|54730892|FG000|Overall Study|Subject moved|30|||
28076289|NCT00095576|54730893|FG001|Overall Study|Subject moved|36|||
28076290|NCT04049578|54730899|FG000|Overall Study|Physician Decision|1|||
28076291|NCT04044352|54730903|FG000|Overall Study|Lost to Follow-up|9|||
28076292|NCT04044352|54730903|FG000|Overall Study|Withdrawal by Subject|2|||
28076293|NCT04043962|54730908|FG000|Post-Treatment|Declined due to lack of time/interest or could not be reached|3|||
28076294|NCT04043962|54730908|FG000|Post-Treatment|Withdrawal by Subject|5|||
28076295|NCT04043962|54730908|FG000|Follow-up|Declined due to lack of time/interest or could not be reached|7|||
28076296|NCT04043728|54730915|FG000|Overall Study|Lost to Follow-up|1|||
28076297|NCT04043728|54730916|FG001|Overall Study|Lost to Follow-up|2|||
28076298|NCT04043728|54730917|FG002|Overall Study|Lost to Follow-up|0|||
28076299|NCT04043416|54730927|FG000|Washout|Change in health condition|0|||
28076300|NCT04043416|54730928|FG001|Washout|Change in health condition|1|||
28076301|NCT00095498|54730940|FG000|Overall Study|Physician Decision|9|||
28076302|NCT00095498|54730941|FG001|Overall Study|Physician Decision|10|||
28076303|NCT00095498|54730942|FG002|Overall Study|Physician Decision|8|||
28076304|NCT00095498|54730940|FG000|Overall Study|Adverse Event|1|||
28076305|NCT00095498|54730941|FG001|Overall Study|Adverse Event|0|||
28076306|NCT00095498|54730942|FG002|Overall Study|Adverse Event|1|||
28076307|NCT00095498|54730940|FG000|Overall Study|Withdrawal by Subject|15|||
28076308|NCT00095498|54730941|FG001|Overall Study|Withdrawal by Subject|16|||
28076309|NCT00095498|54730942|FG002|Overall Study|Withdrawal by Subject|15|||
28076310|NCT00095498|54730940|FG000|Overall Study|Disease progression|0|||
28076311|NCT00095498|54730941|FG001|Overall Study|Disease progression|1|||
28076312|NCT00095498|54730942|FG002|Overall Study|Disease progression|1|||
28076313|NCT00095498|54730940|FG000|Overall Study|Ineligibility determined|3|||
28159339|NCT01379508|54829202|FG000|Treatment to Week 104|Administrative problems|3|||
28159340|NCT01379508|54829203|FG001|Treatment to Week 104|Administrative problems|1|||
28159341|NCT01379508|54829204|FG002|Treatment to Week 104|Administrative problems|0|||
28159342|NCT01379508|54829205|FG003|Treatment to Week 104|Administrative problems|0|||
28159343|NCT01379508|54829202|FG000|Treatment to Week 104|Protocol Violation|1|||
28159344|NCT01379508|54829203|FG001|Treatment to Week 104|Protocol Violation|1|||
28159345|NCT01379508|54829204|FG002|Treatment to Week 104|Protocol Violation|1|||
28159346|NCT01379508|54829205|FG003|Treatment to Week 104|Protocol Violation|0|||
28159347|NCT01379508|54829202|FG000|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
28159348|NCT01379508|54829203|FG001|Extension Period Weeks 109-156|Withdrawal by Subject|1|||
28159349|NCT01379508|54829204|FG002|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
28159350|NCT01379508|54829205|FG003|Extension Period Weeks 109-156|Withdrawal by Subject|0|||
28159351|NCT01379508|54829202|FG000|Extension Period Weeks 109-156|Lost to Follow-up|6|||
28159352|NCT01379508|54829203|FG001|Extension Period Weeks 109-156|Lost to Follow-up|1|||
28159353|NCT01379508|54829204|FG002|Extension Period Weeks 109-156|Lost to Follow-up|5|||
28076314|NCT00095498|54730941|FG001|Overall Study|Ineligibility determined|0|||
28076315|NCT00095498|54730942|FG002|Overall Study|Ineligibility determined|2|||
28076316|NCT00095498|54730940|FG000|Overall Study|Lost to Follow-up|1|||
28076317|NCT00095498|54730941|FG001|Overall Study|Lost to Follow-up|1|||
28076318|NCT00095498|54730942|FG002|Overall Study|Lost to Follow-up|2|||
28076319|NCT00095498|54730940|FG000|Overall Study|Noncompliance|1|||
28076320|NCT00095498|54730941|FG001|Overall Study|Noncompliance|0|||
28076321|NCT00095498|54730942|FG002|Overall Study|Noncompliance|1|||
28076322|NCT00095498|54730940|FG000|Overall Study|Other|6|||
28076323|NCT00095498|54730941|FG001|Overall Study|Other|7|||
28076324|NCT00095498|54730942|FG002|Overall Study|Other|6|||
27825529|NCT01703221|54290962|FG000|Phase B - (Week 25 to 52)|Adverse Event|2|||
27825530|NCT01703221|54290963|FG001|Phase B - (Week 25 to 52)|Adverse Event|3|||
27825531|NCT01703221|54290964|FG002|Phase B - (Week 25 to 52)|Adverse Event|2|||
27825532|NCT01703221|54290962|FG000|Phase B - (Week 25 to 52)|Lack of Efficacy|12|||
27825533|NCT01703221|54290963|FG001|Phase B - (Week 25 to 52)|Lack of Efficacy|10|||
27942397|NCT00993915|54599290|FG000|Overall Study|Insufficient clinical response|3|||
27942398|NCT00993915|54599290|FG000|Overall Study|Withdrawal by Subject|2|||
27942399|NCT00993915|54599290|FG000|Overall Study|Other|1|||
27942400|NCT00993915|54599290|FG000|Overall Study|Ongoing|3|||
27942401|NCT01202591|54599300|FG000|Overall Study|Adverse Event|2|||
27942402|NCT01202591|54599301|FG001|Overall Study|Adverse Event|1|||
27942403|NCT01202591|54599302|FG002|Overall Study|Adverse Event|4|||
27942404|NCT01202591|54599303|FG003|Overall Study|Adverse Event|4|||
27942405|NCT01202591|54599304|FG004|Overall Study|Adverse Event|0|||
27942406|NCT01202591|54599305|FG005|Overall Study|Adverse Event|0|||
27942407|NCT01202591|54599300|FG000|Overall Study|Other reason as per investigator|3|||
27942408|NCT01202591|54599301|FG001|Overall Study|Other reason as per investigator|4|||
27942409|NCT01202591|54599302|FG002|Overall Study|Other reason as per investigator|7|||
27942410|NCT01202591|54599303|FG003|Overall Study|Other reason as per investigator|3|||
27942411|NCT01202591|54599304|FG004|Overall Study|Other reason as per investigator|1|||
27942412|NCT01202591|54599305|FG005|Overall Study|Other reason as per investigator|3|||
27942413|NCT01202591|54599300|FG000|Overall Study|Withdrawal by Subject|0|||
27942414|NCT01202591|54599301|FG001|Overall Study|Withdrawal by Subject|0|||
27942415|NCT01202591|54599302|FG002|Overall Study|Withdrawal by Subject|0|||
27942416|NCT01202591|54599303|FG003|Overall Study|Withdrawal by Subject|0|||
27942417|NCT01202591|54599304|FG004|Overall Study|Withdrawal by Subject|2|||
27942418|NCT01202591|54599305|FG005|Overall Study|Withdrawal by Subject|1|||
27942419|NCT01202591|54599300|FG000|Overall Study|Objective Disease Progression|0|||
27942420|NCT01202591|54599301|FG001|Overall Study|Objective Disease Progression|0|||
27942421|NCT01202591|54599302|FG002|Overall Study|Objective Disease Progression|0|||
27942422|NCT01202591|54599303|FG003|Overall Study|Objective Disease Progression|0|||
27942423|NCT01202591|54599304|FG004|Overall Study|Objective Disease Progression|2|||
27942424|NCT01202591|54599305|FG005|Overall Study|Objective Disease Progression|0|||
27942425|NCT01202279|54599321|FG000|Overall Study|Adverse Event|8|||
27942426|NCT01202279|54599322|FG001|Overall Study|Adverse Event|6|||
27942427|NCT01202279|54599321|FG000|Overall Study|Withdrawal by Subject|13|||
27942428|NCT01202279|54599322|FG001|Overall Study|Withdrawal by Subject|10|||
27942429|NCT01202279|54599321|FG000|Overall Study|Physician Decision|0|||
27942430|NCT01202279|54599322|FG001|Overall Study|Physician Decision|1|||
27942431|NCT01202279|54599321|FG000|Overall Study|Lost to Follow-up|10|||
28159354|NCT01379508|54829205|FG003|Extension Period Weeks 109-156|Lost to Follow-up|0|||
28159355|NCT01379508|54829202|FG000|Extension Period Weeks 109-156|Administrative problems|3|||
28159356|NCT01379508|54829203|FG001|Extension Period Weeks 109-156|Administrative problems|0|||
28159357|NCT01379508|54829204|FG002|Extension Period Weeks 109-156|Administrative problems|1|||
28159358|NCT01379508|54829205|FG003|Extension Period Weeks 109-156|Administrative problems|0|||
28159359|NCT01379508|54829202|FG000|Extension Period Weeks 109-156|Protocol Violation|2|||
28159360|NCT01379508|54829203|FG001|Extension Period Weeks 109-156|Protocol Violation|1|||
28159361|NCT01379508|54829204|FG002|Extension Period Weeks 109-156|Protocol Violation|0|||
28159362|NCT01379508|54829205|FG003|Extension Period Weeks 109-156|Protocol Violation|0|||
28159363|NCT02722928|54829221|FG000|Overall Study|Standard CT was not as required per prot|5|||
28159364|NCT02722928|54829222|FG001|Overall Study|Standard CT was not as required per prot|13|||
28159365|NCT02722928|54829221|FG000|Overall Study|Required Intraoperative MRI|5|||
28159366|NCT02722928|54829222|FG001|Overall Study|Required Intraoperative MRI|7|||
28159367|NCT02722304|54829237|FG000|Overall Study|Study Terminated by Sponsor|1|||
28159368|NCT02722304|54829238|FG001|Overall Study|Study Terminated by Sponsor|0|||
28159369|NCT02722304|54829239|FG002|Overall Study|Study Terminated by Sponsor|2|||
28159370|NCT02722304|54829240|FG003|Overall Study|Study Terminated by Sponsor|1|||
28159371|NCT02722304|54829241|FG004|Overall Study|Study Terminated by Sponsor|1|||
28159372|NCT02722304|54829237|FG000|Overall Study|Other|0|||
28159373|NCT02722304|54829238|FG001|Overall Study|Other|0|||
28159374|NCT02722304|54829239|FG002|Overall Study|Other|0|||
28159375|NCT02722304|54829240|FG003|Overall Study|Other|1|||
28159376|NCT02722304|54829241|FG004|Overall Study|Other|1|||
28159377|NCT00709956|54829257|FG000|Overall Study|Withdrawal by Subject|1|||
28159378|NCT00709956|54829258|FG001|Overall Study|Withdrawal by Subject|1|||
28159379|NCT00709956|54829257|FG000|Overall Study|Inclusion/exclusion criteria violation|2|||
28159380|NCT00709956|54829258|FG001|Overall Study|Inclusion/exclusion criteria violation|3|||
28159381|NCT02719028|54829288|FG000|Overall Study|Adverse Event|2|||
28159382|NCT02719028|54829289|FG001|Overall Study|Adverse Event|1|||
28159383|NCT02719028|54829290|FG002|Overall Study|Adverse Event|4|||
28159384|NCT02719028|54829291|FG003|Overall Study|Adverse Event|8|||
28159385|NCT02719028|54829288|FG000|Overall Study|Physician Decision|0|||
28159386|NCT02719028|54829289|FG001|Overall Study|Physician Decision|1|||
28159387|NCT02719028|54829290|FG002|Overall Study|Physician Decision|1|||
28159388|NCT02719028|54829291|FG003|Overall Study|Physician Decision|1|||
28159389|NCT02719028|54829288|FG000|Overall Study|Use of prohibited medication|0|||
28159390|NCT02719028|54829289|FG001|Overall Study|Use of prohibited medication|0|||
28159391|NCT02719028|54829290|FG002|Overall Study|Use of prohibited medication|1|||
28159392|NCT02719028|54829291|FG003|Overall Study|Use of prohibited medication|0|||
28159393|NCT02719028|54829288|FG000|Overall Study|Protocol Violation|0|||
28159394|NCT02719028|54829289|FG001|Overall Study|Protocol Violation|0|||
28159395|NCT02719028|54829290|FG002|Overall Study|Protocol Violation|0|||
28159396|NCT02719028|54829291|FG003|Overall Study|Protocol Violation|1|||
28159397|NCT02720510|54829303|FG000|Overall Study|Study Terminated by the sponsor|2|||
28159398|NCT02720510|54829304|FG001|Overall Study|Study Terminated by the sponsor|0|||
28159399|NCT02720510|54829303|FG000|Overall Study|Adverse Event|0|||
28159400|NCT02720510|54829304|FG001|Overall Study|Adverse Event|1|||
28159401|NCT02720510|54829303|FG000|Overall Study|Physician Decision|1|||
28159402|NCT02720510|54829304|FG001|Overall Study|Physician Decision|2|||
28159403|NCT02720198|54829312|FG000|Overall Study|Withdrawal by Subject|0|||
28159404|NCT02720198|54829313|FG001|Overall Study|Withdrawal by Subject|1|||
28159405|NCT00703118|54829335|FG000|Overall Study|Adverse Event|1|||
28159406|NCT00703118|54829336|FG001|Overall Study|Adverse Event|2|||
28159407|NCT00703118|54829337|FG002|Overall Study|Adverse Event|2|||
28159408|NCT00703118|54829335|FG000|Overall Study|Subject Ineligible To Continue The Trial|6|||
28159409|NCT00703118|54829336|FG001|Overall Study|Subject Ineligible To Continue The Trial|3|||
28076325|NCT00095498|54730940|FG000|Overall Study|Protocol Violation|0|||
28076326|NCT00095498|54730941|FG001|Overall Study|Protocol Violation|0|||
28076327|NCT00095498|54730942|FG002|Overall Study|Protocol Violation|1|||
28076328|NCT00095498|54730940|FG000|Overall Study|Requirement for alternative therapy|1|||
28076329|NCT00095498|54730941|FG001|Overall Study|Requirement for alternative therapy|0|||
28076330|NCT00095498|54730942|FG002|Overall Study|Requirement for alternative therapy|2|||
28076331|NCT04237792|54730956|FG000|Treatment (Day 1)|Adverse Event|1|||
28076332|NCT04237792|54730957|FG001|Treatment (Day 1)|Adverse Event|0|||
27942432|NCT01202279|54599322|FG001|Overall Study|Lost to Follow-up|7|||
28076333|NCT04237792|54730958|FG002|Treatment (Day 1)|Adverse Event|0|||
28159410|NCT00703118|54829337|FG002|Overall Study|Subject Ineligible To Continue The Trial|2|||
28159411|NCT00703118|54829335|FG000|Overall Study|Lost to Follow-up|6|||
28159412|NCT00703118|54829336|FG001|Overall Study|Lost to Follow-up|4|||
28159413|NCT00703118|54829337|FG002|Overall Study|Lost to Follow-up|4|||
28159414|NCT00703118|54829335|FG000|Overall Study|Withdrawal by Subject|8|||
27850394|NCT04178967|54349323|FG008|Maintenance Open Label Escape Arm|Adverse Event|3|||
27850395|NCT04178967|54349324|FG009|Maintenance Open Label Escape Arm|Adverse Event|3|||
27850396|NCT04178967|54349325|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
27850397|NCT04178967|54349315|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
27850398|NCT04178967|54349316|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
27850399|NCT04178967|54349317|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
27850400|NCT04178967|54349318|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
27850401|NCT04178967|54349319|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
27850402|NCT04178967|54349320|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
27850403|NCT04178967|54349321|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
27850404|NCT04178967|54349322|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
27942433|NCT01202279|54599321|FG000|Overall Study|Protocol Violation|1|||
27942434|NCT01202279|54599322|FG001|Overall Study|Protocol Violation|1|||
27825534|NCT01703221|54290964|FG002|Phase B - (Week 25 to 52)|Lack of Efficacy|3|||
27825535|NCT01722877|54290978|FG000|Overall Study|Death|1|||
27825536|NCT01722877|54290978|FG000|Overall Study|Lost to Follow-up|1|||
27825537|NCT01703065|54291023|FG000|Overall Study|Lack of Efficacy|1|||
27825538|NCT01703065|54291024|FG001|Overall Study|Lack of Efficacy|0|||
27825539|NCT01702987|54291037|FG000|Overall Study|Withdrawal by Subject|1|||
27825540|NCT01702987|54291038|FG001|Overall Study|Withdrawal by Subject|0|||
27825541|NCT01702519|54291059|FG000|Washout Period|Lost to Follow-up|1|||
27825542|NCT01702519|54291060|FG001|Washout Period|Lost to Follow-up|0|||
27825543|NCT01702519|54291059|FG000|Washout Period|Withdrawal by Subject|0|||
27825544|NCT01702519|54291060|FG001|Washout Period|Withdrawal by Subject|2|||
27825545|NCT01739803|54291072|FG000|Overall Study|Lost to Follow-up|9|||
27942435|NCT01202279|54599321|FG000|Overall Study|study compliance|5|||
27942436|NCT01202279|54599322|FG001|Overall Study|study compliance|2|||
27942437|NCT01201967|54599330|FG000|Overall Study|Lost to Follow-up|6|||
27850405|NCT04178967|54349323|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|16|||
27850406|NCT04178967|54349324|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|27|||
27850407|NCT04178967|54349325|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|2|||
27850408|NCT04178967|54349315|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
27850409|NCT04178967|54349316|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
27850410|NCT04178967|54349317|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
27850411|NCT04178967|54349318|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
27850412|NCT04178967|54349319|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
27850413|NCT04178967|54349320|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
27850414|NCT04178967|54349321|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
27850415|NCT04178967|54349322|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
27850416|NCT04178967|54349323|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
27850417|NCT04178967|54349324|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
27850418|NCT04178967|54349325|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
27850419|NCT04178967|54349315|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
27850420|NCT04178967|54349316|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
27850421|NCT04178967|54349317|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
27850422|NCT04178967|54349318|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
27850423|NCT04178967|54349319|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
27850424|NCT04178967|54349320|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
27850425|NCT04178967|54349321|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
27850426|NCT04178967|54349322|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
27850427|NCT04178967|54349323|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|4|||
27850428|NCT04178967|54349324|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|9|||
27850429|NCT04178967|54349325|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
27850430|NCT04178967|54349315|FG000|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
27850431|NCT04178967|54349316|FG001|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
27850432|NCT04178967|54349317|FG002|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
27850433|NCT04178967|54349318|FG003|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
27850434|NCT04178967|54349319|FG004|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
27850435|NCT04178967|54349320|FG005|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
27850436|NCT04178967|54349321|FG006|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
27850437|NCT04178967|54349322|FG007|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
27850438|NCT04178967|54349323|FG008|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
27850439|NCT04178967|54349324|FG009|Maintenance Open Label Escape Arm|Sponsor Decision|1|||
27850440|NCT04178967|54349325|FG010|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
27850441|NCT04178967|54349315|FG000|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
27850442|NCT04178967|54349316|FG001|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
27850443|NCT04178967|54349317|FG002|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
27850444|NCT04178967|54349318|FG003|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
27850445|NCT04178967|54349319|FG004|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
27850446|NCT04178967|54349320|FG005|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
27850447|NCT04178967|54349321|FG006|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
27850448|NCT04178967|54349322|FG007|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
27942438|NCT01201967|54599331|FG001|Overall Study|Lost to Follow-up|5|||
27942439|NCT01201811|54599347|FG000|Overall Study|Adverse Event|6|||
27942440|NCT01201811|54599347|FG000|Overall Study|Disease progression|3|||
27942441|NCT01201811|54599347|FG000|Overall Study|Withdrawal by Subject|3|||
27942442|NCT01201811|54599347|FG000|Overall Study|Death|4|||
27942443|NCT01201811|54599347|FG000|Overall Study|Treatment Failure|2|||
27942444|NCT01201811|54599347|FG000|Overall Study|Physician Decision|1|||
27942445|NCT01201343|54599351|FG000|Overall Study|Adverse Event|6|||
27942446|NCT01201343|54599351|FG000|Overall Study|Withdrawal by Subject|5|||
27942447|NCT01201343|54599351|FG000|Overall Study|Lost to Follow-up|2|||
27942448|NCT01201343|54599351|FG000|Overall Study|Lack of Efficacy|2|||
27942449|NCT01201343|54599351|FG000|Overall Study|Participant wrongly included in trial|1|||
27942450|NCT01201343|54599351|FG000|Overall Study|Randomized, not treated|3|||
27942451|NCT01201265|54599355|FG000|Overall Study|Death|14|||
27942452|NCT01201265|54599355|FG000|Overall Study|Insufficient Therapeutic Response|3|||
27942453|NCT01201265|54599355|FG000|Overall Study|Lost to Follow-up|10|||
27942454|NCT01201265|54599355|FG000|Overall Study|Withdrawal by Subject|7|||
27942455|NCT01201265|54599355|FG000|Overall Study|Disease Progression|4|||
27942456|NCT04246801|54599361|FG000|Overall Study|Adverse Event|1|||
27942457|NCT04246801|54599362|FG001|Overall Study|Adverse Event|1|||
27942458|NCT04246801|54599361|FG000|Overall Study|Protocol Violation|1|||
27942459|NCT04246801|54599362|FG001|Overall Study|Protocol Violation|1|||
27942460|NCT04246801|54599361|FG000|Overall Study|Lack of Efficacy|0|||
27942461|NCT04246801|54599362|FG001|Overall Study|Lack of Efficacy|2|||
27942462|NCT04246801|54599361|FG000|Overall Study|Lost to Follow-up|1|||
27942463|NCT04246801|54599362|FG001|Overall Study|Lost to Follow-up|1|||
27942464|NCT04246801|54599361|FG000|Overall Study|Withdrawal by Subject|2|||
27942465|NCT04246801|54599362|FG001|Overall Study|Withdrawal by Subject|1|||
27942466|NCT01200797|54599368|FG000|Overall Study|symptomatic deterioration|2|||
27942467|NCT01200797|54599368|FG000|Overall Study|Adverse Event|4|||
27942468|NCT01200797|54599368|FG000|Overall Study|Disease Progression|13|||
27942469|NCT01200485|54599373|FG000|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1|||
27942470|NCT01200485|54599374|FG001|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
27942471|NCT01200485|54599375|FG002|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
27942472|NCT01200485|54599373|FG000|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2|||
27942473|NCT01200485|54599374|FG001|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
27942474|NCT01200485|54599375|FG002|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
27942475|NCT01200407|54599382|FG000|Overall Study|Lost to Follow-up|56|||
27942476|NCT01200407|54599382|FG000|Overall Study|Adverse Event|3|||
27942477|NCT01200407|54599382|FG000|Overall Study|Withdrawal by Subject|4|||
27942478|NCT01200407|54599382|FG000|Overall Study|Other|19|||
27942479|NCT01200329|54599386|FG000|Overall Study|Lack of financial coverage|2|||
27942480|NCT01200329|54599386|FG000|Overall Study|Progressive disease|1|||
27942481|NCT01199939|54599390|FG000|Overall Study|Adverse Event|4|||
27942482|NCT01199939|54599390|FG000|Overall Study|Protocol Violation|3|||
27942483|NCT01199939|54599390|FG000|Overall Study|Lost to Follow-up|2|||
27942484|NCT01199939|54599390|FG000|Overall Study|Reached a virologic endpoint|4|||
27942485|NCT01199861|54599396|FG000|Overall Study|Administrative problems|1|||
27942486|NCT01199861|54599397|FG001|Overall Study|Administrative problems|0|||
27942487|NCT01199861|54599396|FG000|Overall Study|Adverse Event|1|||
27942488|NCT01199861|54599397|FG001|Overall Study|Adverse Event|0|||
27942489|NCT01199705|54599417|FG000|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1|||
27942490|NCT01199471|54599432|FG000|Overall Study|Protocol Violation|4|||
27942491|NCT01199471|54599432|FG000|Overall Study|Withdrawal by Subject|1|||
27942492|NCT01199471|54599432|FG000|Overall Study|Physician Decision|1|||
27942493|NCT01198145|54599439|FG000|Overall Study|Withdrawal by Subject|1|||
27942494|NCT01198145|54599440|FG001|Overall Study|Withdrawal by Subject|1|||
27942495|NCT01197911|54599450|FG000|Overall Study|Adverse Event|0|||
27942496|NCT01197911|54599451|FG001|Overall Study|Adverse Event|0|||
27942497|NCT01197911|54599452|FG002|Overall Study|Adverse Event|1|||
27942498|NCT01197755|54599464|FG000|Overall Study|Adverse Event|8|||
27942499|NCT01197755|54599465|FG001|Overall Study|Adverse Event|10|||
27942500|NCT01197755|54599466|FG002|Overall Study|Adverse Event|10|||
27942501|NCT01197755|54599464|FG000|Overall Study|Study-specific discontinuation criteria|2|||
27942502|NCT01197755|54599465|FG001|Overall Study|Study-specific discontinuation criteria|1|||
27942503|NCT01197755|54599466|FG002|Overall Study|Study-specific discontinuation criteria|0|||
27942504|NCT01197755|54599464|FG000|Overall Study|Entered the long-term extension study|18|||
27942505|NCT01197755|54599465|FG001|Overall Study|Entered the long-term extension study|21|||
27942506|NCT01197755|54599466|FG002|Overall Study|Entered the long-term extension study|35|||
27942507|NCT01197755|54599464|FG000|Overall Study|Lack of therapeutic response|0|||
27942508|NCT01197755|54599465|FG001|Overall Study|Lack of therapeutic response|7|||
28159415|NCT00703118|54829336|FG001|Overall Study|Withdrawal by Subject|7|||
28159416|NCT00703118|54829337|FG002|Overall Study|Withdrawal by Subject|13|||
28159417|NCT00703118|54829335|FG000|Overall Study|Other|0|||
28159418|NCT00703118|54829336|FG001|Overall Study|Other|0|||
28159419|NCT00703118|54829337|FG002|Overall Study|Other|1|||
28159420|NCT00909753|54829359|FG000|Period: Washout of 28 Days|Protocol Violation|2|||
28159421|NCT00909753|54829360|FG001|Period: Washout of 28 Days|Protocol Violation|3|||
28159422|NCT00909753|54829359|FG000|Period: Second Intervention|Protocol Violation|1|||
28159423|NCT00909753|54829360|FG001|Period: Second Intervention|Protocol Violation|0|||
28159424|NCT03745638|54829367|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|4|||
28159425|NCT03745638|54829368|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|2|||
28159426|NCT03745638|54829369|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
28159427|NCT03745638|54829370|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
28159428|NCT03745638|54829371|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
28159429|NCT03745638|54829372|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
28159430|NCT03745638|54829373|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
28159431|NCT03745638|54829367|FG000|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|1|||
28159432|NCT03745638|54829368|FG001|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
28159433|NCT03745638|54829369|FG002|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
28159434|NCT03745638|54829370|FG003|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
28159435|NCT03745638|54829371|FG004|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
28159436|NCT03745638|54829372|FG005|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
28159437|NCT03745638|54829373|FG006|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
28160140|NCT02557516|54830247|FG000|Overall Study|Disease progression|0|||
27825546|NCT01739803|54291073|FG001|Overall Study|Lost to Follow-up|6|||
27825547|NCT01739335|54291085|FG000|Overall Study|Lost to Follow-up|7|||
27825548|NCT01739335|54291086|FG001|Overall Study|Lost to Follow-up|4|||
27942509|NCT01197755|54599466|FG002|Overall Study|Lack of therapeutic response|4|||
27942510|NCT01197755|54599464|FG000|Overall Study|Severe non-compliance to the protocol|2|||
27942511|NCT01197755|54599465|FG001|Overall Study|Severe non-compliance to the protocol|1|||
27942512|NCT01197755|54599466|FG002|Overall Study|Severe non-compliance to the protocol|2|||
27942513|NCT01197755|54599464|FG000|Overall Study|Withdrawal by Subject|1|||
27942514|NCT01197755|54599465|FG001|Overall Study|Withdrawal by Subject|0|||
27942515|NCT01197755|54599466|FG002|Overall Study|Withdrawal by Subject|0|||
27942516|NCT01197755|54599464|FG000|Overall Study|Lost to Follow-up|0|||
27942517|NCT01197755|54599465|FG001|Overall Study|Lost to Follow-up|0|||
27942518|NCT01197755|54599466|FG002|Overall Study|Lost to Follow-up|1|||
27942519|NCT01197755|54599464|FG000|Overall Study|eg, change in circumstances|7|||
27942520|NCT01197755|54599465|FG001|Overall Study|eg, change in circumstances|3|||
27942521|NCT01197755|54599466|FG002|Overall Study|eg, change in circumstances|2|||
27942522|NCT01179048|54599478|FG000|Overall Study|Withdrawn - does not allow contact|4|||
27942523|NCT01179048|54599479|FG001|Overall Study|Withdrawn - does not allow contact|8|||
27942524|NCT01179048|54599478|FG000|Overall Study|Lost to Follow-up|8|||
27942525|NCT01179048|54599479|FG001|Overall Study|Lost to Follow-up|9|||
27942526|NCT01179048|54599478|FG000|Overall Study|Alive|127|||
27942527|NCT01179048|54599479|FG001|Overall Study|Alive|142|||
27942528|NCT00603265|54599488|FG000|Overall Study|Adverse Event|2|||
27942529|NCT00603265|54599489|FG001|Overall Study|Adverse Event|11|||
27942530|NCT00603265|54599490|FG002|Overall Study|Adverse Event|1|||
27942531|NCT00603265|54599488|FG000|Overall Study|Withdrawal by Subject|1|||
27942532|NCT00603265|54599489|FG001|Overall Study|Withdrawal by Subject|2|||
27942533|NCT00603265|54599490|FG002|Overall Study|Withdrawal by Subject|1|||
27942534|NCT00603265|54599488|FG000|Overall Study|Lack of Efficacy|3|||
27942535|NCT00603265|54599489|FG001|Overall Study|Lack of Efficacy|0|||
27942536|NCT00603265|54599490|FG002|Overall Study|Lack of Efficacy|3|||
27942537|NCT00603265|54599488|FG000|Overall Study|Lost to Follow-up|0|||
27942538|NCT00603265|54599489|FG001|Overall Study|Lost to Follow-up|1|||
27942539|NCT00603265|54599490|FG002|Overall Study|Lost to Follow-up|0|||
27942540|NCT00603265|54599488|FG000|Overall Study|Out of Town, Ran Out of Study Drug|0|||
27942541|NCT00603265|54599489|FG001|Overall Study|Out of Town, Ran Out of Study Drug|1|||
27942542|NCT00603265|54599490|FG002|Overall Study|Out of Town, Ran Out of Study Drug|0|||
27942543|NCT00603265|54599488|FG000|Overall Study|Participant Left Country, No Responses|0|||
27942544|NCT00603265|54599489|FG001|Overall Study|Participant Left Country, No Responses|1|||
27942545|NCT00603265|54599490|FG002|Overall Study|Participant Left Country, No Responses|0|||
27942546|NCT00603265|54599488|FG000|Overall Study|Protocol Violation|1|||
27942547|NCT00603265|54599489|FG001|Overall Study|Protocol Violation|0|||
27942548|NCT00603265|54599490|FG002|Overall Study|Protocol Violation|0|||
27942549|NCT04010227|54599500|FG000|Overall Study|Death|1|||
27942550|NCT04010227|54599501|FG001|Overall Study|Death|2|||
27942551|NCT04010227|54599500|FG000|Overall Study|Medical Reasons|4|||
27942552|NCT04010227|54599501|FG001|Overall Study|Medical Reasons|3|||
27942553|NCT04010227|54599500|FG000|Overall Study|Withdrawal by Subject|2|||
27942554|NCT04010227|54599501|FG001|Overall Study|Withdrawal by Subject|0|||
27942555|NCT04010227|54599500|FG000|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
27942556|NCT04010227|54599501|FG001|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
27942557|NCT01158534|54599508|FG000|Overall Study|Withdrawal by Subject|1|||
27942558|NCT01158534|54599508|FG000|Overall Study|Death|1|||
27942559|NCT01158534|54599508|FG000|Overall Study|Other|1|||
27942560|NCT01158378|54599514|FG000|Overall Study|Death|4|||
27942561|NCT01158378|54599515|FG001|Overall Study|Death|5|||
28160141|NCT02557516|54830248|FG001|Overall Study|Disease progression|2|||
27850449|NCT04178967|54349323|FG008|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
27942562|NCT01158378|54599514|FG000|Overall Study|Lost to Follow-up|2|||
27942563|NCT01158378|54599515|FG001|Overall Study|Lost to Follow-up|4|||
27942564|NCT01158378|54599514|FG000|Overall Study|Withdrawal by Subject|4|||
27942565|NCT01158378|54599515|FG001|Overall Study|Withdrawal by Subject|0|||
27942566|NCT00602797|54599522|FG000|Overall Study|Adverse Event|1|||
27942567|NCT01158222|54599527|FG000|Overall Study|Not eligible for intermediate phase|17|||
27942568|NCT01197521|54599534|FG000|Overall Study|Not reported|24|||
27942569|NCT01197521|54599535|FG001|Overall Study|Not reported|25|||
27942570|NCT01197521|54599536|FG002|Overall Study|Not reported|21|||
27942571|NCT01197521|54599534|FG000|Overall Study|Enrolment in long term extension|42|||
27942572|NCT01197521|54599535|FG001|Overall Study|Enrolment in long term extension|36|||
27942573|NCT01197521|54599536|FG002|Overall Study|Enrolment in long term extension|87|||
27942574|NCT01197521|54599534|FG000|Overall Study|Severe non-compliance to protocol|1|||
27942575|NCT01197521|54599535|FG001|Overall Study|Severe non-compliance to protocol|3|||
27942576|NCT01197521|54599536|FG002|Overall Study|Severe non-compliance to protocol|3|||
27942577|NCT01197521|54599534|FG000|Overall Study|Lack of therapeutic response|2|||
27942578|NCT01197521|54599535|FG001|Overall Study|Lack of therapeutic response|3|||
27942579|NCT01197521|54599536|FG002|Overall Study|Lack of therapeutic response|4|||
27942580|NCT01197521|54599534|FG000|Overall Study|Dev. of study specific discont. criteria|6|||
27942581|NCT01197521|54599535|FG001|Overall Study|Dev. of study specific discont. criteria|16|||
27942582|NCT01197521|54599536|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
27942583|NCT01197521|54599534|FG000|Overall Study|Lost to Follow-up|3|||
27942584|NCT01197521|54599535|FG001|Overall Study|Lost to Follow-up|2|||
27942585|NCT01197521|54599536|FG002|Overall Study|Lost to Follow-up|2|||
27942586|NCT01197521|54599534|FG000|Overall Study|Adverse Event|25|||
27942587|NCT01197521|54599535|FG001|Overall Study|Adverse Event|28|||
27942588|NCT01197521|54599536|FG002|Overall Study|Adverse Event|24|||
27942589|NCT01157676|54599549|FG000|Randomization|Death|1|||
27942590|NCT01157676|54599550|FG001|Randomization|Death|1|||
27942591|NCT01157676|54599549|FG000|Randomization|unresectable|2|||
27942592|NCT01157676|54599550|FG001|Randomization|unresectable|3|||
27942593|NCT01157676|54599549|FG000|Randomization|Withdrawal by Subject|17|||
27942594|NCT01157676|54599550|FG001|Randomization|Withdrawal by Subject|13|||
27942595|NCT01157676|54599549|FG000|Randomization|Physician Decision|1|||
27942596|NCT01157676|54599550|FG001|Randomization|Physician Decision|0|||
27942597|NCT01157676|54599549|FG000|Surgery|underwent open cystectomy|0|||
27942598|NCT01157676|54599550|FG001|Surgery|underwent open cystectomy|4|||
27942599|NCT01157676|54599549|FG000|Surgery|converted to open procedure|0|||
27942600|NCT01157676|54599550|FG001|Surgery|converted to open procedure|5|||
27942601|NCT01157676|54599549|FG000|Surgery|underwent robotic cystectomy|1|||
27942602|NCT01157676|54599550|FG001|Surgery|underwent robotic cystectomy|0|||
27942603|NCT00991341|54599564|FG000|Overall Study|no surgery w/in 30 days of randomization|11|||
27942604|NCT00991341|54599565|FG001|Overall Study|no surgery w/in 30 days of randomization|18|||
27942605|NCT00991341|54599564|FG000|Overall Study|Death|3|||
27942606|NCT00991341|54599565|FG001|Overall Study|Death|0|||
27942607|NCT00991341|54599564|FG000|Overall Study|no RBCs received 96hrs after randomized|186|||
27942608|NCT00991341|54599565|FG001|Overall Study|no RBCs received 96hrs after randomized|155|||
27942609|NCT00991341|54599564|FG000|Overall Study|Physician Decision|1|||
27942610|NCT00991341|54599565|FG001|Overall Study|Physician Decision|2|||
27942611|NCT00991341|54599564|FG000|Overall Study|Withdrawal by Subject|3|||
27942612|NCT00991341|54599565|FG001|Overall Study|Withdrawal by Subject|4|||
27942613|NCT00990249|54599571|FG000|Overall Study|Disease Progression|8|||
27942614|NCT00990249|54599571|FG000|Overall Study|Non-Compliance|1|||
27942615|NCT00990249|54599571|FG000|Overall Study|Death|2|||
27942616|NCT00990249|54599571|FG000|Overall Study|Not treated|2|||
27942617|NCT02846545|54599577|FG000|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
27942618|NCT02846545|54599578|FG001|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
27942619|NCT02846545|54599577|FG000|Active Treatment Period: Week 0-52|Non-compliance with study drug|1|||
27942620|NCT02846545|54599578|FG001|Active Treatment Period: Week 0-52|Non-compliance with study drug|0|||
27942621|NCT02846545|54599577|FG000|Active Treatment Period: Week 0-52|Withdrawal by Subject|1|||
27942622|NCT02846545|54599578|FG001|Active Treatment Period: Week 0-52|Withdrawal by Subject|5|||
27942623|NCT02846545|54599577|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
27942624|NCT02846545|54599578|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
27942625|NCT02846545|54599577|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
27942626|NCT02846545|54599578|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
27942627|NCT00990093|54599588|FG000|Test Period 1 (1-14 Days)|Adverse Event|1|||
27942628|NCT00990093|54599589|FG001|Test Period 1 (1-14 Days)|Adverse Event|0|||
27942629|NCT00990093|54599588|FG000|Test Period 1 (1-14 Days)|Withdrawal by Subject|2|||
27942630|NCT00990093|54599589|FG001|Test Period 1 (1-14 Days)|Withdrawal by Subject|0|||
27942631|NCT00990093|54599588|FG000|Test Period 1 (1-14 Days)|Other|1|||
27942632|NCT00990093|54599589|FG001|Test Period 1 (1-14 Days)|Other|0|||
27942633|NCT00990093|54599588|FG000|Test Period 1 (1-14 Days)|Lack of Efficacy|0|||
27942634|NCT00990093|54599589|FG001|Test Period 1 (1-14 Days)|Lack of Efficacy|2|||
27942635|NCT00990093|54599588|FG000|Test Period 2 (15-28 Days)|Adverse Event|1|||
27942636|NCT00990093|54599589|FG001|Test Period 2 (15-28 Days)|Adverse Event|0|||
27942637|NCT00990093|54599588|FG000|Test Period 2 (15-28 Days)|Lack of Efficacy|1|||
27942638|NCT00990093|54599589|FG001|Test Period 2 (15-28 Days)|Lack of Efficacy|0|||
27942639|NCT00990093|54599588|FG000|Test Period 2 (15-28 Days)|Other|0|||
27942640|NCT00990093|54599589|FG001|Test Period 2 (15-28 Days)|Other|1|||
27942641|NCT00984165|54599599|FG000|Overall Study|Death on study|2|||
27942642|NCT00984165|54599600|FG001|Overall Study|Death on study|0|||
27942643|NCT00984165|54599601|FG002|Overall Study|Death on study|0|||
27942644|NCT00984165|54599602|FG003|Overall Study|Death on study|0|||
27942645|NCT00984165|54599599|FG000|Overall Study|Disease progression on study|5|||
27942646|NCT00984165|54599600|FG001|Overall Study|Disease progression on study|1|||
27942647|NCT00984165|54599601|FG002|Overall Study|Disease progression on study|0|||
27942648|NCT00984165|54599602|FG003|Overall Study|Disease progression on study|0|||
27942649|NCT00984165|54599599|FG000|Overall Study|Death of recipient|0|||
27942650|NCT00984165|54599600|FG001|Overall Study|Death of recipient|0|||
27942651|NCT00984165|54599601|FG002|Overall Study|Death of recipient|0|||
27942652|NCT00984165|54599602|FG003|Overall Study|Death of recipient|1|||
27942653|NCT00984165|54599599|FG000|Overall Study|New protocol|0|||
27942654|NCT00984165|54599600|FG001|Overall Study|New protocol|0|||
27942655|NCT00984165|54599601|FG002|Overall Study|New protocol|0|||
27942656|NCT00984165|54599602|FG003|Overall Study|New protocol|1|||
27942657|NCT00984165|54599599|FG000|Overall Study|P+/donor pair removed from protocol|0|||
27825549|NCT01739335|54291085|FG000|Overall Study|Ineligible patient randomized|0|||
27942658|NCT00984165|54599600|FG001|Overall Study|P+/donor pair removed from protocol|0|||
27942659|NCT00984165|54599601|FG002|Overall Study|P+/donor pair removed from protocol|0|||
27942660|NCT00984165|54599602|FG003|Overall Study|P+/donor pair removed from protocol|1|||
27942661|NCT00984165|54599599|FG000|Overall Study|removed with a pair recipient|0|||
28076334|NCT04237792|54730959|FG003|Treatment (Day 1)|Adverse Event|0|||
28076335|NCT04237792|54730960|FG004|Treatment (Day 1)|Adverse Event|1|||
28076336|NCT04237792|54730961|FG005|Treatment (Day 1)|Adverse Event|1|||
28076337|NCT04237792|54730956|FG000|Treatment (Day 1)|Other|0|||
28076338|NCT04237792|54730957|FG001|Treatment (Day 1)|Other|0|||
28076339|NCT04237792|54730958|FG002|Treatment (Day 1)|Other|1|||
28076340|NCT04237792|54730959|FG003|Treatment (Day 1)|Other|0|||
28076341|NCT04237792|54730960|FG004|Treatment (Day 1)|Other|0|||
28076342|NCT04237792|54730961|FG005|Treatment (Day 1)|Other|1|||
28076343|NCT04237792|54730956|FG000|Treatment (Day 1)|Not treated|1|||
28076344|NCT04237792|54730957|FG001|Treatment (Day 1)|Not treated|1|||
28076345|NCT04237792|54730958|FG002|Treatment (Day 1)|Not treated|2|||
28076346|NCT04237792|54730959|FG003|Treatment (Day 1)|Not treated|1|||
27825550|NCT01739335|54291086|FG001|Overall Study|Ineligible patient randomized|1|||
28076347|NCT04237792|54730960|FG004|Treatment (Day 1)|Not treated|0|||
28076348|NCT04237792|54730961|FG005|Treatment (Day 1)|Not treated|1|||
28160142|NCT02557516|54830249|FG002|Overall Study|Disease progression|0|||
27942662|NCT00984165|54599600|FG001|Overall Study|removed with a pair recipient|0|||
27942663|NCT00984165|54599601|FG002|Overall Study|removed with a pair recipient|0|||
27942664|NCT00984165|54599602|FG003|Overall Study|removed with a pair recipient|1|||
27825551|NCT01702363|54291111|FG000|Overall Study|Adverse Event|14|||
28076349|NCT00122954|54730992|FG000|Overall Study|Withdrawal by Subject|2|||
28076350|NCT00122954|54730993|FG001|Overall Study|Withdrawal by Subject|2|||
28076351|NCT00122954|54730992|FG000|Overall Study|Protocol Violation|0|||
28076352|NCT00122954|54730993|FG001|Overall Study|Protocol Violation|1|||
28076353|NCT04491994|54731001|FG000|Overall Study|Withdrawal by Subject|10|||
28076354|NCT04491994|54731002|FG001|Overall Study|Withdrawal by Subject|5|||
28076355|NCT04491994|54731001|FG000|Overall Study|developed fever > 3 days|4|||
28076356|NCT04491994|54731002|FG001|Overall Study|developed fever > 3 days|1|||
27942665|NCT00993291|54599613|FG000|Overall Study|Withdrawal by Subject|1|||
27942666|NCT01196975|54599622|FG000|Overall Study|Adverse Event|2|||
28159438|NCT03745638|54829367|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|5|||
28159439|NCT03745638|54829368|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|12|||
28159440|NCT03745638|54829369|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|8|||
28159441|NCT03745638|54829370|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
28159442|NCT03745638|54829371|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
28159443|NCT03745638|54829372|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
28159444|NCT03745638|54829373|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
28159445|NCT03745638|54829367|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
27942667|NCT01196975|54599623|FG001|Overall Study|Adverse Event|2|||
27942668|NCT01196975|54599624|FG002|Overall Study|Adverse Event|0|||
27942669|NCT01196975|54599625|FG003|Overall Study|Adverse Event|0|||
27825552|NCT01702363|54291111|FG000|Overall Study|Lack of Efficacy|4|||
27825553|NCT01702363|54291111|FG000|Overall Study|Withdrawal by Subject|2|||
27825554|NCT01722097|54291118|FG000|Overall Study|Patient sheets not returned|6|||
27825555|NCT01722097|54291119|FG001|Overall Study|Patient sheets not returned|5|||
27942670|NCT01196975|54599626|FG004|Overall Study|Adverse Event|2|||
27942671|NCT01196975|54599622|FG000|Overall Study|Withdrawal by Subject|2|||
27825556|NCT01701973|54291134|FG000|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
27825557|NCT01701973|54291135|FG001|Aim 1: First Intervention (1 Day)|Adverse Event|1|||
28076357|NCT04491994|54731001|FG000|Overall Study|Protocol Violation|11|||
28076358|NCT04491994|54731002|FG001|Overall Study|Protocol Violation|2|||
27942672|NCT01196975|54599623|FG001|Overall Study|Withdrawal by Subject|1|||
27942673|NCT01196975|54599624|FG002|Overall Study|Withdrawal by Subject|0|||
27942674|NCT01196975|54599625|FG003|Overall Study|Withdrawal by Subject|1|||
27942675|NCT01196975|54599626|FG004|Overall Study|Withdrawal by Subject|0|||
27942676|NCT01196975|54599622|FG000|Overall Study|Lost to Follow-up|11|||
27942677|NCT01196975|54599623|FG001|Overall Study|Lost to Follow-up|6|||
27942678|NCT01196975|54599624|FG002|Overall Study|Lost to Follow-up|5|||
27942679|NCT01196975|54599625|FG003|Overall Study|Lost to Follow-up|5|||
27942680|NCT01196975|54599626|FG004|Overall Study|Lost to Follow-up|11|||
27942681|NCT00992589|54599661|FG000|Open-Label Phase|Adverse Event|4|||
27942682|NCT00992589|54599662|FG001|Open-Label Phase|Adverse Event|0|||
27942683|NCT00992589|54599663|FG002|Open-Label Phase|Adverse Event|0|||
27942684|NCT00992589|54599664|FG003|Open-Label Phase|Adverse Event|0|||
27942685|NCT00992589|54599661|FG000|Open-Label Phase|Withdrawal by Subject|20|||
27942686|NCT00992589|54599662|FG001|Open-Label Phase|Withdrawal by Subject|0|||
27942687|NCT00992589|54599663|FG002|Open-Label Phase|Withdrawal by Subject|0|||
27942688|NCT00992589|54599664|FG003|Open-Label Phase|Withdrawal by Subject|0|||
27942689|NCT00992589|54599661|FG000|Open-Label Phase|Lost to Follow-up|1|||
27942690|NCT00992589|54599662|FG001|Open-Label Phase|Lost to Follow-up|0|||
27942691|NCT00992589|54599663|FG002|Open-Label Phase|Lost to Follow-up|0|||
27942692|NCT00992589|54599664|FG003|Open-Label Phase|Lost to Follow-up|0|||
27942693|NCT00992589|54599661|FG000|Open-Label Phase|Protocol Violation|3|||
27942694|NCT00992589|54599662|FG001|Open-Label Phase|Protocol Violation|0|||
27942695|NCT00992589|54599663|FG002|Open-Label Phase|Protocol Violation|0|||
27942696|NCT00992589|54599664|FG003|Open-Label Phase|Protocol Violation|0|||
27942697|NCT00992589|54599661|FG000|Open-Label Phase|Physician Decision|4|||
28076359|NCT04491994|54731001|FG000|Overall Study|Lost to Follow-up|4|||
27942698|NCT00992589|54599662|FG001|Open-Label Phase|Physician Decision|0|||
28076360|NCT04491994|54731002|FG001|Overall Study|Lost to Follow-up|3|||
27942699|NCT00992589|54599663|FG002|Open-Label Phase|Physician Decision|0|||
28076361|NCT04041700|54731008|FG000|Overall Study|Pregnancy|1|||
28076362|NCT04041700|54731008|FG000|Overall Study|Unable to visit the site due to the Covid-19 travel restrictions|1|||
28076363|NCT04227340|54731014|FG000|Overall Study|Withdrawal by Subject|3|||
28076364|NCT04033432|54731021|FG000|Overall Study|Progressive Disease|8|||
28159446|NCT03745638|54829368|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
27942700|NCT00992589|54599664|FG003|Open-Label Phase|Physician Decision|0|||
27942701|NCT00992589|54599661|FG000|Open-Label Phase|Other|45|||
27942702|NCT00992589|54599662|FG001|Open-Label Phase|Other|0|||
27942703|NCT00992589|54599663|FG002|Open-Label Phase|Other|0|||
27942704|NCT00992589|54599664|FG003|Open-Label Phase|Other|0|||
27942705|NCT00992589|54599661|FG000|Double-Blind Phase|Adverse Event|0|||
27942706|NCT00992589|54599662|FG001|Double-Blind Phase|Adverse Event|6|||
27942707|NCT00992589|54599663|FG002|Double-Blind Phase|Adverse Event|2|||
27942708|NCT00992589|54599664|FG003|Double-Blind Phase|Adverse Event|3|||
27942709|NCT00992589|54599661|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
27942710|NCT00992589|54599662|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
27942711|NCT00992589|54599663|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
27942712|NCT00992589|54599664|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
27942713|NCT00992589|54599661|FG000|Double-Blind Phase|Lost to Follow-up|0|||
27942714|NCT00992589|54599662|FG001|Double-Blind Phase|Lost to Follow-up|0|||
27942715|NCT00992589|54599663|FG002|Double-Blind Phase|Lost to Follow-up|0|||
27942716|NCT00992589|54599664|FG003|Double-Blind Phase|Lost to Follow-up|2|||
27942717|NCT00992589|54599661|FG000|Double-Blind Phase|Other|0|||
27942718|NCT00992589|54599662|FG001|Double-Blind Phase|Other|1|||
27942719|NCT00992589|54599663|FG002|Double-Blind Phase|Other|6|||
27942720|NCT00992589|54599664|FG003|Double-Blind Phase|Other|3|||
28076365|NCT04033432|54731021|FG000|Overall Study|Adverse Event|4|||
28076366|NCT04033432|54731021|FG000|Overall Study|Death|1|||
28076367|NCT04223830|54731026|FG000|Overall Study|Lost to Follow-up|9|||
28076368|NCT04223830|54731026|FG000|Overall Study|Adverse Event|1|||
28076369|NCT04032652|54731033|FG000|Overall Study|The study was terminated and the PI has|1|||
28159447|NCT03745638|54829369|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
28159448|NCT03745638|54829370|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
28159449|NCT03745638|54829371|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
28159450|NCT03745638|54829372|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
28159451|NCT03745638|54829373|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
28159452|NCT03745638|54829367|FG000|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|1|||
28159453|NCT03745638|54829368|FG001|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
28159454|NCT03745638|54829369|FG002|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
28159455|NCT03745638|54829370|FG003|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
28159456|NCT03745638|54829371|FG004|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
27825558|NCT01701973|54291136|FG002|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
27825559|NCT01701973|54291137|FG003|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
28159457|NCT03745638|54829372|FG005|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
28159458|NCT03745638|54829373|FG006|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
28159459|NCT03745638|54829367|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
28159460|NCT03745638|54829368|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|3|||
28159461|NCT03745638|54829369|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
28159462|NCT03745638|54829370|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
28159463|NCT03745638|54829371|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
28159464|NCT03745638|54829372|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
28159465|NCT03745638|54829373|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
28076370|NCT04032652|54731034|FG001|Overall Study|The study was terminated and the PI has|1|||
28076371|NCT04031404|54731040|FG000|Baseline|Lost to Follow-up|0|||
28076372|NCT04031404|54731041|FG001|Baseline|Lost to Follow-up|1|||
28076373|NCT04031404|54731040|FG000|Baseline|Did not meet full inclusion/exclusion.|2|||
28076374|NCT04031404|54731041|FG001|Baseline|Did not meet full inclusion/exclusion.|4|||
28076375|NCT04031404|54731040|FG000|Pre-randomization|Withdrawn for COVID19 precautions|1|||
28076376|NCT04031404|54731041|FG001|Pre-randomization|Withdrawn for COVID19 precautions|3|||
28076377|NCT04031404|54731040|FG000|Pre-randomization|Disqualified by TMS safety screening|1|||
28159466|NCT03745638|54829367|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|17|||
28159467|NCT03745638|54829368|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
27825560|NCT01701973|54291138|FG004|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
27825561|NCT01701973|54291139|FG005|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
27942721|NCT01196741|54599684|FG000|Overall Study|Disease progression|34|||
27942722|NCT01196741|54599685|FG001|Overall Study|Disease progression|14|||
27942723|NCT01196741|54599684|FG000|Overall Study|Adverse Event|10|||
27942724|NCT01196741|54599685|FG001|Overall Study|Adverse Event|6|||
27942725|NCT01196741|54599684|FG000|Overall Study|Serious Adverse Event|3|||
27942726|NCT01196741|54599685|FG001|Overall Study|Serious Adverse Event|1|||
28076378|NCT04031404|54731041|FG001|Pre-randomization|Disqualified by TMS safety screening|0|||
27942727|NCT01196741|54599684|FG000|Overall Study|Dose limiting Adverse Event|2|||
27942728|NCT01196741|54599685|FG001|Overall Study|Dose limiting Adverse Event|1|||
27942729|NCT01196741|54599684|FG000|Overall Study|Withdrawal by Subject|3|||
27942730|NCT01196741|54599685|FG001|Overall Study|Withdrawal by Subject|0|||
27942731|NCT01196741|54599684|FG000|Overall Study|Other reason|3|||
27942732|NCT01196741|54599685|FG001|Overall Study|Other reason|3|||
27942733|NCT01196741|54599684|FG000|Overall Study|Other|3|||
27942734|NCT01196741|54599685|FG001|Overall Study|Other|2|||
27942735|NCT01196741|54599684|FG000|Overall Study|Protocol Violation|2|||
27942736|NCT01196741|54599685|FG001|Overall Study|Protocol Violation|1|||
27942737|NCT00983385|54599691|FG000|Observation Period|Not eligible to be dosed|20|||
27942738|NCT00983385|54599691|FG000|Observation Period|Not Evaluable due to Non Compliance|12|||
27942739|NCT00992511|54599714|FG000|Overall Study|Migrated/moved from study area|1|||
27942740|NCT00992511|54599715|FG001|Overall Study|Migrated/moved from study area|0|||
27942741|NCT00992511|54599716|FG002|Overall Study|Migrated/moved from study area|1|||
27942742|NCT00992511|54599717|FG003|Overall Study|Migrated/moved from study area|2|||
27942743|NCT00992511|54599714|FG000|Overall Study|Lost to Follow-up|1|||
27942744|NCT00992511|54599715|FG001|Overall Study|Lost to Follow-up|0|||
27942745|NCT00992511|54599716|FG002|Overall Study|Lost to Follow-up|0|||
27942746|NCT00992511|54599717|FG003|Overall Study|Lost to Follow-up|2|||
27942747|NCT00992511|54599714|FG000|Overall Study|Withdrawal by Subject|0|||
27942748|NCT00992511|54599715|FG001|Overall Study|Withdrawal by Subject|0|||
27942749|NCT00992511|54599716|FG002|Overall Study|Withdrawal by Subject|1|||
28159468|NCT03745638|54829369|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|19|||
27850450|NCT04178967|54349324|FG009|Maintenance Open Label Escape Arm|Participant Missed Study Visits|1|||
27850451|NCT04178967|54349325|FG010|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
27850452|NCT04163900|54349347|FG000|Overall Study|Radiological disease progression|112|||
27850453|NCT04163900|54349348|FG001|Overall Study|Radiological disease progression|127|||
27850454|NCT04163900|54349347|FG000|Overall Study|Study closure|98|||
27850455|NCT04163900|54349348|FG001|Overall Study|Study closure|133|||
27850456|NCT04163900|54349347|FG000|Overall Study|Adverse Event|78|||
27850457|NCT04163900|54349348|FG001|Overall Study|Adverse Event|32|||
27850458|NCT04163900|54349347|FG000|Overall Study|Withdrawal by Subject|37|||
27850459|NCT04163900|54349348|FG001|Overall Study|Withdrawal by Subject|34|||
27850460|NCT04163900|54349347|FG000|Overall Study|Death|29|||
27850461|NCT04163900|54349348|FG001|Overall Study|Death|16|||
27850462|NCT04163900|54349347|FG000|Overall Study|Physician Decision|17|||
27850463|NCT04163900|54349348|FG001|Overall Study|Physician Decision|25|||
27850464|NCT04163900|54349347|FG000|Overall Study|Clinical disease progression|14|||
27850465|NCT04163900|54349348|FG001|Overall Study|Clinical disease progression|13|||
27850466|NCT04163900|54349347|FG000|Overall Study|Protocol Violation|3|||
27850467|NCT04163900|54349348|FG001|Overall Study|Protocol Violation|4|||
27850468|NCT04163900|54349347|FG000|Overall Study|Lost to Follow-up|0|||
27850469|NCT04163900|54349348|FG001|Overall Study|Lost to Follow-up|1|||
27850470|NCT04161495|54349356|FG000|Overall Study|Withdrawal by Subject|3|||
27850471|NCT04161495|54349357|FG001|Overall Study|Withdrawal by Subject|0|||
27850472|NCT04161495|54349356|FG000|Overall Study|Protocol Violation|1|||
27942750|NCT00992511|54599717|FG003|Overall Study|Withdrawal by Subject|1|||
28076379|NCT04031404|54731040|FG000|Washout (5 Day Min)|Lost to Follow-up|1|||
28076380|NCT04031404|54731041|FG001|Washout (5 Day Min)|Lost to Follow-up|0|||
28076381|NCT04476784|54731057|FG000|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|1|||
28076382|NCT04476784|54731058|FG001|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|0|||
28076383|NCT04026568|54731069|FG000|Overall Study|study terminated|0|||
28076384|NCT04026568|54731070|FG001|Overall Study|study terminated|1|||
28076385|NCT04025632|54731078|FG000|Overall Study|Adverse Event|1|||
28076386|NCT04025632|54731079|FG001|Overall Study|Adverse Event|1|||
28076387|NCT04025632|54731078|FG000|Overall Study|Withdrawal by Subject|1|||
28076388|NCT04025632|54731079|FG001|Overall Study|Withdrawal by Subject|1|||
28076389|NCT04025632|54731078|FG000|Overall Study|Study Terminated by Sponsor|10|||
28076390|NCT04025632|54731079|FG001|Overall Study|Study Terminated by Sponsor|9|||
28076391|NCT04025632|54731078|FG000|Overall Study|Physician Decision|3|||
28076392|NCT04025632|54731079|FG001|Overall Study|Physician Decision|1|||
27850473|NCT04161495|54349357|FG001|Overall Study|Protocol Violation|0|||
28076393|NCT04024228|54731090|FG000|Overall Study|Adverse Event|1|||
28076394|NCT04024228|54731091|FG001|Overall Study|Adverse Event|0|||
28076395|NCT04024228|54731090|FG000|Overall Study|Protocol Deviation|0|||
28076396|NCT04024228|54731091|FG001|Overall Study|Protocol Deviation|2|||
28076397|NCT04024228|54731090|FG000|Overall Study|Withdrawal by Subject|3|||
28159469|NCT03745638|54829370|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
28159470|NCT03745638|54829371|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
28159471|NCT03745638|54829372|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
28159472|NCT03745638|54829373|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
28159473|NCT03745638|54829367|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|2|||
28159474|NCT03745638|54829368|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|1|||
28159475|NCT03745638|54829369|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
28076398|NCT04024228|54731091|FG001|Overall Study|Withdrawal by Subject|4|||
28076399|NCT04023994|54731105|FG000|Overall Study|Lost to Follow-up|0|||
28076400|NCT04023994|54731106|FG001|Overall Study|Lost to Follow-up|1|||
28076401|NCT04023994|54731107|FG002|Overall Study|Lost to Follow-up|2|||
28076402|NCT04023994|54731108|FG003|Overall Study|Lost to Follow-up|0|||
28076403|NCT04023994|54731109|FG004|Overall Study|Lost to Follow-up|0|||
28076404|NCT04023994|54731110|FG005|Overall Study|Lost to Follow-up|0|||
28076405|NCT04023994|54731105|FG000|Overall Study|Withdrawal by Subject|0|||
27850474|NCT04161495|54349356|FG000|Overall Study|Prohibited concomitant medication|3|||
27850475|NCT04161495|54349357|FG001|Overall Study|Prohibited concomitant medication|0|||
27850476|NCT04161495|54349356|FG000|Overall Study|Adverse Event|1|||
27850477|NCT04161495|54349357|FG001|Overall Study|Adverse Event|0|||
27850478|NCT04161495|54349356|FG000|Overall Study|Other - Unspecified|1|||
27850479|NCT04161495|54349357|FG001|Overall Study|Other - Unspecified|0|||
27850480|NCT04161495|54349356|FG000|Overall Study|Death|0|||
27850481|NCT04161495|54349357|FG001|Overall Study|Death|1|||
27850482|NCT04108000|54349386|FG000|Overall Study|Death of patient|1|||
27850483|NCT04108000|54349387|FG001|Overall Study|Death of patient|0|||
27850484|NCT04108000|54349388|FG002|Overall Study|Death of patient|1|||
27850485|NCT04108000|54349389|FG003|Overall Study|Death of patient|0|||
27850486|NCT04108000|54349386|FG000|Overall Study|Withdrawal by Subject|2|||
27850487|NCT04108000|54349387|FG001|Overall Study|Withdrawal by Subject|2|||
27850488|NCT04108000|54349388|FG002|Overall Study|Withdrawal by Subject|0|||
27850489|NCT04108000|54349389|FG003|Overall Study|Withdrawal by Subject|0|||
27850490|NCT04108000|54349386|FG000|Overall Study|Death of surrogate partner|0|||
27850491|NCT04108000|54349387|FG001|Overall Study|Death of surrogate partner|1|||
27850492|NCT04108000|54349388|FG002|Overall Study|Death of surrogate partner|0|||
28076406|NCT04023994|54731106|FG001|Overall Study|Withdrawal by Subject|0|||
28076407|NCT04023994|54731107|FG002|Overall Study|Withdrawal by Subject|0|||
28076408|NCT04023994|54731108|FG003|Overall Study|Withdrawal by Subject|1|||
27942751|NCT01196429|54599729|FG000|Overall Study|Ineligible - inadequate pathology|1|||
27942752|NCT01196429|54599730|FG001|Overall Study|Ineligible - inadequate pathology|0|||
27942753|NCT01196429|54599729|FG000|Overall Study|Ineligible - wrong cell type|1|||
27942754|NCT01196429|54599730|FG001|Overall Study|Ineligible - wrong cell type|0|||
27942755|NCT01196429|54599729|FG000|Overall Study|Refused - Never Treated|1|||
27942756|NCT01196429|54599730|FG001|Overall Study|Refused - Never Treated|0|||
27942757|NCT01157364|54599744|FG000|Overall Study|Other Reasons|1|||
27942758|NCT01157364|54599745|FG001|Overall Study|Other Reasons|1|||
27942759|NCT01157364|54599746|FG002|Overall Study|Other Reasons|2|||
27942760|NCT01157364|54599747|FG003|Overall Study|Other Reasons|1|||
27942761|NCT01157364|54599748|FG004|Overall Study|Other Reasons|0|||
27942762|NCT01157364|54599749|FG005|Overall Study|Other Reasons|0|||
27942763|NCT01157364|54599744|FG000|Overall Study|Personal Reasons|0|||
27942764|NCT01157364|54599745|FG001|Overall Study|Personal Reasons|2|||
27942765|NCT01157364|54599746|FG002|Overall Study|Personal Reasons|0|||
27942766|NCT01157364|54599747|FG003|Overall Study|Personal Reasons|0|||
27942767|NCT01157364|54599748|FG004|Overall Study|Personal Reasons|1|||
27942768|NCT01157364|54599749|FG005|Overall Study|Personal Reasons|1|||
27942769|NCT01157364|54599744|FG000|Overall Study|Lost to Follow-up|1|||
27942770|NCT01157364|54599745|FG001|Overall Study|Lost to Follow-up|0|||
27942771|NCT01157364|54599746|FG002|Overall Study|Lost to Follow-up|1|||
27942772|NCT01157364|54599747|FG003|Overall Study|Lost to Follow-up|0|||
27942773|NCT01157364|54599748|FG004|Overall Study|Lost to Follow-up|0|||
27942774|NCT01157364|54599749|FG005|Overall Study|Lost to Follow-up|0|||
27942775|NCT01157364|54599744|FG000|Overall Study|Lack of Efficacy|0|||
27942776|NCT01157364|54599745|FG001|Overall Study|Lack of Efficacy|0|||
27942777|NCT01157364|54599746|FG002|Overall Study|Lack of Efficacy|0|||
27942778|NCT01157364|54599747|FG003|Overall Study|Lack of Efficacy|1|||
27942779|NCT01157364|54599748|FG004|Overall Study|Lack of Efficacy|0|||
27942780|NCT01157364|54599749|FG005|Overall Study|Lack of Efficacy|0|||
27942781|NCT01157364|54599744|FG000|Overall Study|Adverse Event|0|||
27942782|NCT01157364|54599745|FG001|Overall Study|Adverse Event|1|||
27942783|NCT01157364|54599746|FG002|Overall Study|Adverse Event|1|||
27942784|NCT01157364|54599747|FG003|Overall Study|Adverse Event|0|||
27942785|NCT01157364|54599748|FG004|Overall Study|Adverse Event|1|||
27942786|NCT01157364|54599749|FG005|Overall Study|Adverse Event|0|||
27942787|NCT01195415|54599763|FG000|Overall Study|No repeat biopsy due to progression|2|||
27942788|NCT01195103|54599770|FG000|Overall Study|Withdrawal by Subject|1|||
27942789|NCT01195103|54599771|FG001|Overall Study|Withdrawal by Subject|0|||
27942790|NCT01195103|54599772|FG002|Overall Study|Withdrawal by Subject|0|||
27942791|NCT01194869|54599780|FG000|Overall Study|Disease Progression|2|||
27942792|NCT01194869|54599780|FG000|Overall Study|Toxicity|2|||
27942793|NCT01177800|54599786|FG000|Overall Study|Adverse Event|9|||
27942794|NCT01177800|54599787|FG001|Overall Study|Adverse Event|3|||
27942795|NCT01177800|54599786|FG000|Overall Study|Protocol Violation|0|||
27942796|NCT01177800|54599787|FG001|Overall Study|Protocol Violation|1|||
27942797|NCT01177800|54599786|FG000|Overall Study|Physician Decision|1|||
27942798|NCT01177800|54599787|FG001|Overall Study|Physician Decision|0|||
27942799|NCT01177800|54599786|FG000|Overall Study|Withdrawal of informed consent|0|||
27942800|NCT01177800|54599787|FG001|Overall Study|Withdrawal of informed consent|1|||
27942801|NCT01177722|54599797|FG000|Overall Study|Serious Adverse Event|0|||
27942802|NCT01177722|54599798|FG001|Overall Study|Serious Adverse Event|0|||
27942803|NCT01177722|54599799|FG002|Overall Study|Serious Adverse Event|1|||
27942804|NCT01177722|54599800|FG003|Overall Study|Serious Adverse Event|0|||
27942805|NCT01177722|54599797|FG000|Overall Study|Protocol Violation|0|||
27942806|NCT01177722|54599798|FG001|Overall Study|Protocol Violation|0|||
27942807|NCT01177722|54599799|FG002|Overall Study|Protocol Violation|1|||
27942808|NCT01177722|54599800|FG003|Overall Study|Protocol Violation|0|||
27942809|NCT01177722|54599797|FG000|Overall Study|Lost to Follow-up|3|||
27942810|NCT01177722|54599798|FG001|Overall Study|Lost to Follow-up|4|||
27942811|NCT01177722|54599799|FG002|Overall Study|Lost to Follow-up|3|||
27942812|NCT01177722|54599800|FG003|Overall Study|Lost to Follow-up|1|||
27942813|NCT01177722|54599797|FG000|Overall Study|Withdrawal by Subject|10|||
28076409|NCT04023994|54731109|FG004|Overall Study|Withdrawal by Subject|0|||
28076410|NCT04023994|54731110|FG005|Overall Study|Withdrawal by Subject|0|||
28076411|NCT04023682|54731129|FG000|Overall Study|Clinical schedules did not allow continued participation|6|||
28076412|NCT04018612|54731140|FG000|Overall Study|Withdrawal by Subject|1|||
28076413|NCT04018612|54731141|FG001|Overall Study|Withdrawal by Subject|0|||
28076414|NCT04018612|54731142|FG002|Overall Study|Withdrawal by Subject|1|||
28076415|NCT04018066|54731150|FG000|Overall Study|participants started taking medications during the study period|3|||
27942814|NCT01177722|54599798|FG001|Overall Study|Withdrawal by Subject|6|||
27942815|NCT01177722|54599799|FG002|Overall Study|Withdrawal by Subject|4|||
27942816|NCT01177722|54599800|FG003|Overall Study|Withdrawal by Subject|6|||
27942817|NCT01177410|54599814|FG000|Overall Study|Adverse Event|0|||
27942818|NCT01177410|54599815|FG001|Overall Study|Adverse Event|2|||
27942819|NCT01177410|54599816|FG002|Overall Study|Adverse Event|2|||
27942820|NCT01177410|54599814|FG000|Overall Study|Withdrawal by Subject|1|||
28160143|NCT02557516|54830250|FG003|Overall Study|Disease progression|0|||
27942821|NCT01177410|54599815|FG001|Overall Study|Withdrawal by Subject|4|||
27942822|NCT01177410|54599816|FG002|Overall Study|Withdrawal by Subject|3|||
27942823|NCT01177410|54599814|FG000|Overall Study|Lost to Follow-up|0|||
27942824|NCT01177410|54599815|FG001|Overall Study|Lost to Follow-up|1|||
27942825|NCT01177410|54599816|FG002|Overall Study|Lost to Follow-up|0|||
27942826|NCT01156116|54599826|FG000|Overall Study|Withdrawal by Subject|3|||
27942827|NCT01156116|54599827|FG001|Overall Study|Withdrawal by Subject|1|||
27942828|NCT01156116|54599826|FG000|Overall Study|CPAP intolerance|2|||
27942829|NCT01156116|54599827|FG001|Overall Study|CPAP intolerance|0|||
27942830|NCT01155726|54599833|FG000|Period 1, 3 Days (Masked)|Inconvenience|1|||
27942831|NCT01155726|54599834|FG001|Period 1, 3 Days (Masked)|Inconvenience|0|||
27942832|NCT01155726|54599835|FG002|Period 1, 3 Days (Masked)|Inconvenience|2|||
27942833|NCT01155726|54599836|FG003|Period 1, 3 Days (Masked)|Inconvenience|0|||
27942834|NCT01155570|54599858|FG000|Overall Study|Adverse Event|39|||
27942835|NCT01155570|54599858|FG000|Overall Study|Lack of Efficacy|46|||
27942836|NCT01155570|54599858|FG000|Overall Study|Participant's Economic Reasons|17|||
27942837|NCT01155570|54599858|FG000|Overall Study|No Hospital Visits|7|||
27942838|NCT01155570|54599858|FG000|Overall Study|Adverse Event + Lack of Efficacy|2|||
27942839|NCT01155570|54599858|FG000|Overall Study|Adverse Event + Other Reasons|7|||
27942840|NCT01155570|54599858|FG000|Overall Study|Participant's Economic Reasons + Other|1|||
27942841|NCT01155570|54599858|FG000|Overall Study|Other Reasons|23|||
27942842|NCT01155024|54599864|FG000|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0|||
27942843|NCT01155024|54599865|FG001|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2|||
27942844|NCT01155024|54599864|FG000|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0|||
27942845|NCT01155024|54599865|FG001|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2|||
27942846|NCT01155024|54599864|FG000|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0|||
27942847|NCT01155024|54599865|FG001|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2|||
27942848|NCT01176240|54599876|FG000|Study 306A|Lack of Efficacy|2|||
27942849|NCT01176240|54599877|FG001|Study 306A|Lack of Efficacy|1|||
27942850|NCT01176240|54599876|FG000|Study 306A|Protocol Violation|0|||
27942851|NCT01176240|54599877|FG001|Study 306A|Protocol Violation|1|||
27942852|NCT01176240|54599876|FG000|Study 306A|Withdrawal by Subject|0|||
27942853|NCT01176240|54599877|FG001|Study 306A|Withdrawal by Subject|1|||
27942854|NCT01176240|54599876|FG000|Study 306A|Stop due to diverse problems|1|||
27942855|NCT01176240|54599877|FG001|Study 306A|Stop due to diverse problems|0|||
27942856|NCT01176240|54599876|FG000|Study 306B|Lack of Efficacy|5|||
27942857|NCT01176240|54599877|FG001|Study 306B|Lack of Efficacy|3|||
27942858|NCT01176240|54599876|FG000|Study 306B|Adverse Event|10|||
27942859|NCT01176240|54599877|FG001|Study 306B|Adverse Event|5|||
27942860|NCT01176240|54599876|FG000|Study 306B|Protocol Violation|2|||
27942861|NCT01176240|54599877|FG001|Study 306B|Protocol Violation|3|||
27942862|NCT01176240|54599876|FG000|Study 306B|Withdrawal by Subject|4|||
27942863|NCT01176240|54599877|FG001|Study 306B|Withdrawal by Subject|1|||
27942864|NCT01176240|54599876|FG000|Study 306B|Physician Decision|2|||
27942865|NCT01176240|54599877|FG001|Study 306B|Physician Decision|1|||
27942866|NCT01176240|54599876|FG000|Study 306B|Supine Hypertension|1|||
27942867|NCT01176240|54599877|FG001|Study 306B|Supine Hypertension|2|||
27942868|NCT01176240|54599876|FG000|Study 306B|Lost to Follow-up|0|||
27942869|NCT01176240|54599877|FG001|Study 306B|Lost to Follow-up|1|||
27942870|NCT01176240|54599876|FG000|Study 306B|withdrew prior to dosing|2|||
27942871|NCT01176240|54599877|FG001|Study 306B|withdrew prior to dosing|1|||
27942872|NCT00988221|54599886|FG000|Part I|Adverse Event|0|||
28076416|NCT04018066|54731150|FG000|Overall Study|participant dropped out due to schedule conflicts.|1|||
27850493|NCT04108000|54349389|FG003|Overall Study|Death of surrogate partner|1|||
27850494|NCT04098068|54349403|FG000|Overall Study|Disease Progression|7|||
27850495|NCT04098068|54349403|FG000|Overall Study|Withdrawal by Subject|2|||
27850496|NCT04098068|54349403|FG000|Overall Study|New Cancer Diagnosis|1|||
27850497|NCT03945266|54349409|FG000|Overall Study|Withdrawal by Subject|1|||
27850498|NCT03945266|54349410|FG001|Overall Study|Withdrawal by Subject|0|||
27850499|NCT03945266|54349409|FG000|Overall Study|Miscarriage|0|||
27850500|NCT03945266|54349410|FG001|Overall Study|Miscarriage|2|||
27850501|NCT03945266|54349409|FG000|Overall Study|Lost to Follow-up|1|||
27850502|NCT03945266|54349410|FG001|Overall Study|Lost to Follow-up|0|||
27850503|NCT03916484|54349424|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
27850504|NCT03916484|54349425|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|1|||
27850505|NCT03916484|54349426|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
27850506|NCT03916484|54349427|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
27850507|NCT03916484|54349424|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
27850508|NCT03916484|54349425|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|11|||
27850509|NCT03916484|54349426|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|4|||
27850510|NCT03916484|54349427|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
27942873|NCT00988221|54599887|FG001|Part I|Adverse Event|1|||
27942874|NCT00988221|54599888|FG002|Part I|Adverse Event|2|||
27942875|NCT00988221|54599889|FG003|Part I|Adverse Event|0|||
27942876|NCT00988221|54599886|FG000|Part I|Insufficient Therapeutic Response|4|||
27942877|NCT00988221|54599887|FG001|Part I|Insufficient Therapeutic Response|6|||
27942878|NCT00988221|54599888|FG002|Part I|Insufficient Therapeutic Response|5|||
27942879|NCT00988221|54599889|FG003|Part I|Insufficient Therapeutic Response|0|||
27942880|NCT00988221|54599886|FG000|Part I|Refused Treatment|0|||
27942881|NCT00988221|54599887|FG001|Part I|Refused Treatment|2|||
27942882|NCT00988221|54599888|FG002|Part I|Refused Treatment|1|||
27942883|NCT00988221|54599889|FG003|Part I|Refused Treatment|0|||
27942884|NCT00988221|54599886|FG000|Part I|Lost to Follow-up|0|||
27942885|NCT00988221|54599887|FG001|Part I|Lost to Follow-up|1|||
27942886|NCT00988221|54599888|FG002|Part I|Lost to Follow-up|0|||
27942887|NCT00988221|54599889|FG003|Part I|Lost to Follow-up|0|||
27942888|NCT00988221|54599886|FG000|Part II|Adverse Event|1|||
27942889|NCT00988221|54599887|FG001|Part II|Adverse Event|0|||
27942890|NCT00988221|54599888|FG002|Part II|Adverse Event|0|||
27942891|NCT00988221|54599889|FG003|Part II|Adverse Event|1|||
27942892|NCT00988221|54599886|FG000|Part II|Withdrawal by Subject|0|||
27942893|NCT00988221|54599887|FG001|Part II|Withdrawal by Subject|0|||
27942894|NCT00988221|54599888|FG002|Part II|Withdrawal by Subject|2|||
27942895|NCT00988221|54599889|FG003|Part II|Withdrawal by Subject|2|||
27942896|NCT00988221|54599886|FG000|Part II|Reason not Specified|0|||
27942897|NCT00988221|54599887|FG001|Part II|Reason not Specified|0|||
27942898|NCT00988221|54599888|FG002|Part II|Reason not Specified|1|||
27942899|NCT00988221|54599889|FG003|Part II|Reason not Specified|0|||
27942900|NCT00988221|54599886|FG000|Part III|Adverse Event|1|||
27942901|NCT00988221|54599887|FG001|Part III|Adverse Event|0|||
27942902|NCT00988221|54599888|FG002|Part III|Adverse Event|1|||
27942903|NCT00988221|54599889|FG003|Part III|Adverse Event|0|||
27942904|NCT00988221|54599886|FG000|Part III|Insufficient Therapeutic Response|0|||
27942905|NCT00988221|54599887|FG001|Part III|Insufficient Therapeutic Response|1|||
27942906|NCT00988221|54599888|FG002|Part III|Insufficient Therapeutic Response|1|||
27942907|NCT00988221|54599889|FG003|Part III|Insufficient Therapeutic Response|0|||
27942908|NCT00988221|54599886|FG000|Part III|Refused Treatment|0|||
27942909|NCT00988221|54599887|FG001|Part III|Refused Treatment|0|||
27942910|NCT00988221|54599888|FG002|Part III|Refused Treatment|1|||
27942911|NCT00988221|54599889|FG003|Part III|Refused Treatment|0|||
27942912|NCT01149096|54599910|FG000|Overall Study|Lost to Follow-up|0|||
27942913|NCT01149096|54599911|FG001|Overall Study|Lost to Follow-up|1|||
27942914|NCT01175382|54599921|FG000|Overall Study|Lost to Follow-up|4|||
27942915|NCT01175382|54599922|FG001|Overall Study|Lost to Follow-up|3|||
27942916|NCT01175382|54599923|FG002|Overall Study|Lost to Follow-up|1|||
27942917|NCT01175382|54599921|FG000|Overall Study|Physician Decision|0|||
27942918|NCT01175382|54599922|FG001|Overall Study|Physician Decision|1|||
27942919|NCT01175382|54599923|FG002|Overall Study|Physician Decision|0|||
27942920|NCT01175382|54599921|FG000|Overall Study|Withdrawal by Subject|0|||
27942921|NCT01175382|54599922|FG001|Overall Study|Withdrawal by Subject|0|||
27942922|NCT01175382|54599923|FG002|Overall Study|Withdrawal by Subject|1|||
27942923|NCT01175382|54599921|FG000|Overall Study|No longer having problem|1|||
27942924|NCT01175382|54599922|FG001|Overall Study|No longer having problem|0|||
27942925|NCT01175382|54599923|FG002|Overall Study|No longer having problem|1|||
27942926|NCT01175382|54599921|FG000|Overall Study|Unable/unwilling to attend visits|3|||
27942927|NCT01175382|54599922|FG001|Overall Study|Unable/unwilling to attend visits|1|||
27942928|NCT01175382|54599923|FG002|Overall Study|Unable/unwilling to attend visits|2|||
27942929|NCT01175382|54599921|FG000|Overall Study|Unwilling to follow protocol|0|||
27942930|NCT01175382|54599922|FG001|Overall Study|Unwilling to follow protocol|1|||
27942931|NCT01175382|54599923|FG002|Overall Study|Unwilling to follow protocol|0|||
27942932|NCT01175382|54599921|FG000|Overall Study|Unable to tolerate study meds|0|||
27942933|NCT01175382|54599922|FG001|Overall Study|Unable to tolerate study meds|1|||
27942934|NCT01175382|54599923|FG002|Overall Study|Unable to tolerate study meds|1|||
27942935|NCT01194245|54599936|FG000|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5|||
27942936|NCT01194245|54599937|FG001|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
27942937|NCT01194245|54599938|FG002|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
27942938|NCT01194245|54599939|FG003|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
27942939|NCT01194245|54599940|FG004|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
27942940|NCT01194245|54599936|FG000|Titration Period (4 to 6 Weeks)|Physician Decision|3|||
27850511|NCT03769311|54349442|FG000|Overall Study|Withdrawal by Subject|1|||
27942941|NCT01194245|54599937|FG001|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
27942942|NCT01194245|54599938|FG002|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
27850512|NCT03738566|54349450|FG000|Initial Study Phase|Withdrawal by Subject|1|||
27942943|NCT01194245|54599939|FG003|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
27942944|NCT01194245|54599940|FG004|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
27942945|NCT01194245|54599936|FG000|Titration Period (4 to 6 Weeks)|Titration Failure|3|||
27942946|NCT01194245|54599937|FG001|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
27942947|NCT01194245|54599938|FG002|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
27942948|NCT01194245|54599939|FG003|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
27942949|NCT01194245|54599940|FG004|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
27942950|NCT01194245|54599936|FG000|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7|||
27942951|NCT01194245|54599937|FG001|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
27942952|NCT01194245|54599938|FG002|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
27942953|NCT01194245|54599939|FG003|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
27942954|NCT01194245|54599940|FG004|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
27942955|NCT01194245|54599936|FG000|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
27942956|NCT01194245|54599937|FG001|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
27942957|NCT01194245|54599938|FG002|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
27942958|NCT01194245|54599939|FG003|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
27942959|NCT01194245|54599940|FG004|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
28076417|NCT04209400|54731157|FG000|Overall Study|Withdrawal by Subject|0|||
27850513|NCT03738566|54349451|FG001|Initial Study Phase|Withdrawal by Subject|1|||
27850514|NCT03738566|54349452|FG002|Initial Study Phase|Withdrawal by Subject|2|||
27850515|NCT03738566|54349453|FG003|Initial Study Phase|Withdrawal by Subject|0|||
27850516|NCT03738566|54349450|FG000|Initial Study Phase|Death|0|||
27850517|NCT03738566|54349451|FG001|Initial Study Phase|Death|1|||
27850518|NCT03738566|54349452|FG002|Initial Study Phase|Death|0|||
27850519|NCT03738566|54349453|FG003|Initial Study Phase|Death|0|||
27850520|NCT03738566|54349450|FG000|Initial Study Phase|Treatment failure|5|||
27850521|NCT03738566|54349451|FG001|Initial Study Phase|Treatment failure|0|||
27850522|NCT03738566|54349452|FG002|Initial Study Phase|Treatment failure|0|||
27942960|NCT01194245|54599936|FG000|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
27942961|NCT01194245|54599937|FG001|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
27942962|NCT01194245|54599938|FG002|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
27942963|NCT01194245|54599939|FG003|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
27942964|NCT01194245|54599940|FG004|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
27942965|NCT00979407|54599951|FG000|Overall Study|Withdrawal by Subject|3|||
27942966|NCT00979407|54599952|FG001|Overall Study|Withdrawal by Subject|4|||
27942967|NCT00979407|54599951|FG000|Overall Study|Lost to Follow-up|3|||
27942968|NCT00979407|54599952|FG001|Overall Study|Lost to Follow-up|3|||
27942969|NCT01148862|54599960|FG000|Second Intervention|Withdrawal by Subject|0|||
27942970|NCT01148862|54599961|FG001|Second Intervention|Withdrawal by Subject|2|||
27942971|NCT00975975|54599967|FG000|Overall Study|Death|6|||
27942972|NCT01193153|54599971|FG000|Open-label Lead in Period|Lost to Follow-up|32|||
27942973|NCT01193153|54599972|FG001|Open-label Lead in Period|Lost to Follow-up|0|||
27942974|NCT01193153|54599971|FG000|Open-label Lead in Period|Pregnancy|1|||
27942975|NCT01193153|54599972|FG001|Open-label Lead in Period|Pregnancy|0|||
27942976|NCT01193153|54599971|FG000|Open-label Lead in Period|Withdrawal by Subject|69|||
27942977|NCT01193153|54599972|FG001|Open-label Lead in Period|Withdrawal by Subject|0|||
27942978|NCT01193153|54599971|FG000|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4|||
27942979|NCT01193153|54599972|FG001|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0|||
27942980|NCT01193153|54599971|FG000|Open-label Lead in Period|Other|14|||
27942981|NCT01193153|54599972|FG001|Open-label Lead in Period|Other|0|||
27942982|NCT01193153|54599971|FG000|Open-label Lead in Period|Subject Failed Stabilization Criteria|47|||
27942983|NCT01193153|54599972|FG001|Open-label Lead in Period|Subject Failed Stabilization Criteria|0|||
27942984|NCT01193153|54599971|FG000|Open-label Lead in Period|Adverse Event|41|||
27942985|NCT01193153|54599972|FG001|Open-label Lead in Period|Adverse Event|0|||
27942986|NCT01193153|54599971|FG000|Open-label Lead in Period|Death|1|||
27942987|NCT01193153|54599972|FG001|Open-label Lead in Period|Death|0|||
27942988|NCT01193153|54599971|FG000|Open-label Lead in Period|Lack of Efficacy|26|||
27942989|NCT01193153|54599972|FG001|Open-label Lead in Period|Lack of Efficacy|0|||
27942990|NCT01193153|54599971|FG000|Open-label Stabilization Period|Adverse Event|9|||
27942991|NCT01193153|54599972|FG001|Open-label Stabilization Period|Adverse Event|0|||
27942992|NCT01193153|54599971|FG000|Open-label Stabilization Period|Death|2|||
27942993|NCT01193153|54599972|FG001|Open-label Stabilization Period|Death|0|||
27942994|NCT01193153|54599971|FG000|Open-label Stabilization Period|Lost to Follow-up|10|||
27942995|NCT01193153|54599972|FG001|Open-label Stabilization Period|Lost to Follow-up|0|||
27942996|NCT01193153|54599971|FG000|Open-label Stabilization Period|Lack of Efficacy|5|||
27942997|NCT01193153|54599972|FG001|Open-label Stabilization Period|Lack of Efficacy|0|||
27942998|NCT01193153|54599971|FG000|Open-label Stabilization Period|Withdrawal by Subject|29|||
27942999|NCT01193153|54599972|FG001|Open-label Stabilization Period|Withdrawal by Subject|0|||
27943000|NCT01193153|54599971|FG000|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35|||
27943001|NCT01193153|54599972|FG001|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0|||
27943002|NCT01193153|54599971|FG000|Open-label Stabilization Period|Other|8|||
27943003|NCT01193153|54599972|FG001|Open-label Stabilization Period|Other|0|||
27943004|NCT01193153|54599971|FG000|Double Blind Relapse Prevention Period|Other|2|||
27943005|NCT01193153|54599972|FG001|Double Blind Relapse Prevention Period|Other|3|||
27943006|NCT01193153|54599971|FG000|Double Blind Relapse Prevention Period|Adverse Event|12|||
27943007|NCT01193153|54599972|FG001|Double Blind Relapse Prevention Period|Adverse Event|3|||
27943008|NCT01193153|54599971|FG000|Double Blind Relapse Prevention Period|Death|2|||
27943009|NCT01193153|54599972|FG001|Double Blind Relapse Prevention Period|Death|0|||
27943010|NCT01193153|54599971|FG000|Double Blind Relapse Prevention Period|Lost to Follow-up|2|||
27825562|NCT01701973|54291140|FG006|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
27825563|NCT01701973|54291141|FG007|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
27943011|NCT01193153|54599972|FG001|Double Blind Relapse Prevention Period|Lost to Follow-up|9|||
27943012|NCT01193153|54599971|FG000|Double Blind Relapse Prevention Period|Pregnancy|1|||
27943013|NCT01193153|54599972|FG001|Double Blind Relapse Prevention Period|Pregnancy|0|||
27943014|NCT01193153|54599971|FG000|Double Blind Relapse Prevention Period|Withdrawal by Subject|19|||
27943015|NCT01193153|54599972|FG001|Double Blind Relapse Prevention Period|Withdrawal by Subject|30|||
27943016|NCT01193153|54599971|FG000|Double Blind Relapse Prevention Period|Experienced Relapse|25|||
27943017|NCT01193153|54599972|FG001|Double Blind Relapse Prevention Period|Experienced Relapse|57|||
27943018|NCT01193153|54599971|FG000|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1|||
27943019|NCT01193153|54599972|FG001|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3|||
27943020|NCT01192295|54599983|FG000|Overall Study|Adverse Event|3|||
27943021|NCT01192295|54599984|FG001|Overall Study|Adverse Event|7|||
27943022|NCT01192295|54599983|FG000|Overall Study|Withdrawal by Subject|3|||
27943023|NCT01192295|54599984|FG001|Overall Study|Withdrawal by Subject|4|||
27943024|NCT01192295|54599983|FG000|Overall Study|Lost to Follow-up|0|||
27943025|NCT01192295|54599984|FG001|Overall Study|Lost to Follow-up|1|||
27943026|NCT01192295|54599983|FG000|Overall Study|Lack of Efficacy|0|||
27943027|NCT01192295|54599984|FG001|Overall Study|Lack of Efficacy|5|||
27943028|NCT01192295|54599983|FG000|Overall Study|Administrative|4|||
27943029|NCT01192295|54599984|FG001|Overall Study|Administrative|6|||
27943030|NCT01154166|54599994|FG000|Overall Study|Adverse Event|14|||
27825564|NCT01721317|54291192|FG000|Overall Study|Study Closed / Terminated|2|||
27943031|NCT01154166|54599995|FG001|Overall Study|Adverse Event|9|||
27943032|NCT01154166|54599994|FG000|Overall Study|Lost to Follow-up|1|||
27943033|NCT01154166|54599995|FG001|Overall Study|Lost to Follow-up|1|||
27943034|NCT01154166|54599994|FG000|Overall Study|Protocol Violation|4|||
27943035|NCT01154166|54599995|FG001|Overall Study|Protocol Violation|1|||
27943036|NCT01154166|54599994|FG000|Overall Study|Withdrawal by Subject|10|||
27943037|NCT01154166|54599995|FG001|Overall Study|Withdrawal by Subject|1|||
27943038|NCT01154166|54599994|FG000|Overall Study|Lack of Efficacy|3|||
27943039|NCT01154166|54599995|FG001|Overall Study|Lack of Efficacy|0|||
27943040|NCT01154166|54599994|FG000|Overall Study|Disease Progression|1|||
27943041|NCT01154166|54599995|FG001|Overall Study|Disease Progression|0|||
27943042|NCT01154166|54599994|FG000|Overall Study|Poor Compliance|1|||
27943043|NCT01154166|54599995|FG001|Overall Study|Poor Compliance|0|||
27943044|NCT00975585|54600003|FG000|Overall Study|Adverse Event|0|||
27943045|NCT00975585|54600004|FG001|Overall Study|Adverse Event|4|||
27943046|NCT00975585|54600003|FG000|Overall Study|Lost to Follow-up|3|||
27943047|NCT00975585|54600004|FG001|Overall Study|Lost to Follow-up|5|||
27943048|NCT00975585|54600003|FG000|Overall Study|Withdrawal by Subject|2|||
27943049|NCT00975585|54600004|FG001|Overall Study|Withdrawal by Subject|1|||
27943050|NCT00975585|54600003|FG000|Overall Study|Lens issue|2|||
27943051|NCT00975585|54600004|FG001|Overall Study|Lens issue|2|||
27943052|NCT01181921|54600012|FG000|Overall Study|Lost to Follow-up|1|||
27943053|NCT01174446|54600016|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
27943054|NCT01174446|54600017|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
27943055|NCT01174446|54600018|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1|||
27943056|NCT01174446|54600019|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
27943057|NCT01174446|54600016|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
27943058|NCT01174446|54600017|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
27943059|NCT01174446|54600018|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1|||
27943060|NCT01174446|54600019|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
27943061|NCT01174446|54600016|FG000|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1|||
27943062|NCT01174446|54600017|FG001|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
27943063|NCT01174446|54600018|FG002|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
27943064|NCT01174446|54600019|FG003|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
27943065|NCT01174446|54600016|FG000|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
27943066|NCT01174446|54600017|FG001|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1|||
27943067|NCT01174446|54600018|FG002|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
27943068|NCT01174446|54600019|FG003|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
27943069|NCT00932698|54600077|FG000|Part 1 (Dose Escalation)|Progressive Disease|3|||
27943070|NCT00932698|54600078|FG001|Part 1 (Dose Escalation)|Progressive Disease|2|||
27943071|NCT00932698|54600079|FG002|Part 1 (Dose Escalation)|Progressive Disease|2|||
27943072|NCT00932698|54600080|FG003|Part 1 (Dose Escalation)|Progressive Disease|2|||
27943073|NCT00932698|54600081|FG004|Part 1 (Dose Escalation)|Progressive Disease|3|||
27943074|NCT00932698|54600082|FG005|Part 1 (Dose Escalation)|Progressive Disease|5|||
27943075|NCT00932698|54600083|FG006|Part 1 (Dose Escalation)|Progressive Disease|2|||
27943076|NCT00932698|54600084|FG007|Part 1 (Dose Escalation)|Progressive Disease|0|||
27943077|NCT00932698|54600085|FG008|Part 1 (Dose Escalation)|Progressive Disease|0|||
27943078|NCT00932698|54600086|FG009|Part 1 (Dose Escalation)|Progressive Disease|0|||
27943079|NCT00932698|54600087|FG010|Part 1 (Dose Escalation)|Progressive Disease|0|||
27943080|NCT00932698|54600077|FG000|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
28076418|NCT04209400|54731158|FG001|Overall Study|Withdrawal by Subject|1|||
28076419|NCT04207840|54731164|FG000|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
28076420|NCT04207840|54731165|FG001|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
27825565|NCT01721317|54291193|FG001|Overall Study|Study Closed / Terminated|2|||
27943081|NCT00932698|54600078|FG001|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
27943082|NCT00932698|54600079|FG002|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
27943083|NCT00932698|54600080|FG003|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
27943084|NCT00932698|54600081|FG004|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
27943085|NCT00932698|54600082|FG005|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
27943086|NCT00932698|54600083|FG006|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
27943087|NCT00932698|54600084|FG007|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
27943088|NCT00932698|54600085|FG008|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
27943089|NCT00932698|54600086|FG009|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
27943090|NCT00932698|54600087|FG010|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
27943091|NCT00932698|54600077|FG000|Part 1 (Dose Escalation)|Adverse Event|0|||
27943092|NCT00932698|54600078|FG001|Part 1 (Dose Escalation)|Adverse Event|0|||
27943093|NCT00932698|54600079|FG002|Part 1 (Dose Escalation)|Adverse Event|0|||
27943094|NCT00932698|54600080|FG003|Part 1 (Dose Escalation)|Adverse Event|0|||
27943095|NCT00932698|54600081|FG004|Part 1 (Dose Escalation)|Adverse Event|0|||
27943096|NCT00932698|54600082|FG005|Part 1 (Dose Escalation)|Adverse Event|1|||
27943097|NCT00932698|54600083|FG006|Part 1 (Dose Escalation)|Adverse Event|0|||
27943098|NCT00932698|54600084|FG007|Part 1 (Dose Escalation)|Adverse Event|0|||
27943099|NCT00932698|54600085|FG008|Part 1 (Dose Escalation)|Adverse Event|0|||
27943100|NCT00932698|54600086|FG009|Part 1 (Dose Escalation)|Adverse Event|0|||
27943101|NCT00932698|54600087|FG010|Part 1 (Dose Escalation)|Adverse Event|0|||
27943102|NCT00932698|54600077|FG000|Part 1 (Dose Escalation)|Other|0|||
27943103|NCT00932698|54600078|FG001|Part 1 (Dose Escalation)|Other|0|||
27943104|NCT00932698|54600079|FG002|Part 1 (Dose Escalation)|Other|1|||
27943105|NCT00932698|54600080|FG003|Part 1 (Dose Escalation)|Other|0|||
27943106|NCT00932698|54600081|FG004|Part 1 (Dose Escalation)|Other|0|||
27943107|NCT00932698|54600082|FG005|Part 1 (Dose Escalation)|Other|0|||
27943108|NCT00932698|54600083|FG006|Part 1 (Dose Escalation)|Other|1|||
27943109|NCT00932698|54600084|FG007|Part 1 (Dose Escalation)|Other|0|||
27943110|NCT00932698|54600085|FG008|Part 1 (Dose Escalation)|Other|0|||
27943111|NCT00932698|54600086|FG009|Part 1 (Dose Escalation)|Other|0|||
27943112|NCT00932698|54600087|FG010|Part 1 (Dose Escalation)|Other|0|||
27943113|NCT00932698|54600077|FG000|Part 2 (Dose Expansion)|Progressive Disease|0|||
27943114|NCT00932698|54600078|FG001|Part 2 (Dose Expansion)|Progressive Disease|0|||
27943115|NCT00932698|54600079|FG002|Part 2 (Dose Expansion)|Progressive Disease|0|||
27943116|NCT00932698|54600080|FG003|Part 2 (Dose Expansion)|Progressive Disease|0|||
27825566|NCT01721317|54291192|FG000|Overall Study|Physician Decision|0|||
27943117|NCT00932698|54600081|FG004|Part 2 (Dose Expansion)|Progressive Disease|0|||
27943118|NCT00932698|54600082|FG005|Part 2 (Dose Expansion)|Progressive Disease|0|||
27943119|NCT00932698|54600083|FG006|Part 2 (Dose Expansion)|Progressive Disease|0|||
27943120|NCT00932698|54600084|FG007|Part 2 (Dose Expansion)|Progressive Disease|14|||
27943121|NCT00932698|54600085|FG008|Part 2 (Dose Expansion)|Progressive Disease|8|||
27943122|NCT00932698|54600086|FG009|Part 2 (Dose Expansion)|Progressive Disease|3|||
27943123|NCT00932698|54600087|FG010|Part 2 (Dose Expansion)|Progressive Disease|2|||
27943124|NCT00932698|54600077|FG000|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
27943125|NCT00932698|54600078|FG001|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
27943126|NCT00932698|54600079|FG002|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
27943127|NCT00932698|54600080|FG003|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
27943128|NCT00932698|54600081|FG004|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
27943129|NCT00932698|54600082|FG005|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
27943130|NCT00932698|54600083|FG006|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
27943131|NCT00932698|54600084|FG007|Part 2 (Dose Expansion)|Withdrawal by Subject|1|||
27943132|NCT00932698|54600085|FG008|Part 2 (Dose Expansion)|Withdrawal by Subject|3|||
27943133|NCT00932698|54600086|FG009|Part 2 (Dose Expansion)|Withdrawal by Subject|2|||
27943134|NCT00932698|54600087|FG010|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
27943135|NCT00932698|54600077|FG000|Part 2 (Dose Expansion)|Adverse Event|0|||
27943136|NCT00932698|54600078|FG001|Part 2 (Dose Expansion)|Adverse Event|0|||
27943137|NCT00932698|54600079|FG002|Part 2 (Dose Expansion)|Adverse Event|0|||
27943138|NCT00932698|54600080|FG003|Part 2 (Dose Expansion)|Adverse Event|0|||
27943139|NCT00932698|54600081|FG004|Part 2 (Dose Expansion)|Adverse Event|0|||
27943140|NCT00932698|54600082|FG005|Part 2 (Dose Expansion)|Adverse Event|0|||
27943141|NCT00932698|54600083|FG006|Part 2 (Dose Expansion)|Adverse Event|0|||
27943142|NCT00932698|54600084|FG007|Part 2 (Dose Expansion)|Adverse Event|5|||
27943143|NCT00932698|54600085|FG008|Part 2 (Dose Expansion)|Adverse Event|1|||
27943144|NCT00932698|54600086|FG009|Part 2 (Dose Expansion)|Adverse Event|1|||
27943145|NCT00932698|54600087|FG010|Part 2 (Dose Expansion)|Adverse Event|0|||
27943146|NCT00978627|54600115|FG000|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4|||
27943147|NCT00978627|54600116|FG001|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3|||
27943148|NCT00978627|54600115|FG000|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2|||
27943149|NCT00978627|54600116|FG001|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0|||
28160144|NCT02557516|54830247|FG000|Overall Study|Physician Decision|0|||
27825567|NCT01721317|54291193|FG001|Overall Study|Physician Decision|1|||
27825568|NCT01721317|54291192|FG000|Overall Study|Withdrawal by Subject|0|||
27943150|NCT00978627|54600115|FG000|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8|||
27943151|NCT00978627|54600116|FG001|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6|||
27943152|NCT00978627|54600115|FG000|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7|||
27943153|NCT00978627|54600116|FG001|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5|||
27943154|NCT00978627|54600115|FG000|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25|||
27943155|NCT00978627|54600116|FG001|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12|||
27943156|NCT00978627|54600115|FG000|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3|||
27943157|NCT00978627|54600116|FG001|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0|||
27943158|NCT00978627|54600115|FG000|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4|||
27943159|NCT00978627|54600116|FG001|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1|||
27943160|NCT00978627|54600115|FG000|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2|||
27943161|NCT00978627|54600116|FG001|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1|||
27943162|NCT00978627|54600115|FG000|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12|||
27943163|NCT00978627|54600116|FG001|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7|||
27943164|NCT01181609|54600122|FG000|Overall Study|Adverse Event|1|||
27943165|NCT01181609|54600122|FG000|Overall Study|Withdrawal by Subject|1|||
27943166|NCT01181609|54600122|FG000|Overall Study|Lost to Follow-up|1|||
27943167|NCT01181609|54600122|FG000|Overall Study|Death|50|||
27943168|NCT01154010|54600128|FG000|Overall Study|Lost to Follow-up|0|||
27943169|NCT01154010|54600129|FG001|Overall Study|Lost to Follow-up|1|||
27943170|NCT01153698|54600135|FG000|Overall Study|Adverse Event|12|||
27943171|NCT01153698|54600135|FG000|Overall Study|Lost to Follow-up|4|||
27943172|NCT01153698|54600135|FG000|Overall Study|Withdrawal by Subject|2|||
27943173|NCT01153698|54600135|FG000|Overall Study|Switch to other anticoagulants|4|||
27943174|NCT01153698|54600135|FG000|Overall Study|Other|2|||
27943175|NCT01153698|54600135|FG000|Overall Study|Not treated with Pradaxa|5|||
27943176|NCT01174368|54600140|FG000|Overall Study|Withdrawal by Subject|1|||
27943177|NCT01147926|54600146|FG000|Overall Study|Subject Withdrew Consent|9|||
27943178|NCT01147926|54600147|FG001|Overall Study|Subject Withdrew Consent|10|||
27943179|NCT01147926|54600146|FG000|Overall Study|Adverse Event|7|||
27943180|NCT01147926|54600147|FG001|Overall Study|Adverse Event|6|||
27943181|NCT01147926|54600146|FG000|Overall Study|Subject Non-Compliant|5|||
27943182|NCT01147926|54600147|FG001|Overall Study|Subject Non-Compliant|4|||
27943183|NCT01147926|54600146|FG000|Overall Study|Principal investigator left hospital|1|||
27943184|NCT01147926|54600147|FG001|Overall Study|Principal investigator left hospital|3|||
28159476|NCT03745638|54829370|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
28159477|NCT03745638|54829371|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
28160145|NCT02557516|54830248|FG001|Overall Study|Physician Decision|2|||
27825569|NCT01721317|54291193|FG001|Overall Study|Withdrawal by Subject|1|||
27825570|NCT01701193|54291203|FG000|Overall Study|Withdrawal by Subject|2|||
27943185|NCT01147926|54600146|FG000|Overall Study|Selection criteria not met|3|||
27850523|NCT03738566|54349453|FG003|Initial Study Phase|Treatment failure|0|||
27850524|NCT03738566|54349450|FG000|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
27850525|NCT03738566|54349451|FG001|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
28076421|NCT04207840|54731166|FG002|Washout Period 1 (2-7 Days)|Withdrawal by Subject|1|||
27825571|NCT01701193|54291204|FG001|Overall Study|Withdrawal by Subject|2|||
27825572|NCT01701193|54291205|FG002|Overall Study|Withdrawal by Subject|1|||
28076422|NCT04207840|54731164|FG000|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
28076423|NCT04207840|54731165|FG001|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
28076424|NCT04207840|54731166|FG002|Washout Period 2 (2-7 Days)|Withdrawal by Subject|1|||
28076425|NCT04006366|54731174|FG000|Overall Study|Withdrawal by Subject|1|||
28076426|NCT04191148|54731180|FG000|Overall Study|Withdrawal by Subject|1|||
28076427|NCT04191148|54731181|FG001|Overall Study|Withdrawal by Subject|0|||
28076428|NCT04191148|54731180|FG000|Overall Study|Adverse Event|1|||
28076429|NCT04191148|54731181|FG001|Overall Study|Adverse Event|0|||
28076430|NCT04004260|54731191|FG000|Overall Study|Withdrawal by Subject|7|||
28076431|NCT04004260|54731192|FG001|Overall Study|Withdrawal by Subject|3|||
28076432|NCT04004260|54731191|FG000|Overall Study|Lost to Follow-up|22|||
28076433|NCT04004260|54731192|FG001|Overall Study|Lost to Follow-up|12|||
28076434|NCT04004260|54731191|FG000|Overall Study|Did not engage in intervention|13|||
28076435|NCT04004260|54731192|FG001|Overall Study|Did not engage in intervention|17|||
28076436|NCT04470622|54731200|FG000|Overall Study|Withdrawal by Subject|0|||
28076437|NCT04470622|54731201|FG001|Overall Study|Withdrawal by Subject|1|||
28076438|NCT04470622|54731200|FG000|Overall Study|Screen Failure|0|||
28076439|NCT04470622|54731201|FG001|Overall Study|Screen Failure|1|||
28076440|NCT04470622|54731200|FG000|Overall Study|Death|0|||
28076441|NCT04470622|54731201|FG001|Overall Study|Death|1|||
28076442|NCT04465630|54731207|FG000|Overall Study|Sponsor Decision to terminate the study|54|||
28076443|NCT04465630|54731207|FG000|Overall Study|Screen failure|8|||
28076444|NCT04465630|54731207|FG000|Overall Study|Baseline failure|16|||
28076445|NCT04182880|54731214|FG000|Overall Study|Pregnancy|1|||
28076446|NCT04182880|54731215|FG001|Overall Study|Pregnancy|0|||
28076447|NCT04465396|54731225|FG000|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
28076448|NCT04465396|54731226|FG001|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
28076449|NCT04465396|54731227|FG002|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
28076450|NCT04465396|54731228|FG003|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
28076451|NCT03999892|54731253|FG000|Overall Study|Lost to Follow-up|1|||
28076452|NCT03996694|54731257|FG000|First Washout (7 Days)|positive urine drug screen|0|||
28076453|NCT03996694|54731258|FG001|First Washout (7 Days)|positive urine drug screen|0|||
28076454|NCT03996694|54731259|FG002|First Washout (7 Days)|positive urine drug screen|1|||
28076455|NCT03996694|54731260|FG003|First Washout (7 Days)|positive urine drug screen|0|||
28076456|NCT03996694|54731261|FG004|First Washout (7 Days)|positive urine drug screen|0|||
28076457|NCT03996694|54731262|FG005|First Washout (7 Days)|positive urine drug screen|0|||
28076458|NCT03996694|54731257|FG000|First Washout (7 Days)|Adverse Event|0|||
28076459|NCT03996694|54731258|FG001|First Washout (7 Days)|Adverse Event|1|||
28076460|NCT03996694|54731259|FG002|First Washout (7 Days)|Adverse Event|0|||
28076461|NCT03996694|54731260|FG003|First Washout (7 Days)|Adverse Event|0|||
28076462|NCT03996694|54731261|FG004|First Washout (7 Days)|Adverse Event|0|||
28076463|NCT03996694|54731262|FG005|First Washout (7 Days)|Adverse Event|0|||
28076464|NCT03996694|54731257|FG000|First Washout (7 Days)|Lost to Follow-up|0|||
28076465|NCT03996694|54731258|FG001|First Washout (7 Days)|Lost to Follow-up|0|||
28076466|NCT03996694|54731259|FG002|First Washout (7 Days)|Lost to Follow-up|1|||
28076467|NCT03996694|54731260|FG003|First Washout (7 Days)|Lost to Follow-up|0|||
28076468|NCT03996694|54731261|FG004|First Washout (7 Days)|Lost to Follow-up|0|||
28076469|NCT03996694|54731262|FG005|First Washout (7 Days)|Lost to Follow-up|0|||
28076470|NCT03996694|54731257|FG000|Third Washout (7 Days)|Withdrawal by Subject|0|||
28076471|NCT03996694|54731258|FG001|Third Washout (7 Days)|Withdrawal by Subject|0|||
28076472|NCT03996694|54731259|FG002|Third Washout (7 Days)|Withdrawal by Subject|0|||
28076473|NCT03996694|54731260|FG003|Third Washout (7 Days)|Withdrawal by Subject|0|||
28076474|NCT03996694|54731261|FG004|Third Washout (7 Days)|Withdrawal by Subject|1|||
28076475|NCT03996694|54731262|FG005|Third Washout (7 Days)|Withdrawal by Subject|0|||
28076476|NCT04179838|54731278|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
28076477|NCT04179838|54731279|FG001|First Intervention (1 Day)|Withdrawal by Subject|3|||
28076478|NCT04179838|54731278|FG000|Second Intervention (1 Day)|Protocol Violation|0|||
28160146|NCT02557516|54830249|FG002|Overall Study|Physician Decision|0|||
28076479|NCT04179838|54731279|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
28076480|NCT03994120|54731287|FG000|Overall Study|Lost to Follow-up|3|||
28159478|NCT03745638|54829372|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
27825573|NCT01701193|54291206|FG003|Overall Study|Withdrawal by Subject|2|||
28076481|NCT03994120|54731288|FG001|Overall Study|Lost to Follow-up|1|||
28076482|NCT04178590|54731294|FG000|Overall Study|Pregnancy|1|||
28076483|NCT04178590|54731294|FG000|Overall Study|Lost to Follow-up|1|||
28076484|NCT04175392|54731322|FG000|Overall Study|Withdrawal by Subject|3|||
28076485|NCT04175392|54731323|FG001|Overall Study|Withdrawal by Subject|2|||
28076486|NCT03986866|54731331|FG000|Overall Study|Withdrawal by Subject|0|||
28076487|NCT03986866|54731332|FG001|Overall Study|Withdrawal by Subject|3|||
28076488|NCT03986866|54731331|FG000|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
28076489|NCT03986866|54731332|FG001|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
28076490|NCT03980938|54731340|FG000|Treatment Period 1|Study Terminated|1|||
28076491|NCT03980938|54731341|FG001|Treatment Period 1|Study Terminated|1|||
28076492|NCT03980938|54731340|FG000|Treatment Period 2|Study Terminated|2|||
28076493|NCT03980938|54731341|FG001|Treatment Period 2|Study Terminated|2|||
28076494|NCT03656692|54731347|FG000|Overall Study|Worsening of disease activity|2|||
28076495|NCT03656692|54731347|FG000|Overall Study|Physician Decision|1|||
28076496|NCT04439266|54731351|FG000|Overall Study|Ineligible|1|||
28076497|NCT04439266|54731351|FG000|Overall Study|Adverse Event|1|||
28076498|NCT04439266|54731351|FG000|Overall Study|Death|1|||
28076499|NCT04439266|54731351|FG000|Overall Study|Disease progression|1|||
28076500|NCT04439266|54731351|FG000|Overall Study|Still on treatment|1|||
28076501|NCT03682120|54731359|FG000|Overall Study|Lost to Follow-up|11|||
28076502|NCT03682120|54731360|FG001|Overall Study|Lost to Follow-up|4|||
28076503|NCT03682120|54731361|FG002|Overall Study|Lost to Follow-up|5|||
28076504|NCT03682120|54731362|FG003|Overall Study|Lost to Follow-up|2|||
28076505|NCT03682120|54731359|FG000|Overall Study|Physician Decision|1|||
28076506|NCT03682120|54731360|FG001|Overall Study|Physician Decision|0|||
28076507|NCT03682120|54731361|FG002|Overall Study|Physician Decision|0|||
28076508|NCT03682120|54731362|FG003|Overall Study|Physician Decision|0|||
28076509|NCT03682120|54731359|FG000|Overall Study|Withdrawal by Subject|1|||
27825574|NCT01701193|54291203|FG000|Overall Study|Adverse Event|1|||
27825575|NCT01701193|54291204|FG001|Overall Study|Adverse Event|0|||
28076510|NCT03682120|54731360|FG001|Overall Study|Withdrawal by Subject|2|||
28076511|NCT03682120|54731361|FG002|Overall Study|Withdrawal by Subject|3|||
28076512|NCT03682120|54731362|FG003|Overall Study|Withdrawal by Subject|0|||
28076513|NCT03682120|54731359|FG000|Overall Study|Death|0|||
28076514|NCT03682120|54731360|FG001|Overall Study|Death|1|||
27825576|NCT01701193|54291205|FG002|Overall Study|Adverse Event|0|||
27825577|NCT01701193|54291206|FG003|Overall Study|Adverse Event|0|||
27825578|NCT01959347|54291254|FG000|Overall Study|Protocol Violation|9|||
27825579|NCT01959347|54291255|FG001|Overall Study|Protocol Violation|7|||
27825580|NCT01959035|54291281|FG000|Overall Study|Adverse Event|5|||
27825581|NCT01959035|54291281|FG000|Overall Study|Withdrawal by Subject|4|||
27825582|NCT01959035|54291281|FG000|Overall Study|Lost to Follow-up|1|||
27825583|NCT01959035|54291281|FG000|Overall Study|Other (no primary reason given)|1|||
27825584|NCT01700959|54291291|FG000|Overall Study|Adverse Event|0|||
27825585|NCT01700959|54291292|FG001|Overall Study|Adverse Event|1|||
27825586|NCT01700959|54291293|FG002|Overall Study|Adverse Event|1|||
27825587|NCT01700959|54291294|FG003|Overall Study|Adverse Event|2|||
27825588|NCT01700959|54291295|FG004|Overall Study|Adverse Event|0|||
27825589|NCT01700959|54291296|FG005|Overall Study|Adverse Event|2|||
28076515|NCT03682120|54731361|FG002|Overall Study|Death|0|||
28076516|NCT03682120|54731362|FG003|Overall Study|Death|0|||
28076517|NCT03682120|54731359|FG000|Overall Study|Enrolled but Treatment Not Administered|0|||
28076518|NCT03682120|54731360|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
28076519|NCT03682120|54731361|FG002|Overall Study|Enrolled but Treatment Not Administered|0|||
28076520|NCT03682120|54731362|FG003|Overall Study|Enrolled but Treatment Not Administered|0|||
28076521|NCT04428502|54731374|FG000|Overall Study|Did not meet entrance criteria|14|||
28076522|NCT04428424|54731379|FG000|Overall Study|Does not meet entrance criteria|132|||
28076523|NCT04428424|54731379|FG000|Overall Study|Lost to Follow-up|115|||
28076524|NCT03655756|54731383|FG000|Overall Study|Death|1|||
28076525|NCT00095238|54731389|FG000|Overall Study|Lack of Efficacy|9|||
28076526|NCT00095238|54731390|FG001|Overall Study|Lack of Efficacy|9|||
28076527|NCT00095238|54731389|FG000|Overall Study|Adverse Event|331|||
28076528|NCT00095238|54731390|FG001|Overall Study|Adverse Event|287|||
28076529|NCT00095238|54731389|FG000|Overall Study|Subject Withdrew Consent|208|||
28076530|NCT00095238|54731390|FG001|Overall Study|Subject Withdrew Consent|223|||
28076531|NCT00095238|54731389|FG000|Overall Study|Death|154|||
28076532|NCT00095238|54731390|FG001|Overall Study|Death|170|||
28076533|NCT00095238|54731389|FG000|Overall Study|Lost to Follow-up|19|||
28076534|NCT00095238|54731390|FG001|Overall Study|Lost to Follow-up|24|||
28076535|NCT00095238|54731389|FG000|Overall Study|Noncompliance|44|||
27825590|NCT01700959|54291291|FG000|Overall Study|Withdrawal by Subject|15|||
27825591|NCT01700959|54291292|FG001|Overall Study|Withdrawal by Subject|9|||
27825592|NCT01700959|54291293|FG002|Overall Study|Withdrawal by Subject|12|||
28076536|NCT00095238|54731390|FG001|Overall Study|Noncompliance|45|||
28076537|NCT00095238|54731389|FG000|Overall Study|No longer met study criteria|4|||
28159479|NCT03745638|54829373|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
28159480|NCT03745638|54829367|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
27850526|NCT03738566|54349452|FG002|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
27943186|NCT01147926|54600147|FG001|Overall Study|Selection criteria not met|1|||
27943187|NCT01147926|54600146|FG000|Overall Study|Lost to Follow-up|0|||
27943188|NCT01147926|54600147|FG001|Overall Study|Lost to Follow-up|2|||
27943189|NCT01147926|54600146|FG000|Overall Study|Sponsor's Decision|0|||
27943190|NCT01147926|54600147|FG001|Overall Study|Sponsor's Decision|1|||
27943191|NCT01147926|54600146|FG000|Overall Study|Lack of Efficacy|1|||
27943192|NCT01147926|54600147|FG001|Overall Study|Lack of Efficacy|0|||
27943193|NCT01147926|54600146|FG000|Overall Study|Too busy, no time for study|1|||
27943194|NCT01147926|54600147|FG001|Overall Study|Too busy, no time for study|0|||
27943195|NCT01147926|54600146|FG000|Overall Study|Went on holiday|0|||
27943196|NCT01147926|54600147|FG001|Overall Study|Went on holiday|1|||
27943197|NCT01147926|54600146|FG000|Overall Study|Colonoscopy result|0|||
27943198|NCT01147926|54600147|FG001|Overall Study|Colonoscopy result|1|||
27943199|NCT00975507|54600155|FG000|Overall Study|Adverse Event|1|||
27943200|NCT00975507|54600156|FG001|Overall Study|Adverse Event|0|||
27943201|NCT00975507|54600155|FG000|Overall Study|Lost to Follow-up|7|||
27943202|NCT00975507|54600156|FG001|Overall Study|Lost to Follow-up|1|||
27943203|NCT00975507|54600155|FG000|Overall Study|Protocol Violation|2|||
27943204|NCT00975507|54600156|FG001|Overall Study|Protocol Violation|0|||
27943205|NCT00975507|54600155|FG000|Overall Study|Withdrawal by Subject|10|||
28159481|NCT03745638|54829368|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
28159482|NCT03745638|54829369|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
27943206|NCT00975507|54600156|FG001|Overall Study|Withdrawal by Subject|3|||
27943207|NCT01147848|54600166|FG000|Run-in Period|Screen Failure|623|||
27943208|NCT01147848|54600167|FG001|Run-in Period|Screen Failure|0|||
27943209|NCT01147848|54600168|FG002|Run-in Period|Screen Failure|0|||
27943210|NCT01147848|54600166|FG000|Run-in Period|Run-in Failure|135|||
27943211|NCT01147848|54600167|FG001|Run-in Period|Run-in Failure|0|||
27943212|NCT01147848|54600168|FG002|Run-in Period|Run-in Failure|0|||
27943213|NCT01147848|54600166|FG000|Randomized Phase|Adverse Event|0|||
27943214|NCT01147848|54600167|FG001|Randomized Phase|Adverse Event|6|||
27943215|NCT01147848|54600168|FG002|Randomized Phase|Adverse Event|8|||
27943216|NCT01147848|54600166|FG000|Randomized Phase|Lack of Efficacy|0|||
28076538|NCT00095238|54731390|FG001|Overall Study|No longer met study criteria|5|||
28076539|NCT00095238|54731389|FG000|Overall Study|Study terminated by sponsor|0|||
28076540|NCT00095238|54731390|FG001|Overall Study|Study terminated by sponsor|1|||
28159483|NCT03745638|54829370|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
28159484|NCT03745638|54829371|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
28159485|NCT03745638|54829372|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|6|||
28159486|NCT03745638|54829373|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|1|||
27850527|NCT03738566|54349453|FG003|Cross-over for Treatment Failure|Withdrawal by Subject|1|||
27943217|NCT01147848|54600167|FG001|Randomized Phase|Lack of Efficacy|20|||
28076541|NCT00095238|54731389|FG000|Overall Study|Missing|1|||
28076542|NCT00095238|54731390|FG001|Overall Study|Missing|0|||
28076543|NCT00095238|54731389|FG000|Overall Study|Other Reasons|87|||
28076544|NCT00095238|54731390|FG001|Overall Study|Other Reasons|88|||
28076545|NCT00082368|54731428|FG000|Overall Study|Not treated-pt had poor IV access|1|||
28076546|NCT00094770|54731434|FG000|Year 1 ( Week 0 to Week 52)|Adverse Event|25|||
28076547|NCT00094770|54731435|FG001|Year 1 ( Week 0 to Week 52)|Adverse Event|26|||
28076548|NCT00094770|54731434|FG000|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86|||
28076549|NCT00094770|54731435|FG001|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58|||
28159487|NCT03745638|54829367|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
28159488|NCT03745638|54829368|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
27943218|NCT01147848|54600168|FG002|Randomized Phase|Lack of Efficacy|11|||
28076550|NCT00094770|54731434|FG000|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19|||
28159489|NCT03745638|54829369|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
28159490|NCT03745638|54829370|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
28159491|NCT03745638|54829371|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
28159492|NCT03745638|54829372|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
28159493|NCT03745638|54829373|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
28159494|NCT03745638|54829367|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
28159495|NCT03745638|54829368|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
28159496|NCT03745638|54829369|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
27943219|NCT01147848|54600166|FG000|Randomized Phase|Protocol Violation|0|||
27943220|NCT01147848|54600167|FG001|Randomized Phase|Protocol Violation|7|||
27943221|NCT01147848|54600168|FG002|Randomized Phase|Protocol Violation|10|||
27850528|NCT03692052|54349483|FG000|Core Period (Day 1 to Week 24)|Adverse Event|1|||
27850529|NCT03692052|54349483|FG000|Extension Period (Week 25 to 10 Years)|Withdrawal of Consent|1|||
27825593|NCT01700959|54291294|FG003|Overall Study|Withdrawal by Subject|11|||
27825594|NCT01700959|54291295|FG004|Overall Study|Withdrawal by Subject|8|||
27825595|NCT01700959|54291296|FG005|Overall Study|Withdrawal by Subject|12|||
27943222|NCT01147848|54600166|FG000|Randomized Phase|Lost to Follow-up|0|||
27943223|NCT01147848|54600167|FG001|Randomized Phase|Lost to Follow-up|5|||
27825596|NCT01700959|54291291|FG000|Overall Study|Ineligible|2|||
28076551|NCT00094770|54731435|FG001|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10|||
28076552|NCT00094770|54731434|FG000|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
28076553|NCT00094770|54731435|FG001|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
28076554|NCT00094770|54731434|FG000|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19|||
28076555|NCT00094770|54731435|FG001|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25|||
28076556|NCT00094770|54731434|FG000|Year 1 ( Week 0 to Week 52)|Patient Moved|6|||
28076557|NCT00094770|54731435|FG001|Year 1 ( Week 0 to Week 52)|Patient Moved|2|||
28076558|NCT00094770|54731434|FG000|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25|||
28076559|NCT00094770|54731435|FG001|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28|||
28076560|NCT00094770|54731434|FG000|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
28076561|NCT00094770|54731435|FG001|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
28076562|NCT00094770|54731434|FG000|Year 1 ( Week 0 to Week 52)|Other|10|||
28076563|NCT00094770|54731435|FG001|Year 1 ( Week 0 to Week 52)|Other|11|||
28076564|NCT00094770|54731434|FG000|Year 2 (Week 0 to Week 104)|Adverse Event|35|||
28076565|NCT00094770|54731435|FG001|Year 2 (Week 0 to Week 104)|Adverse Event|36|||
28076566|NCT00094770|54731434|FG000|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180|||
28076567|NCT00094770|54731435|FG001|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162|||
28076568|NCT00094770|54731434|FG000|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25|||
28076569|NCT00094770|54731435|FG001|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15|||
28076570|NCT00094770|54731434|FG000|Year 2 (Week 0 to Week 104)|Protocol Violation|13|||
28159497|NCT03745638|54829370|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|3|||
28159498|NCT03745638|54829371|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|5|||
28159499|NCT03745638|54829372|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
28159500|NCT03745638|54829373|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|24|||
28159501|NCT03745638|54829367|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
28159502|NCT03745638|54829368|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
28159503|NCT03745638|54829369|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
28159504|NCT03745638|54829370|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
28159505|NCT03745638|54829371|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
28159506|NCT03745638|54829372|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|3|||
28076571|NCT00094770|54731435|FG001|Year 2 (Week 0 to Week 104)|Protocol Violation|12|||
28076572|NCT00094770|54731434|FG000|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29|||
28076573|NCT00094770|54731435|FG001|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30|||
28159507|NCT03745638|54829373|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
28159508|NCT03745638|54829367|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
28159509|NCT03745638|54829368|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
28159510|NCT03745638|54829369|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
28159511|NCT03745638|54829370|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
28159512|NCT03745638|54829371|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
28159513|NCT03745638|54829372|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
28159514|NCT03745638|54829373|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
28159515|NCT03745638|54829367|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
28159516|NCT03745638|54829368|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
28159517|NCT03745638|54829369|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
28159518|NCT03745638|54829370|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|7|||
28159519|NCT03745638|54829371|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
28159520|NCT03745638|54829372|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|17|||
28159521|NCT03745638|54829373|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|21|||
28159522|NCT03745638|54829367|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
28159523|NCT03745638|54829368|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
28159524|NCT03745638|54829369|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
28159525|NCT03745638|54829370|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
28159526|NCT03745638|54829371|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
28159527|NCT03745638|54829372|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|4|||
28159528|NCT03745638|54829373|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|3|||
28159529|NCT03715764|54829392|FG000|Baseline (Randomized (n=69)|Withdrawal by Subject|2|||
28159530|NCT03715764|54829393|FG001|Baseline (Randomized (n=69)|Withdrawal by Subject|3|||
28159531|NCT03715764|54829392|FG000|3 Month Follow-up|Lost to Follow-up|2|||
28159532|NCT03715764|54829393|FG001|3 Month Follow-up|Lost to Follow-up|2|||
28159533|NCT03715764|54829392|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
28159534|NCT03715764|54829393|FG001|3 Month Follow-up|Withdrawal by Subject|1|||
28159535|NCT03715764|54829392|FG000|6 Month Follow-up|Lost to Follow-up|3|||
28159536|NCT03715764|54829393|FG001|6 Month Follow-up|Lost to Follow-up|0|||
28159537|NCT03715764|54829392|FG000|12 Month Follow-up|Lost to Follow-up|2|||
28159538|NCT03715764|54829393|FG001|12 Month Follow-up|Lost to Follow-up|3|||
28159539|NCT03715764|54829392|FG000|12 Month Follow-up|Pregnancy|0|||
28159540|NCT03715764|54829393|FG001|12 Month Follow-up|Pregnancy|1|||
28159541|NCT03715764|54829392|FG000|12 Month Follow-up|Surgery|2|||
28159542|NCT03715764|54829393|FG001|12 Month Follow-up|Surgery|0|||
28159543|NCT03715764|54829392|FG000|12 Month Follow-up|Wrong address|1|||
28159544|NCT03715764|54829393|FG001|12 Month Follow-up|Wrong address|0|||
28159545|NCT03715764|54829392|FG000|12 Month Follow-up|No symptoms|1|||
28159546|NCT03715764|54829393|FG001|12 Month Follow-up|No symptoms|0|||
28159547|NCT03715764|54829392|FG000|12 Month Follow-up|Changed primary care centre|0|||
28159548|NCT03715764|54829393|FG001|12 Month Follow-up|Changed primary care centre|1|||
28159549|NCT02718326|54829402|FG000|Overall Study|Adverse Event|4|||
28159550|NCT02718326|54829403|FG001|Overall Study|Adverse Event|9|||
28159551|NCT02718326|54829404|FG002|Overall Study|Adverse Event|0|||
28159552|NCT02718326|54829402|FG000|Overall Study|Death|8|||
28159553|NCT02718326|54829403|FG001|Overall Study|Death|1|||
28159554|NCT02718326|54829404|FG002|Overall Study|Death|2|||
28159555|NCT02718326|54829402|FG000|Overall Study|Withdrawal by Subject|4|||
28159556|NCT02718326|54829403|FG001|Overall Study|Withdrawal by Subject|9|||
28159557|NCT02718326|54829404|FG002|Overall Study|Withdrawal by Subject|6|||
28159558|NCT02718326|54829402|FG000|Overall Study|Lost to Follow-up|18|||
28159559|NCT02718326|54829403|FG001|Overall Study|Lost to Follow-up|5|||
28159560|NCT02718326|54829404|FG002|Overall Study|Lost to Follow-up|14|||
28159561|NCT02718326|54829402|FG000|Overall Study|Protocol Deviation|1|||
28159562|NCT02718326|54829403|FG001|Overall Study|Protocol Deviation|0|||
28159563|NCT02718326|54829404|FG002|Overall Study|Protocol Deviation|0|||
28159564|NCT02718326|54829402|FG000|Overall Study|Pregnancy|1|||
28159565|NCT02718326|54829403|FG001|Overall Study|Pregnancy|0|||
28159566|NCT02718326|54829404|FG002|Overall Study|Pregnancy|0|||
28159567|NCT03600714|54829414|FG000|Overall Study|Out of country and could not return for post-treatment visits|1|||
28159568|NCT02720042|54829453|FG000|Overall Study|Death|3|||
28159569|NCT02720042|54829453|FG000|Overall Study|Lost to Follow-up|4|||
28159570|NCT02720042|54829453|FG000|Overall Study|Withdrawal by Subject|1|||
28159571|NCT02720042|54829453|FG000|Overall Study|Physician Decision|3|||
28159572|NCT02720042|54829453|FG000|Overall Study|Phasix Mesh explanted|1|||
28159573|NCT02720042|54829453|FG000|Overall Study|unable due to non-study-related illness|3|||
28159574|NCT01352793|54829459|FG000|Overall Study|Lost to Follow-up|289|||
28159575|NCT01352793|54829460|FG001|Overall Study|Lost to Follow-up|125|||
28159576|NCT01352793|54829459|FG000|Overall Study|Withdrawal by Subject|120|||
28159577|NCT01352793|54829460|FG001|Overall Study|Withdrawal by Subject|55|||
28159578|NCT01352793|54829459|FG000|Overall Study|Protocol Violation|44|||
28159579|NCT01352793|54829460|FG001|Overall Study|Protocol Violation|23|||
28159580|NCT01352793|54829459|FG000|Overall Study|Adverse Event|44|||
28159581|NCT01352793|54829460|FG001|Overall Study|Adverse Event|10|||
28159582|NCT01352793|54829459|FG000|Overall Study|Physician Decision|1|||
28159583|NCT01352793|54829460|FG001|Overall Study|Physician Decision|0|||
28159584|NCT01352793|54829459|FG000|Overall Study|Pregnancy|26|||
28159585|NCT01352793|54829460|FG001|Overall Study|Pregnancy|8|||
28159586|NCT01352793|54829459|FG000|Overall Study|Other|25|||
27825597|NCT01700959|54291292|FG001|Overall Study|Ineligible|1|||
27825598|NCT01700959|54291293|FG002|Overall Study|Ineligible|2|||
28159587|NCT01352793|54829460|FG001|Overall Study|Other|7|||
27825599|NCT01700959|54291294|FG003|Overall Study|Ineligible|0|||
27825600|NCT01700959|54291295|FG004|Overall Study|Ineligible|0|||
27825601|NCT01700959|54291296|FG005|Overall Study|Ineligible|1|||
28159588|NCT01352793|54829459|FG000|Overall Study|Medication error|2|||
28159589|NCT01352793|54829460|FG001|Overall Study|Medication error|2|||
28159590|NCT01352793|54829459|FG000|Overall Study|Death|1|||
28159591|NCT01352793|54829460|FG001|Overall Study|Death|0|||
28159592|NCT01352793|54829459|FG000|Overall Study|Randomized but not vaccinated|8|||
28159593|NCT01352793|54829460|FG001|Overall Study|Randomized but not vaccinated|0|||
28159594|NCT01352793|54829459|FG000|Overall Study|No longer meets eligibility criteria|25|||
28159595|NCT01352793|54829460|FG001|Overall Study|No longer meets eligibility criteria|15|||
28159596|NCT02717546|54829466|FG000|Overall Study|Lost to Follow-up|12|||
28159597|NCT01378962|54829470|FG000|Overall Study|Death|14|||
28159598|NCT01378962|54829470|FG000|Overall Study|Lost to Follow-up|1|||
28159599|NCT01378962|54829470|FG000|Overall Study|Other|2|||
28159600|NCT00890409|54829476|FG000|Overall Study|Lost to Follow-up|20|||
28159601|NCT00890409|54829477|FG001|Overall Study|Lost to Follow-up|21|||
28159602|NCT04495478|54829488|FG000|Overall Study|Withdrawal by Subject|0|||
28159603|NCT04495478|54829489|FG001|Overall Study|Withdrawal by Subject|0|||
28159604|NCT04495478|54829490|FG002|Overall Study|Withdrawal by Subject|0|||
28159605|NCT04495478|54829491|FG003|Overall Study|Withdrawal by Subject|1|||
28159606|NCT04495478|54829492|FG004|Overall Study|Withdrawal by Subject|0|||
28076574|NCT00094770|54731434|FG000|Year 2 (Week 0 to Week 104)|Patient Moved|6|||
28076575|NCT00094770|54731435|FG001|Year 2 (Week 0 to Week 104)|Patient Moved|2|||
28076576|NCT00094770|54731434|FG000|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28|||
28076577|NCT00094770|54731435|FG001|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38|||
28159607|NCT04495478|54829493|FG005|Overall Study|Withdrawal by Subject|0|||
28159608|NCT04495478|54829494|FG006|Overall Study|Withdrawal by Subject|0|||
28159609|NCT04495478|54829488|FG000|Overall Study|Physician Decision|0|||
28159610|NCT04495478|54829489|FG001|Overall Study|Physician Decision|1|||
28076578|NCT00094770|54731434|FG000|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
28076579|NCT00094770|54731435|FG001|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
28076580|NCT00094770|54731434|FG000|Year 2 (Week 0 to Week 104)|Other|15|||
28076581|NCT00094770|54731435|FG001|Year 2 (Week 0 to Week 104)|Other|23|||
28076582|NCT00069576|54731443|FG000|Original Trial|Lost to Follow-up|25|||
28076583|NCT00069576|54731444|FG001|Original Trial|Lost to Follow-up|33|||
28076584|NCT00069576|54731443|FG000|Follow-up Study at 5-10 Years|Not eligible or did not consent|196|||
28076585|NCT00069576|54731444|FG001|Follow-up Study at 5-10 Years|Not eligible or did not consent|204|||
28076586|NCT00069264|54731450|FG000|Overall Study|Adverse Event|3|||
28076587|NCT00069264|54731450|FG000|Overall Study|Progressive Disease|23|||
28076588|NCT00069264|54731450|FG000|Overall Study|Withdrawal by Subject|3|||
28076589|NCT00069264|54731450|FG000|Overall Study|Discon Therapy|3|||
28076590|NCT00069108|54731456|FG000|Overall Study|Withdrawal by Subject|5|||
28076591|NCT00069108|54731457|FG001|Overall Study|Withdrawal by Subject|9|||
28076592|NCT00069108|54731456|FG000|Overall Study|Adverse Event|64|||
28076593|NCT00069108|54731457|FG001|Overall Study|Adverse Event|42|||
28076594|NCT00069108|54731456|FG000|Overall Study|Death|6|||
28076595|NCT00069108|54731457|FG001|Overall Study|Death|6|||
28076596|NCT00069108|54731456|FG000|Overall Study|Administration|15|||
28076597|NCT00069108|54731457|FG001|Overall Study|Administration|4|||
28076598|NCT00069108|54731456|FG000|Overall Study|Insufficient therapy|117|||
28076599|NCT00069108|54731457|FG001|Overall Study|Insufficient therapy|144|||
28159611|NCT04495478|54829490|FG002|Overall Study|Physician Decision|0|||
28159612|NCT04495478|54829491|FG003|Overall Study|Physician Decision|0|||
28159613|NCT04495478|54829492|FG004|Overall Study|Physician Decision|1|||
28159614|NCT04495478|54829493|FG005|Overall Study|Physician Decision|0|||
28159615|NCT04495478|54829494|FG006|Overall Study|Physician Decision|0|||
28159616|NCT00152763|54829520|FG000|Overall Study|Death|4|||
28159617|NCT00152763|54829521|FG001|Overall Study|Death|1|||
28159618|NCT00152763|54829522|FG002|Overall Study|Death|2|||
28159619|NCT00152763|54829523|FG003|Overall Study|Death|1|||
28076600|NCT00069108|54731456|FG000|Overall Study|Violation criteria|1|||
27850530|NCT03692052|54349483|FG000|Extension Period (Week 25 to 10 Years)|Physician Decision|1|||
28076601|NCT00069108|54731457|FG001|Overall Study|Violation criteria|4|||
28076602|NCT00069108|54731456|FG000|Overall Study|Refused treatment|5|||
28076603|NCT00069108|54731457|FG001|Overall Study|Refused treatment|10|||
28076604|NCT00094536|54731464|FG000|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24|||
28159620|NCT00152763|54829520|FG000|Overall Study|Lost to Follow-up|6|||
28159621|NCT00152763|54829521|FG001|Overall Study|Lost to Follow-up|4|||
28159622|NCT00152763|54829522|FG002|Overall Study|Lost to Follow-up|2|||
28076605|NCT00094536|54731464|FG000|Treatment and Follow-up|Adverse Event|4|||
28076606|NCT00094536|54731464|FG000|Treatment and Follow-up|Lack of Efficacy|9|||
28076607|NCT00094536|54731464|FG000|Treatment and Follow-up|Lost to Follow-up|7|||
28076608|NCT00094536|54731464|FG000|Treatment and Follow-up|Withdrawal by Subject|1|||
28076609|NCT00094536|54731464|FG000|Treatment and Follow-up|Subject non-compliance|9|||
28076610|NCT00094536|54731464|FG000|Treatment and Follow-up|Unable to attend visits|1|||
28076611|NCT00405587|54731472|FG000|Overall Study|Death|0|||
28076612|NCT00405587|54731473|FG001|Overall Study|Death|0|||
28076613|NCT00405587|54731474|FG002|Overall Study|Death|0|||
28159623|NCT00152763|54829523|FG003|Overall Study|Lost to Follow-up|13|||
27825602|NCT01700959|54291291|FG000|Overall Study|Noncompliant|9|||
27825603|NCT01700959|54291292|FG001|Overall Study|Noncompliant|9|||
27825604|NCT01700959|54291293|FG002|Overall Study|Noncompliant|17|||
27825605|NCT01700959|54291294|FG003|Overall Study|Noncompliant|18|||
27825606|NCT01700959|54291295|FG004|Overall Study|Noncompliant|15|||
27825607|NCT01700959|54291296|FG005|Overall Study|Noncompliant|9|||
27825608|NCT01700959|54291291|FG000|Overall Study|Side effects|1|||
27825609|NCT01700959|54291292|FG001|Overall Study|Side effects|4|||
27825610|NCT01700959|54291293|FG002|Overall Study|Side effects|8|||
27825611|NCT01700959|54291294|FG003|Overall Study|Side effects|4|||
27825612|NCT01700959|54291295|FG004|Overall Study|Side effects|4|||
27825613|NCT01700959|54291296|FG005|Overall Study|Side effects|1|||
27825614|NCT01738477|54291318|FG000|Overall Study|Lost to Follow-up|1|||
27825615|NCT01738477|54291319|FG001|Overall Study|Lost to Follow-up|4|||
27825616|NCT01737931|54291335|FG000|Overall Study|Withdrawal by Subject|0|||
27825617|NCT01737931|54291336|FG001|Overall Study|Withdrawal by Subject|1|||
28159624|NCT03181542|54829537|FG000|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|1|||
27825618|NCT01737931|54291337|FG002|Overall Study|Withdrawal by Subject|1|||
27825619|NCT01737931|54291335|FG000|Overall Study|Physician Decision|0|||
27825620|NCT01737931|54291336|FG001|Overall Study|Physician Decision|1|||
27825621|NCT01737931|54291337|FG002|Overall Study|Physician Decision|0|||
27825622|NCT01958489|54291343|FG000|Period 2|Adverse Event|0|||
27825623|NCT01958489|54291344|FG001|Period 2|Adverse Event|1|||
27825624|NCT01721161|54291357|FG000|Overall Study|Adverse Event|2|||
27825625|NCT01721161|54291358|FG001|Overall Study|Adverse Event|3|||
27825626|NCT01721161|54291357|FG000|Overall Study|Lost to Follow-up|1|||
27825627|NCT01721161|54291358|FG001|Overall Study|Lost to Follow-up|2|||
27825628|NCT01721161|54291357|FG000|Overall Study|Withdrawal by Subject|1|||
27825629|NCT01721161|54291358|FG001|Overall Study|Withdrawal by Subject|1|||
27825630|NCT01721161|54291357|FG000|Overall Study|Other|0|||
27825631|NCT01721161|54291358|FG001|Overall Study|Other|1|||
27825632|NCT01700179|54291365|FG000|Overall Study|Physician Decision|2|||
27825633|NCT01699867|54291369|FG000|Overall Study|Screening Failure|3|||
27825634|NCT01699789|54291388|FG000|Overall Study|Withdrawal by Subject|18|||
27825635|NCT01699789|54291389|FG001|Overall Study|Withdrawal by Subject|23|||
27825636|NCT01699789|54291388|FG000|Overall Study|Death|1|||
27825637|NCT01699789|54291389|FG001|Overall Study|Death|2|||
27825638|NCT01699789|54291388|FG000|Overall Study|Lost to Follow-up|83|||
27825639|NCT01699789|54291389|FG001|Overall Study|Lost to Follow-up|101|||
27825640|NCT01944839|54291412|FG000|Overall Study|Physician Decision|2|||
27825641|NCT01944839|54291413|FG001|Overall Study|Physician Decision|2|||
27825642|NCT01944839|54291412|FG000|Overall Study|Protocol Violation|0|||
27825643|NCT01944839|54291413|FG001|Overall Study|Protocol Violation|1|||
27825644|NCT01944839|54291412|FG000|Overall Study|Adverse Event|10|||
27825645|NCT01944839|54291413|FG001|Overall Study|Adverse Event|5|||
27825646|NCT01944839|54291412|FG000|Overall Study|Withdrawal by Subject|9|||
27825647|NCT01944839|54291413|FG001|Overall Study|Withdrawal by Subject|17|||
27825648|NCT01944839|54291412|FG000|Overall Study|Lost to Follow-up|1|||
27825649|NCT01944839|54291413|FG001|Overall Study|Lost to Follow-up|0|||
27825650|NCT01944839|54291412|FG000|Overall Study|Subject non-compliance|0|||
27825651|NCT01944839|54291413|FG001|Overall Study|Subject non-compliance|3|||
27825652|NCT01944059|54291428|FG000|Overall Study|Lost to Follow-up|1|||
27825653|NCT01944059|54291428|FG000|Overall Study|Physician Decision|3|||
27825654|NCT01944059|54291428|FG000|Overall Study|Withdrawal by Subject|1|||
27825655|NCT01944059|54291428|FG000|Overall Study|Adverse Event|2|||
27825656|NCT01720225|54291435|FG000|Overall Study|Withdrawal by Subject|0|||
27825657|NCT01720225|54291436|FG001|Overall Study|Withdrawal by Subject|1|||
27825658|NCT01720225|54291435|FG000|Overall Study|Did not complete 2 cycles of therapy|3|||
27825659|NCT01720225|54291436|FG001|Overall Study|Did not complete 2 cycles of therapy|0|||
27825660|NCT01943591|54291444|FG000|Overall Study|Lost to Follow-up|3|||
27825661|NCT01943591|54291445|FG001|Overall Study|Lost to Follow-up|4|||
27825662|NCT01943591|54291444|FG000|Overall Study|Death|2|||
27825663|NCT01943591|54291445|FG001|Overall Study|Death|7|||
27825664|NCT01699087|54291451|FG000|Overall Study|Lost to Follow-up|7|||
27825665|NCT01699087|54291451|FG000|Overall Study|Screen failure (prior to treatment)|15|||
27825666|NCT01699087|54291451|FG000|Overall Study|Unable to make future visits|2|||
27825667|NCT01943435|54291459|FG000|Baseline Eligibility and Randomization|Withdrawal by Subject|4|||
27825668|NCT01943435|54291460|FG001|Baseline Eligibility and Randomization|Withdrawal by Subject|12|||
27825669|NCT01943435|54291461|FG002|Baseline Eligibility and Randomization|Withdrawal by Subject|3|||
27825670|NCT01943435|54291459|FG000|Intervention Period|Withdrawal by Subject|3|||
27825671|NCT01943435|54291460|FG001|Intervention Period|Withdrawal by Subject|3|||
27825672|NCT01943435|54291461|FG002|Intervention Period|Withdrawal by Subject|4|||
27825673|NCT01943435|54291459|FG000|2 Month Follow up|Lost to Follow-up|2|||
27825674|NCT01943435|54291460|FG001|2 Month Follow up|Lost to Follow-up|3|||
27825675|NCT01943435|54291461|FG002|2 Month Follow up|Lost to Follow-up|0|||
27825676|NCT01943435|54291459|FG000|6 Month Follow up|Lost to Follow-up|12|||
27825677|NCT01943435|54291460|FG001|6 Month Follow up|Lost to Follow-up|7|||
27825678|NCT01943435|54291461|FG002|6 Month Follow up|Lost to Follow-up|15|||
27825679|NCT01942733|54291479|FG000|Overall Study|Lost to Follow-up|1|||
27825680|NCT01942733|54291479|FG000|Overall Study|Non-compliance with IMP|1|||
27825681|NCT01942733|54291479|FG000|Overall Study|Administrative|1|||
27825682|NCT01957865|54291495|FG000|Overall Study|Found HIV negative|0|||
27825683|NCT01957865|54291496|FG001|Overall Study|Found HIV negative|0|||
27825684|NCT01957865|54291497|FG002|Overall Study|Found HIV negative|1|||
27825685|NCT01957865|54291495|FG000|Overall Study|Lost to Follow-up|0|||
27825686|NCT01957865|54291496|FG001|Overall Study|Lost to Follow-up|2|||
27825687|NCT01957865|54291497|FG002|Overall Study|Lost to Follow-up|2|||
27825688|NCT01957787|54291506|FG000|Overall Study|Death|18|||
27825689|NCT01957787|54291506|FG000|Overall Study|Lost to Follow-up|3|||
27825690|NCT01957787|54291506|FG000|Overall Study|Withdrawal by Subject|3|||
27825691|NCT01957787|54291506|FG000|Overall Study|Entered Hospice or Similar Program|2|||
27825692|NCT01957787|54291506|FG000|Overall Study|Index Tumor(s) Resected|2|||
27825693|NCT01957787|54291506|FG000|Overall Study|Index Tumor was Primary Lung Cancer|2|||
27825694|NCT01957787|54291506|FG000|Overall Study|Local therapy, not cryoablation|6|||
27825695|NCT01698775|54291512|FG000|Phase A|Adverse Event|2|||
27825696|NCT01698775|54291513|FG001|Phase A|Adverse Event|1|||
27825697|NCT01698775|54291512|FG000|Phase A|Death|1|||
27825698|NCT01698775|54291513|FG001|Phase A|Death|1|||
27825699|NCT01698775|54291512|FG000|Phase A|Lack of Efficacy|1|||
27825700|NCT01698775|54291513|FG001|Phase A|Lack of Efficacy|0|||
27825701|NCT01698775|54291512|FG000|Phase A|Lost to Follow-up|1|||
27825702|NCT01698775|54291513|FG001|Phase A|Lost to Follow-up|2|||
27825703|NCT01698775|54291512|FG000|Phase A|Protocol Violation|1|||
27825704|NCT01698775|54291513|FG001|Phase A|Protocol Violation|0|||
27825705|NCT01698775|54291512|FG000|Phase A|Withdrawal by Subject|3|||
27825706|NCT01698775|54291513|FG001|Phase A|Withdrawal by Subject|4|||
27825707|NCT01698775|54291512|FG000|Phase A|Kidney [transplant]|0|||
27825708|NCT01698775|54291513|FG001|Phase A|Kidney [transplant]|1|||
27825709|NCT01698775|54291512|FG000|Phase B|Hyperglycemia Discontinuation Criteria|0|||
27825710|NCT01698775|54291513|FG001|Phase B|Hyperglycemia Discontinuation Criteria|1|||
27825711|NCT01698775|54291512|FG000|Phase B|Adverse Event|6|||
27825712|NCT01698775|54291513|FG001|Phase B|Adverse Event|3|||
27825713|NCT01698775|54291512|FG000|Phase B|Death|0|||
27825714|NCT01698775|54291513|FG001|Phase B|Death|1|||
27825715|NCT01698775|54291512|FG000|Phase B|Lack of Efficacy|0|||
27825716|NCT01698775|54291513|FG001|Phase B|Lack of Efficacy|1|||
27825717|NCT01698775|54291512|FG000|Phase B|Lost to Follow-up|0|||
27825718|NCT01698775|54291513|FG001|Phase B|Lost to Follow-up|1|||
27825719|NCT01698775|54291512|FG000|Phase B|Physician Decision|1|||
27825720|NCT01698775|54291513|FG001|Phase B|Physician Decision|1|||
27825721|NCT01698775|54291512|FG000|Phase B|Protocol Violation|1|||
27825722|NCT01698775|54291513|FG001|Phase B|Protocol Violation|1|||
27825723|NCT01698775|54291512|FG000|Phase B|Withdrawal by Subject|6|||
27825724|NCT01698775|54291513|FG001|Phase B|Withdrawal by Subject|2|||
27825725|NCT01941095|54291523|FG000|Overall Study|Insufficient therapeutic response|13|||
27825726|NCT01941095|54291523|FG000|Overall Study|Anaphylaxis or serious hypersensitivity|2|||
27825727|NCT01941095|54291523|FG000|Overall Study|Adverse Event|11|||
27825728|NCT01941095|54291523|FG000|Overall Study|Physician Decision|3|||
27825729|NCT01941095|54291523|FG000|Overall Study|Withdrawal by Subject|17|||
27825730|NCT01941095|54291523|FG000|Overall Study|Lost to Follow-up|10|||
27825731|NCT01957709|54291538|FG000|Overall Study|Patient refused to complete post-tx bx|1|||
27825732|NCT01957553|54291555|FG000|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2|||
27825733|NCT01957553|54291556|FG001|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3|||
27825734|NCT01957553|54291555|FG000|Test Period 1 (21 +- 1 Days)|Adverse Event|2|||
27825735|NCT01957553|54291556|FG001|Test Period 1 (21 +- 1 Days)|Adverse Event|0|||
27825736|NCT01957553|54291555|FG000|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2|||
27825737|NCT01957553|54291556|FG001|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0|||
27825738|NCT01957553|54291555|FG000|Test Period 1 (21 +- 1 Days)|screen failure|1|||
27825739|NCT01957553|54291556|FG001|Test Period 1 (21 +- 1 Days)|screen failure|0|||
27825740|NCT01957553|54291555|FG000|Test Period 2 (21 +- 1 Days)|Adverse Event|1|||
27825741|NCT01957553|54291556|FG001|Test Period 2 (21 +- 1 Days)|Adverse Event|3|||
27825742|NCT01957553|54291555|FG000|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1|||
27825743|NCT01957553|54291556|FG001|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2|||
27825744|NCT01957553|54291555|FG000|Test Period 2 (21 +- 1 Days)|completed early by mistake|0|||
27825745|NCT01957553|54291556|FG001|Test Period 2 (21 +- 1 Days)|completed early by mistake|1|||
27825746|NCT01957553|54291555|FG000|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0|||
27825747|NCT01957553|54291556|FG001|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1|||
27825748|NCT01957553|54291555|FG000|Test Period 2 (21 +- 1 Days)|Other|1|||
27825749|NCT01957553|54291556|FG001|Test Period 2 (21 +- 1 Days)|Other|0|||
27825750|NCT01957475|54291581|FG000|Test Period 1|Withdrawal by Subject|1|||
27825751|NCT01957475|54291582|FG001|Test Period 1|Withdrawal by Subject|0|||
27825752|NCT01957475|54291581|FG000|Test Period 1|Other|1|||
27825753|NCT01957475|54291582|FG001|Test Period 1|Other|0|||
27825754|NCT01957475|54291581|FG000|Test Period 1|Lack of Efficacy|0|||
27825755|NCT01957475|54291582|FG001|Test Period 1|Lack of Efficacy|1|||
27825756|NCT01957475|54291581|FG000|Test Period 2|Adverse Event|1|||
27825757|NCT01957475|54291582|FG001|Test Period 2|Adverse Event|0|||
27825758|NCT01940939|54291590|FG000|Overall Study|Withdrawal by Subject|2|||
27825759|NCT01940939|54291591|FG001|Overall Study|Withdrawal by Subject|8|||
27825760|NCT01957397|54291597|FG000|Test Period 1|sudden leakage/small bag|1|||
27825761|NCT01957397|54291598|FG001|Test Period 1|sudden leakage/small bag|1|||
27825762|NCT01957397|54291597|FG000|Test Period 1|Withdrawal by Subject|1|||
27825763|NCT01957397|54291598|FG001|Test Period 1|Withdrawal by Subject|0|||
27825764|NCT01957397|54291597|FG000|Test Period 2|Adverse Event|0|||
27825765|NCT01957397|54291598|FG001|Test Period 2|Adverse Event|1|||
27825766|NCT01957397|54291597|FG000|Test Period 3|Adverse Event|1|||
27825767|NCT01957397|54291598|FG001|Test Period 3|Adverse Event|2|||
27825768|NCT01957397|54291597|FG000|Test Period 3|the adhesive did not work|1|||
27825769|NCT01957397|54291598|FG001|Test Period 3|the adhesive did not work|0|||
27850531|NCT03692052|54349483|FG000|Extension Period (Week 25 to 10 Years)|Ongoing|17|||
27850532|NCT03533751|54349492|FG000|Overall Study|Withdrawal by Subject|12|||
27850533|NCT03533751|54349493|FG001|Overall Study|Withdrawal by Subject|6|||
27825770|NCT01940705|54291612|FG000|Overall Study|Lost to Follow-up|1|||
27825771|NCT01940705|54291613|FG001|Overall Study|Lost to Follow-up|3|||
27825772|NCT01940705|54291614|FG002|Overall Study|Lost to Follow-up|2|||
27825773|NCT01940705|54291615|FG003|Overall Study|Lost to Follow-up|2|||
27825774|NCT01940705|54291612|FG000|Overall Study|Withdrawal by Subject|2|||
27825775|NCT01940705|54291613|FG001|Overall Study|Withdrawal by Subject|2|||
27825776|NCT01940705|54291614|FG002|Overall Study|Withdrawal by Subject|3|||
27825777|NCT01940705|54291615|FG003|Overall Study|Withdrawal by Subject|2|||
27825778|NCT01940705|54291612|FG000|Overall Study|Intervention not given|0|||
27825779|NCT01940705|54291613|FG001|Overall Study|Intervention not given|3|||
27825780|NCT01940705|54291614|FG002|Overall Study|Intervention not given|3|||
27825781|NCT01940705|54291615|FG003|Overall Study|Intervention not given|0|||
27825782|NCT01940705|54291612|FG000|Overall Study|Withdrawal by team - hearing aid change|1|||
27825783|NCT01940705|54291613|FG001|Overall Study|Withdrawal by team - hearing aid change|0|||
27825784|NCT01940705|54291614|FG002|Overall Study|Withdrawal by team - hearing aid change|0|||
27825785|NCT01940705|54291615|FG003|Overall Study|Withdrawal by team - hearing aid change|0|||
27825786|NCT01957163|54291640|FG000|Overall Study|Adverse Event|5|||
27825787|NCT01957163|54291641|FG001|Overall Study|Adverse Event|2|||
27825788|NCT01957163|54291642|FG002|Overall Study|Adverse Event|4|||
27825789|NCT01957163|54291640|FG000|Overall Study|Lack of Efficacy|5|||
27825790|NCT01957163|54291641|FG001|Overall Study|Lack of Efficacy|4|||
27825791|NCT01957163|54291642|FG002|Overall Study|Lack of Efficacy|9|||
27825792|NCT01957163|54291640|FG000|Overall Study|Protocol Violation|1|||
27825793|NCT01957163|54291641|FG001|Overall Study|Protocol Violation|2|||
27825794|NCT01957163|54291642|FG002|Overall Study|Protocol Violation|0|||
27825795|NCT01957163|54291640|FG000|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
27825796|NCT01957163|54291641|FG001|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
27825797|NCT01957163|54291642|FG002|Overall Study|Met Protocol-Defined Stopping Criteria|1|||
27825798|NCT01957163|54291640|FG000|Overall Study|Lost to Follow-up|0|||
27825799|NCT01957163|54291641|FG001|Overall Study|Lost to Follow-up|1|||
27825800|NCT01957163|54291642|FG002|Overall Study|Lost to Follow-up|0|||
27825801|NCT01957163|54291640|FG000|Overall Study|Withdrawal by Subject|4|||
27825802|NCT01957163|54291641|FG001|Overall Study|Withdrawal by Subject|2|||
27825803|NCT01957163|54291642|FG002|Overall Study|Withdrawal by Subject|4|||
27825804|NCT01956773|54291665|FG000|Overall Study|Lost to Follow-up|628|||
27825805|NCT01956773|54291666|FG001|Overall Study|Lost to Follow-up|1|||
27825806|NCT01939223|54291705|FG000|Overall Study|AE not assoc. with disease recurrence|1|||
27825807|NCT01939223|54291706|FG001|Overall Study|AE not assoc. with disease recurrence|1|||
27825808|NCT01939223|54291705|FG000|Overall Study|Disease recurrence (radiological)|1|||
27825809|NCT01939223|54291706|FG001|Overall Study|Disease recurrence (radiological)|3|||
27825810|NCT01939223|54291705|FG000|Overall Study|Study stopped by Sponsor|5|||
27825811|NCT01939223|54291706|FG001|Overall Study|Study stopped by Sponsor|7|||
27825812|NCT01939223|54291705|FG000|Overall Study|Withdrawal by Subject|6|||
27825813|NCT01939223|54291706|FG001|Overall Study|Withdrawal by Subject|0|||
27825814|NCT01954745|54291751|FG000|Overall Study|Radiological Progression|11|||
27825815|NCT01954745|54291751|FG000|Overall Study|Clinical Progression|5|||
27825816|NCT01954745|54291751|FG000|Overall Study|Adverse Event|2|||
27825817|NCT01954745|54291751|FG000|Overall Study|Death|1|||
27825818|NCT01954121|54291766|FG000|Overall Study|Lack of Efficacy|94|||
27825819|NCT01954121|54291767|FG001|Overall Study|Lack of Efficacy|41|||
27825820|NCT01954121|54291766|FG000|Overall Study|Protocol Violation|0|||
27825821|NCT01954121|54291767|FG001|Overall Study|Protocol Violation|2|||
27825822|NCT01954121|54291766|FG000|Overall Study|Lost to Follow-up|5|||
27825823|NCT01954121|54291767|FG001|Overall Study|Lost to Follow-up|6|||
27825824|NCT01954121|54291766|FG000|Overall Study|Withdrawal by Subject|18|||
27825825|NCT01954121|54291767|FG001|Overall Study|Withdrawal by Subject|12|||
27825826|NCT01954121|54291766|FG000|Overall Study|Pregnancy|1|||
27825827|NCT01954121|54291767|FG001|Overall Study|Pregnancy|1|||
27825828|NCT01954121|54291766|FG000|Overall Study|AE, serious fatal|1|||
27825829|NCT01954121|54291767|FG001|Overall Study|AE, serious fatal|0|||
27825830|NCT01954121|54291766|FG000|Overall Study|AE, non-serious non-fatal|5|||
27825831|NCT01954121|54291767|FG001|Overall Study|AE, non-serious non-fatal|22|||
27825832|NCT01954121|54291766|FG000|Overall Study|SAE, non-fatal|1|||
27825833|NCT01954121|54291767|FG001|Overall Study|SAE, non-fatal|4|||
27825834|NCT01954121|54291766|FG000|Overall Study|Non-compliant with study procedures|1|||
27825835|NCT01954121|54291767|FG001|Overall Study|Non-compliant with study procedures|0|||
27825836|NCT01954121|54291766|FG000|Overall Study|Non-compliant patient|1|||
27825837|NCT01954121|54291767|FG001|Overall Study|Non-compliant patient|1|||
27825838|NCT01954121|54291766|FG000|Overall Study|Subject did not follow instructions|0|||
27825839|NCT01954121|54291767|FG001|Overall Study|Subject did not follow instructions|2|||
27825840|NCT01952015|54291802|FG000|Induction|Protocol Violation|1|||
27825841|NCT01952015|54291802|FG000|Maintenance|Adverse Event|2|||
27825842|NCT01952015|54291802|FG000|Treatment Period 3|Physician Decision|9|||
27825843|NCT01951703|54291835|FG000|First Intervention|Withdrawal by Subject|1|||
27825844|NCT01951703|54291836|FG001|First Intervention|Withdrawal by Subject|0|||
27825845|NCT01951703|54291835|FG000|First Intervention|Subject was not compliant|1|||
27825846|NCT01951703|54291836|FG001|First Intervention|Subject was not compliant|1|||
27825847|NCT01951703|54291835|FG000|First Intervention|Physician Decision|1|||
27825848|NCT01951703|54291836|FG001|First Intervention|Physician Decision|0|||
27825849|NCT01951703|54291835|FG000|Second Intervention|Protocol Violation|0|||
27825850|NCT01951703|54291836|FG001|Second Intervention|Protocol Violation|1|||
27825851|NCT01951703|54291835|FG000|Second Intervention|Unsatisfactory Lens fitting|0|||
27825852|NCT01951703|54291836|FG001|Second Intervention|Unsatisfactory Lens fitting|1|||
27825853|NCT01937351|54291862|FG000|Overall Study|Withdrawal by Subject|4|||
27825854|NCT01937351|54291863|FG001|Overall Study|Withdrawal by Subject|2|||
27825855|NCT01937351|54291862|FG000|Overall Study|Death|1|||
27825856|NCT01937351|54291863|FG001|Overall Study|Death|0|||
27825857|NCT01937351|54291862|FG000|Overall Study|Not treated w device, per protocol fail|4|||
27825858|NCT01937351|54291863|FG001|Overall Study|Not treated w device, per protocol fail|0|||
27825859|NCT01737697|54291896|FG000|Acute Phase-Initial 48 Hours|Adverse Event|0|||
27825860|NCT01737697|54291897|FG001|Acute Phase-Initial 48 Hours|Adverse Event|1|||
27825861|NCT01737697|54291898|FG002|Acute Phase-Initial 48 Hours|Adverse Event|0|||
27825862|NCT01737697|54291899|FG003|Acute Phase-Initial 48 Hours|Adverse Event|1|||
27825863|NCT01737697|54291900|FG004|Acute Phase-Initial 48 Hours|Adverse Event|1|||
27825864|NCT01737697|54291901|FG005|Acute Phase-Initial 48 Hours|Adverse Event|0|||
27825865|NCT01737697|54291902|FG006|Acute Phase-Initial 48 Hours|Adverse Event|0|||
27825866|NCT01737697|54291903|FG007|Acute Phase-Initial 48 Hours|Adverse Event|0|||
27825867|NCT01737697|54291904|FG008|Acute Phase-Initial 48 Hours|Adverse Event|0|||
27825868|NCT01737697|54291905|FG009|Acute Phase-Initial 48 Hours|Adverse Event|0|||
27825869|NCT01737697|54291906|FG010|Acute Phase-Initial 48 Hours|Adverse Event|0|||
27825870|NCT01737697|54291907|FG011|Acute Phase-Initial 48 Hours|Adverse Event|0|||
27825871|NCT01737697|54291908|FG012|Acute Phase-Initial 48 Hours|Adverse Event|0|||
27825872|NCT01737697|54291909|FG013|Acute Phase-Initial 48 Hours|Adverse Event|0|||
27825873|NCT01737697|54291910|FG014|Acute Phase-Initial 48 Hours|Adverse Event|0|||
27825874|NCT01737697|54291896|FG000|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
27825875|NCT01737697|54291897|FG001|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
27825876|NCT01737697|54291898|FG002|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3|||
27825877|NCT01737697|54291899|FG003|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
27825878|NCT01737697|54291900|FG004|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
27825879|NCT01737697|54291901|FG005|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
27825880|NCT01737697|54291902|FG006|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
27825881|NCT01737697|54291903|FG007|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
27825882|NCT01737697|54291904|FG008|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
27825883|NCT01737697|54291905|FG009|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
27825884|NCT01737697|54291906|FG010|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
27825885|NCT01737697|54291907|FG011|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
27825886|NCT01737697|54291908|FG012|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
27825887|NCT01737697|54291909|FG013|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
27825888|NCT01737697|54291910|FG014|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
27825889|NCT01737697|54291896|FG000|Acute Phase-Initial 48 Hours|Family emergency|0|||
27825890|NCT01737697|54291897|FG001|Acute Phase-Initial 48 Hours|Family emergency|0|||
27825891|NCT01737697|54291898|FG002|Acute Phase-Initial 48 Hours|Family emergency|0|||
27825892|NCT01737697|54291899|FG003|Acute Phase-Initial 48 Hours|Family emergency|1|||
27825893|NCT01737697|54291900|FG004|Acute Phase-Initial 48 Hours|Family emergency|0|||
27825894|NCT01737697|54291901|FG005|Acute Phase-Initial 48 Hours|Family emergency|0|||
27825895|NCT01737697|54291902|FG006|Acute Phase-Initial 48 Hours|Family emergency|0|||
27825896|NCT01737697|54291903|FG007|Acute Phase-Initial 48 Hours|Family emergency|0|||
27825897|NCT01737697|54291904|FG008|Acute Phase-Initial 48 Hours|Family emergency|0|||
27825898|NCT01737697|54291905|FG009|Acute Phase-Initial 48 Hours|Family emergency|0|||
27825899|NCT01737697|54291906|FG010|Acute Phase-Initial 48 Hours|Family emergency|0|||
27825900|NCT01737697|54291907|FG011|Acute Phase-Initial 48 Hours|Family emergency|0|||
27825901|NCT01737697|54291908|FG012|Acute Phase-Initial 48 Hours|Family emergency|0|||
27825902|NCT01737697|54291909|FG013|Acute Phase-Initial 48 Hours|Family emergency|0|||
27825903|NCT01737697|54291910|FG014|Acute Phase-Initial 48 Hours|Family emergency|0|||
27825904|NCT01737697|54291896|FG000|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
27825905|NCT01737697|54291897|FG001|Acute Phase-Initial 48 Hours|Sponsor's decision|1|||
27825906|NCT01737697|54291898|FG002|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
27825907|NCT01737697|54291899|FG003|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
27825908|NCT01737697|54291900|FG004|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
27825909|NCT01737697|54291901|FG005|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
27825910|NCT01737697|54291902|FG006|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
27825911|NCT01737697|54291903|FG007|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
27825912|NCT01737697|54291904|FG008|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
27825913|NCT01737697|54291905|FG009|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
27825914|NCT01737697|54291906|FG010|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
27825915|NCT01737697|54291907|FG011|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
27825916|NCT01737697|54291908|FG012|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
27825917|NCT01737697|54291909|FG013|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
27943224|NCT01147848|54600168|FG002|Randomized Phase|Lost to Follow-up|7|||
27943225|NCT01147848|54600166|FG000|Randomized Phase|Physician Decision|0|||
28160147|NCT02557516|54830250|FG003|Overall Study|Physician Decision|0|||
27825918|NCT01737697|54291910|FG014|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
27825919|NCT01737697|54291896|FG000|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
27825920|NCT01737697|54291897|FG001|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
27825921|NCT01737697|54291898|FG002|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
27825922|NCT01737697|54291899|FG003|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
27825923|NCT01737697|54291900|FG004|Acute Phase-Initial 48 Hours|Lost to Follow-up|1|||
27825924|NCT01737697|54291901|FG005|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
27825925|NCT01737697|54291902|FG006|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
27825926|NCT01737697|54291903|FG007|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
27825927|NCT01737697|54291904|FG008|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
27825928|NCT01737697|54291905|FG009|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
27825929|NCT01737697|54291906|FG010|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
27825930|NCT01737697|54291907|FG011|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
27825931|NCT01737697|54291908|FG012|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
27825932|NCT01737697|54291909|FG013|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
27825933|NCT01737697|54291910|FG014|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
27825934|NCT01737697|54291896|FG000|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
27825935|NCT01737697|54291897|FG001|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
27825936|NCT01737697|54291898|FG002|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
27825937|NCT01737697|54291899|FG003|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4|||
27825938|NCT01737697|54291900|FG004|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
27825939|NCT01737697|54291901|FG005|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
27825940|NCT01737697|54291902|FG006|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
27825941|NCT01737697|54291903|FG007|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
27825942|NCT01737697|54291904|FG008|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
27825943|NCT01737697|54291905|FG009|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
27825944|NCT01737697|54291906|FG010|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
27825945|NCT01737697|54291907|FG011|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
27825946|NCT01737697|54291908|FG012|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
27825947|NCT01737697|54291909|FG013|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
27825948|NCT01737697|54291910|FG014|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
27825949|NCT01737697|54291896|FG000|Subacute Phase|Adverse Event|0|||
27825950|NCT01737697|54291897|FG001|Subacute Phase|Adverse Event|0|||
27825951|NCT01737697|54291898|FG002|Subacute Phase|Adverse Event|0|||
27825952|NCT01737697|54291899|FG003|Subacute Phase|Adverse Event|0|||
27825953|NCT01737697|54291900|FG004|Subacute Phase|Adverse Event|0|||
27825954|NCT01737697|54291901|FG005|Subacute Phase|Adverse Event|1|||
27825955|NCT01737697|54291902|FG006|Subacute Phase|Adverse Event|1|||
27825956|NCT01737697|54291903|FG007|Subacute Phase|Adverse Event|1|||
27825957|NCT01737697|54291904|FG008|Subacute Phase|Adverse Event|1|||
27825958|NCT01737697|54291905|FG009|Subacute Phase|Adverse Event|1|||
27825959|NCT01737697|54291906|FG010|Subacute Phase|Adverse Event|4|||
27825960|NCT01737697|54291907|FG011|Subacute Phase|Adverse Event|1|||
27825961|NCT01737697|54291908|FG012|Subacute Phase|Adverse Event|1|||
27825962|NCT01737697|54291909|FG013|Subacute Phase|Adverse Event|0|||
27825963|NCT01737697|54291910|FG014|Subacute Phase|Adverse Event|0|||
27825964|NCT01737697|54291896|FG000|Subacute Phase|Withdrawal by Subject|0|||
27825965|NCT01737697|54291897|FG001|Subacute Phase|Withdrawal by Subject|0|||
27825966|NCT01737697|54291898|FG002|Subacute Phase|Withdrawal by Subject|0|||
27825967|NCT01737697|54291899|FG003|Subacute Phase|Withdrawal by Subject|0|||
27825968|NCT01737697|54291900|FG004|Subacute Phase|Withdrawal by Subject|0|||
27825969|NCT01737697|54291901|FG005|Subacute Phase|Withdrawal by Subject|1|||
27825970|NCT01737697|54291902|FG006|Subacute Phase|Withdrawal by Subject|0|||
27825971|NCT01737697|54291903|FG007|Subacute Phase|Withdrawal by Subject|2|||
27825972|NCT01737697|54291904|FG008|Subacute Phase|Withdrawal by Subject|0|||
27825973|NCT01737697|54291905|FG009|Subacute Phase|Withdrawal by Subject|1|||
27825974|NCT01737697|54291906|FG010|Subacute Phase|Withdrawal by Subject|0|||
27825975|NCT01737697|54291907|FG011|Subacute Phase|Withdrawal by Subject|1|||
27825976|NCT01737697|54291908|FG012|Subacute Phase|Withdrawal by Subject|1|||
27825977|NCT01737697|54291909|FG013|Subacute Phase|Withdrawal by Subject|1|||
27825978|NCT01737697|54291910|FG014|Subacute Phase|Withdrawal by Subject|0|||
27825979|NCT01737697|54291896|FG000|Subacute Phase|Lost to Follow-up|0|||
27825980|NCT01737697|54291897|FG001|Subacute Phase|Lost to Follow-up|0|||
27825981|NCT01737697|54291898|FG002|Subacute Phase|Lost to Follow-up|0|||
27825982|NCT01737697|54291899|FG003|Subacute Phase|Lost to Follow-up|0|||
27825983|NCT01737697|54291900|FG004|Subacute Phase|Lost to Follow-up|0|||
27825984|NCT01737697|54291901|FG005|Subacute Phase|Lost to Follow-up|0|||
27825985|NCT01737697|54291902|FG006|Subacute Phase|Lost to Follow-up|0|||
27825986|NCT01737697|54291903|FG007|Subacute Phase|Lost to Follow-up|0|||
27825987|NCT01737697|54291904|FG008|Subacute Phase|Lost to Follow-up|0|||
27825988|NCT01737697|54291905|FG009|Subacute Phase|Lost to Follow-up|0|||
27825989|NCT01737697|54291906|FG010|Subacute Phase|Lost to Follow-up|0|||
27825990|NCT01737697|54291907|FG011|Subacute Phase|Lost to Follow-up|0|||
27825991|NCT01737697|54291908|FG012|Subacute Phase|Lost to Follow-up|0|||
27825992|NCT01737697|54291909|FG013|Subacute Phase|Lost to Follow-up|0|||
27825993|NCT01737697|54291910|FG014|Subacute Phase|Lost to Follow-up|1|||
27825994|NCT01737697|54291896|FG000|Subacute Phase|Hypo-or hyperkalemia|0|||
27825995|NCT01737697|54291897|FG001|Subacute Phase|Hypo-or hyperkalemia|0|||
27825996|NCT01737697|54291898|FG002|Subacute Phase|Hypo-or hyperkalemia|0|||
27825997|NCT01737697|54291899|FG003|Subacute Phase|Hypo-or hyperkalemia|0|||
27825998|NCT01737697|54291900|FG004|Subacute Phase|Hypo-or hyperkalemia|0|||
27825999|NCT01737697|54291901|FG005|Subacute Phase|Hypo-or hyperkalemia|0|||
27826000|NCT01737697|54291902|FG006|Subacute Phase|Hypo-or hyperkalemia|0|||
27826001|NCT01737697|54291903|FG007|Subacute Phase|Hypo-or hyperkalemia|0|||
27826002|NCT01737697|54291904|FG008|Subacute Phase|Hypo-or hyperkalemia|0|||
27826003|NCT01737697|54291905|FG009|Subacute Phase|Hypo-or hyperkalemia|0|||
27826004|NCT01737697|54291906|FG010|Subacute Phase|Hypo-or hyperkalemia|0|||
27826005|NCT01737697|54291907|FG011|Subacute Phase|Hypo-or hyperkalemia|1|||
27826006|NCT01737697|54291908|FG012|Subacute Phase|Hypo-or hyperkalemia|0|||
27826007|NCT01737697|54291909|FG013|Subacute Phase|Hypo-or hyperkalemia|1|||
27826008|NCT01737697|54291910|FG014|Subacute Phase|Hypo-or hyperkalemia|0|||
27826009|NCT01737697|54291896|FG000|Subacute Phase|Protocol Violation|0|||
27826010|NCT01737697|54291897|FG001|Subacute Phase|Protocol Violation|0|||
27826011|NCT01737697|54291898|FG002|Subacute Phase|Protocol Violation|0|||
27826012|NCT01737697|54291899|FG003|Subacute Phase|Protocol Violation|0|||
27826013|NCT01737697|54291900|FG004|Subacute Phase|Protocol Violation|0|||
27826014|NCT01737697|54291901|FG005|Subacute Phase|Protocol Violation|1|||
27826015|NCT01737697|54291902|FG006|Subacute Phase|Protocol Violation|0|||
27826016|NCT01737697|54291903|FG007|Subacute Phase|Protocol Violation|0|||
27826017|NCT01737697|54291904|FG008|Subacute Phase|Protocol Violation|0|||
27826018|NCT01737697|54291905|FG009|Subacute Phase|Protocol Violation|0|||
27826019|NCT01737697|54291906|FG010|Subacute Phase|Protocol Violation|1|||
27826020|NCT01737697|54291907|FG011|Subacute Phase|Protocol Violation|0|||
27826021|NCT01737697|54291908|FG012|Subacute Phase|Protocol Violation|0|||
27826022|NCT01737697|54291909|FG013|Subacute Phase|Protocol Violation|0|||
27826023|NCT01737697|54291910|FG014|Subacute Phase|Protocol Violation|0|||
27826024|NCT01737697|54291896|FG000|Subacute Phase|Physician Decision|0|||
27826025|NCT01737697|54291897|FG001|Subacute Phase|Physician Decision|0|||
27826026|NCT01737697|54291898|FG002|Subacute Phase|Physician Decision|0|||
27826027|NCT01737697|54291899|FG003|Subacute Phase|Physician Decision|0|||
27826028|NCT01737697|54291900|FG004|Subacute Phase|Physician Decision|0|||
27826029|NCT01737697|54291901|FG005|Subacute Phase|Physician Decision|0|||
27826030|NCT01737697|54291902|FG006|Subacute Phase|Physician Decision|0|||
27826031|NCT01737697|54291903|FG007|Subacute Phase|Physician Decision|0|||
27826032|NCT01737697|54291904|FG008|Subacute Phase|Physician Decision|1|||
27826033|NCT01737697|54291905|FG009|Subacute Phase|Physician Decision|0|||
27826034|NCT01737697|54291906|FG010|Subacute Phase|Physician Decision|0|||
27826035|NCT01737697|54291907|FG011|Subacute Phase|Physician Decision|0|||
27826036|NCT01737697|54291908|FG012|Subacute Phase|Physician Decision|0|||
28159625|NCT03181542|54829538|FG001|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|0|||
28159626|NCT00806403|54829546|FG000|Overall Study|Death|4|||
28159627|NCT00806403|54829547|FG001|Overall Study|Death|3|||
28159628|NCT00701558|54829564|FG000|Overall Study|Death|7|||
28159629|NCT00701558|54829564|FG000|Overall Study|Lost to Follow-up|8|||
28159630|NCT01663402|54829570|FG000|Overall Study|Randomized but not treated|19|||
28159631|NCT01663402|54829571|FG001|Overall Study|Randomized but not treated|11|||
28159632|NCT01663402|54829570|FG000|Overall Study|Adverse Event|347|||
28159633|NCT01663402|54829571|FG001|Overall Study|Adverse Event|362|||
28159634|NCT01663402|54829570|FG000|Overall Study|Two consecutive LDL-C <15 mg/dL|0|||
28159635|NCT01663402|54829571|FG001|Overall Study|Two consecutive LDL-C <15 mg/dL|730|||
28159636|NCT01663402|54829570|FG000|Overall Study|Poor compliance to protocol|529|||
28159637|NCT01663402|54829571|FG001|Overall Study|Poor compliance to protocol|454|||
28159638|NCT01663402|54829570|FG000|Overall Study|Physician Decision|77|||
28159639|NCT01663402|54829571|FG001|Overall Study|Physician Decision|62|||
28159640|NCT01663402|54829570|FG000|Overall Study|Site terminated by sponsor|1|||
28159641|NCT01663402|54829571|FG001|Overall Study|Site terminated by sponsor|3|||
27826037|NCT01737697|54291909|FG013|Subacute Phase|Physician Decision|0|||
27826038|NCT01737697|54291910|FG014|Subacute Phase|Physician Decision|0|||
27826039|NCT01737697|54291896|FG000|Subacute Phase|Death|0|||
27826040|NCT01737697|54291897|FG001|Subacute Phase|Death|0|||
27826041|NCT01737697|54291898|FG002|Subacute Phase|Death|0|||
27826042|NCT01737697|54291899|FG003|Subacute Phase|Death|0|||
27826043|NCT01737697|54291900|FG004|Subacute Phase|Death|0|||
27826044|NCT01737697|54291901|FG005|Subacute Phase|Death|0|||
27826045|NCT01737697|54291902|FG006|Subacute Phase|Death|0|||
27826046|NCT01737697|54291903|FG007|Subacute Phase|Death|0|||
27826047|NCT01737697|54291904|FG008|Subacute Phase|Death|0|||
27826048|NCT01737697|54291905|FG009|Subacute Phase|Death|0|||
27826049|NCT01737697|54291906|FG010|Subacute Phase|Death|1|||
28159642|NCT01663402|54829570|FG000|Overall Study|Participant moved|139|||
28159643|NCT01663402|54829571|FG001|Overall Study|Participant moved|104|||
27826050|NCT01737697|54291907|FG011|Subacute Phase|Death|0|||
27826051|NCT01737697|54291908|FG012|Subacute Phase|Death|0|||
27826052|NCT01737697|54291909|FG013|Subacute Phase|Death|0|||
27826053|NCT01737697|54291910|FG014|Subacute Phase|Death|0|||
27826054|NCT01682863|54292066|FG000|Overall Study|Subject/guardian decision|19|||
27826055|NCT01682863|54292067|FG001|Overall Study|Subject/guardian decision|12|||
27826056|NCT01682863|54292068|FG002|Overall Study|Subject/guardian decision|10|||
27826057|NCT01682863|54292066|FG000|Overall Study|Lost to Follow-up|5|||
27826058|NCT01682863|54292067|FG001|Overall Study|Lost to Follow-up|1|||
27826059|NCT01682863|54292068|FG002|Overall Study|Lost to Follow-up|6|||
27826060|NCT01682863|54292066|FG000|Overall Study|Death|1|||
27826061|NCT01682863|54292067|FG001|Overall Study|Death|3|||
27826062|NCT01682863|54292068|FG002|Overall Study|Death|4|||
27826063|NCT01682863|54292066|FG000|Overall Study|Protocol deviation|1|||
27826064|NCT01682863|54292067|FG001|Overall Study|Protocol deviation|0|||
27826065|NCT01682863|54292068|FG002|Overall Study|Protocol deviation|1|||
27826066|NCT01682863|54292066|FG000|Overall Study|Technical problems|1|||
27826067|NCT01682863|54292067|FG001|Overall Study|Technical problems|0|||
27826068|NCT01682863|54292068|FG002|Overall Study|Technical problems|0|||
27826069|NCT01682863|54292066|FG000|Overall Study|Adverse Event|0|||
27826070|NCT01682863|54292067|FG001|Overall Study|Adverse Event|1|||
27826071|NCT01682863|54292068|FG002|Overall Study|Adverse Event|2|||
27826072|NCT01682863|54292066|FG000|Overall Study|Physician Decision|0|||
27826073|NCT01682863|54292067|FG001|Overall Study|Physician Decision|0|||
27826074|NCT01682863|54292068|FG002|Overall Study|Physician Decision|1|||
27826075|NCT01951625|54292081|FG000|Treatment Period|Protocol Violation|2|||
27826076|NCT01951625|54292082|FG001|Treatment Period|Protocol Violation|0|||
27826077|NCT01951625|54292083|FG002|Treatment Period|Protocol Violation|1|||
27826078|NCT01951625|54292084|FG003|Treatment Period|Protocol Violation|3|||
27826079|NCT01951625|54292085|FG004|Treatment Period|Protocol Violation|2|||
27826080|NCT01951625|54292081|FG000|Treatment Period|Physician Decision|0|||
27826081|NCT01951625|54292082|FG001|Treatment Period|Physician Decision|0|||
27826082|NCT01951625|54292083|FG002|Treatment Period|Physician Decision|0|||
27826083|NCT01951625|54292084|FG003|Treatment Period|Physician Decision|0|||
27826084|NCT01951625|54292085|FG004|Treatment Period|Physician Decision|1|||
27826085|NCT01951625|54292081|FG000|Treatment Period|Protocol driven decision point|0|||
27826086|NCT01951625|54292082|FG001|Treatment Period|Protocol driven decision point|5|||
27826087|NCT01951625|54292083|FG002|Treatment Period|Protocol driven decision point|0|||
27826088|NCT01951625|54292084|FG003|Treatment Period|Protocol driven decision point|2|||
27826089|NCT01951625|54292085|FG004|Treatment Period|Protocol driven decision point|1|||
27826090|NCT01951625|54292081|FG000|Treatment Period|Non compliance with study drug|1|||
27826091|NCT01951625|54292082|FG001|Treatment Period|Non compliance with study drug|2|||
27826092|NCT01951625|54292083|FG002|Treatment Period|Non compliance with study drug|2|||
27826093|NCT01951625|54292084|FG003|Treatment Period|Non compliance with study drug|0|||
27826094|NCT01951625|54292085|FG004|Treatment Period|Non compliance with study drug|0|||
27826095|NCT01951625|54292081|FG000|Treatment Period|Death|3|||
27826096|NCT01951625|54292082|FG001|Treatment Period|Death|2|||
27826097|NCT01951625|54292083|FG002|Treatment Period|Death|2|||
27826098|NCT01951625|54292084|FG003|Treatment Period|Death|1|||
27826099|NCT01951625|54292085|FG004|Treatment Period|Death|2|||
27826100|NCT01951625|54292081|FG000|Treatment Period|Adverse Event|7|||
27826101|NCT01951625|54292082|FG001|Treatment Period|Adverse Event|10|||
27826102|NCT01951625|54292083|FG002|Treatment Period|Adverse Event|9|||
27826103|NCT01951625|54292084|FG003|Treatment Period|Adverse Event|8|||
27826104|NCT01951625|54292085|FG004|Treatment Period|Adverse Event|8|||
27826105|NCT01951625|54292081|FG000|Treatment Period|Withdrawal by Subject|5|||
27826106|NCT01951625|54292082|FG001|Treatment Period|Withdrawal by Subject|2|||
27826107|NCT01951625|54292083|FG002|Treatment Period|Withdrawal by Subject|1|||
27826108|NCT01951625|54292084|FG003|Treatment Period|Withdrawal by Subject|7|||
27826109|NCT01951625|54292085|FG004|Treatment Period|Withdrawal by Subject|3|||
27826110|NCT01951625|54292081|FG000|Treatment Period|Lost to Follow-up|1|||
28076614|NCT00405587|54731475|FG003|Overall Study|Death|1|||
28076615|NCT00405587|54731472|FG000|Overall Study|Disease Progression|22|||
28076616|NCT00405587|54731473|FG001|Overall Study|Disease Progression|23|||
27826111|NCT01951625|54292082|FG001|Treatment Period|Lost to Follow-up|0|||
27850534|NCT03533751|54349494|FG002|Overall Study|Withdrawal by Subject|11|||
27826112|NCT01951625|54292083|FG002|Treatment Period|Lost to Follow-up|0|||
27826113|NCT01951625|54292084|FG003|Treatment Period|Lost to Follow-up|1|||
27826114|NCT01951625|54292085|FG004|Treatment Period|Lost to Follow-up|0|||
27826115|NCT01951625|54292081|FG000|Follow Up Period|Non-compliance with study drug|1|||
27826116|NCT01951625|54292082|FG001|Follow Up Period|Non-compliance with study drug|0|||
27826117|NCT01951625|54292083|FG002|Follow Up Period|Non-compliance with study drug|0|||
27826118|NCT01951625|54292084|FG003|Follow Up Period|Non-compliance with study drug|0|||
27826119|NCT01951625|54292085|FG004|Follow Up Period|Non-compliance with study drug|0|||
27826120|NCT01951625|54292081|FG000|Follow Up Period|Death|1|||
27826121|NCT01951625|54292082|FG001|Follow Up Period|Death|3|||
27826122|NCT01951625|54292083|FG002|Follow Up Period|Death|2|||
27826123|NCT01951625|54292084|FG003|Follow Up Period|Death|2|||
27826124|NCT01951625|54292085|FG004|Follow Up Period|Death|1|||
27826125|NCT01951625|54292081|FG000|Follow Up Period|Logistical difficulties|1|||
27826126|NCT01951625|54292082|FG001|Follow Up Period|Logistical difficulties|2|||
27826127|NCT01951625|54292083|FG002|Follow Up Period|Logistical difficulties|0|||
27826128|NCT01951625|54292084|FG003|Follow Up Period|Logistical difficulties|0|||
27826129|NCT01951625|54292085|FG004|Follow Up Period|Logistical difficulties|0|||
27826130|NCT01951625|54292081|FG000|Follow Up Period|Adverse Event|0|||
27826131|NCT01951625|54292082|FG001|Follow Up Period|Adverse Event|3|||
27826132|NCT01951625|54292083|FG002|Follow Up Period|Adverse Event|2|||
27826133|NCT01951625|54292084|FG003|Follow Up Period|Adverse Event|3|||
27826134|NCT01951625|54292085|FG004|Follow Up Period|Adverse Event|5|||
27826135|NCT01951625|54292081|FG000|Follow Up Period|Withdrawal by Subject|4|||
27826136|NCT01951625|54292082|FG001|Follow Up Period|Withdrawal by Subject|1|||
27826137|NCT01951625|54292083|FG002|Follow Up Period|Withdrawal by Subject|0|||
27826138|NCT01951625|54292084|FG003|Follow Up Period|Withdrawal by Subject|5|||
27826139|NCT01951625|54292085|FG004|Follow Up Period|Withdrawal by Subject|3|||
27826140|NCT01951625|54292081|FG000|Follow Up Period|Lost to Follow-up|1|||
27826141|NCT01951625|54292082|FG001|Follow Up Period|Lost to Follow-up|0|||
27826142|NCT01951625|54292083|FG002|Follow Up Period|Lost to Follow-up|0|||
27826143|NCT01951625|54292084|FG003|Follow Up Period|Lost to Follow-up|1|||
27826144|NCT01951625|54292085|FG004|Follow Up Period|Lost to Follow-up|1|||
27826145|NCT04400890|54292100|FG000|Overall Study|Withdrawal by Subject|3|||
27826146|NCT04400890|54292101|FG001|Overall Study|Withdrawal by Subject|2|||
27826147|NCT01936649|54292107|FG000|Overall Study|Withdrawal by Subject|4|||
27826148|NCT01936649|54292107|FG000|Overall Study|Physician Decision|2|||
27826149|NCT01936649|54292107|FG000|Overall Study|Protocol Violation|2|||
27826150|NCT01936649|54292107|FG000|Overall Study|Other than specified above|5|||
27826151|NCT01720069|54292114|FG000|Overall Study|Could not use e-diary correctly|0|||
27826152|NCT01720069|54292115|FG001|Overall Study|Could not use e-diary correctly|1|||
27826153|NCT01720069|54292116|FG002|Overall Study|Could not use e-diary correctly|1|||
27826154|NCT01720069|54292114|FG000|Overall Study|Randomised without baseline values|0|||
27826155|NCT01720069|54292115|FG001|Overall Study|Randomised without baseline values|0|||
27826156|NCT01720069|54292116|FG002|Overall Study|Randomised without baseline values|1|||
27826157|NCT01720069|54292114|FG000|Overall Study|Adverse Event|0|||
27826158|NCT01720069|54292115|FG001|Overall Study|Adverse Event|0|||
27826159|NCT01720069|54292116|FG002|Overall Study|Adverse Event|1|||
27826160|NCT01720069|54292114|FG000|Overall Study|Lack of Efficacy|0|||
27826161|NCT01720069|54292115|FG001|Overall Study|Lack of Efficacy|4|||
27826162|NCT01720069|54292116|FG002|Overall Study|Lack of Efficacy|0|||
27826163|NCT01720069|54292114|FG000|Overall Study|Treatment period withdrawal criteria met|4|||
27826164|NCT01720069|54292115|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
27826165|NCT01720069|54292116|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
27826166|NCT01720069|54292114|FG000|Overall Study|Withdrawal by Subject|0|||
27826167|NCT01720069|54292115|FG001|Overall Study|Withdrawal by Subject|2|||
27826168|NCT01720069|54292116|FG002|Overall Study|Withdrawal by Subject|1|||
27826169|NCT01720069|54292114|FG000|Overall Study|OCS bursts occured, discontinued in line|1|||
27826170|NCT01720069|54292115|FG001|Overall Study|OCS bursts occured, discontinued in line|0|||
27826171|NCT01720069|54292116|FG002|Overall Study|OCS bursts occured, discontinued in line|0|||
27826172|NCT01720069|54292114|FG000|Overall Study|Non-compliance on using e-diary|0|||
27826173|NCT01720069|54292115|FG001|Overall Study|Non-compliance on using e-diary|0|||
27826174|NCT01720069|54292116|FG002|Overall Study|Non-compliance on using e-diary|1|||
27826175|NCT01720069|54292114|FG000|Overall Study|Lost to Follow-up|0|||
27826176|NCT01720069|54292115|FG001|Overall Study|Lost to Follow-up|0|||
27826177|NCT01720069|54292116|FG002|Overall Study|Lost to Follow-up|1|||
27826178|NCT01719757|54292162|FG000|Overall Study|Adverse Event|38|||
27826179|NCT01719757|54292162|FG000|Overall Study|Withdrawal by Subject|15|||
27826180|NCT01719757|54292162|FG000|Overall Study|Lost to Follow-up|20|||
27826181|NCT01719757|54292162|FG000|Overall Study|Protocol Violation|1|||
27826182|NCT01719757|54292162|FG000|Overall Study|well controlled pain|27|||
27826183|NCT01718509|54292170|FG000|Overall Study|Lost to Follow-up|18|||
27826184|NCT01718509|54292171|FG001|Overall Study|Lost to Follow-up|15|||
27826185|NCT01718509|54292170|FG000|Overall Study|Withdrawal by Subject|7|||
27826186|NCT01718509|54292171|FG001|Overall Study|Withdrawal by Subject|13|||
27826187|NCT01718509|54292170|FG000|Overall Study|Adverse Event|5|||
27826188|NCT01718509|54292171|FG001|Overall Study|Adverse Event|7|||
27826189|NCT01718509|54292170|FG000|Overall Study|Other|13|||
27826190|NCT01718509|54292171|FG001|Overall Study|Other|11|||
27826191|NCT01718509|54292170|FG000|Overall Study|Protocol Violation|4|||
27826192|NCT01718509|54292171|FG001|Overall Study|Protocol Violation|2|||
27826193|NCT01718509|54292170|FG000|Overall Study|Lack of Efficacy|1|||
27826194|NCT01718509|54292171|FG001|Overall Study|Lack of Efficacy|0|||
27826195|NCT01857934|54292177|FG000|Overall Study|Relapse or progression|2|||
27826196|NCT01857934|54292177|FG000|Overall Study|Unacceptable toxicity|3|||
27826197|NCT01857934|54292177|FG000|Overall Study|Unwillingness or inability to comply|2|||
27826198|NCT01857934|54292177|FG000|Overall Study|Physician Decision|3|||
27826199|NCT01604941|54292218|FG000|Overall Study|Adverse Event|1|||
27826200|NCT01604941|54292219|FG001|Overall Study|Adverse Event|2|||
27826201|NCT01604941|54292220|FG002|Overall Study|Adverse Event|0|||
27826202|NCT01604941|54292221|FG003|Overall Study|Adverse Event|0|||
27826203|NCT01604941|54292222|FG004|Overall Study|Adverse Event|1|||
27826204|NCT01604941|54292223|FG005|Overall Study|Adverse Event|5|||
27826205|NCT01604941|54292218|FG000|Overall Study|Non-compliance|1|||
27826206|NCT01604941|54292219|FG001|Overall Study|Non-compliance|0|||
27826207|NCT01604941|54292220|FG002|Overall Study|Non-compliance|0|||
27826208|NCT01604941|54292221|FG003|Overall Study|Non-compliance|0|||
27826209|NCT01604941|54292222|FG004|Overall Study|Non-compliance|0|||
27826210|NCT01604941|54292223|FG005|Overall Study|Non-compliance|0|||
27826211|NCT01604941|54292218|FG000|Overall Study|Participant Decision|0|||
27826212|NCT01604941|54292219|FG001|Overall Study|Participant Decision|0|||
27826213|NCT01604941|54292220|FG002|Overall Study|Participant Decision|0|||
27826214|NCT01604941|54292221|FG003|Overall Study|Participant Decision|0|||
27826215|NCT01604941|54292222|FG004|Overall Study|Participant Decision|0|||
27826216|NCT01604941|54292223|FG005|Overall Study|Participant Decision|2|||
27826217|NCT01604941|54292218|FG000|Overall Study|Early Study Termination|9|||
27826218|NCT01604941|54292219|FG001|Overall Study|Early Study Termination|2|||
27826219|NCT01604941|54292220|FG002|Overall Study|Early Study Termination|3|||
27826220|NCT01604941|54292221|FG003|Overall Study|Early Study Termination|3|||
27826221|NCT01604941|54292222|FG004|Overall Study|Early Study Termination|0|||
27826222|NCT01604941|54292223|FG005|Overall Study|Early Study Termination|0|||
27826223|NCT01604785|54292231|FG000|Overall Study|Repeat Visits Not Included in Analysis|7|||
27826224|NCT01604785|54292232|FG001|Overall Study|Repeat Visits Not Included in Analysis|1|||
27826225|NCT01681849|54292241|FG000|Overall Study|Protocol Violation|2|||
27826226|NCT01681849|54292242|FG001|Overall Study|Protocol Violation|0|||
27826227|NCT01681849|54292243|FG002|Overall Study|Protocol Violation|0|||
27826228|NCT01681849|54292241|FG000|Overall Study|Withdrawal by Subject|3|||
27826229|NCT01681849|54292242|FG001|Overall Study|Withdrawal by Subject|5|||
27826230|NCT01681849|54292243|FG002|Overall Study|Withdrawal by Subject|33|||
27826231|NCT01681849|54292241|FG000|Overall Study|Lost to Follow-up|3|||
27826232|NCT01681849|54292242|FG001|Overall Study|Lost to Follow-up|2|||
27826233|NCT01681849|54292243|FG002|Overall Study|Lost to Follow-up|6|||
27826234|NCT01681771|54292252|FG000|Overall Study|Lost to Follow-up|4|||
27826235|NCT01681771|54292253|FG001|Overall Study|Lost to Follow-up|2|||
27826236|NCT04250350|54292259|FG000|Overall Study|Withdrawal by Subject|13|||
27826237|NCT04250350|54292259|FG000|Overall Study|Lost to Follow-up|8|||
27826238|NCT04250350|54292259|FG000|Overall Study|Adverse Event|5|||
27826239|NCT04250350|54292259|FG000|Overall Study|Lack of Efficacy|4|||
27826240|NCT04250350|54292259|FG000|Overall Study|Physician Decision|1|||
27826241|NCT04250350|54292259|FG000|Overall Study|Participant moved out of the country/non-compliance|3|||
27826242|NCT01718353|54292290|FG000|Overall Study|Lost to Follow-up|0|||
27826243|NCT01718353|54292291|FG001|Overall Study|Lost to Follow-up|1|||
27826244|NCT01718353|54292290|FG000|Overall Study|Principal Investigator's Decision|10|||
27826245|NCT01718353|54292291|FG001|Overall Study|Principal Investigator's Decision|4|||
27826246|NCT01718353|54292290|FG000|Overall Study|Randomized but not treated|2|||
27826247|NCT01718353|54292291|FG001|Overall Study|Randomized but not treated|0|||
27826248|NCT01716715|54292301|FG000|Overall Study|Never Treated|2|||
27826249|NCT01716715|54292302|FG001|Overall Study|Never Treated|4|||
27826250|NCT01697449|54292310|FG000|Overall Study|Disease progression|47|||
27826251|NCT01697449|54292310|FG000|Overall Study|Adverse Event|7|||
27826252|NCT01697449|54292310|FG000|Overall Study|Lost to Follow-up|5|||
27826253|NCT01697449|54292310|FG000|Overall Study|Withdrawal by Subject|2|||
27826254|NCT01697449|54292310|FG000|Overall Study|Physician Decision|1|||
27826255|NCT01697449|54292310|FG000|Overall Study|Death|2|||
27826256|NCT01697449|54292310|FG000|Overall Study|Other|1|||
27826257|NCT01697449|54292310|FG000|Overall Study|Missing|25|||
27826258|NCT01696981|54292319|FG000|Overall Study|Cancer Before Rand. (Colo. Screening)|0|||
27826259|NCT01696981|54292320|FG001|Overall Study|Cancer Before Rand. (Colo. Screening)|20|||
27826260|NCT01696981|54292319|FG000|Overall Study|Died Before Randomization|3|||
27826261|NCT01696981|54292320|FG001|Overall Study|Died Before Randomization|8|||
27826262|NCT01696981|54292319|FG000|Overall Study|Died Before ASU (Control)|278|||
27826263|NCT01696981|54292320|FG001|Overall Study|Died Before ASU (Control)|0|||
27826264|NCT01696981|54292319|FG000|Overall Study|Refused ASU (Control)|920|||
27826265|NCT01696981|54292320|FG001|Overall Study|Refused ASU (Control)|0|||
27826266|NCT01696981|54292319|FG000|Overall Study|Refused Screen (Colorectal Screening)|0|||
27826267|NCT01696981|54292320|FG001|Overall Study|Refused Screen (Colorectal Screening)|10346|||
27826268|NCT01696279|54292326|FG000|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1|||
27826269|NCT01696279|54292327|FG001|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
27826270|NCT01696279|54292328|FG002|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
27826271|NCT01696279|54292329|FG003|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
27826272|NCT01696279|54292326|FG000|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
27826273|NCT01696279|54292327|FG001|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5|||
27826274|NCT01696279|54292328|FG002|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
28076617|NCT00405587|54731474|FG002|Overall Study|Disease Progression|21|||
27826275|NCT01696279|54292329|FG003|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
27826276|NCT01696279|54292326|FG000|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
27826277|NCT01696279|54292327|FG001|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1|||
27826278|NCT01696279|54292328|FG002|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
27826279|NCT01696279|54292329|FG003|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
27826280|NCT01696279|54292326|FG000|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
27826281|NCT01696279|54292327|FG001|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1|||
27826282|NCT01696279|54292328|FG002|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
27826283|NCT01696279|54292329|FG003|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
27826284|NCT01696279|54292326|FG000|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
27826285|NCT01696279|54292327|FG001|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3|||
27826286|NCT01696279|54292328|FG002|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
27826287|NCT01696279|54292329|FG003|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
27826288|NCT01696279|54292326|FG000|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
27826289|NCT01696279|54292327|FG001|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7|||
27826290|NCT01696279|54292328|FG002|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
27826291|NCT01696279|54292329|FG003|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
27826292|NCT01696279|54292326|FG000|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
27826293|NCT01696279|54292327|FG001|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2|||
27826294|NCT01696279|54292328|FG002|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
27826295|NCT01696279|54292329|FG003|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
27826296|NCT01696279|54292326|FG000|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
27826297|NCT01696279|54292327|FG001|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
27826298|NCT01696279|54292328|FG002|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1|||
27826299|NCT01696279|54292329|FG003|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
27826300|NCT01696279|54292326|FG000|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
27826301|NCT01696279|54292327|FG001|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
27826302|NCT01696279|54292328|FG002|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
27826303|NCT01696279|54292329|FG003|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6|||
27826304|NCT01696279|54292326|FG000|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
27826305|NCT01696279|54292327|FG001|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
27826306|NCT01696279|54292328|FG002|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
27826307|NCT01696279|54292329|FG003|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1|||
27826308|NCT01696279|54292326|FG000|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
28159644|NCT01663402|54829570|FG000|Overall Study|Withdrawal by Subject|118|||
28159645|NCT01663402|54829571|FG001|Overall Study|Withdrawal by Subject|91|||
28159646|NCT01663402|54829570|FG000|Overall Study|Related to study drug administration|96|||
28159647|NCT01663402|54829571|FG001|Overall Study|Related to study drug administration|105|||
28159648|NCT01663402|54829570|FG000|Overall Study|Lost to Follow-up|17|||
28159649|NCT01663402|54829571|FG001|Overall Study|Lost to Follow-up|15|||
28159650|NCT01663402|54829570|FG000|Overall Study|Other than specified above|172|||
28159651|NCT01663402|54829571|FG001|Overall Study|Other than specified above|147|||
28159652|NCT00859521|54829588|FG000|Washout|Withdrawal by Subject|0|||
28159653|NCT00859521|54829589|FG001|Washout|Withdrawal by Subject|1|||
28159654|NCT00841815|54829604|FG000|Washout|Withdrawal by Subject|0|||
28159655|NCT00841815|54829605|FG001|Washout|Withdrawal by Subject|1|||
28159656|NCT00841659|54829612|FG000|Washout: 2 Weeks|Protocol Violation|1|||
28159657|NCT00841659|54829613|FG001|Washout: 2 Weeks|Protocol Violation|0|||
28159658|NCT02716298|54829617|FG000|First Intervention (1 Month)|Lens discomfort|1|||
28159659|NCT02716298|54829618|FG001|First Intervention (1 Month)|Lens discomfort|1|||
28159660|NCT00840879|54829631|FG000|Second Intervention|Withdrawal by Subject|1|||
28159661|NCT00840879|54829632|FG001|Second Intervention|Withdrawal by Subject|0|||
28159662|NCT00840411|54829647|FG000|First Intervention|Adverse Event|1|||
28159663|NCT00840411|54829648|FG001|First Intervention|Adverse Event|0|||
28159664|NCT00840411|54829647|FG000|Washout|Withdrawal by Subject|1|||
28159665|NCT00840411|54829648|FG001|Washout|Withdrawal by Subject|0|||
28159666|NCT00836901|54829661|FG000|First Intervention|Withdrawal by Subject|1|||
28159667|NCT00836901|54829662|FG001|First Intervention|Withdrawal by Subject|0|||
28159668|NCT04466384|54829666|FG000|First Phase|Protocol Violation|1|||
28159669|NCT04466384|54829667|FG001|First Phase|Protocol Violation|0|||
28159670|NCT04466384|54829666|FG000|First Phase|Missing data|1|||
28159671|NCT04466384|54829667|FG001|First Phase|Missing data|0|||
28159672|NCT04466384|54829666|FG000|Cross Over Phase|Physician Decision|1|||
28159673|NCT04466384|54829667|FG001|Cross Over Phase|Physician Decision|0|||
28159674|NCT04466384|54829666|FG000|Cross Over Phase|Withdrawal by Subject|0|||
28159675|NCT04466384|54829667|FG001|Cross Over Phase|Withdrawal by Subject|1|||
28159676|NCT03050814|54829678|FG000|Overall Study|Screen failures|0|||
28159677|NCT03050814|54829679|FG001|Overall Study|Screen failures|0|||
28159678|NCT03050814|54829680|FG002|Overall Study|Screen failures|4|||
28159679|NCT00835575|54829688|FG000|Washout of 14 Days|Withdrawal by Subject|1|||
27826309|NCT01696279|54292327|FG001|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
27826310|NCT01696279|54292328|FG002|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
27826311|NCT01696279|54292329|FG003|Part 3: Lanthanum Carbonate (6 Months)|Missing|1|||
27826312|NCT01681069|54292340|FG000|Overall Study|Withdrawal by Subject|4|||
27826313|NCT01681069|54292341|FG001|Overall Study|Withdrawal by Subject|5|||
27826314|NCT01681069|54292340|FG000|Overall Study|Protocol Violation|1|||
27826315|NCT01681069|54292341|FG001|Overall Study|Protocol Violation|1|||
27826316|NCT01681069|54292340|FG000|Overall Study|Adverse Event|0|||
27826317|NCT01681069|54292341|FG001|Overall Study|Adverse Event|1|||
27826318|NCT01716559|54292347|FG000|Overall Study|Adverse Event|11|||
27826319|NCT01716559|54292347|FG000|Overall Study|Death|21|||
27826320|NCT01716559|54292347|FG000|Overall Study|Withdrawal by Subject|4|||
27826321|NCT01716559|54292347|FG000|Overall Study|Other withdrawal reason|75|||
27826322|NCT01936181|54292353|FG000|Randomised, Double-blind|Adverse Event|27|||
27826323|NCT01936181|54292354|FG001|Randomised, Double-blind|Adverse Event|21|||
27826324|NCT01936181|54292355|FG002|Randomised, Double-blind|Adverse Event|0|||
27826325|NCT01936181|54292356|FG003|Randomised, Double-blind|Adverse Event|0|||
27826326|NCT01936181|54292353|FG000|Randomised, Double-blind|Protocol Violation|1|||
27826327|NCT01936181|54292354|FG001|Randomised, Double-blind|Protocol Violation|5|||
27826328|NCT01936181|54292355|FG002|Randomised, Double-blind|Protocol Violation|0|||
27826329|NCT01936181|54292356|FG003|Randomised, Double-blind|Protocol Violation|0|||
27826330|NCT01936181|54292353|FG000|Randomised, Double-blind|Lack of Efficacy|5|||
27826331|NCT01936181|54292354|FG001|Randomised, Double-blind|Lack of Efficacy|6|||
27826332|NCT01936181|54292355|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
27826333|NCT01936181|54292356|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
27826334|NCT01936181|54292353|FG000|Randomised, Double-blind|Lost to Follow-up|0|||
27826335|NCT01936181|54292354|FG001|Randomised, Double-blind|Lost to Follow-up|1|||
27826336|NCT01936181|54292355|FG002|Randomised, Double-blind|Lost to Follow-up|0|||
27826337|NCT01936181|54292356|FG003|Randomised, Double-blind|Lost to Follow-up|0|||
27826338|NCT01936181|54292353|FG000|Randomised, Double-blind|Pregnancy|0|||
27826339|NCT01936181|54292354|FG001|Randomised, Double-blind|Pregnancy|1|||
27826340|NCT01936181|54292355|FG002|Randomised, Double-blind|Pregnancy|0|||
27826341|NCT01936181|54292356|FG003|Randomised, Double-blind|Pregnancy|0|||
27826342|NCT01936181|54292353|FG000|Randomised, Double-blind|Physician Decision|4|||
27826343|NCT01936181|54292354|FG001|Randomised, Double-blind|Physician Decision|4|||
27826344|NCT01936181|54292355|FG002|Randomised, Double-blind|Physician Decision|0|||
27826345|NCT01936181|54292356|FG003|Randomised, Double-blind|Physician Decision|0|||
27826346|NCT01936181|54292353|FG000|Randomised, Double-blind|Withdrawal by Subject|23|||
27826347|NCT01936181|54292354|FG001|Randomised, Double-blind|Withdrawal by Subject|26|||
27826348|NCT01936181|54292355|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
27826349|NCT01936181|54292356|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
27826350|NCT01936181|54292353|FG000|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
27826351|NCT01936181|54292354|FG001|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
27826352|NCT01936181|54292355|FG002|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
27826353|NCT01936181|54292356|FG003|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
27826354|NCT01936181|54292353|FG000|Transition-extension|Adverse Event|3|||
27826355|NCT01936181|54292354|FG001|Transition-extension|Adverse Event|0|||
27826356|NCT01936181|54292355|FG002|Transition-extension|Adverse Event|3|||
27826357|NCT01936181|54292356|FG003|Transition-extension|Adverse Event|1|||
27826358|NCT01936181|54292353|FG000|Transition-extension|Lost to Follow-up|3|||
27826359|NCT01936181|54292354|FG001|Transition-extension|Lost to Follow-up|0|||
27826360|NCT01936181|54292355|FG002|Transition-extension|Lost to Follow-up|1|||
27826361|NCT01936181|54292356|FG003|Transition-extension|Lost to Follow-up|2|||
27826362|NCT01936181|54292353|FG000|Transition-extension|Physician Decision|2|||
27826363|NCT01936181|54292354|FG001|Transition-extension|Physician Decision|0|||
27826364|NCT01936181|54292355|FG002|Transition-extension|Physician Decision|0|||
27826365|NCT01936181|54292356|FG003|Transition-extension|Physician Decision|1|||
27826366|NCT01936181|54292353|FG000|Transition-extension|Withdrawal by Subject|7|||
27826367|NCT01936181|54292354|FG001|Transition-extension|Withdrawal by Subject|0|||
27826368|NCT01936181|54292355|FG002|Transition-extension|Withdrawal by Subject|2|||
27826369|NCT01936181|54292356|FG003|Transition-extension|Withdrawal by Subject|1|||
27826370|NCT01696045|54292369|FG000|Overall Study|Study drug toxicity|1|||
27826371|NCT01696045|54292370|FG001|Overall Study|Study drug toxicity|5|||
27826372|NCT01696045|54292369|FG000|Overall Study|Disease progression|2|||
27826373|NCT01696045|54292370|FG001|Overall Study|Disease progression|2|||
27826374|NCT01716169|54292376|FG000|Overall Study|Adverse Event|1|||
27826375|NCT01716169|54292376|FG000|Overall Study|Lost to Follow-up|1|||
27826376|NCT01716169|54292376|FG000|Overall Study|Withdrawal by Subject|1|||
27826377|NCT01716169|54292376|FG000|Overall Study|inconsistent dressing application|1|||
27826378|NCT01935947|54292385|FG000|Overall Study|Adverse Event|0|||
27826379|NCT01935947|54292386|FG001|Overall Study|Adverse Event|2|||
27826380|NCT01935947|54292387|FG002|Overall Study|Adverse Event|0|||
27826381|NCT01935947|54292385|FG000|Overall Study|Diease Progression|2|||
27826382|NCT01935947|54292386|FG001|Overall Study|Diease Progression|2|||
27826383|NCT01935947|54292387|FG002|Overall Study|Diease Progression|2|||
27826384|NCT01935947|54292385|FG000|Overall Study|Death|1|||
27826385|NCT01935947|54292386|FG001|Overall Study|Death|0|||
27826386|NCT01935947|54292387|FG002|Overall Study|Death|0|||
27826387|NCT01618019|54292400|FG000|Overall Study|Withdrawal by Subject|14|||
27826388|NCT01618019|54292401|FG001|Overall Study|Withdrawal by Subject|14|||
27826389|NCT01593787|54292410|FG000|Overall Study|Adverse Event|1|||
27826390|NCT01593787|54292411|FG001|Overall Study|Adverse Event|0|||
27826391|NCT01593787|54292412|FG002|Overall Study|Adverse Event|0|||
27826392|NCT01951157|54292425|FG000|Overall Study|Progressive Disease|12|||
27826393|NCT01951157|54292426|FG001|Overall Study|Progressive Disease|13|||
27826394|NCT01951157|54292427|FG002|Overall Study|Progressive Disease|10|||
27826395|NCT01951157|54292425|FG000|Overall Study|Treatment-unrelated AE|1|||
27826396|NCT01951157|54292426|FG001|Overall Study|Treatment-unrelated AE|0|||
27826397|NCT01951157|54292427|FG002|Overall Study|Treatment-unrelated AE|3|||
27826398|NCT01951157|54292425|FG000|Overall Study|Study Termination|0|||
27826399|NCT01951157|54292426|FG001|Overall Study|Study Termination|0|||
27826400|NCT01951157|54292427|FG002|Overall Study|Study Termination|1|||
27826401|NCT01951157|54292425|FG000|Overall Study|Physician Decision|5|||
27826402|NCT01951157|54292426|FG001|Overall Study|Physician Decision|3|||
27826403|NCT01951157|54292427|FG002|Overall Study|Physician Decision|2|||
27826404|NCT01951157|54292425|FG000|Overall Study|Non-treatmentrelated death|2|||
27826405|NCT01951157|54292426|FG001|Overall Study|Non-treatmentrelated death|2|||
27826406|NCT01951157|54292427|FG002|Overall Study|Non-treatmentrelated death|2|||
27826407|NCT01951157|54292425|FG000|Overall Study|No treated|0|||
27826408|NCT01951157|54292426|FG001|Overall Study|No treated|1|||
27826409|NCT01951157|54292427|FG002|Overall Study|No treated|0|||
27826410|NCT01951157|54292425|FG000|Overall Study|Treatment-related AE|2|||
27826411|NCT01951157|54292426|FG001|Overall Study|Treatment-related AE|0|||
27826412|NCT01951157|54292427|FG002|Overall Study|Treatment-related AE|4|||
27826413|NCT01951157|54292425|FG000|Overall Study|Consent withdrawn by subject|0|||
27826414|NCT01951157|54292426|FG001|Overall Study|Consent withdrawn by subject|1|||
27826415|NCT01951157|54292427|FG002|Overall Study|Consent withdrawn by subject|3|||
27826416|NCT01951157|54292425|FG000|Overall Study|Treatment-related death|0|||
27826417|NCT01951157|54292426|FG001|Overall Study|Treatment-related death|2|||
27826418|NCT01951157|54292427|FG002|Overall Study|Treatment-related death|0|||
27826419|NCT01363349|54292438|FG000|Overall Study|Adverse Event|6|||
27826420|NCT01363349|54292439|FG001|Overall Study|Adverse Event|7|||
27826421|NCT01363349|54292438|FG000|Overall Study|Lack of Efficacy|3|||
27826422|NCT01363349|54292439|FG001|Overall Study|Lack of Efficacy|10|||
27826423|NCT01363349|54292438|FG000|Overall Study|Non compliance/Protocol deviations|2|||
27826424|NCT01363349|54292439|FG001|Overall Study|Non compliance/Protocol deviations|2|||
27826425|NCT01363349|54292438|FG000|Overall Study|Withdrawal by Subject|14|||
27826426|NCT01363349|54292439|FG001|Overall Study|Withdrawal by Subject|6|||
27826427|NCT01363349|54292438|FG000|Overall Study|Lost to Follow-up|5|||
27826428|NCT01363349|54292439|FG001|Overall Study|Lost to Follow-up|6|||
27826429|NCT01363349|54292438|FG000|Overall Study|Not reported|36|||
27826430|NCT01363349|54292439|FG001|Overall Study|Not reported|37|||
27826431|NCT01363349|54292438|FG000|Overall Study|missing|1|||
27826432|NCT01363349|54292439|FG001|Overall Study|missing|2|||
27826433|NCT01933919|54292530|FG000|Double-blind Placebo-controlled Phase|Adverse Event|0|||
27826434|NCT01933919|54292531|FG001|Double-blind Placebo-controlled Phase|Adverse Event|1|||
27826435|NCT01933919|54292530|FG000|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0|||
27826436|NCT01933919|54292531|FG001|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1|||
27826437|NCT01933919|54292530|FG000|Double-blind Placebo-controlled Phase|Lack of Efficacy|0|||
27826438|NCT01933919|54292531|FG001|Double-blind Placebo-controlled Phase|Lack of Efficacy|2|||
27826439|NCT01933919|54292530|FG000|Open-label Long-term Phase|Adverse Event|2|||
27826440|NCT01933919|54292531|FG001|Open-label Long-term Phase|Adverse Event|0|||
27826441|NCT01933919|54292530|FG000|Open-label Long-term Phase|Withdrawal by Subject|3|||
27826442|NCT01933919|54292531|FG001|Open-label Long-term Phase|Withdrawal by Subject|4|||
27826443|NCT01933919|54292530|FG000|Open-label Long-term Phase|Lost to Follow-up|1|||
27826444|NCT01933919|54292531|FG001|Open-label Long-term Phase|Lost to Follow-up|0|||
27826445|NCT01933919|54292530|FG000|Open-label Long-term Phase|Other|1|||
27826446|NCT01933919|54292531|FG001|Open-label Long-term Phase|Other|2|||
27826447|NCT01933217|54292560|FG000|Randomization (4 Weeks)|Withdrawal by Subject|1|||
27826448|NCT01933217|54292561|FG001|Randomization (4 Weeks)|Withdrawal by Subject|3|||
27826449|NCT01933217|54292560|FG000|Randomization (4 Weeks)|Lost to Follow-up|1|||
27826450|NCT01933217|54292561|FG001|Randomization (4 Weeks)|Lost to Follow-up|1|||
27826451|NCT01932437|54292571|FG000|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
27826452|NCT01932437|54292572|FG001|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
27826453|NCT01932437|54292573|FG002|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
27826454|NCT01932437|54292574|FG003|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
27826455|NCT01932437|54292575|FG004|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
27826456|NCT01932437|54292576|FG005|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1|||
27826457|NCT01949051|54292597|FG000|Treatment Period 1 (7 Days)|Protocol Violation|1|||
27826458|NCT01949051|54292598|FG001|Treatment Period 1 (7 Days)|Protocol Violation|0|||
27826459|NCT01949051|54292599|FG002|Treatment Period 1 (7 Days)|Protocol Violation|0|||
27826460|NCT01949051|54292600|FG003|Treatment Period 1 (7 Days)|Protocol Violation|1|||
27826461|NCT01949051|54292601|FG004|Treatment Period 1 (7 Days)|Protocol Violation|0|||
27826462|NCT01949051|54292602|FG005|Treatment Period 1 (7 Days)|Protocol Violation|0|||
27826463|NCT01949051|54292597|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
27826464|NCT01949051|54292598|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
27826465|NCT01949051|54292599|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
27826466|NCT01949051|54292600|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
27826467|NCT01949051|54292601|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
27826468|NCT01949051|54292602|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
27826469|NCT01949051|54292597|FG000|Treatment Period 2 (7 Days)|Protocol Violation|0|||
27826470|NCT01949051|54292598|FG001|Treatment Period 2 (7 Days)|Protocol Violation|0|||
27826471|NCT01949051|54292599|FG002|Treatment Period 2 (7 Days)|Protocol Violation|0|||
27826472|NCT01949051|54292600|FG003|Treatment Period 2 (7 Days)|Protocol Violation|0|||
27826473|NCT01949051|54292601|FG004|Treatment Period 2 (7 Days)|Protocol Violation|0|||
27826474|NCT01949051|54292602|FG005|Treatment Period 2 (7 Days)|Protocol Violation|1|||
27826475|NCT01949051|54292597|FG000|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
27826476|NCT01949051|54292598|FG001|Treatment Period 2 (7 Days)|Lost to Follow-up|1|||
27826477|NCT01949051|54292599|FG002|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
27826478|NCT01949051|54292600|FG003|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
27826479|NCT01949051|54292601|FG004|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
27826480|NCT01949051|54292602|FG005|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
27826481|NCT01949051|54292597|FG000|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
27826482|NCT01949051|54292598|FG001|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
27826483|NCT01949051|54292599|FG002|Treatment Period 2 (7 Days)|Withdrawal by Subject|1|||
27826484|NCT01949051|54292600|FG003|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
27826485|NCT01949051|54292601|FG004|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
27826486|NCT01949051|54292602|FG005|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
27826487|NCT01948427|54292615|FG000|Overall Study|Serious Adverse Event|3|||
27826488|NCT01948427|54292616|FG001|Overall Study|Serious Adverse Event|0|||
27826489|NCT01948427|54292617|FG002|Overall Study|Serious Adverse Event|0|||
27826490|NCT01948427|54292618|FG003|Overall Study|Serious Adverse Event|0|||
27826491|NCT01948427|54292619|FG004|Overall Study|Serious Adverse Event|1|||
27826492|NCT01948427|54292615|FG000|Overall Study|Investigator Request|0|||
27826493|NCT01948427|54292616|FG001|Overall Study|Investigator Request|8|||
27826494|NCT01948427|54292617|FG002|Overall Study|Investigator Request|0|||
27826495|NCT01948427|54292618|FG003|Overall Study|Investigator Request|0|||
27826496|NCT01948427|54292619|FG004|Overall Study|Investigator Request|6|||
27826497|NCT01948427|54292615|FG000|Overall Study|Lost to Follow-up|1|||
27826498|NCT01948427|54292616|FG001|Overall Study|Lost to Follow-up|0|||
27826499|NCT01948427|54292617|FG002|Overall Study|Lost to Follow-up|0|||
27826500|NCT01948427|54292618|FG003|Overall Study|Lost to Follow-up|0|||
27826501|NCT01948427|54292619|FG004|Overall Study|Lost to Follow-up|4|||
27826502|NCT01948427|54292615|FG000|Overall Study|Withdrawal by Subject|2|||
27826503|NCT01948427|54292616|FG001|Overall Study|Withdrawal by Subject|0|||
27826504|NCT01948427|54292617|FG002|Overall Study|Withdrawal by Subject|0|||
27826505|NCT01948427|54292618|FG003|Overall Study|Withdrawal by Subject|0|||
27826506|NCT01948427|54292619|FG004|Overall Study|Withdrawal by Subject|1|||
27826507|NCT01948427|54292615|FG000|Overall Study|Other, Not Specified|1|||
27826508|NCT01948427|54292616|FG001|Overall Study|Other, Not Specified|9|||
27826509|NCT01948427|54292617|FG002|Overall Study|Other, Not Specified|0|||
27826510|NCT01948427|54292618|FG003|Overall Study|Other, Not Specified|0|||
27826511|NCT01948427|54292619|FG004|Overall Study|Other, Not Specified|2|||
27826512|NCT01948193|54292636|FG000|Overall Study|Serious event|2|||
27826513|NCT01948193|54292636|FG000|Overall Study|Lost to Follow-up|7|||
27826514|NCT01694485|54292646|FG000|Overall Study|Withdrawal by Subject|20|||
27826515|NCT01694485|54292647|FG001|Overall Study|Withdrawal by Subject|6|||
27826516|NCT01694485|54292648|FG002|Overall Study|Withdrawal by Subject|7|||
27826517|NCT01694485|54292649|FG003|Overall Study|Withdrawal by Subject|25|||
27826518|NCT01694485|54292650|FG004|Overall Study|Withdrawal by Subject|18|||
27826519|NCT01694485|54292646|FG000|Overall Study|Sponsor Decision|3|||
27826520|NCT01694485|54292647|FG001|Overall Study|Sponsor Decision|0|||
27826521|NCT01694485|54292648|FG002|Overall Study|Sponsor Decision|0|||
27826522|NCT01694485|54292649|FG003|Overall Study|Sponsor Decision|2|||
27826523|NCT01694485|54292650|FG004|Overall Study|Sponsor Decision|0|||
27826524|NCT01694485|54292646|FG000|Overall Study|Lost to Follow-up|9|||
28159680|NCT00835575|54829689|FG001|Washout of 14 Days|Withdrawal by Subject|0|||
27826525|NCT01694485|54292647|FG001|Overall Study|Lost to Follow-up|1|||
27826526|NCT01694485|54292648|FG002|Overall Study|Lost to Follow-up|6|||
27826527|NCT01694485|54292649|FG003|Overall Study|Lost to Follow-up|10|||
28159681|NCT04601194|54829693|FG000|Overall Study|Lost to Follow-up|7|||
28159682|NCT00835263|54829706|FG000|Second Intervention|Adverse Event|1|||
27826528|NCT01694485|54292650|FG004|Overall Study|Lost to Follow-up|7|||
27826529|NCT01694485|54292646|FG000|Overall Study|Death|1|||
27826530|NCT01694485|54292647|FG001|Overall Study|Death|0|||
27826531|NCT01694485|54292648|FG002|Overall Study|Death|0|||
27826532|NCT01694485|54292649|FG003|Overall Study|Death|1|||
27826533|NCT01694485|54292650|FG004|Overall Study|Death|0|||
27826534|NCT01931735|54292671|FG000|Randomized Phase|Lost to Follow-up|2|||
27826535|NCT01931735|54292672|FG001|Randomized Phase|Lost to Follow-up|2|||
27826536|NCT01931735|54292673|FG002|Randomized Phase|Lost to Follow-up|5|||
27826537|NCT01931735|54292674|FG003|Randomized Phase|Lost to Follow-up|0|||
27826538|NCT01931735|54292671|FG000|Observational Non-Randomized Phase|Adverse Event|0|||
27826539|NCT01931735|54292672|FG001|Observational Non-Randomized Phase|Adverse Event|0|||
27826540|NCT01931735|54292673|FG002|Observational Non-Randomized Phase|Adverse Event|0|||
27826541|NCT01931735|54292674|FG003|Observational Non-Randomized Phase|Adverse Event|1|||
27826542|NCT01931735|54292671|FG000|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
27826543|NCT01931735|54292672|FG001|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
27826544|NCT01931735|54292673|FG002|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
27826545|NCT01931735|54292674|FG003|Observational Non-Randomized Phase|Withdrawal by Subject|1|||
27826546|NCT01930799|54292684|FG000|Overall Study|Withdrawal by Subject|3|||
27826547|NCT01930799|54292684|FG000|Overall Study|Lost to Follow-up|5|||
27826548|NCT01947491|54292692|FG000|Overall Study|Lost to Follow-up|5|||
27826549|NCT01947491|54292693|FG001|Overall Study|Lost to Follow-up|3|||
27826550|NCT01947491|54292694|FG002|Overall Study|Lost to Follow-up|1|||
27826551|NCT01947491|54292695|FG003|Overall Study|Lost to Follow-up|2|||
27826552|NCT01947491|54292692|FG000|Overall Study|Lack of Efficacy|1|||
27826553|NCT01947491|54292693|FG001|Overall Study|Lack of Efficacy|0|||
27826554|NCT01947491|54292694|FG002|Overall Study|Lack of Efficacy|0|||
27826555|NCT01947491|54292695|FG003|Overall Study|Lack of Efficacy|1|||
27826556|NCT01947491|54292692|FG000|Overall Study|Protocol Violation|1|||
27826557|NCT01947491|54292693|FG001|Overall Study|Protocol Violation|0|||
27826558|NCT01947491|54292694|FG002|Overall Study|Protocol Violation|0|||
27826559|NCT01947491|54292695|FG003|Overall Study|Protocol Violation|0|||
27826560|NCT01947491|54292692|FG000|Overall Study|Withdrawal by Subject|1|||
27826561|NCT01947491|54292693|FG001|Overall Study|Withdrawal by Subject|1|||
27826562|NCT01947491|54292694|FG002|Overall Study|Withdrawal by Subject|1|||
27826563|NCT01947491|54292695|FG003|Overall Study|Withdrawal by Subject|0|||
27826564|NCT01947491|54292692|FG000|Overall Study|Worsening of condition|0|||
27826565|NCT01947491|54292693|FG001|Overall Study|Worsening of condition|1|||
27826566|NCT01947491|54292694|FG002|Overall Study|Worsening of condition|0|||
27826567|NCT01947491|54292695|FG003|Overall Study|Worsening of condition|0|||
27826568|NCT01947491|54292692|FG000|Overall Study|Adverse Event|0|||
27826569|NCT01947491|54292693|FG001|Overall Study|Adverse Event|1|||
27826570|NCT01947491|54292694|FG002|Overall Study|Adverse Event|0|||
27826571|NCT01947491|54292695|FG003|Overall Study|Adverse Event|2|||
27826572|NCT01715857|54292705|FG000|Overall Study|Did Not Meet Eligibility Criteria|96|||
27826573|NCT01692301|54292711|FG000|Overall Study|Adverse Event|15|||
27826574|NCT01692301|54292712|FG001|Overall Study|Adverse Event|12|||
27826575|NCT01692301|54292711|FG000|Overall Study|Death|1|||
27826576|NCT01692301|54292712|FG001|Overall Study|Death|2|||
27826577|NCT01692301|54292711|FG000|Overall Study|Lack of Efficacy|0|||
27826578|NCT01692301|54292712|FG001|Overall Study|Lack of Efficacy|5|||
27826579|NCT01692301|54292711|FG000|Overall Study|Non-compliance with study treatment|1|||
27826580|NCT01692301|54292712|FG001|Overall Study|Non-compliance with study treatment|2|||
27826581|NCT01692301|54292711|FG000|Overall Study|Protocol deviation|9|||
27826582|NCT01692301|54292712|FG001|Overall Study|Protocol deviation|2|||
27826583|NCT01692301|54292711|FG000|Overall Study|Patient/guardian decision|16|||
27826584|NCT01692301|54292712|FG001|Overall Study|Patient/guardian decision|15|||
27826585|NCT01692301|54292711|FG000|Overall Study|Technical problems|0|||
27826586|NCT01692301|54292712|FG001|Overall Study|Technical problems|1|||
27826587|NCT01692301|54292711|FG000|Overall Study|Physician Decision|2|||
27826588|NCT01692301|54292712|FG001|Overall Study|Physician Decision|2|||
27826589|NCT01692301|54292711|FG000|Overall Study|Lost to Follow-up|1|||
27826590|NCT01692301|54292712|FG001|Overall Study|Lost to Follow-up|1|||
27826591|NCT01592773|54292718|FG000|Overall Study|Study Terminated by Sponsor|582|||
27826592|NCT01592773|54292718|FG000|Overall Study|Withdrawal by Subject|35|||
27826593|NCT01592773|54292718|FG000|Overall Study|Lost to Follow-up|19|||
27826594|NCT01592773|54292718|FG000|Overall Study|Adverse Event|17|||
27826595|NCT01592773|54292718|FG000|Overall Study|Lack of Efficacy|9|||
27826596|NCT01592773|54292718|FG000|Overall Study|Protocol Violation|2|||
27826597|NCT01592773|54292718|FG000|Overall Study|Inclusion/exclusion not meet|1|||
28076618|NCT00405587|54731475|FG003|Overall Study|Disease Progression|17|||
27826598|NCT01592773|54292718|FG000|Overall Study|Other Reason|1|||
27826599|NCT01930175|54292725|FG000|Core Study|Lost to Follow-up|0|||
27826600|NCT01930175|54292726|FG001|Core Study|Lost to Follow-up|1|||
27826601|NCT01930175|54292727|FG002|Core Study|Lost to Follow-up|0|||
27826602|NCT01930175|54292725|FG000|Core Study|Adverse Event|0|||
27826603|NCT01930175|54292726|FG001|Core Study|Adverse Event|0|||
27826604|NCT01930175|54292727|FG002|Core Study|Adverse Event|1|||
27826605|NCT01592695|54292738|FG000|Overall Study|Lost to Follow-up|8|||
27826606|NCT01592695|54292739|FG001|Overall Study|Lost to Follow-up|4|||
27826607|NCT01929863|54292745|FG000|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1|||
27826608|NCT01929863|54292746|FG001|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0|||
27826609|NCT01929863|54292745|FG000|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0|||
27826610|NCT01929863|54292746|FG001|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1|||
27826611|NCT01929863|54292745|FG000|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0|||
27826612|NCT01929863|54292746|FG001|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1|||
27826613|NCT01918085|54292759|FG000|Test Period 1: Strata Strip|Adverse Event|0|||
27826614|NCT01918085|54292760|FG001|Test Period 1: Strata Strip|Adverse Event|1|||
27826615|NCT01714687|54292770|FG000|Overall Study|Withdrawal by Subject|1|||
27826616|NCT01714687|54292771|FG001|Overall Study|Withdrawal by Subject|0|||
27826617|NCT01714687|54292770|FG000|Overall Study|Lost to Follow-up|2|||
27826618|NCT01714687|54292771|FG001|Overall Study|Lost to Follow-up|4|||
27826619|NCT01714609|54292781|FG000|Overall Study|Protocol Violation|1|||
27826620|NCT01714609|54292782|FG001|Overall Study|Protocol Violation|0|||
27826621|NCT01929707|54292788|FG000|Intervention Period 1|Lost to Follow-up|0|||
27826622|NCT01929707|54292789|FG001|Intervention Period 1|Lost to Follow-up|0|||
27826623|NCT01929707|54292790|FG002|Intervention Period 1|Lost to Follow-up|0|||
27826624|NCT01929707|54292791|FG003|Intervention Period 1|Lost to Follow-up|1|||
27826625|NCT01929707|54292792|FG004|Intervention Period 1|Lost to Follow-up|0|||
27826626|NCT01929707|54292793|FG005|Intervention Period 1|Lost to Follow-up|0|||
27826627|NCT01929707|54292794|FG006|Intervention Period 1|Lost to Follow-up|0|||
27826628|NCT01929707|54292795|FG007|Intervention Period 1|Lost to Follow-up|0|||
27826629|NCT01929707|54292788|FG000|Intervention Period 1|Withdrawal by Subject|0|||
27826630|NCT01929707|54292789|FG001|Intervention Period 1|Withdrawal by Subject|0|||
27826631|NCT01929707|54292790|FG002|Intervention Period 1|Withdrawal by Subject|0|||
28076619|NCT00405587|54731472|FG000|Overall Study|Physician Decision|3|||
28076620|NCT00405587|54731473|FG001|Overall Study|Physician Decision|2|||
28076621|NCT00405587|54731474|FG002|Overall Study|Physician Decision|0|||
28076622|NCT00405587|54731475|FG003|Overall Study|Physician Decision|0|||
27826632|NCT01929707|54292791|FG003|Intervention Period 1|Withdrawal by Subject|2|||
28076623|NCT00405587|54731472|FG000|Overall Study|Adverse Event|1|||
28076624|NCT00405587|54731473|FG001|Overall Study|Adverse Event|0|||
27826633|NCT01929707|54292792|FG004|Intervention Period 1|Withdrawal by Subject|0|||
28076625|NCT00405587|54731474|FG002|Overall Study|Adverse Event|0|||
28076626|NCT00405587|54731475|FG003|Overall Study|Adverse Event|0|||
28076627|NCT00405587|54731472|FG000|Overall Study|Lost to Follow-up|0|||
28076628|NCT00405587|54731473|FG001|Overall Study|Lost to Follow-up|1|||
28076629|NCT00405587|54731474|FG002|Overall Study|Lost to Follow-up|1|||
28076630|NCT00405587|54731475|FG003|Overall Study|Lost to Follow-up|0|||
28076631|NCT00405587|54731472|FG000|Overall Study|Radiation induced necrosis|0|||
27826634|NCT01929707|54292793|FG005|Intervention Period 1|Withdrawal by Subject|0|||
27826635|NCT01929707|54292794|FG006|Intervention Period 1|Withdrawal by Subject|0|||
27826636|NCT01929707|54292795|FG007|Intervention Period 1|Withdrawal by Subject|0|||
27826637|NCT01929707|54292788|FG000|Intervention Period 2|Withdrawal by Subject|0|||
27826638|NCT01929707|54292789|FG001|Intervention Period 2|Withdrawal by Subject|0|||
27826639|NCT01929707|54292790|FG002|Intervention Period 2|Withdrawal by Subject|0|||
27826640|NCT01929707|54292791|FG003|Intervention Period 2|Withdrawal by Subject|0|||
27826641|NCT01929707|54292792|FG004|Intervention Period 2|Withdrawal by Subject|0|||
27826642|NCT01929707|54292793|FG005|Intervention Period 2|Withdrawal by Subject|2|||
27826643|NCT01929707|54292794|FG006|Intervention Period 2|Withdrawal by Subject|0|||
27826644|NCT01929707|54292795|FG007|Intervention Period 2|Withdrawal by Subject|0|||
27826645|NCT01714063|54292816|FG000|Overall Study|Equipment malfunction|2|||
27826646|NCT01929395|54292827|FG000|Overall Study|Did not complete - non-related toxicity|1|||
27826647|NCT01929395|54292828|FG001|Overall Study|Did not complete - non-related toxicity|0|||
27826648|NCT01929395|54292829|FG002|Overall Study|Did not complete - non-related toxicity|0|||
27826649|NCT01929395|54292827|FG000|Overall Study|Withdrawal by Subject|0|||
27826650|NCT01929395|54292828|FG001|Overall Study|Withdrawal by Subject|1|||
27826651|NCT01929395|54292829|FG002|Overall Study|Withdrawal by Subject|0|||
27826652|NCT01929395|54292827|FG000|Overall Study|Screen Fail|0|||
27826653|NCT01929395|54292828|FG001|Overall Study|Screen Fail|0|||
27826654|NCT01929395|54292829|FG002|Overall Study|Screen Fail|1|||
27826655|NCT01713283|54292841|FG000|Overall Study|Lack of Efficacy|10|||
27826656|NCT01713283|54292842|FG001|Overall Study|Lack of Efficacy|2|||
27826657|NCT01713283|54292841|FG000|Overall Study|Lost to Follow-up|1|||
27826658|NCT01713283|54292842|FG001|Overall Study|Lost to Follow-up|1|||
27826659|NCT01592383|54292852|FG000|Overall Study|Adverse Event|1|||
27826660|NCT01691521|54292860|FG000|Overall Study|Adverse Event|4|||
27826661|NCT01691521|54292861|FG001|Overall Study|Adverse Event|0|||
27826662|NCT01691521|54292862|FG002|Overall Study|Adverse Event|1|||
27826663|NCT01691521|54292860|FG000|Overall Study|Lack of Efficacy|1|||
27826664|NCT01691521|54292861|FG001|Overall Study|Lack of Efficacy|1|||
27826665|NCT01691521|54292862|FG002|Overall Study|Lack of Efficacy|2|||
27826666|NCT01691521|54292860|FG000|Overall Study|Protocol Violation|0|||
27826667|NCT01691521|54292861|FG001|Overall Study|Protocol Violation|3|||
27826668|NCT01691521|54292862|FG002|Overall Study|Protocol Violation|0|||
27826669|NCT01691521|54292860|FG000|Overall Study|Lost to Follow-up|0|||
27826670|NCT01691521|54292861|FG001|Overall Study|Lost to Follow-up|2|||
27826671|NCT01691521|54292862|FG002|Overall Study|Lost to Follow-up|2|||
27826672|NCT01691521|54292860|FG000|Overall Study|Physician Decision|2|||
27826673|NCT01691521|54292861|FG001|Overall Study|Physician Decision|1|||
27826674|NCT01691521|54292862|FG002|Overall Study|Physician Decision|0|||
27826675|NCT01691521|54292860|FG000|Overall Study|Withdrawal by Subject|5|||
27826676|NCT01691521|54292861|FG001|Overall Study|Withdrawal by Subject|9|||
27826677|NCT01691521|54292862|FG002|Overall Study|Withdrawal by Subject|4|||
27826678|NCT01929317|54292873|FG000|Dose Increase Effect Verification Phase|Adverse Event|5|||
27826679|NCT01929317|54292874|FG001|Dose Increase Effect Verification Phase|Adverse Event|1|||
27826680|NCT01929317|54292873|FG000|Dose Increase Effect Verification Phase|Physician Decision|1|||
27826681|NCT01929317|54292874|FG001|Dose Increase Effect Verification Phase|Physician Decision|0|||
27826682|NCT01929317|54292873|FG000|Dose Increase Effect Verification Phase|Withdrawal by Subject|3|||
27826683|NCT01929317|54292874|FG001|Dose Increase Effect Verification Phase|Withdrawal by Subject|0|||
27826684|NCT01929317|54292873|FG000|Long-term Phase|Adverse Event|5|||
27826685|NCT01929317|54292874|FG001|Long-term Phase|Adverse Event|1|||
27826686|NCT01929317|54292873|FG000|Long-term Phase|Physician Decision|3|||
27826687|NCT01929317|54292874|FG001|Long-term Phase|Physician Decision|0|||
27826688|NCT01929317|54292873|FG000|Long-term Phase|Withdrawal by Subject|4|||
27826689|NCT01929317|54292874|FG001|Long-term Phase|Withdrawal by Subject|0|||
27826690|NCT01929317|54292873|FG000|Long-term Phase|Protocol Violation|1|||
27826691|NCT01929317|54292874|FG001|Long-term Phase|Protocol Violation|0|||
27826692|NCT01929317|54292873|FG000|Long-term Phase|Protocol-defined Stopping Criteria|1|||
27826693|NCT01929317|54292874|FG001|Long-term Phase|Protocol-defined Stopping Criteria|0|||
27826694|NCT01929317|54292873|FG000|Long-term Phase|Study Closed/Terminated|5|||
27826695|NCT01929317|54292874|FG001|Long-term Phase|Study Closed/Terminated|3|||
27826696|NCT01711879|54292888|FG000|Overall Study|Death|1|||
27826697|NCT01711879|54292889|FG001|Overall Study|Death|0|||
28076632|NCT00405587|54731473|FG001|Overall Study|Radiation induced necrosis|1|||
28076633|NCT00405587|54731474|FG002|Overall Study|Radiation induced necrosis|0|||
28076634|NCT00405587|54731475|FG003|Overall Study|Radiation induced necrosis|0|||
27826698|NCT01689649|54292912|FG000|Overall Study|Lack of Efficacy|3|||
27826699|NCT01689649|54292912|FG000|Overall Study|Non-compliance|11|||
27826700|NCT01689649|54292912|FG000|Overall Study|Protocol Violation|3|||
27826701|NCT01689649|54292912|FG000|Overall Study|Lost to Follow-up|5|||
27826702|NCT01929083|54292916|FG000|Intervention 1|Lost to Follow-up|2|||
27826703|NCT01929083|54292917|FG001|Intervention 1|Lost to Follow-up|0|||
28076635|NCT00405587|54731472|FG000|Overall Study|Withdrawal by Subject|0|||
28076636|NCT00405587|54731473|FG001|Overall Study|Withdrawal by Subject|0|||
27826704|NCT01929083|54292916|FG000|Intervention 1|Nonadherent to study medications|1|||
27826705|NCT01929083|54292917|FG001|Intervention 1|Nonadherent to study medications|0|||
27826706|NCT01929083|54292916|FG000|Intervention 2|Adverse Event|0|||
27826707|NCT01929083|54292917|FG001|Intervention 2|Adverse Event|1|||
27826708|NCT01689337|54292923|FG000|Overall Study|Study Discontinuation|1|||
27826709|NCT01688635|54292929|FG000|Washout 1|Withdrawal by Subject|1|||
27826710|NCT01688635|54292930|FG001|Washout 1|Withdrawal by Subject|0|||
27826711|NCT01688635|54292929|FG000|Washout 1|Adverse Event|0|||
27826712|NCT01688635|54292930|FG001|Washout 1|Adverse Event|1|||
27826713|NCT01688635|54292929|FG000|Washout 1|Physician Decision|0|||
27826714|NCT01688635|54292930|FG001|Washout 1|Physician Decision|1|||
27826715|NCT01688635|54292929|FG000|Washout 2|Physician Decision|1|||
27826716|NCT01688635|54292930|FG001|Washout 2|Physician Decision|0|||
27826717|NCT01688635|54292929|FG000|Washout 2|Withdrawal by Subject|1|||
27826718|NCT01688635|54292930|FG001|Washout 2|Withdrawal by Subject|0|||
27826719|NCT01688635|54292929|FG000|Washout 2|Sponsor Decision|1|||
27826720|NCT01688635|54292930|FG001|Washout 2|Sponsor Decision|2|||
27826721|NCT01688635|54292929|FG000|Washout 3|Withdrawal by Subject|1|||
27826722|NCT01688635|54292930|FG001|Washout 3|Withdrawal by Subject|0|||
27826723|NCT01591681|54292937|FG000|Overall Study|Didn't meet min hypoglycemia requirement|3|||
27826724|NCT01591681|54292937|FG000|Overall Study|Failed to use system during run-in|1|||
27826725|NCT01711645|54292952|FG000|Overall Study|Withdrawal by Subject|8|||
27826726|NCT01711645|54292952|FG000|Overall Study|Lost to Follow-up|6|||
27826727|NCT01711645|54292952|FG000|Overall Study|Physician Decision|5|||
27826728|NCT01590433|54292967|FG000|Overall Study|Lost to Follow-up|20|||
27826729|NCT01590433|54292968|FG001|Overall Study|Lost to Follow-up|8|||
27826730|NCT01590433|54292967|FG000|Overall Study|Withdrawal by Subject|21|||
27826731|NCT01590433|54292968|FG001|Overall Study|Withdrawal by Subject|11|||
27826732|NCT01590433|54292967|FG000|Overall Study|Adverse Event|11|||
27826733|NCT01590433|54292968|FG001|Overall Study|Adverse Event|3|||
27826734|NCT01928927|54292985|FG000|Overall Study|Lost to Follow-up|1|||
27826735|NCT01928927|54292986|FG001|Overall Study|Lost to Follow-up|0|||
27826736|NCT01928927|54292985|FG000|Overall Study|Withdrawal by Subject|1|||
27826737|NCT01928927|54292986|FG001|Overall Study|Withdrawal by Subject|1|||
27826738|NCT01710709|54293007|FG000|Overall Study|Lost to Follow-up|29|||
27826739|NCT01710709|54293007|FG000|Overall Study|Adverse Event|48|||
27826740|NCT01710709|54293007|FG000|Overall Study|Participant met withdrawal criteria|33|||
27826741|NCT01710709|54293007|FG000|Overall Study|Participant withdrawn by investigator|2|||
27826742|NCT01710709|54293007|FG000|Overall Study|Withdrawal by Subject|53|||
27826743|NCT01710709|54293007|FG000|Overall Study|Protocol Violation|5|||
27826744|NCT01710709|54293007|FG000|Overall Study|Lack of Efficacy|3|||
27826745|NCT01617629|54293012|FG000|Overall Study|Death|2|||
27826746|NCT01617629|54293012|FG000|Overall Study|Investigator's Clinical Judgement|1|||
27826747|NCT01617629|54293012|FG000|Overall Study|Reason Not Specified|1|||
27826748|NCT01617629|54293012|FG000|Overall Study|Participant Withdrew Consent|2|||
28076637|NCT00405587|54731474|FG002|Overall Study|Withdrawal by Subject|0|||
28076638|NCT00405587|54731475|FG003|Overall Study|Withdrawal by Subject|2|||
28076639|NCT00405587|54731472|FG000|Overall Study|Participant not dosed|0|||
28076640|NCT00405587|54731473|FG001|Overall Study|Participant not dosed|1|||
28076641|NCT00405587|54731474|FG002|Overall Study|Participant not dosed|0|||
28159683|NCT00835263|54829707|FG001|Second Intervention|Adverse Event|0|||
28159684|NCT01963208|54829745|FG000|Treatment Phase 1 (Up to Week 14)|Adverse Event|1|||
28159685|NCT01963208|54829746|FG001|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
28159686|NCT01963208|54829747|FG002|Treatment Phase 1 (Up to Week 14)|Adverse Event|30|||
28159687|NCT01963208|54829748|FG003|Treatment Phase 1 (Up to Week 14)|Adverse Event|11|||
28159688|NCT01963208|54829749|FG004|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
28159689|NCT01963208|54829750|FG005|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
28076642|NCT00405587|54731475|FG003|Overall Study|Participant not dosed|0|||
28076643|NCT00405275|54731513|FG000|Overall Study|Death|1|||
28076644|NCT00405275|54731514|FG001|Overall Study|Death|0|||
28076645|NCT00405275|54731513|FG000|Overall Study|Lost to Follow-up|5|||
28076646|NCT00405275|54731514|FG001|Overall Study|Lost to Follow-up|1|||
28076647|NCT00405275|54731513|FG000|Overall Study|Withdrawal by Subject|7|||
28159690|NCT01963208|54829745|FG000|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
28159691|NCT01963208|54829746|FG001|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|2|||
27826749|NCT01686373|54293027|FG000|Overall Study|Lost to Follow-up|3|||
27826750|NCT01686373|54293028|FG001|Overall Study|Lost to Follow-up|0|||
27826751|NCT01686373|54293027|FG000|Overall Study|Withdrawal by Subject|0|||
27826752|NCT01686373|54293028|FG001|Overall Study|Withdrawal by Subject|1|||
27826753|NCT01686373|54293027|FG000|Overall Study|Adverse Event|0|||
27826754|NCT01686373|54293028|FG001|Overall Study|Adverse Event|1|||
27826755|NCT01709695|54293036|FG000|Overall Study|Withdrawal by Subject|1|||
27826756|NCT01709695|54293037|FG001|Overall Study|Withdrawal by Subject|1|||
28076648|NCT00405275|54731514|FG001|Overall Study|Withdrawal by Subject|9|||
28076649|NCT00405275|54731513|FG000|Overall Study|Unwilling to continue|10|||
28076650|NCT00405275|54731514|FG001|Overall Study|Unwilling to continue|9|||
28076651|NCT00404651|54731524|FG000|Overall Study|Serious Adverse Event|0|||
28159692|NCT01963208|54829747|FG002|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|8|||
28159693|NCT01963208|54829748|FG003|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|9|||
28159694|NCT01963208|54829749|FG004|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
28159695|NCT01963208|54829750|FG005|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
28159696|NCT01963208|54829745|FG000|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
28159697|NCT01963208|54829746|FG001|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
28159698|NCT01963208|54829747|FG002|Treatment Phase 1 (Up to Week 14)|Non-compliance|4|||
28159699|NCT01963208|54829748|FG003|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
28159700|NCT01963208|54829749|FG004|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
28159701|NCT01963208|54829750|FG005|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
28159702|NCT01963208|54829745|FG000|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
28159703|NCT01963208|54829746|FG001|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
28159704|NCT01963208|54829747|FG002|Treatment Phase 1 (Up to Week 14)|Protocol Violation|1|||
28159705|NCT01963208|54829748|FG003|Treatment Phase 1 (Up to Week 14)|Protocol Violation|3|||
28159706|NCT01963208|54829749|FG004|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
28159707|NCT01963208|54829750|FG005|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
28159708|NCT01963208|54829745|FG000|Treatment Phase 1 (Up to Week 14)|Other|0|||
28159709|NCT01963208|54829746|FG001|Treatment Phase 1 (Up to Week 14)|Other|1|||
28159710|NCT01963208|54829747|FG002|Treatment Phase 1 (Up to Week 14)|Other|1|||
28159711|NCT01963208|54829748|FG003|Treatment Phase 1 (Up to Week 14)|Other|1|||
28159712|NCT01963208|54829749|FG004|Treatment Phase 1 (Up to Week 14)|Other|0|||
28159713|NCT01963208|54829750|FG005|Treatment Phase 1 (Up to Week 14)|Other|0|||
28159714|NCT01963208|54829745|FG000|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
28159715|NCT01963208|54829746|FG001|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
27826757|NCT01685983|54293047|FG000|Overall Study|Adverse Event|7|||
27826758|NCT01685983|54293047|FG000|Overall Study|Death|1|||
27826759|NCT01685983|54293047|FG000|Overall Study|Withdrawal by Subject|19|||
27826760|NCT01685983|54293047|FG000|Overall Study|Protocol Violation|2|||
27826761|NCT01685983|54293047|FG000|Overall Study|Physician Decision|13|||
27826762|NCT01685983|54293047|FG000|Overall Study|Other|7|||
27826763|NCT01685983|54293047|FG000|Overall Study|Progressive Disease|32|||
27826764|NCT01685983|54293047|FG000|Overall Study|Noncompliance with Study Drug|1|||
27826765|NCT01685437|54293059|FG000|Overall Study|Withdrawal by Subject|22|||
27826766|NCT01685437|54293059|FG000|Overall Study|Lost to Follow-up|3|||
27826767|NCT01685437|54293059|FG000|Overall Study|Adverse Event|1|||
27826768|NCT01685437|54293059|FG000|Overall Study|Protocol Violation|4|||
27826769|NCT01685437|54293059|FG000|Overall Study|Unable to make visits due to work|1|||
27826770|NCT01685203|54293099|FG000|Overall Study|Lost to Follow-up|3|||
27826771|NCT01685203|54293100|FG001|Overall Study|Lost to Follow-up|3|||
27826772|NCT01685203|54293101|FG002|Overall Study|Lost to Follow-up|0|||
27826773|NCT01685203|54293102|FG003|Overall Study|Lost to Follow-up|1|||
27826774|NCT01685203|54293103|FG004|Overall Study|Lost to Follow-up|0|||
27826775|NCT01685203|54293104|FG005|Overall Study|Lost to Follow-up|0|||
27826776|NCT01685203|54293105|FG006|Overall Study|Lost to Follow-up|0|||
27826777|NCT01685203|54293099|FG000|Overall Study|Adverse Event|0|||
27826778|NCT01685203|54293100|FG001|Overall Study|Adverse Event|0|||
27826779|NCT01685203|54293101|FG002|Overall Study|Adverse Event|0|||
27826780|NCT01685203|54293102|FG003|Overall Study|Adverse Event|0|||
27826781|NCT01685203|54293103|FG004|Overall Study|Adverse Event|0|||
27826782|NCT01685203|54293104|FG005|Overall Study|Adverse Event|2|||
27826783|NCT01685203|54293105|FG006|Overall Study|Adverse Event|0|||
27826784|NCT01685203|54293099|FG000|Overall Study|Adverse event and withdrew consent|1|||
27826785|NCT01685203|54293100|FG001|Overall Study|Adverse event and withdrew consent|0|||
27826786|NCT01685203|54293101|FG002|Overall Study|Adverse event and withdrew consent|0|||
27826787|NCT01685203|54293102|FG003|Overall Study|Adverse event and withdrew consent|0|||
27826788|NCT01685203|54293103|FG004|Overall Study|Adverse event and withdrew consent|0|||
27826789|NCT01685203|54293104|FG005|Overall Study|Adverse event and withdrew consent|0|||
27826790|NCT01685203|54293105|FG006|Overall Study|Adverse event and withdrew consent|0|||
27826791|NCT01685203|54293099|FG000|Overall Study|Patient's decision|0|||
27826792|NCT01685203|54293100|FG001|Overall Study|Patient's decision|0|||
27826793|NCT01685203|54293101|FG002|Overall Study|Patient's decision|0|||
27826794|NCT01685203|54293102|FG003|Overall Study|Patient's decision|0|||
27826795|NCT01685203|54293103|FG004|Overall Study|Patient's decision|0|||
27826796|NCT01685203|54293104|FG005|Overall Study|Patient's decision|1|||
27826797|NCT01685203|54293105|FG006|Overall Study|Patient's decision|0|||
27826798|NCT01928771|54293124|FG000|Overall Study|Adverse Event|6|||
28159716|NCT01963208|54829747|FG002|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
28159717|NCT01963208|54829748|FG003|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|1|||
27826799|NCT01928771|54293125|FG001|Overall Study|Adverse Event|5|||
27826800|NCT01928771|54293126|FG002|Overall Study|Adverse Event|1|||
27826801|NCT01928771|54293124|FG000|Overall Study|Death|2|||
27826802|NCT01928771|54293125|FG001|Overall Study|Death|2|||
27826803|NCT01928771|54293126|FG002|Overall Study|Death|2|||
27826804|NCT01928771|54293124|FG000|Overall Study|Lost to Follow-up|5|||
27826805|NCT01928771|54293125|FG001|Overall Study|Lost to Follow-up|6|||
27826806|NCT01928771|54293126|FG002|Overall Study|Lost to Follow-up|3|||
27826807|NCT01928771|54293124|FG000|Overall Study|Withdrawal by Subject|20|||
27826808|NCT01928771|54293125|FG001|Overall Study|Withdrawal by Subject|15|||
27826809|NCT01928771|54293126|FG002|Overall Study|Withdrawal by Subject|17|||
27826810|NCT01928771|54293124|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
27826811|NCT01928771|54293125|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
27826812|NCT01928771|54293126|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
27826813|NCT01928771|54293124|FG000|Overall Study|Other Reasons|9|||
27826814|NCT01928771|54293125|FG001|Overall Study|Other Reasons|9|||
27826815|NCT01928771|54293126|FG002|Overall Study|Other Reasons|14|||
27826816|NCT01928771|54293124|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
27826817|NCT01928771|54293125|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
27826818|NCT01928771|54293126|FG002|Overall Study|Severe Non-Compliance to Protocol|2|||
27826819|NCT01589653|54293136|FG000|Overall Study|Protocol Violation|3|||
27826820|NCT01589653|54293137|FG001|Overall Study|Protocol Violation|1|||
27826821|NCT01589653|54293136|FG000|Overall Study|Withdrawal criteria|4|||
27826822|NCT01589653|54293137|FG001|Overall Study|Withdrawal criteria|7|||
27826823|NCT01589653|54293136|FG000|Overall Study|Unclassified|0|||
27826824|NCT01589653|54293137|FG001|Overall Study|Unclassified|3|||
27826825|NCT01928615|54293143|FG000|Overall Study|Study Terminated by Sponsor|2|||
27826826|NCT01589497|54293152|FG000|Overall Study|Withdrawal by Subject|0|||
27826827|NCT01589497|54293153|FG001|Overall Study|Withdrawal by Subject|1|||
27826828|NCT01589497|54293154|FG002|Overall Study|Withdrawal by Subject|0|||
27826829|NCT01589497|54293155|FG003|Overall Study|Withdrawal by Subject|1|||
27826830|NCT01589497|54293152|FG000|Overall Study|Death|1|||
27826831|NCT01589497|54293153|FG001|Overall Study|Death|0|||
27826832|NCT01589497|54293154|FG002|Overall Study|Death|0|||
27826833|NCT01589497|54293155|FG003|Overall Study|Death|0|||
27826834|NCT01589497|54293152|FG000|Overall Study|Pre-entry overnight sputum< 10ML|0|||
27826835|NCT01589497|54293153|FG001|Overall Study|Pre-entry overnight sputum< 10ML|0|||
27826836|NCT01589497|54293154|FG002|Overall Study|Pre-entry overnight sputum< 10ML|1|||
27826837|NCT01589497|54293155|FG003|Overall Study|Pre-entry overnight sputum< 10ML|0|||
27826838|NCT01928381|54293170|FG000|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60|||
27826839|NCT01928381|54293171|FG001|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
27826840|NCT01928381|54293172|FG002|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
27826841|NCT01928381|54293173|FG003|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
27826842|NCT01928381|54293174|FG004|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
27826843|NCT01928381|54293175|FG005|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
27826844|NCT01928381|54293176|FG006|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
27826845|NCT01928381|54293170|FG000|Part 1 - Pain Training|Pain training criteria not met|29|||
27826846|NCT01928381|54293171|FG001|Part 1 - Pain Training|Pain training criteria not met|0|||
27826847|NCT01928381|54293172|FG002|Part 1 - Pain Training|Pain training criteria not met|0|||
27826848|NCT01928381|54293173|FG003|Part 1 - Pain Training|Pain training criteria not met|0|||
27826849|NCT01928381|54293174|FG004|Part 1 - Pain Training|Pain training criteria not met|0|||
27826850|NCT01928381|54293175|FG005|Part 1 - Pain Training|Pain training criteria not met|0|||
27826851|NCT01928381|54293176|FG006|Part 1 - Pain Training|Pain training criteria not met|0|||
27826852|NCT01928381|54293170|FG000|Part 1 - Pain Training|Withdrawal by Subject|1|||
27826853|NCT01928381|54293171|FG001|Part 1 - Pain Training|Withdrawal by Subject|0|||
27826854|NCT01928381|54293172|FG002|Part 1 - Pain Training|Withdrawal by Subject|0|||
27826855|NCT01928381|54293173|FG003|Part 1 - Pain Training|Withdrawal by Subject|0|||
27826856|NCT01928381|54293174|FG004|Part 1 - Pain Training|Withdrawal by Subject|0|||
27826857|NCT01928381|54293175|FG005|Part 1 - Pain Training|Withdrawal by Subject|0|||
27826858|NCT01928381|54293176|FG006|Part 1 - Pain Training|Withdrawal by Subject|0|||
27826859|NCT01928381|54293170|FG000|Part 1 - Pain Training|Lost to Follow-up|4|||
27826860|NCT01928381|54293171|FG001|Part 1 - Pain Training|Lost to Follow-up|0|||
27826861|NCT01928381|54293172|FG002|Part 1 - Pain Training|Lost to Follow-up|0|||
27826862|NCT01928381|54293173|FG003|Part 1 - Pain Training|Lost to Follow-up|0|||
27826863|NCT01928381|54293174|FG004|Part 1 - Pain Training|Lost to Follow-up|0|||
27826864|NCT01928381|54293175|FG005|Part 1 - Pain Training|Lost to Follow-up|0|||
27826865|NCT01928381|54293176|FG006|Part 1 - Pain Training|Lost to Follow-up|0|||
27826866|NCT01928381|54293170|FG000|Part 1 - Pain Training|Protocol Violation|1|||
27826867|NCT01928381|54293171|FG001|Part 1 - Pain Training|Protocol Violation|0|||
27826868|NCT01928381|54293172|FG002|Part 1 - Pain Training|Protocol Violation|0|||
27826869|NCT01928381|54293173|FG003|Part 1 - Pain Training|Protocol Violation|0|||
27826870|NCT01928381|54293174|FG004|Part 1 - Pain Training|Protocol Violation|0|||
27826871|NCT01928381|54293175|FG005|Part 1 - Pain Training|Protocol Violation|0|||
27826872|NCT01928381|54293176|FG006|Part 1 - Pain Training|Protocol Violation|0|||
27826873|NCT01928381|54293170|FG000|Placebo run-in & Part 2 Eligibility|Adverse Event|1|||
27943226|NCT01147848|54600167|FG001|Randomized Phase|Physician Decision|0|||
27826874|NCT01928381|54293171|FG001|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
27826875|NCT01928381|54293172|FG002|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
27943227|NCT01147848|54600168|FG002|Randomized Phase|Physician Decision|1|||
27826876|NCT01928381|54293173|FG003|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
27826877|NCT01928381|54293174|FG004|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
27826878|NCT01928381|54293175|FG005|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
27826879|NCT01928381|54293176|FG006|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
27826880|NCT01928381|54293170|FG000|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2|||
28076652|NCT00404651|54731525|FG001|Overall Study|Serious Adverse Event|0|||
28076653|NCT00404651|54731526|FG002|Overall Study|Serious Adverse Event|2|||
28076654|NCT00404651|54731527|FG003|Overall Study|Serious Adverse Event|0|||
28076655|NCT00404651|54731524|FG000|Overall Study|Protocol Violation|10|||
28076656|NCT00404651|54731525|FG001|Overall Study|Protocol Violation|5|||
28076657|NCT00404651|54731526|FG002|Overall Study|Protocol Violation|14|||
28076658|NCT00404651|54731527|FG003|Overall Study|Protocol Violation|5|||
28076659|NCT00404651|54731524|FG000|Overall Study|Lost to Follow-up|15|||
28076660|NCT00404651|54731525|FG001|Overall Study|Lost to Follow-up|11|||
28076661|NCT00404651|54731526|FG002|Overall Study|Lost to Follow-up|13|||
28076662|NCT00404651|54731527|FG003|Overall Study|Lost to Follow-up|10|||
28076663|NCT00404651|54731524|FG000|Overall Study|Withdrawal by Subject|14|||
28076664|NCT00404651|54731525|FG001|Overall Study|Withdrawal by Subject|12|||
28076665|NCT00404651|54731526|FG002|Overall Study|Withdrawal by Subject|16|||
28076666|NCT00404651|54731527|FG003|Overall Study|Withdrawal by Subject|6|||
28076667|NCT00404495|54731539|FG000|Overall Study|Death|37|||
28076668|NCT00404495|54731540|FG001|Overall Study|Death|11|||
28076669|NCT00404495|54731539|FG000|Overall Study|Lost to Follow-up|5|||
28076670|NCT00404495|54731540|FG001|Overall Study|Lost to Follow-up|0|||
28076671|NCT00404495|54731539|FG000|Overall Study|Other|1|||
28076672|NCT00404495|54731540|FG001|Overall Study|Other|0|||
28076673|NCT00404495|54731539|FG000|Overall Study|Withdrawal by Subject|1|||
28076674|NCT00404495|54731540|FG001|Overall Study|Withdrawal by Subject|0|||
28076675|NCT00409409|54731548|FG000|Overall Study|Adverse Event|7|||
28076676|NCT00409409|54731549|FG001|Overall Study|Adverse Event|2|||
28076677|NCT00409409|54731548|FG000|Overall Study|Withdrawal by Subject|1|||
28076678|NCT00409409|54731549|FG001|Overall Study|Withdrawal by Subject|1|||
28076679|NCT00409409|54731548|FG000|Overall Study|Any other reason not above-mentioned|0|||
28076680|NCT00409409|54731549|FG001|Overall Study|Any other reason not above-mentioned|1|||
28076681|NCT00409331|54731555|FG000|Overall Study|Physician Decision|1|||
28076682|NCT00409175|54731561|FG000|Overall Study|Adverse Event|4|||
28076683|NCT00409175|54731562|FG001|Overall Study|Adverse Event|3|||
28076684|NCT00409175|54731561|FG000|Overall Study|Withdrawal by Subject|1|||
28076685|NCT00409175|54731562|FG001|Overall Study|Withdrawal by Subject|2|||
28076686|NCT00409175|54731561|FG000|Overall Study|Negative genotype|0|||
28076687|NCT00409175|54731562|FG001|Overall Study|Negative genotype|1|||
28076688|NCT00409175|54731561|FG000|Overall Study|Liver transplantation|13|||
28076689|NCT00409175|54731562|FG001|Overall Study|Liver transplantation|13|||
28076690|NCT00408629|54731570|FG000|Overall Study|Adverse Event|13|||
28076691|NCT00408629|54731571|FG001|Overall Study|Adverse Event|27|||
28076692|NCT00408629|54731570|FG000|Overall Study|Withdrawal by Subject|8|||
28076693|NCT00408629|54731571|FG001|Overall Study|Withdrawal by Subject|4|||
28076694|NCT00408629|54731570|FG000|Overall Study|Lost to Follow-up|1|||
28076695|NCT00408629|54731571|FG001|Overall Study|Lost to Follow-up|1|||
28076696|NCT00408629|54731570|FG000|Overall Study|Lack of Efficacy|63|||
28076697|NCT00408629|54731571|FG001|Overall Study|Lack of Efficacy|73|||
28076698|NCT00408629|54731570|FG000|Overall Study|Protocol Violation|1|||
28076699|NCT00408629|54731571|FG001|Overall Study|Protocol Violation|5|||
28076700|NCT00408629|54731570|FG000|Overall Study|Miscellaneous|11|||
28076701|NCT00408629|54731571|FG001|Overall Study|Miscellaneous|15|||
28076702|NCT00408317|54731578|FG000|First Intervention Period|Adverse Event|0|||
28076703|NCT00408317|54731579|FG001|First Intervention Period|Adverse Event|1|||
28076704|NCT00408317|54731578|FG000|Second Intervention Period|Adverse Event|2|||
28076705|NCT00408317|54731579|FG001|Second Intervention Period|Adverse Event|0|||
27826881|NCT01928381|54293171|FG001|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
27826882|NCT01928381|54293172|FG002|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
27826883|NCT01928381|54293173|FG003|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
27826884|NCT01928381|54293174|FG004|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
27826885|NCT01928381|54293175|FG005|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
27826886|NCT01928381|54293176|FG006|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
27826887|NCT01928381|54293170|FG000|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1|||
27826888|NCT01928381|54293171|FG001|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
28159718|NCT01963208|54829749|FG004|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
28159719|NCT01963208|54829750|FG005|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
28159720|NCT01963208|54829745|FG000|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
28159721|NCT01963208|54829746|FG001|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
28159722|NCT01963208|54829747|FG002|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
28159723|NCT01963208|54829748|FG003|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|1|||
28159724|NCT01963208|54829749|FG004|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
28159725|NCT01963208|54829750|FG005|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
28159726|NCT01963208|54829745|FG000|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
28159727|NCT01963208|54829746|FG001|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
28159728|NCT01963208|54829747|FG002|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
28159729|NCT01963208|54829748|FG003|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
28159730|NCT01963208|54829749|FG004|Treatment Phase 2 (Up to Week 68)|Adverse Event|16|||
28159731|NCT01963208|54829750|FG005|Treatment Phase 2 (Up to Week 68)|Adverse Event|15|||
28159732|NCT01963208|54829745|FG000|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
28159733|NCT01963208|54829746|FG001|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
28159734|NCT01963208|54829747|FG002|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
28159735|NCT01963208|54829748|FG003|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
28159736|NCT01963208|54829749|FG004|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|7|||
28159737|NCT01963208|54829750|FG005|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|19|||
28159738|NCT01963208|54829745|FG000|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
28159739|NCT01963208|54829746|FG001|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
27826889|NCT01928381|54293172|FG002|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
27826890|NCT01928381|54293173|FG003|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
27826891|NCT01928381|54293174|FG004|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
27826892|NCT01928381|54293175|FG005|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
27826893|NCT01928381|54293176|FG006|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
27826894|NCT01928381|54293170|FG000|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10|||
27826895|NCT01928381|54293171|FG001|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
27826896|NCT01928381|54293172|FG002|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
27826897|NCT01928381|54293173|FG003|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
27826898|NCT01928381|54293174|FG004|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
27826899|NCT01928381|54293175|FG005|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
27826900|NCT01928381|54293176|FG006|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
27826901|NCT01928381|54293170|FG000|Part 2 - First Intervention|Withdrawal by Subject|0|||
27826902|NCT01928381|54293171|FG001|Part 2 - First Intervention|Withdrawal by Subject|0|||
27826903|NCT01928381|54293172|FG002|Part 2 - First Intervention|Withdrawal by Subject|1|||
28076706|NCT00408317|54731578|FG000|Second Intervention Period|Protocol Violation|0|||
28076707|NCT00408317|54731579|FG001|Second Intervention Period|Protocol Violation|1|||
28076708|NCT00408317|54731578|FG000|Second Intervention Period|Withdrawal of consent|0|||
28076709|NCT00408317|54731579|FG001|Second Intervention Period|Withdrawal of consent|1|||
28076710|NCT00112502|54731593|FG000|Overall Study|Withdrawal by Subject|0|||
28076711|NCT00112502|54731594|FG001|Overall Study|Withdrawal by Subject|1|||
28076712|NCT00112502|54731595|FG002|Overall Study|Withdrawal by Subject|1|||
28076713|NCT00112502|54731596|FG003|Overall Study|Withdrawal by Subject|4|||
28076714|NCT00112502|54731597|FG004|Overall Study|Withdrawal by Subject|2|||
28076715|NCT00112502|54731598|FG005|Overall Study|Withdrawal by Subject|5|||
28076716|NCT00112502|54731599|FG006|Overall Study|Withdrawal by Subject|3|||
28076717|NCT00112502|54731600|FG007|Overall Study|Withdrawal by Subject|7|||
28159740|NCT01963208|54829747|FG002|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
28076718|NCT03822182|54731631|FG000|Overall Study|Protocol Violation|0|||
28076719|NCT03822182|54731632|FG001|Overall Study|Protocol Violation|1|||
28076720|NCT03822182|54731633|FG002|Overall Study|Protocol Violation|1|||
28076721|NCT00111800|54731648|FG000|Period 1: Main Phase (12 Weeks)|Adverse Event|5|||
28159741|NCT01963208|54829748|FG003|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
28076722|NCT00111800|54731649|FG001|Period 1: Main Phase (12 Weeks)|Adverse Event|4|||
28076723|NCT00111800|54731650|FG002|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
28076724|NCT00111800|54731651|FG003|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
28076725|NCT00111800|54731652|FG004|Period 1: Main Phase (12 Weeks)|Adverse Event|1|||
27826904|NCT01928381|54293173|FG003|Part 2 - First Intervention|Withdrawal by Subject|0|||
27826905|NCT01928381|54293174|FG004|Part 2 - First Intervention|Withdrawal by Subject|0|||
27826906|NCT01928381|54293175|FG005|Part 2 - First Intervention|Withdrawal by Subject|0|||
27826907|NCT01928381|54293176|FG006|Part 2 - First Intervention|Withdrawal by Subject|0|||
27826908|NCT01928381|54293170|FG000|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
27826909|NCT01928381|54293171|FG001|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
27826910|NCT01928381|54293172|FG002|Part 2 - First Intervention|Study specific withdrawal criteria|1|||
27826911|NCT01928381|54293173|FG003|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
27826912|NCT01928381|54293174|FG004|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
27826913|NCT01928381|54293175|FG005|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
27826914|NCT01928381|54293176|FG006|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
27826915|NCT01928381|54293170|FG000|Part 2 - First Intervention|Eligibility criterion not met|0|||
27826916|NCT01928381|54293171|FG001|Part 2 - First Intervention|Eligibility criterion not met|0|||
27826917|NCT01928381|54293172|FG002|Part 2 - First Intervention|Eligibility criterion not met|0|||
27826918|NCT01928381|54293173|FG003|Part 2 - First Intervention|Eligibility criterion not met|0|||
27826919|NCT01928381|54293174|FG004|Part 2 - First Intervention|Eligibility criterion not met|0|||
27826920|NCT01928381|54293175|FG005|Part 2 - First Intervention|Eligibility criterion not met|1|||
27826921|NCT01928381|54293176|FG006|Part 2 - First Intervention|Eligibility criterion not met|1|||
27826922|NCT01928381|54293170|FG000|Part 2 - First Intervention|Lost to Follow-up|0|||
27826923|NCT01928381|54293171|FG001|Part 2 - First Intervention|Lost to Follow-up|0|||
27826924|NCT01928381|54293172|FG002|Part 2 - First Intervention|Lost to Follow-up|0|||
27826925|NCT01928381|54293173|FG003|Part 2 - First Intervention|Lost to Follow-up|1|||
27826926|NCT01928381|54293174|FG004|Part 2 - First Intervention|Lost to Follow-up|0|||
27826927|NCT01928381|54293175|FG005|Part 2 - First Intervention|Lost to Follow-up|0|||
27826928|NCT01928381|54293176|FG006|Part 2 - First Intervention|Lost to Follow-up|0|||
27826929|NCT01928381|54293170|FG000|Washout First Intervention|Protocol Violation|0|||
27826930|NCT01928381|54293171|FG001|Washout First Intervention|Protocol Violation|0|||
27826931|NCT01928381|54293172|FG002|Washout First Intervention|Protocol Violation|0|||
27826932|NCT01928381|54293173|FG003|Washout First Intervention|Protocol Violation|0|||
27826933|NCT01928381|54293174|FG004|Washout First Intervention|Protocol Violation|1|||
27826934|NCT01928381|54293175|FG005|Washout First Intervention|Protocol Violation|0|||
27826935|NCT01928381|54293176|FG006|Washout First Intervention|Protocol Violation|0|||
27826936|NCT01928381|54293170|FG000|Part 2 - Second Intervention|Lost to Follow-up|0|||
27826937|NCT01928381|54293171|FG001|Part 2 - Second Intervention|Lost to Follow-up|1|||
27826938|NCT01928381|54293172|FG002|Part 2 - Second Intervention|Lost to Follow-up|0|||
27826939|NCT01928381|54293173|FG003|Part 2 - Second Intervention|Lost to Follow-up|1|||
27826940|NCT01928381|54293174|FG004|Part 2 - Second Intervention|Lost to Follow-up|0|||
27826941|NCT01928381|54293175|FG005|Part 2 - Second Intervention|Lost to Follow-up|0|||
27826942|NCT01928381|54293176|FG006|Part 2 - Second Intervention|Lost to Follow-up|0|||
27826943|NCT01928381|54293170|FG000|Part 2 - Post Third Intervention|Protocol Violation|0|||
27826944|NCT01928381|54293171|FG001|Part 2 - Post Third Intervention|Protocol Violation|0|||
27826945|NCT01928381|54293172|FG002|Part 2 - Post Third Intervention|Protocol Violation|1|||
27826946|NCT01928381|54293173|FG003|Part 2 - Post Third Intervention|Protocol Violation|0|||
27826947|NCT01928381|54293174|FG004|Part 2 - Post Third Intervention|Protocol Violation|0|||
27826948|NCT01928381|54293175|FG005|Part 2 - Post Third Intervention|Protocol Violation|0|||
27826949|NCT01928381|54293176|FG006|Part 2 - Post Third Intervention|Protocol Violation|0|||
27826950|NCT01928225|54293188|FG000|Overall Study|Pregnancy|1|||
27826951|NCT01928225|54293189|FG001|Overall Study|Pregnancy|0|||
27826952|NCT01928225|54293188|FG000|Overall Study|basaloid cervical cancer|1|||
27826953|NCT01928225|54293189|FG001|Overall Study|basaloid cervical cancer|0|||
27826954|NCT01928225|54293188|FG000|Overall Study|Lost to Follow-up|1|||
27826955|NCT01928225|54293189|FG001|Overall Study|Lost to Follow-up|3|||
27826956|NCT01927757|54293196|FG000|Overall Study|Withdrawal by Subject|14|||
27826957|NCT01927757|54293196|FG000|Overall Study|Lost to Follow-up|2|||
27826958|NCT01927757|54293196|FG000|Overall Study|Decision by Sponsor|2|||
27826959|NCT01927757|54293196|FG000|Overall Study|Other|1|||
27826960|NCT01927757|54293196|FG000|Overall Study|Ethical Reasons|4|||
27826961|NCT01927367|54293206|FG000|Overall Study|Withdrawal by Subject|7|||
27826962|NCT01927367|54293207|FG001|Overall Study|Withdrawal by Subject|4|||
27826963|NCT01927367|54293206|FG000|Overall Study|No baseline data|0|||
27826964|NCT01927367|54293207|FG001|Overall Study|No baseline data|1|||
27826965|NCT01913639|54293213|FG000|Overall Study|Not Eligible|3|||
28076726|NCT00111800|54731653|FG005|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
28076727|NCT00111800|54731648|FG000|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1|||
28159742|NCT01963208|54829749|FG004|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
28159743|NCT01963208|54829750|FG005|Treatment Phase 2 (Up to Week 68)|Non-Compliance|1|||
27826966|NCT01913483|54293219|FG000|Overall Study|Withdrawal by Subject|1|||
27826967|NCT01913483|54293220|FG001|Overall Study|Withdrawal by Subject|2|||
27826968|NCT01913483|54293219|FG000|Overall Study|Lost to Follow-up|6|||
27826969|NCT01913483|54293220|FG001|Overall Study|Lost to Follow-up|3|||
28160148|NCT02557516|54830247|FG000|Overall Study|Sponsor decision|0|||
27826970|NCT01913483|54293219|FG000|Overall Study|Death|14|||
27826971|NCT01913483|54293220|FG001|Overall Study|Death|17|||
27826972|NCT01913405|54293226|FG000|Overall Study|Withdrawal by Subject|1|||
27826973|NCT01913405|54293226|FG000|Overall Study|Adverse Event|1|||
27826974|NCT01927055|54293246|FG000|Open-label|Adverse Event|6|||
27826975|NCT01927055|54293247|FG001|Open-label|Adverse Event|0|||
27826976|NCT01927055|54293248|FG002|Open-label|Adverse Event|0|||
27826977|NCT01927055|54293246|FG000|Open-label|Withdrawal by Subject|1|||
27826978|NCT01927055|54293247|FG001|Open-label|Withdrawal by Subject|0|||
27826979|NCT01927055|54293248|FG002|Open-label|Withdrawal by Subject|0|||
28076728|NCT00111800|54731649|FG001|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
28076729|NCT00111800|54731650|FG002|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
28159744|NCT01963208|54829745|FG000|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
28159745|NCT01963208|54829746|FG001|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
28076730|NCT00111800|54731651|FG003|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
28076731|NCT00111800|54731652|FG004|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
28076732|NCT00111800|54731653|FG005|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
28076733|NCT00111800|54731648|FG000|Period 1: Main Phase (12 Weeks)|Protocol Violation|0|||
28159746|NCT01963208|54829747|FG002|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
28159747|NCT01963208|54829748|FG003|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
28159748|NCT01963208|54829749|FG004|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
28159749|NCT01963208|54829750|FG005|Treatment Phase 2 (Up to Week 68)|Protocol Violation|1|||
28159750|NCT01963208|54829745|FG000|Treatment Phase 2 (Up to Week 68)|Other|0|||
28159751|NCT01963208|54829746|FG001|Treatment Phase 2 (Up to Week 68)|Other|0|||
28159752|NCT01963208|54829747|FG002|Treatment Phase 2 (Up to Week 68)|Other|0|||
28159753|NCT01963208|54829748|FG003|Treatment Phase 2 (Up to Week 68)|Other|0|||
28076734|NCT00111800|54731649|FG001|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
28076735|NCT00111800|54731650|FG002|Period 1: Main Phase (12 Weeks)|Protocol Violation|4|||
28076736|NCT00111800|54731651|FG003|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
28159754|NCT01963208|54829749|FG004|Treatment Phase 2 (Up to Week 68)|Other|58|||
28159755|NCT01963208|54829750|FG005|Treatment Phase 2 (Up to Week 68)|Other|75|||
28159756|NCT01963208|54829745|FG000|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
28159757|NCT01963208|54829746|FG001|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
28159758|NCT01963208|54829747|FG002|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
28159759|NCT01963208|54829748|FG003|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
28159760|NCT01963208|54829749|FG004|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|20|||
28160149|NCT02557516|54830248|FG001|Overall Study|Sponsor decision|1|||
27826980|NCT01927055|54293246|FG000|Open-label|Study Stopped|4|||
27826981|NCT01927055|54293247|FG001|Open-label|Study Stopped|0|||
27826982|NCT01927055|54293248|FG002|Open-label|Study Stopped|0|||
27826983|NCT01927055|54293246|FG000|Open-label|Supine Hypertension|4|||
27826984|NCT01927055|54293247|FG001|Open-label|Supine Hypertension|0|||
27826985|NCT01927055|54293248|FG002|Open-label|Supine Hypertension|0|||
27826986|NCT01927055|54293246|FG000|Open-label|Difficulty attending study visits|1|||
27826987|NCT01927055|54293247|FG001|Open-label|Difficulty attending study visits|0|||
27826988|NCT01927055|54293248|FG002|Open-label|Difficulty attending study visits|0|||
27826989|NCT01927055|54293246|FG000|Double-Blind|Adverse Event|0|||
27826990|NCT01927055|54293247|FG001|Double-Blind|Adverse Event|1|||
27826991|NCT01927055|54293248|FG002|Double-Blind|Adverse Event|1|||
27826992|NCT01927055|54293246|FG000|Double-Blind|Protocol Violation|0|||
27826993|NCT01927055|54293247|FG001|Double-Blind|Protocol Violation|0|||
27826994|NCT01927055|54293248|FG002|Double-Blind|Protocol Violation|1|||
27826995|NCT01927055|54293246|FG000|Double-Blind|Withdrawal by Subject|0|||
27826996|NCT01927055|54293247|FG001|Double-Blind|Withdrawal by Subject|2|||
27826997|NCT01927055|54293248|FG002|Double-Blind|Withdrawal by Subject|3|||
27826998|NCT01927055|54293246|FG000|Double-Blind|Study Stopped|0|||
27826999|NCT01927055|54293247|FG001|Double-Blind|Study Stopped|7|||
27827000|NCT01927055|54293248|FG002|Double-Blind|Study Stopped|7|||
27827001|NCT01927055|54293246|FG000|Double-Blind|Supine Hypertension|0|||
27827002|NCT01927055|54293247|FG001|Double-Blind|Supine Hypertension|0|||
27827003|NCT01927055|54293248|FG002|Double-Blind|Supine Hypertension|1|||
27827004|NCT01927055|54293246|FG000|Double-Blind|Extended Vacation|0|||
27827005|NCT01927055|54293247|FG001|Double-Blind|Extended Vacation|1|||
27827006|NCT01927055|54293248|FG002|Double-Blind|Extended Vacation|0|||
27827007|NCT01913327|54293257|FG000|Overall Study|Withdrawal by Subject|0|||
27827008|NCT01913327|54293258|FG001|Overall Study|Withdrawal by Subject|1|||
27827009|NCT01926509|54293268|FG000|Overall Study|vital sign met discontinuation criteria|1|||
27827010|NCT01926509|54293269|FG001|Overall Study|vital sign met discontinuation criteria|0|||
27827011|NCT01926509|54293270|FG002|Overall Study|vital sign met discontinuation criteria|0|||
27827012|NCT01926509|54293271|FG003|Overall Study|vital sign met discontinuation criteria|0|||
27827013|NCT01926119|54293281|FG000|Overall Study|Withdrawal by Subject|1|||
27827014|NCT01912781|54293287|FG000|Overall Study|Withdrawal by Subject|2|||
27827015|NCT01912781|54293288|FG001|Overall Study|Withdrawal by Subject|0|||
27827016|NCT01925417|54293295|FG000|Overall Study|Withdrawal by Subject|2|||
27827017|NCT01925417|54293295|FG000|Overall Study|Death|1|||
27827018|NCT01911845|54293300|FG000|Overall Study|Adverse Event|2|||
27827019|NCT01911845|54293300|FG000|Overall Study|Lost to Follow-up|1|||
27827020|NCT01911845|54293300|FG000|Overall Study|Other (not specified)|3|||
27827021|NCT01925183|54293308|FG000|Overall Study|Adverse Event|1|||
27827022|NCT01925183|54293309|FG001|Overall Study|Adverse Event|0|||
27827023|NCT01910519|54293317|FG000|Overall Study|Withdrawal by Subject|2|||
27827024|NCT01910519|54293318|FG001|Overall Study|Withdrawal by Subject|0|||
27827025|NCT01910519|54293317|FG000|Overall Study|Adverse Event|2|||
27827026|NCT01910519|54293318|FG001|Overall Study|Adverse Event|0|||
27827027|NCT01910441|54293326|FG000|Overall Study|Sponsor decision|0|||
27827028|NCT01910441|54293327|FG001|Overall Study|Sponsor decision|2|||
27827029|NCT01910441|54293326|FG000|Overall Study|Lost to Follow-up|6|||
27827030|NCT01910441|54293327|FG001|Overall Study|Lost to Follow-up|5|||
27827031|NCT01910441|54293326|FG000|Overall Study|Withdrawal by Subject|0|||
27827032|NCT01910441|54293327|FG001|Overall Study|Withdrawal by Subject|1|||
27827033|NCT01910441|54293326|FG000|Overall Study|Non-compliance|0|||
27827034|NCT01910441|54293327|FG001|Overall Study|Non-compliance|1|||
27827035|NCT01910441|54293326|FG000|Overall Study|Adverse Event|1|||
27827036|NCT01910441|54293327|FG001|Overall Study|Adverse Event|0|||
27827037|NCT01910441|54293326|FG000|Overall Study|Physician Decision|0|||
27827038|NCT01910441|54293327|FG001|Overall Study|Physician Decision|1|||
27827039|NCT01923467|54293333|FG000|Overall Study|Lost to Follow-up|62|||
27827040|NCT01923467|54293333|FG000|Overall Study|Subject non-interest|479|||
27827041|NCT01910129|54293339|FG000|Randomized Phase 2|Withdrawal by Subject|2|||
27827042|NCT01910129|54293340|FG001|Randomized Phase 2|Withdrawal by Subject|1|||
27827043|NCT01910129|54293341|FG002|Randomized Phase 2|Withdrawal by Subject|0|||
27827044|NCT01910129|54293339|FG000|Randomized Phase 3|Withdrawal by Subject|0|||
27827045|NCT01910129|54293340|FG001|Randomized Phase 3|Withdrawal by Subject|1|||
27827046|NCT01910129|54293341|FG002|Randomized Phase 3|Withdrawal by Subject|0|||
27827047|NCT01909973|54293361|FG000|Overall Study|Lost to Follow-up|1|||
27827048|NCT01909973|54293362|FG001|Overall Study|Lost to Follow-up|0|||
27827049|NCT01617005|54293368|FG000|Overall Study|Pregnancy|1|||
27827050|NCT01617005|54293368|FG000|Overall Study|Lack of motivation for treatment|1|||
27827051|NCT01925339|54293374|FG000|Overall Study|Adverse Event|2|||
27827052|NCT01925339|54293375|FG001|Overall Study|Adverse Event|0|||
27827053|NCT01908803|54293383|FG000|Overall Study|Adverse Event|1|||
27827054|NCT01908803|54293384|FG001|Overall Study|Adverse Event|0|||
27827055|NCT01908803|54293383|FG000|Overall Study|Physician Decision|0|||
27827056|NCT01908803|54293384|FG001|Overall Study|Physician Decision|1|||
27827057|NCT01908803|54293383|FG000|Overall Study|Withdrawal by Subject|1|||
27827058|NCT01908803|54293384|FG001|Overall Study|Withdrawal by Subject|0|||
27827059|NCT01908803|54293383|FG000|Overall Study|Randomization Error|1|||
27827060|NCT01908803|54293384|FG001|Overall Study|Randomization Error|0|||
27827061|NCT01908803|54293383|FG000|Overall Study|Adverse Event (pre-treatment)|1|||
27827062|NCT01908803|54293384|FG001|Overall Study|Adverse Event (pre-treatment)|0|||
27827063|NCT01908101|54293391|FG000|Overall Study|Physician Decision|1|||
27827064|NCT01908101|54293391|FG000|Overall Study|Withdrawal by Subject|1|||
27827065|NCT01908101|54293391|FG000|Overall Study|Incorrect Diagnosis|2|||
27827066|NCT01908101|54293391|FG000|Overall Study|Incorrect Starting Dose|1|||
27827067|NCT01908101|54293391|FG000|Overall Study|Did not complete the first cycle|4|||
27827068|NCT01923389|54293397|FG000|Overall Study|Protocol Violation|1|||
27827069|NCT01923389|54293398|FG001|Overall Study|Protocol Violation|0|||
27827070|NCT01907087|54293405|FG000|Overall Study|Withdrawal by Subject|1|||
27827071|NCT01616771|54293409|FG000|Smaller Sized GVL for 5 Sec|lack of GVL size|4|||
27827072|NCT01589185|54293423|FG000|Overall Study|Death|1|||
27827073|NCT01589185|54293424|FG001|Overall Study|Death|2|||
27827074|NCT01589185|54293425|FG002|Overall Study|Death|2|||
27827075|NCT01589185|54293426|FG003|Overall Study|Death|0|||
27827076|NCT01589185|54293427|FG004|Overall Study|Death|1|||
27827077|NCT01589185|54293423|FG000|Overall Study|Lost to Follow-up|1|||
27827078|NCT01589185|54293424|FG001|Overall Study|Lost to Follow-up|0|||
27827079|NCT01589185|54293425|FG002|Overall Study|Lost to Follow-up|2|||
27827080|NCT01589185|54293426|FG003|Overall Study|Lost to Follow-up|3|||
27827081|NCT01589185|54293427|FG004|Overall Study|Lost to Follow-up|0|||
27827082|NCT01588951|54293443|FG000|Overall Study|Ineligible in retrospect|0|||
27827083|NCT01588951|54293444|FG001|Overall Study|Ineligible in retrospect|0|||
27827084|NCT01588951|54293445|FG002|Overall Study|Ineligible in retrospect|1|||
27827085|NCT01709383|54293455|FG000|Overall Study|Lost to Follow-up|1|||
27827086|NCT01709383|54293456|FG001|Overall Study|Lost to Follow-up|0|||
27827087|NCT01588405|54293464|FG000|Overall Study|Adverse Event|1|||
27827088|NCT01588405|54293464|FG000|Overall Study|Clinical Worsening|1|||
27827089|NCT01923311|54293473|FG000|Overall Study|Pregnancy|1|||
27827090|NCT01923311|54293474|FG001|Overall Study|Pregnancy|0|||
27827091|NCT01923311|54293473|FG000|Overall Study|Investigator's Discretion|1|||
27827092|NCT01923311|54293474|FG001|Overall Study|Investigator's Discretion|0|||
27827093|NCT01923311|54293473|FG000|Overall Study|Non-Compliance with Study Drug|2|||
27827094|NCT01923311|54293474|FG001|Overall Study|Non-Compliance with Study Drug|1|||
27827095|NCT01923311|54293473|FG000|Overall Study|Withdrew Consent|1|||
27827096|NCT01923311|54293474|FG001|Overall Study|Withdrew Consent|0|||
27827097|NCT01923311|54293473|FG000|Overall Study|Study Terminated by Sponsor|12|||
27827098|NCT01923311|54293474|FG001|Overall Study|Study Terminated by Sponsor|0|||
27827099|NCT01603615|54293481|FG000|Overall Study|Did not Receive Treatment|7|||
27827100|NCT01603615|54293481|FG000|Overall Study|Lost to Follow-up|9|||
27827101|NCT01603615|54293481|FG000|Overall Study|Personal Reasons|17|||
27827102|NCT01603615|54293481|FG000|Overall Study|Other Miscellaneous|1|||
27827103|NCT01685047|54293485|FG000|Overall Study|Withdrawal by Subject|20|||
27827104|NCT01685047|54293485|FG000|Overall Study|Death|26|||
27827105|NCT01685047|54293485|FG000|Overall Study|Lost to Follow-up|8|||
27827106|NCT01685047|54293485|FG000|Overall Study|Physician Decision|25|||
27827107|NCT01685047|54293485|FG000|Overall Study|Adverse Event|5|||
27850535|NCT03533751|54349495|FG003|Overall Study|Withdrawal by Subject|9|||
27850536|NCT03533751|54349496|FG004|Overall Study|Withdrawal by Subject|10|||
27943228|NCT01147848|54600166|FG000|Randomized Phase|Withdrawal by Subject|0|||
28076737|NCT00111800|54731652|FG004|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
28076738|NCT00111800|54731653|FG005|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
28076739|NCT00111800|54731648|FG000|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
28076740|NCT00111800|54731649|FG001|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
28076741|NCT00111800|54731650|FG002|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3|||
28076742|NCT00111800|54731651|FG003|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
28076743|NCT00111800|54731652|FG004|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
28076744|NCT00111800|54731653|FG005|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1|||
28076745|NCT00111800|54731648|FG000|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3|||
28076746|NCT00111800|54731649|FG001|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
28076747|NCT00111800|54731650|FG002|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
28076748|NCT00111800|54731651|FG003|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1|||
28076749|NCT00111800|54731652|FG004|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
28076750|NCT00111800|54731653|FG005|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
28159761|NCT01963208|54829750|FG005|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|17|||
27827108|NCT01685047|54293485|FG000|Overall Study|patient withdrawn by sponsor|1|||
28159762|NCT01963208|54829745|FG000|Treatment Phase 2 (Up to Week 68)|Death|0|||
27850537|NCT03533751|54349492|FG000|Overall Study|Adverse Event|4|||
27850538|NCT03533751|54349493|FG001|Overall Study|Adverse Event|7|||
27827109|NCT01905683|54293489|FG000|Overall Study|Protocol Violation|1|||
27827110|NCT01905683|54293489|FG000|Overall Study|Re-injection criteria not met; others|13|||
27827111|NCT01905683|54293489|FG000|Overall Study|Physician Decision|1|||
27827112|NCT01905683|54293489|FG000|Overall Study|Lack of Efficacy|8|||
27827113|NCT01905683|54293489|FG000|Overall Study|Withdrawal by Subject|20|||
27850539|NCT03533751|54349494|FG002|Overall Study|Adverse Event|2|||
27827114|NCT01905683|54293489|FG000|Overall Study|Adverse Event|4|||
27827115|NCT01905683|54293489|FG000|Overall Study|Lost to Follow-up|4|||
27827116|NCT01921829|54293495|FG000|Overall Study|Withdrawal by Subject|0|||
27827117|NCT01921829|54293496|FG001|Overall Study|Withdrawal by Subject|1|||
27827118|NCT01904903|54293502|FG000|Overall Study|Withdrawal by Subject|1|||
27827119|NCT01921517|54293508|FG000|Overall Study|Lost to Follow-up|5|||
27827120|NCT01921517|54293509|FG001|Overall Study|Lost to Follow-up|0|||
27827121|NCT01921517|54293508|FG000|Overall Study|Newly diagnosed health concern|2|||
27827122|NCT01921517|54293509|FG001|Overall Study|Newly diagnosed health concern|0|||
27827123|NCT01921517|54293508|FG000|Overall Study|Physician Decision|0|||
27827124|NCT01921517|54293509|FG001|Overall Study|Physician Decision|2|||
27827125|NCT01921517|54293508|FG000|Overall Study|Withdrawal by Subject|7|||
27827126|NCT01921517|54293509|FG001|Overall Study|Withdrawal by Subject|3|||
27827127|NCT01921517|54293508|FG000|Overall Study|Subject missed final imaging|1|||
27827128|NCT01921517|54293509|FG001|Overall Study|Subject missed final imaging|4|||
27827129|NCT01921205|54293517|FG000|Overall Study|Adverse Event|12|||
27827130|NCT01921205|54293518|FG001|Overall Study|Adverse Event|7|||
27827131|NCT01921205|54293517|FG000|Overall Study|Lack of Efficacy|1|||
27827132|NCT01921205|54293518|FG001|Overall Study|Lack of Efficacy|0|||
27827133|NCT01921205|54293517|FG000|Overall Study|Protocol Violation|1|||
27827134|NCT01921205|54293518|FG001|Overall Study|Protocol Violation|3|||
27827135|NCT01921205|54293517|FG000|Overall Study|Lost to Follow-up|1|||
27827136|NCT01921205|54293518|FG001|Overall Study|Lost to Follow-up|1|||
27827137|NCT01921205|54293517|FG000|Overall Study|Withdrawal by Subject|6|||
27827138|NCT01921205|54293518|FG001|Overall Study|Withdrawal by Subject|5|||
27827139|NCT01921205|54293517|FG000|Overall Study|Use Of Prohibited Medication|0|||
27827140|NCT01921205|54293518|FG001|Overall Study|Use Of Prohibited Medication|1|||
27827141|NCT01921205|54293517|FG000|Overall Study|The Excessive Use Of Rescue Medication|0|||
27827142|NCT01921205|54293518|FG001|Overall Study|The Excessive Use Of Rescue Medication|1|||
27827143|NCT01921205|54293517|FG000|Overall Study|Non Compliance Of The Parent|0|||
27827144|NCT01921205|54293518|FG001|Overall Study|Non Compliance Of The Parent|1|||
27827145|NCT01921205|54293517|FG000|Overall Study|Non Compliance Of Child|0|||
27827146|NCT01921205|54293518|FG001|Overall Study|Non Compliance Of Child|1|||
27827147|NCT01920893|54293526|FG000|Overall Study|Adverse Event|5|||
27827148|NCT01920893|54293527|FG001|Overall Study|Adverse Event|2|||
27827149|NCT01920893|54293526|FG000|Overall Study|Lack of Efficacy|2|||
27827150|NCT01920893|54293527|FG001|Overall Study|Lack of Efficacy|0|||
27827151|NCT01709305|54293534|FG000|Phase 1|Clinical Adverse Event|80|||
27827152|NCT01709305|54293535|FG001|Phase 1|Clinical Adverse Event|0|||
27827153|NCT01709305|54293536|FG002|Phase 1|Clinical Adverse Event|0|||
27827154|NCT01709305|54293537|FG003|Phase 1|Clinical Adverse Event|0|||
27827155|NCT01709305|54293538|FG004|Phase 1|Clinical Adverse Event|0|||
27827156|NCT01709305|54293534|FG000|Phase 1|Death|2|||
27827157|NCT01709305|54293535|FG001|Phase 1|Death|0|||
27827158|NCT01709305|54293536|FG002|Phase 1|Death|0|||
27827159|NCT01709305|54293537|FG003|Phase 1|Death|0|||
27827160|NCT01709305|54293538|FG004|Phase 1|Death|0|||
27827161|NCT01709305|54293534|FG000|Phase 1|Hyperglycemia (lack of efficacy)|13|||
27943229|NCT01147848|54600167|FG001|Randomized Phase|Withdrawal by Subject|7|||
27943230|NCT01147848|54600168|FG002|Randomized Phase|Withdrawal by Subject|9|||
27943231|NCT00929656|54600177|FG000|Overall Study|Lost to Follow-up|0|||
28076751|NCT00111800|54731648|FG000|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
28076752|NCT00111800|54731649|FG001|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
28160150|NCT02557516|54830249|FG002|Overall Study|Sponsor decision|2|||
27827162|NCT01709305|54293535|FG001|Phase 1|Hyperglycemia (lack of efficacy)|0|||
27827163|NCT01709305|54293536|FG002|Phase 1|Hyperglycemia (lack of efficacy)|0|||
27827164|NCT01709305|54293537|FG003|Phase 1|Hyperglycemia (lack of efficacy)|0|||
27827165|NCT01709305|54293538|FG004|Phase 1|Hyperglycemia (lack of efficacy)|0|||
27827166|NCT01709305|54293534|FG000|Phase 1|Laboratory Adverse Event|16|||
27827167|NCT01709305|54293535|FG001|Phase 1|Laboratory Adverse Event|0|||
27827168|NCT01709305|54293536|FG002|Phase 1|Laboratory Adverse Event|0|||
27827169|NCT01709305|54293537|FG003|Phase 1|Laboratory Adverse Event|0|||
27827170|NCT01709305|54293538|FG004|Phase 1|Laboratory Adverse Event|0|||
27827171|NCT01709305|54293534|FG000|Phase 1|Lost to Follow-up|147|||
27827172|NCT01709305|54293535|FG001|Phase 1|Lost to Follow-up|0|||
27827173|NCT01709305|54293536|FG002|Phase 1|Lost to Follow-up|0|||
27827174|NCT01709305|54293537|FG003|Phase 1|Lost to Follow-up|0|||
27827175|NCT01709305|54293538|FG004|Phase 1|Lost to Follow-up|0|||
27827176|NCT01709305|54293534|FG000|Phase 1|Travel, moving, etc.|30|||
27827177|NCT01709305|54293535|FG001|Phase 1|Travel, moving, etc.|0|||
27827178|NCT01709305|54293536|FG002|Phase 1|Travel, moving, etc.|0|||
27827179|NCT01709305|54293537|FG003|Phase 1|Travel, moving, etc.|0|||
27827180|NCT01709305|54293538|FG004|Phase 1|Travel, moving, etc.|0|||
27827181|NCT01709305|54293534|FG000|Phase 1|Physician Decision|13|||
27827182|NCT01709305|54293535|FG001|Phase 1|Physician Decision|0|||
27827183|NCT01709305|54293536|FG002|Phase 1|Physician Decision|0|||
27943232|NCT00929656|54600178|FG001|Overall Study|Lost to Follow-up|1|||
27943233|NCT00977613|54600184|FG000|Overall Study|Lost to Follow-up|16|||
27827184|NCT01709305|54293537|FG003|Phase 1|Physician Decision|0|||
27827185|NCT01709305|54293538|FG004|Phase 1|Physician Decision|0|||
27827186|NCT01709305|54293534|FG000|Phase 1|Protocol Violation|118|||
27827187|NCT01709305|54293535|FG001|Phase 1|Protocol Violation|0|||
27827188|NCT01709305|54293536|FG002|Phase 1|Protocol Violation|0|||
27827189|NCT01709305|54293537|FG003|Phase 1|Protocol Violation|0|||
27827190|NCT01709305|54293538|FG004|Phase 1|Protocol Violation|0|||
27827191|NCT01709305|54293534|FG000|Phase 1|Withdrawal by Subject|218|||
27827192|NCT01709305|54293535|FG001|Phase 1|Withdrawal by Subject|0|||
27827193|NCT01709305|54293536|FG002|Phase 1|Withdrawal by Subject|0|||
27827194|NCT01709305|54293537|FG003|Phase 1|Withdrawal by Subject|0|||
27827195|NCT01709305|54293538|FG004|Phase 1|Withdrawal by Subject|0|||
27827196|NCT01709305|54293534|FG000|Phase 2|Clinical Adverse Event|0|||
27827197|NCT01709305|54293535|FG001|Phase 2|Clinical Adverse Event|10|||
27827198|NCT01709305|54293536|FG002|Phase 2|Clinical Adverse Event|10|||
27827199|NCT01709305|54293537|FG003|Phase 2|Clinical Adverse Event|6|||
27827200|NCT01709305|54293538|FG004|Phase 2|Clinical Adverse Event|11|||
27827201|NCT01709305|54293534|FG000|Phase 2|Death|0|||
27827202|NCT01709305|54293535|FG001|Phase 2|Death|0|||
27827203|NCT01709305|54293536|FG002|Phase 2|Death|1|||
27827204|NCT01709305|54293537|FG003|Phase 2|Death|0|||
27827205|NCT01709305|54293538|FG004|Phase 2|Death|0|||
27827206|NCT01709305|54293534|FG000|Phase 2|Hyperglycemia (lack of efficacy)|0|||
27827207|NCT01709305|54293535|FG001|Phase 2|Hyperglycemia (lack of efficacy)|0|||
27827208|NCT01709305|54293536|FG002|Phase 2|Hyperglycemia (lack of efficacy)|0|||
27827209|NCT01709305|54293537|FG003|Phase 2|Hyperglycemia (lack of efficacy)|0|||
27827210|NCT01709305|54293538|FG004|Phase 2|Hyperglycemia (lack of efficacy)|2|||
27827211|NCT01709305|54293534|FG000|Phase 2|Laboratory Adverse Event|0|||
27827212|NCT01709305|54293535|FG001|Phase 2|Laboratory Adverse Event|1|||
27827213|NCT01709305|54293536|FG002|Phase 2|Laboratory Adverse Event|0|||
27827214|NCT01709305|54293537|FG003|Phase 2|Laboratory Adverse Event|1|||
27827215|NCT01709305|54293538|FG004|Phase 2|Laboratory Adverse Event|1|||
27827216|NCT01709305|54293534|FG000|Phase 2|Lost to Follow-up|0|||
27827217|NCT01709305|54293535|FG001|Phase 2|Lost to Follow-up|10|||
27827218|NCT01709305|54293536|FG002|Phase 2|Lost to Follow-up|6|||
27827219|NCT01709305|54293537|FG003|Phase 2|Lost to Follow-up|9|||
27827220|NCT01709305|54293538|FG004|Phase 2|Lost to Follow-up|5|||
27827221|NCT01709305|54293534|FG000|Phase 2|Travel, moving, etc.|0|||
27827222|NCT01709305|54293535|FG001|Phase 2|Travel, moving, etc.|2|||
27827223|NCT01709305|54293536|FG002|Phase 2|Travel, moving, etc.|3|||
27827224|NCT01709305|54293537|FG003|Phase 2|Travel, moving, etc.|3|||
27827225|NCT01709305|54293538|FG004|Phase 2|Travel, moving, etc.|5|||
27827226|NCT01709305|54293534|FG000|Phase 2|Physician Decision|0|||
27827227|NCT01709305|54293535|FG001|Phase 2|Physician Decision|2|||
27827228|NCT01709305|54293536|FG002|Phase 2|Physician Decision|0|||
27827229|NCT01709305|54293537|FG003|Phase 2|Physician Decision|1|||
27827230|NCT01709305|54293538|FG004|Phase 2|Physician Decision|2|||
27827231|NCT01709305|54293534|FG000|Phase 2|Protocol Violation|0|||
27827232|NCT01709305|54293535|FG001|Phase 2|Protocol Violation|19|||
27827233|NCT01709305|54293536|FG002|Phase 2|Protocol Violation|19|||
27827234|NCT01709305|54293537|FG003|Phase 2|Protocol Violation|13|||
27827235|NCT01709305|54293538|FG004|Phase 2|Protocol Violation|9|||
27827236|NCT01709305|54293534|FG000|Phase 2|Withdrawal by Subject|0|||
27827237|NCT01709305|54293535|FG001|Phase 2|Withdrawal by Subject|8|||
27827238|NCT01709305|54293536|FG002|Phase 2|Withdrawal by Subject|6|||
27827239|NCT01709305|54293537|FG003|Phase 2|Withdrawal by Subject|15|||
27827240|NCT01709305|54293538|FG004|Phase 2|Withdrawal by Subject|12|||
27827241|NCT01684423|54293558|FG000|Overall Study|Withdrawal by Subject|0|||
27827242|NCT01684423|54293559|FG001|Overall Study|Withdrawal by Subject|0|||
27827243|NCT01684423|54293560|FG002|Overall Study|Withdrawal by Subject|1|||
27827244|NCT01684423|54293561|FG003|Overall Study|Withdrawal by Subject|0|||
27827245|NCT01684423|54293562|FG004|Overall Study|Withdrawal by Subject|0|||
27827246|NCT01709227|54293578|FG000|Overall Study|Physician Decision|1|||
27827247|NCT01709227|54293579|FG001|Overall Study|Physician Decision|0|||
27827248|NCT01709227|54293578|FG000|Overall Study|Pleural Peritoneal communication|0|||
27827249|NCT01709227|54293579|FG001|Overall Study|Pleural Peritoneal communication|9|||
27827250|NCT01684033|54293586|FG000|Period 1, First 30 Days|Adverse Event|1|||
27827251|NCT01684033|54293587|FG001|Period 1, First 30 Days|Adverse Event|1|||
27827252|NCT01684033|54293586|FG000|Period 1, First 30 Days|Noncompliance|1|||
27827253|NCT01684033|54293587|FG001|Period 1, First 30 Days|Noncompliance|0|||
27827254|NCT01684033|54293586|FG000|Period 1, First 30 Days|Withdrawal by Subject|1|||
27827255|NCT01684033|54293587|FG001|Period 1, First 30 Days|Withdrawal by Subject|0|||
27827256|NCT01684033|54293586|FG000|Period 1, First 30 Days|Lost to Follow-up|1|||
27827257|NCT01684033|54293587|FG001|Period 1, First 30 Days|Lost to Follow-up|0|||
27827258|NCT01684033|54293586|FG000|Period 2, Second 30 Days|Adverse Event|1|||
27827259|NCT01684033|54293587|FG001|Period 2, Second 30 Days|Adverse Event|0|||
27827260|NCT01903811|54293628|FG000|Overall Study|No measurable disease|1|||
27827261|NCT01903811|54293629|FG001|Overall Study|No measurable disease|1|||
27827262|NCT01903811|54293628|FG000|Overall Study|Incomplete/discontinued prior therapy|1|||
27827263|NCT01903811|54293629|FG001|Overall Study|Incomplete/discontinued prior therapy|1|||
27850540|NCT03533751|54349495|FG003|Overall Study|Adverse Event|4|||
27827264|NCT01903811|54293628|FG000|Overall Study|Baseline lab missing/incomplete/untimely|6|||
27827265|NCT01903811|54293629|FG001|Overall Study|Baseline lab missing/incomplete/untimely|11|||
27827266|NCT01903811|54293628|FG000|Overall Study|Withdrawal by Subject|0|||
27827267|NCT01903811|54293629|FG001|Overall Study|Withdrawal by Subject|1|||
27827268|NCT01709149|54293646|FG000|Open-label Lead-in Phase|Adverse Event|109|||
27827269|NCT01709149|54293647|FG001|Open-label Lead-in Phase|Adverse Event|0|||
27827270|NCT01709149|54293648|FG002|Open-label Lead-in Phase|Adverse Event|0|||
27827271|NCT01709149|54293646|FG000|Open-label Lead-in Phase|Withdrawal by Subject|2|||
27827272|NCT01709149|54293647|FG001|Open-label Lead-in Phase|Withdrawal by Subject|0|||
27827273|NCT01709149|54293648|FG002|Open-label Lead-in Phase|Withdrawal by Subject|0|||
27827274|NCT01709149|54293646|FG000|Open-label Lead-in Phase|Death|1|||
27827275|NCT01709149|54293647|FG001|Open-label Lead-in Phase|Death|0|||
27827276|NCT01709149|54293648|FG002|Open-label Lead-in Phase|Death|0|||
27827277|NCT01709149|54293646|FG000|Open-label Lead-in Phase|Protocol Violation|3|||
27827278|NCT01709149|54293647|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
27827279|NCT01709149|54293648|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
27827280|NCT01709149|54293646|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
27827281|NCT01709149|54293647|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|12|||
27827282|NCT01709149|54293648|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|78|||
27827283|NCT01709149|54293646|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
27827284|NCT01709149|54293647|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7|||
27827285|NCT01709149|54293648|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12|||
27827286|NCT01709149|54293646|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
27827287|NCT01709149|54293647|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|2|||
27827288|NCT01709149|54293648|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|5|||
27827289|NCT01709149|54293646|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
27827290|NCT01709149|54293647|FG001|Double-blind, Placebo-controlled Phase|Death|2|||
27827291|NCT01709149|54293648|FG002|Double-blind, Placebo-controlled Phase|Death|0|||
27827292|NCT01709149|54293646|FG000|Double-blind, Placebo-controlled Phase|not defined|0|||
27827293|NCT01709149|54293647|FG001|Double-blind, Placebo-controlled Phase|not defined|1|||
27827294|NCT01709149|54293648|FG002|Double-blind, Placebo-controlled Phase|not defined|2|||
27827295|NCT01709149|54293646|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
27827296|NCT01709149|54293647|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
27827297|NCT01709149|54293648|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
27827298|NCT01568593|54293657|FG000|Overall Study|Lack of Efficacy|4|||
27827299|NCT01568593|54293658|FG001|Overall Study|Lack of Efficacy|1|||
27827300|NCT01568593|54293657|FG000|Overall Study|Adverse Event|3|||
27827301|NCT01568593|54293658|FG001|Overall Study|Adverse Event|2|||
27827302|NCT01683565|54293666|FG000|Overall Study|Lost to Follow-up|2|||
27827303|NCT01683565|54293667|FG001|Overall Study|Lost to Follow-up|0|||
27827304|NCT01683565|54293666|FG000|Overall Study|Discontinued Intervention|1|||
27827305|NCT01683565|54293667|FG001|Overall Study|Discontinued Intervention|1|||
27827306|NCT01903031|54293691|FG000|Overall Study|Not Able to Attend Clinic|1|||
27827307|NCT01903031|54293692|FG001|Overall Study|Not Able to Attend Clinic|1|||
27827308|NCT01903031|54293693|FG002|Overall Study|Not Able to Attend Clinic|0|||
27827309|NCT01903031|54293691|FG000|Overall Study|Missed Day 21 Primary Endpoint Visit|1|||
27827310|NCT01903031|54293692|FG001|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
27827311|NCT01903031|54293693|FG002|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
27827312|NCT01903031|54293691|FG000|Overall Study|Adverse Event|0|||
27827313|NCT01903031|54293692|FG001|Overall Study|Adverse Event|1|||
27827314|NCT01903031|54293693|FG002|Overall Study|Adverse Event|0|||
27827315|NCT01903031|54293691|FG000|Overall Study|Withdrawal by Subject|0|||
27827316|NCT01903031|54293692|FG001|Overall Study|Withdrawal by Subject|1|||
27827317|NCT01903031|54293693|FG002|Overall Study|Withdrawal by Subject|1|||
27827318|NCT01903031|54293691|FG000|Overall Study|Protocol Violation|0|||
27827319|NCT01903031|54293692|FG001|Overall Study|Protocol Violation|0|||
27827320|NCT01903031|54293693|FG002|Overall Study|Protocol Violation|2|||
27827321|NCT01903031|54293691|FG000|Overall Study|Lost to Follow-up|0|||
27827322|NCT01903031|54293692|FG001|Overall Study|Lost to Follow-up|0|||
27827323|NCT01903031|54293693|FG002|Overall Study|Lost to Follow-up|1|||
27827324|NCT01903031|54293691|FG000|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
27827325|NCT01903031|54293692|FG001|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
27827326|NCT01903031|54293693|FG002|Overall Study|NuvaRing removed prior to Day 21 visit|1|||
27827327|NCT01616693|54293725|FG000|Evaluated for Safety|Physician Decision|1|||
27827328|NCT01616693|54293726|FG001|Evaluated for Safety|Physician Decision|0|||
27827329|NCT01616693|54293727|FG002|Evaluated for Safety|Physician Decision|1|||
27827330|NCT01616693|54293728|FG003|Evaluated for Safety|Physician Decision|0|||
27827331|NCT01616693|54293725|FG000|Received Both Vaccines|Adverse Event|2|||
27827332|NCT01616693|54293726|FG001|Received Both Vaccines|Adverse Event|0|||
27827333|NCT01616693|54293727|FG002|Received Both Vaccines|Adverse Event|0|||
27827334|NCT01616693|54293728|FG003|Received Both Vaccines|Adverse Event|0|||
27827335|NCT01616693|54293725|FG000|Received Both Vaccines|Withdrawal by Subject|7|||
27827336|NCT01616693|54293726|FG001|Received Both Vaccines|Withdrawal by Subject|7|||
27827337|NCT01616693|54293727|FG002|Received Both Vaccines|Withdrawal by Subject|8|||
27827338|NCT01616693|54293728|FG003|Received Both Vaccines|Withdrawal by Subject|15|||
27827339|NCT01616693|54293725|FG000|Received Both Vaccines|Lost to Follow-up|4|||
27827340|NCT01616693|54293726|FG001|Received Both Vaccines|Lost to Follow-up|3|||
27827341|NCT01616693|54293727|FG002|Received Both Vaccines|Lost to Follow-up|4|||
27827342|NCT01616693|54293728|FG003|Received Both Vaccines|Lost to Follow-up|4|||
27827343|NCT01616693|54293725|FG000|Blood Analyzed for Immunogenicity|Protocol Violation|4|||
27827344|NCT01616693|54293726|FG001|Blood Analyzed for Immunogenicity|Protocol Violation|2|||
27827345|NCT01616693|54293727|FG002|Blood Analyzed for Immunogenicity|Protocol Violation|6|||
27827346|NCT01616693|54293728|FG003|Blood Analyzed for Immunogenicity|Protocol Violation|1|||
27827347|NCT01616459|54293835|FG000|Overall Study|Adverse Event|1|||
27827348|NCT01616459|54293836|FG001|Overall Study|Adverse Event|1|||
27827349|NCT01616459|54293837|FG002|Overall Study|Adverse Event|2|||
27827350|NCT01616459|54293838|FG003|Overall Study|Adverse Event|0|||
27827351|NCT01616459|54293835|FG000|Overall Study|Lost to Follow-up|1|||
27827352|NCT01616459|54293836|FG001|Overall Study|Lost to Follow-up|11|||
27827353|NCT01616459|54293837|FG002|Overall Study|Lost to Follow-up|3|||
27827354|NCT01616459|54293838|FG003|Overall Study|Lost to Follow-up|2|||
27827355|NCT01616459|54293835|FG000|Overall Study|Protocol Violation|0|||
27827356|NCT01616459|54293836|FG001|Overall Study|Protocol Violation|0|||
27827357|NCT01616459|54293837|FG002|Overall Study|Protocol Violation|0|||
27827358|NCT01616459|54293838|FG003|Overall Study|Protocol Violation|2|||
27827359|NCT01616459|54293835|FG000|Overall Study|Withdrawal by Subject|2|||
27827360|NCT01616459|54293836|FG001|Overall Study|Withdrawal by Subject|4|||
27827361|NCT01616459|54293837|FG002|Overall Study|Withdrawal by Subject|4|||
27827362|NCT01616459|54293838|FG003|Overall Study|Withdrawal by Subject|4|||
27827363|NCT01616459|54293835|FG000|Overall Study|Other reason|0|||
27827364|NCT01616459|54293836|FG001|Overall Study|Other reason|1|||
27827365|NCT01616459|54293837|FG002|Overall Study|Other reason|1|||
27827366|NCT01616459|54293838|FG003|Overall Study|Other reason|0|||
27827367|NCT01919801|54293855|FG000|Overall Study|Withdrawal by Subject|1|||
27827368|NCT01919801|54293856|FG001|Overall Study|Withdrawal by Subject|0|||
27827369|NCT01919801|54293855|FG000|Overall Study|Physician Decision|0|||
27827370|NCT01919801|54293856|FG001|Overall Study|Physician Decision|1|||
27827371|NCT01919801|54293855|FG000|Overall Study|Lost to Follow-up|0|||
27827372|NCT01919801|54293856|FG001|Overall Study|Lost to Follow-up|1|||
27827373|NCT01919801|54293855|FG000|Overall Study|Other|0|||
27827374|NCT01919801|54293856|FG001|Overall Study|Other|1|||
27827375|NCT01919723|54293864|FG000|Overall Study|Blood Samples Hemolyzed|2|||
27827376|NCT01919723|54293865|FG001|Overall Study|Blood Samples Hemolyzed|2|||
27827377|NCT01919489|54293873|FG000|Overall Study|Rejected the need of injections|4|||
27827378|NCT01919489|54293874|FG001|Overall Study|Rejected the need of injections|7|||
27827379|NCT01919489|54293873|FG000|Overall Study|Adverse Event|10|||
27827380|NCT01919489|54293874|FG001|Overall Study|Adverse Event|0|||
27827381|NCT01919489|54293873|FG000|Overall Study|Hospital readmission|2|||
27827382|NCT01919489|54293874|FG001|Overall Study|Hospital readmission|9|||
27827383|NCT01919489|54293873|FG000|Overall Study|Death|2|||
27827384|NCT01919489|54293874|FG001|Overall Study|Death|1|||
27827385|NCT01919489|54293873|FG000|Overall Study|Lost to Follow-up|38|||
27827386|NCT01919489|54293874|FG001|Overall Study|Lost to Follow-up|27|||
27827387|NCT01919411|54293882|FG000|Overall Study|Lost to Follow-up|2|||
27827388|NCT01919411|54293883|FG001|Overall Study|Lost to Follow-up|4|||
28159763|NCT01963208|54829746|FG001|Treatment Phase 2 (Up to Week 68)|Death|0|||
28159764|NCT01963208|54829747|FG002|Treatment Phase 2 (Up to Week 68)|Death|0|||
27827389|NCT01919411|54293882|FG000|Overall Study|Physician Decision|1|||
27827390|NCT01919411|54293883|FG001|Overall Study|Physician Decision|0|||
27827391|NCT01919411|54293882|FG000|Overall Study|Protocol Violation|2|||
27943234|NCT01152996|54600188|FG000|Overall Study|Withdrawal by Subject|142|||
27943235|NCT01152996|54600188|FG000|Overall Study|Adverse Event|115|||
27943236|NCT01152996|54600188|FG000|Overall Study|Lost to Follow-up|112|||
27827392|NCT01919411|54293883|FG001|Overall Study|Protocol Violation|1|||
27827393|NCT01901393|54293891|FG000|Overall Study|Adverse Event|1|||
27827394|NCT01901393|54293892|FG001|Overall Study|Adverse Event|0|||
27943237|NCT01152996|54600188|FG000|Overall Study|Lack of Efficacy|68|||
27943238|NCT01152996|54600188|FG000|Overall Study|Noncompliance|41|||
27827395|NCT01890707|54293900|FG000|Overall Study|Lost to Follow-up|1|||
27827396|NCT01890707|54293901|FG001|Overall Study|Lost to Follow-up|1|||
27827397|NCT01900691|54293907|FG000|Overall Study|Death|7|||
27827398|NCT01900691|54293907|FG000|Overall Study|Lost to Follow-up|4|||
27827399|NCT01900691|54293907|FG000|Overall Study|Study Device Not Placed|3|||
27827400|NCT01900691|54293907|FG000|Overall Study|Non study stent placed|2|||
27827401|NCT01900691|54293907|FG000|Overall Study|Six month Follow up completed, stent not removed|2|||
27827402|NCT01900691|54293907|FG000|Overall Study|Complete stent migration through digestive tract|1|||
27827403|NCT01890473|54293914|FG000|Overall Study|Lost to Follow-up|1|||
27827404|NCT01890473|54293915|FG001|Overall Study|Lost to Follow-up|0|||
27827405|NCT01890473|54293914|FG000|Overall Study|Poor/non-compliance|1|||
27943239|NCT01152996|54600188|FG000|Overall Study|Other|36|||
27827406|NCT01890473|54293915|FG001|Overall Study|Poor/non-compliance|0|||
27827407|NCT01889069|54293925|FG000|Overall Study|Death|18|||
27827408|NCT01889069|54293925|FG000|Overall Study|Progression of Disease|14|||
27827409|NCT01889069|54293925|FG000|Overall Study|Lost to Follow-up|6|||
27827410|NCT01889069|54293925|FG000|Overall Study|Other|4|||
27827411|NCT01889069|54293925|FG000|Overall Study|Consent Withdrawal|3|||
27827412|NCT02533180|54293937|FG000|Overall Study|Death|0|||
27827413|NCT02533180|54293938|FG001|Overall Study|Death|1|||
27827414|NCT02533180|54293937|FG000|Overall Study|Lost to Follow-up|0|||
27827415|NCT02533180|54293938|FG001|Overall Study|Lost to Follow-up|1|||
27827416|NCT02533180|54293937|FG000|Overall Study|Physician Decision|0|||
27827417|NCT02533180|54293938|FG001|Overall Study|Physician Decision|1|||
27827418|NCT02533180|54293937|FG000|Overall Study|Withdrawal by Subject|2|||
27827419|NCT02533180|54293938|FG001|Overall Study|Withdrawal by Subject|4|||
27827420|NCT02533180|54293937|FG000|Overall Study|Screen Failure|37|||
27827421|NCT02533180|54293938|FG001|Overall Study|Screen Failure|0|||
27827422|NCT02533180|54293937|FG000|Overall Study|Protocol Deviation|0|||
27827423|NCT02533180|54293938|FG001|Overall Study|Protocol Deviation|1|||
27827424|NCT02533180|54293937|FG000|Overall Study|On Study|0|||
27827425|NCT02533180|54293938|FG001|Overall Study|On Study|39|||
27827426|NCT01739348|54293969|FG000|Part I (Base Study)|Adverse Event|41|||
27827427|NCT01739348|54293970|FG001|Part I (Base Study)|Adverse Event|52|||
27827428|NCT01739348|54293971|FG002|Part I (Base Study)|Adverse Event|8|||
27827429|NCT01739348|54293972|FG003|Part I (Base Study)|Adverse Event|33|||
27827430|NCT01739348|54293969|FG000|Part I (Base Study)|Death|10|||
27827431|NCT01739348|54293970|FG001|Part I (Base Study)|Death|7|||
27827432|NCT01739348|54293971|FG002|Part I (Base Study)|Death|2|||
27827433|NCT01739348|54293972|FG003|Part I (Base Study)|Death|8|||
27827434|NCT01739348|54293969|FG000|Part I (Base Study)|Lack of Efficacy|3|||
27827435|NCT01739348|54293970|FG001|Part I (Base Study)|Lack of Efficacy|8|||
27827436|NCT01739348|54293971|FG002|Part I (Base Study)|Lack of Efficacy|0|||
27827437|NCT01739348|54293972|FG003|Part I (Base Study)|Lack of Efficacy|7|||
27850541|NCT03533751|54349496|FG004|Overall Study|Adverse Event|5|||
27850542|NCT03533751|54349492|FG000|Overall Study|Physician Decision|0|||
27850543|NCT03533751|54349493|FG001|Overall Study|Physician Decision|2|||
27850544|NCT03533751|54349494|FG002|Overall Study|Physician Decision|1|||
27850545|NCT03533751|54349495|FG003|Overall Study|Physician Decision|2|||
27850546|NCT03533751|54349496|FG004|Overall Study|Physician Decision|1|||
27850547|NCT03533751|54349492|FG000|Overall Study|Sponsor Decision|0|||
27850548|NCT03533751|54349493|FG001|Overall Study|Sponsor Decision|0|||
27850549|NCT03533751|54349494|FG002|Overall Study|Sponsor Decision|1|||
27850550|NCT03533751|54349495|FG003|Overall Study|Sponsor Decision|1|||
27850551|NCT03533751|54349496|FG004|Overall Study|Sponsor Decision|0|||
27850552|NCT03533751|54349492|FG000|Overall Study|Lost to Follow-up|3|||
27850553|NCT03533751|54349493|FG001|Overall Study|Lost to Follow-up|7|||
27850554|NCT03533751|54349494|FG002|Overall Study|Lost to Follow-up|6|||
27850555|NCT03533751|54349495|FG003|Overall Study|Lost to Follow-up|4|||
27850556|NCT03533751|54349496|FG004|Overall Study|Lost to Follow-up|3|||
27850557|NCT03533751|54349492|FG000|Overall Study|Use of any excluded/prohibited medications|0|||
28076753|NCT00111800|54731650|FG002|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
28076754|NCT00111800|54731651|FG003|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
28076755|NCT00111800|54731652|FG004|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
27827438|NCT01739348|54293969|FG000|Part I (Base Study)|Lost to Follow-up|4|||
27827439|NCT01739348|54293970|FG001|Part I (Base Study)|Lost to Follow-up|2|||
27827440|NCT01739348|54293971|FG002|Part I (Base Study)|Lost to Follow-up|4|||
27827441|NCT01739348|54293972|FG003|Part I (Base Study)|Lost to Follow-up|4|||
27827442|NCT01739348|54293969|FG000|Part I (Base Study)|Non-Compliance with Study Drug|3|||
27827443|NCT01739348|54293970|FG001|Part I (Base Study)|Non-Compliance with Study Drug|2|||
27827444|NCT01739348|54293971|FG002|Part I (Base Study)|Non-Compliance with Study Drug|0|||
27827445|NCT01739348|54293972|FG003|Part I (Base Study)|Non-Compliance with Study Drug|0|||
27827446|NCT01739348|54293969|FG000|Part I (Base Study)|Physician Decision|10|||
27827447|NCT01739348|54293970|FG001|Part I (Base Study)|Physician Decision|7|||
27827448|NCT01739348|54293971|FG002|Part I (Base Study)|Physician Decision|1|||
27827449|NCT01739348|54293972|FG003|Part I (Base Study)|Physician Decision|4|||
27827450|NCT01739348|54293969|FG000|Part I (Base Study)|Protocol Violation|2|||
27827451|NCT01739348|54293970|FG001|Part I (Base Study)|Protocol Violation|0|||
27850558|NCT03533751|54349493|FG001|Overall Study|Use of any excluded/prohibited medications|1|||
27827452|NCT01739348|54293971|FG002|Part I (Base Study)|Protocol Violation|1|||
27827453|NCT01739348|54293972|FG003|Part I (Base Study)|Protocol Violation|2|||
27827454|NCT01739348|54293969|FG000|Part I (Base Study)|Screen Failure|2|||
27827455|NCT01739348|54293970|FG001|Part I (Base Study)|Screen Failure|0|||
27827456|NCT01739348|54293971|FG002|Part I (Base Study)|Screen Failure|0|||
27827457|NCT01739348|54293972|FG003|Part I (Base Study)|Screen Failure|0|||
27827458|NCT01739348|54293969|FG000|Part I (Base Study)|Site Discontinued Study Participation|1|||
27850559|NCT03533751|54349494|FG002|Overall Study|Use of any excluded/prohibited medications|0|||
27850560|NCT03533751|54349495|FG003|Overall Study|Use of any excluded/prohibited medications|0|||
27850561|NCT03533751|54349496|FG004|Overall Study|Use of any excluded/prohibited medications|1|||
27850562|NCT03533751|54349492|FG000|Overall Study|Other|0|||
27850563|NCT03533751|54349493|FG001|Overall Study|Other|2|||
27850564|NCT03533751|54349494|FG002|Overall Study|Other|1|||
27850565|NCT03533751|54349495|FG003|Overall Study|Other|0|||
27850566|NCT03533751|54349496|FG004|Overall Study|Other|3|||
27850567|NCT04856917|54349515|FG000|Overall Study|Withdrawal by Subject|4|||
27850568|NCT04856917|54349516|FG001|Overall Study|Withdrawal by Subject|3|||
27850569|NCT04856917|54349517|FG002|Overall Study|Withdrawal by Subject|1|||
27850570|NCT04856917|54349515|FG000|Overall Study|Lost to Follow-up|3|||
27850571|NCT04856917|54349516|FG001|Overall Study|Lost to Follow-up|1|||
27850572|NCT04856917|54349517|FG002|Overall Study|Lost to Follow-up|1|||
27850573|NCT04856917|54349515|FG000|Overall Study|Used of Prohibited Medication or Treatment|0|||
27850574|NCT04856917|54349516|FG001|Overall Study|Used of Prohibited Medication or Treatment|1|||
27850575|NCT04856917|54349517|FG002|Overall Study|Used of Prohibited Medication or Treatment|2|||
27850576|NCT04856917|54349515|FG000|Overall Study|Other|1|||
27850577|NCT04856917|54349516|FG001|Overall Study|Other|1|||
27850578|NCT04856917|54349517|FG002|Overall Study|Other|0|||
27850579|NCT04615247|54349555|FG000|Overall Study|Adverse Event|0|||
27850580|NCT04615247|54349556|FG001|Overall Study|Adverse Event|2|||
27850581|NCT04615247|54349555|FG000|Overall Study|Withdrawal by Subject|1|||
27850582|NCT04615247|54349556|FG001|Overall Study|Withdrawal by Subject|1|||
27850583|NCT04552132|54349577|FG000|Overall Study|Lost to Follow-up|4|||
27850584|NCT04552132|54349578|FG001|Overall Study|Lost to Follow-up|3|||
27850585|NCT04552132|54349577|FG000|Overall Study|Protocol Violation|1|||
27850586|NCT04552132|54349578|FG001|Overall Study|Protocol Violation|0|||
27850587|NCT04421456|54349587|FG000|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
27850588|NCT04421456|54349588|FG001|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
27850589|NCT04421456|54349589|FG002|Randomized Placebo Run-in Period|Placebo Run-in Failures|18|||
27850590|NCT04421456|54349587|FG000|Randomized Treatment Period|Adverse Event|0|||
27827459|NCT01739348|54293970|FG001|Part I (Base Study)|Site Discontinued Study Participation|3|||
27827460|NCT01739348|54293971|FG002|Part I (Base Study)|Site Discontinued Study Participation|0|||
27827461|NCT01739348|54293972|FG003|Part I (Base Study)|Site Discontinued Study Participation|0|||
27827462|NCT01739348|54293969|FG000|Part I (Base Study)|Study Terminated by Sponsor|72|||
27827463|NCT01739348|54293970|FG001|Part I (Base Study)|Study Terminated by Sponsor|73|||
27827464|NCT01739348|54293971|FG002|Part I (Base Study)|Study Terminated by Sponsor|0|||
27827465|NCT01739348|54293972|FG003|Part I (Base Study)|Study Terminated by Sponsor|86|||
27827466|NCT01739348|54293969|FG000|Part I (Base Study)|Participant Moved|4|||
27827467|NCT01739348|54293970|FG001|Part I (Base Study)|Participant Moved|3|||
27827468|NCT01739348|54293971|FG002|Part I (Base Study)|Participant Moved|1|||
27827469|NCT01739348|54293972|FG003|Part I (Base Study)|Participant Moved|7|||
27827470|NCT01739348|54293969|FG000|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27|||
27827471|NCT01739348|54293970|FG001|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25|||
27827472|NCT01739348|54293971|FG002|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2|||
27827473|NCT01739348|54293972|FG003|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18|||
27827474|NCT01739348|54293969|FG000|Part I (Base Study)|Withdrawal by Subject|23|||
27827475|NCT01739348|54293970|FG001|Part I (Base Study)|Withdrawal by Subject|21|||
27827476|NCT01739348|54293971|FG002|Part I (Base Study)|Withdrawal by Subject|7|||
27827477|NCT01739348|54293972|FG003|Part I (Base Study)|Withdrawal by Subject|20|||
27827478|NCT01739348|54293969|FG000|Part II (Extension Study)|Adverse Event|10|||
27827479|NCT01739348|54293970|FG001|Part II (Extension Study)|Adverse Event|11|||
27850591|NCT04421456|54349588|FG001|Randomized Treatment Period|Adverse Event|1|||
27850592|NCT04421456|54349589|FG002|Randomized Treatment Period|Adverse Event|0|||
27850593|NCT04421456|54349587|FG000|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
28160151|NCT02557516|54830250|FG003|Overall Study|Sponsor decision|8|||
27827480|NCT01739348|54293971|FG002|Part II (Extension Study)|Adverse Event|7|||
27827481|NCT01739348|54293972|FG003|Part II (Extension Study)|Adverse Event|26|||
27827482|NCT01739348|54293969|FG000|Part II (Extension Study)|Death|3|||
27827483|NCT01739348|54293970|FG001|Part II (Extension Study)|Death|3|||
27827484|NCT01739348|54293971|FG002|Part II (Extension Study)|Death|2|||
27827485|NCT01739348|54293972|FG003|Part II (Extension Study)|Death|6|||
27827486|NCT01739348|54293969|FG000|Part II (Extension Study)|Lack of Efficacy|1|||
27827487|NCT01739348|54293970|FG001|Part II (Extension Study)|Lack of Efficacy|5|||
27827488|NCT01739348|54293971|FG002|Part II (Extension Study)|Lack of Efficacy|0|||
27827489|NCT01739348|54293972|FG003|Part II (Extension Study)|Lack of Efficacy|1|||
27850594|NCT04421456|54349588|FG001|Randomized Treatment Period|Withdrawal of parent/legal representative consent|0|||
27850595|NCT04421456|54349589|FG002|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
27850596|NCT04421456|54349587|FG000|Randomized Treatment Period|Lost to Follow-up|2|||
27850597|NCT04421456|54349588|FG001|Randomized Treatment Period|Lost to Follow-up|2|||
27850598|NCT04421456|54349589|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
27850599|NCT04421456|54349587|FG000|Randomized Treatment Period|Participant non-compliance|1|||
27850600|NCT04421456|54349588|FG001|Randomized Treatment Period|Participant non-compliance|1|||
27827490|NCT01739348|54293969|FG000|Part II (Extension Study)|Lost to Follow-up|3|||
27827491|NCT01739348|54293970|FG001|Part II (Extension Study)|Lost to Follow-up|4|||
27827492|NCT01739348|54293971|FG002|Part II (Extension Study)|Lost to Follow-up|0|||
27827493|NCT01739348|54293972|FG003|Part II (Extension Study)|Lost to Follow-up|1|||
27850601|NCT04421456|54349589|FG002|Randomized Treatment Period|Participant non-compliance|2|||
27850602|NCT04421456|54349587|FG000|Randomized Treatment Period|Other|0|||
27850603|NCT04421456|54349588|FG001|Randomized Treatment Period|Other|1|||
27850604|NCT04421456|54349589|FG002|Randomized Treatment Period|Other|3|||
27850605|NCT04341363|54349598|FG000|Overall Study|Adverse Event|1|||
27850606|NCT04341363|54349598|FG000|Overall Study|Withdrawal by Subject|1|||
27850607|NCT04268303|54349609|FG000|Overall Study|Lost to Follow-up|1|||
27850608|NCT04268303|54349610|FG001|Overall Study|Lost to Follow-up|1|||
27850609|NCT04268303|54349611|FG002|Overall Study|Lost to Follow-up|2|||
27850610|NCT04268303|54349609|FG000|Overall Study|Withdrawal by Subject|0|||
27850611|NCT04268303|54349610|FG001|Overall Study|Withdrawal by Subject|1|||
27850612|NCT04268303|54349611|FG002|Overall Study|Withdrawal by Subject|1|||
27850613|NCT04268303|54349609|FG000|Overall Study|Adverse Event|2|||
27850614|NCT04268303|54349610|FG001|Overall Study|Adverse Event|0|||
27850615|NCT04268303|54349611|FG002|Overall Study|Adverse Event|0|||
27850616|NCT04092452|54349655|FG000|Overall Study|Adverse Event|1|||
27850617|NCT04092452|54349656|FG001|Overall Study|Adverse Event|3|||
27850618|NCT04092452|54349657|FG002|Overall Study|Adverse Event|3|||
27850619|NCT04092452|54349658|FG003|Overall Study|Adverse Event|7|||
27850620|NCT04092452|54349655|FG000|Overall Study|Lack of Efficacy|1|||
27850621|NCT04092452|54349656|FG001|Overall Study|Lack of Efficacy|1|||
27850622|NCT04092452|54349657|FG002|Overall Study|Lack of Efficacy|1|||
27850623|NCT04092452|54349658|FG003|Overall Study|Lack of Efficacy|0|||
27850624|NCT04092452|54349655|FG000|Overall Study|Lost to Follow-up|4|||
27850625|NCT04092452|54349656|FG001|Overall Study|Lost to Follow-up|3|||
27850626|NCT04092452|54349657|FG002|Overall Study|Lost to Follow-up|5|||
27850627|NCT04092452|54349658|FG003|Overall Study|Lost to Follow-up|1|||
27850628|NCT04092452|54349655|FG000|Overall Study|Non-Compliance With Study Drug|0|||
27850629|NCT04092452|54349656|FG001|Overall Study|Non-Compliance With Study Drug|0|||
27850630|NCT04092452|54349657|FG002|Overall Study|Non-Compliance With Study Drug|1|||
27850631|NCT04092452|54349658|FG003|Overall Study|Non-Compliance With Study Drug|1|||
27850632|NCT04092452|54349655|FG000|Overall Study|Physician Decision|1|||
27850633|NCT04092452|54349656|FG001|Overall Study|Physician Decision|0|||
27850634|NCT04092452|54349657|FG002|Overall Study|Physician Decision|1|||
27850635|NCT04092452|54349658|FG003|Overall Study|Physician Decision|0|||
27850636|NCT04092452|54349655|FG000|Overall Study|Pregnancy|2|||
27850637|NCT04092452|54349656|FG001|Overall Study|Pregnancy|0|||
27827494|NCT01739348|54293969|FG000|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
27827495|NCT01739348|54293970|FG001|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
27827496|NCT01739348|54293971|FG002|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
27827497|NCT01739348|54293972|FG003|Part II (Extension Study)|Non-Compliance with Study Drug|1|||
27827498|NCT01739348|54293969|FG000|Part II (Extension Study)|Physician Decision|7|||
27850638|NCT04092452|54349657|FG002|Overall Study|Pregnancy|0|||
27850639|NCT04092452|54349658|FG003|Overall Study|Pregnancy|0|||
27850640|NCT04092452|54349655|FG000|Overall Study|Protocol Deviation|1|||
27850641|NCT04092452|54349656|FG001|Overall Study|Protocol Deviation|0|||
27850642|NCT04092452|54349657|FG002|Overall Study|Protocol Deviation|0|||
27850643|NCT04092452|54349658|FG003|Overall Study|Protocol Deviation|0|||
27850644|NCT04092452|54349655|FG000|Overall Study|Withdrawal by Subject|3|||
27850645|NCT04092452|54349656|FG001|Overall Study|Withdrawal by Subject|10|||
27850646|NCT04092452|54349657|FG002|Overall Study|Withdrawal by Subject|3|||
27850647|NCT04092452|54349658|FG003|Overall Study|Withdrawal by Subject|5|||
27850648|NCT04092452|54349655|FG000|Overall Study|Other|0|||
27850649|NCT04092452|54349656|FG001|Overall Study|Other|0|||
27850650|NCT04092452|54349657|FG002|Overall Study|Other|1|||
27850651|NCT04092452|54349658|FG003|Overall Study|Other|2|||
28076756|NCT00111800|54731653|FG005|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
28076757|NCT00111800|54731648|FG000|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
28076758|NCT00111800|54731649|FG001|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
27827499|NCT01739348|54293970|FG001|Part II (Extension Study)|Physician Decision|11|||
27827500|NCT01739348|54293971|FG002|Part II (Extension Study)|Physician Decision|6|||
27850652|NCT04029116|54349673|FG000|Overall Study|Adverse Event|0|||
27850653|NCT04029116|54349674|FG001|Overall Study|Adverse Event|2|||
27850654|NCT04029116|54349673|FG000|Overall Study|Lost to Follow-up|3|||
27850655|NCT04029116|54349674|FG001|Overall Study|Lost to Follow-up|5|||
27850656|NCT04029116|54349673|FG000|Overall Study|Physician Decision|2|||
27850657|NCT04029116|54349674|FG001|Overall Study|Physician Decision|0|||
27850658|NCT04029116|54349673|FG000|Overall Study|Pregnancy|1|||
27850659|NCT04029116|54349674|FG001|Overall Study|Pregnancy|2|||
27850660|NCT04029116|54349673|FG000|Overall Study|Withdrawal by Subject|4|||
27850661|NCT04029116|54349674|FG001|Overall Study|Withdrawal by Subject|6|||
27850662|NCT04029116|54349673|FG000|Overall Study|Other|2|||
27850663|NCT04029116|54349674|FG001|Overall Study|Other|1|||
27850664|NCT03734029|54349705|FG000|Overall Study|Progressive disease as per RECIST v1.1|220|||
27850665|NCT03734029|54349706|FG001|Overall Study|Progressive disease as per RECIST v1.1|130|||
27850666|NCT03734029|54349705|FG000|Overall Study|Adverse Event|60|||
27850667|NCT03734029|54349706|FG001|Overall Study|Adverse Event|14|||
27827501|NCT01739348|54293972|FG003|Part II (Extension Study)|Physician Decision|12|||
27827502|NCT01739348|54293969|FG000|Part II (Extension Study)|Study Terminated by Sponsor|329|||
27827503|NCT01739348|54293970|FG001|Part II (Extension Study)|Study Terminated by Sponsor|315|||
27827504|NCT01739348|54293971|FG002|Part II (Extension Study)|Study Terminated by Sponsor|34|||
27827505|NCT01739348|54293972|FG003|Part II (Extension Study)|Study Terminated by Sponsor|323|||
27827506|NCT01739348|54293969|FG000|Part II (Extension Study)|Participant Moved|3|||
27827507|NCT01739348|54293970|FG001|Part II (Extension Study)|Participant Moved|3|||
27827508|NCT01739348|54293971|FG002|Part II (Extension Study)|Participant Moved|0|||
27827509|NCT01739348|54293972|FG003|Part II (Extension Study)|Participant Moved|3|||
27850668|NCT03734029|54349705|FG000|Overall Study|Withdrawal by Subject|12|||
27850669|NCT03734029|54349706|FG001|Overall Study|Withdrawal by Subject|11|||
27850670|NCT03734029|54349705|FG000|Overall Study|Clinical progression by investigator|10|||
27850671|NCT03734029|54349706|FG001|Overall Study|Clinical progression by investigator|8|||
27850672|NCT03734029|54349705|FG000|Overall Study|Death|5|||
27850673|NCT03734029|54349706|FG001|Overall Study|Death|2|||
27850674|NCT03734029|54349705|FG000|Overall Study|Physician Decision|4|||
27850675|NCT03734029|54349706|FG001|Overall Study|Physician Decision|3|||
27850676|NCT03734029|54349705|FG000|Overall Study|Other|2|||
27850677|NCT03734029|54349706|FG001|Overall Study|Other|0|||
27850678|NCT03734029|54349705|FG000|Overall Study|Lost to Follow-up|0|||
27850679|NCT03734029|54349706|FG001|Overall Study|Lost to Follow-up|1|||
27850680|NCT03734029|54349705|FG000|Overall Study|Randomized, but not treated|2|||
27850681|NCT03734029|54349706|FG001|Overall Study|Randomized, but not treated|12|||
27850682|NCT03732820|54349714|FG000|Overall Study|Death|143|||
27850683|NCT03732820|54349715|FG001|Overall Study|Death|169|||
27850684|NCT03732820|54349714|FG000|Overall Study|Screen failure|0|||
27850685|NCT03732820|54349715|FG001|Overall Study|Screen failure|1|||
27850686|NCT03732820|54349714|FG000|Overall Study|Ongoing study at data cut off|239|||
27850687|NCT03732820|54349715|FG001|Overall Study|Ongoing study at data cut off|216|||
27850688|NCT03732820|54349714|FG000|Overall Study|Failure to meet randomisation criteria|1|||
27850689|NCT03732820|54349715|FG001|Overall Study|Failure to meet randomisation criteria|1|||
27850690|NCT03732820|54349714|FG000|Overall Study|Lost to Follow-up|1|||
27850691|NCT03732820|54349715|FG001|Overall Study|Lost to Follow-up|0|||
27850692|NCT03732820|54349714|FG000|Overall Study|Patient decision|13|||
27850693|NCT03732820|54349715|FG001|Overall Study|Patient decision|8|||
27850694|NCT03732820|54349714|FG000|Overall Study|Other|2|||
27850695|NCT03732820|54349715|FG001|Overall Study|Other|2|||
27850696|NCT03724032|54349724|FG000|Overall Study|Physician Decision|1|||
27850697|NCT03724032|54349725|FG001|Overall Study|Physician Decision|0|||
27850698|NCT03724032|54349726|FG002|Overall Study|Physician Decision|0|||
27850699|NCT03724032|54349724|FG000|Overall Study|Protocol Violation|2|||
27850700|NCT03724032|54349725|FG001|Overall Study|Protocol Violation|2|||
27827510|NCT01739348|54293969|FG000|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18|||
27827511|NCT01739348|54293970|FG001|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12|||
27827512|NCT01739348|54293971|FG002|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8|||
27827513|NCT01739348|54293972|FG003|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16|||
27827514|NCT01739348|54293969|FG000|Part II (Extension Study)|Withdrawal by Subject|5|||
27827515|NCT01739348|54293970|FG001|Part II (Extension Study)|Withdrawal by Subject|2|||
27827516|NCT01739348|54293971|FG002|Part II (Extension Study)|Withdrawal by Subject|4|||
27827517|NCT01739348|54293972|FG003|Part II (Extension Study)|Withdrawal by Subject|7|||
27827518|NCT01738646|54294004|FG000|Overall Study|Still Receiving Treatment|2|||
27827519|NCT01716104|54294011|FG000|Overall Study|Do not meet inclusion criteria|6|||
27850701|NCT03724032|54349726|FG002|Overall Study|Protocol Violation|1|||
27850702|NCT03657797|54349763|FG000|Overall Study|Lost to Follow-up|0|||
27850703|NCT03657797|54349764|FG001|Overall Study|Lost to Follow-up|1|||
27850704|NCT03657797|54349765|FG002|Overall Study|Lost to Follow-up|1|||
27850705|NCT03657797|54349766|FG003|Overall Study|Lost to Follow-up|0|||
27850706|NCT03657797|54349763|FG000|Overall Study|Physician Decision|0|||
27850707|NCT03657797|54349764|FG001|Overall Study|Physician Decision|1|||
27850708|NCT03657797|54349765|FG002|Overall Study|Physician Decision|0|||
27850709|NCT03657797|54349766|FG003|Overall Study|Physician Decision|0|||
27850710|NCT03657797|54349763|FG000|Overall Study|Withdrawal by Subject|0|||
27850711|NCT03657797|54349764|FG001|Overall Study|Withdrawal by Subject|1|||
27850712|NCT03657797|54349765|FG002|Overall Study|Withdrawal by Subject|2|||
27850713|NCT03657797|54349766|FG003|Overall Study|Withdrawal by Subject|0|||
27850714|NCT03657797|54349763|FG000|Overall Study|Adverse Event|0|||
27827520|NCT01716104|54294012|FG001|Overall Study|Do not meet inclusion criteria|7|||
27827521|NCT04426695|54294092|FG000|Overall Study|Death|2|||
27850715|NCT03657797|54349764|FG001|Overall Study|Adverse Event|0|||
27850716|NCT03657797|54349765|FG002|Overall Study|Adverse Event|2|||
27850717|NCT03657797|54349766|FG003|Overall Study|Adverse Event|0|||
27850718|NCT03551938|54349782|FG000|3-Month Follow Up|Lost to Follow-up|39|||
27850719|NCT03551938|54349783|FG001|3-Month Follow Up|Lost to Follow-up|38|||
27850720|NCT03551938|54349782|FG000|6-Month Follow Up|Lost to Follow-up|46|||
27850721|NCT03551938|54349783|FG001|6-Month Follow Up|Lost to Follow-up|42|||
27850722|NCT03551938|54349782|FG000|9-Month Follow Up|Lost to Follow-up|44|||
27827522|NCT04426695|54294093|FG001|Overall Study|Death|0|||
27827523|NCT04426695|54294094|FG002|Overall Study|Death|1|||
27827524|NCT04426695|54294095|FG003|Overall Study|Death|27|||
27827525|NCT04426695|54294096|FG004|Overall Study|Death|25|||
27827526|NCT04426695|54294097|FG005|Overall Study|Death|21|||
27827527|NCT04426695|54294098|FG006|Overall Study|Death|42|||
27827528|NCT04426695|54294099|FG007|Overall Study|Death|23|||
27827529|NCT04426695|54294100|FG008|Overall Study|Death|37|||
27827530|NCT04426695|54294101|FG009|Overall Study|Death|14|||
27850723|NCT03551938|54349783|FG001|9-Month Follow Up|Lost to Follow-up|43|||
27850724|NCT03525600|54349792|FG000|Overall Study|Adverse Event|9|||
27850725|NCT03525600|54349793|FG001|Overall Study|Adverse Event|6|||
27850726|NCT03525600|54349794|FG002|Overall Study|Adverse Event|5|||
27850727|NCT03525600|54349795|FG003|Overall Study|Adverse Event|3|||
27850728|NCT03525600|54349792|FG000|Overall Study|Lost to Follow-up|2|||
27850729|NCT03525600|54349793|FG001|Overall Study|Lost to Follow-up|4|||
27850730|NCT03525600|54349794|FG002|Overall Study|Lost to Follow-up|4|||
27850731|NCT03525600|54349795|FG003|Overall Study|Lost to Follow-up|0|||
27850732|NCT03525600|54349792|FG000|Overall Study|Physician Decision|1|||
27850733|NCT03525600|54349793|FG001|Overall Study|Physician Decision|0|||
27850734|NCT03525600|54349794|FG002|Overall Study|Physician Decision|2|||
27850735|NCT03525600|54349795|FG003|Overall Study|Physician Decision|0|||
27850736|NCT03525600|54349792|FG000|Overall Study|Consent withdrawal|36|||
27850737|NCT03525600|54349793|FG001|Overall Study|Consent withdrawal|20|||
27850738|NCT03525600|54349794|FG002|Overall Study|Consent withdrawal|6|||
27850739|NCT03525600|54349795|FG003|Overall Study|Consent withdrawal|13|||
27850740|NCT03525600|54349792|FG000|Overall Study|Death|7|||
27850741|NCT03525600|54349793|FG001|Overall Study|Death|6|||
27850742|NCT03525600|54349794|FG002|Overall Study|Death|4|||
27850743|NCT03525600|54349795|FG003|Overall Study|Death|3|||
27827531|NCT04426695|54294102|FG010|Overall Study|Death|8|||
27827532|NCT04426695|54294103|FG011|Overall Study|Death|7|||
27827533|NCT04426695|54294104|FG012|Overall Study|Death|13|||
27850744|NCT03525600|54349792|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
27850745|NCT03525600|54349793|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|10|||
27850746|NCT03525600|54349794|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
27850747|NCT03525600|54349795|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
27850748|NCT03525600|54349792|FG000|Overall Study|Other|0|||
27850749|NCT03525600|54349793|FG001|Overall Study|Other|1|||
27850750|NCT03525600|54349794|FG002|Overall Study|Other|0|||
27850751|NCT03525600|54349795|FG003|Overall Study|Other|0|||
27850752|NCT03472040|54349812|FG000|Overall Study|Physician Decision|0|||
27850753|NCT03472040|54349813|FG001|Overall Study|Physician Decision|3|||
27850754|NCT03472040|54349812|FG000|Overall Study|Withdrawal by Subject|10|||
27943240|NCT01152996|54600188|FG000|Overall Study|Protocol Violation|22|||
27943241|NCT01152996|54600188|FG000|Overall Study|Elevated liver enzymes|1|||
27943242|NCT00979953|54600196|FG000|Overall Study|Adverse Event|5|||
27943243|NCT00979953|54600197|FG001|Overall Study|Adverse Event|2|||
27943244|NCT00979953|54600198|FG002|Overall Study|Adverse Event|17|||
27943245|NCT00979953|54600199|FG003|Overall Study|Adverse Event|4|||
27827534|NCT04426695|54294105|FG013|Overall Study|Death|25|||
27827535|NCT04426695|54294106|FG014|Overall Study|Death|19|||
27827536|NCT04426695|54294107|FG015|Overall Study|Death|7|||
27827537|NCT04426695|54294108|FG016|Overall Study|Death|8|||
27827538|NCT04426695|54294109|FG017|Overall Study|Death|4|||
27827539|NCT04426695|54294092|FG000|Overall Study|Lost to Follow-up|2|||
27943246|NCT00979953|54600196|FG000|Overall Study|Lack of Efficacy|1|||
27943247|NCT00979953|54600197|FG001|Overall Study|Lack of Efficacy|2|||
27943248|NCT00979953|54600198|FG002|Overall Study|Lack of Efficacy|0|||
27943249|NCT00979953|54600199|FG003|Overall Study|Lack of Efficacy|0|||
27827540|NCT04426695|54294093|FG001|Overall Study|Lost to Follow-up|4|||
27827541|NCT04426695|54294094|FG002|Overall Study|Lost to Follow-up|1|||
27850755|NCT03472040|54349813|FG001|Overall Study|Withdrawal by Subject|23|||
27850756|NCT03472040|54349812|FG000|Overall Study|Perceived Lack of Efficacy|29|||
27850757|NCT03472040|54349813|FG001|Overall Study|Perceived Lack of Efficacy|30|||
27850758|NCT03472040|54349812|FG000|Overall Study|Lab Abnormality or Adverse Event (AE)|7|||
27943250|NCT00979953|54600196|FG000|Overall Study|Lost to Follow-up|1|||
27943251|NCT00979953|54600197|FG001|Overall Study|Lost to Follow-up|1|||
27827542|NCT04426695|54294095|FG003|Overall Study|Lost to Follow-up|19|||
27850759|NCT03472040|54349813|FG001|Overall Study|Lab Abnormality or Adverse Event (AE)|25|||
27850760|NCT03472040|54349812|FG000|Overall Study|Intercurrent Illness/Medical Condition|2|||
27850761|NCT03472040|54349813|FG001|Overall Study|Intercurrent Illness/Medical Condition|3|||
27943252|NCT00979953|54600198|FG002|Overall Study|Lost to Follow-up|1|||
27827543|NCT04426695|54294096|FG004|Overall Study|Lost to Follow-up|10|||
27827544|NCT04426695|54294097|FG005|Overall Study|Lost to Follow-up|14|||
27827545|NCT04426695|54294098|FG006|Overall Study|Lost to Follow-up|5|||
27827546|NCT04426695|54294099|FG007|Overall Study|Lost to Follow-up|14|||
27827547|NCT04426695|54294100|FG008|Overall Study|Lost to Follow-up|10|||
27827548|NCT04426695|54294101|FG009|Overall Study|Lost to Follow-up|11|||
27827549|NCT04426695|54294102|FG010|Overall Study|Lost to Follow-up|12|||
27827550|NCT04426695|54294103|FG011|Overall Study|Lost to Follow-up|6|||
27827551|NCT04426695|54294104|FG012|Overall Study|Lost to Follow-up|2|||
27827552|NCT04426695|54294105|FG013|Overall Study|Lost to Follow-up|2|||
27827553|NCT04426695|54294106|FG014|Overall Study|Lost to Follow-up|2|||
27827554|NCT04426695|54294107|FG015|Overall Study|Lost to Follow-up|0|||
27827555|NCT04426695|54294108|FG016|Overall Study|Lost to Follow-up|0|||
27827556|NCT04426695|54294109|FG017|Overall Study|Lost to Follow-up|0|||
27827557|NCT04426695|54294092|FG000|Overall Study|Participant Decision|1|||
27827558|NCT04426695|54294093|FG001|Overall Study|Participant Decision|2|||
27827559|NCT04426695|54294094|FG002|Overall Study|Participant Decision|2|||
27827560|NCT04426695|54294095|FG003|Overall Study|Participant Decision|12|||
27827561|NCT04426695|54294096|FG004|Overall Study|Participant Decision|18|||
27827562|NCT04426695|54294097|FG005|Overall Study|Participant Decision|22|||
27827563|NCT04426695|54294098|FG006|Overall Study|Participant Decision|13|||
27827564|NCT04426695|54294099|FG007|Overall Study|Participant Decision|13|||
27827565|NCT04426695|54294100|FG008|Overall Study|Participant Decision|10|||
27827566|NCT04426695|54294101|FG009|Overall Study|Participant Decision|15|||
27827567|NCT04426695|54294102|FG010|Overall Study|Participant Decision|16|||
27827568|NCT04426695|54294103|FG011|Overall Study|Participant Decision|17|||
27827569|NCT04426695|54294104|FG012|Overall Study|Participant Decision|2|||
27827570|NCT04426695|54294105|FG013|Overall Study|Participant Decision|1|||
27827571|NCT04426695|54294106|FG014|Overall Study|Participant Decision|2|||
27827572|NCT04426695|54294107|FG015|Overall Study|Participant Decision|0|||
27827573|NCT04426695|54294108|FG016|Overall Study|Participant Decision|0|||
27827574|NCT04426695|54294109|FG017|Overall Study|Participant Decision|0|||
27827575|NCT04426695|54294092|FG000|Overall Study|Adverse Event|0|||
27827576|NCT04426695|54294093|FG001|Overall Study|Adverse Event|0|||
27827577|NCT04426695|54294094|FG002|Overall Study|Adverse Event|0|||
27827578|NCT04426695|54294095|FG003|Overall Study|Adverse Event|0|||
27827579|NCT04426695|54294096|FG004|Overall Study|Adverse Event|0|||
27827580|NCT04426695|54294097|FG005|Overall Study|Adverse Event|0|||
27827581|NCT04426695|54294098|FG006|Overall Study|Adverse Event|0|||
27827582|NCT04426695|54294099|FG007|Overall Study|Adverse Event|1|||
27827583|NCT04426695|54294100|FG008|Overall Study|Adverse Event|0|||
27827584|NCT04426695|54294101|FG009|Overall Study|Adverse Event|0|||
27827585|NCT04426695|54294102|FG010|Overall Study|Adverse Event|1|||
27827586|NCT04426695|54294103|FG011|Overall Study|Adverse Event|1|||
27827587|NCT04426695|54294104|FG012|Overall Study|Adverse Event|0|||
27827588|NCT04426695|54294105|FG013|Overall Study|Adverse Event|0|||
27827589|NCT04426695|54294106|FG014|Overall Study|Adverse Event|0|||
27827590|NCT04426695|54294107|FG015|Overall Study|Adverse Event|0|||
27827591|NCT04426695|54294108|FG016|Overall Study|Adverse Event|0|||
27827592|NCT04426695|54294109|FG017|Overall Study|Adverse Event|0|||
27827593|NCT04426695|54294092|FG000|Overall Study|Sponsor Request|0|||
27827594|NCT04426695|54294093|FG001|Overall Study|Sponsor Request|0|||
27827595|NCT04426695|54294094|FG002|Overall Study|Sponsor Request|0|||
27827596|NCT04426695|54294095|FG003|Overall Study|Sponsor Request|0|||
27827597|NCT04426695|54294096|FG004|Overall Study|Sponsor Request|0|||
27827598|NCT04426695|54294097|FG005|Overall Study|Sponsor Request|0|||
27827599|NCT04426695|54294098|FG006|Overall Study|Sponsor Request|1|||
27827600|NCT04426695|54294099|FG007|Overall Study|Sponsor Request|0|||
27827601|NCT04426695|54294100|FG008|Overall Study|Sponsor Request|0|||
27827602|NCT04426695|54294101|FG009|Overall Study|Sponsor Request|0|||
27827603|NCT04426695|54294102|FG010|Overall Study|Sponsor Request|0|||
27827604|NCT04426695|54294103|FG011|Overall Study|Sponsor Request|0|||
27827605|NCT04426695|54294104|FG012|Overall Study|Sponsor Request|0|||
27827606|NCT04426695|54294105|FG013|Overall Study|Sponsor Request|0|||
27827607|NCT04426695|54294106|FG014|Overall Study|Sponsor Request|0|||
27827608|NCT04426695|54294107|FG015|Overall Study|Sponsor Request|0|||
27827609|NCT04426695|54294108|FG016|Overall Study|Sponsor Request|0|||
27827610|NCT04426695|54294109|FG017|Overall Study|Sponsor Request|0|||
27827611|NCT04426695|54294092|FG000|Overall Study|Physician Decision|0|||
27827612|NCT04426695|54294093|FG001|Overall Study|Physician Decision|0|||
27827613|NCT04426695|54294094|FG002|Overall Study|Physician Decision|0|||
27827614|NCT04426695|54294095|FG003|Overall Study|Physician Decision|0|||
27827615|NCT04426695|54294096|FG004|Overall Study|Physician Decision|0|||
27827616|NCT04426695|54294097|FG005|Overall Study|Physician Decision|0|||
27827617|NCT04426695|54294098|FG006|Overall Study|Physician Decision|0|||
27827618|NCT04426695|54294099|FG007|Overall Study|Physician Decision|0|||
27827619|NCT04426695|54294100|FG008|Overall Study|Physician Decision|0|||
27827620|NCT04426695|54294101|FG009|Overall Study|Physician Decision|1|||
27827621|NCT04426695|54294102|FG010|Overall Study|Physician Decision|0|||
27827622|NCT04426695|54294103|FG011|Overall Study|Physician Decision|0|||
27827623|NCT04426695|54294104|FG012|Overall Study|Physician Decision|1|||
27827624|NCT04426695|54294105|FG013|Overall Study|Physician Decision|0|||
27827625|NCT04426695|54294106|FG014|Overall Study|Physician Decision|0|||
27827626|NCT04426695|54294107|FG015|Overall Study|Physician Decision|0|||
27827627|NCT04426695|54294108|FG016|Overall Study|Physician Decision|0|||
27827628|NCT04426695|54294109|FG017|Overall Study|Physician Decision|0|||
27827629|NCT04426695|54294092|FG000|Overall Study|Randomized but Never Treated|3|||
27827630|NCT04426695|54294093|FG001|Overall Study|Randomized but Never Treated|1|||
27827631|NCT04426695|54294094|FG002|Overall Study|Randomized but Never Treated|0|||
27827632|NCT04426695|54294095|FG003|Overall Study|Randomized but Never Treated|4|||
27827633|NCT04426695|54294096|FG004|Overall Study|Randomized but Never Treated|5|||
27827634|NCT04426695|54294097|FG005|Overall Study|Randomized but Never Treated|5|||
27827635|NCT04426695|54294098|FG006|Overall Study|Randomized but Never Treated|4|||
27827636|NCT04426695|54294099|FG007|Overall Study|Randomized but Never Treated|6|||
27827637|NCT04426695|54294100|FG008|Overall Study|Randomized but Never Treated|6|||
27827638|NCT04426695|54294101|FG009|Overall Study|Randomized but Never Treated|3|||
27827639|NCT04426695|54294102|FG010|Overall Study|Randomized but Never Treated|3|||
28076759|NCT00111800|54731650|FG002|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
28076760|NCT00111800|54731651|FG003|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
28076761|NCT00111800|54731652|FG004|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
28076762|NCT00111800|54731653|FG005|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
28076763|NCT00111800|54731648|FG000|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
28076764|NCT00111800|54731649|FG001|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
28076765|NCT00111800|54731650|FG002|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
27827640|NCT04426695|54294103|FG011|Overall Study|Randomized but Never Treated|6|||
27827641|NCT04426695|54294104|FG012|Overall Study|Randomized but Never Treated|1|||
27827642|NCT04426695|54294105|FG013|Overall Study|Randomized but Never Treated|2|||
27827643|NCT04426695|54294106|FG014|Overall Study|Randomized but Never Treated|0|||
27827644|NCT04426695|54294107|FG015|Overall Study|Randomized but Never Treated|0|||
27827645|NCT04426695|54294108|FG016|Overall Study|Randomized but Never Treated|0|||
27827646|NCT04426695|54294109|FG017|Overall Study|Randomized but Never Treated|0|||
27827647|NCT01838200|54294186|FG000|Overall Study|Adverse Event|0|||
27827648|NCT01838200|54294187|FG001|Overall Study|Adverse Event|2|||
27827649|NCT01838200|54294186|FG000|Overall Study|Progressive disease|3|||
27827650|NCT01838200|54294187|FG001|Overall Study|Progressive disease|0|||
27827651|NCT03219034|54294230|FG000|Overall Study|Lost to Follow-up|9|||
27827652|NCT03219034|54294231|FG001|Overall Study|Lost to Follow-up|13|||
27827653|NCT03219034|54294230|FG000|Overall Study|Additional dental work needed|1|||
27827654|NCT03219034|54294231|FG001|Overall Study|Additional dental work needed|0|||
27827655|NCT03219034|54294230|FG000|Overall Study|UPPP Surgery|1|||
27827656|NCT03219034|54294231|FG001|Overall Study|UPPP Surgery|0|||
27827657|NCT03219034|54294230|FG000|Overall Study|Dental sensitivity|0|||
27827658|NCT03219034|54294231|FG001|Overall Study|Dental sensitivity|1|||
27827659|NCT03219034|54294230|FG000|Overall Study|Death in family|0|||
27827660|NCT03219034|54294231|FG001|Overall Study|Death in family|1|||
27827661|NCT01706198|54294255|FG000|Overall Study|Adverse Event|12|||
27827662|NCT01706198|54294256|FG001|Overall Study|Adverse Event|15|||
27827663|NCT01706198|54294255|FG000|Overall Study|Protocol Violation|7|||
27827664|NCT01706198|54294256|FG001|Overall Study|Protocol Violation|5|||
27827665|NCT01706198|54294255|FG000|Overall Study|Other: Subject reached stopping criteria|11|||
27827666|NCT01706198|54294256|FG001|Overall Study|Other: Subject reached stopping criteria|13|||
27827667|NCT01706198|54294255|FG000|Overall Study|Lost to Follow-up|97|||
27827668|NCT01706198|54294256|FG001|Overall Study|Lost to Follow-up|93|||
27827669|NCT01706198|54294255|FG000|Overall Study|Physician Decision|23|||
27827670|NCT01706198|54294256|FG001|Overall Study|Physician Decision|37|||
27827671|NCT01706198|54294255|FG000|Overall Study|Withdrawal by Subject|23|||
27827672|NCT01706198|54294256|FG001|Overall Study|Withdrawal by Subject|31|||
27827673|NCT01705730|54294262|FG000|Overall Study|Lack of Efficacy|1|||
27827674|NCT01705730|54294262|FG000|Overall Study|Adverse Event|3|||
27827675|NCT01705730|54294262|FG000|Overall Study|Lost to Follow-up|1|||
27827676|NCT01705730|54294262|FG000|Overall Study|Reason not Specified|4|||
27827677|NCT01705652|54294268|FG000|Overall Study|Adverse Event|1|||
27827678|NCT01705652|54294269|FG001|Overall Study|Adverse Event|0|||
27827679|NCT01705652|54294268|FG000|Overall Study|Withdrawal by Subject|1|||
27827680|NCT01705652|54294269|FG001|Overall Study|Withdrawal by Subject|2|||
27827681|NCT01705652|54294268|FG000|Overall Study|non-compliance|1|||
27827682|NCT01705652|54294269|FG001|Overall Study|non-compliance|1|||
27827683|NCT01705574|54294297|FG000|Double-Blind Phase|Lost to Follow-up|12|||
28076766|NCT00111800|54731651|FG003|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
27827684|NCT01705574|54294298|FG001|Double-Blind Phase|Lost to Follow-up|16|||
27827685|NCT01705574|54294299|FG002|Double-Blind Phase|Lost to Follow-up|0|||
27827686|NCT01705574|54294300|FG003|Double-Blind Phase|Lost to Follow-up|0|||
27827687|NCT01705574|54294297|FG000|Double-Blind Phase|Adverse Event|3|||
27827688|NCT01705574|54294298|FG001|Double-Blind Phase|Adverse Event|10|||
27827689|NCT01705574|54294299|FG002|Double-Blind Phase|Adverse Event|0|||
27827690|NCT01705574|54294300|FG003|Double-Blind Phase|Adverse Event|0|||
27827691|NCT01705574|54294297|FG000|Double-Blind Phase|Withdrew Consent|8|||
27827692|NCT01705574|54294298|FG001|Double-Blind Phase|Withdrew Consent|5|||
27827693|NCT01705574|54294299|FG002|Double-Blind Phase|Withdrew Consent|0|||
27827694|NCT01705574|54294300|FG003|Double-Blind Phase|Withdrew Consent|0|||
27827695|NCT01705574|54294297|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
27827696|NCT01705574|54294298|FG001|Double-Blind Phase|Non-Compliance with Study Drug|5|||
27827697|NCT01705574|54294299|FG002|Double-Blind Phase|Non-Compliance with Study Drug|0|||
27827698|NCT01705574|54294300|FG003|Double-Blind Phase|Non-Compliance with Study Drug|0|||
27827699|NCT01705574|54294297|FG000|Double-Blind Phase|Pregnancy|1|||
27827700|NCT01705574|54294298|FG001|Double-Blind Phase|Pregnancy|1|||
27827701|NCT01705574|54294299|FG002|Double-Blind Phase|Pregnancy|0|||
27827702|NCT01705574|54294300|FG003|Double-Blind Phase|Pregnancy|0|||
27827703|NCT01705574|54294297|FG000|Double-Blind Phase|Protocol Violation|1|||
27827704|NCT01705574|54294298|FG001|Double-Blind Phase|Protocol Violation|0|||
27827705|NCT01705574|54294299|FG002|Double-Blind Phase|Protocol Violation|0|||
27827706|NCT01705574|54294300|FG003|Double-Blind Phase|Protocol Violation|0|||
27827707|NCT01705574|54294297|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
27827708|NCT01705574|54294298|FG001|Double-Blind Phase|Randomized but Not Treated|4|||
27827709|NCT01705574|54294299|FG002|Double-Blind Phase|Randomized but Not Treated|0|||
27827710|NCT01705574|54294300|FG003|Double-Blind Phase|Randomized but Not Treated|0|||
27827711|NCT01705574|54294297|FG000|Open-Label Extension Phase|Lost to Follow-up|6|||
27827712|NCT01705574|54294298|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
27827713|NCT01705574|54294299|FG002|Open-Label Extension Phase|Lost to Follow-up|2|||
27827714|NCT01705574|54294300|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
27827715|NCT01705574|54294297|FG000|Open-Label Extension Phase|Withdrew Consent|4|||
27827716|NCT01705574|54294298|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
27827717|NCT01705574|54294299|FG002|Open-Label Extension Phase|Withdrew Consent|4|||
27827718|NCT01705574|54294300|FG003|Open-Label Extension Phase|Withdrew Consent|1|||
27827719|NCT01705574|54294297|FG000|Open-Label Extension Phase|Adverse Event|3|||
27827720|NCT01705574|54294298|FG001|Open-Label Extension Phase|Adverse Event|0|||
27827721|NCT01705574|54294299|FG002|Open-Label Extension Phase|Adverse Event|0|||
27827722|NCT01705574|54294300|FG003|Open-Label Extension Phase|Adverse Event|1|||
27827723|NCT01705574|54294297|FG000|Open-Label Extension Phase|Death|2|||
27827724|NCT01705574|54294298|FG001|Open-Label Extension Phase|Death|0|||
27827725|NCT01705574|54294299|FG002|Open-Label Extension Phase|Death|1|||
27827726|NCT01705574|54294300|FG003|Open-Label Extension Phase|Death|0|||
27827727|NCT01705574|54294297|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
27827728|NCT01705574|54294298|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
27827729|NCT01705574|54294299|FG002|Open-Label Extension Phase|Non-Compliance with Study Drug|1|||
27827730|NCT01705574|54294300|FG003|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
27827731|NCT01705574|54294297|FG000|Open-Label Extension Phase|Physician Decision|0|||
27827732|NCT01705574|54294298|FG001|Open-Label Extension Phase|Physician Decision|0|||
27827733|NCT01705574|54294299|FG002|Open-Label Extension Phase|Physician Decision|2|||
27827734|NCT01705574|54294300|FG003|Open-Label Extension Phase|Physician Decision|0|||
27827735|NCT01705574|54294297|FG000|Open-Label Extension Phase|Pregnancy|0|||
27827736|NCT01705574|54294298|FG001|Open-Label Extension Phase|Pregnancy|0|||
27827737|NCT01705574|54294299|FG002|Open-Label Extension Phase|Pregnancy|1|||
27827738|NCT01705574|54294300|FG003|Open-Label Extension Phase|Pregnancy|1|||
27827739|NCT01737710|54294321|FG000|Overall Study|Lost to Follow-up|0|||
27827740|NCT01737710|54294322|FG001|Overall Study|Lost to Follow-up|2|||
27827741|NCT01737710|54294323|FG002|Overall Study|Lost to Follow-up|2|||
27827742|NCT01737710|54294324|FG003|Overall Study|Lost to Follow-up|0|||
27827743|NCT01737710|54294325|FG004|Overall Study|Lost to Follow-up|0|||
27827744|NCT01737710|54294321|FG000|Overall Study|Withdrawal by Subject|1|||
27827745|NCT01737710|54294322|FG001|Overall Study|Withdrawal by Subject|1|||
27827746|NCT01737710|54294323|FG002|Overall Study|Withdrawal by Subject|1|||
28159765|NCT01963208|54829748|FG003|Treatment Phase 2 (Up to Week 68)|Death|0|||
28159766|NCT01963208|54829749|FG004|Treatment Phase 2 (Up to Week 68)|Death|0|||
28159767|NCT01963208|54829750|FG005|Treatment Phase 2 (Up to Week 68)|Death|1|||
27827747|NCT01737710|54294324|FG003|Overall Study|Withdrawal by Subject|0|||
27827748|NCT01737710|54294325|FG004|Overall Study|Withdrawal by Subject|0|||
27827749|NCT01737710|54294321|FG000|Overall Study|Vaccinated in Error/Ineligible|1|||
27827750|NCT01737710|54294322|FG001|Overall Study|Vaccinated in Error/Ineligible|1|||
27827751|NCT01737710|54294323|FG002|Overall Study|Vaccinated in Error/Ineligible|0|||
27850762|NCT03472040|54349812|FG000|Overall Study|Other - Not Otherwise Specified (NOS)|4|||
27827752|NCT01737710|54294324|FG003|Overall Study|Vaccinated in Error/Ineligible|0|||
27827753|NCT01737710|54294325|FG004|Overall Study|Vaccinated in Error/Ineligible|0|||
27827754|NCT01682876|54294340|FG000|Overall Study|Administrative reason|4|||
27850763|NCT03472040|54349813|FG001|Overall Study|Other - Not Otherwise Specified (NOS)|19|||
27827755|NCT01682876|54294341|FG001|Overall Study|Administrative reason|4|||
27827756|NCT01682876|54294342|FG002|Overall Study|Administrative reason|0|||
27827757|NCT01682876|54294343|FG003|Overall Study|Administrative reason|3|||
27827758|NCT01682876|54294340|FG000|Overall Study|Adverse Event|0|||
27827759|NCT01682876|54294341|FG001|Overall Study|Adverse Event|0|||
28159768|NCT00834873|54829762|FG000|First Intervention|Adverse Event|0|||
28159769|NCT00834873|54829763|FG001|First Intervention|Adverse Event|1|||
27827760|NCT01682876|54294342|FG002|Overall Study|Adverse Event|0|||
27827761|NCT01682876|54294343|FG003|Overall Study|Adverse Event|1|||
27827762|NCT01682876|54294340|FG000|Overall Study|Lost to Follow-up|11|||
27827763|NCT01682876|54294341|FG001|Overall Study|Lost to Follow-up|15|||
27827764|NCT01682876|54294342|FG002|Overall Study|Lost to Follow-up|9|||
27827765|NCT01682876|54294343|FG003|Overall Study|Lost to Follow-up|11|||
27827766|NCT01682876|54294340|FG000|Overall Study|Protocol Violation|1|||
27827767|NCT01682876|54294341|FG001|Overall Study|Protocol Violation|1|||
27827768|NCT01682876|54294342|FG002|Overall Study|Protocol Violation|1|||
27827769|NCT01682876|54294343|FG003|Overall Study|Protocol Violation|1|||
27827770|NCT01682876|54294340|FG000|Overall Study|Withdrawal by Subject|4|||
27827771|NCT01682876|54294341|FG001|Overall Study|Withdrawal by Subject|0|||
27827772|NCT01682876|54294342|FG002|Overall Study|Withdrawal by Subject|0|||
27827773|NCT01682876|54294343|FG003|Overall Study|Withdrawal by Subject|2|||
27827774|NCT01682876|54294340|FG000|Overall Study|Other|1|||
27827775|NCT01682876|54294341|FG001|Overall Study|Other|0|||
27827776|NCT01682876|54294342|FG002|Overall Study|Other|1|||
27827777|NCT01682876|54294343|FG003|Overall Study|Other|1|||
27827778|NCT01682720|54294360|FG000|Overall Study|Randomized but Not Treated|0|||
27827779|NCT01682720|54294361|FG001|Overall Study|Randomized but Not Treated|1|||
27827780|NCT01682720|54294362|FG002|Overall Study|Randomized but Not Treated|1|||
27827781|NCT01682720|54294363|FG003|Overall Study|Randomized but Not Treated|0|||
27827782|NCT01682720|54294360|FG000|Overall Study|Terminated by Sponsor|83|||
27827783|NCT01682720|54294361|FG001|Overall Study|Terminated by Sponsor|0|||
27827784|NCT01682720|54294362|FG002|Overall Study|Terminated by Sponsor|0|||
27827785|NCT01682720|54294363|FG003|Overall Study|Terminated by Sponsor|0|||
27827786|NCT01682720|54294360|FG000|Overall Study|Efficacy Failure|0|||
27827787|NCT01682720|54294361|FG001|Overall Study|Efficacy Failure|3|||
27827788|NCT01682720|54294362|FG002|Overall Study|Efficacy Failure|3|||
27827789|NCT01682720|54294363|FG003|Overall Study|Efficacy Failure|30|||
27827790|NCT01682720|54294360|FG000|Overall Study|Lost to Follow-up|1|||
27827791|NCT01682720|54294361|FG001|Overall Study|Lost to Follow-up|1|||
27827792|NCT01682720|54294362|FG002|Overall Study|Lost to Follow-up|0|||
27827793|NCT01682720|54294363|FG003|Overall Study|Lost to Follow-up|6|||
27827794|NCT01682720|54294360|FG000|Overall Study|Subject Withdrew Consent|0|||
27827795|NCT01682720|54294361|FG001|Overall Study|Subject Withdrew Consent|0|||
27827796|NCT01682720|54294362|FG002|Overall Study|Subject Withdrew Consent|2|||
27827797|NCT01682720|54294363|FG003|Overall Study|Subject Withdrew Consent|2|||
27827798|NCT01682720|54294360|FG000|Overall Study|Adverse Event|1|||
27827799|NCT01682720|54294361|FG001|Overall Study|Adverse Event|0|||
27827800|NCT01682720|54294362|FG002|Overall Study|Adverse Event|1|||
27827801|NCT01682720|54294363|FG003|Overall Study|Adverse Event|1|||
27827802|NCT01714544|54294382|FG000|Overall Study|Lost to Follow-up|1|||
27827803|NCT01714544|54294382|FG000|Overall Study|Physician Decision|1|||
27827804|NCT01714544|54294382|FG000|Overall Study|Withdrawal by Subject|1|||
27827805|NCT01703858|54294389|FG000|Overall Study|Withdrawal by Subject|0|||
27827806|NCT01703858|54294390|FG001|Overall Study|Withdrawal by Subject|1|||
27827807|NCT01703858|54294391|FG002|Overall Study|Withdrawal by Subject|0|||
27827808|NCT01714310|54294407|FG000|Open Lisdexamfetamine Titration|Protocol Violation|0|||
27827809|NCT01714310|54294408|FG001|Open Lisdexamfetamine Titration|Protocol Violation|0|||
27827810|NCT01714310|54294409|FG002|Open Lisdexamfetamine Titration|Protocol Violation|1|||
27827811|NCT01714310|54294407|FG000|Open Lisdexamfetamine Titration|Adverse Event|0|||
27827812|NCT01714310|54294408|FG001|Open Lisdexamfetamine Titration|Adverse Event|0|||
27827813|NCT01714310|54294409|FG002|Open Lisdexamfetamine Titration|Adverse Event|3|||
27827814|NCT01714310|54294407|FG000|Double Blind Adjunctive Treatment|Adverse Event|1|||
27827815|NCT01714310|54294408|FG001|Double Blind Adjunctive Treatment|Adverse Event|1|||
27827816|NCT01714310|54294409|FG002|Double Blind Adjunctive Treatment|Adverse Event|0|||
28159770|NCT01377480|54829771|FG000|Overall Study|Protocol Violation|0|||
28159771|NCT01377480|54829772|FG001|Overall Study|Protocol Violation|0|||
27827817|NCT01714310|54294407|FG000|Double Blind Adjunctive Treatment|Protocol Violation|1|||
27827818|NCT01714310|54294408|FG001|Double Blind Adjunctive Treatment|Protocol Violation|2|||
27827819|NCT01714310|54294409|FG002|Double Blind Adjunctive Treatment|Protocol Violation|0|||
27827820|NCT01713998|54294430|FG000|Overall Study|Lost to Follow-up|2|||
27827821|NCT01713998|54294431|FG001|Overall Study|Lost to Follow-up|0|||
27827822|NCT01713998|54294432|FG002|Overall Study|Lost to Follow-up|2|||
27827823|NCT01713998|54294430|FG000|Overall Study|Withdrawal by Subject|1|||
27827824|NCT01713998|54294431|FG001|Overall Study|Withdrawal by Subject|0|||
27827825|NCT01713998|54294432|FG002|Overall Study|Withdrawal by Subject|0|||
27827826|NCT01681628|54294442|FG000|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14|||
27827827|NCT01681628|54294443|FG001|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6|||
27827828|NCT01681628|54294442|FG000|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0|||
27827829|NCT01681628|54294443|FG001|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15|||
27827830|NCT01681628|54294442|FG000|19 Months Follow-up|Death|1|||
27827831|NCT01681628|54294443|FG001|19 Months Follow-up|Death|0|||
27827832|NCT01681628|54294442|FG000|19 Months Follow-up|Lost to Follow-up|61|||
27827833|NCT01681628|54294443|FG001|19 Months Follow-up|Lost to Follow-up|43|||
27827834|NCT00016354|54294465|FG000|Overall Study|Lack of Efficacy|0|||
27827835|NCT00016354|54294466|FG001|Overall Study|Lack of Efficacy|0|||
27827836|NCT00016354|54294467|FG002|Overall Study|Lack of Efficacy|0|||
27827837|NCT00016354|54294468|FG003|Overall Study|Lack of Efficacy|0|||
27827838|NCT00016354|54294469|FG004|Overall Study|Lack of Efficacy|0|||
27827839|NCT00016354|54294470|FG005|Overall Study|Lack of Efficacy|0|||
27827840|NCT00016354|54294471|FG006|Overall Study|Lack of Efficacy|0|||
27827841|NCT00016354|54294472|FG007|Overall Study|Lack of Efficacy|1|||
27827842|NCT01681472|54294480|FG000|Overall Study|Adverse Event|0|||
27827843|NCT01681472|54294481|FG001|Overall Study|Adverse Event|1|||
27827844|NCT01681472|54294482|FG002|Overall Study|Adverse Event|0|||
27827845|NCT01681472|54294483|FG003|Overall Study|Adverse Event|0|||
27827846|NCT01049308|54294512|FG000|Pill Counts|Withdrawal by Subject|83|||
27827847|NCT01713686|54294519|FG000|Overall Study|Lost to Follow-up|9|||
28076767|NCT00111800|54731652|FG004|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
28076768|NCT00111800|54731653|FG005|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
28076769|NCT00111800|54731648|FG000|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1|||
28076770|NCT00111800|54731649|FG001|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
28076771|NCT00111800|54731650|FG002|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
28076772|NCT00111800|54731651|FG003|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
28076773|NCT00111800|54731652|FG004|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
28076774|NCT00111800|54731653|FG005|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
28076775|NCT00111800|54731648|FG000|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
28076776|NCT00111800|54731649|FG001|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1|||
28076777|NCT00111800|54731650|FG002|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
28076778|NCT00111800|54731651|FG003|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
28076779|NCT00111800|54731652|FG004|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
28076780|NCT00111800|54731653|FG005|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
28076781|NCT00111800|54731648|FG000|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
28076782|NCT00111800|54731649|FG001|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1|||
28076783|NCT00111800|54731650|FG002|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
28076784|NCT00111800|54731651|FG003|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
28076785|NCT00111800|54731652|FG004|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
28159772|NCT01377480|54829773|FG002|Overall Study|Protocol Violation|0|||
28159773|NCT01377480|54829774|FG003|Overall Study|Protocol Violation|4|||
28159774|NCT01377480|54829771|FG000|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
28159775|NCT01377480|54829772|FG001|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
28159776|NCT01377480|54829773|FG002|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
28159777|NCT01377480|54829774|FG003|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
28159778|NCT01377480|54829771|FG000|Overall Study|Withdrawal by Subject|0|||
28159779|NCT01377480|54829772|FG001|Overall Study|Withdrawal by Subject|0|||
28159780|NCT01377480|54829773|FG002|Overall Study|Withdrawal by Subject|1|||
27827848|NCT01713686|54294519|FG000|Overall Study|Withdrawal by Subject|6|||
27827849|NCT01047436|54294525|FG000|Overall Study|Protocol Violation|1|||
27827850|NCT01047436|54294526|FG001|Overall Study|Protocol Violation|0|||
27827851|NCT01681004|54294534|FG000|Primary Endpoint: 6 Months|Withdrawal by Subject|1|||
27827852|NCT01681004|54294535|FG001|Primary Endpoint: 6 Months|Withdrawal by Subject|2|||
27827853|NCT01681004|54294534|FG000|Study Completion|Lost to Follow-up|8|||
27827854|NCT01681004|54294535|FG001|Study Completion|Lost to Follow-up|3|||
27827855|NCT01681004|54294534|FG000|Study Completion|Physician Decision|1|||
27827856|NCT01681004|54294535|FG001|Study Completion|Physician Decision|3|||
28159781|NCT01377480|54829774|FG003|Overall Study|Withdrawal by Subject|0|||
28159782|NCT01377480|54829771|FG000|Overall Study|Serious adverse event|0|||
27827857|NCT01681004|54294534|FG000|Study Completion|Site Termination|2|||
27827858|NCT01681004|54294535|FG001|Study Completion|Site Termination|1|||
27827859|NCT01681004|54294534|FG000|Study Completion|Death|1|||
27827860|NCT01681004|54294535|FG001|Study Completion|Death|1|||
27827861|NCT01046110|54294547|FG000|Overall Study|Adverse Event|9|||
27827862|NCT01046110|54294548|FG001|Overall Study|Adverse Event|2|||
27827863|NCT01046110|54294547|FG000|Overall Study|Lack of Efficacy|0|||
27827864|NCT01046110|54294548|FG001|Overall Study|Lack of Efficacy|1|||
27827865|NCT01046110|54294547|FG000|Overall Study|Protocol Violation|7|||
27827866|NCT01046110|54294548|FG001|Overall Study|Protocol Violation|12|||
27827867|NCT01046110|54294547|FG000|Overall Study|Withdrawal Criteria|3|||
27827868|NCT01046110|54294548|FG001|Overall Study|Withdrawal Criteria|5|||
27827869|NCT01046110|54294547|FG000|Overall Study|Unclassified|36|||
27827870|NCT01046110|54294548|FG001|Overall Study|Unclassified|35|||
27827871|NCT01713530|54294556|FG000|Overall Study|Adverse Event|0|||
27827872|NCT01713530|54294557|FG001|Overall Study|Adverse Event|5|||
27827873|NCT01713530|54294556|FG000|Overall Study|Withdrawal criteria|21|||
27827874|NCT01713530|54294557|FG001|Overall Study|Withdrawal criteria|12|||
27827875|NCT01713530|54294556|FG000|Overall Study|Unclassified|4|||
27827876|NCT01713530|54294557|FG001|Overall Study|Unclassified|2|||
27827877|NCT01045798|54294565|FG000|Overall Study|Changed to Open-Label Caspofungin|1|||
27827878|NCT01045798|54294566|FG001|Overall Study|Changed to Open-Label Caspofungin|0|||
27827879|NCT01045798|54294565|FG000|Overall Study|Invasive Fungal Infection at Baseline|0|||
27827880|NCT01045798|54294566|FG001|Overall Study|Invasive Fungal Infection at Baseline|1|||
27827881|NCT01045798|54294565|FG000|Overall Study|Changed to Other Antifungal Therapy|1|||
27827882|NCT01045798|54294566|FG001|Overall Study|Changed to Other Antifungal Therapy|2|||
27827883|NCT01045798|54294565|FG000|Overall Study|Received Systemic Antifungal Prestudy|0|||
27827884|NCT01045798|54294566|FG001|Overall Study|Received Systemic Antifungal Prestudy|1|||
27827885|NCT01712984|54294579|FG000|Overall Study|Adverse Event|0|||
27827886|NCT01712984|54294580|FG001|Overall Study|Adverse Event|0|||
27827887|NCT01712984|54294581|FG002|Overall Study|Adverse Event|1|||
27827888|NCT01712984|54294579|FG000|Overall Study|Protocol Violation|2|||
27827889|NCT01712984|54294580|FG001|Overall Study|Protocol Violation|0|||
27827890|NCT01712984|54294581|FG002|Overall Study|Protocol Violation|1|||
27827891|NCT01712984|54294579|FG000|Overall Study|Lost to Follow-up|8|||
27827892|NCT01712984|54294580|FG001|Overall Study|Lost to Follow-up|10|||
27827893|NCT01712984|54294581|FG002|Overall Study|Lost to Follow-up|1|||
27827894|NCT01712984|54294579|FG000|Overall Study|Withdrawal by Subject|6|||
27827895|NCT01712984|54294580|FG001|Overall Study|Withdrawal by Subject|6|||
27827896|NCT01712984|54294581|FG002|Overall Study|Withdrawal by Subject|7|||
27827897|NCT01042678|54294592|FG000|Overall Study|Physician Decision|1|||
27827898|NCT01042678|54294593|FG001|Overall Study|Physician Decision|0|||
27827899|NCT01042678|54294594|FG002|Overall Study|Physician Decision|0|||
27827900|NCT01042678|54294595|FG003|Overall Study|Physician Decision|0|||
27827901|NCT01042678|54294596|FG004|Overall Study|Physician Decision|0|||
27827902|NCT01042678|54294597|FG005|Overall Study|Physician Decision|0|||
27827903|NCT01042600|54294607|FG000|Overall Study|Ineligible|1|||
27827904|NCT01042600|54294608|FG001|Overall Study|Ineligible|0|||
27827905|NCT01041976|54294617|FG000|Overall Study|Withdrawal by Subject|3|||
27827906|NCT01041976|54294618|FG001|Overall Study|Withdrawal by Subject|0|||
27827907|NCT01041976|54294617|FG000|Overall Study|Incarceration|2|||
27827908|NCT01041976|54294618|FG001|Overall Study|Incarceration|0|||
27827909|NCT01041976|54294617|FG000|Overall Study|Death|0|||
27827910|NCT01041976|54294618|FG001|Overall Study|Death|4|||
27827911|NCT01712516|54294644|FG000|Overall Study|Technical problems|0|||
27827912|NCT01712516|54294645|FG001|Overall Study|Technical problems|0|||
27827913|NCT01712516|54294646|FG002|Overall Study|Technical problems|0|||
27827914|NCT01712516|54294647|FG003|Overall Study|Technical problems|2|||
27827915|NCT01712516|54294644|FG000|Overall Study|Lost to Follow-up|0|||
27827916|NCT01712516|54294645|FG001|Overall Study|Lost to Follow-up|0|||
27827917|NCT01712516|54294646|FG002|Overall Study|Lost to Follow-up|2|||
27827918|NCT01712516|54294647|FG003|Overall Study|Lost to Follow-up|1|||
27827919|NCT01712516|54294644|FG000|Overall Study|Death|0|||
27827920|NCT01712516|54294645|FG001|Overall Study|Death|1|||
27827921|NCT01712516|54294646|FG002|Overall Study|Death|0|||
27827922|NCT01712516|54294647|FG003|Overall Study|Death|0|||
27827923|NCT01712516|54294644|FG000|Overall Study|Protocol deviation|1|||
27827924|NCT01712516|54294645|FG001|Overall Study|Protocol deviation|0|||
27827925|NCT01712516|54294646|FG002|Overall Study|Protocol deviation|1|||
27827926|NCT01712516|54294647|FG003|Overall Study|Protocol deviation|0|||
27827927|NCT01712516|54294644|FG000|Overall Study|Physician Decision|2|||
27827928|NCT01712516|54294645|FG001|Overall Study|Physician Decision|0|||
27827929|NCT01712516|54294646|FG002|Overall Study|Physician Decision|0|||
27827930|NCT01712516|54294647|FG003|Overall Study|Physician Decision|1|||
27827931|NCT01712516|54294644|FG000|Overall Study|Withdrawal by Subject|3|||
27827932|NCT01712516|54294645|FG001|Overall Study|Withdrawal by Subject|9|||
27827933|NCT01712516|54294646|FG002|Overall Study|Withdrawal by Subject|3|||
27827934|NCT01712516|54294647|FG003|Overall Study|Withdrawal by Subject|9|||
27827935|NCT01703000|54294657|FG000|Overall Study|Death|1|||
27827936|NCT01040728|54294661|FG000|Overall Study|Adverse Event|4|||
27827937|NCT01040728|54294662|FG001|Overall Study|Adverse Event|8|||
27827938|NCT01040728|54294663|FG002|Overall Study|Adverse Event|0|||
27827939|NCT01040728|54294664|FG003|Overall Study|Adverse Event|4|||
27827940|NCT01040728|54294661|FG000|Overall Study|Withdrawal by Subject|0|||
27827941|NCT01040728|54294662|FG001|Overall Study|Withdrawal by Subject|1|||
27827942|NCT01040728|54294663|FG002|Overall Study|Withdrawal by Subject|1|||
27827943|NCT01040728|54294664|FG003|Overall Study|Withdrawal by Subject|0|||
27827944|NCT01040728|54294661|FG000|Overall Study|Protocol Violation|0|||
27827945|NCT01040728|54294662|FG001|Overall Study|Protocol Violation|0|||
27827946|NCT01040728|54294663|FG002|Overall Study|Protocol Violation|0|||
27827947|NCT01040728|54294664|FG003|Overall Study|Protocol Violation|1|||
27827948|NCT01040728|54294661|FG000|Overall Study|Lack of Efficacy|0|||
27827949|NCT01040728|54294662|FG001|Overall Study|Lack of Efficacy|1|||
27827950|NCT01040728|54294663|FG002|Overall Study|Lack of Efficacy|0|||
27827951|NCT01040728|54294664|FG003|Overall Study|Lack of Efficacy|1|||
27827952|NCT01040728|54294661|FG000|Overall Study|Other reasons not listed above|0|||
27827953|NCT01040728|54294662|FG001|Overall Study|Other reasons not listed above|1|||
27827954|NCT01040728|54294663|FG002|Overall Study|Other reasons not listed above|0|||
27827955|NCT01040728|54294664|FG003|Overall Study|Other reasons not listed above|0|||
27827956|NCT01593020|54294682|FG000|Overall Study|Adverse Event|1|||
27827957|NCT01593020|54294683|FG001|Overall Study|Adverse Event|1|||
27827958|NCT01593020|54294682|FG000|Overall Study|Death|0|||
27827959|NCT01593020|54294683|FG001|Overall Study|Death|1|||
27827960|NCT01593020|54294682|FG000|Overall Study|Ineligible|1|||
27827961|NCT01593020|54294683|FG001|Overall Study|Ineligible|0|||
27827962|NCT01040260|54294691|FG000|Overall Study|Withdrawal by Subject|12|||
27827963|NCT01040260|54294692|FG001|Overall Study|Withdrawal by Subject|6|||
27827964|NCT01040260|54294691|FG000|Overall Study|Lost to Follow-up|3|||
27827965|NCT01040260|54294692|FG001|Overall Study|Lost to Follow-up|5|||
27827966|NCT01712438|54294698|FG000|Overall Study|Not treated with Human-cl rhFVIII|2|||
27827967|NCT01712438|54294698|FG000|Overall Study|Ongoing ITI treatment|6|||
27827968|NCT01712438|54294698|FG000|Overall Study|Violated inclusion & exclusion criteria|4|||
27827969|NCT01712438|54294698|FG000|Overall Study|Prematurely Discontinued|25|||
27827970|NCT01712204|54294709|FG000|Overall Study|Adverse Event|3|||
27827971|NCT01712204|54294710|FG001|Overall Study|Adverse Event|1|||
27827972|NCT01712204|54294709|FG000|Overall Study|Withdrawal by Subject|3|||
27827973|NCT01712204|54294710|FG001|Overall Study|Withdrawal by Subject|3|||
27827974|NCT01712204|54294709|FG000|Overall Study|Lost to Follow-up|1|||
27827975|NCT01712204|54294710|FG001|Overall Study|Lost to Follow-up|0|||
27827976|NCT01712204|54294709|FG000|Overall Study|Protocol Violation|1|||
27827977|NCT01712204|54294710|FG001|Overall Study|Protocol Violation|1|||
27827978|NCT01592864|54294718|FG000|Overall Study|Withdrawal by Subject|0|||
27827979|NCT01592864|54294719|FG001|Overall Study|Withdrawal by Subject|1|||
27827980|NCT01592786|54294725|FG000|Overall Study|Adverse Event|60|||
27827981|NCT01592786|54294725|FG000|Overall Study|Lack of Efficacy|19|||
27827982|NCT01592786|54294725|FG000|Overall Study|Protocol Violation|14|||
27827983|NCT01592786|54294725|FG000|Overall Study|Withdrawal by Subject|23|||
27827984|NCT01592786|54294725|FG000|Overall Study|Lost to Follow-up|19|||
27827985|NCT01592786|54294725|FG000|Overall Study|Other|3|||
27827986|NCT01711736|54294731|FG000|Overall Study|Lost to Follow-up|4|||
27827987|NCT01711736|54294732|FG001|Overall Study|Lost to Follow-up|1|||
27827988|NCT01711736|54294731|FG000|Overall Study|Withdrawal by Subject|6|||
27827989|NCT01711736|54294732|FG001|Overall Study|Withdrawal by Subject|6|||
27827990|NCT01711736|54294731|FG000|Overall Study|Migrated/moved from study area|2|||
27827991|NCT01711736|54294732|FG001|Overall Study|Migrated/moved from study area|1|||
27827992|NCT01592708|54294741|FG000|Overall Study|Protocol Violation|3|||
27827993|NCT01592708|54294742|FG001|Overall Study|Protocol Violation|0|||
27827994|NCT01042522|54294753|FG000|Overall Study|Adverse Event|1|||
27827995|NCT01042522|54294754|FG001|Overall Study|Adverse Event|2|||
27827996|NCT01042522|54294753|FG000|Overall Study|Disease Progression|5|||
27827997|NCT01042522|54294754|FG001|Overall Study|Disease Progression|0|||
27827998|NCT01042522|54294753|FG000|Overall Study|Death|1|||
27827999|NCT01042522|54294754|FG001|Overall Study|Death|0|||
27828000|NCT01042522|54294753|FG000|Overall Study|Patient Refused|0|||
27828001|NCT01042522|54294754|FG001|Overall Study|Patient Refused|3|||
27828002|NCT01042522|54294753|FG000|Overall Study|Withdrawal by Subject|1|||
27828003|NCT01042522|54294754|FG001|Overall Study|Withdrawal by Subject|1|||
27828004|NCT01702844|54294760|FG000|Overall Study|Adverse Event|9|||
27828005|NCT01702844|54294760|FG000|Overall Study|Death|1|||
27828006|NCT01702844|54294760|FG000|Overall Study|Withdrawal by Subject|3|||
27943253|NCT00979953|54600199|FG003|Overall Study|Lost to Follow-up|0|||
28160152|NCT00711555|54830269|FG000|Overall Study|Adverse Event|3|||
27828007|NCT01702844|54294760|FG000|Overall Study|Physician Decision|6|||
27828008|NCT01702532|54294766|FG000|Overall Study|Adverse Event|0|||
27828009|NCT01702532|54294767|FG001|Overall Study|Adverse Event|1|||
27828010|NCT01702454|54294776|FG000|Overall Study|Consent withdrawal|0|||
27828011|NCT01702454|54294777|FG001|Overall Study|Consent withdrawal|1|||
27828012|NCT01702454|54294776|FG000|Overall Study|Migrated/moved from study area|0|||
27828013|NCT01702454|54294777|FG001|Overall Study|Migrated/moved from study area|1|||
27828014|NCT01702454|54294776|FG000|Overall Study|Lost to Follow-up|3|||
27828015|NCT01702454|54294777|FG001|Overall Study|Lost to Follow-up|6|||
27828016|NCT01702298|54294790|FG000|Overall Study|Withdrawal by Subject|1|||
27943254|NCT00979953|54600196|FG000|Overall Study|Withdrawal by Subject|0|||
27828017|NCT01701362|54294796|FG000|Overall Study|Adverse events not related to study drug|1|||
27828018|NCT01701362|54294797|FG001|Overall Study|Adverse events not related to study drug|6|||
27828019|NCT01701362|54294796|FG000|Overall Study|Adverse events related to study drug|12|||
27828020|NCT01701362|54294797|FG001|Overall Study|Adverse events related to study drug|10|||
27828021|NCT01701362|54294796|FG000|Overall Study|Protocol Violation|5|||
27828022|NCT01701362|54294797|FG001|Overall Study|Protocol Violation|3|||
27828023|NCT01701362|54294796|FG000|Overall Study|No longer willing to participate|8|||
27828024|NCT01701362|54294797|FG001|Overall Study|No longer willing to participate|14|||
27828025|NCT01701362|54294796|FG000|Overall Study|Lost to Follow-up|6|||
27828026|NCT01701362|54294797|FG001|Overall Study|Lost to Follow-up|9|||
27828027|NCT01701362|54294796|FG000|Overall Study|Insufficient clinical response|6|||
27828028|NCT01701362|54294797|FG001|Overall Study|Insufficient clinical response|6|||
27828029|NCT01701362|54294796|FG000|Overall Study|Death|0|||
27828030|NCT01701362|54294797|FG001|Overall Study|Death|1|||
27828031|NCT01701362|54294796|FG000|Overall Study|Randomized but not treated|1|||
27828032|NCT01701362|54294797|FG001|Overall Study|Randomized but not treated|2|||
27828033|NCT01701362|54294796|FG000|Overall Study|Reasons other than those mentioned above|3|||
27828034|NCT01701362|54294797|FG001|Overall Study|Reasons other than those mentioned above|5|||
27828035|NCT01710800|54294826|FG000|Overall Study|Withdrawal by Subject|21|||
27828036|NCT01710800|54294826|FG000|Overall Study|Protocol Violation|1|||
27828037|NCT01710020|54294832|FG000|Period 1|Protocol Violation|1|||
27828038|NCT01700348|54294838|FG000|Overall Study|Withdrawal by Subject|22|||
27828039|NCT01700348|54294838|FG000|Overall Study|Lost to Follow-up|1|||
27828040|NCT01700192|54294846|FG000|Overall Study|Adverse Event|73|||
27828041|NCT01700192|54294847|FG001|Overall Study|Adverse Event|18|||
27828042|NCT01700192|54294846|FG000|Overall Study|Lack of Efficacy|1|||
27828043|NCT01700192|54294847|FG001|Overall Study|Lack of Efficacy|0|||
27828044|NCT01700192|54294846|FG000|Overall Study|Lost to Follow-up|42|||
27828045|NCT01700192|54294847|FG001|Overall Study|Lost to Follow-up|29|||
27828046|NCT01700192|54294846|FG000|Overall Study|Noncompliance with study drug|0|||
27828047|NCT01700192|54294847|FG001|Overall Study|Noncompliance with study drug|5|||
27828048|NCT01700192|54294846|FG000|Overall Study|Physician Decision|2|||
27828049|NCT01700192|54294847|FG001|Overall Study|Physician Decision|3|||
27828050|NCT01700192|54294846|FG000|Overall Study|Pregnancy|1|||
27828051|NCT01700192|54294847|FG001|Overall Study|Pregnancy|4|||
27828052|NCT01700192|54294846|FG000|Overall Study|Progressive disease|1|||
27828053|NCT01700192|54294847|FG001|Overall Study|Progressive disease|0|||
27828054|NCT01700192|54294846|FG000|Overall Study|Protocol Violation|3|||
27828055|NCT01700192|54294847|FG001|Overall Study|Protocol Violation|4|||
27828056|NCT01700192|54294846|FG000|Overall Study|Technical problems|0|||
27828057|NCT01700192|54294847|FG001|Overall Study|Technical problems|1|||
27828058|NCT01700192|54294846|FG000|Overall Study|Withdrawal by Subject|56|||
27828059|NCT01700192|54294847|FG001|Overall Study|Withdrawal by Subject|64|||
27828060|NCT01700192|54294846|FG000|Overall Study|Never received study drug|1|||
27828061|NCT01700192|54294847|FG001|Overall Study|Never received study drug|0|||
27828062|NCT01709864|54294864|FG000|Overall Study|Physician Decision|0|||
27828063|NCT01709864|54294865|FG001|Overall Study|Physician Decision|1|||
27828064|NCT01709864|54294864|FG000|Overall Study|subject/guardian decision|5|||
27828065|NCT01709864|54294865|FG001|Overall Study|subject/guardian decision|6|||
27828066|NCT01709864|54294864|FG000|Overall Study|Lost to Follow-up|1|||
27828067|NCT01709864|54294865|FG001|Overall Study|Lost to Follow-up|0|||
27828068|NCT01709864|54294864|FG000|Overall Study|non-compliance with study treatment|1|||
27828069|NCT01709864|54294865|FG001|Overall Study|non-compliance with study treatment|1|||
27828070|NCT01709864|54294864|FG000|Overall Study|Adverse Event|0|||
27828071|NCT01709864|54294865|FG001|Overall Study|Adverse Event|2|||
27828072|NCT01709864|54294864|FG000|Overall Study|Death|0|||
27828073|NCT01709864|54294865|FG001|Overall Study|Death|1|||
27828074|NCT01709708|54294873|FG000|Overall Study|Protocol Violation|1|||
27828075|NCT01709708|54294874|FG001|Overall Study|Protocol Violation|2|||
27828076|NCT01709318|54294897|FG000|Overall Study|Adverse Event|3|||
27828077|NCT01709318|54294898|FG001|Overall Study|Adverse Event|4|||
27828078|NCT01709318|54294899|FG002|Overall Study|Adverse Event|2|||
27828079|NCT01709318|54294900|FG003|Overall Study|Adverse Event|2|||
27828080|NCT01709318|54294901|FG004|Overall Study|Adverse Event|0|||
27828081|NCT01709318|54294902|FG005|Overall Study|Adverse Event|1|||
27828082|NCT01709318|54294903|FG006|Overall Study|Adverse Event|2|||
27828083|NCT01709318|54294897|FG000|Overall Study|Lost to Follow-up|2|||
27828084|NCT01709318|54294898|FG001|Overall Study|Lost to Follow-up|0|||
27828085|NCT01709318|54294899|FG002|Overall Study|Lost to Follow-up|0|||
27828086|NCT01709318|54294900|FG003|Overall Study|Lost to Follow-up|0|||
27828087|NCT01709318|54294901|FG004|Overall Study|Lost to Follow-up|1|||
27828088|NCT01709318|54294902|FG005|Overall Study|Lost to Follow-up|1|||
27828089|NCT01709318|54294903|FG006|Overall Study|Lost to Follow-up|1|||
27828090|NCT01709318|54294897|FG000|Overall Study|Non-compliance with Study Drug|0|||
27828091|NCT01709318|54294898|FG001|Overall Study|Non-compliance with Study Drug|2|||
27828092|NCT01709318|54294899|FG002|Overall Study|Non-compliance with Study Drug|1|||
27828093|NCT01709318|54294900|FG003|Overall Study|Non-compliance with Study Drug|1|||
27828094|NCT01709318|54294901|FG004|Overall Study|Non-compliance with Study Drug|0|||
27828095|NCT01709318|54294902|FG005|Overall Study|Non-compliance with Study Drug|0|||
27828096|NCT01709318|54294903|FG006|Overall Study|Non-compliance with Study Drug|2|||
27828097|NCT01709318|54294897|FG000|Overall Study|Physician Decision|0|||
27828098|NCT01709318|54294898|FG001|Overall Study|Physician Decision|0|||
27828099|NCT01709318|54294899|FG002|Overall Study|Physician Decision|0|||
27828100|NCT01709318|54294900|FG003|Overall Study|Physician Decision|0|||
27828101|NCT01709318|54294901|FG004|Overall Study|Physician Decision|0|||
27828102|NCT01709318|54294902|FG005|Overall Study|Physician Decision|0|||
27828103|NCT01709318|54294903|FG006|Overall Study|Physician Decision|1|||
27828104|NCT01709318|54294897|FG000|Overall Study|Pregnancy|0|||
27828105|NCT01709318|54294898|FG001|Overall Study|Pregnancy|0|||
27828106|NCT01709318|54294899|FG002|Overall Study|Pregnancy|0|||
27828107|NCT01709318|54294900|FG003|Overall Study|Pregnancy|0|||
27828108|NCT01709318|54294901|FG004|Overall Study|Pregnancy|1|||
27828109|NCT01709318|54294902|FG005|Overall Study|Pregnancy|0|||
27828110|NCT01709318|54294903|FG006|Overall Study|Pregnancy|0|||
27828111|NCT01709318|54294897|FG000|Overall Study|Protocol Violation|0|||
27828112|NCT01709318|54294898|FG001|Overall Study|Protocol Violation|0|||
27828113|NCT01709318|54294899|FG002|Overall Study|Protocol Violation|0|||
27828114|NCT01709318|54294900|FG003|Overall Study|Protocol Violation|0|||
27828115|NCT01709318|54294901|FG004|Overall Study|Protocol Violation|2|||
27828116|NCT01709318|54294902|FG005|Overall Study|Protocol Violation|0|||
27828117|NCT01709318|54294903|FG006|Overall Study|Protocol Violation|1|||
27828118|NCT01709318|54294897|FG000|Overall Study|Technical Problems|1|||
27828119|NCT01709318|54294898|FG001|Overall Study|Technical Problems|0|||
27828120|NCT01709318|54294899|FG002|Overall Study|Technical Problems|0|||
27828121|NCT01709318|54294900|FG003|Overall Study|Technical Problems|0|||
27828122|NCT01709318|54294901|FG004|Overall Study|Technical Problems|0|||
27828123|NCT01709318|54294902|FG005|Overall Study|Technical Problems|0|||
27828124|NCT01709318|54294903|FG006|Overall Study|Technical Problems|0|||
27828125|NCT01709318|54294897|FG000|Overall Study|Withdrawal by Subject|3|||
27828126|NCT01709318|54294898|FG001|Overall Study|Withdrawal by Subject|0|||
27828127|NCT01709318|54294899|FG002|Overall Study|Withdrawal by Subject|3|||
27828128|NCT01709318|54294900|FG003|Overall Study|Withdrawal by Subject|3|||
27828129|NCT01709318|54294901|FG004|Overall Study|Withdrawal by Subject|0|||
27828130|NCT01709318|54294902|FG005|Overall Study|Withdrawal by Subject|2|||
27828131|NCT01709318|54294903|FG006|Overall Study|Withdrawal by Subject|4|||
27828132|NCT01709318|54294897|FG000|Overall Study|Other Protocol Specified Criteria|0|||
27828133|NCT01709318|54294898|FG001|Overall Study|Other Protocol Specified Criteria|1|||
27828134|NCT01709318|54294899|FG002|Overall Study|Other Protocol Specified Criteria|0|||
27828135|NCT01709318|54294900|FG003|Overall Study|Other Protocol Specified Criteria|0|||
27828136|NCT01709318|54294901|FG004|Overall Study|Other Protocol Specified Criteria|0|||
27828137|NCT01709318|54294902|FG005|Overall Study|Other Protocol Specified Criteria|0|||
27828138|NCT01709318|54294903|FG006|Overall Study|Other Protocol Specified Criteria|0|||
27828139|NCT01699178|54294921|FG000|Overall Study|Adverse Event|1|||
27828140|NCT01699178|54294922|FG001|Overall Study|Adverse Event|5|||
27828141|NCT01699178|54294921|FG000|Overall Study|Lost to Follow-up|1|||
27828142|NCT01699178|54294922|FG001|Overall Study|Lost to Follow-up|6|||
27828143|NCT01699178|54294921|FG000|Overall Study|Non-compliance with Study Drug|3|||
27828144|NCT01699178|54294922|FG001|Overall Study|Non-compliance with Study Drug|1|||
27828145|NCT01699178|54294921|FG000|Overall Study|Physician Decision|1|||
27828146|NCT01699178|54294922|FG001|Overall Study|Physician Decision|0|||
27828147|NCT01699178|54294921|FG000|Overall Study|Withdrawal by Subject|4|||
27828148|NCT01699178|54294922|FG001|Overall Study|Withdrawal by Subject|12|||
27828149|NCT01699178|54294921|FG000|Overall Study|Hematocrit >54%|1|||
27828150|NCT01699178|54294922|FG001|Overall Study|Hematocrit >54%|1|||
27828151|NCT01699178|54294921|FG000|Overall Study|PSA increase of >1.4 ng/mL|4|||
27828152|NCT01699178|54294922|FG001|Overall Study|PSA increase of >1.4 ng/mL|3|||
27828153|NCT01699178|54294921|FG000|Overall Study|ineligible/noncompliant/ subject reason|4|||
27828154|NCT01699178|54294922|FG001|Overall Study|ineligible/noncompliant/ subject reason|4|||
27828155|NCT01683409|54294933|FG000|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
27828156|NCT01683409|54294934|FG001|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
27828157|NCT01683409|54294935|FG002|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1|||
27828158|NCT01683409|54294936|FG003|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
28076786|NCT00111800|54731653|FG005|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
28076787|NCT00111800|54731648|FG000|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
28076788|NCT00111800|54731649|FG001|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1|||
28076789|NCT00111800|54731650|FG002|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
27828159|NCT01683409|54294937|FG004|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
27828160|NCT01683409|54294933|FG000|Treatment Period (Weeks 1-24)|Adverse Event|0|||
27828161|NCT01683409|54294934|FG001|Treatment Period (Weeks 1-24)|Adverse Event|3|||
27828162|NCT01683409|54294935|FG002|Treatment Period (Weeks 1-24)|Adverse Event|0|||
27828163|NCT01683409|54294936|FG003|Treatment Period (Weeks 1-24)|Adverse Event|1|||
27828164|NCT01683409|54294937|FG004|Treatment Period (Weeks 1-24)|Adverse Event|1|||
27828165|NCT01683409|54294933|FG000|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
27828166|NCT01683409|54294934|FG001|Treatment Period (Weeks 1-24)|Lost to Follow-up|1|||
27828167|NCT01683409|54294935|FG002|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
27828168|NCT01683409|54294936|FG003|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
27828169|NCT01683409|54294937|FG004|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
27828170|NCT01683409|54294933|FG000|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
27828171|NCT01683409|54294934|FG001|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
27828172|NCT01683409|54294935|FG002|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
27828173|NCT01683409|54294936|FG003|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
27828174|NCT01683409|54294937|FG004|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
27828175|NCT01683409|54294933|FG000|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
27828176|NCT01683409|54294934|FG001|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
27828177|NCT01683409|54294935|FG002|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1|||
27828178|NCT01683409|54294936|FG003|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
27828179|NCT01683409|54294937|FG004|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
27828180|NCT01683409|54294933|FG000|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
27828181|NCT01683409|54294934|FG001|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
27828182|NCT01683409|54294935|FG002|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
27828183|NCT01683409|54294936|FG003|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
27828184|NCT01683409|54294937|FG004|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
27828185|NCT01683409|54294933|FG000|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
27828186|NCT01683409|54294934|FG001|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
27828187|NCT01683409|54294935|FG002|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
27828188|NCT01683409|54294936|FG003|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
27828189|NCT01683409|54294937|FG004|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
27828190|NCT01683409|54294933|FG000|Washout Period 1 (Weeks 25-28)|Physician Decision|1|||
27828191|NCT01683409|54294934|FG001|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
27828192|NCT01683409|54294935|FG002|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
27828193|NCT01683409|54294936|FG003|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
27828194|NCT01683409|54294937|FG004|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
27828195|NCT01683409|54294933|FG000|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
27828196|NCT01683409|54294934|FG001|Washout Period 1 (Weeks 25-28)|Adverse Event|4|||
27828197|NCT01683409|54294935|FG002|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
27828198|NCT01683409|54294936|FG003|Washout Period 1 (Weeks 25-28)|Adverse Event|1|||
27828199|NCT01683409|54294937|FG004|Washout Period 1 (Weeks 25-28)|Adverse Event|2|||
27828200|NCT01683409|54294933|FG000|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
27828201|NCT01683409|54294934|FG001|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
27828202|NCT01683409|54294935|FG002|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
27828203|NCT01683409|54294936|FG003|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
27828204|NCT01683409|54294937|FG004|Washout Period 2 (Weeks 29-32)|Adverse Event|3|||
27828205|NCT01683409|54294933|FG000|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
27828206|NCT01683409|54294934|FG001|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
27828207|NCT01683409|54294935|FG002|Washout Period 2 (Weeks 29-32)|Physician Decision|1|||
27828208|NCT01683409|54294936|FG003|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
27828209|NCT01683409|54294937|FG004|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
27828210|NCT01699022|54294963|FG000|Overall Study|Early discontinuation from the study|3|||
27828211|NCT01683019|54294971|FG000|Overall Study|Withdrawal by Subject|2|||
27828212|NCT01683019|54294972|FG001|Overall Study|Withdrawal by Subject|1|||
27828213|NCT01683019|54294973|FG002|Overall Study|Withdrawal by Subject|4|||
27828214|NCT01709162|54294983|FG000|Overall Study|Disease progression|3|||
27828215|NCT01709162|54294984|FG001|Overall Study|Disease progression|3|||
27828216|NCT01709162|54294983|FG000|Overall Study|Study drug toxicity|2|||
27828217|NCT01709162|54294984|FG001|Overall Study|Study drug toxicity|0|||
27828218|NCT01709162|54294983|FG000|Overall Study|Administrative reason by sponsor|0|||
27828219|NCT01709162|54294984|FG001|Overall Study|Administrative reason by sponsor|1|||
27828220|NCT01709162|54294983|FG000|Overall Study|Other|1|||
27828221|NCT01709162|54294984|FG001|Overall Study|Other|0|||
27828222|NCT01709162|54294983|FG000|Overall Study|Withdrawal by Subject|0|||
27828223|NCT01709162|54294984|FG001|Overall Study|Withdrawal by Subject|1|||
27828224|NCT01698554|54294994|FG000|Overall Study|Adverse Event|2|||
27828225|NCT01698554|54294995|FG001|Overall Study|Adverse Event|5|||
27828226|NCT01698554|54294996|FG002|Overall Study|Adverse Event|0|||
27828227|NCT01698554|54294997|FG003|Overall Study|Adverse Event|1|||
27828228|NCT01698554|54294994|FG000|Overall Study|Lost to Follow-up|1|||
28159783|NCT01377480|54829772|FG001|Overall Study|Serious adverse event|0|||
27828229|NCT01698554|54294995|FG001|Overall Study|Lost to Follow-up|0|||
27828230|NCT01698554|54294996|FG002|Overall Study|Lost to Follow-up|0|||
27828231|NCT01698554|54294997|FG003|Overall Study|Lost to Follow-up|0|||
27828232|NCT01698554|54294994|FG000|Overall Study|Personal Reasons|0|||
27828233|NCT01698554|54294995|FG001|Overall Study|Personal Reasons|5|||
27828234|NCT01698554|54294996|FG002|Overall Study|Personal Reasons|1|||
27828235|NCT01698554|54294997|FG003|Overall Study|Personal Reasons|1|||
27828236|NCT01698554|54294994|FG000|Overall Study|Protocol Violation|2|||
27828237|NCT01698554|54294995|FG001|Overall Study|Protocol Violation|0|||
27828238|NCT01698554|54294996|FG002|Overall Study|Protocol Violation|1|||
27828239|NCT01698554|54294997|FG003|Overall Study|Protocol Violation|0|||
27828240|NCT01698554|54294994|FG000|Overall Study|Other Miscellaneous Reasons|1|||
27828241|NCT01698554|54294995|FG001|Overall Study|Other Miscellaneous Reasons|0|||
27828242|NCT01698554|54294996|FG002|Overall Study|Other Miscellaneous Reasons|0|||
27828243|NCT01698554|54294997|FG003|Overall Study|Other Miscellaneous Reasons|0|||
27828244|NCT01698320|54295009|FG000|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24|||
27828245|NCT01698320|54295010|FG001|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
27828246|NCT01698320|54295011|FG002|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
27828247|NCT01698320|54295009|FG000|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1|||
27828248|NCT01698320|54295010|FG001|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
27828249|NCT01698320|54295011|FG002|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
27828250|NCT01698320|54295009|FG000|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1|||
27828251|NCT01698320|54295010|FG001|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
27828252|NCT01698320|54295011|FG002|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
27828253|NCT01698320|54295009|FG000|Run-In Period (Week -1 to Day 0)|Other|1|||
27828254|NCT01698320|54295010|FG001|Run-In Period (Week -1 to Day 0)|Other|0|||
27828255|NCT01698320|54295011|FG002|Run-In Period (Week -1 to Day 0)|Other|0|||
27828256|NCT01698320|54295009|FG000|12-Week Double-Blind Period|Adverse Event|0|||
27828257|NCT01698320|54295010|FG001|12-Week Double-Blind Period|Adverse Event|1|||
27828258|NCT01698320|54295011|FG002|12-Week Double-Blind Period|Adverse Event|1|||
27828259|NCT01698320|54295009|FG000|12-Week Double-Blind Period|Withdrawal by Subject|0|||
27828260|NCT01698320|54295010|FG001|12-Week Double-Blind Period|Withdrawal by Subject|2|||
27828261|NCT01698320|54295011|FG002|12-Week Double-Blind Period|Withdrawal by Subject|2|||
27828262|NCT01698320|54295009|FG000|12-Week Double-Blind Period|Protocol Violation|0|||
27828263|NCT01698320|54295010|FG001|12-Week Double-Blind Period|Protocol Violation|0|||
27828264|NCT01698320|54295011|FG002|12-Week Double-Blind Period|Protocol Violation|2|||
27828265|NCT01698320|54295009|FG000|12-Week Double-Blind Period|Pregnancy|0|||
27828266|NCT01698320|54295010|FG001|12-Week Double-Blind Period|Pregnancy|1|||
27828267|NCT01698320|54295011|FG002|12-Week Double-Blind Period|Pregnancy|1|||
27828268|NCT01698320|54295009|FG000|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
27828269|NCT01698320|54295010|FG001|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
27828270|NCT01698320|54295011|FG002|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2|||
27828271|NCT01698320|54295009|FG000|12-Week Double-Blind Period|Lost to Follow-up|0|||
27828272|NCT01698320|54295010|FG001|12-Week Double-Blind Period|Lost to Follow-up|0|||
27828273|NCT01698320|54295011|FG002|12-Week Double-Blind Period|Lost to Follow-up|4|||
27828274|NCT01698320|54295009|FG000|40-Week Open-Label Period|Adverse Event|0|||
27828275|NCT01698320|54295010|FG001|40-Week Open-Label Period|Adverse Event|3|||
27828276|NCT01698320|54295011|FG002|40-Week Open-Label Period|Adverse Event|2|||
27828277|NCT01698320|54295009|FG000|40-Week Open-Label Period|Withdrawal by Subject|0|||
27828278|NCT01698320|54295010|FG001|40-Week Open-Label Period|Withdrawal by Subject|11|||
27828279|NCT01698320|54295011|FG002|40-Week Open-Label Period|Withdrawal by Subject|7|||
27828280|NCT01698320|54295009|FG000|40-Week Open-Label Period|Pregnancy|0|||
27828281|NCT01698320|54295010|FG001|40-Week Open-Label Period|Pregnancy|2|||
27828282|NCT01698320|54295011|FG002|40-Week Open-Label Period|Pregnancy|1|||
27828283|NCT01698320|54295009|FG000|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
27828284|NCT01698320|54295010|FG001|40-Week Open-Label Period|Sponsor requested subject withdrawal|1|||
27828285|NCT01698320|54295011|FG002|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
27828286|NCT01698320|54295009|FG000|40-Week Open-Label Period|Lost to Follow-up|0|||
27828287|NCT01698320|54295010|FG001|40-Week Open-Label Period|Lost to Follow-up|2|||
27828288|NCT01698320|54295011|FG002|40-Week Open-Label Period|Lost to Follow-up|0|||
27828289|NCT01698008|54295021|FG000|Overall Study|Withdrawal by Subject|1|||
27828290|NCT01698008|54295022|FG001|Overall Study|Withdrawal by Subject|2|||
27828291|NCT01697696|54295038|FG000|Overall Study|Study terminated by sponsor|0|||
27828292|NCT01697696|54295039|FG001|Overall Study|Study terminated by sponsor|3|||
27828293|NCT01697696|54295038|FG000|Overall Study|Protocol deviation|1|||
27828294|NCT01697696|54295039|FG001|Overall Study|Protocol deviation|0|||
27828295|NCT01697696|54295038|FG000|Overall Study|Physician Decision|1|||
27828296|NCT01697696|54295039|FG001|Overall Study|Physician Decision|0|||
27828297|NCT01697696|54295038|FG000|Overall Study|Death|4|||
27828298|NCT01697696|54295039|FG001|Overall Study|Death|2|||
27828299|NCT01697696|54295038|FG000|Overall Study|Lost to Follow-up|10|||
27850764|NCT03472040|54349812|FG000|Overall Study|Subject Non-compliance|2|||
27943255|NCT00979953|54600197|FG001|Overall Study|Withdrawal by Subject|0|||
27943256|NCT00979953|54600198|FG002|Overall Study|Withdrawal by Subject|2|||
27828300|NCT01697696|54295039|FG001|Overall Study|Lost to Follow-up|7|||
27828301|NCT01697696|54295038|FG000|Overall Study|Subject/guardian decision|31|||
27828302|NCT01697696|54295039|FG001|Overall Study|Subject/guardian decision|35|||
27850765|NCT03472040|54349813|FG001|Overall Study|Subject Non-compliance|5|||
27828303|NCT01569152|54295047|FG000|Phase IIa, Period 1|Early Escape|5|||
27828304|NCT01569152|54295048|FG001|Phase IIa, Period 1|Early Escape|22|||
27828305|NCT01569152|54295049|FG002|Phase IIa, Period 1|Early Escape|0|||
27828306|NCT01569152|54295047|FG000|Phase IIa, Period 1|Adverse Event|4|||
27828307|NCT01569152|54295048|FG001|Phase IIa, Period 1|Adverse Event|0|||
27828308|NCT01569152|54295049|FG002|Phase IIa, Period 1|Adverse Event|0|||
27828309|NCT01569152|54295047|FG000|Phase IIa, Period 1|Lost to Follow-up|1|||
27828310|NCT01569152|54295048|FG001|Phase IIa, Period 1|Lost to Follow-up|0|||
27828311|NCT01569152|54295049|FG002|Phase IIa, Period 1|Lost to Follow-up|0|||
27828312|NCT01569152|54295047|FG000|Phase IIa, Period 1|Study Terminated by Sponsor|9|||
27828313|NCT01569152|54295048|FG001|Phase IIa, Period 1|Study Terminated by Sponsor|8|||
27828314|NCT01569152|54295049|FG002|Phase IIa, Period 1|Study Terminated by Sponsor|0|||
27828315|NCT01569152|54295047|FG000|Phase IIa, Period 1|Protocol Violation|0|||
27828316|NCT01569152|54295048|FG001|Phase IIa, Period 1|Protocol Violation|1|||
27828317|NCT01569152|54295049|FG002|Phase IIa, Period 1|Protocol Violation|0|||
27828318|NCT01569152|54295047|FG000|Phase IIa, Period 1|Withdrawal by Subject|2|||
27828319|NCT01569152|54295048|FG001|Phase IIa, Period 1|Withdrawal by Subject|1|||
27828320|NCT01569152|54295049|FG002|Phase IIa, Period 1|Withdrawal by Subject|0|||
27828321|NCT01569152|54295047|FG000|Safety Extension, Period 3|Adverse Event|0|||
27828322|NCT01569152|54295048|FG001|Safety Extension, Period 3|Adverse Event|0|||
27828323|NCT01569152|54295049|FG002|Safety Extension, Period 3|Adverse Event|4|||
27828324|NCT01569152|54295047|FG000|Safety Extension, Period 3|Withdrawal by Subject|0|||
27828325|NCT01569152|54295048|FG001|Safety Extension, Period 3|Withdrawal by Subject|0|||
27828326|NCT01569152|54295049|FG002|Safety Extension, Period 3|Withdrawal by Subject|2|||
27828327|NCT01569152|54295047|FG000|Safety Extension, Period 3|Physician Decision|0|||
27828328|NCT01569152|54295048|FG001|Safety Extension, Period 3|Physician Decision|0|||
27828329|NCT01569152|54295049|FG002|Safety Extension, Period 3|Physician Decision|2|||
27828330|NCT01569152|54295047|FG000|Safety Extension, Period 3|Study terminated by Sponsor|0|||
27828331|NCT01569152|54295048|FG001|Safety Extension, Period 3|Study terminated by Sponsor|0|||
27828332|NCT01569152|54295049|FG002|Safety Extension, Period 3|Study terminated by Sponsor|47|||
27828333|NCT01569074|54295074|FG000|Overall Study|Study stopped|6|||
27828334|NCT01569074|54295075|FG001|Overall Study|Study stopped|6|||
27828335|NCT01569074|54295076|FG002|Overall Study|Study stopped|8|||
27828336|NCT01569074|54295077|FG003|Overall Study|Study stopped|7|||
27828337|NCT01569074|54295078|FG004|Overall Study|Study stopped|7|||
27828338|NCT01569074|54295074|FG000|Overall Study|Study-specific discontinuation criteria|0|||
27828339|NCT01569074|54295075|FG001|Overall Study|Study-specific discontinuation criteria|1|||
27828340|NCT01569074|54295076|FG002|Overall Study|Study-specific discontinuation criteria|0|||
27828341|NCT01569074|54295077|FG003|Overall Study|Study-specific discontinuation criteria|0|||
27828342|NCT01569074|54295078|FG004|Overall Study|Study-specific discontinuation criteria|0|||
27828343|NCT01569074|54295074|FG000|Overall Study|Severe non-compliance to protocol|0|||
27828344|NCT01569074|54295075|FG001|Overall Study|Severe non-compliance to protocol|0|||
27828345|NCT01569074|54295076|FG002|Overall Study|Severe non-compliance to protocol|1|||
27828346|NCT01569074|54295077|FG003|Overall Study|Severe non-compliance to protocol|0|||
27828347|NCT01569074|54295078|FG004|Overall Study|Severe non-compliance to protocol|0|||
27828348|NCT01569074|54295074|FG000|Overall Study|eg change in circumstances|0|||
27828349|NCT01569074|54295075|FG001|Overall Study|eg change in circumstances|2|||
27828350|NCT01569074|54295076|FG002|Overall Study|eg change in circumstances|0|||
27828351|NCT01569074|54295077|FG003|Overall Study|eg change in circumstances|1|||
27828352|NCT01569074|54295078|FG004|Overall Study|eg change in circumstances|1|||
27828353|NCT01569074|54295074|FG000|Overall Study|Adverse Event|1|||
27828354|NCT01569074|54295075|FG001|Overall Study|Adverse Event|0|||
27828355|NCT01569074|54295076|FG002|Overall Study|Adverse Event|3|||
27828356|NCT01569074|54295077|FG003|Overall Study|Adverse Event|0|||
27828357|NCT01569074|54295078|FG004|Overall Study|Adverse Event|0|||
27828358|NCT01604408|54295096|FG000|Treatment Period 1|Protocol Violation|0|||
27828359|NCT01604408|54295097|FG001|Treatment Period 1|Protocol Violation|1|||
27828360|NCT01604408|54295096|FG000|Treatment Period 2|Withdrawal by Subject|1|||
27828361|NCT01604408|54295097|FG001|Treatment Period 2|Withdrawal by Subject|1|||
27828362|NCT01604408|54295096|FG000|Treatment Period 2|Protocol Violation|1|||
27828363|NCT01604408|54295097|FG001|Treatment Period 2|Protocol Violation|0|||
27828364|NCT01604408|54295096|FG000|Treatment Period 2|Adverse Event|0|||
27828365|NCT01604408|54295097|FG001|Treatment Period 2|Adverse Event|1|||
27828366|NCT01604408|54295096|FG000|Treatment Period 3|Protocol Violation|1|||
27828367|NCT01604408|54295097|FG001|Treatment Period 3|Protocol Violation|1|||
27828368|NCT01604408|54295096|FG000|Treatment Period 3|Adverse Event|0|||
27828369|NCT01604408|54295097|FG001|Treatment Period 3|Adverse Event|3|||
27828370|NCT01604408|54295096|FG000|Treatment Period 3|Withdrawal by Subject|3|||
27828371|NCT01604408|54295097|FG001|Treatment Period 3|Withdrawal by Subject|1|||
27828372|NCT01604408|54295096|FG000|Treatment Period 3|Sponsor Decision|1|||
27828373|NCT01604408|54295097|FG001|Treatment Period 3|Sponsor Decision|0|||
27828374|NCT01604408|54295096|FG000|Treatment Period 4|Death|1|||
27828375|NCT01604408|54295097|FG001|Treatment Period 4|Death|0|||
27828376|NCT01604408|54295096|FG000|Treatment Period 4|Withdrawal by Subject|2|||
27828377|NCT01604408|54295097|FG001|Treatment Period 4|Withdrawal by Subject|1|||
27828378|NCT01604408|54295096|FG000|Treatment Period 4|Adverse Event|0|||
27828379|NCT01604408|54295097|FG001|Treatment Period 4|Adverse Event|1|||
27828380|NCT01604408|54295096|FG000|Treatment Period 5|Adverse Event|4|||
27828381|NCT01604408|54295097|FG001|Treatment Period 5|Adverse Event|0|||
27828382|NCT01604408|54295096|FG000|Treatment Period 6|Lost to Follow-up|0|||
27828383|NCT01604408|54295097|FG001|Treatment Period 6|Lost to Follow-up|1|||
27828384|NCT01604408|54295096|FG000|Treatment Period 6|Adverse Event|2|||
27828385|NCT01604408|54295097|FG001|Treatment Period 6|Adverse Event|0|||
27828386|NCT01604408|54295096|FG000|Treatment Period 6|Sponsor decision|0|||
27828387|NCT01604408|54295097|FG001|Treatment Period 6|Sponsor decision|1|||
27828388|NCT01604408|54295096|FG000|Observation Period|Adverse Event|1|||
27828389|NCT01604408|54295097|FG001|Observation Period|Adverse Event|1|||
27828390|NCT01604408|54295096|FG000|Observation Period|Withdrawal by Subject|0|||
27828391|NCT01604408|54295097|FG001|Observation Period|Withdrawal by Subject|2|||
27828392|NCT01567826|54295105|FG000|Overall Study|Lost to Follow-up|3|||
27828393|NCT01567826|54295106|FG001|Overall Study|Lost to Follow-up|2|||
27828394|NCT01697462|54295114|FG000|Overall Study|Disease Progression|1|||
27828395|NCT01697462|54295114|FG000|Overall Study|Adverse Event|6|||
27828396|NCT01697462|54295114|FG000|Overall Study|Lost to Follow-up|21|||
27828397|NCT01697462|54295114|FG000|Overall Study|Withdrawal by Subject|12|||
27828398|NCT01697462|54295114|FG000|Overall Study|Investigator Decision|21|||
27828399|NCT01697462|54295114|FG000|Overall Study|Death|1|||
27828400|NCT01697462|54295114|FG000|Overall Study|Other|10|||
27828401|NCT01697462|54295114|FG000|Overall Study|Missing|5|||
27828402|NCT01696994|54295120|FG000|Overall Study|Cancer Before Rand. (Ovarian Screening)|0|||
27828403|NCT01696994|54295121|FG001|Overall Study|Cancer Before Rand. (Ovarian Screening)|2|||
27828404|NCT01696994|54295120|FG000|Overall Study|Died Before Randomization|1|||
27828405|NCT01696994|54295121|FG001|Overall Study|Died Before Randomization|2|||
27828406|NCT01696994|54295120|FG000|Overall Study|Died Before ASU (Control)|73|||
27828407|NCT01696994|54295121|FG001|Overall Study|Died Before ASU (Control)|0|||
27828408|NCT01696994|54295120|FG000|Overall Study|No Ovaries at Baseline|4807|||
27828409|NCT01696994|54295121|FG001|Overall Study|No Ovaries at Baseline|4851|||
27828410|NCT01696994|54295120|FG000|Overall Study|Refused ASU (Control)|311|||
27828411|NCT01696994|54295121|FG001|Overall Study|Refused ASU (Control)|0|||
27828412|NCT01696994|54295120|FG000|Overall Study|Refused Screen (Ovarian Screening)|0|||
27828413|NCT01696994|54295121|FG001|Overall Study|Refused Screen (Ovarian Screening)|3582|||
27828414|NCT01592240|54295300|FG000|Overall Study|Adverse Event|1|||
27828415|NCT01592240|54295301|FG001|Overall Study|Adverse Event|0|||
27828416|NCT01592240|54295302|FG002|Overall Study|Adverse Event|0|||
27828417|NCT01592240|54295303|FG003|Overall Study|Adverse Event|1|||
27828418|NCT01592240|54295304|FG004|Overall Study|Adverse Event|1|||
27828419|NCT01592240|54295305|FG005|Overall Study|Adverse Event|0|||
27828420|NCT01592240|54295306|FG006|Overall Study|Adverse Event|0|||
27828421|NCT01592240|54295300|FG000|Overall Study|Death|0|||
27828422|NCT01592240|54295301|FG001|Overall Study|Death|1|||
27828423|NCT01592240|54295302|FG002|Overall Study|Death|0|||
27828424|NCT01592240|54295303|FG003|Overall Study|Death|0|||
27828425|NCT01592240|54295304|FG004|Overall Study|Death|0|||
27828426|NCT01592240|54295305|FG005|Overall Study|Death|0|||
27828427|NCT01592240|54295306|FG006|Overall Study|Death|0|||
27828428|NCT01592240|54295300|FG000|Overall Study|Lost to Follow-up|1|||
27828429|NCT01592240|54295301|FG001|Overall Study|Lost to Follow-up|3|||
27828430|NCT01592240|54295302|FG002|Overall Study|Lost to Follow-up|1|||
27828431|NCT01592240|54295303|FG003|Overall Study|Lost to Follow-up|0|||
27828432|NCT01592240|54295304|FG004|Overall Study|Lost to Follow-up|3|||
27828433|NCT01592240|54295305|FG005|Overall Study|Lost to Follow-up|2|||
27828434|NCT01592240|54295306|FG006|Overall Study|Lost to Follow-up|0|||
27828435|NCT01592240|54295300|FG000|Overall Study|Protocol Violation|0|||
27828436|NCT01592240|54295301|FG001|Overall Study|Protocol Violation|0|||
27828437|NCT01592240|54295302|FG002|Overall Study|Protocol Violation|0|||
27828438|NCT01592240|54295303|FG003|Overall Study|Protocol Violation|0|||
27828439|NCT01592240|54295304|FG004|Overall Study|Protocol Violation|0|||
27828440|NCT01592240|54295305|FG005|Overall Study|Protocol Violation|1|||
27828441|NCT01592240|54295306|FG006|Overall Study|Protocol Violation|0|||
27828442|NCT01592240|54295300|FG000|Overall Study|Withdrawal by Subject|0|||
27828443|NCT01592240|54295301|FG001|Overall Study|Withdrawal by Subject|4|||
27828444|NCT01592240|54295302|FG002|Overall Study|Withdrawal by Subject|4|||
27828445|NCT01592240|54295303|FG003|Overall Study|Withdrawal by Subject|1|||
27828446|NCT01592240|54295304|FG004|Overall Study|Withdrawal by Subject|3|||
27828447|NCT01592240|54295305|FG005|Overall Study|Withdrawal by Subject|0|||
27828448|NCT01592240|54295306|FG006|Overall Study|Withdrawal by Subject|2|||
27828449|NCT01592240|54295300|FG000|Overall Study|Other|0|||
27828450|NCT01592240|54295301|FG001|Overall Study|Other|3|||
27828451|NCT01592240|54295302|FG002|Overall Study|Other|1|||
27828452|NCT01592240|54295303|FG003|Overall Study|Other|1|||
27828453|NCT01592240|54295304|FG004|Overall Study|Other|0|||
27828454|NCT01592240|54295305|FG005|Overall Study|Other|0|||
27828455|NCT01592240|54295306|FG006|Overall Study|Other|1|||
27828456|NCT01592240|54295300|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
27828457|NCT01592240|54295301|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
27828458|NCT01592240|54295302|FG002|Overall Study|Did Not Meet Entrance Criteria|1|||
27828459|NCT01592240|54295303|FG003|Overall Study|Did Not Meet Entrance Criteria|0|||
27828460|NCT01592240|54295304|FG004|Overall Study|Did Not Meet Entrance Criteria|0|||
27828461|NCT01592240|54295305|FG005|Overall Study|Did Not Meet Entrance Criteria|0|||
27828462|NCT01592240|54295306|FG006|Overall Study|Did Not Meet Entrance Criteria|0|||
27828463|NCT01591616|54295349|FG000|Overall Study|Withdrawal by Subject|1|||
27828464|NCT01591460|54295505|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
27828465|NCT01591460|54295505|FG000|Overall Study|Futility Rule (Week 12)|7|||
27828466|NCT01591460|54295505|FG000|Overall Study|Futility Rule (Week 24)|3|||
27828467|NCT01591460|54295505|FG000|Overall Study|Rebound or Breakthrough|3|||
27828468|NCT01591460|54295505|FG000|Overall Study|Treatment Discontinued by Error|1|||
27828469|NCT01591460|54295505|FG000|Overall Study|Lost to Follow-up|1|||
27828470|NCT01591460|54295505|FG000|Overall Study|Noncompliance|1|||
27828471|NCT01591460|54295505|FG000|Overall Study|Participant Refusal|3|||
27828472|NCT01591460|54295505|FG000|Overall Study|Withdrawal by Subject|1|||
27828473|NCT01591460|54295505|FG000|Overall Study|Protocol Violation|1|||
27828474|NCT01591382|54295528|FG000|Overall Study|Discharged Prior to Study Completion|2|||
27828475|NCT01591382|54295529|FG001|Overall Study|Discharged Prior to Study Completion|1|||
27828476|NCT01591382|54295528|FG000|Overall Study|Participant Opted for Morphine PCA|1|||
27828477|NCT01591382|54295529|FG001|Overall Study|Participant Opted for Morphine PCA|1|||
27828478|NCT01696214|54295547|FG000|Overall Study|Lost to Follow-up|1|||
27828479|NCT01696214|54295548|FG001|Overall Study|Lost to Follow-up|0|||
27828480|NCT01696214|54295549|FG002|Overall Study|Lost to Follow-up|0|||
27828481|NCT01696214|54295550|FG003|Overall Study|Lost to Follow-up|0|||
27828482|NCT01543087|54295583|FG000|Stage 1 (48 Months)|Lost to Follow-up|3|||
27828483|NCT01543087|54295584|FG001|Stage 1 (48 Months)|Lost to Follow-up|4|||
27828484|NCT01543087|54295585|FG002|Stage 1 (48 Months)|Lost to Follow-up|12|||
27828485|NCT01543087|54295586|FG003|Stage 1 (48 Months)|Lost to Follow-up|0|||
27828486|NCT01543087|54295587|FG004|Stage 1 (48 Months)|Lost to Follow-up|0|||
27828487|NCT01543087|54295588|FG005|Stage 1 (48 Months)|Lost to Follow-up|0|||
27828488|NCT01543087|54295583|FG000|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
27828489|NCT01543087|54295584|FG001|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
27828490|NCT01543087|54295585|FG002|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
27828491|NCT01543087|54295586|FG003|Stage 1 (48 Months)|No longer met eligibility criteria|2|||
27828492|NCT01543087|54295587|FG004|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
27828493|NCT01543087|54295588|FG005|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
27828494|NCT01543087|54295583|FG000|Stage 1 (48 Months)|No longer willing to participate|5|||
27828495|NCT01543087|54295584|FG001|Stage 1 (48 Months)|No longer willing to participate|3|||
27828496|NCT01543087|54295585|FG002|Stage 1 (48 Months)|No longer willing to participate|18|||
27828497|NCT01543087|54295586|FG003|Stage 1 (48 Months)|No longer willing to participate|6|||
27828498|NCT01543087|54295587|FG004|Stage 1 (48 Months)|No longer willing to participate|3|||
27828499|NCT01543087|54295588|FG005|Stage 1 (48 Months)|No longer willing to participate|0|||
27828500|NCT01543087|54295583|FG000|Stage 1 (48 Months)|Other than specified|5|||
27828501|NCT01543087|54295584|FG001|Stage 1 (48 Months)|Other than specified|0|||
27828502|NCT01543087|54295585|FG002|Stage 1 (48 Months)|Other than specified|9|||
27828503|NCT01543087|54295586|FG003|Stage 1 (48 Months)|Other than specified|0|||
27828504|NCT01543087|54295587|FG004|Stage 1 (48 Months)|Other than specified|0|||
27828505|NCT01543087|54295588|FG005|Stage 1 (48 Months)|Other than specified|0|||
27828506|NCT01543087|54295583|FG000|Stage 1 (48 Months)|Protocol Violation|0|||
27828507|NCT01543087|54295584|FG001|Stage 1 (48 Months)|Protocol Violation|3|||
27828508|NCT01543087|54295585|FG002|Stage 1 (48 Months)|Protocol Violation|0|||
27828509|NCT01543087|54295586|FG003|Stage 1 (48 Months)|Protocol Violation|0|||
27828510|NCT01543087|54295587|FG004|Stage 1 (48 Months)|Protocol Violation|0|||
27828511|NCT01543087|54295588|FG005|Stage 1 (48 Months)|Protocol Violation|0|||
27828512|NCT01543087|54295583|FG000|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
27828513|NCT01543087|54295584|FG001|Booster Stage (26 Months)|Withdrawal before booster vaccination|1|||
27828514|NCT01543087|54295585|FG002|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
27850766|NCT03472040|54349812|FG000|Overall Study|Discontinuation due to Rash|0|||
28159784|NCT01377480|54829773|FG002|Overall Study|Serious adverse event|1|||
28159785|NCT01377480|54829774|FG003|Overall Study|Serious adverse event|1|||
28159786|NCT01377480|54829771|FG000|Overall Study|Other|0|||
28159787|NCT01377480|54829772|FG001|Overall Study|Other|0|||
27828515|NCT01543087|54295586|FG003|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
27828516|NCT01543087|54295587|FG004|Booster Stage (26 Months)|Withdrawal before booster vaccination|2|||
27828517|NCT01543087|54295588|FG005|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
27828518|NCT01543087|54295583|FG000|Booster Stage (26 Months)|Lost to Follow-up|0|||
27828519|NCT01543087|54295584|FG001|Booster Stage (26 Months)|Lost to Follow-up|0|||
27828520|NCT01543087|54295585|FG002|Booster Stage (26 Months)|Lost to Follow-up|1|||
27828521|NCT01543087|54295586|FG003|Booster Stage (26 Months)|Lost to Follow-up|0|||
28159788|NCT01377480|54829773|FG002|Overall Study|Other|7|||
27828522|NCT01543087|54295587|FG004|Booster Stage (26 Months)|Lost to Follow-up|0|||
27828523|NCT01543087|54295588|FG005|Booster Stage (26 Months)|Lost to Follow-up|0|||
27828524|NCT01696058|54295626|FG000|Overall Study|Adverse Event|21|||
27828525|NCT01696058|54295627|FG001|Overall Study|Adverse Event|11|||
27828526|NCT01696058|54295626|FG000|Overall Study|Lack of Efficacy|2|||
27828527|NCT01696058|54295627|FG001|Overall Study|Lack of Efficacy|3|||
27828528|NCT01696058|54295626|FG000|Overall Study|Protocol Violation|9|||
27828529|NCT01696058|54295627|FG001|Overall Study|Protocol Violation|3|||
27828530|NCT01696058|54295626|FG000|Overall Study|Lost to Follow-up|2|||
27828531|NCT01696058|54295627|FG001|Overall Study|Lost to Follow-up|5|||
27828532|NCT01696058|54295626|FG000|Overall Study|Withdrawal by Subject|4|||
27828533|NCT01696058|54295627|FG001|Overall Study|Withdrawal by Subject|6|||
27828534|NCT01696058|54295626|FG000|Overall Study|Other reason prematurely discontinued|5|||
27828535|NCT01696058|54295627|FG001|Overall Study|Other reason prematurely discontinued|3|||
27828536|NCT01695746|54295633|FG000|Overall Study|Adverse Event|1|||
27828537|NCT01695746|54295633|FG000|Overall Study|Non-compliance by the participant|3|||
27828538|NCT01695746|54295633|FG000|Overall Study|Protocol Violation|5|||
27828539|NCT01695746|54295633|FG000|Overall Study|Participant not willing to participate|3|||
27828540|NCT01694420|54295644|FG000|Overall Study|Lost to Follow-up|3|||
27828541|NCT01675479|54295815|FG000|Overall Study|Lost to Follow-up|11|||
27828542|NCT00089973|54295937|FG000|Overall Study|Adverse Event|3|||
28076790|NCT00111800|54731651|FG003|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
28076791|NCT00111800|54731652|FG004|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
28076792|NCT00111800|54731653|FG005|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
28076793|NCT00111800|54731648|FG000|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
28076794|NCT00111800|54731649|FG001|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1|||
28076795|NCT00111800|54731650|FG002|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
28159789|NCT01377480|54829774|FG003|Overall Study|Other|6|||
28159790|NCT00834795|54829786|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
27828543|NCT00089973|54295937|FG000|Overall Study|Withdrawal by Subject|1|||
27828544|NCT00089973|54295937|FG000|Overall Study|Disease progression|45|||
27828545|NCT00089973|54295937|FG000|Overall Study|Death|1|||
27828546|NCT00089661|54295955|FG000|Overall Study|Adverse Event|0|||
27828547|NCT00089661|54295956|FG001|Overall Study|Adverse Event|2|||
27828548|NCT00089661|54295955|FG000|Overall Study|Death|1|||
27828549|NCT00089661|54295956|FG001|Overall Study|Death|0|||
27828550|NCT00089661|54295955|FG000|Overall Study|Lost to Follow-up|0|||
27828551|NCT00089661|54295956|FG001|Overall Study|Lost to Follow-up|3|||
27828552|NCT00089661|54295955|FG000|Overall Study|Withdrawal by Subject|11|||
27828553|NCT00089661|54295956|FG001|Overall Study|Withdrawal by Subject|9|||
27828554|NCT00089661|54295955|FG000|Overall Study|Disease progression|1|||
27828555|NCT00089661|54295956|FG001|Overall Study|Disease progression|3|||
27828556|NCT00089661|54295955|FG000|Overall Study|Ineligibility determined|4|||
27828557|NCT00089661|54295956|FG001|Overall Study|Ineligibility determined|4|||
27828558|NCT00089661|54295955|FG000|Overall Study|Noncompliance|2|||
27828559|NCT00089661|54295956|FG001|Overall Study|Noncompliance|4|||
27828560|NCT00089661|54295955|FG000|Overall Study|Other|2|||
27828561|NCT00089661|54295956|FG001|Overall Study|Other|1|||
27828562|NCT00089583|54295977|FG000|Overall Study|Adverse Event|0|||
27828563|NCT00089583|54295978|FG001|Overall Study|Adverse Event|3|||
27828564|NCT00089583|54295977|FG000|Overall Study|Insufficient Viral Load Response|5|||
27828565|NCT00089583|54295978|FG001|Overall Study|Insufficient Viral Load Response|5|||
27828566|NCT00089583|54295977|FG000|Overall Study|Withdrawal by Subject|0|||
27828567|NCT00089583|54295978|FG001|Overall Study|Withdrawal by Subject|4|||
27828568|NCT00089583|54295977|FG000|Overall Study|Participant (Par) Didn't Take Medication|1|||
27828569|NCT00089583|54295978|FG001|Overall Study|Participant (Par) Didn't Take Medication|0|||
27828570|NCT00089583|54295977|FG000|Overall Study|Participant Refused Study Medication|0|||
27828571|NCT00089583|54295978|FG001|Overall Study|Participant Refused Study Medication|2|||
27828572|NCT00089583|54295977|FG000|Overall Study|Non-Compliance|0|||
27828573|NCT00089583|54295978|FG001|Overall Study|Non-Compliance|4|||
27828574|NCT00089583|54295977|FG000|Overall Study|Poor Medical Compliance/Adherence Issues|0|||
27828575|NCT00089583|54295978|FG001|Overall Study|Poor Medical Compliance/Adherence Issues|3|||
28159791|NCT00834795|54829787|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
27828576|NCT00089583|54295977|FG000|Overall Study|Participant Management Criteria Met|0|||
27828577|NCT00089583|54295978|FG001|Overall Study|Participant Management Criteria Met|1|||
27828578|NCT00089583|54295977|FG000|Overall Study|Reason Not Provided|0|||
27828579|NCT00089583|54295978|FG001|Overall Study|Reason Not Provided|1|||
27828580|NCT00089583|54295977|FG000|Overall Study|Protocol Violation|0|||
27828581|NCT00089583|54295978|FG001|Overall Study|Protocol Violation|3|||
27828582|NCT00089583|54295977|FG000|Overall Study|Principal Investigator Decision|0|||
27828583|NCT00089583|54295978|FG001|Overall Study|Principal Investigator Decision|10|||
27828584|NCT00089583|54295977|FG000|Overall Study|Start of Disallowed Medication|0|||
27828585|NCT00089583|54295978|FG001|Overall Study|Start of Disallowed Medication|1|||
27828586|NCT00089583|54295977|FG000|Overall Study|Necessity to Use Prohibited Drug|1|||
27828587|NCT00089583|54295978|FG001|Overall Study|Necessity to Use Prohibited Drug|0|||
27828588|NCT00089583|54295977|FG000|Overall Study|Participant Incarcerated|0|||
27828589|NCT00089583|54295978|FG001|Overall Study|Participant Incarcerated|1|||
27828590|NCT00088881|54295990|FG000|Step 1 - R-CHOP|Patient ineligible|9|||
27828591|NCT00088881|54295990|FG000|Step 1 - R-CHOP|Adverse Event|1|||
27828592|NCT00088881|54295990|FG000|Step 1 - R-CHOP|Withdrawal by Subject|2|||
27828593|NCT00088881|54295990|FG000|Step 1 - R-CHOP|Physician Decision|1|||
27828594|NCT00088881|54295990|FG000|Step 1 - R-CHOP|Insurance company refused to cover|1|||
27828595|NCT00088881|54295990|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8|||
27828596|NCT00088881|54295990|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Other|3|||
27828597|NCT00087555|54296038|FG000|Overall Study|Adverse Event|3|||
27828598|NCT00087555|54296039|FG001|Overall Study|Adverse Event|6|||
27828599|NCT00087555|54296040|FG002|Overall Study|Adverse Event|14|||
27828600|NCT00087555|54296038|FG000|Overall Study|Lost to Follow-up|0|||
27828601|NCT00087555|54296039|FG001|Overall Study|Lost to Follow-up|1|||
27828602|NCT00087555|54296040|FG002|Overall Study|Lost to Follow-up|1|||
27828603|NCT00087555|54296038|FG000|Overall Study|Non - Compliance|1|||
27828604|NCT00087555|54296039|FG001|Overall Study|Non - Compliance|0|||
27828605|NCT00087555|54296040|FG002|Overall Study|Non - Compliance|0|||
27828606|NCT00087555|54296038|FG000|Overall Study|Protocol Violation|0|||
27828607|NCT00087555|54296039|FG001|Overall Study|Protocol Violation|0|||
27828608|NCT00087555|54296040|FG002|Overall Study|Protocol Violation|2|||
27828609|NCT00087555|54296038|FG000|Overall Study|Screen Failure|1|||
27828610|NCT00087555|54296039|FG001|Overall Study|Screen Failure|1|||
27828611|NCT00087555|54296040|FG002|Overall Study|Screen Failure|0|||
27828612|NCT00087555|54296038|FG000|Overall Study|Pregnancy|0|||
27828613|NCT00087555|54296039|FG001|Overall Study|Pregnancy|1|||
27828614|NCT00087555|54296040|FG002|Overall Study|Pregnancy|1|||
27828615|NCT00087555|54296038|FG000|Overall Study|Withdrawal by Subject|3|||
27828616|NCT00087555|54296039|FG001|Overall Study|Withdrawal by Subject|2|||
27828617|NCT00087555|54296040|FG002|Overall Study|Withdrawal by Subject|1|||
27828618|NCT00087555|54296038|FG000|Overall Study|Lack of Efficacy|2|||
27828619|NCT00087555|54296039|FG001|Overall Study|Lack of Efficacy|0|||
27828620|NCT00087555|54296040|FG002|Overall Study|Lack of Efficacy|1|||
27828621|NCT00087555|54296038|FG000|Overall Study|Non Compliance|0|||
27828622|NCT00087555|54296039|FG001|Overall Study|Non Compliance|0|||
27828623|NCT00087555|54296040|FG002|Overall Study|Non Compliance|1|||
27828624|NCT00087555|54296038|FG000|Overall Study|Chronic Migraine Headaches (Med History)|1|||
27828625|NCT00087555|54296039|FG001|Overall Study|Chronic Migraine Headaches (Med History)|0|||
27828626|NCT00087555|54296040|FG002|Overall Study|Chronic Migraine Headaches (Med History)|0|||
27828627|NCT00087555|54296038|FG000|Overall Study|Patient wanted to go back on Med|1|||
27828628|NCT00087555|54296039|FG001|Overall Study|Patient wanted to go back on Med|0|||
27828629|NCT00087555|54296040|FG002|Overall Study|Patient wanted to go back on Med|0|||
27828630|NCT00086619|54296063|FG000|Overall Study|Withdrawal by Subject|6|||
27828631|NCT00086619|54296064|FG001|Overall Study|Withdrawal by Subject|6|||
27828632|NCT00086619|54296063|FG000|Overall Study|Adverse Event|8|||
27828633|NCT00086619|54296064|FG001|Overall Study|Adverse Event|10|||
27828634|NCT00086619|54296063|FG000|Overall Study|Protocol Violation|1|||
27828635|NCT00086619|54296064|FG001|Overall Study|Protocol Violation|1|||
27828636|NCT00085917|54296077|FG000|Overall Study|Adverse Event|4|||
27828637|NCT00085917|54296078|FG001|Overall Study|Adverse Event|3|||
27828638|NCT00084747|54296084|FG000|Overall Study|Relapsed|8|||
27828639|NCT00084747|54296084|FG000|Overall Study|Death|3|||
27828640|NCT00084747|54296084|FG000|Overall Study|Withdrawal by Subject|2|||
27828641|NCT00081159|54296119|FG000|Overall Study|Withdrawal by Subject|0|||
27828642|NCT00081159|54296120|FG001|Overall Study|Withdrawal by Subject|3|||
27828643|NCT00081159|54296119|FG000|Overall Study|Myelosuppression prior to treatment|0|||
27828644|NCT00081159|54296120|FG001|Overall Study|Myelosuppression prior to treatment|1|||
27828645|NCT00081159|54296119|FG000|Overall Study|Lost to Follow-up|2|||
27828646|NCT00081159|54296120|FG001|Overall Study|Lost to Follow-up|1|||
27828647|NCT00080223|54296135|FG000|Overall Study|Adverse Event|23|||
27828648|NCT00080223|54296135|FG000|Overall Study|Death|21|||
27828649|NCT00080223|54296135|FG000|Overall Study|Withdrawal by Subject|13|||
27828650|NCT00080223|54296135|FG000|Overall Study|Lung Transplantation|9|||
27828651|NCT00080223|54296135|FG000|Overall Study|Non-compliance With Study Treatment|7|||
28159792|NCT00834795|54829786|FG000|Second Intervention|Adverse Event|1|||
28159793|NCT00834795|54829787|FG001|Second Intervention|Adverse Event|0|||
27828652|NCT00080223|54296135|FG000|Overall Study|Participant unwilling to continue|2|||
27828653|NCT00080223|54296135|FG000|Overall Study|Physician Decision|1|||
27828654|NCT01899053|54296746|FG000|Overall Study|Progressive Disease|4|||
27828655|NCT01899053|54296747|FG001|Overall Study|Progressive Disease|0|||
27828656|NCT01899053|54296748|FG002|Overall Study|Progressive Disease|3|||
27828657|NCT01899053|54296749|FG003|Overall Study|Progressive Disease|0|||
27828658|NCT01899053|54296750|FG004|Overall Study|Progressive Disease|3|||
27828659|NCT01899053|54296751|FG005|Overall Study|Progressive Disease|1|||
27828660|NCT01899053|54296752|FG006|Overall Study|Progressive Disease|1|||
27828661|NCT01899053|54296753|FG007|Overall Study|Progressive Disease|1|||
27828662|NCT01899053|54296754|FG008|Overall Study|Progressive Disease|4|||
28159794|NCT00834717|54829793|FG000|First Intervention|Adverse Event|1|||
27828663|NCT01899053|54296755|FG009|Overall Study|Progressive Disease|3|||
27828664|NCT01899053|54296756|FG010|Overall Study|Progressive Disease|12|||
27828665|NCT01899053|54296757|FG011|Overall Study|Progressive Disease|5|||
27828666|NCT01899053|54296758|FG012|Overall Study|Progressive Disease|8|||
27828667|NCT01899053|54296759|FG013|Overall Study|Progressive Disease|17|||
27828668|NCT01899053|54296746|FG000|Overall Study|Adverse Event|1|||
27828669|NCT01899053|54296747|FG001|Overall Study|Adverse Event|1|||
27828670|NCT01899053|54296748|FG002|Overall Study|Adverse Event|1|||
27828671|NCT01899053|54296749|FG003|Overall Study|Adverse Event|3|||
27828672|NCT01899053|54296750|FG004|Overall Study|Adverse Event|1|||
27828673|NCT01899053|54296751|FG005|Overall Study|Adverse Event|1|||
27828674|NCT01899053|54296752|FG006|Overall Study|Adverse Event|1|||
27828675|NCT01899053|54296753|FG007|Overall Study|Adverse Event|0|||
27828676|NCT01899053|54296754|FG008|Overall Study|Adverse Event|2|||
27828677|NCT01899053|54296755|FG009|Overall Study|Adverse Event|0|||
27828678|NCT01899053|54296756|FG010|Overall Study|Adverse Event|3|||
27828679|NCT01899053|54296757|FG011|Overall Study|Adverse Event|1|||
27828680|NCT01899053|54296758|FG012|Overall Study|Adverse Event|2|||
27828681|NCT01899053|54296759|FG013|Overall Study|Adverse Event|2|||
27828682|NCT01899053|54296746|FG000|Overall Study|Reason Not Specified|0|||
27828683|NCT01899053|54296747|FG001|Overall Study|Reason Not Specified|0|||
27828684|NCT01899053|54296748|FG002|Overall Study|Reason Not Specified|0|||
27828685|NCT01899053|54296749|FG003|Overall Study|Reason Not Specified|0|||
27828686|NCT01899053|54296750|FG004|Overall Study|Reason Not Specified|0|||
27828687|NCT01899053|54296751|FG005|Overall Study|Reason Not Specified|0|||
27828688|NCT01899053|54296752|FG006|Overall Study|Reason Not Specified|1|||
27828689|NCT01899053|54296753|FG007|Overall Study|Reason Not Specified|0|||
27828690|NCT01899053|54296754|FG008|Overall Study|Reason Not Specified|0|||
27828691|NCT01899053|54296755|FG009|Overall Study|Reason Not Specified|0|||
27828692|NCT01899053|54296756|FG010|Overall Study|Reason Not Specified|0|||
27828693|NCT01899053|54296757|FG011|Overall Study|Reason Not Specified|0|||
27828694|NCT01899053|54296758|FG012|Overall Study|Reason Not Specified|1|||
27828695|NCT01899053|54296759|FG013|Overall Study|Reason Not Specified|0|||
27828696|NCT01899053|54296746|FG000|Overall Study|Withdrawal by Subject|1|||
27828697|NCT01899053|54296747|FG001|Overall Study|Withdrawal by Subject|1|||
27828698|NCT01899053|54296748|FG002|Overall Study|Withdrawal by Subject|2|||
27828699|NCT01899053|54296749|FG003|Overall Study|Withdrawal by Subject|0|||
27828700|NCT01899053|54296750|FG004|Overall Study|Withdrawal by Subject|2|||
27828701|NCT01899053|54296751|FG005|Overall Study|Withdrawal by Subject|0|||
27828702|NCT01899053|54296752|FG006|Overall Study|Withdrawal by Subject|0|||
27828703|NCT01899053|54296753|FG007|Overall Study|Withdrawal by Subject|1|||
27828704|NCT01899053|54296754|FG008|Overall Study|Withdrawal by Subject|0|||
27828705|NCT01899053|54296755|FG009|Overall Study|Withdrawal by Subject|0|||
27828706|NCT01899053|54296756|FG010|Overall Study|Withdrawal by Subject|0|||
27828707|NCT01899053|54296757|FG011|Overall Study|Withdrawal by Subject|0|||
27828708|NCT01899053|54296758|FG012|Overall Study|Withdrawal by Subject|1|||
27828709|NCT01899053|54296759|FG013|Overall Study|Withdrawal by Subject|1|||
27828710|NCT01899053|54296746|FG000|Overall Study|Protocol Violation|0|||
27828711|NCT01899053|54296747|FG001|Overall Study|Protocol Violation|0|||
27828712|NCT01899053|54296748|FG002|Overall Study|Protocol Violation|1|||
27828713|NCT01899053|54296749|FG003|Overall Study|Protocol Violation|0|||
27828714|NCT01899053|54296750|FG004|Overall Study|Protocol Violation|0|||
27828715|NCT01899053|54296751|FG005|Overall Study|Protocol Violation|0|||
27828716|NCT01899053|54296752|FG006|Overall Study|Protocol Violation|0|||
27828717|NCT01899053|54296753|FG007|Overall Study|Protocol Violation|0|||
27828718|NCT01899053|54296754|FG008|Overall Study|Protocol Violation|0|||
27828719|NCT01899053|54296755|FG009|Overall Study|Protocol Violation|0|||
27828720|NCT01899053|54296756|FG010|Overall Study|Protocol Violation|0|||
27828721|NCT01899053|54296757|FG011|Overall Study|Protocol Violation|0|||
27828722|NCT01899053|54296758|FG012|Overall Study|Protocol Violation|0|||
27828723|NCT01899053|54296759|FG013|Overall Study|Protocol Violation|0|||
27828724|NCT01899053|54296746|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
27828725|NCT01899053|54296747|FG001|Overall Study|Unsatisfactory Therapeutic Response|1|||
27828726|NCT01899053|54296748|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
27828727|NCT01899053|54296749|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
27828728|NCT01899053|54296750|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
27828729|NCT01899053|54296751|FG005|Overall Study|Unsatisfactory Therapeutic Response|0|||
27828730|NCT01899053|54296752|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
27828731|NCT01899053|54296753|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
27850767|NCT03472040|54349813|FG001|Overall Study|Discontinuation due to Rash|1|||
27850768|NCT03472040|54349812|FG000|Overall Study|Subsequent Ineligibility|0|||
27828732|NCT01899053|54296754|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
27828733|NCT01899053|54296755|FG009|Overall Study|Unsatisfactory Therapeutic Response|0|||
27828734|NCT01899053|54296756|FG010|Overall Study|Unsatisfactory Therapeutic Response|1|||
27828735|NCT01899053|54296757|FG011|Overall Study|Unsatisfactory Therapeutic Response|0|||
27828736|NCT01899053|54296758|FG012|Overall Study|Unsatisfactory Therapeutic Response|0|||
27828737|NCT01899053|54296759|FG013|Overall Study|Unsatisfactory Therapeutic Response|0|||
27828738|NCT01899053|54296746|FG000|Overall Study|Symptomatic Deterioration|0|||
27828739|NCT01899053|54296747|FG001|Overall Study|Symptomatic Deterioration|0|||
27828740|NCT01899053|54296748|FG002|Overall Study|Symptomatic Deterioration|0|||
27828741|NCT01899053|54296749|FG003|Overall Study|Symptomatic Deterioration|0|||
27828742|NCT01899053|54296750|FG004|Overall Study|Symptomatic Deterioration|0|||
27828743|NCT01899053|54296751|FG005|Overall Study|Symptomatic Deterioration|1|||
27828744|NCT01899053|54296752|FG006|Overall Study|Symptomatic Deterioration|0|||
27828745|NCT01899053|54296753|FG007|Overall Study|Symptomatic Deterioration|1|||
27828746|NCT01899053|54296754|FG008|Overall Study|Symptomatic Deterioration|0|||
27828747|NCT01899053|54296755|FG009|Overall Study|Symptomatic Deterioration|0|||
27828748|NCT01899053|54296756|FG010|Overall Study|Symptomatic Deterioration|0|||
27828749|NCT01899053|54296757|FG011|Overall Study|Symptomatic Deterioration|1|||
27828750|NCT01899053|54296758|FG012|Overall Study|Symptomatic Deterioration|2|||
27828751|NCT01899053|54296759|FG013|Overall Study|Symptomatic Deterioration|0|||
27828752|NCT01888367|54296864|FG000|Overall Study|Physician Decision|3|||
27828753|NCT01888367|54296865|FG001|Overall Study|Physician Decision|4|||
27828754|NCT01888367|54296866|FG002|Overall Study|Physician Decision|2|||
27828755|NCT01888367|54296864|FG000|Overall Study|Death|2|||
27828756|NCT01888367|54296865|FG001|Overall Study|Death|0|||
27828757|NCT01888367|54296866|FG002|Overall Study|Death|1|||
27828758|NCT01888367|54296864|FG000|Overall Study|Withdrawal by Subject|1|||
27828759|NCT01888367|54296865|FG001|Overall Study|Withdrawal by Subject|0|||
27828760|NCT01888367|54296866|FG002|Overall Study|Withdrawal by Subject|1|||
27828761|NCT01888367|54296864|FG000|Overall Study|Lost to Follow-up|1|||
27828762|NCT01888367|54296865|FG001|Overall Study|Lost to Follow-up|1|||
27828763|NCT01888367|54296866|FG002|Overall Study|Lost to Follow-up|0|||
27828764|NCT01888367|54296864|FG000|Overall Study|Protocol Violation|0|||
27828765|NCT01888367|54296865|FG001|Overall Study|Protocol Violation|0|||
27828766|NCT01888367|54296866|FG002|Overall Study|Protocol Violation|1|||
27828767|NCT01888367|54296864|FG000|Overall Study|30-Day Visit Too Early (< 28 Days)|1|||
27828768|NCT01888367|54296865|FG001|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
27828769|NCT01888367|54296866|FG002|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
27850769|NCT03472040|54349813|FG001|Overall Study|Subsequent Ineligibility|2|||
27850770|NCT03472040|54349812|FG000|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|46|||
27850771|NCT03472040|54349813|FG001|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|175|||
27850772|NCT03323385|54349840|FG000|Overall Study|Withdrawal by Subject|1|||
27943257|NCT00979953|54600199|FG003|Overall Study|Withdrawal by Subject|1|||
27943258|NCT00979953|54600196|FG000|Overall Study|Protocol Violation|1|||
27943259|NCT00979953|54600197|FG001|Overall Study|Protocol Violation|0|||
27943260|NCT00979953|54600198|FG002|Overall Study|Protocol Violation|2|||
27943261|NCT00979953|54600199|FG003|Overall Study|Protocol Violation|2|||
27943262|NCT01181531|54600211|FG000|Overall Study|Other|17|||
27943263|NCT01181531|54600212|FG001|Overall Study|Other|12|||
27943264|NCT01181531|54600211|FG000|Overall Study|Partial consent by subject withdrawn|0|||
27943265|NCT01181531|54600212|FG001|Overall Study|Partial consent by subject withdrawn|1|||
27943266|NCT01181531|54600211|FG000|Overall Study|Physician Decision|3|||
27943267|NCT01181531|54600212|FG001|Overall Study|Physician Decision|1|||
27943268|NCT01181531|54600211|FG000|Overall Study|Noncompliance|2|||
27943269|NCT01181531|54600212|FG001|Overall Study|Noncompliance|2|||
27943270|NCT01181531|54600211|FG000|Overall Study|Ineligibility determined|1|||
27943271|NCT01181531|54600212|FG001|Overall Study|Ineligibility determined|2|||
27943272|NCT01181531|54600211|FG000|Overall Study|Protocol Specified Criteria|15|||
27850773|NCT03323385|54349841|FG001|Overall Study|Withdrawal by Subject|2|||
27850774|NCT03323385|54349840|FG000|Overall Study|Noncompliance|0|||
27850775|NCT03323385|54349841|FG001|Overall Study|Noncompliance|1|||
27850776|NCT03298451|54349851|FG000|Overall Study|Death|275|||
27850777|NCT03298451|54349852|FG001|Overall Study|Death|260|||
27850778|NCT03298451|54349853|FG002|Overall Study|Death|122|||
27850779|NCT03298451|54349854|FG003|Overall Study|Death|280|||
27850780|NCT03298451|54349851|FG000|Overall Study|Lost to Follow-up|1|||
27850781|NCT03298451|54349852|FG001|Overall Study|Lost to Follow-up|1|||
27850782|NCT03298451|54349853|FG002|Overall Study|Lost to Follow-up|0|||
27850783|NCT03298451|54349854|FG003|Overall Study|Lost to Follow-up|7|||
27850784|NCT03298451|54349851|FG000|Overall Study|Withdrawal by Subject|9|||
27850785|NCT03298451|54349852|FG001|Overall Study|Withdrawal by Subject|7|||
27850786|NCT03298451|54349853|FG002|Overall Study|Withdrawal by Subject|1|||
27850787|NCT03298451|54349854|FG003|Overall Study|Withdrawal by Subject|20|||
27850788|NCT03164616|54349871|FG000|Overall Study|Death|250|||
27850789|NCT03164616|54349872|FG001|Overall Study|Death|264|||
27943273|NCT01181531|54600212|FG001|Overall Study|Protocol Specified Criteria|8|||
27828770|NCT01898195|54296892|FG000|Smoking Abstinence|Did not have good measurements|35|||
27828771|NCT01898195|54296893|FG001|Smoking Abstinence|Did not have good measurements|38|||
27828772|NCT01898195|54296894|FG002|Smoking Abstinence|Did not have good measurements|36|||
27828773|NCT01897727|54296908|FG000|Overall Study|Exclusion: central sleep apnea|0|||
27828774|NCT01897727|54296909|FG001|Overall Study|Exclusion: central sleep apnea|1|||
27943274|NCT01181531|54600211|FG000|Overall Study|Pregnancy|0|||
27943275|NCT01181531|54600212|FG001|Overall Study|Pregnancy|1|||
27943276|NCT01181531|54600211|FG000|Overall Study|Withdrawal by Subject|8|||
27943277|NCT01181531|54600212|FG001|Overall Study|Withdrawal by Subject|7|||
27943278|NCT01181531|54600211|FG000|Overall Study|Protocol Violation|6|||
27943279|NCT01181531|54600212|FG001|Overall Study|Protocol Violation|6|||
27943280|NCT01181531|54600211|FG000|Overall Study|Death|9|||
27943281|NCT01181531|54600212|FG001|Overall Study|Death|12|||
27943282|NCT01181531|54600211|FG000|Overall Study|Adverse Event|0|||
27943283|NCT01181531|54600212|FG001|Overall Study|Adverse Event|1|||
27943284|NCT01152450|54600218|FG000|Period 1 (4 Weeks)|Adverse Event|0|||
27943285|NCT01152450|54600219|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
27943286|NCT01152450|54600220|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
27943287|NCT01152450|54600221|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
27943288|NCT01152450|54600222|FG004|Period 1 (4 Weeks)|Adverse Event|1|||
27943289|NCT01152450|54600223|FG005|Period 1 (4 Weeks)|Adverse Event|1|||
27943290|NCT01152450|54600218|FG000|Period 1 (4 Weeks)|Protocol Violation|0|||
27943291|NCT01152450|54600219|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
27943292|NCT01152450|54600220|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
27943293|NCT01152450|54600221|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
27943294|NCT01152450|54600222|FG004|Period 1 (4 Weeks)|Protocol Violation|1|||
27943295|NCT01152450|54600223|FG005|Period 1 (4 Weeks)|Protocol Violation|0|||
27943296|NCT01152450|54600218|FG000|Period 1 (4 Weeks)|Lost to Follow-up|0|||
27943297|NCT01152450|54600219|FG001|Period 1 (4 Weeks)|Lost to Follow-up|1|||
27943298|NCT01152450|54600220|FG002|Period 1 (4 Weeks)|Lost to Follow-up|1|||
27943299|NCT01152450|54600221|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
27943300|NCT01152450|54600222|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
27943301|NCT01152450|54600223|FG005|Period 1 (4 Weeks)|Lost to Follow-up|0|||
27943302|NCT01181141|54600233|FG000|Overall Study|Adverse Event|2|||
27943303|NCT01181141|54600234|FG001|Overall Study|Adverse Event|1|||
27943304|NCT01181141|54600233|FG000|Overall Study|Lack of Efficacy|1|||
27943305|NCT01181141|54600234|FG001|Overall Study|Lack of Efficacy|0|||
27943306|NCT01181141|54600233|FG000|Overall Study|Lost to Follow-up|1|||
27943307|NCT01181141|54600234|FG001|Overall Study|Lost to Follow-up|1|||
27943308|NCT01181141|54600233|FG000|Overall Study|Physician Decision|2|||
27943309|NCT01181141|54600234|FG001|Overall Study|Physician Decision|0|||
27943310|NCT01181141|54600233|FG000|Overall Study|Protocol Violation|3|||
27943311|NCT01181141|54600234|FG001|Overall Study|Protocol Violation|1|||
27943312|NCT01181141|54600233|FG000|Overall Study|Withdrawal by Subject|3|||
27943313|NCT01181141|54600234|FG001|Overall Study|Withdrawal by Subject|1|||
27943314|NCT01173120|54600240|FG000|Overall Study|Lack of Efficacy|2|||
27943315|NCT01173120|54600240|FG000|Overall Study|Lost to Follow-up|1|||
27943316|NCT01173120|54600240|FG000|Overall Study|Participant Decision|2|||
27943317|NCT01173120|54600240|FG000|Overall Study|Switch-Administrative Reason By Sponsor|33|||
27943318|NCT01173120|54600240|FG000|Overall Study|Switch-Participant Decision|12|||
27943319|NCT01173120|54600240|FG000|Overall Study|Switch-Difficulty With Device|12|||
27943320|NCT00977379|54600248|FG000|Overall Study|Withdrawal by Subject|1|||
27943321|NCT00977379|54600249|FG001|Overall Study|Withdrawal by Subject|1|||
27943322|NCT00977379|54600248|FG000|Overall Study|Death|7|||
27943323|NCT00977379|54600249|FG001|Overall Study|Death|9|||
27943324|NCT00977379|54600248|FG000|Overall Study|Premature Study Termination|4|||
27943325|NCT00977379|54600249|FG001|Overall Study|Premature Study Termination|0|||
27943326|NCT00977379|54600248|FG000|Overall Study|Participant Moving House|0|||
27943327|NCT00977379|54600249|FG001|Overall Study|Participant Moving House|1|||
27943328|NCT00977379|54600248|FG000|Overall Study|Randomization Error|0|||
27943329|NCT00977379|54600249|FG001|Overall Study|Randomization Error|1|||
27943330|NCT01180985|54600255|FG000|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1|||
27828775|NCT01897493|54296915|FG000|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1|||
27828776|NCT01887353|54296924|FG000|Overall Study|Study stopped early|4|||
27828777|NCT01887353|54296925|FG001|Overall Study|Study stopped early|3|||
27828778|NCT01896869|54296947|FG000|Overall Study|Withdrawal by Subject|0|||
27828779|NCT01896869|54296948|FG001|Overall Study|Withdrawal by Subject|6|||
27828780|NCT01896869|54296947|FG000|Overall Study|Lost to Follow-up|1|||
27828781|NCT01896869|54296948|FG001|Overall Study|Lost to Follow-up|0|||
27828782|NCT01896557|54296958|FG000|Clopidogrel Alone|Adverse Event|1|||
27828783|NCT01896557|54296959|FG001|Clopidogrel Alone|Adverse Event|0|||
27828784|NCT01896557|54296958|FG000|Clopidogrel + GI Protector|low adherence|1|||
27943331|NCT01180985|54600256|FG001|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0|||
27943332|NCT01147536|54600263|FG000|Overall Study|Administrative study close|2|||
27943333|NCT01147536|54600263|FG000|Overall Study|Death|1|||
27943334|NCT01154088|54600270|FG000|Overall Study|Lost to Follow-up|4|||
27828785|NCT01896557|54296959|FG001|Clopidogrel + GI Protector|low adherence|1|||
27943335|NCT01154088|54600271|FG001|Overall Study|Lost to Follow-up|6|||
27943336|NCT01154088|54600272|FG002|Overall Study|Lost to Follow-up|7|||
27943337|NCT01180049|54600283|FG000|Overall Study|Other|9|||
27943338|NCT01180049|54600284|FG001|Overall Study|Other|7|||
27943339|NCT01180049|54600283|FG000|Overall Study|Lost to Follow-up|8|||
27943340|NCT01180049|54600284|FG001|Overall Study|Lost to Follow-up|6|||
27828786|NCT01896557|54296958|FG000|Clopidogrel + GI Protector|Reading error|1|||
28076796|NCT00111800|54731651|FG003|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
28076797|NCT00111800|54731652|FG004|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
28076798|NCT00111800|54731653|FG005|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
28076799|NCT00111800|54731648|FG000|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
28076800|NCT00111800|54731649|FG001|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
28159795|NCT00834717|54829794|FG001|First Intervention|Adverse Event|0|||
28159796|NCT00834717|54829793|FG000|First Intervention|Withdrawal by Subject|0|||
28159797|NCT00834717|54829794|FG001|First Intervention|Withdrawal by Subject|1|||
28159798|NCT00834639|54829800|FG000|Second Intervention|Physician Decision|0|||
28159799|NCT00834639|54829801|FG001|Second Intervention|Physician Decision|2|||
28159800|NCT00834249|54829821|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
28159801|NCT00834249|54829822|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
28159802|NCT00834249|54829821|FG000|Second Intervention|Adverse Event|1|||
28159803|NCT00834249|54829822|FG001|Second Intervention|Adverse Event|0|||
28159804|NCT00833937|54829828|FG000|Washout|Withdrawal by Subject|1|||
28159805|NCT00833937|54829829|FG001|Washout|Withdrawal by Subject|0|||
28159806|NCT00924170|54829835|FG000|Overall Study|Refused further treatment|0|||
28159807|NCT00924170|54829836|FG001|Overall Study|Refused further treatment|1|||
28159808|NCT00924170|54829835|FG000|Overall Study|Physician Decision|0|||
28159809|NCT00924170|54829836|FG001|Overall Study|Physician Decision|1|||
28159810|NCT00924170|54829835|FG000|Overall Study|Progressive disease|3|||
28159811|NCT00924170|54829836|FG001|Overall Study|Progressive disease|6|||
28159812|NCT00924170|54829835|FG000|Overall Study|Stopped due to neutralizing antibodies|3|||
28159813|NCT00924170|54829836|FG001|Overall Study|Stopped due to neutralizing antibodies|0|||
28159814|NCT00924170|54829835|FG000|Overall Study|Death|1|||
28159815|NCT00924170|54829836|FG001|Overall Study|Death|0|||
28159816|NCT00828321|54829850|FG000|Washout of 42 Days|Withdrawal by Subject|2|||
28159817|NCT00828321|54829851|FG001|Washout of 42 Days|Withdrawal by Subject|0|||
28159818|NCT00828321|54829850|FG000|Second Intervention|Protocol Violation|0|||
28159819|NCT00828321|54829851|FG001|Second Intervention|Protocol Violation|1|||
28159820|NCT01352715|54829857|FG000|Overall Study|Death|3|||
28159821|NCT01352715|54829858|FG001|Overall Study|Death|3|||
28159822|NCT01352715|54829857|FG000|Overall Study|Lost to Follow-up|5|||
28159823|NCT01352715|54829858|FG001|Overall Study|Lost to Follow-up|7|||
28159824|NCT01352715|54829857|FG000|Overall Study|Withdrawal by Subject|4|||
28159825|NCT01352715|54829858|FG001|Overall Study|Withdrawal by Subject|8|||
28159826|NCT01352715|54829857|FG000|Overall Study|site closure|16|||
28076801|NCT00111800|54731650|FG002|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
28076802|NCT00111800|54731651|FG003|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1|||
28076803|NCT00111800|54731652|FG004|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
28076804|NCT00111800|54731653|FG005|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
28076805|NCT00111800|54731648|FG000|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
28076806|NCT00111800|54731649|FG001|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
28076807|NCT00111800|54731650|FG002|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
28076808|NCT00111800|54731651|FG003|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1|||
28076809|NCT00111800|54731652|FG004|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
28076810|NCT00111800|54731653|FG005|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
28159827|NCT01352715|54829858|FG001|Overall Study|site closure|15|||
28159828|NCT01352715|54829857|FG000|Overall Study|no final visit in closeout period|15|||
28159829|NCT01352715|54829858|FG001|Overall Study|no final visit in closeout period|12|||
28159830|NCT01352715|54829857|FG000|Overall Study|major ineligibility|2|||
28159831|NCT01352715|54829858|FG001|Overall Study|major ineligibility|1|||
27828787|NCT01896557|54296959|FG001|Clopidogrel + GI Protector|Reading error|3|||
27828788|NCT01886105|54296974|FG000|Overall Study|Lack of Efficacy|3|||
27828789|NCT01895777|54297003|FG000|Overall Study|Adverse Event|1|||
27828790|NCT01895777|54297004|FG001|Overall Study|Adverse Event|2|||
27828791|NCT01895777|54297003|FG000|Overall Study|Lost to Follow-up|2|||
27828792|NCT01895777|54297004|FG001|Overall Study|Lost to Follow-up|0|||
27828793|NCT01895777|54297003|FG000|Overall Study|Not treated|1|||
27828794|NCT01895777|54297004|FG001|Overall Study|Not treated|0|||
27828795|NCT01895777|54297003|FG000|Overall Study|Other reasons|3|||
27828796|NCT01895777|54297004|FG001|Overall Study|Other reasons|2|||
27828797|NCT01895777|54297003|FG000|Overall Study|Non-compliance with the CTP|2|||
27828798|NCT01895777|54297004|FG001|Overall Study|Non-compliance with the CTP|1|||
27828799|NCT01885559|54297032|FG000|Overall Study|Lost to Follow-up|15|||
27828800|NCT01885559|54297033|FG001|Overall Study|Lost to Follow-up|16|||
27828801|NCT01885559|54297032|FG000|Overall Study|Less than full participation|9|||
27828802|NCT01885559|54297033|FG001|Overall Study|Less than full participation|19|||
27828803|NCT01885559|54297032|FG000|Overall Study|Protocol Violation|0|||
27828804|NCT01885559|54297033|FG001|Overall Study|Protocol Violation|1|||
27828805|NCT01884545|54297043|FG000|Overall Study|Lost to Follow-up|6|||
27828806|NCT01884545|54297044|FG001|Overall Study|Lost to Follow-up|4|||
27828807|NCT01884545|54297045|FG002|Overall Study|Lost to Follow-up|9|||
27828808|NCT01884545|54297046|FG003|Overall Study|Lost to Follow-up|4|||
27828809|NCT01884545|54297043|FG000|Overall Study|Patient withdrawn|7|||
27828810|NCT01884545|54297044|FG001|Overall Study|Patient withdrawn|12|||
27828811|NCT01884545|54297045|FG002|Overall Study|Patient withdrawn|5|||
27828812|NCT01884545|54297046|FG003|Overall Study|Patient withdrawn|5|||
27828813|NCT01884545|54297043|FG000|Overall Study|Non-adherence|0|||
27828814|NCT01884545|54297044|FG001|Overall Study|Non-adherence|2|||
27828815|NCT01884545|54297045|FG002|Overall Study|Non-adherence|0|||
27828816|NCT01884545|54297046|FG003|Overall Study|Non-adherence|0|||
27828817|NCT01895543|54297056|FG000|Overall Study|Withdrawal by Subject|43|||
27828818|NCT01895543|54297056|FG000|Overall Study|Lost to Follow-up|25|||
27828819|NCT01895543|54297056|FG000|Overall Study|Adverse Event|28|||
27828820|NCT01895543|54297056|FG000|Overall Study|Subject's substantial non-compliance|6|||
27828821|NCT01895543|54297056|FG000|Overall Study|Protocol Violation|1|||
27828822|NCT01895543|54297056|FG000|Overall Study|Physician Decision|2|||
27828823|NCT01895543|54297056|FG000|Overall Study|Other (Not fulfilling above criteria)|24|||
27828824|NCT04828161|54297153|FG000|Overall Study|Withdrawal by Subject|0|||
27828825|NCT04828161|54297154|FG001|Overall Study|Withdrawal by Subject|3|||
27828826|NCT04828161|54297155|FG002|Overall Study|Withdrawal by Subject|3|||
27828827|NCT04828161|54297156|FG003|Overall Study|Withdrawal by Subject|4|||
27828828|NCT04828161|54297153|FG000|Overall Study|Lost to Follow-up|1|||
27828829|NCT04828161|54297154|FG001|Overall Study|Lost to Follow-up|4|||
27828830|NCT04828161|54297155|FG002|Overall Study|Lost to Follow-up|2|||
27828831|NCT04828161|54297156|FG003|Overall Study|Lost to Follow-up|2|||
27828832|NCT04828161|54297153|FG000|Overall Study|Other|2|||
27828833|NCT04828161|54297154|FG001|Overall Study|Other|0|||
27828834|NCT04828161|54297155|FG002|Overall Study|Other|2|||
27828835|NCT04828161|54297156|FG003|Overall Study|Other|0|||
27828836|NCT04828161|54297153|FG000|Overall Study|Death|0|||
27828837|NCT04828161|54297154|FG001|Overall Study|Death|0|||
27828838|NCT04828161|54297155|FG002|Overall Study|Death|0|||
27828839|NCT04828161|54297156|FG003|Overall Study|Death|2|||
27828840|NCT01895309|54297254|FG000|Overall Study|Adverse Event|13|||
27828841|NCT01895309|54297255|FG001|Overall Study|Adverse Event|17|||
27828842|NCT01895309|54297254|FG000|Overall Study|Protocol Violation|1|||
27828843|NCT01895309|54297255|FG001|Overall Study|Protocol Violation|0|||
27828844|NCT01895309|54297254|FG000|Overall Study|Lack of Efficacy|1|||
27828845|NCT01895309|54297255|FG001|Overall Study|Lack of Efficacy|3|||
27828846|NCT01895309|54297254|FG000|Overall Study|Lost to Follow-up|1|||
27828847|NCT01895309|54297255|FG001|Overall Study|Lost to Follow-up|3|||
27828848|NCT01895309|54297254|FG000|Overall Study|Physician Decision|15|||
28076811|NCT00111800|54731648|FG000|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
28076812|NCT00111800|54731649|FG001|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
28076813|NCT00111800|54731650|FG002|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
27828849|NCT01895309|54297255|FG001|Overall Study|Physician Decision|10|||
27828850|NCT01895309|54297254|FG000|Overall Study|Withdrawal by Subject|9|||
27828851|NCT01895309|54297255|FG001|Overall Study|Withdrawal by Subject|18|||
27828852|NCT01884311|54297265|FG000|Overall Study|Withdrawal by Subject|3|||
27828853|NCT01884311|54297265|FG000|Overall Study|withdrew consent due to AEs|1|||
27828854|NCT01884311|54297265|FG000|Overall Study|Precautionary measure|1|||
27828855|NCT01884077|54297305|FG000|Overall Study|screen fail|0|||
27828856|NCT01884077|54297306|FG001|Overall Study|screen fail|2|||
27828857|NCT01884077|54297305|FG000|Overall Study|canceled surgery|2|||
27828858|NCT01884077|54297306|FG001|Overall Study|canceled surgery|0|||
27828859|NCT01884077|54297305|FG000|Overall Study|Lost to Follow-up|0|||
27828860|NCT01884077|54297306|FG001|Overall Study|Lost to Follow-up|4|||
27828861|NCT01884077|54297305|FG000|Overall Study|study closed|6|||
27828862|NCT01884077|54297306|FG001|Overall Study|study closed|4|||
27828863|NCT01894919|54297325|FG000|Overall Study|Withdrawal by Subject|1|||
27828864|NCT01894919|54297326|FG001|Overall Study|Withdrawal by Subject|0|||
27828865|NCT01894919|54297327|FG002|Overall Study|Withdrawal by Subject|0|||
27828866|NCT01894919|54297328|FG003|Overall Study|Withdrawal by Subject|0|||
27828867|NCT01894919|54297329|FG004|Overall Study|Withdrawal by Subject|1|||
27828868|NCT01894919|54297330|FG005|Overall Study|Withdrawal by Subject|0|||
27828869|NCT01894919|54297331|FG006|Overall Study|Withdrawal by Subject|0|||
27828870|NCT01894919|54297332|FG007|Overall Study|Withdrawal by Subject|0|||
27828871|NCT01894919|54297333|FG008|Overall Study|Withdrawal by Subject|0|||
27828872|NCT01894919|54297334|FG009|Overall Study|Withdrawal by Subject|1|||
27828873|NCT01894919|54297335|FG010|Overall Study|Withdrawal by Subject|1|||
27828874|NCT01894919|54297336|FG011|Overall Study|Withdrawal by Subject|0|||
27828875|NCT01894919|54297337|FG012|Overall Study|Withdrawal by Subject|0|||
27828876|NCT01894919|54297325|FG000|Overall Study|Adverse Event|0|||
27828877|NCT01894919|54297326|FG001|Overall Study|Adverse Event|0|||
27828878|NCT01894919|54297327|FG002|Overall Study|Adverse Event|0|||
27828879|NCT01894919|54297328|FG003|Overall Study|Adverse Event|0|||
27828880|NCT01894919|54297329|FG004|Overall Study|Adverse Event|0|||
27828881|NCT01894919|54297330|FG005|Overall Study|Adverse Event|0|||
27828882|NCT01894919|54297331|FG006|Overall Study|Adverse Event|0|||
27828883|NCT01894919|54297332|FG007|Overall Study|Adverse Event|0|||
27828884|NCT01894919|54297333|FG008|Overall Study|Adverse Event|0|||
27828885|NCT01894919|54297334|FG009|Overall Study|Adverse Event|0|||
27828886|NCT01894919|54297335|FG010|Overall Study|Adverse Event|1|||
27828887|NCT01894919|54297336|FG011|Overall Study|Adverse Event|0|||
27828888|NCT01894919|54297337|FG012|Overall Study|Adverse Event|0|||
27828889|NCT01894919|54297325|FG000|Overall Study|Other-Unspecified|1|||
27828890|NCT01894919|54297326|FG001|Overall Study|Other-Unspecified|0|||
27828891|NCT01894919|54297327|FG002|Overall Study|Other-Unspecified|0|||
27828892|NCT01894919|54297328|FG003|Overall Study|Other-Unspecified|0|||
27828893|NCT01894919|54297329|FG004|Overall Study|Other-Unspecified|0|||
27828894|NCT01894919|54297330|FG005|Overall Study|Other-Unspecified|0|||
27828895|NCT01894919|54297331|FG006|Overall Study|Other-Unspecified|0|||
27828896|NCT01894919|54297332|FG007|Overall Study|Other-Unspecified|0|||
27828897|NCT01894919|54297333|FG008|Overall Study|Other-Unspecified|0|||
27828898|NCT01894919|54297334|FG009|Overall Study|Other-Unspecified|0|||
27828899|NCT01894919|54297335|FG010|Overall Study|Other-Unspecified|0|||
27828900|NCT01894919|54297336|FG011|Overall Study|Other-Unspecified|0|||
27828901|NCT01894919|54297337|FG012|Overall Study|Other-Unspecified|0|||
27828902|NCT01894919|54297325|FG000|Overall Study|Lost to Follow-up|0|||
27828903|NCT01894919|54297326|FG001|Overall Study|Lost to Follow-up|0|||
27828904|NCT01894919|54297327|FG002|Overall Study|Lost to Follow-up|0|||
27828905|NCT01894919|54297328|FG003|Overall Study|Lost to Follow-up|0|||
27828906|NCT01894919|54297329|FG004|Overall Study|Lost to Follow-up|2|||
27828907|NCT01894919|54297330|FG005|Overall Study|Lost to Follow-up|0|||
27828908|NCT01894919|54297331|FG006|Overall Study|Lost to Follow-up|0|||
27828909|NCT01894919|54297332|FG007|Overall Study|Lost to Follow-up|0|||
27828910|NCT01894919|54297333|FG008|Overall Study|Lost to Follow-up|0|||
27828911|NCT01894919|54297334|FG009|Overall Study|Lost to Follow-up|0|||
27828912|NCT01894919|54297335|FG010|Overall Study|Lost to Follow-up|0|||
27828913|NCT01894919|54297336|FG011|Overall Study|Lost to Follow-up|0|||
27828914|NCT01894919|54297337|FG012|Overall Study|Lost to Follow-up|0|||
27828915|NCT01894841|54297381|FG000|Overall Study|Withdrawal by Subject|9|||
27828916|NCT01894841|54297382|FG001|Overall Study|Withdrawal by Subject|4|||
27828917|NCT01894841|54297381|FG000|Overall Study|Withdrawn by investigator|2|||
27828918|NCT01894841|54297382|FG001|Overall Study|Withdrawn by investigator|2|||
27828919|NCT01894841|54297381|FG000|Overall Study|Lost to Follow-up|7|||
27828920|NCT01894841|54297382|FG001|Overall Study|Lost to Follow-up|3|||
27828921|NCT01894607|54297392|FG000|Overall Study|Ineligible|1|||
27850790|NCT03164616|54349873|FG002|Overall Study|Death|279|||
27850791|NCT03164616|54349871|FG000|Overall Study|Lost to Follow-up|2|||
27850792|NCT03164616|54349872|FG001|Overall Study|Lost to Follow-up|2|||
27850793|NCT03164616|54349873|FG002|Overall Study|Lost to Follow-up|2|||
27850794|NCT03164616|54349871|FG000|Overall Study|Withdrawal by Subject|6|||
28159832|NCT00919893|54829869|FG000|Overall Study|Protocol Violation|19|||
27828922|NCT01883453|54297398|FG000|Overall Study|No episode of common cold|25|||
27828923|NCT01883453|54297399|FG001|Overall Study|No episode of common cold|23|||
27828924|NCT01882985|54297433|FG000|Overall Study|Lost to Follow-up|1|||
27828925|NCT01882985|54297433|FG000|Overall Study|Withdrawal by Subject|1|||
27828926|NCT01893905|54297446|FG000|Overall Study|Withdrawal by Subject|1|||
27850795|NCT03164616|54349872|FG001|Overall Study|Withdrawal by Subject|7|||
28159833|NCT00919893|54829870|FG001|Overall Study|Protocol Violation|9|||
27828927|NCT01893905|54297447|FG001|Overall Study|Withdrawal by Subject|0|||
27828928|NCT01893905|54297446|FG000|Overall Study|Adverse Event|9|||
27828929|NCT01893905|54297447|FG001|Overall Study|Adverse Event|3|||
27850796|NCT03164616|54349873|FG002|Overall Study|Withdrawal by Subject|16|||
27828930|NCT01893905|54297446|FG000|Overall Study|Lack of Efficacy|5|||
27828931|NCT01893905|54297447|FG001|Overall Study|Lack of Efficacy|7|||
27828932|NCT01893905|54297446|FG000|Overall Study|Lost to Follow-up|1|||
27828933|NCT01893905|54297447|FG001|Overall Study|Lost to Follow-up|0|||
27828934|NCT01893905|54297446|FG000|Overall Study|Protocol Violation|6|||
27828935|NCT01893905|54297447|FG001|Overall Study|Protocol Violation|1|||
27943341|NCT01180049|54600283|FG000|Overall Study|Death|36|||
27943342|NCT01180049|54600284|FG001|Overall Study|Death|35|||
27943343|NCT01147458|54600290|FG000|First Intervention|Study terminated by sponsor|8|||
27943344|NCT01147458|54600291|FG001|First Intervention|Study terminated by sponsor|8|||
27943345|NCT01147458|54600292|FG002|First Intervention|Study terminated by sponsor|7|||
27943346|NCT01147458|54600293|FG003|First Intervention|Study terminated by sponsor|8|||
27943347|NCT01147458|54600290|FG000|First Intervention|Protocol Violation|2|||
27943348|NCT01147458|54600291|FG001|First Intervention|Protocol Violation|3|||
27828936|NCT01893905|54297446|FG000|Overall Study|Lack of adherence to treatment|2|||
27828937|NCT01893905|54297447|FG001|Overall Study|Lack of adherence to treatment|0|||
27828938|NCT01893905|54297446|FG000|Overall Study|Other reason|1|||
27828939|NCT01893905|54297447|FG001|Overall Study|Other reason|3|||
27828940|NCT01893827|54297460|FG000|Overall Study|Lost to Follow-up|19|||
27828941|NCT01893827|54297461|FG001|Overall Study|Lost to Follow-up|26|||
27828942|NCT01882907|54297469|FG000|Overall Study|Adverse Event|3|||
27828943|NCT01882907|54297470|FG001|Overall Study|Adverse Event|1|||
27828944|NCT01882907|54297469|FG000|Overall Study|Lack of Efficacy|0|||
27828945|NCT01882907|54297470|FG001|Overall Study|Lack of Efficacy|3|||
27828946|NCT01882907|54297469|FG000|Overall Study|Lost to Follow-up|1|||
27828947|NCT01882907|54297470|FG001|Overall Study|Lost to Follow-up|4|||
27828948|NCT01882907|54297469|FG000|Overall Study|Protocol Violation|10|||
27828949|NCT01882907|54297470|FG001|Overall Study|Protocol Violation|14|||
27828950|NCT01882907|54297469|FG000|Overall Study|Withdrawal by Subject|0|||
27828951|NCT01882907|54297470|FG001|Overall Study|Withdrawal by Subject|6|||
27828952|NCT01893281|54297492|FG000|Overall Study|Adverse Event|1|||
27828953|NCT01893281|54297492|FG000|Overall Study|Protocol Violation|1|||
27828954|NCT01893281|54297492|FG000|Overall Study|Withdrawal by Subject|1|||
27828955|NCT01893203|54297496|FG000|Overall Study|Withdrawal by Subject|1|||
27828956|NCT01882829|54297500|FG000|Overall Study|Adverse Event|4|||
27828957|NCT01882829|54297500|FG000|Overall Study|Protocol Violation|1|||
27828958|NCT01882829|54297500|FG000|Overall Study|Withdrawal by Subject|1|||
27828959|NCT01882439|54297584|FG000|Overall Study|Adverse event related to study drug|3|||
27828960|NCT01882439|54297585|FG001|Overall Study|Adverse event related to study drug|8|||
27828961|NCT01882439|54297586|FG002|Overall Study|Adverse event related to study drug|1|||
27828962|NCT01882439|54297587|FG003|Overall Study|Adverse event related to study drug|2|||
27828963|NCT01882439|54297584|FG000|Overall Study|Pregnancy|0|||
27828964|NCT01882439|54297585|FG001|Overall Study|Pregnancy|1|||
27828965|NCT01882439|54297586|FG002|Overall Study|Pregnancy|0|||
27828966|NCT01882439|54297587|FG003|Overall Study|Pregnancy|0|||
27828967|NCT01882439|54297584|FG000|Overall Study|Protocol Violation|2|||
27828968|NCT01882439|54297585|FG001|Overall Study|Protocol Violation|2|||
27828969|NCT01882439|54297586|FG002|Overall Study|Protocol Violation|0|||
27828970|NCT01882439|54297587|FG003|Overall Study|Protocol Violation|1|||
27828971|NCT01882439|54297584|FG000|Overall Study|No longer willing to participate|1|||
27828972|NCT01882439|54297585|FG001|Overall Study|No longer willing to participate|4|||
27828973|NCT01882439|54297586|FG002|Overall Study|No longer willing to participate|2|||
27828974|NCT01882439|54297587|FG003|Overall Study|No longer willing to participate|3|||
27828975|NCT01882439|54297584|FG000|Overall Study|Medication error with no associated AE|0|||
27828976|NCT01882439|54297585|FG001|Overall Study|Medication error with no associated AE|0|||
27828977|NCT01882439|54297586|FG002|Overall Study|Medication error with no associated AE|2|||
27828978|NCT01882439|54297587|FG003|Overall Study|Medication error with no associated AE|0|||
27850797|NCT03161483|54349887|FG000|Placebo Controlled Phase|Participant Withdrew Consent|0|||
27850798|NCT03161483|54349888|FG001|Placebo Controlled Phase|Participant Withdrew Consent|1|||
27850799|NCT03161483|54349889|FG002|Placebo Controlled Phase|Participant Withdrew Consent|0|||
27850800|NCT03161483|54349890|FG003|Placebo Controlled Phase|Participant Withdrew Consent|0|||
27850801|NCT03161483|54349887|FG000|Treatment Period|Death|1|||
27850802|NCT03161483|54349888|FG001|Treatment Period|Death|0|||
27850803|NCT03161483|54349889|FG002|Treatment Period|Death|0|||
27850804|NCT03161483|54349890|FG003|Treatment Period|Death|0|||
27850805|NCT03161483|54349887|FG000|Treatment Period|Adverse Event|5|||
27850806|NCT03161483|54349888|FG001|Treatment Period|Adverse Event|2|||
27850807|NCT03161483|54349889|FG002|Treatment Period|Adverse Event|1|||
27943349|NCT01147458|54600292|FG002|First Intervention|Protocol Violation|2|||
27943350|NCT01147458|54600293|FG003|First Intervention|Protocol Violation|3|||
27943351|NCT01147458|54600290|FG000|First Intervention|Withdrawal by Subject|3|||
27828979|NCT01882439|54297584|FG000|Overall Study|Insufficient clinical response|1|||
27828980|NCT01882439|54297585|FG001|Overall Study|Insufficient clinical response|4|||
27828981|NCT01882439|54297586|FG002|Overall Study|Insufficient clinical response|4|||
27828982|NCT01882439|54297587|FG003|Overall Study|Insufficient clinical response|2|||
27828983|NCT01882439|54297584|FG000|Overall Study|Adverse event unrelated to study drug|2|||
27828984|NCT01882439|54297585|FG001|Overall Study|Adverse event unrelated to study drug|2|||
27828985|NCT01882439|54297586|FG002|Overall Study|Adverse event unrelated to study drug|1|||
27850808|NCT03161483|54349890|FG003|Treatment Period|Adverse Event|11|||
27850809|NCT03161483|54349887|FG000|Treatment Period|Pregnancy|1|||
27850810|NCT03161483|54349888|FG001|Treatment Period|Pregnancy|0|||
27943352|NCT01147458|54600291|FG001|First Intervention|Withdrawal by Subject|0|||
27828986|NCT01882439|54297587|FG003|Overall Study|Adverse event unrelated to study drug|1|||
27828987|NCT01892657|54297634|FG000|Overall Study|Withdrawal by Subject|6|||
27828988|NCT01892657|54297634|FG000|Overall Study|Protocol Violation|12|||
27828989|NCT01881737|54297661|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
27828990|NCT01881737|54297661|FG000|Overall Study|Withdrawal by Subject|1|||
27828991|NCT01881737|54297661|FG000|Overall Study|Worsening of baseline behavior|1|||
27828992|NCT01892501|54297697|FG000|Overall Study|Protocol Violation|2|||
27828993|NCT01892501|54297697|FG000|Overall Study|Puncture not carried out|9|||
27828994|NCT01892501|54297697|FG000|Overall Study|Radiological monitoring not carried out|5|||
27828995|NCT01892501|54297697|FG000|Overall Study|Non-contributory histological result|12|||
27828996|NCT01892345|54297712|FG000|Overall Study|Adverse Event|0|||
27828997|NCT01892345|54297713|FG001|Overall Study|Adverse Event|2|||
27828998|NCT01892345|54297712|FG000|Overall Study|Death|1|||
27828999|NCT01892345|54297713|FG001|Overall Study|Death|0|||
27829000|NCT01892345|54297712|FG000|Overall Study|Lost to Follow-up|3|||
27829001|NCT01892345|54297713|FG001|Overall Study|Lost to Follow-up|0|||
27829002|NCT01892345|54297712|FG000|Overall Study|Withdrawal by Subject|12|||
27829003|NCT01892345|54297713|FG001|Overall Study|Withdrawal by Subject|1|||
27829004|NCT01892189|54297790|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
27829005|NCT01892189|54297791|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
27829006|NCT01892189|54297792|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
27829007|NCT01892189|54297793|FG003|Washout Period 1 (7 Days)|Adverse Event|0|||
27829008|NCT01892189|54297794|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
27829009|NCT01892189|54297795|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
27829010|NCT01892189|54297796|FG006|Washout Period 1 (7 Days)|Adverse Event|0|||
27829011|NCT01892189|54297797|FG007|Washout Period 1 (7 Days)|Adverse Event|0|||
27829012|NCT01892189|54297798|FG008|Washout Period 1 (7 Days)|Adverse Event|1|||
27829013|NCT01892189|54297790|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
27829014|NCT01892189|54297791|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
27829015|NCT01892189|54297792|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|2|||
27829016|NCT01892189|54297793|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
27829017|NCT01892189|54297794|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
27829018|NCT01892189|54297795|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
27829019|NCT01892189|54297796|FG006|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
27829020|NCT01892189|54297797|FG007|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
27829021|NCT01892189|54297798|FG008|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
27829022|NCT01892189|54297790|FG000|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
27829023|NCT01892189|54297791|FG001|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
27829024|NCT01892189|54297792|FG002|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
27829025|NCT01892189|54297793|FG003|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
27829026|NCT01892189|54297794|FG004|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
27829027|NCT01892189|54297795|FG005|Washout Period 1 (7 Days)|Noncompliance, Irritability|1|||
27829028|NCT01892189|54297796|FG006|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
27829029|NCT01892189|54297797|FG007|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
27829030|NCT01892189|54297798|FG008|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
27829031|NCT01881425|54297829|FG000|Overall Study|Death|5|||
27829032|NCT01881425|54297830|FG001|Overall Study|Death|1|||
27829033|NCT01881425|54297829|FG000|Overall Study|Withdrawal by Subject|8|||
27829034|NCT01881425|54297830|FG001|Overall Study|Withdrawal by Subject|3|||
27829035|NCT01881425|54297829|FG000|Overall Study|Physician Decision|2|||
27829036|NCT01881425|54297830|FG001|Overall Study|Physician Decision|1|||
27829037|NCT01881425|54297829|FG000|Overall Study|Adverse Event|3|||
27829038|NCT01881425|54297830|FG001|Overall Study|Adverse Event|0|||
27829039|NCT01881425|54297829|FG000|Overall Study|General Anesthesia panic attack|0|||
27829040|NCT01881425|54297830|FG001|Overall Study|General Anesthesia panic attack|1|||
27829041|NCT01881425|54297829|FG000|Overall Study|Subject randomized after study treatment cut off|0|||
27829042|NCT01881425|54297830|FG001|Overall Study|Subject randomized after study treatment cut off|1|||
28076814|NCT00111800|54731651|FG003|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
28076815|NCT00111800|54731652|FG004|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1|||
27829043|NCT01881425|54297829|FG000|Overall Study|Lost to Follow-up|7|||
27829044|NCT01881425|54297830|FG001|Overall Study|Lost to Follow-up|2|||
27829045|NCT01891721|54297849|FG000|Overall Study|Lost to Follow-up|10|||
28076816|NCT00111800|54731653|FG005|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
27829046|NCT01891721|54297850|FG001|Overall Study|Lost to Follow-up|5|||
27829047|NCT01891721|54297851|FG002|Overall Study|Lost to Follow-up|1|||
27829048|NCT01880957|54297870|FG000|Overall Study|Diagnosis: Unipolar Depression|12|||
27829049|NCT01880957|54297871|FG001|Overall Study|Diagnosis: Unipolar Depression|0|||
27829050|NCT01880957|54297870|FG000|Overall Study|Lost to Follow-up|11|||
27829051|NCT01880957|54297871|FG001|Overall Study|Lost to Follow-up|0|||
27829052|NCT01880957|54297870|FG000|Overall Study|Poor Tolerance to Lithium/Declined Treatment|5|||
27829053|NCT01880957|54297871|FG001|Overall Study|Poor Tolerance to Lithium/Declined Treatment|0|||
27829054|NCT04152837|54297886|FG000|Baseline Period (No Treatment)|Baseline Failure|1|||
27829055|NCT04152837|54297886|FG000|Maintenance Period|Adverse Event|1|||
27829056|NCT04152837|54297886|FG000|Maintenance Period|Withdrawal by Subject|1|||
27829057|NCT04152837|54297886|FG000|Maintenance Period|Sponsor Termination of Study|2|||
27829058|NCT01879553|54297905|FG000|Overall Study|Withdrawal by Subject|1|||
27829059|NCT01879553|54297906|FG001|Overall Study|Withdrawal by Subject|0|||
27829060|NCT01890785|54297927|FG000|Third Intervention|Withdrawal by Subject|0|||
27829061|NCT01890785|54297928|FG001|Third Intervention|Withdrawal by Subject|1|||
27829062|NCT01890785|54297929|FG002|Third Intervention|Withdrawal by Subject|0|||
27829063|NCT01890785|54297930|FG003|Third Intervention|Withdrawal by Subject|0|||
27829064|NCT01890785|54297931|FG004|Third Intervention|Withdrawal by Subject|0|||
27829065|NCT01890785|54297932|FG005|Third Intervention|Withdrawal by Subject|0|||
27829066|NCT01878383|54297956|FG000|Overall Study|Lost to Follow-up|0|||
27829067|NCT01878383|54297957|FG001|Overall Study|Lost to Follow-up|1499|||
27829068|NCT01878149|54297965|FG000|Overall Study|Did Not Meet Eligibility Criteria|2|||
27829069|NCT01878149|54297966|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
27829070|NCT01863953|54297988|FG000|Overall Study|Adverse Event|0|||
27829071|NCT01863953|54297989|FG001|Overall Study|Adverse Event|0|||
27829072|NCT01863953|54297990|FG002|Overall Study|Adverse Event|1|||
27829073|NCT03049449|54298266|FG000|Overall Study|Did not receive treatment.|0|||
27829074|NCT03049449|54298267|FG001|Overall Study|Did not receive treatment.|0|||
27829075|NCT03049449|54298268|FG002|Overall Study|Did not receive treatment.|0|||
27829076|NCT03049449|54298269|FG003|Overall Study|Did not receive treatment.|0|||
27829077|NCT03049449|54298270|FG004|Overall Study|Did not receive treatment.|0|||
27829078|NCT03049449|54298271|FG005|Overall Study|Did not receive treatment.|0|||
27829079|NCT03049449|54298272|FG006|Overall Study|Did not receive treatment.|0|||
27829080|NCT03049449|54298273|FG007|Overall Study|Did not receive treatment.|0|||
27829081|NCT03049449|54298274|FG008|Overall Study|Did not receive treatment.|1|||
27829082|NCT03049449|54298275|FG009|Overall Study|Did not receive treatment.|0|||
27829083|NCT03049449|54298266|FG000|Overall Study|Enrolled and removed from study with no treatment|0|||
27829084|NCT03049449|54298267|FG001|Overall Study|Enrolled and removed from study with no treatment|0|||
27829085|NCT03049449|54298268|FG002|Overall Study|Enrolled and removed from study with no treatment|1|||
27829086|NCT03049449|54298269|FG003|Overall Study|Enrolled and removed from study with no treatment|1|||
27829087|NCT03049449|54298270|FG004|Overall Study|Enrolled and removed from study with no treatment|0|||
27829088|NCT03049449|54298271|FG005|Overall Study|Enrolled and removed from study with no treatment|0|||
27829089|NCT03049449|54298272|FG006|Overall Study|Enrolled and removed from study with no treatment|0|||
27829090|NCT03049449|54298273|FG007|Overall Study|Enrolled and removed from study with no treatment|0|||
27829091|NCT03049449|54298274|FG008|Overall Study|Enrolled and removed from study with no treatment|0|||
27829092|NCT03049449|54298275|FG009|Overall Study|Enrolled and removed from study with no treatment|0|||
27829093|NCT03049449|54298266|FG000|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
27829094|NCT03049449|54298267|FG001|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
27829095|NCT03049449|54298268|FG002|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
27829096|NCT03049449|54298269|FG003|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
27829097|NCT03049449|54298270|FG004|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
27829098|NCT03049449|54298271|FG005|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
27829099|NCT03049449|54298272|FG006|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
27829100|NCT03049449|54298273|FG007|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
27829101|NCT03049449|54298274|FG008|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
27829102|NCT03049449|54298275|FG009|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
27829103|NCT02989857|54298408|FG000|Randomization Phase|Not Treated|3|||
27829104|NCT02989857|54298409|FG001|Randomization Phase|Not Treated|2|||
27829105|NCT02989857|54298410|FG002|Randomization Phase|Not Treated|0|||
27829106|NCT01877915|54298421|FG000|Overall Study|Lost to Follow-up|10|||
27829107|NCT01877915|54298422|FG001|Overall Study|Lost to Follow-up|9|||
27829108|NCT01877915|54298421|FG000|Overall Study|Withdrawal by Subject|42|||
28159834|NCT02559622|54829878|FG000|Overall Study|Progressive disease|0|||
28159835|NCT02559622|54829879|FG001|Overall Study|Progressive disease|1|||
28159836|NCT02559622|54829880|FG002|Overall Study|Progressive disease|0|||
28159837|NCT02559622|54829881|FG003|Overall Study|Progressive disease|0|||
27829109|NCT01877915|54298422|FG001|Overall Study|Withdrawal by Subject|55|||
27829110|NCT01877915|54298421|FG000|Overall Study|Other|2|||
27829111|NCT01877915|54298422|FG001|Overall Study|Other|4|||
27829112|NCT01876979|54298430|FG000|Overall Study|Physician Decision|2|||
27829113|NCT01876979|54298431|FG001|Overall Study|Physician Decision|3|||
28159838|NCT02559622|54829878|FG000|Overall Study|Adverse Event|0|||
28159839|NCT02559622|54829879|FG001|Overall Study|Adverse Event|2|||
28159840|NCT02559622|54829880|FG002|Overall Study|Adverse Event|2|||
28159841|NCT02559622|54829881|FG003|Overall Study|Adverse Event|2|||
27829114|NCT01860989|54298437|FG000|Overall Study|Unsatisfactory therapeutic|5|||
27829115|NCT01860677|54298453|FG000|Second Intervention (1 Day)|Lost to Follow-up|7|||
27829116|NCT01860677|54298454|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
27829117|NCT01876901|54298472|FG000|Overall Study|Protocol Violation|10|||
27829118|NCT01876901|54298473|FG001|Overall Study|Protocol Violation|2|||
27829119|NCT01876901|54298472|FG000|Overall Study|No or other surgical intervention|7|||
27829120|NCT01876901|54298473|FG001|Overall Study|No or other surgical intervention|5|||
27829121|NCT01876823|54298480|FG000|Overall Study|Withdrawal by Subject|5|||
27829122|NCT01876823|54298480|FG000|Overall Study|Physician Decision|2|||
27829123|NCT01876823|54298480|FG000|Overall Study|Patients moved|2|||
27829124|NCT01876511|54298487|FG000|Overall Study|Disease Progression-clinical/radiologic|11|||
27829125|NCT01876511|54298488|FG001|Overall Study|Disease Progression-clinical/radiologic|24|||
27829126|NCT01876511|54298489|FG002|Overall Study|Disease Progression-clinical/radiologic|16|||
27829127|NCT01876511|54298487|FG000|Overall Study|Death (unrelated)|3|||
27829128|NCT01876511|54298488|FG001|Overall Study|Death (unrelated)|0|||
27829129|NCT01876511|54298489|FG002|Overall Study|Death (unrelated)|2|||
27829130|NCT01876511|54298487|FG000|Overall Study|Drug-related Toxicity|5|||
27829131|NCT01876511|54298488|FG001|Overall Study|Drug-related Toxicity|1|||
27829132|NCT01876511|54298489|FG002|Overall Study|Drug-related Toxicity|6|||
27829133|NCT01876511|54298487|FG000|Overall Study|Patient Decision|3|||
27829134|NCT01876511|54298488|FG001|Overall Study|Patient Decision|0|||
27829135|NCT01876511|54298489|FG002|Overall Study|Patient Decision|6|||
27829136|NCT01876511|54298487|FG000|Overall Study|Physician Decision|1|||
27829137|NCT01876511|54298488|FG001|Overall Study|Physician Decision|0|||
27829138|NCT01876511|54298489|FG002|Overall Study|Physician Decision|1|||
27829139|NCT01993719|54298504|FG000|First Drug Administration|Not treated|1|||
27829140|NCT01993719|54298505|FG001|First Drug Administration|Not treated|0|||
27829141|NCT01993719|54298506|FG002|First Drug Administration|Not treated|0|||
27829142|NCT01993719|54298507|FG003|First Drug Administration|Not treated|0|||
27829143|NCT01993719|54298508|FG004|First Drug Administration|Not treated|0|||
27829144|NCT00638235|54298550|FG000|Overall Study|Lost to Follow-up|31|||
27829145|NCT00638235|54298551|FG001|Overall Study|Lost to Follow-up|3|||
27829146|NCT00638235|54298552|FG002|Overall Study|Lost to Follow-up|18|||
27829147|NCT00638235|54298553|FG003|Overall Study|Lost to Follow-up|10|||
27829148|NCT00638235|54298554|FG004|Overall Study|Lost to Follow-up|13|||
27829149|NCT00638235|54298555|FG005|Overall Study|Lost to Follow-up|26|||
27829150|NCT00638235|54298556|FG006|Overall Study|Lost to Follow-up|0|||
27829151|NCT00638235|54298557|FG007|Overall Study|Lost to Follow-up|1|||
27829152|NCT00638235|54298558|FG008|Overall Study|Lost to Follow-up|18|||
27829153|NCT00638157|54298587|FG000|Overall Study|Adverse Event|0|||
27829154|NCT00638157|54298588|FG001|Overall Study|Adverse Event|1|||
27829155|NCT00638157|54298587|FG000|Overall Study|Clinical (symptomatic) failure|1|||
27829156|NCT00638157|54298588|FG001|Overall Study|Clinical (symptomatic) failure|1|||
27829157|NCT00638157|54298587|FG000|Overall Study|Microbiological failure|1|||
27829158|NCT00638157|54298588|FG001|Overall Study|Microbiological failure|0|||
27829159|NCT00638157|54298587|FG000|Overall Study|Lost to Follow-up|1|||
27829160|NCT00638157|54298588|FG001|Overall Study|Lost to Follow-up|0|||
27829161|NCT00638157|54298587|FG000|Overall Study|Physician Decision|1|||
27829162|NCT00638157|54298588|FG001|Overall Study|Physician Decision|0|||
27829163|NCT00638157|54298587|FG000|Overall Study|Other|1|||
27829164|NCT00638157|54298588|FG001|Overall Study|Other|2|||
28159842|NCT02559622|54829878|FG000|Overall Study|Patient/guardian decision|1|||
28159843|NCT02559622|54829879|FG001|Overall Study|Patient/guardian decision|2|||
28159844|NCT02559622|54829880|FG002|Overall Study|Patient/guardian decision|0|||
28159845|NCT02559622|54829881|FG003|Overall Study|Patient/guardian decision|1|||
28159846|NCT02559310|54829897|FG000|Overall Study|Death|4|||
28159847|NCT02559310|54829898|FG001|Overall Study|Death|3|||
28159848|NCT02559310|54829897|FG000|Overall Study|Lost to Follow-up|5|||
28159849|NCT02559310|54829898|FG001|Overall Study|Lost to Follow-up|3|||
28159850|NCT02559310|54829897|FG000|Overall Study|Physician Decision|2|||
28159851|NCT02559310|54829898|FG001|Overall Study|Physician Decision|1|||
28159852|NCT02559310|54829897|FG000|Overall Study|Withdrawal by Subject|13|||
28159853|NCT02559310|54829898|FG001|Overall Study|Withdrawal by Subject|9|||
28159854|NCT02559310|54829897|FG000|Overall Study|Sponsor Decision|0|||
28159855|NCT02559310|54829898|FG001|Overall Study|Sponsor Decision|1|||
27829165|NCT00638157|54298587|FG000|Overall Study|Randomized, not treated|2|||
27829166|NCT00638157|54298588|FG001|Overall Study|Randomized, not treated|0|||
27829167|NCT00637377|54298599|FG000|Overall Study|Adverse Event|2|||
27829168|NCT00637377|54298600|FG001|Overall Study|Adverse Event|6|||
27829169|NCT00637377|54298601|FG002|Overall Study|Adverse Event|8|||
28159856|NCT02559310|54829897|FG000|Overall Study|Randomized but not treated|3|||
28159857|NCT02559310|54829898|FG001|Overall Study|Randomized but not treated|2|||
28159858|NCT03517449|54829906|FG000|Overall Study|Death|184|||
27829170|NCT00637377|54298602|FG003|Overall Study|Adverse Event|9|||
27829171|NCT00637377|54298599|FG000|Overall Study|Death|1|||
27829172|NCT00637377|54298600|FG001|Overall Study|Death|3|||
27829173|NCT00637377|54298601|FG002|Overall Study|Death|2|||
27829174|NCT00637377|54298602|FG003|Overall Study|Death|1|||
27829175|NCT00637377|54298599|FG000|Overall Study|Lack of Efficacy|0|||
27829176|NCT00637377|54298600|FG001|Overall Study|Lack of Efficacy|0|||
27829177|NCT00637377|54298601|FG002|Overall Study|Lack of Efficacy|1|||
27829178|NCT00637377|54298602|FG003|Overall Study|Lack of Efficacy|1|||
27829179|NCT00637377|54298599|FG000|Overall Study|Lost to Follow-up|4|||
27829180|NCT00637377|54298600|FG001|Overall Study|Lost to Follow-up|1|||
27829181|NCT00637377|54298601|FG002|Overall Study|Lost to Follow-up|2|||
27829182|NCT00637377|54298602|FG003|Overall Study|Lost to Follow-up|2|||
27829183|NCT00637377|54298599|FG000|Overall Study|Protocol Violation|2|||
27829184|NCT00637377|54298600|FG001|Overall Study|Protocol Violation|1|||
27829185|NCT00637377|54298601|FG002|Overall Study|Protocol Violation|1|||
27829186|NCT00637377|54298602|FG003|Overall Study|Protocol Violation|0|||
27829187|NCT00637377|54298599|FG000|Overall Study|Withdrawal by Subject|11|||
27829188|NCT00637377|54298600|FG001|Overall Study|Withdrawal by Subject|15|||
27829189|NCT00637377|54298601|FG002|Overall Study|Withdrawal by Subject|13|||
27829190|NCT00637377|54298602|FG003|Overall Study|Withdrawal by Subject|11|||
27829191|NCT00637377|54298599|FG000|Overall Study|Other (no further information available)|7|||
27829192|NCT00637377|54298600|FG001|Overall Study|Other (no further information available)|6|||
27829193|NCT00637377|54298601|FG002|Overall Study|Other (no further information available)|10|||
27829194|NCT00637377|54298602|FG003|Overall Study|Other (no further information available)|5|||
27829195|NCT00636987|54298612|FG000|Overall Study|Death|44|||
27829196|NCT00636987|54298612|FG000|Overall Study|Explanted|13|||
27829197|NCT00636987|54298612|FG000|Overall Study|Lost to Follow-up|63|||
27829198|NCT00636987|54298612|FG000|Overall Study|5 year visit window not complete|69|||
27829199|NCT00636441|54298767|FG000|Overall Study|Adverse Event|0|||
27829200|NCT00636441|54298768|FG001|Overall Study|Adverse Event|1|||
27829201|NCT00636441|54298769|FG002|Overall Study|Adverse Event|1|||
27829202|NCT00636441|54298770|FG003|Overall Study|Adverse Event|0|||
27829203|NCT00636441|54298771|FG004|Overall Study|Adverse Event|0|||
27829204|NCT00636441|54298772|FG005|Overall Study|Adverse Event|1|||
27829205|NCT00636441|54298773|FG006|Overall Study|Adverse Event|0|||
27829206|NCT00636441|54298767|FG000|Overall Study|Late, ineligible|0|||
27829207|NCT00636441|54298768|FG001|Overall Study|Late, ineligible|0|||
27829208|NCT00636441|54298769|FG002|Overall Study|Late, ineligible|0|||
27829209|NCT00636441|54298770|FG003|Overall Study|Late, ineligible|0|||
27829210|NCT00636441|54298771|FG004|Overall Study|Late, ineligible|0|||
27829211|NCT00636441|54298772|FG005|Overall Study|Late, ineligible|0|||
27829212|NCT00636441|54298773|FG006|Overall Study|Late, ineligible|1|||
27829213|NCT00636441|54298767|FG000|Overall Study|Screen Failure|0|||
27829214|NCT00636441|54298768|FG001|Overall Study|Screen Failure|0|||
27829215|NCT00636441|54298769|FG002|Overall Study|Screen Failure|0|||
27829216|NCT00636441|54298770|FG003|Overall Study|Screen Failure|0|||
27829217|NCT00636441|54298771|FG004|Overall Study|Screen Failure|0|||
27829218|NCT00636441|54298772|FG005|Overall Study|Screen Failure|0|||
27829219|NCT00636441|54298773|FG006|Overall Study|Screen Failure|17|||
27829220|NCT00636363|54298796|FG000|Overall Study|Conjunctivitis|0|||
27829221|NCT00636363|54298797|FG001|Overall Study|Conjunctivitis|0|||
27829222|NCT00636363|54298798|FG002|Overall Study|Conjunctivitis|1|||
27829223|NCT00636363|54298796|FG000|Overall Study|Adverse Event|0|||
27829224|NCT00636363|54298797|FG001|Overall Study|Adverse Event|0|||
27829225|NCT00636363|54298798|FG002|Overall Study|Adverse Event|1|||
27829226|NCT00636363|54298796|FG000|Overall Study|Positive slit lamp finding|0|||
27829227|NCT00636363|54298797|FG001|Overall Study|Positive slit lamp finding|2|||
27829228|NCT00636363|54298798|FG002|Overall Study|Positive slit lamp finding|1|||
27829229|NCT00636363|54298796|FG000|Overall Study|Study related symptoms/complaints|8|||
27829230|NCT00636363|54298797|FG001|Overall Study|Study related symptoms/complaints|7|||
27829231|NCT00636363|54298798|FG002|Overall Study|Study related symptoms/complaints|4|||
27829232|NCT00636363|54298796|FG000|Overall Study|Met ineligibility criteria|0|||
27829233|NCT00636363|54298797|FG001|Overall Study|Met ineligibility criteria|0|||
27829234|NCT00636363|54298798|FG002|Overall Study|Met ineligibility criteria|3|||
27943353|NCT01147458|54600292|FG002|First Intervention|Withdrawal by Subject|1|||
27829235|NCT00636363|54298796|FG000|Overall Study|Missed > 1 visit|0|||
27829236|NCT00636363|54298797|FG001|Overall Study|Missed > 1 visit|1|||
27829237|NCT00636363|54298798|FG002|Overall Study|Missed > 1 visit|3|||
27943354|NCT01147458|54600293|FG003|First Intervention|Withdrawal by Subject|0|||
28076817|NCT00111800|54731648|FG000|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
27829238|NCT00636363|54298796|FG000|Overall Study|Lack of motivation|1|||
27829239|NCT00636363|54298797|FG001|Overall Study|Lack of motivation|0|||
27829240|NCT00636363|54298798|FG002|Overall Study|Lack of motivation|1|||
27829241|NCT00636363|54298796|FG000|Overall Study|Protocol Violation|0|||
27829242|NCT00636363|54298797|FG001|Overall Study|Protocol Violation|3|||
27829243|NCT00636363|54298798|FG002|Overall Study|Protocol Violation|0|||
27943355|NCT01147458|54600290|FG000|First Intervention|Adverse Event|0|||
27829244|NCT00636363|54298796|FG000|Overall Study|Lost to Follow-up|3|||
27829245|NCT00636363|54298797|FG001|Overall Study|Lost to Follow-up|4|||
27829246|NCT00636363|54298798|FG002|Overall Study|Lost to Follow-up|2|||
27829247|NCT00636363|54298796|FG000|Overall Study|Withdrawal by Subject|1|||
27829248|NCT00636363|54298797|FG001|Overall Study|Withdrawal by Subject|3|||
27829249|NCT00636363|54298798|FG002|Overall Study|Withdrawal by Subject|2|||
27829250|NCT00636207|54298840|FG000|Overall Study|Adverse Event|1|||
27829251|NCT00636207|54298841|FG001|Overall Study|Adverse Event|0|||
27829252|NCT00636207|54298842|FG002|Overall Study|Adverse Event|0|||
27829253|NCT00636207|54298843|FG003|Overall Study|Adverse Event|0|||
27829254|NCT00636207|54298844|FG004|Overall Study|Adverse Event|0|||
27829255|NCT00636207|54298845|FG005|Overall Study|Adverse Event|0|||
27829256|NCT00636207|54298846|FG006|Overall Study|Adverse Event|0|||
27829257|NCT00636207|54298840|FG000|Overall Study|Withdrawal by Subject|0|||
27829258|NCT00636207|54298841|FG001|Overall Study|Withdrawal by Subject|1|||
27829259|NCT00636207|54298842|FG002|Overall Study|Withdrawal by Subject|0|||
27829260|NCT00636207|54298843|FG003|Overall Study|Withdrawal by Subject|0|||
27829261|NCT00636207|54298844|FG004|Overall Study|Withdrawal by Subject|1|||
27829262|NCT00636207|54298845|FG005|Overall Study|Withdrawal by Subject|0|||
27829263|NCT00636207|54298846|FG006|Overall Study|Withdrawal by Subject|0|||
27829264|NCT00635661|54298867|FG000|Overall Study|Withdrawal by Subject|4|||
27829265|NCT00635427|54298956|FG000|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
27829266|NCT00635427|54298957|FG001|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
27829267|NCT00635427|54298958|FG002|Overall Study|Refusal Of Required DiagnosticEvaluation|1|||
27829268|NCT00635427|54298959|FG003|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
27850811|NCT03161483|54349889|FG002|Treatment Period|Pregnancy|0|||
27850812|NCT03161483|54349890|FG003|Treatment Period|Pregnancy|0|||
27850813|NCT03161483|54349887|FG000|Treatment Period|Lack of Efficacy|0|||
27850814|NCT03161483|54349888|FG001|Treatment Period|Lack of Efficacy|0|||
27850815|NCT03161483|54349889|FG002|Treatment Period|Lack of Efficacy|0|||
27850816|NCT03161483|54349890|FG003|Treatment Period|Lack of Efficacy|1|||
27850817|NCT03161483|54349887|FG000|Treatment Period|Withdrawal by Subject|2|||
27850818|NCT03161483|54349888|FG001|Treatment Period|Withdrawal by Subject|5|||
27850819|NCT03161483|54349889|FG002|Treatment Period|Withdrawal by Subject|2|||
27850820|NCT03161483|54349890|FG003|Treatment Period|Withdrawal by Subject|6|||
27850821|NCT03161483|54349887|FG000|Treatment Period|Lost to Follow-up|0|||
27850822|NCT03161483|54349888|FG001|Treatment Period|Lost to Follow-up|0|||
27850823|NCT03161483|54349889|FG002|Treatment Period|Lost to Follow-up|0|||
27850824|NCT03161483|54349890|FG003|Treatment Period|Lost to Follow-up|1|||
27850825|NCT03161483|54349887|FG000|Treatment Period|Protocol Violation|0|||
27850826|NCT03161483|54349888|FG001|Treatment Period|Protocol Violation|0|||
27850827|NCT03161483|54349889|FG002|Treatment Period|Protocol Violation|0|||
27850828|NCT03161483|54349890|FG003|Treatment Period|Protocol Violation|1|||
27850829|NCT03161483|54349887|FG000|Treatment Period|Other reasons|1|||
27850830|NCT03161483|54349888|FG001|Treatment Period|Other reasons|1|||
27850831|NCT03161483|54349889|FG002|Treatment Period|Other reasons|0|||
27850832|NCT03161483|54349890|FG003|Treatment Period|Other reasons|0|||
27850833|NCT03132636|54349904|FG000|Overall Study|Adverse Event|1|||
27829269|NCT00635427|54298960|FG004|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
27829270|NCT00635427|54298956|FG000|Overall Study|Death|0|||
27829271|NCT00635427|54298957|FG001|Overall Study|Death|0|||
27829272|NCT00635427|54298958|FG002|Overall Study|Death|0|||
27850834|NCT03132636|54349905|FG001|Overall Study|Adverse Event|2|||
27850835|NCT03132636|54349904|FG000|Overall Study|Death|4|||
27850836|NCT03132636|54349905|FG001|Overall Study|Death|7|||
27829273|NCT00635427|54298959|FG003|Overall Study|Death|1|||
27829274|NCT00635427|54298960|FG004|Overall Study|Death|0|||
27829275|NCT00635427|54298956|FG000|Overall Study|Termination Of Study By Sponsor|12|||
27829276|NCT00635427|54298957|FG001|Overall Study|Termination Of Study By Sponsor|6|||
27829277|NCT00635427|54298958|FG002|Overall Study|Termination Of Study By Sponsor|10|||
27829278|NCT00635427|54298959|FG003|Overall Study|Termination Of Study By Sponsor|6|||
27829279|NCT00635427|54298960|FG004|Overall Study|Termination Of Study By Sponsor|6|||
27829280|NCT00635427|54298956|FG000|Overall Study|Withdrawal Of Consent|0|||
27829281|NCT00635427|54298957|FG001|Overall Study|Withdrawal Of Consent|0|||
27829282|NCT00635427|54298958|FG002|Overall Study|Withdrawal Of Consent|0|||
27829283|NCT00635427|54298959|FG003|Overall Study|Withdrawal Of Consent|2|||
27829284|NCT00635427|54298960|FG004|Overall Study|Withdrawal Of Consent|2|||
27829285|NCT00635349|54298972|FG000|Overall Study|Other|8|||
27829286|NCT00635349|54298973|FG001|Overall Study|Other|6|||
27850837|NCT03132636|54349904|FG000|Overall Study|Lost to Follow-up|2|||
27850838|NCT03132636|54349905|FG001|Overall Study|Lost to Follow-up|2|||
27850839|NCT03132636|54349904|FG000|Overall Study|Protocol Violation|1|||
27850840|NCT03132636|54349905|FG001|Overall Study|Protocol Violation|1|||
27850841|NCT03132636|54349904|FG000|Overall Study|Participant Decision|1|||
27850842|NCT03132636|54349905|FG001|Overall Study|Participant Decision|9|||
27850843|NCT03132636|54349904|FG000|Overall Study|Sponsor Decision|0|||
27850844|NCT03132636|54349905|FG001|Overall Study|Sponsor Decision|1|||
27850845|NCT03132636|54349904|FG000|Overall Study|Progressive disease|32|||
27850846|NCT03132636|54349905|FG001|Overall Study|Progressive disease|36|||
27829287|NCT00635349|54298972|FG000|Overall Study|Protocol Violation|18|||
27829288|NCT00635349|54298973|FG001|Overall Study|Protocol Violation|22|||
27829289|NCT00635349|54298972|FG000|Overall Study|Withdrawal by Subject|3|||
27829290|NCT00635349|54298973|FG001|Overall Study|Withdrawal by Subject|8|||
27829291|NCT00635349|54298972|FG000|Overall Study|Lost to Follow-up|4|||
27829292|NCT00635349|54298973|FG001|Overall Study|Lost to Follow-up|3|||
27829293|NCT00635349|54298972|FG000|Overall Study|Adverse Event|11|||
27829294|NCT00635349|54298973|FG001|Overall Study|Adverse Event|9|||
27829295|NCT00634803|54298982|FG000|Overall Study|Lost to Follow-up|6|||
27829296|NCT00634803|54298983|FG001|Overall Study|Lost to Follow-up|7|||
27829297|NCT00634803|54298984|FG002|Overall Study|Lost to Follow-up|7|||
27829298|NCT01217385|54299000|FG000|Overall Study|Withdrawal by Subject|3|||
27829299|NCT01217385|54299000|FG000|Overall Study|DOSI not performed/not eval|12|||
27829300|NCT01217385|54299000|FG000|Overall Study|Central Path not Available|1|||
27829301|NCT01217385|54299000|FG000|Overall Study|Normal Breast TOI not available|10|||
27829302|NCT01378104|54299352|FG000|Overall Study|Adverse Event|8|||
27829303|NCT01378104|54299353|FG001|Overall Study|Adverse Event|8|||
27829304|NCT01378104|54299352|FG000|Overall Study|Lack of Efficacy|7|||
27829305|NCT01378104|54299353|FG001|Overall Study|Lack of Efficacy|5|||
27829306|NCT01378104|54299352|FG000|Overall Study|Withdrawal by Subject|12|||
27829307|NCT01378104|54299353|FG001|Overall Study|Withdrawal by Subject|13|||
27829308|NCT01379274|54299394|FG000|Overall Study|funding withdrawn|1|||
27829309|NCT00634569|54299595|FG000|Overall Study|Withdrawal by Subject|0|||
27829310|NCT00634569|54299596|FG001|Overall Study|Withdrawal by Subject|4|||
27829311|NCT00634569|54299595|FG000|Overall Study|Physician Decision|0|||
27829312|NCT00634569|54299596|FG001|Overall Study|Physician Decision|1|||
27829313|NCT00634179|54299641|FG000|Phase II: Maintenance|Diagnosis changed after re-review|1|||
27829314|NCT03877926|54299716|FG000|Overall Study|Adverse Event|1|||
27829315|NCT03877926|54299717|FG001|Overall Study|Adverse Event|0|||
27829316|NCT03877926|54299718|FG002|Overall Study|Adverse Event|0|||
27829317|NCT03877926|54299719|FG003|Overall Study|Adverse Event|0|||
27829318|NCT03877926|54299716|FG000|Overall Study|Death|2|||
27829319|NCT03877926|54299717|FG001|Overall Study|Death|2|||
27829320|NCT03877926|54299718|FG002|Overall Study|Death|2|||
27829321|NCT03877926|54299719|FG003|Overall Study|Death|0|||
27829322|NCT03877926|54299716|FG000|Overall Study|Lost to Follow-up|41|||
27829323|NCT03877926|54299717|FG001|Overall Study|Lost to Follow-up|52|||
27829324|NCT03877926|54299718|FG002|Overall Study|Lost to Follow-up|45|||
27829325|NCT03877926|54299719|FG003|Overall Study|Lost to Follow-up|17|||
27829326|NCT03877926|54299716|FG000|Overall Study|Physician Decision|2|||
27829327|NCT03877926|54299717|FG001|Overall Study|Physician Decision|0|||
27829328|NCT03877926|54299718|FG002|Overall Study|Physician Decision|2|||
27829329|NCT03877926|54299719|FG003|Overall Study|Physician Decision|0|||
27829330|NCT03877926|54299716|FG000|Overall Study|Withdrawal by Subject|18|||
27829331|NCT03877926|54299717|FG001|Overall Study|Withdrawal by Subject|21|||
27829332|NCT03877926|54299718|FG002|Overall Study|Withdrawal by Subject|12|||
27829333|NCT03877926|54299719|FG003|Overall Study|Withdrawal by Subject|4|||
27829334|NCT03877926|54299716|FG000|Overall Study|Other - Various|4|||
27829335|NCT03877926|54299717|FG001|Overall Study|Other - Various|1|||
27829336|NCT03877926|54299718|FG002|Overall Study|Other - Various|1|||
27829337|NCT03877926|54299719|FG003|Overall Study|Other - Various|0|||
27829338|NCT03877926|54299716|FG000|Overall Study|Not Treated|3|||
27829339|NCT03877926|54299717|FG001|Overall Study|Not Treated|1|||
27829340|NCT03877926|54299718|FG002|Overall Study|Not Treated|1|||
27829341|NCT03877926|54299719|FG003|Overall Study|Not Treated|0|||
27829342|NCT02874144|54299942|FG000|Overall Study|Lost to Follow-up|3|||
27829343|NCT02874144|54299943|FG001|Overall Study|Lost to Follow-up|5|||
27829344|NCT02611830|54299973|FG000|OL Induction Phase|Pretreatment Event/Adverse Event|9|||
27829345|NCT02611830|54299974|FG001|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
27829346|NCT02611830|54299975|FG002|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
27829347|NCT02611830|54299976|FG003|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
27829348|NCT02611830|54299973|FG000|OL Induction Phase|Significant Protocol Deviation|4|||
27829349|NCT02611830|54299974|FG001|OL Induction Phase|Significant Protocol Deviation|0|||
27943356|NCT01147458|54600291|FG001|First Intervention|Adverse Event|3|||
27829350|NCT02611830|54299975|FG002|OL Induction Phase|Significant Protocol Deviation|0|||
27829351|NCT02611830|54299976|FG003|OL Induction Phase|Significant Protocol Deviation|0|||
27829352|NCT02611830|54299973|FG000|OL Induction Phase|Voluntary Withdrawal|5|||
27829353|NCT02611830|54299974|FG001|OL Induction Phase|Voluntary Withdrawal|0|||
27829354|NCT02611830|54299975|FG002|OL Induction Phase|Voluntary Withdrawal|0|||
27829355|NCT02611830|54299976|FG003|OL Induction Phase|Voluntary Withdrawal|0|||
27829356|NCT02611830|54299973|FG000|OL Induction Phase|Lack of Efficacy|9|||
27829357|NCT02611830|54299974|FG001|OL Induction Phase|Lack of Efficacy|0|||
27829358|NCT02611830|54299975|FG002|OL Induction Phase|Lack of Efficacy|0|||
27829359|NCT02611830|54299976|FG003|OL Induction Phase|Lack of Efficacy|0|||
27829360|NCT02611830|54299973|FG000|OL Induction Phase|Reason not specified|3|||
27829361|NCT02611830|54299974|FG001|OL Induction Phase|Reason not specified|0|||
27829362|NCT02611830|54299975|FG002|OL Induction Phase|Reason not specified|0|||
27829363|NCT02611830|54299976|FG003|OL Induction Phase|Reason not specified|0|||
27829364|NCT02611830|54299973|FG000|Maintenance Phase|Lack of Efficacy|0|||
27829365|NCT02611830|54299974|FG001|Maintenance Phase|Lack of Efficacy|29|||
27829366|NCT02611830|54299975|FG002|Maintenance Phase|Lack of Efficacy|18|||
27829367|NCT02611830|54299976|FG003|Maintenance Phase|Lack of Efficacy|6|||
27829368|NCT02611830|54299973|FG000|Maintenance Phase|Pretreatment Event/Adverse Event|0|||
27829369|NCT02611830|54299974|FG001|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
27829370|NCT02611830|54299975|FG002|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
27829371|NCT02611830|54299976|FG003|Maintenance Phase|Pretreatment Event/Adverse Event|2|||
27829372|NCT02611830|54299973|FG000|Maintenance Phase|Significant Protocol Deviation|0|||
27829373|NCT02611830|54299974|FG001|Maintenance Phase|Significant Protocol Deviation|0|||
27829374|NCT02611830|54299975|FG002|Maintenance Phase|Significant Protocol Deviation|1|||
27829375|NCT02611830|54299976|FG003|Maintenance Phase|Significant Protocol Deviation|1|||
27829376|NCT02611830|54299973|FG000|Maintenance Phase|Lost to Follow-up|0|||
27829377|NCT02611830|54299974|FG001|Maintenance Phase|Lost to Follow-up|0|||
27829378|NCT02611830|54299975|FG002|Maintenance Phase|Lost to Follow-up|0|||
27829379|NCT02611830|54299976|FG003|Maintenance Phase|Lost to Follow-up|1|||
27829380|NCT02611830|54299973|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
27829381|NCT02611830|54299974|FG001|Maintenance Phase|Voluntary Withdrawal|1|||
27829382|NCT02611830|54299975|FG002|Maintenance Phase|Voluntary Withdrawal|2|||
27829383|NCT02611830|54299976|FG003|Maintenance Phase|Voluntary Withdrawal|5|||
27829384|NCT02611830|54299973|FG000|Maintenance Phase|Pregnancy|0|||
27829385|NCT02611830|54299974|FG001|Maintenance Phase|Pregnancy|0|||
27829386|NCT02611830|54299975|FG002|Maintenance Phase|Pregnancy|1|||
27829387|NCT02611830|54299976|FG003|Maintenance Phase|Pregnancy|0|||
27829388|NCT02611830|54299973|FG000|Maintenance Phase|Reason not specified|0|||
27829389|NCT02611830|54299974|FG001|Maintenance Phase|Reason not specified|1|||
27829390|NCT02611830|54299975|FG002|Maintenance Phase|Reason not specified|4|||
27829391|NCT02611830|54299976|FG003|Maintenance Phase|Reason not specified|0|||
27829392|NCT01328574|54300162|FG000|Overall Study|Refused further treatment|1|||
27829393|NCT01328496|54300284|FG000|Overall Study|Significant Change in Health Status|1|||
27829394|NCT01328496|54300285|FG001|Overall Study|Significant Change in Health Status|0|||
27829395|NCT02734212|54300405|FG000|Overall Study|Lost to Follow-up|5|||
27829396|NCT02734212|54300406|FG001|Overall Study|Lost to Follow-up|10|||
27829397|NCT04604184|54300483|FG000|Overall Study|Adverse Event|5|||
27829398|NCT04604184|54300484|FG001|Overall Study|Adverse Event|5|||
27829399|NCT04604184|54300483|FG000|Overall Study|Death|2|||
27829400|NCT04604184|54300484|FG001|Overall Study|Death|1|||
27829401|NCT04604184|54300483|FG000|Overall Study|Withdrawal by Subject|1|||
27829402|NCT04604184|54300484|FG001|Overall Study|Withdrawal by Subject|3|||
27829403|NCT04604184|54300483|FG000|Overall Study|Not treated|2|||
27829404|NCT04604184|54300484|FG001|Overall Study|Not treated|2|||
27829405|NCT04604184|54300483|FG000|Overall Study|Due to sponsor decision|9|||
27829406|NCT04604184|54300484|FG001|Overall Study|Due to sponsor decision|7|||
27829407|NCT04604184|54300483|FG000|Overall Study|Physician Decision|0|||
27829408|NCT04604184|54300484|FG001|Overall Study|Physician Decision|1|||
27829409|NCT04604184|54300483|FG000|Overall Study|Transfer to healthcare|1|||
27829410|NCT04604184|54300484|FG001|Overall Study|Transfer to healthcare|0|||
27829411|NCT01859741|54300655|FG000|Overall Study|Death|3|||
27829412|NCT01859741|54300656|FG001|Overall Study|Death|2|||
27829413|NCT01859741|54300657|FG002|Overall Study|Death|4|||
27829414|NCT01859741|54300658|FG003|Overall Study|Death|3|||
27829415|NCT01859741|54300659|FG004|Overall Study|Death|5|||
27829416|NCT01859741|54300660|FG005|Overall Study|Death|4|||
27829417|NCT01859741|54300661|FG006|Overall Study|Death|51|||
27829418|NCT01859741|54300662|FG007|Overall Study|Death|51|||
27829419|NCT01859741|54300655|FG000|Overall Study|Lost to Follow-up|0|||
27829420|NCT01859741|54300656|FG001|Overall Study|Lost to Follow-up|0|||
27829421|NCT01859741|54300657|FG002|Overall Study|Lost to Follow-up|0|||
27829422|NCT01859741|54300658|FG003|Overall Study|Lost to Follow-up|0|||
27829423|NCT01859741|54300659|FG004|Overall Study|Lost to Follow-up|0|||
27829424|NCT01859741|54300660|FG005|Overall Study|Lost to Follow-up|1|||
27829425|NCT01859741|54300661|FG006|Overall Study|Lost to Follow-up|0|||
27829426|NCT01859741|54300662|FG007|Overall Study|Lost to Follow-up|4|||
27829427|NCT01859741|54300655|FG000|Overall Study|Withdrawal by Subject|0|||
27829428|NCT01859741|54300656|FG001|Overall Study|Withdrawal by Subject|1|||
27829429|NCT01859741|54300657|FG002|Overall Study|Withdrawal by Subject|2|||
27829430|NCT01859741|54300658|FG003|Overall Study|Withdrawal by Subject|0|||
27829431|NCT01859741|54300659|FG004|Overall Study|Withdrawal by Subject|0|||
27829432|NCT01859741|54300660|FG005|Overall Study|Withdrawal by Subject|1|||
27829433|NCT01859741|54300661|FG006|Overall Study|Withdrawal by Subject|1|||
27829434|NCT01859741|54300662|FG007|Overall Study|Withdrawal by Subject|1|||
27829435|NCT01859741|54300655|FG000|Overall Study|Study Terminated by Sponsor|0|||
27829436|NCT01859741|54300656|FG001|Overall Study|Study Terminated by Sponsor|0|||
27829437|NCT01859741|54300657|FG002|Overall Study|Study Terminated by Sponsor|0|||
27829438|NCT01859741|54300658|FG003|Overall Study|Study Terminated by Sponsor|0|||
27829439|NCT01859741|54300659|FG004|Overall Study|Study Terminated by Sponsor|1|||
27829440|NCT01859741|54300660|FG005|Overall Study|Study Terminated by Sponsor|0|||
27829441|NCT01859741|54300661|FG006|Overall Study|Study Terminated by Sponsor|16|||
27829442|NCT01859741|54300662|FG007|Overall Study|Study Terminated by Sponsor|14|||
27829443|NCT01859741|54300655|FG000|Overall Study|Other|0|||
27829444|NCT01859741|54300656|FG001|Overall Study|Other|0|||
27829445|NCT01859741|54300657|FG002|Overall Study|Other|0|||
27829446|NCT01859741|54300658|FG003|Overall Study|Other|0|||
27829447|NCT01859741|54300659|FG004|Overall Study|Other|0|||
27829448|NCT01859741|54300660|FG005|Overall Study|Other|0|||
27829449|NCT01859741|54300661|FG006|Overall Study|Other|2|||
27829450|NCT01859741|54300662|FG007|Overall Study|Other|0|||
27829451|NCT01859507|54300708|FG000|Overall Study|left the country|4|||
27829452|NCT01876043|54300713|FG000|Overall Study|Death|1|||
27829453|NCT01876043|54300713|FG000|Overall Study|Withdrawal by Subject|1|||
27829454|NCT01875731|54300719|FG000|Overall Study|Fail to obtain lab sample|1|||
27829455|NCT01875731|54300720|FG001|Overall Study|Fail to obtain lab sample|0|||
27829456|NCT01873859|54300728|FG000|Overall Study|Withdrawal by Subject|0|||
27829457|NCT01873859|54300729|FG001|Overall Study|Withdrawal by Subject|4|||
27829458|NCT01857869|54300746|FG000|Primary/Challenge Phase|Lost to Follow-up|2|||
27829459|NCT01857869|54300747|FG001|Primary/Challenge Phase|Lost to Follow-up|0|||
27829460|NCT01857869|54300748|FG002|Primary/Challenge Phase|Lost to Follow-up|0|||
27829461|NCT01857869|54300749|FG003|Primary/Challenge Phase|Lost to Follow-up|0|||
27829462|NCT01857869|54300750|FG004|Primary/Challenge Phase|Lost to Follow-up|0|||
27829463|NCT01857869|54300751|FG005|Primary/Challenge Phase|Lost to Follow-up|0|||
27829464|NCT01857869|54300752|FG006|Primary/Challenge Phase|Lost to Follow-up|0|||
27829465|NCT01857869|54300753|FG007|Primary/Challenge Phase|Lost to Follow-up|0|||
27829466|NCT01857869|54300754|FG008|Primary/Challenge Phase|Lost to Follow-up|0|||
27829467|NCT01857869|54300755|FG009|Primary/Challenge Phase|Lost to Follow-up|0|||
27829468|NCT01857869|54300746|FG000|Primary/Challenge Phase|Pregnancy|1|||
27829469|NCT01857869|54300747|FG001|Primary/Challenge Phase|Pregnancy|0|||
27829470|NCT01857869|54300748|FG002|Primary/Challenge Phase|Pregnancy|0|||
27829471|NCT01857869|54300749|FG003|Primary/Challenge Phase|Pregnancy|0|||
27829472|NCT01857869|54300750|FG004|Primary/Challenge Phase|Pregnancy|0|||
27829473|NCT01857869|54300751|FG005|Primary/Challenge Phase|Pregnancy|0|||
27829474|NCT01857869|54300752|FG006|Primary/Challenge Phase|Pregnancy|0|||
27829475|NCT01857869|54300753|FG007|Primary/Challenge Phase|Pregnancy|0|||
27829476|NCT01857869|54300754|FG008|Primary/Challenge Phase|Pregnancy|0|||
27829477|NCT01857869|54300755|FG009|Primary/Challenge Phase|Pregnancy|0|||
27829478|NCT01857869|54300746|FG000|Primary/Challenge Phase|Protocol Violation|1|||
27829479|NCT01857869|54300747|FG001|Primary/Challenge Phase|Protocol Violation|0|||
27829480|NCT01857869|54300748|FG002|Primary/Challenge Phase|Protocol Violation|0|||
27829481|NCT01857869|54300749|FG003|Primary/Challenge Phase|Protocol Violation|0|||
27829482|NCT01857869|54300750|FG004|Primary/Challenge Phase|Protocol Violation|0|||
27829483|NCT01857869|54300751|FG005|Primary/Challenge Phase|Protocol Violation|0|||
27829484|NCT01857869|54300752|FG006|Primary/Challenge Phase|Protocol Violation|0|||
27829485|NCT01857869|54300753|FG007|Primary/Challenge Phase|Protocol Violation|0|||
27829486|NCT01857869|54300754|FG008|Primary/Challenge Phase|Protocol Violation|0|||
27829487|NCT01857869|54300755|FG009|Primary/Challenge Phase|Protocol Violation|0|||
27829488|NCT01857869|54300746|FG000|Primary/Challenge Phase|Other|1|||
27829489|NCT01857869|54300747|FG001|Primary/Challenge Phase|Other|1|||
27829490|NCT01857869|54300748|FG002|Primary/Challenge Phase|Other|0|||
27829491|NCT01857869|54300749|FG003|Primary/Challenge Phase|Other|0|||
27829492|NCT01857869|54300750|FG004|Primary/Challenge Phase|Other|0|||
27829493|NCT01857869|54300751|FG005|Primary/Challenge Phase|Other|0|||
27829494|NCT01857869|54300752|FG006|Primary/Challenge Phase|Other|0|||
27829495|NCT01857869|54300753|FG007|Primary/Challenge Phase|Other|0|||
27829496|NCT01857869|54300754|FG008|Primary/Challenge Phase|Other|0|||
27829497|NCT01857869|54300755|FG009|Primary/Challenge Phase|Other|0|||
27829498|NCT01857869|54300746|FG000|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
27829499|NCT01857869|54300747|FG001|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
27829500|NCT01857869|54300748|FG002|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
27829501|NCT01857869|54300749|FG003|Booster/Rechallenge Phase|Withdrawal by Subject|1|||
27829502|NCT01857869|54300750|FG004|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
27829503|NCT01857869|54300751|FG005|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
28159859|NCT03517449|54829907|FG001|Overall Study|Death|236|||
27829504|NCT01857869|54300752|FG006|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
27829505|NCT01857869|54300753|FG007|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
27829506|NCT01857869|54300754|FG008|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
27829507|NCT01857869|54300755|FG009|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
27829508|NCT01857869|54300746|FG000|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
27829509|NCT01857869|54300747|FG001|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
27829510|NCT01857869|54300748|FG002|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
27829511|NCT01857869|54300749|FG003|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1|||
27829512|NCT01857869|54300750|FG004|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
27829513|NCT01857869|54300751|FG005|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
28159860|NCT03517449|54829906|FG000|Overall Study|Lost to Follow-up|0|||
28159861|NCT03517449|54829907|FG001|Overall Study|Lost to Follow-up|2|||
27829514|NCT01857869|54300752|FG006|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
27829515|NCT01857869|54300753|FG007|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
27829516|NCT01857869|54300754|FG008|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
27829517|NCT01857869|54300755|FG009|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
27829518|NCT04452318|54300843|FG000|Overall Study|Physician Decision|1|||
27829519|NCT04452318|54300844|FG001|Overall Study|Physician Decision|2|||
27829520|NCT04452318|54300845|FG002|Overall Study|Physician Decision|0|||
27829521|NCT04452318|54300846|FG003|Overall Study|Physician Decision|2|||
27829522|NCT04452318|54300847|FG004|Overall Study|Physician Decision|0|||
27829523|NCT04452318|54300848|FG005|Overall Study|Physician Decision|2|||
27829524|NCT04452318|54300849|FG006|Overall Study|Physician Decision|5|||
27829525|NCT04452318|54300843|FG000|Overall Study|Death|2|||
27829526|NCT04452318|54300844|FG001|Overall Study|Death|3|||
27829527|NCT04452318|54300845|FG002|Overall Study|Death|0|||
27829528|NCT04452318|54300846|FG003|Overall Study|Death|0|||
27829529|NCT04452318|54300847|FG004|Overall Study|Death|0|||
27829530|NCT04452318|54300848|FG005|Overall Study|Death|0|||
27829531|NCT04452318|54300849|FG006|Overall Study|Death|0|||
27829532|NCT04452318|54300843|FG000|Overall Study|Lost to Follow-up|38|||
27829533|NCT04452318|54300844|FG001|Overall Study|Lost to Follow-up|28|||
27829534|NCT04452318|54300845|FG002|Overall Study|Lost to Follow-up|0|||
27829535|NCT04452318|54300846|FG003|Overall Study|Lost to Follow-up|3|||
27829536|NCT04452318|54300847|FG004|Overall Study|Lost to Follow-up|3|||
27829537|NCT04452318|54300848|FG005|Overall Study|Lost to Follow-up|2|||
27829538|NCT04452318|54300849|FG006|Overall Study|Lost to Follow-up|1|||
27829539|NCT04452318|54300843|FG000|Overall Study|Withdrawal by Subject|46|||
27829540|NCT04452318|54300844|FG001|Overall Study|Withdrawal by Subject|40|||
27829541|NCT04452318|54300845|FG002|Overall Study|Withdrawal by Subject|0|||
27829542|NCT04452318|54300846|FG003|Overall Study|Withdrawal by Subject|18|||
27829543|NCT04452318|54300847|FG004|Overall Study|Withdrawal by Subject|6|||
27829544|NCT04452318|54300848|FG005|Overall Study|Withdrawal by Subject|8|||
27829545|NCT04452318|54300849|FG006|Overall Study|Withdrawal by Subject|6|||
27829546|NCT00634101|54301026|FG000|Overall Study|Study Terminated|3|||
27829547|NCT00634101|54301027|FG001|Overall Study|Study Terminated|3|||
27829548|NCT00634101|54301026|FG000|Overall Study|Lost to Follow-up|2|||
27829549|NCT00634101|54301027|FG001|Overall Study|Lost to Follow-up|0|||
27829550|NCT00633477|54301044|FG000|Overall Study|Death|1|||
27829551|NCT00633477|54301045|FG001|Overall Study|Death|0|||
27829552|NCT00633477|54301044|FG000|Overall Study|Randomized but not treated|1|||
27829553|NCT00633477|54301045|FG001|Overall Study|Randomized but not treated|0|||
27829554|NCT00331773|54301070|FG000|Overall Study|Withdrawal by Subject|6|||
27829555|NCT00331773|54301071|FG001|Overall Study|Withdrawal by Subject|4|||
27829556|NCT00331773|54301070|FG000|Overall Study|Protocol Violation|10|||
27829557|NCT00331773|54301071|FG001|Overall Study|Protocol Violation|3|||
27831271|NCT01812707|54307681|FG000|Overall Study|Consent withdrawn by participant|1|||
27831272|NCT01812707|54307682|FG001|Overall Study|Consent withdrawn by participant|0|||
27831273|NCT01812707|54307683|FG002|Overall Study|Consent withdrawn by participant|0|||
27831274|NCT01812707|54307684|FG003|Overall Study|Consent withdrawn by participant|0|||
27831275|NCT01787279|54307695|FG000|Overall Study|Lost to Follow-up|2|||
27831276|NCT01787279|54307695|FG000|Overall Study|Lack of Efficacy|1|||
27831277|NCT02728206|54307699|FG000|Overall Study|Death|1|||
27831278|NCT01811225|54307703|FG000|Treatment Period 1|Adverse Event|2|||
27831279|NCT01811225|54307704|FG001|Treatment Period 1|Adverse Event|3|||
27831280|NCT01811225|54307703|FG000|Treatment Period 1|Lost to Follow-up|12|||
27831281|NCT01811225|54307704|FG001|Treatment Period 1|Lost to Follow-up|8|||
27831282|NCT01811225|54307703|FG000|Treatment Period 1|transporation|1|||
27831283|NCT01811225|54307704|FG001|Treatment Period 1|transporation|0|||
27831284|NCT01811225|54307703|FG000|Treatment Period 1|unable to remain smoke free overnight|10|||
27831285|NCT01811225|54307704|FG001|Treatment Period 1|unable to remain smoke free overnight|6|||
27831286|NCT01811225|54307703|FG000|Treatment Period 2|Lost to Follow-up|1|||
27831287|NCT01811225|54307704|FG001|Treatment Period 2|Lost to Follow-up|2|||
27831288|NCT01811225|54307703|FG000|Treatment Period 2|unable to remain smoke free overnight|3|||
27831289|NCT01811225|54307704|FG001|Treatment Period 2|unable to remain smoke free overnight|4|||
27831290|NCT01809197|54307712|FG000|Overall Study|Lost to Follow-up|4|||
27831291|NCT01809197|54307713|FG001|Overall Study|Lost to Follow-up|2|||
27831292|NCT01809197|54307712|FG000|Overall Study|Adverse Event|2|||
27831293|NCT01809197|54307713|FG001|Overall Study|Adverse Event|3|||
27831294|NCT01809197|54307712|FG000|Overall Study|Failed slit lamp exam|1|||
27831295|NCT01809197|54307713|FG001|Overall Study|Failed slit lamp exam|0|||
27831296|NCT01809197|54307712|FG000|Overall Study|Non-Compliance|1|||
27831297|NCT01809197|54307713|FG001|Overall Study|Non-Compliance|1|||
27831298|NCT01809197|54307712|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
27831299|NCT01809197|54307713|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
27831300|NCT01809197|54307712|FG000|Overall Study|Withdrawal by Subject|1|||
27831301|NCT01809197|54307713|FG001|Overall Study|Withdrawal by Subject|1|||
27831302|NCT01809197|54307712|FG000|Overall Study|Product not available|0|||
27831303|NCT01809197|54307713|FG001|Overall Study|Product not available|1|||
27829558|NCT00633243|54301104|FG000|Overall Study|Withdrawal by Subject|0|||
27829559|NCT00633243|54301105|FG001|Overall Study|Withdrawal by Subject|1|||
27829560|NCT00633243|54301104|FG000|Overall Study|incarceration|0|||
27829561|NCT00633243|54301105|FG001|Overall Study|incarceration|2|||
27829562|NCT00633243|54301104|FG000|Overall Study|Homeless--no refrigeration for meds|0|||
27829563|NCT00633243|54301105|FG001|Overall Study|Homeless--no refrigeration for meds|1|||
27829564|NCT00633243|54301104|FG000|Overall Study|Not comfortable with self-injecting|0|||
27829565|NCT00633243|54301105|FG001|Overall Study|Not comfortable with self-injecting|1|||
27829566|NCT00633243|54301104|FG000|Overall Study|Mental Health--Depression|0|||
27829567|NCT00633243|54301105|FG001|Overall Study|Mental Health--Depression|1|||
27829568|NCT00633243|54301104|FG000|Overall Study|Couldn't tolerate side-effects|1|||
27829569|NCT00633243|54301105|FG001|Overall Study|Couldn't tolerate side-effects|1|||
27829570|NCT01872689|54301115|FG000|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
27829571|NCT01872689|54301116|FG001|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1|||
27829572|NCT01872689|54301117|FG002|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
27829573|NCT01872689|54301118|FG003|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
27829574|NCT01872689|54301115|FG000|Double-Blind/Placebo-Controlled Period|Other|1|||
27829575|NCT01872689|54301116|FG001|Double-Blind/Placebo-Controlled Period|Other|1|||
27829576|NCT01872689|54301117|FG002|Double-Blind/Placebo-Controlled Period|Other|6|||
27829577|NCT01872689|54301118|FG003|Double-Blind/Placebo-Controlled Period|Other|3|||
27829578|NCT01872689|54301115|FG000|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9|||
27829579|NCT01872689|54301116|FG001|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8|||
27829580|NCT01872689|54301117|FG002|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14|||
27829581|NCT01872689|54301118|FG003|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16|||
27829582|NCT01872689|54301115|FG000|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
27829583|NCT01872689|54301116|FG001|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
27829584|NCT01872689|54301117|FG002|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
27829585|NCT01872689|54301118|FG003|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
27829586|NCT01872689|54301115|FG000|Double-Blind/Placebo-Controlled Period|Physician Decision|0|||
27829587|NCT01872689|54301116|FG001|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
27829588|NCT01872689|54301117|FG002|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
27829589|NCT01872689|54301118|FG003|Double-Blind/Placebo-Controlled Period|Physician Decision|1|||
27829590|NCT01872689|54301115|FG000|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
27829591|NCT01872689|54301116|FG001|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
27829592|NCT01872689|54301117|FG002|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
27829593|NCT01872689|54301118|FG003|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
27829594|NCT01872689|54301115|FG000|Double-Blind/Placebo-Controlled Period|Death|3|||
27829595|NCT01872689|54301116|FG001|Double-Blind/Placebo-Controlled Period|Death|4|||
27829596|NCT01872689|54301117|FG002|Double-Blind/Placebo-Controlled Period|Death|14|||
27829597|NCT01872689|54301118|FG003|Double-Blind/Placebo-Controlled Period|Death|9|||
27829598|NCT01872689|54301115|FG000|Double-Blind/Placebo-Controlled Period|Adverse Event|6|||
27829599|NCT01872689|54301116|FG001|Double-Blind/Placebo-Controlled Period|Adverse Event|3|||
27829600|NCT01872689|54301117|FG002|Double-Blind/Placebo-Controlled Period|Adverse Event|10|||
27829601|NCT01872689|54301118|FG003|Double-Blind/Placebo-Controlled Period|Adverse Event|7|||
27829602|NCT01872689|54301115|FG000|Open-Label Period (Only For Monotherapy)|Other|2|||
27829603|NCT01872689|54301116|FG001|Open-Label Period (Only For Monotherapy)|Other|3|||
27829604|NCT01872689|54301117|FG002|Open-Label Period (Only For Monotherapy)|Other|0|||
27829605|NCT01872689|54301118|FG003|Open-Label Period (Only For Monotherapy)|Other|0|||
27829606|NCT01872689|54301115|FG000|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11|||
27829607|NCT01872689|54301116|FG001|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12|||
27829608|NCT01872689|54301117|FG002|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
27829609|NCT01872689|54301118|FG003|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
27829610|NCT01872689|54301115|FG000|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
27829611|NCT01872689|54301116|FG001|Open-Label Period (Only For Monotherapy)|Physician Decision|1|||
27829612|NCT01872689|54301117|FG002|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
28159862|NCT03517449|54829906|FG000|Overall Study|Withdrawal by Subject|7|||
28159863|NCT03517449|54829907|FG001|Overall Study|Withdrawal by Subject|26|||
28159864|NCT03517449|54829906|FG000|Overall Study|Participants Ongoing|220|||
28159865|NCT03517449|54829907|FG001|Overall Study|Participants Ongoing|152|||
28159866|NCT02555878|54829915|FG000|Overall Study|Lost to Follow-up|2|||
28159867|NCT02555878|54829916|FG001|Overall Study|Lost to Follow-up|3|||
28159868|NCT02555878|54829915|FG000|Overall Study|Withdrawal by Subject|48|||
27829613|NCT01872689|54301118|FG003|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
27829614|NCT01872689|54301115|FG000|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1|||
28159869|NCT02555878|54829916|FG001|Overall Study|Withdrawal by Subject|48|||
27829615|NCT01872689|54301116|FG001|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3|||
27829616|NCT01872689|54301117|FG002|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
27829617|NCT01872689|54301118|FG003|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
27829618|NCT01872689|54301115|FG000|Open-Label Period (Only For Monotherapy)|Death|5|||
27829619|NCT01872689|54301116|FG001|Open-Label Period (Only For Monotherapy)|Death|3|||
27829620|NCT01872689|54301117|FG002|Open-Label Period (Only For Monotherapy)|Death|0|||
27829621|NCT01872689|54301118|FG003|Open-Label Period (Only For Monotherapy)|Death|0|||
27829622|NCT01872689|54301115|FG000|Open-Label Period (Only For Monotherapy)|Adverse Event|2|||
27829623|NCT01872689|54301116|FG001|Open-Label Period (Only For Monotherapy)|Adverse Event|1|||
27829624|NCT01872689|54301117|FG002|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
27829625|NCT01872689|54301118|FG003|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
27829626|NCT00632931|54301131|FG000|Part 1, Period 1|Protocol Violation|1|||
27829627|NCT00632931|54301132|FG001|Part 1, Period 1|Protocol Violation|0|||
27829628|NCT00632931|54301133|FG002|Part 1, Period 1|Protocol Violation|0|||
27829629|NCT00632931|54301131|FG000|Part 1, Period 1|Withdrawal by Subject|1|||
27829630|NCT00632931|54301132|FG001|Part 1, Period 1|Withdrawal by Subject|0|||
27829631|NCT00632931|54301133|FG002|Part 1, Period 1|Withdrawal by Subject|0|||
27829632|NCT00632931|54301131|FG000|Part 2|Adverse Event|0|||
27829633|NCT00632931|54301132|FG001|Part 2|Adverse Event|0|||
27829634|NCT00632931|54301133|FG002|Part 2|Adverse Event|3|||
27829635|NCT00632931|54301131|FG000|Part 2|Death|0|||
27829636|NCT00632931|54301132|FG001|Part 2|Death|0|||
27829637|NCT00632931|54301133|FG002|Part 2|Death|1|||
27829638|NCT00632931|54301131|FG000|Part 2|Lack of Efficacy|0|||
27829639|NCT00632931|54301132|FG001|Part 2|Lack of Efficacy|0|||
27829640|NCT00632931|54301133|FG002|Part 2|Lack of Efficacy|17|||
27829641|NCT00632931|54301131|FG000|Part 2|Withdrawal by Subject|0|||
27829642|NCT00632931|54301132|FG001|Part 2|Withdrawal by Subject|0|||
27829643|NCT00632931|54301133|FG002|Part 2|Withdrawal by Subject|3|||
27829644|NCT01857323|54301138|FG000|Overall Study|Adverse Event|1|||
27829645|NCT01857323|54301138|FG000|Overall Study|Withdrawal by Subject|3|||
27829646|NCT01857323|54301138|FG000|Overall Study|Non-compliance|1|||
27829647|NCT01857323|54301138|FG000|Overall Study|Protocol Violation|6|||
27829648|NCT01857323|54301138|FG000|Overall Study|Lost to Follow-up|1|||
27829649|NCT01857323|54301138|FG000|Overall Study|Other|4|||
27829650|NCT01857323|54301138|FG000|Overall Study|Did not complete 180 doses|48|||
27829651|NCT00632541|54301142|FG000|Overall Study|Adverse Event|7|||
27829652|NCT01872611|54301148|FG000|Overall Study|Adverse Event|3|||
27829653|NCT01872611|54301149|FG001|Overall Study|Adverse Event|1|||
27829654|NCT01872611|54301148|FG000|Overall Study|Adverse Event, prior to treatment|0|||
27829655|NCT01872611|54301149|FG001|Overall Study|Adverse Event, prior to treatment|1|||
27829656|NCT01872611|54301148|FG000|Overall Study|Death|0|||
27829657|NCT01872611|54301149|FG001|Overall Study|Death|1|||
27829658|NCT01872611|54301148|FG000|Overall Study|Death, prior to treatment|0|||
27829659|NCT01872611|54301149|FG001|Overall Study|Death, prior to treatment|1|||
27829660|NCT01872611|54301148|FG000|Overall Study|Lost to Follow-up|8|||
27829661|NCT01872611|54301149|FG001|Overall Study|Lost to Follow-up|1|||
27829662|NCT01872611|54301148|FG000|Overall Study|Physician Decision|1|||
27829663|NCT01872611|54301149|FG001|Overall Study|Physician Decision|0|||
27829664|NCT01872611|54301148|FG000|Overall Study|Withdrawal by Subject|6|||
27829665|NCT01872611|54301149|FG001|Overall Study|Withdrawal by Subject|1|||
27829666|NCT01872611|54301148|FG000|Overall Study|Reason not provided|6|||
27829667|NCT01872611|54301149|FG001|Overall Study|Reason not provided|6|||
27829668|NCT03089853|54301159|FG000|Overall Study|Lost to Follow-up|2|||
27829669|NCT03089853|54301160|FG001|Overall Study|Lost to Follow-up|1|||
27829670|NCT03086967|54301168|FG000|Overall Study|Screen Failure|2|||
27829671|NCT03086967|54301169|FG001|Overall Study|Screen Failure|2|||
27829672|NCT01856543|54301177|FG000|Overall Study|Treatment discontinued|6|||
27829673|NCT01856543|54301178|FG001|Overall Study|Treatment discontinued|3|||
27829674|NCT01856543|54301177|FG000|Overall Study|Withdrawn before start|7|||
27829675|NCT01856543|54301178|FG001|Overall Study|Withdrawn before start|3|||
27829676|NCT00632463|54301188|FG000|Overall Study|Adverse Event|0|||
27829677|NCT00632463|54301189|FG001|Overall Study|Adverse Event|1|||
27829678|NCT00632463|54301190|FG002|Overall Study|Adverse Event|0|||
27829679|NCT00632229|54301200|FG000|Overall Study|Adverse Event|6|||
27829680|NCT00632229|54301201|FG001|Overall Study|Adverse Event|0|||
27829681|NCT00632229|54301200|FG000|Overall Study|Lost to Follow-up|0|||
27829682|NCT00632229|54301201|FG001|Overall Study|Lost to Follow-up|3|||
27829683|NCT00632229|54301200|FG000|Overall Study|Lack of Efficacy|0|||
27829684|NCT00632229|54301201|FG001|Overall Study|Lack of Efficacy|2|||
27829685|NCT00632229|54301200|FG000|Overall Study|Undisclosed reasons within the first wee|0|||
27829686|NCT00632229|54301201|FG001|Overall Study|Undisclosed reasons within the first wee|1|||
27829687|NCT00631137|54301209|FG000|Overall Study|Withdrawal by Subject|1|||
27829688|NCT00631137|54301210|FG001|Overall Study|Withdrawal by Subject|0|||
27829689|NCT00630825|54301229|FG000|Overall Study|Adverse Event|4|||
27829690|NCT00630825|54301230|FG001|Overall Study|Adverse Event|4|||
27829691|NCT00630825|54301231|FG002|Overall Study|Adverse Event|3|||
27829692|NCT00630825|54301232|FG003|Overall Study|Adverse Event|1|||
27829693|NCT00630825|54301229|FG000|Overall Study|Entry Criteria Not Met|1|||
27829694|NCT00630825|54301230|FG001|Overall Study|Entry Criteria Not Met|0|||
27829695|NCT00630825|54301231|FG002|Overall Study|Entry Criteria Not Met|2|||
27829696|NCT00630825|54301232|FG003|Overall Study|Entry Criteria Not Met|1|||
27829697|NCT00630825|54301229|FG000|Overall Study|Lost to Follow-up|1|||
27829698|NCT00630825|54301230|FG001|Overall Study|Lost to Follow-up|1|||
27829699|NCT00630825|54301231|FG002|Overall Study|Lost to Follow-up|1|||
27829700|NCT00630825|54301232|FG003|Overall Study|Lost to Follow-up|1|||
27829701|NCT00630825|54301229|FG000|Overall Study|Physician Decision|1|||
27829702|NCT00630825|54301230|FG001|Overall Study|Physician Decision|0|||
27829703|NCT00630825|54301231|FG002|Overall Study|Physician Decision|0|||
27829704|NCT00630825|54301232|FG003|Overall Study|Physician Decision|0|||
27829705|NCT00630825|54301229|FG000|Overall Study|Withdrawal by Subject|2|||
27829706|NCT00630825|54301230|FG001|Overall Study|Withdrawal by Subject|2|||
27829707|NCT00630825|54301231|FG002|Overall Study|Withdrawal by Subject|2|||
27829708|NCT00630825|54301232|FG003|Overall Study|Withdrawal by Subject|3|||
27829709|NCT04075734|54301538|FG000|Overall Study|Lost to Follow-up|1|||
27829710|NCT04075734|54301539|FG001|Overall Study|Lost to Follow-up|1|||
27829711|NCT04075734|54301540|FG002|Overall Study|Lost to Follow-up|0|||
27829712|NCT04075734|54301538|FG000|Overall Study|Withdrawal by Subject|3|||
27829713|NCT04075734|54301539|FG001|Overall Study|Withdrawal by Subject|0|||
27829714|NCT04075734|54301540|FG002|Overall Study|Withdrawal by Subject|0|||
27829715|NCT00989781|54301585|FG000|Ovarian Response to hCG|Lost to Follow-up|3|||
27829716|NCT00989781|54301586|FG001|Ovarian Response to hCG|Lost to Follow-up|2|||
27829717|NCT00989235|54301627|FG000|Overall Study|Death|0|||
27829718|NCT00989235|54301628|FG001|Overall Study|Death|1|||
27829719|NCT00989235|54301627|FG000|Overall Study|Adverse Event|0|||
27829720|NCT00989235|54301628|FG001|Overall Study|Adverse Event|1|||
27829721|NCT00989235|54301627|FG000|Overall Study|Lack of Efficacy|1|||
27829722|NCT00989235|54301628|FG001|Overall Study|Lack of Efficacy|0|||
27829723|NCT00989235|54301627|FG000|Overall Study|Withdrawal of Consent|1|||
27829724|NCT00989235|54301628|FG001|Overall Study|Withdrawal of Consent|1|||
27829725|NCT00989235|54301627|FG000|Overall Study|Desire to Become Pregnant|1|||
27829726|NCT00989235|54301628|FG001|Overall Study|Desire to Become Pregnant|0|||
27829727|NCT00989235|54301627|FG000|Overall Study|Randomized by Mistake|0|||
27829728|NCT00989235|54301628|FG001|Overall Study|Randomized by Mistake|2|||
27829729|NCT00989235|54301627|FG000|Overall Study|Lost to Follow-up|0|||
27829730|NCT00989235|54301628|FG001|Overall Study|Lost to Follow-up|1|||
27829731|NCT00988533|54301668|FG000|Overall Study|Lost to Follow-up|3|||
27829732|NCT03633396|54301700|FG000|Overall Study|Withdrawal by Subject|4|||
27829733|NCT03633396|54301701|FG001|Overall Study|Withdrawal by Subject|4|||
27829734|NCT03633396|54301700|FG000|Overall Study|Adverse Event|1|||
27829735|NCT03633396|54301701|FG001|Overall Study|Adverse Event|1|||
27829736|NCT03633396|54301700|FG000|Overall Study|Lack of Efficacy|1|||
27829737|NCT03633396|54301701|FG001|Overall Study|Lack of Efficacy|0|||
27829738|NCT03633396|54301700|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|0|||
27829739|NCT03633396|54301701|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|1|||
27829740|NCT00988065|54301714|FG000|Overall Study|Adverse Event|4|||
27829741|NCT00988065|54301715|FG001|Overall Study|Adverse Event|10|||
27829742|NCT00988065|54301716|FG002|Overall Study|Adverse Event|2|||
27829743|NCT00988065|54301714|FG000|Overall Study|Lost to Follow-up|1|||
27829744|NCT00988065|54301715|FG001|Overall Study|Lost to Follow-up|2|||
27829745|NCT00988065|54301716|FG002|Overall Study|Lost to Follow-up|2|||
27829746|NCT00988065|54301714|FG000|Overall Study|Subject withdrew consent|3|||
27829747|NCT00988065|54301715|FG001|Overall Study|Subject withdrew consent|5|||
27829748|NCT00988065|54301716|FG002|Overall Study|Subject withdrew consent|2|||
27829749|NCT00988065|54301714|FG000|Overall Study|Noncompliance with protocol|5|||
27829750|NCT00988065|54301715|FG001|Overall Study|Noncompliance with protocol|6|||
27829751|NCT00988065|54301716|FG002|Overall Study|Noncompliance with protocol|9|||
27829752|NCT00987831|54301740|FG000|Overall Study|Never flared in 12 months|1|||
27829753|NCT00987831|54301741|FG001|Overall Study|Never flared in 12 months|0|||
27829754|NCT00987831|54301742|FG002|Overall Study|Never flared in 12 months|0|||
27829755|NCT00987831|54301740|FG000|Overall Study|Lost to Follow-up|0|||
27829756|NCT00987831|54301741|FG001|Overall Study|Lost to Follow-up|3|||
27829757|NCT00987831|54301742|FG002|Overall Study|Lost to Follow-up|0|||
27829758|NCT00986973|54301773|FG000|Overall Study|Withdrawn by study team|1|||
27829759|NCT00986427|54301780|FG000|Overall Study|Lost to Follow-up|2|||
27829760|NCT00986427|54301781|FG001|Overall Study|Lost to Follow-up|0|||
27829761|NCT00986427|54301780|FG000|Overall Study|Lack of Efficacy|1|||
27829762|NCT00986427|54301781|FG001|Overall Study|Lack of Efficacy|0|||
27829763|NCT00986427|54301780|FG000|Overall Study|Withdrawal by Subject|1|||
27829764|NCT00986427|54301781|FG001|Overall Study|Withdrawal by Subject|0|||
27829765|NCT00986349|54301791|FG000|Overall Study|Unsuccessful implant procedure|3|||
27829766|NCT00986349|54301791|FG000|Overall Study|Adverse Event|2|||
27829767|NCT00986349|54301791|FG000|Overall Study|Physician Decision|1|||
27829768|NCT00986349|54301791|FG000|Overall Study|device migration|1|||
27829769|NCT00985959|54301814|FG000|Overall Study|Adverse Event|0|||
27850847|NCT03132636|54349904|FG000|Overall Study|Withdrawal of consent|2|||
27943357|NCT01147458|54600292|FG002|First Intervention|Adverse Event|2|||
27829770|NCT00985959|54301815|FG001|Overall Study|Adverse Event|0|||
27829771|NCT00985959|54301816|FG002|Overall Study|Adverse Event|19|||
27829772|NCT00985959|54301814|FG000|Overall Study|Withdrawal by Subject|0|||
27829773|NCT00985959|54301815|FG001|Overall Study|Withdrawal by Subject|0|||
27829774|NCT00985959|54301816|FG002|Overall Study|Withdrawal by Subject|8|||
27829775|NCT00985959|54301814|FG000|Overall Study|Progressive disease|1|||
27829776|NCT00985959|54301815|FG001|Overall Study|Progressive disease|2|||
27829777|NCT00985959|54301816|FG002|Overall Study|Progressive disease|8|||
27829778|NCT00985959|54301814|FG000|Overall Study|Unrecovered toxicity|0|||
27829779|NCT00985959|54301815|FG001|Overall Study|Unrecovered toxicity|0|||
27829780|NCT00985959|54301816|FG002|Overall Study|Unrecovered toxicity|7|||
27829781|NCT00985959|54301814|FG000|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
27829782|NCT00985959|54301815|FG001|Overall Study|Pneumonitis or pulmonary fibrosis|0|||
27829783|NCT00985959|54301816|FG002|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
27829784|NCT00985959|54301814|FG000|Overall Study|Complete response observed over 2 cycles|0|||
27829785|NCT00985959|54301815|FG001|Overall Study|Complete response observed over 2 cycles|1|||
27829786|NCT00985959|54301816|FG002|Overall Study|Complete response observed over 2 cycles|4|||
27829787|NCT00985959|54301814|FG000|Overall Study|Other|0|||
27829788|NCT00985959|54301815|FG001|Overall Study|Other|0|||
27829789|NCT00985959|54301816|FG002|Overall Study|Other|11|||
27829790|NCT00985725|54301832|FG000|Overall Study|Adverse Event|4|||
27829791|NCT00985725|54301833|FG001|Overall Study|Adverse Event|1|||
27829792|NCT00985725|54301832|FG000|Overall Study|Protocol Violation|1|||
27829793|NCT00985725|54301833|FG001|Overall Study|Protocol Violation|3|||
27829794|NCT00985725|54301832|FG000|Overall Study|Withdrawal by Subject|4|||
27829795|NCT00985725|54301833|FG001|Overall Study|Withdrawal by Subject|4|||
27829796|NCT00985725|54301832|FG000|Overall Study|Lost to Follow-up|1|||
27829797|NCT00985725|54301833|FG001|Overall Study|Lost to Follow-up|1|||
27829798|NCT00985725|54301832|FG000|Overall Study|Lack of Efficacy|0|||
27829799|NCT00985725|54301833|FG001|Overall Study|Lack of Efficacy|1|||
27829800|NCT00985725|54301832|FG000|Overall Study|Non-compliance|1|||
27829801|NCT00985725|54301833|FG001|Overall Study|Non-compliance|2|||
27829802|NCT00985725|54301832|FG000|Overall Study|Out-of-window visits|0|||
27829803|NCT00985725|54301833|FG001|Overall Study|Out-of-window visits|1|||
27829804|NCT00985491|54301848|FG000|Overall Study|Adverse Event|8|||
27829805|NCT00985491|54301848|FG000|Overall Study|device migration|7|||
27829806|NCT00985491|54301848|FG000|Overall Study|Withdrawal by Subject|1|||
27829807|NCT00985491|54301848|FG000|Overall Study|implant failure|3|||
27829808|NCT00984867|54301883|FG000|Overall Study|Adverse Event|3|||
27829809|NCT00984867|54301884|FG001|Overall Study|Adverse Event|7|||
27829810|NCT00984867|54301883|FG000|Overall Study|Death|1|||
27829811|NCT00984867|54301884|FG001|Overall Study|Death|0|||
27829812|NCT00984867|54301883|FG000|Overall Study|Withdrawal by Subject|13|||
27829813|NCT00984867|54301884|FG001|Overall Study|Withdrawal by Subject|4|||
27829814|NCT00984867|54301883|FG000|Overall Study|Lost to Follow-up|3|||
27829815|NCT00984867|54301884|FG001|Overall Study|Lost to Follow-up|4|||
27829816|NCT00984867|54301883|FG000|Overall Study|Poor/non-compliance|0|||
27829817|NCT00984867|54301884|FG001|Overall Study|Poor/non-compliance|1|||
27829818|NCT00984867|54301883|FG000|Overall Study|Subject no longer meets study criteria|1|||
27829819|NCT00984867|54301884|FG001|Overall Study|Subject no longer meets study criteria|1|||
27829820|NCT00984867|54301883|FG000|Overall Study|site closing|1|||
27829821|NCT00984867|54301884|FG001|Overall Study|site closing|0|||
27829822|NCT00984867|54301883|FG000|Overall Study|lack of efficacy and subject compliance|1|||
27829823|NCT00984867|54301884|FG001|Overall Study|lack of efficacy and subject compliance|0|||
27829824|NCT00984009|54301924|FG000|Grapefruit Juice Alone|missed serving of grapefruit juice|1|||
27829825|NCT00983931|54301931|FG000|14 Day Washout Period|Physician Decision|1|||
27829826|NCT00983853|54301943|FG000|Overall Study|Lost to Follow-up|1|||
27829827|NCT00983853|54301944|FG001|Overall Study|Lost to Follow-up|1|||
27829828|NCT00983853|54301945|FG002|Overall Study|Lost to Follow-up|2|||
27829829|NCT00983853|54301946|FG003|Overall Study|Lost to Follow-up|2|||
27829830|NCT00983853|54301947|FG004|Overall Study|Lost to Follow-up|2|||
27829831|NCT00983853|54301948|FG005|Overall Study|Lost to Follow-up|1|||
27829832|NCT00983853|54301943|FG000|Overall Study|Withdrawal by Subject|0|||
27829833|NCT00983853|54301944|FG001|Overall Study|Withdrawal by Subject|0|||
27829834|NCT00983853|54301945|FG002|Overall Study|Withdrawal by Subject|1|||
27829835|NCT00983853|54301946|FG003|Overall Study|Withdrawal by Subject|0|||
27829836|NCT00983853|54301947|FG004|Overall Study|Withdrawal by Subject|1|||
27829837|NCT00983853|54301948|FG005|Overall Study|Withdrawal by Subject|0|||
27829838|NCT00983853|54301943|FG000|Overall Study|Unable to come to study follow-up visits|0|||
27829839|NCT00983853|54301944|FG001|Overall Study|Unable to come to study follow-up visits|1|||
27829840|NCT00983853|54301945|FG002|Overall Study|Unable to come to study follow-up visits|0|||
27829841|NCT00983853|54301946|FG003|Overall Study|Unable to come to study follow-up visits|0|||
27829842|NCT00983853|54301947|FG004|Overall Study|Unable to come to study follow-up visits|0|||
27829843|NCT00983853|54301948|FG005|Overall Study|Unable to come to study follow-up visits|0|||
27829844|NCT00983073|54301964|FG000|Titration and Optimal Dose Period|Adverse Event|19|||
27829845|NCT00983073|54301964|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|11|||
27829846|NCT00983073|54301964|FG000|Titration and Optimal Dose Period|Lack of Efficacy|5|||
27829847|NCT00983073|54301964|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
27829848|NCT00983073|54301964|FG000|Titration and Optimal Dose Period|Other reason|4|||
27829849|NCT00983073|54301964|FG000|Maintenance Period|Adverse Event|5|||
27829850|NCT00983073|54301964|FG000|Maintenance Period|Withdrawal by Subject|2|||
27829851|NCT00983073|54301964|FG000|Maintenance Period|Lack of Efficacy|2|||
27829852|NCT00983073|54301964|FG000|Maintenance Period|Other Reason|7|||
27829853|NCT00982137|54301973|FG000|Overall Study|Lost to Follow-up|0|||
27829854|NCT00982137|54301974|FG001|Overall Study|Lost to Follow-up|0|||
27829855|NCT00982137|54301975|FG002|Overall Study|Lost to Follow-up|0|||
27829856|NCT00982137|54301976|FG003|Overall Study|Lost to Follow-up|1|||
27829857|NCT00982137|54301973|FG000|Overall Study|Withdrawal by Subject|0|||
27829858|NCT00982137|54301974|FG001|Overall Study|Withdrawal by Subject|1|||
27829859|NCT00982137|54301975|FG002|Overall Study|Withdrawal by Subject|0|||
27829860|NCT00982137|54301976|FG003|Overall Study|Withdrawal by Subject|0|||
27829861|NCT00981747|54301993|FG000|Losartan|Withdrawal by Subject|1|||
27829862|NCT00981747|54301993|FG000|Losartan|Death|1|||
27829863|NCT00981747|54301993|FG000|Placebo Oral Tablet|Withdrawal by Subject|1|||
27829864|NCT01856309|54302148|FG000|Overall Study|Death|4|||
27829865|NCT01856309|54302149|FG001|Overall Study|Death|6|||
27829866|NCT01856309|54302150|FG002|Overall Study|Death|11|||
27829867|NCT01856309|54302151|FG003|Overall Study|Death|6|||
27829868|NCT01856309|54302148|FG000|Overall Study|Lost to Follow-up|6|||
27829869|NCT01856309|54302149|FG001|Overall Study|Lost to Follow-up|2|||
27829870|NCT01856309|54302150|FG002|Overall Study|Lost to Follow-up|4|||
27829871|NCT01856309|54302151|FG003|Overall Study|Lost to Follow-up|8|||
27829872|NCT01856309|54302148|FG000|Overall Study|Withdrawal by Subject|11|||
27829873|NCT01856309|54302149|FG001|Overall Study|Withdrawal by Subject|13|||
27829874|NCT01856309|54302150|FG002|Overall Study|Withdrawal by Subject|28|||
27829875|NCT01856309|54302151|FG003|Overall Study|Withdrawal by Subject|26|||
27829876|NCT01856309|54302148|FG000|Overall Study|Other|227|||
27829877|NCT01856309|54302149|FG001|Overall Study|Other|225|||
27829878|NCT01856309|54302150|FG002|Overall Study|Other|447|||
27829879|NCT01856309|54302151|FG003|Overall Study|Other|469|||
27829880|NCT01856309|54302148|FG000|Overall Study|Lack of Efficacy|14|||
27829881|NCT01856309|54302149|FG001|Overall Study|Lack of Efficacy|9|||
27829882|NCT01856309|54302150|FG002|Overall Study|Lack of Efficacy|40|||
27829883|NCT01856309|54302151|FG003|Overall Study|Lack of Efficacy|25|||
27829884|NCT01856309|54302148|FG000|Overall Study|Adverse Event|31|||
27829885|NCT01856309|54302149|FG001|Overall Study|Adverse Event|31|||
27829886|NCT01856309|54302150|FG002|Overall Study|Adverse Event|55|||
27829887|NCT01856309|54302151|FG003|Overall Study|Adverse Event|65|||
27829888|NCT01856309|54302148|FG000|Overall Study|Pregnancy|0|||
27829889|NCT01856309|54302149|FG001|Overall Study|Pregnancy|0|||
27829890|NCT01856309|54302150|FG002|Overall Study|Pregnancy|0|||
27829891|NCT01856309|54302151|FG003|Overall Study|Pregnancy|1|||
27829892|NCT01856309|54302148|FG000|Overall Study|Physician Decision|6|||
27829893|NCT01856309|54302149|FG001|Overall Study|Physician Decision|1|||
27829894|NCT01856309|54302150|FG002|Overall Study|Physician Decision|6|||
27829895|NCT01856309|54302151|FG003|Overall Study|Physician Decision|8|||
27829896|NCT01856309|54302148|FG000|Overall Study|Noncompliance With Study Drug|0|||
27829897|NCT01856309|54302149|FG001|Overall Study|Noncompliance With Study Drug|1|||
27829898|NCT01856309|54302150|FG002|Overall Study|Noncompliance With Study Drug|4|||
27829899|NCT01856309|54302151|FG003|Overall Study|Noncompliance With Study Drug|1|||
27829900|NCT01855919|54302349|FG000|Overall Study|Adverse Event|16|||
27829901|NCT01855919|54302350|FG001|Overall Study|Adverse Event|8|||
27829902|NCT01855919|54302349|FG000|Overall Study|Lack of Efficacy|1|||
27829903|NCT01855919|54302350|FG001|Overall Study|Lack of Efficacy|3|||
27829904|NCT01855919|54302349|FG000|Overall Study|Withdrawal by Subject|4|||
27829905|NCT01855919|54302350|FG001|Overall Study|Withdrawal by Subject|10|||
27829906|NCT01855919|54302349|FG000|Overall Study|Entry Criteria Not Met|1|||
27829907|NCT01855919|54302350|FG001|Overall Study|Entry Criteria Not Met|1|||
27829908|NCT01855919|54302349|FG000|Overall Study|Protocol Violation|1|||
27829909|NCT01855919|54302350|FG001|Overall Study|Protocol Violation|4|||
27829910|NCT01871519|54302366|FG000|Overall Study|Death|26|||
27829911|NCT01871519|54302366|FG000|Overall Study|Lost to Follow-up|15|||
27829912|NCT01871519|54302366|FG000|Overall Study|Withdrawal by Subject|49|||
27829913|NCT01871285|54302373|FG000|First Intervention (1 Day)|Adverse Event|1|||
27829914|NCT01871285|54302374|FG001|First Intervention (1 Day)|Adverse Event|0|||
27829915|NCT01871285|54302375|FG002|First Intervention (1 Day)|Adverse Event|0|||
27829916|NCT01871285|54302376|FG003|First Intervention (1 Day)|Adverse Event|0|||
27829917|NCT01871285|54302373|FG000|First Intervention (1 Day)|Lost to Follow-up|0|||
27829918|NCT01871285|54302374|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
27829919|NCT01871285|54302375|FG002|First Intervention (1 Day)|Lost to Follow-up|1|||
27829920|NCT01871285|54302376|FG003|First Intervention (1 Day)|Lost to Follow-up|0|||
27829921|NCT01870973|54302402|FG000|Overall Study|Lost to Follow-up|10|||
27829922|NCT01870973|54302403|FG001|Overall Study|Lost to Follow-up|3|||
27829923|NCT01854827|54302422|FG000|Overall Study|Death|1|||
27829924|NCT01854047|54302565|FG000|Overall Study|Lack of Efficacy|1|||
27829925|NCT01854047|54302566|FG001|Overall Study|Lack of Efficacy|0|||
27829926|NCT01854047|54302567|FG002|Overall Study|Lack of Efficacy|0|||
27829927|NCT01854047|54302568|FG003|Overall Study|Lack of Efficacy|0|||
27829928|NCT01854047|54302569|FG004|Overall Study|Lack of Efficacy|0|||
27829929|NCT01854047|54302565|FG000|Overall Study|Poor compliance to protocol|3|||
27829930|NCT01854047|54302566|FG001|Overall Study|Poor compliance to protocol|0|||
27829931|NCT01854047|54302567|FG002|Overall Study|Poor compliance to protocol|2|||
27829932|NCT01854047|54302568|FG003|Overall Study|Poor compliance to protocol|0|||
27829933|NCT01854047|54302569|FG004|Overall Study|Poor compliance to protocol|0|||
27829934|NCT01854047|54302565|FG000|Overall Study|Adverse Event|5|||
27829935|NCT01854047|54302566|FG001|Overall Study|Adverse Event|4|||
27829936|NCT01854047|54302567|FG002|Overall Study|Adverse Event|6|||
27829937|NCT01854047|54302568|FG003|Overall Study|Adverse Event|10|||
27829938|NCT01854047|54302569|FG004|Overall Study|Adverse Event|7|||
27829939|NCT01854047|54302565|FG000|Overall Study|Randomized but not treated|0|||
27829940|NCT01854047|54302566|FG001|Overall Study|Randomized but not treated|1|||
27829941|NCT01854047|54302567|FG002|Overall Study|Randomized but not treated|2|||
27829942|NCT01854047|54302568|FG003|Overall Study|Randomized but not treated|0|||
27829943|NCT01854047|54302569|FG004|Overall Study|Randomized but not treated|4|||
27829944|NCT01854047|54302565|FG000|Overall Study|Other than specified above|3|||
27829945|NCT01854047|54302566|FG001|Overall Study|Other than specified above|3|||
27829946|NCT01854047|54302567|FG002|Overall Study|Other than specified above|3|||
27829947|NCT01854047|54302568|FG003|Overall Study|Other than specified above|5|||
27829948|NCT01854047|54302569|FG004|Overall Study|Other than specified above|8|||
27829949|NCT01870739|54302619|FG000|Single Drug Treatment (12 Weeks)|Protocol deviation|0|||
27829950|NCT01870739|54302620|FG001|Single Drug Treatment (12 Weeks)|Protocol deviation|1|||
27829951|NCT01870739|54302619|FG000|Single Drug Treatment (12 Weeks)|Adverse Event|0|||
27829952|NCT01870739|54302620|FG001|Single Drug Treatment (12 Weeks)|Adverse Event|1|||
27829953|NCT01870739|54302619|FG000|Single Drug Treatment (12 Weeks)|Administrative problems|3|||
27829954|NCT01870739|54302620|FG001|Single Drug Treatment (12 Weeks)|Administrative problems|2|||
27829955|NCT01870739|54302619|FG000|Add-on Period (40 Weeks)|Adverse Event|0|||
27829956|NCT01870739|54302620|FG001|Add-on Period (40 Weeks)|Adverse Event|1|||
27829957|NCT01870739|54302619|FG000|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1|||
27829958|NCT01870739|54302620|FG001|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0|||
27829959|NCT01870739|54302619|FG000|Add-on Period (40 Weeks)|Protocol deviation|1|||
27829960|NCT01870739|54302620|FG001|Add-on Period (40 Weeks)|Protocol deviation|1|||
27829961|NCT01870739|54302619|FG000|Add-on Period (40 Weeks)|Patient withdrew consent|1|||
27829962|NCT01870739|54302620|FG001|Add-on Period (40 Weeks)|Patient withdrew consent|0|||
27829963|NCT01613417|54302647|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|13|||
27829964|NCT01613417|54302648|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|7|||
27829965|NCT01870583|54302676|FG000|Overall Study|Protocol Violation|0|||
27829966|NCT01870583|54302677|FG001|Overall Study|Protocol Violation|5|||
27829967|NCT01870583|54302678|FG002|Overall Study|Protocol Violation|3|||
27829968|NCT01870583|54302676|FG000|Overall Study|Lost to Follow-up|11|||
27829969|NCT01870583|54302677|FG001|Overall Study|Lost to Follow-up|13|||
27829970|NCT01870583|54302678|FG002|Overall Study|Lost to Follow-up|5|||
27829971|NCT01869959|54302736|FG000|Randomization Period|Physician Decision|0|||
27829972|NCT01869959|54302737|FG001|Randomization Period|Physician Decision|0|||
27829973|NCT01869959|54302738|FG002|Randomization Period|Physician Decision|0|||
27829974|NCT01869959|54302739|FG003|Randomization Period|Physician Decision|0|||
27829975|NCT01869959|54302740|FG004|Randomization Period|Physician Decision|1|||
27829976|NCT01869959|54302736|FG000|Treatment Period|Adverse Event|1|||
27829977|NCT01869959|54302737|FG001|Treatment Period|Adverse Event|0|||
27829978|NCT01869959|54302738|FG002|Treatment Period|Adverse Event|3|||
27829979|NCT01869959|54302739|FG003|Treatment Period|Adverse Event|1|||
27829980|NCT01869959|54302740|FG004|Treatment Period|Adverse Event|0|||
27829981|NCT01869959|54302736|FG000|Treatment Period|Sponsor decision|0|||
27829982|NCT01869959|54302737|FG001|Treatment Period|Sponsor decision|1|||
27829983|NCT01869959|54302738|FG002|Treatment Period|Sponsor decision|0|||
28159870|NCT02555878|54829915|FG000|Overall Study|Adverse Event|12|||
28159871|NCT02555878|54829916|FG001|Overall Study|Adverse Event|8|||
27829984|NCT01869959|54302739|FG003|Treatment Period|Sponsor decision|1|||
27829985|NCT01869959|54302740|FG004|Treatment Period|Sponsor decision|0|||
27829986|NCT01869959|54302736|FG000|Treatment Period|Withdrawal by Subject|0|||
27829987|NCT01869959|54302737|FG001|Treatment Period|Withdrawal by Subject|1|||
27829988|NCT01869959|54302738|FG002|Treatment Period|Withdrawal by Subject|0|||
27829989|NCT01869959|54302739|FG003|Treatment Period|Withdrawal by Subject|0|||
27829990|NCT01869959|54302740|FG004|Treatment Period|Withdrawal by Subject|0|||
27829991|NCT01613027|54302801|FG000|Overall Study|Lost to Follow-up|5|||
27829992|NCT01613027|54302801|FG000|Overall Study|Switched Physician|1|||
28159872|NCT02555878|54829915|FG000|Overall Study|Death|74|||
28159873|NCT02555878|54829916|FG001|Overall Study|Death|59|||
27829993|NCT01613027|54302801|FG000|Overall Study|Lack of Efficacy|1|||
27829994|NCT01613027|54302801|FG000|Overall Study|Patient's Decision Due to Adverse Event|1|||
27829995|NCT01869725|54302819|FG000|Overall Study|ineligible after registration|1|||
27829996|NCT01869725|54302819|FG000|Overall Study|Death|1|||
27829997|NCT01869725|54302819|FG000|Overall Study|Lost to Follow-up|2|||
27829998|NCT01851863|54302840|FG000|Overall Study|Did not receive study medication|2|||
27829999|NCT01851863|54302841|FG001|Overall Study|Did not receive study medication|5|||
27830000|NCT01851863|54302842|FG002|Overall Study|Did not receive study medication|3|||
27830001|NCT01851863|54302843|FG003|Overall Study|Did not receive study medication|0|||
27830002|NCT01851863|54302840|FG000|Overall Study|Lost to Follow-up|3|||
27830003|NCT01851863|54302841|FG001|Overall Study|Lost to Follow-up|4|||
27830004|NCT01851863|54302842|FG002|Overall Study|Lost to Follow-up|2|||
27830005|NCT01851863|54302843|FG003|Overall Study|Lost to Follow-up|3|||
27830006|NCT01850615|54302871|FG000|Overall Study|Protocol Violation|4|||
28076818|NCT00111800|54731649|FG001|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
28076819|NCT00111800|54731650|FG002|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
27830007|NCT01850615|54302872|FG001|Overall Study|Protocol Violation|1|||
27830008|NCT01850615|54302871|FG000|Overall Study|Adverse Event|2|||
27830009|NCT01850615|54302872|FG001|Overall Study|Adverse Event|1|||
27830010|NCT01850615|54302871|FG000|Overall Study|Withdrawal by Subject|3|||
27830011|NCT01850615|54302872|FG001|Overall Study|Withdrawal by Subject|1|||
27830012|NCT01850615|54302871|FG000|Overall Study|Lost to Follow-up|0|||
27830013|NCT01850615|54302872|FG001|Overall Study|Lost to Follow-up|1|||
27830014|NCT01850615|54302871|FG000|Overall Study|Unclassified|0|||
28076820|NCT00111800|54731651|FG003|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
28076821|NCT00111800|54731652|FG004|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1|||
28076822|NCT00111800|54731653|FG005|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
28076823|NCT00111800|54731648|FG000|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
28076824|NCT00111800|54731649|FG001|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
28076825|NCT00111800|54731650|FG002|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
28076826|NCT00111800|54731651|FG003|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
28076827|NCT00111800|54731652|FG004|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
28076828|NCT00111800|54731653|FG005|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1|||
28076829|NCT00111800|54731648|FG000|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
28076830|NCT00111800|54731649|FG001|Period 2: Extension Phase (12 Weeks)|Adverse Event|2|||
28076831|NCT00111800|54731650|FG002|Period 2: Extension Phase (12 Weeks)|Adverse Event|1|||
28076832|NCT00111800|54731651|FG003|Period 2: Extension Phase (12 Weeks)|Adverse Event|3|||
28076833|NCT00111800|54731652|FG004|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
28076834|NCT00111800|54731653|FG005|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
28076835|NCT00111800|54731648|FG000|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
28076836|NCT00111800|54731649|FG001|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
28076837|NCT00111800|54731650|FG002|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
28076838|NCT00111800|54731651|FG003|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
28076839|NCT00111800|54731652|FG004|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
28076840|NCT00111800|54731653|FG005|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
28076841|NCT00111800|54731648|FG000|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
28076842|NCT00111800|54731649|FG001|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
28076843|NCT00111800|54731650|FG002|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
28076844|NCT00111800|54731651|FG003|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
28076845|NCT00111800|54731652|FG004|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3|||
28076846|NCT00111800|54731653|FG005|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
28076847|NCT00111800|54731648|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
28076848|NCT00111800|54731649|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
27830015|NCT01850615|54302872|FG001|Overall Study|Unclassified|1|||
27830016|NCT01868477|54302957|FG000|Overall Study|Adverse Event|2|||
27830017|NCT01868477|54302958|FG001|Overall Study|Adverse Event|4|||
27830018|NCT01868477|54302957|FG000|Overall Study|Disease progression|1|||
27830019|NCT01868477|54302958|FG001|Overall Study|Disease progression|1|||
27830020|NCT01868477|54302957|FG000|Overall Study|Withdrawal by Subject|1|||
27830021|NCT01868477|54302958|FG001|Overall Study|Withdrawal by Subject|0|||
27830022|NCT01849289|54302973|FG000|Overall Study|Adverse Event|3|||
27830023|NCT01849289|54302974|FG001|Overall Study|Adverse Event|3|||
28076849|NCT00111800|54731650|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
28076850|NCT00111800|54731651|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
27830024|NCT01849289|54302973|FG000|Overall Study|Protocol Violation|3|||
27830025|NCT01849289|54302974|FG001|Overall Study|Protocol Violation|3|||
27830026|NCT01849289|54302973|FG000|Overall Study|Withdrawal criteria|1|||
28076851|NCT00111800|54731652|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
27850848|NCT03132636|54349905|FG001|Overall Study|Withdrawal of consent|5|||
27830027|NCT01849289|54302974|FG001|Overall Study|Withdrawal criteria|0|||
27830028|NCT01849289|54302973|FG000|Overall Study|Unclassified|25|||
27830029|NCT01849289|54302974|FG001|Overall Study|Unclassified|18|||
27830030|NCT01868243|54302982|FG000|Overall Study|Death|0|||
27830031|NCT01868243|54302983|FG001|Overall Study|Death|1|||
27830032|NCT01611935|54302991|FG000|Overall Study|Family Declined Participation|1|||
27830033|NCT01611935|54302992|FG001|Overall Study|Family Declined Participation|0|||
27830034|NCT01868165|54302998|FG000|Overall Study|Withdrawal by Subject|36|||
27830035|NCT01868165|54302998|FG000|Overall Study|Physician Decision|2|||
27830036|NCT01868165|54302998|FG000|Overall Study|Lost to Follow-up|3|||
27830037|NCT01868165|54302998|FG000|Overall Study|Death|4|||
27830038|NCT01868009|54303037|FG000|Period 1 (5-9 Days)|Adverse Event|0|||
27830039|NCT01868009|54303038|FG001|Period 1 (5-9 Days)|Adverse Event|2|||
27830040|NCT01868009|54303037|FG000|Period 2 (5-9 Days)|Adverse Event|1|||
27830041|NCT01868009|54303038|FG001|Period 2 (5-9 Days)|Adverse Event|0|||
27830042|NCT01868009|54303037|FG000|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1|||
27830043|NCT01868009|54303038|FG001|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0|||
27830044|NCT01849055|54303092|FG000|Overall Study|Withdrawal by Subject|0|||
27830045|NCT01849055|54303093|FG001|Overall Study|Withdrawal by Subject|0|||
27830046|NCT01849055|54303094|FG002|Overall Study|Withdrawal by Subject|1|||
27830047|NCT01849055|54303095|FG003|Overall Study|Withdrawal by Subject|0|||
27830048|NCT01849055|54303096|FG004|Overall Study|Withdrawal by Subject|0|||
27830049|NCT01849055|54303097|FG005|Overall Study|Withdrawal by Subject|0|||
27830050|NCT01848353|54303123|FG000|Phase 1|Withdrawal by Subject|3|||
27830051|NCT01848353|54303124|FG001|Phase 1|Withdrawal by Subject|1|||
27830052|NCT01848353|54303125|FG002|Phase 1|Withdrawal by Subject|0|||
27830053|NCT01848353|54303126|FG003|Phase 1|Withdrawal by Subject|0|||
27830054|NCT01848353|54303123|FG000|Phase 2|Withdrawal by Subject|3|||
27830055|NCT01848353|54303124|FG001|Phase 2|Withdrawal by Subject|2|||
27830056|NCT01848353|54303125|FG002|Phase 2|Withdrawal by Subject|0|||
27830057|NCT01848353|54303126|FG003|Phase 2|Withdrawal by Subject|0|||
27830058|NCT01848353|54303123|FG000|Phase 3|Withdrawal by Subject|1|||
27830059|NCT01848353|54303124|FG001|Phase 3|Withdrawal by Subject|1|||
27830060|NCT01848353|54303125|FG002|Phase 3|Withdrawal by Subject|0|||
27830061|NCT01848353|54303126|FG003|Phase 3|Withdrawal by Subject|0|||
27830062|NCT01847885|54303155|FG000|Initial Enrollment (Consented)|Protocol Violation|1|||
27830063|NCT01847885|54303156|FG001|Initial Enrollment (Consented)|Protocol Violation|0|||
27830064|NCT01847885|54303157|FG002|Initial Enrollment (Consented)|Protocol Violation|0|||
27830065|NCT01847885|54303155|FG000|Initial Enrollment (Consented)|Withdrawal by Subject|2|||
27830066|NCT01847885|54303156|FG001|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
27830067|NCT01847885|54303157|FG002|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
27830068|NCT01847885|54303155|FG000|Initial Enrollment (Consented)|Screen failure|39|||
27830069|NCT01847885|54303156|FG001|Initial Enrollment (Consented)|Screen failure|0|||
27830070|NCT01847885|54303157|FG002|Initial Enrollment (Consented)|Screen failure|0|||
27830071|NCT01847885|54303155|FG000|Initial Enrollment (Consented)|Pending prior to enrollment stop|6|||
27830072|NCT01847885|54303156|FG001|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
27830073|NCT01847885|54303157|FG002|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
27830074|NCT01847885|54303155|FG000|Randomization|Protocol Violation|0|||
27830075|NCT01847885|54303156|FG001|Randomization|Protocol Violation|1|||
27830076|NCT01847885|54303157|FG002|Randomization|Protocol Violation|0|||
27830077|NCT01847885|54303155|FG000|Randomization|Withdrawal by Subject|0|||
27830078|NCT01847885|54303156|FG001|Randomization|Withdrawal by Subject|0|||
27830079|NCT01847885|54303157|FG002|Randomization|Withdrawal by Subject|2|||
27830080|NCT01847885|54303155|FG000|Randomization|Screen Failure|0|||
27830081|NCT01847885|54303156|FG001|Randomization|Screen Failure|3|||
27830082|NCT01847885|54303157|FG002|Randomization|Screen Failure|0|||
27830083|NCT01867307|54303195|FG000|Overall Study|Protocol Violation|2|||
27830084|NCT01867307|54303196|FG001|Overall Study|Protocol Violation|0|||
27830085|NCT01867307|54303195|FG000|Overall Study|Other Adverse Event|1|||
27830086|NCT01867307|54303196|FG001|Overall Study|Other Adverse Event|3|||
27830087|NCT01845077|54303205|FG000|Washout Period|Lost to Follow-up|0|||
27830088|NCT01845077|54303206|FG001|Washout Period|Lost to Follow-up|1|||
27830089|NCT01845077|54303207|FG002|Washout Period|Lost to Follow-up|0|||
27830090|NCT01845077|54303208|FG003|Washout Period|Lost to Follow-up|1|||
27830091|NCT01845077|54303209|FG004|Washout Period|Lost to Follow-up|0|||
27830092|NCT01845077|54303210|FG005|Washout Period|Lost to Follow-up|1|||
27830093|NCT01845077|54303205|FG000|Washout Period|Adverse Event|1|||
27830094|NCT01845077|54303206|FG001|Washout Period|Adverse Event|0|||
27830095|NCT01845077|54303207|FG002|Washout Period|Adverse Event|0|||
27830096|NCT01845077|54303208|FG003|Washout Period|Adverse Event|0|||
27830097|NCT01845077|54303209|FG004|Washout Period|Adverse Event|0|||
27830098|NCT01845077|54303210|FG005|Washout Period|Adverse Event|0|||
27830099|NCT01845077|54303205|FG000|Washout Period|elevated lab values (not clinic. sign.)|0|||
27830100|NCT01845077|54303206|FG001|Washout Period|elevated lab values (not clinic. sign.)|0|||
27830101|NCT01845077|54303207|FG002|Washout Period|elevated lab values (not clinic. sign.)|1|||
27850849|NCT03132636|54349904|FG000|Overall Study|Study ongoing|9|||
27830102|NCT01845077|54303208|FG003|Washout Period|elevated lab values (not clinic. sign.)|0|||
27830103|NCT01845077|54303209|FG004|Washout Period|elevated lab values (not clinic. sign.)|0|||
27830104|NCT01845077|54303210|FG005|Washout Period|elevated lab values (not clinic. sign.)|0|||
27830105|NCT01845077|54303205|FG000|Washout Period|Protocol Violation|0|||
27830106|NCT01845077|54303206|FG001|Washout Period|Protocol Violation|0|||
27830107|NCT01845077|54303207|FG002|Washout Period|Protocol Violation|0|||
27830108|NCT01845077|54303208|FG003|Washout Period|Protocol Violation|1|||
27830109|NCT01845077|54303209|FG004|Washout Period|Protocol Violation|1|||
27830110|NCT01845077|54303210|FG005|Washout Period|Protocol Violation|0|||
27830111|NCT01866917|54303227|FG000|Overall Study|Pharmacist stopped dispensing treatment|4|||
27830112|NCT01866917|54303228|FG001|Overall Study|Pharmacist stopped dispensing treatment|6|||
27830113|NCT01844765|54303363|FG000|Overall Study|Adverse Event|6|||
27830114|NCT01844765|54303364|FG001|Overall Study|Adverse Event|8|||
27830115|NCT01844765|54303363|FG000|Overall Study|Withdrawal by Subject|2|||
27830116|NCT01844765|54303364|FG001|Overall Study|Withdrawal by Subject|3|||
27830117|NCT01844765|54303363|FG000|Overall Study|Disease progression|1|||
27830118|NCT01844765|54303364|FG001|Overall Study|Disease progression|0|||
27830119|NCT01844765|54303363|FG000|Overall Study|Administrative problems|3|||
27830120|NCT01844765|54303364|FG001|Overall Study|Administrative problems|4|||
27830121|NCT01844765|54303363|FG000|Overall Study|Protocol deviation|2|||
27830122|NCT01844765|54303364|FG001|Overall Study|Protocol deviation|0|||
27830123|NCT01844765|54303363|FG000|Overall Study|Untreated|1|||
27830124|NCT01844765|54303364|FG001|Overall Study|Untreated|0|||
27830125|NCT01866293|54303379|FG000|Overall Study|Adverse Event|2|||
27830126|NCT01844687|54303383|FG000|Visit 1|Protocol Violation|3|||
27830127|NCT01844687|54303383|FG000|Visit 1|Lost to Follow-up|5|||
27830128|NCT01844687|54303383|FG000|Visit 2|Withdrawal by Subject|1|||
27830129|NCT01844687|54303383|FG000|Visit 2|Protocol Violation|1|||
27830130|NCT01844687|54303383|FG000|Visit 3|Lost to Follow-up|1|||
27830131|NCT01844687|54303383|FG000|Visit 3|Withdrawal by Subject|3|||
27830132|NCT01844687|54303383|FG000|Visit 3|child care problems|1|||
27830133|NCT01844687|54303383|FG000|Visit 4|Pregnancy|1|||
27830134|NCT01844687|54303383|FG000|Visit 4|Lost to Follow-up|1|||
27830135|NCT01844687|54303383|FG000|Visit 4|Withdrawal by Subject|2|||
27830136|NCT01844531|54303409|FG000|Overall Study|Withdrawal by Subject|0|||
27830137|NCT01844531|54303410|FG001|Overall Study|Withdrawal by Subject|1|||
27830138|NCT01844531|54303411|FG002|Overall Study|Withdrawal by Subject|0|||
27830139|NCT01844531|54303412|FG003|Overall Study|Withdrawal by Subject|0|||
27830140|NCT01844375|54303424|FG000|Overall Study|Protocol Violation|1|||
27830141|NCT01844375|54303425|FG001|Overall Study|Protocol Violation|1|||
27830142|NCT02367456|54303434|FG000|Overall Study|Death|8|||
27830143|NCT02367456|54303435|FG001|Overall Study|Death|21|||
27830144|NCT02367456|54303436|FG002|Overall Study|Death|14|||
27830145|NCT02367456|54303434|FG000|Overall Study|Lost to Follow-up|1|||
27830146|NCT02367456|54303435|FG001|Overall Study|Lost to Follow-up|3|||
27830147|NCT02367456|54303436|FG002|Overall Study|Lost to Follow-up|1|||
27830148|NCT02367456|54303434|FG000|Overall Study|Ongoing|0|||
27830149|NCT02367456|54303435|FG001|Overall Study|Ongoing|6|||
27830150|NCT02367456|54303436|FG002|Overall Study|Ongoing|15|||
27830151|NCT02367456|54303434|FG000|Overall Study|Other reason|3|||
27830152|NCT02367456|54303435|FG001|Overall Study|Other reason|0|||
27830153|NCT02367456|54303436|FG002|Overall Study|Other reason|0|||
27830154|NCT01865747|54303467|FG000|Overall Study (ITT)|Adverse Event|32|||
27830155|NCT01865747|54303468|FG001|Overall Study (ITT)|Adverse Event|31|||
27830156|NCT01865747|54303467|FG000|Overall Study (ITT)|Clinical Deterioration|29|||
27830157|NCT01865747|54303468|FG001|Overall Study (ITT)|Clinical Deterioration|50|||
27830158|NCT01865747|54303467|FG000|Overall Study (ITT)|Lack of Efficacy|3|||
27830159|NCT01865747|54303468|FG001|Overall Study (ITT)|Lack of Efficacy|0|||
27830160|NCT01865747|54303467|FG000|Overall Study (ITT)|Protocol Violation|1|||
27830161|NCT01865747|54303468|FG001|Overall Study (ITT)|Protocol Violation|1|||
27830162|NCT01865747|54303467|FG000|Overall Study (ITT)|Physician Decision|5|||
27830163|NCT01865747|54303468|FG001|Overall Study (ITT)|Physician Decision|2|||
27830164|NCT01865747|54303467|FG000|Overall Study (ITT)|Withdrawal by Subject|6|||
27830165|NCT01865747|54303468|FG001|Overall Study (ITT)|Withdrawal by Subject|11|||
27830166|NCT01865747|54303467|FG000|Overall Study (ITT)|Sponsor Decision|0|||
27830167|NCT01865747|54303468|FG001|Overall Study (ITT)|Sponsor Decision|1|||
27943358|NCT01147458|54600293|FG003|First Intervention|Adverse Event|3|||
27830168|NCT01865747|54303467|FG000|Overall Study (ITT)|Progressive Disease|122|||
27830169|NCT01865747|54303468|FG001|Overall Study (ITT)|Progressive Disease|158|||
27830170|NCT01865747|54303467|FG000|Overall Study (ITT)|Reason Not Provided|0|||
27830171|NCT01865747|54303468|FG001|Overall Study (ITT)|Reason Not Provided|1|||
27830172|NCT01865747|54303467|FG000|Primary Intent to Treat (PITT)|Adverse Event|21|||
27830173|NCT01865747|54303468|FG001|Primary Intent to Treat (PITT)|Adverse Event|20|||
27830174|NCT01865747|54303467|FG000|Primary Intent to Treat (PITT)|Clinical Deterioration|18|||
27830175|NCT01865747|54303468|FG001|Primary Intent to Treat (PITT)|Clinical Deterioration|29|||
27830176|NCT01865747|54303467|FG000|Primary Intent to Treat (PITT)|Lack of Efficacy|2|||
27830177|NCT01865747|54303468|FG001|Primary Intent to Treat (PITT)|Lack of Efficacy|0|||
27830178|NCT01865747|54303467|FG000|Primary Intent to Treat (PITT)|Protocol Violation|1|||
27830179|NCT01865747|54303468|FG001|Primary Intent to Treat (PITT)|Protocol Violation|1|||
27830180|NCT01865747|54303467|FG000|Primary Intent to Treat (PITT)|Physician Decision|4|||
27830181|NCT01865747|54303468|FG001|Primary Intent to Treat (PITT)|Physician Decision|2|||
27830182|NCT01865747|54303467|FG000|Primary Intent to Treat (PITT)|Withdrawal by Subject|3|||
27830183|NCT01865747|54303468|FG001|Primary Intent to Treat (PITT)|Withdrawal by Subject|7|||
27830184|NCT01865747|54303467|FG000|Primary Intent to Treat (PITT)|Progressive Disease|82|||
27830185|NCT01865747|54303468|FG001|Primary Intent to Treat (PITT)|Progressive Disease|92|||
27830186|NCT01865747|54303467|FG000|Primary Intent to Treat (PITT)|Other|0|||
27830187|NCT01865747|54303468|FG001|Primary Intent to Treat (PITT)|Other|1|||
27830188|NCT01843673|54303509|FG000|Overall Study|Lack of Efficacy|2|||
27830189|NCT01843673|54303509|FG000|Overall Study|Withdrawal by Subject|4|||
27830190|NCT01843205|54303528|FG000|First Treatment (11 Days)|Withdrawal by Subject|1|||
27830191|NCT01843205|54303529|FG001|First Treatment (11 Days)|Withdrawal by Subject|0|||
27830192|NCT01835015|54303616|FG000|Overall Study|Adverse Event|0|||
27830193|NCT01835015|54303617|FG001|Overall Study|Adverse Event|0|||
27830194|NCT01835015|54303618|FG002|Overall Study|Adverse Event|1|||
27830195|NCT01835015|54303619|FG003|Overall Study|Adverse Event|0|||
27830196|NCT01835015|54303620|FG004|Overall Study|Adverse Event|0|||
27830197|NCT01842581|54303648|FG000|Overall Study|Adverse Event|6|||
27830198|NCT01842581|54303649|FG001|Overall Study|Adverse Event|4|||
27830199|NCT01842581|54303648|FG000|Overall Study|HE breakthrough|26|||
27830200|NCT01842581|54303649|FG001|Overall Study|HE breakthrough|13|||
27830201|NCT01842581|54303648|FG000|Overall Study|Liver transplant|2|||
27830202|NCT01842581|54303649|FG001|Overall Study|Liver transplant|0|||
27830203|NCT01842581|54303648|FG000|Overall Study|Lost to Follow-up|2|||
27830204|NCT01842581|54303649|FG001|Overall Study|Lost to Follow-up|5|||
27830205|NCT01842581|54303648|FG000|Overall Study|Withdrawal by Subject|5|||
27830206|NCT01842581|54303649|FG001|Overall Study|Withdrawal by Subject|7|||
27830207|NCT01842581|54303648|FG000|Overall Study|Other than specified|3|||
27830208|NCT01842581|54303649|FG001|Overall Study|Other than specified|1|||
27830209|NCT01833533|54303657|FG000|Overall Study|Adverse Event|0|||
27830210|NCT01833533|54303658|FG001|Overall Study|Adverse Event|1|||
27830211|NCT01833533|54303657|FG000|Overall Study|Lost to Follow-up|4|||
27830212|NCT01833533|54303658|FG001|Overall Study|Lost to Follow-up|9|||
27830213|NCT01833533|54303657|FG000|Overall Study|To Enter an Extension Study|0|||
27830214|NCT01833533|54303658|FG001|Overall Study|To Enter an Extension Study|4|||
27830215|NCT01833533|54303657|FG000|Overall Study|Other|2|||
27830216|NCT01833533|54303658|FG001|Overall Study|Other|7|||
27830217|NCT01833455|54303666|FG000|Overall Study|Withdrawal by Subject|1|||
27830218|NCT01833455|54303667|FG001|Overall Study|Withdrawal by Subject|0|||
27830219|NCT01833143|54303685|FG000|Overall Study|Not Treated|1|||
27830220|NCT01841567|54303689|FG000|Overall Study|Adverse Event|3|||
27830221|NCT01833065|54303696|FG000|Overall Study|Adverse Event|6|||
27830222|NCT01833065|54303697|FG001|Overall Study|Adverse Event|1|||
27830223|NCT01833065|54303698|FG002|Overall Study|Adverse Event|0|||
27830224|NCT01833065|54303699|FG003|Overall Study|Adverse Event|2|||
27830225|NCT01833065|54303700|FG004|Overall Study|Adverse Event|3|||
27830226|NCT01833065|54303696|FG000|Overall Study|Protocol Violation|1|||
27830227|NCT01833065|54303697|FG001|Overall Study|Protocol Violation|0|||
27830228|NCT01833065|54303698|FG002|Overall Study|Protocol Violation|0|||
27830229|NCT01833065|54303699|FG003|Overall Study|Protocol Violation|0|||
27830230|NCT01833065|54303700|FG004|Overall Study|Protocol Violation|2|||
27830231|NCT01833065|54303696|FG000|Overall Study|Lost to Follow-up|1|||
27830232|NCT01833065|54303697|FG001|Overall Study|Lost to Follow-up|0|||
27830233|NCT01833065|54303698|FG002|Overall Study|Lost to Follow-up|0|||
27830234|NCT01833065|54303699|FG003|Overall Study|Lost to Follow-up|0|||
27830235|NCT01833065|54303700|FG004|Overall Study|Lost to Follow-up|3|||
27830236|NCT01833065|54303696|FG000|Overall Study|Withdrawal by Subject|6|||
27830237|NCT01833065|54303697|FG001|Overall Study|Withdrawal by Subject|2|||
27830238|NCT01833065|54303698|FG002|Overall Study|Withdrawal by Subject|4|||
27830239|NCT01833065|54303699|FG003|Overall Study|Withdrawal by Subject|3|||
27830240|NCT01833065|54303700|FG004|Overall Study|Withdrawal by Subject|11|||
27830241|NCT01833065|54303696|FG000|Overall Study|Subject's substantial non-compliance|0|||
27830242|NCT01833065|54303697|FG001|Overall Study|Subject's substantial non-compliance|1|||
27830243|NCT01833065|54303698|FG002|Overall Study|Subject's substantial non-compliance|0|||
27830244|NCT01833065|54303699|FG003|Overall Study|Subject's substantial non-compliance|0|||
27830245|NCT01833065|54303700|FG004|Overall Study|Subject's substantial non-compliance|0|||
27943359|NCT01147458|54600290|FG000|First Intervention|Other|1|||
27830246|NCT01833065|54303696|FG000|Overall Study|Trial terminated by sponsor|8|||
27830247|NCT01833065|54303697|FG001|Overall Study|Trial terminated by sponsor|8|||
27830248|NCT01833065|54303698|FG002|Overall Study|Trial terminated by sponsor|7|||
27830249|NCT01833065|54303699|FG003|Overall Study|Trial terminated by sponsor|3|||
27830250|NCT01833065|54303700|FG004|Overall Study|Trial terminated by sponsor|13|||
27830251|NCT01833065|54303696|FG000|Overall Study|Others|2|||
27830252|NCT01833065|54303697|FG001|Overall Study|Others|1|||
27830253|NCT01833065|54303698|FG002|Overall Study|Others|1|||
27830254|NCT01833065|54303699|FG003|Overall Study|Others|1|||
27830255|NCT01833065|54303700|FG004|Overall Study|Others|4|||
28076852|NCT00111800|54731653|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
28076853|NCT00111800|54731648|FG000|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
28076854|NCT00111800|54731649|FG001|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
27943360|NCT01147458|54600291|FG001|First Intervention|Other|2|||
27943361|NCT01147458|54600292|FG002|First Intervention|Other|0|||
27943362|NCT01147458|54600293|FG003|First Intervention|Other|0|||
27943363|NCT01147458|54600290|FG000|Second Intervention|Study terminated by sponsor|7|||
27943364|NCT01147458|54600291|FG001|Second Intervention|Study terminated by sponsor|5|||
27943365|NCT01147458|54600292|FG002|Second Intervention|Study terminated by sponsor|5|||
27943366|NCT01147458|54600293|FG003|Second Intervention|Study terminated by sponsor|3|||
27943367|NCT01147458|54600290|FG000|Second Intervention|Protocol Violation|0|||
27943368|NCT01147458|54600291|FG001|Second Intervention|Protocol Violation|1|||
27943369|NCT01147458|54600292|FG002|Second Intervention|Protocol Violation|1|||
28076855|NCT00111800|54731650|FG002|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0|||
28076856|NCT00111800|54731651|FG003|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
28076857|NCT00111800|54731652|FG004|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
28076858|NCT00111800|54731653|FG005|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
28076859|NCT00111800|54731648|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
28076860|NCT00111800|54731649|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1|||
28159874|NCT02555878|54829915|FG000|Overall Study|Protocol Violation|1|||
28159875|NCT02555878|54829916|FG001|Overall Study|Protocol Violation|2|||
27830256|NCT01831817|54303714|FG000|Overall Study|Lost to Follow-up|1|||
27830257|NCT01831817|54303715|FG001|Overall Study|Lost to Follow-up|0|||
27830258|NCT01831817|54303716|FG002|Overall Study|Lost to Follow-up|0|||
27830259|NCT01831817|54303717|FG003|Overall Study|Lost to Follow-up|0|||
27830260|NCT01831817|54303714|FG000|Overall Study|Withdrawl of Consent|3|||
27830261|NCT01831817|54303715|FG001|Overall Study|Withdrawl of Consent|0|||
27830262|NCT01831817|54303716|FG002|Overall Study|Withdrawl of Consent|0|||
27830263|NCT01831817|54303717|FG003|Overall Study|Withdrawl of Consent|0|||
27830264|NCT01840943|54303742|FG000|Overall Study|Withdrawal by Subject|5|||
27830265|NCT01840943|54303743|FG001|Overall Study|Withdrawal by Subject|6|||
27830266|NCT01840943|54303742|FG000|Overall Study|Physician Decision|4|||
27830267|NCT01840943|54303743|FG001|Overall Study|Physician Decision|2|||
27830268|NCT01840943|54303742|FG000|Overall Study|Lost to Follow-up|4|||
27830269|NCT01840943|54303743|FG001|Overall Study|Lost to Follow-up|4|||
27830270|NCT01840163|54303751|FG000|First Follow up -Primary Outcome|Lost to Follow-up|19|||
27830271|NCT01840163|54303752|FG001|First Follow up -Primary Outcome|Lost to Follow-up|16|||
27830272|NCT01840163|54303751|FG000|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48|||
27830273|NCT01840163|54303752|FG001|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40|||
27830274|NCT01840163|54303751|FG000|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43|||
27830275|NCT01840163|54303752|FG001|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35|||
27830276|NCT01831427|54303905|FG000|Overall Study|Adverse Event|0|||
27830277|NCT01831427|54303906|FG001|Overall Study|Adverse Event|1|||
27830278|NCT01831427|54303907|FG002|Overall Study|Adverse Event|0|||
27830279|NCT01831427|54303908|FG003|Overall Study|Adverse Event|0|||
27830280|NCT01831427|54303909|FG004|Overall Study|Adverse Event|0|||
27830281|NCT01831427|54303910|FG005|Overall Study|Adverse Event|1|||
27830282|NCT01831427|54303911|FG006|Overall Study|Adverse Event|0|||
27830283|NCT01831427|54303912|FG007|Overall Study|Adverse Event|1|||
27830284|NCT01831427|54303913|FG008|Overall Study|Adverse Event|0|||
27830285|NCT01831427|54303914|FG009|Overall Study|Adverse Event|0|||
27830286|NCT01831427|54303915|FG010|Overall Study|Adverse Event|2|||
27830287|NCT01831427|54303905|FG000|Overall Study|Investigator's Discretion|0|||
27830288|NCT01831427|54303906|FG001|Overall Study|Investigator's Discretion|0|||
27830289|NCT01831427|54303907|FG002|Overall Study|Investigator's Discretion|0|||
27830290|NCT01831427|54303908|FG003|Overall Study|Investigator's Discretion|1|||
27830291|NCT01831427|54303909|FG004|Overall Study|Investigator's Discretion|0|||
27850850|NCT03132636|54349905|FG001|Overall Study|Study ongoing|10|||
27943370|NCT01147458|54600293|FG003|Second Intervention|Protocol Violation|0|||
27830292|NCT01831427|54303910|FG005|Overall Study|Investigator's Discretion|0|||
27830293|NCT01831427|54303911|FG006|Overall Study|Investigator's Discretion|0|||
27830294|NCT01831427|54303912|FG007|Overall Study|Investigator's Discretion|0|||
27830295|NCT01831427|54303913|FG008|Overall Study|Investigator's Discretion|0|||
27830296|NCT01831427|54303914|FG009|Overall Study|Investigator's Discretion|0|||
27830297|NCT01831427|54303915|FG010|Overall Study|Investigator's Discretion|0|||
27830298|NCT01831427|54303905|FG000|Overall Study|Withdrew Consent|0|||
28159876|NCT02555878|54829915|FG000|Overall Study|Physician Decision|12|||
28159877|NCT02555878|54829916|FG001|Overall Study|Physician Decision|13|||
27830299|NCT01831427|54303906|FG001|Overall Study|Withdrew Consent|0|||
27830300|NCT01831427|54303907|FG002|Overall Study|Withdrew Consent|0|||
27850851|NCT03132636|54349904|FG000|Overall Study|Other|1|||
27850852|NCT03132636|54349905|FG001|Overall Study|Other|2|||
27830301|NCT01831427|54303908|FG003|Overall Study|Withdrew Consent|0|||
27830302|NCT01831427|54303909|FG004|Overall Study|Withdrew Consent|0|||
27830303|NCT01831427|54303910|FG005|Overall Study|Withdrew Consent|0|||
27830304|NCT01831427|54303911|FG006|Overall Study|Withdrew Consent|2|||
27830305|NCT01831427|54303912|FG007|Overall Study|Withdrew Consent|0|||
27830306|NCT01831427|54303913|FG008|Overall Study|Withdrew Consent|0|||
27830307|NCT01831427|54303914|FG009|Overall Study|Withdrew Consent|1|||
27830308|NCT01831427|54303915|FG010|Overall Study|Withdrew Consent|1|||
27830309|NCT01830881|54303961|FG000|Overall Study|Changed decision to have an abortion|0|||
27830310|NCT01830881|54303962|FG001|Overall Study|Changed decision to have an abortion|1|||
27830311|NCT01838681|54303998|FG000|Period A|Adverse Event|39|||
27830312|NCT01838681|54303999|FG001|Period A|Adverse Event|0|||
27830313|NCT01838681|54304000|FG002|Period A|Adverse Event|0|||
27830314|NCT01838681|54304001|FG003|Period A|Adverse Event|0|||
27830315|NCT01838681|54303998|FG000|Period A|Lack of Efficacy|21|||
27830316|NCT01838681|54303999|FG001|Period A|Lack of Efficacy|0|||
27830317|NCT01838681|54304000|FG002|Period A|Lack of Efficacy|0|||
27830318|NCT01838681|54304001|FG003|Period A|Lack of Efficacy|0|||
27830319|NCT01838681|54303998|FG000|Period A|Early response|148|||
27830320|NCT01838681|54303999|FG001|Period A|Early response|0|||
27830321|NCT01838681|54304000|FG002|Period A|Early response|0|||
27830322|NCT01838681|54304001|FG003|Period A|Early response|0|||
27830323|NCT01838681|54303998|FG000|Period A|Withdrawal by Subject|70|||
27830324|NCT01838681|54303999|FG001|Period A|Withdrawal by Subject|0|||
27830325|NCT01838681|54304000|FG002|Period A|Withdrawal by Subject|0|||
27830326|NCT01838681|54304001|FG003|Period A|Withdrawal by Subject|0|||
27830327|NCT01838681|54303998|FG000|Period A|Protocol Violation|16|||
27830328|NCT01838681|54303999|FG001|Period A|Protocol Violation|0|||
27830329|NCT01838681|54304000|FG002|Period A|Protocol Violation|0|||
27830330|NCT01838681|54304001|FG003|Period A|Protocol Violation|0|||
27830331|NCT01838681|54303998|FG000|Period A|Non-compliance with IMP|6|||
27830332|NCT01838681|54303999|FG001|Period A|Non-compliance with IMP|0|||
27830333|NCT01838681|54304000|FG002|Period A|Non-compliance with IMP|0|||
27830334|NCT01838681|54304001|FG003|Period A|Non-compliance with IMP|0|||
27830335|NCT01838681|54303998|FG000|Period A|Lost to Follow-up|4|||
27830336|NCT01838681|54303999|FG001|Period A|Lost to Follow-up|0|||
27830337|NCT01838681|54304000|FG002|Period A|Lost to Follow-up|0|||
27830338|NCT01838681|54304001|FG003|Period A|Lost to Follow-up|0|||
27830339|NCT01838681|54303998|FG000|Period A|Withdrawal before treatment|4|||
27830340|NCT01838681|54303999|FG001|Period A|Withdrawal before treatment|0|||
27830341|NCT01838681|54304000|FG002|Period A|Withdrawal before treatment|0|||
27830342|NCT01838681|54304001|FG003|Period A|Withdrawal before treatment|0|||
27830343|NCT01838681|54303998|FG000|Period A|Administrative or other reasons|17|||
27830344|NCT01838681|54303999|FG001|Period A|Administrative or other reasons|0|||
27830345|NCT01838681|54304000|FG002|Period A|Administrative or other reasons|0|||
27830346|NCT01838681|54304001|FG003|Period A|Administrative or other reasons|0|||
27830347|NCT01838681|54303998|FG000|Period B/A+|Adverse Event|0|||
27830348|NCT01838681|54303999|FG001|Period B/A+|Adverse Event|13|||
27830349|NCT01838681|54304000|FG002|Period B/A+|Adverse Event|27|||
27830350|NCT01838681|54304001|FG003|Period B/A+|Adverse Event|16|||
27830351|NCT01838681|54303998|FG000|Period B/A+|Lack of Efficacy|0|||
27830352|NCT01838681|54303999|FG001|Period B/A+|Lack of Efficacy|9|||
27830353|NCT01838681|54304000|FG002|Period B/A+|Lack of Efficacy|11|||
27830354|NCT01838681|54304001|FG003|Period B/A+|Lack of Efficacy|6|||
27830355|NCT01838681|54303998|FG000|Period B/A+|Withdrawal by Subject|0|||
27830356|NCT01838681|54303999|FG001|Period B/A+|Withdrawal by Subject|28|||
27830357|NCT01838681|54304000|FG002|Period B/A+|Withdrawal by Subject|35|||
27830358|NCT01838681|54304001|FG003|Period B/A+|Withdrawal by Subject|47|||
27830359|NCT01838681|54303998|FG000|Period B/A+|Protocol Violation|0|||
27830360|NCT01838681|54303999|FG001|Period B/A+|Protocol Violation|1|||
27830361|NCT01838681|54304000|FG002|Period B/A+|Protocol Violation|4|||
27830362|NCT01838681|54304001|FG003|Period B/A+|Protocol Violation|6|||
27830363|NCT01838681|54303998|FG000|Period B/A+|Non-compliance with IMP|0|||
27830364|NCT01838681|54303999|FG001|Period B/A+|Non-compliance with IMP|2|||
27830365|NCT01838681|54304000|FG002|Period B/A+|Non-compliance with IMP|3|||
27830366|NCT01838681|54304001|FG003|Period B/A+|Non-compliance with IMP|3|||
27830367|NCT01838681|54303998|FG000|Period B/A+|Lost to Follow-up|0|||
27830368|NCT01838681|54303999|FG001|Period B/A+|Lost to Follow-up|2|||
27830369|NCT01838681|54304000|FG002|Period B/A+|Lost to Follow-up|5|||
27830370|NCT01838681|54304001|FG003|Period B/A+|Lost to Follow-up|11|||
27830371|NCT01838681|54303998|FG000|Period B/A+|Withdrawal before treatment|0|||
27830372|NCT01838681|54303999|FG001|Period B/A+|Withdrawal before treatment|1|||
27830373|NCT01838681|54304000|FG002|Period B/A+|Withdrawal before treatment|0|||
27850853|NCT02906202|54349911|FG000|Overall Study|Discontinued after mobilization due to pregnancy|1|||
28159878|NCT02555878|54829915|FG000|Overall Study|Other|17|||
27830374|NCT01838681|54304001|FG003|Period B/A+|Withdrawal before treatment|0|||
27830375|NCT01838681|54303998|FG000|Period B/A+|Administrative or other reasons|0|||
27830376|NCT01838681|54303999|FG001|Period B/A+|Administrative or other reasons|6|||
27830377|NCT01838681|54304000|FG002|Period B/A+|Administrative or other reasons|10|||
27830378|NCT01838681|54304001|FG003|Period B/A+|Administrative or other reasons|28|||
27830379|NCT01611857|54304059|FG000|Overall Study|Withdrawal by Subject|0|||
27830380|NCT01611857|54304060|FG001|Overall Study|Withdrawal by Subject|2|||
27830381|NCT01829477|54304083|FG000|Overall Study|Study Terminated by Sponsor|15|||
27830382|NCT01829477|54304084|FG001|Overall Study|Study Terminated by Sponsor|15|||
27830383|NCT01829477|54304083|FG000|Overall Study|Withdrawal by Subject|1|||
27830384|NCT01829477|54304084|FG001|Overall Study|Withdrawal by Subject|0|||
27830385|NCT01611155|54304100|FG000|Overall Study|Adverse Event|1|||
27830386|NCT01611155|54304101|FG001|Overall Study|Adverse Event|1|||
27830387|NCT01611155|54304100|FG000|Overall Study|Refused further treatment|6|||
27830388|NCT01611155|54304101|FG001|Overall Study|Refused further treatment|4|||
27830389|NCT01611155|54304100|FG000|Overall Study|Disease progression|1|||
27830390|NCT01611155|54304101|FG001|Overall Study|Disease progression|0|||
27830391|NCT01611155|54304100|FG000|Overall Study|Withdrawal by Subject|1|||
27830392|NCT01611155|54304101|FG001|Overall Study|Withdrawal by Subject|0|||
27830393|NCT01611155|54304100|FG000|Overall Study|Alternative treatment|0|||
27830394|NCT01611155|54304101|FG001|Overall Study|Alternative treatment|1|||
27830395|NCT01611155|54304100|FG000|Overall Study|Ineligible patient|0|||
27830396|NCT01611155|54304101|FG001|Overall Study|Ineligible patient|1|||
27830397|NCT01829243|54304116|FG000|First Intervention|Screen Failure|4|||
27830398|NCT01829243|54304117|FG001|First Intervention|Screen Failure|2|||
27830399|NCT01838447|54304127|FG000|Overall Study|Change in surgical plan|1|||
27830400|NCT01838447|54304128|FG001|Overall Study|Change in surgical plan|2|||
27830401|NCT01838447|54304127|FG000|Overall Study|Withdrawal by Subject|1|||
27830402|NCT01838447|54304128|FG001|Overall Study|Withdrawal by Subject|1|||
27830403|NCT01829165|54304136|FG000|Overall Study|Did not complete intervention|2|||
27830404|NCT01829165|54304137|FG001|Overall Study|Did not complete intervention|0|||
27830405|NCT01838213|54304145|FG000|Overall Study|Ineligible|166|||
27830406|NCT01838213|54304146|FG001|Overall Study|Ineligible|191|||
27830407|NCT01837823|54304152|FG000|Overall Study|Lost to Follow-up|6|||
27830408|NCT01828073|54304162|FG000|Overall Study|Lost to Follow-up|1|||
27830409|NCT01828073|54304163|FG001|Overall Study|Lost to Follow-up|2|||
27830410|NCT03819114|54304183|FG000|Overall Study|Protocol Violation|0|||
27830411|NCT03819114|54304184|FG001|Overall Study|Protocol Violation|1|||
27830412|NCT03819114|54304185|FG002|Overall Study|Protocol Violation|1|||
27830413|NCT03819114|54304186|FG003|Overall Study|Protocol Violation|0|||
27830414|NCT03819114|54304183|FG000|Overall Study|Lost to Follow-up|0|||
27830415|NCT03819114|54304184|FG001|Overall Study|Lost to Follow-up|0|||
27830416|NCT03819114|54304185|FG002|Overall Study|Lost to Follow-up|1|||
27830417|NCT03819114|54304186|FG003|Overall Study|Lost to Follow-up|0|||
27830418|NCT01827839|54304198|FG000|Overall Study|Adverse Event|1|||
27830419|NCT01827839|54304198|FG000|Overall Study|Consent Withdrawal|2|||
27830420|NCT01827371|54304213|FG000|Overall Study|Adverse Event|0|||
27830421|NCT01827371|54304214|FG001|Overall Study|Adverse Event|0|||
27830422|NCT01827371|54304215|FG002|Overall Study|Adverse Event|4|||
27830423|NCT01827371|54304216|FG003|Overall Study|Adverse Event|2|||
27830424|NCT01827371|54304213|FG000|Overall Study|Lost to Follow-up|0|||
27830425|NCT01827371|54304214|FG001|Overall Study|Lost to Follow-up|2|||
27830426|NCT01827371|54304215|FG002|Overall Study|Lost to Follow-up|0|||
27830427|NCT01827371|54304216|FG003|Overall Study|Lost to Follow-up|4|||
27830428|NCT01827371|54304213|FG000|Overall Study|Protocol Violation|1|||
27830429|NCT01827371|54304214|FG001|Overall Study|Protocol Violation|0|||
27830430|NCT01827371|54304215|FG002|Overall Study|Protocol Violation|0|||
27830431|NCT01827371|54304216|FG003|Overall Study|Protocol Violation|0|||
27830432|NCT01827371|54304213|FG000|Overall Study|Withdrawal by Subject|1|||
27830433|NCT01827371|54304214|FG001|Overall Study|Withdrawal by Subject|2|||
27830434|NCT01827371|54304215|FG002|Overall Study|Withdrawal by Subject|2|||
27830435|NCT01827371|54304216|FG003|Overall Study|Withdrawal by Subject|3|||
27830436|NCT01827371|54304213|FG000|Overall Study|Physician Decision|0|||
27830437|NCT01827371|54304214|FG001|Overall Study|Physician Decision|1|||
27830438|NCT01827371|54304215|FG002|Overall Study|Physician Decision|0|||
27830439|NCT01827371|54304216|FG003|Overall Study|Physician Decision|1|||
27830440|NCT01827371|54304213|FG000|Overall Study|Temporary study halt to vaccinations|11|||
27830441|NCT01827371|54304214|FG001|Overall Study|Temporary study halt to vaccinations|2|||
27830442|NCT01827371|54304215|FG002|Overall Study|Temporary study halt to vaccinations|5|||
27830443|NCT01827371|54304216|FG003|Overall Study|Temporary study halt to vaccinations|13|||
27830444|NCT04409262|54304395|FG000|Overall Study|Adverse Event|0|||
27830445|NCT04409262|54304396|FG001|Overall Study|Adverse Event|2|||
27830446|NCT04409262|54304395|FG000|Overall Study|Death|55|||
27830447|NCT04409262|54304396|FG001|Overall Study|Death|97|||
27830448|NCT04409262|54304395|FG000|Overall Study|Lost to Follow-up|12|||
27830449|NCT04409262|54304396|FG001|Overall Study|Lost to Follow-up|23|||
27830450|NCT04409262|54304395|FG000|Overall Study|Lack of Staff|0|||
27830451|NCT04409262|54304396|FG001|Overall Study|Lack of Staff|1|||
27830452|NCT04409262|54304395|FG000|Overall Study|Protocol Violation|3|||
27830453|NCT04409262|54304396|FG001|Overall Study|Protocol Violation|1|||
27830454|NCT04409262|54304395|FG000|Overall Study|Withdrawal by Subject|5|||
27830455|NCT04409262|54304396|FG001|Overall Study|Withdrawal by Subject|10|||
27830456|NCT04305912|54304440|FG000|First Intervention|COVID-19 Suspension|2|||
27830457|NCT04305912|54304441|FG001|First Intervention|COVID-19 Suspension|0|||
27830458|NCT04305912|54304440|FG000|First Intervention|Withdrawal by Subject|0|||
27830459|NCT04305912|54304441|FG001|First Intervention|Withdrawal by Subject|1|||
27830460|NCT04305912|54304440|FG000|Second Intervention|Adverse Event|0|||
27830461|NCT04305912|54304441|FG001|Second Intervention|Adverse Event|1|||
27830462|NCT00782184|54304670|FG000|Overall Study|Adverse Event|1|||
27830463|NCT00782184|54304671|FG001|Overall Study|Adverse Event|2|||
27830464|NCT00782184|54304670|FG000|Overall Study|Protocol Violation|0|||
27830465|NCT00782184|54304671|FG001|Overall Study|Protocol Violation|1|||
27830466|NCT00782184|54304670|FG000|Overall Study|Withdrawal by Subject|3|||
27830467|NCT00782184|54304671|FG001|Overall Study|Withdrawal by Subject|2|||
27830468|NCT02731638|54304707|FG000|Overall Study|Lost to Follow-up|6|||
27830469|NCT02731638|54304708|FG001|Overall Study|Lost to Follow-up|9|||
27830470|NCT03730662|54305155|FG000|Treatment Period (52 Weeks)|Adverse Event|3|||
27830471|NCT03730662|54305156|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
27830472|NCT03730662|54305157|FG002|Treatment Period (52 Weeks)|Adverse Event|0|||
27830473|NCT03730662|54305158|FG003|Treatment Period (52 Weeks)|Adverse Event|3|||
27830474|NCT03730662|54305155|FG000|Treatment Period (52 Weeks)|Screen Failure|0|||
27830475|NCT03730662|54305156|FG001|Treatment Period (52 Weeks)|Screen Failure|1|||
27830476|NCT03730662|54305157|FG002|Treatment Period (52 Weeks)|Screen Failure|0|||
27830477|NCT03730662|54305158|FG003|Treatment Period (52 Weeks)|Screen Failure|0|||
27830478|NCT03730662|54305155|FG000|Treatment Period (52 Weeks)|Death|6|||
27830479|NCT03730662|54305156|FG001|Treatment Period (52 Weeks)|Death|2|||
27830480|NCT03730662|54305157|FG002|Treatment Period (52 Weeks)|Death|2|||
27830481|NCT03730662|54305158|FG003|Treatment Period (52 Weeks)|Death|9|||
27830482|NCT03730662|54305155|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|4|||
27830483|NCT03730662|54305156|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
27830484|NCT03730662|54305157|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
27830485|NCT03730662|54305158|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|11|||
27830486|NCT03730662|54305155|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
27830487|NCT03730662|54305156|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
27830488|NCT03730662|54305157|FG002|Treatment Period (52 Weeks)|Physician Decision|0|||
27830489|NCT03730662|54305158|FG003|Treatment Period (52 Weeks)|Physician Decision|3|||
27830490|NCT03730662|54305155|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
27830491|NCT03730662|54305156|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
27830492|NCT03730662|54305157|FG002|Treatment Period (52 Weeks)|Protocol Violation|0|||
27830493|NCT03730662|54305158|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
27830494|NCT03730662|54305155|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
27830495|NCT03730662|54305156|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
27830496|NCT03730662|54305157|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
27830497|NCT03730662|54305158|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|23|||
27830498|NCT03730662|54305155|FG000|Treatment Period (52 Weeks)|Personal Reason|2|||
27830499|NCT03730662|54305156|FG001|Treatment Period (52 Weeks)|Personal Reason|2|||
27830500|NCT03730662|54305157|FG002|Treatment Period (52 Weeks)|Personal Reason|0|||
27830501|NCT03730662|54305158|FG003|Treatment Period (52 Weeks)|Personal Reason|2|||
27830502|NCT03730662|54305155|FG000|Variable Treatment Period|Adverse Event|1|||
27830503|NCT03730662|54305156|FG001|Variable Treatment Period|Adverse Event|2|||
27830504|NCT03730662|54305157|FG002|Variable Treatment Period|Adverse Event|0|||
27830505|NCT03730662|54305158|FG003|Variable Treatment Period|Adverse Event|7|||
27830506|NCT03730662|54305155|FG000|Variable Treatment Period|Death|9|||
27830507|NCT03730662|54305156|FG001|Variable Treatment Period|Death|0|||
27830508|NCT03730662|54305157|FG002|Variable Treatment Period|Death|6|||
27830509|NCT03730662|54305158|FG003|Variable Treatment Period|Death|26|||
27850854|NCT02869789|54349919|FG000|Overall Study|Disease progression|184|||
27850855|NCT02869789|54349920|FG001|Overall Study|Disease progression|109|||
27850856|NCT02869789|54349921|FG002|Overall Study|Disease progression|260|||
27850857|NCT02869789|54349922|FG003|Overall Study|Disease progression|19|||
27850858|NCT02869789|54349919|FG000|Overall Study|Study drug toxicity|90|||
27850859|NCT02869789|54349920|FG001|Overall Study|Study drug toxicity|32|||
27850860|NCT02869789|54349921|FG002|Overall Study|Study drug toxicity|55|||
27850861|NCT02869789|54349922|FG003|Overall Study|Study drug toxicity|14|||
27850862|NCT02869789|54349919|FG000|Overall Study|Death|7|||
28159879|NCT02555878|54829916|FG001|Overall Study|Other|17|||
27830510|NCT03730662|54305155|FG000|Variable Treatment Period|Lost to Follow-up|2|||
27830511|NCT03730662|54305156|FG001|Variable Treatment Period|Lost to Follow-up|1|||
27830512|NCT03730662|54305157|FG002|Variable Treatment Period|Lost to Follow-up|4|||
27830513|NCT03730662|54305158|FG003|Variable Treatment Period|Lost to Follow-up|11|||
27830514|NCT03730662|54305155|FG000|Variable Treatment Period|Personal Reason|0|||
28159880|NCT02555722|54829924|FG000|Week 2|Adverse Event|0|||
28159881|NCT02555722|54829925|FG001|Week 2|Adverse Event|1|||
27830515|NCT03730662|54305156|FG001|Variable Treatment Period|Personal Reason|2|||
27830516|NCT03730662|54305157|FG002|Variable Treatment Period|Personal Reason|1|||
27850863|NCT02869789|54349920|FG001|Overall Study|Death|3|||
27850864|NCT02869789|54349921|FG002|Overall Study|Death|5|||
27850865|NCT02869789|54349922|FG003|Overall Study|Death|1|||
28159882|NCT02555722|54829924|FG000|Week 2|Withdrawal by Subject|1|||
27830517|NCT03730662|54305158|FG003|Variable Treatment Period|Personal Reason|6|||
27830518|NCT03730662|54305155|FG000|Variable Treatment Period|Physician Decision|0|||
27830519|NCT03730662|54305156|FG001|Variable Treatment Period|Physician Decision|0|||
27830520|NCT03730662|54305157|FG002|Variable Treatment Period|Physician Decision|0|||
27830521|NCT03730662|54305158|FG003|Variable Treatment Period|Physician Decision|3|||
27830522|NCT03730662|54305155|FG000|Variable Treatment Period|Protocol Violation|0|||
27830523|NCT03730662|54305156|FG001|Variable Treatment Period|Protocol Violation|1|||
27830524|NCT03730662|54305157|FG002|Variable Treatment Period|Protocol Violation|1|||
27830525|NCT03730662|54305158|FG003|Variable Treatment Period|Protocol Violation|1|||
27830526|NCT03730662|54305155|FG000|Variable Treatment Period|Withdrawal by Subject|2|||
27830527|NCT03730662|54305156|FG001|Variable Treatment Period|Withdrawal by Subject|1|||
27830528|NCT03730662|54305157|FG002|Variable Treatment Period|Withdrawal by Subject|4|||
27830529|NCT03730662|54305158|FG003|Variable Treatment Period|Withdrawal by Subject|17|||
27830530|NCT03185832|54305264|FG000|Overall Study|Death|9|||
27830531|NCT03185832|54305265|FG001|Overall Study|Death|14|||
27830532|NCT03185832|54305266|FG002|Overall Study|Death|9|||
27830533|NCT03185832|54305267|FG003|Overall Study|Death|7|||
27830534|NCT03185832|54305264|FG000|Overall Study|Withdrawn - vital status available|0|||
27830535|NCT03185832|54305265|FG001|Overall Study|Withdrawn - vital status available|1|||
27830536|NCT03185832|54305266|FG002|Overall Study|Withdrawn - vital status available|1|||
27830537|NCT03185832|54305267|FG003|Overall Study|Withdrawn - vital status available|4|||
27830538|NCT04569786|54305319|FG000|Overall Study|Lost to Follow-up|1|||
27830539|NCT04569786|54305320|FG001|Overall Study|Lost to Follow-up|0|||
27830540|NCT04569786|54305321|FG002|Overall Study|Lost to Follow-up|4|||
27830541|NCT04569786|54305322|FG003|Overall Study|Lost to Follow-up|1|||
27830542|NCT04569786|54305323|FG004|Overall Study|Lost to Follow-up|0|||
27830543|NCT04569786|54305319|FG000|Overall Study|Withdrawal by Subject|0|||
27830544|NCT04569786|54305320|FG001|Overall Study|Withdrawal by Subject|0|||
27830545|NCT04569786|54305321|FG002|Overall Study|Withdrawal by Subject|0|||
27830546|NCT04569786|54305322|FG003|Overall Study|Withdrawal by Subject|5|||
27830547|NCT04569786|54305323|FG004|Overall Study|Withdrawal by Subject|1|||
27830548|NCT04569786|54305319|FG000|Overall Study|Physician Decision|0|||
27830549|NCT04569786|54305320|FG001|Overall Study|Physician Decision|0|||
27830550|NCT04569786|54305321|FG002|Overall Study|Physician Decision|0|||
27830551|NCT04569786|54305322|FG003|Overall Study|Physician Decision|1|||
27830552|NCT04569786|54305323|FG004|Overall Study|Physician Decision|0|||
27830553|NCT01826981|54305499|FG000|Overall Study|Lack of Efficacy|0|||
27830554|NCT01826981|54305500|FG001|Overall Study|Lack of Efficacy|1|||
27830555|NCT01826981|54305501|FG002|Overall Study|Lack of Efficacy|0|||
27830556|NCT01826981|54305502|FG003|Overall Study|Lack of Efficacy|0|||
27830557|NCT01826981|54305503|FG004|Overall Study|Lack of Efficacy|5|||
27830558|NCT01826981|54305504|FG005|Overall Study|Lack of Efficacy|0|||
27830559|NCT01826981|54305505|FG006|Overall Study|Lack of Efficacy|0|||
27830560|NCT01826981|54305506|FG007|Overall Study|Lack of Efficacy|8|||
27830561|NCT01826981|54305507|FG008|Overall Study|Lack of Efficacy|7|||
27830562|NCT01826981|54305508|FG009|Overall Study|Lack of Efficacy|0|||
27830563|NCT01826981|54305509|FG010|Overall Study|Lack of Efficacy|1|||
27830564|NCT01826981|54305510|FG011|Overall Study|Lack of Efficacy|0|||
27830565|NCT01826981|54305511|FG012|Overall Study|Lack of Efficacy|0|||
27830566|NCT01826981|54305512|FG013|Overall Study|Lack of Efficacy|3|||
27830567|NCT01826981|54305513|FG014|Overall Study|Lack of Efficacy|0|||
27830568|NCT01826981|54305499|FG000|Overall Study|Lost to Follow-up|0|||
27830569|NCT01826981|54305500|FG001|Overall Study|Lost to Follow-up|0|||
27830570|NCT01826981|54305501|FG002|Overall Study|Lost to Follow-up|0|||
27830571|NCT01826981|54305502|FG003|Overall Study|Lost to Follow-up|0|||
27830572|NCT01826981|54305503|FG004|Overall Study|Lost to Follow-up|1|||
27830573|NCT01826981|54305504|FG005|Overall Study|Lost to Follow-up|1|||
27830574|NCT01826981|54305505|FG006|Overall Study|Lost to Follow-up|0|||
27830575|NCT01826981|54305506|FG007|Overall Study|Lost to Follow-up|1|||
27830576|NCT01826981|54305507|FG008|Overall Study|Lost to Follow-up|0|||
27830577|NCT01826981|54305508|FG009|Overall Study|Lost to Follow-up|1|||
27830578|NCT01826981|54305509|FG010|Overall Study|Lost to Follow-up|1|||
27830579|NCT01826981|54305510|FG011|Overall Study|Lost to Follow-up|1|||
27830580|NCT01826981|54305511|FG012|Overall Study|Lost to Follow-up|1|||
27830581|NCT01826981|54305512|FG013|Overall Study|Lost to Follow-up|0|||
27830582|NCT01826981|54305513|FG014|Overall Study|Lost to Follow-up|0|||
27830583|NCT01826981|54305499|FG000|Overall Study|Withdrew Consent|0|||
27830584|NCT01826981|54305500|FG001|Overall Study|Withdrew Consent|0|||
27830585|NCT01826981|54305501|FG002|Overall Study|Withdrew Consent|0|||
27830586|NCT01826981|54305502|FG003|Overall Study|Withdrew Consent|0|||
27830587|NCT01826981|54305503|FG004|Overall Study|Withdrew Consent|0|||
27830588|NCT01826981|54305504|FG005|Overall Study|Withdrew Consent|0|||
27830589|NCT01826981|54305505|FG006|Overall Study|Withdrew Consent|1|||
27830590|NCT01826981|54305506|FG007|Overall Study|Withdrew Consent|1|||
27830591|NCT01826981|54305507|FG008|Overall Study|Withdrew Consent|0|||
27830592|NCT01826981|54305508|FG009|Overall Study|Withdrew Consent|0|||
27830593|NCT01826981|54305509|FG010|Overall Study|Withdrew Consent|0|||
27830594|NCT01826981|54305510|FG011|Overall Study|Withdrew Consent|1|||
27830595|NCT01826981|54305511|FG012|Overall Study|Withdrew Consent|0|||
27830596|NCT01826981|54305512|FG013|Overall Study|Withdrew Consent|1|||
27830597|NCT01826981|54305513|FG014|Overall Study|Withdrew Consent|0|||
28159883|NCT02555722|54829925|FG001|Week 2|Withdrawal by Subject|0|||
28159884|NCT02555722|54829924|FG000|Month 1|Lens Discomfort|1|||
28159885|NCT02555722|54829925|FG001|Month 1|Lens Discomfort|0|||
28159886|NCT02555722|54829924|FG000|Month 2|Withdrawal by Subject|3|||
28159887|NCT02555722|54829925|FG001|Month 2|Withdrawal by Subject|0|||
28159888|NCT02555722|54829924|FG000|Month 2|Lost to Follow-up|1|||
28159889|NCT02555722|54829925|FG001|Month 2|Lost to Follow-up|0|||
28159890|NCT03287960|54829977|FG000|Open-Label Period (10 Weeks)|Adverse Event|1|||
27830598|NCT01826981|54305499|FG000|Overall Study|Adverse Event|0|||
27830599|NCT01826981|54305500|FG001|Overall Study|Adverse Event|0|||
27830600|NCT01826981|54305501|FG002|Overall Study|Adverse Event|0|||
27830601|NCT01826981|54305502|FG003|Overall Study|Adverse Event|0|||
27830602|NCT01826981|54305503|FG004|Overall Study|Adverse Event|1|||
27830603|NCT01826981|54305504|FG005|Overall Study|Adverse Event|0|||
27830604|NCT01826981|54305505|FG006|Overall Study|Adverse Event|0|||
27830605|NCT01826981|54305506|FG007|Overall Study|Adverse Event|0|||
27830606|NCT01826981|54305507|FG008|Overall Study|Adverse Event|0|||
27830607|NCT01826981|54305508|FG009|Overall Study|Adverse Event|0|||
27830608|NCT01826981|54305509|FG010|Overall Study|Adverse Event|0|||
27830609|NCT01826981|54305510|FG011|Overall Study|Adverse Event|0|||
27830610|NCT01826981|54305511|FG012|Overall Study|Adverse Event|0|||
27830611|NCT01826981|54305512|FG013|Overall Study|Adverse Event|0|||
27830612|NCT01826981|54305513|FG014|Overall Study|Adverse Event|0|||
27830613|NCT01826981|54305499|FG000|Overall Study|Upper G-I Haemorrhage|0|||
27830614|NCT01826981|54305500|FG001|Overall Study|Upper G-I Haemorrhage|0|||
27830615|NCT01826981|54305501|FG002|Overall Study|Upper G-I Haemorrhage|0|||
27830616|NCT01826981|54305502|FG003|Overall Study|Upper G-I Haemorrhage|0|||
27830617|NCT01826981|54305503|FG004|Overall Study|Upper G-I Haemorrhage|0|||
27830618|NCT01826981|54305504|FG005|Overall Study|Upper G-I Haemorrhage|0|||
27830619|NCT01826981|54305505|FG006|Overall Study|Upper G-I Haemorrhage|0|||
27830620|NCT01826981|54305506|FG007|Overall Study|Upper G-I Haemorrhage|0|||
27830621|NCT01826981|54305507|FG008|Overall Study|Upper G-I Haemorrhage|0|||
27830622|NCT01826981|54305508|FG009|Overall Study|Upper G-I Haemorrhage|0|||
27830623|NCT01826981|54305509|FG010|Overall Study|Upper G-I Haemorrhage|0|||
27830624|NCT01826981|54305510|FG011|Overall Study|Upper G-I Haemorrhage|0|||
27830625|NCT01826981|54305511|FG012|Overall Study|Upper G-I Haemorrhage|0|||
27830626|NCT01826981|54305512|FG013|Overall Study|Upper G-I Haemorrhage|1|||
27830627|NCT01826981|54305513|FG014|Overall Study|Upper G-I Haemorrhage|0|||
27830628|NCT01826981|54305499|FG000|Overall Study|Enrolled/Randomized but Not Treated|0|||
27830629|NCT01826981|54305500|FG001|Overall Study|Enrolled/Randomized but Not Treated|0|||
27830630|NCT01826981|54305501|FG002|Overall Study|Enrolled/Randomized but Not Treated|0|||
27830631|NCT01826981|54305502|FG003|Overall Study|Enrolled/Randomized but Not Treated|0|||
27830632|NCT01826981|54305503|FG004|Overall Study|Enrolled/Randomized but Not Treated|0|||
27830633|NCT01826981|54305504|FG005|Overall Study|Enrolled/Randomized but Not Treated|0|||
27830634|NCT01826981|54305505|FG006|Overall Study|Enrolled/Randomized but Not Treated|0|||
27830635|NCT01826981|54305506|FG007|Overall Study|Enrolled/Randomized but Not Treated|1|||
27830636|NCT01826981|54305507|FG008|Overall Study|Enrolled/Randomized but Not Treated|0|||
27943371|NCT01147458|54600290|FG000|Second Intervention|Withdrawal by Subject|0|||
27943372|NCT01147458|54600291|FG001|Second Intervention|Withdrawal by Subject|1|||
28159891|NCT03287960|54829977|FG000|Open-Label Period (32 Weeks)|Serious Adverse Event|1|||
28159892|NCT02558296|54829984|FG000|Completed the Study Through Week 24|Adverse Event|9|||
28159893|NCT02558296|54829985|FG001|Completed the Study Through Week 24|Adverse Event|3|||
28159894|NCT02558296|54829984|FG000|Completed the Study Through Week 24|Death|7|||
28159895|NCT02558296|54829985|FG001|Completed the Study Through Week 24|Death|7|||
28159896|NCT02558296|54829984|FG000|Completed the Study Through Week 24|Lost to Follow-up|8|||
28159897|NCT02558296|54829985|FG001|Completed the Study Through Week 24|Lost to Follow-up|1|||
27830637|NCT01826981|54305508|FG009|Overall Study|Enrolled/Randomized but Not Treated|0|||
28159898|NCT02558296|54829984|FG000|Completed the Study Through Week 24|Physician Decision|1|||
27830638|NCT01826981|54305509|FG010|Overall Study|Enrolled/Randomized but Not Treated|0|||
27830639|NCT01826981|54305510|FG011|Overall Study|Enrolled/Randomized but Not Treated|0|||
27830640|NCT01826981|54305511|FG012|Overall Study|Enrolled/Randomized but Not Treated|0|||
27830641|NCT01826981|54305512|FG013|Overall Study|Enrolled/Randomized but Not Treated|0|||
27830642|NCT01826981|54305513|FG014|Overall Study|Enrolled/Randomized but Not Treated|0|||
27830643|NCT01804049|54305585|FG000|Overall Study|Adverse Event|2|||
27830644|NCT01804049|54305586|FG001|Overall Study|Adverse Event|10|||
27830645|NCT01804049|54305585|FG000|Overall Study|Lost to Follow-up|2|||
27830646|NCT01804049|54305586|FG001|Overall Study|Lost to Follow-up|1|||
27830647|NCT01804049|54305585|FG000|Overall Study|Decreased interest/personal|4|||
27830648|NCT01804049|54305586|FG001|Overall Study|Decreased interest/personal|5|||
27830649|NCT01804049|54305585|FG000|Overall Study|Other health concerns|2|||
27830650|NCT01804049|54305586|FG001|Overall Study|Other health concerns|7|||
27830651|NCT01804049|54305585|FG000|Overall Study|Moved out of area|0|||
27830652|NCT01804049|54305586|FG001|Overall Study|Moved out of area|7|||
27830653|NCT01804049|54305585|FG000|Overall Study|other MD recommended|1|||
27830654|NCT01804049|54305586|FG001|Overall Study|other MD recommended|1|||
27830655|NCT01804049|54305585|FG000|Overall Study|Enrollment in dual studies|0|||
27830656|NCT01804049|54305586|FG001|Overall Study|Enrollment in dual studies|1|||
27830657|NCT01826825|54305596|FG000|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|0|||
27830658|NCT01826825|54305597|FG001|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|2|||
27830659|NCT01803737|54305607|FG000|Overall Study|Lack of Time|1|||
27830660|NCT01803737|54305608|FG001|Overall Study|Lack of Time|0|||
27830661|NCT01803737|54305607|FG000|Overall Study|Medical Reason|0|||
27830662|NCT01803737|54305608|FG001|Overall Study|Medical Reason|1|||
27830663|NCT01803737|54305607|FG000|Overall Study|Lost to Follow-up|0|||
27830664|NCT01803737|54305608|FG001|Overall Study|Lost to Follow-up|2|||
27830665|NCT01826201|54305614|FG000|Overall Study|Non compliance with protocol|4|||
27830666|NCT01803269|54305645|FG000|Overall Study|Withdrawal by Subject|3|||
27830667|NCT01803269|54305646|FG001|Overall Study|Withdrawal by Subject|0|||
27830668|NCT01803269|54305647|FG002|Overall Study|Withdrawal by Subject|0|||
27830669|NCT01802879|54305655|FG000|Overall Study|Administrative problems|2|||
27830670|NCT01802879|54305655|FG000|Overall Study|Disease progression|6|||
27830671|NCT01825577|54305659|FG000|Overall Study|Physician Decision|2|||
28076861|NCT00111800|54731650|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
28076862|NCT00111800|54731651|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
28076863|NCT00111800|54731652|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
28076864|NCT00111800|54731653|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
28076865|NCT00111800|54731648|FG000|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
27830672|NCT01825577|54305659|FG000|Overall Study|Withdrawal by Subject|1|||
27830673|NCT01825577|54305659|FG000|Overall Study|Withdrawn by family members|2|||
27830674|NCT01825577|54305659|FG000|Overall Study|Lack of Efficacy|3|||
27830675|NCT01802411|54305665|FG000|Overall Study|Death|2|||
27830676|NCT01802411|54305666|FG001|Overall Study|Death|1|||
27830677|NCT01802411|54305665|FG000|Overall Study|Adverse Event|2|||
27830678|NCT01802411|54305666|FG001|Overall Study|Adverse Event|7|||
27830679|NCT01802411|54305665|FG000|Overall Study|Lack of Efficacy|8|||
27830680|NCT01802411|54305666|FG001|Overall Study|Lack of Efficacy|10|||
27830681|NCT01802411|54305665|FG000|Overall Study|Withdrawal by Subject|0|||
27830682|NCT01802411|54305666|FG001|Overall Study|Withdrawal by Subject|2|||
27830683|NCT01802411|54305665|FG000|Overall Study|Planned pleurodesis as part of the proc|1|||
27830684|NCT01802411|54305666|FG001|Overall Study|Planned pleurodesis as part of the proc|0|||
27830685|NCT01802411|54305665|FG000|Overall Study|Surgery aborted after bronchoscopy|1|||
27830686|NCT01802411|54305666|FG001|Overall Study|Surgery aborted after bronchoscopy|0|||
27830687|NCT01802411|54305665|FG000|Overall Study|Proc changed to video-asst thorascopic|0|||
27830688|NCT01802411|54305666|FG001|Overall Study|Proc changed to video-asst thorascopic|1|||
27830689|NCT02963610|54305707|FG000|Overall Study|Study terminated prematurely due to funding/support being withdrawn by grantor. No analyses occurred|3|||
27830690|NCT02606136|54305789|FG000|Overall Study|Participant/Legal Guardian Decision|5|||
27830691|NCT02606136|54305789|FG000|Overall Study|Withdrawal by Subject|1|||
27830692|NCT01802333|54305932|FG000|Overall Study|Ineligible|2|||
27830693|NCT01802333|54305933|FG001|Overall Study|Ineligible|6|||
27830694|NCT01802333|54305934|FG002|Overall Study|Ineligible|8|||
27830695|NCT01802333|54305932|FG000|Overall Study|Adverse Event|1|||
27830696|NCT01802333|54305933|FG001|Overall Study|Adverse Event|8|||
27830697|NCT01802333|54305934|FG002|Overall Study|Adverse Event|8|||
27830698|NCT01802333|54305932|FG000|Overall Study|Withdrawal by Subject|6|||
27830699|NCT01802333|54305933|FG001|Overall Study|Withdrawal by Subject|6|||
27830700|NCT01802333|54305934|FG002|Overall Study|Withdrawal by Subject|5|||
27830701|NCT01802333|54305932|FG000|Overall Study|Progression/relapse|1|||
27830702|NCT01802333|54305933|FG001|Overall Study|Progression/relapse|3|||
27830703|NCT01802333|54305934|FG002|Overall Study|Progression/relapse|0|||
27830704|NCT01802333|54305932|FG000|Overall Study|Death|7|||
27830705|NCT01802333|54305933|FG001|Overall Study|Death|14|||
27830706|NCT01802333|54305934|FG002|Overall Study|Death|13|||
27830707|NCT01802333|54305932|FG000|Overall Study|Other - not protocol specified|32|||
27830708|NCT01802333|54305933|FG001|Overall Study|Other - not protocol specified|22|||
27830709|NCT01802333|54305934|FG002|Overall Study|Other - not protocol specified|24|||
27830710|NCT01802333|54305932|FG000|Overall Study|Did not start treatment|0|||
27830711|NCT01802333|54305933|FG001|Overall Study|Did not start treatment|2|||
27830712|NCT01802333|54305934|FG002|Overall Study|Did not start treatment|5|||
27830713|NCT00980655|54305979|FG000|Overall Study|Adverse Event|13|||
27830714|NCT00980655|54305980|FG001|Overall Study|Adverse Event|31|||
27830715|NCT00980655|54305979|FG000|Overall Study|Death|0|||
27830716|NCT00980655|54305980|FG001|Overall Study|Death|7|||
27830717|NCT00980655|54305979|FG000|Overall Study|Protocol Violation|2|||
27830718|NCT00980655|54305980|FG001|Overall Study|Protocol Violation|7|||
27830719|NCT00980655|54305979|FG000|Overall Study|Withdrawal by Subject|0|||
27830720|NCT00980655|54305980|FG001|Overall Study|Withdrawal by Subject|4|||
27830721|NCT00980655|54305979|FG000|Overall Study|Lost to Follow-up|0|||
27830722|NCT00980655|54305980|FG001|Overall Study|Lost to Follow-up|1|||
27830723|NCT00980655|54305979|FG000|Overall Study|Parent/legal guardian request|1|||
27830724|NCT00980655|54305980|FG001|Overall Study|Parent/legal guardian request|0|||
27830725|NCT00980655|54305979|FG000|Overall Study|Other|0|||
27830726|NCT00980655|54305980|FG001|Overall Study|Other|1|||
27830727|NCT01801865|54306022|FG000|Overall Study|Patients scanned on another MRI scanner|35|||
27830728|NCT01801865|54306022|FG000|Overall Study|Physician Decision|7|||
27830729|NCT00980343|54306032|FG000|Overall Study|no tumor at surgery - treatment effect|1|||
27830730|NCT00980343|54306033|FG001|Overall Study|no tumor at surgery - treatment effect|3|||
27830731|NCT01801475|54306043|FG000|Overall Study|Withdrawal by Subject|0|||
27830732|NCT01801475|54306044|FG001|Overall Study|Withdrawal by Subject|0|||
27830733|NCT01801475|54306045|FG002|Overall Study|Withdrawal by Subject|0|||
27830734|NCT01801475|54306046|FG003|Overall Study|Withdrawal by Subject|0|||
27830735|NCT01801475|54306047|FG004|Overall Study|Withdrawal by Subject|1|||
27830736|NCT01822925|54306106|FG000|Overall Study|Adverse Event|1|||
27830737|NCT01822925|54306107|FG001|Overall Study|Adverse Event|1|||
27830738|NCT01822925|54306108|FG002|Overall Study|Adverse Event|1|||
27830739|NCT01822925|54306109|FG003|Overall Study|Adverse Event|1|||
27830740|NCT01822925|54306106|FG000|Overall Study|Lost to Follow-up|0|||
27830741|NCT01822925|54306107|FG001|Overall Study|Lost to Follow-up|1|||
27830742|NCT01822925|54306108|FG002|Overall Study|Lost to Follow-up|0|||
27830743|NCT01822925|54306109|FG003|Overall Study|Lost to Follow-up|0|||
27830744|NCT01822925|54306106|FG000|Overall Study|Protocol Violation|1|||
27830745|NCT01822925|54306107|FG001|Overall Study|Protocol Violation|0|||
27830746|NCT01822925|54306108|FG002|Overall Study|Protocol Violation|0|||
27830747|NCT01822925|54306109|FG003|Overall Study|Protocol Violation|1|||
27830748|NCT01822925|54306106|FG000|Overall Study|Withdrawal by Subject|2|||
27830749|NCT01822925|54306107|FG001|Overall Study|Withdrawal by Subject|0|||
27830750|NCT01822925|54306108|FG002|Overall Study|Withdrawal by Subject|2|||
27830751|NCT01822925|54306109|FG003|Overall Study|Withdrawal by Subject|2|||
27830752|NCT01822925|54306106|FG000|Overall Study|Taking prohibited medication|2|||
27830753|NCT01822925|54306107|FG001|Overall Study|Taking prohibited medication|0|||
27830754|NCT01822925|54306108|FG002|Overall Study|Taking prohibited medication|0|||
27830755|NCT01822925|54306109|FG003|Overall Study|Taking prohibited medication|1|||
27830756|NCT01801007|54306142|FG000|Overall Study|Adverse Event|2|||
27830757|NCT01801007|54306142|FG000|Overall Study|Lost to Follow-up|4|||
27830758|NCT01801007|54306142|FG000|Overall Study|Withdrawal by Subject|5|||
27830759|NCT01822691|54306146|FG000|Overall Study|Withdrawal by Subject|2|||
27830760|NCT01822535|54306152|FG000|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2|||
27830761|NCT01822535|54306153|FG001|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0|||
27830762|NCT01822535|54306152|FG000|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4|||
27830763|NCT01822535|54306153|FG001|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2|||
27830764|NCT01822535|54306152|FG000|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1|||
27830765|NCT01822535|54306153|FG001|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0|||
27830766|NCT01799993|54306239|FG000|Overall Study|"Didn't complete CRF page End of FU"|30|||
27830767|NCT01799993|54306240|FG001|Overall Study|"Didn't complete CRF page End of FU"|40|||
27830768|NCT01799993|54306239|FG000|Overall Study|Death|61|||
27830769|NCT01799993|54306240|FG001|Overall Study|Death|45|||
27830770|NCT01799993|54306239|FG000|Overall Study|Withdrawal by Subject|23|||
27830771|NCT01799993|54306240|FG001|Overall Study|Withdrawal by Subject|24|||
27830772|NCT01799993|54306239|FG000|Overall Study|Lost to Follow-up|5|||
27830773|NCT01799993|54306240|FG001|Overall Study|Lost to Follow-up|8|||
27830774|NCT01799993|54306239|FG000|Overall Study|Withdrawal by parent/guardian/LAR|5|||
27830775|NCT01799993|54306240|FG001|Overall Study|Withdrawal by parent/guardian/LAR|3|||
27830776|NCT01799993|54306239|FG000|Overall Study|Protocol driven decision point|0|||
27830777|NCT01799993|54306240|FG001|Overall Study|Protocol driven decision point|3|||
27830778|NCT01799993|54306239|FG000|Overall Study|Protocol Violation|1|||
27830779|NCT01799993|54306240|FG001|Overall Study|Protocol Violation|1|||
27830780|NCT01799993|54306239|FG000|Overall Study|Deterioration of general conditions|2|||
27830781|NCT01799993|54306240|FG001|Overall Study|Deterioration of general conditions|0|||
27830782|NCT01799993|54306239|FG000|Overall Study|Screen failure|0|||
27830783|NCT01799993|54306240|FG001|Overall Study|Screen failure|1|||
27830784|NCT01799993|54306239|FG000|Overall Study|Adverse Event|1|||
27830785|NCT01799993|54306240|FG001|Overall Study|Adverse Event|0|||
27830786|NCT01799993|54306239|FG000|Overall Study|Lack of Efficacy|1|||
27830787|NCT01799993|54306240|FG001|Overall Study|Lack of Efficacy|0|||
27830788|NCT01799993|54306239|FG000|Overall Study|Recovery|0|||
27830789|NCT01799993|54306240|FG001|Overall Study|Recovery|1|||
27830790|NCT01799993|54306239|FG000|Overall Study|Logistical difficulties|1|||
27830791|NCT01799993|54306240|FG001|Overall Study|Logistical difficulties|0|||
27830792|NCT01799993|54306239|FG000|Overall Study|Protocol deviation|1|||
27830793|NCT01799993|54306240|FG001|Overall Study|Protocol deviation|0|||
27830794|NCT01799993|54306239|FG000|Overall Study|Non-compliance with medical device|1|||
27830795|NCT01799993|54306240|FG001|Overall Study|Non-compliance with medical device|0|||
27830796|NCT01799993|54306239|FG000|Overall Study|Withdrawal by parent/guardian|0|||
27830797|NCT01799993|54306240|FG001|Overall Study|Withdrawal by parent/guardian|1|||
27830798|NCT01799993|54306239|FG000|Overall Study|Other|1|||
27830799|NCT01799993|54306240|FG001|Overall Study|Other|0|||
27830800|NCT01799993|54306239|FG000|Overall Study|Subject didn't return for follow-up|0|||
27830801|NCT01799993|54306240|FG001|Overall Study|Subject didn't return for follow-up|1|||
27830802|NCT01822223|54306257|FG000|Overall Study|Death|0|||
27830803|NCT01822223|54306258|FG001|Overall Study|Death|1|||
27830804|NCT02228382|54306344|FG000|Overall Study|Death|5|||
27830805|NCT02228382|54306345|FG001|Overall Study|Death|7|||
27830806|NCT02228382|54306346|FG002|Overall Study|Death|5|||
27830807|NCT02228382|54306347|FG003|Overall Study|Death|0|||
27830808|NCT02228382|54306348|FG004|Overall Study|Death|2|||
27830809|NCT02228382|54306344|FG000|Overall Study|Participant refused further follow-up|0|||
27830810|NCT02228382|54306345|FG001|Overall Study|Participant refused further follow-up|0|||
27830811|NCT02228382|54306346|FG002|Overall Study|Participant refused further follow-up|1|||
27830812|NCT02228382|54306347|FG003|Overall Study|Participant refused further follow-up|0|||
27830813|NCT02228382|54306348|FG004|Overall Study|Participant refused further follow-up|0|||
27830814|NCT02228382|54306344|FG000|Overall Study|Study terminated by sponsor|3|||
27830815|NCT02228382|54306345|FG001|Overall Study|Study terminated by sponsor|5|||
27830816|NCT02228382|54306346|FG002|Overall Study|Study terminated by sponsor|7|||
27830817|NCT02228382|54306347|FG003|Overall Study|Study terminated by sponsor|0|||
27830818|NCT02228382|54306348|FG004|Overall Study|Study terminated by sponsor|0|||
27830819|NCT02228382|54306344|FG000|Overall Study|Lost to Follow-up|0|||
27830820|NCT02228382|54306345|FG001|Overall Study|Lost to Follow-up|0|||
27830821|NCT02228382|54306346|FG002|Overall Study|Lost to Follow-up|3|||
27830822|NCT02228382|54306347|FG003|Overall Study|Lost to Follow-up|1|||
27830823|NCT02228382|54306348|FG004|Overall Study|Lost to Follow-up|0|||
27830824|NCT02228382|54306344|FG000|Overall Study|Withdrawal by Subject|0|||
27830825|NCT02228382|54306345|FG001|Overall Study|Withdrawal by Subject|3|||
27830826|NCT02228382|54306346|FG002|Overall Study|Withdrawal by Subject|2|||
27830827|NCT02228382|54306347|FG003|Overall Study|Withdrawal by Subject|1|||
27830828|NCT02228382|54306348|FG004|Overall Study|Withdrawal by Subject|0|||
27830829|NCT02228382|54306344|FG000|Overall Study|Other|2|||
27830830|NCT02228382|54306345|FG001|Overall Study|Other|3|||
27830831|NCT02228382|54306346|FG002|Overall Study|Other|3|||
27830832|NCT02228382|54306347|FG003|Overall Study|Other|0|||
27830833|NCT02228382|54306348|FG004|Overall Study|Other|0|||
27830834|NCT01900002|54306392|FG000|Overall Study|Withdrawal by Subject|2|||
27830835|NCT01900002|54306392|FG000|Overall Study|ineligible for Y-90|4|||
27830836|NCT01377012|54306422|FG000|Core Study|Study terminated by Sponsor|47|||
27830837|NCT01377012|54306423|FG001|Core Study|Study terminated by Sponsor|54|||
27830838|NCT01377012|54306424|FG002|Core Study|Study terminated by Sponsor|46|||
27830839|NCT01377012|54306422|FG000|Core Study|Technical problems|1|||
27830840|NCT01377012|54306423|FG001|Core Study|Technical problems|0|||
27830841|NCT01377012|54306424|FG002|Core Study|Technical problems|0|||
27830842|NCT01377012|54306422|FG000|Core Study|Withdrawal by Subject|15|||
27830843|NCT01377012|54306423|FG001|Core Study|Withdrawal by Subject|23|||
27830844|NCT01377012|54306424|FG002|Core Study|Withdrawal by Subject|18|||
27830845|NCT01377012|54306422|FG000|Core Study|Protocol Violation|7|||
27830846|NCT01377012|54306423|FG001|Core Study|Protocol Violation|3|||
27830847|NCT01377012|54306424|FG002|Core Study|Protocol Violation|2|||
27830848|NCT01377012|54306422|FG000|Core Study|Pregnancy|0|||
27830849|NCT01377012|54306423|FG001|Core Study|Pregnancy|0|||
27830850|NCT01377012|54306424|FG002|Core Study|Pregnancy|1|||
27830851|NCT01377012|54306422|FG000|Core Study|Physician Decision|5|||
27830852|NCT01377012|54306423|FG001|Core Study|Physician Decision|4|||
27830853|NCT01377012|54306424|FG002|Core Study|Physician Decision|10|||
27830854|NCT01377012|54306422|FG000|Core Study|Non-Compliant with study treatment|0|||
27830855|NCT01377012|54306423|FG001|Core Study|Non-Compliant with study treatment|0|||
27830856|NCT01377012|54306424|FG002|Core Study|Non-Compliant with study treatment|1|||
27830857|NCT01377012|54306422|FG000|Core Study|No Longer require treatment|0|||
27830858|NCT01377012|54306423|FG001|Core Study|No Longer require treatment|0|||
27830859|NCT01377012|54306424|FG002|Core Study|No Longer require treatment|1|||
27830860|NCT01377012|54306422|FG000|Core Study|Lost to Follow-up|7|||
27830861|NCT01377012|54306423|FG001|Core Study|Lost to Follow-up|5|||
27830862|NCT01377012|54306424|FG002|Core Study|Lost to Follow-up|4|||
27830863|NCT01377012|54306422|FG000|Core Study|Lack of Efficacy|41|||
27830864|NCT01377012|54306423|FG001|Core Study|Lack of Efficacy|28|||
27830865|NCT01377012|54306424|FG002|Core Study|Lack of Efficacy|37|||
27830866|NCT01377012|54306422|FG000|Core Study|Death|1|||
27830867|NCT01377012|54306423|FG001|Core Study|Death|1|||
27830868|NCT01377012|54306424|FG002|Core Study|Death|1|||
27830869|NCT01377012|54306422|FG000|Core Study|Adverse Event|10|||
27830870|NCT01377012|54306423|FG001|Core Study|Adverse Event|14|||
27830871|NCT01377012|54306424|FG002|Core Study|Adverse Event|13|||
27830872|NCT01377012|54306422|FG000|Extension Study, Weeks 104-260|Lack of Efficacy|3|||
27830873|NCT01377012|54306423|FG001|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
27830874|NCT01377012|54306424|FG002|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
27830875|NCT01377012|54306422|FG000|Extension Study, Weeks 104-260|Study terminated by sponsor|52|||
27830876|NCT01377012|54306423|FG001|Extension Study, Weeks 104-260|Study terminated by sponsor|69|||
27830877|NCT01377012|54306424|FG002|Extension Study, Weeks 104-260|Study terminated by sponsor|63|||
27830878|NCT01377012|54306422|FG000|Extension Study, Weeks 104-260|Withdrawal by Subject|1|||
27830879|NCT01377012|54306423|FG001|Extension Study, Weeks 104-260|Withdrawal by Subject|0|||
27830880|NCT01377012|54306424|FG002|Extension Study, Weeks 104-260|Withdrawal by Subject|3|||
27830881|NCT01377012|54306422|FG000|Extension Study, Weeks 104-260|Physician Decision|1|||
27830882|NCT01377012|54306423|FG001|Extension Study, Weeks 104-260|Physician Decision|0|||
27830883|NCT01377012|54306424|FG002|Extension Study, Weeks 104-260|Physician Decision|0|||
27830884|NCT01377012|54306422|FG000|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
27830885|NCT01377012|54306423|FG001|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
27830886|NCT01377012|54306424|FG002|Extension Study, Weeks 104-260|Lost to Follow-up|1|||
27830887|NCT01377012|54306422|FG000|Extension Study, Weeks 104-260|Adverse Event|0|||
27830888|NCT01377012|54306423|FG001|Extension Study, Weeks 104-260|Adverse Event|2|||
27830889|NCT01377012|54306424|FG002|Extension Study, Weeks 104-260|Adverse Event|1|||
27830890|NCT01376310|54306673|FG000|Overall Study|Study closed/terminated|1|||
27830891|NCT01376310|54306674|FG001|Overall Study|Study closed/terminated|2|||
27830892|NCT01376310|54306673|FG000|Overall Study|Withdrawal by Subject|8|||
27830893|NCT01376310|54306674|FG001|Overall Study|Withdrawal by Subject|2|||
27830894|NCT01376310|54306673|FG000|Overall Study|Physician Decision|26|||
27830895|NCT01376310|54306674|FG001|Overall Study|Physician Decision|7|||
27830896|NCT01376310|54306673|FG000|Overall Study|Lost to Follow-up|1|||
27830897|NCT01376310|54306674|FG001|Overall Study|Lost to Follow-up|0|||
27830898|NCT01949506|54306680|FG000|Overall Study|Physician Decision|1|||
27830899|NCT00709098|54306777|FG000|Double-blind Period|Withdrawal of consent|3|||
27830900|NCT00709098|54306778|FG001|Double-blind Period|Withdrawal of consent|3|||
27830901|NCT00709098|54306779|FG002|Double-blind Period|Withdrawal of consent|0|||
27830902|NCT00709098|54306777|FG000|Double-blind Period|Administrative reason|1|||
27830903|NCT00709098|54306778|FG001|Double-blind Period|Administrative reason|3|||
27830904|NCT00709098|54306779|FG002|Double-blind Period|Administrative reason|0|||
27830905|NCT00709098|54306777|FG000|Double-blind Period|Death|1|||
27830906|NCT00709098|54306778|FG001|Double-blind Period|Death|1|||
27830907|NCT00709098|54306779|FG002|Double-blind Period|Death|0|||
27830908|NCT00709098|54306777|FG000|Double-blind Period|Lost to Follow-up|1|||
27830909|NCT00709098|54306778|FG001|Double-blind Period|Lost to Follow-up|1|||
27830910|NCT00709098|54306779|FG002|Double-blind Period|Lost to Follow-up|0|||
27830911|NCT00709098|54306777|FG000|Open-label Period|Withdrawal of consent|0|||
27830912|NCT00709098|54306778|FG001|Open-label Period|Withdrawal of consent|0|||
27830913|NCT00709098|54306779|FG002|Open-label Period|Withdrawal of consent|7|||
27830914|NCT00709098|54306777|FG000|Open-label Period|Administrative reason|0|||
27830915|NCT00709098|54306778|FG001|Open-label Period|Administrative reason|0|||
27850866|NCT02869789|54349919|FG000|Overall Study|Adverse Event unrelated to study drug|30|||
27850867|NCT02869789|54349920|FG001|Overall Study|Adverse Event unrelated to study drug|18|||
27850868|NCT02869789|54349921|FG002|Overall Study|Adverse Event unrelated to study drug|21|||
27850869|NCT02869789|54349922|FG003|Overall Study|Adverse Event unrelated to study drug|6|||
27850870|NCT02869789|54349919|FG000|Overall Study|Participant request to discontinue study treatment|10|||
27850871|NCT02869789|54349920|FG001|Overall Study|Participant request to discontinue study treatment|5|||
27850872|NCT02869789|54349921|FG002|Overall Study|Participant request to discontinue study treatment|5|||
27850873|NCT02869789|54349922|FG003|Overall Study|Participant request to discontinue study treatment|3|||
27850874|NCT02869789|54349919|FG000|Overall Study|Withdrawal by Subject|5|||
27850875|NCT02869789|54349920|FG001|Overall Study|Withdrawal by Subject|2|||
27850876|NCT02869789|54349921|FG002|Overall Study|Withdrawal by Subject|7|||
27850877|NCT02869789|54349922|FG003|Overall Study|Withdrawal by Subject|2|||
27850878|NCT02869789|54349919|FG000|Overall Study|Lost to Follow-up|0|||
27850879|NCT02869789|54349920|FG001|Overall Study|Lost to Follow-up|0|||
27830916|NCT00709098|54306779|FG002|Open-label Period|Administrative reason|5|||
27830917|NCT00709098|54306777|FG000|Open-label Period|Death|0|||
27830918|NCT00709098|54306778|FG001|Open-label Period|Death|0|||
27830919|NCT00709098|54306779|FG002|Open-label Period|Death|1|||
27830920|NCT00709098|54306777|FG000|Open-label Period|Lost to Follow-up|0|||
27850880|NCT02869789|54349921|FG002|Overall Study|Lost to Follow-up|2|||
27850881|NCT02869789|54349922|FG003|Overall Study|Lost to Follow-up|0|||
27830921|NCT00709098|54306778|FG001|Open-label Period|Lost to Follow-up|0|||
27830922|NCT00709098|54306779|FG002|Open-label Period|Lost to Follow-up|1|||
27830923|NCT01376700|54306788|FG000|Overall Study|Sponsor terminated study early|8|||
27830924|NCT01376700|54306788|FG000|Overall Study|Low or high titer inhibitor|8|||
27830925|NCT01797965|54306799|FG000|Overall Study|Adverse Event|104|||
27830926|NCT01797965|54306800|FG001|Overall Study|Adverse Event|129|||
27830927|NCT01797965|54306801|FG002|Overall Study|Adverse Event|4|||
27830928|NCT01797965|54306802|FG003|Overall Study|Adverse Event|21|||
27830929|NCT01797965|54306799|FG000|Overall Study|Lost to Follow-up|9|||
27830930|NCT01797965|54306800|FG001|Overall Study|Lost to Follow-up|8|||
27830931|NCT01797965|54306801|FG002|Overall Study|Lost to Follow-up|1|||
27830932|NCT01797965|54306802|FG003|Overall Study|Lost to Follow-up|2|||
27850882|NCT02869789|54349919|FG000|Overall Study|Maximum clinical benefit|5|||
27850883|NCT02869789|54349920|FG001|Overall Study|Maximum clinical benefit|2|||
27850884|NCT02869789|54349921|FG002|Overall Study|Maximum clinical benefit|1|||
27830933|NCT01797965|54306799|FG000|Overall Study|Consent withdrawn|130|||
27850885|NCT02869789|54349922|FG003|Overall Study|Maximum clinical benefit|0|||
27850886|NCT02869789|54349919|FG000|Overall Study|Poor/Non-compliance|0|||
27850887|NCT02869789|54349920|FG001|Overall Study|Poor/Non-compliance|2|||
27850888|NCT02869789|54349921|FG002|Overall Study|Poor/Non-compliance|1|||
27850889|NCT02869789|54349922|FG003|Overall Study|Poor/Non-compliance|0|||
27850890|NCT02869789|54349919|FG000|Overall Study|Participant no longer meets study criteria|0|||
27850891|NCT02869789|54349920|FG001|Overall Study|Participant no longer meets study criteria|1|||
27850892|NCT02869789|54349921|FG002|Overall Study|Participant no longer meets study criteria|1|||
27850893|NCT02869789|54349922|FG003|Overall Study|Participant no longer meets study criteria|0|||
27850894|NCT02869789|54349919|FG000|Overall Study|Administrative reason by sponsor|0|||
27850895|NCT02869789|54349920|FG001|Overall Study|Administrative reason by sponsor|0|||
27850896|NCT02869789|54349921|FG002|Overall Study|Administrative reason by sponsor|1|||
27850897|NCT02869789|54349922|FG003|Overall Study|Administrative reason by sponsor|0|||
27850898|NCT02869789|54349919|FG000|Overall Study|Other reasons|4|||
27850899|NCT02869789|54349920|FG001|Overall Study|Other reasons|8|||
27850900|NCT02869789|54349921|FG002|Overall Study|Other reasons|6|||
27850901|NCT02869789|54349922|FG003|Overall Study|Other reasons|0|||
27850902|NCT02760485|54349943|FG000|Phase 1|Death|3|||
27850903|NCT02760485|54349944|FG001|Phase 1|Death|6|||
27850904|NCT02760485|54349945|FG002|Phase 1|Death|0|||
27850905|NCT02760485|54349943|FG000|Phase 1|Withdrawal by Subject|2|||
27850906|NCT02760485|54349944|FG001|Phase 1|Withdrawal by Subject|0|||
27850907|NCT02760485|54349945|FG002|Phase 1|Withdrawal by Subject|0|||
27850908|NCT02760485|54349943|FG000|Phase 1|Progressive Disease|1|||
27850909|NCT02760485|54349944|FG001|Phase 1|Progressive Disease|0|||
27850910|NCT02760485|54349945|FG002|Phase 1|Progressive Disease|0|||
27850911|NCT02760485|54349943|FG000|Phase 1|Amendment Removed Survival Follow-up|0|||
27850912|NCT02760485|54349944|FG001|Phase 1|Amendment Removed Survival Follow-up|1|||
27850913|NCT02760485|54349945|FG002|Phase 1|Amendment Removed Survival Follow-up|0|||
27850914|NCT02760485|54349943|FG000|Phase 1|Unknown; Did Not Complete End-of-Study Visit|1|||
27850915|NCT02760485|54349944|FG001|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
27850916|NCT02760485|54349945|FG002|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
27850917|NCT02760485|54349943|FG000|Phase 2|Death|0|||
27850918|NCT02760485|54349944|FG001|Phase 2|Death|0|||
27850919|NCT02760485|54349945|FG002|Phase 2|Death|12|||
27850920|NCT02760485|54349943|FG000|Phase 2|Withdrawal by Subject|0|||
27850921|NCT02760485|54349944|FG001|Phase 2|Withdrawal by Subject|0|||
27850922|NCT02760485|54349945|FG002|Phase 2|Withdrawal by Subject|3|||
28076866|NCT00111800|54731649|FG001|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
27830934|NCT01797965|54306800|FG001|Overall Study|Consent withdrawn|117|||
27830935|NCT01797965|54306801|FG002|Overall Study|Consent withdrawn|3|||
27830936|NCT01797965|54306802|FG003|Overall Study|Consent withdrawn|35|||
27830937|NCT01797965|54306799|FG000|Overall Study|Investigator decision|21|||
27850923|NCT02760485|54349943|FG000|Phase 2|Progressive Disease|0|||
27850924|NCT02760485|54349944|FG001|Phase 2|Progressive Disease|0|||
27850925|NCT02760485|54349945|FG002|Phase 2|Progressive Disease|1|||
27850926|NCT02760485|54349943|FG000|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
27850927|NCT02760485|54349944|FG001|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
28076867|NCT00111800|54731650|FG002|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1|||
27830938|NCT01797965|54306800|FG001|Overall Study|Investigator decision|15|||
27830939|NCT01797965|54306801|FG002|Overall Study|Investigator decision|0|||
27830940|NCT01797965|54306802|FG003|Overall Study|Investigator decision|0|||
27850928|NCT02760485|54349945|FG002|Phase 2|Unknown; Did Not Complete End-of-Study Visit|3|||
27850929|NCT02634333|54349980|FG000|Overall Study|Completed out of Window|3|||
27830941|NCT01797965|54306799|FG000|Overall Study|Death|2|||
27850930|NCT02634333|54349981|FG001|Overall Study|Completed out of Window|2|||
27850931|NCT02634333|54349980|FG000|Overall Study|Missed Visit|5|||
27850932|NCT02634333|54349981|FG001|Overall Study|Missed Visit|2|||
27850933|NCT02634333|54349980|FG000|Overall Study|Lost to Follow-up|12|||
27850934|NCT02634333|54349981|FG001|Overall Study|Lost to Follow-up|7|||
27850935|NCT02634333|54349980|FG000|Overall Study|Withdrawal by Subject|9|||
27850936|NCT02634333|54349981|FG001|Overall Study|Withdrawal by Subject|13|||
27850937|NCT02634333|54349980|FG000|Overall Study|Death|11|||
27850938|NCT02634333|54349981|FG001|Overall Study|Death|8|||
27850939|NCT02515630|54349999|FG000|Overall Study|Withdrawal by Subject|5|||
27850940|NCT02515630|54349999|FG000|Overall Study|Adverse Event|4|||
27850941|NCT02515630|54349999|FG000|Overall Study|Physician Decision|4|||
27850942|NCT02515630|54349999|FG000|Overall Study|Death|2|||
27850943|NCT02515630|54349999|FG000|Overall Study|Disease Progression|1|||
27850944|NCT02450331|54350008|FG000|Overall Study|Death|162|||
27850945|NCT02450331|54350009|FG001|Overall Study|Death|171|||
27850946|NCT02450331|54350008|FG000|Overall Study|Lost to Follow-up|14|||
27850947|NCT02450331|54350009|FG001|Overall Study|Lost to Follow-up|12|||
27850948|NCT02450331|54350008|FG000|Overall Study|Withdrawal by Subject|55|||
27850949|NCT02450331|54350009|FG001|Overall Study|Withdrawal by Subject|44|||
27850950|NCT02450331|54350008|FG000|Overall Study|Non-specified other|1|||
27850951|NCT02450331|54350009|FG001|Overall Study|Non-specified other|1|||
27850952|NCT02335944|54350026|FG000|Treatment Phase|Progressive Disease|2|||
27850953|NCT02335944|54350027|FG001|Treatment Phase|Progressive Disease|5|||
27850954|NCT02335944|54350028|FG002|Treatment Phase|Progressive Disease|2|||
27850955|NCT02335944|54350029|FG003|Treatment Phase|Progressive Disease|11|||
27850956|NCT02335944|54350030|FG004|Treatment Phase|Progressive Disease|4|||
27850957|NCT02335944|54350031|FG005|Treatment Phase|Progressive Disease|25|||
27850958|NCT02335944|54350032|FG006|Treatment Phase|Progressive Disease|2|||
27850959|NCT02335944|54350033|FG007|Treatment Phase|Progressive Disease|30|||
27850960|NCT02335944|54350034|FG008|Treatment Phase|Progressive Disease|27|||
27850961|NCT02335944|54350035|FG009|Treatment Phase|Progressive Disease|0|||
27850962|NCT02335944|54350026|FG000|Treatment Phase|Adverse Event|2|||
27850963|NCT02335944|54350027|FG001|Treatment Phase|Adverse Event|0|||
27850964|NCT02335944|54350028|FG002|Treatment Phase|Adverse Event|0|||
27850965|NCT02335944|54350029|FG003|Treatment Phase|Adverse Event|2|||
27850966|NCT02335944|54350030|FG004|Treatment Phase|Adverse Event|1|||
27850967|NCT02335944|54350031|FG005|Treatment Phase|Adverse Event|15|||
27850968|NCT02335944|54350032|FG006|Treatment Phase|Adverse Event|0|||
27850969|NCT02335944|54350033|FG007|Treatment Phase|Adverse Event|5|||
27850970|NCT02335944|54350034|FG008|Treatment Phase|Adverse Event|7|||
27850971|NCT02335944|54350035|FG009|Treatment Phase|Adverse Event|0|||
27850972|NCT02335944|54350026|FG000|Treatment Phase|Physician Decision|0|||
27850973|NCT02335944|54350027|FG001|Treatment Phase|Physician Decision|0|||
27850974|NCT02335944|54350028|FG002|Treatment Phase|Physician Decision|0|||
27850975|NCT02335944|54350029|FG003|Treatment Phase|Physician Decision|1|||
27850976|NCT02335944|54350030|FG004|Treatment Phase|Physician Decision|0|||
27850977|NCT02335944|54350031|FG005|Treatment Phase|Physician Decision|6|||
27850978|NCT02335944|54350032|FG006|Treatment Phase|Physician Decision|1|||
27850979|NCT02335944|54350033|FG007|Treatment Phase|Physician Decision|2|||
27850980|NCT02335944|54350034|FG008|Treatment Phase|Physician Decision|1|||
27850981|NCT02335944|54350035|FG009|Treatment Phase|Physician Decision|0|||
27850982|NCT02335944|54350026|FG000|Treatment Phase|Study Terminated By Sponsor|0|||
27850983|NCT02335944|54350027|FG001|Treatment Phase|Study Terminated By Sponsor|0|||
27850984|NCT02335944|54350028|FG002|Treatment Phase|Study Terminated By Sponsor|0|||
27850985|NCT02335944|54350029|FG003|Treatment Phase|Study Terminated By Sponsor|1|||
27850986|NCT02335944|54350030|FG004|Treatment Phase|Study Terminated By Sponsor|0|||
27850987|NCT02335944|54350031|FG005|Treatment Phase|Study Terminated By Sponsor|3|||
27850988|NCT02335944|54350032|FG006|Treatment Phase|Study Terminated By Sponsor|0|||
27850989|NCT02335944|54350033|FG007|Treatment Phase|Study Terminated By Sponsor|1|||
27850990|NCT02335944|54350034|FG008|Treatment Phase|Study Terminated By Sponsor|1|||
27850991|NCT02335944|54350035|FG009|Treatment Phase|Study Terminated By Sponsor|0|||
27850992|NCT02335944|54350026|FG000|Treatment Phase|Subject/Guardian Decision|0|||
27850993|NCT02335944|54350027|FG001|Treatment Phase|Subject/Guardian Decision|0|||
27850994|NCT02335944|54350028|FG002|Treatment Phase|Subject/Guardian Decision|1|||
28077070|NCT00403481|54731778|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1|||
27850995|NCT02335944|54350029|FG003|Treatment Phase|Subject/Guardian Decision|0|||
27850996|NCT02335944|54350030|FG004|Treatment Phase|Subject/Guardian Decision|0|||
27850997|NCT02335944|54350031|FG005|Treatment Phase|Subject/Guardian Decision|1|||
27850998|NCT02335944|54350032|FG006|Treatment Phase|Subject/Guardian Decision|0|||
27850999|NCT02335944|54350033|FG007|Treatment Phase|Subject/Guardian Decision|4|||
27851000|NCT02335944|54350034|FG008|Treatment Phase|Subject/Guardian Decision|0|||
27851001|NCT02335944|54350035|FG009|Treatment Phase|Subject/Guardian Decision|0|||
27851002|NCT02335944|54350026|FG000|Post-treatment Follow-up|Progressive Disease|0|||
27851003|NCT02335944|54350027|FG001|Post-treatment Follow-up|Progressive Disease|0|||
27943373|NCT01147458|54600292|FG002|Second Intervention|Withdrawal by Subject|0|||
27851004|NCT02335944|54350028|FG002|Post-treatment Follow-up|Progressive Disease|0|||
27851005|NCT02335944|54350029|FG003|Post-treatment Follow-up|Progressive Disease|1|||
27851006|NCT02335944|54350030|FG004|Post-treatment Follow-up|Progressive Disease|0|||
27851007|NCT02335944|54350031|FG005|Post-treatment Follow-up|Progressive Disease|9|||
27851008|NCT02335944|54350032|FG006|Post-treatment Follow-up|Progressive Disease|0|||
27851009|NCT02335944|54350033|FG007|Post-treatment Follow-up|Progressive Disease|2|||
27851010|NCT02335944|54350034|FG008|Post-treatment Follow-up|Progressive Disease|3|||
27851011|NCT02335944|54350035|FG009|Post-treatment Follow-up|Progressive Disease|0|||
27851012|NCT02335944|54350026|FG000|Post-treatment Follow-up|Subject/Guardian Decision|0|||
27851013|NCT02335944|54350027|FG001|Post-treatment Follow-up|Subject/Guardian Decision|0|||
27851014|NCT02335944|54350028|FG002|Post-treatment Follow-up|Subject/Guardian Decision|0|||
27851015|NCT02335944|54350029|FG003|Post-treatment Follow-up|Subject/Guardian Decision|0|||
27851016|NCT02335944|54350030|FG004|Post-treatment Follow-up|Subject/Guardian Decision|0|||
27851017|NCT02335944|54350031|FG005|Post-treatment Follow-up|Subject/Guardian Decision|2|||
27851018|NCT02335944|54350032|FG006|Post-treatment Follow-up|Subject/Guardian Decision|0|||
27851019|NCT02335944|54350033|FG007|Post-treatment Follow-up|Subject/Guardian Decision|0|||
27851020|NCT02335944|54350034|FG008|Post-treatment Follow-up|Subject/Guardian Decision|0|||
27851021|NCT02335944|54350035|FG009|Post-treatment Follow-up|Subject/Guardian Decision|0|||
27851022|NCT02335944|54350026|FG000|Post-treatment Follow-up|Terminated by Sponsor|0|||
27851023|NCT02335944|54350027|FG001|Post-treatment Follow-up|Terminated by Sponsor|0|||
27851024|NCT02335944|54350028|FG002|Post-treatment Follow-up|Terminated by Sponsor|0|||
27851025|NCT02335944|54350029|FG003|Post-treatment Follow-up|Terminated by Sponsor|0|||
27851026|NCT02335944|54350030|FG004|Post-treatment Follow-up|Terminated by Sponsor|0|||
27851027|NCT02335944|54350031|FG005|Post-treatment Follow-up|Terminated by Sponsor|0|||
27851028|NCT02335944|54350032|FG006|Post-treatment Follow-up|Terminated by Sponsor|0|||
27851029|NCT02335944|54350033|FG007|Post-treatment Follow-up|Terminated by Sponsor|2|||
27851030|NCT02335944|54350034|FG008|Post-treatment Follow-up|Terminated by Sponsor|0|||
27851031|NCT02335944|54350035|FG009|Post-treatment Follow-up|Terminated by Sponsor|0|||
27851032|NCT02335944|54350026|FG000|Post-treatment Follow-up|Adverse Event|0|||
27851033|NCT02335944|54350027|FG001|Post-treatment Follow-up|Adverse Event|0|||
27851034|NCT02335944|54350028|FG002|Post-treatment Follow-up|Adverse Event|0|||
27851035|NCT02335944|54350029|FG003|Post-treatment Follow-up|Adverse Event|0|||
27851036|NCT02335944|54350030|FG004|Post-treatment Follow-up|Adverse Event|0|||
27851037|NCT02335944|54350031|FG005|Post-treatment Follow-up|Adverse Event|1|||
27851038|NCT02335944|54350032|FG006|Post-treatment Follow-up|Adverse Event|0|||
27851039|NCT02335944|54350033|FG007|Post-treatment Follow-up|Adverse Event|0|||
27851040|NCT02335944|54350034|FG008|Post-treatment Follow-up|Adverse Event|0|||
27851041|NCT02335944|54350035|FG009|Post-treatment Follow-up|Adverse Event|0|||
27851042|NCT02335944|54350026|FG000|Post-treatment Follow-up|Death|0|||
27851043|NCT02335944|54350027|FG001|Post-treatment Follow-up|Death|0|||
27851044|NCT02335944|54350028|FG002|Post-treatment Follow-up|Death|0|||
27851045|NCT02335944|54350029|FG003|Post-treatment Follow-up|Death|1|||
27851046|NCT02335944|54350030|FG004|Post-treatment Follow-up|Death|0|||
27851047|NCT02335944|54350031|FG005|Post-treatment Follow-up|Death|1|||
27851048|NCT02335944|54350032|FG006|Post-treatment Follow-up|Death|0|||
27851049|NCT02335944|54350033|FG007|Post-treatment Follow-up|Death|0|||
27851050|NCT02335944|54350034|FG008|Post-treatment Follow-up|Death|0|||
27851051|NCT02335944|54350035|FG009|Post-treatment Follow-up|Death|0|||
27851052|NCT02335944|54350026|FG000|Post-treatment Follow-up|Physician Decision|1|||
27851053|NCT02335944|54350027|FG001|Post-treatment Follow-up|Physician Decision|0|||
27851054|NCT02335944|54350028|FG002|Post-treatment Follow-up|Physician Decision|0|||
27851055|NCT02335944|54350029|FG003|Post-treatment Follow-up|Physician Decision|0|||
27851056|NCT02335944|54350030|FG004|Post-treatment Follow-up|Physician Decision|0|||
27851057|NCT02335944|54350031|FG005|Post-treatment Follow-up|Physician Decision|0|||
27851058|NCT02335944|54350032|FG006|Post-treatment Follow-up|Physician Decision|0|||
27851059|NCT02335944|54350033|FG007|Post-treatment Follow-up|Physician Decision|1|||
27851060|NCT02335944|54350034|FG008|Post-treatment Follow-up|Physician Decision|0|||
27851061|NCT02335944|54350035|FG009|Post-treatment Follow-up|Physician Decision|0|||
27830942|NCT01797965|54306800|FG001|Overall Study|Death|4|||
27830943|NCT01797965|54306801|FG002|Overall Study|Death|0|||
27830944|NCT01797965|54306802|FG003|Overall Study|Death|0|||
27830945|NCT01797965|54306799|FG000|Overall Study|Disease progression, defined by protocol|3|||
27830946|NCT01797965|54306800|FG001|Overall Study|Disease progression, defined by protocol|1|||
27830947|NCT01797965|54306801|FG002|Overall Study|Disease progression, defined by protocol|0|||
27830948|NCT01797965|54306802|FG003|Overall Study|Disease progression, defined by protocol|0|||
27830949|NCT01797965|54306799|FG000|Overall Study|Reason Not Specified|280|||
27851062|NCT02326974|54350073|FG000|Overall Study|Withdrawal by Subject|2|||
27851063|NCT02326974|54350073|FG000|Overall Study|failed heterogenity evaluation|5|||
27851064|NCT02246621|54350101|FG000|Overall Study|Withdrawal by Subject|28|||
27851065|NCT02246621|54350102|FG001|Overall Study|Withdrawal by Subject|16|||
27851066|NCT02246621|54350101|FG000|Overall Study|Lost to Follow-up|1|||
27851067|NCT02246621|54350102|FG001|Overall Study|Lost to Follow-up|0|||
27851068|NCT02246621|54350101|FG000|Overall Study|On Study Treatment/ Follow Up|236|||
27851069|NCT02246621|54350102|FG001|Overall Study|On Study Treatment/ Follow Up|119|||
27851070|NCT02200445|54350148|FG000|Overall Study|Lack of Efficacy|1|||
27851071|NCT02200445|54350149|FG001|Overall Study|Lack of Efficacy|2|||
27851072|NCT02200445|54350150|FG002|Overall Study|Lack of Efficacy|2|||
27851073|NCT02200445|54350148|FG000|Overall Study|Adverse Event|0|||
27851074|NCT02200445|54350149|FG001|Overall Study|Adverse Event|2|||
27851075|NCT02200445|54350150|FG002|Overall Study|Adverse Event|0|||
27851076|NCT02152982|54350160|FG000|Overall Study|Ineligible|4|||
27851077|NCT02152982|54350161|FG001|Overall Study|Ineligible|4|||
27851078|NCT02152982|54350160|FG000|Overall Study|Did not start treatment|12|||
27851079|NCT02152982|54350161|FG001|Overall Study|Did not start treatment|6|||
27851080|NCT02120352|54350173|FG000|Induction Period (20 Weeks)|Adverse Event|3|||
27851081|NCT02120352|54350174|FG001|Induction Period (20 Weeks)|Adverse Event|0|||
27851082|NCT02120352|54350175|FG002|Induction Period (20 Weeks)|Adverse Event|0|||
27851083|NCT02120352|54350176|FG003|Induction Period (20 Weeks)|Adverse Event|0|||
27851084|NCT02120352|54350173|FG000|Induction Period (20 Weeks)|Lack of Efficacy|5|||
27851085|NCT02120352|54350174|FG001|Induction Period (20 Weeks)|Lack of Efficacy|0|||
27851086|NCT02120352|54350175|FG002|Induction Period (20 Weeks)|Lack of Efficacy|0|||
27851087|NCT02120352|54350176|FG003|Induction Period (20 Weeks)|Lack of Efficacy|0|||
27851088|NCT02120352|54350173|FG000|Induction Period (20 Weeks)|Protocol Violation|2|||
27851089|NCT02120352|54350174|FG001|Induction Period (20 Weeks)|Protocol Violation|0|||
27851090|NCT02120352|54350175|FG002|Induction Period (20 Weeks)|Protocol Violation|0|||
27851091|NCT02120352|54350176|FG003|Induction Period (20 Weeks)|Protocol Violation|0|||
27851092|NCT02120352|54350173|FG000|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3|||
27851093|NCT02120352|54350174|FG001|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
27851094|NCT02120352|54350175|FG002|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
27851095|NCT02120352|54350176|FG003|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
27851096|NCT02120352|54350173|FG000|Induction Period (20 Weeks)|Lost to Follow-up|2|||
27851097|NCT02120352|54350174|FG001|Induction Period (20 Weeks)|Lost to Follow-up|0|||
27851098|NCT02120352|54350175|FG002|Induction Period (20 Weeks)|Lost to Follow-up|0|||
27851099|NCT02120352|54350176|FG003|Induction Period (20 Weeks)|Lost to Follow-up|0|||
27851100|NCT02120352|54350173|FG000|Induction Period (20 Weeks)|Withdrawal by Subject|5|||
27851101|NCT02120352|54350174|FG001|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
27851102|NCT02120352|54350175|FG002|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
27851103|NCT02120352|54350176|FG003|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
27851104|NCT02120352|54350173|FG000|Induction Period (20 Weeks)|Physician Decision|1|||
27851105|NCT02120352|54350174|FG001|Induction Period (20 Weeks)|Physician Decision|0|||
27851106|NCT02120352|54350175|FG002|Induction Period (20 Weeks)|Physician Decision|0|||
27851107|NCT02120352|54350176|FG003|Induction Period (20 Weeks)|Physician Decision|0|||
27851108|NCT02120352|54350173|FG000|Maintenance Period (32 Weeks)|Adverse Event|0|||
27851109|NCT02120352|54350174|FG001|Maintenance Period (32 Weeks)|Adverse Event|0|||
27851110|NCT02120352|54350175|FG002|Maintenance Period (32 Weeks)|Adverse Event|6|||
27851111|NCT02120352|54350176|FG003|Maintenance Period (32 Weeks)|Adverse Event|1|||
27851112|NCT02120352|54350173|FG000|Maintenance Period (32 Weeks)|Lack of Efficacy|0|||
27851113|NCT02120352|54350174|FG001|Maintenance Period (32 Weeks)|Lack of Efficacy|1|||
27851114|NCT02120352|54350175|FG002|Maintenance Period (32 Weeks)|Lack of Efficacy|0|||
27851115|NCT02120352|54350176|FG003|Maintenance Period (32 Weeks)|Lack of Efficacy|1|||
27851116|NCT02120352|54350173|FG000|Maintenance Period (32 Weeks)|Protocol Violation|0|||
27851117|NCT02120352|54350174|FG001|Maintenance Period (32 Weeks)|Protocol Violation|0|||
27851118|NCT02120352|54350175|FG002|Maintenance Period (32 Weeks)|Protocol Violation|2|||
27851119|NCT02120352|54350176|FG003|Maintenance Period (32 Weeks)|Protocol Violation|0|||
27851120|NCT02120352|54350173|FG000|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|0|||
27851121|NCT02120352|54350174|FG001|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|0|||
27851122|NCT02120352|54350175|FG002|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|1|||
27851123|NCT02120352|54350176|FG003|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|1|||
27851124|NCT02120352|54350173|FG000|Maintenance Period (32 Weeks)|Lost to Follow-up|0|||
28159899|NCT02558296|54829985|FG001|Completed the Study Through Week 24|Physician Decision|0|||
28159900|NCT02558296|54829984|FG000|Completed the Study Through Week 24|Protocol Violation|1|||
28159901|NCT02558296|54829985|FG001|Completed the Study Through Week 24|Protocol Violation|1|||
28159902|NCT02558296|54829984|FG000|Completed the Study Through Week 24|Withdrawal by Subject|17|||
27830950|NCT01797965|54306800|FG001|Overall Study|Reason Not Specified|295|||
27830951|NCT01797965|54306801|FG002|Overall Study|Reason Not Specified|0|||
27830952|NCT01797965|54306802|FG003|Overall Study|Reason Not Specified|15|||
27830953|NCT01376388|54306847|FG000|Overall Study|Adverse Event|13|||
27830954|NCT01376388|54306847|FG000|Overall Study|Lack of Efficacy|2|||
27830955|NCT01376388|54306847|FG000|Overall Study|Withdrawal by Subject|3|||
27830956|NCT01821677|54306868|FG000|Overall Study|Adverse Event|4|||
27830957|NCT01821677|54306869|FG001|Overall Study|Adverse Event|6|||
27830958|NCT01821677|54306870|FG002|Overall Study|Adverse Event|5|||
27830959|NCT01821677|54306868|FG000|Overall Study|Physician Decision|1|||
27830960|NCT01821677|54306869|FG001|Overall Study|Physician Decision|4|||
27830961|NCT01821677|54306870|FG002|Overall Study|Physician Decision|1|||
27830962|NCT01821677|54306868|FG000|Overall Study|Non-compliance|0|||
27830963|NCT01821677|54306869|FG001|Overall Study|Non-compliance|1|||
27830964|NCT01821677|54306870|FG002|Overall Study|Non-compliance|2|||
27851125|NCT02120352|54350174|FG001|Maintenance Period (32 Weeks)|Lost to Follow-up|0|||
27851126|NCT02120352|54350175|FG002|Maintenance Period (32 Weeks)|Lost to Follow-up|0|||
27851127|NCT02120352|54350176|FG003|Maintenance Period (32 Weeks)|Lost to Follow-up|1|||
27851128|NCT02120352|54350173|FG000|Maintenance Period (32 Weeks)|Withdrawal by Subject|0|||
27851129|NCT02120352|54350174|FG001|Maintenance Period (32 Weeks)|Withdrawal by Subject|2|||
27851130|NCT02120352|54350175|FG002|Maintenance Period (32 Weeks)|Withdrawal by Subject|1|||
27851131|NCT02120352|54350176|FG003|Maintenance Period (32 Weeks)|Withdrawal by Subject|2|||
27851132|NCT02120352|54350173|FG000|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|0|||
27851133|NCT02120352|54350174|FG001|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|112|||
27851134|NCT02120352|54350175|FG002|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|105|||
27851135|NCT02120352|54350176|FG003|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|50|||
27851136|NCT02058693|54350192|FG000|Phase 1|Withdrawal by Subject|3|||
27851137|NCT02058693|54350193|FG001|Phase 1|Withdrawal by Subject|2|||
27851138|NCT02058693|54350192|FG000|Phase 1|Adverse Event|0|||
27830965|NCT01821677|54306868|FG000|Overall Study|Lost to Follow-up|2|||
27830966|NCT01821677|54306869|FG001|Overall Study|Lost to Follow-up|1|||
27830967|NCT01821677|54306870|FG002|Overall Study|Lost to Follow-up|3|||
27830968|NCT01821677|54306868|FG000|Overall Study|Protocol Violation|0|||
27830969|NCT01821677|54306869|FG001|Overall Study|Protocol Violation|0|||
27830970|NCT01821677|54306870|FG002|Overall Study|Protocol Violation|2|||
27851139|NCT02058693|54350193|FG001|Phase 1|Adverse Event|1|||
27851140|NCT02058693|54350192|FG000|Phase 1|Lack of Efficacy|1|||
27943374|NCT01147458|54600293|FG003|Second Intervention|Withdrawal by Subject|0|||
27943375|NCT01147458|54600290|FG000|Second Intervention|Adverse Event|2|||
27943376|NCT01147458|54600291|FG001|Second Intervention|Adverse Event|0|||
27943377|NCT01147458|54600292|FG002|Second Intervention|Adverse Event|1|||
27943378|NCT01147458|54600293|FG003|Second Intervention|Adverse Event|1|||
27943379|NCT01147458|54600290|FG000|Second Intervention|Other|0|||
27943380|NCT01147458|54600291|FG001|Second Intervention|Other|0|||
27943381|NCT01147458|54600292|FG002|Second Intervention|Other|1|||
27943382|NCT01147458|54600293|FG003|Second Intervention|Other|0|||
27943383|NCT01172808|54600309|FG000|Overall Study|Adverse Event|8|||
27943384|NCT01172808|54600310|FG001|Overall Study|Adverse Event|4|||
27943385|NCT01172808|54600311|FG002|Overall Study|Adverse Event|8|||
27943386|NCT01172808|54600312|FG003|Overall Study|Adverse Event|3|||
27943387|NCT01172808|54600309|FG000|Overall Study|Lack of Efficacy|1|||
27943388|NCT01172808|54600310|FG001|Overall Study|Lack of Efficacy|0|||
27943389|NCT01172808|54600311|FG002|Overall Study|Lack of Efficacy|0|||
27943390|NCT01172808|54600312|FG003|Overall Study|Lack of Efficacy|0|||
27943391|NCT01172808|54600309|FG000|Overall Study|Protocol Violation|2|||
27943392|NCT01172808|54600310|FG001|Overall Study|Protocol Violation|2|||
27943393|NCT01172808|54600311|FG002|Overall Study|Protocol Violation|2|||
27943394|NCT01172808|54600312|FG003|Overall Study|Protocol Violation|0|||
27943395|NCT01172808|54600309|FG000|Overall Study|Lost to Follow-up|0|||
27943396|NCT01172808|54600310|FG001|Overall Study|Lost to Follow-up|1|||
27943397|NCT01172808|54600311|FG002|Overall Study|Lost to Follow-up|1|||
27943398|NCT01172808|54600312|FG003|Overall Study|Lost to Follow-up|3|||
27943399|NCT01172808|54600309|FG000|Overall Study|Withdrawal by Subject|4|||
27851141|NCT02058693|54350193|FG001|Phase 1|Lack of Efficacy|0|||
27851142|NCT02058693|54350192|FG000|Phase 1|Physician Decision|1|||
27851143|NCT02058693|54350193|FG001|Phase 1|Physician Decision|1|||
27851144|NCT02058693|54350192|FG000|Phase 2|Withdrawal by Subject|0|||
27851145|NCT02058693|54350193|FG001|Phase 2|Withdrawal by Subject|2|||
27851146|NCT02039856|54350203|FG000|Overall Study|Death|5|||
27851147|NCT02039856|54350204|FG001|Overall Study|Death|3|||
27851148|NCT02039856|54350203|FG000|Overall Study|Partial survey completion|61|||
27851149|NCT02039856|54350204|FG001|Overall Study|Partial survey completion|26|||
27851150|NCT02039856|54350203|FG000|Overall Study|Lost to Follow-up|388|||
27851151|NCT02039856|54350204|FG001|Overall Study|Lost to Follow-up|206|||
27851152|NCT02039856|54350203|FG000|Overall Study|Withdrawal by Subject|1573|||
27851153|NCT02039856|54350204|FG001|Overall Study|Withdrawal by Subject|618|||
27851154|NCT01796392|54350214|FG000|Overall Study|Withdrawal by Subject|2|||
27851155|NCT01796392|54350215|FG001|Overall Study|Withdrawal by Subject|0|||
27851156|NCT01796392|54350214|FG000|Overall Study|Death|5|||
27943400|NCT01172808|54600310|FG001|Overall Study|Withdrawal by Subject|1|||
27943401|NCT01172808|54600311|FG002|Overall Study|Withdrawal by Subject|3|||
27943402|NCT01172808|54600312|FG003|Overall Study|Withdrawal by Subject|2|||
27830971|NCT01821677|54306868|FG000|Overall Study|Withdrawal by Subject|7|||
27830972|NCT01821677|54306869|FG001|Overall Study|Withdrawal by Subject|3|||
27830973|NCT01821677|54306870|FG002|Overall Study|Withdrawal by Subject|2|||
27830974|NCT01821677|54306868|FG000|Overall Study|Other|9|||
27830975|NCT01821677|54306869|FG001|Overall Study|Other|0|||
27830976|NCT01821677|54306870|FG002|Overall Study|Other|0|||
27830977|NCT01797731|54306881|FG000|Overall Study|Didn't have proper radiographs required|3|||
27830978|NCT01797731|54306882|FG001|Overall Study|Didn't have proper radiographs required|3|||
27830979|NCT00709722|54306888|FG000|Overall Study|Adverse Event|1|||
27943403|NCT01172808|54600309|FG000|Overall Study|Other|6|||
27830980|NCT01820585|54306909|FG000|Overall Study|Adverse Event|9|||
28076868|NCT00111800|54731651|FG003|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
28076869|NCT00111800|54731652|FG004|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
28076870|NCT00111800|54731653|FG005|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
28076871|NCT00111800|54731648|FG000|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
28076872|NCT00111800|54731649|FG001|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
28076873|NCT00111800|54731650|FG002|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1|||
28076874|NCT00111800|54731651|FG003|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
28076875|NCT00111800|54731652|FG004|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
28076876|NCT00111800|54731653|FG005|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
28076877|NCT00094328|54731676|FG000|Overall Study|Lost to Follow-up|1|||
28076878|NCT00094172|54731682|FG000|Overall Study|Adverse Event|0|||
28076879|NCT00094172|54731683|FG001|Overall Study|Adverse Event|1|||
28076880|NCT00094172|54731682|FG000|Overall Study|Lost to Follow-up|2|||
28076881|NCT00094172|54731683|FG001|Overall Study|Lost to Follow-up|0|||
28076882|NCT00094172|54731682|FG000|Overall Study|Protocol Violation|0|||
28076883|NCT00094172|54731683|FG001|Overall Study|Protocol Violation|1|||
28076884|NCT00094172|54731682|FG000|Overall Study|Withdrawal by Subject|10|||
28076885|NCT00094172|54731683|FG001|Overall Study|Withdrawal by Subject|5|||
28076886|NCT00094172|54731682|FG000|Overall Study|Primary endpoint met.|1|||
28076887|NCT00094172|54731683|FG001|Overall Study|Primary endpoint met.|0|||
28076888|NCT00094172|54731682|FG000|Overall Study|Started other MS therapy due to disease|1|||
28076889|NCT00094172|54731683|FG001|Overall Study|Started other MS therapy due to disease|0|||
28076890|NCT00094094|54731689|FG000|Overall Study|Death|2|||
28076891|NCT00094094|54731689|FG000|Overall Study|Lack of Efficacy|23|||
28076892|NCT00094094|54731689|FG000|Overall Study|Adverse Event|7|||
28076893|NCT00110396|54731693|FG000|Overall Study|Adverse Event|15|||
28076894|NCT00110396|54731693|FG000|Overall Study|Lost to Follow-up|1|||
28076895|NCT00110396|54731693|FG000|Overall Study|Administration of plasmapheresis|1|||
28076896|NCT00110396|54731693|FG000|Overall Study|Initiated mitoxantrone therapy|1|||
28076897|NCT00110396|54731693|FG000|Overall Study|Lack of Efficacy|1|||
28076898|NCT00110396|54731693|FG000|Overall Study|Decided not to continue treatment|1|||
28076899|NCT00110396|54731693|FG000|Overall Study|Patient non-compliance|1|||
28076900|NCT00110396|54731693|FG000|Overall Study|Patient refused to continue|1|||
28076901|NCT00110396|54731693|FG000|Overall Study|Patient refused to participate|1|||
28076902|NCT00110396|54731693|FG000|Overall Study|Patient will|1|||
28076903|NCT00110396|54731693|FG000|Overall Study|Patient's decision|1|||
28076904|NCT00110396|54731693|FG000|Overall Study|Participation in MS vaccine study|1|||
28076905|NCT00110396|54731693|FG000|Overall Study|Pregnancy|1|||
28076906|NCT00110396|54731693|FG000|Overall Study|Pregnancy (Protocol violation)|2|||
28076907|NCT00110396|54731693|FG000|Overall Study|Protocol Violation|2|||
28076908|NCT00110396|54731693|FG000|Overall Study|Patient refused to come back|1|||
28076909|NCT00110396|54731693|FG000|Overall Study|The patient has refused|2|||
28076910|NCT00110396|54731693|FG000|Overall Study|The patient has refused to visit site|1|||
28076911|NCT00110396|54731693|FG000|Overall Study|Patient is to be administered copaxone|1|||
27943404|NCT01172808|54600310|FG001|Overall Study|Other|5|||
28076912|NCT03819218|54731697|FG000|Overall Study|Protocol Violation|1|||
28076913|NCT00093470|54731703|FG000|Overall Study|Disease progression|39|||
28076914|NCT00093470|54731704|FG001|Overall Study|Disease progression|0|||
28076915|NCT00093470|54731703|FG000|Overall Study|Adverse Event|15|||
28076916|NCT00093470|54731704|FG001|Overall Study|Adverse Event|0|||
28159903|NCT02558296|54829985|FG001|Completed the Study Through Week 24|Withdrawal by Subject|13|||
28159904|NCT02558296|54829984|FG000|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|1|||
28076917|NCT00093470|54731703|FG000|Overall Study|Death|2|||
28076918|NCT00093470|54731704|FG001|Overall Study|Death|0|||
28159905|NCT02558296|54829985|FG001|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|0|||
27943405|NCT01172808|54600311|FG002|Overall Study|Other|9|||
27943406|NCT01172808|54600312|FG003|Overall Study|Other|7|||
27943407|NCT04066491|54600325|FG000|Overall Study|Treatment ongoing|2|||
27943408|NCT04066491|54600326|FG001|Overall Study|Treatment ongoing|72|||
27943409|NCT04066491|54600327|FG002|Overall Study|Treatment ongoing|66|||
28076919|NCT00093470|54731703|FG000|Overall Study|Withdrawal by Subject|8|||
28076920|NCT00093470|54731704|FG001|Overall Study|Withdrawal by Subject|0|||
28076921|NCT00093470|54731703|FG000|Overall Study|Alternative therapy|2|||
28076922|NCT00093470|54731704|FG001|Overall Study|Alternative therapy|0|||
28076923|NCT00093470|54731703|FG000|Overall Study|Other complicating disease|3|||
28076924|NCT00093470|54731704|FG001|Overall Study|Other complicating disease|0|||
28076925|NCT00093470|54731703|FG000|Overall Study|Physician Decision|2|||
28076926|NCT00093470|54731704|FG001|Overall Study|Physician Decision|0|||
28076927|NCT00093470|54731703|FG000|Overall Study|Never started treatment|1|||
28076928|NCT00093470|54731704|FG001|Overall Study|Never started treatment|0|||
27851157|NCT01796392|54350215|FG001|Overall Study|Death|1|||
27851158|NCT01796392|54350214|FG000|Overall Study|Excluded for medical reasons|1|||
27851159|NCT01796392|54350215|FG001|Overall Study|Excluded for medical reasons|2|||
27851160|NCT01796392|54350214|FG000|Overall Study|Lost to Follow-up|1|||
27851161|NCT01796392|54350215|FG001|Overall Study|Lost to Follow-up|0|||
27851162|NCT01571635|54350226|FG000|Overall Study|Adverse Event|3|||
27851163|NCT01571635|54350227|FG001|Overall Study|Adverse Event|0|||
27851164|NCT01571635|54350228|FG002|Overall Study|Adverse Event|2|||
27851165|NCT01571635|54350229|FG003|Overall Study|Adverse Event|3|||
27851166|NCT01571635|54350230|FG004|Overall Study|Adverse Event|5|||
27851167|NCT01571635|54350226|FG000|Overall Study|Other reasons|2|||
27851168|NCT01571635|54350227|FG001|Overall Study|Other reasons|1|||
27851169|NCT01571635|54350228|FG002|Overall Study|Other reasons|2|||
27851170|NCT01571635|54350229|FG003|Overall Study|Other reasons|2|||
27851171|NCT01571635|54350230|FG004|Overall Study|Other reasons|1|||
27851172|NCT01571635|54350226|FG000|Overall Study|Study terminated by sponsor|0|||
27851173|NCT01571635|54350227|FG001|Overall Study|Study terminated by sponsor|4|||
27851174|NCT01571635|54350228|FG002|Overall Study|Study terminated by sponsor|1|||
27851175|NCT01571635|54350229|FG003|Overall Study|Study terminated by sponsor|3|||
27851176|NCT01571635|54350230|FG004|Overall Study|Study terminated by sponsor|1|||
27851177|NCT01571635|54350226|FG000|Overall Study|Withdrew consent|1|||
27851178|NCT01571635|54350227|FG001|Overall Study|Withdrew consent|1|||
27851179|NCT01571635|54350228|FG002|Overall Study|Withdrew consent|2|||
27851180|NCT01571635|54350229|FG003|Overall Study|Withdrew consent|3|||
27851181|NCT01571635|54350230|FG004|Overall Study|Withdrew consent|0|||
27851182|NCT01571635|54350226|FG000|Overall Study|Lack of Efficacy|0|||
27851183|NCT01571635|54350227|FG001|Overall Study|Lack of Efficacy|2|||
27851184|NCT01571635|54350228|FG002|Overall Study|Lack of Efficacy|0|||
27851185|NCT01571635|54350229|FG003|Overall Study|Lack of Efficacy|1|||
27851186|NCT01571635|54350230|FG004|Overall Study|Lack of Efficacy|2|||
27851187|NCT01386385|54350247|FG000|Phase I 40mg: Concurrent CRT|Progression/relapse|1|||
27851188|NCT01386385|54350248|FG001|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
27851189|NCT01386385|54350249|FG002|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
27851190|NCT01386385|54350250|FG003|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
27851191|NCT01386385|54350251|FG004|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
27851192|NCT01386385|54350252|FG005|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
27851193|NCT01386385|54350253|FG006|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
27851194|NCT01386385|54350254|FG007|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
27851195|NCT01386385|54350247|FG000|Phase I 40mg: Concurrent CRT|Other- not protocol specified|1|||
27851196|NCT01386385|54350248|FG001|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
27851197|NCT01386385|54350249|FG002|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
27851198|NCT01386385|54350250|FG003|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
27851199|NCT01386385|54350251|FG004|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
27851200|NCT01386385|54350252|FG005|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
27851201|NCT01386385|54350253|FG006|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
27851202|NCT01386385|54350254|FG007|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
27851203|NCT01386385|54350247|FG000|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
27851204|NCT01386385|54350248|FG001|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
27851205|NCT01386385|54350249|FG002|Phase I 80mg: Concurrent CRT|Adverse Event|2|||
27851206|NCT01386385|54350250|FG003|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
27851207|NCT01386385|54350251|FG004|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
27851208|NCT01386385|54350252|FG005|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
27851209|NCT01386385|54350253|FG006|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
27851210|NCT01386385|54350254|FG007|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
27851211|NCT01386385|54350247|FG000|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
27851212|NCT01386385|54350248|FG001|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
27851213|NCT01386385|54350249|FG002|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
27851214|NCT01386385|54350250|FG003|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
27851215|NCT01386385|54350251|FG004|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|1|||
27851216|NCT01386385|54350252|FG005|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
27851217|NCT01386385|54350253|FG006|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
27851218|NCT01386385|54350254|FG007|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
27851219|NCT01386385|54350247|FG000|Phase II Concurrent CRT|Adverse Event|0|||
27851220|NCT01386385|54350248|FG001|Phase II Concurrent CRT|Adverse Event|0|||
27851221|NCT01386385|54350249|FG002|Phase II Concurrent CRT|Adverse Event|0|||
27851222|NCT01386385|54350250|FG003|Phase II Concurrent CRT|Adverse Event|0|||
27851223|NCT01386385|54350251|FG004|Phase II Concurrent CRT|Adverse Event|0|||
27851224|NCT01386385|54350252|FG005|Phase II Concurrent CRT|Adverse Event|0|||
27851225|NCT01386385|54350253|FG006|Phase II Concurrent CRT|Adverse Event|3|||
27851226|NCT01386385|54350254|FG007|Phase II Concurrent CRT|Adverse Event|3|||
27851227|NCT01386385|54350247|FG000|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
27851228|NCT01386385|54350248|FG001|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
28159906|NCT02558296|54829984|FG000|Completed the Study|Adverse Event|14|||
27851229|NCT01386385|54350249|FG002|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
27851230|NCT01386385|54350250|FG003|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
27851231|NCT01386385|54350251|FG004|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
27851232|NCT01386385|54350252|FG005|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
27851233|NCT01386385|54350253|FG006|Phase II Concurrent CRT|Refusal unrelated to AE|3|||
27851234|NCT01386385|54350254|FG007|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
27851235|NCT01386385|54350247|FG000|Phase II: Consolidation Therapy|Adverse Event|0|||
27851236|NCT01386385|54350248|FG001|Phase II: Consolidation Therapy|Adverse Event|0|||
27851237|NCT01386385|54350249|FG002|Phase II: Consolidation Therapy|Adverse Event|0|||
27851238|NCT01386385|54350250|FG003|Phase II: Consolidation Therapy|Adverse Event|0|||
27851239|NCT01386385|54350251|FG004|Phase II: Consolidation Therapy|Adverse Event|0|||
27851240|NCT01386385|54350252|FG005|Phase II: Consolidation Therapy|Adverse Event|0|||
27851241|NCT01386385|54350253|FG006|Phase II: Consolidation Therapy|Adverse Event|2|||
27851242|NCT01386385|54350254|FG007|Phase II: Consolidation Therapy|Adverse Event|1|||
27851243|NCT01386385|54350247|FG000|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
27851244|NCT01386385|54350248|FG001|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
27851245|NCT01386385|54350249|FG002|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
27851246|NCT01386385|54350250|FG003|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
27851247|NCT01386385|54350251|FG004|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
27851248|NCT01386385|54350252|FG005|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
27851249|NCT01386385|54350253|FG006|Phase II: Consolidation Therapy|Refusal unrelated to AE|2|||
27851250|NCT01386385|54350254|FG007|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
27851251|NCT01386385|54350247|FG000|Phase II: Consolidation Therapy|Progression/relapse|0|||
27851252|NCT01386385|54350248|FG001|Phase II: Consolidation Therapy|Progression/relapse|0|||
27851253|NCT01386385|54350249|FG002|Phase II: Consolidation Therapy|Progression/relapse|0|||
27851254|NCT01386385|54350250|FG003|Phase II: Consolidation Therapy|Progression/relapse|0|||
27851255|NCT01386385|54350251|FG004|Phase II: Consolidation Therapy|Progression/relapse|0|||
27851256|NCT01386385|54350252|FG005|Phase II: Consolidation Therapy|Progression/relapse|0|||
27851257|NCT01386385|54350253|FG006|Phase II: Consolidation Therapy|Progression/relapse|1|||
27851258|NCT01386385|54350254|FG007|Phase II: Consolidation Therapy|Progression/relapse|1|||
27851259|NCT01248715|54350281|FG000|Overall Study|Not influenza positive|501|||
27851260|NCT01248715|54350282|FG001|Overall Study|Not influenza positive|510|||
27851261|NCT00937937|54350314|FG000|Overall Study|Adverse Event|6|||
27851262|NCT00937937|54350314|FG000|Overall Study|Withdrawal by Subject|2|||
27851263|NCT00937937|54350314|FG000|Overall Study|Progression/relapse|61|||
27851264|NCT00937937|54350314|FG000|Overall Study|Death|1|||
27851265|NCT00937937|54350314|FG000|Overall Study|Other|2|||
27851266|NCT00812214|54350348|FG000|Overall Study|Lost to Follow-up|3|||
27851267|NCT00812214|54350349|FG001|Overall Study|Lost to Follow-up|1|||
27851268|NCT00792948|54350356|FG000|Overall Study|Adverse Event|6|||
27851269|NCT00792948|54350356|FG000|Overall Study|Death|4|||
27851270|NCT00792948|54350356|FG000|Overall Study|Withdrawal by Subject|3|||
27851271|NCT00792948|54350356|FG000|Overall Study|Ineligible|2|||
27851272|NCT00792948|54350356|FG000|Overall Study|Insurance denial - not treated|1|||
27851273|NCT00792948|54350356|FG000|Overall Study|Physician Decision|11|||
27851274|NCT00792948|54350356|FG000|Overall Study|Protocol Violation|1|||
27851275|NCT00658814|54350365|FG000|Remission Induction Chemotherapy|Adverse Event|1|||
27851276|NCT00658814|54350366|FG001|Remission Induction Chemotherapy|Adverse Event|3|||
27851277|NCT00658814|54350365|FG000|Remission Induction Chemotherapy|Withdrawal by Subject|3|||
28159907|NCT02558296|54829985|FG001|Completed the Study|Adverse Event|5|||
28159908|NCT02558296|54829984|FG000|Completed the Study|Death|39|||
27851278|NCT00658814|54350366|FG001|Remission Induction Chemotherapy|Withdrawal by Subject|4|||
27851279|NCT00658814|54350365|FG000|Remission Induction Chemotherapy|Progression/Relapse|0|||
27851280|NCT00658814|54350366|FG001|Remission Induction Chemotherapy|Progression/Relapse|1|||
27851281|NCT00658814|54350365|FG000|Remission Induction Chemotherapy|Death|1|||
27851282|NCT00658814|54350366|FG001|Remission Induction Chemotherapy|Death|4|||
27851283|NCT00658814|54350365|FG000|Remission Induction Chemotherapy|Not protocol specified|2|||
27851284|NCT00658814|54350366|FG001|Remission Induction Chemotherapy|Not protocol specified|4|||
27851285|NCT00658814|54350365|FG000|Remission Induction Chemotherapy|Not eligible|1|||
27851286|NCT00658814|54350366|FG001|Remission Induction Chemotherapy|Not eligible|2|||
27851287|NCT00658814|54350365|FG000|Consolidation Therapy|Not protocol specified|0|||
27851288|NCT00658814|54350366|FG001|Consolidation Therapy|Not protocol specified|1|||
27851289|NCT00658814|54350365|FG000|Consolidation Therapy|Not eligible|2|||
27851290|NCT00658814|54350366|FG001|Consolidation Therapy|Not eligible|2|||
27851291|NCT00658814|54350365|FG000|Maintenance Therapy|Adverse Event|1|||
27851292|NCT00658814|54350366|FG001|Maintenance Therapy|Adverse Event|1|||
27851293|NCT00658814|54350365|FG000|Maintenance Therapy|Not protocol specified|1|||
27851294|NCT00658814|54350366|FG001|Maintenance Therapy|Not protocol specified|0|||
27851295|NCT00658814|54350365|FG000|Maintenance Therapy|Not eligible|1|||
27851296|NCT00658814|54350366|FG001|Maintenance Therapy|Not eligible|0|||
27851297|NCT00601900|54350378|FG000|Overall Study|Withdrawal by Subject|0|||
27851298|NCT00601900|54350379|FG001|Overall Study|Withdrawal by Subject|3|||
27851299|NCT00433511|54350388|FG000|Step 1|Adverse Event|50|||
27851300|NCT00433511|54350389|FG001|Step 1|Adverse Event|157|||
27851301|NCT00433511|54350390|FG002|Step 1|Adverse Event|153|||
27851302|NCT00433511|54350388|FG000|Step 1|Withdrawal by Subject|45|||
27851303|NCT00433511|54350389|FG001|Step 1|Withdrawal by Subject|143|||
27851304|NCT00433511|54350390|FG002|Step 1|Withdrawal by Subject|154|||
27851305|NCT00433511|54350388|FG000|Step 1|Death|3|||
27851306|NCT00433511|54350389|FG001|Step 1|Death|1|||
27851307|NCT00433511|54350390|FG002|Step 1|Death|1|||
27851308|NCT00433511|54350388|FG000|Step 1|Physician Decision|1|||
27851309|NCT00433511|54350389|FG001|Step 1|Physician Decision|4|||
27851310|NCT00433511|54350390|FG002|Step 1|Physician Decision|3|||
27851311|NCT00433511|54350388|FG000|Step 1|Never started protocol therapy|28|||
27851312|NCT00433511|54350389|FG001|Step 1|Never started protocol therapy|64|||
27851313|NCT00433511|54350390|FG002|Step 1|Never started protocol therapy|66|||
27851314|NCT00433511|54350388|FG000|Step 1|Alternative therapy|2|||
27851315|NCT00433511|54350389|FG001|Step 1|Alternative therapy|1|||
27851316|NCT00433511|54350390|FG002|Step 1|Alternative therapy|3|||
27851317|NCT00433511|54350388|FG000|Step 1|Disease progression, relapse|5|||
27851318|NCT00433511|54350389|FG001|Step 1|Disease progression, relapse|3|||
27851319|NCT00433511|54350390|FG002|Step 1|Disease progression, relapse|3|||
27851320|NCT00433511|54350388|FG000|Step 1|Other complicating disease|2|||
27851321|NCT00433511|54350389|FG001|Step 1|Other complicating disease|6|||
27851322|NCT00433511|54350390|FG002|Step 1|Other complicating disease|3|||
27851323|NCT00433511|54350388|FG000|Step 1|Non-breast cancer surgery/wound issues|0|||
27851324|NCT00433511|54350389|FG001|Step 1|Non-breast cancer surgery/wound issues|4|||
27851325|NCT00433511|54350390|FG002|Step 1|Non-breast cancer surgery/wound issues|1|||
27851326|NCT00433511|54350388|FG000|Step 1|Suspected recurrence|0|||
27851327|NCT00433511|54350389|FG001|Step 1|Suspected recurrence|1|||
27851328|NCT00433511|54350390|FG002|Step 1|Suspected recurrence|0|||
27851329|NCT00433511|54350388|FG000|Step 1|Insurance/drug distribution issues|0|||
27851330|NCT00433511|54350389|FG001|Step 1|Insurance/drug distribution issues|1|||
27851331|NCT00433511|54350390|FG002|Step 1|Insurance/drug distribution issues|2|||
27851332|NCT00433511|54350388|FG000|Step 1|Patient moved|0|||
27851333|NCT00433511|54350389|FG001|Step 1|Patient moved|0|||
27851334|NCT00433511|54350390|FG002|Step 1|Patient moved|1|||
27851335|NCT00433511|54350388|FG000|Step 2 (Arm D)|Adverse Event|0|||
27851336|NCT00433511|54350389|FG001|Step 2 (Arm D)|Adverse Event|0|||
27851337|NCT00433511|54350390|FG002|Step 2 (Arm D)|Adverse Event|135|||
27851338|NCT00433511|54350388|FG000|Step 2 (Arm D)|Withdrawal by Subject|0|||
27851339|NCT00433511|54350389|FG001|Step 2 (Arm D)|Withdrawal by Subject|0|||
27851340|NCT00433511|54350390|FG002|Step 2 (Arm D)|Withdrawal by Subject|181|||
27851341|NCT00433511|54350388|FG000|Step 2 (Arm D)|Never started protocol therapy|0|||
27851342|NCT00433511|54350389|FG001|Step 2 (Arm D)|Never started protocol therapy|0|||
27851343|NCT00433511|54350390|FG002|Step 2 (Arm D)|Never started protocol therapy|148|||
27851344|NCT00433511|54350388|FG000|Step 2 (Arm D)|Physician Decision|0|||
27851345|NCT00433511|54350389|FG001|Step 2 (Arm D)|Physician Decision|0|||
27851346|NCT00433511|54350390|FG002|Step 2 (Arm D)|Physician Decision|9|||
27851347|NCT00433511|54350388|FG000|Step 2 (Arm D)|Disease progression, relapse|0|||
27851348|NCT00433511|54350389|FG001|Step 2 (Arm D)|Disease progression, relapse|0|||
27851349|NCT00433511|54350390|FG002|Step 2 (Arm D)|Disease progression, relapse|7|||
27851350|NCT00433511|54350388|FG000|Step 2 (Arm D)|Other complicating disease|0|||
27851351|NCT00433511|54350389|FG001|Step 2 (Arm D)|Other complicating disease|0|||
27851352|NCT00433511|54350390|FG002|Step 2 (Arm D)|Other complicating disease|3|||
27851353|NCT00433511|54350388|FG000|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
27851354|NCT00433511|54350389|FG001|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
27851355|NCT00433511|54350390|FG002|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2|||
27851356|NCT00433511|54350388|FG000|Step 2 (Arm D)|Suspected recurrence|0|||
27851357|NCT00433511|54350389|FG001|Step 2 (Arm D)|Suspected recurrence|0|||
27851358|NCT00433511|54350390|FG002|Step 2 (Arm D)|Suspected recurrence|1|||
27851359|NCT00433511|54350388|FG000|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
27851360|NCT00433511|54350389|FG001|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
27851361|NCT00433511|54350390|FG002|Step 2 (Arm D)|Insurance/drug distribution issues|4|||
27851362|NCT00433511|54350388|FG000|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
27851363|NCT00433511|54350389|FG001|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
27851364|NCT00433511|54350390|FG002|Step 2 (Arm D)|Unknown (Missing off treatment form)|1|||
27851365|NCT00324805|54350403|FG000|Overall Study|Adverse Event|62|||
27851366|NCT00324805|54350404|FG001|Overall Study|Adverse Event|203|||
27851367|NCT00324805|54350403|FG000|Overall Study|Progression|7|||
27851368|NCT00324805|54350404|FG001|Overall Study|Progression|35|||
27851369|NCT00324805|54350403|FG000|Overall Study|Withdrawal by Subject|51|||
27851370|NCT00324805|54350404|FG001|Overall Study|Withdrawal by Subject|174|||
27851371|NCT00324805|54350403|FG000|Overall Study|Death|6|||
27851372|NCT00324805|54350404|FG001|Overall Study|Death|9|||
27851373|NCT00324805|54350403|FG000|Overall Study|Alternative therapy|4|||
27851374|NCT00324805|54350404|FG001|Overall Study|Alternative therapy|8|||
27851375|NCT00324805|54350403|FG000|Overall Study|Other complicating disease|1|||
27851376|NCT00324805|54350404|FG001|Overall Study|Other complicating disease|9|||
27851377|NCT00324805|54350403|FG000|Overall Study|Other reasons|7|||
27851378|NCT00324805|54350404|FG001|Overall Study|Other reasons|26|||
27851379|NCT00324805|54350403|FG000|Overall Study|Other|0|||
27851380|NCT00324805|54350404|FG001|Overall Study|Other|2|||
27851381|NCT00324805|54350403|FG000|Overall Study|Did not start therapy|12|||
27851382|NCT00324805|54350404|FG001|Overall Study|Did not start therapy|17|||
27851383|NCT00217425|54350427|FG000|Overall Study|Never started treatment|2|||
27851384|NCT00217425|54350427|FG000|Overall Study|Patient ineligible|5|||
27851385|NCT00217425|54350427|FG000|Overall Study|Lack of Efficacy|13|||
27851386|NCT00217425|54350427|FG000|Overall Study|Adverse Event|8|||
27851387|NCT00217425|54350427|FG000|Overall Study|Withdrawal by Subject|4|||
27851388|NCT00217425|54350427|FG000|Overall Study|Other complicating disease|1|||
27851389|NCT00217425|54350427|FG000|Overall Study|Other|4|||
27851390|NCT00070499|54350435|FG000|Overall Study|Adverse Event|6|||
27851391|NCT00070499|54350436|FG001|Overall Study|Adverse Event|6|||
27851392|NCT00070499|54350437|FG002|Overall Study|Adverse Event|19|||
27943410|NCT04066491|54600325|FG000|Overall Study|Treatment completed/discontinued and in follow-up,|2|||
27943411|NCT04066491|54600326|FG001|Overall Study|Treatment completed/discontinued and in follow-up,|39|||
27943412|NCT04066491|54600327|FG002|Overall Study|Treatment completed/discontinued and in follow-up,|41|||
27943413|NCT04066491|54600325|FG000|Overall Study|Randomized, not treated|0|||
27943414|NCT04066491|54600326|FG001|Overall Study|Randomized, not treated|0|||
27943415|NCT04066491|54600327|FG002|Overall Study|Randomized, not treated|2|||
27943416|NCT01151280|54600336|FG000|Overall Study|Adverse Event|1|||
27943417|NCT01151280|54600336|FG000|Overall Study|Lack of Efficacy|3|||
27943418|NCT01149486|54600342|FG000|First Intervention|Adverse Event|0|||
27943419|NCT01149486|54600343|FG001|First Intervention|Adverse Event|1|||
27943420|NCT00601705|54600349|FG000|Overall Study|Withdrawal by Subject|1|||
27943421|NCT01179737|54600358|FG000|Cohort 1 & Cohort 2|Adverse Event|3|||
27943422|NCT01179737|54600359|FG001|Cohort 1 & Cohort 2|Adverse Event|1|||
27830981|NCT01820585|54306910|FG001|Overall Study|Adverse Event|13|||
27830982|NCT01820585|54306911|FG002|Overall Study|Adverse Event|23|||
27830983|NCT01820585|54306912|FG003|Overall Study|Adverse Event|34|||
27830984|NCT01820585|54306909|FG000|Overall Study|Lack of Efficacy|9|||
27830985|NCT01820585|54306910|FG001|Overall Study|Lack of Efficacy|7|||
27830986|NCT01820585|54306911|FG002|Overall Study|Lack of Efficacy|5|||
27830987|NCT01820585|54306912|FG003|Overall Study|Lack of Efficacy|1|||
27830988|NCT01820585|54306909|FG000|Overall Study|Withdrawal by Subject|3|||
27830989|NCT01820585|54306910|FG001|Overall Study|Withdrawal by Subject|7|||
27830990|NCT01820585|54306911|FG002|Overall Study|Withdrawal by Subject|3|||
27830991|NCT01820585|54306912|FG003|Overall Study|Withdrawal by Subject|8|||
27830992|NCT01820585|54306909|FG000|Overall Study|Lost to Follow-up|3|||
27830993|NCT01820585|54306910|FG001|Overall Study|Lost to Follow-up|3|||
27851393|NCT00070499|54350438|FG003|Overall Study|Adverse Event|15|||
27830994|NCT01820585|54306911|FG002|Overall Study|Lost to Follow-up|0|||
27830995|NCT01820585|54306912|FG003|Overall Study|Lost to Follow-up|3|||
27830996|NCT01820585|54306909|FG000|Overall Study|Protocol Violation|3|||
27830997|NCT01820585|54306910|FG001|Overall Study|Protocol Violation|1|||
27830998|NCT01820585|54306911|FG002|Overall Study|Protocol Violation|1|||
27851394|NCT00070499|54350435|FG000|Overall Study|Refusal unrelated to adverse effects|7|||
27851395|NCT00070499|54350436|FG001|Overall Study|Refusal unrelated to adverse effects|5|||
27830999|NCT01820585|54306912|FG003|Overall Study|Protocol Violation|1|||
27943423|NCT01179737|54600360|FG002|Cohort 1 & Cohort 2|Adverse Event|1|||
27831000|NCT01820585|54306909|FG000|Overall Study|Subject non-compliance|0|||
27943424|NCT01179737|54600361|FG003|Cohort 1 & Cohort 2|Adverse Event|0|||
27851396|NCT00070499|54350437|FG002|Overall Study|Refusal unrelated to adverse effects|5|||
27851397|NCT00070499|54350438|FG003|Overall Study|Refusal unrelated to adverse effects|8|||
27851398|NCT00070499|54350435|FG000|Overall Study|Progression/relapse|4|||
27851399|NCT00070499|54350436|FG001|Overall Study|Progression/relapse|2|||
28076929|NCT00093470|54731703|FG000|Overall Study|ANC < 1000 on day 1 of cycle 1|1|||
28076930|NCT00093470|54731704|FG001|Overall Study|ANC < 1000 on day 1 of cycle 1|0|||
28076931|NCT00407537|54731712|FG000|Overall Study|Death|5|||
27831001|NCT01820585|54306910|FG001|Overall Study|Subject non-compliance|0|||
27831002|NCT01820585|54306911|FG002|Overall Study|Subject non-compliance|1|||
27831003|NCT01820585|54306912|FG003|Overall Study|Subject non-compliance|2|||
27831004|NCT01820585|54306909|FG000|Overall Study|at sponsor request|0|||
27851400|NCT00070499|54350437|FG002|Overall Study|Progression/relapse|1|||
27851401|NCT00070499|54350438|FG003|Overall Study|Progression/relapse|4|||
27851402|NCT00070499|54350435|FG000|Overall Study|Death|1|||
27851403|NCT00070499|54350436|FG001|Overall Study|Death|1|||
27851404|NCT00070499|54350437|FG002|Overall Study|Death|1|||
27831005|NCT01820585|54306910|FG001|Overall Study|at sponsor request|0|||
27831006|NCT01820585|54306911|FG002|Overall Study|at sponsor request|1|||
27831007|NCT01820585|54306912|FG003|Overall Study|at sponsor request|0|||
27831008|NCT01820585|54306909|FG000|Overall Study|Pregnancy|0|||
27831009|NCT01820585|54306910|FG001|Overall Study|Pregnancy|1|||
27831010|NCT01820585|54306911|FG002|Overall Study|Pregnancy|0|||
27831011|NCT01820585|54306912|FG003|Overall Study|Pregnancy|0|||
27831012|NCT01797263|54306924|FG000|Overall Study|Withdrawal by Subject|21|||
27831013|NCT01797263|54306925|FG001|Overall Study|Withdrawal by Subject|25|||
27831014|NCT01797263|54306924|FG000|Overall Study|Death|1|||
27831015|NCT01797263|54306925|FG001|Overall Study|Death|0|||
27831016|NCT01797263|54306924|FG000|Overall Study|Lost to Follow-up|15|||
27851405|NCT00070499|54350438|FG003|Overall Study|Death|2|||
27851406|NCT00070499|54350435|FG000|Overall Study|Other - not protocol specified|7|||
27851407|NCT00070499|54350436|FG001|Overall Study|Other - not protocol specified|3|||
27851408|NCT00070499|54350437|FG002|Overall Study|Other - not protocol specified|12|||
27851409|NCT00070499|54350438|FG003|Overall Study|Other - not protocol specified|20|||
27851410|NCT00070499|54350435|FG000|Overall Study|Still on protocol treatment|10|||
27851411|NCT00070499|54350436|FG001|Overall Study|Still on protocol treatment|4|||
27851412|NCT00070499|54350437|FG002|Overall Study|Still on protocol treatment|79|||
27851413|NCT00070499|54350438|FG003|Overall Study|Still on protocol treatment|57|||
27851414|NCT00070499|54350435|FG000|Overall Study|Did not start treatment|1|||
27851415|NCT00070499|54350436|FG001|Overall Study|Did not start treatment|0|||
27851416|NCT00070499|54350437|FG002|Overall Study|Did not start treatment|0|||
27851417|NCT00070499|54350438|FG003|Overall Study|Did not start treatment|2|||
27851418|NCT00070499|54350435|FG000|Overall Study|Not eligible|2|||
27851419|NCT00070499|54350436|FG001|Overall Study|Not eligible|5|||
27851420|NCT00070499|54350437|FG002|Overall Study|Not eligible|3|||
27851421|NCT00070499|54350438|FG003|Overall Study|Not eligible|2|||
27851422|NCT03208231|54350496|FG000|Overall Study|Death|1|||
27851423|NCT03208231|54350497|FG001|Overall Study|Death|2|||
27851424|NCT03208231|54350496|FG000|Overall Study|Moved and unable to get to clinic|1|||
27851425|NCT03208231|54350497|FG001|Overall Study|Moved and unable to get to clinic|0|||
27851426|NCT03208231|54350496|FG000|Overall Study|Unwilling to adhere to study requirements|0|||
27851427|NCT03208231|54350497|FG001|Overall Study|Unwilling to adhere to study requirements|1|||
27851428|NCT03102242|54350520|FG000|Overall Study|Adverse Event|2|||
27851429|NCT03097328|54350524|FG000|Overall Study|Still on Therapy|2|||
27851430|NCT03097328|54350524|FG000|Overall Study|Progressive Disease|29|||
27851431|NCT03097328|54350524|FG000|Overall Study|Adverse Event|4|||
27851432|NCT03097328|54350524|FG000|Overall Study|Withdrawal by Subject|1|||
27851433|NCT03097328|54350524|FG000|Overall Study|Physician Decision|1|||
27851434|NCT03097328|54350524|FG000|Overall Study|Patient Decision|1|||
27851435|NCT03097328|54350524|FG000|Overall Study|Ineligible for Study Drug|1|||
27831017|NCT01797263|54306925|FG001|Overall Study|Lost to Follow-up|15|||
27831018|NCT01797185|54306980|FG000|Overall Study|Adverse Event|5|||
27851436|NCT03033602|54350530|FG000|Overall Study|Withdrawal by Subject|11|||
28076932|NCT00407537|54731713|FG001|Overall Study|Death|2|||
27831019|NCT01797185|54306981|FG001|Overall Study|Adverse Event|15|||
27831020|NCT01797185|54306982|FG002|Overall Study|Adverse Event|6|||
27851437|NCT03033602|54350531|FG001|Overall Study|Withdrawal by Subject|21|||
27851438|NCT03033602|54350530|FG000|Overall Study|discontinued for medical reason or decision by study team|9|||
27851439|NCT03033602|54350531|FG001|Overall Study|discontinued for medical reason or decision by study team|16|||
27851440|NCT02994784|54350542|FG000|6 Months Follow-up|Lost to Follow-up|3|||
27851441|NCT02948829|54350546|FG000|Overall Study|Lost to Follow-up|2|||
27851442|NCT02948829|54350546|FG000|Overall Study|Withdrawal by Subject and/or Subject's Parent(s)/ Legally Authorized Representative (LAR)|5|||
27851443|NCT02948829|54350546|FG000|Overall Study|Pregnancy|1|||
27851444|NCT02948829|54350546|FG000|Overall Study|Other: Reason not Specified|8|||
27851445|NCT02908685|54350577|FG000|Part 1 Exploratory|Withdrawal by Subject|0|||
27851446|NCT02908685|54350578|FG001|Part 1 Exploratory|Withdrawal by Subject|1|||
27851447|NCT02908685|54350579|FG002|Part 1 Exploratory|Withdrawal by Subject|0|||
27851448|NCT02908685|54350580|FG003|Part 1 Exploratory|Withdrawal by Subject|0|||
27851449|NCT02908685|54350581|FG004|Part 1 Exploratory|Withdrawal by Subject|0|||
27851450|NCT02908685|54350582|FG005|Part 1 Exploratory|Withdrawal by Subject|0|||
27851451|NCT02908685|54350583|FG006|Part 1 Exploratory|Withdrawal by Subject|0|||
27851452|NCT02908685|54350584|FG007|Part 1 Exploratory|Withdrawal by Subject|0|||
27831021|NCT01797185|54306980|FG000|Overall Study|Withdrawal by Subject|6|||
27831022|NCT01797185|54306981|FG001|Overall Study|Withdrawal by Subject|9|||
27831023|NCT01797185|54306982|FG002|Overall Study|Withdrawal by Subject|5|||
27831024|NCT01797185|54306980|FG000|Overall Study|Site terminated|8|||
27831025|NCT01797185|54306981|FG001|Overall Study|Site terminated|4|||
27831026|NCT01797185|54306982|FG002|Overall Study|Site terminated|0|||
27831027|NCT01797185|54306980|FG000|Overall Study|Lost to Follow-up|2|||
27831028|NCT01797185|54306981|FG001|Overall Study|Lost to Follow-up|6|||
27831029|NCT01797185|54306982|FG002|Overall Study|Lost to Follow-up|1|||
27831030|NCT01797185|54306980|FG000|Overall Study|Withdrawn per sponsor|5|||
27831031|NCT01797185|54306981|FG001|Overall Study|Withdrawn per sponsor|0|||
27831032|NCT01797185|54306982|FG002|Overall Study|Withdrawn per sponsor|0|||
27831033|NCT01797185|54306980|FG000|Overall Study|Physician Decision|1|||
27831034|NCT01797185|54306981|FG001|Overall Study|Physician Decision|3|||
27831035|NCT01797185|54306982|FG002|Overall Study|Physician Decision|0|||
27831036|NCT01797185|54306980|FG000|Overall Study|Protocol Violation|1|||
27831037|NCT01797185|54306981|FG001|Overall Study|Protocol Violation|1|||
27831038|NCT01797185|54306982|FG002|Overall Study|Protocol Violation|0|||
27831039|NCT01819727|54307038|FG000|Overall Study|Adverse Event|8|||
27831040|NCT01819727|54307039|FG001|Overall Study|Adverse Event|9|||
27831041|NCT01819727|54307038|FG000|Overall Study|Death|1|||
27831042|NCT01819727|54307039|FG001|Overall Study|Death|0|||
27831043|NCT01819727|54307038|FG000|Overall Study|Lost to Follow-up|1|||
27831044|NCT01819727|54307039|FG001|Overall Study|Lost to Follow-up|1|||
27831045|NCT01819727|54307038|FG000|Overall Study|Physician Decision|3|||
27831046|NCT01819727|54307039|FG001|Overall Study|Physician Decision|2|||
27831047|NCT01819727|54307038|FG000|Overall Study|Pregnancy|1|||
27831048|NCT01819727|54307039|FG001|Overall Study|Pregnancy|0|||
27831049|NCT01819727|54307038|FG000|Overall Study|Protocol Violation|0|||
27851453|NCT02908685|54350585|FG008|Part 1 Exploratory|Withdrawal by Subject|0|||
27851454|NCT02908685|54350586|FG009|Part 1 Exploratory|Withdrawal by Subject|0|||
27851455|NCT02908685|54350587|FG010|Part 1 Exploratory|Withdrawal by Subject|0|||
27851456|NCT02908685|54350588|FG011|Part 1 Exploratory|Withdrawal by Subject|0|||
27851457|NCT02908685|54350577|FG000|Part 2 Confirmatory|Changed to Spinraza|0|||
27851458|NCT02908685|54350578|FG001|Part 2 Confirmatory|Changed to Spinraza|0|||
27851459|NCT02908685|54350579|FG002|Part 2 Confirmatory|Changed to Spinraza|0|||
27851460|NCT02908685|54350580|FG003|Part 2 Confirmatory|Changed to Spinraza|0|||
27851461|NCT02908685|54350581|FG004|Part 2 Confirmatory|Changed to Spinraza|0|||
27851462|NCT02908685|54350582|FG005|Part 2 Confirmatory|Changed to Spinraza|0|||
27851463|NCT02908685|54350583|FG006|Part 2 Confirmatory|Changed to Spinraza|0|||
27851464|NCT02908685|54350584|FG007|Part 2 Confirmatory|Changed to Spinraza|0|||
27851465|NCT02908685|54350585|FG008|Part 2 Confirmatory|Changed to Spinraza|0|||
27851466|NCT02908685|54350586|FG009|Part 2 Confirmatory|Changed to Spinraza|0|||
27851467|NCT02908685|54350587|FG010|Part 2 Confirmatory|Changed to Spinraza|2|||
27851468|NCT02908685|54350588|FG011|Part 2 Confirmatory|Changed to Spinraza|1|||
27851469|NCT02908685|54350577|FG000|Part 2 Confirmatory|Changed to other treatment|0|||
27851470|NCT02908685|54350578|FG001|Part 2 Confirmatory|Changed to other treatment|0|||
27851471|NCT02908685|54350579|FG002|Part 2 Confirmatory|Changed to other treatment|0|||
27851472|NCT02908685|54350580|FG003|Part 2 Confirmatory|Changed to other treatment|0|||
27851473|NCT02908685|54350581|FG004|Part 2 Confirmatory|Changed to other treatment|0|||
28076933|NCT00407537|54731712|FG000|Overall Study|Adverse Event|36|||
27831050|NCT01819727|54307039|FG001|Overall Study|Protocol Violation|2|||
27831051|NCT01819727|54307038|FG000|Overall Study|Study Terminated by Sponsor|0|||
27831052|NCT01819727|54307039|FG001|Overall Study|Study Terminated by Sponsor|1|||
27831053|NCT01819727|54307038|FG000|Overall Study|Withdrawal by Subject|6|||
27831054|NCT01819727|54307039|FG001|Overall Study|Withdrawal by Subject|11|||
27851474|NCT02908685|54350582|FG005|Part 2 Confirmatory|Changed to other treatment|0|||
27851475|NCT02908685|54350583|FG006|Part 2 Confirmatory|Changed to other treatment|0|||
27851476|NCT02908685|54350584|FG007|Part 2 Confirmatory|Changed to other treatment|0|||
27851477|NCT02908685|54350585|FG008|Part 2 Confirmatory|Changed to other treatment|0|||
27851478|NCT02908685|54350586|FG009|Part 2 Confirmatory|Changed to other treatment|0|||
27851479|NCT02908685|54350587|FG010|Part 2 Confirmatory|Changed to other treatment|1|||
27851480|NCT02908685|54350588|FG011|Part 2 Confirmatory|Changed to other treatment|0|||
27851481|NCT02617446|54350617|FG000|Overall Study|Withdrawal by Subject|0|||
27851482|NCT02617446|54350618|FG001|Overall Study|Withdrawal by Subject|2|||
27851483|NCT02617446|54350619|FG002|Overall Study|Withdrawal by Subject|0|||
27851484|NCT02617446|54350617|FG000|Overall Study|Adverse Event|1|||
27851485|NCT02617446|54350618|FG001|Overall Study|Adverse Event|0|||
27851486|NCT02617446|54350619|FG002|Overall Study|Adverse Event|5|||
27851487|NCT02617446|54350617|FG000|Overall Study|Lost to Follow-up|3|||
27851488|NCT02617446|54350618|FG001|Overall Study|Lost to Follow-up|0|||
27851489|NCT02617446|54350619|FG002|Overall Study|Lost to Follow-up|0|||
27851490|NCT02617446|54350617|FG000|Overall Study|Death|0|||
27851491|NCT02617446|54350618|FG001|Overall Study|Death|0|||
27851492|NCT02617446|54350619|FG002|Overall Study|Death|2|||
27851493|NCT02549170|54350633|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|17|||
27851494|NCT02549170|54350634|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|4|||
27851495|NCT02549170|54350635|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
27851496|NCT02549170|54350636|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
27851497|NCT02549170|54350637|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
27851498|NCT02549170|54350633|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|5|||
27851499|NCT02549170|54350634|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|2|||
27831055|NCT01819727|54307038|FG000|Overall Study|Unable to demostrate ability self-inject|0|||
27831056|NCT01819727|54307039|FG001|Overall Study|Unable to demostrate ability self-inject|1|||
27831057|NCT01819727|54307038|FG000|Overall Study|Quit due to lack of health benifits|0|||
27831058|NCT01819727|54307039|FG001|Overall Study|Quit due to lack of health benifits|1|||
27831059|NCT01795937|54307098|FG000|Overall Study|Withdrawal by Subject|1|||
27831060|NCT01795937|54307099|FG001|Overall Study|Withdrawal by Subject|0|||
27831061|NCT01795937|54307100|FG002|Overall Study|Withdrawal by Subject|0|||
27831062|NCT01795937|54307098|FG000|Overall Study|Physician Decision|0|||
27831063|NCT01795937|54307099|FG001|Overall Study|Physician Decision|1|||
27831064|NCT01795937|54307100|FG002|Overall Study|Physician Decision|0|||
27831065|NCT01817777|54307142|FG000|Observational Phase (8 Weeks)|Lost to Follow-up|3|||
27831066|NCT01817777|54307143|FG001|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
27831067|NCT01817777|54307144|FG002|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
27831068|NCT01817777|54307142|FG000|Observational Phase (8 Weeks)|Early Study Termination|2|||
27831069|NCT01817777|54307143|FG001|Observational Phase (8 Weeks)|Early Study Termination|0|||
27831070|NCT01817777|54307144|FG002|Observational Phase (8 Weeks)|Early Study Termination|0|||
27831071|NCT01817777|54307142|FG000|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
27831072|NCT01817777|54307143|FG001|Interventional Phase (20 Weeks)|Withdrawal by Subject|3|||
27831073|NCT01817777|54307144|FG002|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
27831074|NCT01817777|54307142|FG000|Interventional Phase (20 Weeks)|Lost to Follow-up|0|||
27831075|NCT01817777|54307143|FG001|Interventional Phase (20 Weeks)|Lost to Follow-up|1|||
27851500|NCT02549170|54350635|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
27851501|NCT02549170|54350636|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
27851502|NCT02549170|54350637|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
27851503|NCT02549170|54350633|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|2|||
27851504|NCT02549170|54350634|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|8|||
27851505|NCT02549170|54350635|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
27851506|NCT02549170|54350636|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
27851507|NCT02549170|54350637|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
27851508|NCT02476916|54350654|FG000|Core Period|Adverse Event|2|||
27851509|NCT02476916|54350655|FG001|Core Period|Adverse Event|2|||
27851510|NCT02476916|54350654|FG000|Core Period|Investigator decision|1|||
27851511|NCT02476916|54350655|FG001|Core Period|Investigator decision|1|||
27851512|NCT02476916|54350654|FG000|Core Period|Withdrawal by Subject|3|||
28076934|NCT00407537|54731713|FG001|Overall Study|Adverse Event|0|||
27851513|NCT02476916|54350655|FG001|Core Period|Withdrawal by Subject|0|||
27851514|NCT02476916|54350654|FG000|Extension Period|Prematurely Discontinued Treatment|6|||
27851515|NCT02476916|54350655|FG001|Extension Period|Prematurely Discontinued Treatment|1|||
27851516|NCT02476916|54350654|FG000|Extension Period|On Treatment|12|||
27851517|NCT02476916|54350655|FG001|Extension Period|On Treatment|17|||
27851518|NCT02410902|54350664|FG000|Overall Study|Adverse Event|2|||
27851519|NCT02410902|54350665|FG001|Overall Study|Adverse Event|3|||
27851520|NCT02410902|54350664|FG000|Overall Study|Lost to Follow-up|4|||
27851521|NCT02410902|54350665|FG001|Overall Study|Lost to Follow-up|1|||
27851522|NCT02410902|54350664|FG000|Overall Study|Protocol Violation|1|||
27851523|NCT02410902|54350665|FG001|Overall Study|Protocol Violation|4|||
27851524|NCT02410902|54350664|FG000|Overall Study|Withdrawal by Subject|6|||
27851525|NCT02410902|54350665|FG001|Overall Study|Withdrawal by Subject|8|||
27851526|NCT02410902|54350664|FG000|Overall Study|Non-Compliance|8|||
27851527|NCT02410902|54350665|FG001|Overall Study|Non-Compliance|2|||
27851528|NCT02101736|54350675|FG000|Overall Study|Protocol Violation|3|||
27851529|NCT02101736|54350676|FG001|Overall Study|Protocol Violation|0|||
27851530|NCT02101736|54350675|FG000|Overall Study|Withdrawal by Subject|1|||
27851531|NCT02101736|54350676|FG001|Overall Study|Withdrawal by Subject|1|||
27851532|NCT01918397|54350688|FG000|Overall Study|Never started treatment|2|||
27851533|NCT01918397|54350689|FG001|Overall Study|Never started treatment|1|||
27851534|NCT01918397|54350690|FG002|Overall Study|Never started treatment|0|||
27851535|NCT01918397|54350691|FG003|Overall Study|Never started treatment|0|||
27851536|NCT01918397|54350688|FG000|Overall Study|Adverse Event|1|||
27851537|NCT01918397|54350689|FG001|Overall Study|Adverse Event|1|||
27851538|NCT01918397|54350690|FG002|Overall Study|Adverse Event|1|||
27851539|NCT01918397|54350691|FG003|Overall Study|Adverse Event|0|||
27851540|NCT01918397|54350688|FG000|Overall Study|Lack of compliance|2|||
27851541|NCT01918397|54350689|FG001|Overall Study|Lack of compliance|2|||
27943425|NCT01179737|54600358|FG000|Cohort 1 & Cohort 2|Withdrew consent|2|||
28076935|NCT00407537|54731712|FG000|Overall Study|Lost to Follow-up|12|||
28076936|NCT00407537|54731713|FG001|Overall Study|Lost to Follow-up|19|||
28076937|NCT00407537|54731712|FG000|Overall Study|Other|6|||
28076938|NCT00407537|54731713|FG001|Overall Study|Other|7|||
28076939|NCT00407537|54731712|FG000|Overall Study|Withdrawal by Subject|34|||
28076940|NCT00407537|54731713|FG001|Overall Study|Withdrawal by Subject|16|||
28076941|NCT00094458|54731722|FG000|Main Study: Through Week 30|Eligibility criteria not met|3|||
28076942|NCT00094458|54731723|FG001|Main Study: Through Week 30|Eligibility criteria not met|8|||
28076943|NCT00094458|54731724|FG002|Main Study: Through Week 30|Eligibility criteria not met|2|||
28076944|NCT00094458|54731725|FG003|Main Study: Through Week 30|Eligibility criteria not met|0|||
28076945|NCT00094458|54731726|FG004|Main Study: Through Week 30|Eligibility criteria not met|0|||
28076946|NCT00094458|54731727|FG005|Main Study: Through Week 30|Eligibility criteria not met|0|||
28076947|NCT00094458|54731722|FG000|Main Study: Through Week 30|Lost to Follow-up|5|||
28076948|NCT00094458|54731723|FG001|Main Study: Through Week 30|Lost to Follow-up|5|||
28076949|NCT00094458|54731724|FG002|Main Study: Through Week 30|Lost to Follow-up|2|||
28076950|NCT00094458|54731725|FG003|Main Study: Through Week 30|Lost to Follow-up|0|||
28076951|NCT00094458|54731726|FG004|Main Study: Through Week 30|Lost to Follow-up|0|||
28076952|NCT00094458|54731727|FG005|Main Study: Through Week 30|Lost to Follow-up|0|||
28076953|NCT00094458|54731722|FG000|Main Study: Through Week 30|Withdrawal by Subject|18|||
28159909|NCT02558296|54829985|FG001|Completed the Study|Death|25|||
28159910|NCT02558296|54829984|FG000|Completed the Study|Lost to Follow-up|31|||
28159911|NCT02558296|54829985|FG001|Completed the Study|Lost to Follow-up|23|||
28159912|NCT02558296|54829984|FG000|Completed the Study|Physician Decision|6|||
28159913|NCT02558296|54829985|FG001|Completed the Study|Physician Decision|0|||
28159914|NCT02558296|54829984|FG000|Completed the Study|Protocol Violation|2|||
28159915|NCT02558296|54829985|FG001|Completed the Study|Protocol Violation|1|||
28159916|NCT02558296|54829984|FG000|Completed the Study|Withdrawal by Subject|53|||
28159917|NCT02558296|54829985|FG001|Completed the Study|Withdrawal by Subject|31|||
28159918|NCT02558296|54829984|FG000|Completed the Study|The subject was randomized, but did not take any investigational product|1|||
28159919|NCT02558296|54829985|FG001|Completed the Study|The subject was randomized, but did not take any investigational product|0|||
28159920|NCT02737475|54830022|FG000|Overall Study|Other reasons|0|||
28159921|NCT02737475|54830023|FG001|Overall Study|Other reasons|0|||
27831076|NCT01817777|54307144|FG002|Interventional Phase (20 Weeks)|Lost to Follow-up|2|||
27831077|NCT01817777|54307142|FG000|Interventional Phase (20 Weeks)|Early Study Termination|0|||
27831078|NCT01817777|54307143|FG001|Interventional Phase (20 Weeks)|Early Study Termination|1|||
27831079|NCT01817777|54307144|FG002|Interventional Phase (20 Weeks)|Early Study Termination|3|||
27831080|NCT01795547|54307170|FG000|Overall Study|Adverse Event|16|||
27831081|NCT01795547|54307171|FG001|Overall Study|Adverse Event|27|||
27831082|NCT01795547|54307170|FG000|Overall Study|Lack of Efficacy|8|||
27831083|NCT01795547|54307171|FG001|Overall Study|Lack of Efficacy|3|||
27831084|NCT01795547|54307170|FG000|Overall Study|Protocol Violation|6|||
27831085|NCT01795547|54307171|FG001|Overall Study|Protocol Violation|4|||
27831086|NCT01795547|54307170|FG000|Overall Study|Lost to Follow-up|2|||
27831087|NCT01795547|54307171|FG001|Overall Study|Lost to Follow-up|5|||
27831088|NCT01795547|54307170|FG000|Overall Study|Withdrawal of consent|7|||
27831089|NCT01795547|54307171|FG001|Overall Study|Withdrawal of consent|12|||
27831090|NCT01795547|54307170|FG000|Overall Study|Not Treated|4|||
27831091|NCT01795547|54307171|FG001|Overall Study|Not Treated|10|||
27831092|NCT01795547|54307170|FG000|Overall Study|Non-compliance with IMP|1|||
27831093|NCT01795547|54307171|FG001|Overall Study|Non-compliance with IMP|1|||
27831094|NCT01795547|54307170|FG000|Overall Study|Others|4|||
27831095|NCT01795547|54307171|FG001|Overall Study|Others|1|||
28076954|NCT00094458|54731723|FG001|Main Study: Through Week 30|Withdrawal by Subject|9|||
28159922|NCT02737475|54830024|FG002|Overall Study|Other reasons|0|||
27851542|NCT01918397|54350690|FG002|Overall Study|Lack of compliance|3|||
27851543|NCT01918397|54350691|FG003|Overall Study|Lack of compliance|0|||
27851544|NCT01918397|54350688|FG000|Overall Study|Pregnancy|0|||
27851545|NCT01918397|54350689|FG001|Overall Study|Pregnancy|1|||
27851546|NCT01918397|54350690|FG002|Overall Study|Pregnancy|0|||
27851547|NCT01918397|54350691|FG003|Overall Study|Pregnancy|0|||
27851548|NCT01918397|54350688|FG000|Overall Study|Rifampin susceptible|0|||
27851549|NCT01918397|54350689|FG001|Overall Study|Rifampin susceptible|0|||
27851550|NCT01918397|54350690|FG002|Overall Study|Rifampin susceptible|0|||
27851551|NCT01918397|54350691|FG003|Overall Study|Rifampin susceptible|2|||
27851552|NCT01918397|54350688|FG000|Overall Study|Treatment failure|0|||
27851553|NCT01918397|54350689|FG001|Overall Study|Treatment failure|0|||
27851554|NCT01918397|54350690|FG002|Overall Study|Treatment failure|0|||
27851555|NCT01918397|54350691|FG003|Overall Study|Treatment failure|1|||
27851556|NCT01918397|54350688|FG000|Overall Study|Withdrawal by Subject|3|||
27851557|NCT01918397|54350689|FG001|Overall Study|Withdrawal by Subject|2|||
27851558|NCT01918397|54350690|FG002|Overall Study|Withdrawal by Subject|1|||
27851559|NCT01918397|54350691|FG003|Overall Study|Withdrawal by Subject|1|||
27851560|NCT01918397|54350688|FG000|Overall Study|XDR at baseline|0|||
27851561|NCT01918397|54350689|FG001|Overall Study|XDR at baseline|0|||
27851562|NCT01918397|54350690|FG002|Overall Study|XDR at baseline|1|||
27851563|NCT01918397|54350691|FG003|Overall Study|XDR at baseline|0|||
27851564|NCT01918397|54350688|FG000|Overall Study|Lost to Follow-up|2|||
27851565|NCT01918397|54350689|FG001|Overall Study|Lost to Follow-up|1|||
27851566|NCT01918397|54350690|FG002|Overall Study|Lost to Follow-up|1|||
27851567|NCT01918397|54350691|FG003|Overall Study|Lost to Follow-up|1|||
27851568|NCT01918397|54350688|FG000|Overall Study|Increased QTc|1|||
27851569|NCT01918397|54350689|FG001|Overall Study|Increased QTc|0|||
27851570|NCT01918397|54350690|FG002|Overall Study|Increased QTc|0|||
27851571|NCT01918397|54350691|FG003|Overall Study|Increased QTc|1|||
27851572|NCT01918397|54350688|FG000|Overall Study|Death|0|||
27851573|NCT01918397|54350689|FG001|Overall Study|Death|0|||
27851574|NCT01918397|54350690|FG002|Overall Study|Death|1|||
27851575|NCT01918397|54350691|FG003|Overall Study|Death|0|||
27851576|NCT01918397|54350688|FG000|Overall Study|Involved in another investigative trial|0|||
27851577|NCT01918397|54350689|FG001|Overall Study|Involved in another investigative trial|0|||
27851578|NCT01918397|54350690|FG002|Overall Study|Involved in another investigative trial|0|||
27851579|NCT01918397|54350691|FG003|Overall Study|Involved in another investigative trial|1|||
27851580|NCT00986921|54350725|FG000|Overall Study|Physician Decision|1|||
27851581|NCT00986921|54350726|FG001|Overall Study|Physician Decision|0|||
27851582|NCT01596972|54350737|FG000|Overall Study|Physician Decision|1|||
27851583|NCT01596972|54350738|FG001|Overall Study|Physician Decision|9|||
27851584|NCT01596972|54350737|FG000|Overall Study|Lost to Follow-up|0|||
27851585|NCT01596972|54350738|FG001|Overall Study|Lost to Follow-up|4|||
27831096|NCT01795547|54307170|FG000|Overall Study|Not stated|0|||
27831097|NCT01795547|54307171|FG001|Overall Study|Not stated|1|||
27831098|NCT01794923|54307197|FG000|Overall Study|Adverse Event|0|||
27851586|NCT01596972|54350737|FG000|Overall Study|Withdrawal by Subject|0|||
27851587|NCT01596972|54350738|FG001|Overall Study|Withdrawal by Subject|1|||
27851588|NCT00985751|54350839|FG000|Overall Study|Adverse Event|0|||
27831099|NCT01794923|54307198|FG001|Overall Study|Adverse Event|0|||
27831100|NCT01794923|54307199|FG002|Overall Study|Adverse Event|1|||
27831101|NCT01794845|54307207|FG000|Overall Study|Withdrawal by Subject|1|||
27831102|NCT01794689|54307215|FG000|Intervention 1 (2 Nights)|Withdrawal by Subject|3|||
27831103|NCT01794689|54307216|FG001|Intervention 1 (2 Nights)|Withdrawal by Subject|0|||
27831104|NCT01794689|54307217|FG002|Intervention 1 (2 Nights)|Withdrawal by Subject|2|||
27851589|NCT00985751|54350840|FG001|Overall Study|Adverse Event|0|||
27851590|NCT00985751|54350841|FG002|Overall Study|Adverse Event|0|||
27831105|NCT01794689|54307218|FG003|Intervention 1 (2 Nights)|Withdrawal by Subject|4|||
27831106|NCT01794689|54307215|FG000|Intervention 1 (2 Nights)|Protocol Violation|1|||
27831107|NCT01794689|54307216|FG001|Intervention 1 (2 Nights)|Protocol Violation|0|||
27831108|NCT01794689|54307217|FG002|Intervention 1 (2 Nights)|Protocol Violation|1|||
27851591|NCT00985751|54350842|FG003|Overall Study|Adverse Event|0|||
27851592|NCT00985751|54350843|FG004|Overall Study|Adverse Event|1|||
27851593|NCT01596582|54350888|FG000|Overall Study|Deemed ineligible after study visit|3|||
27851594|NCT01596582|54350889|FG001|Overall Study|Deemed ineligible after study visit|6|||
27851595|NCT01596582|54350888|FG000|Overall Study|Missing all outcome data|1|||
27851596|NCT01596582|54350889|FG001|Overall Study|Missing all outcome data|1|||
27851597|NCT01596504|54350905|FG000|Overall Study|Participant's Private Reason|0|||
27851598|NCT01596504|54350906|FG001|Overall Study|Participant's Private Reason|1|||
27851599|NCT01596504|54350907|FG002|Overall Study|Participant's Private Reason|0|||
27851600|NCT01596504|54350905|FG000|Overall Study|Adverse Event|1|||
27831109|NCT01794689|54307218|FG003|Intervention 1 (2 Nights)|Protocol Violation|0|||
27831110|NCT01794689|54307215|FG000|Intervention 1 (2 Nights)|Physician Decision|1|||
27831111|NCT01794689|54307216|FG001|Intervention 1 (2 Nights)|Physician Decision|1|||
27831112|NCT01794689|54307217|FG002|Intervention 1 (2 Nights)|Physician Decision|0|||
27831113|NCT01794689|54307218|FG003|Intervention 1 (2 Nights)|Physician Decision|0|||
27831114|NCT01794689|54307215|FG000|Intervention 1 (2 Nights)|Adverse Event|0|||
27831115|NCT01794689|54307216|FG001|Intervention 1 (2 Nights)|Adverse Event|1|||
27831116|NCT01794689|54307217|FG002|Intervention 1 (2 Nights)|Adverse Event|0|||
27831117|NCT01794689|54307218|FG003|Intervention 1 (2 Nights)|Adverse Event|0|||
27831118|NCT01794299|54307234|FG000|Overall Study|ATIR manufacturing not possible|1|||
27831119|NCT01794299|54307234|FG000|Overall Study|Death|14|||
27831120|NCT01794299|54307234|FG000|Overall Study|Graft failure|1|||
27831121|NCT01794299|54307234|FG000|Overall Study|ATIR batch rejected|2|||
27831122|NCT01794299|54307234|FG000|Overall Study|Relapse|2|||
27831123|NCT01794299|54307234|FG000|Overall Study|Discontinued from active follow-up|1|||
27831124|NCT01794299|54307234|FG000|Overall Study|Relapse and rejection of ATIR batch|1|||
27831125|NCT01817075|54307240|FG000|Overall Study|Adverse Event|7|||
27831126|NCT01817075|54307241|FG001|Overall Study|Adverse Event|5|||
27831127|NCT01817075|54307240|FG000|Overall Study|Physician Decision|9|||
27831128|NCT01817075|54307241|FG001|Overall Study|Physician Decision|12|||
27851601|NCT01596504|54350906|FG001|Overall Study|Adverse Event|2|||
27851602|NCT01596504|54350907|FG002|Overall Study|Adverse Event|1|||
27851603|NCT01596504|54350905|FG000|Overall Study|Withdrawal by Subject|1|||
27851604|NCT01596504|54350906|FG001|Overall Study|Withdrawal by Subject|0|||
27851605|NCT01596504|54350907|FG002|Overall Study|Withdrawal by Subject|0|||
27851606|NCT02616900|54350962|FG000|Overall Study|Lack of Efficacy|7|||
27851607|NCT02616900|54350962|FG000|Overall Study|Lost to Follow-up|2|||
28159923|NCT02737475|54830025|FG003|Overall Study|Other reasons|0|||
28159924|NCT02737475|54830026|FG004|Overall Study|Other reasons|1|||
27831129|NCT01817075|54307240|FG000|Overall Study|Withdrawal by Subject|31|||
27831130|NCT01817075|54307241|FG001|Overall Study|Withdrawal by Subject|15|||
27831131|NCT01817075|54307240|FG000|Overall Study|Received Sorafenib after enrollment|0|||
27831132|NCT01817075|54307241|FG001|Overall Study|Received Sorafenib after enrollment|1|||
27831133|NCT01817075|54307240|FG000|Overall Study|Ineligible|0|||
27831134|NCT01817075|54307241|FG001|Overall Study|Ineligible|2|||
27831135|NCT01816763|54307250|FG000|Overall Study|The main reason for an incomplete survey|4|||
27831136|NCT01816763|54307251|FG001|Overall Study|The main reason for an incomplete survey|15|||
27831137|NCT01816763|54307252|FG002|Overall Study|The main reason for an incomplete survey|11|||
27831138|NCT01816685|54307265|FG000|Overall Study|Lost to Follow-up|7|||
27831139|NCT01816685|54307266|FG001|Overall Study|Lost to Follow-up|9|||
27851608|NCT02616900|54350962|FG000|Overall Study|Protocol Violation|5|||
27943426|NCT01179737|54600359|FG001|Cohort 1 & Cohort 2|Withdrew consent|0|||
27943427|NCT01179737|54600360|FG002|Cohort 1 & Cohort 2|Withdrew consent|0|||
27831140|NCT01816685|54307265|FG000|Overall Study|Surgery Cancelled|3|||
27831141|NCT01816685|54307266|FG001|Overall Study|Surgery Cancelled|2|||
27831142|NCT00708552|54307297|FG000|Overall Study|Adverse Event|10|||
27831143|NCT00708552|54307298|FG001|Overall Study|Adverse Event|3|||
27831144|NCT00708552|54307299|FG002|Overall Study|Adverse Event|4|||
27831145|NCT00708552|54307300|FG003|Overall Study|Adverse Event|6|||
27831146|NCT00708552|54307297|FG000|Overall Study|Lack of Efficacy|0|||
27831147|NCT00708552|54307298|FG001|Overall Study|Lack of Efficacy|4|||
27831148|NCT00708552|54307299|FG002|Overall Study|Lack of Efficacy|1|||
27831149|NCT00708552|54307300|FG003|Overall Study|Lack of Efficacy|0|||
27831150|NCT00708552|54307297|FG000|Overall Study|Protocol Violation|0|||
27831151|NCT00708552|54307298|FG001|Overall Study|Protocol Violation|0|||
28160153|NCT02713490|54830274|FG000|Overall Study|Withdrawal by Subject|2|||
28160154|NCT02713490|54830275|FG001|Overall Study|Withdrawal by Subject|1|||
28160155|NCT02713490|54830274|FG000|Overall Study|Did not receive study drug|1|||
28160156|NCT02713490|54830275|FG001|Overall Study|Did not receive study drug|0|||
28160157|NCT02713490|54830274|FG000|Overall Study|Met exclusion criteria|0|||
28077071|NCT00403481|54731778|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1|||
28077072|NCT00403481|54731778|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1|||
28077073|NCT00403481|54731778|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
28077074|NCT00402779|54731787|FG000|Overall Study|Screen Failure|77|||
28077075|NCT00402779|54731788|FG001|Overall Study|Screen Failure|76|||
28077076|NCT00394433|54731794|FG000|Overall Study|Adverse Event|2|||
28077077|NCT00394433|54731794|FG000|Overall Study|Alternative Therapy|1|||
28077078|NCT00092534|54731800|FG000|Base Study Vaccination Period|Randomized not Vaccinated|5|||
28077079|NCT00092534|54731801|FG001|Base Study Vaccination Period|Randomized not Vaccinated|5|||
28077080|NCT00092534|54731802|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
28077081|NCT00092534|54731803|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
28077082|NCT00092534|54731804|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
28160158|NCT02713490|54830275|FG001|Overall Study|Met exclusion criteria|1|||
28160159|NCT03772574|54830284|FG000|Overall Study|Protocol Violation|2|||
28160160|NCT03772574|54830285|FG001|Overall Study|Protocol Violation|0|||
28160161|NCT03772574|54830286|FG002|Overall Study|Protocol Violation|0|||
28160162|NCT03772574|54830284|FG000|Overall Study|Discomfort|0|||
28160163|NCT03772574|54830285|FG001|Overall Study|Discomfort|5|||
28160164|NCT03772574|54830286|FG002|Overall Study|Discomfort|4|||
28160165|NCT02743221|54830296|FG000|Overall Study|Progressive disease|29|||
28160166|NCT02743221|54830297|FG001|Overall Study|Progressive disease|38|||
28160167|NCT02743221|54830296|FG000|Overall Study|Adverse Event|17|||
28160168|NCT02743221|54830297|FG001|Overall Study|Adverse Event|14|||
28160169|NCT02743221|54830296|FG000|Overall Study|non medical reason|8|||
28160170|NCT02743221|54830297|FG001|Overall Study|non medical reason|2|||
28160171|NCT02743221|54830296|FG000|Overall Study|Physician Decision|2|||
28160172|NCT02743221|54830297|FG001|Overall Study|Physician Decision|5|||
28160173|NCT02743221|54830296|FG000|Overall Study|Patient not eligible, not treated|0|||
28160174|NCT02743221|54830297|FG001|Overall Study|Patient not eligible, not treated|1|||
28160175|NCT03929757|54830305|FG000|Main Study: Up to Day 365|Withdrawal by parent/guardian|2|||
28160176|NCT03929757|54830306|FG001|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
28160177|NCT03929757|54830307|FG002|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
28160178|NCT03929757|54830305|FG000|Main Study: Up to Day 365|Other|1|||
28160179|NCT03929757|54830306|FG001|Main Study: Up to Day 365|Other|0|||
28160180|NCT03929757|54830307|FG002|Main Study: Up to Day 365|Other|0|||
28160181|NCT03929757|54830305|FG000|Extension Study: Up to Extension Day 85|Adverse Event|0|||
28160182|NCT03929757|54830306|FG001|Extension Study: Up to Extension Day 85|Adverse Event|0|||
28160183|NCT03929757|54830307|FG002|Extension Study: Up to Extension Day 85|Adverse Event|1|||
28160184|NCT03836625|54830316|FG000|Overall Study|Lost to Follow-up|9|||
28160185|NCT03836625|54830317|FG001|Overall Study|Lost to Follow-up|9|||
28160186|NCT03836625|54830316|FG000|Overall Study|Investigator withdrawn at/near time of enrollment|6|||
28160187|NCT03836625|54830317|FG001|Overall Study|Investigator withdrawn at/near time of enrollment|1|||
28160188|NCT03836625|54830316|FG000|Overall Study|Death|0|||
28160189|NCT03836625|54830317|FG001|Overall Study|Death|1|||
28160190|NCT03836625|54830316|FG000|Overall Study|Refused follow-up|0|||
28160191|NCT03836625|54830317|FG001|Overall Study|Refused follow-up|1|||
28077083|NCT00092534|54731800|FG000|Base Study Vaccination Period|Adverse Event|3|||
28077084|NCT00092534|54731801|FG001|Base Study Vaccination Period|Adverse Event|1|||
28077085|NCT00092534|54731802|FG002|Base Study Vaccination Period|Adverse Event|0|||
28077086|NCT00092534|54731803|FG003|Base Study Vaccination Period|Adverse Event|0|||
28077087|NCT00092534|54731804|FG004|Base Study Vaccination Period|Adverse Event|0|||
28160192|NCT01358968|54830323|FG000|Period 2|Adverse Event|0|||
28160193|NCT01358968|54830324|FG001|Period 2|Adverse Event|1|||
28160194|NCT01358968|54830325|FG002|Period 2|Adverse Event|0|||
28160195|NCT01358968|54830326|FG003|Period 2|Adverse Event|0|||
28077088|NCT00092534|54731800|FG000|Base Study Vaccination Period|Death|5|||
28077089|NCT00092534|54731801|FG001|Base Study Vaccination Period|Death|4|||
28160196|NCT01358968|54830323|FG000|Continued Access Phase|Progression of Disease|0|||
28160197|NCT01358968|54830324|FG001|Continued Access Phase|Progression of Disease|0|||
28160198|NCT01358968|54830325|FG002|Continued Access Phase|Progression of Disease|8|||
28160199|NCT01358968|54830326|FG003|Continued Access Phase|Progression of Disease|4|||
28077090|NCT00092534|54731802|FG002|Base Study Vaccination Period|Death|0|||
28077091|NCT00092534|54731803|FG003|Base Study Vaccination Period|Death|0|||
28077092|NCT00092534|54731804|FG004|Base Study Vaccination Period|Death|0|||
28077093|NCT00092534|54731800|FG000|Base Study Vaccination Period|Lost to Follow-up|41|||
28077094|NCT00092534|54731801|FG001|Base Study Vaccination Period|Lost to Follow-up|37|||
28077095|NCT00092534|54731802|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
28077096|NCT00092534|54731803|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
28077097|NCT00092534|54731804|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
28160200|NCT01358968|54830323|FG000|Continued Access Phase|Protocol Violation|0|||
28160201|NCT01358968|54830324|FG001|Continued Access Phase|Protocol Violation|0|||
28160202|NCT01358968|54830325|FG002|Continued Access Phase|Protocol Violation|0|||
28160203|NCT01358968|54830326|FG003|Continued Access Phase|Protocol Violation|2|||
28160204|NCT01358968|54830323|FG000|Continued Access Phase|Withdrawal by Subject|0|||
28160205|NCT01358968|54830324|FG001|Continued Access Phase|Withdrawal by Subject|0|||
28160206|NCT01358968|54830325|FG002|Continued Access Phase|Withdrawal by Subject|3|||
28160207|NCT01358968|54830326|FG003|Continued Access Phase|Withdrawal by Subject|0|||
28160208|NCT01358968|54830323|FG000|Continued Access Phase|Death|0|||
28077098|NCT00092534|54731800|FG000|Base Study Vaccination Period|Physician Decision|1|||
28077099|NCT00092534|54731801|FG001|Base Study Vaccination Period|Physician Decision|0|||
28077100|NCT00092534|54731802|FG002|Base Study Vaccination Period|Physician Decision|0|||
28077101|NCT00092534|54731803|FG003|Base Study Vaccination Period|Physician Decision|0|||
28077102|NCT00092534|54731804|FG004|Base Study Vaccination Period|Physician Decision|0|||
28077103|NCT00092534|54731800|FG000|Base Study Vaccination Period|Pregnancy|9|||
28077104|NCT00092534|54731801|FG001|Base Study Vaccination Period|Pregnancy|7|||
28077105|NCT00092534|54731802|FG002|Base Study Vaccination Period|Pregnancy|0|||
28077106|NCT00092534|54731803|FG003|Base Study Vaccination Period|Pregnancy|0|||
28077107|NCT00092534|54731804|FG004|Base Study Vaccination Period|Pregnancy|0|||
28077108|NCT00092534|54731800|FG000|Base Study Vaccination Period|Protocol Violation|2|||
28077109|NCT00092534|54731801|FG001|Base Study Vaccination Period|Protocol Violation|1|||
28077110|NCT00092534|54731802|FG002|Base Study Vaccination Period|Protocol Violation|0|||
28077111|NCT00092534|54731803|FG003|Base Study Vaccination Period|Protocol Violation|0|||
28077112|NCT00092534|54731804|FG004|Base Study Vaccination Period|Protocol Violation|0|||
28077113|NCT00092534|54731800|FG000|Base Study Vaccination Period|Withdrawal by Subject|85|||
28077114|NCT00092534|54731801|FG001|Base Study Vaccination Period|Withdrawal by Subject|58|||
28077115|NCT00092534|54731802|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
28077116|NCT00092534|54731803|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
28160209|NCT01358968|54830324|FG001|Continued Access Phase|Death|0|||
28160210|NCT01358968|54830325|FG002|Continued Access Phase|Death|1|||
28160211|NCT01358968|54830326|FG003|Continued Access Phase|Death|1|||
28160212|NCT00701090|54830338|FG000|Overall Study|Adverse Event|11|||
28160213|NCT00701090|54830339|FG001|Overall Study|Adverse Event|2|||
28160214|NCT00701090|54830338|FG000|Overall Study|Death|0|||
28160215|NCT00701090|54830339|FG001|Overall Study|Death|1|||
28160216|NCT00701090|54830338|FG000|Overall Study|Lack of Efficacy|5|||
27851620|NCT00985673|54351077|FG003|Overall Study|Withdrawal by Subject|2|||
27851621|NCT00985673|54351078|FG004|Overall Study|Withdrawal by Subject|2|||
27851622|NCT00985673|54351079|FG005|Overall Study|Withdrawal by Subject|3|||
27851623|NCT00985673|54351074|FG000|Overall Study|Other|1|||
28077117|NCT00092534|54731804|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
28160217|NCT00701090|54830339|FG001|Overall Study|Lack of Efficacy|4|||
27851624|NCT00985673|54351075|FG001|Overall Study|Other|0|||
27851625|NCT00985673|54351076|FG002|Overall Study|Other|1|||
27851626|NCT00985673|54351077|FG003|Overall Study|Other|0|||
28160218|NCT00701090|54830338|FG000|Overall Study|Lost to Follow-up|9|||
28160219|NCT00701090|54830339|FG001|Overall Study|Lost to Follow-up|9|||
28160220|NCT00701090|54830338|FG000|Overall Study|Physician Decision|3|||
28160221|NCT00701090|54830339|FG001|Overall Study|Physician Decision|4|||
28160222|NCT00701090|54830338|FG000|Overall Study|Protocol Violation|2|||
28160223|NCT00701090|54830339|FG001|Overall Study|Protocol Violation|3|||
28160224|NCT00701090|54830338|FG000|Overall Study|Withdrawal by Subject|11|||
28160225|NCT00701090|54830339|FG001|Overall Study|Withdrawal by Subject|16|||
28160226|NCT00701090|54830338|FG000|Overall Study|Other|7|||
28160227|NCT00701090|54830339|FG001|Overall Study|Other|12|||
27851627|NCT00985673|54351078|FG004|Overall Study|Other|1|||
27851628|NCT00985673|54351079|FG005|Overall Study|Other|0|||
28160228|NCT03057977|54830347|FG000|Discontinuation From Treatment|Withdrawal by Subject|124|||
28160229|NCT03057977|54830348|FG001|Discontinuation From Treatment|Withdrawal by Subject|92|||
28160230|NCT03057977|54830347|FG000|Discontinuation From Treatment|Lost to Follow-up|11|||
28160231|NCT03057977|54830348|FG001|Discontinuation From Treatment|Lost to Follow-up|17|||
28160232|NCT03057977|54830347|FG000|Discontinuation From Treatment|Protocol Violation|6|||
28160233|NCT03057977|54830348|FG001|Discontinuation From Treatment|Protocol Violation|5|||
28160234|NCT03057977|54830347|FG000|Discontinuation From Treatment|Not treated|4|||
28160235|NCT03057977|54830348|FG001|Discontinuation From Treatment|Not treated|0|||
28160236|NCT03057977|54830347|FG000|Discontinuation From Treatment|Adverse Event|343|||
28160237|NCT03057977|54830348|FG001|Discontinuation From Treatment|Adverse Event|337|||
28160238|NCT03057977|54830347|FG000|Discontinuation From Treatment|Reason Unknown|0|||
28160239|NCT03057977|54830348|FG001|Discontinuation From Treatment|Reason Unknown|1|||
28160240|NCT03057977|54830347|FG000|Discontinuation From Treatment|Personal Reasons|1|||
28160241|NCT03057977|54830348|FG001|Discontinuation From Treatment|Personal Reasons|1|||
28160242|NCT03057977|54830347|FG000|Discontinuation From Treatment|Unblinded medication|1|||
28160243|NCT03057977|54830348|FG001|Discontinuation From Treatment|Unblinded medication|0|||
28160244|NCT03057977|54830347|FG000|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
28160245|NCT03057977|54830348|FG001|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
28160246|NCT03057977|54830347|FG000|Discontinuation From Treatment|Principle Investigator Decision|2|||
28160247|NCT03057977|54830348|FG001|Discontinuation From Treatment|Principle Investigator Decision|0|||
28160248|NCT03057977|54830347|FG000|Discontinuation From Treatment|Other medical condition (no Adverse Event)|2|||
28160249|NCT03057977|54830348|FG001|Discontinuation From Treatment|Other medical condition (no Adverse Event)|4|||
28160250|NCT03057977|54830347|FG000|Discontinuation From Treatment|Patient moved away/being abroad|4|||
28160251|NCT03057977|54830348|FG001|Discontinuation From Treatment|Patient moved away/being abroad|3|||
28160252|NCT03057977|54830347|FG000|Discontinuation From Treatment|Unable to continue treatment|4|||
28160253|NCT03057977|54830348|FG001|Discontinuation From Treatment|Unable to continue treatment|1|||
28160254|NCT03057977|54830347|FG000|Discontinuation From Treatment|Not attending study visit|3|||
28160255|NCT03057977|54830348|FG001|Discontinuation From Treatment|Not attending study visit|10|||
28160256|NCT03057977|54830347|FG000|Discontinuation From Treatment|Due to Covid-19 Pandemic|1|||
28160257|NCT03057977|54830348|FG001|Discontinuation From Treatment|Due to Covid-19 Pandemic|4|||
28160258|NCT03057977|54830347|FG000|Discontinuation From Treatment|Patient decision to stop/interrupt medication|8|||
28160259|NCT03057977|54830348|FG001|Discontinuation From Treatment|Patient decision to stop/interrupt medication|6|||
28160260|NCT03057977|54830347|FG000|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
28160261|NCT03057977|54830348|FG001|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
28160262|NCT03057977|54830347|FG000|Discontinuation From Trial|Limited follow-up agreed|2|||
28160263|NCT03057977|54830348|FG001|Discontinuation From Trial|Limited follow-up agreed|2|||
28160264|NCT03057977|54830347|FG000|Discontinuation From Trial|Withdrawal by Subject|9|||
28160265|NCT03057977|54830348|FG001|Discontinuation From Trial|Withdrawal by Subject|11|||
28160266|NCT03062891|54830360|FG000|Overall Study|Withdrawal by Subject|2|||
28160267|NCT03062891|54830361|FG001|Overall Study|Withdrawal by Subject|0|||
28160268|NCT03062891|54830360|FG000|Overall Study|Lost to Follow-up|50|||
28160269|NCT03062891|54830361|FG001|Overall Study|Lost to Follow-up|38|||
28077118|NCT00092534|54731800|FG000|Base Study Vaccination Period|Moved|14|||
28077119|NCT00092534|54731801|FG001|Base Study Vaccination Period|Moved|12|||
28077120|NCT00092534|54731802|FG002|Base Study Vaccination Period|Moved|0|||
28160270|NCT02552212|54830370|FG000|Double-Blind Period (Week 0 - 52)|Adverse Event|6|||
28160271|NCT02552212|54830371|FG001|Double-Blind Period (Week 0 - 52)|Adverse Event|3|||
28160272|NCT02552212|54830372|FG002|Double-Blind Period (Week 0 - 52)|Adverse Event|0|||
28077121|NCT00092534|54731803|FG003|Base Study Vaccination Period|Moved|0|||
28077122|NCT00092534|54731804|FG004|Base Study Vaccination Period|Moved|0|||
28077123|NCT00092534|54731800|FG000|Base Study Vaccination Period|New Medical History (Not AEs)|5|||
28160273|NCT02552212|54830370|FG000|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
28160274|NCT02552212|54830371|FG001|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
28160275|NCT02552212|54830372|FG002|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|0|||
28160276|NCT02552212|54830370|FG000|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
28160277|NCT02552212|54830371|FG001|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
28160278|NCT02552212|54830372|FG002|Double-Blind Period (Week 0 - 52)|Protocol Violation|0|||
28160279|NCT02552212|54830370|FG000|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|1|||
28160280|NCT02552212|54830371|FG001|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
28160281|NCT02552212|54830372|FG002|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
28160282|NCT02552212|54830370|FG000|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|3|||
28077124|NCT00092534|54731801|FG001|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
28077125|NCT00092534|54731802|FG002|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
28077126|NCT00092534|54731803|FG003|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
27831304|NCT01786109|54307722|FG000|Overall Study|fail manometry barostat tube placement|1|||
27831305|NCT01786109|54307723|FG001|Overall Study|fail manometry barostat tube placement|0|||
28160283|NCT02552212|54830371|FG001|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|7|||
28160284|NCT02552212|54830372|FG002|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|0|||
28160285|NCT02552212|54830370|FG000|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
28160286|NCT02552212|54830371|FG001|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
28160287|NCT02552212|54830372|FG002|Double-Blind Period (Week 0 - 52)|Study non-compliance|0|||
28160288|NCT02552212|54830370|FG000|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
28160289|NCT02552212|54830371|FG001|Double-Blind Period (Week 0 - 52)|Patient's decision|1|||
28160290|NCT02552212|54830372|FG002|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
28160291|NCT02552212|54830370|FG000|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
28160292|NCT02552212|54830371|FG001|Double-Blind Period (Week 0 - 52)|As per suggestion|1|||
28160293|NCT02552212|54830372|FG002|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
28160294|NCT02552212|54830370|FG000|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
28160295|NCT02552212|54830371|FG001|Double-Blind Period (Week 0 - 52)|Not eligible|1|||
28160296|NCT02552212|54830372|FG002|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
28160297|NCT02552212|54830370|FG000|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|1|||
28160298|NCT02552212|54830371|FG001|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
28160299|NCT02552212|54830372|FG002|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
28160300|NCT02552212|54830370|FG000|SFE Period (Week 52 - 156)|Adverse Event|0|||
28160301|NCT02552212|54830371|FG001|SFE Period (Week 52 - 156)|Adverse Event|0|||
28160302|NCT02552212|54830372|FG002|SFE Period (Week 52 - 156)|Adverse Event|5|||
28160303|NCT02552212|54830370|FG000|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
28077127|NCT00092534|54731804|FG004|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
28077128|NCT00092534|54731800|FG000|Base Study Vaccination Period|Travel|1|||
28077129|NCT00092534|54731801|FG001|Base Study Vaccination Period|Travel|0|||
28160304|NCT02552212|54830371|FG001|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
28160305|NCT02552212|54830372|FG002|SFE Period (Week 52 - 156)|Lack of Efficacy|4|||
28160306|NCT02552212|54830370|FG000|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
28160307|NCT02552212|54830371|FG001|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
28160308|NCT02552212|54830372|FG002|SFE Period (Week 52 - 156)|Lost to Follow-up|2|||
28160309|NCT02552212|54830370|FG000|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
28160310|NCT02552212|54830371|FG001|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
28160311|NCT02552212|54830372|FG002|SFE Period (Week 52 - 156)|Withdrawal by Subject|18|||
28160312|NCT02552212|54830370|FG000|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
28160313|NCT02552212|54830371|FG001|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
28160314|NCT02552212|54830372|FG002|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|1|||
28160315|NCT02552212|54830370|FG000|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
28160316|NCT02552212|54830371|FG001|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
28160317|NCT02552212|54830372|FG002|SFE Period (Week 52 - 156)|Patient's personal reason|1|||
28160318|NCT02552212|54830370|FG000|SFE Period (Week 52 - 156)|Investigator decision|0|||
28160319|NCT02552212|54830371|FG001|SFE Period (Week 52 - 156)|Investigator decision|0|||
28160320|NCT02552212|54830372|FG002|SFE Period (Week 52 - 156)|Investigator decision|1|||
28160321|NCT02552212|54830370|FG000|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
28160322|NCT02552212|54830371|FG001|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
28160323|NCT02552212|54830372|FG002|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|1|||
28160324|NCT02552212|54830370|FG000|SFE Period (Week 52 - 156)|Compassionate access|0|||
28160325|NCT02552212|54830371|FG001|SFE Period (Week 52 - 156)|Compassionate access|0|||
28160326|NCT02552212|54830372|FG002|SFE Period (Week 52 - 156)|Compassionate access|2|||
28160327|NCT02552212|54830370|FG000|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
28160328|NCT02552212|54830371|FG001|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
28160329|NCT02552212|54830372|FG002|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|1|||
28160330|NCT02552212|54830370|FG000|SFE Period (Week 52 - 156)|Decision of Patient|0|||
28160331|NCT02552212|54830371|FG001|SFE Period (Week 52 - 156)|Decision of Patient|0|||
28160332|NCT02552212|54830372|FG002|SFE Period (Week 52 - 156)|Decision of Patient|1|||
28160333|NCT00685919|54830392|FG000|Overall Study|Withdrawal by Subject|0|||
28160334|NCT00685919|54830393|FG001|Overall Study|Withdrawal by Subject|0|||
28160335|NCT00685919|54830394|FG002|Overall Study|Withdrawal by Subject|1|||
28160336|NCT00685919|54830395|FG003|Overall Study|Withdrawal by Subject|0|||
28160337|NCT00685919|54830392|FG000|Overall Study|Physician Decision|1|||
28160338|NCT00685919|54830393|FG001|Overall Study|Physician Decision|0|||
28160339|NCT00685919|54830394|FG002|Overall Study|Physician Decision|0|||
28160340|NCT00685919|54830395|FG003|Overall Study|Physician Decision|0|||
28077130|NCT00092534|54731802|FG002|Base Study Vaccination Period|Travel|0|||
28077131|NCT00092534|54731803|FG003|Base Study Vaccination Period|Travel|0|||
28077132|NCT00092534|54731804|FG004|Base Study Vaccination Period|Travel|0|||
28077133|NCT00092534|54731800|FG000|Base Study Vaccination Period|Site Closed|0|||
28077134|NCT00092534|54731801|FG001|Base Study Vaccination Period|Site Closed|1|||
28077135|NCT00092534|54731802|FG002|Base Study Vaccination Period|Site Closed|0|||
28077136|NCT00092534|54731803|FG003|Base Study Vaccination Period|Site Closed|0|||
28160341|NCT03061331|54830407|FG000|Washout Period (8 Weeks)|Adverse Event|2|||
28160342|NCT03061331|54830408|FG001|Washout Period (8 Weeks)|Adverse Event|1|||
28160343|NCT00700778|54830414|FG000|Overall Study|Inconclusive data due to inadequate sample collection|2|||
28160344|NCT03908476|54830420|FG000|Overall Study|Death|3|||
28160345|NCT03908476|54830421|FG001|Overall Study|Death|0|||
28160346|NCT03908476|54830420|FG000|Overall Study|Lost to Follow-up|3|||
28160347|NCT03908476|54830421|FG001|Overall Study|Lost to Follow-up|1|||
28160348|NCT03908476|54830420|FG000|Overall Study|Withdrawal by Subject|7|||
28160349|NCT03908476|54830421|FG001|Overall Study|Withdrawal by Subject|1|||
28160350|NCT03908476|54830420|FG000|Overall Study|Physician Decision|2|||
28160351|NCT03908476|54830421|FG001|Overall Study|Physician Decision|0|||
28160352|NCT03908476|54830420|FG000|Overall Study|System Explanted and not Replaced|4|||
28160353|NCT03908476|54830421|FG001|Overall Study|System Explanted and not Replaced|0|||
28160354|NCT03908476|54830420|FG000|Overall Study|Intrathecal Pump|1|||
28160355|NCT03908476|54830421|FG001|Overall Study|Intrathecal Pump|0|||
28160356|NCT03908476|54830420|FG000|Overall Study|Patient Has Requested an Explant of the Device|1|||
28160357|NCT03908476|54830421|FG001|Overall Study|Patient Has Requested an Explant of the Device|0|||
28160358|NCT02551666|54830429|FG000|Overall Study|Withdrawal by Subject|1|||
28160359|NCT02551666|54830430|FG001|Overall Study|Withdrawal by Subject|3|||
28160360|NCT03061175|54830442|FG000|Baseline|Participant was deemed ineligible|1|||
28160361|NCT03061175|54830443|FG001|Baseline|Participant was deemed ineligible|0|||
28160362|NCT03061175|54830442|FG000|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6|||
28160363|NCT03061175|54830443|FG001|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2|||
28160364|NCT03061175|54830442|FG000|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0|||
28160365|NCT03061175|54830443|FG001|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1|||
28160366|NCT03061175|54830442|FG000|Followup 2 at 6 Months|Lost to Follow-up|4|||
28160367|NCT03061175|54830443|FG001|Followup 2 at 6 Months|Lost to Follow-up|7|||
28160368|NCT02554474|54830460|FG000|Overall Study|Protocol Violation|1|||
28160369|NCT02554474|54830461|FG001|Overall Study|Protocol Violation|1|||
28160370|NCT02554474|54830460|FG000|Overall Study|Health issue not related to the study|1|||
28160371|NCT02554474|54830461|FG001|Overall Study|Health issue not related to the study|0|||
28160372|NCT02554474|54830460|FG000|Overall Study|Withdrawal by Subject|1|||
28077137|NCT00092534|54731804|FG004|Base Study Vaccination Period|Site Closed|0|||
28077138|NCT00092534|54731800|FG000|Base Study Follow-Up Period|Adverse Event|2|||
28077139|NCT00092534|54731801|FG001|Base Study Follow-Up Period|Adverse Event|4|||
28077140|NCT00092534|54731802|FG002|Base Study Follow-Up Period|Adverse Event|0|||
28077141|NCT00092534|54731803|FG003|Base Study Follow-Up Period|Adverse Event|0|||
28077142|NCT00092534|54731804|FG004|Base Study Follow-Up Period|Adverse Event|0|||
28077143|NCT00092534|54731800|FG000|Base Study Follow-Up Period|Death|2|||
28077144|NCT00092534|54731801|FG001|Base Study Follow-Up Period|Death|1|||
28077145|NCT00092534|54731802|FG002|Base Study Follow-Up Period|Death|0|||
28077146|NCT00092534|54731803|FG003|Base Study Follow-Up Period|Death|0|||
28077147|NCT00092534|54731804|FG004|Base Study Follow-Up Period|Death|0|||
28160373|NCT02554474|54830461|FG001|Overall Study|Withdrawal by Subject|1|||
28160374|NCT03061097|54830469|FG000|Overall Study|Withdrawal by Subject|0|||
28160375|NCT03061097|54830470|FG001|Overall Study|Withdrawal by Subject|3|||
28160376|NCT02554318|54830478|FG000|Overall Study|Withdrawal by Subject|10|||
28160377|NCT02554318|54830479|FG001|Overall Study|Withdrawal by Subject|8|||
28160378|NCT02550106|54830485|FG000|Overall Study|Adverse Event|1|||
28160379|NCT02550106|54830485|FG000|Overall Study|Lack of Efficacy|3|||
28160380|NCT02550106|54830485|FG000|Overall Study|Protocol Violation|6|||
28160381|NCT02550106|54830485|FG000|Overall Study|Withdrawal by Subject|2|||
28160382|NCT03060551|54830491|FG000|Overall Study|Withdrawal by Subject|1|||
28160383|NCT03060551|54830491|FG000|Overall Study|Adverse Event|1|||
28160384|NCT01662310|54830495|FG000|Run-In or Stabilization Phase|Adverse Event|11|||
28160385|NCT01662310|54830496|FG001|Run-In or Stabilization Phase|Adverse Event|0|||
28160386|NCT01662310|54830497|FG002|Run-In or Stabilization Phase|Adverse Event|0|||
28160387|NCT01662310|54830498|FG003|Run-In or Stabilization Phase|Adverse Event|0|||
27943484|NCT01147068|54600395|FG005|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
27943485|NCT01147068|54600396|FG006|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
28160388|NCT01662310|54830499|FG004|Run-In or Stabilization Phase|Adverse Event|0|||
28160389|NCT01662310|54830495|FG000|Run-In or Stabilization Phase|Lack of Efficacy|9|||
28160390|NCT01662310|54830496|FG001|Run-In or Stabilization Phase|Lack of Efficacy|0|||
28160391|NCT01662310|54830497|FG002|Run-In or Stabilization Phase|Lack of Efficacy|0|||
28077148|NCT00092534|54731800|FG000|Base Study Follow-Up Period|Lost to Follow-up|120|||
28077149|NCT00092534|54731801|FG001|Base Study Follow-Up Period|Lost to Follow-up|146|||
28160392|NCT01662310|54830498|FG003|Run-In or Stabilization Phase|Lack of Efficacy|0|||
28160393|NCT01662310|54830499|FG004|Run-In or Stabilization Phase|Lack of Efficacy|0|||
28160394|NCT01662310|54830495|FG000|Run-In or Stabilization Phase|Lost to Follow-up|4|||
28160395|NCT01662310|54830496|FG001|Run-In or Stabilization Phase|Lost to Follow-up|0|||
28160396|NCT01662310|54830497|FG002|Run-In or Stabilization Phase|Lost to Follow-up|0|||
28160397|NCT01662310|54830498|FG003|Run-In or Stabilization Phase|Lost to Follow-up|0|||
28160398|NCT01662310|54830499|FG004|Run-In or Stabilization Phase|Lost to Follow-up|0|||
28160399|NCT01662310|54830495|FG000|Run-In or Stabilization Phase|Protocol Violation|15|||
28160400|NCT01662310|54830496|FG001|Run-In or Stabilization Phase|Protocol Violation|0|||
28160401|NCT01662310|54830497|FG002|Run-In or Stabilization Phase|Protocol Violation|0|||
28160402|NCT01662310|54830498|FG003|Run-In or Stabilization Phase|Protocol Violation|0|||
28160403|NCT01662310|54830499|FG004|Run-In or Stabilization Phase|Protocol Violation|0|||
28160404|NCT01662310|54830495|FG000|Run-In or Stabilization Phase|Withdrawal by Subject|25|||
28160405|NCT01662310|54830496|FG001|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
28160406|NCT01662310|54830497|FG002|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
28160407|NCT01662310|54830498|FG003|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
28160408|NCT01662310|54830499|FG004|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
28160409|NCT01662310|54830495|FG000|Run-In or Stabilization Phase|Other|1|||
28160410|NCT01662310|54830496|FG001|Run-In or Stabilization Phase|Other|0|||
28160411|NCT01662310|54830497|FG002|Run-In or Stabilization Phase|Other|0|||
28160412|NCT01662310|54830498|FG003|Run-In or Stabilization Phase|Other|0|||
28160413|NCT01662310|54830499|FG004|Run-In or Stabilization Phase|Other|0|||
28160414|NCT01662310|54830495|FG000|Double-Blind Phase|Adverse Event|0|||
28160415|NCT01662310|54830496|FG001|Double-Blind Phase|Adverse Event|0|||
28160416|NCT01662310|54830497|FG002|Double-Blind Phase|Adverse Event|1|||
27943486|NCT01147068|54600390|FG000|Subjects That Received 2nd Dose|Ineligible|0|||
27943487|NCT01147068|54600391|FG001|Subjects That Received 2nd Dose|Ineligible|1|||
27943488|NCT01147068|54600392|FG002|Subjects That Received 2nd Dose|Ineligible|0|||
27943489|NCT01147068|54600393|FG003|Subjects That Received 2nd Dose|Ineligible|0|||
27943490|NCT01147068|54600394|FG004|Subjects That Received 2nd Dose|Ineligible|0|||
27943491|NCT01147068|54600395|FG005|Subjects That Received 2nd Dose|Ineligible|0|||
27943492|NCT01147068|54600396|FG006|Subjects That Received 2nd Dose|Ineligible|0|||
27943493|NCT01147068|54600390|FG000|Subjects That Received 2nd Dose|Did not complete the study|0|||
27943494|NCT01147068|54600391|FG001|Subjects That Received 2nd Dose|Did not complete the study|1|||
27943495|NCT01147068|54600392|FG002|Subjects That Received 2nd Dose|Did not complete the study|0|||
27943496|NCT01147068|54600393|FG003|Subjects That Received 2nd Dose|Did not complete the study|0|||
27943497|NCT01147068|54600394|FG004|Subjects That Received 2nd Dose|Did not complete the study|0|||
27943498|NCT01147068|54600395|FG005|Subjects That Received 2nd Dose|Did not complete the study|1|||
27943499|NCT01147068|54600396|FG006|Subjects That Received 2nd Dose|Did not complete the study|0|||
27943500|NCT01147068|54600390|FG000|Subjects That Received 2nd Dose|Other|0|||
27943501|NCT01147068|54600391|FG001|Subjects That Received 2nd Dose|Other|3|||
27943502|NCT01147068|54600392|FG002|Subjects That Received 2nd Dose|Other|3|||
27943503|NCT01147068|54600393|FG003|Subjects That Received 2nd Dose|Other|0|||
27943504|NCT01147068|54600394|FG004|Subjects That Received 2nd Dose|Other|1|||
27943505|NCT01147068|54600395|FG005|Subjects That Received 2nd Dose|Other|0|||
27943506|NCT01147068|54600396|FG006|Subjects That Received 2nd Dose|Other|0|||
27943507|NCT01147068|54600390|FG000|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
27943508|NCT01147068|54600391|FG001|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
27943509|NCT01147068|54600392|FG002|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
27943510|NCT01147068|54600393|FG003|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
27943511|NCT01147068|54600394|FG004|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
27943512|NCT01147068|54600395|FG005|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
27943513|NCT01147068|54600396|FG006|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
27943514|NCT01147068|54600390|FG000|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
27943515|NCT01147068|54600391|FG001|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
27943516|NCT01147068|54600392|FG002|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
27943517|NCT01147068|54600393|FG003|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2|||
27943518|NCT01147068|54600394|FG004|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
27943519|NCT01147068|54600395|FG005|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
27943520|NCT01147068|54600396|FG006|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
27943521|NCT01147068|54600390|FG000|Subjects That Completed Safety Follow-up|Ineligible|0|||
27943522|NCT01147068|54600391|FG001|Subjects That Completed Safety Follow-up|Ineligible|1|||
27943523|NCT01147068|54600392|FG002|Subjects That Completed Safety Follow-up|Ineligible|0|||
28160417|NCT01662310|54830498|FG003|Double-Blind Phase|Adverse Event|0|||
28160418|NCT01662310|54830499|FG004|Double-Blind Phase|Adverse Event|0|||
28160419|NCT01662310|54830495|FG000|Double-Blind Phase|Lost to Follow-up|0|||
27851629|NCT00985439|54351125|FG000|Overall Study|Adverse Event|0|||
28077150|NCT00092534|54731802|FG002|Base Study Follow-Up Period|Lost to Follow-up|0|||
28077151|NCT00092534|54731803|FG003|Base Study Follow-Up Period|Lost to Follow-up|0|||
28077152|NCT00092534|54731804|FG004|Base Study Follow-Up Period|Lost to Follow-up|0|||
28077153|NCT00092534|54731800|FG000|Base Study Follow-Up Period|Pregnancy|6|||
28077154|NCT00092534|54731801|FG001|Base Study Follow-Up Period|Pregnancy|10|||
28077155|NCT00092534|54731802|FG002|Base Study Follow-Up Period|Pregnancy|0|||
28160420|NCT01662310|54830496|FG001|Double-Blind Phase|Lost to Follow-up|3|||
28160421|NCT01662310|54830497|FG002|Double-Blind Phase|Lost to Follow-up|0|||
28160422|NCT01662310|54830498|FG003|Double-Blind Phase|Lost to Follow-up|0|||
28160423|NCT01662310|54830499|FG004|Double-Blind Phase|Lost to Follow-up|0|||
28160424|NCT01662310|54830495|FG000|Double-Blind Phase|Pregnancy|0|||
28160425|NCT01662310|54830496|FG001|Double-Blind Phase|Pregnancy|2|||
28160426|NCT01662310|54830497|FG002|Double-Blind Phase|Pregnancy|0|||
28160427|NCT01662310|54830498|FG003|Double-Blind Phase|Pregnancy|0|||
28077156|NCT00092534|54731803|FG003|Base Study Follow-Up Period|Pregnancy|0|||
28077157|NCT00092534|54731804|FG004|Base Study Follow-Up Period|Pregnancy|0|||
28077158|NCT00092534|54731800|FG000|Base Study Follow-Up Period|Protocol Violation|1|||
28077159|NCT00092534|54731801|FG001|Base Study Follow-Up Period|Protocol Violation|2|||
28077160|NCT00092534|54731802|FG002|Base Study Follow-Up Period|Protocol Violation|0|||
28077161|NCT00092534|54731803|FG003|Base Study Follow-Up Period|Protocol Violation|0|||
28077162|NCT00092534|54731804|FG004|Base Study Follow-Up Period|Protocol Violation|0|||
28077163|NCT00092534|54731800|FG000|Base Study Follow-Up Period|Withdrawal by Subject|71|||
28077164|NCT00092534|54731801|FG001|Base Study Follow-Up Period|Withdrawal by Subject|62|||
28077165|NCT00092534|54731802|FG002|Base Study Follow-Up Period|Withdrawal by Subject|0|||
28077166|NCT00092534|54731803|FG003|Base Study Follow-Up Period|Withdrawal by Subject|0|||
28077167|NCT00092534|54731804|FG004|Base Study Follow-Up Period|Withdrawal by Subject|0|||
28077168|NCT00092534|54731800|FG000|Base Study Follow-Up Period|Moved|62|||
28077169|NCT00092534|54731801|FG001|Base Study Follow-Up Period|Moved|58|||
28160428|NCT01662310|54830499|FG004|Double-Blind Phase|Pregnancy|0|||
28160429|NCT01662310|54830495|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
28160430|NCT01662310|54830496|FG001|Double-Blind Phase|Withdrawal by Subject|9|||
28160431|NCT01662310|54830497|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
28160432|NCT01662310|54830498|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
28160433|NCT01662310|54830499|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
28160434|NCT01662310|54830495|FG000|Double-Blind Phase|Other|0|||
28160435|NCT01662310|54830496|FG001|Double-Blind Phase|Other|0|||
28160436|NCT01662310|54830497|FG002|Double-Blind Phase|Other|1|||
28160437|NCT01662310|54830498|FG003|Double-Blind Phase|Other|0|||
28160438|NCT01662310|54830499|FG004|Double-Blind Phase|Other|0|||
28160439|NCT01662310|54830495|FG000|Double-Blind Phase|Randomized but not treated|0|||
28160440|NCT01662310|54830496|FG001|Double-Blind Phase|Randomized but not treated|1|||
28160441|NCT01662310|54830497|FG002|Double-Blind Phase|Randomized but not treated|0|||
28160442|NCT01662310|54830498|FG003|Double-Blind Phase|Randomized but not treated|0|||
28160443|NCT01662310|54830499|FG004|Double-Blind Phase|Randomized but not treated|0|||
28160444|NCT01662310|54830495|FG000|Open-Label Extension Phase|Adverse Event|0|||
28160445|NCT01662310|54830496|FG001|Open-Label Extension Phase|Adverse Event|0|||
28160446|NCT01662310|54830497|FG002|Open-Label Extension Phase|Adverse Event|0|||
28160447|NCT01662310|54830498|FG003|Open-Label Extension Phase|Adverse Event|3|||
28160448|NCT01662310|54830499|FG004|Open-Label Extension Phase|Adverse Event|0|||
28160449|NCT01662310|54830495|FG000|Open-Label Extension Phase|Death|0|||
28160450|NCT01662310|54830496|FG001|Open-Label Extension Phase|Death|0|||
28160451|NCT01662310|54830497|FG002|Open-Label Extension Phase|Death|0|||
28160452|NCT01662310|54830498|FG003|Open-Label Extension Phase|Death|1|||
28160453|NCT01662310|54830499|FG004|Open-Label Extension Phase|Death|0|||
28160454|NCT01662310|54830495|FG000|Open-Label Extension Phase|Lack of Efficacy|0|||
28160455|NCT01662310|54830496|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
28160456|NCT01662310|54830497|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
28160457|NCT01662310|54830498|FG003|Open-Label Extension Phase|Lack of Efficacy|2|||
28160458|NCT01662310|54830499|FG004|Open-Label Extension Phase|Lack of Efficacy|2|||
28160459|NCT01662310|54830495|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
28077170|NCT00092534|54731802|FG002|Base Study Follow-Up Period|Moved|0|||
28160460|NCT01662310|54830496|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
28077171|NCT00092534|54731803|FG003|Base Study Follow-Up Period|Moved|0|||
28160461|NCT01662310|54830497|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
28160462|NCT01662310|54830498|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
28160463|NCT01662310|54830499|FG004|Open-Label Extension Phase|Lost to Follow-up|1|||
28160464|NCT01662310|54830495|FG000|Open-Label Extension Phase|Pregnancy|0|||
28160465|NCT01662310|54830496|FG001|Open-Label Extension Phase|Pregnancy|0|||
28160466|NCT01662310|54830497|FG002|Open-Label Extension Phase|Pregnancy|0|||
28160467|NCT01662310|54830498|FG003|Open-Label Extension Phase|Pregnancy|1|||
28077172|NCT00092534|54731804|FG004|Base Study Follow-Up Period|Moved|0|||
28160468|NCT01662310|54830499|FG004|Open-Label Extension Phase|Pregnancy|0|||
28160469|NCT01662310|54830495|FG000|Open-Label Extension Phase|Withdrawal by Subject|0|||
28160470|NCT01662310|54830496|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
28160471|NCT01662310|54830497|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
28160472|NCT01662310|54830498|FG003|Open-Label Extension Phase|Withdrawal by Subject|2|||
28160473|NCT01662310|54830499|FG004|Open-Label Extension Phase|Withdrawal by Subject|7|||
28160474|NCT00700622|54830513|FG000|Overall Study|Adverse Event|4|||
28160475|NCT00700622|54830514|FG001|Overall Study|Adverse Event|0|||
28160476|NCT00700622|54830513|FG000|Overall Study|Lost to Follow-up|0|||
28160477|NCT00700622|54830514|FG001|Overall Study|Lost to Follow-up|1|||
28160478|NCT00700622|54830513|FG000|Overall Study|Physician Decision|2|||
28160479|NCT00700622|54830514|FG001|Overall Study|Physician Decision|1|||
28160480|NCT00700622|54830513|FG000|Overall Study|Protocol Violation|0|||
28160481|NCT00700622|54830514|FG001|Overall Study|Protocol Violation|1|||
28160482|NCT00700622|54830513|FG000|Overall Study|Withdrawal by Subject|4|||
28160483|NCT00700622|54830514|FG001|Overall Study|Withdrawal by Subject|1|||
28160484|NCT00700622|54830513|FG000|Overall Study|Other|3|||
28160485|NCT00700622|54830514|FG001|Overall Study|Other|1|||
28160486|NCT02553928|54830522|FG000|Overall Study|Adverse Event|2|||
28160487|NCT02553928|54830523|FG001|Overall Study|Adverse Event|1|||
28160488|NCT02553928|54830522|FG000|Overall Study|Lost to Follow-up|0|||
28160489|NCT02553928|54830523|FG001|Overall Study|Lost to Follow-up|1|||
28160490|NCT02553928|54830522|FG000|Overall Study|Administrative reason(s)|0|||
28160491|NCT02553928|54830523|FG001|Overall Study|Administrative reason(s)|1|||
28160492|NCT03076775|54830532|FG000|Overall Study|Lost to Follow-up|1|||
28160493|NCT03076775|54830533|FG001|Overall Study|Lost to Follow-up|0|||
28160494|NCT03058991|54830550|FG000|Overall Study|Lost to Follow-up|17|||
28160495|NCT03058991|54830551|FG001|Overall Study|Lost to Follow-up|12|||
28160496|NCT03058991|54830552|FG002|Overall Study|Lost to Follow-up|12|||
28160497|NCT03058991|54830550|FG000|Overall Study|Withdrawal by Subject|1|||
28160498|NCT03058991|54830551|FG001|Overall Study|Withdrawal by Subject|0|||
28160499|NCT03058991|54830552|FG002|Overall Study|Withdrawal by Subject|0|||
28160500|NCT00700310|54830564|FG000|Overall Study|Adverse Event|6|||
28160501|NCT00700310|54830565|FG001|Overall Study|Adverse Event|10|||
28160502|NCT00700310|54830566|FG002|Overall Study|Adverse Event|5|||
28160503|NCT00700310|54830567|FG003|Overall Study|Adverse Event|11|||
28160504|NCT00700310|54830564|FG000|Overall Study|Lost to Follow-up|4|||
28160505|NCT00700310|54830565|FG001|Overall Study|Lost to Follow-up|1|||
28160506|NCT00700310|54830566|FG002|Overall Study|Lost to Follow-up|0|||
28160507|NCT00700310|54830567|FG003|Overall Study|Lost to Follow-up|1|||
28160508|NCT00700310|54830564|FG000|Overall Study|Withdrawal by Subject|8|||
28160509|NCT00700310|54830565|FG001|Overall Study|Withdrawal by Subject|9|||
28160510|NCT00700310|54830566|FG002|Overall Study|Withdrawal by Subject|8|||
28160511|NCT00700310|54830567|FG003|Overall Study|Withdrawal by Subject|8|||
28160512|NCT00700310|54830564|FG000|Overall Study|Lack of Efficacy|0|||
28160513|NCT00700310|54830565|FG001|Overall Study|Lack of Efficacy|3|||
28160514|NCT00700310|54830566|FG002|Overall Study|Lack of Efficacy|0|||
28160515|NCT00700310|54830567|FG003|Overall Study|Lack of Efficacy|1|||
28160516|NCT00700310|54830564|FG000|Overall Study|Administrative/Other|1|||
28160517|NCT00700310|54830565|FG001|Overall Study|Administrative/Other|3|||
28160518|NCT00700310|54830566|FG002|Overall Study|Administrative/Other|1|||
28160519|NCT00700310|54830567|FG003|Overall Study|Administrative/Other|3|||
28160520|NCT00700310|54830564|FG000|Overall Study|Randomized, Not Treated|2|||
28160521|NCT00700310|54830565|FG001|Overall Study|Randomized, Not Treated|0|||
28160522|NCT00700310|54830566|FG002|Overall Study|Randomized, Not Treated|2|||
28160523|NCT00700310|54830567|FG003|Overall Study|Randomized, Not Treated|2|||
28160524|NCT01575548|54830588|FG000|Overall Study|Adverse Event|15|||
27851630|NCT00985439|54351126|FG001|Overall Study|Adverse Event|0|||
27851631|NCT00985439|54351127|FG002|Overall Study|Adverse Event|1|||
27851632|NCT00985439|54351128|FG003|Overall Study|Adverse Event|0|||
27851633|NCT02618928|54351138|FG000|Overall Study|Failure to Return|28|||
27851634|NCT02618928|54351138|FG000|Overall Study|Insufficient Virological Response|1|||
27851635|NCT02618928|54351138|FG000|Overall Study|Withdrawal by Subject|2|||
27851636|NCT02618928|54351138|FG000|Overall Study|Death|3|||
27851637|NCT02618928|54351138|FG000|Overall Study|Other|11|||
28160525|NCT01575548|54830589|FG001|Overall Study|Adverse Event|2|||
28160526|NCT01575548|54830588|FG000|Overall Study|Disease progression|12|||
28160527|NCT01575548|54830589|FG001|Overall Study|Disease progression|25|||
27851638|NCT02618928|54351138|FG000|Overall Study|Missing|6|||
27851639|NCT02618928|54351138|FG000|Overall Study|Treatment Never Started|7|||
28160528|NCT01575548|54830588|FG000|Overall Study|Death|1|||
28160529|NCT01575548|54830589|FG001|Overall Study|Death|0|||
28160530|NCT01575548|54830588|FG000|Overall Study|Other complicating disease|1|||
28160531|NCT01575548|54830589|FG001|Overall Study|Other complicating disease|0|||
28160532|NCT01575548|54830588|FG000|Overall Study|Withdrawal by Subject|7|||
27851640|NCT00983957|54351149|FG000|Overall Study|Adverse Event|1|||
27851641|NCT00983957|54351149|FG000|Overall Study|Personal Reasons|1|||
28160533|NCT01575548|54830589|FG001|Overall Study|Withdrawal by Subject|3|||
28160534|NCT01575548|54830588|FG000|Overall Study|Noncompliance|1|||
28160535|NCT01575548|54830589|FG001|Overall Study|Noncompliance|0|||
27851642|NCT00981149|54351203|FG000|Overall Study|Lost to Follow-up|1|||
28160536|NCT01575548|54830588|FG000|Overall Study|Anticipated surgery|0|||
28160537|NCT01575548|54830589|FG001|Overall Study|Anticipated surgery|1|||
28160538|NCT01575548|54830588|FG000|Overall Study|Never started protocol therapy|3|||
28160539|NCT01575548|54830589|FG001|Overall Study|Never started protocol therapy|2|||
28160540|NCT01750281|54830598|FG000|Overall Study|Discontinued Selumetinib/Placebo|37|||
28160541|NCT01750281|54830599|FG001|Overall Study|Discontinued Selumetinib/Placebo|77|||
28160542|NCT01750281|54830600|FG002|Overall Study|Discontinued Selumetinib/Placebo|75|||
28160543|NCT01750281|54830598|FG000|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6|||
28160544|NCT01750281|54830599|FG001|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7|||
28160545|NCT01750281|54830600|FG002|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9|||
28160546|NCT01750281|54830598|FG000|Overall Study|Did not receive treatment|0|||
28160547|NCT01750281|54830599|FG001|Overall Study|Did not receive treatment|1|||
28160548|NCT01750281|54830600|FG002|Overall Study|Did not receive treatment|0|||
28160549|NCT03000569|54830627|FG000|Overall Study|Withdrawal by Subject|1|||
28160550|NCT03000569|54830628|FG001|Overall Study|Withdrawal by Subject|0|||
28160551|NCT02554786|54830647|FG000|Overall Study|Subject/guardian decision|29|||
28160552|NCT02554786|54830648|FG001|Overall Study|Subject/guardian decision|17|||
28160553|NCT02554786|54830649|FG002|Overall Study|Subject/guardian decision|18|||
28160554|NCT02554786|54830650|FG003|Overall Study|Subject/guardian decision|30|||
28160555|NCT02554786|54830651|FG004|Overall Study|Subject/guardian decision|20|||
28160556|NCT02554786|54830647|FG000|Overall Study|Lost to Follow-up|4|||
28160557|NCT02554786|54830648|FG001|Overall Study|Lost to Follow-up|3|||
28160558|NCT02554786|54830649|FG002|Overall Study|Lost to Follow-up|4|||
28160559|NCT02554786|54830650|FG003|Overall Study|Lost to Follow-up|2|||
28160560|NCT02554786|54830651|FG004|Overall Study|Lost to Follow-up|2|||
28160561|NCT02554786|54830647|FG000|Overall Study|Protocol deviation|1|||
28160562|NCT02554786|54830648|FG001|Overall Study|Protocol deviation|3|||
28160563|NCT02554786|54830649|FG002|Overall Study|Protocol deviation|3|||
28160564|NCT02554786|54830650|FG003|Overall Study|Protocol deviation|4|||
28160565|NCT02554786|54830651|FG004|Overall Study|Protocol deviation|2|||
28160566|NCT02554786|54830647|FG000|Overall Study|Technical problems|1|||
28160567|NCT02554786|54830648|FG001|Overall Study|Technical problems|1|||
28160568|NCT02554786|54830649|FG002|Overall Study|Technical problems|0|||
28160569|NCT02554786|54830650|FG003|Overall Study|Technical problems|2|||
28160570|NCT02554786|54830651|FG004|Overall Study|Technical problems|1|||
28160571|NCT02554786|54830647|FG000|Overall Study|Adverse Event|0|||
28160572|NCT02554786|54830648|FG001|Overall Study|Adverse Event|0|||
28160573|NCT02554786|54830649|FG002|Overall Study|Adverse Event|0|||
28160574|NCT02554786|54830650|FG003|Overall Study|Adverse Event|0|||
28160575|NCT02554786|54830651|FG004|Overall Study|Adverse Event|2|||
28160576|NCT02554786|54830647|FG000|Overall Study|Death|0|||
28160577|NCT02554786|54830648|FG001|Overall Study|Death|0|||
28160578|NCT02554786|54830649|FG002|Overall Study|Death|0|||
28160579|NCT02554786|54830650|FG003|Overall Study|Death|1|||
28160580|NCT02554786|54830651|FG004|Overall Study|Death|0|||
28160581|NCT02554786|54830647|FG000|Overall Study|Non-compliance with study treatment|0|||
28160582|NCT02554786|54830648|FG001|Overall Study|Non-compliance with study treatment|1|||
28160583|NCT02554786|54830649|FG002|Overall Study|Non-compliance with study treatment|1|||
28160584|NCT02554786|54830650|FG003|Overall Study|Non-compliance with study treatment|0|||
28160585|NCT02554786|54830651|FG004|Overall Study|Non-compliance with study treatment|1|||
28160586|NCT02554786|54830647|FG000|Overall Study|Physician Decision|0|||
28160587|NCT02554786|54830648|FG001|Overall Study|Physician Decision|1|||
28160588|NCT02554786|54830649|FG002|Overall Study|Physician Decision|4|||
28160589|NCT02554786|54830650|FG003|Overall Study|Physician Decision|1|||
28160590|NCT02554786|54830651|FG004|Overall Study|Physician Decision|1|||
28160591|NCT02554786|54830647|FG000|Overall Study|Pregnancy|0|||
28160592|NCT02554786|54830648|FG001|Overall Study|Pregnancy|0|||
28160593|NCT02554786|54830649|FG002|Overall Study|Pregnancy|0|||
28160594|NCT02554786|54830650|FG003|Overall Study|Pregnancy|1|||
28160595|NCT02554786|54830651|FG004|Overall Study|Pregnancy|1|||
28160596|NCT02893930|54830667|FG000|Overall Study|Adverse Event|3|||
28160597|NCT02893930|54830667|FG000|Overall Study|Death|1|||
28160598|NCT02893930|54830667|FG000|Overall Study|Disease progression|5|||
28160599|NCT02893930|54830667|FG000|Overall Study|Withdrawal by Subject|2|||
28160600|NCT02893930|54830667|FG000|Overall Study|Physician Decision|1|||
28160601|NCT02893930|54830667|FG000|Overall Study|Ineligible|1|||
28160602|NCT01347645|54830676|FG000|Overall Study|Death|1|||
28160603|NCT01347645|54830677|FG001|Overall Study|Death|5|||
28160604|NCT01347645|54830678|FG002|Overall Study|Death|2|||
28160605|NCT01347645|54830679|FG003|Overall Study|Death|7|||
28160606|NCT01347645|54830680|FG004|Overall Study|Death|7|||
28160607|NCT01347645|54830676|FG000|Overall Study|Lost to Follow-up|1|||
28160608|NCT01347645|54830677|FG001|Overall Study|Lost to Follow-up|1|||
28160609|NCT01347645|54830678|FG002|Overall Study|Lost to Follow-up|0|||
28160610|NCT01347645|54830679|FG003|Overall Study|Lost to Follow-up|1|||
28160611|NCT01347645|54830680|FG004|Overall Study|Lost to Follow-up|1|||
28160612|NCT01347645|54830676|FG000|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|0|||
28160613|NCT01347645|54830677|FG001|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|2|||
28160614|NCT01347645|54830678|FG002|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|1|||
28160615|NCT01347645|54830679|FG003|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|22|||
28160616|NCT01347645|54830680|FG004|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|20|||
28160617|NCT01347645|54830676|FG000|Overall Study|Other|1|||
28160618|NCT01347645|54830677|FG001|Overall Study|Other|0|||
27831306|NCT01786109|54307724|FG002|Overall Study|fail manometry barostat tube placement|0|||
28077173|NCT00092534|54731800|FG000|Base Study Follow-Up Period|Travel|10|||
28160619|NCT01347645|54830678|FG002|Overall Study|Other|0|||
28160620|NCT01347645|54830679|FG003|Overall Study|Other|0|||
28160621|NCT01347645|54830680|FG004|Overall Study|Other|1|||
28160622|NCT01347645|54830676|FG000|Overall Study|Withdrawal by Subject|0|||
28160623|NCT01347645|54830677|FG001|Overall Study|Withdrawal by Subject|0|||
28160624|NCT01347645|54830678|FG002|Overall Study|Withdrawal by Subject|0|||
28160625|NCT01347645|54830679|FG003|Overall Study|Withdrawal by Subject|3|||
28160626|NCT01347645|54830680|FG004|Overall Study|Withdrawal by Subject|3|||
28160627|NCT01347645|54830676|FG000|Overall Study|Physician Decision|0|||
28160628|NCT01347645|54830677|FG001|Overall Study|Physician Decision|0|||
28160629|NCT01347645|54830678|FG002|Overall Study|Physician Decision|0|||
28160630|NCT01347645|54830679|FG003|Overall Study|Physician Decision|0|||
28160631|NCT01347645|54830680|FG004|Overall Study|Physician Decision|1|||
28160632|NCT01347645|54830676|FG000|Overall Study|Adverse Event|0|||
28160633|NCT01347645|54830677|FG001|Overall Study|Adverse Event|0|||
28160634|NCT01347645|54830678|FG002|Overall Study|Adverse Event|0|||
28160635|NCT01347645|54830679|FG003|Overall Study|Adverse Event|1|||
28160636|NCT01347645|54830680|FG004|Overall Study|Adverse Event|1|||
28160637|NCT00484419|54830718|FG000|Overall Study|Adverse Event|3|||
28160638|NCT00484419|54830719|FG001|Overall Study|Adverse Event|0|||
28160639|NCT00484419|54830720|FG002|Overall Study|Adverse Event|0|||
28160640|NCT00484419|54830718|FG000|Overall Study|Lost to Follow-up|1|||
28160641|NCT00484419|54830719|FG001|Overall Study|Lost to Follow-up|0|||
28160642|NCT00484419|54830720|FG002|Overall Study|Lost to Follow-up|2|||
28160643|NCT00484419|54830718|FG000|Overall Study|Withdrawal by Subject|3|||
28160644|NCT00484419|54830719|FG001|Overall Study|Withdrawal by Subject|1|||
28160645|NCT00484419|54830720|FG002|Overall Study|Withdrawal by Subject|1|||
28160646|NCT00484419|54830718|FG000|Overall Study|subject met discontinuation criteria|2|||
28160647|NCT00484419|54830719|FG001|Overall Study|subject met discontinuation criteria|2|||
28160648|NCT00484419|54830720|FG002|Overall Study|subject met discontinuation criteria|4|||
28160649|NCT00484419|54830718|FG000|Overall Study|required restricted medication|1|||
28160650|NCT00484419|54830719|FG001|Overall Study|required restricted medication|0|||
28160651|NCT00484419|54830720|FG002|Overall Study|required restricted medication|1|||
28160652|NCT00484419|54830718|FG000|Overall Study|Physician Decision|1|||
28160653|NCT00484419|54830719|FG001|Overall Study|Physician Decision|1|||
28160654|NCT00484419|54830720|FG002|Overall Study|Physician Decision|1|||
28160655|NCT00484419|54830718|FG000|Overall Study|subject unable to receive medication|1|||
28077174|NCT00092534|54731801|FG001|Base Study Follow-Up Period|Travel|7|||
28077175|NCT00092534|54731802|FG002|Base Study Follow-Up Period|Travel|0|||
28077176|NCT00092534|54731803|FG003|Base Study Follow-Up Period|Travel|0|||
28077177|NCT00092534|54731804|FG004|Base Study Follow-Up Period|Travel|0|||
28077178|NCT00092534|54731800|FG000|Base Study Follow-Up Period|Site Closed|0|||
28077179|NCT00092534|54731801|FG001|Base Study Follow-Up Period|Site Closed|2|||
28077180|NCT00092534|54731802|FG002|Base Study Follow-Up Period|Site Closed|0|||
28077181|NCT00092534|54731803|FG003|Base Study Follow-Up Period|Site Closed|0|||
28077182|NCT00092534|54731804|FG004|Base Study Follow-Up Period|Site Closed|0|||
28077183|NCT00092534|54731800|FG000|Base Study Follow-Up Period|Subjects continuing|27|||
28077184|NCT00092534|54731801|FG001|Base Study Follow-Up Period|Subjects continuing|31|||
28077185|NCT00092534|54731802|FG002|Base Study Follow-Up Period|Subjects continuing|0|||
28077186|NCT00092534|54731803|FG003|Base Study Follow-Up Period|Subjects continuing|0|||
28077187|NCT00092534|54731804|FG004|Base Study Follow-Up Period|Subjects continuing|0|||
28077188|NCT00092534|54731800|FG000|Base Study Follow-Up Period|Subjects in extension|15|||
28077189|NCT00092534|54731801|FG001|Base Study Follow-Up Period|Subjects in extension|371|||
28077190|NCT00092534|54731802|FG002|Base Study Follow-Up Period|Subjects in extension|0|||
28077191|NCT00092534|54731803|FG003|Base Study Follow-Up Period|Subjects in extension|0|||
28160656|NCT00484419|54830719|FG001|Overall Study|subject unable to receive medication|0|||
28160657|NCT00484419|54830720|FG002|Overall Study|subject unable to receive medication|0|||
28160658|NCT00484419|54830718|FG000|Overall Study|subject relocated|0|||
28160659|NCT00484419|54830719|FG001|Overall Study|subject relocated|1|||
28160660|NCT00484419|54830720|FG002|Overall Study|subject relocated|0|||
28160661|NCT00484419|54830718|FG000|Overall Study|sponsor decision, randomized in error|0|||
28160662|NCT00484419|54830719|FG001|Overall Study|sponsor decision, randomized in error|0|||
28077192|NCT00092534|54731804|FG004|Base Study Follow-Up Period|Subjects in extension|0|||
28077193|NCT00092534|54731800|FG000|Base Study EXT|Lost to Follow-up|0|||
28077194|NCT00092534|54731801|FG001|Base Study EXT|Lost to Follow-up|0|||
28077195|NCT00092534|54731802|FG002|Base Study EXT|Lost to Follow-up|41|||
28160663|NCT00484419|54830720|FG002|Overall Study|sponsor decision, randomized in error|2|||
28160664|NCT03220724|54830729|FG000|Overall Study|Lost to Follow-up|2|||
28160665|NCT03220724|54830730|FG001|Overall Study|Lost to Follow-up|1|||
28160666|NCT03220724|54830731|FG002|Overall Study|Lost to Follow-up|0|||
28160667|NCT03220724|54830732|FG003|Overall Study|Lost to Follow-up|3|||
28160668|NCT03220724|54830729|FG000|Overall Study|Withdrawal by Subject|1|||
28160669|NCT03220724|54830730|FG001|Overall Study|Withdrawal by Subject|1|||
28077196|NCT00092534|54731803|FG003|Base Study EXT|Lost to Follow-up|0|||
28077197|NCT00092534|54731804|FG004|Base Study EXT|Lost to Follow-up|0|||
28077198|NCT00092534|54731800|FG000|Base Study EXT|Physician Decision|0|||
28077199|NCT00092534|54731801|FG001|Base Study EXT|Physician Decision|0|||
28077200|NCT00092534|54731802|FG002|Base Study EXT|Physician Decision|1|||
28077201|NCT00092534|54731803|FG003|Base Study EXT|Physician Decision|0|||
28077202|NCT00092534|54731804|FG004|Base Study EXT|Physician Decision|0|||
28077203|NCT00092534|54731800|FG000|Base Study EXT|Pregnancy|0|||
27943524|NCT01147068|54600393|FG003|Subjects That Completed Safety Follow-up|Ineligible|0|||
27943525|NCT01147068|54600394|FG004|Subjects That Completed Safety Follow-up|Ineligible|0|||
27943526|NCT01147068|54600395|FG005|Subjects That Completed Safety Follow-up|Ineligible|0|||
27943527|NCT01147068|54600396|FG006|Subjects That Completed Safety Follow-up|Ineligible|0|||
27943528|NCT01146912|54600419|FG000|Overall Study|Already received influenza vaccination|817|||
27943529|NCT01146912|54600420|FG001|Overall Study|Already received influenza vaccination|822|||
27943530|NCT01146912|54600421|FG002|Overall Study|Already received influenza vaccination|13|||
27943531|NCT01146912|54600422|FG003|Overall Study|Already received influenza vaccination|15|||
27943532|NCT01146912|54600423|FG004|Overall Study|Already received influenza vaccination|41|||
27943533|NCT01146912|54600424|FG005|Overall Study|Already received influenza vaccination|61|||
28077204|NCT00092534|54731801|FG001|Base Study EXT|Pregnancy|0|||
28077205|NCT00092534|54731802|FG002|Base Study EXT|Pregnancy|12|||
28077206|NCT00092534|54731803|FG003|Base Study EXT|Pregnancy|0|||
28077207|NCT00092534|54731804|FG004|Base Study EXT|Pregnancy|0|||
28077208|NCT00092534|54731800|FG000|Base Study EXT|Withdrawal by Subject|0|||
28077209|NCT00092534|54731801|FG001|Base Study EXT|Withdrawal by Subject|0|||
28077210|NCT00092534|54731802|FG002|Base Study EXT|Withdrawal by Subject|18|||
28077211|NCT00092534|54731803|FG003|Base Study EXT|Withdrawal by Subject|0|||
28077212|NCT00092534|54731804|FG004|Base Study EXT|Withdrawal by Subject|0|||
28077213|NCT00092534|54731800|FG000|Base Study EXT|Participant moved|0|||
28160670|NCT03220724|54830731|FG002|Overall Study|Withdrawal by Subject|1|||
28160671|NCT03220724|54830732|FG003|Overall Study|Withdrawal by Subject|0|||
28160672|NCT02549092|54830744|FG000|Treatment Period|Adverse Event|2|||
28160673|NCT02549092|54830745|FG001|Treatment Period|Adverse Event|2|||
28160674|NCT02549092|54830744|FG000|Treatment Period|Withdrawal by Subject|1|||
28160675|NCT02549092|54830745|FG001|Treatment Period|Withdrawal by Subject|3|||
28160676|NCT02549092|54830744|FG000|Treatment Period|Lack of Efficacy|0|||
28160677|NCT02549092|54830745|FG001|Treatment Period|Lack of Efficacy|2|||
28160678|NCT02549092|54830744|FG000|Extension/Transition Period|Still in Extension/Transition Period|4|||
28160679|NCT02549092|54830745|FG001|Extension/Transition Period|Still in Extension/Transition Period|8|||
28160680|NCT02549092|54830744|FG000|Extension/Transition Period|Premature Discontinuation for Unspecified Reason|1|||
28160681|NCT02549092|54830745|FG001|Extension/Transition Period|Premature Discontinuation for Unspecified Reason|1|||
28160682|NCT03056573|54830756|FG000|Overall Study|Death|2|||
27943534|NCT01146912|54600425|FG006|Overall Study|Already received influenza vaccination|56|||
27943535|NCT01146912|54600426|FG007|Overall Study|Already received influenza vaccination|0|||
28077214|NCT00092534|54731801|FG001|Base Study EXT|Participant moved|0|||
28077215|NCT00092534|54731802|FG002|Base Study EXT|Participant moved|6|||
28077216|NCT00092534|54731803|FG003|Base Study EXT|Participant moved|0|||
28077217|NCT00092534|54731804|FG004|Base Study EXT|Participant moved|0|||
28077218|NCT00092534|54731800|FG000|Base Study EXT|Travel|0|||
28077219|NCT00092534|54731801|FG001|Base Study EXT|Travel|0|||
28077220|NCT00092534|54731802|FG002|Base Study EXT|Travel|2|||
28160683|NCT03056573|54830757|FG001|Overall Study|Death|4|||
28160684|NCT03056573|54830756|FG000|Overall Study|Withdrawal by Subject|2|||
28160685|NCT03056573|54830757|FG001|Overall Study|Withdrawal by Subject|0|||
28160686|NCT03056573|54830756|FG000|Overall Study|Lost to Follow-up|1|||
28160687|NCT03056573|54830757|FG001|Overall Study|Lost to Follow-up|1|||
28160688|NCT02553772|54830765|FG000|Overall Study|Adverse Event|2|||
28160689|NCT02553772|54830766|FG001|Overall Study|Adverse Event|3|||
28160690|NCT02553772|54830765|FG000|Overall Study|Lost to Follow-up|2|||
28160691|NCT02553772|54830766|FG001|Overall Study|Lost to Follow-up|1|||
28160692|NCT02553772|54830765|FG000|Overall Study|Withdrawal of Consent|1|||
28160693|NCT02553772|54830766|FG001|Overall Study|Withdrawal of Consent|1|||
28160694|NCT02553772|54830765|FG000|Overall Study|Lack of Efficacy|1|||
28160695|NCT02553772|54830766|FG001|Overall Study|Lack of Efficacy|0|||
28160696|NCT02553772|54830765|FG000|Overall Study|Other Miscellaneous Reasons|0|||
28160697|NCT02553772|54830766|FG001|Overall Study|Other Miscellaneous Reasons|1|||
28160698|NCT02553538|54830774|FG000|Overall Study|Could Not Reach by Telephone|133|||
28160699|NCT02553538|54830775|FG001|Overall Study|Could Not Reach by Telephone|0|||
28160700|NCT02553538|54830774|FG000|Overall Study|Died or Left Network|54|||
28160701|NCT02553538|54830775|FG001|Overall Study|Died or Left Network|56|||
28160702|NCT02548156|54830781|FG000|Washout Period 1|Lost to Follow-up|0|||
28160703|NCT02548156|54830782|FG001|Washout Period 1|Lost to Follow-up|0|||
28160704|NCT02548156|54830783|FG002|Washout Period 1|Lost to Follow-up|0|||
28160705|NCT02548156|54830784|FG003|Washout Period 1|Lost to Follow-up|0|||
28160706|NCT02548156|54830785|FG004|Washout Period 1|Lost to Follow-up|1|||
28160707|NCT02548156|54830786|FG005|Washout Period 1|Lost to Follow-up|0|||
28160708|NCT01503515|54830796|FG000|Overall Study|Adverse Event|4|||
28160709|NCT01503515|54830797|FG001|Overall Study|Adverse Event|5|||
28160710|NCT01503515|54830796|FG000|Overall Study|Death|0|||
28160711|NCT01503515|54830797|FG001|Overall Study|Death|1|||
28160712|NCT01503515|54830796|FG000|Overall Study|Physician Decision|14|||
28160713|NCT01503515|54830797|FG001|Overall Study|Physician Decision|23|||
28160714|NCT01503515|54830796|FG000|Overall Study|Withdrawal by Subject|0|||
28160715|NCT01503515|54830797|FG001|Overall Study|Withdrawal by Subject|1|||
28160716|NCT01503515|54830796|FG000|Overall Study|Institutional dx of proven/probable IFI|2|||
28160717|NCT01503515|54830797|FG001|Overall Study|Institutional dx of proven/probable IFI|4|||
28160718|NCT01503515|54830796|FG000|Overall Study|Ineligible|1|||
28160719|NCT01503515|54830797|FG001|Overall Study|Ineligible|1|||
28160720|NCT02742519|54830805|FG000|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
28160721|NCT02742519|54830806|FG001|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
28160722|NCT02742519|54830807|FG002|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0|||
28160723|NCT02742519|54830805|FG000|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
28160724|NCT02742519|54830806|FG001|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
28160725|NCT02742519|54830807|FG002|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9|||
28160726|NCT02742519|54830805|FG000|Part 2 Open Label Period (32 Weeks)|Other|0|||
28160727|NCT02742519|54830806|FG001|Part 2 Open Label Period (32 Weeks)|Other|0|||
28160728|NCT02742519|54830807|FG002|Part 2 Open Label Period (32 Weeks)|Other|1|||
28160729|NCT01375010|54830817|FG000|Overall Study|Lost to Follow-up|8|||
28160730|NCT01375010|54830818|FG001|Overall Study|Lost to Follow-up|2|||
28160731|NCT01375010|54830817|FG000|Overall Study|Withdrawal by Subject|4|||
28160732|NCT01375010|54830818|FG001|Overall Study|Withdrawal by Subject|2|||
28160733|NCT00659061|54830842|FG000|Overall Study|Migration due to political unrest|21|||
28160734|NCT00659061|54830843|FG001|Overall Study|Migration due to political unrest|15|||
28160735|NCT02548078|54830860|FG000|Overall Study|Serious adverse event/Adverse event|1|||
28160736|NCT02548078|54830861|FG001|Overall Study|Serious adverse event/Adverse event|0|||
28160737|NCT02548078|54830860|FG000|Overall Study|Moved from study area|3|||
28160738|NCT02548078|54830861|FG001|Overall Study|Moved from study area|3|||
28160739|NCT02548078|54830860|FG000|Overall Study|Lost to Follow-up|1|||
28160740|NCT02548078|54830861|FG001|Overall Study|Lost to Follow-up|3|||
28160741|NCT02671435|54830889|FG000|Overall Study|Death|1|||
28160742|NCT02671435|54830890|FG001|Overall Study|Death|3|||
28160743|NCT02671435|54830891|FG002|Overall Study|Death|0|||
28160744|NCT02671435|54830892|FG003|Overall Study|Death|16|||
28160745|NCT02671435|54830893|FG004|Overall Study|Death|14|||
28160746|NCT02671435|54830894|FG005|Overall Study|Death|29|||
28160747|NCT02671435|54830895|FG006|Overall Study|Death|34|||
28160748|NCT02671435|54830896|FG007|Overall Study|Death|28|||
28160749|NCT02671435|54830897|FG008|Overall Study|Death|19|||
28160750|NCT02671435|54830898|FG009|Overall Study|Death|10|||
28160751|NCT02671435|54830899|FG010|Overall Study|Death|8|||
28160752|NCT02671435|54830900|FG011|Overall Study|Death|29|||
28160753|NCT02671435|54830901|FG012|Overall Study|Death|29|||
28160754|NCT02671435|54830902|FG013|Overall Study|Death|29|||
28160755|NCT02671435|54830903|FG014|Overall Study|Death|27|||
28160756|NCT02671435|54830889|FG000|Overall Study|Lost to Follow-up|0|||
28160757|NCT02671435|54830890|FG001|Overall Study|Lost to Follow-up|0|||
28160758|NCT02671435|54830891|FG002|Overall Study|Lost to Follow-up|1|||
28160759|NCT02671435|54830892|FG003|Overall Study|Lost to Follow-up|0|||
28160760|NCT02671435|54830893|FG004|Overall Study|Lost to Follow-up|1|||
28160761|NCT02671435|54830894|FG005|Overall Study|Lost to Follow-up|1|||
28160762|NCT02671435|54830895|FG006|Overall Study|Lost to Follow-up|2|||
28160763|NCT02671435|54830896|FG007|Overall Study|Lost to Follow-up|2|||
28160764|NCT02671435|54830897|FG008|Overall Study|Lost to Follow-up|0|||
28160765|NCT02671435|54830898|FG009|Overall Study|Lost to Follow-up|2|||
28160766|NCT02671435|54830899|FG010|Overall Study|Lost to Follow-up|0|||
28160767|NCT02671435|54830900|FG011|Overall Study|Lost to Follow-up|3|||
28160768|NCT02671435|54830901|FG012|Overall Study|Lost to Follow-up|3|||
28160769|NCT02671435|54830902|FG013|Overall Study|Lost to Follow-up|2|||
28160770|NCT02671435|54830903|FG014|Overall Study|Lost to Follow-up|0|||
28160771|NCT02671435|54830889|FG000|Overall Study|Withdrawal by Subject|2|||
28160772|NCT02671435|54830890|FG001|Overall Study|Withdrawal by Subject|0|||
28160773|NCT02671435|54830891|FG002|Overall Study|Withdrawal by Subject|2|||
28160774|NCT02671435|54830892|FG003|Overall Study|Withdrawal by Subject|2|||
28160775|NCT02671435|54830893|FG004|Overall Study|Withdrawal by Subject|2|||
28160776|NCT02671435|54830894|FG005|Overall Study|Withdrawal by Subject|7|||
28160777|NCT02671435|54830895|FG006|Overall Study|Withdrawal by Subject|2|||
28160778|NCT02671435|54830896|FG007|Overall Study|Withdrawal by Subject|7|||
28160779|NCT02671435|54830897|FG008|Overall Study|Withdrawal by Subject|1|||
28160780|NCT02671435|54830898|FG009|Overall Study|Withdrawal by Subject|1|||
28160781|NCT02671435|54830899|FG010|Overall Study|Withdrawal by Subject|2|||
28160782|NCT02671435|54830900|FG011|Overall Study|Withdrawal by Subject|4|||
28160783|NCT02671435|54830901|FG012|Overall Study|Withdrawal by Subject|4|||
28160784|NCT02671435|54830902|FG013|Overall Study|Withdrawal by Subject|4|||
28160785|NCT02671435|54830903|FG014|Overall Study|Withdrawal by Subject|2|||
28160786|NCT02671435|54830889|FG000|Overall Study|Un-specified|0|||
28160787|NCT02671435|54830890|FG001|Overall Study|Un-specified|0|||
28160788|NCT02671435|54830891|FG002|Overall Study|Un-specified|0|||
28160789|NCT02671435|54830892|FG003|Overall Study|Un-specified|0|||
28160790|NCT02671435|54830893|FG004|Overall Study|Un-specified|1|||
28160791|NCT02671435|54830894|FG005|Overall Study|Un-specified|3|||
28160792|NCT02671435|54830895|FG006|Overall Study|Un-specified|2|||
28160793|NCT02671435|54830896|FG007|Overall Study|Un-specified|3|||
27851643|NCT00981149|54351204|FG001|Overall Study|Lost to Follow-up|2|||
27851644|NCT00981149|54351203|FG000|Overall Study|Withdrawal by Subject|1|||
27851645|NCT00981149|54351204|FG001|Overall Study|Withdrawal by Subject|1|||
27851646|NCT01595646|54351262|FG000|Overall Study|Withdrawal by Subject|1|||
27851647|NCT01595646|54351263|FG001|Overall Study|Withdrawal by Subject|0|||
27851648|NCT01595646|54351264|FG002|Overall Study|Withdrawal by Subject|0|||
27851649|NCT00981461|54351292|FG000|Overall Study|Lost to Follow-up|5|||
27851650|NCT00981461|54351293|FG001|Overall Study|Lost to Follow-up|2|||
27851651|NCT02618616|54351310|FG000|Overall Study|Lack of Efficacy|4|||
27851652|NCT02618616|54351311|FG001|Overall Study|Lack of Efficacy|0|||
27851653|NCT02618616|54351310|FG000|Overall Study|Pregnancy|0|||
27851654|NCT02618616|54351311|FG001|Overall Study|Pregnancy|1|||
27851655|NCT02618616|54351310|FG000|Overall Study|Adverse Event|8|||
27851656|NCT02618616|54351311|FG001|Overall Study|Adverse Event|0|||
27851657|NCT02618616|54351310|FG000|Overall Study|Failure to comply with dosing/evaluation|1|||
27851658|NCT02618616|54351311|FG001|Overall Study|Failure to comply with dosing/evaluation|0|||
27851659|NCT02618616|54351310|FG000|Overall Study|Consent withdrawn by subject|8|||
27851660|NCT02618616|54351311|FG001|Overall Study|Consent withdrawn by subject|5|||
27851661|NCT02618616|54351310|FG000|Overall Study|Lost to Follow-up|0|||
27851662|NCT02618616|54351311|FG001|Overall Study|Lost to Follow-up|1|||
27851663|NCT02618382|54351390|FG000|Overall Study|Physician Decision|1|||
27851664|NCT02618382|54351390|FG000|Overall Study|Withdrawal by Subject|1|||
27851665|NCT02618382|54351390|FG000|Overall Study|Protocol Violation|1|||
27851666|NCT00980057|54351434|FG000|Overall Study|Death|13|||
27851667|NCT00980057|54351435|FG001|Overall Study|Death|3|||
27851668|NCT00980057|54351434|FG000|Overall Study|Adverse Event|0|||
27851669|NCT00980057|54351435|FG001|Overall Study|Adverse Event|1|||
27851670|NCT00980057|54351434|FG000|Overall Study|Physician Decision|4|||
27851671|NCT00980057|54351435|FG001|Overall Study|Physician Decision|0|||
28160794|NCT02671435|54830897|FG008|Overall Study|Un-specified|0|||
27851672|NCT00980057|54351434|FG000|Overall Study|Lost to Follow-up|1|||
27851673|NCT00980057|54351435|FG001|Overall Study|Lost to Follow-up|0|||
27851674|NCT00980057|54351434|FG000|Overall Study|Withdrawal by Subject|1|||
27851675|NCT00980057|54351435|FG001|Overall Study|Withdrawal by Subject|1|||
27851676|NCT04126733|54351547|FG000|Treatment Period|Progressive Disease - Radiological Progression|47|||
27943536|NCT01146912|54600419|FG000|Overall Study|< 14 weeks gestational age|0|||
28160795|NCT02671435|54830898|FG009|Overall Study|Un-specified|5|||
28160796|NCT02671435|54830899|FG010|Overall Study|Un-specified|8|||
27851677|NCT04126733|54351547|FG000|Treatment Period|Adverse Event|8|||
27851678|NCT04126733|54351547|FG000|Treatment Period|Progressive Disease - Clinical Assessment|7|||
27851679|NCT04126733|54351547|FG000|Treatment Period|Physician Decision|5|||
27851680|NCT04126733|54351547|FG000|Treatment Period|Death|1|||
27851681|NCT04126733|54351547|FG000|Treatment Period|Other Reasons|2|||
28160797|NCT02671435|54830900|FG011|Overall Study|Un-specified|4|||
28160798|NCT02671435|54830901|FG012|Overall Study|Un-specified|5|||
28160799|NCT02671435|54830902|FG013|Overall Study|Un-specified|9|||
28160800|NCT02671435|54830903|FG014|Overall Study|Un-specified|8|||
28160801|NCT02916433|54830958|FG000|Overall Study|Withdrawal by Subject|1|||
28160802|NCT02916433|54830959|FG001|Overall Study|Withdrawal by Subject|0|||
28160803|NCT02916433|54830958|FG000|Overall Study|Physician Decision|1|||
28160804|NCT02916433|54830959|FG001|Overall Study|Physician Decision|0|||
28160805|NCT00526227|54830968|FG000|Overall Study|Device not implanted|1|||
28160806|NCT00526227|54830968|FG000|Overall Study|Death|1|||
28160807|NCT02547922|54830976|FG000|Overall Study|Withdrawal by Subject|9|||
28160808|NCT02547922|54830977|FG001|Overall Study|Withdrawal by Subject|6|||
28160809|NCT02547922|54830978|FG002|Overall Study|Withdrawal by Subject|10|||
28160810|NCT02547922|54830976|FG000|Overall Study|Adverse Event|3|||
28160811|NCT02547922|54830977|FG001|Overall Study|Adverse Event|1|||
28160812|NCT02547922|54830978|FG002|Overall Study|Adverse Event|2|||
28160813|NCT02547922|54830976|FG000|Overall Study|Lost to Follow-up|1|||
28160814|NCT02547922|54830977|FG001|Overall Study|Lost to Follow-up|0|||
28160815|NCT02547922|54830978|FG002|Overall Study|Lost to Follow-up|0|||
28160816|NCT02547922|54830976|FG000|Overall Study|Lack of Efficacy|5|||
28160817|NCT02547922|54830977|FG001|Overall Study|Lack of Efficacy|7|||
28160818|NCT02547922|54830978|FG002|Overall Study|Lack of Efficacy|4|||
28160819|NCT02547922|54830976|FG000|Overall Study|Death|1|||
28160820|NCT02547922|54830977|FG001|Overall Study|Death|0|||
28160821|NCT02547922|54830978|FG002|Overall Study|Death|0|||
28160822|NCT02547922|54830976|FG000|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|4|||
28160823|NCT02547922|54830977|FG001|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|8|||
28160824|NCT02547922|54830978|FG002|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|9|||
28160825|NCT02547922|54830976|FG000|Overall Study|TECHNICAL PROBLEMS|1|||
28160826|NCT02547922|54830977|FG001|Overall Study|TECHNICAL PROBLEMS|0|||
28160827|NCT02547922|54830978|FG002|Overall Study|TECHNICAL PROBLEMS|0|||
28160828|NCT02547922|54830976|FG000|Overall Study|PROGRESSIVE DISEASE|1|||
28160829|NCT02547922|54830977|FG001|Overall Study|PROGRESSIVE DISEASE|0|||
28160830|NCT02547922|54830978|FG002|Overall Study|PROGRESSIVE DISEASE|2|||
28160831|NCT02547922|54830976|FG000|Overall Study|Physician Decision|2|||
28160832|NCT02547922|54830977|FG001|Overall Study|Physician Decision|1|||
28160833|NCT02547922|54830978|FG002|Overall Study|Physician Decision|2|||
28160834|NCT02547922|54830976|FG000|Overall Study|Patients did not receive IP|1|||
28160835|NCT02547922|54830977|FG001|Overall Study|Patients did not receive IP|1|||
28160836|NCT02547922|54830978|FG002|Overall Study|Patients did not receive IP|0|||
28160837|NCT02547766|54830992|FG000|Overall Study|Withdrawal by Subject|1|||
28160838|NCT02742441|54831005|FG000|Overall Study|Lost to Follow-up|4|||
28160839|NCT02742441|54831006|FG001|Overall Study|Lost to Follow-up|4|||
28160840|NCT02742441|54831005|FG000|Overall Study|Withdrawal by Subject|2|||
28160841|NCT02742441|54831006|FG001|Overall Study|Withdrawal by Subject|2|||
28160842|NCT02742441|54831005|FG000|Overall Study|Adverse Event|0|||
28160843|NCT02742441|54831006|FG001|Overall Study|Adverse Event|2|||
28160844|NCT02547220|54831014|FG000|Overall Study|Withdrawal by Subject|1|||
28160845|NCT02547220|54831015|FG001|Overall Study|Withdrawal by Subject|0|||
28160846|NCT02547220|54831014|FG000|Overall Study|Study terminated by sponsor|18|||
28160847|NCT02547220|54831015|FG001|Overall Study|Study terminated by sponsor|20|||
28160848|NCT02542072|54831023|FG000|First Intervention (1 Month)|Adverse Event|1|||
28160849|NCT02542072|54831024|FG001|First Intervention (1 Month)|Adverse Event|1|||
28160850|NCT02542072|54831023|FG000|First Intervention (1 Month)|Lost to Follow-up|2|||
28160851|NCT02542072|54831024|FG001|First Intervention (1 Month)|Lost to Follow-up|0|||
28160852|NCT02542072|54831023|FG000|First Intervention (1 Month)|Lens discomfort|1|||
28160853|NCT02542072|54831024|FG001|First Intervention (1 Month)|Lens discomfort|2|||
28160854|NCT02542072|54831023|FG000|First Intervention (1 Month)|Protocol Violation|1|||
27851682|NCT04126733|54351547|FG000|Active Follow-up Period|Death|13|||
27851683|NCT04126733|54351547|FG000|Active Follow-up Period|Progressive Disease - Clinical Assessment|4|||
27851684|NCT04126733|54351547|FG000|Active Follow-up Period|Withdrawal by Subject|2|||
27851685|NCT04126733|54351547|FG000|Active Follow-up Period|Other Reasons|1|||
27851686|NCT04126733|54351547|FG000|Long-term Follow-up Period|Death|22|||
27851687|NCT04126733|54351547|FG000|Long-term Follow-up Period|Withdrawal by Subject|1|||
27943537|NCT01146912|54600420|FG001|Overall Study|< 14 weeks gestational age|0|||
28160855|NCT02542072|54831024|FG001|First Intervention (1 Month)|Protocol Violation|0|||
28160856|NCT02542072|54831023|FG000|Second Intervention (1 Month)|Lost to Follow-up|1|||
28160857|NCT02542072|54831024|FG001|Second Intervention (1 Month)|Lost to Follow-up|0|||
28160858|NCT02542072|54831023|FG000|Second Intervention (1 Month)|Lens discomfort|1|||
28160859|NCT02542072|54831024|FG001|Second Intervention (1 Month)|Lens discomfort|0|||
28160860|NCT02547454|54831050|FG000|Overall Study|Due to hemodialysis|53|||
28160861|NCT02547454|54831050|FG000|Overall Study|Due to transplantation|1|||
28160862|NCT02547454|54831050|FG000|Overall Study|Due to no further need to treat|4|||
27943538|NCT01146912|54600421|FG002|Overall Study|< 14 weeks gestational age|3|||
27943539|NCT01146912|54600422|FG003|Overall Study|< 14 weeks gestational age|2|||
27851688|NCT04126733|54351547|FG000|Long-term Follow-up Period|Ongoing with Long Term Follow-up|6|||
27943540|NCT01146912|54600423|FG004|Overall Study|< 14 weeks gestational age|0|||
28077221|NCT00092534|54731803|FG003|Base Study EXT|Travel|0|||
28077222|NCT00092534|54731804|FG004|Base Study EXT|Travel|0|||
28077223|NCT00092534|54731800|FG000|Base Study EXT|Site closed|0|||
28077224|NCT00092534|54731801|FG001|Base Study EXT|Site closed|0|||
28077225|NCT00092534|54731802|FG002|Base Study EXT|Site closed|21|||
28077226|NCT00092534|54731803|FG003|Base Study EXT|Site closed|0|||
28077227|NCT00092534|54731804|FG004|Base Study EXT|Site closed|0|||
28077228|NCT00092534|54731800|FG000|Base Study EXT|Study ended|0|||
27851689|NCT02614794|54351582|FG000|Overall Study|On treatment|118|||
27851690|NCT02614794|54351583|FG001|Overall Study|On treatment|27|||
27851691|NCT02614794|54351582|FG000|Overall Study|In long term follow up|148|||
27851692|NCT02614794|54351583|FG001|Overall Study|In long term follow up|85|||
27851693|NCT02614794|54351582|FG000|Overall Study|Death|126|||
27851694|NCT02614794|54351583|FG001|Overall Study|Death|84|||
27851695|NCT02614794|54351582|FG000|Overall Study|Withdrawal by Subject|16|||
27851696|NCT02614794|54351583|FG001|Overall Study|Withdrawal by Subject|5|||
27851697|NCT02614794|54351582|FG000|Overall Study|Lost to Follow-up|2|||
27851698|NCT02614794|54351583|FG001|Overall Study|Lost to Follow-up|0|||
27851699|NCT02614794|54351582|FG000|Overall Study|Physician Decision|0|||
27851700|NCT02614794|54351583|FG001|Overall Study|Physician Decision|1|||
27851701|NCT00988247|54351591|FG000|Overall Study|Adverse Event|17|||
27851702|NCT00988247|54351592|FG001|Overall Study|Adverse Event|3|||
27851703|NCT00988247|54351591|FG000|Overall Study|Withdrawal by Subject|44|||
27851704|NCT00988247|54351592|FG001|Overall Study|Withdrawal by Subject|13|||
27851705|NCT00988247|54351591|FG000|Overall Study|Pregnancy|1|||
27851706|NCT00988247|54351592|FG001|Overall Study|Pregnancy|2|||
27851707|NCT00988247|54351591|FG000|Overall Study|Lost to Follow-up|11|||
27851708|NCT00988247|54351592|FG001|Overall Study|Lost to Follow-up|2|||
27851709|NCT00988247|54351591|FG000|Overall Study|Protocol Violation|4|||
27851710|NCT00988247|54351592|FG001|Overall Study|Protocol Violation|5|||
27851711|NCT00988247|54351591|FG000|Overall Study|Sponsor requested withdrawal|3|||
27851712|NCT00988247|54351592|FG001|Overall Study|Sponsor requested withdrawal|1|||
27851713|NCT00988247|54351591|FG000|Overall Study|Other|3|||
27851714|NCT00988247|54351592|FG001|Overall Study|Other|0|||
27851715|NCT00984659|54351602|FG000|2-week Run-in Period|Adverse Event|8|||
27851716|NCT00984659|54351603|FG001|2-week Run-in Period|Adverse Event|0|||
27851717|NCT00984659|54351604|FG002|2-week Run-in Period|Adverse Event|0|||
27851718|NCT00984659|54351605|FG003|2-week Run-in Period|Adverse Event|0|||
27851719|NCT00984659|54351602|FG000|2-week Run-in Period|Protocol Violation|5|||
27851720|NCT00984659|54351603|FG001|2-week Run-in Period|Protocol Violation|0|||
27851721|NCT00984659|54351604|FG002|2-week Run-in Period|Protocol Violation|0|||
27851722|NCT00984659|54351605|FG003|2-week Run-in Period|Protocol Violation|0|||
27851723|NCT00984659|54351602|FG000|2-week Run-in Period|Study Closed/Terminated|2|||
27851724|NCT00984659|54351603|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
27851725|NCT00984659|54351604|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
27851726|NCT00984659|54351605|FG003|2-week Run-in Period|Study Closed/Terminated|0|||
27851727|NCT00984659|54351602|FG000|2-week Run-in Period|Lost to Follow-up|3|||
27851728|NCT00984659|54351603|FG001|2-week Run-in Period|Lost to Follow-up|0|||
27851729|NCT00984659|54351604|FG002|2-week Run-in Period|Lost to Follow-up|0|||
27851730|NCT00984659|54351605|FG003|2-week Run-in Period|Lost to Follow-up|0|||
27851731|NCT00984659|54351602|FG000|2-week Run-in Period|Physician Decision|10|||
27851732|NCT00984659|54351603|FG001|2-week Run-in Period|Physician Decision|0|||
27851733|NCT00984659|54351604|FG002|2-week Run-in Period|Physician Decision|0|||
27851734|NCT00984659|54351605|FG003|2-week Run-in Period|Physician Decision|0|||
27851735|NCT00984659|54351602|FG000|2-week Run-in Period|Withdrawal by Subject|10|||
27851736|NCT00984659|54351603|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
27851737|NCT00984659|54351604|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
27851738|NCT00984659|54351605|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
27851739|NCT00984659|54351602|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|14|||
27851740|NCT00984659|54351603|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
27851741|NCT00984659|54351604|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
27851742|NCT00984659|54351605|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
27851743|NCT00984659|54351602|FG000|6-week Double-blind Treatment Period|Adverse Event|0|||
27851744|NCT00984659|54351603|FG001|6-week Double-blind Treatment Period|Adverse Event|3|||
28160863|NCT02547454|54831050|FG000|Overall Study|Death|38|||
28160864|NCT02547454|54831050|FG000|Overall Study|Lost to Follow-up|26|||
27851745|NCT00984659|54351604|FG002|6-week Double-blind Treatment Period|Adverse Event|3|||
27851746|NCT00984659|54351605|FG003|6-week Double-blind Treatment Period|Adverse Event|7|||
27851747|NCT00984659|54351602|FG000|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
27851748|NCT00984659|54351603|FG001|6-week Double-blind Treatment Period|Lack of Efficacy|2|||
27851749|NCT00984659|54351604|FG002|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
27851750|NCT00984659|54351605|FG003|6-week Double-blind Treatment Period|Lack of Efficacy|1|||
28077229|NCT00092534|54731801|FG001|Base Study EXT|Study ended|0|||
27851751|NCT00984659|54351602|FG000|6-week Double-blind Treatment Period|Protocol Violation|0|||
27851752|NCT00984659|54351603|FG001|6-week Double-blind Treatment Period|Protocol Violation|0|||
28077230|NCT00092534|54731802|FG002|Base Study EXT|Study ended|29|||
28077231|NCT00092534|54731803|FG003|Base Study EXT|Study ended|0|||
28077232|NCT00092534|54731804|FG004|Base Study EXT|Study ended|0|||
28077233|NCT00092534|54731800|FG000|Base Study EXT|Protocol Violation|0|||
28077234|NCT00092534|54731801|FG001|Base Study EXT|Protocol Violation|0|||
28077235|NCT00092534|54731802|FG002|Base Study EXT|Protocol Violation|15|||
28077236|NCT00092534|54731803|FG003|Base Study EXT|Protocol Violation|0|||
28077237|NCT00092534|54731804|FG004|Base Study EXT|Protocol Violation|0|||
28077238|NCT00092534|54731800|FG000|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
28077239|NCT00092534|54731801|FG001|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
28077240|NCT00092534|54731802|FG002|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
28077241|NCT00092534|54731803|FG003|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1|||
28077242|NCT00092534|54731804|FG004|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
28077243|NCT00068250|54731817|FG000|Phase I: Dose Level 2|Protocol Violation|0|||
28077244|NCT00068250|54731818|FG001|Phase I: Dose Level 2|Protocol Violation|1|||
28077245|NCT00068250|54731819|FG002|Phase I: Dose Level 2|Protocol Violation|0|||
28077246|NCT00068250|54731820|FG003|Phase I: Dose Level 2|Protocol Violation|0|||
28077247|NCT00393887|54731830|FG000|Overall Study|Physician Decision|5|||
28077248|NCT00393887|54731831|FG001|Overall Study|Physician Decision|0|||
28077249|NCT00393887|54731830|FG000|Overall Study|Lost to Follow-up|11|||
28077250|NCT00393887|54731831|FG001|Overall Study|Lost to Follow-up|9|||
28077251|NCT00393029|54731839|FG000|Overall Study|Not treated|0|||
28077252|NCT00393029|54731840|FG001|Overall Study|Not treated|1|||
28077253|NCT00402233|54731851|FG000|Overall Study|Adverse Event|1|||
28077254|NCT00402233|54731852|FG001|Overall Study|Adverse Event|7|||
28077255|NCT00402233|54731853|FG002|Overall Study|Adverse Event|9|||
28077256|NCT00402233|54731854|FG003|Overall Study|Adverse Event|9|||
28077257|NCT00402233|54731851|FG000|Overall Study|Protocol Violation|0|||
28077258|NCT00402233|54731852|FG001|Overall Study|Protocol Violation|1|||
28077259|NCT00402233|54731853|FG002|Overall Study|Protocol Violation|0|||
28077260|NCT00402233|54731854|FG003|Overall Study|Protocol Violation|0|||
28077261|NCT00402233|54731851|FG000|Overall Study|Withdrawal by Subject|2|||
28077262|NCT00402233|54731852|FG001|Overall Study|Withdrawal by Subject|1|||
28077263|NCT00402233|54731853|FG002|Overall Study|Withdrawal by Subject|2|||
28077264|NCT00402233|54731854|FG003|Overall Study|Withdrawal by Subject|2|||
28077265|NCT00402233|54731851|FG000|Overall Study|Worsening of disease under study|2|||
28077266|NCT00402233|54731852|FG001|Overall Study|Worsening of disease under study|0|||
28077267|NCT00402233|54731853|FG002|Overall Study|Worsening of disease under study|0|||
28077268|NCT00402233|54731854|FG003|Overall Study|Worsening of disease under study|0|||
28077269|NCT00402233|54731851|FG000|Overall Study|Worsening of other pre-existing disease|0|||
28077270|NCT00402233|54731852|FG001|Overall Study|Worsening of other pre-existing disease|1|||
28077271|NCT00402233|54731853|FG002|Overall Study|Worsening of other pre-existing disease|0|||
28077272|NCT00402233|54731854|FG003|Overall Study|Worsening of other pre-existing disease|0|||
28077273|NCT00092456|54731868|FG000|Overall Study|Adverse Event|0|||
28077274|NCT00092456|54731869|FG001|Overall Study|Adverse Event|0|||
28077275|NCT00092456|54731870|FG002|Overall Study|Adverse Event|1|||
28077276|NCT00092456|54731871|FG003|Overall Study|Adverse Event|1|||
28077277|NCT00092456|54731868|FG000|Overall Study|Lost to Follow-up|2|||
28077278|NCT00092456|54731869|FG001|Overall Study|Lost to Follow-up|2|||
28160865|NCT02547454|54831050|FG000|Overall Study|Other|39|||
28160866|NCT02547454|54831050|FG000|Overall Study|No data|11|||
28160867|NCT00415623|54831081|FG000|Overall Study|Adverse Event|3|||
28160868|NCT00415623|54831082|FG001|Overall Study|Adverse Event|4|||
28160869|NCT00415623|54831081|FG000|Overall Study|Death|1|||
28160870|NCT00415623|54831082|FG001|Overall Study|Death|0|||
27943541|NCT01146912|54600424|FG005|Overall Study|< 14 weeks gestational age|0|||
27943542|NCT01146912|54600425|FG006|Overall Study|< 14 weeks gestational age|0|||
27943543|NCT01146912|54600426|FG007|Overall Study|< 14 weeks gestational age|0|||
27943544|NCT01146912|54600419|FG000|Overall Study|Duplicate patient|0|||
27943545|NCT01146912|54600420|FG001|Overall Study|Duplicate patient|0|||
27943546|NCT01146912|54600421|FG002|Overall Study|Duplicate patient|1|||
27943547|NCT01146912|54600422|FG003|Overall Study|Duplicate patient|0|||
27943548|NCT01146912|54600423|FG004|Overall Study|Duplicate patient|0|||
27943549|NCT01146912|54600424|FG005|Overall Study|Duplicate patient|0|||
27943550|NCT01146912|54600425|FG006|Overall Study|Duplicate patient|0|||
27943551|NCT01146912|54600426|FG007|Overall Study|Duplicate patient|0|||
27943552|NCT01134042|54600448|FG000|Overall Study|Adverse Event|3|||
27943553|NCT01134042|54600449|FG001|Overall Study|Adverse Event|7|||
27943554|NCT01134042|54600450|FG002|Overall Study|Adverse Event|2|||
27943555|NCT01134042|54600448|FG000|Overall Study|Lack of Efficacy|21|||
27943556|NCT01134042|54600449|FG001|Overall Study|Lack of Efficacy|6|||
27943557|NCT01134042|54600450|FG002|Overall Study|Lack of Efficacy|18|||
27943558|NCT01134042|54600448|FG000|Overall Study|Protocol Violation|5|||
27943559|NCT01134042|54600449|FG001|Overall Study|Protocol Violation|3|||
28077279|NCT00092456|54731870|FG002|Overall Study|Lost to Follow-up|1|||
28160871|NCT00415623|54831081|FG000|Overall Study|Withdrawal by Subject|1|||
28160872|NCT00415623|54831082|FG001|Overall Study|Withdrawal by Subject|1|||
27943560|NCT01134042|54600450|FG002|Overall Study|Protocol Violation|5|||
28077280|NCT00092456|54731871|FG003|Overall Study|Lost to Follow-up|2|||
28077281|NCT00092456|54731868|FG000|Overall Study|Protocol Violation|5|||
28077282|NCT00092456|54731869|FG001|Overall Study|Protocol Violation|7|||
28077283|NCT00092456|54731870|FG002|Overall Study|Protocol Violation|8|||
28077284|NCT00092456|54731871|FG003|Overall Study|Protocol Violation|6|||
28077285|NCT00092456|54731868|FG000|Overall Study|Withdrawal by Subject|13|||
28077286|NCT00092456|54731869|FG001|Overall Study|Withdrawal by Subject|5|||
28077287|NCT00092456|54731870|FG002|Overall Study|Withdrawal by Subject|16|||
28077288|NCT00092456|54731871|FG003|Overall Study|Withdrawal by Subject|6|||
28077289|NCT00092456|54731868|FG000|Overall Study|Moved|1|||
28077290|NCT00092456|54731869|FG001|Overall Study|Moved|1|||
28077291|NCT00092456|54731870|FG002|Overall Study|Moved|0|||
28077292|NCT00092456|54731871|FG003|Overall Study|Moved|1|||
28077293|NCT00092456|54731868|FG000|Overall Study|Other|4|||
28077294|NCT00092456|54731869|FG001|Overall Study|Other|2|||
28077295|NCT00092456|54731870|FG002|Overall Study|Other|3|||
28160873|NCT01969409|54831091|FG000|Overall Study|Death|2|||
27851753|NCT00984659|54351604|FG002|6-week Double-blind Treatment Period|Protocol Violation|0|||
27851754|NCT00984659|54351605|FG003|6-week Double-blind Treatment Period|Protocol Violation|4|||
27851755|NCT00984659|54351602|FG000|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
27851756|NCT00984659|54351603|FG001|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
27851757|NCT00984659|54351604|FG002|6-week Double-blind Treatment Period|Study Closed/Terminated|1|||
27851758|NCT00984659|54351605|FG003|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
27851759|NCT00984659|54351602|FG000|6-week Double-blind Treatment Period|Withdrawal by Subject|0|||
27851760|NCT00984659|54351603|FG001|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
27851761|NCT00984659|54351604|FG002|6-week Double-blind Treatment Period|Withdrawal by Subject|7|||
27851762|NCT00984659|54351605|FG003|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
27851763|NCT00982319|54351614|FG000|Overall Study|Surgery date change|1|||
27851764|NCT00982319|54351615|FG001|Overall Study|Surgery date change|0|||
27851765|NCT00982319|54351614|FG000|Overall Study|Preop values out of acceptable range|1|||
27851766|NCT00982319|54351615|FG001|Overall Study|Preop values out of acceptable range|1|||
27943561|NCT01134042|54600448|FG000|Overall Study|Lost to Follow-up|2|||
27943562|NCT01134042|54600449|FG001|Overall Study|Lost to Follow-up|0|||
27943563|NCT01134042|54600450|FG002|Overall Study|Lost to Follow-up|1|||
27943564|NCT01134042|54600448|FG000|Overall Study|Physician Decision|4|||
27943565|NCT01134042|54600449|FG001|Overall Study|Physician Decision|8|||
27943566|NCT01134042|54600450|FG002|Overall Study|Physician Decision|1|||
27943567|NCT01134042|54600448|FG000|Overall Study|Withdrawal by Subject|13|||
27943568|NCT01134042|54600449|FG001|Overall Study|Withdrawal by Subject|4|||
27943569|NCT01134042|54600450|FG002|Overall Study|Withdrawal by Subject|7|||
27943570|NCT01179347|54600461|FG000|Double-blind Period (12 Weeks)|Adverse Event|2|||
27943571|NCT01179347|54600462|FG001|Double-blind Period (12 Weeks)|Adverse Event|6|||
27943572|NCT01179347|54600461|FG000|Double-blind Period (12 Weeks)|Protocol Violation|2|||
27943573|NCT01179347|54600462|FG001|Double-blind Period (12 Weeks)|Protocol Violation|0|||
27943574|NCT01179347|54600461|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
27943575|NCT01179347|54600462|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
27943576|NCT01179347|54600461|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|1|||
27943577|NCT01179347|54600462|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|2|||
27943578|NCT01179347|54600461|FG000|Double-blind Period (12 Weeks)|Other|2|||
27943579|NCT01179347|54600462|FG001|Double-blind Period (12 Weeks)|Other|4|||
27943580|NCT01179347|54600461|FG000|Open-label Period (12 Weeks)|Adverse Event|5|||
28077296|NCT00092456|54731871|FG003|Overall Study|Other|0|||
28077297|NCT00067470|54731883|FG000|Overall Study|Withdrawal by Subject|0|||
28077298|NCT00067470|54731884|FG001|Overall Study|Withdrawal by Subject|1|||
28077299|NCT00401843|54731893|FG000|Overall Study|Achieved Complete Response|1|||
27851767|NCT00982319|54351614|FG000|Overall Study|Pregnancy|0|||
27851768|NCT00982319|54351615|FG001|Overall Study|Pregnancy|1|||
27851769|NCT02612064|54351627|FG000|Overall Study|Withdrawal by Subject|1|||
27851770|NCT02612064|54351628|FG001|Overall Study|Withdrawal by Subject|1|||
27851771|NCT02612064|54351627|FG000|Overall Study|Other|0|||
27851772|NCT02612064|54351628|FG001|Overall Study|Other|2|||
27851773|NCT02614560|54351647|FG000|Overall Study|Death|6|||
27851774|NCT02614560|54351648|FG001|Overall Study|Death|2|||
27851775|NCT01669122|54351676|FG000|Period I|Lost to Follow-up|1|||
27851776|NCT01669122|54351676|FG000|Washout Period II|Protocol Violation|2|||
27851777|NCT02611752|54351709|FG000|Overall Study|Adverse Event|0|||
27851778|NCT02611752|54351710|FG001|Overall Study|Adverse Event|1|||
27943581|NCT01179347|54600462|FG001|Open-label Period (12 Weeks)|Adverse Event|9|||
27943582|NCT01179347|54600461|FG000|Open-label Period (12 Weeks)|Lack of Efficacy|0|||
28077300|NCT00401843|54731894|FG001|Overall Study|Achieved Complete Response|5|||
28077301|NCT00401843|54731895|FG002|Overall Study|Achieved Complete Response|11|||
28160874|NCT01969409|54831092|FG001|Overall Study|Death|2|||
27851779|NCT02611362|54351731|FG000|Overall Study|Withdrawal by Subject|7|||
27851780|NCT02611362|54351732|FG001|Overall Study|Withdrawal by Subject|2|||
28077302|NCT00401843|54731893|FG000|Overall Study|Adverse Event|7|||
28160875|NCT01969409|54831091|FG000|Overall Study|Transplant|1|||
28077303|NCT00401843|54731894|FG001|Overall Study|Adverse Event|26|||
28077304|NCT00401843|54731895|FG002|Overall Study|Adverse Event|27|||
28077305|NCT00401843|54731893|FG000|Overall Study|Death|0|||
28077306|NCT00401843|54731894|FG001|Overall Study|Death|8|||
28077307|NCT00401843|54731895|FG002|Overall Study|Death|10|||
28077308|NCT00401843|54731893|FG000|Overall Study|Disease progression|10|||
28077309|NCT00401843|54731894|FG001|Overall Study|Disease progression|60|||
28077310|NCT00401843|54731895|FG002|Overall Study|Disease progression|49|||
28077311|NCT00401843|54731893|FG000|Overall Study|End of Study|1|||
28077312|NCT00401843|54731894|FG001|Overall Study|End of Study|1|||
28077313|NCT00401843|54731895|FG002|Overall Study|End of Study|2|||
28077314|NCT00401843|54731893|FG000|Overall Study|Lost to Follow-up|0|||
28077315|NCT00401843|54731894|FG001|Overall Study|Lost to Follow-up|0|||
28077316|NCT00401843|54731895|FG002|Overall Study|Lost to Follow-up|2|||
28077317|NCT00401843|54731893|FG000|Overall Study|Other Unspecified|0|||
28077318|NCT00401843|54731894|FG001|Overall Study|Other Unspecified|3|||
28077319|NCT00401843|54731895|FG002|Overall Study|Other Unspecified|5|||
28077320|NCT00401843|54731893|FG000|Overall Study|Physician Decision|0|||
28077321|NCT00401843|54731894|FG001|Overall Study|Physician Decision|16|||
28077322|NCT00401843|54731895|FG002|Overall Study|Physician Decision|10|||
28077323|NCT00401843|54731893|FG000|Overall Study|Protocol Violation|0|||
28077324|NCT00401843|54731894|FG001|Overall Study|Protocol Violation|0|||
28077325|NCT00401843|54731895|FG002|Overall Study|Protocol Violation|1|||
28077326|NCT00401843|54731893|FG000|Overall Study|Withdrawal by Subject|1|||
28077327|NCT00401843|54731894|FG001|Overall Study|Withdrawal by Subject|5|||
28077328|NCT00401843|54731895|FG002|Overall Study|Withdrawal by Subject|5|||
28077329|NCT00401843|54731893|FG000|Overall Study|Withdrawal of consent to study agent|1|||
28077330|NCT00401843|54731894|FG001|Overall Study|Withdrawal of consent to study agent|15|||
28077331|NCT00401843|54731895|FG002|Overall Study|Withdrawal of consent to study agent|17|||
28077332|NCT00401843|54731893|FG000|Overall Study|Randomized but not Treated|0|||
28077333|NCT00401843|54731894|FG001|Overall Study|Randomized but not Treated|2|||
28077334|NCT00401843|54731895|FG002|Overall Study|Randomized but not Treated|3|||
28077335|NCT00401843|54731893|FG000|Overall Study|Received incorrect treatment|0|||
28077336|NCT00401843|54731894|FG001|Overall Study|Received incorrect treatment|3|||
28077337|NCT00401843|54731895|FG002|Overall Study|Received incorrect treatment|0|||
28077338|NCT00401531|54731907|FG000|Overall Study|Adverse Event|2|||
28077339|NCT00401531|54731908|FG001|Overall Study|Adverse Event|0|||
28077340|NCT00401531|54731907|FG000|Overall Study|Protocol Violation|3|||
28077341|NCT00401531|54731908|FG001|Overall Study|Protocol Violation|7|||
28077342|NCT00401531|54731907|FG000|Overall Study|Lost to Follow-up|1|||
28077343|NCT00401531|54731908|FG001|Overall Study|Lost to Follow-up|1|||
28077344|NCT00401531|54731907|FG000|Overall Study|Withdrawal by Subject|3|||
28160876|NCT01969409|54831092|FG001|Overall Study|Transplant|1|||
28160877|NCT01969409|54831091|FG000|Overall Study|Withdrawal by Subject|0|||
28160878|NCT01969409|54831092|FG001|Overall Study|Withdrawal by Subject|1|||
28160879|NCT00150813|54831098|FG000|Overall Study|Adverse Event|1|||
28160880|NCT00150813|54831098|FG000|Overall Study|Lack of Efficacy|1|||
28160881|NCT00150813|54831098|FG000|Overall Study|Lost to Follow-up|5|||
28160882|NCT00150813|54831098|FG000|Overall Study|Withdrawal by Subject|5|||
28160883|NCT00150813|54831098|FG000|Overall Study|Remission|3|||
28160884|NCT00150813|54831098|FG000|Overall Study|Planned pregancy|1|||
27831307|NCT01786109|54307722|FG000|Overall Study|unrelated illness|0|||
27943583|NCT01179347|54600462|FG001|Open-label Period (12 Weeks)|Lack of Efficacy|2|||
27943584|NCT01179347|54600461|FG000|Open-label Period (12 Weeks)|Lost to Follow-up|1|||
27943585|NCT01179347|54600462|FG001|Open-label Period (12 Weeks)|Lost to Follow-up|0|||
27943586|NCT01179347|54600461|FG000|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
27943587|NCT01179347|54600462|FG001|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
27943588|NCT01179347|54600461|FG000|Open-label Period (12 Weeks)|Protocol Violation|1|||
27943589|NCT01179347|54600462|FG001|Open-label Period (12 Weeks)|Protocol Violation|0|||
27943590|NCT01179347|54600461|FG000|Open-label Period (12 Weeks)|Other|7|||
27943591|NCT01179347|54600462|FG001|Open-label Period (12 Weeks)|Other|4|||
27943592|NCT01146288|54600472|FG000|First Intervention(1 Day)|Adverse Event|0|||
27943593|NCT01146288|54600473|FG001|First Intervention(1 Day)|Adverse Event|1|||
27943594|NCT01146054|54600480|FG000|Overall Study|Did not meet dose constraints for SBRT|5|||
27943595|NCT01146054|54600480|FG000|Overall Study|Rapid tumor progression|2|||
27943596|NCT01146054|54600480|FG000|Overall Study|Other illness precluded treatment|2|||
27943597|NCT01146054|54600480|FG000|Overall Study|Lost to Follow-up|1|||
28077345|NCT00401531|54731908|FG001|Overall Study|Withdrawal by Subject|2|||
28077346|NCT00401375|54731917|FG000|Overall Study|Protocol Violation|2|||
28077347|NCT00401375|54731918|FG001|Overall Study|Protocol Violation|2|||
28077348|NCT00401375|54731919|FG002|Overall Study|Protocol Violation|1|||
28077349|NCT00401375|54731917|FG000|Overall Study|Adverse Event|6|||
28077350|NCT00401375|54731918|FG001|Overall Study|Adverse Event|11|||
28077351|NCT00401375|54731919|FG002|Overall Study|Adverse Event|10|||
28160885|NCT00150813|54831098|FG000|Overall Study|Switch to commercially available LEV|2|||
28077352|NCT00401375|54731917|FG000|Overall Study|Withdrawal by Subject|9|||
28077353|NCT00401375|54731918|FG001|Overall Study|Withdrawal by Subject|7|||
28077354|NCT00401375|54731919|FG002|Overall Study|Withdrawal by Subject|7|||
28077355|NCT00401375|54731917|FG000|Overall Study|Lost to Follow-up|0|||
28077356|NCT00401375|54731918|FG001|Overall Study|Lost to Follow-up|1|||
28077357|NCT00401375|54731919|FG002|Overall Study|Lost to Follow-up|1|||
28077358|NCT00401375|54731917|FG000|Overall Study|Other than specified|2|||
28077359|NCT00401375|54731918|FG001|Overall Study|Other than specified|1|||
28160886|NCT02712788|54831104|FG000|Overall Study|Physician Decision|1|||
28160887|NCT02712788|54831105|FG001|Overall Study|Physician Decision|0|||
28160888|NCT02712788|54831104|FG000|Overall Study|Protocol Violation|1|||
27943598|NCT01145898|54600486|FG000|3-year Treatment|medication change by treating physician|3|||
27943599|NCT01145898|54600487|FG001|3-year Treatment|medication change by treating physician|16|||
27943600|NCT01133418|54600494|FG000|Overall Study|Lost to Follow-up|5|||
27943601|NCT01133418|54600495|FG001|Overall Study|Lost to Follow-up|6|||
27943602|NCT00931918|54600503|FG000|Overall Study|Adverse Event|4|||
27943603|NCT00931918|54600504|FG001|Overall Study|Adverse Event|6|||
27943604|NCT00931918|54600503|FG000|Overall Study|Progressive Disease|2|||
27943605|NCT00931918|54600504|FG001|Overall Study|Progressive Disease|1|||
27943606|NCT00931918|54600503|FG000|Overall Study|Symptomatic Deterioration|1|||
27943607|NCT00931918|54600504|FG001|Overall Study|Symptomatic Deterioration|0|||
27943608|NCT00931918|54600503|FG000|Overall Study|Withdrawal by Patient|3|||
27943609|NCT00931918|54600504|FG001|Overall Study|Withdrawal by Patient|4|||
27943610|NCT00931918|54600503|FG000|Overall Study|Other Reason not Specified|4|||
27943611|NCT00931918|54600504|FG001|Overall Study|Other Reason not Specified|4|||
27943612|NCT00931918|54600503|FG000|Overall Study|Did not receive study drug|3|||
27943613|NCT00931918|54600504|FG001|Overall Study|Did not receive study drug|2|||
27943614|NCT01179191|54600510|FG000|Titration Phase (up to 6 Weeks)|Adverse Event|47|||
27943615|NCT01179191|54600510|FG000|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19|||
27943616|NCT01179191|54600510|FG000|Titration Phase (up to 6 Weeks)|Physician Decision|30|||
27943617|NCT01179191|54600510|FG000|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162|||
27943618|NCT01179191|54600510|FG000|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13|||
27943619|NCT01179191|54600510|FG000|Titration Phase (up to 6 Weeks)|Other|62|||
27943620|NCT01179191|54600510|FG000|Maintenance Phase (8 Weeks)|Adverse Event|10|||
27943621|NCT01179191|54600510|FG000|Maintenance Phase (8 Weeks)|Lost to Follow-up|9|||
27943622|NCT01179191|54600510|FG000|Maintenance Phase (8 Weeks)|Physician Decision|3|||
27943623|NCT01179191|54600510|FG000|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29|||
28077360|NCT00401375|54731919|FG002|Overall Study|Other than specified|3|||
28160889|NCT02712788|54831105|FG001|Overall Study|Protocol Violation|0|||
28160890|NCT02308111|54831113|FG000|Overall Study|Adverse Event|31|||
27851781|NCT02611362|54351731|FG000|Overall Study|Lost to Follow-up|2|||
27851782|NCT02611362|54351732|FG001|Overall Study|Lost to Follow-up|4|||
27851783|NCT01594476|54351752|FG000|Overall Study|Protocol Violation|1|||
27851784|NCT01594476|54351753|FG001|Overall Study|Protocol Violation|3|||
27851785|NCT01668966|54351767|FG000|Overall Study|Withdrawal by Subject|1|||
27851786|NCT01668966|54351767|FG000|Overall Study|Death|1|||
27851787|NCT01668966|54351767|FG000|Overall Study|Not treated|2|||
27851788|NCT02609724|54351774|FG000|Overall Study|Death|2|||
27851789|NCT02609724|54351775|FG001|Overall Study|Death|0|||
27851790|NCT02609724|54351776|FG002|Overall Study|Death|1|||
27851791|NCT02609724|54351774|FG000|Overall Study|Withdrawal by Subject|1|||
27851792|NCT02609724|54351775|FG001|Overall Study|Withdrawal by Subject|2|||
27851793|NCT02609724|54351776|FG002|Overall Study|Withdrawal by Subject|3|||
27851794|NCT02609724|54351774|FG000|Overall Study|Illness|2|||
27851795|NCT02609724|54351775|FG001|Overall Study|Illness|1|||
27851796|NCT02609724|54351776|FG002|Overall Study|Illness|0|||
27851797|NCT02610816|54351809|FG000|Phase 1|Withdrawal by Subject|2|||
27851798|NCT02610816|54351810|FG001|Phase 1|Withdrawal by Subject|6|||
27851799|NCT02610816|54351811|FG002|Phase 1|Withdrawal by Subject|0|||
27851800|NCT02610816|54351812|FG003|Phase 1|Withdrawal by Subject|0|||
27851801|NCT02610816|54351809|FG000|Phase 1|Lost to Follow-up|2|||
27851802|NCT02610816|54351810|FG001|Phase 1|Lost to Follow-up|1|||
27943624|NCT01179191|54600510|FG000|Maintenance Phase (8 Weeks)|Other|66|||
27943625|NCT01169844|54600516|FG000|Overall Study|Adverse Event|0|||
27943626|NCT01169844|54600517|FG001|Overall Study|Adverse Event|1|||
27943627|NCT01169844|54600516|FG000|Overall Study|Patient withdrew consent|4|||
27943628|NCT01169844|54600517|FG001|Overall Study|Patient withdrew consent|0|||
28077361|NCT00401375|54731917|FG000|Overall Study|Randomized but not treated|3|||
27851803|NCT02610816|54351811|FG002|Phase 1|Lost to Follow-up|0|||
27851804|NCT02610816|54351812|FG003|Phase 1|Lost to Follow-up|0|||
27851805|NCT02610816|54351809|FG000|Phase 1|Physician Decision|0|||
27851806|NCT02610816|54351810|FG001|Phase 1|Physician Decision|1|||
27851807|NCT02610816|54351811|FG002|Phase 1|Physician Decision|0|||
27851808|NCT02610816|54351812|FG003|Phase 1|Physician Decision|0|||
27943629|NCT01169844|54600516|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
27943630|NCT01169844|54600517|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
27943631|NCT01132482|54600525|FG000|Overall Study|Adverse Event|1|||
27943632|NCT01132482|54600526|FG001|Overall Study|Adverse Event|0|||
27943633|NCT00931762|54600532|FG000|Overall Study|Abnormal Laboratory Value (s)|2|||
27943634|NCT00931762|54600532|FG000|Overall Study|Administrative Problems|5|||
27943635|NCT00931762|54600532|FG000|Overall Study|Death|1|||
27943636|NCT00931762|54600532|FG000|Overall Study|Disease Progression|3|||
27943637|NCT00931762|54600532|FG000|Overall Study|Adverse Event (s)|11|||
27943638|NCT00931762|54600532|FG000|Overall Study|Subject withdrew consent|13|||
27943639|NCT01132326|54600536|FG000|Overall Study|Lack of Efficacy|25|||
27943640|NCT01132326|54600536|FG000|Overall Study|Adverse Event|37|||
27943641|NCT01132326|54600536|FG000|Overall Study|Protocol Violation|1|||
27943642|NCT01132326|54600536|FG000|Overall Study|Lost to Follow-up|16|||
27943643|NCT01132326|54600536|FG000|Overall Study|Withdrawal by Subject|40|||
27943644|NCT01132326|54600536|FG000|Overall Study|Physician Decision|10|||
27943645|NCT01132326|54600536|FG000|Overall Study|Study Termination|80|||
27943646|NCT01132326|54600536|FG000|Overall Study|Declining Health|1|||
27943647|NCT01132326|54600536|FG000|Overall Study|Pregnancy|1|||
27943648|NCT01132326|54600536|FG000|Overall Study|Caregiver Withdrew Consent|1|||
27943649|NCT01132326|54600536|FG000|Overall Study|Death|5|||
27943650|NCT01132326|54600536|FG000|Overall Study|Subject Unable to Come To Visits|1|||
27943651|NCT01178411|54600540|FG000|Overall Study|Adverse Event|5|||
27943652|NCT01178411|54600540|FG000|Overall Study|Withdrawal by Subject|4|||
27943653|NCT01178411|54600540|FG000|Overall Study|Protocol Violation|1|||
27943654|NCT01178411|54600540|FG000|Overall Study|Progressive disease per RECIST|32|||
27943655|NCT01178411|54600540|FG000|Overall Study|Progressive disease per clinician|9|||
27943656|NCT01178411|54600540|FG000|Overall Study|Physician Decision|6|||
27943657|NCT01178411|54600540|FG000|Overall Study|Death|1|||
27943658|NCT01178411|54600540|FG000|Overall Study|No reason provided|1|||
27943659|NCT01178411|54600540|FG000|Overall Study|Drug manufacturing ended|1|||
27943660|NCT01145508|54600546|FG000|Overall Study|Adverse Event|1|||
27943661|NCT01145508|54600547|FG001|Overall Study|Adverse Event|0|||
27943662|NCT01145508|54600546|FG000|Overall Study|Death|1|||
27943663|NCT01145508|54600547|FG001|Overall Study|Death|0|||
27943664|NCT01145508|54600546|FG000|Overall Study|Physician Decision|2|||
27943665|NCT01145508|54600547|FG001|Overall Study|Physician Decision|1|||
27943666|NCT01145508|54600546|FG000|Overall Study|Never started treatment|1|||
27943667|NCT01145508|54600547|FG001|Overall Study|Never started treatment|1|||
27943668|NCT00931528|54600555|FG000|Overall Study|Protocol Violation|9|||
27943669|NCT00931528|54600556|FG001|Overall Study|Protocol Violation|12|||
27943670|NCT00931528|54600555|FG000|Overall Study|Withdrawal by Subject|4|||
27943671|NCT00931528|54600556|FG001|Overall Study|Withdrawal by Subject|12|||
27943672|NCT00931528|54600555|FG000|Overall Study|Lost to Follow-up|6|||
27943673|NCT00931528|54600556|FG001|Overall Study|Lost to Follow-up|13|||
27943674|NCT00931528|54600555|FG000|Overall Study|Assessment outside of Time Frame|22|||
27943675|NCT00931528|54600556|FG001|Overall Study|Assessment outside of Time Frame|23|||
27943676|NCT00975195|54600565|FG000|Overall Study|Adverse Event|108|||
27943677|NCT00975195|54600566|FG001|Overall Study|Adverse Event|101|||
27943678|NCT00975195|54600565|FG000|Overall Study|Lack of Efficacy|6|||
27943679|NCT00975195|54600566|FG001|Overall Study|Lack of Efficacy|6|||
27943680|NCT00975195|54600565|FG000|Overall Study|Protocol Violation|27|||
27943681|NCT00975195|54600566|FG001|Overall Study|Protocol Violation|23|||
27943682|NCT00975195|54600565|FG000|Overall Study|Lost to Follow-up|9|||
27943683|NCT00975195|54600566|FG001|Overall Study|Lost to Follow-up|7|||
27943684|NCT00975195|54600565|FG000|Overall Study|Withdrawal by Subject|48|||
27943685|NCT00975195|54600566|FG001|Overall Study|Withdrawal by Subject|61|||
27943686|NCT00975195|54600565|FG000|Overall Study|Other reason not defined above|29|||
27943687|NCT00975195|54600566|FG001|Overall Study|Other reason not defined above|33|||
27943688|NCT00975195|54600565|FG000|Overall Study|Not treated|1|||
27943689|NCT00975195|54600566|FG001|Overall Study|Not treated|2|||
27943690|NCT01145352|54600572|FG000|Overall Study|Found to have been registered twice|6|||
27943691|NCT01145352|54600572|FG000|Overall Study|Treated before marketing approval|4|||
27943692|NCT01145352|54600572|FG000|Overall Study|Syringe formulation was used|1|||
27943693|NCT01178099|54600580|FG000|Overall Study|Physician Decision|0|||
27943694|NCT01178099|54600581|FG001|Overall Study|Physician Decision|1|||
27943695|NCT01169532|54600591|FG000|Overall Study|Withdrawal by Subject|1|||
27943696|NCT00928564|54600597|FG000|Overall Study|Lost to Follow-up|6|||
27943697|NCT00928564|54600598|FG001|Overall Study|Lost to Follow-up|0|||
27943698|NCT01177943|54600606|FG000|First Intervention|Withdrawal by Subject|2|||
27943699|NCT01177943|54600607|FG001|First Intervention|Withdrawal by Subject|0|||
27943700|NCT01131312|54600616|FG000|Overall Study|Lost to Follow-up|425|||
27943701|NCT01131312|54600617|FG001|Overall Study|Lost to Follow-up|229|||
27943702|NCT01131312|54600618|FG002|Overall Study|Lost to Follow-up|351|||
27943703|NCT01177787|54600626|FG000|Cryolipolysis on Thigh|Protocol Violation|4|||
27943704|NCT01177787|54600626|FG000|Cryolipolysis on Thigh|Lack of Efficacy|9|||
27943705|NCT01177787|54600626|FG000|Cryolipolysis on Thigh|Lost to Follow-up|1|||
27943706|NCT00928486|54600638|FG000|Overall Study|Adverse Event|2|||
27943707|NCT00928486|54600638|FG000|Overall Study|Disease Progression|7|||
27943708|NCT00928486|54600638|FG000|Overall Study|Withdrawal by Subject|1|||
27943709|NCT01168596|54600644|FG000|Overall Study|Withdrawal by Subject|3|||
27943710|NCT01168596|54600645|FG001|Overall Study|Withdrawal by Subject|1|||
27943711|NCT01177553|54600653|FG000|Overall Study|babies not yet 6 months of age|1|||
27943712|NCT01177553|54600654|FG001|Overall Study|babies not yet 6 months of age|0|||
27943713|NCT00928408|54600660|FG000|Overall Study|Other|2|||
28077362|NCT00401375|54731918|FG001|Overall Study|Randomized but not treated|3|||
28160891|NCT02308111|54831114|FG001|Overall Study|Adverse Event|19|||
28160892|NCT02308111|54831113|FG000|Overall Study|Death|9|||
28160893|NCT02308111|54831114|FG001|Overall Study|Death|6|||
28160894|NCT02308111|54831113|FG000|Overall Study|Lost to Follow-up|2|||
28160895|NCT02308111|54831114|FG001|Overall Study|Lost to Follow-up|7|||
28160896|NCT02308111|54831113|FG000|Overall Study|Physician Decision|6|||
28160897|NCT02308111|54831114|FG001|Overall Study|Physician Decision|17|||
28160898|NCT02308111|54831113|FG000|Overall Study|Protocol Violation|0|||
28160899|NCT02308111|54831114|FG001|Overall Study|Protocol Violation|1|||
28160900|NCT02308111|54831113|FG000|Overall Study|Withdrawal by Subject|28|||
28160901|NCT02308111|54831114|FG001|Overall Study|Withdrawal by Subject|38|||
28160902|NCT02308111|54831113|FG000|Overall Study|Study Terminated by Sponsor|72|||
28160903|NCT02308111|54831114|FG001|Overall Study|Study Terminated by Sponsor|61|||
28160904|NCT02308111|54831113|FG000|Overall Study|Initiated Commercial OCALIVA|6|||
28160905|NCT02308111|54831114|FG001|Overall Study|Initiated Commercial OCALIVA|8|||
28160906|NCT02308111|54831113|FG000|Overall Study|Site Closure|3|||
28160907|NCT02308111|54831114|FG001|Overall Study|Site Closure|3|||
28160908|NCT02308111|54831113|FG000|Overall Study|Non-compliance with Study Drug|3|||
28160909|NCT02308111|54831114|FG001|Overall Study|Non-compliance with Study Drug|1|||
28160910|NCT02308111|54831113|FG000|Overall Study|COVID-19 Pandemic Limitation|2|||
28160911|NCT02308111|54831114|FG001|Overall Study|COVID-19 Pandemic Limitation|0|||
28160912|NCT02308111|54831113|FG000|Overall Study|Liver Transplant|3|||
28160913|NCT02308111|54831114|FG001|Overall Study|Liver Transplant|3|||
28160914|NCT02308111|54831113|FG000|Overall Study|Liver Transplant Waitlist|2|||
28160915|NCT02308111|54831114|FG001|Overall Study|Liver Transplant Waitlist|2|||
28160916|NCT02308111|54831113|FG000|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|1|||
28160917|NCT02308111|54831114|FG001|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|0|||
28160918|NCT01346189|54831125|FG000|Overall Study|Withdrawal by Subject|7|||
28160919|NCT01346189|54831126|FG001|Overall Study|Withdrawal by Subject|5|||
28160920|NCT01346189|54831127|FG002|Overall Study|Withdrawal by Subject|3|||
28160921|NCT01346189|54831128|FG003|Overall Study|Withdrawal by Subject|5|||
28160922|NCT01346189|54831125|FG000|Overall Study|Physician Decision|4|||
28160923|NCT01346189|54831126|FG001|Overall Study|Physician Decision|0|||
28160924|NCT01346189|54831127|FG002|Overall Study|Physician Decision|0|||
28160925|NCT01346189|54831128|FG003|Overall Study|Physician Decision|0|||
28160926|NCT01346189|54831125|FG000|Overall Study|Moved|3|||
28160927|NCT01346189|54831126|FG001|Overall Study|Moved|0|||
28160928|NCT01346189|54831127|FG002|Overall Study|Moved|4|||
28160929|NCT01346189|54831128|FG003|Overall Study|Moved|0|||
28160930|NCT01346189|54831125|FG000|Overall Study|Other|2|||
28160931|NCT01346189|54831126|FG001|Overall Study|Other|4|||
28160932|NCT01346189|54831127|FG002|Overall Study|Other|7|||
28160933|NCT01346189|54831128|FG003|Overall Study|Other|3|||
28160934|NCT01346189|54831125|FG000|Overall Study|Death|0|||
28160935|NCT01346189|54831126|FG001|Overall Study|Death|3|||
27943714|NCT00928408|54600660|FG000|Overall Study|Withdrawal by Subject|4|||
27943715|NCT00928408|54600660|FG000|Overall Study|Death|5|||
27943716|NCT00928408|54600660|FG000|Overall Study|Lost to Follow-up|12|||
27943717|NCT00928252|54600664|FG000|Overall Study|Physician Decision|3|||
27943718|NCT01177007|54600670|FG000|Overall Study|Lost to Follow-up|2|||
28077363|NCT00401375|54731919|FG002|Overall Study|Randomized but not treated|3|||
28077364|NCT00400985|54731927|FG000|Overall Study|Withdrawal by Subject|5|||
28077365|NCT00400985|54731927|FG000|Overall Study|system modification|8|||
28077366|NCT00400985|54731927|FG000|Overall Study|Death|30|||
28077367|NCT00400985|54731927|FG000|Overall Study|Lost to Follow-up|9|||
28077368|NCT00400517|54731931|FG000|Overall Study|Withdrawal by Subject|1|||
28077369|NCT00400517|54731931|FG000|Overall Study|Physician Decision|1|||
28077370|NCT00392171|54731935|FG000|Overall Study|Did not meet inclusion criteria|4|||
28077371|NCT00392171|54731935|FG000|Overall Study|Disease progression|101|||
28077372|NCT00391625|54731939|FG000|Month 14|Withdrawal by Subject|1|||
28077373|NCT00391625|54731939|FG000|Month 50|Physician Decision|1|||
28160936|NCT01346189|54831127|FG002|Overall Study|Death|0|||
28160937|NCT01346189|54831128|FG003|Overall Study|Death|0|||
27943719|NCT01177007|54600670|FG000|Overall Study|Death|4|||
28077374|NCT00091832|54731972|FG000|Overall Study|Physician Decision|1|||
28160938|NCT01346189|54831125|FG000|Overall Study|Non-health system primary care physician|0|||
28160939|NCT01346189|54831126|FG001|Overall Study|Non-health system primary care physician|5|||
28160940|NCT01346189|54831127|FG002|Overall Study|Non-health system primary care physician|0|||
27851809|NCT02610816|54351809|FG000|Phase 2|Withdrawal by Subject|0|||
27851810|NCT02610816|54351810|FG001|Phase 2|Withdrawal by Subject|0|||
27851811|NCT02610816|54351811|FG002|Phase 2|Withdrawal by Subject|9|||
27851812|NCT02610816|54351812|FG003|Phase 2|Withdrawal by Subject|3|||
27851813|NCT02610816|54351809|FG000|Phase 2|Lost to Follow-up|0|||
27851814|NCT02610816|54351810|FG001|Phase 2|Lost to Follow-up|0|||
27851815|NCT02610816|54351811|FG002|Phase 2|Lost to Follow-up|2|||
27851816|NCT02610816|54351812|FG003|Phase 2|Lost to Follow-up|0|||
27851817|NCT02610816|54351809|FG000|Phase 2|Physician Decision|0|||
27851818|NCT02610816|54351810|FG001|Phase 2|Physician Decision|0|||
27851819|NCT02610816|54351811|FG002|Phase 2|Physician Decision|0|||
27851820|NCT02610816|54351812|FG003|Phase 2|Physician Decision|2|||
27851821|NCT02610816|54351809|FG000|Phase 2|Pregnancy|0|||
27851822|NCT02610816|54351810|FG001|Phase 2|Pregnancy|0|||
28077375|NCT00091832|54731973|FG001|Overall Study|Physician Decision|0|||
28077376|NCT00091832|54731974|FG002|Overall Study|Physician Decision|0|||
28077377|NCT00091832|54731975|FG003|Overall Study|Physician Decision|0|||
28077378|NCT00091832|54731976|FG004|Overall Study|Physician Decision|0|||
28077379|NCT00091832|54731977|FG005|Overall Study|Physician Decision|0|||
28077380|NCT00091832|54731972|FG000|Overall Study|Adverse Event|0|||
28077381|NCT00091832|54731973|FG001|Overall Study|Adverse Event|0|||
28077382|NCT00091832|54731974|FG002|Overall Study|Adverse Event|0|||
28077383|NCT00091832|54731975|FG003|Overall Study|Adverse Event|1|||
28077384|NCT00091832|54731976|FG004|Overall Study|Adverse Event|3|||
28077385|NCT00091832|54731977|FG005|Overall Study|Adverse Event|0|||
28160941|NCT01346189|54831128|FG003|Overall Study|Non-health system primary care physician|0|||
28160942|NCT01346189|54831125|FG000|Overall Study|Travel|0|||
28160943|NCT01346189|54831126|FG001|Overall Study|Travel|0|||
28160944|NCT01346189|54831127|FG002|Overall Study|Travel|0|||
28160945|NCT01346189|54831128|FG003|Overall Study|Travel|3|||
28160946|NCT00369317|54831138|FG000|Overall Study|Adverse Event|3|||
28160947|NCT00369317|54831138|FG000|Overall Study|Death|1|||
28160948|NCT00369317|54831138|FG000|Overall Study|Lack of Efficacy|5|||
28160949|NCT00369317|54831138|FG000|Overall Study|Physician Decision|2|||
28160950|NCT00369317|54831138|FG000|Overall Study|Withdrawal by Subject|8|||
28160951|NCT00369317|54831138|FG000|Overall Study|Ineligible|1|||
28160952|NCT03193021|54831145|FG000|Overall Study|Lost to Follow-up|1|||
28160953|NCT03193021|54831146|FG001|Overall Study|Lost to Follow-up|1|||
28160954|NCT03913091|54831154|FG000|Overall Study|Lost to Follow-up|18|||
28160955|NCT03913091|54831155|FG001|Overall Study|Lost to Follow-up|11|||
28160956|NCT03913091|54831154|FG000|Overall Study|Required additional meds/surgery|1|||
28160957|NCT03913091|54831155|FG001|Overall Study|Required additional meds/surgery|2|||
28160958|NCT03913091|54831154|FG000|Overall Study|Chronic pain/history of substance abuse|1|||
28160959|NCT03913091|54831155|FG001|Overall Study|Chronic pain/history of substance abuse|1|||
28160960|NCT01318499|54831179|FG000|Overall Study|Adverse Event|16|||
28160961|NCT01318499|54831180|FG001|Overall Study|Adverse Event|11|||
28160962|NCT01318499|54831181|FG002|Overall Study|Adverse Event|6|||
28160963|NCT01318499|54831179|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
28160964|NCT01318499|54831180|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
28160965|NCT01318499|54831181|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|2|||
28160966|NCT01318499|54831179|FG000|Overall Study|Noncompliance|2|||
28160967|NCT01318499|54831180|FG001|Overall Study|Noncompliance|3|||
28160968|NCT01318499|54831181|FG002|Overall Study|Noncompliance|0|||
28160969|NCT01318499|54831179|FG000|Overall Study|Treatment Failure|19|||
28160970|NCT01318499|54831180|FG001|Overall Study|Treatment Failure|19|||
28160971|NCT01318499|54831181|FG002|Overall Study|Treatment Failure|101|||
28160972|NCT01318499|54831179|FG000|Overall Study|Protocol Violation|2|||
28160973|NCT01318499|54831180|FG001|Overall Study|Protocol Violation|4|||
28160974|NCT01318499|54831181|FG002|Overall Study|Protocol Violation|2|||
28160975|NCT01318499|54831179|FG000|Overall Study|Patient Did Not Use Study Medication|18|||
28160976|NCT01318499|54831180|FG001|Overall Study|Patient Did Not Use Study Medication|28|||
28160977|NCT01318499|54831181|FG002|Overall Study|Patient Did Not Use Study Medication|14|||
28160978|NCT01318499|54831179|FG000|Overall Study|Other|7|||
28160979|NCT01318499|54831180|FG001|Overall Study|Other|10|||
28160980|NCT01318499|54831181|FG002|Overall Study|Other|22|||
28077386|NCT00091832|54731972|FG000|Overall Study|Withdrawal by Subject|4|||
28077387|NCT00091832|54731973|FG001|Overall Study|Withdrawal by Subject|5|||
28160981|NCT02285595|54831215|FG000|Overall Study|Lost to Follow-up|14|||
28160982|NCT02285595|54831215|FG000|Overall Study|Withdrawal by Subject|1|||
28160983|NCT02712398|54831238|FG000|Overall Study|Withdrawal by Subject|6|||
28160984|NCT02712398|54831238|FG000|Overall Study|Lost to Follow-up|6|||
28160985|NCT02712398|54831238|FG000|Overall Study|Sponsor Decision|1|||
28160986|NCT02712398|54831238|FG000|Overall Study|Physician Decision|1|||
27851823|NCT02610816|54351811|FG002|Phase 2|Pregnancy|0|||
27851824|NCT02610816|54351812|FG003|Phase 2|Pregnancy|1|||
27851825|NCT02612610|54351908|FG000|Overall Study|Withdrawal by Subject|1|||
27851826|NCT02612610|54351909|FG001|Overall Study|Withdrawal by Subject|1|||
27851827|NCT02612610|54351910|FG002|Overall Study|Withdrawal by Subject|0|||
28077388|NCT00091832|54731974|FG002|Overall Study|Withdrawal by Subject|0|||
28160987|NCT02712398|54831238|FG000|Overall Study|Death|2|||
27925590|NCT01258608|54582131|FG000|Overall Study|Lost to Follow-up|0|||
28077389|NCT00091832|54731975|FG003|Overall Study|Withdrawal by Subject|1|||
28077390|NCT00091832|54731976|FG004|Overall Study|Withdrawal by Subject|3|||
28160988|NCT02712398|54831238|FG000|Overall Study|Re-operation|21|||
28160989|NCT00282867|54831245|FG000|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
28160990|NCT00282867|54831246|FG001|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
28160991|NCT00282867|54831247|FG002|Overall Study|d/c prior to prim outcome, 3 m f/u done|0|||
28160992|NCT00151281|54831252|FG000|Overall Study|Not evaluable|3|||
28160993|NCT01318109|54831267|FG000|Overall Study|Adverse Event|0|||
28160994|NCT01318109|54831268|FG001|Overall Study|Adverse Event|2|||
28160995|NCT01318109|54831269|FG002|Overall Study|Adverse Event|0|||
28160996|NCT01318109|54831267|FG000|Overall Study|Withdrawal by Subject|1|||
28160997|NCT01318109|54831268|FG001|Overall Study|Withdrawal by Subject|0|||
28160998|NCT01318109|54831269|FG002|Overall Study|Withdrawal by Subject|0|||
28160999|NCT01318109|54831267|FG000|Overall Study|Schedule Conflict|0|||
28161000|NCT01318109|54831268|FG001|Overall Study|Schedule Conflict|1|||
28161001|NCT01318109|54831269|FG002|Overall Study|Schedule Conflict|0|||
28161002|NCT02712554|54831279|FG000|Part B: Qualification Phase|Drug Discrimination Failure|0|||
28161003|NCT02712554|54831280|FG001|Part B: Qualification Phase|Drug Discrimination Failure|13|||
28161004|NCT02712554|54831279|FG000|Part B: Qualification Phase|Sponsor Decision|0|||
28161005|NCT02712554|54831280|FG001|Part B: Qualification Phase|Sponsor Decision|4|||
28161006|NCT02712554|54831279|FG000|Part B: Qualification Phase|Withdrawal by Subject|0|||
28161007|NCT02712554|54831280|FG001|Part B: Qualification Phase|Withdrawal by Subject|3|||
28161008|NCT02712554|54831279|FG000|Part B: Qualification Phase|Adverse Event|0|||
28161009|NCT02712554|54831280|FG001|Part B: Qualification Phase|Adverse Event|1|||
28161010|NCT02712554|54831279|FG000|Part B: Treatment Phase|Adverse Event|0|||
28161011|NCT02712554|54831280|FG001|Part B: Treatment Phase|Adverse Event|1|||
28161012|NCT02712554|54831279|FG000|Part B: Treatment Phase|Withdrawal by Subject|0|||
28161013|NCT02712554|54831280|FG001|Part B: Treatment Phase|Withdrawal by Subject|1|||
28161014|NCT02712554|54831279|FG000|Part B: Treatment Phase|Other|0|||
28161015|NCT02712554|54831280|FG001|Part B: Treatment Phase|Other|1|||
28161016|NCT02712320|54831303|FG000|Overall Study|Lost to Follow-up|1|||
28161017|NCT02712320|54831303|FG000|Overall Study|Withdrawal by Subject|1|||
28161018|NCT02712320|54831303|FG000|Overall Study|Transferred to another facility|1|||
28161019|NCT02712320|54831303|FG000|Overall Study|Treating with the prohibited medications|2|||
28161020|NCT03052751|54831309|FG000|Dosing Period 1|Adverse Event|0|||
28161021|NCT03052751|54831310|FG001|Dosing Period 1|Adverse Event|1|||
28161022|NCT03052751|54831311|FG002|Dosing Period 1|Adverse Event|0|||
28161023|NCT03052751|54831312|FG003|Dosing Period 1|Adverse Event|0|||
28161024|NCT03052751|54831313|FG004|Dosing Period 1|Adverse Event|0|||
28161025|NCT03052751|54831314|FG005|Dosing Period 1|Adverse Event|0|||
28161026|NCT03052751|54831309|FG000|Dosing Period 2|Adverse Event|0|||
28161027|NCT03052751|54831310|FG001|Dosing Period 2|Adverse Event|0|||
28161028|NCT03052751|54831311|FG002|Dosing Period 2|Adverse Event|3|||
28161029|NCT03052751|54831312|FG003|Dosing Period 2|Adverse Event|0|||
28161030|NCT03052751|54831313|FG004|Dosing Period 2|Adverse Event|0|||
28161031|NCT03052751|54831314|FG005|Dosing Period 2|Adverse Event|0|||
28161032|NCT03052751|54831309|FG000|Observation Period|Adverse Event|0|||
28161033|NCT03052751|54831310|FG001|Observation Period|Adverse Event|0|||
28161034|NCT03052751|54831311|FG002|Observation Period|Adverse Event|0|||
28161035|NCT03052751|54831312|FG003|Observation Period|Adverse Event|0|||
28161036|NCT03052751|54831313|FG004|Observation Period|Adverse Event|1|||
28161037|NCT03052751|54831314|FG005|Observation Period|Adverse Event|0|||
28161038|NCT01317797|54831327|FG000|Overall Study|Other|0|||
28161039|NCT01317797|54831328|FG001|Overall Study|Other|1|||
28161040|NCT01317797|54831329|FG002|Overall Study|Other|0|||
28161041|NCT01317797|54831327|FG000|Overall Study|Withdrawal of Patient|0|||
28161042|NCT01317797|54831328|FG001|Overall Study|Withdrawal of Patient|0|||
28161043|NCT01317797|54831329|FG002|Overall Study|Withdrawal of Patient|1|||
27925591|NCT01258608|54582132|FG001|Overall Study|Lost to Follow-up|1|||
28161044|NCT01343693|54831337|FG000|Overall Study|Lost to Follow-up|9|||
28161045|NCT02712008|54831344|FG000|Baseline (Day 1) up to Week 12|Death|3|||
28161046|NCT02712008|54831345|FG001|Baseline (Day 1) up to Week 12|Death|0|||
28161047|NCT02712008|54831346|FG002|Baseline (Day 1) up to Week 12|Death|0|||
28161048|NCT02712008|54831347|FG003|Baseline (Day 1) up to Week 12|Death|0|||
28161049|NCT02712008|54831348|FG004|Baseline (Day 1) up to Week 12|Death|0|||
28161050|NCT02712008|54831349|FG005|Baseline (Day 1) up to Week 12|Death|0|||
28161051|NCT02712008|54831350|FG006|Baseline (Day 1) up to Week 12|Death|0|||
28161052|NCT02712008|54831351|FG007|Baseline (Day 1) up to Week 12|Death|0|||
28161053|NCT02712008|54831344|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
28161054|NCT02712008|54831345|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2|||
28161055|NCT02712008|54831346|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
28161056|NCT02712008|54831347|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
28161057|NCT02712008|54831348|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
28161058|NCT02712008|54831349|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
28161059|NCT02712008|54831350|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
28161060|NCT02712008|54831351|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
28161061|NCT02712008|54831344|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
28161062|NCT02712008|54831345|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
28161063|NCT02712008|54831346|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|2|||
28161064|NCT02712008|54831347|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
27943720|NCT01177007|54600670|FG000|Overall Study|Entered hospice care|5|||
28077391|NCT00091832|54731977|FG005|Overall Study|Withdrawal by Subject|1|||
28077392|NCT00091832|54731972|FG000|Overall Study|Death|6|||
28077393|NCT00091832|54731973|FG001|Overall Study|Death|4|||
28077394|NCT00091832|54731974|FG002|Overall Study|Death|5|||
28077395|NCT00091832|54731975|FG003|Overall Study|Death|8|||
28077396|NCT00091832|54731976|FG004|Overall Study|Death|5|||
28077397|NCT00091832|54731977|FG005|Overall Study|Death|6|||
28077398|NCT00091832|54731972|FG000|Overall Study|Disease Progression|2|||
28077399|NCT00091832|54731973|FG001|Overall Study|Disease Progression|0|||
28077400|NCT00091832|54731974|FG002|Overall Study|Disease Progression|0|||
28077401|NCT00091832|54731975|FG003|Overall Study|Disease Progression|1|||
28077402|NCT00091832|54731976|FG004|Overall Study|Disease Progression|1|||
28077403|NCT00091832|54731977|FG005|Overall Study|Disease Progression|2|||
28077404|NCT00091832|54731972|FG000|Overall Study|Ineligibility Determined|0|||
28077405|NCT00091832|54731973|FG001|Overall Study|Ineligibility Determined|0|||
28077406|NCT00091832|54731974|FG002|Overall Study|Ineligibility Determined|1|||
28077407|NCT00091832|54731975|FG003|Overall Study|Ineligibility Determined|0|||
28077408|NCT00091832|54731976|FG004|Overall Study|Ineligibility Determined|1|||
28077409|NCT00091832|54731977|FG005|Overall Study|Ineligibility Determined|0|||
28077410|NCT00091832|54731972|FG000|Overall Study|Lost to Follow-up|1|||
28077411|NCT00091832|54731973|FG001|Overall Study|Lost to Follow-up|0|||
28077412|NCT00091832|54731974|FG002|Overall Study|Lost to Follow-up|3|||
28077413|NCT00091832|54731975|FG003|Overall Study|Lost to Follow-up|3|||
28077414|NCT00091832|54731976|FG004|Overall Study|Lost to Follow-up|2|||
28077415|NCT00091832|54731977|FG005|Overall Study|Lost to Follow-up|1|||
28077416|NCT00091832|54731972|FG000|Overall Study|Noncompliance|0|||
28077417|NCT00091832|54731973|FG001|Overall Study|Noncompliance|1|||
28077418|NCT00091832|54731974|FG002|Overall Study|Noncompliance|0|||
28077419|NCT00091832|54731975|FG003|Overall Study|Noncompliance|0|||
28077420|NCT00091832|54731976|FG004|Overall Study|Noncompliance|0|||
28077421|NCT00091832|54731977|FG005|Overall Study|Noncompliance|0|||
28077422|NCT00091832|54731972|FG000|Overall Study|Other|0|||
28077423|NCT00091832|54731973|FG001|Overall Study|Other|1|||
28077424|NCT00091832|54731974|FG002|Overall Study|Other|2|||
28077425|NCT00091832|54731975|FG003|Overall Study|Other|0|||
28077426|NCT00091832|54731976|FG004|Overall Study|Other|0|||
28077427|NCT00091832|54731977|FG005|Overall Study|Other|0|||
28077428|NCT00091832|54731972|FG000|Overall Study|Protocol Violation|0|||
28077429|NCT00091832|54731973|FG001|Overall Study|Protocol Violation|0|||
28077430|NCT00091832|54731974|FG002|Overall Study|Protocol Violation|1|||
28077431|NCT00091832|54731975|FG003|Overall Study|Protocol Violation|0|||
28077432|NCT00091832|54731976|FG004|Overall Study|Protocol Violation|0|||
28077433|NCT00091832|54731977|FG005|Overall Study|Protocol Violation|1|||
28077434|NCT00391391|54731995|FG000|Overall Study|Adverse Event|0|||
28077435|NCT00391391|54731996|FG001|Overall Study|Adverse Event|0|||
28161065|NCT02712008|54831348|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
27943721|NCT01177007|54600670|FG000|Overall Study|Required additional Y90 treatment|6|||
27943722|NCT01177007|54600670|FG000|Overall Study|Change in treatment modality|21|||
28077436|NCT00391391|54731997|FG002|Overall Study|Adverse Event|0|||
28077437|NCT00391391|54731998|FG003|Overall Study|Adverse Event|1|||
28077438|NCT00391391|54731995|FG000|Overall Study|Lost to Follow-up|1|||
28077439|NCT00391391|54731996|FG001|Overall Study|Lost to Follow-up|3|||
28077440|NCT00391391|54731997|FG002|Overall Study|Lost to Follow-up|7|||
28077441|NCT00391391|54731998|FG003|Overall Study|Lost to Follow-up|4|||
27943723|NCT00930982|54600678|FG000|Overall Study|Adverse Event|19|||
27943724|NCT00930982|54600679|FG001|Overall Study|Adverse Event|23|||
28077442|NCT00391391|54731995|FG000|Overall Study|Protocol Violation|2|||
28077443|NCT00391391|54731996|FG001|Overall Study|Protocol Violation|3|||
28077444|NCT00391391|54731997|FG002|Overall Study|Protocol Violation|6|||
28077445|NCT00391391|54731998|FG003|Overall Study|Protocol Violation|7|||
28077446|NCT00391391|54731995|FG000|Overall Study|Withdrawal by Subject|6|||
28077447|NCT00391391|54731996|FG001|Overall Study|Withdrawal by Subject|4|||
28077448|NCT00391391|54731997|FG002|Overall Study|Withdrawal by Subject|10|||
28161066|NCT02712008|54831349|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
28161067|NCT02712008|54831350|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
28077449|NCT00391391|54731998|FG003|Overall Study|Withdrawal by Subject|7|||
28077450|NCT00091442|54732010|FG000|Overall Study|Progressive Disease|220|||
28077451|NCT00091442|54732011|FG001|Overall Study|Progressive Disease|189|||
28077452|NCT00091442|54732010|FG000|Overall Study|Physician Decision|61|||
28077453|NCT00091442|54732011|FG001|Overall Study|Physician Decision|58|||
28077454|NCT00091442|54732010|FG000|Overall Study|Withdrawal by Subject|38|||
28077455|NCT00091442|54732011|FG001|Overall Study|Withdrawal by Subject|46|||
28161068|NCT02712008|54831351|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
28161069|NCT02712008|54831344|FG000|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
28161070|NCT02712008|54831345|FG001|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
28161071|NCT02712008|54831346|FG002|Baseline (Day 1) up to Week 12|Protocol Violation|1|||
28161072|NCT02712008|54831347|FG003|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
28161073|NCT02712008|54831348|FG004|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
28161074|NCT02712008|54831349|FG005|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
28161075|NCT02712008|54831350|FG006|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
28161076|NCT02712008|54831351|FG007|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
28161077|NCT02712008|54831344|FG000|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
28161078|NCT02712008|54831345|FG001|Baseline (Day 1) up to Week 12|Other Unspecified|1|||
28161079|NCT02712008|54831346|FG002|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
28161080|NCT02712008|54831347|FG003|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
28161081|NCT02712008|54831348|FG004|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
28161082|NCT02712008|54831349|FG005|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
28161083|NCT02712008|54831350|FG006|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
28161084|NCT02712008|54831351|FG007|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
28161085|NCT02712008|54831344|FG000|From Week 12 up to Week 36|Adverse Event|0|||
28161086|NCT02712008|54831345|FG001|From Week 12 up to Week 36|Adverse Event|0|||
28161087|NCT02712008|54831346|FG002|From Week 12 up to Week 36|Adverse Event|0|||
28161088|NCT02712008|54831347|FG003|From Week 12 up to Week 36|Adverse Event|0|||
28161089|NCT02712008|54831348|FG004|From Week 12 up to Week 36|Adverse Event|1|||
28161090|NCT02712008|54831349|FG005|From Week 12 up to Week 36|Adverse Event|0|||
28161091|NCT02712008|54831350|FG006|From Week 12 up to Week 36|Adverse Event|0|||
28161092|NCT02712008|54831351|FG007|From Week 12 up to Week 36|Adverse Event|2|||
28161093|NCT02712008|54831344|FG000|From Week 12 up to Week 36|Death|1|||
28161094|NCT02712008|54831345|FG001|From Week 12 up to Week 36|Death|0|||
28161095|NCT02712008|54831346|FG002|From Week 12 up to Week 36|Death|0|||
28161096|NCT02712008|54831347|FG003|From Week 12 up to Week 36|Death|0|||
28161097|NCT02712008|54831348|FG004|From Week 12 up to Week 36|Death|0|||
28161098|NCT02712008|54831349|FG005|From Week 12 up to Week 36|Death|0|||
28161099|NCT02712008|54831350|FG006|From Week 12 up to Week 36|Death|1|||
28161100|NCT02712008|54831351|FG007|From Week 12 up to Week 36|Death|0|||
28161101|NCT02712008|54831344|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
28161102|NCT02712008|54831345|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
28161103|NCT02712008|54831346|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
28161104|NCT02712008|54831347|FG003|From Week 12 up to Week 36|Lost to Follow-up|1|||
28161105|NCT02712008|54831348|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
28161106|NCT02712008|54831349|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
28161107|NCT02712008|54831350|FG006|From Week 12 up to Week 36|Lost to Follow-up|1|||
28161108|NCT02712008|54831351|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
28161109|NCT02712008|54831344|FG000|From Week 12 up to Week 36|Physician Decision|0|||
28161110|NCT02712008|54831345|FG001|From Week 12 up to Week 36|Physician Decision|0|||
28161111|NCT02712008|54831346|FG002|From Week 12 up to Week 36|Physician Decision|0|||
28161112|NCT02712008|54831347|FG003|From Week 12 up to Week 36|Physician Decision|1|||
28161113|NCT02712008|54831348|FG004|From Week 12 up to Week 36|Physician Decision|1|||
28161114|NCT02712008|54831349|FG005|From Week 12 up to Week 36|Physician Decision|0|||
28161115|NCT02712008|54831350|FG006|From Week 12 up to Week 36|Physician Decision|0|||
27831308|NCT01786109|54307723|FG001|Overall Study|unrelated illness|0|||
27943725|NCT00930982|54600678|FG000|Overall Study|Protocol Violation|1|||
27943726|NCT00930982|54600679|FG001|Overall Study|Protocol Violation|5|||
27943727|NCT00930982|54600678|FG000|Overall Study|Withdrawal by Subject|1|||
27943728|NCT00930982|54600679|FG001|Overall Study|Withdrawal by Subject|1|||
27943729|NCT01176773|54600685|FG000|Overall Study|Screen Failure|2|||
27943730|NCT01176773|54600685|FG000|Overall Study|Withdrew consent|1|||
27943731|NCT00928018|54600692|FG000|Overall Study|Withdrawal by Subject|1|||
27943732|NCT00928018|54600693|FG001|Overall Study|Withdrawal by Subject|0|||
27943733|NCT00927940|54600703|FG000|Overall Study|Death|1|||
27943734|NCT00927862|54600710|FG000|Overall Study|Missing data needed for endpt analyses|27|||
27943735|NCT00927862|54600711|FG001|Overall Study|Missing data needed for endpt analyses|45|||
27943736|NCT00976989|54600722|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
27943737|NCT00976989|54600723|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
27943738|NCT00976989|54600724|FG002|Overall Study|Violation of Selection Criteria at Entry|1|||
27943739|NCT00976989|54600722|FG000|Overall Study|Death|5|||
27943740|NCT00976989|54600723|FG001|Overall Study|Death|7|||
28161116|NCT02712008|54831351|FG007|From Week 12 up to Week 36|Physician Decision|0|||
28161117|NCT02712008|54831344|FG000|From Week 12 up to Week 36|Withdrawal by Subject|0|||
27943741|NCT00976989|54600724|FG002|Overall Study|Death|10|||
28077456|NCT00091442|54732010|FG000|Overall Study|Adverse Event|29|||
28077457|NCT00091442|54732011|FG001|Overall Study|Adverse Event|48|||
28077458|NCT00091442|54732010|FG000|Overall Study|2cycles therapy beyond Complete response|9|||
28077459|NCT00091442|54732011|FG001|Overall Study|2cycles therapy beyond Complete response|16|||
28077460|NCT00091442|54732010|FG000|Overall Study|Death|9|||
28077461|NCT00091442|54732011|FG001|Overall Study|Death|7|||
28077462|NCT00091442|54732010|FG000|Overall Study|Lost to Follow-up|1|||
28077463|NCT00091442|54732011|FG001|Overall Study|Lost to Follow-up|3|||
28077464|NCT00091442|54732010|FG000|Overall Study|Other|2|||
28077465|NCT00091442|54732011|FG001|Overall Study|Other|6|||
28077466|NCT00390689|54732020|FG000|Overall Study|Adverse Event|2|||
28077467|NCT00390689|54732021|FG001|Overall Study|Adverse Event|5|||
28077468|NCT00390689|54732022|FG002|Overall Study|Adverse Event|2|||
28077469|NCT00390689|54732020|FG000|Overall Study|Lack of Efficacy|0|||
28077470|NCT00390689|54732021|FG001|Overall Study|Lack of Efficacy|0|||
28077471|NCT00390689|54732022|FG002|Overall Study|Lack of Efficacy|1|||
28077472|NCT00390689|54732020|FG000|Overall Study|Protocol Violation|1|||
28077473|NCT00390689|54732021|FG001|Overall Study|Protocol Violation|0|||
28077474|NCT00390689|54732022|FG002|Overall Study|Protocol Violation|0|||
28077475|NCT00390689|54732020|FG000|Overall Study|Investigator's judgement|2|||
28077476|NCT00390689|54732021|FG001|Overall Study|Investigator's judgement|0|||
28077477|NCT00390689|54732022|FG002|Overall Study|Investigator's judgement|0|||
28077478|NCT00121238|54732039|FG000|Overall Study|disease progression before intervention|1|||
27943742|NCT00976989|54600722|FG000|Overall Study|Refused Treatment|4|||
27943743|NCT00976989|54600723|FG001|Overall Study|Refused Treatment|3|||
27943744|NCT00976989|54600724|FG002|Overall Study|Refused Treatment|5|||
27943745|NCT00976989|54600722|FG000|Overall Study|Failure to Return|2|||
27943746|NCT00976989|54600723|FG001|Overall Study|Failure to Return|1|||
27943747|NCT00976989|54600724|FG002|Overall Study|Failure to Return|0|||
27943748|NCT00976989|54600722|FG000|Overall Study|Recurrence of Disease|0|||
27943749|NCT00976989|54600723|FG001|Overall Study|Recurrence of Disease|1|||
27943750|NCT00976989|54600724|FG002|Overall Study|Recurrence of Disease|0|||
27943751|NCT00976989|54600722|FG000|Overall Study|Other|1|||
27943752|NCT00976989|54600723|FG001|Overall Study|Other|0|||
27943753|NCT00976989|54600724|FG002|Overall Study|Other|1|||
27943754|NCT00927784|54600734|FG000|Overall Study|Death|1|||
27943755|NCT00927784|54600735|FG001|Overall Study|Death|0|||
27943756|NCT00927784|54600734|FG000|Overall Study|Withdrawal by Subject|1|||
27943757|NCT00927784|54600735|FG001|Overall Study|Withdrawal by Subject|0|||
27943758|NCT05056987|54600752|FG000|First Wear Period, Day 14 or Day 28|Adverse Event|1|||
27943759|NCT05056987|54600753|FG001|First Wear Period, Day 14 or Day 28|Adverse Event|0|||
27943760|NCT05056987|54600752|FG000|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|0|||
27943761|NCT05056987|54600753|FG001|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|2|||
27943762|NCT04654468|54600762|FG000|Overall Study|Death|1|||
27943763|NCT04654468|54600762|FG000|Overall Study|Ongoing in the Study|50|||
27943764|NCT03834506|54600781|FG000|Overall Study|Death|268|||
27943765|NCT03834506|54600782|FG001|Overall Study|Death|285|||
27943766|NCT03834506|54600781|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
27943767|NCT03834506|54600782|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
27943768|NCT03834506|54600781|FG000|Overall Study|Withdrawal by Subject|12|||
27943769|NCT03834506|54600782|FG001|Overall Study|Withdrawal by Subject|8|||
27943770|NCT03834506|54600781|FG000|Overall Study|Participants ongoing in the study|234|||
27943771|NCT03834506|54600782|FG001|Overall Study|Participants ongoing in the study|221|||
27943772|NCT03512197|54600799|FG000|Overall Study|Guardian decision|1|||
27943773|NCT03512197|54600800|FG001|Overall Study|Guardian decision|1|||
27943774|NCT03512197|54600799|FG000|Overall Study|Lack of Efficacy|19|||
27943775|NCT03512197|54600800|FG001|Overall Study|Lack of Efficacy|11|||
27943776|NCT03512197|54600799|FG000|Overall Study|New Therapy for Study Indication|16|||
28077479|NCT00121238|54732039|FG000|Overall Study|Protocol Violation|2|||
28077480|NCT00390455|54732045|FG000|Overall Study|Adverse Event|17|||
28077481|NCT00390455|54732046|FG001|Overall Study|Adverse Event|3|||
28077482|NCT00390455|54732045|FG000|Overall Study|Withdrawal by Subject|8|||
28077483|NCT00390455|54732046|FG001|Overall Study|Withdrawal by Subject|8|||
28077484|NCT00390455|54732045|FG000|Overall Study|Alternate Treatment|0|||
28077485|NCT00390455|54732046|FG001|Overall Study|Alternate Treatment|1|||
27943777|NCT03512197|54600800|FG001|Overall Study|New Therapy for Study Indication|16|||
27943778|NCT03512197|54600799|FG000|Overall Study|Physician Decision|60|||
27943779|NCT03512197|54600800|FG001|Overall Study|Physician Decision|60|||
27943780|NCT03512197|54600799|FG000|Overall Study|Protocol Violation|0|||
27943781|NCT03512197|54600800|FG001|Overall Study|Protocol Violation|2|||
27943782|NCT03512197|54600799|FG000|Overall Study|Terminated by Sponsored|46|||
28161118|NCT02712008|54831345|FG001|From Week 12 up to Week 36|Withdrawal by Subject|0|||
28161119|NCT02712008|54831346|FG002|From Week 12 up to Week 36|Withdrawal by Subject|0|||
28161120|NCT02712008|54831347|FG003|From Week 12 up to Week 36|Withdrawal by Subject|0|||
28161121|NCT02712008|54831348|FG004|From Week 12 up to Week 36|Withdrawal by Subject|0|||
28161122|NCT02712008|54831349|FG005|From Week 12 up to Week 36|Withdrawal by Subject|0|||
28161123|NCT02712008|54831350|FG006|From Week 12 up to Week 36|Withdrawal by Subject|3|||
28161124|NCT02712008|54831351|FG007|From Week 12 up to Week 36|Withdrawal by Subject|2|||
28161125|NCT04238481|54831369|FG000|Overall Study|Miscellaneous|0|||
28161126|NCT04238481|54831370|FG001|Overall Study|Miscellaneous|1|||
28161127|NCT04238481|54831371|FG002|Overall Study|Miscellaneous|0|||
28161128|NCT04238481|54831372|FG003|Overall Study|Miscellaneous|0|||
28161129|NCT02711306|54831388|FG000|Overall Study|Withdrawal by Subject|2|||
28161130|NCT02711306|54831389|FG001|Overall Study|Withdrawal by Subject|2|||
28161131|NCT02710292|54831395|FG000|Period 1, First 10 Days of Wear|Adverse Event|0|||
28161132|NCT02710292|54831396|FG001|Period 1, First 10 Days of Wear|Adverse Event|1|||
28161133|NCT02710292|54831395|FG000|Period 1, First 10 Days of Wear|Withdrawal by Subject|1|||
28161134|NCT02710292|54831396|FG001|Period 1, First 10 Days of Wear|Withdrawal by Subject|2|||
28161135|NCT02710214|54831405|FG000|Overall Study|Lost to Follow-up|1|||
28161136|NCT02710214|54831406|FG001|Overall Study|Lost to Follow-up|0|||
28161137|NCT02710214|54831405|FG000|Overall Study|Lack of Efficacy|0|||
28161138|NCT02710214|54831406|FG001|Overall Study|Lack of Efficacy|1|||
28161139|NCT02710214|54831405|FG000|Overall Study|Death|0|||
28161140|NCT02710214|54831406|FG001|Overall Study|Death|1|||
28161141|NCT03052517|54831415|FG000|Overall Study|Study Terminated By Sponsor|928|||
28161142|NCT03052517|54831416|FG001|Overall Study|Study Terminated By Sponsor|938|||
28161143|NCT03052517|54831417|FG002|Overall Study|Study Terminated By Sponsor|296|||
28161144|NCT03052517|54831415|FG000|Overall Study|Subject/Guardian Decision|50|||
28161145|NCT03052517|54831416|FG001|Overall Study|Subject/Guardian Decision|45|||
28161146|NCT03052517|54831417|FG002|Overall Study|Subject/Guardian Decision|22|||
28161147|NCT03052517|54831415|FG000|Overall Study|Lack of Efficacy|23|||
28161148|NCT03052517|54831416|FG001|Overall Study|Lack of Efficacy|14|||
28161149|NCT03052517|54831417|FG002|Overall Study|Lack of Efficacy|7|||
28161150|NCT03052517|54831415|FG000|Overall Study|Adverse Event|6|||
28161151|NCT03052517|54831416|FG001|Overall Study|Adverse Event|5|||
28077486|NCT00390455|54732045|FG000|Overall Study|Other Medical Reasons|7|||
28077487|NCT00390455|54732046|FG001|Overall Study|Other Medical Reasons|11|||
28077488|NCT03812510|54732052|FG000|Overall Study|Lost to Follow-up|39|||
28077489|NCT03812510|54732052|FG000|Overall Study|Withdrawal by Subject|42|||
28077490|NCT03812510|54732052|FG000|Overall Study|Physician Decision|2|||
28077491|NCT03812510|54732052|FG000|Overall Study|Study Terminated by Sponsor|9|||
28077492|NCT03812510|54732052|FG000|Overall Study|Did Not Start Study Medication|55|||
28077493|NCT03812510|54732052|FG000|Overall Study|Adverse Event|5|||
28077494|NCT00390299|54732062|FG000|Overall Study|Cancellation|1|||
28077495|NCT00390299|54732063|FG001|Overall Study|Cancellation|0|||
28077496|NCT00390299|54732064|FG002|Overall Study|Cancellation|0|||
28161152|NCT03052517|54831417|FG002|Overall Study|Adverse Event|0|||
27831309|NCT01786109|54307724|FG002|Overall Study|unrelated illness|1|||
28077497|NCT00390299|54732065|FG003|Overall Study|Cancellation|0|||
28077498|NCT00390299|54732066|FG004|Overall Study|Cancellation|0|||
28077499|NCT00119678|54732082|FG000|Double-blind Treatment Period|Death|1|||
28161153|NCT03052517|54831415|FG000|Overall Study|Physician Decision|4|||
28161154|NCT03052517|54831416|FG001|Overall Study|Physician Decision|5|||
28161155|NCT03052517|54831417|FG002|Overall Study|Physician Decision|1|||
28161156|NCT03052517|54831415|FG000|Overall Study|Death|3|||
28161157|NCT03052517|54831416|FG001|Overall Study|Death|0|||
28161158|NCT03052517|54831417|FG002|Overall Study|Death|1|||
28161159|NCT03052517|54831415|FG000|Overall Study|Lost to Follow-up|2|||
28161160|NCT03052517|54831416|FG001|Overall Study|Lost to Follow-up|4|||
28161161|NCT03052517|54831417|FG002|Overall Study|Lost to Follow-up|0|||
28161162|NCT03052517|54831415|FG000|Overall Study|Pregnancy|1|||
28161163|NCT03052517|54831416|FG001|Overall Study|Pregnancy|0|||
28161164|NCT03052517|54831417|FG002|Overall Study|Pregnancy|1|||
28161165|NCT03052517|54831415|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
28161166|NCT03052517|54831416|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
28161167|NCT03052517|54831417|FG002|Overall Study|Non-Compliance With Study Treatment|0|||
28161168|NCT03052517|54831415|FG000|Overall Study|Technical Problems|0|||
28161169|NCT03052517|54831416|FG001|Overall Study|Technical Problems|1|||
28161170|NCT03052517|54831417|FG002|Overall Study|Technical Problems|0|||
28161171|NCT02708498|54831433|FG000|Overall Study|Death|20|||
28161172|NCT02708498|54831434|FG001|Overall Study|Death|19|||
28161173|NCT02708498|54831435|FG002|Overall Study|Death|0|||
28161174|NCT02708498|54831436|FG003|Overall Study|Death|0|||
28161175|NCT02708498|54831437|FG004|Overall Study|Death|1|||
28161176|NCT02708498|54831438|FG005|Overall Study|Death|0|||
28161177|NCT02708498|54831439|FG006|Overall Study|Death|0|||
28161178|NCT02708498|54831440|FG007|Overall Study|Death|0|||
28161179|NCT02708498|54831433|FG000|Overall Study|Unknown reason, missing data|0|||
28161180|NCT02708498|54831434|FG001|Overall Study|Unknown reason, missing data|0|||
28161181|NCT02708498|54831435|FG002|Overall Study|Unknown reason, missing data|62|||
28077500|NCT00119678|54732083|FG001|Double-blind Treatment Period|Death|0|||
28077501|NCT00119678|54732082|FG000|Double-blind Treatment Period|Adverse Event|7|||
28077502|NCT00119678|54732083|FG001|Double-blind Treatment Period|Adverse Event|1|||
28077503|NCT00119678|54732082|FG000|Double-blind Treatment Period|Lack of Efficacy|21|||
28077504|NCT00119678|54732083|FG001|Double-blind Treatment Period|Lack of Efficacy|12|||
28077505|NCT00119678|54732082|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
28077506|NCT00119678|54732083|FG001|Double-blind Treatment Period|Lost to Follow-up|2|||
28077507|NCT00119678|54732082|FG000|Double-blind Treatment Period|Participant withdrew consent|4|||
28077508|NCT00119678|54732083|FG001|Double-blind Treatment Period|Participant withdrew consent|4|||
28077509|NCT00119678|54732082|FG000|Double-blind Treatment Period|Participants not meeting study criteria|0|||
28077510|NCT00119678|54732083|FG001|Double-blind Treatment Period|Participants not meeting study criteria|1|||
28077511|NCT00119678|54732082|FG000|Double-blind Treatment Period|Poor/Non-compliance|3|||
28077512|NCT00119678|54732083|FG001|Double-blind Treatment Period|Poor/Non-compliance|0|||
28077513|NCT00119678|54732082|FG000|Double-blind Treatment Period|Pregnancy|0|||
28077514|NCT00119678|54732083|FG001|Double-blind Treatment Period|Pregnancy|2|||
28077515|NCT00119678|54732082|FG000|Double-blind Treatment Period|Not treated|1|||
28077516|NCT00119678|54732083|FG001|Double-blind Treatment Period|Not treated|2|||
28077517|NCT00119678|54732082|FG000|Double-blind Treatment Period|Site closed due to non-compliance|3|||
28077518|NCT00119678|54732083|FG001|Double-blind Treatment Period|Site closed due to non-compliance|2|||
28077519|NCT00119678|54732082|FG000|Open-label Treatment Period|Death|1|||
28077520|NCT00119678|54732083|FG001|Open-label Treatment Period|Death|0|||
28077521|NCT00119678|54732082|FG000|Open-label Treatment Period|Adverse Event|3|||
28077522|NCT00119678|54732083|FG001|Open-label Treatment Period|Adverse Event|0|||
28077523|NCT00119678|54732082|FG000|Open-label Treatment Period|Lack of Efficacy|9|||
28077524|NCT00119678|54732083|FG001|Open-label Treatment Period|Lack of Efficacy|0|||
28077525|NCT00119678|54732082|FG000|Open-label Treatment Period|Lost to Follow-up|3|||
28077526|NCT00119678|54732083|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
28077527|NCT00119678|54732082|FG000|Open-label Treatment Period|Participant withdrew consent|4|||
28077528|NCT00119678|54732083|FG001|Open-label Treatment Period|Participant withdrew consent|0|||
28077529|NCT00119678|54732082|FG000|Open-label Treatment Period|Participants not meeting study criteria|2|||
28077530|NCT00119678|54732083|FG001|Open-label Treatment Period|Participants not meeting study criteria|0|||
28077531|NCT00119678|54732082|FG000|Open-label Treatment Period|Pregnancy|1|||
28077532|NCT00119678|54732083|FG001|Open-label Treatment Period|Pregnancy|0|||
28077533|NCT00119678|54732082|FG000|Open-label Treatment Period|Administrative reasons by sponsor|87|||
28077534|NCT00119678|54732083|FG001|Open-label Treatment Period|Administrative reasons by sponsor|0|||
28077535|NCT00110084|54732091|FG000|Overall Study|Adverse Event|9|||
28077536|NCT00110084|54732091|FG000|Overall Study|Death|1|||
28077537|NCT00110084|54732091|FG000|Overall Study|Patient Refusal|10|||
28077538|NCT00110084|54732091|FG000|Overall Study|Alternate Therapy|5|||
28077539|NCT00110084|54732091|FG000|Overall Study|Intercurrent Illness|1|||
28161182|NCT02708498|54831436|FG003|Overall Study|Unknown reason, missing data|51|||
28077540|NCT00110084|54732091|FG000|Overall Study|Other|2|||
28077541|NCT00390221|54732098|FG000|Overall Study|Lost to Follow-up|0|||
28077542|NCT00390221|54732099|FG001|Overall Study|Lost to Follow-up|3|||
28077543|NCT00390221|54732100|FG002|Overall Study|Lost to Follow-up|0|||
28077544|NCT00390221|54732098|FG000|Overall Study|Adverse Event|1|||
28161183|NCT02708498|54831437|FG004|Overall Study|Unknown reason, missing data|195|||
28077545|NCT00390221|54732099|FG001|Overall Study|Adverse Event|4|||
28161184|NCT02708498|54831438|FG005|Overall Study|Unknown reason, missing data|132|||
28161185|NCT02708498|54831439|FG006|Overall Study|Unknown reason, missing data|0|||
28077546|NCT00390221|54732100|FG002|Overall Study|Adverse Event|3|||
28161186|NCT02708498|54831440|FG007|Overall Study|Unknown reason, missing data|0|||
28161187|NCT02710136|54831458|FG000|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1|||
28161188|NCT02710136|54831459|FG001|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0|||
28161189|NCT03702231|54831469|FG000|Overall Study|Withdrawal by Subject|1|||
28161190|NCT03702231|54831470|FG001|Overall Study|Withdrawal by Subject|0|||
28161191|NCT03702231|54831471|FG002|Overall Study|Withdrawal by Subject|0|||
28161192|NCT03702231|54831469|FG000|Overall Study|Protocol Violation|0|||
28161193|NCT03702231|54831470|FG001|Overall Study|Protocol Violation|0|||
28161194|NCT03702231|54831471|FG002|Overall Study|Protocol Violation|1|||
28161195|NCT03702231|54831469|FG000|Overall Study|COVID Pandemic|3|||
28161196|NCT03702231|54831470|FG001|Overall Study|COVID Pandemic|4|||
28161197|NCT03702231|54831471|FG002|Overall Study|COVID Pandemic|1|||
28161198|NCT02741271|54831481|FG000|Overall Study|Lost to Follow-up|2|||
28161199|NCT02741271|54831482|FG001|Overall Study|Lost to Follow-up|0|||
28161200|NCT02741271|54831481|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
28161201|NCT02741271|54831482|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
28161202|NCT02709746|54831495|FG000|Phase A (Single-blind Treatment Period)|Protocol Violation|4|||
28161203|NCT02709746|54831496|FG001|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
28161204|NCT02709746|54831497|FG002|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
28161205|NCT02709746|54831498|FG003|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
28161206|NCT02709746|54831499|FG004|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
28161207|NCT02709746|54831495|FG000|Phase A (Single-blind Treatment Period)|Not sepcified|14|||
28161208|NCT02709746|54831496|FG001|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
28161209|NCT02709746|54831497|FG002|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
28161210|NCT02709746|54831498|FG003|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
28161211|NCT02709746|54831499|FG004|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
28161212|NCT02709746|54831495|FG000|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12|||
28161213|NCT02709746|54831496|FG001|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
28161214|NCT02709746|54831497|FG002|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
28161215|NCT02709746|54831498|FG003|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
28161216|NCT02709746|54831499|FG004|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
28161217|NCT02709746|54831495|FG000|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7|||
28161218|NCT02709746|54831496|FG001|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
28161219|NCT02709746|54831497|FG002|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
28077547|NCT00390221|54732098|FG000|Overall Study|Investigator Decision|0|||
28077548|NCT00390221|54732099|FG001|Overall Study|Investigator Decision|0|||
28077549|NCT00390221|54732100|FG002|Overall Study|Investigator Decision|1|||
28077550|NCT00390221|54732098|FG000|Overall Study|Withdrawal by Subject|13|||
28077551|NCT00390221|54732099|FG001|Overall Study|Withdrawal by Subject|9|||
28077552|NCT00390221|54732100|FG002|Overall Study|Withdrawal by Subject|7|||
28077553|NCT00390221|54732098|FG000|Overall Study|Subject Non-compliance|1|||
28077554|NCT00390221|54732099|FG001|Overall Study|Subject Non-compliance|0|||
28077555|NCT00390221|54732100|FG002|Overall Study|Subject Non-compliance|2|||
28077556|NCT00390221|54732098|FG000|Overall Study|Other|3|||
28077557|NCT00390221|54732099|FG001|Overall Study|Other|4|||
28077558|NCT00390221|54732100|FG002|Overall Study|Other|2|||
28077559|NCT00389831|54732111|FG000|Overall Study|Lack of Efficacy|0|||
28077560|NCT00389831|54732112|FG001|Overall Study|Lack of Efficacy|2|||
28077561|NCT00389831|54732111|FG000|Overall Study|Did not receive treatment.|0|||
28077562|NCT00389831|54732112|FG001|Overall Study|Did not receive treatment.|2|||
28077563|NCT00389831|54732111|FG000|Overall Study|Other reasons|0|||
28077564|NCT00389831|54732112|FG001|Overall Study|Other reasons|2|||
28077565|NCT00389831|54732111|FG000|Overall Study|Lost to Follow-up|0|||
28077566|NCT00389831|54732112|FG001|Overall Study|Lost to Follow-up|1|||
28077567|NCT00389597|54732134|FG000|Overall Study|Lost to Follow-up|8|||
28077568|NCT00389597|54732135|FG001|Overall Study|Lost to Follow-up|6|||
28077569|NCT00389597|54732136|FG002|Overall Study|Lost to Follow-up|4|||
28077570|NCT00389597|54732137|FG003|Overall Study|Lost to Follow-up|6|||
28077571|NCT00389519|54732151|FG000|Placebo Run-In|Did not meet blood pressure criteria|119|||
28077572|NCT00389519|54732152|FG001|Placebo Run-In|Did not meet blood pressure criteria|0|||
28077573|NCT00389519|54732153|FG002|Placebo Run-In|Did not meet blood pressure criteria|0|||
28077574|NCT00389519|54732154|FG003|Placebo Run-In|Did not meet blood pressure criteria|0|||
28077575|NCT00389519|54732151|FG000|Placebo Run-In|Withdrawal by Subject|19|||
28077576|NCT00389519|54732152|FG001|Placebo Run-In|Withdrawal by Subject|0|||
28077577|NCT00389519|54732153|FG002|Placebo Run-In|Withdrawal by Subject|0|||
28077578|NCT00389519|54732154|FG003|Placebo Run-In|Withdrawal by Subject|0|||
28161220|NCT02709746|54831498|FG003|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
28161221|NCT02709746|54831499|FG004|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
28161222|NCT02709746|54831495|FG000|Phase A (Single-blind Treatment Period)|Adverse Event|2|||
28161223|NCT02709746|54831496|FG001|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
28161224|NCT02709746|54831497|FG002|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
28161225|NCT02709746|54831498|FG003|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
28077579|NCT00389519|54732151|FG000|Placebo Run-In|Reason not specified|40|||
28077580|NCT00389519|54732152|FG001|Placebo Run-In|Reason not specified|0|||
28077581|NCT00389519|54732153|FG002|Placebo Run-In|Reason not specified|0|||
28077582|NCT00389519|54732154|FG003|Placebo Run-In|Reason not specified|0|||
28077583|NCT00389519|54732151|FG000|Randomized|Did not receive study drug|2|||
28077584|NCT00389519|54732152|FG001|Randomized|Did not receive study drug|0|||
28077585|NCT00389519|54732153|FG002|Randomized|Did not receive study drug|0|||
28077586|NCT00389519|54732154|FG003|Randomized|Did not receive study drug|0|||
28077587|NCT00389519|54732151|FG000|Treated|Adverse Event|1|||
28077588|NCT00389519|54732152|FG001|Treated|Adverse Event|0|||
28077589|NCT00389519|54732153|FG002|Treated|Adverse Event|0|||
28077590|NCT00389519|54732154|FG003|Treated|Adverse Event|2|||
28077591|NCT00389519|54732151|FG000|Treated|Reason not specified|1|||
28077592|NCT00389519|54732152|FG001|Treated|Reason not specified|1|||
28161226|NCT02709746|54831499|FG004|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
28161227|NCT02709746|54831495|FG000|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12|||
28161228|NCT02709746|54831496|FG001|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
28161229|NCT02709746|54831497|FG002|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
28161230|NCT02709746|54831498|FG003|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
28161231|NCT02709746|54831499|FG004|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
28161232|NCT02709746|54831495|FG000|Phase A (Single-blind Treatment Period)|Enrolled not treated|7|||
28161233|NCT02709746|54831496|FG001|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
28161234|NCT02709746|54831497|FG002|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
28161235|NCT02709746|54831498|FG003|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
28161236|NCT02709746|54831499|FG004|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
28161237|NCT02709746|54831495|FG000|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7|||
28161238|NCT02709746|54831496|FG001|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
28161239|NCT02709746|54831497|FG002|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
27943783|NCT03512197|54600800|FG001|Overall Study|Terminated by Sponsored|50|||
27943784|NCT03512197|54600799|FG000|Overall Study|Subject Decision|15|||
27943785|NCT03512197|54600800|FG001|Overall Study|Subject Decision|12|||
27943786|NCT03512197|54600799|FG000|Overall Study|Withdrawal of informed consent|20|||
27943787|NCT03512197|54600800|FG001|Overall Study|Withdrawal of informed consent|14|||
27943788|NCT03512197|54600799|FG000|Overall Study|Adverse Event|30|||
27943789|NCT03512197|54600800|FG001|Overall Study|Adverse Event|34|||
27943790|NCT03512197|54600799|FG000|Overall Study|Death|14|||
27943791|NCT03512197|54600800|FG001|Overall Study|Death|9|||
27943792|NCT03512197|54600799|FG000|Overall Study|Failure to meet Continuation Criteria|24|||
27943793|NCT03512197|54600800|FG001|Overall Study|Failure to meet Continuation Criteria|28|||
27943794|NCT03512197|54600799|FG000|Overall Study|Missing|3|||
28161240|NCT02709746|54831498|FG003|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
28161241|NCT02709746|54831499|FG004|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
28161242|NCT02709746|54831495|FG000|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103|||
28161243|NCT02709746|54831496|FG001|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
28161244|NCT02709746|54831497|FG002|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
28161245|NCT02709746|54831498|FG003|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
28161246|NCT02709746|54831499|FG004|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
28161247|NCT02709746|54831495|FG000|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
28161248|NCT02709746|54831496|FG001|Phase B (Double-blind Treatment Period)|Protocol Violation|1|||
28161249|NCT02709746|54831497|FG002|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
28161250|NCT02709746|54831498|FG003|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
28161251|NCT02709746|54831499|FG004|Phase B (Double-blind Treatment Period)|Protocol Violation|2|||
28161252|NCT02709746|54831495|FG000|Phase B (Double-blind Treatment Period)|Other|0|||
28161253|NCT02709746|54831496|FG001|Phase B (Double-blind Treatment Period)|Other|6|||
28161254|NCT02709746|54831497|FG002|Phase B (Double-blind Treatment Period)|Other|5|||
27851828|NCT02612610|54351911|FG003|Overall Study|Withdrawal by Subject|2|||
27943795|NCT03512197|54600800|FG001|Overall Study|Missing|13|||
27943796|NCT03439852|54600814|FG000|Baseline to 12 Weeks|Failed complete 12 wk survey|4|||
27943797|NCT03439852|54600815|FG001|Baseline to 12 Weeks|Failed complete 12 wk survey|7|||
27943798|NCT03439852|54600814|FG000|12weeks to 24weeks|failed complete 12 or 24 wk surveys|2|||
27943799|NCT03439852|54600815|FG001|12weeks to 24weeks|failed complete 12 or 24 wk surveys|0|||
28077593|NCT00389519|54732153|FG002|Treated|Reason not specified|0|||
28077594|NCT00389519|54732154|FG003|Treated|Reason not specified|2|||
28077595|NCT00389441|54732164|FG000|Overall Study|Adverse Event|7|||
28077596|NCT00389441|54732164|FG000|Overall Study|Death|4|||
28077597|NCT00389441|54732164|FG000|Overall Study|Lost to Follow-up|2|||
28077598|NCT00389441|54732164|FG000|Overall Study|Withdrawal by Subject|4|||
28077599|NCT00389441|54732164|FG000|Overall Study|Physician Decision|1|||
28077600|NCT00389441|54732164|FG000|Overall Study|Protocol Violation|1|||
28077601|NCT00389441|54732164|FG000|Overall Study|Global deterioration of health status|4|||
28077602|NCT00389441|54732164|FG000|Overall Study|Objective progression or relapse|26|||
28077603|NCT00389441|54732164|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|2|||
27943800|NCT03439852|54600814|FG000|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|1|||
27943801|NCT03439852|54600815|FG001|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|0|||
28077604|NCT00389441|54732164|FG000|Overall Study|Clinical progression|1|||
28077605|NCT00118898|54732172|FG000|Overall Study|Death|6|||
28161255|NCT02709746|54831498|FG003|Phase B (Double-blind Treatment Period)|Other|6|||
28161256|NCT02709746|54831499|FG004|Phase B (Double-blind Treatment Period)|Other|7|||
28161257|NCT02709746|54831495|FG000|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
28161258|NCT02709746|54831496|FG001|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
28161259|NCT02709746|54831497|FG002|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4|||
28161260|NCT02709746|54831498|FG003|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
28161261|NCT02709746|54831499|FG004|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
28161262|NCT02709746|54831495|FG000|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
28161263|NCT02709746|54831496|FG001|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3|||
28161264|NCT02709746|54831497|FG002|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
28161265|NCT02709746|54831498|FG003|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1|||
28161266|NCT02709746|54831499|FG004|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2|||
28161267|NCT02709746|54831495|FG000|Phase B (Double-blind Treatment Period)|Adverse Event|0|||
28161268|NCT02709746|54831496|FG001|Phase B (Double-blind Treatment Period)|Adverse Event|4|||
28161269|NCT02709746|54831497|FG002|Phase B (Double-blind Treatment Period)|Adverse Event|8|||
28161270|NCT02709746|54831498|FG003|Phase B (Double-blind Treatment Period)|Adverse Event|5|||
28161271|NCT02709746|54831499|FG004|Phase B (Double-blind Treatment Period)|Adverse Event|2|||
28161272|NCT02709746|54831495|FG000|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0|||
28161273|NCT02709746|54831496|FG001|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
28161274|NCT02709746|54831497|FG002|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
28161275|NCT02709746|54831498|FG003|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
28161276|NCT02709746|54831499|FG004|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1|||
27851829|NCT02612610|54351908|FG000|Overall Study|Adverse Event|2|||
27851830|NCT02612610|54351909|FG001|Overall Study|Adverse Event|2|||
27851831|NCT02612610|54351910|FG002|Overall Study|Adverse Event|3|||
27851832|NCT02612610|54351911|FG003|Overall Study|Adverse Event|10|||
27851833|NCT02612610|54351908|FG000|Overall Study|Lost to Follow-up|0|||
27851834|NCT02612610|54351909|FG001|Overall Study|Lost to Follow-up|1|||
27943802|NCT03355300|54600826|FG000|Overall Study|Physician Decision|0|||
27943803|NCT03355300|54600827|FG001|Overall Study|Physician Decision|1|||
27943804|NCT03355300|54600826|FG000|Overall Study|Lack of Efficacy|2|||
28161277|NCT02709746|54831495|FG000|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
28161278|NCT02709746|54831496|FG001|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
28161279|NCT02709746|54831497|FG002|Phase B (Double-blind Treatment Period)|enrolled not treated|1|||
28161280|NCT02709746|54831498|FG003|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
28161281|NCT02709746|54831499|FG004|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
28161282|NCT02709746|54831495|FG000|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
28161283|NCT02709746|54831496|FG001|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4|||
28161284|NCT02709746|54831497|FG002|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
28161285|NCT02709746|54831498|FG003|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
28161286|NCT02709746|54831499|FG004|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
28161287|NCT01317641|54831520|FG000|Overall Study|Not treated|0|||
28161288|NCT01317641|54831521|FG001|Overall Study|Not treated|0|||
28161289|NCT01317641|54831522|FG002|Overall Study|Not treated|0|||
27851835|NCT02612610|54351910|FG002|Overall Study|Lost to Follow-up|0|||
27851836|NCT02612610|54351911|FG003|Overall Study|Lost to Follow-up|0|||
27851837|NCT02612610|54351908|FG000|Overall Study|Protocol Violation|0|||
28077606|NCT00118898|54732173|FG001|Overall Study|Death|11|||
28077607|NCT00118898|54732174|FG002|Overall Study|Death|6|||
28077608|NCT00118898|54732175|FG003|Overall Study|Death|8|||
28077609|NCT00118898|54732172|FG000|Overall Study|Lost to Follow-up|26|||
28077610|NCT00118898|54732173|FG001|Overall Study|Lost to Follow-up|34|||
28077611|NCT00118898|54732174|FG002|Overall Study|Lost to Follow-up|33|||
28077612|NCT00118898|54732175|FG003|Overall Study|Lost to Follow-up|33|||
28077613|NCT00118898|54732172|FG000|Overall Study|Withdrawal by Subject|10|||
28077614|NCT00118898|54732173|FG001|Overall Study|Withdrawal by Subject|5|||
28077615|NCT00118898|54732174|FG002|Overall Study|Withdrawal by Subject|8|||
28077616|NCT00118898|54732175|FG003|Overall Study|Withdrawal by Subject|8|||
28077617|NCT00118898|54732172|FG000|Overall Study|Site Closure|33|||
28077618|NCT00118898|54732173|FG001|Overall Study|Site Closure|31|||
28077619|NCT00118898|54732174|FG002|Overall Study|Site Closure|28|||
28077620|NCT00118898|54732175|FG003|Overall Study|Site Closure|37|||
28077621|NCT00118898|54732172|FG000|Overall Study|Severe debilitation|1|||
28161290|NCT01317641|54831523|FG003|Overall Study|Not treated|0|||
28161291|NCT01317641|54831524|FG004|Overall Study|Not treated|0|||
28161292|NCT01317641|54831525|FG005|Overall Study|Not treated|0|||
28161293|NCT01317641|54831526|FG006|Overall Study|Not treated|0|||
28161294|NCT01317641|54831527|FG007|Overall Study|Not treated|1|||
28161295|NCT01317641|54831528|FG008|Overall Study|Not treated|1|||
27851838|NCT02612610|54351909|FG001|Overall Study|Protocol Violation|1|||
27851839|NCT02612610|54351910|FG002|Overall Study|Protocol Violation|1|||
27851840|NCT02612610|54351911|FG003|Overall Study|Protocol Violation|0|||
27851841|NCT02612610|54351908|FG000|Overall Study|Lack of Efficacy|1|||
27851842|NCT02612610|54351909|FG001|Overall Study|Lack of Efficacy|2|||
27851843|NCT02612610|54351910|FG002|Overall Study|Lack of Efficacy|0|||
27851844|NCT02612610|54351911|FG003|Overall Study|Lack of Efficacy|1|||
27851845|NCT02612610|54351908|FG000|Overall Study|Physician Decision|0|||
27851846|NCT02612610|54351909|FG001|Overall Study|Physician Decision|1|||
28077622|NCT00118898|54732173|FG001|Overall Study|Severe debilitation|4|||
28161296|NCT01317641|54831520|FG000|Overall Study|Adverse Event|0|||
28161297|NCT01317641|54831521|FG001|Overall Study|Adverse Event|1|||
28161298|NCT01317641|54831522|FG002|Overall Study|Adverse Event|0|||
28161299|NCT01317641|54831523|FG003|Overall Study|Adverse Event|1|||
28161300|NCT01317641|54831524|FG004|Overall Study|Adverse Event|0|||
28161301|NCT01317641|54831525|FG005|Overall Study|Adverse Event|0|||
28161302|NCT01317641|54831526|FG006|Overall Study|Adverse Event|2|||
28161303|NCT01317641|54831527|FG007|Overall Study|Adverse Event|1|||
28077623|NCT00118898|54732174|FG002|Overall Study|Severe debilitation|6|||
28161304|NCT01317641|54831528|FG008|Overall Study|Adverse Event|0|||
28161305|NCT01317641|54831520|FG000|Overall Study|Protocol Violation|1|||
28161306|NCT01317641|54831521|FG001|Overall Study|Protocol Violation|0|||
27851847|NCT02612610|54351910|FG002|Overall Study|Physician Decision|0|||
27851848|NCT02612610|54351911|FG003|Overall Study|Physician Decision|0|||
27851849|NCT02612610|54351908|FG000|Overall Study|Noncompliance|1|||
28077624|NCT00118898|54732175|FG003|Overall Study|Severe debilitation|4|||
28077625|NCT00118898|54732172|FG000|Overall Study|Not compliant with requirements|11|||
28161307|NCT01317641|54831522|FG002|Overall Study|Protocol Violation|0|||
28161308|NCT01317641|54831523|FG003|Overall Study|Protocol Violation|0|||
28161309|NCT01317641|54831524|FG004|Overall Study|Protocol Violation|0|||
27831310|NCT01786109|54307722|FG000|Overall Study|adverse effects colon preparation|0|||
27831311|NCT01786109|54307723|FG001|Overall Study|adverse effects colon preparation|0|||
27831312|NCT01786109|54307724|FG002|Overall Study|adverse effects colon preparation|1|||
28161310|NCT01317641|54831525|FG005|Overall Study|Protocol Violation|0|||
28161311|NCT01317641|54831526|FG006|Overall Study|Protocol Violation|0|||
28161312|NCT01317641|54831527|FG007|Overall Study|Protocol Violation|0|||
28161313|NCT01317641|54831528|FG008|Overall Study|Protocol Violation|0|||
28161314|NCT01317641|54831520|FG000|Overall Study|Disease progression|0|||
28161315|NCT01317641|54831521|FG001|Overall Study|Disease progression|0|||
28161316|NCT01317641|54831522|FG002|Overall Study|Disease progression|0|||
28161317|NCT01317641|54831523|FG003|Overall Study|Disease progression|0|||
28161318|NCT01317641|54831524|FG004|Overall Study|Disease progression|0|||
28161319|NCT01317641|54831525|FG005|Overall Study|Disease progression|0|||
28161320|NCT01317641|54831526|FG006|Overall Study|Disease progression|0|||
28161321|NCT01317641|54831527|FG007|Overall Study|Disease progression|3|||
28161322|NCT01317641|54831528|FG008|Overall Study|Disease progression|4|||
28161323|NCT01317641|54831520|FG000|Overall Study|Withdrawal by Subject|0|||
28161324|NCT01317641|54831521|FG001|Overall Study|Withdrawal by Subject|0|||
28161325|NCT01317641|54831522|FG002|Overall Study|Withdrawal by Subject|0|||
28161326|NCT01317641|54831523|FG003|Overall Study|Withdrawal by Subject|0|||
28161327|NCT01317641|54831524|FG004|Overall Study|Withdrawal by Subject|0|||
28161328|NCT01317641|54831525|FG005|Overall Study|Withdrawal by Subject|0|||
28161329|NCT01317641|54831526|FG006|Overall Study|Withdrawal by Subject|1|||
28161330|NCT01317641|54831527|FG007|Overall Study|Withdrawal by Subject|0|||
28161331|NCT01317641|54831528|FG008|Overall Study|Withdrawal by Subject|0|||
28161332|NCT03186794|54831564|FG000|Overall Study|Physician Decision|2|||
28161333|NCT03186794|54831564|FG000|Overall Study|Withdrawal due to COVID-19 pandemic closure|2|||
28161334|NCT02290431|54831569|FG000|Overall Study|Adverse Event|20|||
28161335|NCT02290431|54831569|FG000|Overall Study|Progressive disease|4|||
28161336|NCT02290431|54831569|FG000|Overall Study|Study terminated by Sponsor|1|||
28161337|NCT02290431|54831569|FG000|Overall Study|Physician Decision|2|||
28161338|NCT02707952|54831577|FG000|Overall Study|Adverse Event|1|||
27943805|NCT03355300|54600827|FG001|Overall Study|Lack of Efficacy|1|||
27943806|NCT03355300|54600826|FG000|Overall Study|Other reason|1|||
27943807|NCT03355300|54600827|FG001|Overall Study|Other reason|0|||
27943808|NCT03332056|54600835|FG000|Overall Study|Incomplete questionnaires|8|||
27831313|NCT02728830|54307808|FG000|Overall Study|Exclusionary Surgery|9|||
28161339|NCT02707952|54831578|FG001|Overall Study|Adverse Event|0|||
28161340|NCT02707952|54831579|FG002|Overall Study|Adverse Event|0|||
28161341|NCT02707952|54831580|FG003|Overall Study|Adverse Event|0|||
28161342|NCT02707952|54831577|FG000|Overall Study|Lost to Follow-up|1|||
28161343|NCT02707952|54831578|FG001|Overall Study|Lost to Follow-up|0|||
28161344|NCT02707952|54831579|FG002|Overall Study|Lost to Follow-up|0|||
28161345|NCT02707952|54831580|FG003|Overall Study|Lost to Follow-up|0|||
28161346|NCT02707952|54831577|FG000|Overall Study|Withdrawal by Subject|0|||
28161347|NCT02707952|54831578|FG001|Overall Study|Withdrawal by Subject|1|||
28161348|NCT02707952|54831579|FG002|Overall Study|Withdrawal by Subject|2|||
28161349|NCT02707952|54831580|FG003|Overall Study|Withdrawal by Subject|0|||
28161350|NCT03050801|54831598|FG000|Experiment 1|Lost to Follow-up|0|||
28161351|NCT03050801|54831599|FG001|Experiment 1|Lost to Follow-up|1|||
28161352|NCT03050801|54831600|FG002|Experiment 1|Lost to Follow-up|0|||
28161353|NCT03050801|54831601|FG003|Experiment 1|Lost to Follow-up|0|||
28161354|NCT03050801|54831602|FG004|Experiment 1|Lost to Follow-up|0|||
28161355|NCT03050801|54831603|FG005|Experiment 1|Lost to Follow-up|0|||
28161356|NCT03050801|54831598|FG000|Experiment 1|Physician Decision|0|||
28161357|NCT03050801|54831599|FG001|Experiment 1|Physician Decision|3|||
28161358|NCT03050801|54831600|FG002|Experiment 1|Physician Decision|0|||
28161359|NCT03050801|54831601|FG003|Experiment 1|Physician Decision|0|||
28161360|NCT03050801|54831602|FG004|Experiment 1|Physician Decision|0|||
28161361|NCT03050801|54831603|FG005|Experiment 1|Physician Decision|0|||
28161362|NCT03050801|54831598|FG000|Experiment 1|Change of experimental design|0|||
28161363|NCT03050801|54831599|FG001|Experiment 1|Change of experimental design|3|||
28161364|NCT03050801|54831600|FG002|Experiment 1|Change of experimental design|0|||
28161365|NCT03050801|54831601|FG003|Experiment 1|Change of experimental design|0|||
28161366|NCT03050801|54831602|FG004|Experiment 1|Change of experimental design|0|||
28161367|NCT03050801|54831603|FG005|Experiment 1|Change of experimental design|0|||
28161368|NCT03050801|54831598|FG000|Experiment 1|Unable to obtain critical rTMS measure|0|||
28161369|NCT03050801|54831599|FG001|Experiment 1|Unable to obtain critical rTMS measure|0|||
28161370|NCT03050801|54831600|FG002|Experiment 1|Unable to obtain critical rTMS measure|2|||
28161371|NCT03050801|54831601|FG003|Experiment 1|Unable to obtain critical rTMS measure|0|||
28161372|NCT03050801|54831602|FG004|Experiment 1|Unable to obtain critical rTMS measure|0|||
28161373|NCT03050801|54831603|FG005|Experiment 1|Unable to obtain critical rTMS measure|0|||
28161374|NCT03050801|54831598|FG000|Experiment 2|Lost to Follow-up|0|||
28161375|NCT03050801|54831599|FG001|Experiment 2|Lost to Follow-up|0|||
28161376|NCT03050801|54831600|FG002|Experiment 2|Lost to Follow-up|0|||
28161377|NCT03050801|54831601|FG003|Experiment 2|Lost to Follow-up|1|||
28161378|NCT03050801|54831602|FG004|Experiment 2|Lost to Follow-up|1|||
28161379|NCT03050801|54831603|FG005|Experiment 2|Lost to Follow-up|0|||
28161380|NCT03050801|54831598|FG000|Experiment 2|Physician Decision|0|||
28161381|NCT03050801|54831599|FG001|Experiment 2|Physician Decision|0|||
28161382|NCT03050801|54831600|FG002|Experiment 2|Physician Decision|0|||
28161383|NCT03050801|54831601|FG003|Experiment 2|Physician Decision|0|||
28161384|NCT03050801|54831602|FG004|Experiment 2|Physician Decision|1|||
28161385|NCT03050801|54831603|FG005|Experiment 2|Physician Decision|0|||
28161386|NCT03050801|54831598|FG000|Experiment 2|Pregnancy|0|||
28161387|NCT03050801|54831599|FG001|Experiment 2|Pregnancy|0|||
28161388|NCT03050801|54831600|FG002|Experiment 2|Pregnancy|0|||
28161389|NCT03050801|54831601|FG003|Experiment 2|Pregnancy|0|||
28161390|NCT03050801|54831602|FG004|Experiment 2|Pregnancy|1|||
28161391|NCT03050801|54831603|FG005|Experiment 2|Pregnancy|0|||
28161392|NCT03050801|54831598|FG000|Experiment 2|Withdrawal by Subject|0|||
28161393|NCT03050801|54831599|FG001|Experiment 2|Withdrawal by Subject|0|||
28161394|NCT03050801|54831600|FG002|Experiment 2|Withdrawal by Subject|0|||
28161395|NCT03050801|54831601|FG003|Experiment 2|Withdrawal by Subject|1|||
28161396|NCT03050801|54831602|FG004|Experiment 2|Withdrawal by Subject|0|||
28161397|NCT03050801|54831603|FG005|Experiment 2|Withdrawal by Subject|0|||
28161398|NCT03050801|54831598|FG000|Experiment 2|Poor data quality|0|||
28161399|NCT03050801|54831599|FG001|Experiment 2|Poor data quality|0|||
28161400|NCT03050801|54831600|FG002|Experiment 2|Poor data quality|0|||
28161401|NCT03050801|54831601|FG003|Experiment 2|Poor data quality|4|||
28161402|NCT03050801|54831602|FG004|Experiment 2|Poor data quality|1|||
28161403|NCT03050801|54831603|FG005|Experiment 2|Poor data quality|0|||
28161404|NCT03050801|54831598|FG000|Experiment 2|Discomfort during stimulation|0|||
28161405|NCT03050801|54831599|FG001|Experiment 2|Discomfort during stimulation|0|||
28161406|NCT03050801|54831600|FG002|Experiment 2|Discomfort during stimulation|0|||
28161407|NCT03050801|54831601|FG003|Experiment 2|Discomfort during stimulation|0|||
28161408|NCT03050801|54831602|FG004|Experiment 2|Discomfort during stimulation|0|||
28161409|NCT03050801|54831603|FG005|Experiment 2|Discomfort during stimulation|2|||
28161410|NCT02707640|54831622|FG000|Overall Study|Adverse Event|4|||
28161411|NCT02707640|54831623|FG001|Overall Study|Adverse Event|2|||
28161412|NCT02707640|54831622|FG000|Overall Study|Death|1|||
28161413|NCT02707640|54831623|FG001|Overall Study|Death|2|||
28161414|NCT02707640|54831622|FG000|Overall Study|Physician Decision|2|||
28161415|NCT02707640|54831623|FG001|Overall Study|Physician Decision|0|||
28161416|NCT02707640|54831622|FG000|Overall Study|Withdrawal by Subject|0|||
28161417|NCT02707640|54831623|FG001|Overall Study|Withdrawal by Subject|1|||
28161418|NCT02707640|54831622|FG000|Overall Study|Participant's Personal Decision|1|||
28161419|NCT02707640|54831623|FG001|Overall Study|Participant's Personal Decision|2|||
28161420|NCT02707640|54831622|FG000|Overall Study|Sponsor Discretion|1|||
28161421|NCT02707640|54831623|FG001|Overall Study|Sponsor Discretion|0|||
28161422|NCT02708966|54831631|FG000|Overall Study|Lost to Follow-up|2|||
28161423|NCT02708966|54831632|FG001|Overall Study|Lost to Follow-up|2|||
28161424|NCT02706938|54831640|FG000|First Period, 6 Weeks|Adverse Event|8|||
28161425|NCT02706938|54831641|FG001|First Period, 6 Weeks|Adverse Event|0|||
28161426|NCT02706938|54831640|FG000|First Period, 6 Weeks|Lost to Follow-up|2|||
28161427|NCT02706938|54831641|FG001|First Period, 6 Weeks|Lost to Follow-up|2|||
28161428|NCT02706938|54831640|FG000|First Period, 6 Weeks|Withdrawal by Subject|1|||
28161429|NCT02706938|54831641|FG001|First Period, 6 Weeks|Withdrawal by Subject|0|||
28161430|NCT02706938|54831640|FG000|Second Period, 6 Weeks|Adverse Event|0|||
28161431|NCT02706938|54831641|FG001|Second Period, 6 Weeks|Adverse Event|7|||
28161432|NCT02706938|54831640|FG000|Second Period, 6 Weeks|Withdrawal by Subject|0|||
28161433|NCT02706938|54831641|FG001|Second Period, 6 Weeks|Withdrawal by Subject|3|||
28161434|NCT03053063|54831651|FG000|Randomized Phase|Study Terminated by Sponsor|326|||
28161435|NCT03053063|54831652|FG001|Randomized Phase|Study Terminated by Sponsor|317|||
28161436|NCT03053063|54831653|FG002|Randomized Phase|Study Terminated by Sponsor|161|||
28161437|NCT03053063|54831654|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
28161438|NCT03053063|54831651|FG000|Randomized Phase|Withdrew consent|8|||
28161439|NCT03053063|54831652|FG001|Randomized Phase|Withdrew consent|11|||
28161440|NCT03053063|54831653|FG002|Randomized Phase|Withdrew consent|5|||
28161441|NCT03053063|54831654|FG003|Randomized Phase|Withdrew consent|0|||
28161442|NCT03053063|54831651|FG000|Randomized Phase|Investigator's Discretion|8|||
28161443|NCT03053063|54831652|FG001|Randomized Phase|Investigator's Discretion|6|||
28161444|NCT03053063|54831653|FG002|Randomized Phase|Investigator's Discretion|2|||
28161445|NCT03053063|54831654|FG003|Randomized Phase|Investigator's Discretion|0|||
28161446|NCT03053063|54831651|FG000|Randomized Phase|Lost to Follow-up|3|||
28161447|NCT03053063|54831652|FG001|Randomized Phase|Lost to Follow-up|5|||
28161448|NCT03053063|54831653|FG002|Randomized Phase|Lost to Follow-up|1|||
28161449|NCT03053063|54831654|FG003|Randomized Phase|Lost to Follow-up|0|||
28161450|NCT03053063|54831651|FG000|Randomized Phase|Adverse Event|0|||
28161451|NCT03053063|54831652|FG001|Randomized Phase|Adverse Event|1|||
28161452|NCT03053063|54831653|FG002|Randomized Phase|Adverse Event|0|||
28161453|NCT03053063|54831654|FG003|Randomized Phase|Adverse Event|0|||
28161454|NCT03053063|54831651|FG000|Randomized Phase|Randomized but Never Treated|1|||
28161455|NCT03053063|54831652|FG001|Randomized Phase|Randomized but Never Treated|3|||
28161456|NCT03053063|54831653|FG002|Randomized Phase|Randomized but Never Treated|2|||
28161457|NCT03053063|54831654|FG003|Randomized Phase|Randomized but Never Treated|0|||
28161458|NCT03053063|54831651|FG000|Randomized Phase|Entered the Open-Label Phase|9|||
28161459|NCT03053063|54831652|FG001|Randomized Phase|Entered the Open-Label Phase|11|||
28161460|NCT03053063|54831653|FG002|Randomized Phase|Entered the Open-Label Phase|3|||
28161461|NCT03053063|54831654|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
28161462|NCT03053063|54831651|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
28161463|NCT03053063|54831652|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
28161464|NCT03053063|54831653|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
28161465|NCT03053063|54831654|FG003|Open-Label Phase|Study Terminated by Sponsor|19|||
28161466|NCT03053063|54831651|FG000|Open-Label Phase|Death|0|||
28161467|NCT03053063|54831652|FG001|Open-Label Phase|Death|0|||
28161468|NCT03053063|54831653|FG002|Open-Label Phase|Death|0|||
28161469|NCT03053063|54831654|FG003|Open-Label Phase|Death|2|||
28161470|NCT03053063|54831651|FG000|Open-Label Phase|Investigator's discretion|0|||
28161471|NCT03053063|54831652|FG001|Open-Label Phase|Investigator's discretion|0|||
28161472|NCT03053063|54831653|FG002|Open-Label Phase|Investigator's discretion|0|||
28161473|NCT03053063|54831654|FG003|Open-Label Phase|Investigator's discretion|2|||
28161474|NCT01316939|54831676|FG000|Overall Study|Study closed/terminated|26|||
28161475|NCT01316939|54831677|FG001|Overall Study|Study closed/terminated|25|||
28161476|NCT01316939|54831678|FG002|Overall Study|Study closed/terminated|23|||
28161477|NCT01316939|54831676|FG000|Overall Study|Lack of Efficacy|24|||
28161478|NCT01316939|54831677|FG001|Overall Study|Lack of Efficacy|25|||
28161479|NCT01316939|54831678|FG002|Overall Study|Lack of Efficacy|25|||
27851850|NCT02612610|54351909|FG001|Overall Study|Noncompliance|0|||
28161480|NCT01316939|54831676|FG000|Overall Study|Adverse Event|9|||
28161481|NCT01316939|54831677|FG001|Overall Study|Adverse Event|12|||
28161482|NCT01316939|54831678|FG002|Overall Study|Adverse Event|11|||
28161483|NCT01316939|54831676|FG000|Overall Study|Withdrawal by Subject|1|||
28161484|NCT01316939|54831677|FG001|Overall Study|Withdrawal by Subject|3|||
28161485|NCT01316939|54831678|FG002|Overall Study|Withdrawal by Subject|6|||
28161486|NCT01316939|54831676|FG000|Overall Study|Physician Decision|2|||
28161487|NCT01316939|54831677|FG001|Overall Study|Physician Decision|2|||
28161488|NCT01316939|54831678|FG002|Overall Study|Physician Decision|1|||
28161489|NCT01316939|54831676|FG000|Overall Study|Lost to Follow-up|0|||
28161490|NCT01316939|54831677|FG001|Overall Study|Lost to Follow-up|0|||
28161491|NCT01316939|54831678|FG002|Overall Study|Lost to Follow-up|2|||
28161492|NCT01316939|54831676|FG000|Overall Study|Met Liver chemistry stopping criteria|1|||
28161493|NCT01316939|54831677|FG001|Overall Study|Met Liver chemistry stopping criteria|0|||
28161494|NCT01316939|54831678|FG002|Overall Study|Met Liver chemistry stopping criteria|1|||
28161495|NCT01316939|54831676|FG000|Overall Study|Protocol Violation|0|||
28161496|NCT01316939|54831677|FG001|Overall Study|Protocol Violation|1|||
28161497|NCT01316939|54831678|FG002|Overall Study|Protocol Violation|0|||
27851851|NCT02612610|54351910|FG002|Overall Study|Noncompliance|0|||
28161498|NCT03044249|54831688|FG000|Overall Study|Adverse Event|4|||
27851852|NCT02612610|54351911|FG003|Overall Study|Noncompliance|0|||
27851853|NCT02612610|54351908|FG000|Overall Study|Cough Improvement|0|||
28161499|NCT03044249|54831689|FG001|Overall Study|Adverse Event|9|||
28161500|NCT03044249|54831688|FG000|Overall Study|Lost to Follow-up|1|||
28161501|NCT03044249|54831689|FG001|Overall Study|Lost to Follow-up|0|||
28161502|NCT03044249|54831688|FG000|Overall Study|Non-compliance with Study Drug|1|||
28161503|NCT03044249|54831689|FG001|Overall Study|Non-compliance with Study Drug|0|||
28161504|NCT03044249|54831688|FG000|Overall Study|Study Terminated by Sponsor|2|||
28161505|NCT03044249|54831689|FG001|Overall Study|Study Terminated by Sponsor|0|||
28161506|NCT03044249|54831688|FG000|Overall Study|Withdrawal by Subject|2|||
28161507|NCT03044249|54831689|FG001|Overall Study|Withdrawal by Subject|5|||
28161508|NCT02704130|54831702|FG000|Overall Study|Physician Decision|5|||
28161509|NCT02704130|54831703|FG001|Overall Study|Physician Decision|3|||
28161510|NCT03740009|54831709|FG000|Overall Study|Physician Decision|9|||
28161511|NCT03740009|54831709|FG000|Overall Study|Lost to Follow-up|1|||
28161512|NCT03649217|54831713|FG000|Overall Study|subject had severe ataxia not initially found|1|||
28161513|NCT03649217|54831713|FG000|Overall Study|subject had cognitive issues not initially found|1|||
28161514|NCT03138889|54831742|FG000|Overall Study|Withdrawal by Subject|5|||
28161515|NCT03138889|54831743|FG001|Overall Study|Withdrawal by Subject|5|||
28161516|NCT03138889|54831744|FG002|Overall Study|Withdrawal by Subject|0|||
28161517|NCT03138889|54831745|FG003|Overall Study|Withdrawal by Subject|2|||
28161518|NCT03138889|54831746|FG004|Overall Study|Withdrawal by Subject|1|||
28161519|NCT03138889|54831747|FG005|Overall Study|Withdrawal by Subject|3|||
28161520|NCT03138889|54831748|FG006|Overall Study|Withdrawal by Subject|0|||
28161521|NCT03138889|54831749|FG007|Overall Study|Withdrawal by Subject|1|||
28161522|NCT02706392|54831801|FG000|Overall Study|Death|1|||
28161523|NCT02706392|54831802|FG001|Overall Study|Death|0|||
28161524|NCT02706392|54831803|FG002|Overall Study|Death|2|||
28161525|NCT02706392|54831804|FG003|Overall Study|Death|2|||
28161526|NCT02706392|54831805|FG004|Overall Study|Death|5|||
28161527|NCT02706392|54831806|FG005|Overall Study|Death|2|||
28161528|NCT03042767|54831822|FG000|Overall Study|Lost to Follow-up|1|||
28161529|NCT03042767|54831823|FG001|Overall Study|Lost to Follow-up|2|||
28161530|NCT00703820|54831831|FG000|Overall Study|Adverse Event|12|||
28161531|NCT00703820|54831832|FG001|Overall Study|Adverse Event|17|||
28161532|NCT00703820|54831831|FG000|Overall Study|Death|5|||
28161533|NCT00703820|54831832|FG001|Overall Study|Death|0|||
28161534|NCT00703820|54831831|FG000|Overall Study|Lack of Efficacy|11|||
28161535|NCT00703820|54831832|FG001|Overall Study|Lack of Efficacy|11|||
28161536|NCT00703820|54831831|FG000|Overall Study|Received non-protocol therapy|1|||
28161537|NCT00703820|54831832|FG001|Overall Study|Received non-protocol therapy|0|||
28161538|NCT00703820|54831831|FG000|Overall Study|Physician Decision|4|||
28161539|NCT00703820|54831832|FG001|Overall Study|Physician Decision|5|||
28161540|NCT00703820|54831831|FG000|Overall Study|Withdrawal by Subject|2|||
28161541|NCT00703820|54831832|FG001|Overall Study|Withdrawal by Subject|1|||
28161542|NCT03045887|54831850|FG000|Part A,Washout Period 1(4 Weeks)|Physician Decision|3|||
28161543|NCT03045887|54831851|FG001|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
28161544|NCT03045887|54831852|FG002|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
28161545|NCT03045887|54831853|FG003|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
28161546|NCT03045887|54831854|FG004|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
28161547|NCT03045887|54831855|FG005|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
28161548|NCT03045887|54831856|FG006|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
28161549|NCT03045887|54831857|FG007|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
28161550|NCT03045887|54831858|FG008|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
28161551|NCT03045887|54831859|FG009|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
28161552|NCT03045887|54831850|FG000|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
28161553|NCT03045887|54831851|FG001|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
28161554|NCT03045887|54831852|FG002|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
28161555|NCT03045887|54831853|FG003|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1|||
28161556|NCT03045887|54831854|FG004|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
28161557|NCT03045887|54831855|FG005|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
28161558|NCT03045887|54831856|FG006|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
28161559|NCT03045887|54831857|FG007|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
28161560|NCT03045887|54831858|FG008|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
28161561|NCT03045887|54831859|FG009|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
28161562|NCT03045887|54831850|FG000|Part A, Period 2 (1 Day)|Adverse Event|1|||
28161563|NCT03045887|54831851|FG001|Part A, Period 2 (1 Day)|Adverse Event|0|||
28161564|NCT03045887|54831852|FG002|Part A, Period 2 (1 Day)|Adverse Event|0|||
28161565|NCT03045887|54831853|FG003|Part A, Period 2 (1 Day)|Adverse Event|0|||
28161566|NCT03045887|54831854|FG004|Part A, Period 2 (1 Day)|Adverse Event|0|||
28161567|NCT03045887|54831855|FG005|Part A, Period 2 (1 Day)|Adverse Event|0|||
28161568|NCT03045887|54831856|FG006|Part A, Period 2 (1 Day)|Adverse Event|0|||
28161569|NCT03045887|54831857|FG007|Part A, Period 2 (1 Day)|Adverse Event|0|||
28161570|NCT03045887|54831858|FG008|Part A, Period 2 (1 Day)|Adverse Event|0|||
28161571|NCT03045887|54831859|FG009|Part A, Period 2 (1 Day)|Adverse Event|0|||
28161572|NCT03045887|54831850|FG000|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
28161573|NCT03045887|54831851|FG001|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
27943809|NCT03332056|54600836|FG001|Overall Study|Incomplete questionnaires|9|||
27943810|NCT03332056|54600835|FG000|Overall Study|Passed stone prior to surgery date|1|||
28161574|NCT03045887|54831852|FG002|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
28161575|NCT03045887|54831853|FG003|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
28161576|NCT03045887|54831854|FG004|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
28161577|NCT03045887|54831855|FG005|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
28161578|NCT03045887|54831856|FG006|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
28161579|NCT03045887|54831857|FG007|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
28161580|NCT03045887|54831858|FG008|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
28161581|NCT03045887|54831859|FG009|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
28161582|NCT03045887|54831850|FG000|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
28161583|NCT03045887|54831851|FG001|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
28161584|NCT03045887|54831852|FG002|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
28161585|NCT03045887|54831853|FG003|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1|||
28161586|NCT03045887|54831854|FG004|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
28161587|NCT03045887|54831855|FG005|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
28161588|NCT03045887|54831856|FG006|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
28161589|NCT03045887|54831857|FG007|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
28161590|NCT03045887|54831858|FG008|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
28161591|NCT03045887|54831859|FG009|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
28161592|NCT01564537|54831888|FG000|Overall Study|Site Terminated by Sponsor|1|||
28161593|NCT01564537|54831889|FG001|Overall Study|Site Terminated by Sponsor|0|||
28077626|NCT00118898|54732173|FG001|Overall Study|Not compliant with requirements|13|||
28077627|NCT00118898|54732174|FG002|Overall Study|Not compliant with requirements|11|||
28077628|NCT00118898|54732175|FG003|Overall Study|Not compliant with requirements|11|||
28077629|NCT00118898|54732172|FG000|Overall Study|Not able to get to clinic|34|||
28077630|NCT00118898|54732173|FG001|Overall Study|Not able to get to clinic|43|||
28077631|NCT00118898|54732174|FG002|Overall Study|Not able to get to clinic|31|||
28077632|NCT00118898|54732175|FG003|Overall Study|Not able to get to clinic|40|||
28077633|NCT00118430|54732188|FG000|Overall Study|Withdrawal by Subject|6|||
28077634|NCT00118430|54732189|FG001|Overall Study|Withdrawal by Subject|2|||
28077635|NCT00118430|54732190|FG002|Overall Study|Withdrawal by Subject|0|||
28077636|NCT00118430|54732188|FG000|Overall Study|Lost to Follow-up|15|||
28077637|NCT00118430|54732189|FG001|Overall Study|Lost to Follow-up|22|||
28077638|NCT00118430|54732190|FG002|Overall Study|Lost to Follow-up|28|||
28161594|NCT01564537|54831888|FG000|Overall Study|Withdrawal by Subject|12|||
28161595|NCT01564537|54831889|FG001|Overall Study|Withdrawal by Subject|14|||
28161596|NCT01564537|54831888|FG000|Overall Study|Lost to Follow-up|7|||
28161597|NCT01564537|54831889|FG001|Overall Study|Lost to Follow-up|3|||
28161598|NCT01564537|54831888|FG000|Overall Study|Reason not specified|81|||
28161599|NCT01564537|54831889|FG001|Overall Study|Reason not specified|82|||
28161600|NCT03042611|54831900|FG000|Core Phase|Withdrawal by Subject|13|||
28161601|NCT03042611|54831901|FG001|Core Phase|Withdrawal by Subject|4|||
28161602|NCT03042611|54831902|FG002|Core Phase|Withdrawal by Subject|0|||
28161603|NCT03042611|54831903|FG003|Core Phase|Withdrawal by Subject|0|||
28161604|NCT03042611|54831900|FG000|Core Phase|Death|232|||
28161605|NCT03042611|54831901|FG001|Core Phase|Death|110|||
28161606|NCT03042611|54831902|FG002|Core Phase|Death|0|||
28161607|NCT03042611|54831903|FG003|Core Phase|Death|0|||
28161608|NCT03042611|54831900|FG000|Core Phase|Lost to Follow-up|4|||
28161609|NCT03042611|54831901|FG001|Core Phase|Lost to Follow-up|7|||
28161610|NCT03042611|54831902|FG002|Core Phase|Lost to Follow-up|0|||
28161611|NCT03042611|54831903|FG003|Core Phase|Lost to Follow-up|0|||
28161612|NCT03042611|54831900|FG000|Core Phase|Physician Decision|7|||
28161613|NCT03042611|54831901|FG001|Core Phase|Physician Decision|2|||
28161614|NCT03042611|54831902|FG002|Core Phase|Physician Decision|0|||
28161615|NCT03042611|54831903|FG003|Core Phase|Physician Decision|0|||
28161616|NCT03042611|54831900|FG000|Core Phase|Study Closed|0|||
28161617|NCT03042611|54831901|FG001|Core Phase|Study Closed|1|||
28161618|NCT03042611|54831902|FG002|Core Phase|Study Closed|0|||
28161619|NCT03042611|54831903|FG003|Core Phase|Study Closed|0|||
28161620|NCT03042611|54831900|FG000|Extension Phase|Death|0|||
28161621|NCT03042611|54831901|FG001|Extension Phase|Death|0|||
28161622|NCT03042611|54831902|FG002|Extension Phase|Death|34|||
28161623|NCT03042611|54831903|FG003|Extension Phase|Death|16|||
28161624|NCT03042611|54831900|FG000|Extension Phase|Lost to Follow-up|0|||
28161625|NCT03042611|54831901|FG001|Extension Phase|Lost to Follow-up|0|||
28161626|NCT03042611|54831902|FG002|Extension Phase|Lost to Follow-up|1|||
28161627|NCT03042611|54831903|FG003|Extension Phase|Lost to Follow-up|1|||
28161628|NCT03042611|54831900|FG000|Extension Phase|Study Closed|0|||
28161629|NCT03042611|54831901|FG001|Extension Phase|Study Closed|0|||
28161630|NCT03042611|54831902|FG002|Extension Phase|Study Closed|17|||
28161631|NCT03042611|54831903|FG003|Extension Phase|Study Closed|11|||
28161632|NCT02701634|54831911|FG000|Overall Study|Adverse Event|2|||
28161633|NCT02701634|54831912|FG001|Overall Study|Adverse Event|3|||
28161634|NCT02701634|54831911|FG000|Overall Study|Death|1|||
28161635|NCT02701634|54831912|FG001|Overall Study|Death|0|||
28161636|NCT02701634|54831911|FG000|Overall Study|Investigator's Discretion|7|||
28161637|NCT02701634|54831912|FG001|Overall Study|Investigator's Discretion|4|||
28161638|NCT02701634|54831911|FG000|Overall Study|Study terminated by Sponsor|15|||
28161639|NCT02701634|54831912|FG001|Overall Study|Study terminated by Sponsor|17|||
28161640|NCT02701634|54831911|FG000|Overall Study|Withdrew Consent|6|||
28161641|NCT02701634|54831912|FG001|Overall Study|Withdrew Consent|7|||
28161642|NCT02701634|54831911|FG000|Overall Study|Randomized but not treated|1|||
28161643|NCT02701634|54831912|FG001|Overall Study|Randomized but not treated|0|||
28161644|NCT02442765|54831922|FG000|Stage 2- (Days 43 to 85)|Adverse Event|0|||
28161645|NCT02442765|54831923|FG001|Stage 2- (Days 43 to 85)|Adverse Event|0|||
28161646|NCT02442765|54831924|FG002|Stage 2- (Days 43 to 85)|Adverse Event|0|||
28161647|NCT02442765|54831925|FG003|Stage 2- (Days 43 to 85)|Adverse Event|2|||
28161648|NCT02442765|54831926|FG004|Stage 2- (Days 43 to 85)|Adverse Event|6|||
28161649|NCT02442765|54831927|FG005|Stage 2- (Days 43 to 85)|Adverse Event|1|||
28161650|NCT02442765|54831928|FG006|Stage 2- (Days 43 to 85)|Adverse Event|1|||
28161651|NCT02442765|54831929|FG007|Stage 2- (Days 43 to 85)|Adverse Event|5|||
28161652|NCT02442765|54831922|FG000|Stage 2- (Days 43 to 85)|Death|0|||
28161653|NCT02442765|54831923|FG001|Stage 2- (Days 43 to 85)|Death|0|||
28161654|NCT02442765|54831924|FG002|Stage 2- (Days 43 to 85)|Death|0|||
28161655|NCT02442765|54831925|FG003|Stage 2- (Days 43 to 85)|Death|1|||
28161656|NCT02442765|54831926|FG004|Stage 2- (Days 43 to 85)|Death|1|||
28161657|NCT02442765|54831927|FG005|Stage 2- (Days 43 to 85)|Death|0|||
28161658|NCT02442765|54831928|FG006|Stage 2- (Days 43 to 85)|Death|2|||
28161659|NCT02442765|54831929|FG007|Stage 2- (Days 43 to 85)|Death|0|||
28161660|NCT02442765|54831922|FG000|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
28161661|NCT02442765|54831923|FG001|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
28161662|NCT02442765|54831924|FG002|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
28161663|NCT02442765|54831925|FG003|Stage 2- (Days 43 to 85)|Lack of Efficacy|1|||
28161664|NCT02442765|54831926|FG004|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
28161665|NCT02442765|54831927|FG005|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
28161666|NCT02442765|54831928|FG006|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
28161667|NCT02442765|54831929|FG007|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
28161668|NCT02442765|54831922|FG000|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
28161669|NCT02442765|54831923|FG001|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
28161670|NCT02442765|54831924|FG002|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
28161671|NCT02442765|54831925|FG003|Stage 2- (Days 43 to 85)|Protocol Deviation|1|||
28161672|NCT02442765|54831926|FG004|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
28161673|NCT02442765|54831927|FG005|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
28161674|NCT02442765|54831928|FG006|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
28161675|NCT02442765|54831929|FG007|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
28161676|NCT02442765|54831922|FG000|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
28161677|NCT02442765|54831923|FG001|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
28161678|NCT02442765|54831924|FG002|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
28161679|NCT02442765|54831925|FG003|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
28161680|NCT02442765|54831926|FG004|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
28161681|NCT02442765|54831927|FG005|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
28161682|NCT02442765|54831928|FG006|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
28161683|NCT02442765|54831929|FG007|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|4|||
28161684|NCT02442765|54831922|FG000|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
28161685|NCT02442765|54831923|FG001|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
28161686|NCT02442765|54831924|FG002|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
28161687|NCT02442765|54831925|FG003|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
28161688|NCT02442765|54831926|FG004|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
28161689|NCT02442765|54831927|FG005|Stage 2- (Days 43 to 85)|Lost to Follow-up|3|||
28161690|NCT02442765|54831928|FG006|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
28161691|NCT02442765|54831929|FG007|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
28161692|NCT02442765|54831922|FG000|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
28161693|NCT02442765|54831923|FG001|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
28161694|NCT02442765|54831924|FG002|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
28161695|NCT02442765|54831925|FG003|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
28161696|NCT02442765|54831926|FG004|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
28161697|NCT02442765|54831927|FG005|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
28161698|NCT02442765|54831928|FG006|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
28161699|NCT02442765|54831929|FG007|Stage 2- (Days 43 to 85)|Withdrawal by Subject|1|||
28161700|NCT02442765|54831922|FG000|Stage 2- (Days 43 to 85)|Reason not specified|0|||
28161701|NCT02442765|54831923|FG001|Stage 2- (Days 43 to 85)|Reason not specified|0|||
28161702|NCT02442765|54831924|FG002|Stage 2- (Days 43 to 85)|Reason not specified|0|||
28161703|NCT02442765|54831925|FG003|Stage 2- (Days 43 to 85)|Reason not specified|0|||
28161704|NCT02442765|54831926|FG004|Stage 2- (Days 43 to 85)|Reason not specified|1|||
28161705|NCT02442765|54831927|FG005|Stage 2- (Days 43 to 85)|Reason not specified|0|||
28161706|NCT02442765|54831928|FG006|Stage 2- (Days 43 to 85)|Reason not specified|0|||
28161707|NCT02442765|54831929|FG007|Stage 2- (Days 43 to 85)|Reason not specified|1|||
28161708|NCT02699684|54831960|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
28161709|NCT02699684|54831961|FG001|Period 2, Second 30 Days of Wear|Adverse Event|0|||
28161710|NCT02700698|54831970|FG000|Overall Study|Withdrawal by Subject|1|||
28161711|NCT02700698|54831971|FG001|Overall Study|Withdrawal by Subject|0|||
28161712|NCT01774721|54831979|FG000|Overall Study|Death|76|||
28161713|NCT01774721|54831980|FG001|Overall Study|Death|91|||
28161714|NCT01774721|54831979|FG000|Overall Study|Withdrawal by Subject|14|||
28161715|NCT01774721|54831980|FG001|Overall Study|Withdrawal by Subject|10|||
28161716|NCT01774721|54831979|FG000|Overall Study|Lost to Follow-up|1|||
28161717|NCT01774721|54831980|FG001|Overall Study|Lost to Follow-up|1|||
28161718|NCT01774721|54831979|FG000|Overall Study|Did not meet eligibility criteria|0|||
28161719|NCT01774721|54831980|FG001|Overall Study|Did not meet eligibility criteria|3|||
28161720|NCT01774721|54831979|FG000|Overall Study|Ongoing in study|136|||
28161721|NCT01774721|54831980|FG001|Overall Study|Ongoing in study|120|||
28161722|NCT02699450|54831991|FG000|Overall Study|Death|2|||
28161723|NCT02699450|54831992|FG001|Overall Study|Death|1|||
28161724|NCT02699450|54831993|FG002|Overall Study|Death|2|||
28161725|NCT02699450|54831991|FG000|Overall Study|Met Criteria for Study Exit|0|||
28161726|NCT02699450|54831992|FG001|Overall Study|Met Criteria for Study Exit|0|||
28161727|NCT02699450|54831993|FG002|Overall Study|Met Criteria for Study Exit|1|||
28161728|NCT02699450|54831991|FG000|Overall Study|Protocol Violation|4|||
28161729|NCT02699450|54831992|FG001|Overall Study|Protocol Violation|3|||
28161730|NCT02699450|54831993|FG002|Overall Study|Protocol Violation|5|||
28161731|NCT02699450|54831991|FG000|Overall Study|Lost to Follow-up|3|||
28161732|NCT02699450|54831992|FG001|Overall Study|Lost to Follow-up|0|||
28161733|NCT02699450|54831993|FG002|Overall Study|Lost to Follow-up|5|||
28161734|NCT02699450|54831991|FG000|Overall Study|Physician Decision|2|||
28161735|NCT02699450|54831992|FG001|Overall Study|Physician Decision|0|||
28161736|NCT02699450|54831993|FG002|Overall Study|Physician Decision|0|||
28161737|NCT02699450|54831991|FG000|Overall Study|Withdrawal by Subject|3|||
28161738|NCT02699450|54831992|FG001|Overall Study|Withdrawal by Subject|1|||
28161739|NCT02699450|54831993|FG002|Overall Study|Withdrawal by Subject|2|||
28161740|NCT02699450|54831991|FG000|Overall Study|Adverse Event|1|||
28161741|NCT02699450|54831992|FG001|Overall Study|Adverse Event|0|||
28161742|NCT02699450|54831993|FG002|Overall Study|Adverse Event|0|||
28161743|NCT02699996|54832004|FG000|Overall Study|Withdrawal by Subject|5|||
28161744|NCT02699996|54832005|FG001|Overall Study|Withdrawal by Subject|2|||
28161745|NCT02739321|54832014|FG000|Overall Study|Lack of Efficacy|1|||
28161746|NCT02739321|54832015|FG001|Overall Study|Lack of Efficacy|1|||
28161747|NCT02739321|54832014|FG000|Overall Study|Lost to Follow-up|1|||
28161748|NCT02739321|54832015|FG001|Overall Study|Lost to Follow-up|1|||
28161749|NCT02739321|54832014|FG000|Overall Study|Withdrawal by Subject|1|||
28161750|NCT02739321|54832015|FG001|Overall Study|Withdrawal by Subject|2|||
28161751|NCT02696798|54832033|FG000|Blinded Treatment Dosing Period|Adverse Event|2|||
28161752|NCT02696798|54832034|FG001|Blinded Treatment Dosing Period|Adverse Event|9|||
28161753|NCT02696798|54832035|FG002|Blinded Treatment Dosing Period|Adverse Event|2|||
28161754|NCT02696798|54832033|FG000|Blinded Treatment Dosing Period|Death|0|||
28161755|NCT02696798|54832034|FG001|Blinded Treatment Dosing Period|Death|0|||
28161756|NCT02696798|54832035|FG002|Blinded Treatment Dosing Period|Death|1|||
28161757|NCT02696798|54832033|FG000|Blinded Treatment Dosing Period|Lack of Efficacy|2|||
28161758|NCT02696798|54832034|FG001|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
28161759|NCT02696798|54832035|FG002|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
28161760|NCT02696798|54832033|FG000|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
28161761|NCT02696798|54832034|FG001|Blinded Treatment Dosing Period|Lost to Follow-up|1|||
28161762|NCT02696798|54832035|FG002|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
28161763|NCT02696798|54832033|FG000|Blinded Treatment Dosing Period|Physician Decision|0|||
28161764|NCT02696798|54832034|FG001|Blinded Treatment Dosing Period|Physician Decision|1|||
28161765|NCT02696798|54832035|FG002|Blinded Treatment Dosing Period|Physician Decision|0|||
28161766|NCT02696798|54832033|FG000|Blinded Treatment Dosing Period|Withdrawal by Subject|7|||
28161767|NCT02696798|54832034|FG001|Blinded Treatment Dosing Period|Withdrawal by Subject|3|||
28161768|NCT02696798|54832035|FG002|Blinded Treatment Dosing Period|Withdrawal by Subject|4|||
28161769|NCT02696798|54832033|FG000|Extended Treatment Period|Adverse Event|1|||
28161770|NCT02696798|54832034|FG001|Extended Treatment Period|Adverse Event|4|||
28161771|NCT02696798|54832035|FG002|Extended Treatment Period|Adverse Event|5|||
28161772|NCT02696798|54832033|FG000|Extended Treatment Period|Lack of Efficacy|7|||
28161773|NCT02696798|54832034|FG001|Extended Treatment Period|Lack of Efficacy|2|||
28161774|NCT02696798|54832035|FG002|Extended Treatment Period|Lack of Efficacy|2|||
28161775|NCT02696798|54832033|FG000|Extended Treatment Period|Lost to Follow-up|1|||
28161776|NCT02696798|54832034|FG001|Extended Treatment Period|Lost to Follow-up|0|||
28161777|NCT02696798|54832035|FG002|Extended Treatment Period|Lost to Follow-up|0|||
28161778|NCT02696798|54832033|FG000|Extended Treatment Period|Physician Decision|0|||
28161779|NCT02696798|54832034|FG001|Extended Treatment Period|Physician Decision|1|||
28161780|NCT02696798|54832035|FG002|Extended Treatment Period|Physician Decision|0|||
28161781|NCT02696798|54832033|FG000|Extended Treatment Period|Withdrawal by Subject|3|||
28161782|NCT02696798|54832034|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
28161783|NCT02696798|54832035|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
28161784|NCT02696798|54832033|FG000|Post-treatment Follow-up Period|Adverse Event|2|||
28161785|NCT02696798|54832034|FG001|Post-treatment Follow-up Period|Adverse Event|12|||
28161786|NCT02696798|54832035|FG002|Post-treatment Follow-up Period|Adverse Event|6|||
28161787|NCT02696798|54832033|FG000|Post-treatment Follow-up Period|Lost to Follow-up|0|||
28161788|NCT02696798|54832034|FG001|Post-treatment Follow-up Period|Lost to Follow-up|1|||
28161789|NCT02696798|54832035|FG002|Post-treatment Follow-up Period|Lost to Follow-up|1|||
28161790|NCT02696798|54832033|FG000|Post-treatment Follow-up Period|Lack of Efficacy|1|||
28161791|NCT02696798|54832034|FG001|Post-treatment Follow-up Period|Lack of Efficacy|2|||
28161792|NCT02696798|54832035|FG002|Post-treatment Follow-up Period|Lack of Efficacy|0|||
28161793|NCT02696798|54832033|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|2|||
28161794|NCT02696798|54832034|FG001|Post-treatment Follow-up Period|Withdrawal by Subject|8|||
28161795|NCT02696798|54832035|FG002|Post-treatment Follow-up Period|Withdrawal by Subject|12|||
28161796|NCT02696798|54832033|FG000|Post-treatment Follow-up Period|Physician Decision|0|||
28161797|NCT02696798|54832034|FG001|Post-treatment Follow-up Period|Physician Decision|2|||
28161798|NCT02696798|54832035|FG002|Post-treatment Follow-up Period|Physician Decision|0|||
28161799|NCT02696798|54832033|FG000|Post-treatment Follow-up Period|No progressive improvement|0|||
28161800|NCT02696798|54832034|FG001|Post-treatment Follow-up Period|No progressive improvement|1|||
28161801|NCT02696798|54832035|FG002|Post-treatment Follow-up Period|No progressive improvement|0|||
28161802|NCT02698826|54832057|FG000|Overall Study|Death|13|||
28161803|NCT02698826|54832057|FG000|Overall Study|Adverse Event|1|||
28161804|NCT02541604|54832075|FG000|Overall Study|Death|6|||
28161805|NCT02541604|54832076|FG001|Overall Study|Death|5|||
28161806|NCT02541604|54832077|FG002|Overall Study|Death|7|||
27851854|NCT02612610|54351909|FG001|Overall Study|Cough Improvement|0|||
28161807|NCT02541604|54832078|FG003|Overall Study|Death|2|||
28161808|NCT02541604|54832079|FG004|Overall Study|Death|9|||
28161809|NCT02541604|54832080|FG005|Overall Study|Death|8|||
28161810|NCT02541604|54832081|FG006|Overall Study|Death|9|||
28161811|NCT02541604|54832082|FG007|Overall Study|Death|9|||
28161812|NCT02541604|54832083|FG008|Overall Study|Death|3|||
28161813|NCT02541604|54832084|FG009|Overall Study|Death|4|||
28161814|NCT02541604|54832085|FG010|Overall Study|Death|2|||
28161815|NCT02541604|54832086|FG011|Overall Study|Death|3|||
28161816|NCT02541604|54832075|FG000|Overall Study|Lost to Follow-up|2|||
28161817|NCT02541604|54832076|FG001|Overall Study|Lost to Follow-up|0|||
28161818|NCT02541604|54832077|FG002|Overall Study|Lost to Follow-up|1|||
28161819|NCT02541604|54832078|FG003|Overall Study|Lost to Follow-up|0|||
28161820|NCT02541604|54832079|FG004|Overall Study|Lost to Follow-up|0|||
28161821|NCT02541604|54832080|FG005|Overall Study|Lost to Follow-up|1|||
28161822|NCT02541604|54832081|FG006|Overall Study|Lost to Follow-up|1|||
28161823|NCT02541604|54832082|FG007|Overall Study|Lost to Follow-up|0|||
28161824|NCT02541604|54832083|FG008|Overall Study|Lost to Follow-up|0|||
28161825|NCT02541604|54832084|FG009|Overall Study|Lost to Follow-up|0|||
28161826|NCT02541604|54832085|FG010|Overall Study|Lost to Follow-up|0|||
28161827|NCT02541604|54832086|FG011|Overall Study|Lost to Follow-up|0|||
28161828|NCT02541604|54832075|FG000|Overall Study|Withdrawal by Subject|2|||
28161829|NCT02541604|54832076|FG001|Overall Study|Withdrawal by Subject|0|||
28161830|NCT02541604|54832077|FG002|Overall Study|Withdrawal by Subject|1|||
28161831|NCT02541604|54832078|FG003|Overall Study|Withdrawal by Subject|0|||
28161832|NCT02541604|54832079|FG004|Overall Study|Withdrawal by Subject|1|||
28161833|NCT02541604|54832080|FG005|Overall Study|Withdrawal by Subject|1|||
28161834|NCT02541604|54832081|FG006|Overall Study|Withdrawal by Subject|0|||
28161835|NCT02541604|54832082|FG007|Overall Study|Withdrawal by Subject|0|||
28161836|NCT02541604|54832083|FG008|Overall Study|Withdrawal by Subject|1|||
28161837|NCT02541604|54832084|FG009|Overall Study|Withdrawal by Subject|0|||
28161838|NCT02541604|54832085|FG010|Overall Study|Withdrawal by Subject|0|||
28161839|NCT02541604|54832086|FG011|Overall Study|Withdrawal by Subject|0|||
28161840|NCT02541604|54832075|FG000|Overall Study|Study Terminated by Sponsor|1|||
28161841|NCT02541604|54832076|FG001|Overall Study|Study Terminated by Sponsor|4|||
28161842|NCT02541604|54832077|FG002|Overall Study|Study Terminated by Sponsor|2|||
28161843|NCT02541604|54832078|FG003|Overall Study|Study Terminated by Sponsor|1|||
28161844|NCT02541604|54832079|FG004|Overall Study|Study Terminated by Sponsor|0|||
28161845|NCT02541604|54832080|FG005|Overall Study|Study Terminated by Sponsor|0|||
28161846|NCT02541604|54832081|FG006|Overall Study|Study Terminated by Sponsor|0|||
28161847|NCT02541604|54832082|FG007|Overall Study|Study Terminated by Sponsor|0|||
28161848|NCT02541604|54832083|FG008|Overall Study|Study Terminated by Sponsor|0|||
28161849|NCT02541604|54832084|FG009|Overall Study|Study Terminated by Sponsor|0|||
28077639|NCT00090584|54732199|FG000|Baseline to 10 Weeks|Lost to Follow-up|15|||
28077640|NCT00090584|54732200|FG001|Baseline to 10 Weeks|Lost to Follow-up|12|||
28161850|NCT02541604|54832085|FG010|Overall Study|Study Terminated by Sponsor|0|||
28161851|NCT02541604|54832086|FG011|Overall Study|Study Terminated by Sponsor|0|||
28161852|NCT02541604|54832075|FG000|Overall Study|Medical condition may jeopardize safety|0|||
28161853|NCT02541604|54832076|FG001|Overall Study|Medical condition may jeopardize safety|0|||
28077641|NCT00090584|54732199|FG000|Baseline to 8 Months|Lost to Follow-up|44|||
28077642|NCT00090584|54732200|FG001|Baseline to 8 Months|Lost to Follow-up|41|||
28077643|NCT03670810|54732220|FG000|Main Study|Adverse Event|37|||
28077644|NCT03670810|54732221|FG001|Main Study|Adverse Event|38|||
28077645|NCT03670810|54732222|FG002|Main Study|Adverse Event|3|||
28077646|NCT03670810|54732223|FG003|Main Study|Adverse Event|4|||
28077647|NCT03670810|54732224|FG004|Main Study|Adverse Event|4|||
28077648|NCT03670810|54732225|FG005|Main Study|Adverse Event|5|||
28077649|NCT03670810|54732226|FG006|Main Study|Adverse Event|0|||
28161854|NCT02541604|54832077|FG002|Overall Study|Medical condition may jeopardize safety|0|||
28161855|NCT02541604|54832078|FG003|Overall Study|Medical condition may jeopardize safety|0|||
28161856|NCT02541604|54832079|FG004|Overall Study|Medical condition may jeopardize safety|0|||
28161857|NCT02541604|54832080|FG005|Overall Study|Medical condition may jeopardize safety|0|||
28161858|NCT02541604|54832081|FG006|Overall Study|Medical condition may jeopardize safety|0|||
28161859|NCT02541604|54832082|FG007|Overall Study|Medical condition may jeopardize safety|1|||
28161860|NCT02541604|54832083|FG008|Overall Study|Medical condition may jeopardize safety|0|||
28077650|NCT03670810|54732227|FG007|Main Study|Adverse Event|0|||
28077651|NCT03670810|54732228|FG008|Main Study|Adverse Event|0|||
28077652|NCT03670810|54732220|FG000|Main Study|Lack of Efficacy|8|||
28077653|NCT03670810|54732221|FG001|Main Study|Lack of Efficacy|9|||
28161861|NCT02541604|54832084|FG009|Overall Study|Medical condition may jeopardize safety|0|||
28161862|NCT02541604|54832085|FG010|Overall Study|Medical condition may jeopardize safety|0|||
28161863|NCT02541604|54832086|FG011|Overall Study|Medical condition may jeopardize safety|0|||
28161864|NCT02546674|54832135|FG000|Overall Study|Adverse Event|19|||
28161865|NCT02546674|54832135|FG000|Overall Study|Death|1|||
28161866|NCT02546674|54832135|FG000|Overall Study|Lost to Follow-up|1|||
28161867|NCT02546674|54832135|FG000|Overall Study|Physician Decision|13|||
28077654|NCT03670810|54732222|FG002|Main Study|Lack of Efficacy|3|||
28161868|NCT02546674|54832135|FG000|Overall Study|Pregnancy|1|||
28161869|NCT02546674|54832135|FG000|Overall Study|Progressive Disease|2|||
28161870|NCT02546674|54832135|FG000|Overall Study|Protocol Deviation|2|||
28161871|NCT02546674|54832135|FG000|Overall Study|Subject/Guardian Decision|6|||
28161872|NCT02546674|54832135|FG000|Overall Study|Withdrawal of Informed Consent|3|||
28161873|NCT02546362|54832140|FG000|4-week Treatment Period|Lost to Follow-up|1|||
28161874|NCT02546362|54832140|FG000|4-week Treatment Period|Change in medication|2|||
28161875|NCT02546362|54832140|FG000|12-week Treatment Period|Withdrawal by Subject|6|||
28161876|NCT02546362|54832140|FG000|12-week Treatment Period|Lost to Follow-up|2|||
28161877|NCT02546362|54832140|FG000|12-week Treatment Period|Change in medication|1|||
28161878|NCT02698436|54832146|FG000|Overall Study|Adverse Event|1|||
28161879|NCT02698436|54832147|FG001|Overall Study|Adverse Event|0|||
28161880|NCT02698436|54832146|FG000|Overall Study|Withdrawal by Subject|3|||
28161881|NCT02698436|54832147|FG001|Overall Study|Withdrawal by Subject|3|||
28161882|NCT02698436|54832146|FG000|Overall Study|Lost to Follow-up|2|||
28161883|NCT02698436|54832147|FG001|Overall Study|Lost to Follow-up|4|||
28161884|NCT02698436|54832146|FG000|Overall Study|Non-compliance with study regimen|1|||
28161885|NCT02698436|54832147|FG001|Overall Study|Non-compliance with study regimen|0|||
28161886|NCT02694536|54832153|FG000|Overall Study|Progressive Disease|40|||
28161887|NCT02694536|54832153|FG000|Overall Study|Lost to Follow-up|1|||
28161888|NCT02694536|54832153|FG000|Overall Study|Study Drug-Related Adverse Event|1|||
28161889|NCT02694536|54832153|FG000|Overall Study|Withdrawal by Subject|8|||
28077655|NCT03670810|54732223|FG003|Main Study|Lack of Efficacy|4|||
28077656|NCT03670810|54732224|FG004|Main Study|Lack of Efficacy|0|||
28077657|NCT03670810|54732225|FG005|Main Study|Lack of Efficacy|0|||
28077658|NCT03670810|54732226|FG006|Main Study|Lack of Efficacy|0|||
28077659|NCT03670810|54732227|FG007|Main Study|Lack of Efficacy|0|||
28077660|NCT03670810|54732228|FG008|Main Study|Lack of Efficacy|0|||
28077661|NCT03670810|54732220|FG000|Main Study|Lost to Follow-up|9|||
28077662|NCT03670810|54732221|FG001|Main Study|Lost to Follow-up|7|||
28077663|NCT03670810|54732222|FG002|Main Study|Lost to Follow-up|4|||
27851855|NCT02612610|54351910|FG002|Overall Study|Cough Improvement|1|||
28077664|NCT03670810|54732223|FG003|Main Study|Lost to Follow-up|6|||
28077665|NCT03670810|54732224|FG004|Main Study|Lost to Follow-up|1|||
28077666|NCT03670810|54732225|FG005|Main Study|Lost to Follow-up|0|||
28077667|NCT03670810|54732226|FG006|Main Study|Lost to Follow-up|0|||
28161890|NCT02694536|54832153|FG000|Overall Study|Death|8|||
27851856|NCT02612610|54351911|FG003|Overall Study|Cough Improvement|0|||
27851857|NCT02610192|54352120|FG000|Overall Study|Received other treatment|8|||
27851858|NCT02610192|54352120|FG000|Overall Study|Physician Decision|1|||
27851859|NCT02609178|54352264|FG000|First Crown|Withdrawal by Subject|0|||
27851860|NCT02609178|54352265|FG001|First Crown|Withdrawal by Subject|0|||
27851861|NCT02609178|54352266|FG002|First Crown|Withdrawal by Subject|1|||
27851862|NCT02609178|54352267|FG003|First Crown|Withdrawal by Subject|1|||
27851863|NCT02609178|54352268|FG004|First Crown|Withdrawal by Subject|0|||
27851864|NCT02609178|54352269|FG005|First Crown|Withdrawal by Subject|0|||
28161891|NCT02694536|54832153|FG000|Overall Study|Other|22|||
28161892|NCT01661686|54832159|FG000|Overall Study|Lost to Follow-up|2|||
28161893|NCT01661686|54832160|FG001|Overall Study|Lost to Follow-up|1|||
28161894|NCT01661686|54832159|FG000|Overall Study|did not receive allocated intervention|0|||
28161895|NCT01661686|54832160|FG001|Overall Study|did not receive allocated intervention|1|||
27831314|NCT02728830|54307808|FG000|Overall Study|Exclusionary Pathology|6|||
27831315|NCT02728830|54307808|FG000|Overall Study|Physician Decision|3|||
27831316|NCT02728830|54307808|FG000|Overall Study|Withdrawal by Subject|2|||
27831317|NCT02728830|54307808|FG000|Overall Study|Lost to Follow-up|1|||
27831318|NCT02728830|54307808|FG000|Overall Study|Exclusionary Lab Values|1|||
27831319|NCT02728830|54307808|FG000|Overall Study|Contraindicated Illness|1|||
27831320|NCT02728830|54307808|FG000|Overall Study|Language Barrier|1|||
27831321|NCT02728596|54307862|FG000|Overall Study|Refusal unrelated to adverse event|3|||
27831322|NCT02728596|54307863|FG001|Overall Study|Refusal unrelated to adverse event|6|||
27831323|NCT02728596|54307864|FG002|Overall Study|Refusal unrelated to adverse event|7|||
27831324|NCT02728596|54307865|FG003|Overall Study|Refusal unrelated to adverse event|7|||
27831325|NCT02728596|54307862|FG000|Overall Study|Death|44|||
27831326|NCT02728596|54307863|FG001|Overall Study|Death|42|||
27831327|NCT02728596|54307864|FG002|Overall Study|Death|123|||
27831328|NCT02728596|54307865|FG003|Overall Study|Death|68|||
27831329|NCT00708162|54308239|FG000|Randomized Phase|Randomized but Not Treated|7|||
27851865|NCT02607228|54352493|FG000|Overall Study|Progressive Disease|4|||
27851866|NCT02607228|54352494|FG001|Overall Study|Progressive Disease|3|||
27831330|NCT00708162|54308240|FG001|Randomized Phase|Randomized but Not Treated|5|||
27831331|NCT00708162|54308239|FG000|Randomized Phase|Participant Noncompliance|40|||
27831332|NCT00708162|54308240|FG001|Randomized Phase|Participant Noncompliance|32|||
28077668|NCT03670810|54732227|FG007|Main Study|Lost to Follow-up|0|||
28077669|NCT03670810|54732228|FG008|Main Study|Lost to Follow-up|0|||
28077670|NCT03670810|54732220|FG000|Main Study|Non-compliance with Study Drug|0|||
27831333|NCT00708162|54308239|FG000|Randomized Phase|Lost to Follow-up|34|||
28077671|NCT03670810|54732221|FG001|Main Study|Non-compliance with Study Drug|2|||
28161896|NCT02696096|54832166|FG000|Overall Study|ruled out at screening|1|||
28161897|NCT02696096|54832166|FG000|Overall Study|did not attend second fMRI|1|||
28161898|NCT02695628|54832174|FG000|Overall Study|Withdrawal by Subject|1|||
28161899|NCT02693834|54832178|FG000|Baseline Measurement|Withdrawal by Subject|1|||
28161900|NCT02693834|54832179|FG001|Baseline Measurement|Withdrawal by Subject|0|||
28161901|NCT02693834|54832178|FG000|Baseline Measurement|Adverse Event|1|||
28161902|NCT02693834|54832179|FG001|Baseline Measurement|Adverse Event|0|||
28161903|NCT02693834|54832178|FG000|Week 2 Practice|Adverse Event|0|||
28161904|NCT02693834|54832179|FG001|Week 2 Practice|Adverse Event|1|||
28077672|NCT03670810|54732222|FG002|Main Study|Non-compliance with Study Drug|3|||
28077673|NCT03670810|54732223|FG003|Main Study|Non-compliance with Study Drug|0|||
28077674|NCT03670810|54732224|FG004|Main Study|Non-compliance with Study Drug|0|||
28077675|NCT03670810|54732225|FG005|Main Study|Non-compliance with Study Drug|0|||
28161905|NCT02545504|54832187|FG000|Overall Study|Death|174|||
28161906|NCT02545504|54832188|FG001|Overall Study|Death|168|||
28161907|NCT02545504|54832187|FG000|Overall Study|Unknown reason|30|||
28161908|NCT02545504|54832188|FG001|Overall Study|Unknown reason|32|||
28161909|NCT02545504|54832187|FG000|Overall Study|Withdrew consent|9|||
28161910|NCT02545504|54832188|FG001|Overall Study|Withdrew consent|11|||
28161911|NCT02545504|54832187|FG000|Overall Study|Investigator's discretion|3|||
28161912|NCT02545504|54832188|FG001|Overall Study|Investigator's discretion|1|||
28161913|NCT02545504|54832187|FG000|Overall Study|Lost to Follow-up|2|||
28161914|NCT02545504|54832188|FG001|Overall Study|Lost to Follow-up|2|||
28161915|NCT02545270|54832201|FG000|Overall Study|technical difficulties|0|||
28077676|NCT03670810|54732226|FG006|Main Study|Non-compliance with Study Drug|0|||
28077677|NCT03670810|54732227|FG007|Main Study|Non-compliance with Study Drug|1|||
28077678|NCT03670810|54732228|FG008|Main Study|Non-compliance with Study Drug|0|||
28077679|NCT03670810|54732220|FG000|Main Study|Physician Decision|3|||
28077680|NCT03670810|54732221|FG001|Main Study|Physician Decision|0|||
28077681|NCT03670810|54732222|FG002|Main Study|Physician Decision|1|||
28077682|NCT03670810|54732223|FG003|Main Study|Physician Decision|0|||
28077683|NCT03670810|54732224|FG004|Main Study|Physician Decision|0|||
28077684|NCT03670810|54732225|FG005|Main Study|Physician Decision|0|||
28077685|NCT03670810|54732226|FG006|Main Study|Physician Decision|1|||
28077686|NCT03670810|54732227|FG007|Main Study|Physician Decision|1|||
28077687|NCT03670810|54732228|FG008|Main Study|Physician Decision|0|||
28077688|NCT03670810|54732220|FG000|Main Study|Pregnancy|1|||
28077689|NCT03670810|54732221|FG001|Main Study|Pregnancy|2|||
28077690|NCT03670810|54732222|FG002|Main Study|Pregnancy|0|||
28077691|NCT03670810|54732223|FG003|Main Study|Pregnancy|0|||
28077692|NCT03670810|54732224|FG004|Main Study|Pregnancy|0|||
28077693|NCT03670810|54732225|FG005|Main Study|Pregnancy|0|||
28077694|NCT03670810|54732226|FG006|Main Study|Pregnancy|0|||
28077695|NCT03670810|54732227|FG007|Main Study|Pregnancy|0|||
28077696|NCT03670810|54732228|FG008|Main Study|Pregnancy|0|||
28077697|NCT03670810|54732220|FG000|Main Study|Protocol Deviation|2|||
28077698|NCT03670810|54732221|FG001|Main Study|Protocol Deviation|12|||
28077699|NCT03670810|54732222|FG002|Main Study|Protocol Deviation|8|||
28077700|NCT03670810|54732223|FG003|Main Study|Protocol Deviation|4|||
28077701|NCT03670810|54732224|FG004|Main Study|Protocol Deviation|0|||
28077702|NCT03670810|54732225|FG005|Main Study|Protocol Deviation|0|||
28077703|NCT03670810|54732226|FG006|Main Study|Protocol Deviation|0|||
28077704|NCT03670810|54732227|FG007|Main Study|Protocol Deviation|0|||
28077705|NCT03670810|54732228|FG008|Main Study|Protocol Deviation|0|||
28077706|NCT03670810|54732220|FG000|Main Study|Withdrawal by Subject|21|||
28077707|NCT03670810|54732221|FG001|Main Study|Withdrawal by Subject|21|||
28077708|NCT03670810|54732222|FG002|Main Study|Withdrawal by Subject|8|||
28077709|NCT03670810|54732223|FG003|Main Study|Withdrawal by Subject|9|||
28077710|NCT03670810|54732224|FG004|Main Study|Withdrawal by Subject|5|||
28077711|NCT03670810|54732225|FG005|Main Study|Withdrawal by Subject|2|||
28077712|NCT03670810|54732226|FG006|Main Study|Withdrawal by Subject|1|||
28077713|NCT03670810|54732227|FG007|Main Study|Withdrawal by Subject|1|||
28077714|NCT03670810|54732228|FG008|Main Study|Withdrawal by Subject|0|||
28077715|NCT03670810|54732220|FG000|Main Study|Participant did not want to take the three other treatments|1|||
28077716|NCT03670810|54732221|FG001|Main Study|Participant did not want to take the three other treatments|0|||
28077717|NCT03670810|54732222|FG002|Main Study|Participant did not want to take the three other treatments|0|||
28077718|NCT03670810|54732223|FG003|Main Study|Participant did not want to take the three other treatments|0|||
28077719|NCT03670810|54732224|FG004|Main Study|Participant did not want to take the three other treatments|0|||
28161916|NCT02545270|54832202|FG001|Overall Study|technical difficulties|1|||
28077720|NCT03670810|54732225|FG005|Main Study|Participant did not want to take the three other treatments|0|||
28077721|NCT03670810|54732226|FG006|Main Study|Participant did not want to take the three other treatments|0|||
28077722|NCT03670810|54732227|FG007|Main Study|Participant did not want to take the three other treatments|0|||
28161917|NCT02545270|54832203|FG002|Overall Study|technical difficulties|0|||
28161918|NCT02545270|54832201|FG000|Overall Study|Videos being too similar to other|0|||
28161919|NCT02545270|54832202|FG001|Overall Study|Videos being too similar to other|0|||
28077723|NCT03670810|54732228|FG008|Main Study|Participant did not want to take the three other treatments|0|||
28077724|NCT03670810|54732220|FG000|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
28077725|NCT03670810|54732221|FG001|Main Study|Migraines more frequent-GP advised to re-start Topiramate|1|||
28077726|NCT03670810|54732222|FG002|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
28077727|NCT03670810|54732223|FG003|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
28077728|NCT03670810|54732224|FG004|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
28077729|NCT03670810|54732225|FG005|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
28077730|NCT03670810|54732226|FG006|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
28077731|NCT03670810|54732227|FG007|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
28077732|NCT03670810|54732228|FG008|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
28077733|NCT03670810|54732220|FG000|Main Study|Travel and Coronavirus issues|0|||
28077734|NCT03670810|54732221|FG001|Main Study|Travel and Coronavirus issues|0|||
28077735|NCT03670810|54732222|FG002|Main Study|Travel and Coronavirus issues|0|||
28077736|NCT03670810|54732223|FG003|Main Study|Travel and Coronavirus issues|1|||
28077737|NCT03670810|54732224|FG004|Main Study|Travel and Coronavirus issues|0|||
28077738|NCT03670810|54732225|FG005|Main Study|Travel and Coronavirus issues|0|||
28077739|NCT03670810|54732226|FG006|Main Study|Travel and Coronavirus issues|0|||
28077740|NCT03670810|54732227|FG007|Main Study|Travel and Coronavirus issues|0|||
28077741|NCT03670810|54732228|FG008|Main Study|Travel and Coronavirus issues|0|||
28077742|NCT03670810|54732220|FG000|Open Label Extension|Protocol Deviation|0|||
28077743|NCT03670810|54732221|FG001|Open Label Extension|Protocol Deviation|0|||
28077744|NCT03670810|54732222|FG002|Open Label Extension|Protocol Deviation|0|||
28077745|NCT03670810|54732223|FG003|Open Label Extension|Protocol Deviation|0|||
28161920|NCT02545270|54832203|FG002|Overall Study|Videos being too similar to other|2|||
28161921|NCT02540668|54832212|FG000|Period 2 - LY3314814 and Warfarin|Physician Decision|0|||
28161922|NCT02540668|54832213|FG001|Period 2 - LY3314814 and Warfarin|Physician Decision|1|||
28161923|NCT02339740|54832222|FG000|Overall Study|Death|1|||
28161924|NCT02339740|54832223|FG001|Overall Study|Death|0|||
28161925|NCT02339740|54832222|FG000|Overall Study|Physician Decision|0|||
28161926|NCT02339740|54832223|FG001|Overall Study|Physician Decision|2|||
28161927|NCT02339740|54832222|FG000|Overall Study|Withdrawal by Subject|5|||
28161928|NCT02339740|54832223|FG001|Overall Study|Withdrawal by Subject|1|||
28161929|NCT02339740|54832222|FG000|Overall Study|Inevaluable-RQPCR positive not confirmed|3|||
28161930|NCT02339740|54832223|FG001|Overall Study|Inevaluable-RQPCR positive not confirmed|1|||
28161931|NCT02535364|54832246|FG000|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22|||
28161932|NCT02535364|54832246|FG000|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2|||
28161933|NCT02535364|54832246|FG000|Part A Screening Through Leukapheresis|Disease progression|1|||
28077746|NCT03670810|54732224|FG004|Open Label Extension|Protocol Deviation|0|||
28077747|NCT03670810|54732225|FG005|Open Label Extension|Protocol Deviation|0|||
28077748|NCT03670810|54732226|FG006|Open Label Extension|Protocol Deviation|0|||
28077749|NCT03670810|54732227|FG007|Open Label Extension|Protocol Deviation|0|||
28077750|NCT03670810|54732228|FG008|Open Label Extension|Protocol Deviation|5|||
28077751|NCT03670810|54732220|FG000|Open Label Extension|Death|0|||
28077752|NCT03670810|54732221|FG001|Open Label Extension|Death|0|||
28161934|NCT02535364|54832246|FG000|Part B Screening|Study placed on clinical hold by FDA|7|||
28161935|NCT02535364|54832246|FG000|Part B Screening|Unable to manufacture JCAR015|3|||
28161936|NCT02535364|54832246|FG000|Part B Screening|Death|2|||
28161937|NCT02535364|54832246|FG000|Part B Screening|Physician Decision|1|||
28161938|NCT02535364|54832246|FG000|Part B Screening|Withdrawal by Subject|1|||
28161939|NCT02535364|54832246|FG000|Part B Screening|Adverse Event|1|||
28161940|NCT02535364|54832246|FG000|Part B Screening|Change in diagnosis, no longer eligible|2|||
28161941|NCT02535364|54832246|FG000|Study Treatment|Death|1|||
28161942|NCT02535364|54832246|FG000|Study Treatment|Study placed on clinical hold by FDA|1|||
28161943|NCT02535364|54832246|FG000|12-Month Follow-up Period|Disease progression|22|||
28161944|NCT02535364|54832246|FG000|12-Month Follow-up Period|Death|5|||
28161945|NCT02535364|54832246|FG000|12-Month Follow-up Period|Underwent stem cell transplant|5|||
28161946|NCT02535364|54832246|FG000|12-Month Follow-up Period|Subject received alternative therapy|2|||
28161947|NCT02535364|54832246|FG000|12-Month Follow-up Period|Subject transferred to hospice|1|||
28161948|NCT02540356|54832252|FG000|Overall Study|Terminated due to disease progression|1|||
28161949|NCT02540356|54832253|FG001|Overall Study|Terminated due to disease progression|0|||
28161950|NCT02534896|54832261|FG000|Overall Study|Adverse Event|2|||
28161951|NCT02534896|54832262|FG001|Overall Study|Adverse Event|1|||
27851867|NCT02607228|54352495|FG002|Overall Study|Progressive Disease|1|||
28077753|NCT03670810|54732222|FG002|Open Label Extension|Death|0|||
28077754|NCT03670810|54732223|FG003|Open Label Extension|Death|0|||
28077755|NCT03670810|54732224|FG004|Open Label Extension|Death|0|||
28077756|NCT03670810|54732225|FG005|Open Label Extension|Death|0|||
28077757|NCT03670810|54732226|FG006|Open Label Extension|Death|0|||
28077758|NCT03670810|54732227|FG007|Open Label Extension|Death|0|||
28161952|NCT02534896|54832263|FG002|Overall Study|Adverse Event|1|||
27851868|NCT02607228|54352496|FG003|Overall Study|Progressive Disease|5|||
28161953|NCT02534896|54832261|FG000|Overall Study|Insufficient therapeutic response|2|||
28077759|NCT03670810|54732228|FG008|Open Label Extension|Death|1|||
28077760|NCT03670810|54732220|FG000|Open Label Extension|COVID-19|0|||
28077761|NCT03670810|54732221|FG001|Open Label Extension|COVID-19|0|||
28077762|NCT03670810|54732222|FG002|Open Label Extension|COVID-19|0|||
28077763|NCT03670810|54732223|FG003|Open Label Extension|COVID-19|0|||
28077764|NCT03670810|54732224|FG004|Open Label Extension|COVID-19|0|||
28077765|NCT03670810|54732225|FG005|Open Label Extension|COVID-19|0|||
28077766|NCT03670810|54732226|FG006|Open Label Extension|COVID-19|0|||
28077767|NCT03670810|54732227|FG007|Open Label Extension|COVID-19|0|||
28077768|NCT03670810|54732228|FG008|Open Label Extension|COVID-19|1|||
28077769|NCT03670810|54732220|FG000|Open Label Extension|Lack of Efficacy|0|||
28077770|NCT03670810|54732221|FG001|Open Label Extension|Lack of Efficacy|0|||
28077771|NCT03670810|54732222|FG002|Open Label Extension|Lack of Efficacy|0|||
28077772|NCT03670810|54732223|FG003|Open Label Extension|Lack of Efficacy|0|||
28161954|NCT02534896|54832262|FG001|Overall Study|Insufficient therapeutic response|0|||
28161955|NCT02534896|54832263|FG002|Overall Study|Insufficient therapeutic response|0|||
28161956|NCT02697734|54832273|FG000|Core Phase - up to Week 48|Withdrawal by Subject|4|||
28161957|NCT02697734|54832274|FG001|Core Phase - up to Week 48|Withdrawal by Subject|0|||
28161958|NCT02697734|54832273|FG000|Core Phase - up to Week 48|Adverse Event|1|||
28161959|NCT02697734|54832274|FG001|Core Phase - up to Week 48|Adverse Event|2|||
28161960|NCT02697734|54832273|FG000|Core Phase - up to Week 48|Physician Decision|1|||
28161961|NCT02697734|54832274|FG001|Core Phase - up to Week 48|Physician Decision|0|||
28161962|NCT02697734|54832273|FG000|Optional Extension Phase|Adverse Event|5|||
27851869|NCT02607228|54352497|FG004|Overall Study|Progressive Disease|4|||
27851870|NCT02607228|54352498|FG005|Overall Study|Progressive Disease|3|||
27851871|NCT02607228|54352499|FG006|Overall Study|Progressive Disease|1|||
28077773|NCT03670810|54732224|FG004|Open Label Extension|Lack of Efficacy|0|||
28161963|NCT02697734|54832274|FG001|Optional Extension Phase|Adverse Event|1|||
27851872|NCT02607228|54352493|FG000|Overall Study|Adverse Event|1|||
27851873|NCT02607228|54352494|FG001|Overall Study|Adverse Event|0|||
27851874|NCT02607228|54352495|FG002|Overall Study|Adverse Event|1|||
27851875|NCT02607228|54352496|FG003|Overall Study|Adverse Event|0|||
27851876|NCT02607228|54352497|FG004|Overall Study|Adverse Event|1|||
27851877|NCT02607228|54352498|FG005|Overall Study|Adverse Event|1|||
27851878|NCT02607228|54352499|FG006|Overall Study|Adverse Event|1|||
27851879|NCT02607228|54352493|FG000|Overall Study|Investigator's Discretion|0|||
27851880|NCT02607228|54352494|FG001|Overall Study|Investigator's Discretion|0|||
27851881|NCT02607228|54352495|FG002|Overall Study|Investigator's Discretion|1|||
27851882|NCT02607228|54352496|FG003|Overall Study|Investigator's Discretion|0|||
27851883|NCT02607228|54352497|FG004|Overall Study|Investigator's Discretion|0|||
27851884|NCT02607228|54352498|FG005|Overall Study|Investigator's Discretion|1|||
27851885|NCT02607228|54352499|FG006|Overall Study|Investigator's Discretion|0|||
27851886|NCT02607228|54352493|FG000|Overall Study|Withdrew Consent|0|||
27851887|NCT02607228|54352494|FG001|Overall Study|Withdrew Consent|1|||
27851888|NCT02607228|54352495|FG002|Overall Study|Withdrew Consent|0|||
27851889|NCT02607228|54352496|FG003|Overall Study|Withdrew Consent|0|||
27851890|NCT02607228|54352497|FG004|Overall Study|Withdrew Consent|0|||
27851891|NCT02607228|54352498|FG005|Overall Study|Withdrew Consent|1|||
27851892|NCT02607228|54352499|FG006|Overall Study|Withdrew Consent|0|||
27851893|NCT02607228|54352493|FG000|Overall Study|Study Terminated by Sponsor|0|||
27851894|NCT02607228|54352494|FG001|Overall Study|Study Terminated by Sponsor|0|||
27851895|NCT02607228|54352495|FG002|Overall Study|Study Terminated by Sponsor|0|||
27851896|NCT02607228|54352496|FG003|Overall Study|Study Terminated by Sponsor|1|||
27851897|NCT02607228|54352497|FG004|Overall Study|Study Terminated by Sponsor|0|||
27851898|NCT02607228|54352498|FG005|Overall Study|Study Terminated by Sponsor|0|||
27851899|NCT02607228|54352499|FG006|Overall Study|Study Terminated by Sponsor|0|||
27851900|NCT01668654|54352541|FG000|Overall Study|Study Closed/Terminated|3|||
27851901|NCT01668654|54352541|FG000|Overall Study|Withdrawal by Subject|1|||
27851902|NCT02608476|54352635|FG000|Overall Study|Withdrawal by Subject|30|||
27851903|NCT02608476|54352636|FG001|Overall Study|Withdrawal by Subject|37|||
27851904|NCT02608476|54352635|FG000|Overall Study|Lost to Follow-up|24|||
27851905|NCT02608476|54352636|FG001|Overall Study|Lost to Follow-up|24|||
27851906|NCT02608476|54352635|FG000|Overall Study|Adverse Event|2|||
28077774|NCT03670810|54732225|FG005|Open Label Extension|Lack of Efficacy|0|||
28161964|NCT02697734|54832273|FG000|Optional Extension Phase|Physician Decision|0|||
27851907|NCT02608476|54352636|FG001|Overall Study|Adverse Event|8|||
27851908|NCT02608476|54352635|FG000|Overall Study|Withdrawal by Parent/Guardian|5|||
27851909|NCT02608476|54352636|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
27851910|NCT02608476|54352635|FG000|Overall Study|Noncompliance with treatment|1|||
27851911|NCT02608476|54352636|FG001|Overall Study|Noncompliance with treatment|5|||
27851912|NCT02608476|54352635|FG000|Overall Study|Lack of Efficacy|3|||
28077775|NCT03670810|54732226|FG006|Open Label Extension|Lack of Efficacy|0|||
27851913|NCT02608476|54352636|FG001|Overall Study|Lack of Efficacy|1|||
27851914|NCT02608476|54352635|FG000|Overall Study|Other|0|||
27851915|NCT02608476|54352636|FG001|Overall Study|Other|1|||
28161965|NCT02697734|54832274|FG001|Optional Extension Phase|Physician Decision|1|||
28161966|NCT02692586|54832288|FG000|Overall Study|Death from undiagnosed breast cancer through 30-day follow-up|1|||
28077776|NCT03670810|54732227|FG007|Open Label Extension|Lack of Efficacy|0|||
28077777|NCT03670810|54732228|FG008|Open Label Extension|Lack of Efficacy|39|||
28077778|NCT03670810|54732220|FG000|Open Label Extension|Participant refused to comply with face mask use|0|||
28077779|NCT03670810|54732221|FG001|Open Label Extension|Participant refused to comply with face mask use|0|||
28077780|NCT03670810|54732222|FG002|Open Label Extension|Participant refused to comply with face mask use|0|||
28077781|NCT03670810|54732223|FG003|Open Label Extension|Participant refused to comply with face mask use|0|||
28077782|NCT03670810|54732224|FG004|Open Label Extension|Participant refused to comply with face mask use|0|||
28077783|NCT03670810|54732225|FG005|Open Label Extension|Participant refused to comply with face mask use|0|||
28077784|NCT03670810|54732226|FG006|Open Label Extension|Participant refused to comply with face mask use|0|||
28077785|NCT03670810|54732227|FG007|Open Label Extension|Participant refused to comply with face mask use|0|||
28077786|NCT03670810|54732228|FG008|Open Label Extension|Participant refused to comply with face mask use|1|||
28077787|NCT03670810|54732220|FG000|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
28077788|NCT03670810|54732221|FG001|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
28077789|NCT03670810|54732222|FG002|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
28077790|NCT03670810|54732223|FG003|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
28077791|NCT03670810|54732224|FG004|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
28077792|NCT03670810|54732225|FG005|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
28077793|NCT03670810|54732226|FG006|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
28077794|NCT03670810|54732227|FG007|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
28077795|NCT03670810|54732228|FG008|Open Label Extension|Taking medication too restrictive for lifestyle|1|||
28077796|NCT03670810|54732220|FG000|Open Label Extension|Withdrawal by Subject|0|||
28077797|NCT03670810|54732221|FG001|Open Label Extension|Withdrawal by Subject|0|||
28077798|NCT03670810|54732222|FG002|Open Label Extension|Withdrawal by Subject|0|||
28077799|NCT03670810|54732223|FG003|Open Label Extension|Withdrawal by Subject|0|||
28077800|NCT03670810|54732224|FG004|Open Label Extension|Withdrawal by Subject|0|||
28077801|NCT03670810|54732225|FG005|Open Label Extension|Withdrawal by Subject|0|||
28077802|NCT03670810|54732226|FG006|Open Label Extension|Withdrawal by Subject|0|||
28077803|NCT03670810|54732227|FG007|Open Label Extension|Withdrawal by Subject|0|||
28161967|NCT02692586|54832288|FG000|Overall Study|Received adjunctive thrombolytics|2|||
28161968|NCT02534350|54832294|FG000|Overall Study|Randomized But Not Treated|1|||
28161969|NCT02534350|54832295|FG001|Overall Study|Randomized But Not Treated|0|||
28161970|NCT02534350|54832294|FG000|Overall Study|Protocol Violation|1|||
28161971|NCT02534350|54832295|FG001|Overall Study|Protocol Violation|0|||
28161972|NCT02534350|54832294|FG000|Overall Study|Withdrew Consent|2|||
28161973|NCT02534350|54832295|FG001|Overall Study|Withdrew Consent|0|||
28161974|NCT02688764|54832303|FG000|Overall Study|Adverse Event|3|||
28161975|NCT02688764|54832304|FG001|Overall Study|Adverse Event|3|||
28161976|NCT02688764|54832303|FG000|Overall Study|AE/Kidney transplant|1|||
28161977|NCT02688764|54832304|FG001|Overall Study|AE/Kidney transplant|0|||
28161978|NCT02688764|54832303|FG000|Overall Study|AE/Lack of efficacy|1|||
28161979|NCT02688764|54832304|FG001|Overall Study|AE/Lack of efficacy|0|||
28161980|NCT02688764|54832303|FG000|Overall Study|AE/Non-compl.|1|||
28161981|NCT02688764|54832304|FG001|Overall Study|AE/Non-compl.|0|||
28161982|NCT02688764|54832303|FG000|Overall Study|AE/Non-compl./Withd. parent|0|||
28161983|NCT02688764|54832304|FG001|Overall Study|AE/Non-compl./Withd. parent|1|||
28161984|NCT02688764|54832303|FG000|Overall Study|AE/Other|0|||
28161985|NCT02688764|54832304|FG001|Overall Study|AE/Other|1|||
28161986|NCT02688764|54832303|FG000|Overall Study|AE/Physician decision|1|||
28161987|NCT02688764|54832304|FG001|Overall Study|AE/Physician decision|0|||
28161988|NCT02688764|54832303|FG000|Overall Study|AE/Withd. parent|3|||
28161989|NCT02688764|54832304|FG001|Overall Study|AE/Withd. parent|0|||
28161990|NCT02688764|54832303|FG000|Overall Study|AE/Withd. parent/Withd. subject|1|||
28161991|NCT02688764|54832304|FG001|Overall Study|AE/Withd. parent/Withd. subject|1|||
28161992|NCT02688764|54832303|FG000|Overall Study|AE/Withd. subject|1|||
28161993|NCT02688764|54832304|FG001|Overall Study|AE/Withd. subject|0|||
28161994|NCT02688764|54832303|FG000|Overall Study|Kidney transplant|10|||
28161995|NCT02688764|54832304|FG001|Overall Study|Kidney transplant|4|||
28161996|NCT02688764|54832303|FG000|Overall Study|Lack of Efficacy|3|||
28161997|NCT02688764|54832304|FG001|Overall Study|Lack of Efficacy|2|||
28161998|NCT02688764|54832303|FG000|Overall Study|Lack of efficacy/Physician decision|0|||
28161999|NCT02688764|54832304|FG001|Overall Study|Lack of efficacy/Physician decision|1|||
28162000|NCT02688764|54832303|FG000|Overall Study|Non-compliance with study drug|4|||
28162001|NCT02688764|54832304|FG001|Overall Study|Non-compliance with study drug|0|||
28162002|NCT02688764|54832303|FG000|Overall Study|Non-compl./Physician decision|2|||
28162003|NCT02688764|54832304|FG001|Overall Study|Non-compl./Physician decision|0|||
28162004|NCT02688764|54832303|FG000|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
28162005|NCT02688764|54832304|FG001|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
28162006|NCT02688764|54832303|FG000|Overall Study|Non-compl./Withd. subject|0|||
28162007|NCT02688764|54832304|FG001|Overall Study|Non-compl./Withd. subject|2|||
27851916|NCT02608476|54352635|FG000|Overall Study|Physician Decision|1|||
28162008|NCT02688764|54832303|FG000|Overall Study|Phosphorus level outside safe range|0|||
28077804|NCT03670810|54732228|FG008|Open Label Extension|Withdrawal by Subject|46|||
28077805|NCT03670810|54732220|FG000|Open Label Extension|Participant didn't have disposition for OLE period|0|||
28077806|NCT03670810|54732221|FG001|Open Label Extension|Participant didn't have disposition for OLE period|0|||
28077807|NCT03670810|54732222|FG002|Open Label Extension|Participant didn't have disposition for OLE period|0|||
28162009|NCT02688764|54832304|FG001|Overall Study|Phosphorus level outside safe range|1|||
28162010|NCT02688764|54832303|FG000|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1|||
28162011|NCT02688764|54832304|FG001|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0|||
28162012|NCT02688764|54832303|FG000|Overall Study|Study drug taste/Withd. parent|1|||
28162013|NCT02688764|54832304|FG001|Overall Study|Study drug taste/Withd. parent|0|||
28162014|NCT02688764|54832303|FG000|Overall Study|Subject moving out|2|||
28162015|NCT02688764|54832304|FG001|Overall Study|Subject moving out|0|||
28162016|NCT02688764|54832303|FG000|Overall Study|Subject taken off dialysis|1|||
28162017|NCT02688764|54832304|FG001|Overall Study|Subject taken off dialysis|0|||
28162018|NCT02688764|54832303|FG000|Overall Study|Withdrawal by parent|3|||
28162019|NCT02688764|54832304|FG001|Overall Study|Withdrawal by parent|0|||
28162020|NCT02688608|54832313|FG000|Overall Study|Lost to Follow-up|1|||
28077808|NCT03670810|54732223|FG003|Open Label Extension|Participant didn't have disposition for OLE period|0|||
28077809|NCT03670810|54732224|FG004|Open Label Extension|Participant didn't have disposition for OLE period|0|||
28077810|NCT03670810|54732225|FG005|Open Label Extension|Participant didn't have disposition for OLE period|0|||
28077811|NCT03670810|54732226|FG006|Open Label Extension|Participant didn't have disposition for OLE period|0|||
28077812|NCT03670810|54732227|FG007|Open Label Extension|Participant didn't have disposition for OLE period|0|||
28077813|NCT03670810|54732228|FG008|Open Label Extension|Participant didn't have disposition for OLE period|1|||
28077814|NCT03670810|54732220|FG000|Open Label Extension|Physician Decision|0|||
28077815|NCT03670810|54732221|FG001|Open Label Extension|Physician Decision|0|||
28077816|NCT03670810|54732222|FG002|Open Label Extension|Physician Decision|0|||
28077817|NCT03670810|54732223|FG003|Open Label Extension|Physician Decision|0|||
28077818|NCT03670810|54732224|FG004|Open Label Extension|Physician Decision|0|||
28077819|NCT03670810|54732225|FG005|Open Label Extension|Physician Decision|0|||
28162021|NCT02688530|54832321|FG000|Overall Study|Withdrawal by Subject|0|||
28162022|NCT02688530|54832322|FG001|Overall Study|Withdrawal by Subject|1|||
27851917|NCT02608476|54352636|FG001|Overall Study|Physician Decision|0|||
27851918|NCT02608476|54352635|FG000|Overall Study|Pregnancy|0|||
27851919|NCT02608476|54352636|FG001|Overall Study|Pregnancy|1|||
27851920|NCT02608476|54352635|FG000|Overall Study|Progressive disease|1|||
28077820|NCT03670810|54732226|FG006|Open Label Extension|Physician Decision|0|||
28077821|NCT03670810|54732227|FG007|Open Label Extension|Physician Decision|0|||
28077822|NCT03670810|54732228|FG008|Open Label Extension|Physician Decision|2|||
28162023|NCT02688530|54832323|FG002|Overall Study|Withdrawal by Subject|0|||
27851921|NCT02608476|54352636|FG001|Overall Study|Progressive disease|0|||
27851922|NCT02607306|54352774|FG000|Overall Study|Adverse Event|8|||
27851923|NCT02607306|54352775|FG001|Overall Study|Adverse Event|6|||
27851924|NCT02607306|54352776|FG002|Overall Study|Adverse Event|6|||
27851925|NCT02607306|54352774|FG000|Overall Study|Unclassified|1|||
27851926|NCT02607306|54352775|FG001|Overall Study|Unclassified|4|||
27851927|NCT02607306|54352776|FG002|Overall Study|Unclassified|0|||
27851928|NCT02607306|54352774|FG000|Overall Study|Withdrawal by Subject|8|||
27851929|NCT02607306|54352775|FG001|Overall Study|Withdrawal by Subject|10|||
27851930|NCT02607306|54352776|FG002|Overall Study|Withdrawal by Subject|2|||
27851931|NCT02607306|54352774|FG000|Overall Study|Lack of Efficacy|0|||
27851932|NCT02607306|54352775|FG001|Overall Study|Lack of Efficacy|1|||
27851933|NCT02607306|54352776|FG002|Overall Study|Lack of Efficacy|1|||
27851934|NCT02607306|54352774|FG000|Overall Study|Protocol Violation|4|||
27851935|NCT02607306|54352775|FG001|Overall Study|Protocol Violation|2|||
27851936|NCT02607306|54352776|FG002|Overall Study|Protocol Violation|1|||
27851937|NCT02603952|54353099|FG000|Overall Study|Withdrawal by Subject|1|||
27851938|NCT02603952|54353100|FG001|Overall Study|Withdrawal by Subject|0|||
27851939|NCT02603952|54353101|FG002|Overall Study|Withdrawal by Subject|0|||
27851940|NCT02603952|54353102|FG003|Overall Study|Withdrawal by Subject|0|||
27851941|NCT02603952|54353099|FG000|Overall Study|Received oseltamivir by error|0|||
27851942|NCT02603952|54353100|FG001|Overall Study|Received oseltamivir by error|0|||
27851943|NCT02603952|54353101|FG002|Overall Study|Received oseltamivir by error|0|||
27851944|NCT02603952|54353102|FG003|Overall Study|Received oseltamivir by error|1|||
27851945|NCT02603172|54353616|FG000|Part A (Approximately 16 Weeks)|Adverse Event|0|||
28162024|NCT02688530|54832324|FG003|Overall Study|Withdrawal by Subject|0|||
27851946|NCT02603172|54353617|FG001|Part A (Approximately 16 Weeks)|Adverse Event|0|||
28162025|NCT02688530|54832321|FG000|Overall Study|Lost to Follow-up|0|||
28162026|NCT02688530|54832322|FG001|Overall Study|Lost to Follow-up|0|||
27851947|NCT02603172|54353618|FG002|Part A (Approximately 16 Weeks)|Adverse Event|1|||
27851948|NCT02603172|54353619|FG003|Part A (Approximately 16 Weeks)|Adverse Event|0|||
27851949|NCT02603172|54353620|FG004|Part A (Approximately 16 Weeks)|Adverse Event|0|||
27851950|NCT02603172|54353621|FG005|Part A (Approximately 16 Weeks)|Adverse Event|0|||
28077823|NCT03670810|54732220|FG000|Open Label Extension|Non-compliance with study drug|0|||
28077824|NCT03670810|54732221|FG001|Open Label Extension|Non-compliance with study drug|0|||
28077825|NCT03670810|54732222|FG002|Open Label Extension|Non-compliance with study drug|0|||
28077826|NCT03670810|54732223|FG003|Open Label Extension|Non-compliance with study drug|0|||
28077827|NCT03670810|54732224|FG004|Open Label Extension|Non-compliance with study drug|0|||
28077828|NCT03670810|54732225|FG005|Open Label Extension|Non-compliance with study drug|0|||
28077829|NCT03670810|54732226|FG006|Open Label Extension|Non-compliance with study drug|0|||
28077830|NCT03670810|54732227|FG007|Open Label Extension|Non-compliance with study drug|0|||
28077831|NCT03670810|54732228|FG008|Open Label Extension|Non-compliance with study drug|5|||
28077832|NCT03670810|54732220|FG000|Open Label Extension|Pregnancy|0|||
28077833|NCT03670810|54732221|FG001|Open Label Extension|Pregnancy|0|||
28077834|NCT03670810|54732222|FG002|Open Label Extension|Pregnancy|0|||
28077835|NCT03670810|54732223|FG003|Open Label Extension|Pregnancy|0|||
28077836|NCT03670810|54732224|FG004|Open Label Extension|Pregnancy|0|||
28077837|NCT03670810|54732225|FG005|Open Label Extension|Pregnancy|0|||
28077838|NCT03670810|54732226|FG006|Open Label Extension|Pregnancy|0|||
28077839|NCT03670810|54732227|FG007|Open Label Extension|Pregnancy|0|||
28077840|NCT03670810|54732228|FG008|Open Label Extension|Pregnancy|3|||
28077841|NCT03670810|54732220|FG000|Open Label Extension|Adverse Event|0|||
28077842|NCT03670810|54732221|FG001|Open Label Extension|Adverse Event|0|||
28077843|NCT03670810|54732222|FG002|Open Label Extension|Adverse Event|0|||
28077844|NCT03670810|54732223|FG003|Open Label Extension|Adverse Event|0|||
28077845|NCT03670810|54732224|FG004|Open Label Extension|Adverse Event|0|||
28162027|NCT02688530|54832323|FG002|Overall Study|Lost to Follow-up|2|||
28162028|NCT02688530|54832324|FG003|Overall Study|Lost to Follow-up|0|||
28162029|NCT02467270|54832341|FG000|Overall Study|Participants Never Treated|0|||
28162030|NCT02467270|54832342|FG001|Overall Study|Participants Never Treated|1|||
28162031|NCT02467270|54832343|FG002|Overall Study|Participants Never Treated|0|||
28162032|NCT02467270|54832341|FG000|Overall Study|Ongoing|50|||
28162033|NCT02467270|54832342|FG001|Overall Study|Ongoing|41|||
28162034|NCT02467270|54832343|FG002|Overall Study|Ongoing|43|||
28162035|NCT02467270|54832341|FG000|Overall Study|Adverse Event|16|||
28162036|NCT02467270|54832342|FG001|Overall Study|Adverse Event|15|||
28162037|NCT02467270|54832343|FG002|Overall Study|Adverse Event|14|||
28162038|NCT02467270|54832341|FG000|Overall Study|Progressive Disease|7|||
28162039|NCT02467270|54832342|FG001|Overall Study|Progressive Disease|7|||
28162040|NCT02467270|54832343|FG002|Overall Study|Progressive Disease|4|||
28162041|NCT02467270|54832341|FG000|Overall Study|Death|2|||
28162042|NCT02467270|54832342|FG001|Overall Study|Death|0|||
28162043|NCT02467270|54832343|FG002|Overall Study|Death|2|||
28162044|NCT02467270|54832341|FG000|Overall Study|Lack of Efficacy|12|||
28162045|NCT02467270|54832342|FG001|Overall Study|Lack of Efficacy|18|||
28162046|NCT02467270|54832343|FG002|Overall Study|Lack of Efficacy|23|||
28162047|NCT02467270|54832341|FG000|Overall Study|Non-compliance With Study Drug|0|||
28162048|NCT02467270|54832342|FG001|Overall Study|Non-compliance With Study Drug|2|||
28162049|NCT02467270|54832343|FG002|Overall Study|Non-compliance With Study Drug|1|||
27851951|NCT02603172|54353622|FG006|Part A (Approximately 16 Weeks)|Adverse Event|0|||
28077846|NCT03670810|54732225|FG005|Open Label Extension|Adverse Event|0|||
28077847|NCT03670810|54732226|FG006|Open Label Extension|Adverse Event|0|||
28077848|NCT03670810|54732227|FG007|Open Label Extension|Adverse Event|0|||
28077849|NCT03670810|54732228|FG008|Open Label Extension|Adverse Event|24|||
28077850|NCT03670810|54732220|FG000|Open Label Extension|Participant wanted to become pregnant|0|||
28077851|NCT03670810|54732221|FG001|Open Label Extension|Participant wanted to become pregnant|0|||
28077852|NCT03670810|54732222|FG002|Open Label Extension|Participant wanted to become pregnant|0|||
28077853|NCT03670810|54732223|FG003|Open Label Extension|Participant wanted to become pregnant|0|||
28077854|NCT03670810|54732224|FG004|Open Label Extension|Participant wanted to become pregnant|0|||
28077855|NCT03670810|54732225|FG005|Open Label Extension|Participant wanted to become pregnant|0|||
28077856|NCT03670810|54732226|FG006|Open Label Extension|Participant wanted to become pregnant|0|||
28077857|NCT03670810|54732227|FG007|Open Label Extension|Participant wanted to become pregnant|0|||
28077858|NCT03670810|54732228|FG008|Open Label Extension|Participant wanted to become pregnant|1|||
28077859|NCT03670810|54732220|FG000|Open Label Extension|Lost to Follow-up|0|||
28077860|NCT03670810|54732221|FG001|Open Label Extension|Lost to Follow-up|0|||
27851952|NCT02603172|54353623|FG007|Part A (Approximately 16 Weeks)|Adverse Event|0|||
27851953|NCT02605824|54353744|FG000|Overall Study|Physician Decision|1|||
28077861|NCT03670810|54732222|FG002|Open Label Extension|Lost to Follow-up|0|||
28077862|NCT03670810|54732223|FG003|Open Label Extension|Lost to Follow-up|0|||
28077863|NCT03670810|54732224|FG004|Open Label Extension|Lost to Follow-up|0|||
28162050|NCT02467270|54832341|FG000|Overall Study|Lost to Follow-up|2|||
28162051|NCT02467270|54832342|FG001|Overall Study|Lost to Follow-up|1|||
28162052|NCT02467270|54832343|FG002|Overall Study|Lost to Follow-up|0|||
28162053|NCT02467270|54832341|FG000|Overall Study|Pregnancy|0|||
28162054|NCT02467270|54832342|FG001|Overall Study|Pregnancy|1|||
28162055|NCT02467270|54832343|FG002|Overall Study|Pregnancy|0|||
28162056|NCT02467270|54832341|FG000|Overall Study|Physician Decision|0|||
28162057|NCT02467270|54832342|FG001|Overall Study|Physician Decision|4|||
28077864|NCT03670810|54732225|FG005|Open Label Extension|Lost to Follow-up|0|||
28077865|NCT03670810|54732226|FG006|Open Label Extension|Lost to Follow-up|0|||
28077866|NCT03670810|54732227|FG007|Open Label Extension|Lost to Follow-up|0|||
28162058|NCT02467270|54832343|FG002|Overall Study|Physician Decision|1|||
28162059|NCT02467270|54832341|FG000|Overall Study|Withdrawal by Subject|4|||
28162060|NCT02467270|54832342|FG001|Overall Study|Withdrawal by Subject|3|||
28162061|NCT02467270|54832343|FG002|Overall Study|Withdrawal by Subject|5|||
28162062|NCT02467270|54832341|FG000|Overall Study|Reason not Specified|1|||
28162063|NCT02467270|54832342|FG001|Overall Study|Reason not Specified|2|||
28162064|NCT02467270|54832343|FG002|Overall Study|Reason not Specified|1|||
28162065|NCT05083559|54832353|FG000|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|4|||
28162066|NCT05083559|54832354|FG001|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|1|||
28162067|NCT05083559|54832353|FG000|Second at Home Period (3-30 Days)|Withdrawal by Subject|2|||
28162068|NCT05083559|54832354|FG001|Second at Home Period (3-30 Days)|Withdrawal by Subject|0|||
28162069|NCT05083559|54832353|FG000|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|1|||
28162070|NCT05083559|54832354|FG001|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|0|||
28162071|NCT03037307|54832360|FG000|Period 1|Did Not Meet Study Criteria|0|||
28162072|NCT03037307|54832361|FG001|Period 1|Did Not Meet Study Criteria|0|||
28162073|NCT03037307|54832362|FG002|Period 1|Did Not Meet Study Criteria|0|||
28162074|NCT03037307|54832363|FG003|Period 1|Did Not Meet Study Criteria|1|||
28162075|NCT03037307|54832364|FG004|Period 1|Did Not Meet Study Criteria|0|||
28162076|NCT03037307|54832365|FG005|Period 1|Did Not Meet Study Criteria|0|||
28162077|NCT02538094|54832374|FG000|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0|||
28162078|NCT02538094|54832375|FG001|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1|||
28162079|NCT02538094|54832374|FG000|Washout (4 Weeks)|Withdrawal by Subject|0|||
28162080|NCT02538094|54832375|FG001|Washout (4 Weeks)|Withdrawal by Subject|1|||
28162081|NCT02686034|54832383|FG000|Run-In Period 1|Eligibility|12|||
28162082|NCT02686034|54832384|FG001|Run-In Period 1|Eligibility|10|||
28162083|NCT02686034|54832383|FG000|Run-In Period 1|Withdrawal by Subject|4|||
28162084|NCT02686034|54832384|FG001|Run-In Period 1|Withdrawal by Subject|3|||
28162085|NCT02686034|54832383|FG000|Run-In Period 1|Lost to Follow-up|4|||
28162086|NCT02686034|54832384|FG001|Run-In Period 1|Lost to Follow-up|4|||
28162087|NCT02686034|54832383|FG000|Randomized Controlled Period 2|Lost to Follow-up|1|||
28162088|NCT02686034|54832384|FG001|Randomized Controlled Period 2|Lost to Follow-up|2|||
28162089|NCT02686034|54832383|FG000|Randomized Controlled Period 2|Withdrawal by Subject|3|||
28162090|NCT02686034|54832384|FG001|Randomized Controlled Period 2|Withdrawal by Subject|0|||
28162091|NCT02686034|54832383|FG000|Randomized Controlled Period 2|Adverse Event|0|||
28162092|NCT02686034|54832384|FG001|Randomized Controlled Period 2|Adverse Event|2|||
28162093|NCT02686034|54832383|FG000|Randomized Controlled Period 2|Spontaneous reduction in migraines|1|||
28162094|NCT02686034|54832384|FG001|Randomized Controlled Period 2|Spontaneous reduction in migraines|0|||
27851954|NCT02605824|54353745|FG001|Overall Study|Physician Decision|0|||
27851955|NCT02605122|54353875|FG000|Overall Study|Withdrawal by Subject|4|||
27851956|NCT02605122|54353876|FG001|Overall Study|Withdrawal by Subject|1|||
27851957|NCT02605122|54353875|FG000|Overall Study|Lost to Follow-up|1|||
27851958|NCT02605122|54353876|FG001|Overall Study|Lost to Follow-up|1|||
28077867|NCT03670810|54732228|FG008|Open Label Extension|Lost to Follow-up|23|||
28077868|NCT00089648|54732242|FG000|Overall Study|Adverse Event|7|||
28077869|NCT00089648|54732242|FG000|Overall Study|Withdrawal by Subject|1|||
28077870|NCT00089648|54732242|FG000|Overall Study|Lack of Efficacy|33|||
28077871|NCT00118040|54732249|FG000|Overall Study|Adverse Event|0|||
28077872|NCT00118040|54732250|FG001|Overall Study|Adverse Event|1|||
28077873|NCT00118040|54732251|FG002|Overall Study|Adverse Event|0|||
28077874|NCT00118040|54732249|FG000|Overall Study|Withdrawal by Subject|0|||
27851959|NCT01454102|54353927|FG000|Overall Study|Continuing in the treatment period|0|||
27851960|NCT01454102|54353928|FG001|Overall Study|Continuing in the treatment period|0|||
27851961|NCT01454102|54353929|FG002|Overall Study|Continuing in the treatment period|0|||
27851962|NCT01454102|54353930|FG003|Overall Study|Continuing in the treatment period|0|||
27851963|NCT01454102|54353931|FG004|Overall Study|Continuing in the treatment period|3|||
27851964|NCT01454102|54353932|FG005|Overall Study|Continuing in the treatment period|3|||
27851965|NCT01454102|54353933|FG006|Overall Study|Continuing in the treatment period|2|||
27851966|NCT01454102|54353934|FG007|Overall Study|Continuing in the treatment period|0|||
27851967|NCT01454102|54353935|FG008|Overall Study|Continuing in the treatment period|1|||
28077875|NCT00118040|54732250|FG001|Overall Study|Withdrawal by Subject|0|||
28077876|NCT00118040|54732251|FG002|Overall Study|Withdrawal by Subject|2|||
28077877|NCT00118040|54732249|FG000|Overall Study|Medical Contraindication|0|||
28077878|NCT00118040|54732250|FG001|Overall Study|Medical Contraindication|0|||
28077879|NCT00118040|54732251|FG002|Overall Study|Medical Contraindication|1|||
28162095|NCT02686034|54832383|FG000|Open Label Period 3|Lost to Follow-up|0|||
28162096|NCT02686034|54832384|FG001|Open Label Period 3|Lost to Follow-up|1|||
28162097|NCT02685488|54832392|FG000|Overall Study|Withdrawal by Subject|0|||
27851968|NCT01454102|54353936|FG009|Overall Study|Continuing in the treatment period|0|||
27851969|NCT01454102|54353937|FG010|Overall Study|Continuing in the treatment period|0|||
28077880|NCT00118040|54732249|FG000|Overall Study|Non-Compliant Participant|1|||
28077881|NCT00118040|54732250|FG001|Overall Study|Non-Compliant Participant|1|||
28077882|NCT00118040|54732251|FG002|Overall Study|Non-Compliant Participant|2|||
28077883|NCT00118040|54732249|FG000|Overall Study|Other|0|||
28077884|NCT00118040|54732250|FG001|Overall Study|Other|0|||
28077885|NCT00118040|54732251|FG002|Overall Study|Other|1|||
28077886|NCT00389207|54732267|FG000|Overall Study|Adverse Event|26|||
28077887|NCT00389207|54732268|FG001|Overall Study|Adverse Event|32|||
28077888|NCT00389207|54732269|FG002|Overall Study|Adverse Event|10|||
28077889|NCT00389207|54732267|FG000|Overall Study|Protocol Violation|3|||
28077890|NCT00389207|54732268|FG001|Overall Study|Protocol Violation|1|||
28077891|NCT00389207|54732269|FG002|Overall Study|Protocol Violation|4|||
28077892|NCT00389207|54732267|FG000|Overall Study|Lost to Follow-up|12|||
28077893|NCT00389207|54732268|FG001|Overall Study|Lost to Follow-up|9|||
28077894|NCT00389207|54732269|FG002|Overall Study|Lost to Follow-up|7|||
28077895|NCT00389207|54732267|FG000|Overall Study|Withdrawal by Subject|5|||
28077896|NCT00389207|54732268|FG001|Overall Study|Withdrawal by Subject|7|||
28077897|NCT00389207|54732269|FG002|Overall Study|Withdrawal by Subject|11|||
28077898|NCT00389207|54732267|FG000|Overall Study|Other|17|||
28077899|NCT00389207|54732268|FG001|Overall Study|Other|23|||
28077900|NCT00389207|54732269|FG002|Overall Study|Other|9|||
28077901|NCT00388973|54732284|FG000|Overall Study|Adverse Event|16|||
28077902|NCT00388973|54732285|FG001|Overall Study|Adverse Event|6|||
28077903|NCT00388973|54732284|FG000|Overall Study|Lack of Efficacy|1|||
28077904|NCT00388973|54732285|FG001|Overall Study|Lack of Efficacy|12|||
28077905|NCT00388973|54732284|FG000|Overall Study|Protocol Violation|3|||
28077906|NCT00388973|54732285|FG001|Overall Study|Protocol Violation|0|||
28077907|NCT00388973|54732284|FG000|Overall Study|Withdrawal by Subject|14|||
28077908|NCT00388973|54732285|FG001|Overall Study|Withdrawal by Subject|17|||
28077909|NCT00388973|54732284|FG000|Overall Study|Study specific Discontinuation Criteria|0|||
28077910|NCT00388973|54732285|FG001|Overall Study|Study specific Discontinuation Criteria|1|||
28077911|NCT00388973|54732284|FG000|Overall Study|Did not complete 61 days of treatment|5|||
28077912|NCT00388973|54732285|FG001|Overall Study|Did not complete 61 days of treatment|4|||
28077913|NCT00388973|54732284|FG000|Overall Study|Left region|0|||
28077914|NCT00388973|54732285|FG001|Overall Study|Left region|1|||
28077915|NCT00388973|54732284|FG000|Overall Study|Did not complete 2-week follow-up visit|17|||
28077916|NCT00388973|54732285|FG001|Overall Study|Did not complete 2-week follow-up visit|17|||
28077917|NCT00085202|54732293|FG000|Overall Study|Still on therapy|2|||
28077918|NCT00085202|54732294|FG001|Overall Study|Still on therapy|0|||
28077919|NCT00085202|54732293|FG000|Overall Study|Bone involvement confirmed by bone scan|0|||
28077920|NCT00085202|54732294|FG001|Overall Study|Bone involvement confirmed by bone scan|1|||
28077921|NCT00085202|54732293|FG000|Overall Study|Excessive toxicity|6|||
28077922|NCT00085202|54732294|FG001|Overall Study|Excessive toxicity|5|||
28077923|NCT00085202|54732293|FG000|Overall Study|Non-specified|3|||
28077924|NCT00085202|54732294|FG001|Overall Study|Non-specified|5|||
28077925|NCT00085202|54732293|FG000|Overall Study|Withdrawal by Subject|2|||
28077926|NCT00085202|54732294|FG001|Overall Study|Withdrawal by Subject|1|||
28077927|NCT00085202|54732293|FG000|Overall Study|Physician Decision|4|||
28077928|NCT00085202|54732294|FG001|Overall Study|Physician Decision|1|||
28077929|NCT00085202|54732293|FG000|Overall Study|Progressive disease|1|||
28077930|NCT00085202|54732294|FG001|Overall Study|Progressive disease|11|||
28077931|NCT00388583|54732320|FG000|Overall Study|Protocol Violation|1|||
28077932|NCT00388583|54732321|FG001|Overall Study|Protocol Violation|0|||
28077933|NCT00388583|54732320|FG000|Overall Study|Withdrawal by Subject|3|||
28077934|NCT00388583|54732321|FG001|Overall Study|Withdrawal by Subject|3|||
28077935|NCT00388583|54732320|FG000|Overall Study|Serious Adverse Event|2|||
28077936|NCT00388583|54732321|FG001|Overall Study|Serious Adverse Event|0|||
28077937|NCT00388583|54732320|FG000|Overall Study|Did not receive vaccine|0|||
28077938|NCT00388583|54732321|FG001|Overall Study|Did not receive vaccine|1|||
28077939|NCT00117572|54732329|FG000|Overall Study|Site withdrew before starting treatment|2|||
28077940|NCT00117572|54732330|FG001|Overall Study|Site withdrew before starting treatment|3|||
28077941|NCT00117572|54732329|FG000|Overall Study|Withdrawal by Subject|3|||
27851970|NCT01454102|54353938|FG011|Overall Study|Continuing in the treatment period|4|||
27851971|NCT01454102|54353939|FG012|Overall Study|Continuing in the treatment period|7|||
27851972|NCT01454102|54353940|FG013|Overall Study|Continuing in the treatment period|4|||
28077942|NCT00117572|54732330|FG001|Overall Study|Withdrawal by Subject|3|||
28077943|NCT00117572|54732329|FG000|Overall Study|Protocol Violation|1|||
28077944|NCT00117572|54732330|FG001|Overall Study|Protocol Violation|0|||
28077945|NCT00388505|54732338|FG000|Overall Study|Adverse Event or Death|43|||
28077946|NCT00388505|54732339|FG001|Overall Study|Adverse Event or Death|17|||
28077947|NCT00388505|54732338|FG000|Overall Study|Withdrawal by Subject|24|||
28077948|NCT00388505|54732339|FG001|Overall Study|Withdrawal by Subject|9|||
28077949|NCT00388505|54732338|FG000|Overall Study|Lost to Follow-up|5|||
28077950|NCT00388505|54732339|FG001|Overall Study|Lost to Follow-up|3|||
28077951|NCT00388505|54732338|FG000|Overall Study|Inappropriate Enrollment|0|||
28077952|NCT00388505|54732339|FG001|Overall Study|Inappropriate Enrollment|1|||
27851973|NCT01454102|54353941|FG014|Overall Study|Continuing in the treatment period|3|||
28077953|NCT00388505|54732338|FG000|Overall Study|Administrative Reason|1|||
28077954|NCT00388505|54732339|FG001|Overall Study|Administrative Reason|0|||
28077955|NCT00388505|54732338|FG000|Overall Study|Protocol Violation|6|||
28077956|NCT00388505|54732339|FG001|Overall Study|Protocol Violation|5|||
28077957|NCT00388505|54732338|FG000|Overall Study|Unable to classify|4|||
28077958|NCT00388505|54732339|FG001|Overall Study|Unable to classify|3|||
28077959|NCT00388349|54732345|FG000|Phase I Dose Escalation|Dose reduction due to DLT|0|||
28077960|NCT00388349|54732346|FG001|Phase I Dose Escalation|Dose reduction due to DLT|3|||
28077961|NCT00117338|54732356|FG000|Overall Study|Adverse Event|0|||
28077962|NCT00117338|54732357|FG001|Overall Study|Adverse Event|1|||
28077963|NCT00117338|54732356|FG000|Overall Study|Protocol Violation|3|||
28077964|NCT00117338|54732357|FG001|Overall Study|Protocol Violation|2|||
28077965|NCT00117338|54732356|FG000|Overall Study|Withdrawal by Subject|1|||
28077966|NCT00117338|54732357|FG001|Overall Study|Withdrawal by Subject|0|||
28077967|NCT00117338|54732356|FG000|Overall Study|Did not meet Inclusion Criteria|1|||
28077968|NCT00117338|54732357|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
28077969|NCT00117338|54732356|FG000|Overall Study|Lack of Efficacy|0|||
28077970|NCT00117338|54732357|FG001|Overall Study|Lack of Efficacy|1|||
28077971|NCT00388037|54732363|FG000|Overall Study|Protocol Violation|1|||
28077972|NCT00387881|54732369|FG000|Overall Study|Lost to Follow-up|23|||
28077973|NCT00387881|54732370|FG001|Overall Study|Lost to Follow-up|23|||
28077974|NCT00387881|54732369|FG000|Overall Study|Protocol Violation|2|||
28077975|NCT00387881|54732370|FG001|Overall Study|Protocol Violation|12|||
28077976|NCT00387881|54732369|FG000|Overall Study|Withdrawal by Subject|15|||
28077977|NCT00387881|54732370|FG001|Overall Study|Withdrawal by Subject|18|||
28077978|NCT00387881|54732369|FG000|Overall Study|Sponsor terminated Study|0|||
28077979|NCT00387881|54732370|FG001|Overall Study|Sponsor terminated Study|1|||
28077980|NCT00387881|54732369|FG000|Overall Study|Not eligible|6|||
28077981|NCT00387881|54732370|FG001|Overall Study|Not eligible|7|||
28077982|NCT00387881|54732369|FG000|Overall Study|No opportunity to treat headache|32|||
28077983|NCT00387881|54732370|FG001|Overall Study|No opportunity to treat headache|34|||
28077984|NCT00387881|54732369|FG000|Overall Study|Not otherwise specified|11|||
28077985|NCT00387881|54732370|FG001|Overall Study|Not otherwise specified|7|||
28077986|NCT00084656|54732379|FG000|Overall Study|Other reasons|0|||
28077987|NCT00084656|54732380|FG001|Overall Study|Other reasons|12|||
28077988|NCT00084656|54732381|FG002|Overall Study|Other reasons|11|||
28077989|NCT00084656|54732379|FG000|Overall Study|Withdrawal by Subject|15|||
28077990|NCT00084656|54732380|FG001|Overall Study|Withdrawal by Subject|4|||
28077991|NCT00084656|54732381|FG002|Overall Study|Withdrawal by Subject|4|||
28077992|NCT00084656|54732379|FG000|Overall Study|Disease relapse|0|||
28077993|NCT00084656|54732380|FG001|Overall Study|Disease relapse|9|||
28077994|NCT00084656|54732381|FG002|Overall Study|Disease relapse|10|||
28077995|NCT00084656|54732379|FG000|Overall Study|Disease progression|9|||
28077996|NCT00084656|54732380|FG001|Overall Study|Disease progression|0|||
28077997|NCT00084656|54732381|FG002|Overall Study|Disease progression|0|||
28077998|NCT00084656|54732379|FG000|Overall Study|Lost to Follow-up|1|||
28077999|NCT00084656|54732380|FG001|Overall Study|Lost to Follow-up|0|||
28078000|NCT00084656|54732381|FG002|Overall Study|Lost to Follow-up|1|||
28078001|NCT00387725|54732395|FG000|Overall Study|Adverse Event|0|||
28078002|NCT00387725|54732396|FG001|Overall Study|Adverse Event|0|||
28078003|NCT00387725|54732397|FG002|Overall Study|Adverse Event|0|||
28078004|NCT00387725|54732398|FG003|Overall Study|Adverse Event|1|||
28078005|NCT00387725|54732395|FG000|Overall Study|Protocol Violation|0|||
28078006|NCT00387725|54732396|FG001|Overall Study|Protocol Violation|1|||
28078007|NCT00387725|54732397|FG002|Overall Study|Protocol Violation|0|||
28078008|NCT00387725|54732398|FG003|Overall Study|Protocol Violation|0|||
28078009|NCT00387725|54732395|FG000|Overall Study|Withdrawal by Subject|1|||
28078010|NCT00387725|54732396|FG001|Overall Study|Withdrawal by Subject|0|||
28078011|NCT00387725|54732397|FG002|Overall Study|Withdrawal by Subject|1|||
28078012|NCT00387725|54732398|FG003|Overall Study|Withdrawal by Subject|0|||
28078013|NCT00387725|54732395|FG000|Overall Study|Parent/legal guardian request|0|||
28078014|NCT00387725|54732396|FG001|Overall Study|Parent/legal guardian request|0|||
28078015|NCT00387725|54732397|FG002|Overall Study|Parent/legal guardian request|1|||
28078016|NCT00387725|54732398|FG003|Overall Study|Parent/legal guardian request|1|||
28078017|NCT00102596|54732408|FG000|Part A|Screen failures|6|||
28078018|NCT00102596|54732409|FG001|Part A|Screen failures|0|||
28078019|NCT00102596|54732408|FG000|Part A|Adverse Event|1|||
27851974|NCT01454102|54353942|FG015|Overall Study|Continuing in the treatment period|1|||
28078020|NCT00102596|54732409|FG001|Part A|Adverse Event|0|||
28078021|NCT00387647|54732416|FG000|Overall Study|Death|18|||
28078022|NCT00386009|54732422|FG000|Overall Study|Adverse Event|0|||
28078023|NCT00386009|54732423|FG001|Overall Study|Adverse Event|2|||
28078024|NCT00386009|54732422|FG000|Overall Study|Death|1|||
28078025|NCT00386009|54732423|FG001|Overall Study|Death|0|||
28078026|NCT00386009|54732422|FG000|Overall Study|Entry Criteria Not Met|0|||
28162098|NCT02685488|54832393|FG001|Overall Study|Withdrawal by Subject|1|||
28078027|NCT00386009|54732423|FG001|Overall Study|Entry Criteria Not Met|2|||
28078028|NCT00386009|54732422|FG000|Overall Study|Lost to Follow-up|1|||
28078029|NCT00386009|54732423|FG001|Overall Study|Lost to Follow-up|1|||
28078030|NCT00386009|54732422|FG000|Overall Study|Protocol Violation|1|||
28078031|NCT00386009|54732423|FG001|Overall Study|Protocol Violation|0|||
28078032|NCT00386009|54732422|FG000|Overall Study|Sponsor Decision|1|||
28078033|NCT00386009|54732423|FG001|Overall Study|Sponsor Decision|1|||
28078034|NCT00386009|54732422|FG000|Overall Study|Withdrawal by Subject|5|||
28078035|NCT00386009|54732423|FG001|Overall Study|Withdrawal by Subject|4|||
28078036|NCT00373685|54732431|FG000|Overall Study|Death|2|||
28078037|NCT00373685|54732432|FG001|Overall Study|Death|1|||
28078038|NCT00373685|54732431|FG000|Overall Study|Adverse Event|278|||
28078039|NCT00373685|54732432|FG001|Overall Study|Adverse Event|253|||
28078040|NCT00373685|54732431|FG000|Overall Study|Insufficient clinical response|169|||
28078041|NCT00373685|54732432|FG001|Overall Study|Insufficient clinical response|119|||
28078042|NCT00373685|54732431|FG000|Overall Study|Did not meet entrance criteria|167|||
28078043|NCT00373685|54732432|FG001|Overall Study|Did not meet entrance criteria|184|||
28078044|NCT00373685|54732431|FG000|Overall Study|Lost to follow up|83|||
28078045|NCT00373685|54732432|FG001|Overall Study|Lost to follow up|103|||
28078046|NCT00373685|54732431|FG000|Overall Study|No longer willing to participate|337|||
28078047|NCT00373685|54732432|FG001|Overall Study|No longer willing to participate|352|||
28078048|NCT00373685|54732431|FG000|Overall Study|Other|149|||
28078049|NCT00373685|54732432|FG001|Overall Study|Other|146|||
28078050|NCT00373685|54732431|FG000|Overall Study|Protocol Violation|191|||
28078051|NCT00373685|54732432|FG001|Overall Study|Protocol Violation|182|||
28078052|NCT00373685|54732431|FG000|Overall Study|Final Status Unknown|12|||
28078053|NCT00373685|54732432|FG001|Overall Study|Final Status Unknown|4|||
28078054|NCT00373685|54732431|FG000|Overall Study|Randomized, not treated|51|||
28078055|NCT00373685|54732432|FG001|Overall Study|Randomized, not treated|77|||
28078056|NCT00373529|54732438|FG000|Overall Study|Physician Decision|19|||
28078057|NCT00373529|54732438|FG000|Overall Study|Withdrawal by Subject|7|||
28078058|NCT00373529|54732438|FG000|Overall Study|Adverse Event|7|||
28078059|NCT00373529|54732438|FG000|Overall Study|Treatment failure|36|||
28078060|NCT00373529|54732438|FG000|Overall Study|Disease recurrence|10|||
28078061|NCT00373529|54732438|FG000|Overall Study|Death|16|||
28078062|NCT00373529|54732438|FG000|Overall Study|Need for treatment prohibited by study|1|||
28078063|NCT00373529|54732438|FG000|Overall Study|Other|8|||
28078064|NCT00373529|54732438|FG000|Overall Study|Failed independent confirmation of AML|3|||
28078065|NCT00373529|54732438|FG000|Overall Study|Consent violation|1|||
28078066|NCT00373295|54732442|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
28078067|NCT00373295|54732443|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
28078068|NCT00373295|54732444|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
28078069|NCT00373295|54732445|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
28078070|NCT00373295|54732446|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
28078071|NCT00373295|54732447|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
28078072|NCT00385541|54732457|FG000|Overall Study|severe pain, clinician requested unblind|0|||
28078073|NCT00385541|54732458|FG001|Overall Study|severe pain, clinician requested unblind|1|||
28078074|NCT00392015|54732470|FG000|Overall Study|Lost to Follow-up|2|||
28078075|NCT00392015|54732471|FG001|Overall Study|Lost to Follow-up|0|||
28078076|NCT00392015|54732472|FG002|Overall Study|Lost to Follow-up|2|||
28078077|NCT00392015|54732473|FG003|Overall Study|Lost to Follow-up|1|||
28078078|NCT00392015|54732474|FG004|Overall Study|Lost to Follow-up|1|||
28078079|NCT00392015|54732475|FG005|Overall Study|Lost to Follow-up|0|||
28078080|NCT00392015|54732470|FG000|Overall Study|Withdrawal by Subject|0|||
28078081|NCT00392015|54732471|FG001|Overall Study|Withdrawal by Subject|0|||
28078082|NCT00392015|54732472|FG002|Overall Study|Withdrawal by Subject|2|||
28078083|NCT00392015|54732473|FG003|Overall Study|Withdrawal by Subject|0|||
28078084|NCT00392015|54732474|FG004|Overall Study|Withdrawal by Subject|0|||
28078085|NCT00392015|54732475|FG005|Overall Study|Withdrawal by Subject|0|||
28078086|NCT00392015|54732470|FG000|Overall Study|Adverse Event|0|||
28078087|NCT00392015|54732471|FG001|Overall Study|Adverse Event|0|||
28078088|NCT00392015|54732472|FG002|Overall Study|Adverse Event|0|||
28078089|NCT00392015|54732473|FG003|Overall Study|Adverse Event|0|||
28078090|NCT00392015|54732474|FG004|Overall Study|Adverse Event|1|||
28078091|NCT00392015|54732475|FG005|Overall Study|Adverse Event|0|||
28078092|NCT00392015|54732470|FG000|Overall Study|Previous trial recipient|0|||
28078093|NCT00392015|54732471|FG001|Overall Study|Previous trial recipient|0|||
28078094|NCT00392015|54732472|FG002|Overall Study|Previous trial recipient|0|||
28078095|NCT00392015|54732473|FG003|Overall Study|Previous trial recipient|0|||
28078096|NCT00392015|54732474|FG004|Overall Study|Previous trial recipient|1|||
28078097|NCT00392015|54732475|FG005|Overall Study|Previous trial recipient|0|||
28078098|NCT00094302|54732496|FG000|Overall Study|Lost to Follow-up|43|||
28078099|NCT00094302|54732497|FG001|Overall Study|Lost to Follow-up|41|||
28078100|NCT00094302|54732496|FG000|Overall Study|Physician Decision|5|||
28078101|NCT00094302|54732497|FG001|Overall Study|Physician Decision|8|||
28078102|NCT00094302|54732496|FG000|Overall Study|Withdrawal by Subject|103|||
28078103|NCT00094302|54732497|FG001|Overall Study|Withdrawal by Subject|111|||
28078104|NCT00094302|54732496|FG000|Overall Study|Death|266|||
28078105|NCT00094302|54732497|FG001|Overall Study|Death|246|||
28078106|NCT00372905|54732503|FG000|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2|||
28078107|NCT00372905|54732504|FG001|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
28078108|NCT00372905|54732505|FG002|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
28078109|NCT00372905|54732506|FG003|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
28078110|NCT00372905|54732503|FG000|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
28078111|NCT00372905|54732504|FG001|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
28078112|NCT00372905|54732505|FG002|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2|||
28078113|NCT00372905|54732506|FG003|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
28078114|NCT00372905|54732503|FG000|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
28078115|NCT00372905|54732504|FG001|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
28078116|NCT00372905|54732505|FG002|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1|||
28078117|NCT00372905|54732506|FG003|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
28078118|NCT00372905|54732503|FG000|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
28078119|NCT00372905|54732504|FG001|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
28078120|NCT00372905|54732505|FG002|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
28078121|NCT00372905|54732506|FG003|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2|||
28078122|NCT00372905|54732503|FG000|Follow up Until Relapse or Progression|Study closed|0|||
28078123|NCT00372905|54732504|FG001|Follow up Until Relapse or Progression|Study closed|0|||
28078124|NCT00372905|54732505|FG002|Follow up Until Relapse or Progression|Study closed|0|||
28078125|NCT00372905|54732506|FG003|Follow up Until Relapse or Progression|Study closed|3|||
28078126|NCT00372905|54732503|FG000|Follow up Until Relapse or Progression|Other|0|||
27831334|NCT00708162|54308240|FG001|Randomized Phase|Lost to Follow-up|34|||
27831335|NCT00708162|54308239|FG000|Randomized Phase|Withdrew Consent|31|||
27831336|NCT00708162|54308240|FG001|Randomized Phase|Withdrew Consent|22|||
27851975|NCT02602080|54354036|FG000|Overall Study|Protocol Violation|6|||
27851976|NCT02602080|54354037|FG001|Overall Study|Protocol Violation|1|||
27851977|NCT02602080|54354038|FG002|Overall Study|Protocol Violation|3|||
27851978|NCT02604342|54354122|FG000|Overall Study|Death|32|||
27851979|NCT02604342|54354123|FG001|Overall Study|Death|16|||
27851980|NCT02604342|54354122|FG000|Overall Study|Progression of disease|1|||
27851981|NCT02604342|54354123|FG001|Overall Study|Progression of disease|0|||
27851982|NCT02604342|54354122|FG000|Overall Study|Withdrawal by Subject|5|||
27851983|NCT02604342|54354123|FG001|Overall Study|Withdrawal by Subject|6|||
27851984|NCT02604342|54354122|FG000|Overall Study|Other|1|||
27851985|NCT02604342|54354123|FG001|Overall Study|Other|0|||
27851986|NCT02604342|54354122|FG000|Overall Study|Study Termination by Sponsor|1|||
27851987|NCT02604342|54354123|FG001|Overall Study|Study Termination by Sponsor|0|||
27851988|NCT02604342|54354122|FG000|Overall Study|Lost to Follow-up|1|||
27851989|NCT02604342|54354123|FG001|Overall Study|Lost to Follow-up|1|||
27851990|NCT02604342|54354122|FG000|Overall Study|Physician Decision|2|||
27851991|NCT02604342|54354123|FG001|Overall Study|Physician Decision|0|||
27851992|NCT02604264|54354152|FG000|Intervention|Didn't use CVC for at least 21 days|200|||
27851993|NCT02604264|54354153|FG001|Intervention|Didn't use CVC for at least 21 days|242|||
27851994|NCT02601300|54354190|FG000|Induction Phase|Lack of Efficacy|2|||
27851995|NCT02601300|54354190|FG000|Induction Phase|Protocol Violation|1|||
27851996|NCT02601300|54354190|FG000|Extension Phase|Withdrawal by Subject|3|||
27851997|NCT02601300|54354190|FG000|Extension Phase|Adverse Event|4|||
27851998|NCT02601300|54354190|FG000|Extension Phase|Lack of Efficacy|10|||
27851999|NCT01471340|54354229|FG000|Overall Study|Death|5|||
27852000|NCT01471340|54354230|FG001|Overall Study|Death|4|||
27852001|NCT01471340|54354229|FG000|Overall Study|Lost to Follow-up|0|||
27852002|NCT01471340|54354230|FG001|Overall Study|Lost to Follow-up|1|||
27943811|NCT03332056|54600836|FG001|Overall Study|Passed stone prior to surgery date|0|||
27831337|NCT00708162|54308239|FG000|Randomized Phase|Lack of Efficacy|14|||
27831338|NCT00708162|54308240|FG001|Randomized Phase|Lack of Efficacy|19|||
27831339|NCT00708162|54308239|FG000|Randomized Phase|Protocol Violation|10|||
27831340|NCT00708162|54308240|FG001|Randomized Phase|Protocol Violation|11|||
27831341|NCT00708162|54308239|FG000|Randomized Phase|Adverse Event|8|||
27831342|NCT00708162|54308240|FG001|Randomized Phase|Adverse Event|12|||
27831343|NCT00708162|54308239|FG000|Randomized Phase|Investigator's Discretion|7|||
27831344|NCT00708162|54308240|FG001|Randomized Phase|Investigator's Discretion|10|||
27831345|NCT00708162|54308239|FG000|Randomized Phase|Death|2|||
27831346|NCT00708162|54308240|FG001|Randomized Phase|Death|9|||
27831347|NCT00708162|54308239|FG000|Randomized Phase|Pregnancy|3|||
27852003|NCT01471340|54354229|FG000|Overall Study|Investigational site closure|0|||
27852004|NCT01471340|54354230|FG001|Overall Study|Investigational site closure|1|||
27852005|NCT01471340|54354229|FG000|Overall Study|Invalid informed consent|1|||
28078127|NCT00372905|54732504|FG001|Follow up Until Relapse or Progression|Other|1|||
28078128|NCT00372905|54732505|FG002|Follow up Until Relapse or Progression|Other|0|||
27831348|NCT00708162|54308240|FG001|Randomized Phase|Pregnancy|0|||
27831349|NCT00708162|54308239|FG000|Open-Label Phase|Lost to Follow-up|10|||
27831350|NCT00708162|54308240|FG001|Open-Label Phase|Lost to Follow-up|8|||
27831351|NCT00708162|54308239|FG000|Open-Label Phase|Withdrew Consent|12|||
27852006|NCT01471340|54354230|FG001|Overall Study|Invalid informed consent|0|||
27852007|NCT01492400|54354252|FG000|Overall Study|Miscellaneous Reasons|2|||
28078129|NCT00372905|54732506|FG003|Follow up Until Relapse or Progression|Other|0|||
28078130|NCT00384839|54732516|FG000|Overall Study|Adverse Event|4|||
28078131|NCT00384839|54732516|FG000|Overall Study|Investigator Request|1|||
28078132|NCT00384839|54732516|FG000|Overall Study|Patient Request|1|||
28078133|NCT00384839|54732516|FG000|Overall Study|Ineligible|2|||
28078134|NCT00384293|54732522|FG000|MK0524A Active Run-In, Pre-randomization|Adverse Event|120|||
27852008|NCT01492400|54354253|FG001|Overall Study|Miscellaneous Reasons|3|||
27852009|NCT01492400|54354252|FG000|Overall Study|Personal Reasons|0|||
27852010|NCT01492400|54354253|FG001|Overall Study|Personal Reasons|5|||
27852011|NCT01492400|54354252|FG000|Overall Study|Lost to Follow-up|3|||
27852012|NCT01492400|54354253|FG001|Overall Study|Lost to Follow-up|1|||
27852013|NCT01492400|54354252|FG000|Overall Study|Pregnancy|0|||
27852014|NCT01492400|54354253|FG001|Overall Study|Pregnancy|1|||
27852015|NCT01492400|54354252|FG000|Overall Study|Lack of Efficacy|1|||
27852016|NCT01492400|54354253|FG001|Overall Study|Lack of Efficacy|1|||
27852017|NCT01492400|54354252|FG000|Overall Study|Adverse Event|10|||
27852018|NCT01492400|54354253|FG001|Overall Study|Adverse Event|5|||
27852019|NCT02596854|54354378|FG000|Overall Study|Withdrawn|8|||
27852020|NCT02592876|54354515|FG000|Overall Study|Withdrawal by Subject|3|||
27852021|NCT02592876|54354516|FG001|Overall Study|Withdrawal by Subject|3|||
27852022|NCT02592876|54354515|FG000|Overall Study|Study Termination by Sponsor|32|||
27852023|NCT02592876|54354516|FG001|Overall Study|Study Termination by Sponsor|27|||
27852024|NCT02592876|54354515|FG000|Overall Study|Lost to Follow-up|0|||
27852025|NCT02592876|54354516|FG001|Overall Study|Lost to Follow-up|1|||
27852026|NCT02592876|54354515|FG000|Overall Study|Death|6|||
27852027|NCT02592876|54354516|FG001|Overall Study|Death|9|||
27852028|NCT01492088|54354533|FG000|Overall Study|Withdrawal by Patient|0|||
27852029|NCT01492088|54354534|FG001|Overall Study|Withdrawal by Patient|2|||
27852030|NCT01492088|54354535|FG002|Overall Study|Withdrawal by Patient|0|||
27852031|NCT01492088|54354533|FG000|Overall Study|Death|1|||
27852032|NCT01492088|54354534|FG001|Overall Study|Death|6|||
27852033|NCT01492088|54354535|FG002|Overall Study|Death|2|||
27852034|NCT01492088|54354533|FG000|Overall Study|Completed Post Treatment Followup (PTFU)|2|||
27852035|NCT01492088|54354534|FG001|Overall Study|Completed Post Treatment Followup (PTFU)|0|||
27852036|NCT01492088|54354535|FG002|Overall Study|Completed Post Treatment Followup (PTFU)|1|||
27852037|NCT01492088|54354533|FG000|Overall Study|Alive at Last Follow-up|0|||
27852038|NCT01492088|54354534|FG001|Overall Study|Alive at Last Follow-up|6|||
27852039|NCT01492088|54354535|FG002|Overall Study|Alive at Last Follow-up|11|||
27852040|NCT02592798|54354777|FG000|Double-Blind Period 1 (DB1)|Pregnancy|1|||
27852041|NCT02592798|54354778|FG001|Double-Blind Period 1 (DB1)|Pregnancy|0|||
27852042|NCT02592798|54354777|FG000|Double-Blind Period 1 (DB1)|No longer meeting study criteria|0|||
27852043|NCT02592798|54354778|FG001|Double-Blind Period 1 (DB1)|No longer meeting study criteria|1|||
27852044|NCT02592798|54354777|FG000|Double-Blind Period 1 (DB1)|Lack of Efficacy|1|||
27852045|NCT02592798|54354778|FG001|Double-Blind Period 1 (DB1)|Lack of Efficacy|3|||
27852046|NCT02592798|54354777|FG000|Double-Blind Period 1 (DB1)|Adverse Event|1|||
27852047|NCT02592798|54354778|FG001|Double-Blind Period 1 (DB1)|Adverse Event|2|||
27852048|NCT02592798|54354777|FG000|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|3|||
27852049|NCT02592798|54354778|FG001|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|2|||
27852050|NCT02592798|54354777|FG000|Double-Blind Period 2 (DB2)|Other reasons|1|||
27852051|NCT02592798|54354778|FG001|Double-Blind Period 2 (DB2)|Other reasons|0|||
27852052|NCT02592798|54354777|FG000|Double-Blind Period 2 (DB2)|Participant request to discontinue|1|||
27852053|NCT02592798|54354778|FG001|Double-Blind Period 2 (DB2)|Participant request to discontinue|0|||
27852054|NCT02592798|54354777|FG000|Double-Blind Period 2 (DB2)|No longer meeting study criteria|1|||
27852055|NCT02592798|54354778|FG001|Double-Blind Period 2 (DB2)|No longer meeting study criteria|0|||
27852056|NCT02592798|54354777|FG000|Double-Blind Period 2 (DB2)|Lack of Efficacy|1|||
27852057|NCT02592798|54354778|FG001|Double-Blind Period 2 (DB2)|Lack of Efficacy|2|||
27852058|NCT02592798|54354777|FG000|Double-Blind Period 2 (DB2)|Adverse Event|1|||
27852059|NCT02592798|54354778|FG001|Double-Blind Period 2 (DB2)|Adverse Event|0|||
27852060|NCT02592798|54354777|FG000|Transition From DB2 to OLE|Other reasons|1|||
27852061|NCT02592798|54354778|FG001|Transition From DB2 to OLE|Other reasons|0|||
27852062|NCT02592798|54354777|FG000|Open Label Period (OLE)|Other reasons|0|||
27852063|NCT02592798|54354778|FG001|Open Label Period (OLE)|Other reasons|2|||
27852064|NCT02592798|54354777|FG000|Open Label Period (OLE)|Participant request to discontinue|1|||
27852065|NCT02592798|54354778|FG001|Open Label Period (OLE)|Participant request to discontinue|0|||
28078135|NCT00384293|54732523|FG001|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
27852066|NCT02592798|54354777|FG000|Open Label Period (OLE)|Lost to Follow-up|0|||
27852067|NCT02592798|54354778|FG001|Open Label Period (OLE)|Lost to Follow-up|1|||
27852068|NCT02592798|54354777|FG000|Open Label Period (OLE)|Lack of Efficacy|3|||
27852069|NCT02592798|54354778|FG001|Open Label Period (OLE)|Lack of Efficacy|5|||
27852070|NCT02592798|54354777|FG000|Open Label Period (OLE)|Adverse Event|0|||
27852071|NCT02592798|54354778|FG001|Open Label Period (OLE)|Adverse Event|1|||
27852072|NCT00081653|54354818|FG000|Overall Study|Adverse Event|23|||
27852073|NCT00081653|54354819|FG001|Overall Study|Adverse Event|17|||
28078136|NCT00384293|54732524|FG002|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
28078137|NCT00384293|54732522|FG000|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1|||
28078138|NCT00384293|54732523|FG001|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
28078139|NCT00384293|54732524|FG002|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
28078140|NCT00384293|54732522|FG000|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24|||
28078141|NCT00384293|54732523|FG001|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
28078142|NCT00384293|54732524|FG002|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
28078143|NCT00384293|54732522|FG000|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340|||
28078144|NCT00384293|54732523|FG001|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
28078145|NCT00384293|54732524|FG002|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
28078146|NCT00384293|54732522|FG000|MK0524A Active Run-In, Pre-randomization|Trial Termination|16|||
28078147|NCT00384293|54732523|FG001|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
28078148|NCT00384293|54732524|FG002|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
28078149|NCT00384293|54732522|FG000|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2|||
28078150|NCT00384293|54732523|FG001|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
28078151|NCT00384293|54732524|FG002|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
28078152|NCT00384293|54732522|FG000|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1|||
28078153|NCT00384293|54732523|FG001|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
28078154|NCT00384293|54732524|FG002|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
28078155|NCT00384293|54732522|FG000|Post-randomization Period|Adverse Event|0|||
28078156|NCT00384293|54732523|FG001|Post-randomization Period|Adverse Event|23|||
28078157|NCT00384293|54732524|FG002|Post-randomization Period|Adverse Event|7|||
28078158|NCT00384293|54732522|FG000|Post-randomization Period|Lost to Follow-up|0|||
28078159|NCT00384293|54732523|FG001|Post-randomization Period|Lost to Follow-up|2|||
28078160|NCT00384293|54732524|FG002|Post-randomization Period|Lost to Follow-up|1|||
28078161|NCT00384293|54732522|FG000|Post-randomization Period|Protocol Violation|0|||
28078162|NCT00384293|54732523|FG001|Post-randomization Period|Protocol Violation|1|||
28078163|NCT00384293|54732524|FG002|Post-randomization Period|Protocol Violation|0|||
28078164|NCT00384293|54732522|FG000|Post-randomization Period|Withdrawal by Subject|0|||
28078165|NCT00384293|54732523|FG001|Post-randomization Period|Withdrawal by Subject|8|||
28078166|NCT00384293|54732524|FG002|Post-randomization Period|Withdrawal by Subject|6|||
28078167|NCT00384293|54732522|FG000|Post-randomization Period|Trial Termination|0|||
28078168|NCT00384293|54732523|FG001|Post-randomization Period|Trial Termination|180|||
28078169|NCT00384293|54732524|FG002|Post-randomization Period|Trial Termination|204|||
28078170|NCT00384293|54732522|FG000|Post-randomization Period|Patient Randomized in Error|0|||
28078171|NCT00384293|54732523|FG001|Post-randomization Period|Patient Randomized in Error|0|||
28078172|NCT00384293|54732524|FG002|Post-randomization Period|Patient Randomized in Error|1|||
28078173|NCT00067002|54732534|FG000|Overall Study|Early Death|1|||
28078174|NCT00067002|54732535|FG001|Overall Study|Early Death|2|||
28078175|NCT00067002|54732534|FG000|Overall Study|Delayed|1|||
28078176|NCT00067002|54732535|FG001|Overall Study|Delayed|1|||
28078177|NCT00067002|54732534|FG000|Overall Study|Graft Failure|5|||
28078178|NCT00067002|54732535|FG001|Overall Study|Graft Failure|6|||
28078179|NCT00091572|54732543|FG000|Overall Study|Lost to Follow-up|1|||
28078180|NCT00091572|54732544|FG001|Overall Study|Lost to Follow-up|1|||
28078181|NCT00091572|54732543|FG000|Overall Study|Subject's Refusal unrelated to toxicity|14|||
28078182|NCT00091572|54732544|FG001|Overall Study|Subject's Refusal unrelated to toxicity|22|||
28078183|NCT00091572|54732543|FG000|Overall Study|Death not due to malignancy/toxicity|1|||
28078184|NCT00091572|54732544|FG001|Overall Study|Death not due to malignancy/toxicity|3|||
28078185|NCT00091572|54732543|FG000|Overall Study|Medical Decision unrelated toxicity/PD|10|||
28078186|NCT00091572|54732544|FG001|Overall Study|Medical Decision unrelated toxicity/PD|22|||
28078187|NCT00091572|54732543|FG000|Overall Study|Other Reason|6|||
28078188|NCT00091572|54732544|FG001|Overall Study|Other Reason|13|||
28078189|NCT00091572|54732543|FG000|Overall Study|Ongoing (still on treatment)|8|||
28078190|NCT00091572|54732544|FG001|Overall Study|Ongoing (still on treatment)|12|||
28078191|NCT00091572|54732543|FG000|Overall Study|Major Protocol Violation|2|||
28078192|NCT00091572|54732544|FG001|Overall Study|Major Protocol Violation|0|||
28078193|NCT00091572|54732543|FG000|Overall Study|Toxicity (Related AE)|53|||
28078194|NCT00091572|54732544|FG001|Overall Study|Toxicity (Related AE)|9|||
28078195|NCT00084266|54732552|FG000|Overall Study|Death|42|||
28078196|NCT00084266|54732553|FG001|Overall Study|Death|39|||
28078197|NCT00084266|54732552|FG000|Overall Study|Adverse Event|8|||
28078198|NCT00084266|54732553|FG001|Overall Study|Adverse Event|5|||
28078199|NCT00084266|54732552|FG000|Overall Study|Lack of Efficacy|2|||
28078200|NCT00084266|54732553|FG001|Overall Study|Lack of Efficacy|4|||
28078201|NCT00084266|54732552|FG000|Overall Study|Lost to Follow-up|5|||
28078202|NCT00084266|54732553|FG001|Overall Study|Lost to Follow-up|3|||
28078203|NCT00084266|54732552|FG000|Overall Study|Participant not willing to participate|3|||
28078204|NCT00084266|54732553|FG001|Overall Study|Participant not willing to participate|8|||
28078205|NCT00084266|54732552|FG000|Overall Study|Other|360|||
28078206|NCT00084266|54732553|FG001|Overall Study|Other|344|||
28078207|NCT00084266|54732552|FG000|Overall Study|Randomized not treated|21|||
28078208|NCT00084266|54732553|FG001|Overall Study|Randomized not treated|20|||
28078209|NCT00091026|54732561|FG000|Overall Study|Patient deemed non eligible-never receiv|1|||
28078210|NCT00091026|54732562|FG001|Overall Study|Patient deemed non eligible-never receiv|0|||
28078211|NCT00091026|54732561|FG000|Overall Study|Patient withdrew and never received trea|0|||
28078212|NCT00091026|54732562|FG001|Overall Study|Patient withdrew and never received trea|2|||
28078213|NCT00091026|54732561|FG000|Overall Study|Unknown-never received treatment|0|||
28078214|NCT00091026|54732562|FG001|Overall Study|Unknown-never received treatment|1|||
28078215|NCT00116558|54732571|FG000|Overall Study|Death|11|||
28078216|NCT00116558|54732572|FG001|Overall Study|Death|5|||
28078217|NCT00116558|54732573|FG002|Overall Study|Death|3|||
28078218|NCT00116558|54732571|FG000|Overall Study|Withdrawal by Subject|17|||
28078219|NCT00116558|54732572|FG001|Overall Study|Withdrawal by Subject|3|||
28078220|NCT00116558|54732573|FG002|Overall Study|Withdrawal by Subject|12|||
28078221|NCT00116558|54732571|FG000|Overall Study|disease progression|3|||
28078222|NCT00116558|54732572|FG001|Overall Study|disease progression|7|||
28078223|NCT00116558|54732573|FG002|Overall Study|disease progression|18|||
28078224|NCT00116168|54732584|FG000|Overall Study|Lost to Follow-up|6|||
28078225|NCT00116168|54732585|FG001|Overall Study|Lost to Follow-up|5|||
28078226|NCT00116168|54732586|FG002|Overall Study|Lost to Follow-up|0|||
28078227|NCT00116168|54732587|FG003|Overall Study|Lost to Follow-up|0|||
28078228|NCT00115934|54732599|FG000|Overall Study|Lost to Follow-up|1|||
28078229|NCT00115934|54732600|FG001|Overall Study|Lost to Follow-up|0|||
28078230|NCT00115934|54732599|FG000|Overall Study|Did not receive intervention|3|||
28078231|NCT00115934|54732600|FG001|Overall Study|Did not receive intervention|2|||
28078232|NCT00115778|54732606|FG000|Overall Study|Withdrawal by Subject|0|||
28078233|NCT00115778|54732607|FG001|Overall Study|Withdrawal by Subject|1|||
28078234|NCT00100178|54732616|FG000|Overall Study|Lost to Follow-up|0|||
28078235|NCT00100178|54732617|FG001|Overall Study|Lost to Follow-up|6|||
28078236|NCT00100178|54732618|FG002|Overall Study|Lost to Follow-up|5|||
28078237|NCT00100178|54732616|FG000|Overall Study|Adverse Event|2|||
28078238|NCT00100178|54732617|FG001|Overall Study|Adverse Event|2|||
28078239|NCT00100178|54732618|FG002|Overall Study|Adverse Event|1|||
28078240|NCT00100178|54732616|FG000|Overall Study|Withdrawal by Subject|1|||
28078241|NCT00100178|54732617|FG001|Overall Study|Withdrawal by Subject|1|||
28078242|NCT00100178|54732618|FG002|Overall Study|Withdrawal by Subject|1|||
28078243|NCT00100178|54732616|FG000|Overall Study|Physician Decision|6|||
28078244|NCT00100178|54732617|FG001|Overall Study|Physician Decision|1|||
28078245|NCT00100178|54732618|FG002|Overall Study|Physician Decision|3|||
28078246|NCT00099632|54732632|FG000|Overall Study|Lost to Follow-up|1|||
28162099|NCT02533570|54832402|FG000|Overall Study|Adverse Event|0|||
28162100|NCT02533570|54832403|FG001|Overall Study|Adverse Event|1|||
28162101|NCT02533570|54832404|FG002|Overall Study|Adverse Event|1|||
28162102|NCT03036839|54832415|FG000|Overall Study|Adverse Event|0|||
28162103|NCT03036839|54832416|FG001|Overall Study|Adverse Event|0|||
28162104|NCT03036839|54832417|FG002|Overall Study|Adverse Event|1|||
28162105|NCT03036839|54832415|FG000|Overall Study|Death|3|||
28162106|NCT03036839|54832416|FG001|Overall Study|Death|0|||
28162107|NCT03036839|54832417|FG002|Overall Study|Death|3|||
28162108|NCT03036839|54832415|FG000|Overall Study|Withdrew Consent|0|||
28162109|NCT03036839|54832416|FG001|Overall Study|Withdrew Consent|0|||
28162110|NCT03036839|54832417|FG002|Overall Study|Withdrew Consent|1|||
28162111|NCT01286207|54832428|FG000|Overall Study|Adverse Event|27|||
28162112|NCT01286207|54832429|FG001|Overall Study|Adverse Event|41|||
28162113|NCT01286207|54832430|FG002|Overall Study|Adverse Event|8|||
28162114|NCT01286207|54832428|FG000|Overall Study|Lost to Follow-up|49|||
28162115|NCT01286207|54832429|FG001|Overall Study|Lost to Follow-up|43|||
28162116|NCT01286207|54832430|FG002|Overall Study|Lost to Follow-up|20|||
28162117|NCT01286207|54832428|FG000|Overall Study|Withdrawal by Subject|93|||
28162118|NCT01286207|54832429|FG001|Overall Study|Withdrawal by Subject|79|||
28078247|NCT00099632|54732633|FG001|Overall Study|Lost to Follow-up|0|||
28162119|NCT01286207|54832430|FG002|Overall Study|Withdrawal by Subject|41|||
28162120|NCT01286207|54832428|FG000|Overall Study|Lack of Response|92|||
28162121|NCT01286207|54832429|FG001|Overall Study|Lack of Response|38|||
28162122|NCT01286207|54832430|FG002|Overall Study|Lack of Response|8|||
28162123|NCT01286207|54832428|FG000|Overall Study|Other|37|||
28078248|NCT00099632|54732634|FG002|Overall Study|Lost to Follow-up|3|||
28078249|NCT00099632|54732635|FG003|Overall Study|Lost to Follow-up|1|||
28078250|NCT00099632|54732636|FG004|Overall Study|Lost to Follow-up|1|||
28078251|NCT00099632|54732637|FG005|Overall Study|Lost to Follow-up|0|||
28078252|NCT00099632|54732632|FG000|Overall Study|Withdrawal by Subject|0|||
28078253|NCT00099632|54732633|FG001|Overall Study|Withdrawal by Subject|1|||
28078254|NCT00099632|54732634|FG002|Overall Study|Withdrawal by Subject|0|||
28078255|NCT00099632|54732635|FG003|Overall Study|Withdrawal by Subject|0|||
28162124|NCT01286207|54832429|FG001|Overall Study|Other|47|||
28162125|NCT01286207|54832430|FG002|Overall Study|Other|13|||
28078256|NCT00099632|54732636|FG004|Overall Study|Withdrawal by Subject|0|||
28078257|NCT00099632|54732637|FG005|Overall Study|Withdrawal by Subject|1|||
28078258|NCT00099632|54732632|FG000|Overall Study|Protocol Violation|0|||
28078259|NCT00099632|54732633|FG001|Overall Study|Protocol Violation|0|||
28078260|NCT00099632|54732634|FG002|Overall Study|Protocol Violation|0|||
28078261|NCT00099632|54732635|FG003|Overall Study|Protocol Violation|0|||
28078262|NCT00099632|54732636|FG004|Overall Study|Protocol Violation|0|||
28078263|NCT00099632|54732637|FG005|Overall Study|Protocol Violation|1|||
28078264|NCT00098774|54732651|FG000|Overall Study|Adverse Event|2|||
28078265|NCT00098774|54732651|FG000|Overall Study|Disease Progression|9|||
28078266|NCT00098774|54732651|FG000|Overall Study|Withdrawal by Subject|1|||
28078267|NCT00098774|54732651|FG000|Overall Study|Failed (to respond) during induction|4|||
28078268|NCT00098774|54732651|FG000|Overall Study|Physician Decision|2|||
28078269|NCT00384059|54732657|FG000|Infant Series|Not consented|2|||
28078270|NCT00384059|54732658|FG001|Infant Series|Not consented|6|||
28078271|NCT00384059|54732657|FG000|Infant Series|Withdrawal by Subject|2|||
28078272|NCT00384059|54732658|FG001|Infant Series|Withdrawal by Subject|2|||
28078273|NCT00384059|54732657|FG000|Infant Series|Adverse Event|1|||
28078274|NCT00384059|54732658|FG001|Infant Series|Adverse Event|2|||
28078275|NCT00384059|54732657|FG000|Infant Series|Protocol Violation|1|||
28078276|NCT00384059|54732658|FG001|Infant Series|Protocol Violation|2|||
28078277|NCT00384059|54732657|FG000|Infant Series|Lost to Follow-up|0|||
28078278|NCT00384059|54732658|FG001|Infant Series|Lost to Follow-up|1|||
28078279|NCT00384059|54732657|FG000|After Infant Series|Protocol Violation|2|||
28078280|NCT00384059|54732658|FG001|After Infant Series|Protocol Violation|3|||
28078281|NCT00384059|54732657|FG000|After Infant Series|Withdrawal by Subject|2|||
28078282|NCT00384059|54732658|FG001|After Infant Series|Withdrawal by Subject|2|||
28078283|NCT00384059|54732657|FG000|After Infant Series|Failed to Return|0|||
28078284|NCT00384059|54732658|FG001|After Infant Series|Failed to Return|2|||
28078285|NCT00384059|54732657|FG000|After Infant Series|Adverse Event|0|||
28078286|NCT00384059|54732658|FG001|After Infant Series|Adverse Event|1|||
28078287|NCT00384059|54732657|FG000|After Infant Series|Physician Decision|0|||
28078288|NCT00384059|54732658|FG001|After Infant Series|Physician Decision|1|||
28078289|NCT00384059|54732657|FG000|After Infant Series|Lost to Follow-up|0|||
28078290|NCT00384059|54732658|FG001|After Infant Series|Lost to Follow-up|1|||
28078291|NCT00384059|54732657|FG000|Toddler Dose|Lost to Follow-up|1|||
28078292|NCT00384059|54732658|FG001|Toddler Dose|Lost to Follow-up|1|||
28078293|NCT00384059|54732657|FG000|Toddler Dose|Failed to return|0|||
28078294|NCT00384059|54732658|FG001|Toddler Dose|Failed to return|1|||
28078295|NCT00383123|54732687|FG000|Overall Study|Adverse Event|1|||
27852074|NCT00081653|54354818|FG000|Overall Study|Lost to Follow-up|2|||
27852075|NCT00081653|54354819|FG001|Overall Study|Lost to Follow-up|4|||
27852076|NCT00081653|54354818|FG000|Overall Study|Refused Treatment|18|||
27852077|NCT00081653|54354819|FG001|Overall Study|Refused Treatment|14|||
27852078|NCT00081653|54354818|FG000|Overall Study|Low bone mineral density|1|||
27852079|NCT00081653|54354819|FG001|Overall Study|Low bone mineral density|0|||
27852080|NCT00081653|54354818|FG000|Overall Study|Bone loss|2|||
27852081|NCT00081653|54354819|FG001|Overall Study|Bone loss|0|||
27852082|NCT00081653|54354818|FG000|Overall Study|Participant leaving country|1|||
27852083|NCT00081653|54354819|FG001|Overall Study|Participant leaving country|0|||
27852084|NCT00081653|54354818|FG000|Overall Study|Loss of bone mass|0|||
27852085|NCT00081653|54354819|FG001|Overall Study|Loss of bone mass|2|||
27852086|NCT02596620|54354889|FG000|Overall Study|Lost to Follow-up|1|||
27852087|NCT02596620|54354890|FG001|Overall Study|Lost to Follow-up|1|||
27852088|NCT02596230|54355046|FG000|Screening Period for Objective 2|Participants not participating in obj 2|3714|||
27852089|NCT02596230|54355047|FG001|Screening Period for Objective 2|Participants not participating in obj 2|228|||
27852090|NCT02596230|54355048|FG002|Screening Period for Objective 2|Participants not participating in obj 2|0|||
27943812|NCT03332056|54600835|FG000|Overall Study|Did not require a ureteral stent|0|||
27943813|NCT03332056|54600836|FG001|Overall Study|Did not require a ureteral stent|1|||
27943814|NCT03093350|54600842|FG000|Overall Study|Death|1|||
27943815|NCT03093350|54600842|FG000|Overall Study|Signed consent, never began treartment|1|||
27943816|NCT02901041|54600848|FG000|Overall Study|Withdrawal by PI|4|||
27943817|NCT02901041|54600849|FG001|Overall Study|Withdrawal by PI|8|||
27943818|NCT02901041|54600848|FG000|Overall Study|Withdrawal by Subject|7|||
27943819|NCT02901041|54600849|FG001|Overall Study|Withdrawal by Subject|3|||
27943820|NCT02547987|54600887|FG000|Overall Study|Withdrawal by Subject|1|||
27943821|NCT02547987|54600887|FG000|Overall Study|Adverse Event|2|||
27943822|NCT02513199|54600891|FG000|Treatment|Death|1|||
27943823|NCT02513199|54600891|FG000|Treatment|Lost to Follow-up|1|||
27943824|NCT02513199|54600891|FG000|Follow-Up|Death|11|||
28078296|NCT00383123|54732688|FG001|Overall Study|Adverse Event|0|||
28078297|NCT00383123|54732687|FG000|Overall Study|Lost to Follow-up|68|||
28078298|NCT00383123|54732688|FG001|Overall Study|Lost to Follow-up|61|||
28078299|NCT00383123|54732687|FG000|Overall Study|Protocol Violation|5|||
27852091|NCT02596230|54355049|FG003|Screening Period for Objective 2|Participants not participating in obj 2|846|||
27852092|NCT02596230|54355050|FG004|Screening Period for Objective 2|Participants not participating in obj 2|0|||
28078300|NCT00383123|54732688|FG001|Overall Study|Protocol Violation|1|||
28078301|NCT00383123|54732687|FG000|Overall Study|Withdrawal by Subject|27|||
28078302|NCT00383123|54732688|FG001|Overall Study|Withdrawal by Subject|18|||
28078303|NCT00383123|54732687|FG000|Overall Study|Other reason|10|||
28078304|NCT00383123|54732688|FG001|Overall Study|Other reason|6|||
28078305|NCT00382967|54732696|FG000|Overall Study|Protocol Violation|1|||
28078306|NCT00382967|54732697|FG001|Overall Study|Protocol Violation|1|||
28078307|NCT00858364|54732705|FG000|Overall Study|Administrative Decision|3|||
28078308|NCT00858364|54732706|FG001|Overall Study|Administrative Decision|2|||
28078309|NCT00858364|54732705|FG000|Overall Study|Adverse Event|5|||
28078310|NCT00858364|54732706|FG001|Overall Study|Adverse Event|2|||
28078311|NCT00858364|54732705|FG000|Overall Study|Withdrawal by Subject|44|||
28078312|NCT00858364|54732706|FG001|Overall Study|Withdrawal by Subject|118|||
28078313|NCT00858364|54732705|FG000|Overall Study|Ineligibility Determined|1|||
28078314|NCT00858364|54732706|FG001|Overall Study|Ineligibility Determined|10|||
28078315|NCT00858364|54732705|FG000|Overall Study|Lost to Follow-up|24|||
28078316|NCT00858364|54732706|FG001|Overall Study|Lost to Follow-up|54|||
28078317|NCT00858364|54732705|FG000|Overall Study|Noncompliance|3|||
28078318|NCT00858364|54732706|FG001|Overall Study|Noncompliance|4|||
28078319|NCT00858364|54732705|FG000|Overall Study|Protocol Deviation|0|||
28078320|NCT00858364|54732706|FG001|Overall Study|Protocol Deviation|2|||
28078321|NCT00858364|54732705|FG000|Overall Study|Other|9|||
28078322|NCT00858364|54732706|FG001|Overall Study|Other|17|||
28078323|NCT00858364|54732705|FG000|Overall Study|Missing|1|||
28078324|NCT00858364|54732706|FG001|Overall Study|Missing|1|||
28078325|NCT00858364|54732705|FG000|Overall Study|Still on-study|114|||
28078326|NCT00858364|54732706|FG001|Overall Study|Still on-study|247|||
28078327|NCT00382733|54732712|FG000|Overall Study|Withdrawal by Subject|0|||
28078328|NCT00382733|54732713|FG001|Overall Study|Withdrawal by Subject|1|||
28078329|NCT00382733|54732714|FG002|Overall Study|Withdrawal by Subject|0|||
28078330|NCT00382733|54732715|FG003|Overall Study|Withdrawal by Subject|0|||
28078331|NCT00382733|54732716|FG004|Overall Study|Withdrawal by Subject|0|||
28078332|NCT03631732|54732731|FG000|Randomized Phase Up to Week 24|Lost to Follow-up|3|||
28078333|NCT03631732|54732732|FG001|Randomized Phase Up to Week 24|Lost to Follow-up|0|||
28078334|NCT03631732|54732731|FG000|Randomized Phase Up to Week 24|Withdrew Consent|1|||
28078335|NCT03631732|54732732|FG001|Randomized Phase Up to Week 24|Withdrew Consent|2|||
28078336|NCT03631732|54732731|FG000|Randomized Phase Up to Week 24|Adverse Event|2|||
28078337|NCT03631732|54732732|FG001|Randomized Phase Up to Week 24|Adverse Event|0|||
28078338|NCT03631732|54732731|FG000|Randomized Phase Up to Week 24|Randomized but not treated|1|||
28078339|NCT03631732|54732732|FG001|Randomized Phase Up to Week 24|Randomized but not treated|0|||
28078340|NCT03631732|54732731|FG000|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|6|||
28078341|NCT03631732|54732732|FG001|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|1|||
28078342|NCT03631732|54732731|FG000|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
28078343|NCT03631732|54732732|FG001|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
28078344|NCT03631732|54732731|FG000|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|4|||
28078345|NCT03631732|54732732|FG001|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|1|||
28078346|NCT03631732|54732731|FG000|B/F/TAF Treatment Phase (After Week 24)|Death|1|||
28078347|NCT03631732|54732732|FG001|B/F/TAF Treatment Phase (After Week 24)|Death|0|||
28078348|NCT03631732|54732731|FG000|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|1|||
28078349|NCT03631732|54732732|FG001|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|0|||
28078350|NCT03631732|54732731|FG000|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|1|||
28078351|NCT03631732|54732732|FG001|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|0|||
28078352|NCT03630016|54732742|FG000|Overall Study|Poor Sensor Placement|1|||
28078353|NCT03628924|54732749|FG000|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|2|||
28078354|NCT03628924|54732750|FG001|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
28162126|NCT00968201|54832467|FG000|Base Study - (Period II)|Adverse Event|8|||
28162127|NCT00968201|54832468|FG001|Base Study - (Period II)|Adverse Event|0|||
27943825|NCT02181413|54600898|FG000|Overall Study|Adverse Event|7|||
27943826|NCT02181413|54600899|FG001|Overall Study|Adverse Event|24|||
27943827|NCT02181413|54600898|FG000|Overall Study|Progressive Disease|121|||
27943828|NCT02181413|54600899|FG001|Overall Study|Progressive Disease|143|||
27943829|NCT02181413|54600898|FG000|Overall Study|Withdrawal by Subject|5|||
27943830|NCT02181413|54600899|FG001|Overall Study|Withdrawal by Subject|8|||
27943831|NCT02181413|54600898|FG000|Overall Study|Reason Not Specified|19|||
27943832|NCT02181413|54600899|FG001|Overall Study|Reason Not Specified|20|||
27943833|NCT02181413|54600898|FG000|Overall Study|Ongoing Study Treatment|0|||
27943834|NCT02181413|54600899|FG001|Overall Study|Ongoing Study Treatment|1|||
28162128|NCT00968201|54832469|FG002|Base Study - (Period II)|Adverse Event|16|||
27943835|NCT02181413|54600898|FG000|Overall Study|Lost to Follow-up|0|||
28078355|NCT03628924|54732751|FG002|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
28078356|NCT03628924|54732752|FG003|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
28078357|NCT03628924|54732753|FG004|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
27943836|NCT02181413|54600899|FG001|Overall Study|Lost to Follow-up|1|||
28078358|NCT03628924|54732754|FG005|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
28078359|NCT03628924|54732755|FG006|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
28078360|NCT03628924|54732749|FG000|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
28078361|NCT03628924|54732750|FG001|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
28078362|NCT03628924|54732751|FG002|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
28078363|NCT03628924|54732752|FG003|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
28078364|NCT03628924|54732753|FG004|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
28078365|NCT03628924|54732754|FG005|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
28078366|NCT03628924|54732755|FG006|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
28078367|NCT03628924|54732749|FG000|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
28078368|NCT03628924|54732750|FG001|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|2|||
28078369|NCT03628924|54732751|FG002|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
28078370|NCT03628924|54732752|FG003|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
28078371|NCT03628924|54732753|FG004|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
28078372|NCT03628924|54732754|FG005|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
28078373|NCT03628924|54732755|FG006|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
28078374|NCT03628924|54732749|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
28078375|NCT03628924|54732750|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
28078376|NCT03628924|54732751|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
28078377|NCT03628924|54732752|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
28078378|NCT03628924|54732753|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
28078379|NCT03628924|54732754|FG005|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
28078380|NCT03628924|54732755|FG006|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
28078381|NCT03628924|54732749|FG000|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|3|||
28078382|NCT03628924|54732750|FG001|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
28078383|NCT03628924|54732751|FG002|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|1|||
28078384|NCT03628924|54732752|FG003|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
28078385|NCT03628924|54732753|FG004|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
28078386|NCT03628924|54732754|FG005|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
28078387|NCT03628924|54732755|FG006|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
28078388|NCT03628924|54732749|FG000|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
28078389|NCT03628924|54732750|FG001|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
28078390|NCT03628924|54732751|FG002|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
28078391|NCT03628924|54732752|FG003|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
28078392|NCT03628924|54732753|FG004|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
28078393|NCT03628924|54732754|FG005|Active Treatment Period (Week 16-48)|Lost to Follow-up|2|||
28078394|NCT03628924|54732755|FG006|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
28078395|NCT03628924|54732749|FG000|Active Treatment Period (Week 16-48)|Adverse Event|0|||
28078396|NCT03628924|54732750|FG001|Active Treatment Period (Week 16-48)|Adverse Event|0|||
28078397|NCT03628924|54732751|FG002|Active Treatment Period (Week 16-48)|Adverse Event|0|||
28078398|NCT03628924|54732752|FG003|Active Treatment Period (Week 16-48)|Adverse Event|1|||
28078399|NCT03628924|54732753|FG004|Active Treatment Period (Week 16-48)|Adverse Event|0|||
28078400|NCT03628924|54732754|FG005|Active Treatment Period (Week 16-48)|Adverse Event|2|||
28078401|NCT03628924|54732755|FG006|Active Treatment Period (Week 16-48)|Adverse Event|4|||
28078402|NCT03628924|54732749|FG000|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
28078403|NCT03628924|54732750|FG001|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
28078404|NCT03628924|54732751|FG002|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
28078405|NCT03628924|54732752|FG003|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
28078406|NCT03628924|54732753|FG004|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
28078407|NCT03628924|54732754|FG005|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
28078408|NCT03628924|54732755|FG006|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
28078409|NCT03628924|54732749|FG000|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
28078410|NCT03628924|54732750|FG001|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
28078411|NCT03628924|54732751|FG002|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
28078412|NCT03628924|54732752|FG003|Active Treatment Period (Week 16-48)|Lack of Efficacy|5|||
28078413|NCT03628924|54732753|FG004|Active Treatment Period (Week 16-48)|Lack of Efficacy|1|||
28078414|NCT03628924|54732754|FG005|Active Treatment Period (Week 16-48)|Lack of Efficacy|4|||
28078415|NCT03628924|54732755|FG006|Active Treatment Period (Week 16-48)|Lack of Efficacy|2|||
28078416|NCT03628924|54732749|FG000|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
28078417|NCT03628924|54732750|FG001|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
28078418|NCT03628924|54732751|FG002|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
28078419|NCT03628924|54732752|FG003|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
28078420|NCT03628924|54732753|FG004|Active Treatment Period (Week 16-48)|Withdrawal by Subject|1|||
27943837|NCT02151981|54600907|FG000|Overall Study|Death|184|||
28078421|NCT03628924|54732754|FG005|Active Treatment Period (Week 16-48)|Withdrawal by Subject|5|||
28078422|NCT03628924|54732755|FG006|Active Treatment Period (Week 16-48)|Withdrawal by Subject|3|||
28078423|NCT03627832|54732769|FG000|Overall Study|Withdrawal by Subject|10|||
28078424|NCT03627832|54732770|FG001|Overall Study|Withdrawal by Subject|1|||
28078425|NCT00112437|54732781|FG000|Year 1 (12-Month Base Study)|Adverse Event|9|||
28078426|NCT00112437|54732782|FG001|Year 1 (12-Month Base Study)|Adverse Event|10|||
28078427|NCT00112437|54732783|FG002|Year 1 (12-Month Base Study)|Adverse Event|6|||
28078428|NCT00112437|54732784|FG003|Year 1 (12-Month Base Study)|Adverse Event|4|||
28078429|NCT00112437|54732785|FG004|Year 1 (12-Month Base Study)|Adverse Event|3|||
28078430|NCT00112437|54732786|FG005|Year 1 (12-Month Base Study)|Adverse Event|0|||
28078431|NCT00112437|54732787|FG006|Year 1 (12-Month Base Study)|Adverse Event|0|||
28078432|NCT00112437|54732788|FG007|Year 1 (12-Month Base Study)|Adverse Event|0|||
28078433|NCT00112437|54732789|FG008|Year 1 (12-Month Base Study)|Adverse Event|0|||
28078434|NCT00112437|54732790|FG009|Year 1 (12-Month Base Study)|Adverse Event|0|||
28078435|NCT00112437|54732791|FG010|Year 1 (12-Month Base Study)|Adverse Event|0|||
28078436|NCT00112437|54732792|FG011|Year 1 (12-Month Base Study)|Adverse Event|0|||
28078437|NCT00112437|54732793|FG012|Year 1 (12-Month Base Study)|Adverse Event|0|||
28078438|NCT00112437|54732794|FG013|Year 1 (12-Month Base Study)|Adverse Event|0|||
28078439|NCT00112437|54732795|FG014|Year 1 (12-Month Base Study)|Adverse Event|0|||
28078440|NCT00112437|54732796|FG015|Year 1 (12-Month Base Study)|Adverse Event|0|||
28078441|NCT00112437|54732797|FG016|Year 1 (12-Month Base Study)|Adverse Event|0|||
28078442|NCT00112437|54732798|FG017|Year 1 (12-Month Base Study)|Adverse Event|0|||
28078443|NCT00112437|54732799|FG018|Year 1 (12-Month Base Study)|Adverse Event|0|||
28078444|NCT00112437|54732800|FG019|Year 1 (12-Month Base Study)|Adverse Event|0|||
28078445|NCT00112437|54732801|FG020|Year 1 (12-Month Base Study)|Adverse Event|0|||
28078446|NCT00112437|54732802|FG021|Year 1 (12-Month Base Study)|Adverse Event|0|||
28078447|NCT00112437|54732803|FG022|Year 1 (12-Month Base Study)|Adverse Event|0|||
28078448|NCT00112437|54732804|FG023|Year 1 (12-Month Base Study)|Adverse Event|0|||
28078449|NCT00112437|54732805|FG024|Year 1 (12-Month Base Study)|Adverse Event|0|||
28162129|NCT00968201|54832467|FG000|Base Study - (Period II)|Lack of Efficacy|0|||
27852093|NCT02596230|54355046|FG000|Objective 2, One Year|Lost to Follow-up|0|||
27852094|NCT02596230|54355047|FG001|Objective 2, One Year|Lost to Follow-up|41|||
27852095|NCT02596230|54355048|FG002|Objective 2, One Year|Lost to Follow-up|41|||
27852096|NCT02596230|54355049|FG003|Objective 2, One Year|Lost to Follow-up|32|||
27852097|NCT02596230|54355050|FG004|Objective 2, One Year|Lost to Follow-up|46|||
27852098|NCT02596230|54355046|FG000|Objective 2, One Year|Withdrawal by Subject|0|||
27852099|NCT02596230|54355047|FG001|Objective 2, One Year|Withdrawal by Subject|11|||
27852100|NCT02596230|54355048|FG002|Objective 2, One Year|Withdrawal by Subject|14|||
27852101|NCT02596230|54355049|FG003|Objective 2, One Year|Withdrawal by Subject|5|||
27852102|NCT02596230|54355050|FG004|Objective 2, One Year|Withdrawal by Subject|2|||
27852103|NCT02596230|54355046|FG000|Objective 2, One Year|Adverse drug reaction|0|||
27852104|NCT02596230|54355047|FG001|Objective 2, One Year|Adverse drug reaction|1|||
27852105|NCT02596230|54355048|FG002|Objective 2, One Year|Adverse drug reaction|0|||
27852106|NCT02596230|54355049|FG003|Objective 2, One Year|Adverse drug reaction|0|||
27852107|NCT02596230|54355050|FG004|Objective 2, One Year|Adverse drug reaction|0|||
27852108|NCT02596230|54355046|FG000|Objective 2, One Year|Death|0|||
27852109|NCT02596230|54355047|FG001|Objective 2, One Year|Death|12|||
27852110|NCT02596230|54355048|FG002|Objective 2, One Year|Death|41|||
27852111|NCT02596230|54355049|FG003|Objective 2, One Year|Death|21|||
27852112|NCT02596230|54355050|FG004|Objective 2, One Year|Death|30|||
27852113|NCT02596230|54355046|FG000|Objective 2, One Year|Other|0|||
27852114|NCT02596230|54355047|FG001|Objective 2, One Year|Other|3|||
27852115|NCT02596230|54355048|FG002|Objective 2, One Year|Other|2|||
27852116|NCT02596230|54355049|FG003|Objective 2, One Year|Other|0|||
27852117|NCT02596230|54355050|FG004|Objective 2, One Year|Other|0|||
27852118|NCT01667562|54355099|FG000|Diagnostic Phase|Started Erlotinib in Treatment Period|30|||
27852119|NCT01667562|54355100|FG001|Diagnostic Phase|Started Erlotinib in Treatment Period|0|||
27852120|NCT01667562|54355099|FG000|Erlotinib Phase|Lost to Follow-up|0|||
27852121|NCT01667562|54355100|FG001|Erlotinib Phase|Lost to Follow-up|1|||
27852122|NCT01667562|54355099|FG000|Erlotinib Phase|Adverse Event|0|||
28162130|NCT00968201|54832468|FG001|Base Study - (Period II)|Lack of Efficacy|0|||
28162131|NCT00968201|54832469|FG002|Base Study - (Period II)|Lack of Efficacy|1|||
27852123|NCT01667562|54355100|FG001|Erlotinib Phase|Adverse Event|1|||
27852124|NCT01667562|54355099|FG000|Erlotinib Phase|Switch to Commercial Drug|0|||
27852125|NCT01667562|54355100|FG001|Erlotinib Phase|Switch to Commercial Drug|1|||
28078450|NCT00112437|54732806|FG025|Year 1 (12-Month Base Study)|Adverse Event|0|||
28078451|NCT00112437|54732781|FG000|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
28078452|NCT00112437|54732782|FG001|Year 1 (12-Month Base Study)|Lack of Efficacy|1|||
27852126|NCT02595528|54355137|FG000|Overall Study|Withdrawal by Subject|1|||
27852127|NCT02595528|54355138|FG001|Overall Study|Withdrawal by Subject|2|||
27852128|NCT02595528|54355139|FG002|Overall Study|Withdrawal by Subject|1|||
27852129|NCT02595528|54355140|FG003|Overall Study|Withdrawal by Subject|3|||
28078453|NCT00112437|54732783|FG002|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
28078454|NCT00112437|54732784|FG003|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
28078455|NCT00112437|54732785|FG004|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
28078456|NCT00112437|54732786|FG005|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
28078457|NCT00112437|54732787|FG006|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
28078458|NCT00112437|54732788|FG007|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
28078459|NCT00112437|54732789|FG008|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
28078460|NCT00112437|54732790|FG009|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
28078461|NCT00112437|54732791|FG010|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
28078462|NCT00112437|54732792|FG011|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
28078463|NCT00112437|54732793|FG012|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
28078464|NCT00112437|54732794|FG013|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
28078465|NCT00112437|54732795|FG014|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
28078466|NCT00112437|54732796|FG015|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
28078467|NCT00112437|54732797|FG016|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
28078468|NCT00112437|54732798|FG017|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
28078469|NCT00112437|54732799|FG018|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
28078470|NCT00112437|54732800|FG019|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
28078471|NCT00112437|54732801|FG020|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
28078472|NCT00112437|54732802|FG021|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
28078473|NCT00112437|54732803|FG022|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
28078474|NCT00112437|54732804|FG023|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
28078475|NCT00112437|54732805|FG024|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
28078476|NCT00112437|54732806|FG025|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
28078477|NCT00112437|54732781|FG000|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
28078478|NCT00112437|54732782|FG001|Year 1 (12-Month Base Study)|Lost to Follow-up|1|||
28078479|NCT00112437|54732783|FG002|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
28078480|NCT00112437|54732784|FG003|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
28078481|NCT00112437|54732785|FG004|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
28078482|NCT00112437|54732786|FG005|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
28078483|NCT00112437|54732787|FG006|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
28078484|NCT00112437|54732788|FG007|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
28078485|NCT00112437|54732789|FG008|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
28078486|NCT00112437|54732790|FG009|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
28078487|NCT00112437|54732791|FG010|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
28078488|NCT00112437|54732792|FG011|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
28078489|NCT00112437|54732793|FG012|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
28078490|NCT00112437|54732794|FG013|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
28078491|NCT00112437|54732795|FG014|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
28078492|NCT00112437|54732796|FG015|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
28078493|NCT00112437|54732797|FG016|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
28078494|NCT00112437|54732798|FG017|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
28078495|NCT00112437|54732799|FG018|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
28078496|NCT00112437|54732800|FG019|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
28078497|NCT00112437|54732801|FG020|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
28078498|NCT00112437|54732802|FG021|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
28078499|NCT00112437|54732803|FG022|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
28078500|NCT00112437|54732804|FG023|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
28078501|NCT00112437|54732805|FG024|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
27852130|NCT02595528|54355137|FG000|Overall Study|Lost to Follow-up|1|||
27852131|NCT02595528|54355138|FG001|Overall Study|Lost to Follow-up|1|||
27852132|NCT02595528|54355139|FG002|Overall Study|Lost to Follow-up|0|||
27852133|NCT02595528|54355140|FG003|Overall Study|Lost to Follow-up|1|||
27852134|NCT02595450|54355168|FG000|Overall Study|Unspecified (only completed 1 cycle)|73|||
27852135|NCT02595450|54355168|FG000|Overall Study|Enrolled, but not treated|8|||
27852136|NCT02592018|54355172|FG000|Overall Study|Adverse Event|1|||
27852137|NCT02592018|54355172|FG000|Overall Study|Lost to Follow-up|1|||
27852138|NCT02591238|54355180|FG000|Overall Study|Pregnancy|1|||
27852139|NCT02591238|54355181|FG001|Overall Study|Pregnancy|0|||
27852140|NCT02591238|54355182|FG002|Overall Study|Pregnancy|0|||
27852141|NCT02591238|54355183|FG003|Overall Study|Pregnancy|0|||
27852142|NCT02591238|54355180|FG000|Overall Study|Withdrawal by Subject|0|||
28078502|NCT00112437|54732806|FG025|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
28078503|NCT00112437|54732781|FG000|Year 1 (12-Month Base Study)|Protocol Violation|1|||
28078504|NCT00112437|54732782|FG001|Year 1 (12-Month Base Study)|Protocol Violation|0|||
28078505|NCT00112437|54732783|FG002|Year 1 (12-Month Base Study)|Protocol Violation|3|||
28078506|NCT00112437|54732784|FG003|Year 1 (12-Month Base Study)|Protocol Violation|1|||
28078507|NCT00112437|54732785|FG004|Year 1 (12-Month Base Study)|Protocol Violation|1|||
28078508|NCT00112437|54732786|FG005|Year 1 (12-Month Base Study)|Protocol Violation|0|||
27852143|NCT02591238|54355181|FG001|Overall Study|Withdrawal by Subject|0|||
27852144|NCT02591238|54355182|FG002|Overall Study|Withdrawal by Subject|0|||
27852145|NCT02591238|54355183|FG003|Overall Study|Withdrawal by Subject|1|||
28078509|NCT00112437|54732787|FG006|Year 1 (12-Month Base Study)|Protocol Violation|0|||
28078510|NCT00112437|54732788|FG007|Year 1 (12-Month Base Study)|Protocol Violation|0|||
28078511|NCT00112437|54732789|FG008|Year 1 (12-Month Base Study)|Protocol Violation|0|||
28078512|NCT00112437|54732790|FG009|Year 1 (12-Month Base Study)|Protocol Violation|0|||
28078513|NCT00112437|54732791|FG010|Year 1 (12-Month Base Study)|Protocol Violation|0|||
28078514|NCT00112437|54732792|FG011|Year 1 (12-Month Base Study)|Protocol Violation|0|||
28078515|NCT00112437|54732793|FG012|Year 1 (12-Month Base Study)|Protocol Violation|0|||
28078516|NCT00112437|54732794|FG013|Year 1 (12-Month Base Study)|Protocol Violation|0|||
28078517|NCT00112437|54732795|FG014|Year 1 (12-Month Base Study)|Protocol Violation|0|||
28078518|NCT00112437|54732796|FG015|Year 1 (12-Month Base Study)|Protocol Violation|0|||
28078519|NCT00112437|54732797|FG016|Year 1 (12-Month Base Study)|Protocol Violation|0|||
28078520|NCT00112437|54732798|FG017|Year 1 (12-Month Base Study)|Protocol Violation|0|||
28078521|NCT00112437|54732799|FG018|Year 1 (12-Month Base Study)|Protocol Violation|0|||
28078522|NCT00112437|54732800|FG019|Year 1 (12-Month Base Study)|Protocol Violation|0|||
28078523|NCT00112437|54732801|FG020|Year 1 (12-Month Base Study)|Protocol Violation|0|||
28078524|NCT00112437|54732802|FG021|Year 1 (12-Month Base Study)|Protocol Violation|0|||
28078525|NCT00112437|54732803|FG022|Year 1 (12-Month Base Study)|Protocol Violation|0|||
28078526|NCT00112437|54732804|FG023|Year 1 (12-Month Base Study)|Protocol Violation|0|||
28078527|NCT00112437|54732805|FG024|Year 1 (12-Month Base Study)|Protocol Violation|0|||
28078528|NCT00112437|54732806|FG025|Year 1 (12-Month Base Study)|Protocol Violation|0|||
28078529|NCT00112437|54732781|FG000|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
28078530|NCT00112437|54732782|FG001|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
28078531|NCT00112437|54732783|FG002|Year 1 (12-Month Base Study)|Withdrawal by Subject|2|||
28078532|NCT00112437|54732784|FG003|Year 1 (12-Month Base Study)|Withdrawal by Subject|1|||
28078533|NCT00112437|54732785|FG004|Year 1 (12-Month Base Study)|Withdrawal by Subject|7|||
28078534|NCT00112437|54732786|FG005|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
28078535|NCT00112437|54732787|FG006|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
28078536|NCT00112437|54732788|FG007|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
28078537|NCT00112437|54732789|FG008|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
28078538|NCT00112437|54732790|FG009|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
28078539|NCT00112437|54732791|FG010|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
28078540|NCT00112437|54732792|FG011|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
28162132|NCT00968201|54832467|FG000|Base Study - (Period II)|Lost to Follow-up|2|||
28162133|NCT00968201|54832468|FG001|Base Study - (Period II)|Lost to Follow-up|0|||
28162134|NCT00968201|54832469|FG002|Base Study - (Period II)|Lost to Follow-up|7|||
28162135|NCT00968201|54832467|FG000|Base Study - (Period II)|Protocol Violation|12|||
28162136|NCT00968201|54832468|FG001|Base Study - (Period II)|Protocol Violation|0|||
28162137|NCT00968201|54832469|FG002|Base Study - (Period II)|Protocol Violation|12|||
28162138|NCT00968201|54832467|FG000|Base Study - (Period II)|Withdrawal by Subject|4|||
28162139|NCT00968201|54832468|FG001|Base Study - (Period II)|Withdrawal by Subject|0|||
28162140|NCT00968201|54832469|FG002|Base Study - (Period II)|Withdrawal by Subject|8|||
28162141|NCT00968201|54832467|FG000|Base Study - (Period II)|Site Error|0|||
28162142|NCT00968201|54832468|FG001|Base Study - (Period II)|Site Error|0|||
28162143|NCT00968201|54832469|FG002|Base Study - (Period II)|Site Error|1|||
28162144|NCT00968201|54832467|FG000|Extension Study - (Period III)|Adverse Event|0|||
28162145|NCT00968201|54832468|FG001|Extension Study - (Period III)|Adverse Event|5|||
28162146|NCT00968201|54832469|FG002|Extension Study - (Period III)|Adverse Event|22|||
28162147|NCT00968201|54832467|FG000|Extension Study - (Period III)|Lost to Follow-up|0|||
28162148|NCT00968201|54832468|FG001|Extension Study - (Period III)|Lost to Follow-up|7|||
28162149|NCT00968201|54832469|FG002|Extension Study - (Period III)|Lost to Follow-up|13|||
28162150|NCT00968201|54832467|FG000|Extension Study - (Period III)|Protocol Violation|0|||
28162151|NCT00968201|54832468|FG001|Extension Study - (Period III)|Protocol Violation|17|||
28162152|NCT00968201|54832469|FG002|Extension Study - (Period III)|Protocol Violation|14|||
28162153|NCT00968201|54832467|FG000|Extension Study - (Period III)|Withdrawal by Subject|0|||
28162154|NCT00968201|54832468|FG001|Extension Study - (Period III)|Withdrawal by Subject|20|||
28162155|NCT00968201|54832469|FG002|Extension Study - (Period III)|Withdrawal by Subject|40|||
28162156|NCT00968201|54832467|FG000|Extension Study - (Period III)|Patient Relocated|0|||
28162157|NCT00968201|54832468|FG001|Extension Study - (Period III)|Patient Relocated|1|||
28162158|NCT00968201|54832469|FG002|Extension Study - (Period III)|Patient Relocated|1|||
28162159|NCT00968201|54832467|FG000|Extension Study - (Period III)|Noncompliance|0|||
27831352|NCT00708162|54308240|FG001|Open-Label Phase|Withdrew Consent|6|||
27831353|NCT00708162|54308239|FG000|Open-Label Phase|Participant Noncompliance|7|||
27831354|NCT00708162|54308240|FG001|Open-Label Phase|Participant Noncompliance|7|||
27831355|NCT00708162|54308239|FG000|Open-Label Phase|Lack of Efficacy|7|||
27831356|NCT00708162|54308240|FG001|Open-Label Phase|Lack of Efficacy|4|||
27831357|NCT00708162|54308239|FG000|Open-Label Phase|Investigator's Discretion|3|||
27831358|NCT00708162|54308240|FG001|Open-Label Phase|Investigator's Discretion|2|||
27831359|NCT00708162|54308239|FG000|Open-Label Phase|Death|3|||
27831360|NCT00708162|54308240|FG001|Open-Label Phase|Death|1|||
28162160|NCT00968201|54832468|FG001|Extension Study - (Period III)|Noncompliance|0|||
28162161|NCT00968201|54832469|FG002|Extension Study - (Period III)|Noncompliance|3|||
28162162|NCT00968201|54832467|FG000|Extension Study - (Period III)|Other|0|||
28162163|NCT00968201|54832468|FG001|Extension Study - (Period III)|Other|0|||
28162164|NCT00968201|54832469|FG002|Extension Study - (Period III)|Other|2|||
28162165|NCT00968201|54832467|FG000|Extension Study - (Period III)|Study Terminated for Admin Reasons|0|||
28162166|NCT00968201|54832468|FG001|Extension Study - (Period III)|Study Terminated for Admin Reasons|74|||
28162167|NCT00968201|54832469|FG002|Extension Study - (Period III)|Study Terminated for Admin Reasons|185|||
28162168|NCT00943397|54832480|FG000|Overall Study|Adverse Event|0|||
28162169|NCT00943397|54832481|FG001|Overall Study|Adverse Event|6|||
28162170|NCT00943397|54832480|FG000|Overall Study|Lost to Follow-up|0|||
28162171|NCT00943397|54832481|FG001|Overall Study|Lost to Follow-up|4|||
28162172|NCT00943397|54832480|FG000|Overall Study|Protocol Violation|2|||
28162173|NCT00943397|54832481|FG001|Overall Study|Protocol Violation|5|||
28162174|NCT00943397|54832480|FG000|Overall Study|Withdrawal by Subject|1|||
28162175|NCT00943397|54832481|FG001|Overall Study|Withdrawal by Subject|1|||
28162176|NCT00943397|54832480|FG000|Overall Study|Site terminated and other|12|||
28162177|NCT00943397|54832481|FG001|Overall Study|Site terminated and other|56|||
28162178|NCT00702845|54832489|FG000|Overall Study|No/too few/bad quality oocytes retrieved|2|||
28162179|NCT00702845|54832490|FG001|Overall Study|No/too few/bad quality oocytes retrieved|2|||
28162180|NCT00702845|54832489|FG000|Overall Study|Too high ovarian response|5|||
28162181|NCT00702845|54832490|FG001|Overall Study|Too high ovarian response|1|||
28162182|NCT00702845|54832489|FG000|Overall Study|Risk of ovarian hyperstimulation synd.|1|||
28162183|NCT00702845|54832490|FG001|Overall Study|Risk of ovarian hyperstimulation synd.|0|||
28162184|NCT00702845|54832489|FG000|Overall Study|Insufficient ovarian response|1|||
28162185|NCT00702845|54832490|FG001|Overall Study|Insufficient ovarian response|0|||
28162186|NCT00702845|54832489|FG000|Overall Study|No/too few/bad quality embryos retrieved|7|||
28162187|NCT00702845|54832490|FG001|Overall Study|No/too few/bad quality embryos retrieved|1|||
28162188|NCT00702845|54832489|FG000|Overall Study|No or abnormal fertilization|4|||
28162189|NCT00702845|54832490|FG001|Overall Study|No or abnormal fertilization|2|||
28162190|NCT00702845|54832489|FG000|Overall Study|Patient's decision|2|||
28162191|NCT00702845|54832490|FG001|Overall Study|Patient's decision|1|||
28162192|NCT00702845|54832489|FG000|Overall Study|Not randomized|0|||
28162193|NCT00702845|54832490|FG001|Overall Study|Not randomized|1|||
28162194|NCT01302847|54832504|FG000|Overall Study|Ongoing|0|||
28162195|NCT01302847|54832505|FG001|Overall Study|Ongoing|0|||
28162196|NCT01302847|54832506|FG002|Overall Study|Ongoing|0|||
28162197|NCT01302847|54832507|FG003|Overall Study|Ongoing|0|||
28162198|NCT01302847|54832508|FG004|Overall Study|Ongoing|0|||
28162199|NCT01302847|54832509|FG005|Overall Study|Ongoing|27|||
28162200|NCT01302847|54832510|FG006|Overall Study|Ongoing|22|||
28162201|NCT01302847|54832511|FG007|Overall Study|Ongoing|17|||
28162202|NCT01302847|54832504|FG000|Overall Study|Death|0|||
28162203|NCT01302847|54832505|FG001|Overall Study|Death|1|||
27831361|NCT00708162|54308239|FG000|Open-Label Phase|Adverse Event|1|||
27831362|NCT00708162|54308240|FG001|Open-Label Phase|Adverse Event|2|||
27831363|NCT00708162|54308239|FG000|Open-Label Phase|Other|1|||
27852146|NCT02591238|54355180|FG000|Overall Study|influenza|0|||
27852147|NCT02591238|54355181|FG001|Overall Study|influenza|0|||
27831364|NCT00708162|54308240|FG001|Open-Label Phase|Other|0|||
27831365|NCT02245672|54308325|FG000|Overall Study|Adverse Event|4|||
27831366|NCT02245672|54308326|FG001|Overall Study|Adverse Event|4|||
28162204|NCT01302847|54832506|FG002|Overall Study|Death|0|||
28162205|NCT01302847|54832507|FG003|Overall Study|Death|0|||
28162206|NCT01302847|54832508|FG004|Overall Study|Death|0|||
28162207|NCT01302847|54832509|FG005|Overall Study|Death|1|||
28162208|NCT01302847|54832510|FG006|Overall Study|Death|1|||
28162209|NCT01302847|54832511|FG007|Overall Study|Death|0|||
28162210|NCT01302847|54832504|FG000|Overall Study|Pregnancy|2|||
28162211|NCT01302847|54832505|FG001|Overall Study|Pregnancy|0|||
27831367|NCT02245672|54308327|FG002|Overall Study|Adverse Event|4|||
27831368|NCT02245672|54308325|FG000|Overall Study|Lost to Follow-up|3|||
27831369|NCT02245672|54308326|FG001|Overall Study|Lost to Follow-up|5|||
27831370|NCT02245672|54308327|FG002|Overall Study|Lost to Follow-up|1|||
27831371|NCT02245672|54308325|FG000|Overall Study|Withdrawal by Subject|6|||
28162212|NCT01302847|54832506|FG002|Overall Study|Pregnancy|0|||
28162213|NCT01302847|54832507|FG003|Overall Study|Pregnancy|0|||
28162214|NCT01302847|54832508|FG004|Overall Study|Pregnancy|0|||
28162215|NCT01302847|54832509|FG005|Overall Study|Pregnancy|0|||
28162216|NCT01302847|54832510|FG006|Overall Study|Pregnancy|0|||
28162217|NCT01302847|54832511|FG007|Overall Study|Pregnancy|0|||
28162218|NCT01302847|54832504|FG000|Overall Study|Virologic failure|0|||
28162219|NCT01302847|54832505|FG001|Overall Study|Virologic failure|2|||
28162220|NCT01302847|54832506|FG002|Overall Study|Virologic failure|2|||
28162221|NCT01302847|54832507|FG003|Overall Study|Virologic failure|0|||
28162222|NCT01302847|54832508|FG004|Overall Study|Virologic failure|1|||
28162223|NCT01302847|54832509|FG005|Overall Study|Virologic failure|1|||
28162224|NCT01302847|54832510|FG006|Overall Study|Virologic failure|0|||
28162225|NCT01302847|54832511|FG007|Overall Study|Virologic failure|2|||
28162226|NCT01302847|54832504|FG000|Overall Study|Severe debilitation, unable to continue|0|||
28162227|NCT01302847|54832505|FG001|Overall Study|Severe debilitation, unable to continue|0|||
28162228|NCT01302847|54832506|FG002|Overall Study|Severe debilitation, unable to continue|0|||
28162229|NCT01302847|54832507|FG003|Overall Study|Severe debilitation, unable to continue|0|||
28162230|NCT01302847|54832508|FG004|Overall Study|Severe debilitation, unable to continue|0|||
28162231|NCT01302847|54832509|FG005|Overall Study|Severe debilitation, unable to continue|1|||
28162232|NCT01302847|54832510|FG006|Overall Study|Severe debilitation, unable to continue|1|||
28162233|NCT01302847|54832511|FG007|Overall Study|Severe debilitation, unable to continue|0|||
28162234|NCT01302847|54832504|FG000|Overall Study|Not able to get to clinic|1|||
28162235|NCT01302847|54832505|FG001|Overall Study|Not able to get to clinic|1|||
28162236|NCT01302847|54832506|FG002|Overall Study|Not able to get to clinic|0|||
28162237|NCT01302847|54832507|FG003|Overall Study|Not able to get to clinic|0|||
28162238|NCT01302847|54832508|FG004|Overall Study|Not able to get to clinic|0|||
27852148|NCT02591238|54355182|FG002|Overall Study|influenza|0|||
27852149|NCT02591238|54355183|FG003|Overall Study|influenza|1|||
27943838|NCT02151981|54600908|FG001|Overall Study|Death|88|||
28162239|NCT01302847|54832509|FG005|Overall Study|Not able to get to clinic|0|||
28162240|NCT01302847|54832510|FG006|Overall Study|Not able to get to clinic|0|||
28162241|NCT01302847|54832511|FG007|Overall Study|Not able to get to clinic|0|||
28162242|NCT01302847|54832504|FG000|Overall Study|Site closing|2|||
28162243|NCT01302847|54832505|FG001|Overall Study|Site closing|2|||
28162244|NCT01302847|54832506|FG002|Overall Study|Site closing|0|||
28162245|NCT01302847|54832507|FG003|Overall Study|Site closing|0|||
28162246|NCT01302847|54832508|FG004|Overall Study|Site closing|0|||
28162247|NCT01302847|54832509|FG005|Overall Study|Site closing|0|||
28162248|NCT01302847|54832510|FG006|Overall Study|Site closing|0|||
28162249|NCT01302847|54832511|FG007|Overall Study|Site closing|0|||
28162250|NCT01302847|54832504|FG000|Overall Study|Withdrawal by Subject|1|||
28162251|NCT01302847|54832505|FG001|Overall Study|Withdrawal by Subject|0|||
28162252|NCT01302847|54832506|FG002|Overall Study|Withdrawal by Subject|0|||
28162253|NCT01302847|54832507|FG003|Overall Study|Withdrawal by Subject|0|||
28162254|NCT01302847|54832508|FG004|Overall Study|Withdrawal by Subject|1|||
28162255|NCT01302847|54832509|FG005|Overall Study|Withdrawal by Subject|0|||
28162256|NCT01302847|54832510|FG006|Overall Study|Withdrawal by Subject|0|||
28162257|NCT01302847|54832511|FG007|Overall Study|Withdrawal by Subject|1|||
28162258|NCT01302847|54832504|FG000|Overall Study|Not willing to adhere to requirements|5|||
28162259|NCT01302847|54832505|FG001|Overall Study|Not willing to adhere to requirements|0|||
28162260|NCT01302847|54832506|FG002|Overall Study|Not willing to adhere to requirements|0|||
28162261|NCT01302847|54832507|FG003|Overall Study|Not willing to adhere to requirements|1|||
28162262|NCT01302847|54832508|FG004|Overall Study|Not willing to adhere to requirements|0|||
28162263|NCT01302847|54832509|FG005|Overall Study|Not willing to adhere to requirements|0|||
28162264|NCT01302847|54832510|FG006|Overall Study|Not willing to adhere to requirements|0|||
28162265|NCT01302847|54832511|FG007|Overall Study|Not willing to adhere to requirements|2|||
28162266|NCT01302847|54832504|FG000|Overall Study|Site unable to contact participant|2|||
28162267|NCT01302847|54832505|FG001|Overall Study|Site unable to contact participant|1|||
28162268|NCT01302847|54832506|FG002|Overall Study|Site unable to contact participant|0|||
28162269|NCT01302847|54832507|FG003|Overall Study|Site unable to contact participant|0|||
28162270|NCT01302847|54832508|FG004|Overall Study|Site unable to contact participant|0|||
28162271|NCT01302847|54832509|FG005|Overall Study|Site unable to contact participant|0|||
28162272|NCT01302847|54832510|FG006|Overall Study|Site unable to contact participant|2|||
28162273|NCT01302847|54832511|FG007|Overall Study|Site unable to contact participant|0|||
28162274|NCT03039569|54832540|FG000|Overall Study|Lost to Follow-up|5|||
28162275|NCT03039569|54832541|FG001|Overall Study|Lost to Follow-up|4|||
28162276|NCT01272037|54832550|FG000|Overall Study|Death|30|||
28162277|NCT01272037|54832551|FG001|Overall Study|Death|30|||
28162278|NCT01272037|54832550|FG000|Overall Study|Adverse Event|12|||
28162279|NCT01272037|54832551|FG001|Overall Study|Adverse Event|7|||
28162280|NCT01272037|54832550|FG000|Overall Study|Withdrawal by Subject|158|||
28162281|NCT01272037|54832551|FG001|Overall Study|Withdrawal by Subject|83|||
28162282|NCT01272037|54832550|FG000|Overall Study|Disease progression|85|||
28162283|NCT01272037|54832551|FG001|Overall Study|Disease progression|125|||
28162284|NCT01272037|54832550|FG000|Overall Study|Other reason|49|||
28162285|NCT01272037|54832551|FG001|Overall Study|Other reason|45|||
28162286|NCT01272037|54832550|FG000|Overall Study|Delinquent data|6|||
28162287|NCT01272037|54832551|FG001|Overall Study|Delinquent data|4|||
28162288|NCT01272037|54832550|FG000|Overall Study|Reason under review|107|||
28162289|NCT01272037|54832551|FG001|Overall Study|Reason under review|136|||
28162290|NCT01272037|54832550|FG000|Overall Study|On treatment|173|||
27943839|NCT02151981|54600907|FG000|Overall Study|Lost to Follow-up|7|||
27943840|NCT02151981|54600908|FG001|Overall Study|Lost to Follow-up|1|||
28162291|NCT01272037|54832551|FG001|Overall Study|On treatment|185|||
28162292|NCT02738775|54832563|FG000|Overall Study|Withdrawal by Subject|0|||
28162293|NCT02738775|54832564|FG001|Overall Study|Withdrawal by Subject|1|||
28162294|NCT02738775|54832565|FG002|Overall Study|Withdrawal by Subject|0|||
28162295|NCT02738775|54832566|FG003|Overall Study|Withdrawal by Subject|0|||
28162296|NCT02738775|54832567|FG004|Overall Study|Withdrawal by Subject|0|||
28162297|NCT02738775|54832568|FG005|Overall Study|Withdrawal by Subject|0|||
28162298|NCT02738775|54832563|FG000|Overall Study|Adverse Event|0|||
28162299|NCT02738775|54832564|FG001|Overall Study|Adverse Event|0|||
28162300|NCT02738775|54832565|FG002|Overall Study|Adverse Event|0|||
28162301|NCT02738775|54832566|FG003|Overall Study|Adverse Event|1|||
28162302|NCT02738775|54832567|FG004|Overall Study|Adverse Event|0|||
28162303|NCT02738775|54832568|FG005|Overall Study|Adverse Event|0|||
28162304|NCT02738775|54832563|FG000|Overall Study|Pregnancy|0|||
28162305|NCT02738775|54832564|FG001|Overall Study|Pregnancy|1|||
28162306|NCT02738775|54832565|FG002|Overall Study|Pregnancy|0|||
27943841|NCT02151981|54600907|FG000|Overall Study|Withdrawal by Subject|27|||
28162307|NCT02738775|54832566|FG003|Overall Study|Pregnancy|0|||
28162308|NCT02738775|54832567|FG004|Overall Study|Pregnancy|0|||
28162309|NCT02738775|54832568|FG005|Overall Study|Pregnancy|0|||
28162310|NCT02738775|54832563|FG000|Overall Study|Missing|0|||
28162311|NCT02738775|54832564|FG001|Overall Study|Missing|0|||
28162312|NCT02738775|54832565|FG002|Overall Study|Missing|0|||
28162313|NCT02738775|54832566|FG003|Overall Study|Missing|0|||
28162314|NCT02738775|54832567|FG004|Overall Study|Missing|0|||
28162315|NCT02738775|54832568|FG005|Overall Study|Missing|1|||
28162316|NCT02314923|54832605|FG000|Overall Study|Death|0|||
28162317|NCT02314923|54832606|FG001|Overall Study|Death|0|||
28162318|NCT02314923|54832607|FG002|Overall Study|Death|0|||
28162319|NCT02314923|54832608|FG003|Overall Study|Death|1|||
28162320|NCT02314923|54832609|FG004|Overall Study|Death|0|||
28162321|NCT02314923|54832610|FG005|Overall Study|Death|0|||
28162322|NCT02314923|54832611|FG006|Overall Study|Death|0|||
28162323|NCT02314923|54832612|FG007|Overall Study|Death|0|||
28162324|NCT02314923|54832613|FG008|Overall Study|Death|0|||
28162325|NCT02314923|54832614|FG009|Overall Study|Death|0|||
28162326|NCT02314923|54832605|FG000|Overall Study|Lost to Follow-up|2|||
28162327|NCT02314923|54832606|FG001|Overall Study|Lost to Follow-up|3|||
28162328|NCT02314923|54832607|FG002|Overall Study|Lost to Follow-up|1|||
28162329|NCT02314923|54832608|FG003|Overall Study|Lost to Follow-up|0|||
28162330|NCT02314923|54832609|FG004|Overall Study|Lost to Follow-up|0|||
28162331|NCT02314923|54832610|FG005|Overall Study|Lost to Follow-up|0|||
28162332|NCT02314923|54832611|FG006|Overall Study|Lost to Follow-up|3|||
28162333|NCT02314923|54832612|FG007|Overall Study|Lost to Follow-up|4|||
28162334|NCT02314923|54832613|FG008|Overall Study|Lost to Follow-up|2|||
28162335|NCT02314923|54832614|FG009|Overall Study|Lost to Follow-up|0|||
28162336|NCT02314923|54832605|FG000|Overall Study|Withdrawal by Subject|0|||
28162337|NCT02314923|54832606|FG001|Overall Study|Withdrawal by Subject|0|||
28162338|NCT02314923|54832607|FG002|Overall Study|Withdrawal by Subject|1|||
28162339|NCT02314923|54832608|FG003|Overall Study|Withdrawal by Subject|0|||
28162340|NCT02314923|54832609|FG004|Overall Study|Withdrawal by Subject|1|||
28162341|NCT02314923|54832610|FG005|Overall Study|Withdrawal by Subject|0|||
28162342|NCT02314923|54832611|FG006|Overall Study|Withdrawal by Subject|1|||
28162343|NCT02314923|54832612|FG007|Overall Study|Withdrawal by Subject|0|||
28162344|NCT02314923|54832613|FG008|Overall Study|Withdrawal by Subject|0|||
28162345|NCT02314923|54832614|FG009|Overall Study|Withdrawal by Subject|0|||
28162346|NCT02314923|54832605|FG000|Overall Study|Physician Decision|0|||
28162347|NCT02314923|54832606|FG001|Overall Study|Physician Decision|1|||
28162348|NCT02314923|54832607|FG002|Overall Study|Physician Decision|0|||
28162349|NCT02314923|54832608|FG003|Overall Study|Physician Decision|0|||
28162350|NCT02314923|54832609|FG004|Overall Study|Physician Decision|0|||
28162351|NCT02314923|54832610|FG005|Overall Study|Physician Decision|0|||
28162352|NCT02314923|54832611|FG006|Overall Study|Physician Decision|0|||
28162353|NCT02314923|54832612|FG007|Overall Study|Physician Decision|0|||
28162354|NCT02314923|54832613|FG008|Overall Study|Physician Decision|0|||
28162355|NCT02314923|54832614|FG009|Overall Study|Physician Decision|0|||
28162356|NCT02314923|54832605|FG000|Overall Study|Participant unavailable|0|||
28162357|NCT02314923|54832606|FG001|Overall Study|Participant unavailable|0|||
28162358|NCT02314923|54832607|FG002|Overall Study|Participant unavailable|0|||
28162359|NCT02314923|54832608|FG003|Overall Study|Participant unavailable|0|||
28162360|NCT02314923|54832609|FG004|Overall Study|Participant unavailable|0|||
28162361|NCT02314923|54832610|FG005|Overall Study|Participant unavailable|1|||
28162362|NCT02314923|54832611|FG006|Overall Study|Participant unavailable|0|||
28162363|NCT02314923|54832612|FG007|Overall Study|Participant unavailable|0|||
28162364|NCT02314923|54832613|FG008|Overall Study|Participant unavailable|0|||
28162365|NCT02314923|54832614|FG009|Overall Study|Participant unavailable|0|||
28162366|NCT02314923|54832605|FG000|Overall Study|Screen failure|0|||
28162367|NCT02314923|54832606|FG001|Overall Study|Screen failure|0|||
28162368|NCT02314923|54832607|FG002|Overall Study|Screen failure|0|||
28162369|NCT02314923|54832608|FG003|Overall Study|Screen failure|0|||
28162370|NCT02314923|54832609|FG004|Overall Study|Screen failure|0|||
28162371|NCT02314923|54832610|FG005|Overall Study|Screen failure|0|||
28162372|NCT02314923|54832611|FG006|Overall Study|Screen failure|1|||
28162373|NCT02314923|54832612|FG007|Overall Study|Screen failure|0|||
28162374|NCT02314923|54832613|FG008|Overall Study|Screen failure|0|||
28162375|NCT02314923|54832614|FG009|Overall Study|Screen failure|0|||
28162376|NCT02314923|54832605|FG000|Overall Study|Participant relocation|1|||
27831372|NCT02245672|54308326|FG001|Overall Study|Withdrawal by Subject|3|||
28162377|NCT02314923|54832606|FG001|Overall Study|Participant relocation|0|||
27831373|NCT02245672|54308327|FG002|Overall Study|Withdrawal by Subject|0|||
28162378|NCT02314923|54832607|FG002|Overall Study|Participant relocation|0|||
28162379|NCT02314923|54832608|FG003|Overall Study|Participant relocation|0|||
28162380|NCT02314923|54832609|FG004|Overall Study|Participant relocation|0|||
27925592|NCT01258608|54582131|FG000|Overall Study|Lack of compliance|1|||
28162381|NCT02314923|54832610|FG005|Overall Study|Participant relocation|0|||
27852150|NCT02591238|54355180|FG000|Overall Study|personal circumstances|0|||
27852151|NCT02591238|54355181|FG001|Overall Study|personal circumstances|0|||
27852152|NCT02591238|54355182|FG002|Overall Study|personal circumstances|0|||
27852153|NCT02591238|54355183|FG003|Overall Study|personal circumstances|1|||
27852154|NCT02591238|54355180|FG000|Overall Study|personal circumstances|0|||
27852155|NCT02591238|54355181|FG001|Overall Study|personal circumstances|1|||
27852156|NCT02591238|54355182|FG002|Overall Study|personal circumstances|0|||
27852157|NCT02591238|54355183|FG003|Overall Study|personal circumstances|0|||
27852158|NCT02597946|54355265|FG000|Overall Study|Withdrawal by Subject|1|||
27852159|NCT02597946|54355265|FG000|Overall Study|Progressive disease|16|||
27852160|NCT02597946|54355265|FG000|Overall Study|Other than above|1|||
27852161|NCT02597712|54355271|FG000|Overall Study|Baseline biopsies showed indefinite for dysplasia|2|||
27852162|NCT02597712|54355272|FG001|Overall Study|Baseline biopsies showed indefinite for dysplasia|0|||
28162382|NCT02314923|54832611|FG006|Overall Study|Participant relocation|0|||
28162383|NCT02314923|54832612|FG007|Overall Study|Participant relocation|1|||
27852163|NCT02597712|54355271|FG000|Overall Study|Baseline biopsies showed low grade dysplasia|1|||
27852164|NCT02597712|54355272|FG001|Overall Study|Baseline biopsies showed low grade dysplasia|0|||
27852165|NCT02597712|54355271|FG000|Overall Study|Recurrent metastatic prostate cancer|0|||
27852166|NCT02597712|54355272|FG001|Overall Study|Recurrent metastatic prostate cancer|1|||
27852167|NCT02597478|54355280|FG000|Overall Study|Withdrawal by Subject|2|||
27852168|NCT02597478|54355281|FG001|Overall Study|Withdrawal by Subject|0|||
27852169|NCT02597478|54355280|FG000|Overall Study|Change of opioid dose|1|||
27852170|NCT02597478|54355281|FG001|Overall Study|Change of opioid dose|0|||
27852171|NCT02597478|54355280|FG000|Overall Study|Insufficient exertional dyspnea|0|||
27852172|NCT02597478|54355281|FG001|Overall Study|Insufficient exertional dyspnea|1|||
27852173|NCT01471028|54355376|FG000|VTI-208|Adverse Event|39|||
27852174|NCT01471028|54355377|FG001|VTI-208|Adverse Event|41|||
27852175|NCT01471028|54355376|FG000|VTI-208|Withdrawal by Subject|0|||
27852176|NCT01471028|54355377|FG001|VTI-208|Withdrawal by Subject|2|||
27852177|NCT01471028|54355376|FG000|VTI-208|Lost to Follow-up|1|||
27852178|NCT01471028|54355377|FG001|VTI-208|Lost to Follow-up|1|||
27852179|NCT01471028|54355376|FG000|VTI-208E|Death|7|||
27852180|NCT01471028|54355377|FG001|VTI-208E|Death|10|||
27852181|NCT01471028|54355376|FG000|VTI-208E|Withdrawal by Subject|1|||
27852182|NCT01471028|54355377|FG001|VTI-208E|Withdrawal by Subject|0|||
27852183|NCT01471028|54355376|FG000|VTI-208E|Lost to Follow-up|0|||
27852184|NCT01471028|54355377|FG001|VTI-208E|Lost to Follow-up|2|||
27852185|NCT01491854|54355391|FG000|Overall Study|mainly due to premature termination|93|||
27852186|NCT01491854|54355391|FG000|Overall Study|Death|1|||
27852187|NCT01491854|54355391|FG000|Overall Study|Withdrawal by Subject|3|||
27852188|NCT01491854|54355391|FG000|Overall Study|Lost to Follow-up|33|||
27852189|NCT01470248|54355399|FG000|Overall Study|Withdrawal by Subject|1|||
27852190|NCT01490918|54355419|FG000|Overall Study|Lost to Follow-up|2|||
27852191|NCT01490918|54355420|FG001|Overall Study|Lost to Follow-up|1|||
27852192|NCT01490918|54355421|FG002|Overall Study|Lost to Follow-up|0|||
27852193|NCT01490918|54355419|FG000|Overall Study|Withdrawal by Subject|7|||
27852194|NCT01490918|54355420|FG001|Overall Study|Withdrawal by Subject|8|||
27852195|NCT01490918|54355421|FG002|Overall Study|Withdrawal by Subject|3|||
27852196|NCT01490918|54355419|FG000|Overall Study|Adverse Event|0|||
27852197|NCT01490918|54355420|FG001|Overall Study|Adverse Event|0|||
27852198|NCT01490918|54355421|FG002|Overall Study|Adverse Event|1|||
27852199|NCT01490918|54355419|FG000|Overall Study|other cause|4|||
27852200|NCT01490918|54355420|FG001|Overall Study|other cause|5|||
27852201|NCT01490918|54355421|FG002|Overall Study|other cause|8|||
27852202|NCT01490840|54355453|FG000|Phase 1|Lost to Follow-up|1|||
27852203|NCT01490840|54355454|FG001|Phase 1|Lost to Follow-up|0|||
27852204|NCT01490840|54355453|FG000|Phase 1|Adverse Event|2|||
27852205|NCT01490840|54355454|FG001|Phase 1|Adverse Event|1|||
28162384|NCT02314923|54832613|FG008|Overall Study|Participant relocation|0|||
28162385|NCT02314923|54832614|FG009|Overall Study|Participant relocation|0|||
28162386|NCT03023137|54832639|FG000|Overall Study|Multiple pregnancy|2|||
28162387|NCT03023137|54832640|FG001|Overall Study|Multiple pregnancy|4|||
28162388|NCT03023137|54832639|FG000|Overall Study|Lost to Follow-up|1|||
28162389|NCT03023137|54832640|FG001|Overall Study|Lost to Follow-up|1|||
28162390|NCT03023137|54832639|FG000|Overall Study|Protocol Violation|0|||
27852206|NCT01490840|54355453|FG000|Phase 1|Withdrawal by Subject|6|||
27852207|NCT01490840|54355454|FG001|Phase 1|Withdrawal by Subject|5|||
27852208|NCT01490840|54355453|FG000|Phase 1|Visit 6a omitted|1|||
28162391|NCT03023137|54832640|FG001|Overall Study|Protocol Violation|4|||
27852209|NCT01490840|54355454|FG001|Phase 1|Visit 6a omitted|0|||
27852210|NCT01490840|54355453|FG000|Phase 2|Withdrawal by Subject|4|||
27852211|NCT01490840|54355454|FG001|Phase 2|Withdrawal by Subject|3|||
27852212|NCT01490840|54355453|FG000|Phase 2|Permanent interruption of fingolimod|0|||
27852213|NCT01490840|54355454|FG001|Phase 2|Permanent interruption of fingolimod|1|||
27852214|NCT01490840|54355453|FG000|Phase 2|Lost to Follow-up|1|||
27852215|NCT01490840|54355454|FG001|Phase 2|Lost to Follow-up|1|||
28162392|NCT03023137|54832639|FG000|Overall Study|Lost the baby in a car accident|1|||
28162393|NCT03023137|54832640|FG001|Overall Study|Lost the baby in a car accident|0|||
28162394|NCT03049813|54832651|FG000|Randomized Control Trial Phase|Participant placed in nursing home|0|||
28162395|NCT03049813|54832652|FG001|Randomized Control Trial Phase|Participant placed in nursing home|1|||
28162396|NCT03049813|54832653|FG002|Randomized Control Trial Phase|Participant placed in nursing home|0|||
28162397|NCT03049813|54832654|FG003|Randomized Control Trial Phase|Participant placed in nursing home|0|||
28162398|NCT03049813|54832651|FG000|Randomized Control Trial Phase|COVID Quarantine|2|||
28162399|NCT03049813|54832652|FG001|Randomized Control Trial Phase|COVID Quarantine|3|||
28162400|NCT03049813|54832653|FG002|Randomized Control Trial Phase|COVID Quarantine|0|||
28162401|NCT03049813|54832654|FG003|Randomized Control Trial Phase|COVID Quarantine|0|||
28162402|NCT03049813|54832651|FG000|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
28162403|NCT03049813|54832652|FG001|Randomized Control Trial Phase|Participant was in another concurrent study|1|||
28162404|NCT03049813|54832653|FG002|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
28162405|NCT03049813|54832654|FG003|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
28162406|NCT03049813|54832651|FG000|Randomized Control Trial Phase|Lost to Follow-up|0|||
28162407|NCT03049813|54832652|FG001|Randomized Control Trial Phase|Lost to Follow-up|2|||
28162408|NCT03049813|54832653|FG002|Randomized Control Trial Phase|Lost to Follow-up|3|||
28162409|NCT03049813|54832654|FG003|Randomized Control Trial Phase|Lost to Follow-up|0|||
28162410|NCT03022981|54832665|FG000|Overall Study|Adverse Event|0|||
28162411|NCT03022981|54832666|FG001|Overall Study|Adverse Event|1|||
28162412|NCT03022981|54832667|FG002|Overall Study|Adverse Event|0|||
28162413|NCT03022981|54832665|FG000|Overall Study|Investigator's Discretion|0|||
28162414|NCT03022981|54832666|FG001|Overall Study|Investigator's Discretion|1|||
28162415|NCT03022981|54832667|FG002|Overall Study|Investigator's Discretion|2|||
28162416|NCT03022981|54832665|FG000|Overall Study|Lost to Follow-up|6|||
28162417|NCT03022981|54832666|FG001|Overall Study|Lost to Follow-up|2|||
28162418|NCT03022981|54832667|FG002|Overall Study|Lost to Follow-up|1|||
27831374|NCT02245672|54308325|FG000|Overall Study|Randomized in error (not treated)|0|||
27831375|NCT02245672|54308326|FG001|Overall Study|Randomized in error (not treated)|1|||
27831376|NCT02245672|54308327|FG002|Overall Study|Randomized in error (not treated)|0|||
27831377|NCT00706992|54308472|FG000|Overall Study|Study termination|5|||
27831378|NCT00706992|54308473|FG001|Overall Study|Study termination|5|||
27831379|NCT00706992|54308474|FG002|Overall Study|Study termination|6|||
27831380|NCT00706992|54308475|FG003|Overall Study|Study termination|2|||
27831381|NCT00706992|54308476|FG004|Overall Study|Study termination|3|||
27831382|NCT00706992|54308477|FG005|Overall Study|Study termination|2|||
27831383|NCT00706992|54308478|FG006|Overall Study|Study termination|3|||
27831384|NCT00706992|54308472|FG000|Overall Study|Disease progression before treatment|0|||
27831385|NCT00706992|54308473|FG001|Overall Study|Disease progression before treatment|0|||
27831386|NCT00706992|54308474|FG002|Overall Study|Disease progression before treatment|0|||
27831387|NCT00706992|54308475|FG003|Overall Study|Disease progression before treatment|0|||
27831388|NCT00706992|54308476|FG004|Overall Study|Disease progression before treatment|1|||
27831389|NCT00706992|54308477|FG005|Overall Study|Disease progression before treatment|0|||
27831390|NCT00706992|54308478|FG006|Overall Study|Disease progression before treatment|0|||
27831391|NCT01785875|54308531|FG000|Overall Study|Withdrawal by Subject|41|||
27831392|NCT01785875|54308532|FG001|Overall Study|Withdrawal by Subject|34|||
27831393|NCT01785875|54308533|FG002|Overall Study|Withdrawal by Subject|36|||
27831394|NCT01785875|54308531|FG000|Overall Study|Lost to Follow-up|19|||
27831395|NCT01785875|54308532|FG001|Overall Study|Lost to Follow-up|22|||
27831396|NCT01785875|54308533|FG002|Overall Study|Lost to Follow-up|6|||
27831397|NCT01785875|54308531|FG000|Overall Study|Death|27|||
27831398|NCT01785875|54308532|FG001|Overall Study|Death|16|||
27831399|NCT01785875|54308533|FG002|Overall Study|Death|7|||
27831400|NCT01785875|54308531|FG000|Overall Study|Sponsor Decision|0|||
27831401|NCT01785875|54308532|FG001|Overall Study|Sponsor Decision|2|||
27831402|NCT01785875|54308533|FG002|Overall Study|Sponsor Decision|0|||
27831403|NCT01785875|54308531|FG000|Overall Study|Protocol Specified Criteria|207|||
27852216|NCT01490840|54355453|FG000|Phase 2|Adverse Event|1|||
28162419|NCT03022981|54832665|FG000|Overall Study|Non-Compliance With Study Drug|0|||
28162420|NCT03022981|54832666|FG001|Overall Study|Non-Compliance With Study Drug|0|||
28162421|NCT03022981|54832667|FG002|Overall Study|Non-Compliance With Study Drug|2|||
28162422|NCT03022981|54832665|FG000|Overall Study|Withdrew Assent By Parent/Guardian|0|||
28162423|NCT03022981|54832666|FG001|Overall Study|Withdrew Assent By Parent/Guardian|0|||
28162424|NCT03022981|54832667|FG002|Overall Study|Withdrew Assent By Parent/Guardian|1|||
28162425|NCT03377699|54832687|FG000|Overall Study|Withdrawal by Subject|2|||
28162426|NCT03377699|54832688|FG001|Overall Study|Withdrawal by Subject|9|||
28162427|NCT03377699|54832687|FG000|Overall Study|Lost to Follow-up|1|||
28162428|NCT03377699|54832688|FG001|Overall Study|Lost to Follow-up|1|||
28162429|NCT03377699|54832687|FG000|Overall Study|Commencement of medical infertility treatment during the course of the trial|1|||
28162430|NCT03377699|54832688|FG001|Overall Study|Commencement of medical infertility treatment during the course of the trial|0|||
28162431|NCT03377699|54832687|FG000|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
28162432|NCT03377699|54832688|FG001|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
28162433|NCT03377699|54832687|FG000|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|11|||
28162434|NCT03377699|54832688|FG001|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|8|||
28162435|NCT03377699|54832687|FG000|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
28162436|NCT03377699|54832688|FG001|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
28162437|NCT01314443|54832700|FG000|Overall Study|Withdrawal by Subject|2|||
28162438|NCT01314443|54832701|FG001|Overall Study|Withdrawal by Subject|1|||
28162439|NCT01314443|54832702|FG002|Overall Study|Withdrawal by Subject|1|||
28162440|NCT01314443|54832703|FG003|Overall Study|Withdrawal by Subject|1|||
28162441|NCT01314443|54832700|FG000|Overall Study|Protocol Violation|2|||
28162442|NCT01314443|54832701|FG001|Overall Study|Protocol Violation|2|||
28162443|NCT01314443|54832702|FG002|Overall Study|Protocol Violation|1|||
28162444|NCT01314443|54832703|FG003|Overall Study|Protocol Violation|1|||
28162445|NCT02923921|54832715|FG000|Overall Study|Sponsor Decision|39|||
28162446|NCT02923921|54832716|FG001|Overall Study|Sponsor Decision|38|||
28162447|NCT02923921|54832715|FG000|Overall Study|Lost to Follow-up|1|||
28162448|NCT02923921|54832716|FG001|Overall Study|Lost to Follow-up|0|||
28162449|NCT02923921|54832715|FG000|Overall Study|Withdrawal by Subject|6|||
28162450|NCT02923921|54832716|FG001|Overall Study|Withdrawal by Subject|13|||
28162451|NCT02923921|54832715|FG000|Overall Study|Unknown, Not Collected|7|||
28162452|NCT02923921|54832716|FG001|Overall Study|Unknown, Not Collected|6|||
28162453|NCT03039023|54832727|FG000|Overall Study|Withdrawal by Subject|1|||
28162454|NCT03039023|54832728|FG001|Overall Study|Withdrawal by Subject|0|||
28162455|NCT03039023|54832729|FG002|Overall Study|Withdrawal by Subject|1|||
28162456|NCT03039023|54832730|FG003|Overall Study|Withdrawal by Subject|1|||
28162457|NCT03039023|54832731|FG004|Overall Study|Withdrawal by Subject|0|||
28162458|NCT03039023|54832727|FG000|Overall Study|Physician Decision|0|||
28162459|NCT03039023|54832728|FG001|Overall Study|Physician Decision|0|||
28162460|NCT03039023|54832729|FG002|Overall Study|Physician Decision|0|||
28162461|NCT03039023|54832730|FG003|Overall Study|Physician Decision|1|||
28162462|NCT03039023|54832731|FG004|Overall Study|Physician Decision|0|||
28162463|NCT03022045|54832745|FG000|Overall Study|Adverse Event|0|||
28162464|NCT03022045|54832746|FG001|Overall Study|Adverse Event|1|||
28162465|NCT03022045|54832745|FG000|Overall Study|Withdrawal by Subject|1|||
27831404|NCT01785875|54308532|FG001|Overall Study|Protocol Specified Criteria|214|||
27831405|NCT01785875|54308533|FG002|Overall Study|Protocol Specified Criteria|55|||
28162466|NCT03022045|54832746|FG001|Overall Study|Withdrawal by Subject|1|||
28162467|NCT03037619|54832758|FG000|Overall Study|Lost to Follow-up|0|||
28162468|NCT03037619|54832759|FG001|Overall Study|Lost to Follow-up|1|||
28162469|NCT04771013|54832767|FG000|Overall Study|Withdrawal by Subject|2|||
28162470|NCT04771013|54832768|FG001|Overall Study|Withdrawal by Subject|0|||
28162471|NCT04771013|54832767|FG000|Overall Study|Death|0|||
28162472|NCT04771013|54832768|FG001|Overall Study|Death|5|||
28162473|NCT04771013|54832767|FG000|Overall Study|Referred to another hospital before day 20|0|||
28162474|NCT04771013|54832768|FG001|Overall Study|Referred to another hospital before day 20|1|||
28162475|NCT03021265|54832774|FG000|Overall Study|Adverse Event|29|||
28162476|NCT03021265|54832774|FG000|Overall Study|Lack of Efficacy|3|||
28162477|NCT03021265|54832774|FG000|Overall Study|Improved|17|||
28162478|NCT03021265|54832774|FG000|Overall Study|Lost to Follow-up|67|||
28162479|NCT03021265|54832774|FG000|Overall Study|No reason given|2|||
28162480|NCT03021265|54832774|FG000|Overall Study|No visit since the first visit|4|||
28162481|NCT04611789|54832781|FG000|Overall Study|Lost to Follow-up|1|||
28162482|NCT04611789|54832782|FG001|Overall Study|Lost to Follow-up|0|||
28162483|NCT04611789|54832783|FG002|Overall Study|Lost to Follow-up|0|||
28162484|NCT03561597|54832799|FG000|Overall Study|Lost to Follow-up|20|||
28162485|NCT03034967|54832822|FG000|Overall Study|Withdrawal by Subject|9|||
28162486|NCT03034967|54832823|FG001|Overall Study|Withdrawal by Subject|2|||
28162487|NCT03034967|54832824|FG002|Overall Study|Withdrawal by Subject|6|||
28162488|NCT03034967|54832825|FG003|Overall Study|Withdrawal by Subject|6|||
28162489|NCT03034967|54832826|FG004|Overall Study|Withdrawal by Subject|9|||
28162490|NCT03034967|54832827|FG005|Overall Study|Withdrawal by Subject|2|||
28162491|NCT03034967|54832822|FG000|Overall Study|Physician Decision|1|||
28162492|NCT03034967|54832823|FG001|Overall Study|Physician Decision|0|||
28162493|NCT03034967|54832824|FG002|Overall Study|Physician Decision|1|||
28162494|NCT03034967|54832825|FG003|Overall Study|Physician Decision|1|||
28162495|NCT03034967|54832826|FG004|Overall Study|Physician Decision|1|||
28162496|NCT03034967|54832827|FG005|Overall Study|Physician Decision|0|||
28162497|NCT03034967|54832822|FG000|Overall Study|Lost to Follow-up|0|||
28162498|NCT03034967|54832823|FG001|Overall Study|Lost to Follow-up|0|||
28162499|NCT03034967|54832824|FG002|Overall Study|Lost to Follow-up|0|||
28162500|NCT03034967|54832825|FG003|Overall Study|Lost to Follow-up|1|||
28162501|NCT03034967|54832826|FG004|Overall Study|Lost to Follow-up|0|||
28162502|NCT03034967|54832827|FG005|Overall Study|Lost to Follow-up|2|||
28162503|NCT03034967|54832822|FG000|Overall Study|Liver function test abnormality|0|||
28162504|NCT03034967|54832823|FG001|Overall Study|Liver function test abnormality|0|||
28162505|NCT03034967|54832824|FG002|Overall Study|Liver function test abnormality|1|||
28162506|NCT03034967|54832825|FG003|Overall Study|Liver function test abnormality|0|||
28162507|NCT03034967|54832826|FG004|Overall Study|Liver function test abnormality|0|||
28162508|NCT03034967|54832827|FG005|Overall Study|Liver function test abnormality|0|||
28162509|NCT03034967|54832822|FG000|Overall Study|Protocol Violation|1|||
28162510|NCT03034967|54832823|FG001|Overall Study|Protocol Violation|0|||
28162511|NCT03034967|54832824|FG002|Overall Study|Protocol Violation|0|||
28162512|NCT03034967|54832825|FG003|Overall Study|Protocol Violation|0|||
28162513|NCT03034967|54832826|FG004|Overall Study|Protocol Violation|0|||
28162514|NCT03034967|54832827|FG005|Overall Study|Protocol Violation|2|||
28162515|NCT03034967|54832822|FG000|Overall Study|Lack of Efficacy|0|||
28162516|NCT03034967|54832823|FG001|Overall Study|Lack of Efficacy|1|||
28162517|NCT03034967|54832824|FG002|Overall Study|Lack of Efficacy|2|||
28162518|NCT03034967|54832825|FG003|Overall Study|Lack of Efficacy|1|||
28162519|NCT03034967|54832826|FG004|Overall Study|Lack of Efficacy|1|||
28162520|NCT03034967|54832827|FG005|Overall Study|Lack of Efficacy|0|||
28162521|NCT03034967|54832822|FG000|Overall Study|Adverse Event, non-fatal|3|||
28162522|NCT03034967|54832823|FG001|Overall Study|Adverse Event, non-fatal|1|||
28162523|NCT03034967|54832824|FG002|Overall Study|Adverse Event, non-fatal|2|||
28162524|NCT03034967|54832825|FG003|Overall Study|Adverse Event, non-fatal|0|||
28162525|NCT03034967|54832826|FG004|Overall Study|Adverse Event, non-fatal|2|||
28162526|NCT03034967|54832827|FG005|Overall Study|Adverse Event, non-fatal|8|||
28162527|NCT03034967|54832822|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
28162528|NCT03034967|54832823|FG001|Overall Study|Adverse Event, Serious Fatal|1|||
28162529|NCT03034967|54832824|FG002|Overall Study|Adverse Event, Serious Fatal|1|||
28162530|NCT03034967|54832825|FG003|Overall Study|Adverse Event, Serious Fatal|2|||
28162531|NCT03034967|54832826|FG004|Overall Study|Adverse Event, Serious Fatal|1|||
28162532|NCT03034967|54832827|FG005|Overall Study|Adverse Event, Serious Fatal|1|||
28162533|NCT03021187|54832850|FG000|Overall Study|Death|0|||
28162534|NCT03021187|54832851|FG001|Overall Study|Death|0|||
28162535|NCT03021187|54832852|FG002|Overall Study|Death|3|||
28162536|NCT03021187|54832853|FG003|Overall Study|Death|0|||
28162537|NCT03021187|54832850|FG000|Overall Study|Withdrawal by Subject|0|||
28162538|NCT03021187|54832851|FG001|Overall Study|Withdrawal by Subject|6|||
28162539|NCT03021187|54832852|FG002|Overall Study|Withdrawal by Subject|2|||
28162540|NCT03021187|54832853|FG003|Overall Study|Withdrawal by Subject|5|||
28162541|NCT03021187|54832850|FG000|Overall Study|Lost to Follow-up|10|||
28162542|NCT03021187|54832851|FG001|Overall Study|Lost to Follow-up|3|||
28162543|NCT03021187|54832852|FG002|Overall Study|Lost to Follow-up|1|||
28162544|NCT03021187|54832853|FG003|Overall Study|Lost to Follow-up|4|||
28162545|NCT02143414|54832865|FG000|Induction|Adverse Event|1|||
28162546|NCT02143414|54832866|FG001|Induction|Adverse Event|2|||
28162547|NCT02143414|54832865|FG000|Induction|Death|1|||
28162548|NCT02143414|54832866|FG001|Induction|Death|2|||
28162549|NCT02143414|54832865|FG000|Induction|Patient refusal|1|||
28162550|NCT02143414|54832866|FG001|Induction|Patient refusal|1|||
28162551|NCT02143414|54832865|FG000|Induction|Refractory|1|||
28162552|NCT02143414|54832866|FG001|Induction|Refractory|0|||
28162553|NCT02143414|54832865|FG000|Induction|Began alternative treatment|1|||
28162554|NCT02143414|54832866|FG001|Induction|Began alternative treatment|0|||
28162555|NCT02143414|54832865|FG000|Induction|Ineligible for postremission|5|||
28162556|NCT02143414|54832866|FG001|Induction|Ineligible for postremission|1|||
28162557|NCT02143414|54832865|FG000|Post-remission|Adverse Event|0|||
28162558|NCT02143414|54832866|FG001|Post-remission|Adverse Event|2|||
28162559|NCT02143414|54832865|FG000|Post-remission|Disease progression/relapse|5|||
28162560|NCT02143414|54832866|FG001|Post-remission|Disease progression/relapse|0|||
28162561|NCT02143414|54832865|FG000|Maintenance|Adverse Event|4|||
28162562|NCT02143414|54832866|FG001|Maintenance|Adverse Event|6|||
28162563|NCT02143414|54832865|FG000|Maintenance|Disease progression/relapse|3|||
28162564|NCT02143414|54832866|FG001|Maintenance|Disease progression/relapse|2|||
28162565|NCT02143414|54832865|FG000|Maintenance|Patient refusal|2|||
28162566|NCT02143414|54832866|FG001|Maintenance|Patient refusal|1|||
28162567|NCT02143414|54832865|FG000|Maintenance|Physician Decision|1|||
28162568|NCT02143414|54832866|FG001|Maintenance|Physician Decision|0|||
28162569|NCT02143414|54832865|FG000|Maintenance|Death|0|||
28162570|NCT02143414|54832866|FG001|Maintenance|Death|1|||
28162571|NCT02143414|54832865|FG000|Maintenance|On protocol treatment|0|||
28162572|NCT02143414|54832866|FG001|Maintenance|On protocol treatment|6|||
28162573|NCT03014479|54832885|FG000|Overall Study|Adverse Event|0|||
28078541|NCT00112437|54732793|FG012|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
28078542|NCT00112437|54732794|FG013|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
28078543|NCT00112437|54732795|FG014|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
28078544|NCT00112437|54732796|FG015|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
28078545|NCT00112437|54732797|FG016|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
28078546|NCT00112437|54732798|FG017|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
28078547|NCT00112437|54732799|FG018|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
28078548|NCT00112437|54732800|FG019|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
28078549|NCT00112437|54732801|FG020|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
28078550|NCT00112437|54732802|FG021|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
28078551|NCT00112437|54732803|FG022|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
28078552|NCT00112437|54732804|FG023|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
28162574|NCT03014479|54832886|FG001|Overall Study|Adverse Event|1|||
28162575|NCT03014479|54832885|FG000|Overall Study|Voluntary Withdrawal|0|||
28162576|NCT03014479|54832886|FG001|Overall Study|Voluntary Withdrawal|2|||
28078553|NCT00112437|54732805|FG024|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
28078554|NCT00112437|54732806|FG025|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
28078555|NCT00112437|54732781|FG000|Year 1 (12-Month Base Study)|moved|0|||
28078556|NCT00112437|54732782|FG001|Year 1 (12-Month Base Study)|moved|1|||
28078557|NCT00112437|54732783|FG002|Year 1 (12-Month Base Study)|moved|1|||
28078558|NCT00112437|54732784|FG003|Year 1 (12-Month Base Study)|moved|0|||
28078559|NCT00112437|54732785|FG004|Year 1 (12-Month Base Study)|moved|0|||
28078560|NCT00112437|54732786|FG005|Year 1 (12-Month Base Study)|moved|0|||
28078561|NCT00112437|54732787|FG006|Year 1 (12-Month Base Study)|moved|0|||
28078562|NCT00112437|54732788|FG007|Year 1 (12-Month Base Study)|moved|0|||
28078563|NCT00112437|54732789|FG008|Year 1 (12-Month Base Study)|moved|0|||
28078564|NCT00112437|54732790|FG009|Year 1 (12-Month Base Study)|moved|0|||
28078565|NCT00112437|54732791|FG010|Year 1 (12-Month Base Study)|moved|0|||
28078566|NCT00112437|54732792|FG011|Year 1 (12-Month Base Study)|moved|0|||
28078567|NCT00112437|54732793|FG012|Year 1 (12-Month Base Study)|moved|0|||
28078568|NCT00112437|54732794|FG013|Year 1 (12-Month Base Study)|moved|0|||
28078569|NCT00112437|54732795|FG014|Year 1 (12-Month Base Study)|moved|0|||
28078570|NCT00112437|54732796|FG015|Year 1 (12-Month Base Study)|moved|0|||
28078571|NCT00112437|54732797|FG016|Year 1 (12-Month Base Study)|moved|0|||
28078572|NCT00112437|54732798|FG017|Year 1 (12-Month Base Study)|moved|0|||
28078573|NCT00112437|54732799|FG018|Year 1 (12-Month Base Study)|moved|0|||
28078574|NCT00112437|54732800|FG019|Year 1 (12-Month Base Study)|moved|0|||
28078575|NCT00112437|54732801|FG020|Year 1 (12-Month Base Study)|moved|0|||
28162577|NCT03014479|54832885|FG000|Overall Study|Unacceptable Inability of Site Visit|0|||
28162578|NCT03014479|54832886|FG001|Overall Study|Unacceptable Inability of Site Visit|1|||
28162579|NCT04766333|54832894|FG000|Overall Study|Lost to Follow-up|40|||
28162580|NCT04766333|54832895|FG001|Overall Study|Lost to Follow-up|826|||
28162581|NCT03020641|54832903|FG000|Overall Study|Lost to Follow-up|0|||
28162582|NCT03020641|54832904|FG001|Overall Study|Lost to Follow-up|1|||
28162583|NCT03020641|54832903|FG000|Overall Study|Converted to open surgery|2|||
28162584|NCT03020641|54832904|FG001|Overall Study|Converted to open surgery|1|||
28162585|NCT03020641|54832903|FG000|Overall Study|for surgery not performed|0|||
28162586|NCT03020641|54832904|FG001|Overall Study|for surgery not performed|1|||
28162587|NCT03020407|54832915|FG000|Overall Study|Withdrawal by Subject|2|||
28162588|NCT03020407|54832916|FG001|Overall Study|Withdrawal by Subject|1|||
28162589|NCT03020407|54832915|FG000|Overall Study|Lost to Follow-up|2|||
28162590|NCT03020407|54832916|FG001|Overall Study|Lost to Follow-up|3|||
28162591|NCT03020407|54832915|FG000|Overall Study|Protocol Violation|0|||
28162592|NCT03020407|54832916|FG001|Overall Study|Protocol Violation|1|||
28162593|NCT02536846|54832922|FG000|Overall Study|Withdrawal by Subject|1|||
28162594|NCT03014011|54832927|FG000|First Intervention|Withdrawal by Subject|1|||
28162595|NCT03014011|54832928|FG001|First Intervention|Withdrawal by Subject|0|||
28162596|NCT03014011|54832927|FG000|Washout|Withdrawal by Subject|1|||
28162597|NCT03014011|54832928|FG001|Washout|Withdrawal by Subject|0|||
28162598|NCT03012841|54832943|FG000|Overall Study|Protocol Violation|0|||
28162599|NCT03012841|54832944|FG001|Overall Study|Protocol Violation|10|||
28162600|NCT03012841|54832943|FG000|Overall Study|Lost to Follow-up|6|||
28162601|NCT03012841|54832944|FG001|Overall Study|Lost to Follow-up|1|||
28162602|NCT03012841|54832943|FG000|Overall Study|Withdrawal by Subject|6|||
28162603|NCT03012841|54832944|FG001|Overall Study|Withdrawal by Subject|0|||
28162604|NCT03012841|54832943|FG000|Overall Study|Unable to complete 12 month visit|6|||
28162605|NCT03012841|54832944|FG001|Overall Study|Unable to complete 12 month visit|0|||
28162606|NCT03012841|54832943|FG000|Overall Study|Subject relocation|1|||
27852217|NCT01490840|54355454|FG001|Phase 2|Adverse Event|1|||
27852218|NCT01490450|54355486|FG000|Period 1|Lack of Efficacy|2|||
27852219|NCT01490450|54355487|FG001|Period 1|Lack of Efficacy|0|||
27852220|NCT01490450|54355488|FG002|Period 1|Lack of Efficacy|3|||
27852221|NCT01490450|54355489|FG003|Period 1|Lack of Efficacy|0|||
27852222|NCT01490450|54355486|FG000|Period 1|Adverse Event|0|||
27852223|NCT01490450|54355487|FG001|Period 1|Adverse Event|0|||
27852224|NCT01490450|54355488|FG002|Period 1|Adverse Event|0|||
27852225|NCT01490450|54355489|FG003|Period 1|Adverse Event|5|||
27852226|NCT01490450|54355486|FG000|Period 1|Request to discontinue treatment|1|||
27852227|NCT01490450|54355487|FG001|Period 1|Request to discontinue treatment|0|||
27852228|NCT01490450|54355488|FG002|Period 1|Request to discontinue treatment|0|||
27852229|NCT01490450|54355489|FG003|Period 1|Request to discontinue treatment|0|||
27852230|NCT01490450|54355486|FG000|Period 1|Withdrawal by Subject|0|||
27852231|NCT01490450|54355487|FG001|Period 1|Withdrawal by Subject|0|||
27852232|NCT01490450|54355488|FG002|Period 1|Withdrawal by Subject|0|||
27852233|NCT01490450|54355489|FG003|Period 1|Withdrawal by Subject|3|||
27852234|NCT01490450|54355486|FG000|Period 1|No longer met study criteria|0|||
27852235|NCT01490450|54355487|FG001|Period 1|No longer met study criteria|1|||
27852236|NCT01490450|54355488|FG002|Period 1|No longer met study criteria|1|||
27852237|NCT01490450|54355489|FG003|Period 1|No longer met study criteria|0|||
27852238|NCT01490450|54355486|FG000|Period 2|Lack of Efficacy|0|||
27852239|NCT01490450|54355487|FG001|Period 2|Lack of Efficacy|0|||
27852240|NCT01490450|54355488|FG002|Period 2|Lack of Efficacy|0|||
28162607|NCT03012841|54832944|FG001|Overall Study|Subject relocation|0|||
28162608|NCT03012841|54832943|FG000|Overall Study|Seasonal winter travel|1|||
28162609|NCT03012841|54832944|FG001|Overall Study|Seasonal winter travel|0|||
28162610|NCT03012841|54832943|FG000|Overall Study|Physician Decision|0|||
28162611|NCT03012841|54832944|FG001|Overall Study|Physician Decision|2|||
27852241|NCT01490450|54355489|FG003|Period 2|Lack of Efficacy|1|||
27852242|NCT01490450|54355486|FG000|Period 2|Adverse Event|1|||
27852243|NCT01490450|54355487|FG001|Period 2|Adverse Event|1|||
27943842|NCT02151981|54600908|FG001|Overall Study|Withdrawal by Subject|21|||
27852244|NCT01490450|54355488|FG002|Period 2|Adverse Event|0|||
27852245|NCT01490450|54355489|FG003|Period 2|Adverse Event|1|||
28162612|NCT03012841|54832943|FG000|Overall Study|No ablation performed|0|||
28078576|NCT00112437|54732802|FG021|Year 1 (12-Month Base Study)|moved|0|||
28078577|NCT00112437|54732803|FG022|Year 1 (12-Month Base Study)|moved|0|||
28078578|NCT00112437|54732804|FG023|Year 1 (12-Month Base Study)|moved|0|||
28078579|NCT00112437|54732805|FG024|Year 1 (12-Month Base Study)|moved|0|||
28078580|NCT00112437|54732806|FG025|Year 1 (12-Month Base Study)|moved|0|||
28078581|NCT00112437|54732781|FG000|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
28078582|NCT00112437|54732782|FG001|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
28078583|NCT00112437|54732783|FG002|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
28078584|NCT00112437|54732784|FG003|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2|||
28078585|NCT00112437|54732785|FG004|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
28078586|NCT00112437|54732786|FG005|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
28078587|NCT00112437|54732787|FG006|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
28078588|NCT00112437|54732788|FG007|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
28078589|NCT00112437|54732789|FG008|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
28162613|NCT03012841|54832944|FG001|Overall Study|No ablation performed|2|||
28162614|NCT03012841|54832943|FG000|Overall Study|Study reached n=165 treated subject cap|0|||
28162615|NCT03012841|54832944|FG001|Overall Study|Study reached n=165 treated subject cap|5|||
28162616|NCT03012841|54832943|FG000|Overall Study|Insurance change|0|||
28162617|NCT03012841|54832944|FG001|Overall Study|Insurance change|1|||
28162618|NCT02359864|54832951|FG000|Overall Study|Withdrawal by Subject|1|||
28162619|NCT02359864|54832952|FG001|Overall Study|Withdrawal by Subject|0|||
28162620|NCT02533258|54832958|FG000|Overall Study|Adverse Event|1|||
28162621|NCT02533258|54832958|FG000|Overall Study|Death|2|||
28162622|NCT02533258|54832958|FG000|Overall Study|Other|1|||
28162623|NCT02533258|54832958|FG000|Overall Study|Economic factor|1|||
28162624|NCT02533258|54832958|FG000|Overall Study|Progression of pleural effusion|1|||
28162625|NCT02533258|54832958|FG000|Overall Study|Lack of Efficacy|2|||
28162626|NCT03019627|54832977|FG000|Overall Study|Adverse Event|8|||
28162627|NCT03019627|54832978|FG001|Overall Study|Adverse Event|0|||
28162628|NCT03019627|54832977|FG000|Overall Study|Unrelated to adverse event|1|||
28162629|NCT03019627|54832978|FG001|Overall Study|Unrelated to adverse event|3|||
28162630|NCT03019627|54832977|FG000|Overall Study|Lost to Follow-up|2|||
28162631|NCT03019627|54832978|FG001|Overall Study|Lost to Follow-up|1|||
28162632|NCT03019627|54832977|FG000|Overall Study|not compliance|2|||
28162633|NCT03019627|54832978|FG001|Overall Study|not compliance|2|||
28162634|NCT03019627|54832977|FG000|Overall Study|Other|2|||
28162635|NCT03019627|54832978|FG001|Overall Study|Other|2|||
28162636|NCT01661140|54832984|FG000|Open-Label Period|Adverse Event|44|||
28162637|NCT01661140|54832985|FG001|Open-Label Period|Adverse Event|0|||
28162638|NCT01661140|54832986|FG002|Open-Label Period|Adverse Event|0|||
28162639|NCT01661140|54832984|FG000|Open-Label Period|Protocol Violation|3|||
28162640|NCT01661140|54832985|FG001|Open-Label Period|Protocol Violation|0|||
28162641|NCT01661140|54832986|FG002|Open-Label Period|Protocol Violation|0|||
28162642|NCT01661140|54832984|FG000|Open-Label Period|Withdrawal by Subject|5|||
28162643|NCT01661140|54832985|FG001|Open-Label Period|Withdrawal by Subject|0|||
28162644|NCT01661140|54832986|FG002|Open-Label Period|Withdrawal by Subject|0|||
28162645|NCT01661140|54832984|FG000|Open-Label Period|Investigator Decision|3|||
28162646|NCT01661140|54832985|FG001|Open-Label Period|Investigator Decision|0|||
28162647|NCT01661140|54832986|FG002|Open-Label Period|Investigator Decision|0|||
28162648|NCT01661140|54832984|FG000|Open-Label Period|Death|1|||
28162649|NCT01661140|54832985|FG001|Open-Label Period|Death|0|||
28162650|NCT01661140|54832986|FG002|Open-Label Period|Death|0|||
28162651|NCT01661140|54832984|FG000|Open-Label Period|Administrative/Other|1|||
28162652|NCT01661140|54832985|FG001|Open-Label Period|Administrative/Other|0|||
28162653|NCT01661140|54832986|FG002|Open-Label Period|Administrative/Other|0|||
28162654|NCT01661140|54832984|FG000|Open-Label Period|Sponsor termination|16|||
28162655|NCT01661140|54832985|FG001|Open-Label Period|Sponsor termination|0|||
28162656|NCT01661140|54832986|FG002|Open-Label Period|Sponsor termination|0|||
28162657|NCT01661140|54832984|FG000|Open-Label Period|Did not meet EULAR criteria|1|||
28162658|NCT01661140|54832985|FG001|Open-Label Period|Did not meet EULAR criteria|0|||
28162659|NCT01661140|54832986|FG002|Open-Label Period|Did not meet EULAR criteria|0|||
28162660|NCT01661140|54832984|FG000|Open-Label Period|Lost to Follow-up|2|||
28162661|NCT01661140|54832985|FG001|Open-Label Period|Lost to Follow-up|0|||
28162662|NCT01661140|54832986|FG002|Open-Label Period|Lost to Follow-up|0|||
28162663|NCT01661140|54832984|FG000|Double-Blind Period|Refused Treatment|0|||
28162664|NCT01661140|54832985|FG001|Double-Blind Period|Refused Treatment|0|||
28162665|NCT01661140|54832986|FG002|Double-Blind Period|Refused Treatment|1|||
28162666|NCT01661140|54832984|FG000|Double-Blind Period|Adverse Event|0|||
28162667|NCT01661140|54832985|FG001|Double-Blind Period|Adverse Event|16|||
28162668|NCT01661140|54832986|FG002|Double-Blind Period|Adverse Event|18|||
28162669|NCT01661140|54832984|FG000|Double-Blind Period|Protocol Violation|0|||
28162670|NCT01661140|54832985|FG001|Double-Blind Period|Protocol Violation|2|||
28162671|NCT01661140|54832986|FG002|Double-Blind Period|Protocol Violation|3|||
28162672|NCT01661140|54832984|FG000|Double-Blind Period|Withdrawal by Subject|0|||
28162673|NCT01661140|54832985|FG001|Double-Blind Period|Withdrawal by Subject|1|||
28162674|NCT01661140|54832986|FG002|Double-Blind Period|Withdrawal by Subject|3|||
28162675|NCT01661140|54832984|FG000|Double-Blind Period|Investigator's Decision|0|||
28162676|NCT01661140|54832985|FG001|Double-Blind Period|Investigator's Decision|1|||
28162677|NCT01661140|54832986|FG002|Double-Blind Period|Investigator's Decision|2|||
28162678|NCT01661140|54832984|FG000|Double-Blind Period|Sponsor Termination|0|||
27831406|NCT01785875|54308531|FG000|Overall Study|Missing|0|||
28162679|NCT01661140|54832985|FG001|Double-Blind Period|Sponsor Termination|14|||
28162680|NCT01661140|54832986|FG002|Double-Blind Period|Sponsor Termination|17|||
28162681|NCT01661140|54832984|FG000|Double-Blind Period|Administrative/Other|0|||
28162682|NCT01661140|54832985|FG001|Double-Blind Period|Administrative/Other|7|||
28162683|NCT01661140|54832986|FG002|Double-Blind Period|Administrative/Other|6|||
28162684|NCT03019549|54832994|FG000|Washout|DId not meet genotype criteria|11|||
28162685|NCT03019549|54832994|FG000|Period 2|Adverse Event|2|||
28162686|NCT03019549|54832994|FG000|Period 2|Physician Decision|2|||
28162687|NCT03019549|54832994|FG000|Period 2|Withdrawal by Subject|1|||
28162688|NCT01661062|54833003|FG000|Overall Study|Completed Treatment Off Study|3|||
28162689|NCT01661062|54833003|FG000|Overall Study|Withdrawal by Subject|2|||
28162690|NCT02536378|54833009|FG000|Overall Study|Physician Decision|0|||
28162691|NCT02536378|54833010|FG001|Overall Study|Physician Decision|2|||
28162692|NCT02536378|54833009|FG000|Overall Study|Withdrawal by Subject|0|||
27852246|NCT01490450|54355486|FG000|Period 2|Withdrawal by Subject|1|||
27852247|NCT01490450|54355487|FG001|Period 2|Withdrawal by Subject|0|||
27852248|NCT01490450|54355488|FG002|Period 2|Withdrawal by Subject|0|||
27852249|NCT01490450|54355489|FG003|Period 2|Withdrawal by Subject|0|||
27852250|NCT01490450|54355486|FG000|Period 2|Lost to Follow-up|0|||
27852251|NCT01490450|54355487|FG001|Period 2|Lost to Follow-up|0|||
27852252|NCT01490450|54355488|FG002|Period 2|Lost to Follow-up|0|||
27852253|NCT01490450|54355489|FG003|Period 2|Lost to Follow-up|2|||
27852254|NCT01469546|54355533|FG000|Received 5 mg Dose|Adverse Event|13|||
27852255|NCT01469546|54355533|FG000|Received 5 mg Dose|Death|2|||
27852256|NCT01469546|54355533|FG000|Received 5 mg Dose|Protocol Violation|2|||
27852257|NCT01469546|54355533|FG000|Received 5 mg Dose|Progressive Disease|3|||
27852258|NCT01469546|54355533|FG000|Received 5 mg Dose|Physician Decision|3|||
27852259|NCT00081497|54355539|FG000|Overall Study|Adverse Event|2|||
27852260|NCT00081497|54355540|FG001|Overall Study|Adverse Event|0|||
28162693|NCT02536378|54833010|FG001|Overall Study|Withdrawal by Subject|1|||
27852261|NCT00081497|54355539|FG000|Overall Study|Death|0|||
27852262|NCT00081497|54355540|FG001|Overall Study|Death|1|||
27852263|NCT00081497|54355539|FG000|Overall Study|Withdrawal by Subject|1|||
28162694|NCT02536378|54833009|FG000|Overall Study|Death|1|||
28162695|NCT02536378|54833010|FG001|Overall Study|Death|2|||
27852264|NCT00081497|54355540|FG001|Overall Study|Withdrawal by Subject|0|||
27943843|NCT02151981|54600907|FG000|Overall Study|Ongoing Study at Data Cut-off|60|||
27852265|NCT00081497|54355539|FG000|Overall Study|Non-compliance|0|||
28162696|NCT02536378|54833009|FG000|Overall Study|Patient refused further follow up|6|||
28162697|NCT02536378|54833010|FG001|Overall Study|Patient refused further follow up|2|||
27831407|NCT01785875|54308532|FG001|Overall Study|Missing|1|||
27831408|NCT01785875|54308533|FG002|Overall Study|Missing|3|||
27831409|NCT00706914|54308586|FG000|Overall Study|Lack of Efficacy|0|||
27831410|NCT00706914|54308587|FG001|Overall Study|Lack of Efficacy|1|||
27831411|NCT00706914|54308588|FG002|Overall Study|Lack of Efficacy|0|||
27831412|NCT00706914|54308586|FG000|Overall Study|Lost to Follow-up|1|||
27831413|NCT00706914|54308587|FG001|Overall Study|Lost to Follow-up|0|||
27831414|NCT00706914|54308588|FG002|Overall Study|Lost to Follow-up|0|||
27831415|NCT00706914|54308586|FG000|Overall Study|Adverse Event|2|||
27831416|NCT00706914|54308587|FG001|Overall Study|Adverse Event|2|||
27831417|NCT00706914|54308588|FG002|Overall Study|Adverse Event|0|||
27831418|NCT00706914|54308586|FG000|Overall Study|Protocol Violation|3|||
27831419|NCT00706914|54308587|FG001|Overall Study|Protocol Violation|1|||
27831420|NCT00706914|54308588|FG002|Overall Study|Protocol Violation|1|||
27831421|NCT01808651|54308695|FG000|Study Period 1|Lost to Follow-up|1|||
27831422|NCT01808651|54308696|FG001|Study Period 1|Lost to Follow-up|3|||
27831423|NCT01808651|54308697|FG002|Study Period 1|Lost to Follow-up|0|||
27831424|NCT01808651|54308695|FG000|Study Period 1|Protocol Violation|1|||
27831425|NCT01808651|54308696|FG001|Study Period 1|Protocol Violation|0|||
27831426|NCT01808651|54308697|FG002|Study Period 1|Protocol Violation|1|||
27831427|NCT01808651|54308695|FG000|Study Period 1|Physician Decision|3|||
27831428|NCT01808651|54308696|FG001|Study Period 1|Physician Decision|2|||
27831429|NCT01808651|54308697|FG002|Study Period 1|Physician Decision|0|||
27831430|NCT01808651|54308695|FG000|Study Period 1|Lack of Efficacy|2|||
27852266|NCT00081497|54355540|FG001|Overall Study|Non-compliance|1|||
27852267|NCT00081263|54355554|FG000|Overall Study|clerical error|1|||
27852268|NCT00081263|54355555|FG001|Overall Study|clerical error|0|||
27852269|NCT00081263|54355554|FG000|Overall Study|wrong cell type|7|||
27852270|NCT00081263|54355555|FG001|Overall Study|wrong cell type|5|||
27852271|NCT00081263|54355554|FG000|Overall Study|improper pre-protocol therapy|0|||
27852272|NCT00081263|54355555|FG001|Overall Study|improper pre-protocol therapy|1|||
27852273|NCT00081263|54355554|FG000|Overall Study|Inadequate pathology|0|||
27852274|NCT00081263|54355555|FG001|Overall Study|Inadequate pathology|1|||
27852275|NCT00081263|54355554|FG000|Overall Study|Never treated|4|||
27852276|NCT00081263|54355555|FG001|Overall Study|Never treated|5|||
27852277|NCT00081263|54355554|FG000|Overall Study|Inadequate data|5|||
27852278|NCT00081263|54355555|FG001|Overall Study|Inadequate data|10|||
27852279|NCT01490294|54355565|FG000|Overall Study|Prematurely discontinuation|4|||
27852280|NCT01490294|54355566|FG001|Overall Study|Prematurely discontinuation|0|||
27852281|NCT01490294|54355567|FG002|Overall Study|Prematurely discontinuation|1|||
27831431|NCT01808651|54308696|FG001|Study Period 1|Lack of Efficacy|1|||
27831432|NCT01808651|54308697|FG002|Study Period 1|Lack of Efficacy|0|||
27831433|NCT01808651|54308695|FG000|Study Period 1|Adverse Event|10|||
27831434|NCT01808651|54308696|FG001|Study Period 1|Adverse Event|4|||
27852282|NCT01490294|54355568|FG003|Overall Study|Prematurely discontinuation|1|||
27831435|NCT01808651|54308697|FG002|Study Period 1|Adverse Event|1|||
27831436|NCT01808651|54308695|FG000|Study Period 1|Participant Decision|9|||
27852283|NCT01490294|54355565|FG000|Overall Study|Adverse Event|1|||
28162698|NCT01373151|54833025|FG000|Period 1|Lack of Efficacy|3|||
27831437|NCT01808651|54308696|FG001|Study Period 1|Participant Decision|7|||
27852284|NCT01490294|54355566|FG001|Overall Study|Adverse Event|0|||
27852285|NCT01490294|54355567|FG002|Overall Study|Adverse Event|0|||
27852286|NCT01490294|54355568|FG003|Overall Study|Adverse Event|0|||
27831438|NCT01808651|54308697|FG002|Study Period 1|Participant Decision|3|||
27831439|NCT00706134|54308762|FG000|Overall Study|Adverse Event|8|||
27831440|NCT00706134|54308763|FG001|Overall Study|Adverse Event|7|||
27831441|NCT00706134|54308764|FG002|Overall Study|Adverse Event|2|||
27831442|NCT00706134|54308765|FG003|Overall Study|Adverse Event|3|||
27831443|NCT00706134|54308762|FG000|Overall Study|Lost to Follow-up|0|||
27831444|NCT00706134|54308763|FG001|Overall Study|Lost to Follow-up|1|||
27831445|NCT00706134|54308764|FG002|Overall Study|Lost to Follow-up|0|||
27831446|NCT00706134|54308765|FG003|Overall Study|Lost to Follow-up|0|||
27831447|NCT00706134|54308762|FG000|Overall Study|Protocol Violation|0|||
27831448|NCT00706134|54308763|FG001|Overall Study|Protocol Violation|6|||
27831449|NCT00706134|54308764|FG002|Overall Study|Protocol Violation|0|||
27831450|NCT00706134|54308765|FG003|Overall Study|Protocol Violation|3|||
27831451|NCT00706134|54308762|FG000|Overall Study|Withdrawal by Subject|1|||
27831452|NCT00706134|54308763|FG001|Overall Study|Withdrawal by Subject|2|||
27852287|NCT00080483|54355595|FG000|Overall Study|Lost to Follow-up|1|||
27852288|NCT00080483|54355596|FG001|Overall Study|Lost to Follow-up|1|||
27852289|NCT00080483|54355595|FG000|Overall Study|Physician Decision|1|||
27852290|NCT00080483|54355596|FG001|Overall Study|Physician Decision|1|||
27852291|NCT00089141|54355617|FG000|Overall Study|Termination of trial|18|||
27852292|NCT00089141|54355618|FG001|Overall Study|Termination of trial|24|||
27852293|NCT02588664|54355664|FG000|Overall Study|Death|56|||
27852294|NCT02588664|54355665|FG001|Overall Study|Death|55|||
27852295|NCT02588664|54355664|FG000|Overall Study|Lost to Follow-up|1305|||
27852296|NCT02588664|54355665|FG001|Overall Study|Lost to Follow-up|990|||
27852297|NCT00083759|54355728|FG000|Overall Study|Adverse Event|5|||
27943844|NCT02151981|54600908|FG001|Overall Study|Ongoing Study at Data Cut-off|27|||
27831453|NCT00706134|54308764|FG002|Overall Study|Withdrawal by Subject|1|||
27831454|NCT00706134|54308765|FG003|Overall Study|Withdrawal by Subject|0|||
27831455|NCT00706134|54308762|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
27831456|NCT00706134|54308763|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
27831457|NCT00706134|54308764|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
27852298|NCT00083759|54355729|FG001|Overall Study|Adverse Event|3|||
27852299|NCT00083759|54355728|FG000|Overall Study|Lost to Follow-up|1|||
27831458|NCT00706134|54308765|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
27852300|NCT00083759|54355729|FG001|Overall Study|Lost to Follow-up|0|||
27852301|NCT00083759|54355728|FG000|Overall Study|Death|1|||
27852302|NCT00083759|54355729|FG001|Overall Study|Death|1|||
27852303|NCT00083759|54355728|FG000|Overall Study|Inadequate Therapeutic Response|32|||
27852304|NCT00083759|54355729|FG001|Overall Study|Inadequate Therapeutic Response|35|||
27852305|NCT00083759|54355728|FG000|Overall Study|Subject Withdrew Consent|2|||
27852306|NCT00083759|54355729|FG001|Overall Study|Subject Withdrew Consent|2|||
27852307|NCT00083759|54355728|FG000|Overall Study|Non-Compliance|1|||
27852308|NCT00083759|54355729|FG001|Overall Study|Non-Compliance|0|||
27852309|NCT00083759|54355728|FG000|Overall Study|Sponsor's Discretion|28|||
27852310|NCT00083759|54355729|FG001|Overall Study|Sponsor's Discretion|29|||
27852311|NCT00083759|54355728|FG000|Overall Study|Other|14|||
27852312|NCT00083759|54355729|FG001|Overall Study|Other|13|||
27852313|NCT00089609|54355855|FG000|Overall Study|Withdrawal by Subject|3|||
27852314|NCT00089609|54355856|FG001|Overall Study|Withdrawal by Subject|1|||
27852315|NCT02440581|54355997|FG000|Overall Study|Death|0|||
27852316|NCT02440581|54355998|FG001|Overall Study|Death|0|||
27852317|NCT02440581|54355999|FG002|Overall Study|Death|7|||
27852318|NCT02440581|54356000|FG003|Overall Study|Death|5|||
27852319|NCT02440581|54355997|FG000|Overall Study|Transplanted|1|||
27852320|NCT02440581|54355998|FG001|Overall Study|Transplanted|0|||
27852321|NCT02440581|54355999|FG002|Overall Study|Transplanted|3|||
27852322|NCT02440581|54356000|FG003|Overall Study|Transplanted|2|||
27852323|NCT02440581|54355997|FG000|Overall Study|Withdrawal by Subject|4|||
27852324|NCT02440581|54355998|FG001|Overall Study|Withdrawal by Subject|11|||
27852325|NCT02440581|54355999|FG002|Overall Study|Withdrawal by Subject|3|||
27852326|NCT02440581|54356000|FG003|Overall Study|Withdrawal by Subject|7|||
27852327|NCT01359150|54356012|FG000|Overall Study|Lack of Efficacy|1|||
27852328|NCT01359150|54356013|FG001|Overall Study|Lack of Efficacy|1|||
27852329|NCT01359150|54356012|FG000|Overall Study|Withdrawal by Subject|1|||
27852330|NCT01359150|54356013|FG001|Overall Study|Withdrawal by Subject|1|||
27852331|NCT01359150|54356012|FG000|Overall Study|Adverse Event|4|||
27852332|NCT01359150|54356013|FG001|Overall Study|Adverse Event|3|||
27852333|NCT01359150|54356012|FG000|Overall Study|Other|1|||
27852334|NCT01359150|54356013|FG001|Overall Study|Other|0|||
27852335|NCT01469000|54356074|FG000|Overall Study|Withdrawal by Subject|16|||
27852336|NCT01469000|54356075|FG001|Overall Study|Withdrawal by Subject|3|||
27852337|NCT01469000|54356074|FG000|Overall Study|Sponsor Decision|4|||
27852338|NCT01469000|54356075|FG001|Overall Study|Sponsor Decision|1|||
27852339|NCT01490060|54356088|FG000|Cycle 1|Change of Treatment|0|||
27852340|NCT01490060|54356089|FG001|Cycle 1|Change of Treatment|1|||
27852341|NCT01490060|54356090|FG002|Cycle 1|Change of Treatment|1|||
27852342|NCT01490060|54356091|FG003|Cycle 1|Change of Treatment|1|||
27852343|NCT01490060|54356088|FG000|Cycle 1|Insurance Denied|0|||
27852344|NCT01490060|54356089|FG001|Cycle 1|Insurance Denied|0|||
27852345|NCT01490060|54356090|FG002|Cycle 1|Insurance Denied|2|||
27852346|NCT01490060|54356091|FG003|Cycle 1|Insurance Denied|0|||
27852347|NCT01490060|54356088|FG000|Cycle 1|Withdrawal by Subject|0|||
27852348|NCT01490060|54356089|FG001|Cycle 1|Withdrawal by Subject|0|||
27852349|NCT01490060|54356090|FG002|Cycle 1|Withdrawal by Subject|0|||
27852350|NCT01490060|54356091|FG003|Cycle 1|Withdrawal by Subject|1|||
27852351|NCT01490060|54356088|FG000|Cycle 1|Treatment at Another Facility|0|||
27852352|NCT01490060|54356089|FG001|Cycle 1|Treatment at Another Facility|0|||
27852353|NCT01490060|54356090|FG002|Cycle 1|Treatment at Another Facility|0|||
27852354|NCT01490060|54356091|FG003|Cycle 1|Treatment at Another Facility|1|||
27852355|NCT01490060|54356088|FG000|Cycle 2|Change of Treatment|1|||
27852356|NCT01490060|54356089|FG001|Cycle 2|Change of Treatment|1|||
27852357|NCT01490060|54356090|FG002|Cycle 2|Change of Treatment|0|||
27852358|NCT01490060|54356091|FG003|Cycle 2|Change of Treatment|0|||
27852359|NCT01490060|54356088|FG000|Cycle 2|Non-Compliance|0|||
27852360|NCT01490060|54356089|FG001|Cycle 2|Non-Compliance|0|||
27852361|NCT01490060|54356090|FG002|Cycle 2|Non-Compliance|1|||
27852362|NCT01490060|54356091|FG003|Cycle 2|Non-Compliance|0|||
27852363|NCT01490060|54356088|FG000|Cycle 2|Adverse Event Related to Chemotherapy|1|||
27852364|NCT01490060|54356089|FG001|Cycle 2|Adverse Event Related to Chemotherapy|0|||
27852365|NCT01490060|54356090|FG002|Cycle 2|Adverse Event Related to Chemotherapy|0|||
27852366|NCT01490060|54356091|FG003|Cycle 2|Adverse Event Related to Chemotherapy|0|||
27852367|NCT01452152|54356143|FG000|Overall Study|Study termination by sponsor|5|||
27852368|NCT01452152|54356144|FG001|Overall Study|Study termination by sponsor|0|||
27852369|NCT01452152|54356145|FG002|Overall Study|Study termination by sponsor|4|||
27852370|NCT01451762|54356156|FG000|Overall Study|Lost to Follow-up|3|||
27852371|NCT01451762|54356157|FG001|Overall Study|Lost to Follow-up|6|||
27852372|NCT01451762|54356158|FG002|Overall Study|Lost to Follow-up|6|||
27852373|NCT01468844|54356193|FG000|Overall Study|Adverse Event|1|||
27852374|NCT01468844|54356194|FG001|Overall Study|Adverse Event|0|||
27852375|NCT01468844|54356193|FG000|Overall Study|Withdrawal by Subject|1|||
27852376|NCT01468844|54356194|FG001|Overall Study|Withdrawal by Subject|0|||
27852377|NCT01451606|54356218|FG000|Overall Study|Withdrawal by Subject|4|||
27852378|NCT01451606|54356219|FG001|Overall Study|Withdrawal by Subject|3|||
28078590|NCT00112437|54732790|FG009|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
28078591|NCT00112437|54732791|FG010|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
28078592|NCT00112437|54732792|FG011|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
28078593|NCT00112437|54732793|FG012|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
28078594|NCT00112437|54732794|FG013|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
28078595|NCT00112437|54732795|FG014|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
28078596|NCT00112437|54732796|FG015|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
28078597|NCT00112437|54732797|FG016|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
28078598|NCT00112437|54732798|FG017|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
28078599|NCT00112437|54732799|FG018|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
28078600|NCT00112437|54732800|FG019|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
28078601|NCT00112437|54732801|FG020|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
28078602|NCT00112437|54732802|FG021|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
28078603|NCT00112437|54732803|FG022|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
28078604|NCT00112437|54732804|FG023|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
28078605|NCT00112437|54732805|FG024|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
28078606|NCT00112437|54732806|FG025|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
28078607|NCT00112437|54732781|FG000|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
28078608|NCT00112437|54732782|FG001|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
28078609|NCT00112437|54732783|FG002|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
28078610|NCT00112437|54732784|FG003|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
28078611|NCT00112437|54732785|FG004|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1|||
28078612|NCT00112437|54732786|FG005|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
28078613|NCT00112437|54732787|FG006|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
28078614|NCT00112437|54732788|FG007|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
28078615|NCT00112437|54732789|FG008|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
28078616|NCT00112437|54732790|FG009|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
28078617|NCT00112437|54732791|FG010|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
28078618|NCT00112437|54732792|FG011|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
28078619|NCT00112437|54732793|FG012|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
28078620|NCT00112437|54732794|FG013|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
28078621|NCT00112437|54732795|FG014|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
28078622|NCT00112437|54732796|FG015|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
28078623|NCT00112437|54732797|FG016|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
28078624|NCT00112437|54732798|FG017|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
28078625|NCT00112437|54732799|FG018|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
28078626|NCT00112437|54732800|FG019|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
28078627|NCT00112437|54732801|FG020|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
28078628|NCT00112437|54732802|FG021|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
28078629|NCT00112437|54732803|FG022|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
28078630|NCT00112437|54732804|FG023|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
28078631|NCT00112437|54732805|FG024|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
28078632|NCT00112437|54732806|FG025|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
28078633|NCT00112437|54732781|FG000|Year 2 (12-Month Extension)|Adverse Event|0|||
28078634|NCT00112437|54732782|FG001|Year 2 (12-Month Extension)|Adverse Event|0|||
28078635|NCT00112437|54732783|FG002|Year 2 (12-Month Extension)|Adverse Event|0|||
28078636|NCT00112437|54732784|FG003|Year 2 (12-Month Extension)|Adverse Event|0|||
28078637|NCT00112437|54732785|FG004|Year 2 (12-Month Extension)|Adverse Event|0|||
28078638|NCT00112437|54732786|FG005|Year 2 (12-Month Extension)|Adverse Event|1|||
28078639|NCT00112437|54732787|FG006|Year 2 (12-Month Extension)|Adverse Event|2|||
28078640|NCT00112437|54732788|FG007|Year 2 (12-Month Extension)|Adverse Event|6|||
28078641|NCT00112437|54732789|FG008|Year 2 (12-Month Extension)|Adverse Event|1|||
27852379|NCT00473343|54356274|FG000|Overall Study|Adverse Event|9|||
27852380|NCT00473343|54356274|FG000|Overall Study|Lost to Follow-up|8|||
27852381|NCT00473343|54356274|FG000|Overall Study|Treatment failure|27|||
27852382|NCT00473343|54356274|FG000|Overall Study|Withdrew consent|3|||
27852383|NCT00473343|54356274|FG000|Overall Study|Other un-specified reason|3|||
27852384|NCT02587962|54356731|FG000|Overall Study|Adverse Event|0|||
27852385|NCT02587962|54356732|FG001|Overall Study|Adverse Event|0|||
27852386|NCT02587962|54356733|FG002|Overall Study|Adverse Event|1|||
27852387|NCT02587962|54356734|FG003|Overall Study|Adverse Event|0|||
27852388|NCT02587962|54356735|FG004|Overall Study|Adverse Event|0|||
27852389|NCT02587962|54356731|FG000|Overall Study|Withdrawal by Subject|0|||
27852390|NCT02587962|54356732|FG001|Overall Study|Withdrawal by Subject|0|||
27852391|NCT02587962|54356733|FG002|Overall Study|Withdrawal by Subject|1|||
27852392|NCT02587962|54356734|FG003|Overall Study|Withdrawal by Subject|1|||
27852393|NCT02587962|54356735|FG004|Overall Study|Withdrawal by Subject|4|||
27852394|NCT02587962|54356731|FG000|Overall Study|Radiological progression|2|||
27852395|NCT02587962|54356732|FG001|Overall Study|Radiological progression|2|||
27852396|NCT02587962|54356733|FG002|Overall Study|Radiological progression|2|||
27852397|NCT02587962|54356734|FG003|Overall Study|Radiological progression|5|||
27852398|NCT02587962|54356735|FG004|Overall Study|Radiological progression|10|||
27852399|NCT02587962|54356731|FG000|Overall Study|Clinical progression|0|||
27852400|NCT02587962|54356732|FG001|Overall Study|Clinical progression|1|||
27852401|NCT02587962|54356733|FG002|Overall Study|Clinical progression|2|||
27852402|NCT02587962|54356734|FG003|Overall Study|Clinical progression|0|||
27852403|NCT02587962|54356735|FG004|Overall Study|Clinical progression|1|||
27852404|NCT01440374|54356889|FG000|Part 1: Open-label Phase|Adverse Event|5|||
27852405|NCT01440374|54356890|FG001|Part 1: Open-label Phase|Adverse Event|0|||
27852406|NCT01440374|54356891|FG002|Part 1: Open-label Phase|Adverse Event|0|||
27852407|NCT01440374|54356892|FG003|Part 1: Open-label Phase|Adverse Event|0|||
27852408|NCT01440374|54356889|FG000|Part 1: Open-label Phase|Physician Decision|1|||
27852409|NCT01440374|54356890|FG001|Part 1: Open-label Phase|Physician Decision|0|||
27852410|NCT01440374|54356891|FG002|Part 1: Open-label Phase|Physician Decision|0|||
27852411|NCT01440374|54356892|FG003|Part 1: Open-label Phase|Physician Decision|0|||
27852412|NCT01440374|54356889|FG000|Part 2; Double-blind Phase|Physician Decision|0|||
27852413|NCT01440374|54356890|FG001|Part 2; Double-blind Phase|Physician Decision|8|||
27852414|NCT01440374|54356891|FG002|Part 2; Double-blind Phase|Physician Decision|17|||
28078642|NCT00112437|54732790|FG009|Year 2 (12-Month Extension)|Adverse Event|7|||
27852415|NCT01440374|54356892|FG003|Part 2; Double-blind Phase|Physician Decision|0|||
27852416|NCT01440374|54356889|FG000|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
28078643|NCT00112437|54732791|FG010|Year 2 (12-Month Extension)|Adverse Event|0|||
28078644|NCT00112437|54732792|FG011|Year 2 (12-Month Extension)|Adverse Event|0|||
27831459|NCT00706134|54308762|FG000|Overall Study|Did not meet study criteria|2|||
27831460|NCT00706134|54308763|FG001|Overall Study|Did not meet study criteria|0|||
27831461|NCT00706134|54308764|FG002|Overall Study|Did not meet study criteria|0|||
27831462|NCT00706134|54308765|FG003|Overall Study|Did not meet study criteria|0|||
27831463|NCT01808573|54308777|FG000|Overall Study|Death|212|||
27831464|NCT01808573|54308778|FG001|Overall Study|Death|240|||
27831465|NCT01808573|54308777|FG000|Overall Study|Withdrawal by Subject|12|||
27831466|NCT01808573|54308778|FG001|Overall Study|Withdrawal by Subject|10|||
27831467|NCT01808573|54308777|FG000|Overall Study|Lost to Follow-up|3|||
27831468|NCT01808573|54308778|FG001|Overall Study|Lost to Follow-up|0|||
27831469|NCT01808573|54308777|FG000|Overall Study|Discontinuation of study by sponsor|79|||
27831470|NCT01808573|54308778|FG001|Overall Study|Discontinuation of study by sponsor|64|||
27831471|NCT01808573|54308777|FG000|Overall Study|Randomized in Error|1|||
27831472|NCT01808573|54308778|FG001|Overall Study|Randomized in Error|0|||
28078645|NCT00112437|54732793|FG012|Year 2 (12-Month Extension)|Adverse Event|0|||
28078646|NCT00112437|54732794|FG013|Year 2 (12-Month Extension)|Adverse Event|0|||
28078647|NCT00112437|54732795|FG014|Year 2 (12-Month Extension)|Adverse Event|0|||
28078648|NCT00112437|54732796|FG015|Year 2 (12-Month Extension)|Adverse Event|0|||
28078649|NCT00112437|54732797|FG016|Year 2 (12-Month Extension)|Adverse Event|0|||
28078650|NCT00112437|54732798|FG017|Year 2 (12-Month Extension)|Adverse Event|0|||
28078651|NCT00112437|54732799|FG018|Year 2 (12-Month Extension)|Adverse Event|0|||
27831473|NCT02246530|54308805|FG000|Overall Study|Lost to Follow-up|4|||
27831474|NCT02246530|54308806|FG001|Overall Study|Lost to Follow-up|0|||
27831475|NCT01808339|54308812|FG000|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
27852417|NCT01440374|54356890|FG001|Part 2; Double-blind Phase|Withdrawal by Subject|4|||
27852418|NCT01440374|54356891|FG002|Part 2; Double-blind Phase|Withdrawal by Subject|5|||
27831476|NCT01808339|54308813|FG001|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
27831477|NCT01808339|54308814|FG002|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
27831478|NCT01808339|54308815|FG003|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
27831479|NCT01808339|54308816|FG004|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2|||
27831480|NCT01808339|54308817|FG005|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
27831481|NCT01808339|54308812|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
27831482|NCT01808339|54308813|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
27831483|NCT01808339|54308814|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
27831484|NCT01808339|54308815|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
27831485|NCT01808339|54308816|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
27831486|NCT01808339|54308817|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
27831487|NCT01808339|54308812|FG000|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
28078652|NCT00112437|54732800|FG019|Year 2 (12-Month Extension)|Adverse Event|0|||
28078653|NCT00112437|54732801|FG020|Year 2 (12-Month Extension)|Adverse Event|0|||
28078654|NCT00112437|54732802|FG021|Year 2 (12-Month Extension)|Adverse Event|0|||
28078655|NCT00112437|54732803|FG022|Year 2 (12-Month Extension)|Adverse Event|0|||
28078656|NCT00112437|54732804|FG023|Year 2 (12-Month Extension)|Adverse Event|0|||
28078657|NCT00112437|54732805|FG024|Year 2 (12-Month Extension)|Adverse Event|0|||
28078658|NCT00112437|54732806|FG025|Year 2 (12-Month Extension)|Adverse Event|0|||
28078659|NCT00112437|54732781|FG000|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
28078660|NCT00112437|54732782|FG001|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
28078661|NCT00112437|54732783|FG002|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
28078662|NCT00112437|54732784|FG003|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
28078663|NCT00112437|54732785|FG004|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
28162699|NCT01373151|54833026|FG001|Period 1|Lack of Efficacy|0|||
28162700|NCT01373151|54833027|FG002|Period 1|Lack of Efficacy|0|||
28162701|NCT01373151|54833028|FG003|Period 1|Lack of Efficacy|0|||
28162702|NCT01373151|54833029|FG004|Period 1|Lack of Efficacy|1|||
28162703|NCT01373151|54833030|FG005|Period 1|Lack of Efficacy|0|||
28162704|NCT01373151|54833031|FG006|Period 1|Lack of Efficacy|0|||
28162705|NCT01373151|54833025|FG000|Period 1|Adverse Event|0|||
28162706|NCT01373151|54833026|FG001|Period 1|Adverse Event|0|||
28162707|NCT01373151|54833027|FG002|Period 1|Adverse Event|1|||
28162708|NCT01373151|54833028|FG003|Period 1|Adverse Event|0|||
28162709|NCT01373151|54833029|FG004|Period 1|Adverse Event|4|||
28162710|NCT01373151|54833030|FG005|Period 1|Adverse Event|3|||
28162711|NCT01373151|54833031|FG006|Period 1|Adverse Event|0|||
28162712|NCT01373151|54833025|FG000|Period 1|Withdrawal by Subject|2|||
28162713|NCT01373151|54833026|FG001|Period 1|Withdrawal by Subject|0|||
28162714|NCT01373151|54833027|FG002|Period 1|Withdrawal by Subject|3|||
28162715|NCT01373151|54833028|FG003|Period 1|Withdrawal by Subject|1|||
28162716|NCT01373151|54833029|FG004|Period 1|Withdrawal by Subject|0|||
28162717|NCT01373151|54833030|FG005|Period 1|Withdrawal by Subject|1|||
28162718|NCT01373151|54833031|FG006|Period 1|Withdrawal by Subject|0|||
28162719|NCT01373151|54833025|FG000|Period 2|Lack of Efficacy|9|||
28162720|NCT01373151|54833026|FG001|Period 2|Lack of Efficacy|0|||
28162721|NCT01373151|54833027|FG002|Period 2|Lack of Efficacy|0|||
28162722|NCT01373151|54833028|FG003|Period 2|Lack of Efficacy|1|||
28162723|NCT01373151|54833029|FG004|Period 2|Lack of Efficacy|2|||
28162724|NCT01373151|54833030|FG005|Period 2|Lack of Efficacy|0|||
28162725|NCT01373151|54833031|FG006|Period 2|Lack of Efficacy|3|||
28162726|NCT01373151|54833025|FG000|Period 2|Adverse Event|0|||
28162727|NCT01373151|54833026|FG001|Period 2|Adverse Event|0|||
28162728|NCT01373151|54833027|FG002|Period 2|Adverse Event|3|||
28162729|NCT01373151|54833028|FG003|Period 2|Adverse Event|3|||
28162730|NCT01373151|54833029|FG004|Period 2|Adverse Event|0|||
28162731|NCT01373151|54833030|FG005|Period 2|Adverse Event|0|||
28162732|NCT01373151|54833031|FG006|Period 2|Adverse Event|1|||
28162733|NCT01373151|54833025|FG000|Period 2|subject request to discontinue|0|||
28162734|NCT01373151|54833026|FG001|Period 2|subject request to discontinue|1|||
28162735|NCT01373151|54833027|FG002|Period 2|subject request to discontinue|0|||
28162736|NCT01373151|54833028|FG003|Period 2|subject request to discontinue|0|||
28162737|NCT01373151|54833029|FG004|Period 2|subject request to discontinue|0|||
28162738|NCT01373151|54833030|FG005|Period 2|subject request to discontinue|0|||
28162739|NCT01373151|54833031|FG006|Period 2|subject request to discontinue|0|||
28162740|NCT01373151|54833025|FG000|Period 2|Withdrawal by Subject|0|||
28162741|NCT01373151|54833026|FG001|Period 2|Withdrawal by Subject|0|||
28162742|NCT01373151|54833027|FG002|Period 2|Withdrawal by Subject|0|||
28162743|NCT01373151|54833028|FG003|Period 2|Withdrawal by Subject|1|||
28162744|NCT01373151|54833029|FG004|Period 2|Withdrawal by Subject|0|||
28162745|NCT01373151|54833030|FG005|Period 2|Withdrawal by Subject|0|||
28162746|NCT01373151|54833031|FG006|Period 2|Withdrawal by Subject|0|||
28162747|NCT01373151|54833025|FG000|Period 2|Other|0|||
28162748|NCT01373151|54833026|FG001|Period 2|Other|0|||
28162749|NCT01373151|54833027|FG002|Period 2|Other|1|||
28162750|NCT01373151|54833028|FG003|Period 2|Other|0|||
28162751|NCT01373151|54833029|FG004|Period 2|Other|0|||
28162752|NCT01373151|54833030|FG005|Period 2|Other|0|||
28162753|NCT01373151|54833031|FG006|Period 2|Other|1|||
28162754|NCT01660906|54833047|FG000|Overall Study|Discontinued due to study drug toxicity|3|||
28162755|NCT03015181|54833067|FG000|Overall Study|Enrolled, but product never administered|1|||
28162756|NCT03015181|54833068|FG001|Overall Study|Enrolled, but product never administered|0|||
28162757|NCT03015181|54833069|FG002|Overall Study|Enrolled, but product never administered|0|||
28162758|NCT03015181|54833070|FG003|Overall Study|Enrolled, but product never administered|0|||
28162759|NCT03015181|54833071|FG004|Overall Study|Enrolled, but product never administered|0|||
28162760|NCT03015181|54833072|FG005|Overall Study|Enrolled, but product never administered|0|||
28162761|NCT03015181|54833073|FG006|Overall Study|Enrolled, but product never administered|0|||
28162762|NCT03015181|54833067|FG000|Overall Study|Withdrawal by Subject|0|||
28162763|NCT03015181|54833068|FG001|Overall Study|Withdrawal by Subject|0|||
28162764|NCT03015181|54833069|FG002|Overall Study|Withdrawal by Subject|0|||
28162765|NCT03015181|54833070|FG003|Overall Study|Withdrawal by Subject|0|||
28162766|NCT03015181|54833071|FG004|Overall Study|Withdrawal by Subject|0|||
28162767|NCT03015181|54833072|FG005|Overall Study|Withdrawal by Subject|1|||
28162768|NCT03015181|54833073|FG006|Overall Study|Withdrawal by Subject|0|||
28162769|NCT03015181|54833067|FG000|Overall Study|Physician Decision|0|||
28162770|NCT03015181|54833068|FG001|Overall Study|Physician Decision|0|||
28162771|NCT03015181|54833069|FG002|Overall Study|Physician Decision|0|||
28162772|NCT03015181|54833070|FG003|Overall Study|Physician Decision|0|||
28162773|NCT03015181|54833071|FG004|Overall Study|Physician Decision|0|||
28162774|NCT03015181|54833072|FG005|Overall Study|Physician Decision|0|||
28162775|NCT03015181|54833073|FG006|Overall Study|Physician Decision|1|||
28162776|NCT00960297|54833122|FG000|Overall Study|Physician Decision|1|||
28162777|NCT00960297|54833122|FG000|Overall Study|Venous port infection|1|||
28162778|NCT00960297|54833122|FG000|Overall Study|Disease progression|1|||
28162779|NCT03018691|54833129|FG000|Overall Study|Adverse Event|1|||
28162780|NCT03018691|54833130|FG001|Overall Study|Adverse Event|1|||
27831488|NCT01808339|54308813|FG001|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
28162781|NCT03018691|54833131|FG002|Overall Study|Adverse Event|4|||
28162782|NCT03018691|54833129|FG000|Overall Study|Lack of Efficacy|0|||
27831489|NCT01808339|54308814|FG002|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
28162783|NCT03018691|54833130|FG001|Overall Study|Lack of Efficacy|0|||
28162784|NCT03018691|54833131|FG002|Overall Study|Lack of Efficacy|1|||
28162785|NCT03018691|54833129|FG000|Overall Study|Withdrawal by Subject|0|||
28162786|NCT03018691|54833130|FG001|Overall Study|Withdrawal by Subject|0|||
28162787|NCT03018691|54833131|FG002|Overall Study|Withdrawal by Subject|1|||
28162788|NCT03018691|54833129|FG000|Overall Study|Withdrawal by parent/guardian|1|||
28162789|NCT03018691|54833130|FG001|Overall Study|Withdrawal by parent/guardian|0|||
28162790|NCT03018691|54833131|FG002|Overall Study|Withdrawal by parent/guardian|1|||
27852419|NCT01440374|54356892|FG003|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
27852420|NCT01440374|54356889|FG000|Part 2; Double-blind Phase|Protocol Violation|0|||
27852421|NCT01440374|54356890|FG001|Part 2; Double-blind Phase|Protocol Violation|0|||
27852422|NCT01440374|54356891|FG002|Part 2; Double-blind Phase|Protocol Violation|1|||
27852423|NCT01440374|54356892|FG003|Part 2; Double-blind Phase|Protocol Violation|0|||
27852424|NCT01440374|54356889|FG000|Part 2; Double-blind Phase|Lack of Efficacy|0|||
27852425|NCT01440374|54356890|FG001|Part 2; Double-blind Phase|Lack of Efficacy|1|||
27852426|NCT01440374|54356891|FG002|Part 2; Double-blind Phase|Lack of Efficacy|0|||
27852427|NCT01440374|54356892|FG003|Part 2; Double-blind Phase|Lack of Efficacy|0|||
27852428|NCT01440374|54356889|FG000|Part 2; Double-blind Phase|Adverse Event|0|||
27852429|NCT01440374|54356890|FG001|Part 2; Double-blind Phase|Adverse Event|7|||
27852430|NCT01440374|54356891|FG002|Part 2; Double-blind Phase|Adverse Event|31|||
27852431|NCT01440374|54356892|FG003|Part 2; Double-blind Phase|Adverse Event|0|||
27852432|NCT01440374|54356889|FG000|Part 2; Double-blind Phase|Not treated|0|||
27852433|NCT01440374|54356890|FG001|Part 2; Double-blind Phase|Not treated|0|||
27852434|NCT01440374|54356891|FG002|Part 2; Double-blind Phase|Not treated|1|||
28078664|NCT00112437|54732786|FG005|Year 2 (12-Month Extension)|Lack of Efficacy|1|||
28078665|NCT00112437|54732787|FG006|Year 2 (12-Month Extension)|Lack of Efficacy|6|||
28078666|NCT00112437|54732788|FG007|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
28078667|NCT00112437|54732789|FG008|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
27852435|NCT01440374|54356892|FG003|Part 2; Double-blind Phase|Not treated|0|||
27852436|NCT01440374|54356889|FG000|Part 3: Extension|Withdrawal by Subject|0|||
27852437|NCT01440374|54356890|FG001|Part 3: Extension|Withdrawal by Subject|0|||
27852438|NCT01440374|54356891|FG002|Part 3: Extension|Withdrawal by Subject|0|||
27852439|NCT01440374|54356892|FG003|Part 3: Extension|Withdrawal by Subject|5|||
27852440|NCT01440374|54356889|FG000|Part 3: Extension|Adverse Event|0|||
27852441|NCT01440374|54356890|FG001|Part 3: Extension|Adverse Event|0|||
27852442|NCT01440374|54356891|FG002|Part 3: Extension|Adverse Event|0|||
27852443|NCT01440374|54356892|FG003|Part 3: Extension|Adverse Event|13|||
27943845|NCT02151981|54600907|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
27943846|NCT02151981|54600908|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
27943847|NCT02151981|54600907|FG000|Overall Study|Patient had no clinical benefit|1|||
27943848|NCT02151981|54600908|FG001|Overall Study|Patient had no clinical benefit|0|||
27943849|NCT02151981|54600907|FG000|Overall Study|Unwilling to continue to follow up visit|0|||
28078668|NCT00112437|54732790|FG009|Year 2 (12-Month Extension)|Lack of Efficacy|2|||
28078669|NCT00112437|54732791|FG010|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
28078670|NCT00112437|54732792|FG011|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
28078671|NCT00112437|54732793|FG012|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
28078672|NCT00112437|54732794|FG013|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
28078673|NCT00112437|54732795|FG014|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
28078674|NCT00112437|54732796|FG015|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
28078675|NCT00112437|54732797|FG016|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
28078676|NCT00112437|54732798|FG017|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
28078677|NCT00112437|54732799|FG018|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
28078678|NCT00112437|54732800|FG019|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
28078679|NCT00112437|54732801|FG020|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
28078680|NCT00112437|54732802|FG021|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
28078681|NCT00112437|54732803|FG022|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
28078682|NCT00112437|54732804|FG023|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
28078683|NCT00112437|54732805|FG024|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
28078684|NCT00112437|54732806|FG025|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
28078685|NCT00112437|54732781|FG000|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
28078686|NCT00112437|54732782|FG001|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
28078687|NCT00112437|54732783|FG002|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
28078688|NCT00112437|54732784|FG003|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
28078689|NCT00112437|54732785|FG004|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
28078690|NCT00112437|54732786|FG005|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
28078691|NCT00112437|54732787|FG006|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
28078692|NCT00112437|54732788|FG007|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
27852444|NCT01440374|54356889|FG000|Part 3: Extension|Physician Decision|0|||
28162791|NCT03012061|54833144|FG000|Overall Study|Withdrawal by Subject|1|||
28162792|NCT03012061|54833145|FG001|Overall Study|Withdrawal by Subject|5|||
28162793|NCT03012061|54833146|FG002|Overall Study|Withdrawal by Subject|4|||
28162794|NCT03012061|54833144|FG000|Overall Study|Investigator Site Closed|1|||
28162795|NCT03012061|54833145|FG001|Overall Study|Investigator Site Closed|2|||
28162796|NCT03012061|54833146|FG002|Overall Study|Investigator Site Closed|0|||
28162797|NCT03012061|54833144|FG000|Overall Study|Lost to Follow-up|2|||
28162798|NCT03012061|54833145|FG001|Overall Study|Lost to Follow-up|1|||
28162799|NCT03012061|54833146|FG002|Overall Study|Lost to Follow-up|0|||
28162800|NCT03012061|54833144|FG000|Overall Study|Study closed/ Terminated|0|||
28162801|NCT03012061|54833145|FG001|Overall Study|Study closed/ Terminated|0|||
28162802|NCT03012061|54833146|FG002|Overall Study|Study closed/ Terminated|1|||
28162803|NCT03012061|54833144|FG000|Overall Study|Met Protocol Withdrawal Criterion|0|||
28162804|NCT03012061|54833145|FG001|Overall Study|Met Protocol Withdrawal Criterion|0|||
28162805|NCT03012061|54833146|FG002|Overall Study|Met Protocol Withdrawal Criterion|1|||
28162806|NCT03012061|54833144|FG000|Overall Study|Protocol Violation|0|||
28162807|NCT03012061|54833145|FG001|Overall Study|Protocol Violation|0|||
28162808|NCT03012061|54833146|FG002|Overall Study|Protocol Violation|2|||
28162809|NCT03012061|54833144|FG000|Overall Study|Lack of Efficacy|0|||
28162810|NCT03012061|54833145|FG001|Overall Study|Lack of Efficacy|1|||
28162811|NCT03012061|54833146|FG002|Overall Study|Lack of Efficacy|0|||
28162812|NCT03012061|54833144|FG000|Overall Study|Adverse Event|2|||
28162813|NCT03012061|54833145|FG001|Overall Study|Adverse Event|0|||
28162814|NCT03012061|54833146|FG002|Overall Study|Adverse Event|0|||
28162815|NCT03010501|54833154|FG000|Study Week 1|Withdrawal by Subject|2|||
28162816|NCT03010501|54833155|FG001|Study Week 1|Withdrawal by Subject|1|||
28162817|NCT03010501|54833156|FG002|Study Week 1|Withdrawal by Subject|0|||
28162818|NCT03010501|54833157|FG003|Study Week 1|Withdrawal by Subject|2|||
28162819|NCT03010501|54833158|FG004|Study Week 1|Withdrawal by Subject|0|||
28162820|NCT03010501|54833159|FG005|Study Week 1|Withdrawal by Subject|0|||
28078693|NCT00112437|54732789|FG008|Year 2 (12-Month Extension)|Lost to Follow-up|1|||
28078694|NCT00112437|54732790|FG009|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
28078695|NCT00112437|54732791|FG010|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
28078696|NCT00112437|54732792|FG011|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
27852445|NCT01440374|54356890|FG001|Part 3: Extension|Physician Decision|0|||
27852446|NCT01440374|54356891|FG002|Part 3: Extension|Physician Decision|0|||
27852447|NCT01440374|54356892|FG003|Part 3: Extension|Physician Decision|14|||
27852448|NCT01666782|54357040|FG000|Overall Study|Received 2 doses of vaccine|0|||
27852449|NCT01666782|54357041|FG001|Overall Study|Received 2 doses of vaccine|1|||
27852450|NCT01666782|54357040|FG000|Overall Study|Enrolled both years; year 1 data used|4|||
27852451|NCT01666782|54357041|FG001|Overall Study|Enrolled both years; year 1 data used|0|||
27852452|NCT01439360|54357057|FG000|Overall Study|Adverse Event|4|||
27852453|NCT01439360|54357058|FG001|Overall Study|Adverse Event|16|||
27852454|NCT01439360|54357057|FG000|Overall Study|Lost to Follow-up|43|||
27852455|NCT01439360|54357058|FG001|Overall Study|Lost to Follow-up|58|||
27852456|NCT01439360|54357057|FG000|Overall Study|Others|10|||
28078697|NCT00112437|54732793|FG012|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
28078698|NCT00112437|54732794|FG013|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
27852457|NCT01439360|54357058|FG001|Overall Study|Others|5|||
27852458|NCT01439360|54357057|FG000|Overall Study|Protocol Violation|1|||
27852459|NCT01439360|54357058|FG001|Overall Study|Protocol Violation|0|||
27852460|NCT01439360|54357057|FG000|Overall Study|Withdrawal by Subject|140|||
27852461|NCT01439360|54357058|FG001|Overall Study|Withdrawal by Subject|129|||
27852462|NCT01439204|54357235|FG000|Overall Study|Withdrawal by Subject|0|||
27852463|NCT01439204|54357236|FG001|Overall Study|Withdrawal by Subject|1|||
27852464|NCT01439204|54357235|FG000|Overall Study|Lost to Follow-up|0|||
27852465|NCT01439204|54357236|FG001|Overall Study|Lost to Follow-up|2|||
27852466|NCT01439204|54357235|FG000|Overall Study|No longer meets study criteria|1|||
27852467|NCT01439204|54357236|FG001|Overall Study|No longer meets study criteria|0|||
27852468|NCT01439204|54357235|FG000|Overall Study|poor/non-compliance|3|||
27852469|NCT01439204|54357236|FG001|Overall Study|poor/non-compliance|0|||
28078699|NCT00112437|54732795|FG014|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
28078700|NCT00112437|54732796|FG015|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
28078701|NCT00112437|54732797|FG016|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
28078702|NCT00112437|54732798|FG017|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
28162821|NCT03010501|54833154|FG000|Study Week 3|Withdrawal by Subject|0|||
27852470|NCT01439126|54357282|FG000|Overall Study|Adverse Event|2|||
28162822|NCT03010501|54833155|FG001|Study Week 3|Withdrawal by Subject|0|||
28162823|NCT03010501|54833156|FG002|Study Week 3|Withdrawal by Subject|0|||
28162824|NCT03010501|54833157|FG003|Study Week 3|Withdrawal by Subject|1|||
28162825|NCT03010501|54833158|FG004|Study Week 3|Withdrawal by Subject|0|||
28078703|NCT00112437|54732799|FG018|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
28078704|NCT00112437|54732800|FG019|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
28162826|NCT03010501|54833159|FG005|Study Week 3|Withdrawal by Subject|0|||
27852471|NCT01439126|54357283|FG001|Overall Study|Adverse Event|0|||
27852472|NCT01439126|54357282|FG000|Overall Study|Withdrawal by Subject|5|||
28078705|NCT00112437|54732801|FG020|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
28078706|NCT00112437|54732802|FG021|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
28162827|NCT03002623|54833169|FG000|Overall Study|Lost to Follow-up|1|||
28162828|NCT03002623|54833170|FG001|Overall Study|Lost to Follow-up|0|||
28078707|NCT00112437|54732803|FG022|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
28078708|NCT00112437|54732804|FG023|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
28078709|NCT00112437|54732805|FG024|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
28078710|NCT00112437|54732806|FG025|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
28078711|NCT00112437|54732781|FG000|Year 2 (12-Month Extension)|Protocol Violation|0|||
28078712|NCT00112437|54732782|FG001|Year 2 (12-Month Extension)|Protocol Violation|0|||
28078713|NCT00112437|54732783|FG002|Year 2 (12-Month Extension)|Protocol Violation|0|||
28078714|NCT00112437|54732784|FG003|Year 2 (12-Month Extension)|Protocol Violation|0|||
28078715|NCT00112437|54732785|FG004|Year 2 (12-Month Extension)|Protocol Violation|0|||
28078716|NCT00112437|54732786|FG005|Year 2 (12-Month Extension)|Protocol Violation|0|||
28162829|NCT03002623|54833169|FG000|Overall Study|Physician Decision|1|||
28162830|NCT03002623|54833170|FG001|Overall Study|Physician Decision|1|||
28162831|NCT03010423|54833178|FG000|Overall Study|Study termination|8|||
28162832|NCT03002311|54833184|FG000|Overall Study|Lost to Follow-up|13|||
28162833|NCT03002311|54833185|FG001|Overall Study|Lost to Follow-up|26|||
28162834|NCT03002311|54833184|FG000|Overall Study|Referral provider called to schedule app|3|||
28078717|NCT00112437|54732787|FG006|Year 2 (12-Month Extension)|Protocol Violation|0|||
28078718|NCT00112437|54732788|FG007|Year 2 (12-Month Extension)|Protocol Violation|0|||
28162835|NCT03002311|54833185|FG001|Overall Study|Referral provider called to schedule app|3|||
28162836|NCT03002311|54833184|FG000|Overall Study|Physician Decision|3|||
28162837|NCT03002311|54833185|FG001|Overall Study|Physician Decision|1|||
28162838|NCT03002077|54833191|FG000|Overall Study|Non-compliance with Study Drug|4|||
28162839|NCT03002077|54833191|FG000|Overall Study|Non-compliance w/Background ADT|1|||
28162840|NCT03002077|54833191|FG000|Overall Study|Study Terminated by Sponsor|257|||
28162841|NCT03002077|54833191|FG000|Overall Study|Site Terminated by Sponsor|5|||
28162842|NCT03002077|54833191|FG000|Overall Study|Miscellaneous Reasons|10|||
28162843|NCT03002077|54833191|FG000|Overall Study|Adverse Event|23|||
28162844|NCT03002077|54833191|FG000|Overall Study|Lack of Efficacy|20|||
28162845|NCT03002077|54833191|FG000|Overall Study|Withdrawal by Subject|72|||
28162846|NCT03002077|54833191|FG000|Overall Study|Lost to Follow-up|21|||
28162847|NCT03002077|54833191|FG000|Overall Study|Pregnancy|4|||
28162848|NCT03002077|54833191|FG000|Overall Study|Protocol Violation|21|||
28162849|NCT03008005|54833198|FG000|Overall Study|Physician Decision|1|||
28162850|NCT03008005|54833199|FG001|Overall Study|Physician Decision|0|||
28162851|NCT03008005|54833200|FG002|Overall Study|Physician Decision|0|||
28162852|NCT03008005|54833198|FG000|Overall Study|Withdrawal by Subject|1|||
28162853|NCT03008005|54833199|FG001|Overall Study|Withdrawal by Subject|0|||
28162854|NCT03008005|54833200|FG002|Overall Study|Withdrawal by Subject|0|||
28162855|NCT03008005|54833198|FG000|Overall Study|Ineligible|0|||
28162856|NCT03008005|54833199|FG001|Overall Study|Ineligible|1|||
28162857|NCT03008005|54833200|FG002|Overall Study|Ineligible|0|||
28162858|NCT02440425|54833217|FG000|Overall Study|Death likely due to disease progression|1|||
28162859|NCT02440425|54833217|FG000|Overall Study|Withdrawal by Subject|2|||
28162860|NCT02440425|54833217|FG000|Overall Study|Adverse Event|1|||
28162861|NCT02440425|54833217|FG000|Overall Study|Adverse Event/Ineligible|1|||
28162862|NCT03001219|54833232|FG000|Proof of Concept|Study Termination by Sponsor|0|||
28162863|NCT03001219|54833233|FG001|Proof of Concept|Study Termination by Sponsor|1|||
28162864|NCT03001219|54833232|FG000|Proof of Concept|Withdrawal by Subject|0|||
28162865|NCT03001219|54833233|FG001|Proof of Concept|Withdrawal by Subject|4|||
28162866|NCT03001219|54833232|FG000|Proof of Concept|Protocol Deviation|0|||
28162867|NCT03001219|54833233|FG001|Proof of Concept|Protocol Deviation|1|||
28162868|NCT03001219|54833232|FG000|Proof of Concept|Adverse Event|1|||
28162869|NCT03001219|54833233|FG001|Proof of Concept|Adverse Event|1|||
28162870|NCT03001219|54833232|FG000|Proof of Concept|Physician Decision|1|||
28162871|NCT03001219|54833233|FG001|Proof of Concept|Physician Decision|0|||
28162872|NCT03001219|54833232|FG000|Extension Period Analysis|Study Termination by Sponsor|0|||
28162873|NCT03001219|54833233|FG001|Extension Period Analysis|Study Termination by Sponsor|36|||
28162874|NCT03001219|54833232|FG000|Extension Period Analysis|Participant Non-Compliance|0|||
28162875|NCT03001219|54833233|FG001|Extension Period Analysis|Participant Non-Compliance|1|||
28162876|NCT03001219|54833232|FG000|Extension Period Analysis|Physician Decision|0|||
28162877|NCT03001219|54833233|FG001|Extension Period Analysis|Physician Decision|1|||
28162878|NCT03001219|54833232|FG000|Extension Period Analysis|Adverse Event|1|||
28162879|NCT03001219|54833233|FG001|Extension Period Analysis|Adverse Event|1|||
28162880|NCT03001219|54833232|FG000|Extension Period Analysis|Protocol Deviation|0|||
28162881|NCT03001219|54833233|FG001|Extension Period Analysis|Protocol Deviation|1|||
28078719|NCT00112437|54732789|FG008|Year 2 (12-Month Extension)|Protocol Violation|1|||
28078720|NCT00112437|54732790|FG009|Year 2 (12-Month Extension)|Protocol Violation|0|||
28078721|NCT00112437|54732791|FG010|Year 2 (12-Month Extension)|Protocol Violation|0|||
28162882|NCT03001219|54833232|FG000|Extension Period Analysis|Withdrawal by Subject|4|||
28162883|NCT03001219|54833233|FG001|Extension Period Analysis|Withdrawal by Subject|5|||
27831490|NCT01808339|54308815|FG003|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
28078722|NCT00112437|54732792|FG011|Year 2 (12-Month Extension)|Protocol Violation|0|||
28078723|NCT00112437|54732793|FG012|Year 2 (12-Month Extension)|Protocol Violation|0|||
28078724|NCT00112437|54732794|FG013|Year 2 (12-Month Extension)|Protocol Violation|0|||
28078725|NCT00112437|54732795|FG014|Year 2 (12-Month Extension)|Protocol Violation|0|||
28078726|NCT00112437|54732796|FG015|Year 2 (12-Month Extension)|Protocol Violation|0|||
28078727|NCT00112437|54732797|FG016|Year 2 (12-Month Extension)|Protocol Violation|0|||
28078728|NCT00112437|54732798|FG017|Year 2 (12-Month Extension)|Protocol Violation|0|||
28078729|NCT00112437|54732799|FG018|Year 2 (12-Month Extension)|Protocol Violation|0|||
28078730|NCT00112437|54732800|FG019|Year 2 (12-Month Extension)|Protocol Violation|0|||
28078731|NCT00112437|54732801|FG020|Year 2 (12-Month Extension)|Protocol Violation|0|||
28078732|NCT00112437|54732802|FG021|Year 2 (12-Month Extension)|Protocol Violation|0|||
28078733|NCT00112437|54732803|FG022|Year 2 (12-Month Extension)|Protocol Violation|0|||
27831491|NCT01808339|54308816|FG004|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
27831492|NCT01808339|54308817|FG005|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
27831493|NCT02727660|54308867|FG000|Overall Study|Lack of Efficacy|40|||
27831494|NCT02727660|54308868|FG001|Overall Study|Lack of Efficacy|40|||
28078734|NCT00112437|54732804|FG023|Year 2 (12-Month Extension)|Protocol Violation|0|||
28162884|NCT03000673|54833248|FG000|Overall Study|Withdrawal by Subject|1|||
28162885|NCT03000673|54833249|FG001|Overall Study|Withdrawal by Subject|0|||
28162886|NCT03000673|54833250|FG002|Overall Study|Withdrawal by Subject|0|||
28162887|NCT03000673|54833251|FG003|Overall Study|Withdrawal by Subject|0|||
28162888|NCT02912455|54833264|FG000|Overall Study|Withdrawal by Subject|0|||
28162889|NCT02912455|54833265|FG001|Overall Study|Withdrawal by Subject|1|||
28162890|NCT02912455|54833264|FG000|Overall Study|Lack of Efficacy|0|||
28162891|NCT02912455|54833265|FG001|Overall Study|Lack of Efficacy|1|||
27852473|NCT01439126|54357283|FG001|Overall Study|Withdrawal by Subject|21|||
27852474|NCT01439126|54357282|FG000|Overall Study|Protocol Violation|6|||
27852475|NCT01439126|54357283|FG001|Overall Study|Protocol Violation|4|||
27852476|NCT01439126|54357282|FG000|Overall Study|Lost to Follow-up|6|||
27852477|NCT01439126|54357283|FG001|Overall Study|Lost to Follow-up|3|||
27852478|NCT01439126|54357282|FG000|Overall Study|Other-Use of prohibited treatment|0|||
27852479|NCT01439126|54357283|FG001|Overall Study|Other-Use of prohibited treatment|2|||
27852480|NCT01439126|54357282|FG000|Overall Study|Other-Miscellaneous|12|||
27852481|NCT01439126|54357283|FG001|Overall Study|Other-Miscellaneous|12|||
27852482|NCT01449812|54357309|FG000|Overall Study|Migrated/moved from study area|1|||
27852483|NCT01449812|54357310|FG001|Overall Study|Migrated/moved from study area|0|||
27852484|NCT01449812|54357311|FG002|Overall Study|Migrated/moved from study area|0|||
27852485|NCT01449812|54357309|FG000|Overall Study|Withdrawal by Subject|0|||
27852486|NCT01449812|54357310|FG001|Overall Study|Withdrawal by Subject|0|||
27852487|NCT01449812|54357311|FG002|Overall Study|Withdrawal by Subject|1|||
27852488|NCT01449812|54357309|FG000|Overall Study|Lost to Follow-up|1|||
27852489|NCT01449812|54357310|FG001|Overall Study|Lost to Follow-up|0|||
27852490|NCT01449812|54357311|FG002|Overall Study|Lost to Follow-up|0|||
27852491|NCT01665144|54357364|FG000|Overall Study|New therapy for study indication|2|||
27852492|NCT01665144|54357365|FG001|Overall Study|New therapy for study indication|1|||
27852493|NCT01665144|54357364|FG000|Overall Study|Technical problems|2|||
27852494|NCT01665144|54357365|FG001|Overall Study|Technical problems|0|||
27852495|NCT01665144|54357364|FG000|Overall Study|Death|3|||
27852496|NCT01665144|54357365|FG001|Overall Study|Death|1|||
27852497|NCT01665144|54357364|FG000|Overall Study|Protocol deviation|3|||
27852498|NCT01665144|54357365|FG001|Overall Study|Protocol deviation|1|||
27852499|NCT01665144|54357364|FG000|Overall Study|Non-compliance w/study treatment|5|||
27852500|NCT01665144|54357365|FG001|Overall Study|Non-compliance w/study treatment|0|||
27852501|NCT01665144|54357364|FG000|Overall Study|Progressive disease|8|||
27852502|NCT01665144|54357365|FG001|Overall Study|Progressive disease|4|||
27852503|NCT01665144|54357364|FG000|Overall Study|Lost to Follow-up|9|||
27852504|NCT01665144|54357365|FG001|Overall Study|Lost to Follow-up|8|||
27852505|NCT01665144|54357364|FG000|Overall Study|Physician Decision|13|||
27852506|NCT01665144|54357365|FG001|Overall Study|Physician Decision|1|||
27852507|NCT01665144|54357364|FG000|Overall Study|Lack of Efficacy|16|||
27852508|NCT01665144|54357365|FG001|Overall Study|Lack of Efficacy|11|||
27852509|NCT01665144|54357364|FG000|Overall Study|Adverse Event|45|||
27852510|NCT01665144|54357365|FG001|Overall Study|Adverse Event|18|||
27852511|NCT01665144|54357364|FG000|Overall Study|Withdrawal by Subject|96|||
27852512|NCT01665144|54357365|FG001|Overall Study|Withdrawal by Subject|77|||
27852513|NCT01466660|54357500|FG000|Overall Study|Progressive Disease (RECIST 1.1)|120|||
27852514|NCT01466660|54357501|FG001|Overall Study|Progressive Disease (RECIST 1.1)|127|||
27852515|NCT01466660|54357500|FG000|Overall Study|Worsening of underlying cancer disease|5|||
27852516|NCT01466660|54357501|FG001|Overall Study|Worsening of underlying cancer disease|2|||
27852517|NCT01466660|54357500|FG000|Overall Study|Other adverse event|19|||
27852518|NCT01466660|54357501|FG001|Overall Study|Other adverse event|18|||
27943850|NCT02151981|54600908|FG001|Overall Study|Unwilling to continue to follow up visit|1|||
27943851|NCT02151981|54600907|FG000|Overall Study|Study terminated|0|||
27943852|NCT02151981|54600908|FG001|Overall Study|Study terminated|1|||
28078735|NCT00112437|54732805|FG024|Year 2 (12-Month Extension)|Protocol Violation|0|||
28078736|NCT00112437|54732806|FG025|Year 2 (12-Month Extension)|Protocol Violation|0|||
28078737|NCT00112437|54732781|FG000|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
28078738|NCT00112437|54732782|FG001|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
28078739|NCT00112437|54732783|FG002|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
28078740|NCT00112437|54732784|FG003|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
28078741|NCT00112437|54732785|FG004|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
28078742|NCT00112437|54732786|FG005|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
28078743|NCT00112437|54732787|FG006|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
28162892|NCT02912455|54833264|FG000|Overall Study|Lost to Follow-up|2|||
28162893|NCT02912455|54833265|FG001|Overall Study|Lost to Follow-up|1|||
27852519|NCT01466660|54357500|FG000|Overall Study|Protocol Violation|2|||
27852520|NCT01466660|54357501|FG001|Overall Study|Protocol Violation|1|||
27852521|NCT01466660|54357500|FG000|Overall Study|Refused continuation of trial medication|4|||
27852522|NCT01466660|54357501|FG001|Overall Study|Refused continuation of trial medication|3|||
27852523|NCT01466660|54357500|FG000|Overall Study|Other reason not defined above|10|||
27852524|NCT01466660|54357501|FG001|Overall Study|Other reason not defined above|8|||
27852525|NCT01466348|54357526|FG000|Period I - First Intervention|Withdrawal by Subject|0|||
27852526|NCT01466348|54357527|FG001|Period I - First Intervention|Withdrawal by Subject|1|||
27852527|NCT01466270|54357550|FG000|Overall Study|Withdrawal by Subject|4|||
27852528|NCT01466270|54357551|FG001|Overall Study|Withdrawal by Subject|1|||
27852529|NCT01466270|54357550|FG000|Overall Study|Physician Decision|1|||
27852530|NCT01466270|54357551|FG001|Overall Study|Physician Decision|0|||
27852531|NCT01466270|54357550|FG000|Overall Study|Lost to Follow-up|1|||
27852532|NCT01466270|54357551|FG001|Overall Study|Lost to Follow-up|3|||
27852533|NCT01466270|54357550|FG000|Overall Study|Progression|1|||
27852534|NCT01466270|54357551|FG001|Overall Study|Progression|0|||
27852535|NCT01466270|54357550|FG000|Overall Study|Toxicity|4|||
27852536|NCT01466270|54357551|FG001|Overall Study|Toxicity|1|||
27852537|NCT01466270|54357550|FG000|Overall Study|Multiple|1|||
27852538|NCT01466270|54357551|FG001|Overall Study|Multiple|1|||
27852539|NCT01466192|54357584|FG000|Overall Study|Physician Decision|1|||
27852540|NCT01466192|54357584|FG000|Overall Study|Withdrawal by Subject|3|||
27852541|NCT01438814|54357604|FG000|Overall Study|Adverse Event|3|||
27852542|NCT01438814|54357605|FG001|Overall Study|Adverse Event|3|||
27852543|NCT01438814|54357604|FG000|Overall Study|Protocol Violation|1|||
27852544|NCT01438814|54357605|FG001|Overall Study|Protocol Violation|2|||
27852545|NCT01438814|54357604|FG000|Overall Study|Lost to Follow-up|4|||
27852546|NCT01438814|54357605|FG001|Overall Study|Lost to Follow-up|3|||
27852547|NCT01438814|54357604|FG000|Overall Study|Withdrawal by Subject|4|||
27852548|NCT01438814|54357605|FG001|Overall Study|Withdrawal by Subject|2|||
27852549|NCT01438814|54357604|FG000|Overall Study|Other|2|||
27852550|NCT01438814|54357605|FG001|Overall Study|Other|4|||
27852551|NCT02926833|54358186|FG000|Overall Study|Full Consent Withdrawal|0|||
27852552|NCT02926833|54358187|FG001|Overall Study|Full Consent Withdrawal|0|||
27852553|NCT02926833|54358188|FG002|Overall Study|Full Consent Withdrawal|0|||
27852554|NCT02926833|54358189|FG003|Overall Study|Full Consent Withdrawal|2|||
27852555|NCT02926833|54358186|FG000|Overall Study|Death|1|||
27852556|NCT02926833|54358187|FG001|Overall Study|Death|1|||
27852557|NCT02926833|54358188|FG002|Overall Study|Death|1|||
27852558|NCT02926833|54358189|FG003|Overall Study|Death|7|||
27852559|NCT02926833|54358186|FG000|Overall Study|Still on study|2|||
27852560|NCT02926833|54358187|FG001|Overall Study|Still on study|3|||
27852561|NCT02926833|54358188|FG002|Overall Study|Still on study|5|||
27852562|NCT02926833|54358189|FG003|Overall Study|Still on study|14|||
27852563|NCT02926833|54358186|FG000|Overall Study|Adverse Event|0|||
27852564|NCT02926833|54358187|FG001|Overall Study|Adverse Event|0|||
27852565|NCT02926833|54358188|FG002|Overall Study|Adverse Event|1|||
27852566|NCT02926833|54358189|FG003|Overall Study|Adverse Event|0|||
27852567|NCT02851797|54358236|FG000|Overall Study|Withdrawal by Subject|4|||
27852568|NCT02851797|54358237|FG001|Overall Study|Withdrawal by Subject|2|||
27852569|NCT02851797|54358236|FG000|Overall Study|Adverse Event|3|||
27852570|NCT02851797|54358237|FG001|Overall Study|Adverse Event|0|||
27852571|NCT01666314|54358461|FG000|Overall Study|Adverse Event|3|||
27852572|NCT01666314|54358462|FG001|Overall Study|Adverse Event|13|||
27852573|NCT01666314|54358463|FG002|Overall Study|Adverse Event|7|||
27852574|NCT01666314|54358464|FG003|Overall Study|Adverse Event|7|||
27852575|NCT01666314|54358461|FG000|Overall Study|Progressive Disease|11|||
27852576|NCT01666314|54358462|FG001|Overall Study|Progressive Disease|9|||
27852577|NCT01666314|54358463|FG002|Overall Study|Progressive Disease|19|||
27852578|NCT01666314|54358464|FG003|Overall Study|Progressive Disease|20|||
27852579|NCT01666314|54358461|FG000|Overall Study|Symptomatic Deterioration|1|||
27852580|NCT01666314|54358462|FG001|Overall Study|Symptomatic Deterioration|0|||
27852581|NCT01666314|54358463|FG002|Overall Study|Symptomatic Deterioration|2|||
27852582|NCT01666314|54358464|FG003|Overall Study|Symptomatic Deterioration|0|||
27852583|NCT01666314|54358461|FG000|Overall Study|Unsatisfactory Therapeutic Response|7|||
27852584|NCT01666314|54358462|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
28162894|NCT04524507|54833273|FG000|Overall Study|Lost to Follow-up|2|||
27852585|NCT01666314|54358463|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
27852586|NCT01666314|54358464|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
27852587|NCT01666314|54358461|FG000|Overall Study|Withdrawal by Subject|1|||
27852588|NCT01666314|54358462|FG001|Overall Study|Withdrawal by Subject|1|||
27852589|NCT01666314|54358463|FG002|Overall Study|Withdrawal by Subject|2|||
27852590|NCT01666314|54358464|FG003|Overall Study|Withdrawal by Subject|3|||
27852591|NCT01666314|54358461|FG000|Overall Study|Reason not Specified|10|||
27852592|NCT01666314|54358462|FG001|Overall Study|Reason not Specified|7|||
27852593|NCT01666314|54358463|FG002|Overall Study|Reason not Specified|5|||
27852594|NCT01666314|54358464|FG003|Overall Study|Reason not Specified|5|||
27852595|NCT01666002|54358495|FG000|Overall Study|Lost to Follow-up|5|||
27852596|NCT01666002|54358496|FG001|Overall Study|Lost to Follow-up|0|||
27852597|NCT01665768|54358568|FG000|Overall Study|Adverse Event|3|||
27852598|NCT01665768|54358568|FG000|Overall Study|Lack of Efficacy|19|||
28078744|NCT00112437|54732788|FG007|Year 2 (12-Month Extension)|Withdrawal by Subject|2|||
27852599|NCT01665768|54358568|FG000|Overall Study|Withdrawal by Subject|1|||
27852600|NCT02584452|54358776|FG000|Overall Study|Physician Decision|1|||
27852601|NCT02584452|54358777|FG001|Overall Study|Physician Decision|1|||
27852602|NCT02584452|54358776|FG000|Overall Study|Lost to Follow-up|1|||
27852603|NCT02584452|54358777|FG001|Overall Study|Lost to Follow-up|1|||
27852604|NCT02586012|54358824|FG000|Overall Study|Withdrawal by Subject|1|||
27852605|NCT02586012|54358825|FG001|Overall Study|Withdrawal by Subject|1|||
27852606|NCT02586012|54358826|FG002|Overall Study|Withdrawal by Subject|0|||
27852607|NCT02586012|54358827|FG003|Overall Study|Withdrawal by Subject|1|||
27852608|NCT02586012|54358828|FG004|Overall Study|Withdrawal by Subject|0|||
27852609|NCT02586012|54358829|FG005|Overall Study|Withdrawal by Subject|2|||
27852610|NCT02586012|54358824|FG000|Overall Study|Protocol Violation|0|||
27852611|NCT02586012|54358825|FG001|Overall Study|Protocol Violation|0|||
27852612|NCT02586012|54358826|FG002|Overall Study|Protocol Violation|0|||
27852613|NCT02586012|54358827|FG003|Overall Study|Protocol Violation|0|||
27852614|NCT02586012|54358828|FG004|Overall Study|Protocol Violation|0|||
27852615|NCT02586012|54358829|FG005|Overall Study|Protocol Violation|1|||
27852616|NCT02586012|54358824|FG000|Overall Study|study terminated|0|||
27852617|NCT02586012|54358825|FG001|Overall Study|study terminated|2|||
27852618|NCT02586012|54358826|FG002|Overall Study|study terminated|1|||
27852619|NCT02586012|54358827|FG003|Overall Study|study terminated|1|||
27852620|NCT02586012|54358828|FG004|Overall Study|study terminated|1|||
27852621|NCT02586012|54358829|FG005|Overall Study|study terminated|0|||
27852622|NCT02582814|54358840|FG000|Overall Study|Study-specific withdrawal criteria|1|||
27852623|NCT02582814|54358841|FG001|Overall Study|Study-specific withdrawal criteria|0|||
27852624|NCT02582814|54358840|FG000|Overall Study|Withdrawal by Subject|4|||
27852625|NCT02582814|54358841|FG001|Overall Study|Withdrawal by Subject|3|||
27852626|NCT02582814|54358840|FG000|Overall Study|Adverse Event|4|||
27852627|NCT02582814|54358841|FG001|Overall Study|Adverse Event|4|||
27852628|NCT02585934|54358989|FG000|Overall Study|Lost to Follow-up|2|||
27852629|NCT02585934|54358990|FG001|Overall Study|Lost to Follow-up|2|||
27852630|NCT02585934|54358989|FG000|Overall Study|Protocol Violation|14|||
27852631|NCT02585934|54358990|FG001|Overall Study|Protocol Violation|11|||
27852632|NCT02585934|54358989|FG000|Overall Study|Adverse Event|21|||
27831495|NCT02727660|54308869|FG002|Overall Study|Lack of Efficacy|70|||
27831496|NCT02727660|54308867|FG000|Overall Study|Adverse Event|28|||
27831497|NCT02727660|54308868|FG001|Overall Study|Adverse Event|21|||
27831498|NCT02727660|54308869|FG002|Overall Study|Adverse Event|32|||
27831499|NCT02727660|54308867|FG000|Overall Study|Withdrawal by Subject|26|||
27831500|NCT02727660|54308868|FG001|Overall Study|Withdrawal by Subject|25|||
27831501|NCT02727660|54308869|FG002|Overall Study|Withdrawal by Subject|30|||
27831502|NCT02727660|54308867|FG000|Overall Study|Physician Decision|3|||
27831503|NCT02727660|54308868|FG001|Overall Study|Physician Decision|8|||
27831504|NCT02727660|54308869|FG002|Overall Study|Physician Decision|14|||
27831505|NCT02727660|54308867|FG000|Overall Study|Lost to Follow-up|5|||
28162895|NCT04524507|54833274|FG001|Overall Study|Lost to Follow-up|4|||
28162896|NCT04524507|54833273|FG000|Overall Study|Withdrawal by Subject|2|||
28162897|NCT04524507|54833274|FG001|Overall Study|Withdrawal by Subject|9|||
28162898|NCT04524507|54833273|FG000|Overall Study|Death|2|||
28162899|NCT04524507|54833274|FG001|Overall Study|Death|10|||
27831506|NCT02727660|54308868|FG001|Overall Study|Lost to Follow-up|9|||
27831507|NCT02727660|54308869|FG002|Overall Study|Lost to Follow-up|8|||
27831508|NCT02727660|54308867|FG000|Overall Study|Protocol Violation|7|||
27831509|NCT02727660|54308868|FG001|Overall Study|Protocol Violation|5|||
27831510|NCT02727660|54308869|FG002|Overall Study|Protocol Violation|5|||
27852633|NCT02585934|54358990|FG001|Overall Study|Adverse Event|22|||
28162900|NCT02999191|54833283|FG000|Wash-out Period 1 [21 Days]|Adverse Event|0|||
28162901|NCT02999191|54833284|FG001|Wash-out Period 1 [21 Days]|Adverse Event|1|||
28162902|NCT02999191|54833285|FG002|Wash-out Period 1 [21 Days]|Adverse Event|0|||
28162903|NCT02531698|54833295|FG000|Overall Study|Adverse Event|2|||
27852634|NCT02585934|54358989|FG000|Overall Study|Physician Decision|3|||
28162904|NCT02531698|54833296|FG001|Overall Study|Adverse Event|1|||
28162905|NCT02531698|54833295|FG000|Overall Study|Withdrawal by Subject|6|||
28162906|NCT02531698|54833296|FG001|Overall Study|Withdrawal by Subject|1|||
28162907|NCT02531698|54833295|FG000|Overall Study|Protocol Violation|2|||
28162908|NCT02531698|54833296|FG001|Overall Study|Protocol Violation|0|||
28162909|NCT02531698|54833295|FG000|Overall Study|Lost to Follow-up|1|||
28162910|NCT02531698|54833296|FG001|Overall Study|Lost to Follow-up|0|||
28162911|NCT02998021|54833313|FG000|Overall Study|Withdrawal by Subject|3|||
28162912|NCT02998021|54833314|FG001|Overall Study|Withdrawal by Subject|1|||
27831511|NCT02727660|54308867|FG000|Overall Study|Protocol Specified Disc. Criteria|5|||
28162913|NCT02998021|54833313|FG000|Overall Study|unsafe home|0|||
27831512|NCT02727660|54308868|FG001|Overall Study|Protocol Specified Disc. Criteria|5|||
27831513|NCT02727660|54308869|FG002|Overall Study|Protocol Specified Disc. Criteria|2|||
27831514|NCT02727660|54308867|FG000|Overall Study|Administrative Reasons|2|||
27831515|NCT02727660|54308868|FG001|Overall Study|Administrative Reasons|3|||
27852635|NCT02585934|54358990|FG001|Overall Study|Physician Decision|2|||
27852636|NCT02585934|54358989|FG000|Overall Study|Withdrawal by Subject|7|||
27852637|NCT02585934|54358990|FG001|Overall Study|Withdrawal by Subject|21|||
27852638|NCT02585934|54358989|FG000|Overall Study|Lack of Efficacy|2|||
27852639|NCT02585934|54358990|FG001|Overall Study|Lack of Efficacy|1|||
27852640|NCT02585934|54358989|FG000|Overall Study|Death|2|||
27831516|NCT02727660|54308869|FG002|Overall Study|Administrative Reasons|4|||
27831517|NCT01784861|54308883|FG000|Overall Study|Adverse Event|0|||
28078745|NCT00112437|54732789|FG008|Year 2 (12-Month Extension)|Withdrawal by Subject|4|||
28078746|NCT00112437|54732790|FG009|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
28078747|NCT00112437|54732791|FG010|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
28078748|NCT00112437|54732792|FG011|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
28078749|NCT00112437|54732793|FG012|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
28078750|NCT00112437|54732794|FG013|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
28078751|NCT00112437|54732795|FG014|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
28078752|NCT00112437|54732796|FG015|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
28078753|NCT00112437|54732797|FG016|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
28078754|NCT00112437|54732798|FG017|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
28078755|NCT00112437|54732799|FG018|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
28078756|NCT00112437|54732800|FG019|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
28078757|NCT00112437|54732801|FG020|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
28078758|NCT00112437|54732802|FG021|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
28078759|NCT00112437|54732803|FG022|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
28078760|NCT00112437|54732804|FG023|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
28078761|NCT00112437|54732805|FG024|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
28078762|NCT00112437|54732806|FG025|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
28078763|NCT00112437|54732781|FG000|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
28078764|NCT00112437|54732782|FG001|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
28078765|NCT00112437|54732783|FG002|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
28078766|NCT00112437|54732784|FG003|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
28078767|NCT00112437|54732785|FG004|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
28078768|NCT00112437|54732786|FG005|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
28078769|NCT00112437|54732787|FG006|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
28078770|NCT00112437|54732788|FG007|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
28078771|NCT00112437|54732789|FG008|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
28078772|NCT00112437|54732790|FG009|Year 2 (12-Month Extension)|Patient stopped taking medication|1|||
28078773|NCT00112437|54732791|FG010|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
28078774|NCT00112437|54732792|FG011|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
28078775|NCT00112437|54732793|FG012|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
28078776|NCT00112437|54732794|FG013|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
28078777|NCT00112437|54732795|FG014|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
28078778|NCT00112437|54732796|FG015|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
28078779|NCT00112437|54732797|FG016|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
28078780|NCT00112437|54732798|FG017|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
28078781|NCT00112437|54732799|FG018|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
28078782|NCT00112437|54732800|FG019|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
28078783|NCT00112437|54732801|FG020|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
28078784|NCT00112437|54732802|FG021|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
27831518|NCT01784861|54308884|FG001|Overall Study|Adverse Event|0|||
27831519|NCT01784861|54308885|FG002|Overall Study|Adverse Event|1|||
27831520|NCT01784861|54308886|FG003|Overall Study|Adverse Event|2|||
27831521|NCT01784861|54308887|FG004|Overall Study|Adverse Event|1|||
27831522|NCT01784861|54308888|FG005|Overall Study|Adverse Event|0|||
27831523|NCT01784861|54308883|FG000|Overall Study|Withdrawal by Subject|0|||
27831524|NCT01784861|54308884|FG001|Overall Study|Withdrawal by Subject|0|||
27831525|NCT01784861|54308885|FG002|Overall Study|Withdrawal by Subject|0|||
27831526|NCT01784861|54308886|FG003|Overall Study|Withdrawal by Subject|1|||
27831527|NCT01784861|54308887|FG004|Overall Study|Withdrawal by Subject|0|||
27831528|NCT01784861|54308888|FG005|Overall Study|Withdrawal by Subject|0|||
27831529|NCT01784861|54308883|FG000|Overall Study|Physician Decision|0|||
27831530|NCT01784861|54308884|FG001|Overall Study|Physician Decision|0|||
27831531|NCT01784861|54308885|FG002|Overall Study|Physician Decision|0|||
27831532|NCT01784861|54308886|FG003|Overall Study|Physician Decision|2|||
27831533|NCT01784861|54308887|FG004|Overall Study|Physician Decision|0|||
27831534|NCT01784861|54308888|FG005|Overall Study|Physician Decision|1|||
27831535|NCT02727192|54308962|FG000|Overall Study|Lost to Follow-up|1|||
27831536|NCT02727192|54308963|FG001|Overall Study|Lost to Follow-up|0|||
27852641|NCT02585934|54358990|FG001|Overall Study|Death|0|||
27852642|NCT02585934|54358989|FG000|Overall Study|Caregiver Withdrew Consent|7|||
28078785|NCT00112437|54732803|FG022|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
28078786|NCT00112437|54732804|FG023|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
28078787|NCT00112437|54732805|FG024|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
28078788|NCT00112437|54732806|FG025|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
27831537|NCT02727192|54308964|FG002|Overall Study|Lost to Follow-up|0|||
27831538|NCT00705666|54308984|FG000|Overall Study|No post-treatment questionnaire|279|||
28078789|NCT00112437|54732781|FG000|Year 2 (12-Month Extension)|patient was out of windows|0|||
28078790|NCT00112437|54732782|FG001|Year 2 (12-Month Extension)|patient was out of windows|0|||
28078791|NCT00112437|54732783|FG002|Year 2 (12-Month Extension)|patient was out of windows|0|||
28078792|NCT00112437|54732784|FG003|Year 2 (12-Month Extension)|patient was out of windows|0|||
28078793|NCT00112437|54732785|FG004|Year 2 (12-Month Extension)|patient was out of windows|0|||
28078794|NCT00112437|54732786|FG005|Year 2 (12-Month Extension)|patient was out of windows|0|||
28078795|NCT00112437|54732787|FG006|Year 2 (12-Month Extension)|patient was out of windows|0|||
28078796|NCT00112437|54732788|FG007|Year 2 (12-Month Extension)|patient was out of windows|0|||
28078797|NCT00112437|54732789|FG008|Year 2 (12-Month Extension)|patient was out of windows|0|||
28078798|NCT00112437|54732790|FG009|Year 2 (12-Month Extension)|patient was out of windows|1|||
28078799|NCT00112437|54732791|FG010|Year 2 (12-Month Extension)|patient was out of windows|0|||
28078800|NCT00112437|54732792|FG011|Year 2 (12-Month Extension)|patient was out of windows|0|||
28078801|NCT00112437|54732793|FG012|Year 2 (12-Month Extension)|patient was out of windows|0|||
28078802|NCT00112437|54732794|FG013|Year 2 (12-Month Extension)|patient was out of windows|0|||
28078803|NCT00112437|54732795|FG014|Year 2 (12-Month Extension)|patient was out of windows|0|||
28078804|NCT00112437|54732796|FG015|Year 2 (12-Month Extension)|patient was out of windows|0|||
28078805|NCT00112437|54732797|FG016|Year 2 (12-Month Extension)|patient was out of windows|0|||
28078806|NCT00112437|54732798|FG017|Year 2 (12-Month Extension)|patient was out of windows|0|||
28078807|NCT00112437|54732799|FG018|Year 2 (12-Month Extension)|patient was out of windows|0|||
28078808|NCT00112437|54732800|FG019|Year 2 (12-Month Extension)|patient was out of windows|0|||
28078809|NCT00112437|54732801|FG020|Year 2 (12-Month Extension)|patient was out of windows|0|||
28078810|NCT00112437|54732802|FG021|Year 2 (12-Month Extension)|patient was out of windows|0|||
28078811|NCT00112437|54732803|FG022|Year 2 (12-Month Extension)|patient was out of windows|0|||
28078812|NCT00112437|54732804|FG023|Year 2 (12-Month Extension)|patient was out of windows|0|||
28078813|NCT00112437|54732805|FG024|Year 2 (12-Month Extension)|patient was out of windows|0|||
28078814|NCT00112437|54732806|FG025|Year 2 (12-Month Extension)|patient was out of windows|0|||
28078815|NCT00112437|54732781|FG000|Year 2 (12-Month Extension)|Moved|0|||
28078816|NCT00112437|54732782|FG001|Year 2 (12-Month Extension)|Moved|0|||
28078817|NCT00112437|54732783|FG002|Year 2 (12-Month Extension)|Moved|0|||
28078818|NCT00112437|54732784|FG003|Year 2 (12-Month Extension)|Moved|0|||
28078819|NCT00112437|54732785|FG004|Year 2 (12-Month Extension)|Moved|0|||
28162914|NCT02998021|54833314|FG001|Overall Study|unsafe home|1|||
28162915|NCT03034577|54833328|FG000|Overall Study|Withdrawal by Subject|6|||
28162916|NCT03034577|54833329|FG001|Overall Study|Withdrawal by Subject|9|||
28162917|NCT03034577|54833328|FG000|Overall Study|Lost to Follow-up|25|||
28162918|NCT03034577|54833329|FG001|Overall Study|Lost to Follow-up|26|||
28162919|NCT01659736|54833339|FG000|Treatment Period|Adverse Event|1|||
28162920|NCT01659736|54833340|FG001|Treatment Period|Adverse Event|1|||
28162921|NCT01659736|54833339|FG000|Treatment Period|Protocol Violation|3|||
28162922|NCT01659736|54833340|FG001|Treatment Period|Protocol Violation|1|||
28162923|NCT01659736|54833339|FG000|Treatment Period|Withdrawal by Subject|1|||
28162924|NCT01659736|54833340|FG001|Treatment Period|Withdrawal by Subject|0|||
28162925|NCT01659736|54833339|FG000|3-month Follow-up|Lost to Follow-up|0|||
28162926|NCT01659736|54833340|FG001|3-month Follow-up|Lost to Follow-up|1|||
28162927|NCT02997163|54833352|FG000|Overall Study|Adverse Event|1|||
28162928|NCT02997163|54833353|FG001|Overall Study|Adverse Event|0|||
28162929|NCT02997163|54833354|FG002|Overall Study|Adverse Event|0|||
28162930|NCT02997163|54833355|FG003|Overall Study|Adverse Event|1|||
28162931|NCT00458536|54833365|FG000|Overall Study|Disease progression prior to treatment|7|||
28162932|NCT00458536|54833365|FG000|Overall Study|Unable to make vaccine|3|||
28162933|NCT00458536|54833365|FG000|Overall Study|No measurable disease after surgery|2|||
28162934|NCT00458536|54833365|FG000|Overall Study|Did not have renal cell carcinoma|2|||
28162935|NCT00458536|54833365|FG000|Overall Study|Patient did not have surgery|1|||
28078820|NCT00112437|54732786|FG005|Year 2 (12-Month Extension)|Moved|0|||
28078821|NCT00112437|54732787|FG006|Year 2 (12-Month Extension)|Moved|0|||
28078822|NCT00112437|54732788|FG007|Year 2 (12-Month Extension)|Moved|0|||
28078823|NCT00112437|54732789|FG008|Year 2 (12-Month Extension)|Moved|0|||
28078824|NCT00112437|54732790|FG009|Year 2 (12-Month Extension)|Moved|1|||
28078825|NCT00112437|54732791|FG010|Year 2 (12-Month Extension)|Moved|0|||
28078826|NCT00112437|54732792|FG011|Year 2 (12-Month Extension)|Moved|0|||
28078827|NCT00112437|54732793|FG012|Year 2 (12-Month Extension)|Moved|0|||
28078828|NCT00112437|54732794|FG013|Year 2 (12-Month Extension)|Moved|0|||
28078829|NCT00112437|54732795|FG014|Year 2 (12-Month Extension)|Moved|0|||
28162936|NCT00458536|54833365|FG000|Overall Study|Ineligible due to toxicity|1|||
28078830|NCT00112437|54732796|FG015|Year 2 (12-Month Extension)|Moved|0|||
28078831|NCT00112437|54732797|FG016|Year 2 (12-Month Extension)|Moved|0|||
28078832|NCT00112437|54732798|FG017|Year 2 (12-Month Extension)|Moved|0|||
28078833|NCT00112437|54732799|FG018|Year 2 (12-Month Extension)|Moved|0|||
28162937|NCT00458536|54833365|FG000|Overall Study|Withdrawal by Subject|1|||
28162938|NCT00458536|54833365|FG000|Overall Study|Progressive disease during treatment|2|||
28162939|NCT02526550|54833369|FG000|Overall Study|Lost to Follow-up|1|||
28078834|NCT00112437|54732800|FG019|Year 2 (12-Month Extension)|Moved|0|||
28078835|NCT00112437|54732801|FG020|Year 2 (12-Month Extension)|Moved|0|||
28078836|NCT00112437|54732802|FG021|Year 2 (12-Month Extension)|Moved|0|||
28078837|NCT00112437|54732803|FG022|Year 2 (12-Month Extension)|Moved|0|||
28078838|NCT00112437|54732804|FG023|Year 2 (12-Month Extension)|Moved|0|||
28078839|NCT00112437|54732805|FG024|Year 2 (12-Month Extension)|Moved|0|||
28078840|NCT00112437|54732806|FG025|Year 2 (12-Month Extension)|Moved|0|||
28078841|NCT00112437|54732781|FG000|Year 3 (12-Month Extension)|Adverse Event|0|||
28078842|NCT00112437|54732782|FG001|Year 3 (12-Month Extension)|Adverse Event|0|||
28078843|NCT00112437|54732783|FG002|Year 3 (12-Month Extension)|Adverse Event|0|||
28078844|NCT00112437|54732784|FG003|Year 3 (12-Month Extension)|Adverse Event|0|||
28078845|NCT00112437|54732785|FG004|Year 3 (12-Month Extension)|Adverse Event|0|||
28078846|NCT00112437|54732786|FG005|Year 3 (12-Month Extension)|Adverse Event|0|||
28162940|NCT03030989|54833384|FG000|Overall Study|Fever|2|||
28162941|NCT03030989|54833385|FG001|Overall Study|Fever|2|||
28162942|NCT03030989|54833384|FG000|Overall Study|Rash|2|||
28162943|NCT03030989|54833385|FG001|Overall Study|Rash|1|||
28162944|NCT03030989|54833384|FG000|Overall Study|Fatigue/Overwhelmed|1|||
28162945|NCT03030989|54833385|FG001|Overall Study|Fatigue/Overwhelmed|5|||
28162946|NCT03030989|54833384|FG000|Overall Study|Positive Blood Cultures|2|||
28162947|NCT03030989|54833385|FG001|Overall Study|Positive Blood Cultures|1|||
28162948|NCT03030989|54833384|FG000|Overall Study|Line Removed|0|||
28162949|NCT03030989|54833385|FG001|Overall Study|Line Removed|2|||
28078847|NCT00112437|54732787|FG006|Year 3 (12-Month Extension)|Adverse Event|0|||
28078848|NCT00112437|54732788|FG007|Year 3 (12-Month Extension)|Adverse Event|0|||
28078849|NCT00112437|54732789|FG008|Year 3 (12-Month Extension)|Adverse Event|0|||
28078850|NCT00112437|54732790|FG009|Year 3 (12-Month Extension)|Adverse Event|0|||
28078851|NCT00112437|54732791|FG010|Year 3 (12-Month Extension)|Adverse Event|1|||
28078852|NCT00112437|54732792|FG011|Year 3 (12-Month Extension)|Adverse Event|0|||
28078853|NCT00112437|54732793|FG012|Year 3 (12-Month Extension)|Adverse Event|0|||
28078854|NCT00112437|54732794|FG013|Year 3 (12-Month Extension)|Adverse Event|0|||
28078855|NCT00112437|54732795|FG014|Year 3 (12-Month Extension)|Adverse Event|0|||
28078856|NCT00112437|54732796|FG015|Year 3 (12-Month Extension)|Adverse Event|1|||
28078857|NCT00112437|54732797|FG016|Year 3 (12-Month Extension)|Adverse Event|3|||
28078858|NCT00112437|54732798|FG017|Year 3 (12-Month Extension)|Adverse Event|1|||
28078859|NCT00112437|54732799|FG018|Year 3 (12-Month Extension)|Adverse Event|0|||
28078860|NCT00112437|54732800|FG019|Year 3 (12-Month Extension)|Adverse Event|1|||
28078861|NCT00112437|54732801|FG020|Year 3 (12-Month Extension)|Adverse Event|0|||
28078862|NCT00112437|54732802|FG021|Year 3 (12-Month Extension)|Adverse Event|0|||
28078863|NCT00112437|54732803|FG022|Year 3 (12-Month Extension)|Adverse Event|0|||
28078864|NCT00112437|54732804|FG023|Year 3 (12-Month Extension)|Adverse Event|0|||
28078865|NCT00112437|54732805|FG024|Year 3 (12-Month Extension)|Adverse Event|0|||
28078866|NCT00112437|54732806|FG025|Year 3 (12-Month Extension)|Adverse Event|0|||
28078867|NCT00112437|54732781|FG000|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
28078868|NCT00112437|54732782|FG001|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
28078869|NCT00112437|54732783|FG002|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
28078870|NCT00112437|54732784|FG003|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
28078871|NCT00112437|54732785|FG004|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
28078872|NCT00112437|54732786|FG005|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
28078873|NCT00112437|54732787|FG006|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
28162950|NCT03030989|54833384|FG000|Overall Study|No longer interested|5|||
28162951|NCT03030989|54833385|FG001|Overall Study|No longer interested|3|||
28162952|NCT03030599|54833391|FG000|Open Label Treatment and Titration|Protocol deviation|8|||
28162953|NCT03030599|54833392|FG001|Open Label Treatment and Titration|Protocol deviation|0|||
28162954|NCT03030599|54833393|FG002|Open Label Treatment and Titration|Protocol deviation|0|||
28162955|NCT03030599|54833391|FG000|Open Label Treatment and Titration|Other|1|||
28162956|NCT03030599|54833392|FG001|Open Label Treatment and Titration|Other|0|||
28162957|NCT03030599|54833393|FG002|Open Label Treatment and Titration|Other|0|||
28162958|NCT03030599|54833391|FG000|Open Label Treatment and Titration|Physician Decision|3|||
28162959|NCT03030599|54833392|FG001|Open Label Treatment and Titration|Physician Decision|0|||
28162960|NCT03030599|54833393|FG002|Open Label Treatment and Titration|Physician Decision|0|||
28162961|NCT03030599|54833391|FG000|Open Label Treatment and Titration|Lack of Efficacy|1|||
28162962|NCT03030599|54833392|FG001|Open Label Treatment and Titration|Lack of Efficacy|0|||
28162963|NCT03030599|54833393|FG002|Open Label Treatment and Titration|Lack of Efficacy|0|||
28162964|NCT03030599|54833391|FG000|Open Label Treatment and Titration|Non-Compliance with Study Drug|4|||
28162965|NCT03030599|54833392|FG001|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
28162966|NCT03030599|54833393|FG002|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
28162967|NCT03030599|54833391|FG000|Open Label Treatment and Titration|Adverse Event|18|||
28162968|NCT03030599|54833392|FG001|Open Label Treatment and Titration|Adverse Event|0|||
28162969|NCT03030599|54833393|FG002|Open Label Treatment and Titration|Adverse Event|0|||
28162970|NCT03030599|54833391|FG000|Open Label Treatment and Titration|Withdrawal by Subject|6|||
28078874|NCT00112437|54732788|FG007|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
28078875|NCT00112437|54732789|FG008|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
28078876|NCT00112437|54732790|FG009|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
28078877|NCT00112437|54732791|FG010|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
28162971|NCT03030599|54833392|FG001|Open Label Treatment and Titration|Withdrawal by Subject|0|||
28162972|NCT03030599|54833393|FG002|Open Label Treatment and Titration|Withdrawal by Subject|0|||
28162973|NCT03030599|54833391|FG000|Open Label Treatment and Titration|Sponsor decision|2|||
28162974|NCT03030599|54833392|FG001|Open Label Treatment and Titration|Sponsor decision|0|||
28162975|NCT03030599|54833393|FG002|Open Label Treatment and Titration|Sponsor decision|0|||
28162976|NCT03030599|54833391|FG000|Open Label Treatment and Titration|Lost to Follow-up|3|||
28162977|NCT03030599|54833392|FG001|Open Label Treatment and Titration|Lost to Follow-up|0|||
28162978|NCT03030599|54833393|FG002|Open Label Treatment and Titration|Lost to Follow-up|0|||
28162979|NCT03030599|54833391|FG000|Stable Dose|Protocol deviation|3|||
28162980|NCT03030599|54833392|FG001|Stable Dose|Protocol deviation|0|||
28162981|NCT03030599|54833393|FG002|Stable Dose|Protocol deviation|0|||
28162982|NCT03030599|54833391|FG000|Stable Dose|Adverse Event|1|||
28162983|NCT03030599|54833392|FG001|Stable Dose|Adverse Event|0|||
28162984|NCT03030599|54833393|FG002|Stable Dose|Adverse Event|0|||
28162985|NCT03030599|54833391|FG000|Stable Dose|Lost to Follow-up|1|||
27852643|NCT02585934|54358990|FG001|Overall Study|Caregiver Withdrew Consent|7|||
27852644|NCT02585934|54358989|FG000|Overall Study|Sponsor Termination|1|||
27852645|NCT02585934|54358990|FG001|Overall Study|Sponsor Termination|2|||
27852646|NCT02585934|54358989|FG000|Overall Study|Another Reason|10|||
27852647|NCT02585934|54358990|FG001|Overall Study|Another Reason|5|||
27852648|NCT02582658|54359019|FG000|Overall Study|Failure to Return|10|||
27852649|NCT02582658|54359019|FG000|Overall Study|Insufficient Virological Response|2|||
27852650|NCT02582658|54359019|FG000|Overall Study|Withdrawn Consent|1|||
27852651|NCT02582658|54359019|FG000|Overall Study|Death|1|||
27852652|NCT02582658|54359019|FG000|Overall Study|Not further specified|11|||
27852653|NCT02585778|54359121|FG000|Overall Study|Adverse Event|17|||
27852654|NCT02585778|54359122|FG001|Overall Study|Adverse Event|4|||
27852655|NCT02585778|54359121|FG000|Overall Study|Participant did not wish to continue|9|||
27852656|NCT02585778|54359122|FG001|Overall Study|Participant did not wish to continue|4|||
27852657|NCT02585778|54359121|FG000|Overall Study|Poor compliance to study protocol|0|||
27852658|NCT02585778|54359122|FG001|Overall Study|Poor compliance to study protocol|2|||
27852659|NCT02585778|54359121|FG000|Overall Study|Death|0|||
27852660|NCT02585778|54359122|FG001|Overall Study|Death|1|||
27852661|NCT02585778|54359121|FG000|Overall Study|Randomized but not treated|1|||
27852662|NCT02585778|54359122|FG001|Overall Study|Randomized but not treated|2|||
27852663|NCT02585778|54359121|FG000|Overall Study|Other than specified above|6|||
27852664|NCT02585778|54359122|FG001|Overall Study|Other than specified above|2|||
27852665|NCT01438424|54359145|FG000|Overall Study|Continuing treatment|29|||
27852666|NCT01438424|54359145|FG000|Overall Study|Minimal virologic response|95|||
27852667|NCT01438424|54359145|FG000|Overall Study|Not identified|55|||
27852668|NCT01438424|54359145|FG000|Overall Study|Withdrawal by Subject|104|||
27852669|NCT01438424|54359145|FG000|Overall Study|Progression of chronic hepatitis B|22|||
27852670|NCT01438424|54359145|FG000|Overall Study|Death|22|||
27852671|NCT01438424|54359145|FG000|Overall Study|Adverse Event|17|||
27852672|NCT01438424|54359145|FG000|Overall Study|Lost to Follow-up|17|||
27852673|NCT01438424|54359145|FG000|Overall Study|Abnormal laboratory test result|14|||
27852674|NCT01438424|54359145|FG000|Overall Study|Need for drug prohibited by protocol|14|||
27852675|NCT01438424|54359145|FG000|Overall Study|Pregnancy|7|||
27852676|NCT01438424|54359145|FG000|Overall Study|No longer met inclusion criteria|1|||
27852677|NCT01438424|54359145|FG000|Overall Study|Participant noncompliance|20|||
27852678|NCT02580240|54359161|FG000|Overall Study|Physician Decision|2|||
27852679|NCT02580240|54359162|FG001|Overall Study|Physician Decision|0|||
27852680|NCT01465958|54359168|FG000|Run-in Phase|Protocol Violation|1|||
27852681|NCT01465958|54359169|FG001|Run-in Phase|Protocol Violation|0|||
27852682|NCT01465958|54359168|FG000|Subcutaneous (SC) Phase|Adverse Event|0|||
27852683|NCT01465958|54359169|FG001|Subcutaneous (SC) Phase|Adverse Event|1|||
27852684|NCT02581488|54359382|FG000|Overall Study|Adverse Event|6|||
27852685|NCT02581488|54359383|FG001|Overall Study|Adverse Event|7|||
27852686|NCT02581488|54359382|FG000|Overall Study|Lost to Follow-up|1|||
27852687|NCT02581488|54359383|FG001|Overall Study|Lost to Follow-up|0|||
27852688|NCT02581488|54359382|FG000|Overall Study|Withdrawal by Subject|1|||
27852689|NCT02581488|54359383|FG001|Overall Study|Withdrawal by Subject|0|||
28162986|NCT03030599|54833392|FG001|Stable Dose|Lost to Follow-up|0|||
28162987|NCT03030599|54833393|FG002|Stable Dose|Lost to Follow-up|0|||
28162988|NCT03030599|54833391|FG000|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
28162989|NCT03030599|54833392|FG001|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
28162990|NCT03030599|54833393|FG002|Double Blind Randomized Withdrawal|Lack of Efficacy|2|||
27852690|NCT02581488|54359382|FG000|Overall Study|Non-Compliance|1|||
27852691|NCT02581488|54359383|FG001|Overall Study|Non-Compliance|0|||
27852692|NCT02581488|54359382|FG000|Overall Study|Protocol Violation|0|||
27852693|NCT02581488|54359383|FG001|Overall Study|Protocol Violation|4|||
27852694|NCT02581410|54359426|FG000|Vaccination Phase|Adverse Event|2|||
27852695|NCT02581410|54359427|FG001|Vaccination Phase|Adverse Event|1|||
27852696|NCT02581410|54359426|FG000|Vaccination Phase|Withdrawal by Subject|0|||
27852697|NCT02581410|54359427|FG001|Vaccination Phase|Withdrawal by Subject|1|||
27852698|NCT02581410|54359426|FG000|Vaccination Phase|Migrated/moved from study area|0|||
28078878|NCT00112437|54732792|FG011|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
28078879|NCT00112437|54732793|FG012|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
28078880|NCT00112437|54732794|FG013|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
28078881|NCT00112437|54732795|FG014|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
28078882|NCT00112437|54732796|FG015|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
28078883|NCT00112437|54732797|FG016|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
28078884|NCT00112437|54732798|FG017|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
28162991|NCT03030599|54833391|FG000|Double Blind Randomized Withdrawal|Adverse Event|0|||
28162992|NCT03030599|54833392|FG001|Double Blind Randomized Withdrawal|Adverse Event|0|||
28162993|NCT03030599|54833393|FG002|Double Blind Randomized Withdrawal|Adverse Event|3|||
28162994|NCT03030599|54833391|FG000|Double Blind Randomized Withdrawal|Randomized in error|0|||
28162995|NCT03030599|54833392|FG001|Double Blind Randomized Withdrawal|Randomized in error|0|||
28162996|NCT03030599|54833393|FG002|Double Blind Randomized Withdrawal|Randomized in error|2|||
28162997|NCT03030599|54833391|FG000|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
28162998|NCT03030599|54833392|FG001|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
28162999|NCT03030599|54833393|FG002|Double Blind Randomized Withdrawal|Withdrawal by Subject|1|||
28163000|NCT03030599|54833391|FG000|Open-label Extension|Adverse Event|3|||
28163001|NCT03030599|54833392|FG001|Open-label Extension|Adverse Event|0|||
28163002|NCT03030599|54833393|FG002|Open-label Extension|Adverse Event|0|||
28163003|NCT03030599|54833391|FG000|Open-label Extension|Lost to Follow-up|2|||
28163004|NCT03030599|54833392|FG001|Open-label Extension|Lost to Follow-up|0|||
28163005|NCT03030599|54833393|FG002|Open-label Extension|Lost to Follow-up|0|||
28163006|NCT03030599|54833391|FG000|Open-label Extension|Lack of Efficacy|1|||
28163007|NCT03030599|54833392|FG001|Open-label Extension|Lack of Efficacy|0|||
27831539|NCT00705666|54308984|FG000|Overall Study|Withdrawal by Subject|21|||
27831540|NCT00705666|54308984|FG000|Overall Study|Physician Decision|7|||
27831541|NCT00705666|54308984|FG000|Overall Study|Lost to Follow-up|5|||
27831542|NCT00705666|54308984|FG000|Overall Study|Death|1|||
27831543|NCT00705666|54308984|FG000|Overall Study|Adverse Event|4|||
27831544|NCT00705666|54308984|FG000|Overall Study|Other|12|||
27831545|NCT00705666|54308984|FG000|Overall Study|Other|2|||
27831546|NCT00705666|54308984|FG000|Overall Study|Lack of data|3|||
27831547|NCT00705666|54308984|FG000|Overall Study|Untreated|5|||
27831548|NCT02725866|54309143|FG000|Overall Study|Failure to return|6|||
27831549|NCT02725866|54309143|FG000|Overall Study|Withdrew consent|3|||
27831550|NCT02725866|54309143|FG000|Overall Study|Insufficient virological response|1|||
27831551|NCT02725866|54309143|FG000|Overall Study|Other, not specified|4|||
27831552|NCT02726022|54309179|FG000|Overall Study|Adverse Event|14|||
27831553|NCT02726022|54309179|FG000|Overall Study|Treatment Failure|8|||
27852699|NCT02581410|54359427|FG001|Vaccination Phase|Migrated/moved from study area|1|||
27852700|NCT02581410|54359426|FG000|End of Study Phase|Adverse Event|4|||
27852701|NCT02581410|54359427|FG001|End of Study Phase|Adverse Event|3|||
27852702|NCT02581410|54359426|FG000|End of Study Phase|Withdrawal by Subject|1|||
27852703|NCT02581410|54359427|FG001|End of Study Phase|Withdrawal by Subject|2|||
27852704|NCT02581410|54359426|FG000|End of Study Phase|Migrated/moved from study area|0|||
27852705|NCT02581410|54359427|FG001|End of Study Phase|Migrated/moved from study area|3|||
27852706|NCT02581410|54359426|FG000|End of Study Phase|Lost to Follow-up|0|||
27852707|NCT02581410|54359427|FG001|End of Study Phase|Lost to Follow-up|2|||
27852708|NCT02581410|54359426|FG000|End of Study Phase|Other-transfer of subject not completed|0|||
27852709|NCT02581410|54359427|FG001|End of Study Phase|Other-transfer of subject not completed|1|||
27852710|NCT01664130|54359486|FG000|Overall Study|competing secondary disease|2|||
27852711|NCT02579928|54359517|FG000|Overall Study|Withdrawal by Subject|1|||
27852712|NCT02579928|54359518|FG001|Overall Study|Withdrawal by Subject|0|||
27852713|NCT00551460|54359612|FG000|Overall Study|Adverse Event|1|||
27852714|NCT00551460|54359612|FG000|Overall Study|Withdrawal by Subject|1|||
27852715|NCT00551460|54359612|FG000|Overall Study|Physician Decision|1|||
27852716|NCT00551460|54359612|FG000|Overall Study|Death|7|||
27852717|NCT00551460|54359612|FG000|Overall Study|Ineligible|4|||
27852718|NCT00551460|54359612|FG000|Overall Study|Not analyzable (did not start treatment)|4|||
27852719|NCT02579772|54359673|FG000|Overall Study|Withdrawal by Subject|0|||
28163008|NCT03030599|54833393|FG002|Open-label Extension|Lack of Efficacy|0|||
28163009|NCT03030599|54833391|FG000|Open-label Extension|Other Reason|1|||
28163010|NCT03030599|54833392|FG001|Open-label Extension|Other Reason|0|||
28163011|NCT03030599|54833393|FG002|Open-label Extension|Other Reason|0|||
27831554|NCT02726022|54309179|FG000|Overall Study|Poor Compliance|13|||
27831555|NCT02726022|54309179|FG000|Overall Study|Treatment Failure and Poor Compliance|1|||
27831556|NCT02725788|54309194|FG000|Overall Study|Lost to Follow-up|1|||
27831557|NCT02725788|54309195|FG001|Overall Study|Lost to Follow-up|1|||
27831558|NCT02725788|54309194|FG000|Overall Study|Protocol Violation|0|||
27831559|NCT02725788|54309195|FG001|Overall Study|Protocol Violation|1|||
27831560|NCT02725710|54309334|FG000|Overall Study|Lost to Follow-up|1|||
27831561|NCT02725710|54309335|FG001|Overall Study|Lost to Follow-up|0|||
27852720|NCT02579772|54359674|FG001|Overall Study|Withdrawal by Subject|1|||
27852721|NCT02579772|54359673|FG000|Overall Study|Usage of additional antioxidants|1|||
27852722|NCT02579772|54359674|FG001|Overall Study|Usage of additional antioxidants|0|||
27852723|NCT02579772|54359673|FG000|Overall Study|flu-like illness, orthopedic trauma|1|||
28078885|NCT00112437|54732799|FG018|Year 3 (12-Month Extension)|Lack of Efficacy|2|||
28078886|NCT00112437|54732800|FG019|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
28078887|NCT00112437|54732801|FG020|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
28078888|NCT00112437|54732802|FG021|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
28078889|NCT00112437|54732803|FG022|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
28078890|NCT00112437|54732804|FG023|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
28078891|NCT00112437|54732805|FG024|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
28078892|NCT00112437|54732806|FG025|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
28078893|NCT00112437|54732781|FG000|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
28078894|NCT00112437|54732782|FG001|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
28078895|NCT00112437|54732783|FG002|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
28078896|NCT00112437|54732784|FG003|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
28078897|NCT00112437|54732785|FG004|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
28078898|NCT00112437|54732786|FG005|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
28078899|NCT00112437|54732787|FG006|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
28078900|NCT00112437|54732788|FG007|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
28078901|NCT00112437|54732789|FG008|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
28078902|NCT00112437|54732790|FG009|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
28078903|NCT00112437|54732791|FG010|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
28078904|NCT00112437|54732792|FG011|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
28078905|NCT00112437|54732793|FG012|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
27852724|NCT02579772|54359674|FG001|Overall Study|flu-like illness, orthopedic trauma|1|||
27852725|NCT02579616|54359747|FG000|Overall Study|Participants did not receive treatment|3|||
27852726|NCT04027608|54359824|FG000|Overall Study|Withdrawal by Subject|13|||
27852727|NCT04027608|54359825|FG001|Overall Study|Withdrawal by Subject|2|||
27852728|NCT04027608|54359824|FG000|Overall Study|Protocol Violation|2|||
28078906|NCT00112437|54732794|FG013|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
28078907|NCT00112437|54732795|FG014|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
28078908|NCT00112437|54732796|FG015|Year 3 (12-Month Extension)|Lost to Follow-up|1|||
28078909|NCT00112437|54732797|FG016|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
28078910|NCT00112437|54732798|FG017|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
28078911|NCT00112437|54732799|FG018|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
28078912|NCT00112437|54732800|FG019|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
28078913|NCT00112437|54732801|FG020|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
28078914|NCT00112437|54732802|FG021|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
28078915|NCT00112437|54732803|FG022|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
28078916|NCT00112437|54732804|FG023|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
28078917|NCT00112437|54732805|FG024|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
28078918|NCT00112437|54732806|FG025|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
28078919|NCT00112437|54732781|FG000|Year 3 (12-Month Extension)|Protocol Violation|0|||
28078920|NCT00112437|54732782|FG001|Year 3 (12-Month Extension)|Protocol Violation|0|||
27852729|NCT04027608|54359825|FG001|Overall Study|Protocol Violation|1|||
27852730|NCT04027608|54359824|FG000|Overall Study|Physician Decision|1|||
27852731|NCT04027608|54359825|FG001|Overall Study|Physician Decision|0|||
27852732|NCT04027608|54359824|FG000|Overall Study|Lost to Follow-up|20|||
27852733|NCT04027608|54359825|FG001|Overall Study|Lost to Follow-up|4|||
27852734|NCT01664052|54359916|FG000|Phase 1|No device placement|6|||
27852735|NCT01664052|54359917|FG001|Phase 1|No device placement|0|||
27852736|NCT01664052|54359916|FG000|Phase 1|No HSG 1 hr post placement|1|||
27852737|NCT01664052|54359917|FG001|Phase 1|No HSG 1 hr post placement|0|||
27852738|NCT01664052|54359916|FG000|Phase 2|No device placement|0|||
27852739|NCT01664052|54359917|FG001|Phase 2|No device placement|4|||
27852740|NCT01465802|54359964|FG000|Overall Study|Study terminated by sponsor|1|||
28078921|NCT00112437|54732783|FG002|Year 3 (12-Month Extension)|Protocol Violation|0|||
28078922|NCT00112437|54732784|FG003|Year 3 (12-Month Extension)|Protocol Violation|0|||
28078923|NCT00112437|54732785|FG004|Year 3 (12-Month Extension)|Protocol Violation|0|||
28163012|NCT03031847|54833403|FG000|Overall Study|Death|1|||
27831562|NCT02724462|54309366|FG000|3 Month Follow-up Survey|Lost to Follow-up|171|||
27831563|NCT02724462|54309367|FG001|3 Month Follow-up Survey|Lost to Follow-up|151|||
27831564|NCT02724462|54309366|FG000|3 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
27831565|NCT02724462|54309367|FG001|3 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
27831566|NCT02724462|54309366|FG000|6 Month Follow-up Survey|Lost to Follow-up|156|||
27831567|NCT02724462|54309367|FG001|6 Month Follow-up Survey|Lost to Follow-up|123|||
27831568|NCT02724462|54309366|FG000|6 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
27831569|NCT02724462|54309367|FG001|6 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
27831570|NCT02724462|54309366|FG000|12 Month Follow-up Survey|Lost to Follow-up|174|||
27831571|NCT02724462|54309367|FG001|12 Month Follow-up Survey|Lost to Follow-up|134|||
27831572|NCT02724462|54309366|FG000|12 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
27852741|NCT01465802|54359965|FG001|Overall Study|Study terminated by sponsor|0|||
27852742|NCT01465802|54359966|FG002|Overall Study|Study terminated by sponsor|0|||
28078924|NCT00112437|54732786|FG005|Year 3 (12-Month Extension)|Protocol Violation|0|||
28078925|NCT00112437|54732787|FG006|Year 3 (12-Month Extension)|Protocol Violation|0|||
28078926|NCT00112437|54732788|FG007|Year 3 (12-Month Extension)|Protocol Violation|0|||
28078927|NCT00112437|54732789|FG008|Year 3 (12-Month Extension)|Protocol Violation|0|||
28078928|NCT00112437|54732790|FG009|Year 3 (12-Month Extension)|Protocol Violation|0|||
28078929|NCT00112437|54732791|FG010|Year 3 (12-Month Extension)|Protocol Violation|0|||
28078930|NCT00112437|54732792|FG011|Year 3 (12-Month Extension)|Protocol Violation|0|||
28078931|NCT00112437|54732793|FG012|Year 3 (12-Month Extension)|Protocol Violation|0|||
28078932|NCT00112437|54732794|FG013|Year 3 (12-Month Extension)|Protocol Violation|0|||
28078933|NCT00112437|54732795|FG014|Year 3 (12-Month Extension)|Protocol Violation|0|||
28078934|NCT00112437|54732796|FG015|Year 3 (12-Month Extension)|Protocol Violation|1|||
28078935|NCT00112437|54732797|FG016|Year 3 (12-Month Extension)|Protocol Violation|0|||
28078936|NCT00112437|54732798|FG017|Year 3 (12-Month Extension)|Protocol Violation|0|||
28078937|NCT00112437|54732799|FG018|Year 3 (12-Month Extension)|Protocol Violation|0|||
28078938|NCT00112437|54732800|FG019|Year 3 (12-Month Extension)|Protocol Violation|0|||
28078939|NCT00112437|54732801|FG020|Year 3 (12-Month Extension)|Protocol Violation|0|||
28078940|NCT00112437|54732802|FG021|Year 3 (12-Month Extension)|Protocol Violation|0|||
28078941|NCT00112437|54732803|FG022|Year 3 (12-Month Extension)|Protocol Violation|0|||
28078942|NCT00112437|54732804|FG023|Year 3 (12-Month Extension)|Protocol Violation|0|||
28078943|NCT00112437|54732805|FG024|Year 3 (12-Month Extension)|Protocol Violation|0|||
28078944|NCT00112437|54732806|FG025|Year 3 (12-Month Extension)|Protocol Violation|0|||
28078945|NCT00112437|54732781|FG000|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
28163013|NCT03031847|54833404|FG001|Overall Study|Death|1|||
28163014|NCT03031847|54833405|FG002|Overall Study|Death|2|||
27943853|NCT02097134|54600914|FG000|Overall Study|Physician Decision|4|||
27943854|NCT02097134|54600914|FG000|Overall Study|Non-Protocol Therapy|1|||
28078946|NCT00112437|54732782|FG001|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
28078947|NCT00112437|54732783|FG002|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
28078948|NCT00112437|54732784|FG003|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
28163015|NCT03031847|54833406|FG003|Overall Study|Death|3|||
28163016|NCT03031847|54833403|FG000|Overall Study|Lost to Follow-up|1|||
28163017|NCT03031847|54833404|FG001|Overall Study|Lost to Follow-up|1|||
28163018|NCT03031847|54833405|FG002|Overall Study|Lost to Follow-up|2|||
28163019|NCT03031847|54833406|FG003|Overall Study|Lost to Follow-up|3|||
28163020|NCT03028415|54833418|FG000|Overall Study|Lost to Follow-up|6|||
28163021|NCT03028415|54833419|FG001|Overall Study|Lost to Follow-up|3|||
28163022|NCT03028415|54833418|FG000|Overall Study|Withdrawal by Subject|1|||
28163023|NCT03028415|54833419|FG001|Overall Study|Withdrawal by Subject|0|||
28163024|NCT03028415|54833418|FG000|Overall Study|Discontinued due to COVID-19|1|||
28163025|NCT03028415|54833419|FG001|Overall Study|Discontinued due to COVID-19|0|||
28163026|NCT02692040|54833443|FG000|Overall Study|Protocol Violation|0|||
28163027|NCT02692040|54833444|FG001|Overall Study|Protocol Violation|0|||
28163028|NCT02692040|54833445|FG002|Overall Study|Protocol Violation|0|||
28163029|NCT02692040|54833446|FG003|Overall Study|Protocol Violation|0|||
28163030|NCT02692040|54833447|FG004|Overall Study|Protocol Violation|0|||
28163031|NCT02692040|54833448|FG005|Overall Study|Protocol Violation|0|||
28163032|NCT02692040|54833449|FG006|Overall Study|Protocol Violation|0|||
28163033|NCT02692040|54833450|FG007|Overall Study|Protocol Violation|0|||
28163034|NCT02692040|54833451|FG008|Overall Study|Protocol Violation|0|||
28163035|NCT02692040|54833452|FG009|Overall Study|Protocol Violation|0|||
28163036|NCT02692040|54833453|FG010|Overall Study|Protocol Violation|0|||
28163037|NCT02692040|54833454|FG011|Overall Study|Protocol Violation|0|||
28163038|NCT02692040|54833455|FG012|Overall Study|Protocol Violation|1|||
28163039|NCT02692040|54833456|FG013|Overall Study|Protocol Violation|0|||
28163040|NCT02692040|54833457|FG014|Overall Study|Protocol Violation|0|||
28163041|NCT02692040|54833458|FG015|Overall Study|Protocol Violation|0|||
28163042|NCT02692040|54833459|FG016|Overall Study|Protocol Violation|0|||
28163043|NCT02692040|54833443|FG000|Overall Study|Adverse Event|0|||
28163044|NCT02692040|54833444|FG001|Overall Study|Adverse Event|0|||
28163045|NCT02692040|54833445|FG002|Overall Study|Adverse Event|0|||
28163046|NCT02692040|54833446|FG003|Overall Study|Adverse Event|0|||
28078949|NCT00112437|54732785|FG004|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
28163047|NCT02692040|54833447|FG004|Overall Study|Adverse Event|0|||
28163048|NCT02692040|54833448|FG005|Overall Study|Adverse Event|0|||
28163049|NCT02692040|54833449|FG006|Overall Study|Adverse Event|0|||
28163050|NCT02692040|54833450|FG007|Overall Study|Adverse Event|0|||
28163051|NCT02692040|54833451|FG008|Overall Study|Adverse Event|0|||
28163052|NCT02692040|54833452|FG009|Overall Study|Adverse Event|0|||
28163053|NCT02692040|54833453|FG010|Overall Study|Adverse Event|0|||
28163054|NCT02692040|54833454|FG011|Overall Study|Adverse Event|0|||
28163055|NCT02692040|54833455|FG012|Overall Study|Adverse Event|0|||
28163056|NCT02692040|54833456|FG013|Overall Study|Adverse Event|3|||
28163057|NCT02692040|54833457|FG014|Overall Study|Adverse Event|1|||
28163058|NCT02692040|54833458|FG015|Overall Study|Adverse Event|1|||
28163059|NCT02692040|54833459|FG016|Overall Study|Adverse Event|0|||
28163060|NCT03029819|54833538|FG000|Overall Study|Lost to Follow-up|3|||
28163061|NCT03029819|54833539|FG001|Overall Study|Lost to Follow-up|5|||
28163062|NCT03029819|54833538|FG000|Overall Study|Removed due to disruptive behavior|0|||
28163063|NCT03029819|54833539|FG001|Overall Study|Removed due to disruptive behavior|1|||
28163064|NCT02678390|54833550|FG000|AE (1 Day)|Withdrawal by Subject|0|||
28163065|NCT02678390|54833551|FG001|AE (1 Day)|Withdrawal by Subject|1|||
28163066|NCT03027557|54833560|FG000|Overall Study|Adverse Event|1|||
28163067|NCT03027557|54833561|FG001|Overall Study|Adverse Event|0|||
28163068|NCT03027557|54833562|FG002|Overall Study|Adverse Event|0|||
28163069|NCT03029585|54833572|FG000|Overall Study|Death|1|||
28163070|NCT03029585|54833573|FG001|Overall Study|Death|1|||
28163071|NCT03029585|54833572|FG000|Overall Study|Withdrawal by Subject|1|||
28163072|NCT03029585|54833573|FG001|Overall Study|Withdrawal by Subject|0|||
28163073|NCT02678000|54833584|FG000|PART 2|Adverse Event|0|||
28163074|NCT02678000|54833585|FG001|PART 2|Adverse Event|0|||
28163075|NCT02678000|54833586|FG002|PART 2|Adverse Event|2|||
28163076|NCT02678000|54833587|FG003|PART 2|Adverse Event|1|||
28163077|NCT02678000|54833588|FG004|PART 2|Adverse Event|0|||
28163078|NCT02678000|54833584|FG000|PART 2|Withdrawal by Subject|0|||
28163079|NCT02678000|54833585|FG001|PART 2|Withdrawal by Subject|0|||
28163080|NCT02678000|54833586|FG002|PART 2|Withdrawal by Subject|1|||
28163081|NCT02678000|54833587|FG003|PART 2|Withdrawal by Subject|0|||
28163082|NCT02678000|54833588|FG004|PART 2|Withdrawal by Subject|0|||
28163083|NCT02691572|54833615|FG000|Overall Study|Withdrawal by Subject|1|||
28163084|NCT02691572|54833616|FG001|Overall Study|Withdrawal by Subject|0|||
28163085|NCT02691572|54833615|FG000|Overall Study|Protocol Violation|0|||
28163086|NCT02691572|54833616|FG001|Overall Study|Protocol Violation|1|||
28163087|NCT02677844|54833624|FG000|Period 3|Withdrawal by Subject|0|||
28163088|NCT02677844|54833625|FG001|Period 3|Withdrawal by Subject|0|||
28163089|NCT02677844|54833626|FG002|Period 3|Withdrawal by Subject|0|||
28163090|NCT02677844|54833627|FG003|Period 3|Withdrawal by Subject|1|||
28163091|NCT02677844|54833628|FG004|Period 3|Withdrawal by Subject|0|||
28163092|NCT02677844|54833629|FG005|Period 3|Withdrawal by Subject|0|||
28163093|NCT02677844|54833630|FG006|Period 3|Withdrawal by Subject|0|||
28163094|NCT02691494|54833652|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
28163095|NCT02691494|54833653|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
28163096|NCT02691494|54833654|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
28163097|NCT02691494|54833652|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
28163098|NCT02691494|54833653|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
28163099|NCT02691494|54833654|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
28163100|NCT02691494|54833652|FG000|Post-Treatment Follow-Up Period|Other|2|||
28163101|NCT02691494|54833653|FG001|Post-Treatment Follow-Up Period|Other|1|||
28163102|NCT02691494|54833654|FG002|Post-Treatment Follow-Up Period|Other|1|||
28163103|NCT02691494|54833652|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
28163104|NCT02691494|54833653|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
28163105|NCT02691494|54833654|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3|||
28163106|NCT02691494|54833652|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
28163107|NCT02691494|54833653|FG001|Post-Treatment Follow-Up Period|Non-Compliance|1|||
28163108|NCT02691494|54833654|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
28163109|NCT02677220|54833662|FG000|Overall Study|Adverse Event|1|||
28163110|NCT02682602|54833669|FG000|Pre-operative Diseased & Normal Hips|Unusable images|1|||
28163111|NCT02682602|54833670|FG001|Pre-operative Diseased & Normal Hips|Unusable images|0|||
28163112|NCT02682602|54833669|FG000|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3|||
28163113|NCT02682602|54833670|FG001|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0|||
28163114|NCT02681510|54833680|FG000|Overall Study|Withdrawal by Subject|1|||
28163115|NCT02681510|54833680|FG000|Overall Study|Lost to Follow-up|9|||
28163116|NCT02690714|54833684|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Physician Decision|1|||
28163117|NCT02690714|54833684|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Withdrawal by Subject|1|||
28163118|NCT01898793|54833699|FG000|Overall Study|Death|2|||
28163119|NCT01898793|54833700|FG001|Overall Study|Death|1|||
28163120|NCT01898793|54833701|FG002|Overall Study|Death|4|||
28163121|NCT01898793|54833702|FG003|Overall Study|Death|0|||
28163122|NCT01898793|54833703|FG004|Overall Study|Death|0|||
28163123|NCT01898793|54833704|FG005|Overall Study|Death|0|||
28163124|NCT01898793|54833705|FG006|Overall Study|Death|0|||
28163125|NCT01791543|54833724|FG000|Overall Study|Lost to Follow-up|1|||
28163126|NCT01791543|54833724|FG000|Overall Study|Adverse Event|1|||
28163127|NCT02925455|54833731|FG000|Overall Study|Withdrawal by Subject|2|||
28163128|NCT02925455|54833732|FG001|Overall Study|Withdrawal by Subject|0|||
28163129|NCT03033069|54833742|FG000|Overall Study|Adverse Event|6|||
28163130|NCT03033069|54833743|FG001|Overall Study|Adverse Event|7|||
28163131|NCT03033069|54833744|FG002|Overall Study|Adverse Event|4|||
28163132|NCT03033069|54833745|FG003|Overall Study|Adverse Event|6|||
28163133|NCT03033069|54833742|FG000|Overall Study|Lack of Efficacy|0|||
28163134|NCT03033069|54833743|FG001|Overall Study|Lack of Efficacy|0|||
28163135|NCT03033069|54833744|FG002|Overall Study|Lack of Efficacy|1|||
28163136|NCT03033069|54833745|FG003|Overall Study|Lack of Efficacy|0|||
28163137|NCT03033069|54833742|FG000|Overall Study|Lost to Follow-up|6|||
28163138|NCT03033069|54833743|FG001|Overall Study|Lost to Follow-up|5|||
28163139|NCT03033069|54833744|FG002|Overall Study|Lost to Follow-up|5|||
28163140|NCT03033069|54833745|FG003|Overall Study|Lost to Follow-up|6|||
28163141|NCT03033069|54833742|FG000|Overall Study|Non-Compliance With Study Drug|1|||
28163142|NCT03033069|54833743|FG001|Overall Study|Non-Compliance With Study Drug|1|||
28163143|NCT03033069|54833744|FG002|Overall Study|Non-Compliance With Study Drug|1|||
28163144|NCT03033069|54833745|FG003|Overall Study|Non-Compliance With Study Drug|0|||
28163145|NCT03033069|54833742|FG000|Overall Study|Protocol Deviation|0|||
28163146|NCT03033069|54833743|FG001|Overall Study|Protocol Deviation|1|||
28163147|NCT03033069|54833744|FG002|Overall Study|Protocol Deviation|0|||
28163148|NCT03033069|54833745|FG003|Overall Study|Protocol Deviation|0|||
28163149|NCT03033069|54833742|FG000|Overall Study|Withdrawal by Subject|10|||
28163150|NCT03033069|54833743|FG001|Overall Study|Withdrawal by Subject|10|||
28163151|NCT03033069|54833744|FG002|Overall Study|Withdrawal by Subject|11|||
28163152|NCT03033069|54833745|FG003|Overall Study|Withdrawal by Subject|6|||
28163153|NCT03033069|54833742|FG000|Overall Study|Withdrawal By Caregiver|1|||
28163154|NCT03033069|54833743|FG001|Overall Study|Withdrawal By Caregiver|0|||
28163155|NCT03033069|54833744|FG002|Overall Study|Withdrawal By Caregiver|0|||
28163156|NCT03033069|54833745|FG003|Overall Study|Withdrawal By Caregiver|0|||
28163157|NCT03033069|54833742|FG000|Overall Study|Reason not Specified|0|||
28163158|NCT03033069|54833743|FG001|Overall Study|Reason not Specified|1|||
28163159|NCT03033069|54833744|FG002|Overall Study|Reason not Specified|0|||
28163160|NCT03033069|54833745|FG003|Overall Study|Reason not Specified|1|||
28163161|NCT02917265|54833757|FG000|Overall Study|Physician Decision|1|||
28163162|NCT02917265|54833758|FG001|Overall Study|Physician Decision|0|||
28078950|NCT00112437|54732786|FG005|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
28078951|NCT00112437|54732787|FG006|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
28078952|NCT00112437|54732788|FG007|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
28078953|NCT00112437|54732789|FG008|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
28078954|NCT00112437|54732790|FG009|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
28078955|NCT00112437|54732791|FG010|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
28078956|NCT00112437|54732792|FG011|Year 3 (12-Month Extension)|Withdrawal by Subject|3|||
28078957|NCT00112437|54732793|FG012|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
28078958|NCT00112437|54732794|FG013|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
28078959|NCT00112437|54732795|FG014|Year 3 (12-Month Extension)|Withdrawal by Subject|1|||
28078960|NCT00112437|54732796|FG015|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
28078961|NCT00112437|54732797|FG016|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
28078962|NCT00112437|54732798|FG017|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
28078963|NCT00112437|54732799|FG018|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
28163163|NCT02917265|54833757|FG000|Overall Study|Withdrawal by Subject|1|||
28163164|NCT02917265|54833758|FG001|Overall Study|Withdrawal by Subject|0|||
28163165|NCT02136069|54833768|FG000|Overall Study|UC flare-up|1|||
28163166|NCT02136069|54833769|FG001|Overall Study|UC flare-up|0|||
28163167|NCT02136069|54833768|FG000|Overall Study|Adverse Event|6|||
28163168|NCT02136069|54833769|FG001|Overall Study|Adverse Event|8|||
28163169|NCT02136069|54833768|FG000|Overall Study|Death|0|||
28163170|NCT02136069|54833769|FG001|Overall Study|Death|1|||
28163171|NCT02136069|54833768|FG000|Overall Study|Lack of Efficacy|10|||
28163172|NCT02136069|54833769|FG001|Overall Study|Lack of Efficacy|4|||
28163173|NCT02136069|54833768|FG000|Overall Study|Lost to Follow-up|1|||
28163174|NCT02136069|54833769|FG001|Overall Study|Lost to Follow-up|0|||
28163175|NCT02136069|54833768|FG000|Overall Study|Non-Compliance|1|||
28163176|NCT02136069|54833769|FG001|Overall Study|Non-Compliance|0|||
28163177|NCT02136069|54833768|FG000|Overall Study|Physician Decision|5|||
28163178|NCT02136069|54833769|FG001|Overall Study|Physician Decision|4|||
28163179|NCT02136069|54833768|FG000|Overall Study|Withdrawal by Subject|10|||
28163180|NCT02136069|54833769|FG001|Overall Study|Withdrawal by Subject|11|||
28163181|NCT02917031|54833778|FG000|Overall Study|Reason not specified|7|||
28163182|NCT02917031|54833779|FG001|Overall Study|Reason not specified|5|||
28163183|NCT02917031|54833780|FG002|Overall Study|Reason not specified|6|||
28163184|NCT02917031|54833778|FG000|Overall Study|Development of study-specific withdrawal criteria|1|||
28163185|NCT02917031|54833779|FG001|Overall Study|Development of study-specific withdrawal criteria|1|||
28163186|NCT02917031|54833780|FG002|Overall Study|Development of study-specific withdrawal criteria|0|||
28163187|NCT02917031|54833778|FG000|Overall Study|Withdrawal by Subject|3|||
28163188|NCT02917031|54833779|FG001|Overall Study|Withdrawal by Subject|3|||
28163189|NCT02917031|54833780|FG002|Overall Study|Withdrawal by Subject|0|||
28163190|NCT02917031|54833778|FG000|Overall Study|Physician Decision|1|||
28163191|NCT02917031|54833779|FG001|Overall Study|Physician Decision|0|||
28163192|NCT02917031|54833780|FG002|Overall Study|Physician Decision|0|||
28163193|NCT02917031|54833778|FG000|Overall Study|Adverse Event|4|||
28163194|NCT02917031|54833779|FG001|Overall Study|Adverse Event|1|||
28163195|NCT02917031|54833780|FG002|Overall Study|Adverse Event|5|||
28163196|NCT02917031|54833778|FG000|Overall Study|Death|2|||
28163197|NCT02917031|54833779|FG001|Overall Study|Death|3|||
28163198|NCT02917031|54833780|FG002|Overall Study|Death|4|||
28163199|NCT01018563|54833789|FG000|Overall Study|Termination of the study by Sponsor|2|||
28078964|NCT00112437|54732800|FG019|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
28163200|NCT01018563|54833790|FG001|Overall Study|Termination of the study by Sponsor|1|||
28163201|NCT02528188|54833803|FG000|Overall Study|Adverse Event|23|||
28078965|NCT00112437|54732801|FG020|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
28078966|NCT00112437|54732802|FG021|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
28078967|NCT00112437|54732803|FG022|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
28078968|NCT00112437|54732804|FG023|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
28078969|NCT00112437|54732805|FG024|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
28078970|NCT00112437|54732806|FG025|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
28078971|NCT00112437|54732781|FG000|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
28078972|NCT00112437|54732782|FG001|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
28078973|NCT00112437|54732783|FG002|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
28078974|NCT00112437|54732784|FG003|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
28078975|NCT00112437|54732785|FG004|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
28078976|NCT00112437|54732786|FG005|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
28078977|NCT00112437|54732787|FG006|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
28078978|NCT00112437|54732788|FG007|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
28078979|NCT00112437|54732789|FG008|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
28078980|NCT00112437|54732790|FG009|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
28078981|NCT00112437|54732791|FG010|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
28078982|NCT00112437|54732792|FG011|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
28078983|NCT00112437|54732793|FG012|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
28078984|NCT00112437|54732794|FG013|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
28078985|NCT00112437|54732795|FG014|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
28078986|NCT00112437|54732796|FG015|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
28078987|NCT00112437|54732797|FG016|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
28078988|NCT00112437|54732798|FG017|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
28078989|NCT00112437|54732799|FG018|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
28078990|NCT00112437|54732800|FG019|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
28078991|NCT00112437|54732801|FG020|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
28078992|NCT00112437|54732802|FG021|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
28078993|NCT00112437|54732803|FG022|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
28078994|NCT00112437|54732804|FG023|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
28078995|NCT00112437|54732805|FG024|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
28078996|NCT00112437|54732806|FG025|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
28078997|NCT00112437|54732781|FG000|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
28078998|NCT00112437|54732782|FG001|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
28078999|NCT00112437|54732783|FG002|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
28079000|NCT00112437|54732784|FG003|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
28163202|NCT02528188|54833804|FG001|Overall Study|Adverse Event|22|||
28163203|NCT02528188|54833805|FG002|Overall Study|Adverse Event|8|||
28163204|NCT02528188|54833803|FG000|Overall Study|Protocol Violation|4|||
28163205|NCT02528188|54833804|FG001|Overall Study|Protocol Violation|6|||
28163206|NCT02528188|54833805|FG002|Overall Study|Protocol Violation|4|||
28163207|NCT02528188|54833803|FG000|Overall Study|Lack of Efficacy|19|||
28163208|NCT02528188|54833804|FG001|Overall Study|Lack of Efficacy|21|||
28163209|NCT02528188|54833805|FG002|Overall Study|Lack of Efficacy|22|||
28163210|NCT02528188|54833803|FG000|Overall Study|Withdrawal by Subject|97|||
28163211|NCT02528188|54833804|FG001|Overall Study|Withdrawal by Subject|104|||
28163212|NCT02528188|54833805|FG002|Overall Study|Withdrawal by Subject|100|||
28163213|NCT02528188|54833803|FG000|Overall Study|Lost to Follow-up|25|||
28163214|NCT02528188|54833804|FG001|Overall Study|Lost to Follow-up|21|||
28163215|NCT02528188|54833805|FG002|Overall Study|Lost to Follow-up|31|||
28163216|NCT02528188|54833803|FG000|Overall Study|Death|4|||
28163217|NCT02528188|54833804|FG001|Overall Study|Death|4|||
28163218|NCT02528188|54833805|FG002|Overall Study|Death|0|||
28163219|NCT02528188|54833803|FG000|Overall Study|Other|89|||
28163220|NCT02528188|54833804|FG001|Overall Study|Other|91|||
28163221|NCT02528188|54833805|FG002|Overall Study|Other|74|||
28163222|NCT02528188|54833803|FG000|Overall Study|Randomized but not treated|6|||
28163223|NCT02528188|54833804|FG001|Overall Study|Randomized but not treated|7|||
28163224|NCT02528188|54833805|FG002|Overall Study|Randomized but not treated|12|||
28163225|NCT03896165|54833813|FG000|Overall Study|Withdrawal by Subject|2|||
28163226|NCT05361304|54833826|FG000|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|1|||
28079001|NCT00112437|54732785|FG004|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
28079002|NCT00112437|54732786|FG005|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
28079003|NCT00112437|54732787|FG006|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
28079004|NCT00112437|54732788|FG007|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
28079005|NCT00112437|54732789|FG008|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
28079006|NCT00112437|54732790|FG009|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
28079007|NCT00112437|54732791|FG010|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
28079008|NCT00112437|54732792|FG011|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
28079009|NCT00112437|54732793|FG012|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
28079010|NCT00112437|54732794|FG013|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
28079011|NCT00112437|54732795|FG014|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
28079012|NCT00112437|54732796|FG015|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
28079013|NCT00112437|54732797|FG016|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
28079014|NCT00112437|54732798|FG017|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
28079015|NCT00112437|54732799|FG018|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
28079016|NCT00112437|54732800|FG019|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
28079017|NCT00112437|54732801|FG020|Years 4-5 (24-Month Extension)|Lack of Efficacy|2|||
28079018|NCT00112437|54732802|FG021|Years 4-5 (24-Month Extension)|Lack of Efficacy|1|||
28079019|NCT00112437|54732803|FG022|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
28079020|NCT00112437|54732804|FG023|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
28079021|NCT00112437|54732805|FG024|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
28079022|NCT00112437|54732806|FG025|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
28079023|NCT00112437|54732781|FG000|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
28079024|NCT00112437|54732782|FG001|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
28079025|NCT00112437|54732783|FG002|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
28079026|NCT00112437|54732784|FG003|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
28079027|NCT00112437|54732785|FG004|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
28079028|NCT00112437|54732786|FG005|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
28079029|NCT00112437|54732787|FG006|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
28079030|NCT00112437|54732788|FG007|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
28079031|NCT00112437|54732789|FG008|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
28079032|NCT00112437|54732790|FG009|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
28079033|NCT00112437|54732791|FG010|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
28079034|NCT00112437|54732792|FG011|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
28079035|NCT00112437|54732793|FG012|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
28079036|NCT00112437|54732794|FG013|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
28079037|NCT00112437|54732795|FG014|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
28079038|NCT00112437|54732796|FG015|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
28079039|NCT00112437|54732797|FG016|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
28079040|NCT00112437|54732798|FG017|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
28079041|NCT00112437|54732799|FG018|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
28079042|NCT00112437|54732800|FG019|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
28079043|NCT00112437|54732801|FG020|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1|||
28079044|NCT00112437|54732802|FG021|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
28079045|NCT00112437|54732803|FG022|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
28079046|NCT00112437|54732804|FG023|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
28079047|NCT00112437|54732805|FG024|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
28079048|NCT00112437|54732806|FG025|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
28079049|NCT00112437|54732781|FG000|Years 4-5 (24-Month Extension)|Adverse Event|0|||
28079050|NCT00112437|54732782|FG001|Years 4-5 (24-Month Extension)|Adverse Event|0|||
28079051|NCT00112437|54732783|FG002|Years 4-5 (24-Month Extension)|Adverse Event|0|||
28079052|NCT00112437|54732784|FG003|Years 4-5 (24-Month Extension)|Adverse Event|0|||
28079053|NCT00112437|54732785|FG004|Years 4-5 (24-Month Extension)|Adverse Event|0|||
28079054|NCT00112437|54732786|FG005|Years 4-5 (24-Month Extension)|Adverse Event|0|||
28079055|NCT00112437|54732787|FG006|Years 4-5 (24-Month Extension)|Adverse Event|0|||
28079056|NCT00112437|54732788|FG007|Years 4-5 (24-Month Extension)|Adverse Event|0|||
28079057|NCT00112437|54732789|FG008|Years 4-5 (24-Month Extension)|Adverse Event|0|||
28079058|NCT00112437|54732790|FG009|Years 4-5 (24-Month Extension)|Adverse Event|0|||
28079059|NCT00112437|54732791|FG010|Years 4-5 (24-Month Extension)|Adverse Event|0|||
28079060|NCT00112437|54732792|FG011|Years 4-5 (24-Month Extension)|Adverse Event|0|||
28163227|NCT05361304|54833827|FG001|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|0|||
28079061|NCT00112437|54732793|FG012|Years 4-5 (24-Month Extension)|Adverse Event|0|||
28079062|NCT00112437|54732794|FG013|Years 4-5 (24-Month Extension)|Adverse Event|0|||
28163228|NCT05361304|54833826|FG000|Overall Study|COVID-19 Related|1|||
28079063|NCT00112437|54732795|FG014|Years 4-5 (24-Month Extension)|Adverse Event|0|||
28079064|NCT00112437|54732796|FG015|Years 4-5 (24-Month Extension)|Adverse Event|0|||
28079065|NCT00112437|54732797|FG016|Years 4-5 (24-Month Extension)|Adverse Event|0|||
28079066|NCT00112437|54732798|FG017|Years 4-5 (24-Month Extension)|Adverse Event|0|||
28079067|NCT00112437|54732799|FG018|Years 4-5 (24-Month Extension)|Adverse Event|0|||
28079068|NCT00112437|54732800|FG019|Years 4-5 (24-Month Extension)|Adverse Event|0|||
28079069|NCT00112437|54732801|FG020|Years 4-5 (24-Month Extension)|Adverse Event|0|||
28079070|NCT00112437|54732802|FG021|Years 4-5 (24-Month Extension)|Adverse Event|4|||
28079071|NCT00112437|54732803|FG022|Years 4-5 (24-Month Extension)|Adverse Event|0|||
28079072|NCT00112437|54732804|FG023|Years 4-5 (24-Month Extension)|Adverse Event|0|||
28079073|NCT00112437|54732805|FG024|Years 4-5 (24-Month Extension)|Adverse Event|0|||
28079074|NCT00112437|54732806|FG025|Years 4-5 (24-Month Extension)|Adverse Event|0|||
28079075|NCT00112437|54732781|FG000|Years 4-5 (24-Month Extension)|Participant moved|0|||
28079076|NCT00112437|54732782|FG001|Years 4-5 (24-Month Extension)|Participant moved|0|||
28079077|NCT00112437|54732783|FG002|Years 4-5 (24-Month Extension)|Participant moved|0|||
28079078|NCT00112437|54732784|FG003|Years 4-5 (24-Month Extension)|Participant moved|0|||
28079079|NCT00112437|54732785|FG004|Years 4-5 (24-Month Extension)|Participant moved|0|||
28079080|NCT00112437|54732786|FG005|Years 4-5 (24-Month Extension)|Participant moved|0|||
28079081|NCT00112437|54732787|FG006|Years 4-5 (24-Month Extension)|Participant moved|0|||
28079082|NCT00112437|54732788|FG007|Years 4-5 (24-Month Extension)|Participant moved|0|||
28079083|NCT00112437|54732789|FG008|Years 4-5 (24-Month Extension)|Participant moved|0|||
28079084|NCT00112437|54732790|FG009|Years 4-5 (24-Month Extension)|Participant moved|0|||
28079085|NCT00112437|54732791|FG010|Years 4-5 (24-Month Extension)|Participant moved|0|||
28079086|NCT00112437|54732792|FG011|Years 4-5 (24-Month Extension)|Participant moved|0|||
28079087|NCT00112437|54732793|FG012|Years 4-5 (24-Month Extension)|Participant moved|0|||
28079088|NCT00112437|54732794|FG013|Years 4-5 (24-Month Extension)|Participant moved|0|||
28079089|NCT00112437|54732795|FG014|Years 4-5 (24-Month Extension)|Participant moved|0|||
28079090|NCT00112437|54732796|FG015|Years 4-5 (24-Month Extension)|Participant moved|0|||
28079091|NCT00112437|54732797|FG016|Years 4-5 (24-Month Extension)|Participant moved|0|||
28079092|NCT00112437|54732798|FG017|Years 4-5 (24-Month Extension)|Participant moved|0|||
28079093|NCT00112437|54732799|FG018|Years 4-5 (24-Month Extension)|Participant moved|0|||
28079094|NCT00112437|54732800|FG019|Years 4-5 (24-Month Extension)|Participant moved|0|||
28079095|NCT00112437|54732801|FG020|Years 4-5 (24-Month Extension)|Participant moved|0|||
28079096|NCT00112437|54732802|FG021|Years 4-5 (24-Month Extension)|Participant moved|1|||
28079097|NCT00112437|54732803|FG022|Years 4-5 (24-Month Extension)|Participant moved|0|||
28079098|NCT00112437|54732804|FG023|Years 4-5 (24-Month Extension)|Participant moved|0|||
28079099|NCT00112437|54732805|FG024|Years 4-5 (24-Month Extension)|Participant moved|0|||
28079100|NCT00112437|54732806|FG025|Years 4-5 (24-Month Extension)|Participant moved|0|||
28079101|NCT00112437|54732781|FG000|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
28079102|NCT00112437|54732782|FG001|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
28079103|NCT00112437|54732783|FG002|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
28079104|NCT00112437|54732784|FG003|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
28079105|NCT00112437|54732785|FG004|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
28079106|NCT00112437|54732786|FG005|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
28079107|NCT00112437|54732787|FG006|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
28079108|NCT00112437|54732788|FG007|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
28079109|NCT00112437|54732789|FG008|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
28079110|NCT00112437|54732790|FG009|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
28079111|NCT00112437|54732791|FG010|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
28079112|NCT00112437|54732792|FG011|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
28079113|NCT00112437|54732793|FG012|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
28079114|NCT00112437|54732794|FG013|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
28079115|NCT00112437|54732795|FG014|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
28079116|NCT00112437|54732796|FG015|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
28079117|NCT00112437|54732797|FG016|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
28079118|NCT00112437|54732798|FG017|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
28079119|NCT00112437|54732799|FG018|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
28079120|NCT00112437|54732800|FG019|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
28079121|NCT00112437|54732801|FG020|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1|||
28079122|NCT00112437|54732802|FG021|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2|||
28079123|NCT00112437|54732803|FG022|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
28079124|NCT00112437|54732804|FG023|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
28163229|NCT05361304|54833827|FG001|Overall Study|COVID-19 Related|2|||
28079125|NCT00112437|54732805|FG024|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
28079126|NCT00112437|54732806|FG025|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
28079127|NCT00112437|54732781|FG000|Years 6-10 (60-Month Extension)|Adverse Event|0|||
28079128|NCT00112437|54732782|FG001|Years 6-10 (60-Month Extension)|Adverse Event|0|||
28079129|NCT00112437|54732783|FG002|Years 6-10 (60-Month Extension)|Adverse Event|0|||
28079130|NCT00112437|54732784|FG003|Years 6-10 (60-Month Extension)|Adverse Event|0|||
28079131|NCT00112437|54732785|FG004|Years 6-10 (60-Month Extension)|Adverse Event|0|||
28079132|NCT00112437|54732786|FG005|Years 6-10 (60-Month Extension)|Adverse Event|0|||
28079133|NCT00112437|54732787|FG006|Years 6-10 (60-Month Extension)|Adverse Event|0|||
28079134|NCT00112437|54732788|FG007|Years 6-10 (60-Month Extension)|Adverse Event|0|||
28079135|NCT00112437|54732789|FG008|Years 6-10 (60-Month Extension)|Adverse Event|0|||
28079136|NCT00112437|54732790|FG009|Years 6-10 (60-Month Extension)|Adverse Event|0|||
28079137|NCT00112437|54732791|FG010|Years 6-10 (60-Month Extension)|Adverse Event|0|||
28079138|NCT00112437|54732792|FG011|Years 6-10 (60-Month Extension)|Adverse Event|0|||
28079139|NCT00112437|54732793|FG012|Years 6-10 (60-Month Extension)|Adverse Event|0|||
28079140|NCT00112437|54732794|FG013|Years 6-10 (60-Month Extension)|Adverse Event|0|||
28079141|NCT00112437|54732795|FG014|Years 6-10 (60-Month Extension)|Adverse Event|0|||
28079142|NCT00112437|54732796|FG015|Years 6-10 (60-Month Extension)|Adverse Event|0|||
28079143|NCT00112437|54732797|FG016|Years 6-10 (60-Month Extension)|Adverse Event|0|||
28079144|NCT00112437|54732798|FG017|Years 6-10 (60-Month Extension)|Adverse Event|0|||
28079145|NCT00112437|54732799|FG018|Years 6-10 (60-Month Extension)|Adverse Event|0|||
28079146|NCT00112437|54732800|FG019|Years 6-10 (60-Month Extension)|Adverse Event|0|||
28079147|NCT00112437|54732801|FG020|Years 6-10 (60-Month Extension)|Adverse Event|0|||
28079148|NCT00112437|54732802|FG021|Years 6-10 (60-Month Extension)|Adverse Event|0|||
28079149|NCT00112437|54732803|FG022|Years 6-10 (60-Month Extension)|Adverse Event|1|||
28079150|NCT00112437|54732804|FG023|Years 6-10 (60-Month Extension)|Adverse Event|2|||
28079151|NCT00112437|54732805|FG024|Years 6-10 (60-Month Extension)|Adverse Event|0|||
28079152|NCT00112437|54732806|FG025|Years 6-10 (60-Month Extension)|Adverse Event|1|||
28163230|NCT05361304|54833826|FG000|Overall Study|Withdrawal by Subject|1|||
28163231|NCT05361304|54833827|FG001|Overall Study|Withdrawal by Subject|0|||
28163232|NCT02269917|54833850|FG000|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|25|||
28163233|NCT02269917|54833851|FG001|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|7|||
28163234|NCT02269917|54833852|FG002|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|0|||
28163235|NCT02269917|54833850|FG000|BL to EOE-Test and BL to Switch-Control|Other|19|||
28079153|NCT00112437|54732781|FG000|Years 6-10 (60-Month Extension)|Death|0|||
28079154|NCT00112437|54732782|FG001|Years 6-10 (60-Month Extension)|Death|0|||
28079155|NCT00112437|54732783|FG002|Years 6-10 (60-Month Extension)|Death|0|||
28079156|NCT00112437|54732784|FG003|Years 6-10 (60-Month Extension)|Death|0|||
28079157|NCT00112437|54732785|FG004|Years 6-10 (60-Month Extension)|Death|0|||
28079158|NCT00112437|54732786|FG005|Years 6-10 (60-Month Extension)|Death|0|||
28079159|NCT00112437|54732787|FG006|Years 6-10 (60-Month Extension)|Death|0|||
28079160|NCT00112437|54732788|FG007|Years 6-10 (60-Month Extension)|Death|0|||
28079161|NCT00112437|54732789|FG008|Years 6-10 (60-Month Extension)|Death|0|||
28079162|NCT00112437|54732790|FG009|Years 6-10 (60-Month Extension)|Death|0|||
28079163|NCT00112437|54732791|FG010|Years 6-10 (60-Month Extension)|Death|0|||
28079164|NCT00112437|54732792|FG011|Years 6-10 (60-Month Extension)|Death|0|||
28079165|NCT00112437|54732793|FG012|Years 6-10 (60-Month Extension)|Death|0|||
28079166|NCT00112437|54732794|FG013|Years 6-10 (60-Month Extension)|Death|0|||
28079167|NCT00112437|54732795|FG014|Years 6-10 (60-Month Extension)|Death|0|||
28079168|NCT00112437|54732796|FG015|Years 6-10 (60-Month Extension)|Death|0|||
28079169|NCT00112437|54732797|FG016|Years 6-10 (60-Month Extension)|Death|0|||
28079170|NCT00112437|54732798|FG017|Years 6-10 (60-Month Extension)|Death|0|||
28079171|NCT00112437|54732799|FG018|Years 6-10 (60-Month Extension)|Death|0|||
28079172|NCT00112437|54732800|FG019|Years 6-10 (60-Month Extension)|Death|0|||
28079173|NCT00112437|54732801|FG020|Years 6-10 (60-Month Extension)|Death|0|||
28079174|NCT00112437|54732802|FG021|Years 6-10 (60-Month Extension)|Death|0|||
28079175|NCT00112437|54732803|FG022|Years 6-10 (60-Month Extension)|Death|0|||
28079176|NCT00112437|54732804|FG023|Years 6-10 (60-Month Extension)|Death|2|||
28163236|NCT02269917|54833851|FG001|BL to EOE-Test and BL to Switch-Control|Other|4|||
28163237|NCT02269917|54833852|FG002|BL to EOE-Test and BL to Switch-Control|Other|0|||
28079177|NCT00112437|54732805|FG024|Years 6-10 (60-Month Extension)|Death|0|||
28079178|NCT00112437|54732806|FG025|Years 6-10 (60-Month Extension)|Death|0|||
28163238|NCT02269917|54833850|FG000|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|32|||
27925593|NCT01258608|54582132|FG001|Overall Study|Lack of compliance|0|||
28079179|NCT00112437|54732781|FG000|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
28079180|NCT00112437|54732782|FG001|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
28079181|NCT00112437|54732783|FG002|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
28079182|NCT00112437|54732784|FG003|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
28079183|NCT00112437|54732785|FG004|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
28079184|NCT00112437|54732786|FG005|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
28079185|NCT00112437|54732787|FG006|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
28079186|NCT00112437|54732788|FG007|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
28079187|NCT00112437|54732789|FG008|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
28079188|NCT00112437|54732790|FG009|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
28079189|NCT00112437|54732791|FG010|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
28079190|NCT00112437|54732792|FG011|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
28079191|NCT00112437|54732793|FG012|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
28079192|NCT00112437|54732794|FG013|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
28079193|NCT00112437|54732795|FG014|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
27852743|NCT01465802|54359967|FG003|Overall Study|Study terminated by sponsor|1|||
27852744|NCT01465802|54359968|FG004|Overall Study|Study terminated by sponsor|7|||
27852745|NCT01465802|54359964|FG000|Overall Study|Withdrawal by Subject|7|||
27852746|NCT01465802|54359965|FG001|Overall Study|Withdrawal by Subject|7|||
27852747|NCT01465802|54359966|FG002|Overall Study|Withdrawal by Subject|0|||
27852748|NCT01465802|54359967|FG003|Overall Study|Withdrawal by Subject|8|||
27852749|NCT01465802|54359968|FG004|Overall Study|Withdrawal by Subject|1|||
27852750|NCT01465802|54359964|FG000|Overall Study|Lost to Follow-up|1|||
27852751|NCT01465802|54359965|FG001|Overall Study|Lost to Follow-up|1|||
27852752|NCT01465802|54359966|FG002|Overall Study|Lost to Follow-up|0|||
27852753|NCT01465802|54359967|FG003|Overall Study|Lost to Follow-up|0|||
27852754|NCT01465802|54359968|FG004|Overall Study|Lost to Follow-up|0|||
27852755|NCT01465802|54359964|FG000|Overall Study|Reason not specified|9|||
27852756|NCT01465802|54359965|FG001|Overall Study|Reason not specified|4|||
27852757|NCT01465802|54359966|FG002|Overall Study|Reason not specified|0|||
27852758|NCT01465802|54359967|FG003|Overall Study|Reason not specified|10|||
27852759|NCT01465802|54359968|FG004|Overall Study|Reason not specified|2|||
27852760|NCT01465802|54359964|FG000|Overall Study|Death|15|||
27852761|NCT01465802|54359965|FG001|Overall Study|Death|12|||
27852762|NCT01465802|54359966|FG002|Overall Study|Death|0|||
27852763|NCT01465802|54359967|FG003|Overall Study|Death|10|||
27852764|NCT01465802|54359968|FG004|Overall Study|Death|2|||
27852765|NCT01437878|54360013|FG000|Overall Study|Withdrawal by Subject|1|||
27852766|NCT01437878|54360014|FG001|Overall Study|Withdrawal by Subject|0|||
27852767|NCT01465178|54360040|FG000|Overall Study|Withdrawal by Subject|1|||
27852768|NCT01465178|54360041|FG001|Overall Study|Withdrawal by Subject|0|||
27852769|NCT01445678|54360147|FG000|Overall Study|Adverse Event|12|||
27852770|NCT01445678|54360148|FG001|Overall Study|Adverse Event|8|||
27852771|NCT01445678|54360147|FG000|Overall Study|Lack of Efficacy|0|||
27852772|NCT01445678|54360148|FG001|Overall Study|Lack of Efficacy|2|||
27852773|NCT01445678|54360147|FG000|Overall Study|Lost to Follow-up|8|||
27852774|NCT01445678|54360148|FG001|Overall Study|Lost to Follow-up|5|||
27852775|NCT01445678|54360147|FG000|Overall Study|Protocol Violation|1|||
27852776|NCT01445678|54360148|FG001|Overall Study|Protocol Violation|1|||
27852777|NCT01445678|54360147|FG000|Overall Study|Withdrawal by Subject|9|||
27852778|NCT01445678|54360148|FG001|Overall Study|Withdrawal by Subject|5|||
27852779|NCT03769194|54360167|FG000|Overall Study|Withdrawal by Subject|0|||
27852780|NCT03769194|54360168|FG001|Overall Study|Withdrawal by Subject|7|||
27852781|NCT03769194|54360169|FG002|Overall Study|Withdrawal by Subject|4|||
27852782|NCT03769194|54360170|FG003|Overall Study|Withdrawal by Subject|1|||
27852783|NCT03769194|54360167|FG000|Overall Study|moved from study area|0|||
27852784|NCT03769194|54360168|FG001|Overall Study|moved from study area|2|||
27852785|NCT03769194|54360169|FG002|Overall Study|moved from study area|1|||
27852786|NCT03769194|54360170|FG003|Overall Study|moved from study area|1|||
27852787|NCT03769194|54360167|FG000|Overall Study|Lost to Follow-up|3|||
27852788|NCT03769194|54360168|FG001|Overall Study|Lost to Follow-up|6|||
27852789|NCT03769194|54360169|FG002|Overall Study|Lost to Follow-up|3|||
27852790|NCT03769194|54360170|FG003|Overall Study|Lost to Follow-up|6|||
27852791|NCT03769194|54360167|FG000|Overall Study|other|1|||
27852792|NCT03769194|54360168|FG001|Overall Study|other|3|||
28079194|NCT00112437|54732796|FG015|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
28079195|NCT00112437|54732797|FG016|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
28079196|NCT00112437|54732798|FG017|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
28079197|NCT00112437|54732799|FG018|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
28079198|NCT00112437|54732800|FG019|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
28079199|NCT00112437|54732801|FG020|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
28079200|NCT00112437|54732802|FG021|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
28079201|NCT00112437|54732803|FG022|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
28079202|NCT00112437|54732804|FG023|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
27852793|NCT03769194|54360169|FG002|Overall Study|other|0|||
27852794|NCT03769194|54360170|FG003|Overall Study|other|1|||
27943855|NCT02097134|54600914|FG000|Overall Study|Progressive Disease|3|||
27852795|NCT01465022|54360196|FG000|Overall Study|Lost to Follow-up|15|||
27852796|NCT01465022|54360197|FG001|Overall Study|Lost to Follow-up|14|||
27852797|NCT01465022|54360198|FG002|Overall Study|Lost to Follow-up|0|||
27852798|NCT01465022|54360196|FG000|Overall Study|Breastfeeding discontinuation before 8 w|8|||
27852799|NCT01465022|54360197|FG001|Overall Study|Breastfeeding discontinuation before 8 w|9|||
27852800|NCT01465022|54360198|FG002|Overall Study|Breastfeeding discontinuation before 8 w|0|||
27852801|NCT01465022|54360196|FG000|Overall Study|Not Randomized|0|||
27852802|NCT01465022|54360197|FG001|Overall Study|Not Randomized|0|||
27852803|NCT01465022|54360198|FG002|Overall Study|Not Randomized|70|||
27852804|NCT01464788|54360242|FG000|Overall Study|Lost to Follow-up|0|||
27852805|NCT01464788|54360243|FG001|Overall Study|Lost to Follow-up|1|||
27852806|NCT01464788|54360244|FG002|Overall Study|Lost to Follow-up|0|||
27852807|NCT01464788|54360242|FG000|Overall Study|Patient had hemorrhage after tPA started|0|||
27852808|NCT01464788|54360243|FG001|Overall Study|Patient had hemorrhage after tPA started|1|||
27852809|NCT01464788|54360244|FG002|Overall Study|Patient had hemorrhage after tPA started|0|||
27852810|NCT01444898|54360254|FG000|Overall Study|Withdrawal by Subject|1|||
27852811|NCT01419626|54360276|FG000|Overall Study|Protocol Violation|3|||
27852812|NCT01419626|54360277|FG001|Overall Study|Protocol Violation|2|||
27852813|NCT01419626|54360278|FG002|Overall Study|Protocol Violation|2|||
27852814|NCT01419626|54360276|FG000|Overall Study|Withdrawal by Subject|1|||
27852815|NCT01419626|54360277|FG001|Overall Study|Withdrawal by Subject|0|||
27852816|NCT01419626|54360278|FG002|Overall Study|Withdrawal by Subject|0|||
27852817|NCT01419626|54360276|FG000|Overall Study|Lost to Follow-up|0|||
27852818|NCT01419626|54360277|FG001|Overall Study|Lost to Follow-up|1|||
27852819|NCT01419626|54360278|FG002|Overall Study|Lost to Follow-up|1|||
27852820|NCT01444742|54360317|FG000|Overall Study|Death|1|||
27852821|NCT01444430|54360517|FG000|Overall Study|Withdrawal by Subject|53|||
27852822|NCT01444430|54360518|FG001|Overall Study|Withdrawal by Subject|72|||
27852823|NCT01444430|54360517|FG000|Overall Study|Death|6|||
27852824|NCT01444430|54360518|FG001|Overall Study|Death|8|||
27852825|NCT01444430|54360517|FG000|Overall Study|Lost to Follow-up|2|||
27852826|NCT01444430|54360518|FG001|Overall Study|Lost to Follow-up|0|||
27852827|NCT01444430|54360517|FG000|Overall Study|CRF termination module not completed.|0|||
27852828|NCT01444430|54360518|FG001|Overall Study|CRF termination module not completed.|1|||
27852829|NCT01436162|54360594|FG000|Single-blind Lead-in Phase|Adverse Event|26|||
27852830|NCT01436162|54360595|FG001|Single-blind Lead-in Phase|Adverse Event|0|||
27852831|NCT01436162|54360596|FG002|Single-blind Lead-in Phase|Adverse Event|0|||
27852832|NCT01436162|54360594|FG000|Single-blind Lead-in Phase|Protocol Violation|24|||
27852833|NCT01436162|54360595|FG001|Single-blind Lead-in Phase|Protocol Violation|0|||
27852834|NCT01436162|54360596|FG002|Single-blind Lead-in Phase|Protocol Violation|0|||
27852835|NCT01436162|54360594|FG000|Single-blind Lead-in Phase|Withdrawal by Subject|69|||
27852836|NCT01436162|54360595|FG001|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
27852837|NCT01436162|54360596|FG002|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
27852838|NCT01436162|54360594|FG000|Single-blind Lead-in Phase|Lost to Follow-up|43|||
27852839|NCT01436162|54360595|FG001|Single-blind Lead-in Phase|Lost to Follow-up|0|||
27852840|NCT01436162|54360596|FG002|Single-blind Lead-in Phase|Lost to Follow-up|0|||
27852841|NCT01436162|54360594|FG000|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13|||
27852842|NCT01436162|54360595|FG001|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
27852843|NCT01436162|54360596|FG002|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
27852844|NCT01436162|54360594|FG000|Single-blind Lead-in Phase|Other|107|||
27852845|NCT01436162|54360595|FG001|Single-blind Lead-in Phase|Other|0|||
27852846|NCT01436162|54360596|FG002|Single-blind Lead-in Phase|Other|0|||
27852847|NCT01436162|54360594|FG000|Randomized Phase|Adverse Event|1|||
27852848|NCT01436162|54360595|FG001|Randomized Phase|Adverse Event|5|||
27852849|NCT01436162|54360596|FG002|Randomized Phase|Adverse Event|6|||
27852850|NCT01436162|54360594|FG000|Randomized Phase|Protocol Violation|4|||
27852851|NCT01436162|54360595|FG001|Randomized Phase|Protocol Violation|4|||
27852852|NCT01436162|54360596|FG002|Randomized Phase|Protocol Violation|2|||
27852853|NCT01436162|54360594|FG000|Randomized Phase|Withdrawal by Subject|16|||
27852854|NCT01436162|54360595|FG001|Randomized Phase|Withdrawal by Subject|9|||
27852855|NCT01436162|54360596|FG002|Randomized Phase|Withdrawal by Subject|8|||
27852856|NCT01436162|54360594|FG000|Randomized Phase|Lost to Follow-up|17|||
27852857|NCT01436162|54360595|FG001|Randomized Phase|Lost to Follow-up|5|||
27852858|NCT01436162|54360596|FG002|Randomized Phase|Lost to Follow-up|4|||
27852859|NCT01436162|54360594|FG000|Randomized Phase|Lack of Efficacy|0|||
27852860|NCT01436162|54360595|FG001|Randomized Phase|Lack of Efficacy|1|||
27852861|NCT01436162|54360596|FG002|Randomized Phase|Lack of Efficacy|1|||
27852862|NCT01436162|54360594|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4|||
27852863|NCT01436162|54360595|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
27852864|NCT01436162|54360596|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0|||
27852865|NCT01436162|54360594|FG000|Randomized Phase|Other|2|||
27852866|NCT01436162|54360595|FG001|Randomized Phase|Other|5|||
27852867|NCT01436162|54360596|FG002|Randomized Phase|Other|4|||
27852868|NCT02579382|54360608|FG000|Main Study Phase|Lost to Follow-up|0|||
27852869|NCT02579382|54360609|FG001|Main Study Phase|Lost to Follow-up|0|||
27852870|NCT02579382|54360610|FG002|Main Study Phase|Lost to Follow-up|2|||
27852871|NCT02579382|54360611|FG003|Main Study Phase|Lost to Follow-up|0|||
27852872|NCT02579382|54360608|FG000|Main Study Phase|Withdrew Consent|0|||
27852873|NCT02579382|54360609|FG001|Main Study Phase|Withdrew Consent|0|||
27852874|NCT02579382|54360610|FG002|Main Study Phase|Withdrew Consent|0|||
27852875|NCT02579382|54360611|FG003|Main Study Phase|Withdrew Consent|2|||
27852876|NCT02579382|54360608|FG000|Main Study Phase|Lack of Efficacy|0|||
28163239|NCT02269917|54833851|FG001|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|10|||
28163240|NCT02269917|54833852|FG002|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|0|||
28163241|NCT02269917|54833850|FG000|BL to EOE-Test and BL to Switch-Control|Adverse Event|24|||
28163242|NCT02269917|54833851|FG001|BL to EOE-Test and BL to Switch-Control|Adverse Event|4|||
28163243|NCT02269917|54833852|FG002|BL to EOE-Test and BL to Switch-Control|Adverse Event|0|||
28163244|NCT02269917|54833850|FG000|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|4|||
28163245|NCT02269917|54833851|FG001|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
28163246|NCT02269917|54833852|FG002|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
28163247|NCT02269917|54833850|FG000|BL to EOE-Test and BL to Switch-Control|Physician Decision|4|||
28163248|NCT02269917|54833851|FG001|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
28163249|NCT02269917|54833852|FG002|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
28163250|NCT02269917|54833850|FG000|BL to EOE-Test and BL to Switch-Control|Protocol Violation|2|||
28163251|NCT02269917|54833851|FG001|BL to EOE-Test and BL to Switch-Control|Protocol Violation|1|||
28163252|NCT02269917|54833852|FG002|BL to EOE-Test and BL to Switch-Control|Protocol Violation|0|||
28163253|NCT02269917|54833850|FG000|BL to EOE-Test and BL to Switch-Control|Death|4|||
28163254|NCT02269917|54833851|FG001|BL to EOE-Test and BL to Switch-Control|Death|0|||
28163255|NCT02269917|54833852|FG002|BL to EOE-Test and BL to Switch-Control|Death|0|||
28163256|NCT02269917|54833850|FG000|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|3|||
28163257|NCT02269917|54833851|FG001|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|5|||
28163258|NCT02269917|54833852|FG002|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|0|||
28163259|NCT02269917|54833850|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
28163260|NCT02269917|54833851|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
28163261|NCT02269917|54833852|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
28163262|NCT02269917|54833850|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
28163263|NCT02269917|54833851|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
28163264|NCT02269917|54833852|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|10|||
28163265|NCT02269917|54833850|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
28163266|NCT02269917|54833851|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
27831573|NCT02724462|54309367|FG001|12 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
27831574|NCT02725476|54309424|FG000|Overall Study|Physician Decision|2|||
27831575|NCT02725476|54309425|FG001|Overall Study|Physician Decision|0|||
27831576|NCT02725476|54309424|FG000|Overall Study|Adverse Event|1|||
27831577|NCT02725476|54309425|FG001|Overall Study|Adverse Event|1|||
27831578|NCT02725008|54309530|FG000|Overall Study|Lost to Follow-up|7|||
27852877|NCT02579382|54360609|FG001|Main Study Phase|Lack of Efficacy|0|||
27852878|NCT02579382|54360610|FG002|Main Study Phase|Lack of Efficacy|0|||
27852879|NCT02579382|54360611|FG003|Main Study Phase|Lack of Efficacy|1|||
27852880|NCT02579382|54360608|FG000|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0|||
27852881|NCT02579382|54360609|FG001|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3|||
27852882|NCT02579382|54360610|FG002|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1|||
27852883|NCT02579382|54360611|FG003|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4|||
27852884|NCT02579382|54360608|FG000|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1|||
27852885|NCT02579382|54360609|FG001|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
27852886|NCT02579382|54360610|FG002|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2|||
27852887|NCT02579382|54360611|FG003|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
27852888|NCT02579382|54360608|FG000|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0|||
27852889|NCT02579382|54360609|FG001|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
27852890|NCT02579382|54360610|FG002|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
27831579|NCT02725008|54309531|FG001|Overall Study|Lost to Follow-up|9|||
27831580|NCT02725008|54309530|FG000|Overall Study|Withdrawal by Subject|2|||
27831581|NCT02725008|54309531|FG001|Overall Study|Withdrawal by Subject|2|||
27831582|NCT02725008|54309530|FG000|Overall Study|Admitted to hospital|0|||
27831583|NCT02725008|54309531|FG001|Overall Study|Admitted to hospital|1|||
27831584|NCT01807949|54309803|FG000|Overall Study|Adverse Event|1|||
27831585|NCT01807949|54309804|FG001|Overall Study|Adverse Event|2|||
27831586|NCT01807949|54309805|FG002|Overall Study|Adverse Event|2|||
27831587|NCT01807949|54309803|FG000|Overall Study|Withdrawal by Subject|1|||
27831588|NCT01807949|54309804|FG001|Overall Study|Withdrawal by Subject|2|||
27831589|NCT01807949|54309805|FG002|Overall Study|Withdrawal by Subject|2|||
27831590|NCT01807949|54309803|FG000|Overall Study|Non-Compliance|0|||
27831591|NCT01807949|54309804|FG001|Overall Study|Non-Compliance|0|||
27831592|NCT01807949|54309805|FG002|Overall Study|Non-Compliance|1|||
27831593|NCT01807949|54309803|FG000|Overall Study|Undefined|0|||
27831594|NCT01807949|54309804|FG001|Overall Study|Undefined|1|||
27831595|NCT01807949|54309805|FG002|Overall Study|Undefined|2|||
27831596|NCT01807949|54309803|FG000|Overall Study|Randomized But Not Treated|0|||
27831597|NCT01807949|54309804|FG001|Overall Study|Randomized But Not Treated|2|||
27831598|NCT01807949|54309805|FG002|Overall Study|Randomized But Not Treated|2|||
27925594|NCT01258608|54582131|FG000|Overall Study|Lack of Efficacy|0|||
27831599|NCT01806779|54309817|FG000|Overall Study|Physician Decision|2|||
27852891|NCT02579382|54360611|FG003|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
27852892|NCT02579382|54360608|FG000|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
27852893|NCT02579382|54360609|FG001|Optional Treatment Extension Phase(OTEP)|Adverse Event|1|||
27852894|NCT02579382|54360610|FG002|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
28079203|NCT00112437|54732805|FG024|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
28079204|NCT00112437|54732806|FG025|Years 6-10 (60-Month Extension)|Lost to Follow-up|1|||
28079205|NCT00112437|54732781|FG000|Years 6-10 (60-Month Extension)|Other|0|||
28079206|NCT00112437|54732782|FG001|Years 6-10 (60-Month Extension)|Other|0|||
28079207|NCT00112437|54732783|FG002|Years 6-10 (60-Month Extension)|Other|0|||
28079208|NCT00112437|54732784|FG003|Years 6-10 (60-Month Extension)|Other|0|||
28079209|NCT00112437|54732785|FG004|Years 6-10 (60-Month Extension)|Other|0|||
28163267|NCT02269917|54833852|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|11|||
28163268|NCT02269917|54833850|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
27831600|NCT01806779|54309818|FG001|Overall Study|Physician Decision|0|||
27831601|NCT01806779|54309819|FG002|Overall Study|Physician Decision|1|||
28163269|NCT02269917|54833851|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
28163270|NCT02269917|54833852|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
28163271|NCT02269917|54833850|FG000|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
28163272|NCT02269917|54833851|FG001|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
28163273|NCT02269917|54833852|FG002|Switch to D/C/F/TAF (Until EOE)|Pregnancy|2|||
28163274|NCT02269917|54833850|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
28163275|NCT02269917|54833851|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
28163276|NCT02269917|54833852|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|5|||
28163277|NCT02269917|54833850|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
28163278|NCT02269917|54833851|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
28163279|NCT02269917|54833852|FG002|Switch to D/C/F/TAF (Until EOE)|Other|8|||
28163280|NCT02522494|54833863|FG000|Overall Study|Lost to Follow-up|6|||
28163281|NCT02522494|54833864|FG001|Overall Study|Lost to Follow-up|2|||
28163282|NCT02522494|54833863|FG000|Overall Study|Withdrawal by Subject|1|||
28163283|NCT02522494|54833864|FG001|Overall Study|Withdrawal by Subject|0|||
28163284|NCT02522494|54833863|FG000|Overall Study|CVT visit cancelled or no-show for CVT visit|6|||
28163285|NCT02522494|54833864|FG001|Overall Study|CVT visit cancelled or no-show for CVT visit|2|||
28163286|NCT02522494|54833863|FG000|Overall Study|Participant did not watch the video|1|||
28163287|NCT02522494|54833864|FG001|Overall Study|Participant did not watch the video|0|||
28163288|NCT02522494|54833863|FG000|Overall Study|Death|0|||
28163289|NCT02522494|54833864|FG001|Overall Study|Death|1|||
28163290|NCT01658020|54833872|FG000|Overall Study|Adverse Event|3|||
28163291|NCT01658020|54833873|FG001|Overall Study|Adverse Event|3|||
28163292|NCT01658020|54833872|FG000|Overall Study|Lost to Follow-up|1|||
28163293|NCT01658020|54833873|FG001|Overall Study|Lost to Follow-up|0|||
28163294|NCT01658020|54833872|FG000|Overall Study|Withdrawal by Subject|4|||
28163295|NCT01658020|54833873|FG001|Overall Study|Withdrawal by Subject|5|||
28163296|NCT01658020|54833872|FG000|Overall Study|Protocol Violation|0|||
28163297|NCT01658020|54833873|FG001|Overall Study|Protocol Violation|1|||
28163298|NCT03389477|54833891|FG000|Step 1|Withdrawal by Subject|1|||
28163299|NCT03389477|54833892|FG001|Step 1|Withdrawal by Subject|0|||
28163300|NCT03389477|54833891|FG000|Step 2|Withdrawal by Subject|1|||
28163301|NCT03389477|54833892|FG001|Step 2|Withdrawal by Subject|2|||
28163302|NCT03389477|54833891|FG000|Step 2|Disease progression|1|||
28163303|NCT03389477|54833892|FG001|Step 2|Disease progression|0|||
28163304|NCT03389477|54833891|FG000|Step 2|Death|0|||
28163305|NCT03389477|54833892|FG001|Step 2|Death|1|||
28163306|NCT03389477|54833891|FG000|Step 2|Poor performance status and nutrition|0|||
28163307|NCT03389477|54833892|FG001|Step 2|Poor performance status and nutrition|1|||
28163308|NCT03389477|54833891|FG000|Step 3|Withdrawal after 3 cycles|0|||
27831602|NCT01806779|54309817|FG000|Overall Study|Lack of Efficacy|1|||
27831603|NCT01806779|54309818|FG001|Overall Study|Lack of Efficacy|1|||
27831604|NCT01806779|54309819|FG002|Overall Study|Lack of Efficacy|0|||
27831605|NCT01806779|54309817|FG000|Overall Study|Lost to Follow-up|19|||
27831606|NCT01806779|54309818|FG001|Overall Study|Lost to Follow-up|20|||
27831607|NCT01806779|54309819|FG002|Overall Study|Lost to Follow-up|0|||
27831608|NCT01806779|54309817|FG000|Overall Study|Withdrawal by Subject|20|||
27831609|NCT01806779|54309818|FG001|Overall Study|Withdrawal by Subject|23|||
27852895|NCT02579382|54360611|FG003|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
27852896|NCT02579382|54360608|FG000|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
28079210|NCT00112437|54732786|FG005|Years 6-10 (60-Month Extension)|Other|0|||
28079211|NCT00112437|54732787|FG006|Years 6-10 (60-Month Extension)|Other|0|||
28079212|NCT00112437|54732788|FG007|Years 6-10 (60-Month Extension)|Other|0|||
28079213|NCT00112437|54732789|FG008|Years 6-10 (60-Month Extension)|Other|0|||
28163309|NCT03389477|54833892|FG001|Step 3|Withdrawal after 3 cycles|1|||
28163310|NCT03389477|54833891|FG000|Step 3|Still receiving active treatment|4|||
28163311|NCT03389477|54833892|FG001|Step 3|Still receiving active treatment|0|||
28163312|NCT03389477|54833891|FG000|Step 3|Progressive disease after 2 cycles|1|||
27831610|NCT01806779|54309819|FG002|Overall Study|Withdrawal by Subject|22|||
28163313|NCT03389477|54833892|FG001|Step 3|Progressive disease after 2 cycles|0|||
28163314|NCT02680574|54833902|FG000|Overall Study|Death|137|||
28163315|NCT02680574|54833903|FG001|Overall Study|Death|137|||
27852897|NCT02579382|54360609|FG001|Optional Treatment Extension Phase(OTEP)|Pregnancy|1|||
27852898|NCT02579382|54360610|FG002|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
27852899|NCT02579382|54360611|FG003|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
28163316|NCT02680574|54833902|FG000|Overall Study|Withdrawal by Subject|17|||
28163317|NCT02680574|54833903|FG001|Overall Study|Withdrawal by Subject|9|||
28163318|NCT02680574|54833902|FG000|Overall Study|Lost to Follow-up|4|||
28163319|NCT02680574|54833903|FG001|Overall Study|Lost to Follow-up|6|||
28163320|NCT02522884|54833909|FG000|Overall Study|Withdrawal by Subject|6|||
28163321|NCT02522884|54833909|FG000|Overall Study|Death|3|||
28163322|NCT02522884|54833909|FG000|Overall Study|Missed 12-month Follow-up|9|||
28163323|NCT02674568|54833926|FG000|Overall Study|Withdrawal by Subject|5|||
28163324|NCT02674568|54833926|FG000|Overall Study|Death|303|||
28163325|NCT02674568|54833926|FG000|Overall Study|Physician Decision|2|||
28163326|NCT02674568|54833926|FG000|Overall Study|Lost to Follow-up|9|||
28163327|NCT02674568|54833926|FG000|Overall Study|Other, Not Specified|20|||
28163328|NCT03022799|54833955|FG000|Overall Study|Adverse Event|0|||
28163329|NCT03022799|54833956|FG001|Overall Study|Adverse Event|0|||
28163330|NCT03022799|54833957|FG002|Overall Study|Adverse Event|0|||
28163331|NCT03022799|54833958|FG003|Overall Study|Adverse Event|0|||
28163332|NCT03022799|54833959|FG004|Overall Study|Adverse Event|0|||
28163333|NCT03022799|54833960|FG005|Overall Study|Adverse Event|0|||
28163334|NCT03022799|54833961|FG006|Overall Study|Adverse Event|0|||
28163335|NCT03022799|54833962|FG007|Overall Study|Adverse Event|0|||
28163336|NCT03022799|54833963|FG008|Overall Study|Adverse Event|0|||
28163337|NCT03022799|54833964|FG009|Overall Study|Adverse Event|1|||
28163338|NCT03022799|54833965|FG010|Overall Study|Adverse Event|1|||
27852900|NCT02579382|54360608|FG000|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
27852901|NCT02579382|54360609|FG001|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1|||
27852902|NCT02579382|54360610|FG002|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
27852903|NCT02579382|54360611|FG003|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
27852904|NCT01436084|54360647|FG000|Overall Study|Disease Progression|2|||
27852905|NCT01436084|54360647|FG000|Overall Study|Withdrawal by Subject|1|||
27943856|NCT02097134|54600914|FG000|Overall Study|Refusal of Further Protocol Therapy|1|||
28163339|NCT03022799|54833966|FG011|Overall Study|Adverse Event|0|||
28163340|NCT03022799|54833967|FG012|Overall Study|Adverse Event|0|||
28163341|NCT02674334|54834014|FG000|Overall Study|Lost to Follow-up|5|||
28163342|NCT02674334|54834015|FG001|Overall Study|Lost to Follow-up|3|||
28163343|NCT02674334|54834014|FG000|Overall Study|participant difficulty breathing|1|||
28163344|NCT02674334|54834015|FG001|Overall Study|participant difficulty breathing|0|||
28163345|NCT02674334|54834014|FG000|Overall Study|NIRS not recording|1|||
28163346|NCT02674334|54834015|FG001|Overall Study|NIRS not recording|0|||
28163347|NCT03026075|54834021|FG000|Overall Study|Physician Decision|1|||
28163348|NCT01373918|54834027|FG000|Overall Study|Physician Decision|0|||
28163349|NCT01373918|54834028|FG001|Overall Study|Physician Decision|1|||
28163350|NCT02667626|54834036|FG000|Overall Study|Withdrawal by Subject|0|||
28163351|NCT02667626|54834037|FG001|Overall Study|Withdrawal by Subject|1|||
28163352|NCT02522728|54834048|FG000|Overall Study|Withdrawal by Subject|6|||
28163353|NCT02522728|54834049|FG001|Overall Study|Withdrawal by Subject|6|||
28163354|NCT02522728|54834048|FG000|Overall Study|Death|4|||
28163355|NCT02522728|54834049|FG001|Overall Study|Death|3|||
28163356|NCT02522728|54834048|FG000|Overall Study|Adverse Event|2|||
28163357|NCT02522728|54834049|FG001|Overall Study|Adverse Event|1|||
28163358|NCT02522728|54834048|FG000|Overall Study|Did not receive randomized study device|0|||
28163359|NCT02522728|54834049|FG001|Overall Study|Did not receive randomized study device|1|||
28163360|NCT02827877|54834055|FG000|Overall Study|Withdrawal by Subject|1|||
28163361|NCT03025217|54834068|FG000|Overall Study|Pregnancy|1|||
28163362|NCT03025217|54834068|FG000|Overall Study|Lost to Follow-up|1|||
28163363|NCT03025217|54834068|FG000|Overall Study|Not eligible, poor English|2|||
28163364|NCT03023813|54834075|FG000|Overall Study|Lost to Follow-up|1|||
28163365|NCT03023813|54834076|FG001|Overall Study|Lost to Follow-up|2|||
28163366|NCT03023813|54834077|FG002|Overall Study|Lost to Follow-up|0|||
28163367|NCT01365130|54834086|FG000|Overall Study|Progression/worsening of Dx prior to txt|2|||
28163368|NCT01657162|54834092|FG000|Overall Study|Adverse Event|26|||
28163369|NCT01657162|54834093|FG001|Overall Study|Adverse Event|36|||
28163370|NCT01657162|54834092|FG000|Overall Study|Withdrawal by Subject|13|||
28163371|NCT01657162|54834093|FG001|Overall Study|Withdrawal by Subject|13|||
28163372|NCT01657162|54834092|FG000|Overall Study|Continuing Significant Deterioration|9|||
28163373|NCT01657162|54834093|FG001|Overall Study|Continuing Significant Deterioration|3|||
28163374|NCT01657162|54834092|FG000|Overall Study|Refusal of Treatment|4|||
28163375|NCT01657162|54834093|FG001|Overall Study|Refusal of Treatment|6|||
28163376|NCT01657162|54834092|FG000|Overall Study|Lost to Follow-up|3|||
28163377|NCT01657162|54834093|FG001|Overall Study|Lost to Follow-up|4|||
28163378|NCT01657162|54834092|FG000|Overall Study|Death|2|||
27852906|NCT01436084|54360647|FG000|Overall Study|Early Closure of Study|1|||
27852907|NCT01419314|54360662|FG000|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3|||
27852908|NCT01419314|54360663|FG001|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1|||
27852909|NCT01419314|54360662|FG000|Follow-up at Week 3 of the Trial|Lost to Follow-up|3|||
27852910|NCT01419314|54360663|FG001|Follow-up at Week 3 of the Trial|Lost to Follow-up|0|||
27852911|NCT01419314|54360662|FG000|Follow-up at Week 6 of the Trial|Lost to Follow-up|1|||
27852912|NCT01419314|54360663|FG001|Follow-up at Week 6 of the Trial|Lost to Follow-up|2|||
27852913|NCT01419236|54360720|FG000|Overall Study|Adverse Event|1|||
27852914|NCT01419236|54360721|FG001|Overall Study|Adverse Event|0|||
27852915|NCT01419236|54360720|FG000|Overall Study|Lack of Efficacy|0|||
27852916|NCT01419236|54360721|FG001|Overall Study|Lack of Efficacy|1|||
27852917|NCT01419236|54360720|FG000|Overall Study|Lost to Follow-up|1|||
27852918|NCT01419236|54360721|FG001|Overall Study|Lost to Follow-up|0|||
27852919|NCT01419236|54360720|FG000|Overall Study|Physician Decision|1|||
27852920|NCT01419236|54360721|FG001|Overall Study|Physician Decision|0|||
27852921|NCT01419236|54360720|FG000|Overall Study|Withdrawal by Subject|1|||
27852922|NCT01419236|54360721|FG001|Overall Study|Withdrawal by Subject|4|||
28163379|NCT01657162|54834093|FG001|Overall Study|Death|3|||
28163380|NCT01657162|54834092|FG000|Overall Study|Inability to Complete Study Procedures|1|||
28163381|NCT01657162|54834093|FG001|Overall Study|Inability to Complete Study Procedures|7|||
28163382|NCT01657162|54834092|FG000|Overall Study|Protocol Violation|1|||
28163383|NCT01657162|54834093|FG001|Overall Study|Protocol Violation|0|||
27831611|NCT01607957|54309893|FG000|Overall Study|Not treated|1|||
27831612|NCT01607957|54309894|FG001|Overall Study|Not treated|1|||
27831613|NCT01607957|54309893|FG000|Overall Study|Death|367|||
27831614|NCT01607957|54309894|FG001|Overall Study|Death|211|||
27831615|NCT01607957|54309893|FG000|Overall Study|Lost to Follow-up|3|||
27831616|NCT01607957|54309894|FG001|Overall Study|Lost to Follow-up|3|||
27831617|NCT01607957|54309893|FG000|Overall Study|Participant refusal|1|||
27831618|NCT01607957|54309894|FG001|Overall Study|Participant refusal|0|||
27831619|NCT01806623|54309914|FG000|Overall Study|Withdrawal by Subject|1|||
27831620|NCT01806623|54309914|FG000|Overall Study|Adverse Event|1|||
27831621|NCT01806623|54309914|FG000|Overall Study|Did not meet the inclusion criteria|56|||
27831622|NCT01806545|54309920|FG000|Overall Study|Adverse Event|2|||
27831623|NCT01806545|54309921|FG001|Overall Study|Adverse Event|3|||
27831624|NCT01806545|54309920|FG000|Overall Study|Lost to Follow-up|1|||
27831625|NCT01806545|54309921|FG001|Overall Study|Lost to Follow-up|0|||
27831626|NCT01806545|54309920|FG000|Overall Study|Withdrawal by Subject|3|||
27831627|NCT01806545|54309921|FG001|Overall Study|Withdrawal by Subject|2|||
27831628|NCT01806389|54309927|FG000|Overall Study|Withdrawal by Subject|4|||
27852923|NCT01419236|54360720|FG000|Overall Study|Entry Criteria Not Met|1|||
28163384|NCT01657162|54834092|FG000|Overall Study|Hypersensitivity to Alendronate|0|||
28163385|NCT01657162|54834093|FG001|Overall Study|Hypersensitivity to Alendronate|1|||
27831629|NCT01782131|54310183|FG000|Overall Study|Death|93|||
27831630|NCT01782131|54310184|FG001|Overall Study|Death|96|||
28163386|NCT01657162|54834092|FG000|Overall Study|Other than Specified|0|||
28163387|NCT01657162|54834093|FG001|Overall Study|Other than Specified|2|||
28163388|NCT01373294|54834127|FG000|Overall Study|Adverse Event|1|||
28163389|NCT01373294|54834128|FG001|Overall Study|Adverse Event|0|||
28163390|NCT01656304|54834134|FG000|Overall Study|Ineligible, uncontrolled hypertension|1|||
28163391|NCT03023423|54834141|FG000|Overall Study|Death|5|||
28163392|NCT03023423|54834142|FG001|Overall Study|Death|12|||
28163393|NCT03023423|54834143|FG002|Overall Study|Death|20|||
28163394|NCT03023423|54834141|FG000|Overall Study|Other|0|||
28163395|NCT03023423|54834142|FG001|Overall Study|Other|2|||
28163396|NCT03023423|54834143|FG002|Overall Study|Other|2|||
28163397|NCT03023423|54834141|FG000|Overall Study|Ongoing|2|||
28163398|NCT03023423|54834142|FG001|Overall Study|Ongoing|32|||
28163399|NCT03023423|54834143|FG002|Overall Study|Ongoing|24|||
28163400|NCT03185741|54834158|FG000|Baseline|Withdrawal by Subject|1|||
27852924|NCT01419236|54360721|FG001|Overall Study|Entry Criteria Not Met|0|||
27852925|NCT03323658|54360734|FG000|Overall Study|Adverse Event|0|||
27852926|NCT03323658|54360735|FG001|Overall Study|Adverse Event|1|||
27852927|NCT03323658|54360736|FG002|Overall Study|Adverse Event|0|||
27852928|NCT01443026|54360761|FG000|Overall Study|Physician Decision|1|||
27852929|NCT01443026|54360762|FG001|Overall Study|Physician Decision|0|||
27852930|NCT01443026|54360761|FG000|Overall Study|Death|0|||
27852931|NCT01443026|54360762|FG001|Overall Study|Death|1|||
27852932|NCT01443026|54360761|FG000|Overall Study|Withdrawal by Subject|0|||
27852933|NCT01443026|54360762|FG001|Overall Study|Withdrawal by Subject|3|||
27852934|NCT01443026|54360761|FG000|Overall Study|Lost to Follow-up|2|||
27852935|NCT01443026|54360762|FG001|Overall Study|Lost to Follow-up|1|||
28079214|NCT00112437|54732790|FG009|Years 6-10 (60-Month Extension)|Other|0|||
28079215|NCT00112437|54732791|FG010|Years 6-10 (60-Month Extension)|Other|0|||
28079216|NCT00112437|54732792|FG011|Years 6-10 (60-Month Extension)|Other|0|||
28079217|NCT00112437|54732793|FG012|Years 6-10 (60-Month Extension)|Other|0|||
27852936|NCT01442714|54360796|FG000|Overall Study|Death|11|||
27852937|NCT01442714|54360796|FG000|Overall Study|Withdrawal by Subject|1|||
27852938|NCT01418378|54360809|FG000|Overall Study|Death|1|||
27852939|NCT01418378|54360810|FG001|Overall Study|Death|2|||
27852940|NCT01418378|54360809|FG000|Overall Study|Physician Decision|0|||
27852941|NCT01418378|54360810|FG001|Overall Study|Physician Decision|1|||
28079218|NCT00112437|54732794|FG013|Years 6-10 (60-Month Extension)|Other|0|||
28079219|NCT00112437|54732795|FG014|Years 6-10 (60-Month Extension)|Other|0|||
28079220|NCT00112437|54732796|FG015|Years 6-10 (60-Month Extension)|Other|0|||
28079221|NCT00112437|54732797|FG016|Years 6-10 (60-Month Extension)|Other|0|||
28163401|NCT03185741|54834159|FG001|Baseline|Withdrawal by Subject|3|||
28163402|NCT03185741|54834160|FG002|Baseline|Withdrawal by Subject|2|||
27852942|NCT01418378|54360809|FG000|Overall Study|ligament imbalance|0|||
27852943|NCT01418378|54360810|FG001|Overall Study|ligament imbalance|1|||
28079222|NCT00112437|54732798|FG017|Years 6-10 (60-Month Extension)|Other|0|||
28163403|NCT03185741|54834158|FG000|Baseline|Lost to Follow-up|1|||
28163404|NCT03185741|54834159|FG001|Baseline|Lost to Follow-up|2|||
28079223|NCT00112437|54732799|FG018|Years 6-10 (60-Month Extension)|Other|0|||
28079224|NCT00112437|54732800|FG019|Years 6-10 (60-Month Extension)|Other|0|||
28079225|NCT00112437|54732801|FG020|Years 6-10 (60-Month Extension)|Other|0|||
28079226|NCT00112437|54732802|FG021|Years 6-10 (60-Month Extension)|Other|0|||
28163405|NCT03185741|54834160|FG002|Baseline|Lost to Follow-up|3|||
28163406|NCT03185741|54834158|FG000|3Month|Death|1|||
28163407|NCT03185741|54834159|FG001|3Month|Death|1|||
28163408|NCT03185741|54834160|FG002|3Month|Death|2|||
28163409|NCT03185741|54834158|FG000|3Month|Withdrawal by Subject|1|||
28163410|NCT03185741|54834159|FG001|3Month|Withdrawal by Subject|5|||
28163411|NCT03185741|54834160|FG002|3Month|Withdrawal by Subject|1|||
28163412|NCT03185741|54834158|FG000|3Month|Lost to Follow-up|7|||
28163413|NCT03185741|54834159|FG001|3Month|Lost to Follow-up|9|||
28163414|NCT03185741|54834160|FG002|3Month|Lost to Follow-up|8|||
28163415|NCT03185741|54834158|FG000|3Month|Unavailable for 3Month|11|||
28163416|NCT03185741|54834159|FG001|3Month|Unavailable for 3Month|10|||
28163417|NCT03185741|54834160|FG002|3Month|Unavailable for 3Month|11|||
28163418|NCT03185741|54834158|FG000|3Month|Protocol Violation|0|||
28163419|NCT03185741|54834159|FG001|3Month|Protocol Violation|0|||
28163420|NCT03185741|54834160|FG002|3Month|Protocol Violation|3|||
28163421|NCT03185741|54834158|FG000|6Month|Death|1|||
28163422|NCT03185741|54834159|FG001|6Month|Death|1|||
28163423|NCT03185741|54834160|FG002|6Month|Death|2|||
28163424|NCT03185741|54834158|FG000|6Month|Withdrawal by Subject|2|||
27852944|NCT01418378|54360809|FG000|Overall Study|developed chronic myopathy|0|||
28079227|NCT00112437|54732803|FG022|Years 6-10 (60-Month Extension)|Other|0|||
28079228|NCT00112437|54732804|FG023|Years 6-10 (60-Month Extension)|Other|0|||
28079229|NCT00112437|54732805|FG024|Years 6-10 (60-Month Extension)|Other|1|||
28079230|NCT00112437|54732806|FG025|Years 6-10 (60-Month Extension)|Other|0|||
28079231|NCT00112437|54732781|FG000|Years 6-10 (60-Month Extension)|Physician Decision|0|||
28079232|NCT00112437|54732782|FG001|Years 6-10 (60-Month Extension)|Physician Decision|0|||
28079233|NCT00112437|54732783|FG002|Years 6-10 (60-Month Extension)|Physician Decision|0|||
28079234|NCT00112437|54732784|FG003|Years 6-10 (60-Month Extension)|Physician Decision|0|||
28079235|NCT00112437|54732785|FG004|Years 6-10 (60-Month Extension)|Physician Decision|0|||
28163425|NCT03185741|54834159|FG001|6Month|Withdrawal by Subject|3|||
28163426|NCT03185741|54834160|FG002|6Month|Withdrawal by Subject|1|||
28163427|NCT03185741|54834158|FG000|6Month|Lost to Follow-up|16|||
28163428|NCT03185741|54834159|FG001|6Month|Lost to Follow-up|15|||
28163429|NCT03185741|54834160|FG002|6Month|Lost to Follow-up|16|||
28163430|NCT02672852|54834170|FG000|Part A1|Disease Worsening|1|||
28163431|NCT02672852|54834171|FG001|Part A1|Disease Worsening|0|||
28163432|NCT02672852|54834172|FG002|Part A1|Disease Worsening|0|||
28163433|NCT02672852|54834173|FG003|Part A1|Disease Worsening|0|||
28163434|NCT02672852|54834174|FG004|Part A1|Disease Worsening|0|||
28163435|NCT02672852|54834175|FG005|Part A1|Disease Worsening|0|||
28163436|NCT02672852|54834176|FG006|Part A1|Disease Worsening|0|||
28163437|NCT02672852|54834170|FG000|Part A1|Adverse Event|0|||
28163438|NCT02672852|54834171|FG001|Part A1|Adverse Event|1|||
28163439|NCT02672852|54834172|FG002|Part A1|Adverse Event|0|||
28163440|NCT02672852|54834173|FG003|Part A1|Adverse Event|0|||
28163441|NCT02672852|54834174|FG004|Part A1|Adverse Event|0|||
28163442|NCT02672852|54834175|FG005|Part A1|Adverse Event|0|||
28163443|NCT02672852|54834176|FG006|Part A1|Adverse Event|0|||
28163444|NCT02672852|54834170|FG000|Part A1|Lost to Follow-up|1|||
28163445|NCT02672852|54834171|FG001|Part A1|Lost to Follow-up|2|||
28163446|NCT02672852|54834172|FG002|Part A1|Lost to Follow-up|0|||
28163447|NCT02672852|54834173|FG003|Part A1|Lost to Follow-up|0|||
28163448|NCT02672852|54834174|FG004|Part A1|Lost to Follow-up|0|||
28163449|NCT02672852|54834175|FG005|Part A1|Lost to Follow-up|0|||
28163450|NCT02672852|54834176|FG006|Part A1|Lost to Follow-up|0|||
28163451|NCT02672852|54834170|FG000|Part A1|Withdrawal by Subject|1|||
28163452|NCT02672852|54834171|FG001|Part A1|Withdrawal by Subject|1|||
28163453|NCT02672852|54834172|FG002|Part A1|Withdrawal by Subject|0|||
28163454|NCT02672852|54834173|FG003|Part A1|Withdrawal by Subject|0|||
28163455|NCT02672852|54834174|FG004|Part A1|Withdrawal by Subject|0|||
28163456|NCT02672852|54834175|FG005|Part A1|Withdrawal by Subject|0|||
28163457|NCT02672852|54834176|FG006|Part A1|Withdrawal by Subject|0|||
28163458|NCT02672852|54834170|FG000|Part A2|Disease worsening|0|||
28163459|NCT02672852|54834171|FG001|Part A2|Disease worsening|0|||
28163460|NCT02672852|54834172|FG002|Part A2|Disease worsening|1|||
28163461|NCT02672852|54834173|FG003|Part A2|Disease worsening|0|||
28163462|NCT02672852|54834174|FG004|Part A2|Disease worsening|0|||
28163463|NCT02672852|54834175|FG005|Part A2|Disease worsening|0|||
28163464|NCT02672852|54834176|FG006|Part A2|Disease worsening|0|||
28163465|NCT02672852|54834170|FG000|Part A2|Adverse Event|0|||
28163466|NCT02672852|54834171|FG001|Part A2|Adverse Event|0|||
28163467|NCT02672852|54834172|FG002|Part A2|Adverse Event|3|||
28163468|NCT02672852|54834173|FG003|Part A2|Adverse Event|0|||
28163469|NCT02672852|54834174|FG004|Part A2|Adverse Event|0|||
28163470|NCT02672852|54834175|FG005|Part A2|Adverse Event|0|||
28163471|NCT02672852|54834176|FG006|Part A2|Adverse Event|0|||
28163472|NCT02672852|54834170|FG000|Part A2|Lost to Follow-up|0|||
28163473|NCT02672852|54834171|FG001|Part A2|Lost to Follow-up|0|||
28163474|NCT02672852|54834172|FG002|Part A2|Lost to Follow-up|2|||
28163475|NCT02672852|54834173|FG003|Part A2|Lost to Follow-up|0|||
28163476|NCT02672852|54834174|FG004|Part A2|Lost to Follow-up|0|||
28163477|NCT02672852|54834175|FG005|Part A2|Lost to Follow-up|0|||
28163478|NCT02672852|54834176|FG006|Part A2|Lost to Follow-up|0|||
28163479|NCT02672852|54834170|FG000|Part A2|Withdrawal by Subject|0|||
28163480|NCT02672852|54834171|FG001|Part A2|Withdrawal by Subject|0|||
28163481|NCT02672852|54834172|FG002|Part A2|Withdrawal by Subject|1|||
28163482|NCT02672852|54834173|FG003|Part A2|Withdrawal by Subject|0|||
27831631|NCT01782131|54310183|FG000|Overall Study|Lost to Follow-up|1|||
27831632|NCT01782131|54310184|FG001|Overall Study|Lost to Follow-up|3|||
28163483|NCT02672852|54834174|FG004|Part A2|Withdrawal by Subject|0|||
28163484|NCT02672852|54834175|FG005|Part A2|Withdrawal by Subject|0|||
28163485|NCT02672852|54834176|FG006|Part A2|Withdrawal by Subject|0|||
28163486|NCT02672852|54834170|FG000|Part A2|Other|0|||
28163487|NCT02672852|54834171|FG001|Part A2|Other|0|||
28163488|NCT02672852|54834172|FG002|Part A2|Other|3|||
28163489|NCT02672852|54834173|FG003|Part A2|Other|0|||
28163490|NCT02672852|54834174|FG004|Part A2|Other|0|||
28163491|NCT02672852|54834175|FG005|Part A2|Other|0|||
28163492|NCT02672852|54834176|FG006|Part A2|Other|0|||
28163493|NCT02672852|54834170|FG000|Part A2|Not entered in Part B|0|||
28163494|NCT02672852|54834171|FG001|Part A2|Not entered in Part B|0|||
28163495|NCT02672852|54834172|FG002|Part A2|Not entered in Part B|0|||
28163496|NCT02672852|54834173|FG003|Part A2|Not entered in Part B|4|||
28163497|NCT02672852|54834174|FG004|Part A2|Not entered in Part B|0|||
28163498|NCT02672852|54834175|FG005|Part A2|Not entered in Part B|0|||
28163499|NCT02672852|54834176|FG006|Part A2|Not entered in Part B|0|||
28163500|NCT02672852|54834170|FG000|Part B|Disease worsening|0|||
27730808|NCT02776033|54178060|FG000|Overall Study|Withdrawal by Subject|0|||
27730809|NCT02776033|54178061|FG001|Overall Study|Withdrawal by Subject|0|||
27730810|NCT02776033|54178062|FG002|Overall Study|Withdrawal by Subject|2|||
27730811|NCT02776033|54178060|FG000|Overall Study|Physician Decision|2|||
27730812|NCT02776033|54178061|FG001|Overall Study|Physician Decision|0|||
27831633|NCT01782131|54310183|FG000|Overall Study|Withdrawal by Subject|10|||
27831634|NCT01782131|54310184|FG001|Overall Study|Withdrawal by Subject|10|||
27831635|NCT01782131|54310183|FG000|Overall Study|Randomized but not treated|5|||
28163501|NCT02672852|54834171|FG001|Part B|Disease worsening|0|||
28163502|NCT02672852|54834172|FG002|Part B|Disease worsening|0|||
28163503|NCT02672852|54834173|FG003|Part B|Disease worsening|0|||
28163504|NCT02672852|54834174|FG004|Part B|Disease worsening|1|||
27730813|NCT02776033|54178062|FG002|Overall Study|Physician Decision|0|||
27730814|NCT02776033|54178060|FG000|Overall Study|Lost to Follow-up|1|||
27730815|NCT02776033|54178061|FG001|Overall Study|Lost to Follow-up|0|||
27730816|NCT02776033|54178062|FG002|Overall Study|Lost to Follow-up|0|||
27730817|NCT02776033|54178060|FG000|Overall Study|Adverse Event|1|||
27730818|NCT02776033|54178061|FG001|Overall Study|Adverse Event|2|||
27831636|NCT01782131|54310184|FG001|Overall Study|Randomized but not treated|5|||
27730819|NCT02776033|54178062|FG002|Overall Study|Adverse Event|0|||
27730820|NCT02777125|54178078|FG000|Overall Study|Consent form violation|14|||
27730821|NCT02777125|54178079|FG001|Overall Study|Consent form violation|12|||
27730822|NCT02777125|54178078|FG000|Overall Study|Assent form violation|21|||
28163505|NCT02672852|54834175|FG005|Part B|Disease worsening|0|||
28163506|NCT02672852|54834176|FG006|Part B|Disease worsening|1|||
28163507|NCT02672852|54834170|FG000|Part B|Worsening pre-existing condition|0|||
28163508|NCT02672852|54834171|FG001|Part B|Worsening pre-existing condition|0|||
28163509|NCT02672852|54834172|FG002|Part B|Worsening pre-existing condition|0|||
28163510|NCT02672852|54834173|FG003|Part B|Worsening pre-existing condition|0|||
28163511|NCT02672852|54834174|FG004|Part B|Worsening pre-existing condition|0|||
28163512|NCT02672852|54834175|FG005|Part B|Worsening pre-existing condition|1|||
28163513|NCT02672852|54834176|FG006|Part B|Worsening pre-existing condition|0|||
28163514|NCT02672852|54834170|FG000|Part B|Other adverse event|0|||
28163515|NCT02672852|54834171|FG001|Part B|Other adverse event|0|||
28163516|NCT02672852|54834172|FG002|Part B|Other adverse event|0|||
28163517|NCT02672852|54834173|FG003|Part B|Other adverse event|0|||
28163518|NCT02672852|54834174|FG004|Part B|Other adverse event|3|||
28163519|NCT02672852|54834175|FG005|Part B|Other adverse event|5|||
28163520|NCT02672852|54834176|FG006|Part B|Other adverse event|1|||
28163521|NCT02672852|54834170|FG000|Part B|Lost to Follow-up|0|||
28163522|NCT02672852|54834171|FG001|Part B|Lost to Follow-up|0|||
28163523|NCT02672852|54834172|FG002|Part B|Lost to Follow-up|0|||
28163524|NCT02672852|54834173|FG003|Part B|Lost to Follow-up|0|||
28163525|NCT02672852|54834174|FG004|Part B|Lost to Follow-up|3|||
28163526|NCT02672852|54834175|FG005|Part B|Lost to Follow-up|4|||
28163527|NCT02672852|54834176|FG006|Part B|Lost to Follow-up|1|||
28163528|NCT02672852|54834170|FG000|Part B|Withdrawal by Subject|0|||
28163529|NCT02672852|54834171|FG001|Part B|Withdrawal by Subject|0|||
28163530|NCT02672852|54834172|FG002|Part B|Withdrawal by Subject|0|||
28163531|NCT02672852|54834173|FG003|Part B|Withdrawal by Subject|0|||
28163532|NCT02672852|54834174|FG004|Part B|Withdrawal by Subject|5|||
28163533|NCT02672852|54834175|FG005|Part B|Withdrawal by Subject|0|||
28163534|NCT02672852|54834176|FG006|Part B|Withdrawal by Subject|7|||
28163535|NCT02672852|54834170|FG000|Part B|Other|0|||
28163536|NCT02672852|54834171|FG001|Part B|Other|0|||
28163537|NCT02672852|54834172|FG002|Part B|Other|0|||
27730823|NCT02777125|54178079|FG001|Overall Study|Assent form violation|23|||
28079236|NCT00112437|54732786|FG005|Years 6-10 (60-Month Extension)|Physician Decision|0|||
28079237|NCT00112437|54732787|FG006|Years 6-10 (60-Month Extension)|Physician Decision|0|||
28079238|NCT00112437|54732788|FG007|Years 6-10 (60-Month Extension)|Physician Decision|0|||
28079239|NCT00112437|54732789|FG008|Years 6-10 (60-Month Extension)|Physician Decision|0|||
28079240|NCT00112437|54732790|FG009|Years 6-10 (60-Month Extension)|Physician Decision|0|||
28163538|NCT02672852|54834173|FG003|Part B|Other|0|||
28163539|NCT02672852|54834174|FG004|Part B|Other|4|||
28163540|NCT02672852|54834175|FG005|Part B|Other|1|||
28163541|NCT02672852|54834176|FG006|Part B|Other|2|||
28163542|NCT02671760|54834187|FG000|Overall Study|Lost to Follow-up|0|||
28163543|NCT02671760|54834188|FG001|Overall Study|Lost to Follow-up|1|||
28163544|NCT02671760|54834189|FG002|Overall Study|Lost to Follow-up|0|||
28163545|NCT02667236|54834199|FG000|Overall Study|Adverse Event|1|||
28163546|NCT02667236|54834200|FG001|Overall Study|Adverse Event|1|||
28079241|NCT00112437|54732791|FG010|Years 6-10 (60-Month Extension)|Physician Decision|0|||
28079242|NCT00112437|54732792|FG011|Years 6-10 (60-Month Extension)|Physician Decision|0|||
28079243|NCT00112437|54732793|FG012|Years 6-10 (60-Month Extension)|Physician Decision|0|||
28079244|NCT00112437|54732794|FG013|Years 6-10 (60-Month Extension)|Physician Decision|0|||
28079245|NCT00112437|54732795|FG014|Years 6-10 (60-Month Extension)|Physician Decision|0|||
28079246|NCT00112437|54732796|FG015|Years 6-10 (60-Month Extension)|Physician Decision|0|||
28079247|NCT00112437|54732797|FG016|Years 6-10 (60-Month Extension)|Physician Decision|0|||
28079248|NCT00112437|54732798|FG017|Years 6-10 (60-Month Extension)|Physician Decision|0|||
28079249|NCT00112437|54732799|FG018|Years 6-10 (60-Month Extension)|Physician Decision|0|||
28079250|NCT00112437|54732800|FG019|Years 6-10 (60-Month Extension)|Physician Decision|0|||
28079251|NCT00112437|54732801|FG020|Years 6-10 (60-Month Extension)|Physician Decision|0|||
28079252|NCT00112437|54732802|FG021|Years 6-10 (60-Month Extension)|Physician Decision|0|||
28079253|NCT00112437|54732803|FG022|Years 6-10 (60-Month Extension)|Physician Decision|0|||
28079254|NCT00112437|54732804|FG023|Years 6-10 (60-Month Extension)|Physician Decision|2|||
28163547|NCT02667236|54834199|FG000|Overall Study|Withdrawal by Subject|2|||
28163548|NCT02667236|54834200|FG001|Overall Study|Withdrawal by Subject|0|||
28163549|NCT01126749|54834210|FG000|Phase 1b|Other|0|||
28163550|NCT01126749|54834211|FG001|Phase 1b|Other|1|||
28163551|NCT01126749|54834212|FG002|Phase 1b|Other|0|||
28163552|NCT01126749|54834213|FG003|Phase 1b|Other|0|||
27730824|NCT02777125|54178078|FG000|Overall Study|Protocol Violation|8|||
28079255|NCT00112437|54732805|FG024|Years 6-10 (60-Month Extension)|Physician Decision|0|||
28079256|NCT00112437|54732806|FG025|Years 6-10 (60-Month Extension)|Physician Decision|0|||
28079257|NCT00112437|54732781|FG000|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
28079258|NCT00112437|54732782|FG001|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
28079259|NCT00112437|54732783|FG002|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
28163553|NCT01126749|54834210|FG000|Phase 1b|Withdrawal by Subject|0|||
28163554|NCT01126749|54834211|FG001|Phase 1b|Withdrawal by Subject|1|||
28163555|NCT01126749|54834212|FG002|Phase 1b|Withdrawal by Subject|0|||
28163556|NCT01126749|54834213|FG003|Phase 1b|Withdrawal by Subject|0|||
28163557|NCT01126749|54834210|FG000|Phase 1b|Death|3|||
28163558|NCT01126749|54834211|FG001|Phase 1b|Death|4|||
27852945|NCT01418378|54360810|FG001|Overall Study|developed chronic myopathy|1|||
27852946|NCT01435928|54360831|FG000|Open Label Phase - up to 24 Weeks|Adverse Event|83|||
27852947|NCT01435928|54360832|FG001|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
27852948|NCT01435928|54360833|FG002|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
27852949|NCT01435928|54360831|FG000|Open Label Phase - up to 24 Weeks|Death|1|||
27852950|NCT01435928|54360832|FG001|Open Label Phase - up to 24 Weeks|Death|0|||
27852951|NCT01435928|54360833|FG002|Open Label Phase - up to 24 Weeks|Death|0|||
27852952|NCT01435928|54360831|FG000|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46|||
27852953|NCT01435928|54360832|FG001|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
27852954|NCT01435928|54360833|FG002|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
27852955|NCT01435928|54360831|FG000|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60|||
27852956|NCT01435928|54360832|FG001|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
27852957|NCT01435928|54360833|FG002|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
27852958|NCT01435928|54360831|FG000|Open Label Phase - up to 24 Weeks|Protocol Violation|39|||
27852959|NCT01435928|54360832|FG001|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
27852960|NCT01435928|54360833|FG002|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
27852961|NCT01435928|54360831|FG000|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96|||
27852962|NCT01435928|54360832|FG001|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
27852963|NCT01435928|54360833|FG002|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
27852964|NCT01435928|54360831|FG000|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44|||
27852965|NCT01435928|54360832|FG001|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
27852966|NCT01435928|54360833|FG002|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
27852967|NCT01435928|54360831|FG000|Open Label Phase - up to 24 Weeks|Terminated at study completion|6|||
27852968|NCT01435928|54360832|FG001|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
27852969|NCT01435928|54360833|FG002|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
27852970|NCT01435928|54360831|FG000|Open Label Phase - up to 24 Weeks|Administrative|14|||
27852971|NCT01435928|54360832|FG001|Open Label Phase - up to 24 Weeks|Administrative|0|||
27852972|NCT01435928|54360833|FG002|Open Label Phase - up to 24 Weeks|Administrative|0|||
27852973|NCT01435928|54360831|FG000|Double Blind Phase - 28 Weeks|Adverse Event|0|||
27852974|NCT01435928|54360832|FG001|Double Blind Phase - 28 Weeks|Adverse Event|3|||
27852975|NCT01435928|54360833|FG002|Double Blind Phase - 28 Weeks|Adverse Event|1|||
27852976|NCT01435928|54360831|FG000|Double Blind Phase - 28 Weeks|Lost to Follow-up|0|||
27852977|NCT01435928|54360832|FG001|Double Blind Phase - 28 Weeks|Lost to Follow-up|2|||
27852978|NCT01435928|54360833|FG002|Double Blind Phase - 28 Weeks|Lost to Follow-up|5|||
27852979|NCT01435928|54360831|FG000|Double Blind Phase - 28 Weeks|Protocol Violation|0|||
27852980|NCT01435928|54360832|FG001|Double Blind Phase - 28 Weeks|Protocol Violation|11|||
27852981|NCT01435928|54360833|FG002|Double Blind Phase - 28 Weeks|Protocol Violation|4|||
27852982|NCT01435928|54360831|FG000|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0|||
27852983|NCT01435928|54360832|FG001|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5|||
27852984|NCT01435928|54360833|FG002|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12|||
27852985|NCT01435928|54360831|FG000|Double Blind Phase - 28 Weeks|Terminated at study completion|0|||
27852986|NCT01435928|54360832|FG001|Double Blind Phase - 28 Weeks|Terminated at study completion|47|||
27852987|NCT01435928|54360833|FG002|Double Blind Phase - 28 Weeks|Terminated at study completion|39|||
27852988|NCT01435928|54360831|FG000|Double Blind Phase - 28 Weeks|Relapse criteria met|0|||
27852989|NCT01435928|54360832|FG001|Double Blind Phase - 28 Weeks|Relapse criteria met|43|||
27852990|NCT01435928|54360833|FG002|Double Blind Phase - 28 Weeks|Relapse criteria met|58|||
27852991|NCT01435928|54360831|FG000|Double Blind Phase - 28 Weeks|Administrative|0|||
27852992|NCT01435928|54360832|FG001|Double Blind Phase - 28 Weeks|Administrative|5|||
27852993|NCT01435928|54360833|FG002|Double Blind Phase - 28 Weeks|Administrative|2|||
27852994|NCT01416272|54360845|FG000|Overall Study|Unacceptable distance visual acuity|2|||
27852995|NCT01416272|54360845|FG000|Overall Study|Lost to Follow-up|1|||
27852996|NCT01416272|54360845|FG000|Overall Study|Study related complaints|1|||
27852997|NCT01435772|54361344|FG000|Overall Study|Adverse Event|1|||
28079260|NCT00112437|54732784|FG003|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
28079261|NCT00112437|54732785|FG004|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
28079262|NCT00112437|54732786|FG005|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
28079263|NCT00112437|54732787|FG006|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
28163559|NCT01126749|54834212|FG002|Phase 1b|Death|0|||
28079264|NCT00112437|54732788|FG007|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
28079265|NCT00112437|54732789|FG008|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
28079266|NCT00112437|54732790|FG009|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
28079267|NCT00112437|54732791|FG010|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
28163560|NCT01126749|54834213|FG003|Phase 1b|Death|0|||
28163561|NCT01126749|54834210|FG000|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
28163562|NCT01126749|54834211|FG001|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
28163563|NCT01126749|54834212|FG002|Phase 2|Completed 1 Year Follow-Up Per Protocol|4|||
28079268|NCT00112437|54732792|FG011|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
27852998|NCT01435772|54361345|FG001|Overall Study|Adverse Event|0|||
27852999|NCT01435772|54361346|FG002|Overall Study|Adverse Event|2|||
27853000|NCT01435772|54361344|FG000|Overall Study|Withdrawal by Subject|0|||
28079269|NCT00112437|54732793|FG012|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
28079270|NCT00112437|54732794|FG013|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
28079271|NCT00112437|54732795|FG014|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
28163564|NCT01126749|54834213|FG003|Phase 2|Completed 1 Year Follow-Up Per Protocol|7|||
28163565|NCT01126749|54834210|FG000|Phase 2|Study Termination by Sponsor|0|||
28163566|NCT01126749|54834211|FG001|Phase 2|Study Termination by Sponsor|0|||
28163567|NCT01126749|54834212|FG002|Phase 2|Study Termination by Sponsor|12|||
28163568|NCT01126749|54834213|FG003|Phase 2|Study Termination by Sponsor|6|||
28163569|NCT01126749|54834210|FG000|Phase 2|Other|0|||
28163570|NCT01126749|54834211|FG001|Phase 2|Other|0|||
28163571|NCT01126749|54834212|FG002|Phase 2|Other|4|||
28163572|NCT01126749|54834213|FG003|Phase 2|Other|2|||
28163573|NCT01126749|54834210|FG000|Phase 2|Withdrawal by Subject|0|||
28163574|NCT01126749|54834211|FG001|Phase 2|Withdrawal by Subject|0|||
28163575|NCT01126749|54834212|FG002|Phase 2|Withdrawal by Subject|0|||
28163576|NCT01126749|54834213|FG003|Phase 2|Withdrawal by Subject|2|||
28163577|NCT01126749|54834210|FG000|Phase 2|Lost to Follow-up|0|||
28163578|NCT01126749|54834211|FG001|Phase 2|Lost to Follow-up|0|||
28163579|NCT01126749|54834212|FG002|Phase 2|Lost to Follow-up|0|||
28163580|NCT01126749|54834213|FG003|Phase 2|Lost to Follow-up|1|||
28163581|NCT01126749|54834210|FG000|Phase 2|Death|0|||
28163582|NCT01126749|54834211|FG001|Phase 2|Death|0|||
28163583|NCT01126749|54834212|FG002|Phase 2|Death|22|||
28163584|NCT01126749|54834213|FG003|Phase 2|Death|22|||
28163585|NCT01126749|54834210|FG000|Phase 2|Adverse Event|0|||
28163586|NCT01126749|54834211|FG001|Phase 2|Adverse Event|0|||
28163587|NCT01126749|54834212|FG002|Phase 2|Adverse Event|0|||
28163588|NCT01126749|54834213|FG003|Phase 2|Adverse Event|1|||
27730825|NCT02777125|54178079|FG001|Overall Study|Protocol Violation|12|||
27730826|NCT02769481|54178104|FG000|Overall Study|Protocol Violation|1|||
27730827|NCT02769481|54178105|FG001|Overall Study|Protocol Violation|0|||
27730828|NCT02769481|54178104|FG000|Overall Study|Adverse Event|3|||
27730829|NCT02769481|54178105|FG001|Overall Study|Adverse Event|6|||
27730830|NCT02769481|54178104|FG000|Overall Study|Entry Criteria Not Met|1|||
27730831|NCT02769481|54178105|FG001|Overall Study|Entry Criteria Not Met|2|||
27730832|NCT02769481|54178104|FG000|Overall Study|Withdrawal by Subject|14|||
27730833|NCT02769481|54178105|FG001|Overall Study|Withdrawal by Subject|16|||
27730834|NCT02769481|54178104|FG000|Overall Study|Lost to Follow-up|9|||
27730835|NCT02769481|54178105|FG001|Overall Study|Lost to Follow-up|9|||
27730836|NCT02769481|54178104|FG000|Overall Study|Physician Decision|0|||
28079272|NCT00112437|54732796|FG015|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
28079273|NCT00112437|54732797|FG016|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
28079274|NCT00112437|54732798|FG017|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
28079275|NCT00112437|54732799|FG018|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
28079276|NCT00112437|54732800|FG019|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
28079277|NCT00112437|54732801|FG020|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
28079278|NCT00112437|54732802|FG021|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
28079279|NCT00112437|54732803|FG022|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4|||
28079280|NCT00112437|54732804|FG023|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6|||
28079281|NCT00112437|54732805|FG024|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
28079282|NCT00112437|54732806|FG025|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3|||
28079283|NCT03653416|54732862|FG000|Overall Study|Protocol Violation|6|||
28079284|NCT03653416|54732863|FG001|Overall Study|Protocol Violation|1|||
28079285|NCT00112359|54732871|FG000|Overall Study|Unrelated adverse event|16|||
28079286|NCT00112359|54732872|FG001|Overall Study|Unrelated adverse event|8|||
28079287|NCT00112359|54732871|FG000|Overall Study|Trial drug intolerance (adverse event)|2|||
28079288|NCT00112359|54732872|FG001|Overall Study|Trial drug intolerance (adverse event)|0|||
28163589|NCT02521948|54834223|FG000|Overall Study|Adverse Event|2|||
28163590|NCT02521948|54834223|FG000|Overall Study|Death|4|||
28163591|NCT02521948|54834223|FG000|Overall Study|Lost to Follow-up|1|||
28163592|NCT02521948|54834223|FG000|Overall Study|Did not attend one or both follow-ups|6|||
28163593|NCT04446429|54834232|FG000|Overall Study|Lost to Follow-up|6|||
28163594|NCT04446429|54834233|FG001|Overall Study|Lost to Follow-up|0|||
27730837|NCT02769481|54178105|FG001|Overall Study|Physician Decision|1|||
27730838|NCT02769481|54178104|FG000|Overall Study|Terminated by Sponsor|1|||
27730839|NCT02769481|54178105|FG001|Overall Study|Terminated by Sponsor|0|||
27730840|NCT02769481|54178104|FG000|Overall Study|Death|0|||
27730841|NCT02769481|54178105|FG001|Overall Study|Death|1|||
28163595|NCT02832687|54834241|FG000|Overall Study|Adverse Event|0|||
28163596|NCT02832687|54834242|FG001|Overall Study|Adverse Event|2|||
28163597|NCT01656850|54834267|FG000|First Intervention (3 Months)|Withdrawal by Subject|3|||
28163598|NCT01656850|54834268|FG001|First Intervention (3 Months)|Withdrawal by Subject|4|||
27730842|NCT02769481|54178104|FG000|Overall Study|Undefined|4|||
27730843|NCT02769481|54178105|FG001|Overall Study|Undefined|1|||
27730844|NCT02769247|54178115|FG000|Overall Study|Withdrawal by Subject|1|||
27730845|NCT02769247|54178116|FG001|Overall Study|Withdrawal by Subject|0|||
28079289|NCT00112359|54732871|FG000|Overall Study|Related adverse event|5|||
28079290|NCT00112359|54732872|FG001|Overall Study|Related adverse event|3|||
28079291|NCT00112359|54732871|FG000|Overall Study|Lost to Follow-up|0|||
28079292|NCT00112359|54732872|FG001|Overall Study|Lost to Follow-up|1|||
28079293|NCT00112359|54732871|FG000|Overall Study|Personal/administrative|1|||
28079294|NCT00112359|54732872|FG001|Overall Study|Personal/administrative|1|||
28079295|NCT00112359|54732871|FG000|Overall Study|Other|3|||
28079296|NCT00112359|54732872|FG001|Overall Study|Other|0|||
28079297|NCT00119379|54732880|FG000|Overall Study|Adverse Event|4|||
28079298|NCT00119379|54732881|FG001|Overall Study|Adverse Event|1|||
28079299|NCT00118911|54732889|FG000|Overall Study|Withdrawal by Subject|2|||
28079300|NCT00118911|54732890|FG001|Overall Study|Withdrawal by Subject|5|||
28079301|NCT00131937|54732896|FG000|Overall Study|Adverse Event|3|||
28079302|NCT00131937|54732896|FG000|Overall Study|Withdrawal by Subject|2|||
28079303|NCT00131937|54732896|FG000|Overall Study|Physician Decision|1|||
28079304|NCT00131937|54732896|FG000|Overall Study|Disease Progression|7|||
28079305|NCT00131937|54732896|FG000|Overall Study|Alternative therapy|1|||
28079306|NCT00131469|54732902|FG000|Overall Study|Withdrawal by Subject|3|||
28079307|NCT00131469|54732903|FG001|Overall Study|Withdrawal by Subject|4|||
28079308|NCT00131469|54732902|FG000|Overall Study|Protocol Violation|3|||
27730846|NCT02769247|54178117|FG002|Overall Study|Withdrawal by Subject|0|||
27730847|NCT02769247|54178118|FG003|Overall Study|Withdrawal by Subject|1|||
28163599|NCT03116685|54834280|FG000|Overall Study|Physician Decision|0|||
28163600|NCT03116685|54834281|FG001|Overall Study|Physician Decision|1|||
28163601|NCT02666222|54834301|FG000|Overall Study|Death|2|||
28079309|NCT00131469|54732903|FG001|Overall Study|Protocol Violation|1|||
28079310|NCT00131469|54732902|FG000|Overall Study|Death|0|||
28079311|NCT00131469|54732903|FG001|Overall Study|Death|1|||
28079312|NCT00131469|54732902|FG000|Overall Study|Lost to Follow-up|0|||
28079313|NCT00131469|54732903|FG001|Overall Study|Lost to Follow-up|1|||
28079314|NCT00131469|54732902|FG000|Overall Study|scan not analyzable|3|||
27730848|NCT02769247|54178115|FG000|Overall Study|Protocol Violation|0|||
27730849|NCT02769247|54178116|FG001|Overall Study|Protocol Violation|0|||
27730850|NCT02769247|54178117|FG002|Overall Study|Protocol Violation|1|||
27730851|NCT02769247|54178118|FG003|Overall Study|Protocol Violation|0|||
27730852|NCT02769247|54178115|FG000|Overall Study|Physician Decision|1|||
27730853|NCT02769247|54178116|FG001|Overall Study|Physician Decision|0|||
27730854|NCT02769247|54178117|FG002|Overall Study|Physician Decision|0|||
27730855|NCT02769247|54178118|FG003|Overall Study|Physician Decision|0|||
27730856|NCT02773537|54178135|FG000|Overall Study|Lost to Follow-up|0|||
27730857|NCT02773537|54178136|FG001|Overall Study|Lost to Follow-up|1|||
27730858|NCT02773537|54178137|FG002|Overall Study|Lost to Follow-up|4|||
27730859|NCT02780713|54178145|FG000|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
27730860|NCT02780713|54178146|FG001|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
27730861|NCT02780713|54178147|FG002|Period 3: Variant B (100mg)|Withdrawal by Subject|2|||
27730862|NCT02780713|54178148|FG003|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
27730863|NCT02780713|54178149|FG004|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
27730864|NCT02767765|54178168|FG000|Overall Study|Adverse Event|4|||
27730865|NCT02767765|54178168|FG000|Overall Study|Death|1|||
27730866|NCT02767765|54178168|FG000|Overall Study|Insufficient response|1|||
28079315|NCT00131469|54732903|FG001|Overall Study|scan not analyzable|6|||
28079316|NCT00372593|54732912|FG000|Overall Study|Adverse Event|43|||
28079317|NCT00372593|54732913|FG001|Overall Study|Adverse Event|45|||
28079318|NCT00372593|54732914|FG002|Overall Study|Adverse Event|0|||
28079319|NCT00372593|54732912|FG000|Overall Study|Death|16|||
28163602|NCT00739401|54834305|FG000|Overall Study|patients were not due for the 2 year follow-up|34|||
28163603|NCT00739401|54834305|FG000|Overall Study|Death|3|||
28163604|NCT00739401|54834305|FG000|Overall Study|Withdrawal by Subject|4|||
28163605|NCT01365052|54834311|FG000|Overall Study|Adverse Event|4|||
27730867|NCT02767765|54178168|FG000|Overall Study|Lost to Follow-up|2|||
28079320|NCT00372593|54732913|FG001|Overall Study|Death|20|||
28079321|NCT00372593|54732914|FG002|Overall Study|Death|1|||
28079322|NCT00372593|54732912|FG000|Overall Study|Lack of Efficacy|82|||
28079323|NCT00372593|54732913|FG001|Overall Study|Lack of Efficacy|71|||
28079324|NCT00372593|54732914|FG002|Overall Study|Lack of Efficacy|2|||
27730868|NCT02767765|54178168|FG000|Overall Study|Investigator decision|1|||
27730869|NCT02767765|54178168|FG000|Overall Study|Non-Compliance|1|||
27730870|NCT02767765|54178168|FG000|Overall Study|Withdrawal by Subject|1|||
27730871|NCT02772757|54178175|FG000|Overall Study|Withdrawal by Subject|1|||
27730872|NCT02772757|54178176|FG001|Overall Study|Withdrawal by Subject|0|||
28079325|NCT00372593|54732912|FG000|Overall Study|Lost to Follow-up|1|||
28079326|NCT00372593|54732913|FG001|Overall Study|Lost to Follow-up|0|||
28079327|NCT00372593|54732914|FG002|Overall Study|Lost to Follow-up|0|||
27730873|NCT02772757|54178177|FG002|Overall Study|Withdrawal by Subject|1|||
27730874|NCT02772757|54178175|FG000|Overall Study|Protocol Violation|0|||
28079328|NCT00372593|54732912|FG000|Overall Study|Physician Decision|42|||
28163606|NCT01365052|54834312|FG001|Overall Study|Adverse Event|4|||
28163607|NCT01372748|54834320|FG000|Overall Study|Lost to Follow-up|16|||
28163608|NCT01372748|54834321|FG001|Overall Study|Lost to Follow-up|34|||
28163609|NCT01372748|54834320|FG000|Overall Study|Withdrawal by Subject|7|||
28163610|NCT01372748|54834321|FG001|Overall Study|Withdrawal by Subject|5|||
28163611|NCT02268851|54834333|FG000|Overall Study|Death|0|||
28163612|NCT02268851|54834334|FG001|Overall Study|Death|0|||
28163613|NCT02268851|54834335|FG002|Overall Study|Death|0|||
28163614|NCT02268851|54834336|FG003|Overall Study|Death|1|||
28163615|NCT02268851|54834337|FG004|Overall Study|Death|2|||
28163616|NCT02268851|54834338|FG005|Overall Study|Death|1|||
28163617|NCT02268851|54834333|FG000|Overall Study|Adverse Event|0|||
28163618|NCT02268851|54834334|FG001|Overall Study|Adverse Event|0|||
28163619|NCT02268851|54834335|FG002|Overall Study|Adverse Event|0|||
28163620|NCT02268851|54834336|FG003|Overall Study|Adverse Event|0|||
28163621|NCT02268851|54834337|FG004|Overall Study|Adverse Event|2|||
28163622|NCT02268851|54834338|FG005|Overall Study|Adverse Event|2|||
28163623|NCT02268851|54834333|FG000|Overall Study|Withdrawal by Subject|0|||
28163624|NCT02268851|54834334|FG001|Overall Study|Withdrawal by Subject|0|||
28163625|NCT02268851|54834335|FG002|Overall Study|Withdrawal by Subject|0|||
28163626|NCT02268851|54834336|FG003|Overall Study|Withdrawal by Subject|2|||
28163627|NCT02268851|54834337|FG004|Overall Study|Withdrawal by Subject|0|||
28163628|NCT02268851|54834338|FG005|Overall Study|Withdrawal by Subject|1|||
28163629|NCT02268851|54834333|FG000|Overall Study|Progressive Disease|1|||
28163630|NCT02268851|54834334|FG001|Overall Study|Progressive Disease|3|||
28163631|NCT02268851|54834335|FG002|Overall Study|Progressive Disease|0|||
28163632|NCT02268851|54834336|FG003|Overall Study|Progressive Disease|0|||
28163633|NCT02268851|54834337|FG004|Overall Study|Progressive Disease|1|||
28163634|NCT02268851|54834338|FG005|Overall Study|Progressive Disease|4|||
28163635|NCT02268851|54834333|FG000|Overall Study|Physician Decision|0|||
28163636|NCT02268851|54834334|FG001|Overall Study|Physician Decision|0|||
28163637|NCT02268851|54834335|FG002|Overall Study|Physician Decision|1|||
28163638|NCT02268851|54834336|FG003|Overall Study|Physician Decision|0|||
28163639|NCT02268851|54834337|FG004|Overall Study|Physician Decision|0|||
28163640|NCT02268851|54834338|FG005|Overall Study|Physician Decision|1|||
28163641|NCT02268851|54834333|FG000|Overall Study|Patient Compliance|0|||
28163642|NCT02268851|54834334|FG001|Overall Study|Patient Compliance|0|||
28163643|NCT02268851|54834335|FG002|Overall Study|Patient Compliance|0|||
28163644|NCT02268851|54834336|FG003|Overall Study|Patient Compliance|0|||
28163645|NCT02268851|54834337|FG004|Overall Study|Patient Compliance|1|||
28163646|NCT02268851|54834338|FG005|Overall Study|Patient Compliance|1|||
28163647|NCT02268851|54834333|FG000|Overall Study|Co-Morbid Condition|0|||
28163648|NCT02268851|54834334|FG001|Overall Study|Co-Morbid Condition|0|||
28163649|NCT02268851|54834335|FG002|Overall Study|Co-Morbid Condition|0|||
28163650|NCT02268851|54834336|FG003|Overall Study|Co-Morbid Condition|0|||
28163651|NCT02268851|54834337|FG004|Overall Study|Co-Morbid Condition|1|||
28163652|NCT02268851|54834338|FG005|Overall Study|Co-Morbid Condition|1|||
28163653|NCT02736825|54834354|FG000|Overall Study|Lost to Follow-up|10|||
28163654|NCT02736825|54834355|FG001|Overall Study|Lost to Follow-up|11|||
28163655|NCT02736825|54834354|FG000|Overall Study|Early Termination|0|||
27730875|NCT02772757|54178176|FG001|Overall Study|Protocol Violation|0|||
27730876|NCT02772757|54178177|FG002|Overall Study|Protocol Violation|1|||
27730877|NCT02772757|54178175|FG000|Overall Study|Physician Decision|0|||
27730878|NCT02772757|54178176|FG001|Overall Study|Physician Decision|3|||
27730879|NCT02772757|54178177|FG002|Overall Study|Physician Decision|3|||
27925595|NCT01258608|54582132|FG001|Overall Study|Lack of Efficacy|1|||
28079329|NCT00372593|54732913|FG001|Overall Study|Physician Decision|41|||
28079330|NCT00372593|54732914|FG002|Overall Study|Physician Decision|0|||
28079331|NCT00372593|54732912|FG000|Overall Study|Ineligible|20|||
28079332|NCT00372593|54732913|FG001|Overall Study|Ineligible|21|||
28079333|NCT00372593|54732914|FG002|Overall Study|Ineligible|1|||
28079334|NCT03666988|54732929|FG000|Part 1 (Up to 28 Months)|Adverse Event|0|||
28079335|NCT03666988|54732930|FG001|Part 1 (Up to 28 Months)|Adverse Event|1|||
28079336|NCT03666988|54732931|FG002|Part 1 (Up to 28 Months)|Adverse Event|3|||
28079337|NCT03666988|54732932|FG003|Part 1 (Up to 28 Months)|Adverse Event|0|||
28079338|NCT03666988|54732933|FG004|Part 1 (Up to 28 Months)|Adverse Event|0|||
28079339|NCT03666988|54732934|FG005|Part 1 (Up to 28 Months)|Adverse Event|0|||
28163656|NCT02736825|54834355|FG001|Overall Study|Early Termination|1|||
28163657|NCT02670122|54834362|FG000|Overall Study|Lost to Follow-up|4|||
28163658|NCT03283371|54834375|FG000|Placebo-controlled|Adverse Event|1|||
27730880|NCT00103207|54178186|FG000|Overall Study|Adverse Event|3|||
28079340|NCT03666988|54732929|FG000|Part 1 (Up to 28 Months)|Other|0|||
28079341|NCT03666988|54732930|FG001|Part 1 (Up to 28 Months)|Other|1|||
28079342|NCT03666988|54732931|FG002|Part 1 (Up to 28 Months)|Other|1|||
28163659|NCT03283371|54834376|FG001|Placebo-controlled|Adverse Event|1|||
28163660|NCT03283371|54834377|FG002|Placebo-controlled|Adverse Event|0|||
28163661|NCT03283371|54834378|FG003|Placebo-controlled|Adverse Event|0|||
28163662|NCT03283371|54834375|FG000|Placebo-controlled|Lack of Efficacy|1|||
28163663|NCT03283371|54834376|FG001|Placebo-controlled|Lack of Efficacy|0|||
28163664|NCT03283371|54834377|FG002|Placebo-controlled|Lack of Efficacy|0|||
27730881|NCT00103207|54178186|FG000|Overall Study|Death|1|||
27730882|NCT00103207|54178186|FG000|Overall Study|Withdrawal by Subject|2|||
27730883|NCT00103207|54178186|FG000|Overall Study|Other complicating disease|1|||
27730884|NCT00103207|54178186|FG000|Overall Study|Ineligible|4|||
27730885|NCT00103207|54178186|FG000|Overall Study|Diagnosis of BAC not confirmed|27|||
27730886|NCT01369355|54178198|FG000|Week 0 - Week 44 (Maintenance)|Adverse Event|9|||
27730887|NCT01369355|54178199|FG001|Week 0 - Week 44 (Maintenance)|Adverse Event|12|||
27730888|NCT01369355|54178200|FG002|Week 0 - Week 44 (Maintenance)|Adverse Event|6|||
27730889|NCT01369355|54178201|FG003|Week 0 - Week 44 (Maintenance)|Adverse Event|7|||
27730890|NCT01369355|54178202|FG004|Week 0 - Week 44 (Maintenance)|Adverse Event|14|||
27730891|NCT01369355|54178203|FG005|Week 0 - Week 44 (Maintenance)|Adverse Event|25|||
27730892|NCT01369355|54178204|FG006|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
27730893|NCT01369355|54178205|FG007|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
27730894|NCT01369355|54178206|FG008|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
27730895|NCT01369355|54178198|FG000|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
27730896|NCT01369355|54178199|FG001|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14|||
27730897|NCT01369355|54178200|FG002|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
27730898|NCT01369355|54178201|FG003|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
27730899|NCT01369355|54178202|FG004|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126|||
27730900|NCT01369355|54178203|FG005|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217|||
27730901|NCT01369355|54178204|FG006|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
27730902|NCT01369355|54178205|FG007|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
27730903|NCT01369355|54178206|FG008|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
27730904|NCT01369355|54178198|FG000|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
27730905|NCT01369355|54178199|FG001|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
27730906|NCT01369355|54178200|FG002|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
27730907|NCT01369355|54178201|FG003|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
27730908|NCT01369355|54178202|FG004|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
27730909|NCT01369355|54178203|FG005|Week 0 - Week 44 (Maintenance)|Protocol Violation|2|||
27730910|NCT01369355|54178204|FG006|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
27730911|NCT01369355|54178205|FG007|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
27730912|NCT01369355|54178206|FG008|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
27730913|NCT01369355|54178198|FG000|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
27730914|NCT01369355|54178199|FG001|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
27730915|NCT01369355|54178200|FG002|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
27730916|NCT01369355|54178201|FG003|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2|||
27730917|NCT01369355|54178202|FG004|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5|||
27730918|NCT01369355|54178203|FG005|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6|||
27730919|NCT01369355|54178204|FG006|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
27831637|NCT01782131|54310183|FG000|Overall Study|Reason not provided|0|||
27831638|NCT01782131|54310184|FG001|Overall Study|Reason not provided|1|||
27853001|NCT01435772|54361345|FG001|Overall Study|Withdrawal by Subject|1|||
27853002|NCT01435772|54361346|FG002|Overall Study|Withdrawal by Subject|3|||
27853003|NCT01435772|54361344|FG000|Overall Study|Other - study termination|2|||
27853004|NCT01435772|54361345|FG001|Overall Study|Other - study termination|2|||
27853005|NCT01435772|54361346|FG002|Overall Study|Other - study termination|10|||
27853006|NCT01435616|54361565|FG000|Overall Study|Adverse Event|39|||
27831639|NCT01781975|54310205|FG000|Overall Study|Death|1|||
27831640|NCT01781975|54310206|FG001|Overall Study|Death|0|||
27831641|NCT01781975|54310205|FG000|Overall Study|Withdrawal by Subject|1|||
27831642|NCT01781975|54310206|FG001|Overall Study|Withdrawal by Subject|1|||
27831643|NCT01804673|54310227|FG000|Overall Study|Adverse Event|4|||
27831644|NCT01804673|54310227|FG000|Overall Study|Withdrawal by Subject|1|||
27831645|NCT01804673|54310227|FG000|Overall Study|Lack of Efficacy|9|||
27831646|NCT01804673|54310227|FG000|Overall Study|Change to Oral Therapy|37|||
27831647|NCT01804673|54310227|FG000|Overall Study|No Further Therapy Required|84|||
27831648|NCT01804673|54310227|FG000|Overall Study|Use of Prohibited Medication|1|||
27831649|NCT01804673|54310227|FG000|Overall Study|Other|4|||
27831650|NCT01774097|54310237|FG000|Overall Study|Withdrawal by Subject|1|||
27831651|NCT01774097|54310238|FG001|Overall Study|Withdrawal by Subject|1|||
27831652|NCT01774097|54310237|FG000|Overall Study|Adverse Event|1|||
27853007|NCT01435616|54361566|FG001|Overall Study|Adverse Event|21|||
27853008|NCT01435616|54361565|FG000|Overall Study|Death|7|||
27853009|NCT01435616|54361566|FG001|Overall Study|Death|2|||
27853010|NCT01435616|54361565|FG000|Overall Study|Lost to Follow-up|22|||
27853011|NCT01435616|54361566|FG001|Overall Study|Lost to Follow-up|13|||
27853012|NCT01435616|54361565|FG000|Overall Study|Protocol Violation|16|||
27853013|NCT01435616|54361566|FG001|Overall Study|Protocol Violation|13|||
27730920|NCT01369355|54178205|FG007|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
27730921|NCT01369355|54178206|FG008|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
27831653|NCT01774097|54310238|FG001|Overall Study|Adverse Event|1|||
27831654|NCT02859558|54310312|FG000|Step 1|Not Eligible|0|||
27831655|NCT02859558|54310313|FG001|Step 1|Not Eligible|0|||
27853014|NCT01435616|54361565|FG000|Overall Study|Withdrawal by Subject|66|||
27831656|NCT02859558|54310314|FG002|Step 1|Not Eligible|0|||
27730922|NCT01369355|54178198|FG000|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
27730923|NCT01369355|54178199|FG001|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2|||
27730924|NCT01369355|54178200|FG002|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7|||
27730925|NCT01369355|54178201|FG003|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
27730926|NCT01369355|54178202|FG004|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8|||
27730927|NCT01369355|54178203|FG005|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22|||
27730928|NCT01369355|54178204|FG006|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
27730929|NCT01369355|54178205|FG007|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
27730930|NCT01369355|54178206|FG008|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
27730931|NCT01369355|54178198|FG000|Week 0 - Week 44 (Maintenance)|Other|0|||
27730932|NCT01369355|54178199|FG001|Week 0 - Week 44 (Maintenance)|Other|0|||
27730933|NCT01369355|54178200|FG002|Week 0 - Week 44 (Maintenance)|Other|1|||
27730934|NCT01369355|54178201|FG003|Week 0 - Week 44 (Maintenance)|Other|0|||
27730935|NCT01369355|54178202|FG004|Week 0 - Week 44 (Maintenance)|Other|1|||
27730936|NCT01369355|54178203|FG005|Week 0 - Week 44 (Maintenance)|Other|0|||
27730937|NCT01369355|54178204|FG006|Week 0 - Week 44 (Maintenance)|Other|0|||
27730938|NCT01369355|54178205|FG007|Week 0 - Week 44 (Maintenance)|Other|0|||
27730939|NCT01369355|54178206|FG008|Week 0 - Week 44 (Maintenance)|Other|0|||
27730940|NCT01369355|54178198|FG000|Long-term Extension (Week 44-272)|Adverse Event|0|||
27730941|NCT01369355|54178199|FG001|Long-term Extension (Week 44-272)|Adverse Event|0|||
27730942|NCT01369355|54178200|FG002|Long-term Extension (Week 44-272)|Adverse Event|0|||
27730943|NCT01369355|54178201|FG003|Long-term Extension (Week 44-272)|Adverse Event|0|||
27730944|NCT01369355|54178202|FG004|Long-term Extension (Week 44-272)|Adverse Event|0|||
27730945|NCT01369355|54178203|FG005|Long-term Extension (Week 44-272)|Adverse Event|0|||
27730946|NCT01369355|54178204|FG006|Long-term Extension (Week 44-272)|Adverse Event|15|||
27730947|NCT01369355|54178205|FG007|Long-term Extension (Week 44-272)|Adverse Event|29|||
27730948|NCT01369355|54178206|FG008|Long-term Extension (Week 44-272)|Adverse Event|53|||
27730949|NCT01369355|54178198|FG000|Long-term Extension (Week 44-272)|Death|0|||
27730950|NCT01369355|54178199|FG001|Long-term Extension (Week 44-272)|Death|0|||
27730951|NCT01369355|54178200|FG002|Long-term Extension (Week 44-272)|Death|0|||
27730952|NCT01369355|54178201|FG003|Long-term Extension (Week 44-272)|Death|0|||
27730953|NCT01369355|54178202|FG004|Long-term Extension (Week 44-272)|Death|0|||
27730954|NCT01369355|54178203|FG005|Long-term Extension (Week 44-272)|Death|0|||
27730955|NCT01369355|54178204|FG006|Long-term Extension (Week 44-272)|Death|0|||
27730956|NCT01369355|54178205|FG007|Long-term Extension (Week 44-272)|Death|1|||
27730957|NCT01369355|54178206|FG008|Long-term Extension (Week 44-272)|Death|3|||
27730958|NCT01369355|54178198|FG000|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
27730959|NCT01369355|54178199|FG001|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
27730960|NCT01369355|54178200|FG002|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
27730961|NCT01369355|54178201|FG003|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
27730962|NCT01369355|54178202|FG004|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
27730963|NCT01369355|54178203|FG005|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
27730964|NCT01369355|54178204|FG006|Long-term Extension (Week 44-272)|Lack of Efficacy|12|||
27730965|NCT01369355|54178205|FG007|Long-term Extension (Week 44-272)|Lack of Efficacy|26|||
27730966|NCT01369355|54178206|FG008|Long-term Extension (Week 44-272)|Lack of Efficacy|29|||
27730967|NCT01369355|54178198|FG000|Long-term Extension (Week 44-272)|Protocol Violation|0|||
28163665|NCT03283371|54834378|FG003|Placebo-controlled|Lack of Efficacy|0|||
28163666|NCT03283371|54834375|FG000|Placebo-controlled|Withdrawal by Subject|1|||
28163667|NCT03283371|54834376|FG001|Placebo-controlled|Withdrawal by Subject|1|||
28163668|NCT03283371|54834377|FG002|Placebo-controlled|Withdrawal by Subject|0|||
28163669|NCT03283371|54834378|FG003|Placebo-controlled|Withdrawal by Subject|0|||
28163670|NCT03283371|54834375|FG000|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
28163671|NCT03283371|54834376|FG001|Placebo-controlled|Participants Did Not Receive Study Drug|1|||
28163672|NCT03283371|54834377|FG002|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
28163673|NCT03283371|54834378|FG003|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
28163674|NCT03283371|54834375|FG000|Open-label Phase|Adverse Event|0|||
28163675|NCT03283371|54834376|FG001|Open-label Phase|Adverse Event|0|||
28163676|NCT03283371|54834377|FG002|Open-label Phase|Adverse Event|2|||
28163677|NCT03283371|54834378|FG003|Open-label Phase|Adverse Event|0|||
28163678|NCT03283371|54834375|FG000|Open-label Phase|Withdrawal by Subject|0|||
28163679|NCT03283371|54834376|FG001|Open-label Phase|Withdrawal by Subject|0|||
28163680|NCT03283371|54834377|FG002|Open-label Phase|Withdrawal by Subject|1|||
28163681|NCT03283371|54834378|FG003|Open-label Phase|Withdrawal by Subject|0|||
28163682|NCT03283371|54834375|FG000|Open-label Phase|Other|0|||
27730968|NCT01369355|54178199|FG001|Long-term Extension (Week 44-272)|Protocol Violation|0|||
27730969|NCT01369355|54178200|FG002|Long-term Extension (Week 44-272)|Protocol Violation|0|||
27730970|NCT01369355|54178201|FG003|Long-term Extension (Week 44-272)|Protocol Violation|0|||
27730971|NCT01369355|54178202|FG004|Long-term Extension (Week 44-272)|Protocol Violation|0|||
28163683|NCT03283371|54834376|FG001|Open-label Phase|Other|0|||
28163684|NCT03283371|54834377|FG002|Open-label Phase|Other|1|||
28163685|NCT03283371|54834378|FG003|Open-label Phase|Other|1|||
28163686|NCT03069417|54834390|FG000|Overall Study|Lost to Follow-up|2|||
28163687|NCT03069417|54834391|FG001|Overall Study|Lost to Follow-up|0|||
28163688|NCT03069417|54834390|FG000|Overall Study|Reason Unknown|4|||
28163689|NCT03069417|54834391|FG001|Overall Study|Reason Unknown|7|||
28163690|NCT04930263|54834400|FG000|Overall Study|Withdrawal by Subject|3|||
28163691|NCT04930263|54834401|FG001|Overall Study|Withdrawal by Subject|5|||
28163692|NCT02665286|54834410|FG000|Overall Study|Lost to Follow-up|3|||
28163693|NCT02665286|54834411|FG001|Overall Study|Lost to Follow-up|2|||
28163694|NCT02665286|54834412|FG002|Overall Study|Lost to Follow-up|1|||
28163695|NCT02134925|54834422|FG000|Overall Study|Withdrawal by Subject|1|||
28163696|NCT02134925|54834423|FG001|Overall Study|Withdrawal by Subject|0|||
28163697|NCT02134925|54834422|FG000|Overall Study|Cancel|1|||
28163698|NCT02134925|54834423|FG001|Overall Study|Cancel|6|||
28163699|NCT02911519|54834431|FG000|Overall Study|Lost to Follow-up|2|||
28163700|NCT02911519|54834432|FG001|Overall Study|Lost to Follow-up|2|||
28163701|NCT02911519|54834431|FG000|Overall Study|Death|0|||
28163702|NCT02911519|54834432|FG001|Overall Study|Death|2|||
28163703|NCT02911285|54834440|FG000|Overall Study|Lost to Follow-up|8|||
28163704|NCT02911285|54834441|FG001|Overall Study|Lost to Follow-up|5|||
28163705|NCT02911285|54834440|FG000|Overall Study|Participant got a job and no longer had time to participate.|1|||
28163706|NCT02911285|54834441|FG001|Overall Study|Participant got a job and no longer had time to participate.|0|||
28163707|NCT02910739|54834453|FG000|Overall Study|Adverse Event|1|||
28163708|NCT02910739|54834454|FG001|Overall Study|Adverse Event|0|||
28079343|NCT03666988|54732932|FG003|Part 1 (Up to 28 Months)|Other|0|||
28079344|NCT03666988|54732933|FG004|Part 1 (Up to 28 Months)|Other|0|||
28079345|NCT03666988|54732934|FG005|Part 1 (Up to 28 Months)|Other|0|||
28079346|NCT03666988|54732929|FG000|Part 1 (Up to 28 Months)|Disease Progression|2|||
28079347|NCT03666988|54732930|FG001|Part 1 (Up to 28 Months)|Disease Progression|14|||
28079348|NCT03666988|54732931|FG002|Part 1 (Up to 28 Months)|Disease Progression|7|||
28079349|NCT03666988|54732932|FG003|Part 1 (Up to 28 Months)|Disease Progression|0|||
28079350|NCT03666988|54732933|FG004|Part 1 (Up to 28 Months)|Disease Progression|0|||
28079351|NCT03666988|54732934|FG005|Part 1 (Up to 28 Months)|Disease Progression|0|||
28079352|NCT03666988|54732929|FG000|Part 1 (Up to 28 Months)|Physician Decision|0|||
28079353|NCT03666988|54732930|FG001|Part 1 (Up to 28 Months)|Physician Decision|0|||
28079354|NCT03666988|54732931|FG002|Part 1 (Up to 28 Months)|Physician Decision|1|||
28079355|NCT03666988|54732932|FG003|Part 1 (Up to 28 Months)|Physician Decision|0|||
28079356|NCT03666988|54732933|FG004|Part 1 (Up to 28 Months)|Physician Decision|0|||
28079357|NCT03666988|54732934|FG005|Part 1 (Up to 28 Months)|Physician Decision|0|||
28079358|NCT03666988|54732929|FG000|Part 1 (Up to 28 Months)|Withdrawal by Subject|1|||
28079359|NCT03666988|54732930|FG001|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
28079360|NCT03666988|54732931|FG002|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
28079361|NCT03666988|54732932|FG003|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
28079362|NCT03666988|54732933|FG004|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
28079363|NCT03666988|54732934|FG005|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
28079364|NCT00382109|54732954|FG000|Overall Study|Adverse Event|3|||
28079365|NCT00382109|54732955|FG001|Overall Study|Adverse Event|0|||
27943857|NCT01231906|54600936|FG000|Overall Study|Lack of Efficacy|75|||
27943858|NCT01231906|54600937|FG001|Overall Study|Lack of Efficacy|68|||
27943859|NCT01231906|54600936|FG000|Overall Study|Lost to Follow-up|1|||
27943860|NCT01231906|54600937|FG001|Overall Study|Lost to Follow-up|0|||
27943861|NCT01231906|54600936|FG000|Overall Study|Physician Decision|34|||
27943862|NCT01231906|54600937|FG001|Overall Study|Physician Decision|24|||
27943863|NCT01231906|54600936|FG000|Overall Study|Withdrawal by Subject|0|||
28079366|NCT00382109|54732954|FG000|Overall Study|Physician Decision|6|||
28079367|NCT00382109|54732955|FG001|Overall Study|Physician Decision|1|||
28079368|NCT00382109|54732954|FG000|Overall Study|Withdrawal by Subject|1|||
28079369|NCT00382109|54732955|FG001|Overall Study|Withdrawal by Subject|0|||
28079370|NCT00382109|54732954|FG000|Overall Study|ineligible|2|||
28079371|NCT00382109|54732955|FG001|Overall Study|ineligible|0|||
28079372|NCT00382109|54732954|FG000|Overall Study|Other|0|||
28079373|NCT00382109|54732955|FG001|Overall Study|Other|2|||
28079374|NCT00382109|54732954|FG000|Overall Study|consent withdrawal|0|||
28163709|NCT02910739|54834455|FG002|Overall Study|Adverse Event|0|||
28163710|NCT02910739|54834456|FG003|Overall Study|Adverse Event|0|||
28163711|NCT01069939|54834464|FG000|Randomised and Included in the Analyses|Adverse Event|17|||
27730972|NCT01369355|54178203|FG005|Long-term Extension (Week 44-272)|Protocol Violation|0|||
27831657|NCT02859558|54310315|FG003|Step 1|Not Eligible|0|||
28163712|NCT01069939|54834465|FG001|Randomised and Included in the Analyses|Adverse Event|22|||
28163713|NCT01069939|54834464|FG000|Randomised and Included in the Analyses|Withdrawal by Subject|15|||
28079375|NCT00382109|54732955|FG001|Overall Study|consent withdrawal|1|||
28163714|NCT01069939|54834465|FG001|Randomised and Included in the Analyses|Withdrawal by Subject|12|||
28079376|NCT03651622|54732967|FG000|Diet Period 1 (Randomization 1)|Lost to Follow-up|0|||
28079377|NCT03651622|54732968|FG001|Diet Period 1 (Randomization 1)|Lost to Follow-up|6|||
28079378|NCT03651622|54732969|FG002|Diet Period 1 (Randomization 1)|Lost to Follow-up|2|||
27943864|NCT01231906|54600937|FG001|Overall Study|Withdrawal by Subject|4|||
28079379|NCT03651622|54732967|FG000|Diet Period 1 (Randomization 1)|Withdrawal by Subject|4|||
28079380|NCT03651622|54732968|FG001|Diet Period 1 (Randomization 1)|Withdrawal by Subject|1|||
28079381|NCT03651622|54732969|FG002|Diet Period 1 (Randomization 1)|Withdrawal by Subject|7|||
28079382|NCT03651622|54732967|FG000|Diet Period 2 (Randomization 2)|Lost to Follow-up|0|||
28079383|NCT03651622|54732968|FG001|Diet Period 2 (Randomization 2)|Lost to Follow-up|2|||
28079384|NCT03651622|54732969|FG002|Diet Period 2 (Randomization 2)|Lost to Follow-up|3|||
28079385|NCT03651622|54732967|FG000|Diet Period 2 (Randomization 2)|Withdrawal by Subject|2|||
28079386|NCT03651622|54732968|FG001|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
28079387|NCT03651622|54732969|FG002|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
28079388|NCT03651622|54732967|FG000|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
28079389|NCT03651622|54732968|FG001|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
28079390|NCT03651622|54732969|FG002|Diet Period 3 (Randomization 3)|Withdrawal by Subject|1|||
28079391|NCT00381797|54732982|FG000|Overall Study|Withdrawal by Subject|1|||
28079392|NCT00381797|54732983|FG001|Overall Study|Withdrawal by Subject|1|||
28079393|NCT00381797|54732984|FG002|Overall Study|Withdrawal by Subject|0|||
28079394|NCT00381797|54732985|FG003|Overall Study|Withdrawal by Subject|0|||
28079395|NCT00381797|54732986|FG004|Overall Study|Withdrawal by Subject|2|||
28079396|NCT00381797|54732982|FG000|Overall Study|Ineligible|0|||
28079397|NCT00381797|54732983|FG001|Overall Study|Ineligible|0|||
28079398|NCT00381797|54732984|FG002|Overall Study|Ineligible|0|||
28079399|NCT00381797|54732985|FG003|Overall Study|Ineligible|1|||
28079400|NCT00381797|54732986|FG004|Overall Study|Ineligible|0|||
28079401|NCT03665038|54733022|FG000|Overall Study|Lost to Follow-up|0|||
28079402|NCT03665038|54733023|FG001|Overall Study|Lost to Follow-up|0|||
28079403|NCT03665038|54733024|FG002|Overall Study|Lost to Follow-up|1|||
28079404|NCT03664024|54733034|FG000|Overall Study|Follow-up discontinued by sponsor|34|||
28079405|NCT03664024|54733034|FG000|Overall Study|Lost to Follow-up|2|||
28079406|NCT03664024|54733034|FG000|Overall Study|Withdrawal by Subject|2|||
28079407|NCT03664024|54733034|FG000|Overall Study|Death|80|||
28079408|NCT00381641|54733043|FG000|Overall Study|Withdrawal by Subject|0|||
28079409|NCT00381641|54733044|FG001|Overall Study|Withdrawal by Subject|2|||
28079410|NCT00381563|54733052|FG000|Overall Study|Withdrawal by Subject|5|||
28079411|NCT00381563|54733053|FG001|Overall Study|Withdrawal by Subject|5|||
28079412|NCT00381563|54733052|FG000|Overall Study|Lost to Follow-up|2|||
28079413|NCT00381563|54733053|FG001|Overall Study|Lost to Follow-up|0|||
28163715|NCT01069939|54834464|FG000|Randomised and Included in the Analyses|Lost to Follow-up|1|||
28163716|NCT01069939|54834465|FG001|Randomised and Included in the Analyses|Lost to Follow-up|1|||
28163717|NCT01069939|54834464|FG000|Randomised and Included in the Analyses|Protocol Violation|0|||
28163718|NCT01069939|54834465|FG001|Randomised and Included in the Analyses|Protocol Violation|1|||
28163719|NCT01069939|54834464|FG000|Randomised and Included in the Analyses|Lack of Efficacy|0|||
28163720|NCT01069939|54834465|FG001|Randomised and Included in the Analyses|Lack of Efficacy|1|||
28163721|NCT01069939|54834464|FG000|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7|||
28163722|NCT01069939|54834465|FG001|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33|||
28163723|NCT01069939|54834464|FG000|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4|||
28163724|NCT01069939|54834465|FG001|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3|||
28163725|NCT01069939|54834464|FG000|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4|||
28163726|NCT01069939|54834465|FG001|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2|||
27730973|NCT01369355|54178204|FG006|Long-term Extension (Week 44-272)|Protocol Violation|0|||
27730974|NCT01369355|54178205|FG007|Long-term Extension (Week 44-272)|Protocol Violation|1|||
27730975|NCT01369355|54178206|FG008|Long-term Extension (Week 44-272)|Protocol Violation|2|||
27730976|NCT01369355|54178198|FG000|Long-term Extension (Week 44-272)|Physician Decision|0|||
28163727|NCT01069939|54834464|FG000|Randomised and Included in the Analyses|Physician Decision|0|||
28163728|NCT01069939|54834465|FG001|Randomised and Included in the Analyses|Physician Decision|2|||
27730977|NCT01369355|54178199|FG001|Long-term Extension (Week 44-272)|Physician Decision|0|||
27730978|NCT01369355|54178200|FG002|Long-term Extension (Week 44-272)|Physician Decision|0|||
27730979|NCT01369355|54178201|FG003|Long-term Extension (Week 44-272)|Physician Decision|0|||
27730980|NCT01369355|54178202|FG004|Long-term Extension (Week 44-272)|Physician Decision|0|||
27730981|NCT01369355|54178203|FG005|Long-term Extension (Week 44-272)|Physician Decision|0|||
27831658|NCT02859558|54310316|FG004|Step 1|Not Eligible|3|||
27831659|NCT02859558|54310312|FG000|Step 1|Lost to Follow-up|1|||
27831660|NCT02859558|54310313|FG001|Step 1|Lost to Follow-up|3|||
28079414|NCT00381563|54733052|FG000|Overall Study|Protocol Violation|0|||
28079415|NCT00381563|54733053|FG001|Overall Study|Protocol Violation|1|||
28079416|NCT03624946|54733060|FG000|Overall Study|Lost to Follow-up|0|||
28079417|NCT03624946|54733061|FG001|Overall Study|Lost to Follow-up|1|||
28079418|NCT00381095|54733073|FG000|Overall Study|Death|3|||
28079419|NCT00381095|54733074|FG001|Overall Study|Death|4|||
28079420|NCT00381095|54733073|FG000|Overall Study|Lack of Efficacy|2|||
28079421|NCT00381095|54733074|FG001|Overall Study|Lack of Efficacy|4|||
28079422|NCT00381095|54733073|FG000|Overall Study|Other|2|||
28079423|NCT00381095|54733074|FG001|Overall Study|Other|2|||
28163729|NCT01069939|54834464|FG000|Randomised and Included in the Analyses|Removal|1|||
28163730|NCT01069939|54834465|FG001|Randomised and Included in the Analyses|Removal|0|||
28163731|NCT01069705|54834471|FG000|Overall Study|Adverse Event|1|||
28163732|NCT01069705|54834471|FG000|Overall Study|Withdrawal by Subject|2|||
28163733|NCT01069627|54834475|FG000|Overall Study|Disease progression|7|||
28163734|NCT01069627|54834475|FG000|Overall Study|Adverse Event|12|||
28163735|NCT01069627|54834475|FG000|Overall Study|Protocol Violation|1|||
28163736|NCT02422797|54834481|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|11|||
28163737|NCT02422797|54834482|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|1|||
28163738|NCT02422797|54834481|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
28163739|NCT02422797|54834482|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|1|||
28163740|NCT02422797|54834481|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
28163741|NCT02422797|54834482|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
28163742|NCT02422797|54834481|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
28163743|NCT02422797|54834482|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
28163744|NCT02422797|54834481|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|0|||
28163745|NCT02422797|54834482|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|3|||
28163746|NCT02422797|54834481|FG000|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
28163747|NCT02422797|54834482|FG001|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
28163748|NCT02422797|54834481|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2|||
28163749|NCT02422797|54834482|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
28163750|NCT02422797|54834481|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
28163751|NCT02422797|54834482|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1|||
28163752|NCT02422797|54834481|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10|||
28163753|NCT02422797|54834482|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6|||
28163754|NCT02422797|54834481|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5|||
28163755|NCT02422797|54834482|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
28163756|NCT02422797|54834481|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
28163757|NCT02422797|54834482|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
28163758|NCT02422797|54834481|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2|||
28163759|NCT02422797|54834482|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6|||
28163760|NCT02422797|54834481|FG000|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1|||
28163761|NCT02422797|54834482|FG001|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0|||
28163762|NCT02422797|54834481|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
28163763|NCT02422797|54834482|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0|||
28163764|NCT03021551|54834498|FG000|Overall Study|Equipment Issues|2|||
28163765|NCT03021551|54834498|FG000|Overall Study|Protocol Violation|1|||
28163766|NCT01585025|54834505|FG000|Overall Study|Withdrawal by Subject|0|||
28163767|NCT01585025|54834506|FG001|Overall Study|Withdrawal by Subject|3|||
28163768|NCT01585025|54834507|FG002|Overall Study|Withdrawal by Subject|4|||
28163769|NCT01068769|54834515|FG000|Overall Study|Ineligible|1|||
27730982|NCT01369355|54178204|FG006|Long-term Extension (Week 44-272)|Physician Decision|1|||
27730983|NCT01369355|54178205|FG007|Long-term Extension (Week 44-272)|Physician Decision|5|||
27730984|NCT01369355|54178206|FG008|Long-term Extension (Week 44-272)|Physician Decision|11|||
27730985|NCT01369355|54178198|FG000|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
27730986|NCT01369355|54178199|FG001|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
27730987|NCT01369355|54178200|FG002|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
27730988|NCT01369355|54178201|FG003|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
27730989|NCT01369355|54178202|FG004|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
27730990|NCT01369355|54178203|FG005|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
27730991|NCT01369355|54178204|FG006|Long-term Extension (Week 44-272)|Lost to Follow-up|1|||
27730992|NCT01369355|54178205|FG007|Long-term Extension (Week 44-272)|Lost to Follow-up|5|||
27730993|NCT01369355|54178206|FG008|Long-term Extension (Week 44-272)|Lost to Follow-up|9|||
27730994|NCT01369355|54178198|FG000|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
27730995|NCT01369355|54178199|FG001|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
27730996|NCT01369355|54178200|FG002|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
27730997|NCT01369355|54178201|FG003|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
27730998|NCT01369355|54178202|FG004|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
27730999|NCT01369355|54178203|FG005|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
27731000|NCT01369355|54178204|FG006|Long-term Extension (Week 44-272)|Withdrawal by Subject|12|||
27731001|NCT01369355|54178205|FG007|Long-term Extension (Week 44-272)|Withdrawal by Subject|30|||
27831661|NCT02859558|54310314|FG002|Step 1|Lost to Follow-up|3|||
27831662|NCT02859558|54310315|FG003|Step 1|Lost to Follow-up|0|||
28163770|NCT05114564|54834534|FG000|First Intervention|Vision with study contact lens subjectively unacceptable|1|||
28163771|NCT05114564|54834535|FG001|First Intervention|Vision with study contact lens subjectively unacceptable|0|||
28163772|NCT05114564|54834534|FG000|First Intervention|Adverse Event|0|||
28163773|NCT05114564|54834535|FG001|First Intervention|Adverse Event|1|||
28163774|NCT04706416|54834543|FG000|Overall Study|Lost to Follow-up|2|||
27731002|NCT01369355|54178206|FG008|Long-term Extension (Week 44-272)|Withdrawal by Subject|47|||
27731003|NCT01369355|54178198|FG000|Long-term Extension (Week 44-272)|Other|0|||
27731004|NCT01369355|54178199|FG001|Long-term Extension (Week 44-272)|Other|0|||
27731005|NCT01369355|54178200|FG002|Long-term Extension (Week 44-272)|Other|0|||
28163775|NCT04706416|54834544|FG001|Overall Study|Lost to Follow-up|0|||
28163776|NCT04683926|54834557|FG000|Intervention 2 (1 Day)|Adverse Event|0|||
28163777|NCT04683926|54834558|FG001|Intervention 2 (1 Day)|Adverse Event|0|||
28163778|NCT04683926|54834559|FG002|Intervention 2 (1 Day)|Adverse Event|0|||
28163779|NCT04683926|54834560|FG003|Intervention 2 (1 Day)|Adverse Event|1|||
28163780|NCT04285346|54834572|FG000|Treatment Period (Up to 12 Weeks)|Adverse Event|4|||
28163781|NCT04285346|54834573|FG001|Treatment Period (Up to 12 Weeks)|Adverse Event|0|||
28163782|NCT04285346|54834572|FG000|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|1|||
28163783|NCT04285346|54834573|FG001|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|0|||
28163784|NCT04285346|54834572|FG000|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|1|||
28163785|NCT04285346|54834573|FG001|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
28163786|NCT04148287|54834588|FG000|Overall Study|Death|2|||
28163787|NCT03772613|54834616|FG000|Overall Study|Lost to Follow-up|0|||
28163788|NCT03772613|54834617|FG001|Overall Study|Lost to Follow-up|1|||
28163789|NCT03772613|54834618|FG002|Overall Study|Lost to Follow-up|1|||
28163790|NCT03739437|54834628|FG000|Overall Study|Lost to Follow-up|2|||
28163791|NCT03739437|54834629|FG001|Overall Study|Lost to Follow-up|5|||
28163792|NCT03730194|54834637|FG000|First Stage Treatment|Withdrawal by Subject|1|||
28163793|NCT03730194|54834638|FG001|First Stage Treatment|Withdrawal by Subject|1|||
28163794|NCT03730194|54834639|FG002|First Stage Treatment|Withdrawal by Subject|0|||
28163795|NCT03730194|54834640|FG003|First Stage Treatment|Withdrawal by Subject|0|||
28163796|NCT03730194|54834641|FG004|First Stage Treatment|Withdrawal by Subject|0|||
28163797|NCT03730194|54834642|FG005|First Stage Treatment|Withdrawal by Subject|0|||
28163798|NCT03730194|54834637|FG000|First Stage Treatment|Protocol Violation|3|||
28163799|NCT03730194|54834638|FG001|First Stage Treatment|Protocol Violation|3|||
28163800|NCT03730194|54834639|FG002|First Stage Treatment|Protocol Violation|0|||
28163801|NCT03730194|54834640|FG003|First Stage Treatment|Protocol Violation|0|||
28163802|NCT03730194|54834641|FG004|First Stage Treatment|Protocol Violation|0|||
28163803|NCT03730194|54834642|FG005|First Stage Treatment|Protocol Violation|0|||
28163804|NCT03701555|54834685|FG000|Part 2 (Day 1)|Lost to Follow-up|0|||
28163805|NCT03701555|54834686|FG001|Part 2 (Day 1)|Lost to Follow-up|0|||
28163806|NCT03701555|54834687|FG002|Part 2 (Day 1)|Lost to Follow-up|0|||
28163807|NCT03701555|54834688|FG003|Part 2 (Day 1)|Lost to Follow-up|0|||
28163808|NCT03701555|54834689|FG004|Part 2 (Day 1)|Lost to Follow-up|0|||
28163809|NCT03701555|54834690|FG005|Part 2 (Day 1)|Lost to Follow-up|0|||
28163810|NCT03701555|54834691|FG006|Part 2 (Day 1)|Lost to Follow-up|0|||
28163811|NCT03701555|54834692|FG007|Part 2 (Day 1)|Lost to Follow-up|0|||
28163812|NCT03701555|54834693|FG008|Part 2 (Day 1)|Lost to Follow-up|0|||
28163813|NCT03701555|54834694|FG009|Part 2 (Day 1)|Lost to Follow-up|0|||
28163814|NCT03701555|54834695|FG010|Part 2 (Day 1)|Lost to Follow-up|0|||
28163815|NCT03701555|54834696|FG011|Part 2 (Day 1)|Lost to Follow-up|0|||
28163816|NCT03701555|54834697|FG012|Part 2 (Day 1)|Lost to Follow-up|0|||
28163817|NCT03701555|54834698|FG013|Part 2 (Day 1)|Lost to Follow-up|0|||
28163818|NCT03701555|54834699|FG014|Part 2 (Day 1)|Lost to Follow-up|0|||
28163819|NCT03701555|54834700|FG015|Part 2 (Day 1)|Lost to Follow-up|0|||
28163820|NCT03701555|54834701|FG016|Part 2 (Day 1)|Lost to Follow-up|0|||
28163821|NCT03701555|54834702|FG017|Part 2 (Day 1)|Lost to Follow-up|0|||
28163822|NCT03701555|54834703|FG018|Part 2 (Day 1)|Lost to Follow-up|0|||
28163823|NCT03701555|54834704|FG019|Part 2 (Day 1)|Lost to Follow-up|0|||
28163824|NCT03701555|54834705|FG020|Part 2 (Day 1)|Lost to Follow-up|0|||
28163825|NCT03701555|54834706|FG021|Part 2 (Day 1)|Lost to Follow-up|1|||
27731006|NCT01369355|54178201|FG003|Long-term Extension (Week 44-272)|Other|0|||
27731007|NCT01369355|54178202|FG004|Long-term Extension (Week 44-272)|Other|0|||
27731008|NCT01369355|54178203|FG005|Long-term Extension (Week 44-272)|Other|0|||
27731009|NCT01369355|54178204|FG006|Long-term Extension (Week 44-272)|Other|110|||
27731010|NCT01369355|54178205|FG007|Long-term Extension (Week 44-272)|Other|9|||
27731011|NCT01369355|54178206|FG008|Long-term Extension (Week 44-272)|Other|17|||
28163826|NCT03701555|54834707|FG022|Part 2 (Day 1)|Lost to Follow-up|0|||
28163827|NCT03701555|54834708|FG023|Part 2 (Day 1)|Lost to Follow-up|0|||
28163828|NCT03701555|54834709|FG024|Part 2 (Day 1)|Lost to Follow-up|0|||
28163829|NCT03701555|54834710|FG025|Part 2 (Day 1)|Lost to Follow-up|0|||
28163830|NCT03701555|54834711|FG026|Part 2 (Day 1)|Lost to Follow-up|0|||
28163831|NCT03701555|54834712|FG027|Part 2 (Day 1)|Lost to Follow-up|0|||
28163832|NCT03701555|54834713|FG028|Part 2 (Day 1)|Lost to Follow-up|0|||
28163833|NCT03701555|54834714|FG029|Part 2 (Day 1)|Lost to Follow-up|0|||
28163834|NCT03701555|54834715|FG030|Part 2 (Day 1)|Lost to Follow-up|0|||
28163835|NCT03701555|54834716|FG031|Part 2 (Day 1)|Lost to Follow-up|0|||
27731012|NCT02614196|54178229|FG000|Double Blind Treatment Phase|Adverse Event|8|||
27831663|NCT02859558|54310316|FG004|Step 1|Lost to Follow-up|0|||
28163836|NCT03701555|54834717|FG032|Part 2 (Day 1)|Lost to Follow-up|0|||
28163837|NCT03701555|54834718|FG033|Part 2 (Day 1)|Lost to Follow-up|0|||
28163838|NCT03701555|54834719|FG034|Part 2 (Day 1)|Lost to Follow-up|0|||
28163839|NCT03701555|54834720|FG035|Part 2 (Day 1)|Lost to Follow-up|0|||
28163840|NCT03701555|54834685|FG000|Part 2 (Day 1)|Subject Non-compliance|0|||
28163841|NCT03701555|54834686|FG001|Part 2 (Day 1)|Subject Non-compliance|0|||
28163842|NCT03701555|54834687|FG002|Part 2 (Day 1)|Subject Non-compliance|0|||
28163843|NCT03701555|54834688|FG003|Part 2 (Day 1)|Subject Non-compliance|0|||
28163844|NCT03701555|54834689|FG004|Part 2 (Day 1)|Subject Non-compliance|0|||
28163845|NCT03701555|54834690|FG005|Part 2 (Day 1)|Subject Non-compliance|0|||
28163846|NCT03701555|54834691|FG006|Part 2 (Day 1)|Subject Non-compliance|0|||
28163847|NCT03701555|54834692|FG007|Part 2 (Day 1)|Subject Non-compliance|0|||
28163848|NCT03701555|54834693|FG008|Part 2 (Day 1)|Subject Non-compliance|0|||
28163849|NCT03701555|54834694|FG009|Part 2 (Day 1)|Subject Non-compliance|0|||
28163850|NCT03701555|54834695|FG010|Part 2 (Day 1)|Subject Non-compliance|0|||
28163851|NCT03701555|54834696|FG011|Part 2 (Day 1)|Subject Non-compliance|0|||
28163852|NCT03701555|54834697|FG012|Part 2 (Day 1)|Subject Non-compliance|0|||
28163853|NCT03701555|54834698|FG013|Part 2 (Day 1)|Subject Non-compliance|1|||
28163854|NCT03701555|54834699|FG014|Part 2 (Day 1)|Subject Non-compliance|0|||
28163855|NCT03701555|54834700|FG015|Part 2 (Day 1)|Subject Non-compliance|0|||
28163856|NCT03701555|54834701|FG016|Part 2 (Day 1)|Subject Non-compliance|1|||
28163857|NCT03701555|54834702|FG017|Part 2 (Day 1)|Subject Non-compliance|2|||
28163858|NCT03701555|54834703|FG018|Part 2 (Day 1)|Subject Non-compliance|0|||
28163859|NCT03701555|54834704|FG019|Part 2 (Day 1)|Subject Non-compliance|0|||
28163860|NCT03701555|54834705|FG020|Part 2 (Day 1)|Subject Non-compliance|0|||
28163861|NCT03701555|54834706|FG021|Part 2 (Day 1)|Subject Non-compliance|0|||
28163862|NCT03701555|54834707|FG022|Part 2 (Day 1)|Subject Non-compliance|0|||
28163863|NCT03701555|54834708|FG023|Part 2 (Day 1)|Subject Non-compliance|1|||
28163864|NCT03701555|54834709|FG024|Part 2 (Day 1)|Subject Non-compliance|0|||
28163865|NCT03701555|54834710|FG025|Part 2 (Day 1)|Subject Non-compliance|0|||
28163866|NCT03701555|54834711|FG026|Part 2 (Day 1)|Subject Non-compliance|0|||
28163867|NCT03701555|54834712|FG027|Part 2 (Day 1)|Subject Non-compliance|0|||
28163868|NCT03701555|54834713|FG028|Part 2 (Day 1)|Subject Non-compliance|0|||
28163869|NCT03701555|54834714|FG029|Part 2 (Day 1)|Subject Non-compliance|0|||
28163870|NCT03701555|54834715|FG030|Part 2 (Day 1)|Subject Non-compliance|0|||
28163871|NCT03701555|54834716|FG031|Part 2 (Day 1)|Subject Non-compliance|0|||
28163872|NCT03701555|54834717|FG032|Part 2 (Day 1)|Subject Non-compliance|0|||
28163873|NCT03701555|54834718|FG033|Part 2 (Day 1)|Subject Non-compliance|0|||
28163874|NCT03701555|54834719|FG034|Part 2 (Day 1)|Subject Non-compliance|0|||
28163875|NCT03701555|54834720|FG035|Part 2 (Day 1)|Subject Non-compliance|0|||
28163876|NCT03701555|54834685|FG000|Part 2 (Day 1)|Other|0|||
28163877|NCT03701555|54834686|FG001|Part 2 (Day 1)|Other|0|||
28163878|NCT03701555|54834687|FG002|Part 2 (Day 1)|Other|0|||
28163879|NCT03701555|54834688|FG003|Part 2 (Day 1)|Other|0|||
28163880|NCT03701555|54834689|FG004|Part 2 (Day 1)|Other|0|||
28163881|NCT03701555|54834690|FG005|Part 2 (Day 1)|Other|0|||
28163882|NCT03701555|54834691|FG006|Part 2 (Day 1)|Other|0|||
28163883|NCT03701555|54834692|FG007|Part 2 (Day 1)|Other|0|||
28163884|NCT03701555|54834693|FG008|Part 2 (Day 1)|Other|0|||
28163885|NCT03701555|54834694|FG009|Part 2 (Day 1)|Other|0|||
28163886|NCT03701555|54834695|FG010|Part 2 (Day 1)|Other|3|||
28163887|NCT03701555|54834696|FG011|Part 2 (Day 1)|Other|1|||
28163888|NCT03701555|54834697|FG012|Part 2 (Day 1)|Other|0|||
28163889|NCT03701555|54834698|FG013|Part 2 (Day 1)|Other|1|||
28163890|NCT03701555|54834699|FG014|Part 2 (Day 1)|Other|0|||
28163891|NCT03701555|54834700|FG015|Part 2 (Day 1)|Other|2|||
28163892|NCT03701555|54834701|FG016|Part 2 (Day 1)|Other|2|||
28163893|NCT03701555|54834702|FG017|Part 2 (Day 1)|Other|0|||
28163894|NCT03701555|54834703|FG018|Part 2 (Day 1)|Other|0|||
28163895|NCT03701555|54834704|FG019|Part 2 (Day 1)|Other|0|||
28163896|NCT03701555|54834705|FG020|Part 2 (Day 1)|Other|0|||
28163897|NCT03701555|54834706|FG021|Part 2 (Day 1)|Other|0|||
28163898|NCT03701555|54834707|FG022|Part 2 (Day 1)|Other|0|||
28163899|NCT03701555|54834708|FG023|Part 2 (Day 1)|Other|0|||
28163900|NCT03701555|54834709|FG024|Part 2 (Day 1)|Other|0|||
28163901|NCT03701555|54834710|FG025|Part 2 (Day 1)|Other|0|||
28163902|NCT03701555|54834711|FG026|Part 2 (Day 1)|Other|0|||
28163903|NCT03701555|54834712|FG027|Part 2 (Day 1)|Other|0|||
28163904|NCT03701555|54834713|FG028|Part 2 (Day 1)|Other|0|||
28163905|NCT03701555|54834714|FG029|Part 2 (Day 1)|Other|0|||
27943865|NCT01231906|54600936|FG000|Overall Study|Ineligible|10|||
28163906|NCT03701555|54834715|FG030|Part 2 (Day 1)|Other|0|||
28163907|NCT03701555|54834716|FG031|Part 2 (Day 1)|Other|0|||
28163908|NCT03701555|54834717|FG032|Part 2 (Day 1)|Other|0|||
28163909|NCT03701555|54834718|FG033|Part 2 (Day 1)|Other|0|||
28163910|NCT03701555|54834719|FG034|Part 2 (Day 1)|Other|0|||
28163911|NCT03701555|54834720|FG035|Part 2 (Day 1)|Other|0|||
28163912|NCT03701555|54834685|FG000|Part 3 (Day 1)|Subject Non-compliance|0|||
28163913|NCT03701555|54834686|FG001|Part 3 (Day 1)|Subject Non-compliance|0|||
28163914|NCT03701555|54834687|FG002|Part 3 (Day 1)|Subject Non-compliance|0|||
28163915|NCT03701555|54834688|FG003|Part 3 (Day 1)|Subject Non-compliance|0|||
28163916|NCT03701555|54834689|FG004|Part 3 (Day 1)|Subject Non-compliance|0|||
28163917|NCT03701555|54834690|FG005|Part 3 (Day 1)|Subject Non-compliance|0|||
28163918|NCT03701555|54834691|FG006|Part 3 (Day 1)|Subject Non-compliance|0|||
28163919|NCT03701555|54834692|FG007|Part 3 (Day 1)|Subject Non-compliance|0|||
28163920|NCT03701555|54834693|FG008|Part 3 (Day 1)|Subject Non-compliance|0|||
28163921|NCT03701555|54834694|FG009|Part 3 (Day 1)|Subject Non-compliance|0|||
28163922|NCT03701555|54834695|FG010|Part 3 (Day 1)|Subject Non-compliance|0|||
28163923|NCT03701555|54834696|FG011|Part 3 (Day 1)|Subject Non-compliance|0|||
28163924|NCT03701555|54834697|FG012|Part 3 (Day 1)|Subject Non-compliance|0|||
28163925|NCT03701555|54834698|FG013|Part 3 (Day 1)|Subject Non-compliance|0|||
28163926|NCT03701555|54834699|FG014|Part 3 (Day 1)|Subject Non-compliance|0|||
28163927|NCT03701555|54834700|FG015|Part 3 (Day 1)|Subject Non-compliance|0|||
28163928|NCT03701555|54834701|FG016|Part 3 (Day 1)|Subject Non-compliance|0|||
28163929|NCT03701555|54834702|FG017|Part 3 (Day 1)|Subject Non-compliance|0|||
28163930|NCT03701555|54834703|FG018|Part 3 (Day 1)|Subject Non-compliance|0|||
28163931|NCT03701555|54834704|FG019|Part 3 (Day 1)|Subject Non-compliance|0|||
28163932|NCT03701555|54834705|FG020|Part 3 (Day 1)|Subject Non-compliance|0|||
28163933|NCT03701555|54834706|FG021|Part 3 (Day 1)|Subject Non-compliance|0|||
28163934|NCT03701555|54834707|FG022|Part 3 (Day 1)|Subject Non-compliance|0|||
28163935|NCT03701555|54834708|FG023|Part 3 (Day 1)|Subject Non-compliance|0|||
28163936|NCT03701555|54834709|FG024|Part 3 (Day 1)|Subject Non-compliance|0|||
28163937|NCT03701555|54834710|FG025|Part 3 (Day 1)|Subject Non-compliance|0|||
28163938|NCT03701555|54834711|FG026|Part 3 (Day 1)|Subject Non-compliance|0|||
28163939|NCT03701555|54834712|FG027|Part 3 (Day 1)|Subject Non-compliance|0|||
28163940|NCT03701555|54834713|FG028|Part 3 (Day 1)|Subject Non-compliance|0|||
28163941|NCT03701555|54834714|FG029|Part 3 (Day 1)|Subject Non-compliance|1|||
28163942|NCT03701555|54834715|FG030|Part 3 (Day 1)|Subject Non-compliance|0|||
28163943|NCT03701555|54834716|FG031|Part 3 (Day 1)|Subject Non-compliance|1|||
28163944|NCT03701555|54834717|FG032|Part 3 (Day 1)|Subject Non-compliance|0|||
28163945|NCT03701555|54834718|FG033|Part 3 (Day 1)|Subject Non-compliance|0|||
28163946|NCT03701555|54834719|FG034|Part 3 (Day 1)|Subject Non-compliance|0|||
28163947|NCT03701555|54834720|FG035|Part 3 (Day 1)|Subject Non-compliance|0|||
28163948|NCT03701555|54834685|FG000|Part 3 (Day 1)|Subject Decision|0|||
28163949|NCT03701555|54834686|FG001|Part 3 (Day 1)|Subject Decision|0|||
28163950|NCT03701555|54834687|FG002|Part 3 (Day 1)|Subject Decision|0|||
28163951|NCT03701555|54834688|FG003|Part 3 (Day 1)|Subject Decision|0|||
28163952|NCT03701555|54834689|FG004|Part 3 (Day 1)|Subject Decision|0|||
28163953|NCT03701555|54834690|FG005|Part 3 (Day 1)|Subject Decision|0|||
28163954|NCT03701555|54834691|FG006|Part 3 (Day 1)|Subject Decision|0|||
28163955|NCT03701555|54834692|FG007|Part 3 (Day 1)|Subject Decision|0|||
28163956|NCT03701555|54834693|FG008|Part 3 (Day 1)|Subject Decision|0|||
28163957|NCT03701555|54834694|FG009|Part 3 (Day 1)|Subject Decision|0|||
28163958|NCT03701555|54834695|FG010|Part 3 (Day 1)|Subject Decision|0|||
28163959|NCT03701555|54834696|FG011|Part 3 (Day 1)|Subject Decision|0|||
28163960|NCT03701555|54834697|FG012|Part 3 (Day 1)|Subject Decision|0|||
28163961|NCT03701555|54834698|FG013|Part 3 (Day 1)|Subject Decision|0|||
28163962|NCT03701555|54834699|FG014|Part 3 (Day 1)|Subject Decision|0|||
28163963|NCT03701555|54834700|FG015|Part 3 (Day 1)|Subject Decision|0|||
28163964|NCT03701555|54834701|FG016|Part 3 (Day 1)|Subject Decision|0|||
28163965|NCT03701555|54834702|FG017|Part 3 (Day 1)|Subject Decision|0|||
28163966|NCT03701555|54834703|FG018|Part 3 (Day 1)|Subject Decision|0|||
28163967|NCT03701555|54834704|FG019|Part 3 (Day 1)|Subject Decision|0|||
28163968|NCT03701555|54834705|FG020|Part 3 (Day 1)|Subject Decision|0|||
28163969|NCT03701555|54834706|FG021|Part 3 (Day 1)|Subject Decision|0|||
28163970|NCT03701555|54834707|FG022|Part 3 (Day 1)|Subject Decision|0|||
28163971|NCT03701555|54834708|FG023|Part 3 (Day 1)|Subject Decision|0|||
28163972|NCT03701555|54834709|FG024|Part 3 (Day 1)|Subject Decision|0|||
28163973|NCT03701555|54834710|FG025|Part 3 (Day 1)|Subject Decision|0|||
28163974|NCT03701555|54834711|FG026|Part 3 (Day 1)|Subject Decision|1|||
28163975|NCT03701555|54834712|FG027|Part 3 (Day 1)|Subject Decision|0|||
28163976|NCT03701555|54834713|FG028|Part 3 (Day 1)|Subject Decision|0|||
28163977|NCT03701555|54834714|FG029|Part 3 (Day 1)|Subject Decision|0|||
28163978|NCT03701555|54834715|FG030|Part 3 (Day 1)|Subject Decision|0|||
28163979|NCT03701555|54834716|FG031|Part 3 (Day 1)|Subject Decision|2|||
28163980|NCT03701555|54834717|FG032|Part 3 (Day 1)|Subject Decision|1|||
28163981|NCT03701555|54834718|FG033|Part 3 (Day 1)|Subject Decision|1|||
28163982|NCT03701555|54834719|FG034|Part 3 (Day 1)|Subject Decision|0|||
28163983|NCT03701555|54834720|FG035|Part 3 (Day 1)|Subject Decision|0|||
28163984|NCT03701555|54834685|FG000|Part 3 (Day 1)|Other|0|||
28163985|NCT03701555|54834686|FG001|Part 3 (Day 1)|Other|0|||
28163986|NCT03701555|54834687|FG002|Part 3 (Day 1)|Other|0|||
28163987|NCT03701555|54834688|FG003|Part 3 (Day 1)|Other|0|||
28163988|NCT03701555|54834689|FG004|Part 3 (Day 1)|Other|0|||
28163989|NCT03701555|54834690|FG005|Part 3 (Day 1)|Other|0|||
28163990|NCT03701555|54834691|FG006|Part 3 (Day 1)|Other|0|||
28163991|NCT03701555|54834692|FG007|Part 3 (Day 1)|Other|0|||
28163992|NCT03701555|54834693|FG008|Part 3 (Day 1)|Other|0|||
28163993|NCT03701555|54834694|FG009|Part 3 (Day 1)|Other|0|||
28163994|NCT03701555|54834695|FG010|Part 3 (Day 1)|Other|0|||
28163995|NCT03701555|54834696|FG011|Part 3 (Day 1)|Other|0|||
28163996|NCT03701555|54834697|FG012|Part 3 (Day 1)|Other|0|||
28163997|NCT03701555|54834698|FG013|Part 3 (Day 1)|Other|0|||
28163998|NCT03701555|54834699|FG014|Part 3 (Day 1)|Other|0|||
28163999|NCT03701555|54834700|FG015|Part 3 (Day 1)|Other|0|||
28164000|NCT03701555|54834701|FG016|Part 3 (Day 1)|Other|0|||
28164001|NCT03701555|54834702|FG017|Part 3 (Day 1)|Other|0|||
28164002|NCT03701555|54834703|FG018|Part 3 (Day 1)|Other|0|||
28164003|NCT03701555|54834704|FG019|Part 3 (Day 1)|Other|0|||
28164004|NCT03701555|54834705|FG020|Part 3 (Day 1)|Other|0|||
28164005|NCT03701555|54834706|FG021|Part 3 (Day 1)|Other|0|||
28164006|NCT03701555|54834707|FG022|Part 3 (Day 1)|Other|0|||
28164007|NCT03701555|54834708|FG023|Part 3 (Day 1)|Other|0|||
28164008|NCT03701555|54834709|FG024|Part 3 (Day 1)|Other|1|||
28164009|NCT03701555|54834710|FG025|Part 3 (Day 1)|Other|1|||
28164010|NCT03701555|54834711|FG026|Part 3 (Day 1)|Other|0|||
28164011|NCT03701555|54834712|FG027|Part 3 (Day 1)|Other|0|||
28164012|NCT03701555|54834713|FG028|Part 3 (Day 1)|Other|0|||
28164013|NCT03701555|54834714|FG029|Part 3 (Day 1)|Other|1|||
28164014|NCT03701555|54834715|FG030|Part 3 (Day 1)|Other|1|||
28164015|NCT03701555|54834716|FG031|Part 3 (Day 1)|Other|0|||
28164016|NCT03701555|54834717|FG032|Part 3 (Day 1)|Other|1|||
28164017|NCT03701555|54834718|FG033|Part 3 (Day 1)|Other|1|||
28164018|NCT03701555|54834719|FG034|Part 3 (Day 1)|Other|0|||
28164019|NCT03701555|54834720|FG035|Part 3 (Day 1)|Other|0|||
28164020|NCT03699007|54834835|FG000|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|7|||
28164021|NCT03699007|54834836|FG001|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|2|||
28164022|NCT03699007|54834835|FG000|6-month Follow Up|Lost to Follow-up|2|||
28164023|NCT03699007|54834836|FG001|6-month Follow Up|Lost to Follow-up|3|||
28164024|NCT02484443|54834865|FG000|Overall Study|Lack of Efficacy|28|||
28164025|NCT02484443|54834865|FG000|Overall Study|Physician Decision|2|||
28164026|NCT02484443|54834865|FG000|Overall Study|Ineligible|2|||
28164027|NCT02306161|54834871|FG000|Overall Study|Death|1|||
28164028|NCT02306161|54834872|FG001|Overall Study|Death|3|||
28164029|NCT02306161|54834871|FG000|Overall Study|Lack of Efficacy|20|||
28164030|NCT02306161|54834872|FG001|Overall Study|Lack of Efficacy|43|||
28164031|NCT02306161|54834871|FG000|Overall Study|Physician Decision|30|||
28164032|NCT02306161|54834872|FG001|Overall Study|Physician Decision|18|||
28164033|NCT02306161|54834871|FG000|Overall Study|Withdrawal by Subject|4|||
28164034|NCT02306161|54834872|FG001|Overall Study|Withdrawal by Subject|0|||
27731013|NCT02614196|54178230|FG001|Double Blind Treatment Phase|Adverse Event|5|||
27731014|NCT02614196|54178231|FG002|Double Blind Treatment Phase|Adverse Event|9|||
27731015|NCT02614196|54178232|FG003|Double Blind Treatment Phase|Adverse Event|0|||
27731016|NCT02614196|54178233|FG004|Double Blind Treatment Phase|Adverse Event|0|||
27731017|NCT02614196|54178234|FG005|Double Blind Treatment Phase|Adverse Event|0|||
27731018|NCT02614196|54178229|FG000|Double Blind Treatment Phase|Lack of Efficacy|6|||
28164035|NCT02306161|54834871|FG000|Overall Study|Ineligible|9|||
28164036|NCT02306161|54834872|FG001|Overall Study|Ineligible|5|||
28164037|NCT02254278|54834880|FG000|Overall Study|Protocol Violation|1|||
28164038|NCT02254278|54834881|FG001|Overall Study|Protocol Violation|1|||
28164039|NCT02253316|54834890|FG000|Consolidation|Progression|4|||
28164040|NCT02253316|54834891|FG001|Consolidation|Progression|0|||
28164041|NCT02253316|54834892|FG002|Consolidation|Progression|0|||
28164042|NCT02253316|54834890|FG000|Consolidation|Non-Compliance|1|||
28164043|NCT02253316|54834891|FG001|Consolidation|Non-Compliance|0|||
28164044|NCT02253316|54834892|FG002|Consolidation|Non-Compliance|0|||
28164045|NCT02253316|54834890|FG000|Consolidation|Patient Withdrew Logistical Concerns|2|||
28164046|NCT02253316|54834891|FG001|Consolidation|Patient Withdrew Logistical Concerns|0|||
28164047|NCT02253316|54834892|FG002|Consolidation|Patient Withdrew Logistical Concerns|0|||
28164048|NCT02253316|54834890|FG000|Consolidation|Secondary Malignancy|2|||
28164049|NCT02253316|54834891|FG001|Consolidation|Secondary Malignancy|0|||
28164050|NCT02253316|54834892|FG002|Consolidation|Secondary Malignancy|0|||
28164051|NCT02253316|54834890|FG000|Consolidation|Adverse Event|7|||
28164052|NCT02253316|54834891|FG001|Consolidation|Adverse Event|0|||
28164053|NCT02253316|54834892|FG002|Consolidation|Adverse Event|0|||
28164054|NCT02253316|54834890|FG000|Maintenance|Patient Withdrew Logistical Concerns|0|||
28164055|NCT02253316|54834891|FG001|Maintenance|Patient Withdrew Logistical Concerns|7|||
28164056|NCT02253316|54834892|FG002|Maintenance|Patient Withdrew Logistical Concerns|7|||
28164057|NCT02253316|54834890|FG000|Maintenance|Physician Decision|0|||
28164058|NCT02253316|54834891|FG001|Maintenance|Physician Decision|5|||
28164059|NCT02253316|54834892|FG002|Maintenance|Physician Decision|16|||
28164060|NCT02253316|54834890|FG000|Maintenance|Non-Compliance|0|||
27731019|NCT02614196|54178230|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
27943866|NCT01231906|54600937|FG001|Overall Study|Ineligible|3|||
27731020|NCT02614196|54178231|FG002|Double Blind Treatment Phase|Lack of Efficacy|1|||
28164061|NCT02253316|54834891|FG001|Maintenance|Non-Compliance|1|||
28164062|NCT02253316|54834892|FG002|Maintenance|Non-Compliance|0|||
28164063|NCT02253316|54834890|FG000|Maintenance|Secondary Malignancy|0|||
28164064|NCT02253316|54834891|FG001|Maintenance|Secondary Malignancy|1|||
28164065|NCT02253316|54834892|FG002|Maintenance|Secondary Malignancy|5|||
28164066|NCT02253316|54834890|FG000|Maintenance|Adverse Event|0|||
28164067|NCT02253316|54834891|FG001|Maintenance|Adverse Event|8|||
28164068|NCT02253316|54834892|FG002|Maintenance|Adverse Event|12|||
28164069|NCT02253316|54834890|FG000|Maintenance|Still receiving active treatment|0|||
28164070|NCT02253316|54834891|FG001|Maintenance|Still receiving active treatment|23|||
28164071|NCT02253316|54834892|FG002|Maintenance|Still receiving active treatment|26|||
28164072|NCT02178098|54834902|FG000|Overall Study|Withdrawal by Subject|0|||
28164073|NCT02178098|54834903|FG001|Overall Study|Withdrawal by Subject|6|||
28164074|NCT02178098|54834902|FG000|Overall Study|Adverse Event|1|||
28164075|NCT02178098|54834903|FG001|Overall Study|Adverse Event|2|||
28164076|NCT02178098|54834902|FG000|Overall Study|Protocol Violation|1|||
28164077|NCT02178098|54834903|FG001|Overall Study|Protocol Violation|1|||
28164078|NCT02178098|54834902|FG000|Overall Study|Lost to Follow-up|0|||
28164079|NCT02178098|54834903|FG001|Overall Study|Lost to Follow-up|1|||
28164080|NCT02178098|54834902|FG000|Overall Study|Sponsor Request|1|||
28164081|NCT02178098|54834903|FG001|Overall Study|Sponsor Request|0|||
28164082|NCT02178098|54834902|FG000|Overall Study|Other|2|||
27731021|NCT02614196|54178232|FG003|Double Blind Treatment Phase|Lack of Efficacy|0|||
27731022|NCT02614196|54178233|FG004|Double Blind Treatment Phase|Lack of Efficacy|0|||
28164083|NCT02178098|54834903|FG001|Overall Study|Other|2|||
28164084|NCT02101853|54834911|FG000|Block 1 Induction|Adverse Event|11|||
28164085|NCT02101853|54834912|FG001|Block 1 Induction|Adverse Event|0|||
28164086|NCT02101853|54834913|FG002|Block 1 Induction|Adverse Event|0|||
28164087|NCT02101853|54834914|FG003|Block 1 Induction|Adverse Event|0|||
28164088|NCT02101853|54834915|FG004|Block 1 Induction|Adverse Event|0|||
28164089|NCT02101853|54834916|FG005|Block 1 Induction|Adverse Event|0|||
28164090|NCT02101853|54834911|FG000|Block 1 Induction|Death|20|||
28164091|NCT02101853|54834912|FG001|Block 1 Induction|Death|0|||
28164092|NCT02101853|54834913|FG002|Block 1 Induction|Death|0|||
28164093|NCT02101853|54834914|FG003|Block 1 Induction|Death|0|||
28164094|NCT02101853|54834915|FG004|Block 1 Induction|Death|0|||
28164095|NCT02101853|54834916|FG005|Block 1 Induction|Death|0|||
28164096|NCT02101853|54834911|FG000|Block 1 Induction|Lack of Efficacy|6|||
28164097|NCT02101853|54834912|FG001|Block 1 Induction|Lack of Efficacy|0|||
28164098|NCT02101853|54834913|FG002|Block 1 Induction|Lack of Efficacy|0|||
28164099|NCT02101853|54834914|FG003|Block 1 Induction|Lack of Efficacy|0|||
28164100|NCT02101853|54834915|FG004|Block 1 Induction|Lack of Efficacy|0|||
28164101|NCT02101853|54834916|FG005|Block 1 Induction|Lack of Efficacy|0|||
28164102|NCT02101853|54834911|FG000|Block 1 Induction|Physician Decision|61|||
28164103|NCT02101853|54834912|FG001|Block 1 Induction|Physician Decision|0|||
28164104|NCT02101853|54834913|FG002|Block 1 Induction|Physician Decision|0|||
28164105|NCT02101853|54834914|FG003|Block 1 Induction|Physician Decision|0|||
28164106|NCT02101853|54834915|FG004|Block 1 Induction|Physician Decision|0|||
28164107|NCT02101853|54834916|FG005|Block 1 Induction|Physician Decision|0|||
28164108|NCT02101853|54834911|FG000|Block 1 Induction|Protocol Violation|2|||
28164109|NCT02101853|54834912|FG001|Block 1 Induction|Protocol Violation|0|||
28164110|NCT02101853|54834913|FG002|Block 1 Induction|Protocol Violation|0|||
28164111|NCT02101853|54834914|FG003|Block 1 Induction|Protocol Violation|0|||
27731023|NCT02614196|54178234|FG005|Double Blind Treatment Phase|Lack of Efficacy|0|||
27731024|NCT02614196|54178229|FG000|Double Blind Treatment Phase|Lost to Follow-up|10|||
27731025|NCT02614196|54178230|FG001|Double Blind Treatment Phase|Lost to Follow-up|7|||
27731026|NCT02614196|54178231|FG002|Double Blind Treatment Phase|Lost to Follow-up|1|||
27731027|NCT02614196|54178232|FG003|Double Blind Treatment Phase|Lost to Follow-up|0|||
27731028|NCT02614196|54178233|FG004|Double Blind Treatment Phase|Lost to Follow-up|0|||
28164112|NCT02101853|54834915|FG004|Block 1 Induction|Protocol Violation|0|||
28164113|NCT02101853|54834916|FG005|Block 1 Induction|Protocol Violation|0|||
27731029|NCT02614196|54178234|FG005|Double Blind Treatment Phase|Lost to Follow-up|0|||
27731030|NCT02614196|54178229|FG000|Double Blind Treatment Phase|Physician Decision|4|||
28164114|NCT02101853|54834911|FG000|Block 1 Induction|Withdrawal by Subject|65|||
28164115|NCT02101853|54834912|FG001|Block 1 Induction|Withdrawal by Subject|0|||
28164116|NCT02101853|54834913|FG002|Block 1 Induction|Withdrawal by Subject|0|||
28164117|NCT02101853|54834914|FG003|Block 1 Induction|Withdrawal by Subject|0|||
28164118|NCT02101853|54834915|FG004|Block 1 Induction|Withdrawal by Subject|0|||
28164119|NCT02101853|54834916|FG005|Block 1 Induction|Withdrawal by Subject|0|||
28164120|NCT02101853|54834911|FG000|Block 1 Induction|Ineligible|8|||
28164121|NCT02101853|54834912|FG001|Block 1 Induction|Ineligible|0|||
28164122|NCT02101853|54834913|FG002|Block 1 Induction|Ineligible|0|||
28164123|NCT02101853|54834914|FG003|Block 1 Induction|Ineligible|0|||
28164124|NCT02101853|54834915|FG004|Block 1 Induction|Ineligible|0|||
28164125|NCT02101853|54834916|FG005|Block 1 Induction|Ineligible|0|||
28164126|NCT02101853|54834911|FG000|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|1|||
27731031|NCT02614196|54178230|FG001|Double Blind Treatment Phase|Physician Decision|0|||
28164127|NCT02101853|54834912|FG001|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
28164128|NCT02101853|54834913|FG002|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
28164129|NCT02101853|54834914|FG003|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
27731032|NCT02614196|54178231|FG002|Double Blind Treatment Phase|Physician Decision|2|||
28164130|NCT02101853|54834915|FG004|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
28164131|NCT02101853|54834916|FG005|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
28164132|NCT02101853|54834911|FG000|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|1|||
28164133|NCT02101853|54834912|FG001|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
28164134|NCT02101853|54834913|FG002|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
28164135|NCT02101853|54834914|FG003|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
28164136|NCT02101853|54834915|FG004|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
28164137|NCT02101853|54834916|FG005|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
28164138|NCT02101853|54834911|FG000|Post Induction Randomization|Adverse Event|0|||
28164139|NCT02101853|54834912|FG001|Post Induction Randomization|Adverse Event|3|||
28164140|NCT02101853|54834913|FG002|Post Induction Randomization|Adverse Event|8|||
28164141|NCT02101853|54834914|FG003|Post Induction Randomization|Adverse Event|4|||
28164142|NCT02101853|54834915|FG004|Post Induction Randomization|Adverse Event|4|||
28164143|NCT02101853|54834916|FG005|Post Induction Randomization|Adverse Event|0|||
28164144|NCT02101853|54834911|FG000|Post Induction Randomization|Death|0|||
28164145|NCT02101853|54834912|FG001|Post Induction Randomization|Death|9|||
28164146|NCT02101853|54834913|FG002|Post Induction Randomization|Death|2|||
28164147|NCT02101853|54834914|FG003|Post Induction Randomization|Death|2|||
28164148|NCT02101853|54834915|FG004|Post Induction Randomization|Death|0|||
28164149|NCT02101853|54834916|FG005|Post Induction Randomization|Death|0|||
28164150|NCT02101853|54834911|FG000|Post Induction Randomization|Lack of Efficacy|0|||
28164151|NCT02101853|54834912|FG001|Post Induction Randomization|Lack of Efficacy|14|||
28164152|NCT02101853|54834913|FG002|Post Induction Randomization|Lack of Efficacy|23|||
28164153|NCT02101853|54834914|FG003|Post Induction Randomization|Lack of Efficacy|18|||
28164154|NCT02101853|54834915|FG004|Post Induction Randomization|Lack of Efficacy|21|||
28164155|NCT02101853|54834916|FG005|Post Induction Randomization|Lack of Efficacy|0|||
28164156|NCT02101853|54834911|FG000|Post Induction Randomization|Physician Decision|0|||
28164157|NCT02101853|54834912|FG001|Post Induction Randomization|Physician Decision|43|||
28164158|NCT02101853|54834913|FG002|Post Induction Randomization|Physician Decision|23|||
28164159|NCT02101853|54834914|FG003|Post Induction Randomization|Physician Decision|14|||
28164160|NCT02101853|54834915|FG004|Post Induction Randomization|Physician Decision|14|||
28164161|NCT02101853|54834916|FG005|Post Induction Randomization|Physician Decision|0|||
28164162|NCT02101853|54834911|FG000|Post Induction Randomization|Protocol Violation|0|||
28164163|NCT02101853|54834912|FG001|Post Induction Randomization|Protocol Violation|3|||
28164164|NCT02101853|54834913|FG002|Post Induction Randomization|Protocol Violation|0|||
28164165|NCT02101853|54834914|FG003|Post Induction Randomization|Protocol Violation|0|||
28164166|NCT02101853|54834915|FG004|Post Induction Randomization|Protocol Violation|0|||
28164167|NCT02101853|54834916|FG005|Post Induction Randomization|Protocol Violation|0|||
28164168|NCT02101853|54834911|FG000|Post Induction Randomization|Withdrawal by Subject|0|||
28164169|NCT02101853|54834912|FG001|Post Induction Randomization|Withdrawal by Subject|13|||
28164170|NCT02101853|54834913|FG002|Post Induction Randomization|Withdrawal by Subject|12|||
28164171|NCT02101853|54834914|FG003|Post Induction Randomization|Withdrawal by Subject|7|||
28164172|NCT02101853|54834915|FG004|Post Induction Randomization|Withdrawal by Subject|8|||
28164173|NCT02101853|54834916|FG005|Post Induction Randomization|Withdrawal by Subject|0|||
28164174|NCT02101853|54834911|FG000|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
28164175|NCT02101853|54834912|FG001|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
28164176|NCT02101853|54834913|FG002|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
28164177|NCT02101853|54834914|FG003|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|1|||
28164178|NCT02101853|54834915|FG004|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
28164179|NCT02101853|54834916|FG005|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
28164180|NCT02101853|54834911|FG000|Post Induction Randomization|Found to be ineligible for HSCT|0|||
28164181|NCT02101853|54834912|FG001|Post Induction Randomization|Found to be ineligible for HSCT|5|||
28164182|NCT02101853|54834913|FG002|Post Induction Randomization|Found to be ineligible for HSCT|8|||
28164183|NCT02101853|54834914|FG003|Post Induction Randomization|Found to be ineligible for HSCT|0|||
28164184|NCT02101853|54834915|FG004|Post Induction Randomization|Found to be ineligible for HSCT|0|||
28164185|NCT02101853|54834916|FG005|Post Induction Randomization|Found to be ineligible for HSCT|0|||
28164186|NCT02101853|54834911|FG000|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
28164187|NCT02101853|54834912|FG001|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|5|||
28164188|NCT02101853|54834913|FG002|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
28164189|NCT02101853|54834914|FG003|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
28164190|NCT02101853|54834915|FG004|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
28164191|NCT02101853|54834916|FG005|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
28164192|NCT02101853|54834911|FG000|Post Induction Randomization|Patient still receiving protocol therapy|0|||
28164193|NCT02101853|54834912|FG001|Post Induction Randomization|Patient still receiving protocol therapy|0|||
27731033|NCT02614196|54178232|FG003|Double Blind Treatment Phase|Physician Decision|0|||
27731034|NCT02614196|54178233|FG004|Double Blind Treatment Phase|Physician Decision|0|||
27731035|NCT02614196|54178234|FG005|Double Blind Treatment Phase|Physician Decision|0|||
27731036|NCT02614196|54178229|FG000|Double Blind Treatment Phase|Pregnancy|1|||
27731037|NCT02614196|54178230|FG001|Double Blind Treatment Phase|Pregnancy|2|||
27731038|NCT02614196|54178231|FG002|Double Blind Treatment Phase|Pregnancy|0|||
27731039|NCT02614196|54178232|FG003|Double Blind Treatment Phase|Pregnancy|0|||
27731040|NCT02614196|54178233|FG004|Double Blind Treatment Phase|Pregnancy|0|||
27731041|NCT02614196|54178234|FG005|Double Blind Treatment Phase|Pregnancy|0|||
27731042|NCT02614196|54178229|FG000|Double Blind Treatment Phase|Protocol Violation|5|||
27731043|NCT02614196|54178230|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
27731044|NCT02614196|54178231|FG002|Double Blind Treatment Phase|Protocol Violation|1|||
27731045|NCT02614196|54178232|FG003|Double Blind Treatment Phase|Protocol Violation|0|||
27731046|NCT02614196|54178233|FG004|Double Blind Treatment Phase|Protocol Violation|1|||
27731047|NCT02614196|54178234|FG005|Double Blind Treatment Phase|Protocol Violation|0|||
27731048|NCT02614196|54178229|FG000|Double Blind Treatment Phase|Terminated by sponsor|1|||
27731049|NCT02614196|54178230|FG001|Double Blind Treatment Phase|Terminated by sponsor|0|||
27731050|NCT02614196|54178231|FG002|Double Blind Treatment Phase|Terminated by sponsor|0|||
27731051|NCT02614196|54178232|FG003|Double Blind Treatment Phase|Terminated by sponsor|0|||
27731052|NCT02614196|54178233|FG004|Double Blind Treatment Phase|Terminated by sponsor|0|||
27731053|NCT02614196|54178234|FG005|Double Blind Treatment Phase|Terminated by sponsor|0|||
27731054|NCT02614196|54178229|FG000|Double Blind Treatment Phase|Withdrawal by Subject|39|||
27853015|NCT01435616|54361566|FG001|Overall Study|Withdrawal by Subject|24|||
27853016|NCT01435616|54361565|FG000|Overall Study|Physician Decision|20|||
27853017|NCT01435616|54361566|FG001|Overall Study|Physician Decision|7|||
28164194|NCT02101853|54834913|FG002|Post Induction Randomization|Patient still receiving protocol therapy|0|||
28164195|NCT02101853|54834914|FG003|Post Induction Randomization|Patient still receiving protocol therapy|5|||
28164196|NCT02101853|54834915|FG004|Post Induction Randomization|Patient still receiving protocol therapy|1|||
28164197|NCT02101853|54834916|FG005|Post Induction Randomization|Patient still receiving protocol therapy|0|||
28164198|NCT02101853|54834911|FG000|Blinatumomab Salvage Therapy|Death|0|||
28164199|NCT02101853|54834912|FG001|Blinatumomab Salvage Therapy|Death|0|||
28164200|NCT02101853|54834913|FG002|Blinatumomab Salvage Therapy|Death|0|||
28164201|NCT02101853|54834914|FG003|Blinatumomab Salvage Therapy|Death|0|||
27731055|NCT02614196|54178230|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
28079424|NCT00381095|54733073|FG000|Overall Study|Protocol Violation|1|||
28079425|NCT00381095|54733074|FG001|Overall Study|Protocol Violation|1|||
27853018|NCT01435616|54361565|FG000|Overall Study|Sponsor Decision|1|||
27853019|NCT01435616|54361566|FG001|Overall Study|Sponsor Decision|0|||
27853020|NCT01435460|54361616|FG000|Overall Study|Adverse Event|2|||
27853021|NCT01435460|54361617|FG001|Overall Study|Adverse Event|1|||
27853022|NCT01435460|54361616|FG000|Overall Study|Lost to Follow-up|6|||
27853023|NCT01435460|54361617|FG001|Overall Study|Lost to Follow-up|1|||
28079426|NCT00381095|54733073|FG000|Overall Study|Withdrawal by Subject|3|||
28079427|NCT00381095|54733074|FG001|Overall Study|Withdrawal by Subject|3|||
28079428|NCT00381095|54733073|FG000|Overall Study|Adverse Event|2|||
28079429|NCT00381095|54733074|FG001|Overall Study|Adverse Event|7|||
28079430|NCT03619174|54733082|FG000|Overall Study|Lost to Follow-up|3|||
28079431|NCT03619174|54733083|FG001|Overall Study|Lost to Follow-up|0|||
28079432|NCT03619174|54733082|FG000|Overall Study|Withdrawal by Subject|4|||
28079433|NCT03619174|54733083|FG001|Overall Study|Withdrawal by Subject|3|||
28079434|NCT03619174|54733082|FG000|Overall Study|Pregnancy|1|||
28079435|NCT03619174|54733083|FG001|Overall Study|Pregnancy|1|||
28079436|NCT03619174|54733082|FG000|Overall Study|Discomfort during treatment|1|||
28079437|NCT03619174|54733083|FG001|Overall Study|Discomfort during treatment|0|||
28079438|NCT00112047|54733091|FG000|Randomized Phase|Lost to Follow-up|26|||
28079439|NCT00112047|54733092|FG001|Randomized Phase|Lost to Follow-up|33|||
28079440|NCT00112047|54733091|FG000|Randomized Phase|Adverse Event|10|||
27853024|NCT01435460|54361616|FG000|Overall Study|Withdrawal by Subject|1|||
27943867|NCT01231906|54600936|FG000|Overall Study|No treatment|1|||
27943868|NCT01231906|54600937|FG001|Overall Study|No treatment|2|||
27943869|NCT00999804|54600945|FG000|Overall Study|Lack of Efficacy|9|||
27943870|NCT00999804|54600946|FG001|Overall Study|Lack of Efficacy|2|||
27943871|NCT00999804|54600945|FG000|Overall Study|Adverse Event|4|||
27943872|NCT00999804|54600946|FG001|Overall Study|Adverse Event|3|||
27943873|NCT00999804|54600945|FG000|Overall Study|Withdrawal by Subject|4|||
27943874|NCT00999804|54600946|FG001|Overall Study|Withdrawal by Subject|0|||
27943875|NCT00999804|54600945|FG000|Overall Study|Death|1|||
27943876|NCT00999804|54600946|FG001|Overall Study|Death|0|||
27943877|NCT00999804|54600945|FG000|Overall Study|Ineligible|3|||
28079441|NCT00112047|54733092|FG001|Randomized Phase|Adverse Event|10|||
28079442|NCT00112047|54733091|FG000|Randomized Phase|Withrawal of consent|10|||
28079443|NCT00112047|54733092|FG001|Randomized Phase|Withrawal of consent|18|||
28079444|NCT00112047|54733091|FG000|Randomized Phase|Sub-optimal virological response|3|||
28079445|NCT00112047|54733092|FG001|Randomized Phase|Sub-optimal virological response|13|||
27731056|NCT02614196|54178231|FG002|Double Blind Treatment Phase|Withdrawal by Subject|14|||
27731057|NCT02614196|54178232|FG003|Double Blind Treatment Phase|Withdrawal by Subject|4|||
27731058|NCT02614196|54178233|FG004|Double Blind Treatment Phase|Withdrawal by Subject|0|||
27731059|NCT02614196|54178234|FG005|Double Blind Treatment Phase|Withdrawal by Subject|0|||
27731060|NCT02614196|54178229|FG000|Double Blind Treatment Phase|Did not receive study drug|2|||
27731061|NCT02614196|54178230|FG001|Double Blind Treatment Phase|Did not receive study drug|2|||
27731062|NCT02614196|54178231|FG002|Double Blind Treatment Phase|Did not receive study drug|3|||
27731063|NCT02614196|54178232|FG003|Double Blind Treatment Phase|Did not receive study drug|0|||
27731064|NCT02614196|54178233|FG004|Double Blind Treatment Phase|Did not receive study drug|0|||
27731065|NCT02614196|54178234|FG005|Double Blind Treatment Phase|Did not receive study drug|0|||
27731066|NCT02614196|54178229|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|8|||
28164202|NCT02101853|54834915|FG004|Blinatumomab Salvage Therapy|Death|0|||
27925596|NCT01258608|54582131|FG000|Overall Study|Adverse Event|6|||
28164203|NCT02101853|54834916|FG005|Blinatumomab Salvage Therapy|Death|2|||
28164204|NCT02101853|54834911|FG000|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
28164205|NCT02101853|54834912|FG001|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
28164206|NCT02101853|54834913|FG002|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
28164207|NCT02101853|54834914|FG003|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
28164208|NCT02101853|54834915|FG004|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
28164209|NCT02101853|54834916|FG005|Blinatumomab Salvage Therapy|Lack of Efficacy|7|||
28164210|NCT02101853|54834911|FG000|Blinatumomab Salvage Therapy|Physician Decision|0|||
28164211|NCT02101853|54834912|FG001|Blinatumomab Salvage Therapy|Physician Decision|0|||
28164212|NCT02101853|54834913|FG002|Blinatumomab Salvage Therapy|Physician Decision|0|||
28164213|NCT02101853|54834914|FG003|Blinatumomab Salvage Therapy|Physician Decision|0|||
28164214|NCT02101853|54834915|FG004|Blinatumomab Salvage Therapy|Physician Decision|0|||
28164215|NCT02101853|54834916|FG005|Blinatumomab Salvage Therapy|Physician Decision|14|||
28164216|NCT02101853|54834911|FG000|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
28164217|NCT02101853|54834912|FG001|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
27731067|NCT02614196|54178230|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
27731068|NCT02614196|54178231|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
27731069|NCT02614196|54178232|FG003|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
27731070|NCT02614196|54178233|FG004|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
27731071|NCT02614196|54178234|FG005|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
27731072|NCT02614196|54178229|FG000|Post Treatment Follow-up Phase|Pregnancy|2|||
27731073|NCT02614196|54178230|FG001|Post Treatment Follow-up Phase|Pregnancy|0|||
27731074|NCT02614196|54178231|FG002|Post Treatment Follow-up Phase|Pregnancy|0|||
27731075|NCT02614196|54178232|FG003|Post Treatment Follow-up Phase|Pregnancy|0|||
27731076|NCT02614196|54178233|FG004|Post Treatment Follow-up Phase|Pregnancy|0|||
27731077|NCT02614196|54178234|FG005|Post Treatment Follow-up Phase|Pregnancy|0|||
27731078|NCT02614196|54178229|FG000|Post Treatment Follow-up Phase|Protocol Violation|0|||
27731079|NCT02614196|54178230|FG001|Post Treatment Follow-up Phase|Protocol Violation|1|||
27731080|NCT02614196|54178231|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
27731081|NCT02614196|54178232|FG003|Post Treatment Follow-up Phase|Protocol Violation|0|||
27731082|NCT02614196|54178233|FG004|Post Treatment Follow-up Phase|Protocol Violation|1|||
27731083|NCT02614196|54178234|FG005|Post Treatment Follow-up Phase|Protocol Violation|0|||
27731084|NCT02614196|54178229|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|10|||
27731085|NCT02614196|54178230|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
27731086|NCT02614196|54178231|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
27731087|NCT02614196|54178232|FG003|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
27731088|NCT02614196|54178233|FG004|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
27731089|NCT02614196|54178234|FG005|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
27731090|NCT02765035|54178264|FG000|First Intervention (90 Days)|Adverse Event|1|||
27731091|NCT02765035|54178265|FG001|First Intervention (90 Days)|Adverse Event|1|||
27731092|NCT02765035|54178264|FG000|Second Intervention (30 Days)|Protocol Violation|2|||
27731093|NCT02765035|54178265|FG001|Second Intervention (30 Days)|Protocol Violation|2|||
27731094|NCT02307682|54178275|FG000|Overall Study|Adverse Event|9|||
27731095|NCT02307682|54178276|FG001|Overall Study|Adverse Event|8|||
27731096|NCT02307682|54178277|FG002|Overall Study|Adverse Event|12|||
27731097|NCT02307682|54178275|FG000|Overall Study|Lack of Efficacy|1|||
27731098|NCT02307682|54178276|FG001|Overall Study|Lack of Efficacy|0|||
27731099|NCT02307682|54178277|FG002|Overall Study|Lack of Efficacy|1|||
27731100|NCT02307682|54178275|FG000|Overall Study|Physician Decision|2|||
27731101|NCT02307682|54178276|FG001|Overall Study|Physician Decision|2|||
27731102|NCT02307682|54178277|FG002|Overall Study|Physician Decision|8|||
27731103|NCT02307682|54178275|FG000|Overall Study|Progressive Disease|1|||
27731104|NCT02307682|54178276|FG001|Overall Study|Progressive Disease|0|||
27731105|NCT02307682|54178277|FG002|Overall Study|Progressive Disease|0|||
27731106|NCT02307682|54178275|FG000|Overall Study|Withdrawal by Subject|26|||
27731107|NCT02307682|54178276|FG001|Overall Study|Withdrawal by Subject|34|||
27731108|NCT02307682|54178277|FG002|Overall Study|Withdrawal by Subject|23|||
27731109|NCT02307682|54178275|FG000|Overall Study|Death|9|||
27731110|NCT02307682|54178276|FG001|Overall Study|Death|7|||
28164218|NCT02101853|54834913|FG002|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
28164219|NCT02101853|54834914|FG003|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
28164220|NCT02101853|54834915|FG004|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
28164221|NCT02101853|54834916|FG005|Blinatumomab Salvage Therapy|Withdrawal by Subject|2|||
28164222|NCT01915498|54834946|FG000|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
28164223|NCT01915498|54834947|FG001|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
28164224|NCT01915498|54834948|FG002|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
28164225|NCT01915498|54834949|FG003|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
28164226|NCT01915498|54834950|FG004|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
28164227|NCT01915498|54834951|FG005|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
28164228|NCT01915498|54834952|FG006|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
28164229|NCT01915498|54834953|FG007|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
28164230|NCT01915498|54834954|FG008|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
28164231|NCT01915498|54834955|FG009|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
27731111|NCT02307682|54178277|FG002|Overall Study|Death|12|||
27731112|NCT02307682|54178275|FG000|Overall Study|Lost to Follow-up|1|||
27731113|NCT02307682|54178276|FG001|Overall Study|Lost to Follow-up|5|||
27731114|NCT02307682|54178277|FG002|Overall Study|Lost to Follow-up|6|||
27731115|NCT02307682|54178275|FG000|Overall Study|Protocol Deviation|0|||
27731116|NCT02307682|54178276|FG001|Overall Study|Protocol Deviation|0|||
27731117|NCT02307682|54178277|FG002|Overall Study|Protocol Deviation|2|||
27731118|NCT02307682|54178275|FG000|Overall Study|Other|1|||
27731119|NCT02307682|54178276|FG001|Overall Study|Other|1|||
27731120|NCT02307682|54178277|FG002|Overall Study|Other|0|||
27731121|NCT02615990|54178287|FG000|Overall Study|study terminated|1|||
27731122|NCT02615990|54178288|FG001|Overall Study|study terminated|1|||
27731123|NCT02613884|54178294|FG000|Overall Study|Death|1|||
27731124|NCT02613884|54178294|FG000|Overall Study|Lost to Follow-up|1|||
27731125|NCT02791763|54178302|FG000|Overall Study|Protocol Violation|0|||
27731126|NCT02791763|54178303|FG001|Overall Study|Protocol Violation|0|||
27731127|NCT02791763|54178304|FG002|Overall Study|Protocol Violation|1|||
27731128|NCT02791763|54178302|FG000|Overall Study|Withdrawal by Subject|5|||
27731129|NCT02791763|54178303|FG001|Overall Study|Withdrawal by Subject|1|||
28164232|NCT01915498|54834956|FG010|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
28164233|NCT01915498|54834957|FG011|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
28164234|NCT01915498|54834958|FG012|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
28164235|NCT01915498|54834959|FG013|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
28164236|NCT01915498|54834960|FG014|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
28164237|NCT01915498|54834961|FG015|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
28164238|NCT01915498|54834962|FG016|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
28164239|NCT01915498|54834963|FG017|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
28164240|NCT01915498|54834964|FG018|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
28164241|NCT01915498|54834946|FG000|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
28164242|NCT01915498|54834947|FG001|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
28164243|NCT01915498|54834948|FG002|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
28164244|NCT01915498|54834949|FG003|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
28164245|NCT01915498|54834950|FG004|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
28164246|NCT01915498|54834951|FG005|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
28164247|NCT01915498|54834952|FG006|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
28164248|NCT01915498|54834953|FG007|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
28164249|NCT01915498|54834954|FG008|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
28164250|NCT01915498|54834955|FG009|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
28164251|NCT01915498|54834956|FG010|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
28164252|NCT01915498|54834957|FG011|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
28164253|NCT01915498|54834958|FG012|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
28164254|NCT01915498|54834959|FG013|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
28164255|NCT01915498|54834960|FG014|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
28164256|NCT01915498|54834961|FG015|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
28164257|NCT01915498|54834962|FG016|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
28164258|NCT01915498|54834963|FG017|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16|||
28164259|NCT01915498|54834964|FG018|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
27731130|NCT02791763|54178304|FG002|Overall Study|Withdrawal by Subject|0|||
27731131|NCT02791763|54178302|FG000|Overall Study|Physician Decision|0|||
27731132|NCT02791763|54178303|FG001|Overall Study|Physician Decision|1|||
27731133|NCT02791763|54178304|FG002|Overall Study|Physician Decision|0|||
27731134|NCT02791763|54178302|FG000|Overall Study|Needs maintenance/changes in dialysis|16|||
27731135|NCT02791763|54178303|FG001|Overall Study|Needs maintenance/changes in dialysis|19|||
27731136|NCT02791763|54178304|FG002|Overall Study|Needs maintenance/changes in dialysis|5|||
27731137|NCT02791763|54178302|FG000|Overall Study|Cancer event|1|||
28164260|NCT01915498|54834946|FG000|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1|||
28164261|NCT01915498|54834947|FG001|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
28164262|NCT01915498|54834948|FG002|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
28164263|NCT01915498|54834949|FG003|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
28164264|NCT01915498|54834950|FG004|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
28164265|NCT01915498|54834951|FG005|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
28164266|NCT01915498|54834952|FG006|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
28164267|NCT01915498|54834953|FG007|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15|||
28164268|NCT01915498|54834954|FG008|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
28164269|NCT01915498|54834955|FG009|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7|||
28164270|NCT01915498|54834956|FG010|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
28164271|NCT01915498|54834957|FG011|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
28164272|NCT01915498|54834958|FG012|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
28164273|NCT01915498|54834959|FG013|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24|||
28164274|NCT01915498|54834960|FG014|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14|||
28164275|NCT01915498|54834961|FG015|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9|||
28164276|NCT01915498|54834962|FG016|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8|||
28164277|NCT01915498|54834963|FG017|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41|||
28164278|NCT01915498|54834964|FG018|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0|||
28164279|NCT01915498|54834946|FG000|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
28164280|NCT01915498|54834947|FG001|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
28164281|NCT01915498|54834948|FG002|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
27731138|NCT02791763|54178303|FG001|Overall Study|Cancer event|3|||
28079446|NCT00112047|54733091|FG000|Randomized Phase|Noncompliance|8|||
28079447|NCT00112047|54733092|FG001|Randomized Phase|Noncompliance|4|||
28079448|NCT00112047|54733091|FG000|Randomized Phase|Protocol Violation|2|||
28079449|NCT00112047|54733092|FG001|Randomized Phase|Protocol Violation|0|||
28079450|NCT00112047|54733091|FG000|Randomized Phase|Pregnancy|3|||
28079451|NCT00112047|54733092|FG001|Randomized Phase|Pregnancy|1|||
28079452|NCT00112047|54733091|FG000|Randomized Phase|Death|1|||
28079453|NCT00112047|54733092|FG001|Randomized Phase|Death|3|||
28079454|NCT00112047|54733091|FG000|Randomized Phase|Hepatitis C treatment contraindicated|0|||
28079455|NCT00112047|54733092|FG001|Randomized Phase|Hepatitis C treatment contraindicated|1|||
28079456|NCT00112047|54733091|FG000|Randomized Phase|Inability to swallow pills|0|||
28079457|NCT00112047|54733092|FG001|Randomized Phase|Inability to swallow pills|1|||
27731139|NCT02791763|54178304|FG002|Overall Study|Cancer event|0|||
27731140|NCT02791763|54178302|FG000|Overall Study|Participant had renal transplant|3|||
27731141|NCT02791763|54178303|FG001|Overall Study|Participant had renal transplant|0|||
28079458|NCT00112047|54733091|FG000|Randomized Phase|Incarceration|3|||
28164282|NCT01915498|54834949|FG003|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
28164283|NCT01915498|54834950|FG004|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
28164284|NCT01915498|54834951|FG005|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
28164285|NCT01915498|54834952|FG006|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
28164286|NCT01915498|54834953|FG007|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
28164287|NCT01915498|54834954|FG008|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
27731142|NCT02791763|54178304|FG002|Overall Study|Participant had renal transplant|0|||
27731143|NCT02791763|54178302|FG000|Overall Study|Met hemoglobin stopping criteria|1|||
27731144|NCT02791763|54178303|FG001|Overall Study|Met hemoglobin stopping criteria|0|||
27731145|NCT02791763|54178304|FG002|Overall Study|Met hemoglobin stopping criteria|0|||
27731146|NCT02791763|54178302|FG000|Overall Study|Adverse Event|12|||
27731147|NCT02791763|54178303|FG001|Overall Study|Adverse Event|13|||
27731148|NCT02791763|54178304|FG002|Overall Study|Adverse Event|7|||
27731149|NCT02613572|54178324|FG000|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1|||
27731150|NCT02613572|54178325|FG001|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
27731151|NCT02613572|54178326|FG002|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
27731152|NCT02613572|54178324|FG000|Phase II: Double-Blind Rand Plac Control|Death|0|||
27731153|NCT02613572|54178325|FG001|Phase II: Double-Blind Rand Plac Control|Death|1|||
27731154|NCT02613572|54178326|FG002|Phase II: Double-Blind Rand Plac Control|Death|0|||
27731155|NCT02087189|54178338|FG000|Overall Study|enrolled but did not receive a TD01 as implant|2|||
27731156|NCT02341456|54178345|FG000|Overall Study|Disease progression|2|||
27943878|NCT00999804|54600946|FG001|Overall Study|Ineligible|0|||
28164288|NCT01915498|54834955|FG009|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
28164289|NCT01915498|54834956|FG010|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1|||
28164290|NCT01915498|54834957|FG011|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
28164291|NCT01915498|54834958|FG012|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
27731157|NCT02341456|54178346|FG001|Overall Study|Disease progression|3|||
27943879|NCT00927472|54600958|FG000|Overall Study|Withdrawal by Subject|10|||
28079459|NCT00112047|54733092|FG001|Randomized Phase|Incarceration|2|||
28079460|NCT00112047|54733091|FG000|Randomized Phase|Moved out of State|0|||
28079461|NCT00112047|54733092|FG001|Randomized Phase|Moved out of State|1|||
28079462|NCT00112047|54733091|FG000|Randomized Phase|Baseline NNRTI resistance mutations|4|||
28079463|NCT00112047|54733092|FG001|Randomized Phase|Baseline NNRTI resistance mutations|0|||
28079464|NCT00112047|54733091|FG000|Randomized Phase|High Hepatitis B DNA|0|||
28079465|NCT00112047|54733092|FG001|Randomized Phase|High Hepatitis B DNA|1|||
28079466|NCT00112047|54733091|FG000|Atripla Phase|Adverse Event|2|||
28079467|NCT00112047|54733092|FG001|Atripla Phase|Adverse Event|1|||
28079468|NCT00112047|54733091|FG000|Atripla Phase|Lost to Follow-up|5|||
28079469|NCT00112047|54733092|FG001|Atripla Phase|Lost to Follow-up|7|||
28079470|NCT00112047|54733091|FG000|Atripla Phase|Pregnancy|0|||
28079471|NCT00112047|54733092|FG001|Atripla Phase|Pregnancy|1|||
28079472|NCT00112047|54733091|FG000|Atripla Phase|Death|0|||
28079473|NCT00112047|54733092|FG001|Atripla Phase|Death|2|||
28079474|NCT00112047|54733091|FG000|Atripla Phase|Withdrew consent|7|||
28079475|NCT00112047|54733092|FG001|Atripla Phase|Withdrew consent|7|||
28079476|NCT00112047|54733091|FG000|Atripla Phase|Sub-optimal virological response|0|||
28079477|NCT00112047|54733092|FG001|Atripla Phase|Sub-optimal virological response|1|||
28079478|NCT00112047|54733091|FG000|Atripla Phase|Non-compliance|1|||
28079479|NCT00112047|54733092|FG001|Atripla Phase|Non-compliance|0|||
28079480|NCT00112047|54733091|FG000|Atripla Phase|Other|3|||
28079481|NCT00112047|54733092|FG001|Atripla Phase|Other|1|||
28079482|NCT03658876|54733105|FG000|Overall Study|Protocol Violation|3|||
28079483|NCT03658876|54733106|FG001|Overall Study|Protocol Violation|2|||
28079484|NCT03658876|54733105|FG000|Overall Study|Withdrawal by Subject|2|||
28079485|NCT03658876|54733106|FG001|Overall Study|Withdrawal by Subject|0|||
28079486|NCT03658876|54733105|FG000|Overall Study|Death|0|||
28079487|NCT03658876|54733106|FG001|Overall Study|Death|1|||
28079488|NCT03658876|54733105|FG000|Overall Study|Intercurrent illness|6|||
28079489|NCT03658876|54733106|FG001|Overall Study|Intercurrent illness|4|||
28079490|NCT03658876|54733105|FG000|Overall Study|Transplantation/other operation|1|||
28079491|NCT03658876|54733106|FG001|Overall Study|Transplantation/other operation|5|||
28079492|NCT03618628|54733112|FG000|Overall Study|Death|1|||
28079493|NCT03618628|54733112|FG000|Overall Study|Lost to Follow-up|1|||
28079494|NCT03617770|54733118|FG000|Overall Study|Lost to Follow-up|1|||
28079495|NCT03617770|54733119|FG001|Overall Study|Lost to Follow-up|0|||
28079496|NCT03616600|54733127|FG000|Overall Study|Withdrawal by Subject|1|||
28079497|NCT03616600|54733128|FG001|Overall Study|Withdrawal by Subject|0|||
28079498|NCT00380393|54733137|FG000|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6|||
28079499|NCT00380393|54733138|FG001|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5|||
28079500|NCT00380393|54733137|FG000|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0|||
28079501|NCT00380393|54733138|FG001|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1|||
28079502|NCT00380393|54733137|FG000|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37|||
28079503|NCT00380393|54733138|FG001|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29|||
28079504|NCT00380393|54733137|FG000|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
28079505|NCT00380393|54733138|FG001|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
28079506|NCT00380393|54733137|FG000|Month 8 (Cross-sectional Visit)|Others|5|||
28079507|NCT00380393|54733138|FG001|Month 8 (Cross-sectional Visit)|Others|4|||
28079508|NCT00380393|54733137|FG000|Month 14|Withdrawal by Subject|9|||
28079509|NCT00380393|54733138|FG001|Month 14|Withdrawal by Subject|7|||
28079510|NCT00380393|54733137|FG000|Month 14|Death|1|||
28079511|NCT00380393|54733138|FG001|Month 14|Death|0|||
28079512|NCT00380393|54733137|FG000|Month 14|Lost to Follow-up|0|||
28079513|NCT00380393|54733138|FG001|Month 14|Lost to Follow-up|1|||
28079514|NCT00380393|54733137|FG000|Month 14|Migrated/moved from study area|39|||
28164292|NCT01915498|54834959|FG013|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
28164293|NCT01915498|54834960|FG014|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
28164294|NCT01915498|54834961|FG015|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
28164295|NCT01915498|54834962|FG016|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
28164296|NCT01915498|54834963|FG017|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
28164297|NCT01915498|54834964|FG018|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
28164298|NCT01915498|54834946|FG000|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
28164299|NCT01915498|54834947|FG001|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
28164300|NCT01915498|54834948|FG002|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
28164301|NCT01915498|54834949|FG003|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
28164302|NCT01915498|54834950|FG004|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
28164303|NCT01915498|54834951|FG005|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
28164304|NCT01915498|54834952|FG006|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
28079515|NCT00380393|54733138|FG001|Month 14|Migrated/moved from study area|42|||
28079516|NCT00380393|54733137|FG000|Month 14|Protocol Violation|2|||
28079517|NCT00380393|54733138|FG001|Month 14|Protocol Violation|0|||
28079518|NCT00380393|54733137|FG000|Month 14|Others|6|||
28079519|NCT00380393|54733138|FG001|Month 14|Others|6|||
28079520|NCT00380081|54733150|FG000|Overall Study|Withdrawal by Subject|0|||
28079521|NCT00380081|54733151|FG001|Overall Study|Withdrawal by Subject|0|||
28164305|NCT01915498|54834953|FG007|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
28079522|NCT00380081|54733152|FG002|Overall Study|Withdrawal by Subject|0|||
28079523|NCT00380081|54733153|FG003|Overall Study|Withdrawal by Subject|0|||
28079524|NCT00380081|54733154|FG004|Overall Study|Withdrawal by Subject|1|||
28079525|NCT00380081|54733155|FG005|Overall Study|Withdrawal by Subject|0|||
28079526|NCT00380081|54733150|FG000|Overall Study|Family Emergency|0|||
28079527|NCT00380081|54733151|FG001|Overall Study|Family Emergency|0|||
28079528|NCT00380081|54733152|FG002|Overall Study|Family Emergency|0|||
28079529|NCT00380081|54733153|FG003|Overall Study|Family Emergency|0|||
28079530|NCT00380081|54733154|FG004|Overall Study|Family Emergency|0|||
28079531|NCT00380081|54733155|FG005|Overall Study|Family Emergency|1|||
28079532|NCT03579940|54733174|FG000|Period 2|Withdrawal by Subject|0|||
28079533|NCT03579940|54733175|FG001|Period 2|Withdrawal by Subject|0|||
28079534|NCT03579940|54733176|FG002|Period 2|Withdrawal by Subject|1|||
28079535|NCT03579940|54733177|FG003|Period 2|Withdrawal by Subject|0|||
28079536|NCT03579940|54733178|FG004|Period 2|Withdrawal by Subject|0|||
28079537|NCT03579940|54733179|FG005|Period 2|Withdrawal by Subject|0|||
28079538|NCT03579940|54733180|FG006|Period 2|Withdrawal by Subject|0|||
28079539|NCT03579940|54733181|FG007|Period 2|Withdrawal by Subject|0|||
28079540|NCT03579940|54733182|FG008|Period 2|Withdrawal by Subject|0|||
28079541|NCT03579940|54733183|FG009|Period 2|Withdrawal by Subject|0|||
28079542|NCT03579940|54733184|FG010|Period 2|Withdrawal by Subject|0|||
28079543|NCT00098306|54733219|FG000|Double Blind|Randomized, not treated|9|||
28079544|NCT00098306|54733220|FG001|Double Blind|Randomized, not treated|5|||
28079545|NCT00098306|54733221|FG002|Double Blind|Randomized, not treated|2|||
28079546|NCT00098306|54733222|FG003|Double Blind|Randomized, not treated|0|||
28079547|NCT00098306|54733223|FG004|Double Blind|Randomized, not treated|0|||
28079548|NCT00098306|54733224|FG005|Double Blind|Randomized, not treated|0|||
28079549|NCT00098306|54733225|FG006|Double Blind|Randomized, not treated|0|||
28079550|NCT00098306|54733219|FG000|Double Blind|Ongoing at cut-off date|151|||
28079551|NCT00098306|54733220|FG001|Double Blind|Ongoing at cut-off date|166|||
28079552|NCT00098306|54733221|FG002|Double Blind|Ongoing at cut-off date|72|||
28079553|NCT00098306|54733222|FG003|Double Blind|Ongoing at cut-off date|0|||
28079554|NCT00098306|54733223|FG004|Double Blind|Ongoing at cut-off date|0|||
28079555|NCT00098306|54733224|FG005|Double Blind|Ongoing at cut-off date|0|||
28079556|NCT00098306|54733225|FG006|Double Blind|Ongoing at cut-off date|0|||
28079557|NCT00098306|54733219|FG000|Double Blind|Adverse Event|11|||
28079558|NCT00098306|54733220|FG001|Double Blind|Adverse Event|10|||
28079559|NCT00098306|54733221|FG002|Double Blind|Adverse Event|6|||
28079560|NCT00098306|54733222|FG003|Double Blind|Adverse Event|0|||
28079561|NCT00098306|54733223|FG004|Double Blind|Adverse Event|0|||
28079562|NCT00098306|54733224|FG005|Double Blind|Adverse Event|0|||
28079563|NCT00098306|54733225|FG006|Double Blind|Adverse Event|0|||
28079564|NCT00098306|54733219|FG000|Double Blind|Lack of Efficacy|43|||
28079565|NCT00098306|54733220|FG001|Double Blind|Lack of Efficacy|34|||
28079566|NCT00098306|54733221|FG002|Double Blind|Lack of Efficacy|17|||
28079567|NCT00098306|54733222|FG003|Double Blind|Lack of Efficacy|0|||
28079568|NCT00098306|54733223|FG004|Double Blind|Lack of Efficacy|0|||
28079569|NCT00098306|54733224|FG005|Double Blind|Lack of Efficacy|0|||
28079570|NCT00098306|54733225|FG006|Double Blind|Lack of Efficacy|0|||
28079571|NCT00098306|54733219|FG000|Double Blind|Death|1|||
28079572|NCT00098306|54733220|FG001|Double Blind|Death|4|||
28079573|NCT00098306|54733221|FG002|Double Blind|Death|1|||
28079574|NCT00098306|54733222|FG003|Double Blind|Death|0|||
28079575|NCT00098306|54733223|FG004|Double Blind|Death|0|||
28079576|NCT00098306|54733224|FG005|Double Blind|Death|0|||
28079577|NCT00098306|54733225|FG006|Double Blind|Death|0|||
28079578|NCT00098306|54733219|FG000|Double Blind|Participant defaulted|19|||
28079579|NCT00098306|54733220|FG001|Double Blind|Participant defaulted|18|||
28079580|NCT00098306|54733221|FG002|Double Blind|Participant defaulted|11|||
28079581|NCT00098306|54733222|FG003|Double Blind|Participant defaulted|0|||
28079582|NCT00098306|54733223|FG004|Double Blind|Participant defaulted|0|||
28079583|NCT00098306|54733224|FG005|Double Blind|Participant defaulted|0|||
28079584|NCT00098306|54733225|FG006|Double Blind|Participant defaulted|0|||
28079585|NCT00098306|54733219|FG000|Double Blind|Un-specified|7|||
28079586|NCT00098306|54733220|FG001|Double Blind|Un-specified|3|||
28079587|NCT00098306|54733221|FG002|Double Blind|Un-specified|11|||
28079588|NCT00098306|54733222|FG003|Double Blind|Un-specified|0|||
28079589|NCT00098306|54733223|FG004|Double Blind|Un-specified|0|||
28079590|NCT00098306|54733224|FG005|Double Blind|Un-specified|0|||
28079591|NCT00098306|54733225|FG006|Double Blind|Un-specified|0|||
28079592|NCT00098306|54733219|FG000|Open Label|Lack of Efficacy|0|||
28079593|NCT00098306|54733220|FG001|Open Label|Lack of Efficacy|0|||
28079594|NCT00098306|54733221|FG002|Open Label|Lack of Efficacy|0|||
28079595|NCT00098306|54733222|FG003|Open Label|Lack of Efficacy|13|||
28079596|NCT00098306|54733223|FG004|Open Label|Lack of Efficacy|0|||
28079597|NCT00098306|54733224|FG005|Open Label|Lack of Efficacy|0|||
28079598|NCT00098306|54733225|FG006|Open Label|Lack of Efficacy|0|||
28079599|NCT00098306|54733219|FG000|Open Label|Adverse Event|0|||
28079600|NCT00098306|54733220|FG001|Open Label|Adverse Event|0|||
28079601|NCT00098306|54733221|FG002|Open Label|Adverse Event|0|||
28079602|NCT00098306|54733222|FG003|Open Label|Adverse Event|2|||
28079603|NCT00098306|54733223|FG004|Open Label|Adverse Event|0|||
28079604|NCT00098306|54733224|FG005|Open Label|Adverse Event|0|||
28079605|NCT00098306|54733225|FG006|Open Label|Adverse Event|0|||
28079606|NCT00098306|54733219|FG000|Open Label|Death|0|||
28079607|NCT00098306|54733220|FG001|Open Label|Death|0|||
28079608|NCT00098306|54733221|FG002|Open Label|Death|0|||
28079609|NCT00098306|54733222|FG003|Open Label|Death|4|||
28079610|NCT00098306|54733223|FG004|Open Label|Death|0|||
27831664|NCT02859558|54310312|FG000|Step 1|Did Not Return to Clinic|2|||
27831665|NCT02859558|54310313|FG001|Step 1|Did Not Return to Clinic|3|||
27831666|NCT02859558|54310314|FG002|Step 1|Did Not Return to Clinic|4|||
27831667|NCT02859558|54310315|FG003|Step 1|Did Not Return to Clinic|0|||
27831668|NCT02859558|54310316|FG004|Step 1|Did Not Return to Clinic|0|||
27831669|NCT02859558|54310312|FG000|Step 1|Moved|0|||
27831670|NCT02859558|54310313|FG001|Step 1|Moved|1|||
27831671|NCT02859558|54310314|FG002|Step 1|Moved|1|||
27831672|NCT02859558|54310315|FG003|Step 1|Moved|0|||
27831673|NCT02859558|54310316|FG004|Step 1|Moved|0|||
27853025|NCT01435460|54361617|FG001|Overall Study|Withdrawal by Subject|3|||
27853026|NCT01435460|54361616|FG000|Overall Study|Protocol Violation|0|||
28079611|NCT00098306|54733224|FG005|Open Label|Death|0|||
28079612|NCT00098306|54733225|FG006|Open Label|Death|0|||
28079613|NCT00098306|54733219|FG000|Open Label|Participant defaulted|0|||
28079614|NCT00098306|54733220|FG001|Open Label|Participant defaulted|0|||
28079615|NCT00098306|54733221|FG002|Open Label|Participant defaulted|0|||
28079616|NCT00098306|54733222|FG003|Open Label|Participant defaulted|24|||
28079617|NCT00098306|54733223|FG004|Open Label|Participant defaulted|0|||
28079618|NCT00098306|54733224|FG005|Open Label|Participant defaulted|0|||
28079619|NCT00098306|54733225|FG006|Open Label|Participant defaulted|0|||
28079620|NCT00098306|54733219|FG000|Open Label|Un-specified|0|||
28079621|NCT00098306|54733220|FG001|Open Label|Un-specified|0|||
28079622|NCT00098306|54733221|FG002|Open Label|Un-specified|0|||
28079623|NCT00098306|54733222|FG003|Open Label|Un-specified|15|||
28079624|NCT00098306|54733223|FG004|Open Label|Un-specified|0|||
28079625|NCT00098306|54733224|FG005|Open Label|Un-specified|0|||
28079626|NCT00098306|54733225|FG006|Open Label|Un-specified|0|||
28079627|NCT00098306|54733219|FG000|Open Label|Ongoing at cut-off date|0|||
28079628|NCT00098306|54733220|FG001|Open Label|Ongoing at cut-off date|0|||
28079629|NCT00098306|54733221|FG002|Open Label|Ongoing at cut-off date|0|||
28079630|NCT00098306|54733222|FG003|Open Label|Ongoing at cut-off date|269|||
28079631|NCT00098306|54733223|FG004|Open Label|Ongoing at cut-off date|62|||
28079632|NCT00098306|54733224|FG005|Open Label|Ongoing at cut-off date|0|||
28079633|NCT00098306|54733225|FG006|Open Label|Ongoing at cut-off date|0|||
28079634|NCT00098306|54733219|FG000|Observational Phase|Death|0|||
28079635|NCT00098306|54733220|FG001|Observational Phase|Death|0|||
28079636|NCT00098306|54733221|FG002|Observational Phase|Death|0|||
28079637|NCT00098306|54733222|FG003|Observational Phase|Death|0|||
28079638|NCT00098306|54733223|FG004|Observational Phase|Death|0|||
28079639|NCT00098306|54733224|FG005|Observational Phase|Death|5|||
28079640|NCT00098306|54733225|FG006|Observational Phase|Death|4|||
28079641|NCT00098306|54733219|FG000|Observational Phase|Participant defaulted|0|||
28079642|NCT00098306|54733220|FG001|Observational Phase|Participant defaulted|0|||
28079643|NCT00098306|54733221|FG002|Observational Phase|Participant defaulted|0|||
28079644|NCT00098306|54733222|FG003|Observational Phase|Participant defaulted|0|||
28079645|NCT00098306|54733223|FG004|Observational Phase|Participant defaulted|0|||
28079646|NCT00098306|54733224|FG005|Observational Phase|Participant defaulted|34|||
28079647|NCT00098306|54733225|FG006|Observational Phase|Participant defaulted|18|||
28079648|NCT00098306|54733219|FG000|Observational Phase|Un-specified|0|||
28079649|NCT00098306|54733220|FG001|Observational Phase|Un-specified|0|||
28079650|NCT00098306|54733221|FG002|Observational Phase|Un-specified|0|||
28079651|NCT00098306|54733222|FG003|Observational Phase|Un-specified|0|||
28079652|NCT00098306|54733223|FG004|Observational Phase|Un-specified|0|||
28079653|NCT00098306|54733224|FG005|Observational Phase|Un-specified|7|||
28079654|NCT00098306|54733225|FG006|Observational Phase|Un-specified|4|||
28079655|NCT03615040|54733240|FG000|Overall Study|Withdrawal by Subject|2|||
28079656|NCT03615040|54733241|FG001|Overall Study|Withdrawal by Subject|1|||
28079657|NCT03615040|54733240|FG000|Overall Study|Physician Decision|2|||
27853027|NCT01435460|54361617|FG001|Overall Study|Protocol Violation|1|||
28079658|NCT03615040|54733241|FG001|Overall Study|Physician Decision|2|||
28079659|NCT03615040|54733240|FG000|Overall Study|Clinical diagnosis of lung cancer|1|||
28079660|NCT03615040|54733241|FG001|Overall Study|Clinical diagnosis of lung cancer|0|||
28079661|NCT03615040|54733240|FG000|Overall Study|Clinical diagnosis of oesophageal cancer|1|||
28079662|NCT03615040|54733241|FG001|Overall Study|Clinical diagnosis of oesophageal cancer|0|||
28079663|NCT03615040|54733240|FG000|Overall Study|Death|0|||
28079664|NCT03615040|54733241|FG001|Overall Study|Death|2|||
28079665|NCT00068822|54733249|FG000|First Randomized Intervention|Lost to Follow-up|1|||
27831674|NCT02859558|54310312|FG000|Step 1|Withdrawal By Participant|1|||
27831675|NCT02859558|54310313|FG001|Step 1|Withdrawal By Participant|2|||
27831676|NCT02859558|54310314|FG002|Step 1|Withdrawal By Participant|1|||
27831677|NCT02859558|54310315|FG003|Step 1|Withdrawal By Participant|0|||
28079666|NCT00068822|54733250|FG001|First Randomized Intervention|Lost to Follow-up|2|||
28079667|NCT00068588|54733259|FG000|Overall Study|Adverse Event|0|||
28079668|NCT00068588|54733260|FG001|Overall Study|Adverse Event|0|||
28079669|NCT00068588|54733261|FG002|Overall Study|Adverse Event|2|||
28079670|NCT00068588|54733259|FG000|Overall Study|Withdrawal by Subject|0|||
28079671|NCT00068588|54733260|FG001|Overall Study|Withdrawal by Subject|0|||
28079672|NCT00068588|54733261|FG002|Overall Study|Withdrawal by Subject|1|||
28079673|NCT00068588|54733259|FG000|Overall Study|Poor KPS|0|||
28079674|NCT00068588|54733260|FG001|Overall Study|Poor KPS|0|||
28079675|NCT00068588|54733261|FG002|Overall Study|Poor KPS|1|||
28079676|NCT03650452|54733270|FG000|Overall Study|Physician Decision|1|||
28079677|NCT03650452|54733271|FG001|Overall Study|Physician Decision|0|||
28079678|NCT03650452|54733270|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
28079679|NCT03650452|54733271|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
28079680|NCT03650452|54733270|FG000|Overall Study|Adverse Event|3|||
28079681|NCT03650452|54733271|FG001|Overall Study|Adverse Event|4|||
28079682|NCT03650452|54733270|FG000|Overall Study|Early Withdrawal from Study Treatment|3|||
28079683|NCT03650452|54733271|FG001|Overall Study|Early Withdrawal from Study Treatment|0|||
28079684|NCT03575806|54733279|FG000|Overall Study|Withdrawal by Subject|0|||
28079685|NCT03575806|54733280|FG001|Overall Study|Withdrawal by Subject|2|||
28079686|NCT03575806|54733279|FG000|Overall Study|Protocol Violation|0|||
28079687|NCT03575806|54733280|FG001|Overall Study|Protocol Violation|2|||
28079688|NCT03610048|54733286|FG000|Overall Study|Study terminated by sponsor|84|||
28079689|NCT03610048|54733286|FG000|Overall Study|Adverse Event|32|||
28079690|NCT03610048|54733286|FG000|Overall Study|Withdrawal by Subject|31|||
28079691|NCT03610048|54733286|FG000|Overall Study|Lost to Follow-up|8|||
28079692|NCT03610048|54733286|FG000|Overall Study|Other|4|||
28079693|NCT03610048|54733286|FG000|Overall Study|Physician Decision|1|||
28079694|NCT03610048|54733286|FG000|Overall Study|Pregnancy|1|||
28079695|NCT03608254|54733290|FG000|Overall Study|Blood sampling was not completed for 2 participants.|2|||
28079696|NCT03608254|54733290|FG000|Overall Study|One participant chose not to consume the entire 12-ounce dose of watermelon juice.|1|||
28079697|NCT03606460|54733296|FG000|Overall Study|Lost to Follow-up|1|||
28079698|NCT03606460|54733297|FG001|Overall Study|Lost to Follow-up|8|||
28079699|NCT03605836|54733308|FG000|OL Placebo Run-in Period [1 Week]|Adverse Event|2|||
28079700|NCT03605836|54733309|FG001|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
28079701|NCT03605836|54733310|FG002|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
28079702|NCT03605836|54733311|FG003|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
28079703|NCT03605836|54733308|FG000|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|2|||
28079704|NCT03605836|54733309|FG001|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
28079705|NCT03605836|54733310|FG002|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
28079706|NCT03605836|54733311|FG003|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
28079707|NCT03605836|54733308|FG000|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|8|||
28079708|NCT03605836|54733309|FG001|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
28079709|NCT03605836|54733310|FG002|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
28079710|NCT03605836|54733311|FG003|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
28079711|NCT03605836|54733308|FG000|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|4|||
28079712|NCT03605836|54733309|FG001|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
28079713|NCT03605836|54733310|FG002|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
28079714|NCT03605836|54733311|FG003|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
28079715|NCT03605836|54733308|FG000|OL Placebo Run-in Period [1 Week]|Protocol Deviation|4|||
28079716|NCT03605836|54733309|FG001|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
28079717|NCT03605836|54733310|FG002|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
28079718|NCT03605836|54733311|FG003|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
28079719|NCT03605836|54733308|FG000|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|17|||
28079720|NCT03605836|54733309|FG001|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
28079721|NCT03605836|54733310|FG002|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
28079722|NCT03605836|54733311|FG003|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
28079723|NCT03605836|54733308|FG000|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|5|||
28079724|NCT03605836|54733309|FG001|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
28164306|NCT01915498|54834954|FG008|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
28164307|NCT01915498|54834955|FG009|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
28164308|NCT01915498|54834956|FG010|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
28164309|NCT01915498|54834957|FG011|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
28164310|NCT01915498|54834958|FG012|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
28164311|NCT01915498|54834959|FG013|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
28079725|NCT03605836|54733310|FG002|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
28079726|NCT03605836|54733311|FG003|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
27853028|NCT01435460|54361616|FG000|Overall Study|Did not meet eligibility criteria|2|||
28079727|NCT03605836|54733308|FG000|OL Placebo Run-in Period [1 Week]|Physician Decision|7|||
28079728|NCT03605836|54733309|FG001|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
28079729|NCT03605836|54733310|FG002|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
28164312|NCT01915498|54834960|FG014|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
28079730|NCT03605836|54733311|FG003|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
28079731|NCT03605836|54733308|FG000|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|85|||
28079732|NCT03605836|54733309|FG001|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
28079733|NCT03605836|54733310|FG002|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
28079734|NCT03605836|54733311|FG003|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
28079735|NCT03605836|54733308|FG000|OL Placebo Run-in Period [1 Week]|COVID-19 Related|15|||
28079736|NCT03605836|54733309|FG001|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
28079737|NCT03605836|54733310|FG002|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
28079738|NCT03605836|54733311|FG003|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
28079739|NCT03605836|54733308|FG000|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|1|||
28079740|NCT03605836|54733309|FG001|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
28079741|NCT03605836|54733310|FG002|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
28079742|NCT03605836|54733311|FG003|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
28079743|NCT03605836|54733308|FG000|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|0|||
28079744|NCT03605836|54733309|FG001|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|2|||
28079745|NCT03605836|54733310|FG002|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
28079746|NCT03605836|54733311|FG003|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
28079747|NCT03605836|54733308|FG000|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
28079748|NCT03605836|54733309|FG001|Double-blind Treatment Period [6 Weeks]|Adverse Event|5|||
28079749|NCT03605836|54733310|FG002|Double-blind Treatment Period [6 Weeks]|Adverse Event|8|||
28079750|NCT03605836|54733311|FG003|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
28079751|NCT03605836|54733308|FG000|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
28079752|NCT03605836|54733309|FG001|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
28079753|NCT03605836|54733310|FG002|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|2|||
28079754|NCT03605836|54733311|FG003|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|1|||
28079755|NCT03605836|54733308|FG000|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|0|||
28079756|NCT03605836|54733309|FG001|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|3|||
28079757|NCT03605836|54733310|FG002|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|5|||
28079758|NCT03605836|54733311|FG003|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|1|||
28079759|NCT03605836|54733308|FG000|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
28079760|NCT03605836|54733309|FG001|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|1|||
28079761|NCT03605836|54733310|FG002|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
28079762|NCT03605836|54733311|FG003|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|4|||
28079763|NCT03605836|54733308|FG000|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
28079764|NCT03605836|54733309|FG001|Double-blind Treatment Period [6 Weeks]|Pregnancy|1|||
28079765|NCT03605836|54733310|FG002|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
28079766|NCT03605836|54733311|FG003|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
28079767|NCT03605836|54733308|FG000|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|0|||
28079768|NCT03605836|54733309|FG001|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|5|||
28079769|NCT03605836|54733310|FG002|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
28079770|NCT03605836|54733311|FG003|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
28079771|NCT03605836|54733308|FG000|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|0|||
28079772|NCT03605836|54733309|FG001|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|10|||
28079773|NCT03605836|54733310|FG002|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|6|||
28079774|NCT03605836|54733311|FG003|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|4|||
28079775|NCT03605836|54733308|FG000|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
28079776|NCT03605836|54733309|FG001|Double-blind Treatment Period [6 Weeks]|Physician Decision|3|||
28079777|NCT03605836|54733310|FG002|Double-blind Treatment Period [6 Weeks]|Physician Decision|1|||
28079778|NCT03605836|54733311|FG003|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
28079779|NCT03605836|54733308|FG000|Double-blind Treatment Period [6 Weeks]|Reason not Specified|0|||
28079780|NCT03605836|54733309|FG001|Double-blind Treatment Period [6 Weeks]|Reason not Specified|6|||
28079781|NCT03605836|54733310|FG002|Double-blind Treatment Period [6 Weeks]|Reason not Specified|16|||
28079782|NCT03605836|54733311|FG003|Double-blind Treatment Period [6 Weeks]|Reason not Specified|7|||
28079783|NCT03605836|54733308|FG000|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
28079784|NCT03605836|54733309|FG001|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
28079785|NCT03605836|54733310|FG002|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|2|||
28079786|NCT03605836|54733311|FG003|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|1|||
28164313|NCT01915498|54834961|FG015|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
28164314|NCT01915498|54834962|FG016|Main Analysis (Sept 2013 - Sept 2017)|Death|3|||
28164315|NCT01915498|54834963|FG017|Main Analysis (Sept 2013 - Sept 2017)|Death|16|||
28164316|NCT01915498|54834964|FG018|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
28164317|NCT01915498|54834946|FG000|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
28164318|NCT01915498|54834947|FG001|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
28164319|NCT01915498|54834948|FG002|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
28164320|NCT01915498|54834949|FG003|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
28079787|NCT03605680|54733324|FG000|SB Placebo Run-in Period (1 Week)|Adverse Event|6|||
28079788|NCT03605680|54733325|FG001|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
28079789|NCT03605680|54733326|FG002|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
28079790|NCT03605680|54733327|FG003|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
28079791|NCT03605680|54733324|FG000|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|1|||
28079792|NCT03605680|54733325|FG001|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
28164321|NCT01915498|54834950|FG004|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
28164322|NCT01915498|54834951|FG005|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
28164323|NCT01915498|54834952|FG006|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
28164324|NCT01915498|54834953|FG007|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
28164325|NCT01915498|54834954|FG008|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
28164326|NCT01915498|54834955|FG009|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
28164327|NCT01915498|54834956|FG010|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
28164328|NCT01915498|54834957|FG011|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
28164329|NCT01915498|54834958|FG012|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
28164330|NCT01915498|54834959|FG013|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
28164331|NCT01915498|54834960|FG014|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
28164332|NCT01915498|54834961|FG015|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
28164333|NCT01915498|54834962|FG016|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
28164334|NCT01915498|54834963|FG017|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
28164335|NCT01915498|54834964|FG018|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
28164336|NCT01915498|54834946|FG000|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
28164337|NCT01915498|54834947|FG001|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
28164338|NCT01915498|54834948|FG002|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2|||
28164339|NCT01915498|54834949|FG003|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
28164340|NCT01915498|54834950|FG004|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
28164341|NCT01915498|54834951|FG005|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
28164342|NCT01915498|54834952|FG006|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
28164343|NCT01915498|54834953|FG007|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
28164344|NCT01915498|54834954|FG008|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
28164345|NCT01915498|54834955|FG009|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
28164346|NCT01915498|54834956|FG010|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
28164347|NCT01915498|54834957|FG011|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
28164348|NCT01915498|54834958|FG012|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
28164349|NCT01915498|54834959|FG013|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
28164350|NCT01915498|54834960|FG014|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
28164351|NCT01915498|54834961|FG015|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
28164352|NCT01915498|54834962|FG016|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4|||
28164353|NCT01915498|54834963|FG017|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8|||
28164354|NCT01915498|54834964|FG018|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
28164355|NCT01915498|54834946|FG000|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
28164356|NCT01915498|54834947|FG001|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
28164357|NCT01915498|54834948|FG002|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
28164358|NCT01915498|54834949|FG003|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
28164359|NCT01915498|54834950|FG004|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
28164360|NCT01915498|54834951|FG005|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
28164361|NCT01915498|54834952|FG006|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
28164362|NCT01915498|54834953|FG007|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
28164363|NCT01915498|54834954|FG008|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
28164364|NCT01915498|54834955|FG009|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
28164365|NCT01915498|54834956|FG010|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
28164366|NCT01915498|54834957|FG011|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
28164367|NCT01915498|54834958|FG012|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
28164368|NCT01915498|54834959|FG013|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6|||
27831678|NCT02859558|54310316|FG004|Step 1|Withdrawal By Participant|0|||
28079793|NCT03605680|54733326|FG002|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
28079794|NCT03605680|54733327|FG003|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
28079795|NCT03605680|54733324|FG000|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|9|||
28079796|NCT03605680|54733325|FG001|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
27831679|NCT02859558|54310312|FG000|Step 1|Had to Interrupt antiretroviral (ARV)|1|||
27831680|NCT02859558|54310313|FG001|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
28079797|NCT03605680|54733326|FG002|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
28079798|NCT03605680|54733327|FG003|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
28079799|NCT03605680|54733324|FG000|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|3|||
28079800|NCT03605680|54733325|FG001|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
28079801|NCT03605680|54733326|FG002|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
28164369|NCT01915498|54834960|FG014|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5|||
28164370|NCT01915498|54834961|FG015|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
27831681|NCT02859558|54310314|FG002|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
28079802|NCT03605680|54733327|FG003|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
28079803|NCT03605680|54733324|FG000|SB Placebo Run-in Period (1 Week)|Protocol Deviation|13|||
28079804|NCT03605680|54733325|FG001|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
28079805|NCT03605680|54733326|FG002|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
28079806|NCT03605680|54733327|FG003|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
28079807|NCT03605680|54733324|FG000|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|12|||
28079808|NCT03605680|54733325|FG001|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
28079809|NCT03605680|54733326|FG002|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
28079810|NCT03605680|54733327|FG003|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
28079811|NCT03605680|54733324|FG000|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|1|||
28079812|NCT03605680|54733325|FG001|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
28079813|NCT03605680|54733326|FG002|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
28079814|NCT03605680|54733327|FG003|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
28079815|NCT03605680|54733324|FG000|SB Placebo Run-in Period (1 Week)|Physician Decision|6|||
28079816|NCT03605680|54733325|FG001|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
28079817|NCT03605680|54733326|FG002|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
28079818|NCT03605680|54733327|FG003|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
28079819|NCT03605680|54733324|FG000|SB Placebo Run-in Period (1 Week)|Reason not Specified|87|||
28079820|NCT03605680|54733325|FG001|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
28079821|NCT03605680|54733326|FG002|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
28079822|NCT03605680|54733327|FG003|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
28079823|NCT03605680|54733324|FG000|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|0|||
28079824|NCT03605680|54733325|FG001|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|5|||
28079825|NCT03605680|54733326|FG002|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|7|||
28079826|NCT03605680|54733327|FG003|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|8|||
28079827|NCT03605680|54733324|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|0|||
28079828|NCT03605680|54733325|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
28079829|NCT03605680|54733326|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
28079830|NCT03605680|54733327|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
28079831|NCT03605680|54733324|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
28079832|NCT03605680|54733325|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
28079833|NCT03605680|54733326|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
28079834|NCT03605680|54733327|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
28079835|NCT03605680|54733324|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
28079836|NCT03605680|54733325|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
28079837|NCT03605680|54733326|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|4|||
28079838|NCT03605680|54733327|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
28079839|NCT03605680|54733324|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|0|||
28079840|NCT03605680|54733325|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|3|||
28079841|NCT03605680|54733326|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|1|||
28079842|NCT03605680|54733327|FG003|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|2|||
28079843|NCT03605680|54733324|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
28079844|NCT03605680|54733325|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|14|||
28079845|NCT03605680|54733326|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|7|||
28079846|NCT03605680|54733327|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|5|||
28079847|NCT03605680|54733324|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|0|||
28079848|NCT03605680|54733325|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
28079849|NCT03605680|54733326|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
28079850|NCT03605680|54733327|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|7|||
28079851|NCT03605680|54733324|FG000|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
28079852|NCT03605680|54733325|FG001|Double-blind Treatment Period (6 Weeks)|Physician Decision|1|||
28079853|NCT03605680|54733326|FG002|Double-blind Treatment Period (6 Weeks)|Physician Decision|2|||
27831682|NCT02859558|54310315|FG003|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
27831683|NCT02859558|54310316|FG004|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
28079854|NCT03605680|54733327|FG003|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
28079855|NCT03605680|54733324|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
28079856|NCT03605680|54733325|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|5|||
28079857|NCT03605680|54733326|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|4|||
28079858|NCT03605680|54733327|FG003|Double-blind Treatment Period (6 Weeks)|Reason not Specified|3|||
28079859|NCT03605680|54733324|FG000|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|0|||
28079860|NCT03605680|54733325|FG001|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|1|||
28079861|NCT03605680|54733326|FG002|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|2|||
28079862|NCT03605680|54733327|FG003|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|3|||
28079863|NCT03572218|54733338|FG000|Overall Study|Lost to Follow-up|3|||
28079864|NCT03572218|54733339|FG001|Overall Study|Lost to Follow-up|2|||
28079865|NCT03572218|54733338|FG000|Overall Study|No longer available for study visits|2|||
28079866|NCT03572218|54733339|FG001|Overall Study|No longer available for study visits|1|||
28079867|NCT03572218|54733338|FG000|Overall Study|No longer interested|1|||
28079868|NCT03572218|54733339|FG001|Overall Study|No longer interested|2|||
28079869|NCT00111813|54733345|FG000|Overall Study|Adverse Event|1|||
28079870|NCT00111813|54733346|FG001|Overall Study|Adverse Event|2|||
28079871|NCT00111813|54733347|FG002|Overall Study|Adverse Event|4|||
28079872|NCT00111813|54733348|FG003|Overall Study|Adverse Event|2|||
28079873|NCT00111813|54733349|FG004|Overall Study|Adverse Event|2|||
28164371|NCT01915498|54834962|FG016|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
28164372|NCT01915498|54834963|FG017|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9|||
28164373|NCT01915498|54834964|FG018|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
28164374|NCT01915498|54834946|FG000|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
28079874|NCT00111813|54733350|FG005|Overall Study|Adverse Event|2|||
28079875|NCT00111813|54733345|FG000|Overall Study|Progressive disease|2|||
28079876|NCT00111813|54733346|FG001|Overall Study|Progressive disease|1|||
28079877|NCT00111813|54733347|FG002|Overall Study|Progressive disease|5|||
28079878|NCT00111813|54733348|FG003|Overall Study|Progressive disease|3|||
28079879|NCT00111813|54733349|FG004|Overall Study|Progressive disease|4|||
28079880|NCT00111813|54733350|FG005|Overall Study|Progressive disease|3|||
28079881|NCT00111813|54733345|FG000|Overall Study|Lack of Efficacy|0|||
28079882|NCT00111813|54733346|FG001|Overall Study|Lack of Efficacy|0|||
28079883|NCT00111813|54733347|FG002|Overall Study|Lack of Efficacy|0|||
28079884|NCT00111813|54733348|FG003|Overall Study|Lack of Efficacy|0|||
28079885|NCT00111813|54733349|FG004|Overall Study|Lack of Efficacy|0|||
28079886|NCT00111813|54733350|FG005|Overall Study|Lack of Efficacy|1|||
28079887|NCT00111813|54733345|FG000|Overall Study|Other|0|||
28079888|NCT00111813|54733346|FG001|Overall Study|Other|0|||
28079889|NCT00111813|54733347|FG002|Overall Study|Other|1|||
28079890|NCT00111813|54733348|FG003|Overall Study|Other|0|||
28079891|NCT00111813|54733349|FG004|Overall Study|Other|0|||
28079892|NCT00111813|54733350|FG005|Overall Study|Other|0|||
28079893|NCT00118287|54733365|FG000|Overall Study|Intracranial haemorrhage|1|||
28079894|NCT00118287|54733365|FG000|Overall Study|Muscle pain|1|||
28079895|NCT00130689|54733369|FG000|Overall Study|Progressive Disease|29|||
28079896|NCT00130689|54733369|FG000|Overall Study|Death|1|||
28079897|NCT00130689|54733369|FG000|Overall Study|Clinical Deterioration|4|||
28079898|NCT00130689|54733369|FG000|Overall Study|Withdrawal by Subject|3|||
28164375|NCT01915498|54834947|FG001|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
28164376|NCT01915498|54834948|FG002|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
27731158|NCT02341456|54178347|FG002|Overall Study|Disease progression|1|||
27731159|NCT02341456|54178345|FG000|Overall Study|Death|1|||
27731160|NCT02341456|54178346|FG001|Overall Study|Death|1|||
27731161|NCT02341456|54178347|FG002|Overall Study|Death|1|||
27731162|NCT02341456|54178345|FG000|Overall Study|Withdrawal by Subject|0|||
28079899|NCT00130689|54733369|FG000|Overall Study|Ineligible|6|||
28079900|NCT03605212|54733378|FG000|Treatment Period|Adverse Event|1|||
28164377|NCT01915498|54834949|FG003|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
28164378|NCT01915498|54834950|FG004|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
28164379|NCT01915498|54834951|FG005|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
28164380|NCT01915498|54834952|FG006|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
28164381|NCT01915498|54834953|FG007|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
27731163|NCT02341456|54178346|FG001|Overall Study|Withdrawal by Subject|1|||
27731164|NCT02341456|54178347|FG002|Overall Study|Withdrawal by Subject|1|||
28079901|NCT03605212|54733379|FG001|Treatment Period|Adverse Event|0|||
28079902|NCT03605212|54733380|FG002|Treatment Period|Adverse Event|0|||
28079903|NCT03605212|54733381|FG003|Treatment Period|Adverse Event|0|||
28079904|NCT03605212|54733382|FG004|Treatment Period|Adverse Event|0|||
28079905|NCT03605212|54733378|FG000|Treatment Period|Physician Decision|0|||
28079906|NCT03605212|54733379|FG001|Treatment Period|Physician Decision|0|||
28079907|NCT03605212|54733380|FG002|Treatment Period|Physician Decision|0|||
28079908|NCT03605212|54733381|FG003|Treatment Period|Physician Decision|0|||
27943880|NCT00927472|54600959|FG001|Overall Study|Withdrawal by Subject|11|||
27943881|NCT00927472|54600958|FG000|Overall Study|Lost to Follow-up|1|||
27943882|NCT00927472|54600959|FG001|Overall Study|Lost to Follow-up|6|||
27943883|NCT00927472|54600958|FG000|Overall Study|Protocol Violation|0|||
27943884|NCT00927472|54600959|FG001|Overall Study|Protocol Violation|1|||
27943885|NCT00927472|54600958|FG000|Overall Study|Post treatment Assessment out of window|0|||
27943886|NCT00927472|54600959|FG001|Overall Study|Post treatment Assessment out of window|4|||
27943887|NCT00927394|54600967|FG000|Overall Study|Adverse Event|14|||
27943888|NCT00927394|54600968|FG001|Overall Study|Adverse Event|9|||
27943889|NCT00927394|54600967|FG000|Overall Study|Unsatisfactory therapeutic effect|17|||
27943890|NCT00927394|54600968|FG001|Overall Study|Unsatisfactory therapeutic effect|23|||
27943891|NCT00927394|54600967|FG000|Overall Study|Withdrawal by Subject|20|||
27943892|NCT00927394|54600968|FG001|Overall Study|Withdrawal by Subject|24|||
27943893|NCT00927394|54600967|FG000|Overall Study|Lost to Follow-up|8|||
27943894|NCT00927394|54600968|FG001|Overall Study|Lost to Follow-up|14|||
27943895|NCT00927394|54600967|FG000|Overall Study|Administrative Problem|1|||
27943896|NCT00927394|54600968|FG001|Overall Study|Administrative Problem|0|||
27943897|NCT00927394|54600967|FG000|Overall Study|Death|1|||
27943898|NCT00927394|54600968|FG001|Overall Study|Death|1|||
27943899|NCT00927394|54600967|FG000|Overall Study|Protocol deviation|16|||
27943900|NCT00927394|54600968|FG001|Overall Study|Protocol deviation|13|||
27943901|NCT00927394|54600967|FG000|Overall Study|Randomized in error|0|||
27943902|NCT00927394|54600968|FG001|Overall Study|Randomized in error|1|||
27943903|NCT00976911|54600977|FG000|Overall Study|Withdrawal by Subject|4|||
27943904|NCT00976911|54600978|FG001|Overall Study|Withdrawal by Subject|6|||
27943905|NCT00976911|54600977|FG000|Overall Study|Death|138|||
27943906|NCT00976911|54600978|FG001|Overall Study|Death|126|||
27943907|NCT00976911|54600977|FG000|Overall Study|Adverse Event|0|||
27943908|NCT00976911|54600978|FG001|Overall Study|Adverse Event|1|||
27943909|NCT00976911|54600977|FG000|Overall Study|Protocol Violation|2|||
27943910|NCT00976911|54600978|FG001|Overall Study|Protocol Violation|0|||
27943911|NCT00976911|54600977|FG000|Overall Study|Other|8|||
27943912|NCT00976911|54600978|FG001|Overall Study|Other|9|||
27943913|NCT00976911|54600977|FG000|Overall Study|In Follow-Up as of 25 Jan 2013|30|||
27943914|NCT00976911|54600978|FG001|Overall Study|In Follow-Up as of 25 Jan 2013|37|||
27943915|NCT00934648|54600984|FG000|Overall Study|Failure to return|8|||
27943916|NCT00934648|54600984|FG000|Overall Study|Withdrawal by Subject|1|||
27943917|NCT01175213|54600992|FG000|IGSC, 10%/rHuPH20|Withdrawal by Subject|4|||
27943918|NCT01175213|54600993|FG001|IGSC, 10%/rHuPH20|Withdrawal by Subject|0|||
27943919|NCT01175213|54600992|FG000|IGSC, 10%/rHuPH20|Death|1|||
27943920|NCT01175213|54600993|FG001|IGSC, 10%/rHuPH20|Death|0|||
27943921|NCT01175213|54600992|FG000|IGSC, 10%/rHuPH20|bone marrow transplant|1|||
27943922|NCT01175213|54600993|FG001|IGSC, 10%/rHuPH20|bone marrow transplant|0|||
27943923|NCT01175213|54600992|FG000|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6|||
27943924|NCT01175213|54600993|FG001|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0|||
27943925|NCT01175213|54600992|FG000|IGSC, 10%/rHuPH20|site elected to exit study|3|||
27943926|NCT01175213|54600993|FG001|IGSC, 10%/rHuPH20|site elected to exit study|0|||
27943927|NCT01175213|54600992|FG000|Safety Follow-up|Adverse Event|1|||
27943928|NCT01175213|54600993|FG001|Safety Follow-up|Adverse Event|0|||
27943929|NCT00974259|54601004|FG000|Overall Study|Technically inadequate PbtO2 recordings|2|||
27943930|NCT00974259|54601005|FG001|Overall Study|Technically inadequate PbtO2 recordings|1|||
27943931|NCT00927082|54601015|FG000|Overall Study|Lost to Follow-up|9|||
27943932|NCT00927082|54601016|FG001|Overall Study|Lost to Follow-up|8|||
27943933|NCT00927082|54601017|FG002|Overall Study|Lost to Follow-up|12|||
27943934|NCT00927082|54601018|FG003|Overall Study|Lost to Follow-up|16|||
27943935|NCT00927082|54601015|FG000|Overall Study|Withdrawal by Subject|3|||
27943936|NCT00927082|54601016|FG001|Overall Study|Withdrawal by Subject|2|||
27943937|NCT00927082|54601017|FG002|Overall Study|Withdrawal by Subject|7|||
27943938|NCT00927082|54601018|FG003|Overall Study|Withdrawal by Subject|2|||
27943939|NCT00927082|54601015|FG000|Overall Study|Death|0|||
27943940|NCT00927082|54601016|FG001|Overall Study|Death|0|||
28079909|NCT03605212|54733382|FG004|Treatment Period|Physician Decision|1|||
27943941|NCT00927082|54601017|FG002|Overall Study|Death|1|||
28079910|NCT03603652|54733395|FG000|Overall Study|Death|2|||
27943942|NCT00927082|54601018|FG003|Overall Study|Death|0|||
27943943|NCT00927082|54601015|FG000|Overall Study|Screen fail,Participant migrated,Unknown|0|||
27943944|NCT00927082|54601016|FG001|Overall Study|Screen fail,Participant migrated,Unknown|0|||
27943945|NCT00927082|54601017|FG002|Overall Study|Screen fail,Participant migrated,Unknown|2|||
27943946|NCT00927082|54601018|FG003|Overall Study|Screen fail,Participant migrated,Unknown|1|||
27943947|NCT00976677|54601034|FG000|Overall Study|Adverse Event|1|||
27943948|NCT00976677|54601035|FG001|Overall Study|Adverse Event|0|||
27943949|NCT00976677|54601034|FG000|Overall Study|Withdrawal by Subject|0|||
27943950|NCT00976677|54601035|FG001|Overall Study|Withdrawal by Subject|2|||
27943951|NCT00976677|54601034|FG000|Overall Study|Disease progression|1|||
27943952|NCT00976677|54601035|FG001|Overall Study|Disease progression|1|||
28079911|NCT00117507|54733399|FG000|Overall Study|Adverse Event|4|||
27943953|NCT00976677|54601034|FG000|Overall Study|Trial unblinded|2|||
27943954|NCT00976677|54601035|FG001|Overall Study|Trial unblinded|2|||
27943955|NCT00976677|54601034|FG000|Overall Study|Unknown/Missing|1|||
27943956|NCT00976677|54601035|FG001|Overall Study|Unknown/Missing|0|||
27943957|NCT00926536|54601043|FG000|Overall Study|Physician Decision|1|||
27943958|NCT00926536|54601044|FG001|Overall Study|Physician Decision|2|||
27943959|NCT00923260|54601052|FG000|Overall Study|Lost to Follow-up|1|||
27943960|NCT00923260|54601053|FG001|Overall Study|Lost to Follow-up|1|||
27943961|NCT00934102|54601059|FG000|Period 1, One Night of Wear|Personal Reasons|1|||
27943962|NCT00934102|54601060|FG001|Period 1, One Night of Wear|Personal Reasons|0|||
27943963|NCT00934102|54601061|FG002|Period 1, One Night of Wear|Personal Reasons|0|||
27943964|NCT00970281|54601080|FG000|Overall Study|Lack of Efficacy|1|||
27943965|NCT00970281|54601081|FG001|Overall Study|Lack of Efficacy|14|||
27943966|NCT00970281|54601080|FG000|Overall Study|Withdrawal by Subject|0|||
27943967|NCT00970281|54601081|FG001|Overall Study|Withdrawal by Subject|1|||
27943968|NCT00970281|54601080|FG000|Overall Study|Physician Decision|1|||
27943969|NCT00970281|54601081|FG001|Overall Study|Physician Decision|1|||
27943970|NCT00976209|54601089|FG000|Treatment Period 1|Protocol Violation|1|||
27943971|NCT00976209|54601090|FG001|Treatment Period 1|Protocol Violation|0|||
27943972|NCT00976209|54601089|FG000|Treatment Period 1|Lost to Follow-up|2|||
27943973|NCT00976209|54601090|FG001|Treatment Period 1|Lost to Follow-up|0|||
27943974|NCT00976209|54601089|FG000|Treatment Period 1|Other|0|||
27943975|NCT00976209|54601090|FG001|Treatment Period 1|Other|1|||
27943976|NCT00976209|54601089|FG000|Wash-out Period|Adverse Event|1|||
27943977|NCT00976209|54601090|FG001|Wash-out Period|Adverse Event|2|||
27943978|NCT00976209|54601089|FG000|Wash-out Period|Lost to Follow-up|1|||
27943979|NCT00976209|54601090|FG001|Wash-out Period|Lost to Follow-up|0|||
27943980|NCT00976209|54601089|FG000|Wash-out Period|Protocol Violation|1|||
27943981|NCT00976209|54601090|FG001|Wash-out Period|Protocol Violation|0|||
27943982|NCT00976209|54601089|FG000|Wash-out Period|Other|1|||
27943983|NCT00976209|54601090|FG001|Wash-out Period|Other|0|||
27943984|NCT00976209|54601089|FG000|Treatment Period 2|Withdrawal by Subject|0|||
27943985|NCT00976209|54601090|FG001|Treatment Period 2|Withdrawal by Subject|1|||
27943986|NCT00976209|54601089|FG000|Treatment Period 2|Lost to Follow-up|0|||
27943987|NCT00976209|54601090|FG001|Treatment Period 2|Lost to Follow-up|1|||
27943988|NCT00925990|54601097|FG000|Overall Study|Adverse Event|1|||
27943989|NCT00925990|54601098|FG001|Overall Study|Adverse Event|3|||
27943990|NCT00925990|54601097|FG000|Overall Study|Withdrawal by Subject|2|||
27943991|NCT00925990|54601098|FG001|Overall Study|Withdrawal by Subject|2|||
27943992|NCT00925990|54601097|FG000|Overall Study|Lost to Follow-up|1|||
27943993|NCT00925990|54601098|FG001|Overall Study|Lost to Follow-up|3|||
27943994|NCT00925990|54601097|FG000|Overall Study|Physician Decision|1|||
27943995|NCT00925990|54601098|FG001|Overall Study|Physician Decision|1|||
27943996|NCT00925990|54601097|FG000|Overall Study|moved out of state, missed medication|0|||
27943997|NCT00925990|54601098|FG001|Overall Study|moved out of state, missed medication|2|||
27943998|NCT01131078|54601107|FG000|Overall Study|Adverse Event|22|||
27943999|NCT01131078|54601108|FG001|Overall Study|Adverse Event|12|||
27944000|NCT01131078|54601109|FG002|Overall Study|Adverse Event|17|||
27944001|NCT01131078|54601107|FG000|Overall Study|Progressive Disease|58|||
27944002|NCT01131078|54601108|FG001|Overall Study|Progressive Disease|77|||
27944003|NCT01131078|54601109|FG002|Overall Study|Progressive Disease|71|||
27944004|NCT01131078|54601107|FG000|Overall Study|Protocol Violation|1|||
27944005|NCT01131078|54601108|FG001|Overall Study|Protocol Violation|0|||
27944006|NCT01131078|54601109|FG002|Overall Study|Protocol Violation|0|||
27944007|NCT01131078|54601107|FG000|Overall Study|Lost to Follow-up|1|||
27944008|NCT01131078|54601108|FG001|Overall Study|Lost to Follow-up|1|||
27944009|NCT01131078|54601109|FG002|Overall Study|Lost to Follow-up|1|||
27944010|NCT01131078|54601107|FG000|Overall Study|Withdrawal by Subject|2|||
27944011|NCT01131078|54601108|FG001|Overall Study|Withdrawal by Subject|4|||
27944012|NCT01131078|54601109|FG002|Overall Study|Withdrawal by Subject|3|||
27944013|NCT01131078|54601107|FG000|Overall Study|Non-compliance|3|||
28079912|NCT00117507|54733399|FG000|Overall Study|Abnormal laboratory values|3|||
27944014|NCT01131078|54601108|FG001|Overall Study|Non-compliance|0|||
27944015|NCT01131078|54601109|FG002|Overall Study|Non-compliance|0|||
28079913|NCT00117507|54733399|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
28079914|NCT00117507|54733399|FG000|Overall Study|Patient withdrew consent|4|||
27925597|NCT01258608|54582132|FG001|Overall Study|Adverse Event|10|||
27944016|NCT01131078|54601107|FG000|Overall Study|Physician Decision|10|||
27944017|NCT01131078|54601108|FG001|Overall Study|Physician Decision|6|||
28079915|NCT00117507|54733399|FG000|Overall Study|Death|3|||
27944018|NCT01131078|54601109|FG002|Overall Study|Physician Decision|8|||
27944019|NCT01131078|54601107|FG000|Overall Study|Death|4|||
27925598|NCT01258608|54582131|FG000|Overall Study|Withdrawal by Subject|6|||
27925599|NCT01258608|54582132|FG001|Overall Study|Withdrawal by Subject|5|||
27925600|NCT01015612|54582139|FG000|Overall Study|Death|113|||
27925601|NCT01015612|54582139|FG000|Overall Study|Withdrawal by Subject|40|||
27925602|NCT01231659|54582143|FG000|Overall Study|Adverse Event|9|||
27925603|NCT01231659|54582143|FG000|Overall Study|Disease Progression|48|||
27925604|NCT01231659|54582143|FG000|Overall Study|Death|2|||
27731165|NCT02341456|54178345|FG000|Overall Study|Moved to local access programme.|0|||
27853029|NCT01435460|54361617|FG001|Overall Study|Did not meet eligibility criteria|0|||
27853030|NCT01435382|54361703|FG000|Overall Study|Lost to Follow-up|1|||
27853031|NCT01435382|54361704|FG001|Overall Study|Lost to Follow-up|0|||
27853032|NCT01435382|54361705|FG002|Overall Study|Lost to Follow-up|1|||
27853033|NCT01435382|54361706|FG003|Overall Study|Lost to Follow-up|0|||
27853034|NCT01435382|54361703|FG000|Overall Study|Withdrawal by Subject|0|||
27853035|NCT01435382|54361704|FG001|Overall Study|Withdrawal by Subject|2|||
27853036|NCT01435382|54361705|FG002|Overall Study|Withdrawal by Subject|0|||
27853037|NCT01435382|54361706|FG003|Overall Study|Withdrawal by Subject|1|||
27853038|NCT01414166|54361771|FG000|Overall Study|Adverse Event|10|||
27853039|NCT01414166|54361772|FG001|Overall Study|Adverse Event|2|||
27853040|NCT01414166|54361771|FG000|Overall Study|Lost to Follow-up|4|||
27853041|NCT01414166|54361772|FG001|Overall Study|Lost to Follow-up|1|||
27853042|NCT01414166|54361771|FG000|Overall Study|Non-compliance with study drug|2|||
27853043|NCT01414166|54361772|FG001|Overall Study|Non-compliance with study drug|0|||
27853044|NCT01414166|54361771|FG000|Overall Study|Physician Decision|2|||
27853045|NCT01414166|54361772|FG001|Overall Study|Physician Decision|0|||
27853046|NCT01414166|54361771|FG000|Overall Study|Protocol Violation|2|||
27853047|NCT01414166|54361772|FG001|Overall Study|Protocol Violation|0|||
27853048|NCT01414166|54361771|FG000|Overall Study|Study terminated by Sponsor|68|||
27853049|NCT01414166|54361772|FG001|Overall Study|Study terminated by Sponsor|75|||
27853050|NCT01414166|54361771|FG000|Overall Study|Withdrawal by Subject|3|||
27853051|NCT01414166|54361772|FG001|Overall Study|Withdrawal by Subject|5|||
27853052|NCT01434680|54361782|FG000|Overall Study|Withdrawal by Subject|1|||
27853053|NCT01434680|54361783|FG001|Overall Study|Withdrawal by Subject|0|||
27853054|NCT01434680|54361784|FG002|Overall Study|Withdrawal by Subject|2|||
27853055|NCT01434680|54361785|FG003|Overall Study|Withdrawal by Subject|0|||
27853056|NCT01434680|54361782|FG000|Overall Study|Lost to Follow-up|1|||
27853057|NCT01434680|54361783|FG001|Overall Study|Lost to Follow-up|1|||
27853058|NCT01434680|54361784|FG002|Overall Study|Lost to Follow-up|0|||
27853059|NCT01434680|54361785|FG003|Overall Study|Lost to Follow-up|0|||
27853060|NCT01434680|54361782|FG000|Overall Study|Protocol Violation|1|||
27853061|NCT01434680|54361783|FG001|Overall Study|Protocol Violation|1|||
27853062|NCT01434680|54361784|FG002|Overall Study|Protocol Violation|0|||
27853063|NCT01434680|54361785|FG003|Overall Study|Protocol Violation|0|||
27853064|NCT01433978|54361918|FG000|Core Study|Adverse Event, Non-Fatal|0|||
27853065|NCT01433978|54361919|FG001|Core Study|Adverse Event, Non-Fatal|1|||
27853066|NCT01433978|54361920|FG002|Core Study|Adverse Event, Non-Fatal|0|||
27853067|NCT01433978|54361918|FG000|Core Study|Lack of Efficacy|5|||
27853068|NCT01433978|54361919|FG001|Core Study|Lack of Efficacy|1|||
27853069|NCT01433978|54361920|FG002|Core Study|Lack of Efficacy|0|||
27853070|NCT01433978|54361918|FG000|Core Study|Study Terminated by Sponsor|6|||
27853071|NCT01433978|54361919|FG001|Core Study|Study Terminated by Sponsor|9|||
27853072|NCT01433978|54361920|FG002|Core Study|Study Terminated by Sponsor|0|||
27853073|NCT01433978|54361918|FG000|Extension Phase|Adverse Event, Non-Fatal|0|||
27853074|NCT01433978|54361919|FG001|Extension Phase|Adverse Event, Non-Fatal|0|||
27853075|NCT01433978|54361920|FG002|Extension Phase|Adverse Event, Non-Fatal|1|||
27853076|NCT01433978|54361918|FG000|Extension Phase|Lack of Efficacy|0|||
27853077|NCT01433978|54361919|FG001|Extension Phase|Lack of Efficacy|0|||
27853078|NCT01433978|54361920|FG002|Extension Phase|Lack of Efficacy|1|||
27853079|NCT01433978|54361918|FG000|Extension Phase|Study Terminated by Sponsor|0|||
27853080|NCT01433978|54361919|FG001|Extension Phase|Study Terminated by Sponsor|0|||
27853081|NCT01433978|54361920|FG002|Extension Phase|Study Terminated by Sponsor|4|||
27853082|NCT01433354|54361969|FG000|Overall Study|Adverse Event|6|||
27853083|NCT01433354|54361969|FG000|Overall Study|Lost to Follow-up|1|||
27853084|NCT01433354|54361969|FG000|Overall Study|Administrative problems|90|||
27853085|NCT01433354|54361969|FG000|Overall Study|Protocol Violation|2|||
27853086|NCT01433354|54361969|FG000|Overall Study|Lack of Efficacy|17|||
27853087|NCT01433354|54361969|FG000|Overall Study|Subject Withdrew Consent|3|||
27853088|NCT04508023|54362480|FG000|Overall Study|Withdrawal by Subject|1|||
27853089|NCT04508023|54362481|FG001|Overall Study|Withdrawal by Subject|2|||
27853090|NCT04187144|54362489|FG000|Overall Study|Lost to Follow-up|12|||
27731166|NCT02341456|54178346|FG001|Overall Study|Moved to local access programme.|1|||
27731167|NCT02341456|54178347|FG002|Overall Study|Moved to local access programme.|1|||
27731168|NCT02341456|54178345|FG000|Overall Study|Physician Decision|1|||
27731169|NCT02341456|54178346|FG001|Overall Study|Physician Decision|0|||
27731170|NCT02341456|54178347|FG002|Overall Study|Physician Decision|0|||
27731171|NCT02370784|54178357|FG000|Overall Study|Patient started prohibited medication|0|||
27853091|NCT04187144|54362490|FG001|Overall Study|Lost to Follow-up|11|||
27853092|NCT04187144|54362489|FG000|Overall Study|Withdrawal by Subject|20|||
27853093|NCT04187144|54362490|FG001|Overall Study|Withdrawal by Subject|18|||
27853094|NCT04187144|54362489|FG000|Overall Study|Adverse Event|19|||
27853095|NCT04187144|54362490|FG001|Overall Study|Adverse Event|4|||
27853096|NCT04187144|54362489|FG000|Overall Study|Physician Decision|5|||
27853097|NCT04187144|54362490|FG001|Overall Study|Physician Decision|3|||
27731172|NCT02370784|54178358|FG001|Overall Study|Patient started prohibited medication|1|||
27944020|NCT01131078|54601108|FG001|Overall Study|Death|0|||
27944021|NCT01131078|54601109|FG002|Overall Study|Death|2|||
27944022|NCT01131078|54601107|FG000|Overall Study|Other|0|||
27944023|NCT01131078|54601108|FG001|Overall Study|Other|1|||
27944024|NCT01131078|54601109|FG002|Overall Study|Other|0|||
27944025|NCT01167582|54601121|FG000|Overall Study|Lost to Follow-up|0|||
27944026|NCT01167582|54601122|FG001|Overall Study|Lost to Follow-up|1|||
27944027|NCT01167426|54601128|FG000|Overall Study|Lost to Follow-up|6|||
27944028|NCT01167426|54601128|FG000|Overall Study|Protocol Violation|1|||
27944029|NCT01167426|54601128|FG000|Overall Study|Withdrawal by Subject|2|||
27944030|NCT01167426|54601128|FG000|Overall Study|Sponsor Decision|1|||
27944031|NCT00968799|54601133|FG000|Overall Study|Advanced disease, HIPEC not applicable|2|||
27944032|NCT00922636|54601142|FG000|Overall Study|Adverse Event|3|||
27944033|NCT00922636|54601143|FG001|Overall Study|Adverse Event|3|||
27944034|NCT00922636|54601144|FG002|Overall Study|Adverse Event|2|||
27944035|NCT00922636|54601145|FG003|Overall Study|Adverse Event|3|||
27944036|NCT00922636|54601146|FG004|Overall Study|Adverse Event|2|||
27944037|NCT00922636|54601142|FG000|Overall Study|Lack of Efficacy|1|||
27944038|NCT00922636|54601143|FG001|Overall Study|Lack of Efficacy|7|||
27944039|NCT00922636|54601144|FG002|Overall Study|Lack of Efficacy|3|||
27944040|NCT00922636|54601145|FG003|Overall Study|Lack of Efficacy|2|||
27944041|NCT00922636|54601146|FG004|Overall Study|Lack of Efficacy|4|||
27944042|NCT00922636|54601142|FG000|Overall Study|Sponsor Decision|0|||
27944043|NCT00922636|54601143|FG001|Overall Study|Sponsor Decision|0|||
27944044|NCT00922636|54601144|FG002|Overall Study|Sponsor Decision|2|||
27944045|NCT00922636|54601145|FG003|Overall Study|Sponsor Decision|0|||
27944046|NCT00922636|54601146|FG004|Overall Study|Sponsor Decision|0|||
27944047|NCT00922636|54601142|FG000|Overall Study|Withdrawal by Subject|0|||
27944048|NCT00922636|54601143|FG001|Overall Study|Withdrawal by Subject|0|||
27944049|NCT00922636|54601144|FG002|Overall Study|Withdrawal by Subject|5|||
27944050|NCT00922636|54601145|FG003|Overall Study|Withdrawal by Subject|2|||
27944051|NCT00922636|54601146|FG004|Overall Study|Withdrawal by Subject|4|||
27944052|NCT00922636|54601142|FG000|Overall Study|Protocol Violation|0|||
27944053|NCT00922636|54601143|FG001|Overall Study|Protocol Violation|0|||
27944054|NCT00922636|54601144|FG002|Overall Study|Protocol Violation|2|||
27853098|NCT04187144|54362489|FG000|Overall Study|Screening Failure due to creatinine clearance and body mass index|0|||
27853099|NCT04187144|54362490|FG001|Overall Study|Screening Failure due to creatinine clearance and body mass index|1|||
27853100|NCT04187144|54362489|FG000|Overall Study|Protocol Deviation|1|||
27853101|NCT04187144|54362490|FG001|Overall Study|Protocol Deviation|4|||
27853102|NCT04027946|54362496|FG000|Overall Study|Screen failures|3|||
27853103|NCT03856047|54362517|FG000|Overall Study|Withdrawal by Subject|0|||
27853104|NCT03856047|54362518|FG001|Overall Study|Withdrawal by Subject|1|||
27853105|NCT03856047|54362519|FG002|Overall Study|Withdrawal by Subject|1|||
27853106|NCT03856047|54362520|FG003|Overall Study|Withdrawal by Subject|0|||
27853107|NCT03856047|54362521|FG004|Overall Study|Withdrawal by Subject|3|||
27853108|NCT03856047|54362522|FG005|Overall Study|Withdrawal by Subject|0|||
27853109|NCT03856047|54362523|FG006|Overall Study|Withdrawal by Subject|2|||
27853110|NCT03856047|54362517|FG000|Overall Study|Lost to Follow-up|4|||
27853111|NCT03856047|54362518|FG001|Overall Study|Lost to Follow-up|2|||
27853112|NCT03856047|54362519|FG002|Overall Study|Lost to Follow-up|3|||
27853113|NCT03856047|54362520|FG003|Overall Study|Lost to Follow-up|1|||
27853114|NCT03856047|54362521|FG004|Overall Study|Lost to Follow-up|4|||
27853115|NCT03856047|54362522|FG005|Overall Study|Lost to Follow-up|4|||
27853116|NCT03856047|54362523|FG006|Overall Study|Lost to Follow-up|4|||
27853117|NCT03797014|54362540|FG000|Overall Study|Withdrawal by Subject|1|||
27944055|NCT00922636|54601145|FG003|Overall Study|Protocol Violation|2|||
27944056|NCT00922636|54601146|FG004|Overall Study|Protocol Violation|0|||
27944057|NCT00922636|54601142|FG000|Overall Study|Entry Criteria Not Met|0|||
27944058|NCT00922636|54601143|FG001|Overall Study|Entry Criteria Not Met|0|||
27731173|NCT02307370|54178366|FG000|Overall Study|Death|5|||
27853118|NCT03797014|54362540|FG000|Overall Study|Lost to Follow-up|1|||
27853119|NCT03797014|54362540|FG000|Overall Study|Protocol Violation|1|||
27853120|NCT03112603|54362578|FG000|End of Randomization Period|Lost to Follow-up|3|||
27944059|NCT00922636|54601144|FG002|Overall Study|Entry Criteria Not Met|1|||
27944060|NCT00922636|54601145|FG003|Overall Study|Entry Criteria Not Met|1|||
27944061|NCT00922636|54601146|FG004|Overall Study|Entry Criteria Not Met|0|||
27944062|NCT00922636|54601142|FG000|Overall Study|Parent/Caregiver Decision|2|||
27944063|NCT00922636|54601143|FG001|Overall Study|Parent/Caregiver Decision|4|||
27944064|NCT00922636|54601144|FG002|Overall Study|Parent/Caregiver Decision|3|||
27944065|NCT00922636|54601145|FG003|Overall Study|Parent/Caregiver Decision|5|||
28079916|NCT03603496|54733406|FG000|Overall Study|Death|19|||
27944066|NCT00922636|54601146|FG004|Overall Study|Parent/Caregiver Decision|2|||
27944067|NCT00922636|54601142|FG000|Overall Study|Lost to Follow-up|1|||
27944068|NCT00922636|54601143|FG001|Overall Study|Lost to Follow-up|2|||
27944069|NCT00922636|54601144|FG002|Overall Study|Lost to Follow-up|2|||
27944070|NCT00922636|54601145|FG003|Overall Study|Lost to Follow-up|2|||
27944071|NCT00922636|54601146|FG004|Overall Study|Lost to Follow-up|4|||
27944072|NCT01175135|54601167|FG000|Overall Study|Adverse Event|2|||
28079917|NCT03603496|54733407|FG001|Overall Study|Death|24|||
27853121|NCT03112603|54362579|FG001|End of Randomization Period|Lost to Follow-up|0|||
27853122|NCT03112603|54362580|FG002|End of Randomization Period|Lost to Follow-up|0|||
27853123|NCT03112603|54362578|FG000|End of Randomization Period|Participant/Guardian Decision|7|||
27853124|NCT03112603|54362579|FG001|End of Randomization Period|Participant/Guardian Decision|14|||
27853125|NCT03112603|54362580|FG002|End of Randomization Period|Participant/Guardian Decision|0|||
27853126|NCT03112603|54362578|FG000|End of Randomization Period|Physician Decision|43|||
27853127|NCT03112603|54362579|FG001|End of Randomization Period|Physician Decision|18|||
27944073|NCT01175135|54601168|FG001|Overall Study|Adverse Event|5|||
27944074|NCT01175135|54601169|FG002|Overall Study|Adverse Event|3|||
27944075|NCT01175135|54601170|FG003|Overall Study|Adverse Event|4|||
27944076|NCT01175135|54601167|FG000|Overall Study|Death|1|||
27944077|NCT01175135|54601168|FG001|Overall Study|Death|0|||
27944078|NCT01175135|54601169|FG002|Overall Study|Death|0|||
27944079|NCT01175135|54601170|FG003|Overall Study|Death|0|||
27944080|NCT01175135|54601167|FG000|Overall Study|Lack of Efficacy|4|||
27944081|NCT01175135|54601168|FG001|Overall Study|Lack of Efficacy|5|||
27944082|NCT01175135|54601169|FG002|Overall Study|Lack of Efficacy|0|||
27944083|NCT01175135|54601170|FG003|Overall Study|Lack of Efficacy|5|||
27944084|NCT01175135|54601167|FG000|Overall Study|Lost to Follow-up|1|||
27944085|NCT01175135|54601168|FG001|Overall Study|Lost to Follow-up|2|||
27944086|NCT01175135|54601169|FG002|Overall Study|Lost to Follow-up|0|||
27944087|NCT01175135|54601170|FG003|Overall Study|Lost to Follow-up|0|||
27944088|NCT01175135|54601167|FG000|Overall Study|Protocol Violation|1|||
27944089|NCT01175135|54601168|FG001|Overall Study|Protocol Violation|1|||
27944090|NCT01175135|54601169|FG002|Overall Study|Protocol Violation|0|||
27944091|NCT01175135|54601170|FG003|Overall Study|Protocol Violation|0|||
27944092|NCT01175135|54601167|FG000|Overall Study|Withdrawal by Subject|4|||
27944093|NCT01175135|54601168|FG001|Overall Study|Withdrawal by Subject|8|||
27944094|NCT01175135|54601169|FG002|Overall Study|Withdrawal by Subject|5|||
27944095|NCT01175135|54601170|FG003|Overall Study|Withdrawal by Subject|5|||
27944096|NCT01175135|54601167|FG000|Overall Study|Other|3|||
27944097|NCT01175135|54601168|FG001|Overall Study|Other|1|||
27944098|NCT01175135|54601169|FG002|Overall Study|Other|3|||
27944099|NCT01175135|54601170|FG003|Overall Study|Other|0|||
27944100|NCT01175135|54601167|FG000|Overall Study|Randomized But Not Treated|0|||
27944101|NCT01175135|54601168|FG001|Overall Study|Randomized But Not Treated|0|||
27944102|NCT01175135|54601169|FG002|Overall Study|Randomized But Not Treated|1|||
27944103|NCT01175135|54601170|FG003|Overall Study|Randomized But Not Treated|0|||
27944104|NCT00922480|54601182|FG000|Main Study|Protocol Violation|3|||
27944105|NCT00922480|54601183|FG001|Main Study|Protocol Violation|6|||
27944106|NCT00922480|54601182|FG000|Main Study|Adverse Event|6|||
27944107|NCT00922480|54601183|FG001|Main Study|Adverse Event|7|||
27944108|NCT00922480|54601182|FG000|Main Study|Lack of Efficacy|3|||
27944109|NCT00922480|54601183|FG001|Main Study|Lack of Efficacy|0|||
27944110|NCT00922480|54601182|FG000|Main Study|Withdrawal by Subject|20|||
27944111|NCT00922480|54601183|FG001|Main Study|Withdrawal by Subject|15|||
27944112|NCT00922480|54601182|FG000|Main Study|Lost to Follow-up|5|||
27944113|NCT00922480|54601183|FG001|Main Study|Lost to Follow-up|0|||
27944114|NCT00922480|54601182|FG000|Main Study|Physician Decision|0|||
27944115|NCT00922480|54601183|FG001|Main Study|Physician Decision|1|||
27944116|NCT00922480|54601182|FG000|Extension Study|Protocol Violation|3|||
27944117|NCT00922480|54601183|FG001|Extension Study|Protocol Violation|0|||
27944118|NCT00922480|54601182|FG000|Extension Study|Adverse Event|1|||
27944119|NCT00922480|54601183|FG001|Extension Study|Adverse Event|1|||
27944120|NCT00922480|54601182|FG000|Extension Study|Withdrawal by Subject|1|||
27944121|NCT00922480|54601183|FG001|Extension Study|Withdrawal by Subject|1|||
27944122|NCT00922480|54601182|FG000|Extension Study|Others|0|||
27944123|NCT00922480|54601183|FG001|Extension Study|Others|1|||
27944124|NCT00973479|54601193|FG000|Overall Study|Lost to Follow-up|0|||
27944125|NCT00973479|54601194|FG001|Overall Study|Lost to Follow-up|3|||
27944126|NCT00973479|54601193|FG000|Overall Study|Death|2|||
28079918|NCT03603496|54733406|FG000|Overall Study|Lost to Follow-up|141|||
27944127|NCT00973479|54601194|FG001|Overall Study|Death|2|||
27944128|NCT00973479|54601193|FG000|Overall Study|Withdrawal by Subject|15|||
27944129|NCT00973479|54601194|FG001|Overall Study|Withdrawal by Subject|16|||
28079919|NCT03603496|54733407|FG001|Overall Study|Lost to Follow-up|141|||
27944130|NCT00973479|54601193|FG000|Overall Study|Lack of Efficacy|5|||
27944131|NCT00973479|54601194|FG001|Overall Study|Lack of Efficacy|7|||
27944132|NCT00973479|54601193|FG000|Overall Study|Adverse Event|12|||
27944133|NCT00973479|54601194|FG001|Overall Study|Adverse Event|32|||
27944134|NCT00973479|54601193|FG000|Overall Study|Protocol Violation|2|||
27944135|NCT00973479|54601194|FG001|Overall Study|Protocol Violation|2|||
27944136|NCT00973479|54601193|FG000|Overall Study|Other|1|||
27944137|NCT00973479|54601194|FG001|Overall Study|Other|7|||
27944138|NCT01174043|54601202|FG000|Overall Study|Disease progression|5|||
27944139|NCT01174043|54601202|FG000|Overall Study|Adverse Event|3|||
27944140|NCT01174043|54601202|FG000|Overall Study|Death|1|||
27944141|NCT01174043|54601202|FG000|Overall Study|Withdrawal by Subject|2|||
27944142|NCT01173653|54601208|FG000|Overall Study|Pts unwilling to provide follow-up|53|||
27944143|NCT01173653|54601209|FG001|Overall Study|Pts unwilling to provide follow-up|41|||
27944144|NCT01172873|54601217|FG000|Overall Study|Withdrawal by Subject|3|||
27944145|NCT01172873|54601218|FG001|Overall Study|Withdrawal by Subject|2|||
28079920|NCT03603496|54733406|FG000|Overall Study|Withdrawal by Subject|26|||
28079921|NCT03603496|54733407|FG001|Overall Study|Withdrawal by Subject|20|||
27731174|NCT02307370|54178366|FG000|Overall Study|Lost to Follow-up|1|||
27731175|NCT02307370|54178366|FG000|Overall Study|Withdrawal by Subject|1|||
27731176|NCT02307370|54178366|FG000|Overall Study|Declined Addendum ICF|6|||
27731177|NCT02307370|54178366|FG000|Overall Study|No response during telephone contact|5|||
27731178|NCT02307370|54178366|FG000|Overall Study|Protocol Violation|1|||
27731179|NCT02370394|54178374|FG000|Overall Study|Lost to Follow-up|2|||
27731180|NCT02370394|54178375|FG001|Overall Study|Lost to Follow-up|1|||
27731181|NCT02370394|54178374|FG000|Overall Study|Withdrawal by Subject|0|||
27731182|NCT02370394|54178375|FG001|Overall Study|Withdrawal by Subject|1|||
27731183|NCT01595438|54178384|FG000|Overall Study|Lost to Follow-up|20|||
27731184|NCT01595438|54178385|FG001|Overall Study|Lost to Follow-up|20|||
27731185|NCT01595438|54178384|FG000|Overall Study|Withdrawal by Subject|12|||
27731186|NCT01595438|54178385|FG001|Overall Study|Withdrawal by Subject|12|||
27731187|NCT01595438|54178384|FG000|Overall Study|Other Eligibility criteria|11|||
27731188|NCT01595438|54178385|FG001|Overall Study|Other Eligibility criteria|9|||
27731189|NCT02340520|54178391|FG000|Overall Study|Lost to Follow-up|1|||
27731190|NCT02340520|54178391|FG000|Overall Study|Patient did not take drug as specified|1|||
27731191|NCT02340520|54178391|FG000|Overall Study|Withdrawal by Subject|1|||
27731192|NCT02339584|54178397|FG000|Overall Study|Adverse Event|11|||
27731193|NCT02339584|54178398|FG001|Overall Study|Adverse Event|7|||
27731194|NCT02339584|54178397|FG000|Overall Study|Lack of Efficacy|0|||
27731195|NCT02339584|54178398|FG001|Overall Study|Lack of Efficacy|1|||
27731196|NCT02339584|54178397|FG000|Overall Study|Physician Decision|1|||
27731197|NCT02339584|54178398|FG001|Overall Study|Physician Decision|2|||
27731198|NCT02339584|54178397|FG000|Overall Study|Protocol Violation|1|||
27731199|NCT02339584|54178398|FG001|Overall Study|Protocol Violation|1|||
27731200|NCT02339584|54178397|FG000|Overall Study|Withdrawal by Subject|2|||
27731201|NCT02339584|54178398|FG001|Overall Study|Withdrawal by Subject|4|||
27731202|NCT02339506|54178404|FG000|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0|||
27731203|NCT02339506|54178405|FG001|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1|||
27731204|NCT02339506|54178404|FG000|Washout (Period 2)|Withdrawal by Subject|2|||
27731205|NCT02339506|54178405|FG001|Washout (Period 2)|Withdrawal by Subject|0|||
27731206|NCT02305888|54178414|FG000|Overall Study|Lost to Follow-up|0|||
27731207|NCT02305888|54178415|FG001|Overall Study|Lost to Follow-up|0|||
27731208|NCT02305888|54178416|FG002|Overall Study|Lost to Follow-up|1|||
27731209|NCT02305888|54178414|FG000|Overall Study|Adverse Event|0|||
27731210|NCT02305888|54178415|FG001|Overall Study|Adverse Event|1|||
27731211|NCT02305888|54178416|FG002|Overall Study|Adverse Event|0|||
27731212|NCT02338882|54178426|FG000|Overall Study|Death|1|||
27731213|NCT02338882|54178427|FG001|Overall Study|Death|0|||
27731214|NCT02338882|54178426|FG000|Overall Study|Lost to Follow-up|6|||
27731215|NCT02338882|54178427|FG001|Overall Study|Lost to Follow-up|3|||
27731216|NCT01594970|54178439|FG000|Overall Study|Non-Adverse Event Related|4|||
27731217|NCT01594970|54178440|FG001|Overall Study|Non-Adverse Event Related|5|||
27731218|NCT01594970|54178441|FG002|Overall Study|Non-Adverse Event Related|6|||
27731219|NCT01594970|54178439|FG000|Overall Study|Adverse Event|17|||
27731220|NCT01594970|54178440|FG001|Overall Study|Adverse Event|23|||
27731221|NCT01594970|54178441|FG002|Overall Study|Adverse Event|23|||
27731222|NCT01594970|54178439|FG000|Overall Study|Lost to Follow-up|54|||
27731223|NCT01594970|54178440|FG001|Overall Study|Lost to Follow-up|54|||
27731224|NCT01594970|54178441|FG002|Overall Study|Lost to Follow-up|37|||
27731225|NCT02338492|54178449|FG000|Overall Study|Death|32|||
27731226|NCT02338492|54178449|FG000|Overall Study|Adverse Event|3|||
27853128|NCT03112603|54362580|FG002|End of Randomization Period|Physician Decision|0|||
27853129|NCT03112603|54362578|FG000|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|4|||
27853130|NCT03112603|54362579|FG001|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|5|||
27853131|NCT03112603|54362580|FG002|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|0|||
27853132|NCT03112603|54362578|FG000|End of Randomization Period|Death|10|||
27853133|NCT03112603|54362579|FG001|End of Randomization Period|Death|7|||
27853134|NCT03112603|54362580|FG002|End of Randomization Period|Death|0|||
27944146|NCT00925600|54601230|FG000|Overall Study|Withdrawal by Subject|16|||
28079922|NCT03603028|54733413|FG000|Overall Study|Withdrawal by Subject|1|||
28079923|NCT03602482|54733419|FG000|Overall Study|Withdrawal by Subject|6|||
27731227|NCT02338492|54178449|FG000|Overall Study|Lost to Follow-up|4|||
27731228|NCT02338492|54178449|FG000|Overall Study|Reason not captured above|6|||
27731229|NCT02337946|54178453|FG000|Protocol Treatment 1 Period|Adverse Event|7|||
27731230|NCT02337946|54178454|FG001|Protocol Treatment 1 Period|Adverse Event|0|||
27731231|NCT02337946|54178455|FG002|Protocol Treatment 1 Period|Adverse Event|0|||
27731232|NCT02337946|54178453|FG000|Protocol Treatment 1 Period|Major Protocol Deviation|1|||
27731233|NCT02337946|54178454|FG001|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
27731234|NCT02337946|54178455|FG002|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
28079924|NCT03602482|54733420|FG001|Overall Study|Withdrawal by Subject|7|||
27944147|NCT00925600|54601231|FG001|Overall Study|Withdrawal by Subject|14|||
27944148|NCT00925600|54601230|FG000|Overall Study|Death|4|||
27944149|NCT00925600|54601231|FG001|Overall Study|Death|3|||
27944150|NCT00925600|54601230|FG000|Overall Study|Lost to Follow-up|2|||
27944151|NCT00925600|54601231|FG001|Overall Study|Lost to Follow-up|2|||
27944152|NCT00925600|54601230|FG000|Overall Study|Disease Progression|1|||
27944153|NCT00925600|54601231|FG001|Overall Study|Disease Progression|3|||
27944154|NCT00925600|54601230|FG000|Overall Study|Administrative Decision|1|||
27944155|NCT00925600|54601231|FG001|Overall Study|Administrative Decision|1|||
27944156|NCT00925600|54601230|FG000|Overall Study|Noncompliance|2|||
27944157|NCT00925600|54601231|FG001|Overall Study|Noncompliance|0|||
27944158|NCT00925600|54601230|FG000|Overall Study|Ineligibility Determined|2|||
27944159|NCT00925600|54601231|FG001|Overall Study|Ineligibility Determined|0|||
27944160|NCT00925600|54601230|FG000|Overall Study|Protocol Deviation|0|||
27944161|NCT00925600|54601231|FG001|Overall Study|Protocol Deviation|1|||
27944162|NCT00925600|54601230|FG000|Overall Study|Requirement for Alternative Therapy|0|||
27944163|NCT00925600|54601231|FG001|Overall Study|Requirement for Alternative Therapy|1|||
27944164|NCT00925600|54601230|FG000|Overall Study|Other|3|||
27944165|NCT00925600|54601231|FG001|Overall Study|Other|1|||
27944166|NCT00925600|54601230|FG000|Overall Study|Adverse Event|1|||
27944167|NCT00925600|54601231|FG001|Overall Study|Adverse Event|2|||
27944168|NCT00968253|54601244|FG000|Overall Study|Death|0|||
27944169|NCT00968253|54601245|FG001|Overall Study|Death|0|||
27944170|NCT00968253|54601246|FG002|Overall Study|Death|2|||
27944171|NCT00968253|54601244|FG000|Overall Study|Withdrawal by Subject|0|||
27944172|NCT00968253|54601245|FG001|Overall Study|Withdrawal by Subject|0|||
27944173|NCT00968253|54601246|FG002|Overall Study|Withdrawal by Subject|1|||
27944174|NCT00968253|54601244|FG000|Overall Study|Disease Progression|0|||
27944175|NCT00968253|54601245|FG001|Overall Study|Disease Progression|3|||
27944176|NCT00968253|54601246|FG002|Overall Study|Disease Progression|3|||
27944177|NCT00968253|54601244|FG000|Overall Study|Adverse Event|0|||
27944178|NCT00968253|54601245|FG001|Overall Study|Adverse Event|0|||
27944179|NCT00968253|54601246|FG002|Overall Study|Adverse Event|1|||
27944180|NCT00964743|54601255|FG000|Overall Study|Neither patient completed 8 weeks of tre|2|||
27944181|NCT00925522|54601259|FG000|Overall Study|study closed -- business decision|20|||
27944182|NCT01130532|54601266|FG000|Period III (Weeks 0-12)|Adverse Event|3|||
27944183|NCT01130532|54601267|FG001|Period III (Weeks 0-12)|Adverse Event|3|||
27944184|NCT01130532|54601268|FG002|Period III (Weeks 0-12)|Adverse Event|2|||
27944185|NCT01130532|54601269|FG003|Period III (Weeks 0-12)|Adverse Event|0|||
27944186|NCT01130532|54601266|FG000|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
27944187|NCT01130532|54601267|FG001|Period III (Weeks 0-12)|Entry Criteria Not Met|2|||
27944188|NCT01130532|54601268|FG002|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
27944189|NCT01130532|54601269|FG003|Period III (Weeks 0-12)|Entry Criteria Not Met|0|||
27944190|NCT01130532|54601266|FG000|Period III (Weeks 0-12)|Lack of Efficacy|2|||
27944191|NCT01130532|54601267|FG001|Period III (Weeks 0-12)|Lack of Efficacy|0|||
27944192|NCT01130532|54601268|FG002|Period III (Weeks 0-12)|Lack of Efficacy|1|||
27944193|NCT01130532|54601269|FG003|Period III (Weeks 0-12)|Lack of Efficacy|0|||
27944194|NCT01130532|54601266|FG000|Period III (Weeks 0-12)|Lost to Follow-up|2|||
27944195|NCT01130532|54601267|FG001|Period III (Weeks 0-12)|Lost to Follow-up|2|||
27944196|NCT01130532|54601268|FG002|Period III (Weeks 0-12)|Lost to Follow-up|3|||
27944197|NCT01130532|54601269|FG003|Period III (Weeks 0-12)|Lost to Follow-up|0|||
27944198|NCT01130532|54601266|FG000|Period III (Weeks 0-12)|Protocol Violation|0|||
27944199|NCT01130532|54601267|FG001|Period III (Weeks 0-12)|Protocol Violation|0|||
27944200|NCT01130532|54601268|FG002|Period III (Weeks 0-12)|Protocol Violation|1|||
27944201|NCT01130532|54601269|FG003|Period III (Weeks 0-12)|Protocol Violation|0|||
27944202|NCT01130532|54601266|FG000|Period III (Weeks 0-12)|Sponsor Decision|3|||
27944203|NCT01130532|54601267|FG001|Period III (Weeks 0-12)|Sponsor Decision|4|||
27944204|NCT01130532|54601268|FG002|Period III (Weeks 0-12)|Sponsor Decision|2|||
27944205|NCT01130532|54601269|FG003|Period III (Weeks 0-12)|Sponsor Decision|0|||
27944206|NCT01130532|54601266|FG000|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
28164382|NCT01915498|54834954|FG008|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
28164383|NCT01915498|54834955|FG009|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
28164384|NCT01915498|54834956|FG010|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
28164385|NCT01915498|54834957|FG011|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
28164386|NCT01915498|54834958|FG012|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
28164387|NCT01915498|54834959|FG013|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
27944207|NCT01130532|54601267|FG001|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
27944208|NCT01130532|54601268|FG002|Period III (Weeks 0-12)|Withdrawal by Subject|6|||
27944209|NCT01130532|54601269|FG003|Period III (Weeks 0-12)|Withdrawal by Subject|0|||
27831684|NCT02859558|54310312|FG000|Step 1|Incarceration|0|||
27944210|NCT01130532|54601266|FG000|Period IV (Weeks 13-16)|Adverse Event|0|||
27944211|NCT01130532|54601267|FG001|Period IV (Weeks 13-16)|Adverse Event|0|||
27944212|NCT01130532|54601268|FG002|Period IV (Weeks 13-16)|Adverse Event|0|||
27944213|NCT01130532|54601269|FG003|Period IV (Weeks 13-16)|Adverse Event|1|||
27944214|NCT01130532|54601266|FG000|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
27944215|NCT01130532|54601267|FG001|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
27944216|NCT01130532|54601268|FG002|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
27944217|NCT01130532|54601269|FG003|Period IV (Weeks 13-16)|Entry Criteria Not Met|1|||
27944218|NCT01130532|54601266|FG000|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
27944219|NCT01130532|54601267|FG001|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
27944220|NCT01130532|54601268|FG002|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
27944221|NCT01130532|54601269|FG003|Period IV (Weeks 13-16)|Lost to Follow-up|5|||
27944222|NCT01130532|54601266|FG000|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
27944223|NCT01130532|54601267|FG001|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
27944224|NCT01130532|54601268|FG002|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
27944225|NCT01130532|54601269|FG003|Period IV (Weeks 13-16)|Withdrawal by Subject|3|||
27944226|NCT00972777|54601283|FG000|Overall Study|Adverse Event|3|||
27944227|NCT00972777|54601284|FG001|Overall Study|Adverse Event|2|||
27731235|NCT02337946|54178453|FG000|Protocol Treatment 1 Period|Voluntary Withdrawal|6|||
27944228|NCT00972777|54601283|FG000|Overall Study|Lost to Follow-up|0|||
27944229|NCT00972777|54601284|FG001|Overall Study|Lost to Follow-up|4|||
27944230|NCT00972777|54601283|FG000|Overall Study|Withdrawal by Subject|4|||
27944231|NCT00972777|54601284|FG001|Overall Study|Withdrawal by Subject|5|||
28079925|NCT03602482|54733421|FG002|Overall Study|Withdrawal by Subject|0|||
28079926|NCT03602482|54733422|FG003|Overall Study|Withdrawal by Subject|0|||
28079927|NCT00096135|54733437|FG000|Overall Study|Physician Decision|20|||
28079928|NCT00096135|54733438|FG001|Overall Study|Physician Decision|4|||
28164388|NCT01915498|54834960|FG014|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
28164389|NCT01915498|54834961|FG015|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
28164390|NCT01915498|54834962|FG016|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
27853135|NCT03112603|54362578|FG000|End of Randomization Period|Disease Relapse|12|||
27853136|NCT03112603|54362579|FG001|End of Randomization Period|Disease Relapse|7|||
27853137|NCT03112603|54362580|FG002|End of Randomization Period|Disease Relapse|0|||
27853138|NCT03112603|54362578|FG000|End of Randomization Period|Lack of Efficacy|25|||
27853139|NCT03112603|54362579|FG001|End of Randomization Period|Lack of Efficacy|77|||
27853140|NCT03112603|54362580|FG002|End of Randomization Period|Lack of Efficacy|0|||
27853141|NCT03112603|54362578|FG000|End of Randomization Period|Adverse Event|32|||
27731236|NCT02337946|54178454|FG001|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
27731237|NCT02337946|54178455|FG002|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
27731238|NCT02337946|54178453|FG000|Protocol Treatment 1 Period|Lack of Efficacy|15|||
27731239|NCT02337946|54178454|FG001|Protocol Treatment 1 Period|Lack of Efficacy|0|||
27731240|NCT02337946|54178455|FG002|Protocol Treatment 1 Period|Lack of Efficacy|0|||
27731241|NCT02337946|54178453|FG000|Protocol Treatment 1 Period|Death During Protocol Treatment|3|||
27731242|NCT02337946|54178454|FG001|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
27853142|NCT03112603|54362579|FG001|End of Randomization Period|Adverse Event|12|||
27853143|NCT03112603|54362580|FG002|End of Randomization Period|Adverse Event|0|||
27853144|NCT03112603|54362578|FG000|End of Cross Over Period|Death|0|||
27853145|NCT03112603|54362579|FG001|End of Cross Over Period|Death|0|||
27853146|NCT03112603|54362580|FG002|End of Cross Over Period|Death|2|||
27853147|NCT03112603|54362578|FG000|End of Cross Over Period|Participant/Guardian Decision|0|||
27853148|NCT03112603|54362579|FG001|End of Cross Over Period|Participant/Guardian Decision|0|||
27853149|NCT03112603|54362580|FG002|End of Cross Over Period|Participant/Guardian Decision|7|||
27853150|NCT03112603|54362578|FG000|End of Cross Over Period|Physician Decision|0|||
27853151|NCT03112603|54362579|FG001|End of Cross Over Period|Physician Decision|0|||
27853152|NCT03112603|54362580|FG002|End of Cross Over Period|Physician Decision|29|||
27853153|NCT03112603|54362578|FG000|End of Cross Over Period|Lack of Efficacy|0|||
27853154|NCT03112603|54362579|FG001|End of Cross Over Period|Lack of Efficacy|0|||
27853155|NCT03112603|54362580|FG002|End of Cross Over Period|Lack of Efficacy|8|||
27853156|NCT03112603|54362578|FG000|End of Cross Over Period|Adverse Event|0|||
27853157|NCT03112603|54362579|FG001|End of Cross Over Period|Adverse Event|0|||
27853158|NCT03112603|54362580|FG002|End of Cross Over Period|Adverse Event|6|||
27853159|NCT03112603|54362578|FG000|End of Cross Over Period|Disease Relapse|0|||
27853160|NCT03112603|54362579|FG001|End of Cross Over Period|Disease Relapse|0|||
27853161|NCT03112603|54362580|FG002|End of Cross Over Period|Disease Relapse|2|||
27944232|NCT00972777|54601283|FG000|Overall Study|Physician Decision|4|||
28079929|NCT00096135|54733437|FG000|Overall Study|Refusal of further protocol therapy|4|||
28079930|NCT00096135|54733438|FG001|Overall Study|Refusal of further protocol therapy|1|||
27731243|NCT02337946|54178455|FG002|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
27731244|NCT02337946|54178453|FG000|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9|||
27853162|NCT03056001|54362589|FG000|Overall Study|Death|24|||
27853163|NCT03056001|54362589|FG000|Overall Study|Still On Study (in follow up)|1|||
27853164|NCT02725528|54362599|FG000|Overall Study|Lost to Follow-up|1|||
27853165|NCT02725528|54362600|FG001|Overall Study|Lost to Follow-up|4|||
27944233|NCT00972777|54601284|FG001|Overall Study|Physician Decision|0|||
28079931|NCT00096135|54733437|FG000|Overall Study|Progressive disease, Marrow,CNS, Relapse|22|||
27944234|NCT00972777|54601283|FG000|Overall Study|Protocol Violation|0|||
27944235|NCT00972777|54601284|FG001|Overall Study|Protocol Violation|2|||
27944236|NCT00972777|54601283|FG000|Overall Study|Screening Failure|2|||
27944237|NCT00972777|54601284|FG001|Overall Study|Screening Failure|1|||
27944238|NCT00972777|54601283|FG000|Overall Study|Missed visit|1|||
27944239|NCT00972777|54601284|FG001|Overall Study|Missed visit|0|||
27944240|NCT00918736|54601290|FG000|Overall Study|Withdrawal by Subject|4|||
27944241|NCT01172639|54601299|FG000|Overall Study|Death|1|||
27944242|NCT01172639|54601300|FG001|Overall Study|Death|1|||
27944243|NCT01172639|54601301|FG002|Overall Study|Death|0|||
27944244|NCT01172639|54601302|FG003|Overall Study|Death|0|||
27944245|NCT01172639|54601303|FG004|Overall Study|Death|0|||
27944246|NCT01172639|54601299|FG000|Overall Study|Lost to Follow-up|9|||
27944247|NCT01172639|54601300|FG001|Overall Study|Lost to Follow-up|7|||
27944248|NCT01172639|54601301|FG002|Overall Study|Lost to Follow-up|11|||
27944249|NCT01172639|54601302|FG003|Overall Study|Lost to Follow-up|6|||
27944250|NCT01172639|54601303|FG004|Overall Study|Lost to Follow-up|6|||
27944251|NCT01172639|54601299|FG000|Overall Study|Withdrawal by Subject|3|||
27944252|NCT01172639|54601300|FG001|Overall Study|Withdrawal by Subject|3|||
27944253|NCT01172639|54601301|FG002|Overall Study|Withdrawal by Subject|5|||
27944254|NCT01172639|54601302|FG003|Overall Study|Withdrawal by Subject|5|||
27944255|NCT01172639|54601303|FG004|Overall Study|Withdrawal by Subject|0|||
27944256|NCT01144182|54601317|FG000|Overall Study|Death|5|||
27944257|NCT01144182|54601318|FG001|Overall Study|Death|6|||
27944258|NCT01144182|54601317|FG000|Overall Study|Withdrawal by Subject|3|||
27944259|NCT01144182|54601318|FG001|Overall Study|Withdrawal by Subject|6|||
27944260|NCT01144182|54601317|FG000|Overall Study|Lost to Follow-up|9|||
27944261|NCT01144182|54601318|FG001|Overall Study|Lost to Follow-up|9|||
27944262|NCT01225562|54601328|FG000|Overall Study|Withdrawal by Subject|52|||
27944263|NCT01225562|54601329|FG001|Overall Study|Withdrawal by Subject|50|||
27944264|NCT01225562|54601330|FG002|Overall Study|Withdrawal by Subject|52|||
27944265|NCT01225562|54601328|FG000|Overall Study|Lost to Follow-up|3|||
27944266|NCT01225562|54601329|FG001|Overall Study|Lost to Follow-up|6|||
27944267|NCT01225562|54601330|FG002|Overall Study|Lost to Follow-up|1|||
27944268|NCT00925288|54601340|FG000|Overall Study|Lost to Follow-up|9|||
27944269|NCT00925288|54601341|FG001|Overall Study|Lost to Follow-up|7|||
27944270|NCT01143714|54601351|FG000|Overall Study|Adverse Event|4|||
27944271|NCT01143714|54601352|FG001|Overall Study|Adverse Event|2|||
27944272|NCT01143714|54601351|FG000|Overall Study|Withdrawal by Subject|1|||
27944273|NCT01143714|54601352|FG001|Overall Study|Withdrawal by Subject|0|||
27853166|NCT02725528|54362599|FG000|Overall Study|Withdrawal by Subject|0|||
27853167|NCT02725528|54362600|FG001|Overall Study|Withdrawal by Subject|1|||
27944274|NCT01143714|54601351|FG000|Overall Study|Subject non-compliance|0|||
27944275|NCT01143714|54601352|FG001|Overall Study|Subject non-compliance|1|||
27944276|NCT01143714|54601351|FG000|Overall Study|wound closed = deemed healed|1|||
27944277|NCT01143714|54601352|FG001|Overall Study|wound closed = deemed healed|0|||
27944278|NCT01143714|54601351|FG000|Overall Study|wound size increased|1|||
27944279|NCT01143714|54601352|FG001|Overall Study|wound size increased|0|||
27944280|NCT00972543|54601373|FG000|Overall Study|Adverse Event|1|||
27944281|NCT00972543|54601374|FG001|Overall Study|Adverse Event|0|||
27944282|NCT00972543|54601373|FG000|Overall Study|Early study termination by sponsor|4|||
27853168|NCT02627963|54362617|FG000|Overall Study|Randomized but not treated|2|||
27853169|NCT02627963|54362618|FG001|Overall Study|Randomized but not treated|6|||
27853170|NCT02585258|54362626|FG000|Overall Study|Adverse Event|28|||
27853171|NCT02585258|54362627|FG001|Overall Study|Adverse Event|29|||
27853172|NCT02585258|54362626|FG000|Overall Study|Death|3|||
27853173|NCT02585258|54362627|FG001|Overall Study|Death|2|||
27853174|NCT02585258|54362626|FG000|Overall Study|Lack of Efficacy|7|||
27853175|NCT02585258|54362627|FG001|Overall Study|Lack of Efficacy|9|||
27853176|NCT02585258|54362626|FG000|Overall Study|includes covid-related access problems|42|||
27853177|NCT02585258|54362627|FG001|Overall Study|includes covid-related access problems|46|||
27853178|NCT02585258|54362626|FG000|Overall Study|Lost to Follow-up|5|||
27944283|NCT00972543|54601374|FG001|Overall Study|Early study termination by sponsor|1|||
27944284|NCT00925132|54601380|FG000|Overall Study|Withdrawal by Subject|2|||
27944285|NCT00925132|54601381|FG001|Overall Study|Withdrawal by Subject|0|||
27944286|NCT00925132|54601382|FG002|Overall Study|Withdrawal by Subject|0|||
27944287|NCT00925132|54601383|FG003|Overall Study|Withdrawal by Subject|0|||
27944288|NCT00925132|54601384|FG004|Overall Study|Withdrawal by Subject|1|||
27944289|NCT00925132|54601380|FG000|Overall Study|Removed due to disease progression|0|||
27944290|NCT00925132|54601381|FG001|Overall Study|Removed due to disease progression|0|||
27944291|NCT00925132|54601382|FG002|Overall Study|Removed due to disease progression|0|||
27944292|NCT00925132|54601383|FG003|Overall Study|Removed due to disease progression|0|||
27944293|NCT00925132|54601384|FG004|Overall Study|Removed due to disease progression|4|||
27853179|NCT02585258|54362627|FG001|Overall Study|Lost to Follow-up|2|||
27853180|NCT02132611|54362653|FG000|Overall Study|Death|2|||
27853181|NCT01941030|54362659|FG000|Overall Study|Death|3|||
27944294|NCT01143402|54601393|FG000|Overall Study|Rapid clinical decline|1|||
27944295|NCT01143402|54601394|FG001|Overall Study|Rapid clinical decline|1|||
27944296|NCT01143402|54601395|FG002|Overall Study|Rapid clinical decline|0|||
27944297|NCT01143402|54601393|FG000|Overall Study|Not Treated|0|||
27944298|NCT01143402|54601394|FG001|Overall Study|Not Treated|0|||
27944299|NCT01143402|54601395|FG002|Overall Study|Not Treated|1|||
27944300|NCT01171625|54601402|FG000|Overall Study|On-Protocol|67|||
27944301|NCT01171625|54601402|FG000|Overall Study|Death|38|||
27944302|NCT01171625|54601402|FG000|Overall Study|Withdrawal by Subject|31|||
28164391|NCT01915498|54834963|FG017|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
28164392|NCT01915498|54834964|FG018|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
28164393|NCT01915498|54834946|FG000|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1|||
28164394|NCT01915498|54834947|FG001|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
28164395|NCT01915498|54834948|FG002|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
27731245|NCT02337946|54178454|FG001|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
27731246|NCT02337946|54178455|FG002|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
27731247|NCT02337946|54178453|FG000|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1|||
27731248|NCT02337946|54178454|FG001|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
27731249|NCT02337946|54178455|FG002|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
27731250|NCT02337946|54178453|FG000|Protocol Treatment 1 Period|Reason not specified|8|||
27731251|NCT02337946|54178454|FG001|Protocol Treatment 1 Period|Reason not specified|0|||
27731252|NCT02337946|54178455|FG002|Protocol Treatment 1 Period|Reason not specified|0|||
27731253|NCT02337946|54178453|FG000|In-between Period|Without Informed Consent|1|||
27731254|NCT02337946|54178454|FG001|In-between Period|Without Informed Consent|0|||
27731255|NCT02337946|54178455|FG002|In-between Period|Without Informed Consent|0|||
27731256|NCT02337946|54178453|FG000|Protocol Treatment 2 Period|Adverse Event|0|||
27731257|NCT02337946|54178454|FG001|Protocol Treatment 2 Period|Adverse Event|9|||
27731258|NCT02337946|54178455|FG002|Protocol Treatment 2 Period|Adverse Event|9|||
27731259|NCT02337946|54178453|FG000|Protocol Treatment 2 Period|Voluntary Withdrawal|0|||
27853182|NCT01941030|54362660|FG001|Overall Study|Death|2|||
27853183|NCT01941030|54362659|FG000|Overall Study|Lost to Follow-up|6|||
27853184|NCT01941030|54362660|FG001|Overall Study|Lost to Follow-up|5|||
27853185|NCT01941030|54362659|FG000|Overall Study|Withdrawal by Subject|4|||
27853186|NCT01941030|54362660|FG001|Overall Study|Withdrawal by Subject|6|||
27853187|NCT01874353|54362668|FG000|Overall Study|One patient was unblinded and one patient was randomised in error|2|||
27853188|NCT01874353|54362669|FG001|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
27853189|NCT01874353|54362670|FG002|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
27853190|NCT01874353|54362671|FG003|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
27853191|NCT01874353|54362668|FG000|Overall Study|Lost to Follow-up|2|||
27853192|NCT01874353|54362669|FG001|Overall Study|Lost to Follow-up|2|||
27853193|NCT01874353|54362670|FG002|Overall Study|Lost to Follow-up|2|||
27853194|NCT01874353|54362671|FG003|Overall Study|Lost to Follow-up|0|||
27853195|NCT01874353|54362668|FG000|Overall Study|Death|110|||
27853196|NCT01874353|54362669|FG001|Overall Study|Death|60|||
27853197|NCT01874353|54362670|FG002|Overall Study|Death|13|||
27853198|NCT01874353|54362671|FG003|Overall Study|Death|7|||
27853199|NCT01874353|54362668|FG000|Overall Study|Withdrawal by Subject|13|||
27853200|NCT01874353|54362669|FG001|Overall Study|Withdrawal by Subject|11|||
27853201|NCT01874353|54362670|FG002|Overall Study|Withdrawal by Subject|0|||
27853202|NCT01874353|54362671|FG003|Overall Study|Withdrawal by Subject|0|||
27853203|NCT01092416|54362688|FG000|Enrollment|Atherectomy device not inserted|3|||
27853204|NCT01092416|54362688|FG000|30-Day Follow-up|Death|2|||
27853205|NCT01092416|54362688|FG000|30-Day Follow-up|Missed 30-day follow-up|3|||
27853206|NCT01092416|54362688|FG000|30-Day Follow-up|Data collected after close of 30D window|5|||
27853207|NCT01092416|54362688|FG000|12-Month Follow-up|Death|16|||
27853208|NCT01092416|54362688|FG000|12-Month Follow-up|Lost to Follow-up|4|||
27853209|NCT01092416|54362688|FG000|12-Month Follow-up|Withdrawal by Subject|2|||
27853210|NCT01092416|54362688|FG000|12-Month Follow-up|Missed 1-year follow-up|1|||
27853211|NCT01092416|54362688|FG000|12-Month Follow-up|Data collected after close of 1Y window|2|||
27853212|NCT00701220|54362697|FG000|Overall Study|Withdrawal by Subject|0|||
27853213|NCT00701220|54362698|FG001|Overall Study|Withdrawal by Subject|2|||
27944303|NCT01171625|54601402|FG000|Overall Study|Explanted|10|||
27944304|NCT01171625|54601402|FG000|Overall Study|Lost to Follow-up|5|||
27853214|NCT00701220|54362697|FG000|Overall Study|Protocol Violation|2|||
27853215|NCT00701220|54362698|FG001|Overall Study|Protocol Violation|0|||
27853216|NCT00559845|54362772|FG000|Overall Study|Withdrew Consent|1|||
27853217|NCT00559845|54362772|FG000|Overall Study|Disease Progression|1|||
27853218|NCT00559845|54362772|FG000|Overall Study|Adverse Event|3|||
27853219|NCT00559845|54362772|FG000|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1|||
27853220|NCT00559845|54362772|FG000|Overall Study|Premature Surgery-Investigator Decision|1|||
27853221|NCT01393964|54362875|FG000|Overall Study|Disease Progression|4|||
27944305|NCT01171625|54601402|FG000|Overall Study|Patient received valve-in-valve|3|||
27944306|NCT01171625|54601402|FG000|Overall Study|Other|1|||
28164396|NCT01915498|54834949|FG003|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
27853222|NCT01393964|54362876|FG001|Overall Study|Disease Progression|3|||
27853223|NCT01393964|54362877|FG002|Overall Study|Disease Progression|5|||
27853224|NCT01393964|54362875|FG000|Overall Study|Study drug toxicity|1|||
27853225|NCT01393964|54362876|FG001|Overall Study|Study drug toxicity|0|||
27853226|NCT01393964|54362877|FG002|Overall Study|Study drug toxicity|0|||
27853227|NCT01393964|54362875|FG000|Overall Study|Withdrawal by Subject|0|||
27853228|NCT01393964|54362876|FG001|Overall Study|Withdrawal by Subject|0|||
27853229|NCT01393964|54362877|FG002|Overall Study|Withdrawal by Subject|1|||
27853230|NCT01393964|54362875|FG000|Overall Study|Adverse event unrelated to study drug|0|||
27853231|NCT01393964|54362876|FG001|Overall Study|Adverse event unrelated to study drug|3|||
27853232|NCT01393964|54362877|FG002|Overall Study|Adverse event unrelated to study drug|0|||
27853233|NCT01393964|54362875|FG000|Overall Study|Subject request stop study treatment|0|||
27944307|NCT01171625|54601402|FG000|Overall Study|Consented but did not receive device|25|||
27944308|NCT00924898|54601414|FG000|Overall Study|Withdrawal by Subject|2|||
27944309|NCT01167192|54601423|FG000|Overall Study|Adverse Event|1|||
27944310|NCT01167192|54601423|FG000|Overall Study|Death|1|||
27944311|NCT01167192|54601423|FG000|Overall Study|Withdrawal by Subject|1|||
27944312|NCT01167192|54601423|FG000|Overall Study|Insurance denial|1|||
27944313|NCT01166958|54601429|FG000|Overall Study|Withdrawal by Subject|1|||
27944314|NCT01166958|54601430|FG001|Overall Study|Withdrawal by Subject|0|||
27944315|NCT01170221|54601438|FG000|Overall Study|Lost to Follow-up|22|||
27944316|NCT01170221|54601439|FG001|Overall Study|Lost to Follow-up|21|||
27944317|NCT01170221|54601438|FG000|Overall Study|Withdrawal by Subject|9|||
27944318|NCT01170221|54601439|FG001|Overall Study|Withdrawal by Subject|7|||
27944319|NCT01170221|54601438|FG000|Overall Study|Subject completed only screening and LFU|1|||
27944320|NCT01170221|54601439|FG001|Overall Study|Subject completed only screening and LFU|0|||
27944321|NCT01170221|54601438|FG000|Overall Study|Randomized but not treated|1|||
27944322|NCT01170221|54601439|FG001|Overall Study|Randomized but not treated|0|||
27944323|NCT01166646|54601447|FG000|Overall Study|Protocol Violation|0|||
27944324|NCT01166646|54601448|FG001|Overall Study|Protocol Violation|1|||
27944325|NCT01166646|54601447|FG000|Overall Study|Adverse Event|1|||
27944326|NCT01166646|54601448|FG001|Overall Study|Adverse Event|0|||
27944327|NCT01129284|54601457|FG000|Overall Study|Adverse Event|2|||
27944328|NCT01129284|54601458|FG001|Overall Study|Adverse Event|0|||
27944329|NCT01129284|54601459|FG002|Overall Study|Adverse Event|1|||
27944330|NCT01166568|54601470|FG000|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
27853234|NCT01393964|54362876|FG001|Overall Study|Subject request stop study treatment|1|||
27944331|NCT01166568|54601471|FG001|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
27944332|NCT01166568|54601472|FG002|Deferred Implantation- Randomized|Withdrawal by Subject|1|||
27944333|NCT01166568|54601470|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7|||
27944334|NCT01166568|54601471|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
27944335|NCT01166568|54601472|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0|||
27944336|NCT01166568|54601470|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7|||
27944337|NCT01166568|54601471|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
27944338|NCT01166568|54601472|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
27944339|NCT01166178|54601480|FG000|Overall Study|Withdrawal by Subject|1|||
27944340|NCT01166178|54601481|FG001|Overall Study|Withdrawal by Subject|0|||
27944341|NCT01166178|54601480|FG000|Overall Study|Study was terminated|20|||
27944342|NCT01166178|54601481|FG001|Overall Study|Study was terminated|8|||
27944343|NCT00924820|54601487|FG000|Overall Study|Death|2|||
27944344|NCT00924820|54601487|FG000|Overall Study|Ineligible, Screen Failure|5|||
27944345|NCT01225172|54601493|FG000|Overall Study|Subject decision to stop|1|||
27944346|NCT01225172|54601494|FG001|Overall Study|Subject decision to stop|0|||
27944347|NCT01225172|54601493|FG000|Overall Study|Subject request to discontinue treatment|3|||
27944348|NCT01225172|54601494|FG001|Overall Study|Subject request to discontinue treatment|1|||
27944349|NCT01225172|54601493|FG000|Overall Study|Subject no longer meets study criteria|1|||
27944350|NCT01225172|54601494|FG001|Overall Study|Subject no longer meets study criteria|0|||
27944351|NCT01225172|54601493|FG000|Overall Study|Withdrawal by Subject|1|||
27944352|NCT01225172|54601494|FG001|Overall Study|Withdrawal by Subject|0|||
27944353|NCT01143324|54601500|FG000|Overall Study|Lost to Follow-up|11|||
27944354|NCT01143324|54601500|FG000|Overall Study|Withdrawal by Subject|4|||
27944355|NCT01143324|54601500|FG000|Overall Study|Explant of the device|4|||
27944356|NCT01224782|54601504|FG000|Overall Study|Lost to Follow-up|177|||
27944357|NCT01224782|54601504|FG000|Overall Study|Withdrawal by Subject|16|||
27944358|NCT01224782|54601504|FG000|Overall Study|Death|14|||
27944359|NCT01224782|54601504|FG000|Overall Study|Improvement|13|||
27944360|NCT01224782|54601504|FG000|Overall Study|Adverse Event|12|||
27853235|NCT01393964|54362877|FG002|Overall Study|Subject request stop study treatment|0|||
27853236|NCT01393964|54362875|FG000|Overall Study|Subject decided to move to transplant|1|||
27853237|NCT01393964|54362876|FG001|Overall Study|Subject decided to move to transplant|0|||
27853238|NCT01393964|54362877|FG002|Overall Study|Subject decided to move to transplant|0|||
27853239|NCT01393964|54362875|FG000|Overall Study|Subject switched to commercial supply|1|||
27853240|NCT01393964|54362876|FG001|Overall Study|Subject switched to commercial supply|0|||
27944361|NCT01224782|54601504|FG000|Overall Study|Adverse Reaction|11|||
27944362|NCT01224782|54601504|FG000|Overall Study|Noncompliance|10|||
27944363|NCT01224782|54601504|FG000|Overall Study|Other|4|||
27944364|NCT01224782|54601504|FG000|Overall Study|Start of Dialysis|3|||
27944365|NCT01224782|54601504|FG000|Overall Study|Change of Treatment|1|||
27944366|NCT01224782|54601504|FG000|Overall Study|Financial Reasons|1|||
27944367|NCT01224782|54601504|FG000|Overall Study|Deterioration|1|||
27944368|NCT01224782|54601504|FG000|Overall Study|Transplantation|1|||
27944369|NCT01224158|54601510|FG000|Overall Study|Withdrawal by Subject|1|||
27944370|NCT01224158|54601511|FG001|Overall Study|Withdrawal by Subject|0|||
27944371|NCT01129128|54601520|FG000|Overall Study|Lost to Follow-up|2|||
27944372|NCT01129128|54601521|FG001|Overall Study|Lost to Follow-up|2|||
27944373|NCT01129128|54601522|FG002|Overall Study|Lost to Follow-up|1|||
27944374|NCT01129128|54601520|FG000|Overall Study|Protocol Violation|0|||
27944375|NCT01129128|54601521|FG001|Overall Study|Protocol Violation|1|||
27944376|NCT01129128|54601522|FG002|Overall Study|Protocol Violation|0|||
27944377|NCT01129128|54601520|FG000|Overall Study|Withdrawal by Subject|0|||
27944378|NCT01129128|54601521|FG001|Overall Study|Withdrawal by Subject|1|||
27944379|NCT01129128|54601522|FG002|Overall Study|Withdrawal by Subject|3|||
27944380|NCT01129128|54601520|FG000|Overall Study|Physician Decision|1|||
27944381|NCT01129128|54601521|FG001|Overall Study|Physician Decision|0|||
27944382|NCT01129128|54601522|FG002|Overall Study|Physician Decision|0|||
27944383|NCT01222520|54601532|FG000|Open-label run-in Period|Withdrawal by Subject|0|||
27944384|NCT01222520|54601533|FG001|Open-label run-in Period|Withdrawal by Subject|2|||
27944385|NCT01222520|54601532|FG000|Open-label run-in Period|Blood pressure criteria not met|0|||
27944386|NCT01222520|54601533|FG001|Open-label run-in Period|Blood pressure criteria not met|18|||
27944387|NCT01222520|54601532|FG000|Open-label run-in Period|Number of patients fulfilled|0|||
27944388|NCT01222520|54601533|FG001|Open-label run-in Period|Number of patients fulfilled|3|||
27944389|NCT01222520|54601532|FG000|Double-blind Period|Adverse Event|0|||
27944390|NCT01222520|54601533|FG001|Double-blind Period|Adverse Event|1|||
27944391|NCT01222520|54601532|FG000|Double-blind Period|Lack of Efficacy|0|||
27944392|NCT01222520|54601533|FG001|Double-blind Period|Lack of Efficacy|1|||
27944393|NCT01222520|54601532|FG000|Double-blind Period|Study medication stolen|1|||
27944394|NCT01222520|54601533|FG001|Double-blind Period|Study medication stolen|0|||
27944395|NCT01221350|54601541|FG000|Overall Study|Discontinued intervention (GERD)|1|||
27944396|NCT01221350|54601542|FG001|Overall Study|Discontinued intervention (GERD)|0|||
27944397|NCT01221350|54601541|FG000|Overall Study|Exclusion criteria, asthma exacerbation|0|||
27944398|NCT01221350|54601542|FG001|Overall Study|Exclusion criteria, asthma exacerbation|1|||
27944399|NCT01221350|54601541|FG000|Overall Study|Withdrawal by Subject|4|||
27944400|NCT01221350|54601542|FG001|Overall Study|Withdrawal by Subject|2|||
27944401|NCT01221272|54601550|FG000|Period 1|Adverse Event|2|||
27944402|NCT01221272|54601551|FG001|Period 1|Adverse Event|0|||
27944403|NCT01221272|54601550|FG000|Period 1|Consent Withdrawal|0|||
27944404|NCT01221272|54601551|FG001|Period 1|Consent Withdrawal|1|||
27944405|NCT01221272|54601550|FG000|Period 1|Significant Dosing Noncompliance|0|||
27944406|NCT01221272|54601551|FG001|Period 1|Significant Dosing Noncompliance|1|||
27944407|NCT01221272|54601550|FG000|Period 2|Adverse Event|0|||
27944408|NCT01221272|54601551|FG001|Period 2|Adverse Event|2|||
27944409|NCT01220414|54601562|FG000|Overall Study|Withdrawal by Subject|1|||
27944410|NCT01220414|54601563|FG001|Overall Study|Withdrawal by Subject|0|||
27944411|NCT01220414|54601564|FG002|Overall Study|Withdrawal by Subject|0|||
27944412|NCT01220414|54601565|FG003|Overall Study|Withdrawal by Subject|1|||
27944413|NCT01128894|54601574|FG000|Overall Study|Adverse Event|31|||
27944414|NCT01128894|54601575|FG001|Overall Study|Adverse Event|41|||
27944415|NCT01128894|54601574|FG000|Overall Study|Protocol Violation|2|||
27944416|NCT01128894|54601575|FG001|Overall Study|Protocol Violation|1|||
27944417|NCT01128894|54601574|FG000|Overall Study|Noncompliance|4|||
27944418|NCT01128894|54601575|FG001|Overall Study|Noncompliance|5|||
27944419|NCT01128894|54601574|FG000|Overall Study|Lost to Follow-up|8|||
27944420|NCT01128894|54601575|FG001|Overall Study|Lost to Follow-up|8|||
27944421|NCT01128894|54601574|FG000|Overall Study|Withdrawal by Subject|10|||
27944422|NCT01128894|54601575|FG001|Overall Study|Withdrawal by Subject|12|||
27944423|NCT01128894|54601574|FG000|Overall Study|Physician Decision|2|||
27944424|NCT01128894|54601575|FG001|Overall Study|Physician Decision|1|||
27944425|NCT01128894|54601574|FG000|Overall Study|Conflicting HbA1c Results at Screening|1|||
27944426|NCT01128894|54601575|FG001|Overall Study|Conflicting HbA1c Results at Screening|0|||
28079932|NCT00096135|54733438|FG001|Overall Study|Progressive disease, Marrow,CNS, Relapse|7|||
28079933|NCT00096135|54733437|FG000|Overall Study|Other, specify|15|||
28079934|NCT00096135|54733438|FG001|Overall Study|Other, specify|3|||
27944427|NCT01220180|54601584|FG000|Overall Study|Lost to Follow-up|76|||
27944428|NCT01220180|54601584|FG000|Overall Study|Other|72|||
28079935|NCT00096135|54733437|FG000|Overall Study|Ineligible|2|||
27944429|NCT01220180|54601584|FG000|Overall Study|Adverse Event|35|||
27944430|NCT01220180|54601584|FG000|Overall Study|Lack of Efficacy|22|||
27944431|NCT01220180|54601584|FG000|Overall Study|Death|1|||
27944432|NCT01220180|54601584|FG000|Overall Study|Randomized but not treated|1|||
27944433|NCT01220024|54601590|FG000|Overall Study|Lost to Follow-up|1|||
27731260|NCT02337946|54178454|FG001|Protocol Treatment 2 Period|Voluntary Withdrawal|3|||
27731261|NCT02337946|54178455|FG002|Protocol Treatment 2 Period|Voluntary Withdrawal|1|||
27731262|NCT02337946|54178453|FG000|Protocol Treatment 2 Period|Lack of Efficacy|0|||
27944434|NCT01220024|54601591|FG001|Overall Study|Lost to Follow-up|1|||
27944435|NCT01128738|54601599|FG000|First Treatment Phase (TP)|Lost to Follow-up|1|||
27944436|NCT01128738|54601600|FG001|First Treatment Phase (TP)|Lost to Follow-up|0|||
27944437|NCT01128738|54601599|FG000|First Treatment Phase (TP)|Withdrawal by Subject|3|||
27944438|NCT01128738|54601600|FG001|First Treatment Phase (TP)|Withdrawal by Subject|1|||
27944439|NCT01128738|54601599|FG000|Second TP|Lost to Follow-up|0|||
27944440|NCT01128738|54601600|FG001|Second TP|Lost to Follow-up|1|||
27944441|NCT01128738|54601599|FG000|Second TP|Withdrawal by Subject|0|||
27944442|NCT01128738|54601600|FG001|Second TP|Withdrawal by Subject|2|||
27944443|NCT01143090|54601607|FG000|Overall Study|Lack of Efficacy|2|||
27944444|NCT01143090|54601607|FG000|Overall Study|Adverse Event|17|||
27944445|NCT01143090|54601607|FG000|Overall Study|Lost to Follow-up|9|||
27944446|NCT01143090|54601607|FG000|Overall Study|Protocol Violation|2|||
27944447|NCT01143090|54601607|FG000|Overall Study|Withdrawal by Subject|18|||
27944448|NCT01143090|54601607|FG000|Overall Study|Non-compliance with study drug|1|||
27944449|NCT01143090|54601607|FG000|Overall Study|Failure to meet eligibility criteria|1|||
27944450|NCT01143090|54601607|FG000|Overall Study|Administrative|1|||
27944451|NCT01165554|54601611|FG000|Overall Study|Withdrawal by Subject|23|||
27944452|NCT01218308|54601620|FG000|Overall Study|Adverse Event|1|||
27944453|NCT01218308|54601621|FG001|Overall Study|Adverse Event|2|||
27944454|NCT01218308|54601620|FG000|Overall Study|Protocol Violation|0|||
27944455|NCT01218308|54601621|FG001|Overall Study|Protocol Violation|2|||
27944456|NCT01218308|54601620|FG000|Overall Study|Withdrawal by Subject|61|||
27944457|NCT01218308|54601621|FG001|Overall Study|Withdrawal by Subject|64|||
27944458|NCT01218308|54601620|FG000|Overall Study|Lost to Follow-up|27|||
27944459|NCT01218308|54601621|FG001|Overall Study|Lost to Follow-up|31|||
27944460|NCT01218308|54601620|FG000|Overall Study|Other|14|||
27944461|NCT01218308|54601621|FG001|Overall Study|Other|21|||
27944462|NCT01165320|54601629|FG000|Overall Study|Clinical adverse experience|2|||
27944463|NCT01165320|54601630|FG001|Overall Study|Clinical adverse experience|1|||
27944464|NCT01165320|54601631|FG002|Overall Study|Clinical adverse experience|0|||
27944465|NCT01165320|54601629|FG000|Overall Study|Laboratory adverse experience|1|||
27944466|NCT01165320|54601630|FG001|Overall Study|Laboratory adverse experience|0|||
27944467|NCT01165320|54601631|FG002|Overall Study|Laboratory adverse experience|0|||
27944468|NCT01165320|54601629|FG000|Overall Study|Lack of Efficacy|0|||
27944469|NCT01165320|54601630|FG001|Overall Study|Lack of Efficacy|2|||
27944470|NCT01165320|54601631|FG002|Overall Study|Lack of Efficacy|0|||
27944471|NCT01165320|54601629|FG000|Overall Study|Reason unknown|0|||
27944472|NCT01165320|54601630|FG001|Overall Study|Reason unknown|1|||
27944473|NCT01165320|54601631|FG002|Overall Study|Reason unknown|0|||
27944474|NCT01217606|54601639|FG000|Initial Treatment Phase|Other Reasons|0|||
27944475|NCT01217606|54601640|FG001|Initial Treatment Phase|Other Reasons|2|||
27944476|NCT01217606|54601639|FG000|Initial Treatment Phase|Protocol Violation|3|||
27944477|NCT01217606|54601640|FG001|Initial Treatment Phase|Protocol Violation|2|||
27944478|NCT01217606|54601639|FG000|Initial Treatment Phase|Personal Reasons|0|||
27944479|NCT01217606|54601640|FG001|Initial Treatment Phase|Personal Reasons|2|||
27944480|NCT01217606|54601639|FG000|Initial Treatment Phase|Lack of Efficacy|1|||
27944481|NCT01217606|54601640|FG001|Initial Treatment Phase|Lack of Efficacy|0|||
27944482|NCT01217606|54601639|FG000|Initial Treatment Phase|Adverse Event|10|||
27944483|NCT01217606|54601640|FG001|Initial Treatment Phase|Adverse Event|6|||
27944484|NCT01217606|54601639|FG000|9-Month Masked Extension|Adverse Event|3|||
27944485|NCT01217606|54601640|FG001|9-Month Masked Extension|Adverse Event|6|||
27944486|NCT01217606|54601639|FG000|9-Month Masked Extension|Other Reasons|4|||
27944487|NCT01217606|54601640|FG001|9-Month Masked Extension|Other Reasons|4|||
27944488|NCT01217606|54601639|FG000|9-Month Masked Extension|Personal Reasons|2|||
27944489|NCT01217606|54601640|FG001|9-Month Masked Extension|Personal Reasons|1|||
27944490|NCT01217606|54601639|FG000|9-Month Masked Extension|Lost to Follow-up|1|||
27944491|NCT01217606|54601640|FG001|9-Month Masked Extension|Lost to Follow-up|0|||
27944492|NCT01217606|54601639|FG000|9-Month Masked Extension|Pregnancy|1|||
27944493|NCT01217606|54601640|FG001|9-Month Masked Extension|Pregnancy|0|||
27944494|NCT01217606|54601639|FG000|9-Month Masked Extension|Lack of Efficacy|2|||
27731263|NCT02337946|54178454|FG001|Protocol Treatment 2 Period|Lack of Efficacy|29|||
27731264|NCT02337946|54178455|FG002|Protocol Treatment 2 Period|Lack of Efficacy|29|||
27944495|NCT01217606|54601640|FG001|9-Month Masked Extension|Lack of Efficacy|0|||
27944496|NCT01128114|54601646|FG000|Overall Study|Treatment Withdrawn|6|||
27944497|NCT01128114|54601646|FG000|Overall Study|Screening Failed|2|||
27944498|NCT01217060|54601650|FG000|Overall Study|Withdrawal by Subject|1|||
27944499|NCT01216202|54601656|FG000|Overall Study|Withdrawal by Subject|8|||
27944500|NCT01216202|54601657|FG001|Overall Study|Withdrawal by Subject|0|||
27944501|NCT01216202|54601656|FG000|Overall Study|Death|0|||
27944502|NCT01216202|54601657|FG001|Overall Study|Death|2|||
27944503|NCT01216202|54601656|FG000|Overall Study|Lost to Follow-up|14|||
27944504|NCT01216202|54601657|FG001|Overall Study|Lost to Follow-up|0|||
28164397|NCT01915498|54834950|FG004|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
28164398|NCT01915498|54834951|FG005|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1|||
28164399|NCT01915498|54834952|FG006|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
28164400|NCT01915498|54834953|FG007|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
28164401|NCT01915498|54834954|FG008|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
28164402|NCT01915498|54834955|FG009|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
28164403|NCT01915498|54834956|FG010|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
28164404|NCT01915498|54834957|FG011|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
28164405|NCT01915498|54834958|FG012|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
28164406|NCT01915498|54834959|FG013|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
28164407|NCT01915498|54834960|FG014|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1|||
28164408|NCT01915498|54834961|FG015|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
28164409|NCT01915498|54834962|FG016|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
28164410|NCT01915498|54834963|FG017|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|2|||
28164411|NCT01915498|54834964|FG018|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
28164412|NCT01915498|54834946|FG000|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
28164413|NCT01915498|54834947|FG001|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
28164414|NCT01915498|54834948|FG002|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
28164415|NCT01915498|54834949|FG003|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
28164416|NCT01915498|54834950|FG004|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
28164417|NCT01915498|54834951|FG005|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
28164418|NCT01915498|54834952|FG006|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
28164419|NCT01915498|54834953|FG007|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
28164420|NCT01915498|54834954|FG008|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
28164421|NCT01915498|54834955|FG009|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
28164422|NCT01915498|54834956|FG010|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
28164423|NCT01915498|54834957|FG011|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
27731265|NCT02337946|54178453|FG000|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
27853241|NCT01393964|54362877|FG002|Overall Study|Subject switched to commercial supply|2|||
27853242|NCT01393964|54362875|FG000|Overall Study|Subject plateaued in terms of effect|1|||
27853243|NCT01393964|54362876|FG001|Overall Study|Subject plateaued in terms of effect|0|||
27853244|NCT01393964|54362877|FG002|Overall Study|Subject plateaued in terms of effect|0|||
27853245|NCT01393964|54362875|FG000|Overall Study|Investigator removed subject from study|0|||
27853246|NCT01393964|54362876|FG001|Overall Study|Investigator removed subject from study|1|||
27853247|NCT01393964|54362877|FG002|Overall Study|Investigator removed subject from study|0|||
27853248|NCT01393964|54362875|FG000|Overall Study|Subject converted to roll-over study|0|||
27853249|NCT01393964|54362876|FG001|Overall Study|Subject converted to roll-over study|1|||
27853250|NCT01393964|54362877|FG002|Overall Study|Subject converted to roll-over study|0|||
27853251|NCT01393964|54362875|FG000|Overall Study|Subject to receive non-protocol therapy|0|||
27853252|NCT01393964|54362876|FG001|Overall Study|Subject to receive non-protocol therapy|0|||
27853253|NCT01393964|54362877|FG002|Overall Study|Subject to receive non-protocol therapy|1|||
27853254|NCT01393730|54362965|FG000|Overall Study|Withdrawal by Subject|3|||
27853255|NCT01393730|54362965|FG000|Overall Study|Other|2|||
28164424|NCT01915498|54834958|FG012|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
28164425|NCT01915498|54834959|FG013|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
28164426|NCT01915498|54834960|FG014|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
28164427|NCT01915498|54834961|FG015|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
27853256|NCT01393730|54362965|FG000|Overall Study|Adverse Event|1|||
27853257|NCT01393106|54362984|FG000|Overall Study|Adverse Event|3|||
27853258|NCT01393106|54362984|FG000|Overall Study|Withdrawal by Subject|1|||
27853259|NCT01393106|54362984|FG000|Overall Study|Lack of Efficacy|1|||
27853260|NCT00553059|54362990|FG000|Overall Study|Deemed ineligible|1|||
27853261|NCT00553059|54362991|FG001|Overall Study|Deemed ineligible|1|||
27853262|NCT00553059|54362990|FG000|Overall Study|Drug supply not available|0|||
27853263|NCT00553059|54362991|FG001|Overall Study|Drug supply not available|1|||
27853264|NCT01413542|54363024|FG000|Overall Study|Physician Decision|1|||
27853265|NCT01413542|54363025|FG001|Overall Study|Physician Decision|0|||
27853266|NCT01413542|54363026|FG002|Overall Study|Physician Decision|3|||
27731266|NCT02337946|54178454|FG001|Protocol Treatment 2 Period|Death During Protocol Treatment|1|||
27853267|NCT01413542|54363027|FG003|Overall Study|Physician Decision|0|||
27853268|NCT01413542|54363024|FG000|Overall Study|Adverse Event|0|||
27853269|NCT01413542|54363025|FG001|Overall Study|Adverse Event|0|||
27853270|NCT01413542|54363026|FG002|Overall Study|Adverse Event|0|||
27853271|NCT01413542|54363027|FG003|Overall Study|Adverse Event|1|||
27853272|NCT01432730|54363059|FG000|Period 1|Adverse Event|2|||
27853273|NCT01432730|54363060|FG001|Period 1|Adverse Event|0|||
27853274|NCT01432730|54363059|FG000|Period 2|Adverse Event|0|||
27853275|NCT01432730|54363060|FG001|Period 2|Adverse Event|4|||
27853276|NCT01432574|54363075|FG000|Overall Study|Moved|2|||
27944505|NCT04816669|54601669|FG000|Part 1|Adverse Event|1|||
27944506|NCT04816669|54601670|FG001|Part 1|Adverse Event|1|||
27944507|NCT04816669|54601671|FG002|Part 1|Adverse Event|0|||
27944508|NCT04816669|54601672|FG003|Part 1|Adverse Event|0|||
27944509|NCT04816669|54601669|FG000|Part 1|Lost to Follow-up|2|||
27944510|NCT04816669|54601670|FG001|Part 1|Lost to Follow-up|2|||
27944511|NCT04816669|54601671|FG002|Part 1|Lost to Follow-up|0|||
27944512|NCT04816669|54601672|FG003|Part 1|Lost to Follow-up|0|||
28164428|NCT01915498|54834962|FG016|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
28164429|NCT01915498|54834963|FG017|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
28164430|NCT01915498|54834964|FG018|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
28164431|NCT01915498|54834946|FG000|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
28164432|NCT01915498|54834947|FG001|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
28164433|NCT01915498|54834948|FG002|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
28164434|NCT01915498|54834949|FG003|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
28164435|NCT01915498|54834950|FG004|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
28164436|NCT01915498|54834951|FG005|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
28164437|NCT01915498|54834952|FG006|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
28164438|NCT01915498|54834953|FG007|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
28164439|NCT01915498|54834954|FG008|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
28164440|NCT01915498|54834955|FG009|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
28164441|NCT01915498|54834956|FG010|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
28164442|NCT01915498|54834957|FG011|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
28164443|NCT01915498|54834958|FG012|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
28164444|NCT01915498|54834959|FG013|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
28164445|NCT01915498|54834960|FG014|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
28164446|NCT01915498|54834961|FG015|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
28164447|NCT01915498|54834962|FG016|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
28164448|NCT01915498|54834963|FG017|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
28164449|NCT01915498|54834964|FG018|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|2|||
28164450|NCT01798004|54835056|FG000|Overall Study|Death|2|||
27731267|NCT02337946|54178455|FG002|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
27731268|NCT02337946|54178453|FG000|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0|||
28164451|NCT01798004|54835056|FG000|Overall Study|Lack of Efficacy|8|||
28164452|NCT01798004|54835056|FG000|Overall Study|Physician Decision|25|||
28164453|NCT01798004|54835056|FG000|Overall Study|Withdrawal by Subject|4|||
28164454|NCT01798004|54835056|FG000|Overall Study|Ineligible|4|||
28164455|NCT01798004|54835056|FG000|Overall Study|Patient/parent refusal|7|||
28164456|NCT01798004|54835056|FG000|Overall Study|Initiation of other non-protocol therapy|5|||
28164457|NCT01798004|54835056|FG000|Overall Study|Enrollment another COG therapeutic trial|32|||
28164458|NCT01630434|54835062|FG000|Overall Study|Donor lungs turned down|1|||
28164459|NCT01630434|54835063|FG001|Overall Study|Donor lungs turned down|0|||
28164460|NCT01630434|54835062|FG000|Overall Study|Protocol Violation|9|||
28164461|NCT01630434|54835063|FG001|Overall Study|Protocol Violation|4|||
27944513|NCT04816669|54601669|FG000|Part 1|Protocol Violation|0|||
27944514|NCT04816669|54601670|FG001|Part 1|Protocol Violation|1|||
27944515|NCT04816669|54601671|FG002|Part 1|Protocol Violation|0|||
27944516|NCT04816669|54601672|FG003|Part 1|Protocol Violation|0|||
27944517|NCT04816669|54601669|FG000|Part 1|Withdrawal by Subject|1|||
27944518|NCT04816669|54601670|FG001|Part 1|Withdrawal by Subject|2|||
27944519|NCT04816669|54601671|FG002|Part 1|Withdrawal by Subject|0|||
27944520|NCT04816669|54601672|FG003|Part 1|Withdrawal by Subject|0|||
27944521|NCT04816669|54601669|FG000|Part 2|Other|0|||
27944522|NCT04816669|54601670|FG001|Part 2|Other|0|||
27944523|NCT04816669|54601671|FG002|Part 2|Other|1|||
27944524|NCT04816669|54601672|FG003|Part 2|Other|0|||
27944525|NCT04816669|54601669|FG000|Part 2|Withdrawal by Subject|0|||
27944526|NCT04816669|54601670|FG001|Part 2|Withdrawal by Subject|0|||
27944527|NCT04816669|54601671|FG002|Part 2|Withdrawal by Subject|0|||
27944528|NCT04816669|54601672|FG003|Part 2|Withdrawal by Subject|1|||
27944529|NCT04816669|54601669|FG000|Part 2|Lost to Follow-up|0|||
28164462|NCT01630434|54835062|FG000|Overall Study|Death|20|||
28164463|NCT01630434|54835063|FG001|Overall Study|Death|26|||
27731269|NCT02337946|54178454|FG001|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5|||
27831685|NCT02859558|54310313|FG001|Step 1|Incarceration|1|||
28164464|NCT01256398|54835073|FG000|Overall Study|Withdrawal by Subject|1|||
27831686|NCT02859558|54310314|FG002|Step 1|Incarceration|0|||
27831687|NCT02859558|54310315|FG003|Step 1|Incarceration|0|||
27831688|NCT02859558|54310316|FG004|Step 1|Incarceration|0|||
27831689|NCT02859558|54310312|FG000|Step 1|Non-Adherence to Study Drug|2|||
27831690|NCT02859558|54310313|FG001|Step 1|Non-Adherence to Study Drug|0|||
27831691|NCT02859558|54310314|FG002|Step 1|Non-Adherence to Study Drug|1|||
27831692|NCT02859558|54310315|FG003|Step 1|Non-Adherence to Study Drug|0|||
27831693|NCT02859558|54310316|FG004|Step 1|Non-Adherence to Study Drug|0|||
27944530|NCT04816669|54601670|FG001|Part 2|Lost to Follow-up|0|||
27944531|NCT04816669|54601671|FG002|Part 2|Lost to Follow-up|1|||
27944532|NCT04816669|54601672|FG003|Part 2|Lost to Follow-up|0|||
27944533|NCT01165242|54601689|FG000|Overall Study|Unreachable Subjects|1|||
27944534|NCT01165242|54601690|FG001|Overall Study|Unreachable Subjects|0|||
27944535|NCT01165242|54601691|FG002|Overall Study|Unreachable Subjects|0|||
27944536|NCT01165242|54601689|FG000|Overall Study|Incarcerated Subjects|0|||
27944537|NCT01165242|54601690|FG001|Overall Study|Incarcerated Subjects|1|||
27944538|NCT01165242|54601691|FG002|Overall Study|Incarcerated Subjects|0|||
27944539|NCT01165242|54601689|FG000|Overall Study|Visit 2 Declined by Subject|0|||
27944540|NCT01165242|54601690|FG001|Overall Study|Visit 2 Declined by Subject|0|||
27944541|NCT01165242|54601691|FG002|Overall Study|Visit 2 Declined by Subject|1|||
27944542|NCT01165242|54601689|FG000|Overall Study|Withdrawal by Subject|0|||
27944543|NCT01165242|54601690|FG001|Overall Study|Withdrawal by Subject|2|||
27944544|NCT01165242|54601691|FG002|Overall Study|Withdrawal by Subject|2|||
27944545|NCT01165242|54601689|FG000|Overall Study|Extended Holiday|0|||
27944546|NCT01165242|54601690|FG001|Overall Study|Extended Holiday|0|||
27944547|NCT01165242|54601691|FG002|Overall Study|Extended Holiday|1|||
27944548|NCT01165242|54601689|FG000|Overall Study|Lost to Follow-up|9|||
27944549|NCT01165242|54601690|FG001|Overall Study|Lost to Follow-up|7|||
27944550|NCT01165242|54601691|FG002|Overall Study|Lost to Follow-up|10|||
27944551|NCT01170065|54601704|FG000|Overall Study|Adverse Event|17|||
27944552|NCT01170065|54601705|FG001|Overall Study|Adverse Event|50|||
27944553|NCT01170065|54601706|FG002|Overall Study|Adverse Event|10|||
27944554|NCT01170065|54601704|FG000|Overall Study|Lost to Follow-up|1|||
27944555|NCT01170065|54601705|FG001|Overall Study|Lost to Follow-up|4|||
27944556|NCT01170065|54601706|FG002|Overall Study|Lost to Follow-up|1|||
27944557|NCT01170065|54601704|FG000|Overall Study|Consent withdrawn, not due to AE|2|||
27944558|NCT01170065|54601705|FG001|Overall Study|Consent withdrawn, not due to AE|4|||
27944559|NCT01170065|54601706|FG002|Overall Study|Consent withdrawn, not due to AE|2|||
27944560|NCT01170065|54601704|FG000|Overall Study|Reason other than specified|3|||
27944561|NCT01170065|54601705|FG001|Overall Study|Reason other than specified|8|||
27944562|NCT01170065|54601706|FG002|Overall Study|Reason other than specified|3|||
27944563|NCT01170065|54601704|FG000|Overall Study|Ongoing after planned observation time|5|||
27944564|NCT01170065|54601705|FG001|Overall Study|Ongoing after planned observation time|26|||
27944565|NCT01170065|54601706|FG002|Overall Study|Ongoing after planned observation time|10|||
27944566|NCT00966693|54601718|FG000|Overall Study|Adverse Event|0|||
27944567|NCT00966693|54601719|FG001|Overall Study|Adverse Event|0|||
27944568|NCT00966693|54601720|FG002|Overall Study|Adverse Event|1|||
27944569|NCT00966693|54601721|FG003|Overall Study|Adverse Event|2|||
27944570|NCT00966693|54601718|FG000|Overall Study|Death|0|||
27944571|NCT00966693|54601719|FG001|Overall Study|Death|0|||
27731270|NCT02337946|54178455|FG002|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7|||
27731271|NCT02337946|54178453|FG000|Protocol Treatment 2 Period|Reason not specified|0|||
27731272|NCT02337946|54178454|FG001|Protocol Treatment 2 Period|Reason not specified|4|||
27731273|NCT02337946|54178455|FG002|Protocol Treatment 2 Period|Reason not specified|4|||
27731274|NCT01369199|54178461|FG000|Overall Study|Withdrawal by Subject|1|||
27731275|NCT01369199|54178461|FG000|Overall Study|Lost to Follow-up|2|||
27731276|NCT01368965|54178465|FG000|Overall Study|Lost to Follow-up|12|||
27731277|NCT02610140|54178473|FG000|Randomization and Treatment Period|Radiological progression|23|||
27731278|NCT02610140|54178474|FG001|Randomization and Treatment Period|Radiological progression|15|||
27731279|NCT02610140|54178473|FG000|Randomization and Treatment Period|Progressive disease - radiological|54|||
27731280|NCT02610140|54178474|FG001|Randomization and Treatment Period|Progressive disease - radiological|23|||
27731281|NCT02610140|54178473|FG000|Randomization and Treatment Period|Protocol Violation|1|||
27731282|NCT02610140|54178474|FG001|Randomization and Treatment Period|Protocol Violation|0|||
27731283|NCT02610140|54178473|FG000|Randomization and Treatment Period|Physician Decision|0|||
27731284|NCT02610140|54178474|FG001|Randomization and Treatment Period|Physician Decision|1|||
27731285|NCT02610140|54178473|FG000|Randomization and Treatment Period|Lack of Efficacy|1|||
27944572|NCT00966693|54601720|FG002|Overall Study|Death|1|||
27944573|NCT00966693|54601721|FG003|Overall Study|Death|0|||
27944574|NCT00966693|54601718|FG000|Overall Study|Withdrawal by Subject|1|||
27944575|NCT00966693|54601719|FG001|Overall Study|Withdrawal by Subject|0|||
27944576|NCT00966693|54601720|FG002|Overall Study|Withdrawal by Subject|0|||
27944577|NCT00966693|54601721|FG003|Overall Study|Withdrawal by Subject|5|||
27944578|NCT00966693|54601718|FG000|Overall Study|Disease Progression|0|||
27731286|NCT02610140|54178474|FG001|Randomization and Treatment Period|Lack of Efficacy|0|||
27731287|NCT02610140|54178473|FG000|Randomization and Treatment Period|Death|7|||
27944579|NCT00966693|54601719|FG001|Overall Study|Disease Progression|0|||
27853277|NCT01432574|54363075|FG000|Overall Study|Not interested|1|||
27944580|NCT00966693|54601720|FG002|Overall Study|Disease Progression|1|||
27944581|NCT00966693|54601721|FG003|Overall Study|Disease Progression|16|||
27944582|NCT01215968|54601733|FG000|Overall Study|Adverse Event|0|||
27944583|NCT01215968|54601734|FG001|Overall Study|Adverse Event|2|||
27944584|NCT01215968|54601733|FG000|Overall Study|Protocol Violation|2|||
27944585|NCT01215968|54601734|FG001|Overall Study|Protocol Violation|4|||
28079936|NCT00096135|54733438|FG001|Overall Study|Ineligible|0|||
28164465|NCT01175356|54835079|FG000|Overall Study|Death|1|||
27853278|NCT01392560|54363108|FG000|Overall Study|Adverse Event|2|||
27853279|NCT01392560|54363108|FG000|Overall Study|not entered|8|||
27853280|NCT01392560|54363108|FG000|Overall Study|discontinued during placebo run-in|2|||
27853281|NCT00552279|54363169|FG000|Overall Study|Adverse Event|0|||
27853282|NCT00552279|54363170|FG001|Overall Study|Adverse Event|1|||
27853283|NCT00552279|54363169|FG000|Overall Study|Withdrawal by Subject|12|||
27853284|NCT00552279|54363170|FG001|Overall Study|Withdrawal by Subject|1|||
27853285|NCT00552279|54363169|FG000|Overall Study|Lost to Follow-up|1|||
27853286|NCT00552279|54363170|FG001|Overall Study|Lost to Follow-up|0|||
27853287|NCT00552279|54363169|FG000|Overall Study|Other|1|||
27853288|NCT00552279|54363170|FG001|Overall Study|Other|1|||
27853289|NCT00559377|54363211|FG000|Overall Study|Withdrawal by Subject|9|||
27853290|NCT01412060|54363218|FG000|Open-label Run-in Period (RIP)|Adverse Event|86|||
27853291|NCT01412060|54363219|FG001|Open-label Run-in Period (RIP)|Adverse Event|0|||
27853292|NCT01412060|54363220|FG002|Open-label Run-in Period (RIP)|Adverse Event|0|||
27853293|NCT01412060|54363218|FG000|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66|||
27853294|NCT01412060|54363219|FG001|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
27853295|NCT01412060|54363220|FG002|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
27853296|NCT01412060|54363218|FG000|Open-label Run-in Period (RIP)|Protocol Violation|27|||
27853297|NCT01412060|54363219|FG001|Open-label Run-in Period (RIP)|Protocol Violation|0|||
27853298|NCT01412060|54363220|FG002|Open-label Run-in Period (RIP)|Protocol Violation|0|||
27853299|NCT01412060|54363218|FG000|Open-label Run-in Period (RIP)|Withdrawal of Consent|117|||
27853300|NCT01412060|54363219|FG001|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
27853301|NCT01412060|54363220|FG002|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
27853302|NCT01412060|54363218|FG000|Open-label Run-in Period (RIP)|Lost to Follow-up|32|||
27853303|NCT01412060|54363219|FG001|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
27853304|NCT01412060|54363220|FG002|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
27853305|NCT01412060|54363218|FG000|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19|||
27853306|NCT01412060|54363219|FG001|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
27853307|NCT01412060|54363220|FG002|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
27853308|NCT01412060|54363218|FG000|Period Between RIP and SP|Adverse Event|4|||
27853309|NCT01412060|54363219|FG001|Period Between RIP and SP|Adverse Event|0|||
27853310|NCT01412060|54363220|FG002|Period Between RIP and SP|Adverse Event|0|||
27853311|NCT01412060|54363218|FG000|Period Between RIP and SP|Insufficient Therapeutic Response|19|||
27853312|NCT01412060|54363219|FG001|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
27853313|NCT01412060|54363220|FG002|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
27853314|NCT01412060|54363218|FG000|Period Between RIP and SP|Protocol Violation|2|||
27853315|NCT01412060|54363219|FG001|Period Between RIP and SP|Protocol Violation|0|||
27853316|NCT01412060|54363220|FG002|Period Between RIP and SP|Protocol Violation|0|||
27853317|NCT01412060|54363218|FG000|Period Between RIP and SP|Withdrawal of Consent|1|||
27853318|NCT01412060|54363219|FG001|Period Between RIP and SP|Withdrawal of Consent|0|||
27853319|NCT01412060|54363220|FG002|Period Between RIP and SP|Withdrawal of Consent|0|||
27853320|NCT01412060|54363218|FG000|Period Between RIP and SP|Lost to Follow-up|5|||
27853321|NCT01412060|54363219|FG001|Period Between RIP and SP|Lost to Follow-up|0|||
27853322|NCT01412060|54363220|FG002|Period Between RIP and SP|Lost to Follow-up|0|||
27853323|NCT01412060|54363218|FG000|Period Between RIP and SP|Other Miscellaneous Reasons|23|||
27853324|NCT01412060|54363219|FG001|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
27853325|NCT01412060|54363220|FG002|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
27853326|NCT01412060|54363218|FG000|Open-label Stabilization Period (SP)|Adverse Event|9|||
27853327|NCT01412060|54363219|FG001|Open-label Stabilization Period (SP)|Adverse Event|0|||
27853328|NCT01412060|54363220|FG002|Open-label Stabilization Period (SP)|Adverse Event|0|||
27853329|NCT01412060|54363218|FG000|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9|||
27853330|NCT01412060|54363219|FG001|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
27853331|NCT01412060|54363220|FG002|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
27853332|NCT01412060|54363218|FG000|Open-label Stabilization Period (SP)|Protocol Violation|14|||
27853333|NCT01412060|54363219|FG001|Open-label Stabilization Period (SP)|Protocol Violation|0|||
27853334|NCT01412060|54363220|FG002|Open-label Stabilization Period (SP)|Protocol Violation|0|||
27853335|NCT01412060|54363218|FG000|Open-label Stabilization Period (SP)|Withdrawal of Consent|40|||
27853336|NCT01412060|54363219|FG001|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
27944586|NCT01215968|54601733|FG000|Overall Study|Not received study drug|0|||
27944587|NCT01215968|54601734|FG001|Overall Study|Not received study drug|1|||
28079937|NCT00116805|54733446|FG000|Double-blind Period Through Week 48|Lost to Follow-up|6|||
28079938|NCT00116805|54733447|FG001|Double-blind Period Through Week 48|Lost to Follow-up|2|||
28079939|NCT00116805|54733446|FG000|Double-blind Period Through Week 48|Protocol Violation|1|||
28079940|NCT00116805|54733447|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
28164466|NCT01175356|54835079|FG000|Overall Study|Lack of Efficacy|12|||
27853337|NCT01412060|54363220|FG002|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
27944588|NCT00963807|54601743|FG000|Overall Study|Physician Decision|2|||
27944589|NCT00963807|54601743|FG000|Overall Study|Reaction to study chemotherapy regimen|1|||
27944590|NCT00963807|54601743|FG000|Overall Study|Disease progression|15|||
27944591|NCT01142466|54601751|FG000|Overall Study|Adverse Event|2|||
27944592|NCT01142466|54601752|FG001|Overall Study|Adverse Event|1|||
27944593|NCT01142466|54601751|FG000|Overall Study|Withdrawal by Subject|1|||
27944594|NCT01142466|54601752|FG001|Overall Study|Withdrawal by Subject|1|||
27944595|NCT01215734|54601760|FG000|Overall Study|Death|0|||
27944596|NCT01215734|54601761|FG001|Overall Study|Death|1|||
27944597|NCT01169987|54601767|FG000|Overall Study|Withdrawal by Subject|3|||
27944598|NCT01169987|54601767|FG000|Overall Study|Lost to Follow-up|24|||
27944599|NCT01169987|54601767|FG000|Overall Study|Other|4|||
27944600|NCT01215422|54601781|FG000|Overall Study|Relocation|1|||
27944601|NCT01215422|54601782|FG001|Overall Study|Relocation|0|||
27944602|NCT01215422|54601783|FG002|Overall Study|Relocation|0|||
27944603|NCT01215422|54601784|FG003|Overall Study|Relocation|0|||
27944604|NCT01215422|54601781|FG000|Overall Study|Failed intubations|0|||
27944605|NCT01215422|54601782|FG001|Overall Study|Failed intubations|0|||
27944606|NCT01215422|54601783|FG002|Overall Study|Failed intubations|3|||
27944607|NCT01215422|54601784|FG003|Overall Study|Failed intubations|8|||
27944608|NCT01215422|54601781|FG000|Overall Study|Did not complete all intubations|7|||
27944609|NCT01215422|54601782|FG001|Overall Study|Did not complete all intubations|0|||
27944610|NCT01215422|54601783|FG002|Overall Study|Did not complete all intubations|0|||
27944611|NCT01215422|54601784|FG003|Overall Study|Did not complete all intubations|0|||
27944612|NCT00972153|54601809|FG000|Overall Study|Equipment malfunction during case|0|||
27944613|NCT00972153|54601810|FG001|Overall Study|Equipment malfunction during case|1|||
27944614|NCT00972153|54601811|FG002|Overall Study|Equipment malfunction during case|0|||
27944615|NCT00971997|54601819|FG000|Overall Study|Adverse Event|2|||
27944616|NCT00971997|54601819|FG000|Overall Study|Death|1|||
27944617|NCT00971997|54601819|FG000|Overall Study|Protocol Violation|4|||
27944618|NCT00971997|54601819|FG000|Overall Study|Withdrawal by Subject|5|||
27944619|NCT00971997|54601819|FG000|Overall Study|Physician Decision|7|||
27944620|NCT01142388|54601828|FG000|Overall Study|Lack of Efficacy|21|||
27944621|NCT01142388|54601829|FG001|Overall Study|Lack of Efficacy|31|||
27944622|NCT01142388|54601828|FG000|Overall Study|Adverse Event|9|||
27944623|NCT01142388|54601829|FG001|Overall Study|Adverse Event|5|||
27944624|NCT01142388|54601828|FG000|Overall Study|Death|3|||
27944625|NCT01142388|54601829|FG001|Overall Study|Death|2|||
27944626|NCT01142388|54601828|FG000|Overall Study|Withdrawal by Subject|5|||
27944627|NCT01142388|54601829|FG001|Overall Study|Withdrawal by Subject|3|||
27944628|NCT01142388|54601828|FG000|Overall Study|Alternative therapy|1|||
27944629|NCT01142388|54601829|FG001|Overall Study|Alternative therapy|0|||
27944630|NCT01142388|54601828|FG000|Overall Study|Other complications|0|||
27944631|NCT01142388|54601829|FG001|Overall Study|Other complications|2|||
27944632|NCT01142388|54601828|FG000|Overall Study|Other|1|||
27944633|NCT01142388|54601829|FG001|Overall Study|Other|1|||
27944634|NCT01142388|54601828|FG000|Overall Study|Never started therapy|7|||
27944635|NCT01142388|54601829|FG001|Overall Study|Never started therapy|3|||
27944636|NCT01127646|54601837|FG000|Overall Study|Entry Criteria Not Met|1|||
27944637|NCT01127646|54601838|FG001|Overall Study|Entry Criteria Not Met|0|||
27944638|NCT01127646|54601837|FG000|Overall Study|Protocol Violation|0|||
27944639|NCT01127646|54601838|FG001|Overall Study|Protocol Violation|1|||
27944640|NCT01215188|54601849|FG000|Overall Study|Lost to Follow-up|22|||
27944641|NCT01215188|54601850|FG001|Overall Study|Lost to Follow-up|22|||
27944642|NCT01215188|54601851|FG002|Overall Study|Lost to Follow-up|16|||
27944643|NCT01215188|54601849|FG000|Overall Study|Adverse Event|1|||
27944644|NCT01215188|54601850|FG001|Overall Study|Adverse Event|1|||
27944645|NCT01215188|54601851|FG002|Overall Study|Adverse Event|3|||
27944646|NCT01215188|54601849|FG000|Overall Study|Physician Decision|2|||
27944647|NCT01215188|54601850|FG001|Overall Study|Physician Decision|1|||
27944648|NCT01215188|54601851|FG002|Overall Study|Physician Decision|0|||
27944649|NCT01215188|54601849|FG000|Overall Study|Lack of Efficacy|0|||
27944650|NCT01215188|54601850|FG001|Overall Study|Lack of Efficacy|0|||
27944651|NCT01215188|54601851|FG002|Overall Study|Lack of Efficacy|1|||
27944652|NCT01215188|54601849|FG000|Overall Study|Protocol Violation|1|||
27944653|NCT01215188|54601850|FG001|Overall Study|Protocol Violation|1|||
27944654|NCT01215188|54601851|FG002|Overall Study|Protocol Violation|1|||
27944655|NCT01215188|54601849|FG000|Overall Study|Withdrawal by Subject|32|||
27944656|NCT01215188|54601850|FG001|Overall Study|Withdrawal by Subject|34|||
27944657|NCT01215188|54601851|FG002|Overall Study|Withdrawal by Subject|31|||
27944658|NCT01215032|54601859|FG000|Overall Study|Adverse Event|3|||
27944659|NCT01215032|54601859|FG000|Overall Study|Lack of Efficacy|17|||
27944660|NCT00962247|54601865|FG000|25% Reduction of Sedentary Activity|Protocol Violation|4|||
27944661|NCT00962247|54601865|FG000|25% Reduction of Sedentary Activity|Withdrawal by Subject|1|||
27944662|NCT00918580|54601871|FG000|Up to 6-month Follow-up(FU)|Adverse Event|1|||
27944663|NCT00918580|54601871|FG000|Up to 6-month Follow-up(FU)|Lost to Follow-up|5|||
27944664|NCT00918580|54601871|FG000|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2|||
27944665|NCT00918580|54601871|FG000|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2|||
28164467|NCT01175356|54835079|FG000|Overall Study|Lost to Follow-up|1|||
27944666|NCT00918580|54601871|FG000|Up to 6-month Follow-up(FU)|Failed to Return|1|||
27944667|NCT00918580|54601871|FG000|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58|||
27944668|NCT00918580|54601871|FG000|After 6-month FU to 1-year FU|Failed to Return|2|||
27944669|NCT00920686|54601881|FG000|Overall Study|Lost to Follow-up|2|||
27944670|NCT00920686|54601882|FG001|Overall Study|Lost to Follow-up|3|||
27944671|NCT00920686|54601883|FG002|Overall Study|Lost to Follow-up|1|||
27944672|NCT00920686|54601881|FG000|Overall Study|Study drug dosing criteria not met|17|||
27944673|NCT00920686|54601882|FG001|Overall Study|Study drug dosing criteria not met|19|||
27944674|NCT00920686|54601883|FG002|Overall Study|Study drug dosing criteria not met|12|||
27944675|NCT01214720|54601897|FG000|Overall Study|Alive and still on treatment|34|||
27944676|NCT01214720|54601898|FG001|Overall Study|Alive and still on treatment|18|||
27944677|NCT01214720|54601897|FG000|Overall Study|Alive and in follow-up|45|||
27944678|NCT01214720|54601898|FG001|Overall Study|Alive and in follow-up|48|||
27944679|NCT01214720|54601897|FG000|Overall Study|Lost to Follow-up|6|||
27944680|NCT01214720|54601898|FG001|Overall Study|Lost to Follow-up|2|||
27944681|NCT01142232|54601909|FG000|Overall Study|Adverse Event|1|||
27944682|NCT01142232|54601910|FG001|Overall Study|Adverse Event|2|||
27944683|NCT01142232|54601911|FG002|Overall Study|Adverse Event|1|||
27944684|NCT01142232|54601912|FG003|Overall Study|Adverse Event|0|||
27944685|NCT01142232|54601913|FG004|Overall Study|Adverse Event|4|||
27944686|NCT01142232|54601909|FG000|Overall Study|Death|0|||
27944687|NCT01142232|54601910|FG001|Overall Study|Death|0|||
27944688|NCT01142232|54601911|FG002|Overall Study|Death|0|||
27944689|NCT01142232|54601912|FG003|Overall Study|Death|0|||
27944690|NCT01142232|54601913|FG004|Overall Study|Death|1|||
27944691|NCT01142232|54601909|FG000|Overall Study|Disease Progression|2|||
27944692|NCT01142232|54601910|FG001|Overall Study|Disease Progression|0|||
27944693|NCT01142232|54601911|FG002|Overall Study|Disease Progression|1|||
27944694|NCT01142232|54601912|FG003|Overall Study|Disease Progression|2|||
27944695|NCT01142232|54601913|FG004|Overall Study|Disease Progression|12|||
27944696|NCT01142232|54601909|FG000|Overall Study|Withdrawal by Subject|0|||
27944697|NCT01142232|54601910|FG001|Overall Study|Withdrawal by Subject|0|||
27944698|NCT01142232|54601911|FG002|Overall Study|Withdrawal by Subject|0|||
27944699|NCT01142232|54601912|FG003|Overall Study|Withdrawal by Subject|1|||
27944700|NCT01142232|54601913|FG004|Overall Study|Withdrawal by Subject|3|||
27853338|NCT01412060|54363218|FG000|Open-label Stabilization Period (SP)|Lost to Follow-up|9|||
27944701|NCT01142232|54601909|FG000|Overall Study|Physician Decision|0|||
27944702|NCT01142232|54601910|FG001|Overall Study|Physician Decision|1|||
27944703|NCT01142232|54601911|FG002|Overall Study|Physician Decision|0|||
27944704|NCT01142232|54601912|FG003|Overall Study|Physician Decision|2|||
27944705|NCT01142232|54601913|FG004|Overall Study|Physician Decision|10|||
27944706|NCT01142232|54601909|FG000|Overall Study|Alternative Therapy|0|||
27944707|NCT01142232|54601910|FG001|Overall Study|Alternative Therapy|1|||
27944708|NCT01142232|54601911|FG002|Overall Study|Alternative Therapy|1|||
27944709|NCT01142232|54601912|FG003|Overall Study|Alternative Therapy|0|||
27944710|NCT01142232|54601913|FG004|Overall Study|Alternative Therapy|1|||
27944711|NCT01142232|54601909|FG000|Overall Study|Off Trt for other complicating disease|0|||
27944712|NCT01142232|54601910|FG001|Overall Study|Off Trt for other complicating disease|0|||
27944713|NCT01142232|54601911|FG002|Overall Study|Off Trt for other complicating disease|0|||
27944714|NCT01142232|54601912|FG003|Overall Study|Off Trt for other complicating disease|0|||
27944715|NCT01142232|54601913|FG004|Overall Study|Off Trt for other complicating disease|1|||
27944716|NCT01142232|54601909|FG000|Overall Study|Noncompliance|0|||
27944717|NCT01142232|54601910|FG001|Overall Study|Noncompliance|0|||
27944718|NCT01142232|54601911|FG002|Overall Study|Noncompliance|0|||
27944719|NCT01142232|54601912|FG003|Overall Study|Noncompliance|0|||
27944720|NCT01142232|54601913|FG004|Overall Study|Noncompliance|2|||
27944721|NCT01140906|54601929|FG000|Overall Study|Adverse Event|7|||
27853339|NCT01412060|54363219|FG001|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
27853340|NCT01412060|54363220|FG002|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
27853341|NCT01412060|54363218|FG000|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19|||
27853342|NCT01412060|54363219|FG001|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
27853343|NCT01412060|54363220|FG002|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
27853344|NCT01412060|54363218|FG000|Period Between SP and DBP|Protocol Violation|2|||
27853345|NCT01412060|54363219|FG001|Period Between SP and DBP|Protocol Violation|0|||
27853346|NCT01412060|54363220|FG002|Period Between SP and DBP|Protocol Violation|0|||
27853347|NCT01412060|54363218|FG000|Period Between SP and DBP|Withdrawal of Consent|2|||
27853348|NCT01412060|54363219|FG001|Period Between SP and DBP|Withdrawal of Consent|0|||
27853349|NCT01412060|54363220|FG002|Period Between SP and DBP|Withdrawal of Consent|0|||
27853350|NCT01412060|54363218|FG000|Period Between SP and DBP|Lost to Follow-up|1|||
27853351|NCT01412060|54363219|FG001|Period Between SP and DBP|Lost to Follow-up|0|||
27944722|NCT01140906|54601930|FG001|Overall Study|Adverse Event|10|||
27944723|NCT01140906|54601931|FG002|Overall Study|Adverse Event|17|||
27853352|NCT01412060|54363220|FG002|Period Between SP and DBP|Lost to Follow-up|0|||
27944724|NCT01140906|54601932|FG003|Overall Study|Adverse Event|7|||
27944725|NCT01140906|54601929|FG000|Overall Study|Lack of Efficacy|6|||
27944726|NCT01140906|54601930|FG001|Overall Study|Lack of Efficacy|8|||
27944727|NCT01140906|54601931|FG002|Overall Study|Lack of Efficacy|2|||
27944728|NCT01140906|54601932|FG003|Overall Study|Lack of Efficacy|1|||
27944729|NCT01140906|54601929|FG000|Overall Study|Non-compliance|0|||
27944730|NCT01140906|54601930|FG001|Overall Study|Non-compliance|1|||
27944731|NCT01140906|54601931|FG002|Overall Study|Non-compliance|0|||
27944732|NCT01140906|54601932|FG003|Overall Study|Non-compliance|1|||
28164468|NCT01175356|54835079|FG000|Overall Study|Physician Decision|23|||
28164469|NCT01175356|54835079|FG000|Overall Study|Ineligible|1|||
27853353|NCT01412060|54363218|FG000|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4|||
27853354|NCT01412060|54363219|FG001|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
27944733|NCT01140906|54601929|FG000|Overall Study|Protocol Violation|5|||
27944734|NCT01140906|54601930|FG001|Overall Study|Protocol Violation|3|||
27944735|NCT01140906|54601931|FG002|Overall Study|Protocol Violation|2|||
27944736|NCT01140906|54601932|FG003|Overall Study|Protocol Violation|1|||
27944737|NCT01140906|54601929|FG000|Overall Study|Withdrawal of consent|6|||
27853355|NCT01412060|54363220|FG002|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
27853356|NCT01412060|54363218|FG000|Period Between SP and DBP|Other Miscellaneous Reasons|55|||
27853357|NCT01412060|54363219|FG001|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
27853358|NCT01412060|54363220|FG002|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
27853359|NCT01412060|54363218|FG000|Double-blind Treatment Phase (DBP)|Adverse Event|0|||
27853360|NCT01412060|54363219|FG001|Double-blind Treatment Phase (DBP)|Adverse Event|5|||
27944738|NCT01140906|54601930|FG001|Overall Study|Withdrawal of consent|6|||
27944739|NCT01140906|54601931|FG002|Overall Study|Withdrawal of consent|2|||
27944740|NCT01140906|54601932|FG003|Overall Study|Withdrawal of consent|2|||
27944741|NCT01140906|54601929|FG000|Overall Study|Lost to Follow-up|1|||
27944742|NCT01140906|54601930|FG001|Overall Study|Lost to Follow-up|1|||
27944743|NCT01140906|54601931|FG002|Overall Study|Lost to Follow-up|0|||
27944744|NCT01140906|54601932|FG003|Overall Study|Lost to Follow-up|2|||
27944745|NCT01140906|54601929|FG000|Overall Study|Administrative or other reason|0|||
27944746|NCT01140906|54601930|FG001|Overall Study|Administrative or other reason|5|||
27944747|NCT01140906|54601931|FG002|Overall Study|Administrative or other reason|3|||
27944748|NCT01140906|54601932|FG003|Overall Study|Administrative or other reason|2|||
27944749|NCT00962091|54601949|FG000|Overall Study|Withdrawal by Subject|1|||
27944750|NCT00962091|54601950|FG001|Overall Study|Withdrawal by Subject|2|||
27944751|NCT00962091|54601951|FG002|Overall Study|Withdrawal by Subject|1|||
27944752|NCT00962091|54601952|FG003|Overall Study|Withdrawal by Subject|1|||
27944753|NCT00962091|54601953|FG004|Overall Study|Withdrawal by Subject|0|||
27944754|NCT00962091|54601954|FG005|Overall Study|Withdrawal by Subject|1|||
27944755|NCT00962091|54601955|FG006|Overall Study|Withdrawal by Subject|0|||
27944756|NCT00962091|54601949|FG000|Overall Study|Adverse Event|0|||
27944757|NCT00962091|54601950|FG001|Overall Study|Adverse Event|0|||
27944758|NCT00962091|54601951|FG002|Overall Study|Adverse Event|0|||
27944759|NCT00962091|54601952|FG003|Overall Study|Adverse Event|0|||
27944760|NCT00962091|54601953|FG004|Overall Study|Adverse Event|0|||
27944761|NCT00962091|54601954|FG005|Overall Study|Adverse Event|0|||
27944762|NCT00962091|54601955|FG006|Overall Study|Adverse Event|1|||
27944763|NCT01163916|54601982|FG000|Overall Study|Withdrawal by Subject|2|||
27944764|NCT01163916|54601983|FG001|Overall Study|Withdrawal by Subject|0|||
27944765|NCT01163916|54601984|FG002|Overall Study|Withdrawal by Subject|2|||
27944766|NCT01163916|54601982|FG000|Overall Study|Adverse Event|2|||
27944767|NCT01163916|54601983|FG001|Overall Study|Adverse Event|0|||
27944768|NCT01163916|54601984|FG002|Overall Study|Adverse Event|1|||
27944769|NCT01163916|54601982|FG000|Overall Study|Lack of Efficacy|2|||
27944770|NCT01163916|54601983|FG001|Overall Study|Lack of Efficacy|0|||
27944771|NCT01163916|54601984|FG002|Overall Study|Lack of Efficacy|1|||
27944772|NCT01163916|54601982|FG000|Overall Study|Other|24|||
27944773|NCT01163916|54601983|FG001|Overall Study|Other|4|||
27944774|NCT01163916|54601984|FG002|Overall Study|Other|16|||
27944775|NCT01122576|54602000|FG000|Pre-Cataract Surgery|Withdrawal by Subject|0|||
27944776|NCT01122576|54602001|FG001|Pre-Cataract Surgery|Withdrawal by Subject|1|||
27944777|NCT01122576|54602002|FG002|Pre-Cataract Surgery|Withdrawal by Subject|2|||
27944778|NCT01122576|54602000|FG000|Post-Cataract Surgery|Central Macular Edema|0|||
27944779|NCT01122576|54602001|FG001|Post-Cataract Surgery|Central Macular Edema|0|||
27944780|NCT01122576|54602002|FG002|Post-Cataract Surgery|Central Macular Edema|1|||
27944781|NCT01122576|54602000|FG000|Post-Cataract Surgery|Fellow Eye Explanted|0|||
27944782|NCT01122576|54602001|FG001|Post-Cataract Surgery|Fellow Eye Explanted|0|||
27944783|NCT01122576|54602002|FG002|Post-Cataract Surgery|Fellow Eye Explanted|1|||
27944784|NCT00965523|54602013|FG000|Study 221|Progressive Disease|4|||
28164470|NCT01175356|54835079|FG000|Overall Study|Treatment Slot Not Available|18|||
27944785|NCT00965523|54602013|FG000|Study 221|Physician Decision|3|||
27944786|NCT00965523|54602013|FG000|Study 224|Progressive Disease|5|||
27944787|NCT00965523|54602013|FG000|Study 224|Physician Decision|1|||
27944788|NCT01122264|54602020|FG000|Overall Study|Adverse Event|6|||
27944789|NCT01122264|54602021|FG001|Overall Study|Adverse Event|5|||
28164471|NCT01175356|54835079|FG000|Overall Study|Refusal by patient/parent/guardian|6|||
27944790|NCT01122264|54602022|FG002|Overall Study|Adverse Event|7|||
27944791|NCT01122264|54602020|FG000|Overall Study|Death|1|||
27944792|NCT01122264|54602021|FG001|Overall Study|Death|0|||
27944793|NCT01122264|54602022|FG002|Overall Study|Death|0|||
27944794|NCT01122264|54602020|FG000|Overall Study|Lost to Follow-up|5|||
27944795|NCT01122264|54602021|FG001|Overall Study|Lost to Follow-up|9|||
27944796|NCT01122264|54602022|FG002|Overall Study|Lost to Follow-up|13|||
27944797|NCT01122264|54602020|FG000|Overall Study|Entry Criteria Not Met|1|||
27944798|NCT01122264|54602021|FG001|Overall Study|Entry Criteria Not Met|0|||
27944799|NCT01122264|54602022|FG002|Overall Study|Entry Criteria Not Met|0|||
27944800|NCT01122264|54602020|FG000|Overall Study|Protocol Violation|7|||
27944801|NCT01122264|54602021|FG001|Overall Study|Protocol Violation|7|||
27944802|NCT01122264|54602022|FG002|Overall Study|Protocol Violation|9|||
27944803|NCT01122264|54602020|FG000|Overall Study|Withdrawal by Subject|6|||
27944804|NCT01122264|54602021|FG001|Overall Study|Withdrawal by Subject|6|||
27944805|NCT01122264|54602022|FG002|Overall Study|Withdrawal by Subject|16|||
27944806|NCT01122264|54602020|FG000|Overall Study|Physician Decision|3|||
27944807|NCT01122264|54602021|FG001|Overall Study|Physician Decision|1|||
27944808|NCT01122264|54602022|FG002|Overall Study|Physician Decision|1|||
27944809|NCT01122264|54602020|FG000|Overall Study|Lack of Efficacy|3|||
27944810|NCT01122264|54602021|FG001|Overall Study|Lack of Efficacy|1|||
27944811|NCT01122264|54602022|FG002|Overall Study|Lack of Efficacy|1|||
27944812|NCT00920218|54602038|FG000|Overall Study|Serious Adverse Event|2|||
27944813|NCT00920218|54602039|FG001|Overall Study|Serious Adverse Event|0|||
27944814|NCT00920218|54602040|FG002|Overall Study|Serious Adverse Event|2|||
27944815|NCT00920218|54602041|FG003|Overall Study|Serious Adverse Event|1|||
27944816|NCT00920218|54602038|FG000|Overall Study|Withdrawal by Subject|0|||
27944817|NCT00920218|54602039|FG001|Overall Study|Withdrawal by Subject|3|||
27944818|NCT00920218|54602040|FG002|Overall Study|Withdrawal by Subject|2|||
27944819|NCT00920218|54602041|FG003|Overall Study|Withdrawal by Subject|0|||
27944820|NCT00920218|54602038|FG000|Overall Study|Migrated/moved from study area|0|||
27853361|NCT01412060|54363220|FG002|Double-blind Treatment Phase (DBP)|Adverse Event|6|||
27853362|NCT01412060|54363218|FG000|Double-blind Treatment Phase (DBP)|Protocol Violation|0|||
27853363|NCT01412060|54363219|FG001|Double-blind Treatment Phase (DBP)|Protocol Violation|4|||
27853364|NCT01412060|54363220|FG002|Double-blind Treatment Phase (DBP)|Protocol Violation|5|||
27853365|NCT01412060|54363218|FG000|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0|||
27853366|NCT01412060|54363219|FG001|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10|||
27853367|NCT01412060|54363220|FG002|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15|||
27853368|NCT01412060|54363218|FG000|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0|||
27853369|NCT01412060|54363219|FG001|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6|||
27944821|NCT00920218|54602039|FG001|Overall Study|Migrated/moved from study area|0|||
27944822|NCT00920218|54602040|FG002|Overall Study|Migrated/moved from study area|1|||
27944823|NCT00920218|54602041|FG003|Overall Study|Migrated/moved from study area|0|||
27944824|NCT00920218|54602038|FG000|Overall Study|Lost to Follow-up|0|||
27944825|NCT00920218|54602039|FG001|Overall Study|Lost to Follow-up|1|||
27944826|NCT00920218|54602040|FG002|Overall Study|Lost to Follow-up|0|||
27944827|NCT00920218|54602041|FG003|Overall Study|Lost to Follow-up|3|||
27944828|NCT00920218|54602038|FG000|Overall Study|Transplant failed/malignancy recurrence|0|||
27944829|NCT00920218|54602039|FG001|Overall Study|Transplant failed/malignancy recurrence|1|||
27853370|NCT01412060|54363220|FG002|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5|||
27944830|NCT00920218|54602040|FG002|Overall Study|Transplant failed/malignancy recurrence|2|||
27944831|NCT00920218|54602041|FG003|Overall Study|Transplant failed/malignancy recurrence|3|||
27944832|NCT00920218|54602038|FG000|Overall Study|Other|0|||
27944833|NCT00920218|54602039|FG001|Overall Study|Other|0|||
27944834|NCT00920218|54602040|FG002|Overall Study|Other|1|||
27944835|NCT00920218|54602041|FG003|Overall Study|Other|0|||
27944836|NCT01121562|54602055|FG000|Overall Study|Objective progression or relapse|8|||
27944837|NCT01121562|54602055|FG000|Overall Study|Withdrawal by Subject|1|||
27944838|NCT01121562|54602055|FG000|Overall Study|Adverse Event|1|||
27944839|NCT01121562|54602055|FG000|Overall Study|Sponsor Decision|1|||
27944840|NCT01121562|54602055|FG000|Overall Study|Met study discontinuation criteria|1|||
28079941|NCT00116805|54733446|FG000|Double-blind Period Through Week 48|Withdrew Consent|4|||
27944841|NCT01121484|54602061|FG000|Overall Study|Adverse Event|12|||
27944842|NCT01121484|54602062|FG001|Overall Study|Adverse Event|5|||
27944843|NCT01121484|54602061|FG000|Overall Study|Lack of Efficacy|3|||
28079942|NCT00116805|54733447|FG001|Double-blind Period Through Week 48|Withdrew Consent|2|||
28079943|NCT00116805|54733446|FG000|Open-label Period Weeks 49 - 96|Investigator's Discretion|1|||
28079944|NCT00116805|54733447|FG001|Open-label Period Weeks 49 - 96|Investigator's Discretion|0|||
27853371|NCT01412060|54363218|FG000|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0|||
27944844|NCT01121484|54602062|FG001|Overall Study|Lack of Efficacy|11|||
27944845|NCT01121484|54602061|FG000|Overall Study|Lost to Follow-up|5|||
27944846|NCT01121484|54602062|FG001|Overall Study|Lost to Follow-up|9|||
27944847|NCT01121484|54602061|FG000|Overall Study|Physician Decision|0|||
27944848|NCT01121484|54602062|FG001|Overall Study|Physician Decision|3|||
27944849|NCT01121484|54602061|FG000|Overall Study|Protocol Violation|1|||
27853372|NCT01412060|54363219|FG001|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11|||
27944850|NCT01121484|54602062|FG001|Overall Study|Protocol Violation|0|||
27944851|NCT01121484|54602061|FG000|Overall Study|Withdrawal by Subject|8|||
27944852|NCT01121484|54602062|FG001|Overall Study|Withdrawal by Subject|7|||
27944853|NCT01121484|54602061|FG000|Overall Study|Discontinuation of study by sponsor|0|||
27944854|NCT01121484|54602062|FG001|Overall Study|Discontinuation of study by sponsor|1|||
27944855|NCT01121484|54602061|FG000|Overall Study|Other|3|||
27944856|NCT01121484|54602062|FG001|Overall Study|Other|3|||
27944857|NCT01121484|54602061|FG000|Overall Study|Randomized, not treated|1|||
27944858|NCT01121484|54602062|FG001|Overall Study|Randomized, not treated|4|||
27944859|NCT01169675|54602073|FG000|Overall Study|Progressive disease|13|||
27944860|NCT01169675|54602074|FG001|Overall Study|Progressive disease|2|||
27944861|NCT01169675|54602075|FG002|Overall Study|Progressive disease|5|||
27944862|NCT01169675|54602076|FG003|Overall Study|Progressive disease|15|||
27944863|NCT01169675|54602077|FG004|Overall Study|Progressive disease|1|||
27944864|NCT01169675|54602073|FG000|Overall Study|Dose Limiting Toxicity (DLT)|1|||
27944865|NCT01169675|54602074|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
27944866|NCT01169675|54602075|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
28164472|NCT01175356|54835079|FG000|Overall Study|Pts MIBG non-avid after enrollment|2|||
28164473|NCT01175356|54835079|FG000|Overall Study|On other COG study w/tumor tx intent|7|||
28164474|NCT01175356|54835079|FG000|Overall Study|Inadequate stem cell for transplant|1|||
28164475|NCT01175356|54835079|FG000|Overall Study|Initiation other tx prior to completion|9|||
28164476|NCT01151423|54835085|FG000|Overall Study|Study terminated by Sponsor|9|||
28164477|NCT01151423|54835086|FG001|Overall Study|Study terminated by Sponsor|10|||
28164478|NCT01151423|54835085|FG000|Overall Study|Protocol Violation|0|||
28164479|NCT01151423|54835086|FG001|Overall Study|Protocol Violation|1|||
28164480|NCT01151423|54835085|FG000|Overall Study|Physician Decision|1|||
28164481|NCT01151423|54835086|FG001|Overall Study|Physician Decision|1|||
28164482|NCT01151423|54835085|FG000|Overall Study|Pregnancy|0|||
28164483|NCT01151423|54835086|FG001|Overall Study|Pregnancy|1|||
28164484|NCT01151423|54835085|FG000|Overall Study|Death|0|||
27944867|NCT01169675|54602076|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
27944868|NCT01169675|54602077|FG004|Overall Study|Dose Limiting Toxicity (DLT)|2|||
27944869|NCT01169675|54602073|FG000|Overall Study|Adverse Event|5|||
27944870|NCT01169675|54602074|FG001|Overall Study|Adverse Event|1|||
27944871|NCT01169675|54602075|FG002|Overall Study|Adverse Event|2|||
27944872|NCT01169675|54602076|FG003|Overall Study|Adverse Event|0|||
27944873|NCT01169675|54602077|FG004|Overall Study|Adverse Event|0|||
27944874|NCT01169675|54602073|FG000|Overall Study|Withdrawal by Subject|1|||
27944875|NCT01169675|54602074|FG001|Overall Study|Withdrawal by Subject|0|||
27944876|NCT01169675|54602075|FG002|Overall Study|Withdrawal by Subject|0|||
27944877|NCT01169675|54602076|FG003|Overall Study|Withdrawal by Subject|1|||
27944878|NCT01169675|54602077|FG004|Overall Study|Withdrawal by Subject|2|||
27944879|NCT01169675|54602073|FG000|Overall Study|Other Reason Not Defined Above|0|||
27944880|NCT01169675|54602074|FG001|Overall Study|Other Reason Not Defined Above|0|||
27944881|NCT01169675|54602075|FG002|Overall Study|Other Reason Not Defined Above|0|||
27944882|NCT01169675|54602076|FG003|Overall Study|Other Reason Not Defined Above|1|||
27944883|NCT01169675|54602077|FG004|Overall Study|Other Reason Not Defined Above|1|||
27944884|NCT00924664|54602091|FG000|Overall Study|Adverse Event|23|||
27944885|NCT00924664|54602092|FG001|Overall Study|Adverse Event|39|||
27944886|NCT00924664|54602091|FG000|Overall Study|Lack of Efficacy|10|||
27944887|NCT00924664|54602092|FG001|Overall Study|Lack of Efficacy|15|||
27944888|NCT00924664|54602091|FG000|Overall Study|Lost to Follow-up|10|||
28079945|NCT00116805|54733446|FG000|Open-label Period Weeks 49 - 96|Lost to Follow-up|2|||
28079946|NCT00116805|54733447|FG001|Open-label Period Weeks 49 - 96|Lost to Follow-up|0|||
28079947|NCT00116805|54733446|FG000|Open-label Period Weeks 49 - 96|Protocol Violation|2|||
28079948|NCT00116805|54733447|FG001|Open-label Period Weeks 49 - 96|Protocol Violation|0|||
28079949|NCT00116805|54733446|FG000|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
28079950|NCT00116805|54733447|FG001|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0|||
28079951|NCT00116805|54733446|FG000|Open-label Period Weeks 49 - 96|Seroconversion|2|||
27853373|NCT01412060|54363220|FG002|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27|||
27853374|NCT01412060|54363218|FG000|Double-blind Treatment Phase (DBP)|Relapse|0|||
27853375|NCT01412060|54363219|FG001|Double-blind Treatment Phase (DBP)|Relapse|47|||
27853376|NCT01412060|54363220|FG002|Double-blind Treatment Phase (DBP)|Relapse|25|||
27853377|NCT00551421|54363251|FG000|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1|||
27853378|NCT01891643|54363271|FG000|Overall Study|Adverse event unrelated to study drug|2|||
27853379|NCT01891643|54363272|FG001|Overall Study|Adverse event unrelated to study drug|5|||
27853380|NCT01891643|54363271|FG000|Overall Study|Disease Progression|4|||
28079952|NCT00116805|54733447|FG001|Open-label Period Weeks 49 - 96|Seroconversion|0|||
28164485|NCT01151423|54835086|FG001|Overall Study|Death|1|||
28164486|NCT01151423|54835085|FG000|Overall Study|Adverse Event|3|||
27853381|NCT01891643|54363272|FG001|Overall Study|Disease Progression|3|||
27944889|NCT00924664|54602092|FG001|Overall Study|Lost to Follow-up|12|||
27944890|NCT00924664|54602091|FG000|Overall Study|Withdrawal by Subject|47|||
27944891|NCT00924664|54602092|FG001|Overall Study|Withdrawal by Subject|71|||
27944892|NCT00924664|54602091|FG000|Overall Study|Protocol Violation|2|||
27944893|NCT00924664|54602092|FG001|Overall Study|Protocol Violation|5|||
27944894|NCT00924664|54602091|FG000|Overall Study|Pregnancy|1|||
27944895|NCT00924664|54602092|FG001|Overall Study|Pregnancy|1|||
27944896|NCT00924664|54602091|FG000|Overall Study|Death|0|||
27944897|NCT00924664|54602092|FG001|Overall Study|Death|2|||
27944898|NCT00924664|54602091|FG000|Overall Study|Study terminated by sponsor|199|||
27944899|NCT00924664|54602092|FG001|Overall Study|Study terminated by sponsor|330|||
27944900|NCT00924664|54602091|FG000|Overall Study|Other|29|||
27944901|NCT00924664|54602092|FG001|Overall Study|Other|52|||
27944902|NCT00924664|54602091|FG000|Overall Study|Randomized but not Treated|1|||
27944903|NCT00924664|54602092|FG001|Overall Study|Randomized but not Treated|0|||
27944904|NCT00600067|54602100|FG000|Overall Study|Adverse Event|0|||
27944905|NCT00600067|54602101|FG001|Overall Study|Adverse Event|1|||
27944906|NCT00600067|54602100|FG000|Overall Study|Lost to Follow-up|2|||
27944907|NCT00600067|54602101|FG001|Overall Study|Lost to Follow-up|3|||
27944908|NCT00600067|54602100|FG000|Overall Study|protocol non-compliance|0|||
27944909|NCT00600067|54602101|FG001|Overall Study|protocol non-compliance|3|||
27944910|NCT00600067|54602100|FG000|Overall Study|Lack of Efficacy|1|||
27944911|NCT00600067|54602101|FG001|Overall Study|Lack of Efficacy|0|||
27944912|NCT00970593|54602115|FG000|Overall Study|Adverse Event|1|||
27944913|NCT00970593|54602116|FG001|Overall Study|Adverse Event|1|||
27944914|NCT00970593|54602117|FG002|Overall Study|Adverse Event|0|||
27944915|NCT00970593|54602118|FG003|Overall Study|Adverse Event|0|||
27944916|NCT00970593|54602119|FG004|Overall Study|Adverse Event|0|||
27944917|NCT00970593|54602120|FG005|Overall Study|Adverse Event|0|||
27944918|NCT00970593|54602121|FG006|Overall Study|Adverse Event|0|||
27944919|NCT00970593|54602115|FG000|Overall Study|Discontinuation of study by sponsor|0|||
27944920|NCT00970593|54602116|FG001|Overall Study|Discontinuation of study by sponsor|0|||
27944921|NCT00970593|54602117|FG002|Overall Study|Discontinuation of study by sponsor|5|||
27944922|NCT00970593|54602118|FG003|Overall Study|Discontinuation of study by sponsor|0|||
27944923|NCT00970593|54602119|FG004|Overall Study|Discontinuation of study by sponsor|0|||
27944924|NCT00970593|54602120|FG005|Overall Study|Discontinuation of study by sponsor|0|||
27944925|NCT00970593|54602121|FG006|Overall Study|Discontinuation of study by sponsor|2|||
27944926|NCT00970593|54602115|FG000|Overall Study|Withdrawal by Subject|0|||
27944927|NCT00970593|54602116|FG001|Overall Study|Withdrawal by Subject|0|||
27944928|NCT00970593|54602117|FG002|Overall Study|Withdrawal by Subject|1|||
27944929|NCT00970593|54602118|FG003|Overall Study|Withdrawal by Subject|0|||
27944930|NCT00970593|54602119|FG004|Overall Study|Withdrawal by Subject|0|||
27944931|NCT00970593|54602120|FG005|Overall Study|Withdrawal by Subject|0|||
27944932|NCT00970593|54602121|FG006|Overall Study|Withdrawal by Subject|0|||
27944933|NCT00962013|54602141|FG000|Overall Study|Did not have surgery|1|||
27944934|NCT00962013|54602141|FG000|Overall Study|Death|8|||
27944935|NCT00962013|54602141|FG000|Overall Study|Lost to Follow-up|12|||
27944936|NCT00962013|54602141|FG000|Overall Study|Unable/Unwilling to return|6|||
27944937|NCT00962013|54602141|FG000|Overall Study|Withdrawal by Subject|8|||
27944938|NCT00962013|54602141|FG000|Overall Study|Removal of study device|3|||
27944939|NCT00962013|54602141|FG000|Overall Study|Site Termination|24|||
27944940|NCT00962013|54602141|FG000|Overall Study|No 5 year evaluation|6|||
27944941|NCT00970359|54602145|FG000|Overall Study|Not Treated|4|||
27944942|NCT01121406|54602151|FG000|Overall Study|Progressive disease RECIST|44|||
27944943|NCT01121406|54602152|FG001|Overall Study|Progressive disease RECIST|28|||
27944944|NCT01121406|54602151|FG000|Overall Study|Wors. or AE of underlying cancer disease|4|||
27944945|NCT01121406|54602152|FG001|Overall Study|Wors. or AE of underlying cancer disease|6|||
27944946|NCT01121406|54602151|FG000|Overall Study|Other AE|3|||
27944947|NCT01121406|54602152|FG001|Overall Study|Other AE|10|||
27944948|NCT01121406|54602151|FG000|Overall Study|Non-compliant with protocol|0|||
27944949|NCT01121406|54602152|FG001|Overall Study|Non-compliant with protocol|2|||
27944950|NCT01121406|54602151|FG000|Overall Study|Lost to Follow-up|0|||
27944951|NCT01121406|54602152|FG001|Overall Study|Lost to Follow-up|1|||
27944952|NCT01121406|54602151|FG000|Overall Study|Refused continuation of study med.|1|||
27944953|NCT01121406|54602152|FG001|Overall Study|Refused continuation of study med.|2|||
27944954|NCT01121406|54602151|FG000|Overall Study|Reason other than specified above|2|||
27944955|NCT01121406|54602152|FG001|Overall Study|Reason other than specified above|6|||
27944956|NCT01121406|54602151|FG000|Overall Study|Not treated|1|||
27944957|NCT01121406|54602152|FG001|Overall Study|Not treated|0|||
27944958|NCT00960687|54602161|FG000|Washout Period of 7 Days|Adverse Event|3|||
27944959|NCT00960687|54602162|FG001|Washout Period of 7 Days|Adverse Event|2|||
27944960|NCT00960687|54602161|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
27944961|NCT00960687|54602162|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
27944962|NCT00920140|54602173|FG000|Phase 1 (Dose Escalation)|Adverse Event|3|||
27944963|NCT00920140|54602174|FG001|Phase 1 (Dose Escalation)|Adverse Event|3|||
27944964|NCT00920140|54602175|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
27944965|NCT00920140|54602176|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
27944966|NCT00920140|54602177|FG004|Phase 1 (Dose Escalation)|Adverse Event|0|||
28164487|NCT01151423|54835086|FG001|Overall Study|Adverse Event|0|||
27944967|NCT00920140|54602173|FG000|Phase 1 (Dose Escalation)|Lack of Efficacy|2|||
27944968|NCT00920140|54602174|FG001|Phase 1 (Dose Escalation)|Lack of Efficacy|4|||
27944969|NCT00920140|54602175|FG002|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
27944970|NCT00920140|54602176|FG003|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
27944971|NCT00920140|54602177|FG004|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
27944972|NCT00920140|54602173|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
27944973|NCT00920140|54602174|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|2|||
27944974|NCT00920140|54602175|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
27944975|NCT00920140|54602176|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
27944976|NCT00920140|54602177|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
27944977|NCT00920140|54602173|FG000|Phase 2|Adverse Event|0|||
27944978|NCT00920140|54602174|FG001|Phase 2|Adverse Event|0|||
27944979|NCT00920140|54602175|FG002|Phase 2|Adverse Event|14|||
27944980|NCT00920140|54602176|FG003|Phase 2|Adverse Event|2|||
27944981|NCT00920140|54602177|FG004|Phase 2|Adverse Event|3|||
27944982|NCT00920140|54602173|FG000|Phase 2|Lack of Efficacy|0|||
27944983|NCT00920140|54602174|FG001|Phase 2|Lack of Efficacy|0|||
27944984|NCT00920140|54602175|FG002|Phase 2|Lack of Efficacy|29|||
27944985|NCT00920140|54602176|FG003|Phase 2|Lack of Efficacy|14|||
27944986|NCT00920140|54602177|FG004|Phase 2|Lack of Efficacy|5|||
27944987|NCT00920140|54602173|FG000|Phase 2|Lost to Follow-up|0|||
27944988|NCT00920140|54602174|FG001|Phase 2|Lost to Follow-up|0|||
27944989|NCT00920140|54602175|FG002|Phase 2|Lost to Follow-up|0|||
27944990|NCT00920140|54602176|FG003|Phase 2|Lost to Follow-up|1|||
27944991|NCT00920140|54602177|FG004|Phase 2|Lost to Follow-up|0|||
27944992|NCT00920140|54602173|FG000|Phase 2|Physician Decision|0|||
27944993|NCT00920140|54602174|FG001|Phase 2|Physician Decision|0|||
27944994|NCT00920140|54602175|FG002|Phase 2|Physician Decision|3|||
27944995|NCT00920140|54602176|FG003|Phase 2|Physician Decision|3|||
27944996|NCT00920140|54602177|FG004|Phase 2|Physician Decision|2|||
27944997|NCT00920140|54602173|FG000|Phase 2|Withdrawal by Subject|0|||
27944998|NCT00920140|54602174|FG001|Phase 2|Withdrawal by Subject|0|||
27944999|NCT00920140|54602175|FG002|Phase 2|Withdrawal by Subject|4|||
27945000|NCT00920140|54602176|FG003|Phase 2|Withdrawal by Subject|2|||
27945001|NCT00920140|54602177|FG004|Phase 2|Withdrawal by Subject|1|||
27945002|NCT01120782|54602190|FG000|Overall Study|Test article shipping error|11|||
27945003|NCT01120626|54602196|FG000|Overall Study|Withdrawal by Subject|1|||
27945004|NCT01120626|54602197|FG001|Overall Study|Withdrawal by Subject|0|||
27945005|NCT00924508|54602203|FG000|Overall Study|Withdrawal by Subject|3|||
27945006|NCT01139658|54602212|FG000|Overall Study|Adverse Event|10|||
27945007|NCT01139658|54602213|FG001|Overall Study|Adverse Event|27|||
27945008|NCT01139658|54602212|FG000|Overall Study|Lack of Efficacy|15|||
27945009|NCT01139658|54602213|FG001|Overall Study|Lack of Efficacy|7|||
27945010|NCT01139658|54602212|FG000|Overall Study|Withdrawal by Subject|2|||
27945011|NCT01139658|54602213|FG001|Overall Study|Withdrawal by Subject|4|||
27945012|NCT01139658|54602212|FG000|Overall Study|No documentation of treatment|1|||
27945013|NCT01139658|54602213|FG001|Overall Study|No documentation of treatment|0|||
27945014|NCT01139658|54602212|FG000|Overall Study|Other|28|||
27945015|NCT01139658|54602213|FG001|Overall Study|Other|75|||
27945016|NCT01139580|54602221|FG000|Overall Study|Adverse Event|5|||
27945017|NCT01139580|54602222|FG001|Overall Study|Adverse Event|4|||
27945018|NCT01139580|54602221|FG000|Overall Study|Lost to Follow-up|9|||
27945019|NCT01139580|54602222|FG001|Overall Study|Lost to Follow-up|1|||
27945020|NCT01139580|54602221|FG000|Overall Study|Lack of Efficacy|0|||
27945021|NCT01139580|54602222|FG001|Overall Study|Lack of Efficacy|2|||
27945022|NCT01139580|54602221|FG000|Overall Study|Withdrawal by Subject|6|||
27945023|NCT01139580|54602222|FG001|Overall Study|Withdrawal by Subject|9|||
28079953|NCT00116805|54733446|FG000|Open-label Period Weeks 49 - 96|Withdrew Consent|2|||
28079954|NCT00116805|54733447|FG001|Open-label Period Weeks 49 - 96|Withdrew Consent|1|||
28079955|NCT00116805|54733446|FG000|Open-label Period Weeks 97 - 144|Completed Study|1|||
28079956|NCT00116805|54733447|FG001|Open-label Period Weeks 97 - 144|Completed Study|0|||
28079957|NCT00116805|54733446|FG000|Open-label Period Weeks 97 - 144|Investigator's Discretion|2|||
28079958|NCT00116805|54733447|FG001|Open-label Period Weeks 97 - 144|Investigator's Discretion|0|||
28079959|NCT00116805|54733446|FG000|Open-label Period Weeks 97 - 144|Lost to Follow-up|5|||
28079960|NCT00116805|54733447|FG001|Open-label Period Weeks 97 - 144|Lost to Follow-up|2|||
27731288|NCT02610140|54178474|FG001|Randomization and Treatment Period|Death|1|||
27945024|NCT01139580|54602221|FG000|Overall Study|Used Excluded Medicine After Enrollment|1|||
27945025|NCT01139580|54602222|FG001|Overall Study|Used Excluded Medicine After Enrollment|0|||
27945026|NCT01139580|54602221|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
27945027|NCT01139580|54602222|FG001|Overall Study|Did Not Meet Exclusion Criteria|0|||
27731289|NCT02610140|54178473|FG000|Randomization and Treatment Period|Withdrawal by Subject|12|||
27853382|NCT01891643|54363271|FG000|Overall Study|Study Drug Toxicity|3|||
27945028|NCT01139580|54602221|FG000|Overall Study|Misrandomized|1|||
27945029|NCT01139580|54602222|FG001|Overall Study|Misrandomized|0|||
27945030|NCT01139580|54602221|FG000|Overall Study|Beginning Study Exclusion Treatment|0|||
27945031|NCT01139580|54602222|FG001|Overall Study|Beginning Study Exclusion Treatment|1|||
27945032|NCT01139580|54602221|FG000|Overall Study|Participant Randomization in Error|0|||
27945033|NCT01139580|54602222|FG001|Overall Study|Participant Randomization in Error|1|||
27945034|NCT00917644|54602228|FG000|Period: Washout Period of > = 2 Weeks|Protocol Violation|1|||
27945035|NCT00917644|54602229|FG001|Period: Washout Period of > = 2 Weeks|Protocol Violation|0|||
27945036|NCT00917644|54602228|FG000|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1|||
27945037|NCT00917644|54602229|FG001|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0|||
27945038|NCT00917644|54602228|FG000|Period 2: Second Intervention|family emergency|1|||
27945039|NCT00917644|54602229|FG001|Period 2: Second Intervention|family emergency|0|||
27945040|NCT01137786|54602237|FG000|Overall Study|Lost to Follow-up|0|||
27945041|NCT01137786|54602238|FG001|Overall Study|Lost to Follow-up|2|||
27945042|NCT01137786|54602237|FG000|Overall Study|Withdrawal by Subject|1|||
27945043|NCT01137786|54602238|FG001|Overall Study|Withdrawal by Subject|1|||
27945044|NCT00599755|54602246|FG000|Overall Study|Adverse Event|11|||
27945045|NCT00599755|54602246|FG000|Overall Study|Withdrawal by Subject|2|||
27945046|NCT00599755|54602246|FG000|Overall Study|Progression of Disease|3|||
27945047|NCT00599755|54602246|FG000|Overall Study|Other Reason|2|||
27945048|NCT00599755|54602246|FG000|Overall Study|No data available|1|||
27945049|NCT00600613|54602250|FG000|Overall Study|Protocol Deviation|1|||
27945050|NCT01125930|54602256|FG000|Overall Study|Adverse Event|0|||
27945051|NCT01125930|54602257|FG001|Overall Study|Adverse Event|1|||
27945052|NCT01125930|54602256|FG000|Overall Study|Withdrawal by Subject|1|||
27945053|NCT01125930|54602257|FG001|Overall Study|Withdrawal by Subject|6|||
27945054|NCT01125930|54602256|FG000|Overall Study|Protocol Violation|0|||
27945055|NCT01125930|54602257|FG001|Overall Study|Protocol Violation|1|||
27945056|NCT01125930|54602256|FG000|Overall Study|Lost to Follow-up|0|||
27945057|NCT01125930|54602257|FG001|Overall Study|Lost to Follow-up|2|||
27945058|NCT00918346|54602288|FG000|First Treatment Period (4 Weeks)|Lack of Efficacy|0|||
27945059|NCT00918346|54602289|FG001|First Treatment Period (4 Weeks)|Lack of Efficacy|1|||
27945060|NCT00913978|54602300|FG000|Overall Study|Surgeon choice|1|||
27945061|NCT00913978|54602301|FG001|Overall Study|Surgeon choice|3|||
27945062|NCT01137474|54602311|FG000|Overall Study|Adverse Event|3|||
27945063|NCT01137474|54602312|FG001|Overall Study|Adverse Event|5|||
27945064|NCT01137474|54602313|FG002|Overall Study|Adverse Event|1|||
27945065|NCT01137474|54602314|FG003|Overall Study|Adverse Event|3|||
27945066|NCT01137474|54602311|FG000|Overall Study|Withdrawal by Subject|7|||
27945067|NCT01137474|54602312|FG001|Overall Study|Withdrawal by Subject|2|||
27945068|NCT01137474|54602313|FG002|Overall Study|Withdrawal by Subject|6|||
27945069|NCT01137474|54602314|FG003|Overall Study|Withdrawal by Subject|9|||
27945070|NCT01137474|54602311|FG000|Overall Study|No longer met study criteria|6|||
27945071|NCT01137474|54602312|FG001|Overall Study|No longer met study criteria|1|||
27945072|NCT01137474|54602313|FG002|Overall Study|No longer met study criteria|0|||
27831694|NCT02859558|54310312|FG000|Step 1|Non-Adherence to Study Requirements|3|||
27831695|NCT02859558|54310313|FG001|Step 1|Non-Adherence to Study Requirements|1|||
27831696|NCT02859558|54310314|FG002|Step 1|Non-Adherence to Study Requirements|0|||
27831697|NCT02859558|54310315|FG003|Step 1|Non-Adherence to Study Requirements|0|||
27831698|NCT02859558|54310316|FG004|Step 1|Non-Adherence to Study Requirements|0|||
27831699|NCT02859558|54310312|FG000|Step 1|Virologic Failure|2|||
27831700|NCT02859558|54310313|FG001|Step 1|Virologic Failure|1|||
27831701|NCT02859558|54310314|FG002|Step 1|Virologic Failure|1|||
27831702|NCT02859558|54310315|FG003|Step 1|Virologic Failure|0|||
27831703|NCT02859558|54310316|FG004|Step 1|Virologic Failure|0|||
27831704|NCT02859558|54310312|FG000|Step 2|Active On Study|23|||
27831705|NCT02859558|54310313|FG001|Step 2|Active On Study|38|||
27853383|NCT01891643|54363272|FG001|Overall Study|Study Drug Toxicity|0|||
27853384|NCT01891643|54363271|FG000|Overall Study|Maximum Clinical Benefit|0|||
27853385|NCT01891643|54363272|FG001|Overall Study|Maximum Clinical Benefit|1|||
27853386|NCT01891643|54363271|FG000|Overall Study|Poor/Non-compliance|0|||
27853387|NCT01891643|54363272|FG001|Overall Study|Poor/Non-compliance|1|||
27853388|NCT01891643|54363271|FG000|Overall Study|Participant request to discontinue|1|||
27853389|NCT01891643|54363272|FG001|Overall Study|Participant request to discontinue|0|||
27853390|NCT01392326|54363406|FG000|Overall Study|Death|2|||
27853391|NCT01392326|54363407|FG001|Overall Study|Death|0|||
27853392|NCT01392326|54363408|FG002|Overall Study|Death|0|||
27945073|NCT01137474|54602314|FG003|Overall Study|No longer met study criteria|5|||
27945074|NCT01137474|54602311|FG000|Overall Study|Lost to Follow-up|5|||
27945075|NCT01137474|54602312|FG001|Overall Study|Lost to Follow-up|1|||
27945076|NCT01137474|54602313|FG002|Overall Study|Lost to Follow-up|0|||
27945077|NCT01137474|54602314|FG003|Overall Study|Lost to Follow-up|2|||
27945078|NCT01137474|54602311|FG000|Overall Study|Lack of Efficacy|0|||
27945079|NCT01137474|54602312|FG001|Overall Study|Lack of Efficacy|0|||
27945080|NCT01137474|54602313|FG002|Overall Study|Lack of Efficacy|0|||
27945081|NCT01137474|54602314|FG003|Overall Study|Lack of Efficacy|2|||
27853393|NCT01392326|54363406|FG000|Overall Study|Withdrawal by Subject|12|||
27853394|NCT01392326|54363407|FG001|Overall Study|Withdrawal by Subject|11|||
27945082|NCT01137474|54602311|FG000|Overall Study|Other|3|||
27945083|NCT01137474|54602312|FG001|Overall Study|Other|1|||
27831706|NCT02859558|54310314|FG002|Step 2|Active On Study|20|||
27831707|NCT02859558|54310315|FG003|Step 2|Active On Study|0|||
27831708|NCT02859558|54310316|FG004|Step 2|Active On Study|0|||
27945084|NCT01137474|54602313|FG002|Overall Study|Other|0|||
27945085|NCT01137474|54602314|FG003|Overall Study|Other|0|||
27945086|NCT01137474|54602311|FG000|Overall Study|Pregnancy|0|||
27945087|NCT01137474|54602312|FG001|Overall Study|Pregnancy|1|||
27945088|NCT01137474|54602313|FG002|Overall Study|Pregnancy|0|||
27945089|NCT01137474|54602314|FG003|Overall Study|Pregnancy|0|||
28079961|NCT00116805|54733446|FG000|Open-label Period Weeks 97 - 144|Protocol Violation|0|||
28079962|NCT00116805|54733447|FG001|Open-label Period Weeks 97 - 144|Protocol Violation|1|||
28079963|NCT00116805|54733446|FG000|Open-label Period Weeks 97 - 144|Seroconversion|2|||
28079964|NCT00116805|54733447|FG001|Open-label Period Weeks 97 - 144|Seroconversion|3|||
28079965|NCT00116805|54733446|FG000|Open-label Period Weeks 97 - 144|Withdrew Consent|1|||
28079966|NCT00116805|54733447|FG001|Open-label Period Weeks 97 - 144|Withdrew Consent|3|||
28164488|NCT01151423|54835085|FG000|Overall Study|Withdrawal by Subject|1|||
28164489|NCT01151423|54835086|FG001|Overall Study|Withdrawal by Subject|3|||
28164490|NCT01151423|54835085|FG000|Overall Study|Lost to Follow-up|1|||
28164491|NCT01151423|54835086|FG001|Overall Study|Lost to Follow-up|0|||
28164492|NCT01151423|54835085|FG000|Overall Study|Diagnosed as non-TTP patient|0|||
28164493|NCT01151423|54835086|FG001|Overall Study|Diagnosed as non-TTP patient|1|||
27731290|NCT02610140|54178474|FG001|Randomization and Treatment Period|Withdrawal by Subject|12|||
27731291|NCT02610140|54178473|FG000|Randomization and Treatment Period|Adverse Event|44|||
27731292|NCT02610140|54178474|FG001|Randomization and Treatment Period|Adverse Event|13|||
27731293|NCT02610140|54178473|FG000|Randomization and Treatment Period|Progressive disease - clinical|12|||
27731294|NCT02610140|54178474|FG001|Randomization and Treatment Period|Progressive disease - clinical|5|||
27731295|NCT02610140|54178473|FG000|Randomization and Treatment Period|Ongoing but not completed|9|||
27731296|NCT02610140|54178474|FG001|Randomization and Treatment Period|Ongoing but not completed|2|||
27731297|NCT02610140|54178473|FG000|Randomization and Treatment Period|Not treated|3|||
27853395|NCT01392326|54363408|FG002|Overall Study|Withdrawal by Subject|15|||
27853396|NCT01392326|54363406|FG000|Overall Study|Protocol Violation|2|||
27731298|NCT02610140|54178474|FG001|Randomization and Treatment Period|Not treated|10|||
27731299|NCT02610140|54178473|FG000|Safety Follow-up|Other|0|||
27731300|NCT02610140|54178474|FG001|Safety Follow-up|Other|2|||
27731301|NCT02610140|54178473|FG000|Safety Follow-up|Lost to Follow-up|1|||
27731302|NCT02610140|54178474|FG001|Safety Follow-up|Lost to Follow-up|0|||
27731303|NCT02610140|54178473|FG000|Safety Follow-up|No follow-up|5|||
27731304|NCT02610140|54178474|FG001|Safety Follow-up|No follow-up|3|||
27731305|NCT02610140|54178473|FG000|Safety Follow-up|Death|12|||
27731306|NCT02610140|54178474|FG001|Safety Follow-up|Death|2|||
27731307|NCT02610140|54178473|FG000|Safety Follow-up|Deterioration of general conditions|15|||
27731308|NCT02610140|54178474|FG001|Safety Follow-up|Deterioration of general conditions|5|||
27731309|NCT02610140|54178473|FG000|Safety Follow-up|Withdrawal by Subject|12|||
27731310|NCT02610140|54178474|FG001|Safety Follow-up|Withdrawal by Subject|12|||
27731311|NCT02610140|54178473|FG000|Active Follow-up|Progressive disease - radiological|30|||
27731312|NCT02610140|54178474|FG001|Active Follow-up|Progressive disease - radiological|22|||
27731313|NCT02610140|54178473|FG000|Active Follow-up|Death|8|||
27731314|NCT02610140|54178474|FG001|Active Follow-up|Death|1|||
27731315|NCT02610140|54178473|FG000|Active Follow-up|Withdrawal by Subject|4|||
27731316|NCT02610140|54178474|FG001|Active Follow-up|Withdrawal by Subject|0|||
27731317|NCT02610140|54178473|FG000|Active Follow-up|Progressive disease - clinical|1|||
27731318|NCT02610140|54178474|FG001|Active Follow-up|Progressive disease - clinical|2|||
27731319|NCT02610140|54178473|FG000|Active Follow-up|Deterioration of general conditions|1|||
27731320|NCT02610140|54178474|FG001|Active Follow-up|Deterioration of general conditions|0|||
27731321|NCT02610140|54178473|FG000|Active Follow-up|Ongoing but not completed|4|||
27831709|NCT02859558|54310312|FG000|Step 2|Did Not Return to Clinic|2|||
27831710|NCT02859558|54310313|FG001|Step 2|Did Not Return to Clinic|0|||
27831711|NCT02859558|54310314|FG002|Step 2|Did Not Return to Clinic|0|||
27831712|NCT02859558|54310315|FG003|Step 2|Did Not Return to Clinic|0|||
27831713|NCT02859558|54310316|FG004|Step 2|Did Not Return to Clinic|0|||
27831714|NCT02859558|54310312|FG000|Step 2|Unexpected Closure of Site|0|||
27831715|NCT02859558|54310313|FG001|Step 2|Unexpected Closure of Site|1|||
27831716|NCT02859558|54310314|FG002|Step 2|Unexpected Closure of Site|1|||
27853397|NCT01392326|54363407|FG001|Overall Study|Protocol Violation|0|||
27853398|NCT01392326|54363408|FG002|Overall Study|Protocol Violation|0|||
27853399|NCT01392326|54363406|FG000|Overall Study|Pregnancy|0|||
27853400|NCT01392326|54363407|FG001|Overall Study|Pregnancy|0|||
27853401|NCT01392326|54363408|FG002|Overall Study|Pregnancy|1|||
27853402|NCT01392326|54363406|FG000|Overall Study|Physician Decision|7|||
27853403|NCT01392326|54363407|FG001|Overall Study|Physician Decision|5|||
27945090|NCT01137474|54602311|FG000|Overall Study|Administrative reason by sponsor|0|||
27831717|NCT02859558|54310315|FG003|Step 2|Unexpected Closure of Site|0|||
27831718|NCT02859558|54310316|FG004|Step 2|Unexpected Closure of Site|0|||
27831719|NCT00705432|54310367|FG000|Treatment Period|Adverse Event|45|||
27831720|NCT00705432|54310368|FG001|Treatment Period|Adverse Event|37|||
27853404|NCT01392326|54363408|FG002|Overall Study|Physician Decision|2|||
27945091|NCT01137474|54602312|FG001|Overall Study|Administrative reason by sponsor|1|||
27945092|NCT01137474|54602313|FG002|Overall Study|Administrative reason by sponsor|0|||
27945093|NCT01137474|54602314|FG003|Overall Study|Administrative reason by sponsor|0|||
27945094|NCT01168973|54602326|FG000|Overall Study|Progressive Disease|341|||
27945095|NCT01168973|54602327|FG001|Overall Study|Progressive Disease|429|||
27945096|NCT01168973|54602326|FG000|Overall Study|Adverse Event|94|||
27945097|NCT01168973|54602327|FG001|Overall Study|Adverse Event|55|||
27945098|NCT01168973|54602326|FG000|Overall Study|Withdrawal by Subject|90|||
27945099|NCT01168973|54602327|FG001|Overall Study|Withdrawal by Subject|53|||
27945100|NCT01168973|54602326|FG000|Overall Study|Death|42|||
27945101|NCT01168973|54602327|FG001|Overall Study|Death|45|||
27945102|NCT01168973|54602326|FG000|Overall Study|Physician Decision|37|||
27945103|NCT01168973|54602327|FG001|Overall Study|Physician Decision|19|||
27945104|NCT01168973|54602326|FG000|Overall Study|Sponsor Decision|2|||
27945105|NCT01168973|54602327|FG001|Overall Study|Sponsor Decision|1|||
27945106|NCT01168973|54602326|FG000|Overall Study|Protocol Criterion Not Met and Deviation|7|||
27945107|NCT01168973|54602327|FG001|Overall Study|Protocol Criterion Not Met and Deviation|9|||
27945108|NCT03918109|54602337|FG000|Overall Study|Withdrawal by Subject|0|||
27945109|NCT03918109|54602338|FG001|Overall Study|Withdrawal by Subject|0|||
27945110|NCT03918109|54602339|FG002|Overall Study|Withdrawal by Subject|2|||
27945111|NCT03918109|54602340|FG003|Overall Study|Withdrawal by Subject|1|||
27945112|NCT03918109|54602337|FG000|Overall Study|Lost to Follow-up|0|||
27945113|NCT03918109|54602338|FG001|Overall Study|Lost to Follow-up|0|||
27945114|NCT03918109|54602339|FG002|Overall Study|Lost to Follow-up|0|||
27945115|NCT03918109|54602340|FG003|Overall Study|Lost to Follow-up|1|||
27945116|NCT01168427|54602350|FG000|Overall Study|Patient exited prior to implant|1|||
27945117|NCT01124916|54602356|FG000|Overall Study|Lost to Follow-up|3|||
27945118|NCT01124916|54602357|FG001|Overall Study|Lost to Follow-up|2|||
27945119|NCT00916006|54602365|FG000|Overall Study|Adverse Event|1|||
27945120|NCT00916006|54602366|FG001|Overall Study|Adverse Event|1|||
27945121|NCT00916006|54602365|FG000|Overall Study|Withdrawal by Subject|2|||
27945122|NCT00916006|54602366|FG001|Overall Study|Withdrawal by Subject|5|||
27945123|NCT00916006|54602365|FG000|Overall Study|Protocol Violation|0|||
27945124|NCT00916006|54602366|FG001|Overall Study|Protocol Violation|1|||
27945125|NCT01168349|54602383|FG000|Overall Study|Death|157|||
27945126|NCT01168349|54602383|FG000|Overall Study|Lost to Follow-up|34|||
27945127|NCT01168349|54602383|FG000|Overall Study|Withdrawal by Subject|9|||
27945128|NCT01168349|54602383|FG000|Overall Study|Kidney transplantation|3|||
27945129|NCT01168349|54602383|FG000|Overall Study|Other|22|||
27945130|NCT01168349|54602383|FG000|Overall Study|Protocol Violation|76|||
27945131|NCT00915772|54602406|FG000|Overall Study|Adverse Event|12|||
27945132|NCT00915772|54602407|FG001|Overall Study|Adverse Event|13|||
27945133|NCT00915772|54602408|FG002|Overall Study|Adverse Event|11|||
27945134|NCT00915772|54602406|FG000|Overall Study|Protocol Violation|4|||
27945135|NCT00915772|54602407|FG001|Overall Study|Protocol Violation|1|||
27945136|NCT00915772|54602408|FG002|Overall Study|Protocol Violation|2|||
27945137|NCT00915772|54602406|FG000|Overall Study|Lost to Follow-up|1|||
27945138|NCT00915772|54602407|FG001|Overall Study|Lost to Follow-up|2|||
27945139|NCT00915772|54602408|FG002|Overall Study|Lost to Follow-up|2|||
27945140|NCT00915772|54602406|FG000|Overall Study|Lack of Efficacy|9|||
27945141|NCT00915772|54602407|FG001|Overall Study|Lack of Efficacy|15|||
27945142|NCT00915772|54602408|FG002|Overall Study|Lack of Efficacy|3|||
27945143|NCT00915772|54602406|FG000|Overall Study|Refused to continue trial medication|6|||
27945144|NCT00915772|54602407|FG001|Overall Study|Refused to continue trial medication|8|||
27945145|NCT00915772|54602408|FG002|Overall Study|Refused to continue trial medication|4|||
27945146|NCT00915772|54602406|FG000|Overall Study|Any other reason|4|||
27945147|NCT00915772|54602407|FG001|Overall Study|Any other reason|7|||
27945148|NCT00915772|54602408|FG002|Overall Study|Any other reason|7|||
27945149|NCT00912964|54602420|FG000|Overall Study|Eligibility criterion not met|1|||
27945150|NCT00912964|54602421|FG001|Overall Study|Eligibility criterion not met|1|||
27945151|NCT00912964|54602422|FG002|Overall Study|Eligibility criterion not met|0|||
27945152|NCT00912964|54602420|FG000|Overall Study|Adverse Event|15|||
27945153|NCT00912964|54602421|FG001|Overall Study|Adverse Event|18|||
27945154|NCT00912964|54602422|FG002|Overall Study|Adverse Event|12|||
27945155|NCT00912964|54602420|FG000|Overall Study|Lack of Efficacy|11|||
27945156|NCT00912964|54602421|FG001|Overall Study|Lack of Efficacy|4|||
28079967|NCT00116805|54733446|FG000|Open-label Period Weeks 145 - 192|Completed Study|1|||
27731322|NCT02610140|54178474|FG001|Active Follow-up|Ongoing but not completed|1|||
27945157|NCT00912964|54602422|FG002|Overall Study|Lack of Efficacy|3|||
27945158|NCT00912964|54602420|FG000|Overall Study|Withdrawal by Subject|20|||
27945159|NCT00912964|54602421|FG001|Overall Study|Withdrawal by Subject|12|||
27945160|NCT00912964|54602422|FG002|Overall Study|Withdrawal by Subject|18|||
27945161|NCT00912964|54602420|FG000|Overall Study|Lost to Follow-up|4|||
27945162|NCT00912964|54602421|FG001|Overall Study|Lost to Follow-up|3|||
27945163|NCT00912964|54602422|FG002|Overall Study|Lost to Follow-up|3|||
27945164|NCT00912964|54602420|FG000|Overall Study|Protocol Violation|5|||
27945165|NCT00912964|54602421|FG001|Overall Study|Protocol Violation|3|||
27945166|NCT00912964|54602422|FG002|Overall Study|Protocol Violation|8|||
27945167|NCT00912964|54602420|FG000|Overall Study|Taking exclusionary medications|7|||
27945168|NCT00912964|54602421|FG001|Overall Study|Taking exclusionary medications|4|||
27945169|NCT00912964|54602422|FG002|Overall Study|Taking exclusionary medications|8|||
27945170|NCT00912964|54602420|FG000|Overall Study|Medical History|1|||
27945171|NCT00912964|54602421|FG001|Overall Study|Medical History|0|||
27945172|NCT00912964|54602422|FG002|Overall Study|Medical History|0|||
27945173|NCT00912964|54602420|FG000|Overall Study|Non-compliance with study procedures|2|||
27945174|NCT00912964|54602421|FG001|Overall Study|Non-compliance with study procedures|0|||
27945175|NCT00912964|54602422|FG002|Overall Study|Non-compliance with study procedures|0|||
27945176|NCT00912964|54602420|FG000|Overall Study|Violation of exclusion criterion|0|||
27945177|NCT00912964|54602421|FG001|Overall Study|Violation of exclusion criterion|0|||
27945178|NCT00912964|54602422|FG002|Overall Study|Violation of exclusion criterion|2|||
27945179|NCT00912964|54602420|FG000|Overall Study|Randomized but never received study drug|0|||
27945180|NCT00912964|54602421|FG001|Overall Study|Randomized but never received study drug|1|||
27945181|NCT00912964|54602422|FG002|Overall Study|Randomized but never received study drug|0|||
28164494|NCT01151423|54835085|FG000|Overall Study|Participated in other clinical trial|1|||
28164495|NCT01151423|54835086|FG001|Overall Study|Participated in other clinical trial|0|||
28164496|NCT00977574|54835112|FG000|Overall Study|Never Treated|4|||
28164497|NCT00977574|54835113|FG001|Overall Study|Never Treated|2|||
28164498|NCT00977574|54835114|FG002|Overall Study|Never Treated|4|||
28164499|NCT00565617|54835131|FG000|Overall Study|Withdrawal by Subject|1|||
28164500|NCT00453154|54835138|FG000|Double BIind Maintenance|Adverse Event|0|||
27731323|NCT02610140|54178473|FG000|Long-term Follow-up|Death|86|||
27853405|NCT01392326|54363406|FG000|Overall Study|Lost to Follow-up|1|||
27853406|NCT01392326|54363407|FG001|Overall Study|Lost to Follow-up|3|||
27853407|NCT01392326|54363408|FG002|Overall Study|Lost to Follow-up|4|||
27853408|NCT01392326|54363406|FG000|Overall Study|Lack of Efficacy|14|||
27853409|NCT01392326|54363407|FG001|Overall Study|Lack of Efficacy|10|||
27853410|NCT01392326|54363408|FG002|Overall Study|Lack of Efficacy|15|||
27853411|NCT01392326|54363406|FG000|Overall Study|Adverse Event|9|||
27853412|NCT01392326|54363407|FG001|Overall Study|Adverse Event|6|||
27853413|NCT01392326|54363408|FG002|Overall Study|Adverse Event|11|||
27853414|NCT01432262|54363451|FG000|Overall Study|Withdrawal by Subject|2|||
27853415|NCT01432262|54363452|FG001|Overall Study|Withdrawal by Subject|1|||
27853416|NCT01410890|54363472|FG000|Overall Study|Withdrawal by Subject|0|||
27853417|NCT01410890|54363473|FG001|Overall Study|Withdrawal by Subject|1|||
27853418|NCT01431950|54363483|FG000|Overall Study|Study Site Closed/Terminated|7|||
27853419|NCT01431950|54363484|FG001|Overall Study|Study Site Closed/Terminated|3|||
27853420|NCT01431950|54363483|FG000|Overall Study|Withdrawal by Subject|4|||
27853421|NCT01431950|54363484|FG001|Overall Study|Withdrawal by Subject|3|||
27853422|NCT01431950|54363483|FG000|Overall Study|Protocol Violation|2|||
27853423|NCT01431950|54363484|FG001|Overall Study|Protocol Violation|3|||
27853424|NCT01431950|54363483|FG000|Overall Study|Adverse Event|2|||
27853425|NCT01431950|54363484|FG001|Overall Study|Adverse Event|2|||
27853426|NCT01431950|54363483|FG000|Overall Study|Physician Decision|2|||
27853427|NCT01431950|54363484|FG001|Overall Study|Physician Decision|1|||
27853428|NCT01431950|54363483|FG000|Overall Study|Lack of Efficacy|2|||
27853429|NCT01431950|54363484|FG001|Overall Study|Lack of Efficacy|1|||
27853430|NCT01431950|54363483|FG000|Overall Study|Lost to Follow-up|0|||
27853431|NCT01431950|54363484|FG001|Overall Study|Lost to Follow-up|1|||
27853432|NCT01431950|54363483|FG000|Overall Study|Met Protocol-defined Stopping Criteria|0|||
27853433|NCT01431950|54363484|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
27853434|NCT00551031|54363495|FG000|Overall Study|Adverse Event|0|||
27853435|NCT00551031|54363496|FG001|Overall Study|Adverse Event|1|||
27853436|NCT00551031|54363497|FG002|Overall Study|Adverse Event|0|||
27853437|NCT00551031|54363498|FG003|Overall Study|Adverse Event|0|||
27853438|NCT00551031|54363499|FG004|Overall Study|Adverse Event|0|||
27853439|NCT00551031|54363495|FG000|Overall Study|Protocol Violation|1|||
27853440|NCT00551031|54363496|FG001|Overall Study|Protocol Violation|1|||
27853441|NCT00551031|54363497|FG002|Overall Study|Protocol Violation|0|||
27853442|NCT00551031|54363498|FG003|Overall Study|Protocol Violation|0|||
27853443|NCT00551031|54363499|FG004|Overall Study|Protocol Violation|0|||
27853444|NCT00551031|54363495|FG000|Overall Study|Lost to Follow-up|0|||
27853445|NCT00551031|54363496|FG001|Overall Study|Lost to Follow-up|1|||
27853446|NCT00551031|54363497|FG002|Overall Study|Lost to Follow-up|0|||
27853447|NCT00551031|54363498|FG003|Overall Study|Lost to Follow-up|1|||
27945182|NCT00913744|54602432|FG000|Overall Study|Adverse Event|2|||
27945183|NCT00913744|54602433|FG001|Overall Study|Adverse Event|0|||
27853448|NCT00551031|54363499|FG004|Overall Study|Lost to Follow-up|1|||
27853449|NCT00551031|54363495|FG000|Overall Study|Withdrawal by Subject|0|||
27853450|NCT00551031|54363496|FG001|Overall Study|Withdrawal by Subject|4|||
27853451|NCT00551031|54363497|FG002|Overall Study|Withdrawal by Subject|1|||
27853452|NCT00551031|54363498|FG003|Overall Study|Withdrawal by Subject|2|||
27853453|NCT00551031|54363499|FG004|Overall Study|Withdrawal by Subject|0|||
27853454|NCT00551031|54363495|FG000|Overall Study|Serious Adverse Event|0|||
27853455|NCT00551031|54363496|FG001|Overall Study|Serious Adverse Event|2|||
27853456|NCT00551031|54363497|FG002|Overall Study|Serious Adverse Event|1|||
27731324|NCT02610140|54178474|FG001|Long-term Follow-up|Death|44|||
27945184|NCT00913744|54602432|FG000|Overall Study|Withdrawal by Subject|2|||
27945185|NCT00913744|54602433|FG001|Overall Study|Withdrawal by Subject|1|||
27945186|NCT00913744|54602432|FG000|Overall Study|Death|1|||
27945187|NCT00913744|54602433|FG001|Overall Study|Death|0|||
27945188|NCT00912808|54602441|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
27945189|NCT00912808|54602442|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
27945190|NCT00912808|54602441|FG000|Washout|Withdrawal by Subject|0|||
27945191|NCT00912808|54602442|FG001|Washout|Withdrawal by Subject|1|||
27945192|NCT00912808|54602441|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
27945193|NCT00912808|54602442|FG001|Second Intervention (6 Weeks)|Adverse Event|1|||
27945194|NCT00912808|54602441|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
27945195|NCT00912808|54602442|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
27945196|NCT00960531|54602459|FG000|Overall Study|Lack of Efficacy|1|||
27945197|NCT00960531|54602460|FG001|Overall Study|Lack of Efficacy|0|||
27945198|NCT00960531|54602461|FG002|Overall Study|Lack of Efficacy|0|||
27945199|NCT00960531|54602462|FG003|Overall Study|Lack of Efficacy|0|||
27945200|NCT00960531|54602463|FG004|Overall Study|Lack of Efficacy|0|||
27945201|NCT00960531|54602464|FG005|Overall Study|Lack of Efficacy|0|||
27945202|NCT00960531|54602465|FG006|Overall Study|Lack of Efficacy|0|||
27945203|NCT00960531|54602466|FG007|Overall Study|Lack of Efficacy|0|||
27945204|NCT00960531|54602467|FG008|Overall Study|Lack of Efficacy|0|||
27945205|NCT00960531|54602468|FG009|Overall Study|Lack of Efficacy|0|||
27945206|NCT00960531|54602459|FG000|Overall Study|Withdrawal by Subject|1|||
27945207|NCT00960531|54602460|FG001|Overall Study|Withdrawal by Subject|0|||
27945208|NCT00960531|54602461|FG002|Overall Study|Withdrawal by Subject|5|||
27945209|NCT00960531|54602462|FG003|Overall Study|Withdrawal by Subject|2|||
27945210|NCT00960531|54602463|FG004|Overall Study|Withdrawal by Subject|0|||
27945211|NCT00960531|54602464|FG005|Overall Study|Withdrawal by Subject|0|||
27945212|NCT00960531|54602465|FG006|Overall Study|Withdrawal by Subject|2|||
27945213|NCT00960531|54602466|FG007|Overall Study|Withdrawal by Subject|0|||
27945214|NCT00960531|54602467|FG008|Overall Study|Withdrawal by Subject|1|||
27945215|NCT00960531|54602468|FG009|Overall Study|Withdrawal by Subject|0|||
27945216|NCT00960531|54602459|FG000|Overall Study|Caregiver Request|2|||
27945217|NCT00960531|54602460|FG001|Overall Study|Caregiver Request|0|||
27945218|NCT00960531|54602461|FG002|Overall Study|Caregiver Request|6|||
27945219|NCT00960531|54602462|FG003|Overall Study|Caregiver Request|5|||
27945220|NCT00960531|54602463|FG004|Overall Study|Caregiver Request|0|||
27945221|NCT00960531|54602464|FG005|Overall Study|Caregiver Request|2|||
27945222|NCT00960531|54602465|FG006|Overall Study|Caregiver Request|3|||
27945223|NCT00960531|54602466|FG007|Overall Study|Caregiver Request|1|||
27945224|NCT00960531|54602467|FG008|Overall Study|Caregiver Request|3|||
27945225|NCT00960531|54602468|FG009|Overall Study|Caregiver Request|0|||
27945226|NCT00960531|54602459|FG000|Overall Study|Investigator Request|0|||
27945227|NCT00960531|54602460|FG001|Overall Study|Investigator Request|0|||
27945228|NCT00960531|54602461|FG002|Overall Study|Investigator Request|1|||
27945229|NCT00960531|54602462|FG003|Overall Study|Investigator Request|0|||
27945230|NCT00960531|54602463|FG004|Overall Study|Investigator Request|0|||
27945231|NCT00960531|54602464|FG005|Overall Study|Investigator Request|0|||
27945232|NCT00960531|54602465|FG006|Overall Study|Investigator Request|0|||
27945233|NCT00960531|54602466|FG007|Overall Study|Investigator Request|0|||
27945234|NCT00960531|54602467|FG008|Overall Study|Investigator Request|0|||
27945235|NCT00960531|54602468|FG009|Overall Study|Investigator Request|0|||
27945236|NCT00960531|54602459|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
28164501|NCT00453154|54835139|FG001|Double BIind Maintenance|Adverse Event|0|||
27831721|NCT00705432|54310369|FG002|Treatment Period|Adverse Event|51|||
27831722|NCT00705432|54310370|FG003|Treatment Period|Adverse Event|12|||
27831723|NCT00705432|54310371|FG004|Treatment Period|Adverse Event|8|||
27831724|NCT00705432|54310372|FG005|Treatment Period|Adverse Event|9|||
27831725|NCT00705432|54310367|FG000|Treatment Period|Treatment failure|92|||
27831726|NCT00705432|54310368|FG001|Treatment Period|Treatment failure|42|||
27831727|NCT00705432|54310369|FG002|Treatment Period|Treatment failure|33|||
27831728|NCT00705432|54310370|FG003|Treatment Period|Treatment failure|25|||
27831729|NCT00705432|54310371|FG004|Treatment Period|Treatment failure|13|||
27831730|NCT00705432|54310372|FG005|Treatment Period|Treatment failure|14|||
27831731|NCT00705432|54310367|FG000|Treatment Period|Non medical reason|26|||
27831732|NCT00705432|54310368|FG001|Treatment Period|Non medical reason|32|||
27945237|NCT00960531|54602460|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
27831733|NCT00705432|54310369|FG002|Treatment Period|Non medical reason|37|||
27831734|NCT00705432|54310370|FG003|Treatment Period|Non medical reason|4|||
27831735|NCT00705432|54310371|FG004|Treatment Period|Non medical reason|7|||
27945238|NCT00960531|54602461|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
27945239|NCT00960531|54602462|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
27945240|NCT00960531|54602463|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
27945241|NCT00960531|54602464|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
27945242|NCT00960531|54602465|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
27945243|NCT00960531|54602466|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
28079968|NCT00116805|54733447|FG001|Open-label Period Weeks 145 - 192|Completed Study|1|||
28079969|NCT00116805|54733446|FG000|Open-label Period Weeks 145 - 192|Investigator's Discretion|2|||
28079970|NCT00116805|54733447|FG001|Open-label Period Weeks 145 - 192|Investigator's Discretion|0|||
28079971|NCT00116805|54733446|FG000|Open-label Period Weeks 145 - 192|Lost to Follow-up|3|||
28079972|NCT00116805|54733447|FG001|Open-label Period Weeks 145 - 192|Lost to Follow-up|1|||
28079973|NCT00116805|54733446|FG000|Open-label Period Weeks 145 - 192|Protocol Violation|1|||
28079974|NCT00116805|54733447|FG001|Open-label Period Weeks 145 - 192|Protocol Violation|0|||
27945244|NCT00960531|54602467|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
27945245|NCT00960531|54602468|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
27945246|NCT00960531|54602459|FG000|Overall Study|Lost to Follow-up|0|||
27945247|NCT00960531|54602460|FG001|Overall Study|Lost to Follow-up|0|||
27945248|NCT00960531|54602461|FG002|Overall Study|Lost to Follow-up|1|||
27945249|NCT00960531|54602462|FG003|Overall Study|Lost to Follow-up|0|||
27945250|NCT00960531|54602463|FG004|Overall Study|Lost to Follow-up|0|||
27945251|NCT00960531|54602464|FG005|Overall Study|Lost to Follow-up|0|||
27945252|NCT00960531|54602465|FG006|Overall Study|Lost to Follow-up|1|||
27945253|NCT00960531|54602466|FG007|Overall Study|Lost to Follow-up|0|||
27945254|NCT00960531|54602467|FG008|Overall Study|Lost to Follow-up|0|||
27945255|NCT00960531|54602468|FG009|Overall Study|Lost to Follow-up|0|||
27945256|NCT00960531|54602459|FG000|Overall Study|Failed to Return|2|||
27945257|NCT00960531|54602460|FG001|Overall Study|Failed to Return|0|||
27945258|NCT00960531|54602461|FG002|Overall Study|Failed to Return|0|||
27945259|NCT00960531|54602462|FG003|Overall Study|Failed to Return|0|||
27945260|NCT00960531|54602463|FG004|Overall Study|Failed to Return|0|||
27945261|NCT00960531|54602464|FG005|Overall Study|Failed to Return|0|||
27945262|NCT00960531|54602465|FG006|Overall Study|Failed to Return|0|||
27945263|NCT00960531|54602466|FG007|Overall Study|Failed to Return|2|||
27945264|NCT00960531|54602467|FG008|Overall Study|Failed to Return|0|||
27945265|NCT00960531|54602468|FG009|Overall Study|Failed to Return|0|||
27945266|NCT00960531|54602459|FG000|Overall Study|Adverse Event (AE)|2|||
27945267|NCT00960531|54602460|FG001|Overall Study|Adverse Event (AE)|0|||
27945268|NCT00960531|54602461|FG002|Overall Study|Adverse Event (AE)|0|||
27945269|NCT00960531|54602462|FG003|Overall Study|Adverse Event (AE)|0|||
27945270|NCT00960531|54602463|FG004|Overall Study|Adverse Event (AE)|0|||
27945271|NCT00960531|54602464|FG005|Overall Study|Adverse Event (AE)|1|||
27945272|NCT00960531|54602465|FG006|Overall Study|Adverse Event (AE)|2|||
27945273|NCT00960531|54602466|FG007|Overall Study|Adverse Event (AE)|0|||
27945274|NCT00960531|54602467|FG008|Overall Study|Adverse Event (AE)|2|||
27945275|NCT00960531|54602468|FG009|Overall Study|Adverse Event (AE)|0|||
27945276|NCT00960531|54602459|FG000|Overall Study|Reason not Specified|2|||
27945277|NCT00960531|54602460|FG001|Overall Study|Reason not Specified|1|||
27945278|NCT00960531|54602461|FG002|Overall Study|Reason not Specified|13|||
27945279|NCT00960531|54602462|FG003|Overall Study|Reason not Specified|1|||
27945280|NCT00960531|54602463|FG004|Overall Study|Reason not Specified|2|||
27945281|NCT00960531|54602464|FG005|Overall Study|Reason not Specified|0|||
27945282|NCT00960531|54602465|FG006|Overall Study|Reason not Specified|16|||
27945283|NCT00960531|54602466|FG007|Overall Study|Reason not Specified|0|||
27945284|NCT00960531|54602467|FG008|Overall Study|Reason not Specified|8|||
27945285|NCT00960531|54602468|FG009|Overall Study|Reason not Specified|1|||
27945286|NCT00960375|54602496|FG000|Overall Study|Lost to Follow-up|20|||
27945287|NCT00960375|54602497|FG001|Overall Study|Lost to Follow-up|22|||
27945288|NCT00957801|54602516|FG000|Overall Study|Withdrawal by Subject|0|||
27945289|NCT00957801|54602517|FG001|Overall Study|Withdrawal by Subject|0|||
27945290|NCT00957801|54602518|FG002|Overall Study|Withdrawal by Subject|0|||
27945291|NCT00957801|54602519|FG003|Overall Study|Withdrawal by Subject|1|||
27945292|NCT00957723|54602529|FG000|Overall Study|Death|3|||
27945293|NCT00957723|54602529|FG000|Overall Study|Revision/ Removal of Study Implant|3|||
27945294|NCT00957723|54602529|FG000|Overall Study|Lost to Follow-up|8|||
27945295|NCT00957723|54602529|FG000|Overall Study|Withdrawal by Subject|24|||
27945296|NCT00957723|54602529|FG000|Overall Study|Investigative Site Terminated|61|||
27945297|NCT00957723|54602529|FG000|Overall Study|Intercurrent Illness|2|||
28079975|NCT00116805|54733446|FG000|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0|||
28079976|NCT00116805|54733447|FG001|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1|||
27945298|NCT00957723|54602529|FG000|Overall Study|2yr ROM Data Not Evaluable|12|||
27945299|NCT03778021|54602537|FG000|Overall Study|Student failed to respond to follow-up survey|28|||
27945300|NCT03778021|54602538|FG001|Overall Study|Student failed to respond to follow-up survey|53|||
27945301|NCT00911170|54602547|FG000|Treatment Period|Randomized in error|1|||
27945302|NCT00911170|54602548|FG001|Treatment Period|Randomized in error|1|||
27945303|NCT00911170|54602547|FG000|Treatment Period|Ineligibility determined|1|||
27945304|NCT00911170|54602548|FG001|Treatment Period|Ineligibility determined|3|||
27945305|NCT00911170|54602547|FG000|Treatment Period|Protocol deviation|1|||
27945306|NCT00911170|54602548|FG001|Treatment Period|Protocol deviation|2|||
27945307|NCT00911170|54602547|FG000|Treatment Period|Adverse Event|9|||
27945308|NCT00911170|54602548|FG001|Treatment Period|Adverse Event|10|||
27945309|NCT00911170|54602547|FG000|Treatment Period|Withdrawal by Subject|4|||
27945310|NCT00911170|54602548|FG001|Treatment Period|Withdrawal by Subject|4|||
27945311|NCT00911170|54602547|FG000|Treatment Period|Disease progression|0|||
27945312|NCT00911170|54602548|FG001|Treatment Period|Disease progression|2|||
27945313|NCT00911170|54602547|FG000|Treatment Period|Physician Decision|5|||
27945314|NCT00911170|54602548|FG001|Treatment Period|Physician Decision|5|||
27945315|NCT00911170|54602547|FG000|Treatment Period|Lost to Follow-up|0|||
27945316|NCT00911170|54602548|FG001|Treatment Period|Lost to Follow-up|1|||
27945317|NCT00911170|54602547|FG000|Treatment Period|Death|6|||
27945318|NCT00911170|54602548|FG001|Treatment Period|Death|9|||
27945319|NCT00911170|54602547|FG000|Long Term Follow-Up|Continuing in study|274|||
27945320|NCT00911170|54602548|FG001|Long Term Follow-Up|Continuing in study|269|||
27945321|NCT00911170|54602547|FG000|Long Term Follow-Up|Withdrawal by Subject|20|||
27945322|NCT00911170|54602548|FG001|Long Term Follow-Up|Withdrawal by Subject|21|||
27945323|NCT00911170|54602547|FG000|Long Term Follow-Up|Physician Decision|5|||
27945324|NCT00911170|54602548|FG001|Long Term Follow-Up|Physician Decision|4|||
27945325|NCT00911170|54602547|FG000|Long Term Follow-Up|Lost to Follow-up|8|||
27945326|NCT00911170|54602548|FG001|Long Term Follow-Up|Lost to Follow-up|7|||
27945327|NCT00911170|54602547|FG000|Long Term Follow-Up|Death|116|||
27945328|NCT00911170|54602548|FG001|Long Term Follow-Up|Death|121|||
27945329|NCT01167881|54602556|FG000|Overall Study|Adverse Event|47|||
27945330|NCT01167881|54602557|FG001|Overall Study|Adverse Event|51|||
27945331|NCT01167881|54602556|FG000|Overall Study|Lack of Efficacy|4|||
27945332|NCT01167881|54602557|FG001|Overall Study|Lack of Efficacy|7|||
27945333|NCT01167881|54602556|FG000|Overall Study|Non compliant with protocol|9|||
27945334|NCT01167881|54602557|FG001|Overall Study|Non compliant with protocol|18|||
27945335|NCT01167881|54602556|FG000|Overall Study|Lost to Follow-up|19|||
27945336|NCT01167881|54602557|FG001|Overall Study|Lost to Follow-up|20|||
27945337|NCT01167881|54602556|FG000|Overall Study|Patient refusal to cont., not due to AE|45|||
27945338|NCT01167881|54602557|FG001|Overall Study|Patient refusal to cont., not due to AE|40|||
27945339|NCT01167881|54602556|FG000|Overall Study|Not treated|4|||
27945340|NCT01167881|54602557|FG001|Overall Study|Not treated|0|||
27945341|NCT01167881|54602556|FG000|Overall Study|Other not defined above|31|||
27945342|NCT01167881|54602557|FG001|Overall Study|Other not defined above|55|||
27945343|NCT00960063|54602566|FG000|Overall Study|Adverse Event|1|||
27945344|NCT00960063|54602567|FG001|Overall Study|Adverse Event|0|||
27945345|NCT00960063|54602568|FG002|Overall Study|Adverse Event|0|||
27945346|NCT00960063|54602566|FG000|Overall Study|Progression of Disease|0|||
27945347|NCT00960063|54602567|FG001|Overall Study|Progression of Disease|0|||
27945348|NCT00960063|54602568|FG002|Overall Study|Progression of Disease|3|||
27945349|NCT00959907|54602578|FG000|Overall Study|Protocol Violation|0|||
27945350|NCT00959907|54602579|FG001|Overall Study|Protocol Violation|1|||
27945351|NCT00959907|54602578|FG000|Overall Study|Adverse Event|1|||
27945352|NCT00959907|54602579|FG001|Overall Study|Adverse Event|0|||
27945353|NCT00959907|54602578|FG000|Overall Study|Withdrawal by Subject|2|||
27945354|NCT00959907|54602579|FG001|Overall Study|Withdrawal by Subject|0|||
27945355|NCT00912340|54602588|FG000|Overall Study|Adverse Event|2|||
27945356|NCT00912340|54602589|FG001|Overall Study|Adverse Event|4|||
27945357|NCT00912340|54602590|FG002|Overall Study|Adverse Event|0|||
27945358|NCT00912340|54602588|FG000|Overall Study|Protocol revised to remove arm|0|||
27945359|NCT00912340|54602589|FG001|Overall Study|Protocol revised to remove arm|0|||
27945360|NCT00912340|54602590|FG002|Overall Study|Protocol revised to remove arm|4|||
27945361|NCT01167257|54602600|FG000|Overall Study|Lost to Follow-up|2|||
27945362|NCT01167257|54602601|FG001|Overall Study|Lost to Follow-up|2|||
27945363|NCT01167257|54602600|FG000|Overall Study|Withdrew consent|1|||
27945364|NCT01167257|54602601|FG001|Overall Study|Withdrew consent|1|||
27945365|NCT01119846|54602614|FG000|Overall Study|Adverse Event|1|||
27945366|NCT01119846|54602615|FG001|Overall Study|Adverse Event|0|||
27945367|NCT01119846|54602616|FG002|Overall Study|Adverse Event|6|||
27945368|NCT01119846|54602614|FG000|Overall Study|Physician Decision|1|||
27945369|NCT01119846|54602615|FG001|Overall Study|Physician Decision|0|||
27945370|NCT01119846|54602616|FG002|Overall Study|Physician Decision|0|||
27945371|NCT01119846|54602614|FG000|Overall Study|Protocol Violation|0|||
27945372|NCT01119846|54602615|FG001|Overall Study|Protocol Violation|0|||
27945373|NCT01119846|54602616|FG002|Overall Study|Protocol Violation|1|||
27945374|NCT01119846|54602614|FG000|Overall Study|Withdrawal by Subject|0|||
27945375|NCT01119846|54602615|FG001|Overall Study|Withdrawal by Subject|0|||
27945376|NCT01119846|54602616|FG002|Overall Study|Withdrawal by Subject|4|||
27945377|NCT01167179|54602653|FG000|Overall Study|disease recurrence|4|||
27945378|NCT01167179|54602654|FG001|Overall Study|disease recurrence|4|||
27945379|NCT01167179|54602653|FG000|Overall Study|Death|4|||
27945380|NCT01167179|54602654|FG001|Overall Study|Death|10|||
27945381|NCT01167179|54602653|FG000|Overall Study|Withdrawal by Subject|1|||
27945382|NCT01167179|54602654|FG001|Overall Study|Withdrawal by Subject|2|||
27945383|NCT01167179|54602653|FG000|Overall Study|diverse|6|||
27945384|NCT01167179|54602654|FG001|Overall Study|diverse|5|||
27945385|NCT01167023|54602727|FG000|Overall Study|Lost to Follow-up|0|||
27945386|NCT01167023|54602728|FG001|Overall Study|Lost to Follow-up|1|||
27945387|NCT01167023|54602729|FG002|Overall Study|Lost to Follow-up|1|||
27945388|NCT01167023|54602727|FG000|Overall Study|Screen Failure|0|||
27945389|NCT01167023|54602728|FG001|Overall Study|Screen Failure|1|||
27945390|NCT01167023|54602729|FG002|Overall Study|Screen Failure|0|||
27945391|NCT01167023|54602727|FG000|Overall Study|Sponsor Decision|0|||
27945392|NCT01167023|54602728|FG001|Overall Study|Sponsor Decision|1|||
27945393|NCT01167023|54602729|FG002|Overall Study|Sponsor Decision|0|||
27945394|NCT01167023|54602727|FG000|Overall Study|Withdrawal by Subject|0|||
27853457|NCT00551031|54363498|FG003|Overall Study|Serious Adverse Event|0|||
27945395|NCT01167023|54602728|FG001|Overall Study|Withdrawal by Subject|0|||
27945396|NCT01167023|54602729|FG002|Overall Study|Withdrawal by Subject|1|||
27945397|NCT03484117|54602737|FG000|Overall Study|Lost to Follow-up|1|||
27945398|NCT03484117|54602738|FG001|Overall Study|Lost to Follow-up|3|||
27945399|NCT03484117|54602737|FG000|Overall Study|Declined participation in exit assess|1|||
27945400|NCT03484117|54602738|FG001|Overall Study|Declined participation in exit assess|1|||
27945401|NCT01166945|54602746|FG000|Randomized|diagnosed with Group A strep|4|||
27945402|NCT01166945|54602747|FG001|Randomized|diagnosed with Group A strep|4|||
27945403|NCT01166945|54602746|FG000|Day 10|NonCompliance/Lost to Follow Up|3|||
27945404|NCT01166945|54602747|FG001|Day 10|NonCompliance/Lost to Follow Up|2|||
27945405|NCT01166945|54602746|FG000|Day 15|NonCompliance/Lost to Follow Up|2|||
27945406|NCT01166945|54602747|FG001|Day 15|NonCompliance/Lost to Follow Up|1|||
27945407|NCT01166945|54602746|FG000|Day 30|Lost to Follow-up|4|||
27945408|NCT01166945|54602747|FG001|Day 30|Lost to Follow-up|3|||
27945409|NCT00910000|54602761|FG000|Overall Study|Adverse Event|0|||
27945410|NCT00910000|54602762|FG001|Overall Study|Adverse Event|3|||
27945411|NCT00910000|54602763|FG002|Overall Study|Adverse Event|2|||
27945412|NCT00910000|54602764|FG003|Overall Study|Adverse Event|2|||
27945413|NCT00910000|54602765|FG004|Overall Study|Adverse Event|0|||
27945414|NCT00910000|54602766|FG005|Overall Study|Adverse Event|1|||
27945415|NCT00910000|54602761|FG000|Overall Study|Withdrawal by Subject|0|||
27945416|NCT00910000|54602762|FG001|Overall Study|Withdrawal by Subject|0|||
27945417|NCT00910000|54602763|FG002|Overall Study|Withdrawal by Subject|1|||
27945418|NCT00910000|54602764|FG003|Overall Study|Withdrawal by Subject|0|||
27945419|NCT00910000|54602765|FG004|Overall Study|Withdrawal by Subject|1|||
27945420|NCT00910000|54602766|FG005|Overall Study|Withdrawal by Subject|0|||
27945421|NCT01119768|54602787|FG000|Treatment Period|Lack of Efficacy|18|||
27945422|NCT01119768|54602788|FG001|Treatment Period|Lack of Efficacy|25|||
27945423|NCT01165307|54602796|FG000|Overall Study|Lost to Follow-up|11|||
27945424|NCT01165307|54602797|FG001|Overall Study|Lost to Follow-up|3|||
27945425|NCT01165307|54602796|FG000|Overall Study|Withdrawal by Subject|2|||
27945426|NCT01165307|54602797|FG001|Overall Study|Withdrawal by Subject|0|||
27945427|NCT01165307|54602796|FG000|Overall Study|Subject not available for contact|1|||
27945428|NCT01165307|54602797|FG001|Overall Study|Subject not available for contact|0|||
27945429|NCT00960999|54602805|FG000|Overall Study|Withdrawal by Subject|1|||
27945430|NCT00960999|54602806|FG001|Overall Study|Withdrawal by Subject|0|||
27945431|NCT00960999|54602805|FG000|Overall Study|Protocol Violation|5|||
27853458|NCT00551031|54363499|FG004|Overall Study|Serious Adverse Event|0|||
27853459|NCT00551031|54363495|FG000|Overall Study|Did not receive vaccine|1|||
27853460|NCT00551031|54363496|FG001|Overall Study|Did not receive vaccine|2|||
27853461|NCT00551031|54363497|FG002|Overall Study|Did not receive vaccine|0|||
27853462|NCT00551031|54363498|FG003|Overall Study|Did not receive vaccine|0|||
27853463|NCT00551031|54363499|FG004|Overall Study|Did not receive vaccine|0|||
27853464|NCT01431716|54363511|FG000|Overall Study|Withdrawal of consent|1|||
27853465|NCT00550953|54363517|FG000|Overall Study|Adverse Event|4|||
27853466|NCT00550953|54363518|FG001|Overall Study|Adverse Event|3|||
27853467|NCT00550953|54363517|FG000|Overall Study|Not able to visit the site|2|||
27853468|NCT00550953|54363518|FG001|Overall Study|Not able to visit the site|3|||
27853469|NCT00558831|54363553|FG000|Overall Study|Lost to Follow-up|1|||
27853470|NCT01431638|54363562|FG000|Overall Study|Adverse Event|1|||
27853471|NCT01431638|54363563|FG001|Overall Study|Adverse Event|3|||
27853472|NCT01431638|54363564|FG002|Overall Study|Adverse Event|1|||
27853473|NCT01431638|54363562|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
27853474|NCT01431638|54363563|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
27853475|NCT01431638|54363564|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
27853476|NCT01431638|54363562|FG000|Overall Study|Participants condition no longer requires study drug|0|||
27945432|NCT00960999|54602806|FG001|Overall Study|Protocol Violation|2|||
27945433|NCT00960999|54602805|FG000|Overall Study|RT dose constraints not met|2|||
27945434|NCT00960999|54602806|FG001|Overall Study|RT dose constraints not met|0|||
27853477|NCT01431638|54363563|FG001|Overall Study|Participants condition no longer requires study drug|1|||
27853478|NCT01431638|54363564|FG002|Overall Study|Participants condition no longer requires study drug|0|||
27853479|NCT01431638|54363562|FG000|Overall Study|Participant withdrew consent|14|||
27945435|NCT01124838|54602814|FG000|Overall Study|Miscellaneous|4|||
27945436|NCT01124838|54602815|FG001|Overall Study|Miscellaneous|2|||
27945437|NCT01124838|54602814|FG000|Overall Study|Adverse Event|7|||
27945438|NCT01124838|54602815|FG001|Overall Study|Adverse Event|11|||
27945439|NCT01124838|54602814|FG000|Overall Study|Lack of Efficacy|2|||
27945440|NCT01124838|54602815|FG001|Overall Study|Lack of Efficacy|0|||
27945441|NCT01124838|54602814|FG000|Overall Study|Withdrawal by Subject|3|||
27945442|NCT01124838|54602815|FG001|Overall Study|Withdrawal by Subject|2|||
27945443|NCT01124838|54602814|FG000|Overall Study|Lost to Follow-up|2|||
27945444|NCT01124838|54602815|FG001|Overall Study|Lost to Follow-up|0|||
27945445|NCT00959751|54602825|FG000|Overall Study|Lost to Follow-up|2|||
27945446|NCT00959751|54602826|FG001|Overall Study|Lost to Follow-up|3|||
27945447|NCT00959751|54602825|FG000|Overall Study|Consent Withdrawn|0|||
27945448|NCT00959751|54602826|FG001|Overall Study|Consent Withdrawn|1|||
27945449|NCT00959751|54602825|FG000|Overall Study|Non-compliance to Study Procedures|0|||
27945450|NCT00959751|54602826|FG001|Overall Study|Non-compliance to Study Procedures|1|||
27945451|NCT00959751|54602825|FG000|Overall Study|No migraine headache without aura|7|||
27945452|NCT00959751|54602826|FG001|Overall Study|No migraine headache without aura|7|||
27945453|NCT00910858|54602835|FG000|Pharmacokinetic Phase|Adverse Event|1|||
27945454|NCT00910858|54602836|FG001|Pharmacokinetic Phase|Adverse Event|0|||
27945455|NCT00910858|54602837|FG002|Pharmacokinetic Phase|Adverse Event|0|||
27945456|NCT00910858|54602835|FG000|Monotherapy Phase|Adverse Event|3|||
28164502|NCT00453154|54835140|FG002|Double BIind Maintenance|Adverse Event|3|||
27945457|NCT00910858|54602836|FG001|Monotherapy Phase|Adverse Event|2|||
27945458|NCT00910858|54602837|FG002|Monotherapy Phase|Adverse Event|0|||
27945459|NCT00910858|54602835|FG000|Monotherapy Phase|Lack of therapeutic effect|9|||
27945460|NCT00910858|54602836|FG001|Monotherapy Phase|Lack of therapeutic effect|6|||
27945461|NCT00910858|54602837|FG002|Monotherapy Phase|Lack of therapeutic effect|4|||
27945462|NCT00910858|54602835|FG000|Monotherapy Phase|Withdrawal by Subject|1|||
27945463|NCT00910858|54602836|FG001|Monotherapy Phase|Withdrawal by Subject|3|||
27945464|NCT00910858|54602837|FG002|Monotherapy Phase|Withdrawal by Subject|1|||
27945465|NCT00910858|54602835|FG000|Monotherapy Phase|Protocol Violation|1|||
27945466|NCT00910858|54602836|FG001|Monotherapy Phase|Protocol Violation|0|||
27945467|NCT00910858|54602837|FG002|Monotherapy Phase|Protocol Violation|0|||
27945468|NCT00910858|54602835|FG000|Monotherapy Phase|Other|3|||
27945469|NCT00910858|54602836|FG001|Monotherapy Phase|Other|4|||
27945470|NCT00910858|54602837|FG002|Monotherapy Phase|Other|2|||
27945471|NCT00910858|54602835|FG000|Combined Treatment Phase|Lack of therapeutic effect|8|||
27945472|NCT00910858|54602836|FG001|Combined Treatment Phase|Lack of therapeutic effect|6|||
27945473|NCT00910858|54602837|FG002|Combined Treatment Phase|Lack of therapeutic effect|3|||
27945474|NCT00910858|54602835|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
27945475|NCT00910858|54602836|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
27945476|NCT00910858|54602837|FG002|Combined Treatment Phase|Withdrawal by Subject|0|||
27945477|NCT00910858|54602835|FG000|Combined Treatment Phase|Protocol Violation|1|||
27945478|NCT00910858|54602836|FG001|Combined Treatment Phase|Protocol Violation|0|||
27945479|NCT00910858|54602837|FG002|Combined Treatment Phase|Protocol Violation|0|||
27945480|NCT00910858|54602835|FG000|Combined Treatment Phase|Other|0|||
27945481|NCT00910858|54602836|FG001|Combined Treatment Phase|Other|2|||
27945482|NCT00910858|54602837|FG002|Combined Treatment Phase|Other|1|||
27945483|NCT00598975|54602855|FG000|Overall Study|Adverse Event|1|||
27945484|NCT00598975|54602856|FG001|Overall Study|Adverse Event|1|||
27945485|NCT00598975|54602855|FG000|Overall Study|Brain metastases|1|||
27945486|NCT00598975|54602856|FG001|Overall Study|Brain metastases|0|||
27945487|NCT00598975|54602855|FG000|Overall Study|Withdrawal by Subject|1|||
27945488|NCT00598975|54602856|FG001|Overall Study|Withdrawal by Subject|1|||
27945489|NCT00598975|54602855|FG000|Overall Study|Withdrawal of consent|0|||
27945490|NCT00598975|54602856|FG001|Overall Study|Withdrawal of consent|1|||
27945491|NCT00598975|54602855|FG000|Overall Study|Disease progression|8|||
27945492|NCT00598975|54602856|FG001|Overall Study|Disease progression|3|||
28164503|NCT00453154|54835141|FG003|Double BIind Maintenance|Adverse Event|12|||
28164504|NCT00453154|54835138|FG000|Double BIind Maintenance|Death|0|||
27945493|NCT00598975|54602855|FG000|Overall Study|Tx delayed >2 wks, hospitalized for AE|1|||
27945494|NCT00598975|54602856|FG001|Overall Study|Tx delayed >2 wks, hospitalized for AE|0|||
27945495|NCT00957021|54602864|FG000|Overall Study|Death|5|||
27945496|NCT00957021|54602864|FG000|Overall Study|Lost to Follow-up|8|||
27945497|NCT00957021|54602864|FG000|Overall Study|Withdrawal by Subject|34|||
27945498|NCT00957021|54602864|FG000|Overall Study|No 2 yr ROM data|35|||
27945499|NCT00957021|54602864|FG000|Overall Study|Revised study component by 2 yr visit|8|||
27945500|NCT00957021|54602864|FG000|Overall Study|Site Termination by the 2 yr visit|16|||
28164505|NCT00453154|54835139|FG001|Double BIind Maintenance|Death|0|||
27945501|NCT00957021|54602864|FG000|Overall Study|Surgery Cancelled|9|||
27945502|NCT00957021|54602864|FG000|Overall Study|Termination due to language issue|2|||
27945503|NCT01124604|54602871|FG000|Overall Study|Adverse Event|10|||
27945504|NCT01124604|54602872|FG001|Overall Study|Adverse Event|1|||
27945505|NCT01124604|54602871|FG000|Overall Study|Lack of Efficacy|1|||
27945506|NCT01124604|54602872|FG001|Overall Study|Lack of Efficacy|0|||
27945507|NCT01124604|54602871|FG000|Overall Study|Withdrawal by Subject|4|||
27945508|NCT01124604|54602872|FG001|Overall Study|Withdrawal by Subject|0|||
27945509|NCT01124604|54602871|FG000|Overall Study|Disease Progression|0|||
27945510|NCT01124604|54602872|FG001|Overall Study|Disease Progression|1|||
27945511|NCT00909844|54602878|FG000|Overall Study|Adverse Event|1|||
27945512|NCT00909844|54602878|FG000|Overall Study|Withdrawal by Subject|1|||
28164506|NCT00453154|54835140|FG002|Double BIind Maintenance|Death|2|||
27945513|NCT00909844|54602878|FG000|Overall Study|Lost to Follow-up|2|||
27945514|NCT01124448|54602885|FG000|Overall Study|Lost to Follow-up|0|||
27945515|NCT01124448|54602886|FG001|Overall Study|Lost to Follow-up|3|||
27945516|NCT01124448|54602885|FG000|Overall Study|Protocol Violation|2|||
27945517|NCT01124448|54602886|FG001|Overall Study|Protocol Violation|0|||
27945518|NCT01124292|54602895|FG000|Overall Study|Lost to Follow-up|2|||
27945519|NCT01124292|54602896|FG001|Overall Study|Lost to Follow-up|4|||
27945520|NCT01124292|54602897|FG002|Overall Study|Lost to Follow-up|3|||
27945521|NCT01124292|54602895|FG000|Overall Study|Physician Decision|0|||
27945522|NCT01124292|54602896|FG001|Overall Study|Physician Decision|3|||
27945523|NCT01124292|54602897|FG002|Overall Study|Physician Decision|2|||
27945524|NCT01124292|54602895|FG000|Overall Study|Withdrawal by Subject|0|||
27945525|NCT01124292|54602896|FG001|Overall Study|Withdrawal by Subject|6|||
27945526|NCT01124292|54602897|FG002|Overall Study|Withdrawal by Subject|2|||
27945527|NCT01124292|54602895|FG000|Overall Study|medical issue unrelated to the study|0|||
27945528|NCT01124292|54602896|FG001|Overall Study|medical issue unrelated to the study|0|||
27945529|NCT01124292|54602897|FG002|Overall Study|medical issue unrelated to the study|2|||
27945530|NCT01124292|54602895|FG000|Overall Study|piercing track closed|0|||
27945531|NCT01124292|54602896|FG001|Overall Study|piercing track closed|2|||
27945532|NCT01124292|54602897|FG002|Overall Study|piercing track closed|1|||
27945533|NCT01136772|54602910|FG000|Overall Study|Adverse Event|15|||
27945534|NCT01136772|54602911|FG001|Overall Study|Adverse Event|14|||
27945535|NCT01136772|54602910|FG000|Overall Study|Lack of Efficacy|42|||
27945536|NCT01136772|54602911|FG001|Overall Study|Lack of Efficacy|39|||
27945537|NCT01136772|54602910|FG000|Overall Study|Administrative|14|||
27945538|NCT01136772|54602911|FG001|Overall Study|Administrative|12|||
27945539|NCT01136772|54602910|FG000|Overall Study|Withdrawal by Subject|33|||
27945540|NCT01136772|54602911|FG001|Overall Study|Withdrawal by Subject|36|||
27831736|NCT00705432|54310372|FG005|Treatment Period|Non medical reason|7|||
27831737|NCT00705432|54310367|FG000|Follow-up Period (Upto Week 72)|Adverse Event|2|||
27831738|NCT00705432|54310368|FG001|Follow-up Period (Upto Week 72)|Adverse Event|1|||
27853480|NCT01431638|54363563|FG001|Overall Study|Participant withdrew consent|5|||
27853481|NCT01431638|54363564|FG002|Overall Study|Participant withdrew consent|8|||
27853482|NCT01431638|54363562|FG000|Overall Study|Lost to Follow-up|7|||
27853483|NCT01431638|54363563|FG001|Overall Study|Lost to Follow-up|9|||
27853484|NCT01431638|54363564|FG002|Overall Study|Lost to Follow-up|7|||
27853485|NCT01431638|54363562|FG000|Overall Study|Administrative problems|1|||
27853486|NCT01431638|54363563|FG001|Overall Study|Administrative problems|4|||
27853487|NCT01431638|54363564|FG002|Overall Study|Administrative problems|6|||
27853488|NCT01431638|54363562|FG000|Overall Study|Death|1|||
27853489|NCT01431638|54363563|FG001|Overall Study|Death|0|||
27853490|NCT01431638|54363564|FG002|Overall Study|Death|0|||
27853491|NCT01431638|54363562|FG000|Overall Study|Protocol deviation|1|||
27853492|NCT01431638|54363563|FG001|Overall Study|Protocol deviation|1|||
27853493|NCT01431638|54363564|FG002|Overall Study|Protocol deviation|4|||
27853494|NCT01431638|54363562|FG000|Overall Study|Participants Did not enter extension study from core study|39|||
27853495|NCT01431638|54363563|FG001|Overall Study|Participants Did not enter extension study from core study|46|||
27853496|NCT01431638|54363564|FG002|Overall Study|Participants Did not enter extension study from core study|32|||
27853497|NCT01392170|54363572|FG000|Overall Study|Withdrawal by Subject|1|||
27853498|NCT01392170|54363572|FG000|Overall Study|Ineligible|1|||
27853499|NCT00558753|54363578|FG000|Overall Study|Lost to Follow-up|5|||
27853500|NCT00558753|54363579|FG001|Overall Study|Lost to Follow-up|7|||
27853501|NCT01391546|54363587|FG000|Overall Study|History of Herpes Zoster (HZ)|1|||
27831739|NCT00705432|54310369|FG002|Follow-up Period (Upto Week 72)|Adverse Event|1|||
27831740|NCT00705432|54310370|FG003|Follow-up Period (Upto Week 72)|Adverse Event|0|||
27831741|NCT00705432|54310371|FG004|Follow-up Period (Upto Week 72)|Adverse Event|0|||
27831742|NCT00705432|54310372|FG005|Follow-up Period (Upto Week 72)|Adverse Event|0|||
27831743|NCT00705432|54310367|FG000|Follow-up Period (Upto Week 72)|Non medical reason|69|||
27831744|NCT00705432|54310368|FG001|Follow-up Period (Upto Week 72)|Non medical reason|42|||
27831745|NCT00705432|54310369|FG002|Follow-up Period (Upto Week 72)|Non medical reason|24|||
27831746|NCT00705432|54310370|FG003|Follow-up Period (Upto Week 72)|Non medical reason|14|||
27831747|NCT00705432|54310371|FG004|Follow-up Period (Upto Week 72)|Non medical reason|6|||
27831748|NCT00705432|54310372|FG005|Follow-up Period (Upto Week 72)|Non medical reason|7|||
27853502|NCT01391546|54363588|FG001|Overall Study|History of Herpes Zoster (HZ)|0|||
27853503|NCT01410110|54363597|FG000|Overall Study|Withdrawal by Subject|4|||
27853504|NCT01410110|54363598|FG001|Overall Study|Withdrawal by Subject|2|||
27853505|NCT01391000|54363606|FG000|Overall Study|Lost to Follow-up|2|||
27853506|NCT01391000|54363607|FG001|Overall Study|Lost to Follow-up|0|||
27945541|NCT01136772|54602910|FG000|Overall Study|Did not receive injection|10|||
27945542|NCT01136772|54602911|FG001|Overall Study|Did not receive injection|7|||
27945543|NCT01136772|54602910|FG000|Overall Study|Did not follow up after first injection|2|||
27945544|NCT01136772|54602911|FG001|Overall Study|Did not follow up after first injection|2|||
27945545|NCT00909532|54602919|FG000|Overall Study|Adverse Event|4|||
27945546|NCT00909532|54602920|FG001|Overall Study|Adverse Event|1|||
27945547|NCT00909532|54602919|FG000|Overall Study|Pregnancy|0|||
27945548|NCT00909532|54602920|FG001|Overall Study|Pregnancy|1|||
27945549|NCT00909532|54602919|FG000|Overall Study|Prohibited Medication|2|||
27945550|NCT00909532|54602920|FG001|Overall Study|Prohibited Medication|1|||
27945551|NCT00909532|54602919|FG000|Overall Study|Withdrawal of Consent|1|||
27945552|NCT00909532|54602920|FG001|Overall Study|Withdrawal of Consent|1|||
27945553|NCT00909532|54602919|FG000|Overall Study|Noncompliance with Study Requirements|0|||
27945554|NCT00909532|54602920|FG001|Overall Study|Noncompliance with Study Requirements|2|||
27945555|NCT00909532|54602919|FG000|Overall Study|Physician Decision|1|||
27945556|NCT00909532|54602920|FG001|Overall Study|Physician Decision|0|||
27945557|NCT00909532|54602919|FG000|Overall Study|Wrong Genotype|1|||
27945558|NCT00909532|54602920|FG001|Overall Study|Wrong Genotype|0|||
27945559|NCT00909532|54602919|FG000|Overall Study|Increased Lab Draws, Difficult Lab Stick|1|||
27945560|NCT00909532|54602920|FG001|Overall Study|Increased Lab Draws, Difficult Lab Stick|0|||
27945561|NCT01136382|54602929|FG000|Overall Study|Other|8|||
27945562|NCT01136382|54602930|FG001|Overall Study|Other|3|||
27945563|NCT01136382|54602929|FG000|Overall Study|Study-Specific Withdrawal Criteria|48|||
27945564|NCT01136382|54602930|FG001|Overall Study|Study-Specific Withdrawal Criteria|25|||
27945565|NCT01136382|54602929|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
27945566|NCT01136382|54602930|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
27945567|NCT01136382|54602929|FG000|Overall Study|Withdrawal by Subject|4|||
27945568|NCT01136382|54602930|FG001|Overall Study|Withdrawal by Subject|1|||
27945569|NCT00912028|54602939|FG000|Overall Study|Lost to Follow-up|2|||
27945570|NCT00912028|54602940|FG001|Overall Study|Lost to Follow-up|3|||
27945571|NCT00912028|54602941|FG002|Overall Study|Lost to Follow-up|0|||
27945572|NCT00912028|54602942|FG003|Overall Study|Lost to Follow-up|1|||
27945573|NCT00912028|54602943|FG004|Overall Study|Lost to Follow-up|3|||
27945574|NCT00912028|54602939|FG000|Overall Study|Withdrawal by Subject|3|||
27945575|NCT00912028|54602940|FG001|Overall Study|Withdrawal by Subject|0|||
27945576|NCT00912028|54602941|FG002|Overall Study|Withdrawal by Subject|0|||
27945577|NCT00912028|54602942|FG003|Overall Study|Withdrawal by Subject|0|||
27945578|NCT00912028|54602943|FG004|Overall Study|Withdrawal by Subject|0|||
27945579|NCT02731729|54602955|FG000|Overall Study|Death|2|||
27945580|NCT02731729|54602956|FG001|Overall Study|Death|2|||
27945581|NCT02731729|54602955|FG000|Overall Study|Study terminated by Sponsor|6|||
27945582|NCT02731729|54602956|FG001|Overall Study|Study terminated by Sponsor|6|||
27945583|NCT02731729|54602955|FG000|Overall Study|Withdrawal by Subject|1|||
27945584|NCT02731729|54602956|FG001|Overall Study|Withdrawal by Subject|0|||
27945585|NCT01119066|54602966|FG000|Overall Study|Withdrawal by Subject|4|||
27945586|NCT01119066|54602967|FG001|Overall Study|Withdrawal by Subject|6|||
27945587|NCT01119066|54602968|FG002|Overall Study|Withdrawal by Subject|0|||
27945588|NCT01119066|54602969|FG003|Overall Study|Withdrawal by Subject|0|||
27945589|NCT01119066|54602966|FG000|Overall Study|Concern regarding adequacy of transplant cell dose|2|||
27945590|NCT01119066|54602967|FG001|Overall Study|Concern regarding adequacy of transplant cell dose|1|||
27945591|NCT01119066|54602968|FG002|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
27945592|NCT01119066|54602969|FG003|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
27945593|NCT01119066|54602966|FG000|Overall Study|Relapse identified before transplant|1|||
27945594|NCT01119066|54602967|FG001|Overall Study|Relapse identified before transplant|0|||
27945595|NCT01119066|54602968|FG002|Overall Study|Relapse identified before transplant|0|||
27945596|NCT01119066|54602969|FG003|Overall Study|Relapse identified before transplant|0|||
27945597|NCT01119066|54602966|FG000|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
27945598|NCT01119066|54602967|FG001|Overall Study|Intercurrent medication condition rendered patient ineligible|3|||
27945599|NCT01119066|54602968|FG002|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
27945600|NCT01119066|54602969|FG003|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
27945601|NCT01119066|54602966|FG000|Overall Study|Relapse identified before transplant|0|||
27945602|NCT01119066|54602967|FG001|Overall Study|Relapse identified before transplant|4|||
27945603|NCT01119066|54602968|FG002|Overall Study|Relapse identified before transplant|0|||
27945604|NCT01119066|54602969|FG003|Overall Study|Relapse identified before transplant|0|||
27853507|NCT01390844|54363682|FG000|Treatment Phase|Adverse Event|12|||
27853508|NCT01390844|54363683|FG001|Treatment Phase|Adverse Event|2|||
27853509|NCT01390844|54363684|FG002|Treatment Phase|Adverse Event|3|||
27853510|NCT01390844|54363685|FG003|Treatment Phase|Adverse Event|2|||
27853511|NCT01390844|54363682|FG000|Treatment Phase|Treatment Failure|23|||
27853512|NCT01390844|54363683|FG001|Treatment Phase|Treatment Failure|25|||
27853513|NCT01390844|54363684|FG002|Treatment Phase|Treatment Failure|10|||
27853514|NCT01390844|54363685|FG003|Treatment Phase|Treatment Failure|13|||
27853515|NCT01390844|54363682|FG000|Treatment Phase|Non-Medical Reasons|5|||
27853516|NCT01390844|54363683|FG001|Treatment Phase|Non-Medical Reasons|1|||
27853517|NCT01390844|54363684|FG002|Treatment Phase|Non-Medical Reasons|8|||
27945605|NCT00910624|54602983|FG000|Treatment Phase|Adverse Event|2|||
27945606|NCT00910624|54602984|FG001|Treatment Phase|Adverse Event|6|||
27853518|NCT01390844|54363685|FG003|Treatment Phase|Non-Medical Reasons|1|||
27853519|NCT01390844|54363682|FG000|Treatment Phase|Non-GCP Compliant|0|||
27853520|NCT01390844|54363683|FG001|Treatment Phase|Non-GCP Compliant|0|||
27945607|NCT00910624|54602985|FG002|Treatment Phase|Adverse Event|6|||
27945608|NCT00910624|54602986|FG003|Treatment Phase|Adverse Event|0|||
27945609|NCT00910624|54602983|FG000|Treatment Phase|Treatment Failure|23|||
27945610|NCT00910624|54602984|FG001|Treatment Phase|Treatment Failure|10|||
27945611|NCT00910624|54602985|FG002|Treatment Phase|Treatment Failure|0|||
27945612|NCT00910624|54602986|FG003|Treatment Phase|Treatment Failure|0|||
27945613|NCT00910624|54602983|FG000|Treatment Phase|Lost to Follow-up|0|||
27945614|NCT00910624|54602984|FG001|Treatment Phase|Lost to Follow-up|0|||
27945615|NCT00910624|54602985|FG002|Treatment Phase|Lost to Follow-up|1|||
27945616|NCT00910624|54602986|FG003|Treatment Phase|Lost to Follow-up|0|||
27945617|NCT00910624|54602983|FG000|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
27945618|NCT00910624|54602984|FG001|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
27945619|NCT00910624|54602985|FG002|Treatment Phase|Reasons Unrelated To Assigned Treatment|1|||
27945620|NCT00910624|54602986|FG003|Treatment Phase|Reasons Unrelated To Assigned Treatment|0|||
27945621|NCT00910624|54602983|FG000|Treatment Phase|Withdrawal by Subject|2|||
27945622|NCT00910624|54602984|FG001|Treatment Phase|Withdrawal by Subject|1|||
27945623|NCT00910624|54602985|FG002|Treatment Phase|Withdrawal by Subject|0|||
28164507|NCT00453154|54835141|FG003|Double BIind Maintenance|Death|1|||
28164508|NCT00453154|54835138|FG000|Double BIind Maintenance|Withdrawal by Subject|0|||
28164509|NCT00453154|54835139|FG001|Double BIind Maintenance|Withdrawal by Subject|0|||
28164510|NCT00453154|54835140|FG002|Double BIind Maintenance|Withdrawal by Subject|4|||
28164511|NCT00453154|54835141|FG003|Double BIind Maintenance|Withdrawal by Subject|4|||
28164512|NCT00453154|54835138|FG000|Double BIind Maintenance|Progression|0|||
28164513|NCT00453154|54835139|FG001|Double BIind Maintenance|Progression|0|||
28164514|NCT00453154|54835140|FG002|Double BIind Maintenance|Progression|29|||
28164515|NCT00453154|54835141|FG003|Double BIind Maintenance|Progression|26|||
28164516|NCT00453154|54835138|FG000|Double BIind Maintenance|Medical Issues|0|||
28164517|NCT00453154|54835139|FG001|Double BIind Maintenance|Medical Issues|0|||
28164518|NCT00453154|54835140|FG002|Double BIind Maintenance|Medical Issues|3|||
28164519|NCT00453154|54835141|FG003|Double BIind Maintenance|Medical Issues|1|||
28164520|NCT00453154|54835138|FG000|Double BIind Maintenance|Randomized, did not receive therapy|0|||
28164521|NCT00453154|54835139|FG001|Double BIind Maintenance|Randomized, did not receive therapy|0|||
27945624|NCT00910624|54602986|FG003|Treatment Phase|Withdrawal by Subject|0|||
28164522|NCT00453154|54835140|FG002|Double BIind Maintenance|Randomized, did not receive therapy|5|||
27731325|NCT02610140|54178473|FG000|Long-term Follow-up|Withdrawal by Subject|6|||
27731326|NCT02610140|54178474|FG001|Long-term Follow-up|Withdrawal by Subject|3|||
27731327|NCT02610140|54178473|FG000|Long-term Follow-up|Lost to Follow-up|1|||
27731328|NCT02610140|54178474|FG001|Long-term Follow-up|Lost to Follow-up|2|||
27731329|NCT02610140|54178473|FG000|Long-term Follow-up|Ongoing but not completed|30|||
27731330|NCT02610140|54178474|FG001|Long-term Follow-up|Ongoing but not completed|17|||
27731331|NCT02789657|54178484|FG000|Overall Study|Withdrawal by Subject|2|||
27731332|NCT02789657|54178485|FG001|Overall Study|Withdrawal by Subject|0|||
27731333|NCT02789657|54178486|FG002|Overall Study|Withdrawal by Subject|0|||
27831749|NCT00704964|54310383|FG000|Overall Study|Not completed on time|328|||
27831750|NCT00704808|54310399|FG000|Overall Study|Discontinued prior to starting treatment|14|||
27831751|NCT00704808|54310399|FG000|Overall Study|Death|7|||
27831752|NCT00704808|54310399|FG000|Overall Study|Tumor progression|80|||
27853521|NCT01390844|54363684|FG002|Treatment Phase|Non-GCP Compliant|10|||
27853522|NCT01390844|54363685|FG003|Treatment Phase|Non-GCP Compliant|3|||
27945625|NCT00910624|54602983|FG000|Treatment Phase|Non-Compliance With Protocol|0|||
27945626|NCT00910624|54602984|FG001|Treatment Phase|Non-Compliance With Protocol|1|||
28079977|NCT00116805|54733446|FG000|Open-label Period Weeks 145 - 192|Seroconversion|0|||
27945627|NCT00910624|54602985|FG002|Treatment Phase|Non-Compliance With Protocol|1|||
27945628|NCT00910624|54602986|FG003|Treatment Phase|Non-Compliance With Protocol|0|||
27945629|NCT00910624|54602983|FG000|Follow-Up Phase|Adverse Event|0|||
27945630|NCT00910624|54602984|FG001|Follow-Up Phase|Adverse Event|0|||
28079978|NCT00116805|54733447|FG001|Open-label Period Weeks 145 - 192|Seroconversion|1|||
28079979|NCT00116805|54733446|FG000|Open-label Period Weeks 145 - 192|Withdrew Consent|3|||
28079980|NCT00116805|54733447|FG001|Open-label Period Weeks 145 - 192|Withdrew Consent|2|||
28079981|NCT00116805|54733446|FG000|Open-label Period Weeks 193 - 240|Completed Study|0|||
28079982|NCT00116805|54733447|FG001|Open-label Period Weeks 193 - 240|Completed Study|1|||
28079983|NCT00116805|54733446|FG000|Open-label Period Weeks 193 - 240|Investigator's Discretion|1|||
28079984|NCT00116805|54733447|FG001|Open-label Period Weeks 193 - 240|Investigator's Discretion|0|||
28079985|NCT00116805|54733446|FG000|Open-label Period Weeks 193 - 240|Lost to Follow-up|3|||
27731334|NCT02789657|54178487|FG003|Overall Study|Withdrawal by Subject|0|||
27831753|NCT00704808|54310399|FG000|Overall Study|Patient's decision|11|||
27831754|NCT00704808|54310399|FG000|Overall Study|Early therapy discontinuation|16|||
27831755|NCT00704808|54310399|FG000|Overall Study|Adverse Event|1|||
27831756|NCT00704808|54310399|FG000|Overall Study|Lost to Follow-up|1|||
27831757|NCT00704808|54310399|FG000|Overall Study|Treatment change|1|||
27853523|NCT01390844|54363682|FG000|Follow-Up Phase|Non-Medical Reasons|1|||
27945631|NCT00910624|54602985|FG002|Follow-Up Phase|Adverse Event|1|||
27945632|NCT00910624|54602986|FG003|Follow-Up Phase|Adverse Event|0|||
27853524|NCT01390844|54363683|FG001|Follow-Up Phase|Non-Medical Reasons|1|||
27853525|NCT01390844|54363684|FG002|Follow-Up Phase|Non-Medical Reasons|1|||
27853526|NCT01390844|54363685|FG003|Follow-Up Phase|Non-Medical Reasons|0|||
27853527|NCT01430624|54363698|FG000|Overall Study|Lost to Follow-up|23|||
27853528|NCT01430624|54363699|FG001|Overall Study|Lost to Follow-up|29|||
27853529|NCT01430624|54363700|FG002|Overall Study|Lost to Follow-up|27|||
27945633|NCT00910624|54602983|FG000|Follow-Up Phase|Lost to Follow-up|3|||
27945634|NCT00910624|54602984|FG001|Follow-Up Phase|Lost to Follow-up|1|||
27945635|NCT00910624|54602985|FG002|Follow-Up Phase|Lost to Follow-up|2|||
27945636|NCT00910624|54602986|FG003|Follow-Up Phase|Lost to Follow-up|0|||
27945637|NCT00910624|54602983|FG000|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1|||
27945638|NCT00910624|54602984|FG001|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2|||
27945639|NCT00910624|54602985|FG002|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
27945640|NCT00910624|54602986|FG003|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
27945641|NCT00910624|54602983|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
27945642|NCT00910624|54602984|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
27945643|NCT00910624|54602985|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
27945644|NCT00910624|54602986|FG003|Follow-Up Phase|Withdrawal by Subject|0|||
27945645|NCT00910624|54602983|FG000|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1|||
27945646|NCT00910624|54602984|FG001|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
27945647|NCT00910624|54602985|FG002|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
27945648|NCT00910624|54602986|FG003|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
27945649|NCT00910624|54602983|FG000|Follow-Up Phase|Administrative|0|||
27945650|NCT00910624|54602984|FG001|Follow-Up Phase|Administrative|1|||
27945651|NCT00910624|54602985|FG002|Follow-Up Phase|Administrative|1|||
27945652|NCT00910624|54602986|FG003|Follow-Up Phase|Administrative|0|||
27945653|NCT01123980|54603000|FG000|Overall Study|Adverse Event|1|||
27945654|NCT01123980|54603001|FG001|Overall Study|Adverse Event|1|||
27945655|NCT01123980|54603000|FG000|Overall Study|Lack of Efficacy|1|||
27945656|NCT01123980|54603001|FG001|Overall Study|Lack of Efficacy|0|||
27945657|NCT01123980|54603000|FG000|Overall Study|Physician Decision|0|||
27945658|NCT01123980|54603001|FG001|Overall Study|Physician Decision|1|||
27945659|NCT01123980|54603000|FG000|Overall Study|Lost to Follow-up|0|||
27945660|NCT01123980|54603001|FG001|Overall Study|Lost to Follow-up|6|||
27945661|NCT01123980|54603000|FG000|Overall Study|Protocol Violation|6|||
27945662|NCT01123980|54603001|FG001|Overall Study|Protocol Violation|6|||
27945663|NCT01123980|54603000|FG000|Overall Study|Withdrawal by Subject|5|||
27945664|NCT01123980|54603001|FG001|Overall Study|Withdrawal by Subject|3|||
27945665|NCT01123980|54603000|FG000|Overall Study|Unclassified|6|||
27945666|NCT01123980|54603001|FG001|Overall Study|Unclassified|7|||
27945667|NCT01118520|54603010|FG000|Overall Study|AAA repair|9|||
27945668|NCT01118520|54603011|FG001|Overall Study|AAA repair|7|||
27731335|NCT02609984|54178498|FG000|Overall Study|Death|29|||
27853530|NCT01430624|54363698|FG000|Overall Study|technical or eligibility|5|||
27853531|NCT01430624|54363699|FG001|Overall Study|technical or eligibility|5|||
27853532|NCT01430624|54363700|FG002|Overall Study|technical or eligibility|2|||
27853533|NCT01430468|54363725|FG000|Overall Study|Physician Decision|2|||
27853534|NCT01430468|54363726|FG001|Overall Study|Physician Decision|1|||
27853535|NCT01430468|54363725|FG000|Overall Study|Withdrawal by Subject|5|||
27853536|NCT01430468|54363726|FG001|Overall Study|Withdrawal by Subject|5|||
27853537|NCT01409564|54363747|FG000|Overall Study|low medication compliance|4|||
27853538|NCT01409564|54363748|FG001|Overall Study|low medication compliance|3|||
27853539|NCT01409564|54363747|FG000|Overall Study|brain abnormalities found in T1 MR|1|||
27853540|NCT01409564|54363748|FG001|Overall Study|brain abnormalities found in T1 MR|2|||
27853541|NCT01390298|54363758|FG000|Overall Study|Death|1|||
27853542|NCT01390298|54363758|FG000|Overall Study|long term ICU admission|1|||
27853543|NCT01390298|54363758|FG000|Overall Study|Withdrawal by Subject|14|||
27853544|NCT01390298|54363758|FG000|Overall Study|Lost to Follow-up|7|||
27853545|NCT01390298|54363758|FG000|Overall Study|Surgery cancelled|1|||
27853546|NCT01390220|54363776|FG000|Test Dose Phase|Adverse Event|17|||
27853547|NCT01390220|54363777|FG001|Test Dose Phase|Adverse Event|0|||
27853548|NCT01390220|54363778|FG002|Test Dose Phase|Adverse Event|0|||
27945669|NCT01118520|54603012|FG002|Overall Study|AAA repair|9|||
27945670|NCT01118520|54603010|FG000|Overall Study|Adverse Event|3|||
27945671|NCT01118520|54603011|FG001|Overall Study|Adverse Event|3|||
27945672|NCT01118520|54603012|FG002|Overall Study|Adverse Event|3|||
27945673|NCT01118520|54603010|FG000|Overall Study|Withdrawal by Subject|8|||
27945674|NCT01118520|54603011|FG001|Overall Study|Withdrawal by Subject|13|||
27945675|NCT01118520|54603012|FG002|Overall Study|Withdrawal by Subject|8|||
27945676|NCT01135992|54603020|FG000|Overall Study|Adverse Event|1|||
27945677|NCT01135992|54603020|FG000|Overall Study|Lack of Efficacy|1|||
27945678|NCT01135992|54603020|FG000|Overall Study|Protocol Violation|2|||
27945679|NCT01135992|54603020|FG000|Overall Study|Withdrawal criteria|10|||
27945680|NCT01135992|54603020|FG000|Overall Study|Unclassified|7|||
27945681|NCT00959049|54603030|FG000|Overall Study|Adverse Event|1|||
27945682|NCT00959049|54603031|FG001|Overall Study|Adverse Event|0|||
27945683|NCT00959049|54603032|FG002|Overall Study|Adverse Event|0|||
28164523|NCT00453154|54835141|FG003|Double BIind Maintenance|Randomized, did not receive therapy|5|||
28164524|NCT00334815|54835152|FG000|Overall Study|Adverse Event|3|||
28164525|NCT00334815|54835153|FG001|Overall Study|Adverse Event|2|||
27853549|NCT01390220|54363776|FG000|Test Dose Phase|Withdrawal by Subject|8|||
27853550|NCT01390220|54363777|FG001|Test Dose Phase|Withdrawal by Subject|0|||
27853551|NCT01390220|54363778|FG002|Test Dose Phase|Withdrawal by Subject|0|||
27853552|NCT01390220|54363776|FG000|Test Dose Phase|Lost to Follow-up|2|||
27853553|NCT01390220|54363777|FG001|Test Dose Phase|Lost to Follow-up|0|||
27853554|NCT01390220|54363778|FG002|Test Dose Phase|Lost to Follow-up|0|||
28164526|NCT00334815|54835152|FG000|Overall Study|Death|0|||
28164527|NCT00334815|54835153|FG001|Overall Study|Death|2|||
28164528|NCT00334815|54835152|FG000|Overall Study|Progression|1|||
28164529|NCT00334815|54835153|FG001|Overall Study|Progression|0|||
28164530|NCT00334815|54835152|FG000|Overall Study|ineligible|1|||
28164531|NCT00334815|54835153|FG001|Overall Study|ineligible|1|||
27853555|NCT01390220|54363776|FG000|Test Dose Phase|Protocol Violation|8|||
27853556|NCT01390220|54363777|FG001|Test Dose Phase|Protocol Violation|0|||
27853557|NCT01390220|54363778|FG002|Test Dose Phase|Protocol Violation|0|||
27853558|NCT01390220|54363776|FG000|Test Dose Phase|No treated seizure cluster episode|37|||
27853559|NCT01390220|54363777|FG001|Test Dose Phase|No treated seizure cluster episode|0|||
27853560|NCT01390220|54363778|FG002|Test Dose Phase|No treated seizure cluster episode|0|||
27853561|NCT01390220|54363776|FG000|Test Dose Phase|Study/Site closure|6|||
27853562|NCT01390220|54363777|FG001|Test Dose Phase|Study/Site closure|0|||
27853563|NCT01390220|54363778|FG002|Test Dose Phase|Study/Site closure|0|||
27853564|NCT01390220|54363776|FG000|Test Dose Phase|Caregiver no longer available|5|||
27853565|NCT01390220|54363777|FG001|Test Dose Phase|Caregiver no longer available|0|||
27853566|NCT01390220|54363778|FG002|Test Dose Phase|Caregiver no longer available|0|||
27853567|NCT01390220|54363776|FG000|Test Dose Phase|Noncompliance|2|||
27853568|NCT01390220|54363777|FG001|Test Dose Phase|Noncompliance|0|||
27853569|NCT01390220|54363778|FG002|Test Dose Phase|Noncompliance|0|||
27853570|NCT01390220|54363776|FG000|Test Dose Phase|Logistical|6|||
27853571|NCT01390220|54363777|FG001|Test Dose Phase|Logistical|0|||
27853572|NCT01390220|54363778|FG002|Test Dose Phase|Logistical|0|||
27853573|NCT01390220|54363776|FG000|Comparative Phase|Withdrawal by Subject|0|||
27853574|NCT01390220|54363777|FG001|Comparative Phase|Withdrawal by Subject|1|||
27853575|NCT01390220|54363778|FG002|Comparative Phase|Withdrawal by Subject|0|||
27853576|NCT00550173|54363808|FG000|Overall Study|Death|45|||
27853577|NCT00550173|54363809|FG001|Overall Study|Death|38|||
27853578|NCT00550173|54363810|FG002|Overall Study|Death|50|||
27853579|NCT00550173|54363808|FG000|Overall Study|Physician Decision|1|||
27853580|NCT00550173|54363809|FG001|Overall Study|Physician Decision|2|||
27853581|NCT00550173|54363810|FG002|Overall Study|Physician Decision|2|||
27853582|NCT00550173|54363808|FG000|Overall Study|Withdrawal by Subject|9|||
27853583|NCT00550173|54363809|FG001|Overall Study|Withdrawal by Subject|12|||
27853584|NCT00550173|54363810|FG002|Overall Study|Withdrawal by Subject|17|||
27853585|NCT00550173|54363808|FG000|Overall Study|Sponsor Decision|13|||
27853586|NCT00550173|54363809|FG001|Overall Study|Sponsor Decision|7|||
27853587|NCT00550173|54363810|FG002|Overall Study|Sponsor Decision|1|||
27853588|NCT00550173|54363808|FG000|Overall Study|Lost to Follow-up|4|||
27853589|NCT00550173|54363809|FG001|Overall Study|Lost to Follow-up|4|||
27853590|NCT00550173|54363810|FG002|Overall Study|Lost to Follow-up|3|||
27853591|NCT01429298|54363821|FG000|Overall Study|Protocol Violation|4|||
27853592|NCT01429298|54363822|FG001|Overall Study|Protocol Violation|6|||
27853593|NCT01408706|54363834|FG000|Overall Study|Physician Decision|1|||
27853594|NCT01408706|54363835|FG001|Overall Study|Physician Decision|0|||
27853595|NCT01408628|54363843|FG000|Consented|Withdrawal by Subject|12|||
27853596|NCT01408628|54363843|FG000|Completed 6 Month Follow-Up|Lost to Follow-up|3|||
27853597|NCT01408628|54363843|FG000|Completed 6 Month Follow-Up|Protocol Violation|6|||
27853598|NCT01408628|54363843|FG000|Completed 6 Month Follow-Up|Withdrawal by Subject|5|||
27853599|NCT01389752|54363848|FG000|Study Period 1|Sponsor decision|0|||
27853600|NCT01389752|54363849|FG001|Study Period 1|Sponsor decision|2|||
27853601|NCT01389752|54363848|FG000|Study Period 2|Sponsor decision|1|||
27853602|NCT01389752|54363849|FG001|Study Period 2|Sponsor decision|0|||
27853603|NCT01428128|54363856|FG000|Overall Study|Withdrawal by Subject|4|||
27853604|NCT01428128|54363856|FG000|Overall Study|Screen failure by p53|10|||
27853605|NCT01428128|54363856|FG000|Overall Study|Received Neulasta in one cycle|2|||
27853606|NCT01428128|54363856|FG000|Overall Study|Adverse Event|1|||
27853607|NCT01407926|54363861|FG000|Overall Study|Lost to Follow-up|55|||
27853608|NCT01427972|54363888|FG000|Treatment Period 1 (21 Days)|Protocol Violation|0|||
27853609|NCT01427972|54363889|FG001|Treatment Period 1 (21 Days)|Protocol Violation|0|||
27853610|NCT01427972|54363890|FG002|Treatment Period 1 (21 Days)|Protocol Violation|0|||
27853611|NCT01427972|54363891|FG003|Treatment Period 1 (21 Days)|Protocol Violation|0|||
27853612|NCT01427972|54363892|FG004|Treatment Period 1 (21 Days)|Protocol Violation|0|||
28164532|NCT00334815|54835152|FG000|Overall Study|patient refused treatment|0|||
28164533|NCT00334815|54835153|FG001|Overall Study|patient refused treatment|1|||
28164534|NCT00334815|54835152|FG000|Overall Study|Physician Decision|2|||
27853613|NCT01427972|54363893|FG005|Treatment Period 1 (21 Days)|Protocol Violation|0|||
27945684|NCT00959049|54603033|FG003|Overall Study|Adverse Event|0|||
27945685|NCT00959049|54603034|FG004|Overall Study|Adverse Event|0|||
27945686|NCT00959049|54603035|FG005|Overall Study|Adverse Event|0|||
27945687|NCT00959049|54603030|FG000|Overall Study|Lost to Follow-up|17|||
27945688|NCT00959049|54603031|FG001|Overall Study|Lost to Follow-up|5|||
27945689|NCT00959049|54603032|FG002|Overall Study|Lost to Follow-up|1|||
27945690|NCT00959049|54603033|FG003|Overall Study|Lost to Follow-up|10|||
27945691|NCT00959049|54603034|FG004|Overall Study|Lost to Follow-up|9|||
27945692|NCT00959049|54603035|FG005|Overall Study|Lost to Follow-up|1|||
27945693|NCT00959049|54603030|FG000|Overall Study|Contraindicated medication|0|||
27945694|NCT00959049|54603031|FG001|Overall Study|Contraindicated medication|0|||
27945695|NCT00959049|54603032|FG002|Overall Study|Contraindicated medication|0|||
27945696|NCT00959049|54603033|FG003|Overall Study|Contraindicated medication|1|||
27945697|NCT00959049|54603034|FG004|Overall Study|Contraindicated medication|0|||
27945698|NCT00959049|54603035|FG005|Overall Study|Contraindicated medication|0|||
27945699|NCT00959049|54603030|FG000|Overall Study|Withdrawal by Subject|0|||
27945700|NCT00959049|54603031|FG001|Overall Study|Withdrawal by Subject|2|||
27945701|NCT00959049|54603032|FG002|Overall Study|Withdrawal by Subject|0|||
27945702|NCT00959049|54603033|FG003|Overall Study|Withdrawal by Subject|0|||
27945703|NCT00959049|54603034|FG004|Overall Study|Withdrawal by Subject|0|||
27945704|NCT00959049|54603035|FG005|Overall Study|Withdrawal by Subject|0|||
27945705|NCT00956943|54603062|FG000|Overall Study|Lost to Follow-up|9|||
27945706|NCT00956943|54603063|FG001|Overall Study|Lost to Follow-up|10|||
27945707|NCT00958893|54603069|FG000|Overall Study|Study prematurely terminated|4|||
27945708|NCT01135914|54603076|FG000|Overall Study|Withdrawal by Subject|1|||
27945709|NCT01135914|54603077|FG001|Overall Study|Withdrawal by Subject|3|||
27945710|NCT01135914|54603078|FG002|Overall Study|Withdrawal by Subject|6|||
27945711|NCT01135914|54603076|FG000|Overall Study|Lost to Follow-up|1|||
27945712|NCT01135914|54603077|FG001|Overall Study|Lost to Follow-up|0|||
27945713|NCT01135914|54603078|FG002|Overall Study|Lost to Follow-up|1|||
27945714|NCT01135914|54603076|FG000|Overall Study|Protocol Violation|0|||
27945715|NCT01135914|54603077|FG001|Overall Study|Protocol Violation|0|||
27945716|NCT01135914|54603078|FG002|Overall Study|Protocol Violation|3|||
27945717|NCT01135914|54603076|FG000|Overall Study|Lack of Efficacy|2|||
27945718|NCT01135914|54603077|FG001|Overall Study|Lack of Efficacy|1|||
27945719|NCT01135914|54603078|FG002|Overall Study|Lack of Efficacy|10|||
27945720|NCT01135914|54603076|FG000|Overall Study|Adverse Event|0|||
27945721|NCT01135914|54603077|FG001|Overall Study|Adverse Event|1|||
27831758|NCT05166876|54310433|FG000|Overall Study|Withdrawal by Subject|1|||
27945722|NCT01135914|54603078|FG002|Overall Study|Adverse Event|2|||
27945723|NCT00907738|54603091|FG000|Overall Study|Adverse Event|2|||
27945724|NCT00907738|54603092|FG001|Overall Study|Adverse Event|0|||
27945725|NCT00907738|54603093|FG002|Overall Study|Adverse Event|1|||
28079986|NCT00116805|54733447|FG001|Open-label Period Weeks 193 - 240|Lost to Follow-up|0|||
28079987|NCT00116805|54733446|FG000|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
28079988|NCT00116805|54733447|FG001|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
28079989|NCT00116805|54733446|FG000|Open-label Period Weeks 193 - 240|Withdrew Consent|7|||
28079990|NCT00116805|54733447|FG001|Open-label Period Weeks 193 - 240|Withdrew Consent|1|||
28079991|NCT00116805|54733446|FG000|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2|||
28079992|NCT00116805|54733447|FG001|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
28164535|NCT00334815|54835153|FG001|Overall Study|Physician Decision|4|||
28164536|NCT00258960|54835161|FG000|Overall Study|Death|2|||
28164537|NCT00258960|54835161|FG000|Overall Study|Disease Progression|7|||
28164538|NCT00258960|54835161|FG000|Overall Study|Adverse Event|4|||
28164539|NCT00258960|54835161|FG000|Overall Study|Physician Decision|1|||
28164540|NCT00258960|54835161|FG000|Overall Study|Withdrawal by Subject|1|||
28164541|NCT00258960|54835161|FG000|Overall Study|Mistake|2|||
28164542|NCT00121992|54835167|FG000|Overall Study|Treatment not received|2|||
28164543|NCT00121992|54835168|FG001|Overall Study|Treatment not received|11|||
28164544|NCT00070564|54835180|FG000|Overall Study|Progression|2|||
28164545|NCT00070564|54835181|FG001|Overall Study|Progression|4|||
28164546|NCT00070564|54835182|FG002|Overall Study|Progression|7|||
27831759|NCT05166876|54310434|FG001|Overall Study|Withdrawal by Subject|0|||
27945726|NCT00907738|54603094|FG003|Overall Study|Adverse Event|0|||
27945727|NCT00907738|54603095|FG004|Overall Study|Adverse Event|0|||
27945728|NCT00907738|54603091|FG000|Overall Study|not specified or withdrew consent|3|||
27945729|NCT00907738|54603092|FG001|Overall Study|not specified or withdrew consent|0|||
27945730|NCT00907738|54603093|FG002|Overall Study|not specified or withdrew consent|0|||
27945731|NCT00907738|54603094|FG003|Overall Study|not specified or withdrew consent|0|||
27945732|NCT00907738|54603095|FG004|Overall Study|not specified or withdrew consent|0|||
27945733|NCT00907738|54603091|FG000|Overall Study|Disease progression|8|||
27945734|NCT00907738|54603092|FG001|Overall Study|Disease progression|1|||
27831760|NCT05166876|54310435|FG002|Overall Study|Withdrawal by Subject|0|||
27945735|NCT00907738|54603093|FG002|Overall Study|Disease progression|6|||
27945736|NCT00907738|54603094|FG003|Overall Study|Disease progression|4|||
27945737|NCT00907738|54603095|FG004|Overall Study|Disease progression|2|||
27731336|NCT02609984|54178499|FG001|Overall Study|Death|26|||
27731337|NCT02609984|54178498|FG000|Overall Study|Participation Discontinued by Sponsor|12|||
27731338|NCT02609984|54178499|FG001|Overall Study|Participation Discontinued by Sponsor|10|||
27731339|NCT02609984|54178498|FG000|Overall Study|Lost to Follow-up|1|||
27731340|NCT02609984|54178499|FG001|Overall Study|Lost to Follow-up|2|||
27731341|NCT02609984|54178498|FG000|Overall Study|Withdrawal by Subject|0|||
27731342|NCT02609984|54178499|FG001|Overall Study|Withdrawal by Subject|1|||
27731343|NCT02609984|54178498|FG000|Overall Study|Disease Progression|2|||
27731344|NCT02609984|54178499|FG001|Overall Study|Disease Progression|0|||
27731345|NCT02609672|54178507|FG000|Overall Study|Lost to Follow-up|3|||
27731346|NCT02609672|54178508|FG001|Overall Study|Lost to Follow-up|1|||
27731347|NCT02611778|54178516|FG000|Overall Study|Withdrawal by Subject|2|||
27731348|NCT02611778|54178517|FG001|Overall Study|Withdrawal by Subject|8|||
27731349|NCT02611778|54178516|FG000|Overall Study|Adverse Event|1|||
27731350|NCT02611778|54178517|FG001|Overall Study|Adverse Event|2|||
27731351|NCT02611778|54178516|FG000|Overall Study|Death|2|||
27731352|NCT02611778|54178517|FG001|Overall Study|Death|1|||
28164547|NCT00070564|54835183|FG003|Overall Study|Progression|7|||
28164548|NCT00070564|54835184|FG004|Overall Study|Progression|1|||
27731353|NCT02611778|54178516|FG000|Overall Study|Protocol Violation|1|||
27731354|NCT02611778|54178517|FG001|Overall Study|Protocol Violation|0|||
27731355|NCT02611778|54178516|FG000|Overall Study|Lost to Follow-up|3|||
27731356|NCT02611778|54178517|FG001|Overall Study|Lost to Follow-up|1|||
27731357|NCT02611778|54178516|FG000|Overall Study|Need for alternative treatment|1|||
27731358|NCT02611778|54178517|FG001|Overall Study|Need for alternative treatment|0|||
27731359|NCT02611778|54178516|FG000|Overall Study|Other Reason|2|||
27853614|NCT01427972|54363894|FG006|Treatment Period 1 (21 Days)|Protocol Violation|0|||
27853615|NCT01427972|54363895|FG007|Treatment Period 1 (21 Days)|Protocol Violation|1|||
28079993|NCT00116805|54733446|FG000|Open-label Period Weeks 241 - 288|Withdrew Consent|4|||
28079994|NCT00116805|54733447|FG001|Open-label Period Weeks 241 - 288|Withdrew Consent|0|||
28079995|NCT00116805|54733446|FG000|Open-label Period Weeks 289 - 336|Completed Study|0|||
28079996|NCT00116805|54733447|FG001|Open-label Period Weeks 289 - 336|Completed Study|1|||
28079997|NCT00116805|54733446|FG000|Open-label Period Weeks 289 - 336|Investigator's Discretion|3|||
28079998|NCT00116805|54733447|FG001|Open-label Period Weeks 289 - 336|Investigator's Discretion|2|||
28079999|NCT00116805|54733446|FG000|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
28080000|NCT00116805|54733447|FG001|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
28080001|NCT00116805|54733446|FG000|Open-label Period Weeks 289 - 336|Protocol Violation|0|||
28080002|NCT00116805|54733447|FG001|Open-label Period Weeks 289 - 336|Protocol Violation|1|||
28080003|NCT00116805|54733446|FG000|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0|||
28080004|NCT00116805|54733447|FG001|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1|||
28080005|NCT00116805|54733446|FG000|Open-label Period Weeks 289 - 336|Study Site Discontinued|0|||
28080006|NCT00116805|54733447|FG001|Open-label Period Weeks 289 - 336|Study Site Discontinued|1|||
28080007|NCT00116805|54733446|FG000|Open-label Period Weeks 289 - 336|Withdrew Consent|2|||
28080008|NCT00116805|54733447|FG001|Open-label Period Weeks 289 - 336|Withdrew Consent|0|||
28080009|NCT00116805|54733446|FG000|Open-label Period Weeks 337 - 384|Completed Study|1|||
28080010|NCT00116805|54733447|FG001|Open-label Period Weeks 337 - 384|Completed Study|0|||
28080011|NCT00116805|54733446|FG000|Open-label Period Weeks 337 - 384|Investigator's Discretion|1|||
28080012|NCT00116805|54733447|FG001|Open-label Period Weeks 337 - 384|Investigator's Discretion|0|||
28080013|NCT00116805|54733446|FG000|Open-label Period Weeks 337 - 384|Lost to Follow-up|2|||
28080014|NCT00116805|54733447|FG001|Open-label Period Weeks 337 - 384|Lost to Follow-up|0|||
28080015|NCT00116805|54733446|FG000|Open-label Period Weeks 337 - 384|Protocol Violation|1|||
28164549|NCT00070564|54835185|FG005|Overall Study|Progression|0|||
28164550|NCT00070564|54835180|FG000|Overall Study|Delinquent|1|||
28164551|NCT00070564|54835181|FG001|Overall Study|Delinquent|4|||
28164552|NCT00070564|54835182|FG002|Overall Study|Delinquent|2|||
28164553|NCT00070564|54835183|FG003|Overall Study|Delinquent|0|||
28164554|NCT00070564|54835184|FG004|Overall Study|Delinquent|0|||
28164555|NCT00070564|54835185|FG005|Overall Study|Delinquent|0|||
28164556|NCT00070564|54835180|FG000|Overall Study|Adverse Event|150|||
28164557|NCT00070564|54835181|FG001|Overall Study|Adverse Event|142|||
28164558|NCT00070564|54835182|FG002|Overall Study|Adverse Event|120|||
28164559|NCT00070564|54835183|FG003|Overall Study|Adverse Event|108|||
28164560|NCT00070564|54835184|FG004|Overall Study|Adverse Event|63|||
28164561|NCT00070564|54835185|FG005|Overall Study|Adverse Event|36|||
28164562|NCT00070564|54835180|FG000|Overall Study|Death|4|||
28164563|NCT00070564|54835181|FG001|Overall Study|Death|1|||
28164564|NCT00070564|54835182|FG002|Overall Study|Death|5|||
27731360|NCT02611778|54178517|FG001|Overall Study|Other Reason|1|||
27853616|NCT01427972|54363896|FG008|Treatment Period 1 (21 Days)|Protocol Violation|0|||
27853617|NCT01427972|54363897|FG009|Treatment Period 1 (21 Days)|Protocol Violation|0|||
28164565|NCT00070564|54835183|FG003|Overall Study|Death|3|||
27731361|NCT02711553|54178528|FG000|Overall Study|Withdrawal by Subject|2|||
27731362|NCT02711553|54178529|FG001|Overall Study|Withdrawal by Subject|1|||
27731363|NCT02711553|54178530|FG002|Overall Study|Withdrawal by Subject|1|||
27853618|NCT01427972|54363898|FG010|Treatment Period 1 (21 Days)|Protocol Violation|0|||
27853619|NCT01427972|54363899|FG011|Treatment Period 1 (21 Days)|Protocol Violation|0|||
27853620|NCT01427972|54363888|FG000|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
27853621|NCT01427972|54363889|FG001|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
27853622|NCT01427972|54363890|FG002|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
27853623|NCT01427972|54363891|FG003|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
27853624|NCT01427972|54363892|FG004|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
27853625|NCT01427972|54363893|FG005|Washout (at Least 28 Days)|Withdrawal by Subject|2|||
27853626|NCT01427972|54363894|FG006|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
27853627|NCT01427972|54363895|FG007|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
28080016|NCT00116805|54733447|FG001|Open-label Period Weeks 337 - 384|Protocol Violation|0|||
27731364|NCT02711553|54178531|FG003|Overall Study|Withdrawal by Subject|0|||
27731365|NCT02711553|54178528|FG000|Overall Study|Lost to Follow-up|3|||
27853628|NCT01427972|54363896|FG008|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
27853629|NCT01427972|54363897|FG009|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
27853630|NCT01427972|54363898|FG010|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
27853631|NCT01427972|54363899|FG011|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
27853632|NCT01427972|54363888|FG000|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
27853633|NCT01427972|54363889|FG001|Treatment Period 2 (21 Days)|Withdrawal by Subject|1|||
27945738|NCT01123356|54603111|FG000|Overall Study|Adverse Event|2|||
27945739|NCT01123356|54603111|FG000|Overall Study|Lack of Efficacy|4|||
27945740|NCT01123356|54603111|FG000|Overall Study|Withdrawal by Subject|1|||
27945741|NCT00908596|54603120|FG000|Overall Study|Other reasons|46|||
27945742|NCT00908596|54603121|FG001|Overall Study|Other reasons|6|||
27945743|NCT00908596|54603122|FG002|Overall Study|Other reasons|2|||
27945744|NCT00908596|54603123|FG003|Overall Study|Other reasons|0|||
27945745|NCT00908596|54603120|FG000|Overall Study|Lost to Follow-up|0|||
27945746|NCT00908596|54603121|FG001|Overall Study|Lost to Follow-up|1|||
27945747|NCT00908596|54603122|FG002|Overall Study|Lost to Follow-up|12|||
27945748|NCT00908596|54603123|FG003|Overall Study|Lost to Follow-up|4|||
27945749|NCT00908596|54603120|FG000|Overall Study|Death|0|||
27945750|NCT00908596|54603121|FG001|Overall Study|Death|5|||
27945751|NCT00908596|54603122|FG002|Overall Study|Death|57|||
27945752|NCT00908596|54603123|FG003|Overall Study|Death|32|||
27945753|NCT00908596|54603120|FG000|Overall Study|Protocol Violation|1|||
27945754|NCT00908596|54603121|FG001|Overall Study|Protocol Violation|0|||
27945755|NCT00908596|54603122|FG002|Overall Study|Protocol Violation|0|||
27945756|NCT00908596|54603123|FG003|Overall Study|Protocol Violation|0|||
27853634|NCT01427972|54363890|FG002|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
27945757|NCT00908596|54603120|FG000|Overall Study|Withdrawal by Subject|0|||
27945758|NCT00908596|54603121|FG001|Overall Study|Withdrawal by Subject|1|||
27945759|NCT00908596|54603122|FG002|Overall Study|Withdrawal by Subject|3|||
27731366|NCT02711553|54178529|FG001|Overall Study|Lost to Follow-up|3|||
27731367|NCT02711553|54178530|FG002|Overall Study|Lost to Follow-up|6|||
27731368|NCT02711553|54178531|FG003|Overall Study|Lost to Follow-up|3|||
27731369|NCT02711553|54178528|FG000|Overall Study|On Study Treatment at Study Conclusion|1|||
27731370|NCT02711553|54178529|FG001|Overall Study|On Study Treatment at Study Conclusion|1|||
27731371|NCT02711553|54178530|FG002|Overall Study|On Study Treatment at Study Conclusion|3|||
27731372|NCT02711553|54178531|FG003|Overall Study|On Study Treatment at Study Conclusion|1|||
27731373|NCT02709369|54178543|FG000|Overall Study|Lost to Follow-up|15|||
27731374|NCT02709369|54178543|FG000|Overall Study|Withdrawal by Subject|10|||
27731375|NCT02709369|54178543|FG000|Overall Study|Did not received intervention|2|||
27945760|NCT00908596|54603123|FG003|Overall Study|Withdrawal by Subject|1|||
27945761|NCT01118052|54603133|FG000|Overall Study|Never treated|2|||
27731376|NCT02613182|54178547|FG000|Overall Study|Death|6|||
27945762|NCT01123200|54603143|FG000|Overall Study|Withdrawal by Subject|1|||
27945763|NCT00955617|54603147|FG000|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2|||
27945764|NCT00955617|54603148|FG001|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1|||
27945765|NCT00955617|54603147|FG000|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0|||
27945766|NCT00955617|54603148|FG001|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1|||
27945767|NCT00955617|54603147|FG000|Second MRA (Between Day 1 and Day 51)|technical incident|0|||
27945768|NCT00955617|54603148|FG001|Second MRA (Between Day 1 and Day 51)|technical incident|1|||
27945769|NCT00955617|54603147|FG000|Second MRA (Between Day 1 and Day 51)|conventional angiography|1|||
27945770|NCT00955617|54603148|FG001|Second MRA (Between Day 1 and Day 51)|conventional angiography|0|||
27945771|NCT00958347|54603154|FG000|Overall Study|Death|43|||
27945772|NCT00958347|54603154|FG000|Overall Study|Withdrawal by Subject|23|||
27945773|NCT00958347|54603154|FG000|Overall Study|Lost to Follow-up|15|||
27945774|NCT00958347|54603154|FG000|Overall Study|revision/removal|10|||
27945775|NCT00958347|54603154|FG000|Overall Study|study termination|135|||
27945776|NCT00958191|54603158|FG000|Overall Study|Death|4|||
27945777|NCT00958191|54603158|FG000|Overall Study|Lost to Follow-up|5|||
27945778|NCT00958191|54603158|FG000|Overall Study|Inadequate 5 yr x-ray quality|10|||
27945779|NCT00958191|54603158|FG000|Overall Study|Unable/Unwilling to Return/Withdrawal|21|||
27731377|NCT02613182|54178547|FG000|Overall Study|Physician Decision|1|||
27945780|NCT00958191|54603158|FG000|Overall Study|Revision of study device|4|||
27945781|NCT00958191|54603158|FG000|Overall Study|Site termination|11|||
27945782|NCT00958191|54603158|FG000|Overall Study|No 5 yr x-rays|56|||
27945783|NCT00960843|54603166|FG000|Overall Study|Lost to Follow-up|2|||
27945784|NCT00960843|54603167|FG001|Overall Study|Lost to Follow-up|0|||
27945785|NCT00960843|54603166|FG000|Overall Study|Protocol Violation|0|||
27945786|NCT00960843|54603167|FG001|Overall Study|Protocol Violation|4|||
27945787|NCT00960843|54603166|FG000|Overall Study|Repeated needle dislodgment|0|||
27945788|NCT00960843|54603167|FG001|Overall Study|Repeated needle dislodgment|1|||
27945789|NCT02396199|54603173|FG000|Overall Study|Lost to Follow-up|1|||
27945790|NCT02396199|54603173|FG000|Overall Study|Death|4|||
27945791|NCT01605253|54603179|FG000|Overall Study|Physician Decision|3|||
27945792|NCT01605253|54603180|FG001|Overall Study|Physician Decision|2|||
27945793|NCT01605253|54603179|FG000|Overall Study|Lost to Follow-up|3|||
27945794|NCT01605253|54603180|FG001|Overall Study|Lost to Follow-up|1|||
27945795|NCT00955305|54603190|FG000|Overall Study|Disease progression|39|||
27945796|NCT00955305|54603191|FG001|Overall Study|Disease progression|41|||
27945797|NCT00955305|54603190|FG000|Overall Study|Adverse Event|22|||
27945798|NCT00955305|54603191|FG001|Overall Study|Adverse Event|22|||
27945799|NCT00955305|54603190|FG000|Overall Study|Death|2|||
27945800|NCT00955305|54603191|FG001|Overall Study|Death|1|||
27945801|NCT00955305|54603190|FG000|Overall Study|Withdrawal by Subject|5|||
27945802|NCT00955305|54603191|FG001|Overall Study|Withdrawal by Subject|4|||
27945803|NCT00955305|54603190|FG000|Overall Study|Alternative therapy|4|||
27945804|NCT00955305|54603191|FG001|Overall Study|Alternative therapy|0|||
27945805|NCT00955305|54603190|FG000|Overall Study|Other complicating disease|2|||
27945806|NCT00955305|54603191|FG001|Overall Study|Other complicating disease|4|||
27945807|NCT00955305|54603190|FG000|Overall Study|Physician Decision|1|||
27945808|NCT00955305|54603191|FG001|Overall Study|Physician Decision|0|||
27945809|NCT00955305|54603190|FG000|Overall Study|Continued presence of residual disease|0|||
27945810|NCT00955305|54603191|FG001|Overall Study|Continued presence of residual disease|1|||
27945811|NCT00955305|54603190|FG000|Overall Study|Functional decline|2|||
27945812|NCT00955305|54603191|FG001|Overall Study|Functional decline|0|||
27945813|NCT00955305|54603190|FG000|Overall Study|Maximum response achieved|0|||
27945814|NCT00955305|54603191|FG001|Overall Study|Maximum response achieved|1|||
27945815|NCT00955305|54603190|FG000|Overall Study|Lost to Follow-up|0|||
27945816|NCT00955305|54603191|FG001|Overall Study|Lost to Follow-up|1|||
27945817|NCT00955305|54603190|FG000|Overall Study|No off-treatment reason submitted|1|||
27945818|NCT00955305|54603191|FG001|Overall Study|No off-treatment reason submitted|0|||
27945819|NCT00955305|54603190|FG000|Overall Study|Never started protocol treatment|5|||
27945820|NCT00955305|54603191|FG001|Overall Study|Never started protocol treatment|5|||
27945821|NCT00955305|54603190|FG000|Overall Study|Ineligible|5|||
27945822|NCT00955305|54603191|FG001|Overall Study|Ineligible|7|||
27945823|NCT00598585|54603199|FG000|Overall Study|Lost to Follow-up|1|||
27945824|NCT00598585|54603200|FG001|Overall Study|Lost to Follow-up|0|||
27945825|NCT00953667|54603206|FG000|Overall Study|Lost to Follow-up|11|||
27945826|NCT00953667|54603206|FG000|Overall Study|Physician Decision|35|||
27945827|NCT00953667|54603206|FG000|Overall Study|Withdrawal by Subject|63|||
27945828|NCT00953667|54603206|FG000|Overall Study|Adverse Event|10|||
27945829|NCT00953667|54603206|FG000|Overall Study|poor venous access,unable to draw blood|4|||
27945830|NCT00883129|54603212|FG000|Overall Study|Adverse Event|7|||
27945831|NCT00883129|54603213|FG001|Overall Study|Adverse Event|15|||
27945832|NCT00883129|54603212|FG000|Overall Study|Withdrawal by Subject|8|||
27945833|NCT00883129|54603213|FG001|Overall Study|Withdrawal by Subject|9|||
27945834|NCT00883129|54603212|FG000|Overall Study|Non-compliance|3|||
27945835|NCT00883129|54603213|FG001|Overall Study|Non-compliance|6|||
27945836|NCT00883129|54603212|FG000|Overall Study|Lost to Follow-up|1|||
27945837|NCT00883129|54603213|FG001|Overall Study|Lost to Follow-up|2|||
27945838|NCT00883129|54603212|FG000|Overall Study|Death|1|||
28080017|NCT00116805|54733446|FG000|Open-label Period Weeks 337 - 384|Withdrew Consent|3|||
28080018|NCT00116805|54733447|FG001|Open-label Period Weeks 337 - 384|Withdrew Consent|1|||
28080019|NCT00116805|54733446|FG000|Open-label Period Weeks 385 - 432|Investigator's Discretion|1|||
28080020|NCT00116805|54733447|FG001|Open-label Period Weeks 385 - 432|Investigator's Discretion|0|||
27945839|NCT00883129|54603213|FG001|Overall Study|Death|2|||
28080021|NCT00116805|54733446|FG000|Open-label Period Weeks 385 - 432|Withdrew Consent|1|||
28080022|NCT00116805|54733447|FG001|Open-label Period Weeks 385 - 432|Withdrew Consent|0|||
28164566|NCT00070564|54835184|FG004|Overall Study|Death|0|||
27945840|NCT00883129|54603212|FG000|Overall Study|Defined Treatment Failure|0|||
27945841|NCT00883129|54603213|FG001|Overall Study|Defined Treatment Failure|2|||
27945842|NCT00905632|54603244|FG000|Overall Study|Adverse Event|0|||
27945843|NCT00905632|54603245|FG001|Overall Study|Adverse Event|0|||
27945844|NCT00905632|54603246|FG002|Overall Study|Adverse Event|0|||
27945845|NCT00905632|54603247|FG003|Overall Study|Adverse Event|0|||
27945846|NCT00905632|54603248|FG004|Overall Study|Adverse Event|0|||
27945847|NCT00905632|54603249|FG005|Overall Study|Adverse Event|1|||
27945848|NCT00905632|54603250|FG006|Overall Study|Adverse Event|4|||
27945849|NCT00954447|54603275|FG000|Overall Study|Adverse Event|33|||
27945850|NCT00954447|54603276|FG001|Overall Study|Adverse Event|25|||
27945851|NCT00954447|54603275|FG000|Overall Study|Lack of Efficacy|17|||
27945852|NCT00954447|54603276|FG001|Overall Study|Lack of Efficacy|3|||
27853635|NCT01427972|54363891|FG003|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
27853636|NCT01427972|54363892|FG004|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
27853637|NCT01427972|54363893|FG005|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
27853638|NCT01427972|54363894|FG006|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
27853639|NCT01427972|54363895|FG007|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
27853640|NCT01427972|54363896|FG008|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
27731378|NCT02613182|54178547|FG000|Overall Study|Study Terminated by Sponsor|21|||
27853641|NCT01427972|54363897|FG009|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
27853642|NCT01427972|54363898|FG010|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
27853643|NCT01427972|54363899|FG011|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
27853644|NCT01427738|54363936|FG000|Overall Study|Death|12|||
27853645|NCT01427738|54363937|FG001|Overall Study|Death|9|||
27853646|NCT01427738|54363936|FG000|Overall Study|Severe debilitation, unable to continue|0|||
27853647|NCT01427738|54363937|FG001|Overall Study|Severe debilitation, unable to continue|1|||
27853648|NCT01427738|54363936|FG000|Overall Study|Subject unable to get to clinic|5|||
27853649|NCT01427738|54363937|FG001|Overall Study|Subject unable to get to clinic|2|||
27853650|NCT01427738|54363936|FG000|Overall Study|Withdrawal by Subject|0|||
27853651|NCT01427738|54363937|FG001|Overall Study|Withdrawal by Subject|2|||
27853652|NCT01427738|54363936|FG000|Overall Study|Subject not willing to adhere to reqs|1|||
27853653|NCT01427738|54363937|FG001|Overall Study|Subject not willing to adhere to reqs|2|||
27853654|NCT01427738|54363936|FG000|Overall Study|Lost to Follow-up|1|||
27853655|NCT01427738|54363937|FG001|Overall Study|Lost to Follow-up|5|||
27853656|NCT01426958|54363943|FG000|Overall Study|Adverse Event|2|||
27853657|NCT02578992|54364121|FG000|Overall Study|equipment not available or malfunction|3|||
27853658|NCT02578992|54364122|FG001|Overall Study|equipment not available or malfunction|3|||
27853659|NCT00558519|54364186|FG000|Overall Study|Ph+|20|||
27853660|NCT00558519|54364186|FG000|Overall Study|Ineligible|1|||
27853661|NCT00558519|54364186|FG000|Overall Study|Insufficient data|1|||
27853662|NCT00558519|54364186|FG000|Overall Study|Never received treatment|1|||
27853663|NCT00558285|54364230|FG000|Overall Study|Adverse Event|1|||
27853664|NCT00558285|54364231|FG001|Overall Study|Adverse Event|1|||
27853665|NCT00558285|54364232|FG002|Overall Study|Adverse Event|4|||
27853666|NCT00558285|54364233|FG003|Overall Study|Adverse Event|1|||
27853667|NCT00558285|54364234|FG004|Overall Study|Adverse Event|2|||
27853668|NCT00558285|54364230|FG000|Overall Study|Abnormal test procedure result(s)|1|||
27853669|NCT00558285|54364231|FG001|Overall Study|Abnormal test procedure result(s)|0|||
27853670|NCT00558285|54364232|FG002|Overall Study|Abnormal test procedure result(s)|0|||
27853671|NCT00558285|54364233|FG003|Overall Study|Abnormal test procedure result(s)|0|||
27853672|NCT00558285|54364234|FG004|Overall Study|Abnormal test procedure result(s)|0|||
27853673|NCT00558285|54364230|FG000|Overall Study|Subject withdrew consent|2|||
27853674|NCT00558285|54364231|FG001|Overall Study|Subject withdrew consent|0|||
27853675|NCT00558285|54364232|FG002|Overall Study|Subject withdrew consent|1|||
27853676|NCT00558285|54364233|FG003|Overall Study|Subject withdrew consent|1|||
27853677|NCT00558285|54364234|FG004|Overall Study|Subject withdrew consent|1|||
27853678|NCT00558285|54364230|FG000|Overall Study|Lost to Follow-up|1|||
27853679|NCT00558285|54364231|FG001|Overall Study|Lost to Follow-up|1|||
27853680|NCT00558285|54364232|FG002|Overall Study|Lost to Follow-up|0|||
27853681|NCT00558285|54364233|FG003|Overall Study|Lost to Follow-up|0|||
27853682|NCT00558285|54364234|FG004|Overall Study|Lost to Follow-up|0|||
27853683|NCT00558285|54364230|FG000|Overall Study|Administrative problems|0|||
27853684|NCT00558285|54364231|FG001|Overall Study|Administrative problems|0|||
27853685|NCT00558285|54364232|FG002|Overall Study|Administrative problems|0|||
27853686|NCT00558285|54364233|FG003|Overall Study|Administrative problems|1|||
27853687|NCT00558285|54364234|FG004|Overall Study|Administrative problems|1|||
27853688|NCT00558285|54364230|FG000|Overall Study|Protocol deviation|1|||
27853689|NCT00558285|54364231|FG001|Overall Study|Protocol deviation|1|||
27853690|NCT00558285|54364232|FG002|Overall Study|Protocol deviation|0|||
27853691|NCT00558285|54364233|FG003|Overall Study|Protocol deviation|1|||
27853692|NCT00558285|54364234|FG004|Overall Study|Protocol deviation|0|||
27853693|NCT01389596|54364249|FG000|Overall Study|Protocol Violation|3|||
27853694|NCT01389596|54364250|FG001|Overall Study|Protocol Violation|4|||
27853695|NCT01389596|54364251|FG002|Overall Study|Protocol Violation|3|||
27853696|NCT01389596|54364249|FG000|Overall Study|Withdrawal by Subject|1|||
27853697|NCT01389596|54364250|FG001|Overall Study|Withdrawal by Subject|2|||
27853698|NCT01389596|54364251|FG002|Overall Study|Withdrawal by Subject|2|||
27853699|NCT01389596|54364249|FG000|Overall Study|Insufficient Clinical Response|3|||
27853700|NCT01389596|54364250|FG001|Overall Study|Insufficient Clinical Response|4|||
27853701|NCT01389596|54364251|FG002|Overall Study|Insufficient Clinical Response|5|||
27853702|NCT01389596|54364249|FG000|Overall Study|Adverse Event|1|||
27853703|NCT01389596|54364250|FG001|Overall Study|Adverse Event|4|||
27853704|NCT01389596|54364251|FG002|Overall Study|Adverse Event|0|||
27853705|NCT01389596|54364249|FG000|Overall Study|Death|0|||
27945853|NCT00954447|54603275|FG000|Overall Study|Protocol Violation|5|||
27945854|NCT00954447|54603276|FG001|Overall Study|Protocol Violation|7|||
27945855|NCT00954447|54603275|FG000|Overall Study|Lost to Follow-up|8|||
27853706|NCT01389596|54364250|FG001|Overall Study|Death|1|||
27853707|NCT01389596|54364251|FG002|Overall Study|Death|0|||
27945856|NCT00954447|54603276|FG001|Overall Study|Lost to Follow-up|14|||
27853708|NCT01389596|54364249|FG000|Overall Study|Other Unspecified|2|||
27853709|NCT01389596|54364250|FG001|Overall Study|Other Unspecified|1|||
27853710|NCT01389596|54364251|FG002|Overall Study|Other Unspecified|0|||
27853711|NCT01405898|54364287|FG000|Overall Study|Withdrawal by Subject|2|||
27853712|NCT01405898|54364288|FG001|Overall Study|Withdrawal by Subject|2|||
27853713|NCT01389128|54364314|FG000|Overall Study|Fetal distress|1|||
27853714|NCT01389128|54364315|FG001|Overall Study|Fetal distress|0|||
27945857|NCT00954447|54603275|FG000|Overall Study|Withdrawal by Subject|26|||
27945858|NCT00954447|54603276|FG001|Overall Study|Withdrawal by Subject|21|||
27945859|NCT00954447|54603275|FG000|Overall Study|Other|21|||
27945860|NCT00954447|54603276|FG001|Overall Study|Other|18|||
27945861|NCT00904150|54603284|FG000|Saliva Samples (DNA)|saliva samples not suitable for assay|3|||
27945862|NCT00904150|54603285|FG001|Saliva Samples (DNA)|saliva samples not suitable for assay|0|||
27945863|NCT00904150|54603284|FG000|Saliva Samples (DNA)|Australian samples of different genotype|0|||
27945864|NCT00904150|54603285|FG001|Saliva Samples (DNA)|Australian samples of different genotype|145|||
27945865|NCT00903760|54603293|FG000|Overall Study|Disease Progression/Death|8|||
27945866|NCT00903760|54603294|FG001|Overall Study|Disease Progression/Death|6|||
27945867|NCT00903760|54603293|FG000|Overall Study|Stem Cell Transplant|8|||
27945868|NCT00903760|54603294|FG001|Overall Study|Stem Cell Transplant|4|||
27945869|NCT00903760|54603293|FG000|Overall Study|Physician Decision|1|||
27945870|NCT00903760|54603294|FG001|Overall Study|Physician Decision|2|||
27945871|NCT00903760|54603293|FG000|Overall Study|Death|0|||
27945872|NCT00903760|54603294|FG001|Overall Study|Death|1|||
27945873|NCT00903760|54603293|FG000|Overall Study|Lost to Follow-up|1|||
27945874|NCT00903760|54603294|FG001|Overall Study|Lost to Follow-up|0|||
27945875|NCT00903760|54603293|FG000|Overall Study|Withdrawal by Subject|1|||
27945876|NCT00903760|54603294|FG001|Overall Study|Withdrawal by Subject|2|||
27945877|NCT00903760|54603293|FG000|Overall Study|Off treatment for long period|0|||
27945878|NCT00903760|54603294|FG001|Overall Study|Off treatment for long period|1|||
27945879|NCT00883051|54603305|FG000|Overall Study|Lost to Follow-up|0|||
27945880|NCT00883051|54603306|FG001|Overall Study|Lost to Follow-up|0|||
27945881|NCT00883051|54603307|FG002|Overall Study|Lost to Follow-up|0|||
27945882|NCT00883051|54603308|FG003|Overall Study|Lost to Follow-up|0|||
27945883|NCT00883051|54603309|FG004|Overall Study|Lost to Follow-up|1|||
27945884|NCT00883051|54603305|FG000|Overall Study|Did not use study medication|24|||
27731379|NCT02613182|54178547|FG000|Overall Study|Withdrawal by Subject|6|||
27731380|NCT02610842|54178551|FG000|Overall Study|Lost to Follow-up|5|||
27731381|NCT01648582|54178560|FG000|Overall Study|Adverse Event|6|||
27731382|NCT01648582|54178561|FG001|Overall Study|Adverse Event|11|||
27731383|NCT01648582|54178562|FG002|Overall Study|Adverse Event|2|||
27731384|NCT01648582|54178560|FG000|Overall Study|Lost to Follow-up|9|||
27731385|NCT01648582|54178561|FG001|Overall Study|Lost to Follow-up|6|||
27731386|NCT01648582|54178562|FG002|Overall Study|Lost to Follow-up|8|||
27731387|NCT01648582|54178560|FG000|Overall Study|Protocol Violation|1|||
27731388|NCT01648582|54178561|FG001|Overall Study|Protocol Violation|2|||
27731389|NCT01648582|54178562|FG002|Overall Study|Protocol Violation|1|||
27731390|NCT01648582|54178560|FG000|Overall Study|Withdrawal by Subject|15|||
27731391|NCT01648582|54178561|FG001|Overall Study|Withdrawal by Subject|17|||
27731392|NCT01648582|54178562|FG002|Overall Study|Withdrawal by Subject|17|||
27731393|NCT01648582|54178560|FG000|Overall Study|Physician Decision|0|||
27731394|NCT01648582|54178561|FG001|Overall Study|Physician Decision|1|||
27731395|NCT01648582|54178562|FG002|Overall Study|Physician Decision|3|||
27731396|NCT01648582|54178560|FG000|Overall Study|Death|1|||
27731397|NCT01648582|54178561|FG001|Overall Study|Death|0|||
27731398|NCT01648582|54178562|FG002|Overall Study|Death|0|||
27731399|NCT01648582|54178560|FG000|Overall Study|Sponsor Decision|0|||
27731400|NCT01648582|54178561|FG001|Overall Study|Sponsor Decision|1|||
27731401|NCT01648582|54178562|FG002|Overall Study|Sponsor Decision|1|||
27853715|NCT01389128|54364314|FG000|Overall Study|Cervix dilation stop|1|||
27853716|NCT01389128|54364315|FG001|Overall Study|Cervix dilation stop|2|||
27853717|NCT01389128|54364314|FG000|Overall Study|Rapid labor evolution|3|||
27853718|NCT01389128|54364315|FG001|Overall Study|Rapid labor evolution|2|||
27945885|NCT00883051|54603306|FG001|Overall Study|Did not use study medication|22|||
27945886|NCT00883051|54603307|FG002|Overall Study|Did not use study medication|29|||
27945887|NCT00883051|54603308|FG003|Overall Study|Did not use study medication|29|||
27945888|NCT00883051|54603309|FG004|Overall Study|Did not use study medication|17|||
27731402|NCT02607800|54178575|FG000|Overall Study|Lost to Follow-up|7|||
27731403|NCT02607800|54178576|FG001|Overall Study|Lost to Follow-up|10|||
27731404|NCT02607800|54178575|FG000|Overall Study|Withdrew Consent|2|||
27731405|NCT02607800|54178576|FG001|Overall Study|Withdrew Consent|0|||
27731406|NCT02607800|54178575|FG000|Overall Study|Randomized/Enrolled but Not Treated|1|||
27853719|NCT01389128|54364314|FG000|Overall Study|Intolerance to procedure|0|||
27945889|NCT00903682|54603323|FG000|Overall Study|Adverse Event|6|||
27853720|NCT01389128|54364315|FG001|Overall Study|Intolerance to procedure|2|||
27853721|NCT01388816|54364346|FG000|Overall Study|Adverse Event|0|||
27945890|NCT00903682|54603324|FG001|Overall Study|Adverse Event|13|||
27945891|NCT00903682|54603323|FG000|Overall Study|Lost to Follow-up|1|||
27945892|NCT00903682|54603324|FG001|Overall Study|Lost to Follow-up|0|||
27945893|NCT00903682|54603323|FG000|Overall Study|Withdrawal by Subject|5|||
27945894|NCT00903682|54603324|FG001|Overall Study|Withdrawal by Subject|0|||
27945895|NCT00903682|54603323|FG000|Overall Study|Pregnancy|0|||
27945896|NCT00903682|54603324|FG001|Overall Study|Pregnancy|1|||
27945897|NCT00903682|54603323|FG000|Overall Study|Subject Reached A Virologic Endpoint|1|||
27945898|NCT00903682|54603324|FG001|Overall Study|Subject Reached A Virologic Endpoint|1|||
27945899|NCT00903682|54603323|FG000|Overall Study|Subject Non-Compliant|1|||
27945900|NCT00903682|54603324|FG001|Overall Study|Subject Non-Compliant|0|||
27945901|NCT00903682|54603323|FG000|Overall Study|Patient Couldn't Come For The Visit Due|1|||
27945902|NCT00903682|54603324|FG001|Overall Study|Patient Couldn't Come For The Visit Due|0|||
27945903|NCT00903682|54603323|FG000|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1|||
27945904|NCT00903682|54603324|FG001|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0|||
27945905|NCT01117428|54603336|FG000|Overall Study|Lack of Efficacy|1|||
27945906|NCT01117428|54603337|FG001|Overall Study|Lack of Efficacy|0|||
27945907|NCT01117428|54603338|FG002|Overall Study|Lack of Efficacy|0|||
27945908|NCT01117428|54603339|FG003|Overall Study|Lack of Efficacy|0|||
27945909|NCT01117428|54603340|FG004|Overall Study|Lack of Efficacy|0|||
27945910|NCT01117428|54603341|FG005|Overall Study|Lack of Efficacy|0|||
27945911|NCT01117428|54603336|FG000|Overall Study|Adverse Event|4|||
27731407|NCT02607800|54178576|FG001|Overall Study|Randomized/Enrolled but Not Treated|1|||
27731408|NCT02304484|54178583|FG000|Overall Study|Death|9|||
27731409|NCT02304484|54178583|FG000|Overall Study|Withdrawal by Subject|14|||
27731410|NCT02304484|54178583|FG000|Overall Study|Lost to Follow-up|2|||
27731411|NCT02708355|54178590|FG000|Overall Study|Adverse Event|1|||
27853722|NCT01388816|54364347|FG001|Overall Study|Adverse Event|2|||
27853723|NCT01388816|54364348|FG002|Overall Study|Adverse Event|0|||
27853724|NCT01388816|54364349|FG003|Overall Study|Adverse Event|0|||
27853725|NCT01388816|54364346|FG000|Overall Study|Lost to Follow-up|0|||
27853726|NCT01388816|54364347|FG001|Overall Study|Lost to Follow-up|1|||
27853727|NCT01388816|54364348|FG002|Overall Study|Lost to Follow-up|0|||
27853728|NCT01388816|54364349|FG003|Overall Study|Lost to Follow-up|0|||
27853729|NCT01388816|54364346|FG000|Overall Study|Withdrawal by Subject|2|||
27853730|NCT01388816|54364347|FG001|Overall Study|Withdrawal by Subject|1|||
27831761|NCT01375608|54310447|FG000|Overall Study|Withdrawal by Subject|2|||
27831762|NCT00704418|54310462|FG000|Overall Study|Withdrawal by Subject|2|||
27831763|NCT00704418|54310463|FG001|Overall Study|Withdrawal by Subject|0|||
27831764|NCT00704418|54310462|FG000|Overall Study|Over-enrolled/surgery postponed|3|||
27831765|NCT00704418|54310463|FG001|Overall Study|Over-enrolled/surgery postponed|6|||
27831766|NCT00704340|54310532|FG000|Overall Study|Lost to Follow-up|2|||
27831767|NCT00704340|54310533|FG001|Overall Study|Lost to Follow-up|1|||
27831768|NCT00704340|54310532|FG000|Overall Study|Death|0|||
27831769|NCT00704340|54310533|FG001|Overall Study|Death|1|||
27831770|NCT00552058|54310541|FG000|Overall Study|Adverse Event|8|||
27831771|NCT00552058|54310542|FG001|Overall Study|Adverse Event|7|||
27831772|NCT00552058|54310541|FG000|Overall Study|Lack of Efficacy|1|||
27831773|NCT00552058|54310542|FG001|Overall Study|Lack of Efficacy|5|||
27831774|NCT00552058|54310541|FG000|Overall Study|Lost to Follow-up|1|||
27831775|NCT00552058|54310542|FG001|Overall Study|Lost to Follow-up|0|||
27831776|NCT00552058|54310541|FG000|Overall Study|Withdrawal by Subject|4|||
27831777|NCT00552058|54310542|FG001|Overall Study|Withdrawal by Subject|4|||
27731412|NCT02708355|54178591|FG001|Overall Study|Adverse Event|0|||
27731413|NCT02708355|54178592|FG002|Overall Study|Adverse Event|0|||
27731414|NCT02708277|54178602|FG000|Overall Study|Lost to Follow-up|7|||
27731415|NCT02708277|54178603|FG001|Overall Study|Lost to Follow-up|4|||
27831778|NCT00552058|54310541|FG000|Overall Study|Other: Protocol Violation|0|||
27831779|NCT00552058|54310542|FG001|Overall Study|Other: Protocol Violation|1|||
27831780|NCT00552058|54310541|FG000|Overall Study|Other: Non Compliance|1|||
27831781|NCT00552058|54310542|FG001|Overall Study|Other: Non Compliance|2|||
27831782|NCT00552058|54310541|FG000|Overall Study|Other: Crossed Over to a Follow-up Study|0|||
27831783|NCT00552058|54310542|FG001|Overall Study|Other: Crossed Over to a Follow-up Study|1|||
27831784|NCT00552058|54310541|FG000|Overall Study|Other: Low CDAI score, entry violation|0|||
27731416|NCT02337478|54178609|FG000|Overall Study|Lack of Efficacy|5|||
27731417|NCT02303704|54178615|FG000|Overall Study|Protocol Violation|5|||
27831785|NCT00552058|54310542|FG001|Overall Study|Other: Low CDAI score, entry violation|1|||
27831786|NCT00552058|54310541|FG000|Overall Study|Other: Positive Stool Result|0|||
27831787|NCT00552058|54310542|FG001|Overall Study|Other: Positive Stool Result|1|||
27831788|NCT00552058|54310541|FG000|Overall Study|Other: Randomized in error|0|||
27853731|NCT01388816|54364348|FG002|Overall Study|Withdrawal by Subject|1|||
27945912|NCT01117428|54603337|FG001|Overall Study|Adverse Event|0|||
27945913|NCT01117428|54603338|FG002|Overall Study|Adverse Event|0|||
27945914|NCT01117428|54603339|FG003|Overall Study|Adverse Event|0|||
27731418|NCT02303704|54178616|FG001|Overall Study|Protocol Violation|9|||
27831789|NCT00552058|54310542|FG001|Overall Study|Other: Randomized in error|1|||
27831790|NCT00552058|54310541|FG000|Overall Study|Other: Sponsors Decision|0|||
27831791|NCT00552058|54310542|FG001|Overall Study|Other: Sponsors Decision|1|||
27831792|NCT00552058|54310541|FG000|Overall Study|Other: Early Roll Over|1|||
27831793|NCT00552058|54310542|FG001|Overall Study|Other: Early Roll Over|0|||
27831794|NCT00550732|54310571|FG000|Overall Study|Death|4|||
27831795|NCT00550732|54310571|FG000|Overall Study|Withdrawal by Subject|2|||
27831796|NCT00550732|54310571|FG000|Overall Study|Physician Decision|2|||
27831797|NCT00550732|54310571|FG000|Overall Study|Lost to Follow-up|1|||
27831798|NCT00550732|54310571|FG000|Overall Study|Palliative care|1|||
27831799|NCT00550732|54310571|FG000|Overall Study|Adverse Event|1|||
27831800|NCT00550420|54310585|FG000|Overall Study|Adverse Event|28|||
27831801|NCT00550420|54310585|FG000|Overall Study|Lost to Follow-up|8|||
27831802|NCT00550420|54310585|FG000|Overall Study|Protocol Violation|11|||
27831803|NCT00550420|54310585|FG000|Overall Study|Withdrawal by Subject|30|||
27831804|NCT00550420|54310585|FG000|Overall Study|Still in study at termination|206|||
27831805|NCT00550420|54310585|FG000|Overall Study|Missing|2|||
27831806|NCT00550420|54310585|FG000|Overall Study|Prolonged QT Interval Electrocardiogram|12|||
27831807|NCT00550420|54310585|FG000|Overall Study|Investigators opinion|1|||
27831808|NCT00550420|54310585|FG000|Overall Study|Lack of curative effect|1|||
27831809|NCT00550420|54310585|FG000|Overall Study|Unethical stop of enrollment|2|||
27831810|NCT00550420|54310585|FG000|Overall Study|Caregiver's decision to withdraw|1|||
27945915|NCT01117428|54603340|FG004|Overall Study|Adverse Event|1|||
27945916|NCT01117428|54603341|FG005|Overall Study|Adverse Event|2|||
27945917|NCT01117428|54603336|FG000|Overall Study|Death|0|||
27945918|NCT01117428|54603337|FG001|Overall Study|Death|1|||
27945919|NCT01117428|54603338|FG002|Overall Study|Death|2|||
27945920|NCT01117428|54603339|FG003|Overall Study|Death|0|||
27945921|NCT01117428|54603340|FG004|Overall Study|Death|0|||
27945922|NCT01117428|54603341|FG005|Overall Study|Death|1|||
27945923|NCT01117428|54603336|FG000|Overall Study|Physician Decision|0|||
27945924|NCT01117428|54603337|FG001|Overall Study|Physician Decision|1|||
27945925|NCT01117428|54603338|FG002|Overall Study|Physician Decision|0|||
27945926|NCT01117428|54603339|FG003|Overall Study|Physician Decision|0|||
27945927|NCT01117428|54603340|FG004|Overall Study|Physician Decision|0|||
27945928|NCT01117428|54603341|FG005|Overall Study|Physician Decision|0|||
27945929|NCT01117428|54603336|FG000|Overall Study|Withdrawal by Subject|0|||
27945930|NCT01117428|54603337|FG001|Overall Study|Withdrawal by Subject|0|||
27945931|NCT01117428|54603338|FG002|Overall Study|Withdrawal by Subject|1|||
27945932|NCT01117428|54603339|FG003|Overall Study|Withdrawal by Subject|0|||
27945933|NCT01117428|54603340|FG004|Overall Study|Withdrawal by Subject|0|||
27945934|NCT01117428|54603341|FG005|Overall Study|Withdrawal by Subject|0|||
27945935|NCT01117428|54603336|FG000|Overall Study|Progressive disease|15|||
27945936|NCT01117428|54603337|FG001|Overall Study|Progressive disease|27|||
27945937|NCT01117428|54603338|FG002|Overall Study|Progressive disease|10|||
27945938|NCT01117428|54603339|FG003|Overall Study|Progressive disease|12|||
27945939|NCT01117428|54603340|FG004|Overall Study|Progressive disease|16|||
27945940|NCT01117428|54603341|FG005|Overall Study|Progressive disease|17|||
27945941|NCT01135524|54603370|FG000|Overall Study|Withdrawal by Subject|14|||
27945942|NCT01135524|54603370|FG000|Overall Study|Adverse Event|20|||
27945943|NCT01135524|54603370|FG000|Overall Study|Lost to Follow-up|3|||
27945944|NCT01135524|54603370|FG000|Overall Study|Administrative|151|||
27945945|NCT01135524|54603370|FG000|Overall Study|Lack of Efficacy|8|||
27945946|NCT00948675|54603376|FG000|Overall Study|Lost to Follow-up|1|||
27945947|NCT00948675|54603377|FG001|Overall Study|Lost to Follow-up|0|||
27945948|NCT00903370|54603385|FG000|Overall Study|Death|13|||
27945949|NCT00903370|54603386|FG001|Overall Study|Death|10|||
27945950|NCT00903370|54603385|FG000|Overall Study|Withdrawal by Subject|9|||
27945951|NCT00903370|54603386|FG001|Overall Study|Withdrawal by Subject|6|||
27945952|NCT00903370|54603385|FG000|Overall Study|Lost to Follow-up|6|||
27945953|NCT00903370|54603386|FG001|Overall Study|Lost to Follow-up|8|||
27945954|NCT01110408|54603394|FG000|Overall Study|Protocol Violation|1|||
27945955|NCT01110408|54603395|FG001|Overall Study|Protocol Violation|0|||
28164567|NCT00070564|54835185|FG005|Overall Study|Death|1|||
27831811|NCT00550420|54310585|FG000|Overall Study|Out of Electrocardiogram criteria|1|||
27945956|NCT00953043|54603403|FG000|Overall Study|Withdrawal by Subject|4|||
27945957|NCT00953043|54603404|FG001|Overall Study|Withdrawal by Subject|0|||
27945958|NCT00953043|54603403|FG000|Overall Study|Physician Decision|0|||
27945959|NCT00953043|54603404|FG001|Overall Study|Physician Decision|2|||
27945960|NCT01135134|54603412|FG000|Overall Study|Adverse Event|1|||
27945961|NCT01135134|54603413|FG001|Overall Study|Adverse Event|1|||
27831812|NCT00550420|54310585|FG000|Overall Study|Exclusion criteria|1|||
27831813|NCT00550420|54310585|FG000|Overall Study|Prohibited medicine|1|||
27853732|NCT01388816|54364349|FG003|Overall Study|Withdrawal by Subject|0|||
27945962|NCT01135134|54603412|FG000|Overall Study|Did not meet protocol eligibility|1|||
27945963|NCT01135134|54603413|FG001|Overall Study|Did not meet protocol eligibility|0|||
28164568|NCT00070564|54835180|FG000|Overall Study|Other, not protocol specified|17|||
27945964|NCT00948441|54603421|FG000|Overall Study|no longer meet inclusion criteria|1|||
27945965|NCT00948441|54603422|FG001|Overall Study|no longer meet inclusion criteria|4|||
27731419|NCT02608892|54178624|FG000|Overall Study|Lost to Follow-up|1|||
27731420|NCT02608892|54178625|FG001|Overall Study|Lost to Follow-up|0|||
27731421|NCT02706951|54178635|FG000|Overall Study|Adverse Event|1|||
27853733|NCT01388816|54364346|FG000|Overall Study|Protocol Violation|0|||
27853734|NCT01388816|54364347|FG001|Overall Study|Protocol Violation|0|||
27853735|NCT01388816|54364348|FG002|Overall Study|Protocol Violation|2|||
27731422|NCT02706951|54178636|FG001|Overall Study|Adverse Event|5|||
27731423|NCT02706951|54178637|FG002|Overall Study|Adverse Event|3|||
27731424|NCT02706951|54178635|FG000|Overall Study|Withdrawal by Subject|11|||
27731425|NCT02706951|54178636|FG001|Overall Study|Withdrawal by Subject|6|||
27945966|NCT01117350|54603432|FG000|Comparative Period|Not Treated|5|||
27945967|NCT01117350|54603433|FG001|Comparative Period|Not Treated|8|||
27945968|NCT01117350|54603432|FG000|Comparative Period|Adverse Event|6|||
27945969|NCT01117350|54603433|FG001|Comparative Period|Adverse Event|33|||
27945970|NCT01117350|54603432|FG000|Comparative Period|Lost to Follow-up|11|||
27945971|NCT01117350|54603433|FG001|Comparative Period|Lost to Follow-up|7|||
27945972|NCT01117350|54603432|FG000|Comparative Period|Withdrawal by Subject|9|||
27945973|NCT01117350|54603433|FG001|Comparative Period|Withdrawal by Subject|13|||
27945974|NCT01117350|54603432|FG000|Comparative Period|Protocol Violation|8|||
27945975|NCT01117350|54603433|FG001|Comparative Period|Protocol Violation|12|||
27945976|NCT01117350|54603432|FG000|Comparative Period|Lack of Efficacy|1|||
27945977|NCT01117350|54603433|FG001|Comparative Period|Lack of Efficacy|0|||
27945978|NCT01117350|54603432|FG000|Comparative Period|Physician Decision|0|||
27945979|NCT01117350|54603433|FG001|Comparative Period|Physician Decision|1|||
27945980|NCT01117350|54603432|FG000|Comparative Period|Move to another city/country|2|||
27945981|NCT01117350|54603433|FG001|Comparative Period|Move to another city/country|1|||
27945982|NCT01117350|54603432|FG000|Extension Period|Not included in extension, not treated|0|||
27945983|NCT01117350|54603433|FG001|Extension Period|Not included in extension, not treated|50|||
27945984|NCT01117350|54603432|FG000|Extension Period|Adverse Event|0|||
27945985|NCT01117350|54603433|FG001|Extension Period|Adverse Event|2|||
27945986|NCT01117350|54603432|FG000|Extension Period|Protocol Violation|0|||
27945987|NCT01117350|54603433|FG001|Extension Period|Protocol Violation|2|||
27945988|NCT01117350|54603432|FG000|Extension Period|Lost to Follow-up|0|||
27853736|NCT01388816|54364349|FG003|Overall Study|Protocol Violation|0|||
27853737|NCT00555477|54364503|FG000|Overall Study|Adverse Event|0|||
27853738|NCT00555477|54364504|FG001|Overall Study|Adverse Event|9|||
27853739|NCT00555477|54364503|FG000|Overall Study|Withdrawal by Subject|1|||
27853740|NCT00555477|54364504|FG001|Overall Study|Withdrawal by Subject|2|||
27945989|NCT01117350|54603433|FG001|Extension Period|Lost to Follow-up|2|||
27945990|NCT01117350|54603432|FG000|Extension Period|Withdrawal by Subject|0|||
27945991|NCT01117350|54603433|FG001|Extension Period|Withdrawal by Subject|3|||
27945992|NCT01117350|54603432|FG000|Extension Period|Lack of Efficacy|0|||
27945993|NCT01117350|54603433|FG001|Extension Period|Lack of Efficacy|2|||
27945994|NCT01117350|54603432|FG000|Extension Period|Inclusion criteria not respected|0|||
28080023|NCT00116805|54733446|FG000|Open-label Period Weeks 433 - 480|Investigator's Discretion|1|||
28080024|NCT00116805|54733447|FG001|Open-label Period Weeks 433 - 480|Investigator's Discretion|0|||
28080025|NCT00116805|54733446|FG000|Open-label Period Weeks 433 - 480|Withdrew Consent|3|||
27731426|NCT02706951|54178637|FG002|Overall Study|Withdrawal by Subject|6|||
27731427|NCT02706951|54178635|FG000|Overall Study|Lost to Follow-up|0|||
27731428|NCT02706951|54178636|FG001|Overall Study|Lost to Follow-up|4|||
27731429|NCT02706951|54178637|FG002|Overall Study|Lost to Follow-up|1|||
27731430|NCT02706951|54178635|FG000|Overall Study|Other|2|||
28080026|NCT00116805|54733447|FG001|Open-label Period Weeks 433 - 480|Withdrew Consent|0|||
27731431|NCT02706951|54178636|FG001|Overall Study|Other|1|||
27731432|NCT02706951|54178637|FG002|Overall Study|Other|0|||
27731433|NCT02708121|54178647|FG000|Overall Study|Withdrawn by Study Team|1|||
27731434|NCT02708121|54178648|FG001|Overall Study|Withdrawn by Study Team|1|||
27731435|NCT02708121|54178647|FG000|Overall Study|Withdrawal by Subject|0|||
27731436|NCT02708121|54178648|FG001|Overall Study|Withdrawal by Subject|4|||
27731437|NCT02707965|54178663|FG000|Overall Study|Withdrawal by Subject|0|||
27731438|NCT02707965|54178664|FG001|Overall Study|Withdrawal by Subject|0|||
27731439|NCT02707965|54178665|FG002|Overall Study|Withdrawal by Subject|1|||
27731440|NCT02707965|54178666|FG003|Overall Study|Withdrawal by Subject|0|||
27731441|NCT02707965|54178667|FG004|Overall Study|Withdrawal by Subject|0|||
28080027|NCT00116649|54733462|FG000|Overall Study|Adverse Event|20|||
28080028|NCT00116649|54733462|FG000|Overall Study|Lack of Efficacy|1|||
28080029|NCT00116649|54733462|FG000|Overall Study|Lost to Follow-up|32|||
28080030|NCT00116649|54733462|FG000|Overall Study|Withdrawal by Subject|68|||
27945995|NCT01117350|54603433|FG001|Extension Period|Inclusion criteria not respected|1|||
27945996|NCT01117350|54603432|FG000|Extension Period|Prohibited medication|0|||
27945997|NCT01117350|54603433|FG001|Extension Period|Prohibited medication|1|||
27945998|NCT00952731|54603444|FG000|Overall Study|Drug supply expired|1|||
27945999|NCT00952731|54603445|FG001|Overall Study|Drug supply expired|0|||
27946000|NCT00947427|54603453|FG000|Overall Study|Withdrawal by Subject|1|||
27946001|NCT00947427|54603454|FG001|Overall Study|Withdrawal by Subject|3|||
27946002|NCT00947427|54603453|FG000|Overall Study|Protocol Violation|0|||
27946003|NCT00947427|54603454|FG001|Overall Study|Protocol Violation|1|||
27946004|NCT01116882|54603462|FG000|30-day|Lost to Follow-up|50|||
27946005|NCT01116882|54603463|FG001|30-day|Lost to Follow-up|21|||
27946006|NCT01116882|54603462|FG000|30-day|Withdrawal by Subject|2|||
27946007|NCT01116882|54603463|FG001|30-day|Withdrawal by Subject|4|||
27946008|NCT01116882|54603462|FG000|30-day|Other Reasons|16|||
27946009|NCT01116882|54603463|FG001|30-day|Other Reasons|6|||
27946010|NCT01116882|54603462|FG000|12-month|Lost to Follow-up|111|||
27946011|NCT01116882|54603463|FG001|12-month|Lost to Follow-up|42|||
27946012|NCT01116882|54603462|FG000|12-month|Other Reasons|151|||
27946013|NCT01116882|54603463|FG001|12-month|Other Reasons|49|||
27853741|NCT00555477|54364503|FG000|Overall Study|Physician Decision|1|||
27853742|NCT00555477|54364504|FG001|Overall Study|Physician Decision|2|||
27853743|NCT00554619|54364521|FG000|Overall Study|Adverse Event|1|||
27853744|NCT00554619|54364521|FG000|Overall Study|Physician Decision|1|||
27853745|NCT00554619|54364521|FG000|Overall Study|Liver Function Test Abnormality|1|||
27853746|NCT01426412|54364581|FG000|Overall Study|Withdrawal by Subject|1|||
27946014|NCT01116882|54603462|FG000|12-month|Withdrawal by Subject|5|||
27946015|NCT01116882|54603463|FG001|12-month|Withdrawal by Subject|8|||
27853747|NCT01426412|54364582|FG001|Overall Study|Withdrawal by Subject|0|||
27853748|NCT01426412|54364583|FG002|Overall Study|Withdrawal by Subject|0|||
28080031|NCT00116649|54733462|FG000|Overall Study|Local Skin Reaction|9|||
28080032|NCT00116649|54733462|FG000|Overall Study|Various Reasons|18|||
28080033|NCT00116649|54733462|FG000|Overall Study|Protocol Specified|7|||
28080034|NCT00083889|54733468|FG000|Overall Study|Adverse Event|76|||
28080035|NCT00083889|54733469|FG001|Overall Study|Adverse Event|86|||
28080036|NCT00083889|54733468|FG000|Overall Study|Protocol Violation|2|||
28080037|NCT00083889|54733469|FG001|Overall Study|Protocol Violation|2|||
28080038|NCT00083889|54733468|FG000|Overall Study|Withdrawal by Subject|22|||
28080039|NCT00083889|54733469|FG001|Overall Study|Withdrawal by Subject|24|||
28080040|NCT00083889|54733468|FG000|Overall Study|Lack of Efficacy|240|||
28080041|NCT00083889|54733469|FG001|Overall Study|Lack of Efficacy|219|||
28080042|NCT00083889|54733468|FG000|Overall Study|Decision of sponsor|32|||
28080043|NCT00083889|54733469|FG001|Overall Study|Decision of sponsor|4|||
28080044|NCT00083889|54733468|FG000|Overall Study|Randomized: did not take study drug|0|||
28080045|NCT00083889|54733469|FG001|Overall Study|Randomized: did not take study drug|15|||
28080046|NCT00083889|54733468|FG000|Overall Study|Completed on marketed sunitinub|3|||
27853749|NCT01426412|54364584|FG003|Overall Study|Withdrawal by Subject|0|||
27853750|NCT01426412|54364585|FG004|Overall Study|Withdrawal by Subject|1|||
27853751|NCT01426412|54364586|FG005|Overall Study|Withdrawal by Subject|0|||
27853752|NCT01426412|54364587|FG006|Overall Study|Withdrawal by Subject|0|||
27853753|NCT01426412|54364588|FG007|Overall Study|Withdrawal by Subject|3|||
27853754|NCT01426412|54364589|FG008|Overall Study|Withdrawal by Subject|1|||
27853755|NCT00554229|54364793|FG000|Overall Study|Lost to Follow-up|3|||
27853756|NCT00554229|54364794|FG001|Overall Study|Lost to Follow-up|6|||
27853757|NCT00554229|54364793|FG000|Overall Study|Withdrawal by Subject|29|||
27853758|NCT00554229|54364794|FG001|Overall Study|Withdrawal by Subject|37|||
27853759|NCT00554229|54364793|FG000|Overall Study|Adverse Event|71|||
27853760|NCT00554229|54364794|FG001|Overall Study|Adverse Event|39|||
27853761|NCT00554229|54364793|FG000|Overall Study|Protocol Violation|3|||
27853762|NCT00554229|54364794|FG001|Overall Study|Protocol Violation|3|||
27946016|NCT00953745|54603474|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1|||
27946017|NCT00953745|54603475|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0|||
27946018|NCT00953745|54603474|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2|||
27946019|NCT00953745|54603475|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0|||
27946020|NCT00953745|54603474|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3|||
27946021|NCT00953745|54603475|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0|||
27946022|NCT00953745|54603474|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1|||
27946023|NCT00953745|54603475|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0|||
27946024|NCT00953745|54603474|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6|||
27946025|NCT00953745|54603475|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0|||
27946026|NCT00953745|54603474|FG000|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1|||
27946027|NCT00953745|54603475|FG001|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0|||
27946028|NCT00902746|54603492|FG000|Overall Study|Protocol Violation|7|||
27946029|NCT00902746|54603492|FG000|Overall Study|Withdrawal by Subject|16|||
28080047|NCT00083889|54733469|FG001|Overall Study|Completed on marketed sunitinub|0|||
28164569|NCT00070564|54835181|FG001|Overall Study|Other, not protocol specified|15|||
28164570|NCT00070564|54835182|FG002|Overall Study|Other, not protocol specified|14|||
27853763|NCT00554229|54364793|FG000|Overall Study|Reason not otherwise captured, eg; death|119|||
27853764|NCT00554229|54364794|FG001|Overall Study|Reason not otherwise captured, eg; death|140|||
27853765|NCT00554229|54364793|FG000|Overall Study|Randomised but no treatment received|1|||
27853766|NCT00554229|54364794|FG001|Overall Study|Randomised but no treatment received|0|||
27946030|NCT00902746|54603492|FG000|Overall Study|Adverse Event|8|||
27946031|NCT00902746|54603492|FG000|Overall Study|Lost to Follow-up|3|||
27853767|NCT01405820|54364904|FG000|Randomized Treatment Period|Adverse Event|3|||
27853768|NCT01405820|54364905|FG001|Randomized Treatment Period|Adverse Event|3|||
27946032|NCT00902746|54603492|FG000|Overall Study|Physician Decision|2|||
27946033|NCT00902668|54603505|FG000|Overall Study|Protocol stopped due to slow accrual.|3|||
27946034|NCT00947349|54603513|FG000|Triple Treatment Combination Period|Adverse Event|0|||
27946035|NCT00947349|54603514|FG001|Triple Treatment Combination Period|Adverse Event|1|||
27946036|NCT00947349|54603515|FG002|Triple Treatment Combination Period|Adverse Event|0|||
27946037|NCT00947349|54603516|FG003|Triple Treatment Combination Period|Adverse Event|0|||
27946038|NCT00947349|54603513|FG000|Overall Study Standard of Care|Lack of Efficacy|0|||
27946039|NCT00947349|54603514|FG001|Overall Study Standard of Care|Lack of Efficacy|0|||
27946040|NCT00947349|54603515|FG002|Overall Study Standard of Care|Lack of Efficacy|1|||
27946041|NCT00947349|54603516|FG003|Overall Study Standard of Care|Lack of Efficacy|1|||
27946042|NCT00947349|54603513|FG000|Overall Study Standard of Care|Withdrawal by Subject|0|||
27946043|NCT00947349|54603514|FG001|Overall Study Standard of Care|Withdrawal by Subject|0|||
27946044|NCT00947349|54603515|FG002|Overall Study Standard of Care|Withdrawal by Subject|1|||
27853769|NCT01405820|54364906|FG002|Randomized Treatment Period|Adverse Event|3|||
27946045|NCT00947349|54603516|FG003|Overall Study Standard of Care|Withdrawal by Subject|0|||
27946046|NCT00947349|54603513|FG000|Overall Study Standard of Care|Other|0|||
27946047|NCT00947349|54603514|FG001|Overall Study Standard of Care|Other|0|||
27946048|NCT00947349|54603515|FG002|Overall Study Standard of Care|Other|0|||
27946049|NCT00947349|54603516|FG003|Overall Study Standard of Care|Other|1|||
27946050|NCT00947193|54603544|FG000|Overall Study|Lost to Follow-up|1|||
28080048|NCT00083889|54733468|FG000|Overall Study|Crossover to SU011248|0|||
28080049|NCT00083889|54733469|FG001|Overall Study|Crossover to SU011248|25|||
28080050|NCT03572062|54733488|FG000|Overall Study|Adverse Event|0|||
27946051|NCT00947193|54603545|FG001|Overall Study|Lost to Follow-up|0|||
27946052|NCT00947193|54603544|FG000|Overall Study|Withdrawal by Subject|1|||
27946053|NCT00947193|54603545|FG001|Overall Study|Withdrawal by Subject|0|||
27946054|NCT00947193|54603544|FG000|Overall Study|Factor VIII >1%|1|||
27946055|NCT00947193|54603545|FG001|Overall Study|Factor VIII >1%|0|||
27946056|NCT00947115|54603553|FG000|Overall Study|Missed reporting interval|3|||
27946057|NCT00947115|54603554|FG001|Overall Study|Missed reporting interval|4|||
27946058|NCT00947115|54603555|FG002|Overall Study|Missed reporting interval|2|||
27946059|NCT00947115|54603553|FG000|Overall Study|Physician Decision|0|||
27946060|NCT00947115|54603554|FG001|Overall Study|Physician Decision|2|||
27946061|NCT00947115|54603555|FG002|Overall Study|Physician Decision|0|||
27853770|NCT01405820|54364907|FG003|Randomized Treatment Period|Adverse Event|0|||
27853771|NCT01405820|54364908|FG004|Randomized Treatment Period|Adverse Event|2|||
27853772|NCT01405820|54364909|FG005|Randomized Treatment Period|Adverse Event|1|||
27853773|NCT01405820|54364904|FG000|Randomized Treatment Period|Withdrawal by Subject|6|||
27853774|NCT01405820|54364905|FG001|Randomized Treatment Period|Withdrawal by Subject|2|||
27853775|NCT01405820|54364906|FG002|Randomized Treatment Period|Withdrawal by Subject|2|||
27853776|NCT01405820|54364907|FG003|Randomized Treatment Period|Withdrawal by Subject|2|||
27853777|NCT01405820|54364908|FG004|Randomized Treatment Period|Withdrawal by Subject|0|||
27853778|NCT01405820|54364909|FG005|Randomized Treatment Period|Withdrawal by Subject|0|||
27853779|NCT01405820|54364904|FG000|Randomized Treatment Period|Other|2|||
27853780|NCT01405820|54364905|FG001|Randomized Treatment Period|Other|2|||
27853781|NCT01405820|54364906|FG002|Randomized Treatment Period|Other|1|||
27946062|NCT00947115|54603553|FG000|Overall Study|Death|0|||
27946063|NCT00947115|54603554|FG001|Overall Study|Death|1|||
27946064|NCT00947115|54603555|FG002|Overall Study|Death|1|||
27946065|NCT00947115|54603553|FG000|Overall Study|Migrated from study area|2|||
27946066|NCT00947115|54603554|FG001|Overall Study|Migrated from study area|0|||
27946067|NCT00947115|54603555|FG002|Overall Study|Migrated from study area|0|||
27946068|NCT00947115|54603553|FG000|Overall Study|Withdrawal by Subject|1|||
27946069|NCT00947115|54603554|FG001|Overall Study|Withdrawal by Subject|3|||
27946070|NCT00947115|54603555|FG002|Overall Study|Withdrawal by Subject|4|||
27946071|NCT00947115|54603553|FG000|Overall Study|Lost to Follow-up|11|||
27946072|NCT00947115|54603554|FG001|Overall Study|Lost to Follow-up|12|||
27946073|NCT00947115|54603555|FG002|Overall Study|Lost to Follow-up|8|||
27946074|NCT00952419|54603566|FG000|Overall Study|Adverse Event|2|||
27946075|NCT00952419|54603567|FG001|Overall Study|Adverse Event|0|||
27946076|NCT00952419|54603568|FG002|Overall Study|Adverse Event|0|||
28080051|NCT03572062|54733489|FG001|Overall Study|Adverse Event|0|||
27853782|NCT01405820|54364907|FG003|Randomized Treatment Period|Other|1|||
27946077|NCT00952419|54603566|FG000|Overall Study|Protocol Violation|3|||
27946078|NCT00952419|54603567|FG001|Overall Study|Protocol Violation|7|||
27946079|NCT00952419|54603568|FG002|Overall Study|Protocol Violation|0|||
27853783|NCT01405820|54364908|FG004|Randomized Treatment Period|Other|0|||
27853784|NCT01405820|54364909|FG005|Randomized Treatment Period|Other|0|||
27853785|NCT01405820|54364904|FG000|Randomized Treatment Period|Physician Decision|0|||
27853786|NCT01405820|54364905|FG001|Randomized Treatment Period|Physician Decision|2|||
27946080|NCT00952419|54603566|FG000|Overall Study|Withdrawal by Subject|1|||
27946081|NCT00952419|54603567|FG001|Overall Study|Withdrawal by Subject|3|||
27946082|NCT00952419|54603568|FG002|Overall Study|Withdrawal by Subject|0|||
28080052|NCT03572062|54733490|FG002|Overall Study|Adverse Event|0|||
27946083|NCT00902278|54603581|FG000|Overall Study|Physician Decision|1|||
28080053|NCT03572062|54733491|FG003|Overall Study|Adverse Event|0|||
27946084|NCT00902278|54603582|FG001|Overall Study|Physician Decision|0|||
27946085|NCT00902278|54603583|FG002|Overall Study|Physician Decision|2|||
27946086|NCT00902278|54603584|FG003|Overall Study|Physician Decision|0|||
27946087|NCT00902278|54603585|FG004|Overall Study|Physician Decision|1|||
27946088|NCT00902278|54603581|FG000|Overall Study|Lost to Follow-up|3|||
27946089|NCT00902278|54603582|FG001|Overall Study|Lost to Follow-up|2|||
27946090|NCT00902278|54603583|FG002|Overall Study|Lost to Follow-up|3|||
27946091|NCT00902278|54603584|FG003|Overall Study|Lost to Follow-up|0|||
27946092|NCT00902278|54603585|FG004|Overall Study|Lost to Follow-up|1|||
27946093|NCT01998633|54603599|FG000|Overall Study|Death|1|||
27946094|NCT00952341|54603609|FG000|Cycle 1|Adverse Event|4|||
27946095|NCT00952341|54603610|FG001|Cycle 1|Adverse Event|1|||
27946096|NCT00952341|54603609|FG000|Cycle 1|Withdrawal by Subject|3|||
27946097|NCT00952341|54603610|FG001|Cycle 1|Withdrawal by Subject|8|||
27946098|NCT00952341|54603609|FG000|Cycle 1|Protocol Violation|2|||
27946099|NCT00952341|54603610|FG001|Cycle 1|Protocol Violation|1|||
27946100|NCT00952341|54603609|FG000|Cycle 1|Lost to Follow-up|11|||
27946101|NCT00952341|54603610|FG001|Cycle 1|Lost to Follow-up|2|||
27946102|NCT00952341|54603609|FG000|Cycle 1|Physician Decision|0|||
27946103|NCT00952341|54603610|FG001|Cycle 1|Physician Decision|1|||
27946104|NCT00952341|54603609|FG000|Cycle 2|Withdrawal by Subject|1|||
27946105|NCT00952341|54603610|FG001|Cycle 2|Withdrawal by Subject|1|||
27946106|NCT00952341|54603609|FG000|Cycle 2|Protocol Violation|1|||
27946107|NCT00952341|54603610|FG001|Cycle 2|Protocol Violation|0|||
27946108|NCT00952341|54603609|FG000|Cycle 2|Lost to Follow-up|6|||
27946109|NCT00952341|54603610|FG001|Cycle 2|Lost to Follow-up|9|||
27946110|NCT00952341|54603609|FG000|Cycle 2|Physician Decision|1|||
27946111|NCT00952341|54603610|FG001|Cycle 2|Physician Decision|1|||
27946112|NCT00952341|54603609|FG000|Cycle 2|Progressive Disease|0|||
27946113|NCT00952341|54603610|FG001|Cycle 2|Progressive Disease|1|||
27946114|NCT00946881|54603616|FG000|First Treatment|Withdrawal by Subject|1|||
27946115|NCT00946881|54603616|FG000|First Treatment|Patient relocated to another state|1|||
27946116|NCT00946881|54603616|FG000|Retreatment|Withdrawal by Subject|1|||
27946117|NCT01214642|54603653|FG000|Overall Study|Progressive Disease|3|||
27946118|NCT01214642|54603654|FG001|Overall Study|Progressive Disease|2|||
27946119|NCT01214642|54603655|FG002|Overall Study|Progressive Disease|3|||
27946120|NCT01214642|54603656|FG003|Overall Study|Progressive Disease|5|||
27946121|NCT01214642|54603657|FG004|Overall Study|Progressive Disease|5|||
27946122|NCT01214642|54603658|FG005|Overall Study|Progressive Disease|3|||
27946123|NCT01214642|54603659|FG006|Overall Study|Progressive Disease|5|||
27946124|NCT01214642|54603660|FG007|Overall Study|Progressive Disease|3|||
27946125|NCT01214642|54603661|FG008|Overall Study|Progressive Disease|10|||
27946126|NCT01214642|54603662|FG009|Overall Study|Progressive Disease|2|||
27946127|NCT01214642|54603663|FG010|Overall Study|Progressive Disease|1|||
27946128|NCT01214642|54603664|FG011|Overall Study|Progressive Disease|4|||
27946129|NCT01214642|54603653|FG000|Overall Study|Adverse Event|0|||
27946130|NCT01214642|54603654|FG001|Overall Study|Adverse Event|1|||
27946131|NCT01214642|54603655|FG002|Overall Study|Adverse Event|0|||
27853787|NCT01405820|54364906|FG002|Randomized Treatment Period|Physician Decision|1|||
27853788|NCT01405820|54364907|FG003|Randomized Treatment Period|Physician Decision|0|||
27853789|NCT01405820|54364908|FG004|Randomized Treatment Period|Physician Decision|0|||
27853790|NCT01405820|54364909|FG005|Randomized Treatment Period|Physician Decision|0|||
27853791|NCT01405820|54364904|FG000|Randomized Treatment Period|Rescue|0|||
27853792|NCT01405820|54364905|FG001|Randomized Treatment Period|Rescue|1|||
27853793|NCT01405820|54364906|FG002|Randomized Treatment Period|Rescue|13|||
27853794|NCT01405820|54364907|FG003|Randomized Treatment Period|Rescue|10|||
27853795|NCT01405820|54364908|FG004|Randomized Treatment Period|Rescue|8|||
27853796|NCT01405820|54364909|FG005|Randomized Treatment Period|Rescue|8|||
27853797|NCT01405820|54364904|FG000|Randomized Treatment Period|Incorrect Study Treatment|0|||
27853798|NCT01405820|54364905|FG001|Randomized Treatment Period|Incorrect Study Treatment|0|||
27853799|NCT01405820|54364906|FG002|Randomized Treatment Period|Incorrect Study Treatment|3|||
27946132|NCT01214642|54603656|FG003|Overall Study|Adverse Event|0|||
27946133|NCT01214642|54603657|FG004|Overall Study|Adverse Event|0|||
27946134|NCT01214642|54603658|FG005|Overall Study|Adverse Event|0|||
28080054|NCT03572062|54733492|FG004|Overall Study|Adverse Event|0|||
27853800|NCT01405820|54364907|FG003|Randomized Treatment Period|Incorrect Study Treatment|0|||
27946135|NCT01214642|54603659|FG006|Overall Study|Adverse Event|1|||
27946136|NCT01214642|54603660|FG007|Overall Study|Adverse Event|0|||
27946137|NCT01214642|54603661|FG008|Overall Study|Adverse Event|0|||
27946138|NCT01214642|54603662|FG009|Overall Study|Adverse Event|1|||
27946139|NCT01214642|54603663|FG010|Overall Study|Adverse Event|1|||
28080055|NCT03572062|54733493|FG005|Overall Study|Adverse Event|0|||
28080056|NCT03572062|54733494|FG006|Overall Study|Adverse Event|0|||
27946140|NCT01214642|54603664|FG011|Overall Study|Adverse Event|0|||
27946141|NCT01214642|54603653|FG000|Overall Study|Death|0|||
27946142|NCT01214642|54603654|FG001|Overall Study|Death|0|||
27946143|NCT01214642|54603655|FG002|Overall Study|Death|1|||
27946144|NCT01214642|54603656|FG003|Overall Study|Death|0|||
27946145|NCT01214642|54603657|FG004|Overall Study|Death|0|||
28080057|NCT03572062|54733495|FG007|Overall Study|Adverse Event|0|||
27946146|NCT01214642|54603658|FG005|Overall Study|Death|0|||
27946147|NCT01214642|54603659|FG006|Overall Study|Death|0|||
27946148|NCT01214642|54603660|FG007|Overall Study|Death|0|||
27946149|NCT01214642|54603661|FG008|Overall Study|Death|0|||
27946150|NCT01214642|54603662|FG009|Overall Study|Death|0|||
27946151|NCT01214642|54603663|FG010|Overall Study|Death|1|||
27946152|NCT01214642|54603664|FG011|Overall Study|Death|0|||
27946153|NCT01214642|54603653|FG000|Overall Study|Withdrawal by Subject|0|||
27946154|NCT01214642|54603654|FG001|Overall Study|Withdrawal by Subject|0|||
27946155|NCT01214642|54603655|FG002|Overall Study|Withdrawal by Subject|1|||
27946156|NCT01214642|54603656|FG003|Overall Study|Withdrawal by Subject|0|||
27946157|NCT01214642|54603657|FG004|Overall Study|Withdrawal by Subject|0|||
27946158|NCT01214642|54603658|FG005|Overall Study|Withdrawal by Subject|0|||
27946159|NCT01214642|54603659|FG006|Overall Study|Withdrawal by Subject|0|||
27946160|NCT01214642|54603660|FG007|Overall Study|Withdrawal by Subject|0|||
27946161|NCT01214642|54603661|FG008|Overall Study|Withdrawal by Subject|3|||
27946162|NCT01214642|54603662|FG009|Overall Study|Withdrawal by Subject|1|||
27946163|NCT01214642|54603663|FG010|Overall Study|Withdrawal by Subject|1|||
27946164|NCT01214642|54603664|FG011|Overall Study|Withdrawal by Subject|0|||
27946165|NCT01214642|54603653|FG000|Overall Study|Physician Decision|0|||
27946166|NCT01214642|54603654|FG001|Overall Study|Physician Decision|0|||
27946167|NCT01214642|54603655|FG002|Overall Study|Physician Decision|1|||
28164571|NCT00070564|54835183|FG003|Overall Study|Other, not protocol specified|19|||
28164572|NCT00070564|54835184|FG004|Overall Study|Other, not protocol specified|6|||
28164573|NCT00070564|54835185|FG005|Overall Study|Other, not protocol specified|7|||
28164574|NCT00070564|54835180|FG000|Overall Study|Withdrawal by Subject|26|||
28164575|NCT00070564|54835181|FG001|Overall Study|Withdrawal by Subject|37|||
28164576|NCT00070564|54835182|FG002|Overall Study|Withdrawal by Subject|23|||
28164577|NCT00070564|54835183|FG003|Overall Study|Withdrawal by Subject|30|||
28164578|NCT00070564|54835184|FG004|Overall Study|Withdrawal by Subject|8|||
28164579|NCT00070564|54835185|FG005|Overall Study|Withdrawal by Subject|8|||
28164580|NCT00070564|54835180|FG000|Overall Study|Not reported|0|||
28164581|NCT00070564|54835181|FG001|Overall Study|Not reported|0|||
28164582|NCT00070564|54835182|FG002|Overall Study|Not reported|0|||
28164583|NCT00070564|54835183|FG003|Overall Study|Not reported|0|||
28164584|NCT00070564|54835184|FG004|Overall Study|Not reported|1|||
28164585|NCT00070564|54835185|FG005|Overall Study|Not reported|0|||
28164586|NCT02738151|54835211|FG000|Overall Study|Randomized but not treated|4|||
27731442|NCT02707965|54178668|FG005|Overall Study|Withdrawal by Subject|0|||
28164587|NCT02738151|54835212|FG001|Overall Study|Randomized but not treated|1|||
28164588|NCT02738151|54835211|FG000|Overall Study|Adverse Event|4|||
28164589|NCT02738151|54835212|FG001|Overall Study|Adverse Event|5|||
28164590|NCT02738151|54835211|FG000|Overall Study|Hypoglycemia|0|||
28164591|NCT02738151|54835212|FG001|Overall Study|Hypoglycemia|1|||
28164592|NCT02738151|54835211|FG000|Overall Study|Poor Compliance to Protocol|4|||
27731443|NCT02707965|54178669|FG006|Overall Study|Withdrawal by Subject|0|||
27731444|NCT02707965|54178670|FG007|Overall Study|Withdrawal by Subject|2|||
27946168|NCT01214642|54603656|FG003|Overall Study|Physician Decision|1|||
28164593|NCT02738151|54835212|FG001|Overall Study|Poor Compliance to Protocol|3|||
28164594|NCT02738151|54835211|FG000|Overall Study|Other than specified above|11|||
28164595|NCT02738151|54835212|FG001|Overall Study|Other than specified above|21|||
27731445|NCT02707965|54178671|FG008|Overall Study|Withdrawal by Subject|0|||
27831814|NCT00558064|54310597|FG000|Overall Study|Adverse Event|3|||
27831815|NCT00558064|54310598|FG001|Overall Study|Adverse Event|2|||
27831816|NCT00558064|54310597|FG000|Overall Study|Lack of Efficacy|0|||
27831817|NCT00558064|54310598|FG001|Overall Study|Lack of Efficacy|1|||
27831818|NCT00558064|54310597|FG000|Overall Study|Protocol Violation|1|||
27831819|NCT00558064|54310598|FG001|Overall Study|Protocol Violation|0|||
27831820|NCT00558064|54310597|FG000|Overall Study|Lost to Follow-up|0|||
27831821|NCT00558064|54310598|FG001|Overall Study|Lost to Follow-up|1|||
27831822|NCT00558064|54310597|FG000|Overall Study|Withdrawal by Subject|0|||
27831823|NCT00558064|54310598|FG001|Overall Study|Withdrawal by Subject|1|||
27831824|NCT00558064|54310597|FG000|Overall Study|No visit within allowance period|1|||
27831825|NCT00558064|54310598|FG001|Overall Study|No visit within allowance period|0|||
27831826|NCT00557830|54310607|FG000|Screening Treatment Phase|Withdrawal by Subject|1|||
27831827|NCT00557830|54310608|FG001|Screening Treatment Phase|Withdrawal by Subject|0|||
27831828|NCT00557830|54310609|FG002|Screening Treatment Phase|Withdrawal by Subject|0|||
27831829|NCT00557830|54310607|FG000|Screening Treatment Phase|Adverse Event|2|||
27831830|NCT00557830|54310608|FG001|Screening Treatment Phase|Adverse Event|0|||
27831831|NCT00557830|54310609|FG002|Screening Treatment Phase|Adverse Event|0|||
27831832|NCT00557830|54310607|FG000|Screening Treatment Phase|Unable to tolerate standard dose|3|||
27831833|NCT00557830|54310608|FG001|Screening Treatment Phase|Unable to tolerate standard dose|0|||
27831834|NCT00557830|54310609|FG002|Screening Treatment Phase|Unable to tolerate standard dose|0|||
27831835|NCT00557440|54310620|FG000|Treatment Period 1|Adverse Event|0|||
27946169|NCT01214642|54603657|FG004|Overall Study|Physician Decision|1|||
27946170|NCT01214642|54603658|FG005|Overall Study|Physician Decision|0|||
27946171|NCT01214642|54603659|FG006|Overall Study|Physician Decision|0|||
27946172|NCT01214642|54603660|FG007|Overall Study|Physician Decision|0|||
27946173|NCT01214642|54603661|FG008|Overall Study|Physician Decision|0|||
27946174|NCT01214642|54603662|FG009|Overall Study|Physician Decision|0|||
27946175|NCT01214642|54603663|FG010|Overall Study|Physician Decision|0|||
27946176|NCT01214642|54603664|FG011|Overall Study|Physician Decision|2|||
27946177|NCT01214252|54603707|FG000|Overall Study|Not eligible per protocol|82|||
27946178|NCT01214174|54603715|FG000|Overall Study|Withdrawal by Subject|0|||
27946179|NCT01214174|54603716|FG001|Overall Study|Withdrawal by Subject|0|||
27946180|NCT01214174|54603717|FG002|Overall Study|Withdrawal by Subject|1|||
27946181|NCT00901342|54603725|FG000|Overall Study|Adverse Event|1|||
27946182|NCT00901342|54603725|FG000|Overall Study|Death|4|||
27946183|NCT00901342|54603725|FG000|Overall Study|Disease progression|1|||
27946184|NCT00901342|54603725|FG000|Overall Study|Withdrawal by Subject|9|||
27946185|NCT00901186|54603731|FG000|Overall Study|Lack of Efficacy|0|||
27946186|NCT00901186|54603732|FG001|Overall Study|Lack of Efficacy|1|||
27946187|NCT00901186|54603731|FG000|Overall Study|Abnormal laboratory values|0|||
27946188|NCT00901186|54603732|FG001|Overall Study|Abnormal laboratory values|1|||
27946189|NCT00901186|54603731|FG000|Overall Study|Lost to Follow-up|2|||
27946190|NCT00901186|54603732|FG001|Overall Study|Lost to Follow-up|0|||
27946191|NCT00901186|54603731|FG000|Overall Study|Adverse Event|2|||
27946192|NCT00901186|54603732|FG001|Overall Study|Adverse Event|4|||
27946193|NCT00901186|54603731|FG000|Overall Study|Administration problems|0|||
27731446|NCT02707965|54178672|FG009|Overall Study|Withdrawal by Subject|0|||
27731447|NCT02707965|54178673|FG010|Overall Study|Withdrawal by Subject|0|||
27946194|NCT00901186|54603732|FG001|Overall Study|Administration problems|1|||
27946195|NCT00901186|54603731|FG000|Overall Study|Protocol deviations|5|||
27946196|NCT00901186|54603732|FG001|Overall Study|Protocol deviations|4|||
27946197|NCT01213472|54603738|FG000|Overall Study|Recurrence/Progressive disease|25|||
27831836|NCT00557440|54310621|FG001|Treatment Period 1|Adverse Event|0|||
27831837|NCT00557440|54310622|FG002|Treatment Period 1|Adverse Event|1|||
27831838|NCT00556894|54310633|FG000|Overall Study|Adverse Event|2|||
27831839|NCT00556894|54310634|FG001|Overall Study|Adverse Event|3|||
27831840|NCT00556894|54310635|FG002|Overall Study|Adverse Event|3|||
27831841|NCT00556894|54310633|FG000|Overall Study|Death|1|||
27831842|NCT00556894|54310634|FG001|Overall Study|Death|0|||
27831843|NCT00556894|54310635|FG002|Overall Study|Death|0|||
27831844|NCT00556894|54310633|FG000|Overall Study|regulatory decision in Bulgaria|10|||
27831845|NCT00556894|54310634|FG001|Overall Study|regulatory decision in Bulgaria|14|||
27831846|NCT00556894|54310635|FG002|Overall Study|regulatory decision in Bulgaria|13|||
27831847|NCT00556894|54310633|FG000|Overall Study|Change in therapy|2|||
27831848|NCT00556894|54310634|FG001|Overall Study|Change in therapy|1|||
27831849|NCT00556894|54310635|FG002|Overall Study|Change in therapy|2|||
27831850|NCT00556894|54310633|FG000|Overall Study|Withdrawal by Subject|1|||
27831851|NCT00556894|54310634|FG001|Overall Study|Withdrawal by Subject|1|||
27831852|NCT00556894|54310635|FG002|Overall Study|Withdrawal by Subject|1|||
27831853|NCT02722044|54310643|FG000|Overall Study|Adverse Event|2|||
27831854|NCT02722044|54310643|FG000|Overall Study|Physician Decision|1|||
27831855|NCT02722044|54310643|FG000|Overall Study|Withdrawal by Subject|1|||
27831856|NCT02722044|54310643|FG000|Overall Study|Did Not Meet Criteria at Week 14|1|||
27831857|NCT00556426|54310648|FG000|Overall Study|Withdrawal by Subject|3|||
27831858|NCT00556426|54310648|FG000|Overall Study|Death|6|||
27831859|NCT00555568|54310656|FG000|Overall Study|Lost to Follow-up|26|||
27831860|NCT00555568|54310657|FG001|Overall Study|Lost to Follow-up|16|||
27831861|NCT00555568|54310658|FG002|Overall Study|Lost to Follow-up|16|||
27831862|NCT00702702|54310669|FG000|Overall Study|Study prematurely terminated|56|||
27831863|NCT02721966|54310680|FG000|Overall Study|Protocol Violation|1|||
27831864|NCT02721966|54310681|FG001|Overall Study|Protocol Violation|0|||
27831865|NCT02721966|54310682|FG002|Overall Study|Protocol Violation|0|||
27831866|NCT02721966|54310683|FG003|Overall Study|Protocol Violation|0|||
27831867|NCT02721966|54310684|FG004|Overall Study|Protocol Violation|0|||
27831868|NCT02721966|54310680|FG000|Overall Study|Withdrawal by Subject|9|||
27831869|NCT02721966|54310681|FG001|Overall Study|Withdrawal by Subject|2|||
27831870|NCT02721966|54310682|FG002|Overall Study|Withdrawal by Subject|3|||
27831871|NCT02721966|54310683|FG003|Overall Study|Withdrawal by Subject|7|||
27831872|NCT02721966|54310684|FG004|Overall Study|Withdrawal by Subject|0|||
27831873|NCT02721966|54310680|FG000|Overall Study|Adverse Event|4|||
27831874|NCT02721966|54310681|FG001|Overall Study|Adverse Event|4|||
27831875|NCT02721966|54310682|FG002|Overall Study|Adverse Event|3|||
27831876|NCT02721966|54310683|FG003|Overall Study|Adverse Event|0|||
27831877|NCT02721966|54310684|FG004|Overall Study|Adverse Event|0|||
27831878|NCT02721966|54310680|FG000|Overall Study|Death|1|||
27831879|NCT02721966|54310681|FG001|Overall Study|Death|0|||
27831880|NCT02721966|54310682|FG002|Overall Study|Death|0|||
27831881|NCT02721966|54310683|FG003|Overall Study|Death|0|||
27831882|NCT02721966|54310684|FG004|Overall Study|Death|0|||
27831883|NCT02721966|54310680|FG000|Overall Study|Lack of Efficacy|7|||
27831884|NCT02721966|54310681|FG001|Overall Study|Lack of Efficacy|4|||
27831885|NCT02721966|54310682|FG002|Overall Study|Lack of Efficacy|0|||
27946198|NCT01213472|54603738|FG000|Overall Study|Withdrawal by Subject|1|||
27946199|NCT01213472|54603738|FG000|Overall Study|Physician Decision|1|||
27946200|NCT00900796|54603742|FG000|Phase 1|Lacked sufficient information|4|||
27946201|NCT00900796|54603742|FG000|Phase 1|Missing information at Week 16|7|||
27946202|NCT00900796|54603742|FG000|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110|||
27946203|NCT00900796|54603742|FG000|Phase 2|Lost to Follow-up|5|||
27946204|NCT01213082|54603750|FG000|Overall Study|Lost to Follow-up|6|||
27946205|NCT01213082|54603751|FG001|Overall Study|Lost to Follow-up|7|||
27946206|NCT01213082|54603752|FG002|Overall Study|Lost to Follow-up|4|||
27946207|NCT01213082|54603750|FG000|Overall Study|Physician Decision|0|||
27946208|NCT01213082|54603751|FG001|Overall Study|Physician Decision|0|||
27946209|NCT01213082|54603752|FG002|Overall Study|Physician Decision|1|||
27946210|NCT00885703|54603767|FG000|Overall Study|Death|9|||
27946211|NCT00885703|54603768|FG001|Overall Study|Death|7|||
27946212|NCT00885703|54603769|FG002|Overall Study|Death|8|||
27946213|NCT00885703|54603770|FG003|Overall Study|Death|7|||
27946214|NCT00885703|54603771|FG004|Overall Study|Death|7|||
27946215|NCT00885703|54603772|FG005|Overall Study|Death|8|||
27946216|NCT00885703|54603773|FG006|Overall Study|Death|4|||
27946217|NCT00885703|54603767|FG000|Overall Study|Lost to Follow-up|0|||
27946218|NCT00885703|54603768|FG001|Overall Study|Lost to Follow-up|0|||
27946219|NCT00885703|54603769|FG002|Overall Study|Lost to Follow-up|1|||
27946220|NCT00885703|54603770|FG003|Overall Study|Lost to Follow-up|0|||
27946221|NCT00885703|54603771|FG004|Overall Study|Lost to Follow-up|0|||
27946222|NCT00885703|54603772|FG005|Overall Study|Lost to Follow-up|1|||
27946223|NCT00885703|54603773|FG006|Overall Study|Lost to Follow-up|0|||
27946224|NCT00885703|54603767|FG000|Overall Study|Withdrawal by Subject|0|||
27946225|NCT00885703|54603768|FG001|Overall Study|Withdrawal by Subject|0|||
27731448|NCT02707965|54178674|FG011|Overall Study|Withdrawal by Subject|0|||
27731449|NCT02707965|54178675|FG012|Overall Study|Withdrawal by Subject|0|||
27946226|NCT00885703|54603769|FG002|Overall Study|Withdrawal by Subject|0|||
27946227|NCT00885703|54603770|FG003|Overall Study|Withdrawal by Subject|1|||
27946228|NCT00885703|54603771|FG004|Overall Study|Withdrawal by Subject|3|||
27946229|NCT00885703|54603772|FG005|Overall Study|Withdrawal by Subject|1|||
27946230|NCT00885703|54603773|FG006|Overall Study|Withdrawal by Subject|1|||
27946231|NCT00885703|54603767|FG000|Overall Study|Ineligible (no CM)|1|||
27946232|NCT00885703|54603768|FG001|Overall Study|Ineligible (no CM)|3|||
27946233|NCT00885703|54603769|FG002|Overall Study|Ineligible (no CM)|2|||
27946234|NCT00885703|54603770|FG003|Overall Study|Ineligible (no CM)|1|||
27946235|NCT00885703|54603771|FG004|Overall Study|Ineligible (no CM)|2|||
27946236|NCT00885703|54603772|FG005|Overall Study|Ineligible (no CM)|3|||
27946237|NCT00885703|54603773|FG006|Overall Study|Ineligible (no CM)|1|||
27946238|NCT00901576|54603799|FG000|Second Intervention|Withdrawal by Subject|0|||
27946239|NCT00901576|54603800|FG001|Second Intervention|Withdrawal by Subject|0|||
27946240|NCT00901576|54603801|FG002|Second Intervention|Withdrawal by Subject|0|||
27946241|NCT00901576|54603802|FG003|Second Intervention|Withdrawal by Subject|1|||
27946242|NCT00901576|54603803|FG004|Second Intervention|Withdrawal by Subject|0|||
27946243|NCT00901576|54603804|FG005|Second Intervention|Withdrawal by Subject|1|||
27946244|NCT00901576|54603799|FG000|Second Intervention|Physician Decision|1|||
27946245|NCT00901576|54603800|FG001|Second Intervention|Physician Decision|0|||
27946246|NCT00901576|54603801|FG002|Second Intervention|Physician Decision|0|||
27946247|NCT00901576|54603802|FG003|Second Intervention|Physician Decision|0|||
27946248|NCT00901576|54603803|FG004|Second Intervention|Physician Decision|0|||
27946249|NCT00901576|54603804|FG005|Second Intervention|Physician Decision|0|||
27946250|NCT00882583|54603814|FG000|Overall Study|Physician Decision|1|||
27946251|NCT00882583|54603815|FG001|Overall Study|Physician Decision|0|||
27946252|NCT00882583|54603814|FG000|Overall Study|Adverse Event|0|||
27946253|NCT00882583|54603815|FG001|Overall Study|Adverse Event|1|||
27946254|NCT00900562|54603823|FG000|Overall Study|Progressive disease|9|||
27946255|NCT00900562|54603824|FG001|Overall Study|Progressive disease|5|||
27946256|NCT00900562|54603823|FG000|Overall Study|Toxicity|1|||
27946257|NCT00900562|54603824|FG001|Overall Study|Toxicity|0|||
27946258|NCT00900562|54603823|FG000|Overall Study|Death|1|||
27946259|NCT00900562|54603824|FG001|Overall Study|Death|1|||
27946260|NCT00900562|54603823|FG000|Overall Study|Withdrawal by Subject|0|||
27946261|NCT00900562|54603824|FG001|Overall Study|Withdrawal by Subject|1|||
27946262|NCT00900562|54603823|FG000|Overall Study|Unrelated adverse event|1|||
27946263|NCT00900562|54603824|FG001|Overall Study|Unrelated adverse event|0|||
27946264|NCT00599521|54603833|FG000|Overall Study|Lack of Efficacy|4|||
27946265|NCT00599521|54603834|FG001|Overall Study|Lack of Efficacy|8|||
27946266|NCT00599521|54603833|FG000|Overall Study|Adverse Event|4|||
27946267|NCT00599521|54603834|FG001|Overall Study|Adverse Event|1|||
27831886|NCT02721966|54310683|FG003|Overall Study|Lack of Efficacy|0|||
27946268|NCT00599521|54603833|FG000|Overall Study|Withdrawal by Subject|28|||
27946269|NCT00599521|54603834|FG001|Overall Study|Withdrawal by Subject|34|||
27946270|NCT00599521|54603833|FG000|Overall Study|Protocol Violation|1|||
27946271|NCT00599521|54603834|FG001|Overall Study|Protocol Violation|1|||
27946272|NCT00599521|54603833|FG000|Overall Study|Lost to Follow-up|23|||
27946273|NCT00599521|54603834|FG001|Overall Study|Lost to Follow-up|23|||
27946274|NCT00599521|54603833|FG000|Overall Study|Pregnancy|0|||
27946275|NCT00599521|54603834|FG001|Overall Study|Pregnancy|2|||
27946276|NCT00882115|54603840|FG000|Overall Study|Withdrawal by Subject|3|||
27946277|NCT00882115|54603840|FG000|Overall Study|did not respond to DEP challe|6|||
27946278|NCT00881959|54603846|FG000|Overall Study|Lost to Follow-up|2|||
27946279|NCT00881959|54603847|FG001|Overall Study|Lost to Follow-up|4|||
27946280|NCT00884377|54603855|FG000|Overall Study|Withdrawal by Subject|1|||
27946281|NCT00884377|54603856|FG001|Overall Study|Withdrawal by Subject|0|||
27946282|NCT00884377|54603855|FG000|Overall Study|Could not confirm diagnosis|1|||
27946283|NCT00884377|54603856|FG001|Overall Study|Could not confirm diagnosis|0|||
27946284|NCT00884377|54603855|FG000|Overall Study|Physician Decision|0|||
27946285|NCT00884377|54603856|FG001|Overall Study|Physician Decision|1|||
27946286|NCT00884221|54603870|FG000|Overall Study|Withdrawal by Subject|0|||
27853801|NCT01405820|54364908|FG004|Randomized Treatment Period|Incorrect Study Treatment|2|||
27853802|NCT01405820|54364909|FG005|Randomized Treatment Period|Incorrect Study Treatment|0|||
27853803|NCT01405820|54364904|FG000|Randomized Treatment Period|Treatment Arm Closed|0|||
27946287|NCT00884221|54603871|FG001|Overall Study|Withdrawal by Subject|3|||
27946288|NCT00884221|54603870|FG000|Overall Study|Adverse Event|6|||
27946289|NCT00884221|54603871|FG001|Overall Study|Adverse Event|3|||
27946290|NCT00884221|54603870|FG000|Overall Study|Protocol Violation|16|||
27946291|NCT00884221|54603871|FG001|Overall Study|Protocol Violation|13|||
27946292|NCT00884221|54603870|FG000|Overall Study|Cancellation of Cycle and Other Reason|12|||
27946293|NCT00884221|54603871|FG001|Overall Study|Cancellation of Cycle and Other Reason|13|||
27946294|NCT00899548|54603892|FG000|Overall Study|Physician Decision|3|||
27946295|NCT00899392|54603902|FG000|Overall Study|Subject didn't finish/partial pilot data|21|||
27946296|NCT00899392|54603903|FG001|Overall Study|Subject didn't finish/partial pilot data|24|||
27946297|NCT00690898|54603909|FG000|SCREENING|Screen failure|18|||
27946298|NCT00690898|54603909|FG000|TREATMENT|Adverse Event|3|||
27946299|NCT00690898|54603909|FG000|TREATMENT|Lack of Efficacy|18|||
27946300|NCT00690898|54603909|FG000|TREATMENT|Withdrawal by Subject|4|||
27946301|NCT00690898|54603909|FG000|TREATMENT|Other (not otherwise specified)|1|||
27946302|NCT00895414|54603913|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
27946303|NCT00895414|54603914|FG001|First Intervention (14 Days)|Withdrawal by Subject|0|||
27946304|NCT00895414|54603913|FG000|First Intervention (14 Days)|Physician Decision|0|||
27946305|NCT00895414|54603914|FG001|First Intervention (14 Days)|Physician Decision|1|||
27946306|NCT01212770|54603923|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
27946307|NCT01212770|54603924|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
27946308|NCT01212770|54603925|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8|||
27946309|NCT01212770|54603926|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
27946310|NCT01212770|54603927|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
27946311|NCT01212770|54603928|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
27946312|NCT01212770|54603929|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
27946313|NCT01212770|54603930|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
27946314|NCT01212770|54603931|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
27853804|NCT01405820|54364905|FG001|Randomized Treatment Period|Treatment Arm Closed|0|||
27853805|NCT01405820|54364906|FG002|Randomized Treatment Period|Treatment Arm Closed|20|||
27853806|NCT01405820|54364907|FG003|Randomized Treatment Period|Treatment Arm Closed|36|||
27853807|NCT01405820|54364908|FG004|Randomized Treatment Period|Treatment Arm Closed|33|||
27853808|NCT01405820|54364909|FG005|Randomized Treatment Period|Treatment Arm Closed|28|||
27853809|NCT01405820|54364904|FG000|Randomized Treatment Period|Death|0|||
27853810|NCT01405820|54364905|FG001|Randomized Treatment Period|Death|0|||
27853811|NCT01405820|54364906|FG002|Randomized Treatment Period|Death|0|||
27853812|NCT01405820|54364907|FG003|Randomized Treatment Period|Death|1|||
27853813|NCT01405820|54364908|FG004|Randomized Treatment Period|Death|0|||
27853814|NCT01405820|54364909|FG005|Randomized Treatment Period|Death|0|||
27853815|NCT01405820|54364904|FG000|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
27853816|NCT01405820|54364905|FG001|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
27853817|NCT01405820|54364906|FG002|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
27853818|NCT01405820|54364907|FG003|Randomized Treatment Period|Withdrew Prior to Dosing|1|||
27853819|NCT01405820|54364908|FG004|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
27853820|NCT01405820|54364909|FG005|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
27853821|NCT01405820|54364904|FG000|Open-Label Treatment Period|Withdrawal by Subject|3|||
27853822|NCT01405820|54364905|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
27853823|NCT01405820|54364906|FG002|Open-Label Treatment Period|Withdrawal by Subject|1|||
27853824|NCT01405820|54364907|FG003|Open-Label Treatment Period|Withdrawal by Subject|1|||
27853825|NCT01405820|54364908|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
27853826|NCT01405820|54364909|FG005|Open-Label Treatment Period|Withdrawal by Subject|1|||
27853827|NCT01405820|54364904|FG000|Open-Label Treatment Period|Other|1|||
27853828|NCT01405820|54364905|FG001|Open-Label Treatment Period|Other|1|||
27853829|NCT01405820|54364906|FG002|Open-Label Treatment Period|Other|1|||
27853830|NCT01405820|54364907|FG003|Open-Label Treatment Period|Other|1|||
27853831|NCT01405820|54364908|FG004|Open-Label Treatment Period|Other|1|||
27946315|NCT01212770|54603923|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
27853832|NCT01405820|54364909|FG005|Open-Label Treatment Period|Other|1|||
27946316|NCT01212770|54603924|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5|||
27946317|NCT01212770|54603925|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7|||
27946318|NCT01212770|54603926|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
27946319|NCT01212770|54603927|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
27946320|NCT01212770|54603928|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
27946321|NCT01212770|54603929|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
27946322|NCT01212770|54603930|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
27946323|NCT01212770|54603931|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
27946324|NCT01212770|54603923|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
27946325|NCT01212770|54603924|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
27946326|NCT01212770|54603925|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
27946327|NCT01212770|54603926|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
27946328|NCT01212770|54603927|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
27946329|NCT01212770|54603928|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
27946330|NCT01212770|54603929|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
27946331|NCT01212770|54603930|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
27946332|NCT01212770|54603931|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
27946333|NCT01212770|54603923|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
27946334|NCT01212770|54603924|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
27853833|NCT01405820|54364904|FG000|Open-Label Treatment Period|Physician Decision|0|||
27853834|NCT01405820|54364905|FG001|Open-Label Treatment Period|Physician Decision|0|||
27853835|NCT01405820|54364906|FG002|Open-Label Treatment Period|Physician Decision|1|||
27853836|NCT01405820|54364907|FG003|Open-Label Treatment Period|Physician Decision|2|||
27853837|NCT01405820|54364908|FG004|Open-Label Treatment Period|Physician Decision|1|||
27853838|NCT01405820|54364909|FG005|Open-Label Treatment Period|Physician Decision|0|||
27853839|NCT01405820|54364904|FG000|Open-Label Treatment Period|Adverse Event|0|||
27853840|NCT01405820|54364905|FG001|Open-Label Treatment Period|Adverse Event|0|||
27853841|NCT01405820|54364906|FG002|Open-Label Treatment Period|Adverse Event|0|||
27853842|NCT01405820|54364907|FG003|Open-Label Treatment Period|Adverse Event|1|||
27853843|NCT01405820|54364908|FG004|Open-Label Treatment Period|Adverse Event|0|||
27853844|NCT01405820|54364909|FG005|Open-Label Treatment Period|Adverse Event|0|||
27853845|NCT01405742|54364938|FG000|Overall Study|Lost to Follow-up|1|||
27853846|NCT01405742|54364939|FG001|Overall Study|Lost to Follow-up|0|||
27853847|NCT01425632|54364968|FG000|Overall Study|Adverse Event|0|||
27853848|NCT01425632|54364969|FG001|Overall Study|Adverse Event|1|||
27853849|NCT01425632|54364970|FG002|Overall Study|Adverse Event|1|||
27853850|NCT01425632|54364968|FG000|Overall Study|Physician Decision|1|||
27946335|NCT01212770|54603925|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3|||
27946336|NCT01212770|54603926|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
27946337|NCT01212770|54603927|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
27946338|NCT01212770|54603928|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
27946339|NCT01212770|54603929|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
27946340|NCT01212770|54603930|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
27946341|NCT01212770|54603931|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
27946342|NCT01212770|54603923|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
27946343|NCT01212770|54603924|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
27946344|NCT01212770|54603925|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
27946345|NCT01212770|54603926|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
27946346|NCT01212770|54603927|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
27946347|NCT01212770|54603928|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
27946348|NCT01212770|54603929|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
27946349|NCT01212770|54603930|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
27946350|NCT01212770|54603931|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
27946351|NCT01212770|54603923|FG000|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3|||
27853851|NCT01425632|54364969|FG001|Overall Study|Physician Decision|0|||
27853852|NCT01425632|54364970|FG002|Overall Study|Physician Decision|0|||
27853853|NCT01425632|54364968|FG000|Overall Study|Protocol Violation|0|||
27853854|NCT01425632|54364969|FG001|Overall Study|Protocol Violation|0|||
27853855|NCT01425632|54364970|FG002|Overall Study|Protocol Violation|2|||
27853856|NCT01425632|54364968|FG000|Overall Study|Withdrawal by Subject|0|||
27853857|NCT01425632|54364969|FG001|Overall Study|Withdrawal by Subject|0|||
27853858|NCT01425632|54364970|FG002|Overall Study|Withdrawal by Subject|1|||
27853859|NCT01405508|54365007|FG000|Overall Study|AE, non-serious non-fatal|1|||
27853860|NCT01405508|54365008|FG001|Overall Study|AE, non-serious non-fatal|1|||
27853861|NCT01405508|54365009|FG002|Overall Study|AE, non-serious non-fatal|0|||
27853862|NCT01405508|54365010|FG003|Overall Study|AE, non-serious non-fatal|0|||
27853863|NCT01405196|54365146|FG000|Overall Study|Study Terminated by Sponsor|0|||
27853864|NCT01405196|54365147|FG001|Overall Study|Study Terminated by Sponsor|0|||
27853865|NCT01405196|54365148|FG002|Overall Study|Study Terminated by Sponsor|9|||
27946352|NCT01212770|54603924|FG001|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1|||
27946353|NCT01212770|54603925|FG002|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2|||
27946354|NCT01212770|54603926|FG003|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
27946355|NCT01212770|54603927|FG004|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
27946356|NCT01212770|54603928|FG005|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
27946357|NCT01212770|54603929|FG006|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
27946358|NCT01212770|54603930|FG007|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
27946359|NCT01212770|54603931|FG008|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
27946360|NCT01212770|54603923|FG000|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
27946361|NCT01212770|54603924|FG001|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6|||
27946362|NCT01212770|54603925|FG002|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
27946363|NCT01212770|54603926|FG003|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
27946364|NCT01212770|54603927|FG004|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
27946365|NCT01212770|54603928|FG005|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
27946366|NCT01212770|54603929|FG006|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1|||
27946367|NCT01212770|54603930|FG007|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
27946368|NCT01212770|54603931|FG008|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
27946369|NCT01212770|54603923|FG000|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
27946370|NCT01212770|54603924|FG001|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7|||
27946371|NCT01212770|54603925|FG002|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5|||
27946372|NCT01212770|54603926|FG003|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4|||
27946373|NCT01212770|54603927|FG004|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1|||
27946374|NCT01212770|54603928|FG005|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2|||
27946375|NCT01212770|54603929|FG006|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
27946376|NCT01212770|54603930|FG007|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
27946377|NCT01212770|54603931|FG008|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
27946378|NCT01212770|54603923|FG000|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
27946379|NCT01212770|54603924|FG001|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6|||
27946380|NCT01212770|54603925|FG002|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
27946381|NCT01212770|54603926|FG003|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
27946382|NCT01212770|54603927|FG004|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
27946383|NCT01212770|54603928|FG005|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
27946384|NCT01212770|54603929|FG006|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
27946385|NCT01212770|54603930|FG007|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
27946386|NCT01212770|54603931|FG008|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
27946387|NCT01212770|54603923|FG000|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
27946388|NCT01212770|54603924|FG001|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
27946389|NCT01212770|54603925|FG002|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1|||
27946390|NCT01212770|54603926|FG003|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
27946391|NCT01212770|54603927|FG004|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
27946392|NCT01212770|54603928|FG005|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
27946393|NCT01212770|54603929|FG006|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
27946394|NCT01212770|54603930|FG007|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
27946395|NCT01212770|54603931|FG008|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
27946396|NCT01212770|54603923|FG000|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
27946397|NCT01212770|54603924|FG001|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
27946398|NCT01212770|54603925|FG002|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
27946399|NCT01212770|54603926|FG003|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1|||
27946400|NCT01212770|54603927|FG004|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
27946401|NCT01212770|54603928|FG005|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
27946402|NCT01212770|54603929|FG006|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
27946403|NCT01212770|54603930|FG007|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
27946404|NCT01212770|54603931|FG008|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
27946405|NCT01212770|54603923|FG000|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
27946406|NCT01212770|54603924|FG001|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
27946407|NCT01212770|54603925|FG002|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
27946408|NCT01212770|54603926|FG003|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
27946409|NCT01212770|54603927|FG004|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
27946410|NCT01212770|54603928|FG005|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
27946411|NCT01212770|54603929|FG006|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
27946412|NCT01212770|54603930|FG007|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
27946413|NCT01212770|54603931|FG008|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
28080058|NCT03572062|54733496|FG008|Overall Study|Adverse Event|1|||
28080059|NCT03572062|54733497|FG009|Overall Study|Adverse Event|3|||
27831887|NCT02721966|54310684|FG004|Overall Study|Lack of Efficacy|0|||
27946414|NCT01212770|54603923|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
27946415|NCT01212770|54603924|FG001|Long-term Safety Phase (Year 2)|Adverse Event|3|||
27946416|NCT01212770|54603925|FG002|Long-term Safety Phase (Year 2)|Adverse Event|3|||
27946417|NCT01212770|54603926|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
27946418|NCT01212770|54603927|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
27946419|NCT01212770|54603928|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
27946420|NCT01212770|54603929|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
27946421|NCT01212770|54603930|FG007|Long-term Safety Phase (Year 2)|Adverse Event|0|||
27946422|NCT01212770|54603931|FG008|Long-term Safety Phase (Year 2)|Adverse Event|2|||
27946423|NCT01212770|54603923|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
27946424|NCT01212770|54603924|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
27946425|NCT01212770|54603925|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
27946426|NCT01212770|54603926|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
27946427|NCT01212770|54603927|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
27946428|NCT01212770|54603928|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
27946429|NCT01212770|54603929|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
27946430|NCT01212770|54603930|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
27946431|NCT01212770|54603931|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
27946432|NCT01212770|54603923|FG000|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
27946433|NCT01212770|54603924|FG001|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1|||
27946434|NCT01212770|54603925|FG002|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
27946435|NCT01212770|54603926|FG003|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
27946436|NCT01212770|54603927|FG004|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
27946437|NCT01212770|54603928|FG005|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
27946438|NCT01212770|54603929|FG006|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
28080060|NCT03572062|54733488|FG000|Overall Study|Death|0|||
28080061|NCT03572062|54733489|FG001|Overall Study|Death|0|||
27946439|NCT01212770|54603930|FG007|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
27946440|NCT01212770|54603931|FG008|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
28080062|NCT03572062|54733490|FG002|Overall Study|Death|0|||
28080063|NCT03572062|54733491|FG003|Overall Study|Death|0|||
28080064|NCT03572062|54733492|FG004|Overall Study|Death|0|||
28080065|NCT03572062|54733493|FG005|Overall Study|Death|1|||
28080066|NCT03572062|54733494|FG006|Overall Study|Death|0|||
28080067|NCT03572062|54733495|FG007|Overall Study|Death|0|||
28080068|NCT03572062|54733496|FG008|Overall Study|Death|0|||
28080069|NCT03572062|54733497|FG009|Overall Study|Death|0|||
28080070|NCT03572062|54733488|FG000|Overall Study|Lost to Follow-up|0|||
28080071|NCT03572062|54733489|FG001|Overall Study|Lost to Follow-up|0|||
28080072|NCT03572062|54733490|FG002|Overall Study|Lost to Follow-up|0|||
28164596|NCT02993731|54835220|FG000|Overall Study|Study Termination|101|||
28164597|NCT02993731|54835221|FG001|Overall Study|Study Termination|105|||
28164598|NCT02915159|54835239|FG000|Overall Study|Participant no longer meets criteria|2|||
28164599|NCT02915159|54835240|FG001|Overall Study|Participant no longer meets criteria|0|||
28164600|NCT02915159|54835239|FG000|Overall Study|poor/non-compliance|1|||
28164601|NCT02915159|54835240|FG001|Overall Study|poor/non-compliance|0|||
28164602|NCT02915159|54835239|FG000|Overall Study|Participant withdrew consent|5|||
27731450|NCT02707965|54178676|FG013|Overall Study|Withdrawal by Subject|0|||
27731451|NCT02707965|54178677|FG014|Overall Study|Withdrawal by Subject|0|||
27853866|NCT01405196|54365149|FG003|Overall Study|Study Terminated by Sponsor|0|||
27853867|NCT01405196|54365146|FG000|Overall Study|Other|2|||
27853868|NCT01405196|54365147|FG001|Overall Study|Other|2|||
27853869|NCT01405196|54365148|FG002|Overall Study|Other|5|||
27853870|NCT01405196|54365149|FG003|Overall Study|Other|0|||
27853871|NCT01405196|54365146|FG000|Overall Study|Withdrawal by Subject|4|||
27853872|NCT01405196|54365147|FG001|Overall Study|Withdrawal by Subject|6|||
27853873|NCT01405196|54365148|FG002|Overall Study|Withdrawal by Subject|3|||
27853874|NCT01405196|54365149|FG003|Overall Study|Withdrawal by Subject|6|||
27853875|NCT01405196|54365146|FG000|Overall Study|Adverse Event|2|||
27853876|NCT01405196|54365147|FG001|Overall Study|Adverse Event|2|||
27853877|NCT01405196|54365148|FG002|Overall Study|Adverse Event|0|||
27946441|NCT01212770|54603923|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
27946442|NCT01212770|54603924|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9|||
27946443|NCT01212770|54603925|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
27946444|NCT01212770|54603926|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
27946445|NCT01212770|54603927|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
28080073|NCT03572062|54733491|FG003|Overall Study|Lost to Follow-up|0|||
28080074|NCT03572062|54733492|FG004|Overall Study|Lost to Follow-up|0|||
28080075|NCT03572062|54733493|FG005|Overall Study|Lost to Follow-up|1|||
28080076|NCT03572062|54733494|FG006|Overall Study|Lost to Follow-up|1|||
28080077|NCT03572062|54733495|FG007|Overall Study|Lost to Follow-up|0|||
28080078|NCT03572062|54733496|FG008|Overall Study|Lost to Follow-up|0|||
28164603|NCT02915159|54835240|FG001|Overall Study|Participant withdrew consent|1|||
27853878|NCT01405196|54365149|FG003|Overall Study|Adverse Event|2|||
28080079|NCT03572062|54733497|FG009|Overall Study|Lost to Follow-up|0|||
28080080|NCT03572062|54733488|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
28080081|NCT03572062|54733489|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
28080082|NCT03572062|54733490|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
28080083|NCT03572062|54733491|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
28080084|NCT03572062|54733492|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
28080085|NCT03572062|54733493|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
27853879|NCT01405196|54365146|FG000|Overall Study|Death|1|||
27853880|NCT01405196|54365147|FG001|Overall Study|Death|0|||
27946446|NCT01212770|54603928|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
27946447|NCT01212770|54603929|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
27946448|NCT01212770|54603930|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
27946449|NCT01212770|54603931|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
27946450|NCT01212770|54603923|FG000|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
27946451|NCT01212770|54603924|FG001|Long-term Safety Phase (Year 2)|Lost to Follow-up|2|||
27946452|NCT01212770|54603925|FG002|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
27946453|NCT01212770|54603926|FG003|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
27946454|NCT01212770|54603927|FG004|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
27946455|NCT01212770|54603928|FG005|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
27946456|NCT01212770|54603929|FG006|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
27946457|NCT01212770|54603930|FG007|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
27946458|NCT01212770|54603931|FG008|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
27946459|NCT01212770|54603923|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
27946460|NCT01212770|54603924|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|2|||
27946461|NCT01212770|54603925|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
27946462|NCT01212770|54603926|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
27946463|NCT01212770|54603927|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
27946464|NCT01212770|54603928|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
27946465|NCT01212770|54603929|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
27946466|NCT01212770|54603930|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
27946467|NCT01212770|54603931|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
27946468|NCT01212770|54603923|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
27853881|NCT01405196|54365148|FG002|Overall Study|Death|3|||
27853882|NCT01405196|54365149|FG003|Overall Study|Death|0|||
27853883|NCT01405196|54365146|FG000|Overall Study|Lost to Follow-up|2|||
27853884|NCT01405196|54365147|FG001|Overall Study|Lost to Follow-up|2|||
27853885|NCT01405196|54365148|FG002|Overall Study|Lost to Follow-up|3|||
27853886|NCT01405196|54365149|FG003|Overall Study|Lost to Follow-up|1|||
27853887|NCT01402700|54365199|FG000|Overall Study|Death|3|||
27853888|NCT01402700|54365199|FG000|Overall Study|Withdrawal by Subject|3|||
27853889|NCT01402700|54365199|FG000|Overall Study|Missed Visit|1|||
27853890|NCT01424930|54365321|FG000|Overall Study|Adverse Event|0|||
27853891|NCT01424930|54365322|FG001|Overall Study|Adverse Event|1|||
27853892|NCT01424930|54365321|FG000|Overall Study|Death|1|||
27853893|NCT01424930|54365322|FG001|Overall Study|Death|0|||
27946469|NCT01212770|54603924|FG001|Long-term Safety Phase (Year 3)|Adverse Event|2|||
27946470|NCT01212770|54603925|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
27946471|NCT01212770|54603926|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
27946472|NCT01212770|54603927|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
27946473|NCT01212770|54603928|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
27946474|NCT01212770|54603929|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
27946475|NCT01212770|54603930|FG007|Long-term Safety Phase (Year 3)|Adverse Event|2|||
27946476|NCT01212770|54603931|FG008|Long-term Safety Phase (Year 3)|Adverse Event|1|||
27946477|NCT01212770|54603923|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
27946478|NCT01212770|54603924|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|3|||
27946479|NCT01212770|54603925|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
28080086|NCT03572062|54733494|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
27831888|NCT02721966|54310680|FG000|Overall Study|Lost to Follow-up|0|||
27831889|NCT02721966|54310681|FG001|Overall Study|Lost to Follow-up|0|||
27831890|NCT02721966|54310682|FG002|Overall Study|Lost to Follow-up|3|||
27831891|NCT02721966|54310683|FG003|Overall Study|Lost to Follow-up|0|||
27831892|NCT02721966|54310684|FG004|Overall Study|Lost to Follow-up|0|||
27831893|NCT02721966|54310680|FG000|Overall Study|Physician Decision|1|||
27831894|NCT02721966|54310681|FG001|Overall Study|Physician Decision|1|||
27831895|NCT02721966|54310682|FG002|Overall Study|Physician Decision|0|||
27831896|NCT02721966|54310683|FG003|Overall Study|Physician Decision|0|||
27831897|NCT02721966|54310684|FG004|Overall Study|Physician Decision|0|||
27831898|NCT02721966|54310680|FG000|Overall Study|Pregnancy|1|||
27831899|NCT02721966|54310681|FG001|Overall Study|Pregnancy|0|||
27831900|NCT02721966|54310682|FG002|Overall Study|Pregnancy|0|||
27853894|NCT01424930|54365321|FG000|Overall Study|Progressive Disease|3|||
27853895|NCT01424930|54365322|FG001|Overall Study|Progressive Disease|6|||
27831901|NCT02721966|54310683|FG003|Overall Study|Pregnancy|0|||
27853896|NCT01424930|54365321|FG000|Overall Study|Screen Failure|0|||
27946480|NCT01212770|54603926|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
27853897|NCT01424930|54365322|FG001|Overall Study|Screen Failure|1|||
27853898|NCT01424930|54365321|FG000|Overall Study|Reason not specified|0|||
28080087|NCT03572062|54733495|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
28080088|NCT03572062|54733496|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
28080089|NCT03572062|54733497|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
28080090|NCT03572062|54733488|FG000|Overall Study|Study Terminated By Sponsor|0|||
28080091|NCT03572062|54733489|FG001|Overall Study|Study Terminated By Sponsor|0|||
28080092|NCT03572062|54733490|FG002|Overall Study|Study Terminated By Sponsor|0|||
28080093|NCT03572062|54733491|FG003|Overall Study|Study Terminated By Sponsor|0|||
28080094|NCT03572062|54733492|FG004|Overall Study|Study Terminated By Sponsor|0|||
28080095|NCT03572062|54733493|FG005|Overall Study|Study Terminated By Sponsor|0|||
28080096|NCT03572062|54733494|FG006|Overall Study|Study Terminated By Sponsor|0|||
28080097|NCT03572062|54733495|FG007|Overall Study|Study Terminated By Sponsor|0|||
28080098|NCT03572062|54733496|FG008|Overall Study|Study Terminated By Sponsor|29|||
28080099|NCT03572062|54733497|FG009|Overall Study|Study Terminated By Sponsor|27|||
28080100|NCT03572062|54733488|FG000|Overall Study|Physician Decision|0|||
28080101|NCT03572062|54733489|FG001|Overall Study|Physician Decision|0|||
28080102|NCT03572062|54733490|FG002|Overall Study|Physician Decision|0|||
28080103|NCT03572062|54733491|FG003|Overall Study|Physician Decision|0|||
28080104|NCT03572062|54733492|FG004|Overall Study|Physician Decision|0|||
28080105|NCT03572062|54733493|FG005|Overall Study|Physician Decision|0|||
28080106|NCT03572062|54733494|FG006|Overall Study|Physician Decision|0|||
28080107|NCT03572062|54733495|FG007|Overall Study|Physician Decision|0|||
28080108|NCT03572062|54733496|FG008|Overall Study|Physician Decision|1|||
28080109|NCT03572062|54733497|FG009|Overall Study|Physician Decision|0|||
28080110|NCT03572062|54733488|FG000|Overall Study|Withdrawal by Subject|0|||
28080111|NCT03572062|54733489|FG001|Overall Study|Withdrawal by Subject|0|||
28080112|NCT03572062|54733490|FG002|Overall Study|Withdrawal by Subject|0|||
28080113|NCT03572062|54733491|FG003|Overall Study|Withdrawal by Subject|0|||
28080114|NCT03572062|54733492|FG004|Overall Study|Withdrawal by Subject|0|||
28080115|NCT03572062|54733493|FG005|Overall Study|Withdrawal by Subject|0|||
28080116|NCT03572062|54733494|FG006|Overall Study|Withdrawal by Subject|0|||
28080117|NCT03572062|54733495|FG007|Overall Study|Withdrawal by Subject|0|||
28080118|NCT03572062|54733496|FG008|Overall Study|Withdrawal by Subject|0|||
28080119|NCT03572062|54733497|FG009|Overall Study|Withdrawal by Subject|1|||
28080120|NCT03572062|54733488|FG000|Overall Study|Randomized But Not Treated|0|||
28080121|NCT03572062|54733489|FG001|Overall Study|Randomized But Not Treated|0|||
28080122|NCT03572062|54733490|FG002|Overall Study|Randomized But Not Treated|0|||
28080123|NCT03572062|54733491|FG003|Overall Study|Randomized But Not Treated|0|||
28080124|NCT03572062|54733492|FG004|Overall Study|Randomized But Not Treated|1|||
28080125|NCT03572062|54733493|FG005|Overall Study|Randomized But Not Treated|2|||
28080126|NCT03572062|54733494|FG006|Overall Study|Randomized But Not Treated|0|||
28080127|NCT03572062|54733495|FG007|Overall Study|Randomized But Not Treated|1|||
28080128|NCT03572062|54733496|FG008|Overall Study|Randomized But Not Treated|0|||
28080129|NCT03572062|54733497|FG009|Overall Study|Randomized But Not Treated|0|||
28080130|NCT03571516|54733519|FG000|Overall Study|Severe diarrhea|1|||
28080131|NCT03571516|54733520|FG001|Overall Study|Severe diarrhea|0|||
28164604|NCT02915159|54835239|FG000|Overall Study|Request to discontinue treatment|1|||
27831902|NCT02721966|54310684|FG004|Overall Study|Pregnancy|0|||
27831903|NCT02721966|54310680|FG000|Overall Study|Did not continue to period 2|5|||
27831904|NCT02721966|54310681|FG001|Overall Study|Did not continue to period 2|12|||
27831905|NCT02721966|54310682|FG002|Overall Study|Did not continue to period 2|0|||
27831906|NCT02721966|54310683|FG003|Overall Study|Did not continue to period 2|0|||
27831907|NCT02721966|54310684|FG004|Overall Study|Did not continue to period 2|5|||
27831908|NCT00553462|54310692|FG000|Overall Study|Adverse Event|4|||
27831909|NCT00553462|54310692|FG000|Overall Study|Progression|4|||
27831910|NCT00553462|54310692|FG000|Overall Study|Withdrawal by Subject|5|||
27831911|NCT00553462|54310692|FG000|Overall Study|Physician Decision|1|||
27831912|NCT00553150|54310698|FG000|Overall Study|Withdrawal by Subject|0|||
27853899|NCT01424930|54365322|FG001|Overall Study|Reason not specified|6|||
27853900|NCT01424306|54365337|FG000|Overall Study|Protocol Violation|0|||
27853901|NCT01424306|54365338|FG001|Overall Study|Protocol Violation|0|||
27853902|NCT01424306|54365339|FG002|Overall Study|Protocol Violation|0|||
27853903|NCT01424306|54365340|FG003|Overall Study|Protocol Violation|0|||
27853904|NCT01424306|54365341|FG004|Overall Study|Protocol Violation|1|||
27853905|NCT01424306|54365342|FG005|Overall Study|Protocol Violation|0|||
27853906|NCT01424228|54365386|FG000|Overall Study|Withdrawal by Subject|27|||
27853907|NCT01424228|54365387|FG001|Overall Study|Withdrawal by Subject|11|||
27853908|NCT01424228|54365386|FG000|Overall Study|Adverse Event|10|||
27853909|NCT01424228|54365387|FG001|Overall Study|Adverse Event|14|||
27853910|NCT01424228|54365386|FG000|Overall Study|Sponsor's decision|9|||
27853911|NCT01424228|54365387|FG001|Overall Study|Sponsor's decision|12|||
27946481|NCT01212770|54603927|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
28080132|NCT03571516|54733519|FG000|Overall Study|Withdrawal by Subject|0|||
28080133|NCT03571516|54733520|FG001|Overall Study|Withdrawal by Subject|1|||
28164605|NCT02915159|54835240|FG001|Overall Study|Request to discontinue treatment|2|||
28164606|NCT02915159|54835239|FG000|Overall Study|Adverse Event|2|||
28080134|NCT03600376|54733528|FG000|Overall Study|Adverse Event|1|||
28080135|NCT03600376|54733529|FG001|Overall Study|Adverse Event|1|||
28080136|NCT03600376|54733528|FG000|Overall Study|Transferred to other facility|1|||
28080137|NCT03600376|54733529|FG001|Overall Study|Transferred to other facility|0|||
28080138|NCT03600376|54733528|FG000|Overall Study|Investigator Decision|0|||
28080139|NCT03600376|54733529|FG001|Overall Study|Investigator Decision|4|||
28080140|NCT03600376|54733528|FG000|Overall Study|Determined to be ineligible for study|0|||
28080141|NCT03600376|54733529|FG001|Overall Study|Determined to be ineligible for study|1|||
28080142|NCT03599362|54733535|FG000|Overall Study|Screen Failure|3|||
28080143|NCT03598036|54733541|FG000|Overall Study|Withdrawal by Subject|1|||
28080144|NCT03598036|54733542|FG001|Overall Study|Withdrawal by Subject|0|||
28080145|NCT00082407|54733552|FG000|Overall Study|Adverse Event|20|||
28080146|NCT00082407|54733553|FG001|Overall Study|Adverse Event|0|||
28080147|NCT00082407|54733552|FG000|Overall Study|Protocol Violation|14|||
28080148|NCT00082407|54733553|FG001|Overall Study|Protocol Violation|12|||
28080149|NCT00082407|54733552|FG000|Overall Study|Patient Decision|13|||
28080150|NCT00082407|54733553|FG001|Overall Study|Patient Decision|6|||
27946482|NCT01212770|54603928|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
27946483|NCT01212770|54603929|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
28080151|NCT00082407|54733552|FG000|Overall Study|Physician Decision|5|||
28080152|NCT00082407|54733553|FG001|Overall Study|Physician Decision|3|||
28080153|NCT00082407|54733552|FG000|Overall Study|Loss of Glucose Control|2|||
28080154|NCT00082407|54733553|FG001|Overall Study|Loss of Glucose Control|2|||
28080155|NCT00082407|54733552|FG000|Overall Study|Death|2|||
28080156|NCT00082407|54733553|FG001|Overall Study|Death|1|||
28080157|NCT00082407|54733552|FG000|Overall Study|Lost to Follow-up|0|||
28080158|NCT00082407|54733553|FG001|Overall Study|Lost to Follow-up|3|||
28080159|NCT03643432|54733561|FG000|Overall Study|Lost to Follow-up|1|||
28080160|NCT03643432|54733562|FG001|Overall Study|Lost to Follow-up|0|||
28080161|NCT03810183|54733570|FG000|Overall Study|Study terminated by Sponsor|2|||
28080162|NCT03810183|54733571|FG001|Overall Study|Study terminated by Sponsor|1|||
28080163|NCT03597022|54733581|FG000|Overall Study|Premature termination of the study|7|||
28080164|NCT03597022|54733582|FG001|Overall Study|Premature termination of the study|7|||
28080165|NCT03597022|54733583|FG002|Overall Study|Premature termination of the study|8|||
28080166|NCT03597022|54733581|FG000|Overall Study|Serious adverse event|1|||
28080167|NCT03597022|54733582|FG001|Overall Study|Serious adverse event|1|||
28080168|NCT03597022|54733583|FG002|Overall Study|Serious adverse event|0|||
28080169|NCT03571204|54733594|FG000|Overall Study|Stopped due to COVID-19 pandemic|1|||
27946484|NCT01212770|54603930|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
27946485|NCT01212770|54603931|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
27946486|NCT01212770|54603923|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
27946487|NCT01212770|54603924|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3|||
27946488|NCT01212770|54603925|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
27946489|NCT01212770|54603926|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
27946490|NCT01212770|54603927|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
27946491|NCT01212770|54603928|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
28080170|NCT03571204|54733595|FG001|Overall Study|Stopped due to COVID-19 pandemic|1|||
28080171|NCT03571204|54733596|FG002|Overall Study|Stopped due to COVID-19 pandemic|0|||
28080172|NCT03571204|54733594|FG000|Overall Study|Physician Decision|0|||
28164607|NCT02915159|54835240|FG001|Overall Study|Adverse Event|2|||
27831913|NCT00553150|54310699|FG001|Overall Study|Withdrawal by Subject|0|||
27831914|NCT00553150|54310700|FG002|Overall Study|Withdrawal by Subject|0|||
27831915|NCT00553150|54310701|FG003|Overall Study|Withdrawal by Subject|2|||
27831916|NCT00553150|54310698|FG000|Overall Study|Protocol Violation|0|||
27831917|NCT00553150|54310699|FG001|Overall Study|Protocol Violation|0|||
27831918|NCT00553150|54310700|FG002|Overall Study|Protocol Violation|0|||
27831919|NCT00553150|54310701|FG003|Overall Study|Protocol Violation|1|||
27831920|NCT00553150|54310698|FG000|Overall Study|Ineligible|0|||
27831921|NCT00553150|54310699|FG001|Overall Study|Ineligible|0|||
27831922|NCT00553150|54310700|FG002|Overall Study|Ineligible|0|||
27831923|NCT00553150|54310701|FG003|Overall Study|Ineligible|1|||
27831924|NCT03301350|54310709|FG000|Overall Study|Withdrawal by Subject|4|||
27831925|NCT03301350|54310709|FG000|Overall Study|Adverse Event|1|||
27831926|NCT03301350|54310709|FG000|Overall Study|Pt withdrawn per DSMC request|1|||
27831927|NCT03301350|54310709|FG000|Overall Study|completed all chemo cycles, however died prior to definitive surgery|1|||
27831928|NCT03301350|54310709|FG000|Overall Study|no detail provided|1|||
27831929|NCT04735432|54310716|FG000|Overall Study|Other - due to personal reason|1|||
28080173|NCT03571204|54733595|FG001|Overall Study|Physician Decision|1|||
28080174|NCT03571204|54733596|FG002|Overall Study|Physician Decision|0|||
28080175|NCT03569098|54733608|FG000|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
28080176|NCT03569098|54733609|FG001|Double-Blind Treatment Cycle 1|Withdrawal by Subject|2|||
28164608|NCT02915159|54835239|FG000|Overall Study|Lack of Efficacy|0|||
27831930|NCT04735432|54310717|FG001|Overall Study|Other - due to personal reason|0|||
28080177|NCT03569098|54733610|FG002|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
28080178|NCT03569098|54733608|FG000|Double-Blind Treatment Cycle 1|Study terminated by sponsor|0|||
28080179|NCT03569098|54733609|FG001|Double-Blind Treatment Cycle 1|Study terminated by sponsor|6|||
28080180|NCT03569098|54733610|FG002|Double-Blind Treatment Cycle 1|Study terminated by sponsor|3|||
28080181|NCT03569098|54733608|FG000|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
28080182|NCT03569098|54733609|FG001|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
28080183|NCT03569098|54733610|FG002|Double-Blind Treatment Cycle 1|Lost to Follow-up|0|||
27831931|NCT04735432|54310716|FG000|Overall Study|Adverse Event|2|||
27831932|NCT04735432|54310717|FG001|Overall Study|Adverse Event|0|||
27831933|NCT02722278|54310726|FG000|Overall Study|Withdrawal by Subject|5|||
27831934|NCT02722278|54310727|FG001|Overall Study|Withdrawal by Subject|3|||
27831935|NCT02722278|54310726|FG000|Overall Study|Adverse Event|4|||
27831936|NCT02722278|54310727|FG001|Overall Study|Adverse Event|1|||
27831937|NCT02722278|54310726|FG000|Overall Study|Lost to Follow-up|2|||
27946492|NCT01212770|54603929|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
27831938|NCT02722278|54310727|FG001|Overall Study|Lost to Follow-up|0|||
27831939|NCT02722278|54310726|FG000|Overall Study|Protocol Violation|1|||
27831940|NCT02722278|54310727|FG001|Overall Study|Protocol Violation|0|||
27831941|NCT02722278|54310726|FG000|Overall Study|High PSA pre-study/ not eligible|0|||
27831942|NCT02722278|54310727|FG001|Overall Study|High PSA pre-study/ not eligible|1|||
27831943|NCT02722278|54310726|FG000|Overall Study|Subject declined after tx assignment|0|||
27831944|NCT02722278|54310727|FG001|Overall Study|Subject declined after tx assignment|1|||
27831945|NCT02722278|54310726|FG000|Overall Study|Site closure not study related|0|||
27831946|NCT02722278|54310727|FG001|Overall Study|Site closure not study related|1|||
27831947|NCT00703092|54310735|FG000|Overall Study|Withdrawal by Subject|2|||
27831948|NCT02720484|54310739|FG000|Treatment on Study|Adverse Event|1|||
27831949|NCT02720484|54310739|FG000|Treatment on Study|Withdrawal by Subject|1|||
27831950|NCT02720484|54310739|FG000|Treatment on Study|Progressive Disease|4|||
27831951|NCT02720484|54310739|FG000|Follow Up for 2 Years|Withdrawal by Subject|1|||
27831952|NCT02720484|54310739|FG000|Follow Up for 2 Years|Death|3|||
27831953|NCT02720484|54310739|FG000|Follow Up for 2 Years|Lost to Follow-up|2|||
27831954|NCT02715804|54310745|FG000|Overall Study|Death|222|||
27831955|NCT02715804|54310746|FG001|Overall Study|Death|106|||
27831956|NCT02715804|54310745|FG000|Overall Study|Withdrawal by Subject|5|||
27831957|NCT02715804|54310746|FG001|Overall Study|Withdrawal by Subject|4|||
27831958|NCT02715804|54310745|FG000|Overall Study|Other than specified|2|||
27831959|NCT02715804|54310746|FG001|Overall Study|Other than specified|3|||
27831960|NCT02717832|54310752|FG000|Overall Study|Inability to place IV|3|||
27831961|NCT02717754|54310763|FG000|Overall Study|Incorrect Infusion Duration|0|||
27831962|NCT02717754|54310764|FG001|Overall Study|Incorrect Infusion Duration|0|||
27831963|NCT02717754|54310765|FG002|Overall Study|Incorrect Infusion Duration|0|||
27831964|NCT02717754|54310766|FG003|Overall Study|Incorrect Infusion Duration|10|||
27831965|NCT02717754|54310767|FG004|Overall Study|Incorrect Infusion Duration|20|||
27831966|NCT02717754|54310768|FG005|Overall Study|Incorrect Infusion Duration|20|||
27831967|NCT02717130|54310778|FG000|Overall Study|Withdrawal by Subject|1|||
27831968|NCT02717130|54310778|FG000|Overall Study|Adverse Event|1|||
27831969|NCT02717130|54310778|FG000|Overall Study|Physician Decision|1|||
27831970|NCT02717130|54310778|FG000|Overall Study|Study Closure|4|||
27831971|NCT02192502|54310798|FG000|Overall Study|Did not receive intervention due to euvolemia|4|||
27831972|NCT02192502|54310799|FG001|Overall Study|Did not receive intervention due to euvolemia|1|||
27831973|NCT02192502|54310798|FG000|Overall Study|did not receive intervention due to circulatory arrest|2|||
27831974|NCT02192502|54310799|FG001|Overall Study|did not receive intervention due to circulatory arrest|0|||
27831975|NCT02192502|54310798|FG000|Overall Study|did not receive intervention due to logistic reasons|1|||
27831976|NCT02192502|54310799|FG001|Overall Study|did not receive intervention due to logistic reasons|0|||
27831977|NCT01781429|54310820|FG000|Overall Study|Death|0|||
27831978|NCT01781429|54310821|FG001|Overall Study|Death|0|||
27831979|NCT01781429|54310822|FG002|Overall Study|Death|0|||
27831980|NCT01781429|54310823|FG003|Overall Study|Death|0|||
27831981|NCT01781429|54310824|FG004|Overall Study|Death|0|||
27831982|NCT01781429|54310825|FG005|Overall Study|Death|0|||
27831983|NCT01781429|54310826|FG006|Overall Study|Death|0|||
27831984|NCT01781429|54310827|FG007|Overall Study|Death|0|||
27831985|NCT01781429|54310828|FG008|Overall Study|Death|0|||
27831986|NCT01781429|54310829|FG009|Overall Study|Death|1|||
27831987|NCT01781429|54310830|FG010|Overall Study|Death|0|||
27831988|NCT01781429|54310831|FG011|Overall Study|Death|0|||
27831989|NCT01781429|54310832|FG012|Overall Study|Death|1|||
27831990|NCT01781429|54310833|FG013|Overall Study|Death|0|||
27831991|NCT01781429|54310834|FG014|Overall Study|Death|1|||
27831992|NCT01781429|54310835|FG015|Overall Study|Death|0|||
27831993|NCT01781429|54310820|FG000|Overall Study|Withdrawal by Subject|0|||
27831994|NCT01781429|54310821|FG001|Overall Study|Withdrawal by Subject|0|||
27831995|NCT01781429|54310822|FG002|Overall Study|Withdrawal by Subject|0|||
27831996|NCT01781429|54310823|FG003|Overall Study|Withdrawal by Subject|0|||
27831997|NCT01781429|54310824|FG004|Overall Study|Withdrawal by Subject|0|||
27946493|NCT01212770|54603930|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
27853912|NCT01424228|54365386|FG000|Overall Study|Lack of Efficacy|5|||
27853913|NCT01424228|54365387|FG001|Overall Study|Lack of Efficacy|7|||
27853914|NCT01424228|54365386|FG000|Overall Study|inclusion/exclusion criteria not met|2|||
27853915|NCT01424228|54365387|FG001|Overall Study|inclusion/exclusion criteria not met|2|||
27946494|NCT01212770|54603931|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
27946495|NCT01212770|54603923|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
27946496|NCT01212770|54603924|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
27946497|NCT01212770|54603925|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
27946498|NCT01212770|54603926|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
27946499|NCT01212770|54603927|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
27946500|NCT01212770|54603928|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
28164609|NCT02915159|54835240|FG001|Overall Study|Lack of Efficacy|3|||
28164610|NCT02924051|54835252|FG000|Overall Study|Withdrawal by Subject|1|||
28164611|NCT02924051|54835253|FG001|Overall Study|Withdrawal by Subject|9|||
28164612|NCT02923427|54835267|FG000|Overall Study|convert to laparatomy|2|||
28164613|NCT02923427|54835268|FG001|Overall Study|convert to laparatomy|2|||
28164614|NCT02923427|54835267|FG000|Overall Study|destaturation|1|||
28164615|NCT02923427|54835268|FG001|Overall Study|destaturation|0|||
28164616|NCT02923427|54835267|FG000|Overall Study|can not replace LMA|1|||
28164617|NCT02923427|54835268|FG001|Overall Study|can not replace LMA|0|||
28164618|NCT02669264|54835281|FG000|Overall Study|Death|5|||
28164619|NCT02669264|54835282|FG001|Overall Study|Death|5|||
28164620|NCT02669264|54835283|FG002|Overall Study|Death|3|||
28164621|NCT02669264|54835284|FG003|Overall Study|Death|3|||
28164622|NCT02669264|54835285|FG004|Overall Study|Death|3|||
28164623|NCT02669264|54835286|FG005|Overall Study|Death|6|||
28164624|NCT02669264|54835287|FG006|Overall Study|Death|3|||
28164625|NCT02669264|54835281|FG000|Overall Study|Withdrawal by Subject|0|||
28164626|NCT02669264|54835282|FG001|Overall Study|Withdrawal by Subject|1|||
28164627|NCT02669264|54835283|FG002|Overall Study|Withdrawal by Subject|0|||
28164628|NCT02669264|54835284|FG003|Overall Study|Withdrawal by Subject|0|||
28164629|NCT02669264|54835285|FG004|Overall Study|Withdrawal by Subject|1|||
27731452|NCT02707965|54178678|FG015|Overall Study|Withdrawal by Subject|0|||
27731453|NCT02707965|54178663|FG000|Overall Study|PI decisions|0|||
27731454|NCT02707965|54178664|FG001|Overall Study|PI decisions|0|||
27731455|NCT02707965|54178665|FG002|Overall Study|PI decisions|0|||
27731456|NCT02707965|54178666|FG003|Overall Study|PI decisions|0|||
27731457|NCT02707965|54178667|FG004|Overall Study|PI decisions|0|||
27731458|NCT02707965|54178668|FG005|Overall Study|PI decisions|0|||
27731459|NCT02707965|54178669|FG006|Overall Study|PI decisions|0|||
27731460|NCT02707965|54178670|FG007|Overall Study|PI decisions|0|||
27853916|NCT01424228|54365386|FG000|Overall Study|Non-compliance|2|||
27853917|NCT01424228|54365387|FG001|Overall Study|Non-compliance|0|||
27853918|NCT01424228|54365386|FG000|Overall Study|Worsening of symptoms|1|||
27853919|NCT01424228|54365387|FG001|Overall Study|Worsening of symptoms|0|||
27946501|NCT01212770|54603929|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
27946502|NCT01212770|54603930|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
27946503|NCT01212770|54603931|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
27946504|NCT01212770|54603923|FG000|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
27946505|NCT01212770|54603924|FG001|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
27946506|NCT01212770|54603925|FG002|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
27946507|NCT01212770|54603926|FG003|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
27946508|NCT01212770|54603927|FG004|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
27946509|NCT01212770|54603928|FG005|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
27946510|NCT01212770|54603929|FG006|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
27853920|NCT01424228|54365386|FG000|Overall Study|Unplanned journey|0|||
27853921|NCT01424228|54365387|FG001|Overall Study|Unplanned journey|1|||
27853922|NCT01423916|54365396|FG000|Overall Study|Adverse Event|5|||
27853923|NCT01423916|54365397|FG001|Overall Study|Adverse Event|9|||
27853924|NCT01423916|54365398|FG002|Overall Study|Adverse Event|2|||
27946511|NCT01212770|54603930|FG007|Long-term Safety Phase (Year 3)|Protocol Violation|1|||
27946512|NCT01212770|54603931|FG008|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
28164630|NCT02669264|54835286|FG005|Overall Study|Withdrawal by Subject|0|||
28164631|NCT02669264|54835287|FG006|Overall Study|Withdrawal by Subject|0|||
28164632|NCT02669264|54835281|FG000|Overall Study|Lost to Follow-up|0|||
28164633|NCT02669264|54835282|FG001|Overall Study|Lost to Follow-up|0|||
28164634|NCT02669264|54835283|FG002|Overall Study|Lost to Follow-up|0|||
28164635|NCT02669264|54835284|FG003|Overall Study|Lost to Follow-up|0|||
28164636|NCT02669264|54835285|FG004|Overall Study|Lost to Follow-up|1|||
27853925|NCT01423916|54365396|FG000|Overall Study|Met Withdrawal Criteria|1|||
27853926|NCT01423916|54365397|FG001|Overall Study|Met Withdrawal Criteria|1|||
27853927|NCT01423916|54365398|FG002|Overall Study|Met Withdrawal Criteria|1|||
27853928|NCT01423916|54365396|FG000|Overall Study|Physician Decision|1|||
28164637|NCT02669264|54835286|FG005|Overall Study|Lost to Follow-up|0|||
28164638|NCT02669264|54835287|FG006|Overall Study|Lost to Follow-up|0|||
27946513|NCT01212770|54603923|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
27946514|NCT01212770|54603924|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|2|||
27946515|NCT01212770|54603925|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
27946516|NCT01212770|54603926|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
27946517|NCT01212770|54603927|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
27946518|NCT01212770|54603928|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
27946519|NCT01212770|54603929|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
27946520|NCT01212770|54603930|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
27946521|NCT01212770|54603931|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
27946522|NCT01212770|54603923|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
27946523|NCT01212770|54603924|FG001|Long-term Safety Phase (Year 4)|Adverse Event|1|||
27946524|NCT01212770|54603925|FG002|Long-term Safety Phase (Year 4)|Adverse Event|1|||
27946525|NCT01212770|54603926|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
27946526|NCT01212770|54603927|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
27946527|NCT01212770|54603928|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
27946528|NCT01212770|54603929|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
27946529|NCT01212770|54603930|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
27946530|NCT01212770|54603931|FG008|Long-term Safety Phase (Year 4)|Adverse Event|1|||
27946531|NCT01212770|54603923|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
27946532|NCT01212770|54603924|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
27946533|NCT01212770|54603925|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|5|||
27946534|NCT01212770|54603926|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
27946535|NCT01212770|54603927|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
27946536|NCT01212770|54603928|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
27946537|NCT01212770|54603929|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
27946538|NCT01212770|54603930|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|2|||
27946539|NCT01212770|54603931|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
27946540|NCT01212770|54603923|FG000|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
27946541|NCT01212770|54603924|FG001|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
27946542|NCT01212770|54603925|FG002|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
27946543|NCT01212770|54603926|FG003|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
27946544|NCT01212770|54603927|FG004|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
27946545|NCT01212770|54603928|FG005|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
27946546|NCT01212770|54603929|FG006|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
27946547|NCT01212770|54603930|FG007|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
27946548|NCT01212770|54603931|FG008|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
27946549|NCT01212770|54603923|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
27946550|NCT01212770|54603924|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2|||
27946551|NCT01212770|54603925|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3|||
27946552|NCT01212770|54603926|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
27946553|NCT01212770|54603927|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
28164639|NCT02669264|54835281|FG000|Overall Study|Miscellaneous|0|||
27853929|NCT01423916|54365397|FG001|Overall Study|Physician Decision|0|||
27946554|NCT01212770|54603928|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
27946555|NCT01212770|54603929|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
27946556|NCT01212770|54603930|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
27946557|NCT01212770|54603931|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
27946558|NCT01212770|54603923|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
27946559|NCT01212770|54603924|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
27946560|NCT01212770|54603925|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
27946561|NCT01212770|54603926|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
27946562|NCT01212770|54603927|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
27946563|NCT01212770|54603928|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
27853930|NCT01423916|54365398|FG002|Overall Study|Physician Decision|1|||
27853931|NCT01423916|54365396|FG000|Overall Study|Withdrawal by Subject|3|||
27853932|NCT01423916|54365397|FG001|Overall Study|Withdrawal by Subject|10|||
27853933|NCT01423916|54365398|FG002|Overall Study|Withdrawal by Subject|3|||
27853934|NCT01423916|54365396|FG000|Overall Study|Protocol Deviation|1|||
27853935|NCT01423916|54365397|FG001|Overall Study|Protocol Deviation|0|||
27853936|NCT01423916|54365398|FG002|Overall Study|Protocol Deviation|0|||
27853937|NCT01423604|54365517|FG000|Safety Run-In|Adverse Event|3|||
27853938|NCT01423604|54365518|FG001|Safety Run-In|Adverse Event|0|||
27853939|NCT01423604|54365517|FG000|Safety Run-In|Death|1|||
27853940|NCT01423604|54365518|FG001|Safety Run-In|Death|0|||
27853941|NCT01423604|54365517|FG000|Safety Run-In|Physician Decision|1|||
27853942|NCT01423604|54365518|FG001|Safety Run-In|Physician Decision|0|||
27853943|NCT01423604|54365517|FG000|Safety Run-In|Disease progression|3|||
27853944|NCT01423604|54365518|FG001|Safety Run-In|Disease progression|0|||
27853945|NCT01423604|54365517|FG000|Safety Run-In|Patient decision|1|||
27853946|NCT01423604|54365518|FG001|Safety Run-In|Patient decision|0|||
27946564|NCT01212770|54603929|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
27946565|NCT01212770|54603930|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
27946566|NCT01212770|54603931|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
27946567|NCT01212770|54603923|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
27946568|NCT01212770|54603924|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
27946569|NCT01212770|54603925|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
27946570|NCT01212770|54603926|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
27946571|NCT01212770|54603927|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
27946572|NCT01212770|54603928|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
27946573|NCT01212770|54603929|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
27946574|NCT01212770|54603930|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
27946575|NCT01212770|54603931|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
27946576|NCT01212770|54603923|FG000|Long-term Safety Phase (Year 5)|Missing|0|||
27946577|NCT01212770|54603924|FG001|Long-term Safety Phase (Year 5)|Missing|0|||
27946578|NCT01212770|54603925|FG002|Long-term Safety Phase (Year 5)|Missing|1|||
27946579|NCT01212770|54603926|FG003|Long-term Safety Phase (Year 5)|Missing|0|||
27946580|NCT01212770|54603927|FG004|Long-term Safety Phase (Year 5)|Missing|0|||
27946581|NCT01212770|54603928|FG005|Long-term Safety Phase (Year 5)|Missing|0|||
27946582|NCT01212770|54603929|FG006|Long-term Safety Phase (Year 5)|Missing|0|||
27946583|NCT01212770|54603930|FG007|Long-term Safety Phase (Year 5)|Missing|0|||
27946584|NCT01212770|54603931|FG008|Long-term Safety Phase (Year 5)|Missing|0|||
27946585|NCT01212770|54603923|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
27946586|NCT01212770|54603924|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
27946587|NCT01212770|54603925|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|3|||
27946588|NCT01212770|54603926|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
27946589|NCT01212770|54603927|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
27946590|NCT01212770|54603928|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
27946591|NCT01212770|54603929|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
27946592|NCT01212770|54603930|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
27946593|NCT01212770|54603931|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
27946594|NCT01212770|54603923|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
27946595|NCT01212770|54603924|FG001|Long-term Safety Phase (Year 5)|Adverse Event|0|||
27946596|NCT01212770|54603925|FG002|Long-term Safety Phase (Year 5)|Adverse Event|2|||
27946597|NCT01212770|54603926|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
27946598|NCT01212770|54603927|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
27946599|NCT01212770|54603928|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
27946600|NCT01212770|54603929|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
27946601|NCT01212770|54603930|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
27946602|NCT01212770|54603931|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
27946603|NCT01212770|54603923|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
27946604|NCT01212770|54603924|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
27946605|NCT01212770|54603925|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|4|||
27946606|NCT01212770|54603926|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
27946607|NCT01212770|54603927|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
27946608|NCT01212770|54603928|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
27946609|NCT01212770|54603929|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
27946610|NCT01212770|54603930|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
27946611|NCT01212770|54603931|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
27946612|NCT01212770|54603923|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
27946613|NCT01212770|54603924|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
27946614|NCT01212770|54603925|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
27946615|NCT01212770|54603926|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
27946616|NCT01212770|54603927|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
27946617|NCT01212770|54603928|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
27946618|NCT01212770|54603929|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
27946619|NCT01212770|54603930|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
27946620|NCT01212770|54603931|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
27853947|NCT01423604|54365517|FG000|Randomized|Adverse Event|4|||
27853948|NCT01423604|54365518|FG001|Randomized|Adverse Event|10|||
27853949|NCT01423604|54365517|FG000|Randomized|Death|1|||
27853950|NCT01423604|54365518|FG001|Randomized|Death|0|||
27853951|NCT01423604|54365517|FG000|Randomized|Physician Decision|16|||
27853952|NCT01423604|54365518|FG001|Randomized|Physician Decision|13|||
27853953|NCT01423604|54365517|FG000|Randomized|Other - unspecified|37|||
27853954|NCT01423604|54365518|FG001|Randomized|Other - unspecified|31|||
27853955|NCT01423604|54365517|FG000|Randomized|Patient decision|5|||
27853956|NCT01423604|54365518|FG001|Randomized|Patient decision|9|||
27853957|NCT01402544|54365534|FG000|Overall Study|Withdrawal by Subject|6|||
27946621|NCT01212770|54603923|FG000|Long-term Safety Phase (Year 5)|Death|0|||
27946622|NCT01212770|54603924|FG001|Long-term Safety Phase (Year 5)|Death|0|||
27853958|NCT01401842|54365540|FG000|Overall Study|Withdrawal by Subject|3|||
27853959|NCT01401842|54365541|FG001|Overall Study|Withdrawal by Subject|2|||
27853960|NCT01401842|54365540|FG000|Overall Study|academic reason|4|||
27853961|NCT01401842|54365541|FG001|Overall Study|academic reason|1|||
27853962|NCT01401842|54365540|FG000|Overall Study|changed companies|20|||
27853963|NCT01401842|54365541|FG001|Overall Study|changed companies|34|||
27853964|NCT01401842|54365540|FG000|Overall Study|discharged from US Army|3|||
27853965|NCT01401842|54365541|FG001|Overall Study|discharged from US Army|4|||
27853966|NCT01401842|54365540|FG000|Overall Study|invalid follow-up strength data|1|||
27853967|NCT01401842|54365541|FG001|Overall Study|invalid follow-up strength data|4|||
27853968|NCT01401842|54365540|FG000|Overall Study|on profile|9|||
27853969|NCT01401842|54365541|FG001|Overall Study|on profile|5|||
27853970|NCT01401842|54365540|FG000|Overall Study|other/unknown|28|||
27853971|NCT01401842|54365541|FG001|Overall Study|other/unknown|17|||
27853972|NCT01422824|54365547|FG000|Overall Study|Case record form not evaluated|1|||
27853973|NCT01422824|54365547|FG000|Overall Study|Lost to Follow-up|37|||
27853974|NCT01401530|54365610|FG000|Overall Study|Disease Progression|1|||
27853975|NCT01401530|54365611|FG001|Overall Study|Disease Progression|2|||
27853976|NCT01401530|54365612|FG002|Overall Study|Disease Progression|1|||
27853977|NCT01401530|54365610|FG000|Overall Study|Adverse Event|1|||
27946623|NCT01212770|54603925|FG002|Long-term Safety Phase (Year 5)|Death|0|||
27946624|NCT01212770|54603926|FG003|Long-term Safety Phase (Year 5)|Death|0|||
27946625|NCT01212770|54603927|FG004|Long-term Safety Phase (Year 5)|Death|0|||
27946626|NCT01212770|54603928|FG005|Long-term Safety Phase (Year 5)|Death|0|||
27946627|NCT01212770|54603929|FG006|Long-term Safety Phase (Year 5)|Death|0|||
27946628|NCT01212770|54603930|FG007|Long-term Safety Phase (Year 5)|Death|1|||
27946629|NCT01212770|54603931|FG008|Long-term Safety Phase (Year 5)|Death|0|||
27946630|NCT00598273|54603956|FG000|Overall Study|Adverse Event|4|||
27946631|NCT00598273|54603957|FG001|Overall Study|Adverse Event|5|||
27946632|NCT00598273|54603958|FG002|Overall Study|Adverse Event|2|||
28080184|NCT03569098|54733608|FG000|Double-Blind Treatment Cycle 1|Technical problems|0|||
28080185|NCT03569098|54733609|FG001|Double-Blind Treatment Cycle 1|Technical problems|0|||
28080186|NCT03569098|54733610|FG002|Double-Blind Treatment Cycle 1|Technical problems|2|||
28080187|NCT03569098|54733608|FG000|Double-Blind Treatment Cycle 1|Physician Decision|1|||
28080188|NCT03569098|54733609|FG001|Double-Blind Treatment Cycle 1|Physician Decision|0|||
28080189|NCT03569098|54733610|FG002|Double-Blind Treatment Cycle 1|Physician Decision|0|||
28080190|NCT03569098|54733608|FG000|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
28080191|NCT03569098|54733609|FG001|Double-Blind Treatment Cycle 1|Protocol deviation|1|||
28080192|NCT03569098|54733610|FG002|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
28080193|NCT03569098|54733608|FG000|Double-Blind Treatment Cycle 1|Other|1|||
28080194|NCT03569098|54733609|FG001|Double-Blind Treatment Cycle 1|Other|0|||
28080195|NCT03569098|54733610|FG002|Double-Blind Treatment Cycle 1|Other|1|||
28080196|NCT03569098|54733608|FG000|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
28080197|NCT03569098|54733609|FG001|Open-Label Treatment Cycle 2|Study terminated by sponsor|21|||
28080198|NCT03569098|54733610|FG002|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
28080199|NCT03569098|54733608|FG000|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
28080200|NCT03569098|54733609|FG001|Open-Label Treatment Cycle 2|Withdrawal by Subject|11|||
28080201|NCT03569098|54733610|FG002|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
28080202|NCT03569098|54733608|FG000|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
28080203|NCT03569098|54733609|FG001|Open-Label Treatment Cycle 2|Lost to Follow-up|3|||
28080204|NCT03569098|54733610|FG002|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
28080205|NCT03569098|54733608|FG000|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
28080206|NCT03569098|54733609|FG001|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
28080207|NCT03569098|54733610|FG002|Open-Label Treatment Cycle 3|Withdrawal by Subject|4|||
28080208|NCT03569098|54733608|FG000|Open-Label Treatment Cycle 3|Study terminated by sponsor|0|||
28080209|NCT03569098|54733609|FG001|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
28080210|NCT03569098|54733610|FG002|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
28080211|NCT03569098|54733608|FG000|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
28080212|NCT03569098|54733609|FG001|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
28080213|NCT03569098|54733610|FG002|Open-Label Treatment Cycle 3|Lost to Follow-up|1|||
28080214|NCT03568942|54733621|FG000|Overall Study|Family emergency|1|||
28080215|NCT03568942|54733621|FG000|Overall Study|Lost to Follow-up|1|||
28080216|NCT00110019|54733627|FG000|Overall Study|Lack of Efficacy|253|||
28080217|NCT00110019|54733628|FG001|Overall Study|Lack of Efficacy|285|||
28080218|NCT00110019|54733627|FG000|Overall Study|Adverse Event|61|||
28080219|NCT00110019|54733628|FG001|Overall Study|Adverse Event|40|||
28080220|NCT00110019|54733627|FG000|Overall Study|Death|13|||
28164640|NCT02669264|54835282|FG001|Overall Study|Miscellaneous|0|||
28164641|NCT02669264|54835283|FG002|Overall Study|Miscellaneous|0|||
27946633|NCT00598273|54603956|FG000|Overall Study|Death|6|||
27946634|NCT00598273|54603957|FG001|Overall Study|Death|12|||
27946635|NCT00598273|54603958|FG002|Overall Study|Death|8|||
28080221|NCT00110019|54733628|FG001|Overall Study|Death|15|||
28080222|NCT00110019|54733627|FG000|Overall Study|Withdrawal by Subject|21|||
28164642|NCT02669264|54835284|FG003|Overall Study|Miscellaneous|0|||
27853978|NCT01401530|54365611|FG001|Overall Study|Adverse Event|1|||
27853979|NCT01401530|54365612|FG002|Overall Study|Adverse Event|1|||
28080223|NCT00110019|54733628|FG001|Overall Study|Withdrawal by Subject|9|||
28080224|NCT00110019|54733627|FG000|Overall Study|alternative therapy|5|||
28080225|NCT00110019|54733628|FG001|Overall Study|alternative therapy|1|||
28080226|NCT00110019|54733627|FG000|Overall Study|complicating disease|1|||
28080227|NCT00110019|54733628|FG001|Overall Study|complicating disease|1|||
28080228|NCT00110019|54733627|FG000|Overall Study|symptom deterioration|13|||
28080229|NCT00110019|54733628|FG001|Overall Study|symptom deterioration|16|||
28080230|NCT00110019|54733627|FG000|Overall Study|Not start protocol therapy|17|||
27731461|NCT02707965|54178671|FG008|Overall Study|PI decisions|0|||
27946636|NCT00598273|54603956|FG000|Overall Study|Lost to Follow-up|8|||
27946637|NCT00598273|54603957|FG001|Overall Study|Lost to Follow-up|3|||
27946638|NCT00598273|54603958|FG002|Overall Study|Lost to Follow-up|5|||
27946639|NCT00598273|54603956|FG000|Overall Study|Physician Decision|0|||
27946640|NCT00598273|54603957|FG001|Overall Study|Physician Decision|0|||
27946641|NCT00598273|54603958|FG002|Overall Study|Physician Decision|1|||
27946642|NCT00598273|54603956|FG000|Overall Study|Withdrawal by Subject|12|||
27946643|NCT00598273|54603957|FG001|Overall Study|Withdrawal by Subject|10|||
27946644|NCT00598273|54603958|FG002|Overall Study|Withdrawal by Subject|10|||
27946645|NCT00598273|54603956|FG000|Overall Study|Noncompliance|3|||
27946646|NCT00598273|54603957|FG001|Overall Study|Noncompliance|2|||
27946647|NCT00598273|54603958|FG002|Overall Study|Noncompliance|3|||
27946648|NCT00598273|54603956|FG000|Overall Study|Relocation|0|||
27946649|NCT00598273|54603957|FG001|Overall Study|Relocation|2|||
27946650|NCT00598273|54603958|FG002|Overall Study|Relocation|4|||
27946651|NCT00598273|54603956|FG000|Overall Study|Renal transplant|1|||
27946652|NCT00598273|54603957|FG001|Overall Study|Renal transplant|0|||
27946653|NCT00598273|54603958|FG002|Overall Study|Renal transplant|1|||
27946654|NCT00598273|54603956|FG000|Overall Study|Site elected to close|1|||
27946655|NCT00598273|54603957|FG001|Overall Study|Site elected to close|0|||
27946656|NCT00598273|54603958|FG002|Overall Study|Site elected to close|0|||
27946657|NCT00598273|54603956|FG000|Overall Study|Started dialysis|6|||
27946658|NCT00598273|54603957|FG001|Overall Study|Started dialysis|4|||
27946659|NCT00598273|54603958|FG002|Overall Study|Started dialysis|5|||
27946660|NCT01211522|54603969|FG000|Overall Study|Withdrawal by Subject|3|||
27946661|NCT01211522|54603970|FG001|Overall Study|Withdrawal by Subject|7|||
27946662|NCT01211522|54603971|FG002|Overall Study|Withdrawal by Subject|5|||
27731462|NCT02707965|54178672|FG009|Overall Study|PI decisions|0|||
27731463|NCT02707965|54178673|FG010|Overall Study|PI decisions|0|||
27731464|NCT02707965|54178674|FG011|Overall Study|PI decisions|0|||
27731465|NCT02707965|54178675|FG012|Overall Study|PI decisions|0|||
27731466|NCT02707965|54178676|FG013|Overall Study|PI decisions|0|||
27731467|NCT02707965|54178677|FG014|Overall Study|PI decisions|2|||
27731468|NCT02707965|54178678|FG015|Overall Study|PI decisions|0|||
27731469|NCT02707965|54178663|FG000|Overall Study|Protocol deviation|1|||
27731470|NCT02707965|54178664|FG001|Overall Study|Protocol deviation|1|||
27731471|NCT02707965|54178665|FG002|Overall Study|Protocol deviation|0|||
27731472|NCT02707965|54178666|FG003|Overall Study|Protocol deviation|0|||
27731473|NCT02707965|54178667|FG004|Overall Study|Protocol deviation|0|||
27731474|NCT02707965|54178668|FG005|Overall Study|Protocol deviation|0|||
27731475|NCT02707965|54178669|FG006|Overall Study|Protocol deviation|0|||
27731476|NCT02707965|54178670|FG007|Overall Study|Protocol deviation|1|||
27731477|NCT02707965|54178671|FG008|Overall Study|Protocol deviation|0|||
27731478|NCT02707965|54178672|FG009|Overall Study|Protocol deviation|0|||
27731479|NCT02707965|54178673|FG010|Overall Study|Protocol deviation|0|||
27731480|NCT02707965|54178674|FG011|Overall Study|Protocol deviation|0|||
27731481|NCT02707965|54178675|FG012|Overall Study|Protocol deviation|0|||
27853980|NCT01401530|54365610|FG000|Overall Study|Participant Choice|1|||
27853981|NCT01401530|54365611|FG001|Overall Study|Participant Choice|2|||
27853982|NCT01401530|54365612|FG002|Overall Study|Participant Choice|1|||
27853983|NCT01401530|54365610|FG000|Overall Study|Physician Decision|0|||
27853984|NCT01401530|54365611|FG001|Overall Study|Physician Decision|1|||
27853985|NCT01401530|54365612|FG002|Overall Study|Physician Decision|0|||
27853986|NCT01387022|54365624|FG000|Overall Study|Death|1|||
27853987|NCT01387022|54365625|FG001|Overall Study|Death|1|||
27946663|NCT01211288|54603981|FG000|Overall Study|Lost to Follow-up|1|||
27946664|NCT01211288|54603982|FG001|Overall Study|Lost to Follow-up|1|||
27731482|NCT02707965|54178676|FG013|Overall Study|Protocol deviation|0|||
27853988|NCT01387022|54365624|FG000|Overall Study|Lost to Follow-up|0|||
27946665|NCT00883753|54603990|FG000|Overall Study|Adverse Event|37|||
28080231|NCT00110019|54733628|FG001|Overall Study|Not start protocol therapy|16|||
27946666|NCT00883753|54603990|FG000|Overall Study|Death|2|||
27946667|NCT00883753|54603990|FG000|Overall Study|Insufficient therapeutic response|16|||
27946668|NCT00883753|54603990|FG000|Overall Study|Lost to Follow-up|4|||
28080232|NCT00110019|54733627|FG000|Overall Study|other reasons|22|||
27731483|NCT02707965|54178677|FG014|Overall Study|Protocol deviation|0|||
27731484|NCT02707965|54178678|FG015|Overall Study|Protocol deviation|0|||
27853989|NCT01387022|54365625|FG001|Overall Study|Lost to Follow-up|3|||
27731485|NCT01667900|54178716|FG000|Part B|Death|0|||
27731486|NCT01667900|54178717|FG001|Part B|Death|0|||
27853990|NCT01386944|54365651|FG000|Overall Study|Adverse Event|26|||
28080233|NCT00110019|54733628|FG001|Overall Study|other reasons|30|||
27946669|NCT00883753|54603990|FG000|Overall Study|Violation of selection criteria at entry|7|||
27946670|NCT00883753|54603990|FG000|Overall Study|Protocol Violation|2|||
27946671|NCT00883753|54603990|FG000|Overall Study|Refused treatment|4|||
28080234|NCT03595618|54733638|FG000|Overall Study|Adverse Event|16|||
28080235|NCT03595618|54733639|FG001|Overall Study|Adverse Event|17|||
28080236|NCT03595618|54733640|FG002|Overall Study|Adverse Event|20|||
28080237|NCT03595618|54733641|FG003|Overall Study|Adverse Event|8|||
27853991|NCT01386944|54365651|FG000|Overall Study|Lack of Efficacy|14|||
27853992|NCT01386944|54365651|FG000|Overall Study|Lost to Follow-up|8|||
27853993|NCT01386944|54365651|FG000|Overall Study|Unspecified reason|8|||
27853994|NCT01386788|54365662|FG000|Overall Study|Lost to Follow-up|2|||
27853995|NCT01386554|54365727|FG000|Overall Study|Lost to Follow-up|0|||
27853996|NCT01386554|54365728|FG001|Overall Study|Lost to Follow-up|0|||
27853997|NCT01386554|54365729|FG002|Overall Study|Lost to Follow-up|1|||
27853998|NCT01386554|54365727|FG000|Overall Study|Adverse Event|2|||
27853999|NCT01386554|54365728|FG001|Overall Study|Adverse Event|5|||
27854000|NCT01386554|54365729|FG002|Overall Study|Adverse Event|2|||
27854001|NCT01386554|54365727|FG000|Overall Study|Progressive disease|1|||
27854002|NCT01386554|54365728|FG001|Overall Study|Progressive disease|2|||
27854003|NCT01386554|54365729|FG002|Overall Study|Progressive disease|2|||
27854004|NCT01386554|54365727|FG000|Overall Study|Administration of live vaccines|0|||
27854005|NCT01386554|54365728|FG001|Overall Study|Administration of live vaccines|1|||
27854006|NCT01386554|54365729|FG002|Overall Study|Administration of live vaccines|0|||
27854007|NCT01386554|54365727|FG000|Overall Study|Investigator discretion|0|||
27854008|NCT01386554|54365728|FG001|Overall Study|Investigator discretion|0|||
27854009|NCT01386554|54365729|FG002|Overall Study|Investigator discretion|1|||
27854010|NCT01386554|54365727|FG000|Overall Study|Reason not collected|0|||
27854011|NCT01386554|54365728|FG001|Overall Study|Reason not collected|1|||
27854012|NCT01386554|54365729|FG002|Overall Study|Reason not collected|0|||
27854013|NCT01386008|54365754|FG000|Overall Study|exited w/o incident /study discontinued|17|||
27854014|NCT01386008|54365754|FG000|Overall Study|Adverse Event|3|||
27854015|NCT01421342|54365902|FG000|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49|||
27854016|NCT01421342|54365903|FG001|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28|||
27854017|NCT01421342|54365904|FG002|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13|||
27854018|NCT01421342|54365902|FG000|Acute Treatment Phase (12 Weeks)|Adverse Event|53|||
27854019|NCT01421342|54365903|FG001|Acute Treatment Phase (12 Weeks)|Adverse Event|38|||
27854020|NCT01421342|54365904|FG002|Acute Treatment Phase (12 Weeks)|Adverse Event|27|||
27854021|NCT01421342|54365902|FG000|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23|||
27854022|NCT01421342|54365903|FG001|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20|||
27854023|NCT01421342|54365904|FG002|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13|||
27854024|NCT01421342|54365902|FG000|Acute Treatment Phase (12 Weeks)|Death|0|||
27854025|NCT01421342|54365903|FG001|Acute Treatment Phase (12 Weeks)|Death|0|||
27854026|NCT01421342|54365904|FG002|Acute Treatment Phase (12 Weeks)|Death|3|||
27854027|NCT01421342|54365902|FG000|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6|||
27854028|NCT01421342|54365903|FG001|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18|||
27854029|NCT01421342|54365904|FG002|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21|||
27854030|NCT01421342|54365902|FG000|Acute Treatment Phase (12 Weeks)|Non-adherence|15|||
27854031|NCT01421342|54365903|FG001|Acute Treatment Phase (12 Weeks)|Non-adherence|7|||
27854032|NCT01421342|54365904|FG002|Acute Treatment Phase (12 Weeks)|Non-adherence|13|||
27854033|NCT01421342|54365902|FG000|Acute Treatment Phase (12 Weeks)|Dure to other illness|3|||
27854034|NCT01421342|54365903|FG001|Acute Treatment Phase (12 Weeks)|Dure to other illness|2|||
27854035|NCT01421342|54365904|FG002|Acute Treatment Phase (12 Weeks)|Dure to other illness|4|||
27854036|NCT01421342|54365902|FG000|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
27854037|NCT01421342|54365903|FG001|Acute Treatment Phase (12 Weeks)|Participant moved away|6|||
27854038|NCT01421342|54365904|FG002|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
27854039|NCT01421342|54365902|FG000|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8|||
27854040|NCT01421342|54365903|FG001|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9|||
27854041|NCT01421342|54365904|FG002|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4|||
27854042|NCT01421342|54365902|FG000|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111|||
27854043|NCT01421342|54365903|FG001|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93|||
27854044|NCT01421342|54365904|FG002|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88|||
27854045|NCT01421342|54365902|FG000|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7|||
27854046|NCT01421342|54365903|FG001|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10|||
27854047|NCT01421342|54365904|FG002|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12|||
27854048|NCT01421342|54365902|FG000|Completed to Week 12 But Then Withdrawn|Adverse Event|4|||
27854049|NCT01421342|54365903|FG001|Completed to Week 12 But Then Withdrawn|Adverse Event|3|||
27854050|NCT01421342|54365904|FG002|Completed to Week 12 But Then Withdrawn|Adverse Event|6|||
27854051|NCT01421342|54365902|FG000|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13|||
27946672|NCT00883753|54603990|FG000|Overall Study|Withdrew consent|10|||
27946673|NCT00883753|54603990|FG000|Overall Study|Investigator's decision|17|||
28080238|NCT03595618|54733638|FG000|Overall Study|Withdrawal by Subject|12|||
28080239|NCT03595618|54733639|FG001|Overall Study|Withdrawal by Subject|14|||
28164643|NCT02669264|54835285|FG004|Overall Study|Miscellaneous|0|||
27854052|NCT01421342|54365903|FG001|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4|||
27854053|NCT01421342|54365904|FG002|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11|||
27854054|NCT01421342|54365902|FG000|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4|||
27854055|NCT01421342|54365903|FG001|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
27854056|NCT01421342|54365904|FG002|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
27854057|NCT01421342|54365902|FG000|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
27854058|NCT01421342|54365903|FG001|Completed to Week 12 But Then Withdrawn|Non-adherence|4|||
27854059|NCT01421342|54365904|FG002|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
27854060|NCT01421342|54365902|FG000|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1|||
27854061|NCT01421342|54365903|FG001|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0|||
27854062|NCT01421342|54365904|FG002|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2|||
27854063|NCT01421342|54365902|FG000|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1|||
27854064|NCT01421342|54365903|FG001|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
27854065|NCT01421342|54365904|FG002|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
27946674|NCT00883753|54603990|FG000|Overall Study|Administrative/Other|8|||
27946675|NCT01210664|54603997|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
27946676|NCT01210664|54603998|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
27946677|NCT01210664|54603999|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1|||
27946678|NCT01210664|54604000|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
27946679|NCT01210664|54603997|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
27946680|NCT01210664|54603998|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
27946681|NCT01210664|54603999|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1|||
27946682|NCT01210664|54604000|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
27946683|NCT01210664|54603997|FG000|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
27946684|NCT01210664|54603998|FG001|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
27946685|NCT01210664|54603999|FG002|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
27946686|NCT01210664|54604000|FG003|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1|||
27946687|NCT00881569|54604012|FG000|Overall Study|Disease progression|1|||
27946688|NCT00881569|54604013|FG001|Overall Study|Disease progression|1|||
27946689|NCT00881335|54604021|FG000|Overall Study|Lost to Follow-up|3|||
27946690|NCT00881335|54604022|FG001|Overall Study|Lost to Follow-up|2|||
27946691|NCT00879775|54604039|FG000|Overall Study|Lost to Follow-up|2|||
27946692|NCT00879775|54604040|FG001|Overall Study|Lost to Follow-up|1|||
27946693|NCT00894790|54604048|FG000|Overall Study|Protocol Violation|0|||
27946694|NCT00894790|54604049|FG001|Overall Study|Protocol Violation|1|||
27946695|NCT00894790|54604048|FG000|Overall Study|Lost to Follow-up|0|||
27946696|NCT00894790|54604049|FG001|Overall Study|Lost to Follow-up|1|||
27946697|NCT00894790|54604048|FG000|Overall Study|Did not meet entrance criteria|1|||
27946698|NCT00894790|54604049|FG001|Overall Study|Did not meet entrance criteria|0|||
27946699|NCT00879229|54604057|FG000|Overall Study|Study terminated by Sponsor|13|||
27946700|NCT00879229|54604058|FG001|Overall Study|Study terminated by Sponsor|12|||
27946701|NCT00879229|54604057|FG000|Overall Study|Death|4|||
27946702|NCT00879229|54604058|FG001|Overall Study|Death|2|||
27946703|NCT00879229|54604057|FG000|Overall Study|Adverse Event|2|||
27946704|NCT00879229|54604058|FG001|Overall Study|Adverse Event|0|||
27946705|NCT00879229|54604057|FG000|Overall Study|Withdrawal by Subject|1|||
27946706|NCT00879229|54604058|FG001|Overall Study|Withdrawal by Subject|0|||
27946707|NCT00879229|54604057|FG000|Overall Study|Clinical status did not improve|1|||
27946708|NCT00879229|54604058|FG001|Overall Study|Clinical status did not improve|0|||
27946709|NCT00879229|54604057|FG000|Overall Study|Other|1|||
27946710|NCT00879229|54604058|FG001|Overall Study|Other|0|||
27946711|NCT00878995|54604066|FG000|Baseline Study - Midpoint Study|Withdrawal by Subject|0|||
27946712|NCT00878995|54604067|FG001|Baseline Study - Midpoint Study|Withdrawal by Subject|2|||
27946713|NCT00879697|54604075|FG000|Overall Study|Physician Decision|2|||
27946714|NCT00879697|54604076|FG001|Overall Study|Physician Decision|2|||
27946715|NCT00894556|54604085|FG000|Baseline Phase|Did not meet Randomization Criteria|0|||
27946716|NCT00894556|54604086|FG001|Baseline Phase|Did not meet Randomization Criteria|0|||
27946717|NCT00894556|54604087|FG002|Baseline Phase|Did not meet Randomization Criteria|0|||
27946718|NCT00894556|54604088|FG003|Baseline Phase|Did not meet Randomization Criteria|85|||
27946719|NCT00894556|54604085|FG000|Treatment Phase|Lost to Follow-up|2|||
27946720|NCT00894556|54604086|FG001|Treatment Phase|Lost to Follow-up|3|||
28164644|NCT02669264|54835286|FG005|Overall Study|Miscellaneous|0|||
27946721|NCT00894556|54604087|FG002|Treatment Phase|Lost to Follow-up|1|||
27946722|NCT00894556|54604088|FG003|Treatment Phase|Lost to Follow-up|0|||
27946723|NCT00894556|54604085|FG000|Treatment Phase|Lack of Qualifying Event|2|||
27946724|NCT00894556|54604086|FG001|Treatment Phase|Lack of Qualifying Event|1|||
27946725|NCT00894556|54604087|FG002|Treatment Phase|Lack of Qualifying Event|0|||
27946726|NCT00894556|54604088|FG003|Treatment Phase|Lack of Qualifying Event|0|||
27946727|NCT01210352|54604104|FG000|Overall Study|Adverse Event|0|||
27946728|NCT01210352|54604105|FG001|Overall Study|Adverse Event|0|||
27854066|NCT01421342|54365902|FG000|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
27946729|NCT01210352|54604106|FG002|Overall Study|Adverse Event|0|||
27946730|NCT01210352|54604107|FG003|Overall Study|Adverse Event|0|||
27946731|NCT01210352|54604108|FG004|Overall Study|Adverse Event|0|||
28080240|NCT03595618|54733640|FG002|Overall Study|Withdrawal by Subject|14|||
28080241|NCT03595618|54733641|FG003|Overall Study|Withdrawal by Subject|10|||
28080242|NCT03595618|54733638|FG000|Overall Study|Lost to Follow-up|6|||
28080243|NCT03595618|54733639|FG001|Overall Study|Lost to Follow-up|4|||
28080244|NCT03595618|54733640|FG002|Overall Study|Lost to Follow-up|5|||
28080245|NCT03595618|54733641|FG003|Overall Study|Lost to Follow-up|6|||
28080246|NCT03595618|54733638|FG000|Overall Study|Protocol Violation|2|||
28080247|NCT03595618|54733639|FG001|Overall Study|Protocol Violation|0|||
28080248|NCT03595618|54733640|FG002|Overall Study|Protocol Violation|6|||
28080249|NCT03595618|54733641|FG003|Overall Study|Protocol Violation|2|||
28080250|NCT03595618|54733638|FG000|Overall Study|Physician Decision|0|||
28080251|NCT03595618|54733639|FG001|Overall Study|Physician Decision|0|||
28080252|NCT03595618|54733640|FG002|Overall Study|Physician Decision|1|||
28080253|NCT03595618|54733641|FG003|Overall Study|Physician Decision|2|||
28080254|NCT03595618|54733638|FG000|Overall Study|Miscellaneous|7|||
28080255|NCT03595618|54733639|FG001|Overall Study|Miscellaneous|5|||
28080256|NCT03595618|54733640|FG002|Overall Study|Miscellaneous|10|||
28080257|NCT03595618|54733641|FG003|Overall Study|Miscellaneous|6|||
28080258|NCT02954848|54733653|FG000|Overall Study|Randomized but Not Treated|0|||
28080259|NCT02954848|54733654|FG001|Overall Study|Randomized but Not Treated|1|||
28080260|NCT02954848|54733653|FG000|Overall Study|Adverse Event|2|||
28080261|NCT02954848|54733654|FG001|Overall Study|Adverse Event|3|||
28080262|NCT02954848|54733653|FG000|Overall Study|Withdrawal by Participant|0|||
28080263|NCT02954848|54733654|FG001|Overall Study|Withdrawal by Participant|1|||
28080264|NCT03642262|54733660|FG000|Period 1|Withdrawal by Subject|1|||
28080265|NCT03642262|54733661|FG001|Period 1|Withdrawal by Subject|1|||
28080266|NCT03642262|54733660|FG000|Period 1|Adverse Event|0|||
28080267|NCT03642262|54733661|FG001|Period 1|Adverse Event|1|||
28080268|NCT00109707|54733671|FG000|Overall Study|Discontinued in core study without entering the extension study|215|||
28080269|NCT00109707|54733672|FG001|Overall Study|Discontinued in core study without entering the extension study|122|||
28080270|NCT00109707|54733673|FG002|Overall Study|Discontinued in core study without entering the extension study|34|||
28080271|NCT00109707|54733671|FG000|Overall Study|Abnormal laboratory values|1|||
28080272|NCT00109707|54733672|FG001|Overall Study|Abnormal laboratory values|0|||
28080273|NCT00109707|54733673|FG002|Overall Study|Abnormal laboratory values|0|||
28080274|NCT00109707|54733671|FG000|Overall Study|Administrative problems|2|||
28080275|NCT00109707|54733672|FG001|Overall Study|Administrative problems|0|||
28080276|NCT00109707|54733673|FG002|Overall Study|Administrative problems|1|||
28080277|NCT00109707|54733671|FG000|Overall Study|Adverse Event|10|||
28080278|NCT00109707|54733672|FG001|Overall Study|Adverse Event|2|||
28080279|NCT00109707|54733673|FG002|Overall Study|Adverse Event|3|||
28080280|NCT00109707|54733671|FG000|Overall Study|Death|4|||
28080281|NCT00109707|54733672|FG001|Overall Study|Death|0|||
28080282|NCT00109707|54733673|FG002|Overall Study|Death|0|||
28080283|NCT00109707|54733671|FG000|Overall Study|Disease progression|12|||
28080284|NCT00109707|54733672|FG001|Overall Study|Disease progression|4|||
28080285|NCT00109707|54733673|FG002|Overall Study|Disease progression|3|||
28080286|NCT00109707|54733671|FG000|Overall Study|Lost to Follow-up|3|||
28080287|NCT00109707|54733672|FG001|Overall Study|Lost to Follow-up|0|||
28080288|NCT00109707|54733673|FG002|Overall Study|Lost to Follow-up|0|||
27854067|NCT01421342|54365903|FG001|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
27854068|NCT01421342|54365904|FG002|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4|||
27854069|NCT01421342|54365902|FG000|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
27854070|NCT01421342|54365903|FG001|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
27854071|NCT01421342|54365904|FG002|Completed to Week 12 But Then Withdrawn|End of Study Time|2|||
27854072|NCT01421342|54365902|FG000|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
27854073|NCT01421342|54365903|FG001|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5|||
27854074|NCT01421342|54365904|FG002|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
27946732|NCT01210352|54604109|FG005|Overall Study|Adverse Event|0|||
28080289|NCT00109707|54733671|FG000|Overall Study|Protocol Violation|1|||
28080290|NCT00109707|54733672|FG001|Overall Study|Protocol Violation|0|||
28080291|NCT00109707|54733673|FG002|Overall Study|Protocol Violation|0|||
28080292|NCT00109707|54733671|FG000|Overall Study|Patient withdrew consent|6|||
28080293|NCT00109707|54733672|FG001|Overall Study|Patient withdrew consent|1|||
28080294|NCT00109707|54733673|FG002|Overall Study|Patient withdrew consent|0|||
28080295|NCT00095979|54733685|FG000|Overall Study|Ineligible: Second primary cancer site|2|||
28080296|NCT00082173|54733696|FG000|Overall Study|Withdrawal by Subject|3|||
28080297|NCT00082173|54733697|FG001|Overall Study|Withdrawal by Subject|5|||
28080298|NCT00082173|54733696|FG000|Overall Study|Lost to Follow-up|1|||
28080299|NCT00082173|54733697|FG001|Overall Study|Lost to Follow-up|0|||
28080300|NCT00082173|54733696|FG000|Overall Study|Adverse Event|1|||
28080301|NCT00082173|54733697|FG001|Overall Study|Adverse Event|0|||
28080302|NCT00082173|54733696|FG000|Overall Study|Culture negative or resistant at baselin|5|||
27946733|NCT01210352|54604110|FG006|Overall Study|Adverse Event|0|||
27946734|NCT01210352|54604111|FG007|Overall Study|Adverse Event|2|||
27946735|NCT01210352|54604112|FG008|Overall Study|Adverse Event|1|||
27946736|NCT01210352|54604104|FG000|Overall Study|Lack of Efficacy|0|||
27946737|NCT01210352|54604105|FG001|Overall Study|Lack of Efficacy|0|||
27946738|NCT01210352|54604106|FG002|Overall Study|Lack of Efficacy|0|||
27946739|NCT01210352|54604107|FG003|Overall Study|Lack of Efficacy|0|||
27946740|NCT01210352|54604108|FG004|Overall Study|Lack of Efficacy|0|||
27946741|NCT01210352|54604109|FG005|Overall Study|Lack of Efficacy|0|||
27946742|NCT01210352|54604110|FG006|Overall Study|Lack of Efficacy|1|||
27946743|NCT01210352|54604111|FG007|Overall Study|Lack of Efficacy|0|||
27946744|NCT01210352|54604112|FG008|Overall Study|Lack of Efficacy|0|||
27946745|NCT01210352|54604104|FG000|Overall Study|Physician Decision|0|||
27946746|NCT01210352|54604105|FG001|Overall Study|Physician Decision|0|||
27946747|NCT01210352|54604106|FG002|Overall Study|Physician Decision|0|||
27946748|NCT01210352|54604107|FG003|Overall Study|Physician Decision|0|||
27946749|NCT01210352|54604108|FG004|Overall Study|Physician Decision|0|||
27946750|NCT01210352|54604109|FG005|Overall Study|Physician Decision|0|||
27946751|NCT01210352|54604110|FG006|Overall Study|Physician Decision|0|||
27946752|NCT01210352|54604111|FG007|Overall Study|Physician Decision|1|||
27946753|NCT01210352|54604112|FG008|Overall Study|Physician Decision|2|||
28080303|NCT00082173|54733697|FG001|Overall Study|Culture negative or resistant at baselin|6|||
28080304|NCT00108069|54733705|FG000|Overall Study|Never rec'd study drug|0|||
28080305|NCT00108069|54733706|FG001|Overall Study|Never rec'd study drug|1|||
28080306|NCT00108069|54733705|FG000|Overall Study|Adverse Event|1|||
28080307|NCT00108069|54733706|FG001|Overall Study|Adverse Event|1|||
28080308|NCT00108069|54733705|FG000|Overall Study|Withdrawal by Subject|1|||
28080309|NCT00108069|54733706|FG001|Overall Study|Withdrawal by Subject|0|||
28080310|NCT00108069|54733705|FG000|Overall Study|Death|1|||
28080311|NCT00108069|54733706|FG001|Overall Study|Death|0|||
28080312|NCT00108069|54733705|FG000|Overall Study|Progessive disease|27|||
28080313|NCT00108069|54733706|FG001|Overall Study|Progessive disease|11|||
28080314|NCT00079274|54733725|FG000|Overall Study|Withdrawal by Subject|111|||
28080315|NCT00079274|54733726|FG001|Overall Study|Withdrawal by Subject|10|||
28080316|NCT00079274|54733727|FG002|Overall Study|Withdrawal by Subject|12|||
28080317|NCT00079274|54733728|FG003|Overall Study|Withdrawal by Subject|163|||
28080318|NCT00079274|54733729|FG004|Overall Study|Withdrawal by Subject|7|||
28080319|NCT00079274|54733730|FG005|Overall Study|Withdrawal by Subject|8|||
28080320|NCT00079274|54733731|FG006|Overall Study|Withdrawal by Subject|0|||
28080321|NCT00079274|54733725|FG000|Overall Study|Adverse Event|130|||
28080322|NCT00079274|54733726|FG001|Overall Study|Adverse Event|8|||
28080323|NCT00079274|54733727|FG002|Overall Study|Adverse Event|8|||
28080324|NCT00079274|54733728|FG003|Overall Study|Adverse Event|184|||
28080325|NCT00079274|54733729|FG004|Overall Study|Adverse Event|7|||
28080326|NCT00079274|54733730|FG005|Overall Study|Adverse Event|8|||
28080327|NCT00079274|54733731|FG006|Overall Study|Adverse Event|0|||
28080328|NCT00079274|54733725|FG000|Overall Study|Recurrence|21|||
28080329|NCT00079274|54733726|FG001|Overall Study|Recurrence|0|||
28080330|NCT00079274|54733727|FG002|Overall Study|Recurrence|1|||
28080331|NCT00079274|54733728|FG003|Overall Study|Recurrence|15|||
28080332|NCT00079274|54733729|FG004|Overall Study|Recurrence|0|||
28080333|NCT00079274|54733730|FG005|Overall Study|Recurrence|2|||
28080334|NCT00079274|54733731|FG006|Overall Study|Recurrence|0|||
28080335|NCT00079274|54733725|FG000|Overall Study|Alternate Treatment|6|||
28080336|NCT00079274|54733726|FG001|Overall Study|Alternate Treatment|1|||
28080337|NCT00079274|54733727|FG002|Overall Study|Alternate Treatment|0|||
28080338|NCT00079274|54733728|FG003|Overall Study|Alternate Treatment|3|||
28080339|NCT00079274|54733729|FG004|Overall Study|Alternate Treatment|0|||
28080340|NCT00079274|54733730|FG005|Overall Study|Alternate Treatment|0|||
28080341|NCT00079274|54733731|FG006|Overall Study|Alternate Treatment|0|||
28080342|NCT00079274|54733725|FG000|Overall Study|Other Medical Problems|6|||
28080343|NCT00079274|54733726|FG001|Overall Study|Other Medical Problems|1|||
28080344|NCT00079274|54733727|FG002|Overall Study|Other Medical Problems|0|||
28080345|NCT00079274|54733728|FG003|Overall Study|Other Medical Problems|7|||
28080346|NCT00079274|54733729|FG004|Overall Study|Other Medical Problems|0|||
28080347|NCT00079274|54733730|FG005|Overall Study|Other Medical Problems|0|||
28080348|NCT00079274|54733731|FG006|Overall Study|Other Medical Problems|0|||
28080349|NCT00079274|54733725|FG000|Overall Study|Death|4|||
28080350|NCT00079274|54733726|FG001|Overall Study|Death|0|||
27946754|NCT01210352|54604104|FG000|Overall Study|Withdrawal by Subject|0|||
27946755|NCT01210352|54604105|FG001|Overall Study|Withdrawal by Subject|0|||
27946756|NCT01210352|54604106|FG002|Overall Study|Withdrawal by Subject|1|||
27946757|NCT01210352|54604107|FG003|Overall Study|Withdrawal by Subject|0|||
27946758|NCT01210352|54604108|FG004|Overall Study|Withdrawal by Subject|0|||
27946759|NCT01210352|54604109|FG005|Overall Study|Withdrawal by Subject|0|||
27946760|NCT01210352|54604110|FG006|Overall Study|Withdrawal by Subject|1|||
28080351|NCT00079274|54733727|FG002|Overall Study|Death|1|||
27946761|NCT01210352|54604111|FG007|Overall Study|Withdrawal by Subject|0|||
27946762|NCT01210352|54604112|FG008|Overall Study|Withdrawal by Subject|1|||
28080352|NCT00079274|54733728|FG003|Overall Study|Death|15|||
28080353|NCT00079274|54733729|FG004|Overall Study|Death|0|||
28080354|NCT00079274|54733730|FG005|Overall Study|Death|0|||
28080355|NCT00079274|54733731|FG006|Overall Study|Death|0|||
28080356|NCT00079274|54733725|FG000|Overall Study|Cytogenetic resistance|0|||
28080357|NCT00079274|54733726|FG001|Overall Study|Cytogenetic resistance|0|||
28080358|NCT00079274|54733727|FG002|Overall Study|Cytogenetic resistance|0|||
28080359|NCT00079274|54733728|FG003|Overall Study|Cytogenetic resistance|2|||
28080360|NCT00079274|54733729|FG004|Overall Study|Cytogenetic resistance|0|||
28080361|NCT00079274|54733730|FG005|Overall Study|Cytogenetic resistance|0|||
28080362|NCT00079274|54733731|FG006|Overall Study|Cytogenetic resistance|0|||
28080363|NCT00079274|54733725|FG000|Overall Study|Other|43|||
28080364|NCT00079274|54733726|FG001|Overall Study|Other|7|||
28080365|NCT00079274|54733727|FG002|Overall Study|Other|5|||
28080366|NCT00079274|54733728|FG003|Overall Study|Other|55|||
28080367|NCT00079274|54733729|FG004|Overall Study|Other|1|||
28080368|NCT00079274|54733730|FG005|Overall Study|Other|2|||
28080369|NCT00079274|54733731|FG006|Overall Study|Other|0|||
28080370|NCT00079040|54733744|FG000|Overall Study|Withdrew before treatment|1|||
28080371|NCT00079040|54733744|FG000|Overall Study|Ineligible|1|||
28080372|NCT00078806|54733748|FG000|Part 1A|Adverse Event|2|||
28080373|NCT00078806|54733749|FG001|Part 1A|Adverse Event|0|||
28080374|NCT00078806|54733750|FG002|Part 1A|Adverse Event|0|||
28164645|NCT02669264|54835287|FG006|Overall Study|Miscellaneous|2|||
28164646|NCT02521870|54835313|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
28164647|NCT02521870|54835314|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|1|||
27731487|NCT01667900|54178718|FG002|Part B|Death|0|||
27731488|NCT01667900|54178719|FG003|Part B|Death|0|||
27731489|NCT01667900|54178720|FG004|Part B|Death|0|||
27731490|NCT01667900|54178721|FG005|Part B|Death|0|||
27731491|NCT01667900|54178722|FG006|Part B|Death|0|||
27731492|NCT01667900|54178723|FG007|Part B|Death|0|||
27731493|NCT01667900|54178724|FG008|Part B|Death|0|||
27731494|NCT01667900|54178725|FG009|Part B|Death|0|||
27731495|NCT01667900|54178726|FG010|Part B|Death|0|||
27731496|NCT01667900|54178727|FG011|Part B|Death|0|||
27731497|NCT01667900|54178728|FG012|Part B|Death|0|||
27731498|NCT01667900|54178729|FG013|Part B|Death|0|||
27731499|NCT01667900|54178730|FG014|Part B|Death|0|||
27731500|NCT01667900|54178731|FG015|Part B|Death|0|||
27731501|NCT01667900|54178732|FG016|Part B|Death|1|||
27731502|NCT01667900|54178733|FG017|Part B|Death|0|||
27731503|NCT01667900|54178734|FG018|Part B|Death|0|||
27731504|NCT01667900|54178735|FG019|Part B|Death|0|||
27731505|NCT02605928|54178764|FG000|Overall Study|Model tuning phase|28|||
27731506|NCT02605928|54178764|FG000|Overall Study|Lack of Efficacy|5|||
27731507|NCT02706717|54178770|FG000|Overall Study|Withdrawal by Subject|1|||
27731508|NCT02706717|54178771|FG001|Overall Study|Withdrawal by Subject|8|||
27731509|NCT02706717|54178770|FG000|Overall Study|Lost to Follow-up|0|||
27731510|NCT02706717|54178771|FG001|Overall Study|Lost to Follow-up|1|||
27731511|NCT02706717|54178770|FG000|Overall Study|Physician Decision|0|||
27731512|NCT02706717|54178771|FG001|Overall Study|Physician Decision|1|||
27731513|NCT02706717|54178770|FG000|Overall Study|Death|0|||
27731514|NCT02706717|54178771|FG001|Overall Study|Death|1|||
27731515|NCT01331837|54178779|FG000|Overall Study|Death|30|||
27731516|NCT01331837|54178780|FG001|Overall Study|Death|34|||
27731517|NCT01331837|54178779|FG000|Overall Study|Lost to Follow-up|3|||
27731518|NCT01331837|54178780|FG001|Overall Study|Lost to Follow-up|1|||
28080375|NCT00078806|54733751|FG003|Part 1A|Adverse Event|0|||
28080376|NCT00078806|54733748|FG000|Part 1A|Lack of Efficacy|7|||
28080377|NCT00078806|54733749|FG001|Part 1A|Lack of Efficacy|0|||
28164648|NCT02521870|54835315|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
28164649|NCT02521870|54835316|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
28164650|NCT02521870|54835317|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
28164651|NCT02521870|54835318|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
28164652|NCT02521870|54835319|FG006|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
27731519|NCT01331837|54178779|FG000|Overall Study|Info not recorded|10|||
27731520|NCT01331837|54178780|FG001|Overall Study|Info not recorded|16|||
27731521|NCT01331837|54178779|FG000|Overall Study|Withdrawal by Subject|13|||
27731522|NCT01331837|54178780|FG001|Overall Study|Withdrawal by Subject|16|||
27731523|NCT02706483|54178786|FG000|Overall Study|Adverse Event|97|||
27731524|NCT02706483|54178786|FG000|Overall Study|Death|1|||
27731525|NCT02706483|54178786|FG000|Overall Study|Lack of Efficacy|39|||
28080378|NCT00078806|54733750|FG002|Part 1A|Lack of Efficacy|0|||
28080379|NCT00078806|54733751|FG003|Part 1A|Lack of Efficacy|0|||
28080380|NCT00078806|54733748|FG000|Part 1A|Other|1|||
27731526|NCT02706483|54178786|FG000|Overall Study|Lost to Follow-up|101|||
28080381|NCT00078806|54733749|FG001|Part 1A|Other|0|||
28080382|NCT00078806|54733750|FG002|Part 1A|Other|0|||
27731527|NCT02706483|54178786|FG000|Overall Study|Non-compliance with study drug|15|||
27731528|NCT02706483|54178786|FG000|Overall Study|Physician Decision|6|||
27731529|NCT02706483|54178786|FG000|Overall Study|Pregnancy|6|||
27731530|NCT02706483|54178786|FG000|Overall Study|Protocol Violation|18|||
28080383|NCT00078806|54733751|FG003|Part 1A|Other|0|||
28080384|NCT00078806|54733748|FG000|Part 1B|Adverse Event|1|||
28080385|NCT00078806|54733749|FG001|Part 1B|Adverse Event|0|||
28080386|NCT00078806|54733750|FG002|Part 1B|Adverse Event|0|||
28080387|NCT00078806|54733751|FG003|Part 1B|Adverse Event|0|||
28080388|NCT00078806|54733748|FG000|Part 1B|Lack of Efficacy|7|||
28080389|NCT00078806|54733749|FG001|Part 1B|Lack of Efficacy|0|||
28080390|NCT00078806|54733750|FG002|Part 1B|Lack of Efficacy|0|||
28080391|NCT00078806|54733751|FG003|Part 1B|Lack of Efficacy|0|||
28080392|NCT00078806|54733748|FG000|Part 2|Adverse Event|0|||
28080393|NCT00078806|54733749|FG001|Part 2|Adverse Event|1|||
27731531|NCT02706483|54178786|FG000|Overall Study|Withdrawal by Subject|136|||
28164653|NCT02521870|54835320|FG007|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
28164654|NCT02521870|54835321|FG008|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
28164655|NCT02521870|54835322|FG009|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
28164656|NCT02521870|54835323|FG010|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
28164657|NCT02521870|54835324|FG011|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
28164658|NCT02521870|54835313|FG000|Phase 1: Dose Escalation|Adverse Event|2|||
28164659|NCT02521870|54835314|FG001|Phase 1: Dose Escalation|Adverse Event|1|||
28164660|NCT02521870|54835315|FG002|Phase 1: Dose Escalation|Adverse Event|0|||
28164661|NCT02521870|54835316|FG003|Phase 1: Dose Escalation|Adverse Event|0|||
28164662|NCT02521870|54835317|FG004|Phase 1: Dose Escalation|Adverse Event|0|||
28164663|NCT02521870|54835318|FG005|Phase 1: Dose Escalation|Adverse Event|0|||
28164664|NCT02521870|54835319|FG006|Phase 1: Dose Escalation|Adverse Event|0|||
28164665|NCT02521870|54835320|FG007|Phase 1: Dose Escalation|Adverse Event|0|||
28164666|NCT02521870|54835321|FG008|Phase 1: Dose Escalation|Adverse Event|0|||
28164667|NCT02521870|54835322|FG009|Phase 1: Dose Escalation|Adverse Event|0|||
28164668|NCT02521870|54835323|FG010|Phase 1: Dose Escalation|Adverse Event|0|||
28164669|NCT02521870|54835324|FG011|Phase 1: Dose Escalation|Adverse Event|0|||
28164670|NCT02521870|54835313|FG000|Phase 1: Dose Escalation|Progressive Disease|3|||
28164671|NCT02521870|54835314|FG001|Phase 1: Dose Escalation|Progressive Disease|2|||
28164672|NCT02521870|54835315|FG002|Phase 1: Dose Escalation|Progressive Disease|4|||
28164673|NCT02521870|54835316|FG003|Phase 1: Dose Escalation|Progressive Disease|6|||
28164674|NCT02521870|54835317|FG004|Phase 1: Dose Escalation|Progressive Disease|0|||
28164675|NCT02521870|54835318|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
28164676|NCT02521870|54835319|FG006|Phase 1: Dose Escalation|Progressive Disease|0|||
28164677|NCT02521870|54835320|FG007|Phase 1: Dose Escalation|Progressive Disease|0|||
28164678|NCT02521870|54835321|FG008|Phase 1: Dose Escalation|Progressive Disease|0|||
27731532|NCT02706483|54178786|FG000|Overall Study|Non-compliance with visits|6|||
27731533|NCT02706483|54178786|FG000|Overall Study|Site closure|4|||
27731534|NCT02706483|54178786|FG000|Overall Study|Subject moved|1|||
27731535|NCT01648348|54178793|FG000|Overall Study|Cancel|1|||
28080394|NCT00078806|54733750|FG002|Part 2|Adverse Event|0|||
28080395|NCT00078806|54733751|FG003|Part 2|Adverse Event|0|||
28080396|NCT00078338|54733768|FG000|Overall Study|Adverse Event|31|||
28080397|NCT00078338|54733769|FG001|Overall Study|Adverse Event|24|||
28080398|NCT00078338|54733768|FG000|Overall Study|Lost to Follow-up|17|||
28080399|NCT00078338|54733769|FG001|Overall Study|Lost to Follow-up|2|||
28080400|NCT00078338|54733768|FG000|Overall Study|Protocol Violation|2|||
28080401|NCT00078338|54733769|FG001|Overall Study|Protocol Violation|2|||
28080402|NCT00078338|54733768|FG000|Overall Study|Disease Progression|4|||
28080403|NCT00078338|54733769|FG001|Overall Study|Disease Progression|7|||
28080404|NCT00078338|54733768|FG000|Overall Study|Other|28|||
28080405|NCT00078338|54733769|FG001|Overall Study|Other|16|||
28080406|NCT00078338|54733768|FG000|Overall Study|Subjects randomized, but not treated|3|||
28080407|NCT00078338|54733769|FG001|Overall Study|Subjects randomized, but not treated|3|||
28080408|NCT03808688|54733777|FG000|Overall Study|Adverse Event|13|||
28080409|NCT03808688|54733778|FG001|Overall Study|Adverse Event|17|||
28080410|NCT03808688|54733777|FG000|Overall Study|Lack of Efficacy|2|||
28080411|NCT03808688|54733778|FG001|Overall Study|Lack of Efficacy|0|||
28080412|NCT03808688|54733777|FG000|Overall Study|Lost to Follow-up|0|||
28080413|NCT03808688|54733778|FG001|Overall Study|Lost to Follow-up|2|||
28080414|NCT03808688|54733777|FG000|Overall Study|Withdrawal by Subject|1|||
28080415|NCT03808688|54733778|FG001|Overall Study|Withdrawal by Subject|0|||
28080416|NCT03808688|54733777|FG000|Overall Study|Intolerance to Conjunctival Hyperemia|1|||
28080417|NCT03808688|54733778|FG001|Overall Study|Intolerance to Conjunctival Hyperemia|0|||
28164679|NCT02521870|54835322|FG009|Phase 1: Dose Escalation|Progressive Disease|0|||
28164680|NCT02521870|54835323|FG010|Phase 1: Dose Escalation|Progressive Disease|0|||
28164681|NCT02521870|54835324|FG011|Phase 1: Dose Escalation|Progressive Disease|0|||
27731536|NCT01648348|54178794|FG001|Overall Study|Cancel|0|||
27731537|NCT01648348|54178795|FG002|Overall Study|Cancel|0|||
28080418|NCT03808688|54733777|FG000|Overall Study|IOP Too High|1|||
28080419|NCT03808688|54733778|FG001|Overall Study|IOP Too High|1|||
28080420|NCT03808688|54733777|FG000|Overall Study|IOP Too High, Nerve/Visual Field Changes|0|||
28080421|NCT03808688|54733778|FG001|Overall Study|IOP Too High, Nerve/Visual Field Changes|1|||
28080422|NCT03808688|54733777|FG000|Overall Study|Visit Out of Window|0|||
28080423|NCT03808688|54733778|FG001|Overall Study|Visit Out of Window|1|||
28080424|NCT03808688|54733777|FG000|Overall Study|Medication Non-Compliance|0|||
28080425|NCT03808688|54733778|FG001|Overall Study|Medication Non-Compliance|1|||
28080426|NCT03808298|54733786|FG000|Overall Study|Adverse Event|3|||
28080427|NCT03808298|54733786|FG000|Overall Study|Physician Decision|1|||
28080428|NCT03808298|54733786|FG000|Overall Study|Withdrawal by Subject|1|||
28164682|NCT02521870|54835313|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
28164683|NCT02521870|54835314|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
28164684|NCT02521870|54835315|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
28164685|NCT02521870|54835316|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
28164686|NCT02521870|54835317|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|5|||
28164687|NCT02521870|54835318|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
28164688|NCT02521870|54835319|FG006|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
28164689|NCT02521870|54835320|FG007|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
28164690|NCT02521870|54835321|FG008|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
28164691|NCT02521870|54835322|FG009|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
28164692|NCT02521870|54835323|FG010|Phase 2: Dose Expansion|Withdrawal by Subject|2|||
28164693|NCT02521870|54835324|FG011|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
28164694|NCT02521870|54835313|FG000|Phase 2: Dose Expansion|Adverse Event|0|||
28164695|NCT02521870|54835314|FG001|Phase 2: Dose Expansion|Adverse Event|0|||
28164696|NCT02521870|54835315|FG002|Phase 2: Dose Expansion|Adverse Event|0|||
28164697|NCT02521870|54835316|FG003|Phase 2: Dose Expansion|Adverse Event|0|||
28164698|NCT02521870|54835317|FG004|Phase 2: Dose Expansion|Adverse Event|11|||
28164699|NCT02521870|54835318|FG005|Phase 2: Dose Expansion|Adverse Event|2|||
28164700|NCT02521870|54835319|FG006|Phase 2: Dose Expansion|Adverse Event|0|||
28164701|NCT02521870|54835320|FG007|Phase 2: Dose Expansion|Adverse Event|1|||
28164702|NCT02521870|54835321|FG008|Phase 2: Dose Expansion|Adverse Event|5|||
28164703|NCT02521870|54835322|FG009|Phase 2: Dose Expansion|Adverse Event|0|||
28164704|NCT02521870|54835323|FG010|Phase 2: Dose Expansion|Adverse Event|1|||
27731538|NCT01648348|54178796|FG003|Overall Study|Cancel|0|||
27731539|NCT01648348|54178797|FG004|Overall Study|Cancel|3|||
27946763|NCT01210352|54604104|FG000|Overall Study|Patient Discharged Early|0|||
28080429|NCT03808298|54733786|FG000|Overall Study|Positive Urine Drug Screen at Check-in|3|||
28080430|NCT00077636|54733817|FG000|Overall Study|Refused Treatment|9|||
28080431|NCT00077636|54733818|FG001|Overall Study|Refused Treatment|31|||
28080432|NCT00077636|54733817|FG000|Overall Study|Admin|3|||
28080433|NCT00077636|54733818|FG001|Overall Study|Admin|3|||
28080434|NCT00077636|54733817|FG000|Overall Study|Withdrawal by Subject|2|||
28080435|NCT00077636|54733818|FG001|Overall Study|Withdrawal by Subject|2|||
28080436|NCT00077636|54733817|FG000|Overall Study|Adverse Event|17|||
28080437|NCT00077636|54733818|FG001|Overall Study|Adverse Event|34|||
28080438|NCT00077636|54733817|FG000|Overall Study|Protocol Violation|0|||
28080439|NCT00077636|54733818|FG001|Overall Study|Protocol Violation|2|||
28080440|NCT00077636|54733817|FG000|Overall Study|Lost to Follow-up|10|||
28080441|NCT00077636|54733818|FG001|Overall Study|Lost to Follow-up|18|||
28080442|NCT00077636|54733817|FG000|Overall Study|Abnormality Of Laboratory Test|3|||
28080443|NCT00077636|54733818|FG001|Overall Study|Abnormality Of Laboratory Test|2|||
28080444|NCT00095199|54733829|FG000|Overall Study|Adverse Event|40|||
28080445|NCT00095199|54733830|FG001|Overall Study|Adverse Event|22|||
28080446|NCT00095199|54733831|FG002|Overall Study|Adverse Event|26|||
28080447|NCT00095199|54733832|FG003|Overall Study|Adverse Event|11|||
28080448|NCT00095199|54733829|FG000|Overall Study|Progressive disease|213|||
28080449|NCT00095199|54733830|FG001|Overall Study|Progressive disease|179|||
28080450|NCT00095199|54733831|FG002|Overall Study|Progressive disease|105|||
28080451|NCT00095199|54733832|FG003|Overall Study|Progressive disease|98|||
28080452|NCT00095199|54733829|FG000|Overall Study|Death|10|||
28080453|NCT00095199|54733830|FG001|Overall Study|Death|6|||
28080454|NCT00095199|54733831|FG002|Overall Study|Death|11|||
28080455|NCT00095199|54733832|FG003|Overall Study|Death|9|||
28080456|NCT00095199|54733829|FG000|Overall Study|Withdrawal by Subject|21|||
28080457|NCT00095199|54733830|FG001|Overall Study|Withdrawal by Subject|16|||
28080458|NCT00095199|54733831|FG002|Overall Study|Withdrawal by Subject|13|||
28164705|NCT02521870|54835324|FG011|Phase 2: Dose Expansion|Adverse Event|0|||
27854075|NCT01421342|54365902|FG000|Continuation of Treatment (Week 12 - 36)|Adverse Event|0|||
27854076|NCT01421342|54365903|FG001|Continuation of Treatment (Week 12 - 36)|Adverse Event|6|||
27854077|NCT01421342|54365904|FG002|Continuation of Treatment (Week 12 - 36)|Adverse Event|11|||
27854078|NCT01421342|54365902|FG000|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7|||
28164706|NCT02521870|54835313|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
28164707|NCT02521870|54835314|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
28164708|NCT02521870|54835315|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
27731540|NCT01648348|54178798|FG005|Overall Study|Cancel|6|||
27854079|NCT01421342|54365903|FG001|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6|||
27854080|NCT01421342|54365904|FG002|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4|||
27854081|NCT01421342|54365902|FG000|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4|||
27854082|NCT01421342|54365903|FG001|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11|||
27854083|NCT01421342|54365904|FG002|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9|||
27946764|NCT01210352|54604105|FG001|Overall Study|Patient Discharged Early|0|||
27854084|NCT01421342|54365902|FG000|Continuation of Treatment (Week 12 - 36)|Non-adherence|3|||
27854085|NCT01421342|54365903|FG001|Continuation of Treatment (Week 12 - 36)|Non-adherence|8|||
27854086|NCT01421342|54365904|FG002|Continuation of Treatment (Week 12 - 36)|Non-adherence|4|||
27854087|NCT01421342|54365902|FG000|Continuation of Treatment (Week 12 - 36)|End of Study Time|15|||
27854088|NCT01421342|54365903|FG001|Continuation of Treatment (Week 12 - 36)|End of Study Time|20|||
27854089|NCT01421342|54365904|FG002|Continuation of Treatment (Week 12 - 36)|End of Study Time|14|||
27854090|NCT01421342|54365902|FG000|Continuation of Treatment (Week 12 - 36)|Participant moved away|4|||
27854091|NCT01421342|54365903|FG001|Continuation of Treatment (Week 12 - 36)|Participant moved away|1|||
27854092|NCT01421342|54365904|FG002|Continuation of Treatment (Week 12 - 36)|Participant moved away|3|||
27854093|NCT01421342|54365902|FG000|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
27854094|NCT01421342|54365903|FG001|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
27946765|NCT01210352|54604106|FG002|Overall Study|Patient Discharged Early|1|||
27946766|NCT01210352|54604107|FG003|Overall Study|Patient Discharged Early|0|||
28080459|NCT00095199|54733832|FG003|Overall Study|Withdrawal by Subject|22|||
28164709|NCT02521870|54835316|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
28164710|NCT02521870|54835317|FG004|Phase 2: Dose Expansion|Progressive Disease|22|||
27731541|NCT01648348|54178793|FG000|Overall Study|Replaced for MTD analysis|1|||
27731542|NCT01648348|54178794|FG001|Overall Study|Replaced for MTD analysis|0|||
27731543|NCT01648348|54178795|FG002|Overall Study|Replaced for MTD analysis|1|||
27731544|NCT01648348|54178796|FG003|Overall Study|Replaced for MTD analysis|0|||
27731545|NCT01648348|54178797|FG004|Overall Study|Replaced for MTD analysis|0|||
27731546|NCT01648348|54178798|FG005|Overall Study|Replaced for MTD analysis|0|||
27731547|NCT01648270|54178811|FG000|Intravenous Buprenorphine|Withdrawal by Subject|12|||
27731548|NCT02302846|54178821|FG000|Overall Study|Withdrawal by Subject|1|||
27731549|NCT02336230|54178825|FG000|Overall Study|Adverse Event|1|||
27731550|NCT02336230|54178825|FG000|Overall Study|Withdrawal of consent|1|||
27731551|NCT02336230|54178825|FG000|Overall Study|Death|9|||
27731552|NCT02336230|54178825|FG000|Overall Study|Dose not received due to shipping delay|1|||
27731553|NCT02336230|54178825|FG000|Overall Study|Discontinuation of MSC infusion|1|||
27731554|NCT02302222|54178831|FG000|Overall Study|Physician Decision|0|||
27731555|NCT02302222|54178832|FG001|Overall Study|Physician Decision|4|||
27731556|NCT02302222|54178831|FG000|Overall Study|Lost to Follow-up|1|||
27731557|NCT02302222|54178832|FG001|Overall Study|Lost to Follow-up|0|||
27731558|NCT02302222|54178831|FG000|Overall Study|Treatment discontinued before day 5|0|||
27731559|NCT02302222|54178832|FG001|Overall Study|Treatment discontinued before day 5|1|||
27731560|NCT02302222|54178831|FG000|Overall Study|Withdrawn prior to any treatment|0|||
27731561|NCT02302222|54178832|FG001|Overall Study|Withdrawn prior to any treatment|1|||
27731562|NCT02336074|54178840|FG000|Overall Study|Adverse Event|0|||
27731563|NCT02336074|54178841|FG001|Overall Study|Adverse Event|2|||
27731564|NCT02335450|54178852|FG000|Overall Study|Pregnancy|1|||
27731565|NCT04826900|54178864|FG000|Overall Study|Family factor|1|||
27731566|NCT04826900|54178865|FG001|Overall Study|Family factor|1|||
27731567|NCT02302066|54178875|FG000|Overall Study|Adverse Event|1|||
27731568|NCT02302066|54178876|FG001|Overall Study|Adverse Event|1|||
27731569|NCT02302066|54178877|FG002|Overall Study|Adverse Event|3|||
27731570|NCT02302066|54178878|FG003|Overall Study|Adverse Event|0|||
27731571|NCT02302066|54178875|FG000|Overall Study|Lost to Follow-up|4|||
27731572|NCT02302066|54178876|FG001|Overall Study|Lost to Follow-up|5|||
27731573|NCT02302066|54178877|FG002|Overall Study|Lost to Follow-up|24|||
27731574|NCT02302066|54178878|FG003|Overall Study|Lost to Follow-up|7|||
27731575|NCT02302066|54178875|FG000|Overall Study|Withdrawal by Subject|25|||
27731576|NCT02302066|54178876|FG001|Overall Study|Withdrawal by Subject|58|||
27731577|NCT02302066|54178877|FG002|Overall Study|Withdrawal by Subject|124|||
27731578|NCT02302066|54178878|FG003|Overall Study|Withdrawal by Subject|33|||
27731579|NCT02302066|54178875|FG000|Overall Study|Pregnancy|2|||
27731580|NCT02302066|54178876|FG001|Overall Study|Pregnancy|10|||
27731581|NCT02302066|54178877|FG002|Overall Study|Pregnancy|12|||
27731582|NCT02302066|54178878|FG003|Overall Study|Pregnancy|0|||
27731583|NCT02302066|54178875|FG000|Overall Study|Reason Not Specified|1|||
28080460|NCT00095199|54733829|FG000|Overall Study|Protocol Violation|4|||
28164711|NCT02521870|54835318|FG005|Phase 2: Dose Expansion|Progressive Disease|18|||
28164712|NCT02521870|54835319|FG006|Phase 2: Dose Expansion|Progressive Disease|17|||
27731584|NCT02302066|54178876|FG001|Overall Study|Reason Not Specified|1|||
27731585|NCT02302066|54178877|FG002|Overall Study|Reason Not Specified|9|||
27731586|NCT02302066|54178878|FG003|Overall Study|Reason Not Specified|1|||
27731587|NCT02301988|54178900|FG000|Overall Study|Withdrawal by Subject|2|||
27731588|NCT02301988|54178901|FG001|Overall Study|Withdrawal by Subject|1|||
28080461|NCT00095199|54733830|FG001|Overall Study|Protocol Violation|4|||
27731589|NCT02301988|54178900|FG000|Overall Study|Physician Decision|2|||
27731590|NCT02301988|54178901|FG001|Overall Study|Physician Decision|2|||
27731591|NCT02301988|54178900|FG000|Overall Study|Unknown Reason|1|||
27731592|NCT02301988|54178901|FG001|Overall Study|Unknown Reason|3|||
28080462|NCT00095199|54733831|FG002|Overall Study|Protocol Violation|2|||
28080463|NCT00095199|54733832|FG003|Overall Study|Protocol Violation|0|||
28080464|NCT00095199|54733829|FG000|Overall Study|Liver function test results elevated|0|||
28080465|NCT00095199|54733830|FG001|Overall Study|Liver function test results elevated|0|||
28080466|NCT00095199|54733831|FG002|Overall Study|Liver function test results elevated|1|||
28080467|NCT00095199|54733832|FG003|Overall Study|Liver function test results elevated|1|||
28080468|NCT00095199|54733829|FG000|Overall Study|Surgery needed could not start in 7 days|0|||
28080469|NCT00095199|54733830|FG001|Overall Study|Surgery needed could not start in 7 days|0|||
28080470|NCT00095199|54733831|FG002|Overall Study|Surgery needed could not start in 7 days|1|||
28080471|NCT00095199|54733832|FG003|Overall Study|Surgery needed could not start in 7 days|0|||
28080472|NCT00095199|54733829|FG000|Overall Study|Physician Decision|5|||
28080473|NCT00095199|54733830|FG001|Overall Study|Physician Decision|6|||
28080474|NCT00095199|54733831|FG002|Overall Study|Physician Decision|1|||
28080475|NCT00095199|54733832|FG003|Overall Study|Physician Decision|1|||
28080476|NCT00095199|54733829|FG000|Overall Study|Not eligible|1|||
28080477|NCT00095199|54733830|FG001|Overall Study|Not eligible|7|||
28080478|NCT00095199|54733831|FG002|Overall Study|Not eligible|0|||
28080479|NCT00095199|54733832|FG003|Overall Study|Not eligible|1|||
28080480|NCT00095199|54733829|FG000|Overall Study|Started Palliative Radiotherapy|1|||
28080481|NCT00095199|54733830|FG001|Overall Study|Started Palliative Radiotherapy|0|||
28080482|NCT00095199|54733831|FG002|Overall Study|Started Palliative Radiotherapy|0|||
28080483|NCT00095199|54733832|FG003|Overall Study|Started Palliative Radiotherapy|0|||
28080484|NCT00095199|54733829|FG000|Overall Study|Started radiotherapy regimen|0|||
28080485|NCT00095199|54733830|FG001|Overall Study|Started radiotherapy regimen|1|||
28080486|NCT00095199|54733831|FG002|Overall Study|Started radiotherapy regimen|0|||
28080487|NCT00095199|54733832|FG003|Overall Study|Started radiotherapy regimen|0|||
28080488|NCT00095199|54733829|FG000|Overall Study|Primary tumor removed in other surgery|0|||
28080489|NCT00095199|54733830|FG001|Overall Study|Primary tumor removed in other surgery|1|||
28080490|NCT00095199|54733831|FG002|Overall Study|Primary tumor removed in other surgery|0|||
28080491|NCT00095199|54733832|FG003|Overall Study|Primary tumor removed in other surgery|0|||
28080492|NCT00095199|54733829|FG000|Overall Study|Data inadvertently lost by site|1|||
28080493|NCT00095199|54733830|FG001|Overall Study|Data inadvertently lost by site|0|||
28080494|NCT00095199|54733831|FG002|Overall Study|Data inadvertently lost by site|0|||
28080495|NCT00095199|54733832|FG003|Overall Study|Data inadvertently lost by site|0|||
28080496|NCT00075764|54733849|FG000|Overall Study|Adverse Event|5|||
28080497|NCT00075764|54733850|FG001|Overall Study|Adverse Event|12|||
28080498|NCT00075764|54733849|FG000|Overall Study|Death|4|||
28080499|NCT00075764|54733850|FG001|Overall Study|Death|8|||
28080500|NCT00075764|54733849|FG000|Overall Study|Withdrawal by Subject|28|||
28080501|NCT00075764|54733850|FG001|Overall Study|Withdrawal by Subject|18|||
28080502|NCT00075764|54733849|FG000|Overall Study|Progression|269|||
28080503|NCT00075764|54733850|FG001|Overall Study|Progression|274|||
28080504|NCT00075764|54733849|FG000|Overall Study|Still on treatment|8|||
28080505|NCT00075764|54733850|FG001|Overall Study|Still on treatment|15|||
28080506|NCT00075764|54733849|FG000|Overall Study|Delinquent|4|||
28080507|NCT00075764|54733850|FG001|Overall Study|Delinquent|2|||
28080508|NCT00075764|54733849|FG000|Overall Study|Not protocol specified|27|||
28080509|NCT00075764|54733850|FG001|Overall Study|Not protocol specified|19|||
28080510|NCT00075764|54733849|FG000|Overall Study|Under review|0|||
28080511|NCT00075764|54733850|FG001|Overall Study|Under review|1|||
28080512|NCT03568162|54733864|FG000|Overall Study|Adverse Event|0|||
28080513|NCT03568162|54733865|FG001|Overall Study|Adverse Event|1|||
28080514|NCT03568162|54733866|FG002|Overall Study|Adverse Event|2|||
28080515|NCT03568162|54733867|FG003|Overall Study|Adverse Event|0|||
28080516|NCT03568162|54733868|FG004|Overall Study|Adverse Event|0|||
28080517|NCT03568162|54733869|FG005|Overall Study|Adverse Event|1|||
28080518|NCT03568162|54733864|FG000|Overall Study|Death|0|||
28080519|NCT03568162|54733865|FG001|Overall Study|Death|0|||
28080520|NCT03568162|54733866|FG002|Overall Study|Death|0|||
28080521|NCT03568162|54733867|FG003|Overall Study|Death|0|||
28080522|NCT03568162|54733868|FG004|Overall Study|Death|1|||
28080523|NCT03568162|54733869|FG005|Overall Study|Death|0|||
28080524|NCT03568162|54733864|FG000|Overall Study|Lost to Follow-up|3|||
28080525|NCT03568162|54733865|FG001|Overall Study|Lost to Follow-up|2|||
28080526|NCT03568162|54733866|FG002|Overall Study|Lost to Follow-up|4|||
28080527|NCT03568162|54733867|FG003|Overall Study|Lost to Follow-up|2|||
28080528|NCT03568162|54733868|FG004|Overall Study|Lost to Follow-up|3|||
28080529|NCT03568162|54733869|FG005|Overall Study|Lost to Follow-up|2|||
28080530|NCT03568162|54733864|FG000|Overall Study|Physician Decision|0|||
28080531|NCT03568162|54733865|FG001|Overall Study|Physician Decision|1|||
28080532|NCT03568162|54733866|FG002|Overall Study|Physician Decision|1|||
28080533|NCT03568162|54733867|FG003|Overall Study|Physician Decision|0|||
28080534|NCT03568162|54733868|FG004|Overall Study|Physician Decision|1|||
28080535|NCT03568162|54733869|FG005|Overall Study|Physician Decision|0|||
28080536|NCT03568162|54733864|FG000|Overall Study|Pregnancy|0|||
27854095|NCT01421342|54365904|FG002|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
28080537|NCT03568162|54733865|FG001|Overall Study|Pregnancy|0|||
28080538|NCT03568162|54733866|FG002|Overall Study|Pregnancy|0|||
28080539|NCT03568162|54733867|FG003|Overall Study|Pregnancy|1|||
28080540|NCT03568162|54733868|FG004|Overall Study|Pregnancy|0|||
28080541|NCT03568162|54733869|FG005|Overall Study|Pregnancy|0|||
28080542|NCT03568162|54733864|FG000|Overall Study|Protocol Violation|1|||
28080543|NCT03568162|54733865|FG001|Overall Study|Protocol Violation|0|||
28080544|NCT03568162|54733866|FG002|Overall Study|Protocol Violation|1|||
28080545|NCT03568162|54733867|FG003|Overall Study|Protocol Violation|1|||
28080546|NCT03568162|54733868|FG004|Overall Study|Protocol Violation|1|||
28080547|NCT03568162|54733869|FG005|Overall Study|Protocol Violation|1|||
28080548|NCT03568162|54733864|FG000|Overall Study|Withdrawal by Subject|15|||
28080549|NCT03568162|54733865|FG001|Overall Study|Withdrawal by Subject|15|||
28080550|NCT03568162|54733866|FG002|Overall Study|Withdrawal by Subject|26|||
28080551|NCT03568162|54733867|FG003|Overall Study|Withdrawal by Subject|22|||
28080552|NCT03568162|54733868|FG004|Overall Study|Withdrawal by Subject|6|||
28080553|NCT03568162|54733869|FG005|Overall Study|Withdrawal by Subject|9|||
28080554|NCT03568162|54733864|FG000|Overall Study|Others|3|||
28080555|NCT03568162|54733865|FG001|Overall Study|Others|4|||
28080556|NCT03568162|54733866|FG002|Overall Study|Others|1|||
28080557|NCT03568162|54733867|FG003|Overall Study|Others|4|||
28080558|NCT03568162|54733868|FG004|Overall Study|Others|2|||
28080559|NCT03568162|54733869|FG005|Overall Study|Others|1|||
28080560|NCT03567616|54733888|FG000|Overall Study|Disease progression|4|||
28080561|NCT03567616|54733888|FG000|Overall Study|Withdrawal by Subject|1|||
28164713|NCT02521870|54835320|FG007|Phase 2: Dose Expansion|Progressive Disease|7|||
28164714|NCT02521870|54835321|FG008|Phase 2: Dose Expansion|Progressive Disease|5|||
28164715|NCT02521870|54835322|FG009|Phase 2: Dose Expansion|Progressive Disease|17|||
28164716|NCT02521870|54835323|FG010|Phase 2: Dose Expansion|Progressive Disease|17|||
28164717|NCT02521870|54835324|FG011|Phase 2: Dose Expansion|Progressive Disease|21|||
28164718|NCT02521870|54835313|FG000|Phase 2: Dose Expansion|Death|0|||
28164719|NCT02521870|54835314|FG001|Phase 2: Dose Expansion|Death|0|||
28164720|NCT02521870|54835315|FG002|Phase 2: Dose Expansion|Death|0|||
28164721|NCT02521870|54835316|FG003|Phase 2: Dose Expansion|Death|0|||
28164722|NCT02521870|54835317|FG004|Phase 2: Dose Expansion|Death|1|||
28164723|NCT02521870|54835318|FG005|Phase 2: Dose Expansion|Death|1|||
28164724|NCT02521870|54835319|FG006|Phase 2: Dose Expansion|Death|3|||
28164725|NCT02521870|54835320|FG007|Phase 2: Dose Expansion|Death|1|||
28164726|NCT02521870|54835321|FG008|Phase 2: Dose Expansion|Death|1|||
28164727|NCT02521870|54835322|FG009|Phase 2: Dose Expansion|Death|5|||
28164728|NCT02521870|54835323|FG010|Phase 2: Dose Expansion|Death|2|||
28164729|NCT02521870|54835324|FG011|Phase 2: Dose Expansion|Death|2|||
28164730|NCT02521870|54835313|FG000|Phase 2: Dose Expansion|Other|0|||
28164731|NCT02521870|54835314|FG001|Phase 2: Dose Expansion|Other|0|||
28164732|NCT02521870|54835315|FG002|Phase 2: Dose Expansion|Other|0|||
28164733|NCT02521870|54835316|FG003|Phase 2: Dose Expansion|Other|0|||
28164734|NCT02521870|54835317|FG004|Phase 2: Dose Expansion|Other|10|||
28164735|NCT02521870|54835318|FG005|Phase 2: Dose Expansion|Other|3|||
28164736|NCT02521870|54835319|FG006|Phase 2: Dose Expansion|Other|2|||
28080562|NCT03567616|54733888|FG000|Overall Study|Physician Decision|1|||
28080563|NCT03567616|54733888|FG000|Overall Study|Death|1|||
28080564|NCT03567616|54733888|FG000|Overall Study|Adverse Event|1|||
28080565|NCT03567382|54733897|FG000|Overall Study|Lost to Follow-up|1|||
28080566|NCT03567382|54733898|FG001|Overall Study|Lost to Follow-up|21|||
28080567|NCT03567382|54733899|FG002|Overall Study|Lost to Follow-up|1|||
28080568|NCT03567382|54733900|FG003|Overall Study|Lost to Follow-up|21|||
28080569|NCT03567382|54733897|FG000|Overall Study|Withdrawal by Subject|2|||
28080570|NCT03567382|54733898|FG001|Overall Study|Withdrawal by Subject|14|||
28080571|NCT03567382|54733899|FG002|Overall Study|Withdrawal by Subject|1|||
28080572|NCT03567382|54733900|FG003|Overall Study|Withdrawal by Subject|12|||
28080573|NCT03595384|54733911|FG000|Overall Study|Other time commitments|8|||
28080574|NCT03595384|54733911|FG000|Overall Study|Changes to session time|7|||
28164737|NCT02521870|54835320|FG007|Phase 2: Dose Expansion|Other|0|||
28164738|NCT02521870|54835321|FG008|Phase 2: Dose Expansion|Other|10|||
28164739|NCT02521870|54835322|FG009|Phase 2: Dose Expansion|Other|5|||
28164740|NCT02521870|54835323|FG010|Phase 2: Dose Expansion|Other|1|||
28164741|NCT02521870|54835324|FG011|Phase 2: Dose Expansion|Other|7|||
28164742|NCT02521870|54835313|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
28080575|NCT03595384|54733911|FG000|Overall Study|Relocation out of country|1|||
28080576|NCT03591874|54733917|FG000|Overall Study|Adverse Event|4|||
28080577|NCT03591874|54733918|FG001|Overall Study|Adverse Event|0|||
28080578|NCT03591874|54733917|FG000|Overall Study|Withdrawal by Subject|2|||
28080579|NCT03591874|54733918|FG001|Overall Study|Withdrawal by Subject|1|||
28080580|NCT03591874|54733917|FG000|Overall Study|Investigator Withdrawal of Subject|1|||
28080581|NCT03591874|54733918|FG001|Overall Study|Investigator Withdrawal of Subject|0|||
28080582|NCT03591874|54733917|FG000|Overall Study|On Study at Time of Study Termination|12|||
28080583|NCT03591874|54733918|FG001|Overall Study|On Study at Time of Study Termination|6|||
28080584|NCT03566680|54733924|FG000|Overall Study|Pregnancy|1|||
28080585|NCT03566680|54733924|FG000|Overall Study|Lost to Follow-up|13|||
28080586|NCT03566680|54733924|FG000|Overall Study|Withdrawal by Subject|3|||
28080587|NCT00106353|54733930|FG000|Part 1|Disease progression|3|||
28164743|NCT02521870|54835314|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
28164744|NCT02521870|54835315|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
28164745|NCT02521870|54835316|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
28164746|NCT02521870|54835317|FG004|Phase 2: Dose Expansion|Lost to Follow-up|1|||
28164747|NCT02521870|54835318|FG005|Phase 2: Dose Expansion|Lost to Follow-up|0|||
28164748|NCT02521870|54835319|FG006|Phase 2: Dose Expansion|Lost to Follow-up|0|||
28164749|NCT02521870|54835320|FG007|Phase 2: Dose Expansion|Lost to Follow-up|0|||
28080588|NCT00106353|54733931|FG001|Part 1|Disease progression|4|||
28080589|NCT00106353|54733932|FG002|Part 1|Disease progression|1|||
28080590|NCT00106353|54733933|FG003|Part 1|Disease progression|3|||
28080591|NCT00106353|54733934|FG004|Part 1|Disease progression|0|||
28080592|NCT00106353|54733935|FG005|Part 1|Disease progression|0|||
28080593|NCT00106353|54733936|FG006|Part 1|Disease progression|0|||
28080594|NCT00106353|54733930|FG000|Part 1|Withdrawal by Subject|0|||
28080595|NCT00106353|54733931|FG001|Part 1|Withdrawal by Subject|0|||
28080596|NCT00106353|54733932|FG002|Part 1|Withdrawal by Subject|1|||
28080597|NCT00106353|54733933|FG003|Part 1|Withdrawal by Subject|2|||
28080598|NCT00106353|54733934|FG004|Part 1|Withdrawal by Subject|0|||
28080599|NCT00106353|54733935|FG005|Part 1|Withdrawal by Subject|0|||
28080600|NCT00106353|54733936|FG006|Part 1|Withdrawal by Subject|0|||
28164750|NCT02521870|54835321|FG008|Phase 2: Dose Expansion|Lost to Follow-up|0|||
28164751|NCT02521870|54835322|FG009|Phase 2: Dose Expansion|Lost to Follow-up|0|||
28164752|NCT02521870|54835323|FG010|Phase 2: Dose Expansion|Lost to Follow-up|0|||
28164753|NCT02521870|54835324|FG011|Phase 2: Dose Expansion|Lost to Follow-up|0|||
28164754|NCT02521870|54835313|FG000|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
28164755|NCT02521870|54835314|FG001|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
28164756|NCT02521870|54835315|FG002|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
27731593|NCT02301988|54178900|FG000|Overall Study|Lack of Efficacy|3|||
27946767|NCT01210352|54604108|FG004|Overall Study|Patient Discharged Early|0|||
27946768|NCT01210352|54604109|FG005|Overall Study|Patient Discharged Early|0|||
27946769|NCT01210352|54604110|FG006|Overall Study|Patient Discharged Early|0|||
27946770|NCT01210352|54604111|FG007|Overall Study|Patient Discharged Early|0|||
27946771|NCT01210352|54604112|FG008|Overall Study|Patient Discharged Early|0|||
27946772|NCT01210118|54604219|FG000|Overall Study|Lost to Follow-up|1|||
27946773|NCT01210118|54604220|FG001|Overall Study|Lost to Follow-up|1|||
27946774|NCT01210118|54604219|FG000|Overall Study|Protocol Violation|1|||
27946775|NCT01210118|54604220|FG001|Overall Study|Protocol Violation|1|||
27946776|NCT01210118|54604219|FG000|Overall Study|Spontaneous abortion|1|||
27946777|NCT01210118|54604220|FG001|Overall Study|Spontaneous abortion|3|||
27946778|NCT01208870|54604231|FG000|Overall Study|Lost to Follow-up|2|||
27946779|NCT01208870|54604232|FG001|Overall Study|Lost to Follow-up|8|||
28080601|NCT00106353|54733930|FG000|Part 1|Symptomatic deterioration|0|||
28080602|NCT00106353|54733931|FG001|Part 1|Symptomatic deterioration|0|||
28080603|NCT00106353|54733932|FG002|Part 1|Symptomatic deterioration|1|||
28080604|NCT00106353|54733933|FG003|Part 1|Symptomatic deterioration|0|||
28080605|NCT00106353|54733934|FG004|Part 1|Symptomatic deterioration|0|||
28080606|NCT00106353|54733935|FG005|Part 1|Symptomatic deterioration|0|||
28080607|NCT00106353|54733936|FG006|Part 1|Symptomatic deterioration|0|||
28080608|NCT00106353|54733930|FG000|Part 1|Entered follow-up phase|1|||
28080609|NCT00106353|54733931|FG001|Part 1|Entered follow-up phase|1|||
28080610|NCT00106353|54733932|FG002|Part 1|Entered follow-up phase|0|||
28080611|NCT00106353|54733933|FG003|Part 1|Entered follow-up phase|1|||
28080612|NCT00106353|54733934|FG004|Part 1|Entered follow-up phase|0|||
28080613|NCT00106353|54733935|FG005|Part 1|Entered follow-up phase|0|||
28080614|NCT00106353|54733936|FG006|Part 1|Entered follow-up phase|0|||
28080615|NCT00106353|54733930|FG000|Part 1|Adverse Event|0|||
28080616|NCT00106353|54733931|FG001|Part 1|Adverse Event|0|||
28080617|NCT00106353|54733932|FG002|Part 1|Adverse Event|0|||
28080618|NCT00106353|54733933|FG003|Part 1|Adverse Event|1|||
28080619|NCT00106353|54733934|FG004|Part 1|Adverse Event|0|||
28080620|NCT00106353|54733935|FG005|Part 1|Adverse Event|0|||
28080621|NCT00106353|54733936|FG006|Part 1|Adverse Event|0|||
28080622|NCT00106353|54733930|FG000|Part 2|Disease progression|0|||
28080623|NCT00106353|54733931|FG001|Part 2|Disease progression|0|||
28080624|NCT00106353|54733932|FG002|Part 2|Disease progression|0|||
28080625|NCT00106353|54733933|FG003|Part 2|Disease progression|0|||
28080626|NCT00106353|54733934|FG004|Part 2|Disease progression|8|||
28080627|NCT00106353|54733935|FG005|Part 2|Disease progression|14|||
28164757|NCT02521870|54835316|FG003|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
27731594|NCT02301988|54178901|FG001|Overall Study|Lack of Efficacy|2|||
28080628|NCT00106353|54733936|FG006|Part 2|Disease progression|13|||
28080629|NCT00106353|54733930|FG000|Part 2|Death|0|||
28080630|NCT00106353|54733931|FG001|Part 2|Death|0|||
27731595|NCT02301988|54178900|FG000|Overall Study|Death|1|||
27946780|NCT00880555|54604243|FG000|Overall Study|Physician Decision|0|||
27946781|NCT00880555|54604244|FG001|Overall Study|Physician Decision|8|||
27946782|NCT00880555|54604245|FG002|Overall Study|Physician Decision|0|||
27946783|NCT00880555|54604246|FG003|Overall Study|Physician Decision|2|||
27946784|NCT00880555|54604247|FG004|Overall Study|Physician Decision|1|||
28080631|NCT00106353|54733932|FG002|Part 2|Death|0|||
28080632|NCT00106353|54733933|FG003|Part 2|Death|0|||
28080633|NCT00106353|54733934|FG004|Part 2|Death|3|||
27946785|NCT00880555|54604248|FG005|Overall Study|Physician Decision|0|||
27946786|NCT00880555|54604243|FG000|Overall Study|Withdrawal by Subject|1|||
27946787|NCT00880555|54604244|FG001|Overall Study|Withdrawal by Subject|1|||
27946788|NCT00880555|54604245|FG002|Overall Study|Withdrawal by Subject|0|||
27946789|NCT00880555|54604246|FG003|Overall Study|Withdrawal by Subject|0|||
27946790|NCT00880555|54604247|FG004|Overall Study|Withdrawal by Subject|0|||
27946791|NCT00880555|54604248|FG005|Overall Study|Withdrawal by Subject|0|||
27946792|NCT00880555|54604243|FG000|Overall Study|Lack of resources (hired rater)|9|||
27946793|NCT00880555|54604244|FG001|Overall Study|Lack of resources (hired rater)|7|||
27946794|NCT00880555|54604245|FG002|Overall Study|Lack of resources (hired rater)|5|||
27946795|NCT00880555|54604246|FG003|Overall Study|Lack of resources (hired rater)|0|||
27946796|NCT00880555|54604247|FG004|Overall Study|Lack of resources (hired rater)|0|||
27946797|NCT00880555|54604248|FG005|Overall Study|Lack of resources (hired rater)|0|||
27946798|NCT00880555|54604243|FG000|Overall Study|Death|0|||
27946799|NCT00880555|54604244|FG001|Overall Study|Death|0|||
27946800|NCT00880555|54604245|FG002|Overall Study|Death|0|||
27946801|NCT00880555|54604246|FG003|Overall Study|Death|0|||
27731596|NCT02301988|54178901|FG001|Overall Study|Death|0|||
27854096|NCT01421342|54365902|FG000|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6|||
27854097|NCT01421342|54365903|FG001|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0|||
27854098|NCT01421342|54365904|FG002|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7|||
27731597|NCT02301988|54178900|FG000|Overall Study|Adverse Event|1|||
27854099|NCT01384760|54365927|FG000|Overall Study|Lost to Follow-up|0|||
27854100|NCT01384760|54365928|FG001|Overall Study|Lost to Follow-up|6|||
27854101|NCT01384760|54365927|FG000|Overall Study|Protocol Violation|16|||
27854102|NCT01384760|54365928|FG001|Overall Study|Protocol Violation|0|||
27854103|NCT01384292|54365968|FG000|Part B|Severe non-compliance to protocol|1|||
27854104|NCT01384292|54365969|FG001|Part B|Severe non-compliance to protocol|0|||
27854105|NCT01384292|54365970|FG002|Part B|Severe non-compliance to protocol|0|||
27854106|NCT01401452|54365980|FG000|Overall Study|Adverse reaction|9|||
27854107|NCT01401452|54365980|FG000|Overall Study|Lost to Follow-up|12|||
27854108|NCT01401452|54365980|FG000|Overall Study|Lack of Efficacy|30|||
27854109|NCT01401452|54365980|FG000|Overall Study|Participant developed breast cancer|1|||
27854110|NCT01401452|54365980|FG000|Overall Study|Tx stopped due to financial reasons|1|||
27854111|NCT01401452|54365980|FG000|Overall Study|Tx stopped by psychiatrist|1|||
27854112|NCT01401452|54365980|FG000|Overall Study|No more visits within the 36 wk followup|4|||
27854113|NCT01401452|54365980|FG000|Overall Study|Subject did not come to follow up visits|2|||
27854114|NCT01401452|54365980|FG000|Overall Study|Subject didn't return for routine visits|1|||
27854115|NCT01401452|54365980|FG000|Overall Study|Subject moved to another city|1|||
27854116|NCT01401452|54365980|FG000|Overall Study|Subject's wife wants to get pregnant|1|||
27854117|NCT01401452|54365980|FG000|Overall Study|Psoriatic arthritis|1|||
27854118|NCT01401452|54365980|FG000|Overall Study|Participant stopped Tx|2|||
27854119|NCT01401452|54365980|FG000|Overall Study|Discontinuation for personal reasons|1|||
27854120|NCT01401452|54365980|FG000|Overall Study|Treatment failure|1|||
27854121|NCT01401452|54365980|FG000|Overall Study|Unsatisfactory output|1|||
27854122|NCT01401452|54365980|FG000|Overall Study|Subject withdrew because of Tx success|1|||
27854123|NCT01401452|54365980|FG000|Overall Study|Subject chose to discontinue treatment|1|||
27854124|NCT01401452|54365980|FG000|Overall Study|Participant withdrew consent|1|||
27854125|NCT01401062|54366015|FG000|Overall Study|Death|9|||
27854126|NCT01401062|54366016|FG001|Overall Study|Death|7|||
27854127|NCT01401062|54366015|FG000|Overall Study|Physician Decision|1|||
27854128|NCT01401062|54366016|FG001|Overall Study|Physician Decision|0|||
27854129|NCT01401062|54366015|FG000|Overall Study|Withdrawal by Subject|1|||
27854130|NCT01401062|54366016|FG001|Overall Study|Withdrawal by Subject|1|||
27854131|NCT01400516|54366049|FG000|Primary Trial|Withdrawal by Subject|0|||
27854132|NCT01400516|54366050|FG001|Primary Trial|Withdrawal by Subject|2|||
27854133|NCT01383356|54366056|FG000|Period 1|Adverse Event|5|||
27854134|NCT01383356|54366057|FG001|Period 1|Adverse Event|3|||
27854135|NCT01383356|54366056|FG000|Period 1|Non-compliance|3|||
27854136|NCT01383356|54366057|FG001|Period 1|Non-compliance|0|||
27854137|NCT01383356|54366056|FG000|Period 1|Out of Range Mid-study-Test|0|||
27854138|NCT01383356|54366057|FG001|Period 1|Out of Range Mid-study-Test|1|||
27854139|NCT01383356|54366056|FG000|Period 1|Personal|0|||
27854140|NCT01383356|54366057|FG001|Period 1|Personal|2|||
27854141|NCT01399736|54366108|FG000|Overall Study|Withdrawal by Subject|4|||
27854142|NCT01399736|54366109|FG001|Overall Study|Withdrawal by Subject|2|||
27854143|NCT01399736|54366108|FG000|Overall Study|Lost to Follow-up|0|||
27854144|NCT01399736|54366109|FG001|Overall Study|Lost to Follow-up|2|||
27854145|NCT04372927|54366239|FG000|Overall Study|Death|1|||
27854146|NCT01381874|54366246|FG000|Overall Study|Lost to Follow-up|1|||
27854147|NCT01381874|54366247|FG001|Overall Study|Lost to Follow-up|1|||
27946802|NCT00880555|54604247|FG004|Overall Study|Death|0|||
27946803|NCT00880555|54604248|FG005|Overall Study|Death|1|||
27946804|NCT00880555|54604243|FG000|Overall Study|Lost to Follow-up|0|||
27946805|NCT00880555|54604244|FG001|Overall Study|Lost to Follow-up|1|||
27946806|NCT00880555|54604245|FG002|Overall Study|Lost to Follow-up|0|||
27731598|NCT02301988|54178901|FG001|Overall Study|Adverse Event|1|||
27946807|NCT00880555|54604246|FG003|Overall Study|Lost to Follow-up|0|||
27946808|NCT00880555|54604247|FG004|Overall Study|Lost to Follow-up|0|||
27946809|NCT00880555|54604248|FG005|Overall Study|Lost to Follow-up|0|||
27946810|NCT01208402|54604261|FG000|Overall Study|Withdrawal by Subject|1|||
27946811|NCT01208402|54604262|FG001|Overall Study|Withdrawal by Subject|0|||
27946812|NCT01208324|54604272|FG000|Post-randomization of Patch|Withdrawal by Subject|1|||
27946813|NCT01208324|54604273|FG001|Post-randomization of Patch|Withdrawal by Subject|0|||
27946814|NCT01208324|54604274|FG002|Post-randomization of Patch|Withdrawal by Subject|0|||
27946815|NCT01208324|54604275|FG003|Post-randomization of Patch|Withdrawal by Subject|0|||
27946816|NCT00880399|54604288|FG000|Overall Study|Adverse Event|4|||
27946817|NCT00880399|54604289|FG001|Overall Study|Adverse Event|6|||
27946818|NCT00880399|54604290|FG002|Overall Study|Adverse Event|5|||
27946819|NCT00880399|54604288|FG000|Overall Study|Lack of Efficacy|1|||
27946820|NCT00880399|54604289|FG001|Overall Study|Lack of Efficacy|4|||
27946821|NCT00880399|54604290|FG002|Overall Study|Lack of Efficacy|2|||
27946822|NCT00880399|54604288|FG000|Overall Study|Protocol Violation|4|||
27946823|NCT00880399|54604289|FG001|Overall Study|Protocol Violation|4|||
27946824|NCT00880399|54604290|FG002|Overall Study|Protocol Violation|6|||
27946825|NCT00880399|54604288|FG000|Overall Study|Study closed/terminated|3|||
27946826|NCT00880399|54604289|FG001|Overall Study|Study closed/terminated|7|||
27946827|NCT00880399|54604290|FG002|Overall Study|Study closed/terminated|4|||
27946828|NCT00880399|54604288|FG000|Overall Study|Lost to Follow-up|8|||
27946829|NCT00880399|54604289|FG001|Overall Study|Lost to Follow-up|5|||
27946830|NCT00880399|54604290|FG002|Overall Study|Lost to Follow-up|3|||
27946831|NCT00880399|54604288|FG000|Overall Study|Physician Decision|5|||
27946832|NCT00880399|54604289|FG001|Overall Study|Physician Decision|0|||
28080634|NCT00106353|54733935|FG005|Part 2|Death|0|||
28080635|NCT00106353|54733936|FG006|Part 2|Death|1|||
28080636|NCT00106353|54733930|FG000|Part 2|Symptomatic deterioration|0|||
27831998|NCT01781429|54310825|FG005|Overall Study|Withdrawal by Subject|0|||
27831999|NCT01781429|54310826|FG006|Overall Study|Withdrawal by Subject|0|||
27832000|NCT01781429|54310827|FG007|Overall Study|Withdrawal by Subject|0|||
27832001|NCT01781429|54310828|FG008|Overall Study|Withdrawal by Subject|1|||
27832002|NCT01781429|54310829|FG009|Overall Study|Withdrawal by Subject|3|||
27832003|NCT01781429|54310830|FG010|Overall Study|Withdrawal by Subject|1|||
27832004|NCT01781429|54310831|FG011|Overall Study|Withdrawal by Subject|1|||
27832005|NCT01781429|54310832|FG012|Overall Study|Withdrawal by Subject|5|||
27832006|NCT01781429|54310833|FG013|Overall Study|Withdrawal by Subject|2|||
27832007|NCT01781429|54310834|FG014|Overall Study|Withdrawal by Subject|3|||
27854148|NCT01381874|54366248|FG002|Overall Study|Lost to Follow-up|0|||
27854149|NCT01381874|54366246|FG000|Overall Study|Withdrawal by Subject|9|||
27854150|NCT01381874|54366247|FG001|Overall Study|Withdrawal by Subject|10|||
27854151|NCT01381874|54366248|FG002|Overall Study|Withdrawal by Subject|9|||
27854152|NCT01381874|54366246|FG000|Overall Study|Other|67|||
27854153|NCT01381874|54366247|FG001|Overall Study|Other|52|||
27854154|NCT01381874|54366248|FG002|Overall Study|Other|67|||
27854155|NCT01399190|54366256|FG000|Overall Study|Not Eligible for Final Analysis|5|||
27854156|NCT01399190|54366256|FG000|Overall Study|Adverse Event|8|||
27854157|NCT01399190|54366256|FG000|Overall Study|Participant's Request|5|||
27854158|NCT01399190|54366256|FG000|Overall Study|Physician Decision|2|||
27854159|NCT01381718|54366274|FG000|Overall Study|Withdrawal by Subject|2|||
27854160|NCT01381718|54366275|FG001|Overall Study|Withdrawal by Subject|5|||
27854161|NCT01381718|54366274|FG000|Overall Study|Lost to Follow-up|3|||
27854162|NCT01381718|54366275|FG001|Overall Study|Lost to Follow-up|5|||
27854163|NCT01381718|54366274|FG000|Overall Study|Toxicity, side effects or complications related to study|0|||
27854164|NCT01381718|54366275|FG001|Overall Study|Toxicity, side effects or complications related to study|3|||
27854165|NCT01398956|54366294|FG000|Overall Study|Withdrawal by Subject|4|||
27854166|NCT01398956|54366294|FG000|Overall Study|AE, non-serious non-fatal|4|||
27854167|NCT01398956|54366294|FG000|Overall Study|Withdrawal Criteria No.3|1|||
27854168|NCT01398956|54366294|FG000|Overall Study|Subject moved a long distance|1|||
27854169|NCT01381562|54366320|FG000|Overall Study|Adverse Event|0|||
27854170|NCT01381562|54366321|FG001|Overall Study|Adverse Event|1|||
27854171|NCT01381562|54366322|FG002|Overall Study|Adverse Event|0|||
27854172|NCT01381016|54366345|FG000|Overall Study|Lost to Follow-up|1|||
27854173|NCT01381016|54366346|FG001|Overall Study|Lost to Follow-up|1|||
27854174|NCT01381016|54366345|FG000|Overall Study|Screen Failure|2|||
27946833|NCT00880399|54604290|FG002|Overall Study|Physician Decision|3|||
27946834|NCT00880399|54604288|FG000|Overall Study|Withdrawal by Subject|6|||
27946835|NCT00880399|54604289|FG001|Overall Study|Withdrawal by Subject|3|||
27946836|NCT00880399|54604290|FG002|Overall Study|Withdrawal by Subject|3|||
27946837|NCT01207388|54604298|FG000|Overall Study|Death|67|||
27946838|NCT01207388|54604298|FG000|Overall Study|Withdrawal by Subject|1|||
27832008|NCT01781429|54310835|FG015|Overall Study|Withdrawal by Subject|0|||
27854175|NCT01381016|54366346|FG001|Overall Study|Screen Failure|2|||
27854176|NCT01381016|54366345|FG000|Overall Study|Withdrawal by Subject|0|||
27854177|NCT01381016|54366346|FG001|Overall Study|Withdrawal by Subject|1|||
27946839|NCT01206764|54604310|FG000|Overall Study|Adverse Event|20|||
28080637|NCT00106353|54733931|FG001|Part 2|Symptomatic deterioration|0|||
27946840|NCT01206764|54604310|FG000|Overall Study|Abnormal laboratory value|2|||
27946841|NCT01206764|54604310|FG000|Overall Study|Abnormal test procedure result|1|||
27946842|NCT01206764|54604310|FG000|Overall Study|Patient withdrew consent|5|||
27946843|NCT01206764|54604310|FG000|Overall Study|Lost to Follow-up|6|||
27946844|NCT01206764|54604310|FG000|Overall Study|Death|11|||
27946845|NCT01206764|54604310|FG000|Overall Study|New cancer therapy|2|||
27946846|NCT01206764|54604310|FG000|Overall Study|Disease progression|88|||
27946847|NCT01206764|54604310|FG000|Overall Study|Protocol deviation|3|||
27946848|NCT00894322|54604317|FG000|Overall Study|Withdrawal by Subject|1|||
27946849|NCT00894322|54604318|FG001|Overall Study|Withdrawal by Subject|0|||
27946850|NCT00894322|54604319|FG002|Overall Study|Withdrawal by Subject|0|||
27946851|NCT00596635|54604332|FG000|Overall Study|Lost to Follow-up|0|||
27946852|NCT00596635|54604333|FG001|Overall Study|Lost to Follow-up|2|||
28080638|NCT00106353|54733932|FG002|Part 2|Symptomatic deterioration|0|||
28080639|NCT00106353|54733933|FG003|Part 2|Symptomatic deterioration|0|||
28080640|NCT00106353|54733934|FG004|Part 2|Symptomatic deterioration|3|||
28080641|NCT00106353|54733935|FG005|Part 2|Symptomatic deterioration|0|||
28080642|NCT00106353|54733936|FG006|Part 2|Symptomatic deterioration|0|||
28080643|NCT00106353|54733930|FG000|Part 2|Adverse Event|0|||
28080644|NCT00106353|54733931|FG001|Part 2|Adverse Event|0|||
28080645|NCT00106353|54733932|FG002|Part 2|Adverse Event|0|||
28080646|NCT00106353|54733933|FG003|Part 2|Adverse Event|0|||
28080647|NCT00106353|54733934|FG004|Part 2|Adverse Event|0|||
27946853|NCT00596635|54604334|FG002|Overall Study|Lost to Follow-up|0|||
27946854|NCT00596635|54604332|FG000|Overall Study|Treatment for symptomatic UTI|4|||
27946855|NCT00596635|54604333|FG001|Overall Study|Treatment for symptomatic UTI|6|||
28080648|NCT00106353|54733935|FG005|Part 2|Adverse Event|2|||
28080649|NCT00106353|54733936|FG006|Part 2|Adverse Event|1|||
28080650|NCT00106353|54733930|FG000|Part 2|Other|0|||
28080651|NCT00106353|54733931|FG001|Part 2|Other|0|||
28080652|NCT00106353|54733932|FG002|Part 2|Other|0|||
28080653|NCT00106353|54733933|FG003|Part 2|Other|0|||
28080654|NCT00106353|54733934|FG004|Part 2|Other|1|||
28080655|NCT00106353|54733935|FG005|Part 2|Other|1|||
28080656|NCT00106353|54733936|FG006|Part 2|Other|1|||
28080657|NCT00106353|54733930|FG000|Part 2|Withdrawal by Subject|0|||
28080658|NCT00106353|54733931|FG001|Part 2|Withdrawal by Subject|0|||
28080659|NCT00106353|54733932|FG002|Part 2|Withdrawal by Subject|0|||
28080660|NCT00106353|54733933|FG003|Part 2|Withdrawal by Subject|0|||
28080661|NCT00106353|54733934|FG004|Part 2|Withdrawal by Subject|1|||
28080662|NCT00106353|54733935|FG005|Part 2|Withdrawal by Subject|0|||
28080663|NCT00106353|54733936|FG006|Part 2|Withdrawal by Subject|0|||
28080664|NCT00106353|54733930|FG000|Part 2|Physician Decision|0|||
28080665|NCT00106353|54733931|FG001|Part 2|Physician Decision|0|||
28080666|NCT00106353|54733932|FG002|Part 2|Physician Decision|0|||
28080667|NCT00106353|54733933|FG003|Part 2|Physician Decision|0|||
28080668|NCT00106353|54733934|FG004|Part 2|Physician Decision|0|||
28080669|NCT00106353|54733935|FG005|Part 2|Physician Decision|1|||
28080670|NCT00106353|54733936|FG006|Part 2|Physician Decision|0|||
28080671|NCT00080301|54733959|FG000|Overall Study|Randomized but Never Treated|5|||
28080672|NCT00080301|54733960|FG001|Overall Study|Randomized but Never Treated|10|||
28080673|NCT00080301|54733959|FG000|Overall Study|Still on Treatment as of CSR date|0|||
28080674|NCT00080301|54733960|FG001|Overall Study|Still on Treatment as of CSR date|1|||
28080675|NCT00079677|54733969|FG000|Overall Study|Adverse Event|5|||
28080676|NCT00079677|54733970|FG001|Overall Study|Adverse Event|6|||
28080677|NCT00079677|54733969|FG000|Overall Study|Lack of Efficacy|1|||
28080678|NCT00079677|54733970|FG001|Overall Study|Lack of Efficacy|0|||
28080679|NCT00079677|54733969|FG000|Overall Study|Lost to Follow-up|2|||
28080680|NCT00079677|54733970|FG001|Overall Study|Lost to Follow-up|2|||
28080681|NCT00079677|54733969|FG000|Overall Study|Physician Decision|3|||
28080682|NCT00079677|54733970|FG001|Overall Study|Physician Decision|0|||
28080683|NCT00079677|54733969|FG000|Overall Study|Protocol Violation|2|||
28080684|NCT00079677|54733970|FG001|Overall Study|Protocol Violation|3|||
28080685|NCT00079677|54733969|FG000|Overall Study|Withdrawal by Subject|5|||
28080686|NCT00079677|54733970|FG001|Overall Study|Withdrawal by Subject|3|||
28080687|NCT00079677|54733969|FG000|Overall Study|Miscellaneous|2|||
28080688|NCT00079677|54733970|FG001|Overall Study|Miscellaneous|0|||
27832009|NCT01781429|54310820|FG000|Overall Study|Disease Progression|1|||
27946856|NCT00596635|54604334|FG002|Overall Study|Treatment for symptomatic UTI|3|||
27946857|NCT00596635|54604332|FG000|Overall Study|Hip fracture|2|||
27946858|NCT00596635|54604333|FG001|Overall Study|Hip fracture|3|||
27946859|NCT00596635|54604334|FG002|Overall Study|Hip fracture|3|||
27946860|NCT00596635|54604332|FG000|Overall Study|Could not provide urine specimen|1|||
27946861|NCT00596635|54604333|FG001|Overall Study|Could not provide urine specimen|2|||
27946862|NCT00596635|54604334|FG002|Overall Study|Could not provide urine specimen|2|||
28080689|NCT00095121|54733978|FG000|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1|||
28080690|NCT00095121|54733979|FG001|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0|||
28080691|NCT00095121|54733978|FG000|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2|||
28080692|NCT00095121|54733979|FG001|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0|||
28080693|NCT00094809|54733997|FG000|Overall Study|Protocol deviation|2|||
27946863|NCT00894166|54604350|FG000|Overall Study|Withdrew or Lost to Follow-Up|61|||
27946864|NCT00894166|54604351|FG001|Overall Study|Withdrew or Lost to Follow-Up|63|||
27946865|NCT00894166|54604352|FG002|Overall Study|Withdrew or Lost to Follow-Up|62|||
27946866|NCT00894166|54604353|FG003|Overall Study|Withdrew or Lost to Follow-Up|68|||
27946867|NCT00894166|54604354|FG004|Overall Study|Withdrew or Lost to Follow-Up|24|||
27946868|NCT00894166|54604355|FG005|Overall Study|Withdrew or Lost to Follow-Up|16|||
27946869|NCT00894166|54604356|FG006|Overall Study|Withdrew or Lost to Follow-Up|16|||
27946870|NCT00894166|54604357|FG007|Overall Study|Withdrew or Lost to Follow-Up|34|||
27946871|NCT00894166|54604350|FG000|Overall Study|Death|0|||
27946872|NCT00894166|54604351|FG001|Overall Study|Death|0|||
27946873|NCT00894166|54604352|FG002|Overall Study|Death|0|||
27946874|NCT00894166|54604353|FG003|Overall Study|Death|1|||
27946875|NCT00894166|54604354|FG004|Overall Study|Death|0|||
27946876|NCT00894166|54604355|FG005|Overall Study|Death|0|||
27946877|NCT00894166|54604356|FG006|Overall Study|Death|0|||
28080694|NCT00094809|54733998|FG001|Overall Study|Protocol deviation|2|||
28080695|NCT00094809|54733997|FG000|Overall Study|Noncompliance|1|||
28080696|NCT00094809|54733998|FG001|Overall Study|Noncompliance|0|||
28080697|NCT00094809|54733997|FG000|Overall Study|Adverse Event|3|||
28080698|NCT00094809|54733998|FG001|Overall Study|Adverse Event|1|||
28080699|NCT00094809|54733997|FG000|Overall Study|Withdrawal by Subject|8|||
28080700|NCT00094809|54733998|FG001|Overall Study|Withdrawal by Subject|9|||
28080701|NCT00094809|54733997|FG000|Overall Study|Disease progression|3|||
28080702|NCT00094809|54733998|FG001|Overall Study|Disease progression|3|||
28080703|NCT00094809|54733997|FG000|Overall Study|Physician Decision|3|||
28080704|NCT00094809|54733998|FG001|Overall Study|Physician Decision|5|||
28080705|NCT00094809|54733997|FG000|Overall Study|Lost to Follow-up|6|||
28080706|NCT00094809|54733998|FG001|Overall Study|Lost to Follow-up|6|||
28080707|NCT00094809|54733997|FG000|Overall Study|Death|19|||
28164758|NCT02521870|54835317|FG004|Phase 2: Dose Expansion|Non-Compliance with Study Drug|2|||
28164759|NCT02521870|54835318|FG005|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
28164760|NCT02521870|54835319|FG006|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
28080708|NCT00094809|54733998|FG001|Overall Study|Death|25|||
28080709|NCT00094809|54733997|FG000|Overall Study|Protocol-specified criteria|1|||
28080710|NCT00094809|54733998|FG001|Overall Study|Protocol-specified criteria|1|||
28080711|NCT00094809|54733997|FG000|Overall Study|Other|2|||
28080712|NCT00094809|54733998|FG001|Overall Study|Other|4|||
28080713|NCT00094809|54733997|FG000|Overall Study|Informed consent signed after treatment|1|||
28080714|NCT00094809|54733998|FG001|Overall Study|Informed consent signed after treatment|0|||
28080715|NCT00094809|54733997|FG000|Overall Study|Study drug not received|2|||
28080716|NCT00094809|54733998|FG001|Overall Study|Study drug not received|8|||
28080717|NCT00094809|54733997|FG000|Overall Study|Other|1|||
28080718|NCT00094809|54733998|FG001|Overall Study|Other|1|||
28080719|NCT00075218|54734006|FG000|Double-Blind Treatment|Adverse Event|23|||
28080720|NCT00075218|54734007|FG001|Double-Blind Treatment|Adverse Event|4|||
28080721|NCT00075218|54734008|FG002|Double-Blind Treatment|Adverse Event|0|||
28080722|NCT00075218|54734006|FG000|Double-Blind Treatment|Withdrawal by Subject|7|||
28080723|NCT00075218|54734007|FG001|Double-Blind Treatment|Withdrawal by Subject|4|||
28080724|NCT00075218|54734008|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
28080725|NCT00075218|54734006|FG000|Double-Blind Treatment|Lost to Follow-up|1|||
28080726|NCT00075218|54734007|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
28080727|NCT00075218|54734008|FG002|Double-Blind Treatment|Lost to Follow-up|0|||
28080728|NCT00075218|54734006|FG000|Double-Blind Treatment|Lack of Efficacy|58|||
28080729|NCT00075218|54734007|FG001|Double-Blind Treatment|Lack of Efficacy|6|||
28080730|NCT00075218|54734008|FG002|Double-Blind Treatment|Lack of Efficacy|0|||
28080731|NCT00075218|54734006|FG000|Double-Blind Treatment|Decision of Sponsor|0|||
28080732|NCT00075218|54734007|FG001|Double-Blind Treatment|Decision of Sponsor|1|||
28080733|NCT00075218|54734008|FG002|Double-Blind Treatment|Decision of Sponsor|0|||
28080734|NCT00075218|54734006|FG000|Double-Blind Treatment|No study medication taken|2|||
28080735|NCT00075218|54734007|FG001|Double-Blind Treatment|No study medication taken|0|||
28080736|NCT00075218|54734008|FG002|Double-Blind Treatment|No study medication taken|0|||
28080737|NCT00075218|54734006|FG000|Open-Label Treatment|Lack of Efficacy|0|||
28080738|NCT00075218|54734007|FG001|Open-Label Treatment|Lack of Efficacy|0|||
28080739|NCT00075218|54734008|FG002|Open-Label Treatment|Lack of Efficacy|174|||
28164761|NCT02521870|54835320|FG007|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
28164762|NCT02521870|54835321|FG008|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
28164763|NCT02521870|54835322|FG009|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
27946878|NCT00894166|54604357|FG007|Overall Study|Death|0|||
27946879|NCT00880165|54604382|FG000|Overall Study|Withdrawal by Subject|27|||
27946880|NCT00880165|54604383|FG001|Overall Study|Withdrawal by Subject|23|||
27946881|NCT00880165|54604382|FG000|Overall Study|Not diagnosed with OSA|14|||
27946882|NCT00880165|54604383|FG001|Overall Study|Not diagnosed with OSA|8|||
27946883|NCT00880165|54604382|FG000|Overall Study|Required BIPAP or oxygen treatment|12|||
28080740|NCT00075218|54734006|FG000|Open-Label Treatment|Adverse Event|0|||
28080741|NCT00075218|54734007|FG001|Open-Label Treatment|Adverse Event|0|||
28080742|NCT00075218|54734008|FG002|Open-Label Treatment|Adverse Event|51|||
27854178|NCT01381016|54366345|FG000|Overall Study|Physician Decision|0|||
27854179|NCT01381016|54366346|FG001|Overall Study|Physician Decision|2|||
27854180|NCT01398410|54366373|FG000|Overall Study|Adverse Event|12|||
27854181|NCT01398410|54366374|FG001|Overall Study|Adverse Event|16|||
27854182|NCT01398410|54366373|FG000|Overall Study|Participants Choice|8|||
27854183|NCT01398410|54366374|FG001|Overall Study|Participants Choice|11|||
27854184|NCT01398410|54366373|FG000|Overall Study|Inadequate Therapeutic Effect|2|||
27854185|NCT01398410|54366374|FG001|Overall Study|Inadequate Therapeutic Effect|0|||
27854186|NCT01398410|54366373|FG000|Overall Study|Other|36|||
27854187|NCT01398410|54366374|FG001|Overall Study|Other|29|||
27854188|NCT01380782|54366440|FG000|Overall Study|Adverse Event|0|||
27854189|NCT01380782|54366441|FG001|Overall Study|Adverse Event|1|||
27854190|NCT01380782|54366442|FG002|Overall Study|Adverse Event|0|||
27854191|NCT01380782|54366443|FG003|Overall Study|Adverse Event|0|||
27854192|NCT01380782|54366440|FG000|Overall Study|Death|1|||
27854193|NCT01380782|54366441|FG001|Overall Study|Death|0|||
27854194|NCT01380782|54366442|FG002|Overall Study|Death|0|||
27854195|NCT01380782|54366443|FG003|Overall Study|Death|0|||
27854196|NCT01380782|54366440|FG000|Overall Study|Lack of Efficacy|10|||
27854197|NCT01380782|54366441|FG001|Overall Study|Lack of Efficacy|9|||
27854198|NCT01380782|54366442|FG002|Overall Study|Lack of Efficacy|10|||
27854199|NCT01380782|54366443|FG003|Overall Study|Lack of Efficacy|3|||
27854200|NCT01380782|54366440|FG000|Overall Study|Physician Decision|1|||
27854201|NCT01380782|54366441|FG001|Overall Study|Physician Decision|0|||
27854202|NCT01380782|54366442|FG002|Overall Study|Physician Decision|0|||
27854203|NCT01380782|54366443|FG003|Overall Study|Physician Decision|0|||
27854204|NCT01380782|54366440|FG000|Overall Study|Withdrawal by Subject|0|||
27854205|NCT01380782|54366441|FG001|Overall Study|Withdrawal by Subject|0|||
27854206|NCT01380782|54366442|FG002|Overall Study|Withdrawal by Subject|1|||
27854207|NCT01380782|54366443|FG003|Overall Study|Withdrawal by Subject|1|||
27854208|NCT01398176|54366457|FG000|Overall Study|Lost to Follow-up|1|||
27854209|NCT01398176|54366458|FG001|Overall Study|Lost to Follow-up|3|||
27854210|NCT01398176|54366457|FG000|Overall Study|Physician Decision|2|||
27854211|NCT01398176|54366458|FG001|Overall Study|Physician Decision|3|||
27854212|NCT01397786|54366511|FG000|Phase A|Lost to Follow-up|0|||
27854213|NCT01397786|54366512|FG001|Phase A|Lost to Follow-up|0|||
27946884|NCT00880165|54604383|FG001|Overall Study|Required BIPAP or oxygen treatment|4|||
28080743|NCT00075218|54734006|FG000|Open-Label Treatment|Withdrawal by Subject|0|||
28080744|NCT00075218|54734007|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
28080745|NCT00075218|54734008|FG002|Open-Label Treatment|Withdrawal by Subject|12|||
28080746|NCT00075218|54734006|FG000|Open-Label Treatment|Decision of Sponsor|0|||
28080747|NCT00075218|54734007|FG001|Open-Label Treatment|Decision of Sponsor|0|||
28080748|NCT00075218|54734008|FG002|Open-Label Treatment|Decision of Sponsor|8|||
28080749|NCT00075218|54734006|FG000|Open-Label Treatment|Protocol Violation|0|||
28080750|NCT00075218|54734007|FG001|Open-Label Treatment|Protocol Violation|0|||
28080751|NCT00075218|54734008|FG002|Open-Label Treatment|Protocol Violation|1|||
28080752|NCT00075218|54734006|FG000|Open-Label Treatment|enrolled in a separate continuation|0|||
28080753|NCT00075218|54734007|FG001|Open-Label Treatment|enrolled in a separate continuation|0|||
28080754|NCT00075218|54734008|FG002|Open-Label Treatment|enrolled in a separate continuation|9|||
28080755|NCT00094653|54734018|FG000|Overall Study|Death|306|||
28080756|NCT00094653|54734019|FG001|Overall Study|Death|100|||
28080757|NCT00094653|54734020|FG002|Overall Study|Death|119|||
28080758|NCT00094653|54734018|FG000|Overall Study|Subject Withdrew Consent|10|||
27832010|NCT01781429|54310821|FG001|Overall Study|Disease Progression|0|||
27832011|NCT01781429|54310822|FG002|Overall Study|Disease Progression|1|||
27832012|NCT01781429|54310823|FG003|Overall Study|Disease Progression|1|||
27832013|NCT01781429|54310824|FG004|Overall Study|Disease Progression|1|||
27832014|NCT01781429|54310825|FG005|Overall Study|Disease Progression|4|||
27832015|NCT01781429|54310826|FG006|Overall Study|Disease Progression|7|||
27832016|NCT01781429|54310827|FG007|Overall Study|Disease Progression|4|||
27832017|NCT01781429|54310828|FG008|Overall Study|Disease Progression|6|||
27832018|NCT01781429|54310829|FG009|Overall Study|Disease Progression|15|||
27854214|NCT01397786|54366513|FG002|Phase A|Lost to Follow-up|6|||
27854215|NCT01397786|54366511|FG000|Phase A|Adverse Event|0|||
27854216|NCT01397786|54366512|FG001|Phase A|Adverse Event|0|||
27854217|NCT01397786|54366513|FG002|Phase A|Adverse Event|8|||
27854218|NCT01397786|54366511|FG000|Phase A|Subject Met Withdrawal Criteria|0|||
27854219|NCT01397786|54366512|FG001|Phase A|Subject Met Withdrawal Criteria|0|||
27854220|NCT01397786|54366513|FG002|Phase A|Subject Met Withdrawal Criteria|7|||
27854221|NCT01397786|54366511|FG000|Phase A|Physician Decision|0|||
27854222|NCT01397786|54366512|FG001|Phase A|Physician Decision|0|||
27854223|NCT01397786|54366513|FG002|Phase A|Physician Decision|1|||
27946885|NCT00880165|54604382|FG000|Overall Study|Lost to follow|9|||
27832019|NCT01781429|54310830|FG010|Overall Study|Disease Progression|15|||
27832020|NCT01781429|54310831|FG011|Overall Study|Disease Progression|15|||
27832021|NCT01781429|54310832|FG012|Overall Study|Disease Progression|15|||
27854224|NCT01397786|54366511|FG000|Phase A|Withdrawal by Subject|0|||
27854225|NCT01397786|54366512|FG001|Phase A|Withdrawal by Subject|0|||
28080759|NCT00094653|54734019|FG001|Overall Study|Subject Withdrew Consent|2|||
27731599|NCT02334748|54178916|FG000|Overall Study|Adverse Event|1|||
27731600|NCT02334748|54178916|FG000|Overall Study|Inclusion in the CACZ8852306 study|1|||
27946886|NCT00880165|54604383|FG001|Overall Study|Lost to follow|15|||
27946887|NCT01165229|54604391|FG000|Overall Study|Serious Adverse Event|456|||
27946888|NCT01165229|54604392|FG001|Overall Study|Serious Adverse Event|487|||
27946889|NCT01165229|54604391|FG000|Overall Study|Non-Serious Adverse Event|47|||
27946890|NCT01165229|54604392|FG001|Overall Study|Non-Serious Adverse Event|15|||
27946891|NCT01165229|54604391|FG000|Overall Study|Protocol Violation|6|||
27946892|NCT01165229|54604392|FG001|Overall Study|Protocol Violation|8|||
27946893|NCT01165229|54604391|FG000|Overall Study|Withdrawal by Subject|387|||
27946894|NCT01165229|54604392|FG001|Overall Study|Withdrawal by Subject|396|||
27946895|NCT01165229|54604391|FG000|Overall Study|Migrated/moved from study area|51|||
27946896|NCT01165229|54604392|FG001|Overall Study|Migrated/moved from study area|46|||
27946897|NCT01165229|54604391|FG000|Overall Study|Lost to Follow-up|123|||
27946898|NCT01165229|54604392|FG001|Overall Study|Lost to Follow-up|133|||
27946899|NCT01165229|54604391|FG000|Overall Study|Suspected HZ Episode|2|||
27946900|NCT01165229|54604392|FG001|Overall Study|Suspected HZ Episode|2|||
27946901|NCT01165229|54604391|FG000|Overall Study|No reason from the subject|108|||
27946902|NCT01165229|54604392|FG001|Overall Study|No reason from the subject|102|||
27946903|NCT01165229|54604391|FG000|Overall Study|Unknown completion status|0|||
27946904|NCT01165229|54604392|FG001|Overall Study|Unknown completion status|1|||
27946905|NCT00596011|54604430|FG000|Overall Study|Withdrawal by Subject|2|||
27946906|NCT00596011|54604431|FG001|Overall Study|Withdrawal by Subject|3|||
27946907|NCT00596011|54604430|FG000|Overall Study|Adverse Event|11|||
27946908|NCT00596011|54604431|FG001|Overall Study|Adverse Event|7|||
27946909|NCT01163747|54604439|FG000|Overall Study|Adverse Event|0|||
27946910|NCT01163747|54604440|FG001|Overall Study|Adverse Event|5|||
27946911|NCT01163747|54604439|FG000|Overall Study|Insufficient Therapeutic Response|0|||
27946912|NCT01163747|54604440|FG001|Overall Study|Insufficient Therapeutic Response|1|||
27946913|NCT01163747|54604439|FG000|Overall Study|Protocol Violation|0|||
27946914|NCT01163747|54604440|FG001|Overall Study|Protocol Violation|1|||
27946915|NCT01163747|54604439|FG000|Overall Study|Refused Treatment|6|||
27946916|NCT01163747|54604440|FG001|Overall Study|Refused Treatment|4|||
27946917|NCT01163279|54604448|FG000|Overall Study|Withdrawal by Subject|2|||
27946918|NCT01163279|54604449|FG001|Overall Study|Withdrawal by Subject|0|||
27946919|NCT01162499|54604456|FG000|Intervention 1 (4 Hours)|Unable to establish IV access|0|||
27946920|NCT01162499|54604457|FG001|Intervention 1 (4 Hours)|Unable to establish IV access|1|||
27946921|NCT01206140|54604467|FG000|Overall Study|Deemed ineligible due to incorrect diag.|1|||
27946922|NCT01206140|54604468|FG001|Overall Study|Deemed ineligible due to incorrect diag.|0|||
27946923|NCT01162421|54604476|FG000|Overall Study|Did not receive study drug|2|||
27946924|NCT01162421|54604477|FG001|Overall Study|Did not receive study drug|1|||
27946925|NCT01162421|54604476|FG000|Overall Study|Adverse Event|2|||
27946926|NCT01162421|54604477|FG001|Overall Study|Adverse Event|5|||
27946927|NCT01162421|54604476|FG000|Overall Study|Lost to Follow-up|0|||
27946928|NCT01162421|54604477|FG001|Overall Study|Lost to Follow-up|2|||
27946929|NCT01162421|54604476|FG000|Overall Study|Lack of Efficacy|2|||
27946930|NCT01162421|54604477|FG001|Overall Study|Lack of Efficacy|2|||
27946931|NCT01162421|54604476|FG000|Overall Study|Other|2|||
27946932|NCT01162421|54604477|FG001|Overall Study|Other|3|||
27946933|NCT01162343|54604483|FG000|Overall Study|Left ED prior to psychiatrist assessment|80|||
27946934|NCT01162343|54604483|FG000|Overall Study|Refused psychiatrist assessment|12|||
27946935|NCT01188551|54604491|FG000|Overall Study|Pharmacy issues|1|||
27946936|NCT01188551|54604492|FG001|Overall Study|Pharmacy issues|0|||
27946937|NCT01188551|54604493|FG002|Overall Study|Pharmacy issues|0|||
27946938|NCT01188551|54604494|FG003|Overall Study|Pharmacy issues|0|||
27946939|NCT01161407|54604506|FG000|Overall Study|Protocol Violation|3|||
27946940|NCT01161407|54604507|FG001|Overall Study|Protocol Violation|1|||
27946941|NCT01161173|54604513|FG000|Overall Study|Protocol Violation|13|||
27946942|NCT01161173|54604513|FG000|Overall Study|Lost to Follow-up|7|||
27946943|NCT01161173|54604513|FG000|Overall Study|Progressive Disease|82|||
27946944|NCT01161173|54604513|FG000|Overall Study|Withdrawal of Consent|5|||
28080760|NCT00094653|54734020|FG002|Overall Study|Subject Withdrew Consent|3|||
28080761|NCT00094653|54734018|FG000|Overall Study|Other|2|||
28080762|NCT00094653|54734019|FG001|Overall Study|Other|2|||
27946945|NCT01161173|54604513|FG000|Overall Study|Unacceptable Toxicity|21|||
27946946|NCT01161173|54604513|FG000|Overall Study|Death|194|||
27946947|NCT01161173|54604513|FG000|Overall Study|End of Study|2|||
27946948|NCT01161173|54604513|FG000|Overall Study|Reasons Not Specified|23|||
27946949|NCT01159769|54604517|FG000|Overall Study|Adverse Event|1|||
27946950|NCT01159691|54604521|FG000|Overall Study|Lost to Follow-up|2|||
27946951|NCT01159691|54604521|FG000|Overall Study|Unknown reasons|1|||
27946952|NCT01159691|54604521|FG000|Overall Study|Discontinued Neupro due to Adverse Event|6|||
27946953|NCT01159691|54604521|FG000|Overall Study|Discontinued Neupro due to other reasons|1|||
27946954|NCT01159691|54604521|FG000|Overall Study|Disc. Neupro other & lost to follow-up|2|||
28080763|NCT00094653|54734020|FG002|Overall Study|Other|2|||
28080764|NCT00094653|54734018|FG000|Overall Study|Lost to Follow-up|3|||
27946955|NCT01159691|54604521|FG000|Overall Study|Disc. Neupro other & unknown reasons|7|||
27946956|NCT01159691|54604521|FG000|Overall Study|Disc. Neupro due to AE & unknown reasons|2|||
27946957|NCT01159691|54604521|FG000|Overall Study|Disc. Neupro lack of efficacy & unknown|1|||
27946958|NCT01157897|54604529|FG000|Overall Study|Lost to Follow-up|2|||
27946959|NCT01157897|54604530|FG001|Overall Study|Lost to Follow-up|0|||
27946960|NCT01157897|54604531|FG002|Overall Study|Lost to Follow-up|0|||
27946961|NCT01157897|54604532|FG003|Overall Study|Lost to Follow-up|1|||
27946962|NCT01157897|54604529|FG000|Overall Study|Relocated|0|||
27946963|NCT01157897|54604530|FG001|Overall Study|Relocated|2|||
27946964|NCT01157897|54604531|FG002|Overall Study|Relocated|0|||
27946965|NCT01157897|54604532|FG003|Overall Study|Relocated|0|||
27946966|NCT01185821|54604547|FG000|Overall Study|Abnormal laboratory value(s)|1|||
27946967|NCT01185821|54604548|FG001|Overall Study|Abnormal laboratory value(s)|2|||
27946968|NCT01185821|54604549|FG002|Overall Study|Abnormal laboratory value(s)|1|||
27946969|NCT01185821|54604550|FG003|Overall Study|Abnormal laboratory value(s)|0|||
27946970|NCT01185821|54604551|FG004|Overall Study|Abnormal laboratory value(s)|0|||
27946971|NCT01185821|54604547|FG000|Overall Study|Protocol Violation|0|||
27946972|NCT01185821|54604548|FG001|Overall Study|Protocol Violation|0|||
27946973|NCT01185821|54604549|FG002|Overall Study|Protocol Violation|0|||
27946974|NCT01185821|54604550|FG003|Overall Study|Protocol Violation|1|||
27946975|NCT01185821|54604551|FG004|Overall Study|Protocol Violation|1|||
27946976|NCT01185821|54604547|FG000|Overall Study|Abnormal test procedure result|0|||
27946977|NCT01185821|54604548|FG001|Overall Study|Abnormal test procedure result|0|||
27946978|NCT01185821|54604549|FG002|Overall Study|Abnormal test procedure result|0|||
27946979|NCT01185821|54604550|FG003|Overall Study|Abnormal test procedure result|0|||
27946980|NCT01185821|54604551|FG004|Overall Study|Abnormal test procedure result|1|||
27946981|NCT01185821|54604547|FG000|Overall Study|Death|0|||
27946982|NCT01185821|54604548|FG001|Overall Study|Death|1|||
27946983|NCT01185821|54604549|FG002|Overall Study|Death|0|||
27946984|NCT01185821|54604550|FG003|Overall Study|Death|0|||
27946985|NCT01185821|54604551|FG004|Overall Study|Death|0|||
27946986|NCT01185821|54604547|FG000|Overall Study|Condition no longer required study drug|0|||
27946987|NCT01185821|54604548|FG001|Overall Study|Condition no longer required study drug|0|||
27946988|NCT01185821|54604549|FG002|Overall Study|Condition no longer required study drug|0|||
27946989|NCT01185821|54604550|FG003|Overall Study|Condition no longer required study drug|0|||
27946990|NCT01185821|54604551|FG004|Overall Study|Condition no longer required study drug|1|||
27946991|NCT01185821|54604547|FG000|Overall Study|Adverse Event|2|||
27946992|NCT01185821|54604548|FG001|Overall Study|Adverse Event|3|||
27946993|NCT01185821|54604549|FG002|Overall Study|Adverse Event|1|||
27946994|NCT01185821|54604550|FG003|Overall Study|Adverse Event|2|||
27946995|NCT01185821|54604551|FG004|Overall Study|Adverse Event|5|||
27946996|NCT01185821|54604547|FG000|Overall Study|Lack of Efficacy|0|||
27946997|NCT01185821|54604548|FG001|Overall Study|Lack of Efficacy|0|||
27946998|NCT01185821|54604549|FG002|Overall Study|Lack of Efficacy|3|||
27946999|NCT01185821|54604550|FG003|Overall Study|Lack of Efficacy|0|||
27947000|NCT01185821|54604551|FG004|Overall Study|Lack of Efficacy|9|||
27947001|NCT01185821|54604547|FG000|Overall Study|Withdrawal by Subject|3|||
27947002|NCT01185821|54604548|FG001|Overall Study|Withdrawal by Subject|2|||
27947003|NCT01185821|54604549|FG002|Overall Study|Withdrawal by Subject|2|||
27947004|NCT01185821|54604550|FG003|Overall Study|Withdrawal by Subject|1|||
27947005|NCT01185821|54604551|FG004|Overall Study|Withdrawal by Subject|3|||
27947006|NCT01185821|54604547|FG000|Overall Study|Lost to Follow-up|1|||
27947007|NCT01185821|54604548|FG001|Overall Study|Lost to Follow-up|1|||
27947008|NCT01185821|54604549|FG002|Overall Study|Lost to Follow-up|2|||
27947009|NCT01185821|54604550|FG003|Overall Study|Lost to Follow-up|1|||
27947010|NCT01185821|54604551|FG004|Overall Study|Lost to Follow-up|2|||
27947011|NCT01185821|54604547|FG000|Overall Study|Administrative problems|0|||
27947012|NCT01185821|54604548|FG001|Overall Study|Administrative problems|0|||
27947013|NCT01185821|54604549|FG002|Overall Study|Administrative problems|1|||
27947014|NCT01185821|54604550|FG003|Overall Study|Administrative problems|1|||
27947015|NCT01185821|54604551|FG004|Overall Study|Administrative problems|2|||
27947016|NCT00893464|54604573|FG000|Overall Study|Did not complete therapy/experience PD|0|||
27947017|NCT00893464|54604574|FG001|Overall Study|Did not complete therapy/experience PD|0|||
27947018|NCT00893464|54604575|FG002|Overall Study|Did not complete therapy/experience PD|0|||
27947019|NCT00893464|54604576|FG003|Overall Study|Did not complete therapy/experience PD|0|||
27947020|NCT00893464|54604577|FG004|Overall Study|Did not complete therapy/experience PD|0|||
27947021|NCT00893464|54604578|FG005|Overall Study|Did not complete therapy/experience PD|0|||
27947022|NCT00893464|54604579|FG006|Overall Study|Did not complete therapy/experience PD|2|||
27947023|NCT00893464|54604580|FG007|Overall Study|Did not complete therapy/experience PD|2|||
27947024|NCT00891904|54604603|FG000|Overall Study|Death|1|||
27947025|NCT00891904|54604603|FG000|Overall Study|Adverse Event|1|||
27947026|NCT01157351|54604609|FG000|Overall Study|Adverse Event|5|||
27947027|NCT01157351|54604610|FG001|Overall Study|Adverse Event|4|||
27947028|NCT01157351|54604609|FG000|Overall Study|Death|1|||
27947029|NCT01157351|54604610|FG001|Overall Study|Death|0|||
27947030|NCT01157351|54604609|FG000|Overall Study|Lost to Follow-up|53|||
27947031|NCT01157351|54604610|FG001|Overall Study|Lost to Follow-up|55|||
27947032|NCT01157351|54604609|FG000|Overall Study|Withdrawal by Subject|37|||
27947033|NCT01157351|54604610|FG001|Overall Study|Withdrawal by Subject|27|||
27947034|NCT01157351|54604609|FG000|Overall Study|Physician Decision|5|||
27947035|NCT01157351|54604610|FG001|Overall Study|Physician Decision|4|||
27947036|NCT01157351|54604609|FG000|Overall Study|Protocol Violation|0|||
27947037|NCT01157351|54604610|FG001|Overall Study|Protocol Violation|1|||
27947038|NCT01157351|54604609|FG000|Overall Study|Other|32|||
27947039|NCT01157351|54604610|FG001|Overall Study|Other|36|||
27947040|NCT01157351|54604609|FG000|Overall Study|Noncompliance with Study Drug|0|||
27947041|NCT01157351|54604610|FG001|Overall Study|Noncompliance with Study Drug|3|||
27947042|NCT01157351|54604609|FG000|Overall Study|Randomized but not Treated|4|||
27947043|NCT01157351|54604610|FG001|Overall Study|Randomized but not Treated|2|||
27947044|NCT01157117|54604619|FG000|Overall Study|Dosing Symptoms|0|||
27947045|NCT01157117|54604620|FG001|Overall Study|Dosing Symptoms|4|||
27947046|NCT01157117|54604621|FG002|Overall Study|Dosing Symptoms|0|||
27947047|NCT01157117|54604619|FG000|Overall Study|Withdrawal by Subject|4|||
27947048|NCT01157117|54604620|FG001|Overall Study|Withdrawal by Subject|1|||
27947049|NCT01157117|54604621|FG002|Overall Study|Withdrawal by Subject|1|||
27947050|NCT01157117|54604619|FG000|Overall Study|Lack of Efficacy|1|||
27947051|NCT01157117|54604620|FG001|Overall Study|Lack of Efficacy|1|||
27947052|NCT01157117|54604621|FG002|Overall Study|Lack of Efficacy|0|||
27947053|NCT01157117|54604619|FG000|Overall Study|Lost to Follow-up|0|||
27947054|NCT01157117|54604620|FG001|Overall Study|Lost to Follow-up|0|||
27947055|NCT01157117|54604621|FG002|Overall Study|Lost to Follow-up|1|||
27947056|NCT01157117|54604619|FG000|Overall Study|Unknown (Pending Final Form Submission)|4|||
27947057|NCT01157117|54604620|FG001|Overall Study|Unknown (Pending Final Form Submission)|5|||
27947058|NCT01157117|54604621|FG002|Overall Study|Unknown (Pending Final Form Submission)|13|||
27947059|NCT00891202|54604631|FG000|PAP (Up To Week 39)|Withdrawal by Subject|1|||
27947060|NCT00891202|54604632|FG001|PAP (Up To Week 39)|Withdrawal by Subject|0|||
27947061|NCT00891202|54604633|FG002|PAP (Up To Week 39)|Withdrawal by Subject|0|||
27947062|NCT00891202|54604634|FG003|PAP (Up To Week 39)|Withdrawal by Subject|0|||
27854226|NCT01397786|54366513|FG002|Phase A|Withdrawal by Subject|5|||
27854227|NCT01397786|54366511|FG000|Phase A|Lack of Efficacy|0|||
27854228|NCT01397786|54366512|FG001|Phase A|Lack of Efficacy|0|||
27854229|NCT01397786|54366513|FG002|Phase A|Lack of Efficacy|1|||
27854230|NCT01397786|54366511|FG000|Phase B|Lost to Follow-up|22|||
27854231|NCT01397786|54366512|FG001|Phase B|Lost to Follow-up|12|||
27854232|NCT01397786|54366513|FG002|Phase B|Lost to Follow-up|22|||
27854233|NCT01397786|54366511|FG000|Phase B|Adverse Event|109|||
27854234|NCT01397786|54366512|FG001|Phase B|Adverse Event|23|||
27854235|NCT01397786|54366513|FG002|Phase B|Adverse Event|27|||
27854236|NCT01397786|54366511|FG000|Phase B|Subject Met Withdrawal Criteria|38|||
27854237|NCT01397786|54366512|FG001|Phase B|Subject Met Withdrawal Criteria|5|||
27854238|NCT01397786|54366513|FG002|Phase B|Subject Met Withdrawal Criteria|38|||
27854239|NCT01397786|54366511|FG000|Phase B|Physician Decision|9|||
27854240|NCT01397786|54366512|FG001|Phase B|Physician Decision|1|||
27854241|NCT01397786|54366513|FG002|Phase B|Physician Decision|3|||
27854242|NCT01397786|54366511|FG000|Phase B|Withdrawal by Subject|102|||
27854243|NCT01397786|54366512|FG001|Phase B|Withdrawal by Subject|45|||
27854244|NCT01397786|54366513|FG002|Phase B|Withdrawal by Subject|30|||
27854245|NCT01397786|54366511|FG000|Phase B|Protocol Deviation|1|||
27854246|NCT01397786|54366512|FG001|Phase B|Protocol Deviation|2|||
27854247|NCT01397786|54366513|FG002|Phase B|Protocol Deviation|4|||
27854248|NCT01397786|54366511|FG000|Phase B|Lack of Efficacy|22|||
27854249|NCT01397786|54366512|FG001|Phase B|Lack of Efficacy|7|||
27854250|NCT01397786|54366513|FG002|Phase B|Lack of Efficacy|14|||
27854251|NCT01397552|54366572|FG000|Overall Study|Adverse Event|1|||
27854252|NCT01397552|54366573|FG001|Overall Study|Adverse Event|0|||
27854253|NCT01397552|54366572|FG000|Overall Study|Withdrawal by Subject|2|||
27854254|NCT01397552|54366573|FG001|Overall Study|Withdrawal by Subject|1|||
27854255|NCT01397162|54366593|FG000|Overall Study|Adverse Event|4|||
27854256|NCT01397162|54366594|FG001|Overall Study|Adverse Event|0|||
27854257|NCT01397162|54366595|FG002|Overall Study|Adverse Event|0|||
27947063|NCT00891202|54604631|FG000|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
27947064|NCT00891202|54604632|FG001|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
27854258|NCT01397162|54366596|FG003|Overall Study|Adverse Event|0|||
27854259|NCT01397162|54366597|FG004|Overall Study|Adverse Event|0|||
27854260|NCT01397162|54366593|FG000|Overall Study|Not yet defined|3|||
27947065|NCT00891202|54604633|FG002|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4|||
27947066|NCT00891202|54604634|FG003|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
27947067|NCT00891202|54604631|FG000|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
28080765|NCT00094653|54734019|FG001|Overall Study|Lost to Follow-up|2|||
27854261|NCT01397162|54366594|FG001|Overall Study|Not yet defined|4|||
27854262|NCT01397162|54366595|FG002|Overall Study|Not yet defined|3|||
27854263|NCT01397162|54366596|FG003|Overall Study|Not yet defined|5|||
27854264|NCT01397162|54366597|FG004|Overall Study|Not yet defined|3|||
27947068|NCT00891202|54604632|FG001|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
27947069|NCT00891202|54604633|FG002|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1|||
27854265|NCT01397084|54366630|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
27854266|NCT01397084|54366630|FG000|Overall Study|Protocol Violation|2|||
27854267|NCT01397084|54366630|FG000|Overall Study|Adverse Event|2|||
27854268|NCT01397084|54366630|FG000|Overall Study|Withdrawal by Subject|1|||
27854269|NCT01397084|54366630|FG000|Overall Study|Lost to Follow-up|1|||
27854270|NCT01397084|54366630|FG000|Overall Study|Used other proton pump inhibitor|1|||
27854271|NCT01396148|54366670|FG000|Overall Study|Patient Decision|1|||
27854272|NCT01396070|54366703|FG000|Overall Study|Withdrawal by Subject|2|||
27854273|NCT01396070|54366703|FG000|Overall Study|Death|2|||
27854274|NCT01396070|54366703|FG000|Overall Study|Adverse Event|8|||
27854275|NCT01396070|54366703|FG000|Overall Study|Physician Decision|3|||
27854276|NCT01396070|54366703|FG000|Overall Study|Lack of Efficacy|4|||
27854277|NCT01395914|54366720|FG000|Overall Study|Unrelated to study drug AE|6|||
27854278|NCT01395914|54366721|FG001|Overall Study|Unrelated to study drug AE|1|||
27854279|NCT01395914|54366720|FG000|Overall Study|Death|23|||
27854280|NCT01395914|54366721|FG001|Overall Study|Death|17|||
27854281|NCT01395914|54366720|FG000|Overall Study|Other|9|||
27854282|NCT01395914|54366721|FG001|Overall Study|Other|3|||
27854283|NCT01395914|54366720|FG000|Overall Study|Withdrawal by patient|27|||
27947070|NCT00891202|54604634|FG003|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
27947071|NCT00891202|54604631|FG000|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
27947072|NCT00891202|54604632|FG001|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
27947073|NCT00891202|54604633|FG002|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2|||
27947074|NCT00891202|54604634|FG003|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5|||
27947075|NCT01185509|54604644|FG000|Overall Study|Progression/Relapse|9|||
27947076|NCT01185509|54604645|FG001|Overall Study|Progression/Relapse|15|||
27947077|NCT01185509|54604644|FG000|Overall Study|Physician Decision|2|||
27947078|NCT01185509|54604645|FG001|Overall Study|Physician Decision|2|||
27947079|NCT01185509|54604644|FG000|Overall Study|Withdrawal by Subject|0|||
27947080|NCT01185509|54604645|FG001|Overall Study|Withdrawal by Subject|1|||
27947081|NCT01185509|54604644|FG000|Overall Study|Death|0|||
27947082|NCT01185509|54604645|FG001|Overall Study|Death|1|||
27947083|NCT01185509|54604644|FG000|Overall Study|Intercurrent Illness|0|||
27947084|NCT01185509|54604645|FG001|Overall Study|Intercurrent Illness|1|||
27947085|NCT00891046|54604657|FG000|Overall Study|Protocol Violation|1|||
27947086|NCT00891046|54604658|FG001|Overall Study|Protocol Violation|1|||
27947087|NCT00891046|54604659|FG002|Overall Study|Protocol Violation|0|||
27947088|NCT00891046|54604660|FG003|Overall Study|Protocol Violation|0|||
27947089|NCT00891046|54604661|FG004|Overall Study|Protocol Violation|1|||
27947090|NCT00891046|54604657|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
27947091|NCT00891046|54604658|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
27947092|NCT00891046|54604659|FG002|Overall Study|Unsatisfactory therapeutic effect|19|||
27947093|NCT00891046|54604660|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
27947094|NCT00891046|54604661|FG004|Overall Study|Unsatisfactory therapeutic effect|20|||
27947095|NCT00891046|54604657|FG000|Overall Study|Administrative problems|0|||
27947096|NCT00891046|54604658|FG001|Overall Study|Administrative problems|0|||
27947097|NCT00891046|54604659|FG002|Overall Study|Administrative problems|0|||
27947098|NCT00891046|54604660|FG003|Overall Study|Administrative problems|0|||
27947099|NCT00891046|54604661|FG004|Overall Study|Administrative problems|1|||
27947100|NCT00891046|54604657|FG000|Overall Study|Participant no longer required drug|0|||
27947101|NCT00891046|54604658|FG001|Overall Study|Participant no longer required drug|2|||
27947102|NCT00891046|54604659|FG002|Overall Study|Participant no longer required drug|0|||
27947103|NCT00891046|54604660|FG003|Overall Study|Participant no longer required drug|0|||
27947104|NCT00891046|54604661|FG004|Overall Study|Participant no longer required drug|1|||
27947105|NCT00891046|54604657|FG000|Overall Study|Adverse Event|4|||
27947106|NCT00891046|54604658|FG001|Overall Study|Adverse Event|3|||
27947107|NCT00891046|54604659|FG002|Overall Study|Adverse Event|2|||
27947108|NCT00891046|54604660|FG003|Overall Study|Adverse Event|0|||
27947109|NCT00891046|54604661|FG004|Overall Study|Adverse Event|14|||
27947110|NCT00891046|54604657|FG000|Overall Study|Withdrawal by Subject|2|||
27947111|NCT00891046|54604658|FG001|Overall Study|Withdrawal by Subject|1|||
27947112|NCT00891046|54604659|FG002|Overall Study|Withdrawal by Subject|2|||
27947113|NCT00891046|54604660|FG003|Overall Study|Withdrawal by Subject|1|||
27947114|NCT00891046|54604661|FG004|Overall Study|Withdrawal by Subject|1|||
27854284|NCT01395914|54366721|FG001|Overall Study|Withdrawal by patient|14|||
27854285|NCT01395914|54366720|FG000|Overall Study|Study drug-related AE|1|||
27854286|NCT01395914|54366721|FG001|Overall Study|Study drug-related AE|0|||
27854287|NCT01395914|54366720|FG000|Overall Study|Lost to Follow-up|6|||
27947115|NCT00891046|54604657|FG000|Overall Study|Lost to Follow-up|0|||
27947116|NCT00891046|54604658|FG001|Overall Study|Lost to Follow-up|0|||
27947117|NCT00891046|54604659|FG002|Overall Study|Lost to Follow-up|0|||
27854288|NCT01395914|54366721|FG001|Overall Study|Lost to Follow-up|2|||
27947118|NCT00891046|54604660|FG003|Overall Study|Lost to Follow-up|0|||
27947119|NCT00891046|54604661|FG004|Overall Study|Lost to Follow-up|1|||
27947120|NCT00889720|54604688|FG000|Overall Study|Withdrawal by Subject|4|||
27947121|NCT00889720|54604688|FG000|Overall Study|Other|4|||
27947122|NCT01116648|54604707|FG000|Phase 1 Dose Level 3|Adverse Event|0|||
27947123|NCT01116648|54604708|FG001|Phase 1 Dose Level 3|Adverse Event|0|||
27947124|NCT01116648|54604709|FG002|Phase 1 Dose Level 3|Adverse Event|0|||
27947125|NCT01116648|54604710|FG003|Phase 1 Dose Level 3|Adverse Event|2|||
27947126|NCT01116648|54604711|FG004|Phase 1 Dose Level 3|Adverse Event|0|||
27947127|NCT01116648|54604712|FG005|Phase 1 Dose Level 3|Adverse Event|0|||
27947128|NCT01116648|54604713|FG006|Phase 1 Dose Level 3|Adverse Event|0|||
27947129|NCT01116648|54604714|FG007|Phase 1 Dose Level 3|Adverse Event|0|||
27947130|NCT01116648|54604715|FG008|Phase 1 Dose Level 3|Adverse Event|0|||
27947131|NCT01116648|54604716|FG009|Phase 1 Dose Level 3|Adverse Event|0|||
27947132|NCT01116648|54604717|FG010|Phase 1 Dose Level 3|Adverse Event|0|||
27947133|NCT01116648|54604718|FG011|Phase 1 Dose Level 3|Adverse Event|0|||
27832022|NCT01781429|54310833|FG013|Overall Study|Disease Progression|4|||
27832023|NCT01781429|54310834|FG014|Overall Study|Disease Progression|11|||
27832024|NCT01781429|54310835|FG015|Overall Study|Disease Progression|0|||
27832025|NCT01781429|54310820|FG000|Overall Study|Unacceptable Toxicity|0|||
27832026|NCT01781429|54310821|FG001|Overall Study|Unacceptable Toxicity|0|||
27832027|NCT01781429|54310822|FG002|Overall Study|Unacceptable Toxicity|0|||
27832028|NCT01781429|54310823|FG003|Overall Study|Unacceptable Toxicity|0|||
27832029|NCT01781429|54310824|FG004|Overall Study|Unacceptable Toxicity|0|||
27832030|NCT01781429|54310825|FG005|Overall Study|Unacceptable Toxicity|0|||
27832031|NCT01781429|54310826|FG006|Overall Study|Unacceptable Toxicity|0|||
27832032|NCT01781429|54310827|FG007|Overall Study|Unacceptable Toxicity|0|||
27832033|NCT01781429|54310828|FG008|Overall Study|Unacceptable Toxicity|0|||
27832034|NCT01781429|54310829|FG009|Overall Study|Unacceptable Toxicity|0|||
27832035|NCT01781429|54310830|FG010|Overall Study|Unacceptable Toxicity|0|||
27832036|NCT01781429|54310831|FG011|Overall Study|Unacceptable Toxicity|2|||
27832037|NCT01781429|54310832|FG012|Overall Study|Unacceptable Toxicity|0|||
27832038|NCT01781429|54310833|FG013|Overall Study|Unacceptable Toxicity|0|||
27832039|NCT01781429|54310834|FG014|Overall Study|Unacceptable Toxicity|0|||
27832040|NCT01781429|54310835|FG015|Overall Study|Unacceptable Toxicity|0|||
27832041|NCT01781429|54310820|FG000|Overall Study|Patient Condition Changed|0|||
27854289|NCT01395758|54366983|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
27854290|NCT01395758|54366984|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
27854291|NCT01395758|54366985|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
27854292|NCT01395524|54367039|FG000|Overall Study|Non-compliance with study schedule|1|||
27854293|NCT01395524|54367040|FG001|Overall Study|Non-compliance with study schedule|0|||
27854294|NCT01395524|54367041|FG002|Overall Study|Non-compliance with study schedule|1|||
27854295|NCT01395524|54367039|FG000|Overall Study|Lost to Follow-up|3|||
27854296|NCT01395524|54367040|FG001|Overall Study|Lost to Follow-up|1|||
27854297|NCT01395524|54367041|FG002|Overall Study|Lost to Follow-up|1|||
27854298|NCT01395524|54367039|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
27854299|NCT01395524|54367040|FG001|Overall Study|Study-Specific Withdrawal Criteria|2|||
27854300|NCT01395524|54367041|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
27854301|NCT01395524|54367039|FG000|Overall Study|Severe noncompliance with protocol|1|||
27854302|NCT01395524|54367040|FG001|Overall Study|Severe noncompliance with protocol|0|||
27854303|NCT01395524|54367041|FG002|Overall Study|Severe noncompliance with protocol|0|||
27854304|NCT01395524|54367039|FG000|Overall Study|Adverse Event|4|||
27854305|NCT01395524|54367040|FG001|Overall Study|Adverse Event|4|||
27854306|NCT01395524|54367041|FG002|Overall Study|Adverse Event|3|||
27854307|NCT01395524|54367039|FG000|Overall Study|Death|1|||
27854308|NCT01395524|54367040|FG001|Overall Study|Death|0|||
27854309|NCT01395524|54367041|FG002|Overall Study|Death|0|||
27854310|NCT01395524|54367039|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
27854311|NCT01395524|54367040|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
27854312|NCT01395524|54367041|FG002|Overall Study|Eligibility Criteria Not Fulfilled|0|||
27854313|NCT01395524|54367039|FG000|Overall Study|Withdrawal by Subject|4|||
27854314|NCT01395524|54367040|FG001|Overall Study|Withdrawal by Subject|8|||
27854315|NCT01395524|54367041|FG002|Overall Study|Withdrawal by Subject|8|||
27854316|NCT01395524|54367039|FG000|Overall Study|Did not receive treatment|1|||
27854317|NCT01395524|54367040|FG001|Overall Study|Did not receive treatment|1|||
27854318|NCT01395524|54367041|FG002|Overall Study|Did not receive treatment|3|||
27854319|NCT01395524|54367039|FG000|Overall Study|Subject had spinal surgery|0|||
27947134|NCT01116648|54604719|FG012|Phase 1 Dose Level 3|Adverse Event|0|||
27947135|NCT01116648|54604720|FG013|Phase 1 Dose Level 3|Adverse Event|0|||
27947136|NCT01116648|54604721|FG014|Phase 1 Dose Level 3|Adverse Event|0|||
27832042|NCT01781429|54310821|FG001|Overall Study|Patient Condition Changed|0|||
27832043|NCT01781429|54310822|FG002|Overall Study|Patient Condition Changed|0|||
27832044|NCT01781429|54310823|FG003|Overall Study|Patient Condition Changed|0|||
27854320|NCT01395524|54367040|FG001|Overall Study|Subject had spinal surgery|0|||
27854321|NCT01395524|54367041|FG002|Overall Study|Subject had spinal surgery|1|||
27854322|NCT01395368|54367049|FG000|Overall Study|Physician Decision|14|||
27854323|NCT01395368|54367049|FG000|Overall Study|Withdrawal by Subject|2|||
27854324|NCT01394978|54367056|FG000|Overall Study|Withdrawal by Subject|2|||
27947137|NCT00880087|54604748|FG000|Overall Study|Lost to Follow-up|0|||
27947138|NCT00880087|54604749|FG001|Overall Study|Lost to Follow-up|2|||
27947139|NCT00889252|54604757|FG000|Overall Study|Adverse Event|2|||
27947140|NCT00889252|54604758|FG001|Overall Study|Adverse Event|4|||
27947141|NCT00889252|54604757|FG000|Overall Study|Withdrawal by Subject|3|||
27947142|NCT00889252|54604758|FG001|Overall Study|Withdrawal by Subject|0|||
27947143|NCT00889252|54604757|FG000|Overall Study|Protocol Violation|2|||
27947144|NCT00889252|54604758|FG001|Overall Study|Protocol Violation|0|||
27947145|NCT01110330|54604767|FG000|Overall Study|Adverse Event|0|||
27947146|NCT01110330|54604768|FG001|Overall Study|Adverse Event|4|||
27947147|NCT01110330|54604769|FG002|Overall Study|Adverse Event|3|||
27947148|NCT01110330|54604767|FG000|Overall Study|Lack of Efficacy|3|||
27947149|NCT01110330|54604768|FG001|Overall Study|Lack of Efficacy|1|||
27947150|NCT01110330|54604769|FG002|Overall Study|Lack of Efficacy|1|||
27947151|NCT01110330|54604767|FG000|Overall Study|Lost to Follow-up|9|||
27947152|NCT01110330|54604768|FG001|Overall Study|Lost to Follow-up|10|||
27947153|NCT01110330|54604769|FG002|Overall Study|Lost to Follow-up|15|||
27947154|NCT01110330|54604767|FG000|Overall Study|Physician Decision|0|||
27947155|NCT01110330|54604768|FG001|Overall Study|Physician Decision|1|||
27947156|NCT01110330|54604769|FG002|Overall Study|Physician Decision|0|||
27947157|NCT01110330|54604767|FG000|Overall Study|Protocol Violation|2|||
27947158|NCT01110330|54604768|FG001|Overall Study|Protocol Violation|0|||
27947159|NCT01110330|54604769|FG002|Overall Study|Protocol Violation|4|||
27947160|NCT01110330|54604767|FG000|Overall Study|Withdrawal by Subject|0|||
27947161|NCT01110330|54604768|FG001|Overall Study|Withdrawal by Subject|6|||
27947162|NCT01110330|54604769|FG002|Overall Study|Withdrawal by Subject|2|||
27947163|NCT01110330|54604767|FG000|Overall Study|Other|1|||
27947164|NCT01110330|54604768|FG001|Overall Study|Other|1|||
27947165|NCT01110330|54604769|FG002|Overall Study|Other|1|||
27947166|NCT00596947|54604779|FG000|Overall Study|study halted due to low enrollment|5|||
27947167|NCT00596947|54604780|FG001|Overall Study|study halted due to low enrollment|3|||
27947168|NCT00596947|54604779|FG000|Overall Study|Lost to Follow-up|1|||
27947169|NCT00596947|54604780|FG001|Overall Study|Lost to Follow-up|0|||
27947170|NCT00888940|54604788|FG000|Overall Study|Adverse Event|12|||
27947171|NCT00888940|54604789|FG001|Overall Study|Adverse Event|3|||
27947172|NCT00888940|54604788|FG000|Overall Study|Lost to Follow-up|5|||
27947173|NCT00888940|54604789|FG001|Overall Study|Lost to Follow-up|5|||
27947174|NCT00888940|54604788|FG000|Overall Study|Randomized Not Treated|11|||
27947175|NCT00888940|54604789|FG001|Overall Study|Randomized Not Treated|13|||
27947176|NCT00595621|54604797|FG000|Open Label Run in|Adverse Event|1|||
27947177|NCT00595621|54604798|FG001|Open Label Run in|Adverse Event|0|||
27947178|NCT00595621|54604797|FG000|Open Label Run in|Physician Decision|1|||
27947179|NCT00595621|54604798|FG001|Open Label Run in|Physician Decision|0|||
27947180|NCT00595621|54604797|FG000|Open Label Run in|Withdrawal by Subject|1|||
27947181|NCT00595621|54604798|FG001|Open Label Run in|Withdrawal by Subject|0|||
27947182|NCT00595621|54604797|FG000|Randomization and Study|Adverse Event|2|||
27947183|NCT00595621|54604798|FG001|Randomization and Study|Adverse Event|0|||
27947184|NCT00595621|54604797|FG000|Randomization and Study|Withdrawal by Subject|0|||
27947185|NCT00595621|54604798|FG001|Randomization and Study|Withdrawal by Subject|1|||
27947186|NCT00888238|54604805|FG000|Washout Period After Period 2|Adverse Event|0|||
27947187|NCT00888238|54604806|FG001|Washout Period After Period 2|Adverse Event|0|||
27947188|NCT00888238|54604807|FG002|Washout Period After Period 2|Adverse Event|1|||
27947189|NCT00595465|54604816|FG000|Overall Study|Adverse Event|4|||
27947190|NCT00595465|54604817|FG001|Overall Study|Adverse Event|3|||
27947191|NCT00595465|54604818|FG002|Overall Study|Adverse Event|3|||
27947192|NCT00595465|54604816|FG000|Overall Study|Pregnancy|0|||
27947193|NCT00595465|54604817|FG001|Overall Study|Pregnancy|0|||
27947194|NCT00595465|54604818|FG002|Overall Study|Pregnancy|1|||
27731601|NCT02334748|54178916|FG000|Overall Study|Patient no longer required study drug|2|||
27832045|NCT01781429|54310824|FG004|Overall Study|Patient Condition Changed|0|||
27832046|NCT01781429|54310825|FG005|Overall Study|Patient Condition Changed|0|||
27832047|NCT01781429|54310826|FG006|Overall Study|Patient Condition Changed|0|||
27832048|NCT01781429|54310827|FG007|Overall Study|Patient Condition Changed|0|||
27832049|NCT01781429|54310828|FG008|Overall Study|Patient Condition Changed|0|||
27832050|NCT01781429|54310829|FG009|Overall Study|Patient Condition Changed|4|||
27832051|NCT01781429|54310830|FG010|Overall Study|Patient Condition Changed|0|||
27832052|NCT01781429|54310831|FG011|Overall Study|Patient Condition Changed|1|||
27947195|NCT00595465|54604816|FG000|Overall Study|Protocol Violation|2|||
27947196|NCT00595465|54604817|FG001|Overall Study|Protocol Violation|1|||
27947197|NCT00595465|54604818|FG002|Overall Study|Protocol Violation|0|||
27947198|NCT00595465|54604816|FG000|Overall Study|Lost to Follow-up|0|||
27947199|NCT00595465|54604817|FG001|Overall Study|Lost to Follow-up|0|||
27947200|NCT00595465|54604818|FG002|Overall Study|Lost to Follow-up|2|||
28080766|NCT00094653|54734020|FG002|Overall Study|Lost to Follow-up|1|||
27832053|NCT01781429|54310832|FG012|Overall Study|Patient Condition Changed|0|||
27947201|NCT00595465|54604816|FG000|Overall Study|administrative reason|0|||
27947202|NCT00595465|54604817|FG001|Overall Study|administrative reason|0|||
27947203|NCT00595465|54604818|FG002|Overall Study|administrative reason|1|||
27947204|NCT01205438|54604829|FG000|Overall Study|Adverse Event|19|||
27947205|NCT01205438|54604830|FG001|Overall Study|Adverse Event|17|||
27947206|NCT01205438|54604831|FG002|Overall Study|Adverse Event|24|||
27947207|NCT01205438|54604829|FG000|Overall Study|Death|1|||
27947208|NCT01205438|54604830|FG001|Overall Study|Death|1|||
27947209|NCT01205438|54604831|FG002|Overall Study|Death|3|||
27947210|NCT01205438|54604829|FG000|Overall Study|Entry Criteria Not Met|16|||
27947211|NCT01205438|54604830|FG001|Overall Study|Entry Criteria Not Met|15|||
27731602|NCT02334748|54178916|FG000|Overall Study|Lack of Efficacy|4|||
27731603|NCT02332876|54178922|FG000|Overall Study|Lost to Follow-up|1|||
27731604|NCT02332876|54178923|FG001|Overall Study|Lost to Follow-up|1|||
27731605|NCT02332798|54178932|FG000|Overall Study|Unwilling to Participate in Study|0|||
27731606|NCT02332798|54178933|FG001|Overall Study|Unwilling to Participate in Study|1|||
27731607|NCT02332798|54178934|FG002|Overall Study|Unwilling to Participate in Study|1|||
27731608|NCT02332798|54178932|FG000|Overall Study|Positive Urine Drug Test|0|||
27731609|NCT02332798|54178933|FG001|Overall Study|Positive Urine Drug Test|1|||
27731610|NCT02332798|54178934|FG002|Overall Study|Positive Urine Drug Test|0|||
27731611|NCT02332798|54178932|FG000|Overall Study|Abnormal Laboratory Findings|1|||
27731612|NCT02332798|54178933|FG001|Overall Study|Abnormal Laboratory Findings|0|||
27731613|NCT02332798|54178934|FG002|Overall Study|Abnormal Laboratory Findings|0|||
27731614|NCT02790437|54178944|FG000|Overall Study|Patient graft failure - nephrectomy|1|||
27731615|NCT02790437|54178945|FG001|Overall Study|Patient graft failure - nephrectomy|0|||
27731616|NCT02790437|54178944|FG000|Overall Study|Adverse Event|1|||
27731617|NCT02790437|54178945|FG001|Overall Study|Adverse Event|0|||
27731618|NCT02790437|54178944|FG000|Overall Study|Withdrawal by Subject|1|||
27947212|NCT01205438|54604831|FG002|Overall Study|Entry Criteria Not Met|13|||
27947213|NCT01205438|54604829|FG000|Overall Study|Lack of Efficacy|14|||
27947214|NCT01205438|54604830|FG001|Overall Study|Lack of Efficacy|11|||
27947215|NCT01205438|54604831|FG002|Overall Study|Lack of Efficacy|14|||
27947216|NCT01205438|54604829|FG000|Overall Study|Lost to Follow-up|6|||
27947217|NCT01205438|54604830|FG001|Overall Study|Lost to Follow-up|7|||
27947218|NCT01205438|54604831|FG002|Overall Study|Lost to Follow-up|8|||
27947219|NCT01205438|54604829|FG000|Overall Study|Withdrawal by Subject|19|||
27947220|NCT01205438|54604830|FG001|Overall Study|Withdrawal by Subject|25|||
27947221|NCT01205438|54604831|FG002|Overall Study|Withdrawal by Subject|19|||
27947222|NCT01205438|54604829|FG000|Overall Study|Physician Decision|0|||
27947223|NCT01205438|54604830|FG001|Overall Study|Physician Decision|3|||
27947224|NCT01205438|54604831|FG002|Overall Study|Physician Decision|2|||
27947225|NCT01205438|54604829|FG000|Overall Study|Protocol Violation|2|||
27947226|NCT01205438|54604830|FG001|Overall Study|Protocol Violation|7|||
27947227|NCT01205438|54604831|FG002|Overall Study|Protocol Violation|4|||
27947228|NCT01205438|54604829|FG000|Overall Study|Sponsor Decision|0|||
27947229|NCT01205438|54604830|FG001|Overall Study|Sponsor Decision|1|||
27947230|NCT01205438|54604831|FG002|Overall Study|Sponsor Decision|1|||
27947231|NCT01104870|54604845|FG000|Overall Study|Adverse Event|1|||
27947232|NCT01104870|54604846|FG001|Overall Study|Adverse Event|1|||
27947233|NCT01104870|54604847|FG002|Overall Study|Adverse Event|0|||
27947234|NCT01104870|54604845|FG000|Overall Study|Death|0|||
27947235|NCT01104870|54604846|FG001|Overall Study|Death|0|||
27947236|NCT01104870|54604847|FG002|Overall Study|Death|1|||
27947237|NCT01104870|54604845|FG000|Overall Study|Withdrawal by Subject|0|||
27947238|NCT01104870|54604846|FG001|Overall Study|Withdrawal by Subject|0|||
27947239|NCT01104870|54604847|FG002|Overall Study|Withdrawal by Subject|1|||
27947240|NCT01104792|54604855|FG000|Overall Study|Adverse Event|77|||
27947241|NCT01104792|54604855|FG000|Overall Study|Insufficient Therapeutic Response|22|||
27947242|NCT01104792|54604855|FG000|Overall Study|Protocol Violation|45|||
27947243|NCT01104792|54604855|FG000|Overall Study|Withdrawal of Consent|179|||
27947244|NCT01104792|54604855|FG000|Overall Study|Lost to Follow-up|43|||
27947245|NCT01104792|54604855|FG000|Overall Study|Reasons Not Specified|27|||
27947246|NCT01104792|54604855|FG000|Overall Study|Did Not Meet Eligibility Criteria|133|||
27947247|NCT01205126|54604861|FG000|Titration Phase|Adverse Event|5|||
28080767|NCT00094653|54734018|FG000|Overall Study|Protocol Violation|0|||
27731619|NCT02790437|54178945|FG001|Overall Study|Withdrawal by Subject|0|||
27731620|NCT02604212|54178962|FG000|Overall Study|Study Terminated by Sponsor|2|||
27947248|NCT01205126|54604862|FG001|Titration Phase|Adverse Event|3|||
27947249|NCT01205126|54604861|FG000|Titration Phase|Withdrawal by Subject|5|||
27947250|NCT01205126|54604862|FG001|Titration Phase|Withdrawal by Subject|5|||
27947251|NCT01205126|54604861|FG000|Titration Phase|Lost to Follow-up|2|||
27947252|NCT01205126|54604862|FG001|Titration Phase|Lost to Follow-up|2|||
27947253|NCT01205126|54604861|FG000|Titration Phase|No stable titration dose|1|||
27947254|NCT01205126|54604862|FG001|Titration Phase|No stable titration dose|0|||
27947255|NCT01205126|54604861|FG000|Titration Phase|More than maximum dosage required|2|||
27731621|NCT02604212|54178963|FG001|Overall Study|Study Terminated by Sponsor|1|||
27731622|NCT02604212|54178964|FG002|Overall Study|Study Terminated by Sponsor|3|||
27731623|NCT02604212|54178965|FG003|Overall Study|Study Terminated by Sponsor|3|||
27947256|NCT01205126|54604862|FG001|Titration Phase|More than maximum dosage required|3|||
27947257|NCT01205126|54604861|FG000|Titration Phase|Other|8|||
27947258|NCT01205126|54604862|FG001|Titration Phase|Other|6|||
27947259|NCT01205126|54604861|FG000|Between Titration & Maintenance Phase|Other|0|||
27947260|NCT01205126|54604862|FG001|Between Titration & Maintenance Phase|Other|4|||
27947261|NCT01205126|54604861|FG000|Maintenance Phase|Adverse Event|3|||
27947262|NCT01205126|54604862|FG001|Maintenance Phase|Adverse Event|7|||
27947263|NCT01205126|54604861|FG000|Maintenance Phase|Death|4|||
27947264|NCT01205126|54604862|FG001|Maintenance Phase|Death|4|||
27947265|NCT01205126|54604861|FG000|Maintenance Phase|More than the maximum dosage required|5|||
27947266|NCT01205126|54604862|FG001|Maintenance Phase|More than the maximum dosage required|5|||
27947267|NCT01205126|54604861|FG000|Maintenance Phase|Prohibited drugs used|1|||
27947268|NCT01205126|54604862|FG001|Maintenance Phase|Prohibited drugs used|0|||
27947269|NCT01205126|54604861|FG000|Maintenance Phase|Other|11|||
27947270|NCT01205126|54604862|FG001|Maintenance Phase|Other|8|||
27947271|NCT01205126|54604861|FG000|Maintenance Phase|Lost to Follow-up|5|||
27947272|NCT01205126|54604862|FG001|Maintenance Phase|Lost to Follow-up|5|||
27947273|NCT01205126|54604861|FG000|Maintenance Phase|Withdrawal by Subject|8|||
27947274|NCT01205126|54604862|FG001|Maintenance Phase|Withdrawal by Subject|11|||
27947275|NCT00946647|54604873|FG000|Phase 1 Part|Adverse Event|2|||
27947276|NCT00946647|54604874|FG001|Phase 1 Part|Adverse Event|5|||
27947277|NCT00946647|54604875|FG002|Phase 1 Part|Adverse Event|3|||
27947278|NCT00946647|54604876|FG003|Phase 1 Part|Adverse Event|0|||
27947279|NCT00946647|54604877|FG004|Phase 1 Part|Adverse Event|0|||
27947280|NCT00946647|54604873|FG000|Phase 1 Part|Disease progression|3|||
27947281|NCT00946647|54604874|FG001|Phase 1 Part|Disease progression|6|||
27947282|NCT00946647|54604875|FG002|Phase 1 Part|Disease progression|1|||
27947283|NCT00946647|54604876|FG003|Phase 1 Part|Disease progression|0|||
27947284|NCT00946647|54604877|FG004|Phase 1 Part|Disease progression|0|||
27947285|NCT00946647|54604873|FG000|Phase 1 Part|Withdrawal by Subject|1|||
27947286|NCT00946647|54604874|FG001|Phase 1 Part|Withdrawal by Subject|4|||
27947287|NCT00946647|54604875|FG002|Phase 1 Part|Withdrawal by Subject|3|||
27947288|NCT00946647|54604876|FG003|Phase 1 Part|Withdrawal by Subject|0|||
27947289|NCT00946647|54604877|FG004|Phase 1 Part|Withdrawal by Subject|0|||
27947290|NCT00946647|54604873|FG000|Phase 1 Part|Abnormal values|0|||
27947291|NCT00946647|54604874|FG001|Phase 1 Part|Abnormal values|2|||
27947292|NCT00946647|54604875|FG002|Phase 1 Part|Abnormal values|0|||
27947293|NCT00946647|54604876|FG003|Phase 1 Part|Abnormal values|0|||
27947294|NCT00946647|54604877|FG004|Phase 1 Part|Abnormal values|0|||
27947295|NCT00946647|54604873|FG000|Phase 1 Part|Reason missing|0|||
27947296|NCT00946647|54604874|FG001|Phase 1 Part|Reason missing|1|||
27947297|NCT00946647|54604875|FG002|Phase 1 Part|Reason missing|0|||
27947298|NCT00946647|54604876|FG003|Phase 1 Part|Reason missing|0|||
27947299|NCT00946647|54604877|FG004|Phase 1 Part|Reason missing|0|||
27947300|NCT00946647|54604873|FG000|Phase ll Part|Untreated|0|||
27947301|NCT00946647|54604874|FG001|Phase ll Part|Untreated|0|||
27947302|NCT00946647|54604875|FG002|Phase ll Part|Untreated|0|||
27947303|NCT00946647|54604876|FG003|Phase ll Part|Untreated|0|||
27947304|NCT00946647|54604877|FG004|Phase ll Part|Untreated|2|||
27947305|NCT00946647|54604873|FG000|Phase ll Part|Adverse Event|0|||
27947306|NCT00946647|54604874|FG001|Phase ll Part|Adverse Event|0|||
27947307|NCT00946647|54604875|FG002|Phase ll Part|Adverse Event|0|||
27947308|NCT00946647|54604876|FG003|Phase ll Part|Adverse Event|10|||
27947309|NCT00946647|54604877|FG004|Phase ll Part|Adverse Event|6|||
27947310|NCT00946647|54604873|FG000|Phase ll Part|Withdrawal by Subject|0|||
27947311|NCT00946647|54604874|FG001|Phase ll Part|Withdrawal by Subject|0|||
27947312|NCT00946647|54604875|FG002|Phase ll Part|Withdrawal by Subject|0|||
27947313|NCT00946647|54604876|FG003|Phase ll Part|Withdrawal by Subject|8|||
27947314|NCT00946647|54604877|FG004|Phase ll Part|Withdrawal by Subject|6|||
27947315|NCT00946647|54604873|FG000|Phase ll Part|Administrative problems|0|||
27947316|NCT00946647|54604874|FG001|Phase ll Part|Administrative problems|0|||
27947317|NCT00946647|54604875|FG002|Phase ll Part|Administrative problems|0|||
27947318|NCT00946647|54604876|FG003|Phase ll Part|Administrative problems|3|||
27947319|NCT00946647|54604877|FG004|Phase ll Part|Administrative problems|8|||
27947320|NCT00946647|54604873|FG000|Phase ll Part|Death|0|||
27947321|NCT00946647|54604874|FG001|Phase ll Part|Death|0|||
27947322|NCT00946647|54604875|FG002|Phase ll Part|Death|0|||
27947323|NCT00946647|54604876|FG003|Phase ll Part|Death|7|||
27947324|NCT00946647|54604877|FG004|Phase ll Part|Death|4|||
27947325|NCT00946647|54604873|FG000|Phase ll Part|Disease progression|0|||
27947326|NCT00946647|54604874|FG001|Phase ll Part|Disease progression|0|||
27947327|NCT00946647|54604875|FG002|Phase ll Part|Disease progression|0|||
27947328|NCT00946647|54604876|FG003|Phase ll Part|Disease progression|6|||
27947329|NCT00946647|54604877|FG004|Phase ll Part|Disease progression|14|||
27947330|NCT00946647|54604873|FG000|Phase ll Part|Protocol Violation|0|||
27947331|NCT00946647|54604874|FG001|Phase ll Part|Protocol Violation|0|||
27947332|NCT00946647|54604875|FG002|Phase ll Part|Protocol Violation|0|||
27947333|NCT00946647|54604876|FG003|Phase ll Part|Protocol Violation|4|||
27947334|NCT00946647|54604877|FG004|Phase ll Part|Protocol Violation|2|||
27947335|NCT00946647|54604873|FG000|Phase ll Part|Subj cond no longer required study drug|0|||
27947336|NCT00946647|54604874|FG001|Phase ll Part|Subj cond no longer required study drug|0|||
27947337|NCT00946647|54604875|FG002|Phase ll Part|Subj cond no longer required study drug|0|||
27947338|NCT00946647|54604876|FG003|Phase ll Part|Subj cond no longer required study drug|2|||
27947339|NCT00946647|54604877|FG004|Phase ll Part|Subj cond no longer required study drug|0|||
27947340|NCT00946101|54604892|FG000|Overall Study|Lost to Follow-up|2|||
27947341|NCT00946101|54604893|FG001|Overall Study|Lost to Follow-up|1|||
27947342|NCT00946101|54604892|FG000|Overall Study|Withdrawal of consent|2|||
27947343|NCT00946101|54604893|FG001|Overall Study|Withdrawal of consent|0|||
27947344|NCT00946101|54604892|FG000|Overall Study|Physician Decision|0|||
27947345|NCT00946101|54604893|FG001|Overall Study|Physician Decision|1|||
27947346|NCT01109940|54604907|FG000|Overall Study|Administrative problems|2|||
27947347|NCT01109940|54604908|FG001|Overall Study|Administrative problems|0|||
27947348|NCT01109940|54604909|FG002|Overall Study|Administrative problems|0|||
27947349|NCT01109940|54604910|FG003|Overall Study|Administrative problems|0|||
27947350|NCT01109940|54604907|FG000|Overall Study|Serious Adverse Event|2|||
27947351|NCT01109940|54604908|FG001|Overall Study|Serious Adverse Event|1|||
27947352|NCT01109940|54604909|FG002|Overall Study|Serious Adverse Event|0|||
27947353|NCT01109940|54604910|FG003|Overall Study|Serious Adverse Event|0|||
27947354|NCT01109940|54604907|FG000|Overall Study|Lost to Follow-up|1|||
27947355|NCT01109940|54604908|FG001|Overall Study|Lost to Follow-up|0|||
27947356|NCT01109940|54604909|FG002|Overall Study|Lost to Follow-up|0|||
27947357|NCT01109940|54604910|FG003|Overall Study|Lost to Follow-up|0|||
27947358|NCT01109940|54604907|FG000|Overall Study|Patient withdrew consent|1|||
27947359|NCT01109940|54604908|FG001|Overall Study|Patient withdrew consent|1|||
27947360|NCT01109940|54604909|FG002|Overall Study|Patient withdrew consent|0|||
27947361|NCT01109940|54604910|FG003|Overall Study|Patient withdrew consent|0|||
27947362|NCT01109940|54604907|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
27947363|NCT01109940|54604908|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
27947364|NCT01109940|54604909|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
27947365|NCT01109940|54604910|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
27947366|NCT00595309|54604920|FG000|Overall Study|Lost to Follow-up|1|||
27947367|NCT00595309|54604920|FG000|Overall Study|planned vaccination against yellow fever|1|||
27947368|NCT00595309|54604920|FG000|Overall Study|acute infection after V0|1|||
27947369|NCT00595309|54604920|FG000|Overall Study|personal reason|1|||
27854325|NCT01394978|54367057|FG001|Overall Study|Withdrawal by Subject|4|||
27854326|NCT01394978|54367056|FG000|Overall Study|Lost to Follow-up|13|||
27854327|NCT01394978|54367057|FG001|Overall Study|Lost to Follow-up|20|||
27854328|NCT01394978|54367056|FG000|Overall Study|Death|6|||
27854329|NCT01394978|54367057|FG001|Overall Study|Death|7|||
27854330|NCT01394276|54367064|FG000|Overall Study|Related Adverse event (AEs)|15|||
27854331|NCT01394276|54367064|FG000|Overall Study|Not related AEs|9|||
27854332|NCT01394276|54367064|FG000|Overall Study|Remission of disease|2|||
27854333|NCT01394276|54367064|FG000|Overall Study|Insufficient therapeutic effect|17|||
27854334|NCT01394276|54367064|FG000|Overall Study|Insufficient compliance|9|||
27854335|NCT01394276|54367064|FG000|Overall Study|Lost to Follow-up|5|||
27854336|NCT01394276|54367064|FG000|Overall Study|Participant moved to another site|1|||
27854337|NCT01394276|54367064|FG000|Overall Study|Pregnancy|1|||
27854338|NCT01394276|54367064|FG000|Overall Study|unavailability of drug at the Hospital|2|||
27854339|NCT01394276|54367064|FG000|Overall Study|Symptoms of concurrent diseases|1|||
27854340|NCT00211172|54367164|FG000|Overall Study|Died or lost health plan eligibility|39|||
27854341|NCT00211172|54367165|FG001|Overall Study|Died or lost health plan eligibility|32|||
27854342|NCT00210626|54367216|FG000|Overall Study|Adverse Event|1|||
27854343|NCT00210626|54367217|FG001|Overall Study|Adverse Event|2|||
27854344|NCT00210626|54367216|FG000|Overall Study|Protocol Violation|1|||
27854345|NCT00210626|54367217|FG001|Overall Study|Protocol Violation|5|||
27854346|NCT00210626|54367216|FG000|Overall Study|Lost to Follow-up|11|||
27854347|NCT00210626|54367217|FG001|Overall Study|Lost to Follow-up|11|||
27854348|NCT00210626|54367216|FG000|Overall Study|Death|1|||
27854349|NCT00210626|54367217|FG001|Overall Study|Death|0|||
27854350|NCT00210626|54367216|FG000|Overall Study|Withdrawal by Subject|29|||
27854351|NCT00210626|54367217|FG001|Overall Study|Withdrawal by Subject|20|||
27854352|NCT00210626|54367216|FG000|Overall Study|Physician Decision|0|||
27854353|NCT00210626|54367217|FG001|Overall Study|Physician Decision|2|||
27947370|NCT00595075|54604926|FG000|Overall Study|Withdrawal by Subject|1|||
27947371|NCT00595075|54604927|FG001|Overall Study|Withdrawal by Subject|0|||
27947372|NCT00887224|54604936|FG000|Open-label Response (OLR) Phase|Adverse Event|46|||
27947373|NCT00887224|54604937|FG001|Open-label Response (OLR) Phase|Adverse Event|0|||
28080768|NCT00094653|54734019|FG001|Overall Study|Protocol Violation|0|||
28080769|NCT00094653|54734020|FG002|Overall Study|Protocol Violation|1|||
27854354|NCT00210626|54367216|FG000|Overall Study|Sponser Request|1|||
27854355|NCT00210626|54367217|FG001|Overall Study|Sponser Request|0|||
27854356|NCT00210626|54367216|FG000|Overall Study|Other|4|||
27854357|NCT00210626|54367217|FG001|Overall Study|Other|5|||
27854358|NCT00217022|54367239|FG000|Overall Study|Withdrawal by Subject|1|||
27854359|NCT00217022|54367240|FG001|Overall Study|Withdrawal by Subject|1|||
27854360|NCT00219284|54367587|FG000|Treatment Phase - 16 Weeks|Adverse Event|26|||
27854361|NCT00219284|54367588|FG001|Treatment Phase - 16 Weeks|Adverse Event|24|||
27854362|NCT00219284|54367587|FG000|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0|||
27854363|NCT00219284|54367588|FG001|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1|||
27854364|NCT00219284|54367587|FG000|Treatment Phase - 16 Weeks|Lack of Efficacy|3|||
27854365|NCT00219284|54367588|FG001|Treatment Phase - 16 Weeks|Lack of Efficacy|10|||
27854366|NCT00219284|54367587|FG000|Treatment Phase - 16 Weeks|Protocol Violation|9|||
27854367|NCT00219284|54367588|FG001|Treatment Phase - 16 Weeks|Protocol Violation|5|||
27854368|NCT00219284|54367587|FG000|Treatment Phase - 16 Weeks|Withdrawal by Subject|5|||
27854369|NCT00219284|54367588|FG001|Treatment Phase - 16 Weeks|Withdrawal by Subject|9|||
27854370|NCT00219284|54367587|FG000|Treatment Phase - 16 Weeks|Lost to Follow-up|1|||
27854371|NCT00219284|54367588|FG001|Treatment Phase - 16 Weeks|Lost to Follow-up|2|||
27854372|NCT00219284|54367587|FG000|Extension Phase - 8 Weeks|Adverse Event|2|||
27854373|NCT00219284|54367588|FG001|Extension Phase - 8 Weeks|Adverse Event|3|||
27854374|NCT00219284|54367587|FG000|Extension Phase - 8 Weeks|Withdrawal by Subject|0|||
27854375|NCT00219284|54367588|FG001|Extension Phase - 8 Weeks|Withdrawal by Subject|2|||
27854376|NCT00219284|54367587|FG000|Extension Phase - 8 Weeks|Lost to Follow-up|0|||
27854377|NCT00219284|54367588|FG001|Extension Phase - 8 Weeks|Lost to Follow-up|2|||
27854378|NCT00216476|54367727|FG000|Overall Study|Withdrawal by Subject|59|||
27854379|NCT00216476|54367728|FG001|Overall Study|Withdrawal by Subject|72|||
27947374|NCT00887224|54604938|FG002|Open-label Response (OLR) Phase|Adverse Event|0|||
27947375|NCT00887224|54604936|FG000|Open-label Response (OLR) Phase|Failed to return|6|||
27947376|NCT00887224|54604937|FG001|Open-label Response (OLR) Phase|Failed to return|0|||
27947377|NCT00887224|54604938|FG002|Open-label Response (OLR) Phase|Failed to return|0|||
27947378|NCT00887224|54604936|FG000|Open-label Response (OLR) Phase|Lack of Efficacy|26|||
27947379|NCT00887224|54604937|FG001|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
27947380|NCT00887224|54604938|FG002|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
27947381|NCT00887224|54604936|FG000|Open-label Response (OLR) Phase|Lost to Follow-up|16|||
27947382|NCT00887224|54604937|FG001|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
27947383|NCT00887224|54604938|FG002|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
27947384|NCT00887224|54604936|FG000|Open-label Response (OLR) Phase|Other|1|||
27947385|NCT00887224|54604937|FG001|Open-label Response (OLR) Phase|Other|0|||
27947386|NCT00887224|54604938|FG002|Open-label Response (OLR) Phase|Other|0|||
27947387|NCT00887224|54604936|FG000|Open-label Response (OLR) Phase|Protocol Violation|12|||
27947388|NCT00887224|54604937|FG001|Open-label Response (OLR) Phase|Protocol Violation|0|||
27947389|NCT00887224|54604938|FG002|Open-label Response (OLR) Phase|Protocol Violation|0|||
27947390|NCT00887224|54604936|FG000|Open-label Response (OLR) Phase|Withdrawal by Subject|15|||
27947391|NCT00887224|54604937|FG001|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
27947392|NCT00887224|54604938|FG002|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
27947393|NCT00887224|54604936|FG000|Open-label Stability (OLS) Phase|Adverse Event|22|||
27947394|NCT00887224|54604937|FG001|Open-label Stability (OLS) Phase|Adverse Event|0|||
27947395|NCT00887224|54604938|FG002|Open-label Stability (OLS) Phase|Adverse Event|0|||
27947396|NCT00887224|54604936|FG000|Open-label Stability (OLS) Phase|Failed to return|3|||
27947397|NCT00887224|54604937|FG001|Open-label Stability (OLS) Phase|Failed to return|0|||
27947398|NCT00887224|54604938|FG002|Open-label Stability (OLS) Phase|Failed to return|0|||
27947399|NCT00887224|54604936|FG000|Open-label Stability (OLS) Phase|Lack of Efficacy|16|||
27947400|NCT00887224|54604937|FG001|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
27947401|NCT00887224|54604938|FG002|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
27947402|NCT00887224|54604936|FG000|Open-label Stability (OLS) Phase|Lost to Follow-up|9|||
27947403|NCT00887224|54604937|FG001|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
27947404|NCT00887224|54604938|FG002|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
27947405|NCT00887224|54604936|FG000|Open-label Stability (OLS) Phase|Other|1|||
27947406|NCT00887224|54604937|FG001|Open-label Stability (OLS) Phase|Other|0|||
27947407|NCT00887224|54604938|FG002|Open-label Stability (OLS) Phase|Other|0|||
27947408|NCT00887224|54604936|FG000|Open-label Stability (OLS) Phase|Protocol Violation|13|||
27947409|NCT00887224|54604937|FG001|Open-label Stability (OLS) Phase|Protocol Violation|0|||
27947410|NCT00887224|54604938|FG002|Open-label Stability (OLS) Phase|Protocol Violation|0|||
27947411|NCT00887224|54604936|FG000|Open-label Stability (OLS) Phase|Withdrawal by Subject|19|||
27947412|NCT00887224|54604937|FG001|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
27947413|NCT00887224|54604938|FG002|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
27947414|NCT00887224|54604936|FG000|OL Taper Phase / OL Follow Up|Adverse Event|28|||
27947415|NCT00887224|54604937|FG001|OL Taper Phase / OL Follow Up|Adverse Event|0|||
27947416|NCT00887224|54604938|FG002|OL Taper Phase / OL Follow Up|Adverse Event|0|||
27947417|NCT00887224|54604936|FG000|OL Taper Phase / OL Follow Up|Failed to return|17|||
28164764|NCT02521870|54835323|FG010|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
27947418|NCT00887224|54604937|FG001|OL Taper Phase / OL Follow Up|Failed to return|0|||
27947419|NCT00887224|54604938|FG002|OL Taper Phase / OL Follow Up|Failed to return|0|||
28164765|NCT02521870|54835324|FG011|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
27854380|NCT00216476|54367729|FG002|Overall Study|Withdrawal by Subject|9|||
27854381|NCT00216476|54367727|FG000|Overall Study|Lost to Follow-up|10|||
27854382|NCT00216476|54367728|FG001|Overall Study|Lost to Follow-up|9|||
27854383|NCT00216476|54367729|FG002|Overall Study|Lost to Follow-up|1|||
27854384|NCT00216476|54367727|FG000|Overall Study|Adverse Event|6|||
27854385|NCT00216476|54367728|FG001|Overall Study|Adverse Event|10|||
27854386|NCT00216476|54367729|FG002|Overall Study|Adverse Event|1|||
27832054|NCT01781429|54310833|FG013|Overall Study|Patient Condition Changed|1|||
27832055|NCT01781429|54310834|FG014|Overall Study|Patient Condition Changed|0|||
27832056|NCT01781429|54310835|FG015|Overall Study|Patient Condition Changed|0|||
27832057|NCT01781429|54310820|FG000|Overall Study|Other - as entered by PI in eCRF|0|||
27832058|NCT01781429|54310821|FG001|Overall Study|Other - as entered by PI in eCRF|1|||
27832059|NCT01781429|54310822|FG002|Overall Study|Other - as entered by PI in eCRF|0|||
27832060|NCT01781429|54310823|FG003|Overall Study|Other - as entered by PI in eCRF|0|||
27832061|NCT01781429|54310824|FG004|Overall Study|Other - as entered by PI in eCRF|0|||
27832062|NCT01781429|54310825|FG005|Overall Study|Other - as entered by PI in eCRF|0|||
27947420|NCT00887224|54604936|FG000|OL Taper Phase / OL Follow Up|Physician Decision|10|||
27947421|NCT00887224|54604937|FG001|OL Taper Phase / OL Follow Up|Physician Decision|0|||
27947422|NCT00887224|54604938|FG002|OL Taper Phase / OL Follow Up|Physician Decision|0|||
27947423|NCT00887224|54604936|FG000|OL Taper Phase / OL Follow Up|Lost to Follow-up|8|||
27947424|NCT00887224|54604937|FG001|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
27947425|NCT00887224|54604938|FG002|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
27947426|NCT00887224|54604936|FG000|OL Taper Phase / OL Follow Up|Other|30|||
27947427|NCT00887224|54604937|FG001|OL Taper Phase / OL Follow Up|Other|0|||
27947428|NCT00887224|54604938|FG002|OL Taper Phase / OL Follow Up|Other|0|||
27947429|NCT00887224|54604936|FG000|OL Taper Phase / OL Follow Up|Protocol Violation|3|||
27947430|NCT00887224|54604937|FG001|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
27947431|NCT00887224|54604938|FG002|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
27947432|NCT00887224|54604936|FG000|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48|||
27947433|NCT00887224|54604937|FG001|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
27947434|NCT00887224|54604938|FG002|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
27947435|NCT00887224|54604936|FG000|Double-blind (DB) Phase|Adverse Event|0|||
27947436|NCT00887224|54604937|FG001|Double-blind (DB) Phase|Adverse Event|7|||
27947437|NCT00887224|54604938|FG002|Double-blind (DB) Phase|Adverse Event|2|||
27947438|NCT00887224|54604936|FG000|Double-blind (DB) Phase|Failed to return|0|||
27947439|NCT00887224|54604937|FG001|Double-blind (DB) Phase|Failed to return|2|||
27947440|NCT00887224|54604938|FG002|Double-blind (DB) Phase|Failed to return|2|||
27947441|NCT00887224|54604936|FG000|Double-blind (DB) Phase|Lack of Efficacy|0|||
27947442|NCT00887224|54604937|FG001|Double-blind (DB) Phase|Lack of Efficacy|67|||
27947443|NCT00887224|54604938|FG002|Double-blind (DB) Phase|Lack of Efficacy|33|||
27947444|NCT00887224|54604936|FG000|Double-blind (DB) Phase|Lost to Follow-up|0|||
27947445|NCT00887224|54604937|FG001|Double-blind (DB) Phase|Lost to Follow-up|8|||
27947446|NCT00887224|54604938|FG002|Double-blind (DB) Phase|Lost to Follow-up|8|||
27947447|NCT00887224|54604936|FG000|Double-blind (DB) Phase|Other|0|||
27832063|NCT01781429|54310826|FG006|Overall Study|Other - as entered by PI in eCRF|0|||
27832064|NCT01781429|54310827|FG007|Overall Study|Other - as entered by PI in eCRF|0|||
27832065|NCT01781429|54310828|FG008|Overall Study|Other - as entered by PI in eCRF|0|||
27832066|NCT01781429|54310829|FG009|Overall Study|Other - as entered by PI in eCRF|1|||
27854387|NCT00216476|54367727|FG000|Overall Study|Lack of Efficacy|4|||
27854388|NCT00216476|54367728|FG001|Overall Study|Lack of Efficacy|3|||
27854389|NCT00216476|54367729|FG002|Overall Study|Lack of Efficacy|0|||
27854390|NCT00216476|54367727|FG000|Overall Study|Death|2|||
27854391|NCT00216476|54367728|FG001|Overall Study|Death|0|||
27854392|NCT00216476|54367729|FG002|Overall Study|Death|0|||
27947448|NCT00887224|54604937|FG001|Double-blind (DB) Phase|Other|2|||
27947449|NCT00887224|54604938|FG002|Double-blind (DB) Phase|Other|0|||
27947450|NCT00887224|54604936|FG000|Double-blind (DB) Phase|Protocol Violation|0|||
27854393|NCT00216476|54367727|FG000|Overall Study|Pregnancy|0|||
27947451|NCT00887224|54604937|FG001|Double-blind (DB) Phase|Protocol Violation|8|||
27947452|NCT00887224|54604938|FG002|Double-blind (DB) Phase|Protocol Violation|5|||
27947453|NCT00887224|54604936|FG000|Double-blind (DB) Phase|Withdrawal by Subject|0|||
27947454|NCT00887224|54604937|FG001|Double-blind (DB) Phase|Withdrawal by Subject|6|||
27947455|NCT00887224|54604938|FG002|Double-blind (DB) Phase|Withdrawal by Subject|12|||
27947456|NCT00887224|54604936|FG000|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
27947457|NCT00887224|54604937|FG001|DB Taper Phase / Post Study Follow Up|Adverse Event|5|||
28164766|NCT02923349|54835361|FG000|Overall Study|Other|1|||
27854394|NCT00216476|54367728|FG001|Overall Study|Pregnancy|1|||
27854395|NCT00216476|54367729|FG002|Overall Study|Pregnancy|1|||
27854396|NCT00216476|54367727|FG000|Overall Study|Other|0|||
27854397|NCT00216476|54367728|FG001|Overall Study|Other|0|||
27947458|NCT00887224|54604938|FG002|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
28164767|NCT02923349|54835362|FG001|Overall Study|Other|2|||
27832067|NCT01781429|54310830|FG010|Overall Study|Other - as entered by PI in eCRF|1|||
27832068|NCT01781429|54310831|FG011|Overall Study|Other - as entered by PI in eCRF|2|||
27854398|NCT00216476|54367729|FG002|Overall Study|Other|1|||
27854399|NCT00216476|54367727|FG000|Overall Study|Refuses Injection|11|||
27854400|NCT00216476|54367728|FG001|Overall Study|Refuses Injection|0|||
27947459|NCT00887224|54604936|FG000|DB Taper Phase / Post Study Follow Up|Failed to return|0|||
27947460|NCT00887224|54604937|FG001|DB Taper Phase / Post Study Follow Up|Failed to return|5|||
27854401|NCT00216476|54367729|FG002|Overall Study|Refuses Injection|0|||
27854402|NCT00216476|54367727|FG000|Overall Study|No Further Need for Treatment|3|||
27854403|NCT00216476|54367728|FG001|Overall Study|No Further Need for Treatment|4|||
27947461|NCT00887224|54604938|FG002|DB Taper Phase / Post Study Follow Up|Failed to return|4|||
27947462|NCT00887224|54604936|FG000|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
27947463|NCT00887224|54604937|FG001|DB Taper Phase / Post Study Follow Up|Physician Decision|6|||
27947464|NCT00887224|54604938|FG002|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
27947465|NCT00887224|54604936|FG000|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0|||
27947466|NCT00887224|54604937|FG001|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
27947467|NCT00887224|54604938|FG002|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
27947468|NCT00887224|54604936|FG000|DB Taper Phase / Post Study Follow Up|Other|0|||
27947469|NCT00887224|54604937|FG001|DB Taper Phase / Post Study Follow Up|Other|11|||
27947470|NCT00887224|54604938|FG002|DB Taper Phase / Post Study Follow Up|Other|12|||
27947471|NCT00887224|54604936|FG000|DB Taper Phase / Post Study Follow Up|Protocol Violation|0|||
27947472|NCT00887224|54604937|FG001|DB Taper Phase / Post Study Follow Up|Protocol Violation|4|||
27947473|NCT00887224|54604938|FG002|DB Taper Phase / Post Study Follow Up|Protocol Violation|1|||
27947474|NCT00887224|54604936|FG000|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0|||
27947475|NCT00887224|54604937|FG001|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8|||
27947476|NCT00887224|54604938|FG002|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11|||
27947477|NCT01109316|54604956|FG000|Study Period 1|Adverse Event|0|||
27947478|NCT01109316|54604957|FG001|Study Period 1|Adverse Event|0|||
27947479|NCT01109316|54604958|FG002|Study Period 1|Adverse Event|1|||
27947480|NCT01109316|54604959|FG003|Study Period 1|Adverse Event|0|||
27947481|NCT01109316|54604960|FG004|Study Period 1|Adverse Event|0|||
27947482|NCT01109316|54604961|FG005|Study Period 1|Adverse Event|0|||
27947483|NCT01109316|54604956|FG000|Study Period 1|Lost to Follow-up|0|||
27947484|NCT01109316|54604957|FG001|Study Period 1|Lost to Follow-up|0|||
27947485|NCT01109316|54604958|FG002|Study Period 1|Lost to Follow-up|1|||
27947486|NCT01109316|54604959|FG003|Study Period 1|Lost to Follow-up|1|||
27947487|NCT01109316|54604960|FG004|Study Period 1|Lost to Follow-up|0|||
27947488|NCT01109316|54604961|FG005|Study Period 1|Lost to Follow-up|0|||
27947489|NCT01109316|54604956|FG000|Study Period 1|Withdrawal by Subject|0|||
27947490|NCT01109316|54604957|FG001|Study Period 1|Withdrawal by Subject|0|||
27947491|NCT01109316|54604958|FG002|Study Period 1|Withdrawal by Subject|1|||
27947492|NCT01109316|54604959|FG003|Study Period 1|Withdrawal by Subject|0|||
27854404|NCT00216476|54367729|FG002|Overall Study|No Further Need for Treatment|1|||
27854405|NCT00216476|54367727|FG000|Overall Study|Non-compliance|0|||
27854406|NCT00216476|54367728|FG001|Overall Study|Non-compliance|4|||
27854407|NCT00216476|54367729|FG002|Overall Study|Non-compliance|1|||
27854408|NCT00216476|54367727|FG000|Overall Study|Higher dose/Extra Medication Required|2|||
27854409|NCT00216476|54367728|FG001|Overall Study|Higher dose/Extra Medication Required|0|||
27854410|NCT00216476|54367729|FG002|Overall Study|Higher dose/Extra Medication Required|2|||
27854411|NCT00216476|54367727|FG000|Overall Study|Administrative Reasons|1|||
27947493|NCT01109316|54604960|FG004|Study Period 1|Withdrawal by Subject|2|||
27947494|NCT01109316|54604961|FG005|Study Period 1|Withdrawal by Subject|0|||
27947495|NCT01109316|54604956|FG000|Study Period 1|Sponsor Decision|0|||
27947496|NCT01109316|54604957|FG001|Study Period 1|Sponsor Decision|0|||
27947497|NCT01109316|54604958|FG002|Study Period 1|Sponsor Decision|0|||
27947498|NCT01109316|54604959|FG003|Study Period 1|Sponsor Decision|0|||
27947499|NCT01109316|54604960|FG004|Study Period 1|Sponsor Decision|0|||
27947500|NCT01109316|54604961|FG005|Study Period 1|Sponsor Decision|2|||
27947501|NCT01109316|54604956|FG000|Study Period 2|Entry Criteria Not Met|0|||
27947502|NCT01109316|54604957|FG001|Study Period 2|Entry Criteria Not Met|1|||
27947503|NCT01109316|54604958|FG002|Study Period 2|Entry Criteria Not Met|0|||
27947504|NCT01109316|54604959|FG003|Study Period 2|Entry Criteria Not Met|0|||
27947505|NCT01109316|54604960|FG004|Study Period 2|Entry Criteria Not Met|0|||
27947506|NCT01109316|54604961|FG005|Study Period 2|Entry Criteria Not Met|0|||
27947507|NCT01109316|54604956|FG000|Study Period 2|Physician Decision|0|||
27947508|NCT01109316|54604957|FG001|Study Period 2|Physician Decision|0|||
27947509|NCT01109316|54604958|FG002|Study Period 2|Physician Decision|0|||
27947510|NCT01109316|54604959|FG003|Study Period 2|Physician Decision|1|||
27947511|NCT01109316|54604960|FG004|Study Period 2|Physician Decision|0|||
27947512|NCT01109316|54604961|FG005|Study Period 2|Physician Decision|0|||
27947513|NCT01109316|54604956|FG000|Study Period 2|Protocol Violation|1|||
27947514|NCT01109316|54604957|FG001|Study Period 2|Protocol Violation|0|||
27947515|NCT01109316|54604958|FG002|Study Period 2|Protocol Violation|0|||
27947516|NCT01109316|54604959|FG003|Study Period 2|Protocol Violation|0|||
27947517|NCT01109316|54604960|FG004|Study Period 2|Protocol Violation|0|||
27947518|NCT01109316|54604961|FG005|Study Period 2|Protocol Violation|0|||
28080770|NCT00104247|54734031|FG000|Overall Study|Withdrawal by Subject|1|||
28080771|NCT00104247|54734032|FG001|Overall Study|Withdrawal by Subject|0|||
27854412|NCT00216476|54367728|FG001|Overall Study|Administrative Reasons|1|||
27947519|NCT01109316|54604956|FG000|Study Period 2|Withdrawal by Subject|0|||
27947520|NCT01109316|54604957|FG001|Study Period 2|Withdrawal by Subject|0|||
27947521|NCT01109316|54604958|FG002|Study Period 2|Withdrawal by Subject|1|||
27947522|NCT01109316|54604959|FG003|Study Period 2|Withdrawal by Subject|0|||
27947523|NCT01109316|54604960|FG004|Study Period 2|Withdrawal by Subject|0|||
27947524|NCT01109316|54604961|FG005|Study Period 2|Withdrawal by Subject|1|||
27947525|NCT01109316|54604956|FG000|Study Period 3|Lost to Follow-up|0|||
27947526|NCT01109316|54604957|FG001|Study Period 3|Lost to Follow-up|0|||
27947527|NCT01109316|54604958|FG002|Study Period 3|Lost to Follow-up|0|||
27947528|NCT01109316|54604959|FG003|Study Period 3|Lost to Follow-up|0|||
27854413|NCT00216476|54367729|FG002|Overall Study|Administrative Reasons|0|||
27854414|NCT00216476|54367727|FG000|Overall Study|Protocol Deviation|5|||
27854415|NCT00216476|54367728|FG001|Overall Study|Protocol Deviation|1|||
27854416|NCT00216476|54367729|FG002|Overall Study|Protocol Deviation|0|||
27854417|NCT00216476|54367727|FG000|Overall Study|Patient Moved|2|||
27854418|NCT00216476|54367728|FG001|Overall Study|Patient Moved|2|||
27854419|NCT00216476|54367729|FG002|Overall Study|Patient Moved|0|||
27854420|NCT00216086|54367780|FG000|Overall Study|Protocol Violation|1|||
27854421|NCT00216086|54367780|FG000|Overall Study|Diagnosis of Metastatic Disease|1|||
27854422|NCT00216086|54367780|FG000|Overall Study|Social Reasons|2|||
27854423|NCT00215150|54367811|FG000|Open Label Phase|Lost to Follow-up|7|||
27854424|NCT00215150|54367811|FG000|Open Label Phase|Withdrawal by Subject|1|||
27854425|NCT00215150|54367811|FG000|Open Label Phase|Did not complete a post base visit|13|||
27854426|NCT00215150|54367811|FG000|Open Label Phase|Did not meet randomization criteria|9|||
27854427|NCT00215150|54367811|FG000|Randomization Phase Ziprasidone|Lost to Follow-up|2|||
27854428|NCT00215150|54367811|FG000|Randomization Phase Ziprasidone|Withdrawal by Subject|1|||
27854429|NCT00215150|54367811|FG000|Randomization Phase Placebo|Withdrawal by Subject|1|||
27854430|NCT00214136|54367819|FG000|Overall Study|Death|5|||
27854431|NCT00213980|54367825|FG000|Overall Study|Withdrawal by Subject|3|||
27854432|NCT00213980|54367826|FG001|Overall Study|Withdrawal by Subject|1|||
27854433|NCT00213980|54367825|FG000|Overall Study|Adverse Event|1|||
27854434|NCT00213980|54367826|FG001|Overall Study|Adverse Event|1|||
27854435|NCT00213980|54367825|FG000|Overall Study|Disease progression|0|||
27854436|NCT00213980|54367826|FG001|Overall Study|Disease progression|2|||
27854437|NCT00213980|54367825|FG000|Overall Study|Developed ovarian cancer|1|||
27854438|NCT00213980|54367826|FG001|Overall Study|Developed ovarian cancer|0|||
27854439|NCT00213980|54367825|FG000|Overall Study|Failed to obtain all 3 DXAs|1|||
27854440|NCT00213980|54367826|FG001|Overall Study|Failed to obtain all 3 DXAs|3|||
27854441|NCT04388527|54368266|FG000|Overall Study|Death|14|||
27854442|NCT04388527|54368266|FG000|Overall Study|Withdrawal by Subject|2|||
27854443|NCT04388527|54368266|FG000|Overall Study|Lost to Follow-up|1|||
27854444|NCT04149002|54368518|FG000|Overall Study|Lost to Follow-up|1|||
27854445|NCT04149002|54368519|FG001|Overall Study|Lost to Follow-up|0|||
27854446|NCT04149002|54368518|FG000|Overall Study|Withdrawal by Subject|1|||
27854447|NCT04149002|54368519|FG001|Overall Study|Withdrawal by Subject|0|||
27854448|NCT00555321|54368602|FG000|Treatment Phase up to 12-months|Adverse Event|6|||
27854449|NCT00555321|54368603|FG001|Treatment Phase up to 12-months|Adverse Event|7|||
27854450|NCT00555321|54368604|FG002|Treatment Phase up to 12-months|Adverse Event|11|||
27854451|NCT00555321|54368605|FG003|Treatment Phase up to 12-months|Adverse Event|7|||
27854452|NCT00555321|54368606|FG004|Treatment Phase up to 12-months|Adverse Event|18|||
27854453|NCT00555321|54368602|FG000|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
27854454|NCT00555321|54368603|FG001|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
27854455|NCT00555321|54368604|FG002|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
27854456|NCT00555321|54368605|FG003|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
27854457|NCT00555321|54368606|FG004|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
27854458|NCT00555321|54368602|FG000|Treatment Phase up to 12-months|Death|2|||
27854459|NCT00555321|54368603|FG001|Treatment Phase up to 12-months|Death|1|||
27854460|NCT00555321|54368604|FG002|Treatment Phase up to 12-months|Death|4|||
27854461|NCT00555321|54368605|FG003|Treatment Phase up to 12-months|Death|0|||
27854462|NCT00555321|54368606|FG004|Treatment Phase up to 12-months|Death|0|||
27854463|NCT00555321|54368602|FG000|Treatment Phase up to 12-months|Lack of Efficacy|9|||
27854464|NCT00555321|54368603|FG001|Treatment Phase up to 12-months|Lack of Efficacy|8|||
27854465|NCT00555321|54368604|FG002|Treatment Phase up to 12-months|Lack of Efficacy|5|||
27854466|NCT00555321|54368605|FG003|Treatment Phase up to 12-months|Lack of Efficacy|0|||
27854467|NCT00555321|54368606|FG004|Treatment Phase up to 12-months|Lack of Efficacy|0|||
27854468|NCT00555321|54368602|FG000|Treatment Phase up to 12-months|Other Reason|1|||
27854469|NCT00555321|54368603|FG001|Treatment Phase up to 12-months|Other Reason|3|||
27854470|NCT00555321|54368604|FG002|Treatment Phase up to 12-months|Other Reason|2|||
27947529|NCT01109316|54604960|FG004|Study Period 3|Lost to Follow-up|1|||
27854471|NCT00555321|54368605|FG003|Treatment Phase up to 12-months|Other Reason|0|||
27947530|NCT01109316|54604961|FG005|Study Period 3|Lost to Follow-up|0|||
27947531|NCT01109316|54604956|FG000|Study Period 3|Withdrawal by Subject|1|||
27854472|NCT00555321|54368606|FG004|Treatment Phase up to 12-months|Other Reason|0|||
27854473|NCT00555321|54368602|FG000|Treatment Phase up to 12-months|Never treated|2|||
27854474|NCT00555321|54368603|FG001|Treatment Phase up to 12-months|Never treated|3|||
27854475|NCT00555321|54368604|FG002|Treatment Phase up to 12-months|Never treated|1|||
27854476|NCT00555321|54368605|FG003|Treatment Phase up to 12-months|Never treated|0|||
27947532|NCT01109316|54604957|FG001|Study Period 3|Withdrawal by Subject|0|||
27947533|NCT01109316|54604958|FG002|Study Period 3|Withdrawal by Subject|0|||
27947534|NCT01109316|54604959|FG003|Study Period 3|Withdrawal by Subject|0|||
27947535|NCT01109316|54604960|FG004|Study Period 3|Withdrawal by Subject|1|||
27947536|NCT01109316|54604961|FG005|Study Period 3|Withdrawal by Subject|0|||
27947537|NCT00887068|54604971|FG000|Overall Study|Withdrawal by Subject|2|||
27947538|NCT00887068|54604972|FG001|Overall Study|Withdrawal by Subject|0|||
27947539|NCT00887068|54604971|FG000|Overall Study|Didn't meet eligibility to start cycle 1|4|||
27947540|NCT00887068|54604972|FG001|Overall Study|Didn't meet eligibility to start cycle 1|0|||
27947541|NCT00941031|54604982|FG000|Induction Period|Lack of Efficacy|2|||
27947542|NCT00941031|54604983|FG001|Induction Period|Lack of Efficacy|1|||
27947543|NCT00941031|54604984|FG002|Induction Period|Lack of Efficacy|0|||
27947544|NCT00941031|54604985|FG003|Induction Period|Lack of Efficacy|5|||
27947545|NCT00941031|54604986|FG004|Induction Period|Lack of Efficacy|0|||
27947546|NCT00941031|54604987|FG005|Induction Period|Lack of Efficacy|0|||
27947547|NCT00941031|54604988|FG006|Induction Period|Lack of Efficacy|0|||
27947548|NCT00941031|54604982|FG000|Induction Period|Withdrawal by Subject|1|||
27947549|NCT00941031|54604983|FG001|Induction Period|Withdrawal by Subject|2|||
27947550|NCT00941031|54604984|FG002|Induction Period|Withdrawal by Subject|2|||
27947551|NCT00941031|54604985|FG003|Induction Period|Withdrawal by Subject|2|||
27947552|NCT00941031|54604986|FG004|Induction Period|Withdrawal by Subject|0|||
27947553|NCT00941031|54604987|FG005|Induction Period|Withdrawal by Subject|0|||
27947554|NCT00941031|54604988|FG006|Induction Period|Withdrawal by Subject|0|||
27947555|NCT00941031|54604982|FG000|Induction Period|Adminstative Problems|1|||
27947556|NCT00941031|54604983|FG001|Induction Period|Adminstative Problems|1|||
27947557|NCT00941031|54604984|FG002|Induction Period|Adminstative Problems|1|||
27947558|NCT00941031|54604985|FG003|Induction Period|Adminstative Problems|0|||
27947559|NCT00941031|54604986|FG004|Induction Period|Adminstative Problems|0|||
27947560|NCT00941031|54604987|FG005|Induction Period|Adminstative Problems|0|||
27947561|NCT00941031|54604988|FG006|Induction Period|Adminstative Problems|0|||
27947562|NCT00941031|54604982|FG000|Induction Period|Adverse Event|1|||
27947563|NCT00941031|54604983|FG001|Induction Period|Adverse Event|0|||
27947564|NCT00941031|54604984|FG002|Induction Period|Adverse Event|3|||
27947565|NCT00941031|54604985|FG003|Induction Period|Adverse Event|2|||
27947566|NCT00941031|54604986|FG004|Induction Period|Adverse Event|0|||
27947567|NCT00941031|54604987|FG005|Induction Period|Adverse Event|0|||
27947568|NCT00941031|54604988|FG006|Induction Period|Adverse Event|0|||
27947569|NCT00941031|54604982|FG000|Maintenance Period|Withdrawal by Subject|0|||
27947570|NCT00941031|54604983|FG001|Maintenance Period|Withdrawal by Subject|0|||
27947571|NCT00941031|54604984|FG002|Maintenance Period|Withdrawal by Subject|0|||
27947572|NCT00941031|54604985|FG003|Maintenance Period|Withdrawal by Subject|0|||
27947573|NCT00941031|54604986|FG004|Maintenance Period|Withdrawal by Subject|6|||
27947574|NCT00941031|54604987|FG005|Maintenance Period|Withdrawal by Subject|2|||
27854477|NCT00555321|54368606|FG004|Treatment Phase up to 12-months|Never treated|4|||
27854478|NCT00555321|54368602|FG000|Long-term Extension Phase|Adverse Event|2|||
27854479|NCT00555321|54368603|FG001|Long-term Extension Phase|Adverse Event|5|||
27947575|NCT00941031|54604988|FG006|Maintenance Period|Withdrawal by Subject|13|||
27947576|NCT00941031|54604982|FG000|Maintenance Period|Administrative Problems|0|||
27947577|NCT00941031|54604983|FG001|Maintenance Period|Administrative Problems|0|||
27854480|NCT00555321|54368604|FG002|Long-term Extension Phase|Adverse Event|2|||
27854481|NCT00555321|54368605|FG003|Long-term Extension Phase|Adverse Event|1|||
27854482|NCT00555321|54368606|FG004|Long-term Extension Phase|Adverse Event|0|||
27854483|NCT00555321|54368602|FG000|Long-term Extension Phase|Withdrawal by Subject|2|||
27854484|NCT00555321|54368603|FG001|Long-term Extension Phase|Withdrawal by Subject|1|||
27947578|NCT00941031|54604984|FG002|Maintenance Period|Administrative Problems|0|||
27947579|NCT00941031|54604985|FG003|Maintenance Period|Administrative Problems|0|||
27947580|NCT00941031|54604986|FG004|Maintenance Period|Administrative Problems|1|||
27947581|NCT00941031|54604987|FG005|Maintenance Period|Administrative Problems|0|||
27947582|NCT00941031|54604988|FG006|Maintenance Period|Administrative Problems|1|||
27947583|NCT00941031|54604982|FG000|Maintenance Period|Protocol Violation|0|||
27947584|NCT00941031|54604983|FG001|Maintenance Period|Protocol Violation|0|||
27947585|NCT00941031|54604984|FG002|Maintenance Period|Protocol Violation|0|||
27947586|NCT00941031|54604985|FG003|Maintenance Period|Protocol Violation|0|||
27947587|NCT00941031|54604986|FG004|Maintenance Period|Protocol Violation|0|||
27947588|NCT00941031|54604987|FG005|Maintenance Period|Protocol Violation|0|||
27947589|NCT00941031|54604988|FG006|Maintenance Period|Protocol Violation|1|||
28164768|NCT02923349|54835363|FG002|Overall Study|Other|4|||
27947590|NCT00941031|54604982|FG000|Maintenance Period|Adverse Event|0|||
27947591|NCT00941031|54604983|FG001|Maintenance Period|Adverse Event|0|||
27947592|NCT00941031|54604984|FG002|Maintenance Period|Adverse Event|0|||
27947593|NCT00941031|54604985|FG003|Maintenance Period|Adverse Event|0|||
27947594|NCT00941031|54604986|FG004|Maintenance Period|Adverse Event|0|||
27947595|NCT00941031|54604987|FG005|Maintenance Period|Adverse Event|2|||
27947596|NCT00941031|54604988|FG006|Maintenance Period|Adverse Event|8|||
27854485|NCT00555321|54368604|FG002|Long-term Extension Phase|Withdrawal by Subject|2|||
27947597|NCT00941031|54604982|FG000|Maintenance Period|Lost to Follow-up|0|||
27947598|NCT00941031|54604983|FG001|Maintenance Period|Lost to Follow-up|0|||
27947599|NCT00941031|54604984|FG002|Maintenance Period|Lost to Follow-up|0|||
27947600|NCT00941031|54604985|FG003|Maintenance Period|Lost to Follow-up|0|||
27947601|NCT00941031|54604986|FG004|Maintenance Period|Lost to Follow-up|2|||
27947602|NCT00941031|54604987|FG005|Maintenance Period|Lost to Follow-up|2|||
27947603|NCT00941031|54604988|FG006|Maintenance Period|Lost to Follow-up|7|||
27947604|NCT00941031|54604982|FG000|Maintenance Period|Lack of Efficacy|0|||
27947605|NCT00941031|54604983|FG001|Maintenance Period|Lack of Efficacy|0|||
27947606|NCT00941031|54604984|FG002|Maintenance Period|Lack of Efficacy|0|||
27947607|NCT00941031|54604985|FG003|Maintenance Period|Lack of Efficacy|0|||
27947608|NCT00941031|54604986|FG004|Maintenance Period|Lack of Efficacy|0|||
27947609|NCT00941031|54604987|FG005|Maintenance Period|Lack of Efficacy|0|||
27947610|NCT00941031|54604988|FG006|Maintenance Period|Lack of Efficacy|13|||
27947611|NCT00886834|54605009|FG000|Overall Study|Protocol Violation|0|||
27947612|NCT00886834|54605010|FG001|Overall Study|Protocol Violation|3|||
27947613|NCT00880009|54605016|FG000|Overall Study|Study terminated by sponsor|14|||
27947614|NCT00880009|54605016|FG000|Overall Study|Withdrawal by Subject|1|||
27947615|NCT00880009|54605016|FG000|Overall Study|Protocol Violation|1|||
27947616|NCT01104636|54605023|FG000|Overall Study|Lack of Efficacy|43|||
27947617|NCT01104636|54605023|FG000|Overall Study|Lost to Follow-up|24|||
27947618|NCT01104636|54605023|FG000|Overall Study|Withdrawal by Subject|4|||
27947619|NCT01104636|54605023|FG000|Overall Study|Other|43|||
27947620|NCT01104636|54605023|FG000|Overall Study|Study terminated by sponsor|1|||
27947621|NCT01104636|54605023|FG000|Overall Study|Pregnancy|2|||
27947622|NCT01104636|54605023|FG000|Overall Study|Adverse Event|40|||
27947623|NCT01104636|54605023|FG000|Overall Study|Ongoing|21|||
27947624|NCT01104558|54605027|FG000|Overall Study|Protocol Violation|6|||
27947625|NCT01104558|54605027|FG000|Overall Study|Missing of primary efficacy assessment|10|||
27947626|NCT01104558|54605027|FG000|Overall Study|Missing of genetic analysis results|1|||
27947627|NCT00886288|54605033|FG000|Overall Study|no respect of the 12 weeks period|657|||
27947628|NCT00886288|54605034|FG001|Overall Study|no respect of the 12 weeks period|227|||
27947629|NCT00886288|54605033|FG000|Overall Study|Lost to Follow-up|86|||
27947630|NCT00886288|54605034|FG001|Overall Study|Lost to Follow-up|0|||
27947631|NCT01204658|54605046|FG000|Primary Phase|Adverse Event|0|||
27947632|NCT01204658|54605047|FG001|Primary Phase|Adverse Event|0|||
27947633|NCT01204658|54605048|FG002|Primary Phase|Adverse Event|1|||
27947634|NCT01204658|54605049|FG003|Primary Phase|Adverse Event|0|||
27947635|NCT00951483|54605064|FG000|Overall Study|Physician Decision|4|||
27947636|NCT00951483|54605065|FG001|Overall Study|Physician Decision|0|||
27947637|NCT00951483|54605064|FG000|Overall Study|Withdrawal by Subject|15|||
27947638|NCT00951483|54605065|FG001|Overall Study|Withdrawal by Subject|0|||
27947639|NCT01104246|54605073|FG000|Overall Study|Withdrawal by Subject|1|||
27947640|NCT01104246|54605073|FG000|Overall Study|did not meet inclusion criteria|4|||
27947641|NCT01103778|54605077|FG000|Overall Study|Lost to Follow-up|1|||
27947642|NCT01103778|54605077|FG000|Overall Study|Proteinuria improved prior to enrollment|1|||
27947643|NCT01103778|54605077|FG000|Overall Study|Screen failure|1|||
27947644|NCT01103466|54605083|FG000|First Period (14 +/- 3 Days)|Protocol Violation|2|||
27947645|NCT01103466|54605084|FG001|First Period (14 +/- 3 Days)|Protocol Violation|0|||
27947646|NCT01103466|54605085|FG002|First Period (14 +/- 3 Days)|Protocol Violation|0|||
27947647|NCT01103466|54605083|FG000|Second Period (14 +/- 3 Days)|Adverse Event|2|||
27947648|NCT01103466|54605084|FG001|Second Period (14 +/- 3 Days)|Adverse Event|1|||
27947649|NCT01103466|54605085|FG002|Second Period (14 +/- 3 Days)|Adverse Event|0|||
27947650|NCT01103466|54605083|FG000|Second Period (14 +/- 3 Days)|Lack of Efficacy|0|||
27947651|NCT01103466|54605084|FG001|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
27947652|NCT01103466|54605085|FG002|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
27947653|NCT01103466|54605083|FG000|Third Period (14 +/- 3 Days)|Adverse Event|1|||
27947654|NCT01103466|54605084|FG001|Third Period (14 +/- 3 Days)|Adverse Event|0|||
27947655|NCT01103466|54605085|FG002|Third Period (14 +/- 3 Days)|Adverse Event|0|||
28080772|NCT00104247|54734031|FG000|Overall Study|Noncompliant with dosing|0|||
28080773|NCT00104247|54734032|FG001|Overall Study|Noncompliant with dosing|1|||
28080774|NCT03565900|54734040|FG000|Overall Study|Disposition Unknown|4|||
28080775|NCT03565900|54734041|FG001|Overall Study|Disposition Unknown|1|||
28080776|NCT03565900|54734040|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
27947656|NCT01103466|54605083|FG000|Third Period (14 +/- 3 Days)|Lack of Efficacy|1|||
27947657|NCT01103466|54605084|FG001|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
27947658|NCT01103466|54605085|FG002|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
27947659|NCT01103466|54605083|FG000|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
27947660|NCT01103466|54605084|FG001|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
27947661|NCT01103466|54605085|FG002|Third Period (14 +/- 3 Days)|not satisfied with product|1|||
27947662|NCT00945945|54605095|FG000|Overall Study|Adverse Event|15|||
27947663|NCT00945945|54605096|FG001|Overall Study|Adverse Event|35|||
27947664|NCT00945945|54605095|FG000|Overall Study|Withdrawal by Subject|7|||
27947665|NCT00945945|54605096|FG001|Overall Study|Withdrawal by Subject|10|||
27947666|NCT00945945|54605095|FG000|Overall Study|Lost to Follow-up|4|||
27947667|NCT00945945|54605096|FG001|Overall Study|Lost to Follow-up|5|||
27947668|NCT00945945|54605095|FG000|Overall Study|Lack of Efficacy|6|||
27947669|NCT00945945|54605096|FG001|Overall Study|Lack of Efficacy|2|||
27947670|NCT00945945|54605095|FG000|Overall Study|Protocol Violation|4|||
27947671|NCT00945945|54605096|FG001|Overall Study|Protocol Violation|2|||
27947672|NCT00945945|54605095|FG000|Overall Study|Entry Criteria Not Met|0|||
27947673|NCT00945945|54605096|FG001|Overall Study|Entry Criteria Not Met|1|||
27947674|NCT01203956|54605102|FG000|Second Two-week Period|Non-compliant: no evaluable results|5|||
27947675|NCT01203956|54605103|FG001|Second Two-week Period|Non-compliant: no evaluable results|6|||
27947676|NCT01103232|54605112|FG000|Overall Study|Withdrawal by Subject|1|||
27947677|NCT01103232|54605113|FG001|Overall Study|Withdrawal by Subject|1|||
27947678|NCT01103232|54605112|FG000|Overall Study|Protocol Violation|0|||
27947679|NCT01103232|54605113|FG001|Overall Study|Protocol Violation|1|||
27947680|NCT01112982|54605119|FG000|Overall Study|Withdrawal by Subject|1|||
27947681|NCT01112982|54605119|FG000|Overall Study|exceeded weight limit to complete MRI|1|||
27947682|NCT01203878|54605129|FG000|Overall Study|Withdrawal by Subject|0|||
27947683|NCT01203878|54605130|FG001|Overall Study|Withdrawal by Subject|0|||
27947684|NCT01203878|54605131|FG002|Overall Study|Withdrawal by Subject|1|||
27947685|NCT01203878|54605129|FG000|Overall Study|Adverse Event|0|||
27947686|NCT01203878|54605130|FG001|Overall Study|Adverse Event|0|||
27947687|NCT01203878|54605131|FG002|Overall Study|Adverse Event|2|||
27947688|NCT01112514|54605138|FG000|Overall Study|Lost to Follow-up|1|||
27947689|NCT01203098|54605145|FG000|Overall Study|Adverse Event|3|||
27947690|NCT01203098|54605146|FG001|Overall Study|Adverse Event|1|||
27947691|NCT01203098|54605147|FG002|Overall Study|Adverse Event|7|||
27947692|NCT01203098|54605145|FG000|Overall Study|Lost to Follow-up|0|||
27947693|NCT01203098|54605146|FG001|Overall Study|Lost to Follow-up|0|||
27947694|NCT01203098|54605147|FG002|Overall Study|Lost to Follow-up|1|||
27947695|NCT01203098|54605145|FG000|Overall Study|Physician Decision|2|||
27947696|NCT01203098|54605146|FG001|Overall Study|Physician Decision|2|||
27947697|NCT01203098|54605147|FG002|Overall Study|Physician Decision|0|||
27947698|NCT01203098|54605145|FG000|Overall Study|Withdrawal by Subject|1|||
27947699|NCT01203098|54605146|FG001|Overall Study|Withdrawal by Subject|1|||
27947700|NCT01203098|54605147|FG002|Overall Study|Withdrawal by Subject|3|||
27947701|NCT00945555|54605155|FG000|Overall Study|Referred to another hospital|5|||
27947702|NCT00945555|54605155|FG000|Overall Study|Worsening condition, intensive care unit|1|||
27947703|NCT00945555|54605155|FG000|Overall Study|Withdrawal by Subject|2|||
27947704|NCT00945555|54605155|FG000|Overall Study|Participant continued treatment at home|1|||
27947705|NCT00945555|54605155|FG000|Overall Study|Death|18|||
27947706|NCT00945555|54605155|FG000|Overall Study|Other|1|||
27947707|NCT01108458|54605159|FG000|Overall Study|Withdrawal by Subject|1|||
27947708|NCT01108068|54605165|FG000|Overall Study|5 not started, 1 stop due to side effect|6|||
27947709|NCT01108068|54605166|FG001|Overall Study|5 not started, 1 stop due to side effect|0|||
27947710|NCT01201850|54605173|FG000|Overall Study|Tumor progression|4|||
27947711|NCT00951171|54605179|FG000|Overall Study|Adverse Event|2|||
27947712|NCT00951171|54605180|FG001|Overall Study|Adverse Event|0|||
27947713|NCT01200992|54605188|FG000|Overall Study|Study terminated early|35|||
27947714|NCT01200992|54605189|FG001|Overall Study|Study terminated early|41|||
27947715|NCT01200992|54605188|FG000|Overall Study|Randomized but not treated|2|||
27947716|NCT01200992|54605189|FG001|Overall Study|Randomized but not treated|0|||
27947717|NCT00878215|54605201|FG000|Overall Study|Determined to be ineligible|0|||
27947718|NCT00878215|54605202|FG001|Overall Study|Determined to be ineligible|10|||
27947719|NCT00878215|54605203|FG002|Overall Study|Determined to be ineligible|0|||
27947720|NCT00878215|54605204|FG003|Overall Study|Determined to be ineligible|0|||
27947721|NCT01200758|54605216|FG000|Stage I|Death|0|||
27947722|NCT01200758|54605217|FG001|Stage I|Death|1|||
27947723|NCT01200758|54605218|FG002|Stage I|Death|0|||
27947724|NCT01200758|54605219|FG003|Stage I|Death|0|||
27947725|NCT01200758|54605216|FG000|Stage I|Physician Decision|1|||
27947726|NCT01200758|54605217|FG001|Stage I|Physician Decision|1|||
27832069|NCT01781429|54310832|FG012|Overall Study|Other - as entered by PI in eCRF|1|||
27832070|NCT01781429|54310833|FG013|Overall Study|Other - as entered by PI in eCRF|1|||
27832071|NCT01781429|54310834|FG014|Overall Study|Other - as entered by PI in eCRF|1|||
27832072|NCT01781429|54310835|FG015|Overall Study|Other - as entered by PI in eCRF|0|||
27832073|NCT01781429|54310820|FG000|Overall Study|Enrolled, but not treated|0|||
27832074|NCT01781429|54310821|FG001|Overall Study|Enrolled, but not treated|0|||
27832075|NCT01781429|54310822|FG002|Overall Study|Enrolled, but not treated|0|||
27832076|NCT01781429|54310823|FG003|Overall Study|Enrolled, but not treated|0|||
27947727|NCT01200758|54605218|FG002|Stage I|Physician Decision|0|||
27947728|NCT01200758|54605219|FG003|Stage I|Physician Decision|0|||
27947729|NCT01200758|54605216|FG000|Stage I|Lack of Efficacy|2|||
27947730|NCT01200758|54605217|FG001|Stage I|Lack of Efficacy|1|||
27947731|NCT01200758|54605218|FG002|Stage I|Lack of Efficacy|0|||
27947732|NCT01200758|54605219|FG003|Stage I|Lack of Efficacy|0|||
27947733|NCT01200758|54605216|FG000|Stage I|Adverse Event|5|||
27947734|NCT01200758|54605217|FG001|Stage I|Adverse Event|5|||
27947735|NCT01200758|54605218|FG002|Stage I|Adverse Event|0|||
27947736|NCT01200758|54605219|FG003|Stage I|Adverse Event|0|||
27832077|NCT01781429|54310824|FG004|Overall Study|Enrolled, but not treated|0|||
27854486|NCT00555321|54368605|FG003|Long-term Extension Phase|Withdrawal by Subject|3|||
27854487|NCT00555321|54368606|FG004|Long-term Extension Phase|Withdrawal by Subject|2|||
27854488|NCT00555321|54368602|FG000|Long-term Extension Phase|Administrative reason by sponsor|23|||
27854489|NCT00555321|54368603|FG001|Long-term Extension Phase|Administrative reason by sponsor|21|||
27854490|NCT00555321|54368604|FG002|Long-term Extension Phase|Administrative reason by sponsor|18|||
27854491|NCT00555321|54368605|FG003|Long-term Extension Phase|Administrative reason by sponsor|31|||
27947737|NCT01200758|54605216|FG000|Stage I|Withdrawal by Subject|1|||
27947738|NCT01200758|54605217|FG001|Stage I|Withdrawal by Subject|2|||
27947739|NCT01200758|54605218|FG002|Stage I|Withdrawal by Subject|0|||
27947740|NCT01200758|54605219|FG003|Stage I|Withdrawal by Subject|0|||
27947741|NCT01200758|54605216|FG000|Stage I|Disease Progression|9|||
27947742|NCT01200758|54605217|FG001|Stage I|Disease Progression|7|||
27947743|NCT01200758|54605218|FG002|Stage I|Disease Progression|0|||
27947744|NCT01200758|54605219|FG003|Stage I|Disease Progression|0|||
27947745|NCT01200758|54605216|FG000|Stage 2|Disease Progression|0|||
27947746|NCT01200758|54605217|FG001|Stage 2|Disease Progression|0|||
27947747|NCT01200758|54605218|FG002|Stage 2|Disease Progression|16|||
27947748|NCT01200758|54605219|FG003|Stage 2|Disease Progression|21|||
27947749|NCT01200758|54605216|FG000|Stage 2|Lack of Efficacy|0|||
27947750|NCT01200758|54605217|FG001|Stage 2|Lack of Efficacy|0|||
27947751|NCT01200758|54605218|FG002|Stage 2|Lack of Efficacy|4|||
27947752|NCT01200758|54605219|FG003|Stage 2|Lack of Efficacy|2|||
27947753|NCT01200758|54605216|FG000|Stage 2|Physician Decision|0|||
27947754|NCT01200758|54605217|FG001|Stage 2|Physician Decision|0|||
27947755|NCT01200758|54605218|FG002|Stage 2|Physician Decision|5|||
27947756|NCT01200758|54605219|FG003|Stage 2|Physician Decision|7|||
27947757|NCT01200758|54605216|FG000|Stage 2|Adverse Event|0|||
27947758|NCT01200758|54605217|FG001|Stage 2|Adverse Event|0|||
27947759|NCT01200758|54605218|FG002|Stage 2|Adverse Event|5|||
27947760|NCT01200758|54605219|FG003|Stage 2|Adverse Event|9|||
27947761|NCT01200758|54605216|FG000|Stage 2|Withdrawal by Subject|0|||
27947762|NCT01200758|54605217|FG001|Stage 2|Withdrawal by Subject|0|||
27947763|NCT01200758|54605218|FG002|Stage 2|Withdrawal by Subject|4|||
27947764|NCT01200758|54605219|FG003|Stage 2|Withdrawal by Subject|1|||
27947765|NCT01200758|54605216|FG000|Stage 2|Lost to Follow-up|0|||
27947766|NCT01200758|54605217|FG001|Stage 2|Lost to Follow-up|0|||
27947767|NCT01200758|54605218|FG002|Stage 2|Lost to Follow-up|3|||
27947768|NCT01200758|54605219|FG003|Stage 2|Lost to Follow-up|1|||
27947769|NCT01200758|54605216|FG000|Stage 2|Protocol Violation|0|||
27947770|NCT01200758|54605217|FG001|Stage 2|Protocol Violation|0|||
27947771|NCT01200758|54605218|FG002|Stage 2|Protocol Violation|1|||
27947772|NCT01200758|54605219|FG003|Stage 2|Protocol Violation|4|||
27854492|NCT00555321|54368606|FG004|Long-term Extension Phase|Administrative reason by sponsor|23|||
27854493|NCT00555321|54368602|FG000|Long-term Extension Phase|Death|2|||
27854494|NCT00555321|54368603|FG001|Long-term Extension Phase|Death|0|||
27854495|NCT00555321|54368604|FG002|Long-term Extension Phase|Death|0|||
27947773|NCT01200758|54605216|FG000|Stage 2|Death|0|||
27947774|NCT01200758|54605217|FG001|Stage 2|Death|0|||
27947775|NCT01200758|54605218|FG002|Stage 2|Death|3|||
27947776|NCT01200758|54605219|FG003|Stage 2|Death|5|||
27947777|NCT00876343|54605234|FG000|Overall Study|Adverse Event|7|||
27947778|NCT00876343|54605235|FG001|Overall Study|Adverse Event|8|||
27947779|NCT00876343|54605236|FG002|Overall Study|Adverse Event|2|||
27947780|NCT00876343|54605234|FG000|Overall Study|Withdrawal by Subject|4|||
27947781|NCT00876343|54605235|FG001|Overall Study|Withdrawal by Subject|4|||
27947782|NCT00876343|54605236|FG002|Overall Study|Withdrawal by Subject|3|||
27947783|NCT00876343|54605234|FG000|Overall Study|Lack of Efficacy|0|||
27947784|NCT00876343|54605235|FG001|Overall Study|Lack of Efficacy|0|||
27947785|NCT00876343|54605236|FG002|Overall Study|Lack of Efficacy|1|||
27947786|NCT00876343|54605234|FG000|Overall Study|Protocol Violation|4|||
27947787|NCT00876343|54605235|FG001|Overall Study|Protocol Violation|1|||
27854496|NCT00555321|54368605|FG003|Long-term Extension Phase|Death|3|||
27947788|NCT00876343|54605236|FG002|Overall Study|Protocol Violation|1|||
27947789|NCT00876343|54605234|FG000|Overall Study|Physician Decision|0|||
27947790|NCT00876343|54605235|FG001|Overall Study|Physician Decision|1|||
27947791|NCT00876343|54605236|FG002|Overall Study|Physician Decision|1|||
27947792|NCT00876343|54605234|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
27947793|NCT00876343|54605235|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
27947794|NCT00876343|54605236|FG002|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
27854497|NCT00555321|54368606|FG004|Long-term Extension Phase|Death|0|||
27947795|NCT00876343|54605234|FG000|Overall Study|Change of residence or other commitments|2|||
27947796|NCT00876343|54605235|FG001|Overall Study|Change of residence or other commitments|2|||
27947797|NCT00876343|54605236|FG002|Overall Study|Change of residence or other commitments|3|||
27947798|NCT01107912|54605248|FG000|Period 1|Adverse Event|0|||
27947799|NCT01107912|54605249|FG001|Period 1|Adverse Event|0|||
27947800|NCT01107912|54605250|FG002|Period 1|Adverse Event|0|||
27947801|NCT01107912|54605251|FG003|Period 1|Adverse Event|0|||
27947802|NCT01107912|54605252|FG004|Period 1|Adverse Event|2|||
27947803|NCT01107912|54605253|FG005|Period 1|Adverse Event|0|||
27947804|NCT01107912|54605248|FG000|Period 1|Physician Decision|0|||
27947805|NCT01107912|54605249|FG001|Period 1|Physician Decision|0|||
27947806|NCT01107912|54605250|FG002|Period 1|Physician Decision|0|||
27947807|NCT01107912|54605251|FG003|Period 1|Physician Decision|0|||
27947808|NCT01107912|54605252|FG004|Period 1|Physician Decision|1|||
27947809|NCT01107912|54605253|FG005|Period 1|Physician Decision|0|||
27947810|NCT01107912|54605248|FG000|Period 1|Withdrawal by Subject|1|||
27947811|NCT01107912|54605249|FG001|Period 1|Withdrawal by Subject|0|||
27947812|NCT01107912|54605250|FG002|Period 1|Withdrawal by Subject|0|||
27947813|NCT01107912|54605251|FG003|Period 1|Withdrawal by Subject|0|||
27947814|NCT01107912|54605252|FG004|Period 1|Withdrawal by Subject|0|||
27947815|NCT01107912|54605253|FG005|Period 1|Withdrawal by Subject|0|||
27947816|NCT01107912|54605248|FG000|Period 2|Physician Decision|0|||
27947817|NCT01107912|54605249|FG001|Period 2|Physician Decision|0|||
27947818|NCT01107912|54605250|FG002|Period 2|Physician Decision|1|||
27947819|NCT01107912|54605251|FG003|Period 2|Physician Decision|0|||
27947820|NCT01107912|54605252|FG004|Period 2|Physician Decision|0|||
27947821|NCT01107912|54605253|FG005|Period 2|Physician Decision|0|||
27947822|NCT01107912|54605248|FG000|Period 3|Adverse Event|0|||
27947823|NCT01107912|54605249|FG001|Period 3|Adverse Event|1|||
27947824|NCT01107912|54605250|FG002|Period 3|Adverse Event|1|||
27947825|NCT01107912|54605251|FG003|Period 3|Adverse Event|0|||
27947826|NCT01107912|54605252|FG004|Period 3|Adverse Event|0|||
27947827|NCT01107912|54605253|FG005|Period 3|Adverse Event|0|||
27947828|NCT01107912|54605248|FG000|Period 3|Withdrawal by Subject|0|||
27947829|NCT01107912|54605249|FG001|Period 3|Withdrawal by Subject|0|||
27947830|NCT01107912|54605250|FG002|Period 3|Withdrawal by Subject|0|||
27947831|NCT01107912|54605251|FG003|Period 3|Withdrawal by Subject|1|||
27947832|NCT01107912|54605252|FG004|Period 3|Withdrawal by Subject|0|||
27947833|NCT01107912|54605253|FG005|Period 3|Withdrawal by Subject|0|||
27947834|NCT01200524|54605271|FG000|Overall Study|Withdrawal by Subject|1|||
27947835|NCT01200524|54605272|FG001|Overall Study|Withdrawal by Subject|1|||
27947836|NCT01200524|54605273|FG002|Overall Study|Withdrawal by Subject|3|||
27947837|NCT01200524|54605271|FG000|Overall Study|Adverse Event|1|||
27947838|NCT01200524|54605272|FG001|Overall Study|Adverse Event|0|||
27947839|NCT01200524|54605273|FG002|Overall Study|Adverse Event|0|||
27947840|NCT01200524|54605271|FG000|Overall Study|Non availability of study nurse|0|||
27947841|NCT01200524|54605272|FG001|Overall Study|Non availability of study nurse|0|||
27947842|NCT01200524|54605273|FG002|Overall Study|Non availability of study nurse|1|||
27947843|NCT01100034|54605281|FG000|Overall Study|Lost to Follow-up|11|||
27947844|NCT01100034|54605281|FG000|Overall Study|Withdrawal of parent/guardian consent|1|||
27947845|NCT01100034|54605281|FG000|Overall Study|Withdrawal by Subject|4|||
27947846|NCT01100034|54605281|FG000|Overall Study|Sponsor decision|21|||
27947847|NCT01100034|54605281|FG000|Overall Study|Participated in another clinical trial|1|||
27947848|NCT01100034|54605281|FG000|Overall Study|Participants moved to another hospital|4|||
27947849|NCT01100034|54605281|FG000|Overall Study|Site closed due to non-responsiveness|1|||
27947850|NCT00876265|54605285|FG000|Overall Study|Miscellaneous reasons|4|||
27947851|NCT00876265|54605285|FG000|Overall Study|Lost to Follow-up|6|||
27947852|NCT00876265|54605285|FG000|Overall Study|Withdrawal by Subject|2|||
27947853|NCT01107444|54605293|FG000|Overall Study|Withdrawal by Subject|8|||
27947854|NCT01107444|54605294|FG001|Overall Study|Withdrawal by Subject|12|||
27947855|NCT01107444|54605293|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
27947856|NCT01107444|54605294|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
27947857|NCT00876187|54605308|FG000|Overall Study|Adverse Event|14|||
27947858|NCT00876187|54605309|FG001|Overall Study|Adverse Event|12|||
27947859|NCT00876187|54605310|FG002|Overall Study|Adverse Event|19|||
27947860|NCT00876187|54605311|FG003|Overall Study|Adverse Event|29|||
27947861|NCT00876187|54605312|FG004|Overall Study|Adverse Event|10|||
27947862|NCT00876187|54605308|FG000|Overall Study|Lack of Efficacy|59|||
27947863|NCT00876187|54605309|FG001|Overall Study|Lack of Efficacy|34|||
27947864|NCT00876187|54605310|FG002|Overall Study|Lack of Efficacy|45|||
27947865|NCT00876187|54605311|FG003|Overall Study|Lack of Efficacy|34|||
27947866|NCT00876187|54605312|FG004|Overall Study|Lack of Efficacy|59|||
27947867|NCT00876187|54605308|FG000|Overall Study|Lost to Follow-up|9|||
27947868|NCT00876187|54605309|FG001|Overall Study|Lost to Follow-up|10|||
27854498|NCT00555321|54368602|FG000|Long-term Extension Phase|Participant did not meet study criteria|0|||
27854499|NCT00555321|54368603|FG001|Long-term Extension Phase|Participant did not meet study criteria|0|||
27854500|NCT00555321|54368604|FG002|Long-term Extension Phase|Participant did not meet study criteria|0|||
27854501|NCT00555321|54368605|FG003|Long-term Extension Phase|Participant did not meet study criteria|0|||
27854502|NCT00555321|54368606|FG004|Long-term Extension Phase|Participant did not meet study criteria|1|||
27854503|NCT00555321|54368602|FG000|Long-term Extension Phase|Other Reason|1|||
27854504|NCT00555321|54368603|FG001|Long-term Extension Phase|Other Reason|0|||
27947869|NCT00876187|54605310|FG002|Overall Study|Lost to Follow-up|8|||
27947870|NCT00876187|54605311|FG003|Overall Study|Lost to Follow-up|8|||
27947871|NCT00876187|54605312|FG004|Overall Study|Lost to Follow-up|11|||
27947872|NCT00876187|54605308|FG000|Overall Study|Protocol Violation|6|||
27947873|NCT00876187|54605309|FG001|Overall Study|Protocol Violation|7|||
27947874|NCT00876187|54605310|FG002|Overall Study|Protocol Violation|7|||
27947875|NCT00876187|54605311|FG003|Overall Study|Protocol Violation|6|||
27947876|NCT00876187|54605312|FG004|Overall Study|Protocol Violation|3|||
27947877|NCT00876187|54605308|FG000|Overall Study|Withdrawal by Subject|16|||
27947878|NCT00876187|54605309|FG001|Overall Study|Withdrawal by Subject|26|||
27947879|NCT00876187|54605310|FG002|Overall Study|Withdrawal by Subject|32|||
27947880|NCT00876187|54605311|FG003|Overall Study|Withdrawal by Subject|38|||
27947881|NCT00876187|54605312|FG004|Overall Study|Withdrawal by Subject|37|||
27947882|NCT00876187|54605308|FG000|Overall Study|Entered extension study|101|||
27947883|NCT00876187|54605309|FG001|Overall Study|Entered extension study|120|||
27947884|NCT00876187|54605310|FG002|Overall Study|Entered extension study|156|||
27947885|NCT00876187|54605311|FG003|Overall Study|Entered extension study|151|||
27947886|NCT00876187|54605312|FG004|Overall Study|Entered extension study|144|||
27947887|NCT00876187|54605308|FG000|Overall Study|Randomized but not treated|3|||
27947888|NCT00876187|54605309|FG001|Overall Study|Randomized but not treated|1|||
27854505|NCT00555321|54368604|FG002|Long-term Extension Phase|Other Reason|2|||
27854506|NCT00555321|54368605|FG003|Long-term Extension Phase|Other Reason|0|||
27854507|NCT00555321|54368606|FG004|Long-term Extension Phase|Other Reason|0|||
27854508|NCT03589976|54369118|FG000|Overall Study|Death|5|||
27854509|NCT03589976|54369119|FG001|Overall Study|Death|1|||
27854510|NCT03589976|54369118|FG000|Overall Study|Adverse Event|5|||
27854511|NCT03589976|54369119|FG001|Overall Study|Adverse Event|1|||
27854512|NCT03589976|54369118|FG000|Overall Study|Withdrawal by Subject|4|||
27854513|NCT03589976|54369119|FG001|Overall Study|Withdrawal by Subject|1|||
27854514|NCT03589976|54369118|FG000|Overall Study|Lost to Follow-up|1|||
27854515|NCT03589976|54369119|FG001|Overall Study|Lost to Follow-up|0|||
27854516|NCT03589976|54369118|FG000|Overall Study|Other|4|||
27854517|NCT03589976|54369119|FG001|Overall Study|Other|3|||
27854518|NCT03029780|54369275|FG000|Overall Study|Disease Progression|20|||
27854519|NCT03029780|54369276|FG001|Overall Study|Disease Progression|22|||
27854520|NCT03029780|54369275|FG000|Overall Study|Study Drug Toxicity|15|||
27854521|NCT03029780|54369276|FG001|Overall Study|Study Drug Toxicity|11|||
27854522|NCT03029780|54369275|FG000|Overall Study|Adverse Event Unrelated to Study Drug|2|||
27854523|NCT03029780|54369276|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
27854524|NCT03029780|54369275|FG000|Overall Study|Participant request to discontinue study treatment|4|||
27854525|NCT03029780|54369276|FG001|Overall Study|Participant request to discontinue study treatment|1|||
27854526|NCT03029780|54369275|FG000|Overall Study|Maximum clinical benefit|1|||
27854527|NCT03029780|54369276|FG001|Overall Study|Maximum clinical benefit|0|||
27854528|NCT03029780|54369275|FG000|Overall Study|Participant no longer meets study criteria|0|||
27854529|NCT03029780|54369276|FG001|Overall Study|Participant no longer meets study criteria|1|||
27854530|NCT03029780|54369275|FG000|Overall Study|Other reasons|6|||
27854531|NCT03029780|54369276|FG001|Overall Study|Other reasons|6|||
27854532|NCT03029780|54369275|FG000|Overall Study|Not reported|1|||
27854533|NCT03029780|54369276|FG001|Overall Study|Not reported|1|||
27854534|NCT03029780|54369275|FG000|Overall Study|Death|2|||
27854535|NCT03029780|54369276|FG001|Overall Study|Death|6|||
27854536|NCT03029234|54369336|FG000|Overall Study|Sponsor Decision|1|||
27854537|NCT03029234|54369336|FG000|Overall Study|Withdrawal by Subject|5|||
27854538|NCT03029234|54369336|FG000|Overall Study|Death|91|||
27854539|NCT03029234|54369336|FG000|Overall Study|Lost to Follow-up|2|||
27854540|NCT03018080|54369934|FG000|Overall Study|Death|11|||
27854541|NCT03018080|54369935|FG001|Overall Study|Death|19|||
27854542|NCT03018080|54369934|FG000|Overall Study|Still On Study (in follow up)|10|||
27854543|NCT03018080|54369935|FG001|Overall Study|Still On Study (in follow up)|0|||
27854544|NCT00557193|54369989|FG000|Induction|Adverse Event|2|||
27854545|NCT00557193|54369990|FG001|Induction|Adverse Event|0|||
27854546|NCT00557193|54369991|FG002|Induction|Adverse Event|0|||
27854547|NCT00557193|54369992|FG003|Induction|Adverse Event|0|||
27854548|NCT00557193|54369993|FG004|Induction|Adverse Event|0|||
27854549|NCT00557193|54369994|FG005|Induction|Adverse Event|0|||
27854550|NCT00557193|54369989|FG000|Induction|Death|6|||
27854551|NCT00557193|54369990|FG001|Induction|Death|0|||
27854552|NCT00557193|54369991|FG002|Induction|Death|0|||
27854553|NCT00557193|54369992|FG003|Induction|Death|0|||
27854554|NCT00557193|54369993|FG004|Induction|Death|0|||
27854555|NCT00557193|54369994|FG005|Induction|Death|0|||
27947889|NCT00876187|54605310|FG002|Overall Study|Randomized but not treated|3|||
27947890|NCT00876187|54605311|FG003|Overall Study|Randomized but not treated|2|||
28080777|NCT03565900|54734041|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
28080778|NCT03565900|54734040|FG000|Overall Study|Withdrawal by Subject|4|||
27854556|NCT00557193|54369989|FG000|Induction|Physician Decision|3|||
27854557|NCT00557193|54369990|FG001|Induction|Physician Decision|0|||
27854558|NCT00557193|54369991|FG002|Induction|Physician Decision|0|||
27854559|NCT00557193|54369992|FG003|Induction|Physician Decision|0|||
27854560|NCT00557193|54369993|FG004|Induction|Physician Decision|0|||
27854561|NCT00557193|54369994|FG005|Induction|Physician Decision|0|||
27854562|NCT00557193|54369989|FG000|Induction|Withdrawal by Subject|1|||
27854563|NCT00557193|54369990|FG001|Induction|Withdrawal by Subject|0|||
27947891|NCT00876187|54605312|FG004|Overall Study|Randomized but not treated|3|||
27947892|NCT00876187|54605308|FG000|Overall Study|Other|2|||
27854564|NCT00557193|54369991|FG002|Induction|Withdrawal by Subject|0|||
27854565|NCT00557193|54369992|FG003|Induction|Withdrawal by Subject|0|||
27854566|NCT00557193|54369993|FG004|Induction|Withdrawal by Subject|0|||
27854567|NCT00557193|54369994|FG005|Induction|Withdrawal by Subject|0|||
27947893|NCT00876187|54605309|FG001|Overall Study|Other|5|||
27947894|NCT00876187|54605310|FG002|Overall Study|Other|9|||
27947895|NCT00876187|54605311|FG003|Overall Study|Other|7|||
27947896|NCT00876187|54605312|FG004|Overall Study|Other|4|||
27947897|NCT01102374|54605329|FG000|Overall Study|Death|9|||
27947898|NCT01102374|54605330|FG001|Overall Study|Death|13|||
27947899|NCT01102374|54605329|FG000|Overall Study|Lost to Follow-up|7|||
27947900|NCT01102374|54605330|FG001|Overall Study|Lost to Follow-up|6|||
27947901|NCT01106976|54605336|FG000|Overall Study|Lost to Follow-up|8|||
27947902|NCT00875485|54605342|FG000|Challenge Dose Epoch|Pregnancy|1|||
27947903|NCT00875485|54605343|FG001|Challenge Dose Epoch|Pregnancy|0|||
27947904|NCT04547140|54605351|FG000|Overall Study|Adverse Event|0|||
27947905|NCT04547140|54605352|FG001|Overall Study|Adverse Event|1|||
27947906|NCT04547140|54605351|FG000|Overall Study|Withdrawal by Subject|0|||
27947907|NCT04547140|54605352|FG001|Overall Study|Withdrawal by Subject|1|||
27947908|NCT04547140|54605351|FG000|Overall Study|Lost to Follow-up|3|||
27947909|NCT04547140|54605352|FG001|Overall Study|Lost to Follow-up|1|||
27947910|NCT04547140|54605351|FG000|Overall Study|Death|2|||
27947911|NCT04547140|54605352|FG001|Overall Study|Death|1|||
27947912|NCT04547140|54605351|FG000|Overall Study|Physician Decision (Does not Include Adverse Events)|0|||
27947913|NCT04547140|54605352|FG001|Overall Study|Physician Decision (Does not Include Adverse Events)|1|||
27947914|NCT04547140|54605351|FG000|Overall Study|Pregnancy|1|||
27947915|NCT04547140|54605352|FG001|Overall Study|Pregnancy|0|||
27947916|NCT04547140|54605351|FG000|Overall Study|Reason Not Specified|4|||
27947917|NCT04547140|54605352|FG001|Overall Study|Reason Not Specified|1|||
27947918|NCT01098474|54605364|FG000|Active Phase|Other|0|||
27947919|NCT01098474|54605365|FG001|Active Phase|Other|0|||
27947920|NCT01098474|54605366|FG002|Active Phase|Other|3|||
27947921|NCT01098474|54605367|FG003|Active Phase|Other|0|||
27947922|NCT01098474|54605368|FG004|Active Phase|Other|0|||
27947923|NCT01098474|54605369|FG005|Active Phase|Other|0|||
27947924|NCT01098474|54605364|FG000|Active Phase|Withdrawal by Subject|1|||
27947925|NCT01098474|54605365|FG001|Active Phase|Withdrawal by Subject|1|||
27947926|NCT01098474|54605366|FG002|Active Phase|Withdrawal by Subject|2|||
27947927|NCT01098474|54605367|FG003|Active Phase|Withdrawal by Subject|0|||
27947928|NCT01098474|54605368|FG004|Active Phase|Withdrawal by Subject|0|||
27947929|NCT01098474|54605369|FG005|Active Phase|Withdrawal by Subject|0|||
27947930|NCT01098474|54605364|FG000|Active Phase|Lost to Follow-up|1|||
27947931|NCT01098474|54605365|FG001|Active Phase|Lost to Follow-up|0|||
27947932|NCT01098474|54605366|FG002|Active Phase|Lost to Follow-up|0|||
27947933|NCT01098474|54605367|FG003|Active Phase|Lost to Follow-up|0|||
27947934|NCT01098474|54605368|FG004|Active Phase|Lost to Follow-up|0|||
27947935|NCT01098474|54605369|FG005|Active Phase|Lost to Follow-up|0|||
27947936|NCT01098474|54605364|FG000|Follow Up Phase|Travelled out of study area|0|||
27947937|NCT01098474|54605365|FG001|Follow Up Phase|Travelled out of study area|0|||
27947938|NCT01098474|54605366|FG002|Follow Up Phase|Travelled out of study area|0|||
27947939|NCT01098474|54605367|FG003|Follow Up Phase|Travelled out of study area|0|||
27947940|NCT01098474|54605368|FG004|Follow Up Phase|Travelled out of study area|1|||
27947941|NCT01098474|54605369|FG005|Follow Up Phase|Travelled out of study area|0|||
27947942|NCT01098474|54605364|FG000|Follow Up Phase|Other|0|||
27947943|NCT01098474|54605365|FG001|Follow Up Phase|Other|0|||
27947944|NCT01098474|54605366|FG002|Follow Up Phase|Other|0|||
27947945|NCT01098474|54605367|FG003|Follow Up Phase|Other|0|||
27947946|NCT01098474|54605368|FG004|Follow Up Phase|Other|0|||
27947947|NCT01098474|54605369|FG005|Follow Up Phase|Other|4|||
27947948|NCT01098474|54605364|FG000|Follow Up Phase|Withdrawal by Subject|0|||
27947949|NCT01098474|54605365|FG001|Follow Up Phase|Withdrawal by Subject|0|||
28080779|NCT03565900|54734041|FG001|Overall Study|Withdrawal by Subject|5|||
28080780|NCT03565900|54734040|FG000|Overall Study|Randomized By Mistake|0|||
28080781|NCT03565900|54734041|FG001|Overall Study|Randomized By Mistake|2|||
27854568|NCT00557193|54369989|FG000|Induction|Refusal of Further Protocol Therapy|2|||
27854569|NCT00557193|54369990|FG001|Induction|Refusal of Further Protocol Therapy|0|||
27854570|NCT00557193|54369991|FG002|Induction|Refusal of Further Protocol Therapy|0|||
27854571|NCT00557193|54369992|FG003|Induction|Refusal of Further Protocol Therapy|0|||
27854572|NCT00557193|54369993|FG004|Induction|Refusal of Further Protocol Therapy|0|||
27854573|NCT00557193|54369994|FG005|Induction|Refusal of Further Protocol Therapy|0|||
27854574|NCT00557193|54369989|FG000|Induction|Ineligible|8|||
27854575|NCT00557193|54369990|FG001|Induction|Ineligible|0|||
27854576|NCT00557193|54369991|FG002|Induction|Ineligible|0|||
27947950|NCT01098474|54605366|FG002|Follow Up Phase|Withdrawal by Subject|0|||
27947951|NCT01098474|54605367|FG003|Follow Up Phase|Withdrawal by Subject|2|||
27947952|NCT01098474|54605368|FG004|Follow Up Phase|Withdrawal by Subject|0|||
27947953|NCT01098474|54605369|FG005|Follow Up Phase|Withdrawal by Subject|1|||
27947954|NCT01098474|54605364|FG000|Follow Up Phase|Lost to Follow-up|0|||
27947955|NCT01098474|54605365|FG001|Follow Up Phase|Lost to Follow-up|0|||
27947956|NCT01098474|54605366|FG002|Follow Up Phase|Lost to Follow-up|0|||
27947957|NCT01098474|54605367|FG003|Follow Up Phase|Lost to Follow-up|0|||
27947958|NCT01098474|54605368|FG004|Follow Up Phase|Lost to Follow-up|1|||
28080782|NCT03565900|54734040|FG000|Overall Study|Physician Decision|7|||
28080783|NCT03565900|54734041|FG001|Overall Study|Physician Decision|11|||
27947959|NCT01098474|54605369|FG005|Follow Up Phase|Lost to Follow-up|0|||
27947960|NCT01106898|54605393|FG000|Overall Study|Adverse Event|6|||
27947961|NCT00876733|54605401|FG000|Overall Study|Adverse Event|34|||
27947962|NCT00876733|54605402|FG001|Overall Study|Adverse Event|20|||
27947963|NCT00876733|54605403|FG002|Overall Study|Adverse Event|10|||
27947964|NCT00876733|54605404|FG003|Overall Study|Adverse Event|3|||
27947965|NCT00876733|54605401|FG000|Overall Study|Lack of Efficacy|17|||
27947966|NCT00876733|54605402|FG001|Overall Study|Lack of Efficacy|9|||
27947967|NCT00876733|54605403|FG002|Overall Study|Lack of Efficacy|10|||
27947968|NCT00876733|54605404|FG003|Overall Study|Lack of Efficacy|1|||
27854577|NCT00557193|54369992|FG003|Induction|Ineligible|0|||
27947969|NCT00876733|54605401|FG000|Overall Study|Lost to Follow-up|26|||
27947970|NCT00876733|54605402|FG001|Overall Study|Lost to Follow-up|10|||
27947971|NCT00876733|54605403|FG002|Overall Study|Lost to Follow-up|3|||
27947972|NCT00876733|54605404|FG003|Overall Study|Lost to Follow-up|2|||
27947973|NCT00876733|54605401|FG000|Overall Study|Data not available|14|||
27947974|NCT00876733|54605402|FG001|Overall Study|Data not available|3|||
27947975|NCT00876733|54605403|FG002|Overall Study|Data not available|7|||
27947976|NCT00876733|54605404|FG003|Overall Study|Data not available|1|||
27947977|NCT00875017|54605424|FG000|First Intervention|Withdrawal by Subject|1|||
27947978|NCT00875017|54605425|FG001|First Intervention|Withdrawal by Subject|0|||
27947979|NCT00875017|54605426|FG002|First Intervention|Withdrawal by Subject|1|||
27947980|NCT00875017|54605427|FG003|First Intervention|Withdrawal by Subject|0|||
27947981|NCT00875017|54605428|FG004|First Intervention|Withdrawal by Subject|0|||
27947982|NCT00875017|54605429|FG005|First Intervention|Withdrawal by Subject|0|||
27947983|NCT00875017|54605424|FG000|First Intervention|Adverse Event|0|||
27947984|NCT00875017|54605425|FG001|First Intervention|Adverse Event|0|||
27947985|NCT00875017|54605426|FG002|First Intervention|Adverse Event|0|||
27947986|NCT00875017|54605427|FG003|First Intervention|Adverse Event|1|||
27947987|NCT00875017|54605428|FG004|First Intervention|Adverse Event|0|||
27947988|NCT00875017|54605429|FG005|First Intervention|Adverse Event|0|||
27947989|NCT00875017|54605424|FG000|First Intervention|Problems collecting rectal effluent|1|||
27947990|NCT00875017|54605425|FG001|First Intervention|Problems collecting rectal effluent|0|||
28080784|NCT03565900|54734040|FG000|Overall Study|Death|9|||
28080785|NCT03565900|54734041|FG001|Overall Study|Death|7|||
27832078|NCT01781429|54310825|FG005|Overall Study|Enrolled, but not treated|0|||
27832079|NCT01781429|54310826|FG006|Overall Study|Enrolled, but not treated|0|||
27832080|NCT01781429|54310827|FG007|Overall Study|Enrolled, but not treated|0|||
27832081|NCT01781429|54310828|FG008|Overall Study|Enrolled, but not treated|0|||
27832082|NCT01781429|54310829|FG009|Overall Study|Enrolled, but not treated|0|||
27832083|NCT01781429|54310830|FG010|Overall Study|Enrolled, but not treated|1|||
27832084|NCT01781429|54310831|FG011|Overall Study|Enrolled, but not treated|0|||
27832085|NCT01781429|54310832|FG012|Overall Study|Enrolled, but not treated|0|||
27832086|NCT01781429|54310833|FG013|Overall Study|Enrolled, but not treated|0|||
27832087|NCT01781429|54310834|FG014|Overall Study|Enrolled, but not treated|0|||
27832088|NCT01781429|54310835|FG015|Overall Study|Enrolled, but not treated|0|||
27854578|NCT00557193|54369993|FG004|Induction|Ineligible|0|||
27854579|NCT00557193|54369994|FG005|Induction|Ineligible|0|||
27854580|NCT00557193|54369989|FG000|Induction|Inevaluable for post Induction|2|||
27854581|NCT00557193|54369990|FG001|Induction|Inevaluable for post Induction|0|||
27854582|NCT00557193|54369991|FG002|Induction|Inevaluable for post Induction|0|||
27854583|NCT00557193|54369992|FG003|Induction|Inevaluable for post Induction|0|||
27854584|NCT00557193|54369993|FG004|Induction|Inevaluable for post Induction|0|||
27854585|NCT00557193|54369994|FG005|Induction|Inevaluable for post Induction|0|||
27854586|NCT00557193|54369989|FG000|Induction|Unable to receive Lestaurtinib-Not in US|2|||
27854587|NCT00557193|54369990|FG001|Induction|Unable to receive Lestaurtinib-Not in US|0|||
27854588|NCT00557193|54369991|FG002|Induction|Unable to receive Lestaurtinib-Not in US|0|||
27854589|NCT00557193|54369992|FG003|Induction|Unable to receive Lestaurtinib-Not in US|0|||
27854590|NCT00557193|54369993|FG004|Induction|Unable to receive Lestaurtinib-Not in US|0|||
27854591|NCT00557193|54369994|FG005|Induction|Unable to receive Lestaurtinib-Not in US|0|||
27854592|NCT00557193|54369989|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
27854593|NCT00557193|54369990|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
27854594|NCT00557193|54369991|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
27854595|NCT00557193|54369992|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
27854596|NCT00557193|54369993|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
27947991|NCT00875017|54605426|FG002|First Intervention|Problems collecting rectal effluent|0|||
27947992|NCT00875017|54605427|FG003|First Intervention|Problems collecting rectal effluent|0|||
28080786|NCT03591406|54734065|FG000|Overall Study|Adverse Event|5|||
27832089|NCT01773473|54310870|FG000|Overall Study|Adverse Event|3|||
27947993|NCT00875017|54605428|FG004|First Intervention|Problems collecting rectal effluent|0|||
27947994|NCT00875017|54605429|FG005|First Intervention|Problems collecting rectal effluent|0|||
27947995|NCT00875017|54605424|FG000|First Intervention|Intolerance to nasogastric tube|0|||
27947996|NCT00875017|54605425|FG001|First Intervention|Intolerance to nasogastric tube|0|||
27947997|NCT00875017|54605426|FG002|First Intervention|Intolerance to nasogastric tube|0|||
27947998|NCT00875017|54605427|FG003|First Intervention|Intolerance to nasogastric tube|0|||
27947999|NCT00875017|54605428|FG004|First Intervention|Intolerance to nasogastric tube|1|||
27948000|NCT00875017|54605429|FG005|First Intervention|Intolerance to nasogastric tube|0|||
27948001|NCT00875017|54605424|FG000|Washout|Problem collecting rectal effluent|0|||
27948002|NCT00875017|54605425|FG001|Washout|Problem collecting rectal effluent|0|||
27948003|NCT00875017|54605426|FG002|Washout|Problem collecting rectal effluent|1|||
27948004|NCT00875017|54605427|FG003|Washout|Problem collecting rectal effluent|0|||
27948005|NCT00875017|54605428|FG004|Washout|Problem collecting rectal effluent|0|||
27948006|NCT00875017|54605429|FG005|Washout|Problem collecting rectal effluent|0|||
27948007|NCT00875017|54605424|FG000|Second Intervention|Adverse Event|0|||
27948008|NCT00875017|54605425|FG001|Second Intervention|Adverse Event|0|||
27948009|NCT00875017|54605426|FG002|Second Intervention|Adverse Event|0|||
27948010|NCT00875017|54605427|FG003|Second Intervention|Adverse Event|1|||
27948011|NCT00875017|54605428|FG004|Second Intervention|Adverse Event|0|||
27948012|NCT00875017|54605429|FG005|Second Intervention|Adverse Event|0|||
27948013|NCT00875017|54605424|FG000|Washout|Problems collecting rectal effluent|0|||
27948014|NCT00875017|54605425|FG001|Washout|Problems collecting rectal effluent|1|||
27948015|NCT00875017|54605426|FG002|Washout|Problems collecting rectal effluent|0|||
27948016|NCT00875017|54605427|FG003|Washout|Problems collecting rectal effluent|0|||
27948017|NCT00875017|54605428|FG004|Washout|Problems collecting rectal effluent|0|||
27948018|NCT00875017|54605429|FG005|Washout|Problems collecting rectal effluent|0|||
27948019|NCT00875017|54605424|FG000|Third Intervention|Adverse Event|0|||
27948020|NCT00875017|54605425|FG001|Third Intervention|Adverse Event|1|||
27948021|NCT00875017|54605426|FG002|Third Intervention|Adverse Event|1|||
27948022|NCT00875017|54605427|FG003|Third Intervention|Adverse Event|0|||
27948023|NCT00875017|54605428|FG004|Third Intervention|Adverse Event|0|||
27948024|NCT00875017|54605429|FG005|Third Intervention|Adverse Event|0|||
27948025|NCT00875017|54605424|FG000|Washout|Withdrawal by Subject|0|||
27948026|NCT00875017|54605425|FG001|Washout|Withdrawal by Subject|0|||
27948027|NCT00875017|54605426|FG002|Washout|Withdrawal by Subject|0|||
27948028|NCT00875017|54605427|FG003|Washout|Withdrawal by Subject|0|||
27948029|NCT00875017|54605428|FG004|Washout|Withdrawal by Subject|1|||
27948030|NCT00875017|54605429|FG005|Washout|Withdrawal by Subject|0|||
27948031|NCT00875017|54605424|FG000|Fourth Intervention|Inability to comply with fasting|0|||
27948032|NCT00875017|54605425|FG001|Fourth Intervention|Inability to comply with fasting|0|||
27948033|NCT00875017|54605426|FG002|Fourth Intervention|Inability to comply with fasting|0|||
27948034|NCT00875017|54605427|FG003|Fourth Intervention|Inability to comply with fasting|0|||
27948035|NCT00875017|54605428|FG004|Fourth Intervention|Inability to comply with fasting|0|||
27948036|NCT00875017|54605429|FG005|Fourth Intervention|Inability to comply with fasting|1|||
27948037|NCT00875797|54605454|FG000|Overall Study|Protocol Violation|6|||
27948038|NCT00875797|54605455|FG001|Overall Study|Protocol Violation|3|||
27948039|NCT00874939|54605481|FG000|Overall Study|Study terminated|4|||
27948040|NCT00875563|54605491|FG000|Overall Study|Death|4|||
27948041|NCT00875563|54605491|FG000|Overall Study|Withdrawal by Subject|7|||
27948042|NCT00875563|54605491|FG000|Overall Study|No long-term (3-5 year) consent|6|||
27948043|NCT00875563|54605491|FG000|Overall Study|Still be eligible for follow-up|7|||
27948044|NCT01155869|54605497|FG000|Overall Study|Lost to Follow-up|3|||
27948045|NCT01155869|54605498|FG001|Overall Study|Lost to Follow-up|1|||
27948046|NCT01185353|54605509|FG000|Part A (Weeks 0 Through 12)|Adverse Event|1|||
27948047|NCT01185353|54605510|FG001|Part A (Weeks 0 Through 12)|Adverse Event|1|||
27948048|NCT01185353|54605511|FG002|Part A (Weeks 0 Through 12)|Adverse Event|1|||
27948049|NCT01185353|54605512|FG003|Part A (Weeks 0 Through 12)|Adverse Event|1|||
27948050|NCT01185353|54605513|FG004|Part A (Weeks 0 Through 12)|Adverse Event|5|||
27948051|NCT01185353|54605514|FG005|Part A (Weeks 0 Through 12)|Adverse Event|0|||
27948052|NCT01185353|54605515|FG006|Part A (Weeks 0 Through 12)|Adverse Event|0|||
27948053|NCT01185353|54605516|FG007|Part A (Weeks 0 Through 12)|Adverse Event|0|||
27948054|NCT01185353|54605517|FG008|Part A (Weeks 0 Through 12)|Adverse Event|0|||
27948055|NCT01185353|54605518|FG009|Part A (Weeks 0 Through 12)|Adverse Event|0|||
27948056|NCT01185353|54605509|FG000|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
27948057|NCT01185353|54605510|FG001|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
27948058|NCT01185353|54605511|FG002|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
27948059|NCT01185353|54605512|FG003|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
27948060|NCT01185353|54605513|FG004|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4|||
27948061|NCT01185353|54605514|FG005|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
27948062|NCT01185353|54605515|FG006|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
27948063|NCT01185353|54605516|FG007|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
27948064|NCT01185353|54605517|FG008|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
28080787|NCT03591406|54734066|FG001|Overall Study|Adverse Event|3|||
28080788|NCT03591406|54734065|FG000|Overall Study|Protocol Violation|2|||
27832090|NCT01773473|54310871|FG001|Overall Study|Adverse Event|2|||
27948065|NCT01185353|54605518|FG009|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
27948066|NCT01185353|54605509|FG000|Part A (Weeks 0 Through 12)|Lack of Efficacy|2|||
27948067|NCT01185353|54605510|FG001|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
27948068|NCT01185353|54605511|FG002|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
27948069|NCT01185353|54605512|FG003|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
27948070|NCT01185353|54605513|FG004|Part A (Weeks 0 Through 12)|Lack of Efficacy|1|||
27948071|NCT01185353|54605514|FG005|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
27948072|NCT01185353|54605515|FG006|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
27948073|NCT01185353|54605516|FG007|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
27948074|NCT01185353|54605517|FG008|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
27948075|NCT01185353|54605518|FG009|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
27948076|NCT01185353|54605509|FG000|Part A (Weeks 0 Through 12)|Physician Decision|0|||
27948077|NCT01185353|54605510|FG001|Part A (Weeks 0 Through 12)|Physician Decision|0|||
27948078|NCT01185353|54605511|FG002|Part A (Weeks 0 Through 12)|Physician Decision|1|||
27948079|NCT01185353|54605512|FG003|Part A (Weeks 0 Through 12)|Physician Decision|0|||
27948080|NCT01185353|54605513|FG004|Part A (Weeks 0 Through 12)|Physician Decision|2|||
27948081|NCT01185353|54605514|FG005|Part A (Weeks 0 Through 12)|Physician Decision|0|||
27854597|NCT00557193|54369994|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|3|||
27854598|NCT00557193|54369989|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
27854599|NCT00557193|54369990|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
27854600|NCT00557193|54369991|FG002|Post Induction Therapy by Tx Assignment|Death|2|||
27854601|NCT00557193|54369992|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
27854602|NCT00557193|54369993|FG004|Post Induction Therapy by Tx Assignment|Death|2|||
27854603|NCT00557193|54369994|FG005|Post Induction Therapy by Tx Assignment|Death|2|||
27854604|NCT00557193|54369989|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
27854605|NCT00557193|54369990|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|3|||
27854606|NCT00557193|54369991|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|5|||
27854607|NCT00557193|54369992|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|1|||
27854608|NCT00557193|54369993|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
27854609|NCT00557193|54369994|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
27854610|NCT00557193|54369989|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
27948082|NCT01185353|54605515|FG006|Part A (Weeks 0 Through 12)|Physician Decision|0|||
27948083|NCT01185353|54605516|FG007|Part A (Weeks 0 Through 12)|Physician Decision|0|||
27948084|NCT01185353|54605517|FG008|Part A (Weeks 0 Through 12)|Physician Decision|0|||
27948085|NCT01185353|54605518|FG009|Part A (Weeks 0 Through 12)|Physician Decision|0|||
27948086|NCT01185353|54605509|FG000|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
27948087|NCT01185353|54605510|FG001|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
27948088|NCT01185353|54605511|FG002|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
27948089|NCT01185353|54605512|FG003|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
27948090|NCT01185353|54605513|FG004|Part A (Weeks 0 Through 12)|Protocol Violation|1|||
27948091|NCT01185353|54605514|FG005|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
27948092|NCT01185353|54605515|FG006|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
27948093|NCT01185353|54605516|FG007|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
27948094|NCT01185353|54605517|FG008|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
27948095|NCT01185353|54605518|FG009|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
27948096|NCT01185353|54605509|FG000|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2|||
27948097|NCT01185353|54605510|FG001|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
27948098|NCT01185353|54605511|FG002|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
27948099|NCT01185353|54605512|FG003|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
27948100|NCT01185353|54605513|FG004|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3|||
27948101|NCT01185353|54605514|FG005|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
27948102|NCT01185353|54605515|FG006|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
27948103|NCT01185353|54605516|FG007|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
27948104|NCT01185353|54605517|FG008|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
27948105|NCT01185353|54605518|FG009|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
27948106|NCT01185353|54605509|FG000|Part B (Weeks 12 Through 24)|Adverse Event|0|||
27948107|NCT01185353|54605510|FG001|Part B (Weeks 12 Through 24)|Adverse Event|0|||
27948108|NCT01185353|54605511|FG002|Part B (Weeks 12 Through 24)|Adverse Event|1|||
27948109|NCT01185353|54605512|FG003|Part B (Weeks 12 Through 24)|Adverse Event|0|||
27948110|NCT01185353|54605513|FG004|Part B (Weeks 12 Through 24)|Adverse Event|0|||
27948111|NCT01185353|54605514|FG005|Part B (Weeks 12 Through 24)|Adverse Event|1|||
27948112|NCT01185353|54605515|FG006|Part B (Weeks 12 Through 24)|Adverse Event|0|||
27948113|NCT01185353|54605516|FG007|Part B (Weeks 12 Through 24)|Adverse Event|0|||
27948114|NCT01185353|54605517|FG008|Part B (Weeks 12 Through 24)|Adverse Event|0|||
27948115|NCT01185353|54605518|FG009|Part B (Weeks 12 Through 24)|Adverse Event|0|||
27948116|NCT01185353|54605509|FG000|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
27854611|NCT00557193|54369990|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1|||
27854612|NCT00557193|54369991|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
27731624|NCT02604212|54178962|FG000|Overall Study|Withdrawal by Subject|0|||
27948117|NCT01185353|54605510|FG001|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
27948118|NCT01185353|54605511|FG002|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
27948119|NCT01185353|54605512|FG003|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
27948120|NCT01185353|54605513|FG004|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
27948121|NCT01185353|54605514|FG005|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
27948122|NCT01185353|54605515|FG006|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
27948123|NCT01185353|54605516|FG007|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
27948124|NCT01185353|54605517|FG008|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
27948125|NCT01185353|54605518|FG009|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
27948126|NCT01185353|54605509|FG000|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
27854613|NCT00557193|54369992|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
27854614|NCT00557193|54369993|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
27948127|NCT01185353|54605510|FG001|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
27948128|NCT01185353|54605511|FG002|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
27948129|NCT01185353|54605512|FG003|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
27948130|NCT01185353|54605513|FG004|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
27948131|NCT01185353|54605514|FG005|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
27948132|NCT01185353|54605515|FG006|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
27948133|NCT01185353|54605516|FG007|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
27948134|NCT01185353|54605517|FG008|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
27948135|NCT01185353|54605518|FG009|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
27948136|NCT01185353|54605509|FG000|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
27948137|NCT01185353|54605510|FG001|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
27948138|NCT01185353|54605511|FG002|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1|||
27948139|NCT01185353|54605512|FG003|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2|||
27854615|NCT00557193|54369994|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5|||
27854616|NCT00557193|54369989|FG000|Post Induction Therapy by Tx Assignment|Relapse|0|||
27854617|NCT00557193|54369990|FG001|Post Induction Therapy by Tx Assignment|Relapse|5|||
27854618|NCT00557193|54369991|FG002|Post Induction Therapy by Tx Assignment|Relapse|16|||
27854619|NCT00557193|54369992|FG003|Post Induction Therapy by Tx Assignment|Relapse|3|||
27854620|NCT00557193|54369993|FG004|Post Induction Therapy by Tx Assignment|Relapse|1|||
27854621|NCT00557193|54369994|FG005|Post Induction Therapy by Tx Assignment|Relapse|20|||
27854622|NCT00557193|54369989|FG000|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
27854623|NCT00557193|54369990|FG001|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
27854624|NCT00557193|54369991|FG002|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1|||
27854625|NCT00557193|54369992|FG003|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
27854626|NCT00557193|54369993|FG004|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
27854627|NCT00557193|54369994|FG005|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
27854628|NCT00557193|54369989|FG000|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
27854629|NCT00557193|54369990|FG001|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
27854630|NCT00557193|54369991|FG002|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2|||
27854631|NCT00557193|54369992|FG003|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
27854632|NCT00557193|54369993|FG004|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
27948140|NCT01185353|54605513|FG004|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
27948141|NCT01185353|54605514|FG005|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3|||
27948142|NCT01185353|54605515|FG006|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4|||
27948143|NCT01185353|54605516|FG007|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
27948144|NCT01185353|54605517|FG008|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
27948145|NCT01185353|54605518|FG009|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
27948146|NCT01185353|54605509|FG000|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
27948147|NCT01185353|54605510|FG001|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
27948148|NCT01185353|54605511|FG002|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
27948149|NCT01185353|54605512|FG003|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
27948150|NCT01185353|54605513|FG004|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
27948151|NCT01185353|54605514|FG005|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
27948152|NCT01185353|54605515|FG006|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1|||
27948153|NCT01185353|54605516|FG007|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
28080789|NCT03591406|54734066|FG001|Overall Study|Protocol Violation|1|||
28080790|NCT03591406|54734065|FG000|Overall Study|Withdrawal by Subject|0|||
28164769|NCT02923349|54835364|FG003|Overall Study|Other|1|||
27731625|NCT02604212|54178963|FG001|Overall Study|Withdrawal by Subject|0|||
27731626|NCT02604212|54178964|FG002|Overall Study|Withdrawal by Subject|1|||
27731627|NCT02604212|54178965|FG003|Overall Study|Withdrawal by Subject|0|||
27731628|NCT02789111|54178982|FG000|Overall Study|Withdrawal by Subject|1|||
27731629|NCT02789111|54178983|FG001|Overall Study|Withdrawal by Subject|4|||
27948154|NCT01185353|54605517|FG008|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
27948155|NCT01185353|54605518|FG009|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
27948156|NCT01185353|54605509|FG000|Part C (Weeks 24 Through 76)|Adverse Event|0|||
27854633|NCT00557193|54369994|FG005|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
27854634|NCT00557193|54369989|FG000|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
27854635|NCT00557193|54369990|FG001|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
27854636|NCT00557193|54369991|FG002|Post Induction Therapy by Tx Assignment|Induction Failure|4|||
27854637|NCT00557193|54369992|FG003|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
27854638|NCT00557193|54369993|FG004|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
27854639|NCT00557193|54369994|FG005|Post Induction Therapy by Tx Assignment|Induction Failure|5|||
27854640|NCT03991299|54370050|FG000|Overall Study|Study closed, sponsor decision|3|||
27948157|NCT01185353|54605510|FG001|Part C (Weeks 24 Through 76)|Adverse Event|0|||
27948158|NCT01185353|54605511|FG002|Part C (Weeks 24 Through 76)|Adverse Event|0|||
27948159|NCT01185353|54605512|FG003|Part C (Weeks 24 Through 76)|Adverse Event|0|||
27948160|NCT01185353|54605513|FG004|Part C (Weeks 24 Through 76)|Adverse Event|0|||
27948161|NCT01185353|54605514|FG005|Part C (Weeks 24 Through 76)|Adverse Event|0|||
27948162|NCT01185353|54605515|FG006|Part C (Weeks 24 Through 76)|Adverse Event|0|||
27948163|NCT01185353|54605516|FG007|Part C (Weeks 24 Through 76)|Adverse Event|8|||
27948164|NCT01185353|54605517|FG008|Part C (Weeks 24 Through 76)|Adverse Event|2|||
27948165|NCT01185353|54605518|FG009|Part C (Weeks 24 Through 76)|Adverse Event|2|||
27854641|NCT03991299|54370050|FG000|Overall Study|Withdrawal by Subject|1|||
27854642|NCT03155373|54370068|FG000|Overall Study|No longer required surgery|1|||
27854643|NCT03155373|54370068|FG000|Overall Study|Protocol Violation|1|||
27854644|NCT03155373|54370068|FG000|Overall Study|Death|2|||
27854645|NCT03155373|54370068|FG000|Overall Study|Withdrawal by Subject|3|||
27854646|NCT02775903|54370772|FG000|Overall Study|Death|7|||
27854647|NCT02775903|54370773|FG001|Overall Study|Death|11|||
27854648|NCT02775903|54370774|FG002|Overall Study|Death|12|||
27854649|NCT02775903|54370775|FG003|Overall Study|Death|11|||
27854650|NCT02775903|54370772|FG000|Overall Study|Adverse Event|0|||
27854651|NCT02775903|54370773|FG001|Overall Study|Adverse Event|1|||
27854652|NCT02775903|54370774|FG002|Overall Study|Adverse Event|12|||
27854653|NCT02775903|54370775|FG003|Overall Study|Adverse Event|3|||
27854654|NCT02775903|54370772|FG000|Overall Study|Progressive disease|15|||
27854655|NCT02775903|54370773|FG001|Overall Study|Progressive disease|14|||
27854656|NCT02775903|54370774|FG002|Overall Study|Progressive disease|30|||
27854657|NCT02775903|54370775|FG003|Overall Study|Progressive disease|20|||
27854658|NCT02775903|54370772|FG000|Overall Study|Lack of Efficacy|2|||
27854659|NCT02775903|54370773|FG001|Overall Study|Lack of Efficacy|2|||
27854660|NCT02775903|54370774|FG002|Overall Study|Lack of Efficacy|2|||
27854661|NCT02775903|54370775|FG003|Overall Study|Lack of Efficacy|6|||
27854662|NCT02775903|54370772|FG000|Overall Study|Withdrawal by Subject|7|||
27854663|NCT02775903|54370773|FG001|Overall Study|Withdrawal by Subject|5|||
27854664|NCT02775903|54370774|FG002|Overall Study|Withdrawal by Subject|5|||
27854665|NCT02775903|54370775|FG003|Overall Study|Withdrawal by Subject|8|||
27854666|NCT02775903|54370772|FG000|Overall Study|Other reasons|7|||
27854667|NCT02775903|54370773|FG001|Overall Study|Other reasons|8|||
27854668|NCT02775903|54370774|FG002|Overall Study|Other reasons|2|||
27948166|NCT01185353|54605509|FG000|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
27948167|NCT01185353|54605510|FG001|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
27948168|NCT01185353|54605511|FG002|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
27948169|NCT01185353|54605512|FG003|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
27948170|NCT01185353|54605513|FG004|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
27948171|NCT01185353|54605514|FG005|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
27948172|NCT01185353|54605515|FG006|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
27948173|NCT01185353|54605516|FG007|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6|||
27948174|NCT01185353|54605517|FG008|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
27948175|NCT01185353|54605518|FG009|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
27948176|NCT01185353|54605509|FG000|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
27948177|NCT01185353|54605510|FG001|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
27948178|NCT01185353|54605511|FG002|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
27948179|NCT01185353|54605512|FG003|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
27948180|NCT01185353|54605513|FG004|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
27948181|NCT01185353|54605514|FG005|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
27731630|NCT01359644|54179001|FG000|Treatment Period|Lack of Efficacy|0|||
27854669|NCT02775903|54370775|FG003|Overall Study|Other reasons|12|||
27854670|NCT02723019|54370848|FG000|Overall Study|Death|17|||
27948182|NCT01185353|54605515|FG006|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
27948183|NCT01185353|54605516|FG007|Part C (Weeks 24 Through 76)|Lost to Follow-up|2|||
27948184|NCT01185353|54605517|FG008|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
27948185|NCT01185353|54605518|FG009|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
27854671|NCT02723019|54370849|FG001|Overall Study|Death|13|||
27854672|NCT02723019|54370848|FG000|Overall Study|Withdrawal by Subject|11|||
27854673|NCT02723019|54370849|FG001|Overall Study|Withdrawal by Subject|7|||
27854674|NCT02723019|54370848|FG000|Overall Study|Lost to Follow-up|57|||
27854675|NCT02723019|54370849|FG001|Overall Study|Lost to Follow-up|70|||
27854676|NCT00088166|54371099|FG000|Overall Study|Adverse Event|11|||
27854677|NCT00088166|54371100|FG001|Overall Study|Adverse Event|9|||
27854678|NCT00088166|54371099|FG000|Overall Study|Death|3|||
27854679|NCT00088166|54371100|FG001|Overall Study|Death|1|||
27854680|NCT00088166|54371099|FG000|Overall Study|Lost to Follow-up|0|||
27854681|NCT00088166|54371100|FG001|Overall Study|Lost to Follow-up|1|||
27854682|NCT00088166|54371099|FG000|Overall Study|Physician Decision|4|||
27948186|NCT01185353|54605509|FG000|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
27948187|NCT01185353|54605510|FG001|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
27948188|NCT01185353|54605511|FG002|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
27948189|NCT01185353|54605512|FG003|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
27948190|NCT01185353|54605513|FG004|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
27948191|NCT01185353|54605514|FG005|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
27948192|NCT01185353|54605515|FG006|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
27948193|NCT01185353|54605516|FG007|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
27948194|NCT01185353|54605517|FG008|Part C (Weeks 24 Through 76)|Lack of Efficacy|2|||
27948195|NCT01185353|54605518|FG009|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
27948196|NCT01185353|54605509|FG000|Part C (Weeks 24 Through 76)|Death|0|||
27948197|NCT01185353|54605510|FG001|Part C (Weeks 24 Through 76)|Death|0|||
27948198|NCT01185353|54605511|FG002|Part C (Weeks 24 Through 76)|Death|0|||
27948199|NCT01185353|54605512|FG003|Part C (Weeks 24 Through 76)|Death|0|||
27948200|NCT01185353|54605513|FG004|Part C (Weeks 24 Through 76)|Death|0|||
27948201|NCT01185353|54605514|FG005|Part C (Weeks 24 Through 76)|Death|0|||
27948202|NCT01185353|54605515|FG006|Part C (Weeks 24 Through 76)|Death|0|||
27948203|NCT01185353|54605516|FG007|Part C (Weeks 24 Through 76)|Death|0|||
27948204|NCT01185353|54605517|FG008|Part C (Weeks 24 Through 76)|Death|0|||
27948205|NCT01185353|54605518|FG009|Part C (Weeks 24 Through 76)|Death|1|||
27948206|NCT01185353|54605509|FG000|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
27948207|NCT01185353|54605510|FG001|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
27948208|NCT01185353|54605511|FG002|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
27948209|NCT01185353|54605512|FG003|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
27948210|NCT01185353|54605513|FG004|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
27948211|NCT01185353|54605514|FG005|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
27948212|NCT01185353|54605515|FG006|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
27948213|NCT01185353|54605516|FG007|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
27948214|NCT01185353|54605517|FG008|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
27948215|NCT01185353|54605518|FG009|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1|||
27948216|NCT01185353|54605509|FG000|Part C (Weeks 24 Through 76)|Physician Decision|0|||
27948217|NCT01185353|54605510|FG001|Part C (Weeks 24 Through 76)|Physician Decision|0|||
27948218|NCT01185353|54605511|FG002|Part C (Weeks 24 Through 76)|Physician Decision|0|||
27948219|NCT01185353|54605512|FG003|Part C (Weeks 24 Through 76)|Physician Decision|0|||
27948220|NCT01185353|54605513|FG004|Part C (Weeks 24 Through 76)|Physician Decision|0|||
27948221|NCT01185353|54605514|FG005|Part C (Weeks 24 Through 76)|Physician Decision|0|||
27948222|NCT01185353|54605515|FG006|Part C (Weeks 24 Through 76)|Physician Decision|0|||
27948223|NCT01185353|54605516|FG007|Part C (Weeks 24 Through 76)|Physician Decision|0|||
27948224|NCT01185353|54605517|FG008|Part C (Weeks 24 Through 76)|Physician Decision|0|||
27948225|NCT01185353|54605518|FG009|Part C (Weeks 24 Through 76)|Physician Decision|1|||
27948226|NCT01185353|54605509|FG000|Part C (Weeks 24 Through 76)|Reason missing|0|||
27948227|NCT01185353|54605510|FG001|Part C (Weeks 24 Through 76)|Reason missing|0|||
27948228|NCT01185353|54605511|FG002|Part C (Weeks 24 Through 76)|Reason missing|0|||
27948229|NCT01185353|54605512|FG003|Part C (Weeks 24 Through 76)|Reason missing|0|||
27948230|NCT01185353|54605513|FG004|Part C (Weeks 24 Through 76)|Reason missing|0|||
27948231|NCT01185353|54605514|FG005|Part C (Weeks 24 Through 76)|Reason missing|0|||
27948232|NCT01185353|54605515|FG006|Part C (Weeks 24 Through 76)|Reason missing|0|||
27948233|NCT01185353|54605516|FG007|Part C (Weeks 24 Through 76)|Reason missing|0|||
27948234|NCT01185353|54605517|FG008|Part C (Weeks 24 Through 76)|Reason missing|1|||
27948235|NCT01185353|54605518|FG009|Part C (Weeks 24 Through 76)|Reason missing|0|||
27948236|NCT01185353|54605509|FG000|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
27948237|NCT01185353|54605510|FG001|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
27948238|NCT01185353|54605511|FG002|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
27948239|NCT01185353|54605512|FG003|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
27948240|NCT01185353|54605513|FG004|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
27948241|NCT01185353|54605514|FG005|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
27948242|NCT01185353|54605515|FG006|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
28080791|NCT03591406|54734066|FG001|Overall Study|Withdrawal by Subject|5|||
27854683|NCT00088166|54371100|FG001|Overall Study|Physician Decision|1|||
27854684|NCT00088166|54371099|FG000|Overall Study|Protocol Violation|1|||
27854685|NCT00088166|54371100|FG001|Overall Study|Protocol Violation|5|||
28080792|NCT03560986|54734074|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
27948243|NCT01185353|54605516|FG007|Part D (Weeks 76 Through 128)|Lost to Follow-up|1|||
27948244|NCT01185353|54605517|FG008|Part D (Weeks 76 Through 128)|Lost to Follow-up|3|||
27948245|NCT01185353|54605518|FG009|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
27948246|NCT01185353|54605509|FG000|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
27948247|NCT01185353|54605510|FG001|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
27854686|NCT00088166|54371099|FG000|Overall Study|Patient deterioration|29|||
27854687|NCT00088166|54371100|FG001|Overall Study|Patient deterioration|39|||
27854688|NCT00088166|54371099|FG000|Overall Study|Withdrawal by Subject|5|||
27948248|NCT01185353|54605511|FG002|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
27948249|NCT01185353|54605512|FG003|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
27948250|NCT01185353|54605513|FG004|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
27948251|NCT01185353|54605514|FG005|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
27948252|NCT01185353|54605515|FG006|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
27948253|NCT01185353|54605516|FG007|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
27948254|NCT01185353|54605517|FG008|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2|||
27948255|NCT01185353|54605518|FG009|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
27948256|NCT01185353|54605509|FG000|Part D (Weeks 76 Through 128)|Adverse Event|0|||
27948257|NCT01185353|54605510|FG001|Part D (Weeks 76 Through 128)|Adverse Event|0|||
27948258|NCT01185353|54605511|FG002|Part D (Weeks 76 Through 128)|Adverse Event|0|||
27948259|NCT01185353|54605512|FG003|Part D (Weeks 76 Through 128)|Adverse Event|0|||
27948260|NCT01185353|54605513|FG004|Part D (Weeks 76 Through 128)|Adverse Event|0|||
27948261|NCT01185353|54605514|FG005|Part D (Weeks 76 Through 128)|Adverse Event|0|||
27948262|NCT01185353|54605515|FG006|Part D (Weeks 76 Through 128)|Adverse Event|0|||
27948263|NCT01185353|54605516|FG007|Part D (Weeks 76 Through 128)|Adverse Event|1|||
27948264|NCT01185353|54605517|FG008|Part D (Weeks 76 Through 128)|Adverse Event|2|||
27948265|NCT01185353|54605518|FG009|Part D (Weeks 76 Through 128)|Adverse Event|0|||
27948266|NCT01098240|54605557|FG000|Open-Label Phase|Study Terminated by Sponsor|27|||
27948267|NCT01098240|54605558|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
27948268|NCT01098240|54605559|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
27854689|NCT00088166|54371100|FG001|Overall Study|Withdrawal by Subject|5|||
27854690|NCT00087698|54371144|FG000|Overall Study|Lack of Efficacy, Progressive Disease|14|||
27854691|NCT00087698|54371144|FG000|Overall Study|Death from Other Causes|3|||
27948269|NCT01098240|54605557|FG000|Open-Label Phase|Protocol Violation|4|||
27948270|NCT01098240|54605558|FG001|Open-Label Phase|Protocol Violation|0|||
27948271|NCT01098240|54605559|FG002|Open-Label Phase|Protocol Violation|0|||
27948272|NCT01098240|54605557|FG000|Open-Label Phase|Lost to Follow-up|13|||
27948273|NCT01098240|54605558|FG001|Open-Label Phase|Lost to Follow-up|0|||
27948274|NCT01098240|54605559|FG002|Open-Label Phase|Lost to Follow-up|0|||
27948275|NCT01098240|54605557|FG000|Open-Label Phase|Other|19|||
27948276|NCT01098240|54605558|FG001|Open-Label Phase|Other|0|||
27948277|NCT01098240|54605559|FG002|Open-Label Phase|Other|0|||
27948278|NCT01098240|54605557|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|50|||
27948279|NCT01098240|54605558|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
27948280|NCT01098240|54605559|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
27948281|NCT01098240|54605557|FG000|Open-Label Phase|Pregnancy|1|||
27948282|NCT01098240|54605558|FG001|Open-Label Phase|Pregnancy|0|||
27948283|NCT01098240|54605559|FG002|Open-Label Phase|Pregnancy|0|||
27948284|NCT01098240|54605557|FG000|Open-Label Phase|Withdrawal by Subject|9|||
27948285|NCT01098240|54605558|FG001|Open-Label Phase|Withdrawal by Subject|0|||
27948286|NCT01098240|54605559|FG002|Open-Label Phase|Withdrawal by Subject|0|||
27948287|NCT01098240|54605557|FG000|Open-Label Phase|Adverse Event|12|||
27948288|NCT01098240|54605558|FG001|Open-Label Phase|Adverse Event|0|||
27948289|NCT01098240|54605559|FG002|Open-Label Phase|Adverse Event|0|||
27948290|NCT01098240|54605557|FG000|Double-Blind Phase|Study Terminated by Sponsor|0|||
27948291|NCT01098240|54605558|FG001|Double-Blind Phase|Study Terminated by Sponsor|5|||
27948292|NCT01098240|54605559|FG002|Double-Blind Phase|Study Terminated by Sponsor|8|||
27948293|NCT01098240|54605557|FG000|Double-Blind Phase|Protocol Violation|0|||
27854692|NCT00087698|54371144|FG000|Overall Study|Adverse Event|4|||
27854693|NCT00087698|54371144|FG000|Overall Study|Withdrawal by Subject|4|||
27854694|NCT00087698|54371144|FG000|Overall Study|Lack of Efficacy, Physician Perception|3|||
27948294|NCT01098240|54605558|FG001|Double-Blind Phase|Protocol Violation|2|||
27948295|NCT01098240|54605559|FG002|Double-Blind Phase|Protocol Violation|4|||
27948296|NCT01098240|54605557|FG000|Double-Blind Phase|Lost to Follow-up|0|||
27948297|NCT01098240|54605558|FG001|Double-Blind Phase|Lost to Follow-up|2|||
27948298|NCT01098240|54605559|FG002|Double-Blind Phase|Lost to Follow-up|0|||
27854695|NCT00087698|54371144|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
27854696|NCT00087698|54371144|FG000|Overall Study|Clinical Relapse|1|||
27854697|NCT00087698|54371144|FG000|Overall Study|Death from Study Disease|2|||
27948299|NCT01098240|54605557|FG000|Double-Blind Phase|Other|0|||
27948300|NCT01098240|54605558|FG001|Double-Blind Phase|Other|2|||
27948301|NCT01098240|54605559|FG002|Double-Blind Phase|Other|2|||
27948302|NCT01098240|54605557|FG000|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
27948303|NCT01098240|54605558|FG001|Double-Blind Phase|Did Not Meet Entrance Criteria|1|||
27948304|NCT01098240|54605559|FG002|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
27948305|NCT01098240|54605557|FG000|Double-Blind Phase|Insufficient Clinical Response|0|||
27948306|NCT01098240|54605558|FG001|Double-Blind Phase|Insufficient Clinical Response|1|||
27948307|NCT01098240|54605559|FG002|Double-Blind Phase|Insufficient Clinical Response|2|||
27948308|NCT01098240|54605557|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
27948309|NCT01098240|54605558|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
27948310|NCT01098240|54605559|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
27948311|NCT01098240|54605557|FG000|Double-Blind Phase|Adverse Event|0|||
27948312|NCT01098240|54605558|FG001|Double-Blind Phase|Adverse Event|3|||
27948313|NCT01098240|54605559|FG002|Double-Blind Phase|Adverse Event|3|||
27948314|NCT01098162|54605566|FG000|Overall Study|Adverse Event|37|||
27948315|NCT01098162|54605566|FG000|Overall Study|Lack of Efficacy|4|||
27948316|NCT01098162|54605566|FG000|Overall Study|Wish of Patient|7|||
27948317|NCT01098162|54605566|FG000|Overall Study|Lost to Follow-up|9|||
27948318|NCT01098162|54605566|FG000|Overall Study|Lack of Efficacy & Wish of Patient|5|||
27948319|NCT01098162|54605566|FG000|Overall Study|Adverse Event & Lack of Efficacy|6|||
27948320|NCT01098162|54605566|FG000|Overall Study|Adverse Event & Wish of Patient|13|||
27948321|NCT01098162|54605566|FG000|Overall Study|Adverse Event & Lost to Follow-up|2|||
27948322|NCT01098162|54605566|FG000|Overall Study|AE & Lack of Efficacy & Wish of Patient|1|||
27948323|NCT01098162|54605566|FG000|Overall Study|Wish of Patient & Lost to Follow-up|1|||
27948324|NCT01098162|54605566|FG000|Overall Study|Other Reason|1|||
27948325|NCT01098162|54605566|FG000|Overall Study|Reason Unknown|26|||
27948326|NCT01097694|54605572|FG000|Overall Study|Adverse Event|5|||
27948327|NCT01097694|54605573|FG001|Overall Study|Adverse Event|0|||
27948328|NCT01097694|54605572|FG000|Overall Study|Lost to Follow-up|0|||
27948329|NCT01097694|54605573|FG001|Overall Study|Lost to Follow-up|3|||
27948330|NCT01097694|54605572|FG000|Overall Study|Withdrawal by Subject|3|||
27948331|NCT01097694|54605573|FG001|Overall Study|Withdrawal by Subject|1|||
27948332|NCT01102140|54605581|FG000|Overall Study|Lost to Follow-up|1|||
27948333|NCT01102140|54605582|FG001|Overall Study|Lost to Follow-up|0|||
27948334|NCT01102140|54605581|FG000|Overall Study|Investigator terminated study|2|||
27948335|NCT01102140|54605582|FG001|Overall Study|Investigator terminated study|2|||
27948336|NCT00874549|54605594|FG000|Overall Study|Adverse Event|0|||
27948337|NCT00874549|54605595|FG001|Overall Study|Adverse Event|0|||
27948338|NCT00874549|54605596|FG002|Overall Study|Adverse Event|1|||
27948339|NCT00874549|54605597|FG003|Overall Study|Adverse Event|0|||
27948340|NCT00874549|54605594|FG000|Overall Study|Protocol Violation|1|||
27948341|NCT00874549|54605595|FG001|Overall Study|Protocol Violation|0|||
27948342|NCT00874549|54605596|FG002|Overall Study|Protocol Violation|2|||
27948343|NCT00874549|54605597|FG003|Overall Study|Protocol Violation|1|||
27948344|NCT00874549|54605594|FG000|Overall Study|Lost to Follow-up|0|||
27948345|NCT00874549|54605595|FG001|Overall Study|Lost to Follow-up|0|||
27948346|NCT00874549|54605596|FG002|Overall Study|Lost to Follow-up|1|||
27948347|NCT00874549|54605597|FG003|Overall Study|Lost to Follow-up|0|||
27948348|NCT00874549|54605594|FG000|Overall Study|Withdrawal by Subject|0|||
27948349|NCT00874549|54605595|FG001|Overall Study|Withdrawal by Subject|1|||
27948350|NCT00874549|54605596|FG002|Overall Study|Withdrawal by Subject|0|||
27948351|NCT00874549|54605597|FG003|Overall Study|Withdrawal by Subject|1|||
27948352|NCT01155479|54605612|FG000|Part I|Adverse Event|13|||
27948353|NCT01155479|54605613|FG001|Part I|Adverse Event|8|||
27948354|NCT01155479|54605614|FG002|Part I|Adverse Event|18|||
27948355|NCT01155479|54605615|FG003|Part I|Adverse Event|7|||
27948356|NCT01155479|54605616|FG004|Part I|Adverse Event|6|||
27948357|NCT01155479|54605612|FG000|Part I|Administrative|2|||
27948358|NCT01155479|54605613|FG001|Part I|Administrative|2|||
27948359|NCT01155479|54605614|FG002|Part I|Administrative|2|||
27948360|NCT01155479|54605615|FG003|Part I|Administrative|0|||
27948361|NCT01155479|54605616|FG004|Part I|Administrative|0|||
27948362|NCT01155479|54605612|FG000|Part I|Did Not Meet Protocol Eligibility|3|||
27948363|NCT01155479|54605613|FG001|Part I|Did Not Meet Protocol Eligibility|1|||
27948364|NCT01155479|54605614|FG002|Part I|Did Not Meet Protocol Eligibility|2|||
27948365|NCT01155479|54605615|FG003|Part I|Did Not Meet Protocol Eligibility|1|||
27948366|NCT01155479|54605616|FG004|Part I|Did Not Meet Protocol Eligibility|3|||
27948367|NCT01155479|54605612|FG000|Part I|Withdrawal by Subject|11|||
28080793|NCT03560986|54734075|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
27948368|NCT01155479|54605613|FG001|Part I|Withdrawal by Subject|13|||
27948369|NCT01155479|54605614|FG002|Part I|Withdrawal by Subject|8|||
27948370|NCT01155479|54605615|FG003|Part I|Withdrawal by Subject|8|||
27948371|NCT01155479|54605616|FG004|Part I|Withdrawal by Subject|9|||
27948372|NCT01155479|54605612|FG000|Part I|Lost to Follow-up|0|||
27948373|NCT01155479|54605613|FG001|Part I|Lost to Follow-up|0|||
27948374|NCT01155479|54605614|FG002|Part I|Lost to Follow-up|1|||
27948375|NCT01155479|54605615|FG003|Part I|Lost to Follow-up|1|||
27948376|NCT01155479|54605616|FG004|Part I|Lost to Follow-up|0|||
27948377|NCT01155479|54605612|FG000|Part I|Treatment Failure|3|||
27948378|NCT01155479|54605613|FG001|Part I|Treatment Failure|0|||
27948379|NCT01155479|54605614|FG002|Part I|Treatment Failure|3|||
27948380|NCT01155479|54605615|FG003|Part I|Treatment Failure|1|||
27948381|NCT01155479|54605616|FG004|Part I|Treatment Failure|2|||
27948382|NCT01155479|54605612|FG000|Part I|Did Not Receive Treatment|4|||
27948383|NCT01155479|54605613|FG001|Part I|Did Not Receive Treatment|2|||
27948384|NCT01155479|54605614|FG002|Part I|Did Not Receive Treatment|2|||
27948385|NCT01155479|54605615|FG003|Part I|Did Not Receive Treatment|6|||
27948386|NCT01155479|54605616|FG004|Part I|Did Not Receive Treatment|1|||
27948387|NCT01155479|54605612|FG000|Part I|Non-Compliance with Protocol|2|||
27948388|NCT01155479|54605613|FG001|Part I|Non-Compliance with Protocol|1|||
27948389|NCT01155479|54605614|FG002|Part I|Non-Compliance with Protocol|3|||
27948390|NCT01155479|54605615|FG003|Part I|Non-Compliance with Protocol|3|||
27948391|NCT01155479|54605616|FG004|Part I|Non-Compliance with Protocol|2|||
27948392|NCT01155479|54605612|FG000|Part II|Adverse Event|7|||
27948393|NCT01155479|54605613|FG001|Part II|Adverse Event|6|||
27948394|NCT01155479|54605614|FG002|Part II|Adverse Event|8|||
27948395|NCT01155479|54605615|FG003|Part II|Adverse Event|3|||
27948396|NCT01155479|54605616|FG004|Part II|Adverse Event|4|||
27948397|NCT01155479|54605612|FG000|Part II|Administrative|43|||
27948398|NCT01155479|54605613|FG001|Part II|Administrative|49|||
27948399|NCT01155479|54605614|FG002|Part II|Administrative|36|||
27948400|NCT01155479|54605615|FG003|Part II|Administrative|38|||
27948401|NCT01155479|54605616|FG004|Part II|Administrative|46|||
27948402|NCT01155479|54605612|FG000|Part II|Withdrawal by Subject|8|||
27948403|NCT01155479|54605613|FG001|Part II|Withdrawal by Subject|4|||
27948404|NCT01155479|54605614|FG002|Part II|Withdrawal by Subject|12|||
27948405|NCT01155479|54605615|FG003|Part II|Withdrawal by Subject|7|||
27948406|NCT01155479|54605616|FG004|Part II|Withdrawal by Subject|3|||
27948407|NCT01155479|54605612|FG000|Part II|Lost to Follow-up|1|||
27948408|NCT01155479|54605613|FG001|Part II|Lost to Follow-up|0|||
27948409|NCT01155479|54605614|FG002|Part II|Lost to Follow-up|0|||
27854698|NCT00087698|54371144|FG000|Overall Study|Death from Study Drug Toxicity|2|||
27854699|NCT00087698|54371144|FG000|Overall Study|Protocol Violation|1|||
27854700|NCT00087152|54371162|FG000|Overall Study|Ineligible|6|||
27854701|NCT00086996|54371214|FG000|Overall Study|Adverse Event|29|||
27854702|NCT00086996|54371214|FG000|Overall Study|Death|4|||
27854703|NCT00086996|54371214|FG000|Overall Study|progression/relapse|7|||
27854704|NCT00086996|54371214|FG000|Overall Study|Withdrawal by Subject|13|||
27948410|NCT01155479|54605615|FG003|Part II|Lost to Follow-up|0|||
27948411|NCT01155479|54605616|FG004|Part II|Lost to Follow-up|1|||
27948412|NCT01155479|54605612|FG000|Part II|Treatment Failure|0|||
27948413|NCT01155479|54605613|FG001|Part II|Treatment Failure|1|||
27948414|NCT01155479|54605614|FG002|Part II|Treatment Failure|2|||
27948415|NCT01155479|54605615|FG003|Part II|Treatment Failure|0|||
27948416|NCT01155479|54605616|FG004|Part II|Treatment Failure|1|||
27948417|NCT01155479|54605612|FG000|Part II|Non-Compliance with Protocol|0|||
27948418|NCT01155479|54605613|FG001|Part II|Non-Compliance with Protocol|1|||
27948419|NCT01155479|54605614|FG002|Part II|Non-Compliance with Protocol|0|||
27948420|NCT01155479|54605615|FG003|Part II|Non-Compliance with Protocol|2|||
27948421|NCT01155479|54605616|FG004|Part II|Non-Compliance with Protocol|0|||
27948422|NCT01155323|54605644|FG000|First Intervention|exclusion criteria|1|||
27948423|NCT01155323|54605645|FG001|First Intervention|exclusion criteria|1|||
27948424|NCT01155323|54605644|FG000|Second Intervention|Lost to Follow-up|1|||
27948425|NCT01155323|54605645|FG001|Second Intervention|Lost to Follow-up|1|||
27948426|NCT01155167|54605653|FG000|Overall Study|Insufficient ultrasound data|2|||
27948427|NCT01155167|54605654|FG001|Overall Study|Insufficient ultrasound data|0|||
27948428|NCT01155167|54605653|FG000|Overall Study|Access site changed to femoral artery|1|||
27948429|NCT01155167|54605654|FG001|Overall Study|Access site changed to femoral artery|0|||
27948430|NCT01106586|54605662|FG000|Overall Study|Adverse Event|9|||
27948431|NCT01106586|54605663|FG001|Overall Study|Adverse Event|15|||
27948432|NCT01106586|54605662|FG000|Overall Study|Death|1|||
27948433|NCT01106586|54605663|FG001|Overall Study|Death|3|||
27948434|NCT01106586|54605662|FG000|Overall Study|Pregnancy|2|||
27948435|NCT01106586|54605663|FG001|Overall Study|Pregnancy|2|||
27948436|NCT01106586|54605662|FG000|Overall Study|Lack of Efficacy|1|||
27948437|NCT01106586|54605663|FG001|Overall Study|Lack of Efficacy|0|||
27948438|NCT01106586|54605662|FG000|Overall Study|Investigator's Discretion|5|||
27948439|NCT01106586|54605663|FG001|Overall Study|Investigator's Discretion|8|||
27948440|NCT01106586|54605662|FG000|Overall Study|Withdrew Consent|18|||
27948441|NCT01106586|54605663|FG001|Overall Study|Withdrew Consent|30|||
27854705|NCT00086996|54371214|FG000|Overall Study|Other|6|||
27854706|NCT00086996|54371214|FG000|Overall Study|not eligible|5|||
27948442|NCT01106586|54605662|FG000|Overall Study|Lost to Follow-up|24|||
27948443|NCT01106586|54605663|FG001|Overall Study|Lost to Follow-up|20|||
27948444|NCT01106586|54605662|FG000|Overall Study|Participant Noncompliance|12|||
27948445|NCT01106586|54605663|FG001|Overall Study|Participant Noncompliance|10|||
27948446|NCT01106586|54605662|FG000|Overall Study|Protocol Violation|1|||
27948447|NCT01106586|54605663|FG001|Overall Study|Protocol Violation|0|||
27948448|NCT01106586|54605662|FG000|Overall Study|Participant Transferred to Another Study|212|||
27948449|NCT01106586|54605663|FG001|Overall Study|Participant Transferred to Another Study|197|||
27948450|NCT01155011|54605671|FG000|Baseline to 6 Months|Withdrawal by Subject|18|||
27948451|NCT01155011|54605672|FG001|Baseline to 6 Months|Withdrawal by Subject|19|||
27948452|NCT01155011|54605671|FG000|Baseline to 6 Months|investigator decision, moved|4|||
27948453|NCT01155011|54605672|FG001|Baseline to 6 Months|investigator decision, moved|5|||
27948454|NCT01155011|54605671|FG000|Baseline to 6 Months|Death|0|||
27948455|NCT01155011|54605672|FG001|Baseline to 6 Months|Death|1|||
27948456|NCT01155011|54605671|FG000|6 to 12 Months|Withdrawal by Subject|8|||
27948457|NCT01155011|54605672|FG001|6 to 12 Months|Withdrawal by Subject|5|||
27948458|NCT01155011|54605671|FG000|6 to 12 Months|Death|1|||
27948459|NCT01155011|54605672|FG001|6 to 12 Months|Death|5|||
27948460|NCT01106430|54605684|FG000|Overall Study|Adverse Event|8|||
27948461|NCT01106430|54605685|FG001|Overall Study|Adverse Event|10|||
27948462|NCT01106430|54605684|FG000|Overall Study|Lack of Efficacy|2|||
27948463|NCT01106430|54605685|FG001|Overall Study|Lack of Efficacy|13|||
27948464|NCT01106430|54605684|FG000|Overall Study|Lost to Follow-up|5|||
27948465|NCT01106430|54605685|FG001|Overall Study|Lost to Follow-up|1|||
27948466|NCT01106430|54605684|FG000|Overall Study|Early Termination Requested By Sponsor|1|||
27948467|NCT01106430|54605685|FG001|Overall Study|Early Termination Requested By Sponsor|0|||
27948468|NCT01106430|54605684|FG000|Overall Study|Moved Out Of State|0|||
27948469|NCT01106430|54605685|FG001|Overall Study|Moved Out Of State|1|||
27948470|NCT01106430|54605684|FG000|Overall Study|Refused To Take Medication|0|||
27948471|NCT01106430|54605685|FG001|Overall Study|Refused To Take Medication|1|||
27948472|NCT01106430|54605684|FG000|Overall Study|Noncompliance|0|||
27948473|NCT01106430|54605685|FG001|Overall Study|Noncompliance|1|||
27948474|NCT01106430|54605684|FG000|Overall Study|Hard Time Swallowing The Pills|1|||
27948475|NCT01106430|54605685|FG001|Overall Study|Hard Time Swallowing The Pills|0|||
27948476|NCT01106430|54605684|FG000|Overall Study|Previous Use Of Marijuana|1|||
27948477|NCT01106430|54605685|FG001|Overall Study|Previous Use Of Marijuana|0|||
27948478|NCT01106430|54605684|FG000|Overall Study|Protocol Violation|7|||
27948479|NCT01106430|54605685|FG001|Overall Study|Protocol Violation|2|||
27948480|NCT01106430|54605684|FG000|Overall Study|Withdrawal by Subject|8|||
27948481|NCT01106430|54605685|FG001|Overall Study|Withdrawal by Subject|4|||
27948482|NCT01154231|54605691|FG000|Overall Study|Safety Unassessable, No Drug Admin.|1|||
27948483|NCT01154231|54605691|FG000|Overall Study|No Info. After 1st Day, No Drug Admin.|1|||
27948484|NCT01154153|54605697|FG000|Overall Study|Poor compliance to protocol|2|||
27948485|NCT01154153|54605698|FG001|Overall Study|Poor compliance to protocol|0|||
27948486|NCT01154153|54605697|FG000|Overall Study|Unable to use labs|2|||
27948487|NCT01154153|54605698|FG001|Overall Study|Unable to use labs|3|||
27948488|NCT01154153|54605697|FG000|Overall Study|Withdrew consent|1|||
27948489|NCT01154153|54605698|FG001|Overall Study|Withdrew consent|0|||
27948490|NCT00874237|54605704|FG000|Overall Study|Physician Decision|0|||
27948491|NCT00874237|54605705|FG001|Overall Study|Physician Decision|1|||
27948492|NCT00874237|54605706|FG002|Overall Study|Physician Decision|0|||
27948493|NCT00874237|54605707|FG003|Overall Study|Physician Decision|0|||
27948494|NCT00874237|54605708|FG004|Overall Study|Physician Decision|0|||
27948495|NCT00874237|54605709|FG005|Overall Study|Physician Decision|0|||
27948496|NCT00874237|54605704|FG000|Overall Study|Withdrawal by Subject|0|||
27948497|NCT00874237|54605705|FG001|Overall Study|Withdrawal by Subject|0|||
27948498|NCT00874237|54605706|FG002|Overall Study|Withdrawal by Subject|1|||
27948499|NCT00874237|54605707|FG003|Overall Study|Withdrawal by Subject|0|||
27948500|NCT00874237|54605708|FG004|Overall Study|Withdrawal by Subject|0|||
27948501|NCT00874237|54605709|FG005|Overall Study|Withdrawal by Subject|0|||
27948502|NCT01153841|54605721|FG000|Overall Study|Adverse Event|1|||
27948503|NCT01153841|54605722|FG001|Overall Study|Adverse Event|0|||
27948504|NCT01153841|54605721|FG000|Overall Study|Withdrawal by Subject|1|||
27948505|NCT01153841|54605722|FG001|Overall Study|Withdrawal by Subject|0|||
27948506|NCT01153841|54605721|FG000|Overall Study|Protocol Violation|2|||
27948507|NCT01153841|54605722|FG001|Overall Study|Protocol Violation|0|||
27948508|NCT01153841|54605721|FG000|Overall Study|Lost to Follow-up|2|||
27948509|NCT01153841|54605722|FG001|Overall Study|Lost to Follow-up|0|||
27948510|NCT01153763|54605728|FG000|Overall Study|Study Closed|16|||
27948511|NCT01153763|54605728|FG000|Overall Study|Lost to Follow-up|1|||
27948512|NCT01153763|54605728|FG000|Overall Study|Physician Decision|2|||
27948513|NCT01153763|54605728|FG000|Overall Study|Withdrawal by Subject|2|||
27948514|NCT00871741|54605734|FG000|Overall Study|Premature study termination|9|||
27948515|NCT00871741|54605735|FG001|Overall Study|Premature study termination|7|||
27948516|NCT01152437|54605744|FG000|Overall Study|Other Adverse Event|8|||
27948517|NCT01152437|54605745|FG001|Overall Study|Other Adverse Event|1|||
28080794|NCT03560986|54734074|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
27731631|NCT01359644|54179002|FG001|Treatment Period|Lack of Efficacy|1|||
27948518|NCT01152437|54605746|FG002|Overall Study|Other Adverse Event|7|||
27948519|NCT01152437|54605744|FG000|Overall Study|Not treated|0|||
27948520|NCT01152437|54605745|FG001|Overall Study|Not treated|1|||
27948521|NCT01152437|54605746|FG002|Overall Study|Not treated|2|||
27948522|NCT01152437|54605744|FG000|Overall Study|Progressive disease|27|||
27948523|NCT01152437|54605745|FG001|Overall Study|Progressive disease|13|||
27948524|NCT01152437|54605746|FG002|Overall Study|Progressive disease|32|||
27948525|NCT01152437|54605744|FG000|Overall Study|Refusal to continue taking trial medicat|1|||
28164770|NCT02923349|54835365|FG004|Overall Study|Other|3|||
27948526|NCT01152437|54605745|FG001|Overall Study|Refusal to continue taking trial medicat|0|||
27948527|NCT01152437|54605746|FG002|Overall Study|Refusal to continue taking trial medicat|2|||
27948528|NCT01151579|54605758|FG000|Overall Study|Physician Decision|3|||
27948529|NCT01151579|54605759|FG001|Overall Study|Physician Decision|1|||
27948530|NCT01151579|54605758|FG000|Overall Study|Withdrawal by Subject|3|||
27948531|NCT01151579|54605759|FG001|Overall Study|Withdrawal by Subject|2|||
27948532|NCT01151579|54605758|FG000|Overall Study|Not meet inclusion criteria|6|||
27948533|NCT01151579|54605759|FG001|Overall Study|Not meet inclusion criteria|4|||
27948534|NCT01097616|54605768|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6|||
27948535|NCT01097616|54605769|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15|||
27948536|NCT01097616|54605770|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21|||
27948537|NCT01097616|54605771|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
27948538|NCT01097616|54605772|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
27948539|NCT01097616|54605773|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
27948540|NCT01097616|54605774|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
27948541|NCT01097616|54605775|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
27948542|NCT01097616|54605768|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6|||
27948543|NCT01097616|54605769|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
27948544|NCT01097616|54605770|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12|||
27948545|NCT01097616|54605771|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
27948546|NCT01097616|54605772|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
27948547|NCT01097616|54605773|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
27948548|NCT01097616|54605774|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
27948549|NCT01097616|54605775|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
27948550|NCT01097616|54605768|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
27948551|NCT01097616|54605769|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3|||
27948552|NCT01097616|54605770|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1|||
27948553|NCT01097616|54605771|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
27948554|NCT01097616|54605772|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
27948555|NCT01097616|54605773|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
27948556|NCT01097616|54605774|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
27948557|NCT01097616|54605775|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
27948558|NCT01097616|54605768|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
27948559|NCT01097616|54605769|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
27948560|NCT01097616|54605770|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
27948561|NCT01097616|54605771|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
27948562|NCT01097616|54605772|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
27948563|NCT01097616|54605773|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
27948564|NCT01097616|54605774|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
27948565|NCT01097616|54605775|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
27948566|NCT01097616|54605768|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1|||
27948567|NCT01097616|54605769|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
27948568|NCT01097616|54605770|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9|||
27948569|NCT01097616|54605771|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
27948570|NCT01097616|54605772|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
27948571|NCT01097616|54605773|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
27948572|NCT01097616|54605774|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
27948573|NCT01097616|54605775|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
27948574|NCT01097616|54605768|FG000|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
27948575|NCT01097616|54605769|FG001|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
27948576|NCT01097616|54605770|FG002|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
27948577|NCT01097616|54605771|FG003|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
27948578|NCT01097616|54605772|FG004|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
27948579|NCT01097616|54605773|FG005|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
27948580|NCT01097616|54605774|FG006|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
27948581|NCT01097616|54605775|FG007|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
27948582|NCT01097616|54605768|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4|||
27948583|NCT01097616|54605769|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3|||
27948584|NCT01097616|54605770|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
28080795|NCT03560986|54734075|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
27948585|NCT01097616|54605771|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
27948586|NCT01097616|54605772|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
27948587|NCT01097616|54605773|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
27948588|NCT01097616|54605774|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
28080796|NCT03560986|54734074|FG000|Treatment Period A/Follow-up Period 1|Protocol Violation|0|||
28080797|NCT03560986|54734075|FG001|Treatment Period A/Follow-up Period 1|Protocol Violation|1|||
28080798|NCT03560986|54734074|FG000|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32|||
27948589|NCT01097616|54605775|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
27948590|NCT01097616|54605768|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
27948591|NCT01097616|54605769|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
27948592|NCT01097616|54605770|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
27948593|NCT01097616|54605771|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
27948594|NCT01097616|54605772|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
27948595|NCT01097616|54605773|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
27948596|NCT01097616|54605774|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
27948597|NCT01097616|54605775|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
27948598|NCT01097616|54605768|FG000|Optional DB EXT Phase|Adverse Event|0|||
27948599|NCT01097616|54605769|FG001|Optional DB EXT Phase|Adverse Event|7|||
27948600|NCT01097616|54605770|FG002|Optional DB EXT Phase|Adverse Event|2|||
27948601|NCT01097616|54605771|FG003|Optional DB EXT Phase|Adverse Event|0|||
27948602|NCT01097616|54605772|FG004|Optional DB EXT Phase|Adverse Event|0|||
27948603|NCT01097616|54605773|FG005|Optional DB EXT Phase|Adverse Event|0|||
27948604|NCT01097616|54605774|FG006|Optional DB EXT Phase|Adverse Event|0|||
27948605|NCT01097616|54605775|FG007|Optional DB EXT Phase|Adverse Event|0|||
27948606|NCT01097616|54605768|FG000|Optional DB EXT Phase|Withdrawal by Subject|12|||
27948607|NCT01097616|54605769|FG001|Optional DB EXT Phase|Withdrawal by Subject|6|||
27948608|NCT01097616|54605770|FG002|Optional DB EXT Phase|Withdrawal by Subject|3|||
27948609|NCT01097616|54605771|FG003|Optional DB EXT Phase|Withdrawal by Subject|0|||
27948610|NCT01097616|54605772|FG004|Optional DB EXT Phase|Withdrawal by Subject|0|||
27948611|NCT01097616|54605773|FG005|Optional DB EXT Phase|Withdrawal by Subject|0|||
27948612|NCT01097616|54605774|FG006|Optional DB EXT Phase|Withdrawal by Subject|0|||
27948613|NCT01097616|54605775|FG007|Optional DB EXT Phase|Withdrawal by Subject|0|||
27948614|NCT01097616|54605768|FG000|Optional DB EXT Phase|Protocol Violation|0|||
27948615|NCT01097616|54605769|FG001|Optional DB EXT Phase|Protocol Violation|2|||
27948616|NCT01097616|54605770|FG002|Optional DB EXT Phase|Protocol Violation|3|||
27948617|NCT01097616|54605771|FG003|Optional DB EXT Phase|Protocol Violation|0|||
27948618|NCT01097616|54605772|FG004|Optional DB EXT Phase|Protocol Violation|0|||
27948619|NCT01097616|54605773|FG005|Optional DB EXT Phase|Protocol Violation|0|||
27948620|NCT01097616|54605774|FG006|Optional DB EXT Phase|Protocol Violation|0|||
27948621|NCT01097616|54605775|FG007|Optional DB EXT Phase|Protocol Violation|0|||
27948622|NCT01097616|54605768|FG000|Optional DB EXT Phase|Lost to Follow-up|1|||
27948623|NCT01097616|54605769|FG001|Optional DB EXT Phase|Lost to Follow-up|5|||
27948624|NCT01097616|54605770|FG002|Optional DB EXT Phase|Lost to Follow-up|1|||
28164771|NCT02923349|54835366|FG005|Overall Study|Other|0|||
28164772|NCT02923349|54835367|FG006|Overall Study|Other|1|||
28164773|NCT02923349|54835361|FG000|Overall Study|Withdrawal by Subject|2|||
27948625|NCT01097616|54605771|FG003|Optional DB EXT Phase|Lost to Follow-up|0|||
27948626|NCT01097616|54605772|FG004|Optional DB EXT Phase|Lost to Follow-up|0|||
27948627|NCT01097616|54605773|FG005|Optional DB EXT Phase|Lost to Follow-up|0|||
27948628|NCT01097616|54605774|FG006|Optional DB EXT Phase|Lost to Follow-up|0|||
27948629|NCT01097616|54605775|FG007|Optional DB EXT Phase|Lost to Follow-up|0|||
27948630|NCT01097616|54605768|FG000|Optional DB EXT Phase|Lack of Efficacy|1|||
27948631|NCT01097616|54605769|FG001|Optional DB EXT Phase|Lack of Efficacy|1|||
27948632|NCT01097616|54605770|FG002|Optional DB EXT Phase|Lack of Efficacy|1|||
27948633|NCT01097616|54605771|FG003|Optional DB EXT Phase|Lack of Efficacy|0|||
27948634|NCT01097616|54605772|FG004|Optional DB EXT Phase|Lack of Efficacy|0|||
27948635|NCT01097616|54605773|FG005|Optional DB EXT Phase|Lack of Efficacy|0|||
27948636|NCT01097616|54605774|FG006|Optional DB EXT Phase|Lack of Efficacy|0|||
27948637|NCT01097616|54605775|FG007|Optional DB EXT Phase|Lack of Efficacy|0|||
27948638|NCT01097616|54605768|FG000|Optional DB EXT Phase|Physician Decision|1|||
27948639|NCT01097616|54605769|FG001|Optional DB EXT Phase|Physician Decision|0|||
27948640|NCT01097616|54605770|FG002|Optional DB EXT Phase|Physician Decision|0|||
27948641|NCT01097616|54605771|FG003|Optional DB EXT Phase|Physician Decision|0|||
27948642|NCT01097616|54605772|FG004|Optional DB EXT Phase|Physician Decision|0|||
27948643|NCT01097616|54605773|FG005|Optional DB EXT Phase|Physician Decision|0|||
27948644|NCT01097616|54605774|FG006|Optional DB EXT Phase|Physician Decision|0|||
28164774|NCT02923349|54835362|FG001|Overall Study|Withdrawal by Subject|2|||
28164775|NCT02923349|54835363|FG002|Overall Study|Withdrawal by Subject|8|||
28164776|NCT02923349|54835364|FG003|Overall Study|Withdrawal by Subject|10|||
27948645|NCT01097616|54605775|FG007|Optional DB EXT Phase|Physician Decision|0|||
27948646|NCT01097616|54605768|FG000|DB RO Phase|Adverse Event|0|||
27948647|NCT01097616|54605769|FG001|DB RO Phase|Adverse Event|0|||
27948648|NCT01097616|54605770|FG002|DB RO Phase|Adverse Event|0|||
27948649|NCT01097616|54605771|FG003|DB RO Phase|Adverse Event|0|||
27948650|NCT01097616|54605772|FG004|DB RO Phase|Adverse Event|0|||
27948651|NCT01097616|54605773|FG005|DB RO Phase|Adverse Event|0|||
27948652|NCT01097616|54605774|FG006|DB RO Phase|Adverse Event|1|||
28164777|NCT02923349|54835365|FG004|Overall Study|Withdrawal by Subject|12|||
27948653|NCT01097616|54605775|FG007|DB RO Phase|Adverse Event|0|||
27948654|NCT01097616|54605768|FG000|DB RO Phase|Withdrawal by Subject|0|||
28164778|NCT02923349|54835366|FG005|Overall Study|Withdrawal by Subject|3|||
28164779|NCT02923349|54835367|FG006|Overall Study|Withdrawal by Subject|0|||
27948655|NCT01097616|54605769|FG001|DB RO Phase|Withdrawal by Subject|0|||
27854707|NCT00086684|54371516|FG000|Overall Study|Adverse Event|12|||
27854708|NCT00086684|54371517|FG001|Overall Study|Adverse Event|17|||
27854709|NCT00086684|54371518|FG002|Overall Study|Adverse Event|14|||
27854710|NCT00086684|54371516|FG000|Overall Study|Lack of Efficacy|6|||
27854711|NCT00086684|54371517|FG001|Overall Study|Lack of Efficacy|6|||
27854712|NCT00086684|54371518|FG002|Overall Study|Lack of Efficacy|5|||
27854713|NCT00086684|54371516|FG000|Overall Study|Lost to Follow-up|15|||
27854714|NCT00086684|54371517|FG001|Overall Study|Lost to Follow-up|8|||
27854715|NCT00086684|54371518|FG002|Overall Study|Lost to Follow-up|10|||
27854716|NCT00086684|54371516|FG000|Overall Study|Protocol Violation|8|||
27854717|NCT00086684|54371517|FG001|Overall Study|Protocol Violation|3|||
27854718|NCT00086684|54371518|FG002|Overall Study|Protocol Violation|0|||
27854719|NCT00086684|54371516|FG000|Overall Study|Withdrawal by Subject|0|||
27854720|NCT00086684|54371517|FG001|Overall Study|Withdrawal by Subject|4|||
27854721|NCT00086684|54371518|FG002|Overall Study|Withdrawal by Subject|10|||
27854722|NCT00086684|54371516|FG000|Overall Study|NONCOMPLIANCE|5|||
27854723|NCT00086684|54371517|FG001|Overall Study|NONCOMPLIANCE|7|||
27854724|NCT00086684|54371518|FG002|Overall Study|NONCOMPLIANCE|6|||
27854725|NCT00086684|54371516|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
27854726|NCT00086684|54371517|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
27854727|NCT00086684|54371518|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
27854728|NCT00086684|54371516|FG000|Overall Study|WITHDRAWAL OF CONSENT|5|||
27854729|NCT00086684|54371517|FG001|Overall Study|WITHDRAWAL OF CONSENT|7|||
27854730|NCT00086684|54371518|FG002|Overall Study|WITHDRAWAL OF CONSENT|5|||
27854731|NCT00086684|54371516|FG000|Overall Study|Other|4|||
27854732|NCT00086684|54371517|FG001|Overall Study|Other|2|||
27854733|NCT00086684|54371518|FG002|Overall Study|Other|3|||
27854734|NCT00082628|54371582|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
27854735|NCT00082628|54371583|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1|||
27854736|NCT00082628|54371584|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
27854737|NCT00082628|54371585|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
27854738|NCT00082628|54371586|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
27854739|NCT00082628|54371582|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2|||
27854740|NCT00082628|54371583|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1|||
27854741|NCT00082628|54371584|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
27854742|NCT00082628|54371585|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
27854743|NCT00082628|54371586|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
27854744|NCT00082628|54371582|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5|||
27948656|NCT01097616|54605770|FG002|DB RO Phase|Withdrawal by Subject|0|||
27832091|NCT01773473|54310870|FG000|Overall Study|Protocol Violation|0|||
27832092|NCT01773473|54310871|FG001|Overall Study|Protocol Violation|4|||
27832093|NCT01773473|54310870|FG000|Overall Study|Physician Decision|3|||
27832094|NCT01773473|54310871|FG001|Overall Study|Physician Decision|5|||
27832095|NCT01773473|54310870|FG000|Overall Study|Sponsor Decision|2|||
27832096|NCT01773473|54310871|FG001|Overall Study|Sponsor Decision|0|||
27832097|NCT01773473|54310870|FG000|Overall Study|Lack of Efficacy|0|||
27832098|NCT01773473|54310871|FG001|Overall Study|Lack of Efficacy|1|||
27832099|NCT01773473|54310870|FG000|Overall Study|Non-Compliance with study drug|1|||
27832100|NCT01773473|54310871|FG001|Overall Study|Non-Compliance with study drug|4|||
27832101|NCT01773473|54310870|FG000|Overall Study|Withdrawal by Subject|5|||
27832102|NCT01773473|54310871|FG001|Overall Study|Withdrawal by Subject|3|||
27832103|NCT01773473|54310870|FG000|Overall Study|Lost to Follow-up|2|||
27832104|NCT01773473|54310871|FG001|Overall Study|Lost to Follow-up|0|||
27832105|NCT01772693|54310879|FG000|Overall Study|Health Concerns Unrelated to Study|2|||
27832106|NCT01772693|54310880|FG001|Overall Study|Health Concerns Unrelated to Study|1|||
27832107|NCT01772693|54310879|FG000|Overall Study|Withdrawal by Subject|2|||
27832108|NCT01772693|54310880|FG001|Overall Study|Withdrawal by Subject|0|||
27832109|NCT01772693|54310879|FG000|Overall Study|Alternative Treatment|2|||
27832110|NCT01772693|54310880|FG001|Overall Study|Alternative Treatment|0|||
27832111|NCT01779869|54310886|FG000|Overall Study|Physician Decision|2|||
27832112|NCT01772537|54310893|FG000|Overall Study|unsuccessful lumbar drain placement|1|||
27832113|NCT01772537|54310894|FG001|Overall Study|unsuccessful lumbar drain placement|0|||
27832114|NCT01772537|54310895|FG002|Overall Study|unsuccessful lumbar drain placement|0|||
27832115|NCT01772147|54310908|FG000|Overall Study|Adverse Event|13|||
27832116|NCT01772147|54310909|FG001|Overall Study|Adverse Event|10|||
27832117|NCT01772147|54310910|FG002|Overall Study|Adverse Event|6|||
27832118|NCT01772147|54310908|FG000|Overall Study|Withdrew Consent|7|||
27832119|NCT01772147|54310909|FG001|Overall Study|Withdrew Consent|8|||
27832120|NCT01772147|54310910|FG002|Overall Study|Withdrew Consent|4|||
27832121|NCT01772147|54310908|FG000|Overall Study|Lost to Follow-up|1|||
27832122|NCT01772147|54310909|FG001|Overall Study|Lost to Follow-up|0|||
27832123|NCT01772147|54310910|FG002|Overall Study|Lost to Follow-up|1|||
27832124|NCT01772147|54310908|FG000|Overall Study|Protocol Deviation|2|||
27948657|NCT01097616|54605771|FG003|DB RO Phase|Withdrawal by Subject|0|||
27948658|NCT01097616|54605772|FG004|DB RO Phase|Withdrawal by Subject|0|||
27948659|NCT01097616|54605773|FG005|DB RO Phase|Withdrawal by Subject|1|||
27948660|NCT01097616|54605774|FG006|DB RO Phase|Withdrawal by Subject|0|||
27948661|NCT01097616|54605775|FG007|DB RO Phase|Withdrawal by Subject|0|||
27948662|NCT01097616|54605768|FG000|DB RO Phase|Lost to Follow-up|0|||
27948663|NCT01097616|54605769|FG001|DB RO Phase|Lost to Follow-up|0|||
27948664|NCT01097616|54605770|FG002|DB RO Phase|Lost to Follow-up|0|||
27948665|NCT01097616|54605771|FG003|DB RO Phase|Lost to Follow-up|1|||
27948666|NCT01097616|54605772|FG004|DB RO Phase|Lost to Follow-up|1|||
27948667|NCT01097616|54605773|FG005|DB RO Phase|Lost to Follow-up|0|||
27948668|NCT01097616|54605774|FG006|DB RO Phase|Lost to Follow-up|0|||
27948669|NCT01097616|54605775|FG007|DB RO Phase|Lost to Follow-up|1|||
27948670|NCT01097616|54605768|FG000|DB RO Phase|Not Treated in RO|0|||
27948671|NCT01097616|54605769|FG001|DB RO Phase|Not Treated in RO|0|||
27948672|NCT01097616|54605770|FG002|DB RO Phase|Not Treated in RO|0|||
27948673|NCT01097616|54605771|FG003|DB RO Phase|Not Treated in RO|0|||
27948674|NCT01097616|54605772|FG004|DB RO Phase|Not Treated in RO|0|||
27948675|NCT01097616|54605773|FG005|DB RO Phase|Not Treated in RO|1|||
27948676|NCT01097616|54605774|FG006|DB RO Phase|Not Treated in RO|0|||
27948677|NCT01097616|54605775|FG007|DB RO Phase|Not Treated in RO|0|||
27948678|NCT00871429|54605801|FG000|Overall Study|Lost to Follow-up|6|||
27948679|NCT00871429|54605801|FG000|Overall Study|Withdrawal by Subject|17|||
27948680|NCT00871429|54605801|FG000|Overall Study|Questionnaire not completed|1|||
27948681|NCT01151345|54605809|FG000|First Intervention Period|Protocol Violation|0|||
27948682|NCT01151345|54605810|FG001|First Intervention Period|Protocol Violation|1|||
27948683|NCT00593827|54605818|FG000|Overall Study|On Active Treatment/Pending|0|||
27948684|NCT00593827|54605819|FG001|Overall Study|On Active Treatment/Pending|2|||
27948685|NCT01150097|54605828|FG000|Months 24 to 36 Post-transplantation|Death|2|||
27948686|NCT01150097|54605829|FG001|Months 24 to 36 Post-transplantation|Death|0|||
27948687|NCT01150097|54605830|FG002|Months 24 to 36 Post-transplantation|Death|0|||
27948688|NCT01150097|54605828|FG000|Months 24 to 36 Post-transplantation|Administrative problems|5|||
27948689|NCT01150097|54605829|FG001|Months 24 to 36 Post-transplantation|Administrative problems|2|||
27948690|NCT01150097|54605830|FG002|Months 24 to 36 Post-transplantation|Administrative problems|2|||
27948691|NCT01150097|54605828|FG000|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
27948692|NCT01150097|54605829|FG001|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
27948693|NCT01150097|54605830|FG002|Months 24 to 36 Post-transplantation|Lost to Follow-up|3|||
27948694|NCT01150097|54605828|FG000|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
27948695|NCT01150097|54605829|FG001|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0|||
27948696|NCT01150097|54605830|FG002|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
27948697|NCT01150097|54605828|FG000|Months 24 to 48 Post-transplantation|Administrative problems|5|||
27948698|NCT01150097|54605829|FG001|Months 24 to 48 Post-transplantation|Administrative problems|4|||
27948699|NCT01150097|54605830|FG002|Months 24 to 48 Post-transplantation|Administrative problems|0|||
27948700|NCT01150097|54605828|FG000|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4|||
27948701|NCT01150097|54605829|FG001|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
27948702|NCT01150097|54605830|FG002|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
27948703|NCT01150097|54605828|FG000|Months 24 to 48 Post-transplantation|Death|2|||
27948704|NCT01150097|54605829|FG001|Months 24 to 48 Post-transplantation|Death|0|||
27948705|NCT01150097|54605830|FG002|Months 24 to 48 Post-transplantation|Death|0|||
27948706|NCT01149863|54605840|FG000|Overall Study|Missing data or Not receiveing studydrug|3|||
27948707|NCT01149473|54605846|FG000|First Intervention|Adverse Event|1|||
27948708|NCT01149473|54605847|FG001|First Intervention|Adverse Event|1|||
27948709|NCT01149473|54605846|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
27948710|NCT01149473|54605847|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
27948711|NCT00872989|54605855|FG000|Overall Study|Adverse Event|7|||
27948712|NCT00872989|54605856|FG001|Overall Study|Adverse Event|15|||
27948713|NCT00872989|54605855|FG000|Overall Study|Withdrawal by Subject|8|||
27948714|NCT00872989|54605856|FG001|Overall Study|Withdrawal by Subject|5|||
27948715|NCT00872989|54605855|FG000|Overall Study|Progression/relapse|47|||
27948716|NCT00872989|54605856|FG001|Overall Study|Progression/relapse|35|||
27948717|NCT00872989|54605855|FG000|Overall Study|Not protocol specified|3|||
27948718|NCT00872989|54605856|FG001|Overall Study|Not protocol specified|8|||
27948719|NCT01148771|54605870|FG000|Washout Period|Withdrawal by Subject|0|||
27948720|NCT01148771|54605871|FG001|Washout Period|Withdrawal by Subject|1|||
27948721|NCT01148693|54605883|FG000|Overall Study|Attempts for cannulation were failed|13|||
27948722|NCT01148693|54605884|FG001|Overall Study|Attempts for cannulation were failed|10|||
28080799|NCT03560986|54734075|FG001|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35|||
27948723|NCT00872599|54605890|FG000|Second Washout Period|Adverse Event|1|||
27948724|NCT00872599|54605891|FG001|Second Washout Period|Adverse Event|1|||
27948725|NCT01148537|54605900|FG000|Overall Study|Withdrawal by Subject|1|||
27948726|NCT01148537|54605901|FG001|Overall Study|Withdrawal by Subject|0|||
27948727|NCT01148537|54605902|FG002|Overall Study|Withdrawal by Subject|2|||
28080800|NCT03560986|54734074|FG000|Treatment Period B/Follow-up Period 2|Adverse Event|1|||
27948728|NCT01148537|54605900|FG000|Overall Study|Adverse Event|2|||
27948729|NCT01148537|54605901|FG001|Overall Study|Adverse Event|0|||
27948730|NCT01148537|54605902|FG002|Overall Study|Adverse Event|1|||
27948731|NCT01148459|54605913|FG000|Overall Study|Serious Adverse Event|5|||
27948732|NCT01148459|54605914|FG001|Overall Study|Serious Adverse Event|4|||
27948733|NCT01148459|54605913|FG000|Overall Study|Withdrawal by Subject|1|||
27948734|NCT01148459|54605914|FG001|Overall Study|Withdrawal by Subject|0|||
27948735|NCT01148459|54605913|FG000|Overall Study|Migrated/moved from study area|3|||
27948736|NCT01148459|54605914|FG001|Overall Study|Migrated/moved from study area|6|||
27948737|NCT01148459|54605913|FG000|Overall Study|Lost to Follow-up|2|||
27948738|NCT01148459|54605914|FG001|Overall Study|Lost to Follow-up|0|||
27948739|NCT01148459|54605913|FG000|Overall Study|Refusal|1|||
27948740|NCT01148459|54605914|FG001|Overall Study|Refusal|0|||
27948741|NCT01148459|54605913|FG000|Overall Study|Failure to comply with study procedures|0|||
27948742|NCT01148459|54605914|FG001|Overall Study|Failure to comply with study procedures|1|||
27948743|NCT00872521|54605923|FG000|Completed PAD Induction|Patient choice|0|||
27948744|NCT00872521|54605924|FG001|Completed PAD Induction|Patient choice|1|||
27948745|NCT00872521|54605925|FG002|Completed PAD Induction|Patient choice|0|||
27948746|NCT00872521|54605923|FG000|Completed PAD Induction|Disease progression|0|||
27948747|NCT00872521|54605924|FG001|Completed PAD Induction|Disease progression|2|||
27948748|NCT00872521|54605925|FG002|Completed PAD Induction|Disease progression|0|||
27948749|NCT00872521|54605923|FG000|Completed PAD Induction|Adverse Event|4|||
27948750|NCT00872521|54605924|FG001|Completed PAD Induction|Adverse Event|0|||
27948751|NCT00872521|54605925|FG002|Completed PAD Induction|Adverse Event|0|||
27948752|NCT00872521|54605923|FG000|Completed PAD Induction|Death|1|||
27948753|NCT00872521|54605924|FG001|Completed PAD Induction|Death|1|||
27948754|NCT00872521|54605925|FG002|Completed PAD Induction|Death|0|||
27948755|NCT00872521|54605923|FG000|Primary Endpoint Analysis|Other|1|||
27948756|NCT00872521|54605924|FG001|Primary Endpoint Analysis|Other|2|||
27948757|NCT00872521|54605925|FG002|Primary Endpoint Analysis|Other|0|||
27948758|NCT00872521|54605923|FG000|Primary Endpoint Analysis|Patient choice|0|||
27948759|NCT00872521|54605924|FG001|Primary Endpoint Analysis|Patient choice|1|||
27948760|NCT00872521|54605925|FG002|Primary Endpoint Analysis|Patient choice|0|||
27948761|NCT00872521|54605923|FG000|Primary Endpoint Analysis|Efficacy data unavailable|0|||
27948762|NCT00872521|54605924|FG001|Primary Endpoint Analysis|Efficacy data unavailable|2|||
27948763|NCT00872521|54605925|FG002|Primary Endpoint Analysis|Efficacy data unavailable|0|||
27948764|NCT00872521|54605923|FG000|Primary Endpoint Analysis|Patient response missing|0|||
27948765|NCT00872521|54605924|FG001|Primary Endpoint Analysis|Patient response missing|0|||
27948766|NCT00872521|54605925|FG002|Primary Endpoint Analysis|Patient response missing|1|||
27948767|NCT00872521|54605923|FG000|Completed 3-month Follow up|Other|0|||
27948768|NCT00872521|54605924|FG001|Completed 3-month Follow up|Other|2|||
27948769|NCT00872521|54605925|FG002|Completed 3-month Follow up|Other|0|||
27948770|NCT00872521|54605923|FG000|Completed 3-month Follow up|Physician Decision|0|||
27948771|NCT00872521|54605924|FG001|Completed 3-month Follow up|Physician Decision|1|||
27948772|NCT00872521|54605925|FG002|Completed 3-month Follow up|Physician Decision|0|||
27948773|NCT00872521|54605923|FG000|Secondary Endpoint Analysis|Efficacy data unavailable|0|||
27948774|NCT00872521|54605924|FG001|Secondary Endpoint Analysis|Efficacy data unavailable|2|||
27832125|NCT01772147|54310909|FG001|Overall Study|Protocol Deviation|1|||
27832126|NCT01772147|54310910|FG002|Overall Study|Protocol Deviation|1|||
27832127|NCT01772147|54310908|FG000|Overall Study|Lack of Efficacy|8|||
27832128|NCT01772147|54310909|FG001|Overall Study|Lack of Efficacy|6|||
27832129|NCT01772147|54310910|FG002|Overall Study|Lack of Efficacy|6|||
27832130|NCT01771913|54310920|FG000|Overall Study|Withdrawal by Subject|1|||
27832131|NCT01771913|54310921|FG001|Overall Study|Withdrawal by Subject|0|||
27948775|NCT00872521|54605925|FG002|Secondary Endpoint Analysis|Efficacy data unavailable|1|||
27948776|NCT01148225|54605944|FG000|Overall Study|Other|185|||
27948777|NCT01190891|54605953|FG000|Overall Study|Protocol Violation|1|||
27948778|NCT01190891|54605954|FG001|Overall Study|Protocol Violation|0|||
28080801|NCT03560986|54734075|FG001|Treatment Period B/Follow-up Period 2|Adverse Event|0|||
27832132|NCT01606787|54310929|FG000|Overall Study|Withdrawal by Subject|4|||
27832133|NCT01606787|54310930|FG001|Overall Study|Withdrawal by Subject|5|||
27832134|NCT01606787|54310929|FG000|Overall Study|Surgery canceled|0|||
27832135|NCT01606787|54310930|FG001|Overall Study|Surgery canceled|2|||
27832136|NCT01778855|54310938|FG000|Overall Study|Death|0|||
27832137|NCT01778855|54310939|FG001|Overall Study|Death|1|||
27832138|NCT01777997|54310945|FG000|12 Week lead-in of no ART|Severe debilitation|2|||
27832139|NCT01777997|54310945|FG000|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1|||
27832140|NCT01777997|54310945|FG000|Weeks 48 to 72/96 on ART|Death|1|||
27948779|NCT01190891|54605953|FG000|Overall Study|Withdrawal by Subject|5|||
27948780|NCT01190891|54605954|FG001|Overall Study|Withdrawal by Subject|0|||
27948781|NCT00871975|54605960|FG000|Overall Study|Technical difficulty w155-1ith equipment|3|||
27948782|NCT00871975|54605960|FG000|Overall Study|Catheters could not be inserted|1|||
27948783|NCT00871975|54605960|FG000|Overall Study|Patient unable to void/insufficient vol|13|||
27948784|NCT00871975|54605960|FG000|Overall Study|Motion artifact, tracing uninterpretable|5|||
28164780|NCT02923349|54835361|FG000|Overall Study|Physician Decision|0|||
27948785|NCT01190813|54605966|FG000|Overall Study|Lost to Follow-up|1|||
27948786|NCT01190813|54605967|FG001|Overall Study|Lost to Follow-up|2|||
27948787|NCT01190813|54605966|FG000|Overall Study|Withdrawal by Subject|2|||
27948788|NCT01190813|54605967|FG001|Overall Study|Withdrawal by Subject|1|||
27948789|NCT01190813|54605966|FG000|Overall Study|Refused study treatment after randomized|1|||
27948790|NCT01190813|54605967|FG001|Overall Study|Refused study treatment after randomized|0|||
27948791|NCT01190813|54605966|FG000|Overall Study|Adverse Event|0|||
27948792|NCT01190813|54605967|FG001|Overall Study|Adverse Event|1|||
27948793|NCT00870727|54605989|FG000|Overall Study|Lost to Follow-up|0|||
27948794|NCT00870727|54605990|FG001|Overall Study|Lost to Follow-up|1|||
27948795|NCT00870727|54605989|FG000|Overall Study|Lack of Efficacy|1|||
27948796|NCT00870727|54605990|FG001|Overall Study|Lack of Efficacy|3|||
27948797|NCT00870727|54605989|FG000|Overall Study|Adverse Event|0|||
27948798|NCT00870727|54605990|FG001|Overall Study|Adverse Event|1|||
27948799|NCT01147055|54605996|FG000|First Intervention Period|Lost to Follow-up|1|||
27948800|NCT01147055|54605997|FG001|First Intervention Period|Lost to Follow-up|0|||
27948801|NCT01146665|54606005|FG000|Overall Study|Withdrawal by Subject|10|||
27948802|NCT01146665|54606006|FG001|Overall Study|Withdrawal by Subject|16|||
27948803|NCT01145885|54606021|FG000|Overall Study|Progressive Disease|7|||
27948804|NCT01190267|54606033|FG000|Overall Study|Adverse Event|10|||
27948805|NCT01190267|54606034|FG001|Overall Study|Adverse Event|0|||
27948806|NCT01190267|54606033|FG000|Overall Study|Treatment Failure|8|||
27948807|NCT01190267|54606034|FG001|Overall Study|Treatment Failure|2|||
27948808|NCT01190267|54606033|FG000|Overall Study|Lost to Follow-up|2|||
27948809|NCT01190267|54606034|FG001|Overall Study|Lost to Follow-up|0|||
27948810|NCT01190267|54606033|FG000|Overall Study|Withdrawal by Subject|13|||
27948811|NCT01190267|54606034|FG001|Overall Study|Withdrawal by Subject|1|||
27948812|NCT01190267|54606033|FG000|Overall Study|Protocol Violation|8|||
27948813|NCT01190267|54606034|FG001|Overall Study|Protocol Violation|1|||
27948814|NCT00869089|54606040|FG000|Overall Study|Lost to Follow-up|1|||
27948815|NCT00869089|54606040|FG000|Overall Study|Withdrawal by Subject|1|||
28164781|NCT02923349|54835362|FG001|Overall Study|Physician Decision|0|||
28164782|NCT02923349|54835363|FG002|Overall Study|Physician Decision|0|||
28164783|NCT02923349|54835364|FG003|Overall Study|Physician Decision|1|||
28164784|NCT02923349|54835365|FG004|Overall Study|Physician Decision|1|||
28164785|NCT02923349|54835366|FG005|Overall Study|Physician Decision|0|||
28164786|NCT02923349|54835367|FG006|Overall Study|Physician Decision|2|||
28164787|NCT02923349|54835361|FG000|Overall Study|Lost to Follow-up|0|||
28164788|NCT02923349|54835362|FG001|Overall Study|Lost to Follow-up|0|||
28164789|NCT02923349|54835363|FG002|Overall Study|Lost to Follow-up|3|||
28164790|NCT02923349|54835364|FG003|Overall Study|Lost to Follow-up|0|||
28164791|NCT02923349|54835365|FG004|Overall Study|Lost to Follow-up|1|||
28164792|NCT02923349|54835366|FG005|Overall Study|Lost to Follow-up|1|||
28164793|NCT02923349|54835367|FG006|Overall Study|Lost to Follow-up|0|||
28164794|NCT02923349|54835361|FG000|Overall Study|Death|1|||
28164795|NCT02923349|54835362|FG001|Overall Study|Death|0|||
28164796|NCT02923349|54835363|FG002|Overall Study|Death|2|||
28164797|NCT02923349|54835364|FG003|Overall Study|Death|4|||
28164798|NCT02923349|54835365|FG004|Overall Study|Death|2|||
28164799|NCT02923349|54835366|FG005|Overall Study|Death|3|||
28164800|NCT02923349|54835367|FG006|Overall Study|Death|0|||
28164801|NCT02521792|54835383|FG000|Overall Study|Study Terminated|6|||
28164802|NCT03020615|54835390|FG000|Overall Study|Physician Decision|3|||
28164803|NCT03020615|54835391|FG001|Overall Study|Physician Decision|1|||
27854745|NCT00082628|54371583|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43|||
27854746|NCT00082628|54371584|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
27854747|NCT00082628|54371585|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
27854748|NCT00082628|54371586|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
27948816|NCT00869089|54606040|FG000|Overall Study|Screen Fail|1|||
28164804|NCT03020615|54835392|FG002|Overall Study|Physician Decision|2|||
28164805|NCT03020615|54835390|FG000|Overall Study|Parent/guardian/patient choice|3|||
28164806|NCT03020615|54835391|FG001|Overall Study|Parent/guardian/patient choice|0|||
27948817|NCT01190189|54606044|FG000|Overall Study|Lost to Follow-up|4|||
27948818|NCT01190189|54606044|FG000|Overall Study|Withdrawal by Subject|1|||
28164807|NCT03020615|54835392|FG002|Overall Study|Parent/guardian/patient choice|4|||
28164808|NCT03020615|54835390|FG000|Overall Study|Screen failure|0|||
28164809|NCT03020615|54835391|FG001|Overall Study|Screen failure|0|||
28164810|NCT03020615|54835392|FG002|Overall Study|Screen failure|1|||
28164811|NCT03020615|54835390|FG000|Overall Study|Death|1|||
28164812|NCT03020615|54835391|FG001|Overall Study|Death|0|||
27948819|NCT01190189|54606044|FG000|Overall Study|Migrated/moved from study area|1|||
27948820|NCT00871117|54606050|FG000|Overall Study|Lost to Follow-up|5|||
27948821|NCT00871117|54606051|FG001|Overall Study|Lost to Follow-up|6|||
28164813|NCT03020615|54835392|FG002|Overall Study|Death|0|||
28164814|NCT03020615|54835390|FG000|Overall Study|Lost to Follow-up|0|||
28164815|NCT03020615|54835391|FG001|Overall Study|Lost to Follow-up|1|||
28164816|NCT03020615|54835392|FG002|Overall Study|Lost to Follow-up|0|||
28164817|NCT03020069|54835405|FG000|Overall Study|Lost to Follow-up|0|||
28164818|NCT03020069|54835406|FG001|Overall Study|Lost to Follow-up|1|||
28164819|NCT03693170|54835412|FG000|Overall Study|Disease Progression|48|||
28164820|NCT03693170|54835412|FG000|Overall Study|Adverse Event|16|||
28164821|NCT03693170|54835412|FG000|Overall Study|Physician Decision|6|||
28164822|NCT03693170|54835412|FG000|Overall Study|Protocol Violation|2|||
28164823|NCT03693170|54835412|FG000|Overall Study|Death|1|||
28164824|NCT03693170|54835412|FG000|Overall Study|Non compliance with study drug|1|||
28164825|NCT03693170|54835412|FG000|Overall Study|Withdrawal by Subject|1|||
28164826|NCT03021005|54835419|FG000|Overall Study|Lost to Follow-up|39|||
28164827|NCT03021005|54835420|FG001|Overall Study|Lost to Follow-up|26|||
28164828|NCT02914457|54835426|FG000|Overall Study|Withdrawal by Subject|1|||
28164829|NCT02914457|54835426|FG000|Overall Study|Physician Decision|1|||
28164830|NCT02914457|54835426|FG000|Overall Study|No veins available for lead placement|1|||
28164831|NCT02914457|54835426|FG000|Overall Study|Electrical instability of patient|1|||
27832141|NCT01777997|54310945|FG000|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1|||
27832142|NCT01770509|54310951|FG000|Overall Study|Injury|0|||
27832143|NCT01770509|54310952|FG001|Overall Study|Injury|1|||
27948822|NCT00871117|54606050|FG000|Overall Study|Other|0|||
27948823|NCT00871117|54606051|FG001|Overall Study|Other|4|||
27948824|NCT00870103|54606058|FG000|Overall Study|Physician Decision|2|||
27948825|NCT00870103|54606058|FG000|Overall Study|Lost to Follow-up|2|||
27948826|NCT01145417|54606077|FG000|Overall Study|Death|1|||
27948827|NCT01145417|54606078|FG001|Overall Study|Death|0|||
27948828|NCT01145417|54606077|FG000|Overall Study|Lost to Follow-up|2|||
27948829|NCT01145417|54606078|FG001|Overall Study|Lost to Follow-up|1|||
27948830|NCT01145417|54606077|FG000|Overall Study|Withdrawal by Subject|1|||
27948831|NCT01145417|54606078|FG001|Overall Study|Withdrawal by Subject|2|||
27948832|NCT01145417|54606077|FG000|Overall Study|Pregnancy|1|||
27948833|NCT01145417|54606078|FG001|Overall Study|Pregnancy|0|||
27948834|NCT01145417|54606077|FG000|Overall Study|Adverse Event|0|||
27948835|NCT01145417|54606078|FG001|Overall Study|Adverse Event|1|||
27948836|NCT01145417|54606077|FG000|Overall Study|Study terminated by sponsor|35|||
27948837|NCT01145417|54606078|FG001|Overall Study|Study terminated by sponsor|43|||
27948838|NCT01145417|54606077|FG000|Overall Study|Other|1|||
27948839|NCT01145417|54606078|FG001|Overall Study|Other|0|||
27948840|NCT01144715|54606086|FG000|Overall Study|Lost to Follow-up|2|||
27948841|NCT01144715|54606087|FG001|Overall Study|Lost to Follow-up|1|||
27948842|NCT01144715|54606086|FG000|Overall Study|Withdrawal by Subject|2|||
27948843|NCT01144715|54606087|FG001|Overall Study|Withdrawal by Subject|1|||
27948844|NCT01144715|54606086|FG000|Overall Study|Adverse Event|0|||
27948845|NCT01144715|54606087|FG001|Overall Study|Adverse Event|1|||
27948846|NCT01189487|54606093|FG000|Overall Study|Lack of Efficacy|2|||
27948847|NCT01189487|54606093|FG000|Overall Study|Adverse Event|1|||
27948848|NCT01106352|54606102|FG000|Overall Study|Subjects untreated|0|||
27948849|NCT01106352|54606103|FG001|Overall Study|Subjects untreated|0|||
27948850|NCT01106352|54606104|FG002|Overall Study|Subjects untreated|0|||
27948851|NCT01106352|54606105|FG003|Overall Study|Subjects untreated|3|||
27948852|NCT01106352|54606106|FG004|Overall Study|Subjects untreated|4|||
27948853|NCT01106352|54606102|FG000|Overall Study|Sponsor Decision|1|||
27948854|NCT01106352|54606103|FG001|Overall Study|Sponsor Decision|0|||
27948855|NCT01106352|54606104|FG002|Overall Study|Sponsor Decision|0|||
27948856|NCT01106352|54606105|FG003|Overall Study|Sponsor Decision|0|||
28164832|NCT02914457|54835426|FG000|Overall Study|ECG acquisition error due to sweating|1|||
28164833|NCT02914457|54835426|FG000|Overall Study|Protocol Violation|1|||
27832144|NCT01770509|54310951|FG000|Overall Study|Lost to Follow-up|1|||
27832145|NCT01770509|54310952|FG001|Overall Study|Lost to Follow-up|2|||
27832146|NCT01770353|54310960|FG000|Overall Study|Progressive disease|2|||
27832147|NCT01770353|54310961|FG001|Overall Study|Progressive disease|1|||
27832148|NCT01770353|54310960|FG000|Overall Study|Adverse Event|0|||
27832149|NCT01770353|54310961|FG001|Overall Study|Adverse Event|1|||
27832150|NCT01770353|54310960|FG000|Overall Study|Protocol Violation|1|||
27832151|NCT01770353|54310961|FG001|Overall Study|Protocol Violation|0|||
27832152|NCT01770353|54310960|FG000|Overall Study|Physician Decision|0|||
27832153|NCT01770353|54310961|FG001|Overall Study|Physician Decision|3|||
27832154|NCT01770353|54310960|FG000|Overall Study|Clinical deterioration|3|||
27832155|NCT01770353|54310961|FG001|Overall Study|Clinical deterioration|6|||
27832156|NCT01770353|54310960|FG000|Overall Study|Toxicity related diarrhoea + progression|0|||
27832157|NCT01770353|54310961|FG001|Overall Study|Toxicity related diarrhoea + progression|1|||
27832158|NCT01777763|54310977|FG000|Overall Study|Adverse Event|2|||
27832159|NCT01777763|54310978|FG001|Overall Study|Adverse Event|32|||
27948857|NCT01106352|54606106|FG004|Overall Study|Sponsor Decision|0|||
27948858|NCT01106352|54606102|FG000|Overall Study|Too ill to come in for the visit|0|||
27948859|NCT01106352|54606103|FG001|Overall Study|Too ill to come in for the visit|0|||
27948860|NCT01106352|54606104|FG002|Overall Study|Too ill to come in for the visit|1|||
27948861|NCT01106352|54606105|FG003|Overall Study|Too ill to come in for the visit|0|||
27948862|NCT01106352|54606106|FG004|Overall Study|Too ill to come in for the visit|0|||
27948863|NCT01106352|54606102|FG000|Overall Study|Lost to Follow-up|0|||
28164834|NCT02665052|54835434|FG000|Overall Study|Lost to Follow-up|1|||
28164835|NCT02665052|54835435|FG001|Overall Study|Lost to Follow-up|0|||
27948864|NCT01106352|54606103|FG001|Overall Study|Lost to Follow-up|0|||
27731632|NCT01359644|54179003|FG002|Treatment Period|Lack of Efficacy|0|||
27731633|NCT01359644|54179004|FG003|Treatment Period|Lack of Efficacy|0|||
27731634|NCT01359644|54179005|FG004|Treatment Period|Lack of Efficacy|0|||
27731635|NCT01359644|54179006|FG005|Treatment Period|Lack of Efficacy|0|||
27731636|NCT01359644|54179007|FG006|Treatment Period|Lack of Efficacy|0|||
27731637|NCT01359644|54179008|FG007|Treatment Period|Lack of Efficacy|0|||
27731638|NCT01359644|54179009|FG008|Treatment Period|Lack of Efficacy|0|||
27731639|NCT01359644|54179010|FG009|Treatment Period|Lack of Efficacy|0|||
27731640|NCT01359644|54179001|FG000|Treatment Period|Adverse Event|0|||
27731641|NCT01359644|54179002|FG001|Treatment Period|Adverse Event|0|||
27731642|NCT01359644|54179003|FG002|Treatment Period|Adverse Event|1|||
27731643|NCT01359644|54179004|FG003|Treatment Period|Adverse Event|0|||
27731644|NCT01359644|54179005|FG004|Treatment Period|Adverse Event|0|||
27731645|NCT01359644|54179006|FG005|Treatment Period|Adverse Event|1|||
27731646|NCT01359644|54179007|FG006|Treatment Period|Adverse Event|0|||
27731647|NCT01359644|54179008|FG007|Treatment Period|Adverse Event|0|||
27731648|NCT01359644|54179009|FG008|Treatment Period|Adverse Event|0|||
27731649|NCT01359644|54179010|FG009|Treatment Period|Adverse Event|0|||
27731650|NCT01359644|54179001|FG000|Treatment Period|Lost to Follow-up|0|||
27731651|NCT01359644|54179002|FG001|Treatment Period|Lost to Follow-up|0|||
27731652|NCT01359644|54179003|FG002|Treatment Period|Lost to Follow-up|0|||
27731653|NCT01359644|54179004|FG003|Treatment Period|Lost to Follow-up|0|||
27731654|NCT01359644|54179005|FG004|Treatment Period|Lost to Follow-up|0|||
27731655|NCT01359644|54179006|FG005|Treatment Period|Lost to Follow-up|1|||
27731656|NCT01359644|54179007|FG006|Treatment Period|Lost to Follow-up|0|||
27731657|NCT01359644|54179008|FG007|Treatment Period|Lost to Follow-up|0|||
27731658|NCT01359644|54179009|FG008|Treatment Period|Lost to Follow-up|0|||
27731659|NCT01359644|54179010|FG009|Treatment Period|Lost to Follow-up|0|||
27731660|NCT01359644|54179001|FG000|Follow-up Period|Withdrawal by Subject|0|||
27731661|NCT01359644|54179002|FG001|Follow-up Period|Withdrawal by Subject|0|||
27731662|NCT01359644|54179003|FG002|Follow-up Period|Withdrawal by Subject|0|||
27731663|NCT01359644|54179004|FG003|Follow-up Period|Withdrawal by Subject|0|||
27731664|NCT01359644|54179005|FG004|Follow-up Period|Withdrawal by Subject|0|||
27731665|NCT01359644|54179006|FG005|Follow-up Period|Withdrawal by Subject|1|||
27731666|NCT01359644|54179007|FG006|Follow-up Period|Withdrawal by Subject|0|||
27731667|NCT01359644|54179008|FG007|Follow-up Period|Withdrawal by Subject|0|||
27731668|NCT01359644|54179009|FG008|Follow-up Period|Withdrawal by Subject|0|||
27731669|NCT01359644|54179010|FG009|Follow-up Period|Withdrawal by Subject|0|||
27731670|NCT01359644|54179001|FG000|Follow-up Period|Lost to Follow-up|0|||
27731671|NCT01359644|54179002|FG001|Follow-up Period|Lost to Follow-up|0|||
27731672|NCT01359644|54179003|FG002|Follow-up Period|Lost to Follow-up|0|||
27731673|NCT01359644|54179004|FG003|Follow-up Period|Lost to Follow-up|0|||
27731674|NCT01359644|54179005|FG004|Follow-up Period|Lost to Follow-up|0|||
27731675|NCT01359644|54179006|FG005|Follow-up Period|Lost to Follow-up|0|||
27731676|NCT01359644|54179007|FG006|Follow-up Period|Lost to Follow-up|1|||
27731677|NCT01359644|54179008|FG007|Follow-up Period|Lost to Follow-up|2|||
27731678|NCT01359644|54179009|FG008|Follow-up Period|Lost to Follow-up|0|||
27731679|NCT01359644|54179010|FG009|Follow-up Period|Lost to Follow-up|0|||
27731680|NCT02603120|54179045|FG000|Double-Blind Treatment Phase|Withdrew consent|4|||
27948865|NCT01106352|54606104|FG002|Overall Study|Lost to Follow-up|0|||
27731681|NCT02603120|54179046|FG001|Double-Blind Treatment Phase|Withdrew consent|8|||
27731682|NCT02603120|54179045|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
27731683|NCT02603120|54179046|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
27731684|NCT02603120|54179045|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
27731685|NCT02603120|54179046|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
27731686|NCT02603120|54179045|FG000|Double-Blind Treatment Phase|Death|2|||
27731687|NCT02603120|54179046|FG001|Double-Blind Treatment Phase|Death|0|||
27731688|NCT02603120|54179045|FG000|Double-Blind Treatment Phase|Investigator's discretion|2|||
27731689|NCT02603120|54179046|FG001|Double-Blind Treatment Phase|Investigator's discretion|0|||
27731690|NCT02603120|54179045|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
27731691|NCT02603120|54179046|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
27731692|NCT02603120|54179045|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
27731693|NCT02603120|54179046|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
27731694|NCT02603120|54179045|FG000|Double-Blind Treatment Phase|Did not receive study drug|2|||
27731695|NCT02603120|54179046|FG001|Double-Blind Treatment Phase|Did not receive study drug|2|||
27731696|NCT02603120|54179045|FG000|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3|||
27731697|NCT02603120|54179046|FG001|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4|||
27731698|NCT02603120|54179045|FG000|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1|||
27948866|NCT01106352|54606105|FG003|Overall Study|Lost to Follow-up|0|||
27731699|NCT02603120|54179046|FG001|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2|||
27731700|NCT02603120|54179045|FG000|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1|||
27731701|NCT02603120|54179046|FG001|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2|||
27731702|NCT02603120|54179045|FG000|OL Extension B/F/TAF Treatment Phase|Adverse Event|0|||
27948867|NCT01106352|54606106|FG004|Overall Study|Lost to Follow-up|1|||
27948868|NCT01106352|54606102|FG000|Overall Study|Death|0|||
27948869|NCT01106352|54606103|FG001|Overall Study|Death|0|||
27948870|NCT01106352|54606104|FG002|Overall Study|Death|1|||
27948871|NCT01106352|54606105|FG003|Overall Study|Death|3|||
27948872|NCT01106352|54606106|FG004|Overall Study|Death|1|||
27948873|NCT01106352|54606102|FG000|Overall Study|Disease progression|0|||
27948874|NCT01106352|54606103|FG001|Overall Study|Disease progression|0|||
27948875|NCT01106352|54606104|FG002|Overall Study|Disease progression|0|||
27948876|NCT01106352|54606105|FG003|Overall Study|Disease progression|1|||
27948877|NCT01106352|54606106|FG004|Overall Study|Disease progression|0|||
27948878|NCT01106352|54606102|FG000|Overall Study|Withdrawal by Subject|0|||
27948879|NCT01106352|54606103|FG001|Overall Study|Withdrawal by Subject|0|||
27948880|NCT01106352|54606104|FG002|Overall Study|Withdrawal by Subject|0|||
27948881|NCT01106352|54606105|FG003|Overall Study|Withdrawal by Subject|3|||
27948882|NCT01106352|54606106|FG004|Overall Study|Withdrawal by Subject|2|||
27948883|NCT01106352|54606102|FG000|Overall Study|Went on hospice|0|||
27948884|NCT01106352|54606103|FG001|Overall Study|Went on hospice|0|||
27948885|NCT01106352|54606104|FG002|Overall Study|Went on hospice|0|||
27948886|NCT01106352|54606105|FG003|Overall Study|Went on hospice|1|||
27948887|NCT01106352|54606106|FG004|Overall Study|Went on hospice|0|||
27948888|NCT01106352|54606102|FG000|Overall Study|Subject entered hospice|0|||
27948889|NCT01106352|54606103|FG001|Overall Study|Subject entered hospice|0|||
27948890|NCT01106352|54606104|FG002|Overall Study|Subject entered hospice|0|||
27948891|NCT01106352|54606105|FG003|Overall Study|Subject entered hospice|1|||
27948892|NCT01106352|54606106|FG004|Overall Study|Subject entered hospice|0|||
27948893|NCT01106352|54606102|FG000|Overall Study|Home hospice since July 2013|0|||
27948894|NCT01106352|54606103|FG001|Overall Study|Home hospice since July 2013|0|||
27948895|NCT01106352|54606104|FG002|Overall Study|Home hospice since July 2013|0|||
27948896|NCT01106352|54606105|FG003|Overall Study|Home hospice since July 2013|1|||
27948897|NCT01106352|54606106|FG004|Overall Study|Home hospice since July 2013|0|||
27948898|NCT01144403|54606122|FG000|Overall Study|Lost to Follow-up|3|||
27948899|NCT01144403|54606122|FG000|Overall Study|Death|1|||
27948900|NCT01144403|54606122|FG000|Overall Study|Adverse Event|1|||
27948901|NCT01143389|54606129|FG000|Overall Study|Lost to Follow-up|26|||
27948902|NCT01143389|54606130|FG001|Overall Study|Lost to Follow-up|25|||
27948903|NCT00868231|54606136|FG000|Treatment Period 1|Adverse Event|0|||
27948904|NCT00868231|54606137|FG001|Treatment Period 1|Adverse Event|0|||
27948905|NCT00868231|54606138|FG002|Treatment Period 1|Adverse Event|0|||
27948906|NCT00868231|54606139|FG003|Treatment Period 1|Adverse Event|0|||
27948907|NCT00868231|54606140|FG004|Treatment Period 1|Adverse Event|1|||
27948908|NCT00868231|54606141|FG005|Treatment Period 1|Adverse Event|0|||
27948909|NCT00868231|54606136|FG000|Treatment Period 2|Adverse Event|1|||
27948910|NCT00868231|54606137|FG001|Treatment Period 2|Adverse Event|0|||
27948911|NCT00868231|54606138|FG002|Treatment Period 2|Adverse Event|0|||
27948912|NCT00868231|54606139|FG003|Treatment Period 2|Adverse Event|0|||
27948913|NCT00868231|54606140|FG004|Treatment Period 2|Adverse Event|0|||
27948914|NCT00868231|54606141|FG005|Treatment Period 2|Adverse Event|0|||
27948915|NCT00868231|54606136|FG000|Treatment Period 3|Adverse Event|0|||
27948916|NCT00868231|54606137|FG001|Treatment Period 3|Adverse Event|0|||
27948917|NCT00868231|54606138|FG002|Treatment Period 3|Adverse Event|1|||
27948918|NCT00868231|54606139|FG003|Treatment Period 3|Adverse Event|0|||
27948919|NCT00868231|54606140|FG004|Treatment Period 3|Adverse Event|0|||
27948920|NCT00868231|54606141|FG005|Treatment Period 3|Adverse Event|0|||
27948921|NCT01143077|54606152|FG000|Overall Study|Lack of Efficacy|0|||
27948922|NCT01143077|54606153|FG001|Overall Study|Lack of Efficacy|2|||
27948923|NCT01143077|54606154|FG002|Overall Study|Lack of Efficacy|1|||
27948924|NCT01143077|54606152|FG000|Overall Study|Adverse Event|5|||
27948925|NCT01143077|54606153|FG001|Overall Study|Adverse Event|6|||
27948926|NCT01143077|54606154|FG002|Overall Study|Adverse Event|5|||
27948927|NCT01143077|54606152|FG000|Overall Study|Lost to Follow-up|2|||
27948928|NCT01143077|54606153|FG001|Overall Study|Lost to Follow-up|3|||
27948929|NCT01143077|54606154|FG002|Overall Study|Lost to Follow-up|4|||
27948930|NCT01143077|54606152|FG000|Overall Study|Protocol Violation|2|||
27948931|NCT01143077|54606153|FG001|Overall Study|Protocol Violation|0|||
27948932|NCT01143077|54606154|FG002|Overall Study|Protocol Violation|0|||
27832160|NCT01777763|54310977|FG000|Overall Study|Protocol Violation|1|||
27832161|NCT01777763|54310978|FG001|Overall Study|Protocol Violation|7|||
27948933|NCT01143077|54606152|FG000|Overall Study|Withdrawal by Subject|4|||
27948934|NCT01143077|54606153|FG001|Overall Study|Withdrawal by Subject|3|||
27948935|NCT01143077|54606154|FG002|Overall Study|Withdrawal by Subject|3|||
27948936|NCT01143077|54606152|FG000|Overall Study|Non-compliance with study drug|0|||
27948937|NCT01143077|54606153|FG001|Overall Study|Non-compliance with study drug|1|||
27948938|NCT01143077|54606154|FG002|Overall Study|Non-compliance with study drug|1|||
27948939|NCT01143077|54606152|FG000|Overall Study|Administrative|1|||
28080802|NCT03560986|54734074|FG000|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0|||
27948940|NCT01143077|54606153|FG001|Overall Study|Administrative|0|||
27948941|NCT01143077|54606154|FG002|Overall Study|Administrative|0|||
27948942|NCT01143077|54606152|FG000|Overall Study|Principal Investigator Decision|2|||
27948943|NCT01143077|54606153|FG001|Overall Study|Principal Investigator Decision|0|||
27948944|NCT01143077|54606154|FG002|Overall Study|Principal Investigator Decision|1|||
27948945|NCT01096446|54606164|FG000|Overall Study|Death|1|||
27948946|NCT01096446|54606165|FG001|Overall Study|Death|0|||
27948947|NCT01096446|54606164|FG000|Overall Study|Protocol Violation|2|||
27948948|NCT01096446|54606165|FG001|Overall Study|Protocol Violation|0|||
27948949|NCT00864721|54606170|FG000|Overall Study|Patient request|11|||
27948950|NCT00864721|54606170|FG000|Overall Study|Hospitalized|1|||
27948951|NCT00864721|54606170|FG000|Overall Study|Drug hold/delay more than 4 weeks|1|||
27948952|NCT00864721|54606170|FG000|Overall Study|Adverse Event|21|||
27854749|NCT00082628|54371582|FG000|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1|||
27854750|NCT00082628|54371583|FG001|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15|||
27854751|NCT00082628|54371584|FG002|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
27854752|NCT00082628|54371585|FG003|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
27854753|NCT00082628|54371586|FG004|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
27854754|NCT00082628|54371582|FG000|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
27854755|NCT00082628|54371583|FG001|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
27854756|NCT00082628|54371584|FG002|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
27854757|NCT00082628|54371585|FG003|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
27854758|NCT00082628|54371586|FG004|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1|||
27854759|NCT00082628|54371582|FG000|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
27854760|NCT00082628|54371583|FG001|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
27854761|NCT00082628|54371584|FG002|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
27854762|NCT00082628|54371585|FG003|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1|||
27854763|NCT00082628|54371586|FG004|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
27854764|NCT00082628|54371582|FG000|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
27854765|NCT00082628|54371583|FG001|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
27854766|NCT00082628|54371584|FG002|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
27854767|NCT00082628|54371585|FG003|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
27854768|NCT00082628|54371586|FG004|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17|||
27854769|NCT02993263|54371942|FG000|Overall Study|Equipment Software failed and results were lost.|323|||
27948953|NCT01095666|54606177|FG000|Overall Study|Lack of Efficacy|0|||
27948954|NCT01095666|54606178|FG001|Overall Study|Lack of Efficacy|0|||
27948955|NCT01095666|54606179|FG002|Overall Study|Lack of Efficacy|1|||
27948956|NCT01095666|54606177|FG000|Overall Study|Adverse Event|2|||
27948957|NCT01095666|54606178|FG001|Overall Study|Adverse Event|1|||
27948958|NCT01095666|54606179|FG002|Overall Study|Adverse Event|3|||
27948959|NCT01095666|54606177|FG000|Overall Study|Lost to Follow-up|2|||
27948960|NCT01095666|54606178|FG001|Overall Study|Lost to Follow-up|2|||
27948961|NCT01095666|54606179|FG002|Overall Study|Lost to Follow-up|0|||
27948962|NCT01095666|54606177|FG000|Overall Study|Withdrawal by Subject|6|||
27948963|NCT01095666|54606178|FG001|Overall Study|Withdrawal by Subject|6|||
27854770|NCT01274533|54371970|FG000|Overall Study|Withdrawal by Subject|1|||
27854771|NCT01274533|54371970|FG000|Overall Study|Non-compliance|1|||
27948964|NCT01095666|54606179|FG002|Overall Study|Withdrawal by Subject|1|||
27948965|NCT01095666|54606177|FG000|Overall Study|Non-compliance, not met criteria etc.|7|||
27948966|NCT01095666|54606178|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
27948967|NCT01095666|54606179|FG002|Overall Study|Non-compliance, not met criteria etc.|2|||
27948968|NCT01100658|54606187|FG000|Overall Study|Withdrawal by Subject|1|||
27948969|NCT01100502|54606193|FG000|Overall Study|Withdrawal by Subject|18|||
27948970|NCT01100502|54606194|FG001|Overall Study|Withdrawal by Subject|25|||
27948971|NCT01100502|54606193|FG000|Overall Study|Lost to Follow-up|13|||
27948972|NCT01100502|54606194|FG001|Overall Study|Lost to Follow-up|28|||
27948973|NCT01100502|54606193|FG000|Overall Study|Site request to end participation in study|0|||
27948974|NCT01100502|54606194|FG001|Overall Study|Site request to end participation in study|1|||
27948975|NCT01100502|54606193|FG000|Overall Study|Death|45|||
27948976|NCT01100502|54606194|FG001|Overall Study|Death|40|||
27948977|NCT01094886|54606200|FG000|Overall Study|Adverse Event|2|||
27948978|NCT01094886|54606200|FG000|Overall Study|Withdrawal by Subject|5|||
27832162|NCT01777763|54310977|FG000|Overall Study|Withdrawal by Subject|0|||
27832163|NCT01777763|54310978|FG001|Overall Study|Withdrawal by Subject|2|||
27832164|NCT01777763|54310977|FG000|Overall Study|Treatment Failure|1|||
27832165|NCT01777763|54310978|FG001|Overall Study|Treatment Failure|6|||
27832166|NCT01769339|54310984|FG000|Overall Study|Lost to Follow-up|42|||
27832167|NCT01769339|54310984|FG000|Overall Study|Adverse Event|1|||
27832168|NCT01769105|54310990|FG000|First Intervention|Protocol Violation|2|||
27832169|NCT01769105|54310991|FG001|First Intervention|Protocol Violation|2|||
27948979|NCT01094808|54606207|FG000|Overall Study|Withdrawal by Subject|1|||
27948980|NCT01094808|54606208|FG001|Overall Study|Withdrawal by Subject|1|||
27948981|NCT01094808|54606209|FG002|Overall Study|Withdrawal by Subject|0|||
27832170|NCT01769105|54310990|FG000|Cross-over|Lost to Follow-up|5|||
27948982|NCT00864253|54606219|FG000|Overall Study|Adverse Event|56|||
27948983|NCT00864253|54606220|FG001|Overall Study|Adverse Event|11|||
27948984|NCT00864253|54606219|FG000|Overall Study|Unrelated Adverse Event|3|||
27948985|NCT00864253|54606220|FG001|Overall Study|Unrelated Adverse Event|1|||
27948986|NCT00864253|54606219|FG000|Overall Study|Physician Decision|11|||
27948987|NCT00864253|54606220|FG001|Overall Study|Physician Decision|15|||
27948988|NCT00864253|54606219|FG000|Overall Study|Protocol Violation|0|||
27948989|NCT00864253|54606220|FG001|Overall Study|Protocol Violation|2|||
27948990|NCT00864253|54606219|FG000|Overall Study|Lost to Follow-up|1|||
27948991|NCT00864253|54606220|FG001|Overall Study|Lost to Follow-up|1|||
27948992|NCT00864253|54606219|FG000|Overall Study|Withdrawal by Subject|18|||
27948993|NCT00864253|54606220|FG001|Overall Study|Withdrawal by Subject|18|||
27948994|NCT00864253|54606219|FG000|Overall Study|Death|1|||
27948995|NCT00864253|54606220|FG001|Overall Study|Death|0|||
27948996|NCT00864253|54606219|FG000|Overall Study|Ongoing|2|||
27948997|NCT00864253|54606220|FG001|Overall Study|Ongoing|3|||
27948998|NCT00864253|54606219|FG000|Overall Study|Untreated|7|||
27948999|NCT00864253|54606220|FG001|Overall Study|Untreated|7|||
27949000|NCT01094730|54606228|FG000|Period 1 (14 Days)|Lost to Follow-up|0|||
27949001|NCT01094730|54606229|FG001|Period 1 (14 Days)|Lost to Follow-up|1|||
27949002|NCT01094730|54606228|FG000|Period 1 (14 Days)|Withdrawal by Subject|0|||
27949003|NCT01094730|54606229|FG001|Period 1 (14 Days)|Withdrawal by Subject|1|||
27949004|NCT01094730|54606228|FG000|Period 1 (14 Days)|No time for the follow-up visit|1|||
27949005|NCT01094730|54606229|FG001|Period 1 (14 Days)|No time for the follow-up visit|0|||
27949006|NCT01094730|54606228|FG000|Period 1 (14 Days)|Unsatisfactory visual response|1|||
27949007|NCT01094730|54606229|FG001|Period 1 (14 Days)|Unsatisfactory visual response|0|||
27949008|NCT01094730|54606228|FG000|Period 2 (14 Days)|Protocol Violation|2|||
27949009|NCT01094730|54606229|FG001|Period 2 (14 Days)|Protocol Violation|0|||
27949010|NCT01094730|54606228|FG000|Period 2 (14 Days)|No time for the follow-up visit|1|||
27949011|NCT01094730|54606229|FG001|Period 2 (14 Days)|No time for the follow-up visit|0|||
27949012|NCT01094730|54606228|FG000|Period 2 (14 Days)|Adverse Event|0|||
27949013|NCT01094730|54606229|FG001|Period 2 (14 Days)|Adverse Event|1|||
27949014|NCT01094730|54606228|FG000|Period 2 (14 Days)|Unsatisfactory lens fitting|0|||
27949015|NCT01094730|54606229|FG001|Period 2 (14 Days)|Unsatisfactory lens fitting|1|||
27949016|NCT00864097|54606244|FG000|Overall Study|Death|0|||
27949017|NCT00864097|54606245|FG001|Overall Study|Death|1|||
27949018|NCT00864097|54606246|FG002|Overall Study|Death|0|||
27949019|NCT00864097|54606247|FG003|Overall Study|Death|0|||
27949020|NCT00864097|54606244|FG000|Overall Study|Adverse Event|6|||
27949021|NCT00864097|54606245|FG001|Overall Study|Adverse Event|8|||
27949022|NCT00864097|54606246|FG002|Overall Study|Adverse Event|11|||
27949023|NCT00864097|54606247|FG003|Overall Study|Adverse Event|9|||
27949024|NCT00864097|54606244|FG000|Overall Study|Lack of Efficacy|9|||
27949025|NCT00864097|54606245|FG001|Overall Study|Lack of Efficacy|3|||
27949026|NCT00864097|54606246|FG002|Overall Study|Lack of Efficacy|7|||
27949027|NCT00864097|54606247|FG003|Overall Study|Lack of Efficacy|2|||
27949028|NCT00864097|54606244|FG000|Overall Study|Lost to Follow-up|0|||
27949029|NCT00864097|54606245|FG001|Overall Study|Lost to Follow-up|1|||
27949030|NCT00864097|54606246|FG002|Overall Study|Lost to Follow-up|0|||
27949031|NCT00864097|54606247|FG003|Overall Study|Lost to Follow-up|1|||
27949032|NCT00864097|54606244|FG000|Overall Study|Withdrawal by Subject|15|||
27949033|NCT00864097|54606245|FG001|Overall Study|Withdrawal by Subject|11|||
27949034|NCT00864097|54606246|FG002|Overall Study|Withdrawal by Subject|11|||
27949035|NCT00864097|54606247|FG003|Overall Study|Withdrawal by Subject|12|||
27949036|NCT00864097|54606244|FG000|Overall Study|Protocol Violation|2|||
27949037|NCT00864097|54606245|FG001|Overall Study|Protocol Violation|1|||
27949038|NCT00864097|54606246|FG002|Overall Study|Protocol Violation|0|||
27949039|NCT00864097|54606247|FG003|Overall Study|Protocol Violation|1|||
27949040|NCT00864097|54606244|FG000|Overall Study|Terminated by sponsor|105|||
27949041|NCT00864097|54606245|FG001|Overall Study|Terminated by sponsor|112|||
27949042|NCT00864097|54606246|FG002|Overall Study|Terminated by sponsor|102|||
27949043|NCT00864097|54606247|FG003|Overall Study|Terminated by sponsor|99|||
27949044|NCT00864097|54606244|FG000|Overall Study|Randomized but not treated|2|||
27949045|NCT00864097|54606245|FG001|Overall Study|Randomized but not treated|0|||
27949046|NCT00864097|54606246|FG002|Overall Study|Randomized but not treated|1|||
27949047|NCT00864097|54606247|FG003|Overall Study|Randomized but not treated|0|||
27949048|NCT00864097|54606244|FG000|Overall Study|Other|0|||
27949049|NCT00864097|54606245|FG001|Overall Study|Other|0|||
27949050|NCT00864097|54606246|FG002|Overall Study|Other|0|||
27949051|NCT00864097|54606247|FG003|Overall Study|Other|1|||
27949052|NCT01183013|54606264|FG000|Overall Study|Adverse Event|6|||
27949053|NCT01183013|54606265|FG001|Overall Study|Adverse Event|8|||
27949054|NCT01183013|54606266|FG002|Overall Study|Adverse Event|5|||
27949055|NCT01183013|54606267|FG003|Overall Study|Adverse Event|5|||
27949056|NCT01183013|54606268|FG004|Overall Study|Adverse Event|10|||
27949057|NCT01183013|54606269|FG005|Overall Study|Adverse Event|10|||
27949058|NCT01183013|54606270|FG006|Overall Study|Adverse Event|6|||
27949059|NCT01183013|54606264|FG000|Overall Study|Lack of Efficacy|3|||
27949060|NCT01183013|54606265|FG001|Overall Study|Lack of Efficacy|2|||
27949061|NCT01183013|54606266|FG002|Overall Study|Lack of Efficacy|1|||
27949062|NCT01183013|54606267|FG003|Overall Study|Lack of Efficacy|2|||
27949063|NCT01183013|54606268|FG004|Overall Study|Lack of Efficacy|1|||
27949064|NCT01183013|54606269|FG005|Overall Study|Lack of Efficacy|2|||
27949065|NCT01183013|54606270|FG006|Overall Study|Lack of Efficacy|0|||
27949066|NCT01183013|54606264|FG000|Overall Study|Protocol Violation|5|||
27949067|NCT01183013|54606265|FG001|Overall Study|Protocol Violation|2|||
27949068|NCT01183013|54606266|FG002|Overall Study|Protocol Violation|4|||
27949069|NCT01183013|54606267|FG003|Overall Study|Protocol Violation|0|||
27949070|NCT01183013|54606268|FG004|Overall Study|Protocol Violation|4|||
27949071|NCT01183013|54606269|FG005|Overall Study|Protocol Violation|3|||
27949072|NCT01183013|54606270|FG006|Overall Study|Protocol Violation|3|||
27949073|NCT01183013|54606264|FG000|Overall Study|Lost to Follow-up|7|||
27949074|NCT01183013|54606265|FG001|Overall Study|Lost to Follow-up|3|||
27949075|NCT01183013|54606266|FG002|Overall Study|Lost to Follow-up|4|||
27949076|NCT01183013|54606267|FG003|Overall Study|Lost to Follow-up|3|||
27854772|NCT01274533|54371970|FG000|Overall Study|Disease progression|2|||
27854773|NCT01273597|54371974|FG000|Overall Study|Adverse Event|5|||
27854774|NCT01273597|54371974|FG000|Overall Study|Underwent Kidney Transplantation|2|||
27854775|NCT01273597|54371974|FG000|Overall Study|Reason Not Reported|1|||
27854776|NCT01273519|54371981|FG000|Overall Study|Adverse Event|3|||
27854777|NCT01273519|54371982|FG001|Overall Study|Adverse Event|0|||
27854778|NCT01273519|54371983|FG002|Overall Study|Adverse Event|0|||
27854779|NCT01273519|54371981|FG000|Overall Study|Lost to Follow-up|2|||
27854780|NCT01273519|54371982|FG001|Overall Study|Lost to Follow-up|1|||
27854781|NCT01273519|54371983|FG002|Overall Study|Lost to Follow-up|3|||
27949077|NCT01183013|54606268|FG004|Overall Study|Lost to Follow-up|2|||
27949078|NCT01183013|54606269|FG005|Overall Study|Lost to Follow-up|6|||
27949079|NCT01183013|54606270|FG006|Overall Study|Lost to Follow-up|5|||
27949080|NCT01183013|54606264|FG000|Overall Study|Withdrawal by Subject|9|||
27949081|NCT01183013|54606265|FG001|Overall Study|Withdrawal by Subject|13|||
27949082|NCT01183013|54606266|FG002|Overall Study|Withdrawal by Subject|10|||
27949083|NCT01183013|54606267|FG003|Overall Study|Withdrawal by Subject|8|||
27949084|NCT01183013|54606268|FG004|Overall Study|Withdrawal by Subject|7|||
27949085|NCT01183013|54606269|FG005|Overall Study|Withdrawal by Subject|9|||
27949086|NCT01183013|54606270|FG006|Overall Study|Withdrawal by Subject|10|||
27949087|NCT01183013|54606264|FG000|Overall Study|Reasons other than stated above|15|||
27949088|NCT01183013|54606265|FG001|Overall Study|Reasons other than stated above|11|||
27949089|NCT01183013|54606266|FG002|Overall Study|Reasons other than stated above|17|||
27949090|NCT01183013|54606267|FG003|Overall Study|Reasons other than stated above|12|||
27949091|NCT01183013|54606268|FG004|Overall Study|Reasons other than stated above|12|||
27949092|NCT01183013|54606269|FG005|Overall Study|Reasons other than stated above|15|||
27949093|NCT01183013|54606270|FG006|Overall Study|Reasons other than stated above|13|||
27949094|NCT01141283|54606294|FG000|Overall Study|Adverse Event|56|||
27949095|NCT01141283|54606294|FG000|Overall Study|Lost to Follow-up|4|||
27949096|NCT01141283|54606294|FG000|Overall Study|Withdrawal by Subject|14|||
27949097|NCT01141283|54606294|FG000|Overall Study|Administrative|4|||
27949098|NCT01141283|54606294|FG000|Overall Study|Lack of Efficacy|10|||
27949099|NCT00863707|54606300|FG000|Overall Study|Randomized, but drug not received|4|||
27949100|NCT00863707|54606301|FG001|Overall Study|Randomized, but drug not received|3|||
27949101|NCT01094184|54606309|FG000|Overall Study|Death|35|||
27949102|NCT01094184|54606310|FG001|Overall Study|Death|11|||
27949103|NCT01134731|54606319|FG000|Overall Study|Adverse Event|3|||
27949104|NCT01134731|54606320|FG001|Overall Study|Adverse Event|2|||
27949105|NCT01134731|54606321|FG002|Overall Study|Adverse Event|1|||
27949106|NCT01134731|54606319|FG000|Overall Study|Physician Decision|2|||
27949107|NCT01134731|54606320|FG001|Overall Study|Physician Decision|2|||
27949108|NCT01134731|54606321|FG002|Overall Study|Physician Decision|2|||
27949109|NCT01134731|54606319|FG000|Overall Study|Lack of Efficacy|0|||
27949110|NCT01134731|54606320|FG001|Overall Study|Lack of Efficacy|0|||
27949111|NCT01134731|54606321|FG002|Overall Study|Lack of Efficacy|1|||
27949112|NCT01134731|54606319|FG000|Overall Study|Withdrawal by Subject|3|||
27949113|NCT01134731|54606320|FG001|Overall Study|Withdrawal by Subject|3|||
27949114|NCT01134731|54606321|FG002|Overall Study|Withdrawal by Subject|1|||
27949115|NCT01134731|54606319|FG000|Overall Study|Lost to Follow-up|5|||
27949116|NCT01134731|54606320|FG001|Overall Study|Lost to Follow-up|4|||
27949117|NCT01134731|54606321|FG002|Overall Study|Lost to Follow-up|3|||
27949118|NCT01141205|54606332|FG000|Overall Study|Physician Decision|1|||
27949119|NCT01141205|54606333|FG001|Overall Study|Physician Decision|1|||
27949120|NCT01141205|54606332|FG000|Overall Study|Lost to Follow-up|1|||
27854782|NCT01273519|54371981|FG000|Overall Study|Lack of Efficacy|8|||
27854783|NCT01273519|54371982|FG001|Overall Study|Lack of Efficacy|3|||
27949121|NCT01141205|54606333|FG001|Overall Study|Lost to Follow-up|0|||
27854784|NCT01273519|54371983|FG002|Overall Study|Lack of Efficacy|4|||
27854785|NCT01273519|54371981|FG000|Overall Study|Other|6|||
27949122|NCT01141205|54606332|FG000|Overall Study|Withdrawal by Subject|1|||
27949123|NCT01141205|54606333|FG001|Overall Study|Withdrawal by Subject|1|||
27949124|NCT01140503|54606343|FG000|Overall Study|Withdrawal by Subject|1|||
27949125|NCT00863317|54606349|FG000|Overall Study|Lost to Follow-up|8|||
27949126|NCT00863317|54606350|FG001|Overall Study|Lost to Follow-up|9|||
27949127|NCT01200368|54606359|FG000|Infant Series|Adverse Event|2|||
27949128|NCT01200368|54606360|FG001|Infant Series|Adverse Event|2|||
27949129|NCT01200368|54606361|FG002|Infant Series|Adverse Event|3|||
27949130|NCT01200368|54606359|FG000|Infant Series|Withdrawal by Subject|0|||
27949131|NCT01200368|54606360|FG001|Infant Series|Withdrawal by Subject|2|||
27949132|NCT01200368|54606361|FG002|Infant Series|Withdrawal by Subject|2|||
27949133|NCT01200368|54606359|FG000|Infant Series|Did not meet entrance criteria|0|||
27949134|NCT01200368|54606360|FG001|Infant Series|Did not meet entrance criteria|1|||
27949135|NCT01200368|54606361|FG002|Infant Series|Did not meet entrance criteria|0|||
27949136|NCT01200368|54606359|FG000|Infant Series|Randomized, not vaccinated|0|||
27949137|NCT01200368|54606360|FG001|Infant Series|Randomized, not vaccinated|1|||
27949138|NCT01200368|54606361|FG002|Infant Series|Randomized, not vaccinated|1|||
27949139|NCT01200368|54606359|FG000|Infant Series|Other|1|||
27949140|NCT01200368|54606360|FG001|Infant Series|Other|0|||
27949141|NCT01200368|54606361|FG002|Infant Series|Other|0|||
27949142|NCT01200368|54606359|FG000|After Infant Series|Adverse Event|6|||
27949143|NCT01200368|54606360|FG001|After Infant Series|Adverse Event|6|||
27949144|NCT01200368|54606361|FG002|After Infant Series|Adverse Event|3|||
27949145|NCT01200368|54606359|FG000|After Infant Series|Withdrawal by Subject|10|||
27949146|NCT01200368|54606360|FG001|After Infant Series|Withdrawal by Subject|8|||
27949147|NCT01200368|54606361|FG002|After Infant Series|Withdrawal by Subject|4|||
27949148|NCT01200368|54606359|FG000|After Infant Series|Lost to Follow-up|1|||
27949149|NCT01200368|54606360|FG001|After Infant Series|Lost to Follow-up|0|||
27949150|NCT01200368|54606361|FG002|After Infant Series|Lost to Follow-up|0|||
27949151|NCT01200368|54606359|FG000|After Infant Series|Other|1|||
27949152|NCT01200368|54606360|FG001|After Infant Series|Other|2|||
27949153|NCT01200368|54606361|FG002|After Infant Series|Other|2|||
27949154|NCT01200368|54606359|FG000|Toddler Dose|Adverse Event|0|||
27949155|NCT01200368|54606360|FG001|Toddler Dose|Adverse Event|3|||
27949156|NCT01200368|54606361|FG002|Toddler Dose|Adverse Event|1|||
27949157|NCT01079130|54606382|FG000|Overall Study|Adverse Event|1|||
27949158|NCT01079130|54606383|FG001|Overall Study|Adverse Event|1|||
27949159|NCT01079130|54606384|FG002|Overall Study|Adverse Event|0|||
27949160|NCT01079130|54606385|FG003|Overall Study|Adverse Event|1|||
27949161|NCT01079130|54606386|FG004|Overall Study|Adverse Event|5|||
27949162|NCT01079130|54606387|FG005|Overall Study|Adverse Event|1|||
28080803|NCT03560986|54734075|FG001|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1|||
28080804|NCT03560986|54734074|FG000|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
28080805|NCT03560986|54734075|FG001|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
28080806|NCT03560518|54734090|FG000|Double Blind Treatment Period|Miscellaneous Reasons|1|||
28080807|NCT03560518|54734091|FG001|Double Blind Treatment Period|Miscellaneous Reasons|0|||
27731703|NCT02603120|54179046|FG001|OL Extension B/F/TAF Treatment Phase|Adverse Event|1|||
27949163|NCT01079130|54606382|FG000|Overall Study|Administrative problems|1|||
27949164|NCT01079130|54606383|FG001|Overall Study|Administrative problems|3|||
27949165|NCT01079130|54606384|FG002|Overall Study|Administrative problems|0|||
27949166|NCT01079130|54606385|FG003|Overall Study|Administrative problems|0|||
27949167|NCT01079130|54606386|FG004|Overall Study|Administrative problems|0|||
27949168|NCT01079130|54606387|FG005|Overall Study|Administrative problems|1|||
27949169|NCT01079130|54606382|FG000|Overall Study|Withdrawal by Subject|0|||
27949170|NCT01079130|54606383|FG001|Overall Study|Withdrawal by Subject|1|||
27949171|NCT01079130|54606384|FG002|Overall Study|Withdrawal by Subject|0|||
27949172|NCT01079130|54606385|FG003|Overall Study|Withdrawal by Subject|0|||
27949173|NCT01079130|54606386|FG004|Overall Study|Withdrawal by Subject|1|||
27949174|NCT01079130|54606387|FG005|Overall Study|Withdrawal by Subject|3|||
27949175|NCT01079130|54606382|FG000|Overall Study|Protocol deviation|0|||
27949176|NCT01079130|54606383|FG001|Overall Study|Protocol deviation|2|||
27949177|NCT01079130|54606384|FG002|Overall Study|Protocol deviation|1|||
27949178|NCT01079130|54606385|FG003|Overall Study|Protocol deviation|2|||
27949179|NCT01079130|54606386|FG004|Overall Study|Protocol deviation|0|||
27949180|NCT01079130|54606387|FG005|Overall Study|Protocol deviation|0|||
27949181|NCT01079130|54606382|FG000|Overall Study|Abnormal test procedure result(s)|0|||
27949182|NCT01079130|54606383|FG001|Overall Study|Abnormal test procedure result(s)|0|||
27949183|NCT01079130|54606384|FG002|Overall Study|Abnormal test procedure result(s)|0|||
27949184|NCT01079130|54606385|FG003|Overall Study|Abnormal test procedure result(s)|0|||
27949185|NCT01079130|54606386|FG004|Overall Study|Abnormal test procedure result(s)|1|||
27949186|NCT01079130|54606387|FG005|Overall Study|Abnormal test procedure result(s)|0|||
27832171|NCT01769105|54310991|FG001|Cross-over|Lost to Follow-up|0|||
27949187|NCT01079130|54606382|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
27832172|NCT01777139|54310999|FG000|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7|||
27949188|NCT01079130|54606383|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
27949189|NCT01079130|54606384|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
27949190|NCT01079130|54606385|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
27949191|NCT01079130|54606386|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
27949192|NCT01079130|54606387|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
27949193|NCT01079130|54606382|FG000|Overall Study|Lost to Follow-up|0|||
27949194|NCT01079130|54606383|FG001|Overall Study|Lost to Follow-up|0|||
27949195|NCT01079130|54606384|FG002|Overall Study|Lost to Follow-up|0|||
27949196|NCT01079130|54606385|FG003|Overall Study|Lost to Follow-up|0|||
27949197|NCT01079130|54606386|FG004|Overall Study|Lost to Follow-up|1|||
27949198|NCT01079130|54606387|FG005|Overall Study|Lost to Follow-up|0|||
27949199|NCT01078974|54606401|FG000|Overall Study|Adverse Event|3|||
27949200|NCT00869557|54606407|FG000|Randomized Phase|Lost to Follow-up|2|||
27949201|NCT00869557|54606408|FG001|Randomized Phase|Lost to Follow-up|1|||
27949202|NCT00869557|54606407|FG000|Randomized Phase|Investigator's Discretion|1|||
27949203|NCT00869557|54606408|FG001|Randomized Phase|Investigator's Discretion|0|||
27949204|NCT00869557|54606407|FG000|Randomized Phase|Withdrew Consent|0|||
27949205|NCT00869557|54606408|FG001|Randomized Phase|Withdrew Consent|1|||
27949206|NCT00869557|54606407|FG000|Extension Phase|Adverse Event|2|||
27949207|NCT00869557|54606408|FG001|Extension Phase|Adverse Event|2|||
27949208|NCT00869557|54606407|FG000|Extension Phase|Lack of Efficacy|1|||
27949209|NCT00869557|54606408|FG001|Extension Phase|Lack of Efficacy|0|||
27949210|NCT00869557|54606407|FG000|Extension Phase|Lost to Follow-up|3|||
27949211|NCT00869557|54606408|FG001|Extension Phase|Lost to Follow-up|1|||
27949212|NCT00869557|54606407|FG000|Extension Phase|Investigator's Discretion|2|||
27949213|NCT00869557|54606408|FG001|Extension Phase|Investigator's Discretion|0|||
27949214|NCT00869557|54606407|FG000|Extension Phase|Withdrew Consent|2|||
27949215|NCT00869557|54606408|FG001|Extension Phase|Withdrew Consent|0|||
27949216|NCT01200290|54606415|FG000|Treatment Period|Adverse Event|1|||
27949217|NCT01200290|54606415|FG000|Post-Treatment Follow-Up Period|Death|2|||
27949218|NCT01134263|54606424|FG000|Overall Study|Serious adverse event|2|||
27949219|NCT01134263|54606425|FG001|Overall Study|Serious adverse event|1|||
27949220|NCT01134263|54606426|FG002|Overall Study|Serious adverse event|1|||
27949221|NCT01134263|54606427|FG003|Overall Study|Serious adverse event|1|||
27949222|NCT01134263|54606428|FG004|Overall Study|Serious adverse event|1|||
27949223|NCT01134263|54606424|FG000|Overall Study|Other adverse event|1|||
27949224|NCT01134263|54606425|FG001|Overall Study|Other adverse event|2|||
27949225|NCT01134263|54606426|FG002|Overall Study|Other adverse event|5|||
27949226|NCT01134263|54606427|FG003|Overall Study|Other adverse event|3|||
27949227|NCT01134263|54606428|FG004|Overall Study|Other adverse event|0|||
27949228|NCT01134263|54606424|FG000|Overall Study|Protocol Violation|8|||
27949229|NCT01134263|54606425|FG001|Overall Study|Protocol Violation|7|||
27949230|NCT01134263|54606426|FG002|Overall Study|Protocol Violation|2|||
27949231|NCT01134263|54606427|FG003|Overall Study|Protocol Violation|4|||
27949232|NCT01134263|54606428|FG004|Overall Study|Protocol Violation|2|||
27949233|NCT01134263|54606424|FG000|Overall Study|Lost to Follow-up|4|||
27949234|NCT01134263|54606425|FG001|Overall Study|Lost to Follow-up|3|||
27949235|NCT01134263|54606426|FG002|Overall Study|Lost to Follow-up|5|||
27949236|NCT01134263|54606427|FG003|Overall Study|Lost to Follow-up|3|||
27949237|NCT01134263|54606428|FG004|Overall Study|Lost to Follow-up|1|||
27949238|NCT01134263|54606424|FG000|Overall Study|Withdrawal by Subject|8|||
27949239|NCT01134263|54606425|FG001|Overall Study|Withdrawal by Subject|6|||
27949240|NCT01134263|54606426|FG002|Overall Study|Withdrawal by Subject|16|||
27949241|NCT01134263|54606427|FG003|Overall Study|Withdrawal by Subject|7|||
27949242|NCT01134263|54606428|FG004|Overall Study|Withdrawal by Subject|5|||
27949243|NCT01134263|54606424|FG000|Overall Study|Enrolled, but not treated|1|||
27949244|NCT01134263|54606425|FG001|Overall Study|Enrolled, but not treated|1|||
27949245|NCT01134263|54606426|FG002|Overall Study|Enrolled, but not treated|0|||
27949246|NCT01134263|54606427|FG003|Overall Study|Enrolled, but not treated|1|||
27949247|NCT01134263|54606428|FG004|Overall Study|Enrolled, but not treated|0|||
27949248|NCT01199822|54606449|FG000|Overall Study|Investigator discontinued therapy|0|||
27949249|NCT01199822|54606450|FG001|Overall Study|Investigator discontinued therapy|1|||
27854786|NCT01273519|54371982|FG001|Overall Study|Other|1|||
27854787|NCT01273519|54371983|FG002|Overall Study|Other|1|||
27854788|NCT01272661|54372040|FG000|Overall Study|lost to followup/case closed/ no birth|126|||
27854789|NCT01272661|54372041|FG001|Overall Study|lost to followup/case closed/ no birth|209|||
27854790|NCT01272661|54372042|FG002|Overall Study|lost to followup/case closed/ no birth|72|||
27854791|NCT04276051|54372208|FG000|Overall Study|Lost to Follow-up|0|||
27854792|NCT04276051|54372209|FG001|Overall Study|Lost to Follow-up|1|||
27854793|NCT04276051|54372208|FG000|Overall Study|Physician Decision|0|||
27949250|NCT01199822|54606451|FG002|Overall Study|Investigator discontinued therapy|0|||
27949251|NCT01096056|54606468|FG000|Overall Study|Lost to Follow-up|0|||
27854794|NCT04276051|54372209|FG001|Overall Study|Physician Decision|1|||
27949252|NCT01096056|54606469|FG001|Overall Study|Lost to Follow-up|1|||
27949253|NCT00866359|54606477|FG000|Treatment Phase (Days 1 to 85)|Adverse Event|5|||
27949254|NCT00866359|54606478|FG001|Treatment Phase (Days 1 to 85)|Adverse Event|4|||
27949255|NCT00866359|54606479|FG002|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
27949256|NCT00866359|54606480|FG003|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
28080808|NCT03560518|54734092|FG002|Double Blind Treatment Period|Miscellaneous Reasons|0|||
27949257|NCT00866359|54606477|FG000|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3|||
28080809|NCT03560518|54734090|FG000|Double Blind Treatment Period|Study Terminated by the Sponsor|6|||
28080810|NCT03560518|54734091|FG001|Double Blind Treatment Period|Study Terminated by the Sponsor|9|||
27949258|NCT00866359|54606478|FG001|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
27949259|NCT00866359|54606479|FG002|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
27949260|NCT00866359|54606480|FG003|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
27949261|NCT00866359|54606477|FG000|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1|||
27949262|NCT00866359|54606478|FG001|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
27949263|NCT00866359|54606479|FG002|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
27949264|NCT00866359|54606480|FG003|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
27949265|NCT00866359|54606477|FG000|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
27854795|NCT04276051|54372208|FG000|Overall Study|Withdrawal by Subject|1|||
27854796|NCT04276051|54372209|FG001|Overall Study|Withdrawal by Subject|1|||
27854797|NCT00081770|54372469|FG000|Overall Study|Adverse Event|130|||
27854798|NCT00081770|54372470|FG001|Overall Study|Adverse Event|98|||
27854799|NCT00081770|54372471|FG002|Overall Study|Adverse Event|136|||
27854800|NCT00081770|54372469|FG000|Overall Study|Lack of Efficacy|262|||
27854801|NCT00081770|54372470|FG001|Overall Study|Lack of Efficacy|357|||
27854802|NCT00081770|54372471|FG002|Overall Study|Lack of Efficacy|211|||
27854803|NCT00081770|54372469|FG000|Overall Study|Lost to Follow-up|45|||
27949266|NCT00866359|54606478|FG001|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
27949267|NCT00866359|54606479|FG002|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
27949268|NCT00866359|54606480|FG003|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
27949269|NCT00866359|54606477|FG000|Treatment Phase (Days 1 to 85)|Other|1|||
27949270|NCT00866359|54606478|FG001|Treatment Phase (Days 1 to 85)|Other|0|||
27949271|NCT00866359|54606479|FG002|Treatment Phase (Days 1 to 85)|Other|0|||
27949272|NCT00866359|54606480|FG003|Treatment Phase (Days 1 to 85)|Other|0|||
27949273|NCT00866359|54606477|FG000|Extension Phase (Day 86 to 169)|Adverse Event|0|||
27949274|NCT00866359|54606478|FG001|Extension Phase (Day 86 to 169)|Adverse Event|0|||
27949275|NCT00866359|54606479|FG002|Extension Phase (Day 86 to 169)|Adverse Event|1|||
27949276|NCT00866359|54606480|FG003|Extension Phase (Day 86 to 169)|Adverse Event|3|||
27949277|NCT01199198|54606509|FG000|Overall Study|Adverse Event|3|||
27949278|NCT01199198|54606510|FG001|Overall Study|Adverse Event|0|||
27949279|NCT01199198|54606509|FG000|Overall Study|Lost to Follow-up|1|||
27949280|NCT01199198|54606510|FG001|Overall Study|Lost to Follow-up|5|||
27949281|NCT01199198|54606509|FG000|Overall Study|Withdrawal by Subject|1|||
27949282|NCT01199198|54606510|FG001|Overall Study|Withdrawal by Subject|2|||
27949283|NCT01199198|54606509|FG000|Overall Study|ICU Transfer|1|||
27949284|NCT01199198|54606510|FG001|Overall Study|ICU Transfer|2|||
27949285|NCT01199198|54606509|FG000|Overall Study|Hospice-care transfer|1|||
27949286|NCT01199198|54606510|FG001|Overall Study|Hospice-care transfer|2|||
27949287|NCT01095978|54606516|FG000|Overall Study|Did not take Klacid SR|2|||
27949288|NCT01095978|54606516|FG000|Overall Study|Adverse Event|1|||
27949289|NCT01134107|54606524|FG000|Period 1-First Treatment Intervention|Adverse Event|1|||
27949290|NCT01134107|54606525|FG001|Period 1-First Treatment Intervention|Adverse Event|0|||
27949291|NCT01134107|54606524|FG000|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
27949292|NCT01134107|54606525|FG001|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
27949293|NCT01134107|54606524|FG000|Period 1-First Treatment Intervention|Withdrawal by Subject|3|||
27949294|NCT01134107|54606525|FG001|Period 1-First Treatment Intervention|Withdrawal by Subject|4|||
27949295|NCT01134107|54606524|FG000|Period 1-First Treatment Intervention|Physician Decision|1|||
27949296|NCT01134107|54606525|FG001|Period 1-First Treatment Intervention|Physician Decision|0|||
27854804|NCT00081770|54372470|FG001|Overall Study|Lost to Follow-up|34|||
27854805|NCT00081770|54372471|FG002|Overall Study|Lost to Follow-up|45|||
27854806|NCT00081770|54372469|FG000|Overall Study|Protocol Violation|15|||
27854807|NCT00081770|54372470|FG001|Overall Study|Protocol Violation|10|||
27854808|NCT00081770|54372471|FG002|Overall Study|Protocol Violation|10|||
27854809|NCT00081770|54372469|FG000|Overall Study|Withdrawal by Subject|45|||
27854810|NCT00081770|54372470|FG001|Overall Study|Withdrawal by Subject|40|||
27854811|NCT00081770|54372471|FG002|Overall Study|Withdrawal by Subject|42|||
27949297|NCT01134107|54606524|FG000|Period 2-Second Treatment Intervention|Withdrawal by Subject|2|||
27949298|NCT01134107|54606525|FG001|Period 2-Second Treatment Intervention|Withdrawal by Subject|0|||
27949299|NCT01134107|54606524|FG000|Period 2-Second Treatment Intervention|Physician Decision|1|||
27949300|NCT01134107|54606525|FG001|Period 2-Second Treatment Intervention|Physician Decision|0|||
27949301|NCT01134107|54606524|FG000|Period 2-Second Treatment Intervention|Sponsor Decision|1|||
27949302|NCT01134107|54606525|FG001|Period 2-Second Treatment Intervention|Sponsor Decision|0|||
27731704|NCT02603120|54179045|FG000|OL Extension B/F/TAF Treatment Phase|Death|0|||
27854812|NCT00081770|54372469|FG000|Overall Study|Did not meet protocol eligibility|2|||
27854813|NCT00081770|54372470|FG001|Overall Study|Did not meet protocol eligibility|0|||
27949303|NCT01199042|54606531|FG000|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2|||
27949304|NCT01199042|54606531|FG000|At Home (3 Months)|Lost to Follow-up|1|||
27949305|NCT01198574|54606544|FG000|Overall Study|Resigned from schools|4|||
27949306|NCT01198574|54606545|FG001|Overall Study|Resigned from schools|1|||
27854814|NCT00081770|54372471|FG002|Overall Study|Did not meet protocol eligibility|3|||
27854815|NCT00081770|54372469|FG000|Overall Study|Administrative|1|||
27854816|NCT00081770|54372470|FG001|Overall Study|Administrative|0|||
27949307|NCT01198574|54606546|FG002|Overall Study|Resigned from schools|1|||
27949308|NCT01198574|54606547|FG003|Overall Study|Resigned from schools|4|||
27949309|NCT01198028|54606557|FG000|Overall Study|Adverse Event|5|||
27949310|NCT01198028|54606557|FG000|Overall Study|Death|3|||
27949311|NCT01198028|54606557|FG000|Overall Study|Physician Decision|2|||
27949312|NCT01197950|54606564|FG000|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
27949313|NCT01197950|54606565|FG001|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
27949314|NCT01197950|54606566|FG002|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|18|||
27949315|NCT01092780|54606574|FG000|Washout Period 1|Adverse Event|0|||
27949316|NCT01092780|54606575|FG001|Washout Period 1|Adverse Event|1|||
27949317|NCT01092780|54606576|FG002|Washout Period 1|Adverse Event|0|||
27949318|NCT01092780|54606577|FG003|Washout Period 1|Adverse Event|0|||
27949319|NCT01092780|54606574|FG000|Washout Period 1|Noncompliance with nCPAP|1|||
27949320|NCT01092780|54606575|FG001|Washout Period 1|Noncompliance with nCPAP|0|||
27949321|NCT01092780|54606576|FG002|Washout Period 1|Noncompliance with nCPAP|0|||
27949322|NCT01092780|54606577|FG003|Washout Period 1|Noncompliance with nCPAP|0|||
27949323|NCT01092780|54606574|FG000|Washout Period 2|Adverse Event|0|||
27949324|NCT01092780|54606575|FG001|Washout Period 2|Adverse Event|1|||
27949325|NCT01092780|54606576|FG002|Washout Period 2|Adverse Event|1|||
27949326|NCT01092780|54606577|FG003|Washout Period 2|Adverse Event|0|||
27854817|NCT00081770|54372471|FG002|Overall Study|Administrative|1|||
27854818|NCT00081770|54372469|FG000|Overall Study|Other|2|||
27854819|NCT00081770|54372470|FG001|Overall Study|Other|7|||
27854820|NCT00081770|54372471|FG002|Overall Study|Other|8|||
27854821|NCT00081458|54372571|FG000|Overall Study|Adverse Event|1|||
27854822|NCT00081458|54372572|FG001|Overall Study|Adverse Event|5|||
27854823|NCT00081458|54372573|FG002|Overall Study|Adverse Event|2|||
27854824|NCT00081458|54372571|FG000|Overall Study|Withdrawal by Subject|0|||
27949327|NCT01092702|54606587|FG000|Overall Study|Withdrawal by Subject|7|||
27949328|NCT01092702|54606587|FG000|Overall Study|Lost to Follow-up|2|||
27949329|NCT01092546|54606591|FG000|Overall Study|Subjects withdrawn prior to dosing|4|||
27949330|NCT01197794|54606602|FG000|Overall Study|Adverse Event|3|||
27832173|NCT01777139|54311000|FG001|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0|||
27832174|NCT01777139|54310999|FG000|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6|||
27832175|NCT01777139|54311000|FG001|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0|||
27832176|NCT01777139|54310999|FG000|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8|||
27832177|NCT01777139|54311000|FG001|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0|||
27832178|NCT01777139|54310999|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3|||
27832179|NCT01777139|54311000|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0|||
27832180|NCT01777139|54310999|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2|||
27832181|NCT01777139|54311000|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0|||
27832182|NCT01777139|54310999|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4|||
27832183|NCT01777139|54311000|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0|||
27832184|NCT01777139|54310999|FG000|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0|||
27832185|NCT01777139|54311000|FG001|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1|||
27832186|NCT01777139|54310999|FG000|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0|||
27832187|NCT01777139|54311000|FG001|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3|||
27832188|NCT01768637|54311009|FG000|Overall Study|Lost to Follow-up|2|||
27832189|NCT01768637|54311010|FG001|Overall Study|Lost to Follow-up|7|||
27832190|NCT01768637|54311009|FG000|Overall Study|Difficult blood draw|1|||
27832191|NCT01768637|54311010|FG001|Overall Study|Difficult blood draw|0|||
27832192|NCT01768559|54311019|FG000|Overall Study|Randomized but not treated|0|||
27832193|NCT01768559|54311020|FG001|Overall Study|Randomized but not treated|0|||
27832194|NCT01768559|54311021|FG002|Overall Study|Randomized but not treated|1|||
27832195|NCT01768559|54311019|FG000|Overall Study|Adverse Event|15|||
27832196|NCT01768559|54311020|FG001|Overall Study|Adverse Event|2|||
27832197|NCT01768559|54311021|FG002|Overall Study|Adverse Event|5|||
27832198|NCT01768559|54311019|FG000|Overall Study|Lack of Efficacy|6|||
27832199|NCT01768559|54311020|FG001|Overall Study|Lack of Efficacy|4|||
27832200|NCT01768559|54311021|FG002|Overall Study|Lack of Efficacy|0|||
27832201|NCT01768559|54311019|FG000|Overall Study|Poor compliance to protocol|0|||
27832202|NCT01768559|54311020|FG001|Overall Study|Poor compliance to protocol|3|||
27832203|NCT01768559|54311021|FG002|Overall Study|Poor compliance to protocol|2|||
27832204|NCT01768559|54311019|FG000|Overall Study|Other than specified|9|||
27832205|NCT01768559|54311020|FG001|Overall Study|Other than specified|8|||
27832206|NCT01768559|54311021|FG002|Overall Study|Other than specified|5|||
27832207|NCT00983619|54311045|FG000|Overall Study|Lost to Follow-up|0|||
27832208|NCT00983619|54311046|FG001|Overall Study|Lost to Follow-up|1|||
27832209|NCT00983619|54311047|FG002|Overall Study|Lost to Follow-up|0|||
27854825|NCT00081458|54372572|FG001|Overall Study|Withdrawal by Subject|3|||
27854826|NCT00081458|54372573|FG002|Overall Study|Withdrawal by Subject|1|||
27949331|NCT01197794|54606603|FG001|Overall Study|Adverse Event|2|||
27949332|NCT01197794|54606604|FG002|Overall Study|Adverse Event|4|||
27949333|NCT01197794|54606605|FG003|Overall Study|Adverse Event|4|||
27949334|NCT01197794|54606606|FG004|Overall Study|Adverse Event|4|||
27949335|NCT01197794|54606607|FG005|Overall Study|Adverse Event|2|||
27949336|NCT01197794|54606608|FG006|Overall Study|Adverse Event|3|||
27949337|NCT01197794|54606602|FG000|Overall Study|Protocol Violation|0|||
27949338|NCT01197794|54606603|FG001|Overall Study|Protocol Violation|0|||
27949339|NCT01197794|54606604|FG002|Overall Study|Protocol Violation|0|||
27949340|NCT01197794|54606605|FG003|Overall Study|Protocol Violation|0|||
27949341|NCT01197794|54606606|FG004|Overall Study|Protocol Violation|2|||
27949342|NCT01197794|54606607|FG005|Overall Study|Protocol Violation|0|||
27949343|NCT01197794|54606608|FG006|Overall Study|Protocol Violation|1|||
27949344|NCT01197794|54606602|FG000|Overall Study|Development of study withdrawal criteria|3|||
27949345|NCT01197794|54606603|FG001|Overall Study|Development of study withdrawal criteria|0|||
27949346|NCT01197794|54606604|FG002|Overall Study|Development of study withdrawal criteria|0|||
27949347|NCT01197794|54606605|FG003|Overall Study|Development of study withdrawal criteria|1|||
27949348|NCT01197794|54606606|FG004|Overall Study|Development of study withdrawal criteria|0|||
27949349|NCT01197794|54606607|FG005|Overall Study|Development of study withdrawal criteria|0|||
27949350|NCT01197794|54606608|FG006|Overall Study|Development of study withdrawal criteria|1|||
27949351|NCT01197794|54606602|FG000|Overall Study|Eligibility criteria not fulfilled|5|||
27949352|NCT01197794|54606603|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
27949353|NCT01197794|54606604|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
27949354|NCT01197794|54606605|FG003|Overall Study|Eligibility criteria not fulfilled|5|||
27949355|NCT01197794|54606606|FG004|Overall Study|Eligibility criteria not fulfilled|5|||
27949356|NCT01197794|54606607|FG005|Overall Study|Eligibility criteria not fulfilled|9|||
27949357|NCT01197794|54606608|FG006|Overall Study|Eligibility criteria not fulfilled|6|||
27949358|NCT01197794|54606602|FG000|Overall Study|Withdrawal by Subject|3|||
27949359|NCT01197794|54606603|FG001|Overall Study|Withdrawal by Subject|3|||
27949360|NCT01197794|54606604|FG002|Overall Study|Withdrawal by Subject|4|||
27949361|NCT01197794|54606605|FG003|Overall Study|Withdrawal by Subject|1|||
27949362|NCT01197794|54606606|FG004|Overall Study|Withdrawal by Subject|1|||
27949363|NCT01197794|54606607|FG005|Overall Study|Withdrawal by Subject|5|||
27949364|NCT01197794|54606608|FG006|Overall Study|Withdrawal by Subject|6|||
27949365|NCT01197794|54606602|FG000|Overall Study|Lost to Follow-up|1|||
27949366|NCT01197794|54606603|FG001|Overall Study|Lost to Follow-up|1|||
27949367|NCT01197794|54606604|FG002|Overall Study|Lost to Follow-up|0|||
27949368|NCT01197794|54606605|FG003|Overall Study|Lost to Follow-up|1|||
27949369|NCT01197794|54606606|FG004|Overall Study|Lost to Follow-up|0|||
27949370|NCT01197794|54606607|FG005|Overall Study|Lost to Follow-up|1|||
27949371|NCT01197794|54606608|FG006|Overall Study|Lost to Follow-up|0|||
27949372|NCT01197794|54606602|FG000|Overall Study|Other|1|||
27949373|NCT01197794|54606603|FG001|Overall Study|Other|1|||
27949374|NCT01197794|54606604|FG002|Overall Study|Other|3|||
27949375|NCT01197794|54606605|FG003|Overall Study|Other|0|||
27949376|NCT01197794|54606606|FG004|Overall Study|Other|2|||
27949377|NCT01197794|54606607|FG005|Overall Study|Other|2|||
27949378|NCT01197794|54606608|FG006|Overall Study|Other|4|||
27949379|NCT01078662|54606630|FG000|Overall Study|Death|41|||
27949380|NCT01078662|54606631|FG001|Overall Study|Death|103|||
27949381|NCT01078662|54606632|FG002|Overall Study|Death|18|||
27949382|NCT01078662|54606633|FG003|Overall Study|Death|5|||
27949383|NCT01078662|54606634|FG004|Overall Study|Death|8|||
27949384|NCT01078662|54606630|FG000|Overall Study|Patients reached data cut-off|12|||
27949385|NCT01078662|54606631|FG001|Overall Study|Patients reached data cut-off|53|||
27949386|NCT01078662|54606632|FG002|Overall Study|Patients reached data cut-off|2|||
27949387|NCT01078662|54606633|FG003|Overall Study|Patients reached data cut-off|2|||
27949388|NCT01078662|54606634|FG004|Overall Study|Patients reached data cut-off|3|||
27949389|NCT01078662|54606630|FG000|Overall Study|Withdrawal by Subject|4|||
27949390|NCT01078662|54606631|FG001|Overall Study|Withdrawal by Subject|11|||
27949391|NCT01078662|54606632|FG002|Overall Study|Withdrawal by Subject|1|||
27949392|NCT01078662|54606633|FG003|Overall Study|Withdrawal by Subject|0|||
27949393|NCT01078662|54606634|FG004|Overall Study|Withdrawal by Subject|0|||
27949394|NCT01078662|54606630|FG000|Overall Study|Protocol Violation|0|||
27949395|NCT01078662|54606631|FG001|Overall Study|Protocol Violation|1|||
27949396|NCT01078662|54606632|FG002|Overall Study|Protocol Violation|0|||
27949397|NCT01078662|54606633|FG003|Overall Study|Protocol Violation|0|||
27949398|NCT01078662|54606634|FG004|Overall Study|Protocol Violation|0|||
27949399|NCT01078662|54606630|FG000|Overall Study|Lost to Follow-up|1|||
27949400|NCT01078662|54606631|FG001|Overall Study|Lost to Follow-up|0|||
27949401|NCT01078662|54606632|FG002|Overall Study|Lost to Follow-up|0|||
27832210|NCT00983619|54311048|FG003|Overall Study|Lost to Follow-up|0|||
27949402|NCT01078662|54606633|FG003|Overall Study|Lost to Follow-up|0|||
27949403|NCT01078662|54606634|FG004|Overall Study|Lost to Follow-up|0|||
27949404|NCT01091454|54606643|FG000|Overall Study|Ineligible|1|||
27949405|NCT01140347|54606649|FG000|Overall Study|Lost to Follow-up|5|||
27949406|NCT01140347|54606650|FG001|Overall Study|Lost to Follow-up|6|||
27949407|NCT01140347|54606649|FG000|Overall Study|Withdrawal by Subject|13|||
27949408|NCT01140347|54606650|FG001|Overall Study|Withdrawal by Subject|8|||
27949409|NCT01197560|54606658|FG000|Overall Study|Adverse Event|6|||
27949410|NCT01197560|54606659|FG001|Overall Study|Adverse Event|8|||
27949411|NCT01197560|54606658|FG000|Overall Study|Death|3|||
27949412|NCT01197560|54606659|FG001|Overall Study|Death|5|||
27949413|NCT01197560|54606658|FG000|Overall Study|Withdrawal by Subject|1|||
27949414|NCT01197560|54606659|FG001|Overall Study|Withdrawal by Subject|1|||
27949415|NCT01197560|54606658|FG000|Overall Study|Disease progression|40|||
27949416|NCT01197560|54606659|FG001|Overall Study|Disease progression|35|||
27949417|NCT01197560|54606658|FG000|Overall Study|Miscellaneous|4|||
27949418|NCT01197560|54606659|FG001|Overall Study|Miscellaneous|3|||
27949419|NCT01197560|54606658|FG000|Overall Study|Missing|0|||
27949420|NCT01197560|54606659|FG001|Overall Study|Missing|1|||
27949421|NCT01133405|54606676|FG000|Period 1|Withdrawal by Subject|0|||
27949422|NCT01133405|54606677|FG001|Period 1|Withdrawal by Subject|1|||
27949423|NCT01133405|54606678|FG002|Period 1|Withdrawal by Subject|0|||
27949424|NCT01133405|54606679|FG003|Period 1|Withdrawal by Subject|1|||
27949425|NCT01133405|54606680|FG004|Period 1|Withdrawal by Subject|0|||
27949426|NCT01133405|54606681|FG005|Period 1|Withdrawal by Subject|1|||
27949427|NCT01133405|54606682|FG006|Period 1|Withdrawal by Subject|0|||
27949428|NCT01133405|54606683|FG007|Period 1|Withdrawal by Subject|0|||
27949429|NCT01133405|54606684|FG008|Period 1|Withdrawal by Subject|0|||
27949430|NCT01133405|54606685|FG009|Period 1|Withdrawal by Subject|0|||
27949431|NCT01133405|54606676|FG000|Period 1|Physician Decision|0|||
27949432|NCT01133405|54606677|FG001|Period 1|Physician Decision|0|||
27949433|NCT01133405|54606678|FG002|Period 1|Physician Decision|0|||
27949434|NCT01133405|54606679|FG003|Period 1|Physician Decision|1|||
27949435|NCT01133405|54606680|FG004|Period 1|Physician Decision|0|||
27949436|NCT01133405|54606681|FG005|Period 1|Physician Decision|0|||
27949437|NCT01133405|54606682|FG006|Period 1|Physician Decision|0|||
27949438|NCT01133405|54606683|FG007|Period 1|Physician Decision|0|||
27949439|NCT01133405|54606684|FG008|Period 1|Physician Decision|0|||
27949440|NCT01133405|54606685|FG009|Period 1|Physician Decision|0|||
27949441|NCT01133405|54606676|FG000|Period 1|Discontinued after randomization|1|||
27949442|NCT01133405|54606677|FG001|Period 1|Discontinued after randomization|0|||
27949443|NCT01133405|54606678|FG002|Period 1|Discontinued after randomization|0|||
27949444|NCT01133405|54606679|FG003|Period 1|Discontinued after randomization|0|||
27949445|NCT01133405|54606680|FG004|Period 1|Discontinued after randomization|0|||
27949446|NCT01133405|54606681|FG005|Period 1|Discontinued after randomization|0|||
27949447|NCT01133405|54606682|FG006|Period 1|Discontinued after randomization|1|||
27949448|NCT01133405|54606683|FG007|Period 1|Discontinued after randomization|0|||
27949449|NCT01133405|54606684|FG008|Period 1|Discontinued after randomization|0|||
27949450|NCT01133405|54606685|FG009|Period 1|Discontinued after randomization|0|||
27949451|NCT01133405|54606676|FG000|Period 1|Received drug only in period 2|0|||
27949452|NCT01133405|54606677|FG001|Period 1|Received drug only in period 2|1|||
27949453|NCT01133405|54606678|FG002|Period 1|Received drug only in period 2|0|||
27949454|NCT01133405|54606679|FG003|Period 1|Received drug only in period 2|2|||
27949455|NCT01133405|54606680|FG004|Period 1|Received drug only in period 2|0|||
27949456|NCT01133405|54606681|FG005|Period 1|Received drug only in period 2|1|||
27949457|NCT01133405|54606682|FG006|Period 1|Received drug only in period 2|0|||
27949458|NCT01133405|54606683|FG007|Period 1|Received drug only in period 2|0|||
27949459|NCT01133405|54606684|FG008|Period 1|Received drug only in period 2|0|||
27949460|NCT01133405|54606685|FG009|Period 1|Received drug only in period 2|0|||
27949461|NCT01133405|54606676|FG000|Period 1|Received drug only in period 3|0|||
27949462|NCT01133405|54606677|FG001|Period 1|Received drug only in period 3|1|||
27949463|NCT01133405|54606678|FG002|Period 1|Received drug only in period 3|1|||
27949464|NCT01133405|54606679|FG003|Period 1|Received drug only in period 3|0|||
27949465|NCT01133405|54606680|FG004|Period 1|Received drug only in period 3|0|||
27949466|NCT01133405|54606681|FG005|Period 1|Received drug only in period 3|0|||
27949467|NCT01133405|54606682|FG006|Period 1|Received drug only in period 3|0|||
27949468|NCT01133405|54606683|FG007|Period 1|Received drug only in period 3|0|||
27949469|NCT01133405|54606684|FG008|Period 1|Received drug only in period 3|0|||
27949470|NCT01133405|54606685|FG009|Period 1|Received drug only in period 3|0|||
27949471|NCT01133405|54606676|FG000|Period 2|Adverse Event|0|||
27949472|NCT01133405|54606677|FG001|Period 2|Adverse Event|0|||
27949473|NCT01133405|54606678|FG002|Period 2|Adverse Event|1|||
27949474|NCT01133405|54606679|FG003|Period 2|Adverse Event|0|||
27949475|NCT01133405|54606680|FG004|Period 2|Adverse Event|0|||
27949476|NCT01133405|54606681|FG005|Period 2|Adverse Event|0|||
27949477|NCT01133405|54606682|FG006|Period 2|Adverse Event|0|||
27949478|NCT01133405|54606683|FG007|Period 2|Adverse Event|0|||
27949479|NCT01133405|54606684|FG008|Period 2|Adverse Event|0|||
27949480|NCT01133405|54606685|FG009|Period 2|Adverse Event|0|||
27949481|NCT01133405|54606676|FG000|Period 2|Withdrawal by Subject|0|||
27949482|NCT01133405|54606677|FG001|Period 2|Withdrawal by Subject|0|||
27949483|NCT01133405|54606678|FG002|Period 2|Withdrawal by Subject|0|||
27949484|NCT01133405|54606679|FG003|Period 2|Withdrawal by Subject|1|||
27949485|NCT01133405|54606680|FG004|Period 2|Withdrawal by Subject|0|||
27949486|NCT01133405|54606681|FG005|Period 2|Withdrawal by Subject|1|||
27949487|NCT01133405|54606682|FG006|Period 2|Withdrawal by Subject|0|||
27949488|NCT01133405|54606683|FG007|Period 2|Withdrawal by Subject|0|||
27949489|NCT01133405|54606684|FG008|Period 2|Withdrawal by Subject|0|||
27949490|NCT01133405|54606685|FG009|Period 2|Withdrawal by Subject|0|||
27949491|NCT01133405|54606676|FG000|Period 2|Entry Criteria Not Met|0|||
27949492|NCT01133405|54606677|FG001|Period 2|Entry Criteria Not Met|1|||
27949493|NCT01133405|54606678|FG002|Period 2|Entry Criteria Not Met|0|||
27949494|NCT01133405|54606679|FG003|Period 2|Entry Criteria Not Met|0|||
27949495|NCT01133405|54606680|FG004|Period 2|Entry Criteria Not Met|0|||
27949496|NCT01133405|54606681|FG005|Period 2|Entry Criteria Not Met|0|||
27949497|NCT01133405|54606682|FG006|Period 2|Entry Criteria Not Met|0|||
27949498|NCT01133405|54606683|FG007|Period 2|Entry Criteria Not Met|0|||
27949499|NCT01133405|54606684|FG008|Period 2|Entry Criteria Not Met|0|||
27949500|NCT01133405|54606685|FG009|Period 2|Entry Criteria Not Met|0|||
27949501|NCT01133405|54606676|FG000|Period 2|Physician Decision|0|||
27949502|NCT01133405|54606677|FG001|Period 2|Physician Decision|0|||
27949503|NCT01133405|54606678|FG002|Period 2|Physician Decision|0|||
27949504|NCT01133405|54606679|FG003|Period 2|Physician Decision|0|||
27949505|NCT01133405|54606680|FG004|Period 2|Physician Decision|0|||
27949506|NCT01133405|54606681|FG005|Period 2|Physician Decision|1|||
27949507|NCT01133405|54606682|FG006|Period 2|Physician Decision|0|||
27949508|NCT01133405|54606683|FG007|Period 2|Physician Decision|0|||
27949509|NCT01133405|54606684|FG008|Period 2|Physician Decision|0|||
27949510|NCT01133405|54606685|FG009|Period 2|Physician Decision|0|||
27949511|NCT01196078|54606717|FG000|Overall Study|Withdrawal by Subject|3|||
27949512|NCT01196078|54606718|FG001|Overall Study|Withdrawal by Subject|5|||
27949513|NCT01196078|54606717|FG000|Overall Study|Adverse Event|4|||
27949514|NCT01196078|54606718|FG001|Overall Study|Adverse Event|4|||
27949515|NCT01196078|54606717|FG000|Overall Study|Protocol Violation|2|||
27949516|NCT01196078|54606718|FG001|Overall Study|Protocol Violation|1|||
27949517|NCT01196078|54606717|FG000|Overall Study|Lack of Efficacy|17|||
27949518|NCT01196078|54606718|FG001|Overall Study|Lack of Efficacy|23|||
27949519|NCT01196078|54606717|FG000|Overall Study|Lost to Follow-up|1|||
27949520|NCT01196078|54606718|FG001|Overall Study|Lost to Follow-up|0|||
27949521|NCT01196078|54606717|FG000|Overall Study|Death|6|||
27949522|NCT01196078|54606718|FG001|Overall Study|Death|4|||
27949523|NCT01078584|54606724|FG000|Overall Study|Final Status Unknown|1073|||
27949524|NCT01078584|54606724|FG000|Overall Study|Lost to Follow-up|670|||
27949525|NCT01078584|54606724|FG000|Overall Study|Non-serious Adverse Event|577|||
27949526|NCT01078584|54606724|FG000|Overall Study|Withdrawal of Consent|244|||
27949527|NCT01078584|54606724|FG000|Overall Study|Physician Withdrew from Study|90|||
27949528|NCT01078584|54606724|FG000|Overall Study|Non-compliance|67|||
27949529|NCT01078584|54606724|FG000|Overall Study|Blood Pressure Controlled|49|||
27949530|NCT01078584|54606724|FG000|Overall Study|Physician Switched Medication|26|||
27949531|NCT01078584|54606724|FG000|Overall Study|Physician Discontinued Patient|12|||
27949532|NCT01078584|54606724|FG000|Overall Study|Lack of Efficacy|98|||
27949533|NCT01078584|54606724|FG000|Overall Study|Protocol Violation|75|||
27949534|NCT01078584|54606724|FG000|Overall Study|Serious Adverse Event|27|||
27949535|NCT01078584|54606724|FG000|Overall Study|Multiple Reasons|2|||
27949536|NCT01133171|54606744|FG000|Overall Study|Withdrawal by Subject|1|||
27949537|NCT01133171|54606745|FG001|Overall Study|Withdrawal by Subject|2|||
27949538|NCT01133171|54606746|FG002|Overall Study|Withdrawal by Subject|0|||
27949539|NCT01195844|54606754|FG000|Overall Study|Fecal sample not collected|40|||
27949540|NCT01132547|54606770|FG000|Overall Study|Withdrawal by Subject|3|||
27949541|NCT01132547|54606771|FG001|Overall Study|Withdrawal by Subject|1|||
27949542|NCT01132547|54606770|FG000|Overall Study|Death|1|||
27949543|NCT01132547|54606771|FG001|Overall Study|Death|0|||
27949544|NCT01194830|54606779|FG000|Overall Study|Adverse Event|3|||
27949545|NCT01194830|54606780|FG001|Overall Study|Adverse Event|2|||
27949546|NCT01194830|54606779|FG000|Overall Study|Protocol Violation|5|||
27949547|NCT01194830|54606780|FG001|Overall Study|Protocol Violation|4|||
27949548|NCT01194830|54606779|FG000|Overall Study|Lost to Follow-up|9|||
27949549|NCT01194830|54606780|FG001|Overall Study|Lost to Follow-up|7|||
27949550|NCT01194830|54606779|FG000|Overall Study|Withdrawal by Subject|2|||
27949551|NCT01194830|54606780|FG001|Overall Study|Withdrawal by Subject|1|||
27949552|NCT01194830|54606779|FG000|Overall Study|Lack of Efficacy|1|||
27949553|NCT01194830|54606780|FG001|Overall Study|Lack of Efficacy|1|||
27949554|NCT01194830|54606779|FG000|Overall Study|Non-compliance issues|4|||
27949555|NCT01194830|54606780|FG001|Overall Study|Non-compliance issues|4|||
27949556|NCT01194830|54606779|FG000|Overall Study|Other Reason|12|||
27949557|NCT01194830|54606780|FG001|Overall Study|Other Reason|8|||
27949558|NCT01194440|54606786|FG000|Baseline (First Dose)|Reason not specified|4|||
27949559|NCT01194440|54606786|FG000|Baseline (First Dose)|Lack of Efficacy|1|||
27949560|NCT01194440|54606786|FG000|Baseline (First Dose)|Change in therapy|1|||
27949561|NCT01194440|54606786|FG000|Baseline (First Dose)|Adverse Event|1|||
27949562|NCT01194440|54606786|FG000|6-months (2nd Dose)|Change in therapy|4|||
27949563|NCT00951015|54606795|FG000|Randomization Phase 96 Week|Adverse Event|1|||
27949564|NCT00951015|54606796|FG001|Randomization Phase 96 Week|Adverse Event|1|||
27949565|NCT00951015|54606797|FG002|Randomization Phase 96 Week|Adverse Event|2|||
27949566|NCT00951015|54606798|FG003|Randomization Phase 96 Week|Adverse Event|5|||
27949567|NCT00951015|54606799|FG004|Randomization Phase 96 Week|Adverse Event|0|||
27949568|NCT00951015|54606795|FG000|Randomization Phase 96 Week|Lack of Efficacy|1|||
27949569|NCT00951015|54606796|FG001|Randomization Phase 96 Week|Lack of Efficacy|1|||
27949570|NCT00951015|54606797|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
27949571|NCT00951015|54606798|FG003|Randomization Phase 96 Week|Lack of Efficacy|0|||
27949572|NCT00951015|54606799|FG004|Randomization Phase 96 Week|Lack of Efficacy|0|||
27949573|NCT00951015|54606795|FG000|Randomization Phase 96 Week|Protocol Violation|1|||
27949574|NCT00951015|54606796|FG001|Randomization Phase 96 Week|Protocol Violation|1|||
27949575|NCT00951015|54606797|FG002|Randomization Phase 96 Week|Protocol Violation|1|||
27949576|NCT00951015|54606798|FG003|Randomization Phase 96 Week|Protocol Violation|0|||
27949577|NCT00951015|54606799|FG004|Randomization Phase 96 Week|Protocol Violation|0|||
27949578|NCT00951015|54606795|FG000|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
27949579|NCT00951015|54606796|FG001|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
27949580|NCT00951015|54606797|FG002|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
27949581|NCT00951015|54606798|FG003|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1|||
27949582|NCT00951015|54606799|FG004|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
27949583|NCT00951015|54606795|FG000|Randomization Phase 96 Week|Lost to Follow-up|0|||
27949584|NCT00951015|54606796|FG001|Randomization Phase 96 Week|Lost to Follow-up|3|||
27949585|NCT00951015|54606797|FG002|Randomization Phase 96 Week|Lost to Follow-up|1|||
27949586|NCT00951015|54606798|FG003|Randomization Phase 96 Week|Lost to Follow-up|2|||
27949587|NCT00951015|54606799|FG004|Randomization Phase 96 Week|Lost to Follow-up|0|||
27949588|NCT00951015|54606795|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
27949589|NCT00951015|54606796|FG001|Randomization Phase 96 Week|Withdrawal by Subject|1|||
27949590|NCT00951015|54606797|FG002|Randomization Phase 96 Week|Withdrawal by Subject|1|||
27949591|NCT00951015|54606798|FG003|Randomization Phase 96 Week|Withdrawal by Subject|2|||
27949592|NCT00951015|54606799|FG004|Randomization Phase 96 Week|Withdrawal by Subject|0|||
27949593|NCT00951015|54606795|FG000|Open-label Phase|Adverse Event|0|||
27949594|NCT00951015|54606796|FG001|Open-label Phase|Adverse Event|0|||
27949595|NCT00951015|54606797|FG002|Open-label Phase|Adverse Event|0|||
27949596|NCT00951015|54606798|FG003|Open-label Phase|Adverse Event|0|||
27949597|NCT00951015|54606799|FG004|Open-label Phase|Adverse Event|3|||
27949598|NCT00951015|54606795|FG000|Open-label Phase|Lack of Efficacy|0|||
27949599|NCT00951015|54606796|FG001|Open-label Phase|Lack of Efficacy|0|||
27949600|NCT00951015|54606797|FG002|Open-label Phase|Lack of Efficacy|0|||
27949601|NCT00951015|54606798|FG003|Open-label Phase|Lack of Efficacy|0|||
27949602|NCT00951015|54606799|FG004|Open-label Phase|Lack of Efficacy|1|||
27949603|NCT00951015|54606795|FG000|Open-label Phase|Protocol Violation|0|||
27949604|NCT00951015|54606796|FG001|Open-label Phase|Protocol Violation|0|||
27949605|NCT00951015|54606797|FG002|Open-label Phase|Protocol Violation|0|||
27949606|NCT00951015|54606798|FG003|Open-label Phase|Protocol Violation|0|||
27949607|NCT00951015|54606799|FG004|Open-label Phase|Protocol Violation|12|||
27949608|NCT00951015|54606795|FG000|Open-label Phase|Lost to Follow-up|0|||
27949609|NCT00951015|54606796|FG001|Open-label Phase|Lost to Follow-up|0|||
27949610|NCT00951015|54606797|FG002|Open-label Phase|Lost to Follow-up|0|||
27949611|NCT00951015|54606798|FG003|Open-label Phase|Lost to Follow-up|0|||
27949612|NCT00951015|54606799|FG004|Open-label Phase|Lost to Follow-up|12|||
27949613|NCT00951015|54606795|FG000|Open-label Phase|Withdrawal by Subject|0|||
27949614|NCT00951015|54606796|FG001|Open-label Phase|Withdrawal by Subject|0|||
27949615|NCT00951015|54606797|FG002|Open-label Phase|Withdrawal by Subject|0|||
27949616|NCT00951015|54606798|FG003|Open-label Phase|Withdrawal by Subject|0|||
27832211|NCT00983619|54311049|FG004|Overall Study|Lost to Follow-up|0|||
27832212|NCT00983619|54311050|FG005|Overall Study|Lost to Follow-up|2|||
27832213|NCT00983619|54311051|FG006|Overall Study|Lost to Follow-up|0|||
27832214|NCT00983619|54311052|FG007|Overall Study|Lost to Follow-up|0|||
27832215|NCT00983619|54311053|FG008|Overall Study|Lost to Follow-up|0|||
27832216|NCT00983619|54311054|FG009|Overall Study|Lost to Follow-up|0|||
27832217|NCT00983619|54311055|FG010|Overall Study|Lost to Follow-up|0|||
27832218|NCT00983619|54311056|FG011|Overall Study|Lost to Follow-up|2|||
27832219|NCT00983619|54311045|FG000|Overall Study|Withdrawal by Subject|2|||
27949617|NCT00951015|54606799|FG004|Open-label Phase|Withdrawal by Subject|14|||
27949618|NCT00951015|54606795|FG000|Open-label Phase|Physician Decision|0|||
27949619|NCT00951015|54606796|FG001|Open-label Phase|Physician Decision|0|||
27949620|NCT00951015|54606797|FG002|Open-label Phase|Physician Decision|0|||
27949621|NCT00951015|54606798|FG003|Open-label Phase|Physician Decision|0|||
27949622|NCT00951015|54606799|FG004|Open-label Phase|Physician Decision|8|||
27949623|NCT01139021|54606828|FG000|Overall Study|Adverse Event|0|||
27949624|NCT01139021|54606829|FG001|Overall Study|Adverse Event|0|||
27949625|NCT01139021|54606830|FG002|Overall Study|Adverse Event|0|||
27949626|NCT01139021|54606831|FG003|Overall Study|Adverse Event|0|||
27949627|NCT01139021|54606832|FG004|Overall Study|Adverse Event|1|||
27949628|NCT01139021|54606833|FG005|Overall Study|Adverse Event|0|||
27949629|NCT01139021|54606828|FG000|Overall Study|Lost to Follow-up|0|||
27949630|NCT01139021|54606829|FG001|Overall Study|Lost to Follow-up|0|||
27949631|NCT01139021|54606830|FG002|Overall Study|Lost to Follow-up|0|||
27949632|NCT01139021|54606831|FG003|Overall Study|Lost to Follow-up|0|||
27949633|NCT01139021|54606832|FG004|Overall Study|Lost to Follow-up|2|||
27949634|NCT01139021|54606833|FG005|Overall Study|Lost to Follow-up|0|||
27949635|NCT01139021|54606828|FG000|Overall Study|Protocol Violation|1|||
27949636|NCT01139021|54606829|FG001|Overall Study|Protocol Violation|0|||
27949637|NCT01139021|54606830|FG002|Overall Study|Protocol Violation|0|||
27949638|NCT01139021|54606831|FG003|Overall Study|Protocol Violation|0|||
27949639|NCT01139021|54606832|FG004|Overall Study|Protocol Violation|2|||
27949640|NCT01139021|54606833|FG005|Overall Study|Protocol Violation|0|||
27949641|NCT01139021|54606828|FG000|Overall Study|Withdrawal by Subject|0|||
27949642|NCT01139021|54606829|FG001|Overall Study|Withdrawal by Subject|0|||
27949643|NCT01139021|54606830|FG002|Overall Study|Withdrawal by Subject|0|||
27949644|NCT01139021|54606831|FG003|Overall Study|Withdrawal by Subject|1|||
27854827|NCT00081458|54372571|FG000|Overall Study|Randomized but not dosed|0|||
27854828|NCT00081458|54372572|FG001|Overall Study|Randomized but not dosed|0|||
27854829|NCT00081458|54372573|FG002|Overall Study|Randomized but not dosed|1|||
27854830|NCT01271803|54372650|FG000|Overall Study|Progressive disease|0|||
27949645|NCT01139021|54606832|FG004|Overall Study|Withdrawal by Subject|4|||
27949646|NCT01139021|54606833|FG005|Overall Study|Withdrawal by Subject|0|||
27949647|NCT01193660|54606851|FG000|Overall Study|Withdrawal by Subject|2|||
27854831|NCT01271803|54372651|FG001|Overall Study|Progressive disease|0|||
27949648|NCT01193660|54606852|FG001|Overall Study|Withdrawal by Subject|3|||
27949649|NCT01193660|54606853|FG002|Overall Study|Withdrawal by Subject|1|||
27949650|NCT01193660|54606851|FG000|Overall Study|Death|1|||
27949651|NCT01193660|54606852|FG001|Overall Study|Death|0|||
27949652|NCT01193660|54606853|FG002|Overall Study|Death|0|||
27949653|NCT01193660|54606851|FG000|Overall Study|Physician Decision|1|||
27949654|NCT01193660|54606852|FG001|Overall Study|Physician Decision|0|||
27949655|NCT01193660|54606853|FG002|Overall Study|Physician Decision|1|||
27949656|NCT01076166|54606861|FG000|Overall Study|Adverse Event|3|||
27949657|NCT01076166|54606861|FG000|Overall Study|Symptoms improved/resolved|6|||
27949658|NCT01193582|54606872|FG000|Vaccination Series|Withdrawal by Subject|11|||
27949659|NCT01193582|54606873|FG001|Vaccination Series|Withdrawal by Subject|13|||
27949660|NCT01193582|54606874|FG002|Vaccination Series|Withdrawal by Subject|8|||
27949661|NCT01193582|54606875|FG003|Vaccination Series|Withdrawal by Subject|3|||
27949662|NCT01193582|54606872|FG000|12 Month Follow-up|Death|0|||
27949663|NCT01193582|54606873|FG001|12 Month Follow-up|Death|0|||
27949664|NCT01193582|54606874|FG002|12 Month Follow-up|Death|1|||
27949665|NCT01193582|54606875|FG003|12 Month Follow-up|Death|0|||
27949666|NCT01193582|54606872|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
27949667|NCT01193582|54606873|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
27949668|NCT01193582|54606874|FG002|12 Month Follow-up|Withdrawal by Subject|3|||
27949669|NCT01193582|54606875|FG003|12 Month Follow-up|Withdrawal by Subject|11|||
27949670|NCT00945477|54606887|FG000|Overall Study|Adverse Event|3|||
27949671|NCT00945477|54606887|FG000|Overall Study|Lack of Efficacy|2|||
27949672|NCT00945477|54606887|FG000|Overall Study|Withdrawal by Subject|1|||
27949673|NCT01076088|54606898|FG000|Overall Study|Adverse Event|1|||
27949674|NCT01076088|54606899|FG001|Overall Study|Adverse Event|6|||
27949675|NCT01076088|54606900|FG002|Overall Study|Adverse Event|3|||
27949676|NCT01076088|54606901|FG003|Overall Study|Adverse Event|2|||
27949677|NCT01076088|54606902|FG004|Overall Study|Adverse Event|3|||
27949678|NCT01076088|54606903|FG005|Overall Study|Adverse Event|3|||
27949679|NCT01076088|54606898|FG000|Overall Study|Lost to Follow-up|1|||
27949680|NCT01076088|54606899|FG001|Overall Study|Lost to Follow-up|1|||
27949681|NCT01076088|54606900|FG002|Overall Study|Lost to Follow-up|0|||
27949682|NCT01076088|54606901|FG003|Overall Study|Lost to Follow-up|1|||
27949683|NCT01076088|54606902|FG004|Overall Study|Lost to Follow-up|1|||
27949684|NCT01076088|54606903|FG005|Overall Study|Lost to Follow-up|2|||
27949685|NCT01076088|54606898|FG000|Overall Study|Non-compliance with study drug|0|||
27949686|NCT01076088|54606899|FG001|Overall Study|Non-compliance with study drug|0|||
27949687|NCT01076088|54606900|FG002|Overall Study|Non-compliance with study drug|0|||
27949688|NCT01076088|54606901|FG003|Overall Study|Non-compliance with study drug|1|||
27949689|NCT01076088|54606902|FG004|Overall Study|Non-compliance with study drug|0|||
27949690|NCT01076088|54606903|FG005|Overall Study|Non-compliance with study drug|0|||
27949691|NCT01076088|54606898|FG000|Overall Study|Physician Decision|1|||
27949692|NCT01076088|54606899|FG001|Overall Study|Physician Decision|3|||
27949693|NCT01076088|54606900|FG002|Overall Study|Physician Decision|0|||
27949694|NCT01076088|54606901|FG003|Overall Study|Physician Decision|1|||
27854832|NCT01271803|54372652|FG002|Overall Study|Progressive disease|2|||
27854833|NCT01271803|54372650|FG000|Overall Study|Death|53|||
27854834|NCT01271803|54372651|FG001|Overall Study|Death|34|||
27854835|NCT01271803|54372652|FG002|Overall Study|Death|0|||
27949695|NCT01076088|54606902|FG004|Overall Study|Physician Decision|1|||
27949696|NCT01076088|54606903|FG005|Overall Study|Physician Decision|0|||
27854836|NCT01271803|54372650|FG000|Overall Study|Withdrawal by Subject|1|||
27949697|NCT01076088|54606898|FG000|Overall Study|Withdrawal by Subject|8|||
27949698|NCT01076088|54606899|FG001|Overall Study|Withdrawal by Subject|8|||
27949699|NCT01076088|54606900|FG002|Overall Study|Withdrawal by Subject|14|||
27949700|NCT01076088|54606901|FG003|Overall Study|Withdrawal by Subject|10|||
28164836|NCT02665052|54835436|FG002|Overall Study|Lost to Follow-up|0|||
27854837|NCT01271803|54372651|FG001|Overall Study|Withdrawal by Subject|5|||
27949701|NCT01076088|54606902|FG004|Overall Study|Withdrawal by Subject|11|||
27949702|NCT01076088|54606903|FG005|Overall Study|Withdrawal by Subject|17|||
27949703|NCT01076088|54606898|FG000|Overall Study|Other protocol specified criteria|0|||
27949704|NCT01076088|54606899|FG001|Overall Study|Other protocol specified criteria|0|||
27949705|NCT01076088|54606900|FG002|Overall Study|Other protocol specified criteria|0|||
27949706|NCT01076088|54606901|FG003|Overall Study|Other protocol specified criteria|0|||
27949707|NCT01076088|54606902|FG004|Overall Study|Other protocol specified criteria|0|||
27949708|NCT01076088|54606903|FG005|Overall Study|Other protocol specified criteria|1|||
27949709|NCT01193348|54606918|FG000|Screening Period|Screen Failure|5|||
27949710|NCT01193348|54606918|FG000|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1|||
27949711|NCT01193348|54606918|FG000|Treatment Period (26 Weeks)|Serious Adverse Event|1|||
27949712|NCT01193348|54606918|FG000|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1|||
27949713|NCT01193348|54606918|FG000|Extension Treatment Period|Physician Decision|1|||
27949714|NCT01193348|54606918|FG000|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2|||
27949715|NCT00945321|54606927|FG000|Period 1|Adverse Event|0|||
27949716|NCT00945321|54606928|FG001|Period 1|Adverse Event|0|||
27949717|NCT00945321|54606929|FG002|Period 1|Adverse Event|0|||
27949718|NCT00945321|54606930|FG003|Period 1|Adverse Event|0|||
27949719|NCT00945321|54606931|FG004|Period 1|Adverse Event|1|||
27949720|NCT00945321|54606932|FG005|Period 1|Adverse Event|0|||
27949721|NCT00945321|54606927|FG000|Period 4|Lost to Follow-up|0|||
27949722|NCT00945321|54606928|FG001|Period 4|Lost to Follow-up|0|||
27949723|NCT00945321|54606929|FG002|Period 4|Lost to Follow-up|0|||
27949724|NCT00945321|54606930|FG003|Period 4|Lost to Follow-up|0|||
27949725|NCT00945321|54606931|FG004|Period 4|Lost to Follow-up|0|||
27949726|NCT00945321|54606932|FG005|Period 4|Lost to Follow-up|1|||
27949727|NCT00945243|54606950|FG000|Overall Study|Study Terminated: Subjects Dispositioned|3|||
27949728|NCT01192412|54606956|FG000|Overall Study|Lost to Follow-up|2|||
27949729|NCT01192412|54606957|FG001|Overall Study|Lost to Follow-up|1|||
27949730|NCT01192412|54606956|FG000|Overall Study|Withdrawal by Subject|2|||
27949731|NCT01192412|54606957|FG001|Overall Study|Withdrawal by Subject|1|||
27949732|NCT01192178|54606965|FG000|Overall Study|Withdrawal by Subject|6|||
27949733|NCT01192178|54606966|FG001|Overall Study|Withdrawal by Subject|10|||
27949734|NCT01192178|54606965|FG000|Overall Study|Protocol Violation|10|||
27949735|NCT01192178|54606966|FG001|Overall Study|Protocol Violation|3|||
27949736|NCT01192178|54606965|FG000|Overall Study|Physician Decision|2|||
27949737|NCT01192178|54606966|FG001|Overall Study|Physician Decision|4|||
27949738|NCT01192178|54606965|FG000|Overall Study|Lost to Follow-up|3|||
27949739|NCT01192178|54606966|FG001|Overall Study|Lost to Follow-up|3|||
27949740|NCT01192178|54606965|FG000|Overall Study|Adverse Event|2|||
27949741|NCT01192178|54606966|FG001|Overall Study|Adverse Event|1|||
27949742|NCT01192178|54606965|FG000|Overall Study|Lack of Efficacy|1|||
27949743|NCT01192178|54606966|FG001|Overall Study|Lack of Efficacy|2|||
27949744|NCT01192100|54606974|FG000|Overall Study|Withdrawal by Subject|0|||
27949745|NCT01192100|54606975|FG001|Overall Study|Withdrawal by Subject|0|||
27949746|NCT01192100|54606976|FG002|Overall Study|Withdrawal by Subject|0|||
27949747|NCT01192100|54606977|FG003|Overall Study|Withdrawal by Subject|0|||
27949748|NCT01192100|54606978|FG004|Overall Study|Withdrawal by Subject|1|||
27949749|NCT01192100|54606979|FG005|Overall Study|Withdrawal by Subject|0|||
27949750|NCT01192100|54606974|FG000|Overall Study|Protocol Violation|0|||
27949751|NCT01192100|54606975|FG001|Overall Study|Protocol Violation|0|||
27949752|NCT01192100|54606976|FG002|Overall Study|Protocol Violation|0|||
27949753|NCT01192100|54606977|FG003|Overall Study|Protocol Violation|1|||
27949754|NCT01192100|54606978|FG004|Overall Study|Protocol Violation|0|||
27949755|NCT01192100|54606979|FG005|Overall Study|Protocol Violation|0|||
27949756|NCT00869401|54606992|FG000|Overall Study|Withdrawal by Subject|0|||
27949757|NCT00869401|54606993|FG001|Overall Study|Withdrawal by Subject|0|||
27949758|NCT00869401|54606994|FG002|Overall Study|Withdrawal by Subject|0|||
27949759|NCT00869401|54606995|FG003|Overall Study|Withdrawal by Subject|5|||
27949760|NCT00869401|54606996|FG004|Overall Study|Withdrawal by Subject|3|||
27949761|NCT01076010|54607011|FG000|Overall Study|Death|15|||
27949762|NCT01076010|54607012|FG001|Overall Study|Death|1|||
27949763|NCT01076010|54607013|FG002|Overall Study|Death|0|||
27949764|NCT01076010|54607011|FG000|Overall Study|Adverse Event|7|||
27949765|NCT01076010|54607012|FG001|Overall Study|Adverse Event|2|||
27949766|NCT01076010|54607013|FG002|Overall Study|Adverse Event|0|||
27949767|NCT01076010|54607011|FG000|Overall Study|Progressive disease|90|||
27949768|NCT01076010|54607012|FG001|Overall Study|Progressive disease|30|||
27949769|NCT01076010|54607013|FG002|Overall Study|Progressive disease|1|||
27832220|NCT00983619|54311046|FG001|Overall Study|Withdrawal by Subject|1|||
27832221|NCT00983619|54311047|FG002|Overall Study|Withdrawal by Subject|1|||
27832222|NCT00983619|54311048|FG003|Overall Study|Withdrawal by Subject|3|||
27949770|NCT01076010|54607011|FG000|Overall Study|Lack of Efficacy|4|||
27949771|NCT01076010|54607012|FG001|Overall Study|Lack of Efficacy|0|||
27949772|NCT01076010|54607013|FG002|Overall Study|Lack of Efficacy|0|||
27949773|NCT01076010|54607011|FG000|Overall Study|Treatment Interruption for > 2 Weeks|0|||
27949774|NCT01076010|54607012|FG001|Overall Study|Treatment Interruption for > 2 Weeks|1|||
28080811|NCT03560518|54734092|FG002|Double Blind Treatment Period|Study Terminated by the Sponsor|10|||
27949775|NCT01076010|54607013|FG002|Overall Study|Treatment Interruption for > 2 Weeks|0|||
27949776|NCT01076010|54607011|FG000|Overall Study|Significant Surgical Procedure|0|||
27949777|NCT01076010|54607012|FG001|Overall Study|Significant Surgical Procedure|1|||
27949778|NCT01076010|54607013|FG002|Overall Study|Significant Surgical Procedure|0|||
27949779|NCT01076010|54607011|FG000|Overall Study|Protocol Violation|0|||
27949780|NCT01076010|54607012|FG001|Overall Study|Protocol Violation|1|||
27949781|NCT01076010|54607013|FG002|Overall Study|Protocol Violation|0|||
27949782|NCT01076010|54607011|FG000|Overall Study|Noncompliance|1|||
27949783|NCT01076010|54607012|FG001|Overall Study|Noncompliance|1|||
27949784|NCT01076010|54607013|FG002|Overall Study|Noncompliance|0|||
27949785|NCT01076010|54607011|FG000|Overall Study|Withdrawal by Subject|3|||
27949786|NCT01076010|54607012|FG001|Overall Study|Withdrawal by Subject|0|||
27949787|NCT01076010|54607013|FG002|Overall Study|Withdrawal by Subject|1|||
27949788|NCT01076010|54607011|FG000|Overall Study|Other|5|||
27949789|NCT01076010|54607012|FG001|Overall Study|Other|2|||
27949790|NCT01076010|54607013|FG002|Overall Study|Other|0|||
27949791|NCT01075152|54607023|FG000|Overall Study|Withdrawal by Subject|1|||
27949792|NCT01075152|54607024|FG001|Overall Study|Withdrawal by Subject|0|||
27949793|NCT01078116|54607032|FG000|Overall Study|Lost to Follow-up|17|||
27949794|NCT01078116|54607032|FG000|Overall Study|Adverse Event|5|||
27949795|NCT01078116|54607032|FG000|Overall Study|Withdrawal by Subject|8|||
27949796|NCT01078116|54607032|FG000|Overall Study|Lack of effectiveness|15|||
27949797|NCT01078116|54607032|FG000|Overall Study|Case report form not completed|3|||
27949798|NCT00950859|54607038|FG000|Overall Study|Adverse Event|3|||
27949799|NCT00950859|54607039|FG001|Overall Study|Adverse Event|3|||
27949800|NCT00950859|54607038|FG000|Overall Study|Insufficient Viral Load Response|12|||
27949801|NCT00950859|54607039|FG001|Overall Study|Insufficient Viral Load Response|3|||
27949802|NCT00950859|54607038|FG000|Overall Study|Protocol Violation|1|||
27949803|NCT00950859|54607039|FG001|Overall Study|Protocol Violation|1|||
27949804|NCT00950859|54607038|FG000|Overall Study|Lost to Follow-up|0|||
27949805|NCT00950859|54607039|FG001|Overall Study|Lost to Follow-up|3|||
27949806|NCT00862849|54607045|FG000|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
27949807|NCT00862849|54607046|FG001|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1|||
27949808|NCT00862849|54607047|FG002|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
27949809|NCT00862849|54607048|FG003|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
27949810|NCT00862849|54607049|FG004|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
27949811|NCT00862849|54607050|FG005|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
27949812|NCT00862849|54607045|FG000|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
27949813|NCT00862849|54607046|FG001|Washout 2 (3 to 14 Days)|Protocol Violation|1|||
27949814|NCT00862849|54607047|FG002|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
27949815|NCT00862849|54607048|FG003|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
27949816|NCT00862849|54607049|FG004|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
27949817|NCT00862849|54607050|FG005|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
27949818|NCT01090050|54607060|FG000|Overall Study|Lost to Follow-up|0|||
27949819|NCT01090050|54607061|FG001|Overall Study|Lost to Follow-up|1|||
27949820|NCT01090050|54607060|FG000|Overall Study|Lack of Efficacy|1|||
27949821|NCT01090050|54607061|FG001|Overall Study|Lack of Efficacy|5|||
27949822|NCT01090050|54607060|FG000|Overall Study|Physician Decision|0|||
27949823|NCT01090050|54607061|FG001|Overall Study|Physician Decision|1|||
27949824|NCT00944229|54607071|FG000|Overall Study|Withdrawal by Subject|11|||
27949825|NCT00944229|54607071|FG000|Overall Study|Physician Decision|14|||
27949826|NCT01077960|54607075|FG000|Overall Study|Adverse Event|6|||
27949827|NCT01077960|54607075|FG000|Overall Study|Protocol Violation|3|||
27949828|NCT01077960|54607075|FG000|Overall Study|Lost to Follow-up|5|||
27949829|NCT01077960|54607075|FG000|Overall Study|Subject decision|1|||
27949830|NCT01077960|54607075|FG000|Overall Study|Reason unspecified|1|||
27949831|NCT00944697|54607081|FG000|Overall Study|Withdrawal by Subject|1|||
27949832|NCT00944697|54607082|FG001|Overall Study|Withdrawal by Subject|1|||
27949833|NCT00944697|54607081|FG000|Overall Study|Adverse Event|0|||
27949834|NCT00944697|54607082|FG001|Overall Study|Adverse Event|3|||
27949835|NCT00944697|54607081|FG000|Overall Study|Administrative|1|||
27949836|NCT00944697|54607082|FG001|Overall Study|Administrative|1|||
27949837|NCT01077804|54607088|FG000|Overall Study|Unreachable|102|||
27949838|NCT01077804|54607088|FG000|Overall Study|Refused to continue|79|||
27949839|NCT01077804|54607088|FG000|Overall Study|Other|18|||
27949840|NCT01075074|54607112|FG000|Overall Study|Surgeon changed to open incisional case|1|||
27949841|NCT01075074|54607113|FG001|Overall Study|Surgeon changed to open incisional case|2|||
27949842|NCT01075074|54607114|FG002|Overall Study|Surgeon changed to open incisional case|2|||
27832223|NCT00983619|54311049|FG004|Overall Study|Withdrawal by Subject|1|||
27949843|NCT00866281|54607128|FG000|Overall Study|Adverse Event|1|||
27949844|NCT00866281|54607129|FG001|Overall Study|Adverse Event|0|||
27949845|NCT00866281|54607128|FG000|Overall Study|Withdrawal by participants|3|||
27949846|NCT00866281|54607129|FG001|Overall Study|Withdrawal by participants|0|||
27949847|NCT00866281|54607128|FG000|Overall Study|Disease progression|3|||
27949848|NCT00866281|54607129|FG001|Overall Study|Disease progression|11|||
27949849|NCT00866281|54607128|FG000|Overall Study|New cancer therapy|0|||
27949850|NCT00866281|54607129|FG001|Overall Study|New cancer therapy|4|||
27949851|NCT01077258|54607138|FG000|Overall Study|Lost to Follow-up|1390|||
27949852|NCT01077258|54607138|FG000|Overall Study|Adverse drug reaction|218|||
27949853|NCT01077258|54607138|FG000|Overall Study|Lack of Efficacy|663|||
27949854|NCT01077258|54607138|FG000|Overall Study|Clinical remission|37|||
27949855|NCT01077258|54607138|FG000|Overall Study|Other reasons|260|||
27949856|NCT00943917|54607166|FG000|Stage I|Adverse Event|1|||
27949857|NCT00943917|54607167|FG001|Stage I|Adverse Event|2|||
27949858|NCT00943917|54607168|FG002|Stage I|Adverse Event|2|||
27949859|NCT00943917|54607169|FG003|Stage I|Adverse Event|0|||
27949860|NCT00943917|54607170|FG004|Stage I|Adverse Event|0|||
27949861|NCT00943917|54607171|FG005|Stage I|Adverse Event|0|||
27949862|NCT00943917|54607172|FG006|Stage I|Adverse Event|0|||
27949863|NCT00943917|54607173|FG007|Stage I|Adverse Event|0|||
27949864|NCT00943917|54607174|FG008|Stage I|Adverse Event|0|||
27949865|NCT00943917|54607175|FG009|Stage I|Adverse Event|0|||
27949866|NCT00943917|54607176|FG010|Stage I|Adverse Event|0|||
27949867|NCT00943917|54607177|FG011|Stage I|Adverse Event|0|||
27949868|NCT00943917|54607178|FG012|Stage I|Adverse Event|0|||
27949869|NCT00943917|54607179|FG013|Stage I|Adverse Event|0|||
27949870|NCT00943917|54607180|FG014|Stage I|Adverse Event|0|||
27949871|NCT00943917|54607166|FG000|Stage I|Lost to Follow-up|0|||
27949872|NCT00943917|54607167|FG001|Stage I|Lost to Follow-up|0|||
27949873|NCT00943917|54607168|FG002|Stage I|Lost to Follow-up|1|||
27949874|NCT00943917|54607169|FG003|Stage I|Lost to Follow-up|0|||
27949875|NCT00943917|54607170|FG004|Stage I|Lost to Follow-up|0|||
27949876|NCT00943917|54607171|FG005|Stage I|Lost to Follow-up|0|||
27949877|NCT00943917|54607172|FG006|Stage I|Lost to Follow-up|0|||
27949878|NCT00943917|54607173|FG007|Stage I|Lost to Follow-up|0|||
27949879|NCT00943917|54607174|FG008|Stage I|Lost to Follow-up|0|||
27949880|NCT00943917|54607175|FG009|Stage I|Lost to Follow-up|0|||
27949881|NCT00943917|54607176|FG010|Stage I|Lost to Follow-up|0|||
27949882|NCT00943917|54607177|FG011|Stage I|Lost to Follow-up|0|||
27949883|NCT00943917|54607178|FG012|Stage I|Lost to Follow-up|0|||
27949884|NCT00943917|54607179|FG013|Stage I|Lost to Follow-up|0|||
27949885|NCT00943917|54607180|FG014|Stage I|Lost to Follow-up|0|||
27949886|NCT00943917|54607166|FG000|Stage I|hyperglycemia|0|||
27949887|NCT00943917|54607167|FG001|Stage I|hyperglycemia|0|||
27949888|NCT00943917|54607168|FG002|Stage I|hyperglycemia|1|||
27949889|NCT00943917|54607169|FG003|Stage I|hyperglycemia|0|||
27949890|NCT00943917|54607170|FG004|Stage I|hyperglycemia|0|||
27949891|NCT00943917|54607171|FG005|Stage I|hyperglycemia|0|||
27949892|NCT00943917|54607172|FG006|Stage I|hyperglycemia|0|||
27949893|NCT00943917|54607173|FG007|Stage I|hyperglycemia|0|||
27949894|NCT00943917|54607174|FG008|Stage I|hyperglycemia|0|||
27949895|NCT00943917|54607175|FG009|Stage I|hyperglycemia|0|||
27949896|NCT00943917|54607176|FG010|Stage I|hyperglycemia|0|||
27949897|NCT00943917|54607177|FG011|Stage I|hyperglycemia|0|||
27949898|NCT00943917|54607178|FG012|Stage I|hyperglycemia|0|||
27949899|NCT00943917|54607179|FG013|Stage I|hyperglycemia|0|||
27949900|NCT00943917|54607180|FG014|Stage I|hyperglycemia|0|||
27949901|NCT00943917|54607166|FG000|Stage I|A1C elevation|1|||
27949902|NCT00943917|54607167|FG001|Stage I|A1C elevation|0|||
27949903|NCT00943917|54607168|FG002|Stage I|A1C elevation|0|||
27949904|NCT00943917|54607169|FG003|Stage I|A1C elevation|0|||
27949905|NCT00943917|54607170|FG004|Stage I|A1C elevation|0|||
27949906|NCT00943917|54607171|FG005|Stage I|A1C elevation|0|||
27949907|NCT00943917|54607172|FG006|Stage I|A1C elevation|0|||
27949908|NCT00943917|54607173|FG007|Stage I|A1C elevation|0|||
27949909|NCT00943917|54607174|FG008|Stage I|A1C elevation|0|||
27949910|NCT00943917|54607175|FG009|Stage I|A1C elevation|0|||
27949911|NCT00943917|54607176|FG010|Stage I|A1C elevation|0|||
27949912|NCT00943917|54607177|FG011|Stage I|A1C elevation|0|||
27949913|NCT00943917|54607178|FG012|Stage I|A1C elevation|0|||
27949914|NCT00943917|54607179|FG013|Stage I|A1C elevation|0|||
27949915|NCT00943917|54607180|FG014|Stage I|A1C elevation|0|||
27949916|NCT00943917|54607166|FG000|Stage I|Withdrawal by Subject|2|||
27949917|NCT00943917|54607167|FG001|Stage I|Withdrawal by Subject|1|||
27949918|NCT00943917|54607168|FG002|Stage I|Withdrawal by Subject|2|||
27949919|NCT00943917|54607169|FG003|Stage I|Withdrawal by Subject|0|||
27949920|NCT00943917|54607170|FG004|Stage I|Withdrawal by Subject|0|||
27949921|NCT00943917|54607171|FG005|Stage I|Withdrawal by Subject|0|||
27949922|NCT00943917|54607172|FG006|Stage I|Withdrawal by Subject|0|||
28080812|NCT03560518|54734090|FG000|Double Blind Treatment Period|Protocol Violation|1|||
27949923|NCT00943917|54607173|FG007|Stage I|Withdrawal by Subject|0|||
27949924|NCT00943917|54607174|FG008|Stage I|Withdrawal by Subject|0|||
27949925|NCT00943917|54607175|FG009|Stage I|Withdrawal by Subject|0|||
27949926|NCT00943917|54607176|FG010|Stage I|Withdrawal by Subject|0|||
27949927|NCT00943917|54607177|FG011|Stage I|Withdrawal by Subject|0|||
27949928|NCT00943917|54607178|FG012|Stage I|Withdrawal by Subject|0|||
27949929|NCT00943917|54607179|FG013|Stage I|Withdrawal by Subject|0|||
27949930|NCT00943917|54607180|FG014|Stage I|Withdrawal by Subject|0|||
27949931|NCT00943917|54607166|FG000|Stage II|Adverse Event|0|||
27949932|NCT00943917|54607167|FG001|Stage II|Adverse Event|0|||
27949933|NCT00943917|54607168|FG002|Stage II|Adverse Event|0|||
27949934|NCT00943917|54607169|FG003|Stage II|Adverse Event|0|||
27949935|NCT00943917|54607170|FG004|Stage II|Adverse Event|0|||
27949936|NCT00943917|54607171|FG005|Stage II|Adverse Event|1|||
27949937|NCT00943917|54607172|FG006|Stage II|Adverse Event|3|||
27949938|NCT00943917|54607173|FG007|Stage II|Adverse Event|0|||
27949939|NCT00943917|54607174|FG008|Stage II|Adverse Event|1|||
27949940|NCT00943917|54607175|FG009|Stage II|Adverse Event|0|||
27949941|NCT00943917|54607176|FG010|Stage II|Adverse Event|0|||
27949942|NCT00943917|54607177|FG011|Stage II|Adverse Event|0|||
27949943|NCT00943917|54607178|FG012|Stage II|Adverse Event|0|||
27949944|NCT00943917|54607179|FG013|Stage II|Adverse Event|0|||
27949945|NCT00943917|54607180|FG014|Stage II|Adverse Event|0|||
27949946|NCT00943917|54607166|FG000|Stage II|Withdrawal by Subject|0|||
27949947|NCT00943917|54607167|FG001|Stage II|Withdrawal by Subject|0|||
27949948|NCT00943917|54607168|FG002|Stage II|Withdrawal by Subject|0|||
27949949|NCT00943917|54607169|FG003|Stage II|Withdrawal by Subject|0|||
27949950|NCT00943917|54607170|FG004|Stage II|Withdrawal by Subject|0|||
27949951|NCT00943917|54607171|FG005|Stage II|Withdrawal by Subject|1|||
27949952|NCT00943917|54607172|FG006|Stage II|Withdrawal by Subject|0|||
27949953|NCT00943917|54607173|FG007|Stage II|Withdrawal by Subject|0|||
27949954|NCT00943917|54607174|FG008|Stage II|Withdrawal by Subject|0|||
27949955|NCT00943917|54607175|FG009|Stage II|Withdrawal by Subject|0|||
27949956|NCT00943917|54607176|FG010|Stage II|Withdrawal by Subject|0|||
27949957|NCT00943917|54607177|FG011|Stage II|Withdrawal by Subject|0|||
27949958|NCT00943917|54607178|FG012|Stage II|Withdrawal by Subject|0|||
27949959|NCT00943917|54607179|FG013|Stage II|Withdrawal by Subject|0|||
27949960|NCT00943917|54607180|FG014|Stage II|Withdrawal by Subject|0|||
27949961|NCT00943917|54607166|FG000|Stage II|Pregnancy|0|||
27949962|NCT00943917|54607167|FG001|Stage II|Pregnancy|0|||
27949963|NCT00943917|54607168|FG002|Stage II|Pregnancy|0|||
27949964|NCT00943917|54607169|FG003|Stage II|Pregnancy|0|||
27949965|NCT00943917|54607170|FG004|Stage II|Pregnancy|0|||
27949966|NCT00943917|54607171|FG005|Stage II|Pregnancy|1|||
27949967|NCT00943917|54607172|FG006|Stage II|Pregnancy|0|||
27949968|NCT00943917|54607173|FG007|Stage II|Pregnancy|0|||
27949969|NCT00943917|54607174|FG008|Stage II|Pregnancy|0|||
27949970|NCT00943917|54607175|FG009|Stage II|Pregnancy|0|||
27949971|NCT00943917|54607176|FG010|Stage II|Pregnancy|0|||
27949972|NCT00943917|54607177|FG011|Stage II|Pregnancy|0|||
27949973|NCT00943917|54607178|FG012|Stage II|Pregnancy|0|||
27949974|NCT00943917|54607179|FG013|Stage II|Pregnancy|0|||
27949975|NCT00943917|54607180|FG014|Stage II|Pregnancy|0|||
27949976|NCT00943917|54607166|FG000|Stage II Continuation|Adverse Event|0|||
27949977|NCT00943917|54607167|FG001|Stage II Continuation|Adverse Event|0|||
27949978|NCT00943917|54607168|FG002|Stage II Continuation|Adverse Event|0|||
27949979|NCT00943917|54607169|FG003|Stage II Continuation|Adverse Event|0|||
27949980|NCT00943917|54607170|FG004|Stage II Continuation|Adverse Event|0|||
27949981|NCT00943917|54607171|FG005|Stage II Continuation|Adverse Event|0|||
27949982|NCT00943917|54607172|FG006|Stage II Continuation|Adverse Event|0|||
27949983|NCT00943917|54607173|FG007|Stage II Continuation|Adverse Event|0|||
27949984|NCT00943917|54607174|FG008|Stage II Continuation|Adverse Event|0|||
27949985|NCT00943917|54607175|FG009|Stage II Continuation|Adverse Event|0|||
27949986|NCT00943917|54607176|FG010|Stage II Continuation|Adverse Event|0|||
27949987|NCT00943917|54607177|FG011|Stage II Continuation|Adverse Event|1|||
27949988|NCT00943917|54607178|FG012|Stage II Continuation|Adverse Event|2|||
27949989|NCT00943917|54607179|FG013|Stage II Continuation|Adverse Event|1|||
27949990|NCT00943917|54607180|FG014|Stage II Continuation|Adverse Event|1|||
27949991|NCT00943917|54607166|FG000|Stage II Continuation|Withdrawal by Subject|0|||
27949992|NCT00943917|54607167|FG001|Stage II Continuation|Withdrawal by Subject|0|||
27949993|NCT00943917|54607168|FG002|Stage II Continuation|Withdrawal by Subject|0|||
27949994|NCT00943917|54607169|FG003|Stage II Continuation|Withdrawal by Subject|0|||
27949995|NCT00943917|54607170|FG004|Stage II Continuation|Withdrawal by Subject|0|||
27832224|NCT00983619|54311050|FG005|Overall Study|Withdrawal by Subject|23|||
27832225|NCT00983619|54311051|FG006|Overall Study|Withdrawal by Subject|0|||
27949996|NCT00943917|54607171|FG005|Stage II Continuation|Withdrawal by Subject|0|||
27949997|NCT00943917|54607172|FG006|Stage II Continuation|Withdrawal by Subject|0|||
27949998|NCT00943917|54607173|FG007|Stage II Continuation|Withdrawal by Subject|0|||
27949999|NCT00943917|54607174|FG008|Stage II Continuation|Withdrawal by Subject|0|||
27950000|NCT00943917|54607175|FG009|Stage II Continuation|Withdrawal by Subject|0|||
27950001|NCT00943917|54607176|FG010|Stage II Continuation|Withdrawal by Subject|0|||
27950002|NCT00943917|54607177|FG011|Stage II Continuation|Withdrawal by Subject|0|||
28080813|NCT03560518|54734091|FG001|Double Blind Treatment Period|Protocol Violation|2|||
27950003|NCT00943917|54607178|FG012|Stage II Continuation|Withdrawal by Subject|0|||
27950004|NCT00943917|54607179|FG013|Stage II Continuation|Withdrawal by Subject|1|||
27950005|NCT00943917|54607180|FG014|Stage II Continuation|Withdrawal by Subject|3|||
28080814|NCT03560518|54734092|FG002|Double Blind Treatment Period|Protocol Violation|0|||
27950006|NCT00943917|54607166|FG000|Stage II Continuation|Protocol Violation|0|||
27950007|NCT00943917|54607167|FG001|Stage II Continuation|Protocol Violation|0|||
27950008|NCT00943917|54607168|FG002|Stage II Continuation|Protocol Violation|0|||
27950009|NCT00943917|54607169|FG003|Stage II Continuation|Protocol Violation|0|||
27950010|NCT00943917|54607170|FG004|Stage II Continuation|Protocol Violation|0|||
27950011|NCT00943917|54607171|FG005|Stage II Continuation|Protocol Violation|0|||
27950012|NCT00943917|54607172|FG006|Stage II Continuation|Protocol Violation|0|||
27950013|NCT00943917|54607173|FG007|Stage II Continuation|Protocol Violation|0|||
27950014|NCT00943917|54607174|FG008|Stage II Continuation|Protocol Violation|0|||
27950015|NCT00943917|54607175|FG009|Stage II Continuation|Protocol Violation|1|||
27950016|NCT00943917|54607176|FG010|Stage II Continuation|Protocol Violation|0|||
27950017|NCT00943917|54607177|FG011|Stage II Continuation|Protocol Violation|1|||
27950018|NCT00943917|54607178|FG012|Stage II Continuation|Protocol Violation|0|||
27950019|NCT00943917|54607179|FG013|Stage II Continuation|Protocol Violation|0|||
27950020|NCT00943917|54607180|FG014|Stage II Continuation|Protocol Violation|0|||
27731705|NCT02603120|54179046|FG001|OL Extension B/F/TAF Treatment Phase|Death|1|||
27731706|NCT02603120|54179045|FG000|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0|||
27731707|NCT02603120|54179046|FG001|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1|||
27731708|NCT02599688|54179054|FG000|Overall Study|Lack of Efficacy|1|||
27731709|NCT02599688|54179054|FG000|Overall Study|Withdrawal by Subject|1|||
27731710|NCT02599688|54179054|FG000|Overall Study|Termination by Sponsor|2|||
27731711|NCT01331681|54179061|FG000|Overall Study|Adverse Event|10|||
27731712|NCT01331681|54179062|FG001|Overall Study|Adverse Event|13|||
27731713|NCT01331681|54179063|FG002|Overall Study|Adverse Event|10|||
27731714|NCT01331681|54179061|FG000|Overall Study|Death|6|||
27731715|NCT01331681|54179062|FG001|Overall Study|Death|6|||
27731716|NCT01331681|54179063|FG002|Overall Study|Death|2|||
27731717|NCT01331681|54179061|FG000|Overall Study|Lack of Efficacy|0|||
27731718|NCT01331681|54179062|FG001|Overall Study|Lack of Efficacy|1|||
27731719|NCT01331681|54179063|FG002|Overall Study|Lack of Efficacy|0|||
27731720|NCT01331681|54179061|FG000|Overall Study|Withdrawal by Subject|12|||
27731721|NCT01331681|54179062|FG001|Overall Study|Withdrawal by Subject|8|||
27731722|NCT01331681|54179063|FG002|Overall Study|Withdrawal by Subject|15|||
27731723|NCT01331681|54179061|FG000|Overall Study|Protocol Violation|1|||
27731724|NCT01331681|54179062|FG001|Overall Study|Protocol Violation|1|||
27731725|NCT01331681|54179063|FG002|Overall Study|Protocol Violation|0|||
27731726|NCT01331681|54179061|FG000|Overall Study|Lost to Follow-up|2|||
27731727|NCT01331681|54179062|FG001|Overall Study|Lost to Follow-up|4|||
27731728|NCT01331681|54179063|FG002|Overall Study|Lost to Follow-up|1|||
27731729|NCT01331681|54179061|FG000|Overall Study|Physician Decision|2|||
27731730|NCT01331681|54179062|FG001|Overall Study|Physician Decision|0|||
27731731|NCT01331681|54179063|FG002|Overall Study|Physician Decision|4|||
27731732|NCT01331681|54179061|FG000|Overall Study|Therapeutic procedure required|1|||
27731733|NCT01331681|54179062|FG001|Overall Study|Therapeutic procedure required|0|||
27731734|NCT01331681|54179063|FG002|Overall Study|Therapeutic procedure required|0|||
27731735|NCT01331681|54179061|FG000|Overall Study|Sponsor decision|1|||
27731736|NCT01331681|54179062|FG001|Overall Study|Sponsor decision|1|||
27731737|NCT01331681|54179063|FG002|Overall Study|Sponsor decision|0|||
27731738|NCT01331681|54179061|FG000|Overall Study|Switching to other therapy|0|||
27731739|NCT01331681|54179062|FG001|Overall Study|Switching to other therapy|0|||
27731740|NCT01331681|54179063|FG002|Overall Study|Switching to other therapy|1|||
27731741|NCT01331681|54179061|FG000|Overall Study|Not Received Study Treatment|0|||
27731742|NCT01331681|54179062|FG001|Overall Study|Not Received Study Treatment|0|||
27731743|NCT01331681|54179063|FG002|Overall Study|Not Received Study Treatment|2|||
27731744|NCT01331291|54179073|FG000|Overall Study|Lack of Efficacy|2|||
27731745|NCT01331291|54179074|FG001|Overall Study|Lack of Efficacy|8|||
27731746|NCT01331291|54179073|FG000|Overall Study|Death|0|||
27731747|NCT01331291|54179074|FG001|Overall Study|Death|1|||
27731748|NCT02601560|54179087|FG000|Overall Study|Other|0|||
27731749|NCT02601560|54179088|FG001|Overall Study|Other|0|||
27731750|NCT02601560|54179089|FG002|Overall Study|Other|0|||
27731751|NCT02601560|54179090|FG003|Overall Study|Other|0|||
27731752|NCT02601560|54179091|FG004|Overall Study|Other|0|||
27731753|NCT02601560|54179092|FG005|Overall Study|Other|0|||
27731754|NCT02601560|54179093|FG006|Overall Study|Other|1|||
27731755|NCT02601560|54179094|FG007|Overall Study|Other|0|||
27731756|NCT02595398|54179125|FG000|Overall Study|Non-compliance|1|||
27731757|NCT02595398|54179126|FG001|Overall Study|Non-compliance|0|||
27950021|NCT00943917|54607166|FG000|Stage II Continuation|hypoglycemia|0|||
27950022|NCT00943917|54607167|FG001|Stage II Continuation|hypoglycemia|0|||
27950023|NCT00943917|54607168|FG002|Stage II Continuation|hypoglycemia|0|||
27731758|NCT02595398|54179125|FG000|Overall Study|Withdrawal by Subject|2|||
27731759|NCT02595398|54179126|FG001|Overall Study|Withdrawal by Subject|1|||
27950024|NCT00943917|54607169|FG003|Stage II Continuation|hypoglycemia|0|||
27950025|NCT00943917|54607170|FG004|Stage II Continuation|hypoglycemia|0|||
27731760|NCT02595398|54179125|FG000|Overall Study|Lost to Follow-up|1|||
27731761|NCT02595398|54179126|FG001|Overall Study|Lost to Follow-up|0|||
27731762|NCT01368497|54179132|FG000|Overall Study|Lost to Follow-up|2|||
27731763|NCT02595008|54179138|FG000|Overall Study|Enrolled In Error|1|||
27731764|NCT02595008|54179139|FG001|Overall Study|Enrolled In Error|0|||
27731765|NCT02598128|54179145|FG000|Period A: Days -7 to -1|Adverse Event|1|||
27731766|NCT02598128|54179146|FG001|Period A: Days -7 to -1|Adverse Event|0|||
27731767|NCT02598128|54179147|FG002|Period A: Days -7 to -1|Adverse Event|0|||
27950026|NCT00943917|54607171|FG005|Stage II Continuation|hypoglycemia|0|||
27950027|NCT00943917|54607172|FG006|Stage II Continuation|hypoglycemia|0|||
27950028|NCT00943917|54607173|FG007|Stage II Continuation|hypoglycemia|0|||
27950029|NCT00943917|54607174|FG008|Stage II Continuation|hypoglycemia|0|||
27950030|NCT00943917|54607175|FG009|Stage II Continuation|hypoglycemia|0|||
27950031|NCT00943917|54607176|FG010|Stage II Continuation|hypoglycemia|0|||
27950032|NCT00943917|54607177|FG011|Stage II Continuation|hypoglycemia|0|||
27950033|NCT00943917|54607178|FG012|Stage II Continuation|hypoglycemia|1|||
27950034|NCT00943917|54607179|FG013|Stage II Continuation|hypoglycemia|0|||
27950035|NCT00943917|54607180|FG014|Stage II Continuation|hypoglycemia|0|||
27950036|NCT00943917|54607166|FG000|Stage II Continuation|A1C elevation|0|||
27950037|NCT00943917|54607167|FG001|Stage II Continuation|A1C elevation|0|||
27950038|NCT00943917|54607168|FG002|Stage II Continuation|A1C elevation|0|||
27950039|NCT00943917|54607169|FG003|Stage II Continuation|A1C elevation|0|||
27950040|NCT00943917|54607170|FG004|Stage II Continuation|A1C elevation|0|||
27950041|NCT00943917|54607171|FG005|Stage II Continuation|A1C elevation|0|||
27950042|NCT00943917|54607172|FG006|Stage II Continuation|A1C elevation|0|||
27950043|NCT00943917|54607173|FG007|Stage II Continuation|A1C elevation|0|||
27950044|NCT00943917|54607174|FG008|Stage II Continuation|A1C elevation|0|||
27950045|NCT00943917|54607175|FG009|Stage II Continuation|A1C elevation|0|||
27950046|NCT00943917|54607176|FG010|Stage II Continuation|A1C elevation|0|||
27950047|NCT00943917|54607177|FG011|Stage II Continuation|A1C elevation|0|||
27950048|NCT00943917|54607178|FG012|Stage II Continuation|A1C elevation|0|||
27950049|NCT00943917|54607179|FG013|Stage II Continuation|A1C elevation|1|||
27950050|NCT00943917|54607180|FG014|Stage II Continuation|A1C elevation|0|||
27950051|NCT01077024|54607215|FG000|Overall Study|Lost to Follow-up|20|||
27950052|NCT01077024|54607216|FG001|Overall Study|Lost to Follow-up|14|||
27950053|NCT01077024|54607215|FG000|Overall Study|Withdrawal by Subject|0|||
27950054|NCT01077024|54607216|FG001|Overall Study|Withdrawal by Subject|2|||
27950055|NCT01077024|54607215|FG000|Overall Study|Incarcerated|7|||
27950056|NCT01077024|54607216|FG001|Overall Study|Incarcerated|8|||
27950057|NCT01077024|54607215|FG000|Overall Study|Other|4|||
27950058|NCT01077024|54607216|FG001|Overall Study|Other|4|||
27950059|NCT01089582|54607222|FG000|Overall Study|Death|2|||
27950060|NCT01089582|54607222|FG000|Overall Study|Adverse Event|15|||
27950061|NCT01089582|54607222|FG000|Overall Study|Lost to Follow-up|8|||
27950062|NCT01089582|54607222|FG000|Overall Study|Other|4|||
27950063|NCT01089582|54607222|FG000|Overall Study|Withdrawal by Subject|1|||
27950064|NCT00862459|54607229|FG000|Overall Study|Lost to Follow-up|1|||
27950065|NCT00862459|54607230|FG001|Overall Study|Lost to Follow-up|2|||
27950066|NCT00862459|54607231|FG002|Overall Study|Lost to Follow-up|2|||
27950067|NCT00862459|54607229|FG000|Overall Study|Protocol Violation|1|||
27950068|NCT00862459|54607230|FG001|Overall Study|Protocol Violation|0|||
27950069|NCT00862459|54607231|FG002|Overall Study|Protocol Violation|0|||
27950070|NCT00862459|54607229|FG000|Overall Study|Withdrawal by Subject|1|||
27950071|NCT00862459|54607230|FG001|Overall Study|Withdrawal by Subject|1|||
27950072|NCT00862459|54607231|FG002|Overall Study|Withdrawal by Subject|3|||
27950073|NCT00862459|54607229|FG000|Overall Study|Adverse Event|0|||
27950074|NCT00862459|54607230|FG001|Overall Study|Adverse Event|1|||
27950075|NCT00862459|54607231|FG002|Overall Study|Adverse Event|0|||
27950076|NCT00862459|54607229|FG000|Overall Study|Personal reasons|1|||
27950077|NCT00862459|54607230|FG001|Overall Study|Personal reasons|0|||
27950078|NCT00862459|54607231|FG002|Overall Study|Personal reasons|0|||
27950079|NCT00862459|54607229|FG000|Overall Study|Operation|1|||
27950080|NCT00862459|54607230|FG001|Overall Study|Operation|1|||
27950081|NCT00862459|54607231|FG002|Overall Study|Operation|0|||
27950082|NCT00862459|54607229|FG000|Overall Study|Intravenous (IV) site problems|1|||
27950083|NCT00862459|54607230|FG001|Overall Study|Intravenous (IV) site problems|0|||
28080815|NCT03560518|54734090|FG000|Double Blind Treatment Period|Pregnancy|0|||
28080816|NCT03560518|54734091|FG001|Double Blind Treatment Period|Pregnancy|2|||
27950084|NCT00862459|54607231|FG002|Overall Study|Intravenous (IV) site problems|1|||
27950085|NCT00862459|54607229|FG000|Overall Study|Unable to hold still for imaging|0|||
27950086|NCT00862459|54607230|FG001|Overall Study|Unable to hold still for imaging|1|||
27950087|NCT00862459|54607231|FG002|Overall Study|Unable to hold still for imaging|0|||
27950088|NCT00862459|54607229|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
27950089|NCT00862459|54607230|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
27950090|NCT00862459|54607231|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
27950091|NCT00862459|54607229|FG000|Overall Study|Administrative problems|0|||
27950092|NCT00862459|54607230|FG001|Overall Study|Administrative problems|1|||
27950093|NCT00862459|54607231|FG002|Overall Study|Administrative problems|0|||
27950094|NCT00580047|54607243|FG000|Overall Study|Lost to Follow-up|1|||
27950095|NCT00580047|54607244|FG001|Overall Study|Lost to Follow-up|1|||
27950096|NCT00580047|54607245|FG002|Overall Study|Lost to Follow-up|0|||
27950097|NCT00580047|54607243|FG000|Overall Study|Withdrawal by Subject|1|||
27950098|NCT00580047|54607244|FG001|Overall Study|Withdrawal by Subject|1|||
27950099|NCT00580047|54607245|FG002|Overall Study|Withdrawal by Subject|2|||
27950100|NCT00580047|54607243|FG000|Overall Study|Withdrawal by Subject|1|||
27950101|NCT00580047|54607244|FG001|Overall Study|Withdrawal by Subject|0|||
27950102|NCT00580047|54607245|FG002|Overall Study|Withdrawal by Subject|0|||
27950103|NCT01074450|54607258|FG000|First Intervention|Emesis in Dosing Interval|0|||
27950104|NCT01074450|54607259|FG001|First Intervention|Emesis in Dosing Interval|2|||
27950105|NCT01074450|54607258|FG000|Second Intervention|Protocol Violation|1|||
27950106|NCT01074450|54607259|FG001|Second Intervention|Protocol Violation|0|||
27950107|NCT01074450|54607258|FG000|Second Intervention|Physician Decision|0|||
27950108|NCT01074450|54607259|FG001|Second Intervention|Physician Decision|1|||
27950109|NCT00943761|54607267|FG000|Overall Study|Lost to Follow-up|2|||
27950110|NCT00943761|54607268|FG001|Overall Study|Lost to Follow-up|0|||
27950111|NCT00943761|54607267|FG000|Overall Study|Withdrawal by Subject|2|||
27950112|NCT00943761|54607268|FG001|Overall Study|Withdrawal by Subject|1|||
27950113|NCT00949533|54607276|FG000|Overall Study|Lost to Follow-up|0|||
27950114|NCT00949533|54607277|FG001|Overall Study|Lost to Follow-up|1|||
27950115|NCT00866047|54607283|FG000|Treatment Period|Progressive disease|13|||
27950116|NCT00866047|54607283|FG000|Treatment Period|Adverse Event|16|||
27950117|NCT00866047|54607283|FG000|Treatment Period|Physician Decision|14|||
27950118|NCT00866047|54607283|FG000|Treatment Period|Withdrawal by Subject|5|||
27950119|NCT00866047|54607283|FG000|Follow-up Period|Lost to Follow-up|5|||
27950120|NCT00869323|54607287|FG000|Maintenance Therapy|concurrent illness|1|||
27950121|NCT01192022|54607295|FG000|Overall Study|Withdrawal of Consent|3|||
27950122|NCT01192022|54607296|FG001|Overall Study|Withdrawal of Consent|1|||
27950123|NCT01192022|54607297|FG002|Overall Study|Withdrawal of Consent|0|||
27950124|NCT01192022|54607298|FG003|Overall Study|Withdrawal of Consent|0|||
27950125|NCT01192022|54607299|FG004|Overall Study|Withdrawal of Consent|0|||
27950126|NCT01192022|54607295|FG000|Overall Study|Lost to Follow-up|4|||
27950127|NCT01192022|54607296|FG001|Overall Study|Lost to Follow-up|2|||
27950128|NCT01192022|54607297|FG002|Overall Study|Lost to Follow-up|1|||
27950129|NCT01192022|54607298|FG003|Overall Study|Lost to Follow-up|1|||
27950130|NCT01192022|54607299|FG004|Overall Study|Lost to Follow-up|0|||
27950131|NCT01192022|54607295|FG000|Overall Study|Adverse Event|1|||
27950132|NCT01192022|54607296|FG001|Overall Study|Adverse Event|0|||
27950133|NCT01192022|54607297|FG002|Overall Study|Adverse Event|0|||
27950134|NCT01192022|54607298|FG003|Overall Study|Adverse Event|0|||
27950135|NCT01192022|54607299|FG004|Overall Study|Adverse Event|0|||
27950136|NCT01192022|54607295|FG000|Overall Study|Fatal Adverse Event|4|||
27950137|NCT01192022|54607296|FG001|Overall Study|Fatal Adverse Event|6|||
27950138|NCT01192022|54607297|FG002|Overall Study|Fatal Adverse Event|0|||
27950139|NCT01192022|54607298|FG003|Overall Study|Fatal Adverse Event|0|||
27950140|NCT01192022|54607299|FG004|Overall Study|Fatal Adverse Event|1|||
27950141|NCT01192022|54607295|FG000|Overall Study|Physician withdrew-patient hardship|1|||
27950142|NCT01192022|54607296|FG001|Overall Study|Physician withdrew-patient hardship|0|||
27950143|NCT01192022|54607297|FG002|Overall Study|Physician withdrew-patient hardship|0|||
27950144|NCT01192022|54607298|FG003|Overall Study|Physician withdrew-patient hardship|0|||
27950145|NCT01192022|54607299|FG004|Overall Study|Physician withdrew-patient hardship|0|||
27950146|NCT01192022|54607295|FG000|Overall Study|Patient too sick from chemotherapy|0|||
27950147|NCT01192022|54607296|FG001|Overall Study|Patient too sick from chemotherapy|1|||
27950148|NCT01192022|54607297|FG002|Overall Study|Patient too sick from chemotherapy|0|||
27950149|NCT01192022|54607298|FG003|Overall Study|Patient too sick from chemotherapy|0|||
27950150|NCT01192022|54607299|FG004|Overall Study|Patient too sick from chemotherapy|0|||
27950151|NCT01192022|54607295|FG000|Overall Study|Patient needed surgery|0|||
27950152|NCT01192022|54607296|FG001|Overall Study|Patient needed surgery|1|||
27950153|NCT01192022|54607297|FG002|Overall Study|Patient needed surgery|0|||
27950154|NCT01192022|54607298|FG003|Overall Study|Patient needed surgery|0|||
27854838|NCT01271803|54372652|FG002|Overall Study|Withdrawal by Subject|0|||
27950155|NCT01192022|54607299|FG004|Overall Study|Patient needed surgery|0|||
27950156|NCT01192022|54607295|FG000|Overall Study|Parents did not allow all follow up|0|||
27950157|NCT01192022|54607296|FG001|Overall Study|Parents did not allow all follow up|0|||
27950158|NCT01192022|54607297|FG002|Overall Study|Parents did not allow all follow up|0|||
27950159|NCT01192022|54607298|FG003|Overall Study|Parents did not allow all follow up|1|||
27950160|NCT01192022|54607299|FG004|Overall Study|Parents did not allow all follow up|0|||
27950161|NCT01191944|54607312|FG000|Overall Study|Adverse Event|11|||
27950162|NCT01191944|54607313|FG001|Overall Study|Adverse Event|12|||
27950163|NCT01191944|54607312|FG000|Overall Study|Protocol Violation|1|||
27854839|NCT01271803|54372650|FG000|Overall Study|Lost to Follow-up|1|||
27854840|NCT01271803|54372651|FG001|Overall Study|Lost to Follow-up|0|||
28164837|NCT02665052|54835437|FG003|Overall Study|Lost to Follow-up|0|||
27950164|NCT01191944|54607313|FG001|Overall Study|Protocol Violation|2|||
27950165|NCT01191944|54607312|FG000|Overall Study|Withdrawal by Subject|4|||
27950166|NCT01191944|54607313|FG001|Overall Study|Withdrawal by Subject|2|||
27950167|NCT01191944|54607312|FG000|Overall Study|Other|1|||
27950168|NCT01191944|54607313|FG001|Overall Study|Other|3|||
27950169|NCT01191788|54607321|FG000|Overall Study|Lost to Follow-up|21|||
27950170|NCT01191788|54607322|FG001|Overall Study|Lost to Follow-up|22|||
27950171|NCT00940875|54607331|FG000|Treatment Phase|Adverse Event|9|||
27950172|NCT00940875|54607332|FG001|Treatment Phase|Adverse Event|3|||
27950173|NCT00940875|54607331|FG000|Treatment Phase|Death|3|||
27950174|NCT00940875|54607332|FG001|Treatment Phase|Death|5|||
27950175|NCT00940875|54607331|FG000|Treatment Phase|Lack of Efficacy|1|||
27950176|NCT00940875|54607332|FG001|Treatment Phase|Lack of Efficacy|0|||
27950177|NCT00940875|54607331|FG000|Treatment Phase|Withdrawal by Subject|3|||
27950178|NCT00940875|54607332|FG001|Treatment Phase|Withdrawal by Subject|0|||
27950179|NCT00940875|54607331|FG000|Treatment Phase|Disease progression|9|||
27950180|NCT00940875|54607332|FG001|Treatment Phase|Disease progression|11|||
27950181|NCT00940875|54607331|FG000|Treatment Phase|Physician Decision|1|||
27950182|NCT00940875|54607332|FG001|Treatment Phase|Physician Decision|0|||
27950183|NCT00940875|54607331|FG000|Post-Study Treatment|Death|0|||
27950184|NCT00940875|54607332|FG001|Post-Study Treatment|Death|1|||
27950185|NCT00940875|54607331|FG000|Post-Study Treatment|Disease Progression|0|||
27950186|NCT00940875|54607332|FG001|Post-Study Treatment|Disease Progression|2|||
27950187|NCT00940485|54607341|FG000|Overall Study|HBeAb positive at Baseline|3|||
27950188|NCT00940485|54607342|FG001|Overall Study|HBeAb positive at Baseline|2|||
27950189|NCT00940485|54607341|FG000|Overall Study|Lost to Follow-up|2|||
27950190|NCT00940485|54607342|FG001|Overall Study|Lost to Follow-up|3|||
27950191|NCT00940485|54607341|FG000|Overall Study|Adverse Event|8|||
27950192|NCT00940485|54607342|FG001|Overall Study|Adverse Event|0|||
27950193|NCT00940485|54607341|FG000|Overall Study|Withdrawal by Subject|1|||
27950194|NCT00940485|54607342|FG001|Overall Study|Withdrawal by Subject|1|||
27950195|NCT00940485|54607341|FG000|Overall Study|Others|1|||
27950196|NCT00940485|54607342|FG001|Overall Study|Others|1|||
27950197|NCT00943605|54607350|FG000|Overall Study|Study termination|30|||
27950198|NCT00943605|54607351|FG001|Overall Study|Study termination|30|||
27950199|NCT01132313|54607369|FG000|Overall Study|Lack of Efficacy|1|||
27950200|NCT01132313|54607370|FG001|Overall Study|Lack of Efficacy|0|||
27950201|NCT01132313|54607371|FG002|Overall Study|Lack of Efficacy|0|||
27950202|NCT01132313|54607372|FG003|Overall Study|Lack of Efficacy|0|||
27950203|NCT01132313|54607373|FG004|Overall Study|Lack of Efficacy|0|||
27950204|NCT01132313|54607374|FG005|Overall Study|Lack of Efficacy|0|||
27950205|NCT01132313|54607375|FG006|Overall Study|Lack of Efficacy|0|||
27950206|NCT01132313|54607376|FG007|Overall Study|Lack of Efficacy|3|||
27950207|NCT01132313|54607377|FG008|Overall Study|Lack of Efficacy|14|||
27950208|NCT01132313|54607378|FG009|Overall Study|Lack of Efficacy|16|||
27950209|NCT01132313|54607379|FG010|Overall Study|Lack of Efficacy|0|||
27950210|NCT01132313|54607380|FG011|Overall Study|Lack of Efficacy|0|||
27950211|NCT01132313|54607369|FG000|Overall Study|Not treated|2|||
27950212|NCT01132313|54607370|FG001|Overall Study|Not treated|0|||
27950213|NCT01132313|54607371|FG002|Overall Study|Not treated|0|||
28164838|NCT02665052|54835434|FG000|Overall Study|Withdrawal by Subject|1|||
28164839|NCT02665052|54835435|FG001|Overall Study|Withdrawal by Subject|1|||
28164840|NCT02665052|54835436|FG002|Overall Study|Withdrawal by Subject|0|||
28164841|NCT02665052|54835437|FG003|Overall Study|Withdrawal by Subject|5|||
28164842|NCT02665052|54835434|FG000|Overall Study|Adverse Event|1|||
28164843|NCT02665052|54835435|FG001|Overall Study|Adverse Event|1|||
28164844|NCT02665052|54835436|FG002|Overall Study|Adverse Event|0|||
28164845|NCT02665052|54835437|FG003|Overall Study|Adverse Event|0|||
28164846|NCT03019289|54835457|FG000|Overall Study|Adverse Event|1|||
28164847|NCT03019289|54835458|FG001|Overall Study|Adverse Event|0|||
28164848|NCT03019289|54835459|FG002|Overall Study|Adverse Event|0|||
28164849|NCT03019289|54835460|FG003|Overall Study|Adverse Event|0|||
27950214|NCT01132313|54607372|FG003|Overall Study|Not treated|0|||
27950215|NCT01132313|54607373|FG004|Overall Study|Not treated|2|||
28164850|NCT03019289|54835461|FG004|Overall Study|Adverse Event|0|||
28164851|NCT03019289|54835462|FG005|Overall Study|Adverse Event|0|||
28164852|NCT03019289|54835463|FG006|Overall Study|Adverse Event|0|||
27950216|NCT01132313|54607374|FG005|Overall Study|Not treated|1|||
28080817|NCT03560518|54734092|FG002|Double Blind Treatment Period|Pregnancy|0|||
28080818|NCT03560518|54734090|FG000|Double Blind Treatment Period|Lost to Follow-up|5|||
28080819|NCT03560518|54734091|FG001|Double Blind Treatment Period|Lost to Follow-up|6|||
28080820|NCT03560518|54734092|FG002|Double Blind Treatment Period|Lost to Follow-up|6|||
28080821|NCT03560518|54734090|FG000|Double Blind Treatment Period|Withdrawal by Subject|10|||
28080822|NCT03560518|54734091|FG001|Double Blind Treatment Period|Withdrawal by Subject|6|||
28080823|NCT03560518|54734092|FG002|Double Blind Treatment Period|Withdrawal by Subject|5|||
28080824|NCT03560518|54734090|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
28164853|NCT03019289|54835464|FG007|Overall Study|Adverse Event|0|||
28164854|NCT03019289|54835465|FG008|Overall Study|Adverse Event|1|||
27950217|NCT01132313|54607375|FG006|Overall Study|Not treated|3|||
27854841|NCT01271803|54372652|FG002|Overall Study|Lost to Follow-up|0|||
27950218|NCT01132313|54607376|FG007|Overall Study|Not treated|0|||
28080825|NCT03560518|54734091|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
28164855|NCT03019289|54835457|FG000|Overall Study|Other|1|||
27950219|NCT01132313|54607377|FG008|Overall Study|Not treated|0|||
27950220|NCT01132313|54607378|FG009|Overall Study|Not treated|0|||
27950221|NCT01132313|54607379|FG010|Overall Study|Not treated|0|||
27950222|NCT01132313|54607380|FG011|Overall Study|Not treated|0|||
27950223|NCT01132313|54607369|FG000|Overall Study|Adverse Event|0|||
28164856|NCT03019289|54835458|FG001|Overall Study|Other|0|||
28164857|NCT03019289|54835459|FG002|Overall Study|Other|0|||
28164858|NCT03019289|54835460|FG003|Overall Study|Other|0|||
28164859|NCT03019289|54835461|FG004|Overall Study|Other|0|||
28164860|NCT03019289|54835462|FG005|Overall Study|Other|0|||
28164861|NCT03019289|54835463|FG006|Overall Study|Other|0|||
28164862|NCT03019289|54835464|FG007|Overall Study|Other|0|||
28164863|NCT03019289|54835465|FG008|Overall Study|Other|0|||
28164864|NCT02520388|54835488|FG000|Overall Study|Physician Decision|1|||
28164865|NCT02520388|54835489|FG001|Overall Study|Physician Decision|0|||
28164866|NCT02520388|54835488|FG000|Overall Study|Subject or parent/guardian request|0|||
28164867|NCT02520388|54835489|FG001|Overall Study|Subject or parent/guardian request|6|||
28164868|NCT02520388|54835488|FG000|Overall Study|Adverse Event|1|||
28164869|NCT02520388|54835489|FG001|Overall Study|Adverse Event|4|||
28164870|NCT02520388|54835488|FG000|Overall Study|Lost to Follow-up|3|||
28164871|NCT02520388|54835489|FG001|Overall Study|Lost to Follow-up|2|||
28164872|NCT02520388|54835488|FG000|Overall Study|Other (reason not defined)|4|||
28164873|NCT02520388|54835489|FG001|Overall Study|Other (reason not defined)|4|||
28164874|NCT02924129|54835497|FG000|Overall Study|Adverse Event Unrelated to Device or Stimulation|2|||
28164875|NCT02924129|54835498|FG001|Overall Study|Adverse Event Unrelated to Device or Stimulation|1|||
28164876|NCT02924129|54835497|FG000|Overall Study|Withdrawal by Subject|2|||
28164877|NCT02924129|54835498|FG001|Overall Study|Withdrawal by Subject|2|||
28164878|NCT02924129|54835497|FG000|Overall Study|Physician Decision|1|||
28164879|NCT02924129|54835498|FG001|Overall Study|Physician Decision|0|||
28164880|NCT02924129|54835497|FG000|Overall Study|Missed Visit|0|||
28164881|NCT02924129|54835498|FG001|Overall Study|Missed Visit|1|||
28164882|NCT02668640|54835504|FG000|Overall Study|Lost to Follow-up|13|||
28164883|NCT02668640|54835504|FG000|Overall Study|Other, not specified|1|||
28164884|NCT03014453|54835508|FG000|Overall Study|Lost to Follow-up|12|||
28164885|NCT03014453|54835508|FG000|Overall Study|Discontinued GER|3|||
28164886|NCT03014453|54835508|FG000|Overall Study|Excluded|19|||
28164887|NCT03014453|54835508|FG000|Overall Study|Refused to take part in|37|||
28164888|NCT02664272|54835512|FG000|Overall Study|Fluoroscopic images not made available|2|||
28164889|NCT02663882|54835518|FG000|Overall Study|Lost to Follow-up|4|||
28164890|NCT02663882|54835519|FG001|Overall Study|Lost to Follow-up|2|||
28164891|NCT03011333|54835532|FG000|Overall Study|Lost to Follow-up|0|||
28164892|NCT03011333|54835533|FG001|Overall Study|Lost to Follow-up|1|||
28164893|NCT03011333|54835534|FG002|Overall Study|Lost to Follow-up|0|||
28164894|NCT03011333|54835535|FG003|Overall Study|Lost to Follow-up|1|||
28164895|NCT03011333|54835536|FG004|Overall Study|Lost to Follow-up|4|||
28164896|NCT03011333|54835537|FG005|Overall Study|Lost to Follow-up|4|||
28164897|NCT03011333|54835538|FG006|Overall Study|Lost to Follow-up|5|||
28164898|NCT03011099|54835556|FG000|Overall Study|Withdrawal by Subject|0|||
28164899|NCT03011099|54835557|FG001|Overall Study|Withdrawal by Subject|2|||
28164900|NCT03013985|54835567|FG000|Overall Study|Protocol Violation|2|||
28164901|NCT03013985|54835568|FG001|Overall Study|Protocol Violation|2|||
28164902|NCT03013985|54835567|FG000|Overall Study|Withdrawal by Subject|14|||
28164903|NCT03013985|54835568|FG001|Overall Study|Withdrawal by Subject|17|||
28164904|NCT03016403|54835578|FG000|Baseline|Death|5|||
28164905|NCT03016403|54835579|FG001|Baseline|Death|8|||
28164906|NCT03016403|54835580|FG002|Baseline|Death|1|||
28164907|NCT03016403|54835581|FG003|Baseline|Death|0|||
28164908|NCT03016403|54835578|FG000|Baseline|Withdrawal by Subject|2|||
27731768|NCT02598128|54179148|FG003|Period A: Days -7 to -1|Adverse Event|0|||
27731769|NCT02788175|54179160|FG000|Overall Study|Protocol Violation|3|||
27854842|NCT00080288|54372703|FG000|Overall Study|Adverse Event|7|||
27854843|NCT00080288|54372704|FG001|Overall Study|Adverse Event|4|||
28080826|NCT03560518|54734092|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
28080827|NCT03560518|54734090|FG000|Double Blind Treatment Period|Adverse Event|0|||
28080828|NCT03560518|54734091|FG001|Double Blind Treatment Period|Adverse Event|3|||
28080829|NCT03560518|54734092|FG002|Double Blind Treatment Period|Adverse Event|1|||
28080830|NCT03560206|54734102|FG000|Overall Study|Lost to Follow-up|19|||
28080831|NCT03560206|54734103|FG001|Overall Study|Lost to Follow-up|11|||
28080832|NCT03560206|54734102|FG000|Overall Study|Withdrawal by Subject|2|||
28080833|NCT03560206|54734103|FG001|Overall Study|Withdrawal by Subject|4|||
28080834|NCT03560206|54734102|FG000|Overall Study|caregivers' health condition and not becoming non-caregiver|5|||
28080835|NCT03560206|54734103|FG001|Overall Study|caregivers' health condition and not becoming non-caregiver|0|||
28080836|NCT03560206|54734102|FG000|Overall Study|Busy schedule|14|||
28164909|NCT03016403|54835579|FG001|Baseline|Withdrawal by Subject|8|||
28164910|NCT03016403|54835580|FG002|Baseline|Withdrawal by Subject|4|||
28164911|NCT03016403|54835581|FG003|Baseline|Withdrawal by Subject|10|||
28164912|NCT03016403|54835578|FG000|Baseline|Lost to Follow-up|9|||
28164913|NCT03016403|54835579|FG001|Baseline|Lost to Follow-up|11|||
28164914|NCT03016403|54835580|FG002|Baseline|Lost to Follow-up|6|||
28164915|NCT03016403|54835581|FG003|Baseline|Lost to Follow-up|24|||
28164916|NCT03016403|54835578|FG000|6-week Follow-up|Death|1|||
28164917|NCT03016403|54835579|FG001|6-week Follow-up|Death|4|||
28164918|NCT03016403|54835580|FG002|6-week Follow-up|Death|0|||
28164919|NCT03016403|54835581|FG003|6-week Follow-up|Death|0|||
28164920|NCT03016403|54835578|FG000|6-week Follow-up|Lost to Follow-up|2|||
27731770|NCT02788175|54179160|FG000|Overall Study|Withdrawal by Subject|4|||
27854844|NCT00080288|54372703|FG000|Overall Study|Lost to Follow-up|3|||
27950224|NCT01132313|54607370|FG001|Overall Study|Adverse Event|0|||
27950225|NCT01132313|54607371|FG002|Overall Study|Adverse Event|4|||
27950226|NCT01132313|54607372|FG003|Overall Study|Adverse Event|10|||
27950227|NCT01132313|54607373|FG004|Overall Study|Adverse Event|19|||
27950228|NCT01132313|54607374|FG005|Overall Study|Adverse Event|6|||
27950229|NCT01132313|54607375|FG006|Overall Study|Adverse Event|5|||
27950230|NCT01132313|54607376|FG007|Overall Study|Adverse Event|3|||
27950231|NCT01132313|54607377|FG008|Overall Study|Adverse Event|7|||
27950232|NCT01132313|54607378|FG009|Overall Study|Adverse Event|2|||
27950233|NCT01132313|54607379|FG010|Overall Study|Adverse Event|0|||
27950234|NCT01132313|54607380|FG011|Overall Study|Adverse Event|0|||
27950235|NCT01132313|54607369|FG000|Overall Study|Protocol Violation|0|||
27950236|NCT01132313|54607370|FG001|Overall Study|Protocol Violation|0|||
27950237|NCT01132313|54607371|FG002|Overall Study|Protocol Violation|0|||
27950238|NCT01132313|54607372|FG003|Overall Study|Protocol Violation|1|||
27950239|NCT01132313|54607373|FG004|Overall Study|Protocol Violation|0|||
27950240|NCT01132313|54607374|FG005|Overall Study|Protocol Violation|0|||
27950241|NCT01132313|54607375|FG006|Overall Study|Protocol Violation|0|||
27950242|NCT01132313|54607376|FG007|Overall Study|Protocol Violation|0|||
27950243|NCT01132313|54607377|FG008|Overall Study|Protocol Violation|0|||
27950244|NCT01132313|54607378|FG009|Overall Study|Protocol Violation|0|||
27950245|NCT01132313|54607379|FG010|Overall Study|Protocol Violation|0|||
27950246|NCT01132313|54607380|FG011|Overall Study|Protocol Violation|0|||
27950247|NCT01132313|54607369|FG000|Overall Study|Lost to Follow-up|0|||
27950248|NCT01132313|54607370|FG001|Overall Study|Lost to Follow-up|0|||
27950249|NCT01132313|54607371|FG002|Overall Study|Lost to Follow-up|1|||
27950250|NCT01132313|54607372|FG003|Overall Study|Lost to Follow-up|0|||
27950251|NCT01132313|54607373|FG004|Overall Study|Lost to Follow-up|0|||
27950252|NCT01132313|54607374|FG005|Overall Study|Lost to Follow-up|0|||
27950253|NCT01132313|54607375|FG006|Overall Study|Lost to Follow-up|0|||
27950254|NCT01132313|54607376|FG007|Overall Study|Lost to Follow-up|1|||
27950255|NCT01132313|54607377|FG008|Overall Study|Lost to Follow-up|0|||
27950256|NCT01132313|54607378|FG009|Overall Study|Lost to Follow-up|0|||
27950257|NCT01132313|54607379|FG010|Overall Study|Lost to Follow-up|0|||
27950258|NCT01132313|54607380|FG011|Overall Study|Lost to Follow-up|0|||
27950259|NCT01132313|54607369|FG000|Overall Study|Withdrawal by Subject|0|||
27950260|NCT01132313|54607370|FG001|Overall Study|Withdrawal by Subject|0|||
27950261|NCT01132313|54607371|FG002|Overall Study|Withdrawal by Subject|3|||
27950262|NCT01132313|54607372|FG003|Overall Study|Withdrawal by Subject|3|||
27950263|NCT01132313|54607373|FG004|Overall Study|Withdrawal by Subject|6|||
27950264|NCT01132313|54607374|FG005|Overall Study|Withdrawal by Subject|0|||
27950265|NCT01132313|54607375|FG006|Overall Study|Withdrawal by Subject|1|||
27950266|NCT01132313|54607376|FG007|Overall Study|Withdrawal by Subject|0|||
27950267|NCT01132313|54607377|FG008|Overall Study|Withdrawal by Subject|0|||
27950268|NCT01132313|54607378|FG009|Overall Study|Withdrawal by Subject|2|||
27950269|NCT01132313|54607379|FG010|Overall Study|Withdrawal by Subject|0|||
27950270|NCT01132313|54607380|FG011|Overall Study|Withdrawal by Subject|0|||
27950271|NCT01132313|54607369|FG000|Overall Study|Lack of antiviral response|0|||
27950272|NCT01132313|54607370|FG001|Overall Study|Lack of antiviral response|0|||
27950273|NCT01132313|54607371|FG002|Overall Study|Lack of antiviral response|12|||
27950274|NCT01132313|54607372|FG003|Overall Study|Lack of antiviral response|18|||
27950275|NCT01132313|54607373|FG004|Overall Study|Lack of antiviral response|18|||
27950276|NCT01132313|54607374|FG005|Overall Study|Lack of antiviral response|18|||
27950277|NCT01132313|54607375|FG006|Overall Study|Lack of antiviral response|21|||
27950278|NCT01132313|54607376|FG007|Overall Study|Lack of antiviral response|0|||
27950279|NCT01132313|54607377|FG008|Overall Study|Lack of antiviral response|0|||
27950280|NCT01132313|54607378|FG009|Overall Study|Lack of antiviral response|0|||
27950281|NCT01132313|54607379|FG010|Overall Study|Lack of antiviral response|1|||
27950282|NCT01132313|54607380|FG011|Overall Study|Lack of antiviral response|0|||
27950283|NCT01132313|54607369|FG000|Overall Study|Other reason not defined above|0|||
27950284|NCT01132313|54607370|FG001|Overall Study|Other reason not defined above|0|||
27950285|NCT01132313|54607371|FG002|Overall Study|Other reason not defined above|0|||
27950286|NCT01132313|54607372|FG003|Overall Study|Other reason not defined above|0|||
27950287|NCT01132313|54607373|FG004|Overall Study|Other reason not defined above|0|||
27950288|NCT01132313|54607374|FG005|Overall Study|Other reason not defined above|0|||
27854845|NCT00080288|54372704|FG001|Overall Study|Lost to Follow-up|5|||
27950289|NCT01132313|54607375|FG006|Overall Study|Other reason not defined above|0|||
27950290|NCT01132313|54607376|FG007|Overall Study|Other reason not defined above|1|||
27950291|NCT01132313|54607377|FG008|Overall Study|Other reason not defined above|0|||
27950292|NCT01132313|54607378|FG009|Overall Study|Other reason not defined above|0|||
27950293|NCT01132313|54607379|FG010|Overall Study|Other reason not defined above|0|||
27950294|NCT01132313|54607380|FG011|Overall Study|Other reason not defined above|0|||
27950295|NCT00861757|54607415|FG000|Overall Study|Adverse Event|1|||
27950296|NCT00861757|54607416|FG001|Overall Study|Adverse Event|5|||
27950297|NCT00861757|54607417|FG002|Overall Study|Adverse Event|7|||
27950298|NCT00861757|54607418|FG003|Overall Study|Adverse Event|2|||
27950299|NCT00861757|54607415|FG000|Overall Study|Entry Criteria Not Met|1|||
27950300|NCT00861757|54607416|FG001|Overall Study|Entry Criteria Not Met|2|||
27950301|NCT00861757|54607417|FG002|Overall Study|Entry Criteria Not Met|1|||
27950302|NCT00861757|54607418|FG003|Overall Study|Entry Criteria Not Met|1|||
27950303|NCT00861757|54607415|FG000|Overall Study|Lack of Efficacy|3|||
27950304|NCT00861757|54607416|FG001|Overall Study|Lack of Efficacy|1|||
27950305|NCT00861757|54607417|FG002|Overall Study|Lack of Efficacy|0|||
27950306|NCT00861757|54607418|FG003|Overall Study|Lack of Efficacy|1|||
27950307|NCT00861757|54607415|FG000|Overall Study|Lost to Follow-up|1|||
27950308|NCT00861757|54607416|FG001|Overall Study|Lost to Follow-up|0|||
27950309|NCT00861757|54607417|FG002|Overall Study|Lost to Follow-up|1|||
27950310|NCT00861757|54607418|FG003|Overall Study|Lost to Follow-up|1|||
27950311|NCT00861757|54607415|FG000|Overall Study|Physician Decision|0|||
27950312|NCT00861757|54607416|FG001|Overall Study|Physician Decision|0|||
27950313|NCT00861757|54607417|FG002|Overall Study|Physician Decision|0|||
27950314|NCT00861757|54607418|FG003|Overall Study|Physician Decision|1|||
27950315|NCT00861757|54607415|FG000|Overall Study|Protocol Violation|2|||
27950316|NCT00861757|54607416|FG001|Overall Study|Protocol Violation|2|||
27950317|NCT00861757|54607417|FG002|Overall Study|Protocol Violation|4|||
27950318|NCT00861757|54607418|FG003|Overall Study|Protocol Violation|1|||
27950319|NCT00861757|54607415|FG000|Overall Study|Withdrawal by Subject|1|||
27950320|NCT00861757|54607416|FG001|Overall Study|Withdrawal by Subject|5|||
27950321|NCT00861757|54607417|FG002|Overall Study|Withdrawal by Subject|5|||
27950322|NCT00861757|54607418|FG003|Overall Study|Withdrawal by Subject|2|||
27950323|NCT01131455|54607435|FG000|Overall Study|Death of PI|6|||
27950324|NCT01131455|54607436|FG001|Overall Study|Death of PI|4|||
27950325|NCT01131455|54607437|FG002|Overall Study|Death of PI|0|||
27950326|NCT01138007|54607448|FG000|Overall Study|Adverse Event|4|||
27950327|NCT01138007|54607449|FG001|Overall Study|Adverse Event|12|||
27950328|NCT01138007|54607450|FG002|Overall Study|Adverse Event|9|||
27950329|NCT01138007|54607448|FG000|Overall Study|Lack of Efficacy|2|||
27950330|NCT01138007|54607449|FG001|Overall Study|Lack of Efficacy|0|||
27950331|NCT01138007|54607450|FG002|Overall Study|Lack of Efficacy|6|||
27950332|NCT01138007|54607448|FG000|Overall Study|Protocol Violation|2|||
27950333|NCT01138007|54607449|FG001|Overall Study|Protocol Violation|3|||
27950334|NCT01138007|54607450|FG002|Overall Study|Protocol Violation|2|||
27950335|NCT01138007|54607448|FG000|Overall Study|Protocol-Defined Stopping Criteria|6|||
27950336|NCT01138007|54607449|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
27950337|NCT01138007|54607450|FG002|Overall Study|Protocol-Defined Stopping Criteria|8|||
27950338|NCT01138007|54607448|FG000|Overall Study|Lost to Follow-up|3|||
27950339|NCT01138007|54607449|FG001|Overall Study|Lost to Follow-up|3|||
27950340|NCT01138007|54607450|FG002|Overall Study|Lost to Follow-up|5|||
27950341|NCT01138007|54607448|FG000|Overall Study|Physician Decision|0|||
27950342|NCT01138007|54607449|FG001|Overall Study|Physician Decision|5|||
27950343|NCT01138007|54607450|FG002|Overall Study|Physician Decision|3|||
27950344|NCT01138007|54607448|FG000|Overall Study|Withdrawal by Subject|5|||
27950345|NCT01138007|54607449|FG001|Overall Study|Withdrawal by Subject|6|||
27950346|NCT01138007|54607450|FG002|Overall Study|Withdrawal by Subject|15|||
27950347|NCT00865345|54607460|FG000|Overall Study|Withdrawal by Subject|2|||
27950348|NCT01131299|54607464|FG000|Overall Study|Withdrawal by Subject|4|||
27950349|NCT01131299|54607465|FG001|Overall Study|Withdrawal by Subject|7|||
27950350|NCT01130831|54607470|FG000|Overall Study|Withdrawal by Subject|7|||
27950351|NCT01130831|54607470|FG000|Overall Study|Death|4|||
27950352|NCT01130831|54607470|FG000|Overall Study|Information was missing|3|||
27950353|NCT01130597|54607486|FG000|Overall Study|Protocol-specified (High K+)|1|||
27950354|NCT01130597|54607486|FG000|Overall Study|Adverse Event|4|||
27950355|NCT01130597|54607486|FG000|Overall Study|Death|1|||
27950356|NCT01130597|54607486|FG000|Overall Study|Protocol Violation|1|||
27950357|NCT00939003|54607492|FG000|Double-blind Treatment Period|Adverse Event|1|||
27950358|NCT00939003|54607493|FG001|Double-blind Treatment Period|Adverse Event|1|||
28080837|NCT03560206|54734103|FG001|Overall Study|Busy schedule|2|||
28080838|NCT03560206|54734102|FG000|Overall Study|patients' new health condition such as cancer|10|||
28080839|NCT03560206|54734103|FG001|Overall Study|patients' new health condition such as cancer|1|||
27731771|NCT02788175|54179160|FG000|Overall Study|Ineligible prior to study agent|6|||
27731772|NCT02787083|54179166|FG000|Overall Study|Adverse Event|1|||
27854846|NCT00080288|54372703|FG000|Overall Study|Physician Decision|6|||
27950359|NCT00939003|54607492|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
27950360|NCT00939003|54607493|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
27950361|NCT00939003|54607492|FG000|Double-blind Treatment Period|Pregnancy|0|||
27950362|NCT00939003|54607493|FG001|Double-blind Treatment Period|Pregnancy|1|||
28080840|NCT02892760|54734109|FG000|Overall Study|Withdrawal by Subject|3|||
27950363|NCT00939003|54607492|FG000|Double-blind Treatment Period|MRI Not Diagnostic|1|||
27950364|NCT00939003|54607493|FG001|Double-blind Treatment Period|MRI Not Diagnostic|1|||
27950365|NCT00939003|54607492|FG000|Open-label Treatment Period|Adverse Event|4|||
27950366|NCT00939003|54607493|FG001|Open-label Treatment Period|Adverse Event|8|||
27950367|NCT00939003|54607492|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
27950368|NCT00939003|54607493|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
27950369|NCT00939003|54607492|FG000|Open-label Treatment Period|Lack of Efficacy|6|||
27950370|NCT00939003|54607493|FG001|Open-label Treatment Period|Lack of Efficacy|9|||
27950371|NCT00939003|54607492|FG000|Open-label Treatment Period|Pregnancy|1|||
27950372|NCT00939003|54607493|FG001|Open-label Treatment Period|Pregnancy|1|||
27950373|NCT00939003|54607492|FG000|Open-label Treatment Period|Exclusion Criteria|1|||
27950374|NCT00939003|54607493|FG001|Open-label Treatment Period|Exclusion Criteria|0|||
27950375|NCT00939003|54607492|FG000|Open-label Treatment Period|Site Closure|3|||
27950376|NCT00939003|54607493|FG001|Open-label Treatment Period|Site Closure|4|||
27950377|NCT01188668|54607502|FG000|Period 1: ARIP Alone|Protocol Violation|2|||
27950378|NCT01188668|54607502|FG000|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2|||
27950379|NCT01188668|54607502|FG000|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1|||
27950380|NCT01130051|54607509|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
27950381|NCT01130051|54607510|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
27950382|NCT01130051|54607509|FG000|Washout Period of 14 Days|Protocol Violation|1|||
27950383|NCT01130051|54607510|FG001|Washout Period of 14 Days|Protocol Violation|1|||
27950384|NCT00865189|54607518|FG000|Overall Study|Other|1|||
27950385|NCT00865189|54607519|FG001|Overall Study|Other|2|||
27950386|NCT00865189|54607518|FG000|Overall Study|Death|4|||
27950387|NCT00865189|54607519|FG001|Overall Study|Death|11|||
27950388|NCT00865189|54607518|FG000|Overall Study|Lost to Follow-up|6|||
27950389|NCT00865189|54607519|FG001|Overall Study|Lost to Follow-up|6|||
27950390|NCT00865189|54607518|FG000|Overall Study|Withdrawal by Subject|1|||
27950391|NCT00865189|54607519|FG001|Overall Study|Withdrawal by Subject|0|||
27950392|NCT01182194|54607527|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
27950393|NCT01182194|54607528|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
27950394|NCT01181726|54607536|FG000|First Intervention|Adverse Event|1|||
27950395|NCT01181726|54607537|FG001|First Intervention|Adverse Event|0|||
27950396|NCT01137071|54607543|FG000|Overall Study|Disease Progression|11|||
27950397|NCT01137071|54607543|FG000|Overall Study|Withdrawal by Subject|2|||
27950398|NCT01137071|54607543|FG000|Overall Study|Wrongly Included|1|||
27950399|NCT00860743|54607558|FG000|Overall Study|Withdrawal by Subject|3|||
27950400|NCT00860743|54607559|FG001|Overall Study|Withdrawal by Subject|0|||
27950401|NCT01186796|54607567|FG000|Overall Study|Adverse Event|3|||
27950402|NCT01186796|54607568|FG001|Overall Study|Adverse Event|0|||
27950403|NCT01186796|54607567|FG000|Overall Study|Withdrawal by Subject|1|||
27950404|NCT01186796|54607568|FG001|Overall Study|Withdrawal by Subject|1|||
27950405|NCT01186796|54607567|FG000|Overall Study|Protocol Violation|0|||
27950406|NCT01186796|54607568|FG001|Overall Study|Protocol Violation|1|||
27950407|NCT01136915|54607576|FG000|Overall Study|Lost to Follow-up|2|||
27950408|NCT01136915|54607577|FG001|Overall Study|Lost to Follow-up|0|||
27950409|NCT01136915|54607576|FG000|Overall Study|Exclusion criterion met|0|||
27950410|NCT01136915|54607577|FG001|Overall Study|Exclusion criterion met|1|||
27950411|NCT00940017|54607585|FG000|Overall Study|did not meet entrance criteria|3|||
27950412|NCT00940017|54607585|FG000|Overall Study|Adverse Event|1|||
27950413|NCT01129583|54607591|FG000|Overall Study|Death|1|||
27950414|NCT01129583|54607592|FG001|Overall Study|Death|0|||
27950415|NCT01129583|54607591|FG000|Overall Study|Lost to Follow-up|1|||
27950416|NCT01129583|54607592|FG001|Overall Study|Lost to Follow-up|1|||
27950417|NCT01129583|54607591|FG000|Overall Study|Ipsilateral Upper Extremity Injury|1|||
27950418|NCT01129583|54607592|FG001|Overall Study|Ipsilateral Upper Extremity Injury|1|||
27950419|NCT01186328|54607598|FG000|Overall Study|Death|1|||
27950420|NCT01186328|54607599|FG001|Overall Study|Death|0|||
27950421|NCT01186328|54607600|FG002|Overall Study|Death|0|||
27950422|NCT00848497|54607607|FG000|Overall Study|Screen failure|2|||
27950423|NCT00848497|54607608|FG001|Overall Study|Screen failure|0|||
27950424|NCT00848497|54607607|FG000|Overall Study|Withdrawal by Subject|0|||
27950425|NCT00848497|54607608|FG001|Overall Study|Withdrawal by Subject|1|||
27950426|NCT00857623|54607618|FG000|Overall Study|Adverse Event|5|||
27950427|NCT00857623|54607619|FG001|Overall Study|Adverse Event|2|||
27950428|NCT00857623|54607618|FG000|Overall Study|Study-specific discontinuation criteria|5|||
27950429|NCT00857623|54607619|FG001|Overall Study|Study-specific discontinuation criteria|3|||
27950430|NCT00857623|54607618|FG000|Overall Study|Withdrawal by Subject|2|||
27950431|NCT00857623|54607619|FG001|Overall Study|Withdrawal by Subject|1|||
27950432|NCT00857623|54607618|FG000|Overall Study|Lack of Efficacy|1|||
27950433|NCT00857623|54607619|FG001|Overall Study|Lack of Efficacy|1|||
27950434|NCT00857623|54607618|FG000|Overall Study|Severe non-compliance to protocol|1|||
27950435|NCT00857623|54607619|FG001|Overall Study|Severe non-compliance to protocol|1|||
27950436|NCT00857623|54607618|FG000|Overall Study|Intake of prohibited medication|0|||
27950437|NCT00857623|54607619|FG001|Overall Study|Intake of prohibited medication|1|||
27950438|NCT00857623|54607618|FG000|Overall Study|Positive for HEP C|0|||
27950439|NCT00857623|54607619|FG001|Overall Study|Positive for HEP C|1|||
27950440|NCT01185782|54607627|FG000|Overall Study|Adverse Event|0|||
27950441|NCT01185782|54607628|FG001|Overall Study|Adverse Event|1|||
27950442|NCT01185782|54607627|FG000|Overall Study|Protocol Violation|1|||
27950443|NCT01185782|54607628|FG001|Overall Study|Protocol Violation|0|||
27950444|NCT01185782|54607627|FG000|Overall Study|Poor Response to Treatment|3|||
27950445|NCT01185782|54607628|FG001|Overall Study|Poor Response to Treatment|1|||
27950446|NCT01185782|54607627|FG000|Overall Study|Other|2|||
27950447|NCT01185782|54607628|FG001|Overall Study|Other|5|||
27950448|NCT01185782|54607627|FG000|Overall Study|Randomized but not treated|0|||
27950449|NCT01185782|54607628|FG001|Overall Study|Randomized but not treated|4|||
27950450|NCT01129115|54607638|FG000|Overall Study|Adverse Event|1|||
28080841|NCT03635086|54734118|FG000|Overall Study|Withdrawal of consent|0|||
28080842|NCT03635086|54734119|FG001|Overall Study|Withdrawal of consent|0|||
28080843|NCT03635086|54734120|FG002|Overall Study|Withdrawal of consent|1|||
28080844|NCT03635086|54734121|FG003|Overall Study|Withdrawal of consent|0|||
28080845|NCT03635086|54734122|FG004|Overall Study|Withdrawal of consent|0|||
28080846|NCT03635086|54734118|FG000|Overall Study|Adverse Event|0|||
28080847|NCT03635086|54734119|FG001|Overall Study|Adverse Event|1|||
28080848|NCT03635086|54734120|FG002|Overall Study|Adverse Event|0|||
28080849|NCT03635086|54734121|FG003|Overall Study|Adverse Event|0|||
28080850|NCT03635086|54734122|FG004|Overall Study|Adverse Event|0|||
28080851|NCT03635086|54734118|FG000|Overall Study|Lost to Follow-up|1|||
28080852|NCT03635086|54734119|FG001|Overall Study|Lost to Follow-up|0|||
28080853|NCT03635086|54734120|FG002|Overall Study|Lost to Follow-up|0|||
28080854|NCT03635086|54734121|FG003|Overall Study|Lost to Follow-up|0|||
28080855|NCT03635086|54734122|FG004|Overall Study|Lost to Follow-up|0|||
28080856|NCT03588910|54734137|FG000|Overall Study|Withdrawal by Subject|1|||
28080857|NCT03588910|54734138|FG001|Overall Study|Withdrawal by Subject|0|||
28080858|NCT03588910|54734137|FG000|Overall Study|Allergy|2|||
28080859|NCT03588910|54734138|FG001|Overall Study|Allergy|0|||
28080860|NCT03588910|54734137|FG000|Overall Study|Protocol Violation|0|||
28080861|NCT03588910|54734138|FG001|Overall Study|Protocol Violation|3|||
28080862|NCT03588910|54734137|FG000|Overall Study|Did not complete Day 1 Survey|5|||
28080863|NCT03588910|54734138|FG001|Overall Study|Did not complete Day 1 Survey|10|||
28080864|NCT03588910|54734137|FG000|Overall Study|Did not complete Day 7 Survey|5|||
28080865|NCT03588910|54734138|FG001|Overall Study|Did not complete Day 7 Survey|2|||
28080866|NCT03587974|54734146|FG000|Overall Study|caregiver demented, care recipient died|3|||
28080867|NCT03587974|54734147|FG001|Overall Study|caregiver demented, care recipient died|3|||
28080868|NCT03587974|54734146|FG000|Overall Study|Withdrawal by Subject|2|||
28080869|NCT03587974|54734147|FG001|Overall Study|Withdrawal by Subject|1|||
28080870|NCT00103857|54734160|FG000|54-Week Base Study|Adverse Event|12|||
28080871|NCT00103857|54734161|FG001|54-Week Base Study|Adverse Event|9|||
28080872|NCT00103857|54734162|FG002|54-Week Base Study|Adverse Event|11|||
28080873|NCT00103857|54734163|FG003|54-Week Base Study|Adverse Event|6|||
28080874|NCT00103857|54734164|FG004|54-Week Base Study|Adverse Event|5|||
28080875|NCT00103857|54734165|FG005|54-Week Base Study|Adverse Event|11|||
28080876|NCT00103857|54734166|FG006|54-Week Base Study|Adverse Event|3|||
28080877|NCT00103857|54734160|FG000|54-Week Base Study|Death|0|||
28080878|NCT00103857|54734161|FG001|54-Week Base Study|Death|0|||
28080879|NCT00103857|54734162|FG002|54-Week Base Study|Death|0|||
28080880|NCT00103857|54734163|FG003|54-Week Base Study|Death|0|||
28080881|NCT00103857|54734164|FG004|54-Week Base Study|Death|1|||
28080882|NCT00103857|54734165|FG005|54-Week Base Study|Death|1|||
28080883|NCT00103857|54734166|FG006|54-Week Base Study|Death|0|||
28080884|NCT00103857|54734160|FG000|54-Week Base Study|Lack of Efficacy|11|||
28080885|NCT00103857|54734161|FG001|54-Week Base Study|Lack of Efficacy|14|||
28080886|NCT00103857|54734162|FG002|54-Week Base Study|Lack of Efficacy|8|||
28080887|NCT00103857|54734163|FG003|54-Week Base Study|Lack of Efficacy|4|||
28080888|NCT00103857|54734164|FG004|54-Week Base Study|Lack of Efficacy|3|||
28080889|NCT00103857|54734165|FG005|54-Week Base Study|Lack of Efficacy|14|||
28080890|NCT00103857|54734166|FG006|54-Week Base Study|Lack of Efficacy|19|||
28080891|NCT00103857|54734160|FG000|54-Week Base Study|Lost to Follow-up|5|||
28080892|NCT00103857|54734161|FG001|54-Week Base Study|Lost to Follow-up|4|||
28080893|NCT00103857|54734162|FG002|54-Week Base Study|Lost to Follow-up|7|||
28080894|NCT00103857|54734163|FG003|54-Week Base Study|Lost to Follow-up|5|||
28080895|NCT00103857|54734164|FG004|54-Week Base Study|Lost to Follow-up|10|||
28080896|NCT00103857|54734165|FG005|54-Week Base Study|Lost to Follow-up|9|||
28080897|NCT00103857|54734166|FG006|54-Week Base Study|Lost to Follow-up|3|||
28080898|NCT00103857|54734160|FG000|54-Week Base Study|Physician Decision|1|||
27731773|NCT02787083|54179167|FG001|Overall Study|Adverse Event|0|||
27731774|NCT02787083|54179166|FG000|Overall Study|Withdrawal by Subject|2|||
27731775|NCT02787083|54179167|FG001|Overall Study|Withdrawal by Subject|2|||
28080899|NCT00103857|54734161|FG001|54-Week Base Study|Physician Decision|1|||
28080900|NCT00103857|54734162|FG002|54-Week Base Study|Physician Decision|0|||
28080901|NCT00103857|54734163|FG003|54-Week Base Study|Physician Decision|0|||
28080902|NCT00103857|54734164|FG004|54-Week Base Study|Physician Decision|1|||
28080903|NCT00103857|54734165|FG005|54-Week Base Study|Physician Decision|0|||
28080904|NCT00103857|54734166|FG006|54-Week Base Study|Physician Decision|0|||
28080905|NCT00103857|54734160|FG000|54-Week Base Study|Pregnancy|1|||
28080906|NCT00103857|54734161|FG001|54-Week Base Study|Pregnancy|0|||
28080907|NCT00103857|54734162|FG002|54-Week Base Study|Pregnancy|0|||
28080908|NCT00103857|54734163|FG003|54-Week Base Study|Pregnancy|0|||
28080909|NCT00103857|54734164|FG004|54-Week Base Study|Pregnancy|1|||
27950451|NCT01129115|54607639|FG001|Overall Study|Adverse Event|2|||
27950452|NCT01129115|54607640|FG002|Overall Study|Adverse Event|3|||
27950453|NCT01129115|54607641|FG003|Overall Study|Adverse Event|3|||
27950454|NCT01129115|54607638|FG000|Overall Study|Withdrawal by Subject|1|||
27950455|NCT01129115|54607639|FG001|Overall Study|Withdrawal by Subject|3|||
27950456|NCT01129115|54607640|FG002|Overall Study|Withdrawal by Subject|1|||
27950457|NCT01129115|54607641|FG003|Overall Study|Withdrawal by Subject|4|||
27950458|NCT01129115|54607638|FG000|Overall Study|Protocol Violation|0|||
27950459|NCT01129115|54607639|FG001|Overall Study|Protocol Violation|2|||
27950460|NCT01129115|54607640|FG002|Overall Study|Protocol Violation|2|||
27950461|NCT01129115|54607641|FG003|Overall Study|Protocol Violation|2|||
27950462|NCT01185704|54607653|FG000|Overall Study|Randomized but not treated|3|||
27950463|NCT01185704|54607654|FG001|Overall Study|Randomized but not treated|3|||
27950464|NCT01185704|54607653|FG000|Overall Study|Lack of ovarian response|5|||
27950465|NCT01185704|54607654|FG001|Overall Study|Lack of ovarian response|1|||
27950466|NCT01185704|54607653|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|5|||
27950467|NCT01185704|54607654|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
27950468|NCT01185704|54607653|FG000|Overall Study|Ectopic pregnancy|0|||
27950469|NCT01185704|54607654|FG001|Overall Study|Ectopic pregnancy|1|||
27950470|NCT01128959|54607660|FG000|Lead in Period|Adverse Event|3|||
27950471|NCT01128959|54607660|FG000|Treatment Period|Adverse Event|3|||
27950472|NCT01128959|54607660|FG000|Treatment Period|Withdrawal by Subject|1|||
27950473|NCT00859573|54607668|FG000|Overall Study|Withdrawal by Subject|4|||
27950474|NCT00859573|54607669|FG001|Overall Study|Withdrawal by Subject|1|||
27950475|NCT00859573|54607668|FG000|Overall Study|Physician Decision|1|||
27950476|NCT00859573|54607669|FG001|Overall Study|Physician Decision|1|||
27950477|NCT01136291|54607677|FG000|Overall Study|Lost to Follow-up|1|||
27950478|NCT01136291|54607678|FG001|Overall Study|Lost to Follow-up|1|||
27950479|NCT01185548|54607684|FG000|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2|||
27950480|NCT01128569|54607697|FG000|Washout Period 1|Adverse Event|0|||
27950481|NCT01128569|54607698|FG001|Washout Period 1|Adverse Event|0|||
27950482|NCT01128569|54607699|FG002|Washout Period 1|Adverse Event|1|||
27950483|NCT01128569|54607700|FG003|Washout Period 1|Adverse Event|0|||
27950484|NCT01128569|54607701|FG004|Washout Period 1|Adverse Event|0|||
27950485|NCT01128569|54607702|FG005|Washout Period 1|Adverse Event|0|||
27950486|NCT01128569|54607697|FG000|Treatment Period 2|Withdrawal by Subject|0|||
27950487|NCT01128569|54607698|FG001|Treatment Period 2|Withdrawal by Subject|1|||
27950488|NCT01128569|54607699|FG002|Treatment Period 2|Withdrawal by Subject|0|||
27950489|NCT01128569|54607700|FG003|Treatment Period 2|Withdrawal by Subject|0|||
27950490|NCT01128569|54607701|FG004|Treatment Period 2|Withdrawal by Subject|0|||
27950491|NCT01128569|54607702|FG005|Treatment Period 2|Withdrawal by Subject|0|||
27950492|NCT01128413|54607712|FG000|Overall Study|Withdrawal by Subject|1|||
27950493|NCT01128413|54607713|FG001|Overall Study|Withdrawal by Subject|0|||
27950494|NCT01128413|54607712|FG000|Overall Study|NICOM Monitor Problems|2|||
27950495|NCT01128413|54607713|FG001|Overall Study|NICOM Monitor Problems|1|||
27950496|NCT01128413|54607712|FG000|Overall Study|Pt made DNR|1|||
27950497|NCT01128413|54607713|FG001|Overall Study|Pt made DNR|0|||
27950498|NCT01185080|54607722|FG000|Overall Study|Adverse Event|1|||
27950499|NCT01185080|54607723|FG001|Overall Study|Adverse Event|1|||
27950500|NCT01185080|54607724|FG002|Overall Study|Adverse Event|0|||
27950501|NCT01185080|54607722|FG000|Overall Study|Personal reasons|0|||
27950502|NCT01185080|54607723|FG001|Overall Study|Personal reasons|0|||
27950503|NCT01185080|54607724|FG002|Overall Study|Personal reasons|1|||
27950504|NCT01128179|54607734|FG000|Overall Study|Death|1|||
27950505|NCT01128179|54607735|FG001|Overall Study|Death|0|||
27950506|NCT01128179|54607734|FG000|Overall Study|Protocol Violation|1|||
27854847|NCT00080288|54372704|FG001|Overall Study|Physician Decision|2|||
27854848|NCT00080288|54372703|FG000|Overall Study|Withdrawal by Subject|3|||
27854849|NCT00080288|54372704|FG001|Overall Study|Withdrawal by Subject|16|||
27854850|NCT00080288|54372703|FG000|Overall Study|Miscellaneous|11|||
27854851|NCT00080288|54372704|FG001|Overall Study|Miscellaneous|11|||
27854852|NCT01271725|54372778|FG000|Part A|Progressive disease according to RECIST|8|||
27854853|NCT01271725|54372779|FG001|Part A|Progressive disease according to RECIST|0|||
27854854|NCT01271725|54372778|FG000|Part A|Clinical signs/symptoms of progression|2|||
27854855|NCT01271725|54372779|FG001|Part A|Clinical signs/symptoms of progression|0|||
27854856|NCT01271725|54372778|FG000|Part A|Other Adverse Event|8|||
27854857|NCT01271725|54372779|FG001|Part A|Other Adverse Event|0|||
27854858|NCT01271725|54372778|FG000|Part A|Lost to Follow-up|1|||
27854859|NCT01271725|54372779|FG001|Part A|Lost to Follow-up|0|||
27950507|NCT01128179|54607735|FG001|Overall Study|Protocol Violation|0|||
27950508|NCT01181102|54607743|FG000|Overall Study|Adverse Event|28|||
27950509|NCT01181102|54607744|FG001|Overall Study|Adverse Event|26|||
27950510|NCT01181102|54607743|FG000|Overall Study|Lack of Efficacy|3|||
27950511|NCT01181102|54607744|FG001|Overall Study|Lack of Efficacy|1|||
27950512|NCT01181102|54607743|FG000|Overall Study|Lost to Follow-up|2|||
27950513|NCT01181102|54607744|FG001|Overall Study|Lost to Follow-up|0|||
27950514|NCT01181102|54607743|FG000|Overall Study|Physician Decision|3|||
27950515|NCT01181102|54607744|FG001|Overall Study|Physician Decision|1|||
27950516|NCT01181102|54607743|FG000|Overall Study|Protocol Violation|5|||
27950517|NCT01181102|54607744|FG001|Overall Study|Protocol Violation|6|||
27950518|NCT01181102|54607743|FG000|Overall Study|Withdrawal by Subject|10|||
27950519|NCT01181102|54607744|FG001|Overall Study|Withdrawal by Subject|12|||
27950520|NCT00858637|54607752|FG000|Active Comparison Phase|Adverse Event|14|||
27950521|NCT00858637|54607753|FG001|Active Comparison Phase|Adverse Event|0|||
27950522|NCT00858637|54607754|FG002|Active Comparison Phase|Adverse Event|0|||
27950523|NCT00858637|54607755|FG003|Active Comparison Phase|Adverse Event|9|||
27950524|NCT00858637|54607756|FG004|Active Comparison Phase|Adverse Event|0|||
27950525|NCT00858637|54607757|FG005|Active Comparison Phase|Adverse Event|0|||
27950526|NCT00858637|54607752|FG000|Active Comparison Phase|Death|1|||
27950527|NCT00858637|54607753|FG001|Active Comparison Phase|Death|0|||
27950528|NCT00858637|54607754|FG002|Active Comparison Phase|Death|0|||
27950529|NCT00858637|54607755|FG003|Active Comparison Phase|Death|1|||
27950530|NCT00858637|54607756|FG004|Active Comparison Phase|Death|0|||
27950531|NCT00858637|54607757|FG005|Active Comparison Phase|Death|0|||
27950532|NCT00858637|54607752|FG000|Active Comparison Phase|Physician Decision|1|||
27950533|NCT00858637|54607753|FG001|Active Comparison Phase|Physician Decision|0|||
27950534|NCT00858637|54607754|FG002|Active Comparison Phase|Physician Decision|0|||
27950535|NCT00858637|54607755|FG003|Active Comparison Phase|Physician Decision|1|||
27950536|NCT00858637|54607756|FG004|Active Comparison Phase|Physician Decision|0|||
27950537|NCT00858637|54607757|FG005|Active Comparison Phase|Physician Decision|0|||
27950538|NCT00858637|54607752|FG000|Active Comparison Phase|Withdrawal by Subject|7|||
27950539|NCT00858637|54607753|FG001|Active Comparison Phase|Withdrawal by Subject|0|||
27950540|NCT00858637|54607754|FG002|Active Comparison Phase|Withdrawal by Subject|0|||
27950541|NCT00858637|54607755|FG003|Active Comparison Phase|Withdrawal by Subject|6|||
27950542|NCT00858637|54607756|FG004|Active Comparison Phase|Withdrawal by Subject|0|||
27950543|NCT00858637|54607757|FG005|Active Comparison Phase|Withdrawal by Subject|0|||
27950544|NCT00858637|54607752|FG000|Active Comparison Phase|Other Reasons|1|||
27950545|NCT00858637|54607753|FG001|Active Comparison Phase|Other Reasons|0|||
27950546|NCT00858637|54607754|FG002|Active Comparison Phase|Other Reasons|0|||
27950547|NCT00858637|54607755|FG003|Active Comparison Phase|Other Reasons|1|||
27950548|NCT00858637|54607756|FG004|Active Comparison Phase|Other Reasons|0|||
27950549|NCT00858637|54607757|FG005|Active Comparison Phase|Other Reasons|0|||
27950550|NCT00858637|54607752|FG000|Placebo-controlled Withdrawal Phase|Death|0|||
27950551|NCT00858637|54607753|FG001|Placebo-controlled Withdrawal Phase|Death|0|||
27950552|NCT00858637|54607754|FG002|Placebo-controlled Withdrawal Phase|Death|1|||
27950553|NCT00858637|54607755|FG003|Placebo-controlled Withdrawal Phase|Death|0|||
27950554|NCT00858637|54607756|FG004|Placebo-controlled Withdrawal Phase|Death|1|||
27950555|NCT00858637|54607757|FG005|Placebo-controlled Withdrawal Phase|Death|0|||
27950556|NCT00858637|54607752|FG000|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
27950557|NCT00858637|54607753|FG001|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
27950558|NCT00858637|54607754|FG002|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
27950559|NCT00858637|54607755|FG003|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
27950560|NCT00858637|54607756|FG004|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
27950561|NCT00858637|54607757|FG005|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1|||
27950562|NCT00858403|54607767|FG000|Overall Study|Withdrawal by Subject|1|||
27854860|NCT01271725|54372778|FG000|Part A|Withdrawal by Subject|12|||
27950563|NCT00858403|54607767|FG000|Overall Study|Death|3|||
27950564|NCT00858403|54607767|FG000|Overall Study|Disease Progression|1|||
27950565|NCT00858247|54607773|FG000|Baseline Assessment|Withdrawal by Subject|1|||
27950566|NCT00858247|54607774|FG001|Baseline Assessment|Withdrawal by Subject|1|||
27950567|NCT00858247|54607773|FG000|Baseline Assessment|Poor IV access|1|||
27950568|NCT00858247|54607774|FG001|Baseline Assessment|Poor IV access|0|||
27950569|NCT00858247|54607773|FG000|Baseline Assessment|Protocol Violation|0|||
27950570|NCT00858247|54607774|FG001|Baseline Assessment|Protocol Violation|1|||
27950571|NCT00858247|54607773|FG000|Week 12 Follow-up|Withdrawal by Subject|0|||
27950572|NCT00858247|54607774|FG001|Week 12 Follow-up|Withdrawal by Subject|1|||
27950573|NCT00838435|54607780|FG000|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1|||
27950574|NCT00838435|54607780|FG000|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2|||
27950575|NCT00838435|54607780|FG000|Part 2 (7 Years)|Adverse Event|2|||
27950576|NCT00838435|54607780|FG000|Part 2 (7 Years)|Lost to Follow-up|2|||
27950577|NCT00838435|54607780|FG000|Part 2 (7 Years)|Physician Decision|1|||
27832226|NCT00983619|54311052|FG007|Overall Study|Withdrawal by Subject|0|||
27950578|NCT00838435|54607780|FG000|Part 2 (7 Years)|Sponsor Decision|6|||
27950579|NCT00838435|54607780|FG000|Part 2 (7 Years)|Withdrawal by Subject|5|||
27832227|NCT00983619|54311053|FG008|Overall Study|Withdrawal by Subject|0|||
27832228|NCT00983619|54311054|FG009|Overall Study|Withdrawal by Subject|0|||
27832229|NCT00983619|54311055|FG010|Overall Study|Withdrawal by Subject|1|||
27832230|NCT00983619|54311056|FG011|Overall Study|Withdrawal by Subject|1|||
27832231|NCT00983619|54311045|FG000|Overall Study|Death|0|||
27832232|NCT00983619|54311046|FG001|Overall Study|Death|2|||
27832233|NCT00983619|54311047|FG002|Overall Study|Death|2|||
27832234|NCT00983619|54311048|FG003|Overall Study|Death|1|||
27950580|NCT00838201|54607789|FG000|Overall Study|Investigator decision, or other reasons|2|||
27950581|NCT00838201|54607790|FG001|Overall Study|Investigator decision, or other reasons|3|||
27950582|NCT00838201|54607789|FG000|Overall Study|Noncompliance|0|||
27950583|NCT00838201|54607790|FG001|Overall Study|Noncompliance|1|||
27950584|NCT00838201|54607789|FG000|Overall Study|Administrative decision|1|||
27950585|NCT00838201|54607790|FG001|Overall Study|Administrative decision|2|||
27950586|NCT00838201|54607789|FG000|Overall Study|Disease progression|3|||
27950587|NCT00838201|54607790|FG001|Overall Study|Disease progression|3|||
27950588|NCT00838201|54607789|FG000|Overall Study|Consent withdrawn|16|||
27950589|NCT00838201|54607790|FG001|Overall Study|Consent withdrawn|19|||
27950590|NCT00838201|54607789|FG000|Overall Study|Lost to Follow-up|4|||
27950591|NCT00838201|54607790|FG001|Overall Study|Lost to Follow-up|3|||
27950592|NCT00838201|54607789|FG000|Overall Study|Adverse Event|5|||
27950593|NCT00838201|54607790|FG001|Overall Study|Adverse Event|9|||
27950594|NCT00838201|54607789|FG000|Overall Study|Death|11|||
27950595|NCT00838201|54607790|FG001|Overall Study|Death|13|||
27950596|NCT00837967|54607796|FG000|Washout Period of 7 - 14 Days|Adverse Event|2|||
27950597|NCT00837967|54607797|FG001|Washout Period of 7 - 14 Days|Adverse Event|0|||
27950598|NCT02756806|54607803|FG000|Overall Study|Study terminated early|5|||
27950599|NCT00942357|54607809|FG000|Overall Study|Ineligible|37|||
27950600|NCT00942357|54607810|FG001|Overall Study|Ineligible|40|||
27950601|NCT00939783|54607816|FG000|Overall Study|Death|6|||
27950602|NCT00939783|54607816|FG000|Overall Study|Adverse Event|39|||
27950603|NCT00939783|54607816|FG000|Overall Study|Study Terminated by Sponsor|498|||
27950604|NCT00939783|54607816|FG000|Overall Study|Withdrawal by Subject|78|||
27950605|NCT00939783|54607816|FG000|Overall Study|Other|16|||
27950606|NCT00939783|54607816|FG000|Overall Study|Lost to Follow-up|8|||
27950607|NCT00939783|54607816|FG000|Overall Study|Protocol Violation|3|||
27950608|NCT00939783|54607816|FG000|Overall Study|Enrolled but not treated|1|||
27950609|NCT00939627|54607822|FG000|Overall Study|Disease Progression|16|||
27950610|NCT00939627|54607823|FG001|Overall Study|Disease Progression|12|||
27950611|NCT00939627|54607824|FG002|Overall Study|Disease Progression|0|||
27950612|NCT00939627|54607822|FG000|Overall Study|Adverse Event|6|||
27950613|NCT00939627|54607823|FG001|Overall Study|Adverse Event|7|||
27950614|NCT00939627|54607824|FG002|Overall Study|Adverse Event|0|||
27950615|NCT00939627|54607822|FG000|Overall Study|Death|0|||
27950616|NCT00939627|54607823|FG001|Overall Study|Death|2|||
27950617|NCT00939627|54607824|FG002|Overall Study|Death|0|||
27950618|NCT00939627|54607822|FG000|Overall Study|Withdrawal by Subject|2|||
27950619|NCT00939627|54607823|FG001|Overall Study|Withdrawal by Subject|4|||
27950620|NCT00939627|54607824|FG002|Overall Study|Withdrawal by Subject|0|||
27950621|NCT00939627|54607822|FG000|Overall Study|Other complicating disease|1|||
27950622|NCT00939627|54607823|FG001|Overall Study|Other complicating disease|1|||
27950623|NCT00939627|54607824|FG002|Overall Study|Other complicating disease|0|||
27950624|NCT00939627|54607822|FG000|Overall Study|Not compliant|2|||
27950625|NCT00939627|54607823|FG001|Overall Study|Not compliant|0|||
27950626|NCT00939627|54607824|FG002|Overall Study|Not compliant|0|||
27950627|NCT00939627|54607822|FG000|Overall Study|No off-tx reason given|0|||
27950628|NCT00939627|54607823|FG001|Overall Study|No off-tx reason given|2|||
27950629|NCT00939627|54607824|FG002|Overall Study|No off-tx reason given|0|||
27950630|NCT00937833|54607832|FG000|Overall Study|Protocol Violation|1|||
27950631|NCT00937833|54607833|FG001|Overall Study|Protocol Violation|2|||
27950632|NCT00937833|54607832|FG000|Overall Study|Procedure delayed; enrollment closed|0|||
27950633|NCT00937833|54607833|FG001|Overall Study|Procedure delayed; enrollment closed|1|||
27950634|NCT00937833|54607832|FG000|Overall Study|Lost to Follow-up|10|||
27950635|NCT00937833|54607833|FG001|Overall Study|Lost to Follow-up|8|||
27950636|NCT00937833|54607832|FG000|Overall Study|Withdrawal by Subject|4|||
27950637|NCT00937833|54607833|FG001|Overall Study|Withdrawal by Subject|6|||
27950638|NCT01135511|54607848|FG000|Overall Study|Adverse Event|0|||
27950639|NCT01135511|54607849|FG001|Overall Study|Adverse Event|1|||
27950640|NCT01135511|54607850|FG002|Overall Study|Adverse Event|2|||
27950641|NCT01135511|54607851|FG003|Overall Study|Adverse Event|0|||
27950642|NCT01135511|54607852|FG004|Overall Study|Adverse Event|0|||
27950643|NCT01135511|54607853|FG005|Overall Study|Adverse Event|1|||
27950644|NCT01135511|54607854|FG006|Overall Study|Adverse Event|0|||
27950645|NCT01135511|54607855|FG007|Overall Study|Adverse Event|1|||
27950646|NCT01135511|54607856|FG008|Overall Study|Adverse Event|0|||
27950647|NCT01135511|54607848|FG000|Overall Study|Lack of Efficacy|0|||
28080910|NCT00103857|54734165|FG005|54-Week Base Study|Pregnancy|0|||
27950648|NCT01135511|54607849|FG001|Overall Study|Lack of Efficacy|1|||
27950649|NCT01135511|54607850|FG002|Overall Study|Lack of Efficacy|1|||
27950650|NCT01135511|54607851|FG003|Overall Study|Lack of Efficacy|2|||
27950651|NCT01135511|54607852|FG004|Overall Study|Lack of Efficacy|0|||
27950652|NCT01135511|54607853|FG005|Overall Study|Lack of Efficacy|0|||
27950653|NCT01135511|54607854|FG006|Overall Study|Lack of Efficacy|0|||
27950654|NCT01135511|54607855|FG007|Overall Study|Lack of Efficacy|0|||
27950655|NCT01135511|54607856|FG008|Overall Study|Lack of Efficacy|0|||
27950656|NCT01135511|54607848|FG000|Overall Study|Protocol Violation|0|||
27950657|NCT01135511|54607849|FG001|Overall Study|Protocol Violation|0|||
27950658|NCT01135511|54607850|FG002|Overall Study|Protocol Violation|3|||
28080911|NCT00103857|54734166|FG006|54-Week Base Study|Pregnancy|1|||
27950659|NCT01135511|54607851|FG003|Overall Study|Protocol Violation|0|||
27950660|NCT01135511|54607852|FG004|Overall Study|Protocol Violation|0|||
27950661|NCT01135511|54607853|FG005|Overall Study|Protocol Violation|0|||
27950662|NCT01135511|54607854|FG006|Overall Study|Protocol Violation|0|||
27950663|NCT01135511|54607855|FG007|Overall Study|Protocol Violation|0|||
27950664|NCT01135511|54607856|FG008|Overall Study|Protocol Violation|0|||
27950665|NCT01135511|54607848|FG000|Overall Study|Pregnancy|0|||
27950666|NCT01135511|54607849|FG001|Overall Study|Pregnancy|0|||
27950667|NCT01135511|54607850|FG002|Overall Study|Pregnancy|0|||
27950668|NCT01135511|54607851|FG003|Overall Study|Pregnancy|1|||
27950669|NCT01135511|54607852|FG004|Overall Study|Pregnancy|0|||
27950670|NCT01135511|54607853|FG005|Overall Study|Pregnancy|0|||
27950671|NCT01135511|54607854|FG006|Overall Study|Pregnancy|0|||
27950672|NCT01135511|54607855|FG007|Overall Study|Pregnancy|0|||
27950673|NCT01135511|54607856|FG008|Overall Study|Pregnancy|0|||
27950674|NCT01135511|54607848|FG000|Overall Study|could not visit the clinic|0|||
27950675|NCT01135511|54607849|FG001|Overall Study|could not visit the clinic|1|||
27950676|NCT01135511|54607850|FG002|Overall Study|could not visit the clinic|2|||
27950677|NCT01135511|54607851|FG003|Overall Study|could not visit the clinic|0|||
27950678|NCT01135511|54607852|FG004|Overall Study|could not visit the clinic|0|||
27950679|NCT01135511|54607853|FG005|Overall Study|could not visit the clinic|0|||
27950680|NCT01135511|54607854|FG006|Overall Study|could not visit the clinic|0|||
27950681|NCT01135511|54607855|FG007|Overall Study|could not visit the clinic|0|||
27950682|NCT01135511|54607856|FG008|Overall Study|could not visit the clinic|0|||
27950683|NCT01135511|54607848|FG000|Overall Study|noncompliance with study drug taken|0|||
27950684|NCT01135511|54607849|FG001|Overall Study|noncompliance with study drug taken|0|||
27950685|NCT01135511|54607850|FG002|Overall Study|noncompliance with study drug taken|0|||
27950686|NCT01135511|54607851|FG003|Overall Study|noncompliance with study drug taken|0|||
27950687|NCT01135511|54607852|FG004|Overall Study|noncompliance with study drug taken|1|||
27950688|NCT01135511|54607853|FG005|Overall Study|noncompliance with study drug taken|0|||
27950689|NCT01135511|54607854|FG006|Overall Study|noncompliance with study drug taken|0|||
27950690|NCT01135511|54607855|FG007|Overall Study|noncompliance with study drug taken|0|||
27950691|NCT01135511|54607856|FG008|Overall Study|noncompliance with study drug taken|0|||
27950692|NCT01135511|54607848|FG000|Overall Study|Withdrawal by Subject|0|||
27950693|NCT01135511|54607849|FG001|Overall Study|Withdrawal by Subject|0|||
27950694|NCT01135511|54607850|FG002|Overall Study|Withdrawal by Subject|0|||
27950695|NCT01135511|54607851|FG003|Overall Study|Withdrawal by Subject|0|||
27950696|NCT01135511|54607852|FG004|Overall Study|Withdrawal by Subject|0|||
27950697|NCT01135511|54607853|FG005|Overall Study|Withdrawal by Subject|0|||
27950698|NCT01135511|54607854|FG006|Overall Study|Withdrawal by Subject|1|||
27950699|NCT01135511|54607855|FG007|Overall Study|Withdrawal by Subject|0|||
27950700|NCT01135511|54607856|FG008|Overall Study|Withdrawal by Subject|1|||
27950701|NCT01180790|54607892|FG000|Overall Study|Adverse Event|1|||
27950702|NCT01180790|54607893|FG001|Overall Study|Adverse Event|1|||
27950703|NCT01180790|54607894|FG002|Overall Study|Adverse Event|2|||
27950704|NCT01180790|54607895|FG003|Overall Study|Adverse Event|0|||
27950705|NCT01180790|54607896|FG004|Overall Study|Adverse Event|1|||
27950706|NCT01180790|54607897|FG005|Overall Study|Adverse Event|3|||
27950707|NCT01180790|54607898|FG006|Overall Study|Adverse Event|0|||
27950708|NCT01180790|54607892|FG000|Overall Study|Withdrawal by Subject|3|||
27950709|NCT01180790|54607893|FG001|Overall Study|Withdrawal by Subject|0|||
27950710|NCT01180790|54607894|FG002|Overall Study|Withdrawal by Subject|5|||
27950711|NCT01180790|54607895|FG003|Overall Study|Withdrawal by Subject|0|||
27950712|NCT01180790|54607896|FG004|Overall Study|Withdrawal by Subject|2|||
27950713|NCT01180790|54607897|FG005|Overall Study|Withdrawal by Subject|1|||
27950714|NCT01180790|54607898|FG006|Overall Study|Withdrawal by Subject|0|||
27950715|NCT01180790|54607892|FG000|Overall Study|Lost to Follow-up|3|||
27950716|NCT01180790|54607893|FG001|Overall Study|Lost to Follow-up|1|||
27950717|NCT01180790|54607894|FG002|Overall Study|Lost to Follow-up|0|||
27950718|NCT01180790|54607895|FG003|Overall Study|Lost to Follow-up|2|||
27950719|NCT01180790|54607896|FG004|Overall Study|Lost to Follow-up|1|||
27950720|NCT01180790|54607897|FG005|Overall Study|Lost to Follow-up|0|||
27950721|NCT01180790|54607898|FG006|Overall Study|Lost to Follow-up|1|||
27950722|NCT01180790|54607892|FG000|Overall Study|Physician Decision|1|||
27950723|NCT01180790|54607893|FG001|Overall Study|Physician Decision|0|||
27950724|NCT01180790|54607894|FG002|Overall Study|Physician Decision|0|||
27950725|NCT01180790|54607895|FG003|Overall Study|Physician Decision|1|||
27950726|NCT01180790|54607896|FG004|Overall Study|Physician Decision|0|||
27950727|NCT01180790|54607897|FG005|Overall Study|Physician Decision|0|||
27950728|NCT01180790|54607898|FG006|Overall Study|Physician Decision|0|||
27950729|NCT01180790|54607892|FG000|Overall Study|Lack of Efficacy|1|||
27950730|NCT01180790|54607893|FG001|Overall Study|Lack of Efficacy|2|||
27950731|NCT01180790|54607894|FG002|Overall Study|Lack of Efficacy|5|||
27950732|NCT01180790|54607895|FG003|Overall Study|Lack of Efficacy|6|||
27950733|NCT01180790|54607896|FG004|Overall Study|Lack of Efficacy|1|||
27950734|NCT01180790|54607897|FG005|Overall Study|Lack of Efficacy|3|||
27950735|NCT01180790|54607898|FG006|Overall Study|Lack of Efficacy|0|||
27950736|NCT01180790|54607892|FG000|Overall Study|compliance|0|||
27950737|NCT01180790|54607893|FG001|Overall Study|compliance|1|||
27950738|NCT01180790|54607894|FG002|Overall Study|compliance|0|||
27950739|NCT01180790|54607895|FG003|Overall Study|compliance|0|||
27950740|NCT01180790|54607896|FG004|Overall Study|compliance|0|||
27950741|NCT01180790|54607897|FG005|Overall Study|compliance|0|||
27950742|NCT01180790|54607898|FG006|Overall Study|compliance|0|||
27950743|NCT01180790|54607892|FG000|Overall Study|Severe coronary atherosclerosis (death)|0|||
27950744|NCT01180790|54607893|FG001|Overall Study|Severe coronary atherosclerosis (death)|0|||
27950745|NCT01180790|54607894|FG002|Overall Study|Severe coronary atherosclerosis (death)|1|||
27950746|NCT01180790|54607895|FG003|Overall Study|Severe coronary atherosclerosis (death)|0|||
27950747|NCT01180790|54607896|FG004|Overall Study|Severe coronary atherosclerosis (death)|0|||
27950748|NCT01180790|54607897|FG005|Overall Study|Severe coronary atherosclerosis (death)|0|||
27950749|NCT01180790|54607898|FG006|Overall Study|Severe coronary atherosclerosis (death)|0|||
27950750|NCT01184846|54607942|FG000|Overall Study|Adverse Event|2|||
27950751|NCT01184846|54607942|FG000|Overall Study|Insufficient response|1|||
27950752|NCT01180400|54607950|FG000|Overall Study|Withdrawal by Subject|5|||
27950753|NCT01180400|54607951|FG001|Overall Study|Withdrawal by Subject|6|||
27950754|NCT01180400|54607950|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
27950755|NCT01180400|54607951|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
27950756|NCT01180400|54607950|FG000|Overall Study|Adverse Event|12|||
27950757|NCT01180400|54607951|FG001|Overall Study|Adverse Event|10|||
27950758|NCT01180400|54607950|FG000|Overall Study|Severe non-compliance to protocol|1|||
27950759|NCT01180400|54607951|FG001|Overall Study|Severe non-compliance to protocol|2|||
27950760|NCT01180400|54607950|FG000|Overall Study|Condition under investigation worsened|2|||
27950761|NCT01180400|54607951|FG001|Overall Study|Condition under investigation worsened|1|||
27950762|NCT01180400|54607950|FG000|Overall Study|Lack of Efficacy|2|||
27950763|NCT01180400|54607951|FG001|Overall Study|Lack of Efficacy|0|||
27950764|NCT01180400|54607950|FG000|Overall Study|Study-specific withdrawal criteria|1|||
27950765|NCT01180400|54607951|FG001|Overall Study|Study-specific withdrawal criteria|2|||
27950766|NCT01180400|54607950|FG000|Overall Study|Lost to Follow-up|2|||
27950767|NCT01180400|54607951|FG001|Overall Study|Lost to Follow-up|3|||
27950768|NCT01180400|54607950|FG000|Overall Study|Other|0|||
27950769|NCT01180400|54607951|FG001|Overall Study|Other|1|||
27950770|NCT01180244|54607959|FG000|Overall Study|Lack of Efficacy|0|||
27950771|NCT01180244|54607960|FG001|Overall Study|Lack of Efficacy|7|||
27950772|NCT01180244|54607959|FG000|Overall Study|Physician Decision|3|||
27950773|NCT01180244|54607960|FG001|Overall Study|Physician Decision|0|||
27950774|NCT01180244|54607959|FG000|Overall Study|Adverse Event|1|||
27950775|NCT01180244|54607960|FG001|Overall Study|Adverse Event|0|||
27950776|NCT01180244|54607959|FG000|Overall Study|Withdrawal by Subject|0|||
27950777|NCT01180244|54607960|FG001|Overall Study|Withdrawal by Subject|1|||
27950778|NCT01180244|54607959|FG000|Overall Study|Protocol Violation|1|||
27950779|NCT01180244|54607960|FG001|Overall Study|Protocol Violation|0|||
27950780|NCT01180244|54607959|FG000|Overall Study|Lost to Follow-up|1|||
27950781|NCT01180244|54607960|FG001|Overall Study|Lost to Follow-up|0|||
27950782|NCT01191086|54607966|FG000|Overall Study|Adverse Event|20|||
27950783|NCT01191086|54607966|FG000|Overall Study|Lack of Efficacy|10|||
27950784|NCT01191086|54607966|FG000|Overall Study|Lost to Follow-up|4|||
27950785|NCT01191086|54607966|FG000|Overall Study|Physician Decision|2|||
27950786|NCT01191086|54607966|FG000|Overall Study|Withdrawal by Subject|24|||
27950787|NCT01191086|54607966|FG000|Overall Study|Discontinuation criterion met|1|||
27950788|NCT01191086|54607966|FG000|Overall Study|Other|1|||
27950789|NCT01088412|54607973|FG000|Overall Study|Adverse Event|38|||
27950790|NCT01088412|54607974|FG001|Overall Study|Adverse Event|0|||
27950791|NCT01088412|54607975|FG002|Overall Study|Adverse Event|0|||
27950792|NCT01088412|54607973|FG000|Overall Study|Death|42|||
27950793|NCT01088412|54607974|FG001|Overall Study|Death|6|||
27950794|NCT01088412|54607975|FG002|Overall Study|Death|0|||
27950795|NCT01088412|54607973|FG000|Overall Study|Other Reason per Case Report Form|2089|||
27950796|NCT01088412|54607974|FG001|Overall Study|Other Reason per Case Report Form|103|||
27950797|NCT01088412|54607975|FG002|Overall Study|Other Reason per Case Report Form|9|||
27950798|NCT01088412|54607973|FG000|Overall Study|Withdrawal by Subject|1761|||
27950799|NCT01088412|54607974|FG001|Overall Study|Withdrawal by Subject|25|||
27950800|NCT01088412|54607975|FG002|Overall Study|Withdrawal by Subject|1|||
27950801|NCT01088412|54607973|FG000|Overall Study|Received Another GH Product|79|||
27950802|NCT01088412|54607974|FG001|Overall Study|Received Another GH Product|0|||
27950803|NCT01088412|54607975|FG002|Overall Study|Received Another GH Product|0|||
27950804|NCT01088412|54607973|FG000|Overall Study|Participant Moved|601|||
27950805|NCT01088412|54607974|FG001|Overall Study|Participant Moved|21|||
27950806|NCT01088412|54607975|FG002|Overall Study|Participant Moved|2|||
27950807|NCT01088412|54607973|FG000|Overall Study|Physician Decision|1041|||
27950808|NCT01088412|54607974|FG001|Overall Study|Physician Decision|8|||
27950809|NCT01088412|54607975|FG002|Overall Study|Physician Decision|4|||
27950810|NCT01088412|54607973|FG000|Overall Study|Sponsor Decision|4467|||
27950811|NCT01088412|54607974|FG001|Overall Study|Sponsor Decision|79|||
27950812|NCT01088412|54607975|FG002|Overall Study|Sponsor Decision|23|||
27950813|NCT01088412|54607973|FG000|Overall Study|Third Party Required to Change Brand|487|||
27950814|NCT01088412|54607974|FG001|Overall Study|Third Party Required to Change Brand|0|||
27950815|NCT01088412|54607975|FG002|Overall Study|Third Party Required to Change Brand|0|||
27950816|NCT01088412|54607973|FG000|Overall Study|Lost to Follow-up|3052|||
27950817|NCT01088412|54607974|FG001|Overall Study|Lost to Follow-up|130|||
27950818|NCT01088412|54607975|FG002|Overall Study|Lost to Follow-up|11|||
27950819|NCT01088412|54607973|FG000|Overall Study|Study Summary Not Completed|4360|||
27950820|NCT01088412|54607974|FG001|Overall Study|Study Summary Not Completed|64|||
27950821|NCT01088412|54607975|FG002|Overall Study|Study Summary Not Completed|22|||
27950822|NCT01076400|54607986|FG000|Overall Study|Adverse Event|2|||
27950823|NCT01076400|54607987|FG001|Overall Study|Adverse Event|0|||
27950824|NCT01076400|54607988|FG002|Overall Study|Adverse Event|0|||
27950825|NCT01076400|54607986|FG000|Overall Study|Progressive Disease|5|||
27950826|NCT01076400|54607987|FG001|Overall Study|Progressive Disease|0|||
27950827|NCT01076400|54607988|FG002|Overall Study|Progressive Disease|0|||
27950828|NCT01086384|54607994|FG000|2-week Run-in Period|Adverse Event|1|||
27950829|NCT01086384|54607995|FG001|2-week Run-in Period|Adverse Event|0|||
27950830|NCT01086384|54607996|FG002|2-week Run-in Period|Adverse Event|0|||
27950831|NCT01086384|54607994|FG000|2-week Run-in Period|Protocol Violation|1|||
27950832|NCT01086384|54607995|FG001|2-week Run-in Period|Protocol Violation|0|||
27950833|NCT01086384|54607996|FG002|2-week Run-in Period|Protocol Violation|0|||
27950834|NCT01086384|54607994|FG000|2-week Run-in Period|Lost to Follow-up|1|||
27950835|NCT01086384|54607995|FG001|2-week Run-in Period|Lost to Follow-up|0|||
27950836|NCT01086384|54607996|FG002|2-week Run-in Period|Lost to Follow-up|0|||
27950837|NCT01086384|54607994|FG000|2-week Run-in Period|Physician Decision|6|||
27950838|NCT01086384|54607995|FG001|2-week Run-in Period|Physician Decision|0|||
27950839|NCT01086384|54607996|FG002|2-week Run-in Period|Physician Decision|0|||
27950840|NCT01086384|54607994|FG000|2-week Run-in Period|Withdrawal by Subject|19|||
27950841|NCT01086384|54607995|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
27950842|NCT01086384|54607996|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
27950843|NCT01086384|54607994|FG000|2-week Run-in Period|Study Closed/Terminated|42|||
27950844|NCT01086384|54607995|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
27950845|NCT01086384|54607996|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
27950846|NCT01086384|54607994|FG000|2-week Run-in Period|Continuation Criteria Not Met|92|||
27950847|NCT01086384|54607995|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
27950848|NCT01086384|54607996|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
27950849|NCT01086384|54607994|FG000|2-week Run-in Period|Randomized in Error|1|||
27950850|NCT01086384|54607995|FG001|2-week Run-in Period|Randomized in Error|0|||
27950851|NCT01086384|54607996|FG002|2-week Run-in Period|Randomized in Error|0|||
27950852|NCT01086384|54607994|FG000|Treatment Period|Withdrawal by Subject|0|||
27950853|NCT01086384|54607995|FG001|Treatment Period|Withdrawal by Subject|53|||
27950854|NCT01086384|54607996|FG002|Treatment Period|Withdrawal by Subject|55|||
28080912|NCT00103857|54734160|FG000|54-Week Base Study|Protocol Violation|6|||
28080913|NCT00103857|54734161|FG001|54-Week Base Study|Protocol Violation|4|||
28080914|NCT00103857|54734162|FG002|54-Week Base Study|Protocol Violation|2|||
28080915|NCT00103857|54734163|FG003|54-Week Base Study|Protocol Violation|4|||
28080916|NCT00103857|54734164|FG004|54-Week Base Study|Protocol Violation|0|||
28080917|NCT00103857|54734165|FG005|54-Week Base Study|Protocol Violation|3|||
28080918|NCT00103857|54734166|FG006|54-Week Base Study|Protocol Violation|3|||
28080919|NCT00103857|54734160|FG000|54-Week Base Study|Withdrawal by Subject|17|||
28080920|NCT00103857|54734161|FG001|54-Week Base Study|Withdrawal by Subject|16|||
28080921|NCT00103857|54734162|FG002|54-Week Base Study|Withdrawal by Subject|16|||
28080922|NCT00103857|54734163|FG003|54-Week Base Study|Withdrawal by Subject|15|||
28080923|NCT00103857|54734164|FG004|54-Week Base Study|Withdrawal by Subject|10|||
28080924|NCT00103857|54734165|FG005|54-Week Base Study|Withdrawal by Subject|15|||
28080925|NCT00103857|54734166|FG006|54-Week Base Study|Withdrawal by Subject|4|||
28080926|NCT00103857|54734160|FG000|54-Week Base Study|protocol discontinuation criteria|2|||
28080927|NCT00103857|54734161|FG001|54-Week Base Study|protocol discontinuation criteria|5|||
28080928|NCT00103857|54734162|FG002|54-Week Base Study|protocol discontinuation criteria|2|||
28080929|NCT00103857|54734163|FG003|54-Week Base Study|protocol discontinuation criteria|6|||
28080930|NCT00103857|54734164|FG004|54-Week Base Study|protocol discontinuation criteria|5|||
27950855|NCT01086384|54607994|FG000|Treatment Period|Protocol Violation|0|||
27950856|NCT01086384|54607995|FG001|Treatment Period|Protocol Violation|26|||
27950857|NCT01086384|54607996|FG002|Treatment Period|Protocol Violation|17|||
27950858|NCT01086384|54607994|FG000|Treatment Period|Lack of Efficacy|0|||
27950859|NCT01086384|54607995|FG001|Treatment Period|Lack of Efficacy|22|||
28080931|NCT00103857|54734165|FG005|54-Week Base Study|protocol discontinuation criteria|3|||
28080932|NCT00103857|54734166|FG006|54-Week Base Study|protocol discontinuation criteria|5|||
28080933|NCT00103857|54734160|FG000|54-Week Base Study|patient moved|0|||
27950860|NCT01086384|54607996|FG002|Treatment Period|Lack of Efficacy|13|||
27950861|NCT01086384|54607994|FG000|Treatment Period|Adverse Event|0|||
28080934|NCT00103857|54734161|FG001|54-Week Base Study|patient moved|1|||
28080935|NCT00103857|54734162|FG002|54-Week Base Study|patient moved|1|||
28080936|NCT00103857|54734163|FG003|54-Week Base Study|patient moved|2|||
27832235|NCT00983619|54311049|FG004|Overall Study|Death|2|||
27950862|NCT01086384|54607995|FG001|Treatment Period|Adverse Event|19|||
27950863|NCT01086384|54607996|FG002|Treatment Period|Adverse Event|15|||
27950864|NCT01086384|54607994|FG000|Treatment Period|Lost to Follow-up|0|||
27950865|NCT01086384|54607995|FG001|Treatment Period|Lost to Follow-up|11|||
27950866|NCT01086384|54607996|FG002|Treatment Period|Lost to Follow-up|9|||
27950867|NCT01086384|54607994|FG000|Treatment Period|Physician Decision|0|||
27950868|NCT01086384|54607995|FG001|Treatment Period|Physician Decision|9|||
27950869|NCT01086384|54607996|FG002|Treatment Period|Physician Decision|6|||
27950870|NCT01086384|54607994|FG000|Treatment Period|Study Closed/Terminated|0|||
27950871|NCT01086384|54607995|FG001|Treatment Period|Study Closed/Terminated|7|||
27950872|NCT01086384|54607996|FG002|Treatment Period|Study Closed/Terminated|8|||
27950873|NCT01086384|54607994|FG000|Treatment Period|Protocol-Defined Stopping Criteria|0|||
27950874|NCT01086384|54607995|FG001|Treatment Period|Protocol-Defined Stopping Criteria|0|||
27950875|NCT01086384|54607996|FG002|Treatment Period|Protocol-Defined Stopping Criteria|1|||
27950876|NCT01086384|54607994|FG000|Treatment Period|Received Treatment in Error|0|||
27950877|NCT01086384|54607995|FG001|Treatment Period|Received Treatment in Error|1|||
27950878|NCT01086384|54607996|FG002|Treatment Period|Received Treatment in Error|0|||
27950879|NCT01127633|54608017|FG000|Overall Study|Adverse Event|74|||
27950880|NCT01127633|54608018|FG001|Overall Study|Adverse Event|73|||
27950881|NCT01127633|54608017|FG000|Overall Study|Death|40|||
27950882|NCT01127633|54608018|FG001|Overall Study|Death|43|||
27950883|NCT01127633|54608017|FG000|Overall Study|Lost to Follow-up|4|||
27950884|NCT01127633|54608018|FG001|Overall Study|Lost to Follow-up|0|||
27950885|NCT01127633|54608017|FG000|Overall Study|Parent/Caregiver Decision|246|||
27950886|NCT01127633|54608018|FG001|Overall Study|Parent/Caregiver Decision|228|||
27950887|NCT01127633|54608017|FG000|Overall Study|Physician Decision|60|||
27950888|NCT01127633|54608018|FG001|Overall Study|Physician Decision|45|||
27950889|NCT01127633|54608017|FG000|Overall Study|Withdrawal by Subject|57|||
27950890|NCT01127633|54608018|FG001|Overall Study|Withdrawal by Subject|72|||
27950891|NCT01127633|54608017|FG000|Overall Study|Sponsor Decision|163|||
27950892|NCT01127633|54608018|FG001|Overall Study|Sponsor Decision|195|||
27950893|NCT01127633|54608017|FG000|Overall Study|Protocol Violation|8|||
27950894|NCT01127633|54608018|FG001|Overall Study|Protocol Violation|16|||
27950895|NCT01127633|54608017|FG000|Overall Study|Abnormal Lab/ECG Result|0|||
27950896|NCT01127633|54608018|FG001|Overall Study|Abnormal Lab/ECG Result|1|||
27950897|NCT01127633|54608017|FG000|Overall Study|Not treated|1|||
27950898|NCT01127633|54608018|FG001|Overall Study|Not treated|0|||
27950899|NCT01122173|54608024|FG000|Overall Study|Lost to Follow-up|3|||
27950900|NCT01122173|54608024|FG000|Overall Study|Withdrawal by Subject|3|||
27950901|NCT01122173|54608024|FG000|Overall Study|Left study for other reasons|3|||
27950902|NCT01127165|54608031|FG000|Overall Study|Adverse Event|2|||
27950903|NCT01127165|54608032|FG001|Overall Study|Adverse Event|2|||
27950904|NCT01127165|54608031|FG000|Overall Study|Lack of Efficacy|10|||
27950905|NCT01127165|54608032|FG001|Overall Study|Lack of Efficacy|8|||
27950906|NCT01127165|54608031|FG000|Overall Study|Lost to Follow-up|3|||
27950907|NCT01127165|54608032|FG001|Overall Study|Lost to Follow-up|5|||
27950908|NCT01127165|54608031|FG000|Overall Study|Withdrawal by Subject|1|||
27950909|NCT01127165|54608032|FG001|Overall Study|Withdrawal by Subject|3|||
27950910|NCT01127165|54608031|FG000|Overall Study|Protocol Violation|0|||
27950911|NCT01127165|54608032|FG001|Overall Study|Protocol Violation|1|||
27950912|NCT01126619|54608038|FG000|Overall Study|Not eligible for the study|2|||
27950913|NCT01126619|54608038|FG000|Overall Study|Investigator decision|4|||
27950914|NCT01126619|54608038|FG000|Overall Study|Serious adverse event|1|||
27950915|NCT01126619|54608038|FG000|Overall Study|Withdrawal by Subject|9|||
27950916|NCT01126619|54608038|FG000|Overall Study|Non-compliance|1|||
27950917|NCT00941733|54608046|FG000|Overall Study|Death|24|||
27950918|NCT00941733|54608047|FG001|Overall Study|Death|10|||
27950919|NCT00941733|54608046|FG000|Overall Study|Withdrawal by Subject|14|||
27950920|NCT00941733|54608047|FG001|Overall Study|Withdrawal by Subject|6|||
27950921|NCT00941733|54608046|FG000|Overall Study|Adverse Event|20|||
28080937|NCT00103857|54734164|FG004|54-Week Base Study|patient moved|3|||
28080938|NCT00103857|54734165|FG005|54-Week Base Study|patient moved|1|||
28080939|NCT00103857|54734166|FG006|54-Week Base Study|patient moved|0|||
27731776|NCT02787863|54179181|FG000|Overall Study|Death|1|||
27832236|NCT00983619|54311050|FG005|Overall Study|Death|30|||
27832237|NCT00983619|54311051|FG006|Overall Study|Death|1|||
27832238|NCT00983619|54311052|FG007|Overall Study|Death|0|||
27950922|NCT00941733|54608047|FG001|Overall Study|Adverse Event|4|||
27950923|NCT00941733|54608046|FG000|Overall Study|Lost to Follow-up|1|||
27950924|NCT00941733|54608047|FG001|Overall Study|Lost to Follow-up|2|||
27950925|NCT00941733|54608046|FG000|Overall Study|Protocol Violation|15|||
27950926|NCT00941733|54608047|FG001|Overall Study|Protocol Violation|6|||
27950927|NCT00941655|54608055|FG000|Overall Study|received some chemo, 4 and 9 cycles|1|||
27950928|NCT00941655|54608056|FG001|Overall Study|received some chemo, 4 and 9 cycles|0|||
27950929|NCT00941655|54608055|FG000|Overall Study|not meet criteria for chemo foll surgery|4|||
27950930|NCT00941655|54608056|FG001|Overall Study|not meet criteria for chemo foll surgery|0|||
27950931|NCT00941655|54608055|FG000|Overall Study|progressed while on chemo|0|||
27950932|NCT00941655|54608056|FG001|Overall Study|progressed while on chemo|2|||
27950933|NCT00941655|54608055|FG000|Overall Study|refused further treatment|0|||
27950934|NCT00941655|54608056|FG001|Overall Study|refused further treatment|1|||
27950935|NCT00941655|54608055|FG000|Overall Study|withdrew consent|0|||
27950936|NCT00941655|54608056|FG001|Overall Study|withdrew consent|1|||
27950937|NCT00941655|54608055|FG000|Overall Study|non-compliant|0|||
27950938|NCT00941655|54608056|FG001|Overall Study|non-compliant|1|||
27950939|NCT00939393|54608065|FG000|Overall Study|Withdrawal by Subject|1|||
27950940|NCT00939393|54608066|FG001|Overall Study|Withdrawal by Subject|0|||
27950941|NCT00939393|54608065|FG000|Overall Study|Lost to Follow-up|3|||
27950942|NCT00939393|54608066|FG001|Overall Study|Lost to Follow-up|0|||
27950943|NCT00936117|54608083|FG000|Overall Study|Adverse Event|7|||
27950944|NCT00936117|54608083|FG000|Overall Study|Unable to continue oral medication|3|||
27950945|NCT04088500|54608088|FG000|Overall Study|Reason unknown|1|||
27950946|NCT04088500|54608088|FG000|Overall Study|Participant withdrew consent|1|||
27950947|NCT04088500|54608088|FG000|Overall Study|Disease progression|3|||
27950948|NCT01082874|54608096|FG000|Overall Study|Lost to Follow-up|10|||
27950949|NCT01082874|54608097|FG001|Overall Study|Lost to Follow-up|10|||
27950950|NCT01082874|54608098|FG002|Overall Study|Lost to Follow-up|6|||
27950951|NCT01082874|54608099|FG003|Overall Study|Lost to Follow-up|10|||
27950952|NCT01082874|54608096|FG000|Overall Study|Withdrawal by Subject|1|||
27950953|NCT01082874|54608097|FG001|Overall Study|Withdrawal by Subject|2|||
27950954|NCT01082874|54608098|FG002|Overall Study|Withdrawal by Subject|5|||
27950955|NCT01082874|54608099|FG003|Overall Study|Withdrawal by Subject|3|||
27950956|NCT00933543|54608111|FG000|Overall Study|Adverse Event|2|||
27950957|NCT00933543|54608112|FG001|Overall Study|Adverse Event|1|||
27950958|NCT00933543|54608111|FG000|Overall Study|Lost to Follow-up|0|||
27950959|NCT00933543|54608112|FG001|Overall Study|Lost to Follow-up|1|||
27950960|NCT00933543|54608111|FG000|Overall Study|Withdrawal by Subject|0|||
27950961|NCT00933543|54608112|FG001|Overall Study|Withdrawal by Subject|1|||
27950962|NCT00933543|54608111|FG000|Overall Study|Lack of Efficacy|0|||
27950963|NCT00933543|54608112|FG001|Overall Study|Lack of Efficacy|3|||
27950964|NCT00933543|54608111|FG000|Overall Study|Other|1|||
27950965|NCT00933543|54608112|FG001|Overall Study|Other|1|||
27950966|NCT01082328|54608118|FG000|Overall Study|Adverse Event|1|||
27950967|NCT01079988|54608127|FG000|Overall Study|Lost to Follow-up|0|||
27950968|NCT01079988|54608128|FG001|Overall Study|Lost to Follow-up|0|||
27950969|NCT01079988|54608129|FG002|Overall Study|Lost to Follow-up|0|||
27950970|NCT01079988|54608130|FG003|Overall Study|Lost to Follow-up|1|||
27950971|NCT01079988|54608131|FG004|Overall Study|Lost to Follow-up|0|||
27950972|NCT01079988|54608127|FG000|Overall Study|Lack of Efficacy|1|||
27950973|NCT01079988|54608128|FG001|Overall Study|Lack of Efficacy|0|||
27950974|NCT01079988|54608129|FG002|Overall Study|Lack of Efficacy|0|||
27950975|NCT01079988|54608130|FG003|Overall Study|Lack of Efficacy|0|||
27950976|NCT01079988|54608131|FG004|Overall Study|Lack of Efficacy|0|||
27950977|NCT01079988|54608127|FG000|Overall Study|Other|0|||
27950978|NCT01079988|54608128|FG001|Overall Study|Other|0|||
27950979|NCT01079988|54608129|FG002|Overall Study|Other|0|||
27950980|NCT01079988|54608130|FG003|Overall Study|Other|2|||
27950981|NCT01079988|54608131|FG004|Overall Study|Other|1|||
27950982|NCT01074216|54608143|FG000|Overall Study|Physician Decision|1|||
27950983|NCT01074216|54608143|FG000|Overall Study|Not Treated|12|||
27950984|NCT01079832|54608147|FG000|Overall Study|Withdrawal by Subject|1|||
27950985|NCT01072344|54608153|FG000|Overall Study|Relasped-reached end point|7|||
27950986|NCT01072344|54608154|FG001|Overall Study|Relasped-reached end point|12|||
27950987|NCT01072344|54608153|FG000|Overall Study|Protocol Violation|1|||
27950988|NCT01072344|54608154|FG001|Overall Study|Protocol Violation|2|||
27950989|NCT01072344|54608153|FG000|Overall Study|Lost to Follow-up|3|||
27950990|NCT01072344|54608154|FG001|Overall Study|Lost to Follow-up|4|||
27950991|NCT01071954|54608160|FG000|Overall Study|Noncompliance|4|||
27950992|NCT01071954|54608160|FG000|Overall Study|Adverse Event|1|||
27950993|NCT01071954|54608160|FG000|Overall Study|Withdrawal by Subject|11|||
27950994|NCT01071954|54608160|FG000|Overall Study|Requirement for Alternative Therapy|5|||
27950995|NCT01071954|54608160|FG000|Overall Study|Administrative Decision|5|||
27950996|NCT01071954|54608160|FG000|Overall Study|Protocol Specified Criteria|1|||
27854861|NCT01271725|54372779|FG001|Part A|Withdrawal by Subject|0|||
27854862|NCT01271725|54372778|FG000|Part A|Other than specified|3|||
27950997|NCT00837811|54608167|FG000|Overall Study|Adverse Event|4|||
27950998|NCT00837811|54608168|FG001|Overall Study|Adverse Event|6|||
27950999|NCT00837811|54608169|FG002|Overall Study|Adverse Event|0|||
27951000|NCT00837811|54608167|FG000|Overall Study|Death|1|||
28164921|NCT03016403|54835579|FG001|6-week Follow-up|Lost to Follow-up|7|||
28164922|NCT03016403|54835580|FG002|6-week Follow-up|Lost to Follow-up|4|||
27951001|NCT00837811|54608168|FG001|Overall Study|Death|1|||
27951002|NCT00837811|54608169|FG002|Overall Study|Death|0|||
28164923|NCT03016403|54835581|FG003|6-week Follow-up|Lost to Follow-up|8|||
27951003|NCT00837811|54608167|FG000|Overall Study|Lack of Efficacy|0|||
27951004|NCT00837811|54608168|FG001|Overall Study|Lack of Efficacy|11|||
27951005|NCT00837811|54608169|FG002|Overall Study|Lack of Efficacy|0|||
27951006|NCT00837811|54608167|FG000|Overall Study|Lost to Follow-up|1|||
27951007|NCT00837811|54608168|FG001|Overall Study|Lost to Follow-up|3|||
27951008|NCT00837811|54608169|FG002|Overall Study|Lost to Follow-up|0|||
27951009|NCT00837811|54608167|FG000|Overall Study|Physician Decision|0|||
27951010|NCT00837811|54608168|FG001|Overall Study|Physician Decision|2|||
28080940|NCT00103857|54734160|FG000|54-Week Base Study|non-compliance with study procedures|1|||
28080941|NCT00103857|54734161|FG001|54-Week Base Study|non-compliance with study procedures|2|||
28080942|NCT00103857|54734162|FG002|54-Week Base Study|non-compliance with study procedures|0|||
28080943|NCT00103857|54734163|FG003|54-Week Base Study|non-compliance with study procedures|0|||
28080944|NCT00103857|54734164|FG004|54-Week Base Study|non-compliance with study procedures|0|||
28080945|NCT00103857|54734165|FG005|54-Week Base Study|non-compliance with study procedures|2|||
28080946|NCT00103857|54734166|FG006|54-Week Base Study|non-compliance with study procedures|0|||
28080947|NCT00103857|54734160|FG000|54-Week Base Study|patient incarcerated|0|||
28080948|NCT00103857|54734161|FG001|54-Week Base Study|patient incarcerated|0|||
28080949|NCT00103857|54734162|FG002|54-Week Base Study|patient incarcerated|0|||
28080950|NCT00103857|54734163|FG003|54-Week Base Study|patient incarcerated|0|||
28080951|NCT00103857|54734164|FG004|54-Week Base Study|patient incarcerated|1|||
28080952|NCT00103857|54734165|FG005|54-Week Base Study|patient incarcerated|1|||
28080953|NCT00103857|54734166|FG006|54-Week Base Study|patient incarcerated|0|||
28080954|NCT00103857|54734160|FG000|54-Week Base Study|laboratory reporting error|0|||
28080955|NCT00103857|54734161|FG001|54-Week Base Study|laboratory reporting error|0|||
28080956|NCT00103857|54734162|FG002|54-Week Base Study|laboratory reporting error|0|||
28080957|NCT00103857|54734163|FG003|54-Week Base Study|laboratory reporting error|0|||
28080958|NCT00103857|54734164|FG004|54-Week Base Study|laboratory reporting error|1|||
28080959|NCT00103857|54734165|FG005|54-Week Base Study|laboratory reporting error|0|||
28080960|NCT00103857|54734166|FG006|54-Week Base Study|laboratory reporting error|0|||
28080961|NCT00103857|54734160|FG000|54-Week Base Study|site error|0|||
28080962|NCT00103857|54734161|FG001|54-Week Base Study|site error|0|||
28080963|NCT00103857|54734162|FG002|54-Week Base Study|site error|0|||
28080964|NCT00103857|54734163|FG003|54-Week Base Study|site error|0|||
28080965|NCT00103857|54734164|FG004|54-Week Base Study|site error|0|||
28080966|NCT00103857|54734165|FG005|54-Week Base Study|site error|1|||
28080967|NCT00103857|54734166|FG006|54-Week Base Study|site error|0|||
28080968|NCT00103857|54734160|FG000|54-Week Base Study|patient intolerance to rescue therapy|1|||
28080969|NCT00103857|54734161|FG001|54-Week Base Study|patient intolerance to rescue therapy|0|||
28080970|NCT00103857|54734162|FG002|54-Week Base Study|patient intolerance to rescue therapy|0|||
28080971|NCT00103857|54734163|FG003|54-Week Base Study|patient intolerance to rescue therapy|0|||
28080972|NCT00103857|54734164|FG004|54-Week Base Study|patient intolerance to rescue therapy|0|||
28080973|NCT00103857|54734165|FG005|54-Week Base Study|patient intolerance to rescue therapy|0|||
28080974|NCT00103857|54734166|FG006|54-Week Base Study|patient intolerance to rescue therapy|0|||
28080975|NCT00103857|54734160|FG000|50-Week Extension Study|Adverse Event|2|||
28080976|NCT00103857|54734161|FG001|50-Week Extension Study|Adverse Event|3|||
28080977|NCT00103857|54734162|FG002|50-Week Extension Study|Adverse Event|2|||
28080978|NCT00103857|54734163|FG003|50-Week Extension Study|Adverse Event|0|||
28080979|NCT00103857|54734164|FG004|50-Week Extension Study|Adverse Event|1|||
28080980|NCT00103857|54734165|FG005|50-Week Extension Study|Adverse Event|1|||
28080981|NCT00103857|54734166|FG006|50-Week Extension Study|Adverse Event|0|||
28080982|NCT00103857|54734160|FG000|50-Week Extension Study|Death|0|||
28080983|NCT00103857|54734161|FG001|50-Week Extension Study|Death|0|||
28080984|NCT00103857|54734162|FG002|50-Week Extension Study|Death|0|||
27854863|NCT01271725|54372779|FG001|Part A|Other than specified|0|||
27854864|NCT01271725|54372778|FG000|Part A|Protocol Violation|1|||
27854865|NCT01271725|54372779|FG001|Part A|Protocol Violation|0|||
27854866|NCT01271725|54372778|FG000|Part B|Other than specified|0|||
27854867|NCT01271725|54372779|FG001|Part B|Other than specified|2|||
27854868|NCT01271725|54372778|FG000|Part B|Clinical signs/symptoms of progression|0|||
27854869|NCT01271725|54372779|FG001|Part B|Clinical signs/symptoms of progression|2|||
27854870|NCT01271725|54372778|FG000|Part B|Other Adverse Event|0|||
27854871|NCT01271725|54372779|FG001|Part B|Other Adverse Event|1|||
27854872|NCT01271725|54372778|FG000|Part B|Protocol Violation|0|||
27854873|NCT01271725|54372779|FG001|Part B|Protocol Violation|1|||
27854874|NCT01271725|54372778|FG000|Part B|Withdrawal by Subject|0|||
28080985|NCT00103857|54734163|FG003|50-Week Extension Study|Death|1|||
28080986|NCT00103857|54734164|FG004|50-Week Extension Study|Death|0|||
28080987|NCT00103857|54734165|FG005|50-Week Extension Study|Death|1|||
28080988|NCT00103857|54734166|FG006|50-Week Extension Study|Death|0|||
28080989|NCT00103857|54734160|FG000|50-Week Extension Study|Lack of Efficacy|26|||
28080990|NCT00103857|54734161|FG001|50-Week Extension Study|Lack of Efficacy|15|||
28080991|NCT00103857|54734162|FG002|50-Week Extension Study|Lack of Efficacy|13|||
28080992|NCT00103857|54734163|FG003|50-Week Extension Study|Lack of Efficacy|16|||
28080993|NCT00103857|54734164|FG004|50-Week Extension Study|Lack of Efficacy|8|||
28080994|NCT00103857|54734165|FG005|50-Week Extension Study|Lack of Efficacy|8|||
28080995|NCT00103857|54734166|FG006|50-Week Extension Study|Lack of Efficacy|0|||
27854875|NCT01271725|54372779|FG001|Part B|Withdrawal by Subject|6|||
28080996|NCT00103857|54734160|FG000|50-Week Extension Study|Lost to Follow-up|4|||
28080997|NCT00103857|54734161|FG001|50-Week Extension Study|Lost to Follow-up|0|||
27854876|NCT01270321|54372804|FG000|Overall Study|Death|3|||
27854877|NCT01270321|54372805|FG001|Overall Study|Death|1|||
27951011|NCT00837811|54608169|FG002|Overall Study|Physician Decision|1|||
27951012|NCT00837811|54608167|FG000|Overall Study|Withdrawal by Subject|1|||
27951013|NCT00837811|54608168|FG001|Overall Study|Withdrawal by Subject|9|||
27951014|NCT00837811|54608169|FG002|Overall Study|Withdrawal by Subject|0|||
27951015|NCT00837811|54608167|FG000|Overall Study|Sponsor Decision|0|||
27951016|NCT00837811|54608168|FG001|Overall Study|Sponsor Decision|2|||
27832239|NCT00983619|54311053|FG008|Overall Study|Death|1|||
27832240|NCT00983619|54311054|FG009|Overall Study|Death|2|||
27832241|NCT00983619|54311055|FG010|Overall Study|Death|9|||
27832242|NCT00983619|54311056|FG011|Overall Study|Death|8|||
27832243|NCT00983619|54311045|FG000|Overall Study|Other|1|||
27832244|NCT00983619|54311046|FG001|Overall Study|Other|0|||
27832245|NCT00983619|54311047|FG002|Overall Study|Other|0|||
27832246|NCT00983619|54311048|FG003|Overall Study|Other|1|||
27832247|NCT00983619|54311049|FG004|Overall Study|Other|0|||
27854878|NCT01270321|54372806|FG002|Overall Study|Death|4|||
27854879|NCT01270321|54372804|FG000|Overall Study|Adverse Event|7|||
27854880|NCT01270321|54372805|FG001|Overall Study|Adverse Event|9|||
27854881|NCT01270321|54372806|FG002|Overall Study|Adverse Event|5|||
27854882|NCT00249769|54372900|FG000|Overall Study|Withdrawal by Subject|1|||
27854883|NCT00249769|54372901|FG001|Overall Study|Withdrawal by Subject|10|||
27854884|NCT00249769|54372902|FG002|Overall Study|Withdrawal by Subject|6|||
27854885|NCT00249769|54372900|FG000|Overall Study|Migration from Study Area|1|||
27854886|NCT00249769|54372901|FG001|Overall Study|Migration from Study Area|3|||
27854887|NCT00249769|54372902|FG002|Overall Study|Migration from Study Area|14|||
27854888|NCT00249769|54372900|FG000|Overall Study|Miscellaneous|0|||
27854889|NCT00249769|54372901|FG001|Overall Study|Miscellaneous|2|||
27854890|NCT00249769|54372902|FG002|Overall Study|Miscellaneous|2|||
27854891|NCT00249769|54372900|FG000|Overall Study|Adverse Event|0|||
27854892|NCT00249769|54372901|FG001|Overall Study|Adverse Event|0|||
27854893|NCT00249769|54372902|FG002|Overall Study|Adverse Event|1|||
27854894|NCT00249769|54372900|FG000|Overall Study|Physician Decision|0|||
27854895|NCT00249769|54372901|FG001|Overall Study|Physician Decision|0|||
27854896|NCT00249769|54372902|FG002|Overall Study|Physician Decision|2|||
27854897|NCT00249769|54372900|FG000|Overall Study|Lost to Follow-up|0|||
27854898|NCT00249769|54372901|FG001|Overall Study|Lost to Follow-up|0|||
27854899|NCT00249769|54372902|FG002|Overall Study|Lost to Follow-up|3|||
27854900|NCT00249613|54372912|FG000|12 Month Follow-up|Death|1|||
27854901|NCT00249613|54372913|FG001|12 Month Follow-up|Death|1|||
27854902|NCT00249613|54372912|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
27854903|NCT00249613|54372913|FG001|12 Month Follow-up|Withdrawal by Subject|6|||
27854904|NCT00249613|54372912|FG000|12 Month Follow-up|Lost to Follow-up|10|||
27854905|NCT00249613|54372913|FG001|12 Month Follow-up|Lost to Follow-up|8|||
27854906|NCT00248833|54372949|FG000|Overall Study|Adverse Event|2|||
27951017|NCT00837811|54608169|FG002|Overall Study|Sponsor Decision|0|||
27951018|NCT00857389|54608186|FG000|Overall Study|Did not proceed to transplant|2|||
27951019|NCT01071798|54608190|FG000|Participants Who Received One Cycle|Lack of Efficacy|18|||
27951020|NCT01071798|54608190|FG000|Participants Who Received One Cycle|Lack of tolerability|14|||
27951021|NCT01071798|54608190|FG000|Participants Who Received One Cycle|Patient requirement|20|||
27951022|NCT01071798|54608190|FG000|Participants Who Received One Cycle|Death|5|||
27951023|NCT01071798|54608190|FG000|Participants Who Received One Cycle|Change of therapy|6|||
27951024|NCT01071798|54608190|FG000|Participants Who Received One Cycle|Severe concomitant disease|2|||
27951025|NCT01071798|54608190|FG000|Subpopulation Who Received Two Cycles|Remission|1|||
27951026|NCT01071798|54608190|FG000|Subpopulation Who Received Two Cycles|Lack of Efficacy|3|||
27951027|NCT01071798|54608190|FG000|Subpopulation Who Received Two Cycles|Lack of Tolerability|4|||
27951028|NCT01071798|54608190|FG000|Subpopulation Who Received Two Cycles|Patient Requirement|7|||
27951029|NCT00857311|54608208|FG000|Overall Study|Lost to Follow-up|1|||
27951030|NCT00857311|54608209|FG001|Overall Study|Lost to Follow-up|0|||
27951031|NCT00857311|54608210|FG002|Overall Study|Lost to Follow-up|0|||
27951032|NCT00857311|54608211|FG003|Overall Study|Lost to Follow-up|0|||
27951033|NCT00857233|54608217|FG000|Overall Study|Adverse Event|24|||
27951034|NCT00857233|54608217|FG000|Overall Study|Lack of Efficacy|1|||
27951035|NCT00857233|54608217|FG000|Overall Study|Non-compliance|1|||
27951036|NCT00857233|54608217|FG000|Overall Study|Withdrawal of Consent|9|||
27951037|NCT00857233|54608217|FG000|Overall Study|Lost to Follow-up|4|||
27951038|NCT00857233|54608217|FG000|Overall Study|Nursing Home Placement|14|||
27951039|NCT00857233|54608217|FG000|Overall Study|Other Reasons|2|||
27731777|NCT02787863|54179182|FG001|Overall Study|Death|0|||
27854907|NCT00248833|54372950|FG001|Overall Study|Adverse Event|0|||
27854908|NCT00248833|54372951|FG002|Overall Study|Adverse Event|0|||
27951040|NCT00856999|54608221|FG000|Overall Study|Withdrawal by Subject|5|||
27951041|NCT01071252|54608231|FG000|Overall Study|unsatisfactory therapeutic effect|4|||
27951042|NCT01071252|54608232|FG001|Overall Study|unsatisfactory therapeutic effect|6|||
27832248|NCT00983619|54311050|FG005|Overall Study|Other|12|||
27832249|NCT00983619|54311051|FG006|Overall Study|Other|2|||
27854909|NCT00248833|54372949|FG000|Overall Study|Withdrawal by Subject|0|||
27854910|NCT00248833|54372950|FG001|Overall Study|Withdrawal by Subject|1|||
27951043|NCT01071252|54608233|FG002|Overall Study|unsatisfactory therapeutic effect|2|||
27951044|NCT01071252|54608234|FG003|Overall Study|unsatisfactory therapeutic effect|0|||
27951045|NCT01071252|54608235|FG004|Overall Study|unsatisfactory therapeutic effect|6|||
27951046|NCT01071252|54608231|FG000|Overall Study|Withdrawal by Subject|8|||
27951047|NCT01071252|54608232|FG001|Overall Study|Withdrawal by Subject|2|||
27951048|NCT01071252|54608233|FG002|Overall Study|Withdrawal by Subject|1|||
27951049|NCT01071252|54608234|FG003|Overall Study|Withdrawal by Subject|2|||
27951050|NCT01071252|54608235|FG004|Overall Study|Withdrawal by Subject|3|||
27951051|NCT01071252|54608231|FG000|Overall Study|administrative problems|1|||
27951052|NCT01071252|54608232|FG001|Overall Study|administrative problems|1|||
27951053|NCT01071252|54608233|FG002|Overall Study|administrative problems|0|||
27951054|NCT01071252|54608234|FG003|Overall Study|administrative problems|2|||
27951055|NCT01071252|54608235|FG004|Overall Study|administrative problems|1|||
27951056|NCT01071252|54608231|FG000|Overall Study|Lost to Follow-up|1|||
27951057|NCT01071252|54608232|FG001|Overall Study|Lost to Follow-up|0|||
27951058|NCT01071252|54608233|FG002|Overall Study|Lost to Follow-up|1|||
27951059|NCT01071252|54608234|FG003|Overall Study|Lost to Follow-up|2|||
27951060|NCT01071252|54608235|FG004|Overall Study|Lost to Follow-up|0|||
27951061|NCT01071252|54608231|FG000|Overall Study|Adverse Event|1|||
27951062|NCT01071252|54608232|FG001|Overall Study|Adverse Event|1|||
27951063|NCT01071252|54608233|FG002|Overall Study|Adverse Event|0|||
28080998|NCT00103857|54734162|FG002|50-Week Extension Study|Lost to Follow-up|1|||
28080999|NCT00103857|54734163|FG003|50-Week Extension Study|Lost to Follow-up|4|||
28081000|NCT00103857|54734164|FG004|50-Week Extension Study|Lost to Follow-up|3|||
28081001|NCT00103857|54734165|FG005|50-Week Extension Study|Lost to Follow-up|3|||
28081002|NCT00103857|54734166|FG006|50-Week Extension Study|Lost to Follow-up|0|||
28081003|NCT00103857|54734160|FG000|50-Week Extension Study|Physician Decision|0|||
28081004|NCT00103857|54734161|FG001|50-Week Extension Study|Physician Decision|1|||
28081005|NCT00103857|54734162|FG002|50-Week Extension Study|Physician Decision|1|||
28081006|NCT00103857|54734163|FG003|50-Week Extension Study|Physician Decision|0|||
28081007|NCT00103857|54734164|FG004|50-Week Extension Study|Physician Decision|0|||
28081008|NCT00103857|54734165|FG005|50-Week Extension Study|Physician Decision|0|||
28081009|NCT00103857|54734166|FG006|50-Week Extension Study|Physician Decision|0|||
28081010|NCT00103857|54734160|FG000|50-Week Extension Study|Pregnancy|0|||
28081011|NCT00103857|54734161|FG001|50-Week Extension Study|Pregnancy|0|||
28081012|NCT00103857|54734162|FG002|50-Week Extension Study|Pregnancy|1|||
28081013|NCT00103857|54734163|FG003|50-Week Extension Study|Pregnancy|0|||
28081014|NCT00103857|54734164|FG004|50-Week Extension Study|Pregnancy|1|||
28081015|NCT00103857|54734165|FG005|50-Week Extension Study|Pregnancy|0|||
28081016|NCT00103857|54734166|FG006|50-Week Extension Study|Pregnancy|0|||
28081017|NCT00103857|54734160|FG000|50-Week Extension Study|Protocol Violation|1|||
28081018|NCT00103857|54734161|FG001|50-Week Extension Study|Protocol Violation|1|||
28081019|NCT00103857|54734162|FG002|50-Week Extension Study|Protocol Violation|1|||
28081020|NCT00103857|54734163|FG003|50-Week Extension Study|Protocol Violation|2|||
28081021|NCT00103857|54734164|FG004|50-Week Extension Study|Protocol Violation|0|||
28081022|NCT00103857|54734165|FG005|50-Week Extension Study|Protocol Violation|1|||
28081023|NCT00103857|54734166|FG006|50-Week Extension Study|Protocol Violation|0|||
28081024|NCT00103857|54734160|FG000|50-Week Extension Study|Withdrawal by Subject|2|||
28081025|NCT00103857|54734161|FG001|50-Week Extension Study|Withdrawal by Subject|5|||
28081026|NCT00103857|54734162|FG002|50-Week Extension Study|Withdrawal by Subject|2|||
28081027|NCT00103857|54734163|FG003|50-Week Extension Study|Withdrawal by Subject|8|||
28081028|NCT00103857|54734164|FG004|50-Week Extension Study|Withdrawal by Subject|3|||
28081029|NCT00103857|54734165|FG005|50-Week Extension Study|Withdrawal by Subject|3|||
28081030|NCT00103857|54734166|FG006|50-Week Extension Study|Withdrawal by Subject|0|||
28081031|NCT00103857|54734160|FG000|50-Week Extension Study|protocol discontinuation criteria|2|||
28081032|NCT00103857|54734161|FG001|50-Week Extension Study|protocol discontinuation criteria|2|||
28081033|NCT00103857|54734162|FG002|50-Week Extension Study|protocol discontinuation criteria|3|||
28081034|NCT00103857|54734163|FG003|50-Week Extension Study|protocol discontinuation criteria|2|||
28081035|NCT00103857|54734164|FG004|50-Week Extension Study|protocol discontinuation criteria|3|||
28081036|NCT00103857|54734165|FG005|50-Week Extension Study|protocol discontinuation criteria|3|||
28081037|NCT00103857|54734166|FG006|50-Week Extension Study|protocol discontinuation criteria|0|||
28081038|NCT00103857|54734160|FG000|50-Week Extension Study|non-compliance with study procedures|1|||
28081039|NCT00103857|54734161|FG001|50-Week Extension Study|non-compliance with study procedures|0|||
28081040|NCT00103857|54734162|FG002|50-Week Extension Study|non-compliance with study procedures|0|||
28081041|NCT00103857|54734163|FG003|50-Week Extension Study|non-compliance with study procedures|1|||
28081042|NCT00103857|54734164|FG004|50-Week Extension Study|non-compliance with study procedures|1|||
28081043|NCT00103857|54734165|FG005|50-Week Extension Study|non-compliance with study procedures|0|||
28081044|NCT00103857|54734166|FG006|50-Week Extension Study|non-compliance with study procedures|0|||
27951064|NCT01071252|54608234|FG003|Overall Study|Adverse Event|1|||
27951065|NCT01071252|54608235|FG004|Overall Study|Adverse Event|0|||
27951066|NCT01071252|54608231|FG000|Overall Study|Death|0|||
27731778|NCT02787863|54179183|FG002|Overall Study|Death|1|||
27951067|NCT01071252|54608232|FG001|Overall Study|Death|0|||
27951068|NCT01071252|54608233|FG002|Overall Study|Death|0|||
27951069|NCT01071252|54608234|FG003|Overall Study|Death|0|||
27951070|NCT01071252|54608235|FG004|Overall Study|Death|1|||
27951071|NCT00856843|54608249|FG000|Overall Study|Withdrawal by Subject|1|||
27951072|NCT00856843|54608250|FG001|Overall Study|Withdrawal by Subject|5|||
27951073|NCT00856843|54608249|FG000|Overall Study|Lack of Efficacy|1|||
27951074|NCT00856843|54608250|FG001|Overall Study|Lack of Efficacy|0|||
27951075|NCT00856609|54608258|FG000|Overall Study|Adverse Event|1|||
27951076|NCT00856609|54608259|FG001|Overall Study|Adverse Event|0|||
27951077|NCT01071096|54608265|FG000|First Intervention (90 Days)|Lost to Follow-up|1|||
27951078|NCT01071096|54608266|FG001|First Intervention (90 Days)|Lost to Follow-up|0|||
27951079|NCT00856375|54608285|FG000|Overall Study|Other|0|||
27951080|NCT00856375|54608286|FG001|Overall Study|Other|1|||
27951081|NCT00856375|54608285|FG000|Overall Study|Death|32|||
27951082|NCT00856375|54608286|FG001|Overall Study|Death|30|||
27951083|NCT00856375|54608285|FG000|Overall Study|Sponsor Terminated Study|7|||
27951084|NCT00856375|54608286|FG001|Overall Study|Sponsor Terminated Study|7|||
27951085|NCT00856375|54608285|FG000|Overall Study|Withdrawal by Subject|2|||
27951086|NCT00856375|54608286|FG001|Overall Study|Withdrawal by Subject|1|||
27951087|NCT00856375|54608285|FG000|Overall Study|Lost to Follow-up|1|||
27951088|NCT00856375|54608286|FG001|Overall Study|Lost to Follow-up|2|||
28081045|NCT00103857|54734160|FG000|50-Week Extension Study|patient moved|0|||
28081046|NCT00103857|54734161|FG001|50-Week Extension Study|patient moved|0|||
28081047|NCT00103857|54734162|FG002|50-Week Extension Study|patient moved|1|||
28081048|NCT00103857|54734163|FG003|50-Week Extension Study|patient moved|2|||
28164924|NCT03016403|54835578|FG000|6-week Follow-up|Withdrawal by Subject|0|||
28164925|NCT03016403|54835579|FG001|6-week Follow-up|Withdrawal by Subject|2|||
28164926|NCT03016403|54835580|FG002|6-week Follow-up|Withdrawal by Subject|0|||
28081049|NCT00103857|54734164|FG004|50-Week Extension Study|patient moved|0|||
28081050|NCT00103857|54734165|FG005|50-Week Extension Study|patient moved|0|||
28081051|NCT00103857|54734166|FG006|50-Week Extension Study|patient moved|0|||
28081052|NCT00103857|54734160|FG000|50-Week Extension Study|patient scheduled for elective surgery|0|||
28081053|NCT00103857|54734161|FG001|50-Week Extension Study|patient scheduled for elective surgery|0|||
28164927|NCT03016403|54835581|FG003|6-week Follow-up|Withdrawal by Subject|1|||
28164928|NCT03016403|54835578|FG000|3-month Follow-up and 6-month Follow-up|Death|6|||
28164929|NCT03016403|54835579|FG001|3-month Follow-up and 6-month Follow-up|Death|4|||
28164930|NCT03016403|54835580|FG002|3-month Follow-up and 6-month Follow-up|Death|0|||
28164931|NCT03016403|54835581|FG003|3-month Follow-up and 6-month Follow-up|Death|0|||
28164932|NCT03016403|54835578|FG000|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
28164933|NCT03016403|54835579|FG001|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|7|||
28164934|NCT03016403|54835580|FG002|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|8|||
28164935|NCT03016403|54835581|FG003|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
28164936|NCT03016403|54835578|FG000|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
28164937|NCT03016403|54835579|FG001|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
28164938|NCT03016403|54835580|FG002|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
28164939|NCT03016403|54835581|FG003|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|1|||
28164940|NCT02520310|54835593|FG000|At 6 Months Clinical Follow-up|Death|1|||
28164941|NCT02520310|54835593|FG000|At 1 Year Clinical Follow-up|Withdrawal by Subject|1|||
28164942|NCT02520310|54835593|FG000|AT 3 Year Clinical Follow-up|Death|2|||
28164943|NCT02520310|54835593|FG000|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2|||
28164944|NCT02520310|54835593|FG000|AT 4 Year Clinical Follow-up|Death|1|||
28164945|NCT02520310|54835593|FG000|AT 4 Year Clinical Follow-up|missed visit|1|||
28164946|NCT02662556|54835599|FG000|Overall Study|Adverse Event|4|||
28164947|NCT02662556|54835599|FG000|Overall Study|Lack of Efficacy|4|||
28164948|NCT02516098|54835606|FG000|Period 1|Protocol Violation|1|||
28164949|NCT02516098|54835607|FG001|Period 1|Protocol Violation|0|||
28164950|NCT02516098|54835606|FG000|Washout After Period 1|Adverse Event|0|||
28164951|NCT02516098|54835607|FG001|Washout After Period 1|Adverse Event|1|||
28164952|NCT02516098|54835606|FG000|Period 2|Withdrawal by Subject|0|||
27951089|NCT01070784|54608294|FG000|Overall Study|Withdrawal by Subject|6|||
28081054|NCT00103857|54734162|FG002|50-Week Extension Study|patient scheduled for elective surgery|1|||
28081055|NCT00103857|54734163|FG003|50-Week Extension Study|patient scheduled for elective surgery|0|||
28164953|NCT02516098|54835607|FG001|Period 2|Withdrawal by Subject|1|||
28164954|NCT01364428|54835615|FG000|Overall Study|Adverse Event|1|||
28164955|NCT01364428|54835616|FG001|Overall Study|Adverse Event|2|||
28164956|NCT01364428|54835615|FG000|Overall Study|Protocol Violation|2|||
28164957|NCT01364428|54835616|FG001|Overall Study|Protocol Violation|0|||
28164958|NCT01364428|54835615|FG000|Overall Study|Withdrawal Criteria|14|||
28164959|NCT01364428|54835616|FG001|Overall Study|Withdrawal Criteria|10|||
27832250|NCT00983619|54311052|FG007|Overall Study|Other|2|||
27951090|NCT01070784|54608295|FG001|Overall Study|Withdrawal by Subject|9|||
27951091|NCT01070784|54608294|FG000|Overall Study|Adverse Event|14|||
28081056|NCT00103857|54734164|FG004|50-Week Extension Study|patient scheduled for elective surgery|0|||
28164960|NCT01364428|54835615|FG000|Overall Study|Other|3|||
27731779|NCT02787863|54179184|FG003|Overall Study|Death|0|||
27731780|NCT02787863|54179185|FG004|Overall Study|Death|0|||
27731781|NCT02787863|54179186|FG005|Overall Study|Death|0|||
27731782|NCT02787863|54179187|FG006|Overall Study|Death|0|||
27731783|NCT02787863|54179188|FG007|Overall Study|Death|0|||
27731784|NCT02787863|54179181|FG000|Overall Study|Withdrawal by Subject|0|||
27731785|NCT02787863|54179182|FG001|Overall Study|Withdrawal by Subject|1|||
27731786|NCT02787863|54179183|FG002|Overall Study|Withdrawal by Subject|1|||
27731787|NCT02787863|54179184|FG003|Overall Study|Withdrawal by Subject|0|||
27731788|NCT02787863|54179185|FG004|Overall Study|Withdrawal by Subject|0|||
27731789|NCT02787863|54179186|FG005|Overall Study|Withdrawal by Subject|0|||
27731790|NCT02787863|54179187|FG006|Overall Study|Withdrawal by Subject|0|||
27731791|NCT02787863|54179188|FG007|Overall Study|Withdrawal by Subject|0|||
27731792|NCT02596958|54179229|FG000|Overall Study|Serious Adverse Drug Reactions|44|||
27731793|NCT02596958|54179229|FG000|Overall Study|Cancer Progression|441|||
27731794|NCT02596958|54179229|FG000|Overall Study|Death From Cancer|112|||
27731795|NCT02596958|54179229|FG000|Overall Study|Death From Other Cause|33|||
27731796|NCT02596958|54179229|FG000|Overall Study|Refusal of Treatment/Poor Cooperation|61|||
27731797|NCT02596958|54179229|FG000|Overall Study|Administrative Reasons/Other|231|||
27731798|NCT02596958|54179229|FG000|Overall Study|Lost to Follow-up|33|||
27731799|NCT02596958|54179229|FG000|Overall Study|Missing|32|||
27731800|NCT02596958|54179229|FG000|Overall Study|Excluded Due to Second Line Treatment|9|||
27731801|NCT01367249|54179235|FG000|Overall Study|Withdrawal by Subject|6|||
27731802|NCT01367249|54179236|FG001|Overall Study|Withdrawal by Subject|6|||
27731803|NCT01367249|54179235|FG000|Overall Study|Other|3|||
27731804|NCT01367249|54179236|FG001|Overall Study|Other|10|||
27731805|NCT02786927|54179242|FG000|Overall Study|Adverse Event|1|||
27731806|NCT02786927|54179242|FG000|Overall Study|Protocol Violation|4|||
27731807|NCT02592434|54179247|FG000|Open-Label Phase (18 Weeks)|Adverse Event|12|||
27731808|NCT02592434|54179248|FG001|Open-Label Phase (18 Weeks)|Adverse Event|0|||
27731809|NCT02592434|54179249|FG002|Open-Label Phase (18 Weeks)|Adverse Event|0|||
27731810|NCT02592434|54179247|FG000|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21|||
27731811|NCT02592434|54179248|FG001|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
27731812|NCT02592434|54179249|FG002|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
27731813|NCT02592434|54179247|FG000|Open-Label Phase (18 Weeks)|Other|3|||
27731814|NCT02592434|54179248|FG001|Open-Label Phase (18 Weeks)|Other|0|||
27731815|NCT02592434|54179249|FG002|Open-Label Phase (18 Weeks)|Other|0|||
27731816|NCT02592434|54179247|FG000|Open-Label Phase (18 Weeks)|Protocol Deviation|4|||
27731817|NCT02592434|54179248|FG001|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
27731818|NCT02592434|54179249|FG002|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
27731819|NCT02592434|54179247|FG000|Double Blind Phase (26 Weeks)|Adverse Event|0|||
27731820|NCT02592434|54179248|FG001|Double Blind Phase (26 Weeks)|Adverse Event|2|||
27731821|NCT02592434|54179249|FG002|Double Blind Phase (26 Weeks)|Adverse Event|2|||
27731822|NCT02592434|54179247|FG000|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0|||
27731823|NCT02592434|54179248|FG001|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22|||
27731824|NCT02592434|54179249|FG002|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44|||
27731825|NCT02592434|54179247|FG000|Double Blind Phase (26 Weeks)|Other|0|||
27731826|NCT02592434|54179248|FG001|Double Blind Phase (26 Weeks)|Other|1|||
27731827|NCT02592434|54179249|FG002|Double Blind Phase (26 Weeks)|Other|0|||
27731828|NCT02592434|54179247|FG000|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
27731829|NCT02592434|54179248|FG001|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
27731830|NCT02592434|54179249|FG002|Double Blind Phase (26 Weeks)|Protocol Deviation|1|||
27731831|NCT02592434|54179247|FG000|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
27731832|NCT02592434|54179248|FG001|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1|||
27731833|NCT02592434|54179249|FG002|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
27731834|NCT02592434|54179247|FG000|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
27731835|NCT02592434|54179248|FG001|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1|||
27731836|NCT02592434|54179249|FG002|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
27731837|NCT02785913|54179257|FG000|Overall Study|Adverse Event|5|||
27731838|NCT02785913|54179257|FG000|Overall Study|Death|2|||
27731839|NCT02785913|54179257|FG000|Overall Study|Progression|18|||
27731840|NCT02785913|54179257|FG000|Overall Study|Not protocol specified|1|||
27731841|NCT02590562|54179266|FG000|Overall Study|Did Not Meet the Inclusion Criteria|6|||
27854911|NCT00248833|54372951|FG002|Overall Study|Withdrawal by Subject|1|||
27854912|NCT00248833|54372949|FG000|Overall Study|Lost to Follow-up|1|||
27731842|NCT02783729|54179293|FG000|Overall Study|Lack of Efficacy|1|||
27731843|NCT02783729|54179294|FG001|Overall Study|Lack of Efficacy|0|||
27731844|NCT02783729|54179295|FG002|Overall Study|Lack of Efficacy|0|||
27731845|NCT02783729|54179296|FG003|Overall Study|Lack of Efficacy|0|||
27731846|NCT02783729|54179293|FG000|Overall Study|Adverse Event|2|||
27731847|NCT02783729|54179294|FG001|Overall Study|Adverse Event|6|||
27731848|NCT02783729|54179295|FG002|Overall Study|Adverse Event|2|||
27731849|NCT02783729|54179296|FG003|Overall Study|Adverse Event|3|||
27854913|NCT00248833|54372950|FG001|Overall Study|Lost to Follow-up|1|||
27951092|NCT01070784|54608295|FG001|Overall Study|Adverse Event|9|||
27951093|NCT00837577|54608303|FG000|Double-blind Period|Clinical Adverse Event|1|||
27951094|NCT00837577|54608304|FG001|Double-blind Period|Clinical Adverse Event|0|||
27951095|NCT00837577|54608303|FG000|Double-blind Period|Withdrawal by Subject|1|||
27951096|NCT00837577|54608304|FG001|Double-blind Period|Withdrawal by Subject|0|||
27951097|NCT00837577|54608303|FG000|Open-label Period|Clinical Adverse Event|2|||
27951098|NCT00837577|54608304|FG001|Open-label Period|Clinical Adverse Event|2|||
27951099|NCT00837577|54608303|FG000|Open-label Period|Laboratory Adverse Event|0|||
27951100|NCT00837577|54608304|FG001|Open-label Period|Laboratory Adverse Event|1|||
27951101|NCT00837577|54608303|FG000|Open-label Period|Lack of Efficacy|4|||
27951102|NCT00837577|54608304|FG001|Open-label Period|Lack of Efficacy|3|||
27951103|NCT00837577|54608303|FG000|Open-label Period|Withdrawal by Subject|1|||
27951104|NCT00837577|54608304|FG001|Open-label Period|Withdrawal by Subject|2|||
27951105|NCT00837577|54608303|FG000|Open-label Period|Other Reason|1|||
27951106|NCT00837577|54608304|FG001|Open-label Period|Other Reason|1|||
27951107|NCT01070550|54608317|FG000|Overall Study|Adverse Event|43|||
27951108|NCT01070550|54608318|FG001|Overall Study|Adverse Event|1|||
27951109|NCT01070550|54608319|FG002|Overall Study|Adverse Event|3|||
27951110|NCT01070550|54608320|FG003|Overall Study|Adverse Event|0|||
27951111|NCT01070550|54608321|FG004|Overall Study|Adverse Event|0|||
27951112|NCT01070550|54608322|FG005|Overall Study|Adverse Event|0|||
27951113|NCT01070550|54608317|FG000|Overall Study|Death|20|||
27951114|NCT01070550|54608318|FG001|Overall Study|Death|4|||
27951115|NCT01070550|54608319|FG002|Overall Study|Death|3|||
27951116|NCT01070550|54608320|FG003|Overall Study|Death|0|||
27951117|NCT01070550|54608321|FG004|Overall Study|Death|0|||
27951118|NCT01070550|54608322|FG005|Overall Study|Death|0|||
27951119|NCT01070550|54608317|FG000|Overall Study|Not meeting inclusion/exclusion criteria|2|||
27951120|NCT01070550|54608318|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
27951121|NCT01070550|54608319|FG002|Overall Study|Not meeting inclusion/exclusion criteria|1|||
27951122|NCT01070550|54608320|FG003|Overall Study|Not meeting inclusion/exclusion criteria|0|||
27951123|NCT01070550|54608321|FG004|Overall Study|Not meeting inclusion/exclusion criteria|0|||
27951124|NCT01070550|54608322|FG005|Overall Study|Not meeting inclusion/exclusion criteria|0|||
27951125|NCT01070550|54608317|FG000|Overall Study|Early termination|3|||
27951126|NCT01070550|54608318|FG001|Overall Study|Early termination|0|||
27951127|NCT01070550|54608319|FG002|Overall Study|Early termination|0|||
27951128|NCT01070550|54608320|FG003|Overall Study|Early termination|0|||
27951129|NCT01070550|54608321|FG004|Overall Study|Early termination|0|||
27951130|NCT01070550|54608322|FG005|Overall Study|Early termination|0|||
27951131|NCT01070550|54608317|FG000|Overall Study|Failed to return|450|||
27951132|NCT01070550|54608318|FG001|Overall Study|Failed to return|33|||
27951133|NCT01070550|54608319|FG002|Overall Study|Failed to return|144|||
27951134|NCT01070550|54608320|FG003|Overall Study|Failed to return|40|||
27951135|NCT01070550|54608321|FG004|Overall Study|Failed to return|1|||
27951136|NCT01070550|54608322|FG005|Overall Study|Failed to return|2|||
27951137|NCT01070550|54608317|FG000|Overall Study|Incomplete treatment|2|||
27951138|NCT01070550|54608318|FG001|Overall Study|Incomplete treatment|0|||
27951139|NCT01070550|54608319|FG002|Overall Study|Incomplete treatment|0|||
27951140|NCT01070550|54608320|FG003|Overall Study|Incomplete treatment|0|||
27951141|NCT01070550|54608321|FG004|Overall Study|Incomplete treatment|0|||
27951142|NCT01070550|54608322|FG005|Overall Study|Incomplete treatment|0|||
27951143|NCT01070550|54608317|FG000|Overall Study|Lab test not done|22|||
27951144|NCT01070550|54608318|FG001|Overall Study|Lab test not done|3|||
27951145|NCT01070550|54608319|FG002|Overall Study|Lab test not done|4|||
27951146|NCT01070550|54608320|FG003|Overall Study|Lab test not done|1|||
27951147|NCT01070550|54608321|FG004|Overall Study|Lab test not done|0|||
27951148|NCT01070550|54608322|FG005|Overall Study|Lab test not done|1|||
27951149|NCT01070550|54608317|FG000|Overall Study|Lack of Efficacy|65|||
27951150|NCT01070550|54608318|FG001|Overall Study|Lack of Efficacy|1|||
27951151|NCT01070550|54608319|FG002|Overall Study|Lack of Efficacy|5|||
27951152|NCT01070550|54608320|FG003|Overall Study|Lack of Efficacy|5|||
28164961|NCT01364428|54835616|FG001|Overall Study|Other|3|||
28164962|NCT02515942|54835625|FG000|Overall Study|Adverse Event|5|||
28164963|NCT02515942|54835626|FG001|Overall Study|Adverse Event|0|||
27951153|NCT01070550|54608321|FG004|Overall Study|Lack of Efficacy|0|||
27951154|NCT01070550|54608322|FG005|Overall Study|Lack of Efficacy|1|||
27951155|NCT01070550|54608317|FG000|Overall Study|Miscellaneous|12|||
27951156|NCT01070550|54608318|FG001|Overall Study|Miscellaneous|2|||
27951157|NCT01070550|54608319|FG002|Overall Study|Miscellaneous|3|||
27951158|NCT01070550|54608320|FG003|Overall Study|Miscellaneous|1|||
27951159|NCT01070550|54608321|FG004|Overall Study|Miscellaneous|0|||
27951160|NCT01070550|54608322|FG005|Overall Study|Miscellaneous|0|||
27951161|NCT01070550|54608317|FG000|Overall Study|New treatment started|3|||
27951162|NCT01070550|54608318|FG001|Overall Study|New treatment started|1|||
27951163|NCT01070550|54608319|FG002|Overall Study|New treatment started|0|||
27951164|NCT01070550|54608320|FG003|Overall Study|New treatment started|2|||
27951165|NCT01070550|54608321|FG004|Overall Study|New treatment started|0|||
28164964|NCT02515942|54835627|FG002|Overall Study|Adverse Event|0|||
27951166|NCT01070550|54608322|FG005|Overall Study|New treatment started|0|||
27951167|NCT01070550|54608317|FG000|Overall Study|Non-responders|493|||
27951168|NCT01070550|54608318|FG001|Overall Study|Non-responders|4|||
27951169|NCT01070550|54608319|FG002|Overall Study|Non-responders|21|||
27951170|NCT01070550|54608320|FG003|Overall Study|Non-responders|20|||
27951171|NCT01070550|54608321|FG004|Overall Study|Non-responders|0|||
27951172|NCT01070550|54608322|FG005|Overall Study|Non-responders|2|||
27951173|NCT01070550|54608317|FG000|Overall Study|Not categorized|33|||
27951174|NCT01070550|54608318|FG001|Overall Study|Not categorized|2|||
27951175|NCT01070550|54608319|FG002|Overall Study|Not categorized|6|||
27951176|NCT01070550|54608320|FG003|Overall Study|Not categorized|1|||
27951177|NCT01070550|54608321|FG004|Overall Study|Not categorized|0|||
27951178|NCT01070550|54608322|FG005|Overall Study|Not categorized|1|||
27951179|NCT01070550|54608317|FG000|Overall Study|Protocol Violation|15|||
27951180|NCT01070550|54608318|FG001|Overall Study|Protocol Violation|1|||
27951181|NCT01070550|54608319|FG002|Overall Study|Protocol Violation|1|||
27951182|NCT01070550|54608320|FG003|Overall Study|Protocol Violation|1|||
27951183|NCT01070550|54608321|FG004|Overall Study|Protocol Violation|0|||
27951184|NCT01070550|54608322|FG005|Overall Study|Protocol Violation|0|||
27951185|NCT01070550|54608317|FG000|Overall Study|Relapse|44|||
27951186|NCT01070550|54608318|FG001|Overall Study|Relapse|5|||
27951187|NCT01070550|54608319|FG002|Overall Study|Relapse|14|||
27951188|NCT01070550|54608320|FG003|Overall Study|Relapse|4|||
27951189|NCT01070550|54608321|FG004|Overall Study|Relapse|0|||
27951190|NCT01070550|54608322|FG005|Overall Study|Relapse|0|||
27951191|NCT01070550|54608317|FG000|Overall Study|Result not available|3|||
27951192|NCT01070550|54608318|FG001|Overall Study|Result not available|1|||
27951193|NCT01070550|54608319|FG002|Overall Study|Result not available|3|||
27951194|NCT01070550|54608320|FG003|Overall Study|Result not available|0|||
27951195|NCT01070550|54608321|FG004|Overall Study|Result not available|0|||
27951196|NCT01070550|54608322|FG005|Overall Study|Result not available|0|||
27951197|NCT01070550|54608317|FG000|Overall Study|Screen failure|1|||
27951198|NCT01070550|54608318|FG001|Overall Study|Screen failure|0|||
27951199|NCT01070550|54608319|FG002|Overall Study|Screen failure|0|||
27951200|NCT01070550|54608320|FG003|Overall Study|Screen failure|0|||
27951201|NCT01070550|54608321|FG004|Overall Study|Screen failure|0|||
27951202|NCT01070550|54608322|FG005|Overall Study|Screen failure|0|||
27951203|NCT01070550|54608317|FG000|Overall Study|Sponsor decision|1|||
27951204|NCT01070550|54608318|FG001|Overall Study|Sponsor decision|0|||
27951205|NCT01070550|54608319|FG002|Overall Study|Sponsor decision|0|||
27951206|NCT01070550|54608320|FG003|Overall Study|Sponsor decision|0|||
27951207|NCT01070550|54608321|FG004|Overall Study|Sponsor decision|0|||
27951208|NCT01070550|54608322|FG005|Overall Study|Sponsor decision|0|||
27951209|NCT01070550|54608317|FG000|Overall Study|Treatment duration shortened|1|||
27951210|NCT01070550|54608318|FG001|Overall Study|Treatment duration shortened|0|||
27951211|NCT01070550|54608319|FG002|Overall Study|Treatment duration shortened|0|||
27951212|NCT01070550|54608320|FG003|Overall Study|Treatment duration shortened|0|||
27951213|NCT01070550|54608321|FG004|Overall Study|Treatment duration shortened|0|||
27951214|NCT01070550|54608322|FG005|Overall Study|Treatment duration shortened|0|||
27951215|NCT01070550|54608317|FG000|Overall Study|Treatment interrupted|7|||
27951216|NCT01070550|54608318|FG001|Overall Study|Treatment interrupted|0|||
27951217|NCT01070550|54608319|FG002|Overall Study|Treatment interrupted|1|||
27951218|NCT01070550|54608320|FG003|Overall Study|Treatment interrupted|1|||
27951219|NCT01070550|54608321|FG004|Overall Study|Treatment interrupted|0|||
27951220|NCT01070550|54608322|FG005|Overall Study|Treatment interrupted|0|||
27951221|NCT01070550|54608317|FG000|Overall Study|Treatment not started|14|||
27951222|NCT01070550|54608318|FG001|Overall Study|Treatment not started|2|||
27951223|NCT01070550|54608319|FG002|Overall Study|Treatment not started|4|||
27951224|NCT01070550|54608320|FG003|Overall Study|Treatment not started|0|||
27951225|NCT01070550|54608321|FG004|Overall Study|Treatment not started|0|||
27951226|NCT01070550|54608322|FG005|Overall Study|Treatment not started|0|||
27951227|NCT01070550|54608317|FG000|Overall Study|Treatment restarted|0|||
27951228|NCT01070550|54608318|FG001|Overall Study|Treatment restarted|1|||
27951229|NCT01070550|54608319|FG002|Overall Study|Treatment restarted|0|||
27951230|NCT01070550|54608320|FG003|Overall Study|Treatment restarted|0|||
27951231|NCT01070550|54608321|FG004|Overall Study|Treatment restarted|0|||
27951232|NCT01070550|54608322|FG005|Overall Study|Treatment restarted|0|||
27951233|NCT01070550|54608317|FG000|Overall Study|Treatment stopped|3|||
27951234|NCT01070550|54608318|FG001|Overall Study|Treatment stopped|0|||
27951235|NCT01070550|54608319|FG002|Overall Study|Treatment stopped|0|||
27951236|NCT01070550|54608320|FG003|Overall Study|Treatment stopped|0|||
27951237|NCT01070550|54608321|FG004|Overall Study|Treatment stopped|0|||
27951238|NCT01070550|54608322|FG005|Overall Study|Treatment stopped|0|||
27951239|NCT01070550|54608317|FG000|Overall Study|Treatment unavailable|1|||
27951240|NCT01070550|54608318|FG001|Overall Study|Treatment unavailable|0|||
27951241|NCT01070550|54608319|FG002|Overall Study|Treatment unavailable|0|||
27951242|NCT01070550|54608320|FG003|Overall Study|Treatment unavailable|0|||
27951243|NCT01070550|54608321|FG004|Overall Study|Treatment unavailable|0|||
27951244|NCT01070550|54608322|FG005|Overall Study|Treatment unavailable|0|||
27951245|NCT01070550|54608317|FG000|Overall Study|Treatment was stopped early|7|||
27951246|NCT01070550|54608318|FG001|Overall Study|Treatment was stopped early|0|||
27951247|NCT01070550|54608319|FG002|Overall Study|Treatment was stopped early|0|||
27951248|NCT01070550|54608320|FG003|Overall Study|Treatment was stopped early|0|||
27951249|NCT01070550|54608321|FG004|Overall Study|Treatment was stopped early|0|||
27951250|NCT01070550|54608322|FG005|Overall Study|Treatment was stopped early|0|||
27951251|NCT01070550|54608317|FG000|Overall Study|Other|5|||
27951252|NCT01070550|54608318|FG001|Overall Study|Other|0|||
27951253|NCT01070550|54608319|FG002|Overall Study|Other|0|||
27951254|NCT01070550|54608320|FG003|Overall Study|Other|1|||
27951255|NCT01070550|54608321|FG004|Overall Study|Other|0|||
27951256|NCT01070550|54608322|FG005|Overall Study|Other|0|||
27951257|NCT01070550|54608317|FG000|Overall Study|Withdrawal by Subject|35|||
27951258|NCT01070550|54608318|FG001|Overall Study|Withdrawal by Subject|0|||
27951259|NCT01070550|54608319|FG002|Overall Study|Withdrawal by Subject|3|||
27951260|NCT01070550|54608320|FG003|Overall Study|Withdrawal by Subject|0|||
27951261|NCT01070550|54608321|FG004|Overall Study|Withdrawal by Subject|0|||
27951262|NCT01070550|54608322|FG005|Overall Study|Withdrawal by Subject|0|||
27951263|NCT00848107|54608337|FG000|Overall Study|Lost to Follow-up|2|||
27951264|NCT00848107|54608337|FG000|Overall Study|Withdrawal by Subject|8|||
27951265|NCT00848107|54608337|FG000|Overall Study|Adverse Event|9|||
27951266|NCT00848107|54608337|FG000|Overall Study|Death|1|||
27951267|NCT00848107|54608337|FG000|Overall Study|Pregnancy|1|||
27951268|NCT00856297|54608346|FG000|Overall Study|Unable to classify|2|||
27951269|NCT00856297|54608347|FG001|Overall Study|Unable to classify|0|||
27951270|NCT00856297|54608348|FG002|Overall Study|Unable to classify|0|||
27951271|NCT00856297|54608349|FG003|Overall Study|Unable to classify|0|||
27951272|NCT00856297|54608350|FG004|Overall Study|Unable to classify|0|||
27951273|NCT01046136|54608369|FG000|Overall Study|Withdrawal by Subject|0|||
27951274|NCT01046136|54608370|FG001|Overall Study|Withdrawal by Subject|4|||
27951275|NCT01046136|54608369|FG000|Overall Study|Physician Decision|1|||
27951276|NCT01046136|54608370|FG001|Overall Study|Physician Decision|1|||
27951277|NCT01046136|54608369|FG000|Overall Study|Lost to Follow-up|3|||
27951278|NCT01046136|54608370|FG001|Overall Study|Lost to Follow-up|3|||
27951279|NCT01070394|54608378|FG000|Overall Study|Adverse Event|6|||
27951280|NCT01070394|54608378|FG000|Overall Study|Withdrawal by Subject|1|||
27951281|NCT00836953|54608384|FG000|Overall Study|Withdrawal by Subject|1|||
27951282|NCT00836953|54608384|FG000|Overall Study|Lost to Follow-up|1|||
27951283|NCT01070316|54608388|FG000|Extension Phase|Lack of Efficacy|3|||
27951284|NCT01070316|54608388|FG000|Extension Phase|Withdrawal by Subject|1|||
27951285|NCT01126541|54608395|FG000|Overall Study|Adverse Event|0|||
27951286|NCT01126541|54608396|FG001|Overall Study|Adverse Event|2|||
27951287|NCT01126541|54608397|FG002|Overall Study|Adverse Event|4|||
27951288|NCT01126541|54608395|FG000|Overall Study|Death|0|||
27951289|NCT01126541|54608396|FG001|Overall Study|Death|1|||
27951290|NCT01126541|54608397|FG002|Overall Study|Death|0|||
27951291|NCT01126541|54608395|FG000|Overall Study|Lack of Efficacy|6|||
27951292|NCT01126541|54608396|FG001|Overall Study|Lack of Efficacy|1|||
27951293|NCT01126541|54608397|FG002|Overall Study|Lack of Efficacy|11|||
27951294|NCT01126541|54608395|FG000|Overall Study|Lost to Follow-up|1|||
27951295|NCT01126541|54608396|FG001|Overall Study|Lost to Follow-up|2|||
27951296|NCT01126541|54608397|FG002|Overall Study|Lost to Follow-up|2|||
27951297|NCT01126541|54608395|FG000|Overall Study|Withdrawal by Subject|2|||
27951298|NCT01126541|54608396|FG001|Overall Study|Withdrawal by Subject|5|||
27951299|NCT01126541|54608397|FG002|Overall Study|Withdrawal by Subject|6|||
27951300|NCT01126541|54608395|FG000|Overall Study|Protocol Violation|0|||
27951301|NCT01126541|54608396|FG001|Overall Study|Protocol Violation|0|||
27951302|NCT01126541|54608397|FG002|Overall Study|Protocol Violation|1|||
27951303|NCT01126541|54608395|FG000|Overall Study|Administrative reason or other|1|||
27951304|NCT01126541|54608396|FG001|Overall Study|Administrative reason or other|1|||
27951305|NCT01126541|54608397|FG002|Overall Study|Administrative reason or other|2|||
27951306|NCT00836875|54608409|FG000|Overall Study|Death|3|||
27951307|NCT00836875|54608410|FG001|Overall Study|Death|2|||
27951308|NCT00836875|54608409|FG000|Overall Study|Withdrawal by Subject|0|||
27951309|NCT00836875|54608410|FG001|Overall Study|Withdrawal by Subject|1|||
27951310|NCT01125917|54608416|FG000|Overall Study|Adverse Event|43|||
27951311|NCT01125917|54608416|FG000|Overall Study|Lost to Follow-up|23|||
27951312|NCT01125917|54608416|FG000|Overall Study|Withdrawal by Subject|31|||
27951313|NCT01125917|54608416|FG000|Overall Study|Administrative|223|||
27951314|NCT01125917|54608416|FG000|Overall Study|Lack of Efficacy|19|||
27951315|NCT00847561|54608422|FG000|Overall Study|Withdrawal by Subject|4|||
27951316|NCT00847561|54608423|FG001|Overall Study|Withdrawal by Subject|3|||
27951317|NCT00847561|54608422|FG000|Overall Study|Unable to schedule|9|||
27951318|NCT00847561|54608423|FG001|Overall Study|Unable to schedule|1|||
27951319|NCT01121549|54608429|FG000|Overall Study|Adverse Event|10|||
27951320|NCT01121549|54608429|FG000|Overall Study|Lack of Efficacy|11|||
27951321|NCT01121549|54608429|FG000|Overall Study|Lost to Follow-up|12|||
27951322|NCT01121549|54608429|FG000|Overall Study|Did not meet entrance criteria|9|||
27951323|NCT01121549|54608429|FG000|Overall Study|Study terminated by sponsor|197|||
27951324|NCT01121549|54608429|FG000|Overall Study|Pregnancy|1|||
27951325|NCT01121549|54608429|FG000|Overall Study|Protocol Violation|33|||
27951326|NCT01121549|54608429|FG000|Overall Study|Withdrawal by Subject|16|||
27951327|NCT01121549|54608429|FG000|Overall Study|Other|58|||
27951328|NCT00847405|54608435|FG000|First Intervention|Adverse Event|0|||
27951329|NCT00847405|54608436|FG001|First Intervention|Adverse Event|1|||
27951330|NCT00847405|54608435|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
27951331|NCT00847405|54608436|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
27951332|NCT00836095|54608442|FG000|Overall Study|Physician Decision|0|||
27951333|NCT00836095|54608443|FG001|Overall Study|Physician Decision|3|||
27951334|NCT00835237|54608460|FG000|Overall Study|Lost to Follow-up|4|||
27951335|NCT00835237|54608461|FG001|Overall Study|Lost to Follow-up|0|||
27951336|NCT00835237|54608460|FG000|Overall Study|Withdrawal by Subject|2|||
27951337|NCT00835237|54608461|FG001|Overall Study|Withdrawal by Subject|0|||
27951338|NCT01072500|54608469|FG000|Overall Study|Death|2|||
27951339|NCT01072500|54608470|FG001|Overall Study|Death|2|||
27951340|NCT01072500|54608469|FG000|Overall Study|Lost to Follow-up|5|||
27951341|NCT01072500|54608470|FG001|Overall Study|Lost to Follow-up|2|||
27951342|NCT01072500|54608469|FG000|Overall Study|Withdrawal by Subject|17|||
27951343|NCT01072500|54608470|FG001|Overall Study|Withdrawal by Subject|10|||
27951344|NCT00847015|54608478|FG000|Overall Study|Withdrawal by Subject|1|||
27951345|NCT00847015|54608478|FG000|Overall Study|declined any surgery|1|||
27951346|NCT00847015|54608478|FG000|Overall Study|partial cystectomy vs radical cystectomy|1|||
27951347|NCT00855595|54608484|FG000|Overall Study|Withdrawal by Subject|1|||
27951348|NCT00855595|54608485|FG001|Overall Study|Withdrawal by Subject|2|||
27951349|NCT00855595|54608484|FG000|Overall Study|Lost to Follow-up|3|||
27951350|NCT00855595|54608485|FG001|Overall Study|Lost to Follow-up|3|||
27951351|NCT00855595|54608484|FG000|Overall Study|Adverse Event|1|||
27951352|NCT00855595|54608485|FG001|Overall Study|Adverse Event|1|||
27951353|NCT00855595|54608484|FG000|Overall Study|patient moved out of state|1|||
27951354|NCT00855595|54608485|FG001|Overall Study|patient moved out of state|0|||
27951355|NCT00855595|54608484|FG000|Overall Study|patient left country|0|||
27951356|NCT00855595|54608485|FG001|Overall Study|patient left country|1|||
27951357|NCT00855439|54608493|FG000|Overall Study|Withdrawal by Subject|2|||
27951358|NCT00855439|54608494|FG001|Overall Study|Withdrawal by Subject|0|||
27951359|NCT00855439|54608493|FG000|Overall Study|Pregnancy|1|||
27951360|NCT00855439|54608494|FG001|Overall Study|Pregnancy|0|||
27951361|NCT01064856|54608502|FG000|Double-blind (DB) Period|Adverse Event|1|||
27951362|NCT01064856|54608503|FG001|Double-blind (DB) Period|Adverse Event|0|||
27951363|NCT01064856|54608504|FG002|Double-blind (DB) Period|Adverse Event|0|||
27951364|NCT01064856|54608505|FG003|Double-blind (DB) Period|Adverse Event|0|||
27951365|NCT01064856|54608502|FG000|Double-blind (DB) Period|Consent withdrawn by participant|1|||
27951366|NCT01064856|54608503|FG001|Double-blind (DB) Period|Consent withdrawn by participant|0|||
27951367|NCT01064856|54608504|FG002|Double-blind (DB) Period|Consent withdrawn by participant|0|||
27951368|NCT01064856|54608505|FG003|Double-blind (DB) Period|Consent withdrawn by participant|0|||
27951369|NCT01064856|54608502|FG000|Open-label (OL) Period|Adverse Event|0|||
27951370|NCT01064856|54608503|FG001|Open-label (OL) Period|Adverse Event|0|||
27951371|NCT01064856|54608504|FG002|Open-label (OL) Period|Adverse Event|12|||
27951372|NCT01064856|54608505|FG003|Open-label (OL) Period|Adverse Event|6|||
27951373|NCT01064856|54608502|FG000|Open-label (OL) Period|Consent withdrawn by participant|0|||
27951374|NCT01064856|54608503|FG001|Open-label (OL) Period|Consent withdrawn by participant|0|||
27951375|NCT01064856|54608504|FG002|Open-label (OL) Period|Consent withdrawn by participant|5|||
27951376|NCT01064856|54608505|FG003|Open-label (OL) Period|Consent withdrawn by participant|6|||
27951377|NCT01064856|54608502|FG000|Open-label (OL) Period|Lost to Follow-up|0|||
27951378|NCT01064856|54608503|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
27951379|NCT01064856|54608504|FG002|Open-label (OL) Period|Lost to Follow-up|2|||
27951380|NCT01064856|54608505|FG003|Open-label (OL) Period|Lost to Follow-up|1|||
27951381|NCT01064856|54608502|FG000|Open-label (OL) Period|Other|0|||
27951382|NCT01064856|54608503|FG001|Open-label (OL) Period|Other|0|||
27951383|NCT01064856|54608504|FG002|Open-label (OL) Period|Other|7|||
27951384|NCT01064856|54608505|FG003|Open-label (OL) Period|Other|7|||
27951385|NCT00846391|54608515|FG000|Overall Study|Physician Decision|0|||
27951386|NCT00846391|54608516|FG001|Overall Study|Physician Decision|0|||
27951387|NCT00846391|54608517|FG002|Overall Study|Physician Decision|1|||
27951388|NCT00846391|54608515|FG000|Overall Study|Study Terminated by Sponsor|1|||
27951389|NCT00846391|54608516|FG001|Overall Study|Study Terminated by Sponsor|2|||
27951390|NCT00846391|54608517|FG002|Overall Study|Study Terminated by Sponsor|2|||
27951391|NCT01042392|54608527|FG000|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6|||
27951392|NCT01042392|54608528|FG001|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
27951393|NCT01042392|54608529|FG002|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5|||
27951394|NCT01042392|54608530|FG003|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
27951395|NCT01042392|54608527|FG000|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1|||
27951396|NCT01042392|54608528|FG001|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
27951397|NCT01042392|54608529|FG002|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
27951398|NCT01042392|54608530|FG003|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
27951399|NCT01042392|54608527|FG000|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1|||
27951400|NCT01042392|54608528|FG001|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
27951401|NCT01042392|54608529|FG002|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2|||
27951402|NCT01042392|54608530|FG003|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
27951403|NCT01042392|54608527|FG000|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
27951404|NCT01042392|54608528|FG001|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
27951405|NCT01042392|54608529|FG002|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1|||
27951406|NCT01042392|54608530|FG003|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
27951407|NCT01042392|54608527|FG000|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2|||
27951408|NCT01042392|54608528|FG001|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
27951409|NCT01042392|54608529|FG002|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
27951410|NCT01042392|54608530|FG003|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
27951411|NCT01042392|54608527|FG000|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
27951412|NCT01042392|54608528|FG001|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
27951413|NCT01042392|54608529|FG002|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1|||
27951414|NCT01042392|54608530|FG003|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
27951415|NCT01042392|54608527|FG000|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2|||
27951416|NCT01042392|54608528|FG001|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
27951417|NCT01042392|54608529|FG002|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
27951418|NCT01042392|54608530|FG003|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
27951419|NCT01042392|54608527|FG000|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
27951420|NCT01042392|54608528|FG001|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
27951421|NCT01042392|54608529|FG002|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2|||
27951422|NCT01042392|54608530|FG003|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
27951423|NCT01042392|54608527|FG000|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0|||
27951424|NCT01042392|54608528|FG001|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
27951425|NCT01042392|54608529|FG002|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
27951426|NCT01042392|54608530|FG003|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
27951427|NCT01064310|54608544|FG000|Period 1|Adverse Event|7|||
27951428|NCT01064310|54608545|FG001|Period 1|Adverse Event|10|||
27951429|NCT01064310|54608546|FG002|Period 1|Adverse Event|0|||
27951430|NCT01064310|54608544|FG000|Period 1|Physician Decision|1|||
27951431|NCT01064310|54608545|FG001|Period 1|Physician Decision|0|||
27951432|NCT01064310|54608546|FG002|Period 1|Physician Decision|0|||
27951433|NCT01064310|54608544|FG000|Period 1|Withdrawal by Subject|2|||
27951434|NCT01064310|54608545|FG001|Period 1|Withdrawal by Subject|2|||
27951435|NCT01064310|54608546|FG002|Period 1|Withdrawal by Subject|0|||
27951436|NCT01064310|54608544|FG000|Period 1|Lack of Efficacy|3|||
27951437|NCT01064310|54608545|FG001|Period 1|Lack of Efficacy|5|||
27951438|NCT01064310|54608546|FG002|Period 1|Lack of Efficacy|0|||
27951439|NCT01064310|54608544|FG000|Period 1|Entered Open-label Period|1|||
27951440|NCT01064310|54608545|FG001|Period 1|Entered Open-label Period|1|||
27951441|NCT01064310|54608546|FG002|Period 1|Entered Open-label Period|0|||
27951442|NCT01064310|54608544|FG000|Period 2|Adverse Event|2|||
27951443|NCT01064310|54608545|FG001|Period 2|Adverse Event|1|||
27951444|NCT01064310|54608546|FG002|Period 2|Adverse Event|0|||
27951445|NCT01064310|54608544|FG000|Period 2|Physician Decision|0|||
27951446|NCT01064310|54608545|FG001|Period 2|Physician Decision|1|||
27951447|NCT01064310|54608546|FG002|Period 2|Physician Decision|0|||
27951448|NCT01064310|54608544|FG000|Period 2|Entered Open-label Period|1|||
27951449|NCT01064310|54608545|FG001|Period 2|Entered Open-label Period|0|||
27951450|NCT01064310|54608546|FG002|Period 2|Entered Open-label Period|0|||
27951451|NCT01064310|54608544|FG000|Period 2|Lack of Efficacy|1|||
27951452|NCT01064310|54608545|FG001|Period 2|Lack of Efficacy|4|||
27951453|NCT01064310|54608546|FG002|Period 2|Lack of Efficacy|0|||
27951454|NCT01064310|54608544|FG000|Open Label Pazopinib|Withdrawal by Subject|0|||
27951455|NCT01064310|54608545|FG001|Open Label Pazopinib|Withdrawal by Subject|0|||
27951456|NCT01064310|54608546|FG002|Open Label Pazopinib|Withdrawal by Subject|1|||
28164965|NCT02515942|54835625|FG000|Overall Study|Death|0|||
27731850|NCT02783729|54179293|FG000|Overall Study|Other|1|||
27854914|NCT00248833|54372951|FG002|Overall Study|Lost to Follow-up|1|||
27854915|NCT00248833|54372949|FG000|Overall Study|Other|0|||
27854916|NCT00248833|54372950|FG001|Overall Study|Other|1|||
27854917|NCT00248833|54372951|FG002|Overall Study|Other|0|||
27854918|NCT00247273|54373131|FG000|Overall Study|Adverse Event|85|||
27951457|NCT01064310|54608544|FG000|Open Label Pazopinib|Adverse Event|0|||
27951458|NCT01064310|54608545|FG001|Open Label Pazopinib|Adverse Event|0|||
28164966|NCT02515942|54835626|FG001|Overall Study|Death|0|||
28164967|NCT02515942|54835627|FG002|Overall Study|Death|1|||
27731851|NCT02783729|54179294|FG001|Overall Study|Other|6|||
27731852|NCT02783729|54179295|FG002|Overall Study|Other|2|||
27854919|NCT00247273|54373132|FG001|Overall Study|Adverse Event|80|||
27854920|NCT00247273|54373131|FG000|Overall Study|Physician Decision|6|||
27951459|NCT01064310|54608546|FG002|Open Label Pazopinib|Adverse Event|12|||
27951460|NCT01064310|54608544|FG000|Open Label Pazopinib|Lack of Efficacy|0|||
27951461|NCT01064310|54608545|FG001|Open Label Pazopinib|Lack of Efficacy|0|||
27951462|NCT01064310|54608546|FG002|Open Label Pazopinib|Lack of Efficacy|51|||
27951463|NCT01064310|54608544|FG000|Open Label Pazopinib|Physician Decision|0|||
27951464|NCT01064310|54608545|FG001|Open Label Pazopinib|Physician Decision|0|||
27951465|NCT01064310|54608546|FG002|Open Label Pazopinib|Physician Decision|20|||
27951466|NCT01037244|54608559|FG000|Overall Study|Adverse Event|3|||
27951467|NCT01037244|54608560|FG001|Overall Study|Adverse Event|2|||
27951468|NCT01037244|54608561|FG002|Overall Study|Adverse Event|6|||
27951469|NCT01037244|54608562|FG003|Overall Study|Adverse Event|3|||
27951470|NCT01037244|54608559|FG000|Overall Study|Lack of Efficacy|1|||
27951471|NCT01037244|54608560|FG001|Overall Study|Lack of Efficacy|1|||
27951472|NCT01037244|54608561|FG002|Overall Study|Lack of Efficacy|0|||
27951473|NCT01037244|54608562|FG003|Overall Study|Lack of Efficacy|1|||
27951474|NCT01037244|54608559|FG000|Overall Study|Lost to Follow-up|3|||
27951475|NCT01037244|54608560|FG001|Overall Study|Lost to Follow-up|3|||
27951476|NCT01037244|54608561|FG002|Overall Study|Lost to Follow-up|4|||
27951477|NCT01037244|54608562|FG003|Overall Study|Lost to Follow-up|4|||
27951478|NCT01037244|54608559|FG000|Overall Study|Withdrawal by Subject|1|||
27951479|NCT01037244|54608560|FG001|Overall Study|Withdrawal by Subject|5|||
27951480|NCT01037244|54608561|FG002|Overall Study|Withdrawal by Subject|3|||
27951481|NCT01037244|54608562|FG003|Overall Study|Withdrawal by Subject|5|||
27951482|NCT01037244|54608559|FG000|Overall Study|Partner Withdrew Consent|2|||
27951483|NCT01037244|54608560|FG001|Overall Study|Partner Withdrew Consent|1|||
27951484|NCT01037244|54608561|FG002|Overall Study|Partner Withdrew Consent|0|||
27951485|NCT01037244|54608562|FG003|Overall Study|Partner Withdrew Consent|0|||
27951486|NCT01037244|54608559|FG000|Overall Study|Various|3|||
27951487|NCT01037244|54608560|FG001|Overall Study|Various|2|||
27951488|NCT01037244|54608561|FG002|Overall Study|Various|1|||
27951489|NCT01037244|54608562|FG003|Overall Study|Various|1|||
27951490|NCT00833989|54608576|FG000|Overall Study|Physician Decision|0|||
27951491|NCT00833989|54608577|FG001|Overall Study|Physician Decision|0|||
27951492|NCT00833989|54608578|FG002|Overall Study|Physician Decision|0|||
27951493|NCT00833989|54608579|FG003|Overall Study|Physician Decision|1|||
27951494|NCT00833989|54608576|FG000|Overall Study|Withdrawal by Subject|3|||
27951495|NCT00833989|54608577|FG001|Overall Study|Withdrawal by Subject|0|||
27951496|NCT00833989|54608578|FG002|Overall Study|Withdrawal by Subject|1|||
27951497|NCT00833989|54608579|FG003|Overall Study|Withdrawal by Subject|1|||
27951498|NCT01037088|54608592|FG000|Overall Study|Withdrawal by Subject|3|||
27951499|NCT01042236|54608601|FG000|Treatment Period 1|Adverse Event|0|||
27951500|NCT01042236|54608602|FG001|Treatment Period 1|Adverse Event|1|||
27951501|NCT01042236|54608603|FG002|Treatment Period 1|Adverse Event|0|||
27951502|NCT01042236|54608604|FG003|Treatment Period 1|Adverse Event|0|||
27951503|NCT01042236|54608605|FG004|Treatment Period 1|Adverse Event|1|||
27951504|NCT01042236|54608606|FG005|Treatment Period 1|Adverse Event|0|||
27951505|NCT01042236|54608601|FG000|Treatment Period 3|Adverse Event|0|||
27951506|NCT01042236|54608602|FG001|Treatment Period 3|Adverse Event|0|||
27951507|NCT01042236|54608603|FG002|Treatment Period 3|Adverse Event|0|||
27951508|NCT01042236|54608604|FG003|Treatment Period 3|Adverse Event|1|||
27951509|NCT01042236|54608605|FG004|Treatment Period 3|Adverse Event|0|||
27951510|NCT01042236|54608606|FG005|Treatment Period 3|Adverse Event|0|||
27951511|NCT01042236|54608601|FG000|Treatment Period 3|Protocol Violation|0|||
27951512|NCT01042236|54608602|FG001|Treatment Period 3|Protocol Violation|0|||
27951513|NCT01042236|54608603|FG002|Treatment Period 3|Protocol Violation|0|||
27951514|NCT01042236|54608604|FG003|Treatment Period 3|Protocol Violation|1|||
27951515|NCT01042236|54608605|FG004|Treatment Period 3|Protocol Violation|0|||
27951516|NCT01042236|54608606|FG005|Treatment Period 3|Protocol Violation|0|||
27951517|NCT00592501|54608614|FG000|Overall Study|Withdrawal by Subject|1|||
27951518|NCT00592501|54608614|FG000|Overall Study|Participant found to have metastatic disease after enrollment thus deemed ineligible|1|||
27951519|NCT01040832|54608620|FG000|Overall Study|Adverse Event|4|||
27951520|NCT01040832|54608621|FG001|Overall Study|Adverse Event|5|||
27951521|NCT01040832|54608620|FG000|Overall Study|Death|4|||
27951522|NCT01040832|54608621|FG001|Overall Study|Death|6|||
27951523|NCT01040832|54608620|FG000|Overall Study|Withdrawal by Subject|2|||
27951524|NCT01040832|54608621|FG001|Overall Study|Withdrawal by Subject|3|||
27951525|NCT01040832|54608620|FG000|Overall Study|Progressive disease|32|||
27951526|NCT01040832|54608621|FG001|Overall Study|Progressive disease|17|||
27951527|NCT01040832|54608620|FG000|Overall Study|Symptomatic deterioration|2|||
27951528|NCT01040832|54608621|FG001|Overall Study|Symptomatic deterioration|5|||
27951529|NCT01040832|54608620|FG000|Overall Study|Other|2|||
27951530|NCT01040832|54608621|FG001|Overall Study|Other|1|||
27951531|NCT00854581|54608627|FG000|Induction (Up to Day 21)|Lack of Efficacy|4|||
27951532|NCT00854581|54608627|FG000|Induction (Up to Day 21)|Death|1|||
27951533|NCT00854581|54608627|FG000|Induction (Up to Day 21)|Physician Decision|1|||
27951534|NCT00854581|54608627|FG000|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3|||
27951535|NCT00833911|54608636|FG000|Titration|Adverse Event|18|||
27951536|NCT00833911|54608636|FG000|Titration|Withdrawal by Subject|3|||
27951537|NCT00833911|54608636|FG000|Maintenance Phase I|Adverse Event|73|||
27951538|NCT00833911|54608636|FG000|Maintenance Phase I|Withdrawal by Subject|11|||
27951539|NCT00833911|54608636|FG000|Maintenance Phase I|Physician Decision|10|||
27951540|NCT00833911|54608636|FG000|Maintenance Phase I|Lack of Efficacy|4|||
27951541|NCT00833911|54608636|FG000|Maintenance Phase II|Adverse Event|6|||
27951542|NCT00833911|54608636|FG000|Maintenance Phase II|Physician Decision|2|||
27951543|NCT00833911|54608636|FG000|Maintenance Phase II|Withdrawal by Subject|1|||
27951544|NCT00833911|54608636|FG000|Maintenance Phase II|Lack of Efficacy|1|||
27951545|NCT01125293|54608650|FG000|Overall Study|Disease Progression|1|||
27951546|NCT01125293|54608651|FG001|Overall Study|Disease Progression|3|||
27951547|NCT01125293|54608652|FG002|Overall Study|Disease Progression|4|||
27951548|NCT01125293|54608653|FG003|Overall Study|Disease Progression|3|||
27951549|NCT01125293|54608654|FG004|Overall Study|Disease Progression|5|||
27951550|NCT01125293|54608655|FG005|Overall Study|Disease Progression|12|||
27951551|NCT01125293|54608650|FG000|Overall Study|Adverse Event|1|||
27951552|NCT01125293|54608651|FG001|Overall Study|Adverse Event|0|||
27951553|NCT01125293|54608652|FG002|Overall Study|Adverse Event|0|||
27951554|NCT01125293|54608653|FG003|Overall Study|Adverse Event|0|||
27951555|NCT01125293|54608654|FG004|Overall Study|Adverse Event|2|||
27951556|NCT01125293|54608655|FG005|Overall Study|Adverse Event|8|||
27951557|NCT01125293|54608650|FG000|Overall Study|Symptomatic Deterioration|1|||
27951558|NCT01125293|54608651|FG001|Overall Study|Symptomatic Deterioration|0|||
27951559|NCT01125293|54608652|FG002|Overall Study|Symptomatic Deterioration|0|||
27951560|NCT01125293|54608653|FG003|Overall Study|Symptomatic Deterioration|0|||
27951561|NCT01125293|54608654|FG004|Overall Study|Symptomatic Deterioration|0|||
27951562|NCT01125293|54608655|FG005|Overall Study|Symptomatic Deterioration|0|||
27951563|NCT01125293|54608650|FG000|Overall Study|Death|0|||
27832251|NCT00983619|54311053|FG008|Overall Study|Other|0|||
27832252|NCT00983619|54311054|FG009|Overall Study|Other|1|||
27832253|NCT00983619|54311055|FG010|Overall Study|Other|1|||
27832254|NCT00983619|54311056|FG011|Overall Study|Other|0|||
27832255|NCT00653068|54311106|FG000|Overall Study|Death|9|||
27832256|NCT00653068|54311106|FG000|Overall Study|Lack of Efficacy|34|||
27832257|NCT00653068|54311106|FG000|Overall Study|Physician Decision|4|||
27832258|NCT00653068|54311106|FG000|Overall Study|Withdrawal by Subject|1|||
27832259|NCT00653068|54311106|FG000|Overall Study|Ineligible|2|||
27832260|NCT01767857|54311115|FG000|Overall Study|Adverse Event|27|||
27832261|NCT01767857|54311116|FG001|Overall Study|Adverse Event|7|||
27832262|NCT01767857|54311115|FG000|Overall Study|Death|28|||
27832263|NCT01767857|54311116|FG001|Overall Study|Death|13|||
27951564|NCT01125293|54608651|FG001|Overall Study|Death|0|||
27951565|NCT01125293|54608652|FG002|Overall Study|Death|0|||
27951566|NCT01125293|54608653|FG003|Overall Study|Death|0|||
27951567|NCT01125293|54608654|FG004|Overall Study|Death|1|||
27951568|NCT01125293|54608655|FG005|Overall Study|Death|0|||
27951569|NCT01125293|54608650|FG000|Overall Study|Withdrawal by Subject|0|||
27951570|NCT01125293|54608651|FG001|Overall Study|Withdrawal by Subject|0|||
27951571|NCT01125293|54608652|FG002|Overall Study|Withdrawal by Subject|0|||
27951572|NCT01125293|54608653|FG003|Overall Study|Withdrawal by Subject|0|||
27951573|NCT01125293|54608654|FG004|Overall Study|Withdrawal by Subject|2|||
27951574|NCT01125293|54608655|FG005|Overall Study|Withdrawal by Subject|1|||
27951575|NCT01125293|54608650|FG000|Overall Study|Physician Decision|0|||
27951576|NCT01125293|54608651|FG001|Overall Study|Physician Decision|0|||
27951577|NCT01125293|54608652|FG002|Overall Study|Physician Decision|0|||
27951578|NCT01125293|54608653|FG003|Overall Study|Physician Decision|0|||
27951579|NCT01125293|54608654|FG004|Overall Study|Physician Decision|0|||
27951580|NCT01125293|54608655|FG005|Overall Study|Physician Decision|2|||
27951581|NCT01121393|54608674|FG000|Overall Study|Progressive disease|201|||
27951582|NCT01121393|54608675|FG001|Overall Study|Progressive disease|20|||
27951583|NCT01121393|54608674|FG000|Overall Study|Other Adverse events|24|||
27951584|NCT01121393|54608675|FG001|Overall Study|Other Adverse events|45|||
27951585|NCT01121393|54608674|FG000|Overall Study|Non-compliant with protocol|0|||
27951586|NCT01121393|54608675|FG001|Overall Study|Non-compliant with protocol|3|||
27951587|NCT01121393|54608674|FG000|Overall Study|Lost to Follow-up|1|||
27951588|NCT01121393|54608675|FG001|Overall Study|Lost to Follow-up|0|||
27951589|NCT01121393|54608674|FG000|Overall Study|Refused cont. medication|7|||
27951590|NCT01121393|54608675|FG001|Overall Study|Refused cont. medication|7|||
27951591|NCT01121393|54608674|FG000|Overall Study|Not treated|3|||
28164968|NCT02515942|54835625|FG000|Overall Study|Lack of Efficacy|0|||
28164969|NCT02515942|54835626|FG001|Overall Study|Lack of Efficacy|0|||
27731853|NCT02783729|54179296|FG003|Overall Study|Other|3|||
27951592|NCT01121393|54608675|FG001|Overall Study|Not treated|9|||
27951593|NCT01121393|54608674|FG000|Overall Study|Other than listed|6|||
27951594|NCT01121393|54608675|FG001|Overall Study|Other than listed|0|||
27951595|NCT00937521|54608726|FG000|Overall Study - Prior to Booster Dose|Adverse Event|0|||
27951596|NCT00937521|54608727|FG001|Overall Study - Prior to Booster Dose|Adverse Event|0|||
28164970|NCT02515942|54835627|FG002|Overall Study|Lack of Efficacy|1|||
27832264|NCT01767857|54311115|FG000|Overall Study|Lack of Efficacy|299|||
27832265|NCT01767857|54311116|FG001|Overall Study|Lack of Efficacy|151|||
27832266|NCT01767857|54311115|FG000|Overall Study|Lost to Follow-up|1|||
27951597|NCT00937521|54608728|FG002|Overall Study - Prior to Booster Dose|Adverse Event|2|||
27951598|NCT00937521|54608729|FG003|Overall Study - Prior to Booster Dose|Adverse Event|0|||
27951599|NCT00937521|54608730|FG004|Overall Study - Prior to Booster Dose|Adverse Event|0|||
27951600|NCT00937521|54608731|FG005|Overall Study - Prior to Booster Dose|Adverse Event|0|||
27951601|NCT00937521|54608732|FG006|Overall Study - Prior to Booster Dose|Adverse Event|1|||
27951602|NCT00937521|54608733|FG007|Overall Study - Prior to Booster Dose|Adverse Event|0|||
27951603|NCT00937521|54608726|FG000|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
27951604|NCT00937521|54608727|FG001|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
27951605|NCT00937521|54608728|FG002|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3|||
27951606|NCT00937521|54608729|FG003|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
27951607|NCT00937521|54608730|FG004|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
27951608|NCT00937521|54608731|FG005|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
27951609|NCT00937521|54608732|FG006|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
27951610|NCT00937521|54608733|FG007|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
27951611|NCT00937521|54608726|FG000|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
27951612|NCT00937521|54608727|FG001|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
27951613|NCT00937521|54608728|FG002|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
27951614|NCT00937521|54608729|FG003|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
27951615|NCT00937521|54608730|FG004|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
27951616|NCT00937521|54608731|FG005|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
27951617|NCT00937521|54608732|FG006|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
27951618|NCT00937521|54608733|FG007|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
27951619|NCT00937521|54608726|FG000|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
27951620|NCT00937521|54608727|FG001|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4|||
27951621|NCT00937521|54608728|FG002|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
27951622|NCT00937521|54608729|FG003|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
27951623|NCT00937521|54608730|FG004|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2|||
27951624|NCT00937521|54608731|FG005|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
27951625|NCT00937521|54608732|FG006|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
27951626|NCT00937521|54608733|FG007|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
27951627|NCT00937521|54608726|FG000|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
27951628|NCT00937521|54608727|FG001|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
27951629|NCT00937521|54608728|FG002|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
28081057|NCT00103857|54734165|FG005|50-Week Extension Study|patient scheduled for elective surgery|0|||
28081058|NCT00103857|54734166|FG006|50-Week Extension Study|patient scheduled for elective surgery|0|||
28081059|NCT00103857|54734160|FG000|50-Week Extension Study|reason unspecified|0|||
28081060|NCT00103857|54734161|FG001|50-Week Extension Study|reason unspecified|0|||
28081061|NCT00103857|54734162|FG002|50-Week Extension Study|reason unspecified|0|||
28081062|NCT00103857|54734163|FG003|50-Week Extension Study|reason unspecified|0|||
28081063|NCT00103857|54734164|FG004|50-Week Extension Study|reason unspecified|1|||
28081064|NCT00103857|54734165|FG005|50-Week Extension Study|reason unspecified|0|||
28081065|NCT00103857|54734166|FG006|50-Week Extension Study|reason unspecified|0|||
28081066|NCT03587584|54734183|FG000|Overall Study|SOC deviations|4|||
28081067|NCT03587584|54734184|FG001|Overall Study|SOC deviations|6|||
28081068|NCT03587584|54734183|FG000|Overall Study|Incomplete data|0|||
28081069|NCT03587584|54734184|FG001|Overall Study|Incomplete data|3|||
28081070|NCT03586726|54734190|FG000|Overall Study|Withdrawal by Subject|1|||
28081071|NCT03586648|54734194|FG000|Period 1|Withdrawal by Subject|0|||
28081072|NCT03586648|54734195|FG001|Period 1|Withdrawal by Subject|1|||
28081073|NCT03586648|54734194|FG000|Period 1|Lost to Follow-up|1|||
28081074|NCT03586648|54734195|FG001|Period 1|Lost to Follow-up|1|||
28081075|NCT03586648|54734194|FG000|Period 1|Adverse Event|1|||
28081076|NCT03586648|54734195|FG001|Period 1|Adverse Event|0|||
28081077|NCT03586648|54734194|FG000|Period 1|Study related symptoms or complaints|2|||
28081078|NCT03586648|54734195|FG001|Period 1|Study related symptoms or complaints|1|||
28081079|NCT03586648|54734194|FG000|Period 1|Physician Decision|0|||
28081080|NCT03586648|54734195|FG001|Period 1|Physician Decision|1|||
28081081|NCT03586648|54734194|FG000|Period 2|Adverse Event|1|||
28081082|NCT03586648|54734195|FG001|Period 2|Adverse Event|0|||
28081083|NCT02892448|54734204|FG000|Overall Study|Screening failure|2|||
28081084|NCT02892448|54734205|FG001|Overall Study|Screening failure|2|||
28081085|NCT02892448|54734206|FG002|Overall Study|Screening failure|1|||
28081086|NCT03585712|54734214|FG000|Treatment Period 1|Protocol Violation|1|||
28081087|NCT03585712|54734215|FG001|Treatment Period 1|Protocol Violation|0|||
28081088|NCT03585712|54734216|FG002|Treatment Period 1|Protocol Violation|0|||
28081089|NCT03585712|54734214|FG000|Treatment Periods 2 and 3|Protocol Violation|0|||
28081090|NCT03585712|54734215|FG001|Treatment Periods 2 and 3|Protocol Violation|1|||
28081091|NCT03585712|54734216|FG002|Treatment Periods 2 and 3|Protocol Violation|1|||
28081092|NCT03585712|54734214|FG000|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
27951630|NCT00937521|54608729|FG003|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
27951631|NCT00937521|54608730|FG004|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
27951632|NCT00937521|54608731|FG005|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
27951633|NCT00937521|54608732|FG006|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
27951634|NCT00937521|54608733|FG007|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
27951635|NCT00937521|54608726|FG000|Booster Phase|Adverse Event|0|||
27951636|NCT00937521|54608727|FG001|Booster Phase|Adverse Event|0|||
27951637|NCT00937521|54608728|FG002|Booster Phase|Adverse Event|0|||
27951638|NCT00937521|54608729|FG003|Booster Phase|Adverse Event|0|||
27951639|NCT00937521|54608730|FG004|Booster Phase|Adverse Event|0|||
27951640|NCT00937521|54608731|FG005|Booster Phase|Adverse Event|0|||
27951641|NCT00937521|54608732|FG006|Booster Phase|Adverse Event|1|||
27951642|NCT00937521|54608733|FG007|Booster Phase|Adverse Event|0|||
27951643|NCT00937521|54608726|FG000|Booster Phase|Withdrawal by Subject|1|||
27951644|NCT00937521|54608727|FG001|Booster Phase|Withdrawal by Subject|0|||
27951645|NCT00937521|54608728|FG002|Booster Phase|Withdrawal by Subject|0|||
27951646|NCT00937521|54608729|FG003|Booster Phase|Withdrawal by Subject|1|||
27951647|NCT00937521|54608730|FG004|Booster Phase|Withdrawal by Subject|0|||
27951648|NCT00937521|54608731|FG005|Booster Phase|Withdrawal by Subject|0|||
28081093|NCT03585712|54734215|FG001|Treatment Periods 2 and 3|Withdrawal by Subject|2|||
28081094|NCT03585712|54734216|FG002|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
28081095|NCT03585712|54734214|FG000|Treatment Periods 2 and 3|Physician Decision|0|||
28081096|NCT03585712|54734215|FG001|Treatment Periods 2 and 3|Physician Decision|0|||
28081097|NCT03585712|54734216|FG002|Treatment Periods 2 and 3|Physician Decision|2|||
28081098|NCT03585244|54734233|FG000|Overall Study|Withdrawal by Subject|15|||
28081099|NCT00074984|54734239|FG000|Overall Study|Death|1|||
28081100|NCT00074984|54734240|FG001|Overall Study|Death|2|||
28081101|NCT00074984|54734239|FG000|Overall Study|Withdrawal by Subject|2|||
28081102|NCT00074984|54734240|FG001|Overall Study|Withdrawal by Subject|3|||
28081103|NCT00074984|54734239|FG000|Overall Study|Patient Withdrawn Per Protocol|0|||
28081104|NCT00074984|54734240|FG001|Overall Study|Patient Withdrawn Per Protocol|3|||
28081105|NCT03583606|54734250|FG000|Overall Study|Lost to Follow-up|0|||
28081106|NCT03583606|54734251|FG001|Overall Study|Lost to Follow-up|1|||
28081107|NCT03583606|54734252|FG002|Overall Study|Lost to Follow-up|0|||
28081108|NCT03583606|54734250|FG000|Overall Study|Ineligible at baseline|1|||
28081109|NCT03583606|54734251|FG001|Overall Study|Ineligible at baseline|0|||
28081110|NCT03583606|54734252|FG002|Overall Study|Ineligible at baseline|0|||
28081111|NCT03583450|54734263|FG000|Overall Study|hardware malfunction (battery depletion)|1|||
28081112|NCT03583450|54734264|FG001|Overall Study|hardware malfunction (battery depletion)|0|||
28081113|NCT03583372|54734276|FG000|Overall Study|Withdrawal by Subject|6|||
28081114|NCT03583372|54734277|FG001|Overall Study|Withdrawal by Subject|11|||
28081115|NCT03583372|54734278|FG002|Overall Study|Withdrawal by Subject|7|||
28081116|NCT03583372|54734279|FG003|Overall Study|Withdrawal by Subject|8|||
28081117|NCT03583372|54734276|FG000|Overall Study|Lost to Follow-up|4|||
28081118|NCT03583372|54734277|FG001|Overall Study|Lost to Follow-up|6|||
28081119|NCT03583372|54734278|FG002|Overall Study|Lost to Follow-up|3|||
28081120|NCT03583372|54734279|FG003|Overall Study|Lost to Follow-up|2|||
28081121|NCT03583372|54734276|FG000|Overall Study|Adverse Event|1|||
28081122|NCT03583372|54734277|FG001|Overall Study|Adverse Event|3|||
28081123|NCT03583372|54734278|FG002|Overall Study|Adverse Event|4|||
28081124|NCT03583372|54734279|FG003|Overall Study|Adverse Event|4|||
28081125|NCT03583372|54734276|FG000|Overall Study|Physician Decision|0|||
28081126|NCT03583372|54734277|FG001|Overall Study|Physician Decision|1|||
28081127|NCT03583372|54734278|FG002|Overall Study|Physician Decision|1|||
28081128|NCT03583372|54734279|FG003|Overall Study|Physician Decision|1|||
28081129|NCT03583372|54734276|FG000|Overall Study|Lack of Efficacy|0|||
28081130|NCT03583372|54734277|FG001|Overall Study|Lack of Efficacy|1|||
28081131|NCT03583372|54734278|FG002|Overall Study|Lack of Efficacy|0|||
28081132|NCT03583372|54734279|FG003|Overall Study|Lack of Efficacy|1|||
28081133|NCT03583372|54734276|FG000|Overall Study|Death|1|||
28081134|NCT03583372|54734277|FG001|Overall Study|Death|0|||
28081135|NCT03583372|54734278|FG002|Overall Study|Death|0|||
28081136|NCT03583372|54734279|FG003|Overall Study|Death|0|||
28081137|NCT03583372|54734276|FG000|Overall Study|Protocol Violation|0|||
28081138|NCT03583372|54734277|FG001|Overall Study|Protocol Violation|1|||
28081139|NCT03583372|54734278|FG002|Overall Study|Protocol Violation|0|||
28081140|NCT03583372|54734279|FG003|Overall Study|Protocol Violation|0|||
28081141|NCT03583372|54734276|FG000|Overall Study|Subject Withdrawn due to Sponsor|0|||
28081142|NCT03583372|54734277|FG001|Overall Study|Subject Withdrawn due to Sponsor|0|||
28081143|NCT03583372|54734278|FG002|Overall Study|Subject Withdrawn due to Sponsor|0|||
28081144|NCT03583372|54734279|FG003|Overall Study|Subject Withdrawn due to Sponsor|1|||
28081145|NCT03583372|54734276|FG000|Overall Study|Did Not Receive Study Drug|0|||
28081146|NCT03583372|54734277|FG001|Overall Study|Did Not Receive Study Drug|1|||
28081147|NCT03583372|54734278|FG002|Overall Study|Did Not Receive Study Drug|0|||
28081148|NCT03583372|54734279|FG003|Overall Study|Did Not Receive Study Drug|0|||
28081149|NCT03583372|54734276|FG000|Overall Study|Captured as Other in the Database|1|||
27951649|NCT00937521|54608732|FG006|Booster Phase|Withdrawal by Subject|0|||
27951650|NCT00937521|54608733|FG007|Booster Phase|Withdrawal by Subject|2|||
27951651|NCT00937521|54608726|FG000|Booster Phase|Lost to Follow-up|2|||
27951652|NCT00937521|54608727|FG001|Booster Phase|Lost to Follow-up|2|||
27951653|NCT00937521|54608728|FG002|Booster Phase|Lost to Follow-up|4|||
27951654|NCT00937521|54608729|FG003|Booster Phase|Lost to Follow-up|2|||
27951655|NCT00937521|54608730|FG004|Booster Phase|Lost to Follow-up|4|||
27951656|NCT00937521|54608731|FG005|Booster Phase|Lost to Follow-up|4|||
27951657|NCT00937521|54608732|FG006|Booster Phase|Lost to Follow-up|3|||
27951658|NCT00937521|54608733|FG007|Booster Phase|Lost to Follow-up|0|||
27951659|NCT00937521|54608726|FG000|Booster Phase|Administrative Reason|0|||
27951660|NCT00937521|54608727|FG001|Booster Phase|Administrative Reason|0|||
27951661|NCT00937521|54608728|FG002|Booster Phase|Administrative Reason|1|||
27951662|NCT00937521|54608729|FG003|Booster Phase|Administrative Reason|0|||
27951663|NCT00937521|54608730|FG004|Booster Phase|Administrative Reason|1|||
27951664|NCT00937521|54608731|FG005|Booster Phase|Administrative Reason|1|||
27951665|NCT00937521|54608732|FG006|Booster Phase|Administrative Reason|0|||
27951666|NCT00937521|54608733|FG007|Booster Phase|Administrative Reason|0|||
27951667|NCT00937521|54608726|FG000|Booster Phase|Protocol Deviation|0|||
27951668|NCT00937521|54608727|FG001|Booster Phase|Protocol Deviation|0|||
27951669|NCT00937521|54608728|FG002|Booster Phase|Protocol Deviation|0|||
27951670|NCT00937521|54608729|FG003|Booster Phase|Protocol Deviation|0|||
27951671|NCT00937521|54608730|FG004|Booster Phase|Protocol Deviation|0|||
27951672|NCT00937521|54608731|FG005|Booster Phase|Protocol Deviation|0|||
27951673|NCT00937521|54608732|FG006|Booster Phase|Protocol Deviation|1|||
27951674|NCT00937521|54608733|FG007|Booster Phase|Protocol Deviation|0|||
27951675|NCT00935883|54608768|FG000|Treatment Period|Physician Decision|1|||
27951676|NCT00935883|54608769|FG001|Treatment Period|Physician Decision|0|||
27951677|NCT00935883|54608768|FG000|Treatment Period|Withdrawal by Subject|0|||
27951678|NCT00935883|54608769|FG001|Treatment Period|Withdrawal by Subject|2|||
27951679|NCT00936975|54608775|FG000|Overall Study|Withdrawal by Subject|1|||
27951680|NCT00936975|54608775|FG000|Overall Study|Disease progression|3|||
27951681|NCT00936975|54608775|FG000|Overall Study|Post-Tx scan uninterpretable|2|||
27951682|NCT00936897|54608782|FG000|Overall Study|Withdrawal by Subject|9|||
27951683|NCT00936897|54608783|FG001|Overall Study|Withdrawal by Subject|19|||
27951684|NCT00936897|54608782|FG000|Overall Study|Adverse Event|4|||
27951685|NCT00936897|54608783|FG001|Overall Study|Adverse Event|13|||
27951686|NCT00936897|54608782|FG000|Overall Study|Other|3|||
27951687|NCT00936897|54608783|FG001|Overall Study|Other|9|||
27951688|NCT00936897|54608782|FG000|Overall Study|Lost to Follow-up|1|||
27951689|NCT00936897|54608783|FG001|Overall Study|Lost to Follow-up|10|||
27951690|NCT00936897|54608782|FG000|Overall Study|Administrative Decision|1|||
27951691|NCT00936897|54608783|FG001|Overall Study|Administrative Decision|2|||
27951692|NCT00936897|54608782|FG000|Overall Study|Protocol Violation|1|||
27951693|NCT00936897|54608783|FG001|Overall Study|Protocol Violation|1|||
27951694|NCT00936897|54608782|FG000|Overall Study|Ineligibility Determined|0|||
27951695|NCT00936897|54608783|FG001|Overall Study|Ineligibility Determined|3|||
27951696|NCT00936897|54608782|FG000|Overall Study|Noncompliance|0|||
27951697|NCT00936897|54608783|FG001|Overall Study|Noncompliance|2|||
27951698|NCT00936897|54608782|FG000|Overall Study|Death|0|||
27951699|NCT00936897|54608783|FG001|Overall Study|Death|1|||
27951700|NCT01120691|54608792|FG000|Overall Study|Adverse Event|59|||
27951701|NCT01120691|54608793|FG001|Overall Study|Adverse Event|67|||
27951702|NCT01120691|54608794|FG002|Overall Study|Adverse Event|47|||
27951703|NCT01120691|54608792|FG000|Overall Study|Subject withdrew consent|33|||
27951704|NCT01120691|54608793|FG001|Overall Study|Subject withdrew consent|50|||
27951705|NCT01120691|54608794|FG002|Overall Study|Subject withdrew consent|44|||
27951706|NCT01120691|54608792|FG000|Overall Study|Death|21|||
27951707|NCT01120691|54608793|FG001|Overall Study|Death|22|||
27951708|NCT01120691|54608794|FG002|Overall Study|Death|24|||
27951709|NCT01120691|54608792|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
27951710|NCT01120691|54608793|FG001|Overall Study|Unsatisfactory therapeutic effect|32|||
27951711|NCT01120691|54608794|FG002|Overall Study|Unsatisfactory therapeutic effect|38|||
27951712|NCT01120691|54608792|FG000|Overall Study|Administrative problems|15|||
27951713|NCT01120691|54608793|FG001|Overall Study|Administrative problems|8|||
27951714|NCT01120691|54608794|FG002|Overall Study|Administrative problems|9|||
27951715|NCT01120691|54608792|FG000|Overall Study|Protocol deviation|13|||
27951716|NCT01120691|54608793|FG001|Overall Study|Protocol deviation|12|||
28081150|NCT03583372|54734277|FG001|Overall Study|Captured as Other in the Database|2|||
27731854|NCT02783729|54179293|FG000|Overall Study|Withdrawal by Subject|2|||
27951717|NCT01120691|54608794|FG002|Overall Study|Protocol deviation|12|||
27951718|NCT01120691|54608792|FG000|Overall Study|Lost to Follow-up|5|||
27951719|NCT01120691|54608793|FG001|Overall Study|Lost to Follow-up|6|||
27951720|NCT01120691|54608794|FG002|Overall Study|Lost to Follow-up|4|||
27951721|NCT01120691|54608792|FG000|Overall Study|Abnormal test procedure result(s)|3|||
27951722|NCT01120691|54608793|FG001|Overall Study|Abnormal test procedure result(s)|2|||
27951723|NCT01120691|54608794|FG002|Overall Study|Abnormal test procedure result(s)|1|||
27951724|NCT01120691|54608792|FG000|Overall Study|Patient's inability to use the device|3|||
27951725|NCT01120691|54608793|FG001|Overall Study|Patient's inability to use the device|1|||
27951726|NCT01120691|54608794|FG002|Overall Study|Patient's inability to use the device|0|||
27951727|NCT01120691|54608792|FG000|Overall Study|Abnormal laboratory value(s)|1|||
27951728|NCT01120691|54608793|FG001|Overall Study|Abnormal laboratory value(s)|3|||
27951729|NCT01120691|54608794|FG002|Overall Study|Abnormal laboratory value(s)|4|||
27951730|NCT00935493|54608818|FG000|Overall Study|Lost to Follow-up|1|||
27951731|NCT00935493|54608819|FG001|Overall Study|Lost to Follow-up|1|||
27951732|NCT00935493|54608820|FG002|Overall Study|Lost to Follow-up|1|||
27951733|NCT00935493|54608818|FG000|Overall Study|Treatment Discontinued|0|||
27951734|NCT00935493|54608819|FG001|Overall Study|Treatment Discontinued|1|||
27951735|NCT00935493|54608820|FG002|Overall Study|Treatment Discontinued|0|||
27951736|NCT03856996|54608830|FG000|Overall Study|Withdrawal by Subject|1|||
27951737|NCT03856996|54608831|FG001|Overall Study|Withdrawal by Subject|0|||
27951738|NCT03856996|54608830|FG000|Overall Study|Lost to Follow-up|0|||
27951739|NCT03856996|54608831|FG001|Overall Study|Lost to Follow-up|1|||
27951740|NCT03856996|54608830|FG000|Overall Study|Adverse Event|1|||
27951741|NCT03856996|54608831|FG001|Overall Study|Adverse Event|1|||
27951742|NCT03856996|54608830|FG000|Overall Study|Other|1|||
27951743|NCT03856996|54608831|FG001|Overall Study|Other|0|||
27951744|NCT00935259|54608837|FG000|Period 1|Administrative (scheduling conflict)|1|||
27951745|NCT00935259|54608838|FG001|Period 1|Administrative (scheduling conflict)|1|||
27951746|NCT01120379|54608855|FG000|One Year Timepoint|Withdrawal by Subject|41|||
27951747|NCT01120379|54608855|FG000|One Year Timepoint|Lost to Follow-up|115|||
27951748|NCT01120379|54608855|FG000|One Year Timepoint|Death|108|||
27951749|NCT01120379|54608855|FG000|One Year Timepoint|Physician Decision|9|||
27951750|NCT01120379|54608855|FG000|One Year Timepoint|Any other reason for early termination|5|||
27951751|NCT01120379|54608855|FG000|Two Year Timepoint|Withdrawal by Subject|11|||
27951752|NCT01120379|54608855|FG000|Two Year Timepoint|Lost to Follow-up|87|||
27951753|NCT01120379|54608855|FG000|Two Year Timepoint|Death|123|||
27951754|NCT01120379|54608855|FG000|Two Year Timepoint|Physician Decision|12|||
27951755|NCT01120379|54608855|FG000|Two Year Timepoint|Any other reason for early termination|4|||
27951756|NCT01120379|54608855|FG000|Three Year Timepoint|Withdrawal by Subject|25|||
27951757|NCT01120379|54608855|FG000|Three Year Timepoint|Lost to Follow-up|43|||
27951758|NCT01120379|54608855|FG000|Three Year Timepoint|Death|120|||
27951759|NCT01120379|54608855|FG000|Three Year Timepoint|Physician Decision|9|||
27951760|NCT01120379|54608855|FG000|Three Year Timepoint|Any other reason for early termination|17|||
27951761|NCT01120379|54608855|FG000|Four Year Timepoint|Withdrawal by Subject|5|||
27951762|NCT01120379|54608855|FG000|Four Year Timepoint|Lost to Follow-up|10|||
27951763|NCT01120379|54608855|FG000|Four Year Timepoint|Death|131|||
27951764|NCT01120379|54608855|FG000|Four Year Timepoint|Physician Decision|5|||
27951765|NCT01120379|54608855|FG000|Four Year Timepoint|Any other reason for early termination|217|||
27951766|NCT01120067|54608861|FG000|Overall Study|Lost to Follow-up|3|||
27951767|NCT01120067|54608862|FG001|Overall Study|Lost to Follow-up|1|||
27951768|NCT01120067|54608861|FG000|Overall Study|fail to engage >3 sessions|2|||
27951769|NCT01120067|54608862|FG001|Overall Study|fail to engage >3 sessions|0|||
27951770|NCT01124045|54608870|FG000|Overall Study|Lost to Follow-up|0|||
27951771|NCT01124045|54608871|FG001|Overall Study|Lost to Follow-up|1|||
27951772|NCT01124045|54608870|FG000|Overall Study|Physician Decision|0|||
27951773|NCT01124045|54608871|FG001|Overall Study|Physician Decision|2|||
27951774|NCT01123889|54608879|FG000|Overall Study|Lost to Follow-up|3|||
27951775|NCT01123889|54608880|FG001|Overall Study|Lost to Follow-up|1|||
27951776|NCT00934947|54608888|FG000|Overall Study|Adverse Event|0|||
27951777|NCT00934947|54608889|FG001|Overall Study|Adverse Event|2|||
27951778|NCT01123655|54608899|FG000|Overall Study|Medication for RA had to be changed|1|||
27951779|NCT01123655|54608900|FG001|Overall Study|Medication for RA had to be changed|0|||
27951780|NCT01123655|54608901|FG002|Overall Study|Medication for RA had to be changed|0|||
27951781|NCT01123655|54608899|FG000|Overall Study|new illness|0|||
27951782|NCT01123655|54608900|FG001|Overall Study|new illness|1|||
27951783|NCT01123655|54608901|FG002|Overall Study|new illness|0|||
27951784|NCT01123655|54608899|FG000|Overall Study|began prohibitive drug|0|||
27951785|NCT01123655|54608900|FG001|Overall Study|began prohibitive drug|0|||
27951786|NCT01123655|54608901|FG002|Overall Study|began prohibitive drug|1|||
27951787|NCT00934791|54608909|FG000|Overall Study|Withdrawal by Subject|1|||
27951788|NCT00934791|54608910|FG001|Overall Study|Withdrawal by Subject|0|||
27951789|NCT01119443|54608918|FG000|Crossover Period 1 (5 Days)|Adverse Event|0|||
27951790|NCT01119443|54608919|FG001|Crossover Period 1 (5 Days)|Adverse Event|1|||
27951791|NCT01111019|54608928|FG000|Overall Study|Withdrew Prematurely|2|||
27731855|NCT02783729|54179294|FG001|Overall Study|Withdrawal by Subject|3|||
27731856|NCT02783729|54179295|FG002|Overall Study|Withdrawal by Subject|1|||
27731857|NCT02783729|54179296|FG003|Overall Study|Withdrawal by Subject|2|||
27951792|NCT01111019|54608928|FG000|Overall Study|Other|1|||
27951793|NCT01119287|54608947|FG000|Overall Study|Patient Decision, not related to AE|0|||
28164971|NCT02515942|54835625|FG000|Overall Study|Lost to Follow-up|2|||
27951794|NCT01119287|54608948|FG001|Overall Study|Patient Decision, not related to AE|0|||
27951795|NCT01119287|54608949|FG002|Overall Study|Patient Decision, not related to AE|2|||
27951796|NCT01119287|54608950|FG003|Overall Study|Patient Decision, not related to AE|2|||
27951797|NCT01119287|54608951|FG004|Overall Study|Patient Decision, not related to AE|1|||
27951798|NCT01119287|54608952|FG005|Overall Study|Patient Decision, not related to AE|0|||
27951799|NCT01110707|54608966|FG000|Overall Study|Protocol Violation|0|||
27951800|NCT01110707|54608967|FG001|Overall Study|Protocol Violation|3|||
27951801|NCT01119131|54608977|FG000|Overall Study|Adverse Event|1|||
27951802|NCT01119131|54608978|FG001|Overall Study|Adverse Event|1|||
27951803|NCT01119131|54608979|FG002|Overall Study|Adverse Event|1|||
27951804|NCT01119131|54608977|FG000|Overall Study|Non-Compliance|1|||
27951805|NCT01119131|54608978|FG001|Overall Study|Non-Compliance|0|||
27951806|NCT01119131|54608979|FG002|Overall Study|Non-Compliance|4|||
27832267|NCT01767857|54311116|FG001|Overall Study|Lost to Follow-up|1|||
27832268|NCT01767857|54311115|FG000|Overall Study|Withdrawal by Subject|38|||
27832269|NCT01767857|54311116|FG001|Overall Study|Withdrawal by Subject|18|||
27832270|NCT01767857|54311115|FG000|Overall Study|Physician Decision|17|||
27832271|NCT01767857|54311116|FG001|Overall Study|Physician Decision|10|||
27951807|NCT01119131|54608977|FG000|Overall Study|Physician Decision|0|||
27951808|NCT01119131|54608978|FG001|Overall Study|Physician Decision|0|||
27951809|NCT01119131|54608979|FG002|Overall Study|Physician Decision|1|||
27951810|NCT01118975|54608989|FG000|Overall Study|Adverse Event|0|||
27951811|NCT01118975|54608990|FG001|Overall Study|Adverse Event|1|||
27951812|NCT01110239|54609000|FG000|Sham Preconditioning|Withdrawal by Subject|0|||
27951813|NCT01110239|54609001|FG001|Sham Preconditioning|Withdrawal by Subject|0|||
27951814|NCT01110239|54609002|FG002|Sham Preconditioning|Withdrawal by Subject|1|||
27951815|NCT01110239|54609003|FG003|Sham Preconditioning|Withdrawal by Subject|0|||
27951816|NCT01110239|54609000|FG000|7.5 Min Ischemia|Withdrawal by Subject|0|||
27951817|NCT01110239|54609001|FG001|7.5 Min Ischemia|Withdrawal by Subject|0|||
27951818|NCT01110239|54609002|FG002|7.5 Min Ischemia|Withdrawal by Subject|1|||
27951819|NCT01110239|54609003|FG003|7.5 Min Ischemia|Withdrawal by Subject|0|||
27951820|NCT01118663|54609016|FG000|Overall Study|Adverse Event|2|||
27951821|NCT01118663|54609017|FG001|Overall Study|Adverse Event|1|||
27951822|NCT01118663|54609016|FG000|Overall Study|Withdrawal by Subject|0|||
27951823|NCT01118663|54609017|FG001|Overall Study|Withdrawal by Subject|1|||
27951824|NCT01118351|54609023|FG000|Overall Study|Adverse Event|3|||
27951825|NCT01118351|54609023|FG000|Overall Study|Withdrawal by Subject|1|||
27951826|NCT01110005|54609029|FG000|Overall Study|ineligible|1|||
27951827|NCT01110005|54609030|FG001|Overall Study|ineligible|2|||
27951828|NCT01110005|54609029|FG000|Overall Study|missing consent|3|||
27951829|NCT01110005|54609030|FG001|Overall Study|missing consent|2|||
27951830|NCT01110005|54609029|FG000|Overall Study|Withdrawal by Subject|0|||
27951831|NCT01110005|54609030|FG001|Overall Study|Withdrawal by Subject|1|||
27951832|NCT01118117|54609053|FG000|Overall Study|Death|8|||
27951833|NCT01118117|54609054|FG001|Overall Study|Death|0|||
27951834|NCT01118117|54609053|FG000|Overall Study|Lost to Follow-up|6|||
27951835|NCT01118117|54609054|FG001|Overall Study|Lost to Follow-up|0|||
27951836|NCT01118117|54609053|FG000|Overall Study|Missed 12 Month Visit|7|||
27951837|NCT01118117|54609054|FG001|Overall Study|Missed 12 Month Visit|0|||
27951838|NCT01109849|54609062|FG000|Initial Randomization: ADHD Treatment|Lost to Follow-up|9|||
27951839|NCT01109849|54609063|FG001|Initial Randomization: ADHD Treatment|Lost to Follow-up|35|||
27951840|NCT01109849|54609064|FG002|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
27951841|NCT01109849|54609065|FG003|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
27951842|NCT01109849|54609066|FG004|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
27951843|NCT01109849|54609062|FG000|Initial Randomization: ADHD Treatment|Protocol Violation|1|||
27951844|NCT01109849|54609063|FG001|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
27951845|NCT01109849|54609064|FG002|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
27951846|NCT01109849|54609065|FG003|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
27951847|NCT01109849|54609066|FG004|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
27951848|NCT01109849|54609062|FG000|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6|||
27951849|NCT01109849|54609063|FG001|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7|||
27951850|NCT01109849|54609064|FG002|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
27951851|NCT01109849|54609065|FG003|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
27951852|NCT01109849|54609066|FG004|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
27951853|NCT01109849|54609062|FG000|Initial Randomization: ADHD Treatment|move away|2|||
27951854|NCT01109849|54609063|FG001|Initial Randomization: ADHD Treatment|move away|7|||
27951855|NCT01109849|54609064|FG002|Initial Randomization: ADHD Treatment|move away|0|||
27951856|NCT01109849|54609065|FG003|Initial Randomization: ADHD Treatment|move away|0|||
28081151|NCT03583372|54734278|FG002|Overall Study|Captured as Other in the Database|4|||
27832272|NCT01767857|54311115|FG000|Overall Study|Protocol Terminated|1|||
27951857|NCT01109849|54609066|FG004|Initial Randomization: ADHD Treatment|move away|0|||
27951858|NCT01109849|54609062|FG000|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
27951859|NCT01109849|54609063|FG001|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
28081152|NCT03583372|54734279|FG003|Overall Study|Captured as Other in the Database|1|||
27951860|NCT01109849|54609064|FG002|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
28081153|NCT03582826|54734291|FG000|Overall Study|Lost to Follow-up|39|||
27832273|NCT01767857|54311116|FG001|Overall Study|Protocol Terminated|0|||
27951861|NCT01109849|54609065|FG003|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
27951862|NCT01109849|54609066|FG004|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
27951863|NCT01109849|54609062|FG000|Adaptive Randomization: Weight Recovery|moved away|0|||
27951864|NCT01109849|54609063|FG001|Adaptive Randomization: Weight Recovery|moved away|0|||
27951865|NCT01109849|54609064|FG002|Adaptive Randomization: Weight Recovery|moved away|0|||
27951866|NCT01109849|54609065|FG003|Adaptive Randomization: Weight Recovery|moved away|2|||
27951867|NCT01109849|54609066|FG004|Adaptive Randomization: Weight Recovery|moved away|0|||
27951868|NCT01061736|54609096|FG000|Overall Study|Dose regimen not selected|0|||
27951869|NCT01061736|54609097|FG001|Overall Study|Dose regimen not selected|0|||
27951870|NCT01061736|54609098|FG002|Overall Study|Dose regimen not selected|0|||
27951871|NCT01061736|54609099|FG003|Overall Study|Dose regimen not selected|0|||
27951872|NCT01061736|54609100|FG004|Overall Study|Dose regimen not selected|0|||
27951873|NCT01061736|54609101|FG005|Overall Study|Dose regimen not selected|0|||
27951874|NCT01061736|54609102|FG006|Overall Study|Dose regimen not selected|79|||
27951875|NCT01061736|54609103|FG007|Overall Study|Dose regimen not selected|0|||
27951876|NCT01061736|54609104|FG008|Overall Study|Dose regimen not selected|0|||
27951877|NCT01061736|54609105|FG009|Overall Study|Dose regimen not selected|0|||
27951878|NCT01061736|54609096|FG000|Overall Study|Adverse Event|13|||
27951879|NCT01061736|54609097|FG001|Overall Study|Adverse Event|1|||
27951880|NCT01061736|54609098|FG002|Overall Study|Adverse Event|3|||
27951881|NCT01061736|54609099|FG003|Overall Study|Adverse Event|2|||
27951882|NCT01061736|54609100|FG004|Overall Study|Adverse Event|4|||
27951883|NCT01061736|54609101|FG005|Overall Study|Adverse Event|1|||
27951884|NCT01061736|54609102|FG006|Overall Study|Adverse Event|4|||
27951885|NCT01061736|54609103|FG007|Overall Study|Adverse Event|63|||
27951886|NCT01061736|54609104|FG008|Overall Study|Adverse Event|67|||
27951887|NCT01061736|54609105|FG009|Overall Study|Adverse Event|34|||
27951888|NCT01061736|54609096|FG000|Overall Study|Lack of Efficacy|0|||
27951889|NCT01061736|54609097|FG001|Overall Study|Lack of Efficacy|2|||
27951890|NCT01061736|54609098|FG002|Overall Study|Lack of Efficacy|1|||
27951891|NCT01061736|54609099|FG003|Overall Study|Lack of Efficacy|1|||
27951892|NCT01061736|54609100|FG004|Overall Study|Lack of Efficacy|1|||
27951893|NCT01061736|54609101|FG005|Overall Study|Lack of Efficacy|2|||
27951894|NCT01061736|54609102|FG006|Overall Study|Lack of Efficacy|1|||
27951895|NCT01061736|54609103|FG007|Overall Study|Lack of Efficacy|9|||
27951896|NCT01061736|54609104|FG008|Overall Study|Lack of Efficacy|9|||
27951897|NCT01061736|54609105|FG009|Overall Study|Lack of Efficacy|10|||
27951898|NCT01061736|54609096|FG000|Overall Study|Poor compliance to protocol|0|||
27951899|NCT01061736|54609097|FG001|Overall Study|Poor compliance to protocol|0|||
27951900|NCT01061736|54609098|FG002|Overall Study|Poor compliance to protocol|0|||
27951901|NCT01061736|54609099|FG003|Overall Study|Poor compliance to protocol|0|||
27951902|NCT01061736|54609100|FG004|Overall Study|Poor compliance to protocol|0|||
27951903|NCT01061736|54609101|FG005|Overall Study|Poor compliance to protocol|0|||
27951904|NCT01061736|54609102|FG006|Overall Study|Poor compliance to protocol|0|||
27951905|NCT01061736|54609103|FG007|Overall Study|Poor compliance to protocol|2|||
27951906|NCT01061736|54609104|FG008|Overall Study|Poor compliance to protocol|5|||
27951907|NCT01061736|54609105|FG009|Overall Study|Poor compliance to protocol|9|||
27951908|NCT01061736|54609096|FG000|Overall Study|Not treated|0|||
27951909|NCT01061736|54609097|FG001|Overall Study|Not treated|0|||
27951910|NCT01061736|54609098|FG002|Overall Study|Not treated|0|||
27951911|NCT01061736|54609099|FG003|Overall Study|Not treated|0|||
27951912|NCT01061736|54609100|FG004|Overall Study|Not treated|1|||
27951913|NCT01061736|54609101|FG005|Overall Study|Not treated|0|||
27951914|NCT01061736|54609102|FG006|Overall Study|Not treated|0|||
27951915|NCT01061736|54609103|FG007|Overall Study|Not treated|2|||
27951916|NCT01061736|54609104|FG008|Overall Study|Not treated|1|||
27951917|NCT01061736|54609105|FG009|Overall Study|Not treated|0|||
27951918|NCT01061736|54609096|FG000|Overall Study|Other than specified above|0|||
27951919|NCT01061736|54609097|FG001|Overall Study|Other than specified above|1|||
27951920|NCT01061736|54609098|FG002|Overall Study|Other than specified above|2|||
27951921|NCT01061736|54609099|FG003|Overall Study|Other than specified above|0|||
27951922|NCT01061736|54609100|FG004|Overall Study|Other than specified above|1|||
28164972|NCT02515942|54835626|FG001|Overall Study|Lost to Follow-up|0|||
28164973|NCT02515942|54835627|FG002|Overall Study|Lost to Follow-up|0|||
27832274|NCT01767857|54311115|FG000|Overall Study|Randomized But Never Treated|19|||
27951923|NCT01061736|54609101|FG005|Overall Study|Other than specified above|0|||
27951924|NCT01061736|54609102|FG006|Overall Study|Other than specified above|0|||
27951925|NCT01061736|54609103|FG007|Overall Study|Other than specified above|18|||
27951926|NCT01061736|54609104|FG008|Overall Study|Other than specified above|15|||
27951927|NCT01061736|54609105|FG009|Overall Study|Other than specified above|21|||
27951928|NCT01117337|54609132|FG000|Overall Study|Lost to Follow-up|4|||
27951929|NCT01117337|54609133|FG001|Overall Study|Lost to Follow-up|0|||
27951930|NCT01108523|54609143|FG000|Overall Study|Protocol Violation|4|||
27951931|NCT01035606|54609150|FG000|Overall Study|change in health, job demands,family|3|||
27951932|NCT01035606|54609151|FG001|Overall Study|change in health, job demands,family|3|||
27951933|NCT01035606|54609152|FG002|Overall Study|change in health, job demands,family|4|||
27951934|NCT01117181|54609162|FG000|Overall Study|Lost to Follow-up|1|||
27951935|NCT01117181|54609163|FG001|Overall Study|Lost to Follow-up|0|||
27951936|NCT01117181|54609162|FG000|Overall Study|Withdrawal by Subject|0|||
27951937|NCT01117181|54609163|FG001|Overall Study|Withdrawal by Subject|2|||
27951938|NCT01040130|54609171|FG000|Overall Study|Adverse Event|1|||
27951939|NCT01040130|54609172|FG001|Overall Study|Adverse Event|1|||
27951940|NCT01040130|54609173|FG002|Overall Study|Adverse Event|0|||
27951941|NCT01040130|54609174|FG003|Overall Study|Adverse Event|5|||
27951942|NCT01040130|54609175|FG004|Overall Study|Adverse Event|0|||
27951943|NCT01040130|54609176|FG005|Overall Study|Adverse Event|3|||
27951944|NCT01040130|54609171|FG000|Overall Study|Protocol Violation|0|||
27951945|NCT01040130|54609172|FG001|Overall Study|Protocol Violation|0|||
27951946|NCT01040130|54609173|FG002|Overall Study|Protocol Violation|2|||
27951947|NCT01040130|54609174|FG003|Overall Study|Protocol Violation|0|||
27854921|NCT00247273|54373132|FG001|Overall Study|Physician Decision|3|||
27854922|NCT00247273|54373131|FG000|Overall Study|Lost to Follow-up|7|||
27854923|NCT00247273|54373132|FG001|Overall Study|Lost to Follow-up|7|||
27854924|NCT00247273|54373131|FG000|Overall Study|Withdrawal by Subject|46|||
27854925|NCT00247273|54373132|FG001|Overall Study|Withdrawal by Subject|47|||
27951948|NCT01040130|54609175|FG004|Overall Study|Protocol Violation|0|||
27951949|NCT01040130|54609176|FG005|Overall Study|Protocol Violation|0|||
27951950|NCT01040130|54609171|FG000|Overall Study|Withdrawal by Subject|0|||
27951951|NCT01040130|54609172|FG001|Overall Study|Withdrawal by Subject|2|||
27951952|NCT01040130|54609173|FG002|Overall Study|Withdrawal by Subject|0|||
27951953|NCT01040130|54609174|FG003|Overall Study|Withdrawal by Subject|0|||
27951954|NCT01040130|54609175|FG004|Overall Study|Withdrawal by Subject|0|||
27951955|NCT01040130|54609176|FG005|Overall Study|Withdrawal by Subject|1|||
27951956|NCT01040130|54609171|FG000|Overall Study|Other reasons not listed above|2|||
27951957|NCT01040130|54609172|FG001|Overall Study|Other reasons not listed above|0|||
27951958|NCT01040130|54609173|FG002|Overall Study|Other reasons not listed above|0|||
27951959|NCT01040130|54609174|FG003|Overall Study|Other reasons not listed above|0|||
27951960|NCT01040130|54609175|FG004|Overall Study|Other reasons not listed above|0|||
27951961|NCT01040130|54609176|FG005|Overall Study|Other reasons not listed above|0|||
27951962|NCT00932451|54609186|FG000|Overall Study|Withdrawal by Subject|69|||
27951963|NCT00932451|54609186|FG000|Overall Study|Lost to Follow-up|22|||
27951964|NCT00932451|54609186|FG000|Overall Study|Death|726|||
27951965|NCT00932451|54609186|FG000|Overall Study|Other reasons|5|||
27951966|NCT01108055|54609194|FG000|Overall Study|Ineligible|11|||
27951967|NCT01108055|54609194|FG000|Overall Study|Not evaluable- didn't complete treatment|4|||
27951968|NCT01107899|54609201|FG000|Overall Study|Physician Decision|5|||
27951969|NCT01107899|54609202|FG001|Overall Study|Physician Decision|0|||
27951970|NCT01107899|54609203|FG002|Overall Study|Physician Decision|3|||
27951971|NCT01107899|54609201|FG000|Overall Study|Withdrawal by Subject|0|||
27951972|NCT01107899|54609202|FG001|Overall Study|Withdrawal by Subject|0|||
27951973|NCT01107899|54609203|FG002|Overall Study|Withdrawal by Subject|1|||
27951974|NCT01115933|54609214|FG000|Overall Study|Did not receive XIENCE PRIME SV|1|||
27951975|NCT01107743|54609271|FG000|Overall Study|Protocol Violation|46|||
27951976|NCT01059864|54609320|FG000|Open-Label Run-In Phase|Adverse Event|7|||
27951977|NCT01059864|54609321|FG001|Open-Label Run-In Phase|Adverse Event|0|||
27951978|NCT01059864|54609322|FG002|Open-Label Run-In Phase|Adverse Event|0|||
27951979|NCT01059864|54609320|FG000|Open-Label Run-In Phase|Lack of Efficacy|1|||
27951980|NCT01059864|54609321|FG001|Open-Label Run-In Phase|Lack of Efficacy|0|||
27951981|NCT01059864|54609322|FG002|Open-Label Run-In Phase|Lack of Efficacy|0|||
27951982|NCT01059864|54609320|FG000|Open-Label Run-In Phase|Lost to Follow-up|2|||
27951983|NCT01059864|54609321|FG001|Open-Label Run-In Phase|Lost to Follow-up|0|||
27951984|NCT01059864|54609322|FG002|Open-Label Run-In Phase|Lost to Follow-up|0|||
27951985|NCT01059864|54609320|FG000|Open-Label Run-In Phase|Withdrawal by Subject|1|||
27951986|NCT01059864|54609321|FG001|Open-Label Run-In Phase|Withdrawal by Subject|0|||
27951987|NCT01059864|54609322|FG002|Open-Label Run-In Phase|Withdrawal by Subject|0|||
27951988|NCT01059864|54609320|FG000|Open-Label Run-In Phase|Protocol Violation|2|||
27951989|NCT01059864|54609321|FG001|Open-Label Run-In Phase|Protocol Violation|0|||
27951990|NCT01059864|54609322|FG002|Open-Label Run-In Phase|Protocol Violation|0|||
27951991|NCT01059864|54609320|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
27951992|NCT01059864|54609321|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
27854926|NCT00247273|54373131|FG000|Overall Study|Did not take any study drug|2|||
27854927|NCT00247273|54373132|FG001|Overall Study|Did not take any study drug|0|||
28164974|NCT02515942|54835625|FG000|Overall Study|Withdrawal by Subject|0|||
27854928|NCT00246259|54373220|FG000|Overall Study|Other|3|||
28164975|NCT02515942|54835626|FG001|Overall Study|Withdrawal by Subject|3|||
28164976|NCT02515942|54835627|FG002|Overall Study|Withdrawal by Subject|2|||
28164977|NCT02991859|54835654|FG000|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
27951993|NCT01059864|54609322|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
27951994|NCT01035138|54609332|FG000|Overall Study|Adverse Event|4|||
28164978|NCT02991859|54835655|FG001|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
28164979|NCT02991859|54835656|FG002|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
27854929|NCT00246259|54373221|FG001|Overall Study|Other|3|||
27951995|NCT01035138|54609333|FG001|Overall Study|Adverse Event|0|||
27951996|NCT01035138|54609334|FG002|Overall Study|Adverse Event|2|||
27951997|NCT01035138|54609332|FG000|Overall Study|Caregiver Decision|2|||
27951998|NCT01035138|54609333|FG001|Overall Study|Caregiver Decision|0|||
27951999|NCT01035138|54609334|FG002|Overall Study|Caregiver Decision|1|||
27952000|NCT01035138|54609332|FG000|Overall Study|Withdrawal by Subject|1|||
27952001|NCT01035138|54609333|FG001|Overall Study|Withdrawal by Subject|0|||
27952002|NCT01035138|54609334|FG002|Overall Study|Withdrawal by Subject|0|||
27952003|NCT01035138|54609332|FG000|Overall Study|Physician Decision|0|||
27952004|NCT01035138|54609333|FG001|Overall Study|Physician Decision|0|||
27952005|NCT01035138|54609334|FG002|Overall Study|Physician Decision|1|||
27952006|NCT01035138|54609332|FG000|Overall Study|Sponsor Decision|66|||
27952007|NCT01035138|54609333|FG001|Overall Study|Sponsor Decision|60|||
27952008|NCT01035138|54609334|FG002|Overall Study|Sponsor Decision|42|||
27952009|NCT01035138|54609332|FG000|Overall Study|Lost to Follow-up|0|||
27952010|NCT01035138|54609333|FG001|Overall Study|Lost to Follow-up|0|||
27952011|NCT01035138|54609334|FG002|Overall Study|Lost to Follow-up|1|||
27952012|NCT03739840|54609348|FG000|Treatment Period: Wk0-16|Adverse Event|2|||
27952013|NCT03739840|54609349|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
27952014|NCT03739840|54609350|FG002|Treatment Period: Wk0-16|Adverse Event|6|||
27952015|NCT03739840|54609351|FG003|Treatment Period: Wk0-16|Adverse Event|12|||
27952016|NCT03739840|54609348|FG000|Treatment Period: Wk0-16|Lack of Efficacy|0|||
27952017|NCT03739840|54609349|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
27952018|NCT03739840|54609350|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
27952019|NCT03739840|54609351|FG003|Treatment Period: Wk0-16|Lack of Efficacy|3|||
27952020|NCT03739840|54609348|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
27952021|NCT03739840|54609349|FG001|Treatment Period: Wk0-16|Protocol Violation|0|||
27952022|NCT03739840|54609350|FG002|Treatment Period: Wk0-16|Protocol Violation|1|||
27952023|NCT03739840|54609351|FG003|Treatment Period: Wk0-16|Protocol Violation|0|||
27952024|NCT03739840|54609348|FG000|Treatment Period: Wk0-16|Consent Withdrawn|1|||
27952025|NCT03739840|54609349|FG001|Treatment Period: Wk0-16|Consent Withdrawn|3|||
27952026|NCT03739840|54609350|FG002|Treatment Period: Wk0-16|Consent Withdrawn|1|||
27952027|NCT03739840|54609351|FG003|Treatment Period: Wk0-16|Consent Withdrawn|1|||
27952028|NCT03739840|54609348|FG000|Treatment Period: Wk0-16|Program Termination|3|||
27952029|NCT03739840|54609349|FG001|Treatment Period: Wk0-16|Program Termination|0|||
27952030|NCT03739840|54609350|FG002|Treatment Period: Wk0-16|Program Termination|1|||
27952031|NCT03739840|54609351|FG003|Treatment Period: Wk0-16|Program Termination|1|||
27952032|NCT03739840|54609348|FG000|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|1|||
27952033|NCT03739840|54609349|FG001|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
27952034|NCT03739840|54609350|FG002|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
27952035|NCT03739840|54609351|FG003|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
27952036|NCT03739840|54609348|FG000|Treatment Period: Wk0-16|Sponsors Decision|3|||
27952037|NCT03739840|54609349|FG001|Treatment Period: Wk0-16|Sponsors Decision|2|||
28081154|NCT03582826|54734292|FG001|Overall Study|Lost to Follow-up|0|||
27731858|NCT02783729|54179293|FG000|Overall Study|Participant's choice|2|||
27731859|NCT02783729|54179294|FG001|Overall Study|Participant's choice|1|||
27731860|NCT02783729|54179295|FG002|Overall Study|Participant's choice|2|||
27731861|NCT02783729|54179296|FG003|Overall Study|Participant's choice|1|||
27731862|NCT02783729|54179293|FG000|Overall Study|Lost to Follow-up|2|||
27731863|NCT02783729|54179294|FG001|Overall Study|Lost to Follow-up|1|||
27731864|NCT02783729|54179295|FG002|Overall Study|Lost to Follow-up|1|||
27731865|NCT02783729|54179296|FG003|Overall Study|Lost to Follow-up|0|||
27731866|NCT02784431|54179318|FG000|Overall Study|Unsuccessful Implant Attempt|1|||
27731867|NCT02784431|54179318|FG000|Overall Study|Early Study Termination|19|||
27731868|NCT02590406|54179324|FG000|Overall Study|Adverse Event|1|||
27731869|NCT02590406|54179325|FG001|Overall Study|Adverse Event|0|||
27731870|NCT02590406|54179324|FG000|Overall Study|Saturometer malfunction|0|||
27731871|NCT02590406|54179325|FG001|Overall Study|Saturometer malfunction|1|||
27731872|NCT01359254|54179333|FG000|Overall Study|Death|1|||
27731873|NCT01359254|54179334|FG001|Overall Study|Death|0|||
27731874|NCT01667432|54179340|FG000|Overall Study|Premature Study Termination|26|||
27731875|NCT01667432|54179340|FG000|Overall Study|Failure to Return|10|||
27731876|NCT01667432|54179340|FG000|Overall Study|Moved to Another Center|3|||
27731877|NCT01667432|54179340|FG000|Overall Study|Lost to Follow-up|3|||
27731878|NCT01667432|54179340|FG000|Overall Study|Refused Treatment/Withdrew Consent|1|||
27731879|NCT01667432|54179340|FG000|Overall Study|Insufficient Therapeutic Response|4|||
27731880|NCT01667432|54179340|FG000|Overall Study|Adverse Event|1|||
27952038|NCT03739840|54609350|FG002|Treatment Period: Wk0-16|Sponsors Decision|1|||
28081155|NCT03582826|54734291|FG000|Overall Study|Withdrawal by Subject|2|||
28081156|NCT03582826|54734292|FG001|Overall Study|Withdrawal by Subject|0|||
28081157|NCT03518008|54734307|FG000|Period 2, Second Week of Wear|Family emergency|0|||
27731881|NCT01667432|54179340|FG000|Overall Study|Protocol Deviation|2|||
27731882|NCT01667432|54179340|FG000|Overall Study|Principal Investigator Decision|1|||
27731883|NCT01667432|54179340|FG000|Overall Study|Reason Not Specified|2|||
27731884|NCT01667432|54179340|FG000|Overall Study|Missing Information|4|||
27952039|NCT03739840|54609351|FG003|Treatment Period: Wk0-16|Sponsors Decision|3|||
27952040|NCT03739840|54609348|FG000|Treatment Period: Wk0-16|Promotor Decision|0|||
27952041|NCT03739840|54609349|FG001|Treatment Period: Wk0-16|Promotor Decision|1|||
27952042|NCT03739840|54609350|FG002|Treatment Period: Wk0-16|Promotor Decision|0|||
27952043|NCT03739840|54609351|FG003|Treatment Period: Wk0-16|Promotor Decision|0|||
27952044|NCT03739840|54609348|FG000|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
27952045|NCT03739840|54609349|FG001|Treatment Period: Wk0-16|Per Sponsor Study Closed|1|||
27952046|NCT03739840|54609350|FG002|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
27952047|NCT03739840|54609351|FG003|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
27952048|NCT03739840|54609348|FG000|Treatment Period: Wk0-16|Premature Program Termination|0|||
27952049|NCT03739840|54609349|FG001|Treatment Period: Wk0-16|Premature Program Termination|1|||
27731885|NCT01563107|54179348|FG000|Overall Study|Physician Decision|0|||
27731886|NCT01563107|54179349|FG001|Overall Study|Physician Decision|1|||
27731887|NCT01563107|54179350|FG002|Overall Study|Physician Decision|1|||
27731888|NCT01563107|54179351|FG003|Overall Study|Physician Decision|3|||
27731889|NCT01563107|54179348|FG000|Overall Study|Withdrawal by Subject|1|||
27731890|NCT01563107|54179349|FG001|Overall Study|Withdrawal by Subject|2|||
27731891|NCT01563107|54179350|FG002|Overall Study|Withdrawal by Subject|1|||
27731892|NCT01563107|54179351|FG003|Overall Study|Withdrawal by Subject|2|||
27731893|NCT02589626|54179413|FG000|Overall Study|Other than the reason specified|1|||
27731894|NCT02589626|54179414|FG001|Overall Study|Other than the reason specified|0|||
27731895|NCT02589626|54179413|FG000|Overall Study|Withdrawal by Subject|1|||
27731896|NCT02589626|54179414|FG001|Overall Study|Withdrawal by Subject|1|||
27731897|NCT02589626|54179413|FG000|Overall Study|Adverse Event|1|||
27731898|NCT02589626|54179414|FG001|Overall Study|Adverse Event|1|||
27731899|NCT01666730|54179429|FG000|Overall Study|Adverse Event|16|||
27731900|NCT01666730|54179429|FG000|Overall Study|Death|2|||
27731901|NCT01666730|54179429|FG000|Overall Study|Physician Decision|5|||
27731902|NCT01666730|54179429|FG000|Overall Study|Withdrawal by Subject|9|||
27731903|NCT01666730|54179429|FG000|Overall Study|Disease progression/relapse|18|||
27731904|NCT00103285|54179442|FG000|Induction|Adverse Event|14|||
27731905|NCT00103285|54179443|FG001|Induction|Adverse Event|0|||
27731906|NCT00103285|54179444|FG002|Induction|Adverse Event|0|||
27731907|NCT00103285|54179445|FG003|Induction|Adverse Event|0|||
27731908|NCT00103285|54179446|FG004|Induction|Adverse Event|0|||
27731909|NCT00103285|54179447|FG005|Induction|Adverse Event|0|||
27731910|NCT00103285|54179448|FG006|Induction|Adverse Event|0|||
27731911|NCT00103285|54179449|FG007|Induction|Adverse Event|0|||
27731912|NCT00103285|54179442|FG000|Induction|Death|24|||
27731913|NCT00103285|54179443|FG001|Induction|Death|0|||
27731914|NCT00103285|54179444|FG002|Induction|Death|0|||
27731915|NCT00103285|54179445|FG003|Induction|Death|0|||
27731916|NCT00103285|54179446|FG004|Induction|Death|0|||
27731917|NCT00103285|54179447|FG005|Induction|Death|0|||
27731918|NCT00103285|54179448|FG006|Induction|Death|0|||
27731919|NCT00103285|54179449|FG007|Induction|Death|0|||
27731920|NCT00103285|54179442|FG000|Induction|Physician Decision|103|||
27731921|NCT00103285|54179443|FG001|Induction|Physician Decision|0|||
27731922|NCT00103285|54179444|FG002|Induction|Physician Decision|0|||
27731923|NCT00103285|54179445|FG003|Induction|Physician Decision|0|||
27731924|NCT00103285|54179446|FG004|Induction|Physician Decision|0|||
27731925|NCT00103285|54179447|FG005|Induction|Physician Decision|0|||
27731926|NCT00103285|54179448|FG006|Induction|Physician Decision|0|||
27731927|NCT00103285|54179449|FG007|Induction|Physician Decision|0|||
27731928|NCT00103285|54179442|FG000|Induction|Withdrawal by Subject|1|||
27731929|NCT00103285|54179443|FG001|Induction|Withdrawal by Subject|0|||
27731930|NCT00103285|54179444|FG002|Induction|Withdrawal by Subject|0|||
27731931|NCT00103285|54179445|FG003|Induction|Withdrawal by Subject|0|||
27731932|NCT00103285|54179446|FG004|Induction|Withdrawal by Subject|0|||
27731933|NCT00103285|54179447|FG005|Induction|Withdrawal by Subject|0|||
27731934|NCT00103285|54179448|FG006|Induction|Withdrawal by Subject|0|||
27731935|NCT00103285|54179449|FG007|Induction|Withdrawal by Subject|0|||
27952050|NCT03739840|54609350|FG002|Treatment Period: Wk0-16|Premature Program Termination|0|||
27952051|NCT03739840|54609351|FG003|Treatment Period: Wk0-16|Premature Program Termination|0|||
27731936|NCT00103285|54179442|FG000|Induction|Ineligible|43|||
27731937|NCT00103285|54179443|FG001|Induction|Ineligible|0|||
27731938|NCT00103285|54179444|FG002|Induction|Ineligible|0|||
27731939|NCT00103285|54179445|FG003|Induction|Ineligible|0|||
27731940|NCT00103285|54179446|FG004|Induction|Ineligible|0|||
27731941|NCT00103285|54179447|FG005|Induction|Ineligible|0|||
27731942|NCT00103285|54179448|FG006|Induction|Ineligible|0|||
27731943|NCT00103285|54179449|FG007|Induction|Ineligible|0|||
27731944|NCT00103285|54179442|FG000|Induction|Refusal|906|||
27731945|NCT00103285|54179443|FG001|Induction|Refusal|0|||
27731946|NCT00103285|54179444|FG002|Induction|Refusal|0|||
27731947|NCT00103285|54179445|FG003|Induction|Refusal|0|||
27731948|NCT00103285|54179446|FG004|Induction|Refusal|0|||
27731949|NCT00103285|54179447|FG005|Induction|Refusal|0|||
27731950|NCT00103285|54179448|FG006|Induction|Refusal|0|||
27731951|NCT00103285|54179449|FG007|Induction|Refusal|0|||
27731952|NCT00103285|54179442|FG000|Induction|Other|258|||
27952052|NCT03739840|54609348|FG000|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
27952053|NCT03739840|54609349|FG001|Treatment Period: Wk0-16|Trial Closed By Sponsor|1|||
27952054|NCT03739840|54609350|FG002|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
27952055|NCT03739840|54609351|FG003|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
27952056|NCT03739840|54609348|FG000|Treatment Period: Wk0-16|Study Early Closure|0|||
27952057|NCT03739840|54609349|FG001|Treatment Period: Wk0-16|Study Early Closure|0|||
27952058|NCT03739840|54609350|FG002|Treatment Period: Wk0-16|Study Early Closure|1|||
27952059|NCT03739840|54609351|FG003|Treatment Period: Wk0-16|Study Early Closure|0|||
27952060|NCT03739840|54609348|FG000|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
27952061|NCT03739840|54609349|FG001|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
27952062|NCT03739840|54609350|FG002|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|1|||
27952063|NCT03739840|54609351|FG003|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
27952064|NCT03739840|54609348|FG000|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
28081158|NCT03518008|54734308|FG001|Period 2, Second Week of Wear|Family emergency|1|||
28081159|NCT03810014|54734318|FG000|Overall Study|Pregnancy|2|||
27952065|NCT03739840|54609349|FG001|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
27952066|NCT03739840|54609350|FG002|Treatment Period: Wk0-16|Premature Closure Of The Study|1|||
28081160|NCT03810014|54734319|FG001|Overall Study|Pregnancy|2|||
28081161|NCT03810014|54734320|FG002|Overall Study|Pregnancy|0|||
27952067|NCT03739840|54609351|FG003|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
27952068|NCT03739840|54609348|FG000|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
27952069|NCT03739840|54609349|FG001|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
28164980|NCT02991859|54835657|FG003|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
28164981|NCT02991859|54835658|FG004|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
28164982|NCT02991859|54835659|FG005|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
28164983|NCT02991859|54835660|FG006|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
28164984|NCT02991859|54835661|FG007|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
28164985|NCT02991859|54835662|FG008|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
28164986|NCT02991859|54835663|FG009|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
28164987|NCT02991859|54835664|FG010|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
28164988|NCT02991859|54835665|FG011|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
28164989|NCT02991859|54835666|FG012|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
28081162|NCT03810014|54734321|FG003|Overall Study|Pregnancy|2|||
28081163|NCT05012163|54734335|FG000|Overall Study|Protocol Violation|0|||
28081164|NCT05012163|54734336|FG001|Overall Study|Protocol Violation|0|||
28081165|NCT05012163|54734337|FG002|Overall Study|Protocol Violation|1|||
28081166|NCT05012163|54734338|FG003|Overall Study|Protocol Violation|1|||
28081167|NCT05009251|54734353|FG000|Overall Study|Protocol Violation|100|||
28081168|NCT05009251|54734354|FG001|Overall Study|Protocol Violation|105|||
28081169|NCT05009251|54734355|FG002|Overall Study|Protocol Violation|119|||
28081170|NCT05009251|54734356|FG003|Overall Study|Protocol Violation|120|||
28081171|NCT05009251|54734357|FG004|Overall Study|Protocol Violation|119|||
28081172|NCT05009251|54734353|FG000|Overall Study|Death|25|||
28081173|NCT05009251|54734354|FG001|Overall Study|Death|22|||
28081174|NCT05009251|54734355|FG002|Overall Study|Death|24|||
28081175|NCT05009251|54734356|FG003|Overall Study|Death|19|||
27731953|NCT00103285|54179443|FG001|Induction|Other|0|||
28081176|NCT05009251|54734357|FG004|Overall Study|Death|15|||
28081177|NCT04978363|54734380|FG000|Overall Study|Other medical issues unrelated to the study|0|||
28081178|NCT04978363|54734381|FG001|Overall Study|Other medical issues unrelated to the study|0|||
28081179|NCT04978363|54734382|FG002|Overall Study|Other medical issues unrelated to the study|0|||
28081180|NCT04978363|54734383|FG003|Overall Study|Other medical issues unrelated to the study|0|||
28081181|NCT04978363|54734384|FG004|Overall Study|Other medical issues unrelated to the study|1|||
28081182|NCT04978363|54734385|FG005|Overall Study|Other medical issues unrelated to the study|0|||
28081183|NCT04978363|54734386|FG006|Overall Study|Other medical issues unrelated to the study|0|||
28081184|NCT04978363|54734387|FG007|Overall Study|Other medical issues unrelated to the study|0|||
28081185|NCT04978363|54734388|FG008|Overall Study|Other medical issues unrelated to the study|0|||
28081186|NCT04978363|54734389|FG009|Overall Study|Other medical issues unrelated to the study|0|||
28081187|NCT04978363|54734390|FG010|Overall Study|Other medical issues unrelated to the study|0|||
28081188|NCT04978363|54734380|FG000|Overall Study|Unable to meet the necessary time commitment|0|||
28081189|NCT04978363|54734381|FG001|Overall Study|Unable to meet the necessary time commitment|0|||
28081190|NCT04978363|54734382|FG002|Overall Study|Unable to meet the necessary time commitment|1|||
28081191|NCT04978363|54734383|FG003|Overall Study|Unable to meet the necessary time commitment|0|||
28081192|NCT04978363|54734384|FG004|Overall Study|Unable to meet the necessary time commitment|0|||
28164990|NCT02991859|54835667|FG013|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
28164991|NCT02991859|54835668|FG014|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
28081193|NCT04978363|54734385|FG005|Overall Study|Unable to meet the necessary time commitment|0|||
27731954|NCT00103285|54179444|FG002|Induction|Other|0|||
28081194|NCT04978363|54734386|FG006|Overall Study|Unable to meet the necessary time commitment|0|||
27952070|NCT03739840|54609350|FG002|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
27952071|NCT03739840|54609351|FG003|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|1|||
27952072|NCT03739840|54609348|FG000|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
27952073|NCT03739840|54609349|FG001|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
27952074|NCT03739840|54609350|FG002|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
27952075|NCT03739840|54609351|FG003|Treatment Period: Wk0-16|Due To Sponsor Instruction|1|||
27952076|NCT03739840|54609348|FG000|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
27952077|NCT03739840|54609349|FG001|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
27952078|NCT03739840|54609350|FG002|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
27952079|NCT03739840|54609351|FG003|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|1|||
27952080|NCT03739840|54609348|FG000|Post-Treatment Period: Wk16-23|Adverse Event|3|||
27952081|NCT03739840|54609349|FG001|Post-Treatment Period: Wk16-23|Adverse Event|0|||
27952082|NCT03739840|54609350|FG002|Post-Treatment Period: Wk16-23|Adverse Event|0|||
27952083|NCT03739840|54609351|FG003|Post-Treatment Period: Wk16-23|Adverse Event|0|||
27952084|NCT03739840|54609348|FG000|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
27952085|NCT03739840|54609349|FG001|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
27952086|NCT03739840|54609350|FG002|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
27952087|NCT03739840|54609351|FG003|Post-Treatment Period: Wk16-23|Consent Withdrawn|1|||
27952088|NCT03739840|54609348|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|1|||
27952089|NCT03739840|54609349|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
27952090|NCT03739840|54609350|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
27952091|NCT03739840|54609351|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
27952092|NCT03739840|54609348|FG000|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
27952093|NCT03739840|54609349|FG001|Post-Treatment Period: Wk16-23|Sponsor's Decision|1|||
27952094|NCT03739840|54609350|FG002|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
27952095|NCT03739840|54609351|FG003|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
27952096|NCT03739840|54609348|FG000|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
27952097|NCT03739840|54609349|FG001|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|1|||
27952098|NCT03739840|54609350|FG002|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
27952099|NCT03739840|54609351|FG003|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
27952100|NCT03739840|54609348|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
27952101|NCT03739840|54609349|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
27952102|NCT03739840|54609350|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|1|||
27952103|NCT03739840|54609351|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
27952104|NCT03739840|54609348|FG000|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
27952105|NCT03739840|54609349|FG001|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
28081195|NCT04978363|54734387|FG007|Overall Study|Unable to meet the necessary time commitment|0|||
28081196|NCT04978363|54734388|FG008|Overall Study|Unable to meet the necessary time commitment|0|||
28081197|NCT04978363|54734389|FG009|Overall Study|Unable to meet the necessary time commitment|0|||
28081198|NCT04978363|54734390|FG010|Overall Study|Unable to meet the necessary time commitment|0|||
28081199|NCT04978363|54734380|FG000|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
28081200|NCT04978363|54734381|FG001|Overall Study|Didn't feel safe and had pain with hands-free crutch|1|||
28081201|NCT04978363|54734382|FG002|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
28081202|NCT04978363|54734383|FG003|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
28081203|NCT04978363|54734384|FG004|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
28081204|NCT04978363|54734385|FG005|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
28081205|NCT04978363|54734386|FG006|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
28081206|NCT04978363|54734387|FG007|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
28081207|NCT04978363|54734388|FG008|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
28081208|NCT04978363|54734389|FG009|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
28081209|NCT04978363|54734390|FG010|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
28081210|NCT04101422|54734470|FG000|Overall Study|Ineligible|1|||
28081211|NCT04101422|54734471|FG001|Overall Study|Ineligible|0|||
28081212|NCT04101422|54734472|FG002|Overall Study|Ineligible|9|||
28081213|NCT04101422|54734473|FG003|Overall Study|Ineligible|0|||
28081214|NCT04101422|54734470|FG000|Overall Study|Withdrawal by Subject|0|||
28081215|NCT04101422|54734471|FG001|Overall Study|Withdrawal by Subject|0|||
28081216|NCT04101422|54734472|FG002|Overall Study|Withdrawal by Subject|1|||
28081217|NCT04101422|54734473|FG003|Overall Study|Withdrawal by Subject|0|||
28081218|NCT04101422|54734470|FG000|Overall Study|Not attending to the stimuli|0|||
28081219|NCT04101422|54734471|FG001|Overall Study|Not attending to the stimuli|0|||
28081220|NCT04101422|54734472|FG002|Overall Study|Not attending to the stimuli|4|||
28081221|NCT04101422|54734473|FG003|Overall Study|Not attending to the stimuli|0|||
27952106|NCT03739840|54609350|FG002|Post-Treatment Period: Wk16-23|Early Study Closure|1|||
27952107|NCT03739840|54609351|FG003|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
27952108|NCT03739840|54609348|FG000|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
27952109|NCT03739840|54609349|FG001|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
27952110|NCT03739840|54609350|FG002|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|1|||
27952111|NCT03739840|54609351|FG003|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
27952112|NCT01035060|54609375|FG000|Overall Study|Lost to Follow-up|0|||
27952113|NCT01035060|54609376|FG001|Overall Study|Lost to Follow-up|7|||
27952114|NCT01035060|54609375|FG000|Overall Study|Did not quality after 2nd screening|14|||
27952115|NCT01035060|54609376|FG001|Overall Study|Did not quality after 2nd screening|1|||
27952116|NCT01035060|54609375|FG000|Overall Study|Withdrawal by Subject|8|||
27952117|NCT01035060|54609376|FG001|Overall Study|Withdrawal by Subject|6|||
27952118|NCT01035060|54609375|FG000|Overall Study|Physician Decision|2|||
27952119|NCT01035060|54609376|FG001|Overall Study|Physician Decision|0|||
27952120|NCT01039428|54609384|FG000|Overall Study|Protocol Violation|1|||
27952121|NCT01039428|54609385|FG001|Overall Study|Protocol Violation|0|||
27952122|NCT01039428|54609384|FG000|Overall Study|Withdrawal by Subject|1|||
27952123|NCT01039428|54609385|FG001|Overall Study|Withdrawal by Subject|0|||
27952124|NCT01034358|54609391|FG000|Overall Study|Withdrawal by Subject|1|||
27952125|NCT01034358|54609391|FG000|Overall Study|Protocol Violation|1|||
27952126|NCT01033734|54609399|FG000|Overall Study|Withdrawal by Subject|1|||
27952127|NCT01115855|54609414|FG000|Overall Study|Adverse Event|16|||
27952128|NCT01115855|54609415|FG001|Overall Study|Adverse Event|18|||
27952129|NCT01115855|54609414|FG000|Overall Study|Death|6|||
27952130|NCT01115855|54609415|FG001|Overall Study|Death|5|||
27952131|NCT01115855|54609414|FG000|Overall Study|Lab Abnormality|1|||
27952132|NCT01115855|54609415|FG001|Overall Study|Lab Abnormality|1|||
27952133|NCT01115855|54609414|FG000|Overall Study|Protocol Violation|0|||
27952134|NCT01115855|54609415|FG001|Overall Study|Protocol Violation|1|||
27952135|NCT01115855|54609414|FG000|Overall Study|Withdrawal by Subject|5|||
27952136|NCT01115855|54609415|FG001|Overall Study|Withdrawal by Subject|5|||
27952137|NCT01115855|54609414|FG000|Overall Study|Other|8|||
27952138|NCT01115855|54609415|FG001|Overall Study|Other|6|||
27952139|NCT01115309|54609425|FG000|Procedure Safety (1-Month)|Lost to Follow-up|2|||
27952140|NCT01115309|54609425|FG000|Procedure Safety (1-Month)|Withdrawal by Subject|1|||
27952141|NCT01115309|54609425|FG000|Long-term Follow-up|Lost to Follow-up|6|||
27952142|NCT03638128|54609433|FG000|Overall Study|Withdrawal by Subject|1|||
27952143|NCT03638128|54609434|FG001|Overall Study|Withdrawal by Subject|7|||
27952144|NCT03638128|54609435|FG002|Overall Study|Withdrawal by Subject|6|||
27952145|NCT03638128|54609433|FG000|Overall Study|Sponsor Decision|15|||
27952146|NCT03638128|54609434|FG001|Overall Study|Sponsor Decision|12|||
27952147|NCT03638128|54609435|FG002|Overall Study|Sponsor Decision|19|||
27952148|NCT03638128|54609433|FG000|Overall Study|Lost to Follow-up|0|||
27952149|NCT03638128|54609434|FG001|Overall Study|Lost to Follow-up|0|||
27952150|NCT03638128|54609435|FG002|Overall Study|Lost to Follow-up|1|||
27952151|NCT01059630|54609448|FG000|Overall Study|Death|100|||
27952152|NCT01059630|54609449|FG001|Overall Study|Death|84|||
27952153|NCT01059630|54609448|FG000|Overall Study|Lost to Follow-up|4|||
27952154|NCT01059630|54609449|FG001|Overall Study|Lost to Follow-up|1|||
27952155|NCT01059630|54609448|FG000|Overall Study|Physician Decision|2|||
27952156|NCT01059630|54609449|FG001|Overall Study|Physician Decision|4|||
27952157|NCT01059630|54609448|FG000|Overall Study|Withdrawal by Subject|21|||
27952158|NCT01059630|54609449|FG001|Overall Study|Withdrawal by Subject|14|||
27952159|NCT00932373|54609466|FG000|Overall Study|Progressive disease|3|||
27952160|NCT00932373|54609467|FG001|Overall Study|Progressive disease|1|||
27952161|NCT00932373|54609468|FG002|Overall Study|Progressive disease|0|||
27952162|NCT00932373|54609469|FG003|Overall Study|Progressive disease|0|||
27952163|NCT00932373|54609470|FG004|Overall Study|Progressive disease|10|||
27952164|NCT00932373|54609471|FG005|Overall Study|Progressive disease|1|||
27952165|NCT00932373|54609472|FG006|Overall Study|Progressive disease|0|||
27952166|NCT00932373|54609473|FG007|Overall Study|Progressive disease|2|||
27952167|NCT00932373|54609474|FG008|Overall Study|Progressive disease|1|||
28081222|NCT04101422|54734470|FG000|Overall Study|Did not download app|0|||
27854930|NCT00246259|54373220|FG000|Overall Study|Not stable by Week 18|2|||
27854931|NCT00246259|54373221|FG001|Overall Study|Not stable by Week 18|1|||
27952168|NCT00932373|54609475|FG009|Overall Study|Progressive disease|9|||
27952169|NCT00932373|54609476|FG010|Overall Study|Progressive disease|2|||
27952170|NCT00932373|54609466|FG000|Overall Study|Adverse Event|0|||
27952171|NCT00932373|54609467|FG001|Overall Study|Adverse Event|0|||
27952172|NCT00932373|54609468|FG002|Overall Study|Adverse Event|0|||
28081223|NCT04101422|54734471|FG001|Overall Study|Did not download app|0|||
27952173|NCT00932373|54609469|FG003|Overall Study|Adverse Event|0|||
27854932|NCT00246259|54373220|FG000|Overall Study|Participant non-compliant|4|||
27952174|NCT00932373|54609470|FG004|Overall Study|Adverse Event|2|||
27952175|NCT00932373|54609471|FG005|Overall Study|Adverse Event|1|||
27952176|NCT00932373|54609472|FG006|Overall Study|Adverse Event|0|||
27952177|NCT00932373|54609473|FG007|Overall Study|Adverse Event|1|||
27952178|NCT00932373|54609474|FG008|Overall Study|Adverse Event|0|||
27952179|NCT00932373|54609475|FG009|Overall Study|Adverse Event|2|||
27952180|NCT00932373|54609476|FG010|Overall Study|Adverse Event|1|||
27952181|NCT00932373|54609466|FG000|Overall Study|Physician Decision|0|||
27952182|NCT00932373|54609467|FG001|Overall Study|Physician Decision|0|||
27952183|NCT00932373|54609468|FG002|Overall Study|Physician Decision|1|||
27952184|NCT00932373|54609469|FG003|Overall Study|Physician Decision|0|||
27952185|NCT00932373|54609470|FG004|Overall Study|Physician Decision|2|||
27952186|NCT00932373|54609471|FG005|Overall Study|Physician Decision|0|||
27952187|NCT00932373|54609472|FG006|Overall Study|Physician Decision|0|||
27952188|NCT00932373|54609473|FG007|Overall Study|Physician Decision|0|||
27952189|NCT00932373|54609474|FG008|Overall Study|Physician Decision|0|||
27952190|NCT00932373|54609475|FG009|Overall Study|Physician Decision|1|||
27952191|NCT00932373|54609476|FG010|Overall Study|Physician Decision|0|||
27952192|NCT00932373|54609466|FG000|Overall Study|Dose limiting toxicity|0|||
27952193|NCT00932373|54609467|FG001|Overall Study|Dose limiting toxicity|0|||
27952194|NCT00932373|54609468|FG002|Overall Study|Dose limiting toxicity|0|||
27952195|NCT00932373|54609469|FG003|Overall Study|Dose limiting toxicity|0|||
27952196|NCT00932373|54609470|FG004|Overall Study|Dose limiting toxicity|0|||
27952197|NCT00932373|54609471|FG005|Overall Study|Dose limiting toxicity|1|||
27952198|NCT00932373|54609472|FG006|Overall Study|Dose limiting toxicity|0|||
27952199|NCT00932373|54609473|FG007|Overall Study|Dose limiting toxicity|0|||
27952200|NCT00932373|54609474|FG008|Overall Study|Dose limiting toxicity|0|||
27952201|NCT00932373|54609475|FG009|Overall Study|Dose limiting toxicity|0|||
27952202|NCT00932373|54609476|FG010|Overall Study|Dose limiting toxicity|0|||
27952203|NCT00932373|54609466|FG000|Overall Study|Withdrawal by Subject|0|||
27952204|NCT00932373|54609467|FG001|Overall Study|Withdrawal by Subject|0|||
27952205|NCT00932373|54609468|FG002|Overall Study|Withdrawal by Subject|0|||
27952206|NCT00932373|54609469|FG003|Overall Study|Withdrawal by Subject|0|||
27952207|NCT00932373|54609470|FG004|Overall Study|Withdrawal by Subject|0|||
27952208|NCT00932373|54609471|FG005|Overall Study|Withdrawal by Subject|0|||
27952209|NCT00932373|54609472|FG006|Overall Study|Withdrawal by Subject|0|||
27952210|NCT00932373|54609473|FG007|Overall Study|Withdrawal by Subject|0|||
27952211|NCT00932373|54609474|FG008|Overall Study|Withdrawal by Subject|1|||
27952212|NCT00932373|54609475|FG009|Overall Study|Withdrawal by Subject|0|||
27952213|NCT00932373|54609476|FG010|Overall Study|Withdrawal by Subject|0|||
27952214|NCT00932373|54609466|FG000|Overall Study|Clinical progression|0|||
27952215|NCT00932373|54609467|FG001|Overall Study|Clinical progression|0|||
27952216|NCT00932373|54609468|FG002|Overall Study|Clinical progression|0|||
27952217|NCT00932373|54609469|FG003|Overall Study|Clinical progression|0|||
27952218|NCT00932373|54609470|FG004|Overall Study|Clinical progression|0|||
27952219|NCT00932373|54609471|FG005|Overall Study|Clinical progression|0|||
27952220|NCT00932373|54609472|FG006|Overall Study|Clinical progression|1|||
27952221|NCT00932373|54609473|FG007|Overall Study|Clinical progression|0|||
27952222|NCT00932373|54609474|FG008|Overall Study|Clinical progression|0|||
27952223|NCT00932373|54609475|FG009|Overall Study|Clinical progression|0|||
27952224|NCT00932373|54609476|FG010|Overall Study|Clinical progression|0|||
27952225|NCT00932373|54609466|FG000|Overall Study|Lack of Efficacy|0|||
27952226|NCT00932373|54609467|FG001|Overall Study|Lack of Efficacy|0|||
27952227|NCT00932373|54609468|FG002|Overall Study|Lack of Efficacy|0|||
27952228|NCT00932373|54609469|FG003|Overall Study|Lack of Efficacy|0|||
27952229|NCT00932373|54609470|FG004|Overall Study|Lack of Efficacy|0|||
27952230|NCT00932373|54609471|FG005|Overall Study|Lack of Efficacy|0|||
27952231|NCT00932373|54609472|FG006|Overall Study|Lack of Efficacy|0|||
27952232|NCT00932373|54609473|FG007|Overall Study|Lack of Efficacy|0|||
27952233|NCT00932373|54609474|FG008|Overall Study|Lack of Efficacy|0|||
27952234|NCT00932373|54609475|FG009|Overall Study|Lack of Efficacy|1|||
27952235|NCT00932373|54609476|FG010|Overall Study|Lack of Efficacy|0|||
28081224|NCT04101422|54734472|FG002|Overall Study|Did not download app|0|||
28081225|NCT04101422|54734473|FG003|Overall Study|Did not download app|17|||
28081226|NCT04101422|54734470|FG000|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
27854933|NCT00246259|54373221|FG001|Overall Study|Participant non-compliant|9|||
27854934|NCT00246259|54373220|FG000|Overall Study|Lack of Efficacy|2|||
27854935|NCT00246259|54373221|FG001|Overall Study|Lack of Efficacy|2|||
27854936|NCT00246259|54373220|FG000|Overall Study|Investigator withdrew participant|2|||
27854937|NCT00246259|54373221|FG001|Overall Study|Investigator withdrew participant|0|||
27854938|NCT00246259|54373220|FG000|Overall Study|Adverse Event|5|||
27854939|NCT00246259|54373221|FG001|Overall Study|Adverse Event|0|||
27854940|NCT00246259|54373220|FG000|Overall Study|Lost to Follow-up|3|||
27854941|NCT00246259|54373221|FG001|Overall Study|Lost to Follow-up|4|||
28081227|NCT04101422|54734471|FG001|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
28081228|NCT04101422|54734472|FG002|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
27854942|NCT00246259|54373220|FG000|Overall Study|Withdrawal by Subject|5|||
28081229|NCT04101422|54734473|FG003|Overall Study|Did not use app on 4 or more occasions per protocol|3|||
28081230|NCT03841604|54734485|FG000|Overall Study|Withdrawal by Subject|3|||
28081231|NCT03841604|54734486|FG001|Overall Study|Withdrawal by Subject|1|||
28081232|NCT03841604|54734485|FG000|Overall Study|Adverse Event|4|||
28081233|NCT03841604|54734486|FG001|Overall Study|Adverse Event|2|||
28081234|NCT03841604|54734485|FG000|Overall Study|Physician Decision|1|||
27952236|NCT01055496|54609510|FG000|Overall Study|Withdrawal by Subject|2|||
27952237|NCT01055496|54609511|FG001|Overall Study|Withdrawal by Subject|4|||
27952238|NCT01055496|54609510|FG000|Overall Study|Death|13|||
27952239|NCT01055496|54609511|FG001|Overall Study|Death|23|||
27952240|NCT01055496|54609510|FG000|Overall Study|Lost to Follow-up|0|||
27952241|NCT01055496|54609511|FG001|Overall Study|Lost to Follow-up|2|||
27952242|NCT01055496|54609510|FG000|Overall Study|Other - Unspecified|0|||
27952243|NCT01055496|54609511|FG001|Overall Study|Other - Unspecified|1|||
27952244|NCT01055262|54609538|FG000|Overall Study|Adverse Event|5|||
27952245|NCT01055262|54609538|FG000|Overall Study|Protocol Violation|3|||
27952246|NCT01055262|54609538|FG000|Overall Study|Uncooperativeness|1|||
27952247|NCT01052844|54609544|FG000|Overall Study|Adverse Event|0|||
27952248|NCT01052844|54609545|FG001|Overall Study|Adverse Event|1|||
27952249|NCT01049412|54609553|FG000|Period I|Withdrawal by Subject|4|||
27952250|NCT01049412|54609554|FG001|Period I|Withdrawal by Subject|6|||
27952251|NCT01049412|54609553|FG000|Period I|Lost to Follow-up|2|||
27952252|NCT01049412|54609554|FG001|Period I|Lost to Follow-up|2|||
27952253|NCT01049412|54609553|FG000|Period I|Physician Decision|0|||
27952254|NCT01049412|54609554|FG001|Period I|Physician Decision|3|||
27952255|NCT01049412|54609553|FG000|Period I|Protocol Violation|1|||
27952256|NCT01049412|54609554|FG001|Period I|Protocol Violation|2|||
27952257|NCT01049412|54609553|FG000|Period I|Adverse Event|1|||
27952258|NCT01049412|54609554|FG001|Period I|Adverse Event|0|||
27952259|NCT01049412|54609553|FG000|Period II|Withdrawal by Subject|2|||
27952260|NCT01049412|54609554|FG001|Period II|Withdrawal by Subject|3|||
27952261|NCT01049412|54609553|FG000|Period II|Adverse Event|1|||
27952262|NCT01049412|54609554|FG001|Period II|Adverse Event|0|||
27952263|NCT01049412|54609553|FG000|Period II|Lost to Follow-up|1|||
27952264|NCT01049412|54609554|FG001|Period II|Lost to Follow-up|0|||
27952265|NCT00934089|54609564|FG000|First Intervention Period (14 Days)|Withdrawal by Subject|1|||
27952266|NCT00934089|54609565|FG001|First Intervention Period (14 Days)|Withdrawal by Subject|0|||
27952267|NCT00934089|54609564|FG000|First Intervention Period (14 Days)|Randomized, but not treated|1|||
27952268|NCT00934089|54609565|FG001|First Intervention Period (14 Days)|Randomized, but not treated|0|||
27952269|NCT01032174|54609573|FG000|Overall Study|Adverse Event|0|||
27952270|NCT01032174|54609574|FG001|Overall Study|Adverse Event|1|||
27952271|NCT00933933|54609585|FG000|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
27952272|NCT00933933|54609586|FG001|General Population From 16 to 89 Years|Did not meet criteria for analysis|20|||
27952273|NCT00933933|54609587|FG002|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
27952274|NCT00933933|54609585|FG000|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
27952275|NCT00933933|54609586|FG001|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2|||
27952276|NCT00933933|54609587|FG002|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
27952277|NCT01032018|54609605|FG000|Overall Study|Lost to Follow-up|6|||
27952278|NCT01032018|54609606|FG001|Overall Study|Lost to Follow-up|5|||
27952279|NCT01032018|54609605|FG000|Overall Study|Death|0|||
27952280|NCT01032018|54609606|FG001|Overall Study|Death|1|||
27952281|NCT01031706|54609614|FG000|Overall Study|Adverse Event|1|||
27952282|NCT01031706|54609615|FG001|Overall Study|Adverse Event|0|||
27952283|NCT01031706|54609614|FG000|Overall Study|Withdrawal by Subject|1|||
27952284|NCT01031706|54609615|FG001|Overall Study|Withdrawal by Subject|1|||
27952285|NCT00927069|54609623|FG000|Week 0 to Week 12|Worsening of psoriasis|1|||
27952286|NCT00927069|54609624|FG001|Week 0 to Week 12|Worsening of psoriasis|1|||
27952287|NCT00927069|54609625|FG002|Week 0 to Week 12|Worsening of psoriasis|0|||
27952288|NCT00927069|54609626|FG003|Week 0 to Week 12|Worsening of psoriasis|0|||
27952289|NCT00927069|54609623|FG000|Week 12 to Week 24|Lack of Efficacy|0|||
27952290|NCT00927069|54609624|FG001|Week 12 to Week 24|Lack of Efficacy|0|||
27952291|NCT00927069|54609625|FG002|Week 12 to Week 24|Lack of Efficacy|2|||
27952292|NCT00927069|54609626|FG003|Week 12 to Week 24|Lack of Efficacy|3|||
27952293|NCT00927069|54609623|FG000|Week 12 to Week 24|Lost to Follow-up|0|||
27952294|NCT00927069|54609624|FG001|Week 12 to Week 24|Lost to Follow-up|0|||
27952295|NCT00927069|54609625|FG002|Week 12 to Week 24|Lost to Follow-up|1|||
27952296|NCT00927069|54609626|FG003|Week 12 to Week 24|Lost to Follow-up|0|||
27952297|NCT00927069|54609623|FG000|Week 12 to Week 24|Withdrawal by Subject|1|||
27952298|NCT00927069|54609624|FG001|Week 12 to Week 24|Withdrawal by Subject|0|||
27952299|NCT00927069|54609625|FG002|Week 12 to Week 24|Withdrawal by Subject|0|||
27952300|NCT00927069|54609626|FG003|Week 12 to Week 24|Withdrawal by Subject|0|||
27952301|NCT00927069|54609623|FG000|Week 12 to Week 24|Had a vaccination, removed from study|1|||
27952302|NCT00927069|54609624|FG001|Week 12 to Week 24|Had a vaccination, removed from study|0|||
27952303|NCT00927069|54609625|FG002|Week 12 to Week 24|Had a vaccination, removed from study|0|||
27952304|NCT00927069|54609626|FG003|Week 12 to Week 24|Had a vaccination, removed from study|0|||
27952305|NCT01031628|54609640|FG000|Overall Study|Study terminated early|0|||
27952306|NCT01031628|54609641|FG001|Overall Study|Study terminated early|1|||
27952307|NCT01031628|54609642|FG002|Overall Study|Study terminated early|3|||
27952308|NCT01031628|54609643|FG003|Overall Study|Study terminated early|0|||
27952309|NCT01031004|54609655|FG000|Overall Study|Protocol Violation|0|||
27952310|NCT01031004|54609656|FG001|Overall Study|Protocol Violation|1|||
27952311|NCT01031004|54609655|FG000|Overall Study|Lost to Follow-up|1|||
27952312|NCT01031004|54609656|FG001|Overall Study|Lost to Follow-up|0|||
27952313|NCT00931515|54609664|FG000|Overall Study|Lost to Follow-up|2|||
27952314|NCT00931515|54609665|FG001|Overall Study|Lost to Follow-up|5|||
27952315|NCT01028352|54609671|FG000|Overall Study|Ineligible due to baseline average pain|5|||
27952316|NCT01028352|54609671|FG000|Overall Study|Withdrawal by Subject|1|||
27952317|NCT00929643|54609688|FG000|Overall Study|Protocol Violation|2|||
27952318|NCT00926367|54609694|FG000|Overall Study|Withdrawal by Subject|0|||
27952319|NCT00926367|54609695|FG001|Overall Study|Withdrawal by Subject|1|||
27952320|NCT00926367|54609694|FG000|Overall Study|Lost to Follow-up|1|||
27952321|NCT00926367|54609695|FG001|Overall Study|Lost to Follow-up|0|||
27952322|NCT00926367|54609694|FG000|Overall Study|Skin Irritation|1|||
27952323|NCT00926367|54609695|FG001|Overall Study|Skin Irritation|2|||
27952324|NCT01114529|54609706|FG000|Completed Study Medication at Month 24|Adverse Event|87|||
27952325|NCT01114529|54609707|FG001|Completed Study Medication at Month 24|Adverse Event|18|||
27952326|NCT01114529|54609708|FG002|Completed Study Medication at Month 24|Adverse Event|17|||
27952327|NCT01114529|54609706|FG000|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6|||
27952328|NCT01114529|54609707|FG001|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0|||
27952329|NCT01114529|54609708|FG002|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1|||
27952330|NCT01114529|54609706|FG000|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3|||
27952331|NCT01114529|54609707|FG001|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0|||
27952332|NCT01114529|54609708|FG002|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1|||
27952333|NCT01114529|54609706|FG000|Completed Study Medication at Month 24|Lack of Efficacy|2|||
27952334|NCT01114529|54609707|FG001|Completed Study Medication at Month 24|Lack of Efficacy|1|||
27952335|NCT01114529|54609708|FG002|Completed Study Medication at Month 24|Lack of Efficacy|2|||
27952336|NCT01114529|54609706|FG000|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
27952337|NCT01114529|54609707|FG001|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
27952338|NCT01114529|54609708|FG002|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
27952339|NCT01114529|54609706|FG000|Completed Study Medication at Month 24|Withdrawal by Subject|18|||
27952340|NCT01114529|54609707|FG001|Completed Study Medication at Month 24|Withdrawal by Subject|8|||
27952341|NCT01114529|54609708|FG002|Completed Study Medication at Month 24|Withdrawal by Subject|2|||
27952342|NCT01114529|54609706|FG000|Completed Study Medication at Month 24|Lost to Follow-up|1|||
27952343|NCT01114529|54609707|FG001|Completed Study Medication at Month 24|Lost to Follow-up|4|||
27952344|NCT01114529|54609708|FG002|Completed Study Medication at Month 24|Lost to Follow-up|2|||
27952345|NCT01114529|54609706|FG000|Completed Study Medication at Month 24|Administrative problems|2|||
27952346|NCT01114529|54609707|FG001|Completed Study Medication at Month 24|Administrative problems|1|||
27952347|NCT01114529|54609708|FG002|Completed Study Medication at Month 24|Administrative problems|2|||
27952348|NCT01114529|54609706|FG000|Completed Study Medication at Month 24|Death|2|||
27952349|NCT01114529|54609707|FG001|Completed Study Medication at Month 24|Death|1|||
27952350|NCT01114529|54609708|FG002|Completed Study Medication at Month 24|Death|2|||
27952351|NCT01114529|54609706|FG000|Completed Study Medication at Month 24|Graft loss|0|||
27952352|NCT01114529|54609707|FG001|Completed Study Medication at Month 24|Graft loss|2|||
27952353|NCT01114529|54609708|FG002|Completed Study Medication at Month 24|Graft loss|0|||
27952354|NCT01114529|54609706|FG000|Completed Study Medication at Month 24|Protocol Violation|0|||
27952355|NCT01114529|54609707|FG001|Completed Study Medication at Month 24|Protocol Violation|5|||
27952356|NCT01114529|54609708|FG002|Completed Study Medication at Month 24|Protocol Violation|2|||
27952357|NCT01114529|54609706|FG000|Completed Study Medication at Month 24|Missing|2|||
27952358|NCT01114529|54609707|FG001|Completed Study Medication at Month 24|Missing|0|||
27952359|NCT01114529|54609708|FG002|Completed Study Medication at Month 24|Missing|0|||
27952360|NCT01114529|54609706|FG000|Completed Study Phase at Month 24|Withdrawal by Subject|18|||
27952361|NCT01114529|54609707|FG001|Completed Study Phase at Month 24|Withdrawal by Subject|6|||
27952362|NCT01114529|54609708|FG002|Completed Study Phase at Month 24|Withdrawal by Subject|3|||
27952363|NCT01114529|54609706|FG000|Completed Study Phase at Month 24|Lost to Follow-up|10|||
27952364|NCT01114529|54609707|FG001|Completed Study Phase at Month 24|Lost to Follow-up|5|||
27952365|NCT01114529|54609708|FG002|Completed Study Phase at Month 24|Lost to Follow-up|7|||
27952366|NCT01114529|54609706|FG000|Completed Study Phase at Month 24|Death|8|||
27952367|NCT01114529|54609707|FG001|Completed Study Phase at Month 24|Death|5|||
27952368|NCT01114529|54609708|FG002|Completed Study Phase at Month 24|Death|4|||
27952369|NCT01114529|54609706|FG000|Completed Study Phase at Month 24|Other|2|||
27952370|NCT01114529|54609707|FG001|Completed Study Phase at Month 24|Other|0|||
27952371|NCT01114529|54609708|FG002|Completed Study Phase at Month 24|Other|0|||
27952372|NCT01114529|54609706|FG000|Completed Study Phase at Month 24|Missing|2|||
27952373|NCT01114529|54609707|FG001|Completed Study Phase at Month 24|Missing|0|||
27952374|NCT01114529|54609708|FG002|Completed Study Phase at Month 24|Missing|0|||
27952375|NCT00926289|54609720|FG000|Overall Study|Adverse Event|9|||
27952376|NCT00926289|54609721|FG001|Overall Study|Adverse Event|11|||
27952377|NCT00926289|54609720|FG000|Overall Study|Protocol Violation|8|||
27952378|NCT00926289|54609721|FG001|Overall Study|Protocol Violation|12|||
27731955|NCT00103285|54179445|FG003|Induction|Other|0|||
27952379|NCT00926289|54609720|FG000|Overall Study|Lost to Follow-up|3|||
27952380|NCT00926289|54609721|FG001|Overall Study|Lost to Follow-up|6|||
27952381|NCT00926289|54609720|FG000|Overall Study|Withdrawal by Subject|4|||
27952382|NCT00926289|54609721|FG001|Overall Study|Withdrawal by Subject|4|||
27952383|NCT00926289|54609720|FG000|Overall Study|Other|1|||
27952384|NCT00926289|54609721|FG001|Overall Study|Other|3|||
27952385|NCT03208036|54609746|FG000|Baseline Assessment|Withdrawal by Subject|1|||
27952386|NCT03208036|54609747|FG001|Baseline Assessment|Withdrawal by Subject|1|||
27952387|NCT03208036|54609746|FG000|2nd Baseline Assessment|Withdrawal by Subject|1|||
28081235|NCT03841604|54734486|FG001|Overall Study|Physician Decision|0|||
28081236|NCT03541187|54734503|FG000|Overall Study|Lost to Follow-up|2|||
28081237|NCT03541187|54734504|FG001|Overall Study|Lost to Follow-up|6|||
28081238|NCT03541187|54734503|FG000|Overall Study|Pregnancy|0|||
28081239|NCT03541187|54734504|FG001|Overall Study|Pregnancy|1|||
28081240|NCT03541187|54734503|FG000|Overall Study|Withdrawal by Subject|6|||
27952388|NCT03208036|54609747|FG001|2nd Baseline Assessment|Withdrawal by Subject|2|||
27952389|NCT03208036|54609746|FG000|Intervention|Withdrawal by Subject|3|||
27952390|NCT03208036|54609747|FG001|Intervention|Withdrawal by Subject|2|||
27952391|NCT03208036|54609746|FG000|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|1|||
27952392|NCT03208036|54609747|FG001|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|2|||
27952393|NCT00926211|54609753|FG000|Overall Study|Lost to Follow-up|1|||
27952394|NCT01114373|54609758|FG000|Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
27952395|NCT01114373|54609759|FG001|Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
27952396|NCT01114373|54609758|FG000|Intervention 1 (4 Weeks)|Incarceration|1|||
27952397|NCT01114373|54609759|FG001|Intervention 1 (4 Weeks)|Incarceration|0|||
27952398|NCT01114373|54609758|FG000|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1|||
27952399|NCT01114373|54609759|FG001|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0|||
27952400|NCT01114373|54609758|FG000|Intervention 2 (4 Weeks)|Lost to Follow-up|0|||
27952401|NCT01114373|54609759|FG001|Intervention 2 (4 Weeks)|Lost to Follow-up|1|||
27952402|NCT00925899|54609771|FG000|Part 1|Death|1|||
27952403|NCT00925899|54609772|FG001|Part 1|Death|2|||
27952404|NCT00925899|54609771|FG000|Part 1|Withdrawal by Subject|10|||
27952405|NCT00925899|54609772|FG001|Part 1|Withdrawal by Subject|9|||
27952406|NCT01114217|54609781|FG000|Overall Study|Adverse Event|5|||
27952407|NCT01114217|54609782|FG001|Overall Study|Adverse Event|3|||
27952408|NCT01114217|54609781|FG000|Overall Study|Lost to Follow-up|17|||
27952409|NCT01114217|54609782|FG001|Overall Study|Lost to Follow-up|33|||
27952410|NCT01114217|54609781|FG000|Overall Study|Withdrawal by Subject|21|||
27952411|NCT01114217|54609782|FG001|Overall Study|Withdrawal by Subject|28|||
27952412|NCT01114217|54609781|FG000|Overall Study|Other-Clerical Error|3|||
27952413|NCT01114217|54609782|FG001|Overall Study|Other-Clerical Error|0|||
27952414|NCT01114217|54609781|FG000|Overall Study|Other-Early termination|6|||
27952415|NCT01114217|54609782|FG001|Overall Study|Other-Early termination|10|||
27952416|NCT01114217|54609781|FG000|Overall Study|Other-Procedure|1|||
27952417|NCT01114217|54609782|FG001|Overall Study|Other-Procedure|1|||
27952418|NCT01114217|54609781|FG000|Overall Study|Other-Pregnancy|2|||
27952419|NCT01114217|54609782|FG001|Overall Study|Other-Pregnancy|4|||
27952420|NCT01114217|54609781|FG000|Overall Study|Other-Protocol Violation|1|||
27952421|NCT01114217|54609782|FG001|Overall Study|Other-Protocol Violation|3|||
27952422|NCT01114217|54609781|FG000|Overall Study|Other-Lack of Efficacy|1|||
27952423|NCT01114217|54609782|FG001|Overall Study|Other-Lack of Efficacy|0|||
27952424|NCT01114217|54609781|FG000|Overall Study|Other-Non Compliance|2|||
27952425|NCT01114217|54609782|FG001|Overall Study|Other-Non Compliance|0|||
27952426|NCT01114217|54609781|FG000|Overall Study|Other-Physician Decision|1|||
27952427|NCT01114217|54609782|FG001|Overall Study|Other-Physician Decision|1|||
27952428|NCT01114217|54609781|FG000|Overall Study|Other-Sponsor Decision|10|||
27952429|NCT01114217|54609782|FG001|Overall Study|Other-Sponsor Decision|12|||
27952430|NCT01114217|54609781|FG000|Overall Study|Other-Study Termination|0|||
27952431|NCT01114217|54609782|FG001|Overall Study|Other-Study Termination|1|||
27952432|NCT01114217|54609781|FG000|Overall Study|Other-Study Withdrawn|1|||
27952433|NCT01114217|54609782|FG001|Overall Study|Other-Study Withdrawn|1|||
28081241|NCT03541187|54734504|FG001|Overall Study|Withdrawal by Subject|2|||
28081242|NCT03541187|54734503|FG000|Overall Study|Moved out of town|1|||
28081243|NCT03541187|54734504|FG001|Overall Study|Moved out of town|0|||
27952434|NCT01114217|54609781|FG000|Overall Study|Other-Site Stopped Communicating|2|||
27952435|NCT01114217|54609782|FG001|Overall Study|Other-Site Stopped Communicating|0|||
27952436|NCT01114217|54609781|FG000|Overall Study|Other-Lost to Follow-up|1|||
27952437|NCT01114217|54609782|FG001|Overall Study|Other-Lost to Follow-up|0|||
27952438|NCT01114217|54609781|FG000|Overall Study|Other-Withdrawal by Subject|1|||
27952439|NCT01114217|54609782|FG001|Overall Study|Other-Withdrawal by Subject|1|||
27952440|NCT01030536|54609791|FG000|Overall Study|Withdrawal by Subject|0|||
27952441|NCT01030536|54609792|FG001|Overall Study|Withdrawal by Subject|0|||
28081244|NCT03541187|54734503|FG000|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
27952442|NCT01030536|54609793|FG002|Overall Study|Withdrawal by Subject|1|||
27952443|NCT01030536|54609794|FG003|Overall Study|Withdrawal by Subject|0|||
27952444|NCT01030536|54609795|FG004|Overall Study|Withdrawal by Subject|0|||
27952445|NCT01030536|54609791|FG000|Overall Study|undefined|1|||
27952446|NCT01030536|54609792|FG001|Overall Study|undefined|0|||
27952447|NCT01030536|54609793|FG002|Overall Study|undefined|1|||
27952448|NCT01030536|54609794|FG003|Overall Study|undefined|1|||
27952449|NCT01030536|54609795|FG004|Overall Study|undefined|0|||
27952450|NCT01030536|54609791|FG000|Overall Study|Adverse Event|0|||
27952451|NCT01030536|54609792|FG001|Overall Study|Adverse Event|3|||
27952452|NCT01030536|54609793|FG002|Overall Study|Adverse Event|1|||
27952453|NCT01030536|54609794|FG003|Overall Study|Adverse Event|0|||
27952454|NCT01030536|54609795|FG004|Overall Study|Adverse Event|1|||
27952455|NCT01030536|54609791|FG000|Overall Study|Progressive disease|6|||
27952456|NCT01030536|54609792|FG001|Overall Study|Progressive disease|2|||
27952457|NCT01030536|54609793|FG002|Overall Study|Progressive disease|3|||
27952458|NCT01030536|54609794|FG003|Overall Study|Progressive disease|2|||
27952459|NCT01030536|54609795|FG004|Overall Study|Progressive disease|0|||
27952460|NCT01030536|54609791|FG000|Overall Study|Death|0|||
27952461|NCT01030536|54609792|FG001|Overall Study|Death|1|||
27952462|NCT01030536|54609793|FG002|Overall Study|Death|0|||
27952463|NCT01030536|54609794|FG003|Overall Study|Death|0|||
27952464|NCT01030536|54609795|FG004|Overall Study|Death|0|||
27952465|NCT01030458|54609813|FG000|Overall Study|Lost to Follow-up|9|||
27952466|NCT01030458|54609814|FG001|Overall Study|Lost to Follow-up|10|||
27952467|NCT01030458|54609813|FG000|Overall Study|Withdrawal by Subject|2|||
27952468|NCT01030458|54609814|FG001|Overall Study|Withdrawal by Subject|3|||
27952469|NCT01030458|54609813|FG000|Overall Study|Logistical reasons|9|||
27952470|NCT01030458|54609814|FG001|Overall Study|Logistical reasons|5|||
27952471|NCT01030458|54609813|FG000|Overall Study|Moved or changed job|6|||
27952472|NCT01030458|54609814|FG001|Overall Study|Moved or changed job|13|||
27952473|NCT01030458|54609813|FG000|Overall Study|Side effect of medication|1|||
27952474|NCT01030458|54609814|FG001|Overall Study|Side effect of medication|1|||
27952475|NCT00930969|54609820|FG000|Overall Study|Death|5|||
27952476|NCT00930969|54609820|FG000|Overall Study|Lost to Follow-up|1|||
27952477|NCT00930969|54609820|FG000|Overall Study|Physician Decision|13|||
27952478|NCT00930969|54609820|FG000|Overall Study|Withdrawal by Subject|19|||
27952479|NCT01114139|54609826|FG000|Overall Study|Adverse Event|3|||
27952480|NCT01114139|54609827|FG001|Overall Study|Adverse Event|2|||
27952481|NCT01114139|54609826|FG000|Overall Study|Lost to Follow-up|15|||
27952482|NCT01114139|54609827|FG001|Overall Study|Lost to Follow-up|3|||
27952483|NCT01114139|54609826|FG000|Overall Study|Withdrawal by Subject|17|||
27952484|NCT01114139|54609827|FG001|Overall Study|Withdrawal by Subject|6|||
27952485|NCT01114139|54609826|FG000|Overall Study|Other-Missed 1 visit|1|||
27952486|NCT01114139|54609827|FG001|Overall Study|Other-Missed 1 visit|0|||
27952487|NCT01114139|54609826|FG000|Overall Study|Other-Protocol Violation|1|||
27952488|NCT01114139|54609827|FG001|Overall Study|Other-Protocol Violation|0|||
28081245|NCT03541187|54734504|FG001|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
28081246|NCT03541187|54734503|FG000|Overall Study|Did not meet randomization criteria|1|||
28081247|NCT03541187|54734504|FG001|Overall Study|Did not meet randomization criteria|1|||
28081248|NCT03541187|54734503|FG000|Overall Study|Potential inability to tolerate maintenance dose|1|||
28081249|NCT03541187|54734504|FG001|Overall Study|Potential inability to tolerate maintenance dose|0|||
28081250|NCT03541187|54734503|FG000|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|0|||
28081251|NCT03541187|54734504|FG001|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|1|||
28081252|NCT03240081|54734525|FG000|Overall Study|Withdrawal by Subject|0|||
28081253|NCT03240081|54734526|FG001|Overall Study|Withdrawal by Subject|2|||
28081254|NCT03240081|54734525|FG000|Overall Study|Lost to Follow-up|0|||
28081255|NCT03240081|54734526|FG001|Overall Study|Lost to Follow-up|1|||
28081256|NCT03003520|54734547|FG000|Overall Study|Adverse Event|9|||
28081257|NCT03003520|54734548|FG001|Overall Study|Adverse Event|0|||
28081258|NCT03003520|54734547|FG000|Overall Study|Death|1|||
28081259|NCT03003520|54734548|FG001|Overall Study|Death|0|||
28081260|NCT03003520|54734547|FG000|Overall Study|Other reasons|4|||
27731956|NCT00103285|54179446|FG004|Induction|Other|0|||
27952489|NCT01114139|54609826|FG000|Overall Study|Other-Out of window for study drug dose|1|||
27952490|NCT01114139|54609827|FG001|Overall Study|Other-Out of window for study drug dose|0|||
27952491|NCT01114139|54609826|FG000|Overall Study|Other-Participant falsified records|0|||
27952492|NCT01114139|54609827|FG001|Overall Study|Other-Participant falsified records|1|||
27952493|NCT01114139|54609826|FG000|Overall Study|Other-Participant went on hospice|0|||
27952494|NCT01114139|54609827|FG001|Overall Study|Other-Participant went on hospice|1|||
28081261|NCT03003520|54734548|FG001|Overall Study|Other reasons|0|||
28081262|NCT03003520|54734547|FG000|Overall Study|Withdrawal by Subject|6|||
28081263|NCT03003520|54734548|FG001|Overall Study|Withdrawal by Subject|0|||
28081264|NCT03003520|54734547|FG000|Overall Study|Progressive disease|9|||
28081265|NCT03003520|54734548|FG001|Overall Study|Progressive disease|1|||
27952495|NCT01114139|54609826|FG000|Overall Study|Other-Physician changed treatment|1|||
27952496|NCT01114139|54609827|FG001|Overall Study|Other-Physician changed treatment|0|||
27731957|NCT00103285|54179447|FG005|Induction|Other|0|||
27952497|NCT01114139|54609826|FG000|Overall Study|Other-Withdrew prior to receiving dose|1|||
27952498|NCT01114139|54609827|FG001|Overall Study|Other-Withdrew prior to receiving dose|3|||
27952499|NCT01027884|54609835|FG000|Overall Study|Adverse Event|2|||
27952500|NCT01027884|54609836|FG001|Overall Study|Adverse Event|1|||
27952501|NCT01027884|54609835|FG000|Overall Study|Protocol Violation|1|||
27952502|NCT01027884|54609836|FG001|Overall Study|Protocol Violation|0|||
27952503|NCT01027884|54609835|FG000|Overall Study|Non-compliance|1|||
27952504|NCT01027884|54609836|FG001|Overall Study|Non-compliance|1|||
27952505|NCT01027884|54609835|FG000|Overall Study|Withdrawal by Subject|0|||
27952506|NCT01027884|54609836|FG001|Overall Study|Withdrawal by Subject|1|||
27952507|NCT01027884|54609835|FG000|Overall Study|Lost to Follow-up|0|||
27952508|NCT01027884|54609836|FG001|Overall Study|Lost to Follow-up|1|||
27952509|NCT01027884|54609835|FG000|Overall Study|Spinal fixation surgery|0|||
27952510|NCT01027884|54609836|FG001|Overall Study|Spinal fixation surgery|3|||
27952511|NCT03387514|54609844|FG000|Overall Study|Withdrawal by Subject|2|||
27952512|NCT03387514|54609844|FG000|Overall Study|Physician Decision|1|||
27952513|NCT03387514|54609844|FG000|Overall Study|Lost to Follow-up|2|||
27952514|NCT01113749|54609859|FG000|Overall Study|Lost to Follow-up|1|||
27952515|NCT01113749|54609860|FG001|Overall Study|Lost to Follow-up|2|||
27952516|NCT01022580|54609868|FG000|Overall Study|Death|18|||
27952517|NCT01022580|54609869|FG001|Overall Study|Death|22|||
27952518|NCT01107353|54609883|FG000|Overall Study|Positive Drug Screen|1|||
27952519|NCT01107353|54609884|FG001|Overall Study|Positive Drug Screen|0|||
27952520|NCT01107197|54609892|FG000|Overall Study|Death|12|||
27952521|NCT01107197|54609893|FG001|Overall Study|Death|10|||
27952522|NCT01107197|54609892|FG000|Overall Study|Lost to Follow-up|5|||
27952523|NCT01107197|54609893|FG001|Overall Study|Lost to Follow-up|8|||
27952524|NCT01107197|54609892|FG000|Overall Study|Withdrawal by Subject|3|||
27952525|NCT01107197|54609893|FG001|Overall Study|Withdrawal by Subject|5|||
27952526|NCT01112579|54609910|FG000|Overall Study|Missed Visit|1|||
27952527|NCT01112579|54609911|FG001|Overall Study|Missed Visit|1|||
27952528|NCT01112579|54609910|FG000|Overall Study|Death|0|||
27952529|NCT01112579|54609911|FG001|Overall Study|Death|2|||
27952530|NCT01112267|54609919|FG000|Overall Study|Adverse Event|24|||
27952531|NCT01112267|54609920|FG001|Overall Study|Adverse Event|6|||
27952532|NCT01112267|54609919|FG000|Overall Study|Withdrawal by Subject|3|||
27952533|NCT01112267|54609920|FG001|Overall Study|Withdrawal by Subject|5|||
27952534|NCT01112267|54609919|FG000|Overall Study|Protocol Violation|5|||
27952535|NCT01112267|54609920|FG001|Overall Study|Protocol Violation|3|||
27952536|NCT01112267|54609919|FG000|Overall Study|Participants not compliant|1|||
27952537|NCT01112267|54609920|FG001|Overall Study|Participants not compliant|2|||
27952538|NCT01112267|54609919|FG000|Overall Study|Participants not receive any study drug|1|||
27952539|NCT01112267|54609920|FG001|Overall Study|Participants not receive any study drug|2|||
27952540|NCT00925587|54609928|FG000|Overall Study|Protocol Specified Criteria|6|||
27952541|NCT00925587|54609929|FG001|Overall Study|Protocol Specified Criteria|6|||
27952542|NCT00925587|54609928|FG000|Overall Study|Physician Decision|4|||
27952543|NCT00925587|54609929|FG001|Overall Study|Physician Decision|1|||
27952544|NCT00925587|54609928|FG000|Overall Study|Protocol Violation|6|||
27952545|NCT00925587|54609929|FG001|Overall Study|Protocol Violation|4|||
27952546|NCT00925587|54609928|FG000|Overall Study|Withdrawal by Subject|9|||
27952547|NCT00925587|54609929|FG001|Overall Study|Withdrawal by Subject|6|||
27952548|NCT00925587|54609928|FG000|Overall Study|Death|5|||
27952549|NCT00925587|54609929|FG001|Overall Study|Death|5|||
27952550|NCT00925587|54609928|FG000|Overall Study|Adverse Event|6|||
27952551|NCT00925587|54609929|FG001|Overall Study|Adverse Event|2|||
27952552|NCT00925587|54609928|FG000|Overall Study|Lost to Follow-up|0|||
28081266|NCT02958527|54734571|FG000|Overall Study|Not collected CRFs|12|||
28081267|NCT02586025|54734593|FG000|Neoadjuvant Treatment|Withdrawal by Subject|4|||
28081268|NCT02586025|54734594|FG001|Neoadjuvant Treatment|Withdrawal by Subject|3|||
28081269|NCT02586025|54734593|FG000|Neoadjuvant Treatment|Progression of Disease|2|||
28081270|NCT02586025|54734594|FG001|Neoadjuvant Treatment|Progression of Disease|3|||
28081271|NCT02586025|54734593|FG000|Neoadjuvant Treatment|Did Not Receive Study Drug|1|||
28081272|NCT02586025|54734594|FG001|Neoadjuvant Treatment|Did Not Receive Study Drug|0|||
28081273|NCT02586025|54734593|FG000|Neoadjuvant Treatment|Death|1|||
28081274|NCT02586025|54734594|FG001|Neoadjuvant Treatment|Death|0|||
28081275|NCT02586025|54734593|FG000|Neoadjuvant Treatment|Adverse Event|1|||
27952553|NCT00925587|54609929|FG001|Overall Study|Lost to Follow-up|1|||
27952554|NCT00928707|54609941|FG000|Overall Study|Protocol Violation|1|||
27952555|NCT00928707|54609942|FG001|Overall Study|Protocol Violation|0|||
27952556|NCT00930813|54609950|FG000|Overall Study|Death|4|||
27952557|NCT00930813|54609951|FG001|Overall Study|Death|5|||
27952558|NCT00930813|54609950|FG000|Overall Study|Withdrawal by Subject|2|||
27952559|NCT00930813|54609951|FG001|Overall Study|Withdrawal by Subject|5|||
27952560|NCT00930813|54609950|FG000|Overall Study|Lost to Follow-up|2|||
27952561|NCT00930813|54609951|FG001|Overall Study|Lost to Follow-up|4|||
28081276|NCT02586025|54734594|FG001|Neoadjuvant Treatment|Adverse Event|0|||
27952562|NCT00930579|54609959|FG000|Overall Study|Withdrawal by Subject|1|||
27952563|NCT00930579|54609959|FG000|Overall Study|Discontinued due to rescheduled surgery|1|||
27952564|NCT03367156|54609965|FG000|Overall Study|Lack of interest|3|||
27952565|NCT03367156|54609966|FG001|Overall Study|Lack of interest|1|||
27952566|NCT03367156|54609965|FG000|Overall Study|Death|2|||
28081277|NCT02586025|54734593|FG000|Neoadjuvant Treatment|Physician Decision|2|||
28081278|NCT02586025|54734594|FG001|Neoadjuvant Treatment|Physician Decision|1|||
28081279|NCT02586025|54734593|FG000|Adjuvant Treatment|Withdrawal by Subject|5|||
28081280|NCT02586025|54734594|FG001|Adjuvant Treatment|Withdrawal by Subject|3|||
28081281|NCT02586025|54734593|FG000|Adjuvant Treatment|Recurrent Disease|4|||
28081282|NCT02586025|54734594|FG001|Adjuvant Treatment|Recurrent Disease|5|||
28081283|NCT02586025|54734593|FG000|Adjuvant Treatment|Physician Decision|0|||
28081284|NCT02586025|54734594|FG001|Adjuvant Treatment|Physician Decision|1|||
28081285|NCT02586025|54734593|FG000|Adjuvant Treatment|Pregnancy|1|||
28081286|NCT02586025|54734594|FG001|Adjuvant Treatment|Pregnancy|0|||
28081287|NCT02586025|54734593|FG000|Treatment-Free Follow-Up|Death|11|||
28081288|NCT02586025|54734594|FG001|Treatment-Free Follow-Up|Death|11|||
28081289|NCT02586025|54734593|FG000|Treatment-Free Follow-Up|Lost to Follow-up|9|||
28081290|NCT02586025|54734594|FG001|Treatment-Free Follow-Up|Lost to Follow-up|4|||
28081291|NCT02586025|54734593|FG000|Treatment-Free Follow-Up|Withdrawal by Subject|13|||
28081292|NCT02586025|54734594|FG001|Treatment-Free Follow-Up|Withdrawal by Subject|3|||
28081293|NCT02586025|54734593|FG000|Treatment-Free Follow-Up|Non-compliance|0|||
28081294|NCT02586025|54734594|FG001|Treatment-Free Follow-Up|Non-compliance|1|||
28081295|NCT02586025|54734593|FG000|Treatment-Free Follow-Up|Reason Not Specified|0|||
28081296|NCT02586025|54734594|FG001|Treatment-Free Follow-Up|Reason Not Specified|3|||
28081297|NCT02446600|54734614|FG000|Overall Study|Never treated|20|||
28081298|NCT02446600|54734615|FG001|Overall Study|Never treated|2|||
28081299|NCT02446600|54734616|FG002|Overall Study|Never treated|6|||
28081300|NCT02446600|54734617|FG003|Overall Study|Never treated|0|||
28081301|NCT02446600|54734614|FG000|Overall Study|Withdrawal by Subject|19|||
28081302|NCT02446600|54734615|FG001|Overall Study|Withdrawal by Subject|5|||
28081303|NCT02446600|54734616|FG002|Overall Study|Withdrawal by Subject|17|||
28081304|NCT02446600|54734617|FG003|Overall Study|Withdrawal by Subject|0|||
28081305|NCT02446600|54734614|FG000|Overall Study|Ineligible|1|||
28081306|NCT02446600|54734615|FG001|Overall Study|Ineligible|4|||
28081307|NCT02446600|54734616|FG002|Overall Study|Ineligible|4|||
28081308|NCT02446600|54734617|FG003|Overall Study|Ineligible|1|||
28081309|NCT02446600|54734614|FG000|Overall Study|Duplicate Enrollment|0|||
28081310|NCT02446600|54734615|FG001|Overall Study|Duplicate Enrollment|1|||
28081311|NCT02446600|54734616|FG002|Overall Study|Duplicate Enrollment|0|||
28081312|NCT02446600|54734617|FG003|Overall Study|Duplicate Enrollment|0|||
28081313|NCT02285114|54734630|FG000|Overall Study|Investigator's Discretion|0|||
28081314|NCT02285114|54734631|FG001|Overall Study|Investigator's Discretion|2|||
28081315|NCT02285114|54734632|FG002|Overall Study|Investigator's Discretion|0|||
28081316|NCT02285114|54734630|FG000|Overall Study|Withdrew Consent|0|||
28081317|NCT02285114|54734631|FG001|Overall Study|Withdrew Consent|0|||
28081318|NCT02285114|54734632|FG002|Overall Study|Withdrew Consent|1|||
28081319|NCT02285114|54734630|FG000|Overall Study|Enrolled but not treated|1|||
28081320|NCT02285114|54734631|FG001|Overall Study|Enrolled but not treated|0|||
28081321|NCT02285114|54734632|FG002|Overall Study|Enrolled but not treated|0|||
28081322|NCT02285114|54734630|FG000|Overall Study|Still on study|21|||
28081323|NCT02285114|54734631|FG001|Overall Study|Still on study|5|||
28081324|NCT02285114|54734632|FG002|Overall Study|Still on study|2|||
27832275|NCT01767857|54311116|FG001|Overall Study|Randomized But Never Treated|13|||
28081325|NCT02094261|54734646|FG000|Overall Study|Death|24|||
28081326|NCT02094261|54734646|FG000|Overall Study|Lost to Follow-up|1|||
28081327|NCT02094261|54734646|FG000|Overall Study|Withdrawal by Subject|4|||
28081328|NCT02094261|54734646|FG000|Overall Study|Ongoing Study at Data Cut-off|181|||
28081329|NCT01721577|54734652|FG000|Overall Study|Lack of Efficacy|1|||
28081330|NCT01721577|54734653|FG001|Overall Study|Lack of Efficacy|0|||
28081331|NCT01721577|54734652|FG000|Overall Study|Death|1|||
28081332|NCT01721577|54734653|FG001|Overall Study|Death|0|||
28081333|NCT01721577|54734652|FG000|Overall Study|Dose Escalation to 400mg BID|0|||
28081334|NCT01721577|54734653|FG001|Overall Study|Dose Escalation to 400mg BID|1|||
28081335|NCT01721577|54734652|FG000|Overall Study|Adverse Event|0|||
28081336|NCT01721577|54734653|FG001|Overall Study|Adverse Event|2|||
28081337|NCT01411332|54734670|FG000|Enrollment|Protocol Violation|0|||
28081338|NCT01411332|54734671|FG001|Enrollment|Protocol Violation|1|||
28081339|NCT01411332|54734670|FG000|Enrollment|Withdrawal by Subject|0|||
28081340|NCT01411332|54734671|FG001|Enrollment|Withdrawal by Subject|1|||
27952567|NCT03367156|54609966|FG001|Overall Study|Death|0|||
27952568|NCT03367156|54609965|FG000|Overall Study|Lost to Follow-up|2|||
28081341|NCT01411332|54734670|FG000|Treatment|Lost to Follow-up|1|||
28081342|NCT01411332|54734671|FG001|Treatment|Lost to Follow-up|0|||
28081343|NCT01194570|54734680|FG000|Overall Study|Death|1|||
28081344|NCT01194570|54734681|FG001|Overall Study|Death|3|||
28081345|NCT01194570|54734680|FG000|Overall Study|Ongoing at CCOD|162|||
27952569|NCT03367156|54609966|FG001|Overall Study|Lost to Follow-up|1|||
28081346|NCT01194570|54734681|FG001|Overall Study|Ongoing at CCOD|387|||
28081347|NCT01194570|54734680|FG000|Overall Study|Physician Decision|2|||
27952570|NCT03367156|54609965|FG000|Overall Study|Became ineligible|1|||
27952571|NCT03367156|54609966|FG001|Overall Study|Became ineligible|2|||
27952572|NCT03367156|54609965|FG000|Overall Study|Hospitalization|1|||
27952573|NCT03367156|54609966|FG001|Overall Study|Hospitalization|0|||
27952574|NCT03367156|54609965|FG000|Overall Study|Concerned about Treatment|11|||
27952575|NCT03367156|54609966|FG001|Overall Study|Concerned about Treatment|3|||
27952576|NCT03367156|54609965|FG000|Overall Study|Started new treatment|4|||
27952577|NCT03367156|54609966|FG001|Overall Study|Started new treatment|1|||
27952578|NCT00925353|54609974|FG000|Overall Study|Failed preliminary EKG or lab criteria.|3|||
27952579|NCT01106651|54609998|FG000|Overall Study|Adverse Event|17|||
27952580|NCT01106651|54609999|FG001|Overall Study|Adverse Event|9|||
27952581|NCT01106651|54610000|FG002|Overall Study|Adverse Event|23|||
27952582|NCT01106651|54609998|FG000|Overall Study|Lost to Follow-up|8|||
27952583|NCT01106651|54609999|FG001|Overall Study|Lost to Follow-up|2|||
27952584|NCT01106651|54610000|FG002|Overall Study|Lost to Follow-up|6|||
27952585|NCT01106651|54609998|FG000|Overall Study|Physician Decision|4|||
27952586|NCT01106651|54609999|FG001|Overall Study|Physician Decision|3|||
27952587|NCT01106651|54610000|FG002|Overall Study|Physician Decision|1|||
27952588|NCT01106651|54609998|FG000|Overall Study|Protocol Violation|1|||
27952589|NCT01106651|54609999|FG001|Overall Study|Protocol Violation|2|||
27952590|NCT01106651|54610000|FG002|Overall Study|Protocol Violation|1|||
27952591|NCT01106651|54609998|FG000|Overall Study|Withdrawal by Subject|14|||
27952592|NCT01106651|54609999|FG001|Overall Study|Withdrawal by Subject|7|||
27952593|NCT01106651|54610000|FG002|Overall Study|Withdrawal by Subject|4|||
27952594|NCT01106651|54609998|FG000|Overall Study|Noncompliance with study drug|1|||
27952595|NCT01106651|54609999|FG001|Overall Study|Noncompliance with study drug|0|||
27952596|NCT01106651|54610000|FG002|Overall Study|Noncompliance with study drug|2|||
27952597|NCT01106651|54609998|FG000|Overall Study|Other|34|||
27952598|NCT01106651|54609999|FG001|Overall Study|Other|31|||
27952599|NCT01106651|54610000|FG002|Overall Study|Other|21|||
27952600|NCT01106651|54609998|FG000|Overall Study|Death|0|||
27952601|NCT01106651|54609999|FG001|Overall Study|Death|3|||
27952602|NCT01106651|54610000|FG002|Overall Study|Death|0|||
27952603|NCT01027650|54610019|FG000|Overall Study|Personal Reasons|0|||
27952604|NCT01027650|54610020|FG001|Overall Study|Personal Reasons|0|||
27952605|NCT01027650|54610021|FG002|Overall Study|Personal Reasons|0|||
27952606|NCT01027650|54610022|FG003|Overall Study|Personal Reasons|0|||
27952607|NCT01027650|54610023|FG004|Overall Study|Personal Reasons|2|||
27952608|NCT01027650|54610024|FG005|Overall Study|Personal Reasons|1|||
27952609|NCT01027650|54610025|FG006|Overall Study|Personal Reasons|0|||
27952610|NCT01027650|54610026|FG007|Overall Study|Personal Reasons|0|||
27952611|NCT01027650|54610019|FG000|Overall Study|Lost to Follow-up|0|||
27952612|NCT01027650|54610020|FG001|Overall Study|Lost to Follow-up|0|||
27952613|NCT01027650|54610021|FG002|Overall Study|Lost to Follow-up|0|||
27952614|NCT01027650|54610022|FG003|Overall Study|Lost to Follow-up|0|||
27952615|NCT01027650|54610023|FG004|Overall Study|Lost to Follow-up|0|||
27952616|NCT01027650|54610024|FG005|Overall Study|Lost to Follow-up|0|||
27952617|NCT01027650|54610025|FG006|Overall Study|Lost to Follow-up|1|||
27952618|NCT01027650|54610026|FG007|Overall Study|Lost to Follow-up|0|||
27952619|NCT01027650|54610019|FG000|Overall Study|Lack of Efficacy|0|||
27952620|NCT01027650|54610020|FG001|Overall Study|Lack of Efficacy|0|||
27952621|NCT01027650|54610021|FG002|Overall Study|Lack of Efficacy|0|||
27952622|NCT01027650|54610022|FG003|Overall Study|Lack of Efficacy|0|||
27952623|NCT01027650|54610023|FG004|Overall Study|Lack of Efficacy|0|||
27952624|NCT01027650|54610024|FG005|Overall Study|Lack of Efficacy|1|||
27952625|NCT01027650|54610025|FG006|Overall Study|Lack of Efficacy|0|||
27952626|NCT01027650|54610026|FG007|Overall Study|Lack of Efficacy|0|||
27952627|NCT01106027|54610044|FG000|Overall Study|Lost graft early, discontinued|1|||
27952628|NCT00927927|54610063|FG000|Overall Study|Withdrawal by Subject|0|||
27952629|NCT00927927|54610064|FG001|Overall Study|Withdrawal by Subject|0|||
27952630|NCT00927927|54610065|FG002|Overall Study|Withdrawal by Subject|0|||
27952631|NCT00927927|54610066|FG003|Overall Study|Withdrawal by Subject|0|||
27952632|NCT00927927|54610067|FG004|Overall Study|Withdrawal by Subject|0|||
27952633|NCT00927927|54610068|FG005|Overall Study|Withdrawal by Subject|0|||
27952634|NCT00927927|54610069|FG006|Overall Study|Withdrawal by Subject|0|||
27952635|NCT00927927|54610070|FG007|Overall Study|Withdrawal by Subject|2|||
27952636|NCT00927927|54610071|FG008|Overall Study|Withdrawal by Subject|0|||
27952637|NCT00927927|54610072|FG009|Overall Study|Withdrawal by Subject|0|||
27952638|NCT00927927|54610073|FG010|Overall Study|Withdrawal by Subject|0|||
27952639|NCT00927927|54610074|FG011|Overall Study|Withdrawal by Subject|2|||
27952640|NCT00927927|54610075|FG012|Overall Study|Withdrawal by Subject|0|||
28081348|NCT01194570|54734681|FG001|Overall Study|Physician Decision|6|||
27952641|NCT00927927|54610076|FG013|Overall Study|Withdrawal by Subject|0|||
27952642|NCT00927927|54610077|FG014|Overall Study|Withdrawal by Subject|0|||
27952643|NCT01027416|54610111|FG000|Overall Study|Withdrawal by Subject|0|||
27952644|NCT01027416|54610112|FG001|Overall Study|Withdrawal by Subject|1|||
27952645|NCT01027416|54610111|FG000|Overall Study|Physician Decision|1|||
27952646|NCT01027416|54610112|FG001|Overall Study|Physician Decision|4|||
27952647|NCT00923559|54610120|FG000|Overall Study|Lost to Follow-up|2|||
27952648|NCT00923559|54610121|FG001|Overall Study|Lost to Follow-up|3|||
27952649|NCT01015638|54610131|FG000|Overall Study|Withdrawal by Subject|1|||
27952650|NCT01015638|54610132|FG001|Overall Study|Withdrawal by Subject|0|||
27952651|NCT01022502|54610138|FG000|Overall Study|Adverse Event|1|||
27952652|NCT01022502|54610138|FG000|Overall Study|employment related reasons|1|||
27952653|NCT01022502|54610138|FG000|Overall Study|Withdrawal by Subject|1|||
27952654|NCT01105091|54610146|FG000|Overall Study|Death|2|||
27952655|NCT01105091|54610147|FG001|Overall Study|Death|0|||
27952656|NCT00924729|54610157|FG000|Overall Study|insufficient volume for analysis|1|||
27952657|NCT00924729|54610158|FG001|Overall Study|insufficient volume for analysis|0|||
27952658|NCT00924729|54610157|FG000|Overall Study|Protocol Violation|1|||
27952659|NCT00924729|54610158|FG001|Overall Study|Protocol Violation|0|||
27952660|NCT01099709|54610166|FG000|Period 1|Withdrawal by Subject|0|||
27952661|NCT01099709|54610167|FG001|Period 1|Withdrawal by Subject|1|||
27952662|NCT01099709|54610166|FG000|Period 1|Positive cotinine test|0|||
27952663|NCT01099709|54610167|FG001|Period 1|Positive cotinine test|1|||
27952664|NCT01099709|54610166|FG000|Period 1|Adverse Event|1|||
27952665|NCT01099709|54610167|FG001|Period 1|Adverse Event|0|||
27952666|NCT01099397|54610174|FG000|Overall Study|Lost to Follow-up|4|||
27952667|NCT01099397|54610174|FG000|Overall Study|Protocol Violation|4|||
27952668|NCT01099397|54610174|FG000|Overall Study|Withdrawal by Subject|5|||
27952669|NCT01022424|54610179|FG000|Overall Study|Adverse Event|1|||
27952670|NCT01022424|54610179|FG000|Overall Study|Physician Decision|1|||
27952671|NCT01022424|54610179|FG000|Overall Study|eGFR under the withdrawal criteria|2|||
27952672|NCT01098851|54610189|FG000|Overall Study|Equipment failure|1|||
27952673|NCT01098851|54610190|FG001|Overall Study|Equipment failure|0|||
27952674|NCT01026948|54610196|FG000|Overall Study|Physician Decision|8|||
27952675|NCT01104779|54610204|FG000|Overall Study|Protocol Violation|1|||
27952676|NCT01104779|54610205|FG001|Overall Study|Protocol Violation|2|||
27952677|NCT01104779|54610206|FG002|Overall Study|Protocol Violation|2|||
27952678|NCT01104779|54610204|FG000|Overall Study|Lack of Efficacy|26|||
27952679|NCT01104779|54610205|FG001|Overall Study|Lack of Efficacy|12|||
27952680|NCT01104779|54610206|FG002|Overall Study|Lack of Efficacy|13|||
27952681|NCT01104779|54610204|FG000|Overall Study|Adverse Event|13|||
27952682|NCT01104779|54610205|FG001|Overall Study|Adverse Event|14|||
27952683|NCT01104779|54610206|FG002|Overall Study|Adverse Event|13|||
27952684|NCT01104779|54610204|FG000|Overall Study|Did not meet inc/exc criteria|1|||
27952685|NCT01104779|54610205|FG001|Overall Study|Did not meet inc/exc criteria|1|||
27952686|NCT01104779|54610206|FG002|Overall Study|Did not meet inc/exc criteria|1|||
27952687|NCT01104779|54610204|FG000|Overall Study|Other reasons|0|||
27952688|NCT01104779|54610205|FG001|Overall Study|Other reasons|1|||
27952689|NCT01104779|54610206|FG002|Overall Study|Other reasons|0|||
27952690|NCT01104779|54610204|FG000|Overall Study|Lost to Follow-up|2|||
27952691|NCT01104779|54610205|FG001|Overall Study|Lost to Follow-up|0|||
27952692|NCT01104779|54610206|FG002|Overall Study|Lost to Follow-up|1|||
27952693|NCT01104779|54610204|FG000|Overall Study|Withdrawal by Subject|16|||
27952694|NCT01104779|54610205|FG001|Overall Study|Withdrawal by Subject|25|||
27952695|NCT01104779|54610206|FG002|Overall Study|Withdrawal by Subject|32|||
27952696|NCT00918957|54610216|FG000|Overall Study|Adverse Event|2|||
27952697|NCT00918957|54610217|FG001|Overall Study|Adverse Event|0|||
28081349|NCT01194570|54734680|FG000|Overall Study|Reason not specified|13|||
28081350|NCT01194570|54734681|FG001|Overall Study|Reason not specified|20|||
28081351|NCT01194570|54734680|FG000|Overall Study|Protocol Violation|0|||
28081352|NCT01194570|54734681|FG001|Overall Study|Protocol Violation|2|||
28081353|NCT01194570|54734680|FG000|Overall Study|Non-compliance with study drug|2|||
28081354|NCT01194570|54734681|FG001|Overall Study|Non-compliance with study drug|2|||
28081355|NCT01194570|54734680|FG000|Overall Study|Adverse Event|12|||
28164992|NCT02991859|54835669|FG015|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
28164993|NCT02991859|54835670|FG016|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
28164994|NCT02991859|54835654|FG000|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
28164995|NCT02991859|54835655|FG001|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
28164996|NCT02991859|54835656|FG002|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
27731958|NCT00103285|54179448|FG006|Induction|Other|0|||
27952698|NCT00918957|54610216|FG000|Overall Study|Withdrawal by Subject|1|||
28081356|NCT01194570|54734681|FG001|Overall Study|Adverse Event|18|||
28081357|NCT01194570|54734680|FG000|Overall Study|Non-compliance|2|||
27731959|NCT00103285|54179449|FG007|Induction|Other|0|||
27952699|NCT00918957|54610217|FG001|Overall Study|Withdrawal by Subject|0|||
27952700|NCT01022268|54610225|FG000|Overall Study|Withdrawal by Subject|1|||
27952701|NCT01022268|54610226|FG001|Overall Study|Withdrawal by Subject|0|||
27952702|NCT01022268|54610225|FG000|Overall Study|Withdrawal by Subject|1|||
27952703|NCT01022268|54610226|FG001|Overall Study|Withdrawal by Subject|0|||
27952704|NCT01015560|54610232|FG000|Overall Study|Adverse Event|1|||
27952705|NCT01015560|54610232|FG000|Overall Study|Not protocol specified|1|||
27952706|NCT01015560|54610232|FG000|Overall Study|Withdrawal by Subject|1|||
27952707|NCT00918879|54610238|FG000|Overall Study|Withdrawal by Subject|4|||
27952708|NCT00918879|54610239|FG001|Overall Study|Withdrawal by Subject|4|||
27952709|NCT00918879|54610238|FG000|Overall Study|Lost to Follow-up|1|||
27952710|NCT00918879|54610239|FG001|Overall Study|Lost to Follow-up|1|||
27952711|NCT00918879|54610238|FG000|Overall Study|Severe non-compliance to protocol|1|||
27952712|NCT00918879|54610239|FG001|Overall Study|Severe non-compliance to protocol|1|||
27952713|NCT01026792|54610245|FG000|Overall Study|Protocol Violation|1|||
27952714|NCT01026324|54610252|FG000|Follow up/Survival|Withdrawal by Subject|1|||
27952715|NCT01026324|54610253|FG001|Follow up/Survival|Withdrawal by Subject|0|||
27952716|NCT01026324|54610254|FG002|Follow up/Survival|Withdrawal by Subject|0|||
27952717|NCT01098539|54610265|FG000|Overall Study|Adverse Event|26|||
27952718|NCT01098539|54610266|FG001|Overall Study|Adverse Event|26|||
27952719|NCT01098539|54610265|FG000|Overall Study|Protocol Violation|1|||
27952720|NCT01098539|54610266|FG001|Overall Study|Protocol Violation|4|||
27952721|NCT01098539|54610265|FG000|Overall Study|Noncompliance|3|||
27952722|NCT01098539|54610266|FG001|Overall Study|Noncompliance|5|||
27952723|NCT01098539|54610265|FG000|Overall Study|Lost to Follow-up|4|||
27952724|NCT01098539|54610266|FG001|Overall Study|Lost to Follow-up|4|||
27952725|NCT01098539|54610265|FG000|Overall Study|Withdrawal by Subject|12|||
27952726|NCT01098539|54610266|FG001|Overall Study|Withdrawal by Subject|26|||
27952727|NCT01098539|54610265|FG000|Overall Study|Physician Decision|5|||
27952728|NCT01098539|54610266|FG001|Overall Study|Physician Decision|3|||
27952729|NCT01098461|54610276|FG000|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10|||
27952730|NCT01098461|54610277|FG001|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2|||
27952731|NCT01098461|54610278|FG002|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
27952732|NCT01098461|54610279|FG003|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
27952733|NCT01098461|54610276|FG000|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
27952734|NCT01098461|54610277|FG001|Treatment Period (TP) (16 Weeks)|Adverse Event|2|||
27952735|NCT01098461|54610278|FG002|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
27952736|NCT01098461|54610279|FG003|Treatment Period (TP) (16 Weeks)|Adverse Event|3|||
27952737|NCT01098461|54610276|FG000|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1|||
27952738|NCT01098461|54610277|FG001|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2|||
27952739|NCT01098461|54610278|FG002|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
27952740|NCT01098461|54610279|FG003|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
27952741|NCT01098461|54610276|FG000|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
27952742|NCT01098461|54610277|FG001|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1|||
27952743|NCT01098461|54610278|FG002|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
27952744|NCT01098461|54610279|FG003|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
27952745|NCT01098461|54610276|FG000|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
27952746|NCT01098461|54610277|FG001|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1|||
27952747|NCT01098461|54610278|FG002|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
27952748|NCT01098461|54610279|FG003|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
27952749|NCT01098461|54610276|FG000|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
27952750|NCT01098461|54610277|FG001|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1|||
27952751|NCT01098461|54610278|FG002|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
27952752|NCT01098461|54610279|FG003|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
27952753|NCT01098461|54610276|FG000|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
27952754|NCT01098461|54610277|FG001|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
27952755|NCT01098461|54610278|FG002|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
27952756|NCT01098461|54610279|FG003|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
27952757|NCT01098305|54610292|FG000|Overall Study|Lost to Follow-up|31|||
27952758|NCT01098305|54610293|FG001|Overall Study|Lost to Follow-up|33|||
27952759|NCT00833833|54610305|FG000|Phase 1 (as of 01 April 2011)|Still active in study|0|||
27952760|NCT00833833|54610306|FG001|Phase 1 (as of 01 April 2011)|Still active in study|0|||
27952761|NCT00833833|54610307|FG002|Phase 1 (as of 01 April 2011)|Still active in study|2|||
27952762|NCT00833833|54610308|FG003|Phase 1 (as of 01 April 2011)|Still active in study|2|||
27952763|NCT00833833|54610309|FG004|Phase 1 (as of 01 April 2011)|Still active in study|0|||
27952764|NCT00833833|54610310|FG005|Phase 1 (as of 01 April 2011)|Still active in study|0|||
27952765|NCT00833833|54610305|FG000|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
27952766|NCT00833833|54610306|FG001|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
27952767|NCT00833833|54610307|FG002|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
27952768|NCT00833833|54610308|FG003|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
27952769|NCT00833833|54610309|FG004|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
27952770|NCT00833833|54610310|FG005|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
27952771|NCT00833833|54610305|FG000|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
27952772|NCT00833833|54610306|FG001|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
28081358|NCT01194570|54734681|FG001|Overall Study|Non-compliance|2|||
27952773|NCT00833833|54610307|FG002|Phase 1 (as of 01 April 2011)|Adverse Event|2|||
27952774|NCT00833833|54610308|FG003|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
27952775|NCT00833833|54610309|FG004|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
27952776|NCT00833833|54610310|FG005|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
27952777|NCT00833833|54610305|FG000|Phase 1 (as of 01 April 2011)|Death|0|||
27952778|NCT00833833|54610306|FG001|Phase 1 (as of 01 April 2011)|Death|1|||
27952779|NCT00833833|54610307|FG002|Phase 1 (as of 01 April 2011)|Death|2|||
27952780|NCT00833833|54610308|FG003|Phase 1 (as of 01 April 2011)|Death|0|||
27952781|NCT00833833|54610309|FG004|Phase 1 (as of 01 April 2011)|Death|0|||
27952782|NCT00833833|54610310|FG005|Phase 1 (as of 01 April 2011)|Death|0|||
27952783|NCT00833833|54610305|FG000|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
27952784|NCT00833833|54610306|FG001|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
27952785|NCT00833833|54610307|FG002|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
27952786|NCT00833833|54610308|FG003|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
27952787|NCT00833833|54610309|FG004|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
27952788|NCT00833833|54610310|FG005|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
27952789|NCT00833833|54610305|FG000|Phase 1 (as of 01 April 2011)|Other|1|||
27952790|NCT00833833|54610306|FG001|Phase 1 (as of 01 April 2011)|Other|3|||
27952791|NCT00833833|54610307|FG002|Phase 1 (as of 01 April 2011)|Other|0|||
27952792|NCT00833833|54610308|FG003|Phase 1 (as of 01 April 2011)|Other|1|||
27952793|NCT00833833|54610309|FG004|Phase 1 (as of 01 April 2011)|Other|0|||
27952794|NCT00833833|54610310|FG005|Phase 1 (as of 01 April 2011)|Other|0|||
27952795|NCT00833833|54610305|FG000|Phase 2 (as of 01 April 2011)|Still active in study|0|||
27952796|NCT00833833|54610306|FG001|Phase 2 (as of 01 April 2011)|Still active in study|0|||
27952797|NCT00833833|54610307|FG002|Phase 2 (as of 01 April 2011)|Still active in study|0|||
27952798|NCT00833833|54610308|FG003|Phase 2 (as of 01 April 2011)|Still active in study|0|||
27952799|NCT00833833|54610309|FG004|Phase 2 (as of 01 April 2011)|Still active in study|23|||
27952800|NCT00833833|54610310|FG005|Phase 2 (as of 01 April 2011)|Still active in study|22|||
27952801|NCT00833833|54610305|FG000|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
27952802|NCT00833833|54610306|FG001|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
27952803|NCT00833833|54610307|FG002|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
27952804|NCT00833833|54610308|FG003|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
27952805|NCT00833833|54610309|FG004|Phase 2 (as of 01 April 2011)|Adverse Event|8|||
27952806|NCT00833833|54610310|FG005|Phase 2 (as of 01 April 2011)|Adverse Event|13|||
27952807|NCT00833833|54610305|FG000|Phase 2 (as of 01 April 2011)|Death|0|||
27952808|NCT00833833|54610306|FG001|Phase 2 (as of 01 April 2011)|Death|0|||
27952809|NCT00833833|54610307|FG002|Phase 2 (as of 01 April 2011)|Death|0|||
27952810|NCT00833833|54610308|FG003|Phase 2 (as of 01 April 2011)|Death|0|||
27952811|NCT00833833|54610309|FG004|Phase 2 (as of 01 April 2011)|Death|8|||
27952812|NCT00833833|54610310|FG005|Phase 2 (as of 01 April 2011)|Death|9|||
27952813|NCT00833833|54610305|FG000|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
27952814|NCT00833833|54610306|FG001|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
27952815|NCT00833833|54610307|FG002|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
27952816|NCT00833833|54610308|FG003|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
27952817|NCT00833833|54610309|FG004|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7|||
27952818|NCT00833833|54610310|FG005|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6|||
27952819|NCT00833833|54610305|FG000|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
27952820|NCT00833833|54610306|FG001|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
27952821|NCT00833833|54610307|FG002|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
27952822|NCT00833833|54610308|FG003|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
27952823|NCT00833833|54610309|FG004|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5|||
28081359|NCT01194570|54734680|FG000|Overall Study|Lack of Efficacy|27|||
28081360|NCT01194570|54734681|FG001|Overall Study|Lack of Efficacy|21|||
28081361|NCT01194570|54734680|FG000|Overall Study|Withdrawal by Subject|21|||
28081362|NCT01194570|54734681|FG001|Overall Study|Withdrawal by Subject|22|||
28081363|NCT01194570|54734680|FG000|Overall Study|Pregnancy|1|||
28081364|NCT01194570|54734681|FG001|Overall Study|Pregnancy|1|||
28081365|NCT01194570|54734680|FG000|Overall Study|Lost to Follow-up|1|||
28081366|NCT01194570|54734681|FG001|Overall Study|Lost to Follow-up|4|||
28081367|NCT04881747|54734707|FG000|Period 2 Washout|Adverse Event|1|||
28081368|NCT04881747|54734708|FG001|Period 2 Washout|Adverse Event|0|||
28081369|NCT04881747|54734709|FG002|Period 2 Washout|Adverse Event|0|||
27952824|NCT00833833|54610310|FG005|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7|||
27952825|NCT00833833|54610305|FG000|Phase 2 (as of 01 April 2011)|Other|0|||
27952826|NCT00833833|54610306|FG001|Phase 2 (as of 01 April 2011)|Other|0|||
27952827|NCT00833833|54610307|FG002|Phase 2 (as of 01 April 2011)|Other|0|||
27952828|NCT00833833|54610308|FG003|Phase 2 (as of 01 April 2011)|Other|0|||
27952829|NCT00833833|54610309|FG004|Phase 2 (as of 01 April 2011)|Other|4|||
28081370|NCT04881747|54734710|FG003|Period 2 Washout|Adverse Event|0|||
28081371|NCT04881747|54734711|FG004|Period 2 Washout|Adverse Event|1|||
28081372|NCT04881747|54734712|FG005|Period 2 Washout|Adverse Event|0|||
27832276|NCT01775501|54311123|FG000|Overall Study|Discontinued prior to treatment|1|||
28081373|NCT04881747|54734707|FG000|Period 2 Washout|Withdrawal by Subject|1|||
28081374|NCT04881747|54734708|FG001|Period 2 Washout|Withdrawal by Subject|0|||
27832277|NCT01775189|54311152|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
28081375|NCT04881747|54734709|FG002|Period 2 Washout|Withdrawal by Subject|0|||
28081376|NCT04881747|54734710|FG003|Period 2 Washout|Withdrawal by Subject|1|||
28081377|NCT04881747|54734711|FG004|Period 2 Washout|Withdrawal by Subject|0|||
28081378|NCT04881747|54734712|FG005|Period 2 Washout|Withdrawal by Subject|0|||
28081379|NCT04795622|54734722|FG000|Overall Study|Adverse Event|1|||
28081380|NCT04795622|54734723|FG001|Overall Study|Adverse Event|0|||
28081381|NCT04795622|54734722|FG000|Overall Study|Withdrawal by Subject|3|||
28081382|NCT04795622|54734723|FG001|Overall Study|Withdrawal by Subject|3|||
28081383|NCT04795622|54734722|FG000|Overall Study|Protocol Violation|0|||
28081384|NCT04795622|54734723|FG001|Overall Study|Protocol Violation|2|||
28081385|NCT04795622|54734722|FG000|Overall Study|Lost to Follow-up|2|||
28081386|NCT04795622|54734723|FG001|Overall Study|Lost to Follow-up|3|||
28081387|NCT04795622|54734722|FG000|Overall Study|Other|7|||
28081388|NCT04795622|54734723|FG001|Overall Study|Other|8|||
28081389|NCT04652245|54734744|FG000|Wash-Out Period|Adverse Event|0|||
28081390|NCT04652245|54734745|FG001|Wash-Out Period|Adverse Event|2|||
28081391|NCT04652245|54734744|FG000|Wash-Out Period|Withdrawal by Subject|0|||
28081392|NCT04652245|54734745|FG001|Wash-Out Period|Withdrawal by Subject|2|||
28081393|NCT04405739|54734762|FG000|Overall Study|Adverse Event|0|||
28081394|NCT04405739|54734763|FG001|Overall Study|Adverse Event|1|||
28081395|NCT04405739|54734764|FG002|Overall Study|Adverse Event|0|||
28081396|NCT04405739|54734765|FG003|Overall Study|Adverse Event|0|||
28081397|NCT04405739|54734762|FG000|Overall Study|Lost to Follow-up|0|||
28081398|NCT04405739|54734763|FG001|Overall Study|Lost to Follow-up|2|||
28081399|NCT04405739|54734764|FG002|Overall Study|Lost to Follow-up|1|||
28081400|NCT04405739|54734765|FG003|Overall Study|Lost to Follow-up|3|||
28081401|NCT04405739|54734762|FG000|Overall Study|Withdrawal by Subject|0|||
28081402|NCT04405739|54734763|FG001|Overall Study|Withdrawal by Subject|2|||
28081403|NCT04405739|54734764|FG002|Overall Study|Withdrawal by Subject|1|||
28081404|NCT04405739|54734765|FG003|Overall Study|Withdrawal by Subject|1|||
28081405|NCT04405739|54734762|FG000|Overall Study|Death|0|||
28081406|NCT04405739|54734763|FG001|Overall Study|Death|0|||
28081407|NCT04405739|54734764|FG002|Overall Study|Death|1|||
28081408|NCT04405739|54734765|FG003|Overall Study|Death|0|||
28081409|NCT04405739|54734762|FG000|Overall Study|Transferred to rehab|0|||
28081410|NCT04405739|54734763|FG001|Overall Study|Transferred to rehab|0|||
28081411|NCT04405739|54734764|FG002|Overall Study|Transferred to rehab|0|||
28081412|NCT04405739|54734765|FG003|Overall Study|Transferred to rehab|1|||
28081413|NCT04405739|54734762|FG000|Overall Study|Pt. refused IP after 1 dose|0|||
28081414|NCT04405739|54734763|FG001|Overall Study|Pt. refused IP after 1 dose|0|||
28081415|NCT04405739|54734764|FG002|Overall Study|Pt. refused IP after 1 dose|0|||
28081416|NCT04405739|54734765|FG003|Overall Study|Pt. refused IP after 1 dose|1|||
28164997|NCT02991859|54835657|FG003|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
28164998|NCT02991859|54835658|FG004|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
28164999|NCT02991859|54835659|FG005|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
28165000|NCT02991859|54835660|FG006|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
28165001|NCT02991859|54835661|FG007|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
28165002|NCT02991859|54835662|FG008|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
28165003|NCT02991859|54835663|FG009|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
28165004|NCT02991859|54835664|FG010|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
28165005|NCT02991859|54835665|FG011|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
28165006|NCT02991859|54835666|FG012|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
28165007|NCT02991859|54835667|FG013|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
28165008|NCT02991859|54835668|FG014|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
28165009|NCT02991859|54835669|FG015|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
28165010|NCT02991859|54835670|FG016|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
28165011|NCT02991859|54835654|FG000|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
28165012|NCT02991859|54835655|FG001|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
28165013|NCT02991859|54835656|FG002|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
28165014|NCT02991859|54835657|FG003|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
28165015|NCT02991859|54835658|FG004|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
28165016|NCT02991859|54835659|FG005|Wash Out, Up to Day 77|Withdrawal by Subject|1|||
28165017|NCT02991859|54835660|FG006|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
28165018|NCT02991859|54835661|FG007|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
28165019|NCT02991859|54835662|FG008|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
28165020|NCT02991859|54835663|FG009|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
28165021|NCT02991859|54835664|FG010|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
28165022|NCT02991859|54835665|FG011|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
28165023|NCT02991859|54835666|FG012|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
28165024|NCT02991859|54835667|FG013|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
28165025|NCT02991859|54835668|FG014|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
28165026|NCT02991859|54835669|FG015|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
28165027|NCT02991859|54835670|FG016|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
28081417|NCT04954326|54734798|FG000|Overall Study|Protocol Violation|0|||
28081418|NCT04954326|54734799|FG001|Overall Study|Protocol Violation|1|||
28081419|NCT04954326|54734798|FG000|Overall Study|Death|0|||
28081420|NCT04954326|54734799|FG001|Overall Study|Death|2|||
28081421|NCT04954326|54734798|FG000|Overall Study|Physician Decision|0|||
28081422|NCT04954326|54734799|FG001|Overall Study|Physician Decision|1|||
28081423|NCT04914819|54734807|FG000|Overall Study|Pregnancy|3|||
28081424|NCT04914819|54734808|FG001|Overall Study|Pregnancy|1|||
28081425|NCT04914819|54734807|FG000|Overall Study|Discontinued study|4|||
28081426|NCT04914819|54734808|FG001|Overall Study|Discontinued study|1|||
28081427|NCT04914819|54734807|FG000|Overall Study|Lost to Follow-up|7|||
28081428|NCT04914819|54734808|FG001|Overall Study|Lost to Follow-up|0|||
28081429|NCT04818346|54734823|FG000|24-Week Placebo-Controlled Period|Adverse Event|1|||
28081430|NCT04818346|54734824|FG001|24-Week Placebo-Controlled Period|Adverse Event|2|||
28081431|NCT04818346|54734825|FG002|24-Week Placebo-Controlled Period|Adverse Event|0|||
28081432|NCT04818346|54734826|FG003|24-Week Placebo-Controlled Period|Adverse Event|3|||
28081433|NCT04818346|54734823|FG000|24-Week Placebo-Controlled Period|Lost to Follow-up|3|||
28081434|NCT04818346|54734824|FG001|24-Week Placebo-Controlled Period|Lost to Follow-up|2|||
28081435|NCT04818346|54734825|FG002|24-Week Placebo-Controlled Period|Lost to Follow-up|3|||
28081436|NCT04818346|54734826|FG003|24-Week Placebo-Controlled Period|Lost to Follow-up|1|||
28081437|NCT04818346|54734823|FG000|24-Week Placebo-Controlled Period|Physician Decision|1|||
28081438|NCT04818346|54734824|FG001|24-Week Placebo-Controlled Period|Physician Decision|0|||
28081439|NCT04818346|54734825|FG002|24-Week Placebo-Controlled Period|Physician Decision|0|||
28081440|NCT04818346|54734826|FG003|24-Week Placebo-Controlled Period|Physician Decision|0|||
28081441|NCT04818346|54734823|FG000|24-Week Placebo-Controlled Period|Protocol Violation|0|||
28081442|NCT04818346|54734824|FG001|24-Week Placebo-Controlled Period|Protocol Violation|0|||
28081443|NCT04818346|54734825|FG002|24-Week Placebo-Controlled Period|Protocol Violation|1|||
28081444|NCT04818346|54734826|FG003|24-Week Placebo-Controlled Period|Protocol Violation|1|||
28081445|NCT04818346|54734823|FG000|24-Week Placebo-Controlled Period|Withdrawal by Subject|1|||
28081446|NCT04818346|54734824|FG001|24-Week Placebo-Controlled Period|Withdrawal by Subject|1|||
28081447|NCT04818346|54734825|FG002|24-Week Placebo-Controlled Period|Withdrawal by Subject|6|||
28081448|NCT04818346|54734826|FG003|24-Week Placebo-Controlled Period|Withdrawal by Subject|2|||
28081449|NCT04818346|54734823|FG000|24-Week Placebo-Controlled Period|Subject Terminated by Sponsor|1|||
28081450|NCT04818346|54734824|FG001|24-Week Placebo-Controlled Period|Subject Terminated by Sponsor|0|||
28081451|NCT04818346|54734825|FG002|24-Week Placebo-Controlled Period|Subject Terminated by Sponsor|0|||
28081452|NCT04818346|54734826|FG003|24-Week Placebo-Controlled Period|Subject Terminated by Sponsor|0|||
28081453|NCT04818346|54734823|FG000|24-Week Placebo-Controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|1|||
28081454|NCT04818346|54734824|FG001|24-Week Placebo-Controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
28081455|NCT04818346|54734825|FG002|24-Week Placebo-Controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
28081456|NCT04818346|54734826|FG003|24-Week Placebo-Controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
28081457|NCT04818346|54734823|FG000|24-Week Placebo-Controlled Period|Use of Prohibited Concomitant Medication|0|||
28081458|NCT04818346|54734824|FG001|24-Week Placebo-Controlled Period|Use of Prohibited Concomitant Medication|0|||
28081459|NCT04818346|54734825|FG002|24-Week Placebo-Controlled Period|Use of Prohibited Concomitant Medication|1|||
28081460|NCT04818346|54734826|FG003|24-Week Placebo-Controlled Period|Use of Prohibited Concomitant Medication|0|||
27952830|NCT00833833|54610310|FG005|Phase 2 (as of 01 April 2011)|Other|3|||
27952831|NCT00833833|54610305|FG000|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
27952832|NCT00833833|54610306|FG001|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
27952833|NCT00833833|54610307|FG002|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
27952834|NCT00833833|54610308|FG003|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
27952835|NCT00833833|54610309|FG004|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
28081461|NCT04818346|54734823|FG000|24-Week Placebo-Controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
28081462|NCT04818346|54734824|FG001|24-Week Placebo-Controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
28081463|NCT04818346|54734825|FG002|24-Week Placebo-Controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
28081464|NCT04818346|54734826|FG003|24-Week Placebo-Controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|1|||
28081465|NCT04723394|54734838|FG000|Overall Study|Adverse Event|0|||
28081466|NCT04723394|54734839|FG001|Overall Study|Adverse Event|3|||
28081467|NCT04723394|54734838|FG000|Overall Study|Death|8|||
28081468|NCT04723394|54734839|FG001|Overall Study|Death|8|||
28081469|NCT04723394|54734838|FG000|Overall Study|Lost to Follow-up|20|||
28081470|NCT04723394|54734839|FG001|Overall Study|Lost to Follow-up|17|||
28081471|NCT04723394|54734838|FG000|Overall Study|Physician Decision|1|||
28081472|NCT04723394|54734839|FG001|Overall Study|Physician Decision|0|||
28081473|NCT04723394|54734838|FG000|Overall Study|Withdrawal by Subject|20|||
28081474|NCT04723394|54734839|FG001|Overall Study|Withdrawal by Subject|34|||
28081475|NCT04723394|54734838|FG000|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|0|||
28081476|NCT04723394|54734839|FG001|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|2|||
27952836|NCT00833833|54610310|FG005|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1|||
27952837|NCT01098071|54610330|FG000|Overall Study|Surgery (adenoidectomy)|2|||
27952838|NCT01098071|54610330|FG000|Overall Study|Lost to Follow-up|13|||
27952839|NCT01097057|54610334|FG000|Overall Study|Physician Decision|3|||
27952840|NCT01022112|54610343|FG000|Overall Study|Adverse Event|1|||
27952841|NCT01022112|54610344|FG001|Overall Study|Adverse Event|2|||
27952842|NCT01022112|54610345|FG002|Overall Study|Adverse Event|0|||
27952843|NCT01022112|54610346|FG003|Overall Study|Adverse Event|1|||
27952844|NCT01022112|54610347|FG004|Overall Study|Adverse Event|0|||
27952845|NCT01022112|54610343|FG000|Overall Study|Lack of Efficacy|1|||
27952846|NCT01022112|54610344|FG001|Overall Study|Lack of Efficacy|0|||
27952847|NCT01022112|54610345|FG002|Overall Study|Lack of Efficacy|0|||
27952848|NCT01022112|54610346|FG003|Overall Study|Lack of Efficacy|0|||
27952849|NCT01022112|54610347|FG004|Overall Study|Lack of Efficacy|1|||
27952850|NCT01022112|54610343|FG000|Overall Study|Physician Decision|0|||
27952851|NCT01022112|54610344|FG001|Overall Study|Physician Decision|0|||
27952852|NCT01022112|54610345|FG002|Overall Study|Physician Decision|1|||
27952853|NCT01022112|54610346|FG003|Overall Study|Physician Decision|0|||
27952854|NCT01022112|54610347|FG004|Overall Study|Physician Decision|1|||
27952855|NCT01022112|54610343|FG000|Overall Study|Withdrawal by Subject|0|||
27952856|NCT01022112|54610344|FG001|Overall Study|Withdrawal by Subject|1|||
27952857|NCT01022112|54610345|FG002|Overall Study|Withdrawal by Subject|2|||
27952858|NCT01022112|54610346|FG003|Overall Study|Withdrawal by Subject|2|||
27952859|NCT01022112|54610347|FG004|Overall Study|Withdrawal by Subject|1|||
27952860|NCT01022112|54610343|FG000|Overall Study|Fasting plasma glucose level increased|1|||
27952861|NCT01022112|54610344|FG001|Overall Study|Fasting plasma glucose level increased|0|||
27952862|NCT01022112|54610345|FG002|Overall Study|Fasting plasma glucose level increased|0|||
27952863|NCT01022112|54610346|FG003|Overall Study|Fasting plasma glucose level increased|0|||
28081477|NCT04696055|54734847|FG000|Overall Study|Adverse Event|10|||
28081478|NCT04696055|54734848|FG001|Overall Study|Adverse Event|0|||
28081479|NCT04696055|54734847|FG000|Overall Study|Death|2|||
28081480|NCT04696055|54734848|FG001|Overall Study|Death|1|||
28081481|NCT04696055|54734847|FG000|Overall Study|Other|4|||
28081482|NCT04696055|54734848|FG001|Overall Study|Other|0|||
28081483|NCT04696055|54734847|FG000|Overall Study|Physician Decision|1|||
28081484|NCT04696055|54734848|FG001|Overall Study|Physician Decision|0|||
28081485|NCT04696055|54734847|FG000|Overall Study|Progressive Disease - Clinical Progression|1|||
28081486|NCT04696055|54734848|FG001|Overall Study|Progressive Disease - Clinical Progression|1|||
28081487|NCT04696055|54734847|FG000|Overall Study|Progressive Disease - Radiological Progression|36|||
28081488|NCT04696055|54734848|FG001|Overall Study|Progressive Disease - Radiological Progression|13|||
28081489|NCT04696055|54734847|FG000|Overall Study|Subject Decision|1|||
28081490|NCT04696055|54734848|FG001|Overall Study|Subject Decision|2|||
28081491|NCT04696055|54734847|FG000|Overall Study|Ongoing with study treatment|13|||
28081492|NCT04696055|54734848|FG001|Overall Study|Ongoing with study treatment|10|||
28081493|NCT04478266|54734860|FG000|Overall Study|Adverse Event|17|||
28081494|NCT04478266|54734861|FG001|Overall Study|Adverse Event|18|||
28081495|NCT04478266|54734860|FG000|Overall Study|Progressive disease|99|||
28081496|NCT04478266|54734861|FG001|Overall Study|Progressive disease|118|||
28081497|NCT04478266|54734860|FG000|Overall Study|Poor compliance to protocol|1|||
28081498|NCT04478266|54734861|FG001|Overall Study|Poor compliance to protocol|0|||
28081499|NCT04478266|54734860|FG000|Overall Study|Withdrawal by Subject|14|||
28081500|NCT04478266|54734861|FG001|Overall Study|Withdrawal by Subject|16|||
28081501|NCT04478266|54734860|FG000|Overall Study|Other: unspecified|5|||
28081502|NCT04478266|54734861|FG001|Overall Study|Other: unspecified|4|||
28081503|NCT04478266|54734860|FG000|Overall Study|Randomized not treated|1|||
28081504|NCT04478266|54734861|FG001|Overall Study|Randomized not treated|1|||
28081505|NCT04478266|54734860|FG000|Overall Study|Ongoing|397|||
28081506|NCT04478266|54734861|FG001|Overall Study|Ongoing|377|||
28081507|NCT04409002|54734869|FG000|Overall Study|Disease progression prior to starting study treatment|3|||
28081508|NCT04325828|54734873|FG000|Overall Study|Ongoing|26|||
28081509|NCT04289363|54734879|FG000|Overall Study|Lost to Follow-up|14|||
27952864|NCT01022112|54610347|FG004|Overall Study|Fasting plasma glucose level increased|7|||
27952865|NCT01096667|54610364|FG000|Overall Study|Lost to Follow-up|1|||
27952866|NCT01096667|54610365|FG001|Overall Study|Lost to Follow-up|1|||
27952867|NCT01096667|54610366|FG002|Overall Study|Lost to Follow-up|1|||
27952868|NCT01096667|54610367|FG003|Overall Study|Lost to Follow-up|0|||
27952869|NCT01096667|54610368|FG004|Overall Study|Lost to Follow-up|0|||
27952870|NCT01096667|54610364|FG000|Overall Study|Withdrawal by Subject|1|||
27952871|NCT01096667|54610365|FG001|Overall Study|Withdrawal by Subject|0|||
27952872|NCT01096667|54610366|FG002|Overall Study|Withdrawal by Subject|0|||
27952873|NCT01096667|54610367|FG003|Overall Study|Withdrawal by Subject|1|||
28081510|NCT04289363|54734880|FG001|Overall Study|Lost to Follow-up|0|||
28081511|NCT04235959|54734889|FG000|Overall Study|Protocol Violation|0|||
28081512|NCT04235959|54734890|FG001|Overall Study|Protocol Violation|1|||
28081513|NCT04235959|54734891|FG002|Overall Study|Protocol Violation|0|||
27952874|NCT01096667|54610368|FG004|Overall Study|Withdrawal by Subject|0|||
28081514|NCT04235959|54734889|FG000|Overall Study|Adverse Event|1|||
27952875|NCT01096667|54610364|FG000|Overall Study|Reason not available|0|||
27952876|NCT01096667|54610365|FG001|Overall Study|Reason not available|1|||
27952877|NCT01096667|54610366|FG002|Overall Study|Reason not available|1|||
27952878|NCT01096667|54610367|FG003|Overall Study|Reason not available|1|||
27952879|NCT01096667|54610368|FG004|Overall Study|Reason not available|0|||
27952880|NCT01096667|54610364|FG000|Overall Study|Protocol Violation|0|||
27952881|NCT01096667|54610365|FG001|Overall Study|Protocol Violation|0|||
27952882|NCT01096667|54610366|FG002|Overall Study|Protocol Violation|0|||
27952883|NCT01096667|54610367|FG003|Overall Study|Protocol Violation|1|||
27952884|NCT01096667|54610368|FG004|Overall Study|Protocol Violation|0|||
27952885|NCT01096667|54610364|FG000|Overall Study|Not treated|1|||
27952886|NCT01096667|54610365|FG001|Overall Study|Not treated|0|||
27952887|NCT01096667|54610366|FG002|Overall Study|Not treated|0|||
27952888|NCT01096667|54610367|FG003|Overall Study|Not treated|0|||
27952889|NCT01096667|54610368|FG004|Overall Study|Not treated|0|||
27952890|NCT01014624|54610383|FG000|Overall Study|Adverse Event|0|||
27952891|NCT01014624|54610384|FG001|Overall Study|Adverse Event|1|||
27952892|NCT01014624|54610383|FG000|Overall Study|Protocol Violation|1|||
27952893|NCT01014624|54610384|FG001|Overall Study|Protocol Violation|0|||
27952894|NCT01014624|54610383|FG000|Overall Study|Withdrawal by Subject|1|||
27952895|NCT01014624|54610384|FG001|Overall Study|Withdrawal by Subject|0|||
27952896|NCT01021878|54610394|FG000|Overall Study|Lost to Follow-up|4|||
27952897|NCT01021878|54610395|FG001|Overall Study|Lost to Follow-up|3|||
27952898|NCT01021878|54610394|FG000|Overall Study|Death|0|||
27952899|NCT01021878|54610395|FG001|Overall Study|Death|1|||
27952900|NCT01021878|54610394|FG000|Overall Study|Adverse Event|6|||
27952901|NCT01021878|54610395|FG001|Overall Study|Adverse Event|5|||
27952902|NCT01021878|54610394|FG000|Overall Study|Transplantation|6|||
27952903|NCT01021878|54610395|FG001|Overall Study|Transplantation|1|||
27952904|NCT00854113|54610415|FG000|Overall Study|Adverse Event|0|||
27952905|NCT00854113|54610416|FG001|Overall Study|Adverse Event|0|||
27952906|NCT00854113|54610417|FG002|Overall Study|Adverse Event|0|||
27952907|NCT00854113|54610418|FG003|Overall Study|Adverse Event|0|||
27952908|NCT00854113|54610419|FG004|Overall Study|Adverse Event|0|||
27952909|NCT00854113|54610420|FG005|Overall Study|Adverse Event|0|||
27952910|NCT00854113|54610421|FG006|Overall Study|Adverse Event|0|||
27952911|NCT00854113|54610422|FG007|Overall Study|Adverse Event|2|||
27952912|NCT00854113|54610423|FG008|Overall Study|Adverse Event|0|||
27952913|NCT00854113|54610424|FG009|Overall Study|Adverse Event|0|||
27952914|NCT00854113|54610425|FG010|Overall Study|Adverse Event|0|||
27952915|NCT00854113|54610415|FG000|Overall Study|Withdrawal by Subject|0|||
27952916|NCT00854113|54610416|FG001|Overall Study|Withdrawal by Subject|0|||
27952917|NCT00854113|54610417|FG002|Overall Study|Withdrawal by Subject|0|||
27952918|NCT00854113|54610418|FG003|Overall Study|Withdrawal by Subject|0|||
27952919|NCT00854113|54610419|FG004|Overall Study|Withdrawal by Subject|0|||
27952920|NCT00854113|54610420|FG005|Overall Study|Withdrawal by Subject|0|||
27952921|NCT00854113|54610421|FG006|Overall Study|Withdrawal by Subject|0|||
27952922|NCT00854113|54610422|FG007|Overall Study|Withdrawal by Subject|1|||
27952923|NCT00854113|54610423|FG008|Overall Study|Withdrawal by Subject|1|||
27952924|NCT00854113|54610424|FG009|Overall Study|Withdrawal by Subject|0|||
27952925|NCT00854113|54610425|FG010|Overall Study|Withdrawal by Subject|0|||
27952926|NCT00845845|54610451|FG000|Overall Study|Lost to Follow-up|0|||
27952927|NCT00845845|54610452|FG001|Overall Study|Lost to Follow-up|4|||
27952928|NCT01104701|54610462|FG000|Overall Study|Withdrawal by Subject|0|||
27952929|NCT01104701|54610463|FG001|Overall Study|Withdrawal by Subject|1|||
27952930|NCT01104701|54610464|FG002|Overall Study|Withdrawal by Subject|2|||
27952931|NCT01104701|54610465|FG003|Overall Study|Withdrawal by Subject|1|||
27731960|NCT00103285|54179442|FG000|Response Assignment|Adverse Event|0|||
27952932|NCT01104701|54610462|FG000|Overall Study|Adverse Event|0|||
27952933|NCT01104701|54610463|FG001|Overall Study|Adverse Event|0|||
27952934|NCT01104701|54610464|FG002|Overall Study|Adverse Event|0|||
27952935|NCT01104701|54610465|FG003|Overall Study|Adverse Event|1|||
27952936|NCT01104701|54610462|FG000|Overall Study|Physician Decision|0|||
27952937|NCT01104701|54610463|FG001|Overall Study|Physician Decision|2|||
27952938|NCT01104701|54610464|FG002|Overall Study|Physician Decision|0|||
27952939|NCT01104701|54610465|FG003|Overall Study|Physician Decision|0|||
27952940|NCT00833755|54610479|FG000|Overall Study|Physician Decision|4|||
27952941|NCT00833755|54610480|FG001|Overall Study|Physician Decision|4|||
27952942|NCT00833755|54610481|FG002|Overall Study|Physician Decision|2|||
27952943|NCT00833755|54610482|FG003|Overall Study|Physician Decision|6|||
27952944|NCT00833755|54610479|FG000|Overall Study|Subject had scheduling issues|0|||
27952945|NCT00833755|54610480|FG001|Overall Study|Subject had scheduling issues|1|||
27952946|NCT00833755|54610481|FG002|Overall Study|Subject had scheduling issues|0|||
27952947|NCT00833755|54610482|FG003|Overall Study|Subject had scheduling issues|0|||
27952948|NCT01021332|54610493|FG000|Overall Study|Not fulfilling incl./excl.criteria|5|||
27952949|NCT01021332|54610493|FG000|Overall Study|Adverse Event|43|||
27832278|NCT01775189|54311153|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
27952950|NCT01021332|54610493|FG000|Overall Study|Lack of Efficacy|19|||
27952951|NCT01021332|54610493|FG000|Overall Study|Withdrawal of Consent|23|||
27952952|NCT01021332|54610493|FG000|Overall Study|Lost to Follow-up|4|||
27952953|NCT01021332|54610493|FG000|Overall Study|Protocol Violation|9|||
27952954|NCT01021332|54610493|FG000|Overall Study|Miscellaneous|3|||
27952955|NCT00923091|54610507|FG000|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11|||
27952956|NCT00923091|54610508|FG001|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3|||
27952957|NCT00923091|54610509|FG002|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7|||
27952958|NCT00923091|54610510|FG003|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13|||
27952959|NCT00923091|54610511|FG004|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10|||
27952960|NCT00923091|54610512|FG005|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5|||
27952961|NCT00923091|54610513|FG006|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9|||
27952962|NCT00923091|54610514|FG007|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17|||
27952963|NCT00923091|54610515|FG008|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
27952964|NCT00923091|54610516|FG009|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
27952965|NCT00923091|54610517|FG010|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
27952966|NCT00923091|54610518|FG011|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
27952967|NCT00923091|54610519|FG012|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
27952968|NCT00923091|54610507|FG000|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4|||
27952969|NCT00923091|54610508|FG001|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
27952970|NCT00923091|54610509|FG002|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
27952971|NCT00923091|54610510|FG003|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8|||
27952972|NCT00923091|54610511|FG004|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7|||
27952973|NCT00923091|54610512|FG005|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
27952974|NCT00923091|54610513|FG006|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
27952975|NCT00923091|54610514|FG007|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
27952976|NCT00923091|54610515|FG008|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
27952977|NCT00923091|54610516|FG009|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
27952978|NCT00923091|54610517|FG010|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
27952979|NCT00923091|54610518|FG011|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
27952980|NCT00923091|54610519|FG012|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
27952981|NCT00923091|54610507|FG000|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
27952982|NCT00923091|54610508|FG001|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
27952983|NCT00923091|54610509|FG002|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
27952984|NCT00923091|54610510|FG003|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5|||
27952985|NCT00923091|54610511|FG004|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
28165028|NCT02991859|54835654|FG000|Wash Out, Up to Day 77|Lost to Follow-up|0|||
28165029|NCT02991859|54835655|FG001|Wash Out, Up to Day 77|Lost to Follow-up|0|||
28165030|NCT02991859|54835656|FG002|Wash Out, Up to Day 77|Lost to Follow-up|0|||
28165031|NCT02991859|54835657|FG003|Wash Out, Up to Day 77|Lost to Follow-up|0|||
28165032|NCT02991859|54835658|FG004|Wash Out, Up to Day 77|Lost to Follow-up|0|||
28165033|NCT02991859|54835659|FG005|Wash Out, Up to Day 77|Lost to Follow-up|0|||
28165034|NCT02991859|54835660|FG006|Wash Out, Up to Day 77|Lost to Follow-up|0|||
28165035|NCT02991859|54835661|FG007|Wash Out, Up to Day 77|Lost to Follow-up|0|||
27952986|NCT00923091|54610512|FG005|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2|||
27952987|NCT00923091|54610513|FG006|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
27952988|NCT00923091|54610514|FG007|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3|||
27952989|NCT00923091|54610515|FG008|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
27952990|NCT00923091|54610516|FG009|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
27952991|NCT00923091|54610517|FG010|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
27952992|NCT00923091|54610518|FG011|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
27952993|NCT00923091|54610519|FG012|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
27952994|NCT00923091|54610507|FG000|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
27952995|NCT00923091|54610508|FG001|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
27952996|NCT00923091|54610509|FG002|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
27952997|NCT00923091|54610510|FG003|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
27952998|NCT00923091|54610511|FG004|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
27952999|NCT00923091|54610512|FG005|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1|||
27953000|NCT00923091|54610513|FG006|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
27953001|NCT00923091|54610514|FG007|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
27953002|NCT00923091|54610515|FG008|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
27953003|NCT00923091|54610516|FG009|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
27953004|NCT00923091|54610517|FG010|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
27953005|NCT00923091|54610518|FG011|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
27953006|NCT00923091|54610519|FG012|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
27953007|NCT00923091|54610507|FG000|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
28165036|NCT02991859|54835662|FG008|Wash Out, Up to Day 77|Lost to Follow-up|0|||
28165037|NCT02991859|54835663|FG009|Wash Out, Up to Day 77|Lost to Follow-up|1|||
28165038|NCT02991859|54835664|FG010|Wash Out, Up to Day 77|Lost to Follow-up|0|||
27953008|NCT00923091|54610508|FG001|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
27953009|NCT00923091|54610509|FG002|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
27953010|NCT00923091|54610510|FG003|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
27953011|NCT00923091|54610511|FG004|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
27953012|NCT00923091|54610512|FG005|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
27953013|NCT00923091|54610513|FG006|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
27953014|NCT00923091|54610514|FG007|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
27953015|NCT00923091|54610515|FG008|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
27953016|NCT00923091|54610516|FG009|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
27953017|NCT00923091|54610517|FG010|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
27953018|NCT00923091|54610518|FG011|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
27953019|NCT00923091|54610519|FG012|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
27953020|NCT00923091|54610507|FG000|Period III (Single-Blind)|Adverse Event|5|||
27953021|NCT00923091|54610508|FG001|Period III (Single-Blind)|Adverse Event|0|||
27854943|NCT00246259|54373221|FG001|Overall Study|Withdrawal by Subject|1|||
27854944|NCT00246259|54373220|FG000|Overall Study|randomly assigned, not eligible for ITT|2|||
27953022|NCT00923091|54610509|FG002|Period III (Single-Blind)|Adverse Event|0|||
27953023|NCT00923091|54610510|FG003|Period III (Single-Blind)|Adverse Event|0|||
27953024|NCT00923091|54610511|FG004|Period III (Single-Blind)|Adverse Event|0|||
27953025|NCT00923091|54610512|FG005|Period III (Single-Blind)|Adverse Event|0|||
27953026|NCT00923091|54610513|FG006|Period III (Single-Blind)|Adverse Event|0|||
27953027|NCT00923091|54610514|FG007|Period III (Single-Blind)|Adverse Event|0|||
27953028|NCT00923091|54610515|FG008|Period III (Single-Blind)|Adverse Event|0|||
27953029|NCT00923091|54610516|FG009|Period III (Single-Blind)|Adverse Event|0|||
27953030|NCT00923091|54610517|FG010|Period III (Single-Blind)|Adverse Event|0|||
27953031|NCT00923091|54610518|FG011|Period III (Single-Blind)|Adverse Event|0|||
27953032|NCT00923091|54610519|FG012|Period III (Single-Blind)|Adverse Event|0|||
27953033|NCT00923091|54610507|FG000|Period III (Single-Blind)|Withdrawal by Subject|10|||
27953034|NCT00923091|54610508|FG001|Period III (Single-Blind)|Withdrawal by Subject|0|||
27953035|NCT00923091|54610509|FG002|Period III (Single-Blind)|Withdrawal by Subject|0|||
27953036|NCT00923091|54610510|FG003|Period III (Single-Blind)|Withdrawal by Subject|0|||
27953037|NCT00923091|54610511|FG004|Period III (Single-Blind)|Withdrawal by Subject|0|||
27953038|NCT00923091|54610512|FG005|Period III (Single-Blind)|Withdrawal by Subject|0|||
27953039|NCT00923091|54610513|FG006|Period III (Single-Blind)|Withdrawal by Subject|0|||
27953040|NCT00923091|54610514|FG007|Period III (Single-Blind)|Withdrawal by Subject|0|||
27953041|NCT00923091|54610515|FG008|Period III (Single-Blind)|Withdrawal by Subject|0|||
27953042|NCT00923091|54610516|FG009|Period III (Single-Blind)|Withdrawal by Subject|0|||
27953043|NCT00923091|54610517|FG010|Period III (Single-Blind)|Withdrawal by Subject|0|||
27953044|NCT00923091|54610518|FG011|Period III (Single-Blind)|Withdrawal by Subject|0|||
27953045|NCT00923091|54610519|FG012|Period III (Single-Blind)|Withdrawal by Subject|0|||
27953046|NCT00923091|54610507|FG000|Period III (Single-Blind)|Protocol Violation|3|||
27953047|NCT00923091|54610508|FG001|Period III (Single-Blind)|Protocol Violation|0|||
27953048|NCT00923091|54610509|FG002|Period III (Single-Blind)|Protocol Violation|0|||
27953049|NCT00923091|54610510|FG003|Period III (Single-Blind)|Protocol Violation|0|||
27953050|NCT00923091|54610511|FG004|Period III (Single-Blind)|Protocol Violation|0|||
27953051|NCT00923091|54610512|FG005|Period III (Single-Blind)|Protocol Violation|0|||
27953052|NCT00923091|54610513|FG006|Period III (Single-Blind)|Protocol Violation|0|||
27953053|NCT00923091|54610514|FG007|Period III (Single-Blind)|Protocol Violation|0|||
27953054|NCT00923091|54610515|FG008|Period III (Single-Blind)|Protocol Violation|0|||
27953055|NCT00923091|54610516|FG009|Period III (Single-Blind)|Protocol Violation|0|||
27854945|NCT00246259|54373221|FG001|Overall Study|randomly assigned, not eligible for ITT|6|||
27854946|NCT00246025|54373273|FG000|Overall Study|Adverse Event|7|||
27854947|NCT00246025|54373274|FG001|Overall Study|Adverse Event|9|||
27854948|NCT00246025|54373275|FG002|Overall Study|Adverse Event|9|||
27854949|NCT00246025|54373276|FG003|Overall Study|Adverse Event|10|||
27854950|NCT00246025|54373273|FG000|Overall Study|Withdrawal by Subject|3|||
27854951|NCT00246025|54373274|FG001|Overall Study|Withdrawal by Subject|0|||
27854952|NCT00246025|54373275|FG002|Overall Study|Withdrawal by Subject|1|||
27854953|NCT00246025|54373276|FG003|Overall Study|Withdrawal by Subject|2|||
27854954|NCT00246025|54373273|FG000|Overall Study|unsuitable medical history was found|0|||
27854955|NCT00246025|54373274|FG001|Overall Study|unsuitable medical history was found|0|||
27854956|NCT00246025|54373275|FG002|Overall Study|unsuitable medical history was found|0|||
27854957|NCT00246025|54373276|FG003|Overall Study|unsuitable medical history was found|1|||
27854958|NCT00245011|54373406|FG000|Overall Study|Lack of Efficacy|1|||
27854959|NCT00244855|54373425|FG000|Overall Study|Withdrawal by Subject|0|||
27854960|NCT00244855|54373426|FG001|Overall Study|Withdrawal by Subject|1|||
27953056|NCT00923091|54610517|FG010|Period III (Single-Blind)|Protocol Violation|0|||
27731961|NCT00103285|54179443|FG001|Response Assignment|Adverse Event|8|||
27854961|NCT00244621|54373456|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
27953057|NCT00923091|54610518|FG011|Period III (Single-Blind)|Protocol Violation|0|||
27953058|NCT00923091|54610519|FG012|Period III (Single-Blind)|Protocol Violation|0|||
27953059|NCT00923091|54610507|FG000|Period III (Single-Blind)|Lost to Follow-up|2|||
27953060|NCT00923091|54610508|FG001|Period III (Single-Blind)|Lost to Follow-up|0|||
27953061|NCT00923091|54610509|FG002|Period III (Single-Blind)|Lost to Follow-up|0|||
27953062|NCT00923091|54610510|FG003|Period III (Single-Blind)|Lost to Follow-up|0|||
27953063|NCT00923091|54610511|FG004|Period III (Single-Blind)|Lost to Follow-up|0|||
27953064|NCT00923091|54610512|FG005|Period III (Single-Blind)|Lost to Follow-up|0|||
27953065|NCT00923091|54610513|FG006|Period III (Single-Blind)|Lost to Follow-up|0|||
27953066|NCT00923091|54610514|FG007|Period III (Single-Blind)|Lost to Follow-up|0|||
27953067|NCT00923091|54610515|FG008|Period III (Single-Blind)|Lost to Follow-up|0|||
27953068|NCT00923091|54610516|FG009|Period III (Single-Blind)|Lost to Follow-up|0|||
27953069|NCT00923091|54610517|FG010|Period III (Single-Blind)|Lost to Follow-up|0|||
27953070|NCT00923091|54610518|FG011|Period III (Single-Blind)|Lost to Follow-up|0|||
27953071|NCT00923091|54610519|FG012|Period III (Single-Blind)|Lost to Follow-up|0|||
27953072|NCT00923091|54610507|FG000|Period IV (Double-Blind)|Adverse Event|2|||
27953073|NCT00923091|54610508|FG001|Period IV (Double-Blind)|Adverse Event|0|||
27953074|NCT00923091|54610509|FG002|Period IV (Double-Blind)|Adverse Event|0|||
27953075|NCT00923091|54610510|FG003|Period IV (Double-Blind)|Adverse Event|0|||
27953076|NCT00923091|54610511|FG004|Period IV (Double-Blind)|Adverse Event|0|||
27953077|NCT00923091|54610512|FG005|Period IV (Double-Blind)|Adverse Event|0|||
27953078|NCT00923091|54610513|FG006|Period IV (Double-Blind)|Adverse Event|0|||
27953079|NCT00923091|54610514|FG007|Period IV (Double-Blind)|Adverse Event|0|||
27953080|NCT00923091|54610515|FG008|Period IV (Double-Blind)|Adverse Event|0|||
27953081|NCT00923091|54610516|FG009|Period IV (Double-Blind)|Adverse Event|0|||
27953082|NCT00923091|54610517|FG010|Period IV (Double-Blind)|Adverse Event|0|||
27953083|NCT00923091|54610518|FG011|Period IV (Double-Blind)|Adverse Event|0|||
27953084|NCT00923091|54610519|FG012|Period IV (Double-Blind)|Adverse Event|0|||
27953085|NCT00923091|54610507|FG000|Period IV (Double-Blind)|Withdrawal by Subject|0|||
27953086|NCT00923091|54610508|FG001|Period IV (Double-Blind)|Withdrawal by Subject|1|||
27953087|NCT00923091|54610509|FG002|Period IV (Double-Blind)|Withdrawal by Subject|0|||
27953088|NCT00923091|54610510|FG003|Period IV (Double-Blind)|Withdrawal by Subject|0|||
27953089|NCT00923091|54610511|FG004|Period IV (Double-Blind)|Withdrawal by Subject|0|||
27953090|NCT00923091|54610512|FG005|Period IV (Double-Blind)|Withdrawal by Subject|0|||
27953091|NCT00923091|54610513|FG006|Period IV (Double-Blind)|Withdrawal by Subject|0|||
27953092|NCT00923091|54610514|FG007|Period IV (Double-Blind)|Withdrawal by Subject|0|||
27953093|NCT00923091|54610515|FG008|Period IV (Double-Blind)|Withdrawal by Subject|0|||
27953094|NCT00923091|54610516|FG009|Period IV (Double-Blind)|Withdrawal by Subject|0|||
27953095|NCT00923091|54610517|FG010|Period IV (Double-Blind)|Withdrawal by Subject|0|||
27953096|NCT00923091|54610518|FG011|Period IV (Double-Blind)|Withdrawal by Subject|0|||
27953097|NCT00923091|54610519|FG012|Period IV (Double-Blind)|Withdrawal by Subject|0|||
27953098|NCT00923091|54610507|FG000|Period IV (Double-Blind)|Protocol Violation|0|||
27953099|NCT00923091|54610508|FG001|Period IV (Double-Blind)|Protocol Violation|1|||
27953100|NCT00923091|54610509|FG002|Period IV (Double-Blind)|Protocol Violation|0|||
27953101|NCT00923091|54610510|FG003|Period IV (Double-Blind)|Protocol Violation|0|||
27953102|NCT00923091|54610511|FG004|Period IV (Double-Blind)|Protocol Violation|0|||
27953103|NCT00923091|54610512|FG005|Period IV (Double-Blind)|Protocol Violation|0|||
27953104|NCT00923091|54610513|FG006|Period IV (Double-Blind)|Protocol Violation|0|||
27953105|NCT00923091|54610514|FG007|Period IV (Double-Blind)|Protocol Violation|0|||
27953106|NCT00923091|54610515|FG008|Period IV (Double-Blind)|Protocol Violation|0|||
27731962|NCT00103285|54179444|FG002|Response Assignment|Adverse Event|3|||
27731963|NCT00103285|54179445|FG003|Response Assignment|Adverse Event|2|||
27731964|NCT00103285|54179446|FG004|Response Assignment|Adverse Event|3|||
27731965|NCT00103285|54179447|FG005|Response Assignment|Adverse Event|1|||
27731966|NCT00103285|54179448|FG006|Response Assignment|Adverse Event|1|||
27731967|NCT00103285|54179449|FG007|Response Assignment|Adverse Event|2|||
27731968|NCT00103285|54179442|FG000|Response Assignment|Death|0|||
27731969|NCT00103285|54179443|FG001|Response Assignment|Death|5|||
27731970|NCT00103285|54179444|FG002|Response Assignment|Death|2|||
27731971|NCT00103285|54179445|FG003|Response Assignment|Death|2|||
27731972|NCT00103285|54179446|FG004|Response Assignment|Death|3|||
27731973|NCT00103285|54179447|FG005|Response Assignment|Death|1|||
27731974|NCT00103285|54179448|FG006|Response Assignment|Death|0|||
27731975|NCT00103285|54179449|FG007|Response Assignment|Death|8|||
27731976|NCT00103285|54179442|FG000|Response Assignment|Lost to Follow-up|0|||
27731977|NCT00103285|54179443|FG001|Response Assignment|Lost to Follow-up|9|||
27731978|NCT00103285|54179444|FG002|Response Assignment|Lost to Follow-up|5|||
27731979|NCT00103285|54179445|FG003|Response Assignment|Lost to Follow-up|5|||
27731980|NCT00103285|54179446|FG004|Response Assignment|Lost to Follow-up|1|||
27953107|NCT00923091|54610516|FG009|Period IV (Double-Blind)|Protocol Violation|0|||
27953108|NCT00923091|54610517|FG010|Period IV (Double-Blind)|Protocol Violation|0|||
27953109|NCT00923091|54610518|FG011|Period IV (Double-Blind)|Protocol Violation|0|||
27731981|NCT00103285|54179447|FG005|Response Assignment|Lost to Follow-up|2|||
27731982|NCT00103285|54179448|FG006|Response Assignment|Lost to Follow-up|2|||
27731983|NCT00103285|54179449|FG007|Response Assignment|Lost to Follow-up|5|||
27731984|NCT00103285|54179442|FG000|Response Assignment|Physician Decision|0|||
27953110|NCT00923091|54610519|FG012|Period IV (Double-Blind)|Protocol Violation|0|||
27953111|NCT00923091|54610507|FG000|Period V (Double -Blind)|Withdrawal by Subject|0|||
27953112|NCT00923091|54610508|FG001|Period V (Double -Blind)|Withdrawal by Subject|0|||
27953113|NCT00923091|54610509|FG002|Period V (Double -Blind)|Withdrawal by Subject|0|||
27953114|NCT00923091|54610510|FG003|Period V (Double -Blind)|Withdrawal by Subject|0|||
27953115|NCT00923091|54610511|FG004|Period V (Double -Blind)|Withdrawal by Subject|0|||
27953116|NCT00923091|54610512|FG005|Period V (Double -Blind)|Withdrawal by Subject|0|||
27953117|NCT00923091|54610513|FG006|Period V (Double -Blind)|Withdrawal by Subject|0|||
27953118|NCT00923091|54610514|FG007|Period V (Double -Blind)|Withdrawal by Subject|0|||
27953119|NCT00923091|54610515|FG008|Period V (Double -Blind)|Withdrawal by Subject|1|||
27953120|NCT00923091|54610516|FG009|Period V (Double -Blind)|Withdrawal by Subject|0|||
27953121|NCT00923091|54610517|FG010|Period V (Double -Blind)|Withdrawal by Subject|0|||
27953122|NCT00923091|54610518|FG011|Period V (Double -Blind)|Withdrawal by Subject|0|||
27953123|NCT00923091|54610519|FG012|Period V (Double -Blind)|Withdrawal by Subject|1|||
27953124|NCT00923091|54610507|FG000|Period V (Double -Blind)|Protocol Violation|0|||
27953125|NCT00923091|54610508|FG001|Period V (Double -Blind)|Protocol Violation|0|||
27953126|NCT00923091|54610509|FG002|Period V (Double -Blind)|Protocol Violation|0|||
27953127|NCT00923091|54610510|FG003|Period V (Double -Blind)|Protocol Violation|0|||
27953128|NCT00923091|54610511|FG004|Period V (Double -Blind)|Protocol Violation|0|||
27953129|NCT00923091|54610512|FG005|Period V (Double -Blind)|Protocol Violation|0|||
27953130|NCT00923091|54610513|FG006|Period V (Double -Blind)|Protocol Violation|0|||
27953131|NCT00923091|54610514|FG007|Period V (Double -Blind)|Protocol Violation|0|||
27953132|NCT00923091|54610515|FG008|Period V (Double -Blind)|Protocol Violation|0|||
27953133|NCT00923091|54610516|FG009|Period V (Double -Blind)|Protocol Violation|0|||
27953134|NCT00923091|54610517|FG010|Period V (Double -Blind)|Protocol Violation|0|||
27953135|NCT00923091|54610518|FG011|Period V (Double -Blind)|Protocol Violation|0|||
27953136|NCT00923091|54610519|FG012|Period V (Double -Blind)|Protocol Violation|1|||
27953137|NCT00923091|54610507|FG000|Period V (Double -Blind)|Lost to Follow-up|0|||
27953138|NCT00923091|54610508|FG001|Period V (Double -Blind)|Lost to Follow-up|0|||
27953139|NCT00923091|54610509|FG002|Period V (Double -Blind)|Lost to Follow-up|0|||
27953140|NCT00923091|54610510|FG003|Period V (Double -Blind)|Lost to Follow-up|0|||
27953141|NCT00923091|54610511|FG004|Period V (Double -Blind)|Lost to Follow-up|0|||
27953142|NCT00923091|54610512|FG005|Period V (Double -Blind)|Lost to Follow-up|0|||
27953143|NCT00923091|54610513|FG006|Period V (Double -Blind)|Lost to Follow-up|0|||
27953144|NCT00923091|54610514|FG007|Period V (Double -Blind)|Lost to Follow-up|0|||
27953145|NCT00923091|54610515|FG008|Period V (Double -Blind)|Lost to Follow-up|0|||
27953146|NCT00923091|54610516|FG009|Period V (Double -Blind)|Lost to Follow-up|0|||
27953147|NCT00923091|54610517|FG010|Period V (Double -Blind)|Lost to Follow-up|1|||
27953148|NCT00923091|54610518|FG011|Period V (Double -Blind)|Lost to Follow-up|0|||
27953149|NCT00923091|54610519|FG012|Period V (Double -Blind)|Lost to Follow-up|0|||
27953150|NCT00923091|54610507|FG000|Period VI (Open-Label)|Adverse Event|17|||
27953151|NCT00923091|54610508|FG001|Period VI (Open-Label)|Adverse Event|0|||
27953152|NCT00923091|54610509|FG002|Period VI (Open-Label)|Adverse Event|4|||
27953153|NCT00923091|54610510|FG003|Period VI (Open-Label)|Adverse Event|1|||
27953154|NCT00923091|54610511|FG004|Period VI (Open-Label)|Adverse Event|1|||
27953155|NCT00923091|54610512|FG005|Period VI (Open-Label)|Adverse Event|0|||
27953156|NCT00923091|54610513|FG006|Period VI (Open-Label)|Adverse Event|0|||
27953157|NCT00923091|54610514|FG007|Period VI (Open-Label)|Adverse Event|0|||
27953158|NCT00923091|54610515|FG008|Period VI (Open-Label)|Adverse Event|0|||
27953159|NCT00923091|54610516|FG009|Period VI (Open-Label)|Adverse Event|0|||
27953160|NCT00923091|54610517|FG010|Period VI (Open-Label)|Adverse Event|0|||
27953161|NCT00923091|54610518|FG011|Period VI (Open-Label)|Adverse Event|0|||
27953162|NCT00923091|54610519|FG012|Period VI (Open-Label)|Adverse Event|0|||
27953163|NCT00923091|54610507|FG000|Period VI (Open-Label)|Withdrawal by Subject|15|||
27953164|NCT00923091|54610508|FG001|Period VI (Open-Label)|Withdrawal by Subject|7|||
27953165|NCT00923091|54610509|FG002|Period VI (Open-Label)|Withdrawal by Subject|5|||
27953166|NCT00923091|54610510|FG003|Period VI (Open-Label)|Withdrawal by Subject|0|||
27953167|NCT00923091|54610511|FG004|Period VI (Open-Label)|Withdrawal by Subject|1|||
27953168|NCT00923091|54610512|FG005|Period VI (Open-Label)|Withdrawal by Subject|0|||
27953169|NCT00923091|54610513|FG006|Period VI (Open-Label)|Withdrawal by Subject|0|||
27953170|NCT00923091|54610514|FG007|Period VI (Open-Label)|Withdrawal by Subject|0|||
27953171|NCT00923091|54610515|FG008|Period VI (Open-Label)|Withdrawal by Subject|0|||
27953172|NCT00923091|54610516|FG009|Period VI (Open-Label)|Withdrawal by Subject|0|||
27953173|NCT00923091|54610517|FG010|Period VI (Open-Label)|Withdrawal by Subject|0|||
27953174|NCT00923091|54610518|FG011|Period VI (Open-Label)|Withdrawal by Subject|0|||
28081515|NCT04235959|54734890|FG001|Overall Study|Adverse Event|0|||
27953175|NCT00923091|54610519|FG012|Period VI (Open-Label)|Withdrawal by Subject|0|||
27953176|NCT00923091|54610507|FG000|Period VI (Open-Label)|Protocol Violation|6|||
27953177|NCT00923091|54610508|FG001|Period VI (Open-Label)|Protocol Violation|1|||
27953178|NCT00923091|54610509|FG002|Period VI (Open-Label)|Protocol Violation|3|||
27953179|NCT00923091|54610510|FG003|Period VI (Open-Label)|Protocol Violation|1|||
27953180|NCT00923091|54610511|FG004|Period VI (Open-Label)|Protocol Violation|4|||
27953181|NCT00923091|54610512|FG005|Period VI (Open-Label)|Protocol Violation|0|||
27953182|NCT00923091|54610513|FG006|Period VI (Open-Label)|Protocol Violation|0|||
27953183|NCT00923091|54610514|FG007|Period VI (Open-Label)|Protocol Violation|0|||
27953184|NCT00923091|54610515|FG008|Period VI (Open-Label)|Protocol Violation|0|||
27953185|NCT00923091|54610516|FG009|Period VI (Open-Label)|Protocol Violation|0|||
27953186|NCT00923091|54610517|FG010|Period VI (Open-Label)|Protocol Violation|0|||
27953187|NCT00923091|54610518|FG011|Period VI (Open-Label)|Protocol Violation|0|||
27953188|NCT00923091|54610519|FG012|Period VI (Open-Label)|Protocol Violation|0|||
27953189|NCT00923091|54610507|FG000|Period VI (Open-Label)|Lost to Follow-up|1|||
27953190|NCT00923091|54610508|FG001|Period VI (Open-Label)|Lost to Follow-up|0|||
27953191|NCT00923091|54610509|FG002|Period VI (Open-Label)|Lost to Follow-up|1|||
27953192|NCT00923091|54610510|FG003|Period VI (Open-Label)|Lost to Follow-up|0|||
27953193|NCT00923091|54610511|FG004|Period VI (Open-Label)|Lost to Follow-up|0|||
27953194|NCT00923091|54610512|FG005|Period VI (Open-Label)|Lost to Follow-up|0|||
27953195|NCT00923091|54610513|FG006|Period VI (Open-Label)|Lost to Follow-up|0|||
27953196|NCT00923091|54610514|FG007|Period VI (Open-Label)|Lost to Follow-up|0|||
27953197|NCT00923091|54610515|FG008|Period VI (Open-Label)|Lost to Follow-up|0|||
27953198|NCT00923091|54610516|FG009|Period VI (Open-Label)|Lost to Follow-up|0|||
27953199|NCT00923091|54610517|FG010|Period VI (Open-Label)|Lost to Follow-up|0|||
27953200|NCT00923091|54610518|FG011|Period VI (Open-Label)|Lost to Follow-up|0|||
27953201|NCT00923091|54610519|FG012|Period VI (Open-Label)|Lost to Follow-up|0|||
27953202|NCT00923091|54610507|FG000|Period VI (Open-Label)|Other Reason|0|||
27953203|NCT00923091|54610508|FG001|Period VI (Open-Label)|Other Reason|0|||
27953204|NCT00923091|54610509|FG002|Period VI (Open-Label)|Other Reason|0|||
27953205|NCT00923091|54610510|FG003|Period VI (Open-Label)|Other Reason|1|||
27953206|NCT00923091|54610511|FG004|Period VI (Open-Label)|Other Reason|1|||
27953207|NCT00923091|54610512|FG005|Period VI (Open-Label)|Other Reason|0|||
27953208|NCT00923091|54610513|FG006|Period VI (Open-Label)|Other Reason|0|||
27953209|NCT00923091|54610514|FG007|Period VI (Open-Label)|Other Reason|0|||
27953210|NCT00923091|54610515|FG008|Period VI (Open-Label)|Other Reason|0|||
27953211|NCT00923091|54610516|FG009|Period VI (Open-Label)|Other Reason|0|||
27953212|NCT00923091|54610517|FG010|Period VI (Open-Label)|Other Reason|0|||
27953213|NCT00923091|54610518|FG011|Period VI (Open-Label)|Other Reason|0|||
27953214|NCT00923091|54610519|FG012|Period VI (Open-Label)|Other Reason|0|||
27953215|NCT00853957|54610546|FG000|Overall Study|Adverse Event|9|||
27953216|NCT00853957|54610547|FG001|Overall Study|Adverse Event|3|||
27953217|NCT00853957|54610546|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
27953218|NCT00853957|54610547|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
28081516|NCT04235959|54734891|FG002|Overall Study|Adverse Event|0|||
28081517|NCT03735121|54734932|FG000|Overall Study|Death|3|||
28081518|NCT03735121|54734933|FG001|Overall Study|Death|6|||
28081519|NCT03735121|54734934|FG002|Overall Study|Death|8|||
28081520|NCT03735121|54734935|FG003|Overall Study|Death|37|||
28081521|NCT03735121|54734936|FG004|Overall Study|Death|86|||
28081522|NCT03735121|54734932|FG000|Overall Study|Withdrawal by Subject|1|||
28081523|NCT03735121|54734933|FG001|Overall Study|Withdrawal by Subject|1|||
28081524|NCT03735121|54734934|FG002|Overall Study|Withdrawal by Subject|3|||
28081525|NCT03735121|54734935|FG003|Overall Study|Withdrawal by Subject|4|||
28081526|NCT03735121|54734936|FG004|Overall Study|Withdrawal by Subject|2|||
28081527|NCT03735121|54734932|FG000|Overall Study|Progressive Disease|0|||
28081528|NCT03735121|54734933|FG001|Overall Study|Progressive Disease|0|||
28081529|NCT03735121|54734934|FG002|Overall Study|Progressive Disease|1|||
28081530|NCT03735121|54734935|FG003|Overall Study|Progressive Disease|0|||
28081531|NCT03735121|54734936|FG004|Overall Study|Progressive Disease|0|||
28081532|NCT03735121|54734932|FG000|Overall Study|Lost to Follow-up|0|||
28081533|NCT03735121|54734933|FG001|Overall Study|Lost to Follow-up|0|||
27854962|NCT00244621|54373457|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
27854963|NCT00244621|54373458|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
27854964|NCT00244621|54373456|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
27953219|NCT00853957|54610546|FG000|Overall Study|Subject withdrew consent|4|||
27953220|NCT00853957|54610547|FG001|Overall Study|Subject withdrew consent|5|||
27953221|NCT00853957|54610546|FG000|Overall Study|Lost to Follow-up|1|||
27953222|NCT00853957|54610547|FG001|Overall Study|Lost to Follow-up|6|||
27953223|NCT00853957|54610546|FG000|Overall Study|Protocol deviation|0|||
27953224|NCT00853957|54610547|FG001|Overall Study|Protocol deviation|3|||
27953225|NCT01021020|54610553|FG000|Period I|Protocol Violation|1|||
27953226|NCT01021020|54610553|FG000|Period I|Withdrawal by Subject|1|||
27953227|NCT01021020|54610553|FG000|14 Day Washout Period A|Physician Decision|1|||
27953228|NCT00833053|54610567|FG000|Overall Study|Adverse Event|4|||
27953229|NCT00833053|54610568|FG001|Overall Study|Adverse Event|0|||
28081534|NCT03735121|54734934|FG002|Overall Study|Lost to Follow-up|0|||
28081535|NCT03735121|54734935|FG003|Overall Study|Lost to Follow-up|0|||
28081536|NCT03735121|54734936|FG004|Overall Study|Lost to Follow-up|1|||
27953230|NCT00833053|54610567|FG000|Overall Study|Treatment Failure|3|||
27953231|NCT00833053|54610568|FG001|Overall Study|Treatment Failure|1|||
28081537|NCT03735121|54734932|FG000|Overall Study|Ongoing|3|||
27953232|NCT00833053|54610567|FG000|Overall Study|Withdrawal by Subject|0|||
27953233|NCT00833053|54610568|FG001|Overall Study|Withdrawal by Subject|1|||
27953234|NCT00833053|54610567|FG000|Overall Study|Protocol Violation|2|||
27953235|NCT00833053|54610568|FG001|Overall Study|Protocol Violation|1|||
27953236|NCT00832975|54610574|FG000|Overall Study|Lost to Follow-up|7|||
27953237|NCT00832975|54610574|FG000|Overall Study|Protocol Violation|6|||
27953238|NCT00832975|54610574|FG000|Overall Study|Death|5|||
27953239|NCT00832975|54610574|FG000|Overall Study|Physician Decision|4|||
27953240|NCT00832975|54610574|FG000|Overall Study|Withdrawal by Subject|3|||
27953241|NCT00832975|54610574|FG000|Overall Study|Other reasons|14|||
27953242|NCT01020786|54610578|FG000|Induction Period|Entry Criteria Not Met|2|||
27953243|NCT01020786|54610578|FG000|Induction Period|Adverse Event|10|||
27953244|NCT01020786|54610578|FG000|Induction Period|Progressive Disease|31|||
27953245|NCT01020786|54610578|FG000|Induction Period|Investigator Decision|3|||
27953246|NCT01020786|54610578|FG000|Induction Period|Withdrawal by Subject|3|||
27953247|NCT01020786|54610578|FG000|Maintenance Period|Adverse Event|8|||
27953248|NCT01020786|54610578|FG000|Maintenance Period|Progressive Disease|43|||
27953249|NCT01020786|54610578|FG000|Maintenance Period|Withdrawal by Subject|8|||
27953250|NCT01020786|54610578|FG000|Maintenance Period|Sponsor Decision|1|||
27953251|NCT00918645|54610583|FG000|Overall Study|Withdrawal by Subject|1|||
27953252|NCT00922935|54610590|FG000|Overall Study|Protocol Violation|0|||
27953253|NCT00922935|54610591|FG001|Overall Study|Protocol Violation|3|||
27953254|NCT00922935|54610592|FG002|Overall Study|Protocol Violation|0|||
27953255|NCT00922935|54610590|FG000|Overall Study|Physician Decision|1|||
27953256|NCT00922935|54610591|FG001|Overall Study|Physician Decision|1|||
27953257|NCT00922935|54610592|FG002|Overall Study|Physician Decision|0|||
27953258|NCT00922935|54610590|FG000|Overall Study|Lost to Follow-up|0|||
27953259|NCT00922935|54610591|FG001|Overall Study|Lost to Follow-up|1|||
27953260|NCT00922935|54610592|FG002|Overall Study|Lost to Follow-up|0|||
27953261|NCT01020474|54610602|FG000|Overall Study|Adverse Event|4|||
27953262|NCT01020474|54610603|FG001|Overall Study|Adverse Event|4|||
27953263|NCT01020474|54610602|FG000|Overall Study|Protocol Violation|0|||
27953264|NCT01020474|54610603|FG001|Overall Study|Protocol Violation|2|||
27953265|NCT01020474|54610602|FG000|Overall Study|Withdrawal by Subject|5|||
27953266|NCT01020474|54610603|FG001|Overall Study|Withdrawal by Subject|7|||
27953267|NCT01020474|54610602|FG000|Overall Study|Other Reasons|1|||
27953268|NCT01020474|54610603|FG001|Overall Study|Other Reasons|1|||
27953269|NCT01020474|54610602|FG000|Overall Study|Insufficient Clinical Response|0|||
27953270|NCT01020474|54610603|FG001|Overall Study|Insufficient Clinical Response|3|||
27953271|NCT00922779|54610609|FG000|Overall Study|Adverse Event|67|||
27953272|NCT00922779|54610609|FG000|Overall Study|Pregnancy|7|||
27953273|NCT00922779|54610609|FG000|Overall Study|Withdrawal by Subject|308|||
27953274|NCT00922779|54610609|FG000|Overall Study|Lost to Follow-up|44|||
27953275|NCT00922779|54610609|FG000|Overall Study|Other|27|||
27953276|NCT00922779|54610609|FG000|Overall Study|Missing|1874|||
27953277|NCT00924651|54610615|FG000|Overall Study|Chemo started too soon|2|||
27953278|NCT00924651|54610616|FG001|Overall Study|Chemo started too soon|3|||
27953279|NCT00924651|54610615|FG000|Overall Study|No Reason|3|||
27953280|NCT00924651|54610616|FG001|Overall Study|No Reason|7|||
27953281|NCT00924651|54610615|FG000|Overall Study|Overwhelmed|6|||
27953282|NCT00924651|54610616|FG001|Overall Study|Overwhelmed|6|||
27953283|NCT00924651|54610615|FG000|Overall Study|Noncompliant|1|||
27953284|NCT00924651|54610616|FG001|Overall Study|Noncompliant|4|||
27953285|NCT00924651|54610615|FG000|Overall Study|Medical|1|||
27953286|NCT00924651|54610616|FG001|Overall Study|Medical|3|||
27953287|NCT00924651|54610615|FG000|Overall Study|Changed Mind|10|||
27953288|NCT00924651|54610616|FG001|Overall Study|Changed Mind|1|||
27953289|NCT00924651|54610615|FG000|Overall Study|Incomplete Form|2|||
27953290|NCT00924651|54610616|FG001|Overall Study|Incomplete Form|1|||
27953291|NCT00922623|54610622|FG000|Overall Study|Other|4|||
27953292|NCT00922623|54610622|FG000|Overall Study|Lost to Follow-up|1|||
27953293|NCT01025232|54610630|FG000|Overall Study|Study drug no longer available|3|||
27953294|NCT01025232|54610631|FG001|Overall Study|Study drug no longer available|6|||
27953295|NCT01025154|54610637|FG000|Overall Study|Lost to Follow-up|1|||
27953296|NCT01025154|54610637|FG000|Overall Study|Withdrawal by Subject|1|||
27953297|NCT00832819|54610644|FG000|Overall Study|Adverse Event|0|||
27953298|NCT00832819|54610645|FG001|Overall Study|Adverse Event|1|||
28081538|NCT03735121|54734933|FG001|Overall Study|Ongoing|3|||
27953299|NCT00832819|54610646|FG002|Overall Study|Adverse Event|0|||
27953300|NCT00832819|54610644|FG000|Overall Study|Protocol Violation|0|||
27953301|NCT00832819|54610645|FG001|Overall Study|Protocol Violation|0|||
28081539|NCT03735121|54734934|FG002|Overall Study|Ongoing|26|||
27953302|NCT00832819|54610646|FG002|Overall Study|Protocol Violation|1|||
27953303|NCT00853723|54610655|FG000|Overall Study|Adverse Event|3|||
27953304|NCT00853723|54610656|FG001|Overall Study|Adverse Event|4|||
27953305|NCT00853723|54610657|FG002|Overall Study|Adverse Event|1|||
27953306|NCT00853723|54610655|FG000|Overall Study|Withdrawal by Subject|2|||
27953307|NCT00853723|54610656|FG001|Overall Study|Withdrawal by Subject|1|||
27953308|NCT00853723|54610657|FG002|Overall Study|Withdrawal by Subject|0|||
27953309|NCT00853723|54610655|FG000|Overall Study|Protocol Violation|1|||
27953310|NCT00853723|54610656|FG001|Overall Study|Protocol Violation|2|||
27953311|NCT00853723|54610657|FG002|Overall Study|Protocol Violation|1|||
27953312|NCT01104545|54610671|FG000|Overall Study|Adverse Event|0|||
27953313|NCT01104545|54610672|FG001|Overall Study|Adverse Event|1|||
27953314|NCT01104545|54610673|FG002|Overall Study|Adverse Event|2|||
27953315|NCT00918255|54610721|FG000|Overall Study|Adverse Event|1|||
27953316|NCT00918255|54610722|FG001|Overall Study|Adverse Event|0|||
27953317|NCT00918255|54610723|FG002|Overall Study|Adverse Event|0|||
27953318|NCT00918255|54610721|FG000|Overall Study|Withdrawal by Subject|1|||
27953319|NCT00918255|54610722|FG001|Overall Study|Withdrawal by Subject|0|||
27953320|NCT00918255|54610723|FG002|Overall Study|Withdrawal by Subject|2|||
27953321|NCT00918255|54610721|FG000|Overall Study|Lack of Efficacy|1|||
27953322|NCT00918255|54610722|FG001|Overall Study|Lack of Efficacy|0|||
27953323|NCT00918255|54610723|FG002|Overall Study|Lack of Efficacy|0|||
27953324|NCT00918255|54610721|FG000|Overall Study|Lost to Follow-up|1|||
27953325|NCT00918255|54610722|FG001|Overall Study|Lost to Follow-up|0|||
27953326|NCT00918255|54610723|FG002|Overall Study|Lost to Follow-up|2|||
27953327|NCT00918255|54610721|FG000|Overall Study|Exceeded allowed number of interventions|0|||
27953328|NCT00918255|54610722|FG001|Overall Study|Exceeded allowed number of interventions|0|||
27953329|NCT00918255|54610723|FG002|Overall Study|Exceeded allowed number of interventions|1|||
27953330|NCT00918255|54610721|FG000|Overall Study|Non-compliance|1|||
27953331|NCT00918255|54610722|FG001|Overall Study|Non-compliance|0|||
27953332|NCT00918255|54610723|FG002|Overall Study|Non-compliance|0|||
27953333|NCT00918255|54610721|FG000|Overall Study|Investigator discretion|1|||
27953334|NCT00918255|54610722|FG001|Overall Study|Investigator discretion|0|||
27953335|NCT00918255|54610723|FG002|Overall Study|Investigator discretion|0|||
27953336|NCT01096589|54610735|FG000|Overall Study|Adverse Event|2|||
27953337|NCT01096589|54610736|FG001|Overall Study|Adverse Event|1|||
27953338|NCT01096589|54610737|FG002|Overall Study|Adverse Event|2|||
27953339|NCT01096589|54610738|FG003|Overall Study|Adverse Event|1|||
27953340|NCT01096589|54610735|FG000|Overall Study|Withdrawal by Subject|2|||
27953341|NCT01096589|54610736|FG001|Overall Study|Withdrawal by Subject|1|||
27953342|NCT01096589|54610737|FG002|Overall Study|Withdrawal by Subject|1|||
27731985|NCT00103285|54179443|FG001|Response Assignment|Physician Decision|13|||
27731986|NCT00103285|54179444|FG002|Response Assignment|Physician Decision|14|||
27731987|NCT00103285|54179445|FG003|Response Assignment|Physician Decision|9|||
27731988|NCT00103285|54179446|FG004|Response Assignment|Physician Decision|13|||
27832279|NCT01775189|54311154|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
27953343|NCT01096589|54610738|FG003|Overall Study|Withdrawal by Subject|1|||
27953344|NCT01096589|54610735|FG000|Overall Study|Compliance with protocol|0|||
27953345|NCT01096589|54610736|FG001|Overall Study|Compliance with protocol|0|||
27953346|NCT01096589|54610737|FG002|Overall Study|Compliance with protocol|1|||
27953347|NCT01096589|54610738|FG003|Overall Study|Compliance with protocol|0|||
27953348|NCT01096589|54610735|FG000|Overall Study|found treatment exhausting|0|||
27953349|NCT01096589|54610736|FG001|Overall Study|found treatment exhausting|0|||
27953350|NCT01096589|54610737|FG002|Overall Study|found treatment exhausting|0|||
27953351|NCT01096589|54610738|FG003|Overall Study|found treatment exhausting|1|||
27953352|NCT00845065|54610754|FG000|Overall Study|Adverse Event|3|||
27953353|NCT00845065|54610755|FG001|Overall Study|Adverse Event|23|||
27953354|NCT00845065|54610754|FG000|Overall Study|Lack of Efficacy|43|||
27953355|NCT00845065|54610755|FG001|Overall Study|Lack of Efficacy|21|||
27953356|NCT00845065|54610754|FG000|Overall Study|Non-Medical Reasons|1|||
27953357|NCT00845065|54610755|FG001|Overall Study|Non-Medical Reasons|11|||
27953358|NCT00832585|54610761|FG000|Overall Study|Withdrawal by Subject|1|||
27953359|NCT00832585|54610761|FG000|Overall Study|Lost to Follow-up|1|||
27953360|NCT00918567|54610767|FG000|Overall Study|Lack of Efficacy|3|||
27953361|NCT00918567|54610768|FG001|Overall Study|Lack of Efficacy|1|||
27953362|NCT00918567|54610767|FG000|Overall Study|Withdrawal by Subject|1|||
27953363|NCT00918567|54610768|FG001|Overall Study|Withdrawal by Subject|1|||
27953364|NCT00918567|54610767|FG000|Overall Study|Adverse Event|1|||
27953365|NCT00918567|54610768|FG001|Overall Study|Adverse Event|0|||
27953366|NCT01024920|54610776|FG000|Overall Study|Progressive disease|47|||
27953367|NCT01024920|54610777|FG001|Overall Study|Progressive disease|25|||
27953368|NCT01024920|54610776|FG000|Overall Study|Adverse Event|8|||
27953369|NCT01024920|54610777|FG001|Overall Study|Adverse Event|4|||
27953370|NCT01024920|54610776|FG000|Overall Study|Lost to Follow-up|0|||
27953371|NCT01024920|54610777|FG001|Overall Study|Lost to Follow-up|1|||
27832280|NCT01775189|54311155|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
27953372|NCT01024920|54610776|FG000|Overall Study|Patient refusal to continue|4|||
27953373|NCT01024920|54610777|FG001|Overall Study|Patient refusal to continue|0|||
27953374|NCT01024920|54610776|FG000|Overall Study|Other than listed|5|||
27953375|NCT01024920|54610777|FG001|Overall Study|Other than listed|1|||
27953376|NCT01024920|54610776|FG000|Overall Study|Not treated|3|||
27731989|NCT00103285|54179447|FG005|Response Assignment|Physician Decision|7|||
27832281|NCT01775189|54311156|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
27953377|NCT01024920|54610777|FG001|Overall Study|Not treated|0|||
27953378|NCT01024920|54610776|FG000|Overall Study|Protocol Violation|0|||
27953379|NCT01024920|54610777|FG001|Overall Study|Protocol Violation|1|||
27953380|NCT00832117|54610785|FG000|Overall Study|Death|1|||
27953381|NCT00832117|54610785|FG000|Overall Study|Disease Progression|11|||
27953382|NCT01104311|54610794|FG000|Overall Study|Withdrawal by Subject|6|||
27953383|NCT01104311|54610795|FG001|Overall Study|Withdrawal by Subject|6|||
27953384|NCT01104311|54610794|FG000|Overall Study|Protocol Violation|0|||
27953385|NCT01104311|54610795|FG001|Overall Study|Protocol Violation|1|||
27953386|NCT01104311|54610794|FG000|Overall Study|Physician Decision|2|||
27953387|NCT01104311|54610795|FG001|Overall Study|Physician Decision|2|||
27953388|NCT01104311|54610794|FG000|Overall Study|low compliance|1|||
27953389|NCT01104311|54610795|FG001|Overall Study|low compliance|1|||
27953390|NCT01104311|54610794|FG000|Overall Study|Adverse Event|1|||
27953391|NCT01104311|54610795|FG001|Overall Study|Adverse Event|2|||
27953392|NCT00831493|54610805|FG000|Overall Study|Intractable nausea and vomiting|1|||
27953393|NCT00853567|54610812|FG000|Overall Study|Study prematurely terminated|71|||
27953394|NCT00853489|54610822|FG000|Overall Study|Lost to Follow-up|5|||
27953395|NCT00853489|54610823|FG001|Overall Study|Lost to Follow-up|2|||
27953396|NCT01019694|54610832|FG000|Overall Study|Adverse Event|12|||
27953397|NCT01019694|54610833|FG001|Overall Study|Adverse Event|16|||
27953398|NCT01019694|54610834|FG002|Overall Study|Adverse Event|19|||
27953399|NCT01019694|54610832|FG000|Overall Study|Protocol Violation|2|||
27953400|NCT01019694|54610833|FG001|Overall Study|Protocol Violation|6|||
27953401|NCT01019694|54610834|FG002|Overall Study|Protocol Violation|4|||
27953402|NCT01019694|54610832|FG000|Overall Study|Lost to Follow-up|5|||
27953403|NCT01019694|54610833|FG001|Overall Study|Lost to Follow-up|3|||
27953404|NCT01019694|54610834|FG002|Overall Study|Lost to Follow-up|3|||
27953405|NCT01019694|54610832|FG000|Overall Study|Withdrawal by Subject|4|||
27953406|NCT01019694|54610833|FG001|Overall Study|Withdrawal by Subject|6|||
27953407|NCT01019694|54610834|FG002|Overall Study|Withdrawal by Subject|12|||
27953408|NCT01019694|54610832|FG000|Overall Study|Not treated|0|||
27953409|NCT01019694|54610833|FG001|Overall Study|Not treated|2|||
27953410|NCT01019694|54610834|FG002|Overall Study|Not treated|3|||
27953411|NCT01019694|54610832|FG000|Overall Study|Other reason (not specified)|1|||
27953412|NCT01019694|54610833|FG001|Overall Study|Other reason (not specified)|5|||
28081540|NCT03735121|54734935|FG003|Overall Study|Ongoing|83|||
28081541|NCT03735121|54734936|FG004|Overall Study|Ongoing|158|||
28081542|NCT03525613|54734963|FG000|Overall Study|Adverse Event|11|||
28081543|NCT03525613|54734964|FG001|Overall Study|Adverse Event|8|||
28081544|NCT03525613|54734965|FG002|Overall Study|Adverse Event|3|||
28081545|NCT03525613|54734966|FG003|Overall Study|Adverse Event|3|||
28081546|NCT03525613|54734963|FG000|Overall Study|Lost to Follow-up|4|||
28081547|NCT03525613|54734964|FG001|Overall Study|Lost to Follow-up|5|||
28081548|NCT03525613|54734965|FG002|Overall Study|Lost to Follow-up|3|||
28081549|NCT03525613|54734966|FG003|Overall Study|Lost to Follow-up|2|||
28081550|NCT03525613|54734963|FG000|Overall Study|Physician Decision|0|||
28081551|NCT03525613|54734964|FG001|Overall Study|Physician Decision|1|||
28081552|NCT03525613|54734965|FG002|Overall Study|Physician Decision|0|||
28081553|NCT03525613|54734966|FG003|Overall Study|Physician Decision|1|||
28081554|NCT03525613|54734963|FG000|Overall Study|Consent Withdrawal|25|||
28081555|NCT03525613|54734964|FG001|Overall Study|Consent Withdrawal|16|||
28081556|NCT03525613|54734965|FG002|Overall Study|Consent Withdrawal|12|||
28081557|NCT03525613|54734966|FG003|Overall Study|Consent Withdrawal|9|||
28081558|NCT03525613|54734963|FG000|Overall Study|Death|20|||
28081559|NCT03525613|54734964|FG001|Overall Study|Death|9|||
28081560|NCT03525613|54734965|FG002|Overall Study|Death|7|||
28081561|NCT03525613|54734966|FG003|Overall Study|Death|1|||
28081562|NCT03525613|54734963|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|9|||
28081563|NCT03525613|54734964|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
28081564|NCT03525613|54734965|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|5|||
28081565|NCT03525613|54734966|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|8|||
28081566|NCT03500692|54734980|FG000|Overall Study|Death|163|||
28081567|NCT03500692|54734980|FG000|Overall Study|Lost to Follow-up|76|||
28081568|NCT03500692|54734980|FG000|Overall Study|Termination Reasons|3|||
28081569|NCT03404960|54734999|FG000|Overall Study|Adverse Event|0|||
28081570|NCT03404960|54735000|FG001|Overall Study|Adverse Event|2|||
28081571|NCT03404960|54734999|FG000|Overall Study|Rapidly declined before 1st follow-up scan|0|||
28081572|NCT03404960|54735000|FG001|Overall Study|Rapidly declined before 1st follow-up scan|2|||
28081573|NCT03404960|54734999|FG000|Overall Study|Bowel obstruction|0|||
28081574|NCT03404960|54735000|FG001|Overall Study|Bowel obstruction|1|||
28081575|NCT03404960|54734999|FG000|Overall Study|Incorrect pathological diagnosis on internal review|2|||
28081576|NCT03404960|54735000|FG001|Overall Study|Incorrect pathological diagnosis on internal review|0|||
27953413|NCT01019694|54610834|FG002|Overall Study|Other reason (not specified)|6|||
27953414|NCT00831415|54610842|FG000|Overall Study|Adverse Event|14|||
27953415|NCT00831415|54610842|FG000|Overall Study|Failed to return|3|||
27953416|NCT00831415|54610842|FG000|Overall Study|Physician Decision|6|||
27953417|NCT00831415|54610842|FG000|Overall Study|Lost to Follow-up|9|||
27953418|NCT00831415|54610842|FG000|Overall Study|Protocol Violation|3|||
28081577|NCT03382834|54735008|FG000|Overall Study|Lost to Follow-up|1|||
28081578|NCT03382834|54735009|FG001|Overall Study|Lost to Follow-up|0|||
28081579|NCT03382834|54735008|FG000|Overall Study|Withdrawal by Subject|0|||
28081580|NCT03382834|54735009|FG001|Overall Study|Withdrawal by Subject|1|||
28081581|NCT03381274|54735020|FG000|Overall Study|Death|2|||
28081582|NCT03381274|54735021|FG001|Overall Study|Death|9|||
28081583|NCT03381274|54735022|FG002|Overall Study|Death|3|||
28081584|NCT03381274|54735023|FG003|Overall Study|Death|2|||
28081585|NCT03381274|54735024|FG004|Overall Study|Death|3|||
28081586|NCT03381274|54735020|FG000|Overall Study|Lost to Follow-up|0|||
28081587|NCT03381274|54735021|FG001|Overall Study|Lost to Follow-up|0|||
28081588|NCT03381274|54735022|FG002|Overall Study|Lost to Follow-up|0|||
28081589|NCT03381274|54735023|FG003|Overall Study|Lost to Follow-up|1|||
28081590|NCT03381274|54735024|FG004|Overall Study|Lost to Follow-up|0|||
28081591|NCT03381274|54735020|FG000|Overall Study|Withdrawal by Subject|2|||
28081592|NCT03381274|54735021|FG001|Overall Study|Withdrawal by Subject|1|||
28081593|NCT03381274|54735022|FG002|Overall Study|Withdrawal by Subject|3|||
28081594|NCT03381274|54735023|FG003|Overall Study|Withdrawal by Subject|1|||
28081595|NCT03381274|54735024|FG004|Overall Study|Withdrawal by Subject|0|||
28081596|NCT03381274|54735020|FG000|Overall Study|Other|1|||
28081597|NCT03381274|54735021|FG001|Overall Study|Other|11|||
28081598|NCT03381274|54735022|FG002|Overall Study|Other|0|||
28081599|NCT03381274|54735023|FG003|Overall Study|Other|2|||
28081600|NCT03381274|54735024|FG004|Overall Study|Other|2|||
28081601|NCT03298022|54735040|FG000|Overall Study|Lack of Efficacy|4|||
28081602|NCT03298022|54735040|FG000|Overall Study|Withdrawal by Subject|7|||
28081603|NCT03298022|54735040|FG000|Overall Study|Adverse Event|1|||
28081604|NCT03298022|54735040|FG000|Overall Study|disease relapse|1|||
28081605|NCT03264404|54735050|FG000|Overall Study|Death|2|||
28081606|NCT03264404|54735050|FG000|Overall Study|Physician Decision|1|||
28081607|NCT03264404|54735050|FG000|Overall Study|Disease Progression|28|||
28081608|NCT03264404|54735050|FG000|Overall Study|Adverse Event|1|||
28081609|NCT03264404|54735050|FG000|Overall Study|Off study prior to treatment|2|||
28081610|NCT03118570|54735068|FG000|Overall Study|Adverse Event|2|||
28081611|NCT03118570|54735069|FG001|Overall Study|Adverse Event|0|||
28081612|NCT03118570|54735070|FG002|Overall Study|Adverse Event|0|||
28081613|NCT03118570|54735071|FG003|Overall Study|Adverse Event|0|||
28081614|NCT03118570|54735072|FG004|Overall Study|Adverse Event|3|||
28081615|NCT03118570|54735068|FG000|Overall Study|Withdrawal by Subject|0|||
28081616|NCT03118570|54735069|FG001|Overall Study|Withdrawal by Subject|1|||
28081617|NCT03118570|54735070|FG002|Overall Study|Withdrawal by Subject|4|||
28081618|NCT03118570|54735071|FG003|Overall Study|Withdrawal by Subject|0|||
28081619|NCT03118570|54735072|FG004|Overall Study|Withdrawal by Subject|1|||
28081620|NCT03118570|54735068|FG000|Overall Study|Lost to Follow-up|2|||
28081621|NCT03118570|54735069|FG001|Overall Study|Lost to Follow-up|3|||
28081622|NCT03118570|54735070|FG002|Overall Study|Lost to Follow-up|1|||
28081623|NCT03118570|54735071|FG003|Overall Study|Lost to Follow-up|0|||
28081624|NCT03118570|54735072|FG004|Overall Study|Lost to Follow-up|1|||
28081625|NCT03118570|54735068|FG000|Overall Study|Other, Not Specified|1|||
28081626|NCT03118570|54735069|FG001|Overall Study|Other, Not Specified|3|||
28081627|NCT03118570|54735070|FG002|Overall Study|Other, Not Specified|0|||
28081628|NCT03118570|54735071|FG003|Overall Study|Other, Not Specified|0|||
28081629|NCT03118570|54735072|FG004|Overall Study|Other, Not Specified|0|||
27953419|NCT00831415|54610842|FG000|Overall Study|Withdrawal by Subject|35|||
27953420|NCT00831415|54610842|FG000|Overall Study|Unsatisfactory response - Efficacy|4|||
27953421|NCT00831415|54610842|FG000|Overall Study|Death|1|||
27953422|NCT01095653|54610849|FG000|Overall Study|Lack of Efficacy|3|||
27953423|NCT01095653|54610850|FG001|Overall Study|Lack of Efficacy|0|||
27953424|NCT01095653|54610851|FG002|Overall Study|Lack of Efficacy|0|||
27953425|NCT01095653|54610849|FG000|Overall Study|Adverse Event|1|||
28081630|NCT02971683|54735087|FG000|Overall Study|Other reasons|0|||
28081631|NCT02971683|54735088|FG001|Overall Study|Other reasons|1|||
28081632|NCT02971683|54735087|FG000|Overall Study|Poor/Non-Compliance|0|||
28081633|NCT02971683|54735088|FG001|Overall Study|Poor/Non-Compliance|1|||
28081634|NCT02971683|54735087|FG000|Overall Study|Lost to Follow-up|1|||
28081635|NCT02971683|54735088|FG001|Overall Study|Lost to Follow-up|0|||
28081636|NCT02971683|54735087|FG000|Overall Study|Participant withdrew consent|1|||
28081637|NCT02971683|54735088|FG001|Overall Study|Participant withdrew consent|1|||
28081638|NCT02971683|54735087|FG000|Overall Study|Participant request to discontinue study treatment|1|||
27731990|NCT00103285|54179448|FG006|Response Assignment|Physician Decision|4|||
27953426|NCT01095653|54610850|FG001|Overall Study|Adverse Event|4|||
27953427|NCT01095653|54610851|FG002|Overall Study|Adverse Event|4|||
27953428|NCT01095653|54610849|FG000|Overall Study|Lost to Follow-up|1|||
28081639|NCT02971683|54735088|FG001|Overall Study|Participant request to discontinue study treatment|1|||
28081640|NCT02971683|54735087|FG000|Overall Study|Adverse Event|1|||
28081641|NCT02971683|54735088|FG001|Overall Study|Adverse Event|2|||
28081642|NCT02971683|54735087|FG000|Overall Study|Lack of Efficacy|2|||
28081643|NCT02971683|54735088|FG001|Overall Study|Lack of Efficacy|2|||
28081644|NCT02949219|54735094|FG000|Overall Study|Withdrawal by Subject|1|||
28081645|NCT02927262|54735100|FG000|Overall Study|Adverse Event|7|||
28081646|NCT02927262|54735101|FG001|Overall Study|Adverse Event|1|||
27953429|NCT01095653|54610850|FG001|Overall Study|Lost to Follow-up|0|||
27953430|NCT01095653|54610851|FG002|Overall Study|Lost to Follow-up|4|||
27953431|NCT01095653|54610849|FG000|Overall Study|Withdrawal by Subject|4|||
27953432|NCT01095653|54610850|FG001|Overall Study|Withdrawal by Subject|5|||
27953433|NCT01095653|54610851|FG002|Overall Study|Withdrawal by Subject|3|||
27953434|NCT01095653|54610849|FG000|Overall Study|non-compliance, not met criteria, etc.|10|||
27953435|NCT01095653|54610850|FG001|Overall Study|non-compliance, not met criteria, etc.|6|||
27953436|NCT01095653|54610851|FG002|Overall Study|non-compliance, not met criteria, etc.|5|||
27953437|NCT00920907|54610861|FG000|Induction Period|Adverse Event|0|||
27953438|NCT00920907|54610862|FG001|Induction Period|Adverse Event|2|||
27953439|NCT00920907|54610861|FG000|Induction Period|Death|1|||
27953440|NCT00920907|54610862|FG001|Induction Period|Death|1|||
27953441|NCT00920907|54610861|FG000|Induction Period|Disease Progression|12|||
27953442|NCT00920907|54610862|FG001|Induction Period|Disease Progression|11|||
27953443|NCT00920907|54610861|FG000|Induction Period|Study Drug Toxicity|8|||
27953444|NCT00920907|54610862|FG001|Induction Period|Study Drug Toxicity|6|||
27953445|NCT00920907|54610861|FG000|Induction Period|No longer meets study criteria|0|||
27953446|NCT00920907|54610862|FG001|Induction Period|No longer meets study criteria|1|||
27953447|NCT00920907|54610861|FG000|Induction Period|Withdrawal by Subject|1|||
27953448|NCT00920907|54610862|FG001|Induction Period|Withdrawal by Subject|1|||
27953449|NCT00920907|54610861|FG000|Maintenance Period|Disease Progression|3|||
27953450|NCT00920907|54610862|FG001|Maintenance Period|Disease Progression|7|||
27953451|NCT00920907|54610861|FG000|Maintenance Period|Administrative (study closure)|7|||
27953452|NCT00920907|54610862|FG001|Maintenance Period|Administrative (study closure)|2|||
27953453|NCT00920907|54610861|FG000|Maintenance Period|Study Drug Toxicity|0|||
27953454|NCT00920907|54610862|FG001|Maintenance Period|Study Drug Toxicity|2|||
27953455|NCT00920907|54610861|FG000|Maintenance Period|Death|1|||
27953456|NCT00920907|54610862|FG001|Maintenance Period|Death|1|||
27953457|NCT00920907|54610861|FG000|Maintenance Period|Withdrawal by Subject|1|||
27953458|NCT00920907|54610862|FG001|Maintenance Period|Withdrawal by Subject|0|||
27953459|NCT00920907|54610861|FG000|Maintenance Period|Adverse Event|0|||
27953460|NCT00920907|54610862|FG001|Maintenance Period|Adverse Event|1|||
27953461|NCT01103141|54610872|FG000|Overall Study|Death|0|||
27953462|NCT01103141|54610873|FG001|Overall Study|Death|1|||
27953463|NCT01103141|54610872|FG000|Overall Study|Lost to Follow-up|2|||
27953464|NCT01103141|54610873|FG001|Overall Study|Lost to Follow-up|1|||
27953465|NCT00844831|54610879|FG000|Overall Study|Withdrawal by Subject|4|||
27953466|NCT00844831|54610879|FG000|Overall Study|Adverse Event|1|||
27953467|NCT00844831|54610879|FG000|Overall Study|Physician Decision|1|||
27953468|NCT00920829|54610891|FG000|Allocation|No post randomization data|3|||
27953469|NCT00920829|54610892|FG001|Allocation|No post randomization data|1|||
27953470|NCT00920829|54610893|FG002|Allocation|No post randomization data|0|||
27953471|NCT00920829|54610894|FG003|Allocation|No post randomization data|2|||
27953472|NCT00920829|54610891|FG000|Available for Analysis|Withdrawal by Subject|6|||
27953473|NCT00920829|54610892|FG001|Available for Analysis|Withdrawal by Subject|6|||
27953474|NCT00920829|54610893|FG002|Available for Analysis|Withdrawal by Subject|6|||
27953475|NCT00920829|54610894|FG003|Available for Analysis|Withdrawal by Subject|10|||
27953476|NCT00920829|54610891|FG000|Available for Analysis|Required Medical Treatment|0|||
27953477|NCT00920829|54610892|FG001|Available for Analysis|Required Medical Treatment|1|||
27953478|NCT00920829|54610893|FG002|Available for Analysis|Required Medical Treatment|2|||
27953479|NCT00920829|54610894|FG003|Available for Analysis|Required Medical Treatment|0|||
27953480|NCT00920829|54610891|FG000|Available for Analysis|Adverse Event|1|||
27953481|NCT00920829|54610892|FG001|Available for Analysis|Adverse Event|2|||
27953482|NCT00920829|54610893|FG002|Available for Analysis|Adverse Event|1|||
27953483|NCT00920829|54610894|FG003|Available for Analysis|Adverse Event|0|||
27953484|NCT00920829|54610891|FG000|Available for Analysis|Death|1|||
27953485|NCT00920829|54610892|FG001|Available for Analysis|Death|0|||
27953486|NCT00920829|54610893|FG002|Available for Analysis|Death|0|||
27953487|NCT00920829|54610894|FG003|Available for Analysis|Death|0|||
27953488|NCT00920829|54610891|FG000|Available for Analysis|Protocol Violation|0|||
27953489|NCT00920829|54610892|FG001|Available for Analysis|Protocol Violation|0|||
27953490|NCT00920829|54610893|FG002|Available for Analysis|Protocol Violation|1|||
27953491|NCT00920829|54610894|FG003|Available for Analysis|Protocol Violation|0|||
27953492|NCT00920829|54610891|FG000|Available for Analysis|Required more treatment|0|||
27953493|NCT00920829|54610892|FG001|Available for Analysis|Required more treatment|2|||
27953494|NCT00920829|54610893|FG002|Available for Analysis|Required more treatment|0|||
27953495|NCT00920829|54610894|FG003|Available for Analysis|Required more treatment|1|||
27953496|NCT00831181|54610904|FG000|Overall Study|Adverse Event|12|||
27953497|NCT01023672|54610909|FG000|Overall Study|Worsening disease|2|||
27731991|NCT00103285|54179449|FG007|Response Assignment|Physician Decision|35|||
27953498|NCT01023672|54610909|FG000|Overall Study|Death|1|||
27953499|NCT01094171|54610913|FG000|Overall Study|Lost to Follow-up|2|||
27953500|NCT01094171|54610913|FG000|Overall Study|Informed consent withdrawal|4|||
27953501|NCT01094171|54610913|FG000|Overall Study|Migration from the study area|3|||
27953502|NCT01094171|54610913|FG000|Overall Study|Other|1|||
27953503|NCT01093625|54610919|FG000|Baseline and Dispensed|Withdrawal by Subject|2|||
27953504|NCT01093625|54610920|FG001|Baseline and Dispensed|Withdrawal by Subject|0|||
27953505|NCT01093625|54610919|FG000|2-Week Visit|Withdrawal by Subject|1|||
27953506|NCT01093625|54610920|FG001|2-Week Visit|Withdrawal by Subject|0|||
27953507|NCT01093625|54610919|FG000|1-Month Visit|Lost to Follow-up|2|||
27953508|NCT01093625|54610920|FG001|1-Month Visit|Lost to Follow-up|0|||
27953509|NCT01093625|54610919|FG000|3-Month Visit|Lost to Follow-up|2|||
27953510|NCT01093625|54610920|FG001|3-Month Visit|Lost to Follow-up|0|||
27953511|NCT01093625|54610919|FG000|6-Month Visit|Withdrawal by Subject|6|||
27953512|NCT01093625|54610920|FG001|6-Month Visit|Withdrawal by Subject|7|||
27953513|NCT01093625|54610919|FG000|6-Month Visit|Lost to Follow-up|2|||
27953514|NCT01093625|54610920|FG001|6-Month Visit|Lost to Follow-up|2|||
27953515|NCT01093625|54610919|FG000|1-Year Visit|Lost to Follow-up|5|||
27953516|NCT01093625|54610920|FG001|1-Year Visit|Lost to Follow-up|3|||
27953517|NCT01023516|54610928|FG000|Overall Study|Voluntary discontinuation|7|||
27953518|NCT01023516|54610929|FG001|Overall Study|Voluntary discontinuation|5|||
27953519|NCT01023516|54610928|FG000|Overall Study|Adverse Event|9|||
27953520|NCT01023516|54610929|FG001|Overall Study|Adverse Event|6|||
27953521|NCT01023516|54610928|FG000|Overall Study|Safety reason|0|||
27953522|NCT01023516|54610929|FG001|Overall Study|Safety reason|3|||
27953523|NCT01023516|54610928|FG000|Overall Study|Study-specific criteria|4|||
27953524|NCT01023516|54610929|FG001|Overall Study|Study-specific criteria|2|||
27953525|NCT01023516|54610928|FG000|Overall Study|Incorrect enrolment|4|||
27953526|NCT01023516|54610929|FG001|Overall Study|Incorrect enrolment|2|||
27953527|NCT00844753|54610939|FG000|Overall Study|Lack of Efficacy|1|||
27953528|NCT00844753|54610940|FG001|Overall Study|Lack of Efficacy|0|||
27953529|NCT00844753|54610941|FG002|Overall Study|Lack of Efficacy|2|||
27953530|NCT00844753|54610942|FG003|Overall Study|Lack of Efficacy|2|||
27953531|NCT00844753|54610939|FG000|Overall Study|Adverse Event|3|||
27953532|NCT00844753|54610940|FG001|Overall Study|Adverse Event|2|||
27953533|NCT00844753|54610941|FG002|Overall Study|Adverse Event|5|||
27953534|NCT00844753|54610942|FG003|Overall Study|Adverse Event|5|||
27953535|NCT00844753|54610939|FG000|Overall Study|Lost to Follow-up|1|||
27953536|NCT00844753|54610940|FG001|Overall Study|Lost to Follow-up|1|||
27953537|NCT00844753|54610941|FG002|Overall Study|Lost to Follow-up|0|||
27953538|NCT00844753|54610942|FG003|Overall Study|Lost to Follow-up|1|||
27953539|NCT00844753|54610939|FG000|Overall Study|could not swallow medication|2|||
27953540|NCT00844753|54610940|FG001|Overall Study|could not swallow medication|0|||
27953541|NCT00844753|54610941|FG002|Overall Study|could not swallow medication|0|||
27953542|NCT00844753|54610942|FG003|Overall Study|could not swallow medication|0|||
27953543|NCT00844753|54610939|FG000|Overall Study|Withdrawal by Subject|1|||
27953544|NCT00844753|54610940|FG001|Overall Study|Withdrawal by Subject|0|||
27953545|NCT00844753|54610941|FG002|Overall Study|Withdrawal by Subject|0|||
27953546|NCT00844753|54610942|FG003|Overall Study|Withdrawal by Subject|3|||
27953547|NCT00830947|54610952|FG000|Overall Study|Lost to Follow-up|4|||
27953548|NCT00830947|54610953|FG001|Overall Study|Lost to Follow-up|4|||
27953549|NCT01018992|54610961|FG000|Overall Study|Adverse Event|8|||
27953550|NCT01018992|54610962|FG001|Overall Study|Adverse Event|3|||
27953551|NCT01018992|54610961|FG000|Overall Study|Withdrawal by Subject|3|||
27953552|NCT01018992|54610962|FG001|Overall Study|Withdrawal by Subject|8|||
27953553|NCT01018992|54610961|FG000|Overall Study|Protocol Violation|0|||
27953554|NCT01018992|54610962|FG001|Overall Study|Protocol Violation|4|||
27953555|NCT01018992|54610961|FG000|Overall Study|Lost to Follow-up|5|||
27953556|NCT01018992|54610962|FG001|Overall Study|Lost to Follow-up|1|||
27953557|NCT00917553|54610970|FG000|Overall Study|Lost to Follow-up|2|||
27953558|NCT00917553|54610971|FG001|Overall Study|Lost to Follow-up|1|||
27953559|NCT01018680|54610979|FG000|Overall Study|Adverse Event|23|||
27953560|NCT01018680|54610980|FG001|Overall Study|Adverse Event|40|||
27953561|NCT01018680|54610979|FG000|Overall Study|Withdrawal by Subject|10|||
27953562|NCT01018680|54610980|FG001|Overall Study|Withdrawal by Subject|10|||
27953563|NCT01018680|54610979|FG000|Overall Study|Protocol Violation|5|||
27953564|NCT01018680|54610980|FG001|Overall Study|Protocol Violation|8|||
27953565|NCT01018680|54610979|FG000|Overall Study|Sponsor Decision|6|||
27953566|NCT01018680|54610980|FG001|Overall Study|Sponsor Decision|7|||
27953567|NCT01018680|54610979|FG000|Overall Study|Lack of Efficacy|8|||
27953568|NCT01018680|54610980|FG001|Overall Study|Lack of Efficacy|2|||
27953569|NCT01018680|54610979|FG000|Overall Study|Lost to Follow-up|5|||
28081647|NCT02927262|54735100|FG000|Overall Study|Death|1|||
28081648|NCT02927262|54735101|FG001|Overall Study|Death|0|||
27953570|NCT01018680|54610980|FG001|Overall Study|Lost to Follow-up|3|||
27953571|NCT01018680|54610979|FG000|Overall Study|Entry Criteria Not Met|1|||
28081649|NCT02927262|54735100|FG000|Overall Study|Withdrawal by Subject|3|||
27832282|NCT01775189|54311157|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
27953572|NCT01018680|54610980|FG001|Overall Study|Entry Criteria Not Met|4|||
27953573|NCT01018680|54610979|FG000|Overall Study|Physician Decision|3|||
28081650|NCT02927262|54735101|FG001|Overall Study|Withdrawal by Subject|0|||
27953574|NCT01018680|54610980|FG001|Overall Study|Physician Decision|1|||
27953575|NCT01012440|54610986|FG000|Overall Study|Withdrawal by Subject|2|||
28081651|NCT02927262|54735100|FG000|Overall Study|Disease Relapse|23|||
28081652|NCT02927262|54735101|FG001|Overall Study|Disease Relapse|18|||
27953576|NCT00916929|54610992|FG000|Overall Study|Lost to Follow-up|1|||
27953577|NCT00916929|54610993|FG001|Overall Study|Lost to Follow-up|3|||
27953578|NCT00916929|54610992|FG000|Overall Study|Death|5|||
27953579|NCT00916929|54610993|FG001|Overall Study|Death|10|||
27953580|NCT00916929|54610992|FG000|Overall Study|Withdrawal by Subject|1|||
27953581|NCT00916929|54610993|FG001|Overall Study|Withdrawal by Subject|5|||
27953582|NCT00916929|54610992|FG000|Overall Study|Left ventricular epicardial lead|1|||
27953583|NCT00916929|54610993|FG001|Overall Study|Left ventricular epicardial lead|2|||
27953584|NCT00916929|54610992|FG000|Overall Study|Transferred to hospice care|1|||
27953585|NCT00916929|54610993|FG001|Overall Study|Transferred to hospice care|1|||
27953586|NCT00916929|54610992|FG000|Overall Study|System explant|1|||
27953587|NCT00916929|54610993|FG001|Overall Study|System explant|0|||
27953588|NCT00916929|54610992|FG000|Overall Study|Moved to another state|0|||
27953589|NCT00916929|54610993|FG001|Overall Study|Moved to another state|1|||
27953590|NCT00916929|54610992|FG000|Overall Study|Device unable to process impedance data|0|||
27953591|NCT00916929|54610993|FG001|Overall Study|Device unable to process impedance data|7|||
27953592|NCT00844597|54611007|FG000|Overall Study|Adverse Event|0|||
27953593|NCT00844597|54611008|FG001|Overall Study|Adverse Event|0|||
27953594|NCT00844597|54611009|FG002|Overall Study|Adverse Event|0|||
27953595|NCT00844597|54611010|FG003|Overall Study|Adverse Event|1|||
27953596|NCT00844597|54611011|FG004|Overall Study|Adverse Event|0|||
27953597|NCT00844597|54611012|FG005|Overall Study|Adverse Event|0|||
27953598|NCT01017120|54611030|FG000|Overall Study|Adverse Event|9|||
27953599|NCT01017120|54611031|FG001|Overall Study|Adverse Event|0|||
27953600|NCT01017120|54611030|FG000|Overall Study|Lost to Follow-up|13|||
27953601|NCT01017120|54611031|FG001|Overall Study|Lost to Follow-up|11|||
27953602|NCT01017120|54611030|FG000|Overall Study|Lack of Efficacy|1|||
27953603|NCT01017120|54611031|FG001|Overall Study|Lack of Efficacy|0|||
27953604|NCT01017120|54611030|FG000|Overall Study|Withdrawal by Subject|39|||
27953605|NCT01017120|54611031|FG001|Overall Study|Withdrawal by Subject|21|||
27953606|NCT01017120|54611030|FG000|Overall Study|Pregnancy|1|||
27953607|NCT01017120|54611031|FG001|Overall Study|Pregnancy|1|||
27953608|NCT01017120|54611030|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
27953609|NCT01017120|54611031|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
27953610|NCT01017120|54611030|FG000|Overall Study|Relocated Out of Town|0|||
27953611|NCT01017120|54611031|FG001|Overall Study|Relocated Out of Town|2|||
27953612|NCT01017120|54611030|FG000|Overall Study|Protocol Violation|1|||
27953613|NCT01017120|54611031|FG001|Overall Study|Protocol Violation|0|||
27953614|NCT01017120|54611030|FG000|Overall Study|Parent Unable to Provide Transportation|1|||
27953615|NCT01017120|54611031|FG001|Overall Study|Parent Unable to Provide Transportation|0|||
27953616|NCT01016964|54611039|FG000|Overall Study|Lost to Follow-up|3|||
27953617|NCT01016964|54611040|FG001|Overall Study|Lost to Follow-up|3|||
27953618|NCT02996110|54611051|FG000|Pre-Treatment|Other Reasons|0|||
27953619|NCT02996110|54611052|FG001|Pre-Treatment|Other Reasons|1|||
27953620|NCT02996110|54611053|FG002|Pre-Treatment|Other Reasons|0|||
27953621|NCT02996110|54611054|FG003|Pre-Treatment|Other Reasons|0|||
27953622|NCT02996110|54611055|FG004|Pre-Treatment|Other Reasons|1|||
27953623|NCT02996110|54611051|FG000|Pre-Treatment|Participant Withdrew Consent|0|||
27953624|NCT02996110|54611052|FG001|Pre-Treatment|Participant Withdrew Consent|0|||
27953625|NCT02996110|54611053|FG002|Pre-Treatment|Participant Withdrew Consent|1|||
27953626|NCT02996110|54611054|FG003|Pre-Treatment|Participant Withdrew Consent|0|||
27953627|NCT02996110|54611055|FG004|Pre-Treatment|Participant Withdrew Consent|1|||
27953628|NCT02996110|54611051|FG000|Track 1|Disease Progression|15|||
27953629|NCT02996110|54611052|FG001|Track 1|Disease Progression|17|||
27953630|NCT02996110|54611053|FG002|Track 1|Disease Progression|0|||
27832283|NCT01775189|54311158|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
27832284|NCT01775189|54311152|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
27832285|NCT01775189|54311153|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|1|||
27953631|NCT02996110|54611054|FG003|Track 1|Disease Progression|0|||
27953632|NCT02996110|54611055|FG004|Track 1|Disease Progression|0|||
27953633|NCT02996110|54611051|FG000|Track 1|Adverse Event Unrelated to Study Drug|1|||
27953634|NCT02996110|54611052|FG001|Track 1|Adverse Event Unrelated to Study Drug|1|||
27953635|NCT02996110|54611053|FG002|Track 1|Adverse Event Unrelated to Study Drug|0|||
27953636|NCT02996110|54611054|FG003|Track 1|Adverse Event Unrelated to Study Drug|0|||
27953637|NCT02996110|54611055|FG004|Track 1|Adverse Event Unrelated to Study Drug|0|||
27953638|NCT02996110|54611051|FG000|Track 1|Study Drug Toxicity|5|||
27953639|NCT02996110|54611052|FG001|Track 1|Study Drug Toxicity|3|||
27953640|NCT02996110|54611053|FG002|Track 1|Study Drug Toxicity|0|||
27953641|NCT02996110|54611054|FG003|Track 1|Study Drug Toxicity|0|||
27953642|NCT02996110|54611055|FG004|Track 1|Study Drug Toxicity|0|||
27953643|NCT02996110|54611051|FG000|Track 1|Participant Requested to Discontinue Study Treatment|1|||
27953644|NCT02996110|54611052|FG001|Track 1|Participant Requested to Discontinue Study Treatment|0|||
27953645|NCT02996110|54611053|FG002|Track 1|Participant Requested to Discontinue Study Treatment|0|||
27953646|NCT02996110|54611054|FG003|Track 1|Participant Requested to Discontinue Study Treatment|0|||
27953647|NCT02996110|54611055|FG004|Track 1|Participant Requested to Discontinue Study Treatment|0|||
27953648|NCT02996110|54611051|FG000|Track 1|Administrative Reason by Sponsor|0|||
27953649|NCT02996110|54611052|FG001|Track 1|Administrative Reason by Sponsor|1|||
27953650|NCT02996110|54611053|FG002|Track 1|Administrative Reason by Sponsor|0|||
27953651|NCT02996110|54611054|FG003|Track 1|Administrative Reason by Sponsor|0|||
27953652|NCT02996110|54611055|FG004|Track 1|Administrative Reason by Sponsor|0|||
27953653|NCT02996110|54611051|FG000|Track 1|Participant no Longer Met Study Criteria|1|||
27953654|NCT02996110|54611052|FG001|Track 1|Participant no Longer Met Study Criteria|0|||
27953655|NCT02996110|54611053|FG002|Track 1|Participant no Longer Met Study Criteria|0|||
27953656|NCT02996110|54611054|FG003|Track 1|Participant no Longer Met Study Criteria|0|||
27953657|NCT02996110|54611055|FG004|Track 1|Participant no Longer Met Study Criteria|0|||
27953658|NCT02996110|54611051|FG000|Track 2|Disease Progression|33|||
27953659|NCT02996110|54611052|FG001|Track 2|Disease Progression|26|||
27953660|NCT02996110|54611053|FG002|Track 2|Disease Progression|19|||
27953661|NCT02996110|54611054|FG003|Track 2|Disease Progression|16|||
27953662|NCT02996110|54611055|FG004|Track 2|Disease Progression|15|||
27953663|NCT02996110|54611051|FG000|Track 2|Adverse Event Unrelated to Study Drug|4|||
27953664|NCT02996110|54611052|FG001|Track 2|Adverse Event Unrelated to Study Drug|0|||
27953665|NCT02996110|54611053|FG002|Track 2|Adverse Event Unrelated to Study Drug|0|||
27953666|NCT02996110|54611054|FG003|Track 2|Adverse Event Unrelated to Study Drug|1|||
27953667|NCT02996110|54611055|FG004|Track 2|Adverse Event Unrelated to Study Drug|1|||
27953668|NCT02996110|54611051|FG000|Track 2|Death|0|||
27953669|NCT02996110|54611052|FG001|Track 2|Death|0|||
27953670|NCT02996110|54611053|FG002|Track 2|Death|1|||
27953671|NCT02996110|54611054|FG003|Track 2|Death|0|||
27953672|NCT02996110|54611055|FG004|Track 2|Death|1|||
27953673|NCT02996110|54611051|FG000|Track 2|Study Drug Toxicity|4|||
27953674|NCT02996110|54611052|FG001|Track 2|Study Drug Toxicity|1|||
27953675|NCT02996110|54611053|FG002|Track 2|Study Drug Toxicity|4|||
27953676|NCT02996110|54611054|FG003|Track 2|Study Drug Toxicity|1|||
27953677|NCT02996110|54611055|FG004|Track 2|Study Drug Toxicity|0|||
27953678|NCT02996110|54611051|FG000|Track 2|Participant Requested to Discontinue Study Treatment|0|||
27953679|NCT02996110|54611052|FG001|Track 2|Participant Requested to Discontinue Study Treatment|0|||
27953680|NCT02996110|54611053|FG002|Track 2|Participant Requested to Discontinue Study Treatment|2|||
27953681|NCT02996110|54611054|FG003|Track 2|Participant Requested to Discontinue Study Treatment|1|||
27953682|NCT02996110|54611055|FG004|Track 2|Participant Requested to Discontinue Study Treatment|2|||
27953683|NCT02996110|54611051|FG000|Track 2|Participant Withdrew Consent|1|||
27953684|NCT02996110|54611052|FG001|Track 2|Participant Withdrew Consent|2|||
27953685|NCT02996110|54611053|FG002|Track 2|Participant Withdrew Consent|3|||
27953686|NCT02996110|54611054|FG003|Track 2|Participant Withdrew Consent|1|||
27953687|NCT02996110|54611055|FG004|Track 2|Participant Withdrew Consent|1|||
27953688|NCT02996110|54611051|FG000|Track 2|Other Reasons|0|||
27953689|NCT02996110|54611052|FG001|Track 2|Other Reasons|0|||
27953690|NCT02996110|54611053|FG002|Track 2|Other Reasons|1|||
27953691|NCT02996110|54611054|FG003|Track 2|Other Reasons|0|||
27953692|NCT02996110|54611055|FG004|Track 2|Other Reasons|1|||
27953693|NCT00916617|54611073|FG000|Overall Study|Adverse Event|3|||
27953694|NCT00916617|54611074|FG001|Overall Study|Adverse Event|2|||
27953695|NCT00916617|54611075|FG002|Overall Study|Adverse Event|6|||
27953696|NCT00916617|54611076|FG003|Overall Study|Adverse Event|3|||
27953697|NCT00916617|54611073|FG000|Overall Study|Withdrawal by Subject|3|||
27953698|NCT00916617|54611074|FG001|Overall Study|Withdrawal by Subject|2|||
27953699|NCT00916617|54611075|FG002|Overall Study|Withdrawal by Subject|0|||
27953700|NCT00916617|54611076|FG003|Overall Study|Withdrawal by Subject|1|||
27953701|NCT00916617|54611073|FG000|Overall Study|Caregiver Request|3|||
27953702|NCT00916617|54611074|FG001|Overall Study|Caregiver Request|2|||
27953703|NCT00916617|54611075|FG002|Overall Study|Caregiver Request|1|||
27953704|NCT00916617|54611076|FG003|Overall Study|Caregiver Request|0|||
27953705|NCT00916617|54611073|FG000|Overall Study|Physician Decision|1|||
27953706|NCT00916617|54611074|FG001|Overall Study|Physician Decision|1|||
27953707|NCT00916617|54611075|FG002|Overall Study|Physician Decision|0|||
27953708|NCT00916617|54611076|FG003|Overall Study|Physician Decision|0|||
27953709|NCT00916617|54611073|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
27953710|NCT00916617|54611074|FG001|Overall Study|Discontinuation of Study by Sponsor|13|||
27953711|NCT00916617|54611075|FG002|Overall Study|Discontinuation of Study by Sponsor|3|||
27953712|NCT00916617|54611076|FG003|Overall Study|Discontinuation of Study by Sponsor|1|||
27953713|NCT00916617|54611073|FG000|Overall Study|Lost to Follow-up|2|||
27953714|NCT00916617|54611074|FG001|Overall Study|Lost to Follow-up|1|||
27953715|NCT00916617|54611075|FG002|Overall Study|Lost to Follow-up|0|||
27953716|NCT00916617|54611076|FG003|Overall Study|Lost to Follow-up|0|||
27953717|NCT00916617|54611073|FG000|Overall Study|Lack of Efficacy|1|||
27953718|NCT00916617|54611074|FG001|Overall Study|Lack of Efficacy|0|||
27953719|NCT00916617|54611075|FG002|Overall Study|Lack of Efficacy|0|||
27953720|NCT00916617|54611076|FG003|Overall Study|Lack of Efficacy|0|||
27953721|NCT00916617|54611073|FG000|Overall Study|Other|2|||
27953722|NCT00916617|54611074|FG001|Overall Study|Other|0|||
27953723|NCT00916617|54611075|FG002|Overall Study|Other|0|||
27953724|NCT00916617|54611076|FG003|Overall Study|Other|2|||
27953725|NCT01103063|54611088|FG000|Overall Study|Adverse Event|3|||
27953726|NCT01103063|54611089|FG001|Overall Study|Adverse Event|1|||
27953727|NCT01103063|54611088|FG000|Overall Study|Lost to Follow-up|68|||
27953728|NCT01103063|54611089|FG001|Overall Study|Lost to Follow-up|51|||
27953729|NCT01103063|54611088|FG000|Overall Study|Withdrawal by Subject|60|||
27953730|NCT01103063|54611089|FG001|Overall Study|Withdrawal by Subject|15|||
27953731|NCT01103063|54611088|FG000|Overall Study|Other|16|||
27953732|NCT01103063|54611089|FG001|Overall Study|Other|11|||
27953733|NCT01103063|54611088|FG000|Overall Study|Protocol Violation|1|||
27953734|NCT01103063|54611089|FG001|Overall Study|Protocol Violation|0|||
27953735|NCT01103063|54611088|FG000|Overall Study|Study terminated by Sponsor|326|||
27953736|NCT01103063|54611089|FG001|Overall Study|Study terminated by Sponsor|342|||
27953737|NCT01103063|54611088|FG000|Overall Study|Death|3|||
27953738|NCT01103063|54611089|FG001|Overall Study|Death|1|||
27953739|NCT01091675|54611097|FG000|Overall Study|Adverse Event|7|||
27953740|NCT01091675|54611097|FG000|Overall Study|Lack of Efficacy|27|||
27953741|NCT01091519|54611103|FG000|Overall Study|Adverse Event|12|||
27953742|NCT01091519|54611104|FG001|Overall Study|Adverse Event|16|||
27953743|NCT01091519|54611103|FG000|Overall Study|Death|1|||
27953744|NCT01091519|54611104|FG001|Overall Study|Death|0|||
27953745|NCT01091519|54611103|FG000|Overall Study|Lack of Efficacy|16|||
27953746|NCT01091519|54611104|FG001|Overall Study|Lack of Efficacy|19|||
27953747|NCT01091519|54611103|FG000|Overall Study|Lost to Follow-up|14|||
27953748|NCT01091519|54611104|FG001|Overall Study|Lost to Follow-up|24|||
27953749|NCT01091519|54611103|FG000|Overall Study|Withdrawal by Subject|2|||
27953750|NCT01091519|54611104|FG001|Overall Study|Withdrawal by Subject|2|||
27953751|NCT01091519|54611103|FG000|Overall Study|Other|6|||
27953752|NCT01091519|54611104|FG001|Overall Study|Other|8|||
27953753|NCT01091519|54611103|FG000|Overall Study|Randomized not treated|4|||
28081653|NCT02927262|54735100|FG000|Overall Study|Miscellaneous|5|||
28081654|NCT02927262|54735101|FG001|Overall Study|Miscellaneous|4|||
28081655|NCT02927262|54735100|FG000|Overall Study|Ongoing|4|||
28081656|NCT02927262|54735101|FG001|Overall Study|Ongoing|0|||
28081657|NCT02899299|54735109|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
28081658|NCT02899299|54735110|FG001|Pre-treatment|Participant request to discontinue study treatment|3|||
28081659|NCT02899299|54735109|FG000|Pre-treatment|Participant withdrew consent|1|||
28165039|NCT02991859|54835665|FG011|Wash Out, Up to Day 77|Lost to Follow-up|0|||
28165040|NCT02991859|54835666|FG012|Wash Out, Up to Day 77|Lost to Follow-up|0|||
28165041|NCT02991859|54835667|FG013|Wash Out, Up to Day 77|Lost to Follow-up|0|||
28165042|NCT02991859|54835668|FG014|Wash Out, Up to Day 77|Lost to Follow-up|0|||
28081660|NCT02899299|54735110|FG001|Pre-treatment|Participant withdrew consent|11|||
28081661|NCT02899299|54735109|FG000|Pre-treatment|Participant no longer meets study criteria|2|||
28081662|NCT02899299|54735110|FG001|Pre-treatment|Participant no longer meets study criteria|3|||
28081663|NCT02899299|54735109|FG000|Pre-treatment|Not reported|0|||
28081664|NCT02899299|54735110|FG001|Pre-treatment|Not reported|1|||
28081665|NCT02899299|54735109|FG000|Treatment|Disease Progression|182|||
28081666|NCT02899299|54735110|FG001|Treatment|Disease Progression|44|||
28081667|NCT02899299|54735109|FG000|Treatment|Study Drug Toxicity|59|||
28081668|NCT02899299|54735110|FG001|Treatment|Study Drug Toxicity|24|||
28165043|NCT02991859|54835669|FG015|Wash Out, Up to Day 77|Lost to Follow-up|0|||
27731992|NCT00103285|54179442|FG000|Response Assignment|Protocol Violation|0|||
27953754|NCT01091519|54611104|FG001|Overall Study|Randomized not treated|4|||
27953755|NCT01011738|54611113|FG000|Overall Study|Death|12|||
27953756|NCT01011738|54611114|FG001|Overall Study|Death|3|||
27953757|NCT01011738|54611115|FG002|Overall Study|Death|0|||
27953758|NCT01011738|54611113|FG000|Overall Study|Unknown reasons|312|||
27953759|NCT01011738|54611114|FG001|Overall Study|Unknown reasons|291|||
27953760|NCT01011738|54611115|FG002|Overall Study|Unknown reasons|17|||
27953761|NCT00918333|54611126|FG000|Overall Study|Drug not taken per protocol|1|||
27953762|NCT00918333|54611127|FG001|Overall Study|Drug not taken per protocol|0|||
27953763|NCT00918333|54611126|FG000|Overall Study|Inadequate amount of drugs provided|1|||
27953764|NCT00918333|54611127|FG001|Overall Study|Inadequate amount of drugs provided|4|||
27953765|NCT00918333|54611126|FG000|Overall Study|Ineligible|1|||
28081669|NCT02899299|54735109|FG000|Treatment|Adverse Event unrelated to Study Drug|12|||
28081670|NCT02899299|54735110|FG001|Treatment|Adverse Event unrelated to Study Drug|9|||
28081671|NCT02899299|54735109|FG000|Treatment|Participant request to discontinue Study treatment|4|||
28081672|NCT02899299|54735110|FG001|Treatment|Participant request to discontinue Study treatment|10|||
27953766|NCT00918333|54611127|FG001|Overall Study|Ineligible|0|||
27953767|NCT00918333|54611126|FG000|Overall Study|Withdrawal by Subject|0|||
28081673|NCT02899299|54735109|FG000|Treatment|Participant withdrew consent|6|||
28165044|NCT02991859|54835670|FG016|Wash Out, Up to Day 77|Lost to Follow-up|0|||
27953768|NCT00918333|54611127|FG001|Overall Study|Withdrawal by Subject|1|||
27953769|NCT01091363|54611138|FG000|Overall Study|Withdrawal by Subject|11|||
27953770|NCT01091363|54611139|FG001|Overall Study|Withdrawal by Subject|15|||
27953771|NCT01091363|54611138|FG000|Overall Study|Lost to Follow-up|2|||
27953772|NCT01091363|54611139|FG001|Overall Study|Lost to Follow-up|2|||
27953773|NCT01090973|54611145|FG000|Overall Study|Disease progression|1|||
27953774|NCT01090739|54611149|FG000|Enrollment|Withdrawal by Subject|24|||
27953775|NCT01090739|54611149|FG000|Enrollment|Protocol Violation|14|||
27953776|NCT01090739|54611149|FG000|Enrollment|Lost to Follow-up|5|||
27953777|NCT01090739|54611149|FG000|Enrollment|Physician Decision|5|||
27953778|NCT01090739|54611149|FG000|Enrollment|Sponsor termination of site|4|||
27953779|NCT01090739|54611149|FG000|Enrollment|Study implant limit reached|2|||
27953780|NCT01090739|54611149|FG000|Enrollment|Adverse Event|1|||
27953781|NCT01090739|54611149|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
27953782|NCT01090739|54611149|FG000|12 Month Follow-up|Lost to Follow-up|1|||
27953783|NCT01090739|54611149|FG000|12 Month Follow-up|Physician Decision|1|||
27953784|NCT01090739|54611149|FG000|12 Month Follow-up|Death|1|||
27953785|NCT01090739|54611149|FG000|24 Month Follow-up|Withdrawal by Subject|7|||
27953786|NCT01090739|54611149|FG000|24 Month Follow-up|Lost to Follow-up|1|||
27953787|NCT01090739|54611149|FG000|24 Month Follow-up|Death|1|||
27953788|NCT01090739|54611149|FG000|36 Month Follow-up|Withdrawal by Subject|6|||
27953789|NCT01090739|54611149|FG000|36 Month Follow-up|Visit still pending|17|||
27953790|NCT00916383|54611167|FG000|Overall Study|Adverse Event|1|||
27953791|NCT00916383|54611167|FG000|Overall Study|Death|1|||
27953792|NCT00916383|54611167|FG000|Overall Study|Protocol Violation|1|||
27953793|NCT00916305|54611177|FG000|Overall Study|Lost to Follow-up|21|||
27953794|NCT00916305|54611178|FG001|Overall Study|Lost to Follow-up|27|||
27953795|NCT00916305|54611177|FG000|Overall Study|Withdrawal by Subject|0|||
27953796|NCT00916305|54611178|FG001|Overall Study|Withdrawal by Subject|1|||
27953797|NCT00916149|54611187|FG000|Overall Study|Lost to Follow-up|3|||
27953798|NCT00916149|54611188|FG001|Overall Study|Lost to Follow-up|2|||
27953799|NCT00916149|54611189|FG002|Overall Study|Lost to Follow-up|0|||
27953800|NCT00916149|54611187|FG000|Overall Study|Unable to place scalp EEG leads|1|||
27953801|NCT00916149|54611188|FG001|Overall Study|Unable to place scalp EEG leads|0|||
27953802|NCT00916149|54611189|FG002|Overall Study|Unable to place scalp EEG leads|0|||
27953803|NCT01090427|54611199|FG000|After Controlled Period|Death|0|||
27953804|NCT01090427|54611200|FG001|After Controlled Period|Death|0|||
27953805|NCT01090427|54611201|FG002|After Controlled Period|Death|0|||
27731993|NCT00103285|54179443|FG001|Response Assignment|Protocol Violation|2|||
27953806|NCT01090427|54611202|FG003|After Controlled Period|Death|0|||
27953807|NCT01090427|54611203|FG004|After Controlled Period|Death|0|||
27953808|NCT01090427|54611204|FG005|After Controlled Period|Death|1|||
27953809|NCT01090427|54611205|FG006|After Controlled Period|Death|0|||
27953810|NCT01090427|54611199|FG000|After Controlled Period|Lack of Efficacy|0|||
27953811|NCT01090427|54611200|FG001|After Controlled Period|Lack of Efficacy|0|||
27953812|NCT01090427|54611201|FG002|After Controlled Period|Lack of Efficacy|0|||
27953813|NCT01090427|54611202|FG003|After Controlled Period|Lack of Efficacy|0|||
27953814|NCT01090427|54611203|FG004|After Controlled Period|Lack of Efficacy|0|||
27953815|NCT01090427|54611204|FG005|After Controlled Period|Lack of Efficacy|3|||
27953816|NCT01090427|54611205|FG006|After Controlled Period|Lack of Efficacy|2|||
27953817|NCT01090427|54611199|FG000|After Controlled Period|Adverse Event|0|||
27953818|NCT01090427|54611200|FG001|After Controlled Period|Adverse Event|0|||
27953819|NCT01090427|54611201|FG002|After Controlled Period|Adverse Event|0|||
27953820|NCT01090427|54611202|FG003|After Controlled Period|Adverse Event|2|||
27953821|NCT01090427|54611203|FG004|After Controlled Period|Adverse Event|0|||
27953822|NCT01090427|54611204|FG005|After Controlled Period|Adverse Event|1|||
27953823|NCT01090427|54611205|FG006|After Controlled Period|Adverse Event|0|||
27953824|NCT01016262|54611229|FG000|Double-blind Phase|Adverse Event|0|||
27953825|NCT01016262|54611230|FG001|Double-blind Phase|Adverse Event|0|||
27953826|NCT01016262|54611231|FG002|Double-blind Phase|Adverse Event|1|||
27953827|NCT01016262|54611232|FG003|Double-blind Phase|Adverse Event|0|||
27953828|NCT01016262|54611233|FG004|Double-blind Phase|Adverse Event|0|||
27953829|NCT01016262|54611234|FG005|Double-blind Phase|Adverse Event|0|||
27953830|NCT01016262|54611229|FG000|Double-blind Phase|Lack of Efficacy|1|||
27953831|NCT01016262|54611230|FG001|Double-blind Phase|Lack of Efficacy|0|||
27953832|NCT01016262|54611231|FG002|Double-blind Phase|Lack of Efficacy|5|||
27953833|NCT01016262|54611232|FG003|Double-blind Phase|Lack of Efficacy|0|||
27953834|NCT01016262|54611233|FG004|Double-blind Phase|Lack of Efficacy|0|||
27953835|NCT01016262|54611234|FG005|Double-blind Phase|Lack of Efficacy|0|||
27953836|NCT01016262|54611229|FG000|Double-blind Phase|Disease Progression|0|||
27953837|NCT01016262|54611230|FG001|Double-blind Phase|Disease Progression|1|||
27953838|NCT01016262|54611231|FG002|Double-blind Phase|Disease Progression|2|||
28081674|NCT02899299|54735110|FG001|Treatment|Participant withdrew consent|3|||
28081675|NCT02899299|54735109|FG000|Treatment|Lost to Follow-up|0|||
28081676|NCT02899299|54735110|FG001|Treatment|Lost to Follow-up|1|||
27953839|NCT01016262|54611232|FG003|Double-blind Phase|Disease Progression|0|||
27953840|NCT01016262|54611233|FG004|Double-blind Phase|Disease Progression|0|||
27953841|NCT01016262|54611234|FG005|Double-blind Phase|Disease Progression|0|||
27953842|NCT01016262|54611229|FG000|Double-blind Phase|Withdrawal of Informed Consent|0|||
27953843|NCT01016262|54611230|FG001|Double-blind Phase|Withdrawal of Informed Consent|0|||
27953844|NCT01016262|54611231|FG002|Double-blind Phase|Withdrawal of Informed Consent|1|||
27953845|NCT01016262|54611232|FG003|Double-blind Phase|Withdrawal of Informed Consent|0|||
27953846|NCT01016262|54611233|FG004|Double-blind Phase|Withdrawal of Informed Consent|0|||
28081677|NCT02899299|54735109|FG000|Treatment|Maximum Clinical Benefit|10|||
27953847|NCT01016262|54611234|FG005|Double-blind Phase|Withdrawal of Informed Consent|0|||
27953848|NCT01016262|54611229|FG000|Open-Label Phase|Adverse Event|0|||
27953849|NCT01016262|54611230|FG001|Open-Label Phase|Adverse Event|0|||
27953850|NCT01016262|54611231|FG002|Open-Label Phase|Adverse Event|0|||
27953851|NCT01016262|54611232|FG003|Open-Label Phase|Adverse Event|1|||
27953852|NCT01016262|54611233|FG004|Open-Label Phase|Adverse Event|0|||
27953853|NCT01016262|54611234|FG005|Open-Label Phase|Adverse Event|0|||
27953854|NCT01016262|54611229|FG000|Open-Label Phase|Lost to Follow-up|0|||
27953855|NCT01016262|54611230|FG001|Open-Label Phase|Lost to Follow-up|0|||
27953856|NCT01016262|54611231|FG002|Open-Label Phase|Lost to Follow-up|0|||
27953857|NCT01016262|54611232|FG003|Open-Label Phase|Lost to Follow-up|0|||
27953858|NCT01016262|54611233|FG004|Open-Label Phase|Lost to Follow-up|1|||
27953859|NCT01016262|54611234|FG005|Open-Label Phase|Lost to Follow-up|0|||
27953860|NCT01016262|54611229|FG000|Open-Label Phase|Lack of Efficacy|0|||
27953861|NCT01016262|54611230|FG001|Open-Label Phase|Lack of Efficacy|0|||
27953862|NCT01016262|54611231|FG002|Open-Label Phase|Lack of Efficacy|0|||
27953863|NCT01016262|54611232|FG003|Open-Label Phase|Lack of Efficacy|1|||
27953864|NCT01016262|54611233|FG004|Open-Label Phase|Lack of Efficacy|0|||
27953865|NCT01016262|54611234|FG005|Open-Label Phase|Lack of Efficacy|0|||
27953866|NCT01016262|54611229|FG000|Open-Label Phase|Withdrawal of Informed Consent|0|||
27953867|NCT01016262|54611230|FG001|Open-Label Phase|Withdrawal of Informed Consent|0|||
27953868|NCT01016262|54611231|FG002|Open-Label Phase|Withdrawal of Informed Consent|0|||
27953869|NCT01016262|54611232|FG003|Open-Label Phase|Withdrawal of Informed Consent|0|||
27953870|NCT01016262|54611233|FG004|Open-Label Phase|Withdrawal of Informed Consent|1|||
27953871|NCT01016262|54611234|FG005|Open-Label Phase|Withdrawal of Informed Consent|0|||
27953872|NCT01001910|54611245|FG000|Overall Study|Did not meet protocol defined eligibility s7.1.1 for primary outcome|6|||
27953873|NCT01009554|54611251|FG000|Overall Study|Adverse Event|1|||
27953874|NCT01009554|54611252|FG001|Overall Study|Adverse Event|1|||
27953875|NCT01009554|54611251|FG000|Overall Study|Withdrawal by Subject|1|||
27953876|NCT01009554|54611252|FG001|Overall Study|Withdrawal by Subject|3|||
27953877|NCT01009554|54611251|FG000|Overall Study|Noncompliant with Study Product|0|||
27953878|NCT01009554|54611252|FG001|Overall Study|Noncompliant with Study Product|3|||
27953879|NCT01006590|54611260|FG000|Overall Study|Adverse Event|2|||
27953880|NCT01006590|54611261|FG001|Overall Study|Adverse Event|3|||
27953881|NCT01006590|54611260|FG000|Overall Study|Death|1|||
27953882|NCT01006590|54611261|FG001|Overall Study|Death|1|||
27953883|NCT01006590|54611260|FG000|Overall Study|Lost to Follow-up|1|||
27953884|NCT01006590|54611261|FG001|Overall Study|Lost to Follow-up|1|||
27953885|NCT01006590|54611260|FG000|Overall Study|Protocol Violation|1|||
27953886|NCT01006590|54611261|FG001|Overall Study|Protocol Violation|0|||
27953887|NCT01006590|54611260|FG000|Overall Study|Withdrawal by Subject|4|||
27953888|NCT01006590|54611261|FG001|Overall Study|Withdrawal by Subject|2|||
27953889|NCT01006590|54611260|FG000|Overall Study|Study specific discontinuation criteria|16|||
27953890|NCT01006590|54611261|FG001|Overall Study|Study specific discontinuation criteria|23|||
27953891|NCT01006590|54611260|FG000|Overall Study|Other|3|||
27953892|NCT01006590|54611261|FG001|Overall Study|Other|2|||
27953893|NCT01001832|54611269|FG000|Short-term Period|Adverse Event|2|||
27953894|NCT01001832|54611270|FG001|Short-term Period|Adverse Event|3|||
27953895|NCT01001832|54611269|FG000|Long-term Period|Adverse Event|2|||
27953896|NCT01001832|54611270|FG001|Long-term Period|Adverse Event|1|||
27953897|NCT01001832|54611269|FG000|Long-term Period|Withdrawal by Subject|1|||
27953898|NCT01001832|54611270|FG001|Long-term Period|Withdrawal by Subject|0|||
27953899|NCT01001832|54611269|FG000|Long-term Period|Lack of Efficacy|0|||
27953900|NCT01001832|54611270|FG001|Long-term Period|Lack of Efficacy|2|||
27953901|NCT01001832|54611269|FG000|Long-term Period|Other|1|||
27953902|NCT01001832|54611270|FG001|Long-term Period|Other|2|||
27953903|NCT01001832|54611269|FG000|Follow-up Period|Withdrawal by Subject|1|||
27953904|NCT01001832|54611270|FG001|Follow-up Period|Withdrawal by Subject|0|||
27953905|NCT01001832|54611269|FG000|Follow-up Period|Follow-up no longer required /protocol|15|||
27953906|NCT01001832|54611270|FG001|Follow-up Period|Follow-up no longer required /protocol|20|||
28081678|NCT02899299|54735110|FG001|Treatment|Maximum Clinical Benefit|2|||
28081679|NCT02899299|54735109|FG000|Treatment|Poor/Non-compliance|1|||
28081680|NCT02899299|54735110|FG001|Treatment|Poor/Non-compliance|0|||
28081681|NCT02899299|54735109|FG000|Treatment|Participant no longer meets Study criteria|4|||
28081682|NCT02899299|54735110|FG001|Treatment|Participant no longer meets Study criteria|0|||
27953907|NCT01001832|54611269|FG000|Follow-up Period|Other|2|||
27953908|NCT01001832|54611270|FG001|Follow-up Period|Other|1|||
27953909|NCT01001598|54611279|FG000|Overall Study|Hematopoietic Stem Cell Transplant|1|||
27953910|NCT01001598|54611279|FG000|Overall Study|Adverse Event|1|||
27953911|NCT01006356|54611283|FG000|Overall Study|Adverse Event|6|||
27953912|NCT01006356|54611283|FG000|Overall Study|Physician Decision|1|||
27953913|NCT01006356|54611283|FG000|Overall Study|Paticipants did not cooperate|6|||
27953914|NCT01006356|54611283|FG000|Overall Study|Withdrawal by Subject|1|||
27953915|NCT01006356|54611283|FG000|Overall Study|Choice by participants|2|||
27953916|NCT01006356|54611283|FG000|Overall Study|Protocol Violation|3|||
27953917|NCT01006356|54611283|FG000|Overall Study|Other|23|||
27953918|NCT01089725|54611292|FG000|Overall Study|Adverse Event|1|||
27953919|NCT01089725|54611293|FG001|Overall Study|Adverse Event|1|||
27953920|NCT01089725|54611294|FG002|Overall Study|Adverse Event|0|||
27953921|NCT01089725|54611295|FG003|Overall Study|Adverse Event|0|||
27953922|NCT01089725|54611296|FG004|Overall Study|Adverse Event|2|||
27953923|NCT01089725|54611292|FG000|Overall Study|Lack of Efficacy|4|||
27953924|NCT01089725|54611293|FG001|Overall Study|Lack of Efficacy|3|||
27953925|NCT01089725|54611294|FG002|Overall Study|Lack of Efficacy|1|||
27953926|NCT01089725|54611295|FG003|Overall Study|Lack of Efficacy|0|||
27953927|NCT01089725|54611296|FG004|Overall Study|Lack of Efficacy|4|||
27953928|NCT01089725|54611292|FG000|Overall Study|Lost to Follow-up|2|||
27953929|NCT01089725|54611293|FG001|Overall Study|Lost to Follow-up|2|||
27953930|NCT01089725|54611294|FG002|Overall Study|Lost to Follow-up|0|||
27953931|NCT01089725|54611295|FG003|Overall Study|Lost to Follow-up|3|||
27953932|NCT01089725|54611296|FG004|Overall Study|Lost to Follow-up|0|||
27953933|NCT01089725|54611292|FG000|Overall Study|Protocol Violation|0|||
27953934|NCT01089725|54611293|FG001|Overall Study|Protocol Violation|0|||
27953935|NCT01089725|54611294|FG002|Overall Study|Protocol Violation|1|||
27953936|NCT01089725|54611295|FG003|Overall Study|Protocol Violation|1|||
27953937|NCT01089725|54611296|FG004|Overall Study|Protocol Violation|0|||
27953938|NCT01089725|54611292|FG000|Overall Study|Withdrawal by Subject|5|||
27953939|NCT01089725|54611293|FG001|Overall Study|Withdrawal by Subject|5|||
27953940|NCT01089725|54611294|FG002|Overall Study|Withdrawal by Subject|4|||
27953941|NCT01089725|54611295|FG003|Overall Study|Withdrawal by Subject|5|||
27953942|NCT01089725|54611296|FG004|Overall Study|Withdrawal by Subject|4|||
27953943|NCT01089725|54611292|FG000|Overall Study|Study Terminated by Sponsor|51|||
27953944|NCT01089725|54611293|FG001|Overall Study|Study Terminated by Sponsor|56|||
27953945|NCT01089725|54611294|FG002|Overall Study|Study Terminated by Sponsor|53|||
27953946|NCT01089725|54611295|FG003|Overall Study|Study Terminated by Sponsor|68|||
27953947|NCT01089725|54611296|FG004|Overall Study|Study Terminated by Sponsor|68|||
27953948|NCT01089725|54611292|FG000|Overall Study|Randomized, but not treated|0|||
27953949|NCT01089725|54611293|FG001|Overall Study|Randomized, but not treated|1|||
27953950|NCT01089725|54611294|FG002|Overall Study|Randomized, but not treated|2|||
27953951|NCT01089725|54611295|FG003|Overall Study|Randomized, but not treated|1|||
27953952|NCT01089725|54611296|FG004|Overall Study|Randomized, but not treated|2|||
27953953|NCT01089725|54611292|FG000|Overall Study|Other|3|||
27953954|NCT01089725|54611293|FG001|Overall Study|Other|0|||
27953955|NCT01089725|54611294|FG002|Overall Study|Other|0|||
27953956|NCT01089725|54611295|FG003|Overall Study|Other|1|||
27953957|NCT01089725|54611296|FG004|Overall Study|Other|0|||
27953958|NCT01190930|54611314|FG000|Induction|Adverse Event|17|||
27953959|NCT01190930|54611315|FG001|Induction|Adverse Event|0|||
27953960|NCT01190930|54611316|FG002|Induction|Adverse Event|0|||
27953961|NCT01190930|54611317|FG003|Induction|Adverse Event|0|||
27953962|NCT01190930|54611318|FG004|Induction|Adverse Event|0|||
27953963|NCT01190930|54611319|FG005|Induction|Adverse Event|0|||
27953964|NCT01190930|54611320|FG006|Induction|Adverse Event|0|||
27953965|NCT01190930|54611321|FG007|Induction|Adverse Event|0|||
27953966|NCT01190930|54611322|FG008|Induction|Adverse Event|0|||
27953967|NCT01190930|54611323|FG009|Induction|Adverse Event|0|||
27953968|NCT01190930|54611314|FG000|Induction|Death|34|||
27953969|NCT01190930|54611315|FG001|Induction|Death|0|||
27953970|NCT01190930|54611316|FG002|Induction|Death|0|||
27953971|NCT01190930|54611317|FG003|Induction|Death|0|||
27953972|NCT01190930|54611318|FG004|Induction|Death|0|||
27953973|NCT01190930|54611319|FG005|Induction|Death|0|||
27953974|NCT01190930|54611320|FG006|Induction|Death|0|||
27953975|NCT01190930|54611321|FG007|Induction|Death|0|||
27953976|NCT01190930|54611322|FG008|Induction|Death|0|||
27953977|NCT01190930|54611323|FG009|Induction|Death|0|||
27953978|NCT01190930|54611314|FG000|Induction|Lost to Follow-up|1|||
27953979|NCT01190930|54611315|FG001|Induction|Lost to Follow-up|0|||
27953980|NCT01190930|54611316|FG002|Induction|Lost to Follow-up|0|||
27953981|NCT01190930|54611317|FG003|Induction|Lost to Follow-up|0|||
27953982|NCT01190930|54611318|FG004|Induction|Lost to Follow-up|0|||
27953983|NCT01190930|54611319|FG005|Induction|Lost to Follow-up|0|||
27953984|NCT01190930|54611320|FG006|Induction|Lost to Follow-up|0|||
27953985|NCT01190930|54611321|FG007|Induction|Lost to Follow-up|0|||
27953986|NCT01190930|54611322|FG008|Induction|Lost to Follow-up|0|||
27953987|NCT01190930|54611323|FG009|Induction|Lost to Follow-up|0|||
27731994|NCT00103285|54179444|FG002|Response Assignment|Protocol Violation|0|||
27953988|NCT01190930|54611314|FG000|Induction|Physician Decision|125|||
27953989|NCT01190930|54611315|FG001|Induction|Physician Decision|3|||
27953990|NCT01190930|54611316|FG002|Induction|Physician Decision|0|||
27953991|NCT01190930|54611317|FG003|Induction|Physician Decision|0|||
27953992|NCT01190930|54611318|FG004|Induction|Physician Decision|0|||
27953993|NCT01190930|54611319|FG005|Induction|Physician Decision|0|||
27953994|NCT01190930|54611320|FG006|Induction|Physician Decision|0|||
27953995|NCT01190930|54611321|FG007|Induction|Physician Decision|0|||
27953996|NCT01190930|54611322|FG008|Induction|Physician Decision|0|||
27953997|NCT01190930|54611323|FG009|Induction|Physician Decision|0|||
27953998|NCT01190930|54611314|FG000|Induction|Withdrawal by Subject|9|||
27953999|NCT01190930|54611315|FG001|Induction|Withdrawal by Subject|0|||
27954000|NCT01190930|54611316|FG002|Induction|Withdrawal by Subject|0|||
27954001|NCT01190930|54611317|FG003|Induction|Withdrawal by Subject|0|||
27954002|NCT01190930|54611318|FG004|Induction|Withdrawal by Subject|0|||
27954003|NCT01190930|54611319|FG005|Induction|Withdrawal by Subject|0|||
27954004|NCT01190930|54611320|FG006|Induction|Withdrawal by Subject|0|||
27954005|NCT01190930|54611321|FG007|Induction|Withdrawal by Subject|0|||
27954006|NCT01190930|54611322|FG008|Induction|Withdrawal by Subject|0|||
27954007|NCT01190930|54611323|FG009|Induction|Withdrawal by Subject|0|||
27954008|NCT01190930|54611314|FG000|Induction|Refusal|235|||
27954009|NCT01190930|54611315|FG001|Induction|Refusal|0|||
27954010|NCT01190930|54611316|FG002|Induction|Refusal|0|||
27954011|NCT01190930|54611317|FG003|Induction|Refusal|0|||
27954012|NCT01190930|54611318|FG004|Induction|Refusal|0|||
27954013|NCT01190930|54611319|FG005|Induction|Refusal|0|||
27954014|NCT01190930|54611320|FG006|Induction|Refusal|0|||
27954015|NCT01190930|54611321|FG007|Induction|Refusal|0|||
27954016|NCT01190930|54611322|FG008|Induction|Refusal|0|||
27954017|NCT01190930|54611323|FG009|Induction|Refusal|0|||
27954018|NCT01190930|54611314|FG000|Induction|Inevaluable|23|||
27954019|NCT01190930|54611315|FG001|Induction|Inevaluable|1|||
27954020|NCT01190930|54611316|FG002|Induction|Inevaluable|0|||
27954021|NCT01190930|54611317|FG003|Induction|Inevaluable|0|||
27954022|NCT01190930|54611318|FG004|Induction|Inevaluable|0|||
27954023|NCT01190930|54611319|FG005|Induction|Inevaluable|0|||
27954024|NCT01190930|54611320|FG006|Induction|Inevaluable|0|||
27954025|NCT01190930|54611321|FG007|Induction|Inevaluable|0|||
27954026|NCT01190930|54611322|FG008|Induction|Inevaluable|0|||
27954027|NCT01190930|54611323|FG009|Induction|Inevaluable|0|||
27954028|NCT01190930|54611314|FG000|Induction|BM MRD >= 0.01% on Day 29 of Induction|61|||
27954029|NCT01190930|54611315|FG001|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
27954030|NCT01190930|54611316|FG002|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
27954031|NCT01190930|54611317|FG003|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
27954032|NCT01190930|54611318|FG004|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
27954033|NCT01190930|54611319|FG005|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
27954034|NCT01190930|54611320|FG006|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
27954035|NCT01190930|54611321|FG007|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
27954036|NCT01190930|54611322|FG008|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
27954037|NCT01190930|54611323|FG009|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
27954038|NCT01190930|54611314|FG000|Induction|High Risk Downs|80|||
27954039|NCT01190930|54611315|FG001|Induction|High Risk Downs|0|||
27954040|NCT01190930|54611316|FG002|Induction|High Risk Downs|0|||
27954041|NCT01190930|54611317|FG003|Induction|High Risk Downs|0|||
27954042|NCT01190930|54611318|FG004|Induction|High Risk Downs|0|||
27954043|NCT01190930|54611319|FG005|Induction|High Risk Downs|0|||
27954044|NCT01190930|54611320|FG006|Induction|High Risk Downs|0|||
27954045|NCT01190930|54611321|FG007|Induction|High Risk Downs|0|||
27954046|NCT01190930|54611322|FG008|Induction|High Risk Downs|0|||
27954047|NCT01190930|54611323|FG009|Induction|High Risk Downs|0|||
27954048|NCT01190930|54611314|FG000|Induction|Enrollment onto another COG Protocol|1|||
27954049|NCT01190930|54611315|FG001|Induction|Enrollment onto another COG Protocol|0|||
27954050|NCT01190930|54611316|FG002|Induction|Enrollment onto another COG Protocol|0|||
27954051|NCT01190930|54611317|FG003|Induction|Enrollment onto another COG Protocol|0|||
27954052|NCT01190930|54611318|FG004|Induction|Enrollment onto another COG Protocol|0|||
27954053|NCT01190930|54611319|FG005|Induction|Enrollment onto another COG Protocol|0|||
27954054|NCT01190930|54611320|FG006|Induction|Enrollment onto another COG Protocol|0|||
27954055|NCT01190930|54611321|FG007|Induction|Enrollment onto another COG Protocol|0|||
27954056|NCT01190930|54611322|FG008|Induction|Enrollment onto another COG Protocol|0|||
27954057|NCT01190930|54611323|FG009|Induction|Enrollment onto another COG Protocol|0|||
27954058|NCT01190930|54611314|FG000|Induction|Average Risk|1847|||
27954059|NCT01190930|54611315|FG001|Induction|Average Risk|0|||
27954060|NCT01190930|54611316|FG002|Induction|Average Risk|0|||
27954061|NCT01190930|54611317|FG003|Induction|Average Risk|0|||
27954062|NCT01190930|54611318|FG004|Induction|Average Risk|0|||
27954063|NCT01190930|54611319|FG005|Induction|Average Risk|0|||
27954064|NCT01190930|54611320|FG006|Induction|Average Risk|0|||
27954065|NCT01190930|54611321|FG007|Induction|Average Risk|0|||
27954066|NCT01190930|54611322|FG008|Induction|Average Risk|0|||
27954067|NCT01190930|54611323|FG009|Induction|Average Risk|0|||
27954068|NCT01190930|54611314|FG000|Induction|High Risk|1227|||
27954069|NCT01190930|54611315|FG001|Induction|High Risk|0|||
27954070|NCT01190930|54611316|FG002|Induction|High Risk|0|||
27954071|NCT01190930|54611317|FG003|Induction|High Risk|0|||
27954072|NCT01190930|54611318|FG004|Induction|High Risk|0|||
27954073|NCT01190930|54611319|FG005|Induction|High Risk|0|||
27954074|NCT01190930|54611320|FG006|Induction|High Risk|0|||
27954075|NCT01190930|54611321|FG007|Induction|High Risk|0|||
27954076|NCT01190930|54611322|FG008|Induction|High Risk|0|||
27954077|NCT01190930|54611323|FG009|Induction|High Risk|0|||
27954078|NCT01190930|54611314|FG000|Induction|Low Risk|443|||
27954079|NCT01190930|54611315|FG001|Induction|Low Risk|0|||
27954080|NCT01190930|54611316|FG002|Induction|Low Risk|0|||
27954081|NCT01190930|54611317|FG003|Induction|Low Risk|0|||
27954082|NCT01190930|54611318|FG004|Induction|Low Risk|0|||
27954083|NCT01190930|54611319|FG005|Induction|Low Risk|0|||
27954084|NCT01190930|54611320|FG006|Induction|Low Risk|0|||
27954085|NCT01190930|54611321|FG007|Induction|Low Risk|0|||
27954086|NCT01190930|54611322|FG008|Induction|Low Risk|0|||
27954087|NCT01190930|54611323|FG009|Induction|Low Risk|0|||
27954088|NCT01190930|54611314|FG000|Induction|Very High Risk|1012|||
27954089|NCT01190930|54611315|FG001|Induction|Very High Risk|0|||
27954090|NCT01190930|54611316|FG002|Induction|Very High Risk|0|||
27954091|NCT01190930|54611317|FG003|Induction|Very High Risk|0|||
27954092|NCT01190930|54611318|FG004|Induction|Very High Risk|0|||
27954093|NCT01190930|54611319|FG005|Induction|Very High Risk|0|||
27954094|NCT01190930|54611320|FG006|Induction|Very High Risk|0|||
27954095|NCT01190930|54611321|FG007|Induction|Very High Risk|0|||
27954096|NCT01190930|54611322|FG008|Induction|Very High Risk|0|||
27954097|NCT01190930|54611323|FG009|Induction|Very High Risk|0|||
27954098|NCT01190930|54611314|FG000|Induction|Philadelphia chromosome-positive|99|||
27954099|NCT01190930|54611315|FG001|Induction|Philadelphia chromosome-positive|0|||
27954100|NCT01190930|54611316|FG002|Induction|Philadelphia chromosome-positive|0|||
27954101|NCT01190930|54611317|FG003|Induction|Philadelphia chromosome-positive|0|||
27954102|NCT01190930|54611318|FG004|Induction|Philadelphia chromosome-positive|0|||
27954103|NCT01190930|54611319|FG005|Induction|Philadelphia chromosome-positive|0|||
27954104|NCT01190930|54611320|FG006|Induction|Philadelphia chromosome-positive|0|||
27954105|NCT01190930|54611321|FG007|Induction|Philadelphia chromosome-positive|0|||
27954106|NCT01190930|54611322|FG008|Induction|Philadelphia chromosome-positive|0|||
27954107|NCT01190930|54611323|FG009|Induction|Philadelphia chromosome-positive|0|||
27954108|NCT01190930|54611314|FG000|Induction|Incomplete Induction data|63|||
27954109|NCT01190930|54611315|FG001|Induction|Incomplete Induction data|0|||
27954110|NCT01190930|54611316|FG002|Induction|Incomplete Induction data|0|||
27954111|NCT01190930|54611317|FG003|Induction|Incomplete Induction data|0|||
27954112|NCT01190930|54611318|FG004|Induction|Incomplete Induction data|0|||
27954113|NCT01190930|54611319|FG005|Induction|Incomplete Induction data|0|||
27954114|NCT01190930|54611320|FG006|Induction|Incomplete Induction data|0|||
27954115|NCT01190930|54611321|FG007|Induction|Incomplete Induction data|0|||
27954116|NCT01190930|54611322|FG008|Induction|Incomplete Induction data|0|||
27954117|NCT01190930|54611323|FG009|Induction|Incomplete Induction data|0|||
27954118|NCT01190930|54611314|FG000|Induction|Progressive disease|0|||
27954119|NCT01190930|54611315|FG001|Induction|Progressive disease|1|||
27954120|NCT01190930|54611316|FG002|Induction|Progressive disease|0|||
27954121|NCT01190930|54611317|FG003|Induction|Progressive disease|0|||
27954122|NCT01190930|54611318|FG004|Induction|Progressive disease|0|||
27954123|NCT01190930|54611319|FG005|Induction|Progressive disease|0|||
27954124|NCT01190930|54611320|FG006|Induction|Progressive disease|0|||
27954125|NCT01190930|54611321|FG007|Induction|Progressive disease|0|||
27954126|NCT01190930|54611322|FG008|Induction|Progressive disease|0|||
27954127|NCT01190930|54611323|FG009|Induction|Progressive disease|0|||
27954128|NCT01190930|54611314|FG000|Induction|No treatment|3|||
27954129|NCT01190930|54611315|FG001|Induction|No treatment|0|||
27832286|NCT01775189|54311154|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
27832287|NCT01775189|54311155|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
27832288|NCT01775189|54311156|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
27954130|NCT01190930|54611316|FG002|Induction|No treatment|0|||
27954131|NCT01190930|54611317|FG003|Induction|No treatment|0|||
28081683|NCT02899299|54735109|FG000|Treatment|Administrative reason by Sponsor|2|||
28081684|NCT02899299|54735110|FG001|Treatment|Administrative reason by Sponsor|0|||
27954132|NCT01190930|54611318|FG004|Induction|No treatment|0|||
27954133|NCT01190930|54611319|FG005|Induction|No treatment|0|||
27954134|NCT01190930|54611320|FG006|Induction|No treatment|0|||
27954135|NCT01190930|54611321|FG007|Induction|No treatment|0|||
27954136|NCT01190930|54611322|FG008|Induction|No treatment|0|||
27954137|NCT01190930|54611323|FG009|Induction|No treatment|0|||
27954138|NCT01190930|54611314|FG000|Induction|Ineligible|69|||
27954139|NCT01190930|54611315|FG001|Induction|Ineligible|4|||
27954140|NCT01190930|54611316|FG002|Induction|Ineligible|0|||
27954141|NCT01190930|54611317|FG003|Induction|Ineligible|0|||
27954142|NCT01190930|54611318|FG004|Induction|Ineligible|0|||
27954143|NCT01190930|54611319|FG005|Induction|Ineligible|0|||
27954144|NCT01190930|54611320|FG006|Induction|Ineligible|0|||
28081685|NCT02899299|54735109|FG000|Treatment|Other reasons|11|||
28081686|NCT02899299|54735110|FG001|Treatment|Other reasons|2|||
28081687|NCT02899299|54735109|FG000|Treatment|Not reported: Includes participants who achieved max duration of treatment|4|||
28081688|NCT02899299|54735110|FG001|Treatment|Not reported: Includes participants who achieved max duration of treatment|189|||
28081689|NCT02899195|54735116|FG000|Concurrent Durvalumab|Adverse Event|4|||
27954145|NCT01190930|54611321|FG007|Induction|Ineligible|0|||
28081690|NCT02899195|54735116|FG000|Concurrent Durvalumab|Physician Decision|1|||
28081691|NCT02899195|54735116|FG000|Concurrent Durvalumab|Withdrawal by Subject|1|||
27954146|NCT01190930|54611322|FG008|Induction|Ineligible|0|||
27954147|NCT01190930|54611323|FG009|Induction|Ineligible|0|||
27954148|NCT01190930|54611314|FG000|Post Induction Pre-Maintenance|Adverse Event|0|||
27954149|NCT01190930|54611315|FG001|Post Induction Pre-Maintenance|Adverse Event|0|||
27954150|NCT01190930|54611316|FG002|Post Induction Pre-Maintenance|Adverse Event|8|||
27954151|NCT01190930|54611317|FG003|Post Induction Pre-Maintenance|Adverse Event|0|||
27954152|NCT01190930|54611318|FG004|Post Induction Pre-Maintenance|Adverse Event|0|||
27954153|NCT01190930|54611319|FG005|Post Induction Pre-Maintenance|Adverse Event|0|||
27954154|NCT01190930|54611320|FG006|Post Induction Pre-Maintenance|Adverse Event|0|||
27954155|NCT01190930|54611321|FG007|Post Induction Pre-Maintenance|Adverse Event|0|||
27954156|NCT01190930|54611322|FG008|Post Induction Pre-Maintenance|Adverse Event|0|||
27954157|NCT01190930|54611323|FG009|Post Induction Pre-Maintenance|Adverse Event|0|||
27954158|NCT01190930|54611314|FG000|Post Induction Pre-Maintenance|Death|0|||
27954159|NCT01190930|54611315|FG001|Post Induction Pre-Maintenance|Death|0|||
27954160|NCT01190930|54611316|FG002|Post Induction Pre-Maintenance|Death|8|||
27954161|NCT01190930|54611317|FG003|Post Induction Pre-Maintenance|Death|4|||
27954162|NCT01190930|54611318|FG004|Post Induction Pre-Maintenance|Death|0|||
27954163|NCT01190930|54611319|FG005|Post Induction Pre-Maintenance|Death|0|||
27954164|NCT01190930|54611320|FG006|Post Induction Pre-Maintenance|Death|0|||
27954165|NCT01190930|54611321|FG007|Post Induction Pre-Maintenance|Death|0|||
27954166|NCT01190930|54611322|FG008|Post Induction Pre-Maintenance|Death|0|||
27954167|NCT01190930|54611323|FG009|Post Induction Pre-Maintenance|Death|0|||
27731995|NCT00103285|54179445|FG003|Response Assignment|Protocol Violation|0|||
27731996|NCT00103285|54179446|FG004|Response Assignment|Protocol Violation|0|||
27731997|NCT00103285|54179447|FG005|Response Assignment|Protocol Violation|0|||
27731998|NCT00103285|54179448|FG006|Response Assignment|Protocol Violation|0|||
27731999|NCT00103285|54179449|FG007|Response Assignment|Protocol Violation|0|||
27732000|NCT00103285|54179442|FG000|Response Assignment|Withdrawal by Subject|0|||
27732001|NCT00103285|54179443|FG001|Response Assignment|Withdrawal by Subject|4|||
27732002|NCT00103285|54179444|FG002|Response Assignment|Withdrawal by Subject|1|||
27732003|NCT00103285|54179445|FG003|Response Assignment|Withdrawal by Subject|1|||
27732004|NCT00103285|54179446|FG004|Response Assignment|Withdrawal by Subject|2|||
27732005|NCT00103285|54179447|FG005|Response Assignment|Withdrawal by Subject|2|||
27732006|NCT00103285|54179448|FG006|Response Assignment|Withdrawal by Subject|0|||
27732007|NCT00103285|54179449|FG007|Response Assignment|Withdrawal by Subject|2|||
27732008|NCT00103285|54179442|FG000|Response Assignment|Ineligible|0|||
27954168|NCT01190930|54611314|FG000|Post Induction Pre-Maintenance|Physician Decision|0|||
27732009|NCT00103285|54179443|FG001|Response Assignment|Ineligible|8|||
27732010|NCT00103285|54179444|FG002|Response Assignment|Ineligible|6|||
27732011|NCT00103285|54179445|FG003|Response Assignment|Ineligible|2|||
27732012|NCT00103285|54179446|FG004|Response Assignment|Ineligible|0|||
27732013|NCT00103285|54179447|FG005|Response Assignment|Ineligible|3|||
27732014|NCT00103285|54179448|FG006|Response Assignment|Ineligible|1|||
27732015|NCT00103285|54179449|FG007|Response Assignment|Ineligible|5|||
27732016|NCT00103285|54179442|FG000|Response Assignment|Refusal|0|||
27732017|NCT00103285|54179443|FG001|Response Assignment|Refusal|53|||
27732018|NCT00103285|54179444|FG002|Response Assignment|Refusal|5|||
27732019|NCT00103285|54179445|FG003|Response Assignment|Refusal|3|||
27732020|NCT00103285|54179446|FG004|Response Assignment|Refusal|25|||
27732021|NCT00103285|54179447|FG005|Response Assignment|Refusal|15|||
27732022|NCT00103285|54179448|FG006|Response Assignment|Refusal|30|||
27732023|NCT00103285|54179449|FG007|Response Assignment|Refusal|10|||
27732024|NCT00103285|54179442|FG000|Response Assignment|Other|0|||
27732025|NCT00103285|54179443|FG001|Response Assignment|Other|30|||
27732026|NCT00103285|54179444|FG002|Response Assignment|Other|48|||
27732027|NCT00103285|54179445|FG003|Response Assignment|Other|38|||
27732028|NCT00103285|54179446|FG004|Response Assignment|Other|37|||
27732029|NCT00103285|54179447|FG005|Response Assignment|Other|17|||
27732030|NCT00103285|54179448|FG006|Response Assignment|Other|11|||
27732031|NCT00103285|54179449|FG007|Response Assignment|Other|53|||
27732032|NCT02783573|54179477|FG000|Placebo-Controlled Treatment Period|Adverse Event|13|||
27732033|NCT02783573|54179478|FG001|Placebo-Controlled Treatment Period|Adverse Event|17|||
27732034|NCT02783573|54179479|FG002|Placebo-Controlled Treatment Period|Adverse Event|13|||
27732035|NCT02783573|54179477|FG000|Placebo-Controlled Treatment Period|Death|4|||
27732036|NCT02783573|54179478|FG001|Placebo-Controlled Treatment Period|Death|2|||
27732037|NCT02783573|54179479|FG002|Placebo-Controlled Treatment Period|Death|3|||
27732038|NCT02783573|54179477|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
27732039|NCT02783573|54179478|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
27954169|NCT01190930|54611315|FG001|Post Induction Pre-Maintenance|Physician Decision|2|||
27954170|NCT01190930|54611316|FG002|Post Induction Pre-Maintenance|Physician Decision|35|||
27732040|NCT02783573|54179479|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
27732041|NCT02783573|54179477|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
27732042|NCT02783573|54179478|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
27732043|NCT02783573|54179479|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
27732044|NCT02783573|54179477|FG000|Placebo-Controlled Treatment Period|Non-Compliance|0|||
27732045|NCT02783573|54179478|FG001|Placebo-Controlled Treatment Period|Non-Compliance|1|||
27732046|NCT02783573|54179479|FG002|Placebo-Controlled Treatment Period|Non-Compliance|0|||
27732047|NCT02783573|54179477|FG000|Placebo-Controlled Treatment Period|Other-determined by Investigator|0|||
27732048|NCT02783573|54179478|FG001|Placebo-Controlled Treatment Period|Other-determined by Investigator|1|||
27954171|NCT01190930|54611317|FG003|Post Induction Pre-Maintenance|Physician Decision|7|||
27954172|NCT01190930|54611318|FG004|Post Induction Pre-Maintenance|Physician Decision|5|||
27954173|NCT01190930|54611319|FG005|Post Induction Pre-Maintenance|Physician Decision|3|||
27954174|NCT01190930|54611320|FG006|Post Induction Pre-Maintenance|Physician Decision|0|||
27954175|NCT01190930|54611321|FG007|Post Induction Pre-Maintenance|Physician Decision|0|||
27954176|NCT01190930|54611322|FG008|Post Induction Pre-Maintenance|Physician Decision|0|||
27954177|NCT01190930|54611323|FG009|Post Induction Pre-Maintenance|Physician Decision|0|||
27954178|NCT01190930|54611314|FG000|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
27954179|NCT01190930|54611315|FG001|Post Induction Pre-Maintenance|Withdrawal by Subject|1|||
27954180|NCT01190930|54611316|FG002|Post Induction Pre-Maintenance|Withdrawal by Subject|5|||
27954181|NCT01190930|54611317|FG003|Post Induction Pre-Maintenance|Withdrawal by Subject|2|||
27954182|NCT01190930|54611318|FG004|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
27954183|NCT01190930|54611319|FG005|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
27954184|NCT01190930|54611320|FG006|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
27954185|NCT01190930|54611321|FG007|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
27954186|NCT01190930|54611322|FG008|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
27954187|NCT01190930|54611323|FG009|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
27954188|NCT01190930|54611314|FG000|Post Induction Pre-Maintenance|Refusal|0|||
27954189|NCT01190930|54611315|FG001|Post Induction Pre-Maintenance|Refusal|2|||
27954190|NCT01190930|54611316|FG002|Post Induction Pre-Maintenance|Refusal|694|||
27954191|NCT01190930|54611317|FG003|Post Induction Pre-Maintenance|Refusal|4|||
27954192|NCT01190930|54611318|FG004|Post Induction Pre-Maintenance|Refusal|0|||
27954193|NCT01190930|54611319|FG005|Post Induction Pre-Maintenance|Refusal|3|||
27954194|NCT01190930|54611320|FG006|Post Induction Pre-Maintenance|Refusal|0|||
27954195|NCT01190930|54611321|FG007|Post Induction Pre-Maintenance|Refusal|0|||
27954196|NCT01190930|54611322|FG008|Post Induction Pre-Maintenance|Refusal|0|||
27954197|NCT01190930|54611323|FG009|Post Induction Pre-Maintenance|Refusal|0|||
27954198|NCT01190930|54611314|FG000|Post Induction Pre-Maintenance|Inevaluable|0|||
27954199|NCT01190930|54611315|FG001|Post Induction Pre-Maintenance|Inevaluable|0|||
27954200|NCT01190930|54611316|FG002|Post Induction Pre-Maintenance|Inevaluable|6|||
27954201|NCT01190930|54611317|FG003|Post Induction Pre-Maintenance|Inevaluable|0|||
27954202|NCT01190930|54611318|FG004|Post Induction Pre-Maintenance|Inevaluable|0|||
27954203|NCT01190930|54611319|FG005|Post Induction Pre-Maintenance|Inevaluable|0|||
27954204|NCT01190930|54611320|FG006|Post Induction Pre-Maintenance|Inevaluable|0|||
27954205|NCT01190930|54611321|FG007|Post Induction Pre-Maintenance|Inevaluable|0|||
27954206|NCT01190930|54611322|FG008|Post Induction Pre-Maintenance|Inevaluable|0|||
27954207|NCT01190930|54611323|FG009|Post Induction Pre-Maintenance|Inevaluable|0|||
27954208|NCT01190930|54611314|FG000|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
27954209|NCT01190930|54611315|FG001|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1|||
27954210|NCT01190930|54611316|FG002|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
27954211|NCT01190930|54611317|FG003|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
27954212|NCT01190930|54611318|FG004|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
27954213|NCT01190930|54611319|FG005|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
27954214|NCT01190930|54611320|FG006|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
27954215|NCT01190930|54611321|FG007|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
27954216|NCT01190930|54611322|FG008|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
27954217|NCT01190930|54611323|FG009|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
27954218|NCT01190930|54611314|FG000|Post Induction Pre-Maintenance|Progressive disease|0|||
27954219|NCT01190930|54611315|FG001|Post Induction Pre-Maintenance|Progressive disease|0|||
27954220|NCT01190930|54611316|FG002|Post Induction Pre-Maintenance|Progressive disease|1|||
27954221|NCT01190930|54611317|FG003|Post Induction Pre-Maintenance|Progressive disease|0|||
27954222|NCT01190930|54611318|FG004|Post Induction Pre-Maintenance|Progressive disease|0|||
27954223|NCT01190930|54611319|FG005|Post Induction Pre-Maintenance|Progressive disease|0|||
27954224|NCT01190930|54611320|FG006|Post Induction Pre-Maintenance|Progressive disease|0|||
27954225|NCT01190930|54611321|FG007|Post Induction Pre-Maintenance|Progressive disease|0|||
27954226|NCT01190930|54611322|FG008|Post Induction Pre-Maintenance|Progressive disease|0|||
28165045|NCT02991859|54835654|FG000|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
27954227|NCT01190930|54611323|FG009|Post Induction Pre-Maintenance|Progressive disease|0|||
27832289|NCT01775189|54311157|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
27832290|NCT01775189|54311158|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
27832291|NCT01775189|54311152|FG000|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
27832292|NCT01775189|54311153|FG001|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2|||
27832293|NCT01775189|54311154|FG002|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7|||
27832294|NCT01775189|54311155|FG003|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
27832295|NCT01775189|54311156|FG004|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
27832296|NCT01775189|54311157|FG005|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
27954228|NCT01190930|54611314|FG000|Post Induction Pre-Maintenance|Relapse|0|||
27954229|NCT01190930|54611315|FG001|Post Induction Pre-Maintenance|Relapse|0|||
27954230|NCT01190930|54611316|FG002|Post Induction Pre-Maintenance|Relapse|1|||
27954231|NCT01190930|54611317|FG003|Post Induction Pre-Maintenance|Relapse|0|||
27954232|NCT01190930|54611318|FG004|Post Induction Pre-Maintenance|Relapse|0|||
27954233|NCT01190930|54611319|FG005|Post Induction Pre-Maintenance|Relapse|0|||
27954234|NCT01190930|54611320|FG006|Post Induction Pre-Maintenance|Relapse|0|||
27954235|NCT01190930|54611321|FG007|Post Induction Pre-Maintenance|Relapse|0|||
27954236|NCT01190930|54611322|FG008|Post Induction Pre-Maintenance|Relapse|0|||
27954237|NCT01190930|54611323|FG009|Post Induction Pre-Maintenance|Relapse|0|||
27954238|NCT01190930|54611314|FG000|Maintenance|Adverse Event|0|||
27954239|NCT01190930|54611315|FG001|Maintenance|Adverse Event|0|||
27954240|NCT01190930|54611316|FG002|Maintenance|Adverse Event|0|||
27954241|NCT01190930|54611317|FG003|Maintenance|Adverse Event|0|||
27954242|NCT01190930|54611318|FG004|Maintenance|Adverse Event|0|||
27954243|NCT01190930|54611319|FG005|Maintenance|Adverse Event|1|||
27954244|NCT01190930|54611320|FG006|Maintenance|Adverse Event|1|||
27954245|NCT01190930|54611321|FG007|Maintenance|Adverse Event|3|||
27954246|NCT01190930|54611322|FG008|Maintenance|Adverse Event|3|||
27954247|NCT01190930|54611323|FG009|Maintenance|Adverse Event|0|||
27954248|NCT01190930|54611314|FG000|Maintenance|Death|0|||
27954249|NCT01190930|54611315|FG001|Maintenance|Death|0|||
27954250|NCT01190930|54611316|FG002|Maintenance|Death|0|||
27954251|NCT01190930|54611317|FG003|Maintenance|Death|1|||
27954252|NCT01190930|54611318|FG004|Maintenance|Death|0|||
27954253|NCT01190930|54611319|FG005|Maintenance|Death|0|||
27954254|NCT01190930|54611320|FG006|Maintenance|Death|2|||
27954255|NCT01190930|54611321|FG007|Maintenance|Death|2|||
27954256|NCT01190930|54611322|FG008|Maintenance|Death|2|||
27954257|NCT01190930|54611323|FG009|Maintenance|Death|2|||
27954258|NCT01190930|54611314|FG000|Maintenance|Lost to Follow-up|0|||
27954259|NCT01190930|54611315|FG001|Maintenance|Lost to Follow-up|0|||
27954260|NCT01190930|54611316|FG002|Maintenance|Lost to Follow-up|0|||
27954261|NCT01190930|54611317|FG003|Maintenance|Lost to Follow-up|0|||
27954262|NCT01190930|54611318|FG004|Maintenance|Lost to Follow-up|0|||
27954263|NCT01190930|54611319|FG005|Maintenance|Lost to Follow-up|0|||
27954264|NCT01190930|54611320|FG006|Maintenance|Lost to Follow-up|1|||
27954265|NCT01190930|54611321|FG007|Maintenance|Lost to Follow-up|1|||
27954266|NCT01190930|54611322|FG008|Maintenance|Lost to Follow-up|1|||
27954267|NCT01190930|54611323|FG009|Maintenance|Lost to Follow-up|0|||
27954268|NCT01190930|54611314|FG000|Maintenance|Physician Decision|0|||
27954269|NCT01190930|54611315|FG001|Maintenance|Physician Decision|1|||
27954270|NCT01190930|54611316|FG002|Maintenance|Physician Decision|0|||
27954271|NCT01190930|54611317|FG003|Maintenance|Physician Decision|5|||
27954272|NCT01190930|54611318|FG004|Maintenance|Physician Decision|9|||
27954273|NCT01190930|54611319|FG005|Maintenance|Physician Decision|4|||
27954274|NCT01190930|54611320|FG006|Maintenance|Physician Decision|8|||
27954275|NCT01190930|54611321|FG007|Maintenance|Physician Decision|8|||
27954276|NCT01190930|54611322|FG008|Maintenance|Physician Decision|10|||
27954277|NCT01190930|54611323|FG009|Maintenance|Physician Decision|17|||
27954278|NCT01190930|54611314|FG000|Maintenance|Withdrawal by Subject|0|||
27954279|NCT01190930|54611315|FG001|Maintenance|Withdrawal by Subject|0|||
27954280|NCT01190930|54611316|FG002|Maintenance|Withdrawal by Subject|0|||
27954281|NCT01190930|54611317|FG003|Maintenance|Withdrawal by Subject|0|||
27954282|NCT01190930|54611318|FG004|Maintenance|Withdrawal by Subject|0|||
27954283|NCT01190930|54611319|FG005|Maintenance|Withdrawal by Subject|0|||
27954284|NCT01190930|54611320|FG006|Maintenance|Withdrawal by Subject|2|||
27954285|NCT01190930|54611321|FG007|Maintenance|Withdrawal by Subject|1|||
27954286|NCT01190930|54611322|FG008|Maintenance|Withdrawal by Subject|4|||
27954287|NCT01190930|54611323|FG009|Maintenance|Withdrawal by Subject|1|||
27954288|NCT01190930|54611314|FG000|Maintenance|Refusal|0|||
27954289|NCT01190930|54611315|FG001|Maintenance|Refusal|1|||
27954290|NCT01190930|54611316|FG002|Maintenance|Refusal|0|||
27954291|NCT01190930|54611317|FG003|Maintenance|Refusal|2|||
27954292|NCT01190930|54611318|FG004|Maintenance|Refusal|0|||
27954293|NCT01190930|54611319|FG005|Maintenance|Refusal|4|||
27954294|NCT01190930|54611320|FG006|Maintenance|Refusal|5|||
27954295|NCT01190930|54611321|FG007|Maintenance|Refusal|17|||
27954296|NCT01190930|54611322|FG008|Maintenance|Refusal|13|||
27954297|NCT01190930|54611323|FG009|Maintenance|Refusal|6|||
27954298|NCT01190930|54611314|FG000|Maintenance|second malignant neoplasm|0|||
28081692|NCT02899195|54735116|FG000|Concurrent Durvalumab|Progressive Disease|5|||
27954299|NCT01190930|54611315|FG001|Maintenance|second malignant neoplasm|0|||
27954300|NCT01190930|54611316|FG002|Maintenance|second malignant neoplasm|0|||
27954301|NCT01190930|54611317|FG003|Maintenance|second malignant neoplasm|1|||
27954302|NCT01190930|54611318|FG004|Maintenance|second malignant neoplasm|0|||
27954303|NCT01190930|54611319|FG005|Maintenance|second malignant neoplasm|1|||
27954304|NCT01190930|54611320|FG006|Maintenance|second malignant neoplasm|0|||
27954305|NCT01190930|54611321|FG007|Maintenance|second malignant neoplasm|0|||
27954306|NCT01190930|54611322|FG008|Maintenance|second malignant neoplasm|1|||
27954307|NCT01190930|54611323|FG009|Maintenance|second malignant neoplasm|0|||
27954308|NCT01190930|54611314|FG000|Maintenance|Inevaluable|0|||
27954309|NCT01190930|54611315|FG001|Maintenance|Inevaluable|0|||
27954310|NCT01190930|54611316|FG002|Maintenance|Inevaluable|0|||
27954311|NCT01190930|54611317|FG003|Maintenance|Inevaluable|0|||
27954312|NCT01190930|54611318|FG004|Maintenance|Inevaluable|0|||
27954313|NCT01190930|54611319|FG005|Maintenance|Inevaluable|1|||
27954314|NCT01190930|54611320|FG006|Maintenance|Inevaluable|1|||
27954315|NCT01190930|54611321|FG007|Maintenance|Inevaluable|1|||
27954316|NCT01190930|54611322|FG008|Maintenance|Inevaluable|0|||
27954317|NCT01190930|54611323|FG009|Maintenance|Inevaluable|0|||
27954318|NCT01190930|54611314|FG000|Maintenance|Enrollment onto another COG Protocol|0|||
27954319|NCT01190930|54611315|FG001|Maintenance|Enrollment onto another COG Protocol|0|||
27954320|NCT01190930|54611316|FG002|Maintenance|Enrollment onto another COG Protocol|0|||
27954321|NCT01190930|54611317|FG003|Maintenance|Enrollment onto another COG Protocol|0|||
27954322|NCT01190930|54611318|FG004|Maintenance|Enrollment onto another COG Protocol|0|||
27954323|NCT01190930|54611319|FG005|Maintenance|Enrollment onto another COG Protocol|0|||
27954324|NCT01190930|54611320|FG006|Maintenance|Enrollment onto another COG Protocol|0|||
27954325|NCT01190930|54611321|FG007|Maintenance|Enrollment onto another COG Protocol|0|||
27954326|NCT01190930|54611322|FG008|Maintenance|Enrollment onto another COG Protocol|1|||
27954327|NCT01190930|54611323|FG009|Maintenance|Enrollment onto another COG Protocol|0|||
27954328|NCT01190930|54611314|FG000|Maintenance|Relapse|0|||
27954329|NCT01190930|54611315|FG001|Maintenance|Relapse|0|||
27954330|NCT01190930|54611316|FG002|Maintenance|Relapse|0|||
27954331|NCT01190930|54611317|FG003|Maintenance|Relapse|2|||
27954332|NCT01190930|54611318|FG004|Maintenance|Relapse|0|||
27954333|NCT01190930|54611319|FG005|Maintenance|Relapse|1|||
27954334|NCT01190930|54611320|FG006|Maintenance|Relapse|6|||
27954335|NCT01190930|54611321|FG007|Maintenance|Relapse|13|||
27954336|NCT01190930|54611322|FG008|Maintenance|Relapse|11|||
27954337|NCT01190930|54611323|FG009|Maintenance|Relapse|11|||
27954338|NCT01190930|54611314|FG000|Maintenance|Still on therapy|0|||
27954339|NCT01190930|54611315|FG001|Maintenance|Still on therapy|8|||
27954340|NCT01190930|54611316|FG002|Maintenance|Still on therapy|0|||
27954341|NCT01190930|54611317|FG003|Maintenance|Still on therapy|29|||
27954342|NCT01190930|54611318|FG004|Maintenance|Still on therapy|0|||
27954343|NCT01190930|54611319|FG005|Maintenance|Still on therapy|0|||
27954344|NCT01190930|54611320|FG006|Maintenance|Still on therapy|0|||
27954345|NCT01190930|54611321|FG007|Maintenance|Still on therapy|0|||
28081693|NCT02899195|54735116|FG000|Maintenance Durvalumab|Adverse Event|1|||
28081694|NCT02899195|54735116|FG000|Maintenance Durvalumab|Physician Decision|1|||
28081695|NCT02899195|54735116|FG000|Maintenance Durvalumab|Withdrawal by Subject|1|||
28081696|NCT02899195|54735116|FG000|Maintenance Durvalumab|Progressive Disease|31|||
28081697|NCT02562235|54735202|FG000|Overall Study|Adverse Event|3|||
28081698|NCT02527200|54735215|FG000|Overall Study|Withdrawal by Subject|3|||
28081699|NCT02527200|54735216|FG001|Overall Study|Withdrawal by Subject|2|||
28081700|NCT02527200|54735217|FG002|Overall Study|Withdrawal by Subject|1|||
28081701|NCT02527200|54735218|FG003|Overall Study|Withdrawal by Subject|0|||
28081702|NCT02527200|54735215|FG000|Overall Study|Unclassified|0|||
28081703|NCT02527200|54735216|FG001|Overall Study|Unclassified|1|||
28081704|NCT02527200|54735217|FG002|Overall Study|Unclassified|0|||
28081705|NCT02527200|54735218|FG003|Overall Study|Unclassified|0|||
28081706|NCT02527200|54735215|FG000|Overall Study|Lost to Follow-up|0|||
28081707|NCT02527200|54735216|FG001|Overall Study|Lost to Follow-up|0|||
28081708|NCT02527200|54735217|FG002|Overall Study|Lost to Follow-up|1|||
28081709|NCT02527200|54735218|FG003|Overall Study|Lost to Follow-up|0|||
28081710|NCT02510040|54735235|FG000|Overall Study|Deemed no longer eligible|18|||
28081711|NCT02510040|54735236|FG001|Overall Study|Deemed no longer eligible|3|||
28081712|NCT02510040|54735237|FG002|Overall Study|Deemed no longer eligible|1|||
28081713|NCT02296125|54735261|FG000|Overall Study|Withdrawal by Subject|18|||
28081714|NCT02296125|54735262|FG001|Overall Study|Withdrawal by Subject|8|||
28081715|NCT02296125|54735263|FG002|Overall Study|Withdrawal by Subject|6|||
28081716|NCT02296125|54735264|FG003|Overall Study|Withdrawal by Subject|2|||
27832297|NCT01775189|54311158|FG006|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
27954346|NCT01190930|54611322|FG008|Maintenance|Still on therapy|0|||
28081717|NCT02296125|54735261|FG000|Overall Study|Adverse Event|41|||
27832298|NCT01775189|54311152|FG000|Treatment Phase: Washout Period 1|Protocol Violation|0|||
27832299|NCT01775189|54311153|FG001|Treatment Phase: Washout Period 1|Protocol Violation|0|||
27832300|NCT01775189|54311154|FG002|Treatment Phase: Washout Period 1|Protocol Violation|0|||
27832301|NCT01775189|54311155|FG003|Treatment Phase: Washout Period 1|Protocol Violation|0|||
27832302|NCT01775189|54311156|FG004|Treatment Phase: Washout Period 1|Protocol Violation|0|||
27832303|NCT01775189|54311157|FG005|Treatment Phase: Washout Period 1|Protocol Violation|1|||
27832304|NCT01775189|54311158|FG006|Treatment Phase: Washout Period 1|Protocol Violation|0|||
27954347|NCT01190930|54611323|FG009|Maintenance|Still on therapy|0|||
27954348|NCT01101191|54611347|FG000|Period 1|Withdrawal by Subject|1|||
27954349|NCT01101191|54611348|FG001|Period 1|Withdrawal by Subject|0|||
27954350|NCT01101191|54611347|FG000|Period 1|Adverse Event|1|||
27954351|NCT01101191|54611348|FG001|Period 1|Adverse Event|2|||
27954352|NCT01178762|54611355|FG000|Overall Study|Lost to Follow-up|15|||
27954353|NCT01178294|54611359|FG000|Overall Study|Adverse Event|4|||
27954354|NCT01178294|54611359|FG000|Overall Study|Lost to Follow-up|2|||
28081718|NCT02296125|54735262|FG001|Overall Study|Adverse Event|52|||
28081719|NCT02296125|54735263|FG002|Overall Study|Adverse Event|9|||
28081720|NCT02296125|54735264|FG003|Overall Study|Adverse Event|4|||
28081721|NCT02296125|54735261|FG000|Overall Study|Severe non-compliance to protocol|0|||
28081722|NCT02296125|54735262|FG001|Overall Study|Severe non-compliance to protocol|1|||
28081723|NCT02296125|54735263|FG002|Overall Study|Severe non-compliance to protocol|0|||
28081724|NCT02296125|54735264|FG003|Overall Study|Severe non-compliance to protocol|0|||
28081725|NCT02296125|54735261|FG000|Overall Study|Condition under investigation worsened|153|||
28081726|NCT02296125|54735262|FG001|Overall Study|Condition under investigation worsened|199|||
28081727|NCT02296125|54735263|FG002|Overall Study|Condition under investigation worsened|39|||
28081728|NCT02296125|54735264|FG003|Overall Study|Condition under investigation worsened|56|||
28081729|NCT02296125|54735261|FG000|Overall Study|Any reason not specifically recorded|6|||
28081730|NCT02296125|54735262|FG001|Overall Study|Any reason not specifically recorded|4|||
28081731|NCT02296125|54735263|FG002|Overall Study|Any reason not specifically recorded|2|||
28081732|NCT02296125|54735264|FG003|Overall Study|Any reason not specifically recorded|0|||
28081733|NCT02043678|54735281|FG000|Overall Study|Never treated|11|||
28081734|NCT02043678|54735282|FG001|Overall Study|Never treated|9|||
28081735|NCT02043678|54735281|FG000|Overall Study|AE with clinical progressive disease(PD)|18|||
28081736|NCT02043678|54735282|FG001|Overall Study|AE with clinical progressive disease(PD)|18|||
28081737|NCT02043678|54735281|FG000|Overall Study|AE without clinical PD|51|||
28081738|NCT02043678|54735282|FG001|Overall Study|AE without clinical PD|34|||
28081739|NCT02043678|54735281|FG000|Overall Study|Lost to Follow-up|1|||
28081740|NCT02043678|54735282|FG001|Overall Study|Lost to Follow-up|1|||
28081741|NCT02043678|54735281|FG000|Overall Study|Other|19|||
28081742|NCT02043678|54735282|FG001|Overall Study|Other|16|||
28081743|NCT02043678|54735281|FG000|Overall Study|Clinical PD|108|||
28081744|NCT02043678|54735282|FG001|Overall Study|Clinical PD|138|||
28081745|NCT02043678|54735281|FG000|Overall Study|Radiological PD|91|||
28081746|NCT02043678|54735282|FG001|Overall Study|Radiological PD|80|||
28081747|NCT02043678|54735281|FG000|Overall Study|Protocol-driven decision point|56|||
28081748|NCT02043678|54735282|FG001|Overall Study|Protocol-driven decision point|56|||
28081749|NCT02043678|54735281|FG000|Overall Study|Withdrawal by Subject|12|||
28081750|NCT02043678|54735282|FG001|Overall Study|Withdrawal by Subject|15|||
28081751|NCT02043678|54735281|FG000|Overall Study|Ongoing with treatment|34|||
28081752|NCT02043678|54735282|FG001|Overall Study|Ongoing with treatment|38|||
28081753|NCT01935089|54735288|FG000|Overall Study|Adverse Event|2|||
28081754|NCT01935089|54735288|FG000|Overall Study|Withdrawal by Subject|1|||
28081755|NCT01169337|54735314|FG000|Overall Study|Lack of Efficacy|5|||
28081756|NCT01169337|54735315|FG001|Overall Study|Lack of Efficacy|7|||
28081757|NCT01169337|54735316|FG002|Overall Study|Lack of Efficacy|0|||
28081758|NCT01169337|54735314|FG000|Overall Study|Adverse Event|12|||
28081759|NCT01169337|54735315|FG001|Overall Study|Adverse Event|18|||
28081760|NCT01169337|54735316|FG002|Overall Study|Adverse Event|0|||
28081761|NCT01169337|54735314|FG000|Overall Study|Death|2|||
28081762|NCT01169337|54735315|FG001|Overall Study|Death|0|||
28081763|NCT01169337|54735316|FG002|Overall Study|Death|0|||
28081764|NCT01169337|54735314|FG000|Overall Study|Withdrawal by Subject|11|||
28081765|NCT01169337|54735315|FG001|Overall Study|Withdrawal by Subject|11|||
28081766|NCT01169337|54735316|FG002|Overall Study|Withdrawal by Subject|6|||
28081767|NCT01169337|54735314|FG000|Overall Study|Noncompliance|2|||
28081768|NCT01169337|54735315|FG001|Overall Study|Noncompliance|0|||
28081769|NCT01169337|54735316|FG002|Overall Study|Noncompliance|0|||
28081770|NCT01169337|54735314|FG000|Overall Study|Other complicating disease|1|||
28081771|NCT01169337|54735315|FG001|Overall Study|Other complicating disease|1|||
28081772|NCT01169337|54735316|FG002|Overall Study|Other complicating disease|0|||
28081773|NCT01169337|54735314|FG000|Overall Study|Physician Decision|1|||
28081774|NCT01169337|54735315|FG001|Overall Study|Physician Decision|5|||
28081775|NCT01169337|54735316|FG002|Overall Study|Physician Decision|0|||
28081776|NCT01169337|54735314|FG000|Overall Study|Alternative therapy|0|||
28081777|NCT01169337|54735315|FG001|Overall Study|Alternative therapy|2|||
28081778|NCT01169337|54735316|FG002|Overall Study|Alternative therapy|0|||
28081779|NCT01169337|54735314|FG000|Overall Study|Changed hospital|0|||
28081780|NCT01169337|54735315|FG001|Overall Study|Changed hospital|1|||
28081781|NCT01169337|54735316|FG002|Overall Study|Changed hospital|0|||
28081782|NCT01169337|54735314|FG000|Overall Study|Never started treatment|0|||
28165046|NCT02991859|54835655|FG001|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
27732049|NCT02783573|54179479|FG002|Placebo-Controlled Treatment Period|Other-determined by Investigator|2|||
28081783|NCT01169337|54735315|FG001|Overall Study|Never started treatment|2|||
28081784|NCT01169337|54735316|FG002|Overall Study|Never started treatment|0|||
28081785|NCT01169337|54735314|FG000|Overall Study|Reason not reported|1|||
28081786|NCT01169337|54735315|FG001|Overall Study|Reason not reported|0|||
28081787|NCT01169337|54735316|FG002|Overall Study|Reason not reported|0|||
28081788|NCT01169337|54735314|FG000|Overall Study|Continuing lenalidomide|9|||
28081789|NCT01169337|54735315|FG001|Overall Study|Continuing lenalidomide|43|||
28081790|NCT01169337|54735316|FG002|Overall Study|Continuing lenalidomide|0|||
28081791|NCT00770809|54735340|FG000|Overall Study|Adverse Event|9|||
28081792|NCT00770809|54735341|FG001|Overall Study|Adverse Event|1|||
28081793|NCT00770809|54735342|FG002|Overall Study|Adverse Event|12|||
28081794|NCT00770809|54735340|FG000|Overall Study|Death|1|||
28081795|NCT00770809|54735341|FG001|Overall Study|Death|0|||
28081796|NCT00770809|54735342|FG002|Overall Study|Death|0|||
27954355|NCT01178294|54611359|FG000|Overall Study|Lack of Efficacy|1|||
27954356|NCT01178294|54611359|FG000|Overall Study|Death|1|||
27954357|NCT01178294|54611359|FG000|Overall Study|Development of inhibitors to OBI-1|1|||
27954358|NCT01178294|54611359|FG000|Overall Study|Subject status is terminal|1|||
27954359|NCT01178294|54611359|FG000|Overall Study|Completion status could not be verified|1|||
27954360|NCT01178138|54611363|FG000|Overall Study|Lost to Follow-up|8|||
27954361|NCT01178138|54611363|FG000|Overall Study|Withdrawal by Subject|7|||
27954362|NCT01178138|54611363|FG000|Overall Study|Physician Decision|8|||
27954363|NCT01177670|54611372|FG000|Overall Study|Study Terminated|115|||
27954364|NCT01177670|54611372|FG000|Overall Study|Physician Decision|50|||
27954365|NCT01177670|54611372|FG000|Overall Study|Withdrawal by Subject|4|||
27954366|NCT01190228|54611379|FG000|Overall Study|Protocol Violation|4|||
27954367|NCT01190228|54611380|FG001|Overall Study|Protocol Violation|0|||
27954368|NCT01190228|54611381|FG002|Overall Study|Protocol Violation|0|||
28081797|NCT00770809|54735340|FG000|Overall Study|Withdrawal by Subject|3|||
28081798|NCT00770809|54735341|FG001|Overall Study|Withdrawal by Subject|3|||
28081799|NCT00770809|54735342|FG002|Overall Study|Withdrawal by Subject|7|||
28081800|NCT00770809|54735340|FG000|Overall Study|Progression|2|||
28081801|NCT00770809|54735341|FG001|Overall Study|Progression|2|||
28081802|NCT00770809|54735342|FG002|Overall Study|Progression|0|||
28081803|NCT00770809|54735340|FG000|Overall Study|Complicating illness|0|||
28165047|NCT02991859|54835656|FG002|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
27732050|NCT02783573|54179477|FG000|Placebo-Controlled Treatment Period|Physician Decision|3|||
27954369|NCT01190228|54611379|FG000|Overall Study|Withdrawal by Subject|1|||
27954370|NCT01190228|54611380|FG001|Overall Study|Withdrawal by Subject|0|||
27954371|NCT01190228|54611381|FG002|Overall Study|Withdrawal by Subject|0|||
27954372|NCT01009086|54611394|FG000|Overall Study|Lack of Efficacy|16|||
27954373|NCT01009086|54611395|FG001|Overall Study|Lack of Efficacy|15|||
27954374|NCT01009086|54611396|FG002|Overall Study|Lack of Efficacy|9|||
27954375|NCT01009086|54611394|FG000|Overall Study|Lost to Follow-up|4|||
27954376|NCT01009086|54611395|FG001|Overall Study|Lost to Follow-up|5|||
27954377|NCT01009086|54611396|FG002|Overall Study|Lost to Follow-up|3|||
27954378|NCT01009086|54611394|FG000|Overall Study|Adverse Event|12|||
27954379|NCT01009086|54611395|FG001|Overall Study|Adverse Event|11|||
27954380|NCT01009086|54611396|FG002|Overall Study|Adverse Event|8|||
27954381|NCT01009086|54611394|FG000|Overall Study|Withdrawal by Subject|9|||
27954382|NCT01009086|54611395|FG001|Overall Study|Withdrawal by Subject|11|||
27954383|NCT01009086|54611396|FG002|Overall Study|Withdrawal by Subject|13|||
27954384|NCT01009086|54611394|FG000|Overall Study|Other|3|||
27954385|NCT01009086|54611395|FG001|Overall Study|Other|5|||
27954386|NCT01009086|54611396|FG002|Overall Study|Other|1|||
27954387|NCT01190150|54611411|FG000|First Treatment|Withdrawal by Subject|1|||
27954388|NCT01190150|54611412|FG001|First Treatment|Withdrawal by Subject|0|||
27954389|NCT01190150|54611411|FG000|Washout|Withdrawal by Subject|0|||
27954390|NCT01190150|54611412|FG001|Washout|Withdrawal by Subject|1|||
27954391|NCT01190150|54611411|FG000|Washout|Difficulty in adherence|0|||
27954392|NCT01190150|54611412|FG001|Washout|Difficulty in adherence|1|||
27954393|NCT01001520|54611418|FG000|Medication Period 1|Withdrawal by Subject|2|||
27954394|NCT01001520|54611419|FG001|Medication Period 1|Withdrawal by Subject|2|||
27954395|NCT01001520|54611418|FG000|Medication Period 1|Ineligible: Positive Urine Drug Screen|0|||
27954396|NCT01001520|54611419|FG001|Medication Period 1|Ineligible: Positive Urine Drug Screen|3|||
27954397|NCT01001520|54611418|FG000|Medication Period 1|Ineligible: fMRI contraindicated metal|0|||
27954398|NCT01001520|54611419|FG001|Medication Period 1|Ineligible: fMRI contraindicated metal|2|||
27954399|NCT01001520|54611418|FG000|Medication Period 1|Ineligible: Claustrophobia in fMRI|2|||
27954400|NCT01001520|54611419|FG001|Medication Period 1|Ineligible: Claustrophobia in fMRI|0|||
27954401|NCT01001520|54611418|FG000|Washout Period|Withdrawal by Subject|2|||
28081804|NCT00770809|54735341|FG001|Overall Study|Complicating illness|0|||
28081805|NCT00770809|54735342|FG002|Overall Study|Complicating illness|1|||
28081806|NCT00770809|54735340|FG000|Overall Study|Other Medical Reasons|2|||
28165048|NCT02991859|54835657|FG003|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
27732051|NCT02783573|54179478|FG001|Placebo-Controlled Treatment Period|Physician Decision|1|||
27954402|NCT01001520|54611419|FG001|Washout Period|Withdrawal by Subject|1|||
27954403|NCT01001520|54611418|FG000|Medication Period 2|Withdrawal by Subject|0|||
27954404|NCT01001520|54611419|FG001|Medication Period 2|Withdrawal by Subject|3|||
27954405|NCT01189604|54611443|FG000|Overall Study|Impossible to visit|0|||
27954406|NCT01189604|54611444|FG001|Overall Study|Impossible to visit|0|||
27954407|NCT01189604|54611445|FG002|Overall Study|Impossible to visit|0|||
27954408|NCT01189604|54611446|FG003|Overall Study|Impossible to visit|0|||
27954409|NCT01189604|54611447|FG004|Overall Study|Impossible to visit|0|||
27954410|NCT01189604|54611448|FG005|Overall Study|Impossible to visit|1|||
27954411|NCT01189604|54611449|FG006|Overall Study|Impossible to visit|0|||
27954412|NCT01189604|54611443|FG000|Overall Study|Adverse Event|0|||
27954413|NCT01189604|54611444|FG001|Overall Study|Adverse Event|1|||
27954414|NCT01189604|54611445|FG002|Overall Study|Adverse Event|0|||
27954415|NCT01189604|54611446|FG003|Overall Study|Adverse Event|0|||
27954416|NCT01189604|54611447|FG004|Overall Study|Adverse Event|2|||
27954417|NCT01189604|54611448|FG005|Overall Study|Adverse Event|0|||
27954418|NCT01189604|54611449|FG006|Overall Study|Adverse Event|1|||
27954419|NCT01189604|54611443|FG000|Overall Study|Withdrawal by Subject|1|||
27954420|NCT01189604|54611444|FG001|Overall Study|Withdrawal by Subject|0|||
27954421|NCT01189604|54611445|FG002|Overall Study|Withdrawal by Subject|0|||
27954422|NCT01189604|54611446|FG003|Overall Study|Withdrawal by Subject|0|||
27954423|NCT01189604|54611447|FG004|Overall Study|Withdrawal by Subject|0|||
27954424|NCT01189604|54611448|FG005|Overall Study|Withdrawal by Subject|0|||
27954425|NCT01189604|54611449|FG006|Overall Study|Withdrawal by Subject|0|||
27954426|NCT01008696|54611467|FG000|Overall Study|Participant's evasion of hospital visit|5|||
27954427|NCT01008696|54611468|FG001|Overall Study|Participant's evasion of hospital visit|4|||
27954428|NCT01008696|54611467|FG000|Overall Study|Withdrawal by Subject|2|||
27954429|NCT01008696|54611468|FG001|Overall Study|Withdrawal by Subject|4|||
27954430|NCT01008696|54611467|FG000|Overall Study|Physician Decision|5|||
27954431|NCT01008696|54611468|FG001|Overall Study|Physician Decision|1|||
27954432|NCT01008696|54611467|FG000|Overall Study|Adverse Event|1|||
27954433|NCT01008696|54611468|FG001|Overall Study|Adverse Event|0|||
27954434|NCT01008696|54611467|FG000|Overall Study|Participants' non-cooperation|2|||
27954435|NCT01008696|54611468|FG001|Overall Study|Participants' non-cooperation|3|||
27954436|NCT01008696|54611467|FG000|Overall Study|Other|2|||
27954437|NCT01008696|54611468|FG001|Overall Study|Other|3|||
27954438|NCT01008696|54611467|FG000|Overall Study|Other|0|||
27954439|NCT01008696|54611468|FG001|Overall Study|Other|2|||
27954440|NCT01176968|54611487|FG000|Overall Study|Adverse Event|10|||
27954441|NCT01176968|54611488|FG001|Overall Study|Adverse Event|11|||
27954442|NCT01176968|54611487|FG000|Overall Study|Death|2|||
27954443|NCT01176968|54611488|FG001|Overall Study|Death|3|||
27954444|NCT01176968|54611487|FG000|Overall Study|Lack of Efficacy|0|||
27954445|NCT01176968|54611488|FG001|Overall Study|Lack of Efficacy|1|||
27954446|NCT01176968|54611487|FG000|Overall Study|Lost to Follow-up|16|||
27954447|NCT01176968|54611488|FG001|Overall Study|Lost to Follow-up|14|||
27954448|NCT01176968|54611487|FG000|Overall Study|Withdrawal by Subject|48|||
27954449|NCT01176968|54611488|FG001|Overall Study|Withdrawal by Subject|48|||
27954450|NCT01176968|54611487|FG000|Overall Study|Protocol Violation|2|||
27954451|NCT01176968|54611488|FG001|Overall Study|Protocol Violation|1|||
27954452|NCT01176968|54611487|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
27954453|NCT01176968|54611488|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
27954454|NCT01176968|54611487|FG000|Overall Study|Study terminated by sponsor|0|||
27954455|NCT01176968|54611488|FG001|Overall Study|Study terminated by sponsor|1|||
27954456|NCT01176968|54611487|FG000|Overall Study|Reason not defined|5|||
27954457|NCT01176968|54611488|FG001|Overall Study|Reason not defined|3|||
27954458|NCT01006122|54611499|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
27954459|NCT01006122|54611500|FG001|First Double-blind Intervention Period|Lost to Follow-up|2|||
27954460|NCT01006122|54611499|FG000|First Double-blind Intervention Period|Protocol Violation|1|||
27954461|NCT01006122|54611500|FG001|First Double-blind Intervention Period|Protocol Violation|1|||
27954462|NCT01006122|54611499|FG000|First Double-blind Intervention Period|Pregnancy|0|||
27954463|NCT01006122|54611500|FG001|First Double-blind Intervention Period|Pregnancy|1|||
28081807|NCT00770809|54735341|FG001|Overall Study|Other Medical Reasons|4|||
28081808|NCT00770809|54735342|FG002|Overall Study|Other Medical Reasons|3|||
28081809|NCT00571727|54735350|FG000|Overall Study|Did not enter in this study|1|||
28081810|NCT00571727|54735350|FG000|Overall Study|Non-compliance|4|||
28081811|NCT00571727|54735350|FG000|Overall Study|Lost to Follow-up|30|||
28081812|NCT00571727|54735350|FG000|Overall Study|Poor growth|1|||
28081813|NCT00571727|54735350|FG000|Overall Study|Parent/patient decision|2|||
28081814|NCT00571727|54735350|FG000|Overall Study|Participant transferred to commercial drug|14|||
28081815|NCT00571727|54735350|FG000|Overall Study|Unable to provide study drug|6|||
28081816|NCT00571727|54735350|FG000|Overall Study|On-treatment at end of study|8|||
28081817|NCT00489307|54735356|FG000|Overall Study|Death|1|||
28081818|NCT00489307|54735357|FG001|Overall Study|Death|1|||
28081819|NCT00489307|54735356|FG000|Overall Study|Lost to Follow-up|2|||
28081820|NCT00489307|54735357|FG001|Overall Study|Lost to Follow-up|2|||
28081821|NCT00489307|54735356|FG000|Overall Study|Physician Decision|1|||
27954464|NCT01006122|54611499|FG000|First Double-blind Intervention Period|Withdrawal by Subject|9|||
27954465|NCT01006122|54611500|FG001|First Double-blind Intervention Period|Withdrawal by Subject|8|||
27954466|NCT01006122|54611499|FG000|First Double-blind Intervention Period|Does not meet entrance criteria|1|||
27954467|NCT01006122|54611500|FG001|First Double-blind Intervention Period|Does not meet entrance criteria|0|||
27954468|NCT01006122|54611499|FG000|First Double-blind Intervention Period|Lack of Efficacy|2|||
27954469|NCT01006122|54611500|FG001|First Double-blind Intervention Period|Lack of Efficacy|1|||
27954470|NCT01006122|54611499|FG000|First Double-blind Intervention Period|Other|3|||
27954471|NCT01006122|54611500|FG001|First Double-blind Intervention Period|Other|0|||
27954472|NCT01006122|54611499|FG000|First Double-blind Intervention Period|Adverse Event|0|||
27954473|NCT01006122|54611500|FG001|First Double-blind Intervention Period|Adverse Event|4|||
27954474|NCT01006122|54611499|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
27954475|NCT01006122|54611500|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
27954476|NCT01006122|54611499|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
27954477|NCT01006122|54611500|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
27954478|NCT01006122|54611499|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
27954479|NCT01006122|54611500|FG001|Second Double-blind Intervention Period|Lost to Follow-up|3|||
28081822|NCT00489307|54735357|FG001|Overall Study|Physician Decision|0|||
28081823|NCT00489307|54735356|FG000|Overall Study|Withdrawal by Subject|2|||
28081824|NCT00489307|54735357|FG001|Overall Study|Withdrawal by Subject|4|||
28081825|NCT00489307|54735356|FG000|Overall Study|Hospitalization unrelated to treatment|10|||
28081826|NCT00489307|54735357|FG001|Overall Study|Hospitalization unrelated to treatment|7|||
28081827|NCT00489307|54735356|FG000|Overall Study|Surgery after assignment|1|||
28081828|NCT00489307|54735357|FG001|Overall Study|Surgery after assignment|0|||
28081829|NCT00489307|54735356|FG000|Overall Study|Did not fill up the forms|2|||
28081830|NCT00489307|54735357|FG001|Overall Study|Did not fill up the forms|1|||
28081831|NCT00489307|54735356|FG000|Overall Study|Patient or family refusal|5|||
28081832|NCT00489307|54735357|FG001|Overall Study|Patient or family refusal|9|||
28081833|NCT00427349|54735363|FG000|Overall Study|Lack of Efficacy|23|||
27954480|NCT01006122|54611499|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
27954481|NCT01006122|54611500|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|2|||
27954482|NCT01006122|54611499|FG000|Second Double-blind Intervention Period|Death|0|||
27954483|NCT01006122|54611500|FG001|Second Double-blind Intervention Period|Death|1|||
27954484|NCT01005966|54611506|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
27954485|NCT01005966|54611507|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
27954486|NCT01005966|54611508|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
27954487|NCT01005966|54611509|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
27954488|NCT01005966|54611510|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
27954489|NCT01005966|54611506|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
27954490|NCT01005966|54611507|FG001|Treatment Period 1 (14 Days)|Protocol Violation|0|||
27954491|NCT01005966|54611508|FG002|Treatment Period 1 (14 Days)|Protocol Violation|1|||
27954492|NCT01005966|54611509|FG003|Treatment Period 1 (14 Days)|Protocol Violation|0|||
27954493|NCT01005966|54611510|FG004|Treatment Period 1 (14 Days)|Protocol Violation|0|||
27954494|NCT01005966|54611506|FG000|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
27954495|NCT01005966|54611507|FG001|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
27954496|NCT01005966|54611508|FG002|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
27954497|NCT01005966|54611509|FG003|Washout Period 1 (4 Days)|Withdrawal by Subject|1|||
27954498|NCT01005966|54611510|FG004|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
27954499|NCT01005966|54611506|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
27954500|NCT01005966|54611507|FG001|Treatment Period 2 (14 Days)|Adverse Event|1|||
27954501|NCT01005966|54611508|FG002|Treatment Period 2 (14 Days)|Adverse Event|1|||
27954502|NCT01005966|54611509|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
27954503|NCT01005966|54611510|FG004|Treatment Period 2 (14 Days)|Adverse Event|0|||
27954504|NCT01005966|54611506|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
27954505|NCT01005966|54611507|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
27954506|NCT01005966|54611508|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
27954507|NCT01005966|54611509|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
27954508|NCT01005966|54611510|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
27954509|NCT01005966|54611506|FG000|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
27954510|NCT01005966|54611507|FG001|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
27954511|NCT01005966|54611508|FG002|Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
27954512|NCT01005966|54611509|FG003|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
27954513|NCT01005966|54611510|FG004|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
27954514|NCT01005966|54611506|FG000|Treatment Period 3 (14 Days)|Protocol Violation|0|||
27954515|NCT01005966|54611507|FG001|Treatment Period 3 (14 Days)|Protocol Violation|1|||
27954516|NCT01005966|54611508|FG002|Treatment Period 3 (14 Days)|Protocol Violation|0|||
27954517|NCT01005966|54611509|FG003|Treatment Period 3 (14 Days)|Protocol Violation|0|||
27954518|NCT01005966|54611510|FG004|Treatment Period 3 (14 Days)|Protocol Violation|1|||
27954519|NCT01005966|54611506|FG000|Treatment Period 4 (14 Days)|Protocol Violation|0|||
27954520|NCT01005966|54611507|FG001|Treatment Period 4 (14 Days)|Protocol Violation|1|||
27954521|NCT01005966|54611508|FG002|Treatment Period 4 (14 Days)|Protocol Violation|0|||
27954522|NCT01005966|54611509|FG003|Treatment Period 4 (14 Days)|Protocol Violation|0|||
27954523|NCT01005966|54611510|FG004|Treatment Period 4 (14 Days)|Protocol Violation|0|||
27954524|NCT01005966|54611506|FG000|Treatment Period 4 (14 Days)|Other Reason|0|||
28081834|NCT00427349|54735363|FG000|Overall Study|Adverse Event|14|||
28081835|NCT00427349|54735363|FG000|Overall Study|Death|1|||
28081836|NCT00427349|54735363|FG000|Overall Study|Withdrawal by Subject|3|||
27954525|NCT01005966|54611507|FG001|Treatment Period 4 (14 Days)|Other Reason|0|||
27954526|NCT01005966|54611508|FG002|Treatment Period 4 (14 Days)|Other Reason|0|||
27954527|NCT01005966|54611509|FG003|Treatment Period 4 (14 Days)|Other Reason|0|||
28165049|NCT02991859|54835658|FG004|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
28165050|NCT02991859|54835659|FG005|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
28165051|NCT02991859|54835660|FG006|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
27954528|NCT01005966|54611510|FG004|Treatment Period 4 (14 Days)|Other Reason|1|||
27954529|NCT01005732|54611536|FG000|Overall Study|Lost to Follow-up|10|||
27954530|NCT01005732|54611536|FG000|Overall Study|Death|1|||
27954531|NCT00603382|54611550|FG000|Overall Study|Adverse Event|0|||
27954532|NCT00603382|54611551|FG001|Overall Study|Adverse Event|1|||
27954533|NCT00603382|54611552|FG002|Overall Study|Adverse Event|1|||
27954534|NCT00603382|54611553|FG003|Overall Study|Adverse Event|2|||
27954535|NCT00603382|54611554|FG004|Overall Study|Adverse Event|1|||
27954536|NCT00603382|54611555|FG005|Overall Study|Adverse Event|2|||
27954537|NCT00603382|54611550|FG000|Overall Study|Lack of Efficacy|14|||
27954538|NCT00603382|54611551|FG001|Overall Study|Lack of Efficacy|9|||
27954539|NCT00603382|54611552|FG002|Overall Study|Lack of Efficacy|3|||
27954540|NCT00603382|54611553|FG003|Overall Study|Lack of Efficacy|6|||
27954541|NCT00603382|54611554|FG004|Overall Study|Lack of Efficacy|6|||
27954542|NCT00603382|54611555|FG005|Overall Study|Lack of Efficacy|11|||
27954543|NCT00603382|54611550|FG000|Overall Study|Protocol Violation|1|||
27954544|NCT00603382|54611551|FG001|Overall Study|Protocol Violation|0|||
27954545|NCT00603382|54611552|FG002|Overall Study|Protocol Violation|1|||
27954546|NCT00603382|54611553|FG003|Overall Study|Protocol Violation|2|||
27954547|NCT00603382|54611554|FG004|Overall Study|Protocol Violation|1|||
27954548|NCT00603382|54611555|FG005|Overall Study|Protocol Violation|0|||
27954549|NCT00603382|54611550|FG000|Overall Study|Lost to Follow-up|0|||
28081837|NCT00427349|54735363|FG000|Overall Study|Alternative therapy|1|||
28081838|NCT00427349|54735363|FG000|Overall Study|Other|2|||
28081839|NCT00427349|54735363|FG000|Overall Study|Ineligible|1|||
28081840|NCT00427349|54735363|FG000|Overall Study|Never started therapy|1|||
28081841|NCT00309985|54735369|FG000|Overall Study|Disease progression|12|||
28081842|NCT00309985|54735370|FG001|Overall Study|Disease progression|0|||
28081843|NCT00309985|54735369|FG000|Overall Study|Adverse Event|30|||
28081844|NCT00309985|54735370|FG001|Overall Study|Adverse Event|0|||
28081845|NCT00309985|54735369|FG000|Overall Study|Death|2|||
28081846|NCT00309985|54735370|FG001|Overall Study|Death|0|||
28081847|NCT00309985|54735369|FG000|Overall Study|Withdrawal by Subject|5|||
28081848|NCT00309985|54735370|FG001|Overall Study|Withdrawal by Subject|1|||
28081849|NCT00309985|54735369|FG000|Overall Study|Physician Decision|3|||
28165052|NCT02991859|54835661|FG007|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
28081850|NCT00309985|54735370|FG001|Overall Study|Physician Decision|0|||
28081851|NCT00309985|54735369|FG000|Overall Study|Never started treatment|7|||
28081852|NCT00309985|54735370|FG001|Overall Study|Never started treatment|0|||
28081853|NCT00309985|54735369|FG000|Overall Study|Complicating disease|1|||
28081854|NCT00309985|54735370|FG001|Overall Study|Complicating disease|0|||
28081855|NCT00309985|54735369|FG000|Overall Study|Non-compliance|1|||
28081856|NCT00309985|54735370|FG001|Overall Study|Non-compliance|0|||
28081857|NCT00309985|54735369|FG000|Overall Study|Chemotherapy discontinued only|1|||
28165053|NCT02991859|54835662|FG008|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1|||
28165054|NCT02991859|54835663|FG009|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
28165055|NCT02991859|54835664|FG010|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
28165056|NCT02991859|54835665|FG011|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
28165057|NCT02991859|54835666|FG012|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
28165058|NCT02991859|54835667|FG013|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
28165059|NCT02991859|54835668|FG014|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
28165060|NCT02991859|54835669|FG015|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
28165061|NCT02991859|54835670|FG016|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
28165062|NCT03016325|54835753|FG000|Treatment Period|Participant withdrew consent|0|||
27732052|NCT02783573|54179479|FG002|Placebo-Controlled Treatment Period|Physician Decision|3|||
27732053|NCT02783573|54179477|FG000|Placebo-Controlled Treatment Period|Protocol Violation|1|||
27832305|NCT01775189|54311152|FG000|Treatment Phase: Washout Period 2|Protocol Violation|0|||
27832306|NCT01775189|54311153|FG001|Treatment Phase: Washout Period 2|Protocol Violation|0|||
27832307|NCT01775189|54311154|FG002|Treatment Phase: Washout Period 2|Protocol Violation|0|||
27832308|NCT01775189|54311155|FG003|Treatment Phase: Washout Period 2|Protocol Violation|1|||
27832309|NCT01775189|54311156|FG004|Treatment Phase: Washout Period 2|Protocol Violation|0|||
27832310|NCT01775189|54311157|FG005|Treatment Phase: Washout Period 2|Protocol Violation|0|||
27832311|NCT01775189|54311158|FG006|Treatment Phase: Washout Period 2|Protocol Violation|0|||
27832312|NCT01775189|54311152|FG000|Treatment Phase: Washout Period 3|Protocol Violation|0|||
27832313|NCT01775189|54311153|FG001|Treatment Phase: Washout Period 3|Protocol Violation|0|||
27954550|NCT00603382|54611551|FG001|Overall Study|Lost to Follow-up|1|||
27954551|NCT00603382|54611552|FG002|Overall Study|Lost to Follow-up|1|||
27954552|NCT00603382|54611553|FG003|Overall Study|Lost to Follow-up|1|||
27954553|NCT00603382|54611554|FG004|Overall Study|Lost to Follow-up|0|||
27954554|NCT00603382|54611555|FG005|Overall Study|Lost to Follow-up|1|||
27954555|NCT00603382|54611550|FG000|Overall Study|Physician Decision|0|||
27954556|NCT00603382|54611551|FG001|Overall Study|Physician Decision|0|||
27954557|NCT00603382|54611552|FG002|Overall Study|Physician Decision|2|||
27954558|NCT00603382|54611553|FG003|Overall Study|Physician Decision|0|||
27954559|NCT00603382|54611554|FG004|Overall Study|Physician Decision|1|||
27954560|NCT00603382|54611555|FG005|Overall Study|Physician Decision|3|||
27954561|NCT00603382|54611550|FG000|Overall Study|Withdrawal by Subject|3|||
27954562|NCT00603382|54611551|FG001|Overall Study|Withdrawal by Subject|3|||
27954563|NCT00603382|54611552|FG002|Overall Study|Withdrawal by Subject|1|||
27954564|NCT00603382|54611553|FG003|Overall Study|Withdrawal by Subject|1|||
27954565|NCT00603382|54611554|FG004|Overall Study|Withdrawal by Subject|0|||
27954566|NCT00603382|54611555|FG005|Overall Study|Withdrawal by Subject|1|||
27954567|NCT01176266|54611569|FG000|Overall Study|Death|6|||
27954568|NCT01176266|54611569|FG000|Overall Study|Withdrawal by Subject|3|||
27954569|NCT01182428|54611579|FG000|Overall Study|Physician Decision|1|||
27954570|NCT01182428|54611580|FG001|Overall Study|Physician Decision|0|||
27954571|NCT01182428|54611579|FG000|Overall Study|Lost to Follow-up|9|||
27954572|NCT01182428|54611580|FG001|Overall Study|Lost to Follow-up|1|||
27954573|NCT01182428|54611579|FG000|Overall Study|Withdrawal by Subject|1|||
27954574|NCT01182428|54611580|FG001|Overall Study|Withdrawal by Subject|0|||
27954575|NCT00603304|54611588|FG000|Overall Study|Lost to Follow-up|5|||
27954576|NCT00603304|54611589|FG001|Overall Study|Lost to Follow-up|7|||
27954577|NCT00603304|54611588|FG000|Overall Study|Withdrawal by Subject|8|||
27954578|NCT00603304|54611589|FG001|Overall Study|Withdrawal by Subject|5|||
27954579|NCT00603304|54611588|FG000|Overall Study|Protocol Violation|1|||
27954580|NCT00603304|54611589|FG001|Overall Study|Protocol Violation|0|||
27954581|NCT00603304|54611588|FG000|Overall Study|Adverse Event|4|||
27954582|NCT00603304|54611589|FG001|Overall Study|Adverse Event|2|||
27954583|NCT00603304|54611588|FG000|Overall Study|Unacceptable Treatment Toxicity|5|||
27954584|NCT00603304|54611589|FG001|Overall Study|Unacceptable Treatment Toxicity|8|||
27954585|NCT00603304|54611588|FG000|Overall Study|Crossed Over to Open Label Therapy|3|||
27954586|NCT00603304|54611589|FG001|Overall Study|Crossed Over to Open Label Therapy|3|||
27954587|NCT00603304|54611588|FG000|Overall Study|Exclusionary Medication|2|||
27954588|NCT00603304|54611589|FG001|Overall Study|Exclusionary Medication|3|||
27954589|NCT00603304|54611588|FG000|Overall Study|Non-Compliant|0|||
27954590|NCT00603304|54611589|FG001|Overall Study|Non-Compliant|1|||
27954591|NCT00603304|54611588|FG000|Overall Study|Moved Away|0|||
27954592|NCT00603304|54611589|FG001|Overall Study|Moved Away|2|||
27954593|NCT00603304|54611588|FG000|Overall Study|Other|2|||
27954594|NCT00603304|54611589|FG001|Overall Study|Other|0|||
27954595|NCT00603304|54611588|FG000|Overall Study|Patient Decision|2|||
27954596|NCT00603304|54611589|FG001|Overall Study|Patient Decision|0|||
27954597|NCT01176032|54611599|FG000|Overall Study|Adverse Event|1|||
27954598|NCT01176032|54611600|FG001|Overall Study|Adverse Event|0|||
27954599|NCT01176032|54611599|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
27954600|NCT01176032|54611600|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
27954601|NCT01176032|54611599|FG000|Overall Study|Protocol Violation|1|||
27954602|NCT01176032|54611600|FG001|Overall Study|Protocol Violation|0|||
27954603|NCT01176032|54611599|FG000|Overall Study|Informed consent withdrawn|3|||
27954604|NCT01176032|54611600|FG001|Overall Study|Informed consent withdrawn|0|||
27954605|NCT01176032|54611599|FG000|Overall Study|Other|1|||
27954606|NCT01176032|54611600|FG001|Overall Study|Other|0|||
27954607|NCT01008618|54611611|FG000|Period 1 (Titration Period)|Physician Decision|2|||
27954608|NCT01008618|54611612|FG001|Period 1 (Titration Period)|Physician Decision|0|||
27954609|NCT01008618|54611613|FG002|Period 1 (Titration Period)|Physician Decision|0|||
27954610|NCT01008618|54611611|FG000|Period 1 (Titration Period)|Adverse Event|33|||
27954611|NCT01008618|54611612|FG001|Period 1 (Titration Period)|Adverse Event|0|||
27954612|NCT01008618|54611613|FG002|Period 1 (Titration Period)|Adverse Event|0|||
27954613|NCT01008618|54611611|FG000|Period 1 (Titration Period)|Withdrawal by Subject|11|||
27954614|NCT01008618|54611612|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
27954615|NCT01008618|54611613|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
27954616|NCT01008618|54611611|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20|||
28081858|NCT00309985|54735370|FG001|Overall Study|Chemotherapy discontinued only|0|||
27954617|NCT01008618|54611612|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
27954618|NCT01008618|54611613|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
27954619|NCT01008618|54611611|FG000|Period 1 (Titration Period)|Aggravated symptom|2|||
27954620|NCT01008618|54611612|FG001|Period 1 (Titration Period)|Aggravated symptom|0|||
27954621|NCT01008618|54611613|FG002|Period 1 (Titration Period)|Aggravated symptom|0|||
27954622|NCT01008618|54611611|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
27954623|NCT01008618|54611612|FG001|Period 2 (Double-Blind Period)|Adverse Event|11|||
27954624|NCT01008618|54611613|FG002|Period 2 (Double-Blind Period)|Adverse Event|2|||
27954625|NCT01008618|54611611|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
27954626|NCT01008618|54611612|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|3|||
27954627|NCT01008618|54611613|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
27954628|NCT01008618|54611611|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
27954629|NCT01008618|54611612|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
27954630|NCT01008618|54611613|FG002|Period 2 (Double-Blind Period)|Physician Decision|0|||
27954631|NCT01008618|54611611|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
27954632|NCT01008618|54611612|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
27954633|NCT01008618|54611613|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3|||
27954634|NCT01008618|54611611|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
27954635|NCT01008618|54611612|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
27954636|NCT01008618|54611613|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
27954637|NCT01008618|54611611|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
27954638|NCT01008618|54611612|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21|||
27732054|NCT02783573|54179478|FG001|Placebo-Controlled Treatment Period|Protocol Violation|2|||
27732055|NCT02783573|54179479|FG002|Placebo-Controlled Treatment Period|Protocol Violation|0|||
27732056|NCT02783573|54179477|FG000|Placebo-Controlled Treatment Period|Withdrawal by Subject|15|||
27732057|NCT02783573|54179478|FG001|Placebo-Controlled Treatment Period|Withdrawal by Subject|20|||
27732058|NCT02783573|54179479|FG002|Placebo-Controlled Treatment Period|Withdrawal by Subject|23|||
27732059|NCT02783573|54179477|FG000|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
27732060|NCT02783573|54179478|FG001|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
27954639|NCT01008618|54611613|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29|||
27954640|NCT01008618|54611611|FG000|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
27954641|NCT01008618|54611612|FG001|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
27954642|NCT01008618|54611613|FG002|Period 2 (Double-Blind Period)|Not appropriate for this study|1|||
27954643|NCT01001208|54611624|FG000|Overall Study|Adverse Event|10|||
27954644|NCT01001208|54611625|FG001|Overall Study|Adverse Event|5|||
27954645|NCT01001208|54611624|FG000|Overall Study|Lost to Follow-up|5|||
27954646|NCT01001208|54611625|FG001|Overall Study|Lost to Follow-up|9|||
27954647|NCT01001208|54611624|FG000|Overall Study|Physician Decision|1|||
27954648|NCT01001208|54611625|FG001|Overall Study|Physician Decision|0|||
27954649|NCT01001208|54611624|FG000|Overall Study|Withdrawal by Subject|4|||
27954650|NCT01001208|54611625|FG001|Overall Study|Withdrawal by Subject|5|||
27954651|NCT01001208|54611624|FG000|Overall Study|Ineligibility Determined|4|||
27954652|NCT01001208|54611625|FG001|Overall Study|Ineligibility Determined|2|||
27954653|NCT01001208|54611624|FG000|Overall Study|Noncompliance|4|||
27954654|NCT01001208|54611625|FG001|Overall Study|Noncompliance|7|||
27954655|NCT01001208|54611624|FG000|Overall Study|Disease Progression|0|||
27954656|NCT01001208|54611625|FG001|Overall Study|Disease Progression|3|||
27954657|NCT01001208|54611624|FG000|Overall Study|Other|0|||
27954658|NCT01001208|54611625|FG001|Overall Study|Other|2|||
27954659|NCT01000974|54611634|FG000|Primary Vaccination Phase|Withdrawal by Subject|109|||
27954660|NCT01000974|54611635|FG001|Primary Vaccination Phase|Withdrawal by Subject|17|||
27954661|NCT01000974|54611636|FG002|Primary Vaccination Phase|Withdrawal by Subject|21|||
27954662|NCT01000974|54611634|FG000|Primary Vaccination Phase|Lost to Follow-up|171|||
27954663|NCT01000974|54611635|FG001|Primary Vaccination Phase|Lost to Follow-up|19|||
27954664|NCT01000974|54611636|FG002|Primary Vaccination Phase|Lost to Follow-up|26|||
27954665|NCT01000974|54611634|FG000|Primary Vaccination Phase|Protocol Violation|40|||
27954666|NCT01000974|54611635|FG001|Primary Vaccination Phase|Protocol Violation|3|||
27954667|NCT01000974|54611636|FG002|Primary Vaccination Phase|Protocol Violation|2|||
27954668|NCT01000974|54611634|FG000|Primary Vaccination Phase|Adverse Event|14|||
27954669|NCT01000974|54611635|FG001|Primary Vaccination Phase|Adverse Event|2|||
27954670|NCT01000974|54611636|FG002|Primary Vaccination Phase|Adverse Event|2|||
27954671|NCT01000974|54611634|FG000|Primary Vaccination Phase|Other|4|||
27954672|NCT01000974|54611635|FG001|Primary Vaccination Phase|Other|9|||
27954673|NCT01000974|54611636|FG002|Primary Vaccination Phase|Other|12|||
27954674|NCT01000974|54611634|FG000|Booster Vaccination Phase|Protocol Violation|0|||
27954675|NCT01000974|54611635|FG001|Booster Vaccination Phase|Protocol Violation|0|||
27954676|NCT01000974|54611636|FG002|Booster Vaccination Phase|Protocol Violation|2|||
28165063|NCT03016325|54835754|FG001|Treatment Period|Participant withdrew consent|1|||
28165064|NCT03016325|54835755|FG002|Treatment Period|Participant withdrew consent|0|||
27732061|NCT02783573|54179479|FG002|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9|||
27954677|NCT01000974|54611634|FG000|Booster Vaccination Phase|Withdrawal by Subject|3|||
27954678|NCT01000974|54611635|FG001|Booster Vaccination Phase|Withdrawal by Subject|1|||
27954679|NCT01000974|54611636|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
27954680|NCT01000974|54611634|FG000|Booster Vaccination Phase|Lost to Follow-up|40|||
27954681|NCT01000974|54611635|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
27954682|NCT01000974|54611636|FG002|Booster Vaccination Phase|Lost to Follow-up|7|||
27954683|NCT01000974|54611634|FG000|Booster Vaccination Phase|Other|24|||
27954684|NCT01000974|54611635|FG001|Booster Vaccination Phase|Other|6|||
27954685|NCT01000974|54611636|FG002|Booster Vaccination Phase|Other|4|||
27954686|NCT01193842|54611652|FG000|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
27954687|NCT01193842|54611653|FG001|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1|||
27954688|NCT01193842|54611654|FG002|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
27954689|NCT01193842|54611655|FG003|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
27954690|NCT01193842|54611656|FG004|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
27954691|NCT01193842|54611652|FG000|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1|||
27954692|NCT01193842|54611653|FG001|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
27954693|NCT01193842|54611654|FG002|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
27954694|NCT01193842|54611655|FG003|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
27954695|NCT01193842|54611656|FG004|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
27954696|NCT01193842|54611652|FG000|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
27954697|NCT01193842|54611653|FG001|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
27954698|NCT01193842|54611654|FG002|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1|||
27954699|NCT01193842|54611655|FG003|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
27954700|NCT01193842|54611656|FG004|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
27954701|NCT01193842|54611652|FG000|Phase II: Randomized Groups|Death|0|||
27954702|NCT01193842|54611653|FG001|Phase II: Randomized Groups|Death|0|||
27954703|NCT01193842|54611654|FG002|Phase II: Randomized Groups|Death|0|||
27954704|NCT01193842|54611655|FG003|Phase II: Randomized Groups|Death|1|||
27954705|NCT01193842|54611656|FG004|Phase II: Randomized Groups|Death|1|||
27954706|NCT01193842|54611652|FG000|Phase II: Randomized Groups|Adverse Event|0|||
27954707|NCT01193842|54611653|FG001|Phase II: Randomized Groups|Adverse Event|0|||
27954708|NCT01193842|54611654|FG002|Phase II: Randomized Groups|Adverse Event|0|||
27954709|NCT01193842|54611655|FG003|Phase II: Randomized Groups|Adverse Event|5|||
27954710|NCT01193842|54611656|FG004|Phase II: Randomized Groups|Adverse Event|3|||
27954711|NCT01193842|54611652|FG000|Phase II: Randomized Groups|Withdrawal by Subject|0|||
27954712|NCT01193842|54611653|FG001|Phase II: Randomized Groups|Withdrawal by Subject|0|||
27954713|NCT01193842|54611654|FG002|Phase II: Randomized Groups|Withdrawal by Subject|0|||
27954714|NCT01193842|54611655|FG003|Phase II: Randomized Groups|Withdrawal by Subject|1|||
27954715|NCT01193842|54611656|FG004|Phase II: Randomized Groups|Withdrawal by Subject|2|||
27954716|NCT01193842|54611652|FG000|Phase II: Randomized Groups|Ineligible|0|||
27954717|NCT01193842|54611653|FG001|Phase II: Randomized Groups|Ineligible|0|||
27954718|NCT01193842|54611654|FG002|Phase II: Randomized Groups|Ineligible|0|||
27954719|NCT01193842|54611655|FG003|Phase II: Randomized Groups|Ineligible|0|||
27954720|NCT01193842|54611656|FG004|Phase II: Randomized Groups|Ineligible|1|||
27954721|NCT01193842|54611652|FG000|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
27954722|NCT01193842|54611653|FG001|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
27954723|NCT01193842|54611654|FG002|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
27954724|NCT01193842|54611655|FG003|Phase II: Randomized Groups|Disease progression/relapse on treatment|5|||
27954725|NCT01193842|54611656|FG004|Phase II: Randomized Groups|Disease progression/relapse on treatment|3|||
27954726|NCT01004406|54611675|FG000|Overall Study|Withdrawal by Subject|2|||
27954727|NCT01004406|54611676|FG001|Overall Study|Withdrawal by Subject|0|||
27954728|NCT01004406|54611675|FG000|Overall Study|Lost to Follow-up|1|||
27954729|NCT01004406|54611676|FG001|Overall Study|Lost to Follow-up|0|||
27954730|NCT01182350|54611691|FG000|Overall Study|Adverse Event|5|||
27954731|NCT01182350|54611692|FG001|Overall Study|Adverse Event|0|||
27954732|NCT01182350|54611693|FG002|Overall Study|Adverse Event|0|||
27954733|NCT01182350|54611694|FG003|Overall Study|Adverse Event|0|||
27954734|NCT01182350|54611695|FG004|Overall Study|Adverse Event|0|||
27954735|NCT01182350|54611691|FG000|Overall Study|Disease Progression|15|||
27954736|NCT01182350|54611692|FG001|Overall Study|Disease Progression|12|||
27954737|NCT01182350|54611693|FG002|Overall Study|Disease Progression|0|||
27954738|NCT01182350|54611694|FG003|Overall Study|Disease Progression|1|||
27954739|NCT01182350|54611695|FG004|Overall Study|Disease Progression|0|||
27954740|NCT01182350|54611691|FG000|Overall Study|Death|0|||
27954741|NCT01182350|54611692|FG001|Overall Study|Death|1|||
27954742|NCT01182350|54611693|FG002|Overall Study|Death|1|||
27954743|NCT01182350|54611694|FG003|Overall Study|Death|0|||
27954744|NCT01182350|54611695|FG004|Overall Study|Death|0|||
27732062|NCT02783573|54179477|FG000|Placebo-Controlled Treatment Period|Sponsor Decision|494|||
27832314|NCT01775189|54311154|FG002|Treatment Phase: Washout Period 3|Protocol Violation|0|||
27832315|NCT01775189|54311155|FG003|Treatment Phase: Washout Period 3|Protocol Violation|1|||
27954745|NCT01182350|54611691|FG000|Overall Study|Withdrawal by Subject|3|||
27954746|NCT01182350|54611692|FG001|Overall Study|Withdrawal by Subject|1|||
27954747|NCT01182350|54611693|FG002|Overall Study|Withdrawal by Subject|0|||
27954748|NCT01182350|54611694|FG003|Overall Study|Withdrawal by Subject|1|||
27954749|NCT01182350|54611695|FG004|Overall Study|Withdrawal by Subject|0|||
27954750|NCT01182350|54611691|FG000|Overall Study|Alternative Therapy|2|||
27954751|NCT01182350|54611692|FG001|Overall Study|Alternative Therapy|0|||
27954752|NCT01182350|54611693|FG002|Overall Study|Alternative Therapy|1|||
27954753|NCT01182350|54611694|FG003|Overall Study|Alternative Therapy|0|||
27954754|NCT01182350|54611695|FG004|Overall Study|Alternative Therapy|0|||
27954755|NCT01182350|54611691|FG000|Overall Study|Travel Issue/Prefer Treatment at Home|2|||
27954756|NCT01182350|54611692|FG001|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
27954757|NCT01182350|54611693|FG002|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
27954758|NCT01182350|54611694|FG003|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
27954759|NCT01182350|54611695|FG004|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
27954760|NCT01182350|54611691|FG000|Overall Study|Unevaluable for Biopsy|0|||
27954761|NCT01182350|54611692|FG001|Overall Study|Unevaluable for Biopsy|0|||
27954762|NCT01182350|54611693|FG002|Overall Study|Unevaluable for Biopsy|0|||
27954763|NCT01182350|54611694|FG003|Overall Study|Unevaluable for Biopsy|0|||
27954764|NCT01182350|54611695|FG004|Overall Study|Unevaluable for Biopsy|3|||
27954765|NCT01163474|54611711|FG000|Overall Study|Withdrawal by Subject|1|||
27954766|NCT01163474|54611711|FG000|Overall Study|Tech barriers to videoteleconference vis|12|||
27954767|NCT01163474|54611711|FG000|Overall Study|Lost to Follow-up|3|||
27954768|NCT00603538|54611721|FG000|Overall Study|Adverse Event|0|||
27954769|NCT00603538|54611722|FG001|Overall Study|Adverse Event|4|||
27954770|NCT00603538|54611723|FG002|Overall Study|Adverse Event|2|||
27954771|NCT00603538|54611721|FG000|Overall Study|Objective progression or relapse|3|||
27954772|NCT00603538|54611722|FG001|Overall Study|Objective progression or relapse|0|||
27954773|NCT00603538|54611723|FG002|Overall Study|Objective progression or relapse|0|||
27954774|NCT01163318|54611734|FG000|Overall Study|Off-Label Use of Adalimumab|8|||
27954775|NCT01163318|54611734|FG000|Overall Study|Did Not Continue Use of Adalimumab|26|||
27954776|NCT01163318|54611734|FG000|Overall Study|History/comorbidity of malignant tumor|3|||
27954777|NCT01163318|54611734|FG000|Overall Study|Participants Without Case Report Form|7|||
27954778|NCT01163318|54611734|FG000|Overall Study|Multiple Reasons Per Participant|224|||
27954779|NCT01162304|54611738|FG000|Overall Study|Beck scale to high|11|||
27954780|NCT04515394|54611744|FG000|Overall Study|Participant did not receive treatment|1|||
27954781|NCT01175018|54611750|FG000|Overall Study|Adverse Event|3|||
27954782|NCT01175018|54611751|FG001|Overall Study|Adverse Event|1|||
27954783|NCT01174784|54611759|FG000|Overall Study|Screen fails|4|||
27954784|NCT01174550|54611766|FG000|Overall Study|Death|75|||
27954785|NCT01174550|54611767|FG001|Overall Study|Death|74|||
27954786|NCT01174550|54611766|FG000|Overall Study|Lost to Follow-up|652|||
27954787|NCT01174550|54611767|FG001|Overall Study|Lost to Follow-up|510|||
27954788|NCT01174550|54611766|FG000|Overall Study|Withdrawal by Subject|543|||
27954789|NCT01174550|54611767|FG001|Overall Study|Withdrawal by Subject|289|||
27954790|NCT01008150|54611777|FG000|Overall Study|did not receive study drug|1|||
27954791|NCT01008150|54611778|FG001|Overall Study|did not receive study drug|1|||
27954792|NCT01008150|54611779|FG002|Overall Study|did not receive study drug|1|||
27954793|NCT01008150|54611780|FG003|Overall Study|did not receive study drug|0|||
27954794|NCT01007916|54611791|FG000|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1|||
27954795|NCT01007916|54611792|FG001|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0|||
27954796|NCT01007916|54611791|FG000|Period 2, 4 Weeks of Wear|Relocation|1|||
27954797|NCT01007916|54611792|FG001|Period 2, 4 Weeks of Wear|Relocation|0|||
27954798|NCT01007838|54611802|FG000|Overall Study|Withdrawal by Subject|1|||
27954799|NCT01007838|54611803|FG001|Overall Study|Withdrawal by Subject|0|||
28165065|NCT03016325|54835756|FG003|Treatment Period|Participant withdrew consent|0|||
27854965|NCT00244621|54373457|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
27854966|NCT00244621|54373458|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
27854967|NCT00244621|54373456|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
27854968|NCT00244621|54373457|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
27854969|NCT00244621|54373458|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
27854970|NCT00244621|54373456|FG000|Double-blind Treatment Period|Multiple Reasons|2|||
27854971|NCT00244621|54373457|FG001|Double-blind Treatment Period|Multiple Reasons|1|||
27854972|NCT00244621|54373458|FG002|Double-blind Treatment Period|Multiple Reasons|1|||
27854973|NCT00244621|54373456|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
27854974|NCT00244621|54373457|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
27854975|NCT00244621|54373458|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
27854976|NCT00244621|54373456|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
27854977|NCT00244621|54373457|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
27854978|NCT00244621|54373458|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
27854979|NCT00244621|54373456|FG000|Open-label Treatment Period|Adverse Event|0|||
27854980|NCT00244621|54373457|FG001|Open-label Treatment Period|Adverse Event|0|||
27854981|NCT00244621|54373458|FG002|Open-label Treatment Period|Adverse Event|1|||
27854982|NCT00244621|54373456|FG000|Open-label Treatment Period|Moved abroad|0|||
27732063|NCT02783573|54179478|FG001|Placebo-Controlled Treatment Period|Sponsor Decision|512|||
27854983|NCT00244621|54373457|FG001|Open-label Treatment Period|Moved abroad|0|||
27954800|NCT01007838|54611804|FG002|Overall Study|Withdrawal by Subject|0|||
27954801|NCT01007838|54611805|FG003|Overall Study|Withdrawal by Subject|0|||
27954802|NCT01007838|54611802|FG000|Overall Study|Physician Decision|1|||
27954803|NCT01007838|54611803|FG001|Overall Study|Physician Decision|0|||
27954804|NCT01007838|54611804|FG002|Overall Study|Physician Decision|0|||
27954805|NCT01007838|54611805|FG003|Overall Study|Physician Decision|0|||
27954806|NCT01007838|54611802|FG000|Overall Study|Started home haemodialysis|1|||
27954807|NCT01007838|54611803|FG001|Overall Study|Started home haemodialysis|0|||
27954808|NCT01007838|54611804|FG002|Overall Study|Started home haemodialysis|0|||
27954809|NCT01007838|54611805|FG003|Overall Study|Started home haemodialysis|0|||
27954810|NCT01007448|54611817|FG000|Overall Study|Continuing Prohibited Systemic Drugs|1|||
27954811|NCT01007448|54611818|FG001|Overall Study|Continuing Prohibited Systemic Drugs|0|||
27954812|NCT01007448|54611817|FG000|Overall Study|Staph Skin Infection Flare|1|||
27954813|NCT01007448|54611818|FG001|Overall Study|Staph Skin Infection Flare|0|||
27954814|NCT01007448|54611817|FG000|Overall Study|Participant Leaving the Country|1|||
27954815|NCT01007448|54611818|FG001|Overall Study|Participant Leaving the Country|0|||
27954816|NCT01007448|54611817|FG000|Overall Study|Participant Given Prohibited Medication|1|||
27954817|NCT01007448|54611818|FG001|Overall Study|Participant Given Prohibited Medication|0|||
27954818|NCT01007448|54611817|FG000|Overall Study|Progressive Disease|1|||
27954819|NCT01007448|54611818|FG001|Overall Study|Progressive Disease|2|||
27954820|NCT01007448|54611817|FG000|Overall Study|Lack of Efficacy|2|||
27954821|NCT01007448|54611818|FG001|Overall Study|Lack of Efficacy|0|||
27954822|NCT01007448|54611817|FG000|Overall Study|Withdrawal by Subject|2|||
27954823|NCT01007448|54611818|FG001|Overall Study|Withdrawal by Subject|3|||
27954824|NCT01007448|54611817|FG000|Overall Study|Adverse Event|1|||
27954825|NCT01007448|54611818|FG001|Overall Study|Adverse Event|4|||
27954826|NCT03538756|54611824|FG000|Long-Term Follow-up|Adverse Event|0|||
27954827|NCT03538756|54611825|FG001|Long-Term Follow-up|Adverse Event|0|||
27954828|NCT03538756|54611826|FG002|Long-Term Follow-up|Adverse Event|6|||
27954829|NCT03538756|54611824|FG000|Long-Term Follow-up|Death|0|||
27954830|NCT03538756|54611825|FG001|Long-Term Follow-up|Death|0|||
27954831|NCT03538756|54611826|FG002|Long-Term Follow-up|Death|1|||
27954832|NCT03538756|54611824|FG000|Long-Term Follow-up|Withdrawal by Subject|0|||
27954833|NCT03538756|54611825|FG001|Long-Term Follow-up|Withdrawal by Subject|0|||
27954834|NCT03538756|54611826|FG002|Long-Term Follow-up|Withdrawal by Subject|5|||
27954835|NCT03538756|54611824|FG000|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
27954836|NCT03538756|54611825|FG001|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
27954837|NCT03538756|54611826|FG002|Long-Term Follow-up|COVID-19 Disruptions at Sites|13|||
27954838|NCT03538756|54611824|FG000|Long-Term Follow-up|Device Dissatisfaction|0|||
27954839|NCT03538756|54611825|FG001|Long-Term Follow-up|Device Dissatisfaction|0|||
27954840|NCT03538756|54611826|FG002|Long-Term Follow-up|Device Dissatisfaction|8|||
27954841|NCT01004250|54611836|FG000|Induction Therapy Period|Adverse Event|10|||
27954842|NCT01004250|54611836|FG000|Induction Therapy Period|Entry Criteria Not Met|1|||
27954843|NCT01004250|54611836|FG000|Induction Therapy Period|Withdrawal by Subject|2|||
27954844|NCT01004250|54611836|FG000|Induction Therapy Period|Physician Decision|2|||
27954845|NCT01004250|54611836|FG000|Maintenance Therapy Period|Adverse Event|15|||
27954846|NCT01004250|54611836|FG000|Maintenance Therapy Period|Lost to Follow-up|1|||
27954847|NCT01004250|54611836|FG000|Maintenance Therapy Period|Protocol Violation|1|||
27954848|NCT01004250|54611836|FG000|Maintenance Therapy Period|Withdrawal by Subject|5|||
27954849|NCT01004250|54611836|FG000|Maintenance Therapy Period|Physician Decision|4|||
27954850|NCT01004250|54611836|FG000|Follow-Up (FU) Period|Lost to Follow-up|1|||
27954851|NCT01004172|54611844|FG000|Overall Study|Progressive Disease in CNS Only|16|||
27954852|NCT01004172|54611844|FG000|Overall Study|Progressive Disease in Non-CNS Only|16|||
27954853|NCT01004172|54611844|FG000|Overall Study|Progressive Disease in CNS and Non-CNS|2|||
27954854|NCT01004172|54611844|FG000|Overall Study|Adverse Event|1|||
27954855|NCT01004172|54611844|FG000|Overall Study|Physician Decision|1|||
27954856|NCT01004172|54611844|FG000|Overall Study|Symptomatic Deterioration|2|||
27954857|NCT01161524|54611851|FG000|Core Study (23 Weeks)|Adverse Event|3|||
27954858|NCT01161524|54611852|FG001|Core Study (23 Weeks)|Adverse Event|0|||
27954859|NCT01161524|54611853|FG002|Core Study (23 Weeks)|Adverse Event|0|||
27954860|NCT01161524|54611851|FG000|Core Study (23 Weeks)|Other|1|||
27954861|NCT01161524|54611852|FG001|Core Study (23 Weeks)|Other|0|||
27954862|NCT01161524|54611853|FG002|Core Study (23 Weeks)|Other|0|||
27954863|NCT01161524|54611851|FG000|Core Study (23 Weeks)|Withdrawal of Consent|1|||
27954864|NCT01161524|54611852|FG001|Core Study (23 Weeks)|Withdrawal of Consent|1|||
27954865|NCT01161524|54611853|FG002|Core Study (23 Weeks)|Withdrawal of Consent|0|||
27954866|NCT01161524|54611851|FG000|Core Study (23 Weeks)|Lost to Follow-up|1|||
27954867|NCT01161524|54611852|FG001|Core Study (23 Weeks)|Lost to Follow-up|2|||
27954868|NCT01161524|54611853|FG002|Core Study (23 Weeks)|Lost to Follow-up|0|||
27954869|NCT01161524|54611851|FG000|Core Study (23 Weeks)|Subject Choice|3|||
27954870|NCT01161524|54611852|FG001|Core Study (23 Weeks)|Subject Choice|2|||
27954871|NCT01161524|54611853|FG002|Core Study (23 Weeks)|Subject Choice|0|||
27954872|NCT01161524|54611851|FG000|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
27954873|NCT01161524|54611852|FG001|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
27954874|NCT01161524|54611853|FG002|Extension Phase (Approximately 83 Weeks)|Adverse Event|8|||
27954875|NCT01161524|54611851|FG000|Extension Phase (Approximately 83 Weeks)|Other|0|||
27954876|NCT01161524|54611852|FG001|Extension Phase (Approximately 83 Weeks)|Other|0|||
27954877|NCT01161524|54611853|FG002|Extension Phase (Approximately 83 Weeks)|Other|6|||
27954878|NCT01161524|54611851|FG000|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
27954879|NCT01161524|54611852|FG001|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
27954880|NCT01161524|54611853|FG002|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1|||
27954881|NCT01161524|54611851|FG000|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
27954882|NCT01161524|54611852|FG001|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
27954883|NCT01161524|54611853|FG002|Extension Phase (Approximately 83 Weeks)|Subject Choice|5|||
27954884|NCT01161524|54611851|FG000|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
27954885|NCT01161524|54611852|FG001|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
27954886|NCT01161524|54611853|FG002|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4|||
27954887|NCT01000506|54611866|FG000|Overall Study|Adverse Event|6|||
27954888|NCT01000506|54611867|FG001|Overall Study|Adverse Event|5|||
27954889|NCT01000506|54611868|FG002|Overall Study|Adverse Event|8|||
27954890|NCT01000506|54611869|FG003|Overall Study|Adverse Event|9|||
27954891|NCT01000506|54611866|FG000|Overall Study|Lack of Efficacy|8|||
27954892|NCT01000506|54611867|FG001|Overall Study|Lack of Efficacy|6|||
27954893|NCT01000506|54611868|FG002|Overall Study|Lack of Efficacy|4|||
27954894|NCT01000506|54611869|FG003|Overall Study|Lack of Efficacy|4|||
27954895|NCT01000506|54611866|FG000|Overall Study|Protocol Violation|1|||
27954896|NCT01000506|54611867|FG001|Overall Study|Protocol Violation|1|||
27954897|NCT01000506|54611868|FG002|Overall Study|Protocol Violation|0|||
27954898|NCT01000506|54611869|FG003|Overall Study|Protocol Violation|0|||
27954899|NCT01000506|54611866|FG000|Overall Study|Lost to Follow-up|1|||
27954900|NCT01000506|54611867|FG001|Overall Study|Lost to Follow-up|1|||
27954901|NCT01000506|54611868|FG002|Overall Study|Lost to Follow-up|4|||
27954902|NCT01000506|54611869|FG003|Overall Study|Lost to Follow-up|0|||
27954903|NCT01000506|54611866|FG000|Overall Study|Physician Decision|1|||
27954904|NCT01000506|54611867|FG001|Overall Study|Physician Decision|3|||
27954905|NCT01000506|54611868|FG002|Overall Study|Physician Decision|3|||
27954906|NCT01000506|54611869|FG003|Overall Study|Physician Decision|3|||
27954907|NCT01000506|54611866|FG000|Overall Study|Withdrawal by Subject|11|||
27954908|NCT01000506|54611867|FG001|Overall Study|Withdrawal by Subject|8|||
27954909|NCT01000506|54611868|FG002|Overall Study|Withdrawal by Subject|2|||
27954910|NCT01000506|54611869|FG003|Overall Study|Withdrawal by Subject|7|||
27954911|NCT01174238|54611879|FG000|Overall Study|Lost to Follow-up|2|||
27954912|NCT01174160|54611888|FG000|Overall Study|Adverse Event|1|||
27954913|NCT01174160|54611889|FG001|Overall Study|Adverse Event|0|||
27954914|NCT01174160|54611888|FG000|Overall Study|Lost to Follow-up|1|||
27954915|NCT01174160|54611889|FG001|Overall Study|Lost to Follow-up|0|||
27954916|NCT01174160|54611888|FG000|Overall Study|Physician Decision|1|||
27954917|NCT01174160|54611889|FG001|Overall Study|Physician Decision|0|||
27954918|NCT01174160|54611888|FG000|Overall Study|Protocol Violation|4|||
27954919|NCT01174160|54611889|FG001|Overall Study|Protocol Violation|6|||
27954920|NCT01174160|54611888|FG000|Overall Study|Withdrawal by Subject|1|||
27954921|NCT01174160|54611889|FG001|Overall Study|Withdrawal by Subject|0|||
27954922|NCT01161446|54611897|FG000|Overall Study|Lost to Follow-up|18|||
27954923|NCT01161446|54611898|FG001|Overall Study|Lost to Follow-up|14|||
27954924|NCT01161446|54611897|FG000|Overall Study|Withdrawal by Subject|0|||
27954925|NCT01161446|54611898|FG001|Overall Study|Withdrawal by Subject|1|||
27954926|NCT01174004|54611906|FG000|Overall Study|Adverse Event|2|||
27954927|NCT01174004|54611907|FG001|Overall Study|Adverse Event|10|||
27954928|NCT01174004|54611906|FG000|Overall Study|Withdrawal by Subject|2|||
27954929|NCT01174004|54611907|FG001|Overall Study|Withdrawal by Subject|3|||
27954930|NCT01174004|54611906|FG000|Overall Study|At Discretion of Sponsor|2|||
27954931|NCT01174004|54611907|FG001|Overall Study|At Discretion of Sponsor|2|||
27954932|NCT01174004|54611906|FG000|Overall Study|Protocol Violation|0|||
27954933|NCT01174004|54611907|FG001|Overall Study|Protocol Violation|1|||
27954934|NCT01174004|54611906|FG000|Overall Study|Physician Decision|1|||
27954935|NCT01174004|54611907|FG001|Overall Study|Physician Decision|0|||
27954936|NCT01173692|54611915|FG000|Overall Study|Adverse Event|1|||
27954937|NCT01173692|54611916|FG001|Overall Study|Adverse Event|2|||
27954938|NCT01173692|54611915|FG000|Overall Study|Withdrawal by Subject|1|||
27954939|NCT01173692|54611916|FG001|Overall Study|Withdrawal by Subject|3|||
27954940|NCT01101035|54611924|FG000|Overall Study|Adverse Event|191|||
27954941|NCT01101035|54611925|FG001|Overall Study|Adverse Event|172|||
27954942|NCT01101035|54611924|FG000|Overall Study|Major Protocol Deviation|52|||
27954943|NCT01101035|54611925|FG001|Overall Study|Major Protocol Deviation|46|||
27954944|NCT01101035|54611924|FG000|Overall Study|Lost to Follow-up|226|||
27954945|NCT01101035|54611925|FG001|Overall Study|Lost to Follow-up|223|||
27954946|NCT01101035|54611924|FG000|Overall Study|Voluntary Withdrawal|595|||
28165066|NCT03016325|54835757|FG004|Treatment Period|Participant withdrew consent|0|||
28165067|NCT03016325|54835758|FG005|Treatment Period|Participant withdrew consent|0|||
27954947|NCT01101035|54611925|FG001|Overall Study|Voluntary Withdrawal|587|||
27954948|NCT01101035|54611924|FG000|Overall Study|Reason not Specified|333|||
27954949|NCT01101035|54611925|FG001|Overall Study|Reason not Specified|363|||
27954950|NCT01100567|54611933|FG000|Overall Study|Withdrawal by Subject|5|||
27954951|NCT01100567|54611934|FG001|Overall Study|Withdrawal by Subject|8|||
27954952|NCT01100567|54611933|FG000|Overall Study|Early Hospital Discharge|6|||
27954953|NCT01100567|54611934|FG001|Overall Study|Early Hospital Discharge|4|||
27954954|NCT01100567|54611933|FG000|Overall Study|Lost to Follow-up|1|||
27954955|NCT01100567|54611934|FG001|Overall Study|Lost to Follow-up|2|||
27954956|NCT01100567|54611933|FG000|Overall Study|Physician Decision|0|||
27954957|NCT01100567|54611934|FG001|Overall Study|Physician Decision|1|||
27954958|NCT01100567|54611933|FG000|Overall Study|Deemed ineligible after consent|0|||
27954959|NCT01100567|54611934|FG001|Overall Study|Deemed ineligible after consent|1|||
27954960|NCT01160822|54611947|FG000|Overall Study|Adverse Event|0|||
27954961|NCT01160822|54611948|FG001|Overall Study|Adverse Event|0|||
27954962|NCT01160822|54611949|FG002|Overall Study|Adverse Event|0|||
27954963|NCT01160822|54611950|FG003|Overall Study|Adverse Event|0|||
27954964|NCT01160822|54611951|FG004|Overall Study|Adverse Event|1|||
27954965|NCT01160822|54611952|FG005|Overall Study|Adverse Event|2|||
27954966|NCT01160822|54611953|FG006|Overall Study|Adverse Event|5|||
27954967|NCT01160822|54611947|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
27954968|NCT01160822|54611948|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
27954969|NCT01160822|54611949|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
27954970|NCT01160822|54611950|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
27954971|NCT01160822|54611951|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
27954972|NCT01160822|54611952|FG005|Overall Study|Unsatisfactory therapeutic effect|5|||
27954973|NCT01160822|54611953|FG006|Overall Study|Unsatisfactory therapeutic effect|3|||
27954974|NCT01160822|54611947|FG000|Overall Study|Withdrawal by Subject|0|||
27954975|NCT01160822|54611948|FG001|Overall Study|Withdrawal by Subject|0|||
27954976|NCT01160822|54611949|FG002|Overall Study|Withdrawal by Subject|0|||
27954977|NCT01160822|54611950|FG003|Overall Study|Withdrawal by Subject|0|||
27954978|NCT01160822|54611951|FG004|Overall Study|Withdrawal by Subject|0|||
27954979|NCT01160822|54611952|FG005|Overall Study|Withdrawal by Subject|0|||
27954980|NCT01160822|54611953|FG006|Overall Study|Withdrawal by Subject|1|||
27954981|NCT01160822|54611947|FG000|Overall Study|Lost to Follow-up|0|||
27954982|NCT01160822|54611948|FG001|Overall Study|Lost to Follow-up|0|||
27954983|NCT01160822|54611949|FG002|Overall Study|Lost to Follow-up|0|||
27954984|NCT01160822|54611950|FG003|Overall Study|Lost to Follow-up|0|||
27954985|NCT01160822|54611951|FG004|Overall Study|Lost to Follow-up|1|||
27954986|NCT01160822|54611952|FG005|Overall Study|Lost to Follow-up|0|||
27954987|NCT01160822|54611953|FG006|Overall Study|Lost to Follow-up|0|||
27954988|NCT01160822|54611947|FG000|Overall Study|Administrative problems|0|||
27954989|NCT01160822|54611948|FG001|Overall Study|Administrative problems|0|||
27954990|NCT01160822|54611949|FG002|Overall Study|Administrative problems|0|||
27954991|NCT01160822|54611950|FG003|Overall Study|Administrative problems|0|||
27954992|NCT01160822|54611951|FG004|Overall Study|Administrative problems|1|||
27954993|NCT01160822|54611952|FG005|Overall Study|Administrative problems|0|||
27954994|NCT01160822|54611953|FG006|Overall Study|Administrative problems|0|||
27954995|NCT01160822|54611947|FG000|Overall Study|Protocol deviation|0|||
27954996|NCT01160822|54611948|FG001|Overall Study|Protocol deviation|0|||
27954997|NCT01160822|54611949|FG002|Overall Study|Protocol deviation|0|||
27954998|NCT01160822|54611950|FG003|Overall Study|Protocol deviation|0|||
28081859|NCT00098787|54735403|FG000|Overall Study|Never started treatment|3|||
28081860|NCT00098787|54735404|FG001|Overall Study|Never started treatment|2|||
28081861|NCT00098787|54735405|FG002|Overall Study|Never started treatment|1|||
28081862|NCT00098787|54735403|FG000|Overall Study|Ineligible|9|||
28081863|NCT00098787|54735404|FG001|Overall Study|Ineligible|7|||
28081864|NCT00098787|54735405|FG002|Overall Study|Ineligible|3|||
28081865|NCT00098787|54735403|FG000|Overall Study|Disease progression|28|||
28081866|NCT00098787|54735404|FG001|Overall Study|Disease progression|17|||
28081867|NCT00098787|54735405|FG002|Overall Study|Disease progression|23|||
28081868|NCT00098787|54735403|FG000|Overall Study|Adverse Event|8|||
28081869|NCT00098787|54735404|FG001|Overall Study|Adverse Event|17|||
28081870|NCT00098787|54735405|FG002|Overall Study|Adverse Event|8|||
28081871|NCT00098787|54735403|FG000|Overall Study|Death|6|||
28081872|NCT00098787|54735404|FG001|Overall Study|Death|1|||
28081873|NCT00098787|54735405|FG002|Overall Study|Death|0|||
28081874|NCT00098787|54735403|FG000|Overall Study|Withdrawal by Subject|4|||
28081875|NCT00098787|54735404|FG001|Overall Study|Withdrawal by Subject|12|||
28081876|NCT00098787|54735405|FG002|Overall Study|Withdrawal by Subject|6|||
28081877|NCT00098787|54735403|FG000|Overall Study|Alternative therapy|8|||
28081878|NCT00098787|54735404|FG001|Overall Study|Alternative therapy|13|||
28081879|NCT00098787|54735405|FG002|Overall Study|Alternative therapy|13|||
27732064|NCT02783573|54179479|FG002|Placebo-Controlled Treatment Period|Sponsor Decision|492|||
27732065|NCT02783573|54179477|FG000|Delayed-Start Period|Sponsor Decision|0|||
27732066|NCT02783573|54179478|FG001|Delayed-Start Period|Sponsor Decision|17|||
27732067|NCT02783573|54179479|FG002|Delayed-Start Period|Sponsor Decision|12|||
28081880|NCT00098787|54735403|FG000|Overall Study|Other|7|||
28081881|NCT00098787|54735404|FG001|Overall Study|Other|6|||
28081882|NCT00098787|54735405|FG002|Overall Study|Other|9|||
27732068|NCT01666652|54179495|FG000|Overall Study|Serious Adverse Event|0|||
27954999|NCT01160822|54611951|FG004|Overall Study|Protocol deviation|2|||
27955000|NCT01160822|54611952|FG005|Overall Study|Protocol deviation|0|||
27955001|NCT01160822|54611953|FG006|Overall Study|Protocol deviation|0|||
27955002|NCT01006980|54611972|FG000|Vemurafenib and Dacarbazine|Randomized but Not Treated|1|||
27955003|NCT01006980|54611973|FG001|Vemurafenib and Dacarbazine|Randomized but Not Treated|45|||
27955004|NCT01006980|54611972|FG000|Vemurafenib and Dacarbazine|Adverse Event|25|||
27955005|NCT01006980|54611973|FG001|Vemurafenib and Dacarbazine|Adverse Event|5|||
27955006|NCT01006980|54611972|FG000|Vemurafenib and Dacarbazine|Death|13|||
27955007|NCT01006980|54611973|FG001|Vemurafenib and Dacarbazine|Death|12|||
28081883|NCT00098475|54735415|FG000|Step 1|Progressive disease|33|||
28081884|NCT00098475|54735416|FG001|Step 1|Progressive disease|35|||
27955008|NCT01006980|54611972|FG000|Vemurafenib and Dacarbazine|Progression|257|||
27955009|NCT01006980|54611973|FG001|Vemurafenib and Dacarbazine|Progression|218|||
27955010|NCT01006980|54611972|FG000|Vemurafenib and Dacarbazine|Withdrawal of Consent|4|||
27955011|NCT01006980|54611973|FG001|Vemurafenib and Dacarbazine|Withdrawal of Consent|6|||
27955012|NCT01006980|54611972|FG000|Vemurafenib and Dacarbazine|Refuse Treatment|9|||
27955013|NCT01006980|54611973|FG001|Vemurafenib and Dacarbazine|Refuse Treatment|6|||
27955014|NCT01006980|54611972|FG000|Vemurafenib and Dacarbazine|Protocol Violation|2|||
27955015|NCT01006980|54611973|FG001|Vemurafenib and Dacarbazine|Protocol Violation|3|||
27955016|NCT01006980|54611972|FG000|Vemurafenib and Dacarbazine|Reason Not Specified|26|||
27955017|NCT01006980|54611973|FG001|Vemurafenib and Dacarbazine|Reason Not Specified|43|||
27955018|NCT01006980|54611972|FG000|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0|||
27955019|NCT01006980|54611973|FG001|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4|||
27955020|NCT01006980|54611972|FG000|Crossover: Dacarbazine to Vemurafenib|Death|0|||
27955021|NCT01006980|54611973|FG001|Crossover: Dacarbazine to Vemurafenib|Death|4|||
27955022|NCT01006980|54611972|FG000|Crossover: Dacarbazine to Vemurafenib|Progression|0|||
27955023|NCT01006980|54611973|FG001|Crossover: Dacarbazine to Vemurafenib|Progression|65|||
27955024|NCT01006980|54611972|FG000|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0|||
27955025|NCT01006980|54611973|FG001|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1|||
27955026|NCT01006980|54611972|FG000|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0|||
27955027|NCT01006980|54611973|FG001|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10|||
27955028|NCT00887926|54611984|FG000|Overall Study|Withdrawal by Subject|0|||
27955029|NCT00887926|54611985|FG001|Overall Study|Withdrawal by Subject|1|||
27955030|NCT00887926|54611986|FG002|Overall Study|Withdrawal by Subject|0|||
27955031|NCT00887926|54611987|FG003|Overall Study|Withdrawal by Subject|0|||
27955032|NCT00998400|54612005|FG000|Overall Study|Lack of interest/motivation|1|||
27955033|NCT00998400|54612006|FG001|Overall Study|Lack of interest/motivation|2|||
27955034|NCT00998400|54612005|FG000|Overall Study|Logistical problems|1|||
27955035|NCT00998400|54612006|FG001|Overall Study|Logistical problems|0|||
27955036|NCT00997386|54612013|FG000|Overall Study|Death|7|||
27955037|NCT00996996|54612017|FG000|Overall Study|Progressive Disease|10|||
27955038|NCT00996996|54612017|FG000|Overall Study|Non-compliance|8|||
27955039|NCT00996996|54612017|FG000|Overall Study|Lost to Follow-up|9|||
27955040|NCT00996996|54612017|FG000|Overall Study|Death|5|||
27955041|NCT00996996|54612017|FG000|Overall Study|Did Not Receive Study Medications|1|||
27955042|NCT00996918|54612026|FG000|Overall Study|Lack of Efficacy|1|||
27955043|NCT00996918|54612027|FG001|Overall Study|Lack of Efficacy|1|||
27955044|NCT00996918|54612028|FG002|Overall Study|Lack of Efficacy|2|||
27955045|NCT00996918|54612029|FG003|Overall Study|Lack of Efficacy|2|||
27955046|NCT00996918|54612030|FG004|Overall Study|Lack of Efficacy|0|||
27955047|NCT00996918|54612026|FG000|Overall Study|Adverse Event|2|||
27955048|NCT00996918|54612027|FG001|Overall Study|Adverse Event|5|||
27955049|NCT00996918|54612028|FG002|Overall Study|Adverse Event|2|||
27955050|NCT00996918|54612029|FG003|Overall Study|Adverse Event|6|||
27955051|NCT00996918|54612030|FG004|Overall Study|Adverse Event|0|||
27955052|NCT00996918|54612026|FG000|Overall Study|Withdrawal by Subject|1|||
27955053|NCT00996918|54612027|FG001|Overall Study|Withdrawal by Subject|4|||
27955054|NCT00996918|54612028|FG002|Overall Study|Withdrawal by Subject|3|||
27955055|NCT00996918|54612029|FG003|Overall Study|Withdrawal by Subject|3|||
27955056|NCT00996918|54612030|FG004|Overall Study|Withdrawal by Subject|2|||
27955057|NCT00996918|54612026|FG000|Overall Study|Physician Decision|1|||
27955058|NCT00996918|54612027|FG001|Overall Study|Physician Decision|0|||
27955059|NCT00996918|54612028|FG002|Overall Study|Physician Decision|0|||
27955060|NCT00996918|54612029|FG003|Overall Study|Physician Decision|0|||
27955061|NCT00996918|54612030|FG004|Overall Study|Physician Decision|0|||
27955062|NCT00996918|54612026|FG000|Overall Study|Discontinuation of Study by Sponsor|31|||
27955063|NCT00996918|54612027|FG001|Overall Study|Discontinuation of Study by Sponsor|54|||
27955064|NCT00996918|54612028|FG002|Overall Study|Discontinuation of Study by Sponsor|30|||
27955065|NCT00996918|54612029|FG003|Overall Study|Discontinuation of Study by Sponsor|45|||
27955066|NCT00996918|54612030|FG004|Overall Study|Discontinuation of Study by Sponsor|2|||
27955067|NCT00996918|54612026|FG000|Overall Study|Loss of Caregiver|0|||
27955068|NCT00996918|54612027|FG001|Overall Study|Loss of Caregiver|1|||
28081885|NCT00098475|54735417|FG002|Step 1|Progressive disease|2|||
27732069|NCT01666652|54179496|FG001|Overall Study|Serious Adverse Event|0|||
27832316|NCT01775189|54311156|FG004|Treatment Phase: Washout Period 3|Protocol Violation|0|||
27832317|NCT01775189|54311157|FG005|Treatment Phase: Washout Period 3|Protocol Violation|0|||
27832318|NCT01775189|54311158|FG006|Treatment Phase: Washout Period 3|Protocol Violation|1|||
27955069|NCT00996918|54612028|FG002|Overall Study|Loss of Caregiver|0|||
27955070|NCT00996918|54612029|FG003|Overall Study|Loss of Caregiver|0|||
27955071|NCT00996918|54612030|FG004|Overall Study|Loss of Caregiver|0|||
27955072|NCT00996918|54612026|FG000|Overall Study|Other|3|||
27955073|NCT00996918|54612027|FG001|Overall Study|Other|1|||
27955074|NCT00996918|54612028|FG002|Overall Study|Other|0|||
27955075|NCT00996918|54612029|FG003|Overall Study|Other|0|||
27955076|NCT00996918|54612030|FG004|Overall Study|Other|0|||
27955077|NCT01160744|54612046|FG000|Overall Study|Withdrawal by Subject|11|||
27955078|NCT01160744|54612047|FG001|Overall Study|Withdrawal by Subject|5|||
27955079|NCT01160744|54612048|FG002|Overall Study|Withdrawal by Subject|6|||
27955080|NCT01160744|54612049|FG003|Overall Study|Withdrawal by Subject|4|||
27955081|NCT01160744|54612046|FG000|Overall Study|Not meet inclusion/exclusion criteria|0|||
27955082|NCT01160744|54612047|FG001|Overall Study|Not meet inclusion/exclusion criteria|0|||
27955083|NCT01160744|54612048|FG002|Overall Study|Not meet inclusion/exclusion criteria|1|||
27955084|NCT01160744|54612049|FG003|Overall Study|Not meet inclusion/exclusion criteria|0|||
27955085|NCT01160354|54612064|FG000|Overall Study|Death|0|||
27955086|NCT01160354|54612065|FG001|Overall Study|Death|1|||
27955087|NCT01160354|54612066|FG002|Overall Study|Death|1|||
27955088|NCT01160198|54612077|FG000|Overall Study|Withdrawal by Subject|2|||
27955089|NCT01160198|54612078|FG001|Overall Study|Withdrawal by Subject|1|||
27955090|NCT01160198|54612079|FG002|Overall Study|Withdrawal by Subject|0|||
27955091|NCT01160198|54612077|FG000|Overall Study|Adverse Event|0|||
27955092|NCT01160198|54612078|FG001|Overall Study|Adverse Event|1|||
27955093|NCT01160198|54612079|FG002|Overall Study|Adverse Event|0|||
27955094|NCT01160198|54612077|FG000|Overall Study|Lost to Follow-up|0|||
27955095|NCT01160198|54612078|FG001|Overall Study|Lost to Follow-up|1|||
27955096|NCT01160198|54612079|FG002|Overall Study|Lost to Follow-up|0|||
27955097|NCT01160198|54612077|FG000|Overall Study|Participant lost drug; withdrew consent|0|||
27955098|NCT01160198|54612078|FG001|Overall Study|Participant lost drug; withdrew consent|0|||
27955099|NCT01160198|54612079|FG002|Overall Study|Participant lost drug; withdrew consent|1|||
27955100|NCT01159574|54612087|FG000|Treatment Phase|non-evaluable/not included in analysis|1|||
27955101|NCT01159574|54612087|FG000|Treatment Phase|Adverse Event|3|||
27955102|NCT01159574|54612087|FG000|Treatment Phase|Death|6|||
27955103|NCT01159574|54612087|FG000|Treatment Phase|Physician Decision|2|||
27955104|NCT01159574|54612087|FG000|Treatment Phase|Withdrawal by Subject|7|||
27955105|NCT01159574|54612087|FG000|Treatment Phase|still on treatment|2|||
27955106|NCT01159574|54612087|FG000|Follow Up Phase|Lost to Follow-up|2|||
27955107|NCT01159574|54612087|FG000|Follow Up Phase|still being followed for overall surviva|18|||
27955108|NCT01158950|54612091|FG000|1st Intervention (1 Day)|Physician Decision|1|||
27955109|NCT01158950|54612092|FG001|1st Intervention (1 Day)|Physician Decision|2|||
27955110|NCT01172288|54612099|FG000|Overall Study|Adverse Event|1|||
27955111|NCT01172288|54612100|FG001|Overall Study|Adverse Event|0|||
27955112|NCT01172288|54612099|FG000|Overall Study|Protocol Violation|0|||
27955113|NCT01172288|54612100|FG001|Overall Study|Protocol Violation|1|||
27955114|NCT00996840|54612111|FG000|Overall Study|Adverse Event|0|||
27955115|NCT00996840|54612112|FG001|Overall Study|Adverse Event|1|||
27955116|NCT00996840|54612113|FG002|Overall Study|Adverse Event|0|||
27955117|NCT00996840|54612114|FG003|Overall Study|Adverse Event|0|||
27955118|NCT00996840|54612115|FG004|Overall Study|Adverse Event|0|||
27955119|NCT00996840|54612111|FG000|Overall Study|Physician Decision|0|||
27955120|NCT00996840|54612112|FG001|Overall Study|Physician Decision|0|||
27955121|NCT00996840|54612113|FG002|Overall Study|Physician Decision|1|||
27955122|NCT00996840|54612114|FG003|Overall Study|Physician Decision|1|||
27955123|NCT00996840|54612115|FG004|Overall Study|Physician Decision|2|||
27955124|NCT00996840|54612111|FG000|Overall Study|Withdrawal by Subject|1|||
27955125|NCT00996840|54612112|FG001|Overall Study|Withdrawal by Subject|1|||
27955126|NCT00996840|54612113|FG002|Overall Study|Withdrawal by Subject|0|||
27955127|NCT00996840|54612114|FG003|Overall Study|Withdrawal by Subject|0|||
27955128|NCT00996840|54612115|FG004|Overall Study|Withdrawal by Subject|0|||
27955129|NCT00998946|54612131|FG000|Overall Study|Lost to Follow-up|1|||
27955130|NCT00998946|54612131|FG000|Overall Study|Withdrawal by Subject|1|||
27955131|NCT00998946|54612131|FG000|Overall Study|Death|2|||
27955132|NCT00998946|54612131|FG000|Overall Study|Reason Unspecified|3|||
27955133|NCT00998946|54612131|FG000|Overall Study|Enrolled but not Dosed|2|||
27955134|NCT01158404|54612143|FG000|Overall Study|Withdrawal by Subject|0|||
27955135|NCT01158404|54612144|FG001|Overall Study|Withdrawal by Subject|1|||
27955136|NCT01158404|54612145|FG002|Overall Study|Withdrawal by Subject|0|||
27955137|NCT01158404|54612146|FG003|Overall Study|Withdrawal by Subject|0|||
27955138|NCT01158404|54612147|FG004|Overall Study|Withdrawal by Subject|3|||
27955139|NCT01158404|54612148|FG005|Overall Study|Withdrawal by Subject|1|||
27955140|NCT01158404|54612149|FG006|Overall Study|Withdrawal by Subject|0|||
27955141|NCT01158404|54612150|FG007|Overall Study|Withdrawal by Subject|1|||
27955142|NCT01158404|54612143|FG000|Overall Study|Physician Decision|0|||
27955143|NCT01158404|54612144|FG001|Overall Study|Physician Decision|0|||
27955144|NCT01158404|54612145|FG002|Overall Study|Physician Decision|0|||
27955145|NCT01158404|54612146|FG003|Overall Study|Physician Decision|0|||
27955146|NCT01158404|54612147|FG004|Overall Study|Physician Decision|0|||
27955147|NCT01158404|54612148|FG005|Overall Study|Physician Decision|0|||
27955148|NCT01158404|54612149|FG006|Overall Study|Physician Decision|0|||
27955149|NCT01158404|54612150|FG007|Overall Study|Physician Decision|1|||
27955150|NCT01158404|54612143|FG000|Overall Study|Progressive Disease|0|||
27955151|NCT01158404|54612144|FG001|Overall Study|Progressive Disease|0|||
27955152|NCT01158404|54612145|FG002|Overall Study|Progressive Disease|0|||
27955153|NCT01158404|54612146|FG003|Overall Study|Progressive Disease|0|||
27955154|NCT01158404|54612147|FG004|Overall Study|Progressive Disease|0|||
27955155|NCT01158404|54612148|FG005|Overall Study|Progressive Disease|0|||
27955156|NCT01158404|54612149|FG006|Overall Study|Progressive Disease|1|||
27955157|NCT01158404|54612150|FG007|Overall Study|Progressive Disease|0|||
27955158|NCT00998790|54612170|FG000|Overall Study|Withdrawal by Subject|21|||
27955159|NCT01001988|54612174|FG000|Overall Study|Protocol Violation|84|||
27955160|NCT01001988|54612174|FG000|Overall Study|Withdrawal by Subject|18|||
27955161|NCT01001988|54612174|FG000|Overall Study|Lost to Follow-up|15|||
27955162|NCT00996606|54612178|FG000|Overall Study|Adverse Event or Intercurrent Illness|2|||
27955163|NCT00996606|54612178|FG000|Overall Study|Insufficient Therapeutic Response|2|||
27955164|NCT00996606|54612178|FG000|Overall Study|Protocol Violation|1|||
27955165|NCT00996606|54612178|FG000|Overall Study|Withdrawal by Subject|3|||
27955166|NCT00995436|54612185|FG000|Overall Study|Withdrawal by Subject|2|||
27955167|NCT00995436|54612186|FG001|Overall Study|Withdrawal by Subject|5|||
27955168|NCT00995436|54612187|FG002|Overall Study|Withdrawal by Subject|0|||
27955169|NCT00994890|54612198|FG000|Overall Study|Adverse Event|13|||
27955170|NCT00994890|54612199|FG001|Overall Study|Adverse Event|9|||
27955171|NCT00994890|54612200|FG002|Overall Study|Adverse Event|11|||
27955172|NCT00994890|54612198|FG000|Overall Study|Lack of Efficacy|0|||
27955173|NCT00994890|54612199|FG001|Overall Study|Lack of Efficacy|0|||
27955174|NCT00994890|54612200|FG002|Overall Study|Lack of Efficacy|1|||
27955175|NCT00994890|54612198|FG000|Overall Study|Lost to Follow-up|6|||
27955176|NCT00994890|54612199|FG001|Overall Study|Lost to Follow-up|1|||
27955177|NCT00994890|54612200|FG002|Overall Study|Lost to Follow-up|3|||
27955178|NCT00994890|54612198|FG000|Overall Study|No longer willing to participate|8|||
27955179|NCT00994890|54612199|FG001|Overall Study|No longer willing to participate|5|||
27955180|NCT00994890|54612200|FG002|Overall Study|No longer willing to participate|13|||
27955181|NCT00994890|54612198|FG000|Overall Study|Protocol Violation|2|||
27955182|NCT00994890|54612199|FG001|Overall Study|Protocol Violation|4|||
27955183|NCT00994890|54612200|FG002|Overall Study|Protocol Violation|0|||
27955184|NCT00994890|54612198|FG000|Overall Study|Study terminated by sponsor|199|||
27955185|NCT00994890|54612199|FG001|Overall Study|Study terminated by sponsor|201|||
27955186|NCT00994890|54612200|FG002|Overall Study|Study terminated by sponsor|197|||
27955187|NCT00994890|54612198|FG000|Overall Study|Randomized, but not treated|1|||
27955188|NCT00994890|54612199|FG001|Overall Study|Randomized, but not treated|0|||
27955189|NCT00994890|54612200|FG002|Overall Study|Randomized, but not treated|0|||
27955190|NCT00994890|54612198|FG000|Overall Study|Other|2|||
27955191|NCT00994890|54612199|FG001|Overall Study|Other|2|||
27955192|NCT00994890|54612200|FG002|Overall Study|Other|1|||
27955193|NCT00994422|54612210|FG000|Overall Study|Lost to Follow-up|7|||
27955194|NCT00994422|54612211|FG001|Overall Study|Lost to Follow-up|1|||
27955195|NCT01171976|54612222|FG000|Overall Study|Protocol Violation|0|||
27955196|NCT01171976|54612223|FG001|Overall Study|Protocol Violation|0|||
27955197|NCT01171976|54612224|FG002|Overall Study|Protocol Violation|1|||
27955198|NCT01171976|54612222|FG000|Overall Study|Death|2|||
27955199|NCT01171976|54612223|FG001|Overall Study|Death|4|||
27955200|NCT01171976|54612224|FG002|Overall Study|Death|1|||
27955201|NCT01171976|54612222|FG000|Overall Study|Lost to Follow-up|4|||
27955202|NCT01171976|54612223|FG001|Overall Study|Lost to Follow-up|0|||
27955203|NCT01171976|54612224|FG002|Overall Study|Lost to Follow-up|2|||
27955204|NCT01171976|54612222|FG000|Overall Study|Withdrawal by Subject|1|||
27955205|NCT01171976|54612223|FG001|Overall Study|Withdrawal by Subject|5|||
27955206|NCT01171976|54612224|FG002|Overall Study|Withdrawal by Subject|6|||
27955207|NCT01171976|54612222|FG000|Overall Study|Abnormal test result|1|||
27955208|NCT01171976|54612223|FG001|Overall Study|Abnormal test result|0|||
27955209|NCT01171976|54612224|FG002|Overall Study|Abnormal test result|0|||
27955210|NCT01171976|54612222|FG000|Overall Study|Adverse Event|6|||
27955211|NCT01171976|54612223|FG001|Overall Study|Adverse Event|2|||
27955212|NCT01171976|54612224|FG002|Overall Study|Adverse Event|5|||
27955213|NCT00996216|54612232|FG000|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1|||
27955214|NCT00996216|54612232|FG000|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3|||
27955215|NCT00996216|54612232|FG000|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1|||
27955216|NCT00830869|54612249|FG000|Period 1: Part 1|Symptomatic deterioration|0|||
27955217|NCT00830869|54612250|FG001|Period 1: Part 1|Symptomatic deterioration|0|||
27955218|NCT00830869|54612251|FG002|Period 1: Part 1|Symptomatic deterioration|0|||
27955219|NCT00830869|54612252|FG003|Period 1: Part 1|Symptomatic deterioration|1|||
27955220|NCT00830869|54612253|FG004|Period 1: Part 1|Symptomatic deterioration|0|||
27955221|NCT00830869|54612254|FG005|Period 1: Part 1|Symptomatic deterioration|1|||
27955222|NCT00830869|54612255|FG006|Period 1: Part 1|Symptomatic deterioration|1|||
27955223|NCT00830869|54612256|FG007|Period 1: Part 1|Symptomatic deterioration|0|||
27955224|NCT00830869|54612257|FG008|Period 1: Part 1|Symptomatic deterioration|0|||
27955225|NCT00830869|54612258|FG009|Period 1: Part 1|Symptomatic deterioration|0|||
27955226|NCT00830869|54612259|FG010|Period 1: Part 1|Symptomatic deterioration|0|||
27955227|NCT00830869|54612260|FG011|Period 1: Part 1|Symptomatic deterioration|0|||
27955228|NCT00830869|54612249|FG000|Period 1: Part 1|Withdrawal by Subject|0|||
27955229|NCT00830869|54612250|FG001|Period 1: Part 1|Withdrawal by Subject|1|||
27832319|NCT01770743|54311224|FG000|Overall Study|Adverse Event|1|||
27955230|NCT00830869|54612251|FG002|Period 1: Part 1|Withdrawal by Subject|0|||
27955231|NCT00830869|54612252|FG003|Period 1: Part 1|Withdrawal by Subject|0|||
27955232|NCT00830869|54612253|FG004|Period 1: Part 1|Withdrawal by Subject|0|||
27955233|NCT00830869|54612254|FG005|Period 1: Part 1|Withdrawal by Subject|0|||
27955234|NCT00830869|54612255|FG006|Period 1: Part 1|Withdrawal by Subject|0|||
27955235|NCT00830869|54612256|FG007|Period 1: Part 1|Withdrawal by Subject|0|||
27955236|NCT00830869|54612257|FG008|Period 1: Part 1|Withdrawal by Subject|0|||
27955237|NCT00830869|54612258|FG009|Period 1: Part 1|Withdrawal by Subject|0|||
27955238|NCT00830869|54612259|FG010|Period 1: Part 1|Withdrawal by Subject|0|||
27955239|NCT00830869|54612260|FG011|Period 1: Part 1|Withdrawal by Subject|0|||
27955240|NCT00830869|54612249|FG000|Period 1: Part 1|Adverse Event|0|||
27955241|NCT00830869|54612250|FG001|Period 1: Part 1|Adverse Event|0|||
27955242|NCT00830869|54612251|FG002|Period 1: Part 1|Adverse Event|0|||
27955243|NCT00830869|54612252|FG003|Period 1: Part 1|Adverse Event|0|||
27955244|NCT00830869|54612253|FG004|Period 1: Part 1|Adverse Event|0|||
27955245|NCT00830869|54612254|FG005|Period 1: Part 1|Adverse Event|1|||
27955246|NCT00830869|54612255|FG006|Period 1: Part 1|Adverse Event|1|||
27955247|NCT00830869|54612256|FG007|Period 1: Part 1|Adverse Event|0|||
27955248|NCT00830869|54612257|FG008|Period 1: Part 1|Adverse Event|0|||
27955249|NCT00830869|54612258|FG009|Period 1: Part 1|Adverse Event|0|||
27955250|NCT00830869|54612259|FG010|Period 1: Part 1|Adverse Event|0|||
27955251|NCT00830869|54612260|FG011|Period 1: Part 1|Adverse Event|0|||
27955252|NCT00830869|54612249|FG000|Period 1: Part 1|Progressive disease|1|||
27955253|NCT00830869|54612250|FG001|Period 1: Part 1|Progressive disease|0|||
27955254|NCT00830869|54612251|FG002|Period 1: Part 1|Progressive disease|1|||
27955255|NCT00830869|54612252|FG003|Period 1: Part 1|Progressive disease|6|||
27955256|NCT00830869|54612253|FG004|Period 1: Part 1|Progressive disease|4|||
27955257|NCT00830869|54612254|FG005|Period 1: Part 1|Progressive disease|4|||
27955258|NCT00830869|54612255|FG006|Period 1: Part 1|Progressive disease|1|||
27955259|NCT00830869|54612256|FG007|Period 1: Part 1|Progressive disease|0|||
27955260|NCT00830869|54612257|FG008|Period 1: Part 1|Progressive disease|0|||
27955261|NCT00830869|54612258|FG009|Period 1: Part 1|Progressive disease|0|||
27955262|NCT00830869|54612259|FG010|Period 1: Part 1|Progressive disease|0|||
27955263|NCT00830869|54612260|FG011|Period 1: Part 1|Progressive disease|0|||
27955264|NCT00830869|54612249|FG000|Period 2: Part 2|Protocol Violation|0|||
27955265|NCT00830869|54612250|FG001|Period 2: Part 2|Protocol Violation|0|||
27955266|NCT00830869|54612251|FG002|Period 2: Part 2|Protocol Violation|0|||
27955267|NCT00830869|54612252|FG003|Period 2: Part 2|Protocol Violation|0|||
27955268|NCT00830869|54612253|FG004|Period 2: Part 2|Protocol Violation|0|||
27955269|NCT00830869|54612254|FG005|Period 2: Part 2|Protocol Violation|0|||
27955270|NCT00830869|54612255|FG006|Period 2: Part 2|Protocol Violation|0|||
27955271|NCT00830869|54612256|FG007|Period 2: Part 2|Protocol Violation|1|||
27955272|NCT00830869|54612257|FG008|Period 2: Part 2|Protocol Violation|0|||
27955273|NCT00830869|54612258|FG009|Period 2: Part 2|Protocol Violation|1|||
27955274|NCT00830869|54612259|FG010|Period 2: Part 2|Protocol Violation|0|||
27955275|NCT00830869|54612260|FG011|Period 2: Part 2|Protocol Violation|0|||
27955276|NCT00830869|54612249|FG000|Period 2: Part 2|Withdrawal by Subject|0|||
27955277|NCT00830869|54612250|FG001|Period 2: Part 2|Withdrawal by Subject|0|||
27955278|NCT00830869|54612251|FG002|Period 2: Part 2|Withdrawal by Subject|0|||
27955279|NCT00830869|54612252|FG003|Period 2: Part 2|Withdrawal by Subject|0|||
27955280|NCT00830869|54612253|FG004|Period 2: Part 2|Withdrawal by Subject|0|||
27955281|NCT00830869|54612254|FG005|Period 2: Part 2|Withdrawal by Subject|0|||
27955282|NCT00830869|54612255|FG006|Period 2: Part 2|Withdrawal by Subject|0|||
27955283|NCT00830869|54612256|FG007|Period 2: Part 2|Withdrawal by Subject|1|||
27955284|NCT00830869|54612257|FG008|Period 2: Part 2|Withdrawal by Subject|2|||
27955285|NCT00830869|54612258|FG009|Period 2: Part 2|Withdrawal by Subject|1|||
27955286|NCT00830869|54612259|FG010|Period 2: Part 2|Withdrawal by Subject|0|||
27955287|NCT00830869|54612260|FG011|Period 2: Part 2|Withdrawal by Subject|1|||
27955288|NCT00830869|54612249|FG000|Period 2: Part 2|Adverse Event|0|||
27955289|NCT00830869|54612250|FG001|Period 2: Part 2|Adverse Event|0|||
27955290|NCT00830869|54612251|FG002|Period 2: Part 2|Adverse Event|0|||
27955291|NCT00830869|54612252|FG003|Period 2: Part 2|Adverse Event|0|||
27955292|NCT00830869|54612253|FG004|Period 2: Part 2|Adverse Event|0|||
28081886|NCT00098475|54735418|FG003|Step 1|Progressive disease|1|||
28081887|NCT00098475|54735415|FG000|Step 1|Adverse Event|56|||
27955293|NCT00830869|54612254|FG005|Period 2: Part 2|Adverse Event|0|||
27955294|NCT00830869|54612255|FG006|Period 2: Part 2|Adverse Event|0|||
27955295|NCT00830869|54612256|FG007|Period 2: Part 2|Adverse Event|4|||
27955296|NCT00830869|54612257|FG008|Period 2: Part 2|Adverse Event|3|||
27955297|NCT00830869|54612258|FG009|Period 2: Part 2|Adverse Event|2|||
27955298|NCT00830869|54612259|FG010|Period 2: Part 2|Adverse Event|2|||
27832320|NCT01770743|54311225|FG001|Overall Study|Adverse Event|0|||
27955299|NCT00830869|54612260|FG011|Period 2: Part 2|Adverse Event|0|||
27955300|NCT00830869|54612249|FG000|Period 2: Part 2|Symptomatic Deterioration|0|||
27832321|NCT01770743|54311226|FG002|Overall Study|Adverse Event|0|||
27955301|NCT00830869|54612250|FG001|Period 2: Part 2|Symptomatic Deterioration|0|||
27832322|NCT01770743|54311227|FG003|Overall Study|Adverse Event|0|||
27955302|NCT00830869|54612251|FG002|Period 2: Part 2|Symptomatic Deterioration|0|||
27955303|NCT00830869|54612252|FG003|Period 2: Part 2|Symptomatic Deterioration|0|||
27955304|NCT00830869|54612253|FG004|Period 2: Part 2|Symptomatic Deterioration|0|||
27955305|NCT00830869|54612254|FG005|Period 2: Part 2|Symptomatic Deterioration|0|||
27955306|NCT00830869|54612255|FG006|Period 2: Part 2|Symptomatic Deterioration|0|||
27955307|NCT00830869|54612256|FG007|Period 2: Part 2|Symptomatic Deterioration|0|||
27955308|NCT00830869|54612257|FG008|Period 2: Part 2|Symptomatic Deterioration|6|||
27955309|NCT00830869|54612258|FG009|Period 2: Part 2|Symptomatic Deterioration|3|||
27955310|NCT00830869|54612259|FG010|Period 2: Part 2|Symptomatic Deterioration|1|||
27955311|NCT00830869|54612260|FG011|Period 2: Part 2|Symptomatic Deterioration|4|||
27955312|NCT00830869|54612249|FG000|Period 2: Part 2|Progressive disease|0|||
27955313|NCT00830869|54612250|FG001|Period 2: Part 2|Progressive disease|0|||
27955314|NCT00830869|54612251|FG002|Period 2: Part 2|Progressive disease|0|||
27955315|NCT00830869|54612252|FG003|Period 2: Part 2|Progressive disease|0|||
27955316|NCT00830869|54612253|FG004|Period 2: Part 2|Progressive disease|0|||
27955317|NCT00830869|54612254|FG005|Period 2: Part 2|Progressive disease|0|||
27955318|NCT00830869|54612255|FG006|Period 2: Part 2|Progressive disease|0|||
27955319|NCT00830869|54612256|FG007|Period 2: Part 2|Progressive disease|14|||
28165068|NCT03016325|54835759|FG006|Treatment Period|Participant withdrew consent|0|||
28165069|NCT03016325|54835760|FG007|Treatment Period|Participant withdrew consent|0|||
28165070|NCT03016325|54835753|FG000|Treatment Period|Death|0|||
28165071|NCT03016325|54835754|FG001|Treatment Period|Death|0|||
28165072|NCT03016325|54835755|FG002|Treatment Period|Death|0|||
28165073|NCT03016325|54835756|FG003|Treatment Period|Death|0|||
27955320|NCT00830869|54612257|FG008|Period 2: Part 2|Progressive disease|11|||
27955321|NCT00830869|54612258|FG009|Period 2: Part 2|Progressive disease|12|||
27955322|NCT00830869|54612259|FG010|Period 2: Part 2|Progressive disease|8|||
27955323|NCT00830869|54612260|FG011|Period 2: Part 2|Progressive disease|15|||
27955324|NCT00830869|54612249|FG000|Period 2: Part 2|Other|0|||
27955325|NCT00830869|54612250|FG001|Period 2: Part 2|Other|0|||
27955326|NCT00830869|54612251|FG002|Period 2: Part 2|Other|0|||
27955327|NCT00830869|54612252|FG003|Period 2: Part 2|Other|0|||
27955328|NCT00830869|54612253|FG004|Period 2: Part 2|Other|0|||
27955329|NCT00830869|54612254|FG005|Period 2: Part 2|Other|0|||
27955330|NCT00830869|54612255|FG006|Period 2: Part 2|Other|0|||
27955331|NCT00830869|54612256|FG007|Period 2: Part 2|Other|0|||
27955332|NCT00830869|54612257|FG008|Period 2: Part 2|Other|0|||
27955333|NCT00830869|54612258|FG009|Period 2: Part 2|Other|1|||
27955334|NCT00830869|54612259|FG010|Period 2: Part 2|Other|0|||
27955335|NCT00830869|54612260|FG011|Period 2: Part 2|Other|0|||
27955336|NCT00844519|54612289|FG000|Overall Study|Withdrawal by Subject|1|||
27955337|NCT00844519|54612290|FG001|Overall Study|Withdrawal by Subject|1|||
27955338|NCT00844519|54612289|FG000|Overall Study|Adverse Event|1|||
27955339|NCT00844519|54612290|FG001|Overall Study|Adverse Event|0|||
27955340|NCT01171820|54612298|FG000|Overall Study|Death|3|||
27955341|NCT01171820|54612299|FG001|Overall Study|Death|3|||
27955342|NCT01171820|54612298|FG000|Overall Study|Lost to Follow-up|0|||
27955343|NCT01171820|54612299|FG001|Overall Study|Lost to Follow-up|1|||
27955344|NCT01171820|54612298|FG000|Overall Study|Withdrawal by Subject|2|||
27955345|NCT01171820|54612299|FG001|Overall Study|Withdrawal by Subject|0|||
27955346|NCT01171820|54612298|FG000|Overall Study|Physician Decision|0|||
27955347|NCT01171820|54612299|FG001|Overall Study|Physician Decision|1|||
27955348|NCT01171820|54612298|FG000|Overall Study|1-Year Missed Visit|1|||
27955349|NCT01171820|54612299|FG001|Overall Study|1-Year Missed Visit|1|||
27955350|NCT00994110|54612307|FG000|Overall Study|Withdrawal by Subject|9|||
27955351|NCT00994110|54612308|FG001|Overall Study|Withdrawal by Subject|9|||
27955352|NCT00994110|54612307|FG000|Overall Study|Not Treated|4|||
27955353|NCT00994110|54612308|FG001|Overall Study|Not Treated|8|||
27955354|NCT00994110|54612307|FG000|Overall Study|Adverse Event|1|||
27955355|NCT00994110|54612308|FG001|Overall Study|Adverse Event|0|||
27955356|NCT00994110|54612307|FG000|Overall Study|Patient not resected|41|||
27955357|NCT00994110|54612308|FG001|Overall Study|Patient not resected|52|||
27955358|NCT00994110|54612307|FG000|Overall Study|Pt not eligible|10|||
27955359|NCT00994110|54612308|FG001|Overall Study|Pt not eligible|5|||
27955360|NCT00993954|54612316|FG000|Overall Study|Protocol Violation|21|||
27955361|NCT00993954|54612317|FG001|Overall Study|Protocol Violation|2|||
27955362|NCT01157234|54612325|FG000|Overall Study|Withdrawal by Subject|1|||
27955363|NCT01157234|54612326|FG001|Overall Study|Withdrawal by Subject|0|||
27955364|NCT00991302|54612341|FG000|Overall Study|Death|0|||
27955365|NCT00991302|54612342|FG001|Overall Study|Death|1|||
27955366|NCT00991302|54612341|FG000|Overall Study|Lost to Follow-up|14|||
27955367|NCT00991302|54612342|FG001|Overall Study|Lost to Follow-up|12|||
27955368|NCT00995670|54612351|FG000|Overall Study|Failed arterial cannulation|1|||
27955369|NCT00995670|54612352|FG001|Overall Study|Failed arterial cannulation|0|||
27955370|NCT00995670|54612353|FG002|Overall Study|Failed arterial cannulation|3|||
27955371|NCT00601354|54612363|FG000|Overall Study|Lost to Follow-up|4|||
27955372|NCT00601354|54612364|FG001|Overall Study|Lost to Follow-up|5|||
27955373|NCT00853099|54612373|FG000|Double-blind Period|Adverse Event|7|||
28165074|NCT03016325|54835757|FG004|Treatment Period|Death|2|||
27955374|NCT00853099|54612374|FG001|Double-blind Period|Adverse Event|9|||
27955375|NCT00853099|54612375|FG002|Double-blind Period|Adverse Event|13|||
27955376|NCT00853099|54612376|FG003|Double-blind Period|Adverse Event|0|||
27955377|NCT00853099|54612373|FG000|Double-blind Period|Withdrawal by Subject|2|||
27955378|NCT00853099|54612374|FG001|Double-blind Period|Withdrawal by Subject|3|||
27955379|NCT00853099|54612375|FG002|Double-blind Period|Withdrawal by Subject|0|||
27955380|NCT00853099|54612376|FG003|Double-blind Period|Withdrawal by Subject|0|||
27955381|NCT00853099|54612373|FG000|Double-blind Period|Lack of Efficacy|14|||
27955382|NCT00853099|54612374|FG001|Double-blind Period|Lack of Efficacy|17|||
27955383|NCT00853099|54612375|FG002|Double-blind Period|Lack of Efficacy|16|||
27955384|NCT00853099|54612376|FG003|Double-blind Period|Lack of Efficacy|0|||
27955385|NCT00853099|54612373|FG000|Double-blind Period|Other|0|||
27955386|NCT00853099|54612374|FG001|Double-blind Period|Other|0|||
27955387|NCT00853099|54612375|FG002|Double-blind Period|Other|1|||
27955388|NCT00853099|54612376|FG003|Double-blind Period|Other|0|||
27955389|NCT00853099|54612373|FG000|Double-blind Period|Mistreated with rescue study drug|0|||
27955390|NCT00853099|54612374|FG001|Double-blind Period|Mistreated with rescue study drug|0|||
27955391|NCT00853099|54612375|FG002|Double-blind Period|Mistreated with rescue study drug|1|||
27955392|NCT00853099|54612376|FG003|Double-blind Period|Mistreated with rescue study drug|0|||
27955393|NCT00853099|54612373|FG000|Double-blind + Open-label Periods|Lack of Efficacy|0|||
27955394|NCT00853099|54612374|FG001|Double-blind + Open-label Periods|Lack of Efficacy|0|||
27955395|NCT00853099|54612375|FG002|Double-blind + Open-label Periods|Lack of Efficacy|0|||
27955396|NCT00853099|54612376|FG003|Double-blind + Open-label Periods|Lack of Efficacy|74|||
27955397|NCT00853099|54612373|FG000|Double-blind + Open-label Periods|Adverse Event|0|||
27955398|NCT00853099|54612374|FG001|Double-blind + Open-label Periods|Adverse Event|0|||
27955399|NCT00853099|54612375|FG002|Double-blind + Open-label Periods|Adverse Event|0|||
27955400|NCT00853099|54612376|FG003|Double-blind + Open-label Periods|Adverse Event|47|||
27955401|NCT00853099|54612373|FG000|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
27955402|NCT00853099|54612374|FG001|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
27955403|NCT00853099|54612375|FG002|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
27955404|NCT00853099|54612376|FG003|Double-blind + Open-label Periods|Withdrawal by Subject|20|||
27955405|NCT00853099|54612373|FG000|Double-blind + Open-label Periods|Other|0|||
27955406|NCT00853099|54612374|FG001|Double-blind + Open-label Periods|Other|0|||
27955407|NCT00853099|54612375|FG002|Double-blind + Open-label Periods|Other|0|||
27955408|NCT00853099|54612376|FG003|Double-blind + Open-label Periods|Other|6|||
27955409|NCT00992784|54612389|FG000|Overall Study|Adverse Event|2|||
27955410|NCT00992784|54612390|FG001|Overall Study|Adverse Event|1|||
27955411|NCT00992784|54612391|FG002|Overall Study|Adverse Event|0|||
27955412|NCT00992784|54612389|FG000|Overall Study|Withdrawal by Subject|1|||
27955413|NCT00992784|54612390|FG001|Overall Study|Withdrawal by Subject|1|||
27955414|NCT00992784|54612391|FG002|Overall Study|Withdrawal by Subject|1|||
27955415|NCT00830167|54612401|FG000|Overall Study|Lack of Efficacy|26|||
27955416|NCT00830167|54612402|FG001|Overall Study|Lack of Efficacy|10|||
27955417|NCT00830167|54612401|FG000|Overall Study|Adverse Event|8|||
27955418|NCT00830167|54612402|FG001|Overall Study|Adverse Event|24|||
27955419|NCT00830167|54612401|FG000|Overall Study|Not meeting entrance criteria|2|||
27955420|NCT00830167|54612402|FG001|Overall Study|Not meeting entrance criteria|5|||
27955421|NCT00830167|54612401|FG000|Overall Study|Withdrawal by Subject|2|||
27955422|NCT00830167|54612402|FG001|Overall Study|Withdrawal by Subject|0|||
27955423|NCT00830167|54612401|FG000|Overall Study|Lost to Follow-up|0|||
27955424|NCT00830167|54612402|FG001|Overall Study|Lost to Follow-up|1|||
27955425|NCT00830167|54612401|FG000|Overall Study|Protocol Violation|0|||
27955426|NCT00830167|54612402|FG001|Overall Study|Protocol Violation|1|||
27955427|NCT00830167|54612401|FG000|Overall Study|Other|2|||
27955428|NCT00830167|54612402|FG001|Overall Study|Other|2|||
27955429|NCT00992394|54612410|FG000|Overall Study|Lack of Efficacy|6|||
27955430|NCT00992394|54612411|FG001|Overall Study|Lack of Efficacy|3|||
27955431|NCT00992394|54612410|FG000|Overall Study|Adverse Event|4|||
27955432|NCT00992394|54612411|FG001|Overall Study|Adverse Event|5|||
27955433|NCT00992394|54612410|FG000|Overall Study|Withdrawal by Subject|8|||
27955434|NCT00992394|54612411|FG001|Overall Study|Withdrawal by Subject|2|||
27955435|NCT00992394|54612410|FG000|Overall Study|Physician Decision|1|||
27955436|NCT00992394|54612411|FG001|Overall Study|Physician Decision|0|||
27955437|NCT00992394|54612410|FG000|Overall Study|Protocol Violation|2|||
27955438|NCT00992394|54612411|FG001|Overall Study|Protocol Violation|4|||
27955439|NCT00992394|54612410|FG000|Overall Study|Lost to Follow-up|2|||
27955440|NCT00992394|54612411|FG001|Overall Study|Lost to Follow-up|0|||
27955441|NCT00992394|54612410|FG000|Overall Study|Other event|1|||
27955442|NCT00992394|54612411|FG001|Overall Study|Other event|0|||
27955443|NCT00829933|54612421|FG000|Overall Study|Adverse Event|2|||
27955444|NCT00829933|54612422|FG001|Overall Study|Adverse Event|3|||
27955445|NCT00829933|54612423|FG002|Overall Study|Adverse Event|2|||
27955446|NCT00829933|54612424|FG003|Overall Study|Adverse Event|1|||
27955447|NCT00829933|54612421|FG000|Overall Study|Death|0|||
27955448|NCT00829933|54612422|FG001|Overall Study|Death|0|||
27955449|NCT00829933|54612423|FG002|Overall Study|Death|1|||
27955450|NCT00829933|54612424|FG003|Overall Study|Death|1|||
27955451|NCT00829933|54612421|FG000|Overall Study|Lack of Efficacy|0|||
27955452|NCT00829933|54612422|FG001|Overall Study|Lack of Efficacy|1|||
27955453|NCT00829933|54612423|FG002|Overall Study|Lack of Efficacy|0|||
27955454|NCT00829933|54612424|FG003|Overall Study|Lack of Efficacy|0|||
27955455|NCT00829933|54612421|FG000|Overall Study|Physician Decision|5|||
27955456|NCT00829933|54612422|FG001|Overall Study|Physician Decision|7|||
27955457|NCT00829933|54612423|FG002|Overall Study|Physician Decision|8|||
27955458|NCT00829933|54612424|FG003|Overall Study|Physician Decision|1|||
27955459|NCT00829933|54612421|FG000|Overall Study|Pregnancy|0|||
27955460|NCT00829933|54612422|FG001|Overall Study|Pregnancy|0|||
27955461|NCT00829933|54612423|FG002|Overall Study|Pregnancy|0|||
27955462|NCT00829933|54612424|FG003|Overall Study|Pregnancy|2|||
27955463|NCT00829933|54612421|FG000|Overall Study|Protocol Violation|2|||
27955464|NCT00829933|54612422|FG001|Overall Study|Protocol Violation|1|||
27955465|NCT00829933|54612423|FG002|Overall Study|Protocol Violation|0|||
27955466|NCT00829933|54612424|FG003|Overall Study|Protocol Violation|0|||
27955467|NCT00829933|54612421|FG000|Overall Study|withdrew before treatment started|5|||
27955468|NCT00829933|54612422|FG001|Overall Study|withdrew before treatment started|1|||
27955469|NCT00829933|54612423|FG002|Overall Study|withdrew before treatment started|2|||
27955470|NCT00829933|54612424|FG003|Overall Study|withdrew before treatment started|9|||
27955471|NCT01170962|54612437|FG000|Treatment Period|Lack of Efficacy|96|||
27955472|NCT01170962|54612438|FG001|Treatment Period|Lack of Efficacy|91|||
27955473|NCT01170962|54612439|FG002|Treatment Period|Lack of Efficacy|7|||
27955474|NCT01170962|54612437|FG000|Treatment Period|Adverse Event|11|||
27955475|NCT01170962|54612438|FG001|Treatment Period|Adverse Event|12|||
27955476|NCT01170962|54612439|FG002|Treatment Period|Adverse Event|3|||
27955477|NCT01170962|54612437|FG000|Treatment Period|Withdrawal by Subject|2|||
27955478|NCT01170962|54612438|FG001|Treatment Period|Withdrawal by Subject|1|||
27955479|NCT01170962|54612439|FG002|Treatment Period|Withdrawal by Subject|0|||
27955480|NCT01170962|54612437|FG000|Treatment Period|Lost to Follow-up|1|||
27955481|NCT01170962|54612438|FG001|Treatment Period|Lost to Follow-up|1|||
27955482|NCT01170962|54612439|FG002|Treatment Period|Lost to Follow-up|1|||
27955483|NCT01170962|54612437|FG000|Treatment Period|Participant no longer meets criteria|0|||
27955484|NCT01170962|54612438|FG001|Treatment Period|Participant no longer meets criteria|1|||
27955485|NCT01170962|54612439|FG002|Treatment Period|Participant no longer meets criteria|0|||
27955486|NCT01170962|54612437|FG000|Treatment Period|Request to discontinue treatment|7|||
27955487|NCT01170962|54612438|FG001|Treatment Period|Request to discontinue treatment|3|||
27955488|NCT01170962|54612439|FG002|Treatment Period|Request to discontinue treatment|1|||
27955489|NCT01170962|54612437|FG000|Treatment Period|Completed 24 Week treatment period only|10|||
27955490|NCT01170962|54612438|FG001|Treatment Period|Completed 24 Week treatment period only|2|||
27955491|NCT01170962|54612439|FG002|Treatment Period|Completed 24 Week treatment period only|0|||
27955492|NCT01170962|54612437|FG000|Follow up Period|Withdrawal by Subject|14|||
27955493|NCT01170962|54612438|FG001|Follow up Period|Withdrawal by Subject|10|||
28081888|NCT00098475|54735416|FG001|Step 1|Adverse Event|37|||
27732070|NCT01666652|54179497|FG002|Overall Study|Serious Adverse Event|0|||
27732071|NCT01666652|54179498|FG003|Overall Study|Serious Adverse Event|1|||
27732072|NCT01666652|54179499|FG004|Overall Study|Serious Adverse Event|0|||
27732073|NCT01666652|54179495|FG000|Overall Study|Withdrawal by Subject|0|||
27732074|NCT01666652|54179496|FG001|Overall Study|Withdrawal by Subject|0|||
27732075|NCT01666652|54179497|FG002|Overall Study|Withdrawal by Subject|0|||
27732076|NCT01666652|54179498|FG003|Overall Study|Withdrawal by Subject|0|||
27732077|NCT01666652|54179499|FG004|Overall Study|Withdrawal by Subject|1|||
27732078|NCT01666652|54179495|FG000|Overall Study|Moved from study area|1|||
27732079|NCT01666652|54179496|FG001|Overall Study|Moved from study area|0|||
27732080|NCT01666652|54179497|FG002|Overall Study|Moved from study area|0|||
27732081|NCT01666652|54179498|FG003|Overall Study|Moved from study area|2|||
27732082|NCT01666652|54179499|FG004|Overall Study|Moved from study area|0|||
27732083|NCT01666652|54179495|FG000|Overall Study|Lost to Follow-up|1|||
27732084|NCT01666652|54179496|FG001|Overall Study|Lost to Follow-up|1|||
27732085|NCT01666652|54179497|FG002|Overall Study|Lost to Follow-up|1|||
27732086|NCT01666652|54179498|FG003|Overall Study|Lost to Follow-up|1|||
27955494|NCT01170962|54612439|FG002|Follow up Period|Withdrawal by Subject|2|||
27955495|NCT01170962|54612437|FG000|Follow up Period|Lost to Follow-up|13|||
27955496|NCT01170962|54612438|FG001|Follow up Period|Lost to Follow-up|8|||
27955497|NCT01170962|54612439|FG002|Follow up Period|Lost to Follow-up|1|||
27955498|NCT01170962|54612437|FG000|Follow up Period|Death|2|||
27955499|NCT01170962|54612438|FG001|Follow up Period|Death|2|||
27955500|NCT01170962|54612439|FG002|Follow up Period|Death|0|||
27955501|NCT01170962|54612437|FG000|Follow up Period|Others|10|||
27955502|NCT01170962|54612438|FG001|Follow up Period|Others|7|||
27955503|NCT01170962|54612439|FG002|Follow up Period|Others|3|||
27955504|NCT00843193|54612458|FG000|Overall Study|Adverse Event|2|||
27955505|NCT00843193|54612459|FG001|Overall Study|Adverse Event|4|||
27832323|NCT01770743|54311228|FG004|Overall Study|Adverse Event|0|||
27832324|NCT01770743|54311224|FG000|Overall Study|Withdrawal by Subject|0|||
27832325|NCT01770743|54311225|FG001|Overall Study|Withdrawal by Subject|0|||
27732087|NCT01666652|54179499|FG004|Overall Study|Lost to Follow-up|0|||
27955506|NCT00843193|54612458|FG000|Overall Study|Lack of Efficacy|1|||
27955507|NCT00843193|54612459|FG001|Overall Study|Lack of Efficacy|1|||
27955508|NCT00843193|54612458|FG000|Overall Study|Protocol Violation|1|||
27955509|NCT00843193|54612459|FG001|Overall Study|Protocol Violation|2|||
27955510|NCT00843193|54612458|FG000|Overall Study|Lost to Follow-up|1|||
27955511|NCT00843193|54612459|FG001|Overall Study|Lost to Follow-up|0|||
27955512|NCT00843193|54612458|FG000|Overall Study|Physician Decision|0|||
27955513|NCT00843193|54612459|FG001|Overall Study|Physician Decision|1|||
27955514|NCT00843193|54612458|FG000|Overall Study|Withdrawal by Subject|3|||
27955515|NCT00843193|54612459|FG001|Overall Study|Withdrawal by Subject|3|||
27955516|NCT00829621|54612468|FG000|Overall Study|Death|1|||
27955517|NCT00829621|54612469|FG001|Overall Study|Death|0|||
27955518|NCT00829621|54612468|FG000|Overall Study|Lost to Follow-up|3|||
27955519|NCT00829621|54612469|FG001|Overall Study|Lost to Follow-up|4|||
27955520|NCT01157078|54612477|FG000|Overall Study|Withdrawal by Subject|12|||
27955521|NCT01157078|54612478|FG001|Overall Study|Withdrawal by Subject|14|||
27955522|NCT01157078|54612477|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
27955523|NCT01157078|54612478|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
27955524|NCT01157078|54612477|FG000|Overall Study|Adverse Event|6|||
27955525|NCT01157078|54612478|FG001|Overall Study|Adverse Event|6|||
27955526|NCT01157078|54612477|FG000|Overall Study|Severe non-compliance to protocol|2|||
27955527|NCT01157078|54612478|FG001|Overall Study|Severe non-compliance to protocol|4|||
27955528|NCT01157078|54612477|FG000|Overall Study|Condition under investigation worsened|0|||
27955529|NCT01157078|54612478|FG001|Overall Study|Condition under investigation worsened|1|||
27955530|NCT01157078|54612477|FG000|Overall Study|Lack of Efficacy|2|||
27955531|NCT01157078|54612478|FG001|Overall Study|Lack of Efficacy|0|||
27955532|NCT01157078|54612477|FG000|Overall Study|Study-specific withdrawal criteria|2|||
27955533|NCT01157078|54612478|FG001|Overall Study|Study-specific withdrawal criteria|2|||
27955534|NCT01157078|54612477|FG000|Overall Study|Lost to Follow-up|7|||
27955535|NCT01157078|54612478|FG001|Overall Study|Lost to Follow-up|5|||
27955536|NCT01157078|54612477|FG000|Overall Study|Other|2|||
27955537|NCT01157078|54612478|FG001|Overall Study|Other|4|||
27955538|NCT00591721|54612486|FG000|Overall Study|Withdrawal by Subject|10|||
27955539|NCT00591721|54612487|FG001|Overall Study|Withdrawal by Subject|10|||
27955540|NCT00591721|54612486|FG000|Overall Study|Lost to Follow-up|1|||
27955541|NCT00591721|54612487|FG001|Overall Study|Lost to Follow-up|4|||
27955542|NCT00591721|54612486|FG000|Overall Study|Intervention not received|10|||
27955543|NCT00591721|54612487|FG001|Overall Study|Intervention not received|8|||
27955544|NCT01156844|54612497|FG000|Overall Study|Adverse Event|0|||
27955545|NCT01156844|54612498|FG001|Overall Study|Adverse Event|0|||
27955546|NCT01156844|54612499|FG002|Overall Study|Adverse Event|1|||
27955547|NCT01156844|54612500|FG003|Overall Study|Adverse Event|1|||
27955548|NCT01156844|54612497|FG000|Overall Study|Abnormal test procedure result(s)|0|||
27955549|NCT01156844|54612498|FG001|Overall Study|Abnormal test procedure result(s)|1|||
27955550|NCT01156844|54612499|FG002|Overall Study|Abnormal test procedure result(s)|2|||
27955551|NCT01156844|54612500|FG003|Overall Study|Abnormal test procedure result(s)|2|||
27955552|NCT01156844|54612497|FG000|Overall Study|Withdrawal by Subject|0|||
27955553|NCT01156844|54612498|FG001|Overall Study|Withdrawal by Subject|0|||
27955554|NCT01156844|54612499|FG002|Overall Study|Withdrawal by Subject|2|||
27955555|NCT01156844|54612500|FG003|Overall Study|Withdrawal by Subject|2|||
27955556|NCT01156844|54612497|FG000|Overall Study|Lost to Follow-up|0|||
27955557|NCT01156844|54612498|FG001|Overall Study|Lost to Follow-up|0|||
27955558|NCT01156844|54612499|FG002|Overall Study|Lost to Follow-up|1|||
27955559|NCT01156844|54612500|FG003|Overall Study|Lost to Follow-up|0|||
27955560|NCT01156844|54612497|FG000|Overall Study|Administrative problems|0|||
27955561|NCT01156844|54612498|FG001|Overall Study|Administrative problems|1|||
27955562|NCT01156844|54612499|FG002|Overall Study|Administrative problems|0|||
27955563|NCT01156844|54612500|FG003|Overall Study|Administrative problems|1|||
27955564|NCT01156844|54612497|FG000|Overall Study|Protocol deviation|2|||
27955565|NCT01156844|54612498|FG001|Overall Study|Protocol deviation|0|||
27955566|NCT01156844|54612499|FG002|Overall Study|Protocol deviation|0|||
27955567|NCT01156844|54612500|FG003|Overall Study|Protocol deviation|0|||
27955568|NCT00853021|54612513|FG000|Overall Study|Adverse Event|2|||
27955569|NCT00853021|54612513|FG000|Overall Study|Withdrawal by Subject|2|||
27955570|NCT00853021|54612513|FG000|Overall Study|Death|1|||
27955571|NCT01156532|54612517|FG000|Overall Study|Family Reasons|1|||
27955572|NCT01156532|54612517|FG000|Overall Study|Lost to Follow-up|1|||
27955573|NCT00843115|54612521|FG000|Overall Study|Death|4|||
27955574|NCT00843115|54612521|FG000|Overall Study|Adverse Event|30|||
27955575|NCT00843115|54612521|FG000|Overall Study|Lost to Follow-up|4|||
27955576|NCT00843115|54612521|FG000|Overall Study|Withdrawal by Subject|17|||
27955577|NCT00843115|54612521|FG000|Overall Study|Family wanted meds stopped|1|||
27955578|NCT00843115|54612521|FG000|Overall Study|Family does not want continuation|1|||
27955579|NCT00843115|54612521|FG000|Overall Study|Patient forgot to take meds|1|||
27955580|NCT00843115|54612521|FG000|Overall Study|Does not meet entrance criteria|1|||
27955581|NCT00843115|54612521|FG000|Overall Study|Physician Decision|1|||
27955582|NCT00843115|54612521|FG000|Overall Study|Family discontinued meds|1|||
28081889|NCT00098475|54735417|FG002|Step 1|Adverse Event|0|||
27955583|NCT00843115|54612521|FG000|Overall Study|patient took for 2 days then stopped|1|||
27955584|NCT00843115|54612521|FG000|Overall Study|patient never took the medication|1|||
27955585|NCT00843115|54612521|FG000|Overall Study|hospitalized due to deterioration|1|||
27955586|NCT00843115|54612521|FG000|Overall Study|week 12 not done|1|||
27955587|NCT00843115|54612521|FG000|Overall Study|Syndrome De Glissement|1|||
27955588|NCT01156376|54612528|FG000|Overall Study|Adverse Event|1|||
27955589|NCT01156376|54612529|FG001|Overall Study|Adverse Event|0|||
27955590|NCT01156376|54612530|FG002|Overall Study|Adverse Event|1|||
27955591|NCT01156376|54612528|FG000|Overall Study|Withdrawal by Subject|0|||
27955592|NCT01156376|54612529|FG001|Overall Study|Withdrawal by Subject|0|||
27955593|NCT01156376|54612530|FG002|Overall Study|Withdrawal by Subject|3|||
27955594|NCT00829387|54612540|FG000|Overall Study|Withdrawal by Subject|2|||
27955595|NCT00829387|54612541|FG001|Overall Study|Withdrawal by Subject|3|||
27955596|NCT00829387|54612540|FG000|Overall Study|Disqualified by PI|1|||
27955597|NCT00829387|54612541|FG001|Overall Study|Disqualified by PI|0|||
27955598|NCT01156142|54612549|FG000|Overall Study|Withdrawal by Subject|8|||
27955599|NCT01156142|54612550|FG001|Overall Study|Withdrawal by Subject|6|||
27955600|NCT01156142|54612549|FG000|Overall Study|Ineligible|0|||
27955601|NCT01156142|54612550|FG001|Overall Study|Ineligible|1|||
27955602|NCT00842257|54612556|FG000|Overall Study|Adverse Event|1|||
27955603|NCT00852475|54612562|FG000|Overall Study|Lost to Follow-up|3|||
27955604|NCT00852475|54612563|FG001|Overall Study|Lost to Follow-up|4|||
27955605|NCT01155284|54612573|FG000|Overall Study|Withdrawal by Subject|4|||
27955606|NCT01155284|54612574|FG001|Overall Study|Withdrawal by Subject|3|||
27955607|NCT01155284|54612573|FG000|Overall Study|Lost to Follow-up|1|||
27955608|NCT01155284|54612574|FG001|Overall Study|Lost to Follow-up|2|||
27955609|NCT01155284|54612573|FG000|Overall Study|Physician Decision|1|||
27955610|NCT01155284|54612574|FG001|Overall Study|Physician Decision|0|||
27955611|NCT01155284|54612573|FG000|Overall Study|Adverse Event|1|||
27955612|NCT01155284|54612574|FG001|Overall Study|Adverse Event|0|||
27955613|NCT00852397|54612585|FG000|Overall Study|Adverse Event|4|||
27955614|NCT00852397|54612586|FG001|Overall Study|Adverse Event|6|||
27955615|NCT00852397|54612587|FG002|Overall Study|Adverse Event|4|||
27955616|NCT00852397|54612585|FG000|Overall Study|Death|0|||
27955617|NCT00852397|54612586|FG001|Overall Study|Death|0|||
27955618|NCT00852397|54612587|FG002|Overall Study|Death|1|||
27955619|NCT00852397|54612585|FG000|Overall Study|Withdrawal by Subject|4|||
27955620|NCT00852397|54612586|FG001|Overall Study|Withdrawal by Subject|1|||
27955621|NCT00852397|54612587|FG002|Overall Study|Withdrawal by Subject|2|||
27955622|NCT00852397|54612585|FG000|Overall Study|Study terminated by sponsor|2|||
27955623|NCT00852397|54612586|FG001|Overall Study|Study terminated by sponsor|1|||
27955624|NCT00852397|54612587|FG002|Overall Study|Study terminated by sponsor|6|||
27955625|NCT00852397|54612585|FG000|Overall Study|Difficulty in study site visit|1|||
27955626|NCT00852397|54612586|FG001|Overall Study|Difficulty in study site visit|0|||
27955627|NCT00852397|54612587|FG002|Overall Study|Difficulty in study site visit|0|||
27955628|NCT00852397|54612585|FG000|Overall Study|Protocol Violation|0|||
27955629|NCT00852397|54612586|FG001|Overall Study|Protocol Violation|0|||
27955630|NCT00852397|54612587|FG002|Overall Study|Protocol Violation|1|||
27955631|NCT00841321|54612597|FG000|Overall Study|Lost to Follow-up|1|||
27955632|NCT00841321|54612598|FG001|Overall Study|Lost to Follow-up|1|||
27955633|NCT00841321|54612597|FG000|Overall Study|Adverse Event|0|||
27955634|NCT00841321|54612598|FG001|Overall Study|Adverse Event|2|||
27955635|NCT00986232|54612610|FG000|Overall Study|Adverse Event|1|||
27832326|NCT01770743|54311226|FG002|Overall Study|Withdrawal by Subject|1|||
27955636|NCT00986232|54612611|FG001|Overall Study|Adverse Event|2|||
27955637|NCT00986232|54612612|FG002|Overall Study|Adverse Event|3|||
27955638|NCT00986232|54612613|FG003|Overall Study|Adverse Event|0|||
27955639|NCT00986232|54612610|FG000|Overall Study|Lost to Follow-up|19|||
27955640|NCT00986232|54612611|FG001|Overall Study|Lost to Follow-up|12|||
27955641|NCT00986232|54612612|FG002|Overall Study|Lost to Follow-up|12|||
27955642|NCT00986232|54612613|FG003|Overall Study|Lost to Follow-up|7|||
27955643|NCT00986232|54612610|FG000|Overall Study|Protocol Violation|2|||
27955644|NCT00986232|54612611|FG001|Overall Study|Protocol Violation|3|||
27955645|NCT00986232|54612612|FG002|Overall Study|Protocol Violation|0|||
27955646|NCT00986232|54612613|FG003|Overall Study|Protocol Violation|1|||
27955647|NCT00986232|54612610|FG000|Overall Study|Withdrawal by Subject|13|||
27955648|NCT00986232|54612611|FG001|Overall Study|Withdrawal by Subject|16|||
27955649|NCT00986232|54612612|FG002|Overall Study|Withdrawal by Subject|12|||
27955650|NCT00986232|54612613|FG003|Overall Study|Withdrawal by Subject|3|||
27955651|NCT00986232|54612610|FG000|Overall Study|Missed one or more bleeds|13|||
27832327|NCT01770743|54311227|FG003|Overall Study|Withdrawal by Subject|1|||
27955652|NCT00986232|54612611|FG001|Overall Study|Missed one or more bleeds|10|||
27832328|NCT01770743|54311228|FG004|Overall Study|Withdrawal by Subject|1|||
27832329|NCT01770743|54311224|FG000|Overall Study|Lost to Follow-up|0|||
27955653|NCT00986232|54612612|FG002|Overall Study|Missed one or more bleeds|6|||
27955654|NCT00986232|54612613|FG003|Overall Study|Missed one or more bleeds|7|||
27955655|NCT00986232|54612610|FG000|Overall Study|Incomplete safety follow-up|3|||
27955656|NCT00986232|54612611|FG001|Overall Study|Incomplete safety follow-up|7|||
27955657|NCT00986232|54612612|FG002|Overall Study|Incomplete safety follow-up|2|||
27955658|NCT00986232|54612613|FG003|Overall Study|Incomplete safety follow-up|2|||
27955659|NCT00852241|54612629|FG000|Overall Study|Physician Decision|18|||
27955660|NCT01169636|54612638|FG000|Overall Study|Adverse Event|0|||
27955661|NCT01169636|54612639|FG001|Overall Study|Adverse Event|0|||
27955662|NCT01169636|54612640|FG002|Overall Study|Adverse Event|1|||
27955663|NCT01169636|54612641|FG003|Overall Study|Adverse Event|1|||
27955664|NCT01169636|54612642|FG004|Overall Study|Adverse Event|0|||
27955665|NCT01169636|54612638|FG000|Overall Study|Screen failure|0|||
27955666|NCT01169636|54612639|FG001|Overall Study|Screen failure|0|||
27955667|NCT01169636|54612640|FG002|Overall Study|Screen failure|2|||
27955668|NCT01169636|54612641|FG003|Overall Study|Screen failure|0|||
27955669|NCT01169636|54612642|FG004|Overall Study|Screen failure|0|||
27955670|NCT01169636|54612638|FG000|Overall Study|Withdrawal by Subject|0|||
27955671|NCT01169636|54612639|FG001|Overall Study|Withdrawal by Subject|0|||
27955672|NCT01169636|54612640|FG002|Overall Study|Withdrawal by Subject|0|||
27955673|NCT01169636|54612641|FG003|Overall Study|Withdrawal by Subject|0|||
27955674|NCT01169636|54612642|FG004|Overall Study|Withdrawal by Subject|3|||
27955675|NCT01169558|54612652|FG000|Overall Study|Disease progression|98|||
27955676|NCT01169558|54612652|FG000|Overall Study|Adverse Event|25|||
27955677|NCT01169558|54612652|FG000|Overall Study|Withdrawal of Consent|8|||
27955678|NCT01169558|54612652|FG000|Overall Study|Medical Decision|7|||
27955679|NCT01169558|54612652|FG000|Overall Study|Stable Disease|4|||
27955680|NCT01169558|54612652|FG000|Overall Study|Lost to Follow-up|4|||
27955681|NCT01169558|54612652|FG000|Overall Study|Need for Surgery|4|||
27955682|NCT01169558|54612652|FG000|Overall Study|Non-compliance|2|||
27955683|NCT01169558|54612652|FG000|Overall Study|Protocol Violation|2|||
27955684|NCT01169558|54612652|FG000|Overall Study|Partial response|2|||
27955685|NCT00840463|54612658|FG000|Overall Study|Adverse Event|1|||
27955686|NCT00840463|54612659|FG001|Overall Study|Adverse Event|0|||
27955687|NCT01155050|54612669|FG000|Overall Study|Lost to Follow-up|15|||
27955688|NCT01155050|54612670|FG001|Overall Study|Lost to Follow-up|20|||
27955689|NCT01155050|54612671|FG002|Overall Study|Lost to Follow-up|19|||
27955690|NCT01155050|54612672|FG003|Overall Study|Lost to Follow-up|22|||
27955691|NCT01168856|54612684|FG000|Overall Study|Lost to Follow-up|4|||
27955692|NCT01168856|54612685|FG001|Overall Study|Lost to Follow-up|34|||
27955693|NCT01168856|54612684|FG000|Overall Study|Withdrawal by Subject|6|||
27955694|NCT01168856|54612685|FG001|Overall Study|Withdrawal by Subject|8|||
27955695|NCT01168856|54612684|FG000|Overall Study|Physician Decision|2|||
27955696|NCT01168856|54612685|FG001|Overall Study|Physician Decision|1|||
27955697|NCT01168856|54612684|FG000|Overall Study|Confirmed Quantifiable HCV RNA|0|||
27955698|NCT01168856|54612685|FG001|Overall Study|Confirmed Quantifiable HCV RNA|1|||
27955699|NCT01168856|54612684|FG000|Overall Study|Participant received anti-HCV treatment|1|||
27955700|NCT01168856|54612685|FG001|Overall Study|Participant received anti-HCV treatment|0|||
27955701|NCT01168856|54612684|FG000|Overall Study|Death|0|||
27955702|NCT01168856|54612685|FG001|Overall Study|Death|2|||
27955703|NCT01168856|54612684|FG000|Overall Study|Other|1|||
27955704|NCT01168856|54612685|FG001|Overall Study|Other|291|||
27955705|NCT01168856|54612684|FG000|Overall Study|Protocol Violation|4|||
27955706|NCT01168856|54612685|FG001|Overall Study|Protocol Violation|6|||
27955707|NCT00828451|54612696|FG000|Overall Study|Death|2|||
27955708|NCT00828451|54612696|FG000|Overall Study|Lack of intravenous line|7|||
27955709|NCT00828451|54612696|FG000|Overall Study|Withdrawal by Subject|1|||
27955710|NCT00828451|54612696|FG000|Overall Study|Deterioration in clinical status|1|||
27955711|NCT00839917|54612702|FG000|Overall Study|Lost to Follow-up|1|||
27955712|NCT00839917|54612703|FG001|Overall Study|Lost to Follow-up|0|||
27955713|NCT00839917|54612702|FG000|Overall Study|Did not receive vaccine|0|||
27955714|NCT00839917|54612703|FG001|Overall Study|Did not receive vaccine|1|||
27955715|NCT00839527|54612712|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
27955716|NCT00839527|54612713|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|29|||
27955717|NCT00839527|54612714|FG002|Treatment Period (TP) (156 Weeks)|Adverse Event|22|||
27955718|NCT00839527|54612712|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|4|||
27955719|NCT00839527|54612713|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|7|||
28081890|NCT00098475|54735418|FG003|Step 1|Adverse Event|1|||
28081891|NCT00098475|54735415|FG000|Step 1|Death|8|||
28081892|NCT00098475|54735416|FG001|Step 1|Death|5|||
28081893|NCT00098475|54735417|FG002|Step 1|Death|0|||
27955720|NCT00839527|54612714|FG002|Treatment Period (TP) (156 Weeks)|Protocol Violation|1|||
27955721|NCT00839527|54612712|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|5|||
27955722|NCT00839527|54612713|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|6|||
27955723|NCT00839527|54612714|FG002|Treatment Period (TP) (156 Weeks)|Noncompliance|16|||
27955724|NCT00839527|54612712|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3|||
27955725|NCT00839527|54612713|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12|||
27832330|NCT01770743|54311225|FG001|Overall Study|Lost to Follow-up|2|||
27955726|NCT00839527|54612714|FG002|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
27955727|NCT00839527|54612712|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32|||
27955728|NCT00839527|54612713|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46|||
27955729|NCT00839527|54612714|FG002|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64|||
27955730|NCT00839527|54612712|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
27955731|NCT00839527|54612713|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|6|||
27854984|NCT00244621|54373458|FG002|Open-label Treatment Period|Moved abroad|1|||
27854985|NCT00243841|54373541|FG000|Overall Study|Physician Decision|0|||
27854986|NCT00243841|54373542|FG001|Overall Study|Physician Decision|0|||
27955732|NCT00839527|54612714|FG002|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
27955733|NCT00839527|54612712|FG000|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3|||
27955734|NCT00839527|54612713|FG001|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8|||
27955735|NCT00839527|54612714|FG002|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5|||
27955736|NCT00839527|54612712|FG000|Treatment Period (TP) (156 Weeks)|Missing|0|||
27955737|NCT00839527|54612713|FG001|Treatment Period (TP) (156 Weeks)|Missing|1|||
27955738|NCT00839527|54612714|FG002|Treatment Period (TP) (156 Weeks)|Missing|0|||
27955739|NCT00839527|54612712|FG000|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
27955740|NCT00839527|54612713|FG001|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
27955741|NCT00839527|54612714|FG002|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1|||
27955742|NCT00839527|54612712|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
27955743|NCT00839527|54612713|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
27955744|NCT00839527|54612714|FG002|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
27955745|NCT00839527|54612712|FG000|Treatment Period (TP) (156 Weeks)|Site Closed|1|||
27955746|NCT00839527|54612713|FG001|Treatment Period (TP) (156 Weeks)|Site Closed|2|||
27955747|NCT00839527|54612714|FG002|Treatment Period (TP) (156 Weeks)|Site Closed|0|||
27955748|NCT00839527|54612712|FG000|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
27955749|NCT00839527|54612713|FG001|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
27955750|NCT00839527|54612714|FG002|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1|||
27955751|NCT00839527|54612712|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
27955752|NCT00839527|54612713|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2|||
27955753|NCT00839527|54612714|FG002|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
27955754|NCT00839527|54612712|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
27955755|NCT00839527|54612713|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
27955756|NCT00839527|54612714|FG002|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5|||
27955757|NCT00839527|54612712|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8|||
27955758|NCT00839527|54612713|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20|||
27955759|NCT00839527|54612714|FG002|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29|||
27955760|NCT00839527|54612712|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12|||
28081894|NCT00098475|54735418|FG003|Step 1|Death|1|||
28081895|NCT00098475|54735415|FG000|Step 1|Withdrawal by Subject|14|||
28081896|NCT00098475|54735416|FG001|Step 1|Withdrawal by Subject|11|||
28081897|NCT00098475|54735417|FG002|Step 1|Withdrawal by Subject|0|||
28081898|NCT00098475|54735418|FG003|Step 1|Withdrawal by Subject|0|||
28081899|NCT00098475|54735415|FG000|Step 1|Physician Decision|5|||
28081900|NCT00098475|54735416|FG001|Step 1|Physician Decision|2|||
28165075|NCT03016325|54835758|FG005|Treatment Period|Death|0|||
28165076|NCT03016325|54835759|FG006|Treatment Period|Death|0|||
28165077|NCT03016325|54835760|FG007|Treatment Period|Death|0|||
28165078|NCT03016325|54835753|FG000|Treatment Period|Participant refuses assessments|0|||
28165079|NCT03016325|54835754|FG001|Treatment Period|Participant refuses assessments|0|||
27732088|NCT00109733|54179513|FG000|Overall Study|Protocol Violation|0|||
28081901|NCT00098475|54735417|FG002|Step 1|Physician Decision|0|||
28081902|NCT00098475|54735418|FG003|Step 1|Physician Decision|0|||
28081903|NCT00098475|54735415|FG000|Step 1|Alternative therapy|31|||
28081904|NCT00098475|54735416|FG001|Step 1|Alternative therapy|43|||
28081905|NCT00098475|54735417|FG002|Step 1|Alternative therapy|1|||
28081906|NCT00098475|54735418|FG003|Step 1|Alternative therapy|0|||
28081907|NCT00098475|54735415|FG000|Step 1|Other disease|2|||
28081908|NCT00098475|54735416|FG001|Step 1|Other disease|1|||
28081909|NCT00098475|54735417|FG002|Step 1|Other disease|1|||
28081910|NCT00098475|54735418|FG003|Step 1|Other disease|0|||
28081911|NCT00098475|54735415|FG000|Step 1|Never started treatment|0|||
28081912|NCT00098475|54735416|FG001|Step 1|Never started treatment|2|||
27732089|NCT00109733|54179514|FG001|Overall Study|Protocol Violation|1|||
27732090|NCT00109733|54179513|FG000|Overall Study|Stopped taking study drug|1|||
27854987|NCT00243841|54373543|FG002|Overall Study|Physician Decision|1|||
27854988|NCT00243841|54373544|FG003|Overall Study|Physician Decision|0|||
27854989|NCT00243841|54373545|FG004|Overall Study|Physician Decision|0|||
28165080|NCT03016325|54835755|FG002|Treatment Period|Participant refuses assessments|1|||
27732091|NCT00109733|54179514|FG001|Overall Study|Stopped taking study drug|1|||
28081913|NCT00098475|54735417|FG002|Step 1|Never started treatment|0|||
28081914|NCT00098475|54735418|FG003|Step 1|Never started treatment|0|||
28081915|NCT00098475|54735415|FG000|Step 1|Still on treatment as of this analysis|14|||
28081916|NCT00098475|54735416|FG001|Step 1|Still on treatment as of this analysis|27|||
28165081|NCT03016325|54835756|FG003|Treatment Period|Participant refuses assessments|0|||
27732092|NCT00109733|54179513|FG000|Overall Study|Non-compliant|0|||
27854990|NCT00243841|54373546|FG005|Overall Study|Physician Decision|2|||
27955761|NCT00839527|54612713|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21|||
27955762|NCT00839527|54612714|FG002|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19|||
27955763|NCT00839527|54612712|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
27955764|NCT00839527|54612713|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
27955765|NCT00839527|54612714|FG002|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
27955766|NCT00839527|54612712|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3|||
27955767|NCT00839527|54612713|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10|||
27955768|NCT00839527|54612714|FG002|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5|||
27955769|NCT00839527|54612712|FG000|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1|||
27955770|NCT00839527|54612713|FG001|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
27955771|NCT00839527|54612714|FG002|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
27955772|NCT00839527|54612712|FG000|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1|||
27955773|NCT00839527|54612713|FG001|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
27955774|NCT00839527|54612714|FG002|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
27955775|NCT00839527|54612712|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
27955776|NCT00839527|54612713|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closed|1|||
27955777|NCT00839527|54612714|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
27955778|NCT00839527|54612712|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
27955779|NCT00839527|54612713|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0|||
27955780|NCT00839527|54612714|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
27955781|NCT00839527|54612712|FG000|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
27955782|NCT00839527|54612713|FG001|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1|||
27955783|NCT00839527|54612714|FG002|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
27955784|NCT00839527|54612712|FG000|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0|||
27955785|NCT00839527|54612713|FG001|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
27955786|NCT00839527|54612714|FG002|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
27955787|NCT00600886|54612726|FG000|Core Phase - Full Analysis Set (FAS)|Adverse Event|14|||
27955788|NCT00600886|54612727|FG001|Core Phase - Full Analysis Set (FAS)|Adverse Event|6|||
27955789|NCT00600886|54612726|FG000|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7|||
27955790|NCT00600886|54612727|FG001|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8|||
27955791|NCT00600886|54612726|FG000|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5|||
27955792|NCT00600886|54612727|FG001|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8|||
27955793|NCT00600886|54612726|FG000|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5|||
27955794|NCT00600886|54612727|FG001|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3|||
27955795|NCT00600886|54612726|FG000|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2|||
27955796|NCT00600886|54612727|FG001|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0|||
27955797|NCT00600886|54612726|FG000|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1|||
27955798|NCT00600886|54612727|FG001|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0|||
27955799|NCT00600886|54612726|FG000|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1|||
27955800|NCT00600886|54612727|FG001|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0|||
27955801|NCT00600886|54612726|FG000|Core Phase - Full Analysis Set (FAS)|Death|0|||
27955802|NCT00600886|54612727|FG001|Core Phase - Full Analysis Set (FAS)|Death|1|||
27955803|NCT00600886|54612726|FG000|Extension - Same Treatment (FAS)|Withdrawal by Subject|16|||
27955804|NCT00600886|54612727|FG001|Extension - Same Treatment (FAS)|Withdrawal by Subject|2|||
27955805|NCT00600886|54612726|FG000|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
27955806|NCT00600886|54612727|FG001|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
27955807|NCT00600886|54612726|FG000|Extension - Same Treatment (FAS)|Administrative Problems|9|||
27955808|NCT00600886|54612727|FG001|Extension - Same Treatment (FAS)|Administrative Problems|3|||
27955809|NCT00600886|54612726|FG000|Extension - Same Treatment (FAS)|Lost to Follow-up|3|||
27955810|NCT00600886|54612727|FG001|Extension - Same Treatment (FAS)|Lost to Follow-up|1|||
27955811|NCT00600886|54612726|FG000|Extension - Same Treatment (FAS)|Adverse Event|4|||
27955812|NCT00600886|54612727|FG001|Extension - Same Treatment (FAS)|Adverse Event|1|||
27955813|NCT00600886|54612726|FG000|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4|||
27955814|NCT00600886|54612727|FG001|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0|||
27955815|NCT00600886|54612726|FG000|Extension - Same Treatment (FAS)|Death|1|||
27955816|NCT00600886|54612727|FG001|Extension - Same Treatment (FAS)|Death|1|||
27955817|NCT00600886|54612726|FG000|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6|||
27955818|NCT00600886|54612727|FG001|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0|||
27955819|NCT00600886|54612726|FG000|Extension - After Crossover (CAS)|Adverse Event|19|||
27955820|NCT00600886|54612727|FG001|Extension - After Crossover (CAS)|Adverse Event|1|||
27955821|NCT00600886|54612726|FG000|Extension - After Crossover (CAS)|Withdrawal by Subject|19|||
27955822|NCT00600886|54612727|FG001|Extension - After Crossover (CAS)|Withdrawal by Subject|4|||
27854991|NCT02980731|54373739|FG000|Overall Study|Death|63|||
27732093|NCT00109733|54179514|FG001|Overall Study|Non-compliant|1|||
27955823|NCT00600886|54612726|FG000|Extension - After Crossover (CAS)|Lack of Efficacy|13|||
27955824|NCT00600886|54612727|FG001|Extension - After Crossover (CAS)|Lack of Efficacy|4|||
27955825|NCT00600886|54612726|FG000|Extension - After Crossover (CAS)|Administrative Problems|4|||
27955826|NCT00600886|54612727|FG001|Extension - After Crossover (CAS)|Administrative Problems|4|||
27955827|NCT00600886|54612726|FG000|Extension - After Crossover (CAS)|Subject no longer requires study drug|3|||
27955828|NCT00600886|54612727|FG001|Extension - After Crossover (CAS)|Subject no longer requires study drug|0|||
27955829|NCT00600886|54612726|FG000|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3|||
27955830|NCT00600886|54612727|FG001|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0|||
27955831|NCT00600886|54612726|FG000|Extension - After Crossover (CAS)|Death|1|||
27955832|NCT00600886|54612727|FG001|Extension - After Crossover (CAS)|Death|0|||
27955833|NCT00838903|54612751|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
27955834|NCT00838903|54612752|FG001|Treatment Period (156 Weeks)|Adverse Event|13|||
27955835|NCT00838903|54612753|FG002|Treatment Period (156 Weeks)|Adverse Event|17|||
27955836|NCT00838903|54612754|FG003|Treatment Period (156 Weeks)|Adverse Event|25|||
27955837|NCT00838903|54612751|FG000|Treatment Period (156 Weeks)|Protocol Violation|1|||
27955838|NCT00838903|54612752|FG001|Treatment Period (156 Weeks)|Protocol Violation|6|||
27955839|NCT00838903|54612753|FG002|Treatment Period (156 Weeks)|Protocol Violation|6|||
27955840|NCT00838903|54612754|FG003|Treatment Period (156 Weeks)|Protocol Violation|5|||
27955841|NCT00838903|54612751|FG000|Treatment Period (156 Weeks)|Noncompliance|9|||
27955842|NCT00838903|54612752|FG001|Treatment Period (156 Weeks)|Noncompliance|13|||
27955843|NCT00838903|54612753|FG002|Treatment Period (156 Weeks)|Noncompliance|12|||
27955844|NCT00838903|54612754|FG003|Treatment Period (156 Weeks)|Noncompliance|6|||
27955845|NCT00838903|54612751|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
27955846|NCT00838903|54612752|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
27955847|NCT00838903|54612753|FG002|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
27955848|NCT00838903|54612754|FG003|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
27955849|NCT00838903|54612751|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|4|||
27955850|NCT00838903|54612752|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|16|||
27955851|NCT00838903|54612753|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|15|||
27955852|NCT00838903|54612754|FG003|Treatment Period (156 Weeks)|Lost to Follow-up|13|||
27955853|NCT00838903|54612751|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|20|||
27955854|NCT00838903|54612752|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|55|||
27955855|NCT00838903|54612753|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|56|||
27955856|NCT00838903|54612754|FG003|Treatment Period (156 Weeks)|Withdrawal by Subject|53|||
27955857|NCT00838903|54612751|FG000|Treatment Period (156 Weeks)|Physician Decision|1|||
27955858|NCT00838903|54612752|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
27955859|NCT00838903|54612753|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
27955860|NCT00838903|54612754|FG003|Treatment Period (156 Weeks)|Physician Decision|2|||
27955861|NCT00838903|54612751|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3|||
27955862|NCT00838903|54612752|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
27955863|NCT00838903|54612753|FG002|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
27955864|NCT00838903|54612754|FG003|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4|||
27955865|NCT00838903|54612751|FG000|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
27955866|NCT00838903|54612752|FG001|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1|||
27955867|NCT00838903|54612753|FG002|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
27955868|NCT00838903|54612754|FG003|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
27955869|NCT00838903|54612751|FG000|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
27955870|NCT00838903|54612752|FG001|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
27955871|NCT00838903|54612753|FG002|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
27955872|NCT00838903|54612754|FG003|Treatment Period (156 Weeks)|Poor Glycemic Control|1|||
27955873|NCT00838903|54612751|FG000|Treatment Period (156 Weeks)|Poor Therapeutic Response|1|||
27955874|NCT00838903|54612752|FG001|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
27955875|NCT00838903|54612753|FG002|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
27955876|NCT00838903|54612754|FG003|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
27955877|NCT00838903|54612751|FG000|Treatment Period (156 Weeks)|Pregnancy|0|||
27955878|NCT00838903|54612752|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
27955879|NCT00838903|54612753|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
27955880|NCT00838903|54612754|FG003|Treatment Period (156 Weeks)|Pregnancy|0|||
27955881|NCT00838903|54612751|FG000|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
27955882|NCT00838903|54612752|FG001|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
27955883|NCT00838903|54612753|FG002|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1|||
27955884|NCT00838903|54612754|FG003|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
27955885|NCT00838903|54612751|FG000|Treatment Period (156 Weeks)|Site closed|0|||
27955886|NCT00838903|54612752|FG001|Treatment Period (156 Weeks)|Site closed|0|||
27955887|NCT00838903|54612753|FG002|Treatment Period (156 Weeks)|Site closed|1|||
27955888|NCT00838903|54612754|FG003|Treatment Period (156 Weeks)|Site closed|0|||
27832331|NCT01770743|54311226|FG002|Overall Study|Lost to Follow-up|0|||
27955889|NCT00838903|54612751|FG000|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1|||
27955890|NCT00838903|54612752|FG001|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
27955891|NCT00838903|54612753|FG002|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
27955892|NCT00838903|54612754|FG003|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
27955893|NCT00838903|54612751|FG000|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
27955894|NCT00838903|54612752|FG001|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
27955895|NCT00838903|54612753|FG002|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
27955896|NCT00838903|54612754|FG003|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
27955897|NCT00838903|54612751|FG000|Treatment Period (156 Weeks)|Missing Active Treatment Status|1|||
27854992|NCT02980731|54373739|FG000|Overall Study|Withdrawal by Subject|6|||
27854993|NCT02980731|54373739|FG000|Overall Study|Lost to Follow-up|5|||
27854994|NCT02980731|54373739|FG000|Overall Study|Study terminated by Sponsor|4|||
27854995|NCT02980731|54373739|FG000|Overall Study|Completed survival follow-up period|65|||
27854996|NCT02980731|54373739|FG000|Overall Study|COVID-19 infection|1|||
27854997|NCT02980731|54373739|FG000|Overall Study|Other, not specified|66|||
27854998|NCT02641587|54373779|FG000|Confinement Period|Adverse Event|1|||
27854999|NCT02641587|54373780|FG001|Confinement Period|Adverse Event|0|||
27855000|NCT02641587|54373779|FG000|Confinement Period|Withdrawal by Subject|2|||
27855001|NCT02641587|54373780|FG001|Confinement Period|Withdrawal by Subject|1|||
27855002|NCT02641587|54373779|FG000|Ambulatory Period|Withdrawal by Subject|1|||
27855003|NCT02641587|54373780|FG001|Ambulatory Period|Withdrawal by Subject|0|||
27855004|NCT04672083|54373898|FG000|Overall Study|Lost to Follow-up|1|||
27855005|NCT04672083|54373899|FG001|Overall Study|Lost to Follow-up|0|||
27855006|NCT04672083|54373900|FG002|Overall Study|Lost to Follow-up|0|||
27855007|NCT04672083|54373901|FG003|Overall Study|Lost to Follow-up|0|||
27855008|NCT04672083|54373902|FG004|Overall Study|Lost to Follow-up|0|||
27855009|NCT01781637|54374005|FG000|Overall Study|Adverse Event|1|||
27855010|NCT01781637|54374006|FG001|Overall Study|Adverse Event|0|||
27855011|NCT01781637|54374005|FG000|Overall Study|Lack of Efficacy|2|||
27855012|NCT01781637|54374006|FG001|Overall Study|Lack of Efficacy|6|||
27855013|NCT01781637|54374005|FG000|Overall Study|Withdrawal by Subject|1|||
27855014|NCT01781637|54374006|FG001|Overall Study|Withdrawal by Subject|0|||
27855015|NCT01459497|54374054|FG000|Overall Study|Inability to meet trial constraints.|1|||
27855016|NCT01459497|54374055|FG001|Overall Study|Inability to meet trial constraints.|0|||
27855017|NCT01459497|54374054|FG000|Overall Study|Physician Decision|1|||
27855018|NCT01459497|54374055|FG001|Overall Study|Physician Decision|1|||
27855019|NCT01459497|54374054|FG000|Overall Study|Hospitalization.|0|||
27855020|NCT01459497|54374055|FG001|Overall Study|Hospitalization.|3|||
27855021|NCT01459497|54374054|FG000|Overall Study|Disease progression.|0|||
27855022|NCT01459497|54374055|FG001|Overall Study|Disease progression.|1|||
27855023|NCT04575584|54374404|FG000|Overall Study|Death|6|||
27855024|NCT04575584|54374405|FG001|Overall Study|Death|4|||
27855025|NCT04575584|54374406|FG002|Overall Study|Death|6|||
27855026|NCT04575584|54374407|FG003|Overall Study|Death|2|||
27855027|NCT04575584|54374408|FG004|Overall Study|Death|0|||
27855028|NCT04575584|54374409|FG005|Overall Study|Death|0|||
27855029|NCT04575584|54374404|FG000|Overall Study|Lost to Follow-up|1|||
27855030|NCT04575584|54374405|FG001|Overall Study|Lost to Follow-up|1|||
27855031|NCT04575584|54374406|FG002|Overall Study|Lost to Follow-up|1|||
27855032|NCT04575584|54374407|FG003|Overall Study|Lost to Follow-up|1|||
27855033|NCT04575584|54374408|FG004|Overall Study|Lost to Follow-up|0|||
27855034|NCT04575584|54374409|FG005|Overall Study|Lost to Follow-up|0|||
27855035|NCT04575584|54374404|FG000|Overall Study|Physician Decision|0|||
27855036|NCT04575584|54374405|FG001|Overall Study|Physician Decision|1|||
27855037|NCT04575584|54374406|FG002|Overall Study|Physician Decision|1|||
27855038|NCT04575584|54374407|FG003|Overall Study|Physician Decision|1|||
27855039|NCT04575584|54374408|FG004|Overall Study|Physician Decision|0|||
27955898|NCT00838903|54612752|FG001|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
27955899|NCT00838903|54612753|FG002|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
27955900|NCT00838903|54612754|FG003|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
27732094|NCT00109733|54179513|FG000|Overall Study|Could not commit time for study|1|||
27832332|NCT01770743|54311227|FG003|Overall Study|Lost to Follow-up|0|||
27832333|NCT01770743|54311228|FG004|Overall Study|Lost to Follow-up|1|||
27832334|NCT01770743|54311224|FG000|Overall Study|Sponsor Terminated Subject|1|||
27832335|NCT01770743|54311225|FG001|Overall Study|Sponsor Terminated Subject|0|||
27832336|NCT01770743|54311226|FG002|Overall Study|Sponsor Terminated Subject|0|||
27832337|NCT01770743|54311227|FG003|Overall Study|Sponsor Terminated Subject|1|||
27832338|NCT01770743|54311228|FG004|Overall Study|Sponsor Terminated Subject|0|||
27832339|NCT01770743|54311224|FG000|Overall Study|Moving Out of State|0|||
27832340|NCT01770743|54311225|FG001|Overall Study|Moving Out of State|1|||
27855040|NCT04575584|54374409|FG005|Overall Study|Physician Decision|0|||
27855041|NCT04575584|54374404|FG000|Overall Study|Withdrawal by Subject|7|||
27855042|NCT04575584|54374405|FG001|Overall Study|Withdrawal by Subject|9|||
27855043|NCT04575584|54374406|FG002|Overall Study|Withdrawal by Subject|5|||
27855044|NCT04575584|54374407|FG003|Overall Study|Withdrawal by Subject|3|||
27955901|NCT00838903|54612751|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
27955902|NCT00838903|54612752|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
27955903|NCT00838903|54612753|FG002|Follow-up Period (8 Weeks)|Adverse Event|3|||
27955904|NCT00838903|54612754|FG003|Follow-up Period (8 Weeks)|Adverse Event|1|||
27955905|NCT00838903|54612751|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
27955906|NCT00838903|54612752|FG001|Follow-up Period (8 Weeks)|Noncompliance|8|||
27955907|NCT00838903|54612753|FG002|Follow-up Period (8 Weeks)|Noncompliance|5|||
27955908|NCT00838903|54612754|FG003|Follow-up Period (8 Weeks)|Noncompliance|5|||
27955909|NCT00838903|54612751|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|6|||
27955910|NCT00838903|54612752|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|28|||
27955911|NCT00838903|54612753|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
27955912|NCT00838903|54612754|FG003|Follow-up Period (8 Weeks)|Lost to Follow-up|24|||
27955913|NCT00838903|54612751|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5|||
27955914|NCT00838903|54612752|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
27955915|NCT00838903|54612753|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12|||
27955916|NCT00838903|54612754|FG003|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
27955917|NCT00838903|54612751|FG000|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8|||
27955918|NCT00838903|54612752|FG001|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13|||
27955919|NCT00838903|54612753|FG002|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
27955920|NCT00838903|54612754|FG003|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
27955921|NCT00838903|54612751|FG000|Follow-up Period (8 Weeks)|Physician Decision|1|||
27955922|NCT00838903|54612752|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
27955923|NCT00838903|54612753|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
27955924|NCT00838903|54612754|FG003|Follow-up Period (8 Weeks)|Physician Decision|1|||
27955925|NCT00838903|54612751|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3|||
27955926|NCT00838903|54612752|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
27955927|NCT00838903|54612753|FG002|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6|||
27955928|NCT00838903|54612754|FG003|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
27955929|NCT00838903|54612751|FG000|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
27955930|NCT00838903|54612752|FG001|Follow-up Period (8 Weeks)|ICF Withdrawn|1|||
27955931|NCT00838903|54612753|FG002|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
27955932|NCT00838903|54612754|FG003|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
27955933|NCT00838903|54612751|FG000|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
27732095|NCT00109733|54179514|FG001|Overall Study|Could not commit time for study|1|||
27955934|NCT00838903|54612752|FG001|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1|||
27955935|NCT00838903|54612753|FG002|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
27955936|NCT00838903|54612754|FG003|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
27955937|NCT00838903|54612751|FG000|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
27955938|NCT00838903|54612752|FG001|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
27955939|NCT00838903|54612753|FG002|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
27955940|NCT00838903|54612754|FG003|Follow-up Period (8 Weeks)|Subject Moved out of Town|1|||
27955941|NCT00838903|54612751|FG000|Follow-up Period (8 Weeks)|Missing|1|||
27955942|NCT00838903|54612752|FG001|Follow-up Period (8 Weeks)|Missing|2|||
27955943|NCT00838903|54612753|FG002|Follow-up Period (8 Weeks)|Missing|1|||
27955944|NCT00838903|54612754|FG003|Follow-up Period (8 Weeks)|Missing|1|||
27955945|NCT00828139|54612768|FG000|Overall Study|Adverse Event|8|||
27955946|NCT00828139|54612769|FG001|Overall Study|Adverse Event|1|||
27955947|NCT00828139|54612770|FG002|Overall Study|Adverse Event|10|||
27955948|NCT00828139|54612771|FG003|Overall Study|Adverse Event|5|||
27955949|NCT00828139|54612768|FG000|Overall Study|Death|2|||
27955950|NCT00828139|54612769|FG001|Overall Study|Death|1|||
27955951|NCT00828139|54612770|FG002|Overall Study|Death|0|||
27955952|NCT00828139|54612771|FG003|Overall Study|Death|2|||
27955953|NCT00828139|54612768|FG000|Overall Study|Refusal unrelated to toxicity|3|||
27955954|NCT00828139|54612769|FG001|Overall Study|Refusal unrelated to toxicity|4|||
27955955|NCT00828139|54612770|FG002|Overall Study|Refusal unrelated to toxicity|5|||
27955956|NCT00828139|54612771|FG003|Overall Study|Refusal unrelated to toxicity|3|||
27955957|NCT00828139|54612768|FG000|Overall Study|Disease Progression|24|||
27955958|NCT00828139|54612769|FG001|Overall Study|Disease Progression|33|||
27955959|NCT00828139|54612770|FG002|Overall Study|Disease Progression|35|||
27955960|NCT00828139|54612771|FG003|Overall Study|Disease Progression|39|||
27955961|NCT00828139|54612768|FG000|Overall Study|Other|4|||
27955962|NCT00828139|54612769|FG001|Overall Study|Other|2|||
28081917|NCT00098475|54735417|FG002|Step 1|Still on treatment as of this analysis|0|||
28081918|NCT00098475|54735418|FG003|Step 1|Still on treatment as of this analysis|0|||
28081919|NCT00098475|54735415|FG000|Step 1|Knee surgery|1|||
28081920|NCT00098475|54735416|FG001|Step 1|Knee surgery|0|||
28081921|NCT00098475|54735417|FG002|Step 1|Knee surgery|0|||
27955963|NCT00828139|54612770|FG002|Overall Study|Other|5|||
27955964|NCT00828139|54612771|FG003|Overall Study|Other|2|||
27955965|NCT00838513|54612781|FG000|Screening Period|Screen Failure|3|||
27955966|NCT00838513|54612781|FG000|Extension Treatment Period|Death|1|||
28081922|NCT00098475|54735418|FG003|Step 1|Knee surgery|0|||
27955967|NCT00838513|54612781|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
27955968|NCT00600106|54612787|FG000|Overall Study|Withdrawal by Subject|1|||
27955969|NCT00600106|54612788|FG001|Overall Study|Withdrawal by Subject|1|||
27955970|NCT00850993|54612798|FG000|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
27955971|NCT00850993|54612799|FG001|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
27955972|NCT00850993|54612800|FG002|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
27955973|NCT00850993|54612801|FG003|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
27955974|NCT00818779|54612813|FG000|Overall Study|Protocol Violation|1|||
27955975|NCT00818779|54612814|FG001|Overall Study|Protocol Violation|0|||
27955976|NCT00818779|54612813|FG000|Overall Study|Lost to Follow-up|1|||
27955977|NCT00818779|54612814|FG001|Overall Study|Lost to Follow-up|0|||
27955978|NCT00818779|54612813|FG000|Overall Study|Adverse Event|4|||
27955979|NCT00818779|54612814|FG001|Overall Study|Adverse Event|1|||
27955980|NCT00850759|54612824|FG000|Overall Study|Lost to Follow-up|7|||
27955981|NCT00850759|54612825|FG001|Overall Study|Lost to Follow-up|5|||
27955982|NCT00850759|54612826|FG002|Overall Study|Lost to Follow-up|5|||
27955983|NCT00850759|54612827|FG003|Overall Study|Lost to Follow-up|3|||
27955984|NCT00827827|54612839|FG000|Overall Study|Lost to Follow-up|3|||
27955985|NCT00827827|54612840|FG001|Overall Study|Lost to Follow-up|0|||
27955986|NCT00827827|54612839|FG000|Overall Study|Fall at home- hospitalization|1|||
27955987|NCT00827827|54612840|FG001|Overall Study|Fall at home- hospitalization|0|||
27955988|NCT00827827|54612839|FG000|Overall Study|Another cerebrovascular accident (CVA)|1|||
27955989|NCT00827827|54612840|FG001|Overall Study|Another cerebrovascular accident (CVA)|0|||
27955990|NCT00827827|54612839|FG000|Overall Study|Gout|1|||
27955991|NCT00827827|54612840|FG001|Overall Study|Gout|0|||
27955992|NCT00827827|54612839|FG000|Overall Study|Transportation issues|1|||
27955993|NCT00827827|54612840|FG001|Overall Study|Transportation issues|0|||
27955994|NCT00827827|54612839|FG000|Overall Study|Burned with water at home|1|||
27955995|NCT00827827|54612840|FG001|Overall Study|Burned with water at home|0|||
27955996|NCT00600028|54612849|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
27955997|NCT00600028|54612850|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
27955998|NCT00600028|54612849|FG000|First Intervention (12 Weeks)|Adverse Event|0|||
27955999|NCT00600028|54612850|FG001|First Intervention (12 Weeks)|Adverse Event|1|||
27956000|NCT00600028|54612849|FG000|Second Intervention (12 Weeks)|Adverse Event|0|||
27956001|NCT00600028|54612850|FG001|Second Intervention (12 Weeks)|Adverse Event|2|||
27956002|NCT03542266|54612859|FG000|Treatment Phase|Withdrawal by Subject|1|||
27956003|NCT03542266|54612859|FG000|Treatment Phase|Adverse Event|1|||
27956004|NCT03542266|54612859|FG000|Treatment Phase|PD|1|||
27956005|NCT03201250|54612866|FG000|Overall Study|screen failures|3|||
27956006|NCT03201250|54612867|FG001|Overall Study|screen failures|0|||
27956007|NCT03201250|54612868|FG002|Overall Study|screen failures|0|||
27956008|NCT00818623|54612885|FG000|Overall Study|Adverse Event|1|||
27956009|NCT00818623|54612886|FG001|Overall Study|Adverse Event|0|||
27956010|NCT00818623|54612887|FG002|Overall Study|Adverse Event|1|||
27956011|NCT00818623|54612888|FG003|Overall Study|Adverse Event|0|||
27956012|NCT00818623|54612889|FG004|Overall Study|Adverse Event|0|||
27956013|NCT00818623|54612890|FG005|Overall Study|Adverse Event|1|||
27956014|NCT00818623|54612891|FG006|Overall Study|Adverse Event|0|||
27956015|NCT00818623|54612892|FG007|Overall Study|Adverse Event|0|||
27956016|NCT00818623|54612885|FG000|Overall Study|Bad prostate specific antigen response|0|||
27956017|NCT00818623|54612886|FG001|Overall Study|Bad prostate specific antigen response|3|||
27956018|NCT00818623|54612887|FG002|Overall Study|Bad prostate specific antigen response|2|||
27956019|NCT00818623|54612888|FG003|Overall Study|Bad prostate specific antigen response|5|||
27956020|NCT00818623|54612889|FG004|Overall Study|Bad prostate specific antigen response|0|||
27956021|NCT00818623|54612890|FG005|Overall Study|Bad prostate specific antigen response|1|||
27956022|NCT00818623|54612891|FG006|Overall Study|Bad prostate specific antigen response|0|||
27956023|NCT00818623|54612892|FG007|Overall Study|Bad prostate specific antigen response|0|||
27956024|NCT00818623|54612885|FG000|Overall Study|Withdrawal by Subject|0|||
27956025|NCT00818623|54612886|FG001|Overall Study|Withdrawal by Subject|1|||
27956026|NCT00818623|54612887|FG002|Overall Study|Withdrawal by Subject|1|||
27956027|NCT00818623|54612888|FG003|Overall Study|Withdrawal by Subject|0|||
27956028|NCT00818623|54612889|FG004|Overall Study|Withdrawal by Subject|0|||
27956029|NCT00818623|54612890|FG005|Overall Study|Withdrawal by Subject|1|||
27956030|NCT00818623|54612891|FG006|Overall Study|Withdrawal by Subject|1|||
27956031|NCT00818623|54612892|FG007|Overall Study|Withdrawal by Subject|1|||
27832341|NCT01770743|54311226|FG002|Overall Study|Moving Out of State|0|||
27832342|NCT01770743|54311227|FG003|Overall Study|Moving Out of State|0|||
27832343|NCT01770743|54311228|FG004|Overall Study|Moving Out of State|0|||
27956032|NCT00818623|54612885|FG000|Overall Study|Protocol Violation|1|||
27956033|NCT00818623|54612886|FG001|Overall Study|Protocol Violation|0|||
27956034|NCT00818623|54612887|FG002|Overall Study|Protocol Violation|0|||
27956035|NCT00818623|54612888|FG003|Overall Study|Protocol Violation|0|||
27956036|NCT00818623|54612889|FG004|Overall Study|Protocol Violation|1|||
27956037|NCT00818623|54612890|FG005|Overall Study|Protocol Violation|0|||
27956038|NCT00818623|54612891|FG006|Overall Study|Protocol Violation|1|||
27956039|NCT00818623|54612892|FG007|Overall Study|Protocol Violation|0|||
27956040|NCT00818623|54612885|FG000|Overall Study|Need of additional treatment|0|||
27956041|NCT00818623|54612886|FG001|Overall Study|Need of additional treatment|0|||
27956042|NCT00818623|54612887|FG002|Overall Study|Need of additional treatment|0|||
27956043|NCT00818623|54612888|FG003|Overall Study|Need of additional treatment|0|||
27956044|NCT00818623|54612889|FG004|Overall Study|Need of additional treatment|1|||
27956045|NCT00818623|54612890|FG005|Overall Study|Need of additional treatment|0|||
27956046|NCT00818623|54612891|FG006|Overall Study|Need of additional treatment|0|||
27956047|NCT00818623|54612892|FG007|Overall Study|Need of additional treatment|0|||
27956048|NCT00818623|54612885|FG000|Overall Study|Lack of trial drug at site|0|||
27956049|NCT00818623|54612886|FG001|Overall Study|Lack of trial drug at site|0|||
27956050|NCT00818623|54612887|FG002|Overall Study|Lack of trial drug at site|0|||
27956051|NCT00818623|54612888|FG003|Overall Study|Lack of trial drug at site|0|||
27956052|NCT00818623|54612889|FG004|Overall Study|Lack of trial drug at site|2|||
27956053|NCT00818623|54612890|FG005|Overall Study|Lack of trial drug at site|0|||
27956054|NCT00818623|54612891|FG006|Overall Study|Lack of trial drug at site|1|||
27956055|NCT00818623|54612892|FG007|Overall Study|Lack of trial drug at site|0|||
27956056|NCT00818623|54612885|FG000|Overall Study|Disease progression|0|||
27956057|NCT00818623|54612886|FG001|Overall Study|Disease progression|0|||
27956058|NCT00818623|54612887|FG002|Overall Study|Disease progression|0|||
27956059|NCT00818623|54612888|FG003|Overall Study|Disease progression|0|||
27956060|NCT00818623|54612889|FG004|Overall Study|Disease progression|0|||
27956061|NCT00818623|54612890|FG005|Overall Study|Disease progression|0|||
27956062|NCT00818623|54612891|FG006|Overall Study|Disease progression|1|||
27956063|NCT00818623|54612892|FG007|Overall Study|Disease progression|0|||
27956064|NCT00827359|54612910|FG000|Overall Study|Progressive Diseas|19|||
27956065|NCT00827359|54612910|FG000|Overall Study|Unacceptable Toxicity|5|||
27956066|NCT00827359|54612910|FG000|Overall Study|Ineligible|1|||
27956067|NCT00818389|54612916|FG000|Overall Study|Death|1|||
27956068|NCT00818389|54612917|FG001|Overall Study|Death|3|||
27956069|NCT00818389|54612916|FG000|Overall Study|ALS Disease Progression|1|||
27956070|NCT00818389|54612917|FG001|Overall Study|ALS Disease Progression|0|||
27956071|NCT00818389|54612916|FG000|Overall Study|Withdrawal by Subject|2|||
27956072|NCT00818389|54612917|FG001|Overall Study|Withdrawal by Subject|2|||
27956073|NCT00818389|54612916|FG000|Overall Study|Adverse Event|0|||
27956074|NCT00818389|54612917|FG001|Overall Study|Adverse Event|1|||
27956075|NCT00850135|54612923|FG000|Overall Study|Physician Decision|1|||
27956076|NCT01154816|54612941|FG000|Overall Study|Withdrawal by Subject|1|||
27956077|NCT01154816|54612942|FG001|Overall Study|Withdrawal by Subject|0|||
27956078|NCT01154816|54612943|FG002|Overall Study|Withdrawal by Subject|0|||
27956079|NCT01154816|54612944|FG003|Overall Study|Withdrawal by Subject|1|||
27956080|NCT01154816|54612945|FG004|Overall Study|Withdrawal by Subject|0|||
27956081|NCT01154816|54612946|FG005|Overall Study|Withdrawal by Subject|0|||
27956082|NCT01154816|54612947|FG006|Overall Study|Withdrawal by Subject|0|||
27956083|NCT01154816|54612948|FG007|Overall Study|Withdrawal by Subject|0|||
27956084|NCT01154816|54612949|FG008|Overall Study|Withdrawal by Subject|1|||
27956085|NCT01154816|54612950|FG009|Overall Study|Withdrawal by Subject|3|||
27956086|NCT01154816|54612951|FG010|Overall Study|Withdrawal by Subject|0|||
27956087|NCT01154816|54612952|FG011|Overall Study|Withdrawal by Subject|0|||
27956088|NCT01154816|54612941|FG000|Overall Study|Progressive Disease|13|||
27956089|NCT01154816|54612942|FG001|Overall Study|Progressive Disease|8|||
27956090|NCT01154816|54612943|FG002|Overall Study|Progressive Disease|9|||
27956091|NCT01154816|54612944|FG003|Overall Study|Progressive Disease|9|||
27956092|NCT01154816|54612945|FG004|Overall Study|Progressive Disease|8|||
27956093|NCT01154816|54612946|FG005|Overall Study|Progressive Disease|8|||
27956094|NCT01154816|54612947|FG006|Overall Study|Progressive Disease|5|||
27956095|NCT01154816|54612948|FG007|Overall Study|Progressive Disease|6|||
27956096|NCT01154816|54612949|FG008|Overall Study|Progressive Disease|8|||
27956097|NCT01154816|54612950|FG009|Overall Study|Progressive Disease|6|||
27956098|NCT01154816|54612951|FG010|Overall Study|Progressive Disease|10|||
28081923|NCT00098475|54735415|FG000|Step 1|Complications|1|||
28081924|NCT00098475|54735416|FG001|Step 1|Complications|0|||
28081925|NCT00098475|54735417|FG002|Step 1|Complications|0|||
27832344|NCT01767467|54311324|FG000|Vaccination Phase (up to Month 2)|Adverse Event|8|||
27956099|NCT01154816|54612952|FG011|Overall Study|Progressive Disease|3|||
27956100|NCT01154816|54612941|FG000|Overall Study|Physician Decision|1|||
27956101|NCT01154816|54612942|FG001|Overall Study|Physician Decision|0|||
27956102|NCT01154816|54612943|FG002|Overall Study|Physician Decision|1|||
27956103|NCT01154816|54612944|FG003|Overall Study|Physician Decision|0|||
27956104|NCT01154816|54612945|FG004|Overall Study|Physician Decision|2|||
27956105|NCT01154816|54612946|FG005|Overall Study|Physician Decision|0|||
27956106|NCT01154816|54612947|FG006|Overall Study|Physician Decision|0|||
27956107|NCT01154816|54612948|FG007|Overall Study|Physician Decision|0|||
27956108|NCT01154816|54612949|FG008|Overall Study|Physician Decision|0|||
27956109|NCT01154816|54612950|FG009|Overall Study|Physician Decision|1|||
27956110|NCT01154816|54612951|FG010|Overall Study|Physician Decision|1|||
27956111|NCT01154816|54612952|FG011|Overall Study|Physician Decision|1|||
28081926|NCT00098475|54735418|FG003|Step 1|Complications|0|||
27956112|NCT01154816|54612941|FG000|Overall Study|Adverse Event|5|||
27956113|NCT01154816|54612942|FG001|Overall Study|Adverse Event|2|||
27956114|NCT01154816|54612943|FG002|Overall Study|Adverse Event|0|||
27956115|NCT01154816|54612944|FG003|Overall Study|Adverse Event|0|||
27956116|NCT01154816|54612945|FG004|Overall Study|Adverse Event|0|||
27956117|NCT01154816|54612946|FG005|Overall Study|Adverse Event|0|||
27956118|NCT01154816|54612947|FG006|Overall Study|Adverse Event|1|||
27956119|NCT01154816|54612948|FG007|Overall Study|Adverse Event|1|||
27956120|NCT01154816|54612949|FG008|Overall Study|Adverse Event|0|||
27956121|NCT01154816|54612950|FG009|Overall Study|Adverse Event|0|||
27956122|NCT01154816|54612951|FG010|Overall Study|Adverse Event|0|||
27956123|NCT01154816|54612952|FG011|Overall Study|Adverse Event|0|||
27956124|NCT00849901|54612998|FG000|Acute Treatment Phase|Adverse Event|9|||
27956125|NCT00849901|54612999|FG001|Acute Treatment Phase|Adverse Event|1|||
27956126|NCT00849901|54613000|FG002|Acute Treatment Phase|Adverse Event|3|||
27956127|NCT00849901|54612998|FG000|Acute Treatment Phase|Lost to Follow-up|2|||
27956128|NCT00849901|54612999|FG001|Acute Treatment Phase|Lost to Follow-up|4|||
27956129|NCT00849901|54613000|FG002|Acute Treatment Phase|Lost to Follow-up|1|||
27956130|NCT00849901|54612998|FG000|Acute Treatment Phase|Protocol Violation|0|||
27956131|NCT00849901|54612999|FG001|Acute Treatment Phase|Protocol Violation|2|||
27956132|NCT00849901|54613000|FG002|Acute Treatment Phase|Protocol Violation|1|||
27956133|NCT00849901|54612998|FG000|Acute Treatment Phase|Withdrawal by Subject|4|||
27956134|NCT00849901|54612999|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
27956135|NCT00849901|54613000|FG002|Acute Treatment Phase|Withdrawal by Subject|4|||
27956136|NCT00849901|54612998|FG000|Acute Treatment Phase|Parent or Caregiver Decision|11|||
27956137|NCT00849901|54612999|FG001|Acute Treatment Phase|Parent or Caregiver Decision|5|||
27956138|NCT00849901|54613000|FG002|Acute Treatment Phase|Parent or Caregiver Decision|4|||
27956139|NCT00849901|54612998|FG000|Acute Treatment Phase|Physician Decision|1|||
27956140|NCT00849901|54612999|FG001|Acute Treatment Phase|Physician Decision|1|||
27956141|NCT00849901|54613000|FG002|Acute Treatment Phase|Physician Decision|1|||
27956142|NCT00849901|54612998|FG000|Acute Treatment Phase|Sponsor Decision|1|||
27956143|NCT00849901|54612999|FG001|Acute Treatment Phase|Sponsor Decision|0|||
27956144|NCT00849901|54613000|FG002|Acute Treatment Phase|Sponsor Decision|0|||
27956145|NCT00849901|54612998|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
27956146|NCT00849901|54612999|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
27956147|NCT00849901|54613000|FG002|Acute Treatment Phase|Lack of Efficacy|2|||
27956148|NCT00849901|54612998|FG000|Extension Phase|Adverse Event|2|||
27956149|NCT00849901|54612999|FG001|Extension Phase|Adverse Event|8|||
27956150|NCT00849901|54613000|FG002|Extension Phase|Adverse Event|4|||
27956151|NCT00849901|54612998|FG000|Extension Phase|Lost to Follow-up|3|||
27956152|NCT00849901|54612999|FG001|Extension Phase|Lost to Follow-up|0|||
27956153|NCT00849901|54613000|FG002|Extension Phase|Lost to Follow-up|1|||
27956154|NCT00849901|54612998|FG000|Extension Phase|Protocol Violation|2|||
27956155|NCT00849901|54612999|FG001|Extension Phase|Protocol Violation|2|||
27956156|NCT00849901|54613000|FG002|Extension Phase|Protocol Violation|4|||
27956157|NCT00849901|54612998|FG000|Extension Phase|Withdrawal by Subject|7|||
27956158|NCT00849901|54612999|FG001|Extension Phase|Withdrawal by Subject|6|||
27956159|NCT00849901|54613000|FG002|Extension Phase|Withdrawal by Subject|3|||
27956160|NCT00849901|54612998|FG000|Extension Phase|Parent or Caregiver Decision|10|||
27956161|NCT00849901|54612999|FG001|Extension Phase|Parent or Caregiver Decision|4|||
27956162|NCT00849901|54613000|FG002|Extension Phase|Parent or Caregiver Decision|4|||
27956163|NCT00849901|54612998|FG000|Extension Phase|Physician Decision|1|||
27956164|NCT00849901|54612999|FG001|Extension Phase|Physician Decision|2|||
27956165|NCT00849901|54613000|FG002|Extension Phase|Physician Decision|0|||
27956166|NCT00849901|54612998|FG000|Extension Phase|Lack of Efficacy|2|||
27956167|NCT00849901|54612999|FG001|Extension Phase|Lack of Efficacy|4|||
27956168|NCT00849901|54613000|FG002|Extension Phase|Lack of Efficacy|1|||
27956169|NCT01168232|54613014|FG000|Overall Study|Ineligible-Second primary cancer site|1|||
27956170|NCT01168232|54613014|FG000|Overall Study|Ineligible- Wrong cell type|6|||
27956171|NCT01168232|54613014|FG000|Overall Study|Ineligible-Inadequate pathology|1|||
27956172|NCT00817531|54613018|FG000|Overall Study|Adverse Event|1|||
27956173|NCT00817531|54613018|FG000|Overall Study|Lack of Efficacy|1|||
27956174|NCT00817063|54613024|FG000|Overall Study|Adverse Event|32|||
27956175|NCT00817063|54613025|FG001|Overall Study|Adverse Event|13|||
28081927|NCT00098475|54735415|FG000|Step 1|Cannot comply due to other tx|0|||
27956176|NCT00817063|54613024|FG000|Overall Study|Death|1|||
27956177|NCT00817063|54613025|FG001|Overall Study|Death|1|||
27956178|NCT00817063|54613024|FG000|Overall Study|Lack of Efficacy|33|||
27956179|NCT00817063|54613025|FG001|Overall Study|Lack of Efficacy|86|||
27956180|NCT00817063|54613024|FG000|Overall Study|Failure to Return|13|||
27956181|NCT00817063|54613025|FG001|Overall Study|Failure to Return|12|||
27956182|NCT00817063|54613024|FG000|Overall Study|Violation of Selection at Entry|7|||
27956183|NCT00817063|54613025|FG001|Overall Study|Violation of Selection at Entry|4|||
27956184|NCT00817063|54613024|FG000|Overall Study|Protocol Violation|3|||
27956185|NCT00817063|54613025|FG001|Overall Study|Protocol Violation|8|||
27956186|NCT00817063|54613024|FG000|Overall Study|Withdrawal by Subject|17|||
27956187|NCT00817063|54613025|FG001|Overall Study|Withdrawal by Subject|37|||
27956188|NCT00817063|54613024|FG000|Overall Study|Early Improvement|19|||
27956189|NCT00817063|54613025|FG001|Overall Study|Early Improvement|4|||
27956190|NCT00817063|54613024|FG000|Overall Study|Administrative|10|||
27956191|NCT00817063|54613025|FG001|Overall Study|Administrative|4|||
27956192|NCT00817063|54613024|FG000|Overall Study|Abnormality of Laboratory Test|2|||
27956193|NCT00817063|54613025|FG001|Overall Study|Abnormality of Laboratory Test|1|||
27956194|NCT01167140|54613031|FG000|Overall Study|Withdrawal by Subject|1|||
27956195|NCT01166750|54613037|FG000|Overall Study|Lost to Follow-up|1|||
27956196|NCT01166750|54613038|FG001|Overall Study|Lost to Follow-up|0|||
27956197|NCT00826267|54613047|FG000|Overall Study|Other Adverse Event|1|||
27956198|NCT00826267|54613048|FG001|Overall Study|Other Adverse Event|0|||
27956199|NCT00826267|54613049|FG002|Overall Study|Other Adverse Event|0|||
27956200|NCT00986154|54613060|FG000|Overall Study|Death|136|||
27956201|NCT00986154|54613061|FG001|Overall Study|Death|127|||
27956202|NCT00986154|54613060|FG000|Overall Study|Lost to Follow-up|7|||
27956203|NCT00986154|54613061|FG001|Overall Study|Lost to Follow-up|4|||
27956204|NCT00986154|54613060|FG000|Overall Study|Withdrawal by Subject|32|||
27956205|NCT00986154|54613061|FG001|Overall Study|Withdrawal by Subject|33|||
27956206|NCT00986154|54613060|FG000|Overall Study|investigator/subject decide not continue|6|||
27956207|NCT00986154|54613061|FG001|Overall Study|investigator/subject decide not continue|3|||
27956208|NCT00986154|54613060|FG000|Overall Study|never received study drug|25|||
27956209|NCT00986154|54613061|FG001|Overall Study|never received study drug|27|||
27956210|NCT00848965|54613067|FG000|Overall Study|Adverse Event|1|||
27956211|NCT00848965|54613067|FG000|Overall Study|Withdrawal by Subject|1|||
27956212|NCT01154036|54613086|FG000|Phase I|Physician Decision|0|||
27956213|NCT01154036|54613087|FG001|Phase I|Physician Decision|1|||
27956214|NCT01154036|54613088|FG002|Phase I|Physician Decision|0|||
27956215|NCT01154036|54613089|FG003|Phase I|Physician Decision|0|||
27956216|NCT01154036|54613090|FG004|Phase I|Physician Decision|0|||
27956217|NCT01154036|54613091|FG005|Phase I|Physician Decision|0|||
27956218|NCT01154036|54613092|FG006|Phase I|Physician Decision|0|||
27956219|NCT01154036|54613093|FG007|Phase I|Physician Decision|0|||
27956220|NCT01154036|54613086|FG000|Phase I|Lost to Follow-up|0|||
27956221|NCT01154036|54613087|FG001|Phase I|Lost to Follow-up|3|||
27956222|NCT01154036|54613088|FG002|Phase I|Lost to Follow-up|6|||
27956223|NCT01154036|54613089|FG003|Phase I|Lost to Follow-up|0|||
27956224|NCT01154036|54613090|FG004|Phase I|Lost to Follow-up|0|||
27956225|NCT01154036|54613091|FG005|Phase I|Lost to Follow-up|0|||
27956226|NCT01154036|54613092|FG006|Phase I|Lost to Follow-up|0|||
27956227|NCT01154036|54613093|FG007|Phase I|Lost to Follow-up|0|||
27956228|NCT01154036|54613086|FG000|Phase I|Protocol Violation|0|||
27956229|NCT01154036|54613087|FG001|Phase I|Protocol Violation|3|||
27956230|NCT01154036|54613088|FG002|Phase I|Protocol Violation|9|||
27956231|NCT01154036|54613089|FG003|Phase I|Protocol Violation|0|||
27956232|NCT01154036|54613090|FG004|Phase I|Protocol Violation|0|||
27956233|NCT01154036|54613091|FG005|Phase I|Protocol Violation|0|||
28081928|NCT00098475|54735416|FG001|Step 1|Cannot comply due to other tx|1|||
27956234|NCT01154036|54613092|FG006|Phase I|Protocol Violation|0|||
27956235|NCT01154036|54613093|FG007|Phase I|Protocol Violation|0|||
27956236|NCT01154036|54613086|FG000|Phase I|Withdrawal by Subject|2|||
27956237|NCT01154036|54613087|FG001|Phase I|Withdrawal by Subject|10|||
27956238|NCT01154036|54613088|FG002|Phase I|Withdrawal by Subject|29|||
27956239|NCT01154036|54613089|FG003|Phase I|Withdrawal by Subject|0|||
27956240|NCT01154036|54613090|FG004|Phase I|Withdrawal by Subject|0|||
27956241|NCT01154036|54613091|FG005|Phase I|Withdrawal by Subject|0|||
27956242|NCT01154036|54613092|FG006|Phase I|Withdrawal by Subject|0|||
27956243|NCT01154036|54613093|FG007|Phase I|Withdrawal by Subject|0|||
27956244|NCT01154036|54613086|FG000|Phase I|Adverse Event|1|||
27956245|NCT01154036|54613087|FG001|Phase I|Adverse Event|11|||
27956246|NCT01154036|54613088|FG002|Phase I|Adverse Event|12|||
27956247|NCT01154036|54613089|FG003|Phase I|Adverse Event|0|||
27956248|NCT01154036|54613090|FG004|Phase I|Adverse Event|0|||
27956249|NCT01154036|54613091|FG005|Phase I|Adverse Event|0|||
27956250|NCT01154036|54613092|FG006|Phase I|Adverse Event|0|||
27956251|NCT01154036|54613093|FG007|Phase I|Adverse Event|0|||
27956252|NCT01154036|54613086|FG000|Phase II|Adverse Event|0|||
27956253|NCT01154036|54613087|FG001|Phase II|Adverse Event|0|||
28081929|NCT00098475|54735417|FG002|Step 1|Cannot comply due to other tx|0|||
28081930|NCT00098475|54735418|FG003|Step 1|Cannot comply due to other tx|0|||
27732096|NCT02706405|54179528|FG000|Overall Study|Death|3|||
27956254|NCT01154036|54613088|FG002|Phase II|Adverse Event|0|||
27956255|NCT01154036|54613089|FG003|Phase II|Adverse Event|0|||
27956256|NCT01154036|54613090|FG004|Phase II|Adverse Event|1|||
27956257|NCT01154036|54613091|FG005|Phase II|Adverse Event|1|||
27956258|NCT01154036|54613092|FG006|Phase II|Adverse Event|1|||
27956259|NCT01154036|54613093|FG007|Phase II|Adverse Event|1|||
27956260|NCT01154036|54613086|FG000|Phase II|Physician Decision|0|||
27956261|NCT01154036|54613087|FG001|Phase II|Physician Decision|0|||
27956262|NCT01154036|54613088|FG002|Phase II|Physician Decision|0|||
27956263|NCT01154036|54613089|FG003|Phase II|Physician Decision|0|||
28081931|NCT00098475|54735415|FG000|Step 1|Both patient and physician's decision|2|||
27956264|NCT01154036|54613090|FG004|Phase II|Physician Decision|0|||
27956265|NCT01154036|54613091|FG005|Phase II|Physician Decision|0|||
27956266|NCT01154036|54613092|FG006|Phase II|Physician Decision|1|||
27956267|NCT01154036|54613093|FG007|Phase II|Physician Decision|0|||
27956268|NCT01154036|54613086|FG000|Phase II|Lost to Follow-up|0|||
27956269|NCT01154036|54613087|FG001|Phase II|Lost to Follow-up|0|||
27956270|NCT01154036|54613088|FG002|Phase II|Lost to Follow-up|0|||
27956271|NCT01154036|54613089|FG003|Phase II|Lost to Follow-up|1|||
27956272|NCT01154036|54613090|FG004|Phase II|Lost to Follow-up|2|||
27956273|NCT01154036|54613091|FG005|Phase II|Lost to Follow-up|0|||
27956274|NCT01154036|54613092|FG006|Phase II|Lost to Follow-up|2|||
27956275|NCT01154036|54613093|FG007|Phase II|Lost to Follow-up|1|||
27956276|NCT01154036|54613086|FG000|Phase II|Protocol Violation|0|||
27956277|NCT01154036|54613087|FG001|Phase II|Protocol Violation|0|||
27956278|NCT01154036|54613088|FG002|Phase II|Protocol Violation|0|||
27956279|NCT01154036|54613089|FG003|Phase II|Protocol Violation|0|||
27956280|NCT01154036|54613090|FG004|Phase II|Protocol Violation|1|||
27956281|NCT01154036|54613091|FG005|Phase II|Protocol Violation|2|||
28081932|NCT00098475|54735416|FG001|Step 1|Both patient and physician's decision|1|||
28081933|NCT00098475|54735417|FG002|Step 1|Both patient and physician's decision|0|||
28081934|NCT00098475|54735418|FG003|Step 1|Both patient and physician's decision|0|||
28081935|NCT00098475|54735415|FG000|Step 1|Incorrect disease assessment|2|||
28081936|NCT00098475|54735416|FG001|Step 1|Incorrect disease assessment|0|||
28081937|NCT00098475|54735417|FG002|Step 1|Incorrect disease assessment|0|||
27956282|NCT01154036|54613092|FG006|Phase II|Protocol Violation|0|||
27956283|NCT01154036|54613093|FG007|Phase II|Protocol Violation|0|||
27956284|NCT01154036|54613086|FG000|Phase II|Withdrawal by Subject|0|||
27956285|NCT01154036|54613087|FG001|Phase II|Withdrawal by Subject|0|||
27956286|NCT01154036|54613088|FG002|Phase II|Withdrawal by Subject|0|||
27956287|NCT01154036|54613089|FG003|Phase II|Withdrawal by Subject|0|||
27956288|NCT01154036|54613090|FG004|Phase II|Withdrawal by Subject|4|||
27956289|NCT01154036|54613091|FG005|Phase II|Withdrawal by Subject|2|||
27956290|NCT01154036|54613092|FG006|Phase II|Withdrawal by Subject|5|||
27956291|NCT01154036|54613093|FG007|Phase II|Withdrawal by Subject|4|||
27956292|NCT00816595|54613115|FG000|Overall Study|Withdrawal by Subject|2|||
27956293|NCT00816595|54613116|FG001|Overall Study|Withdrawal by Subject|0|||
27956294|NCT01166438|54613126|FG000|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8|||
27956295|NCT01166438|54613127|FG001|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4|||
27956296|NCT01166438|54613126|FG000|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0|||
27956297|NCT01166438|54613127|FG001|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4|||
27956298|NCT01166438|54613126|FG000|Double-blind Phase: 1st 6 Months|Not treated|1|||
27956299|NCT01166438|54613127|FG001|Double-blind Phase: 1st 6 Months|Not treated|1|||
27956300|NCT01166438|54613126|FG000|Off Treatment Follow-up Phase|Withdrawal by Subject|1|||
27956301|NCT01166438|54613127|FG001|Off Treatment Follow-up Phase|Withdrawal by Subject|2|||
27956302|NCT01166438|54613126|FG000|Off Treatment Follow-up Phase|Lost to Follow-up|4|||
27956303|NCT01166438|54613127|FG001|Off Treatment Follow-up Phase|Lost to Follow-up|2|||
27956304|NCT01166438|54613126|FG000|Off Treatment Follow-up Phase|Lack of Efficacy|29|||
27956305|NCT01166438|54613127|FG001|Off Treatment Follow-up Phase|Lack of Efficacy|52|||
27956306|NCT01153958|54613136|FG000|Overall Study|Study Terminated|36|||
27956307|NCT01153958|54613137|FG001|Overall Study|Study Terminated|32|||
27956308|NCT00599638|54613147|FG000|First Intervention Period (2 Weeks)|Adverse Event|1|||
27956309|NCT00599638|54613148|FG001|First Intervention Period (2 Weeks)|Adverse Event|0|||
27956310|NCT00599638|54613149|FG002|First Intervention Period (2 Weeks)|Adverse Event|3|||
27956311|NCT00599638|54613150|FG003|First Intervention Period (2 Weeks)|Adverse Event|2|||
27956312|NCT00599638|54613147|FG000|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
27956313|NCT00599638|54613148|FG001|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
27956314|NCT00599638|54613149|FG002|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
27956315|NCT00599638|54613150|FG003|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
27956316|NCT00599638|54613147|FG000|First Intervention Period (2 Weeks)|Protocol Violation|0|||
27956317|NCT00599638|54613148|FG001|First Intervention Period (2 Weeks)|Protocol Violation|1|||
27956318|NCT00599638|54613149|FG002|First Intervention Period (2 Weeks)|Protocol Violation|0|||
27956319|NCT00599638|54613150|FG003|First Intervention Period (2 Weeks)|Protocol Violation|1|||
27956320|NCT00599638|54613147|FG000|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
27956321|NCT00599638|54613148|FG001|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
27956322|NCT00599638|54613149|FG002|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
28081938|NCT00098475|54735418|FG003|Step 1|Incorrect disease assessment|0|||
28081939|NCT00098475|54735415|FG000|Step 1|Off treatment for > specified timeframe|1|||
28081940|NCT00098475|54735416|FG001|Step 1|Off treatment for > specified timeframe|1|||
27956323|NCT00599638|54613150|FG003|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
27956324|NCT00599638|54613147|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
27956325|NCT00599638|54613148|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
27956326|NCT00599638|54613149|FG002|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
28081941|NCT00098475|54735417|FG002|Step 1|Off treatment for > specified timeframe|0|||
27956327|NCT00599638|54613150|FG003|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
27956328|NCT00599638|54613147|FG000|Washout Period (2 Weeks)|Adverse Event|0|||
27956329|NCT00599638|54613148|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
27956330|NCT00599638|54613149|FG002|Washout Period (2 Weeks)|Adverse Event|0|||
27956331|NCT00599638|54613150|FG003|Washout Period (2 Weeks)|Adverse Event|1|||
27956332|NCT00599638|54613147|FG000|Washout Period (2 Weeks)|Lost to Follow-up|0|||
27956333|NCT00599638|54613148|FG001|Washout Period (2 Weeks)|Lost to Follow-up|0|||
27956334|NCT00599638|54613149|FG002|Washout Period (2 Weeks)|Lost to Follow-up|0|||
27956335|NCT00599638|54613150|FG003|Washout Period (2 Weeks)|Lost to Follow-up|1|||
27956336|NCT00599638|54613147|FG000|Washout Period (2 Weeks)|Protocol Violation|0|||
27956337|NCT00599638|54613148|FG001|Washout Period (2 Weeks)|Protocol Violation|1|||
27956338|NCT00599638|54613149|FG002|Washout Period (2 Weeks)|Protocol Violation|0|||
27956339|NCT00599638|54613150|FG003|Washout Period (2 Weeks)|Protocol Violation|0|||
27956340|NCT00599638|54613147|FG000|Second Intervention Period (2 Weeks)|Protocol Violation|1|||
27956341|NCT00599638|54613148|FG001|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
27956342|NCT00599638|54613149|FG002|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
27956343|NCT00599638|54613150|FG003|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
27956344|NCT01166282|54613160|FG000|Open-label Period|Adverse Event|0|||
27956345|NCT01166282|54613161|FG001|Open-label Period|Adverse Event|0|||
27956346|NCT01166282|54613162|FG002|Open-label Period|Adverse Event|6|||
27956347|NCT01166282|54613160|FG000|Open-label Period|Withdrawal by Subject|0|||
27956348|NCT01166282|54613161|FG001|Open-label Period|Withdrawal by Subject|0|||
27956349|NCT01166282|54613162|FG002|Open-label Period|Withdrawal by Subject|4|||
27956350|NCT01166282|54613160|FG000|Open-label Period|Lack of Efficacy|0|||
27956351|NCT01166282|54613161|FG001|Open-label Period|Lack of Efficacy|0|||
27956352|NCT01166282|54613162|FG002|Open-label Period|Lack of Efficacy|2|||
27956353|NCT01166282|54613160|FG000|Open-label Period|Remission|0|||
27956354|NCT01166282|54613161|FG001|Open-label Period|Remission|0|||
27956355|NCT01166282|54613162|FG002|Open-label Period|Remission|4|||
27956356|NCT01166282|54613160|FG000|Open-label Period|Irregular Compliance|0|||
27956357|NCT01166282|54613161|FG001|Open-label Period|Irregular Compliance|0|||
27956358|NCT01166282|54613162|FG002|Open-label Period|Irregular Compliance|1|||
27956359|NCT01153724|54613170|FG000|Treatment Period 1|Withdrawal by Subject|1|||
27956360|NCT01153724|54613170|FG000|Treatment Period 2|Adverse Event|1|||
27956361|NCT01153724|54613170|FG000|Treatment Period 2|Other reason not defined above|1|||
27956362|NCT01152788|54613178|FG000|Overall Study|Withdrawal by Subject|0|||
27956363|NCT01152788|54613179|FG001|Overall Study|Withdrawal by Subject|3|||
27956364|NCT01152788|54613178|FG000|Overall Study|No treatment|0|||
27956365|NCT01152788|54613179|FG001|Overall Study|No treatment|1|||
27956366|NCT01165424|54613185|FG000|Overall Study|Clinical adverse experiences|1|||
27956367|NCT01165424|54613185|FG000|Overall Study|Laboratory adverse experiences|1|||
27956368|NCT01165424|54613185|FG000|Overall Study|Did not meet entry criteria|1|||
27956369|NCT01165424|54613185|FG000|Overall Study|Participant moved (relocated)|1|||
27956370|NCT01152554|54613191|FG000|Overall Study|Withdrawal by Subject|73|||
27956371|NCT01152554|54613192|FG001|Overall Study|Withdrawal by Subject|28|||
27956372|NCT01152554|54613191|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
27956373|NCT01152554|54613192|FG001|Overall Study|Eligiblity criteria not fulfilled|1|||
27956374|NCT01152554|54613191|FG000|Overall Study|Adverse Event|67|||
27956375|NCT01152554|54613192|FG001|Overall Study|Adverse Event|14|||
27956376|NCT01152554|54613191|FG000|Overall Study|Severe non-compliance to protocol|36|||
27956377|NCT01152554|54613192|FG001|Overall Study|Severe non-compliance to protocol|14|||
27956378|NCT01152554|54613191|FG000|Overall Study|Condition under investigation worsened|5|||
27956379|NCT01152554|54613192|FG001|Overall Study|Condition under investigation worsened|2|||
27956380|NCT01152554|54613191|FG000|Overall Study|Lack of Efficacy|20|||
27956381|NCT01152554|54613192|FG001|Overall Study|Lack of Efficacy|3|||
27956382|NCT01152554|54613191|FG000|Overall Study|Study-specific withdrawal criteria|17|||
27956383|NCT01152554|54613192|FG001|Overall Study|Study-specific withdrawal criteria|8|||
27956384|NCT01152554|54613191|FG000|Overall Study|Lost to Follow-up|87|||
27956385|NCT01152554|54613192|FG001|Overall Study|Lost to Follow-up|32|||
27956386|NCT01152554|54613191|FG000|Overall Study|Other|28|||
27956387|NCT01152554|54613192|FG001|Overall Study|Other|8|||
27956388|NCT01152554|54613191|FG000|Overall Study|Death|1|||
27956389|NCT01152554|54613192|FG001|Overall Study|Death|1|||
27956390|NCT00598702|54613206|FG000|Overall Study|Other|0|||
27956391|NCT00598702|54613207|FG001|Overall Study|Other|2|||
27956392|NCT00598702|54613208|FG002|Overall Study|Other|0|||
27956393|NCT00598702|54613209|FG003|Overall Study|Other|0|||
27956394|NCT00598702|54613210|FG004|Overall Study|Other|0|||
27956395|NCT00598702|54613211|FG005|Overall Study|Other|1|||
27956396|NCT00598702|54613212|FG006|Overall Study|Other|0|||
27956397|NCT00598702|54613213|FG007|Overall Study|Other|0|||
27956398|NCT00598702|54613206|FG000|Overall Study|Early discharge from hospital|0|||
27956399|NCT00598702|54613207|FG001|Overall Study|Early discharge from hospital|0|||
27956400|NCT00598702|54613208|FG002|Overall Study|Early discharge from hospital|2|||
27956401|NCT00598702|54613209|FG003|Overall Study|Early discharge from hospital|5|||
27956402|NCT00598702|54613210|FG004|Overall Study|Early discharge from hospital|0|||
27956403|NCT00598702|54613211|FG005|Overall Study|Early discharge from hospital|10|||
27956404|NCT00598702|54613212|FG006|Overall Study|Early discharge from hospital|1|||
27956405|NCT00598702|54613213|FG007|Overall Study|Early discharge from hospital|0|||
27956406|NCT00598702|54613206|FG000|Overall Study|Adverse Event|0|||
27956407|NCT00598702|54613207|FG001|Overall Study|Adverse Event|0|||
27956408|NCT00598702|54613208|FG002|Overall Study|Adverse Event|0|||
27956409|NCT00598702|54613209|FG003|Overall Study|Adverse Event|1|||
27956410|NCT00598702|54613210|FG004|Overall Study|Adverse Event|0|||
27956411|NCT00598702|54613211|FG005|Overall Study|Adverse Event|0|||
27956412|NCT00598702|54613212|FG006|Overall Study|Adverse Event|0|||
27956413|NCT00598702|54613213|FG007|Overall Study|Adverse Event|0|||
27956414|NCT00598702|54613206|FG000|Overall Study|Withdrawal by Subject|0|||
27956415|NCT00598702|54613207|FG001|Overall Study|Withdrawal by Subject|0|||
27956416|NCT00598702|54613208|FG002|Overall Study|Withdrawal by Subject|0|||
27956417|NCT00598702|54613209|FG003|Overall Study|Withdrawal by Subject|1|||
27956418|NCT00598702|54613210|FG004|Overall Study|Withdrawal by Subject|1|||
27956419|NCT00598702|54613211|FG005|Overall Study|Withdrawal by Subject|0|||
27956420|NCT00598702|54613212|FG006|Overall Study|Withdrawal by Subject|0|||
27956421|NCT00598702|54613213|FG007|Overall Study|Withdrawal by Subject|0|||
27956422|NCT00598702|54613206|FG000|Overall Study|Physician Decision|0|||
27956423|NCT00598702|54613207|FG001|Overall Study|Physician Decision|0|||
27956424|NCT00598702|54613208|FG002|Overall Study|Physician Decision|0|||
27956425|NCT00598702|54613209|FG003|Overall Study|Physician Decision|0|||
27956426|NCT00598702|54613210|FG004|Overall Study|Physician Decision|1|||
27956427|NCT00598702|54613211|FG005|Overall Study|Physician Decision|0|||
27956428|NCT00598702|54613212|FG006|Overall Study|Physician Decision|0|||
27956429|NCT00598702|54613213|FG007|Overall Study|Physician Decision|0|||
27956430|NCT00598702|54613206|FG000|Overall Study|Dose limiting toxicity|0|||
27956431|NCT00598702|54613207|FG001|Overall Study|Dose limiting toxicity|0|||
27956432|NCT00598702|54613208|FG002|Overall Study|Dose limiting toxicity|0|||
27956433|NCT00598702|54613209|FG003|Overall Study|Dose limiting toxicity|1|||
27956434|NCT00598702|54613210|FG004|Overall Study|Dose limiting toxicity|1|||
27956435|NCT00598702|54613211|FG005|Overall Study|Dose limiting toxicity|1|||
27956436|NCT00598702|54613212|FG006|Overall Study|Dose limiting toxicity|0|||
27956437|NCT00598702|54613213|FG007|Overall Study|Dose limiting toxicity|0|||
27956438|NCT01148810|54613233|FG000|Overall Study|Adverse Event|0|||
27956439|NCT01148810|54613234|FG001|Overall Study|Adverse Event|2|||
27956440|NCT01148810|54613233|FG000|Overall Study|Lack of Efficacy|0|||
27956441|NCT01148810|54613234|FG001|Overall Study|Lack of Efficacy|1|||
27956442|NCT01148810|54613233|FG000|Overall Study|Withdrawal by Subject|0|||
27956443|NCT01148810|54613234|FG001|Overall Study|Withdrawal by Subject|2|||
27956444|NCT01148810|54613233|FG000|Overall Study|Protocol Violation|1|||
27956445|NCT01148810|54613234|FG001|Overall Study|Protocol Violation|0|||
27956446|NCT01151618|54613241|FG000|Overall Study|Adverse Event|2|||
27956447|NCT01151618|54613241|FG000|Overall Study|Withdrawal by Subject|7|||
27956448|NCT01164956|54613245|FG000|Overall Study|Side Effects|1|||
27956449|NCT01164956|54613246|FG001|Overall Study|Side Effects|0|||
27956450|NCT01164956|54613247|FG002|Overall Study|Side Effects|1|||
27956451|NCT01164722|54613257|FG000|Overall Study|Adverse Event|0|||
27956452|NCT01164722|54613258|FG001|Overall Study|Adverse Event|1|||
27956453|NCT01164722|54613257|FG000|Overall Study|Withdrawal by Subject|3|||
27956454|NCT01164722|54613258|FG001|Overall Study|Withdrawal by Subject|4|||
27956455|NCT01164722|54613257|FG000|Overall Study|Lost to Follow-up|3|||
27956456|NCT01164722|54613258|FG001|Overall Study|Lost to Follow-up|6|||
27956457|NCT01164722|54613257|FG000|Overall Study|met protocol criteria for non-treatment|11|||
28081942|NCT00098475|54735418|FG003|Step 1|Off treatment for > specified timeframe|0|||
28081943|NCT00098475|54735415|FG000|Step 1|Declining performance status|0|||
28081944|NCT00098475|54735416|FG001|Step 1|Declining performance status|1|||
27956458|NCT01164722|54613258|FG001|Overall Study|met protocol criteria for non-treatment|1|||
27956459|NCT01164722|54613257|FG000|Overall Study|enrolled on other study, concomitant med|1|||
27956460|NCT01164722|54613258|FG001|Overall Study|enrolled on other study, concomitant med|3|||
27956461|NCT01151540|54613264|FG000|Overall Study|Other|2|||
27956462|NCT01151540|54613264|FG000|Overall Study|Adverse event, non-fatal|4|||
27956463|NCT01151540|54613264|FG000|Overall Study|Withdrawal by Subject|7|||
27956464|NCT01163786|54613268|FG000|Treatment With Bortezomib|Withdrawal by Subject|1|||
27956465|NCT01163786|54613268|FG000|Treatment With Bortezomib|Adverse Event|2|||
27956466|NCT01163786|54613268|FG000|Completed Follow up (Visit 9 and 10)|Other|1|||
27956467|NCT00984282|54613274|FG000|Double Blind Treatment|Adverse Event|40|||
27956468|NCT00984282|54613275|FG001|Double Blind Treatment|Adverse Event|6|||
27956469|NCT00984282|54613274|FG000|Double Blind Treatment|Progression, recurrence or relapse|25|||
27956470|NCT00984282|54613275|FG001|Double Blind Treatment|Progression, recurrence or relapse|3|||
27956471|NCT00984282|54613274|FG000|Double Blind Treatment|Physician Decision|1|||
27956472|NCT00984282|54613275|FG001|Double Blind Treatment|Physician Decision|2|||
27956473|NCT00984282|54613274|FG000|Double Blind Treatment|Noncompliance with study medication|3|||
28081945|NCT00098475|54735417|FG002|Step 1|Declining performance status|0|||
27956474|NCT00984282|54613275|FG001|Double Blind Treatment|Noncompliance with study medication|0|||
27956475|NCT00984282|54613274|FG000|Double Blind Treatment|Progression by clinical judgment|2|||
27956476|NCT00984282|54613275|FG001|Double Blind Treatment|Progression by clinical judgment|0|||
27956477|NCT00984282|54613274|FG000|Double Blind Treatment|Withdrawal by Subject|13|||
27956478|NCT00984282|54613275|FG001|Double Blind Treatment|Withdrawal by Subject|18|||
27956479|NCT00984282|54613274|FG000|Double Blind Treatment|Lost to Follow-up|3|||
27956480|NCT00984282|54613275|FG001|Double Blind Treatment|Lost to Follow-up|0|||
27956481|NCT00984282|54613274|FG000|Double Blind Treatment|Death|8|||
27956482|NCT00984282|54613275|FG001|Double Blind Treatment|Death|4|||
27956483|NCT00984282|54613274|FG000|Double Blind Treatment|Not treated|0|||
27956484|NCT00984282|54613275|FG001|Double Blind Treatment|Not treated|1|||
27956485|NCT00984282|54613274|FG000|Double Blind Treatment|Switched to commercial drug|6|||
27956486|NCT00984282|54613275|FG001|Double Blind Treatment|Switched to commercial drug|1|||
27956487|NCT00984282|54613274|FG000|Double Blind Treatment|protocol driven decision point|1|||
27956488|NCT00984282|54613275|FG001|Double Blind Treatment|protocol driven decision point|1|||
27956489|NCT00984282|54613274|FG000|Double Blind Treatment|Radiological and clinical progression|0|||
27956490|NCT00984282|54613275|FG001|Double Blind Treatment|Radiological and clinical progression|1|||
27956491|NCT00984282|54613274|FG000|Double Blind Treatment|Transferred to treat. continuation study|2|||
27956492|NCT00984282|54613275|FG001|Double Blind Treatment|Transferred to treat. continuation study|1|||
27956493|NCT00984282|54613274|FG000|Open-label Treatment|Adverse Event|20|||
27956494|NCT00984282|54613275|FG001|Open-label Treatment|Adverse Event|30|||
27956495|NCT00984282|54613274|FG000|Open-label Treatment|Withdrawal by Subject|6|||
27956496|NCT00984282|54613275|FG001|Open-label Treatment|Withdrawal by Subject|21|||
27956497|NCT00984282|54613274|FG000|Open-label Treatment|Death|7|||
27956498|NCT00984282|54613275|FG001|Open-label Treatment|Death|15|||
27956499|NCT00984282|54613274|FG000|Open-label Treatment|Progression, recurrence or relapse|40|||
27956500|NCT00984282|54613275|FG001|Open-label Treatment|Progression, recurrence or relapse|82|||
27956501|NCT00984282|54613274|FG000|Open-label Treatment|Lost to Follow-up|1|||
27956502|NCT00984282|54613275|FG001|Open-label Treatment|Lost to Follow-up|1|||
27956503|NCT00984282|54613274|FG000|Open-label Treatment|Patient convenience|1|||
27956504|NCT00984282|54613275|FG001|Open-label Treatment|Patient convenience|0|||
27956505|NCT00984282|54613274|FG000|Open-label Treatment|Non-compliant with study medication|1|||
27956506|NCT00984282|54613275|FG001|Open-label Treatment|Non-compliant with study medication|0|||
27956507|NCT00984282|54613274|FG000|Open-label Treatment|Target lesion removed|0|||
27956508|NCT00984282|54613275|FG001|Open-label Treatment|Target lesion removed|1|||
27956509|NCT00984282|54613274|FG000|Open-label Treatment|Protocol driven decision point|1|||
27956510|NCT00984282|54613275|FG001|Open-label Treatment|Protocol driven decision point|1|||
27956511|NCT00984282|54613274|FG000|Open-label Treatment|Transferred to treat. continuation study|2|||
27956512|NCT00984282|54613275|FG001|Open-label Treatment|Transferred to treat. continuation study|3|||
27956513|NCT00984282|54613274|FG000|Open-label Treatment|Switched to commercial drug|6|||
27956514|NCT00984282|54613275|FG001|Open-label Treatment|Switched to commercial drug|7|||
27956515|NCT00984282|54613274|FG000|Open-label Treatment|Physician Decision|1|||
27956516|NCT00984282|54613275|FG001|Open-label Treatment|Physician Decision|0|||
27956517|NCT00984282|54613274|FG000|Long Term Follow-up|Withdrawal by Subject|8|||
27956518|NCT00984282|54613275|FG001|Long Term Follow-up|Withdrawal by Subject|14|||
27956519|NCT00984282|54613274|FG000|Long Term Follow-up|Death|27|||
27956520|NCT00984282|54613275|FG001|Long Term Follow-up|Death|68|||
27956521|NCT00984282|54613274|FG000|Long Term Follow-up|Lost to Follow-up|3|||
27956522|NCT00984282|54613275|FG001|Long Term Follow-up|Lost to Follow-up|6|||
27956523|NCT00984282|54613274|FG000|Long Term Follow-up|Protocol driven decision point|25|||
27956524|NCT00984282|54613275|FG001|Long Term Follow-up|Protocol driven decision point|26|||
27956525|NCT00984282|54613274|FG000|Long Term Follow-up|Transferred to treat. continuation study|2|||
27956526|NCT00984282|54613275|FG001|Long Term Follow-up|Transferred to treat. continuation study|3|||
27956527|NCT00984282|54613274|FG000|Long Term Follow-up|Switched to commercial drug|4|||
27956528|NCT00984282|54613275|FG001|Long Term Follow-up|Switched to commercial drug|2|||
27956529|NCT00984282|54613274|FG000|Long Term Follow-up|Disease prog., recurrence or relapse|0|||
27956530|NCT00984282|54613275|FG001|Long Term Follow-up|Disease prog., recurrence or relapse|1|||
27956531|NCT01147874|54613283|FG000|Overall Study|Adverse Event|5|||
28081946|NCT00098475|54735418|FG003|Step 1|Declining performance status|0|||
27732097|NCT02706405|54179529|FG001|Overall Study|Death|2|||
27832345|NCT01767467|54311325|FG001|Vaccination Phase (up to Month 2)|Adverse Event|8|||
27956532|NCT01147874|54613283|FG000|Overall Study|Investigator's Request|1|||
27956533|NCT01147874|54613283|FG000|Overall Study|Lost to Follow-up|25|||
27956534|NCT01147874|54613283|FG000|Overall Study|Other|5|||
27732098|NCT02706405|54179530|FG002|Overall Study|Death|0|||
27956535|NCT01147874|54613283|FG000|Overall Study|Protocol Violation|5|||
27956536|NCT01147874|54613283|FG000|Overall Study|Sponsor's Decision|2|||
27956537|NCT01147874|54613283|FG000|Overall Study|Withdrawal by Subject|24|||
27956538|NCT01147640|54613289|FG000|Overall Study|Adverse Event|2|||
27956539|NCT01147640|54613290|FG001|Overall Study|Adverse Event|0|||
27956540|NCT01147640|54613289|FG000|Overall Study|Physician Decision|1|||
28081947|NCT00098475|54735415|FG000|Step 1|Insurance issue|0|||
27956541|NCT01147640|54613290|FG001|Overall Study|Physician Decision|0|||
27956542|NCT01147640|54613289|FG000|Overall Study|Withdrawal by Subject|1|||
27956543|NCT01147640|54613290|FG001|Overall Study|Withdrawal by Subject|0|||
27956544|NCT01147640|54613289|FG000|Overall Study|Lost to Follow-up|0|||
27956545|NCT01147640|54613290|FG001|Overall Study|Lost to Follow-up|1|||
27956546|NCT01147640|54613289|FG000|Overall Study|Didn't meet eligibility criteria|1|||
27956547|NCT01147640|54613290|FG001|Overall Study|Didn't meet eligibility criteria|0|||
27956548|NCT01121900|54613296|FG000|First Intervention Period|Adverse Event|1|||
27956549|NCT01121900|54613297|FG001|First Intervention Period|Adverse Event|1|||
27956550|NCT01121900|54613296|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
27956551|NCT01121900|54613297|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
27956552|NCT01121666|54613305|FG000|Overall Study|Protocol Violation|29|||
27956553|NCT01121666|54613306|FG001|Overall Study|Protocol Violation|10|||
27956554|NCT00984126|54613316|FG000|Overall Study|Protocol Violation|0|||
27956555|NCT00984126|54613317|FG001|Overall Study|Protocol Violation|0|||
27956556|NCT00984126|54613318|FG002|Overall Study|Protocol Violation|1|||
27956557|NCT00984126|54613319|FG003|Overall Study|Protocol Violation|2|||
27956558|NCT00984126|54613316|FG000|Overall Study|Adverse Event|0|||
27956559|NCT00984126|54613317|FG001|Overall Study|Adverse Event|0|||
27956560|NCT00984126|54613318|FG002|Overall Study|Adverse Event|0|||
27956561|NCT00984126|54613319|FG003|Overall Study|Adverse Event|2|||
27956562|NCT00984126|54613316|FG000|Overall Study|Choose to join Pathfinder trial™ + other|7|||
27956563|NCT00984126|54613317|FG001|Overall Study|Choose to join Pathfinder trial™ + other|7|||
27956564|NCT00984126|54613318|FG002|Overall Study|Choose to join Pathfinder trial™ + other|3|||
27956565|NCT00984126|54613319|FG003|Overall Study|Choose to join Pathfinder trial™ + other|46|||
27956566|NCT00984126|54613316|FG000|Overall Study|Withdrawal criteria|0|||
27956567|NCT00984126|54613317|FG001|Overall Study|Withdrawal criteria|1|||
27956568|NCT00984126|54613318|FG002|Overall Study|Withdrawal criteria|3|||
27956569|NCT00984126|54613319|FG003|Overall Study|Withdrawal criteria|9|||
27956570|NCT00979602|54613340|FG000|Overall Study|Serious Adverse Event|5|||
27956571|NCT00979602|54613341|FG001|Overall Study|Serious Adverse Event|3|||
27956572|NCT00979602|54613340|FG000|Overall Study|Protocol Violation|3|||
27956573|NCT00979602|54613341|FG001|Overall Study|Protocol Violation|0|||
27956574|NCT00979602|54613340|FG000|Overall Study|Withdrawal by Subject|31|||
27956575|NCT00979602|54613341|FG001|Overall Study|Withdrawal by Subject|25|||
27956576|NCT00979602|54613340|FG000|Overall Study|Lost to Follow-up|100|||
27956577|NCT00979602|54613341|FG001|Overall Study|Lost to Follow-up|96|||
27956578|NCT00979602|54613340|FG000|Overall Study|Migrated/moved from study area|3|||
27956579|NCT00979602|54613341|FG001|Overall Study|Migrated/moved from study area|6|||
27956580|NCT00979602|54613340|FG000|Overall Study|Others|3|||
27956581|NCT00979602|54613341|FG001|Overall Study|Others|3|||
27956582|NCT00816361|54613366|FG000|Overall Study|Withdrawal by Subject|0|||
27956583|NCT00816361|54613367|FG001|Overall Study|Withdrawal by Subject|0|||
27956584|NCT00816361|54613368|FG002|Overall Study|Withdrawal by Subject|0|||
27956585|NCT00816361|54613369|FG003|Overall Study|Withdrawal by Subject|0|||
27956586|NCT00816361|54613370|FG004|Overall Study|Withdrawal by Subject|1|||
27956587|NCT00816361|54613371|FG005|Overall Study|Withdrawal by Subject|2|||
27956588|NCT00816361|54613372|FG006|Overall Study|Withdrawal by Subject|0|||
27956589|NCT00816361|54613373|FG007|Overall Study|Withdrawal by Subject|2|||
27956590|NCT00816361|54613374|FG008|Overall Study|Withdrawal by Subject|1|||
27956591|NCT00816361|54613366|FG000|Overall Study|Death|4|||
27956592|NCT00816361|54613367|FG001|Overall Study|Death|3|||
27956593|NCT00816361|54613368|FG002|Overall Study|Death|3|||
27956594|NCT00816361|54613369|FG003|Overall Study|Death|3|||
27956595|NCT00816361|54613370|FG004|Overall Study|Death|1|||
27956596|NCT00816361|54613371|FG005|Overall Study|Death|1|||
27956597|NCT00816361|54613372|FG006|Overall Study|Death|3|||
27956598|NCT00816361|54613373|FG007|Overall Study|Death|7|||
27956599|NCT00816361|54613374|FG008|Overall Study|Death|8|||
28165082|NCT03016325|54835757|FG004|Treatment Period|Participant refuses assessments|0|||
28165083|NCT03016325|54835758|FG005|Treatment Period|Participant refuses assessments|0|||
27732099|NCT02706405|54179531|FG003|Overall Study|Death|1|||
27956600|NCT00816361|54613366|FG000|Overall Study|Other|0|||
28165084|NCT03016325|54835759|FG006|Treatment Period|Participant refuses assessments|0|||
27956601|NCT00816361|54613367|FG001|Overall Study|Other|0|||
27956602|NCT00816361|54613368|FG002|Overall Study|Other|0|||
27956603|NCT00816361|54613369|FG003|Overall Study|Other|0|||
27956604|NCT00816361|54613370|FG004|Overall Study|Other|0|||
27956605|NCT00816361|54613371|FG005|Overall Study|Other|0|||
27956606|NCT00816361|54613372|FG006|Overall Study|Other|0|||
27956607|NCT00816361|54613373|FG007|Overall Study|Other|0|||
27956608|NCT00816361|54613374|FG008|Overall Study|Other|1|||
27956609|NCT00826111|54613397|FG000|Overall Study|Lost to Follow-up|0|||
27956610|NCT00826111|54613398|FG001|Overall Study|Lost to Follow-up|1|||
27956611|NCT00826111|54613397|FG000|Overall Study|Protocol Violation|1|||
27956612|NCT00826111|54613398|FG001|Overall Study|Protocol Violation|0|||
27956613|NCT00826111|54613397|FG000|Overall Study|Withdrawal by Subject|5|||
27956614|NCT00826111|54613398|FG001|Overall Study|Withdrawal by Subject|0|||
27956615|NCT00826111|54613397|FG000|Overall Study|Physician Decision|1|||
27956616|NCT00826111|54613398|FG001|Overall Study|Physician Decision|1|||
27956617|NCT00982644|54613409|FG000|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20|||
27956618|NCT00982644|54613410|FG001|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5|||
27956619|NCT00982644|54613409|FG000|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7|||
27956620|NCT00982644|54613410|FG001|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2|||
27956621|NCT00982644|54613409|FG000|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46|||
27956622|NCT00982644|54613410|FG001|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18|||
27956623|NCT00982644|54613409|FG000|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9|||
27956624|NCT00982644|54613410|FG001|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5|||
27956625|NCT00982644|54613409|FG000|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84|||
27956626|NCT00982644|54613410|FG001|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30|||
27956627|NCT00982644|54613409|FG000|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12|||
27956628|NCT00982644|54613410|FG001|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5|||
27956629|NCT00982644|54613409|FG000|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3|||
27956630|NCT00982644|54613410|FG001|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1|||
27956631|NCT00982644|54613409|FG000|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2|||
27956632|NCT00982644|54613410|FG001|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4|||
27956633|NCT00982644|54613409|FG000|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6|||
27956634|NCT00982644|54613410|FG001|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3|||
27956635|NCT00982644|54613409|FG000|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23|||
27956636|NCT00982644|54613410|FG001|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7|||
27956637|NCT00815659|54613416|FG000|Overall Study|Adverse Event|9|||
27956638|NCT00815659|54613416|FG000|Overall Study|Withdrawal by Subject|9|||
27956639|NCT00815659|54613416|FG000|Overall Study|Lost to Follow-up|4|||
27956640|NCT00815659|54613416|FG000|Overall Study|Protocol Violation|1|||
27956641|NCT00825175|54613422|FG000|Overall Study|Withdrawal by Subject|0|||
27956642|NCT00825175|54613423|FG001|Overall Study|Withdrawal by Subject|5|||
27956643|NCT00824473|54613431|FG000|Overall Study|Adverse Event|4|||
27956644|NCT00824473|54613432|FG001|Overall Study|Adverse Event|5|||
27956645|NCT00824473|54613431|FG000|Overall Study|Lack of Efficacy|2|||
27956646|NCT00824473|54613432|FG001|Overall Study|Lack of Efficacy|2|||
27956647|NCT00824473|54613431|FG000|Overall Study|Protocol Violation|2|||
27956648|NCT00824473|54613432|FG001|Overall Study|Protocol Violation|0|||
27956649|NCT00824473|54613431|FG000|Overall Study|Non-Compliance|4|||
27956650|NCT00824473|54613432|FG001|Overall Study|Non-Compliance|2|||
27956651|NCT00824473|54613431|FG000|Overall Study|Withdrawal by Subject|2|||
27956652|NCT00824473|54613432|FG001|Overall Study|Withdrawal by Subject|3|||
27956653|NCT00824473|54613431|FG000|Overall Study|Other|1|||
27956654|NCT00824473|54613432|FG001|Overall Study|Other|1|||
27956655|NCT00815191|54613444|FG000|Overall Study|Protocol Violation|1|||
27956656|NCT00815191|54613445|FG001|Overall Study|Protocol Violation|1|||
27956657|NCT00812929|54613451|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
27956658|NCT00812929|54613452|FG001|Washout Period 1 (7 Days)|Physician Decision|0|||
27956659|NCT00812929|54613453|FG002|Washout Period 1 (7 Days)|Physician Decision|1|||
27956660|NCT00812929|54613454|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
27956661|NCT00812929|54613455|FG004|Washout Period 1 (7 Days)|Physician Decision|0|||
27956662|NCT00812929|54613456|FG005|Washout Period 1 (7 Days)|Physician Decision|0|||
27956663|NCT00812929|54613457|FG006|Washout Period 1 (7 Days)|Physician Decision|0|||
27956664|NCT00812929|54613458|FG007|Washout Period 1 (7 Days)|Physician Decision|0|||
27956665|NCT00812929|54613459|FG008|Washout Period 1 (7 Days)|Physician Decision|0|||
27956666|NCT00812929|54613460|FG009|Washout Period 1 (7 Days)|Physician Decision|0|||
27956667|NCT00812929|54613451|FG000|Washout Period 2 (7 Days)|Physician Decision|0|||
27956668|NCT00812929|54613452|FG001|Washout Period 2 (7 Days)|Physician Decision|0|||
27956669|NCT00812929|54613453|FG002|Washout Period 2 (7 Days)|Physician Decision|0|||
27956670|NCT00812929|54613454|FG003|Washout Period 2 (7 Days)|Physician Decision|0|||
27956671|NCT00812929|54613455|FG004|Washout Period 2 (7 Days)|Physician Decision|0|||
27956672|NCT00812929|54613456|FG005|Washout Period 2 (7 Days)|Physician Decision|0|||
27956673|NCT00812929|54613457|FG006|Washout Period 2 (7 Days)|Physician Decision|0|||
27956674|NCT00812929|54613458|FG007|Washout Period 2 (7 Days)|Physician Decision|0|||
28165085|NCT03016325|54835760|FG007|Treatment Period|Participant refuses assessments|0|||
28165086|NCT03016325|54835753|FG000|32-Day Follow-Up Period|Death|2|||
27832346|NCT01767467|54311324|FG000|Vaccination Phase (up to Month 2)|Protocol Violation|1|||
27956675|NCT00812929|54613459|FG008|Washout Period 2 (7 Days)|Physician Decision|0|||
27956676|NCT00812929|54613460|FG009|Washout Period 2 (7 Days)|Physician Decision|1|||
27956677|NCT00812929|54613451|FG000|Washout Period 3 (7 Days)|Adverse Event|0|||
27956678|NCT00812929|54613452|FG001|Washout Period 3 (7 Days)|Adverse Event|0|||
27956679|NCT00812929|54613453|FG002|Washout Period 3 (7 Days)|Adverse Event|0|||
27956680|NCT00812929|54613454|FG003|Washout Period 3 (7 Days)|Adverse Event|0|||
27956681|NCT00812929|54613455|FG004|Washout Period 3 (7 Days)|Adverse Event|0|||
27956682|NCT00812929|54613456|FG005|Washout Period 3 (7 Days)|Adverse Event|1|||
27956683|NCT00812929|54613457|FG006|Washout Period 3 (7 Days)|Adverse Event|0|||
27956684|NCT00812929|54613458|FG007|Washout Period 3 (7 Days)|Adverse Event|0|||
27956685|NCT00812929|54613459|FG008|Washout Period 3 (7 Days)|Adverse Event|0|||
27956686|NCT00812929|54613460|FG009|Washout Period 3 (7 Days)|Adverse Event|0|||
27956687|NCT00824161|54613477|FG000|Overall Study|Withdrawal by Subject|1|||
27956688|NCT00824161|54613477|FG000|Overall Study|Screen Failure|1|||
27956689|NCT00979134|54613486|FG000|Overall Study|Disease progression|18|||
27956690|NCT00979134|54613487|FG001|Overall Study|Disease progression|2|||
27956691|NCT00979134|54613488|FG002|Overall Study|Disease progression|5|||
27956692|NCT00979134|54613486|FG000|Overall Study|Adverse Event|0|||
27956693|NCT00979134|54613487|FG001|Overall Study|Adverse Event|0|||
27956694|NCT00979134|54613488|FG002|Overall Study|Adverse Event|2|||
27956695|NCT00979134|54613486|FG000|Overall Study|Withdrawal by Subject|1|||
27956696|NCT00979134|54613487|FG001|Overall Study|Withdrawal by Subject|1|||
27732100|NCT02706405|54179532|FG004|Overall Study|Death|0|||
27732101|NCT02706405|54179533|FG005|Overall Study|Death|0|||
27732102|NCT02706405|54179534|FG006|Overall Study|Death|3|||
27732103|NCT02706405|54179535|FG007|Overall Study|Death|4|||
27732104|NCT02706405|54179528|FG000|Overall Study|Disease progression|0|||
27732105|NCT02706405|54179529|FG001|Overall Study|Disease progression|0|||
27732106|NCT02706405|54179530|FG002|Overall Study|Disease progression|0|||
27732107|NCT02706405|54179531|FG003|Overall Study|Disease progression|0|||
27732108|NCT02706405|54179532|FG004|Overall Study|Disease progression|0|||
27732109|NCT02706405|54179533|FG005|Overall Study|Disease progression|0|||
27732110|NCT02706405|54179534|FG006|Overall Study|Disease progression|0|||
27732111|NCT02706405|54179535|FG007|Overall Study|Disease progression|1|||
27732112|NCT02706405|54179528|FG000|Overall Study|Pt moved to new therapy|0|||
27732113|NCT02706405|54179529|FG001|Overall Study|Pt moved to new therapy|0|||
27732114|NCT02706405|54179530|FG002|Overall Study|Pt moved to new therapy|0|||
27732115|NCT02706405|54179531|FG003|Overall Study|Pt moved to new therapy|0|||
27732116|NCT02706405|54179532|FG004|Overall Study|Pt moved to new therapy|0|||
27732117|NCT02706405|54179533|FG005|Overall Study|Pt moved to new therapy|1|||
27732118|NCT02706405|54179534|FG006|Overall Study|Pt moved to new therapy|0|||
27732119|NCT02706405|54179535|FG007|Overall Study|Pt moved to new therapy|1|||
27732120|NCT02706405|54179528|FG000|Overall Study|Physician Decision|1|||
27732121|NCT02706405|54179529|FG001|Overall Study|Physician Decision|0|||
27732122|NCT02706405|54179530|FG002|Overall Study|Physician Decision|0|||
27732123|NCT02706405|54179531|FG003|Overall Study|Physician Decision|0|||
27732124|NCT02706405|54179532|FG004|Overall Study|Physician Decision|0|||
27732125|NCT02706405|54179533|FG005|Overall Study|Physician Decision|0|||
27732126|NCT02706405|54179534|FG006|Overall Study|Physician Decision|0|||
27732127|NCT02706405|54179535|FG007|Overall Study|Physician Decision|0|||
27732128|NCT02761993|54179564|FG000|Overall Study|Adverse Event|0|||
27732129|NCT02761993|54179565|FG001|Overall Study|Adverse Event|2|||
27732130|NCT02761993|54179566|FG002|Overall Study|Adverse Event|0|||
27732131|NCT02761993|54179564|FG000|Overall Study|Lost to Follow-up|1|||
27732132|NCT02761993|54179565|FG001|Overall Study|Lost to Follow-up|3|||
27732133|NCT02761993|54179566|FG002|Overall Study|Lost to Follow-up|2|||
27732134|NCT02761993|54179564|FG000|Overall Study|Withdrawal by Subject|1|||
27732135|NCT02761993|54179565|FG001|Overall Study|Withdrawal by Subject|1|||
27732136|NCT02761993|54179566|FG002|Overall Study|Withdrawal by Subject|2|||
27732137|NCT02766283|54179574|FG000|Overall Study|Lost to Follow-up|27|||
27732138|NCT02761915|54179597|FG000|Overall Study|Death|3|||
27732139|NCT02761915|54179598|FG001|Overall Study|Death|1|||
27732140|NCT02761915|54179599|FG002|Overall Study|Death|1|||
27732141|NCT02761915|54179600|FG003|Overall Study|Death|1|||
27732142|NCT02761915|54179601|FG004|Overall Study|Death|0|||
27732143|NCT02761915|54179602|FG005|Overall Study|Death|1|||
27732144|NCT02761915|54179597|FG000|Overall Study|Withdrawal by Subject|1|||
27732145|NCT02761915|54179598|FG001|Overall Study|Withdrawal by Subject|0|||
27732146|NCT02761915|54179599|FG002|Overall Study|Withdrawal by Subject|0|||
27732147|NCT02761915|54179600|FG003|Overall Study|Withdrawal by Subject|0|||
27732148|NCT02761915|54179601|FG004|Overall Study|Withdrawal by Subject|1|||
27732149|NCT02761915|54179602|FG005|Overall Study|Withdrawal by Subject|2|||
27732150|NCT02761915|54179597|FG000|Overall Study|Disease Progression|0|||
27732151|NCT02761915|54179598|FG001|Overall Study|Disease Progression|0|||
27732152|NCT02761915|54179599|FG002|Overall Study|Disease Progression|0|||
27956697|NCT00979134|54613488|FG002|Overall Study|Withdrawal by Subject|2|||
27732153|NCT02761915|54179600|FG003|Overall Study|Disease Progression|2|||
27732154|NCT02761915|54179601|FG004|Overall Study|Disease Progression|2|||
27732155|NCT02761915|54179602|FG005|Overall Study|Disease Progression|2|||
27732156|NCT02706327|54179623|FG000|Overall Study|Lost to Follow-up|1|||
27956698|NCT00979134|54613486|FG000|Overall Study|Lost to Follow-up|2|||
27732157|NCT02706327|54179624|FG001|Overall Study|Lost to Follow-up|1|||
27732158|NCT02706327|54179625|FG002|Overall Study|Lost to Follow-up|2|||
27732159|NCT02764333|54179633|FG000|Overall Study|Ineligible|1|||
27732160|NCT02705625|54179640|FG000|Overall Study|Protocol Violation|1|||
27732161|NCT02705625|54179641|FG001|Overall Study|Protocol Violation|0|||
27732162|NCT02705625|54179642|FG002|Overall Study|Protocol Violation|0|||
27732163|NCT02705625|54179640|FG000|Overall Study|Adverse Event|6|||
27956699|NCT00979134|54613487|FG001|Overall Study|Lost to Follow-up|2|||
27956700|NCT00979134|54613488|FG002|Overall Study|Lost to Follow-up|0|||
27956701|NCT00979134|54613486|FG000|Overall Study|Death|4|||
27956702|NCT00979134|54613487|FG001|Overall Study|Death|0|||
27956703|NCT00979134|54613488|FG002|Overall Study|Death|26|||
27956704|NCT00979134|54613486|FG000|Overall Study|Other|8|||
27956705|NCT00979134|54613487|FG001|Overall Study|Other|1|||
27956706|NCT00979134|54613488|FG002|Overall Study|Other|5|||
27956707|NCT00824005|54613503|FG000|Overall Study|Death|0|||
27956708|NCT00824005|54613504|FG001|Overall Study|Death|1|||
27956709|NCT00824005|54613503|FG000|Overall Study|Lost to Follow-up|0|||
27956710|NCT00824005|54613504|FG001|Overall Study|Lost to Follow-up|1|||
27956711|NCT00814879|54613512|FG000|By Week 24|Cancer Diagnosis|1|||
27956712|NCT00814879|54613513|FG001|By Week 24|Cancer Diagnosis|0|||
27956713|NCT00814879|54613512|FG000|By Week 24|Incarceration|0|||
27956714|NCT00814879|54613513|FG001|By Week 24|Incarceration|1|||
27956715|NCT00814879|54613512|FG000|By Week 48|Lost to Follow-up|2|||
27956716|NCT00814879|54613513|FG001|By Week 48|Lost to Follow-up|2|||
27956717|NCT00814879|54613512|FG000|By Week 48|Death|0|||
27956718|NCT00814879|54613513|FG001|By Week 48|Death|1|||
27956719|NCT03347422|54613522|FG000|Part A (26 Weeks)|Adverse Event|3|||
27956720|NCT03347422|54613523|FG001|Part A (26 Weeks)|Adverse Event|0|||
27956721|NCT03347422|54613522|FG000|Part B (149 Weeks)|Lack of Efficacy|1|||
27956722|NCT03347422|54613523|FG001|Part B (149 Weeks)|Lack of Efficacy|2|||
27956723|NCT03347422|54613522|FG000|Part B (149 Weeks)|Adverse Event|0|||
27956724|NCT03347422|54613523|FG001|Part B (149 Weeks)|Adverse Event|1|||
27956725|NCT03347422|54613522|FG000|Part B (149 Weeks)|Withdrawal by Subject|1|||
27956726|NCT03347422|54613523|FG001|Part B (149 Weeks)|Withdrawal by Subject|1|||
27956727|NCT03347422|54613522|FG000|Part B (149 Weeks)|Other|1|||
27956728|NCT03347422|54613523|FG001|Part B (149 Weeks)|Other|0|||
27956729|NCT00814801|54613539|FG000|Overall Study|Adverse Event|15|||
27956730|NCT00814801|54613540|FG001|Overall Study|Adverse Event|16|||
27956731|NCT00814801|54613541|FG002|Overall Study|Adverse Event|19|||
27956732|NCT00814801|54613539|FG000|Overall Study|Withdrawal by Subject|9|||
27956733|NCT00814801|54613540|FG001|Overall Study|Withdrawal by Subject|11|||
27956734|NCT00814801|54613541|FG002|Overall Study|Withdrawal by Subject|14|||
27956735|NCT00814801|54613539|FG000|Overall Study|Inappropriate as a subject|1|||
27956736|NCT00814801|54613540|FG001|Overall Study|Inappropriate as a subject|1|||
27956737|NCT00814801|54613541|FG002|Overall Study|Inappropriate as a subject|1|||
27956738|NCT00814801|54613539|FG000|Overall Study|Change of patients for CIBIC plus-J|1|||
27956739|NCT00814801|54613540|FG001|Overall Study|Change of patients for CIBIC plus-J|1|||
27956740|NCT00814801|54613541|FG002|Overall Study|Change of patients for CIBIC plus-J|0|||
27956741|NCT00814801|54613539|FG000|Overall Study|Missing or change of caregiver|6|||
27956742|NCT00814801|54613540|FG001|Overall Study|Missing or change of caregiver|2|||
27956743|NCT00814801|54613541|FG002|Overall Study|Missing or change of caregiver|4|||
27956744|NCT00814801|54613539|FG000|Overall Study|Non-compliance|0|||
27956745|NCT00814801|54613540|FG001|Overall Study|Non-compliance|1|||
27956746|NCT00814801|54613541|FG002|Overall Study|Non-compliance|1|||
27956747|NCT00814801|54613539|FG000|Overall Study|Other|2|||
27956748|NCT00814801|54613540|FG001|Overall Study|Other|6|||
27956749|NCT00814801|54613541|FG002|Overall Study|Other|4|||
27956750|NCT00823615|54613549|FG000|Period 2|Lost to Follow-up|2|||
27956751|NCT00823615|54613550|FG001|Period 2|Lost to Follow-up|0|||
27956752|NCT00823615|54613549|FG000|Period 2|Time/Job Conflict|1|||
27956753|NCT00823615|54613550|FG001|Period 2|Time/Job Conflict|2|||
27956754|NCT00812461|54613558|FG000|All Randomised Patients|Did not receive placebo/nalmefene|23|||
27956755|NCT00812461|54613559|FG001|All Randomised Patients|Did not receive placebo/nalmefene|17|||
27956756|NCT00812461|54613558|FG000|All Treated Patients|Adverse Event|8|||
27956757|NCT00812461|54613559|FG001|All Treated Patients|Adverse Event|15|||
27956758|NCT00812461|54613558|FG000|All Treated Patients|Lack of Efficacy|13|||
27956759|NCT00812461|54613559|FG001|All Treated Patients|Lack of Efficacy|7|||
27956760|NCT00812461|54613558|FG000|All Treated Patients|Non-compliance|6|||
27956761|NCT00812461|54613559|FG001|All Treated Patients|Non-compliance|9|||
27956762|NCT00812461|54613558|FG000|All Treated Patients|Protocol Violation|36|||
28165087|NCT03016325|54835754|FG001|32-Day Follow-Up Period|Death|0|||
27956763|NCT00812461|54613559|FG001|All Treated Patients|Protocol Violation|27|||
27956764|NCT00812461|54613558|FG000|All Treated Patients|Withdrawal by Subject|45|||
27956765|NCT00812461|54613559|FG001|All Treated Patients|Withdrawal by Subject|54|||
27956766|NCT00812461|54613558|FG000|All Treated Patients|Lost to Follow-up|11|||
27956767|NCT00812461|54613559|FG001|All Treated Patients|Lost to Follow-up|14|||
27956768|NCT00812461|54613558|FG000|All Treated Patients|Other Reason|13|||
27956769|NCT00812461|54613559|FG001|All Treated Patients|Other Reason|21|||
27956770|NCT00599326|54613565|FG000|Overall Study|Lost to Follow-up|1|||
27956771|NCT00599326|54613565|FG000|Overall Study|Noncompliant|1|||
27956772|NCT00978432|54613572|FG000|Overall Study|Withdrawal by Subject|0|||
27956773|NCT00978432|54613573|FG001|Overall Study|Withdrawal by Subject|0|||
27956774|NCT00978432|54613574|FG002|Overall Study|Withdrawal by Subject|1|||
27956775|NCT00978432|54613572|FG000|Overall Study|Lack of Efficacy|1|||
27956776|NCT00978432|54613573|FG001|Overall Study|Lack of Efficacy|1|||
27956777|NCT00978432|54613574|FG002|Overall Study|Lack of Efficacy|3|||
27956778|NCT00978432|54613572|FG000|Overall Study|Adverse Event|2|||
27956779|NCT00978432|54613573|FG001|Overall Study|Adverse Event|0|||
27956780|NCT00978432|54613574|FG002|Overall Study|Adverse Event|1|||
27956781|NCT00975780|54613584|FG000|Follow Up|Death|88|||
27956782|NCT00975780|54613585|FG001|Follow Up|Death|122|||
27956783|NCT00975780|54613584|FG000|Follow Up|Facility Withdrawal|7|||
27956784|NCT00975780|54613585|FG001|Follow Up|Facility Withdrawal|23|||
27956785|NCT00975780|54613584|FG000|Follow Up|Discharged from Facility|7|||
27956786|NCT00975780|54613585|FG001|Follow Up|Discharged from Facility|12|||
27956787|NCT00814489|54613594|FG000|Overall Study|Other|2|||
27956788|NCT00814489|54613595|FG001|Overall Study|Other|0|||
27956789|NCT00814489|54613596|FG002|Overall Study|Other|1|||
27956790|NCT00814333|54613608|FG000|Enrollment|Lost to Follow-up|1|||
27956791|NCT00814333|54613609|FG001|Enrollment|Lost to Follow-up|0|||
27956792|NCT01147250|54613617|FG000|Overall Study|Lost to Follow-up|14|||
27956793|NCT01147250|54613618|FG001|Overall Study|Lost to Follow-up|11|||
27956794|NCT01147250|54613617|FG000|Overall Study|Withdrawal by Subject|83|||
27956795|NCT01147250|54613618|FG001|Overall Study|Withdrawal by Subject|88|||
27956796|NCT01147250|54613617|FG000|Overall Study|Site termination by sponsor|13|||
27956797|NCT01147250|54613618|FG001|Overall Study|Site termination by sponsor|5|||
27956798|NCT01147250|54613617|FG000|Overall Study|Other than specified|0|||
27956799|NCT01147250|54613618|FG001|Overall Study|Other than specified|1|||
27956800|NCT00813943|54613627|FG000|Overall Study|Ongoing at cut-off date|5|||
27956801|NCT00813943|54613628|FG001|Overall Study|Ongoing at cut-off date|5|||
27956802|NCT00813943|54613629|FG002|Overall Study|Ongoing at cut-off date|3|||
27956803|NCT00821509|54613641|FG000|Overall Study|Withdrawal by Subject|12|||
27956804|NCT00821509|54613642|FG001|Overall Study|Withdrawal by Subject|11|||
27956805|NCT00821509|54613643|FG002|Overall Study|Withdrawal by Subject|34|||
27956806|NCT00821431|54613653|FG000|Overall Study|Adverse Event|6|||
27956807|NCT00821431|54613654|FG001|Overall Study|Adverse Event|3|||
27956808|NCT00821431|54613653|FG000|Overall Study|Withdrawal by Subject|5|||
27956809|NCT00821431|54613654|FG001|Overall Study|Withdrawal by Subject|0|||
27956810|NCT00821431|54613653|FG000|Overall Study|Lost to Follow-up|1|||
27956811|NCT00821431|54613654|FG001|Overall Study|Lost to Follow-up|0|||
27956812|NCT00821431|54613653|FG000|Overall Study|Protocol Violation|3|||
27956813|NCT00821431|54613654|FG001|Overall Study|Protocol Violation|1|||
27956814|NCT00821431|54613653|FG000|Overall Study|Physician Decision|0|||
27956815|NCT00821431|54613654|FG001|Overall Study|Physician Decision|1|||
27956816|NCT01134614|54613662|FG000|Overall Study|Still on treatment as of March 2013|21|||
27956817|NCT01134614|54613663|FG001|Overall Study|Still on treatment as of March 2013|13|||
27956818|NCT01134614|54613662|FG000|Overall Study|Progressive disease|60|||
27956819|NCT01134614|54613663|FG001|Overall Study|Progressive disease|54|||
27956820|NCT01134614|54613662|FG000|Overall Study|Adverse Event|26|||
27956821|NCT01134614|54613663|FG001|Overall Study|Adverse Event|39|||
27956822|NCT01134614|54613662|FG000|Overall Study|Death|5|||
27956823|NCT01134614|54613663|FG001|Overall Study|Death|8|||
27956824|NCT01134614|54613662|FG000|Overall Study|Withdrawal by Subject|3|||
27956825|NCT01134614|54613663|FG001|Overall Study|Withdrawal by Subject|2|||
27956826|NCT01134614|54613662|FG000|Overall Study|Alternative therapy|2|||
27956827|NCT01134614|54613663|FG001|Overall Study|Alternative therapy|0|||
27956828|NCT01134614|54613662|FG000|Overall Study|Complicating disease|2|||
27956829|NCT01134614|54613663|FG001|Overall Study|Complicating disease|1|||
27956830|NCT01134614|54613662|FG000|Overall Study|Physician's decision|0|||
27956831|NCT01134614|54613663|FG001|Overall Study|Physician's decision|1|||
27956832|NCT01134614|54613662|FG000|Overall Study|Never started treatment|4|||
27956833|NCT01134614|54613663|FG001|Overall Study|Never started treatment|1|||
27956834|NCT01134614|54613662|FG000|Overall Study|Pt received tx not allowed on study|0|||
27956835|NCT01134614|54613663|FG001|Overall Study|Pt received tx not allowed on study|1|||
27956836|NCT01134614|54613662|FG000|Overall Study|Symptomatic deterioration|0|||
27956837|NCT01134614|54613663|FG001|Overall Study|Symptomatic deterioration|1|||
27956838|NCT01134614|54613662|FG000|Overall Study|Patient in hospice care|0|||
27956839|NCT01134614|54613663|FG001|Overall Study|Patient in hospice care|1|||
27956840|NCT03982368|54613672|FG000|Overall Study|Adverse Event|6|||
27956841|NCT03982368|54613673|FG001|Overall Study|Adverse Event|4|||
27956842|NCT03982368|54613674|FG002|Overall Study|Adverse Event|3|||
27956843|NCT03982368|54613672|FG000|Overall Study|Lost to Follow-up|2|||
27956844|NCT03982368|54613673|FG001|Overall Study|Lost to Follow-up|1|||
27956845|NCT03982368|54613674|FG002|Overall Study|Lost to Follow-up|0|||
27956846|NCT03982368|54613672|FG000|Overall Study|Withdrawal by Subject|1|||
27956847|NCT03982368|54613673|FG001|Overall Study|Withdrawal by Subject|2|||
27956848|NCT03982368|54613674|FG002|Overall Study|Withdrawal by Subject|0|||
27956849|NCT03982368|54613672|FG000|Overall Study|unknow|4|||
27956850|NCT03982368|54613673|FG001|Overall Study|unknow|0|||
27732164|NCT02705625|54179641|FG001|Overall Study|Adverse Event|5|||
27732165|NCT02705625|54179642|FG002|Overall Study|Adverse Event|2|||
27956851|NCT03982368|54613674|FG002|Overall Study|unknow|2|||
27956852|NCT00813865|54613685|FG000|Overall Study|Failure to Respond|3|||
27956853|NCT00813865|54613685|FG000|Overall Study|Lost to Follow-up|3|||
27956854|NCT00813865|54613685|FG000|Overall Study|Withdrawal by Subject|1|||
27956855|NCT01147172|54613689|FG000|Overall Study|Withdrawal by Subject|2|||
27956856|NCT01147172|54613689|FG000|Overall Study|Lost to Follow-up|2|||
27956857|NCT01120964|54613697|FG000|Overall Study|Did not receive full treatment|1|||
27956858|NCT01120964|54613698|FG001|Overall Study|Did not receive full treatment|0|||
27956859|NCT01146860|54613706|FG000|Overall Study|Withdrawal by Subject|0|||
27956860|NCT01146860|54613707|FG001|Overall Study|Withdrawal by Subject|1|||
27956861|NCT00591565|54613713|FG000|Overall Study|lost follow up, withdrawn|5|||
27956862|NCT01146782|54613717|FG000|Screening Cohort|Screen Failure|187|||
27956863|NCT01146782|54613717|FG000|Screening Cohort|Lost to Follow-up|4|||
27956864|NCT01146782|54613717|FG000|Screening Cohort|Physician Decision|1|||
27956865|NCT01146782|54613717|FG000|Screening Cohort|Withdrawal by Subject|29|||
27956866|NCT01146782|54613717|FG000|Safety Cohort|Screen Failure|61|||
27956867|NCT01146782|54613717|FG000|Safety Cohort|Withdrawal by Subject|4|||
27956868|NCT01146782|54613717|FG000|Safety Cohort|Control AHI <5|4|||
27956869|NCT01146782|54613717|FG000|Safety Cohort|TST <4 hrs|14|||
27956870|NCT01146782|54613717|FG000|Primary Endpoint Cohort|Withdrawal by Subject|5|||
27956871|NCT01146782|54613717|FG000|Primary Endpoint Cohort|Physician Decision|1|||
27956872|NCT00978120|54613726|FG000|Overall Study|Death|0|||
27956873|NCT00978120|54613727|FG001|Overall Study|Death|0|||
27956874|NCT00978120|54613728|FG002|Overall Study|Death|0|||
27956875|NCT00978120|54613729|FG003|Overall Study|Death|1|||
27956876|NCT00978120|54613726|FG000|Overall Study|Lost to Follow-up|0|||
27956877|NCT00978120|54613727|FG001|Overall Study|Lost to Follow-up|0|||
27956878|NCT00978120|54613728|FG002|Overall Study|Lost to Follow-up|3|||
27956879|NCT00978120|54613729|FG003|Overall Study|Lost to Follow-up|0|||
27956880|NCT00978120|54613726|FG000|Overall Study|Withdrawal by Subject|2|||
27956881|NCT00978120|54613727|FG001|Overall Study|Withdrawal by Subject|0|||
27956882|NCT00978120|54613728|FG002|Overall Study|Withdrawal by Subject|0|||
27956883|NCT00978120|54613729|FG003|Overall Study|Withdrawal by Subject|0|||
27956884|NCT00978120|54613726|FG000|Overall Study|Moved out of state|0|||
27956885|NCT00978120|54613727|FG001|Overall Study|Moved out of state|0|||
27956886|NCT00978120|54613728|FG002|Overall Study|Moved out of state|0|||
27956887|NCT00978120|54613729|FG003|Overall Study|Moved out of state|1|||
27956888|NCT00978042|54613745|FG000|Initial Treatment Period|Treated in Error|0|||
27956889|NCT00978042|54613746|FG001|Initial Treatment Period|Treated in Error|3|||
27956890|NCT00978042|54613745|FG000|Initial Treatment Period|Ineligibility|1|||
27956891|NCT00978042|54613746|FG001|Initial Treatment Period|Ineligibility|0|||
27956892|NCT00978042|54613745|FG000|Initial Treatment Period|Lost to Follow-up|21|||
27956893|NCT00978042|54613746|FG001|Initial Treatment Period|Lost to Follow-up|3|||
27956894|NCT00978042|54613745|FG000|Initial Treatment Period|Adverse Event|2|||
27956895|NCT00978042|54613746|FG001|Initial Treatment Period|Adverse Event|0|||
27956896|NCT00978042|54613745|FG000|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2|||
27956897|NCT00978042|54613746|FG001|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0|||
27956898|NCT00978042|54613745|FG000|Initial Treatment Period|Consent withdrawn|22|||
27956899|NCT00978042|54613746|FG001|Initial Treatment Period|Consent withdrawn|9|||
27956900|NCT00978042|54613745|FG000|Initial Treatment Period|Other Miscellaneous Reasons|13|||
27956901|NCT00978042|54613746|FG001|Initial Treatment Period|Other Miscellaneous Reasons|0|||
27956902|NCT01133678|54613754|FG000|Overall Study|Death|1|||
27956903|NCT01133678|54613755|FG001|Overall Study|Death|1|||
27956904|NCT01133522|54613771|FG000|Overall Study|Withdrawal by Subject|0|||
27956905|NCT01133522|54613772|FG001|Overall Study|Withdrawal by Subject|1|||
27956906|NCT01133522|54613773|FG002|Overall Study|Withdrawal by Subject|0|||
27956907|NCT01133522|54613774|FG003|Overall Study|Withdrawal by Subject|1|||
27956908|NCT01133522|54613775|FG004|Overall Study|Withdrawal by Subject|0|||
27956909|NCT01133522|54613776|FG005|Overall Study|Withdrawal by Subject|0|||
27956910|NCT01133522|54613777|FG006|Overall Study|Withdrawal by Subject|0|||
27956911|NCT01133522|54613778|FG007|Overall Study|Withdrawal by Subject|0|||
27956912|NCT01133522|54613779|FG008|Overall Study|Withdrawal by Subject|0|||
27956913|NCT01133522|54613780|FG009|Overall Study|Withdrawal by Subject|0|||
27956914|NCT01133522|54613771|FG000|Overall Study|Physician Decision|0|||
27956915|NCT01133522|54613772|FG001|Overall Study|Physician Decision|0|||
27956916|NCT01133522|54613773|FG002|Overall Study|Physician Decision|0|||
27956917|NCT01133522|54613774|FG003|Overall Study|Physician Decision|0|||
27956918|NCT01133522|54613775|FG004|Overall Study|Physician Decision|1|||
27956919|NCT01133522|54613776|FG005|Overall Study|Physician Decision|0|||
27956920|NCT01133522|54613777|FG006|Overall Study|Physician Decision|0|||
27956921|NCT01133522|54613778|FG007|Overall Study|Physician Decision|0|||
27956922|NCT01133522|54613779|FG008|Overall Study|Physician Decision|0|||
27956923|NCT01133522|54613780|FG009|Overall Study|Physician Decision|0|||
27832347|NCT01767467|54311325|FG001|Vaccination Phase (up to Month 2)|Protocol Violation|0|||
27832348|NCT01767467|54311324|FG000|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7|||
27956924|NCT01133288|54613809|FG000|Eligibility Assessment|met exclusion criteria|5|||
27956925|NCT01133288|54613809|FG000|Intervention Allocation|study terminated|2|||
27956926|NCT00883090|54613817|FG000|Overall Study|Sponsor's decision|1|||
27956927|NCT00883090|54613817|FG000|Overall Study|Withdrawal by Subject|1|||
27956928|NCT01132820|54613821|FG000|Overall Study|Ineligible: wrong cell type|1|||
27956929|NCT01132820|54613821|FG000|Overall Study|Ineligible:Improper pre-protocol therapy|1|||
27956930|NCT01132820|54613821|FG000|Overall Study|Ineligible:Inadequate pathology|1|||
27956931|NCT01132820|54613821|FG000|Overall Study|Never treated|1|||
27956932|NCT01132820|54613821|FG000|Overall Study|Inadequate data|1|||
27956933|NCT00885352|54613840|FG000|Overall Study|Adverse Event|2|||
27956934|NCT00885352|54613841|FG001|Overall Study|Adverse Event|3|||
27956935|NCT00885352|54613840|FG000|Overall Study|Lost to Follow-up|2|||
27956936|NCT00885352|54613841|FG001|Overall Study|Lost to Follow-up|2|||
27956937|NCT00885352|54613840|FG000|Overall Study|Physician Decision|0|||
27956938|NCT00885352|54613841|FG001|Overall Study|Physician Decision|3|||
27956939|NCT00885352|54613840|FG000|Overall Study|Protocol Violation|0|||
27956940|NCT00885352|54613841|FG001|Overall Study|Protocol Violation|2|||
27956941|NCT00885352|54613840|FG000|Overall Study|Withdrawal by Subject|1|||
27956942|NCT00885352|54613841|FG001|Overall Study|Withdrawal by Subject|5|||
27956943|NCT00885352|54613840|FG000|Overall Study|Contradiction to study medication|0|||
27956944|NCT00885352|54613841|FG001|Overall Study|Contradiction to study medication|2|||
27956945|NCT00885352|54613840|FG000|Overall Study|Excluded medication|2|||
27956946|NCT00885352|54613841|FG001|Overall Study|Excluded medication|2|||
27956947|NCT00885352|54613840|FG000|Overall Study|Lab abnormalities|1|||
27956948|NCT00885352|54613841|FG001|Overall Study|Lab abnormalities|1|||
27956949|NCT00885118|54613852|FG000|Overall Study|Adverse Event|1|||
27956950|NCT00885118|54613853|FG001|Overall Study|Adverse Event|0|||
27956951|NCT00885118|54613854|FG002|Overall Study|Adverse Event|0|||
27956952|NCT00885118|54613855|FG003|Overall Study|Adverse Event|0|||
27956953|NCT00885118|54613856|FG004|Overall Study|Adverse Event|0|||
27956954|NCT00885118|54613852|FG000|Overall Study|Withdrawal by Subject|0|||
27956955|NCT00885118|54613853|FG001|Overall Study|Withdrawal by Subject|0|||
27956956|NCT00885118|54613854|FG002|Overall Study|Withdrawal by Subject|0|||
27956957|NCT00885118|54613855|FG003|Overall Study|Withdrawal by Subject|0|||
27956958|NCT00885118|54613856|FG004|Overall Study|Withdrawal by Subject|1|||
27956959|NCT00885118|54613852|FG000|Overall Study|Other reason not defined above|0|||
27956960|NCT00885118|54613853|FG001|Overall Study|Other reason not defined above|0|||
27956961|NCT00885118|54613854|FG002|Overall Study|Other reason not defined above|1|||
27956962|NCT00885118|54613855|FG003|Overall Study|Other reason not defined above|0|||
27956963|NCT00885118|54613856|FG004|Overall Study|Other reason not defined above|0|||
27956964|NCT00880906|54613874|FG000|Overall Study|Lost to Follow-up|0|||
27956965|NCT00880906|54613875|FG001|Overall Study|Lost to Follow-up|1|||
27956966|NCT00880906|54613874|FG000|Overall Study|Did not meet criteria following patholog|12|||
27956967|NCT00880906|54613875|FG001|Overall Study|Did not meet criteria following patholog|6|||
27956968|NCT00882310|54613881|FG000|Overall Study|Screen Failure|10|||
27956969|NCT00882310|54613881|FG000|Overall Study|Never received treatment|1|||
27956970|NCT00882310|54613881|FG000|Overall Study|Death|6|||
27956971|NCT00882310|54613881|FG000|Overall Study|Progression of disease|4|||
27956972|NCT00882310|54613881|FG000|Overall Study|Adverse Event|1|||
27956973|NCT00884650|54613887|FG000|Overall Study|Did not return complete pain diaries|7|||
28081948|NCT00098475|54735416|FG001|Step 1|Insurance issue|1|||
27832349|NCT01767467|54311325|FG001|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10|||
27832350|NCT01767467|54311324|FG000|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0|||
27832351|NCT01767467|54311325|FG001|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1|||
27832352|NCT01767467|54311324|FG000|Vaccination Phase (up to Month 2)|Physician Decision|1|||
27832353|NCT01767467|54311325|FG001|Vaccination Phase (up to Month 2)|Physician Decision|0|||
27832354|NCT01767467|54311324|FG000|Vaccination Phase (up to Month 2)|Subject unavailable|0|||
27832355|NCT01767467|54311325|FG001|Vaccination Phase (up to Month 2)|Subject unavailable|1|||
27832356|NCT01767467|54311324|FG000|End of Study Phase (up to Month 13)|Adverse Event|29|||
27832357|NCT01767467|54311325|FG001|End of Study Phase (up to Month 13)|Adverse Event|39|||
27832358|NCT01767467|54311324|FG000|End of Study Phase (up to Month 13)|Protocol Violation|2|||
27832359|NCT01767467|54311325|FG001|End of Study Phase (up to Month 13)|Protocol Violation|0|||
27832360|NCT01767467|54311324|FG000|End of Study Phase (up to Month 13)|Withdrawal by Subject|9|||
27832361|NCT01767467|54311325|FG001|End of Study Phase (up to Month 13)|Withdrawal by Subject|14|||
27832362|NCT01767467|54311324|FG000|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0|||
27832363|NCT01767467|54311325|FG001|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3|||
27832364|NCT01767467|54311324|FG000|End of Study Phase (up to Month 13)|Lost to Follow-up|6|||
27832365|NCT01767467|54311325|FG001|End of Study Phase (up to Month 13)|Lost to Follow-up|4|||
27832366|NCT01767467|54311324|FG000|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0|||
27832367|NCT01767467|54311325|FG001|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1|||
27832368|NCT01767467|54311324|FG000|End of Study Phase (up to Month 13)|Physician Decision|1|||
27832369|NCT01767467|54311325|FG001|End of Study Phase (up to Month 13)|Physician Decision|0|||
27832370|NCT01767467|54311324|FG000|End of Study Phase (up to Month 13)|Subject Unavailable|0|||
27832371|NCT01767467|54311325|FG001|End of Study Phase (up to Month 13)|Subject Unavailable|2|||
27832372|NCT04126083|54311398|FG000|Overall Study|Withdrawal by Subject|1|||
27832373|NCT01766921|54311438|FG000|Overall Study|Administrative Reason|5|||
27832374|NCT01766921|54311439|FG001|Overall Study|Administrative Reason|5|||
27832375|NCT01766921|54311438|FG000|Overall Study|Death|1|||
27956974|NCT00884650|54613888|FG001|Overall Study|Did not return complete pain diaries|7|||
27956975|NCT00884650|54613887|FG000|Overall Study|Admitted Post-Op|1|||
27956976|NCT00884650|54613888|FG001|Overall Study|Admitted Post-Op|0|||
27956977|NCT00884650|54613887|FG000|Overall Study|Femoral Stress Fracture|1|||
27956978|NCT00884650|54613888|FG001|Overall Study|Femoral Stress Fracture|0|||
27956979|NCT00884650|54613887|FG000|Overall Study|Pain Pump Complication|0|||
27956980|NCT00884650|54613888|FG001|Overall Study|Pain Pump Complication|1|||
27956981|NCT00881608|54613900|FG000|Overall Study|Study prematurely terminated|11|||
27956982|NCT01088399|54613915|FG000|Overall Study|Adverse Event|211|||
27956983|NCT01088399|54613916|FG001|Overall Study|Adverse Event|16|||
27956984|NCT01088399|54613917|FG002|Overall Study|Adverse Event|0|||
27956985|NCT01088399|54613915|FG000|Overall Study|Death|204|||
27956986|NCT01088399|54613916|FG001|Overall Study|Death|45|||
27956987|NCT01088399|54613917|FG002|Overall Study|Death|0|||
27956988|NCT01088399|54613915|FG000|Overall Study|Lack of Efficacy|298|||
27956989|NCT01088399|54613916|FG001|Overall Study|Lack of Efficacy|7|||
27956990|NCT01088399|54613917|FG002|Overall Study|Lack of Efficacy|5|||
27956991|NCT01088399|54613915|FG000|Overall Study|Lost to Follow-up|1070|||
27956992|NCT01088399|54613916|FG001|Overall Study|Lost to Follow-up|278|||
27956993|NCT01088399|54613917|FG002|Overall Study|Lost to Follow-up|58|||
27956994|NCT01088399|54613915|FG000|Overall Study|Physician Decision|531|||
27956995|NCT01088399|54613916|FG001|Overall Study|Physician Decision|88|||
27956996|NCT01088399|54613917|FG002|Overall Study|Physician Decision|16|||
27956997|NCT01088399|54613915|FG000|Overall Study|Withdrawal by Subject|544|||
27956998|NCT01088399|54613916|FG001|Overall Study|Withdrawal by Subject|195|||
27956999|NCT01088399|54613917|FG002|Overall Study|Withdrawal by Subject|33|||
27957000|NCT01088399|54613915|FG000|Overall Study|Change to or start of somatropin therapy|234|||
27957001|NCT01088399|54613916|FG001|Overall Study|Change to or start of somatropin therapy|17|||
27957002|NCT01088399|54613917|FG002|Overall Study|Change to or start of somatropin therapy|12|||
27957003|NCT01088399|54613915|FG000|Overall Study|Sponsor decision|1573|||
27957004|NCT01088399|54613916|FG001|Overall Study|Sponsor decision|298|||
27957005|NCT01088399|54613917|FG002|Overall Study|Sponsor decision|7|||
27957006|NCT01088399|54613915|FG000|Overall Study|Protocol Violation|10|||
27957007|NCT01088399|54613916|FG001|Overall Study|Protocol Violation|1|||
27957008|NCT01088399|54613917|FG002|Overall Study|Protocol Violation|0|||
27957009|NCT01088399|54613915|FG000|Overall Study|Enrollment criteria not met|48|||
27957010|NCT01088399|54613916|FG001|Overall Study|Enrollment criteria not met|119|||
27957011|NCT01088399|54613917|FG002|Overall Study|Enrollment criteria not met|70|||
27957012|NCT01088399|54613915|FG000|Overall Study|Study summary visit not completed|2398|||
27957013|NCT01088399|54613916|FG001|Overall Study|Study summary visit not completed|283|||
27957014|NCT01088399|54613917|FG002|Overall Study|Study summary visit not completed|80|||
27957015|NCT00598078|54613925|FG000|Period 2 (Day 2)|Adverse Event|1|||
27732166|NCT02705625|54179640|FG000|Overall Study|Death|0|||
27732167|NCT02705625|54179641|FG001|Overall Study|Death|0|||
27957016|NCT00598078|54613926|FG001|Period 2 (Day 2)|Adverse Event|0|||
27957017|NCT01079195|54613934|FG000|Overall Study|No Documentation of Tarka Therapy|739|||
27957018|NCT01079195|54613934|FG000|Overall Study|No Documentation Available|437|||
27957019|NCT01079195|54613934|FG000|Overall Study|Adverse Event|157|||
27957020|NCT01079195|54613934|FG000|Overall Study|Reason Unknown|39|||
27855045|NCT04575584|54374408|FG004|Overall Study|Withdrawal by Subject|0|||
27855046|NCT04575584|54374409|FG005|Overall Study|Withdrawal by Subject|0|||
27855047|NCT04575584|54374404|FG000|Overall Study|Not recorded|0|||
27855048|NCT04575584|54374405|FG001|Overall Study|Not recorded|0|||
27855049|NCT04575584|54374406|FG002|Overall Study|Not recorded|0|||
27855050|NCT04575584|54374407|FG003|Overall Study|Not recorded|1|||
27855051|NCT04575584|54374408|FG004|Overall Study|Not recorded|0|||
27855052|NCT04575584|54374409|FG005|Overall Study|Not recorded|0|||
27855053|NCT03721965|54374448|FG000|Overall Study|Death|1|||
27855054|NCT03721965|54374448|FG000|Overall Study|Study Terminated by Sponsor|1|||
27855055|NCT03873116|54374504|FG000|Overall Study|Study drug discontinuation due to rash|0|||
27855056|NCT03873116|54374505|FG001|Overall Study|Study drug discontinuation due to rash|0|||
27855057|NCT03873116|54374506|FG002|Overall Study|Study drug discontinuation due to rash|1|||
27855058|NCT02312258|54374792|FG000|Overall Study|Adverse Event|15|||
27855059|NCT02312258|54374793|FG001|Overall Study|Adverse Event|47|||
27957021|NCT01079195|54613934|FG000|Overall Study|Withdrawal by Subject|18|||
27957022|NCT01079195|54613934|FG000|Overall Study|Financial Reasons|15|||
27957023|NCT01079195|54613934|FG000|Overall Study|Lack of Effectiveness|12|||
27957024|NCT01079195|54613934|FG000|Overall Study|Physician Decision|4|||
27957025|NCT01079195|54613934|FG000|Overall Study|Improved Status of Participant|4|||
27957026|NCT01079195|54613934|FG000|Overall Study|No Follow-up Documentation Available|4|||
27957027|NCT01079195|54613934|FG000|Overall Study|Non-compliance|2|||
27855060|NCT02312258|54374792|FG000|Overall Study|Lost to Follow-up|0|||
27957028|NCT00883558|54613938|FG000|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2|||
27732168|NCT02705625|54179642|FG002|Overall Study|Death|1|||
27855061|NCT02312258|54374793|FG001|Overall Study|Lost to Follow-up|1|||
27957029|NCT00883558|54613939|FG001|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
27957030|NCT00883558|54613940|FG002|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
27957031|NCT00883558|54613938|FG000|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
27957032|NCT00883558|54613939|FG001|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1|||
27957033|NCT00883558|54613940|FG002|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
27957034|NCT00883558|54613938|FG000|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0|||
27957035|NCT00883558|54613939|FG001|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
27957036|NCT00883558|54613940|FG002|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
27957037|NCT00883558|54613938|FG000|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
27957038|NCT00883558|54613939|FG001|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1|||
27957039|NCT00883558|54613940|FG002|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
27957040|NCT00883558|54613938|FG000|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
27957041|NCT00883558|54613939|FG001|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
27957042|NCT00883558|54613940|FG002|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1|||
27957043|NCT00880750|54613948|FG000|First Intervention|Adverse Event|1|||
27957044|NCT00880750|54613949|FG001|First Intervention|Adverse Event|0|||
27957045|NCT00880750|54613948|FG000|First Intervention|Unable to collect urine|4|||
27957046|NCT00880750|54613949|FG001|First Intervention|Unable to collect urine|0|||
27957047|NCT00880750|54613948|FG000|First Intervention|Non-compliance with meals|0|||
27957048|NCT00880750|54613949|FG001|First Intervention|Non-compliance with meals|1|||
27957049|NCT00880750|54613948|FG000|First Intervention|Withdrawal by Subject|2|||
27957050|NCT00880750|54613949|FG001|First Intervention|Withdrawal by Subject|0|||
27957051|NCT00880750|54613948|FG000|First Intervention|Lost to Follow-up|2|||
27957052|NCT00880750|54613949|FG001|First Intervention|Lost to Follow-up|0|||
27957053|NCT00880750|54613948|FG000|Second Intervention|Withdrawal by Subject|2|||
27957054|NCT00880750|54613949|FG001|Second Intervention|Withdrawal by Subject|2|||
27957055|NCT00880750|54613948|FG000|Second Intervention|Protocol Violation|1|||
27957056|NCT00880750|54613949|FG001|Second Intervention|Protocol Violation|0|||
27957057|NCT00880750|54613948|FG000|Second Intervention|Unable to collect urine|1|||
27957058|NCT00880750|54613949|FG001|Second Intervention|Unable to collect urine|0|||
27957059|NCT00597766|54613958|FG000|Follow-up 1, Week 4|Withdrawal by Subject|1|||
27957060|NCT00597766|54613959|FG001|Follow-up 1, Week 4|Withdrawal by Subject|0|||
27957061|NCT00597766|54613960|FG002|Follow-up 1, Week 4|Withdrawal by Subject|0|||
27957062|NCT00597766|54613958|FG000|Follow-up 2, Week 8|Lost to Follow-up|0|||
27957063|NCT00597766|54613959|FG001|Follow-up 2, Week 8|Lost to Follow-up|0|||
27957064|NCT00597766|54613960|FG002|Follow-up 2, Week 8|Lost to Follow-up|1|||
27957065|NCT00979992|54613968|FG000|Overall Study|Ineligible - inadequate pathology|1|||
27957066|NCT00979992|54613968|FG000|Overall Study|Ineligible - wrong cell type|2|||
27957067|NCT00979992|54613968|FG000|Overall Study|Refused - Never Treated|2|||
27957068|NCT01079741|54613977|FG000|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
27957069|NCT01079741|54613978|FG001|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1|||
27957070|NCT01079741|54613979|FG002|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
27957071|NCT01079741|54613980|FG003|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
27957072|NCT01079741|54613981|FG004|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
27957073|NCT01079741|54613977|FG000|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
27957074|NCT01079741|54613978|FG001|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
27957075|NCT01079741|54613979|FG002|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
27957076|NCT01079741|54613980|FG003|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
27957077|NCT01079741|54613981|FG004|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3|||
27957078|NCT01079663|54613995|FG000|Overall Study|Adverse Event|0|||
27957079|NCT01079663|54613996|FG001|Overall Study|Adverse Event|2|||
27957080|NCT01079663|54613995|FG000|Overall Study|Protocol Violation|0|||
27957081|NCT01079663|54613996|FG001|Overall Study|Protocol Violation|2|||
27957082|NCT00879814|54614006|FG000|Overall Study|Adverse Event|0|||
27957083|NCT00879814|54614007|FG001|Overall Study|Adverse Event|1|||
27957084|NCT00879814|54614008|FG002|Overall Study|Adverse Event|0|||
27957085|NCT00879814|54614009|FG003|Overall Study|Adverse Event|0|||
27957086|NCT00879814|54614006|FG000|Overall Study|Lost to Follow-up|1|||
27957087|NCT00879814|54614007|FG001|Overall Study|Lost to Follow-up|0|||
27957088|NCT00879814|54614008|FG002|Overall Study|Lost to Follow-up|0|||
27957089|NCT00879814|54614009|FG003|Overall Study|Lost to Follow-up|2|||
27957090|NCT00879814|54614006|FG000|Overall Study|Participant Failed to Return|0|||
27957091|NCT00879814|54614007|FG001|Overall Study|Participant Failed to Return|0|||
27957092|NCT00879814|54614008|FG002|Overall Study|Participant Failed to Return|0|||
27957093|NCT00879814|54614009|FG003|Overall Study|Participant Failed to Return|1|||
27957094|NCT00879814|54614006|FG000|Overall Study|Withdrawal by Subject|3|||
27957095|NCT00879814|54614007|FG001|Overall Study|Withdrawal by Subject|1|||
27832376|NCT01766921|54311439|FG001|Overall Study|Death|1|||
27957096|NCT00879814|54614008|FG002|Overall Study|Withdrawal by Subject|1|||
27957097|NCT00879814|54614009|FG003|Overall Study|Withdrawal by Subject|2|||
27957098|NCT00879814|54614006|FG000|Overall Study|Physician Decision|0|||
27957099|NCT00879814|54614007|FG001|Overall Study|Physician Decision|0|||
27957100|NCT00879814|54614008|FG002|Overall Study|Physician Decision|1|||
27957101|NCT00879814|54614009|FG003|Overall Study|Physician Decision|0|||
27957102|NCT00879814|54614006|FG000|Overall Study|Other|0|||
27957103|NCT00879814|54614007|FG001|Overall Study|Other|0|||
27957104|NCT00879814|54614008|FG002|Overall Study|Other|1|||
28081949|NCT00098475|54735417|FG002|Step 1|Insurance issue|0|||
28081950|NCT00098475|54735418|FG003|Step 1|Insurance issue|0|||
28081951|NCT00098475|54735415|FG000|Step 1|Rising paraprotein|0|||
28081952|NCT00098475|54735416|FG001|Step 1|Rising paraprotein|1|||
28081953|NCT00098475|54735417|FG002|Step 1|Rising paraprotein|0|||
28081954|NCT00098475|54735418|FG003|Step 1|Rising paraprotein|0|||
28081955|NCT00098475|54735415|FG000|Step 1|Referred to other physicians|0|||
28081956|NCT00098475|54735416|FG001|Step 1|Referred to other physicians|1|||
28081957|NCT00098475|54735417|FG002|Step 1|Referred to other physicians|0|||
28081958|NCT00098475|54735418|FG003|Step 1|Referred to other physicians|0|||
28081959|NCT00098475|54735415|FG000|Step 1|Criteria to continue treatment not met|0|||
28081960|NCT00098475|54735416|FG001|Step 1|Criteria to continue treatment not met|1|||
28081961|NCT00098475|54735417|FG002|Step 1|Criteria to continue treatment not met|0|||
28081962|NCT00098475|54735418|FG003|Step 1|Criteria to continue treatment not met|0|||
28081963|NCT00098475|54735415|FG000|Step 1|Misinterpretation of lab data|0|||
28081964|NCT00098475|54735416|FG001|Step 1|Misinterpretation of lab data|1|||
28081965|NCT00098475|54735417|FG002|Step 1|Misinterpretation of lab data|0|||
28081966|NCT00098475|54735418|FG003|Step 1|Misinterpretation of lab data|0|||
28081967|NCT00098475|54735415|FG000|Step 1|Patient fell with fracture|1|||
28081968|NCT00098475|54735416|FG001|Step 1|Patient fell with fracture|0|||
28081969|NCT00098475|54735417|FG002|Step 1|Patient fell with fracture|0|||
28081970|NCT00098475|54735418|FG003|Step 1|Patient fell with fracture|0|||
28081971|NCT00098475|54735415|FG000|Step 1|Not documented|0|||
28081972|NCT00098475|54735416|FG001|Step 1|Not documented|1|||
28081973|NCT00098475|54735417|FG002|Step 1|Not documented|0|||
28081974|NCT00098475|54735418|FG003|Step 1|Not documented|0|||
28081975|NCT00098475|54735415|FG000|Step 2|Disease progression|1|||
28081976|NCT00098475|54735416|FG001|Step 2|Disease progression|4|||
28081977|NCT00098475|54735417|FG002|Step 2|Disease progression|0|||
28081978|NCT00098475|54735418|FG003|Step 2|Disease progression|0|||
28081979|NCT00098475|54735415|FG000|Step 2|Adverse Event|2|||
28081980|NCT00098475|54735416|FG001|Step 2|Adverse Event|0|||
28081981|NCT00098475|54735417|FG002|Step 2|Adverse Event|0|||
28081982|NCT00098475|54735418|FG003|Step 2|Adverse Event|0|||
28081983|NCT00098475|54735415|FG000|Step 2|Withdrawal by Subject|0|||
28081984|NCT00098475|54735416|FG001|Step 2|Withdrawal by Subject|2|||
28081985|NCT00098475|54735417|FG002|Step 2|Withdrawal by Subject|0|||
28081986|NCT00098475|54735418|FG003|Step 2|Withdrawal by Subject|0|||
28081987|NCT00098475|54735415|FG000|Step 2|Physician Decision|0|||
28081988|NCT00098475|54735416|FG001|Step 2|Physician Decision|1|||
28081989|NCT00098475|54735417|FG002|Step 2|Physician Decision|0|||
28081990|NCT00098475|54735418|FG003|Step 2|Physician Decision|0|||
28081991|NCT00098475|54735415|FG000|Step 2|Alternative therapy|1|||
28081992|NCT00098475|54735416|FG001|Step 2|Alternative therapy|2|||
28081993|NCT00098475|54735417|FG002|Step 2|Alternative therapy|0|||
28081994|NCT00098475|54735418|FG003|Step 2|Alternative therapy|0|||
28081995|NCT00098475|54735415|FG000|Step 2|Never started treatment|1|||
28081996|NCT00098475|54735416|FG001|Step 2|Never started treatment|1|||
28081997|NCT00098475|54735417|FG002|Step 2|Never started treatment|0|||
28081998|NCT00098475|54735418|FG003|Step 2|Never started treatment|0|||
28081999|NCT00091169|54735430|FG000|Overall Study|Disease progression|3|||
28082000|NCT00091169|54735431|FG001|Overall Study|Disease progression|1|||
28082001|NCT00091169|54735430|FG000|Overall Study|Adverse Event|11|||
28082002|NCT00091169|54735431|FG001|Overall Study|Adverse Event|17|||
28082003|NCT00091169|54735430|FG000|Overall Study|Death|4|||
28082004|NCT00091169|54735431|FG001|Overall Study|Death|1|||
28082005|NCT00091169|54735430|FG000|Overall Study|Withdrawal by Subject|10|||
28082006|NCT00091169|54735431|FG001|Overall Study|Withdrawal by Subject|13|||
28082007|NCT00091169|54735430|FG000|Overall Study|Other|3|||
28082008|NCT00091169|54735431|FG001|Overall Study|Other|4|||
27957105|NCT00879814|54614009|FG003|Overall Study|Other|0|||
28082009|NCT00091169|54735430|FG000|Overall Study|Not start protocol therapy|26|||
28082010|NCT00091169|54735431|FG001|Overall Study|Not start protocol therapy|17|||
28082011|NCT00075946|54735443|FG000|Overall Study|Path ineligible: undetermined histology|0|||
27832377|NCT01766921|54311438|FG000|Overall Study|Lost to Follow-up|1|||
27832378|NCT01766921|54311439|FG001|Overall Study|Lost to Follow-up|3|||
27957106|NCT01132664|54614024|FG000|Phase lb|Adverse Event|0|||
28082012|NCT00075946|54735444|FG001|Overall Study|Path ineligible: undetermined histology|0|||
28082013|NCT00075946|54735445|FG002|Overall Study|Path ineligible: undetermined histology|0|||
28082014|NCT00075946|54735446|FG003|Overall Study|Path ineligible: undetermined histology|0|||
28082015|NCT00075946|54735447|FG004|Overall Study|Path ineligible: undetermined histology|6|||
28082016|NCT00075946|54735443|FG000|Overall Study|Did not achieve response after induction|0|||
28082017|NCT00075946|54735444|FG001|Overall Study|Did not achieve response after induction|0|||
28082018|NCT00075946|54735445|FG002|Overall Study|Did not achieve response after induction|0|||
28082019|NCT00075946|54735446|FG003|Overall Study|Did not achieve response after induction|0|||
28082020|NCT00075946|54735447|FG004|Overall Study|Did not achieve response after induction|182|||
28082021|NCT00075946|54735443|FG000|Overall Study|Incorrectly randomized (no response)|5|||
27957107|NCT01132664|54614025|FG001|Phase lb|Adverse Event|1|||
27957108|NCT01132664|54614026|FG002|Phase lb|Adverse Event|0|||
27957109|NCT01132664|54614027|FG003|Phase lb|Adverse Event|0|||
27957110|NCT01132664|54614028|FG004|Phase lb|Adverse Event|0|||
27957111|NCT01132664|54614024|FG000|Phase lb|Withdrawal by Subject|1|||
27957112|NCT01132664|54614025|FG001|Phase lb|Withdrawal by Subject|2|||
27957113|NCT01132664|54614026|FG002|Phase lb|Withdrawal by Subject|0|||
27957114|NCT01132664|54614027|FG003|Phase lb|Withdrawal by Subject|0|||
27957115|NCT01132664|54614028|FG004|Phase lb|Withdrawal by Subject|0|||
27957116|NCT01132664|54614024|FG000|Phase lb|Disease Progression|4|||
27957117|NCT01132664|54614025|FG001|Phase lb|Disease Progression|9|||
27957118|NCT01132664|54614026|FG002|Phase lb|Disease Progression|0|||
27957119|NCT01132664|54614027|FG003|Phase lb|Disease Progression|0|||
27957120|NCT01132664|54614028|FG004|Phase lb|Disease Progression|0|||
27957121|NCT01132664|54614024|FG000|Phase ll|Death|0|||
27957122|NCT01132664|54614025|FG001|Phase ll|Death|0|||
27957123|NCT01132664|54614026|FG002|Phase ll|Death|2|||
27957124|NCT01132664|54614027|FG003|Phase ll|Death|0|||
27957125|NCT01132664|54614028|FG004|Phase ll|Death|0|||
27957126|NCT01132664|54614024|FG000|Phase ll|Adverse Event|0|||
27957127|NCT01132664|54614025|FG001|Phase ll|Adverse Event|0|||
27957128|NCT01132664|54614026|FG002|Phase ll|Adverse Event|10|||
27957129|NCT01132664|54614027|FG003|Phase ll|Adverse Event|0|||
27957130|NCT01132664|54614028|FG004|Phase ll|Adverse Event|0|||
27957131|NCT01132664|54614024|FG000|Phase ll|Withdrawal by Subject|0|||
27957132|NCT01132664|54614025|FG001|Phase ll|Withdrawal by Subject|0|||
27957133|NCT01132664|54614026|FG002|Phase ll|Withdrawal by Subject|3|||
27957134|NCT01132664|54614027|FG003|Phase ll|Withdrawal by Subject|0|||
27957135|NCT01132664|54614028|FG004|Phase ll|Withdrawal by Subject|0|||
27957136|NCT01132664|54614024|FG000|Phase ll|Disease progression|0|||
27957137|NCT01132664|54614025|FG001|Phase ll|Disease progression|0|||
27957138|NCT01132664|54614026|FG002|Phase ll|Disease progression|35|||
27957139|NCT01132664|54614027|FG003|Phase ll|Disease progression|0|||
27957140|NCT01132664|54614028|FG004|Phase ll|Disease progression|0|||
27957141|NCT01132664|54614024|FG000|BM Cohort|Disease progression|0|||
27957142|NCT01132664|54614025|FG001|BM Cohort|Disease progression|0|||
27957143|NCT01132664|54614026|FG002|BM Cohort|Disease progression|0|||
27957144|NCT01132664|54614027|FG003|BM Cohort|Disease progression|3|||
27957145|NCT01132664|54614028|FG004|BM Cohort|Disease progression|4|||
27957146|NCT01132664|54614024|FG000|BM Cohort|Adverse Event|0|||
27957147|NCT01132664|54614025|FG001|BM Cohort|Adverse Event|0|||
27957148|NCT01132664|54614026|FG002|BM Cohort|Adverse Event|0|||
27957149|NCT01132664|54614027|FG003|BM Cohort|Adverse Event|0|||
27957150|NCT01132664|54614028|FG004|BM Cohort|Adverse Event|1|||
27957151|NCT01132664|54614024|FG000|BM Cohort|Withdrawal by Subject|0|||
27957152|NCT01132664|54614025|FG001|BM Cohort|Withdrawal by Subject|0|||
27957153|NCT01132664|54614026|FG002|BM Cohort|Withdrawal by Subject|0|||
27957154|NCT01132664|54614027|FG003|BM Cohort|Withdrawal by Subject|0|||
27957155|NCT01132664|54614028|FG004|BM Cohort|Withdrawal by Subject|1|||
27957156|NCT00591409|54614050|FG000|Overall Study|Not Treated|0|||
27957157|NCT00591409|54614051|FG001|Overall Study|Not Treated|0|||
27957158|NCT00591409|54614052|FG002|Overall Study|Not Treated|0|||
27957159|NCT00591409|54614053|FG003|Overall Study|Not Treated|0|||
27957160|NCT00591409|54614054|FG004|Overall Study|Not Treated|1|||
27957161|NCT00591409|54614055|FG005|Overall Study|Not Treated|0|||
27732169|NCT02705625|54179640|FG000|Overall Study|Withdrawal by Subject|1|||
27732170|NCT02705625|54179641|FG001|Overall Study|Withdrawal by Subject|4|||
27732171|NCT02705625|54179642|FG002|Overall Study|Withdrawal by Subject|5|||
27732172|NCT02705625|54179640|FG000|Overall Study|Lost to Follow-up|0|||
27732173|NCT02705625|54179641|FG001|Overall Study|Lost to Follow-up|0|||
27732174|NCT02705625|54179642|FG002|Overall Study|Lost to Follow-up|1|||
27732175|NCT02705625|54179640|FG000|Overall Study|Non-compliance|0|||
27832379|NCT01766921|54311438|FG000|Overall Study|Unclassified|2|||
27957162|NCT00591409|54614056|FG006|Overall Study|Not Treated|0|||
27957163|NCT00591409|54614057|FG007|Overall Study|Not Treated|0|||
27957164|NCT00591409|54614058|FG008|Overall Study|Not Treated|0|||
27957165|NCT00591409|54614059|FG009|Overall Study|Not Treated|1|||
27957166|NCT01078805|54614081|FG000|Overall Study|Clinically significant abnormal lab|5|||
27957167|NCT01078805|54614081|FG000|Overall Study|Death|134|||
27957168|NCT01078805|54614081|FG000|Overall Study|Lost to Follow-up|676|||
27957169|NCT01078805|54614081|FG000|Overall Study|Physician Decision|169|||
27957170|NCT01078805|54614081|FG000|Overall Study|Serious adverse event|26|||
28082022|NCT00075946|54735444|FG001|Overall Study|Incorrectly randomized (no response)|5|||
28082023|NCT00075946|54735445|FG002|Overall Study|Incorrectly randomized (no response)|5|||
27732176|NCT02705625|54179641|FG001|Overall Study|Non-compliance|1|||
27832380|NCT01766921|54311439|FG001|Overall Study|Unclassified|2|||
27957171|NCT01078805|54614081|FG000|Overall Study|Sponsor decision|46|||
27957172|NCT01078805|54614081|FG000|Overall Study|Withdrawal by Subject|739|||
27957173|NCT01078805|54614081|FG000|Overall Study|Other|173|||
27957174|NCT01078805|54614081|FG000|Overall Study|Didn't take study drug|82|||
27957175|NCT00820027|54614089|FG000|Overall Study|Adverse Event|15|||
27957176|NCT00820027|54614090|FG001|Overall Study|Adverse Event|8|||
27957177|NCT00820027|54614091|FG002|Overall Study|Adverse Event|10|||
27957178|NCT00820027|54614092|FG003|Overall Study|Adverse Event|5|||
27957179|NCT00820027|54614089|FG000|Overall Study|Lack of Efficacy|2|||
27957180|NCT00820027|54614090|FG001|Overall Study|Lack of Efficacy|1|||
27957181|NCT00820027|54614091|FG002|Overall Study|Lack of Efficacy|2|||
27957182|NCT00820027|54614092|FG003|Overall Study|Lack of Efficacy|2|||
27957183|NCT00820027|54614089|FG000|Overall Study|Physician Decision|0|||
27957184|NCT00820027|54614090|FG001|Overall Study|Physician Decision|1|||
27957185|NCT00820027|54614091|FG002|Overall Study|Physician Decision|1|||
27957186|NCT00820027|54614092|FG003|Overall Study|Physician Decision|0|||
27957187|NCT00820027|54614089|FG000|Overall Study|Protocol Violation|3|||
27957188|NCT00820027|54614090|FG001|Overall Study|Protocol Violation|0|||
27957189|NCT00820027|54614091|FG002|Overall Study|Protocol Violation|4|||
27957190|NCT00820027|54614092|FG003|Overall Study|Protocol Violation|0|||
27957191|NCT00820027|54614089|FG000|Overall Study|Withdrawal by Subject|6|||
27957192|NCT00820027|54614090|FG001|Overall Study|Withdrawal by Subject|4|||
27957193|NCT00820027|54614091|FG002|Overall Study|Withdrawal by Subject|4|||
27957194|NCT00820027|54614092|FG003|Overall Study|Withdrawal by Subject|6|||
27957195|NCT01076153|54614103|FG000|Overall Study|Symptoms improved/resolved|10|||
27957196|NCT01076153|54614103|FG000|Overall Study|Adverse Event|1|||
27957197|NCT01076075|54614113|FG000|Overall Study|Adverse Event|3|||
27957198|NCT01076075|54614114|FG001|Overall Study|Adverse Event|9|||
27957199|NCT01076075|54614113|FG000|Overall Study|Lack of Efficacy|5|||
27957200|NCT01076075|54614114|FG001|Overall Study|Lack of Efficacy|4|||
27957201|NCT01076075|54614113|FG000|Overall Study|Lost to Follow-up|6|||
27957202|NCT01076075|54614114|FG001|Overall Study|Lost to Follow-up|5|||
27957203|NCT01076075|54614113|FG000|Overall Study|other|19|||
27957204|NCT01076075|54614114|FG001|Overall Study|other|9|||
27957205|NCT01076075|54614113|FG000|Overall Study|Protocol Violation|0|||
27957206|NCT01076075|54614114|FG001|Overall Study|Protocol Violation|1|||
27957207|NCT01076075|54614113|FG000|Overall Study|Withdrawal by Subject|8|||
27957208|NCT01076075|54614114|FG001|Overall Study|Withdrawal by Subject|19|||
27957209|NCT01075763|54614125|FG000|Overall Study|Lost to Follow-up|2|||
27957210|NCT01075763|54614126|FG001|Overall Study|Lost to Follow-up|1|||
27957211|NCT01075763|54614125|FG000|Overall Study|Lack of Efficacy|0|||
27957212|NCT01075763|54614126|FG001|Overall Study|Lack of Efficacy|1|||
27957213|NCT01075763|54614125|FG000|Overall Study|Withdrawal by Subject|2|||
27957214|NCT01075763|54614126|FG001|Overall Study|Withdrawal by Subject|2|||
27957215|NCT00881530|54614138|FG000|Overall Study|Adverse Event|5|||
27957216|NCT00881530|54614139|FG001|Overall Study|Adverse Event|1|||
27957217|NCT00881530|54614140|FG002|Overall Study|Adverse Event|1|||
27957218|NCT00881530|54614141|FG003|Overall Study|Adverse Event|4|||
27957219|NCT00881530|54614142|FG004|Overall Study|Adverse Event|10|||
27957220|NCT00881530|54614143|FG005|Overall Study|Adverse Event|2|||
27957221|NCT00881530|54614138|FG000|Overall Study|Lack of Efficacy|1|||
27957222|NCT00881530|54614139|FG001|Overall Study|Lack of Efficacy|0|||
27957223|NCT00881530|54614140|FG002|Overall Study|Lack of Efficacy|0|||
27957224|NCT00881530|54614141|FG003|Overall Study|Lack of Efficacy|0|||
27957225|NCT00881530|54614142|FG004|Overall Study|Lack of Efficacy|1|||
27957226|NCT00881530|54614143|FG005|Overall Study|Lack of Efficacy|1|||
27957227|NCT00881530|54614138|FG000|Overall Study|Not compliant with the protocol|0|||
27957228|NCT00881530|54614139|FG001|Overall Study|Not compliant with the protocol|0|||
27957229|NCT00881530|54614140|FG002|Overall Study|Not compliant with the protocol|0|||
27957230|NCT00881530|54614141|FG003|Overall Study|Not compliant with the protocol|0|||
27957231|NCT00881530|54614142|FG004|Overall Study|Not compliant with the protocol|2|||
27957232|NCT00881530|54614143|FG005|Overall Study|Not compliant with the protocol|0|||
27957233|NCT00881530|54614138|FG000|Overall Study|Lost to Follow-up|0|||
27957234|NCT00881530|54614139|FG001|Overall Study|Lost to Follow-up|1|||
27957235|NCT00881530|54614140|FG002|Overall Study|Lost to Follow-up|1|||
27957236|NCT00881530|54614141|FG003|Overall Study|Lost to Follow-up|3|||
27957237|NCT00881530|54614142|FG004|Overall Study|Lost to Follow-up|1|||
27957238|NCT00881530|54614143|FG005|Overall Study|Lost to Follow-up|0|||
27957239|NCT00881530|54614138|FG000|Overall Study|Refused to continue medication|7|||
27957240|NCT00881530|54614139|FG001|Overall Study|Refused to continue medication|2|||
27957241|NCT00881530|54614140|FG002|Overall Study|Refused to continue medication|1|||
27957242|NCT00881530|54614141|FG003|Overall Study|Refused to continue medication|2|||
27957243|NCT00881530|54614142|FG004|Overall Study|Refused to continue medication|0|||
27957244|NCT00881530|54614143|FG005|Overall Study|Refused to continue medication|0|||
27957245|NCT00881530|54614138|FG000|Overall Study|Other reason not defined above|1|||
27957246|NCT00881530|54614139|FG001|Overall Study|Other reason not defined above|1|||
27957247|NCT00881530|54614140|FG002|Overall Study|Other reason not defined above|2|||
27957248|NCT00881530|54614141|FG003|Overall Study|Other reason not defined above|0|||
27957249|NCT00881530|54614142|FG004|Overall Study|Other reason not defined above|0|||
28082024|NCT00075946|54735446|FG003|Overall Study|Incorrectly randomized (no response)|1|||
27957250|NCT00881530|54614143|FG005|Overall Study|Other reason not defined above|2|||
27957251|NCT01075685|54614159|FG000|Overall Study|Protocol Violation|9|||
27957252|NCT01075685|54614160|FG001|Overall Study|Protocol Violation|1|||
27957253|NCT01075685|54614159|FG000|Overall Study|Withdrawal by Subject|20|||
27957254|NCT01075685|54614160|FG001|Overall Study|Withdrawal by Subject|5|||
27957255|NCT01075685|54614159|FG000|Overall Study|Lost to Follow-up|563|||
27957256|NCT01075685|54614160|FG001|Overall Study|Lost to Follow-up|220|||
27957257|NCT01075217|54614168|FG000|Overall Study|Adverse Event|1|||
27957258|NCT01075217|54614169|FG001|Overall Study|Adverse Event|1|||
27957259|NCT01075217|54614168|FG000|Overall Study|Physician Decision|1|||
27957260|NCT01075217|54614169|FG001|Overall Study|Physician Decision|0|||
27957261|NCT01078571|54614183|FG000|Overall Study|Adverse Event|36|||
27957262|NCT01078571|54614183|FG000|Overall Study|Lack of effectiveness|36|||
27957263|NCT01078571|54614183|FG000|Overall Study|Reason not reported|21|||
27957264|NCT01078571|54614183|FG000|Overall Study|Withdrawal by Subject|12|||
27957265|NCT01078571|54614183|FG000|Overall Study|Lost to Follow-up|8|||
27957266|NCT01078571|54614183|FG000|Overall Study|Protocol Violation|2|||
27957267|NCT00977106|54614194|FG000|Overall Study|Adverse Event|5|||
27957268|NCT00977106|54614195|FG001|Overall Study|Adverse Event|6|||
27957269|NCT00977106|54614194|FG000|Overall Study|Withdrawal by Subject|2|||
27957270|NCT00977106|54614195|FG001|Overall Study|Withdrawal by Subject|2|||
27957271|NCT00977106|54614194|FG000|Overall Study|Lack of Efficacy|2|||
27957272|NCT00977106|54614195|FG001|Overall Study|Lack of Efficacy|2|||
27957273|NCT00977106|54614194|FG000|Overall Study|Protocol Violation|0|||
27957274|NCT00977106|54614195|FG001|Overall Study|Protocol Violation|1|||
27957275|NCT00977106|54614194|FG000|Overall Study|Other|1|||
27957276|NCT00977106|54614195|FG001|Overall Study|Other|0|||
27957277|NCT01077713|54614205|FG000|Overall Study|Withdrawal by Subject|1|||
27957278|NCT01077713|54614206|FG001|Overall Study|Withdrawal by Subject|2|||
27957279|NCT01077713|54614205|FG000|Overall Study|Progressive Disease (PD)|0|||
27957280|NCT01077713|54614206|FG001|Overall Study|Progressive Disease (PD)|1|||
27957281|NCT01077713|54614205|FG000|Overall Study|Death|28|||
27957282|NCT01077713|54614206|FG001|Overall Study|Death|29|||
27957283|NCT01077713|54614205|FG000|Overall Study|Lost to Follow-up|1|||
27957284|NCT01077713|54614206|FG001|Overall Study|Lost to Follow-up|1|||
27957285|NCT01077713|54614205|FG000|Overall Study|Adverse Event|2|||
27957286|NCT01077713|54614206|FG001|Overall Study|Adverse Event|1|||
27957287|NCT01077713|54614205|FG000|Overall Study|Other|4|||
27957288|NCT01077713|54614206|FG001|Overall Study|Other|2|||
27957289|NCT00813709|54614215|FG000|Double Blind Period|Adverse Event|4|||
27957290|NCT00813709|54614216|FG001|Double Blind Period|Adverse Event|1|||
27957291|NCT00813709|54614217|FG002|Double Blind Period|Adverse Event|4|||
27957292|NCT00813709|54614218|FG003|Double Blind Period|Adverse Event|0|||
27957293|NCT00813709|54614219|FG004|Double Blind Period|Adverse Event|0|||
27957294|NCT00813709|54614220|FG005|Double Blind Period|Adverse Event|0|||
27957295|NCT00813709|54614215|FG000|Double Blind Period|Lost to Follow-up|3|||
27957296|NCT00813709|54614216|FG001|Double Blind Period|Lost to Follow-up|2|||
27957297|NCT00813709|54614217|FG002|Double Blind Period|Lost to Follow-up|2|||
27957298|NCT00813709|54614218|FG003|Double Blind Period|Lost to Follow-up|0|||
27957299|NCT00813709|54614219|FG004|Double Blind Period|Lost to Follow-up|0|||
27957300|NCT00813709|54614220|FG005|Double Blind Period|Lost to Follow-up|0|||
27957301|NCT00813709|54614215|FG000|Double Blind Period|Switched to open label phase|9|||
27957302|NCT00813709|54614216|FG001|Double Blind Period|Switched to open label phase|26|||
27957303|NCT00813709|54614217|FG002|Double Blind Period|Switched to open label phase|18|||
27957304|NCT00813709|54614218|FG003|Double Blind Period|Switched to open label phase|0|||
27957305|NCT00813709|54614219|FG004|Double Blind Period|Switched to open label phase|0|||
27957306|NCT00813709|54614220|FG005|Double Blind Period|Switched to open label phase|0|||
27957307|NCT00813709|54614215|FG000|Double Blind Period|Randomized but not treated|1|||
27957308|NCT00813709|54614216|FG001|Double Blind Period|Randomized but not treated|3|||
27957309|NCT00813709|54614217|FG002|Double Blind Period|Randomized but not treated|1|||
27957310|NCT00813709|54614218|FG003|Double Blind Period|Randomized but not treated|0|||
27957311|NCT00813709|54614219|FG004|Double Blind Period|Randomized but not treated|0|||
27957312|NCT00813709|54614220|FG005|Double Blind Period|Randomized but not treated|0|||
27957313|NCT00813709|54614215|FG000|Double Blind Period|Other|14|||
27957314|NCT00813709|54614216|FG001|Double Blind Period|Other|9|||
27957315|NCT00813709|54614217|FG002|Double Blind Period|Other|6|||
27957316|NCT00813709|54614218|FG003|Double Blind Period|Other|0|||
27957317|NCT00813709|54614219|FG004|Double Blind Period|Other|0|||
27957318|NCT00813709|54614220|FG005|Double Blind Period|Other|0|||
27957319|NCT00813709|54614215|FG000|Open Label Period|Adverse Event|0|||
27957320|NCT00813709|54614216|FG001|Open Label Period|Adverse Event|0|||
28082025|NCT00075946|54735447|FG004|Overall Study|Incorrectly randomized (no response)|0|||
28082026|NCT00075946|54735443|FG000|Overall Study|Still on treatment at time of analysis|52|||
27832381|NCT01766921|54311438|FG000|Overall Study|Protocol Violation|1|||
27832382|NCT01766921|54311439|FG001|Overall Study|Protocol Violation|1|||
27832383|NCT01766921|54311438|FG000|Overall Study|Withdrawal by Subject|14|||
27855062|NCT02312258|54374792|FG000|Overall Study|Progressive Disease|174|||
27957321|NCT00813709|54614217|FG002|Open Label Period|Adverse Event|0|||
27957322|NCT00813709|54614218|FG003|Open Label Period|Adverse Event|5|||
27957323|NCT00813709|54614219|FG004|Open Label Period|Adverse Event|4|||
27957324|NCT00813709|54614220|FG005|Open Label Period|Adverse Event|3|||
27957325|NCT00813709|54614215|FG000|Open Label Period|Lack of Efficacy|0|||
27957326|NCT00813709|54614216|FG001|Open Label Period|Lack of Efficacy|0|||
27957327|NCT00813709|54614217|FG002|Open Label Period|Lack of Efficacy|0|||
27957328|NCT00813709|54614218|FG003|Open Label Period|Lack of Efficacy|3|||
27957329|NCT00813709|54614219|FG004|Open Label Period|Lack of Efficacy|1|||
27957330|NCT00813709|54614220|FG005|Open Label Period|Lack of Efficacy|1|||
27957331|NCT00813709|54614215|FG000|Open Label Period|Randomized but not treated|0|||
27957332|NCT00813709|54614216|FG001|Open Label Period|Randomized but not treated|0|||
27957333|NCT00813709|54614217|FG002|Open Label Period|Randomized but not treated|0|||
27957334|NCT00813709|54614218|FG003|Open Label Period|Randomized but not treated|1|||
27957335|NCT00813709|54614219|FG004|Open Label Period|Randomized but not treated|0|||
27957336|NCT00813709|54614220|FG005|Open Label Period|Randomized but not treated|1|||
27957337|NCT00813709|54614215|FG000|Open Label Period|Other|0|||
27957338|NCT00813709|54614216|FG001|Open Label Period|Other|0|||
27957339|NCT00813709|54614217|FG002|Open Label Period|Other|0|||
27957340|NCT00813709|54614218|FG003|Open Label Period|Other|11|||
27957341|NCT00813709|54614219|FG004|Open Label Period|Other|5|||
27957342|NCT00813709|54614220|FG005|Open Label Period|Other|6|||
27957343|NCT01077323|54614252|FG000|Overall Study|<9 months enroll before drug dispensed|11226|||
27957344|NCT01077323|54614253|FG001|Overall Study|<9 months enroll before drug dispensed|263954|||
27957345|NCT01077323|54614254|FG002|Overall Study|<9 months enroll before drug dispensed|11655523|||
27832384|NCT01766921|54311439|FG001|Overall Study|Withdrawal by Subject|5|||
27832385|NCT01774799|54311457|FG000|Overall Study|Lost to Follow-up|1|||
27832386|NCT01774799|54311458|FG001|Overall Study|Lost to Follow-up|1|||
27832387|NCT01774799|54311459|FG002|Overall Study|Lost to Follow-up|0|||
27832388|NCT01774799|54311460|FG003|Overall Study|Lost to Follow-up|0|||
27832389|NCT01774253|54311466|FG000|Overall Study|Lack of Efficacy|4|||
27832390|NCT01774253|54311466|FG000|Overall Study|Physician Decision|2|||
27832391|NCT01774253|54311466|FG000|Overall Study|Withdrawal by Subject|2|||
27832392|NCT01774253|54311466|FG000|Overall Study|Death|1|||
27832393|NCT01765751|54311506|FG000|Overall Study|Lost to Follow-up|0|||
27832394|NCT01765751|54311507|FG001|Overall Study|Lost to Follow-up|2|||
27832395|NCT01765751|54311508|FG002|Overall Study|Lost to Follow-up|1|||
27832396|NCT01736657|54311528|FG000|Overall Study|insufficient vascular access|1|||
27855063|NCT02312258|54374793|FG001|Overall Study|Progressive Disease|188|||
27855064|NCT02312258|54374792|FG000|Overall Study|Withdrawal by Subject|8|||
27855065|NCT02312258|54374793|FG001|Overall Study|Withdrawal by Subject|9|||
27957346|NCT01077323|54614252|FG000|Overall Study|Dispensing of drug in baseline period|0|||
27957347|NCT01077323|54614253|FG001|Overall Study|Dispensing of drug in baseline period|120229|||
27957348|NCT01077323|54614254|FG002|Overall Study|Dispensing of drug in baseline period|256446|||
27957349|NCT01077323|54614252|FG000|Overall Study|Baseline diagnosis of pancreatic disease|152|||
27957350|NCT01077323|54614253|FG001|Overall Study|Baseline diagnosis of pancreatic disease|2080|||
27957351|NCT01077323|54614254|FG002|Overall Study|Baseline diagnosis of pancreatic disease|120|||
27957352|NCT00976950|54614262|FG000|Overall Study|Adverse Event|3|||
27855066|NCT02312258|54374792|FG000|Overall Study|Reason not Specified|11|||
27855067|NCT02312258|54374793|FG001|Overall Study|Reason not Specified|31|||
27855068|NCT02312258|54374792|FG000|Overall Study|Participants Ongoing Treatment|43|||
27855069|NCT02312258|54374793|FG001|Overall Study|Participants Ongoing Treatment|83|||
27855070|NCT03686384|54374963|FG000|Overall Study|Lack of Efficacy|4|||
27855071|NCT03686384|54374964|FG001|Overall Study|Lack of Efficacy|13|||
27855072|NCT03686384|54374963|FG000|Overall Study|Lost to Follow-up|3|||
27855073|NCT03686384|54374964|FG001|Overall Study|Lost to Follow-up|0|||
27855074|NCT03686384|54374963|FG000|Overall Study|Physician Decision|0|||
27855075|NCT03686384|54374964|FG001|Overall Study|Physician Decision|1|||
27855076|NCT03686384|54374963|FG000|Overall Study|Took prohibited medication|0|||
27855077|NCT03686384|54374964|FG001|Overall Study|Took prohibited medication|1|||
27855078|NCT00240331|54375036|FG000|Overall Study|Withdrawal by Subject|125|||
27855079|NCT00240331|54375037|FG001|Overall Study|Withdrawal by Subject|132|||
27855080|NCT00240331|54375036|FG000|Overall Study|Option selected by investigator|1|||
27855081|NCT00240331|54375037|FG001|Overall Study|Option selected by investigator|2|||
27855082|NCT00240097|54375043|FG000|Part I|Adverse Event|1|||
27855083|NCT00240097|54375043|FG000|Part I|Death|1|||
27855084|NCT00240097|54375043|FG000|Part I|histology|1|||
27855085|NCT00240097|54375043|FG000|Part I|unevaluable|1|||
27855086|NCT00240097|54375043|FG000|Part II|did not continue from Part I|23|||
27855087|NCT03620162|54375134|FG000|Overall Study|Physician Decision|4|||
27957353|NCT00976950|54614262|FG000|Overall Study|Events with no relationship to Aptivus|3|||
27957354|NCT00976716|54614266|FG000|Overall Study|Adverse Event|1|||
27957355|NCT00819247|54614274|FG000|Overall Study|Adverse Event|0|||
27957356|NCT00819247|54614275|FG001|Overall Study|Adverse Event|5|||
28165088|NCT03016325|54835755|FG002|32-Day Follow-Up Period|Death|5|||
27832397|NCT01736579|54311543|FG000|Overall Study|Termination of Study by Sponsor|2|||
27855088|NCT03620162|54375135|FG001|Overall Study|Physician Decision|0|||
27855089|NCT03620162|54375136|FG002|Overall Study|Physician Decision|1|||
27855090|NCT03620162|54375137|FG003|Overall Study|Physician Decision|0|||
27855091|NCT03620162|54375138|FG004|Overall Study|Physician Decision|2|||
27855092|NCT03620162|54375134|FG000|Overall Study|Lost to Follow-up|2|||
27855093|NCT03620162|54375135|FG001|Overall Study|Lost to Follow-up|6|||
27957357|NCT00819247|54614276|FG002|Overall Study|Adverse Event|3|||
27957358|NCT00819247|54614274|FG000|Overall Study|Insufficient testosterone response|5|||
27957359|NCT00819247|54614275|FG001|Overall Study|Insufficient testosterone response|8|||
27957360|NCT00819247|54614276|FG002|Overall Study|Insufficient testosterone response|10|||
27957361|NCT00819247|54614274|FG000|Overall Study|Withdrawal by Subject|1|||
27957362|NCT00819247|54614275|FG001|Overall Study|Withdrawal by Subject|0|||
27957363|NCT00819247|54614276|FG002|Overall Study|Withdrawal by Subject|0|||
27957364|NCT00819247|54614274|FG000|Overall Study|Protocol Violation|1|||
27957365|NCT00819247|54614275|FG001|Overall Study|Protocol Violation|0|||
27957366|NCT00819247|54614276|FG002|Overall Study|Protocol Violation|1|||
27957367|NCT00819247|54614274|FG000|Overall Study|Mistakenly withdrawn|0|||
27957368|NCT00819247|54614275|FG001|Overall Study|Mistakenly withdrawn|1|||
27957369|NCT00819247|54614276|FG002|Overall Study|Mistakenly withdrawn|0|||
27957370|NCT00819247|54614274|FG000|Overall Study|Bad prostate-specific antigen response|3|||
27957371|NCT00819247|54614275|FG001|Overall Study|Bad prostate-specific antigen response|2|||
27957372|NCT00819247|54614276|FG002|Overall Study|Bad prostate-specific antigen response|0|||
27957373|NCT00819247|54614274|FG000|Overall Study|Other|1|||
27957374|NCT00819247|54614275|FG001|Overall Study|Other|0|||
27957375|NCT00819247|54614276|FG002|Overall Study|Other|0|||
27957376|NCT00973674|54614286|FG000|Overall Study|Protocol Violation|2|||
27957377|NCT00973674|54614287|FG001|Overall Study|Protocol Violation|0|||
27957378|NCT00819091|54614296|FG000|Overall Study|Adverse Event|3|||
27957379|NCT00819091|54614297|FG001|Overall Study|Adverse Event|5|||
27957380|NCT00819091|54614296|FG000|Overall Study|Protocol Violation|0|||
27957381|NCT00819091|54614297|FG001|Overall Study|Protocol Violation|1|||
27957382|NCT00819091|54614296|FG000|Overall Study|Lost to Follow-up|2|||
27957383|NCT00819091|54614297|FG001|Overall Study|Lost to Follow-up|0|||
27957384|NCT00819091|54614296|FG000|Overall Study|Withdrawal by Subject|1|||
27957385|NCT00819091|54614297|FG001|Overall Study|Withdrawal by Subject|2|||
27957386|NCT00819091|54614296|FG000|Overall Study|Other|1|||
27957387|NCT00819091|54614297|FG001|Overall Study|Other|2|||
27957388|NCT00973362|54614305|FG000|Baseline Evaluation|W/D, later determined to be ineligible|25|||
27957389|NCT00973362|54614306|FG001|Baseline Evaluation|W/D, later determined to be ineligible|0|||
27957390|NCT00973362|54614305|FG000|Baseline Evaluation|No colposcopy visit|62|||
27957391|NCT00973362|54614306|FG001|Baseline Evaluation|No colposcopy visit|0|||
27957392|NCT00973362|54614305|FG000|Baseline Evaluation|Inevaluable|686|||
27957393|NCT00973362|54614306|FG001|Baseline Evaluation|Inevaluable|223|||
27957394|NCT00973362|54614305|FG000|3-Year Follow-up|Lost to Follow-up|17|||
27957395|NCT00973362|54614306|FG001|3-Year Follow-up|Lost to Follow-up|0|||
27957396|NCT00819013|54614319|FG000|Overall Study|Not meeting continuing study eligibility|2|||
27957397|NCT00819013|54614320|FG001|Overall Study|Not meeting continuing study eligibility|1|||
27957398|NCT00819013|54614321|FG002|Overall Study|Not meeting continuing study eligibility|2|||
27957399|NCT00819013|54614322|FG003|Overall Study|Not meeting continuing study eligibility|1|||
27957400|NCT00819013|54614319|FG000|Overall Study|Adverse Event|0|||
27957401|NCT00819013|54614320|FG001|Overall Study|Adverse Event|0|||
27957402|NCT00819013|54614321|FG002|Overall Study|Adverse Event|1|||
27957403|NCT00819013|54614322|FG003|Overall Study|Adverse Event|0|||
27957404|NCT00819013|54614319|FG000|Overall Study|Withdrawal by Subject|1|||
27957405|NCT00819013|54614320|FG001|Overall Study|Withdrawal by Subject|0|||
27957406|NCT00819013|54614321|FG002|Overall Study|Withdrawal by Subject|1|||
27957407|NCT00819013|54614322|FG003|Overall Study|Withdrawal by Subject|0|||
27957408|NCT00819013|54614319|FG000|Overall Study|Lost to Follow-up|0|||
27957409|NCT00819013|54614320|FG001|Overall Study|Lost to Follow-up|0|||
27957410|NCT00819013|54614321|FG002|Overall Study|Lost to Follow-up|1|||
27957411|NCT00819013|54614322|FG003|Overall Study|Lost to Follow-up|2|||
27957412|NCT00819013|54614319|FG000|Overall Study|Death|0|||
27957413|NCT00819013|54614320|FG001|Overall Study|Death|0|||
27957414|NCT00819013|54614321|FG002|Overall Study|Death|0|||
27957415|NCT00819013|54614322|FG003|Overall Study|Death|1|||
27957416|NCT00976560|54614334|FG000|Overall Study|Adverse Event|5|||
27957417|NCT00976560|54614335|FG001|Overall Study|Adverse Event|5|||
27957418|NCT00976560|54614334|FG000|Overall Study|Lack of Efficacy|3|||
27957419|NCT00976560|54614335|FG001|Overall Study|Lack of Efficacy|5|||
27957420|NCT00976560|54614334|FG000|Overall Study|Protocol Violation|1|||
27957421|NCT00976560|54614335|FG001|Overall Study|Protocol Violation|0|||
27957422|NCT00976560|54614334|FG000|Overall Study|Lost to Follow-up|1|||
27957423|NCT00976560|54614335|FG001|Overall Study|Lost to Follow-up|0|||
27957424|NCT00976560|54614334|FG000|Overall Study|Physician Decision|2|||
27957425|NCT00976560|54614335|FG001|Overall Study|Physician Decision|0|||
28082027|NCT00075946|54735444|FG001|Overall Study|Still on treatment at time of analysis|19|||
27957426|NCT00976560|54614334|FG000|Overall Study|Withdrawal by Subject|2|||
27957427|NCT00976560|54614335|FG001|Overall Study|Withdrawal by Subject|3|||
27957428|NCT00976482|54614341|FG000|Overall Study|Death|208|||
27957429|NCT00976482|54614341|FG000|Overall Study|Withdrawal by Subject|45|||
27957430|NCT00976482|54614341|FG000|Overall Study|Center terminated|1|||
27957431|NCT00976482|54614341|FG000|Overall Study|Protocol Violation|5|||
27957432|NCT00975156|54614347|FG000|Overall Study|Protocol Violation|0|||
27957433|NCT00975156|54614348|FG001|Overall Study|Protocol Violation|1|||
27957434|NCT00810043|54614360|FG000|Overall Study|Withdrawal by Subject|1|||
27957435|NCT00810043|54614361|FG001|Overall Study|Withdrawal by Subject|0|||
27957436|NCT00810043|54614362|FG002|Overall Study|Withdrawal by Subject|2|||
27957437|NCT00810043|54614360|FG000|Overall Study|Lost to Follow-up|1|||
27957438|NCT00810043|54614361|FG001|Overall Study|Lost to Follow-up|0|||
27957439|NCT00810043|54614362|FG002|Overall Study|Lost to Follow-up|0|||
27957440|NCT00810043|54614360|FG000|Overall Study|Physician Decision|0|||
27957441|NCT00810043|54614361|FG001|Overall Study|Physician Decision|0|||
27957442|NCT00810043|54614362|FG002|Overall Study|Physician Decision|2|||
27957443|NCT00810043|54614360|FG000|Overall Study|Death|2|||
27957444|NCT00810043|54614361|FG001|Overall Study|Death|0|||
27957445|NCT00810043|54614362|FG002|Overall Study|Death|0|||
27957446|NCT00810043|54614360|FG000|Overall Study|Unrelated medical problem|0|||
27957447|NCT00810043|54614361|FG001|Overall Study|Unrelated medical problem|1|||
27957448|NCT00810043|54614362|FG002|Overall Study|Unrelated medical problem|0|||
27957449|NCT00810043|54614360|FG000|Overall Study|Non-medical problem|0|||
27957450|NCT00810043|54614361|FG001|Overall Study|Non-medical problem|0|||
27957451|NCT00810043|54614362|FG002|Overall Study|Non-medical problem|1|||
27957452|NCT00810043|54614360|FG000|Overall Study|No longer met enrollment criteria|0|||
27957453|NCT00810043|54614361|FG001|Overall Study|No longer met enrollment criteria|0|||
27957454|NCT00810043|54614362|FG002|Overall Study|No longer met enrollment criteria|3|||
27957455|NCT01120184|54614374|FG000|Overall Study|Adverse Event|0|||
27957456|NCT01120184|54614375|FG001|Overall Study|Adverse Event|1|||
27957457|NCT01120184|54614376|FG002|Overall Study|Adverse Event|0|||
27957458|NCT01120184|54614374|FG000|Overall Study|Lost to Follow-up|13|||
27957459|NCT01120184|54614375|FG001|Overall Study|Lost to Follow-up|13|||
27957460|NCT01120184|54614376|FG002|Overall Study|Lost to Follow-up|11|||
27957461|NCT01120184|54614374|FG000|Overall Study|Physician Decision|9|||
27957462|NCT01120184|54614375|FG001|Overall Study|Physician Decision|1|||
27957463|NCT01120184|54614376|FG002|Overall Study|Physician Decision|3|||
27957464|NCT01120184|54614374|FG000|Overall Study|Reason not Specified|8|||
27957465|NCT01120184|54614375|FG001|Overall Study|Reason not Specified|3|||
27957466|NCT01120184|54614376|FG002|Overall Study|Reason not Specified|12|||
27957467|NCT01120184|54614374|FG000|Overall Study|Sponsor Decision to Terminate Study|133|||
27957468|NCT01120184|54614375|FG001|Overall Study|Sponsor Decision to Terminate Study|144|||
27957469|NCT01120184|54614376|FG002|Overall Study|Sponsor Decision to Terminate Study|143|||
27957470|NCT01120184|54614374|FG000|Overall Study|Subject/ Guardian Decision to Withdraw|32|||
27957471|NCT01120184|54614375|FG001|Overall Study|Subject/ Guardian Decision to Withdraw|29|||
27957472|NCT01120184|54614376|FG002|Overall Study|Subject/ Guardian Decision to Withdraw|25|||
27957473|NCT01120184|54614374|FG000|Overall Study|Death|170|||
27957474|NCT01120184|54614375|FG001|Overall Study|Death|176|||
27957475|NCT01120184|54614376|FG002|Overall Study|Death|169|||
27957476|NCT01120028|54614388|FG000|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
27957477|NCT01120028|54614389|FG001|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5|||
27957478|NCT01120028|54614390|FG002|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
27957479|NCT01120028|54614391|FG003|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
27957480|NCT01120028|54614388|FG000|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14|||
27957481|NCT01120028|54614389|FG001|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18|||
27957482|NCT01120028|54614390|FG002|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
27957483|NCT01120028|54614391|FG003|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
27957484|NCT00878800|54614407|FG000|Overall Study|Adverse Event|0|||
27957485|NCT00878800|54614408|FG001|Overall Study|Adverse Event|0|||
27957486|NCT00878800|54614409|FG002|Overall Study|Adverse Event|2|||
27957487|NCT00878800|54614410|FG003|Overall Study|Adverse Event|0|||
27957488|NCT00878800|54614411|FG004|Overall Study|Adverse Event|1|||
27957489|NCT00878800|54614407|FG000|Overall Study|Progressive disease|1|||
27957490|NCT00878800|54614408|FG001|Overall Study|Progressive disease|5|||
27957491|NCT00878800|54614409|FG002|Overall Study|Progressive disease|6|||
27957492|NCT00878800|54614410|FG003|Overall Study|Progressive disease|5|||
27957493|NCT00878800|54614411|FG004|Overall Study|Progressive disease|13|||
27957494|NCT00878800|54614407|FG000|Overall Study|Withdrew consent|1|||
27957495|NCT00878800|54614408|FG001|Overall Study|Withdrew consent|1|||
27957496|NCT00878800|54614409|FG002|Overall Study|Withdrew consent|0|||
27957497|NCT00878800|54614410|FG003|Overall Study|Withdrew consent|1|||
27957498|NCT00878800|54614411|FG004|Overall Study|Withdrew consent|1|||
27732177|NCT02705625|54179642|FG002|Overall Study|Non-compliance|1|||
27832398|NCT01736579|54311544|FG001|Overall Study|Termination of Study by Sponsor|2|||
27957499|NCT00878800|54614407|FG000|Overall Study|Death|0|||
27957500|NCT00878800|54614408|FG001|Overall Study|Death|0|||
27957501|NCT00878800|54614409|FG002|Overall Study|Death|1|||
27957502|NCT00878800|54614410|FG003|Overall Study|Death|0|||
27957503|NCT00878800|54614411|FG004|Overall Study|Death|0|||
27957504|NCT00878800|54614407|FG000|Overall Study|Other|1|||
27957505|NCT00878800|54614408|FG001|Overall Study|Other|1|||
27957506|NCT00878800|54614409|FG002|Overall Study|Other|0|||
27957507|NCT00878800|54614410|FG003|Overall Study|Other|0|||
27957508|NCT00878800|54614411|FG004|Overall Study|Other|1|||
27957509|NCT01119950|54614422|FG000|Overall Study|Adverse Event|25|||
27957510|NCT01119950|54614422|FG000|Overall Study|Withdrawal by Subject|9|||
27957511|NCT01119950|54614422|FG000|Overall Study|Protocol Violation|5|||
27957512|NCT01119950|54614422|FG000|Overall Study|Lost to Follow-up|4|||
27957513|NCT01119950|54614422|FG000|Overall Study|Administrative|2|||
27957514|NCT01119950|54614422|FG000|Overall Study|Abnormal lab value|1|||
27957515|NCT01119950|54614422|FG000|Overall Study|Death|1|||
27957516|NCT01145222|54614452|FG000|Overall Study|Procedure not done (no anesthesiologist)|0|||
27957517|NCT01145222|54614453|FG001|Overall Study|Procedure not done (no anesthesiologist)|0|||
27957518|NCT01145222|54614454|FG002|Overall Study|Procedure not done (no anesthesiologist)|1|||
27957519|NCT01145222|54614455|FG003|Overall Study|Procedure not done (no anesthesiologist)|0|||
27957520|NCT01145222|54614452|FG000|Overall Study|Poor bowel preparation|0|||
27957521|NCT01145222|54614453|FG001|Overall Study|Poor bowel preparation|0|||
27957522|NCT01145222|54614454|FG002|Overall Study|Poor bowel preparation|0|||
27957523|NCT01145222|54614455|FG003|Overall Study|Poor bowel preparation|1|||
27957524|NCT01145066|54614468|FG000|Overall Study|To resume NSAIDs|2|||
27957525|NCT01145066|54614469|FG001|Overall Study|To resume NSAIDs|2|||
27957526|NCT01145066|54614470|FG002|Overall Study|To resume NSAIDs|1|||
27957527|NCT01145066|54614468|FG000|Overall Study|Non-related surgery|0|||
27957528|NCT01145066|54614469|FG001|Overall Study|Non-related surgery|0|||
27957529|NCT01145066|54614470|FG002|Overall Study|Non-related surgery|1|||
27957530|NCT01145066|54614468|FG000|Overall Study|Withdrawal by Subject|0|||
27957531|NCT01145066|54614469|FG001|Overall Study|Withdrawal by Subject|0|||
27957532|NCT01145066|54614470|FG002|Overall Study|Withdrawal by Subject|2|||
27957533|NCT01145066|54614468|FG000|Overall Study|To start new med|1|||
27957534|NCT01145066|54614469|FG001|Overall Study|To start new med|0|||
27957535|NCT01145066|54614470|FG002|Overall Study|To start new med|0|||
27957536|NCT01145066|54614468|FG000|Overall Study|problems swallowing capsule|1|||
27957537|NCT01145066|54614469|FG001|Overall Study|problems swallowing capsule|0|||
27957538|NCT01145066|54614470|FG002|Overall Study|problems swallowing capsule|0|||
27957539|NCT01145066|54614468|FG000|Overall Study|Abdominal discomfort|0|||
27957540|NCT01145066|54614469|FG001|Overall Study|Abdominal discomfort|1|||
27957541|NCT01145066|54614470|FG002|Overall Study|Abdominal discomfort|0|||
27957542|NCT01145066|54614468|FG000|Overall Study|Low platelet count|0|||
27957543|NCT01145066|54614469|FG001|Overall Study|Low platelet count|1|||
27957544|NCT01145066|54614470|FG002|Overall Study|Low platelet count|0|||
27957545|NCT01132118|54614480|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
27957546|NCT01132118|54614481|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
27957547|NCT01132118|54614480|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
27957548|NCT01132118|54614481|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|3|||
27957549|NCT01132118|54614480|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
27957550|NCT01132118|54614481|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
27957551|NCT00972816|54614495|FG000|Overall Study|Adverse Event|0|||
27957552|NCT00972816|54614496|FG001|Overall Study|Adverse Event|0|||
27957553|NCT00972816|54614497|FG002|Overall Study|Adverse Event|1|||
27957554|NCT00972816|54614498|FG003|Overall Study|Adverse Event|0|||
27957555|NCT00972816|54614499|FG004|Overall Study|Adverse Event|0|||
27957556|NCT00972816|54614500|FG005|Overall Study|Adverse Event|0|||
27957557|NCT00972816|54614501|FG006|Overall Study|Adverse Event|0|||
27957558|NCT00972816|54614502|FG007|Overall Study|Adverse Event|0|||
27957559|NCT00972816|54614495|FG000|Overall Study|Withdrawal by Subject|4|||
27957560|NCT00972816|54614496|FG001|Overall Study|Withdrawal by Subject|2|||
27957561|NCT00972816|54614497|FG002|Overall Study|Withdrawal by Subject|1|||
27957562|NCT00972816|54614498|FG003|Overall Study|Withdrawal by Subject|3|||
27957563|NCT00972816|54614499|FG004|Overall Study|Withdrawal by Subject|0|||
27957564|NCT00972816|54614500|FG005|Overall Study|Withdrawal by Subject|1|||
27957565|NCT00972816|54614501|FG006|Overall Study|Withdrawal by Subject|1|||
27957566|NCT00972816|54614502|FG007|Overall Study|Withdrawal by Subject|2|||
27957567|NCT00972816|54614495|FG000|Overall Study|Lost to Follow-up|11|||
27957568|NCT00972816|54614496|FG001|Overall Study|Lost to Follow-up|9|||
27957569|NCT00972816|54614497|FG002|Overall Study|Lost to Follow-up|7|||
27957570|NCT00972816|54614498|FG003|Overall Study|Lost to Follow-up|5|||
27957571|NCT00972816|54614499|FG004|Overall Study|Lost to Follow-up|11|||
27957572|NCT00972816|54614500|FG005|Overall Study|Lost to Follow-up|10|||
27957573|NCT00972816|54614501|FG006|Overall Study|Lost to Follow-up|7|||
27957574|NCT00972816|54614502|FG007|Overall Study|Lost to Follow-up|7|||
27957575|NCT00972816|54614495|FG000|Overall Study|Inappropriate enrolment|0|||
27957576|NCT00972816|54614496|FG001|Overall Study|Inappropriate enrolment|0|||
27957577|NCT00972816|54614497|FG002|Overall Study|Inappropriate enrolment|0|||
27957578|NCT00972816|54614498|FG003|Overall Study|Inappropriate enrolment|0|||
27957579|NCT00972816|54614499|FG004|Overall Study|Inappropriate enrolment|0|||
27957580|NCT00972816|54614500|FG005|Overall Study|Inappropriate enrolment|0|||
27732178|NCT02705625|54179640|FG000|Overall Study|Overdosing|0|||
27957581|NCT00972816|54614501|FG006|Overall Study|Inappropriate enrolment|2|||
27957582|NCT00972816|54614502|FG007|Overall Study|Inappropriate enrolment|0|||
27957583|NCT00972816|54614495|FG000|Overall Study|Unable to classify|2|||
27957584|NCT00972816|54614496|FG001|Overall Study|Unable to classify|0|||
27957585|NCT00972816|54614497|FG002|Overall Study|Unable to classify|0|||
27957586|NCT00972816|54614498|FG003|Overall Study|Unable to classify|0|||
27957587|NCT00972816|54614499|FG004|Overall Study|Unable to classify|1|||
27957588|NCT00972816|54614500|FG005|Overall Study|Unable to classify|0|||
27957589|NCT00972816|54614501|FG006|Overall Study|Unable to classify|0|||
27957590|NCT00972816|54614502|FG007|Overall Study|Unable to classify|0|||
27957591|NCT00969618|54614520|FG000|Overall Study|Adverse Event|29|||
27957592|NCT00969618|54614520|FG000|Overall Study|Entry Criteria Not Met|3|||
27957593|NCT00969618|54614520|FG000|Overall Study|Lack of Efficacy|2|||
27957594|NCT00969618|54614520|FG000|Overall Study|Lost to Follow-up|7|||
27957595|NCT00969618|54614520|FG000|Overall Study|Physician Decision|1|||
27957596|NCT00969618|54614520|FG000|Overall Study|Protocol Violation|9|||
27957597|NCT00969618|54614520|FG000|Overall Study|Withdrawal by Subject|27|||
27957598|NCT00969540|54614526|FG000|Overall Study|Lost to Follow-up|1|||
27957599|NCT00969540|54614527|FG001|Overall Study|Lost to Follow-up|1|||
27957600|NCT00975000|54614547|FG000|Overall Study|Other|1|||
27957601|NCT00975000|54614548|FG001|Overall Study|Other|0|||
27957602|NCT00975000|54614547|FG000|Overall Study|Adverse Event|1|||
27957603|NCT00975000|54614548|FG001|Overall Study|Adverse Event|1|||
27957604|NCT00975000|54614547|FG000|Overall Study|Withdrawal by Subject|2|||
27957605|NCT00975000|54614548|FG001|Overall Study|Withdrawal by Subject|2|||
27957606|NCT00975000|54614547|FG000|Overall Study|Lost to Follow-up|0|||
27957607|NCT00975000|54614548|FG001|Overall Study|Lost to Follow-up|1|||
27957608|NCT00975000|54614547|FG000|Overall Study|Protocol-specified Criteria|1|||
27957609|NCT00975000|54614548|FG001|Overall Study|Protocol-specified Criteria|0|||
27957610|NCT00975000|54614547|FG000|Overall Study|Non-compliance|0|||
27957611|NCT00975000|54614548|FG001|Overall Study|Non-compliance|1|||
27957612|NCT00974922|54614554|FG000|Overall Study|study terminated|24|||
27957613|NCT00972504|54614558|FG000|Overall Study|Adverse Event|2|||
27957614|NCT00972504|54614558|FG000|Overall Study|Investigator discretion|1|||
27957615|NCT00969228|54614570|FG000|Overall Study|Adverse Event|1|||
27957616|NCT00969228|54614571|FG001|Overall Study|Adverse Event|0|||
27957617|NCT00969228|54614570|FG000|Overall Study|Withdrawal by Subject|4|||
27957618|NCT00969228|54614571|FG001|Overall Study|Withdrawal by Subject|0|||
27957619|NCT00969228|54614570|FG000|Overall Study|Porcine circovirus detection in vaccine|38|||
27957620|NCT00969228|54614571|FG001|Overall Study|Porcine circovirus detection in vaccine|14|||
27957621|NCT00969150|54614579|FG000|Overall Study|Adverse Event|4|||
27957622|NCT00969150|54614580|FG001|Overall Study|Adverse Event|14|||
27957623|NCT00969150|54614579|FG000|Overall Study|Lack of Efficacy|1|||
27957624|NCT00969150|54614580|FG001|Overall Study|Lack of Efficacy|1|||
27957625|NCT00969150|54614579|FG000|Overall Study|Protocol Violation|9|||
27957626|NCT00969150|54614580|FG001|Overall Study|Protocol Violation|12|||
27957627|NCT00969150|54614579|FG000|Overall Study|Withdrawal by Subject|13|||
27957628|NCT00969150|54614580|FG001|Overall Study|Withdrawal by Subject|9|||
27957629|NCT00969150|54614579|FG000|Overall Study|Lost to Follow-up|5|||
27957630|NCT00969150|54614580|FG001|Overall Study|Lost to Follow-up|4|||
27957631|NCT00969150|54614579|FG000|Overall Study|Other reasons|1|||
27957632|NCT00969150|54614580|FG001|Overall Study|Other reasons|0|||
27957633|NCT00974220|54614588|FG000|Treatment Period 1|Adverse Event|2|||
27957634|NCT00974220|54614589|FG001|Treatment Period 1|Adverse Event|1|||
27957635|NCT00974220|54614588|FG000|Treatment Period 1|noncompliant subjects|0|||
27957636|NCT00974220|54614589|FG001|Treatment Period 1|noncompliant subjects|1|||
27957637|NCT00971178|54614598|FG000|Overall Study|Lost to Follow-up|2|||
27957638|NCT00971178|54614599|FG001|Overall Study|Lost to Follow-up|2|||
27957639|NCT00971178|54614600|FG002|Overall Study|Lost to Follow-up|2|||
27957640|NCT03670602|54614610|FG000|Overall Study|Lost to Follow-up|1|||
27957641|NCT03670602|54614611|FG001|Overall Study|Lost to Follow-up|0|||
27957642|NCT03670602|54614610|FG000|Overall Study|Withdrawal by Subject|0|||
27957643|NCT03670602|54614611|FG001|Overall Study|Withdrawal by Subject|3|||
27957644|NCT00968526|54614619|FG000|Overall Study|Adverse Event|2|||
27957645|NCT00968526|54614620|FG001|Overall Study|Adverse Event|0|||
27957646|NCT00968526|54614619|FG000|Overall Study|Migrated/moved from study area|1|||
27957647|NCT00968526|54614620|FG001|Overall Study|Migrated/moved from study area|0|||
27957648|NCT03664674|54614637|FG000|Overall Study|Adverse Event|1|||
27957649|NCT03664674|54614638|FG001|Overall Study|Adverse Event|1|||
27832399|NCT01765673|54311575|FG000|Overall Study|No transportation for 2nd/3rd visits|1|||
27832400|NCT01764659|54311582|FG000|Overall Study|Death|1|||
27957650|NCT03664674|54614637|FG000|Overall Study|Physician Decision|0|||
27957651|NCT03664674|54614638|FG001|Overall Study|Physician Decision|1|||
27957652|NCT03664674|54614637|FG000|Overall Study|Withdrawal by Subject|2|||
27957653|NCT03664674|54614638|FG001|Overall Study|Withdrawal by Subject|0|||
27957654|NCT00967668|54614649|FG000|Overall Study|Withdrawal by Subject|13|||
27957655|NCT00967668|54614650|FG001|Overall Study|Withdrawal by Subject|8|||
27957656|NCT00967668|54614651|FG002|Overall Study|Withdrawal by Subject|8|||
27832401|NCT01764659|54311582|FG000|Overall Study|Physician Decision|1|||
27957657|NCT00967668|54614649|FG000|Overall Study|Death|0|||
27957658|NCT00967668|54614650|FG001|Overall Study|Death|2|||
27957659|NCT00967668|54614651|FG002|Overall Study|Death|4|||
27957660|NCT00967668|54614649|FG000|Overall Study|Removed due to behavior|1|||
27957661|NCT00967668|54614650|FG001|Overall Study|Removed due to behavior|1|||
27957662|NCT00967668|54614651|FG002|Overall Study|Removed due to behavior|2|||
27957663|NCT00967668|54614649|FG000|Overall Study|Refused Year 2|11|||
27957664|NCT00967668|54614650|FG001|Overall Study|Refused Year 2|6|||
27957665|NCT00967668|54614651|FG002|Overall Study|Refused Year 2|4|||
27957666|NCT00967668|54614649|FG000|Overall Study|Lost to follow-up at 12-mo|27|||
27957667|NCT00967668|54614650|FG001|Overall Study|Lost to follow-up at 12-mo|29|||
27957668|NCT00967668|54614651|FG002|Overall Study|Lost to follow-up at 12-mo|26|||
27957669|NCT00967668|54614649|FG000|Overall Study|Lost to Follow-up|15|||
27957670|NCT00967668|54614650|FG001|Overall Study|Lost to Follow-up|9|||
27957671|NCT00967668|54614651|FG002|Overall Study|Lost to Follow-up|16|||
27957672|NCT00967668|54614649|FG000|Overall Study|Refused 12-mo assessment|3|||
27957673|NCT00967668|54614650|FG001|Overall Study|Refused 12-mo assessment|1|||
27957674|NCT00967668|54614651|FG002|Overall Study|Refused 12-mo assessment|9|||
27957675|NCT00967668|54614649|FG000|Overall Study|Pregnancy|1|||
27957676|NCT00967668|54614650|FG001|Overall Study|Pregnancy|0|||
27957677|NCT00967668|54614651|FG002|Overall Study|Pregnancy|0|||
27957678|NCT00970944|54614664|FG000|Overall Study|Death|1|||
27957679|NCT00970944|54614665|FG001|Overall Study|Death|0|||
27957680|NCT00970944|54614664|FG000|Overall Study|Physician Decision|0|||
27957681|NCT00970944|54614665|FG001|Overall Study|Physician Decision|2|||
27957682|NCT04839289|54614674|FG000|Overall Study|Withdrawal by Subject|1|||
27957683|NCT04839289|54614675|FG001|Overall Study|Withdrawal by Subject|0|||
27957684|NCT04440813|54614683|FG000|Overall Study|Lost to Follow-up|5|||
27957685|NCT04440813|54614684|FG001|Overall Study|Lost to Follow-up|5|||
27957686|NCT04233073|54614698|FG000|Overall Study|Death|5|||
27957687|NCT04120116|54614706|FG000|Overall Study|Lost to Follow-up|0|||
27957688|NCT04120116|54614707|FG001|Overall Study|Lost to Follow-up|1|||
27957689|NCT04120116|54614708|FG002|Overall Study|Lost to Follow-up|0|||
27957690|NCT04120116|54614709|FG003|Overall Study|Lost to Follow-up|2|||
27957691|NCT04120116|54614706|FG000|Overall Study|Withdrawal by Subject|1|||
27957692|NCT04120116|54614707|FG001|Overall Study|Withdrawal by Subject|0|||
27957693|NCT04120116|54614708|FG002|Overall Study|Withdrawal by Subject|1|||
27957694|NCT04120116|54614709|FG003|Overall Study|Withdrawal by Subject|1|||
27957695|NCT04120116|54614706|FG000|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
27957696|NCT04120116|54614707|FG001|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
27957697|NCT04120116|54614708|FG002|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|1|||
27957698|NCT04120116|54614709|FG003|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
27957699|NCT03657810|54614732|FG000|Overall Study|Adverse Event|0|||
27957700|NCT03657810|54614733|FG001|Overall Study|Adverse Event|1|||
27957701|NCT03657810|54614734|FG002|Overall Study|Adverse Event|0|||
27957702|NCT03657810|54614732|FG000|Overall Study|Lack of Efficacy|4|||
27957703|NCT03657810|54614733|FG001|Overall Study|Lack of Efficacy|1|||
27957704|NCT03657810|54614734|FG002|Overall Study|Lack of Efficacy|3|||
27957705|NCT03657810|54614732|FG000|Overall Study|Protocol Violation|1|||
27957706|NCT03657810|54614733|FG001|Overall Study|Protocol Violation|0|||
27957707|NCT03657810|54614734|FG002|Overall Study|Protocol Violation|0|||
27957708|NCT03657810|54614732|FG000|Overall Study|Lost to Follow-up|0|||
27957709|NCT03657810|54614733|FG001|Overall Study|Lost to Follow-up|1|||
27957710|NCT03657810|54614734|FG002|Overall Study|Lost to Follow-up|0|||
27957711|NCT03657810|54614732|FG000|Overall Study|Not provided|0|||
27957712|NCT03657810|54614733|FG001|Overall Study|Not provided|1|||
27957713|NCT03657810|54614734|FG002|Overall Study|Not provided|0|||
27957714|NCT03370341|54614756|FG000|Overall Study|Lost to Follow-up|0|||
27957715|NCT03370341|54614757|FG001|Overall Study|Lost to Follow-up|1|||
27957716|NCT02614066|54614818|FG000|Overall Study|Initiated KTE-X19 and Died|5|||
27957717|NCT02614066|54614819|FG001|Overall Study|Initiated KTE-X19 and Died|12|||
27957718|NCT02614066|54614820|FG002|Overall Study|Initiated KTE-X19 and Died|11|||
27957719|NCT02614066|54614821|FG003|Overall Study|Initiated KTE-X19 and Died|20|||
27957720|NCT02614066|54614818|FG000|Overall Study|Full Consent Withdrawn|0|||
27957721|NCT02614066|54614819|FG001|Overall Study|Full Consent Withdrawn|1|||
27957722|NCT02614066|54614820|FG002|Overall Study|Full Consent Withdrawn|0|||
27957723|NCT02614066|54614821|FG003|Overall Study|Full Consent Withdrawn|3|||
27957724|NCT02614066|54614818|FG000|Overall Study|Lost to Follow-up|0|||
27957725|NCT02614066|54614819|FG001|Overall Study|Lost to Follow-up|1|||
27957726|NCT02614066|54614820|FG002|Overall Study|Lost to Follow-up|0|||
27957727|NCT02614066|54614821|FG003|Overall Study|Lost to Follow-up|0|||
27957728|NCT02614066|54614818|FG000|Overall Study|Still on-study|1|||
27957729|NCT02614066|54614819|FG001|Overall Study|Still on-study|9|||
27957730|NCT02614066|54614820|FG002|Overall Study|Still on-study|5|||
27957731|NCT02614066|54614821|FG003|Overall Study|Still on-study|32|||
27957732|NCT02614066|54614818|FG000|Overall Study|Enrolled But Did Not Initiate KTE-X19|0|||
27957733|NCT02614066|54614819|FG001|Overall Study|Enrolled But Did Not Initiate KTE-X19|5|||
27957734|NCT02614066|54614820|FG002|Overall Study|Enrolled But Did Not Initiate KTE-X19|4|||
27957735|NCT02614066|54614821|FG003|Overall Study|Enrolled But Did Not Initiate KTE-X19|16|||
27957736|NCT02544074|54614850|FG000|Overall Study|Withdrawal by Subject|0|||
27957737|NCT02544074|54614851|FG001|Overall Study|Withdrawal by Subject|1|||
27957738|NCT02544074|54614852|FG002|Overall Study|Withdrawal by Subject|0|||
27957739|NCT02544074|54614853|FG003|Overall Study|Withdrawal by Subject|0|||
27957740|NCT02544074|54614854|FG004|Overall Study|Withdrawal by Subject|0|||
27957741|NCT02544074|54614855|FG005|Overall Study|Withdrawal by Subject|0|||
27957742|NCT02544074|54614856|FG006|Overall Study|Withdrawal by Subject|0|||
27957743|NCT02544074|54614857|FG007|Overall Study|Withdrawal by Subject|0|||
27957744|NCT02544074|54614858|FG008|Overall Study|Withdrawal by Subject|0|||
27832402|NCT01736189|54311588|FG000|Overall Study|Violation of registration criteria|41|||
27832403|NCT01736189|54311588|FG000|Overall Study|Protocol Violation|4|||
27832404|NCT01736189|54311588|FG000|Overall Study|Criteria and protocol violations|1|||
27832405|NCT01735175|54311620|FG000|Overall Study|Withdrawal by Subject|9|||
27832406|NCT01735175|54311621|FG001|Overall Study|Withdrawal by Subject|2|||
27832407|NCT01735175|54311620|FG000|Overall Study|Lost to Follow-up|4|||
27832408|NCT01735175|54311621|FG001|Overall Study|Lost to Follow-up|2|||
27957745|NCT02544074|54614859|FG009|Overall Study|Withdrawal by Subject|0|||
27957746|NCT02544074|54614860|FG010|Overall Study|Withdrawal by Subject|0|||
27957747|NCT02544074|54614861|FG011|Overall Study|Withdrawal by Subject|0|||
27957748|NCT02544074|54614862|FG012|Overall Study|Withdrawal by Subject|0|||
27957749|NCT02544074|54614863|FG013|Overall Study|Withdrawal by Subject|0|||
27957750|NCT02544074|54614864|FG014|Overall Study|Withdrawal by Subject|0|||
27957751|NCT02544074|54614865|FG015|Overall Study|Withdrawal by Subject|0|||
27957752|NCT02544074|54614866|FG016|Overall Study|Withdrawal by Subject|0|||
27957753|NCT02544074|54614867|FG017|Overall Study|Withdrawal by Subject|0|||
27957754|NCT02544074|54614868|FG018|Overall Study|Withdrawal by Subject|0|||
27957755|NCT02544074|54614869|FG019|Overall Study|Withdrawal by Subject|0|||
27957756|NCT02544074|54614870|FG020|Overall Study|Withdrawal by Subject|0|||
27957757|NCT02544074|54614850|FG000|Overall Study|Tablet error|0|||
27957758|NCT02544074|54614851|FG001|Overall Study|Tablet error|0|||
27957759|NCT02544074|54614852|FG002|Overall Study|Tablet error|0|||
27957760|NCT02544074|54614853|FG003|Overall Study|Tablet error|0|||
27957761|NCT02544074|54614854|FG004|Overall Study|Tablet error|0|||
27957762|NCT02544074|54614855|FG005|Overall Study|Tablet error|1|||
27957763|NCT02544074|54614856|FG006|Overall Study|Tablet error|0|||
27957764|NCT02544074|54614857|FG007|Overall Study|Tablet error|0|||
27957765|NCT02544074|54614858|FG008|Overall Study|Tablet error|0|||
27957766|NCT02544074|54614859|FG009|Overall Study|Tablet error|1|||
27957767|NCT02544074|54614860|FG010|Overall Study|Tablet error|0|||
27957768|NCT02544074|54614861|FG011|Overall Study|Tablet error|0|||
27957769|NCT02544074|54614862|FG012|Overall Study|Tablet error|0|||
27957770|NCT02544074|54614863|FG013|Overall Study|Tablet error|0|||
27957771|NCT02544074|54614864|FG014|Overall Study|Tablet error|0|||
27957772|NCT02544074|54614865|FG015|Overall Study|Tablet error|0|||
27957773|NCT02544074|54614866|FG016|Overall Study|Tablet error|0|||
27957774|NCT02544074|54614867|FG017|Overall Study|Tablet error|0|||
27957775|NCT02544074|54614868|FG018|Overall Study|Tablet error|0|||
27957776|NCT02544074|54614869|FG019|Overall Study|Tablet error|0|||
27957777|NCT02544074|54614870|FG020|Overall Study|Tablet error|0|||
27957778|NCT02502799|54614908|FG000|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
27957779|NCT02502799|54614909|FG001|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
27957780|NCT02502799|54614910|FG002|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
27957781|NCT02502799|54614911|FG003|Phase 1: Brief Intervention Sessions|Lost to Follow-up|12|||
27957782|NCT02502799|54614908|FG000|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
27957783|NCT02502799|54614909|FG001|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
27957784|NCT02502799|54614910|FG002|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
27957785|NCT02502799|54614911|FG003|Phase 1: Brief Intervention Sessions|Early termination of study|5|||
27957786|NCT02502799|54614908|FG000|Phase 2: Intervention Phase|Lost to Follow-up|3|||
27957787|NCT02502799|54614909|FG001|Phase 2: Intervention Phase|Lost to Follow-up|4|||
27957788|NCT02502799|54614910|FG002|Phase 2: Intervention Phase|Lost to Follow-up|1|||
27957789|NCT02502799|54614911|FG003|Phase 2: Intervention Phase|Lost to Follow-up|0|||
27957790|NCT02502799|54614908|FG000|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
27957791|NCT02502799|54614909|FG001|Phase 2: Intervention Phase|Withdrawal by Subject|2|||
27832409|NCT01735175|54311620|FG000|Overall Study|Death|3|||
27957792|NCT02502799|54614910|FG002|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
27957793|NCT02502799|54614911|FG003|Phase 2: Intervention Phase|Withdrawal by Subject|0|||
27957794|NCT02502799|54614908|FG000|Phase 2: Intervention Phase|Study terminated prior to completion|4|||
27957795|NCT02502799|54614909|FG001|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
27957796|NCT02502799|54614910|FG002|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
27957797|NCT02502799|54614911|FG003|Phase 2: Intervention Phase|Study terminated prior to completion|0|||
27957798|NCT02086448|54614924|FG000|Overall Study|Withdrawal by Subject|1|||
27957799|NCT02086448|54614925|FG001|Overall Study|Withdrawal by Subject|0|||
27957800|NCT02086448|54614926|FG002|Overall Study|Withdrawal by Subject|0|||
27957801|NCT02086448|54614927|FG003|Overall Study|Withdrawal by Subject|2|||
27957802|NCT01993836|54614940|FG000|Overall Study|Surgery Cancelled|3|||
27957803|NCT01993836|54614941|FG001|Overall Study|Surgery Cancelled|0|||
27957804|NCT01993836|54614942|FG002|Overall Study|Surgery Cancelled|0|||
27957805|NCT01993836|54614940|FG000|Overall Study|Physician Decision|2|||
27957806|NCT01993836|54614941|FG001|Overall Study|Physician Decision|1|||
27957807|NCT01993836|54614942|FG002|Overall Study|Physician Decision|0|||
27957808|NCT01993836|54614940|FG000|Overall Study|Death|0|||
27957809|NCT01993836|54614941|FG001|Overall Study|Death|2|||
27957810|NCT01993836|54614942|FG002|Overall Study|Death|0|||
27957811|NCT01993836|54614940|FG000|Overall Study|Withdrawal by Subject|12|||
27957812|NCT01993836|54614941|FG001|Overall Study|Withdrawal by Subject|10|||
27957813|NCT01993836|54614942|FG002|Overall Study|Withdrawal by Subject|5|||
27957814|NCT00753545|54614957|FG000|Overall Study|Death|98|||
27957815|NCT00753545|54614958|FG001|Overall Study|Death|112|||
27957816|NCT00753545|54614957|FG000|Overall Study|Lost to Follow-up|2|||
27957817|NCT00753545|54614958|FG001|Overall Study|Lost to Follow-up|3|||
27957818|NCT00753545|54614957|FG000|Overall Study|Protocol Violation|1|||
27957819|NCT00753545|54614958|FG001|Overall Study|Protocol Violation|0|||
27957820|NCT00753545|54614957|FG000|Overall Study|Voluntary Discontinuation of Patient|7|||
27957821|NCT00753545|54614958|FG001|Overall Study|Voluntary Discontinuation of Patient|3|||
27957822|NCT00278915|54614973|FG000|Overall Study|Lack of Efficacy|1|||
27957823|NCT00970632|54614980|FG000|Overall Study|Adverse Event|2|||
27957824|NCT00970632|54614981|FG001|Overall Study|Adverse Event|2|||
27957825|NCT00970632|54614982|FG002|Overall Study|Adverse Event|1|||
27957826|NCT00970632|54614980|FG000|Overall Study|Lack of Efficacy|3|||
27957827|NCT00970632|54614981|FG001|Overall Study|Lack of Efficacy|0|||
27957828|NCT00970632|54614982|FG002|Overall Study|Lack of Efficacy|0|||
27957829|NCT00970632|54614980|FG000|Overall Study|Lost to Follow-up|3|||
27957830|NCT00970632|54614981|FG001|Overall Study|Lost to Follow-up|0|||
27957831|NCT00970632|54614982|FG002|Overall Study|Lost to Follow-up|2|||
27957832|NCT00970632|54614980|FG000|Overall Study|Protocol Violation|8|||
27957833|NCT00970632|54614981|FG001|Overall Study|Protocol Violation|5|||
27957834|NCT00970632|54614982|FG002|Overall Study|Protocol Violation|8|||
27957835|NCT00970632|54614980|FG000|Overall Study|Withdrawal by Subject|7|||
27957836|NCT00970632|54614981|FG001|Overall Study|Withdrawal by Subject|6|||
27957837|NCT00970632|54614982|FG002|Overall Study|Withdrawal by Subject|4|||
27957838|NCT00970632|54614980|FG000|Overall Study|Entry criteria not met|0|||
27957839|NCT00970632|54614981|FG001|Overall Study|Entry criteria not met|2|||
27957840|NCT00970632|54614982|FG002|Overall Study|Entry criteria not met|2|||
27957841|NCT00970632|54614980|FG000|Overall Study|Sponsor decision|1|||
27957842|NCT00970632|54614981|FG001|Overall Study|Sponsor decision|0|||
27957843|NCT00970632|54614982|FG002|Overall Study|Sponsor decision|1|||
27957844|NCT01144364|54614992|FG000|Induction Phase|Disease progression|14|||
27957845|NCT01144364|54614993|FG001|Induction Phase|Disease progression|0|||
27957846|NCT01144364|54614994|FG002|Induction Phase|Disease progression|0|||
27957847|NCT01144364|54614992|FG000|Induction Phase|Adverse Event|9|||
27957848|NCT01144364|54614993|FG001|Induction Phase|Adverse Event|0|||
27957849|NCT01144364|54614994|FG002|Induction Phase|Adverse Event|0|||
27957850|NCT01144364|54614992|FG000|Induction Phase|Death|1|||
27957851|NCT01144364|54614993|FG001|Induction Phase|Death|0|||
27957852|NCT01144364|54614994|FG002|Induction Phase|Death|0|||
27957853|NCT01144364|54614992|FG000|Induction Phase|Withdrawal by Subject|1|||
27957854|NCT01144364|54614993|FG001|Induction Phase|Withdrawal by Subject|0|||
27957855|NCT01144364|54614994|FG002|Induction Phase|Withdrawal by Subject|0|||
27957856|NCT01144364|54614992|FG000|Induction Phase|Lost to Follow-up|2|||
27957857|NCT01144364|54614993|FG001|Induction Phase|Lost to Follow-up|0|||
27957858|NCT01144364|54614994|FG002|Induction Phase|Lost to Follow-up|0|||
27957859|NCT01144364|54614992|FG000|Induction Phase|Physician Decision|1|||
27957860|NCT01144364|54614993|FG001|Induction Phase|Physician Decision|0|||
27957861|NCT01144364|54614994|FG002|Induction Phase|Physician Decision|0|||
27957862|NCT01144364|54614992|FG000|Induction Phase|Stable disease|2|||
27957863|NCT01144364|54614993|FG001|Induction Phase|Stable disease|0|||
27957864|NCT01144364|54614994|FG002|Induction Phase|Stable disease|0|||
27957865|NCT01144364|54614992|FG000|Induction Phase|Secondary neoplasia|1|||
27957866|NCT01144364|54614993|FG001|Induction Phase|Secondary neoplasia|0|||
27957867|NCT01144364|54614994|FG002|Induction Phase|Secondary neoplasia|0|||
27957868|NCT01144364|54614992|FG000|Induction Phase|Protocol Violation|1|||
27957869|NCT01144364|54614993|FG001|Induction Phase|Protocol Violation|0|||
27957870|NCT01144364|54614994|FG002|Induction Phase|Protocol Violation|0|||
27957871|NCT01144364|54614992|FG000|Follow-Up/Maintenance Phase|Disease progression|0|||
27957872|NCT01144364|54614993|FG001|Follow-Up/Maintenance Phase|Disease progression|23|||
27957873|NCT01144364|54614994|FG002|Follow-Up/Maintenance Phase|Disease progression|29|||
28165089|NCT03016325|54835756|FG003|32-Day Follow-Up Period|Death|6|||
27832410|NCT01735175|54311621|FG001|Overall Study|Death|2|||
27957874|NCT01144364|54614992|FG000|Follow-Up/Maintenance Phase|Adverse Event|0|||
27957875|NCT01144364|54614993|FG001|Follow-Up/Maintenance Phase|Adverse Event|3|||
27957876|NCT01144364|54614994|FG002|Follow-Up/Maintenance Phase|Adverse Event|1|||
27957877|NCT01144364|54614992|FG000|Follow-Up/Maintenance Phase|Death|0|||
27957878|NCT01144364|54614993|FG001|Follow-Up/Maintenance Phase|Death|2|||
27957879|NCT01144364|54614994|FG002|Follow-Up/Maintenance Phase|Death|0|||
27732179|NCT02705625|54179641|FG001|Overall Study|Overdosing|0|||
27732180|NCT02705625|54179642|FG002|Overall Study|Overdosing|1|||
27732181|NCT02588612|54179650|FG000|Overall Study|Physician Decision|1|||
27732182|NCT02588612|54179650|FG000|Overall Study|Leukapheresis did not yield enough cells|1|||
27732183|NCT02588612|54179650|FG000|Overall Study|Failed eligibility prior to chemotherapy|2|||
27732184|NCT02588612|54179650|FG000|Overall Study|Death prior to T-cell infusion|1|||
27732185|NCT02704689|54179667|FG000|Overall Study|Physician Decision|1|||
27732186|NCT02704689|54179667|FG000|Overall Study|Study device not implanted|2|||
27732187|NCT02704143|54179671|FG000|Overall Study|disease progression|10|||
27732188|NCT02586506|54179675|FG000|Overall Study|Protocol Violation|6|||
27732189|NCT02586506|54179675|FG000|Overall Study|Lost to Follow-up|1|||
27732190|NCT02586506|54179675|FG000|Overall Study|Other Reason|2|||
27732191|NCT00109031|54179683|FG000|Overall Study|Adverse Event|0|||
27732192|NCT00109031|54179684|FG001|Overall Study|Adverse Event|0|||
27732193|NCT00109031|54179685|FG002|Overall Study|Adverse Event|1|||
27732194|NCT00109031|54179686|FG003|Overall Study|Adverse Event|0|||
27732195|NCT00109031|54179683|FG000|Overall Study|Withdrawal by Subject|0|||
27732196|NCT00109031|54179684|FG001|Overall Study|Withdrawal by Subject|1|||
27732197|NCT00109031|54179685|FG002|Overall Study|Withdrawal by Subject|0|||
27732198|NCT00109031|54179686|FG003|Overall Study|Withdrawal by Subject|0|||
27732199|NCT00109031|54179683|FG000|Overall Study|Physician Decision|0|||
27732200|NCT00109031|54179684|FG001|Overall Study|Physician Decision|1|||
27732201|NCT00109031|54179685|FG002|Overall Study|Physician Decision|0|||
27732202|NCT00109031|54179686|FG003|Overall Study|Physician Decision|0|||
27732203|NCT00109031|54179683|FG000|Overall Study|Protocol Violation|0|||
27732204|NCT00109031|54179684|FG001|Overall Study|Protocol Violation|0|||
27732205|NCT00109031|54179685|FG002|Overall Study|Protocol Violation|1|||
27732206|NCT00109031|54179686|FG003|Overall Study|Protocol Violation|0|||
27732207|NCT01664624|54179700|FG000|Overall Study|Adverse Event|0|||
27732208|NCT01664624|54179701|FG001|Overall Study|Adverse Event|1|||
27732209|NCT01664624|54179702|FG002|Overall Study|Adverse Event|0|||
27732210|NCT01664624|54179703|FG003|Overall Study|Adverse Event|0|||
27732211|NCT02702193|54179715|FG000|Baseline Assessment/Randomization|Withdrawal by Subject|1|||
27732212|NCT02702193|54179716|FG001|Baseline Assessment/Randomization|Withdrawal by Subject|0|||
27732213|NCT02702193|54179715|FG000|4 Month Follow up|Withdrawal by Subject|1|||
27732214|NCT02702193|54179716|FG001|4 Month Follow up|Withdrawal by Subject|0|||
27732215|NCT02702193|54179715|FG000|4 Month Follow up|Lost to Follow-up|17|||
27732216|NCT02702193|54179716|FG001|4 Month Follow up|Lost to Follow-up|18|||
27732217|NCT02702193|54179715|FG000|8 Month Follow up|Withdrawal by Subject|1|||
27732218|NCT02702193|54179716|FG001|8 Month Follow up|Withdrawal by Subject|0|||
27732219|NCT02702193|54179715|FG000|8 Month Follow up|Lost to Follow-up|14|||
27732220|NCT02702193|54179716|FG001|8 Month Follow up|Lost to Follow-up|18|||
27732221|NCT02702193|54179715|FG000|12 Month Follow up|Withdrawal by Subject|1|||
27732222|NCT02702193|54179716|FG001|12 Month Follow up|Withdrawal by Subject|0|||
27732223|NCT02702193|54179715|FG000|12 Month Follow up|Lost to Follow-up|16|||
27732224|NCT02702193|54179716|FG001|12 Month Follow up|Lost to Follow-up|18|||
27732225|NCT02761057|54179726|FG000|Overall Study|Currently On Study Treatment|0|||
27732226|NCT02761057|54179727|FG001|Overall Study|Currently On Study Treatment|3|||
27732227|NCT02761057|54179728|FG002|Overall Study|Currently On Study Treatment|0|||
27732228|NCT02761057|54179729|FG003|Overall Study|Currently On Study Treatment|0|||
27732229|NCT02761057|54179726|FG000|Overall Study|Adverse Event|11|||
27732230|NCT02761057|54179727|FG001|Overall Study|Adverse Event|9|||
27732231|NCT02761057|54179728|FG002|Overall Study|Adverse Event|5|||
27732232|NCT02761057|54179729|FG003|Overall Study|Adverse Event|3|||
27732233|NCT02761057|54179726|FG000|Overall Study|Refusal Unrelated to Adverse Event|2|||
27732234|NCT02761057|54179727|FG001|Overall Study|Refusal Unrelated to Adverse Event|2|||
27732235|NCT02761057|54179728|FG002|Overall Study|Refusal Unrelated to Adverse Event|0|||
27732236|NCT02761057|54179729|FG003|Overall Study|Refusal Unrelated to Adverse Event|2|||
27732237|NCT02761057|54179726|FG000|Overall Study|Progression/Relapse|29|||
27732238|NCT02761057|54179727|FG001|Overall Study|Progression/Relapse|27|||
27732239|NCT02761057|54179728|FG002|Overall Study|Progression/Relapse|20|||
27732240|NCT02761057|54179729|FG003|Overall Study|Progression/Relapse|23|||
27732241|NCT02761057|54179726|FG000|Overall Study|Death|2|||
27732242|NCT02761057|54179727|FG001|Overall Study|Death|2|||
27732243|NCT02761057|54179728|FG002|Overall Study|Death|1|||
27732244|NCT02761057|54179729|FG003|Overall Study|Death|1|||
27732245|NCT02761057|54179726|FG000|Overall Study|Other - Not Protocol Specified|2|||
27832411|NCT01735175|54311620|FG000|Overall Study|Other (mostly EOS/EOT visit missing)|13|||
27732246|NCT02761057|54179727|FG001|Overall Study|Other - Not Protocol Specified|1|||
27732247|NCT02761057|54179728|FG002|Overall Study|Other - Not Protocol Specified|2|||
27732248|NCT02761057|54179729|FG003|Overall Study|Other - Not Protocol Specified|0|||
27732249|NCT02701413|54179741|FG000|Overall Study|Withdrawal by Subject|7|||
27732250|NCT02701413|54179742|FG001|Overall Study|Withdrawal by Subject|11|||
27732251|NCT02582684|54179748|FG000|Overall Study|Unable to contact subject/parent|4|||
27732252|NCT02582684|54179748|FG000|Overall Study|Subject not able to get to clinic|10|||
27732253|NCT02582684|54179748|FG000|Overall Study|Subject withdrew consent|1|||
27957880|NCT01144364|54614992|FG000|Follow-Up/Maintenance Phase|Withdrawal by Subject|0|||
27957881|NCT01144364|54614993|FG001|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
27957882|NCT01144364|54614994|FG002|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
27957883|NCT01144364|54614992|FG000|Follow-Up/Maintenance Phase|Lost to Follow-up|0|||
27957884|NCT01144364|54614993|FG001|Follow-Up/Maintenance Phase|Lost to Follow-up|1|||
27957885|NCT01144364|54614994|FG002|Follow-Up/Maintenance Phase|Lost to Follow-up|4|||
27957886|NCT01144364|54614992|FG000|Follow-Up/Maintenance Phase|Relapse|0|||
27957887|NCT01144364|54614993|FG001|Follow-Up/Maintenance Phase|Relapse|5|||
27957888|NCT01144364|54614994|FG002|Follow-Up/Maintenance Phase|Relapse|5|||
27957889|NCT01144364|54614992|FG000|Follow-Up/Maintenance Phase|Physician Decision|0|||
27957890|NCT01144364|54614993|FG001|Follow-Up/Maintenance Phase|Physician Decision|0|||
27957891|NCT01144364|54614994|FG002|Follow-Up/Maintenance Phase|Physician Decision|1|||
27957892|NCT01119248|54615004|FG000|Overall Study|Physician Decision|5|||
27957893|NCT01131494|54615009|FG000|Overall Study|Withdrawal by Subject|2|||
27957894|NCT01131260|54615016|FG000|Overall Study|Randomization error|5|||
27957895|NCT01131260|54615017|FG001|Overall Study|Randomization error|1|||
27957896|NCT01131260|54615016|FG000|Overall Study|Declined to continue participation|8|||
27957897|NCT01131260|54615017|FG001|Overall Study|Declined to continue participation|13|||
27957898|NCT01131260|54615016|FG000|Overall Study|Physician Decision|22|||
27957899|NCT01131260|54615017|FG001|Overall Study|Physician Decision|24|||
27957900|NCT01131260|54615016|FG000|Overall Study|Technical problems|7|||
27957901|NCT01131260|54615017|FG001|Overall Study|Technical problems|6|||
27957902|NCT01131260|54615016|FG000|Overall Study|Staff error|2|||
27957903|NCT01131260|54615017|FG001|Overall Study|Staff error|1|||
27957904|NCT01131260|54615016|FG000|Overall Study|Ineligible|0|||
27957905|NCT01131260|54615017|FG001|Overall Study|Ineligible|2|||
27957906|NCT00965094|54615027|FG000|Overall Study|Adverse Event|5|||
27957907|NCT00965094|54615028|FG001|Overall Study|Adverse Event|0|||
27957908|NCT00965094|54615027|FG000|Overall Study|Lost to Follow-up|0|||
27957909|NCT00965094|54615028|FG001|Overall Study|Lost to Follow-up|1|||
27957910|NCT01131182|54615037|FG000|Overall Study|Withdrawal by Subject|1|||
27957911|NCT01131182|54615038|FG001|Overall Study|Withdrawal by Subject|1|||
27957912|NCT01131182|54615037|FG000|Overall Study|Lost to Follow-up|14|||
27957913|NCT01131182|54615038|FG001|Overall Study|Lost to Follow-up|15|||
27957914|NCT01131182|54615037|FG000|Overall Study|Other Reason|1|||
27957915|NCT01131182|54615038|FG001|Overall Study|Other Reason|0|||
27957916|NCT00964860|54615046|FG000|Overall Study|Withdrawal by Subject|0|||
27957917|NCT00964860|54615047|FG001|Overall Study|Withdrawal by Subject|1|||
27957918|NCT01131104|54615053|FG000|Overall Study|Withdrawal by Subject|3|||
27957919|NCT01131104|54615053|FG000|Overall Study|Physician Decision|4|||
27957920|NCT01131104|54615053|FG000|Overall Study|Information Not Available|5|||
27957921|NCT01131104|54615053|FG000|Overall Study|No Information on Index Date of Onset|1|||
27957922|NCT01118780|54615059|FG000|Overall Study|Adverse Event|15|||
27957923|NCT01118780|54615060|FG001|Overall Study|Adverse Event|15|||
27957924|NCT01118780|54615059|FG000|Overall Study|Death|1|||
27957925|NCT01118780|54615060|FG001|Overall Study|Death|0|||
27957926|NCT01118780|54615059|FG000|Overall Study|Lack of Efficacy|2|||
27957927|NCT01118780|54615060|FG001|Overall Study|Lack of Efficacy|6|||
27957928|NCT01118780|54615059|FG000|Overall Study|Physician Decision|2|||
27957929|NCT01118780|54615060|FG001|Overall Study|Physician Decision|0|||
27957930|NCT01118780|54615059|FG000|Overall Study|Protocol Violation|3|||
27957931|NCT01118780|54615060|FG001|Overall Study|Protocol Violation|6|||
27957932|NCT01118780|54615059|FG000|Overall Study|Withdrawal by Subject|13|||
27957933|NCT01118780|54615060|FG001|Overall Study|Withdrawal by Subject|8|||
27957934|NCT00964782|54615071|FG000|Overall Study|Lost to Follow-up|1|||
27957935|NCT00964782|54615072|FG001|Overall Study|Lost to Follow-up|0|||
27957936|NCT00966654|54615080|FG000|Overall Study|Study was terminated,PI left institution|12|||
27957937|NCT03262116|54615092|FG000|Overall Study|Physician Decision|0|||
27957938|NCT03262116|54615093|FG001|Overall Study|Physician Decision|2|||
27957939|NCT03262116|54615094|FG002|Overall Study|Physician Decision|1|||
27957940|NCT03262116|54615095|FG003|Overall Study|Physician Decision|1|||
27957941|NCT03262116|54615096|FG004|Overall Study|Physician Decision|1|||
27957942|NCT03262116|54615097|FG005|Overall Study|Physician Decision|2|||
28165090|NCT03016325|54835757|FG004|32-Day Follow-Up Period|Death|3|||
27732254|NCT02582684|54179748|FG000|Overall Study|Found to be ineligible after enrollment|2|||
27957943|NCT01130168|54615105|FG000|Period 1|Withdrawal by Subject|0|||
27957944|NCT01130168|54615106|FG001|Period 1|Withdrawal by Subject|1|||
28165091|NCT03016325|54835758|FG005|32-Day Follow-Up Period|Death|0|||
27957945|NCT01130168|54615107|FG002|Period 1|Withdrawal by Subject|0|||
27957946|NCT01130168|54615108|FG003|Period 1|Withdrawal by Subject|1|||
27957947|NCT01130168|54615109|FG004|Period 1|Withdrawal by Subject|0|||
27957948|NCT01130168|54615110|FG005|Period 1|Withdrawal by Subject|0|||
27957949|NCT01130168|54615105|FG000|Period 1|Discontinued For Other Reason|0|||
27957950|NCT01130168|54615106|FG001|Period 1|Discontinued For Other Reason|0|||
27957951|NCT01130168|54615107|FG002|Period 1|Discontinued For Other Reason|1|||
27957952|NCT01130168|54615108|FG003|Period 1|Discontinued For Other Reason|1|||
27957953|NCT01130168|54615109|FG004|Period 1|Discontinued For Other Reason|0|||
28165092|NCT03016325|54835759|FG006|32-Day Follow-Up Period|Death|0|||
27957954|NCT01130168|54615110|FG005|Period 1|Discontinued For Other Reason|0|||
27957955|NCT01130168|54615105|FG000|Period 1|Adverse Event|0|||
27957956|NCT01130168|54615106|FG001|Period 1|Adverse Event|0|||
27957957|NCT01130168|54615107|FG002|Period 1|Adverse Event|0|||
27957958|NCT01130168|54615108|FG003|Period 1|Adverse Event|1|||
27957959|NCT01130168|54615109|FG004|Period 1|Adverse Event|0|||
27957960|NCT01130168|54615110|FG005|Period 1|Adverse Event|0|||
28082028|NCT00075946|54735445|FG002|Overall Study|Still on treatment at time of analysis|3|||
28082029|NCT00075946|54735446|FG003|Overall Study|Still on treatment at time of analysis|9|||
28082030|NCT00075946|54735447|FG004|Overall Study|Still on treatment at time of analysis|0|||
28082031|NCT00075946|54735443|FG000|Overall Study|Adverse Event|2|||
28082032|NCT00075946|54735444|FG001|Overall Study|Adverse Event|10|||
28082033|NCT00075946|54735445|FG002|Overall Study|Adverse Event|0|||
28082034|NCT00075946|54735446|FG003|Overall Study|Adverse Event|2|||
28082035|NCT00075946|54735447|FG004|Overall Study|Adverse Event|0|||
28082036|NCT00075946|54735443|FG000|Overall Study|Death|0|||
28082037|NCT00075946|54735444|FG001|Overall Study|Death|1|||
28082038|NCT00075946|54735445|FG002|Overall Study|Death|0|||
28082039|NCT00075946|54735446|FG003|Overall Study|Death|0|||
28082040|NCT00075946|54735447|FG004|Overall Study|Death|0|||
28082041|NCT00075946|54735443|FG000|Overall Study|Withdrawal by Subject|23|||
28082042|NCT00075946|54735444|FG001|Overall Study|Withdrawal by Subject|58|||
28082043|NCT00075946|54735445|FG002|Overall Study|Withdrawal by Subject|4|||
28082044|NCT00075946|54735446|FG003|Overall Study|Withdrawal by Subject|9|||
28082045|NCT00075946|54735447|FG004|Overall Study|Withdrawal by Subject|0|||
28082046|NCT00075946|54735443|FG000|Overall Study|Alternative therapy|16|||
28082047|NCT00075946|54735444|FG001|Overall Study|Alternative therapy|2|||
28082048|NCT00075946|54735445|FG002|Overall Study|Alternative therapy|5|||
28082049|NCT00075946|54735446|FG003|Overall Study|Alternative therapy|0|||
28082050|NCT00075946|54735447|FG004|Overall Study|Alternative therapy|0|||
28082051|NCT00075946|54735443|FG000|Overall Study|Other complicating disease|7|||
28082052|NCT00075946|54735444|FG001|Overall Study|Other complicating disease|13|||
28082053|NCT00075946|54735445|FG002|Overall Study|Other complicating disease|1|||
28082054|NCT00075946|54735446|FG003|Overall Study|Other complicating disease|4|||
28082055|NCT00075946|54735447|FG004|Overall Study|Other complicating disease|0|||
28082056|NCT00075946|54735443|FG000|Overall Study|No response to retreatment|23|||
28082057|NCT00075946|54735444|FG001|Overall Study|No response to retreatment|0|||
28082058|NCT00075946|54735445|FG002|Overall Study|No response to retreatment|2|||
28082059|NCT00075946|54735446|FG003|Overall Study|No response to retreatment|0|||
28082060|NCT00075946|54735447|FG004|Overall Study|No response to retreatment|0|||
28082061|NCT00075946|54735443|FG000|Overall Study|Time to progression less than 6 months|15|||
28082062|NCT00075946|54735444|FG001|Overall Study|Time to progression less than 6 months|30|||
28082063|NCT00075946|54735445|FG002|Overall Study|Time to progression less than 6 months|8|||
28082064|NCT00075946|54735446|FG003|Overall Study|Time to progression less than 6 months|3|||
28082065|NCT00075946|54735447|FG004|Overall Study|Time to progression less than 6 months|0|||
28082066|NCT00075946|54735443|FG000|Overall Study|Other|5|||
28082067|NCT00075946|54735444|FG001|Overall Study|Other|13|||
28082068|NCT00075946|54735445|FG002|Overall Study|Other|0|||
28082069|NCT00075946|54735446|FG003|Overall Study|Other|2|||
28082070|NCT00075946|54735447|FG004|Overall Study|Other|0|||
28082071|NCT00057876|54735464|FG000|Overall Study|Adverse Event|8|||
28082072|NCT00057876|54735465|FG001|Overall Study|Adverse Event|8|||
28082073|NCT00057876|54735464|FG000|Overall Study|Death|2|||
28082074|NCT00057876|54735465|FG001|Overall Study|Death|1|||
28082075|NCT00057876|54735464|FG000|Overall Study|Withdrawal by Subject|5|||
28082076|NCT00057876|54735465|FG001|Overall Study|Withdrawal by Subject|6|||
28082077|NCT00057876|54735464|FG000|Overall Study|Lack of Efficacy|10|||
28082078|NCT00057876|54735465|FG001|Overall Study|Lack of Efficacy|8|||
28082079|NCT00057876|54735464|FG000|Overall Study|Ineligible|1|||
28082080|NCT00057876|54735465|FG001|Overall Study|Ineligible|2|||
28082081|NCT00057876|54735464|FG000|Overall Study|other reason|2|||
28082082|NCT00057876|54735465|FG001|Overall Study|other reason|2|||
28082083|NCT00057876|54735464|FG000|Overall Study|other complicating disease|1|||
28082084|NCT00057876|54735465|FG001|Overall Study|other complicating disease|0|||
28082085|NCT00057837|54735473|FG000|Overall Study|Progression/relapse|12|||
28082086|NCT00057837|54735474|FG001|Overall Study|Progression/relapse|14|||
28082087|NCT00057837|54735473|FG000|Overall Study|Adverse Event|2|||
28082088|NCT00057837|54735474|FG001|Overall Study|Adverse Event|12|||
28082089|NCT00057837|54735473|FG000|Overall Study|Death|5|||
28082090|NCT00057837|54735474|FG001|Overall Study|Death|4|||
28082091|NCT00057837|54735473|FG000|Overall Study|Withdrawal by Subject|5|||
28082092|NCT00057837|54735474|FG001|Overall Study|Withdrawal by Subject|3|||
28082093|NCT00057837|54735473|FG000|Overall Study|Alternative therapy|0|||
28082094|NCT00057837|54735474|FG001|Overall Study|Alternative therapy|1|||
28082095|NCT00057837|54735473|FG000|Overall Study|Other complicating disease|2|||
28082096|NCT00057837|54735474|FG001|Overall Study|Other complicating disease|1|||
28082097|NCT00057837|54735473|FG000|Overall Study|Physician Decision|1|||
27957961|NCT01144052|54615121|FG000|Overall Study|Withdrawal by Subject|1|||
27957962|NCT01144052|54615122|FG001|Overall Study|Withdrawal by Subject|1|||
27957963|NCT01143896|54615132|FG000|Overall Study|Did not complete Baseline Interview|5|||
27957964|NCT01143896|54615133|FG001|Overall Study|Did not complete Baseline Interview|4|||
27957965|NCT01143896|54615132|FG000|Overall Study|Lost to Follow-up|18|||
27957966|NCT01143896|54615133|FG001|Overall Study|Lost to Follow-up|13|||
27957967|NCT01143896|54615132|FG000|Overall Study|Withdrawal by Subject|13|||
27957968|NCT01143896|54615133|FG001|Overall Study|Withdrawal by Subject|5|||
27957969|NCT01143896|54615132|FG000|Overall Study|Death|6|||
27957970|NCT01143896|54615133|FG001|Overall Study|Death|3|||
27957971|NCT01118312|54615142|FG000|Overall Study|Lost to Follow-up|33|||
27957972|NCT01118312|54615143|FG001|Overall Study|Lost to Follow-up|32|||
27957973|NCT01118312|54615142|FG000|Overall Study|Withdrawal by Subject|1|||
27957974|NCT01118312|54615143|FG001|Overall Study|Withdrawal by Subject|3|||
27957975|NCT01117766|54615149|FG000|First Intervention|Adverse Event|0|||
27957976|NCT01117766|54615150|FG001|First Intervention|Adverse Event|1|||
27957977|NCT01117766|54615149|FG000|First Intervention|Protocol Violation|1|||
27957978|NCT01117766|54615150|FG001|First Intervention|Protocol Violation|0|||
27957979|NCT01117766|54615149|FG000|Washout Period|Protocol Violation|0|||
27957980|NCT01117766|54615150|FG001|Washout Period|Protocol Violation|2|||
27957981|NCT01117766|54615149|FG000|Second Intervention|Lost to Follow-up|1|||
27957982|NCT01117766|54615150|FG001|Second Intervention|Lost to Follow-up|0|||
27957983|NCT01117766|54615149|FG000|Second Intervention|Other|1|||
27957984|NCT01117766|54615150|FG001|Second Intervention|Other|2|||
27957985|NCT01117766|54615149|FG000|Second Intervention|Adverse Event|0|||
27957986|NCT01117766|54615150|FG001|Second Intervention|Adverse Event|2|||
27957987|NCT01117766|54615149|FG000|Second Intervention|Withdrawal by Subject|0|||
27957988|NCT01117766|54615150|FG001|Second Intervention|Withdrawal by Subject|1|||
27957989|NCT01117454|54615158|FG000|Overall Study|Pregnancy|0|||
27957990|NCT01117454|54615159|FG001|Overall Study|Pregnancy|1|||
27957991|NCT01116440|54615167|FG000|Treatment|Withdrawal by Subject|2|||
27957992|NCT01116440|54615168|FG001|Treatment|Withdrawal by Subject|2|||
27957993|NCT01116440|54615167|FG000|Treatment|Lost to Follow-up|1|||
27957994|NCT01116440|54615168|FG001|Treatment|Lost to Follow-up|1|||
27957995|NCT01116440|54615167|FG000|Treatment|Protocol Violation|0|||
27957996|NCT01116440|54615168|FG001|Treatment|Protocol Violation|2|||
27957997|NCT01116440|54615167|FG000|Treatment|Lack of Efficacy|0|||
27957998|NCT01116440|54615168|FG001|Treatment|Lack of Efficacy|1|||
27957999|NCT01116440|54615167|FG000|Treatment|Adverse Event|0|||
27958000|NCT01116440|54615168|FG001|Treatment|Adverse Event|1|||
27958001|NCT01116440|54615167|FG000|Withdrawal|Withdrawal by Subject|0|||
27958002|NCT01116440|54615168|FG001|Withdrawal|Withdrawal by Subject|1|||
27958003|NCT01116440|54615167|FG000|Withdrawal|Lost to Follow-up|0|||
27958004|NCT01116440|54615168|FG001|Withdrawal|Lost to Follow-up|1|||
27958005|NCT01116440|54615167|FG000|Follow-up|Lost to Follow-up|0|||
27958006|NCT01116440|54615168|FG001|Follow-up|Lost to Follow-up|1|||
27958007|NCT01116440|54615167|FG000|Follow-up|Withdrawal by Subject|0|||
27958008|NCT01116440|54615168|FG001|Follow-up|Withdrawal by Subject|1|||
27958009|NCT01129622|54615176|FG000|Overall Study|Withdrawal by Subject|2|||
27958010|NCT01128842|54615181|FG000|Overall Study|Adverse Event|1|||
27958011|NCT01128842|54615181|FG000|Overall Study|Disease Progression|6|||
27958012|NCT03624036|54615190|FG000|Overall Study|Still on Study|5|||
27958013|NCT03624036|54615191|FG001|Overall Study|Still on Study|1|||
27958014|NCT03624036|54615192|FG002|Overall Study|Still on Study|3|||
27958015|NCT03624036|54615193|FG003|Overall Study|Still on Study|3|||
27958016|NCT03624036|54615190|FG000|Overall Study|Death|1|||
27958017|NCT03624036|54615191|FG001|Overall Study|Death|2|||
27958018|NCT03624036|54615192|FG002|Overall Study|Death|0|||
27958019|NCT03624036|54615193|FG003|Overall Study|Death|0|||
27958020|NCT03624036|54615190|FG000|Overall Study|Enrolled but Never Treated|1|||
27958021|NCT03624036|54615191|FG001|Overall Study|Enrolled but Never Treated|0|||
27958022|NCT03624036|54615192|FG002|Overall Study|Enrolled but Never Treated|0|||
27958023|NCT03624036|54615193|FG003|Overall Study|Enrolled but Never Treated|0|||
27958024|NCT01143038|54615203|FG000|Overall Study|Withdrawal by Subject|4|||
27958025|NCT01143038|54615203|FG000|Overall Study|Requirement for alternative therapy|5|||
27958026|NCT01143038|54615203|FG000|Overall Study|Adverse Event|3|||
27958027|NCT01143038|54615203|FG000|Overall Study|Lost to Follow-up|2|||
27958028|NCT01143038|54615203|FG000|Overall Study|Protocol Deviation|1|||
27958029|NCT01143038|54615203|FG000|Overall Study|Death|1|||
27832412|NCT01735175|54311621|FG001|Overall Study|Other (mostly EOS/EOT visit missing)|7|||
27832413|NCT01762943|54311633|FG000|Overall Study|Physician Decision|1|||
27832414|NCT01762943|54311634|FG001|Overall Study|Physician Decision|1|||
27958030|NCT00966264|54615209|FG000|Overall Study|Lost to Follow-up|4|||
27958031|NCT00966264|54615210|FG001|Overall Study|Lost to Follow-up|3|||
27958032|NCT00915525|54615218|FG000|Overall Study|Protocol Violation|9|||
27958033|NCT00915525|54615219|FG001|Overall Study|Protocol Violation|4|||
27958034|NCT00915525|54615218|FG000|Overall Study|Withdrawal by Subject|59|||
27958035|NCT00915525|54615219|FG001|Overall Study|Withdrawal by Subject|21|||
27958036|NCT00915525|54615218|FG000|Overall Study|Lost to Follow-up|27|||
27958037|NCT00915525|54615219|FG001|Overall Study|Lost to Follow-up|16|||
27958038|NCT00915525|54615218|FG000|Overall Study|Pregnancy|2|||
27958039|NCT00915525|54615219|FG001|Overall Study|Pregnancy|0|||
27958040|NCT00915525|54615218|FG000|Overall Study|Lack of Efficacy|15|||
27958041|NCT00915525|54615219|FG001|Overall Study|Lack of Efficacy|32|||
27958042|NCT00915525|54615218|FG000|Overall Study|Adverse Event|29|||
27958043|NCT00915525|54615219|FG001|Overall Study|Adverse Event|13|||
27958044|NCT00915525|54615218|FG000|Overall Study|Missing|12|||
27958045|NCT00915525|54615219|FG001|Overall Study|Missing|1|||
27958046|NCT00915525|54615218|FG000|Overall Study|Other Reason|35|||
27958047|NCT00915525|54615219|FG001|Overall Study|Other Reason|12|||
27958048|NCT00915525|54615218|FG000|Overall Study|Site Closed|27|||
27958049|NCT00915525|54615219|FG001|Overall Study|Site Closed|9|||
27958050|NCT00915525|54615218|FG000|Overall Study|Retreat Request >Wk 144 (exclusionary)|4|||
27958051|NCT00915525|54615219|FG001|Overall Study|Retreat Request >Wk 144 (exclusionary)|5|||
27958052|NCT00915525|54615218|FG000|Overall Study|Study Burden|28|||
27958053|NCT00915525|54615219|FG001|Overall Study|Study Burden|12|||
27958054|NCT00915525|54615218|FG000|Overall Study|Non-Compliance|3|||
27958055|NCT00915525|54615219|FG001|Overall Study|Non-Compliance|1|||
27958056|NCT00915525|54615218|FG000|Overall Study|Patient Moved|15|||
27958057|NCT00915525|54615219|FG001|Overall Study|Patient Moved|9|||
27958058|NCT01074047|54615247|FG000|Treatment Phase|Adverse Event|89|||
27958059|NCT01074047|54615248|FG001|Treatment Phase|Adverse Event|66|||
27958060|NCT01074047|54615247|FG000|Treatment Phase|Disease Progression|16|||
27958061|NCT01074047|54615248|FG001|Treatment Phase|Disease Progression|21|||
27958062|NCT01074047|54615247|FG000|Treatment Phase|Withdrawal by Subject|27|||
27958063|NCT01074047|54615248|FG001|Treatment Phase|Withdrawal by Subject|48|||
27958064|NCT01074047|54615247|FG000|Treatment Phase|Death|53|||
27958065|NCT01074047|54615248|FG001|Treatment Phase|Death|58|||
27958066|NCT01074047|54615247|FG000|Treatment Phase|Lost to Follow-up|0|||
27958067|NCT01074047|54615248|FG001|Treatment Phase|Lost to Follow-up|1|||
27958068|NCT01074047|54615247|FG000|Treatment Phase|Protocol Violation|0|||
27958069|NCT01074047|54615248|FG001|Treatment Phase|Protocol Violation|1|||
27958070|NCT01074047|54615247|FG000|Treatment Phase|Miscellaneous|32|||
27958071|NCT01074047|54615248|FG001|Treatment Phase|Miscellaneous|39|||
27958072|NCT01074047|54615247|FG000|Survival Follow-Up Phase|Withdrawal by Subject|5|||
27958073|NCT01074047|54615248|FG001|Survival Follow-Up Phase|Withdrawal by Subject|8|||
27958074|NCT01074047|54615247|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
27958075|NCT01074047|54615248|FG001|Survival Follow-Up Phase|Lost to Follow-up|1|||
27958076|NCT01074047|54615247|FG000|Survival Follow-Up Phase|Death|116|||
27958077|NCT01074047|54615248|FG001|Survival Follow-Up Phase|Death|124|||
27958078|NCT01074047|54615247|FG000|Survival Follow-Up Phase|Alive at study closure|1|||
27958079|NCT01074047|54615248|FG001|Survival Follow-Up Phase|Alive at study closure|3|||
27958080|NCT01074047|54615247|FG000|Extension Phase|Physician Decision|1|||
27958081|NCT01074047|54615248|FG001|Extension Phase|Physician Decision|0|||
27958082|NCT01074047|54615247|FG000|Extension Phase|Adverse Event|5|||
27958083|NCT01074047|54615248|FG001|Extension Phase|Adverse Event|0|||
27958084|NCT01074047|54615247|FG000|Extension Phase|Disease Progression|9|||
27958085|NCT01074047|54615248|FG001|Extension Phase|Disease Progression|0|||
27958086|NCT01074047|54615247|FG000|Extension Phase|Withdrawal by Subject|2|||
27958087|NCT01074047|54615248|FG001|Extension Phase|Withdrawal by Subject|0|||
27958088|NCT01074047|54615247|FG000|Extension Phase|Death|5|||
27958089|NCT01074047|54615248|FG001|Extension Phase|Death|0|||
27958090|NCT01142726|54615264|FG000|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
27958091|NCT01142726|54615265|FG001|Treatment Phase: Day 1 Through Month 12|Adverse Event|8|||
27958092|NCT01142726|54615266|FG002|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
27958093|NCT01142726|54615264|FG000|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4|||
27958094|NCT01142726|54615265|FG001|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9|||
27958095|NCT01142726|54615266|FG002|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3|||
27958096|NCT01142726|54615264|FG000|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
27958097|NCT01142726|54615265|FG001|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2|||
27958098|NCT01142726|54615266|FG002|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
27958099|NCT01142726|54615264|FG000|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1|||
27958100|NCT01142726|54615265|FG001|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
27958101|NCT01142726|54615266|FG002|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
27958102|NCT01142726|54615264|FG000|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5|||
27958103|NCT01142726|54615265|FG001|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6|||
27958104|NCT01142726|54615266|FG002|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11|||
27958105|NCT01142726|54615264|FG000|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
27958106|NCT01142726|54615265|FG001|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
27958107|NCT01142726|54615266|FG002|Withdrawal Phase: Months 12 up to 24|Adverse Event|1|||
27958108|NCT01142726|54615264|FG000|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
27732255|NCT02585960|54179755|FG000|PK/Safety Assessment Period|Physician Decision|0|||
27958109|NCT01142726|54615265|FG001|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
27958110|NCT01142726|54615266|FG002|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2|||
27958111|NCT01142726|54615264|FG000|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
27958112|NCT01142726|54615265|FG001|Withdrawal Phase: Months 12 up to 24|Pregnancy|0|||
27958113|NCT01142726|54615266|FG002|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
27958114|NCT01142726|54615264|FG000|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2|||
27958115|NCT01142726|54615265|FG001|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
27958116|NCT01142726|54615266|FG002|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
27958117|NCT01142726|54615264|FG000|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1|||
27958118|NCT01142726|54615265|FG001|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
27958119|NCT01142726|54615266|FG002|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
27958120|NCT01142726|54615264|FG000|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65|||
27958121|NCT01142726|54615265|FG001|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54|||
27958122|NCT01142726|54615266|FG002|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53|||
27958123|NCT01142726|54615264|FG000|Withdrawal Phase: Months 12 up to 24|non-specified|0|||
27958124|NCT01142726|54615265|FG001|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
27958125|NCT01142726|54615266|FG002|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
27958126|NCT01142726|54615264|FG000|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
27958127|NCT01142726|54615265|FG001|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
27958128|NCT01142726|54615266|FG002|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1|||
27958129|NCT01142726|54615264|FG000|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
27958130|NCT01142726|54615265|FG001|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
27958131|NCT01142726|54615266|FG002|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
27958132|NCT01142726|54615264|FG000|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
27958133|NCT01142726|54615265|FG001|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
27958134|NCT01142726|54615266|FG002|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1|||
27958135|NCT01142726|54615264|FG000|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
27958136|NCT01142726|54615265|FG001|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1|||
27958137|NCT01142726|54615266|FG002|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
27958138|NCT01073267|54615282|FG000|Overall Study|Disease Progression|3|||
27958139|NCT01142336|54615288|FG000|Overall Study|Adverse Event|1|||
27958140|NCT01142336|54615289|FG001|Overall Study|Adverse Event|1|||
27958141|NCT01142336|54615288|FG000|Overall Study|Lost to Follow-up|0|||
27958142|NCT01142336|54615289|FG001|Overall Study|Lost to Follow-up|1|||
27958143|NCT00915681|54615298|FG000|Overall Study|Screening failures|46|||
27958144|NCT01128296|54615302|FG000|Overall Study|Physician Decision|0|||
27958145|NCT01128296|54615303|FG001|Overall Study|Physician Decision|0|||
27958146|NCT01128296|54615304|FG002|Overall Study|Physician Decision|0|||
27958147|NCT01128296|54615305|FG003|Overall Study|Physician Decision|0|||
27958148|NCT01128296|54615306|FG004|Overall Study|Physician Decision|0|||
27958149|NCT01128296|54615307|FG005|Overall Study|Physician Decision|3|||
27958150|NCT01128296|54615302|FG000|Overall Study|Withdrawal by Subject|0|||
27958151|NCT01128296|54615303|FG001|Overall Study|Withdrawal by Subject|0|||
27958152|NCT01128296|54615304|FG002|Overall Study|Withdrawal by Subject|0|||
27958153|NCT01128296|54615305|FG003|Overall Study|Withdrawal by Subject|0|||
27958154|NCT01128296|54615306|FG004|Overall Study|Withdrawal by Subject|0|||
27958155|NCT01128296|54615307|FG005|Overall Study|Withdrawal by Subject|2|||
27958156|NCT01115738|54615321|FG000|Overall Study|Death|1|||
27958157|NCT01115738|54615322|FG001|Overall Study|Death|0|||
27958158|NCT01115738|54615323|FG002|Overall Study|Death|0|||
27958159|NCT01115738|54615321|FG000|Overall Study|Lost to Follow-up|0|||
27958160|NCT01115738|54615322|FG001|Overall Study|Lost to Follow-up|0|||
27958161|NCT01115738|54615323|FG002|Overall Study|Lost to Follow-up|1|||
27958162|NCT01115738|54615321|FG000|Overall Study|Physician Decision|18|||
27958163|NCT01115738|54615322|FG001|Overall Study|Physician Decision|15|||
27958164|NCT01115738|54615323|FG002|Overall Study|Physician Decision|17|||
27958165|NCT01115738|54615321|FG000|Overall Study|Withdrawal by Subject|6|||
27958166|NCT01115738|54615322|FG001|Overall Study|Withdrawal by Subject|6|||
27958167|NCT01115738|54615323|FG002|Overall Study|Withdrawal by Subject|9|||
27958168|NCT01141478|54615341|FG000|Overall Study|Withdrawal by Subject|1|||
27958169|NCT01141478|54615342|FG001|Overall Study|Withdrawal by Subject|1|||
27958170|NCT01114880|54615350|FG000|Period 1 (Week 0 to Week 12)|Adverse Event|4|||
27958171|NCT01114880|54615351|FG001|Period 1 (Week 0 to Week 12)|Adverse Event|0|||
27958172|NCT01114880|54615350|FG000|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1|||
27958173|NCT01114880|54615351|FG001|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0|||
27958174|NCT01114880|54615350|FG000|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0|||
27958175|NCT01114880|54615351|FG001|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1|||
27958176|NCT01114880|54615350|FG000|Period 1 (Week 0 to Week 12)|Poor subject compliance|0|||
27958177|NCT01114880|54615351|FG001|Period 1 (Week 0 to Week 12)|Poor subject compliance|1|||
27958178|NCT01114880|54615350|FG000|Period 2 (Week 12 to Week 24)|Adverse Event|3|||
27958179|NCT01114880|54615351|FG001|Period 2 (Week 12 to Week 24)|Adverse Event|0|||
27958180|NCT01114880|54615350|FG000|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0|||
27958181|NCT01114880|54615351|FG001|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2|||
27958182|NCT01114724|54615359|FG000|Overall Study|Death|8|||
27958183|NCT01114724|54615359|FG000|Overall Study|Lost to Follow-up|1|||
27958184|NCT01114724|54615359|FG000|Overall Study|Withdrawal by Subject|1|||
27958185|NCT00964392|54615366|FG000|Overall Study|Withdrawal by Subject|4|||
27958186|NCT00964392|54615367|FG001|Overall Study|Withdrawal by Subject|6|||
27958187|NCT00964392|54615366|FG000|Overall Study|Lost to Follow-up|4|||
27958188|NCT00964392|54615367|FG001|Overall Study|Lost to Follow-up|10|||
27958189|NCT00964392|54615366|FG000|Overall Study|Early Termination, non-study arrhythmia|1|||
27958190|NCT00964392|54615367|FG001|Overall Study|Early Termination, non-study arrhythmia|6|||
27958191|NCT00964392|54615366|FG000|Overall Study|Not completed|44|||
27958192|NCT00964392|54615367|FG001|Overall Study|Not completed|168|||
27958193|NCT00914589|54615376|FG000|Overall Study|Adverse Event|1|||
27958194|NCT00914589|54615377|FG001|Overall Study|Adverse Event|0|||
27958195|NCT00914589|54615378|FG002|Overall Study|Adverse Event|1|||
27958196|NCT00914589|54615376|FG000|Overall Study|Protocol Violation|8|||
27958197|NCT00914589|54615377|FG001|Overall Study|Protocol Violation|6|||
27958198|NCT00914589|54615378|FG002|Overall Study|Protocol Violation|3|||
27958199|NCT00914589|54615376|FG000|Overall Study|unclassified|16|||
27958200|NCT00914589|54615377|FG001|Overall Study|unclassified|9|||
27958201|NCT00914589|54615378|FG002|Overall Study|unclassified|7|||
27958202|NCT00914589|54615376|FG000|Overall Study|Death|0|||
27958203|NCT00914589|54615377|FG001|Overall Study|Death|1|||
27958204|NCT00914589|54615378|FG002|Overall Study|Death|1|||
27958205|NCT00912405|54615386|FG000|Overall Study|Lost to Follow-up|5|||
27958206|NCT00878722|54615398|FG000|Overall Study|Progressive disease|3|||
27958207|NCT00878722|54615399|FG001|Overall Study|Progressive disease|3|||
27958208|NCT00878722|54615400|FG002|Overall Study|Progressive disease|3|||
27958209|NCT00878722|54615401|FG003|Overall Study|Progressive disease|7|||
27958210|NCT00878722|54615402|FG004|Overall Study|Progressive disease|7|||
27958211|NCT00878722|54615403|FG005|Overall Study|Progressive disease|1|||
27958212|NCT00878722|54615404|FG006|Overall Study|Progressive disease|4|||
27958213|NCT00878722|54615405|FG007|Overall Study|Progressive disease|3|||
27958214|NCT00878722|54615398|FG000|Overall Study|Death|0|||
27958215|NCT00878722|54615399|FG001|Overall Study|Death|0|||
27958216|NCT00878722|54615400|FG002|Overall Study|Death|0|||
27958217|NCT00878722|54615401|FG003|Overall Study|Death|1|||
27958218|NCT00878722|54615402|FG004|Overall Study|Death|0|||
27958219|NCT00878722|54615403|FG005|Overall Study|Death|1|||
27958220|NCT00878722|54615404|FG006|Overall Study|Death|0|||
27958221|NCT00878722|54615405|FG007|Overall Study|Death|2|||
27958222|NCT00878722|54615398|FG000|Overall Study|Adverse Event|0|||
27958223|NCT00878722|54615399|FG001|Overall Study|Adverse Event|0|||
27958224|NCT00878722|54615400|FG002|Overall Study|Adverse Event|0|||
27958225|NCT00878722|54615401|FG003|Overall Study|Adverse Event|0|||
27958226|NCT00878722|54615402|FG004|Overall Study|Adverse Event|0|||
27958227|NCT00878722|54615403|FG005|Overall Study|Adverse Event|0|||
27958228|NCT00878722|54615404|FG006|Overall Study|Adverse Event|2|||
27958229|NCT00878722|54615405|FG007|Overall Study|Adverse Event|0|||
27958230|NCT00878722|54615398|FG000|Overall Study|Withdrawal by Subject|0|||
27958231|NCT00878722|54615399|FG001|Overall Study|Withdrawal by Subject|0|||
27958232|NCT00878722|54615400|FG002|Overall Study|Withdrawal by Subject|0|||
27958233|NCT00878722|54615401|FG003|Overall Study|Withdrawal by Subject|0|||
27958234|NCT00878722|54615402|FG004|Overall Study|Withdrawal by Subject|0|||
27958235|NCT00878722|54615403|FG005|Overall Study|Withdrawal by Subject|0|||
27958236|NCT00878722|54615404|FG006|Overall Study|Withdrawal by Subject|0|||
27958237|NCT00878722|54615405|FG007|Overall Study|Withdrawal by Subject|2|||
27958238|NCT00878722|54615398|FG000|Overall Study|Relapse|0|||
27958239|NCT00878722|54615399|FG001|Overall Study|Relapse|0|||
27958240|NCT00878722|54615400|FG002|Overall Study|Relapse|0|||
27958241|NCT00878722|54615401|FG003|Overall Study|Relapse|1|||
27958242|NCT00878722|54615402|FG004|Overall Study|Relapse|0|||
27958243|NCT00878722|54615403|FG005|Overall Study|Relapse|0|||
27958244|NCT00878722|54615404|FG006|Overall Study|Relapse|0|||
27958245|NCT00878722|54615405|FG007|Overall Study|Relapse|0|||
27958246|NCT00964158|54615433|FG000|Overall Study|Lost to Follow-up|0|||
27958247|NCT00964158|54615434|FG001|Overall Study|Lost to Follow-up|1|||
27958248|NCT00964158|54615435|FG002|Overall Study|Lost to Follow-up|2|||
27958249|NCT00964158|54615433|FG000|Overall Study|Withdrawal by Subject|0|||
27958250|NCT00964158|54615434|FG001|Overall Study|Withdrawal by Subject|0|||
27958251|NCT00964158|54615435|FG002|Overall Study|Withdrawal by Subject|6|||
27958252|NCT00961350|54615448|FG000|Overall Study|Adverse Event|18|||
27958253|NCT00961350|54615449|FG001|Overall Study|Adverse Event|33|||
27958254|NCT00961350|54615448|FG000|Overall Study|Withdrawal by Subject|10|||
27958255|NCT00961350|54615449|FG001|Overall Study|Withdrawal by Subject|10|||
27958256|NCT00961350|54615448|FG000|Overall Study|Lost to Follow-up|3|||
27958257|NCT00961350|54615449|FG001|Overall Study|Lost to Follow-up|3|||
27958258|NCT00961350|54615448|FG000|Overall Study|Misc|16|||
27958259|NCT00961350|54615449|FG001|Overall Study|Misc|21|||
27958260|NCT00963924|54615457|FG000|Overall Study|Adverse Event|1|||
27958261|NCT00963924|54615458|FG001|Overall Study|Adverse Event|0|||
27958262|NCT00963924|54615457|FG000|Overall Study|Withdrawal by Subject|0|||
27958263|NCT00963924|54615458|FG001|Overall Study|Withdrawal by Subject|1|||
27958264|NCT00963924|54615457|FG000|Overall Study|Changed antipsychotic|0|||
27958265|NCT00963924|54615458|FG001|Overall Study|Changed antipsychotic|1|||
27958266|NCT00963924|54615457|FG000|Overall Study|Lost to Follow-up|0|||
27958267|NCT00963924|54615458|FG001|Overall Study|Lost to Follow-up|1|||
27958268|NCT03265665|54615468|FG000|24-week Data Collection|Withdrawal by Subject|2|||
27958269|NCT03265665|54615469|FG001|24-week Data Collection|Withdrawal by Subject|2|||
27958270|NCT03265665|54615468|FG000|24-week Data Collection|Lost to Follow-up|4|||
27958271|NCT03265665|54615469|FG001|24-week Data Collection|Lost to Follow-up|5|||
27958272|NCT03265665|54615468|FG000|36-week Data Collection|Lost to Follow-up|6|||
27958273|NCT03265665|54615469|FG001|36-week Data Collection|Lost to Follow-up|8|||
27958274|NCT01114646|54615479|FG000|Overall Study|Withdrawal by Subject|3|||
27958275|NCT01114646|54615480|FG001|Overall Study|Withdrawal by Subject|2|||
27958276|NCT00965562|54615489|FG000|Overall Study|Lost to Follow-up|1|||
27958277|NCT00965562|54615490|FG001|Overall Study|Lost to Follow-up|2|||
27958278|NCT00965562|54615491|FG002|Overall Study|Lost to Follow-up|3|||
27958279|NCT00965562|54615489|FG000|Overall Study|Withdrawal by Subject|2|||
27958280|NCT00965562|54615490|FG001|Overall Study|Withdrawal by Subject|2|||
27958281|NCT00965562|54615491|FG002|Overall Study|Withdrawal by Subject|0|||
27958282|NCT00912093|54615505|FG000|The Controlled Phase|Death|0|||
27958283|NCT00912093|54615506|FG001|The Controlled Phase|Death|1|||
27958284|NCT00912093|54615507|FG002|The Controlled Phase|Death|0|||
27958285|NCT00912093|54615508|FG003|The Controlled Phase|Death|0|||
27958286|NCT00912093|54615509|FG004|The Controlled Phase|Death|0|||
27958287|NCT00912093|54615505|FG000|The Controlled Phase|Medical Condition|0|||
27958288|NCT00912093|54615506|FG001|The Controlled Phase|Medical Condition|1|||
27958289|NCT00912093|54615507|FG002|The Controlled Phase|Medical Condition|0|||
27958290|NCT00912093|54615508|FG003|The Controlled Phase|Medical Condition|0|||
27958291|NCT00912093|54615509|FG004|The Controlled Phase|Medical Condition|0|||
27958292|NCT00912093|54615505|FG000|The Controlled Phase|Lost to Follow-up|0|||
27958293|NCT00912093|54615506|FG001|The Controlled Phase|Lost to Follow-up|0|||
27958294|NCT00912093|54615507|FG002|The Controlled Phase|Lost to Follow-up|0|||
27958295|NCT00912093|54615508|FG003|The Controlled Phase|Lost to Follow-up|0|||
27958296|NCT00912093|54615509|FG004|The Controlled Phase|Lost to Follow-up|1|||
27958297|NCT00965484|54615517|FG000|Overall Study|Protocol Violation|1|||
27958298|NCT00965484|54615517|FG000|Overall Study|Withdrawal by Subject|1|||
27958299|NCT00961116|54615521|FG000|Washout Period of 7 Days|Adverse Event|1|||
27958300|NCT00961116|54615522|FG001|Washout Period of 7 Days|Adverse Event|1|||
27958301|NCT00961116|54615521|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
27958302|NCT00961116|54615522|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
27958303|NCT00961116|54615521|FG000|Washout Period of 7 Days|Protocol Violation|0|||
27958304|NCT00961116|54615522|FG001|Washout Period of 7 Days|Protocol Violation|1|||
27958305|NCT00912015|54615533|FG000|Overall Study|Lack of Efficacy|1|||
27958306|NCT00912015|54615534|FG001|Overall Study|Lack of Efficacy|0|||
27958307|NCT00912015|54615535|FG002|Overall Study|Lack of Efficacy|0|||
27958308|NCT00912015|54615536|FG003|Overall Study|Lack of Efficacy|0|||
27958309|NCT00912015|54615533|FG000|Overall Study|Withdrawal by Subject|8|||
27958310|NCT00912015|54615534|FG001|Overall Study|Withdrawal by Subject|8|||
27958311|NCT00912015|54615535|FG002|Overall Study|Withdrawal by Subject|3|||
27958312|NCT00912015|54615536|FG003|Overall Study|Withdrawal by Subject|0|||
27958313|NCT00912015|54615533|FG000|Overall Study|Protocol Violation|1|||
27958314|NCT00912015|54615534|FG001|Overall Study|Protocol Violation|0|||
27958315|NCT00912015|54615535|FG002|Overall Study|Protocol Violation|0|||
27958316|NCT00912015|54615536|FG003|Overall Study|Protocol Violation|1|||
27958317|NCT00912015|54615533|FG000|Overall Study|Adverse Event|6|||
27958318|NCT00912015|54615534|FG001|Overall Study|Adverse Event|0|||
27958319|NCT00912015|54615535|FG002|Overall Study|Adverse Event|0|||
27958320|NCT00912015|54615536|FG003|Overall Study|Adverse Event|1|||
27958321|NCT00960804|54615549|FG000|Overall Study|Adverse Event|1|||
27958322|NCT00960804|54615550|FG001|Overall Study|Adverse Event|0|||
27958323|NCT00960804|54615551|FG002|Overall Study|Adverse Event|0|||
27958324|NCT00960804|54615549|FG000|Overall Study|Withdrawal by Subject|1|||
27958325|NCT00960804|54615550|FG001|Overall Study|Withdrawal by Subject|0|||
27958326|NCT00960804|54615551|FG002|Overall Study|Withdrawal by Subject|0|||
27958327|NCT00960804|54615549|FG000|Overall Study|Study terminated by the sponsor|5|||
27958328|NCT00960804|54615550|FG001|Overall Study|Study terminated by the sponsor|4|||
27958329|NCT00960804|54615551|FG002|Overall Study|Study terminated by the sponsor|10|||
27855094|NCT03620162|54375136|FG002|Overall Study|Lost to Follow-up|7|||
27958330|NCT01126580|54615562|FG000|Overall Study|Adverse Event|14|||
27958331|NCT01126580|54615563|FG001|Overall Study|Adverse Event|8|||
27958332|NCT01126580|54615564|FG002|Overall Study|Adverse Event|12|||
27958333|NCT01126580|54615562|FG000|Overall Study|Withdrawal by Subject|11|||
27958334|NCT01126580|54615563|FG001|Overall Study|Withdrawal by Subject|19|||
27958335|NCT01126580|54615564|FG002|Overall Study|Withdrawal by Subject|14|||
27958336|NCT01126580|54615562|FG000|Overall Study|Sponsor Decision|5|||
27958337|NCT01126580|54615563|FG001|Overall Study|Sponsor Decision|4|||
27958338|NCT01126580|54615564|FG002|Overall Study|Sponsor Decision|7|||
27958339|NCT01126580|54615562|FG000|Overall Study|Physician Decision|1|||
27958340|NCT01126580|54615563|FG001|Overall Study|Physician Decision|1|||
27958341|NCT01126580|54615564|FG002|Overall Study|Physician Decision|2|||
27958342|NCT01126580|54615562|FG000|Overall Study|Entry Criteria Not Met|1|||
27958343|NCT01126580|54615563|FG001|Overall Study|Entry Criteria Not Met|1|||
27958344|NCT01126580|54615564|FG002|Overall Study|Entry Criteria Not Met|2|||
27958345|NCT01126580|54615562|FG000|Overall Study|Lack of Efficacy|2|||
27958346|NCT01126580|54615563|FG001|Overall Study|Lack of Efficacy|3|||
27958347|NCT01126580|54615564|FG002|Overall Study|Lack of Efficacy|4|||
27958348|NCT01126580|54615562|FG000|Overall Study|Protocol Violation|0|||
27958349|NCT01126580|54615563|FG001|Overall Study|Protocol Violation|1|||
27958350|NCT01126580|54615564|FG002|Overall Study|Protocol Violation|2|||
27958351|NCT01126580|54615562|FG000|Overall Study|Lost to Follow-up|15|||
27958352|NCT01126580|54615563|FG001|Overall Study|Lost to Follow-up|13|||
27958353|NCT01126580|54615564|FG002|Overall Study|Lost to Follow-up|9|||
27958354|NCT01126580|54615562|FG000|Overall Study|Treatment Non-compliance|0|||
27958355|NCT01126580|54615563|FG001|Overall Study|Treatment Non-compliance|2|||
27958356|NCT01126580|54615564|FG002|Overall Study|Treatment Non-compliance|3|||
27958357|NCT00911157|54615575|FG000|Overall Study|Adverse Event|4|||
27958358|NCT00911157|54615576|FG001|Overall Study|Adverse Event|1|||
27958359|NCT00911157|54615575|FG000|Overall Study|Withdrawal by Subject|1|||
27958360|NCT00911157|54615576|FG001|Overall Study|Withdrawal by Subject|1|||
27958361|NCT00911157|54615575|FG000|Overall Study|Need for prohibited drug (heparin)|1|||
27958362|NCT00911157|54615576|FG001|Overall Study|Need for prohibited drug (heparin)|0|||
27958363|NCT00911157|54615575|FG000|Overall Study|Need to treat for lung cancer|1|||
27958364|NCT00911157|54615576|FG001|Overall Study|Need to treat for lung cancer|0|||
27958365|NCT00960570|54615582|FG000|21 Day Washout Period|Adverse Event|1|||
27958366|NCT00960570|54615582|FG000|21 Day Washout Period|Withdrawal by Subject|1|||
27958367|NCT00960570|54615582|FG000|1 Day Period Between Dosing|Adverse Event|2|||
27958368|NCT00960570|54615582|FG000|1 Day Period Between Dosing|Withdrawal by Subject|1|||
27958369|NCT01126424|54615595|FG000|Overall Study|Adverse Event|0|||
27958370|NCT01126424|54615596|FG001|Overall Study|Adverse Event|0|||
27958371|NCT01126424|54615597|FG002|Overall Study|Adverse Event|0|||
27958372|NCT01126424|54615598|FG003|Overall Study|Adverse Event|0|||
27958373|NCT01126424|54615599|FG004|Overall Study|Adverse Event|1|||
27958374|NCT01126424|54615600|FG005|Overall Study|Adverse Event|0|||
27958375|NCT01126424|54615595|FG000|Overall Study|Withdrawal by Subject|0|||
27958376|NCT01126424|54615596|FG001|Overall Study|Withdrawal by Subject|0|||
27958377|NCT01126424|54615597|FG002|Overall Study|Withdrawal by Subject|1|||
27958378|NCT01126424|54615598|FG003|Overall Study|Withdrawal by Subject|3|||
27958379|NCT01126424|54615599|FG004|Overall Study|Withdrawal by Subject|1|||
27958380|NCT01126424|54615600|FG005|Overall Study|Withdrawal by Subject|0|||
27958381|NCT01126268|54615608|FG000|Overall Study|Adverse Event|1|||
27958382|NCT00879658|54615619|FG000|Overall Study|Abnormal laboratory value(s)|3|||
27958383|NCT00879658|54615620|FG001|Overall Study|Abnormal laboratory value(s)|0|||
27958384|NCT00879658|54615621|FG002|Overall Study|Abnormal laboratory value(s)|0|||
27958385|NCT00879658|54615622|FG003|Overall Study|Abnormal laboratory value(s)|1|||
27958386|NCT00879658|54615623|FG004|Overall Study|Abnormal laboratory value(s)|0|||
27958387|NCT00879658|54615624|FG005|Overall Study|Abnormal laboratory value(s)|0|||
27958388|NCT00879658|54615625|FG006|Overall Study|Abnormal laboratory value(s)|0|||
27958389|NCT00879658|54615619|FG000|Overall Study|Administrative problems|2|||
27958390|NCT00879658|54615620|FG001|Overall Study|Administrative problems|1|||
27958391|NCT00879658|54615621|FG002|Overall Study|Administrative problems|0|||
27958392|NCT00879658|54615622|FG003|Overall Study|Administrative problems|1|||
27958393|NCT00879658|54615623|FG004|Overall Study|Administrative problems|0|||
27958394|NCT00879658|54615624|FG005|Overall Study|Administrative problems|0|||
27958395|NCT00879658|54615625|FG006|Overall Study|Administrative problems|0|||
27958396|NCT00879658|54615619|FG000|Overall Study|Adverse Event|6|||
27958397|NCT00879658|54615620|FG001|Overall Study|Adverse Event|4|||
27958398|NCT00879658|54615621|FG002|Overall Study|Adverse Event|3|||
27958399|NCT00879658|54615622|FG003|Overall Study|Adverse Event|1|||
27958400|NCT00879658|54615623|FG004|Overall Study|Adverse Event|2|||
27958401|NCT00879658|54615624|FG005|Overall Study|Adverse Event|0|||
27958402|NCT00879658|54615625|FG006|Overall Study|Adverse Event|0|||
27958403|NCT00879658|54615619|FG000|Overall Study|Protocol Violation|1|||
27958404|NCT00879658|54615620|FG001|Overall Study|Protocol Violation|0|||
27958405|NCT00879658|54615621|FG002|Overall Study|Protocol Violation|0|||
27958406|NCT00879658|54615622|FG003|Overall Study|Protocol Violation|0|||
27958407|NCT00879658|54615623|FG004|Overall Study|Protocol Violation|0|||
27958408|NCT00879658|54615624|FG005|Overall Study|Protocol Violation|0|||
27958409|NCT00879658|54615625|FG006|Overall Study|Protocol Violation|0|||
27958410|NCT00879658|54615619|FG000|Overall Study|Withdrawal by Subject|3|||
27732256|NCT02585960|54179756|FG001|PK/Safety Assessment Period|Physician Decision|1|||
27732257|NCT02585960|54179757|FG002|PK/Safety Assessment Period|Physician Decision|0|||
27958411|NCT00879658|54615620|FG001|Overall Study|Withdrawal by Subject|0|||
27958412|NCT00879658|54615621|FG002|Overall Study|Withdrawal by Subject|2|||
27958413|NCT00879658|54615622|FG003|Overall Study|Withdrawal by Subject|0|||
27958414|NCT00879658|54615623|FG004|Overall Study|Withdrawal by Subject|0|||
28082098|NCT00057837|54735474|FG001|Overall Study|Physician Decision|0|||
27958415|NCT00879658|54615624|FG005|Overall Study|Withdrawal by Subject|1|||
27958416|NCT00879658|54615625|FG006|Overall Study|Withdrawal by Subject|0|||
27958417|NCT00879658|54615619|FG000|Overall Study|Lack of Efficacy|0|||
27958418|NCT00879658|54615620|FG001|Overall Study|Lack of Efficacy|0|||
27958419|NCT00879658|54615621|FG002|Overall Study|Lack of Efficacy|2|||
27958420|NCT00879658|54615622|FG003|Overall Study|Lack of Efficacy|0|||
27958421|NCT00879658|54615623|FG004|Overall Study|Lack of Efficacy|0|||
27958422|NCT00879658|54615624|FG005|Overall Study|Lack of Efficacy|0|||
27958423|NCT00879658|54615625|FG006|Overall Study|Lack of Efficacy|0|||
27958424|NCT00879658|54615619|FG000|Overall Study|misrandomized (never received study med)|0|||
27958425|NCT00879658|54615620|FG001|Overall Study|misrandomized (never received study med)|0|||
27958426|NCT00879658|54615621|FG002|Overall Study|misrandomized (never received study med)|0|||
27958427|NCT00879658|54615622|FG003|Overall Study|misrandomized (never received study med)|1|||
27958428|NCT00879658|54615623|FG004|Overall Study|misrandomized (never received study med)|0|||
27958429|NCT00879658|54615624|FG005|Overall Study|misrandomized (never received study med)|0|||
27958430|NCT00879658|54615625|FG006|Overall Study|misrandomized (never received study med)|0|||
27958431|NCT00959946|54615655|FG000|Overall Study|Adverse Event|0|||
27958432|NCT00959946|54615656|FG001|Overall Study|Adverse Event|0|||
27958433|NCT00959946|54615657|FG002|Overall Study|Adverse Event|2|||
27958434|NCT00959946|54615658|FG003|Overall Study|Adverse Event|1|||
27958435|NCT00959946|54615659|FG004|Overall Study|Adverse Event|0|||
27958436|NCT00959946|54615660|FG005|Overall Study|Adverse Event|1|||
27958437|NCT00959946|54615661|FG006|Overall Study|Adverse Event|0|||
27958438|NCT00959946|54615662|FG007|Overall Study|Adverse Event|0|||
27958439|NCT00959946|54615655|FG000|Overall Study|Death|0|||
27958440|NCT00959946|54615656|FG001|Overall Study|Death|0|||
27958441|NCT00959946|54615657|FG002|Overall Study|Death|0|||
27958442|NCT00959946|54615658|FG003|Overall Study|Death|0|||
27958443|NCT00959946|54615659|FG004|Overall Study|Death|0|||
27958444|NCT00959946|54615660|FG005|Overall Study|Death|1|||
27958445|NCT00959946|54615661|FG006|Overall Study|Death|0|||
27958446|NCT00959946|54615662|FG007|Overall Study|Death|0|||
27958447|NCT00959946|54615655|FG000|Overall Study|Disease Progression|2|||
27958448|NCT00959946|54615656|FG001|Overall Study|Disease Progression|4|||
27958449|NCT00959946|54615657|FG002|Overall Study|Disease Progression|2|||
27958450|NCT00959946|54615658|FG003|Overall Study|Disease Progression|4|||
27958451|NCT00959946|54615659|FG004|Overall Study|Disease Progression|4|||
27958452|NCT00959946|54615660|FG005|Overall Study|Disease Progression|6|||
27958453|NCT00959946|54615661|FG006|Overall Study|Disease Progression|2|||
27958454|NCT00959946|54615662|FG007|Overall Study|Disease Progression|2|||
27958455|NCT00959946|54615655|FG000|Overall Study|Withdrawal by Subject|0|||
27958456|NCT00959946|54615656|FG001|Overall Study|Withdrawal by Subject|0|||
27958457|NCT00959946|54615657|FG002|Overall Study|Withdrawal by Subject|0|||
27958458|NCT00959946|54615658|FG003|Overall Study|Withdrawal by Subject|0|||
27958459|NCT00959946|54615659|FG004|Overall Study|Withdrawal by Subject|0|||
27958460|NCT00959946|54615660|FG005|Overall Study|Withdrawal by Subject|1|||
27958461|NCT00959946|54615661|FG006|Overall Study|Withdrawal by Subject|0|||
27958462|NCT00959946|54615662|FG007|Overall Study|Withdrawal by Subject|0|||
27958463|NCT00911937|54615687|FG000|Overall Study|Death|1|||
27958464|NCT00911937|54615688|FG001|Overall Study|Death|0|||
27958465|NCT00911937|54615687|FG000|Overall Study|Lost to Follow-up|8|||
27958466|NCT00911937|54615688|FG001|Overall Study|Lost to Follow-up|5|||
27958467|NCT00911937|54615687|FG000|Overall Study|Withdrawal by Subject|10|||
27958468|NCT00911937|54615688|FG001|Overall Study|Withdrawal by Subject|7|||
27958469|NCT00911937|54615687|FG000|Overall Study|Withdrawn due to pregnancy|1|||
27958470|NCT00911937|54615688|FG001|Overall Study|Withdrawn due to pregnancy|0|||
27958471|NCT00911937|54615687|FG000|Overall Study|Adverse Event|11|||
27958472|NCT00911937|54615688|FG001|Overall Study|Adverse Event|25|||
27958473|NCT00911937|54615687|FG000|Overall Study|Lack of Efficacy|11|||
27958474|NCT00911937|54615688|FG001|Overall Study|Lack of Efficacy|6|||
27958475|NCT00911937|54615687|FG000|Overall Study|Did not meet inclusion criteria|9|||
27958476|NCT00911937|54615688|FG001|Overall Study|Did not meet inclusion criteria|11|||
27958477|NCT00911937|54615687|FG000|Overall Study|Protocol Violation|14|||
27958478|NCT00911937|54615688|FG001|Overall Study|Protocol Violation|23|||
27958479|NCT00911937|54615687|FG000|Overall Study|Randomized but not treated|13|||
27958480|NCT00911937|54615688|FG001|Overall Study|Randomized but not treated|13|||
27958481|NCT00911937|54615687|FG000|Overall Study|Other|9|||
27958482|NCT00911937|54615688|FG001|Overall Study|Other|5|||
27958483|NCT00880048|54615697|FG000|Overall Study|Adverse Event|2|||
27958484|NCT00880048|54615698|FG001|Overall Study|Adverse Event|3|||
27958485|NCT00880048|54615699|FG002|Overall Study|Adverse Event|5|||
27958486|NCT00880048|54615697|FG000|Overall Study|Lack of Efficacy|1|||
27958487|NCT00880048|54615698|FG001|Overall Study|Lack of Efficacy|2|||
27958488|NCT00880048|54615699|FG002|Overall Study|Lack of Efficacy|2|||
27958489|NCT00880048|54615697|FG000|Overall Study|Protocol Violation|4|||
27958490|NCT00880048|54615698|FG001|Overall Study|Protocol Violation|6|||
27958491|NCT00880048|54615699|FG002|Overall Study|Protocol Violation|5|||
27958492|NCT00880048|54615697|FG000|Overall Study|Lost to Follow-up|6|||
27958493|NCT00880048|54615698|FG001|Overall Study|Lost to Follow-up|6|||
27958494|NCT00880048|54615699|FG002|Overall Study|Lost to Follow-up|5|||
27958495|NCT00880048|54615697|FG000|Overall Study|Physician Decision|1|||
27958496|NCT00880048|54615698|FG001|Overall Study|Physician Decision|1|||
27958497|NCT00880048|54615699|FG002|Overall Study|Physician Decision|7|||
27958498|NCT00880048|54615697|FG000|Overall Study|Withdrawal by Subject|5|||
27958499|NCT00880048|54615698|FG001|Overall Study|Withdrawal by Subject|8|||
27958500|NCT00880048|54615699|FG002|Overall Study|Withdrawal by Subject|5|||
27958501|NCT00880048|54615697|FG000|Overall Study|Study closed/terminated|9|||
27958502|NCT00880048|54615698|FG001|Overall Study|Study closed/terminated|7|||
27958503|NCT00880048|54615699|FG002|Overall Study|Study closed/terminated|6|||
27958504|NCT00962208|54615709|FG000|Overall Study|Could not achieve good vision|9|||
27958505|NCT00962208|54615710|FG001|Overall Study|Could not achieve good vision|0|||
27958506|NCT00962208|54615709|FG000|Overall Study|Contraindicated to continue study|5|||
27958507|NCT00962208|54615710|FG001|Overall Study|Contraindicated to continue study|1|||
27958508|NCT00962208|54615709|FG000|Overall Study|Lost to Follow-up|0|||
27958509|NCT00962208|54615710|FG001|Overall Study|Lost to Follow-up|9|||
27958510|NCT01076543|54615722|FG000|Overall Study|Withdrawal by Subject|2|||
27958511|NCT01076543|54615723|FG001|Overall Study|Withdrawal by Subject|0|||
27958512|NCT01076543|54615724|FG002|Overall Study|Withdrawal by Subject|0|||
27958513|NCT01076543|54615725|FG003|Overall Study|Withdrawal by Subject|0|||
27958514|NCT01076543|54615726|FG004|Overall Study|Withdrawal by Subject|0|||
27958515|NCT01076543|54615727|FG005|Overall Study|Withdrawal by Subject|0|||
27958516|NCT01072877|54615747|FG000|Overall Study|Lost to Follow-up|1|||
27958517|NCT01072877|54615748|FG001|Overall Study|Lost to Follow-up|1|||
27958518|NCT01072877|54615749|FG002|Overall Study|Lost to Follow-up|0|||
27958519|NCT01072877|54615750|FG003|Overall Study|Lost to Follow-up|2|||
27958520|NCT01072877|54615751|FG004|Overall Study|Lost to Follow-up|0|||
27958521|NCT00961896|54615768|FG000|Overall Study|Abnormal laboratory value|0|||
27958522|NCT00961896|54615769|FG001|Overall Study|Abnormal laboratory value|0|||
27958523|NCT00961896|54615770|FG002|Overall Study|Abnormal laboratory value|1|||
27958524|NCT00957528|54615784|FG000|Overall Study|Protocol Violation|0|||
27958525|NCT00957528|54615785|FG001|Overall Study|Protocol Violation|1|||
27958526|NCT00957528|54615786|FG002|Overall Study|Protocol Violation|0|||
27958527|NCT00957528|54615784|FG000|Overall Study|Withdrawal by Subject|0|||
27958528|NCT00957528|54615785|FG001|Overall Study|Withdrawal by Subject|0|||
27958529|NCT00957528|54615786|FG002|Overall Study|Withdrawal by Subject|1|||
27958530|NCT00958776|54615796|FG000|Overall Study|Adverse Event|0|||
27958531|NCT00958776|54615797|FG001|Overall Study|Adverse Event|1|||
27958532|NCT00958776|54615796|FG000|Overall Study|Physician Decision|1|||
27958533|NCT00958776|54615797|FG001|Overall Study|Physician Decision|0|||
27958534|NCT00958776|54615796|FG000|Overall Study|Lost to Follow-up|2|||
27958535|NCT00958776|54615797|FG001|Overall Study|Lost to Follow-up|6|||
27958536|NCT00958776|54615796|FG000|Overall Study|Withdrawal by Subject|7|||
27958537|NCT00958776|54615797|FG001|Overall Study|Withdrawal by Subject|16|||
27958538|NCT00958776|54615796|FG000|Overall Study|Protocol Violation|1|||
27958539|NCT00958776|54615797|FG001|Overall Study|Protocol Violation|1|||
27958540|NCT00958776|54615796|FG000|Overall Study|Death|2|||
27958541|NCT00958776|54615797|FG001|Overall Study|Death|1|||
27958542|NCT00958776|54615796|FG000|Overall Study|Noncompliance; Protocol Deviations|2|||
27958543|NCT00958776|54615797|FG001|Overall Study|Noncompliance; Protocol Deviations|3|||
27958544|NCT00958776|54615796|FG000|Overall Study|Missing|1|||
27958545|NCT00958776|54615797|FG001|Overall Study|Missing|1|||
27958546|NCT00596830|54615806|FG000|Overall Study|Death|258|||
27958547|NCT00596830|54615807|FG001|Overall Study|Death|247|||
27958548|NCT00596830|54615806|FG000|Overall Study|Lost to Follow-up|7|||
27958549|NCT00596830|54615807|FG001|Overall Study|Lost to Follow-up|11|||
27958550|NCT00596830|54615806|FG000|Overall Study|Withdrawal by Subject|22|||
27958551|NCT00596830|54615807|FG001|Overall Study|Withdrawal by Subject|12|||
27958552|NCT00596830|54615806|FG000|Overall Study|Study terminated by sponsor|51|||
27958553|NCT00596830|54615807|FG001|Overall Study|Study terminated by sponsor|62|||
27958554|NCT00596830|54615806|FG000|Overall Study|Follow-up was discontinued|1|||
27958555|NCT00596830|54615807|FG001|Overall Study|Follow-up was discontinued|0|||
27958556|NCT00596830|54615806|FG000|Overall Study|Randomized but not treated|3|||
27958557|NCT00596830|54615807|FG001|Overall Study|Randomized but not treated|7|||
27958558|NCT00957372|54615816|FG000|PART I|Lost to Follow-up|0|||
27958559|NCT00957372|54615817|FG001|PART I|Lost to Follow-up|0|||
27958560|NCT00957372|54615818|FG002|PART I|Lost to Follow-up|1|||
27958561|NCT00957372|54615819|FG003|PART I|Lost to Follow-up|0|||
27958562|NCT00957372|54615816|FG000|PART II|Withdrawal by Subject|0|||
27958563|NCT00957372|54615817|FG001|PART II|Withdrawal by Subject|0|||
27958564|NCT00957372|54615818|FG002|PART II|Withdrawal by Subject|0|||
27732258|NCT02585960|54179755|FG000|PK/Safety Assessment Period|Withdrawal by Subject|1|||
27958565|NCT00957372|54615819|FG003|PART II|Withdrawal by Subject|8|||
27958566|NCT00957372|54615816|FG000|PART II|Physician Decision|0|||
27958567|NCT00957372|54615817|FG001|PART II|Physician Decision|0|||
27958568|NCT00957372|54615818|FG002|PART II|Physician Decision|0|||
27958569|NCT00957372|54615819|FG003|PART II|Physician Decision|1|||
27958570|NCT00957372|54615816|FG000|PART II|Pregnancy|0|||
27958571|NCT00957372|54615817|FG001|PART II|Pregnancy|0|||
27958572|NCT00957372|54615818|FG002|PART II|Pregnancy|0|||
27958573|NCT00957372|54615819|FG003|PART II|Pregnancy|1|||
27958574|NCT00957372|54615816|FG000|PART II|Not Know|0|||
27958575|NCT00957372|54615817|FG001|PART II|Not Know|0|||
27958576|NCT00957372|54615818|FG002|PART II|Not Know|0|||
27958577|NCT00957372|54615819|FG003|PART II|Not Know|20|||
27958578|NCT00957372|54615816|FG000|PART II|Adverse Event|0|||
27958579|NCT00957372|54615817|FG001|PART II|Adverse Event|0|||
27958580|NCT00957372|54615818|FG002|PART II|Adverse Event|0|||
27958581|NCT00957372|54615819|FG003|PART II|Adverse Event|10|||
27958582|NCT00957372|54615816|FG000|PART II|Patient non-compliance|0|||
27958583|NCT00957372|54615817|FG001|PART II|Patient non-compliance|0|||
27958584|NCT00957372|54615818|FG002|PART II|Patient non-compliance|0|||
27958585|NCT00957372|54615819|FG003|PART II|Patient non-compliance|4|||
27958586|NCT00953160|54615835|FG000|Overall Study|Lost to Follow-up|23|||
27958587|NCT00953160|54615835|FG000|Overall Study|Withdrawal by Subject|4|||
27958588|NCT00952848|54615839|FG000|Overall Study|Withdrawal by Subject|4|||
27958589|NCT00952614|54615843|FG000|Overall Study|Death|3|||
27958590|NCT00952614|54615843|FG000|Overall Study|Lost to Follow-up|3|||
27958591|NCT00952614|54615843|FG000|Overall Study|other reason|1|||
27958592|NCT00911859|54615851|FG000|Treatment Period|Adverse Event|3|||
27958593|NCT00911859|54615852|FG001|Treatment Period|Adverse Event|3|||
27958594|NCT00911859|54615853|FG002|Treatment Period|Adverse Event|7|||
27958595|NCT00911859|54615851|FG000|Treatment Period|Death|1|||
27958596|NCT00911859|54615852|FG001|Treatment Period|Death|3|||
27958597|NCT00911859|54615853|FG002|Treatment Period|Death|5|||
27958598|NCT00911859|54615851|FG000|Treatment Period|Lack of Efficacy|1|||
27958599|NCT00911859|54615852|FG001|Treatment Period|Lack of Efficacy|7|||
27958600|NCT00911859|54615853|FG002|Treatment Period|Lack of Efficacy|5|||
27958601|NCT00911859|54615851|FG000|Treatment Period|Physician Decision|3|||
27958602|NCT00911859|54615852|FG001|Treatment Period|Physician Decision|3|||
27958603|NCT00911859|54615853|FG002|Treatment Period|Physician Decision|3|||
27958604|NCT00911859|54615851|FG000|Treatment Period|Withdrawal by Subject|0|||
27958605|NCT00911859|54615852|FG001|Treatment Period|Withdrawal by Subject|4|||
27958606|NCT00911859|54615853|FG002|Treatment Period|Withdrawal by Subject|5|||
27958607|NCT00911859|54615851|FG000|Treatment Period|Did not receive study treatment|0|||
27958608|NCT00911859|54615852|FG001|Treatment Period|Did not receive study treatment|1|||
27958609|NCT00911859|54615853|FG002|Treatment Period|Did not receive study treatment|0|||
27958610|NCT00911859|54615851|FG000|Maintainance Period|Lack of Efficacy|0|||
27958611|NCT00911859|54615852|FG001|Maintainance Period|Lack of Efficacy|0|||
27958612|NCT00911859|54615853|FG002|Maintainance Period|Lack of Efficacy|9|||
27958613|NCT00911859|54615851|FG000|Maintainance Period|Physician Decision|0|||
27958614|NCT00911859|54615852|FG001|Maintainance Period|Physician Decision|0|||
27958615|NCT00911859|54615853|FG002|Maintainance Period|Physician Decision|9|||
27958616|NCT00911859|54615851|FG000|Maintainance Period|Withdrawal by Subject|0|||
27958617|NCT00911859|54615852|FG001|Maintainance Period|Withdrawal by Subject|0|||
27958618|NCT00911859|54615853|FG002|Maintainance Period|Withdrawal by Subject|3|||
27958619|NCT00911859|54615851|FG000|Follow-up Period|Death|5|||
27958620|NCT00911859|54615852|FG001|Follow-up Period|Death|8|||
27958621|NCT00911859|54615853|FG002|Follow-up Period|Death|10|||
27958622|NCT00911859|54615851|FG000|Follow-up Period|Lost to Follow-up|1|||
27958623|NCT00911859|54615852|FG001|Follow-up Period|Lost to Follow-up|1|||
27958624|NCT00911859|54615853|FG002|Follow-up Period|Lost to Follow-up|0|||
27958625|NCT00911859|54615851|FG000|Follow-up Period|Withdrawal by Subject|0|||
27958626|NCT00911859|54615852|FG001|Follow-up Period|Withdrawal by Subject|4|||
27958627|NCT00911859|54615853|FG002|Follow-up Period|Withdrawal by Subject|4|||
27958628|NCT00911859|54615851|FG000|Follow-up Period|Study terminated by sponsor|5|||
27958629|NCT00911859|54615852|FG001|Follow-up Period|Study terminated by sponsor|33|||
27958630|NCT00911859|54615853|FG002|Follow-up Period|Study terminated by sponsor|27|||
27958631|NCT00956592|54615863|FG000|Overall Study|Protocol Violation|1|||
27958632|NCT00956592|54615864|FG001|Overall Study|Protocol Violation|3|||
27958633|NCT00955968|54615874|FG000|Overall Study|Death|2|||
27732259|NCT02585960|54179756|FG001|PK/Safety Assessment Period|Withdrawal by Subject|2|||
27832415|NCT01762943|54311633|FG000|Overall Study|Protocol Violation|1|||
27958634|NCT00955968|54615875|FG001|Overall Study|Death|4|||
27958635|NCT00955968|54615874|FG000|Overall Study|Withdrawal by Subject|35|||
27958636|NCT00955968|54615875|FG001|Overall Study|Withdrawal by Subject|31|||
27958637|NCT00955968|54615874|FG000|Overall Study|Lost to Follow-up|45|||
27958638|NCT00955968|54615875|FG001|Overall Study|Lost to Follow-up|39|||
27958639|NCT00955968|54615874|FG000|Overall Study|Site closed|55|||
27958640|NCT00955968|54615875|FG001|Overall Study|Site closed|52|||
27732260|NCT02585960|54179757|FG002|PK/Safety Assessment Period|Withdrawal by Subject|5|||
27958641|NCT02725593|54615886|FG000|Blinded Treatment Period|Withdrawal by Subject|4|||
27958642|NCT02725593|54615887|FG001|Blinded Treatment Period|Withdrawal by Subject|3|||
27958643|NCT02725593|54615886|FG000|Blinded Treatment Period|Withdrawal by Parent/Guardian|0|||
27958644|NCT02725593|54615887|FG001|Blinded Treatment Period|Withdrawal by Parent/Guardian|2|||
27958645|NCT02725593|54615886|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
27958646|NCT02725593|54615887|FG001|Blinded Treatment Period|Lost to Follow-up|1|||
27958647|NCT02725593|54615886|FG000|Long Term Extension|Withdrawal by Subject|1|||
27958648|NCT02725593|54615887|FG001|Long Term Extension|Withdrawal by Subject|3|||
27958649|NCT00911625|54615895|FG000|Overall Study|Lost to Follow-up|7|||
27958650|NCT00911625|54615896|FG001|Overall Study|Lost to Follow-up|0|||
27958651|NCT00596752|54615904|FG000|Overall Study|Other Reason|44|||
27958652|NCT00596752|54615905|FG001|Overall Study|Other Reason|49|||
27958653|NCT00596752|54615904|FG000|Overall Study|Adverse Event|34|||
27958654|NCT00596752|54615905|FG001|Overall Study|Adverse Event|34|||
27958655|NCT00596752|54615904|FG000|Overall Study|Lost to Follow-up|22|||
27958656|NCT00596752|54615905|FG001|Overall Study|Lost to Follow-up|38|||
27958657|NCT00596752|54615904|FG000|Overall Study|Withdrawal by Subject|12|||
27958658|NCT00596752|54615905|FG001|Overall Study|Withdrawal by Subject|9|||
27958659|NCT00596752|54615904|FG000|Overall Study|Unsatisfactory Compliance|9|||
27958660|NCT00596752|54615905|FG001|Overall Study|Unsatisfactory Compliance|6|||
27958661|NCT00596752|54615904|FG000|Overall Study|Lack of Efficacy|4|||
27958662|NCT00596752|54615905|FG001|Overall Study|Lack of Efficacy|7|||
27958663|NCT00596752|54615904|FG000|Overall Study|Protocol Violation|1|||
27958664|NCT00596752|54615905|FG001|Overall Study|Protocol Violation|0|||
27958665|NCT00958074|54615913|FG000|Overall Study|Withdrawal by Subject|0|||
27958666|NCT00958074|54615914|FG001|Overall Study|Withdrawal by Subject|1|||
27958667|NCT00809965|54615923|FG000|Overall Study|Death|194|||
27958668|NCT00809965|54615924|FG001|Overall Study|Death|147|||
27958669|NCT00809965|54615925|FG002|Overall Study|Death|196|||
27958670|NCT00809965|54615923|FG000|Overall Study|Lost to Follow-up|17|||
27958671|NCT00809965|54615924|FG001|Overall Study|Lost to Follow-up|10|||
27958672|NCT00809965|54615925|FG002|Overall Study|Lost to Follow-up|18|||
27958673|NCT00809965|54615923|FG000|Overall Study|Withdrawal by Subject|405|||
27958674|NCT00809965|54615924|FG001|Overall Study|Withdrawal by Subject|448|||
27958675|NCT00809965|54615925|FG002|Overall Study|Withdrawal by Subject|441|||
27958676|NCT00809965|54615923|FG000|Overall Study|Other Reason|167|||
27958677|NCT00809965|54615924|FG001|Overall Study|Other Reason|170|||
27958678|NCT00809965|54615925|FG002|Overall Study|Other Reason|189|||
27958679|NCT00597376|54615935|FG000|Overall Study|Withdrawal by Subject|4|||
27958680|NCT00597376|54615936|FG001|Overall Study|Withdrawal by Subject|3|||
27958681|NCT00597376|54615935|FG000|Overall Study|Adverse Event|4|||
27958682|NCT00597376|54615936|FG001|Overall Study|Adverse Event|1|||
27958683|NCT00910689|54615972|FG000|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2|||
27958684|NCT00910689|54615973|FG001|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1|||
27958685|NCT00910689|54615974|FG002|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5|||
27958686|NCT00910689|54615975|FG003|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10|||
27958687|NCT00910689|54615972|FG000|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
27958688|NCT00910689|54615973|FG001|Month 2- 4: Treatment Period|Lost to Follow-up|4|||
27958689|NCT00910689|54615974|FG002|Month 2- 4: Treatment Period|Lost to Follow-up|1|||
27958690|NCT00910689|54615975|FG003|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
27958691|NCT00910689|54615972|FG000|Month 2- 4: Treatment Period|Adverse Event|2|||
27958692|NCT00910689|54615973|FG001|Month 2- 4: Treatment Period|Adverse Event|3|||
27958693|NCT00910689|54615974|FG002|Month 2- 4: Treatment Period|Adverse Event|2|||
27958694|NCT00910689|54615975|FG003|Month 2- 4: Treatment Period|Adverse Event|0|||
27958695|NCT00910689|54615972|FG000|Month 2- 4: Treatment Period|Time Demands|1|||
27958696|NCT00910689|54615973|FG001|Month 2- 4: Treatment Period|Time Demands|0|||
27958697|NCT00910689|54615974|FG002|Month 2- 4: Treatment Period|Time Demands|4|||
27958698|NCT00910689|54615975|FG003|Month 2- 4: Treatment Period|Time Demands|8|||
27958699|NCT00910689|54615972|FG000|Month 2- 4: Treatment Period|Lack of Efficacy|2|||
27958700|NCT00910689|54615973|FG001|Month 2- 4: Treatment Period|Lack of Efficacy|1|||
27958701|NCT00910689|54615974|FG002|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
27958702|NCT00910689|54615975|FG003|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
27958703|NCT00910689|54615972|FG000|Month 2- 4: Treatment Period|Perceived Improvement|0|||
27958704|NCT00910689|54615973|FG001|Month 2- 4: Treatment Period|Perceived Improvement|0|||
27958705|NCT00910689|54615974|FG002|Month 2- 4: Treatment Period|Perceived Improvement|1|||
27958706|NCT00910689|54615975|FG003|Month 2- 4: Treatment Period|Perceived Improvement|0|||
27958707|NCT00910689|54615972|FG000|Month 2- 4: Treatment Period|Pregnancy|0|||
27958708|NCT00910689|54615973|FG001|Month 2- 4: Treatment Period|Pregnancy|2|||
27958709|NCT00910689|54615974|FG002|Month 2- 4: Treatment Period|Pregnancy|0|||
27958710|NCT00910689|54615975|FG003|Month 2- 4: Treatment Period|Pregnancy|0|||
27958711|NCT00910689|54615972|FG000|Month 2- 4: Treatment Period|Protocol Violation|1|||
27958712|NCT00910689|54615973|FG001|Month 2- 4: Treatment Period|Protocol Violation|0|||
27958713|NCT00910689|54615974|FG002|Month 2- 4: Treatment Period|Protocol Violation|0|||
27958714|NCT00910689|54615975|FG003|Month 2- 4: Treatment Period|Protocol Violation|0|||
27958715|NCT00910689|54615972|FG000|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2|||
27958716|NCT00910689|54615973|FG001|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5|||
27958717|NCT00910689|54615974|FG002|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
27958718|NCT00910689|54615975|FG003|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
27958719|NCT00910689|54615972|FG000|Months 5 - 10: Evaluation Period I|Adverse Event|1|||
27958720|NCT00910689|54615973|FG001|Months 5 - 10: Evaluation Period I|Adverse Event|0|||
27832416|NCT01762943|54311634|FG001|Overall Study|Protocol Violation|0|||
27958721|NCT00910689|54615974|FG002|Months 5 - 10: Evaluation Period I|Adverse Event|2|||
27958722|NCT00910689|54615975|FG003|Months 5 - 10: Evaluation Period I|Adverse Event|4|||
27958723|NCT00910689|54615972|FG000|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0|||
27958724|NCT00910689|54615973|FG001|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
27958725|NCT00910689|54615974|FG002|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
27958726|NCT00910689|54615975|FG003|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
27958727|NCT00910689|54615972|FG000|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
27958728|NCT00910689|54615973|FG001|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
27958729|NCT00910689|54615974|FG002|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
27958730|NCT00910689|54615975|FG003|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
27958731|NCT00910689|54615972|FG000|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
27958732|NCT00910689|54615973|FG001|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
27958733|NCT00910689|54615974|FG002|Months 5 - 10: Evaluation Period I|Pregnancy|2|||
27958734|NCT00910689|54615975|FG003|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
27958735|NCT00910689|54615972|FG000|Months 5 - 10: Evaluation Period I|Time Demands|0|||
27958736|NCT00910689|54615973|FG001|Months 5 - 10: Evaluation Period I|Time Demands|0|||
27958737|NCT00910689|54615974|FG002|Months 5 - 10: Evaluation Period I|Time Demands|1|||
27958738|NCT00910689|54615975|FG003|Months 5 - 10: Evaluation Period I|Time Demands|1|||
27958739|NCT00910689|54615972|FG000|Months 11- 16: Evaluation Period II|Lost to Follow-up|3|||
27958740|NCT00910689|54615973|FG001|Months 11- 16: Evaluation Period II|Lost to Follow-up|0|||
27958741|NCT00910689|54615974|FG002|Months 11- 16: Evaluation Period II|Lost to Follow-up|1|||
27958742|NCT00910689|54615975|FG003|Months 11- 16: Evaluation Period II|Lost to Follow-up|2|||
27958743|NCT00910689|54615972|FG000|Months 11- 16: Evaluation Period II|Adverse Event|2|||
27958744|NCT00910689|54615973|FG001|Months 11- 16: Evaluation Period II|Adverse Event|4|||
27958745|NCT00910689|54615974|FG002|Months 11- 16: Evaluation Period II|Adverse Event|2|||
27958746|NCT00910689|54615975|FG003|Months 11- 16: Evaluation Period II|Adverse Event|2|||
27958747|NCT00910689|54615972|FG000|Months 11- 16: Evaluation Period II|Pregnancy|1|||
27958748|NCT00910689|54615973|FG001|Months 11- 16: Evaluation Period II|Pregnancy|0|||
27958749|NCT00910689|54615974|FG002|Months 11- 16: Evaluation Period II|Pregnancy|0|||
27958750|NCT00910689|54615975|FG003|Months 11- 16: Evaluation Period II|Pregnancy|0|||
27958751|NCT00910689|54615972|FG000|Months 11- 16: Evaluation Period II|Lack of Efficacy|2|||
27958752|NCT00910689|54615973|FG001|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
27958753|NCT00910689|54615974|FG002|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
27958754|NCT00910689|54615975|FG003|Months 11- 16: Evaluation Period II|Lack of Efficacy|1|||
27958755|NCT00910689|54615972|FG000|Months 11- 16: Evaluation Period II|Time Demands|2|||
27958756|NCT00910689|54615973|FG001|Months 11- 16: Evaluation Period II|Time Demands|1|||
27958757|NCT00910689|54615974|FG002|Months 11- 16: Evaluation Period II|Time Demands|0|||
27958758|NCT00910689|54615975|FG003|Months 11- 16: Evaluation Period II|Time Demands|0|||
27958759|NCT00910689|54615972|FG000|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
27958760|NCT00910689|54615973|FG001|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
27958761|NCT00910689|54615974|FG002|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
27958762|NCT00910689|54615975|FG003|Months 11- 16: Evaluation Period II|Perceived Improvement|1|||
27958763|NCT00910689|54615972|FG000|Months 11- 16: Evaluation Period II|Physician Decision|0|||
27958764|NCT00910689|54615973|FG001|Months 11- 16: Evaluation Period II|Physician Decision|2|||
27732261|NCT02585960|54179755|FG000|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
27732262|NCT02585960|54179756|FG001|PK/Safety Assessment Period|Non-compliance to study procedures|2|||
27732263|NCT02585960|54179757|FG002|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
27732264|NCT02585960|54179755|FG000|PK/Safety Assessment Period|Other|4|||
27732265|NCT02585960|54179756|FG001|PK/Safety Assessment Period|Other|4|||
27732266|NCT02585960|54179757|FG002|PK/Safety Assessment Period|Other|0|||
27732267|NCT02585960|54179755|FG000|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
27732268|NCT02585960|54179756|FG001|PK/Safety Assessment Period|Withdrawn by sponsor|1|||
27732269|NCT02585960|54179757|FG002|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
27732270|NCT02585960|54179755|FG000|PK/Safety Assessment Period|Screen Failure|0|||
27732271|NCT02585960|54179756|FG001|PK/Safety Assessment Period|Screen Failure|0|||
27732272|NCT02585960|54179757|FG002|PK/Safety Assessment Period|Screen Failure|1|||
27732273|NCT02585960|54179755|FG000|Prophylactic Treatment Period|Major protocol deviation|0|||
27732274|NCT02585960|54179756|FG001|Prophylactic Treatment Period|Major protocol deviation|4|||
27732275|NCT02585960|54179757|FG002|Prophylactic Treatment Period|Major protocol deviation|0|||
27732276|NCT02585960|54179755|FG000|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
27732277|NCT02585960|54179756|FG001|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1|||
27958765|NCT00910689|54615974|FG002|Months 11- 16: Evaluation Period II|Physician Decision|1|||
27958766|NCT00910689|54615975|FG003|Months 11- 16: Evaluation Period II|Physician Decision|0|||
27958767|NCT00807001|54615990|FG000|Overall Study|Non-compliance|0|||
27958768|NCT00807001|54615991|FG001|Overall Study|Non-compliance|1|||
27958769|NCT00807001|54615992|FG002|Overall Study|Non-compliance|0|||
27958770|NCT00807001|54615993|FG003|Overall Study|Non-compliance|0|||
27958771|NCT00807001|54615994|FG004|Overall Study|Non-compliance|0|||
27732278|NCT02585960|54179757|FG002|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
27732279|NCT02760433|54179773|FG000|Overall Study|Lost to Follow-up|1|||
27732280|NCT02760433|54179774|FG001|Overall Study|Lost to Follow-up|0|||
27732281|NCT02760433|54179775|FG002|Overall Study|Lost to Follow-up|1|||
27732282|NCT02760433|54179776|FG003|Overall Study|Lost to Follow-up|0|||
27732283|NCT02760433|54179777|FG004|Overall Study|Lost to Follow-up|0|||
27732284|NCT02760433|54179773|FG000|Overall Study|Withdrawal by Subject|23|||
27732285|NCT02760433|54179774|FG001|Overall Study|Withdrawal by Subject|9|||
27732286|NCT02760433|54179775|FG002|Overall Study|Withdrawal by Subject|0|||
27732287|NCT02760433|54179776|FG003|Overall Study|Withdrawal by Subject|2|||
27958772|NCT00809341|54616008|FG000|Overall Study|Physician Decision|0|||
27958773|NCT00809341|54616009|FG001|Overall Study|Physician Decision|1|||
27958774|NCT01125800|54616020|FG000|Phase I|Protocol Violation|0|||
27958775|NCT01125800|54616021|FG001|Phase I|Protocol Violation|3|||
27958776|NCT01125800|54616022|FG002|Phase I|Protocol Violation|1|||
27958777|NCT01125800|54616023|FG003|Phase I|Protocol Violation|1|||
27958778|NCT01125800|54616024|FG004|Phase I|Protocol Violation|0|||
27958779|NCT01125800|54616020|FG000|Phase I|Adverse Event|2|||
27958780|NCT01125800|54616021|FG001|Phase I|Adverse Event|2|||
27958781|NCT01125800|54616022|FG002|Phase I|Adverse Event|1|||
27958782|NCT01125800|54616023|FG003|Phase I|Adverse Event|7|||
27958783|NCT01125800|54616024|FG004|Phase I|Adverse Event|0|||
27958784|NCT01125800|54616020|FG000|Phase I|Administrative problems|1|||
27958785|NCT01125800|54616021|FG001|Phase I|Administrative problems|0|||
27958786|NCT01125800|54616022|FG002|Phase I|Administrative problems|0|||
27958787|NCT01125800|54616023|FG003|Phase I|Administrative problems|0|||
27958788|NCT01125800|54616024|FG004|Phase I|Administrative problems|0|||
27958789|NCT01125800|54616020|FG000|Phase I|Withdrawal by Subject|0|||
27958790|NCT01125800|54616021|FG001|Phase I|Withdrawal by Subject|0|||
27958791|NCT01125800|54616022|FG002|Phase I|Withdrawal by Subject|1|||
27958792|NCT01125800|54616023|FG003|Phase I|Withdrawal by Subject|0|||
27958793|NCT01125800|54616024|FG004|Phase I|Withdrawal by Subject|0|||
27958794|NCT01125800|54616020|FG000|Phase I|Disease progression|5|||
27958795|NCT01125800|54616021|FG001|Phase I|Disease progression|4|||
27958796|NCT01125800|54616022|FG002|Phase I|Disease progression|1|||
27958797|NCT01125800|54616023|FG003|Phase I|Disease progression|3|||
27958798|NCT01125800|54616024|FG004|Phase I|Disease progression|0|||
27958799|NCT01125800|54616020|FG000|Phase II|Protocol Violation|0|||
27958800|NCT01125800|54616021|FG001|Phase II|Protocol Violation|0|||
27958801|NCT01125800|54616022|FG002|Phase II|Protocol Violation|0|||
27958802|NCT01125800|54616023|FG003|Phase II|Protocol Violation|0|||
27958803|NCT01125800|54616024|FG004|Phase II|Protocol Violation|1|||
27958804|NCT01125800|54616020|FG000|Phase II|Adverse Event|0|||
27958805|NCT01125800|54616021|FG001|Phase II|Adverse Event|0|||
27958806|NCT01125800|54616022|FG002|Phase II|Adverse Event|0|||
27958807|NCT01125800|54616023|FG003|Phase II|Adverse Event|0|||
27958808|NCT01125800|54616024|FG004|Phase II|Adverse Event|2|||
27958809|NCT01125800|54616020|FG000|Phase II|Disease progression|0|||
27958810|NCT01125800|54616021|FG001|Phase II|Disease progression|0|||
27958811|NCT01125800|54616022|FG002|Phase II|Disease progression|0|||
27958812|NCT01125800|54616023|FG003|Phase II|Disease progression|1|||
27958813|NCT01125800|54616024|FG004|Phase II|Disease progression|8|||
27958814|NCT01125722|54616041|FG000|Overall Study|Withdrawal by Subject|2|||
27958815|NCT01125722|54616042|FG001|Overall Study|Withdrawal by Subject|1|||
27958816|NCT01125722|54616041|FG000|Overall Study|Lost to Follow-up|1|||
27958817|NCT01125722|54616042|FG001|Overall Study|Lost to Follow-up|0|||
27958818|NCT00811135|54616048|FG000|Overall Study|Adverse Event/Intercurrent Illness|8|||
27958819|NCT00811135|54616048|FG000|Overall Study|Death|3|||
27732288|NCT02760433|54179777|FG004|Overall Study|Withdrawal by Subject|9|||
27958820|NCT00811135|54616048|FG000|Overall Study|Protocol Violation|2|||
27958821|NCT00811135|54616048|FG000|Overall Study|Violation of Selection Criteria|1|||
27958822|NCT00811135|54616048|FG000|Overall Study|Refused Treatment|1|||
27958823|NCT00811135|54616048|FG000|Overall Study|Withdrawal by Subject|3|||
27958824|NCT00811135|54616048|FG000|Overall Study|Administrative/Other Unspecified|11|||
27958825|NCT00811135|54616048|FG000|Overall Study|Ongoing|59|||
27958826|NCT00811057|54616055|FG000|Overall Study|Protocol Violation|5|||
27958827|NCT00811057|54616056|FG001|Overall Study|Protocol Violation|10|||
27958828|NCT00811057|54616057|FG002|Overall Study|Protocol Violation|10|||
27958829|NCT00879970|54616068|FG000|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
27958830|NCT00879970|54616069|FG001|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
27958831|NCT00879970|54616070|FG002|Period 1 TZD Randomization|Refused to Attend Final Visit|4|||
27732289|NCT02760433|54179773|FG000|Overall Study|Lack of Response At Week 14|0|||
27958832|NCT00879970|54616071|FG003|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
27958833|NCT00879970|54616072|FG004|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
27958834|NCT00879970|54616068|FG000|Period 1 TZD Randomization|Lost to Follow-up|1|||
27958835|NCT00879970|54616069|FG001|Period 1 TZD Randomization|Lost to Follow-up|0|||
27958836|NCT00879970|54616070|FG002|Period 1 TZD Randomization|Lost to Follow-up|1|||
27958837|NCT00879970|54616071|FG003|Period 1 TZD Randomization|Lost to Follow-up|0|||
27958838|NCT00879970|54616072|FG004|Period 1 TZD Randomization|Lost to Follow-up|0|||
27958839|NCT00879970|54616068|FG000|Period 1 TZD Randomization|Death|2|||
27958840|NCT00879970|54616069|FG001|Period 1 TZD Randomization|Death|1|||
27958841|NCT00879970|54616070|FG002|Period 1 TZD Randomization|Death|0|||
27958842|NCT00879970|54616071|FG003|Period 1 TZD Randomization|Death|0|||
27958843|NCT00879970|54616072|FG004|Period 1 TZD Randomization|Death|0|||
27958844|NCT00879970|54616068|FG000|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2|||
27958845|NCT00879970|54616069|FG001|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
27958846|NCT00879970|54616070|FG002|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1|||
27958847|NCT00879970|54616071|FG003|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
27958848|NCT00879970|54616072|FG004|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
27958849|NCT00879970|54616068|FG000|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
27958850|NCT00879970|54616069|FG001|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
28165093|NCT03016325|54835760|FG007|32-Day Follow-Up Period|Death|0|||
28165094|NCT03016325|54835753|FG000|32-Day Follow-Up Period|Lost to Follow-up|1|||
28165095|NCT03016325|54835754|FG001|32-Day Follow-Up Period|Lost to Follow-up|0|||
28165096|NCT03016325|54835755|FG002|32-Day Follow-Up Period|Lost to Follow-up|1|||
28165097|NCT03016325|54835756|FG003|32-Day Follow-Up Period|Lost to Follow-up|1|||
28165098|NCT03016325|54835757|FG004|32-Day Follow-Up Period|Lost to Follow-up|0|||
28165099|NCT03016325|54835758|FG005|32-Day Follow-Up Period|Lost to Follow-up|0|||
27958851|NCT00879970|54616070|FG002|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
27958852|NCT00879970|54616071|FG003|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2|||
27958853|NCT00879970|54616072|FG004|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6|||
27958854|NCT00879970|54616068|FG000|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
27958855|NCT00879970|54616069|FG001|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
27958856|NCT00879970|54616070|FG002|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
27958857|NCT00879970|54616071|FG003|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
27958858|NCT00879970|54616072|FG004|Period 2 Vitamin D Randomization|Lost to Follow-up|1|||
27958859|NCT00879970|54616068|FG000|Period 2 Vitamin D Randomization|Death|0|||
27958860|NCT00879970|54616069|FG001|Period 2 Vitamin D Randomization|Death|0|||
27958861|NCT00879970|54616070|FG002|Period 2 Vitamin D Randomization|Death|0|||
27958862|NCT00879970|54616071|FG003|Period 2 Vitamin D Randomization|Death|2|||
27958863|NCT00879970|54616072|FG004|Period 2 Vitamin D Randomization|Death|0|||
27958864|NCT00808639|54616090|FG000|Overall Study|Disease progression before surgery.|1|||
27958865|NCT00810901|54616096|FG000|Overall Study|Lost to Follow-up|88|||
27958866|NCT00810901|54616097|FG001|Overall Study|Lost to Follow-up|58|||
27958867|NCT00910299|54616105|FG000|Overall Study|Withdrawal by Subject|16|||
27958868|NCT00910299|54616106|FG001|Overall Study|Withdrawal by Subject|13|||
27958869|NCT00910299|54616105|FG000|Overall Study|Sponsor Decision|58|||
27958870|NCT00910299|54616106|FG001|Overall Study|Sponsor Decision|60|||
27958871|NCT00910299|54616105|FG000|Overall Study|Didn't receive any study drug|2|||
27958872|NCT00910299|54616106|FG001|Overall Study|Didn't receive any study drug|1|||
27958873|NCT00595504|54616114|FG000|Overall Study|Withdrawal by Subject|1|||
27958874|NCT00595504|54616115|FG001|Overall Study|Withdrawal by Subject|3|||
27958875|NCT00595504|54616114|FG000|Overall Study|Physician Decision|1|||
27958876|NCT00595504|54616115|FG001|Overall Study|Physician Decision|0|||
27958877|NCT00808483|54616123|FG000|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
27958878|NCT00808483|54616124|FG001|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
27958879|NCT00808483|54616123|FG000|From 3 to 5 Months After Surgery|Lack of Efficacy|1|||
27958880|NCT00808483|54616124|FG001|From 3 to 5 Months After Surgery|Lack of Efficacy|0|||
27958881|NCT00808483|54616123|FG000|From 5 Months to 12 Months|Lack of Efficacy|1|||
27958882|NCT00808483|54616124|FG001|From 5 Months to 12 Months|Lack of Efficacy|0|||
27958883|NCT00810511|54616139|FG000|Overall Study|Protocol Violation|0|||
27958884|NCT00810511|54616140|FG001|Overall Study|Protocol Violation|1|||
27958885|NCT00810511|54616139|FG000|Overall Study|Lack of Efficacy|9|||
27958886|NCT00810511|54616140|FG001|Overall Study|Lack of Efficacy|1|||
27958887|NCT00810511|54616139|FG000|Overall Study|death in the family|0|||
27958888|NCT00810511|54616140|FG001|Overall Study|death in the family|1|||
27958889|NCT00810511|54616139|FG000|Overall Study|Lost to Follow-up|1|||
27958890|NCT00810511|54616140|FG001|Overall Study|Lost to Follow-up|0|||
27958891|NCT00810511|54616139|FG000|Overall Study|deposits on contact lens|0|||
27958892|NCT00810511|54616140|FG001|Overall Study|deposits on contact lens|1|||
27958893|NCT00596362|54616146|FG000|Overall Study|Progressive Disease|1|||
28082099|NCT00057837|54735473|FG000|Overall Study|Ineligible|3|||
28082100|NCT00057837|54735474|FG001|Overall Study|Ineligible|3|||
28082101|NCT00057837|54735473|FG000|Overall Study|Never started treatment|1|||
28082102|NCT00057837|54735474|FG001|Overall Study|Never started treatment|1|||
28082103|NCT00046930|54735482|FG000|Overall Study|Ineligible|12|||
28082104|NCT00046930|54735483|FG001|Overall Study|Ineligible|4|||
28082105|NCT00042939|54735494|FG000|Overall Study|Adverse Event|6|||
28082106|NCT00042939|54735495|FG001|Overall Study|Adverse Event|7|||
28082107|NCT00042939|54735494|FG000|Overall Study|Death|3|||
28082108|NCT00042939|54735495|FG001|Overall Study|Death|2|||
28082109|NCT00042939|54735494|FG000|Overall Study|Withdrawal by Subject|3|||
27958894|NCT00907803|54616153|FG000|Overall Study|Withdrawal of consent - long commute|1|||
27958895|NCT00907803|54616154|FG001|Overall Study|Withdrawal of consent - long commute|0|||
27958896|NCT00907803|54616155|FG002|Overall Study|Withdrawal of consent - long commute|0|||
27958897|NCT00907803|54616153|FG000|Overall Study|Adverse Event|2|||
27958898|NCT00907803|54616154|FG001|Overall Study|Adverse Event|0|||
27958899|NCT00907803|54616155|FG002|Overall Study|Adverse Event|0|||
27958900|NCT00907803|54616153|FG000|Overall Study|Withdrawal by Subject|0|||
27958901|NCT00907803|54616154|FG001|Overall Study|Withdrawal by Subject|1|||
27958902|NCT00907803|54616155|FG002|Overall Study|Withdrawal by Subject|0|||
27958903|NCT00907803|54616153|FG000|Overall Study|Lost to Follow-up|0|||
27958904|NCT00907803|54616154|FG001|Overall Study|Lost to Follow-up|1|||
27958905|NCT00907803|54616155|FG002|Overall Study|Lost to Follow-up|0|||
27958906|NCT00907803|54616153|FG000|Overall Study|Protocol Violation|0|||
27958907|NCT00907803|54616154|FG001|Overall Study|Protocol Violation|1|||
27958908|NCT00907803|54616155|FG002|Overall Study|Protocol Violation|0|||
27958909|NCT00808249|54616167|FG000|Overall Study|Adverse Event|4|||
27958910|NCT00808249|54616168|FG001|Overall Study|Adverse Event|7|||
27958911|NCT00808249|54616169|FG002|Overall Study|Adverse Event|10|||
27958912|NCT00808249|54616170|FG003|Overall Study|Adverse Event|6|||
27958913|NCT00808249|54616167|FG000|Overall Study|Lost to Follow-up|2|||
27958914|NCT00808249|54616168|FG001|Overall Study|Lost to Follow-up|3|||
27958915|NCT00808249|54616169|FG002|Overall Study|Lost to Follow-up|3|||
27958916|NCT00808249|54616170|FG003|Overall Study|Lost to Follow-up|5|||
27958917|NCT00808249|54616167|FG000|Overall Study|Withdrawal by Subject|4|||
27958918|NCT00808249|54616168|FG001|Overall Study|Withdrawal by Subject|0|||
27958919|NCT00808249|54616169|FG002|Overall Study|Withdrawal by Subject|2|||
27958920|NCT00808249|54616170|FG003|Overall Study|Withdrawal by Subject|4|||
27958921|NCT00808249|54616167|FG000|Overall Study|Protocol Violation|3|||
27958922|NCT00808249|54616168|FG001|Overall Study|Protocol Violation|3|||
27958923|NCT00808249|54616169|FG002|Overall Study|Protocol Violation|3|||
27958924|NCT00808249|54616170|FG003|Overall Study|Protocol Violation|0|||
27958925|NCT00808249|54616167|FG000|Overall Study|Lack of Efficacy|1|||
27958926|NCT00808249|54616168|FG001|Overall Study|Lack of Efficacy|1|||
27958927|NCT00808249|54616169|FG002|Overall Study|Lack of Efficacy|0|||
27958928|NCT00808249|54616170|FG003|Overall Study|Lack of Efficacy|0|||
27958929|NCT00808249|54616167|FG000|Overall Study|study specific discontinuation criteria|1|||
27958930|NCT00808249|54616168|FG001|Overall Study|study specific discontinuation criteria|0|||
27958931|NCT00808249|54616169|FG002|Overall Study|study specific discontinuation criteria|1|||
27958932|NCT00808249|54616170|FG003|Overall Study|study specific discontinuation criteria|0|||
27958933|NCT00808249|54616167|FG000|Overall Study|All other reasons|2|||
27958934|NCT00808249|54616168|FG001|Overall Study|All other reasons|1|||
27958935|NCT00808249|54616169|FG002|Overall Study|All other reasons|3|||
27958936|NCT00808249|54616170|FG003|Overall Study|All other reasons|1|||
27958937|NCT00908895|54616182|FG000|Overall Study|Lost to Follow-up|1|||
27958938|NCT00908895|54616183|FG001|Overall Study|Lost to Follow-up|3|||
28082110|NCT00042939|54735495|FG001|Overall Study|Withdrawal by Subject|4|||
28082111|NCT00042939|54735494|FG000|Overall Study|Other disease|1|||
28082112|NCT00042939|54735495|FG001|Overall Study|Other disease|0|||
28082113|NCT00042939|54735494|FG000|Overall Study|Ineligible|2|||
28082114|NCT00042939|54735495|FG001|Overall Study|Ineligible|2|||
28082115|NCT00042939|54735494|FG000|Overall Study|Deterioration of health|3|||
28082116|NCT00042939|54735495|FG001|Overall Study|Deterioration of health|4|||
28082117|NCT00042939|54735494|FG000|Overall Study|QOL diminished|1|||
28082118|NCT00042939|54735495|FG001|Overall Study|QOL diminished|0|||
28082119|NCT00042939|54735494|FG000|Overall Study|Rising ca 19-9|1|||
28082120|NCT00042939|54735495|FG001|Overall Study|Rising ca 19-9|0|||
28082121|NCT00042939|54735494|FG000|Overall Study|Patient non-compliance|1|||
28082122|NCT00042939|54735495|FG001|Overall Study|Patient non-compliance|0|||
28082123|NCT00042939|54735494|FG000|Overall Study|Still on treatment|1|||
28082124|NCT00042939|54735495|FG001|Overall Study|Still on treatment|0|||
27958939|NCT00908895|54616182|FG000|Overall Study|algodystrophy|2|||
27958940|NCT00908895|54616183|FG001|Overall Study|algodystrophy|2|||
27958941|NCT00908895|54616182|FG000|Overall Study|Adverse Event|1|||
27958942|NCT00908895|54616183|FG001|Overall Study|Adverse Event|1|||
27958943|NCT00591253|54616192|FG000|Overall Study|Adverse Event|3|||
27958944|NCT00591253|54616193|FG001|Overall Study|Adverse Event|3|||
27958945|NCT00591253|54616194|FG002|Overall Study|Adverse Event|1|||
28082125|NCT00042939|54735494|FG000|Overall Study|Treatment break > 4 weeks|0|||
28082126|NCT00042939|54735495|FG001|Overall Study|Treatment break > 4 weeks|1|||
28082127|NCT00042939|54735494|FG000|Overall Study|Did not start treatment|2|||
27958946|NCT00591253|54616192|FG000|Overall Study|Protocol Violation|2|||
27958947|NCT00591253|54616193|FG001|Overall Study|Protocol Violation|2|||
27958948|NCT00591253|54616194|FG002|Overall Study|Protocol Violation|2|||
27958949|NCT00591253|54616192|FG000|Overall Study|Lost to Follow-up|2|||
27958950|NCT00591253|54616193|FG001|Overall Study|Lost to Follow-up|4|||
27958951|NCT00591253|54616194|FG002|Overall Study|Lost to Follow-up|0|||
28082128|NCT00042939|54735495|FG001|Overall Study|Did not start treatment|1|||
27958952|NCT00591253|54616192|FG000|Overall Study|Withdrawal by Subject|1|||
27958953|NCT00591253|54616193|FG001|Overall Study|Withdrawal by Subject|7|||
27958954|NCT00591253|54616194|FG002|Overall Study|Withdrawal by Subject|6|||
27958955|NCT00591253|54616192|FG000|Overall Study|Lack of Efficacy|1|||
27958956|NCT00591253|54616193|FG001|Overall Study|Lack of Efficacy|0|||
27958957|NCT00591253|54616194|FG002|Overall Study|Lack of Efficacy|3|||
27958958|NCT00591253|54616192|FG000|Overall Study|Other|5|||
27958959|NCT00591253|54616193|FG001|Overall Study|Other|5|||
27958960|NCT00591253|54616194|FG002|Overall Study|Other|3|||
27958961|NCT00908583|54616202|FG000|Phase 1|Withdrawal by Subject|1|||
27958962|NCT00908583|54616202|FG000|Phase 1|Adverse Event|4|||
27958963|NCT00908583|54616202|FG000|Phase 2|Physician Decision|1|||
27958964|NCT00908583|54616202|FG000|Phase 2|Adverse Event|1|||
27958965|NCT00908583|54616202|FG000|Phase 3|Adverse Event|2|||
27958966|NCT00908583|54616202|FG000|Phase 4|Adverse Event|1|||
27958967|NCT00908583|54616202|FG000|Phase 4|Physician Decision|1|||
27958968|NCT00908583|54616202|FG000|Phase 5|Adverse Event|3|||
27958969|NCT00909363|54616223|FG000|Overall Study|Withdrawal by Subject|1|||
27958970|NCT00909363|54616224|FG001|Overall Study|Withdrawal by Subject|0|||
27958971|NCT00909363|54616225|FG002|Overall Study|Withdrawal by Subject|0|||
27958972|NCT00909363|54616223|FG000|Overall Study|Lack of Efficacy|1|||
27958973|NCT00909363|54616224|FG001|Overall Study|Lack of Efficacy|0|||
27958974|NCT00909363|54616225|FG002|Overall Study|Lack of Efficacy|0|||
27958975|NCT00810355|54616239|FG000|Overall Study|Lost to Follow-up|13|||
27958976|NCT00810355|54616240|FG001|Overall Study|Lost to Follow-up|17|||
27958977|NCT00810355|54616241|FG002|Overall Study|Lost to Follow-up|11|||
27958978|NCT00810355|54616239|FG000|Overall Study|Withdrawal by Subject|1|||
27958979|NCT00810355|54616240|FG001|Overall Study|Withdrawal by Subject|0|||
27855095|NCT03620162|54375137|FG003|Overall Study|Lost to Follow-up|3|||
27855096|NCT03620162|54375138|FG004|Overall Study|Lost to Follow-up|2|||
27855097|NCT03620162|54375134|FG000|Overall Study|Consent withdrawn by parent/guardian|9|||
27855098|NCT03620162|54375135|FG001|Overall Study|Consent withdrawn by parent/guardian|8|||
27855099|NCT03620162|54375136|FG002|Overall Study|Consent withdrawn by parent/guardian|25|||
27855100|NCT03620162|54375137|FG003|Overall Study|Consent withdrawn by parent/guardian|17|||
27855101|NCT03620162|54375138|FG004|Overall Study|Consent withdrawn by parent/guardian|9|||
27855102|NCT03084302|54375279|FG000|Overall Study|Miscarriage, twin pregnancy, congenital abnormality|9|||
27855103|NCT03084302|54375279|FG000|Overall Study|No valid objective monitor data|6|||
27855104|NCT01279681|54375412|FG000|Overall Study|Disease Progression|9|||
27855105|NCT01279681|54375413|FG001|Overall Study|Disease Progression|6|||
27855106|NCT01279681|54375412|FG000|Overall Study|Withdrawal by Subject|3|||
27855107|NCT01279681|54375413|FG001|Overall Study|Withdrawal by Subject|4|||
27855108|NCT01279681|54375412|FG000|Overall Study|Adverse Event|2|||
27855109|NCT01279681|54375413|FG001|Overall Study|Adverse Event|3|||
27958980|NCT00810355|54616241|FG002|Overall Study|Withdrawal by Subject|0|||
27958981|NCT00908349|54616249|FG000|Overall Study|Adverse Event|10|||
27958982|NCT00908349|54616249|FG000|Overall Study|Withdrawal by Subject|9|||
27958983|NCT00908349|54616249|FG000|Overall Study|Physician Decision|5|||
27958984|NCT00908349|54616249|FG000|Overall Study|Lost to Follow-up|5|||
27958985|NCT00908349|54616249|FG000|Overall Study|Various|6|||
27958986|NCT01125566|54616255|FG000|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182|||
27958987|NCT01125566|54616256|FG001|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119|||
27958988|NCT01125566|54616257|FG002|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0|||
27958989|NCT01125566|54616255|FG000|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
27958990|NCT01125566|54616256|FG001|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
27958991|NCT01125566|54616257|FG002|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0|||
27958992|NCT01125566|54616255|FG000|Patients Before the Switch (26Apr2013)|Adverse Event|25|||
27958993|NCT01125566|54616256|FG001|Patients Before the Switch (26Apr2013)|Adverse Event|5|||
27958994|NCT01125566|54616257|FG002|Patients Before the Switch (26Apr2013)|Adverse Event|0|||
27958995|NCT01125566|54616255|FG000|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
27958996|NCT01125566|54616256|FG001|Patients Before the Switch (26Apr2013)|Protocol Violation|2|||
27958997|NCT01125566|54616257|FG002|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
27958998|NCT01125566|54616255|FG000|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24|||
27958999|NCT01125566|54616256|FG001|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23|||
27855110|NCT01279681|54375412|FG000|Overall Study|Death|0|||
27855111|NCT01279681|54375413|FG001|Overall Study|Death|1|||
27855112|NCT01279681|54375412|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
27855113|NCT01279681|54375413|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
27855114|NCT01279681|54375412|FG000|Overall Study|Physician Decision|1|||
27959000|NCT01125566|54616257|FG002|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0|||
27959001|NCT01125566|54616255|FG000|Patients Before the Switch (26Apr2013)|Not treated|2|||
27959002|NCT01125566|54616256|FG001|Patients Before the Switch (26Apr2013)|Not treated|0|||
27959003|NCT01125566|54616257|FG002|Patients Before the Switch (26Apr2013)|Not treated|0|||
28165100|NCT03016325|54835759|FG006|32-Day Follow-Up Period|Lost to Follow-up|0|||
27959004|NCT01125566|54616255|FG000|Patients Before the Switch (26Apr2013)|Other than listed above|25|||
27959005|NCT01125566|54616256|FG001|Patients Before the Switch (26Apr2013)|Other than listed above|13|||
27959006|NCT01125566|54616257|FG002|Patients Before the Switch (26Apr2013)|Other than listed above|0|||
27959007|NCT01125566|54616255|FG000|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
27959008|NCT01125566|54616256|FG001|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
27959009|NCT01125566|54616257|FG002|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0|||
27959010|NCT01125566|54616255|FG000|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
27959011|NCT01125566|54616256|FG001|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
27959012|NCT01125566|54616257|FG002|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59|||
27959013|NCT01125566|54616255|FG000|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
27959014|NCT01125566|54616256|FG001|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
27959015|NCT01125566|54616257|FG002|Patients Who Switched From AV to TV|Refused to continue taking medication|7|||
27959016|NCT01125566|54616255|FG000|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
27959017|NCT01125566|54616256|FG001|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
27959018|NCT01125566|54616257|FG002|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3|||
27959019|NCT01125566|54616255|FG000|Patients Who Switched From AV to TV|Other than listed above|0|||
27959020|NCT01125566|54616256|FG001|Patients Who Switched From AV to TV|Other than listed above|0|||
27959021|NCT01125566|54616257|FG002|Patients Who Switched From AV to TV|Other than listed above|4|||
27959022|NCT00810277|54616264|FG000|Overall Study|Adverse Event|1|||
27959023|NCT00595582|54616268|FG000|Overall Study|Pilot study that PI terminated|2|||
27959024|NCT00595582|54616268|FG000|Overall Study|Lost to Follow-up|1|||
27959025|NCT00595582|54616268|FG000|Overall Study|Adverse Event|2|||
27959026|NCT00595582|54616268|FG000|Overall Study|Physician Decision|5|||
27959027|NCT00808015|54616272|FG000|Overall Study|Death|1|||
27959028|NCT00808015|54616272|FG000|Overall Study|Lack of Efficacy|58|||
27959029|NCT00808015|54616272|FG000|Overall Study|Lost to Follow-up|76|||
27959030|NCT00808015|54616272|FG000|Overall Study|Participants not willing to participate|158|||
27959031|NCT00808015|54616272|FG000|Overall Study|Adverse Event|22|||
27959032|NCT00808015|54616272|FG000|Overall Study|Other|25|||
27959033|NCT00808015|54616272|FG000|Overall Study|Enrolled but not treated|4|||
27959034|NCT00810199|54616278|FG000|Overall Study|Adverse Event|24|||
27959035|NCT00810199|54616279|FG001|Overall Study|Adverse Event|26|||
27959036|NCT00810199|54616278|FG000|Overall Study|Death|4|||
27959037|NCT00810199|54616279|FG001|Overall Study|Death|6|||
27959038|NCT00810199|54616278|FG000|Overall Study|Withdrew consent|9|||
27959039|NCT00810199|54616279|FG001|Overall Study|Withdrew consent|12|||
27959040|NCT00810199|54616278|FG000|Overall Study|Insufficient therapeutic response|5|||
27959041|NCT00810199|54616279|FG001|Overall Study|Insufficient therapeutic response|14|||
27959042|NCT00810199|54616278|FG000|Overall Study|Refused treatment/Did not cooperate|7|||
27959043|NCT00810199|54616279|FG001|Overall Study|Refused treatment/Did not cooperate|7|||
27959044|NCT00810199|54616278|FG000|Overall Study|Administrative/Other|5|||
27959045|NCT00810199|54616279|FG001|Overall Study|Administrative/Other|6|||
27959046|NCT00810199|54616278|FG000|Overall Study|Protocol Violation|2|||
27959047|NCT00810199|54616279|FG001|Overall Study|Protocol Violation|6|||
27959048|NCT00810199|54616278|FG000|Overall Study|Failure to return|1|||
27959049|NCT00810199|54616279|FG001|Overall Study|Failure to return|4|||
27959050|NCT00810199|54616278|FG000|Overall Study|Did not receive study drug|2|||
27959051|NCT00810199|54616279|FG001|Overall Study|Did not receive study drug|1|||
27959052|NCT00877006|54616293|FG000|Treatment Period|Death|2|||
27959053|NCT00877006|54616294|FG001|Treatment Period|Death|1|||
27959054|NCT00877006|54616293|FG000|Treatment Period|Adverse Event|10|||
27959055|NCT00877006|54616294|FG001|Treatment Period|Adverse Event|3|||
27959056|NCT00877006|54616293|FG000|Treatment Period|Withdrawal by Subject|2|||
27959057|NCT00877006|54616294|FG001|Treatment Period|Withdrawal by Subject|3|||
27959058|NCT00877006|54616293|FG000|Treatment Period|Protocol Violation|1|||
27959059|NCT00877006|54616294|FG001|Treatment Period|Protocol Violation|0|||
27959060|NCT00877006|54616293|FG000|Treatment Period|Lost to Follow-up|0|||
27959061|NCT00877006|54616294|FG001|Treatment Period|Lost to Follow-up|1|||
27959062|NCT00877006|54616293|FG000|Treatment Period|Disease Progression|1|||
27959063|NCT00877006|54616294|FG001|Treatment Period|Disease Progression|2|||
28165101|NCT03016325|54835760|FG007|32-Day Follow-Up Period|Lost to Follow-up|0|||
28165102|NCT03016325|54835753|FG000|32-Day Follow-Up Period|Poor/non-compliance|1|||
27832417|NCT01762943|54311633|FG000|Overall Study|Withdrawal by Subject|2|||
27832418|NCT01762943|54311634|FG001|Overall Study|Withdrawal by Subject|1|||
27959064|NCT00877006|54616293|FG000|Treatment Period|Started New Treatment Regimen|2|||
27959065|NCT00877006|54616294|FG001|Treatment Period|Started New Treatment Regimen|5|||
27959066|NCT00877006|54616293|FG000|Treatment Period|Other|4|||
27959067|NCT00877006|54616294|FG001|Treatment Period|Other|4|||
27959068|NCT00877006|54616293|FG000|Treatment Period|Randomized but Not Treated|3|||
27832419|NCT01734785|54311697|FG000|Open-Label Period|Adverse Event|0|||
27959069|NCT00877006|54616294|FG001|Treatment Period|Randomized but Not Treated|8|||
27959070|NCT00877006|54616293|FG000|Long-Term Follow-up Period|Withdrawal by Subject|12|||
27959071|NCT00877006|54616294|FG001|Long-Term Follow-up Period|Withdrawal by Subject|19|||
27959072|NCT00877006|54616293|FG000|Long-Term Follow-up Period|Lost to Follow-up|8|||
27959073|NCT00877006|54616294|FG001|Long-Term Follow-up Period|Lost to Follow-up|9|||
27959074|NCT00877006|54616293|FG000|Long-Term Follow-up Period|Death|26|||
27959075|NCT00877006|54616294|FG001|Long-Term Follow-up Period|Death|18|||
27959076|NCT00877006|54616293|FG000|Long-Term Follow-up Period|Other|7|||
27959077|NCT00877006|54616294|FG001|Long-Term Follow-up Period|Other|9|||
27959078|NCT00876928|54616304|FG000|Overall Study|Lost to Follow-up|2|||
27959079|NCT00876928|54616305|FG001|Overall Study|Lost to Follow-up|5|||
27959080|NCT00876928|54616304|FG000|Overall Study|Hypokalemia-affects insulin secretion|1|||
27959081|NCT00876928|54616305|FG001|Overall Study|Hypokalemia-affects insulin secretion|0|||
27959082|NCT00807937|54616315|FG000|Overall Study|Adverse Event|12|||
27959083|NCT00807937|54616316|FG001|Overall Study|Adverse Event|12|||
27959084|NCT00807937|54616317|FG002|Overall Study|Adverse Event|5|||
27959085|NCT00807937|54616318|FG003|Overall Study|Adverse Event|4|||
27959086|NCT00807937|54616315|FG000|Overall Study|Protocol Violation|4|||
27959087|NCT00807937|54616316|FG001|Overall Study|Protocol Violation|5|||
27959088|NCT00807937|54616317|FG002|Overall Study|Protocol Violation|3|||
27959089|NCT00807937|54616318|FG003|Overall Study|Protocol Violation|3|||
27959090|NCT00807937|54616315|FG000|Overall Study|Withdrawal by Subject|5|||
28165103|NCT03016325|54835754|FG001|32-Day Follow-Up Period|Poor/non-compliance|0|||
27732290|NCT02760433|54179774|FG001|Overall Study|Lack of Response At Week 14|0|||
27732291|NCT02760433|54179775|FG002|Overall Study|Lack of Response At Week 14|0|||
27732292|NCT02760433|54179776|FG003|Overall Study|Lack of Response At Week 14|0|||
27732293|NCT02760433|54179777|FG004|Overall Study|Lack of Response At Week 14|1|||
27732294|NCT02760433|54179773|FG000|Overall Study|Subject refused to continue the study|1|||
27732295|NCT02760433|54179774|FG001|Overall Study|Subject refused to continue the study|0|||
27732296|NCT02760433|54179775|FG002|Overall Study|Subject refused to continue the study|0|||
27732297|NCT02760433|54179776|FG003|Overall Study|Subject refused to continue the study|0|||
27732298|NCT02760433|54179777|FG004|Overall Study|Subject refused to continue the study|0|||
27732299|NCT02760433|54179773|FG000|Overall Study|Subject was taking prohibited medications and refused to stop.|2|||
27732300|NCT02760433|54179774|FG001|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
27732301|NCT02760433|54179775|FG002|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
27732302|NCT02760433|54179776|FG003|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
27732303|NCT02760433|54179777|FG004|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
27732304|NCT02760433|54179773|FG000|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
27732305|NCT02760433|54179774|FG001|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|1|||
27732306|NCT02760433|54179775|FG002|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
27732307|NCT02760433|54179776|FG003|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
27732308|NCT02760433|54179777|FG004|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
27732309|NCT02699463|54179796|FG000|Overall Study|Lost to Follow-up|11|||
27732310|NCT02699463|54179797|FG001|Overall Study|Lost to Follow-up|8|||
27732311|NCT02699463|54179796|FG000|Overall Study|Withdrawal by Subject|4|||
27732312|NCT02699463|54179797|FG001|Overall Study|Withdrawal by Subject|1|||
27732313|NCT00100789|54179803|FG000|Overall Study|Adverse Event|10|||
27732314|NCT00100789|54179803|FG000|Overall Study|Withdrawal by Subject|1|||
27732315|NCT00100789|54179803|FG000|Overall Study|Progression/relapse|42|||
27732316|NCT00100789|54179803|FG000|Overall Study|Death|2|||
27732317|NCT00100789|54179803|FG000|Overall Study|Not protocol specified|5|||
27732318|NCT00100789|54179803|FG000|Overall Study|Ineligible|3|||
27732319|NCT00100789|54179803|FG000|Overall Study|Never received treatment|1|||
27732320|NCT00708123|54179808|FG000|Period 1|Protocol Violation|0|||
27732321|NCT00708123|54179809|FG001|Period 1|Protocol Violation|1|||
27732322|NCT00708123|54179810|FG002|Period 1|Protocol Violation|0|||
27732323|NCT00708123|54179811|FG003|Period 1|Protocol Violation|1|||
27732324|NCT00708123|54179812|FG004|Period 1|Protocol Violation|0|||
27732325|NCT00708123|54179808|FG000|Period 1|Adverse Event|0|||
27732326|NCT00708123|54179809|FG001|Period 1|Adverse Event|0|||
27732327|NCT00708123|54179810|FG002|Period 1|Adverse Event|1|||
27732328|NCT00708123|54179811|FG003|Period 1|Adverse Event|0|||
27832420|NCT01734785|54311698|FG001|Open-Label Period|Adverse Event|0|||
27959091|NCT00807937|54616316|FG001|Overall Study|Withdrawal by Subject|4|||
28165104|NCT03016325|54835755|FG002|32-Day Follow-Up Period|Poor/non-compliance|0|||
28165105|NCT03016325|54835756|FG003|32-Day Follow-Up Period|Poor/non-compliance|1|||
27732329|NCT00708123|54179812|FG004|Period 1|Adverse Event|0|||
27732330|NCT00708123|54179808|FG000|Period 2|Protocol Violation|0|||
27732331|NCT00708123|54179809|FG001|Period 2|Protocol Violation|0|||
27732332|NCT00708123|54179810|FG002|Period 2|Protocol Violation|0|||
27959092|NCT00807937|54616317|FG002|Overall Study|Withdrawal by Subject|1|||
27959093|NCT00807937|54616318|FG003|Overall Study|Withdrawal by Subject|4|||
27959094|NCT00807937|54616315|FG000|Overall Study|Lost to Follow-up|4|||
27959095|NCT00807937|54616316|FG001|Overall Study|Lost to Follow-up|0|||
27959096|NCT00807937|54616317|FG002|Overall Study|Lost to Follow-up|2|||
27959097|NCT00807937|54616318|FG003|Overall Study|Lost to Follow-up|1|||
27959098|NCT00807937|54616315|FG000|Overall Study|Lack of Efficacy|0|||
27959099|NCT00807937|54616316|FG001|Overall Study|Lack of Efficacy|0|||
27959100|NCT00807937|54616317|FG002|Overall Study|Lack of Efficacy|1|||
27959101|NCT00807937|54616318|FG003|Overall Study|Lack of Efficacy|2|||
27959102|NCT00807937|54616315|FG000|Overall Study|Intake of prohibited medicine|0|||
27959103|NCT00807937|54616316|FG001|Overall Study|Intake of prohibited medicine|0|||
27959104|NCT00807937|54616317|FG002|Overall Study|Intake of prohibited medicine|2|||
27959105|NCT00807937|54616318|FG003|Overall Study|Intake of prohibited medicine|0|||
27959106|NCT00807937|54616315|FG000|Overall Study|All other reasons (not provided)|2|||
27959107|NCT00807937|54616316|FG001|Overall Study|All other reasons (not provided)|4|||
27959108|NCT00807937|54616317|FG002|Overall Study|All other reasons (not provided)|0|||
27959109|NCT00807937|54616318|FG003|Overall Study|All other reasons (not provided)|1|||
27959110|NCT00906945|54616333|FG000|Overall Study|Found to be not eligible|0|||
27959111|NCT00906945|54616334|FG001|Overall Study|Found to be not eligible|0|||
27959112|NCT00906945|54616335|FG002|Overall Study|Found to be not eligible|0|||
27959113|NCT00906945|54616336|FG003|Overall Study|Found to be not eligible|1|||
27959114|NCT00906945|54616337|FG004|Overall Study|Found to be not eligible|1|||
27959115|NCT00906945|54616338|FG005|Overall Study|Found to be not eligible|1|||
27959116|NCT00906945|54616333|FG000|Overall Study|Physician Decision|0|||
27959117|NCT00906945|54616334|FG001|Overall Study|Physician Decision|0|||
27959118|NCT00906945|54616335|FG002|Overall Study|Physician Decision|0|||
27959119|NCT00906945|54616336|FG003|Overall Study|Physician Decision|0|||
27959120|NCT00906945|54616337|FG004|Overall Study|Physician Decision|0|||
28082129|NCT00008385|54735503|FG000|Overall Study|Off treatment reasons not reported|79|||
28082130|NCT00008385|54735504|FG001|Overall Study|Off treatment reasons not reported|70|||
28082131|NCT00008385|54735503|FG000|Overall Study|Progressive disease|52|||
28082132|NCT00008385|54735504|FG001|Overall Study|Progressive disease|117|||
28082133|NCT00008385|54735503|FG000|Overall Study|Adverse Event|8|||
28082134|NCT00008385|54735504|FG001|Overall Study|Adverse Event|20|||
28082135|NCT00008385|54735503|FG000|Overall Study|Death|12|||
28082136|NCT00008385|54735504|FG001|Overall Study|Death|18|||
28082137|NCT00008385|54735503|FG000|Overall Study|Withdrawal by Subject|67|||
28082138|NCT00008385|54735504|FG001|Overall Study|Withdrawal by Subject|157|||
27959121|NCT00906945|54616338|FG005|Overall Study|Physician Decision|1|||
27959122|NCT00807235|54616356|FG000|Overall Study|Adverse Event|1|||
27959123|NCT00807235|54616357|FG001|Overall Study|Adverse Event|0|||
27959124|NCT00876694|54616365|FG000|Overall Study|Adverse Event|10|||
27959125|NCT00876694|54616366|FG001|Overall Study|Adverse Event|7|||
27959126|NCT00876694|54616365|FG000|Overall Study|Subject withdrew consent|6|||
27959127|NCT00876694|54616366|FG001|Overall Study|Subject withdrew consent|4|||
27959128|NCT00876694|54616365|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
27959129|NCT00876694|54616366|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
27959130|NCT00876694|54616365|FG000|Overall Study|Abnormal test procedure result(s)|1|||
27959131|NCT00876694|54616366|FG001|Overall Study|Abnormal test procedure result(s)|0|||
27959132|NCT00876694|54616365|FG000|Overall Study|Administrative problems|1|||
27959133|NCT00876694|54616366|FG001|Overall Study|Administrative problems|1|||
27959134|NCT00876694|54616365|FG000|Overall Study|Death|1|||
27959135|NCT00876694|54616366|FG001|Overall Study|Death|0|||
27959136|NCT00805441|54616374|FG000|Overall Study|Adverse Event|5|||
27959137|NCT00805441|54616375|FG001|Overall Study|Adverse Event|2|||
27959138|NCT00805441|54616374|FG000|Overall Study|Lack of Efficacy|0|||
27959139|NCT00805441|54616375|FG001|Overall Study|Lack of Efficacy|2|||
27959140|NCT00805441|54616374|FG000|Overall Study|Protocol Violation|4|||
27959141|NCT00805441|54616375|FG001|Overall Study|Protocol Violation|8|||
27959142|NCT00805441|54616374|FG000|Overall Study|Lost to Follow-up|10|||
27959143|NCT00805441|54616375|FG001|Overall Study|Lost to Follow-up|13|||
27959144|NCT00805441|54616374|FG000|Overall Study|Withdrawal by Subject|15|||
27959145|NCT00805441|54616375|FG001|Overall Study|Withdrawal by Subject|9|||
27959146|NCT00805441|54616374|FG000|Overall Study|Physician Decision|0|||
27959147|NCT00805441|54616375|FG001|Overall Study|Physician Decision|1|||
27959148|NCT00805441|54616374|FG000|Overall Study|Acute Alcohol Withdrawal|0|||
27959149|NCT00805441|54616375|FG001|Overall Study|Acute Alcohol Withdrawal|1|||
27959150|NCT00590317|54616383|FG000|Overall Study|Lack of Efficacy|1|||
27959151|NCT00590317|54616384|FG001|Overall Study|Lack of Efficacy|5|||
27959152|NCT01139762|54616393|FG000|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258|||
27959153|NCT01139762|54616394|FG001|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
27959154|NCT01139762|54616395|FG002|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
27959155|NCT01139762|54616393|FG000|Washout and Placebo Lead-In Period|Adverse Event|1|||
28082139|NCT00008385|54735503|FG000|Overall Study|Start non-protocol therapy|3|||
27732333|NCT00708123|54179811|FG003|Period 2|Protocol Violation|1|||
27959156|NCT01139762|54616394|FG001|Washout and Placebo Lead-In Period|Adverse Event|0|||
27959157|NCT01139762|54616395|FG002|Washout and Placebo Lead-In Period|Adverse Event|0|||
27959158|NCT01139762|54616393|FG000|Washout and Placebo Lead-In Period|Withdrawal by Subject|83|||
27732334|NCT00708123|54179812|FG004|Period 2|Protocol Violation|0|||
27959159|NCT01139762|54616394|FG001|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
27959160|NCT01139762|54616395|FG002|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
27959161|NCT01139762|54616393|FG000|Washout and Placebo Lead-In Period|Physician Decision|12|||
27959162|NCT01139762|54616394|FG001|Washout and Placebo Lead-In Period|Physician Decision|0|||
27959163|NCT01139762|54616395|FG002|Washout and Placebo Lead-In Period|Physician Decision|0|||
27959164|NCT01139762|54616393|FG000|Washout and Placebo Lead-In Period|Sponsor Decision|10|||
27959165|NCT01139762|54616394|FG001|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
27959166|NCT01139762|54616395|FG002|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
27959167|NCT01139762|54616393|FG000|Washout and Placebo Lead-In Period|Lost to Follow-up|10|||
27959168|NCT01139762|54616394|FG001|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
27959169|NCT01139762|54616395|FG002|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
27959170|NCT01139762|54616393|FG000|Double-Blind Randomized Active Treatment|Adverse Event|0|||
27959171|NCT01139762|54616394|FG001|Double-Blind Randomized Active Treatment|Adverse Event|4|||
27959172|NCT01139762|54616395|FG002|Double-Blind Randomized Active Treatment|Adverse Event|10|||
27959173|NCT01139762|54616393|FG000|Double-Blind Randomized Active Treatment|Death|0|||
27959174|NCT01139762|54616394|FG001|Double-Blind Randomized Active Treatment|Death|1|||
27959175|NCT01139762|54616395|FG002|Double-Blind Randomized Active Treatment|Death|1|||
27959176|NCT01139762|54616393|FG000|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0|||
27959177|NCT01139762|54616394|FG001|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14|||
27959178|NCT01139762|54616395|FG002|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17|||
27959179|NCT01139762|54616393|FG000|Double-Blind Randomized Active Treatment|Protocol Violation|0|||
27959180|NCT01139762|54616394|FG001|Double-Blind Randomized Active Treatment|Protocol Violation|2|||
27959181|NCT01139762|54616395|FG002|Double-Blind Randomized Active Treatment|Protocol Violation|8|||
27959182|NCT01139762|54616393|FG000|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0|||
27959183|NCT01139762|54616394|FG001|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6|||
27959184|NCT01139762|54616395|FG002|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13|||
27959185|NCT01139762|54616393|FG000|Double-Blind Randomized Active Treatment|Physician Decision|0|||
27959186|NCT01139762|54616394|FG001|Double-Blind Randomized Active Treatment|Physician Decision|2|||
27959187|NCT01139762|54616395|FG002|Double-Blind Randomized Active Treatment|Physician Decision|0|||
27959188|NCT01139762|54616393|FG000|Double-Blind Randomized Active Treatment|Sponsor Decision|0|||
27959189|NCT01139762|54616394|FG001|Double-Blind Randomized Active Treatment|Sponsor Decision|5|||
27959190|NCT01139762|54616395|FG002|Double-Blind Randomized Active Treatment|Sponsor Decision|6|||
27959191|NCT01139762|54616393|FG000|Double-Blind Randomized Active Treatment|Lack of Efficacy|0|||
27959192|NCT01139762|54616394|FG001|Double-Blind Randomized Active Treatment|Lack of Efficacy|3|||
27959193|NCT01139762|54616395|FG002|Double-Blind Randomized Active Treatment|Lack of Efficacy|5|||
27959194|NCT01139762|54616393|FG000|Double-Blind Randomized Active Treatment|Lost to Follow-up|0|||
27959195|NCT01139762|54616394|FG001|Double-Blind Randomized Active Treatment|Lost to Follow-up|3|||
27959196|NCT01139762|54616395|FG002|Double-Blind Randomized Active Treatment|Lost to Follow-up|4|||
27959197|NCT00805285|54616402|FG000|Overall Study|Lack of Efficacy|1|||
27959198|NCT01139450|54616409|FG000|Overall Study|Withdrawal by Subject|7|||
27832421|NCT01734785|54311699|FG002|Open-Label Period|Adverse Event|0|||
27959199|NCT01139450|54616410|FG001|Overall Study|Withdrawal by Subject|10|||
27959200|NCT01139450|54616411|FG002|Overall Study|Withdrawal by Subject|13|||
27959201|NCT01139450|54616409|FG000|Overall Study|Lack of Efficacy|3|||
27959202|NCT01139450|54616410|FG001|Overall Study|Lack of Efficacy|1|||
27959203|NCT01139450|54616411|FG002|Overall Study|Lack of Efficacy|8|||
27959204|NCT01139450|54616409|FG000|Overall Study|Protocol Violation|6|||
27959205|NCT01139450|54616410|FG001|Overall Study|Protocol Violation|5|||
27959206|NCT01139450|54616411|FG002|Overall Study|Protocol Violation|2|||
27959207|NCT01139450|54616409|FG000|Overall Study|Lost to Follow-up|9|||
27959208|NCT01139450|54616410|FG001|Overall Study|Lost to Follow-up|7|||
27959209|NCT01139450|54616411|FG002|Overall Study|Lost to Follow-up|11|||
27959210|NCT01139450|54616409|FG000|Overall Study|Administrative|0|||
27959211|NCT01139450|54616410|FG001|Overall Study|Administrative|0|||
27959212|NCT01139450|54616411|FG002|Overall Study|Administrative|1|||
27959213|NCT01139450|54616409|FG000|Overall Study|Adverse Event|2|||
27959214|NCT01139450|54616410|FG001|Overall Study|Adverse Event|2|||
27959215|NCT01139450|54616411|FG002|Overall Study|Adverse Event|3|||
27959216|NCT00805207|54616428|FG000|Overall Study|Protocol Violation|0|||
27959217|NCT00805207|54616429|FG001|Overall Study|Protocol Violation|0|||
27959218|NCT00805207|54616430|FG002|Overall Study|Protocol Violation|1|||
27959219|NCT00805207|54616431|FG003|Overall Study|Protocol Violation|0|||
28165106|NCT03016325|54835757|FG004|32-Day Follow-Up Period|Poor/non-compliance|1|||
27832422|NCT01734785|54311700|FG003|Open-Label Period|Adverse Event|9|||
27832423|NCT01734785|54311697|FG000|Open-Label Period|Lack of Efficacy|0|||
27832424|NCT01734785|54311698|FG001|Open-Label Period|Lack of Efficacy|0|||
27959220|NCT00805207|54616432|FG004|Overall Study|Protocol Violation|0|||
27959221|NCT00805207|54616433|FG005|Overall Study|Protocol Violation|0|||
27832425|NCT01734785|54311699|FG002|Open-Label Period|Lack of Efficacy|0|||
27832426|NCT01734785|54311700|FG003|Open-Label Period|Lack of Efficacy|1|||
27959222|NCT00805207|54616434|FG006|Overall Study|Protocol Violation|0|||
27959223|NCT00805207|54616435|FG007|Overall Study|Protocol Violation|0|||
27959224|NCT00805207|54616436|FG008|Overall Study|Protocol Violation|0|||
27959225|NCT00805207|54616428|FG000|Overall Study|Physician Decision|0|||
27959226|NCT00805207|54616429|FG001|Overall Study|Physician Decision|1|||
27959227|NCT00805207|54616430|FG002|Overall Study|Physician Decision|0|||
27959228|NCT00805207|54616431|FG003|Overall Study|Physician Decision|0|||
27959229|NCT00805207|54616432|FG004|Overall Study|Physician Decision|0|||
27959230|NCT00805207|54616433|FG005|Overall Study|Physician Decision|1|||
27959231|NCT00805207|54616434|FG006|Overall Study|Physician Decision|0|||
27959232|NCT00805207|54616435|FG007|Overall Study|Physician Decision|0|||
27959233|NCT00805207|54616436|FG008|Overall Study|Physician Decision|0|||
27959234|NCT00805207|54616428|FG000|Overall Study|Withdrawal by Subject|0|||
27959235|NCT00805207|54616429|FG001|Overall Study|Withdrawal by Subject|1|||
27959236|NCT00805207|54616430|FG002|Overall Study|Withdrawal by Subject|0|||
27959237|NCT00805207|54616431|FG003|Overall Study|Withdrawal by Subject|0|||
27959238|NCT00805207|54616432|FG004|Overall Study|Withdrawal by Subject|1|||
27959239|NCT00805207|54616433|FG005|Overall Study|Withdrawal by Subject|2|||
27959240|NCT00805207|54616434|FG006|Overall Study|Withdrawal by Subject|0|||
27959241|NCT00805207|54616435|FG007|Overall Study|Withdrawal by Subject|0|||
27959242|NCT00805207|54616436|FG008|Overall Study|Withdrawal by Subject|0|||
27959243|NCT00805675|54616463|FG000|Overall Study|Adverse Event|0|||
27959244|NCT00805675|54616464|FG001|Overall Study|Adverse Event|0|||
27959245|NCT00805675|54616465|FG002|Overall Study|Adverse Event|1|||
27959246|NCT00589303|54616479|FG000|Overall Study|Withdrawal by Subject|2|||
27959247|NCT00589303|54616480|FG001|Overall Study|Withdrawal by Subject|1|||
27959248|NCT00952380|54616491|FG000|Overall Study|Other|0|||
27959249|NCT00952380|54616492|FG001|Overall Study|Other|0|||
27959250|NCT00952380|54616493|FG002|Overall Study|Other|0|||
27959251|NCT00952380|54616494|FG003|Overall Study|Other|0|||
27959252|NCT00952380|54616495|FG004|Overall Study|Other|1|||
27959253|NCT00952380|54616491|FG000|Overall Study|Withdrawal by Subject|0|||
27959254|NCT00952380|54616492|FG001|Overall Study|Withdrawal by Subject|0|||
27959255|NCT00952380|54616493|FG002|Overall Study|Withdrawal by Subject|1|||
27959256|NCT00952380|54616494|FG003|Overall Study|Withdrawal by Subject|0|||
27959257|NCT00952380|54616495|FG004|Overall Study|Withdrawal by Subject|2|||
27959258|NCT00952380|54616491|FG000|Overall Study|Adverse Event|0|||
27959259|NCT00952380|54616492|FG001|Overall Study|Adverse Event|1|||
27959260|NCT00952380|54616493|FG002|Overall Study|Adverse Event|0|||
27959261|NCT00952380|54616494|FG003|Overall Study|Adverse Event|0|||
27959262|NCT00952380|54616495|FG004|Overall Study|Adverse Event|3|||
27959263|NCT00952380|54616491|FG000|Overall Study|Physician Decision|0|||
27959264|NCT00952380|54616492|FG001|Overall Study|Physician Decision|0|||
27959265|NCT00952380|54616493|FG002|Overall Study|Physician Decision|1|||
27959266|NCT00952380|54616494|FG003|Overall Study|Physician Decision|2|||
27959267|NCT00952380|54616495|FG004|Overall Study|Physician Decision|0|||
27959268|NCT00952380|54616491|FG000|Overall Study|Non-compliant to protocol|0|||
27959269|NCT00952380|54616492|FG001|Overall Study|Non-compliant to protocol|0|||
27959270|NCT00952380|54616493|FG002|Overall Study|Non-compliant to protocol|0|||
27959271|NCT00952380|54616494|FG003|Overall Study|Non-compliant to protocol|1|||
27959272|NCT00952380|54616495|FG004|Overall Study|Non-compliant to protocol|0|||
27959273|NCT00803179|54616512|FG000|Overall Study|Lost to Follow-up|3|||
27959274|NCT00804193|54616519|FG000|Overall Study|Lack of baseline fungus|32|||
27959275|NCT00804193|54616520|FG001|Overall Study|Lack of baseline fungus|31|||
27959276|NCT00804193|54616521|FG002|Overall Study|Lack of baseline fungus|19|||
27959277|NCT00804193|54616519|FG000|Overall Study|Adverse Event|0|||
27959278|NCT00804193|54616520|FG001|Overall Study|Adverse Event|0|||
27959279|NCT00804193|54616521|FG002|Overall Study|Adverse Event|2|||
27959280|NCT00804193|54616519|FG000|Overall Study|Lack of Efficacy|1|||
27959281|NCT00804193|54616520|FG001|Overall Study|Lack of Efficacy|1|||
27959282|NCT00804193|54616521|FG002|Overall Study|Lack of Efficacy|3|||
27959283|NCT00804193|54616519|FG000|Overall Study|Protocol Violation|0|||
27959284|NCT00804193|54616520|FG001|Overall Study|Protocol Violation|8|||
27959285|NCT00804193|54616521|FG002|Overall Study|Protocol Violation|2|||
27959286|NCT00804193|54616519|FG000|Overall Study|Lost to Follow-up|3|||
27959287|NCT00804193|54616520|FG001|Overall Study|Lost to Follow-up|3|||
27959288|NCT00804193|54616521|FG002|Overall Study|Lost to Follow-up|4|||
27959289|NCT00804193|54616519|FG000|Overall Study|Withdrawal by Subject|3|||
27959290|NCT00804193|54616520|FG001|Overall Study|Withdrawal by Subject|1|||
27959291|NCT00804193|54616521|FG002|Overall Study|Withdrawal by Subject|2|||
27959292|NCT00957996|54616531|FG000|Overall Study|Death|4|||
27959293|NCT00957996|54616532|FG001|Overall Study|Death|10|||
27959294|NCT00957996|54616531|FG000|Overall Study|Lost to Follow-up|4|||
27959295|NCT00957996|54616532|FG001|Overall Study|Lost to Follow-up|7|||
27959296|NCT00957996|54616531|FG000|Overall Study|Withdrawal by Subject|9|||
27959297|NCT00957996|54616532|FG001|Overall Study|Withdrawal by Subject|2|||
27959298|NCT00957996|54616531|FG000|Overall Study|Adverse Event|2|||
27959299|NCT00957996|54616532|FG001|Overall Study|Adverse Event|1|||
27959300|NCT00957996|54616531|FG000|Overall Study|Physician Decision|1|||
27959301|NCT00957996|54616532|FG001|Overall Study|Physician Decision|1|||
27959302|NCT00957996|54616531|FG000|Overall Study|Influenza-related complication|0|||
27959303|NCT00957996|54616532|FG001|Overall Study|Influenza-related complication|1|||
27959304|NCT00957996|54616531|FG000|Overall Study|Missing|1|||
27959305|NCT00957996|54616532|FG001|Overall Study|Missing|0|||
27959306|NCT00957996|54616531|FG000|Overall Study|Noncompliance; Protocol Deviations|5|||
27959307|NCT00957996|54616532|FG001|Overall Study|Noncompliance; Protocol Deviations|6|||
27959308|NCT00589693|54616542|FG000|Overall Study|randomized in error|12|||
27959309|NCT00589693|54616543|FG001|Overall Study|randomized in error|6|||
27959310|NCT00589693|54616542|FG000|Overall Study|Adverse Event|4|||
27959311|NCT00589693|54616543|FG001|Overall Study|Adverse Event|4|||
27959312|NCT00589693|54616542|FG000|Overall Study|Death|26|||
27959313|NCT00589693|54616543|FG001|Overall Study|Death|16|||
27959314|NCT00589693|54616542|FG000|Overall Study|Lack of Efficacy|0|||
27959315|NCT00589693|54616543|FG001|Overall Study|Lack of Efficacy|1|||
27959316|NCT00589693|54616542|FG000|Overall Study|Lost to Follow-up|1|||
27959317|NCT00589693|54616543|FG001|Overall Study|Lost to Follow-up|0|||
27959318|NCT00589693|54616542|FG000|Overall Study|Physician Decision|0|||
27959319|NCT00589693|54616543|FG001|Overall Study|Physician Decision|1|||
27959320|NCT00589693|54616542|FG000|Overall Study|Protocol Violation|1|||
27959321|NCT00589693|54616543|FG001|Overall Study|Protocol Violation|1|||
27959322|NCT00803101|54616551|FG000|Overall Study|Death / Serious Adverse Event|4|||
27959323|NCT00803101|54616552|FG001|Overall Study|Death / Serious Adverse Event|6|||
27959324|NCT00803101|54616551|FG000|Overall Study|Withdrawal by Subject|6|||
27959325|NCT00803101|54616552|FG001|Overall Study|Withdrawal by Subject|4|||
27959326|NCT00803101|54616551|FG000|Overall Study|Lost to Follow-up|2|||
27959327|NCT00803101|54616552|FG001|Overall Study|Lost to Follow-up|2|||
27959328|NCT00803101|54616551|FG000|Overall Study|Protocol Violation|1|||
27959329|NCT00803101|54616552|FG001|Overall Study|Protocol Violation|7|||
27959330|NCT00803101|54616551|FG000|Overall Study|Surgery finished outside protocol window|1|||
27959331|NCT00803101|54616552|FG001|Overall Study|Surgery finished outside protocol window|1|||
27732335|NCT00708123|54179808|FG000|Period 2|Other Reason|1|||
27732336|NCT00708123|54179809|FG001|Period 2|Other Reason|0|||
27959332|NCT00803101|54616551|FG000|Overall Study|Patient died outside SAE report period|1|||
27959333|NCT00803101|54616552|FG001|Overall Study|Patient died outside SAE report period|0|||
27959334|NCT00803101|54616551|FG000|Overall Study|Patient did not attend scheduled visit|2|||
27959335|NCT00803101|54616552|FG001|Overall Study|Patient did not attend scheduled visit|1|||
27959336|NCT00803101|54616551|FG000|Overall Study|Patient did not have surgery|1|||
27959337|NCT00803101|54616552|FG001|Overall Study|Patient did not have surgery|1|||
27959338|NCT00801229|54616560|FG000|Signed Consent|Withdrawal by Subject|2|||
27959339|NCT00801229|54616561|FG001|Signed Consent|Withdrawal by Subject|2|||
27959340|NCT00801229|54616560|FG000|Signed Consent|Found Ineligible|1|||
27959341|NCT00801229|54616561|FG001|Signed Consent|Found Ineligible|1|||
27959342|NCT00801229|54616560|FG000|Received Study Drug/Placebo|Elevated SGOT level|1|||
27959343|NCT00801229|54616561|FG001|Received Study Drug/Placebo|Elevated SGOT level|0|||
27959344|NCT00801229|54616560|FG000|Received Study Drug/Placebo|Sub-threshold ADHD|0|||
27959345|NCT00801229|54616561|FG001|Received Study Drug/Placebo|Sub-threshold ADHD|1|||
27959346|NCT00801229|54616560|FG000|Received Study Drug/Placebo|Simulator sickness|1|||
27959347|NCT00801229|54616561|FG001|Received Study Drug/Placebo|Simulator sickness|1|||
27959348|NCT00801229|54616560|FG000|Received Study Drug/Placebo|Withdrawal by Subject|1|||
27959349|NCT00801229|54616561|FG001|Received Study Drug/Placebo|Withdrawal by Subject|0|||
27959350|NCT00801229|54616560|FG000|Received Study Drug/Placebo|Lost to Follow-up|0|||
27959351|NCT00801229|54616561|FG001|Received Study Drug/Placebo|Lost to Follow-up|1|||
27959352|NCT00801229|54616560|FG000|Received Study Drug/Placebo|Adverse Event|1|||
27959353|NCT00801229|54616561|FG001|Received Study Drug/Placebo|Adverse Event|1|||
27959354|NCT00948246|54616567|FG000|Overall Study|Lost to Follow-up|11|||
27959355|NCT00948246|54616567|FG000|Overall Study|Adverse Event|11|||
27959356|NCT00948246|54616567|FG000|Overall Study|Death|1|||
27959357|NCT00948246|54616567|FG000|Overall Study|Withdrawal by Subject|1|||
27959358|NCT00800683|54616573|FG000|Overall Study|Adverse Event|11|||
27959359|NCT00800683|54616574|FG001|Overall Study|Adverse Event|8|||
27959360|NCT00800683|54616573|FG000|Overall Study|Lost to Follow-up|3|||
27959361|NCT00800683|54616574|FG001|Overall Study|Lost to Follow-up|1|||
27959362|NCT00800683|54616573|FG000|Overall Study|Withdrawal by Subject|1|||
27732337|NCT00708123|54179810|FG002|Period 2|Other Reason|0|||
27959363|NCT00800683|54616574|FG001|Overall Study|Withdrawal by Subject|7|||
27959364|NCT00800683|54616573|FG000|Overall Study|Lack of Efficacy|1|||
27959365|NCT00800683|54616574|FG001|Overall Study|Lack of Efficacy|1|||
27732338|NCT00708123|54179811|FG003|Period 2|Other Reason|0|||
27959366|NCT00800683|54616573|FG000|Overall Study|Other|1|||
27732339|NCT00708123|54179812|FG004|Period 2|Other Reason|0|||
27959367|NCT00800683|54616574|FG001|Overall Study|Other|2|||
27959368|NCT01124864|54616586|FG000|Overall Study|Follow up phase competed as per protocol|18|||
27959369|NCT01124864|54616587|FG001|Overall Study|Follow up phase competed as per protocol|22|||
27959370|NCT01124864|54616588|FG002|Overall Study|Follow up phase competed as per protocol|24|||
27732340|NCT00708123|54179808|FG000|Period 3|Lost to Follow-up|0|||
27959371|NCT01124864|54616589|FG003|Overall Study|Follow up phase competed as per protocol|18|||
27959372|NCT01124864|54616590|FG004|Overall Study|Follow up phase competed as per protocol|26|||
27959373|NCT01124864|54616591|FG005|Overall Study|Follow up phase competed as per protocol|2|||
27959374|NCT01124864|54616586|FG000|Overall Study|Death|6|||
27959375|NCT01124864|54616587|FG001|Overall Study|Death|9|||
27959376|NCT01124864|54616588|FG002|Overall Study|Death|6|||
27959377|NCT01124864|54616589|FG003|Overall Study|Death|2|||
27959378|NCT01124864|54616590|FG004|Overall Study|Death|1|||
27959379|NCT01124864|54616591|FG005|Overall Study|Death|0|||
27959380|NCT01124864|54616586|FG000|Overall Study|Withdrawal by Subject|2|||
27959381|NCT01124864|54616587|FG001|Overall Study|Withdrawal by Subject|3|||
27959382|NCT01124864|54616588|FG002|Overall Study|Withdrawal by Subject|4|||
27959383|NCT01124864|54616589|FG003|Overall Study|Withdrawal by Subject|0|||
27959384|NCT01124864|54616590|FG004|Overall Study|Withdrawal by Subject|2|||
27959385|NCT01124864|54616591|FG005|Overall Study|Withdrawal by Subject|1|||
27959386|NCT01124864|54616586|FG000|Overall Study|Lost to Follow-up|1|||
27959387|NCT01124864|54616587|FG001|Overall Study|Lost to Follow-up|1|||
27959388|NCT01124864|54616588|FG002|Overall Study|Lost to Follow-up|0|||
27959389|NCT01124864|54616589|FG003|Overall Study|Lost to Follow-up|1|||
27959390|NCT01124864|54616590|FG004|Overall Study|Lost to Follow-up|0|||
27959391|NCT01124864|54616591|FG005|Overall Study|Lost to Follow-up|0|||
27959392|NCT01124864|54616586|FG000|Overall Study|Protocol Violation|1|||
27959393|NCT01124864|54616587|FG001|Overall Study|Protocol Violation|0|||
27959394|NCT01124864|54616588|FG002|Overall Study|Protocol Violation|0|||
27959395|NCT01124864|54616589|FG003|Overall Study|Protocol Violation|0|||
27959396|NCT01124864|54616590|FG004|Overall Study|Protocol Violation|1|||
27959397|NCT01124864|54616591|FG005|Overall Study|Protocol Violation|0|||
27959398|NCT01113710|54616607|FG000|Overall Study|Adverse Event|64|||
27959399|NCT01113710|54616607|FG000|Overall Study|Lack of Efficacy|41|||
27959400|NCT01113710|54616607|FG000|Overall Study|No Information Available|40|||
27959401|NCT01113710|54616607|FG000|Overall Study|Withdrawal by Subject|28|||
27959402|NCT01113710|54616607|FG000|Overall Study|Lost to Follow-up|20|||
27959403|NCT01113710|54616607|FG000|Overall Study|Lack of Efficacy/Withdrawal by Subject|13|||
27959404|NCT01113710|54616607|FG000|Overall Study|Withdrawal by Subject/Adverse Event|11|||
27959405|NCT01113710|54616607|FG000|Overall Study|Lack of Patient's Compliance|8|||
27959406|NCT01113710|54616607|FG000|Overall Study|Other|7|||
27959407|NCT01113710|54616607|FG000|Overall Study|Adverse Event/Other|5|||
27959408|NCT01113710|54616607|FG000|Overall Study|Patient's Compliance/Lost to Follow up|5|||
27959409|NCT01113710|54616607|FG000|Overall Study|Lack of Efficacy/Other|4|||
27959410|NCT01113710|54616607|FG000|Overall Study|Patient Compliance/Withdrawal by Subject|4|||
27959411|NCT01113710|54616607|FG000|Overall Study|Lack of Efficacy/Adverse Event|3|||
27959412|NCT01113710|54616607|FG000|Overall Study|Efficacy/Subject Withdrawal/AE|2|||
27959413|NCT01113710|54616607|FG000|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2|||
27959414|NCT01113710|54616607|FG000|Overall Study|Lost to Follow up/Withdrawal by Subject|2|||
27959415|NCT01113710|54616607|FG000|Overall Study|Efficacy/Withdrawal by Subject/Other|1|||
27959416|NCT01113710|54616607|FG000|Overall Study|Compliance/Efficacy/Adverse Event|1|||
27959417|NCT01113710|54616607|FG000|Overall Study|Compliance/Efficacy/AE/Other|1|||
27959418|NCT01113710|54616607|FG000|Overall Study|Compliance/Efficacy/Subject Withdrawal|1|||
27959419|NCT01113710|54616607|FG000|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1|||
27959420|NCT01113710|54616607|FG000|Overall Study|Lack of Patient's Compliance/Other|1|||
27959421|NCT01113710|54616607|FG000|Overall Study|Compliance/Subject Withdrawal/AE|1|||
27959422|NCT01113710|54616607|FG000|Overall Study|Subject Did Not Receive Neupro|3|||
27959423|NCT01124162|54616613|FG000|First Intervention|Adverse Event|2|||
27959424|NCT01124162|54616614|FG001|First Intervention|Adverse Event|0|||
27959425|NCT01124162|54616613|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
27959426|NCT01124162|54616614|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
27959427|NCT00906399|54616623|FG000|Year 1|Randomized But Not Treated|0|||
27959428|NCT00906399|54616624|FG001|Year 1|Randomized But Not Treated|1|||
27959429|NCT00906399|54616625|FG002|Year 1|Randomized But Not Treated|3|||
27959430|NCT00906399|54616626|FG003|Year 1|Randomized But Not Treated|0|||
28165107|NCT03016325|54835758|FG005|32-Day Follow-Up Period|Poor/non-compliance|0|||
28165108|NCT03016325|54835759|FG006|32-Day Follow-Up Period|Poor/non-compliance|0|||
28165109|NCT03016325|54835760|FG007|32-Day Follow-Up Period|Poor/non-compliance|0|||
28165110|NCT03016325|54835753|FG000|32-Day Follow-Up Period|Participant refused to visit|0|||
27959431|NCT00906399|54616627|FG004|Year 1|Randomized But Not Treated|0|||
27959432|NCT00906399|54616628|FG005|Year 1|Randomized But Not Treated|0|||
27959433|NCT00906399|54616629|FG006|Year 1|Randomized But Not Treated|0|||
27959434|NCT00906399|54616623|FG000|Year 1|Adverse Event|4|||
27959435|NCT00906399|54616624|FG001|Year 1|Adverse Event|22|||
27959436|NCT00906399|54616625|FG002|Year 1|Adverse Event|24|||
27959437|NCT00906399|54616626|FG003|Year 1|Adverse Event|0|||
27959438|NCT00906399|54616627|FG004|Year 1|Adverse Event|0|||
27959439|NCT00906399|54616628|FG005|Year 1|Adverse Event|0|||
27959440|NCT00906399|54616629|FG006|Year 1|Adverse Event|0|||
27959441|NCT00906399|54616623|FG000|Year 1|Lost to Follow-up|4|||
27959442|NCT00906399|54616624|FG001|Year 1|Lost to Follow-up|4|||
27959443|NCT00906399|54616625|FG002|Year 1|Lost to Follow-up|2|||
27959444|NCT00906399|54616626|FG003|Year 1|Lost to Follow-up|0|||
27959445|NCT00906399|54616627|FG004|Year 1|Lost to Follow-up|0|||
27959446|NCT00906399|54616628|FG005|Year 1|Lost to Follow-up|0|||
27959447|NCT00906399|54616629|FG006|Year 1|Lost to Follow-up|0|||
27959448|NCT00906399|54616623|FG000|Year 1|Withdrawal by Subject|30|||
27959449|NCT00906399|54616624|FG001|Year 1|Withdrawal by Subject|32|||
27959450|NCT00906399|54616625|FG002|Year 1|Withdrawal by Subject|36|||
27959451|NCT00906399|54616626|FG003|Year 1|Withdrawal by Subject|0|||
27959452|NCT00906399|54616627|FG004|Year 1|Withdrawal by Subject|0|||
27959453|NCT00906399|54616628|FG005|Year 1|Withdrawal by Subject|0|||
27959454|NCT00906399|54616629|FG006|Year 1|Withdrawal by Subject|0|||
27959455|NCT00906399|54616623|FG000|Year 1|Physician Decision|0|||
27959456|NCT00906399|54616624|FG001|Year 1|Physician Decision|1|||
27959457|NCT00906399|54616625|FG002|Year 1|Physician Decision|3|||
27959458|NCT00906399|54616626|FG003|Year 1|Physician Decision|0|||
27959459|NCT00906399|54616627|FG004|Year 1|Physician Decision|0|||
27959460|NCT00906399|54616628|FG005|Year 1|Physician Decision|0|||
27959461|NCT00906399|54616629|FG006|Year 1|Physician Decision|0|||
27959462|NCT00906399|54616623|FG000|Year 1|Death|2|||
27959463|NCT00906399|54616624|FG001|Year 1|Death|1|||
27959464|NCT00906399|54616625|FG002|Year 1|Death|1|||
27959465|NCT00906399|54616626|FG003|Year 1|Death|0|||
27959466|NCT00906399|54616627|FG004|Year 1|Death|0|||
27959467|NCT00906399|54616628|FG005|Year 1|Death|0|||
27959468|NCT00906399|54616629|FG006|Year 1|Death|0|||
27959469|NCT00906399|54616623|FG000|Year 1|Other|4|||
27959470|NCT00906399|54616624|FG001|Year 1|Other|2|||
27959471|NCT00906399|54616625|FG002|Year 1|Other|7|||
27959472|NCT00906399|54616626|FG003|Year 1|Other|0|||
27959473|NCT00906399|54616627|FG004|Year 1|Other|0|||
27959474|NCT00906399|54616628|FG005|Year 1|Other|0|||
27959475|NCT00906399|54616629|FG006|Year 1|Other|0|||
27959476|NCT00906399|54616623|FG000|Year 2|Adverse Event|0|||
27959477|NCT00906399|54616624|FG001|Year 2|Adverse Event|0|||
27959478|NCT00906399|54616625|FG002|Year 2|Adverse Event|0|||
27959479|NCT00906399|54616626|FG003|Year 2|Adverse Event|9|||
27959480|NCT00906399|54616627|FG004|Year 2|Adverse Event|8|||
27959481|NCT00906399|54616628|FG005|Year 2|Adverse Event|11|||
27959482|NCT00906399|54616629|FG006|Year 2|Adverse Event|6|||
27959483|NCT00906399|54616623|FG000|Year 2|Lost to Follow-up|0|||
27959484|NCT00906399|54616624|FG001|Year 2|Lost to Follow-up|0|||
27959485|NCT00906399|54616625|FG002|Year 2|Lost to Follow-up|0|||
27959486|NCT00906399|54616626|FG003|Year 2|Lost to Follow-up|1|||
27959487|NCT00906399|54616627|FG004|Year 2|Lost to Follow-up|4|||
27959488|NCT00906399|54616628|FG005|Year 2|Lost to Follow-up|2|||
27959489|NCT00906399|54616629|FG006|Year 2|Lost to Follow-up|4|||
27959490|NCT00906399|54616623|FG000|Year 2|Withdrawal by Subject|0|||
27959491|NCT00906399|54616624|FG001|Year 2|Withdrawal by Subject|0|||
27959492|NCT00906399|54616625|FG002|Year 2|Withdrawal by Subject|0|||
27959493|NCT00906399|54616626|FG003|Year 2|Withdrawal by Subject|17|||
27959494|NCT00906399|54616627|FG004|Year 2|Withdrawal by Subject|18|||
27959495|NCT00906399|54616628|FG005|Year 2|Withdrawal by Subject|27|||
27959496|NCT00906399|54616629|FG006|Year 2|Withdrawal by Subject|13|||
27959497|NCT00906399|54616623|FG000|Year 2|Physician Decision|0|||
27959498|NCT00906399|54616624|FG001|Year 2|Physician Decision|0|||
27959499|NCT00906399|54616625|FG002|Year 2|Physician Decision|0|||
27959500|NCT00906399|54616626|FG003|Year 2|Physician Decision|0|||
27959501|NCT00906399|54616627|FG004|Year 2|Physician Decision|2|||
27959502|NCT00906399|54616628|FG005|Year 2|Physician Decision|6|||
27959503|NCT00906399|54616629|FG006|Year 2|Physician Decision|3|||
27959504|NCT00906399|54616623|FG000|Year 2|Death|0|||
27959505|NCT00906399|54616624|FG001|Year 2|Death|0|||
27959506|NCT00906399|54616625|FG002|Year 2|Death|0|||
27959507|NCT00906399|54616626|FG003|Year 2|Death|1|||
27959508|NCT00906399|54616627|FG004|Year 2|Death|0|||
27959509|NCT00906399|54616628|FG005|Year 2|Death|0|||
27959510|NCT00906399|54616629|FG006|Year 2|Death|3|||
27959511|NCT00906399|54616623|FG000|Year 2|Other|0|||
27959512|NCT00906399|54616624|FG001|Year 2|Other|0|||
27959513|NCT00906399|54616625|FG002|Year 2|Other|0|||
27959514|NCT00906399|54616626|FG003|Year 2|Other|2|||
27959515|NCT00906399|54616627|FG004|Year 2|Other|3|||
27959516|NCT00906399|54616628|FG005|Year 2|Other|1|||
27959517|NCT00906399|54616629|FG006|Year 2|Other|0|||
27959518|NCT01111838|54616641|FG000|Overall Study|Patient Ineligible|2|||
27959519|NCT01111838|54616641|FG000|Overall Study|Not Treated|3|||
27959520|NCT01111838|54616641|FG000|Overall Study|Clinical deterioration|1|||
27959521|NCT01111838|54616641|FG000|Overall Study|Other Complicating Disease|1|||
27959522|NCT00947856|54616647|FG000|Treatment Period|Progressive Disease|33|||
27959523|NCT00947856|54616648|FG001|Treatment Period|Progressive Disease|12|||
27959524|NCT00947856|54616647|FG000|Treatment Period|Adverse Event|15|||
27959525|NCT00947856|54616648|FG001|Treatment Period|Adverse Event|9|||
27959526|NCT00947856|54616647|FG000|Treatment Period|Physician Decision|14|||
27959527|NCT00947856|54616648|FG001|Treatment Period|Physician Decision|6|||
27959528|NCT00947856|54616647|FG000|Treatment Period|Study Stopped by Sponsor|4|||
27959529|NCT00947856|54616648|FG001|Treatment Period|Study Stopped by Sponsor|4|||
27959530|NCT00947856|54616647|FG000|Treatment Period|Withdrawal by Subject|12|||
27959531|NCT00947856|54616648|FG001|Treatment Period|Withdrawal by Subject|1|||
27959532|NCT00947856|54616647|FG000|Follow-up Period|Study Stopped by Sponsor|40|||
27959533|NCT00947856|54616648|FG001|Follow-up Period|Study Stopped by Sponsor|20|||
27959534|NCT00947856|54616647|FG000|Follow-up Period|Re-enrolled for Retreatment|2|||
27959535|NCT00947856|54616648|FG001|Follow-up Period|Re-enrolled for Retreatment|3|||
27959536|NCT00947856|54616647|FG000|Follow-up Period|Lost to Follow-up|7|||
27959537|NCT00947856|54616648|FG001|Follow-up Period|Lost to Follow-up|0|||
27959538|NCT00947856|54616647|FG000|Follow-up Period|Patient unavailable for site visits|1|||
27959539|NCT00947856|54616648|FG001|Follow-up Period|Patient unavailable for site visits|0|||
27959540|NCT00947856|54616647|FG000|Follow-up Period|Withdrawal by Subject|1|||
27959541|NCT00947856|54616648|FG001|Follow-up Period|Withdrawal by Subject|0|||
27959542|NCT00947544|54616663|FG000|Safety-Extension Period (12 Months)|Withdrawal by Subject|1|||
27959543|NCT00947544|54616664|FG001|Safety-Extension Period (12 Months)|Withdrawal by Subject|0|||
27959544|NCT00907335|54616676|FG000|Overall Study|Withdrawal by Subject|2|||
27959545|NCT00907335|54616677|FG001|Overall Study|Withdrawal by Subject|0|||
27959546|NCT00907335|54616676|FG000|Overall Study|Adverse Event|4|||
27959547|NCT00907335|54616677|FG001|Overall Study|Adverse Event|1|||
27959548|NCT00907335|54616676|FG000|Overall Study|Lost to Follow-up|2|||
27959549|NCT00907335|54616677|FG001|Overall Study|Lost to Follow-up|0|||
27959550|NCT00947154|54616683|FG000|Overall Study|Lost to Follow-up|1|||
27959551|NCT01124006|54616691|FG000|Overall Study|Withdrawal by Subject|2|||
27959552|NCT01124006|54616692|FG001|Overall Study|Withdrawal by Subject|2|||
27959553|NCT01124006|54616693|FG002|Overall Study|Withdrawal by Subject|0|||
27959554|NCT01124006|54616691|FG000|Overall Study|Lost to Follow-up|1|||
27959555|NCT01124006|54616692|FG001|Overall Study|Lost to Follow-up|0|||
27959556|NCT01124006|54616693|FG002|Overall Study|Lost to Follow-up|1|||
27959557|NCT01124006|54616691|FG000|Overall Study|Other|0|||
27959558|NCT01124006|54616692|FG001|Overall Study|Other|0|||
27959559|NCT01124006|54616693|FG002|Overall Study|Other|1|||
27959560|NCT00952068|54616701|FG000|Overall Study|Adverse Event|3|||
27959561|NCT00952068|54616701|FG000|Overall Study|Withdrawal by Subject|4|||
27959562|NCT01123850|54616705|FG000|Overall Study|Slow enrollment|45|||
27959563|NCT01123382|54616711|FG000|Overall Study|Withdrawal by Subject|1|||
27959564|NCT01123382|54616712|FG001|Overall Study|Withdrawal by Subject|4|||
27959565|NCT01123382|54616711|FG000|Overall Study|Lost to Follow-up|1|||
27959566|NCT01123382|54616712|FG001|Overall Study|Lost to Follow-up|2|||
27959567|NCT00951912|54616721|FG000|Overall Study|Lack of Efficacy|1|||
27959568|NCT00951912|54616722|FG001|Overall Study|Lack of Efficacy|0|||
27959569|NCT00951912|54616723|FG002|Overall Study|Lack of Efficacy|0|||
27959570|NCT00951912|54616721|FG000|Overall Study|Adverse Event|0|||
27959571|NCT00951912|54616722|FG001|Overall Study|Adverse Event|1|||
27959572|NCT00951912|54616723|FG002|Overall Study|Adverse Event|1|||
27959573|NCT00951912|54616721|FG000|Overall Study|Lost to Follow-up|2|||
27959574|NCT00951912|54616722|FG001|Overall Study|Lost to Follow-up|2|||
27959575|NCT00951912|54616723|FG002|Overall Study|Lost to Follow-up|0|||
27959576|NCT00951912|54616721|FG000|Overall Study|Physician Decision|1|||
27959577|NCT00951912|54616722|FG001|Overall Study|Physician Decision|0|||
27959578|NCT00951912|54616723|FG002|Overall Study|Physician Decision|1|||
27959579|NCT00951912|54616721|FG000|Overall Study|Withdrawal by Subject|1|||
27959580|NCT00951912|54616722|FG001|Overall Study|Withdrawal by Subject|1|||
27959581|NCT00951912|54616723|FG002|Overall Study|Withdrawal by Subject|0|||
27959582|NCT00951912|54616721|FG000|Overall Study|Other:Depression|1|||
27959583|NCT00951912|54616722|FG001|Overall Study|Other:Depression|0|||
27959584|NCT00951912|54616723|FG002|Overall Study|Other:Depression|0|||
27959585|NCT00951912|54616721|FG000|Overall Study|Other: Colon cancer|1|||
27959586|NCT00951912|54616722|FG001|Overall Study|Other: Colon cancer|0|||
27959587|NCT00951912|54616723|FG002|Overall Study|Other: Colon cancer|0|||
27959588|NCT00951912|54616721|FG000|Overall Study|Other: Stroke|0|||
27959589|NCT00951912|54616722|FG001|Overall Study|Other: Stroke|1|||
27959590|NCT00951912|54616723|FG002|Overall Study|Other: Stroke|0|||
27959591|NCT01123148|54616731|FG000|Overall Study|Coughing caused unacceptable EEG quality|1|||
27959592|NCT01123148|54616731|FG000|Overall Study|Didn't meet milestone criteria|1|||
27959593|NCT01123070|54616739|FG000|Part B Double Blind Period|Protocol Violation|0|||
27959594|NCT01123070|54616740|FG001|Part B Double Blind Period|Protocol Violation|0|||
27959595|NCT01123070|54616741|FG002|Part B Double Blind Period|Protocol Violation|0|||
27959596|NCT01123070|54616742|FG003|Part B Double Blind Period|Protocol Violation|1|||
27959597|NCT01123070|54616739|FG000|Part B Double Blind Period|Adverse Event|0|||
27959598|NCT01123070|54616740|FG001|Part B Double Blind Period|Adverse Event|0|||
27959599|NCT01123070|54616741|FG002|Part B Double Blind Period|Adverse Event|2|||
27959600|NCT01123070|54616742|FG003|Part B Double Blind Period|Adverse Event|0|||
27959601|NCT01123070|54616739|FG000|Part B Double Blind Period|Sponsor's Decision|0|||
27959602|NCT01123070|54616740|FG001|Part B Double Blind Period|Sponsor's Decision|0|||
27959603|NCT01123070|54616741|FG002|Part B Double Blind Period|Sponsor's Decision|2|||
27959604|NCT01123070|54616742|FG003|Part B Double Blind Period|Sponsor's Decision|2|||
27959605|NCT01122680|54616753|FG000|Period 1 (4 Weeks)|Adverse Event|1|||
27959606|NCT01122680|54616754|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
27959607|NCT01122680|54616755|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
27959608|NCT01122680|54616756|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
27959609|NCT01122680|54616753|FG000|Period 1 (4 Weeks)|Protocol Violation|1|||
27959610|NCT01122680|54616754|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
27959611|NCT01122680|54616755|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
27959612|NCT01122680|54616756|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
27959613|NCT01122680|54616753|FG000|Period 1 (4 Weeks)|Other|1|||
27959614|NCT01122680|54616754|FG001|Period 1 (4 Weeks)|Other|1|||
27959615|NCT01122680|54616755|FG002|Period 1 (4 Weeks)|Other|0|||
27959616|NCT01122680|54616756|FG003|Period 1 (4 Weeks)|Other|0|||
27959617|NCT01122680|54616753|FG000|Period 2 (4 Weeks)|Protocol Violation|0|||
27959618|NCT01122680|54616754|FG001|Period 2 (4 Weeks)|Protocol Violation|0|||
27959619|NCT01122680|54616755|FG002|Period 2 (4 Weeks)|Protocol Violation|0|||
27959620|NCT01122680|54616756|FG003|Period 2 (4 Weeks)|Protocol Violation|1|||
27959621|NCT01122680|54616753|FG000|Period 2 (4 Weeks)|Other|1|||
27959622|NCT01122680|54616754|FG001|Period 2 (4 Weeks)|Other|0|||
27959623|NCT01122680|54616755|FG002|Period 2 (4 Weeks)|Other|0|||
27959624|NCT01122680|54616756|FG003|Period 2 (4 Weeks)|Other|0|||
27959625|NCT01122680|54616753|FG000|Period 3 (4 Weeks)|Adverse Event|1|||
27959626|NCT01122680|54616754|FG001|Period 3 (4 Weeks)|Adverse Event|0|||
27959627|NCT01122680|54616755|FG002|Period 3 (4 Weeks)|Adverse Event|0|||
27959628|NCT01122680|54616756|FG003|Period 3 (4 Weeks)|Adverse Event|0|||
27959629|NCT01122680|54616753|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
27959630|NCT01122680|54616754|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
27959631|NCT01122680|54616755|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
27959632|NCT01122680|54616756|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
27959633|NCT00946998|54616768|FG000|Overall Study|Exited prior to first outcome assessment|5|||
27959634|NCT00946998|54616769|FG001|Overall Study|Exited prior to first outcome assessment|3|||
27959635|NCT01138826|54616775|FG000|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
27959636|NCT01138826|54616776|FG001|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
27959637|NCT01138826|54616777|FG002|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
27959638|NCT01138826|54616778|FG003|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
27959639|NCT01138826|54616779|FG004|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
27959640|NCT01138826|54616780|FG005|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
27959641|NCT00906087|54616788|FG000|Initial Washout|Withdrawal by Subject|1|||
27959642|NCT00906087|54616788|FG000|Initial Washout|Physician Decision|1|||
27959643|NCT00907257|54616797|FG000|Overall Study|Adverse Event|0|||
27959644|NCT00907257|54616798|FG001|Overall Study|Adverse Event|4|||
27959645|NCT00907257|54616797|FG000|Overall Study|Protocol Violation|1|||
27959646|NCT00907257|54616798|FG001|Overall Study|Protocol Violation|2|||
27959647|NCT00907257|54616797|FG000|Overall Study|Lost to Follow-up|3|||
27959648|NCT00907257|54616798|FG001|Overall Study|Lost to Follow-up|3|||
27959649|NCT00907257|54616797|FG000|Overall Study|Withdrawal by Subject|1|||
27959650|NCT00907257|54616798|FG001|Overall Study|Withdrawal by Subject|2|||
27959651|NCT00907257|54616797|FG000|Overall Study|Per IRB-Subject became vulnerable|1|||
27959652|NCT00907257|54616798|FG001|Overall Study|Per IRB-Subject became vulnerable|0|||
27959653|NCT00907257|54616797|FG000|Overall Study|Moved|1|||
27959654|NCT00907257|54616798|FG001|Overall Study|Moved|0|||
27959655|NCT00907257|54616797|FG000|Overall Study|Personal Reasons|6|||
27959656|NCT00907257|54616798|FG001|Overall Study|Personal Reasons|1|||
27959657|NCT01138046|54616804|FG000|Overall Study|Withdrawal due to death|6|||
27959658|NCT00876460|54616816|FG000|Combination Therapy Phase|Progressive disease|2|||
27959659|NCT00876460|54616817|FG001|Combination Therapy Phase|Progressive disease|3|||
27959660|NCT00876460|54616818|FG002|Combination Therapy Phase|Progressive disease|3|||
27959661|NCT00876460|54616819|FG003|Combination Therapy Phase|Progressive disease|3|||
27959662|NCT00876460|54616820|FG004|Combination Therapy Phase|Progressive disease|3|||
27959663|NCT00876460|54616821|FG005|Combination Therapy Phase|Progressive disease|1|||
27959664|NCT00876460|54616822|FG006|Combination Therapy Phase|Progressive disease|1|||
27959665|NCT00876460|54616823|FG007|Combination Therapy Phase|Progressive disease|1|||
27959666|NCT00876460|54616816|FG000|Combination Therapy Phase|Dose limiting toxicity|0|||
27959667|NCT00876460|54616817|FG001|Combination Therapy Phase|Dose limiting toxicity|1|||
27959668|NCT00876460|54616818|FG002|Combination Therapy Phase|Dose limiting toxicity|0|||
27959669|NCT00876460|54616819|FG003|Combination Therapy Phase|Dose limiting toxicity|1|||
27959670|NCT00876460|54616820|FG004|Combination Therapy Phase|Dose limiting toxicity|1|||
27959671|NCT00876460|54616821|FG005|Combination Therapy Phase|Dose limiting toxicity|2|||
27959672|NCT00876460|54616822|FG006|Combination Therapy Phase|Dose limiting toxicity|2|||
27959673|NCT00876460|54616823|FG007|Combination Therapy Phase|Dose limiting toxicity|1|||
27959674|NCT00876460|54616816|FG000|Combination Therapy Phase|Adverse Event|0|||
27959675|NCT00876460|54616817|FG001|Combination Therapy Phase|Adverse Event|2|||
27959676|NCT00876460|54616818|FG002|Combination Therapy Phase|Adverse Event|0|||
27959677|NCT00876460|54616819|FG003|Combination Therapy Phase|Adverse Event|2|||
27959678|NCT00876460|54616820|FG004|Combination Therapy Phase|Adverse Event|2|||
27959679|NCT00876460|54616821|FG005|Combination Therapy Phase|Adverse Event|0|||
27959680|NCT00876460|54616822|FG006|Combination Therapy Phase|Adverse Event|3|||
27959681|NCT00876460|54616823|FG007|Combination Therapy Phase|Adverse Event|2|||
27959682|NCT00876460|54616816|FG000|Combination Therapy Phase|Withdrawal by Subject|1|||
27959683|NCT00876460|54616817|FG001|Combination Therapy Phase|Withdrawal by Subject|1|||
27959684|NCT00876460|54616818|FG002|Combination Therapy Phase|Withdrawal by Subject|0|||
27959685|NCT00876460|54616819|FG003|Combination Therapy Phase|Withdrawal by Subject|0|||
27959686|NCT00876460|54616820|FG004|Combination Therapy Phase|Withdrawal by Subject|1|||
27959687|NCT00876460|54616821|FG005|Combination Therapy Phase|Withdrawal by Subject|0|||
27959688|NCT00876460|54616822|FG006|Combination Therapy Phase|Withdrawal by Subject|0|||
27959689|NCT00876460|54616823|FG007|Combination Therapy Phase|Withdrawal by Subject|0|||
27959690|NCT00876460|54616816|FG000|Combination Therapy Phase|Other reason not defined above|0|||
27959691|NCT00876460|54616817|FG001|Combination Therapy Phase|Other reason not defined above|0|||
27959692|NCT00876460|54616818|FG002|Combination Therapy Phase|Other reason not defined above|0|||
27959693|NCT00876460|54616819|FG003|Combination Therapy Phase|Other reason not defined above|0|||
27959694|NCT00876460|54616820|FG004|Combination Therapy Phase|Other reason not defined above|0|||
27959695|NCT00876460|54616821|FG005|Combination Therapy Phase|Other reason not defined above|0|||
27959696|NCT00876460|54616822|FG006|Combination Therapy Phase|Other reason not defined above|1|||
27959697|NCT00876460|54616823|FG007|Combination Therapy Phase|Other reason not defined above|2|||
27959698|NCT00876460|54616816|FG000|Combination Therapy Phase|Not treated|0|||
27959699|NCT00876460|54616817|FG001|Combination Therapy Phase|Not treated|0|||
27959700|NCT00876460|54616818|FG002|Combination Therapy Phase|Not treated|0|||
27959701|NCT00876460|54616819|FG003|Combination Therapy Phase|Not treated|0|||
27959702|NCT00876460|54616820|FG004|Combination Therapy Phase|Not treated|0|||
27959703|NCT00876460|54616821|FG005|Combination Therapy Phase|Not treated|0|||
27959704|NCT00876460|54616822|FG006|Combination Therapy Phase|Not treated|1|||
27959705|NCT00876460|54616823|FG007|Combination Therapy Phase|Not treated|0|||
27959706|NCT00876460|54616816|FG000|Mono Therapy Phase|Progressive disease|0|||
27959707|NCT00876460|54616817|FG001|Mono Therapy Phase|Progressive disease|0|||
27959708|NCT00876460|54616818|FG002|Mono Therapy Phase|Progressive disease|0|||
27959709|NCT00876460|54616819|FG003|Mono Therapy Phase|Progressive disease|0|||
27959710|NCT00876460|54616820|FG004|Mono Therapy Phase|Progressive disease|2|||
27959711|NCT00876460|54616821|FG005|Mono Therapy Phase|Progressive disease|0|||
27959712|NCT00876460|54616822|FG006|Mono Therapy Phase|Progressive disease|1|||
27959713|NCT00876460|54616823|FG007|Mono Therapy Phase|Progressive disease|3|||
27959714|NCT00876460|54616816|FG000|Mono Therapy Phase|Withdrawal by Subject|0|||
27959715|NCT00876460|54616817|FG001|Mono Therapy Phase|Withdrawal by Subject|1|||
27959716|NCT00876460|54616818|FG002|Mono Therapy Phase|Withdrawal by Subject|0|||
27959717|NCT00876460|54616819|FG003|Mono Therapy Phase|Withdrawal by Subject|0|||
27959718|NCT00876460|54616820|FG004|Mono Therapy Phase|Withdrawal by Subject|0|||
27959719|NCT00876460|54616821|FG005|Mono Therapy Phase|Withdrawal by Subject|0|||
27959720|NCT00876460|54616822|FG006|Mono Therapy Phase|Withdrawal by Subject|0|||
27959721|NCT00876460|54616823|FG007|Mono Therapy Phase|Withdrawal by Subject|0|||
27959722|NCT00876460|54616816|FG000|Mono Therapy Phase|Adverse Event|0|||
27959723|NCT00876460|54616817|FG001|Mono Therapy Phase|Adverse Event|0|||
27959724|NCT00876460|54616818|FG002|Mono Therapy Phase|Adverse Event|0|||
27959725|NCT00876460|54616819|FG003|Mono Therapy Phase|Adverse Event|1|||
27959726|NCT00876460|54616820|FG004|Mono Therapy Phase|Adverse Event|0|||
27959727|NCT00876460|54616821|FG005|Mono Therapy Phase|Adverse Event|0|||
27959728|NCT00876460|54616822|FG006|Mono Therapy Phase|Adverse Event|0|||
27959729|NCT00876460|54616823|FG007|Mono Therapy Phase|Adverse Event|0|||
27959730|NCT00908115|54616853|FG000|Overall Study|Other|14|||
27959731|NCT01137812|54616859|FG000|Overall Study|Adverse Event|21|||
27959732|NCT01137812|54616860|FG001|Overall Study|Adverse Event|14|||
27959733|NCT01137812|54616859|FG000|Overall Study|Lost to Follow-up|6|||
27959734|NCT01137812|54616860|FG001|Overall Study|Lost to Follow-up|8|||
27959735|NCT01137812|54616859|FG000|Overall Study|Physician Decision|25|||
27959736|NCT01137812|54616860|FG001|Overall Study|Physician Decision|17|||
27959737|NCT01137812|54616859|FG000|Overall Study|Protocol Violation|5|||
27959738|NCT01137812|54616860|FG001|Overall Study|Protocol Violation|4|||
27959739|NCT01137812|54616859|FG000|Overall Study|Withdrawal by Subject|5|||
27959740|NCT01137812|54616860|FG001|Overall Study|Withdrawal by Subject|13|||
27959741|NCT01137812|54616859|FG000|Overall Study|Death|2|||
27959742|NCT01137812|54616860|FG001|Overall Study|Death|0|||
27959743|NCT01137812|54616859|FG000|Overall Study|Patient met glycemic withdrawal criteria|40|||
27959744|NCT01137812|54616860|FG001|Overall Study|Patient met glycemic withdrawal criteria|85|||
27959745|NCT01137812|54616859|FG000|Overall Study|Other|19|||
27959746|NCT01137812|54616860|FG001|Overall Study|Other|27|||
27959747|NCT01137578|54616866|FG000|Overall Study|Participant requested to Discontinue|3|||
27959748|NCT01137578|54616867|FG001|Overall Study|Participant requested to Discontinue|0|||
27959749|NCT01137578|54616868|FG002|Overall Study|Participant requested to Discontinue|0|||
27959750|NCT01137578|54616866|FG000|Overall Study|Withdrawal by Subject|1|||
27959751|NCT01137578|54616867|FG001|Overall Study|Withdrawal by Subject|0|||
27959752|NCT01137578|54616868|FG002|Overall Study|Withdrawal by Subject|0|||
27959753|NCT01137578|54616866|FG000|Overall Study|Other|12|||
27959754|NCT01137578|54616867|FG001|Overall Study|Other|2|||
27732341|NCT00708123|54179809|FG001|Period 3|Lost to Follow-up|0|||
27959755|NCT01137578|54616868|FG002|Overall Study|Other|6|||
27959756|NCT00946920|54616898|FG000|Overall Study|Withdrawal by Subject|28|||
27959757|NCT00946920|54616899|FG001|Overall Study|Withdrawal by Subject|15|||
27959758|NCT00946920|54616898|FG000|Overall Study|Lost to Follow-up|2|||
27959759|NCT00946920|54616899|FG001|Overall Study|Lost to Follow-up|2|||
27959760|NCT00946920|54616898|FG000|Overall Study|Physician Decision|5|||
27959761|NCT00946920|54616899|FG001|Overall Study|Physician Decision|2|||
27959762|NCT00946920|54616898|FG000|Overall Study|Adverse Event|41|||
27959763|NCT00946920|54616899|FG001|Overall Study|Adverse Event|14|||
27959764|NCT00946920|54616898|FG000|Overall Study|Protocol Violation|16|||
27959765|NCT00946920|54616899|FG001|Overall Study|Protocol Violation|8|||
27959766|NCT00946920|54616898|FG000|Overall Study|Miscellaneous reasons|18|||
27959767|NCT00946920|54616899|FG001|Overall Study|Miscellaneous reasons|3|||
27959768|NCT00946530|54616909|FG000|Overall Study|Withdrawal by Subject|0|||
27959769|NCT00946530|54616910|FG001|Overall Study|Withdrawal by Subject|3|||
27959770|NCT00946530|54616911|FG002|Overall Study|Withdrawal by Subject|0|||
27959771|NCT00946530|54616912|FG003|Overall Study|Withdrawal by Subject|3|||
27959772|NCT00946530|54616909|FG000|Overall Study|Physician Decision|1|||
27959773|NCT00946530|54616910|FG001|Overall Study|Physician Decision|1|||
27959774|NCT00946530|54616911|FG002|Overall Study|Physician Decision|1|||
27959775|NCT00946530|54616912|FG003|Overall Study|Physician Decision|1|||
27959776|NCT00946296|54616928|FG000|Overall Study|Physician Decision|3|||
27959777|NCT00946296|54616929|FG001|Overall Study|Physician Decision|0|||
27959778|NCT00945906|54616935|FG000|Overall Study|Withdrawal by Subject|1|||
27959779|NCT00945906|54616935|FG000|Overall Study|Did not want to return for last visit|2|||
27959780|NCT00945906|54616935|FG000|Overall Study|Unable to return for last visit|2|||
27959781|NCT00945906|54616935|FG000|Overall Study|Moved to another country|2|||
28082140|NCT00008385|54735504|FG001|Overall Study|Start non-protocol therapy|1|||
28082141|NCT00008385|54735503|FG000|Overall Study|Other complicating disease|17|||
28082142|NCT00008385|54735504|FG001|Overall Study|Other complicating disease|30|||
28082143|NCT00008385|54735503|FG000|Overall Study|Maximum dose reached|0|||
28082144|NCT00008385|54735504|FG001|Overall Study|Maximum dose reached|2|||
28082145|NCT00008385|54735503|FG000|Overall Study|Other|105|||
28082146|NCT00008385|54735504|FG001|Overall Study|Other|212|||
28082147|NCT00008385|54735503|FG000|Overall Study|Not start protocol therapy|44|||
28082148|NCT00008385|54735504|FG001|Overall Study|Not start protocol therapy|175|||
28082149|NCT00003907|54735519|FG000|Overall Study|Adverse Event|2|||
28082150|NCT00003907|54735520|FG001|Overall Study|Adverse Event|11|||
28082151|NCT00003907|54735519|FG000|Overall Study|Death|2|||
28082152|NCT00003907|54735520|FG001|Overall Study|Death|0|||
28082153|NCT00003907|54735519|FG000|Overall Study|Withdrawal by Subject|1|||
28082154|NCT00003907|54735520|FG001|Overall Study|Withdrawal by Subject|3|||
28082155|NCT00003907|54735519|FG000|Overall Study|Progressive disease|4|||
28082156|NCT00003907|54735520|FG001|Overall Study|Progressive disease|4|||
28082157|NCT00003907|54735519|FG000|Overall Study|Complicating disease|1|||
28082158|NCT00003907|54735520|FG001|Overall Study|Complicating disease|0|||
28082159|NCT00003907|54735519|FG000|Overall Study|Other|1|||
28082160|NCT00003907|54735520|FG001|Overall Study|Other|3|||
28082161|NCT00003907|54735519|FG000|Overall Study|ineligible or not treated|2|||
28082162|NCT00003907|54735520|FG001|Overall Study|ineligible or not treated|2|||
28082163|NCT04241315|54735528|FG000|Overall Study|Withdrawal by Subject|0|||
28082164|NCT04241315|54735529|FG001|Overall Study|Withdrawal by Subject|1|||
28082165|NCT04225026|54735535|FG000|Overall Study|Withdrawal by Subject|4|||
28082166|NCT04225026|54735535|FG000|Overall Study|Adverse Event|1|||
28082167|NCT04225026|54735535|FG000|Overall Study|Other|1|||
28082168|NCT04225026|54735535|FG000|Overall Study|Death|11|||
28082169|NCT04225026|54735535|FG000|Overall Study|Study Terminated Early By Sponsor|7|||
28082170|NCT03493958|54735941|FG000|Overall Study|Withdrawal by Subject|6|||
28082171|NCT03493958|54735941|FG000|Overall Study|Lost to Follow-up|7|||
28082172|NCT03493958|54735941|FG000|Overall Study|Did not complete all required study procedures|2|||
28082173|NCT03486223|54735947|FG000|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|0|||
28082174|NCT03486223|54735948|FG001|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|1|||
28082175|NCT03482024|54735959|FG000|Overall Study|Physician Decision|1|||
28082176|NCT03482024|54735960|FG001|Overall Study|Physician Decision|0|||
28082177|NCT03482024|54735961|FG002|Overall Study|Physician Decision|0|||
28082178|NCT03482024|54735962|FG003|Overall Study|Physician Decision|0|||
28082179|NCT03482024|54735963|FG004|Overall Study|Physician Decision|0|||
28165111|NCT03016325|54835754|FG001|32-Day Follow-Up Period|Participant refused to visit|1|||
28082180|NCT03468309|54735975|FG000|Overall Study|Lost to Follow-up|4|||
28082181|NCT03468309|54735975|FG000|Overall Study|Withdrawal by Subject|2|||
28165112|NCT03016325|54835755|FG002|32-Day Follow-Up Period|Participant refused to visit|2|||
28082182|NCT03423147|54735981|FG000|Overall Study|Lost to Follow-up|5|||
28082183|NCT03423147|54735982|FG001|Overall Study|Lost to Follow-up|8|||
28082184|NCT03423147|54735981|FG000|Overall Study|Withdrawal by Subject|1|||
28082185|NCT03423147|54735982|FG001|Overall Study|Withdrawal by Subject|0|||
27959782|NCT00594646|54616939|FG000|Overall Study|Withdrawal by Subject|1|||
27959783|NCT00594646|54616939|FG000|Overall Study|Lost to Follow-up|15|||
27959784|NCT01111604|54616947|FG000|Overall Study|Lost to Follow-up|0|||
27959785|NCT01111604|54616948|FG001|Overall Study|Lost to Follow-up|0|||
27959786|NCT01111604|54616949|FG002|Overall Study|Lost to Follow-up|1|||
28082186|NCT03423147|54735981|FG000|Overall Study|withdrawn due to vaginal delivery|1|||
28082187|NCT03423147|54735982|FG001|Overall Study|withdrawn due to vaginal delivery|0|||
28082188|NCT03423147|54735981|FG000|Overall Study|Age < 18|1|||
28082189|NCT03423147|54735982|FG001|Overall Study|Age < 18|0|||
28082190|NCT03423147|54735981|FG000|Overall Study|No Trial of Labor|0|||
28082191|NCT03423147|54735982|FG001|Overall Study|No Trial of Labor|1|||
28082192|NCT03322631|54735992|FG000|Overall Study|Withdrawal by Subject|0|||
28082193|NCT03322631|54735993|FG001|Overall Study|Withdrawal by Subject|1|||
28082194|NCT03322631|54735994|FG002|Overall Study|Withdrawal by Subject|0|||
27732342|NCT00708123|54179810|FG002|Period 3|Lost to Follow-up|1|||
28082195|NCT03322631|54735995|FG003|Overall Study|Withdrawal by Subject|0|||
28082196|NCT03322631|54735992|FG000|Overall Study|Adverse Event|0|||
27959787|NCT01111604|54616947|FG000|Overall Study|Withdrew Consent|3|||
27959788|NCT01111604|54616948|FG001|Overall Study|Withdrew Consent|0|||
27959789|NCT01111604|54616949|FG002|Overall Study|Withdrew Consent|2|||
27959790|NCT01111604|54616947|FG000|Overall Study|Withdrawal by Subject|2|||
27959791|NCT01111604|54616948|FG001|Overall Study|Withdrawal by Subject|0|||
27959792|NCT01111604|54616949|FG002|Overall Study|Withdrawal by Subject|0|||
27959793|NCT01111604|54616947|FG000|Overall Study|Death|1|||
27959794|NCT01111604|54616948|FG001|Overall Study|Death|0|||
27959795|NCT01111604|54616949|FG002|Overall Study|Death|0|||
27959796|NCT01111604|54616947|FG000|Overall Study|Met Exclusion Criteria|2|||
27959797|NCT01111604|54616948|FG001|Overall Study|Met Exclusion Criteria|0|||
27959798|NCT01111604|54616949|FG002|Overall Study|Met Exclusion Criteria|0|||
27959799|NCT00950742|54616977|FG000|Overall Study|Other Adverse Event|1|||
27959800|NCT00950742|54616978|FG001|Overall Study|Other Adverse Event|0|||
27732343|NCT00708123|54179811|FG003|Period 3|Lost to Follow-up|1|||
27732344|NCT00708123|54179812|FG004|Period 3|Lost to Follow-up|0|||
27732345|NCT00708123|54179808|FG000|Period 4|Protocol Violation|0|||
27732346|NCT00708123|54179809|FG001|Period 4|Protocol Violation|1|||
27732347|NCT00708123|54179810|FG002|Period 4|Protocol Violation|0|||
27732348|NCT00708123|54179811|FG003|Period 4|Protocol Violation|0|||
27732349|NCT00708123|54179812|FG004|Period 4|Protocol Violation|0|||
27732350|NCT02165215|54179831|FG000|Induction Phase|Adverse Event|1|||
27732351|NCT02165215|54179832|FG001|Induction Phase|Adverse Event|0|||
27959801|NCT00950742|54616977|FG000|Overall Study|Withdrawal by Subject|3|||
27959802|NCT00950742|54616978|FG001|Overall Study|Withdrawal by Subject|0|||
27959803|NCT00950742|54616977|FG000|Overall Study|Progressive Disease|6|||
27959804|NCT00950742|54616978|FG001|Overall Study|Progressive Disease|2|||
27959805|NCT00950742|54616977|FG000|Overall Study|Dose limiting toxicity|6|||
27959806|NCT00950742|54616978|FG001|Overall Study|Dose limiting toxicity|0|||
27959807|NCT00955110|54616988|FG000|Qualification Phase|Did not meet eligibility criteria|24|||
27959808|NCT00955110|54616988|FG000|Treatment Phase|Adverse Event|2|||
27959809|NCT00955110|54616988|FG000|Treatment Phase|Administrative reasons|2|||
27959810|NCT00955110|54616988|FG000|Treatment Phase|Non-compliance with study restrictions|1|||
27959811|NCT00955110|54616988|FG000|Treatment Phase|Withdrawn by physician pre-treatment|1|||
27959812|NCT00950664|54617002|FG000|First Intervention|Lost to Follow-up|1|||
27959813|NCT00950664|54617003|FG001|First Intervention|Lost to Follow-up|3|||
27959814|NCT00950664|54617002|FG000|First Intervention|Withdrawal by Subject|2|||
27732352|NCT02165215|54179833|FG002|Induction Phase|Adverse Event|0|||
27732353|NCT02165215|54179831|FG000|Induction Phase|Withdrawal by Subject|10|||
27959815|NCT00950664|54617003|FG001|First Intervention|Withdrawal by Subject|2|||
27959816|NCT01111526|54617009|FG000|Overall Study|GVHD Disease Progression|0|||
27959817|NCT01111526|54617010|FG001|Overall Study|GVHD Disease Progression|1|||
27959818|NCT01111526|54617011|FG002|Overall Study|GVHD Disease Progression|2|||
27959819|NCT01111292|54617017|FG000|Treatment|Physician Decision|1|||
27959820|NCT01111292|54617018|FG001|Treatment|Physician Decision|1|||
27959821|NCT00944658|54617026|FG000|Treatment 12 Weeks|Adverse Event|0|||
27959822|NCT00944658|54617027|FG001|Treatment 12 Weeks|Adverse Event|2|||
27959823|NCT01110200|54617035|FG000|Overall Study|Adverse Event|28|||
28082197|NCT03322631|54735993|FG001|Overall Study|Adverse Event|0|||
28082198|NCT03322631|54735994|FG002|Overall Study|Adverse Event|1|||
28082199|NCT03322631|54735995|FG003|Overall Study|Adverse Event|0|||
27732354|NCT02165215|54179832|FG001|Induction Phase|Withdrawal by Subject|0|||
27832427|NCT01734785|54311697|FG000|Open-Label Period|Protocol Violation|0|||
27832428|NCT01734785|54311698|FG001|Open-Label Period|Protocol Violation|0|||
27959824|NCT01110200|54617036|FG001|Overall Study|Adverse Event|28|||
27959825|NCT01110200|54617035|FG000|Overall Study|Withdrawal by Subject|25|||
28082200|NCT03018704|54736014|FG000|Overall Study|Lost to Follow-up|1|||
28082201|NCT03018704|54736015|FG001|Overall Study|Lost to Follow-up|1|||
27959826|NCT01110200|54617036|FG001|Overall Study|Withdrawal by Subject|32|||
27959827|NCT01110200|54617035|FG000|Overall Study|Lack of Efficacy|16|||
27959828|NCT01110200|54617036|FG001|Overall Study|Lack of Efficacy|25|||
27732355|NCT02165215|54179833|FG002|Induction Phase|Withdrawal by Subject|0|||
27732356|NCT02165215|54179831|FG000|Induction Phase|Protocol Violation|1|||
27732357|NCT02165215|54179832|FG001|Induction Phase|Protocol Violation|0|||
27959829|NCT01110200|54617035|FG000|Overall Study|Protocol Violation|14|||
28082202|NCT02663349|54736021|FG000|Overall Study|Withdrawal by Subject|6|||
27959830|NCT01110200|54617036|FG001|Overall Study|Protocol Violation|12|||
27959831|NCT01110200|54617035|FG000|Overall Study|Physician Decision|13|||
27959832|NCT01110200|54617036|FG001|Overall Study|Physician Decision|17|||
27959833|NCT01110200|54617035|FG000|Overall Study|Lost to Follow-up|10|||
27959834|NCT01110200|54617036|FG001|Overall Study|Lost to Follow-up|7|||
27959835|NCT01108796|54617046|FG000|Overall Study|Adverse Event|0|||
27959836|NCT01108796|54617047|FG001|Overall Study|Adverse Event|1|||
27959837|NCT01108796|54617046|FG000|Overall Study|Lost to Follow-up|7|||
27959838|NCT01108796|54617047|FG001|Overall Study|Lost to Follow-up|6|||
27959839|NCT01108718|54617057|FG000|Received Second Intervention (2 Months)|Withdrawal by Subject|1|||
27959840|NCT01108718|54617058|FG001|Received Second Intervention (2 Months)|Withdrawal by Subject|0|||
27959841|NCT01137110|54617065|FG000|Overall Study|Protocol Violation|1|||
27959842|NCT01137110|54617066|FG001|Overall Study|Protocol Violation|0|||
27959843|NCT01136954|54617074|FG000|Overall Study|Adverse Event|3|||
27959844|NCT01136954|54617075|FG001|Overall Study|Adverse Event|2|||
27959845|NCT01136954|54617074|FG000|Overall Study|Withdrawal by Subject|6|||
27959846|NCT01136954|54617075|FG001|Overall Study|Withdrawal by Subject|2|||
27959847|NCT01136954|54617074|FG000|Overall Study|Lack of Efficacy|14|||
27959848|NCT01136954|54617075|FG001|Overall Study|Lack of Efficacy|13|||
27959849|NCT01136954|54617074|FG000|Overall Study|Physician Decision|0|||
27959850|NCT01136954|54617075|FG001|Overall Study|Physician Decision|1|||
27959851|NCT01136954|54617074|FG000|Overall Study|Other|1|||
27959852|NCT01136954|54617075|FG001|Overall Study|Other|3|||
27959853|NCT01136876|54617084|FG000|Overall Study|Lost to Follow-up|0|||
27959854|NCT01136876|54617085|FG001|Overall Study|Lost to Follow-up|1|||
27959855|NCT01136876|54617084|FG000|Overall Study|Physician Decision|3|||
27959856|NCT01136876|54617085|FG001|Overall Study|Physician Decision|5|||
27959857|NCT01136876|54617084|FG000|Overall Study|Missing NGAL measurement|2|||
27959858|NCT01136876|54617085|FG001|Overall Study|Missing NGAL measurement|5|||
27959859|NCT01105130|54617096|FG000|Overall Study|Withdrawal by Subject|4|||
27959860|NCT01105130|54617097|FG001|Overall Study|Withdrawal by Subject|6|||
27959861|NCT01105130|54617098|FG002|Overall Study|Withdrawal by Subject|2|||
27959862|NCT01105130|54617096|FG000|Overall Study|Never Started|2|||
27959863|NCT01105130|54617097|FG001|Overall Study|Never Started|2|||
27959864|NCT01105130|54617098|FG002|Overall Study|Never Started|4|||
27959865|NCT01105130|54617096|FG000|Overall Study|Toxicity|1|||
27959866|NCT01105130|54617097|FG001|Overall Study|Toxicity|3|||
27959867|NCT01105130|54617098|FG002|Overall Study|Toxicity|2|||
27959868|NCT01105130|54617096|FG000|Overall Study|Multiple Reasons|3|||
27959869|NCT01105130|54617097|FG001|Overall Study|Multiple Reasons|0|||
27959870|NCT01105130|54617098|FG002|Overall Study|Multiple Reasons|2|||
27959871|NCT01108094|54617110|FG000|Overall Study|Adverse Event|2|||
27959872|NCT01108094|54617111|FG001|Overall Study|Adverse Event|0|||
27959873|NCT01108094|54617112|FG002|Overall Study|Adverse Event|0|||
27959874|NCT01108094|54617113|FG003|Overall Study|Adverse Event|0|||
27959875|NCT01108094|54617110|FG000|Overall Study|Withdrawal by Subject|1|||
27959876|NCT01108094|54617111|FG001|Overall Study|Withdrawal by Subject|0|||
27959877|NCT01108094|54617112|FG002|Overall Study|Withdrawal by Subject|0|||
27959878|NCT01108094|54617113|FG003|Overall Study|Withdrawal by Subject|0|||
27959879|NCT00954174|54617130|FG000|Overall Study|Adverse Event|28|||
27959880|NCT00954174|54617131|FG001|Overall Study|Adverse Event|23|||
27959881|NCT00954174|54617132|FG002|Overall Study|Adverse Event|4|||
27959882|NCT00954174|54617133|FG003|Overall Study|Adverse Event|9|||
27959883|NCT00954174|54617130|FG000|Overall Study|Death|4|||
27959884|NCT00954174|54617131|FG001|Overall Study|Death|2|||
27959885|NCT00954174|54617132|FG002|Overall Study|Death|0|||
27959886|NCT00954174|54617133|FG003|Overall Study|Death|0|||
27959887|NCT00954174|54617130|FG000|Overall Study|Lack of Efficacy|32|||
27959888|NCT00954174|54617131|FG001|Overall Study|Lack of Efficacy|22|||
27959889|NCT00954174|54617132|FG002|Overall Study|Lack of Efficacy|8|||
27959890|NCT00954174|54617133|FG003|Overall Study|Lack of Efficacy|6|||
27959891|NCT00954174|54617130|FG000|Overall Study|Withdrawal by Subject|14|||
27959892|NCT00954174|54617131|FG001|Overall Study|Withdrawal by Subject|10|||
27959893|NCT00954174|54617132|FG002|Overall Study|Withdrawal by Subject|4|||
27959894|NCT00954174|54617133|FG003|Overall Study|Withdrawal by Subject|3|||
27959895|NCT00954174|54617130|FG000|Overall Study|Medical Reason|4|||
27959896|NCT00954174|54617131|FG001|Overall Study|Medical Reason|2|||
27959897|NCT00954174|54617132|FG002|Overall Study|Medical Reason|1|||
27959898|NCT00954174|54617133|FG003|Overall Study|Medical Reason|0|||
28082203|NCT02558491|54736025|FG000|First Invention|Withdrawal by Subject|3|||
28082204|NCT02558491|54736026|FG001|First Invention|Withdrawal by Subject|1|||
27855115|NCT01279681|54375413|FG001|Overall Study|Physician Decision|0|||
27959899|NCT00954174|54617130|FG000|Overall Study|Ineligible|40|||
27959900|NCT00954174|54617131|FG001|Overall Study|Ineligible|47|||
27959901|NCT00954174|54617132|FG002|Overall Study|Ineligible|7|||
27959902|NCT00954174|54617133|FG003|Overall Study|Ineligible|4|||
27959903|NCT00954174|54617130|FG000|Overall Study|Never Treated|4|||
27959904|NCT00954174|54617131|FG001|Overall Study|Never Treated|17|||
27959905|NCT00954174|54617132|FG002|Overall Study|Never Treated|0|||
27959906|NCT00954174|54617133|FG003|Overall Study|Never Treated|3|||
27959907|NCT01136408|54617149|FG000|Overall Study|Adverse Event|4|||
27959908|NCT01136408|54617150|FG001|Overall Study|Adverse Event|8|||
27959909|NCT01136408|54617151|FG002|Overall Study|Adverse Event|4|||
27959910|NCT01136408|54617149|FG000|Overall Study|Protocol Violation|1|||
27959911|NCT01136408|54617150|FG001|Overall Study|Protocol Violation|1|||
27959912|NCT01136408|54617151|FG002|Overall Study|Protocol Violation|1|||
27959913|NCT01136174|54617167|FG000|Overall Study|Adverse Event|0|||
27959914|NCT01136174|54617168|FG001|Overall Study|Adverse Event|0|||
27959915|NCT01136174|54617169|FG002|Overall Study|Adverse Event|0|||
27959916|NCT01136174|54617170|FG003|Overall Study|Adverse Event|4|||
27959917|NCT01135394|54617189|FG000|Screening|Lost to Follow-up|2|||
27959918|NCT01135394|54617189|FG000|Screening|Withdrawal by Subject|10|||
27959919|NCT01135394|54617189|FG000|Screening|Screening failure|16|||
27959920|NCT01135394|54617189|FG000|Screening|Physician Decision|5|||
27959921|NCT01135394|54617189|FG000|Baseline Assessment|Withdrawal by Subject|9|||
27959922|NCT01135394|54617189|FG000|Baseline Assessment|Physician Decision|3|||
27959923|NCT01135394|54617189|FG000|Baseline Assessment|Lost to Follow-up|2|||
27959924|NCT01135394|54617189|FG000|Baseline Assessment|Adverse Event|1|||
27959925|NCT01135394|54617189|FG000|Study Treatment|Withdrawal by Subject|1|||
27959926|NCT01135394|54617189|FG000|Study Treatment|Physician Decision|1|||
28082205|NCT02558491|54736025|FG000|First Invention|Data collection issues|1|||
28082206|NCT02558491|54736026|FG001|First Invention|Data collection issues|0|||
28082207|NCT02558491|54736025|FG000|First Invention|Stopping criteria|0|||
28082208|NCT02558491|54736026|FG001|First Invention|Stopping criteria|1|||
28082209|NCT02558491|54736025|FG000|First Invention|Changed parameters during trial|1|||
28082210|NCT02558491|54736026|FG001|First Invention|Changed parameters during trial|0|||
28082211|NCT02558491|54736025|FG000|Second Intervention|Withdrawal by Subject|1|||
28082212|NCT02558491|54736026|FG001|Second Intervention|Withdrawal by Subject|0|||
28082213|NCT02558491|54736025|FG000|Second Intervention|Stopping Criteria|1|||
28082214|NCT02558491|54736026|FG001|Second Intervention|Stopping Criteria|0|||
28082215|NCT02490878|54736035|FG000|Overall Study|deemed ineligible|0|||
28082216|NCT02490878|54736036|FG001|Overall Study|deemed ineligible|1|||
28082217|NCT02490878|54736035|FG000|Overall Study|progression prior to treatment|0|||
28082218|NCT02490878|54736036|FG001|Overall Study|progression prior to treatment|1|||
28082219|NCT02490878|54736035|FG000|Overall Study|only submitted baseline QOL|0|||
28082220|NCT02490878|54736036|FG001|Overall Study|only submitted baseline QOL|1|||
28082221|NCT02421601|54736042|FG000|Overall Study|Adverse Event|4|||
28082222|NCT02421601|54736042|FG000|Overall Study|Lack of Efficacy|5|||
28082223|NCT02421601|54736042|FG000|Overall Study|Physician Decision|1|||
28082224|NCT02421601|54736042|FG000|Overall Study|Withdrawal by Subject|31|||
28082225|NCT02421601|54736042|FG000|Overall Study|Others|41|||
28082226|NCT01934218|54736048|FG000|Double-blind Phase|Adverse Event|8|||
28082227|NCT01934218|54736049|FG001|Double-blind Phase|Adverse Event|8|||
28082228|NCT01934218|54736048|FG000|Double-blind Phase|Lack of Efficacy|6|||
28082229|NCT01934218|54736049|FG001|Double-blind Phase|Lack of Efficacy|7|||
28082230|NCT01934218|54736048|FG000|Double-blind Phase|Lost to Follow-up|7|||
28082231|NCT01934218|54736049|FG001|Double-blind Phase|Lost to Follow-up|14|||
28082232|NCT01934218|54736048|FG000|Double-blind Phase|Physician Decision|1|||
28082233|NCT01934218|54736049|FG001|Double-blind Phase|Physician Decision|2|||
28082234|NCT01934218|54736048|FG000|Double-blind Phase|Protocol Violation|4|||
28082235|NCT01934218|54736049|FG001|Double-blind Phase|Protocol Violation|0|||
28082236|NCT01934218|54736048|FG000|Double-blind Phase|Withdrawal by Subject|16|||
28082237|NCT01934218|54736049|FG001|Double-blind Phase|Withdrawal by Subject|13|||
28082238|NCT01934218|54736048|FG000|Double-blind Phase|Noncompliance with Study Protocol|5|||
28082239|NCT01934218|54736049|FG001|Double-blind Phase|Noncompliance with Study Protocol|8|||
28082240|NCT01934218|54736048|FG000|Double-blind Phase|Protocol Violation of Study Eligibility|1|||
28082241|NCT01934218|54736049|FG001|Double-blind Phase|Protocol Violation of Study Eligibility|2|||
28082242|NCT01934218|54736048|FG000|Open-Label Phase|Adverse Event|2|||
28082243|NCT01934218|54736049|FG001|Open-Label Phase|Adverse Event|4|||
28082244|NCT01934218|54736048|FG000|Open-Label Phase|Lack of Efficacy|1|||
28082245|NCT01934218|54736049|FG001|Open-Label Phase|Lack of Efficacy|4|||
28082246|NCT01934218|54736048|FG000|Open-Label Phase|Lost to Follow-up|4|||
28082247|NCT01934218|54736049|FG001|Open-Label Phase|Lost to Follow-up|2|||
28082248|NCT01934218|54736048|FG000|Open-Label Phase|Physician Decision|1|||
28082249|NCT01934218|54736049|FG001|Open-Label Phase|Physician Decision|0|||
28165113|NCT03016325|54835756|FG003|32-Day Follow-Up Period|Participant refused to visit|0|||
27959927|NCT01135394|54617189|FG000|Study Treatment|Adverse Event|2|||
27959928|NCT00949884|54617196|FG000|Overall Study|Adverse Event|14|||
27959929|NCT00949884|54617197|FG001|Overall Study|Adverse Event|3|||
28082250|NCT01934218|54736048|FG000|Open-Label Phase|Protocol Violation|1|||
27959930|NCT00949884|54617198|FG002|Overall Study|Adverse Event|12|||
27959931|NCT00949884|54617196|FG000|Overall Study|Did not meet inclusion/exclusion|2|||
27959932|NCT00949884|54617197|FG001|Overall Study|Did not meet inclusion/exclusion|1|||
27959933|NCT00949884|54617198|FG002|Overall Study|Did not meet inclusion/exclusion|3|||
27959934|NCT00949884|54617196|FG000|Overall Study|Lost to Follow-up|7|||
28082251|NCT01934218|54736049|FG001|Open-Label Phase|Protocol Violation|0|||
27959935|NCT00949884|54617197|FG001|Overall Study|Lost to Follow-up|5|||
27959936|NCT00949884|54617198|FG002|Overall Study|Lost to Follow-up|5|||
27959937|NCT00949884|54617196|FG000|Overall Study|Physician Decision|5|||
27959938|NCT00949884|54617197|FG001|Overall Study|Physician Decision|0|||
27959939|NCT00949884|54617198|FG002|Overall Study|Physician Decision|6|||
27959940|NCT00949884|54617196|FG000|Overall Study|Treatment non-compliance|5|||
27959941|NCT00949884|54617197|FG001|Overall Study|Treatment non-compliance|0|||
27959942|NCT00949884|54617198|FG002|Overall Study|Treatment non-compliance|8|||
27959943|NCT00949884|54617196|FG000|Overall Study|Withdrawal by Subject|13|||
27959944|NCT00949884|54617197|FG001|Overall Study|Withdrawal by Subject|4|||
27959945|NCT00949884|54617198|FG002|Overall Study|Withdrawal by Subject|16|||
27959946|NCT00949884|54617196|FG000|Overall Study|Lack of Efficacy|4|||
27959947|NCT00949884|54617197|FG001|Overall Study|Lack of Efficacy|2|||
27959948|NCT00949884|54617198|FG002|Overall Study|Lack of Efficacy|7|||
27959949|NCT00949884|54617196|FG000|Overall Study|Study terminated by sponsor|0|||
27959950|NCT00949884|54617197|FG001|Overall Study|Study terminated by sponsor|0|||
27959951|NCT00949884|54617198|FG002|Overall Study|Study terminated by sponsor|1|||
27959952|NCT00949650|54617209|FG000|Overall Study|Progressive disease|188|||
27959953|NCT00949650|54617210|FG001|Overall Study|Progressive disease|19|||
27959954|NCT00949650|54617209|FG000|Overall Study|Completed 6 courses of chemotherapy|0|||
27959955|NCT00949650|54617210|FG001|Overall Study|Completed 6 courses of chemotherapy|60|||
27959956|NCT00949650|54617209|FG000|Overall Study|Other Adverse Event (AE)|28|||
27959957|NCT00949650|54617210|FG001|Overall Study|Other Adverse Event (AE)|17|||
27959958|NCT00949650|54617209|FG000|Overall Study|Protocol Violation|1|||
27959959|NCT00949650|54617210|FG001|Overall Study|Protocol Violation|4|||
27959960|NCT00949650|54617209|FG000|Overall Study|Refusal to continue medication|7|||
27959961|NCT00949650|54617210|FG001|Overall Study|Refusal to continue medication|11|||
27959962|NCT00949650|54617209|FG000|Overall Study|Not treated|1|||
27959963|NCT00949650|54617210|FG001|Overall Study|Not treated|4|||
27959964|NCT00949650|54617209|FG000|Overall Study|Other not specified above|5|||
27959965|NCT00949650|54617210|FG001|Overall Study|Other not specified above|0|||
27959966|NCT00908037|54617227|FG000|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
27959967|NCT00908037|54617228|FG001|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
27959968|NCT00908037|54617229|FG002|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
27959969|NCT00908037|54617230|FG003|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
27959970|NCT00908037|54617231|FG004|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
27959971|NCT00908037|54617232|FG005|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
27959972|NCT00908037|54617233|FG006|Part 2 (7 Week Randomized Period)|Protocol Violation|3|||
27959973|NCT00908037|54617234|FG007|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
27959974|NCT00908037|54617235|FG008|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
27959975|NCT00908037|54617236|FG009|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
27959976|NCT00908037|54617237|FG010|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
27959977|NCT00908037|54617238|FG011|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
27959978|NCT00908037|54617227|FG000|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
27959979|NCT00908037|54617228|FG001|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
27959980|NCT00908037|54617229|FG002|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
27959981|NCT00908037|54617230|FG003|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
27959982|NCT00908037|54617231|FG004|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2|||
27959983|NCT00908037|54617232|FG005|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
27959984|NCT00908037|54617233|FG006|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
27959985|NCT00908037|54617234|FG007|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
27959986|NCT00908037|54617235|FG008|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4|||
27959987|NCT00908037|54617236|FG009|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
27959988|NCT00908037|54617237|FG010|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
27959989|NCT00908037|54617238|FG011|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
27959990|NCT00908037|54617227|FG000|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
27959991|NCT00908037|54617228|FG001|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
27959992|NCT00908037|54617229|FG002|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
27959993|NCT00908037|54617230|FG003|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
27959994|NCT00908037|54617231|FG004|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
27959995|NCT00908037|54617232|FG005|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
27959996|NCT00908037|54617233|FG006|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
28165114|NCT03016325|54835757|FG004|32-Day Follow-Up Period|Participant refused to visit|2|||
28165115|NCT03016325|54835758|FG005|32-Day Follow-Up Period|Participant refused to visit|0|||
28165116|NCT03016325|54835759|FG006|32-Day Follow-Up Period|Participant refused to visit|0|||
28165117|NCT03016325|54835760|FG007|32-Day Follow-Up Period|Participant refused to visit|0|||
28165118|NCT03016325|54835753|FG000|32-Day Follow-Up Period|Participant withdrew consent|0|||
27959997|NCT00908037|54617234|FG007|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
28165119|NCT03016325|54835754|FG001|32-Day Follow-Up Period|Participant withdrew consent|0|||
28165120|NCT03016325|54835755|FG002|32-Day Follow-Up Period|Participant withdrew consent|0|||
27959998|NCT00908037|54617235|FG008|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
27959999|NCT00908037|54617236|FG009|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
27960000|NCT00908037|54617237|FG010|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
27960001|NCT00908037|54617238|FG011|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
27960002|NCT00908037|54617227|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
27960003|NCT00908037|54617228|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
27960004|NCT00908037|54617229|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
27960005|NCT00908037|54617230|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
27960006|NCT00908037|54617231|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
27960007|NCT00908037|54617232|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
27960008|NCT00908037|54617233|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
27960009|NCT00908037|54617234|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
27960010|NCT00908037|54617235|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
27960011|NCT00908037|54617236|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
27960012|NCT00908037|54617237|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
27960013|NCT00908037|54617238|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1|||
27960014|NCT00908037|54617227|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
27960015|NCT00908037|54617228|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
27960016|NCT00908037|54617229|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
27960017|NCT00908037|54617230|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
27960018|NCT00908037|54617231|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
27960019|NCT00908037|54617232|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
27960020|NCT00908037|54617233|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
27960021|NCT00908037|54617234|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
27960022|NCT00908037|54617235|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
27960023|NCT00908037|54617236|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1|||
27960024|NCT00908037|54617237|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
27960025|NCT00908037|54617238|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2|||
27960026|NCT00908037|54617227|FG000|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
27960027|NCT00908037|54617228|FG001|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
27960028|NCT00908037|54617229|FG002|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
27960029|NCT00908037|54617230|FG003|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
27960030|NCT00908037|54617231|FG004|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
27960031|NCT00908037|54617232|FG005|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
27960032|NCT00908037|54617233|FG006|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
27960033|NCT00908037|54617234|FG007|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
27960034|NCT00908037|54617235|FG008|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
27960035|NCT00908037|54617236|FG009|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1|||
27960036|NCT00908037|54617237|FG010|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
27960037|NCT00908037|54617238|FG011|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
27732358|NCT02165215|54179833|FG002|Induction Phase|Protocol Violation|0|||
27732359|NCT02165215|54179831|FG000|Induction Phase|Physician Decision|1|||
27732360|NCT02165215|54179832|FG001|Induction Phase|Physician Decision|0|||
27732361|NCT02165215|54179833|FG002|Induction Phase|Physician Decision|0|||
27732362|NCT02165215|54179831|FG000|Induction Phase|Lack of Efficacy|2|||
27732363|NCT02165215|54179832|FG001|Induction Phase|Lack of Efficacy|0|||
27732364|NCT02165215|54179833|FG002|Induction Phase|Lack of Efficacy|0|||
27732365|NCT02165215|54179831|FG000|Induction Phase|Non-Compliance|2|||
27732366|NCT02165215|54179832|FG001|Induction Phase|Non-Compliance|0|||
27732367|NCT02165215|54179833|FG002|Induction Phase|Non-Compliance|0|||
27732368|NCT02165215|54179831|FG000|Induction Phase|Lost to Follow-up|6|||
27732369|NCT02165215|54179832|FG001|Induction Phase|Lost to Follow-up|0|||
27732370|NCT02165215|54179833|FG002|Induction Phase|Lost to Follow-up|0|||
27732371|NCT02165215|54179831|FG000|Maintenance Phase|Withdrawal by Subject|0|||
27732372|NCT02165215|54179832|FG001|Maintenance Phase|Withdrawal by Subject|7|||
27732373|NCT02165215|54179833|FG002|Maintenance Phase|Withdrawal by Subject|3|||
27732374|NCT02165215|54179831|FG000|Maintenance Phase|Multiple reasons|0|||
27960038|NCT00908037|54617227|FG000|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
27960039|NCT00908037|54617228|FG001|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
27960040|NCT00908037|54617229|FG002|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
27960041|NCT00908037|54617230|FG003|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
27960042|NCT00908037|54617231|FG004|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
27960043|NCT00908037|54617232|FG005|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
27732375|NCT02165215|54179832|FG001|Maintenance Phase|Multiple reasons|2|||
27732376|NCT02165215|54179833|FG002|Maintenance Phase|Multiple reasons|1|||
27732377|NCT02165215|54179831|FG000|Maintenance Phase|Lost to Follow-up|0|||
27732378|NCT02165215|54179832|FG001|Maintenance Phase|Lost to Follow-up|2|||
27960044|NCT00908037|54617233|FG006|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
27960045|NCT00908037|54617234|FG007|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
27960046|NCT00908037|54617235|FG008|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
27960047|NCT00908037|54617236|FG009|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
27960048|NCT00908037|54617237|FG010|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2|||
27960049|NCT00908037|54617238|FG011|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
27960050|NCT00908037|54617227|FG000|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
27960051|NCT00908037|54617228|FG001|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
27960052|NCT00908037|54617229|FG002|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
27960053|NCT00908037|54617230|FG003|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
27960054|NCT00908037|54617231|FG004|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
27960055|NCT00908037|54617232|FG005|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
27960056|NCT00908037|54617233|FG006|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
27960057|NCT00908037|54617234|FG007|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
27960058|NCT00908037|54617235|FG008|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
27960059|NCT00908037|54617236|FG009|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1|||
27960060|NCT00908037|54617237|FG010|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
27960061|NCT00908037|54617238|FG011|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
27960062|NCT00908037|54617227|FG000|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
27960063|NCT00908037|54617228|FG001|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
27960064|NCT00908037|54617229|FG002|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
27960065|NCT00908037|54617230|FG003|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
27960066|NCT00908037|54617231|FG004|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
27960067|NCT00908037|54617232|FG005|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
27960068|NCT00908037|54617233|FG006|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
27960069|NCT00908037|54617234|FG007|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
27960070|NCT00908037|54617235|FG008|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
27960071|NCT00908037|54617236|FG009|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
27960072|NCT00908037|54617237|FG010|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2|||
27960073|NCT00908037|54617238|FG011|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
27960074|NCT00904215|54617290|FG000|Overall Study|Adverse Event|25|||
27960075|NCT00904215|54617290|FG000|Overall Study|Protocol Violation|10|||
27960076|NCT00904215|54617290|FG000|Overall Study|Lost to Follow-up|63|||
27960077|NCT00904215|54617290|FG000|Overall Study|Withdrawal by Subject|9|||
27960078|NCT00904215|54617290|FG000|Overall Study|Other|28|||
27960079|NCT00905307|54617300|FG000|Overall Study|Switched to Open Label Rescue|7|||
27960080|NCT00905307|54617301|FG001|Overall Study|Switched to Open Label Rescue|17|||
27960081|NCT00905307|54617302|FG002|Overall Study|Switched to Open Label Rescue|11|||
27960082|NCT00905307|54617303|FG003|Overall Study|Switched to Open Label Rescue|11|||
27960083|NCT00905307|54617304|FG004|Overall Study|Switched to Open Label Rescue|4|||
27960084|NCT00905307|54617305|FG005|Overall Study|Switched to Open Label Rescue|15|||
27960085|NCT00905307|54617300|FG000|Overall Study|Lost to Follow-up|0|||
27960086|NCT00905307|54617301|FG001|Overall Study|Lost to Follow-up|0|||
27960087|NCT00905307|54617302|FG002|Overall Study|Lost to Follow-up|0|||
27960088|NCT00905307|54617303|FG003|Overall Study|Lost to Follow-up|0|||
27960089|NCT00905307|54617304|FG004|Overall Study|Lost to Follow-up|1|||
27960090|NCT00905307|54617305|FG005|Overall Study|Lost to Follow-up|1|||
27960091|NCT00905307|54617300|FG000|Overall Study|Adverse Event|3|||
27960092|NCT00905307|54617301|FG001|Overall Study|Adverse Event|4|||
27960093|NCT00905307|54617302|FG002|Overall Study|Adverse Event|5|||
27960094|NCT00905307|54617303|FG003|Overall Study|Adverse Event|11|||
27960095|NCT00905307|54617304|FG004|Overall Study|Adverse Event|3|||
27960096|NCT00905307|54617305|FG005|Overall Study|Adverse Event|5|||
27960097|NCT00905307|54617300|FG000|Overall Study|Withdrawal by Subject|5|||
27960098|NCT00905307|54617301|FG001|Overall Study|Withdrawal by Subject|13|||
27960099|NCT00905307|54617302|FG002|Overall Study|Withdrawal by Subject|15|||
27960100|NCT00905307|54617303|FG003|Overall Study|Withdrawal by Subject|11|||
27960101|NCT00905307|54617304|FG004|Overall Study|Withdrawal by Subject|4|||
27960102|NCT00905307|54617305|FG005|Overall Study|Withdrawal by Subject|13|||
27960103|NCT00905307|54617300|FG000|Overall Study|Protocol Violation|1|||
27960104|NCT00905307|54617301|FG001|Overall Study|Protocol Violation|0|||
27960105|NCT00905307|54617302|FG002|Overall Study|Protocol Violation|1|||
27960106|NCT00905307|54617303|FG003|Overall Study|Protocol Violation|0|||
27855116|NCT01279681|54375412|FG000|Overall Study|Other Reason|0|||
27960107|NCT00905307|54617304|FG004|Overall Study|Protocol Violation|0|||
27960108|NCT00905307|54617305|FG005|Overall Study|Protocol Violation|0|||
27960109|NCT00905307|54617300|FG000|Overall Study|Lack of Efficacy|6|||
27855117|NCT01279681|54375413|FG001|Overall Study|Other Reason|2|||
27960110|NCT00905307|54617301|FG001|Overall Study|Lack of Efficacy|3|||
27960111|NCT00905307|54617302|FG002|Overall Study|Lack of Efficacy|5|||
27960112|NCT00905307|54617303|FG003|Overall Study|Lack of Efficacy|4|||
27960113|NCT00905307|54617304|FG004|Overall Study|Lack of Efficacy|4|||
27960114|NCT00905307|54617305|FG005|Overall Study|Lack of Efficacy|8|||
27960115|NCT00907881|54617332|FG000|Overall Study|Lost to Follow-up|59|||
27960116|NCT00907881|54617332|FG000|Overall Study|Noncompliance|5|||
27960117|NCT00907881|54617332|FG000|Overall Study|Withdrawal by Subject|5|||
27960118|NCT00907881|54617332|FG000|Overall Study|Protocol Violation|1|||
27960119|NCT00907881|54617332|FG000|Overall Study|Missing discontinuation information|15|||
27960120|NCT00904917|54617340|FG000|Overall Study|Lost to Follow-up|2|||
27960121|NCT00904917|54617341|FG001|Overall Study|Lost to Follow-up|2|||
27960122|NCT00904917|54617342|FG002|Overall Study|Lost to Follow-up|2|||
27960123|NCT00904917|54617343|FG003|Overall Study|Lost to Follow-up|2|||
27960124|NCT00904839|54617358|FG000|Overall Study|Adverse Event|0|||
27960125|NCT00904839|54617359|FG001|Overall Study|Adverse Event|5|||
28165121|NCT03016325|54835756|FG003|32-Day Follow-Up Period|Participant withdrew consent|0|||
28165122|NCT03016325|54835757|FG004|32-Day Follow-Up Period|Participant withdrew consent|2|||
28165123|NCT03016325|54835758|FG005|32-Day Follow-Up Period|Participant withdrew consent|0|||
28165124|NCT03016325|54835759|FG006|32-Day Follow-Up Period|Participant withdrew consent|1|||
28165125|NCT03016325|54835760|FG007|32-Day Follow-Up Period|Participant withdrew consent|0|||
27960126|NCT00904839|54617360|FG002|Overall Study|Adverse Event|4|||
28082252|NCT01934218|54736048|FG000|Open-Label Phase|Withdrawal by Subject|13|||
28082253|NCT01934218|54736049|FG001|Open-Label Phase|Withdrawal by Subject|11|||
28082254|NCT01934218|54736048|FG000|Open-Label Phase|Noncompliance with Study Protocol|4|||
28082255|NCT01934218|54736049|FG001|Open-Label Phase|Noncompliance with Study Protocol|2|||
28082256|NCT01934218|54736048|FG000|Open-Label Phase|Failure to Exam Primary Evaluation|0|||
27960127|NCT00904839|54617358|FG000|Overall Study|Protocol Violation|0|||
27960128|NCT00904839|54617359|FG001|Overall Study|Protocol Violation|1|||
27960129|NCT00904839|54617360|FG002|Overall Study|Protocol Violation|1|||
27960130|NCT00904839|54617358|FG000|Overall Study|Lost to Follow-up|0|||
27960131|NCT00904839|54617359|FG001|Overall Study|Lost to Follow-up|1|||
27960132|NCT00904839|54617360|FG002|Overall Study|Lost to Follow-up|2|||
27960133|NCT00904839|54617358|FG000|Overall Study|Withdrawal by Subject|0|||
27960134|NCT00904839|54617359|FG001|Overall Study|Withdrawal by Subject|2|||
27960135|NCT00904839|54617360|FG002|Overall Study|Withdrawal by Subject|0|||
27960136|NCT00904839|54617358|FG000|Overall Study|Not treated|1|||
27960137|NCT00904839|54617359|FG001|Overall Study|Not treated|0|||
27960138|NCT00904839|54617360|FG002|Overall Study|Not treated|1|||
27960139|NCT00904839|54617358|FG000|Overall Study|Other than above|0|||
27960140|NCT00904839|54617359|FG001|Overall Study|Other than above|9|||
27960141|NCT00904839|54617360|FG002|Overall Study|Other than above|7|||
27960142|NCT00903357|54617371|FG000|First Intervention|Withdrawal by Subject|5|||
27960143|NCT00903357|54617372|FG001|First Intervention|Withdrawal by Subject|3|||
27960144|NCT00903357|54617371|FG000|First Intervention|Flu|0|||
27960145|NCT00903357|54617372|FG001|First Intervention|Flu|1|||
27960146|NCT00903357|54617371|FG000|Wash Out Period of 2 Weeks|Flu|0|||
27960147|NCT00903357|54617372|FG001|Wash Out Period of 2 Weeks|Flu|1|||
27960148|NCT00903357|54617371|FG000|Second Intervention|Lost to Follow-up|1|||
27960149|NCT00903357|54617372|FG001|Second Intervention|Lost to Follow-up|0|||
27960150|NCT00904371|54617382|FG000|Overall Study|Adverse Event|2|||
27960151|NCT00904371|54617382|FG000|Overall Study|Lost to Follow-up|4|||
27960152|NCT00904371|54617382|FG000|Overall Study|Discontinued at target blood pressure|2|||
27960153|NCT00904371|54617382|FG000|Overall Study|Continued with Tritace|1|||
27960154|NCT01104662|54617394|FG000|Overall Study|Adverse Event|2|||
27960155|NCT01104662|54617395|FG001|Overall Study|Adverse Event|2|||
27960156|NCT01104662|54617396|FG002|Overall Study|Adverse Event|0|||
27960157|NCT01104662|54617397|FG003|Overall Study|Adverse Event|1|||
27960158|NCT01104662|54617398|FG004|Overall Study|Adverse Event|1|||
27960159|NCT01104662|54617399|FG005|Overall Study|Adverse Event|1|||
27960160|NCT01104662|54617400|FG006|Overall Study|Adverse Event|0|||
27960161|NCT01104662|54617401|FG007|Overall Study|Adverse Event|0|||
27960162|NCT01104662|54617394|FG000|Overall Study|Clinical Failure|1|||
28082257|NCT01934218|54736049|FG001|Open-Label Phase|Failure to Exam Primary Evaluation|1|||
28082258|NCT01702805|54736057|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
27960163|NCT01104662|54617395|FG001|Overall Study|Clinical Failure|0|||
27960164|NCT01104662|54617396|FG002|Overall Study|Clinical Failure|0|||
27960165|NCT01104662|54617397|FG003|Overall Study|Clinical Failure|0|||
27960166|NCT01104662|54617398|FG004|Overall Study|Clinical Failure|0|||
28165126|NCT03016325|54835753|FG000|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
27732379|NCT02165215|54179833|FG002|Maintenance Phase|Lost to Follow-up|0|||
27960167|NCT01104662|54617399|FG005|Overall Study|Clinical Failure|1|||
27960168|NCT01104662|54617400|FG006|Overall Study|Clinical Failure|0|||
27960169|NCT01104662|54617401|FG007|Overall Study|Clinical Failure|0|||
27960170|NCT01104662|54617394|FG000|Overall Study|Participant left investigator's care|1|||
27960171|NCT01104662|54617395|FG001|Overall Study|Participant left investigator's care|1|||
27960172|NCT01104662|54617396|FG002|Overall Study|Participant left investigator's care|0|||
27960173|NCT01104662|54617397|FG003|Overall Study|Participant left investigator's care|0|||
27960174|NCT01104662|54617398|FG004|Overall Study|Participant left investigator's care|0|||
27960175|NCT01104662|54617399|FG005|Overall Study|Participant left investigator's care|0|||
27960176|NCT01104662|54617400|FG006|Overall Study|Participant left investigator's care|0|||
27960177|NCT01104662|54617401|FG007|Overall Study|Participant left investigator's care|0|||
27960178|NCT01104662|54617394|FG000|Overall Study|Reason not specified|3|||
27960179|NCT01104662|54617395|FG001|Overall Study|Reason not specified|3|||
27960180|NCT01104662|54617396|FG002|Overall Study|Reason not specified|0|||
27960181|NCT01104662|54617397|FG003|Overall Study|Reason not specified|0|||
27960182|NCT01104662|54617398|FG004|Overall Study|Reason not specified|0|||
27960183|NCT01104662|54617399|FG005|Overall Study|Reason not specified|1|||
27960184|NCT01104662|54617400|FG006|Overall Study|Reason not specified|0|||
27960185|NCT01104662|54617401|FG007|Overall Study|Reason not specified|0|||
27960186|NCT01104662|54617394|FG000|Overall Study|Randomized but not treated|3|||
27960187|NCT01104662|54617395|FG001|Overall Study|Randomized but not treated|4|||
27960188|NCT01104662|54617396|FG002|Overall Study|Randomized but not treated|1|||
27960189|NCT01104662|54617397|FG003|Overall Study|Randomized but not treated|0|||
27960190|NCT01104662|54617398|FG004|Overall Study|Randomized but not treated|0|||
27960191|NCT01104662|54617399|FG005|Overall Study|Randomized but not treated|1|||
27960192|NCT01104662|54617400|FG006|Overall Study|Randomized but not treated|0|||
27960193|NCT01104662|54617401|FG007|Overall Study|Randomized but not treated|0|||
27960194|NCT01104584|54617420|FG000|Overall Study|Study drug never administered|21|||
27960195|NCT01104584|54617420|FG000|Overall Study|Study prematurely discontinued|2|||
27960196|NCT01103960|54617444|FG000|Overall Study|Adverse Event|2|||
27960197|NCT01103960|54617445|FG001|Overall Study|Adverse Event|1|||
27960198|NCT01103960|54617444|FG000|Overall Study|Withdrawal by Subject|2|||
27960199|NCT01103960|54617445|FG001|Overall Study|Withdrawal by Subject|1|||
27960200|NCT01103960|54617444|FG000|Overall Study|Other|1|||
27960201|NCT01103960|54617445|FG001|Overall Study|Other|0|||
27960202|NCT01107392|54617453|FG000|Overall Study|Adverse Event|2|||
27960203|NCT01107392|54617454|FG001|Overall Study|Adverse Event|0|||
27960204|NCT01107392|54617453|FG000|Overall Study|Personal Reasons|2|||
27960205|NCT01107392|54617454|FG001|Overall Study|Personal Reasons|3|||
27960206|NCT01107392|54617453|FG000|Overall Study|Administrative decision|1|||
27960207|NCT01107392|54617454|FG001|Overall Study|Administrative decision|0|||
27960208|NCT01106846|54617462|FG000|Overall Study|Change in surgical procedure|0|||
27960209|NCT01106846|54617463|FG001|Overall Study|Change in surgical procedure|1|||
27960210|NCT00902577|54617469|FG000|Overall Study|Withdrawal by Subject|6|||
27960211|NCT00902577|54617469|FG000|Overall Study|FMISO production failure|2|||
27960212|NCT01106690|54617504|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
27960213|NCT01106690|54617505|FG001|Core Period: Baseline to Week 26|Adverse Event|1|||
27960214|NCT01106690|54617506|FG002|Core Period: Baseline to Week 26|Adverse Event|4|||
27960215|NCT01106690|54617504|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
27960216|NCT01106690|54617505|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
27960217|NCT01106690|54617506|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
27960218|NCT01106690|54617504|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
27960219|NCT01106690|54617505|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
27960220|NCT01106690|54617506|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
27960221|NCT01106690|54617504|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
27960222|NCT01106690|54617505|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
27960223|NCT01106690|54617506|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|0|||
27960224|NCT01106690|54617504|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0|||
27960225|NCT01106690|54617505|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
27960226|NCT01106690|54617506|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
28082259|NCT01702805|54736058|FG001|Overall Study|Data withdrawn prior to hospital discharge|7|||
28082260|NCT01702805|54736057|FG000|Overall Study|Incomplete Follow-up|18|||
28082261|NCT01702805|54736058|FG001|Overall Study|Incomplete Follow-up|15|||
28082262|NCT01702805|54736057|FG000|Overall Study|Vital Status Assessment Only|40|||
28082263|NCT01702805|54736058|FG001|Overall Study|Vital Status Assessment Only|39|||
28082264|NCT01702805|54736057|FG000|Overall Study|Lost to Follow-up|5|||
28082265|NCT01702805|54736058|FG001|Overall Study|Lost to Follow-up|5|||
28082266|NCT00097370|54736081|FG000|Stage 1|Adverse Event|3|||
28082267|NCT00097370|54736081|FG000|Stage 1|Withdrawal by Subject|1|||
28082268|NCT00097370|54736081|FG000|Stage 1|Lack of Efficacy|2|||
27960227|NCT01106690|54617504|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
27960228|NCT01106690|54617505|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
28082269|NCT00097370|54736081|FG000|Stage 2|Adverse Event|5|||
27960229|NCT01106690|54617506|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
27960230|NCT01106690|54617504|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
27960231|NCT01106690|54617505|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
28082270|NCT00097370|54736081|FG000|Stage 2|Withdrawal by Subject|1|||
28082271|NCT00097370|54736081|FG000|Stage 2|Lack of Efficacy|3|||
28082272|NCT00097370|54736081|FG000|Stage 2|Pregnancy|1|||
28082273|NCT00097370|54736081|FG000|Stage 2|Sponsor Terminated Study|2|||
28082274|NCT00097370|54736081|FG000|Stage 2|Lost to Follow-up|1|||
28082275|NCT00097370|54736081|FG000|Stage 3|Adverse Event|2|||
28082276|NCT00097370|54736081|FG000|Stage 3|Withdrawal by Subject|3|||
27960232|NCT01106690|54617506|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
27960233|NCT01106690|54617504|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
27960234|NCT01106690|54617505|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
27960235|NCT01106690|54617506|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
27960236|NCT01106690|54617504|FG000|Core Period: Baseline to Week 26|Other|10|||
27960237|NCT01106690|54617505|FG001|Core Period: Baseline to Week 26|Other|2|||
27960238|NCT01106690|54617506|FG002|Core Period: Baseline to Week 26|Other|6|||
27960239|NCT01106690|54617504|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
27960240|NCT01106690|54617505|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
27960241|NCT01106690|54617506|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
27960242|NCT01106690|54617504|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
27960243|NCT01106690|54617505|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
27960244|NCT01106690|54617506|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
27960245|NCT01106690|54617504|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
27960246|NCT01106690|54617505|FG001|Extension Period: Week 26 to Week 52|Physician Decision|2|||
27960247|NCT01106690|54617506|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
27960248|NCT01106690|54617504|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
27960249|NCT01106690|54617505|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
27960250|NCT01106690|54617506|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
27960251|NCT01106690|54617504|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
27960252|NCT01106690|54617505|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
27960253|NCT01106690|54617506|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
27960254|NCT01106690|54617504|FG000|Extension Period: Week 26 to Week 52|Other|8|||
27960255|NCT01106690|54617505|FG001|Extension Period: Week 26 to Week 52|Other|3|||
27960256|NCT01106690|54617506|FG002|Extension Period: Week 26 to Week 52|Other|4|||
27960257|NCT01106690|54617504|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
27960258|NCT01106690|54617505|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
27960259|NCT01106690|54617506|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
27960260|NCT01103180|54617536|FG000|Overall Study|Withdrawal by Subject|8|||
27960261|NCT01103180|54617537|FG001|Overall Study|Withdrawal by Subject|13|||
27960262|NCT01103180|54617536|FG000|Overall Study|Lost to Follow-up|13|||
27960263|NCT01103180|54617537|FG001|Overall Study|Lost to Follow-up|7|||
27960264|NCT01103180|54617536|FG000|Overall Study|Physician Decision|1|||
27960265|NCT01103180|54617537|FG001|Overall Study|Physician Decision|0|||
27960266|NCT01103180|54617536|FG000|Overall Study|Protocol Violation|0|||
27960267|NCT01103180|54617537|FG001|Overall Study|Protocol Violation|1|||
27960268|NCT00944034|54617555|FG000|Overall Study|Inappropriate enrollment|0|||
27960269|NCT00944034|54617556|FG001|Overall Study|Inappropriate enrollment|1|||
27960270|NCT00944034|54617557|FG002|Overall Study|Inappropriate enrollment|0|||
27960271|NCT00944034|54617558|FG003|Overall Study|Inappropriate enrollment|1|||
27960272|NCT00944034|54617559|FG004|Overall Study|Inappropriate enrollment|2|||
27960273|NCT00944034|54617560|FG005|Overall Study|Inappropriate enrollment|1|||
27960274|NCT00944034|54617561|FG006|Overall Study|Inappropriate enrollment|0|||
27960275|NCT00944034|54617562|FG007|Overall Study|Inappropriate enrollment|0|||
27960276|NCT00944034|54617563|FG008|Overall Study|Inappropriate enrollment|1|||
27960277|NCT00944034|54617564|FG009|Overall Study|Inappropriate enrollment|1|||
27960278|NCT00944034|54617565|FG010|Overall Study|Inappropriate enrollment|0|||
27960279|NCT00944034|54617566|FG011|Overall Study|Inappropriate enrollment|0|||
27960280|NCT00944034|54617555|FG000|Overall Study|Withdrawal by Subject|3|||
28082277|NCT00097370|54736081|FG000|Stage 3|Lack of Efficacy|1|||
28082278|NCT00097370|54736081|FG000|Stage 3|Sponsor Terminated Study|52|||
28082279|NCT00097370|54736081|FG000|Stage 3|Lost to Follow-up|1|||
28082280|NCT03515824|54736097|FG000|Overall Study|Death|3|||
28082281|NCT03515824|54736098|FG001|Overall Study|Death|2|||
28082282|NCT03515824|54736099|FG002|Overall Study|Death|6|||
28082283|NCT03515824|54736100|FG003|Overall Study|Death|0|||
28082284|NCT03515824|54736097|FG000|Overall Study|Lost to Follow-up|0|||
27960281|NCT00944034|54617556|FG001|Overall Study|Withdrawal by Subject|2|||
27960282|NCT00944034|54617557|FG002|Overall Study|Withdrawal by Subject|6|||
27960283|NCT00944034|54617558|FG003|Overall Study|Withdrawal by Subject|2|||
27960284|NCT00944034|54617559|FG004|Overall Study|Withdrawal by Subject|5|||
27960285|NCT00944034|54617560|FG005|Overall Study|Withdrawal by Subject|8|||
27960286|NCT00944034|54617561|FG006|Overall Study|Withdrawal by Subject|2|||
28082285|NCT03515824|54736098|FG001|Overall Study|Lost to Follow-up|1|||
28082286|NCT03515824|54736099|FG002|Overall Study|Lost to Follow-up|1|||
28082287|NCT03515824|54736100|FG003|Overall Study|Lost to Follow-up|0|||
28082288|NCT03515824|54736097|FG000|Overall Study|Study terminated by sponsor|0|||
27960287|NCT00944034|54617562|FG007|Overall Study|Withdrawal by Subject|2|||
27960288|NCT00944034|54617563|FG008|Overall Study|Withdrawal by Subject|3|||
27960289|NCT00944034|54617564|FG009|Overall Study|Withdrawal by Subject|4|||
27960290|NCT00944034|54617565|FG010|Overall Study|Withdrawal by Subject|0|||
27960291|NCT00944034|54617566|FG011|Overall Study|Withdrawal by Subject|4|||
27960292|NCT00944034|54617555|FG000|Overall Study|Lost to Follow-up|0|||
27960293|NCT00944034|54617556|FG001|Overall Study|Lost to Follow-up|4|||
27960294|NCT00944034|54617557|FG002|Overall Study|Lost to Follow-up|2|||
27960295|NCT00944034|54617558|FG003|Overall Study|Lost to Follow-up|0|||
27960296|NCT00944034|54617559|FG004|Overall Study|Lost to Follow-up|5|||
27960297|NCT00944034|54617560|FG005|Overall Study|Lost to Follow-up|7|||
27960298|NCT00944034|54617561|FG006|Overall Study|Lost to Follow-up|0|||
27960299|NCT00944034|54617562|FG007|Overall Study|Lost to Follow-up|1|||
27960300|NCT00944034|54617563|FG008|Overall Study|Lost to Follow-up|5|||
27960301|NCT00944034|54617564|FG009|Overall Study|Lost to Follow-up|1|||
27960302|NCT00944034|54617565|FG010|Overall Study|Lost to Follow-up|1|||
27960303|NCT00944034|54617566|FG011|Overall Study|Lost to Follow-up|0|||
27960304|NCT00944034|54617555|FG000|Overall Study|Death|0|||
27960305|NCT00944034|54617556|FG001|Overall Study|Death|0|||
27960306|NCT00944034|54617557|FG002|Overall Study|Death|1|||
27960307|NCT00944034|54617558|FG003|Overall Study|Death|0|||
27960308|NCT00944034|54617559|FG004|Overall Study|Death|0|||
27960309|NCT00944034|54617560|FG005|Overall Study|Death|0|||
27960310|NCT00944034|54617561|FG006|Overall Study|Death|0|||
27960311|NCT00944034|54617562|FG007|Overall Study|Death|0|||
27960312|NCT00944034|54617563|FG008|Overall Study|Death|0|||
27960313|NCT00944034|54617564|FG009|Overall Study|Death|0|||
27960314|NCT00944034|54617565|FG010|Overall Study|Death|0|||
27960315|NCT00944034|54617566|FG011|Overall Study|Death|0|||
27960316|NCT00944034|54617555|FG000|Overall Study|Protocol Violation|2|||
27960317|NCT00944034|54617556|FG001|Overall Study|Protocol Violation|0|||
27960318|NCT00944034|54617557|FG002|Overall Study|Protocol Violation|0|||
27960319|NCT00944034|54617558|FG003|Overall Study|Protocol Violation|1|||
27960320|NCT00944034|54617559|FG004|Overall Study|Protocol Violation|2|||
27960321|NCT00944034|54617560|FG005|Overall Study|Protocol Violation|3|||
27960322|NCT00944034|54617561|FG006|Overall Study|Protocol Violation|0|||
27960323|NCT00944034|54617562|FG007|Overall Study|Protocol Violation|1|||
27960324|NCT00944034|54617563|FG008|Overall Study|Protocol Violation|1|||
27960325|NCT00944034|54617564|FG009|Overall Study|Protocol Violation|4|||
27960326|NCT00944034|54617565|FG010|Overall Study|Protocol Violation|0|||
27960327|NCT00944034|54617566|FG011|Overall Study|Protocol Violation|0|||
27960328|NCT00944034|54617555|FG000|Overall Study|Unable to classify|0|||
27960329|NCT00944034|54617556|FG001|Overall Study|Unable to classify|0|||
27960330|NCT00944034|54617557|FG002|Overall Study|Unable to classify|0|||
27960331|NCT00944034|54617558|FG003|Overall Study|Unable to classify|0|||
27960332|NCT00944034|54617559|FG004|Overall Study|Unable to classify|0|||
27960333|NCT00944034|54617560|FG005|Overall Study|Unable to classify|1|||
27960334|NCT00944034|54617561|FG006|Overall Study|Unable to classify|1|||
27960335|NCT00944034|54617562|FG007|Overall Study|Unable to classify|1|||
27960336|NCT00944034|54617563|FG008|Overall Study|Unable to classify|0|||
27960337|NCT00944034|54617564|FG009|Overall Study|Unable to classify|0|||
27960338|NCT00944034|54617565|FG010|Overall Study|Unable to classify|0|||
27960339|NCT00944034|54617566|FG011|Overall Study|Unable to classify|0|||
27960340|NCT00944034|54617555|FG000|Overall Study|Administrative reason|0|||
27960341|NCT00944034|54617556|FG001|Overall Study|Administrative reason|0|||
27960342|NCT00944034|54617557|FG002|Overall Study|Administrative reason|0|||
27960343|NCT00944034|54617558|FG003|Overall Study|Administrative reason|0|||
27960344|NCT00944034|54617559|FG004|Overall Study|Administrative reason|0|||
27960345|NCT00944034|54617560|FG005|Overall Study|Administrative reason|0|||
27960346|NCT00944034|54617561|FG006|Overall Study|Administrative reason|1|||
27960347|NCT00944034|54617562|FG007|Overall Study|Administrative reason|0|||
27960348|NCT00944034|54617563|FG008|Overall Study|Administrative reason|0|||
27960349|NCT00944034|54617564|FG009|Overall Study|Administrative reason|0|||
27960350|NCT00944034|54617565|FG010|Overall Study|Administrative reason|0|||
27960351|NCT00944034|54617566|FG011|Overall Study|Administrative reason|0|||
27960352|NCT01106534|54617609|FG000|Overall Study|Withdrawal by Subject|18|||
27960353|NCT01106534|54617609|FG000|Overall Study|Lost to Follow-up|2|||
27960354|NCT01106534|54617609|FG000|Overall Study|Death|16|||
27960355|NCT01106534|54617609|FG000|Overall Study|Physician Decision|1|||
27960356|NCT00941304|54617619|FG000|Overall Study|Lost to Follow-up|1|||
27960357|NCT00941304|54617620|FG001|Overall Study|Lost to Follow-up|0|||
27960358|NCT00941304|54617621|FG002|Overall Study|Lost to Follow-up|0|||
27960359|NCT00941304|54617622|FG003|Overall Study|Lost to Follow-up|0|||
27960360|NCT00941304|54617623|FG004|Overall Study|Lost to Follow-up|0|||
27960361|NCT00941070|54617635|FG000|Overall Study|Patient non-compliant|1|||
27960362|NCT01098812|54617644|FG000|Overall Study|Death|2|||
27960363|NCT01098812|54617645|FG001|Overall Study|Death|0|||
27960364|NCT01098812|54617646|FG002|Overall Study|Death|1|||
27960365|NCT01098812|54617644|FG000|Overall Study|Lost to Follow-up|0|||
27960366|NCT01098812|54617645|FG001|Overall Study|Lost to Follow-up|1|||
27960367|NCT01098812|54617646|FG002|Overall Study|Lost to Follow-up|0|||
27960368|NCT00903201|54617656|FG000|Overall Study|Adverse Event|1|||
27960369|NCT00903201|54617657|FG001|Overall Study|Adverse Event|4|||
27960370|NCT00903201|54617658|FG002|Overall Study|Adverse Event|0|||
27960371|NCT00903201|54617656|FG000|Overall Study|Protocol Violation|2|||
27960372|NCT00903201|54617657|FG001|Overall Study|Protocol Violation|1|||
27960373|NCT00903201|54617658|FG002|Overall Study|Protocol Violation|0|||
27960374|NCT00903201|54617656|FG000|Overall Study|Lost to Follow-up|0|||
27960375|NCT00903201|54617657|FG001|Overall Study|Lost to Follow-up|1|||
27960376|NCT00903201|54617658|FG002|Overall Study|Lost to Follow-up|0|||
27960377|NCT00903201|54617656|FG000|Overall Study|Physician Decision|1|||
27960378|NCT00903201|54617657|FG001|Overall Study|Physician Decision|0|||
27960379|NCT00903201|54617658|FG002|Overall Study|Physician Decision|1|||
27960380|NCT00903201|54617656|FG000|Overall Study|Withdrawal by Subject|1|||
27960381|NCT00903201|54617657|FG001|Overall Study|Withdrawal by Subject|0|||
27960382|NCT00903201|54617658|FG002|Overall Study|Withdrawal by Subject|1|||
27960383|NCT00902265|54617668|FG000|Overall Study|Lost to Follow-up Prior to First Visit|1|||
27960384|NCT00902265|54617668|FG000|Overall Study|Adverse Event|2|||
27960385|NCT00902265|54617668|FG000|Overall Study|Lack of Efficacy|2|||
27960386|NCT00902265|54617668|FG000|Overall Study|Protocol Violation|1|||
27960387|NCT00943722|54617695|FG000|Base Study|Adverse Event|0|||
27960388|NCT00943722|54617696|FG001|Base Study|Adverse Event|0|||
27960389|NCT00943722|54617697|FG002|Base Study|Adverse Event|0|||
27960390|NCT00943722|54617698|FG003|Base Study|Adverse Event|1|||
27960391|NCT00943722|54617699|FG004|Base Study|Adverse Event|0|||
27960392|NCT00943722|54617700|FG005|Base Study|Adverse Event|0|||
28082289|NCT03515824|54736098|FG001|Overall Study|Study terminated by sponsor|1|||
28082290|NCT03515824|54736099|FG002|Overall Study|Study terminated by sponsor|6|||
28082291|NCT03515824|54736100|FG003|Overall Study|Study terminated by sponsor|0|||
28082292|NCT03515824|54736097|FG000|Overall Study|Status not recorded|0|||
28082293|NCT03515824|54736098|FG001|Overall Study|Status not recorded|0|||
28082294|NCT03515824|54736099|FG002|Overall Study|Status not recorded|2|||
28082295|NCT03515824|54736100|FG003|Overall Study|Status not recorded|0|||
28082296|NCT01089374|54736110|FG000|Overall Study|Lost to Follow-up|3|||
27732380|NCT02165215|54179831|FG000|Maintenance Phase|Adverse Event|0|||
27732381|NCT02165215|54179832|FG001|Maintenance Phase|Adverse Event|1|||
27732382|NCT02165215|54179833|FG002|Maintenance Phase|Adverse Event|1|||
27732383|NCT02757625|54179848|FG000|Overall Study|Investigator's discretion|0|||
27732384|NCT02757625|54179849|FG001|Overall Study|Investigator's discretion|0|||
27732385|NCT02757625|54179850|FG002|Overall Study|Investigator's discretion|1|||
27732386|NCT02757625|54179851|FG003|Overall Study|Investigator's discretion|0|||
27732387|NCT02757625|54179848|FG000|Overall Study|Adverse Event|0|||
27732388|NCT02757625|54179849|FG001|Overall Study|Adverse Event|0|||
27732389|NCT02757625|54179850|FG002|Overall Study|Adverse Event|1|||
27732390|NCT02757625|54179851|FG003|Overall Study|Adverse Event|0|||
27732391|NCT02581202|54179863|FG000|Overall Study|Lack of Efficacy|2|||
27732392|NCT02581202|54179863|FG000|Overall Study|Withdrawal by Subject|4|||
27732393|NCT02581202|54179863|FG000|Overall Study|Lost to Follow-up|5|||
27732394|NCT02581202|54179863|FG000|Overall Study|Pregnancy|3|||
27732395|NCT02758171|54179870|FG000|Wash-out|Withdrawal by Subject|1|||
27732396|NCT02758171|54179871|FG001|Wash-out|Withdrawal by Subject|0|||
27732397|NCT02758171|54179870|FG000|Wash-out|Other reason|1|||
27732398|NCT02758171|54179871|FG001|Wash-out|Other reason|0|||
27732399|NCT00101101|54179877|FG000|Overall Study|never received vaccine|20|||
27732400|NCT01664078|54179904|FG000|Overall Study|Death|9|||
27732401|NCT01664078|54179904|FG000|Overall Study|Withdrawal by Subject|4|||
27732402|NCT01664078|54179904|FG000|Overall Study|Lost to Follow-up|2|||
27732403|NCT01664078|54179904|FG000|Overall Study|missed 5 year visit|1|||
27732404|NCT01664078|54179904|FG000|Overall Study|Other|53|||
27732405|NCT03367403|54179957|FG000|Overall Study|Adverse Event|20|||
27732406|NCT03367403|54179958|FG001|Overall Study|Adverse Event|6|||
27732407|NCT03367403|54179959|FG002|Overall Study|Adverse Event|2|||
27732408|NCT03367403|54179957|FG000|Overall Study|Withdrawal by Subject|12|||
27732409|NCT03367403|54179958|FG001|Overall Study|Withdrawal by Subject|13|||
27832429|NCT01734785|54311699|FG002|Open-Label Period|Protocol Violation|0|||
27832430|NCT01734785|54311700|FG003|Open-Label Period|Protocol Violation|13|||
27832431|NCT01734785|54311697|FG000|Open-Label Period|Lost to Follow-up|0|||
27832432|NCT01734785|54311698|FG001|Open-Label Period|Lost to Follow-up|0|||
27832433|NCT01734785|54311699|FG002|Open-Label Period|Lost to Follow-up|0|||
27832434|NCT01734785|54311700|FG003|Open-Label Period|Lost to Follow-up|14|||
27732410|NCT03367403|54179959|FG002|Overall Study|Withdrawal by Subject|1|||
27732411|NCT03367403|54179957|FG000|Overall Study|Death|1|||
27832435|NCT01734785|54311697|FG000|Open-Label Period|Withdrawal by Subject|0|||
27960393|NCT00943722|54617701|FG006|Base Study|Adverse Event|0|||
27960394|NCT00943722|54617695|FG000|Base Study|Lost to Follow-up|12|||
27732412|NCT03367403|54179958|FG001|Overall Study|Death|2|||
27960395|NCT00943722|54617696|FG001|Base Study|Lost to Follow-up|8|||
27960396|NCT00943722|54617697|FG002|Base Study|Lost to Follow-up|10|||
27960397|NCT00943722|54617698|FG003|Base Study|Lost to Follow-up|8|||
27960398|NCT00943722|54617699|FG004|Base Study|Lost to Follow-up|11|||
27960399|NCT00943722|54617700|FG005|Base Study|Lost to Follow-up|0|||
27960400|NCT00943722|54617701|FG006|Base Study|Lost to Follow-up|0|||
27960401|NCT00943722|54617695|FG000|Base Study|Physician Decision|1|||
27960402|NCT00943722|54617696|FG001|Base Study|Physician Decision|0|||
27960403|NCT00943722|54617697|FG002|Base Study|Physician Decision|0|||
27960404|NCT00943722|54617698|FG003|Base Study|Physician Decision|0|||
27960405|NCT00943722|54617699|FG004|Base Study|Physician Decision|1|||
27960406|NCT00943722|54617700|FG005|Base Study|Physician Decision|0|||
27960407|NCT00943722|54617701|FG006|Base Study|Physician Decision|0|||
27960408|NCT00943722|54617695|FG000|Base Study|Pregnancy|0|||
27960409|NCT00943722|54617696|FG001|Base Study|Pregnancy|0|||
27960410|NCT00943722|54617697|FG002|Base Study|Pregnancy|1|||
27960411|NCT00943722|54617698|FG003|Base Study|Pregnancy|0|||
27960412|NCT00943722|54617699|FG004|Base Study|Pregnancy|2|||
27960413|NCT00943722|54617700|FG005|Base Study|Pregnancy|0|||
27960414|NCT00943722|54617701|FG006|Base Study|Pregnancy|0|||
27960415|NCT00943722|54617695|FG000|Base Study|Protocol Violation|0|||
27960416|NCT00943722|54617696|FG001|Base Study|Protocol Violation|1|||
27960417|NCT00943722|54617697|FG002|Base Study|Protocol Violation|0|||
27960418|NCT00943722|54617698|FG003|Base Study|Protocol Violation|0|||
27960419|NCT00943722|54617699|FG004|Base Study|Protocol Violation|2|||
27960420|NCT00943722|54617700|FG005|Base Study|Protocol Violation|0|||
27960421|NCT00943722|54617701|FG006|Base Study|Protocol Violation|0|||
27960422|NCT00943722|54617695|FG000|Base Study|Withdrawal by Subject|12|||
27960423|NCT00943722|54617696|FG001|Base Study|Withdrawal by Subject|13|||
27960424|NCT00943722|54617697|FG002|Base Study|Withdrawal by Subject|2|||
27960425|NCT00943722|54617698|FG003|Base Study|Withdrawal by Subject|13|||
28082297|NCT01089374|54736111|FG001|Overall Study|Lost to Follow-up|0|||
28082298|NCT01089374|54736110|FG000|Overall Study|Withdrawal by Subject|1|||
28082299|NCT01089374|54736111|FG001|Overall Study|Withdrawal by Subject|0|||
28082300|NCT01089374|54736110|FG000|Overall Study|Study closed early - low accrual|6|||
28082301|NCT01089374|54736111|FG001|Overall Study|Study closed early - low accrual|0|||
28082302|NCT03511378|54736118|FG000|Overall Study|Withdrawal by Subject|2|||
28082303|NCT03511378|54736119|FG001|Overall Study|Withdrawal by Subject|2|||
27960426|NCT00943722|54617699|FG004|Base Study|Withdrawal by Subject|8|||
27960427|NCT00943722|54617700|FG005|Base Study|Withdrawal by Subject|0|||
27960428|NCT00943722|54617701|FG006|Base Study|Withdrawal by Subject|0|||
27960429|NCT00943722|54617695|FG000|Base Study|Month 12 visit not completed|0|||
27732413|NCT03367403|54179959|FG002|Overall Study|Death|0|||
27732414|NCT03367403|54179957|FG000|Overall Study|Physician Decision|0|||
27732415|NCT03367403|54179958|FG001|Overall Study|Physician Decision|1|||
27732416|NCT03367403|54179959|FG002|Overall Study|Physician Decision|0|||
27732417|NCT03367403|54179957|FG000|Overall Study|Protocol Violation|1|||
27732418|NCT03367403|54179958|FG001|Overall Study|Protocol Violation|1|||
27732419|NCT03367403|54179959|FG002|Overall Study|Protocol Violation|0|||
27732420|NCT03367403|54179957|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
27732421|NCT03367403|54179958|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|2|||
27732422|NCT03367403|54179959|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
27732423|NCT03367403|54179957|FG000|Overall Study|COVID-19|3|||
27732424|NCT03367403|54179958|FG001|Overall Study|COVID-19|6|||
27732425|NCT03367403|54179959|FG002|Overall Study|COVID-19|0|||
27732426|NCT03367403|54179957|FG000|Overall Study|Abuse of Alcohol Intake|0|||
27732427|NCT03367403|54179958|FG001|Overall Study|Abuse of Alcohol Intake|1|||
27732428|NCT03367403|54179959|FG002|Overall Study|Abuse of Alcohol Intake|0|||
27732429|NCT03367403|54179957|FG000|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
27732430|NCT03367403|54179958|FG001|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|1|||
27732431|NCT03367403|54179959|FG002|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
27960430|NCT00943722|54617696|FG001|Base Study|Month 12 visit not completed|0|||
27960431|NCT00943722|54617697|FG002|Base Study|Month 12 visit not completed|0|||
28082304|NCT03511378|54736118|FG000|Overall Study|Patient not coming or schedule visit|1|||
27960432|NCT00943722|54617698|FG003|Base Study|Month 12 visit not completed|0|||
27960433|NCT00943722|54617699|FG004|Base Study|Month 12 visit not completed|2|||
27960434|NCT00943722|54617700|FG005|Base Study|Month 12 visit not completed|0|||
27960435|NCT00943722|54617701|FG006|Base Study|Month 12 visit not completed|0|||
27960436|NCT00943722|54617695|FG000|First Extension Study: EXT 1|Adverse Event|0|||
27960437|NCT00943722|54617696|FG001|First Extension Study: EXT 1|Adverse Event|0|||
28082305|NCT03511378|54736119|FG001|Overall Study|Patient not coming or schedule visit|0|||
28082306|NCT03511066|54736128|FG000|Overall Study|Withdrawal by Subject|1|||
28082307|NCT03511066|54736129|FG001|Overall Study|Withdrawal by Subject|2|||
28082308|NCT03511066|54736130|FG002|Overall Study|Withdrawal by Subject|3|||
28082309|NCT03511066|54736128|FG000|Overall Study|Lost to Follow-up|2|||
28082310|NCT03511066|54736129|FG001|Overall Study|Lost to Follow-up|3|||
28082311|NCT03511066|54736130|FG002|Overall Study|Lost to Follow-up|0|||
28082312|NCT03510910|54736140|FG000|Overall Study|Incomplete Survey|2|||
28082313|NCT03510910|54736141|FG001|Overall Study|Incomplete Survey|3|||
28082314|NCT03509350|54736149|FG000|Overall Study|Withdrawal by Subject|0|||
28082315|NCT03509350|54736150|FG001|Overall Study|Withdrawal by Subject|2|||
28165127|NCT03016325|54835754|FG001|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
27732432|NCT02577146|54179967|FG000|Overall Study|Lost to Follow-up|8|||
27732433|NCT02577146|54179967|FG000|Overall Study|Physician Decision|3|||
27732434|NCT02577146|54179967|FG000|Overall Study|Screen Failure|17|||
27732435|NCT00109967|54179973|FG000|Overall Study|Cancel Prior to Treatment|2|||
27732436|NCT00109967|54179974|FG001|Overall Study|Cancel Prior to Treatment|0|||
27732437|NCT00109967|54179973|FG000|Overall Study|Adverse Event|12|||
28165128|NCT03016325|54835755|FG002|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1|||
28165129|NCT03016325|54835756|FG003|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
28165130|NCT03016325|54835757|FG004|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
28165131|NCT03016325|54835758|FG005|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
28165132|NCT03016325|54835759|FG006|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
28165133|NCT03016325|54835760|FG007|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
28165134|NCT03016325|54835753|FG000|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
28165135|NCT03016325|54835754|FG001|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1|||
27855118|NCT01279057|54375431|FG000|Overall Study|Adverse Event|1|||
27855119|NCT01279057|54375432|FG001|Overall Study|Adverse Event|0|||
27960438|NCT00943722|54617697|FG002|First Extension Study: EXT 1|Adverse Event|0|||
27960439|NCT00943722|54617698|FG003|First Extension Study: EXT 1|Adverse Event|0|||
27960440|NCT00943722|54617699|FG004|First Extension Study: EXT 1|Adverse Event|0|||
27960441|NCT00943722|54617700|FG005|First Extension Study: EXT 1|Adverse Event|1|||
27960442|NCT00943722|54617701|FG006|First Extension Study: EXT 1|Adverse Event|0|||
27960443|NCT00943722|54617695|FG000|First Extension Study: EXT 1|Lost to Follow-up|0|||
27960444|NCT00943722|54617696|FG001|First Extension Study: EXT 1|Lost to Follow-up|0|||
27960445|NCT00943722|54617697|FG002|First Extension Study: EXT 1|Lost to Follow-up|0|||
27960446|NCT00943722|54617698|FG003|First Extension Study: EXT 1|Lost to Follow-up|0|||
27960447|NCT00943722|54617699|FG004|First Extension Study: EXT 1|Lost to Follow-up|0|||
27960448|NCT00943722|54617700|FG005|First Extension Study: EXT 1|Lost to Follow-up|38|||
27960449|NCT00943722|54617701|FG006|First Extension Study: EXT 1|Lost to Follow-up|10|||
27960450|NCT00943722|54617695|FG000|First Extension Study: EXT 1|Withdrawal by Subject|0|||
27960451|NCT00943722|54617696|FG001|First Extension Study: EXT 1|Withdrawal by Subject|0|||
27960452|NCT00943722|54617697|FG002|First Extension Study: EXT 1|Withdrawal by Subject|0|||
27960453|NCT00943722|54617698|FG003|First Extension Study: EXT 1|Withdrawal by Subject|0|||
27960454|NCT00943722|54617699|FG004|First Extension Study: EXT 1|Withdrawal by Subject|0|||
27960455|NCT00943722|54617700|FG005|First Extension Study: EXT 1|Withdrawal by Subject|32|||
27960456|NCT00943722|54617701|FG006|First Extension Study: EXT 1|Withdrawal by Subject|10|||
27960457|NCT00943722|54617695|FG000|First Extension Study: EXT 1|Disposition Unknown|0|||
27960458|NCT00943722|54617696|FG001|First Extension Study: EXT 1|Disposition Unknown|0|||
27960459|NCT00943722|54617697|FG002|First Extension Study: EXT 1|Disposition Unknown|0|||
27960460|NCT00943722|54617698|FG003|First Extension Study: EXT 1|Disposition Unknown|0|||
27960461|NCT00943722|54617699|FG004|First Extension Study: EXT 1|Disposition Unknown|0|||
27960462|NCT00943722|54617700|FG005|First Extension Study: EXT 1|Disposition Unknown|44|||
27960463|NCT00943722|54617701|FG006|First Extension Study: EXT 1|Disposition Unknown|21|||
27960464|NCT00943722|54617695|FG000|Second Extension Study: EXT 2|Adverse Event|0|||
27960465|NCT00943722|54617696|FG001|Second Extension Study: EXT 2|Adverse Event|0|||
27960466|NCT00943722|54617697|FG002|Second Extension Study: EXT 2|Adverse Event|0|||
27960467|NCT00943722|54617698|FG003|Second Extension Study: EXT 2|Adverse Event|0|||
27960468|NCT00943722|54617699|FG004|Second Extension Study: EXT 2|Adverse Event|0|||
27960469|NCT00943722|54617700|FG005|Second Extension Study: EXT 2|Adverse Event|1|||
27960470|NCT00943722|54617701|FG006|Second Extension Study: EXT 2|Adverse Event|0|||
27960471|NCT00943722|54617695|FG000|Second Extension Study: EXT 2|Lost to Follow-up|0|||
27960472|NCT00943722|54617696|FG001|Second Extension Study: EXT 2|Lost to Follow-up|0|||
27960473|NCT00943722|54617697|FG002|Second Extension Study: EXT 2|Lost to Follow-up|0|||
27960474|NCT00943722|54617698|FG003|Second Extension Study: EXT 2|Lost to Follow-up|0|||
27960475|NCT00943722|54617699|FG004|Second Extension Study: EXT 2|Lost to Follow-up|0|||
27960476|NCT00943722|54617700|FG005|Second Extension Study: EXT 2|Lost to Follow-up|111|||
27960477|NCT00943722|54617701|FG006|Second Extension Study: EXT 2|Lost to Follow-up|46|||
27960478|NCT00943722|54617695|FG000|Second Extension Study: EXT 2|Physician Decision|0|||
27960479|NCT00943722|54617696|FG001|Second Extension Study: EXT 2|Physician Decision|0|||
27960480|NCT00943722|54617697|FG002|Second Extension Study: EXT 2|Physician Decision|0|||
27960481|NCT00943722|54617698|FG003|Second Extension Study: EXT 2|Physician Decision|0|||
27960482|NCT00943722|54617699|FG004|Second Extension Study: EXT 2|Physician Decision|0|||
27960483|NCT00943722|54617700|FG005|Second Extension Study: EXT 2|Physician Decision|1|||
27960484|NCT00943722|54617701|FG006|Second Extension Study: EXT 2|Physician Decision|3|||
27732438|NCT00109967|54179974|FG001|Overall Study|Adverse Event|1|||
27732439|NCT00109967|54179973|FG000|Overall Study|Withdrawal by Subject|5|||
27855120|NCT01279057|54375433|FG002|Overall Study|Adverse Event|1|||
27855121|NCT01279057|54375431|FG000|Overall Study|Insufficient therapeutic response|0|||
27732440|NCT00109967|54179974|FG001|Overall Study|Withdrawal by Subject|0|||
27960485|NCT00943722|54617695|FG000|Second Extension Study: EXT 2|Pregnancy|0|||
27960486|NCT00943722|54617696|FG001|Second Extension Study: EXT 2|Pregnancy|0|||
27960487|NCT00943722|54617697|FG002|Second Extension Study: EXT 2|Pregnancy|0|||
27960488|NCT00943722|54617698|FG003|Second Extension Study: EXT 2|Pregnancy|0|||
27960489|NCT00943722|54617699|FG004|Second Extension Study: EXT 2|Pregnancy|0|||
27960490|NCT00943722|54617700|FG005|Second Extension Study: EXT 2|Pregnancy|1|||
27960491|NCT00943722|54617701|FG006|Second Extension Study: EXT 2|Pregnancy|0|||
27960492|NCT00943722|54617695|FG000|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
27960493|NCT00943722|54617696|FG001|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
27960494|NCT00943722|54617697|FG002|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
27960495|NCT00943722|54617698|FG003|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
27960496|NCT00943722|54617699|FG004|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
27960497|NCT00943722|54617700|FG005|Second Extension Study: EXT 2|Withdrawal by Subject|137|||
27960498|NCT00943722|54617701|FG006|Second Extension Study: EXT 2|Withdrawal by Subject|50|||
27960499|NCT00901485|54617724|FG000|Overall Study|Lack of Efficacy|0|||
27960500|NCT00901485|54617725|FG001|Overall Study|Lack of Efficacy|2|||
27960501|NCT00901485|54617724|FG000|Overall Study|Withdrawal by Subject|1|||
27960502|NCT00901485|54617725|FG001|Overall Study|Withdrawal by Subject|2|||
27960503|NCT00896337|54617731|FG000|Overall Study|Death|7|||
27960504|NCT00896337|54617731|FG000|Overall Study|Withdrawal by Subject|7|||
27960505|NCT00896337|54617731|FG000|Overall Study|Lost to Follow-up|11|||
27960506|NCT00953706|54617742|FG000|Part A (16-Week Double-Blind Treatment)|Adverse Event|2|||
27960507|NCT00953706|54617743|FG001|Part A (16-Week Double-Blind Treatment)|Adverse Event|3|||
27960508|NCT00953706|54617744|FG002|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
27960509|NCT00953706|54617745|FG003|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
27960510|NCT00953706|54617742|FG000|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
27960511|NCT00953706|54617743|FG001|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1|||
27960512|NCT00953706|54617744|FG002|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
27960513|NCT00953706|54617745|FG003|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
27960514|NCT00953706|54617742|FG000|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
27960515|NCT00953706|54617743|FG001|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2|||
27960516|NCT00953706|54617744|FG002|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
27960517|NCT00953706|54617745|FG003|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
27960518|NCT00953706|54617742|FG000|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
27960519|NCT00953706|54617743|FG001|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1|||
27960520|NCT00953706|54617744|FG002|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
27960521|NCT00953706|54617745|FG003|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
27960522|NCT00953706|54617742|FG000|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
27960523|NCT00953706|54617743|FG001|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1|||
27960524|NCT00953706|54617744|FG002|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
27960525|NCT00953706|54617745|FG003|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
27960526|NCT00953706|54617742|FG000|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
27960527|NCT00953706|54617743|FG001|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
27960528|NCT00953706|54617744|FG002|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
27960529|NCT00953706|54617745|FG003|Part B (96-Week Open-Label Extension)|Adverse Event|2|||
27960530|NCT00953706|54617742|FG000|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
27960531|NCT00953706|54617743|FG001|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
27960532|NCT00953706|54617744|FG002|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
27960533|NCT00953706|54617745|FG003|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1|||
27960534|NCT00953706|54617742|FG000|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
27960535|NCT00953706|54617743|FG001|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
27960536|NCT00953706|54617744|FG002|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
27960537|NCT00953706|54617745|FG003|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1|||
27960538|NCT00953706|54617742|FG000|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
27960539|NCT00953706|54617743|FG001|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
27960540|NCT00953706|54617744|FG002|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4|||
27960541|NCT00953706|54617745|FG003|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25|||
27960542|NCT00953706|54617742|FG000|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
27960543|NCT00953706|54617743|FG001|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
27960544|NCT00953706|54617744|FG002|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1|||
27960545|NCT00953706|54617745|FG003|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2|||
27960546|NCT00953706|54617742|FG000|Part B (96-Week Open-Label Extension)|Other|0|||
27960547|NCT00953706|54617743|FG001|Part B (96-Week Open-Label Extension)|Other|0|||
27960548|NCT00953706|54617744|FG002|Part B (96-Week Open-Label Extension)|Other|0|||
28082316|NCT00072410|54736158|FG000|Overall Study|Progressive disease|0|||
27960549|NCT00953706|54617745|FG003|Part B (96-Week Open-Label Extension)|Other|2|||
27960550|NCT00940992|54617758|FG000|Overall Study|Adverse Event|2|||
27960551|NCT00940992|54617759|FG001|Overall Study|Adverse Event|0|||
27960552|NCT00940992|54617760|FG002|Overall Study|Adverse Event|1|||
27960553|NCT00940992|54617758|FG000|Overall Study|subject request|2|||
27960554|NCT00940992|54617759|FG001|Overall Study|subject request|1|||
27960555|NCT00940992|54617760|FG002|Overall Study|subject request|0|||
27960556|NCT00940992|54617758|FG000|Overall Study|Lost to Follow-up|0|||
27960557|NCT00940992|54617759|FG001|Overall Study|Lost to Follow-up|1|||
27960558|NCT00940992|54617760|FG002|Overall Study|Lost to Follow-up|1|||
27960559|NCT00938964|54617770|FG000|Overall Study|Death|3|||
27960560|NCT00938964|54617771|FG001|Overall Study|Death|3|||
27960561|NCT00938964|54617770|FG000|Overall Study|Lost to Follow-up|2|||
27960562|NCT00938964|54617771|FG001|Overall Study|Lost to Follow-up|3|||
27960563|NCT00938964|54617770|FG000|Overall Study|Withdrawal by Subject|22|||
27960564|NCT00938964|54617771|FG001|Overall Study|Withdrawal by Subject|18|||
27960565|NCT00938964|54617770|FG000|Overall Study|Found to Meet Exclusion Criteria|3|||
27960566|NCT00938964|54617771|FG001|Overall Study|Found to Meet Exclusion Criteria|4|||
27960567|NCT00938886|54617779|FG000|Overall Study|Death|0|||
27960568|NCT00938886|54617780|FG001|Overall Study|Death|1|||
27960569|NCT00938886|54617779|FG000|Overall Study|Withdrawal by Subject|4|||
27960570|NCT00938886|54617780|FG001|Overall Study|Withdrawal by Subject|7|||
27960571|NCT00938886|54617779|FG000|Overall Study|Lost to Follow-up|3|||
27960572|NCT00938886|54617780|FG001|Overall Study|Lost to Follow-up|2|||
27960573|NCT00938340|54617786|FG000|Overall Study|Withdrawal by Subject|3|||
27960574|NCT00938340|54617786|FG000|Overall Study|Protocol Violation|1|||
27960575|NCT00938340|54617786|FG000|Overall Study|Adverse Event|1|||
27960576|NCT00942708|54617832|FG000|Overall Study|Withdrawal by Subject|1|||
27960577|NCT00937950|54617837|FG000|Overall Study|Withdrawal by Subject|23|||
27960578|NCT00937950|54617837|FG000|Overall Study|Migrated/moved from study area|27|||
27960579|NCT00937950|54617837|FG000|Overall Study|Lost to Follow-up|144|||
27960580|NCT00937950|54617837|FG000|Overall Study|Missing confirmed|4|||
27960581|NCT00937950|54617837|FG000|Overall Study|Other|18|||
27960582|NCT00942162|54617844|FG000|Overall Study|Death|45|||
27960583|NCT00942162|54617845|FG001|Overall Study|Death|35|||
27960584|NCT00942162|54617846|FG002|Overall Study|Death|0|||
27960585|NCT00942162|54617844|FG000|Overall Study|Withdrawal by Subject|7|||
27960586|NCT00942162|54617845|FG001|Overall Study|Withdrawal by Subject|2|||
27960587|NCT00942162|54617846|FG002|Overall Study|Withdrawal by Subject|0|||
27960588|NCT00942162|54617844|FG000|Overall Study|Lost to Follow-up|4|||
27960589|NCT00942162|54617845|FG001|Overall Study|Lost to Follow-up|0|||
27960590|NCT00942162|54617846|FG002|Overall Study|Lost to Follow-up|0|||
27960591|NCT00942162|54617844|FG000|Overall Study|Other|14|||
27960592|NCT00942162|54617845|FG001|Overall Study|Other|13|||
27960593|NCT00942162|54617846|FG002|Overall Study|Other|2|||
27960594|NCT00942084|54617856|FG000|Overall Study|Death|2|||
27960595|NCT00941928|54617860|FG000|Overall Study|Withdrawal by Subject|1|||
27960596|NCT00941928|54617860|FG000|Overall Study|Disease Progression|1|||
27960597|NCT00937560|54617864|FG000|Initial Treatment|Death|6|||
27960598|NCT00937560|54617864|FG000|Initial Treatment|Withdraw consent|3|||
27960599|NCT00937560|54617864|FG000|Initial Treatment|Adverse Event|1|||
27960600|NCT00937560|54617864|FG000|Initial Treatment|Lost to Follow-up|1|||
27960601|NCT00937560|54617864|FG000|Initial Treatment|No end of study page|10|||
27960602|NCT00937560|54617864|FG000|Maintenance Treatment|Death|12|||
27960603|NCT00937560|54617864|FG000|Maintenance Treatment|Withdraw consent|5|||
27960604|NCT00937560|54617864|FG000|Maintenance Treatment|According to protocol|1|||
27960605|NCT00594568|54617871|FG000|Initial Treatment|Adverse Event|51|||
27960606|NCT00594568|54617872|FG001|Initial Treatment|Adverse Event|121|||
27960607|NCT00594568|54617873|FG002|Initial Treatment|Adverse Event|144|||
27960608|NCT00594568|54617871|FG000|Initial Treatment|Death|6|||
27960609|NCT00594568|54617872|FG001|Initial Treatment|Death|11|||
27960610|NCT00594568|54617873|FG002|Initial Treatment|Death|15|||
27960611|NCT00594568|54617871|FG000|Initial Treatment|Lost to Follow-up|4|||
27960612|NCT00594568|54617872|FG001|Initial Treatment|Lost to Follow-up|1|||
27960613|NCT00594568|54617873|FG002|Initial Treatment|Lost to Follow-up|4|||
27960614|NCT00594568|54617871|FG000|Initial Treatment|Physician Decision|3|||
27960615|NCT00594568|54617872|FG001|Initial Treatment|Physician Decision|2|||
27960616|NCT00594568|54617873|FG002|Initial Treatment|Physician Decision|4|||
27960617|NCT00594568|54617871|FG000|Initial Treatment|Protocol Violation|2|||
27960618|NCT00594568|54617872|FG001|Initial Treatment|Protocol Violation|2|||
27960619|NCT00594568|54617873|FG002|Initial Treatment|Protocol Violation|5|||
27960620|NCT00594568|54617871|FG000|Initial Treatment|Withdrawal by Subject|25|||
27960621|NCT00594568|54617872|FG001|Initial Treatment|Withdrawal by Subject|31|||
27960622|NCT00594568|54617873|FG002|Initial Treatment|Withdrawal by Subject|46|||
27960623|NCT00594568|54617871|FG000|Initial Treatment|Sponsor decision|193|||
27960624|NCT00594568|54617872|FG001|Initial Treatment|Sponsor decision|142|||
27960625|NCT00594568|54617873|FG002|Initial Treatment|Sponsor decision|147|||
27960626|NCT00594568|54617871|FG000|Initial Treatment|Caregiver decision|21|||
27960627|NCT00594568|54617872|FG001|Initial Treatment|Caregiver decision|36|||
27960628|NCT00594568|54617873|FG002|Initial Treatment|Caregiver decision|36|||
27960629|NCT00594568|54617871|FG000|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
27960630|NCT00594568|54617872|FG001|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
27960631|NCT00594568|54617873|FG002|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6|||
27960632|NCT00594568|54617871|FG000|Initial Treatment|Entry criteria exclusion|0|||
27960633|NCT00594568|54617872|FG001|Initial Treatment|Entry criteria exclusion|1|||
27960634|NCT00594568|54617873|FG002|Initial Treatment|Entry criteria exclusion|1|||
27960635|NCT00594568|54617871|FG000|Delayed Start|Death|0|||
27960636|NCT00594568|54617872|FG001|Delayed Start|Death|0|||
27960637|NCT00594568|54617873|FG002|Delayed Start|Death|1|||
27960638|NCT00594568|54617871|FG000|Delayed Start|Adverse Event|12|||
27960639|NCT00594568|54617872|FG001|Delayed Start|Adverse Event|2|||
27960640|NCT00594568|54617873|FG002|Delayed Start|Adverse Event|2|||
27960641|NCT00594568|54617871|FG000|Delayed Start|Withdrawal by Subject|4|||
27960642|NCT00594568|54617872|FG001|Delayed Start|Withdrawal by Subject|3|||
27960643|NCT00594568|54617873|FG002|Delayed Start|Withdrawal by Subject|0|||
27960644|NCT00594568|54617871|FG000|Delayed Start|Physician Decision|0|||
27960645|NCT00594568|54617872|FG001|Delayed Start|Physician Decision|0|||
27960646|NCT00594568|54617873|FG002|Delayed Start|Physician Decision|1|||
27960647|NCT00594568|54617871|FG000|Delayed Start|Lost to Follow-up|0|||
27960648|NCT00594568|54617872|FG001|Delayed Start|Lost to Follow-up|0|||
27960649|NCT00594568|54617873|FG002|Delayed Start|Lost to Follow-up|1|||
27960650|NCT00594568|54617871|FG000|Delayed Start|Caregiver Decision|5|||
27960651|NCT00594568|54617872|FG001|Delayed Start|Caregiver Decision|6|||
27960652|NCT00594568|54617873|FG002|Delayed Start|Caregiver Decision|2|||
27960653|NCT00594568|54617871|FG000|Delayed Start|Sponsor Decision|77|||
27960654|NCT00594568|54617872|FG001|Delayed Start|Sponsor Decision|66|||
27960655|NCT00594568|54617873|FG002|Delayed Start|Sponsor Decision|59|||
27960656|NCT00594568|54617871|FG000|Safety Follow Up (SFU)-Optional|Death|0|||
27960657|NCT00594568|54617872|FG001|Safety Follow Up (SFU)-Optional|Death|1|||
27960658|NCT00594568|54617873|FG002|Safety Follow Up (SFU)-Optional|Death|0|||
27960659|NCT00594568|54617871|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|5|||
27960660|NCT00594568|54617872|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
27960661|NCT00594568|54617873|FG002|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
27960662|NCT00594568|54617871|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12|||
27960663|NCT00594568|54617872|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15|||
27960664|NCT00594568|54617873|FG002|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13|||
27960665|NCT00594568|54617871|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
27960666|NCT00594568|54617872|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
27960667|NCT00594568|54617873|FG002|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
27960668|NCT00594568|54617871|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|17|||
27960669|NCT00594568|54617872|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|16|||
27960670|NCT00594568|54617873|FG002|Safety Follow Up (SFU)-Optional|Caregiver Decision|9|||
27960671|NCT00594568|54617871|FG000|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25|||
27960672|NCT00594568|54617872|FG001|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22|||
27960673|NCT00594568|54617873|FG002|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18|||
27960674|NCT00875056|54617901|FG000|Overall Study|Adverse Event|6|||
27960675|NCT00875056|54617902|FG001|Overall Study|Adverse Event|1|||
27960676|NCT00875056|54617903|FG002|Overall Study|Adverse Event|2|||
27960677|NCT00875056|54617901|FG000|Overall Study|Progressive Disease|14|||
27960678|NCT00875056|54617902|FG001|Overall Study|Progressive Disease|8|||
27960679|NCT00875056|54617903|FG002|Overall Study|Progressive Disease|3|||
27960680|NCT00875056|54617901|FG000|Overall Study|Withdrawal by Subject|3|||
27960681|NCT00875056|54617902|FG001|Overall Study|Withdrawal by Subject|0|||
27960682|NCT00875056|54617903|FG002|Overall Study|Withdrawal by Subject|1|||
27960683|NCT00940602|54617913|FG000|Overall Study|Administrative problems|1|||
27960684|NCT00940602|54617914|FG001|Overall Study|Administrative problems|1|||
27960685|NCT00940602|54617913|FG000|Overall Study|Patient/guardian decision|13|||
27960686|NCT00940602|54617914|FG001|Overall Study|Patient/guardian decision|28|||
27960687|NCT00940602|54617913|FG000|Overall Study|Physician Decision|8|||
28165136|NCT03016325|54835755|FG002|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
28165137|NCT03016325|54835756|FG003|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
27960688|NCT00940602|54617914|FG001|Overall Study|Physician Decision|5|||
27960689|NCT00940602|54617913|FG000|Overall Study|Pregnancy|1|||
27960690|NCT00940602|54617914|FG001|Overall Study|Pregnancy|0|||
27732441|NCT00109967|54179973|FG000|Overall Study|Physician Decision|1|||
27960691|NCT00940602|54617913|FG000|Overall Study|Protocol Deviation (untreated)|1|||
27960692|NCT00940602|54617914|FG001|Overall Study|Protocol Deviation (untreated)|0|||
27960693|NCT00940602|54617913|FG000|Overall Study|Disease progression|8|||
27960694|NCT00940602|54617914|FG001|Overall Study|Disease progression|2|||
27960695|NCT00940602|54617913|FG000|Overall Study|Death|38|||
27960696|NCT00940602|54617914|FG001|Overall Study|Death|19|||
27960697|NCT00940602|54617913|FG000|Overall Study|Lost to Follow-up|3|||
27960698|NCT00940602|54617914|FG001|Overall Study|Lost to Follow-up|1|||
27960699|NCT00940602|54617913|FG000|Overall Study|Patient withdrew consent|26|||
27960700|NCT00940602|54617914|FG001|Overall Study|Patient withdrew consent|13|||
27960701|NCT00940602|54617913|FG000|Overall Study|Adverse Event|7|||
27960702|NCT00940602|54617914|FG001|Overall Study|Adverse Event|2|||
27960703|NCT00940602|54617913|FG000|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43|||
27960704|NCT00940602|54617914|FG001|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5|||
27960705|NCT00874822|54617921|FG000|Overall Study|excluded by criteria|8|||
27960706|NCT00875524|54617927|FG000|Overall Study|Serious adverse event|0|||
27960707|NCT00875524|54617928|FG001|Overall Study|Serious adverse event|1|||
27960708|NCT00875524|54617927|FG000|Overall Study|Protocol Violation|4|||
27960709|NCT00875524|54617928|FG001|Overall Study|Protocol Violation|0|||
27960710|NCT00875524|54617927|FG000|Overall Study|Lost to Follow-up|1|||
27960711|NCT00875524|54617928|FG001|Overall Study|Lost to Follow-up|0|||
27960712|NCT00875524|54617927|FG000|Overall Study|Withdrawal by Subject|3|||
27960713|NCT00875524|54617928|FG001|Overall Study|Withdrawal by Subject|5|||
27960714|NCT01094288|54617942|FG000|Overall Study|Adverse Event|0|||
27960715|NCT01094288|54617943|FG001|Overall Study|Adverse Event|3|||
27960716|NCT01094288|54617944|FG002|Overall Study|Adverse Event|1|||
27960717|NCT01094288|54617945|FG003|Overall Study|Adverse Event|1|||
27960718|NCT01094288|54617946|FG004|Overall Study|Adverse Event|0|||
27960719|NCT01094288|54617947|FG005|Overall Study|Adverse Event|0|||
27960720|NCT01094288|54617948|FG006|Overall Study|Adverse Event|0|||
27960721|NCT01094288|54617949|FG007|Overall Study|Adverse Event|0|||
27960722|NCT01094288|54617942|FG000|Overall Study|Withdrawal by Subject|0|||
27960723|NCT01094288|54617943|FG001|Overall Study|Withdrawal by Subject|1|||
27960724|NCT01094288|54617944|FG002|Overall Study|Withdrawal by Subject|2|||
27960725|NCT01094288|54617945|FG003|Overall Study|Withdrawal by Subject|0|||
27960726|NCT01094288|54617946|FG004|Overall Study|Withdrawal by Subject|0|||
27960727|NCT01094288|54617947|FG005|Overall Study|Withdrawal by Subject|0|||
27960728|NCT01094288|54617948|FG006|Overall Study|Withdrawal by Subject|0|||
27960729|NCT01094288|54617949|FG007|Overall Study|Withdrawal by Subject|2|||
27960730|NCT01094288|54617942|FG000|Overall Study|Initiation of Alternative Therapy|0|||
27960731|NCT01094288|54617943|FG001|Overall Study|Initiation of Alternative Therapy|0|||
27960732|NCT01094288|54617944|FG002|Overall Study|Initiation of Alternative Therapy|1|||
27960733|NCT01094288|54617945|FG003|Overall Study|Initiation of Alternative Therapy|0|||
27960734|NCT01094288|54617946|FG004|Overall Study|Initiation of Alternative Therapy|0|||
27960735|NCT01094288|54617947|FG005|Overall Study|Initiation of Alternative Therapy|0|||
27960736|NCT01094288|54617948|FG006|Overall Study|Initiation of Alternative Therapy|0|||
27960737|NCT01094288|54617949|FG007|Overall Study|Initiation of Alternative Therapy|0|||
27960738|NCT01094288|54617942|FG000|Overall Study|Reason not Specified|2|||
27960739|NCT01094288|54617943|FG001|Overall Study|Reason not Specified|3|||
27960740|NCT01094288|54617944|FG002|Overall Study|Reason not Specified|0|||
27960741|NCT01094288|54617945|FG003|Overall Study|Reason not Specified|1|||
27832436|NCT01734785|54311698|FG001|Open-Label Period|Withdrawal by Subject|0|||
27832437|NCT01734785|54311699|FG002|Open-Label Period|Withdrawal by Subject|0|||
27832438|NCT01734785|54311700|FG003|Open-Label Period|Withdrawal by Subject|12|||
27832439|NCT01734785|54311697|FG000|Open-Label Period|Other Reasons|0|||
27832440|NCT01734785|54311698|FG001|Open-Label Period|Other Reasons|0|||
27832441|NCT01734785|54311699|FG002|Open-Label Period|Other Reasons|0|||
27855122|NCT01279057|54375432|FG001|Overall Study|Insufficient therapeutic response|0|||
27855123|NCT01279057|54375433|FG002|Overall Study|Insufficient therapeutic response|1|||
27855124|NCT01279057|54375431|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
27855125|NCT01279057|54375432|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
27855126|NCT01279057|54375433|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
27855127|NCT01279057|54375431|FG000|Overall Study|Withdrew consent|2|||
27855128|NCT01279057|54375432|FG001|Overall Study|Withdrew consent|0|||
27855129|NCT01279057|54375433|FG002|Overall Study|Withdrew consent|1|||
27855130|NCT01279057|54375431|FG000|Overall Study|Pregnancy|0|||
27855131|NCT01279057|54375432|FG001|Overall Study|Pregnancy|1|||
27832442|NCT01734785|54311700|FG003|Open-Label Period|Other Reasons|224|||
27832443|NCT01734785|54311697|FG000|Double-Blind Period|Adverse Event|0|||
27960742|NCT01094288|54617946|FG004|Overall Study|Reason not Specified|0|||
27960743|NCT01094288|54617947|FG005|Overall Study|Reason not Specified|0|||
27960744|NCT01094288|54617948|FG006|Overall Study|Reason not Specified|0|||
27960745|NCT01094288|54617949|FG007|Overall Study|Reason not Specified|0|||
27960746|NCT01094288|54617942|FG000|Overall Study|Ongoing Participants|0|||
27960747|NCT01094288|54617943|FG001|Overall Study|Ongoing Participants|3|||
27960748|NCT01094288|54617944|FG002|Overall Study|Ongoing Participants|0|||
27960749|NCT01094288|54617945|FG003|Overall Study|Ongoing Participants|0|||
27960750|NCT01094288|54617946|FG004|Overall Study|Ongoing Participants|0|||
27960751|NCT01094288|54617947|FG005|Overall Study|Ongoing Participants|0|||
27960752|NCT01094288|54617948|FG006|Overall Study|Ongoing Participants|0|||
27832444|NCT01734785|54311698|FG001|Double-Blind Period|Adverse Event|3|||
27832445|NCT01734785|54311699|FG002|Double-Blind Period|Adverse Event|2|||
27832446|NCT01734785|54311700|FG003|Double-Blind Period|Adverse Event|0|||
28082317|NCT00072410|54736159|FG001|Overall Study|Progressive disease|3|||
28082318|NCT03478696|54736167|FG000|Overall Study|Adverse Event|1|||
28082319|NCT03478696|54736168|FG001|Overall Study|Adverse Event|5|||
28082320|NCT03478696|54736167|FG000|Overall Study|Lost to Follow-up|1|||
28082321|NCT03478696|54736168|FG001|Overall Study|Lost to Follow-up|0|||
28082322|NCT03478696|54736167|FG000|Overall Study|Physician Decision|6|||
28082323|NCT03478696|54736168|FG001|Overall Study|Physician Decision|3|||
28082324|NCT03478696|54736167|FG000|Overall Study|Withdrawal by Subject|9|||
28082325|NCT03478696|54736168|FG001|Overall Study|Withdrawal by Subject|4|||
28082326|NCT03477838|54736174|FG000|Overall Study|Lost to Follow-up|14|||
28082327|NCT00072176|54736180|FG000|Overall Study|Withdrawal by Subject|1|||
28082328|NCT00072176|54736181|FG001|Overall Study|Withdrawal by Subject|0|||
28082329|NCT00072176|54736180|FG000|Overall Study|Protocol Violation|0|||
28082330|NCT00072176|54736181|FG001|Overall Study|Protocol Violation|1|||
28082331|NCT00071396|54736187|FG000|Overall Study|Withdrawal by Subject|1|||
28082332|NCT00071396|54736187|FG000|Overall Study|Physician Decision|2|||
28082333|NCT03473236|54736201|FG000|Overall Study|Withdrawal by Subject|0|||
28082334|NCT03473236|54736202|FG001|Overall Study|Withdrawal by Subject|0|||
28082335|NCT03473236|54736203|FG002|Overall Study|Withdrawal by Subject|0|||
28082336|NCT03473236|54736204|FG003|Overall Study|Withdrawal by Subject|0|||
28082337|NCT03473236|54736205|FG004|Overall Study|Withdrawal by Subject|0|||
28082338|NCT03473236|54736206|FG005|Overall Study|Withdrawal by Subject|1|||
27960753|NCT01094288|54617949|FG007|Overall Study|Ongoing Participants|0|||
27960754|NCT00874120|54617973|FG000|First Intervention|Adverse Event|0|||
27960755|NCT00874120|54617974|FG001|First Intervention|Adverse Event|1|||
27960756|NCT00874120|54617973|FG000|First Intervention|Withdrawal by Subject|2|||
27960757|NCT00874120|54617974|FG001|First Intervention|Withdrawal by Subject|0|||
27960758|NCT00874120|54617973|FG000|First Intervention|Lost to Follow-up|0|||
27960759|NCT00874120|54617974|FG001|First Intervention|Lost to Follow-up|1|||
27960760|NCT00874120|54617973|FG000|First Intervention|Protocol Violation|3|||
27960761|NCT00874120|54617974|FG001|First Intervention|Protocol Violation|0|||
27960762|NCT00874120|54617973|FG000|First Intervention|positive drug test|1|||
27960763|NCT00874120|54617974|FG001|First Intervention|positive drug test|0|||
27960764|NCT00874120|54617973|FG000|Second Intervention|Withdrawal by Subject|1|||
27960765|NCT00874120|54617974|FG001|Second Intervention|Withdrawal by Subject|0|||
27960766|NCT00874120|54617973|FG000|Second Intervention|Protocol Violation|1|||
27960767|NCT00874120|54617974|FG001|Second Intervention|Protocol Violation|0|||
27960768|NCT00939822|54617982|FG000|Overall Study|Lost to Follow-up|1|||
27960769|NCT00939822|54617983|FG001|Overall Study|Lost to Follow-up|0|||
27960770|NCT00939822|54617982|FG000|Overall Study|withdrew from study due to busy schedule|1|||
27960771|NCT00939822|54617983|FG001|Overall Study|withdrew from study due to busy schedule|1|||
27960772|NCT00939822|54617982|FG000|Overall Study|Mental health issues|0|||
27960773|NCT00939822|54617983|FG001|Overall Study|Mental health issues|2|||
27960774|NCT00939510|54617989|FG000|Overall Study|Withdrawal by Subject|1|||
27960775|NCT01098266|54617995|FG000|Overall Study|Physician Decision|1|||
27960776|NCT01098266|54617996|FG001|Overall Study|Physician Decision|0|||
27960777|NCT01098266|54617995|FG000|Overall Study|Death|3|||
27960778|NCT01098266|54617996|FG001|Overall Study|Death|2|||
27960779|NCT01098266|54617995|FG000|Overall Study|Withdrawal by Subject|3|||
27960780|NCT01098266|54617996|FG001|Overall Study|Withdrawal by Subject|5|||
27960781|NCT00935532|54618004|FG000|Overall Study|Adverse Event|11|||
27960782|NCT00935532|54618005|FG001|Overall Study|Adverse Event|6|||
27960783|NCT00935532|54618004|FG000|Overall Study|Death|1|||
27960784|NCT00935532|54618005|FG001|Overall Study|Death|0|||
27960785|NCT00935532|54618004|FG000|Overall Study|Lost to Follow-up|1|||
27960786|NCT00935532|54618005|FG001|Overall Study|Lost to Follow-up|0|||
27960787|NCT00935532|54618004|FG000|Overall Study|Physician Decision|1|||
27960788|NCT00935532|54618005|FG001|Overall Study|Physician Decision|2|||
27960789|NCT00935532|54618004|FG000|Overall Study|Protocol Violation|2|||
27960790|NCT00935532|54618005|FG001|Overall Study|Protocol Violation|1|||
27960791|NCT00935532|54618004|FG000|Overall Study|Subject Decision|2|||
27960792|NCT00935532|54618005|FG001|Overall Study|Subject Decision|1|||
28082339|NCT03473236|54736207|FG006|Overall Study|Withdrawal by Subject|0|||
28082340|NCT03473236|54736208|FG007|Overall Study|Withdrawal by Subject|0|||
28082341|NCT03473236|54736209|FG008|Overall Study|Withdrawal by Subject|1|||
28082342|NCT03473236|54736210|FG009|Overall Study|Withdrawal by Subject|0|||
28082343|NCT03550378|54736242|FG000|Overall Study|Death|0|||
28082344|NCT03550378|54736243|FG001|Overall Study|Death|1|||
28082345|NCT03472534|54736250|FG000|Overall Study|Withdrawal by Subject|9|||
27960793|NCT00935532|54618004|FG000|Overall Study|Sponsor Decision|0|||
27960794|NCT00935532|54618005|FG001|Overall Study|Sponsor Decision|1|||
27960795|NCT00935532|54618004|FG000|Overall Study|Loss Glucose Control|4|||
27960796|NCT00935532|54618005|FG001|Overall Study|Loss Glucose Control|0|||
27960797|NCT01093586|54618011|FG000|Overall Study|Failed to engraft|3|||
27960798|NCT00937404|54618015|FG000|Overall Study|Protocol Violation|1|||
27960799|NCT00937404|54618015|FG000|Overall Study|Withdrawal by Subject|1|||
28082346|NCT03472534|54736250|FG000|Overall Study|Adverse Event|2|||
28082347|NCT03549130|54736256|FG000|Overall Study|Adverse Event|0|||
27960800|NCT01098110|54618022|FG000|Overall Study|Withdrawal by Subject|14|||
27960801|NCT01098110|54618023|FG001|Overall Study|Withdrawal by Subject|24|||
27960802|NCT01098110|54618024|FG002|Overall Study|Withdrawal by Subject|19|||
27960803|NCT01098110|54618022|FG000|Overall Study|Adverse Event|30|||
27960804|NCT01098110|54618023|FG001|Overall Study|Adverse Event|32|||
27960805|NCT01098110|54618024|FG002|Overall Study|Adverse Event|43|||
27960806|NCT01098110|54618022|FG000|Overall Study|Lack of Efficacy|13|||
27960807|NCT01098110|54618023|FG001|Overall Study|Lack of Efficacy|9|||
27960808|NCT01098110|54618024|FG002|Overall Study|Lack of Efficacy|27|||
27960809|NCT01098110|54618022|FG000|Overall Study|Other|4|||
27960810|NCT01098110|54618023|FG001|Overall Study|Other|7|||
27960811|NCT01098110|54618024|FG002|Overall Study|Other|5|||
27960812|NCT01098110|54618022|FG000|Overall Study|Untreated|1|||
27960813|NCT01098110|54618023|FG001|Overall Study|Untreated|1|||
27960814|NCT01098110|54618024|FG002|Overall Study|Untreated|0|||
27960815|NCT01092728|54618034|FG000|Overall Study|Withdrawal by Subject|2|||
27960816|NCT01092728|54618035|FG001|Overall Study|Withdrawal by Subject|0|||
27960817|NCT01092728|54618034|FG000|Overall Study|Adverse Event|0|||
27960818|NCT01092728|54618035|FG001|Overall Study|Adverse Event|1|||
27960819|NCT01092728|54618034|FG000|Overall Study|Disease Progression|1|||
27960820|NCT01092728|54618035|FG001|Overall Study|Disease Progression|13|||
27960821|NCT01092728|54618034|FG000|Overall Study|Prohibited Concomitant Medications|1|||
27960822|NCT01092728|54618035|FG001|Overall Study|Prohibited Concomitant Medications|0|||
27960823|NCT01096550|54618043|FG000|Overall Study|discontinued site|10|||
27960824|NCT01096550|54618044|FG001|Overall Study|discontinued site|11|||
27960825|NCT01096550|54618043|FG000|Overall Study|non-regular treatment track at clinic|1|||
27960826|NCT01096550|54618044|FG001|Overall Study|non-regular treatment track at clinic|1|||
27960827|NCT01096550|54618043|FG000|Overall Study|clinic readmission|1|||
27960828|NCT01096550|54618044|FG001|Overall Study|clinic readmission|1|||
27960829|NCT01096550|54618043|FG000|Overall Study|Withdrawal by Subject|0|||
27960830|NCT01096550|54618044|FG001|Overall Study|Withdrawal by Subject|1|||
27960831|NCT01096550|54618043|FG000|Overall Study|non-African American participant|13|||
27960832|NCT01096550|54618044|FG001|Overall Study|non-African American participant|6|||
27960833|NCT01096550|54618043|FG000|Overall Study|Lost to Follow-up|12|||
27960834|NCT01096550|54618044|FG001|Overall Study|Lost to Follow-up|9|||
27960835|NCT01101542|54618050|FG000|Year 3 Surveillance Period|Lost to Follow-up|7|||
27960836|NCT01101542|54618050|FG000|Year 3 Surveillance Period|Withdrawal by Subject|4|||
27960837|NCT01101542|54618050|FG000|Year 4 Surveillance Period|Other|287|||
27960838|NCT01101542|54618050|FG000|Year 5 Surveillance Period|Lost to Follow-up|140|||
27960839|NCT01101542|54618050|FG000|Year 5 Surveillance Period|Pregnancy|1|||
27960840|NCT01101542|54618050|FG000|Year 6 Surveillance Period|Lost to Follow-up|986|||
27960841|NCT01101542|54618050|FG000|Year 6 Surveillance Period|Pregnancy|1|||
27960842|NCT01101542|54618050|FG000|Year 6 Surveillance Period|Withdrawal by Subject|4|||
27960843|NCT00937326|54618059|FG000|Overall Study|Adverse Event|0|||
27960844|NCT00937326|54618060|FG001|Overall Study|Adverse Event|3|||
27960845|NCT00937326|54618061|FG002|Overall Study|Adverse Event|1|||
27960846|NCT00937326|54618062|FG003|Overall Study|Adverse Event|1|||
27960847|NCT00937326|54618063|FG004|Overall Study|Adverse Event|2|||
27960848|NCT00937326|54618059|FG000|Overall Study|Death|0|||
27960849|NCT00937326|54618060|FG001|Overall Study|Death|0|||
27960850|NCT00937326|54618061|FG002|Overall Study|Death|1|||
27960851|NCT00937326|54618062|FG003|Overall Study|Death|0|||
27960852|NCT00937326|54618063|FG004|Overall Study|Death|0|||
27960853|NCT00937326|54618059|FG000|Overall Study|Withdrawal by Subject|3|||
27960854|NCT00937326|54618060|FG001|Overall Study|Withdrawal by Subject|4|||
27960855|NCT00937326|54618061|FG002|Overall Study|Withdrawal by Subject|1|||
28082348|NCT03549130|54736257|FG001|Overall Study|Adverse Event|1|||
28082349|NCT03549130|54736256|FG000|Overall Study|Lost to Follow-up|0|||
28082350|NCT03549130|54736257|FG001|Overall Study|Lost to Follow-up|1|||
27960856|NCT00937326|54618062|FG003|Overall Study|Withdrawal by Subject|4|||
27960857|NCT00937326|54618063|FG004|Overall Study|Withdrawal by Subject|3|||
27960858|NCT00937326|54618059|FG000|Overall Study|Chest X-ray showed a suspicious shadow|0|||
27960859|NCT00937326|54618060|FG001|Overall Study|Chest X-ray showed a suspicious shadow|0|||
27960860|NCT00937326|54618061|FG002|Overall Study|Chest X-ray showed a suspicious shadow|1|||
27960861|NCT00937326|54618062|FG003|Overall Study|Chest X-ray showed a suspicious shadow|0|||
27960862|NCT00937326|54618063|FG004|Overall Study|Chest X-ray showed a suspicious shadow|0|||
27960863|NCT00873730|54618082|FG000|Overall Study|Protocol Deviation|5|||
27960864|NCT00873730|54618083|FG001|Overall Study|Protocol Deviation|2|||
27960865|NCT00873730|54618082|FG000|Overall Study|Adverse Event|0|||
27960866|NCT00873730|54618083|FG001|Overall Study|Adverse Event|2|||
27960867|NCT00873730|54618082|FG000|Overall Study|Withdrawal by Subject|0|||
27732442|NCT00109967|54179974|FG001|Overall Study|Physician Decision|3|||
27960868|NCT00873730|54618083|FG001|Overall Study|Withdrawal by Subject|1|||
27960869|NCT00873730|54618082|FG000|Overall Study|Sponsor decision|1|||
27960870|NCT00873730|54618083|FG001|Overall Study|Sponsor decision|0|||
27960871|NCT00874432|54618093|FG000|Overall Study|Withdrawal by Subject|1|||
27960872|NCT00874432|54618094|FG001|Overall Study|Withdrawal by Subject|0|||
27960873|NCT00874432|54618095|FG002|Overall Study|Withdrawal by Subject|0|||
27960874|NCT00874432|54618096|FG003|Overall Study|Withdrawal by Subject|0|||
27960875|NCT00874432|54618093|FG000|Overall Study|Physician Decision|1|||
27960876|NCT00874432|54618094|FG001|Overall Study|Physician Decision|0|||
27960877|NCT00874432|54618095|FG002|Overall Study|Physician Decision|0|||
27960878|NCT00874432|54618096|FG003|Overall Study|Physician Decision|0|||
27960879|NCT00874432|54618093|FG000|Overall Study|Other|1|||
27960880|NCT00874432|54618094|FG001|Overall Study|Other|2|||
27960881|NCT00874432|54618095|FG002|Overall Study|Other|8|||
27960882|NCT00874432|54618096|FG003|Overall Study|Other|3|||
27960883|NCT00935220|54618108|FG000|Overall Study|Adverse Event|1|||
27960884|NCT00935220|54618108|FG000|Overall Study|Other reason (not specified)|1|||
27960885|NCT00874276|54618114|FG000|Overall Study|Withdrawal by Subject|1|||
27960886|NCT00874276|54618115|FG001|Overall Study|Withdrawal by Subject|1|||
27960887|NCT00594958|54618126|FG000|Overall Study|Withdrawal by Subject|1|||
27960888|NCT00594958|54618127|FG001|Overall Study|Withdrawal by Subject|0|||
27960889|NCT00594958|54618128|FG002|Overall Study|Withdrawal by Subject|1|||
27960890|NCT00594958|54618126|FG000|Overall Study|Adverse Event|4|||
27960891|NCT00594958|54618127|FG001|Overall Study|Adverse Event|1|||
27960892|NCT00594958|54618128|FG002|Overall Study|Adverse Event|2|||
27960893|NCT00594958|54618126|FG000|Overall Study|Pregnancy|0|||
27960894|NCT00594958|54618127|FG001|Overall Study|Pregnancy|2|||
27960895|NCT00594958|54618128|FG002|Overall Study|Pregnancy|0|||
27960896|NCT00594958|54618126|FG000|Overall Study|Protocol Violation|1|||
27960897|NCT00594958|54618127|FG001|Overall Study|Protocol Violation|0|||
27960898|NCT00594958|54618128|FG002|Overall Study|Protocol Violation|2|||
27960899|NCT00594958|54618126|FG000|Overall Study|Lost to Follow-up|5|||
27960900|NCT00594958|54618127|FG001|Overall Study|Lost to Follow-up|0|||
27960901|NCT00594958|54618128|FG002|Overall Study|Lost to Follow-up|3|||
27960902|NCT00594958|54618126|FG000|Overall Study|administrative|3|||
27960903|NCT00594958|54618127|FG001|Overall Study|administrative|0|||
27960904|NCT00594958|54618128|FG002|Overall Study|administrative|2|||
27960905|NCT00594880|54618138|FG000|Overall Study|Withdrawal by Subject|1|||
27960906|NCT00594880|54618139|FG001|Overall Study|Withdrawal by Subject|1|||
27960907|NCT00594880|54618138|FG000|Overall Study|Lost to Follow-up|1|||
27960908|NCT00594880|54618139|FG001|Overall Study|Lost to Follow-up|0|||
27960909|NCT00871858|54618151|FG000|Overall Study|Protocol Violation|3|||
27960910|NCT00871858|54618152|FG001|Overall Study|Protocol Violation|4|||
27960911|NCT00871858|54618151|FG000|Overall Study|Adverse Event|1|||
27960912|NCT00871858|54618152|FG001|Overall Study|Adverse Event|1|||
27960913|NCT00871858|54618151|FG000|Overall Study|Withdrawal by Subject|1|||
27960914|NCT00871858|54618152|FG001|Overall Study|Withdrawal by Subject|1|||
27960915|NCT00871858|54618151|FG000|Overall Study|Lost to Follow-up|0|||
27960916|NCT00871858|54618152|FG001|Overall Study|Lost to Follow-up|1|||
27960917|NCT00871780|54618158|FG000|Overall Study|Enrolled But Not Treated|6|||
28082351|NCT03470194|54736267|FG000|Overall Study|Lost to Follow-up|11|||
28082352|NCT03470194|54736268|FG001|Overall Study|Lost to Follow-up|17|||
28082353|NCT03469336|54736274|FG000|Overall Study|Adverse Event|1|||
28082354|NCT03469258|54736284|FG000|Overall Study|Upon surgery, did not meet criteria|4|||
28082355|NCT03503188|54736290|FG000|Overall Study|Non eligible in the sub study|0|||
28082356|NCT03503188|54736291|FG001|Overall Study|Non eligible in the sub study|1|||
27732443|NCT00109967|54179973|FG000|Overall Study|Death|0|||
27732444|NCT00109967|54179974|FG001|Overall Study|Death|2|||
27732445|NCT02579096|54179982|FG000|Phase 1, Weeks 0 - 24|Side effects with study medications|10|||
27732446|NCT02579096|54179983|FG001|Phase 1, Weeks 0 - 24|Side effects with study medications|6|||
27732447|NCT02579096|54179982|FG000|Phase 1, Weeks 0 - 24|Physician Decision|2|||
27732448|NCT02579096|54179983|FG001|Phase 1, Weeks 0 - 24|Physician Decision|1|||
27732449|NCT02579096|54179982|FG000|Phase 1, Weeks 0 - 24|Withdrawal by Subject|32|||
27960918|NCT00871780|54618158|FG000|Overall Study|Withdrawal by Subject|9|||
27960919|NCT00871780|54618158|FG000|Overall Study|Adverse Event|6|||
27960920|NCT00871780|54618158|FG000|Overall Study|Voluntary Discontinuation|4|||
27960921|NCT00871780|54618158|FG000|Overall Study|Death|1|||
27960922|NCT00871780|54618158|FG000|Overall Study|Physician Decision|1|||
27960923|NCT00594178|54618165|FG000|Overall Study|Physician Decision|5|||
27960924|NCT00933270|54618169|FG000|Overall Study|Withdrawal by Subject|26|||
27960925|NCT00933270|54618169|FG000|Overall Study|Insufficient Follow-up|10|||
27960926|NCT00933270|54618169|FG000|Overall Study|Lost to Follow-up|14|||
27732450|NCT02579096|54179983|FG001|Phase 1, Weeks 0 - 24|Withdrawal by Subject|36|||
28082357|NCT03502798|54736299|FG000|Overall Study|equipment failure|0|||
28082358|NCT03502798|54736300|FG001|Overall Study|equipment failure|7|||
27732451|NCT02579096|54179982|FG000|Phase 1, Weeks 0 - 24|Lost to Follow-up|9|||
27960927|NCT00933270|54618169|FG000|Overall Study|Adverse Event|1|||
27960928|NCT00933270|54618169|FG000|Overall Study|Missed Visit|2|||
27960929|NCT00933270|54618169|FG000|Overall Study|Death|24|||
27960930|NCT00933270|54618169|FG000|Overall Study|Moved or would not return|10|||
27960931|NCT00936858|54618174|FG000|Overall Study|Death|3|||
27960932|NCT00936858|54618174|FG000|Overall Study|Progression|29|||
27960933|NCT00936858|54618174|FG000|Overall Study|Withdrawal by Subject|5|||
27960934|NCT00936858|54618174|FG000|Overall Study|Adverse Event|1|||
27960935|NCT00936858|54618174|FG000|Overall Study|Physician Decision|7|||
27960936|NCT00936858|54618174|FG000|Overall Study|Still on protocol treatment/ No documentation to say off protocol treatment|4|||
27960937|NCT00936858|54618174|FG000|Overall Study|Lost to Follow-up|1|||
27960938|NCT00872170|54618181|FG000|Overall Study|Adverse Event|1|||
27960939|NCT00872170|54618182|FG001|Overall Study|Adverse Event|0|||
27960940|NCT00936702|54618187|FG000|Overall Study|Disease progression|34|||
27960941|NCT00936702|54618187|FG000|Overall Study|Adverse Event|8|||
27960942|NCT00936702|54618187|FG000|Overall Study|Withdrawal by Subject|2|||
27960943|NCT00936702|54618187|FG000|Overall Study|Alternative Treatment|1|||
27960944|NCT00936702|54618187|FG000|Overall Study|Other|1|||
27960945|NCT00594100|54618191|FG000|Procedure|Technical Failure|9|||
27960946|NCT00594100|54618191|FG000|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2|||
27960947|NCT00594100|54618191|FG000|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6|||
27960948|NCT00594100|54618191|FG000|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4|||
27960949|NCT01092182|54618198|FG000|Overall Study|Death|0|||
27960950|NCT01092182|54618199|FG001|Overall Study|Death|5|||
27960951|NCT01092182|54618200|FG002|Overall Study|Death|3|||
27960952|NCT01092182|54618198|FG000|Overall Study|participant safety|1|||
27960953|NCT01092182|54618199|FG001|Overall Study|participant safety|2|||
27960954|NCT01092182|54618200|FG002|Overall Study|participant safety|0|||
27960955|NCT01092182|54618198|FG000|Overall Study|Physician Decision|0|||
27960956|NCT01092182|54618199|FG001|Overall Study|Physician Decision|6|||
27960957|NCT01092182|54618200|FG002|Overall Study|Physician Decision|0|||
27960958|NCT01092182|54618198|FG000|Overall Study|Did not meet criteria|0|||
27960959|NCT01092182|54618199|FG001|Overall Study|Did not meet criteria|0|||
27960960|NCT01092182|54618200|FG002|Overall Study|Did not meet criteria|25|||
27960961|NCT01092182|54618198|FG000|Overall Study|Non-compliance|0|||
27960962|NCT01092182|54618199|FG001|Overall Study|Non-compliance|3|||
27960963|NCT01092182|54618200|FG002|Overall Study|Non-compliance|0|||
27960964|NCT01092182|54618198|FG000|Overall Study|Participant refused follow-up|0|||
27960965|NCT01092182|54618199|FG001|Overall Study|Participant refused follow-up|2|||
27960966|NCT01092182|54618200|FG002|Overall Study|Participant refused follow-up|0|||
27960967|NCT00932646|54618208|FG000|Overall Study|Adverse Event|2|||
27960968|NCT00932646|54618209|FG001|Overall Study|Adverse Event|1|||
27960969|NCT00932646|54618210|FG002|Overall Study|Adverse Event|1|||
27960970|NCT00932646|54618211|FG003|Overall Study|Adverse Event|1|||
27960971|NCT00932646|54618208|FG000|Overall Study|Lost to Follow-up|2|||
27960972|NCT00932646|54618209|FG001|Overall Study|Lost to Follow-up|1|||
27960973|NCT00932646|54618210|FG002|Overall Study|Lost to Follow-up|0|||
27960974|NCT00932646|54618211|FG003|Overall Study|Lost to Follow-up|0|||
27960975|NCT00932646|54618208|FG000|Overall Study|Withdrawal by Subject|1|||
27960976|NCT00932646|54618209|FG001|Overall Study|Withdrawal by Subject|1|||
27960977|NCT00932646|54618210|FG002|Overall Study|Withdrawal by Subject|3|||
27960978|NCT00932646|54618211|FG003|Overall Study|Withdrawal by Subject|0|||
27960979|NCT00871234|54618225|FG000|Overall Study|Adverse Event|2|||
27960980|NCT00871234|54618225|FG000|Overall Study|Lost to Follow-up|3|||
27960981|NCT01091246|54618232|FG000|Overall Study|Lost to Follow-up|23|||
27960982|NCT01091246|54618233|FG001|Overall Study|Lost to Follow-up|11|||
27960983|NCT01091246|54618234|FG002|Overall Study|Lost to Follow-up|7|||
27960984|NCT01091246|54618232|FG000|Overall Study|Adverse Event|1|||
27960985|NCT01091246|54618233|FG001|Overall Study|Adverse Event|0|||
27960986|NCT01091246|54618234|FG002|Overall Study|Adverse Event|1|||
27960987|NCT01091246|54618232|FG000|Overall Study|Withdrawal by Subject|9|||
27960988|NCT01091246|54618233|FG001|Overall Study|Withdrawal by Subject|5|||
27960989|NCT01091246|54618234|FG002|Overall Study|Withdrawal by Subject|4|||
27960990|NCT01091246|54618232|FG000|Overall Study|Subject not dosed|2|||
27960991|NCT01091246|54618233|FG001|Overall Study|Subject not dosed|0|||
27960992|NCT01091246|54618234|FG002|Overall Study|Subject not dosed|1|||
27960993|NCT01097330|54618246|FG000|Overall Study|Study terminated early|7|||
27960994|NCT01097330|54618247|FG001|Overall Study|Study terminated early|5|||
27960995|NCT00934440|54618253|FG000|Overall Study|Lost to Follow-up|1|||
27960996|NCT00934362|54618260|FG000|Overall Study|Adverse Event|1|||
27960997|NCT00934362|54618261|FG001|Overall Study|Adverse Event|0|||
27960998|NCT00934128|54618269|FG000|First Intervention (2 Hours)|Withdrawal by Subject|0|||
27960999|NCT00934128|54618270|FG001|First Intervention (2 Hours)|Withdrawal by Subject|1|||
27961000|NCT00934128|54618269|FG000|First Intervention (2 Hours)|Adverse Event|4|||
27961001|NCT00934128|54618270|FG001|First Intervention (2 Hours)|Adverse Event|1|||
27961002|NCT00934128|54618269|FG000|First Intervention (2 Hours)|Treatment Delivery Order Switched|1|||
27961003|NCT00934128|54618270|FG001|First Intervention (2 Hours)|Treatment Delivery Order Switched|0|||
27961004|NCT00934128|54618269|FG000|Washout Period (1 Hour)|Patient preference|1|||
27961005|NCT00934128|54618270|FG001|Washout Period (1 Hour)|Patient preference|3|||
27961006|NCT00934128|54618269|FG000|Washout Period (1 Hour)|Pain|1|||
27961007|NCT00934128|54618270|FG001|Washout Period (1 Hour)|Pain|0|||
27961008|NCT00934128|54618269|FG000|Washout Period (1 Hour)|Too tired|1|||
27961009|NCT00934128|54618270|FG001|Washout Period (1 Hour)|Too tired|0|||
27961010|NCT00934128|54618269|FG000|Washout Period (1 Hour)|Dyspnea too low to continue|4|||
27961011|NCT00934128|54618270|FG001|Washout Period (1 Hour)|Dyspnea too low to continue|2|||
27961012|NCT00934128|54618269|FG000|Second Intervention (2 Hours)|Claustrophobia/anxiety|0|||
27961013|NCT00934128|54618270|FG001|Second Intervention (2 Hours)|Claustrophobia/anxiety|3|||
27961014|NCT00871000|54618278|FG000|Overall Study|Withdrawal by Subject|1|||
27961015|NCT00871000|54618279|FG001|Overall Study|Withdrawal by Subject|0|||
27961016|NCT01096784|54618287|FG000|Overall Study|Withdrawal by Subject|2|||
28082359|NCT00066170|54736310|FG000|Overall Study|Adverse Event|2|||
28082360|NCT00066170|54736311|FG001|Overall Study|Adverse Event|4|||
28082361|NCT00066170|54736312|FG002|Overall Study|Adverse Event|1|||
28082362|NCT00066170|54736313|FG003|Overall Study|Adverse Event|7|||
28082363|NCT00066170|54736310|FG000|Overall Study|Serious Adverse Event|0|||
28082364|NCT00066170|54736311|FG001|Overall Study|Serious Adverse Event|0|||
28082365|NCT00066170|54736312|FG002|Overall Study|Serious Adverse Event|1|||
28082366|NCT00066170|54736313|FG003|Overall Study|Serious Adverse Event|1|||
28082367|NCT00066170|54736310|FG000|Overall Study|Lost to Follow-up|0|||
28082368|NCT00066170|54736311|FG001|Overall Study|Lost to Follow-up|1|||
28082369|NCT00066170|54736312|FG002|Overall Study|Lost to Follow-up|0|||
28082370|NCT00066170|54736313|FG003|Overall Study|Lost to Follow-up|0|||
28082371|NCT00066170|54736310|FG000|Overall Study|Non-Compliance with Trial Medicine|1|||
28082372|NCT00066170|54736311|FG001|Overall Study|Non-Compliance with Trial Medicine|0|||
28082373|NCT00066170|54736312|FG002|Overall Study|Non-Compliance with Trial Medicine|0|||
28082374|NCT00066170|54736313|FG003|Overall Study|Non-Compliance with Trial Medicine|1|||
27961017|NCT01096784|54618288|FG001|Overall Study|Withdrawal by Subject|1|||
27961018|NCT01096784|54618287|FG000|Overall Study|Adverse Event|11|||
27961019|NCT01096784|54618288|FG001|Overall Study|Adverse Event|9|||
27961020|NCT01096784|54618287|FG000|Overall Study|Protocol Deviation|2|||
27961021|NCT01096784|54618288|FG001|Overall Study|Protocol Deviation|2|||
27961022|NCT01096784|54618287|FG000|Overall Study|Administrative Decision|0|||
27961023|NCT01096784|54618288|FG001|Overall Study|Administrative Decision|1|||
27961024|NCT01096784|54618287|FG000|Overall Study|Other Unspecified|0|||
27961025|NCT01096784|54618288|FG001|Overall Study|Other Unspecified|1|||
27961026|NCT00934050|54618302|FG000|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
27961027|NCT00934050|54618303|FG001|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
27961028|NCT00934050|54618304|FG002|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
27961029|NCT00934050|54618305|FG003|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
27961030|NCT00934050|54618306|FG004|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
28082375|NCT00066170|54736310|FG000|Overall Study|Protocol Violation|3|||
28082376|NCT00066170|54736311|FG001|Overall Study|Protocol Violation|0|||
28082377|NCT00066170|54736312|FG002|Overall Study|Protocol Violation|0|||
27732452|NCT02579096|54179983|FG001|Phase 1, Weeks 0 - 24|Lost to Follow-up|4|||
27961031|NCT00934050|54618307|FG005|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
27961032|NCT00934050|54618302|FG000|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
27961033|NCT00934050|54618303|FG001|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12|||
27961034|NCT00934050|54618304|FG002|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
27961035|NCT00934050|54618305|FG003|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13|||
27961036|NCT00934050|54618306|FG004|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
27961037|NCT00934050|54618307|FG005|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
27961038|NCT00934050|54618302|FG000|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
27961039|NCT00934050|54618303|FG001|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
27961040|NCT00934050|54618304|FG002|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1|||
27961041|NCT00934050|54618305|FG003|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
27961042|NCT00934050|54618306|FG004|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
27961043|NCT00934050|54618307|FG005|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
27961044|NCT00934050|54618302|FG000|Enrolled After 15 Dec 2009|Adverse Event|0|||
27961045|NCT00934050|54618303|FG001|Enrolled After 15 Dec 2009|Adverse Event|0|||
27961046|NCT00934050|54618304|FG002|Enrolled After 15 Dec 2009|Adverse Event|0|||
27961047|NCT00934050|54618305|FG003|Enrolled After 15 Dec 2009|Adverse Event|0|||
27961048|NCT00934050|54618306|FG004|Enrolled After 15 Dec 2009|Adverse Event|3|||
27961049|NCT00934050|54618307|FG005|Enrolled After 15 Dec 2009|Adverse Event|0|||
27961050|NCT00934050|54618302|FG000|Enrolled After 15 Dec 2009|Death|0|||
27961051|NCT00934050|54618303|FG001|Enrolled After 15 Dec 2009|Death|0|||
27961052|NCT00934050|54618304|FG002|Enrolled After 15 Dec 2009|Death|0|||
27961053|NCT00934050|54618305|FG003|Enrolled After 15 Dec 2009|Death|0|||
27961054|NCT00934050|54618306|FG004|Enrolled After 15 Dec 2009|Death|0|||
27961055|NCT00934050|54618307|FG005|Enrolled After 15 Dec 2009|Death|1|||
27961056|NCT00934050|54618302|FG000|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
27961057|NCT00934050|54618303|FG001|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
27961058|NCT00934050|54618304|FG002|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
27961059|NCT00934050|54618305|FG003|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
28082378|NCT00066170|54736313|FG003|Overall Study|Protocol Violation|0|||
28082379|NCT00066170|54736310|FG000|Overall Study|Other|1|||
28082380|NCT00066170|54736311|FG001|Overall Study|Other|5|||
28082381|NCT00066170|54736312|FG002|Overall Study|Other|2|||
28082382|NCT00066170|54736313|FG003|Overall Study|Other|0|||
27732453|NCT02579096|54179982|FG000|Phase 1, Weeks 0 - 24|Other reasons|4|||
27961060|NCT00934050|54618306|FG004|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
27961061|NCT00934050|54618307|FG005|Enrolled After 15 Dec 2009|Lost to Follow-up|1|||
27961062|NCT00934050|54618302|FG000|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
27961063|NCT00934050|54618303|FG001|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
27961064|NCT00934050|54618304|FG002|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
27961065|NCT00934050|54618305|FG003|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
27961066|NCT00934050|54618306|FG004|Enrolled After 15 Dec 2009|Withdrawal by Subject|4|||
27961067|NCT00934050|54618307|FG005|Enrolled After 15 Dec 2009|Withdrawal by Subject|2|||
27961068|NCT01091168|54618319|FG000|Overall Study|Progressive disease|250|||
27961069|NCT01091168|54618320|FG001|Overall Study|Progressive disease|234|||
27961070|NCT01091168|54618319|FG000|Overall Study|Adverse Event|21|||
27961071|NCT01091168|54618320|FG001|Overall Study|Adverse Event|24|||
27961072|NCT01091168|54618319|FG000|Overall Study|Lost to Follow-up|0|||
27961073|NCT01091168|54618320|FG001|Overall Study|Lost to Follow-up|1|||
27961074|NCT01091168|54618319|FG000|Overall Study|Physician, patient's decision, other|27|||
27961075|NCT01091168|54618320|FG001|Overall Study|Physician, patient's decision, other|37|||
27961076|NCT00864916|54618328|FG000|Overall Study|Lost to Follow-up|4|||
27961077|NCT00864916|54618329|FG001|Overall Study|Lost to Follow-up|4|||
27961078|NCT00864916|54618328|FG000|Overall Study|Protocol Violation|1|||
27961079|NCT00864916|54618329|FG001|Overall Study|Protocol Violation|0|||
27961080|NCT00864916|54618328|FG000|Overall Study|Withdrawal by Subject|1|||
27961081|NCT00864916|54618329|FG001|Overall Study|Withdrawal by Subject|0|||
27961082|NCT00864682|54618338|FG000|Overall Study|Protocol Violation|2|||
27961083|NCT00864682|54618339|FG001|Overall Study|Protocol Violation|1|||
27961084|NCT00864682|54618340|FG002|Overall Study|Protocol Violation|2|||
27961085|NCT00931944|54618348|FG000|Overall Study|Adverse Event|4|||
27961086|NCT00931944|54618348|FG000|Overall Study|W/D Consent (due to ALS progression))|19|||
27961087|NCT00931944|54618348|FG000|Overall Study|Withdrawal Consent (due to other)|2|||
27961088|NCT00931944|54618348|FG000|Overall Study|Death|28|||
27961089|NCT00931944|54618348|FG000|Overall Study|Other|2|||
27961090|NCT00929994|54618352|FG000|Overall Study|Withdrawal by Subject|1|||
27961091|NCT00929994|54618352|FG000|Overall Study|medical issue unrelated to intervention|4|||
27961092|NCT00929994|54618352|FG000|Overall Study|employment|1|||
27961093|NCT01090310|54618363|FG000|Core Study|Adverse Event|2|||
27961094|NCT01090310|54618364|FG001|Core Study|Adverse Event|2|||
27961095|NCT01090310|54618365|FG002|Core Study|Adverse Event|1|||
27961096|NCT01090310|54618366|FG003|Core Study|Adverse Event|1|||
27961097|NCT01090310|54618363|FG000|Core Study|Subject withdrew consent|0|||
27961098|NCT01090310|54618364|FG001|Core Study|Subject withdrew consent|3|||
27961099|NCT01090310|54618365|FG002|Core Study|Subject withdrew consent|1|||
27961100|NCT01090310|54618366|FG003|Core Study|Subject withdrew consent|1|||
27961101|NCT01090310|54618363|FG000|Core Study|Abnormal test procedure result|0|||
27961102|NCT01090310|54618364|FG001|Core Study|Abnormal test procedure result|0|||
27961103|NCT01090310|54618365|FG002|Core Study|Abnormal test procedure result|1|||
27961104|NCT01090310|54618366|FG003|Core Study|Abnormal test procedure result|0|||
27961105|NCT01090310|54618363|FG000|Core Study|Administrative reasons|5|||
27961106|NCT01090310|54618364|FG001|Core Study|Administrative reasons|6|||
27961107|NCT01090310|54618365|FG002|Core Study|Administrative reasons|4|||
27961108|NCT01090310|54618366|FG003|Core Study|Administrative reasons|4|||
27961109|NCT01090310|54618363|FG000|Core Study|Protocol deviation|1|||
27961110|NCT01090310|54618364|FG001|Core Study|Protocol deviation|0|||
27961111|NCT01090310|54618365|FG002|Core Study|Protocol deviation|0|||
27961112|NCT01090310|54618366|FG003|Core Study|Protocol deviation|1|||
27961113|NCT01090310|54618363|FG000|Extension Study|Aministrative problems|13|||
27961114|NCT01090310|54618364|FG001|Extension Study|Aministrative problems|15|||
27961115|NCT01090310|54618365|FG002|Extension Study|Aministrative problems|14|||
27961116|NCT01090310|54618366|FG003|Extension Study|Aministrative problems|18|||
27961117|NCT01090310|54618363|FG000|Extension Study|Adverse Event|0|||
27961118|NCT01090310|54618364|FG001|Extension Study|Adverse Event|0|||
27961119|NCT01090310|54618365|FG002|Extension Study|Adverse Event|0|||
27961120|NCT01090310|54618366|FG003|Extension Study|Adverse Event|1|||
27961121|NCT01090310|54618363|FG000|Extension Study|Unsatisfactory therapeutic effect|1|||
27961122|NCT01090310|54618364|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
27961123|NCT01090310|54618365|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
27961124|NCT01090310|54618366|FG003|Extension Study|Unsatisfactory therapeutic effect|1|||
27961125|NCT01090310|54618363|FG000|Extension Study|Subject withdrew consent|0|||
27961126|NCT01090310|54618364|FG001|Extension Study|Subject withdrew consent|1|||
27961127|NCT01090310|54618365|FG002|Extension Study|Subject withdrew consent|0|||
27961128|NCT01090310|54618366|FG003|Extension Study|Subject withdrew consent|0|||
27961129|NCT01090076|54618378|FG000|Overall Study|Death|1|||
27961130|NCT01090076|54618379|FG001|Overall Study|Death|1|||
27961131|NCT01090076|54618378|FG000|Overall Study|Withdrawal by Subject|0|||
27961132|NCT01090076|54618379|FG001|Overall Study|Withdrawal by Subject|1|||
27961133|NCT00869050|54618387|FG000|Overall Study|Screen Failure|3|||
27961134|NCT00927186|54618393|FG000|12 Months Primary Study|Adverse Event|5|||
27961135|NCT00927186|54618394|FG001|12 Months Primary Study|Adverse Event|2|||
27961136|NCT00927186|54618393|FG000|12 Months Primary Study|Lost to Follow-up|1|||
27961137|NCT00927186|54618394|FG001|12 Months Primary Study|Lost to Follow-up|0|||
27961138|NCT00927186|54618393|FG000|12 Months Primary Study|Protocol Violation|0|||
27961139|NCT00927186|54618394|FG001|12 Months Primary Study|Protocol Violation|1|||
27961140|NCT00927186|54618393|FG000|12 Months Primary Study|Withdrawal by Subject|1|||
27961141|NCT00927186|54618394|FG001|12 Months Primary Study|Withdrawal by Subject|1|||
27961142|NCT00593554|54618405|FG000|Overall Study|Death|1|||
27961143|NCT00593554|54618406|FG001|Overall Study|Death|2|||
27961144|NCT00593554|54618405|FG000|Overall Study|Physician Decision|0|||
27961145|NCT00593554|54618406|FG001|Overall Study|Physician Decision|1|||
27961146|NCT00593554|54618405|FG000|Overall Study|Withdrawal by Subject|1|||
27961147|NCT00593554|54618406|FG001|Overall Study|Withdrawal by Subject|0|||
27961148|NCT00593554|54618405|FG000|Overall Study|Disease Progression|1|||
27961149|NCT00593554|54618406|FG001|Overall Study|Disease Progression|2|||
27961150|NCT01101308|54618412|FG000|Period 1|Adverse Event|2|||
27961151|NCT01101308|54618413|FG001|Period 1|Adverse Event|1|||
27961152|NCT01101308|54618412|FG000|Period 1|Positive for cotinine|1|||
27961153|NCT01101308|54618413|FG001|Period 1|Positive for cotinine|0|||
27961154|NCT00926796|54618422|FG000|Overall Study|Did not receive randomized treatment|4|||
27961155|NCT00926796|54618423|FG001|Overall Study|Did not receive randomized treatment|7|||
27961156|NCT00926796|54618422|FG000|Overall Study|Ineligible, negative for gonorrhea|57|||
27961157|NCT00926796|54618423|FG001|Overall Study|Ineligible, negative for gonorrhea|60|||
27961158|NCT00926796|54618422|FG000|Overall Study|Ineligible, but positive for gonorrhea|1|||
27961159|NCT00926796|54618423|FG001|Overall Study|Ineligible, but positive for gonorrhea|1|||
27961160|NCT00926796|54618422|FG000|Overall Study|Adverse Event|7|||
27961161|NCT00926796|54618423|FG001|Overall Study|Adverse Event|14|||
27961162|NCT00926796|54618422|FG000|Overall Study|Lost to Follow-up|22|||
27961163|NCT00926796|54618423|FG001|Overall Study|Lost to Follow-up|13|||
27961164|NCT00926796|54618422|FG000|Overall Study|Protocol Violation|15|||
27961165|NCT00926796|54618423|FG001|Overall Study|Protocol Violation|11|||
27961166|NCT00926796|54618422|FG000|Overall Study|Withdrawal by Subject|1|||
27961167|NCT00926796|54618423|FG001|Overall Study|Withdrawal by Subject|0|||
27961168|NCT01087736|54618433|FG000|Overall Study|Lost to Follow-up|1|||
27961169|NCT01087736|54618434|FG001|Overall Study|Lost to Follow-up|0|||
27961170|NCT01087736|54618433|FG000|Overall Study|Death|0|||
27961171|NCT01087736|54618434|FG001|Overall Study|Death|1|||
27961172|NCT01087736|54618433|FG000|Overall Study|Withdrawal by Subject|0|||
27961173|NCT01087736|54618434|FG001|Overall Study|Withdrawal by Subject|1|||
27961174|NCT01079936|54618444|FG000|Phase I: MTD|First Remission Status|2|||
27961175|NCT01079936|54618445|FG001|Phase I: MTD|First Remission Status|0|||
27961176|NCT01079936|54618446|FG002|Phase I: MTD|First Remission Status|0|||
27961177|NCT01079936|54618447|FG003|Phase I: MTD|First Remission Status|0|||
27961178|NCT01079936|54618448|FG004|Phase I: MTD|First Remission Status|0|||
27961179|NCT01079936|54618444|FG000|Phase I: MTD|No Stem Cell Transplantation|2|||
27961180|NCT01079936|54618445|FG001|Phase I: MTD|No Stem Cell Transplantation|0|||
27961181|NCT01079936|54618446|FG002|Phase I: MTD|No Stem Cell Transplantation|0|||
27961182|NCT01079936|54618447|FG003|Phase I: MTD|No Stem Cell Transplantation|0|||
27961183|NCT01079936|54618448|FG004|Phase I: MTD|No Stem Cell Transplantation|0|||
27961184|NCT01079936|54618444|FG000|Phase II|Adverse Event|0|||
27961185|NCT01079936|54618445|FG001|Phase II|Adverse Event|0|||
27961186|NCT01079936|54618446|FG002|Phase II|Adverse Event|1|||
27961187|NCT01079936|54618447|FG003|Phase II|Adverse Event|0|||
27961188|NCT01079936|54618448|FG004|Phase II|Adverse Event|0|||
27961189|NCT01079936|54618444|FG000|Phase II|Insurance Issue|0|||
27961190|NCT01079936|54618445|FG001|Phase II|Insurance Issue|0|||
27961191|NCT01079936|54618446|FG002|Phase II|Insurance Issue|0|||
27961192|NCT01079936|54618447|FG003|Phase II|Insurance Issue|0|||
27961193|NCT01079936|54618448|FG004|Phase II|Insurance Issue|1|||
27961194|NCT00931710|54618461|FG000|Overall Study|Adverse Event|16|||
27961195|NCT00931710|54618462|FG001|Overall Study|Adverse Event|10|||
27961196|NCT00931710|54618461|FG000|Overall Study|Abnormal test procedure results|2|||
27961197|NCT00931710|54618462|FG001|Overall Study|Abnormal test procedure results|0|||
27961198|NCT00931710|54618461|FG000|Overall Study|Unsatisfactory therapeutic effects|5|||
27855132|NCT01279057|54375433|FG002|Overall Study|Pregnancy|0|||
27961199|NCT00931710|54618462|FG001|Overall Study|Unsatisfactory therapeutic effects|12|||
27961200|NCT00931710|54618461|FG000|Overall Study|Patient withdrew consent|4|||
27961201|NCT00931710|54618462|FG001|Overall Study|Patient withdrew consent|9|||
27961202|NCT00931710|54618461|FG000|Overall Study|Lost to Follow-up|6|||
27961203|NCT00931710|54618462|FG001|Overall Study|Lost to Follow-up|5|||
27961204|NCT00931710|54618461|FG000|Overall Study|Protocol deviation|1|||
27961205|NCT00931710|54618462|FG001|Overall Study|Protocol deviation|2|||
27961206|NCT01100528|54618468|FG000|Overall Study|Death|1|||
27961207|NCT01100528|54618468|FG000|Overall Study|Withdrawal by Subject|2|||
27961208|NCT01079234|54618475|FG000|Main: Week 0 to 26|Adverse Event|5|||
27961209|NCT01079234|54618476|FG001|Main: Week 0 to 26|Adverse Event|4|||
27961210|NCT01079234|54618477|FG002|Main: Week 0 to 26|Adverse Event|1|||
27961211|NCT01079234|54618478|FG003|Main: Week 0 to 26|Adverse Event|0|||
27961212|NCT01079234|54618475|FG000|Main: Week 0 to 26|Lack of Efficacy|2|||
27961213|NCT01079234|54618476|FG001|Main: Week 0 to 26|Lack of Efficacy|1|||
27961214|NCT01079234|54618477|FG002|Main: Week 0 to 26|Lack of Efficacy|1|||
27961215|NCT01079234|54618478|FG003|Main: Week 0 to 26|Lack of Efficacy|0|||
27961216|NCT01079234|54618475|FG000|Main: Week 0 to 26|Protocol Violation|6|||
27961217|NCT01079234|54618476|FG001|Main: Week 0 to 26|Protocol Violation|2|||
27961218|NCT01079234|54618477|FG002|Main: Week 0 to 26|Protocol Violation|4|||
27961219|NCT01079234|54618478|FG003|Main: Week 0 to 26|Protocol Violation|0|||
27961220|NCT01079234|54618475|FG000|Main: Week 0 to 26|Withdrawal criteria|6|||
27961221|NCT01079234|54618476|FG001|Main: Week 0 to 26|Withdrawal criteria|6|||
27961222|NCT01079234|54618477|FG002|Main: Week 0 to 26|Withdrawal criteria|2|||
27961223|NCT01079234|54618478|FG003|Main: Week 0 to 26|Withdrawal criteria|0|||
27961224|NCT01079234|54618475|FG000|Main: Week 0 to 26|Unclassified|7|||
27961225|NCT01079234|54618476|FG001|Main: Week 0 to 26|Unclassified|13|||
27961226|NCT01079234|54618477|FG002|Main: Week 0 to 26|Unclassified|4|||
27961227|NCT01079234|54618478|FG003|Main: Week 0 to 26|Unclassified|0|||
27961228|NCT01079234|54618475|FG000|Extension: Week 27 to 52|Adverse Event|0|||
27961229|NCT01079234|54618476|FG001|Extension: Week 27 to 52|Adverse Event|0|||
27961230|NCT01079234|54618477|FG002|Extension: Week 27 to 52|Adverse Event|1|||
27961231|NCT01079234|54618478|FG003|Extension: Week 27 to 52|Adverse Event|0|||
27961232|NCT01079234|54618475|FG000|Extension: Week 27 to 52|Lack of Efficacy|0|||
27961233|NCT01079234|54618476|FG001|Extension: Week 27 to 52|Lack of Efficacy|0|||
27961234|NCT01079234|54618477|FG002|Extension: Week 27 to 52|Lack of Efficacy|0|||
27961235|NCT01079234|54618478|FG003|Extension: Week 27 to 52|Lack of Efficacy|2|||
27961236|NCT01079234|54618475|FG000|Extension: Week 27 to 52|Protocol Violation|0|||
27961237|NCT01079234|54618476|FG001|Extension: Week 27 to 52|Protocol Violation|0|||
27961238|NCT01079234|54618477|FG002|Extension: Week 27 to 52|Protocol Violation|2|||
27961239|NCT01079234|54618478|FG003|Extension: Week 27 to 52|Protocol Violation|5|||
27961240|NCT01079234|54618475|FG000|Extension: Week 27 to 52|Withdrawal criteria|0|||
27961241|NCT01079234|54618476|FG001|Extension: Week 27 to 52|Withdrawal criteria|0|||
27961242|NCT01079234|54618477|FG002|Extension: Week 27 to 52|Withdrawal criteria|4|||
27961243|NCT01079234|54618478|FG003|Extension: Week 27 to 52|Withdrawal criteria|2|||
27961244|NCT01079234|54618475|FG000|Extension: Week 27 to 52|Unclassified|0|||
27961245|NCT01079234|54618476|FG001|Extension: Week 27 to 52|Unclassified|0|||
27961246|NCT01079234|54618477|FG002|Extension: Week 27 to 52|Unclassified|4|||
27961247|NCT01079234|54618478|FG003|Extension: Week 27 to 52|Unclassified|7|||
27961248|NCT00931632|54618489|FG000|Overall Study|Withdrawal by Subject|2|||
27961249|NCT00931632|54618490|FG001|Overall Study|Withdrawal by Subject|3|||
27961250|NCT00931632|54618489|FG000|Overall Study|Adverse Event|19|||
27961251|NCT00931632|54618490|FG001|Overall Study|Adverse Event|15|||
27961252|NCT01078922|54618496|FG000|Overall Study|Adverse Event|1|||
27961253|NCT00863746|54618503|FG000|Treatment|Not treated|4|||
27961254|NCT00863746|54618504|FG001|Treatment|Not treated|2|||
27961255|NCT00863746|54618503|FG000|Treatment|Adverse Event|41|||
27961256|NCT00863746|54618504|FG001|Treatment|Adverse Event|16|||
27961257|NCT00863746|54618503|FG000|Treatment|non-compliant with study medication|4|||
27961258|NCT00863746|54618504|FG001|Treatment|non-compliant with study medication|0|||
27961259|NCT00863746|54618503|FG000|Treatment|Consent withdrawn|15|||
27961260|NCT00863746|54618504|FG001|Treatment|Consent withdrawn|14|||
27961261|NCT00863746|54618503|FG000|Treatment|Lost to Follow-up|1|||
27961262|NCT00863746|54618504|FG001|Treatment|Lost to Follow-up|0|||
27961263|NCT00863746|54618503|FG000|Treatment|Protocol Violation|5|||
27961264|NCT00863746|54618504|FG001|Treatment|Protocol Violation|3|||
27961265|NCT00863746|54618503|FG000|Treatment|Other|1|||
27961266|NCT00863746|54618504|FG001|Treatment|Other|0|||
27961267|NCT00863746|54618503|FG000|Survival Follow up|Death|244|||
27961268|NCT00863746|54618504|FG001|Survival Follow up|Death|271|||
27961269|NCT00863746|54618503|FG000|Survival Follow up|Lost to Follow-up|2|||
27961270|NCT00863746|54618504|FG001|Survival Follow up|Lost to Follow-up|1|||
27961271|NCT00863746|54618503|FG000|Survival Follow up|Consent Withdrawn|7|||
27961272|NCT00863746|54618504|FG001|Survival Follow up|Consent Withdrawn|8|||
28082383|NCT00065468|54736326|FG000|Overall Study|Death|172|||
28082384|NCT00065468|54736327|FG001|Overall Study|Death|169|||
28082385|NCT00065468|54736328|FG002|Overall Study|Death|171|||
28082386|NCT00065468|54736326|FG000|Overall Study|Withdrawal by Subject|3|||
27961273|NCT00926328|54618512|FG000|Overall Study|Lost to Follow-up|12|||
27961274|NCT00926328|54618513|FG001|Overall Study|Lost to Follow-up|14|||
27961275|NCT00863512|54618521|FG000|Overall Study|Adverse Event|2|||
27961276|NCT00863512|54618522|FG001|Overall Study|Adverse Event|0|||
27961277|NCT00863512|54618521|FG000|Overall Study|Withdrawal by Subject|11|||
27961278|NCT00863512|54618522|FG001|Overall Study|Withdrawal by Subject|0|||
27961279|NCT00863512|54618521|FG000|Overall Study|Physician Decision|1|||
27961280|NCT00863512|54618522|FG001|Overall Study|Physician Decision|0|||
27961281|NCT00868192|54618528|FG000|Overall Study|Ineligible|4|||
27961282|NCT00867568|54618532|FG000|Overall Study|Lack of Efficacy|10|||
27961283|NCT00867568|54618532|FG000|Overall Study|Adverse Event|4|||
27855133|NCT01279057|54375431|FG000|Overall Study|Other|3|||
27961284|NCT00867568|54618532|FG000|Overall Study|Withdrawal by Subject|1|||
27961285|NCT00930930|54618538|FG000|Overall Study|Death|1|||
27961286|NCT00930930|54618539|FG001|Overall Study|Death|0|||
27961287|NCT00930930|54618538|FG000|Overall Study|Physician Decision|1|||
27961288|NCT00930930|54618539|FG001|Overall Study|Physician Decision|0|||
27961289|NCT00930930|54618538|FG000|Overall Study|Adverse Event|13|||
27961290|NCT00930930|54618539|FG001|Overall Study|Adverse Event|3|||
27961291|NCT00930930|54618538|FG000|Overall Study|Withdrawal by Subject|3|||
27961292|NCT00930930|54618539|FG001|Overall Study|Withdrawal by Subject|1|||
27961293|NCT00930930|54618538|FG000|Overall Study|Disease progression|2|||
27961294|NCT00930930|54618539|FG001|Overall Study|Disease progression|3|||
27961295|NCT00930930|54618538|FG000|Overall Study|excessive lapse btw txs, not eligible|0|||
27961296|NCT00930930|54618539|FG001|Overall Study|excessive lapse btw txs, not eligible|1|||
27961297|NCT00930930|54618538|FG000|Overall Study|patients not compliant|1|||
27961298|NCT00930930|54618539|FG001|Overall Study|patients not compliant|1|||
27961299|NCT00862654|54618549|FG000|Overall Study|Lack of Efficacy|1|||
27961300|NCT00862654|54618550|FG001|Overall Study|Lack of Efficacy|0|||
27961301|NCT00862654|54618551|FG002|Overall Study|Lack of Efficacy|1|||
27961302|NCT00862654|54618552|FG003|Overall Study|Lack of Efficacy|0|||
27961303|NCT00862654|54618549|FG000|Overall Study|Lost to Follow-up|1|||
27961304|NCT00862654|54618550|FG001|Overall Study|Lost to Follow-up|2|||
27961305|NCT00862654|54618551|FG002|Overall Study|Lost to Follow-up|1|||
27961306|NCT00862654|54618552|FG003|Overall Study|Lost to Follow-up|3|||
27961307|NCT00862654|54618549|FG000|Overall Study|Adverse Event|0|||
27961308|NCT00862654|54618550|FG001|Overall Study|Adverse Event|1|||
27961309|NCT00862654|54618551|FG002|Overall Study|Adverse Event|1|||
27961310|NCT00862654|54618552|FG003|Overall Study|Adverse Event|0|||
27961311|NCT00862654|54618549|FG000|Overall Study|Pregnancy|1|||
27961312|NCT00862654|54618550|FG001|Overall Study|Pregnancy|1|||
27961313|NCT00862654|54618551|FG002|Overall Study|Pregnancy|0|||
27961314|NCT00862654|54618552|FG003|Overall Study|Pregnancy|0|||
27961315|NCT00862654|54618549|FG000|Overall Study|Withdrawal by Subject|2|||
27961316|NCT00862654|54618550|FG001|Overall Study|Withdrawal by Subject|2|||
27961317|NCT00862654|54618551|FG002|Overall Study|Withdrawal by Subject|2|||
27961318|NCT00862654|54618552|FG003|Overall Study|Withdrawal by Subject|3|||
27961319|NCT00862654|54618549|FG000|Overall Study|Subject mistake|0|||
27961320|NCT00862654|54618550|FG001|Overall Study|Subject mistake|1|||
28082387|NCT00065468|54736327|FG001|Overall Study|Withdrawal by Subject|4|||
28082388|NCT00065468|54736328|FG002|Overall Study|Withdrawal by Subject|5|||
28082389|NCT00065468|54736326|FG000|Overall Study|Lost to Follow-up|5|||
28082390|NCT00065468|54736327|FG001|Overall Study|Lost to Follow-up|3|||
28082391|NCT00065468|54736328|FG002|Overall Study|Lost to Follow-up|2|||
28082392|NCT00065468|54736326|FG000|Overall Study|Discontinuation of study by Sponsor|13|||
28082393|NCT00065468|54736327|FG001|Overall Study|Discontinuation of study by Sponsor|9|||
28082394|NCT00065468|54736328|FG002|Overall Study|Discontinuation of study by Sponsor|13|||
28082395|NCT00065468|54736326|FG000|Overall Study|Disease progression|0|||
28082396|NCT00065468|54736327|FG001|Overall Study|Disease progression|0|||
28082397|NCT00065468|54736328|FG002|Overall Study|Disease progression|1|||
28082398|NCT00065468|54736326|FG000|Overall Study|Other|14|||
28165138|NCT03016325|54835757|FG004|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
28165139|NCT03016325|54835758|FG005|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
27961321|NCT00862654|54618551|FG002|Overall Study|Subject mistake|0|||
27961322|NCT00862654|54618552|FG003|Overall Study|Subject mistake|0|||
27961323|NCT00862654|54618549|FG000|Overall Study|Familly constraint|0|||
27961324|NCT00862654|54618550|FG001|Overall Study|Familly constraint|1|||
27961325|NCT00862654|54618551|FG002|Overall Study|Familly constraint|0|||
27961326|NCT00862654|54618552|FG003|Overall Study|Familly constraint|0|||
27961327|NCT00862654|54618549|FG000|Overall Study|Never used study drugs|1|||
27961328|NCT00862654|54618550|FG001|Overall Study|Never used study drugs|0|||
27961329|NCT00862654|54618551|FG002|Overall Study|Never used study drugs|0|||
27961330|NCT00862654|54618552|FG003|Overall Study|Never used study drugs|0|||
27961331|NCT00862654|54618549|FG000|Overall Study|Included after end of inclusions|0|||
27961332|NCT00862654|54618550|FG001|Overall Study|Included after end of inclusions|0|||
27961333|NCT00862654|54618551|FG002|Overall Study|Included after end of inclusions|1|||
27961334|NCT00862654|54618552|FG003|Overall Study|Included after end of inclusions|0|||
28165140|NCT03016325|54835759|FG006|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
27961335|NCT00867490|54618562|FG000|Phase 1 - Candesartan+HCTZ|Adverse Event|5|||
27961336|NCT00867490|54618562|FG000|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4|||
28165141|NCT03016325|54835760|FG007|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
28165142|NCT03016325|54835753|FG000|182-Day Follow-Up Period|Death|3|||
27961337|NCT00867490|54618562|FG000|Phase 1 - Candesartan+HCTZ|Administrative Problems|1|||
27961338|NCT00867490|54618562|FG000|Phase 2 - Aliskiren+HCTZ|Adverse Event|2|||
27961339|NCT00867490|54618562|FG000|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1|||
27961340|NCT00930774|54618573|FG000|Overall Study|Withdrawal by Subject|1|||
27961341|NCT00930774|54618574|FG001|Overall Study|Withdrawal by Subject|9|||
27961342|NCT00930774|54618575|FG002|Overall Study|Withdrawal by Subject|2|||
28082399|NCT00065468|54736327|FG001|Overall Study|Other|24|||
28082400|NCT00065468|54736328|FG002|Overall Study|Other|18|||
28082401|NCT00071006|54736336|FG000|Overall Study|Lack of Efficacy|7|||
28165143|NCT03016325|54835754|FG001|182-Day Follow-Up Period|Death|3|||
27961343|NCT00930774|54618576|FG003|Overall Study|Withdrawal by Subject|0|||
27961344|NCT00867334|54618589|FG000|Overall Study|Withdrawal by Subject|0|||
27961345|NCT00867334|54618590|FG001|Overall Study|Withdrawal by Subject|1|||
27961346|NCT00867334|54618589|FG000|Overall Study|Withdrawal by Subject|1|||
27961347|NCT00867334|54618590|FG001|Overall Study|Withdrawal by Subject|0|||
27961348|NCT00867334|54618589|FG000|Overall Study|Withdrawal by Subject|1|||
27961349|NCT00867334|54618590|FG001|Overall Study|Withdrawal by Subject|0|||
27961350|NCT00925704|54618602|FG000|First Intervention|Withdrew consent|0|||
27961351|NCT00925704|54618603|FG001|First Intervention|Withdrew consent|0|||
27961352|NCT00925704|54618604|FG002|First Intervention|Withdrew consent|0|||
27961353|NCT00925704|54618605|FG003|First Intervention|Withdrew consent|1|||
27961354|NCT00925704|54618606|FG004|First Intervention|Withdrew consent|1|||
27961355|NCT00925704|54618607|FG005|First Intervention|Withdrew consent|0|||
27961356|NCT00925704|54618602|FG000|Second Intervention|Withdrawal by Subject|1|||
27961357|NCT00925704|54618603|FG001|Second Intervention|Withdrawal by Subject|0|||
27961358|NCT00925704|54618604|FG002|Second Intervention|Withdrawal by Subject|0|||
27961359|NCT00925704|54618605|FG003|Second Intervention|Withdrawal by Subject|0|||
27961360|NCT00925704|54618606|FG004|Second Intervention|Withdrawal by Subject|1|||
27961361|NCT00925704|54618607|FG005|Second Intervention|Withdrawal by Subject|0|||
27961362|NCT00925704|54618602|FG000|Third Intervention|Withdrew consent|0|||
27961363|NCT00925704|54618603|FG001|Third Intervention|Withdrew consent|0|||
27961364|NCT00925704|54618604|FG002|Third Intervention|Withdrew consent|0|||
27961365|NCT00925704|54618605|FG003|Third Intervention|Withdrew consent|0|||
27961366|NCT00925704|54618606|FG004|Third Intervention|Withdrew consent|0|||
27961367|NCT00925704|54618607|FG005|Third Intervention|Withdrew consent|1|||
27961368|NCT01076192|54618618|FG000|Overall Study|Other|197|||
27961369|NCT01076036|54618623|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|2|||
27961370|NCT01075958|54618627|FG000|Overall Study|Blood sample could not be obtained|44|||
27961371|NCT01096316|54618633|FG000|Overall Study|Lost to Follow-up|15|||
28082402|NCT00071006|54736336|FG000|Overall Study|Adverse Event|1|||
28082403|NCT00071006|54736336|FG000|Overall Study|Withdrawal by Subject|1|||
27961372|NCT01096316|54618634|FG001|Overall Study|Lost to Follow-up|9|||
27961373|NCT00925548|54618642|FG000|Overall Study|Discontinuation of trial by sponsor|10|||
27961374|NCT00925548|54618643|FG001|Overall Study|Discontinuation of trial by sponsor|5|||
27961375|NCT00866788|54618654|FG000|Overall Study|Adverse Event|0|||
27961376|NCT00866788|54618655|FG001|Overall Study|Adverse Event|2|||
27961377|NCT00866788|54618656|FG002|Overall Study|Adverse Event|0|||
27961378|NCT00866788|54618657|FG003|Overall Study|Adverse Event|1|||
27961379|NCT00866788|54618654|FG000|Overall Study|Lost to Follow-up|1|||
27961380|NCT00866788|54618655|FG001|Overall Study|Lost to Follow-up|1|||
27961381|NCT00866788|54618656|FG002|Overall Study|Lost to Follow-up|0|||
27961382|NCT00866788|54618657|FG003|Overall Study|Lost to Follow-up|2|||
27961383|NCT00866788|54618654|FG000|Overall Study|Withdrawal by Subject|2|||
27961384|NCT00866788|54618655|FG001|Overall Study|Withdrawal by Subject|1|||
27961385|NCT00866788|54618656|FG002|Overall Study|Withdrawal by Subject|0|||
27961386|NCT00866788|54618657|FG003|Overall Study|Withdrawal by Subject|1|||
27961387|NCT00866788|54618654|FG000|Overall Study|Pregnancy|0|||
27961388|NCT00866788|54618655|FG001|Overall Study|Pregnancy|1|||
27961389|NCT00866788|54618656|FG002|Overall Study|Pregnancy|0|||
27961390|NCT00866788|54618657|FG003|Overall Study|Pregnancy|0|||
27961391|NCT00866788|54618654|FG000|Overall Study|Disease progression|3|||
27961392|NCT00866788|54618655|FG001|Overall Study|Disease progression|1|||
27961393|NCT00866788|54618656|FG002|Overall Study|Disease progression|1|||
27961394|NCT00866788|54618657|FG003|Overall Study|Disease progression|0|||
27961395|NCT00866788|54618654|FG000|Overall Study|Physician Decision|0|||
27961396|NCT00866788|54618655|FG001|Overall Study|Physician Decision|0|||
27961397|NCT00866788|54618656|FG002|Overall Study|Physician Decision|1|||
27961398|NCT00866788|54618657|FG003|Overall Study|Physician Decision|1|||
27961399|NCT00860470|54618672|FG000|Overall Study|Death|6|||
27961400|NCT00860470|54618673|FG001|Overall Study|Death|10|||
27961401|NCT00860470|54618672|FG000|Overall Study|Moved away|8|||
27961402|NCT00860470|54618673|FG001|Overall Study|Moved away|10|||
27961403|NCT00860470|54618672|FG000|Overall Study|Lost to Follow-up|34|||
27961404|NCT00860470|54618673|FG001|Overall Study|Lost to Follow-up|39|||
28082404|NCT00071006|54736336|FG000|Overall Study|Other|3|||
27961405|NCT00923364|54618679|FG000|Overall Study|Death|3|||
27961406|NCT00923364|54618680|FG001|Overall Study|Death|0|||
27961407|NCT00923364|54618679|FG000|Overall Study|Did not go to transplant|1|||
27961408|NCT00923364|54618680|FG001|Overall Study|Did not go to transplant|0|||
27961409|NCT01096160|54618695|FG000|Overall Study|Adverse Event|0|||
27961410|NCT01096160|54618696|FG001|Overall Study|Adverse Event|0|||
27961411|NCT01096160|54618697|FG002|Overall Study|Adverse Event|1|||
27961412|NCT01096160|54618698|FG003|Overall Study|Adverse Event|0|||
27961413|NCT01096160|54618699|FG004|Overall Study|Adverse Event|0|||
27961414|NCT01096160|54618700|FG005|Overall Study|Adverse Event|0|||
27961415|NCT01096160|54618701|FG006|Overall Study|Adverse Event|0|||
27961416|NCT01096160|54618702|FG007|Overall Study|Adverse Event|0|||
28082405|NCT00094575|54736342|FG000|Overall Study|Death|146|||
28082406|NCT00094575|54736343|FG001|Overall Study|Death|146|||
27961417|NCT01096160|54618703|FG008|Overall Study|Adverse Event|0|||
27961418|NCT01096160|54618704|FG009|Overall Study|Adverse Event|1|||
27961419|NCT01096160|54618695|FG000|Overall Study|Met stopping criteria per protocol|0|||
27961420|NCT01096160|54618696|FG001|Overall Study|Met stopping criteria per protocol|0|||
27961421|NCT01096160|54618697|FG002|Overall Study|Met stopping criteria per protocol|0|||
27961422|NCT01096160|54618698|FG003|Overall Study|Met stopping criteria per protocol|0|||
27961423|NCT01096160|54618699|FG004|Overall Study|Met stopping criteria per protocol|1|||
27961424|NCT01096160|54618700|FG005|Overall Study|Met stopping criteria per protocol|0|||
27961425|NCT01096160|54618701|FG006|Overall Study|Met stopping criteria per protocol|2|||
27961426|NCT01096160|54618702|FG007|Overall Study|Met stopping criteria per protocol|0|||
27961427|NCT01096160|54618703|FG008|Overall Study|Met stopping criteria per protocol|2|||
27961428|NCT01096160|54618704|FG009|Overall Study|Met stopping criteria per protocol|0|||
27961429|NCT00860158|54618739|FG000|Overall Study|Study Terminated|1|||
27961430|NCT00929526|54618745|FG000|Overall Study|Withdrawal by Subject|1|||
27961431|NCT00929526|54618746|FG001|Overall Study|Withdrawal by Subject|11|||
27961432|NCT00929526|54618745|FG000|Overall Study|Lost to Follow-up|8|||
27961433|NCT00929526|54618746|FG001|Overall Study|Lost to Follow-up|12|||
27961434|NCT00929526|54618745|FG000|Overall Study|Other|8|||
27961435|NCT00929526|54618746|FG001|Overall Study|Other|6|||
27961436|NCT00859456|54618752|FG000|Overall Study|Adverse Event|3|||
27961437|NCT00859456|54618752|FG000|Overall Study|Progressive disease|2|||
27961438|NCT00859456|54618752|FG000|Overall Study|Non-compliance|3|||
27961439|NCT01075646|54618760|FG000|Overall Study|Lost to Follow-up|4|||
27961440|NCT01075646|54618761|FG001|Overall Study|Lost to Follow-up|3|||
27961441|NCT01075646|54618762|FG002|Overall Study|Lost to Follow-up|1|||
27961442|NCT01075646|54618763|FG003|Overall Study|Lost to Follow-up|2|||
27961443|NCT01075412|54618775|FG000|Overall Study|Withdrawal by Subject|0|||
27961444|NCT01075412|54618776|FG001|Overall Study|Withdrawal by Subject|1|||
27961445|NCT00799903|54618783|FG000|Overall Study|Investigator Site Closed|25|||
27961446|NCT00799903|54618784|FG001|Overall Study|Investigator Site Closed|23|||
27961447|NCT00799903|54618783|FG000|Overall Study|Withdrawal by Subject|179|||
27961448|NCT00799903|54618784|FG001|Overall Study|Withdrawal by Subject|175|||
27961449|NCT00799903|54618783|FG000|Overall Study|Lost to Follow-up|69|||
27961450|NCT00799903|54618784|FG001|Overall Study|Lost to Follow-up|80|||
27961451|NCT01075256|54618793|FG000|Overall Study|Withdrawal by Subject|1|||
27961452|NCT01075256|54618794|FG001|Overall Study|Withdrawal by Subject|0|||
27961453|NCT01075256|54618795|FG002|Overall Study|Withdrawal by Subject|0|||
27961454|NCT00923130|54618808|FG000|Overall Study|Stopped treatment due to progression|17|||
27961455|NCT00923130|54618808|FG000|Overall Study|Death|1|||
27961456|NCT00923130|54618808|FG000|Overall Study|Discontinued treatment due to toxicities|3|||
27961457|NCT00923130|54618808|FG000|Overall Study|Switched to alternative treatment|2|||
27961458|NCT00923130|54618808|FG000|Overall Study|Refused further treatment|2|||
27961459|NCT03253627|54618814|FG000|Overall Study|Lost to Follow-up|1|||
27961460|NCT03253627|54618815|FG001|Overall Study|Lost to Follow-up|2|||
27961461|NCT03253627|54618814|FG000|Overall Study|Withdrawal by Subject|0|||
27961462|NCT03253627|54618815|FG001|Overall Study|Withdrawal by Subject|2|||
27961463|NCT03253627|54618814|FG000|Overall Study|Inability to complete MRI|1|||
27961464|NCT03253627|54618815|FG001|Overall Study|Inability to complete MRI|0|||
27961465|NCT01075178|54618823|FG000|Subject Matching|eligible but not matched|130|||
27961466|NCT01075178|54618824|FG001|Subject Matching|eligible but not matched|403|||
27961467|NCT01075178|54618823|FG000|Subject Chart Review|died before chart review period|0|||
27961468|NCT01075178|54618824|FG001|Subject Chart Review|died before chart review period|2|||
27961469|NCT01075178|54618823|FG000|Subject Chart Review|no data collected due to site closure|3|||
27961470|NCT01075178|54618824|FG001|Subject Chart Review|no data collected due to site closure|4|||
27961471|NCT01075178|54618823|FG000|Subject Chart Review|matched partner excluded (reasons above)|6|||
27961472|NCT01075178|54618824|FG001|Subject Chart Review|matched partner excluded (reasons above)|3|||
27961473|NCT00799825|54618830|FG000|Overall Study|Adverse Event|1|||
27961474|NCT00799825|54618830|FG000|Overall Study|Withdrawal by Subject|6|||
27961475|NCT00799825|54618830|FG000|Overall Study|Lost to Follow-up|38|||
27961476|NCT00799825|54618830|FG000|Overall Study|Pregnancy|3|||
27961477|NCT00799591|54618834|FG000|Overall Study|De-escalation of doses|20|||
27961478|NCT00799591|54618834|FG000|Overall Study|Death|14|||
27961479|NCT00799591|54618834|FG000|Overall Study|Technical failure|12|||
27732454|NCT02579096|54179983|FG001|Phase 1, Weeks 0 - 24|Other reasons|3|||
27732455|NCT02579096|54179982|FG000|Phase 2, Weeks 25 - 48|Death|2|||
27961480|NCT00799591|54618834|FG000|Overall Study|Resistant germ|11|||
27961481|NCT00799591|54618834|FG000|Overall Study|New infection|4|||
27961482|NCT00799591|54618834|FG000|Overall Study|Resistance germ and technical failure|2|||
27961483|NCT00799591|54618834|FG000|Overall Study|Persistance of fever undetermined origin|1|||
27961484|NCT00799591|54618834|FG000|Overall Study|Antibiotic changed, no apparent reason|1|||
27961485|NCT00799591|54618834|FG000|Overall Study|Infectious origin not probable|1|||
27961486|NCT01075100|54618840|FG000|Overall Study|Adverse Event|15|||
27961487|NCT01075100|54618841|FG001|Overall Study|Adverse Event|18|||
27961488|NCT01075100|54618840|FG000|Overall Study|Patient Request|4|||
27961489|NCT01075100|54618841|FG001|Overall Study|Patient Request|4|||
27961490|NCT01075100|54618840|FG000|Overall Study|Investigator Request|2|||
27961491|NCT01075100|54618841|FG001|Overall Study|Investigator Request|1|||
27961492|NCT01075100|54618840|FG000|Overall Study|Disease Progression|25|||
27961493|NCT01075100|54618841|FG001|Overall Study|Disease Progression|29|||
27961494|NCT01075100|54618840|FG000|Overall Study|Other|3|||
27961495|NCT01075100|54618841|FG001|Overall Study|Other|1|||
27961496|NCT00803023|54618853|FG000|Overall Study|Adverse Event|5|||
27961497|NCT00803023|54618854|FG001|Overall Study|Adverse Event|4|||
27961498|NCT00803023|54618855|FG002|Overall Study|Adverse Event|8|||
27961499|NCT00803023|54618856|FG003|Overall Study|Adverse Event|6|||
27961500|NCT00803023|54618853|FG000|Overall Study|Withdrawal by Subject|0|||
27961501|NCT00803023|54618854|FG001|Overall Study|Withdrawal by Subject|2|||
27961502|NCT00803023|54618855|FG002|Overall Study|Withdrawal by Subject|0|||
27961503|NCT00803023|54618856|FG003|Overall Study|Withdrawal by Subject|0|||
27961504|NCT00803023|54618853|FG000|Overall Study|Lost to Follow-up|0|||
27961505|NCT00803023|54618854|FG001|Overall Study|Lost to Follow-up|1|||
27961506|NCT00803023|54618855|FG002|Overall Study|Lost to Follow-up|2|||
27961507|NCT00803023|54618856|FG003|Overall Study|Lost to Follow-up|1|||
27961508|NCT00803023|54618853|FG000|Overall Study|Lack of Efficacy|0|||
27961509|NCT00803023|54618854|FG001|Overall Study|Lack of Efficacy|1|||
27961510|NCT00803023|54618855|FG002|Overall Study|Lack of Efficacy|1|||
27961511|NCT00803023|54618856|FG003|Overall Study|Lack of Efficacy|1|||
27961512|NCT00859222|54618869|FG000|Overall Study|Adverse Event|2|||
27961513|NCT00859222|54618870|FG001|Overall Study|Adverse Event|3|||
27961514|NCT00859222|54618871|FG002|Overall Study|Adverse Event|6|||
27961515|NCT00859222|54618872|FG003|Overall Study|Adverse Event|24|||
27961516|NCT00859222|54618873|FG004|Overall Study|Adverse Event|15|||
27961517|NCT00859222|54618869|FG000|Overall Study|DLT|1|||
27961518|NCT00859222|54618870|FG001|Overall Study|DLT|0|||
27961519|NCT00859222|54618871|FG002|Overall Study|DLT|0|||
27961520|NCT00859222|54618872|FG003|Overall Study|DLT|0|||
27961521|NCT00859222|54618873|FG004|Overall Study|DLT|0|||
27961522|NCT01072448|54618890|FG000|Overall Study|Adverse Event|9|||
27961523|NCT01072448|54618891|FG001|Overall Study|Adverse Event|10|||
27961524|NCT01072448|54618890|FG000|Overall Study|Subject withdrew consent|4|||
27961525|NCT01072448|54618891|FG001|Overall Study|Subject withdrew consent|9|||
27961526|NCT01072448|54618890|FG000|Overall Study|Protocol deviation|3|||
27961527|NCT01072448|54618891|FG001|Overall Study|Protocol deviation|4|||
27961528|NCT01072448|54618890|FG000|Overall Study|Abnormal test procedure result(s)|1|||
27961529|NCT01072448|54618891|FG001|Overall Study|Abnormal test procedure result(s)|0|||
27961530|NCT01072448|54618890|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
27961531|NCT01072448|54618891|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
27961532|NCT01072448|54618890|FG000|Overall Study|Lost to Follow-up|1|||
27961533|NCT01072448|54618891|FG001|Overall Study|Lost to Follow-up|1|||
27961534|NCT01072448|54618890|FG000|Overall Study|Abnormal laboratory value(s)|0|||
27961535|NCT01072448|54618891|FG001|Overall Study|Abnormal laboratory value(s)|1|||
27961536|NCT01072448|54618890|FG000|Overall Study|Death|0|||
28082407|NCT00057746|54736354|FG000|Overall Study|Withdrawal by Subject|0|||
28082408|NCT00057746|54736355|FG001|Overall Study|Withdrawal by Subject|0|||
28082409|NCT00057746|54736356|FG002|Overall Study|Withdrawal by Subject|1|||
28082410|NCT00094107|54736364|FG000|Overall Study|Lack of Efficacy|23|||
28082411|NCT00094107|54736364|FG000|Overall Study|Death|5|||
28082412|NCT00094107|54736364|FG000|Overall Study|Adverse Event|3|||
28082413|NCT00094107|54736364|FG000|Overall Study|Withdrawal due to Disease Progression|1|||
28082414|NCT00102063|54736371|FG000|Overall Study|Lack of Efficacy|5|||
28082415|NCT00102063|54736372|FG001|Overall Study|Lack of Efficacy|1|||
28082416|NCT00102063|54736373|FG002|Overall Study|Lack of Efficacy|1|||
27961537|NCT01072448|54618891|FG001|Overall Study|Death|2|||
27961538|NCT00922974|54618900|FG000|Phase II Component|Protocol Violation|2|||
27961539|NCT00922974|54618901|FG001|Phase II Component|Protocol Violation|0|||
27961540|NCT00922974|54618900|FG000|Phase II Component|Not evaluable for treatment review|5|||
27961541|NCT00922974|54618901|FG001|Phase II Component|Not evaluable for treatment review|0|||
27961542|NCT00922974|54618900|FG000|Phase III Component|Protocol Violation|8|||
27961543|NCT00922974|54618901|FG001|Phase III Component|Protocol Violation|6|||
27961544|NCT00858988|54618911|FG000|Analysis|Lactulose unable to be detected in urine|2|||
27961545|NCT00858988|54618912|FG001|Analysis|Lactulose unable to be detected in urine|1|||
28082417|NCT00102063|54736371|FG000|Overall Study|Adverse Event|7|||
27961546|NCT00858832|54618920|FG000|Overall Study|became ineligible: delivered vaginally|1|||
27961547|NCT00858832|54618921|FG001|Overall Study|became ineligible: delivered vaginally|0|||
27961548|NCT00858832|54618920|FG000|Overall Study|Adverse Event|0|||
27961549|NCT00858832|54618921|FG001|Overall Study|Adverse Event|1|||
27961550|NCT01071512|54618927|FG000|Overall Study|Adverse Event|1|||
27961551|NCT01071512|54618927|FG000|Overall Study|Development of antibodies to drug|2|||
27961552|NCT01071512|54618927|FG000|Overall Study|positive anti-JC virus antibody test|2|||
27961553|NCT00858442|54618933|FG000|Compression:Start to Finish|Lost to Follow-up|1|||
28082418|NCT00102063|54736372|FG001|Overall Study|Adverse Event|4|||
28082419|NCT00102063|54736373|FG002|Overall Study|Adverse Event|2|||
27961554|NCT00858442|54618934|FG001|Compression:Start to Finish|Lost to Follow-up|3|||
27961555|NCT01071278|54618941|FG000|Overall Study|Premature Discontinuation|254|||
27961556|NCT01071278|54618941|FG000|Overall Study|Completion Status Unknown|459|||
27961557|NCT00858208|54618947|FG000|Overall Study|Adverse Event|3|||
27961558|NCT00858208|54618947|FG000|Overall Study|Lost to Follow-up|26|||
27961559|NCT00858208|54618947|FG000|Overall Study|Participant refused|40|||
27961560|NCT00858208|54618947|FG000|Overall Study|Other|10|||
27961561|NCT01071200|54618953|FG000|Overall Study|Lack of ovarian response|1|||
27961562|NCT01071200|54618954|FG001|Overall Study|Lack of ovarian response|1|||
27961563|NCT01071200|54618953|FG000|Overall Study|No fertilization|4|||
27961564|NCT01071200|54618954|FG001|Overall Study|No fertilization|0|||
27961565|NCT01071200|54618953|FG000|Overall Study|No oocytes retrieved|1|||
27961566|NCT01071200|54618954|FG001|Overall Study|No oocytes retrieved|1|||
27961567|NCT01071200|54618953|FG000|Overall Study|Ovarian Hyper Stimulation Syndrome|1|||
27961568|NCT01071200|54618954|FG001|Overall Study|Ovarian Hyper Stimulation Syndrome|0|||
27961569|NCT01071200|54618953|FG000|Overall Study|No viable embryos|0|||
27961570|NCT01071200|54618954|FG001|Overall Study|No viable embryos|1|||
27961571|NCT02207569|54618960|FG000|1-Month|Death|6|||
27961572|NCT02207569|54618960|FG000|1-Month|Withdrawal by Subject|2|||
27961573|NCT02207569|54618960|FG000|1-Month|Subject anesthetized but product not onsite, for medical justification treated w/commercial device|1|||
27961574|NCT02207569|54618960|FG000|6-Month|Death|8|||
27961575|NCT02207569|54618960|FG000|6-Month|Withdrawal by Subject|2|||
27961576|NCT02207569|54618960|FG000|12-Month|Death|14|||
27961577|NCT02207569|54618960|FG000|12-Month|Withdrawal by Subject|2|||
27961578|NCT02207569|54618960|FG000|24-Month|Death|23|||
27961579|NCT02207569|54618960|FG000|24-Month|Withdrawal by Subject|3|||
27961580|NCT02207569|54618960|FG000|36-Month|Death|23|||
27961581|NCT02207569|54618960|FG000|36-Month|Withdrawal by Subject|4|||
27961582|NCT02207569|54618960|FG000|48-Month|Death|25|||
27961583|NCT02207569|54618960|FG000|48-Month|Withdrawal by Subject|2|||
27961584|NCT02207569|54618960|FG000|48-Month|Lost to Follow-up|4|||
27961585|NCT02207569|54618960|FG000|60-Month|Death|1|||
27961586|NCT02207569|54618960|FG000|60-Month|Lost to Follow-up|1|||
27961587|NCT02207569|54618960|FG000|60-Month|pt 103 years old no longer traveling for MD visits|1|||
27961588|NCT02207569|54618960|FG000|60-Month|Covid-19 pt not willing to be seen|1|||
27961589|NCT01070966|54618964|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|59|||
27961590|NCT01070966|54618964|FG000|Participants for Safety Evaluation|Off-label use|9|||
27961591|NCT01070966|54618964|FG000|Participants for Safety Evaluation|Duplicate Participants|4|||
27961592|NCT01070966|54618964|FG000|Participants for Safety Evaluation|Violation inclusion criteria/off label|3|||
27961593|NCT01070966|54618964|FG000|Participants for Safety Evaluation|TMT given before date of contract|3|||
27961594|NCT01070966|54618964|FG000|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61|||
27961595|NCT01070966|54618964|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|19|||
27961596|NCT01070966|54618964|FG000|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2|||
27961597|NCT01070888|54618977|FG000|First Intervention (14 Days)|Adverse Event|0|||
27961598|NCT01070888|54618978|FG001|First Intervention (14 Days)|Adverse Event|1|||
27961599|NCT01070888|54618977|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
27961600|NCT01070888|54618978|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
27961601|NCT01070888|54618977|FG000|Washout (14 Days)|Physician Decision|1|||
27961602|NCT01070888|54618978|FG001|Washout (14 Days)|Physician Decision|0|||
27961603|NCT00857896|54618984|FG000|Baseline to Week 4|Withdrawal by Subject|1|||
27961604|NCT00857818|54618991|FG000|Overall Study|Lack of Efficacy|1|||
27961605|NCT00857818|54618992|FG001|Overall Study|Lack of Efficacy|0|||
27961606|NCT00857818|54618991|FG000|Overall Study|Adverse Event|3|||
27961607|NCT00857818|54618992|FG001|Overall Study|Adverse Event|0|||
27961608|NCT00857818|54618991|FG000|Overall Study|Withdrawal by Subject|0|||
27961609|NCT00857818|54618992|FG001|Overall Study|Withdrawal by Subject|4|||
27961610|NCT00857818|54618991|FG000|Overall Study|Sponsor terminated study|6|||
27961611|NCT00857818|54618992|FG001|Overall Study|Sponsor terminated study|4|||
27961612|NCT00857818|54618991|FG000|Overall Study|Investigator decision|1|||
27961613|NCT00857818|54618992|FG001|Overall Study|Investigator decision|0|||
27961614|NCT01074944|54618998|FG000|Lead-in Period (up to 78 Weeks)|Adverse Event|2|||
27961615|NCT01074944|54618999|FG001|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
27961616|NCT01074944|54619000|FG002|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
27961617|NCT01074944|54619001|FG003|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
27961618|NCT01074944|54619002|FG004|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
27961619|NCT01074944|54618998|FG000|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1|||
27961620|NCT01074944|54618999|FG001|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
27961621|NCT01074944|54619000|FG002|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
27961622|NCT01074944|54619001|FG003|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
27961623|NCT01074944|54619002|FG004|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
27961624|NCT01074944|54618998|FG000|Lead-in Period (up to 78 Weeks)|Pregnancy|4|||
27961625|NCT01074944|54618999|FG001|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
27961626|NCT01074944|54619000|FG002|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
27961627|NCT01074944|54619001|FG003|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
28165144|NCT03016325|54835755|FG002|182-Day Follow-Up Period|Death|11|||
27961628|NCT01074944|54619002|FG004|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
27961629|NCT01074944|54618998|FG000|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6|||
27961630|NCT01074944|54618999|FG001|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
27961631|NCT01074944|54619000|FG002|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
27961632|NCT01074944|54619001|FG003|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
27961633|NCT01074944|54619002|FG004|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
27961634|NCT01074944|54618998|FG000|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
27961635|NCT01074944|54618999|FG001|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2|||
27961636|NCT01074944|54619000|FG002|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3|||
27961637|NCT01074944|54619001|FG003|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
27961638|NCT01074944|54619002|FG004|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
27961639|NCT01074944|54618998|FG000|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
27961640|NCT01074944|54618999|FG001|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6|||
27961641|NCT01074944|54619000|FG002|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1|||
27961642|NCT01074944|54619001|FG003|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
27961643|NCT01074944|54619002|FG004|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
27961644|NCT01074944|54618998|FG000|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
27961645|NCT01074944|54618999|FG001|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
27961646|NCT01074944|54619000|FG002|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
27961647|NCT01074944|54619001|FG003|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
27961648|NCT01074944|54619002|FG004|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
27961649|NCT01074944|54618998|FG000|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
27961650|NCT01074944|54618999|FG001|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1|||
27961651|NCT01074944|54619000|FG002|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
27961652|NCT01074944|54619001|FG003|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
27961653|NCT01074944|54619002|FG004|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
27961654|NCT01074944|54618998|FG000|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
27961655|NCT01074944|54618999|FG001|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
27961656|NCT01074944|54619000|FG002|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
27961657|NCT01074944|54619001|FG003|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
27961658|NCT01074944|54619002|FG004|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
28082420|NCT00102063|54736371|FG000|Overall Study|Withdrawal by Subject|4|||
28082421|NCT00102063|54736372|FG001|Overall Study|Withdrawal by Subject|12|||
28082422|NCT00102063|54736373|FG002|Overall Study|Withdrawal by Subject|5|||
28082423|NCT00102063|54736371|FG000|Overall Study|Lost to Follow-up|0|||
28082424|NCT00102063|54736372|FG001|Overall Study|Lost to Follow-up|0|||
28082425|NCT00102063|54736373|FG002|Overall Study|Lost to Follow-up|1|||
28082426|NCT00102063|54736371|FG000|Overall Study|Protocol Violation|0|||
28082427|NCT00102063|54736372|FG001|Overall Study|Protocol Violation|1|||
28082428|NCT00102063|54736373|FG002|Overall Study|Protocol Violation|1|||
28082429|NCT00065156|54736381|FG000|Overall Study|Adverse Event|37|||
28082430|NCT00065156|54736381|FG000|Overall Study|Lack of Efficacy|52|||
28082431|NCT00065156|54736381|FG000|Overall Study|Withdrawal by Subject|8|||
28082432|NCT00065156|54736381|FG000|Overall Study|Lost to Follow-up|1|||
28082433|NCT00065156|54736381|FG000|Overall Study|Death|11|||
28082434|NCT00065156|54736381|FG000|Overall Study|Study Closed by Sponsor|2|||
28082435|NCT00065156|54736381|FG000|Overall Study|Disease Progression|7|||
28082436|NCT00065156|54736381|FG000|Overall Study|Investigator Decision|2|||
28082437|NCT00065156|54736381|FG000|Overall Study|Non-Compliance|2|||
28082438|NCT00065156|54736381|FG000|Overall Study|Loss of Response|1|||
28082439|NCT00065156|54736381|FG000|Overall Study|Secondary Malign Disease|1|||
28082440|NCT00064298|54736387|FG000|Overall Study|Withdrawal by Subject|2|||
28082441|NCT00064298|54736388|FG001|Overall Study|Withdrawal by Subject|1|||
28082442|NCT00064298|54736387|FG000|Overall Study|Lost to Follow-up|2|||
28082443|NCT00064298|54736388|FG001|Overall Study|Lost to Follow-up|2|||
28082444|NCT00064298|54736387|FG000|Overall Study|Death|0|||
28082445|NCT00064298|54736388|FG001|Overall Study|Death|1|||
28082446|NCT00064298|54736387|FG000|Overall Study|Disease Progression|2|||
28082447|NCT00064298|54736388|FG001|Overall Study|Disease Progression|1|||
27961659|NCT01074944|54618998|FG000|Long Term Treatment|Adverse Event|0|||
27961660|NCT01074944|54618999|FG001|Long Term Treatment|Adverse Event|0|||
28082448|NCT00078819|54736396|FG000|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
28082449|NCT00078819|54736397|FG001|Double-blind Treatment Period: Week 1-12|Adverse Event|1|||
28082450|NCT00078819|54736398|FG002|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
28082451|NCT00078819|54736399|FG003|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
27832447|NCT01734785|54311697|FG000|Double-Blind Period|Lack of Efficacy|0|||
28082452|NCT00078819|54736396|FG000|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1|||
28082453|NCT00078819|54736397|FG001|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
28082454|NCT00078819|54736398|FG002|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
28082455|NCT00078819|54736399|FG003|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
27961661|NCT01074944|54619000|FG002|Long Term Treatment|Adverse Event|0|||
27961662|NCT01074944|54619001|FG003|Long Term Treatment|Adverse Event|3|||
27961663|NCT01074944|54619002|FG004|Long Term Treatment|Adverse Event|0|||
27961664|NCT01074944|54618998|FG000|Long Term Treatment|Lost to Follow-up|0|||
27961665|NCT01074944|54618999|FG001|Long Term Treatment|Lost to Follow-up|0|||
27961666|NCT01074944|54619000|FG002|Long Term Treatment|Lost to Follow-up|0|||
27961667|NCT01074944|54619001|FG003|Long Term Treatment|Lost to Follow-up|2|||
27961668|NCT01074944|54619002|FG004|Long Term Treatment|Lost to Follow-up|0|||
27961669|NCT01074944|54618998|FG000|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
27961670|NCT01074944|54618999|FG001|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
27961671|NCT01074944|54619000|FG002|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
27961672|NCT01074944|54619001|FG003|Long Term Treatment|Transitioned to Commercial Eliglustat|18|||
27961673|NCT01074944|54619002|FG004|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
27961674|NCT01074944|54618998|FG000|Long Term Treatment|Entered in Period, But Not Treated|0|||
27961675|NCT01074944|54618999|FG001|Long Term Treatment|Entered in Period, But Not Treated|0|||
27961676|NCT01074944|54619000|FG002|Long Term Treatment|Entered in Period, But Not Treated|0|||
27961677|NCT01074944|54619001|FG003|Long Term Treatment|Entered in Period, But Not Treated|1|||
27961678|NCT01074944|54619002|FG004|Long Term Treatment|Entered in Period, But Not Treated|0|||
27961679|NCT01074944|54618998|FG000|Long Term Treatment|Withdrawal by Subject|0|||
27961680|NCT01074944|54618999|FG001|Long Term Treatment|Withdrawal by Subject|0|||
27961681|NCT01074944|54619000|FG002|Long Term Treatment|Withdrawal by Subject|0|||
27961682|NCT01074944|54619001|FG003|Long Term Treatment|Withdrawal by Subject|2|||
27961683|NCT01074944|54619002|FG004|Long Term Treatment|Withdrawal by Subject|0|||
27961684|NCT01074944|54618998|FG000|Extended Treatment (up to 42 Months)|Pregnancy|0|||
27961685|NCT01074944|54618999|FG001|Extended Treatment (up to 42 Months)|Pregnancy|0|||
27961686|NCT01074944|54619000|FG002|Extended Treatment (up to 42 Months)|Pregnancy|0|||
27961687|NCT01074944|54619001|FG003|Extended Treatment (up to 42 Months)|Pregnancy|0|||
27961688|NCT01074944|54619002|FG004|Extended Treatment (up to 42 Months)|Pregnancy|2|||
27961689|NCT01074944|54618998|FG000|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
27961690|NCT01074944|54618999|FG001|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
27961691|NCT01074944|54619000|FG002|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
27961692|NCT01074944|54619001|FG003|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
27961693|NCT01074944|54619002|FG004|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3|||
27961694|NCT00802945|54619012|FG000|Overall Study|Death|27|||
27961695|NCT00802945|54619013|FG001|Overall Study|Death|23|||
27961696|NCT00802945|54619012|FG000|Overall Study|Terminated by sponsor|8|||
27961697|NCT00802945|54619013|FG001|Overall Study|Terminated by sponsor|12|||
27961698|NCT01074554|54619023|FG000|Overall Study|Adverse Event|3|||
27961699|NCT01074554|54619024|FG001|Overall Study|Adverse Event|3|||
27961700|NCT01074554|54619023|FG000|Overall Study|Lost to Follow-up|0|||
27961701|NCT01074554|54619024|FG001|Overall Study|Lost to Follow-up|1|||
27961702|NCT00857584|54619032|FG000|Overall Study|Lack of Efficacy|1|||
27961703|NCT00857584|54619033|FG001|Overall Study|Lack of Efficacy|2|||
27961704|NCT00857584|54619032|FG000|Overall Study|Adverse Event|2|||
27961705|NCT00857584|54619033|FG001|Overall Study|Adverse Event|2|||
27961706|NCT00857584|54619032|FG000|Overall Study|Physician Decision|1|||
27961707|NCT00857584|54619033|FG001|Overall Study|Physician Decision|1|||
27961708|NCT00798967|54619041|FG000|Overall Study|Adverse Event|2|||
27961709|NCT00798967|54619042|FG001|Overall Study|Adverse Event|3|||
27961710|NCT00798967|54619041|FG000|Overall Study|Withdrawal by Subject|0|||
27961711|NCT00798967|54619042|FG001|Overall Study|Withdrawal by Subject|1|||
27961712|NCT00798967|54619041|FG000|Overall Study|Physician Decision|1|||
27961713|NCT00798967|54619042|FG001|Overall Study|Physician Decision|0|||
27961714|NCT00798967|54619041|FG000|Overall Study|Randomized in error by site|1|||
27961715|NCT00798967|54619042|FG001|Overall Study|Randomized in error by site|0|||
27961716|NCT01074242|54619049|FG000|Overall Study|Case report before date of contract|40|||
27961717|NCT01074242|54619049|FG000|Overall Study|Lost to Follow-up|1|||
28082456|NCT00078819|54736396|FG000|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
28082457|NCT00078819|54736397|FG001|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
28082458|NCT00078819|54736398|FG002|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
28082459|NCT00078819|54736399|FG003|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
28082460|NCT00078819|54736396|FG000|Open-label Treatment Period: Weeks 13-36|Adverse Event|3|||
28082461|NCT00078819|54736397|FG001|Open-label Treatment Period: Weeks 13-36|Adverse Event|2|||
28082462|NCT00078819|54736398|FG002|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
27961718|NCT01074242|54619049|FG000|Overall Study|Case report unclear|6|||
27961719|NCT01074242|54619049|FG000|Overall Study|Violation of vaccine dose or dosage|351|||
27961720|NCT01074242|54619049|FG000|Overall Study|Duplicate Case Report Form|5|||
27961721|NCT00798889|54619053|FG000|Overall Study|Adverse Event|53|||
27961722|NCT00798889|54619053|FG000|Overall Study|Protocol Violation|2|||
27961723|NCT00798889|54619053|FG000|Overall Study|Withdrawal by Subject|31|||
27961724|NCT00798889|54619053|FG000|Overall Study|Lost to Follow-up|1|||
27961725|NCT00798889|54619053|FG000|Overall Study|Lack of Efficacy|213|||
28082463|NCT00078819|54736399|FG003|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
28082464|NCT00078819|54736396|FG000|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
28082465|NCT00078819|54736397|FG001|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
28082466|NCT00078819|54736398|FG002|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
28082467|NCT00078819|54736399|FG003|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
28082468|NCT00078819|54736396|FG000|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34|||
28082469|NCT00078819|54736397|FG001|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25|||
28082470|NCT00078819|54736398|FG002|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
28082471|NCT00078819|54736399|FG003|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
28082472|NCT00078819|54736396|FG000|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
28082473|NCT00078819|54736397|FG001|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
28082474|NCT00078819|54736398|FG002|Withdrawal Period: Weeks 37-48|Entered Retreatment|29|||
27961726|NCT00798889|54619053|FG000|Overall Study|Decision of Sponsor|11|||
27961727|NCT00798889|54619053|FG000|Overall Study|Enrolled, Not treated|3|||
27961728|NCT00796861|54619057|FG000|Overall Study|Withdrawal by Subject|2|||
27961729|NCT00796861|54619057|FG000|Overall Study|Death|2|||
27961730|NCT00802867|54619061|FG000|Overall Study|Lost to Follow-up|6|||
27961731|NCT00802867|54619061|FG000|Overall Study|Protocol Violation|6|||
27961732|NCT00802867|54619061|FG000|Overall Study|Withdrawal by Subject|1|||
27961733|NCT00798655|54619065|FG000|Overall Study|Did not receive at least one dose of pan|2|||
27961734|NCT00796549|54619069|FG000|Overall Study|Adverse Event|11|||
27961735|NCT00796549|54619069|FG000|Overall Study|not entered|149|||
27961736|NCT00796549|54619069|FG000|Overall Study|Other|2|||
27961737|NCT00796549|54619069|FG000|Overall Study|Progressive disease|56|||
27961738|NCT00856492|54619078|FG000|Overall Study|Ineligible or withdrew consent|1|||
27961739|NCT00856492|54619079|FG001|Overall Study|Ineligible or withdrew consent|1|||
27961740|NCT00856492|54619080|FG002|Overall Study|Ineligible or withdrew consent|2|||
27961741|NCT00856180|54619091|FG000|Overall Study|Adverse Event|4|||
27961742|NCT00856180|54619091|FG000|Overall Study|Progressive Disease|16|||
27961743|NCT00900627|54619103|FG000|Overall Study|Condition under investigation worsened|4|||
27961744|NCT00900627|54619104|FG001|Overall Study|Condition under investigation worsened|0|||
27961745|NCT00900627|54619105|FG002|Overall Study|Condition under investigation worsened|5|||
27961746|NCT00900627|54619106|FG003|Overall Study|Condition under investigation worsened|3|||
27961747|NCT00900627|54619107|FG004|Overall Study|Condition under investigation worsened|0|||
27961748|NCT00900627|54619108|FG005|Overall Study|Condition under investigation worsened|0|||
27961749|NCT00900627|54619103|FG000|Overall Study|Withdrawal by Subject|1|||
27961750|NCT00900627|54619104|FG001|Overall Study|Withdrawal by Subject|0|||
27961751|NCT00900627|54619105|FG002|Overall Study|Withdrawal by Subject|1|||
27961752|NCT00900627|54619106|FG003|Overall Study|Withdrawal by Subject|0|||
27961753|NCT00900627|54619107|FG004|Overall Study|Withdrawal by Subject|1|||
27961754|NCT00900627|54619108|FG005|Overall Study|Withdrawal by Subject|2|||
27961755|NCT00900627|54619103|FG000|Overall Study|Adverse Event|1|||
27961756|NCT00900627|54619104|FG001|Overall Study|Adverse Event|2|||
27961757|NCT00900627|54619105|FG002|Overall Study|Adverse Event|0|||
27961758|NCT00900627|54619106|FG003|Overall Study|Adverse Event|3|||
27961759|NCT00900627|54619107|FG004|Overall Study|Adverse Event|0|||
27961760|NCT00900627|54619108|FG005|Overall Study|Adverse Event|0|||
27961761|NCT00900627|54619103|FG000|Overall Study|Death|0|||
27961762|NCT00900627|54619104|FG001|Overall Study|Death|0|||
27961763|NCT00900627|54619105|FG002|Overall Study|Death|0|||
27961764|NCT00900627|54619106|FG003|Overall Study|Death|0|||
27961765|NCT00900627|54619107|FG004|Overall Study|Death|28|||
27961766|NCT00900627|54619108|FG005|Overall Study|Death|24|||
27961767|NCT00866320|54619122|FG000|Overall Study|Withdrawal by Subject|4|||
27961768|NCT00866320|54619122|FG000|Overall Study|Death|2|||
27961769|NCT00869518|54619130|FG000|Overall Study|Lost to Follow-up|1|||
27961770|NCT00869518|54619131|FG001|Overall Study|Lost to Follow-up|1|||
27961771|NCT00797563|54619137|FG000|Overall Study|Adverse Event|1|||
27961772|NCT00869440|54619145|FG000|Overall Study|Withdrawal by Subject|1|||
27961773|NCT00869440|54619146|FG001|Overall Study|Withdrawal by Subject|0|||
27961774|NCT00869440|54619147|FG002|Overall Study|Withdrawal by Subject|0|||
27961775|NCT00869440|54619148|FG003|Overall Study|Withdrawal by Subject|0|||
27961776|NCT00869440|54619145|FG000|Overall Study|Physician Decision|1|||
28082475|NCT00078819|54736399|FG003|Withdrawal Period: Weeks 37-48|Entered Retreatment|13|||
28082476|NCT00078819|54736396|FG000|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
28082477|NCT00078819|54736397|FG001|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
27961777|NCT00869440|54619146|FG001|Overall Study|Physician Decision|1|||
27961778|NCT00869440|54619147|FG002|Overall Study|Physician Decision|0|||
27961779|NCT00869440|54619148|FG003|Overall Study|Physician Decision|0|||
27961780|NCT00895947|54619160|FG000|Overall Study|Adverse Event|3|||
27961781|NCT00895947|54619161|FG001|Overall Study|Adverse Event|4|||
27961782|NCT00895947|54619160|FG000|Overall Study|Lost to Follow-up|3|||
27961783|NCT00895947|54619161|FG001|Overall Study|Lost to Follow-up|4|||
27961784|NCT00895947|54619160|FG000|Overall Study|Protocol Violation|4|||
27961785|NCT00895947|54619161|FG001|Overall Study|Protocol Violation|2|||
27961786|NCT00895947|54619160|FG000|Overall Study|Withdrawal by Subject|2|||
27961787|NCT00895947|54619161|FG001|Overall Study|Withdrawal by Subject|0|||
27961788|NCT00869362|54619169|FG000|Overall Study|Death|0|||
27961789|NCT00869362|54619170|FG001|Overall Study|Death|2|||
27961790|NCT00869362|54619169|FG000|Overall Study|Lost to Follow-up|1|||
27961791|NCT00869362|54619170|FG001|Overall Study|Lost to Follow-up|3|||
27961792|NCT00588445|54619177|FG000|Overall Study|Protocol Violation|1|||
27961793|NCT00588445|54619177|FG000|Overall Study|Withdrawal by Subject|3|||
27961794|NCT00588445|54619177|FG000|Overall Study|Disease Progression|1|||
27961795|NCT00588445|54619177|FG000|Overall Study|Not Treated|10|||
27961796|NCT00796315|54619183|FG000|Overall Study|Protocol Violation|0|||
27961797|NCT00796315|54619184|FG001|Overall Study|Protocol Violation|1|||
27961798|NCT00796315|54619185|FG002|Overall Study|Protocol Violation|0|||
27961799|NCT00855166|54619198|FG000|Overall Study|Adverse Event|0|||
27961800|NCT00855166|54619199|FG001|Overall Study|Adverse Event|2|||
27961801|NCT00855166|54619198|FG000|Overall Study|Death|0|||
27961802|NCT00855166|54619199|FG001|Overall Study|Death|1|||
27961803|NCT00855166|54619198|FG000|Overall Study|Withdrawal by Subject|1|||
27961804|NCT00855166|54619199|FG001|Overall Study|Withdrawal by Subject|4|||
27961805|NCT00855166|54619198|FG000|Overall Study|Poor/non-compliance|2|||
27961806|NCT00855166|54619199|FG001|Overall Study|Poor/non-compliance|0|||
27961807|NCT00855166|54619198|FG000|Overall Study|Administrative reasons by sponsor|1|||
27961808|NCT00855166|54619199|FG001|Overall Study|Administrative reasons by sponsor|0|||
27961809|NCT00855166|54619198|FG000|Overall Study|Subject no longer meets study criteria|1|||
27961810|NCT00855166|54619199|FG001|Overall Study|Subject no longer meets study criteria|1|||
27961811|NCT00587587|54619209|FG000|Overall Study|Lost to Follow-up|6|||
27961812|NCT00587587|54619210|FG001|Overall Study|Lost to Follow-up|1|||
27961813|NCT00854620|54619218|FG000|Overall Study|Adverse Event|1|||
27961814|NCT00793585|54619224|FG000|Overall Study|Adverse Event|1|||
27961815|NCT00793585|54619225|FG001|Overall Study|Adverse Event|1|||
27961816|NCT00793585|54619224|FG000|Overall Study|Protocol Violation|1|||
27961817|NCT00793585|54619225|FG001|Overall Study|Protocol Violation|2|||
27961818|NCT00898443|54619233|FG000|Overall Study|Withdrawal by Subject|1|||
27961819|NCT00898443|54619234|FG001|Overall Study|Withdrawal by Subject|0|||
27961820|NCT00900159|54619242|FG000|Second Intervention|disempanelled for inappropriate behavior|1|||
27961821|NCT00900159|54619243|FG001|Second Intervention|disempanelled for inappropriate behavior|0|||
27961822|NCT00854308|54619262|FG000|Overall Study|Disease progression|42|||
27961823|NCT00854308|54619263|FG001|Overall Study|Disease progression|50|||
27961824|NCT00854308|54619262|FG000|Overall Study|Adverse Event|8|||
27961825|NCT00854308|54619263|FG001|Overall Study|Adverse Event|3|||
27961826|NCT00854308|54619262|FG000|Overall Study|Death|2|||
27961827|NCT00854308|54619263|FG001|Overall Study|Death|5|||
27961828|NCT00854308|54619262|FG000|Overall Study|Physician Decision|6|||
27961829|NCT00854308|54619263|FG001|Overall Study|Physician Decision|6|||
27961830|NCT00854308|54619262|FG000|Overall Study|Withdrawal by Subject|4|||
27961831|NCT00854308|54619263|FG001|Overall Study|Withdrawal by Subject|2|||
27961832|NCT00854308|54619262|FG000|Overall Study|Sponsor's decision to terminate study|0|||
27961833|NCT00854308|54619263|FG001|Overall Study|Sponsor's decision to terminate study|1|||
27961834|NCT00592852|54619269|FG000|Overall Study|Non-compliance|1|||
27961835|NCT00592852|54619269|FG000|Overall Study|Adverse Event|3|||
27961836|NCT00592852|54619269|FG000|Overall Study|Found ineligible|1|||
27961837|NCT00592852|54619269|FG000|Overall Study|Withdrawal by Subject|1|||
27961838|NCT00895245|54619273|FG000|Overall Study|Lack of Efficacy|6|||
27961839|NCT00865306|54619279|FG000|Controlled Trial|Lost to Follow-up|1|||
27961840|NCT00865306|54619280|FG001|Controlled Trial|Lost to Follow-up|1|||
27961841|NCT00865306|54619279|FG000|Controlled Trial|Difficulty commuting|2|||
27961842|NCT00865306|54619280|FG001|Controlled Trial|Difficulty commuting|0|||
27961843|NCT00865306|54619279|FG000|Controlled Trial|Improved btw baseline and first session|1|||
27961844|NCT00865306|54619280|FG001|Controlled Trial|Improved btw baseline and first session|0|||
27961845|NCT00865306|54619279|FG000|Controlled Trial|Sought treatment for conduct disorder|1|||
27961846|NCT00865306|54619280|FG001|Controlled Trial|Sought treatment for conduct disorder|0|||
27961847|NCT00865306|54619279|FG000|Controlled Trial|Withdrawal by Subject|0|||
27961848|NCT00865306|54619280|FG001|Controlled Trial|Withdrawal by Subject|1|||
28165145|NCT03016325|54835756|FG003|182-Day Follow-Up Period|Death|12|||
27832448|NCT01734785|54311698|FG001|Double-Blind Period|Lack of Efficacy|1|||
27961849|NCT00896649|54619286|FG000|Overall Study|Physician Decision|1|||
27961850|NCT00896649|54619286|FG000|Overall Study|Pregnancy|1|||
27961851|NCT00896649|54619286|FG000|Overall Study|missing documentation|1|||
27961852|NCT00896649|54619286|FG000|Overall Study|technical difficulties|2|||
27961853|NCT00796003|54619293|FG000|Overall Study|Disease Progression|2|||
27961854|NCT00796003|54619294|FG001|Overall Study|Disease Progression|13|||
27961855|NCT00796003|54619293|FG000|Overall Study|Adverse Event|1|||
27961856|NCT00796003|54619294|FG001|Overall Study|Adverse Event|7|||
27961857|NCT00796003|54619293|FG000|Overall Study|Specified organ function not met|0|||
27961858|NCT00796003|54619294|FG001|Overall Study|Specified organ function not met|1|||
27961859|NCT00796003|54619293|FG000|Overall Study|Physician Decision|0|||
27961860|NCT00796003|54619294|FG001|Overall Study|Physician Decision|4|||
27961861|NCT00796003|54619293|FG000|Overall Study|Withdrawal by Subject|0|||
27961862|NCT00796003|54619294|FG001|Overall Study|Withdrawal by Subject|1|||
27961863|NCT00796003|54619293|FG000|Overall Study|Other|0|||
27961864|NCT00796003|54619294|FG001|Overall Study|Other|1|||
27961865|NCT00796003|54619293|FG000|Overall Study|Participants Not treated|0|||
27961866|NCT00796003|54619294|FG001|Overall Study|Participants Not treated|2|||
27961867|NCT00895011|54619306|FG000|Overall Study|Withdrawal by Subject|14|||
27961868|NCT00895011|54619307|FG001|Overall Study|Withdrawal by Subject|7|||
27961869|NCT00895011|54619308|FG002|Overall Study|Withdrawal by Subject|2|||
27961870|NCT00895011|54619306|FG000|Overall Study|Lost to Follow-up|5|||
27961871|NCT00895011|54619307|FG001|Overall Study|Lost to Follow-up|4|||
27961872|NCT00895011|54619308|FG002|Overall Study|Lost to Follow-up|1|||
27961873|NCT00895011|54619306|FG000|Overall Study|Protocol Violation|3|||
27961874|NCT00895011|54619307|FG001|Overall Study|Protocol Violation|1|||
27961875|NCT00895011|54619308|FG002|Overall Study|Protocol Violation|3|||
27961876|NCT00895011|54619306|FG000|Overall Study|Adverse Event|1|||
28082478|NCT00078819|54736398|FG002|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
28082479|NCT00078819|54736399|FG003|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1|||
28082480|NCT00098865|54736416|FG000|Overall Study|Progressive Disease|6|||
28082481|NCT00098865|54736416|FG000|Overall Study|Adverse Event|2|||
27961877|NCT00895011|54619307|FG001|Overall Study|Adverse Event|2|||
27961878|NCT00895011|54619308|FG002|Overall Study|Adverse Event|2|||
27961879|NCT00895011|54619306|FG000|Overall Study|schedule conflict|1|||
27961880|NCT00895011|54619307|FG001|Overall Study|schedule conflict|0|||
27961881|NCT00895011|54619308|FG002|Overall Study|schedule conflict|0|||
27961882|NCT00899847|54619317|FG000|Overall Study|Lack of suitable allogeneic donor|2|||
27961883|NCT00795535|54619323|FG000|Overall Study|incomplete data and technical problems|20|||
27961884|NCT00853762|54619331|FG000|Overall Study|Premature Termination|16|||
27961885|NCT00853762|54619332|FG001|Overall Study|Premature Termination|15|||
27961886|NCT00853762|54619333|FG002|Overall Study|Premature Termination|14|||
27961887|NCT00853762|54619334|FG003|Overall Study|Premature Termination|21|||
27961888|NCT00853762|54619331|FG000|Overall Study|Protocol Violation|0|||
27961889|NCT00853762|54619332|FG001|Overall Study|Protocol Violation|0|||
27961890|NCT00853762|54619333|FG002|Overall Study|Protocol Violation|0|||
27961891|NCT00853762|54619334|FG003|Overall Study|Protocol Violation|1|||
27961892|NCT00853762|54619331|FG000|Overall Study|Withdrawal by Subject|0|||
27961893|NCT00853762|54619332|FG001|Overall Study|Withdrawal by Subject|0|||
27961894|NCT00853762|54619333|FG002|Overall Study|Withdrawal by Subject|1|||
27961895|NCT00853762|54619334|FG003|Overall Study|Withdrawal by Subject|0|||
27961896|NCT00853762|54619331|FG000|Overall Study|Other|0|||
27961897|NCT00853762|54619332|FG001|Overall Study|Other|2|||
27961898|NCT00853762|54619333|FG002|Overall Study|Other|0|||
27961899|NCT00853762|54619334|FG003|Overall Study|Other|0|||
28082482|NCT00098865|54736416|FG000|Overall Study|Alternative Therapy|1|||
28082483|NCT02954458|54736424|FG000|Overall Study|Adverse Event|0|||
28082484|NCT02954458|54736425|FG001|Overall Study|Adverse Event|0|||
28082485|NCT02954458|54736426|FG002|Overall Study|Adverse Event|0|||
28082486|NCT02954458|54736427|FG003|Overall Study|Adverse Event|1|||
28082487|NCT02954458|54736424|FG000|Overall Study|Withdrawal by Subject|0|||
28165146|NCT03016325|54835757|FG004|182-Day Follow-Up Period|Death|9|||
28082488|NCT02954458|54736425|FG001|Overall Study|Withdrawal by Subject|0|||
28082489|NCT02954458|54736426|FG002|Overall Study|Withdrawal by Subject|0|||
28082490|NCT02954458|54736427|FG003|Overall Study|Withdrawal by Subject|1|||
28082491|NCT02954458|54736424|FG000|Overall Study|Physician Decision|0|||
28082492|NCT02954458|54736425|FG001|Overall Study|Physician Decision|0|||
28082493|NCT02954458|54736426|FG002|Overall Study|Physician Decision|1|||
28165147|NCT03016325|54835758|FG005|182-Day Follow-Up Period|Death|0|||
28165148|NCT03016325|54835759|FG006|182-Day Follow-Up Period|Death|0|||
28165149|NCT03016325|54835760|FG007|182-Day Follow-Up Period|Death|1|||
28165150|NCT03016325|54835753|FG000|182-Day Follow-Up Period|Alive, per national insurance system|1|||
28165151|NCT03016325|54835754|FG001|182-Day Follow-Up Period|Alive, per national insurance system|0|||
27961900|NCT00853762|54619331|FG000|Overall Study|Randomised but not Treated|0|||
28082494|NCT02954458|54736427|FG003|Overall Study|Physician Decision|1|||
28165152|NCT03016325|54835755|FG002|182-Day Follow-Up Period|Alive, per national insurance system|0|||
28165153|NCT03016325|54835756|FG003|182-Day Follow-Up Period|Alive, per national insurance system|0|||
27961901|NCT00853762|54619332|FG001|Overall Study|Randomised but not Treated|2|||
27961902|NCT00853762|54619333|FG002|Overall Study|Randomised but not Treated|2|||
27961903|NCT00853762|54619334|FG003|Overall Study|Randomised but not Treated|0|||
27961904|NCT00789529|54619346|FG000|Overall Study|Withdrawal by Subject|0|||
27961905|NCT00789529|54619347|FG001|Overall Study|Withdrawal by Subject|1|||
27961906|NCT00789529|54619346|FG000|Overall Study|Other Reason|1|||
28082495|NCT02954458|54736424|FG000|Overall Study|Lost to Follow-up|1|||
28082496|NCT02954458|54736425|FG001|Overall Study|Lost to Follow-up|0|||
27961907|NCT00789529|54619347|FG001|Overall Study|Other Reason|0|||
28082497|NCT02954458|54736426|FG002|Overall Study|Lost to Follow-up|0|||
28082498|NCT02954458|54736427|FG003|Overall Study|Lost to Follow-up|1|||
27961908|NCT00894933|54619353|FG000|Overall Study|Lost to Follow-up|2|||
28082499|NCT02954458|54736424|FG000|Overall Study|Death|0|||
28082500|NCT02954458|54736425|FG001|Overall Study|Death|0|||
28082501|NCT02954458|54736426|FG002|Overall Study|Death|0|||
28082502|NCT02954458|54736427|FG003|Overall Study|Death|1|||
28082503|NCT02954458|54736424|FG000|Overall Study|Other|0|||
28082504|NCT02954458|54736425|FG001|Overall Study|Other|0|||
28082505|NCT02954458|54736426|FG002|Overall Study|Other|0|||
27855134|NCT01279057|54375432|FG001|Overall Study|Other|3|||
27855135|NCT01279057|54375433|FG002|Overall Study|Other|0|||
27855136|NCT02999633|54375441|FG000|Overall Study|Adverse Event|2|||
27961909|NCT00894933|54619353|FG000|Overall Study|Cancelled Procedure|1|||
28082506|NCT02954458|54736427|FG003|Overall Study|Other|7|||
28082507|NCT03500224|54736441|FG000|Overall Study|Withdrawal by Subject|2|||
28082508|NCT03495154|54736445|FG000|Overall Study|Screen Failures Pre-Operatively|3|||
28082509|NCT03495154|54736445|FG000|Overall Study|Withdrawn Prior to Surgery|11|||
28082510|NCT03495154|54736445|FG000|Overall Study|Screen Failures During Surgery|6|||
27961910|NCT00894933|54619353|FG000|Overall Study|Did not meeting incl/excl criteria|1|||
27961911|NCT00792805|54619360|FG000|Overall Study|Adverse Event|12|||
27961912|NCT00792805|54619361|FG001|Overall Study|Adverse Event|10|||
27961913|NCT00792805|54619362|FG002|Overall Study|Adverse Event|10|||
27961914|NCT00792805|54619360|FG000|Overall Study|Subject withdrew consent|5|||
27961915|NCT00792805|54619361|FG001|Overall Study|Subject withdrew consent|6|||
27961916|NCT00792805|54619362|FG002|Overall Study|Subject withdrew consent|5|||
27961917|NCT00792805|54619360|FG000|Overall Study|Administrative problems|2|||
27961918|NCT00792805|54619361|FG001|Overall Study|Administrative problems|0|||
27961919|NCT00792805|54619362|FG002|Overall Study|Administrative problems|4|||
27961920|NCT00792805|54619360|FG000|Overall Study|Abnormal test procedure result(s)|1|||
27961921|NCT00792805|54619361|FG001|Overall Study|Abnormal test procedure result(s)|2|||
27961922|NCT00792805|54619362|FG002|Overall Study|Abnormal test procedure result(s)|0|||
27961923|NCT00792805|54619360|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
27961924|NCT00792805|54619361|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
28082511|NCT03495154|54736445|FG000|Overall Study|Death|2|||
28082512|NCT03495154|54736445|FG000|Overall Study|Lost to Follow-up|6|||
27961925|NCT00792805|54619362|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
27961926|NCT00792805|54619360|FG000|Overall Study|Lost to Follow-up|1|||
27961927|NCT00792805|54619361|FG001|Overall Study|Lost to Follow-up|1|||
27961928|NCT00792805|54619362|FG002|Overall Study|Lost to Follow-up|6|||
27961929|NCT00792805|54619360|FG000|Overall Study|Abnormal laboratory value(s)|0|||
27961930|NCT00792805|54619361|FG001|Overall Study|Abnormal laboratory value(s)|0|||
27961931|NCT00792805|54619362|FG002|Overall Study|Abnormal laboratory value(s)|1|||
27961932|NCT00792805|54619360|FG000|Overall Study|Protocol deviation|0|||
27961933|NCT00792805|54619361|FG001|Overall Study|Protocol deviation|1|||
27961934|NCT00792805|54619362|FG002|Overall Study|Protocol deviation|1|||
27961935|NCT00925002|54619373|FG000|Overall Study|Other|1|||
27961936|NCT00925002|54619374|FG001|Overall Study|Other|4|||
27961937|NCT00925002|54619375|FG002|Overall Study|Other|0|||
27961938|NCT00925002|54619373|FG000|Overall Study|Death|1|||
27961939|NCT00925002|54619374|FG001|Overall Study|Death|1|||
27961940|NCT00925002|54619375|FG002|Overall Study|Death|5|||
27961941|NCT00925002|54619373|FG000|Overall Study|Adverse Event|3|||
27961942|NCT00925002|54619374|FG001|Overall Study|Adverse Event|1|||
27961943|NCT00925002|54619375|FG002|Overall Study|Adverse Event|2|||
27961944|NCT00925002|54619373|FG000|Overall Study|Participant withdrew consent|1|||
27961945|NCT00925002|54619374|FG001|Overall Study|Participant withdrew consent|3|||
27961946|NCT00925002|54619375|FG002|Overall Study|Participant withdrew consent|3|||
27961947|NCT00928746|54619384|FG000|Overall Study|Adverse Event|2|||
27961948|NCT00928746|54619384|FG000|Overall Study|Protocol Violation|1|||
27961949|NCT00928746|54619384|FG000|Overall Study|Withdrawal by Subject|1|||
27961950|NCT00928746|54619384|FG000|Overall Study|Other|2|||
27961951|NCT00922428|54619390|FG000|Overall Study|retrospective/extremely implausible data|2|||
27961952|NCT00922428|54619390|FG000|Overall Study|no medication use or questionable use|13|||
27961953|NCT00894543|54619402|FG000|Baseline to Week 4|No diary or lost or withdrew|3|||
27961954|NCT00894543|54619403|FG001|Baseline to Week 4|No diary or lost or withdrew|2|||
27961955|NCT00894543|54619402|FG000|Week 4 to Week 8|No diary or lost or withdrew|4|||
27961956|NCT00894543|54619403|FG001|Week 4 to Week 8|No diary or lost or withdrew|2|||
27961957|NCT00922272|54619409|FG000|Open-label Phase|Adverse Event|5|||
28082513|NCT03495154|54736445|FG000|Overall Study|Protocol Violation|1|||
28082514|NCT03495154|54736445|FG000|Overall Study|Withdrawal by Subject|1|||
27855137|NCT02999633|54375441|FG000|Overall Study|Progressive disease|12|||
27855138|NCT01278745|54375543|FG000|Overall Study|Death|2|||
28082515|NCT00077649|54736453|FG000|Overall Study|Adverse Event|5|||
27855139|NCT01278745|54375544|FG001|Overall Study|Death|5|||
27855140|NCT01278745|54375545|FG002|Overall Study|Death|7|||
27961958|NCT00922272|54619410|FG001|Open-label Phase|Adverse Event|0|||
27961959|NCT00922272|54619409|FG000|Open-label Phase|Protocol Violation|1|||
28082516|NCT00077649|54736454|FG001|Overall Study|Adverse Event|1|||
28082517|NCT00077649|54736455|FG002|Overall Study|Adverse Event|7|||
27961960|NCT00922272|54619410|FG001|Open-label Phase|Protocol Violation|0|||
27961961|NCT00922272|54619409|FG000|Open-label Phase|Withdrawal by Subject|11|||
27961962|NCT00922272|54619410|FG001|Open-label Phase|Withdrawal by Subject|0|||
27961963|NCT00922272|54619409|FG000|Open-label Phase|Failure to meet randomization criteria|1|||
27961964|NCT00922272|54619410|FG001|Open-label Phase|Failure to meet randomization criteria|0|||
27961965|NCT00922272|54619409|FG000|Open-label Phase|Withdrawal criteria met|5|||
28082518|NCT00077649|54736456|FG003|Overall Study|Adverse Event|9|||
27732456|NCT02579096|54179983|FG001|Phase 2, Weeks 25 - 48|Death|4|||
27961966|NCT00922272|54619410|FG001|Open-label Phase|Withdrawal criteria met|0|||
27961967|NCT00922272|54619409|FG000|Double-blind Phase|Adverse Event|1|||
27961968|NCT00922272|54619410|FG001|Double-blind Phase|Adverse Event|1|||
27961969|NCT00922272|54619409|FG000|Double-blind Phase|Withdrawal by Subject|1|||
27961970|NCT00922272|54619410|FG001|Double-blind Phase|Withdrawal by Subject|1|||
27961971|NCT00922272|54619409|FG000|Double-blind Phase|Lost to Follow-up|2|||
27961972|NCT00922272|54619410|FG001|Double-blind Phase|Lost to Follow-up|1|||
27961973|NCT00922272|54619409|FG000|Double-blind Phase|Withdrawal criteria met|1|||
27961974|NCT00922272|54619410|FG001|Double-blind Phase|Withdrawal criteria met|1|||
27961975|NCT00922272|54619409|FG000|Double-blind Phase|Noncompliance|1|||
27961976|NCT00922272|54619410|FG001|Double-blind Phase|Noncompliance|1|||
27961977|NCT00922272|54619409|FG000|Double-blind Phase|Positive urine drug screen|1|||
27961978|NCT00922272|54619410|FG001|Double-blind Phase|Positive urine drug screen|1|||
27961979|NCT00853372|54619420|FG000|Overall Study|Death|30|||
27961980|NCT00853372|54619421|FG001|Overall Study|Death|26|||
27961981|NCT00853372|54619420|FG000|Overall Study|Lost to Follow-up|1|||
27961982|NCT00853372|54619421|FG001|Overall Study|Lost to Follow-up|2|||
27961983|NCT00853372|54619420|FG000|Overall Study|Full Consent Withdrawn|1|||
27961984|NCT00853372|54619421|FG001|Overall Study|Full Consent Withdrawn|1|||
28082519|NCT00077649|54736453|FG000|Overall Study|Lack of Efficacy|5|||
27732457|NCT02579096|54179982|FG000|Phase 2, Weeks 25 - 48|Side effects with study medications|3|||
27732458|NCT02579096|54179983|FG001|Phase 2, Weeks 25 - 48|Side effects with study medications|1|||
27732459|NCT02579096|54179982|FG000|Phase 2, Weeks 25 - 48|Physician Decision|4|||
27732460|NCT02579096|54179983|FG001|Phase 2, Weeks 25 - 48|Physician Decision|0|||
27732461|NCT02579096|54179982|FG000|Phase 2, Weeks 25 - 48|Withdrawal by Subject|9|||
27732462|NCT02579096|54179983|FG001|Phase 2, Weeks 25 - 48|Withdrawal by Subject|12|||
27732463|NCT02579096|54179982|FG000|Phase 2, Weeks 25 - 48|Lost to Follow-up|4|||
27732464|NCT02579096|54179983|FG001|Phase 2, Weeks 25 - 48|Lost to Follow-up|9|||
27732465|NCT02579096|54179982|FG000|Phase 2, Weeks 25 - 48|Other reasons|0|||
27732466|NCT02579096|54179983|FG001|Phase 2, Weeks 25 - 48|Other reasons|5|||
27732467|NCT02579096|54179982|FG000|Phase 3, Weeks 49 - 72|Death|3|||
27732468|NCT02579096|54179983|FG001|Phase 3, Weeks 49 - 72|Death|2|||
27732469|NCT02579096|54179982|FG000|Phase 3, Weeks 49 - 72|Side effects with study medications|0|||
27732470|NCT02579096|54179983|FG001|Phase 3, Weeks 49 - 72|Side effects with study medications|1|||
27732471|NCT02579096|54179982|FG000|Phase 3, Weeks 49 - 72|Physician Decision|0|||
27732472|NCT02579096|54179983|FG001|Phase 3, Weeks 49 - 72|Physician Decision|5|||
27732473|NCT02579096|54179982|FG000|Phase 3, Weeks 49 - 72|Withdrawal by Subject|6|||
27732474|NCT02579096|54179983|FG001|Phase 3, Weeks 49 - 72|Withdrawal by Subject|4|||
27732475|NCT02579096|54179982|FG000|Phase 3, Weeks 49 - 72|Lost to Follow-up|10|||
27732476|NCT02579096|54179983|FG001|Phase 3, Weeks 49 - 72|Lost to Follow-up|5|||
27732477|NCT02579096|54179982|FG000|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|0|||
27732478|NCT02579096|54179983|FG001|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|1|||
27732479|NCT02579096|54179982|FG000|Phase 3, Weeks 49 - 72|Other reasons|3|||
27732480|NCT02579096|54179983|FG001|Phase 3, Weeks 49 - 72|Other reasons|0|||
27732481|NCT02578940|54179989|FG000|Overall Study|Screening failure|5|||
27732482|NCT02578940|54179989|FG000|Overall Study|Lost to Follow-up|1|||
27732483|NCT02578862|54179997|FG000|Overall Study|Withdrawal by Subject|0|||
27732484|NCT02578862|54179998|FG001|Overall Study|Withdrawal by Subject|1|||
27732485|NCT02578862|54179997|FG000|Overall Study|Unplanned unilateral procedure|0|||
27732486|NCT02578862|54179998|FG001|Overall Study|Unplanned unilateral procedure|1|||
27732487|NCT02578706|54180007|FG000|Overall Study|Withdrawal by Subject|1|||
27732488|NCT02578706|54180008|FG001|Overall Study|Withdrawal by Subject|0|||
27732489|NCT02578706|54180009|FG002|Overall Study|Withdrawal by Subject|0|||
27732490|NCT02578706|54180007|FG000|Overall Study|Lost to Follow-up|0|||
27732491|NCT02578706|54180008|FG001|Overall Study|Lost to Follow-up|4|||
27732492|NCT02578706|54180009|FG002|Overall Study|Lost to Follow-up|0|||
27832449|NCT01734785|54311699|FG002|Double-Blind Period|Lack of Efficacy|0|||
27832450|NCT01734785|54311700|FG003|Double-Blind Period|Lack of Efficacy|0|||
27961985|NCT00848536|54619429|FG000|Overall Study|Adverse Event|2|||
27961986|NCT00848536|54619430|FG001|Overall Study|Adverse Event|2|||
27961987|NCT00848536|54619429|FG000|Overall Study|Withdrawal by Subject|0|||
27961988|NCT00848536|54619430|FG001|Overall Study|Withdrawal by Subject|1|||
27961989|NCT00848536|54619429|FG000|Overall Study|Protocol Violation|0|||
27961990|NCT00848536|54619430|FG001|Overall Study|Protocol Violation|1|||
27961991|NCT00848536|54619429|FG000|Overall Study|Noncompliance|1|||
27961992|NCT00848536|54619430|FG001|Overall Study|Noncompliance|0|||
27961993|NCT00848536|54619429|FG000|Overall Study|Inadequate Control of IOP|1|||
27961994|NCT00848536|54619430|FG001|Overall Study|Inadequate Control of IOP|1|||
27961995|NCT00848536|54619429|FG000|Overall Study|Patient Moved|0|||
27961996|NCT00848536|54619430|FG001|Overall Study|Patient Moved|2|||
27961997|NCT00922116|54619436|FG000|Overall Study|Adverse Event|4|||
27961998|NCT00922116|54619436|FG000|Overall Study|Death|1|||
27961999|NCT00922116|54619436|FG000|Overall Study|Lost to Follow-up|1|||
27962000|NCT00922116|54619436|FG000|Overall Study|Withdrawal by Subject|4|||
27962001|NCT00922116|54619436|FG000|Overall Study|Other|5|||
27962002|NCT00921024|54619442|FG000|Overall Study|Lost to Follow-up|2|||
27962003|NCT00921024|54619443|FG001|Overall Study|Lost to Follow-up|0|||
27962004|NCT00921024|54619442|FG000|Overall Study|Received concomittant therapy|2|||
27962005|NCT00921024|54619443|FG001|Overall Study|Received concomittant therapy|0|||
27962006|NCT00921024|54619442|FG000|Overall Study|Withdrawal by Subject|0|||
27962007|NCT00921024|54619443|FG001|Overall Study|Withdrawal by Subject|3|||
27962008|NCT00928668|54619449|FG000|Overall Study|Adverse Event|1|||
27962009|NCT00928668|54619450|FG001|Overall Study|Adverse Event|0|||
27962010|NCT00928668|54619451|FG002|Overall Study|Adverse Event|0|||
27962011|NCT00928668|54619452|FG003|Overall Study|Adverse Event|0|||
28082520|NCT00077649|54736454|FG001|Overall Study|Lack of Efficacy|3|||
28082521|NCT00077649|54736455|FG002|Overall Study|Lack of Efficacy|3|||
28082522|NCT00077649|54736456|FG003|Overall Study|Lack of Efficacy|2|||
28082523|NCT00077649|54736453|FG000|Overall Study|Withdrawal by Subject|0|||
28082524|NCT00077649|54736454|FG001|Overall Study|Withdrawal by Subject|1|||
28082525|NCT00077649|54736455|FG002|Overall Study|Withdrawal by Subject|1|||
28082526|NCT00077649|54736456|FG003|Overall Study|Withdrawal by Subject|2|||
28082527|NCT00077649|54736453|FG000|Overall Study|Lost to Follow-up|2|||
28082528|NCT00077649|54736454|FG001|Overall Study|Lost to Follow-up|2|||
28082529|NCT00077649|54736455|FG002|Overall Study|Lost to Follow-up|3|||
28082530|NCT00077649|54736456|FG003|Overall Study|Lost to Follow-up|2|||
28082531|NCT00077649|54736453|FG000|Overall Study|Abnormality of Laboratory Test|1|||
28082532|NCT00077649|54736454|FG001|Overall Study|Abnormality of Laboratory Test|2|||
28082533|NCT00077649|54736455|FG002|Overall Study|Abnormality of Laboratory Test|1|||
28082534|NCT00077649|54736456|FG003|Overall Study|Abnormality of Laboratory Test|2|||
27962012|NCT00928668|54619453|FG004|Overall Study|Adverse Event|0|||
27962013|NCT00928668|54619449|FG000|Overall Study|Protocol Violation|0|||
27962014|NCT00928668|54619450|FG001|Overall Study|Protocol Violation|0|||
27962015|NCT00928668|54619451|FG002|Overall Study|Protocol Violation|0|||
27962016|NCT00928668|54619452|FG003|Overall Study|Protocol Violation|0|||
27962017|NCT00928668|54619453|FG004|Overall Study|Protocol Violation|1|||
27962018|NCT00928668|54619449|FG000|Overall Study|Withdrawal by Subject|0|||
27962019|NCT00928668|54619450|FG001|Overall Study|Withdrawal by Subject|1|||
27962020|NCT00928668|54619451|FG002|Overall Study|Withdrawal by Subject|1|||
27962021|NCT00928668|54619452|FG003|Overall Study|Withdrawal by Subject|0|||
27962022|NCT00928668|54619453|FG004|Overall Study|Withdrawal by Subject|0|||
27962023|NCT00928668|54619449|FG000|Overall Study|Other reasons not listed above|0|||
27962024|NCT00928668|54619450|FG001|Overall Study|Other reasons not listed above|0|||
27962025|NCT00928668|54619451|FG002|Overall Study|Other reasons not listed above|0|||
27962026|NCT00928668|54619452|FG003|Overall Study|Other reasons not listed above|1|||
27962027|NCT00928668|54619453|FG004|Overall Study|Other reasons not listed above|0|||
27962028|NCT00592774|54619475|FG000|Overall Study|Adverse Event|5|||
28082535|NCT00077649|54736453|FG000|Overall Study|Randomized but never dosed|1|||
28082536|NCT00077649|54736454|FG001|Overall Study|Randomized but never dosed|0|||
28082537|NCT00077649|54736455|FG002|Overall Study|Randomized but never dosed|0|||
28082538|NCT00077649|54736456|FG003|Overall Study|Randomized but never dosed|0|||
28082539|NCT00038948|54736472|FG000|Overall Study|Adverse Event|131|||
28082540|NCT00038948|54736473|FG001|Overall Study|Adverse Event|43|||
28082541|NCT00038948|54736472|FG000|Overall Study|Lost to Follow-up|4|||
28082542|NCT00038948|54736473|FG001|Overall Study|Lost to Follow-up|4|||
27962029|NCT00592774|54619476|FG001|Overall Study|Adverse Event|19|||
27962030|NCT00592774|54619477|FG002|Overall Study|Adverse Event|2|||
27962031|NCT00592774|54619478|FG003|Overall Study|Adverse Event|14|||
27962032|NCT00592774|54619479|FG004|Overall Study|Adverse Event|8|||
27962033|NCT00592774|54619475|FG000|Overall Study|Protocol Violation|0|||
27962034|NCT00592774|54619476|FG001|Overall Study|Protocol Violation|1|||
27962035|NCT00592774|54619477|FG002|Overall Study|Protocol Violation|0|||
27962036|NCT00592774|54619478|FG003|Overall Study|Protocol Violation|0|||
27962037|NCT00592774|54619479|FG004|Overall Study|Protocol Violation|1|||
28082543|NCT00038948|54736472|FG000|Overall Study|Nonmedical event|5|||
28082544|NCT00038948|54736473|FG001|Overall Study|Nonmedical event|7|||
28082545|NCT00038948|54736472|FG000|Overall Study|Withdrawal by Subject|23|||
28082546|NCT00038948|54736473|FG001|Overall Study|Withdrawal by Subject|10|||
28082547|NCT00038948|54736472|FG000|Overall Study|Protocol Violation|3|||
27962038|NCT00592774|54619475|FG000|Overall Study|Withdrawal by Subject|3|||
27962039|NCT00592774|54619476|FG001|Overall Study|Withdrawal by Subject|7|||
27962040|NCT00592774|54619477|FG002|Overall Study|Withdrawal by Subject|0|||
27962041|NCT00592774|54619478|FG003|Overall Study|Withdrawal by Subject|0|||
28082548|NCT00038948|54736473|FG001|Overall Study|Protocol Violation|7|||
27962042|NCT00592774|54619479|FG004|Overall Study|Withdrawal by Subject|0|||
27962043|NCT00592774|54619475|FG000|Overall Study|Lack of Efficacy|3|||
27962044|NCT00592774|54619476|FG001|Overall Study|Lack of Efficacy|3|||
27962045|NCT00592774|54619477|FG002|Overall Study|Lack of Efficacy|0|||
27962046|NCT00592774|54619478|FG003|Overall Study|Lack of Efficacy|0|||
27962047|NCT00592774|54619479|FG004|Overall Study|Lack of Efficacy|2|||
27962048|NCT00592774|54619475|FG000|Overall Study|Physician Decision|0|||
27962049|NCT00592774|54619476|FG001|Overall Study|Physician Decision|1|||
27962050|NCT00592774|54619477|FG002|Overall Study|Physician Decision|1|||
27962051|NCT00592774|54619478|FG003|Overall Study|Physician Decision|0|||
27962052|NCT00592774|54619479|FG004|Overall Study|Physician Decision|1|||
27962053|NCT00592774|54619475|FG000|Overall Study|Other|0|||
27962054|NCT00592774|54619476|FG001|Overall Study|Other|1|||
27962055|NCT00592774|54619477|FG002|Overall Study|Other|1|||
27962056|NCT00592774|54619478|FG003|Overall Study|Other|0|||
27962057|NCT00592774|54619479|FG004|Overall Study|Other|2|||
27962058|NCT00837694|54619497|FG000|Overall Study|Lost to Follow-up|2|||
27962059|NCT00837694|54619498|FG001|Overall Study|Lost to Follow-up|0|||
27962060|NCT00837694|54619499|FG002|Overall Study|Lost to Follow-up|2|||
27832451|NCT01734785|54311697|FG000|Double-Blind Period|Protocol Violation|0|||
27832452|NCT01734785|54311698|FG001|Double-Blind Period|Protocol Violation|1|||
27832453|NCT01734785|54311699|FG002|Double-Blind Period|Protocol Violation|1|||
27832454|NCT01734785|54311700|FG003|Double-Blind Period|Protocol Violation|0|||
27832455|NCT01734785|54311697|FG000|Double-Blind Period|Lost to Follow-up|2|||
27832456|NCT01734785|54311698|FG001|Double-Blind Period|Lost to Follow-up|4|||
27832457|NCT01734785|54311699|FG002|Double-Blind Period|Lost to Follow-up|2|||
27832458|NCT01734785|54311700|FG003|Double-Blind Period|Lost to Follow-up|0|||
27832459|NCT01734785|54311697|FG000|Double-Blind Period|Withdrawal by Subject|2|||
27832460|NCT01734785|54311698|FG001|Double-Blind Period|Withdrawal by Subject|0|||
27832461|NCT01734785|54311699|FG002|Double-Blind Period|Withdrawal by Subject|0|||
27832462|NCT01734785|54311700|FG003|Double-Blind Period|Withdrawal by Subject|0|||
27832463|NCT01734785|54311697|FG000|Double-Blind Period|Not treated|1|||
27832464|NCT01734785|54311698|FG001|Double-Blind Period|Not treated|0|||
27832465|NCT01734785|54311699|FG002|Double-Blind Period|Not treated|0|||
27832466|NCT01734785|54311700|FG003|Double-Blind Period|Not treated|0|||
27832467|NCT01734395|54311709|FG000|Overall Study|Other|65|||
27832468|NCT01734395|54311709|FG000|Overall Study|Lost to Follow-up|287|||
27832469|NCT01734395|54311709|FG000|Overall Study|Lack of Efficacy|5|||
27832470|NCT01734395|54311709|FG000|Overall Study|Adverse Event|40|||
27832471|NCT01734395|54311709|FG000|Overall Study|Withdrawal by Subject|10|||
27832472|NCT01734395|54311709|FG000|Overall Study|Missing the reasons for not completed|3|||
27962061|NCT00837694|54619500|FG003|Overall Study|Lost to Follow-up|1|||
27962062|NCT00837694|54619501|FG004|Overall Study|Lost to Follow-up|1|||
27962063|NCT00837694|54619502|FG005|Overall Study|Lost to Follow-up|1|||
27962064|NCT00852202|54619519|FG000|Overall Study|Adverse Event|2|||
27855141|NCT01278745|54375546|FG003|Overall Study|Death|0|||
27962065|NCT00852202|54619520|FG001|Overall Study|Adverse Event|3|||
27962066|NCT00852202|54619521|FG002|Overall Study|Adverse Event|7|||
27962067|NCT00852202|54619519|FG000|Overall Study|Lack of Efficacy|4|||
27962068|NCT00852202|54619520|FG001|Overall Study|Lack of Efficacy|1|||
28082549|NCT00038948|54736472|FG000|Overall Study|Lack of Efficacy|3|||
28082550|NCT00038948|54736473|FG001|Overall Study|Lack of Efficacy|6|||
28082551|NCT00054704|54736487|FG000|Overall Study|Lack of Efficacy|2|||
28082552|NCT00054704|54736488|FG001|Overall Study|Lack of Efficacy|3|||
27962069|NCT00852202|54619521|FG002|Overall Study|Lack of Efficacy|2|||
27962070|NCT00852202|54619519|FG000|Overall Study|Protocol Violation|2|||
27962071|NCT00852202|54619520|FG001|Overall Study|Protocol Violation|2|||
27962072|NCT00852202|54619521|FG002|Overall Study|Protocol Violation|7|||
27962073|NCT00852202|54619519|FG000|Overall Study|Withdrawal by Subject|3|||
27962074|NCT00852202|54619520|FG001|Overall Study|Withdrawal by Subject|1|||
27962075|NCT00852202|54619521|FG002|Overall Study|Withdrawal by Subject|2|||
27962076|NCT00852202|54619519|FG000|Overall Study|Lost to Follow-up|5|||
27962077|NCT00852202|54619520|FG001|Overall Study|Lost to Follow-up|5|||
27855142|NCT01278745|54375543|FG000|Overall Study|Physician Decision|1|||
27962078|NCT00852202|54619521|FG002|Overall Study|Lost to Follow-up|6|||
27832481|NCT01597505|54311752|FG000|Overall Study|Physician Decision|5|||
27832482|NCT01597505|54311753|FG001|Overall Study|Physician Decision|0|||
27832483|NCT01597505|54311752|FG000|Overall Study|Adverse Event|19|||
27962079|NCT00852202|54619519|FG000|Overall Study|pregnancy,moving away and surgery|1|||
28082553|NCT00054704|54736487|FG000|Overall Study|Adverse Event|3|||
27832484|NCT01597505|54311753|FG001|Overall Study|Adverse Event|7|||
27962080|NCT00852202|54619520|FG001|Overall Study|pregnancy,moving away and surgery|0|||
27962081|NCT00852202|54619521|FG002|Overall Study|pregnancy,moving away and surgery|2|||
27832485|NCT01597505|54311752|FG000|Overall Study|Lost to Follow-up|4|||
27962082|NCT01074008|54619539|FG000|Overall Study|Adverse Event|0|||
27962083|NCT01074008|54619540|FG001|Overall Study|Adverse Event|1|||
27962084|NCT01074008|54619541|FG002|Overall Study|Adverse Event|0|||
27962085|NCT01074008|54619542|FG003|Overall Study|Adverse Event|0|||
27962086|NCT01074008|54619543|FG004|Overall Study|Adverse Event|0|||
28082554|NCT00054704|54736488|FG001|Overall Study|Adverse Event|1|||
28082555|NCT00054704|54736487|FG000|Overall Study|Lost to Follow-up|0|||
28082556|NCT00054704|54736488|FG001|Overall Study|Lost to Follow-up|1|||
28082557|NCT00031694|54736494|FG000|Overall Study|Adverse Event|12|||
28082558|NCT00031694|54736494|FG000|Overall Study|Death|2|||
28082559|NCT00031694|54736494|FG000|Overall Study|Withdrawal by Subject|5|||
28082560|NCT00093795|54736502|FG000|Overall Study|No follow up data|20|||
28082561|NCT00093795|54736503|FG001|Overall Study|No follow up data|16|||
28082562|NCT00093795|54736504|FG002|Overall Study|No follow up data|17|||
28082563|NCT03467152|54736514|FG000|Overall Study|Adverse Event|4|||
28082564|NCT03467152|54736515|FG001|Overall Study|Adverse Event|5|||
28082565|NCT03467152|54736516|FG002|Overall Study|Adverse Event|0|||
27855143|NCT01278745|54375544|FG001|Overall Study|Physician Decision|0|||
27855144|NCT01278745|54375545|FG002|Overall Study|Physician Decision|0|||
27855145|NCT01278745|54375546|FG003|Overall Study|Physician Decision|9|||
27855146|NCT01278745|54375543|FG000|Overall Study|Withdrawal by Subject|1|||
27855147|NCT01278745|54375544|FG001|Overall Study|Withdrawal by Subject|1|||
27855148|NCT01278745|54375545|FG002|Overall Study|Withdrawal by Subject|5|||
27855149|NCT01278745|54375546|FG003|Overall Study|Withdrawal by Subject|1|||
27855150|NCT01278745|54375543|FG000|Overall Study|Sponsor Decision|1|||
27855151|NCT01278745|54375544|FG001|Overall Study|Sponsor Decision|0|||
27855152|NCT01278745|54375545|FG002|Overall Study|Sponsor Decision|62|||
27962087|NCT01074008|54619544|FG005|Overall Study|Adverse Event|0|||
27962088|NCT01074008|54619545|FG006|Overall Study|Adverse Event|0|||
27962089|NCT01074008|54619546|FG007|Overall Study|Adverse Event|0|||
27962090|NCT01074008|54619547|FG008|Overall Study|Adverse Event|0|||
27962091|NCT01074008|54619539|FG000|Overall Study|Withdrawal by Subject|1|||
27962092|NCT01074008|54619540|FG001|Overall Study|Withdrawal by Subject|1|||
27962093|NCT01074008|54619541|FG002|Overall Study|Withdrawal by Subject|1|||
27962094|NCT01074008|54619542|FG003|Overall Study|Withdrawal by Subject|0|||
27962095|NCT01074008|54619543|FG004|Overall Study|Withdrawal by Subject|1|||
27962096|NCT01074008|54619544|FG005|Overall Study|Withdrawal by Subject|0|||
27962097|NCT01074008|54619545|FG006|Overall Study|Withdrawal by Subject|0|||
27962098|NCT01074008|54619546|FG007|Overall Study|Withdrawal by Subject|0|||
27962099|NCT01074008|54619547|FG008|Overall Study|Withdrawal by Subject|0|||
27962100|NCT01074008|54619539|FG000|Overall Study|Lost to Follow-up|0|||
27962101|NCT01074008|54619540|FG001|Overall Study|Lost to Follow-up|1|||
27962102|NCT01074008|54619541|FG002|Overall Study|Lost to Follow-up|1|||
27962103|NCT01074008|54619542|FG003|Overall Study|Lost to Follow-up|1|||
27962104|NCT01074008|54619543|FG004|Overall Study|Lost to Follow-up|1|||
27962105|NCT01074008|54619544|FG005|Overall Study|Lost to Follow-up|0|||
27962106|NCT01074008|54619545|FG006|Overall Study|Lost to Follow-up|1|||
27962107|NCT01074008|54619546|FG007|Overall Study|Lost to Follow-up|0|||
27962108|NCT01074008|54619547|FG008|Overall Study|Lost to Follow-up|4|||
27962109|NCT01073930|54619578|FG000|Overall Study|Withdrawal by Subject|3|||
27962110|NCT01073930|54619579|FG001|Overall Study|Withdrawal by Subject|2|||
27962111|NCT01073930|54619578|FG000|Overall Study|Lost to Follow-up|0|||
27962112|NCT01073930|54619579|FG001|Overall Study|Lost to Follow-up|1|||
27962113|NCT01073930|54619578|FG000|Overall Study|Adverse Event|0|||
27962114|NCT01073930|54619579|FG001|Overall Study|Adverse Event|1|||
27962115|NCT01073930|54619578|FG000|Overall Study|Noncompliance with study drug|0|||
27962116|NCT01073930|54619579|FG001|Overall Study|Noncompliance with study drug|1|||
27962117|NCT01073930|54619578|FG000|Overall Study|Inadequate prep; unable to do procedure|0|||
27962118|NCT01073930|54619579|FG001|Overall Study|Inadequate prep; unable to do procedure|1|||
27962119|NCT01073618|54619585|FG000|Overall Study|Death|208|||
27962120|NCT01073618|54619585|FG000|Overall Study|Adverse Event|19|||
27962121|NCT01073618|54619585|FG000|Overall Study|Other|80|||
27962122|NCT01073462|54619589|FG000|Overall Study|Death|14|||
27962123|NCT01073462|54619589|FG000|Overall Study|Kidney transplant|10|||
27962124|NCT01073462|54619589|FG000|Overall Study|Low parathyroid hormone levels|8|||
27962125|NCT01073462|54619589|FG000|Overall Study|Serious adverse event|2|||
27962126|NCT01073462|54619589|FG000|Overall Study|Lost to Follow-up|7|||
27962127|NCT00789373|54619593|FG000|Induction|Adverse Event|64|||
27962128|NCT00789373|54619594|FG001|Induction|Adverse Event|0|||
28082566|NCT03467152|54736514|FG000|Overall Study|Subject Choice|1|||
27962129|NCT00789373|54619595|FG002|Induction|Adverse Event|0|||
27962130|NCT00789373|54619593|FG000|Induction|Death Due to study disease|24|||
27962131|NCT00789373|54619594|FG001|Induction|Death Due to study disease|0|||
27962132|NCT00789373|54619595|FG002|Induction|Death Due to study disease|0|||
28082567|NCT03467152|54736515|FG001|Overall Study|Subject Choice|3|||
27855153|NCT01278745|54375546|FG003|Overall Study|Sponsor Decision|6|||
27855154|NCT01278745|54375543|FG000|Overall Study|Ineligible|0|||
27855155|NCT01278745|54375544|FG001|Overall Study|Ineligible|0|||
27962133|NCT00789373|54619593|FG000|Induction|Death due to adverse event|19|||
27962134|NCT00789373|54619594|FG001|Induction|Death due to adverse event|0|||
27962135|NCT00789373|54619595|FG002|Induction|Death due to adverse event|0|||
27962136|NCT00789373|54619593|FG000|Induction|Death due to toxicity|11|||
27962137|NCT00789373|54619594|FG001|Induction|Death due to toxicity|0|||
28082568|NCT03467152|54736516|FG002|Overall Study|Subject Choice|0|||
28082569|NCT03467152|54736514|FG000|Overall Study|Lost to Follow-up|1|||
27962138|NCT00789373|54619595|FG002|Induction|Death due to toxicity|0|||
27962139|NCT00789373|54619593|FG000|Induction|Death due to procedure|1|||
27962140|NCT00789373|54619594|FG001|Induction|Death due to procedure|0|||
27962141|NCT00789373|54619595|FG002|Induction|Death due to procedure|0|||
27962142|NCT00789373|54619593|FG000|Induction|Investigator decision|7|||
27962143|NCT00789373|54619594|FG001|Induction|Investigator decision|0|||
27962144|NCT00789373|54619595|FG002|Induction|Investigator decision|0|||
27962145|NCT00789373|54619593|FG000|Induction|Protocol entry criteria not met|9|||
27962146|NCT00789373|54619594|FG001|Induction|Protocol entry criteria not met|0|||
27962147|NCT00789373|54619595|FG002|Induction|Protocol entry criteria not met|0|||
27962148|NCT00789373|54619593|FG000|Induction|Lost to Follow-up|6|||
27962149|NCT00789373|54619594|FG001|Induction|Lost to Follow-up|0|||
27962150|NCT00789373|54619595|FG002|Induction|Lost to Follow-up|0|||
27962151|NCT00789373|54619593|FG000|Induction|Protocol Violation|1|||
27962152|NCT00789373|54619594|FG001|Induction|Protocol Violation|0|||
27962153|NCT00789373|54619595|FG002|Induction|Protocol Violation|0|||
27962154|NCT00789373|54619593|FG000|Induction|Progressive Disease|220|||
27962155|NCT00789373|54619594|FG001|Induction|Progressive Disease|0|||
27962156|NCT00789373|54619595|FG002|Induction|Progressive Disease|0|||
27962157|NCT00789373|54619593|FG000|Induction|Withdrawal by Subject|37|||
27962158|NCT00789373|54619594|FG001|Induction|Withdrawal by Subject|0|||
27962159|NCT00789373|54619595|FG002|Induction|Withdrawal by Subject|0|||
27962160|NCT00789373|54619593|FG000|Maintenance|Adverse Event|0|||
27962161|NCT00789373|54619594|FG001|Maintenance|Adverse Event|65|||
27962162|NCT00789373|54619595|FG002|Maintenance|Adverse Event|12|||
27962163|NCT00789373|54619593|FG000|Maintenance|Death due to study disease|0|||
27962164|NCT00789373|54619594|FG001|Maintenance|Death due to study disease|3|||
27962165|NCT00789373|54619595|FG002|Maintenance|Death due to study disease|1|||
27962166|NCT00789373|54619593|FG000|Maintenance|Death due to adverse event|0|||
27962167|NCT00789373|54619594|FG001|Maintenance|Death due to adverse event|4|||
27962168|NCT00789373|54619595|FG002|Maintenance|Death due to adverse event|1|||
27962169|NCT00789373|54619593|FG000|Maintenance|Death due to toxicity|0|||
27962170|NCT00789373|54619594|FG001|Maintenance|Death due to toxicity|1|||
27962171|NCT00789373|54619595|FG002|Maintenance|Death due to toxicity|2|||
27962172|NCT00789373|54619593|FG000|Maintenance|Investigator Decision|0|||
27962173|NCT00789373|54619594|FG001|Maintenance|Investigator Decision|4|||
27962174|NCT00789373|54619595|FG002|Maintenance|Investigator Decision|2|||
27962175|NCT00789373|54619593|FG000|Maintenance|Protocol entry criteria not met|0|||
27962176|NCT00789373|54619594|FG001|Maintenance|Protocol entry criteria not met|2|||
27962177|NCT00789373|54619595|FG002|Maintenance|Protocol entry criteria not met|0|||
28082570|NCT03467152|54736515|FG001|Overall Study|Lost to Follow-up|0|||
27962178|NCT00789373|54619593|FG000|Maintenance|Lost to Follow-up|0|||
27962179|NCT00789373|54619594|FG001|Maintenance|Lost to Follow-up|2|||
27962180|NCT00789373|54619595|FG002|Maintenance|Lost to Follow-up|0|||
27962181|NCT00789373|54619593|FG000|Maintenance|Progressive Disease|0|||
27962182|NCT00789373|54619594|FG001|Maintenance|Progressive Disease|253|||
27962183|NCT00789373|54619595|FG002|Maintenance|Progressive Disease|152|||
27962184|NCT00789373|54619593|FG000|Maintenance|Withdrawal by Subject|0|||
27962185|NCT00789373|54619594|FG001|Maintenance|Withdrawal by Subject|21|||
27962186|NCT00789373|54619595|FG002|Maintenance|Withdrawal by Subject|8|||
27962187|NCT00789373|54619593|FG000|Maintenance|Sponsor Decision|0|||
27962188|NCT00789373|54619594|FG001|Maintenance|Sponsor Decision|0|||
27962189|NCT00789373|54619595|FG002|Maintenance|Sponsor Decision|2|||
27962190|NCT00789373|54619593|FG000|Maintenance|Participants On-Going at Data Cut-Off|0|||
27962191|NCT00789373|54619594|FG001|Maintenance|Participants On-Going at Data Cut-Off|4|||
27962192|NCT00789373|54619595|FG002|Maintenance|Participants On-Going at Data Cut-Off|0|||
27962193|NCT00851890|54619610|FG000|Overall Study|Lost to Follow-up|0|||
27962194|NCT00851890|54619611|FG001|Overall Study|Lost to Follow-up|1|||
27962195|NCT00851890|54619612|FG002|Overall Study|Lost to Follow-up|0|||
27962196|NCT00851890|54619613|FG003|Overall Study|Lost to Follow-up|1|||
27962197|NCT00788827|54619623|FG000|Overall Study|Lack of Efficacy|2|||
27962198|NCT00592072|54619629|FG000|Wash Out Period|Lost to Follow-up|1|||
27962199|NCT00592072|54619630|FG001|Wash Out Period|Lost to Follow-up|1|||
27962200|NCT00792571|54619636|FG000|Overall Study|Death|1|||
27962201|NCT00792571|54619636|FG000|Overall Study|Adverse Event|4|||
27962202|NCT00792571|54619636|FG000|Overall Study|Withdrawal by Subject|1|||
27962203|NCT00792571|54619636|FG000|Overall Study|Other|4|||
27962204|NCT01069484|54619642|FG000|Overall Study|Death-in-near-family|1|||
27962205|NCT01069484|54619643|FG001|Overall Study|Death-in-near-family|0|||
27962206|NCT01069484|54619642|FG000|Overall Study|No specific reason|8|||
27962207|NCT01069484|54619643|FG001|Overall Study|No specific reason|2|||
27962208|NCT01069484|54619642|FG000|Overall Study|Illness mother or child|3|||
27962209|NCT01069484|54619643|FG001|Overall Study|Illness mother or child|1|||
27962210|NCT00794365|54619650|FG000|Overall Study|Lost to Follow-up|38|||
27962211|NCT00794365|54619650|FG000|Overall Study|Other|17|||
27962212|NCT00794365|54619650|FG000|Overall Study|Poor Compliance|11|||
27962213|NCT00794365|54619650|FG000|Overall Study|Adverse Event|10|||
27962214|NCT00794365|54619650|FG000|Overall Study|Lack of Efficacy|3|||
27962215|NCT01067144|54619656|FG000|Treatment|Did not receive allocated intervention|4|||
27962216|NCT01067144|54619657|FG001|Treatment|Did not receive allocated intervention|7|||
27962217|NCT01067144|54619656|FG000|Follow-up|Lost to Follow-up|22|||
27962218|NCT01067144|54619657|FG001|Follow-up|Lost to Follow-up|12|||
27962219|NCT01067144|54619656|FG000|Follow-up|Censored owing to second surgery|19|||
27962220|NCT01067144|54619657|FG001|Follow-up|Censored owing to second surgery|28|||
27962221|NCT01067144|54619656|FG000|Follow-up|Withdrawal by Subject|18|||
27962222|NCT01067144|54619657|FG001|Follow-up|Withdrawal by Subject|14|||
27962223|NCT01067144|54619656|FG000|Follow-up|Surgery cancelled|0|||
27962224|NCT01067144|54619657|FG001|Follow-up|Surgery cancelled|1|||
27962225|NCT01067144|54619656|FG000|Follow-up|Death|0|||
27962226|NCT01067144|54619657|FG001|Follow-up|Death|1|||
27962227|NCT01078298|54619665|FG000|Overall Study|Lost to Follow-up|12|||
27962228|NCT01078298|54619666|FG001|Overall Study|Lost to Follow-up|13|||
27962229|NCT01078298|54619665|FG000|Overall Study|Withdrawal by Subject|31|||
27962230|NCT01078298|54619666|FG001|Overall Study|Withdrawal by Subject|33|||
27962231|NCT01078298|54619665|FG000|Overall Study|Protocol Violation|6|||
27962232|NCT01078298|54619666|FG001|Overall Study|Protocol Violation|6|||
27962233|NCT01078298|54619665|FG000|Overall Study|Adverse Event|6|||
27962234|NCT01078298|54619666|FG001|Overall Study|Adverse Event|5|||
27962235|NCT01078298|54619665|FG000|Overall Study|Death|2|||
27962236|NCT01078298|54619666|FG001|Overall Study|Death|0|||
27962237|NCT01078298|54619665|FG000|Overall Study|Did not meet entrance criteria|0|||
27962238|NCT01078298|54619666|FG001|Overall Study|Did not meet entrance criteria|1|||
27962239|NCT01078298|54619665|FG000|Overall Study|Other|24|||
27962240|NCT01078298|54619666|FG001|Overall Study|Other|32|||
27962241|NCT00788593|54619672|FG000|Placebo Run-in Phase|Adverse Event|2|||
27962242|NCT00788593|54619673|FG001|Placebo Run-in Phase|Adverse Event|0|||
27962243|NCT00788593|54619674|FG002|Placebo Run-in Phase|Adverse Event|0|||
27962244|NCT00788593|54619672|FG000|Placebo Run-in Phase|Withdrawal by Subject|2|||
27962245|NCT00788593|54619673|FG001|Placebo Run-in Phase|Withdrawal by Subject|0|||
27962246|NCT00788593|54619674|FG002|Placebo Run-in Phase|Withdrawal by Subject|0|||
27962247|NCT00788593|54619672|FG000|Placebo Run-in Phase|Protocol Violation|2|||
27962248|NCT00788593|54619673|FG001|Placebo Run-in Phase|Protocol Violation|0|||
27962249|NCT00788593|54619674|FG002|Placebo Run-in Phase|Protocol Violation|0|||
27962250|NCT00788593|54619672|FG000|First Intervention Period|Adverse Event|0|||
27962251|NCT00788593|54619673|FG001|First Intervention Period|Adverse Event|1|||
27962252|NCT00788593|54619674|FG002|First Intervention Period|Adverse Event|0|||
27962253|NCT00788593|54619672|FG000|Second Intervention Period|Lost to Follow-up|0|||
27962254|NCT00788593|54619673|FG001|Second Intervention Period|Lost to Follow-up|1|||
27962255|NCT00788593|54619674|FG002|Second Intervention Period|Lost to Follow-up|0|||
27962256|NCT00788593|54619672|FG000|Second Intervention Period|Other|0|||
27962257|NCT00788593|54619673|FG001|Second Intervention Period|Other|0|||
27962258|NCT00788593|54619674|FG002|Second Intervention Period|Other|1|||
27962259|NCT00793819|54619686|FG000|Overall Study|Adverse Event|8|||
27962260|NCT00793819|54619687|FG001|Overall Study|Adverse Event|4|||
27962261|NCT00793819|54619686|FG000|Overall Study|Lack of Efficacy|1|||
27962262|NCT00793819|54619687|FG001|Overall Study|Lack of Efficacy|1|||
27962263|NCT00793819|54619686|FG000|Overall Study|Withdrawal by Subject|4|||
27962264|NCT00793819|54619687|FG001|Overall Study|Withdrawal by Subject|3|||
27962265|NCT00793819|54619686|FG000|Overall Study|Lost to Follow-up|1|||
27962266|NCT00793819|54619687|FG001|Overall Study|Lost to Follow-up|1|||
27962267|NCT00792259|54619696|FG000|Overall Study|Poor Quality Scans|1|||
27962268|NCT00792259|54619697|FG001|Overall Study|Poor Quality Scans|0|||
27962269|NCT00792259|54619698|FG002|Overall Study|Poor Quality Scans|0|||
27962270|NCT00894387|54619708|FG000|Overall Study|Adverse Event|44|||
27962271|NCT00894387|54619709|FG001|Overall Study|Adverse Event|45|||
27962272|NCT00894387|54619708|FG000|Overall Study|Abnormal Laboratory values|2|||
27962273|NCT00894387|54619709|FG001|Overall Study|Abnormal Laboratory values|2|||
27962274|NCT00894387|54619708|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
27962275|NCT00894387|54619709|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
27962276|NCT00894387|54619708|FG000|Overall Study|Lost to Follow-up|3|||
27962277|NCT00894387|54619709|FG001|Overall Study|Lost to Follow-up|5|||
27962278|NCT00894387|54619708|FG000|Overall Study|Administrative problems|2|||
27962279|NCT00894387|54619709|FG001|Overall Study|Administrative problems|2|||
28082571|NCT03467152|54736516|FG002|Overall Study|Lost to Follow-up|0|||
27962280|NCT00894387|54619708|FG000|Overall Study|Death|77|||
27962281|NCT00894387|54619709|FG001|Overall Study|Death|76|||
27962282|NCT00894387|54619708|FG000|Overall Study|Protocol Deviation|4|||
28082572|NCT03467152|54736514|FG000|Overall Study|Withdrawal by Subject|4|||
28082573|NCT03467152|54736515|FG001|Overall Study|Withdrawal by Subject|2|||
28082574|NCT03467152|54736516|FG002|Overall Study|Withdrawal by Subject|0|||
27962283|NCT00894387|54619709|FG001|Overall Study|Protocol Deviation|0|||
27962284|NCT00894387|54619708|FG000|Overall Study|Patient's request|25|||
27962285|NCT00894387|54619709|FG001|Overall Study|Patient's request|30|||
27962286|NCT00894387|54619708|FG000|Overall Study|Other (Missing)|5|||
27962287|NCT00894387|54619709|FG001|Overall Study|Other (Missing)|3|||
27962288|NCT00894387|54619708|FG000|Overall Study|Mis-randomized|13|||
27962289|NCT00894387|54619709|FG001|Overall Study|Mis-randomized|9|||
27962290|NCT00894387|54619708|FG000|Overall Study|GCP non-compliance|0|||
27962291|NCT00894387|54619709|FG001|Overall Study|GCP non-compliance|2|||
27962292|NCT00928512|54619720|FG000|Overall Study|Adverse Event|4|||
27962293|NCT00928512|54619721|FG001|Overall Study|Adverse Event|3|||
27962294|NCT00928512|54619722|FG002|Overall Study|Adverse Event|2|||
27962295|NCT00928512|54619723|FG003|Overall Study|Adverse Event|8|||
27962296|NCT00928512|54619724|FG004|Overall Study|Adverse Event|6|||
27962297|NCT00928512|54619720|FG000|Overall Study|Lack of Efficacy|2|||
27962298|NCT00928512|54619721|FG001|Overall Study|Lack of Efficacy|0|||
27962299|NCT00928512|54619722|FG002|Overall Study|Lack of Efficacy|4|||
27962300|NCT00928512|54619723|FG003|Overall Study|Lack of Efficacy|7|||
27962301|NCT00928512|54619724|FG004|Overall Study|Lack of Efficacy|3|||
27962302|NCT00928512|54619720|FG000|Overall Study|Protocol Violation|0|||
27962303|NCT00928512|54619721|FG001|Overall Study|Protocol Violation|1|||
27962304|NCT00928512|54619722|FG002|Overall Study|Protocol Violation|0|||
27962305|NCT00928512|54619723|FG003|Overall Study|Protocol Violation|1|||
27962306|NCT00928512|54619724|FG004|Overall Study|Protocol Violation|3|||
27962307|NCT00928512|54619720|FG000|Overall Study|Withdrawal by Subject|3|||
27962308|NCT00928512|54619721|FG001|Overall Study|Withdrawal by Subject|0|||
27962309|NCT00928512|54619722|FG002|Overall Study|Withdrawal by Subject|3|||
27962310|NCT00928512|54619723|FG003|Overall Study|Withdrawal by Subject|4|||
27962311|NCT00928512|54619724|FG004|Overall Study|Withdrawal by Subject|0|||
27962312|NCT00928512|54619720|FG000|Overall Study|Lost to Follow-up|1|||
27962313|NCT00928512|54619721|FG001|Overall Study|Lost to Follow-up|1|||
27962314|NCT00928512|54619722|FG002|Overall Study|Lost to Follow-up|2|||
27962315|NCT00928512|54619723|FG003|Overall Study|Lost to Follow-up|1|||
27962316|NCT00928512|54619724|FG004|Overall Study|Lost to Follow-up|3|||
27962317|NCT00928512|54619720|FG000|Overall Study|Administrative Problems|0|||
27962318|NCT00928512|54619721|FG001|Overall Study|Administrative Problems|1|||
27962319|NCT00928512|54619722|FG002|Overall Study|Administrative Problems|0|||
27962320|NCT00928512|54619723|FG003|Overall Study|Administrative Problems|0|||
27962321|NCT00928512|54619724|FG004|Overall Study|Administrative Problems|0|||
27962322|NCT00787891|54619742|FG000|Short-term Double-blind Phase (Part 1)|Adverse Event|1|||
27962323|NCT00787891|54619743|FG001|Short-term Double-blind Phase (Part 1)|Adverse Event|2|||
27962324|NCT00787891|54619742|FG000|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
27962325|NCT00787891|54619743|FG001|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
27962326|NCT00787891|54619742|FG000|Short-term Double-blind Phase (Part 1)|Protocol Violation|0|||
27962327|NCT00787891|54619743|FG001|Short-term Double-blind Phase (Part 1)|Protocol Violation|1|||
27962328|NCT00787891|54619742|FG000|Short-term Double-blind Phase (Part 1)|Physician Decision|1|||
27962329|NCT00787891|54619743|FG001|Short-term Double-blind Phase (Part 1)|Physician Decision|0|||
27962330|NCT00787891|54619742|FG000|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6|||
27962331|NCT00787891|54619743|FG001|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2|||
27962332|NCT00787891|54619742|FG000|Short-term Double-blind Phase (Part 1)|Other|0|||
27962333|NCT00787891|54619743|FG001|Short-term Double-blind Phase (Part 1)|Other|2|||
27962334|NCT00787891|54619742|FG000|Maintenance Double-blind Phase (Part 2)|Adverse Event|0|||
27962335|NCT00787891|54619743|FG001|Maintenance Double-blind Phase (Part 2)|Adverse Event|1|||
27962336|NCT00787891|54619742|FG000|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
27962337|NCT00787891|54619743|FG001|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
27962338|NCT00787891|54619742|FG000|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1|||
27962339|NCT00787891|54619743|FG001|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3|||
27962340|NCT00787891|54619742|FG000|Maintenance Double-blind Phase (Part 2)|Other|5|||
27962341|NCT00787891|54619743|FG001|Maintenance Double-blind Phase (Part 2)|Other|2|||
27962342|NCT00892437|54619753|FG000|Randomized Phase|Randomized but not treated|6|||
27962343|NCT00892437|54619754|FG001|Randomized Phase|Randomized but not treated|0|||
27962344|NCT00892437|54619753|FG000|Randomized Phase|Adverse Event|2|||
27962345|NCT00892437|54619754|FG001|Randomized Phase|Adverse Event|2|||
27962346|NCT00892437|54619753|FG000|Randomized Phase|Lost to Follow-up|1|||
27962347|NCT00892437|54619754|FG001|Randomized Phase|Lost to Follow-up|3|||
27962348|NCT00892437|54619753|FG000|Randomized Phase|Investigator's Discretion|1|||
27962349|NCT00892437|54619754|FG001|Randomized Phase|Investigator's Discretion|0|||
27962350|NCT00892437|54619753|FG000|Randomized Phase|Withdrew Consent|1|||
27962351|NCT00892437|54619754|FG001|Randomized Phase|Withdrew Consent|0|||
27962352|NCT00892437|54619753|FG000|Open-Label Extension Phase|Adverse Event|4|||
27962353|NCT00892437|54619754|FG001|Open-Label Extension Phase|Adverse Event|2|||
27732493|NCT02578706|54180007|FG000|Overall Study|Physician Decision|0|||
27732494|NCT02578706|54180008|FG001|Overall Study|Physician Decision|1|||
27962354|NCT00892437|54619753|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
27962355|NCT00892437|54619754|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
27962356|NCT00892437|54619753|FG000|Open-Label Extension Phase|Lost to Follow-up|3|||
27962357|NCT00892437|54619754|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
27962358|NCT00892437|54619753|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
27962359|NCT00892437|54619754|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
27962360|NCT00892437|54619753|FG000|Open-Label Extension Phase|Withdrew Consent|3|||
27962361|NCT00892437|54619754|FG001|Open-Label Extension Phase|Withdrew Consent|1|||
27962362|NCT00792103|54619761|FG000|Overall Study|Enrolled, not treated|15|||
27962363|NCT00792103|54619761|FG000|Overall Study|Lost to Follow-up|17|||
27962364|NCT00792103|54619761|FG000|Overall Study|Adverse Event|25|||
27962365|NCT00792103|54619761|FG000|Overall Study|Withdrawal by Subject|52|||
27962366|NCT00792103|54619761|FG000|Overall Study|Protocol Violation|10|||
27962367|NCT00792103|54619761|FG000|Overall Study|Did not apply 6 patches in 1st 3 mths|14|||
27962368|NCT00892281|54619767|FG000|Overall Study|Adverse Event|65|||
27962369|NCT00892281|54619768|FG001|Overall Study|Adverse Event|8|||
27962370|NCT00892281|54619767|FG000|Overall Study|Lost to Follow-up|81|||
27962371|NCT00892281|54619768|FG001|Overall Study|Lost to Follow-up|8|||
27962372|NCT00892281|54619767|FG000|Overall Study|Pregnancy|1|||
27962373|NCT00892281|54619768|FG001|Overall Study|Pregnancy|0|||
27962374|NCT00892281|54619767|FG000|Overall Study|Protocol Violation|7|||
27962375|NCT00892281|54619768|FG001|Overall Study|Protocol Violation|2|||
27962376|NCT00892281|54619767|FG000|Overall Study|Withdrawal by Subject|86|||
27962377|NCT00892281|54619768|FG001|Overall Study|Withdrawal by Subject|14|||
27962378|NCT00892281|54619767|FG000|Overall Study|Subject failed to return for final visit|2|||
27962379|NCT00892281|54619768|FG001|Overall Study|Subject failed to return for final visit|0|||
27962380|NCT00892281|54619767|FG000|Overall Study|Subject unable to keep follow-up visits|1|||
27962381|NCT00892281|54619768|FG001|Overall Study|Subject unable to keep follow-up visits|0|||
27962382|NCT00892281|54619767|FG000|Overall Study|Final visit completed 4 weeks late|0|||
27962383|NCT00892281|54619768|FG001|Overall Study|Final visit completed 4 weeks late|1|||
27962384|NCT00892281|54619767|FG000|Overall Study|Subject completed day after study closed|1|||
27962385|NCT00892281|54619768|FG001|Overall Study|Subject completed day after study closed|0|||
27962386|NCT00892281|54619767|FG000|Overall Study|Family emergency|1|||
27962387|NCT00892281|54619768|FG001|Overall Study|Family emergency|0|||
27962388|NCT00892281|54619767|FG000|Overall Study|Last visit not done - death in family|1|||
27962389|NCT00892281|54619768|FG001|Overall Study|Last visit not done - death in family|0|||
27962390|NCT00892281|54619767|FG000|Overall Study|Did not meet incl/excl criteria|1|||
27962391|NCT00892281|54619768|FG001|Overall Study|Did not meet incl/excl criteria|0|||
28082575|NCT03467152|54736514|FG000|Overall Study|Others|3|||
28082576|NCT03467152|54736515|FG001|Overall Study|Others|0|||
27962392|NCT00892281|54619767|FG000|Overall Study|Rosacea cleared; subject D/C'd self|1|||
27962393|NCT00892281|54619768|FG001|Overall Study|Rosacea cleared; subject D/C'd self|0|||
27962394|NCT00892281|54619767|FG000|Overall Study|Unable to redeem the drug voucher|1|||
27962395|NCT00892281|54619768|FG001|Overall Study|Unable to redeem the drug voucher|0|||
27962396|NCT00892281|54619767|FG000|Overall Study|Subject not good candidate for study|1|||
27962397|NCT00892281|54619768|FG001|Overall Study|Subject not good candidate for study|0|||
27962398|NCT00892281|54619767|FG000|Overall Study|Subject did not return for any visits|1|||
27962399|NCT00892281|54619768|FG001|Overall Study|Subject did not return for any visits|0|||
27962400|NCT00892281|54619767|FG000|Overall Study|Subject missed several visits/lost meds|1|||
27962401|NCT00892281|54619768|FG001|Overall Study|Subject missed several visits/lost meds|0|||
27962402|NCT00892281|54619767|FG000|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
27962403|NCT00892281|54619768|FG001|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
27962404|NCT00892281|54619767|FG000|Overall Study|Scheduled for knee replacement|0|||
27962405|NCT00892281|54619768|FG001|Overall Study|Scheduled for knee replacement|1|||
27962406|NCT00892281|54619767|FG000|Overall Study|PI complained of inadequate compensation|3|||
27962407|NCT00892281|54619768|FG001|Overall Study|PI complained of inadequate compensation|0|||
27962408|NCT00892281|54619767|FG000|Overall Study|Subject lost interest in program|0|||
27962409|NCT00892281|54619768|FG001|Overall Study|Subject lost interest in program|1|||
27962410|NCT00892281|54619767|FG000|Overall Study|Bad taste in mouth after taking Oracea®|0|||
27962411|NCT00892281|54619768|FG001|Overall Study|Bad taste in mouth after taking Oracea®|1|||
27962412|NCT00892281|54619767|FG000|Overall Study|Death in family|1|||
27962413|NCT00892281|54619768|FG001|Overall Study|Death in family|0|||
27962414|NCT00892281|54619767|FG000|Overall Study|Lack of efficacy of study product|2|||
27962415|NCT00892281|54619768|FG001|Overall Study|Lack of efficacy of study product|0|||
27962416|NCT00892281|54619767|FG000|Overall Study|Subject not seen by PI at final visit|1|||
27962417|NCT00892281|54619768|FG001|Overall Study|Subject not seen by PI at final visit|0|||
27962418|NCT00892281|54619767|FG000|Overall Study|No show Visit 2; prescription not filled|1|||
27962419|NCT00892281|54619768|FG001|Overall Study|No show Visit 2; prescription not filled|0|||
27962420|NCT00892281|54619767|FG000|Overall Study|Missed multiple visits|1|||
27962421|NCT00892281|54619768|FG001|Overall Study|Missed multiple visits|0|||
27962422|NCT00892281|54619767|FG000|Overall Study|Missed visits rescheduled out of window|1|||
28082577|NCT03467152|54736516|FG002|Overall Study|Others|0|||
28082578|NCT03467152|54736514|FG000|Overall Study|Not treated|3|||
27962423|NCT00892281|54619768|FG001|Overall Study|Missed visits rescheduled out of window|0|||
27962424|NCT00892281|54619767|FG000|Overall Study|Non-compliant with visits as scheduled|1|||
27962425|NCT00892281|54619768|FG001|Overall Study|Non-compliant with visits as scheduled|0|||
27962426|NCT00892281|54619767|FG000|Overall Study|Subject had history of drug abuse|1|||
27962427|NCT00892281|54619768|FG001|Overall Study|Subject had history of drug abuse|0|||
28082579|NCT03467152|54736515|FG001|Overall Study|Not treated|1|||
27962428|NCT00892281|54619767|FG000|Overall Study|Rash on hand|1|||
27962429|NCT00892281|54619768|FG001|Overall Study|Rash on hand|0|||
27962430|NCT00892281|54619767|FG000|Overall Study|Visit 4 date out of window|1|||
27962431|NCT00892281|54619768|FG001|Overall Study|Visit 4 date out of window|0|||
27962432|NCT00784693|54619776|FG000|Overall Study|Lost to Follow-up|0|||
27962433|NCT00784693|54619777|FG001|Overall Study|Lost to Follow-up|1|||
27962434|NCT00784693|54619776|FG000|Overall Study|Lack of Efficacy|1|||
27962435|NCT00784693|54619777|FG001|Overall Study|Lack of Efficacy|1|||
27962436|NCT00784693|54619776|FG000|Overall Study|Withdrawal by Subject|0|||
28165154|NCT03016325|54835757|FG004|182-Day Follow-Up Period|Alive, per national insurance system|0|||
27962437|NCT00784693|54619777|FG001|Overall Study|Withdrawal by Subject|4|||
27962438|NCT00784693|54619776|FG000|Overall Study|Randomized but not Treated|1|||
27962439|NCT00784693|54619777|FG001|Overall Study|Randomized but not Treated|0|||
27962440|NCT00784693|54619776|FG000|Overall Study|Other|1|||
27962441|NCT00784693|54619777|FG001|Overall Study|Other|0|||
27962442|NCT00893763|54619785|FG000|Overall Study|extubated|110|||
27962443|NCT00893763|54619786|FG001|Overall Study|extubated|110|||
27962444|NCT00892047|54619796|FG000|Overall Study|Adverse Event|2|||
27962445|NCT00892047|54619797|FG001|Overall Study|Adverse Event|2|||
27962446|NCT00892047|54619796|FG000|Overall Study|subject burden|2|||
27962447|NCT00892047|54619797|FG001|Overall Study|subject burden|3|||
27962448|NCT00892047|54619796|FG000|Overall Study|Lack of Efficacy|0|||
27962449|NCT00892047|54619797|FG001|Overall Study|Lack of Efficacy|2|||
27962450|NCT00787267|54619805|FG000|Overall Study|Screen failure/Ineligible|10|||
27962451|NCT00787267|54619805|FG000|Overall Study|No Reason Provided|1|||
27962452|NCT00787267|54619805|FG000|Overall Study|Withdrawal by Subject|1|||
27962453|NCT00928434|54619812|FG000|Overall Study|Adverse Event|14|||
27962454|NCT00928434|54619813|FG001|Overall Study|Adverse Event|5|||
27962455|NCT00928434|54619814|FG002|Overall Study|Adverse Event|18|||
27962456|NCT00928434|54619812|FG000|Overall Study|Protocol Violation|5|||
27962457|NCT00928434|54619813|FG001|Overall Study|Protocol Violation|0|||
27962458|NCT00928434|54619814|FG002|Overall Study|Protocol Violation|8|||
27962459|NCT00928434|54619812|FG000|Overall Study|Physician Decision|2|||
27962460|NCT00928434|54619813|FG001|Overall Study|Physician Decision|0|||
27962461|NCT00928434|54619814|FG002|Overall Study|Physician Decision|3|||
27962462|NCT00928434|54619812|FG000|Overall Study|Lost to Follow-up|1|||
27962463|NCT00928434|54619813|FG001|Overall Study|Lost to Follow-up|0|||
27962464|NCT00928434|54619814|FG002|Overall Study|Lost to Follow-up|3|||
27962465|NCT00928434|54619812|FG000|Overall Study|Withdrawal by Subject|5|||
27962466|NCT00928434|54619813|FG001|Overall Study|Withdrawal by Subject|3|||
27962467|NCT00928434|54619814|FG002|Overall Study|Withdrawal by Subject|2|||
27962468|NCT00928434|54619812|FG000|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10|||
27962469|NCT00928434|54619813|FG001|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4|||
27962470|NCT00928434|54619814|FG002|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7|||
27962471|NCT00928434|54619812|FG000|Overall Study|PSA failure (>2 ng/mL) on other visit|2|||
27962472|NCT00928434|54619813|FG001|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
27962473|NCT00928434|54619814|FG002|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
27962474|NCT00928434|54619812|FG000|Overall Study|Other (not meeting above criteria)|5|||
27962475|NCT00928434|54619813|FG001|Overall Study|Other (not meeting above criteria)|1|||
27962476|NCT00928434|54619814|FG002|Overall Study|Other (not meeting above criteria)|2|||
27962477|NCT00787189|54619832|FG000|Overall Study|Lost to Follow-up|2|||
27962478|NCT00787189|54619833|FG001|Overall Study|Lost to Follow-up|2|||
28082580|NCT03467152|54736516|FG002|Overall Study|Not treated|6|||
28082581|NCT03466060|54736525|FG000|Period 1|Test Lens Damage|0|||
28082582|NCT03466060|54736526|FG001|Period 1|Test Lens Damage|2|||
28082583|NCT03466060|54736527|FG002|Period 1|Test Lens Damage|0|||
28082584|NCT03466060|54736528|FG003|Period 1|Test Lens Damage|0|||
28082585|NCT03466060|54736529|FG004|Period 1|Test Lens Damage|0|||
28082586|NCT03466060|54736530|FG005|Period 1|Test Lens Damage|0|||
28082587|NCT03466060|54736525|FG000|Period 1|Withdrawal by Subject|0|||
28082588|NCT03466060|54736526|FG001|Period 1|Withdrawal by Subject|0|||
28082589|NCT03466060|54736527|FG002|Period 1|Withdrawal by Subject|2|||
28082590|NCT03466060|54736528|FG003|Period 1|Withdrawal by Subject|0|||
28082591|NCT03466060|54736529|FG004|Period 1|Withdrawal by Subject|0|||
28082592|NCT03466060|54736530|FG005|Period 1|Withdrawal by Subject|0|||
28082593|NCT03466060|54736525|FG000|Period 1|Lost to Follow-up|0|||
28082594|NCT03466060|54736526|FG001|Period 1|Lost to Follow-up|0|||
28165155|NCT03016325|54835758|FG005|182-Day Follow-Up Period|Alive, per national insurance system|0|||
27962479|NCT00784459|54619841|FG000|Overall Study|Adverse Event|0|||
27962480|NCT00784459|54619842|FG001|Overall Study|Adverse Event|2|||
27962481|NCT00786799|54619850|FG000|Overall Study|Lost to Follow-up|1|||
27962482|NCT00786799|54619851|FG001|Overall Study|Lost to Follow-up|1|||
27962483|NCT00786565|54619862|FG000|Enrollment Prior to Surgery|Site Closed|3|||
27962484|NCT00786565|54619862|FG000|Enrollment Prior to Surgery|Protocol Violation|3|||
27962485|NCT00786565|54619862|FG000|Post Surgery|Abnormal macular pucker|1|||
27962486|NCT00786565|54619862|FG000|Post Surgery|Adapt AO implanted posterior side up|1|||
27962487|NCT00784147|54619870|FG000|Overall Study|Lost to Follow-up|2|||
27962488|NCT00784147|54619871|FG001|Overall Study|Lost to Follow-up|4|||
27962489|NCT00784147|54619870|FG000|Overall Study|Withdrawal by Subject|1|||
27962490|NCT00784147|54619871|FG001|Overall Study|Withdrawal by Subject|3|||
27962491|NCT00784147|54619870|FG000|Overall Study|Physician Decision|2|||
27962492|NCT00784147|54619871|FG001|Overall Study|Physician Decision|1|||
27962493|NCT00784147|54619870|FG000|Overall Study|Protocol Violation|1|||
27962494|NCT00784147|54619871|FG001|Overall Study|Protocol Violation|1|||
27962495|NCT00784147|54619870|FG000|Overall Study|Death|2|||
27962496|NCT00784147|54619871|FG001|Overall Study|Death|0|||
27962497|NCT00891813|54619877|FG000|Overall Study|Adverse Event|3|||
27962498|NCT00891813|54619877|FG000|Overall Study|Withdrawal by Subject|1|||
27962499|NCT00891813|54619877|FG000|Overall Study|Patient Noncompliance|6|||
27962500|NCT00891813|54619877|FG000|Overall Study|Protocol Violation|2|||
27962501|NCT00783835|54619894|FG000|Overall Study|Adverse Event|3|||
27962502|NCT00783835|54619894|FG000|Overall Study|Medical Criteria|1|||
27962503|NCT00783835|54619894|FG000|Overall Study|Withdrawal by Subject|2|||
27962504|NCT00783835|54619894|FG000|Overall Study|Lost to Follow-up|1|||
27962505|NCT00783835|54619894|FG000|Overall Study|Participant not Adherent|3|||
27962506|NCT00783289|54619902|FG000|Overall Study|Protocol Violation|0|||
27962507|NCT00783289|54619903|FG001|Overall Study|Protocol Violation|1|||
27962508|NCT00783289|54619904|FG002|Overall Study|Protocol Violation|0|||
27962509|NCT00783289|54619905|FG003|Overall Study|Protocol Violation|0|||
27962510|NCT00847912|54619920|FG000|Overall Study|Protocol Violation|6|||
27962511|NCT00847912|54619921|FG001|Overall Study|Protocol Violation|7|||
27962512|NCT00847912|54619920|FG000|Overall Study|Withdrawal by Subject|3|||
28082595|NCT03466060|54736527|FG002|Period 1|Lost to Follow-up|0|||
28082596|NCT03466060|54736528|FG003|Period 1|Lost to Follow-up|1|||
28082597|NCT03466060|54736529|FG004|Period 1|Lost to Follow-up|0|||
28082598|NCT03466060|54736530|FG005|Period 1|Lost to Follow-up|0|||
28082599|NCT03466060|54736525|FG000|Period 1|Grade 2 Conjunctivitis|0|||
28082600|NCT03466060|54736526|FG001|Period 1|Grade 2 Conjunctivitis|0|||
28082601|NCT03466060|54736527|FG002|Period 1|Grade 2 Conjunctivitis|1|||
28082602|NCT03466060|54736528|FG003|Period 1|Grade 2 Conjunctivitis|0|||
28082603|NCT03466060|54736529|FG004|Period 1|Grade 2 Conjunctivitis|0|||
28082604|NCT03466060|54736530|FG005|Period 1|Grade 2 Conjunctivitis|0|||
28082605|NCT03466060|54736525|FG000|Period 2|Lens Handling Difficulties|0|||
28082606|NCT03466060|54736526|FG001|Period 2|Lens Handling Difficulties|0|||
28082607|NCT03466060|54736527|FG002|Period 2|Lens Handling Difficulties|1|||
28082608|NCT03466060|54736528|FG003|Period 2|Lens Handling Difficulties|0|||
28082609|NCT03466060|54736529|FG004|Period 2|Lens Handling Difficulties|0|||
28082610|NCT03466060|54736530|FG005|Period 2|Lens Handling Difficulties|0|||
28082611|NCT00092547|54736546|FG000|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5|||
28082612|NCT00092547|54736547|FG001|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1|||
28082613|NCT00092547|54736548|FG002|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0|||
28082614|NCT00092547|54736546|FG000|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4|||
28082615|NCT00092547|54736547|FG001|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1|||
28082616|NCT00092547|54736548|FG002|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0|||
28082617|NCT00092547|54736546|FG000|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18|||
28082618|NCT00092547|54736547|FG001|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7|||
28082619|NCT00092547|54736548|FG002|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0|||
28082620|NCT00092547|54736546|FG000|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28|||
28082621|NCT00092547|54736547|FG001|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21|||
28082622|NCT00092547|54736548|FG002|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0|||
28082623|NCT00092547|54736546|FG000|Base Vaccine Phase (Day 1 to Month 7)|Moved|3|||
28082624|NCT00092547|54736547|FG001|Base Vaccine Phase (Day 1 to Month 7)|Moved|1|||
28082625|NCT00092547|54736548|FG002|Base Vaccine Phase (Day 1 to Month 7)|Moved|0|||
28082626|NCT00092547|54736546|FG000|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
28082627|NCT00092547|54736547|FG001|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1|||
28082628|NCT00092547|54736548|FG002|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
28082629|NCT00092547|54736546|FG000|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
28082630|NCT00092547|54736547|FG001|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1|||
28082631|NCT00092547|54736548|FG002|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
28082632|NCT00092547|54736546|FG000|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5|||
28082633|NCT00092547|54736547|FG001|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3|||
28082634|NCT00092547|54736548|FG002|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0|||
27855156|NCT01278745|54375545|FG002|Overall Study|Ineligible|42|||
27855157|NCT01278745|54375546|FG003|Overall Study|Ineligible|61|||
27962513|NCT00847912|54619921|FG001|Overall Study|Withdrawal by Subject|6|||
27962514|NCT00850564|54619928|FG000|Overall Study|Withdrawal by Subject|2|||
27962515|NCT00837148|54619932|FG000|Overall Study|Adverse Event|1|||
27962516|NCT00837148|54619932|FG000|Overall Study|Death|1|||
27962517|NCT00849940|54619936|FG000|Overall Study|Physician Decision|4|||
27962518|NCT00849472|54619940|FG000|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2|||
28082635|NCT00092547|54736546|FG000|Base Follow-up Phase (Month 7 to 18)|Subject moved|1|||
27962519|NCT00849472|54619940|FG000|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1|||
27962520|NCT00849472|54619940|FG000|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1|||
27962521|NCT00849472|54619940|FG000|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1|||
27962522|NCT00849472|54619940|FG000|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1|||
27962523|NCT00849472|54619940|FG000|Weekly Paclitaxel|Disease Progression|1|||
27962524|NCT00849472|54619940|FG000|Weekly Paclitaxel|Adverse Event|11|||
27962525|NCT00849472|54619940|FG000|Weekly Paclitaxel|Withdrawal by Subject|1|||
27962526|NCT00849472|54619940|FG000|Weekly Paclitaxel|Physician Decision|3|||
27962527|NCT00849472|54619940|FG000|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52|||
27962528|NCT00849472|54619940|FG000|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4|||
27962529|NCT00849472|54619940|FG000|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1|||
27962530|NCT00849472|54619940|FG000|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1|||
27962531|NCT00849472|54619940|FG000|Pazopanib Postsurgery Treatment|Adverse Event|19|||
27962532|NCT00849472|54619940|FG000|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5|||
27962533|NCT00849472|54619940|FG000|Pazopanib Postsurgery Treatment|Moved|1|||
27962534|NCT00849472|54619940|FG000|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1|||
27962535|NCT00782509|54619948|FG000|Overall Study|Adverse Event|20|||
27962536|NCT00782509|54619949|FG001|Overall Study|Adverse Event|10|||
27962537|NCT00782509|54619950|FG002|Overall Study|Adverse Event|20|||
27962538|NCT00782509|54619948|FG000|Overall Study|Lost to Follow-up|1|||
27962539|NCT00782509|54619949|FG001|Overall Study|Lost to Follow-up|2|||
27962540|NCT00782509|54619950|FG002|Overall Study|Lost to Follow-up|3|||
27962541|NCT00782509|54619948|FG000|Overall Study|Withdrawal by Subject|3|||
27962542|NCT00782509|54619949|FG001|Overall Study|Withdrawal by Subject|5|||
27962543|NCT00782509|54619950|FG002|Overall Study|Withdrawal by Subject|8|||
27962544|NCT00782509|54619948|FG000|Overall Study|Non compliance with protocol|2|||
27962545|NCT00782509|54619949|FG001|Overall Study|Non compliance with protocol|0|||
27962546|NCT00782509|54619950|FG002|Overall Study|Non compliance with protocol|0|||
27962547|NCT00782509|54619948|FG000|Overall Study|Other reasons not stated above|5|||
27962548|NCT00782509|54619949|FG001|Overall Study|Other reasons not stated above|2|||
27962549|NCT00782509|54619950|FG002|Overall Study|Other reasons not stated above|3|||
27962550|NCT00782509|54619948|FG000|Overall Study|Lack of Efficacy|10|||
27962551|NCT00782509|54619949|FG001|Overall Study|Lack of Efficacy|5|||
27962552|NCT00782509|54619950|FG002|Overall Study|Lack of Efficacy|2|||
27962553|NCT00927810|54619969|FG000|Overall Study|Withdrawal by Subject|0|||
27962554|NCT00927810|54619970|FG001|Overall Study|Withdrawal by Subject|3|||
27962555|NCT00927810|54619971|FG002|Overall Study|Withdrawal by Subject|0|||
27962556|NCT00927810|54619972|FG003|Overall Study|Withdrawal by Subject|1|||
27962557|NCT00927810|54619969|FG000|Overall Study|Lost to Follow-up|0|||
27962558|NCT00927810|54619970|FG001|Overall Study|Lost to Follow-up|2|||
27962559|NCT00927810|54619971|FG002|Overall Study|Lost to Follow-up|1|||
27962560|NCT00927810|54619972|FG003|Overall Study|Lost to Follow-up|1|||
27962561|NCT00927810|54619969|FG000|Overall Study|Death|0|||
27962562|NCT00927810|54619970|FG001|Overall Study|Death|2|||
27962563|NCT00927810|54619971|FG002|Overall Study|Death|0|||
27962564|NCT00927810|54619972|FG003|Overall Study|Death|0|||
27962565|NCT00927810|54619969|FG000|Overall Study|Abnormal laboratory value(s)|0|||
27962566|NCT00927810|54619970|FG001|Overall Study|Abnormal laboratory value(s)|1|||
27962567|NCT00927810|54619971|FG002|Overall Study|Abnormal laboratory value(s)|0|||
27962568|NCT00927810|54619972|FG003|Overall Study|Abnormal laboratory value(s)|0|||
27962569|NCT00848926|54619990|FG000|Treatment Period|Progressive disease|45|||
27962570|NCT00848926|54619990|FG000|Treatment Period|Adverse Event|20|||
27962571|NCT00848926|54619990|FG000|Treatment Period|Physician Decision|12|||
27962572|NCT00848926|54619990|FG000|Treatment Period|Withdrawal by Subject|7|||
27962573|NCT00848926|54619990|FG000|Follow-up Period|Lost to Follow-up|7|||
27962574|NCT00848926|54619990|FG000|Follow-up Period|Withdrawal by Subject|3|||
27962575|NCT00848926|54619990|FG000|Follow-up Period|Other|2|||
28082636|NCT00092547|54736547|FG001|Base Follow-up Phase (Month 7 to 18)|Subject moved|5|||
28082637|NCT00092547|54736548|FG002|Base Follow-up Phase (Month 7 to 18)|Subject moved|0|||
27962576|NCT00847132|54619996|FG000|Overall Study|Death|1|||
27962577|NCT00847132|54619997|FG001|Overall Study|Death|1|||
27962578|NCT00918138|54620005|FG000|Overall Study|Subject withdrew consent|1|||
27962579|NCT00918138|54620006|FG001|Overall Study|Subject withdrew consent|1|||
27832486|NCT01597505|54311753|FG001|Overall Study|Lost to Follow-up|2|||
27962580|NCT00918138|54620005|FG000|Overall Study|Death|1|||
27962581|NCT00918138|54620006|FG001|Overall Study|Death|0|||
27962582|NCT00782275|54620012|FG000|Overall Study|Adverse Event|11|||
27962583|NCT00782275|54620012|FG000|Overall Study|Withdrawal by Subject|1|||
27962584|NCT00782275|54620012|FG000|Overall Study|Progressive Disease|21|||
27962585|NCT00782275|54620012|FG000|Overall Study|Physician Decision|4|||
27962586|NCT00782275|54620012|FG000|Overall Study|Not started treatment|1|||
27962587|NCT00782275|54620012|FG000|Overall Study|Other|3|||
27962588|NCT00791557|54620016|FG000|Overall Study|Adverse Event|1|||
27962589|NCT00920790|54620020|FG000|Overall Study|aggravation of general condition|14|||
27962590|NCT00781963|54620026|FG000|Overall Study|Death|3|||
27962591|NCT00781963|54620027|FG001|Overall Study|Death|0|||
27962592|NCT00781963|54620026|FG000|Overall Study|Lost to Follow-up|2|||
27962593|NCT00781963|54620027|FG001|Overall Study|Lost to Follow-up|1|||
27962594|NCT00781963|54620026|FG000|Overall Study|Withdrawal by Subject|3|||
28082638|NCT00092547|54736546|FG000|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4|||
28082639|NCT00092547|54736547|FG001|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2|||
28082640|NCT00092547|54736548|FG002|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0|||
28082641|NCT00092547|54736546|FG000|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13|||
28082642|NCT00092547|54736547|FG001|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7|||
28082643|NCT00092547|54736548|FG002|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0|||
28082644|NCT00092547|54736546|FG000|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1|||
28082645|NCT00092547|54736547|FG001|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
28082646|NCT00092547|54736548|FG002|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
27962595|NCT00781963|54620027|FG001|Overall Study|Withdrawal by Subject|1|||
27962596|NCT00781963|54620026|FG000|Overall Study|Refused follow-up|9|||
27962597|NCT00781963|54620027|FG001|Overall Study|Refused follow-up|0|||
27962598|NCT00920556|54620033|FG000|Overall Study|Adverse Event|16|||
27962599|NCT00920556|54620033|FG000|Overall Study|Physician Decision|7|||
27962600|NCT00920556|54620033|FG000|Overall Study|Withdrawal by Subject|1|||
27962601|NCT00781885|54620041|FG000|Overall Study|Physician Decision|1|||
27962602|NCT00918684|54620045|FG000|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16|||
27962603|NCT00918684|54620045|FG000|Treatment Phase|Lack of Efficacy|6|||
27962604|NCT00918684|54620045|FG000|Treatment Phase|Lost to Follow-up|2|||
27962605|NCT00918684|54620045|FG000|Treatment Phase|Physician Decision|8|||
27962606|NCT00918684|54620045|FG000|Treatment Phase|Protocol Violation|1|||
27962607|NCT00918684|54620045|FG000|Treatment Phase|Withdrawal by Subject|8|||
27962608|NCT00786409|54620049|FG000|Overall Study|Withdrawal by Subject|2|||
27962609|NCT00786409|54620049|FG000|Overall Study|Adverse Event|2|||
27962610|NCT00786409|54620049|FG000|Overall Study|Pregnancy|2|||
27962611|NCT00786409|54620049|FG000|Overall Study|Lost to Follow-up|1|||
27962612|NCT00919854|54620053|FG000|Overall Study|Adverse Event|1|||
28082647|NCT00092547|54736546|FG000|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1|||
28082648|NCT00092547|54736547|FG001|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
27962613|NCT00891735|54620061|FG000|Overall Study|Adverse Event|2|||
27962614|NCT00891735|54620062|FG001|Overall Study|Adverse Event|0|||
27962615|NCT00891735|54620063|FG002|Overall Study|Adverse Event|2|||
27962616|NCT00891735|54620064|FG003|Overall Study|Adverse Event|0|||
27962617|NCT00891735|54620061|FG000|Overall Study|Death|8|||
27962618|NCT00891735|54620062|FG001|Overall Study|Death|5|||
27962619|NCT00891735|54620063|FG002|Overall Study|Death|4|||
27962620|NCT00891735|54620064|FG003|Overall Study|Death|5|||
27962621|NCT00891735|54620061|FG000|Overall Study|Lost to Follow-up|2|||
27962622|NCT00891735|54620062|FG001|Overall Study|Lost to Follow-up|2|||
27962623|NCT00891735|54620063|FG002|Overall Study|Lost to Follow-up|2|||
27962624|NCT00891735|54620064|FG003|Overall Study|Lost to Follow-up|2|||
27962625|NCT00891735|54620061|FG000|Overall Study|Physician's decision to withdraw patient|1|||
27962626|NCT00891735|54620062|FG001|Overall Study|Physician's decision to withdraw patient|0|||
27962627|NCT00891735|54620063|FG002|Overall Study|Physician's decision to withdraw patient|0|||
27962628|NCT00891735|54620064|FG003|Overall Study|Physician's decision to withdraw patient|0|||
27962629|NCT00891735|54620061|FG000|Overall Study|Patient's decision to withdraw|4|||
27962630|NCT00891735|54620062|FG001|Overall Study|Patient's decision to withdraw|9|||
27962631|NCT00891735|54620063|FG002|Overall Study|Patient's decision to withdraw|4|||
27962632|NCT00891735|54620064|FG003|Overall Study|Patient's decision to withdraw|8|||
27962633|NCT00891657|54620076|FG000|Overall Study|Withdrawal by Subject|1|||
27962634|NCT00891657|54620077|FG001|Overall Study|Withdrawal by Subject|1|||
27962635|NCT00917124|54620085|FG000|Overall Study|Protocol Violation|4|||
27962636|NCT00917124|54620086|FG001|Overall Study|Protocol Violation|6|||
27962637|NCT00889863|54620092|FG000|Part I: Open Label|Death|1|||
27962638|NCT00889863|54620093|FG001|Part I: Open Label|Death|0|||
27962639|NCT00889863|54620092|FG000|Part I: Open Label|Adverse Event|4|||
27962640|NCT00889863|54620093|FG001|Part I: Open Label|Adverse Event|0|||
28082649|NCT00092547|54736548|FG002|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
27962641|NCT00889863|54620092|FG000|Part I: Open Label|Unsatisfactory therapeutic effect|72|||
27962642|NCT00889863|54620093|FG001|Part I: Open Label|Unsatisfactory therapeutic effect|0|||
27962643|NCT00889863|54620092|FG000|Part II: Randomized Double Blind|Adverse Event|0|||
27962644|NCT00889863|54620093|FG001|Part II: Randomized Double Blind|Adverse Event|4|||
28082650|NCT00092547|54736546|FG000|Base Follow-up Phase (Month 18 to 30)|Subject moved|4|||
27962645|NCT00889863|54620092|FG000|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11|||
27962646|NCT00889863|54620093|FG001|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20|||
27962647|NCT00889863|54620092|FG000|Part II: Randomized Double Blind|Withdrawal by Subject|0|||
27962648|NCT00889863|54620093|FG001|Part II: Randomized Double Blind|Withdrawal by Subject|1|||
27962649|NCT00889863|54620092|FG000|Part II: Randomized Double Blind|Protocol deviation|0|||
27962650|NCT00889863|54620093|FG001|Part II: Randomized Double Blind|Protocol deviation|1|||
27962651|NCT00915018|54620103|FG000|Overall Study|Death|75|||
27962652|NCT00915018|54620104|FG001|Overall Study|Death|70|||
27962653|NCT00915018|54620103|FG000|Overall Study|Lost to Follow-up|10|||
27962654|NCT00915018|54620104|FG001|Overall Study|Lost to Follow-up|5|||
27962655|NCT00915018|54620103|FG000|Overall Study|Withdrawal by Subject|38|||
27962656|NCT00915018|54620104|FG001|Overall Study|Withdrawal by Subject|27|||
27962657|NCT00915018|54620103|FG000|Overall Study|By Sponsor due to Protocol Amendment|92|||
27962658|NCT00915018|54620104|FG001|Overall Study|By Sponsor due to Protocol Amendment|105|||
27962659|NCT00916578|54620110|FG000|Overall Study|Physician Decision|2|||
27962660|NCT00916578|54620110|FG000|Overall Study|Withdrawal by Subject|3|||
27962661|NCT00916578|54620110|FG000|Overall Study|Insurance Denial|2|||
27962662|NCT00889707|54620116|FG000|Overall Study|Adverse Event|1|||
27962663|NCT00889707|54620117|FG001|Overall Study|Adverse Event|0|||
27962664|NCT00889707|54620116|FG000|Overall Study|Withdrawal by Subject|4|||
27962665|NCT00889707|54620117|FG001|Overall Study|Withdrawal by Subject|3|||
27962666|NCT00889707|54620116|FG000|Overall Study|Lost to Follow-up|0|||
27962667|NCT00889707|54620117|FG001|Overall Study|Lost to Follow-up|2|||
27962668|NCT00889707|54620116|FG000|Overall Study|Lack of Efficacy|2|||
27962669|NCT00889707|54620117|FG001|Overall Study|Lack of Efficacy|5|||
27962670|NCT00914940|54620123|FG000|D0 to D100 Post-transplant|Death|2|||
27962671|NCT00914940|54620123|FG000|D101 to 2 Years Post-transplant|Death|8|||
27962672|NCT00914940|54620123|FG000|2 Years to 5 Years Post-transplant|Death|3|||
27962673|NCT00835978|54620131|FG000|Overall Study|Death|33|||
27962674|NCT00835978|54620132|FG001|Overall Study|Death|40|||
27962675|NCT00835978|54620133|FG002|Overall Study|Death|49|||
27962676|NCT00835978|54620134|FG003|Overall Study|Death|4|||
27962677|NCT00835978|54620131|FG000|Overall Study|Lost to Follow-up|3|||
27962678|NCT00835978|54620132|FG001|Overall Study|Lost to Follow-up|4|||
27962679|NCT00835978|54620133|FG002|Overall Study|Lost to Follow-up|2|||
27962680|NCT00835978|54620134|FG003|Overall Study|Lost to Follow-up|1|||
27962681|NCT00835978|54620131|FG000|Overall Study|Other|5|||
27962682|NCT00835978|54620132|FG001|Overall Study|Other|1|||
27962683|NCT00835978|54620133|FG002|Overall Study|Other|8|||
27962684|NCT00835978|54620134|FG003|Overall Study|Other|0|||
27962685|NCT00835978|54620131|FG000|Overall Study|Objective progression or relapse|2|||
27962686|NCT00835978|54620132|FG001|Overall Study|Objective progression or relapse|0|||
27962687|NCT00835978|54620133|FG002|Overall Study|Objective progression or relapse|1|||
27962688|NCT00835978|54620134|FG003|Overall Study|Objective progression or relapse|0|||
27962689|NCT00835978|54620131|FG000|Overall Study|Adverse Event|1|||
27962690|NCT00835978|54620132|FG001|Overall Study|Adverse Event|0|||
27962691|NCT00835978|54620133|FG002|Overall Study|Adverse Event|1|||
27962692|NCT00835978|54620134|FG003|Overall Study|Adverse Event|0|||
27962693|NCT00835978|54620131|FG000|Overall Study|Withdrawal by Subject|0|||
27962694|NCT00835978|54620132|FG001|Overall Study|Withdrawal by Subject|3|||
27962695|NCT00835978|54620133|FG002|Overall Study|Withdrawal by Subject|0|||
27962696|NCT00835978|54620134|FG003|Overall Study|Withdrawal by Subject|5|||
27962697|NCT00835978|54620131|FG000|Overall Study|Study terminated by sponsor|12|||
27962698|NCT00835978|54620132|FG001|Overall Study|Study terminated by sponsor|8|||
27962699|NCT00835978|54620133|FG002|Overall Study|Study terminated by sponsor|30|||
27962700|NCT00835978|54620134|FG003|Overall Study|Study terminated by sponsor|0|||
27962701|NCT00914628|54620151|FG000|Overall Study|Death|35|||
27962702|NCT00914628|54620152|FG001|Overall Study|Death|17|||
27962703|NCT00914628|54620151|FG000|Overall Study|Medical decision|4|||
27962704|NCT00914628|54620152|FG001|Overall Study|Medical decision|0|||
27962705|NCT00914628|54620151|FG000|Overall Study|Protocol Violation|1|||
27962706|NCT00914628|54620152|FG001|Overall Study|Protocol Violation|0|||
27962707|NCT00914628|54620151|FG000|Overall Study|Lack of Efficacy|1|||
27962708|NCT00914628|54620152|FG001|Overall Study|Lack of Efficacy|0|||
27962709|NCT00914628|54620151|FG000|Overall Study|non-randomized|1|||
27962710|NCT00914628|54620152|FG001|Overall Study|non-randomized|0|||
27962711|NCT00914628|54620151|FG000|Overall Study|Relapse|1|||
27962712|NCT00914628|54620152|FG001|Overall Study|Relapse|2|||
27962713|NCT00914628|54620151|FG000|Overall Study|Study terminated by Sponsor|14|||
27962714|NCT00914628|54620152|FG001|Overall Study|Study terminated by Sponsor|8|||
27962715|NCT00914628|54620151|FG000|Overall Study|Patients who did not receive a single dose|7|||
27962716|NCT00914628|54620152|FG001|Overall Study|Patients who did not receive a single dose|1|||
27962717|NCT01077518|54620164|FG000|Treatment Phase - no Optional Ofa|Lost to Follow-up|8|||
27962718|NCT01077518|54620165|FG001|Treatment Phase - no Optional Ofa|Lost to Follow-up|4|||
28165156|NCT03016325|54835759|FG006|182-Day Follow-Up Period|Alive, per national insurance system|0|||
28165157|NCT03016325|54835760|FG007|182-Day Follow-Up Period|Alive, per national insurance system|0|||
27962719|NCT01077518|54620166|FG002|Treatment Phase - no Optional Ofa|Lost to Follow-up|0|||
27962720|NCT01077518|54620164|FG000|Treatment Phase - no Optional Ofa|Physician Decision|10|||
27962721|NCT01077518|54620165|FG001|Treatment Phase - no Optional Ofa|Physician Decision|11|||
27962722|NCT01077518|54620166|FG002|Treatment Phase - no Optional Ofa|Physician Decision|0|||
27962723|NCT01077518|54620164|FG000|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28|||
27962724|NCT01077518|54620165|FG001|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22|||
27962725|NCT01077518|54620166|FG002|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0|||
27962726|NCT01077518|54620164|FG000|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32|||
27962727|NCT01077518|54620165|FG001|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28|||
27962728|NCT01077518|54620166|FG002|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0|||
27962729|NCT01077518|54620164|FG000|Optional Ofa Phase|Physician Decision|0|||
27962730|NCT01077518|54620165|FG001|Optional Ofa Phase|Physician Decision|0|||
27962731|NCT01077518|54620166|FG002|Optional Ofa Phase|Physician Decision|1|||
27962732|NCT01077518|54620164|FG000|Optional Ofa Phase|Study Terminated by Sponsor|0|||
27962733|NCT01077518|54620165|FG001|Optional Ofa Phase|Study Terminated by Sponsor|0|||
27962734|NCT01077518|54620166|FG002|Optional Ofa Phase|Study Terminated by Sponsor|12|||
27962735|NCT01077518|54620164|FG000|Optional Ofa Phase|Withdrawal by Subject|0|||
27962736|NCT01077518|54620165|FG001|Optional Ofa Phase|Withdrawal by Subject|0|||
27962737|NCT01077518|54620166|FG002|Optional Ofa Phase|Withdrawal by Subject|3|||
27962738|NCT00835120|54620175|FG000|Overall Study|Lack of Efficacy|1|||
27962739|NCT00835120|54620175|FG000|Overall Study|Lost to Follow-up|3|||
27962740|NCT00835120|54620175|FG000|Overall Study|Adverse Event|2|||
27962741|NCT00835120|54620175|FG000|Overall Study|Withdrawal by Subject|2|||
27962742|NCT00914316|54620183|FG000|Phase 1|Physician Decision|4|||
27962743|NCT00914316|54620184|FG001|Phase 1|Physician Decision|0|||
27962744|NCT00914316|54620185|FG002|Phase 1|Physician Decision|1|||
27962745|NCT00914316|54620186|FG003|Phase 1|Physician Decision|2|||
27962746|NCT00914316|54620183|FG000|Phase 1|Withdrawal by Subject|0|||
27962747|NCT00914316|54620184|FG001|Phase 1|Withdrawal by Subject|2|||
27962748|NCT00914316|54620185|FG002|Phase 1|Withdrawal by Subject|4|||
27962749|NCT00914316|54620186|FG003|Phase 1|Withdrawal by Subject|0|||
27962750|NCT00914316|54620183|FG000|Phase 1|Adverse Event|1|||
27962751|NCT00914316|54620184|FG001|Phase 1|Adverse Event|0|||
27962752|NCT00914316|54620185|FG002|Phase 1|Adverse Event|0|||
27962753|NCT00914316|54620186|FG003|Phase 1|Adverse Event|0|||
27962754|NCT00914316|54620183|FG000|Phase 2|Withdrawal by Subject|1|||
27962755|NCT00914316|54620184|FG001|Phase 2|Withdrawal by Subject|0|||
27962756|NCT00914316|54620185|FG002|Phase 2|Withdrawal by Subject|1|||
27962757|NCT00914316|54620186|FG003|Phase 2|Withdrawal by Subject|0|||
27962758|NCT00827632|54620198|FG000|Overall Study|Lost to Follow-up|8|||
27962759|NCT00827632|54620199|FG001|Overall Study|Lost to Follow-up|12|||
27962760|NCT00827632|54620198|FG000|Overall Study|Early withdrawal|14|||
27962761|NCT00827632|54620199|FG001|Overall Study|Early withdrawal|11|||
27962762|NCT00827242|54620207|FG000|Overall Study|Withdrawal by Subject|2|||
27962763|NCT00827242|54620208|FG001|Overall Study|Withdrawal by Subject|4|||
27962764|NCT00827242|54620207|FG000|Overall Study|Protocol Violation|1|||
27962765|NCT00827242|54620208|FG001|Overall Study|Protocol Violation|3|||
27962766|NCT00827242|54620207|FG000|Overall Study|Lost to Follow-up|0|||
27962767|NCT00827242|54620208|FG001|Overall Study|Lost to Follow-up|3|||
27962768|NCT00827242|54620207|FG000|Overall Study|Adverse Event Excluding Death|2|||
27962769|NCT00827242|54620208|FG001|Overall Study|Adverse Event Excluding Death|1|||
27962770|NCT00827242|54620207|FG000|Overall Study|Entry Criteria Not Met|4|||
27962771|NCT00827242|54620208|FG001|Overall Study|Entry Criteria Not Met|1|||
27962772|NCT00827242|54620207|FG000|Overall Study|Physician Decision|2|||
27962773|NCT00827242|54620208|FG001|Overall Study|Physician Decision|0|||
27962774|NCT00827242|54620207|FG000|Overall Study|Death|1|||
27962775|NCT00827242|54620208|FG001|Overall Study|Death|0|||
27962776|NCT00827242|54620207|FG000|Overall Study|Lack of Efficacy|1|||
27962777|NCT00827242|54620208|FG001|Overall Study|Lack of Efficacy|0|||
27962778|NCT01077362|54620217|FG000|Overall Study|Lack of Efficacy|13|||
27962779|NCT01077362|54620218|FG001|Overall Study|Lack of Efficacy|8|||
27962780|NCT01077362|54620219|FG002|Overall Study|Lack of Efficacy|10|||
28082651|NCT00092547|54736547|FG001|Base Follow-up Phase (Month 18 to 30)|Subject moved|2|||
28082652|NCT00092547|54736548|FG002|Base Follow-up Phase (Month 18 to 30)|Subject moved|0|||
27962781|NCT01077362|54620217|FG000|Overall Study|Lost to Follow-up|1|||
27962782|NCT01077362|54620218|FG001|Overall Study|Lost to Follow-up|0|||
27962783|NCT01077362|54620219|FG002|Overall Study|Lost to Follow-up|3|||
27962784|NCT01077362|54620217|FG000|Overall Study|Adverse Event|12|||
27962785|NCT01077362|54620218|FG001|Overall Study|Adverse Event|7|||
27962786|NCT01077362|54620219|FG002|Overall Study|Adverse Event|4|||
27732495|NCT02578706|54180009|FG002|Overall Study|Physician Decision|0|||
27962787|NCT01077362|54620217|FG000|Overall Study|Withdrawal by Subject|5|||
27962788|NCT01077362|54620218|FG001|Overall Study|Withdrawal by Subject|3|||
27962789|NCT01077362|54620219|FG002|Overall Study|Withdrawal by Subject|5|||
27962790|NCT01077362|54620217|FG000|Overall Study|Other|0|||
27962791|NCT01077362|54620218|FG001|Overall Study|Other|1|||
27962792|NCT01077362|54620219|FG002|Overall Study|Other|2|||
27962793|NCT00846586|54620234|FG000|Overall Study|Adverse Event|20|||
27962794|NCT00846586|54620235|FG001|Overall Study|Adverse Event|10|||
27962795|NCT00846586|54620234|FG000|Overall Study|Subject withdrew consent|8|||
27962796|NCT00846586|54620235|FG001|Overall Study|Subject withdrew consent|10|||
27962797|NCT00846586|54620234|FG000|Overall Study|Administrative problems|5|||
27962798|NCT00846586|54620235|FG001|Overall Study|Administrative problems|4|||
27962799|NCT00846586|54620234|FG000|Overall Study|Death|2|||
27962800|NCT00846586|54620235|FG001|Overall Study|Death|0|||
27962801|NCT00846586|54620234|FG000|Overall Study|Protocol deviation|2|||
27962802|NCT00846586|54620235|FG001|Overall Study|Protocol deviation|6|||
27962803|NCT00846586|54620234|FG000|Overall Study|Abnormal test procedure result(s)|1|||
27962804|NCT00846586|54620235|FG001|Overall Study|Abnormal test procedure result(s)|0|||
27962805|NCT00846586|54620234|FG000|Overall Study|Lost to Follow-up|1|||
27962806|NCT00846586|54620235|FG001|Overall Study|Lost to Follow-up|4|||
27962807|NCT00846586|54620234|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
27962808|NCT00846586|54620235|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
27962809|NCT00785785|54620243|FG000|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3|||
27962810|NCT00785785|54620244|FG001|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4|||
27962811|NCT00785785|54620243|FG000|Core Phase up to 36 Months|Adverse Event|31|||
27962812|NCT00785785|54620244|FG001|Core Phase up to 36 Months|Adverse Event|21|||
27962813|NCT00785785|54620243|FG000|Core Phase up to 36 Months|Abnormal laboratory value|1|||
27962814|NCT00785785|54620244|FG001|Core Phase up to 36 Months|Abnormal laboratory value|0|||
27962815|NCT00785785|54620243|FG000|Core Phase up to 36 Months|Abnormal test procedure result|2|||
27962816|NCT00785785|54620244|FG001|Core Phase up to 36 Months|Abnormal test procedure result|2|||
27962817|NCT00785785|54620243|FG000|Core Phase up to 36 Months|Withdrawal by Subject|16|||
27962818|NCT00785785|54620244|FG001|Core Phase up to 36 Months|Withdrawal by Subject|17|||
27962819|NCT00785785|54620243|FG000|Core Phase up to 36 Months|Lost to Follow-up|3|||
27962820|NCT00785785|54620244|FG001|Core Phase up to 36 Months|Lost to Follow-up|7|||
27962821|NCT00785785|54620243|FG000|Core Phase up to 36 Months|Administrative problems|3|||
27962822|NCT00785785|54620244|FG001|Core Phase up to 36 Months|Administrative problems|3|||
27962823|NCT00785785|54620243|FG000|Core Phase up to 36 Months|Death|5|||
27962824|NCT00785785|54620244|FG001|Core Phase up to 36 Months|Death|8|||
27962825|NCT00785785|54620243|FG000|Core Phase up to 36 Months|Disease progression|139|||
27962826|NCT00785785|54620244|FG001|Core Phase up to 36 Months|Disease progression|119|||
27962827|NCT00785785|54620243|FG000|Core Phase up to 36 Months|Protocol deviation|5|||
27962828|NCT00785785|54620244|FG001|Core Phase up to 36 Months|Protocol deviation|6|||
27962829|NCT00785785|54620243|FG000|Core Phase up to 36 Months|Study terminated by sponsor|116|||
27962830|NCT00785785|54620244|FG001|Core Phase up to 36 Months|Study terminated by sponsor|133|||
27962831|NCT00785785|54620243|FG000|Optional Extension Phase|Adverse Event|4|||
27962832|NCT00785785|54620244|FG001|Optional Extension Phase|Adverse Event|5|||
27962833|NCT00785785|54620243|FG000|Optional Extension Phase|Withdrawal by Subject|6|||
27962834|NCT00785785|54620244|FG001|Optional Extension Phase|Withdrawal by Subject|6|||
27962835|NCT00785785|54620243|FG000|Optional Extension Phase|Lost to Follow-up|1|||
27962836|NCT00785785|54620244|FG001|Optional Extension Phase|Lost to Follow-up|0|||
27962837|NCT00785785|54620243|FG000|Optional Extension Phase|Administrative problems|2|||
27962838|NCT00785785|54620244|FG001|Optional Extension Phase|Administrative problems|0|||
27962839|NCT00785785|54620243|FG000|Optional Extension Phase|Death|1|||
27962840|NCT00785785|54620244|FG001|Optional Extension Phase|Death|5|||
27962841|NCT00785785|54620243|FG000|Optional Extension Phase|Disease progression|22|||
27962842|NCT00785785|54620244|FG001|Optional Extension Phase|Disease progression|70|||
27962843|NCT00785785|54620243|FG000|Optional Extension Phase|Protocol deviation|0|||
27962844|NCT00785785|54620244|FG001|Optional Extension Phase|Protocol deviation|2|||
27962845|NCT00785785|54620243|FG000|Optional Extension Phase|Study terminated by sponsor|3|||
27962846|NCT00785785|54620244|FG001|Optional Extension Phase|Study terminated by sponsor|37|||
27962847|NCT01077284|54620255|FG000|Overall Study|Adverse Event|2|||
27962848|NCT01077284|54620256|FG001|Overall Study|Adverse Event|0|||
27962849|NCT01077284|54620257|FG002|Overall Study|Adverse Event|1|||
27962850|NCT01077284|54620255|FG000|Overall Study|Lost to Follow-up|1|||
27962851|NCT01077284|54620256|FG001|Overall Study|Lost to Follow-up|2|||
27962852|NCT01077284|54620257|FG002|Overall Study|Lost to Follow-up|0|||
27962853|NCT01077284|54620255|FG000|Overall Study|Withdrawal by Subject|2|||
27962854|NCT01077284|54620256|FG001|Overall Study|Withdrawal by Subject|3|||
27962855|NCT01077284|54620257|FG002|Overall Study|Withdrawal by Subject|1|||
27962856|NCT01077284|54620255|FG000|Overall Study|Other|0|||
27962857|NCT01077284|54620256|FG001|Overall Study|Other|0|||
27962858|NCT01077284|54620257|FG002|Overall Study|Other|1|||
27962859|NCT00826618|54620265|FG000|Overall Study|Withdrawal by Subject|1|||
27962860|NCT01077128|54620269|FG000|Overall Study|Adverse Event|8|||
27962861|NCT01077128|54620269|FG000|Overall Study|Lack of Efficacy|1|||
27962862|NCT01077128|54620269|FG000|Overall Study|Disease exacerbation|1|||
27962863|NCT01077128|54620269|FG000|Overall Study|Adverse event and consent withdrawal|1|||
27962864|NCT01077128|54620269|FG000|Overall Study|Adverse event and disease exacerbation|1|||
27962865|NCT01077128|54620269|FG000|Overall Study|Lack of efficacy/disease exacerbation|1|||
27962866|NCT01077128|54620269|FG000|Overall Study|Other|54|||
27962867|NCT00826540|54620323|FG000|Overall Study|ineligible|3|||
27962868|NCT00826540|54620323|FG000|Overall Study|Withdrawal by Subject|1|||
27732496|NCT00108953|54180019|FG000|Follow-up|Death|18|||
27962869|NCT01077050|54620327|FG000|Overall Study|Subjects signed ICF could not be located|1|||
27962870|NCT01077050|54620327|FG000|Overall Study|Screen failure|8|||
27962871|NCT00592384|54620333|FG000|Overall Study|Withdrawal by Subject|5|||
27962872|NCT00592384|54620334|FG001|Overall Study|Withdrawal by Subject|6|||
27962873|NCT00846040|54620343|FG000|Baseline: Days 1-5|Withdrawal by Subject|1|||
27962874|NCT00846040|54620344|FG001|Baseline: Days 1-5|Withdrawal by Subject|0|||
27962875|NCT00846040|54620345|FG002|Baseline: Days 1-5|Withdrawal by Subject|0|||
27962876|NCT00846040|54620343|FG000|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
27962877|NCT00846040|54620344|FG001|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|2|||
27962878|NCT00846040|54620345|FG002|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
27962879|NCT00826228|54620354|FG000|Overall Study|Withdrawal by Subject|1|||
27962880|NCT00825994|54620359|FG000|Overall Study|Withdrawal by Subject|2|||
27962881|NCT00825994|54620359|FG000|Overall Study|Lost to Follow-up|1|||
27962882|NCT00825994|54620359|FG000|Overall Study|Protocol Violation|1|||
27962883|NCT00825994|54620359|FG000|Overall Study|Placebo Responder at V2|1|||
27962884|NCT00825916|54620366|FG000|Overall Study|Lost to Follow-up|4|||
27962885|NCT00825916|54620367|FG001|Overall Study|Lost to Follow-up|2|||
27962886|NCT00825916|54620368|FG002|Overall Study|Lost to Follow-up|1|||
27962887|NCT00791479|54620415|FG000|Overall Study|Dose Discontinued per Sponsor Decision|0|||
27732497|NCT00108953|54180020|FG001|Follow-up|Death|26|||
27732498|NCT00108953|54180019|FG000|Follow-up|Lost to Follow-up|1|||
27732499|NCT00108953|54180020|FG001|Follow-up|Lost to Follow-up|1|||
27732500|NCT00108953|54180019|FG000|Follow-up|Study terminated by sponsor|10|||
27732501|NCT00108953|54180020|FG001|Follow-up|Study terminated by sponsor|6|||
27732502|NCT02578316|54180028|FG000|Extension Phase|Progression of disease|6|||
27732503|NCT02576678|54180039|FG000|Overall Study|Adverse Event|0|||
27732504|NCT02576678|54180040|FG001|Overall Study|Adverse Event|0|||
27732505|NCT02576678|54180041|FG002|Overall Study|Adverse Event|2|||
27732506|NCT02576678|54180039|FG000|Overall Study|Withdrawal by Subject|3|||
27732507|NCT02576678|54180040|FG001|Overall Study|Withdrawal by Subject|1|||
27732508|NCT02576678|54180041|FG002|Overall Study|Withdrawal by Subject|2|||
27732509|NCT02576678|54180039|FG000|Overall Study|Lost to Follow-up|0|||
27732510|NCT02576678|54180040|FG001|Overall Study|Lost to Follow-up|0|||
27732511|NCT02576678|54180041|FG002|Overall Study|Lost to Follow-up|1|||
27732512|NCT02576678|54180039|FG000|Overall Study|Miscellaneous|2|||
27732513|NCT02576678|54180040|FG001|Overall Study|Miscellaneous|0|||
27732514|NCT02576678|54180041|FG002|Overall Study|Miscellaneous|0|||
27732515|NCT00108745|54180052|FG000|Overall Study|Withdrawal by Subject|19|||
27732516|NCT00108745|54180053|FG001|Overall Study|Withdrawal by Subject|12|||
27732517|NCT00108745|54180054|FG002|Overall Study|Withdrawal by Subject|12|||
27732518|NCT00108745|54180052|FG000|Overall Study|Never Treated|8|||
27732519|NCT00108745|54180053|FG001|Overall Study|Never Treated|10|||
27732520|NCT00108745|54180054|FG002|Overall Study|Never Treated|12|||
27732521|NCT00108745|54180052|FG000|Overall Study|Ineligible|7|||
27732522|NCT00108745|54180053|FG001|Overall Study|Ineligible|13|||
27732523|NCT00108745|54180054|FG002|Overall Study|Ineligible|13|||
27732524|NCT02716805|54180084|FG000|Overall Study|Progressive disease|2|||
27732525|NCT02716805|54180085|FG001|Overall Study|Progressive disease|0|||
27732526|NCT02716805|54180086|FG002|Overall Study|Progressive disease|0|||
27732527|NCT02716805|54180087|FG003|Overall Study|Progressive disease|0|||
27732528|NCT02581982|54180091|FG000|Overall Study|Lack of Efficacy|12|||
27732529|NCT02581982|54180091|FG000|Overall Study|Adverse Event|3|||
27732530|NCT02581982|54180091|FG000|Overall Study|Physician Decision|1|||
27962888|NCT00791479|54620416|FG001|Overall Study|Dose Discontinued per Sponsor Decision|0|||
27962889|NCT00791479|54620417|FG002|Overall Study|Dose Discontinued per Sponsor Decision|0|||
27962890|NCT00791479|54620418|FG003|Overall Study|Dose Discontinued per Sponsor Decision|0|||
27962891|NCT00791479|54620419|FG004|Overall Study|Dose Discontinued per Sponsor Decision|3|||
27962892|NCT00791479|54620420|FG005|Overall Study|Dose Discontinued per Sponsor Decision|0|||
27962893|NCT00791479|54620415|FG000|Overall Study|Adverse Event|0|||
27962894|NCT00791479|54620416|FG001|Overall Study|Adverse Event|1|||
27962895|NCT00791479|54620417|FG002|Overall Study|Adverse Event|0|||
27962896|NCT00791479|54620418|FG003|Overall Study|Adverse Event|2|||
27962897|NCT00791479|54620419|FG004|Overall Study|Adverse Event|0|||
27732541|NCT04510285|54180104|FG000|Overall Study|Death|1|||
27732542|NCT02576054|54180108|FG000|Overall Study|Withdrawal by Subject|1|||
27732543|NCT01606202|54180116|FG000|Overall Study|Adverse Event|5|||
27732544|NCT01606202|54180117|FG001|Overall Study|Adverse Event|0|||
27732545|NCT01606202|54180116|FG000|Overall Study|Withdrawal by Subject|2|||
27732546|NCT01606202|54180117|FG001|Overall Study|Withdrawal by Subject|1|||
27732547|NCT01606202|54180116|FG000|Overall Study|Personal problems|0|||
27732548|NCT01606202|54180117|FG001|Overall Study|Personal problems|1|||
27855158|NCT01278745|54375543|FG000|Overall Study|Moves,enrollment in mx studies, et al.|0|||
27962898|NCT00791479|54620420|FG005|Overall Study|Adverse Event|1|||
27962899|NCT00791479|54620415|FG000|Overall Study|Lost to Follow-up|0|||
27962900|NCT00791479|54620416|FG001|Overall Study|Lost to Follow-up|1|||
27732549|NCT01606202|54180116|FG000|Overall Study|Problems with administration|0|||
27732550|NCT01606202|54180117|FG001|Overall Study|Problems with administration|1|||
27732551|NCT01493960|54180125|FG000|Overall Study|Adverse Event|0|||
27732552|NCT01493960|54180126|FG001|Overall Study|Adverse Event|1|||
27732553|NCT01493960|54180125|FG000|Overall Study|Lack of Efficacy|15|||
27962901|NCT00791479|54620417|FG002|Overall Study|Lost to Follow-up|0|||
27962902|NCT00791479|54620418|FG003|Overall Study|Lost to Follow-up|0|||
27962903|NCT00791479|54620419|FG004|Overall Study|Lost to Follow-up|0|||
27962904|NCT00791479|54620420|FG005|Overall Study|Lost to Follow-up|1|||
27962905|NCT00791479|54620415|FG000|Overall Study|Protocol Violation|2|||
27962906|NCT00791479|54620416|FG001|Overall Study|Protocol Violation|1|||
27962907|NCT00791479|54620417|FG002|Overall Study|Protocol Violation|0|||
27962908|NCT00791479|54620418|FG003|Overall Study|Protocol Violation|1|||
27962909|NCT00791479|54620419|FG004|Overall Study|Protocol Violation|0|||
27962910|NCT00791479|54620420|FG005|Overall Study|Protocol Violation|0|||
27962911|NCT00791479|54620415|FG000|Overall Study|Withdrawal by Subject|0|||
27962912|NCT00791479|54620416|FG001|Overall Study|Withdrawal by Subject|0|||
28082653|NCT00092547|54736546|FG000|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1|||
28082654|NCT00092547|54736547|FG001|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3|||
28082655|NCT00092547|54736548|FG002|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0|||
28082656|NCT00092547|54736546|FG000|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2|||
28082657|NCT00092547|54736547|FG001|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
28082658|NCT00092547|54736548|FG002|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
28082659|NCT00092547|54736546|FG000|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1|||
28082660|NCT00092547|54736547|FG001|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
28082661|NCT00092547|54736548|FG002|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
28082662|NCT00092547|54736546|FG000|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3|||
28082663|NCT00092547|54736547|FG001|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
28082664|NCT00092547|54736548|FG002|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
28082665|NCT00092547|54736546|FG000|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6|||
28082666|NCT00092547|54736547|FG001|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0|||
28082667|NCT00092547|54736548|FG002|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9|||
28082668|NCT00092547|54736546|FG000|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14|||
28082669|NCT00092547|54736547|FG001|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0|||
28082670|NCT00092547|54736548|FG002|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7|||
28082671|NCT00092547|54736546|FG000|Long-term Follow-up (Month 42 Visit)|Adverse Event|1|||
27732554|NCT01493960|54180126|FG001|Overall Study|Lack of Efficacy|9|||
27732555|NCT01493960|54180125|FG000|Overall Study|Protocol Violation|3|||
27732556|NCT01493960|54180126|FG001|Overall Study|Protocol Violation|0|||
27962913|NCT00791479|54620417|FG002|Overall Study|Withdrawal by Subject|0|||
27962914|NCT00791479|54620418|FG003|Overall Study|Withdrawal by Subject|1|||
27962915|NCT00791479|54620419|FG004|Overall Study|Withdrawal by Subject|0|||
27962916|NCT00791479|54620420|FG005|Overall Study|Withdrawal by Subject|1|||
27962917|NCT00890097|54620444|FG000|Overall Study|Adverse Event|21|||
27962918|NCT00890097|54620445|FG001|Overall Study|Adverse Event|32|||
27962919|NCT00890097|54620446|FG002|Overall Study|Adverse Event|28|||
27962920|NCT00890097|54620444|FG000|Overall Study|Decision Unrelated to an Adverse Event|15|||
27962921|NCT00890097|54620445|FG001|Overall Study|Decision Unrelated to an Adverse Event|12|||
27962922|NCT00890097|54620446|FG002|Overall Study|Decision Unrelated to an Adverse Event|17|||
27962923|NCT00890097|54620444|FG000|Overall Study|Withdrew Consent|9|||
27962924|NCT00890097|54620445|FG001|Overall Study|Withdrew Consent|6|||
27962925|NCT00890097|54620446|FG002|Overall Study|Withdrew Consent|9|||
27962926|NCT00890097|54620444|FG000|Overall Study|Lost to Follow-up|5|||
27962927|NCT00890097|54620445|FG001|Overall Study|Lost to Follow-up|5|||
27962928|NCT00890097|54620446|FG002|Overall Study|Lost to Follow-up|5|||
27962929|NCT00890097|54620444|FG000|Overall Study|Noncompliance|0|||
27962930|NCT00890097|54620445|FG001|Overall Study|Noncompliance|4|||
27962931|NCT00890097|54620446|FG002|Overall Study|Noncompliance|4|||
27962932|NCT00890097|54620444|FG000|Overall Study|Sponsor Decision|7|||
27962933|NCT00890097|54620445|FG001|Overall Study|Sponsor Decision|11|||
27962934|NCT00890097|54620446|FG002|Overall Study|Sponsor Decision|7|||
27962935|NCT00890097|54620444|FG000|Overall Study|Did not attend final visit|2|||
27962936|NCT00890097|54620445|FG001|Overall Study|Did not attend final visit|3|||
27962937|NCT00890097|54620446|FG002|Overall Study|Did not attend final visit|0|||
27962938|NCT00890097|54620444|FG000|Overall Study|Subject Decision|3|||
27962939|NCT00890097|54620445|FG001|Overall Study|Subject Decision|2|||
27962940|NCT00890097|54620446|FG002|Overall Study|Subject Decision|6|||
27962941|NCT00890097|54620444|FG000|Overall Study|Randomization Error|2|||
27962942|NCT00890097|54620445|FG001|Overall Study|Randomization Error|0|||
27962943|NCT00890097|54620446|FG002|Overall Study|Randomization Error|0|||
27962944|NCT00890097|54620444|FG000|Overall Study|Failed inclusion criteria|3|||
27962945|NCT00890097|54620445|FG001|Overall Study|Failed inclusion criteria|4|||
27962946|NCT00890097|54620446|FG002|Overall Study|Failed inclusion criteria|0|||
27962947|NCT00890097|54620444|FG000|Overall Study|Transportation|0|||
27962948|NCT00890097|54620445|FG001|Overall Study|Transportation|2|||
27962949|NCT00890097|54620446|FG002|Overall Study|Transportation|0|||
27962950|NCT00890097|54620444|FG000|Overall Study|Subject Moved|0|||
27962951|NCT00890097|54620445|FG001|Overall Study|Subject Moved|4|||
27962952|NCT00890097|54620446|FG002|Overall Study|Subject Moved|0|||
27962953|NCT00890097|54620444|FG000|Overall Study|Protocol Deviation|1|||
27962954|NCT00890097|54620445|FG001|Overall Study|Protocol Deviation|1|||
27962955|NCT00890097|54620446|FG002|Overall Study|Protocol Deviation|1|||
27962956|NCT00913458|54620454|FG000|Phase 1|Non-Responder|54|||
27962957|NCT00913458|54620455|FG001|Phase 1|Non-Responder|0|||
27962958|NCT00913458|54620456|FG002|Phase 1|Non-Responder|0|||
27962959|NCT00913458|54620457|FG003|Phase 1|Non-Responder|0|||
27962960|NCT00913458|54620458|FG004|Phase 1|Non-Responder|0|||
27962961|NCT00913458|54620459|FG005|Phase 1|Non-Responder|0|||
27962962|NCT00913458|54620460|FG006|Phase 1|Non-Responder|0|||
27962963|NCT00913458|54620454|FG000|Phase 1|Subject Request|17|||
27962964|NCT00913458|54620455|FG001|Phase 1|Subject Request|0|||
27962965|NCT00913458|54620456|FG002|Phase 1|Subject Request|0|||
27962966|NCT00913458|54620457|FG003|Phase 1|Subject Request|0|||
27962967|NCT00913458|54620458|FG004|Phase 1|Subject Request|0|||
27962968|NCT00913458|54620459|FG005|Phase 1|Subject Request|0|||
27962969|NCT00913458|54620460|FG006|Phase 1|Subject Request|0|||
27962970|NCT00913458|54620454|FG000|Phase 1|Adverse Event|20|||
27962971|NCT00913458|54620455|FG001|Phase 1|Adverse Event|0|||
27962972|NCT00913458|54620456|FG002|Phase 1|Adverse Event|0|||
27962973|NCT00913458|54620457|FG003|Phase 1|Adverse Event|0|||
27962974|NCT00913458|54620458|FG004|Phase 1|Adverse Event|0|||
27962975|NCT00913458|54620459|FG005|Phase 1|Adverse Event|0|||
27962976|NCT00913458|54620460|FG006|Phase 1|Adverse Event|0|||
27962977|NCT00913458|54620454|FG000|Phase 1|Lost to Follow-up|2|||
27962978|NCT00913458|54620455|FG001|Phase 1|Lost to Follow-up|0|||
28082672|NCT00092547|54736547|FG001|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
28082673|NCT00092547|54736548|FG002|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
27962979|NCT00913458|54620456|FG002|Phase 1|Lost to Follow-up|0|||
27962980|NCT00913458|54620457|FG003|Phase 1|Lost to Follow-up|0|||
27962981|NCT00913458|54620458|FG004|Phase 1|Lost to Follow-up|0|||
27962982|NCT00913458|54620459|FG005|Phase 1|Lost to Follow-up|0|||
27962983|NCT00913458|54620460|FG006|Phase 1|Lost to Follow-up|0|||
27962984|NCT00913458|54620454|FG000|Phase 1|Protocol Violation|10|||
27962985|NCT00913458|54620455|FG001|Phase 1|Protocol Violation|0|||
27732557|NCT01493960|54180125|FG000|Overall Study|Withdrawal by Subject|10|||
27962986|NCT00913458|54620456|FG002|Phase 1|Protocol Violation|0|||
27962987|NCT00913458|54620457|FG003|Phase 1|Protocol Violation|0|||
27962988|NCT00913458|54620458|FG004|Phase 1|Protocol Violation|0|||
27962989|NCT00913458|54620459|FG005|Phase 1|Protocol Violation|0|||
27962990|NCT00913458|54620460|FG006|Phase 1|Protocol Violation|0|||
27962991|NCT00913458|54620454|FG000|Phase 1|Sponsor|2|||
27962992|NCT00913458|54620455|FG001|Phase 1|Sponsor|0|||
27962993|NCT00913458|54620456|FG002|Phase 1|Sponsor|0|||
27962994|NCT00913458|54620457|FG003|Phase 1|Sponsor|0|||
27962995|NCT00913458|54620458|FG004|Phase 1|Sponsor|0|||
27962996|NCT00913458|54620459|FG005|Phase 1|Sponsor|0|||
27962997|NCT00913458|54620460|FG006|Phase 1|Sponsor|0|||
27962998|NCT00913458|54620454|FG000|Phase 1|Unsatisfactory Response per Investigator|7|||
27962999|NCT00913458|54620455|FG001|Phase 1|Unsatisfactory Response per Investigator|0|||
27963000|NCT00913458|54620456|FG002|Phase 1|Unsatisfactory Response per Investigator|0|||
27963001|NCT00913458|54620457|FG003|Phase 1|Unsatisfactory Response per Investigator|0|||
27963002|NCT00913458|54620458|FG004|Phase 1|Unsatisfactory Response per Investigator|0|||
27963003|NCT00913458|54620459|FG005|Phase 1|Unsatisfactory Response per Investigator|0|||
27963004|NCT00913458|54620460|FG006|Phase 1|Unsatisfactory Response per Investigator|0|||
27963005|NCT00913458|54620454|FG000|Phase 2|Non-Responder|0|||
27963006|NCT00913458|54620455|FG001|Phase 2|Non-Responder|5|||
27963007|NCT00913458|54620456|FG002|Phase 2|Non-Responder|7|||
27963008|NCT00913458|54620457|FG003|Phase 2|Non-Responder|12|||
27963009|NCT00913458|54620458|FG004|Phase 2|Non-Responder|0|||
27963010|NCT00913458|54620459|FG005|Phase 2|Non-Responder|0|||
27963011|NCT00913458|54620460|FG006|Phase 2|Non-Responder|0|||
27963012|NCT00913458|54620454|FG000|Phase 2|Subject Request|0|||
27963013|NCT00913458|54620455|FG001|Phase 2|Subject Request|0|||
27963014|NCT00913458|54620456|FG002|Phase 2|Subject Request|1|||
27963015|NCT00913458|54620457|FG003|Phase 2|Subject Request|2|||
27963016|NCT00913458|54620458|FG004|Phase 2|Subject Request|0|||
27963017|NCT00913458|54620459|FG005|Phase 2|Subject Request|0|||
27963018|NCT00913458|54620460|FG006|Phase 2|Subject Request|0|||
27963019|NCT00913458|54620454|FG000|Phase 2|Adverse Event|0|||
27963020|NCT00913458|54620455|FG001|Phase 2|Adverse Event|3|||
27963021|NCT00913458|54620456|FG002|Phase 2|Adverse Event|0|||
27963022|NCT00913458|54620457|FG003|Phase 2|Adverse Event|1|||
27963023|NCT00913458|54620458|FG004|Phase 2|Adverse Event|0|||
27963024|NCT00913458|54620459|FG005|Phase 2|Adverse Event|0|||
28082674|NCT03802994|54736564|FG000|Overall Study|Lost to Follow-up|0|||
27963025|NCT00913458|54620460|FG006|Phase 2|Adverse Event|0|||
27963026|NCT00913458|54620454|FG000|Phase 2|Lost to Follow-up|0|||
27963027|NCT00913458|54620455|FG001|Phase 2|Lost to Follow-up|0|||
27963028|NCT00913458|54620456|FG002|Phase 2|Lost to Follow-up|0|||
27963029|NCT00913458|54620457|FG003|Phase 2|Lost to Follow-up|1|||
27963030|NCT00913458|54620458|FG004|Phase 2|Lost to Follow-up|0|||
27963031|NCT00913458|54620459|FG005|Phase 2|Lost to Follow-up|0|||
27963032|NCT00913458|54620460|FG006|Phase 2|Lost to Follow-up|0|||
27963033|NCT00913458|54620454|FG000|Phase 2|Protocol Violation|0|||
27963034|NCT00913458|54620455|FG001|Phase 2|Protocol Violation|2|||
27963035|NCT00913458|54620456|FG002|Phase 2|Protocol Violation|0|||
27963036|NCT00913458|54620457|FG003|Phase 2|Protocol Violation|0|||
27963037|NCT00913458|54620458|FG004|Phase 2|Protocol Violation|0|||
27963038|NCT00913458|54620459|FG005|Phase 2|Protocol Violation|0|||
27963039|NCT00913458|54620460|FG006|Phase 2|Protocol Violation|0|||
27963040|NCT00913458|54620454|FG000|Phase 2|Unsatisfactory Response per Investigator|0|||
27963041|NCT00913458|54620455|FG001|Phase 2|Unsatisfactory Response per Investigator|0|||
27963042|NCT00913458|54620456|FG002|Phase 2|Unsatisfactory Response per Investigator|11|||
27963043|NCT00913458|54620457|FG003|Phase 2|Unsatisfactory Response per Investigator|17|||
27963044|NCT00913458|54620458|FG004|Phase 2|Unsatisfactory Response per Investigator|0|||
27963045|NCT00913458|54620459|FG005|Phase 2|Unsatisfactory Response per Investigator|0|||
27963046|NCT00913458|54620460|FG006|Phase 2|Unsatisfactory Response per Investigator|0|||
27963047|NCT00913458|54620454|FG000|Phase 3|Adverse Event|0|||
27963048|NCT00913458|54620455|FG001|Phase 3|Adverse Event|0|||
27963049|NCT00913458|54620456|FG002|Phase 3|Adverse Event|0|||
27963050|NCT00913458|54620457|FG003|Phase 3|Adverse Event|0|||
27963051|NCT00913458|54620458|FG004|Phase 3|Adverse Event|5|||
27963052|NCT00913458|54620459|FG005|Phase 3|Adverse Event|4|||
27963053|NCT00913458|54620460|FG006|Phase 3|Adverse Event|1|||
27963054|NCT00913458|54620454|FG000|Phase 3|Lost to Follow-up|0|||
27963055|NCT00913458|54620455|FG001|Phase 3|Lost to Follow-up|0|||
27963056|NCT00913458|54620456|FG002|Phase 3|Lost to Follow-up|0|||
27963057|NCT00913458|54620457|FG003|Phase 3|Lost to Follow-up|0|||
27963058|NCT00913458|54620458|FG004|Phase 3|Lost to Follow-up|2|||
27963059|NCT00913458|54620459|FG005|Phase 3|Lost to Follow-up|0|||
27963060|NCT00913458|54620460|FG006|Phase 3|Lost to Follow-up|0|||
27963061|NCT00913458|54620454|FG000|Phase 3|Non-Responder|0|||
27963062|NCT00913458|54620455|FG001|Phase 3|Non-Responder|0|||
27963063|NCT00913458|54620456|FG002|Phase 3|Non-Responder|0|||
27963064|NCT00913458|54620457|FG003|Phase 3|Non-Responder|0|||
27963065|NCT00913458|54620458|FG004|Phase 3|Non-Responder|0|||
27963066|NCT00913458|54620459|FG005|Phase 3|Non-Responder|1|||
27963067|NCT00913458|54620460|FG006|Phase 3|Non-Responder|3|||
27963068|NCT00913458|54620454|FG000|Phase 3|Withdrawal by Subject|0|||
27963069|NCT00913458|54620455|FG001|Phase 3|Withdrawal by Subject|0|||
27963070|NCT00913458|54620456|FG002|Phase 3|Withdrawal by Subject|0|||
27963071|NCT00913458|54620457|FG003|Phase 3|Withdrawal by Subject|0|||
27963072|NCT00913458|54620458|FG004|Phase 3|Withdrawal by Subject|1|||
27963073|NCT00913458|54620459|FG005|Phase 3|Withdrawal by Subject|2|||
27963074|NCT00913458|54620460|FG006|Phase 3|Withdrawal by Subject|0|||
27963075|NCT00913458|54620454|FG000|Phase 3|Unsatisfactory Response per Investigator|0|||
27963076|NCT00913458|54620455|FG001|Phase 3|Unsatisfactory Response per Investigator|0|||
27963077|NCT00913458|54620456|FG002|Phase 3|Unsatisfactory Response per Investigator|0|||
27963078|NCT00913458|54620457|FG003|Phase 3|Unsatisfactory Response per Investigator|0|||
27963079|NCT00913458|54620458|FG004|Phase 3|Unsatisfactory Response per Investigator|14|||
27963080|NCT00913458|54620459|FG005|Phase 3|Unsatisfactory Response per Investigator|11|||
27963081|NCT00913458|54620460|FG006|Phase 3|Unsatisfactory Response per Investigator|4|||
27963082|NCT00785707|54620477|FG000|Overall Study|Lost to Follow-up|7|||
27963083|NCT00913380|54620483|FG000|Clinical Outcomes|Lost to Follow-up|6|||
27963084|NCT00913380|54620484|FG001|Clinical Outcomes|Lost to Follow-up|6|||
27963085|NCT00785629|54620494|FG000|Overall Study|Adverse Event|2|||
27963086|NCT00785629|54620495|FG001|Overall Study|Adverse Event|1|||
27963087|NCT00785629|54620496|FG002|Overall Study|Adverse Event|1|||
27963088|NCT00785629|54620497|FG003|Overall Study|Adverse Event|5|||
27963089|NCT00785629|54620494|FG000|Overall Study|Protocol Violation|1|||
27963090|NCT00785629|54620495|FG001|Overall Study|Protocol Violation|2|||
27963091|NCT00785629|54620496|FG002|Overall Study|Protocol Violation|4|||
27963092|NCT00785629|54620497|FG003|Overall Study|Protocol Violation|5|||
27963093|NCT00785629|54620494|FG000|Overall Study|administrative decision|5|||
27963094|NCT00785629|54620495|FG001|Overall Study|administrative decision|1|||
27963095|NCT00785629|54620496|FG002|Overall Study|administrative decision|3|||
27963096|NCT00785629|54620497|FG003|Overall Study|administrative decision|4|||
27963097|NCT00785629|54620494|FG000|Overall Study|Withdrawal by Subject|0|||
27963098|NCT00785629|54620495|FG001|Overall Study|Withdrawal by Subject|1|||
27963099|NCT00785629|54620496|FG002|Overall Study|Withdrawal by Subject|2|||
27963100|NCT00785629|54620497|FG003|Overall Study|Withdrawal by Subject|2|||
27963101|NCT00916344|54620505|FG000|Overall Study|Death|2|||
27963102|NCT00916344|54620505|FG000|Overall Study|ICD upgrade|1|||
27963103|NCT00916344|54620505|FG000|Overall Study|Drop-out|5|||
27963104|NCT00913770|54620512|FG000|Overall Study|Unable to contact|24|||
27963105|NCT00913770|54620513|FG001|Overall Study|Unable to contact|19|||
27963106|NCT00913770|54620514|FG002|Overall Study|Unable to contact|13|||
27963107|NCT00913770|54620512|FG000|Overall Study|Refused|11|||
27963108|NCT00913770|54620513|FG001|Overall Study|Refused|10|||
27963109|NCT00913770|54620514|FG002|Overall Study|Refused|8|||
27963110|NCT00780559|54620524|FG000|Overall Study|Lost to Follow-up|2|||
27963111|NCT00780559|54620525|FG001|Overall Study|Lost to Follow-up|7|||
27963112|NCT00780559|54620524|FG000|Overall Study|Death|1|||
27963113|NCT00780559|54620525|FG001|Overall Study|Death|0|||
27963114|NCT00912912|54620533|FG000|Overall Study|Withdrawal by Subject|1|||
27963115|NCT00912912|54620533|FG000|Overall Study|Disease Progression|3|||
27963116|NCT00889005|54620539|FG000|Overall Study|Lost to Follow-up|4|||
27963117|NCT00889005|54620540|FG001|Overall Study|Lost to Follow-up|2|||
27963118|NCT00889005|54620539|FG000|Overall Study|Withdrawal by Subject|4|||
27963119|NCT00889005|54620540|FG001|Overall Study|Withdrawal by Subject|0|||
27963120|NCT00779857|54620546|FG000|Overall Study|Death|1|||
27963121|NCT00779857|54620546|FG000|Overall Study|Withdrawal by Subject|3|||
27963122|NCT00779857|54620546|FG000|Overall Study|Missed Visit|2|||
27963123|NCT00913692|54620550|FG000|Screening (4 Months)|Physician Decision|3|||
27963124|NCT00913692|54620550|FG000|Screening (4 Months)|Not eligible after screening phase.|6|||
27963125|NCT00913692|54620550|FG000|Treatment Phase 1 (5 Months)|Physician Decision|1|||
27963126|NCT00784927|54620557|FG000|Overall Study|Cancel Prior to Initiating Treatment|1|||
27963127|NCT00784927|54620557|FG000|Overall Study|Protocol Violation|1|||
27963128|NCT00784927|54620557|FG000|Overall Study|Ineligible|1|||
27963129|NCT00779779|54620562|FG000|Overall Study|Adverse Event|1|||
27963130|NCT00779779|54620562|FG000|Overall Study|Protocol Violation|14|||
27963131|NCT00779779|54620562|FG000|Overall Study|Withdrawal by Subject|4|||
27963132|NCT00779779|54620562|FG000|Overall Study|Lost to Follow-up|5|||
27963133|NCT00845728|54620568|FG000|Overall Study|Abnormal laboratory value (s)|2|||
27963134|NCT00845728|54620569|FG001|Overall Study|Abnormal laboratory value (s)|2|||
27963135|NCT00845728|54620568|FG000|Overall Study|Patient's inability to use the device|4|||
27963136|NCT00845728|54620569|FG001|Overall Study|Patient's inability to use the device|6|||
27963137|NCT00845728|54620568|FG000|Overall Study|Abnormal test procedure result (s)|7|||
27963138|NCT00845728|54620569|FG001|Overall Study|Abnormal test procedure result (s)|2|||
27963139|NCT00845728|54620568|FG000|Overall Study|Lost to Follow-up|22|||
27963140|NCT00845728|54620569|FG001|Overall Study|Lost to Follow-up|13|||
27963141|NCT00845728|54620568|FG000|Overall Study|Death|24|||
27963142|NCT00845728|54620569|FG001|Overall Study|Death|26|||
27963143|NCT00845728|54620568|FG000|Overall Study|Administrative Problems|34|||
27963144|NCT00845728|54620569|FG001|Overall Study|Administrative Problems|26|||
27963145|NCT00845728|54620568|FG000|Overall Study|Protocol Violation|36|||
27963146|NCT00845728|54620569|FG001|Overall Study|Protocol Violation|24|||
27963147|NCT00845728|54620568|FG000|Overall Study|Lack of Efficacy|51|||
27963148|NCT00845728|54620569|FG001|Overall Study|Lack of Efficacy|39|||
27963149|NCT00845728|54620568|FG000|Overall Study|Adverse Event|101|||
27963150|NCT00845728|54620569|FG001|Overall Study|Adverse Event|96|||
27963151|NCT00845728|54620568|FG000|Overall Study|Withdrawal by Subject|105|||
27963152|NCT00845728|54620569|FG001|Overall Study|Withdrawal by Subject|108|||
27963153|NCT00779467|54620579|FG000|Overall Study|Lack of Efficacy|11|||
27963154|NCT00779467|54620580|FG001|Overall Study|Lack of Efficacy|2|||
27963155|NCT00779467|54620581|FG002|Overall Study|Lack of Efficacy|6|||
27963156|NCT00779467|54620582|FG003|Overall Study|Lack of Efficacy|11|||
27963157|NCT00779467|54620579|FG000|Overall Study|failed inclusion criteria|3|||
27963158|NCT00779467|54620580|FG001|Overall Study|failed inclusion criteria|3|||
27963159|NCT00779467|54620581|FG002|Overall Study|failed inclusion criteria|1|||
27963160|NCT00779467|54620582|FG003|Overall Study|failed inclusion criteria|2|||
27963161|NCT00779467|54620579|FG000|Overall Study|missing data|1|||
27963162|NCT00779467|54620580|FG001|Overall Study|missing data|0|||
27963163|NCT00779467|54620581|FG002|Overall Study|missing data|1|||
27963164|NCT00779467|54620582|FG003|Overall Study|missing data|4|||
27963165|NCT00779467|54620579|FG000|Overall Study|technical issue|0|||
27963166|NCT00779467|54620580|FG001|Overall Study|technical issue|0|||
27963167|NCT00779467|54620581|FG002|Overall Study|technical issue|2|||
27963168|NCT00779467|54620582|FG003|Overall Study|technical issue|1|||
27963169|NCT00779467|54620579|FG000|Overall Study|unavailable research staff|0|||
27963170|NCT00779467|54620580|FG001|Overall Study|unavailable research staff|0|||
27963171|NCT00779467|54620581|FG002|Overall Study|unavailable research staff|0|||
27963172|NCT00779467|54620582|FG003|Overall Study|unavailable research staff|1|||
27963173|NCT00778921|54620595|FG000|Overall Study|Adverse Event|9|||
27963174|NCT00778921|54620596|FG001|Overall Study|Adverse Event|10|||
27963175|NCT00778921|54620597|FG002|Overall Study|Adverse Event|14|||
27963176|NCT00778921|54620595|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
27963177|NCT00778921|54620596|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
27963178|NCT00778921|54620597|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
27963179|NCT00778921|54620595|FG000|Overall Study|Abnormal Test Procedure Result(s)|0|||
27963180|NCT00778921|54620596|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
27963181|NCT00778921|54620597|FG002|Overall Study|Abnormal Test Procedure Result(s)|2|||
27963182|NCT00778921|54620595|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
27963183|NCT00778921|54620596|FG001|Overall Study|Unsatisfactory therapeutic response|1|||
27963184|NCT00778921|54620597|FG002|Overall Study|Unsatisfactory therapeutic response|1|||
27963185|NCT00778921|54620595|FG000|Overall Study|Patient No Longer Requires Study Drug|0|||
27963186|NCT00778921|54620596|FG001|Overall Study|Patient No Longer Requires Study Drug|1|||
27963187|NCT00778921|54620597|FG002|Overall Study|Patient No Longer Requires Study Drug|0|||
27963188|NCT00778921|54620595|FG000|Overall Study|Patient withdrew request|3|||
27963189|NCT00778921|54620596|FG001|Overall Study|Patient withdrew request|1|||
28082675|NCT03802994|54736565|FG001|Overall Study|Lost to Follow-up|2|||
28082676|NCT03802994|54736566|FG002|Overall Study|Lost to Follow-up|3|||
28082677|NCT03802994|54736567|FG003|Overall Study|Lost to Follow-up|2|||
28082678|NCT03802994|54736568|FG004|Overall Study|Lost to Follow-up|2|||
28082679|NCT03465904|54736593|FG000|Overall Study|Withdrawal by Subject|9|||
28082680|NCT03465904|54736594|FG001|Overall Study|Withdrawal by Subject|5|||
28082681|NCT03465904|54736593|FG000|Overall Study|Lost to Follow-up|10|||
28082682|NCT03465904|54736594|FG001|Overall Study|Lost to Follow-up|9|||
28082683|NCT03465904|54736593|FG000|Overall Study|Protocol Violation|8|||
28082684|NCT03465904|54736594|FG001|Overall Study|Protocol Violation|5|||
28082685|NCT03465904|54736593|FG000|Overall Study|Ineligible for mITT analysis|62|||
28082686|NCT03465904|54736594|FG001|Overall Study|Ineligible for mITT analysis|47|||
27963190|NCT00778921|54620597|FG002|Overall Study|Patient withdrew request|6|||
27963191|NCT00778921|54620595|FG000|Overall Study|Lost to Follow-up|0|||
27963192|NCT00778921|54620596|FG001|Overall Study|Lost to Follow-up|2|||
27963193|NCT00778921|54620597|FG002|Overall Study|Lost to Follow-up|1|||
27963194|NCT00778921|54620595|FG000|Overall Study|Administrative Problems|1|||
27963195|NCT00778921|54620596|FG001|Overall Study|Administrative Problems|2|||
27963196|NCT00778921|54620597|FG002|Overall Study|Administrative Problems|0|||
27963197|NCT00778921|54620595|FG000|Overall Study|Protocol Violation|3|||
27963198|NCT00778921|54620596|FG001|Overall Study|Protocol Violation|0|||
27963199|NCT00778921|54620597|FG002|Overall Study|Protocol Violation|2|||
28082687|NCT03802916|54736602|FG000|Overall Study|Adverse Event|0|||
28082688|NCT03802916|54736603|FG001|Overall Study|Adverse Event|1|||
28082689|NCT03802916|54736602|FG000|Overall Study|Withdrawal by Subject|0|||
28082690|NCT03802916|54736603|FG001|Overall Study|Withdrawal by Subject|1|||
28082691|NCT00076011|54736611|FG000|Overall Study|Death|1|||
28082692|NCT00076011|54736611|FG000|Overall Study|Adverse Event|10|||
28082693|NCT00076011|54736611|FG000|Overall Study|Lack of Efficacy|25|||
28082694|NCT00076011|54736611|FG000|Overall Study|Withdrawal by Subject|1|||
27963200|NCT00778921|54620595|FG000|Overall Study|Not treated|0|||
27963201|NCT00778921|54620596|FG001|Overall Study|Not treated|2|||
28082695|NCT00076011|54736611|FG000|Overall Study|Study terminated by sponsor|3|||
28082696|NCT00076011|54736611|FG000|Overall Study|Other|11|||
28082697|NCT00076011|54736611|FG000|Overall Study|Ongoing|1|||
28082698|NCT03465436|54736619|FG000|Period 1|Protocol Violation|0|||
28082699|NCT03465436|54736620|FG001|Period 1|Protocol Violation|0|||
28082700|NCT03465436|54736621|FG002|Period 1|Protocol Violation|1|||
28082701|NCT03465436|54736622|FG003|Period 1|Protocol Violation|0|||
28082702|NCT03465436|54736619|FG000|Period 2|Protocol Violation|0|||
28082703|NCT03465436|54736620|FG001|Period 2|Protocol Violation|1|||
28082704|NCT03465436|54736621|FG002|Period 2|Protocol Violation|0|||
28082705|NCT03465436|54736622|FG003|Period 2|Protocol Violation|0|||
28082706|NCT03465436|54736619|FG000|Period 3|Protocol Violation|1|||
28082707|NCT03465436|54736620|FG001|Period 3|Protocol Violation|1|||
28082708|NCT03465436|54736621|FG002|Period 3|Protocol Violation|0|||
28082709|NCT03465436|54736622|FG003|Period 3|Protocol Violation|0|||
28082710|NCT03465436|54736619|FG000|Period 4|Protocol Violation|0|||
28082711|NCT03465436|54736620|FG001|Period 4|Protocol Violation|0|||
28082712|NCT03465436|54736621|FG002|Period 4|Protocol Violation|1|||
28082713|NCT03465436|54736622|FG003|Period 4|Protocol Violation|0|||
28082714|NCT00053846|54736636|FG000|Overall Study|Changed mind|8|||
28082715|NCT00053846|54736637|FG001|Overall Study|Changed mind|13|||
28082716|NCT00053846|54736636|FG000|Overall Study|Became too ill|8|||
28082717|NCT00053846|54736637|FG001|Overall Study|Became too ill|7|||
27963202|NCT00778921|54620597|FG002|Overall Study|Not treated|2|||
27963203|NCT00915876|54620607|FG000|Overall Study|Adverse Event|0|||
27963204|NCT00915876|54620608|FG001|Overall Study|Adverse Event|1|||
27963205|NCT00587431|54620616|FG000|Overall Study|Adverse Event|1|||
27963206|NCT00587431|54620617|FG001|Overall Study|Adverse Event|0|||
27963207|NCT00587431|54620616|FG000|Overall Study|Withdrawal by Subject|0|||
28082718|NCT00053846|54736636|FG000|Overall Study|Expired|5|||
28082719|NCT00053846|54736637|FG001|Overall Study|Expired|0|||
28082720|NCT00053846|54736636|FG000|Overall Study|Became ineligible|3|||
28082721|NCT00053846|54736637|FG001|Overall Study|Became ineligible|1|||
28082722|NCT00053846|54736636|FG000|Overall Study|Did not return data|1|||
28082723|NCT00053846|54736637|FG001|Overall Study|Did not return data|2|||
27963208|NCT00587431|54620617|FG001|Overall Study|Withdrawal by Subject|1|||
27963209|NCT00776659|54620626|FG000|Overall Study|Lost to Follow-up|15|||
27963210|NCT00776659|54620626|FG000|Overall Study|Withdrawal by Subject|10|||
27963211|NCT00776659|54620626|FG000|Overall Study|Study Terminated by Sponsor|1|||
28082724|NCT00053846|54736636|FG000|Overall Study|Quit due to side effects|1|||
28082725|NCT00053846|54736637|FG001|Overall Study|Quit due to side effects|3|||
28082726|NCT00053846|54736636|FG000|Overall Study|Pills too large|0|||
28082727|NCT00053846|54736637|FG001|Overall Study|Pills too large|1|||
28082728|NCT00090987|54736643|FG000|Overall Study|Adverse Event|5|||
28082729|NCT00090987|54736643|FG000|Overall Study|Lack of Efficacy|7|||
28082730|NCT00090987|54736643|FG000|Overall Study|Withdrawal by Subject|3|||
27963212|NCT00825682|54620632|FG000|Overall Study|personal reasons/ inconvenience|13|||
28082731|NCT00090987|54736643|FG000|Overall Study|alternative therapy|1|||
28082732|NCT00090987|54736643|FG000|Overall Study|Non-compliance|4|||
28082733|NCT00090987|54736643|FG000|Overall Study|Incarcerated|1|||
28082734|NCT03464422|54736647|FG000|Overall Study|Lost to Follow-up|2|||
28082735|NCT03464422|54736647|FG000|Overall Study|Withdrawal by Subject|2|||
28082736|NCT03489304|54736653|FG000|Overall Study|Lost to Follow-up|4|||
28082737|NCT03543358|54736657|FG000|Overall Study|Death|1|||
28082738|NCT03543358|54736658|FG001|Overall Study|Death|0|||
28082739|NCT03543358|54736657|FG000|Overall Study|Disease Progression|1|||
28082740|NCT03543358|54736658|FG001|Overall Study|Disease Progression|0|||
28082741|NCT03543358|54736657|FG000|Overall Study|Parent Study Closure|1|||
28082742|NCT03543358|54736658|FG001|Overall Study|Parent Study Closure|0|||
28082743|NCT03485950|54736664|FG000|Overall Study|Adverse Event|1|||
28082744|NCT03485950|54736665|FG001|Overall Study|Adverse Event|0|||
28082745|NCT03485950|54736664|FG000|Overall Study|Death|3|||
28082746|NCT03485950|54736665|FG001|Overall Study|Death|2|||
28082747|NCT03485950|54736664|FG000|Overall Study|Withdrawal by Subject|3|||
28082748|NCT03485950|54736665|FG001|Overall Study|Withdrawal by Subject|0|||
28082749|NCT00060944|54736673|FG000|Overall Study|Adverse Event|12|||
28082750|NCT00060944|54736674|FG001|Overall Study|Adverse Event|10|||
28082751|NCT00060944|54736673|FG000|Overall Study|Death|2|||
28082752|NCT00060944|54736674|FG001|Overall Study|Death|3|||
28082753|NCT00060944|54736673|FG000|Overall Study|Withdrawal by Subject|18|||
28082754|NCT00060944|54736674|FG001|Overall Study|Withdrawal by Subject|5|||
28082755|NCT00060944|54736673|FG000|Overall Study|Disease Progression|93|||
28082756|NCT00060944|54736674|FG001|Overall Study|Disease Progression|94|||
28082757|NCT00060944|54736673|FG000|Overall Study|Lost to Follow-up|1|||
28082758|NCT00060944|54736674|FG001|Overall Study|Lost to Follow-up|0|||
28082759|NCT00060944|54736673|FG000|Overall Study|Subject Ineligible To Continue|2|||
28082760|NCT00060944|54736674|FG001|Overall Study|Subject Ineligible To Continue|1|||
28082761|NCT00060944|54736673|FG000|Overall Study|Treatment Switch|0|||
28082762|NCT00060944|54736674|FG001|Overall Study|Treatment Switch|13|||
28082763|NCT00060944|54736673|FG000|Overall Study|Other|2|||
28082764|NCT00060944|54736674|FG001|Overall Study|Other|4|||
27963213|NCT00825682|54620633|FG001|Overall Study|personal reasons/ inconvenience|5|||
27963214|NCT00833794|54620642|FG000|Open-label Phase|Adverse Event|225|||
27963215|NCT00833794|54620643|FG001|Open-label Phase|Adverse Event|0|||
27963216|NCT00833794|54620642|FG000|Open-label Phase|Lack of Efficacy|28|||
27963217|NCT00833794|54620643|FG001|Open-label Phase|Lack of Efficacy|0|||
27963218|NCT00833794|54620642|FG000|Open-label Phase|Withdrawal by Subject|48|||
27963219|NCT00833794|54620643|FG001|Open-label Phase|Withdrawal by Subject|0|||
28082765|NCT00060944|54736673|FG000|Overall Study|randomized but not treated|6|||
28082766|NCT00060944|54736674|FG001|Overall Study|randomized but not treated|4|||
28082767|NCT03462082|54736680|FG000|Open Label Phase|Symptom worsening (Treatment failure)|0|||
28082768|NCT03462082|54736681|FG001|Open Label Phase|Symptom worsening (Treatment failure)|0|||
28082769|NCT03462082|54736682|FG002|Open Label Phase|Symptom worsening (Treatment failure)|0|||
28082770|NCT03462082|54736683|FG003|Open Label Phase|Symptom worsening (Treatment failure)|0|||
28082771|NCT03462082|54736684|FG004|Open Label Phase|Symptom worsening (Treatment failure)|0|||
28082772|NCT03462082|54736685|FG005|Open Label Phase|Symptom worsening (Treatment failure)|0|||
28082773|NCT03462082|54736686|FG006|Open Label Phase|Symptom worsening (Treatment failure)|1|||
28082774|NCT03462082|54736687|FG007|Open Label Phase|Symptom worsening (Treatment failure)|2|||
28082775|NCT03461146|54736697|FG000|Overall Study|Adverse Event|2|||
28082776|NCT03461146|54736697|FG000|Overall Study|Physician Decision|1|||
27732558|NCT01493960|54180126|FG001|Overall Study|Withdrawal by Subject|4|||
27732559|NCT01493960|54180125|FG000|Overall Study|Non-specified|4|||
27963220|NCT00833794|54620642|FG000|Open-label Phase|Physician Decision|20|||
27963221|NCT00833794|54620643|FG001|Open-label Phase|Physician Decision|0|||
27963222|NCT00833794|54620642|FG000|Open-label Phase|Administrative reason|1|||
27963223|NCT00833794|54620643|FG001|Open-label Phase|Administrative reason|0|||
27963224|NCT00833794|54620642|FG000|Open-label Phase|Protocol Violation|47|||
27963225|NCT00833794|54620643|FG001|Open-label Phase|Protocol Violation|0|||
27963226|NCT00833794|54620642|FG000|Open-label Phase|Did not complete wash-out period|12|||
27963227|NCT00833794|54620643|FG001|Open-label Phase|Did not complete wash-out period|0|||
27963228|NCT00833794|54620642|FG000|Open-label Phase|enrolled in error (immediately D/C)|1|||
27963229|NCT00833794|54620643|FG001|Open-label Phase|enrolled in error (immediately D/C)|0|||
27963230|NCT00833794|54620642|FG000|Double-blind Phase|Adverse Event|44|||
28082777|NCT03541252|54736701|FG000|Overall Study|Withdrawal by Subject|1|||
28082778|NCT00031460|54736707|FG000|Overall Study|Lost to Follow-up|0|||
28082779|NCT00031460|54736708|FG001|Overall Study|Lost to Follow-up|1|||
28082780|NCT00031460|54736707|FG000|Overall Study|Withdrawal by Subject|1|||
28082781|NCT00031460|54736708|FG001|Overall Study|Withdrawal by Subject|1|||
28082782|NCT00031460|54736707|FG000|Overall Study|Non-Compliant|1|||
28082783|NCT00031460|54736708|FG001|Overall Study|Non-Compliant|1|||
28082784|NCT00031460|54736707|FG000|Overall Study|Death|0|||
28082785|NCT00031460|54736708|FG001|Overall Study|Death|1|||
28082786|NCT00031460|54736707|FG000|Overall Study|Reactivation of Disease|5|||
28082787|NCT00031460|54736708|FG001|Overall Study|Reactivation of Disease|9|||
28082788|NCT00031460|54736707|FG000|Overall Study|Disruption of blinded drug supply|2|||
28082789|NCT00031460|54736708|FG001|Overall Study|Disruption of blinded drug supply|0|||
28082790|NCT00031460|54736707|FG000|Overall Study|Confirmed unevaluable|0|||
28082791|NCT00031460|54736708|FG001|Overall Study|Confirmed unevaluable|1|||
28082792|NCT03540160|54736714|FG000|Overall Study|Protocol Violation|1|||
28082793|NCT03540160|54736714|FG000|Overall Study|Physician Decision|8|||
27963231|NCT00833794|54620643|FG001|Double-blind Phase|Adverse Event|11|||
27963232|NCT00833794|54620642|FG000|Double-blind Phase|Lack of Efficacy|34|||
27963233|NCT00833794|54620643|FG001|Double-blind Phase|Lack of Efficacy|22|||
27963234|NCT00833794|54620642|FG000|Double-blind Phase|Withdrawal by Subject|23|||
27963235|NCT00833794|54620643|FG001|Double-blind Phase|Withdrawal by Subject|6|||
27963236|NCT00833794|54620642|FG000|Double-blind Phase|Physician Decision|4|||
27963237|NCT00833794|54620643|FG001|Double-blind Phase|Physician Decision|7|||
27963238|NCT00833794|54620642|FG000|Double-blind Phase|Administrative reason|1|||
27963239|NCT00833794|54620643|FG001|Double-blind Phase|Administrative reason|3|||
27963240|NCT00912288|54620653|FG000|Overall Study|Death|0|||
27963241|NCT00912288|54620654|FG001|Overall Study|Death|1|||
27963242|NCT00912288|54620653|FG000|Overall Study|Adverse Event|1|||
27963243|NCT00912288|54620654|FG001|Overall Study|Adverse Event|1|||
27963244|NCT00912288|54620653|FG000|Overall Study|Lost to Follow-up|1|||
27963245|NCT00912288|54620654|FG001|Overall Study|Lost to Follow-up|0|||
27963246|NCT00912288|54620653|FG000|Overall Study|Protocol Violation|1|||
27963247|NCT00912288|54620654|FG001|Overall Study|Protocol Violation|0|||
27963248|NCT00912288|54620653|FG000|Overall Study|Withdrawal by Subject|3|||
27963249|NCT00912288|54620654|FG001|Overall Study|Withdrawal by Subject|3|||
27963250|NCT00912288|54620653|FG000|Overall Study|Study terminated by sponsor|34|||
27963251|NCT00912288|54620654|FG001|Overall Study|Study terminated by sponsor|35|||
27963252|NCT00912288|54620653|FG000|Overall Study|Other|1|||
27963253|NCT00912288|54620654|FG001|Overall Study|Other|0|||
27963254|NCT00778375|54620660|FG000|Overall Study|Ineligible|3|||
27963255|NCT00777829|54620666|FG000|Overall Study|Withdrawal by Subject|0|||
27963256|NCT00777829|54620667|FG001|Overall Study|Withdrawal by Subject|2|||
27963257|NCT00775021|54620675|FG000|First Intervention|Lost to Follow-up|1|||
27963258|NCT00775021|54620676|FG001|First Intervention|Lost to Follow-up|0|||
27963259|NCT00775021|54620675|FG000|Second Intervention|Adverse Event|0|||
27963260|NCT00775021|54620676|FG001|Second Intervention|Adverse Event|1|||
27963261|NCT00777205|54620684|FG000|Overall Study|Lost to Follow-up|25|||
27963262|NCT00777205|54620685|FG001|Overall Study|Lost to Follow-up|9|||
27963263|NCT00777205|54620684|FG000|Overall Study|Withdrawal by Subject|6|||
27963264|NCT00777205|54620685|FG001|Overall Study|Withdrawal by Subject|4|||
27963265|NCT00777205|54620684|FG000|Overall Study|Death|0|||
27963266|NCT00777205|54620685|FG001|Overall Study|Death|2|||
27963267|NCT00777205|54620684|FG000|Overall Study|Protocol Violation|0|||
27963268|NCT00777205|54620685|FG001|Overall Study|Protocol Violation|56|||
27963269|NCT00833638|54620696|FG000|Phase 2: Double-blind Treatment Phase|Adverse Event|1|||
27963270|NCT00833638|54620697|FG001|Phase 2: Double-blind Treatment Phase|Adverse Event|2|||
27963271|NCT00833638|54620698|FG002|Phase 2: Double-blind Treatment Phase|Adverse Event|0|||
27963272|NCT00833638|54620696|FG000|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3|||
27963273|NCT00833638|54620697|FG001|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2|||
27963274|NCT00833638|54620698|FG002|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1|||
27963275|NCT00833638|54620696|FG000|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
27963276|NCT00833638|54620697|FG001|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2|||
27963277|NCT00833638|54620698|FG002|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
27963278|NCT00833638|54620696|FG000|Phase 2: Double-blind Treatment Phase|Physician Decision|1|||
27963279|NCT00833638|54620697|FG001|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
27963280|NCT00833638|54620698|FG002|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
27963281|NCT00833638|54620696|FG000|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
27963282|NCT00833638|54620697|FG001|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
27963283|NCT00833638|54620698|FG002|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
27963284|NCT00833638|54620696|FG000|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
27963285|NCT00833638|54620697|FG001|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
27963286|NCT00833638|54620698|FG002|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2|||
27963287|NCT00833638|54620696|FG000|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
27963288|NCT00833638|54620697|FG001|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
27963289|NCT00833638|54620698|FG002|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2|||
27963290|NCT00833638|54620696|FG000|Phase 3: Open-label Extension Phase|Lost to Follow-up|1|||
27963291|NCT00833638|54620697|FG001|Phase 3: Open-label Extension Phase|Lost to Follow-up|2|||
27963292|NCT00833638|54620698|FG002|Phase 3: Open-label Extension Phase|Lost to Follow-up|0|||
27963293|NCT00833638|54620696|FG000|Phase 3: Open-label Extension Phase|Protocol Violation|0|||
27963294|NCT00833638|54620697|FG001|Phase 3: Open-label Extension Phase|Protocol Violation|1|||
27963295|NCT00833638|54620698|FG002|Phase 3: Open-label Extension Phase|Protocol Violation|2|||
27963296|NCT01041404|54620716|FG000|Overall Study|Adverse Event|45|||
27963297|NCT01041404|54620717|FG001|Overall Study|Adverse Event|35|||
28082794|NCT03540160|54736714|FG000|Overall Study|Lack of Efficacy|60|||
28082795|NCT03540160|54736714|FG000|Overall Study|Pregnancy|1|||
28082796|NCT03540160|54736714|FG000|Overall Study|Adverse Event|20|||
28082797|NCT03540160|54736714|FG000|Overall Study|Withdrawal by Subject|68|||
28082798|NCT03540160|54736714|FG000|Overall Study|COVID-19|2|||
28082799|NCT03540160|54736714|FG000|Overall Study|Study Closure|10|||
28082800|NCT03540160|54736714|FG000|Overall Study|Lost to Follow-up|18|||
28082801|NCT03540160|54736714|FG000|Overall Study|Sponsor decision|191|||
28082802|NCT03459196|54736718|FG000|Overall Study|Subject didn't receive study catheter|2|||
28082803|NCT03459040|54736722|FG000|Overall Study|Death|8|||
28082804|NCT03459040|54736722|FG000|Overall Study|Withdrawal by Subject|1|||
28082805|NCT03457636|54736727|FG000|Overall Study|Lost to Follow-up|2|||
28082806|NCT03481816|54736733|FG000|Starting Dose|Refused further vaccines after 1 dose|1|||
28082807|NCT03481816|54736734|FG001|Starting Dose|Refused further vaccines after 1 dose|0|||
28082808|NCT03481816|54736733|FG000|Dose Expansion|Off treatment due to progressive disease|0|||
28082809|NCT03481816|54736734|FG001|Dose Expansion|Off treatment due to progressive disease|5|||
28082810|NCT03481816|54736733|FG000|Dose Expansion|Withdrawal by Subject|0|||
28082811|NCT03481816|54736734|FG001|Dose Expansion|Withdrawal by Subject|2|||
28082812|NCT03481816|54736733|FG000|Dose Expansion|Physician Decision|0|||
28082813|NCT03481816|54736734|FG001|Dose Expansion|Physician Decision|5|||
28082814|NCT03538054|54736742|FG000|Baseline Phase (2 Weeks)|Physician Decision|1|||
28082815|NCT03538054|54736742|FG000|Placebo Phase (5 Weeks)|Withdrawal by Subject|2|||
27963298|NCT01041404|54620716|FG000|Overall Study|Lack of Efficacy|200|||
27963299|NCT01041404|54620717|FG001|Overall Study|Lack of Efficacy|210|||
27963300|NCT01041404|54620716|FG000|Overall Study|Violation of Selection Criteria|0|||
27963301|NCT01041404|54620717|FG001|Overall Study|Violation of Selection Criteria|1|||
27963302|NCT01041404|54620716|FG000|Overall Study|Protocol Violation|4|||
27963303|NCT01041404|54620717|FG001|Overall Study|Protocol Violation|0|||
28082816|NCT03538054|54736742|FG000|Dextromethorphan Phase (10 Weeks)|Withdrawal by Subject|2|||
28082817|NCT03480802|54736750|FG000|Overall Study|Lost to Follow-up|5|||
27963304|NCT01041404|54620716|FG000|Overall Study|Withdrawal by Subject|29|||
27963305|NCT01041404|54620717|FG001|Overall Study|Withdrawal by Subject|23|||
27963306|NCT01041404|54620716|FG000|Overall Study|Failure to Return|1|||
27963307|NCT01041404|54620717|FG001|Overall Study|Failure to Return|2|||
27963308|NCT01041404|54620716|FG000|Overall Study|Other|11|||
28082818|NCT03480802|54736751|FG001|Overall Study|Lost to Follow-up|1|||
27963309|NCT01041404|54620717|FG001|Overall Study|Other|23|||
28082819|NCT03480802|54736750|FG000|Overall Study|Withdrawal by Subject|2|||
28082820|NCT03480802|54736751|FG001|Overall Study|Withdrawal by Subject|1|||
28082821|NCT03480802|54736750|FG000|Overall Study|Relocated|0|||
28082822|NCT03480802|54736751|FG001|Overall Study|Relocated|1|||
28082823|NCT00050960|54736761|FG000|Overall Study|Progressive Disease|137|||
28082824|NCT00050960|54736762|FG001|Overall Study|Progressive Disease|93|||
28082825|NCT00050960|54736761|FG000|Overall Study|Stable Disease|19|||
28082826|NCT00050960|54736762|FG001|Overall Study|Stable Disease|48|||
28082827|NCT00050960|54736761|FG000|Overall Study|Partial Response|14|||
28082828|NCT00050960|54736762|FG001|Overall Study|Partial Response|19|||
28082829|NCT00050960|54736761|FG000|Overall Study|Complete Response|0|||
28082830|NCT00050960|54736762|FG001|Overall Study|Complete Response|2|||
28082831|NCT00050960|54736761|FG000|Overall Study|Adverse Event|62|||
28082832|NCT00050960|54736762|FG001|Overall Study|Adverse Event|61|||
27963310|NCT00777049|54620728|FG000|Overall Study|Withdrawal by Subject|1|||
27963311|NCT00777049|54620729|FG001|Overall Study|Withdrawal by Subject|0|||
27963312|NCT00777049|54620728|FG000|Overall Study|No treatment (elevated liver enzymes)|0|||
28082833|NCT00050960|54736761|FG000|Overall Study|Lost to Follow-up|0|||
27963313|NCT00777049|54620729|FG001|Overall Study|No treatment (elevated liver enzymes)|1|||
27963314|NCT00774787|54620735|FG000|Overall Study|Lost to Follow-up|1|||
27963315|NCT00888927|54620743|FG000|Overall Study|Adverse Event|0|||
27963316|NCT00888927|54620744|FG001|Overall Study|Adverse Event|0|||
27963317|NCT00888927|54620745|FG002|Overall Study|Adverse Event|0|||
27963318|NCT00888927|54620746|FG003|Overall Study|Adverse Event|1|||
27963319|NCT00888927|54620743|FG000|Overall Study|Withdrawal of consent|0|||
27963320|NCT00888927|54620744|FG001|Overall Study|Withdrawal of consent|0|||
27963321|NCT00888927|54620745|FG002|Overall Study|Withdrawal of consent|0|||
27963322|NCT00888927|54620746|FG003|Overall Study|Withdrawal of consent|1|||
27963323|NCT01040780|54620758|FG000|Overall Study|Protocol Violation|1|||
27963324|NCT01040780|54620759|FG001|Overall Study|Protocol Violation|3|||
28082834|NCT00050960|54736762|FG001|Overall Study|Lost to Follow-up|1|||
28082835|NCT00050960|54736761|FG000|Overall Study|Withdrawal by Subject|23|||
28082836|NCT00050960|54736762|FG001|Overall Study|Withdrawal by Subject|18|||
28082837|NCT00050960|54736761|FG000|Overall Study|Administrative|31|||
28082838|NCT00050960|54736762|FG001|Overall Study|Administrative|46|||
28082839|NCT00050960|54736761|FG000|Overall Study|Non-compliance|3|||
28082840|NCT00050960|54736762|FG001|Overall Study|Non-compliance|1|||
28165158|NCT03016325|54835753|FG000|182-Day Follow-Up Period|Participant withdrew consent|0|||
28165159|NCT03016325|54835754|FG001|182-Day Follow-Up Period|Participant withdrew consent|0|||
28082841|NCT00050960|54736761|FG000|Overall Study|Death|13|||
27963325|NCT00888849|54620770|FG000|Overall Study|Death|4|||
27963326|NCT00888849|54620771|FG001|Overall Study|Death|7|||
27963327|NCT00888849|54620770|FG000|Overall Study|Lost to Follow-up|1|||
27963328|NCT00888849|54620771|FG001|Overall Study|Lost to Follow-up|2|||
27963329|NCT01059812|54620779|FG000|Overall Study|Adverse Event|9|||
27963330|NCT01059812|54620780|FG001|Overall Study|Adverse Event|5|||
27963331|NCT01059812|54620779|FG000|Overall Study|Lack of Efficacy|2|||
27963332|NCT01059812|54620780|FG001|Overall Study|Lack of Efficacy|2|||
27963333|NCT01059812|54620779|FG000|Overall Study|Protocol Violation|3|||
27963334|NCT01059812|54620780|FG001|Overall Study|Protocol Violation|1|||
27963335|NCT01059812|54620779|FG000|Overall Study|Withdrawal Criteria|9|||
27963336|NCT01059812|54620780|FG001|Overall Study|Withdrawal Criteria|4|||
27963337|NCT01059812|54620779|FG000|Overall Study|Unclassified|14|||
27963338|NCT01059812|54620780|FG001|Overall Study|Unclassified|4|||
27963339|NCT00888615|54620786|FG000|Overall Study|No treatment|2|||
27963340|NCT00845650|54620796|FG000|Overall Study|Withdrawal by Subject|0|||
27963341|NCT00845650|54620797|FG001|Overall Study|Withdrawal by Subject|0|||
27963342|NCT00845650|54620798|FG002|Overall Study|Withdrawal by Subject|0|||
27963343|NCT00845650|54620799|FG003|Overall Study|Withdrawal by Subject|0|||
27963344|NCT00845650|54620800|FG004|Overall Study|Withdrawal by Subject|2|||
27963345|NCT00845650|54620801|FG005|Overall Study|Withdrawal by Subject|0|||
27963346|NCT00845650|54620796|FG000|Overall Study|Lost to Follow-up|0|||
27963347|NCT00845650|54620797|FG001|Overall Study|Lost to Follow-up|0|||
27963348|NCT00845650|54620798|FG002|Overall Study|Lost to Follow-up|3|||
27963349|NCT00845650|54620799|FG003|Overall Study|Lost to Follow-up|1|||
28165160|NCT03016325|54835755|FG002|182-Day Follow-Up Period|Participant withdrew consent|0|||
27732560|NCT01493960|54180126|FG001|Overall Study|Non-specified|4|||
27732561|NCT02630459|54180136|FG000|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
27963350|NCT00845650|54620800|FG004|Overall Study|Lost to Follow-up|0|||
27963351|NCT00845650|54620801|FG005|Overall Study|Lost to Follow-up|1|||
27963352|NCT00845650|54620796|FG000|Overall Study|Sponsor hold on dosing|0|||
27963353|NCT00845650|54620797|FG001|Overall Study|Sponsor hold on dosing|0|||
27963354|NCT00845650|54620798|FG002|Overall Study|Sponsor hold on dosing|0|||
27963355|NCT00845650|54620799|FG003|Overall Study|Sponsor hold on dosing|0|||
27963356|NCT00845650|54620800|FG004|Overall Study|Sponsor hold on dosing|1|||
27963357|NCT00845650|54620801|FG005|Overall Study|Sponsor hold on dosing|1|||
27963358|NCT00845650|54620796|FG000|Overall Study|Unable to access IV line|1|||
27963359|NCT00845650|54620797|FG001|Overall Study|Unable to access IV line|0|||
27963360|NCT00845650|54620798|FG002|Overall Study|Unable to access IV line|0|||
27963361|NCT00845650|54620799|FG003|Overall Study|Unable to access IV line|0|||
27963362|NCT00845650|54620800|FG004|Overall Study|Unable to access IV line|0|||
27963363|NCT00845650|54620801|FG005|Overall Study|Unable to access IV line|0|||
27963364|NCT00888381|54620819|FG000|Overall Study|Lost to Follow-up|0|||
27963365|NCT00888381|54620820|FG001|Overall Study|Lost to Follow-up|1|||
27963366|NCT00887913|54620826|FG000|Overall Study|Withdrawal by Subject|6|||
27963367|NCT00833560|54620830|FG000|Overall Study|Toxicity|13|||
27963368|NCT00833560|54620830|FG000|Overall Study|Adverse Event|11|||
27963369|NCT00833560|54620830|FG000|Overall Study|Protocol Violation|6|||
27963370|NCT00833560|54620830|FG000|Overall Study|Lack of Efficacy|4|||
27963371|NCT00833560|54620830|FG000|Overall Study|Death|2|||
27963372|NCT00833560|54620830|FG000|Overall Study|Pregression of other disease|1|||
27963373|NCT00833560|54620830|FG000|Overall Study|Other|5|||
27963374|NCT00887679|54620834|FG000|Overall Study|Withdrawal by Subject|1|||
27963375|NCT00887679|54620834|FG000|Overall Study|Lost to Follow-up|4|||
27963376|NCT00887679|54620834|FG000|Overall Study|Physician Decision|5|||
27963377|NCT00833482|54620841|FG000|Days 11-20|Adverse Event|0|||
27963378|NCT00833482|54620842|FG001|Days 11-20|Adverse Event|2|||
27963379|NCT00833482|54620843|FG002|Days 11-20|Adverse Event|0|||
27963380|NCT00833482|54620844|FG003|Days 11-20|Adverse Event|0|||
27963381|NCT00833482|54620845|FG004|Days 11-20|Adverse Event|0|||
27963382|NCT00833482|54620846|FG005|Days 11-20|Adverse Event|0|||
27963383|NCT00833482|54620841|FG000|Days 11-20|Withdrawal by Subject|0|||
27963384|NCT00833482|54620842|FG001|Days 11-20|Withdrawal by Subject|1|||
27963385|NCT00833482|54620843|FG002|Days 11-20|Withdrawal by Subject|0|||
27963386|NCT00833482|54620844|FG003|Days 11-20|Withdrawal by Subject|0|||
27963387|NCT00833482|54620845|FG004|Days 11-20|Withdrawal by Subject|0|||
27963388|NCT00833482|54620846|FG005|Days 11-20|Withdrawal by Subject|0|||
27963389|NCT00833482|54620841|FG000|Days 21-30|Adverse Event|0|||
27963390|NCT00833482|54620842|FG001|Days 21-30|Adverse Event|0|||
27963391|NCT00833482|54620843|FG002|Days 21-30|Adverse Event|1|||
27963392|NCT00833482|54620844|FG003|Days 21-30|Adverse Event|0|||
28165161|NCT03016325|54835756|FG003|182-Day Follow-Up Period|Participant withdrew consent|0|||
27732562|NCT02630459|54180137|FG001|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1|||
27855159|NCT01278745|54375544|FG001|Overall Study|Moves,enrollment in mx studies, et al.|0|||
27963393|NCT00833482|54620845|FG004|Days 21-30|Adverse Event|0|||
27963394|NCT00833482|54620846|FG005|Days 21-30|Adverse Event|0|||
27963395|NCT00833482|54620841|FG000|Days 21-30|Withdrawal by Subject|0|||
27963396|NCT00833482|54620842|FG001|Days 21-30|Withdrawal by Subject|0|||
27963397|NCT00833482|54620843|FG002|Days 21-30|Withdrawal by Subject|0|||
27963398|NCT00833482|54620844|FG003|Days 21-30|Withdrawal by Subject|0|||
27963399|NCT00833482|54620845|FG004|Days 21-30|Withdrawal by Subject|1|||
27963400|NCT00833482|54620846|FG005|Days 21-30|Withdrawal by Subject|0|||
27963401|NCT00845182|54620871|FG000|Overall Study|Lost to Follow-up|3|||
27963402|NCT00845182|54620872|FG001|Overall Study|Lost to Follow-up|3|||
27963403|NCT00845182|54620873|FG002|Overall Study|Lost to Follow-up|4|||
27963404|NCT00845182|54620871|FG000|Overall Study|Adverse Event|0|||
27963405|NCT00845182|54620872|FG001|Overall Study|Adverse Event|1|||
27963406|NCT00845182|54620873|FG002|Overall Study|Adverse Event|1|||
27963407|NCT00845182|54620871|FG000|Overall Study|Physician Decision|0|||
27963408|NCT00845182|54620872|FG001|Overall Study|Physician Decision|0|||
27963409|NCT00845182|54620873|FG002|Overall Study|Physician Decision|1|||
27963410|NCT00833248|54620887|FG000|Overall Study|Adverse Event|3|||
27963411|NCT00833248|54620888|FG001|Overall Study|Adverse Event|0|||
27963412|NCT00833248|54620887|FG000|Overall Study|Protocol Violation|1|||
27963413|NCT00833248|54620888|FG001|Overall Study|Protocol Violation|2|||
27963414|NCT00833248|54620887|FG000|Overall Study|Withdrawal by Subject|0|||
27963415|NCT00833248|54620888|FG001|Overall Study|Withdrawal by Subject|1|||
27963416|NCT00887289|54620894|FG000|Overall Study|Lack of Efficacy|14|||
27963417|NCT00887289|54620894|FG000|Overall Study|Adverse Event|27|||
27963418|NCT00887289|54620894|FG000|Overall Study|Withdrawal by Subject|26|||
27963419|NCT00887289|54620894|FG000|Overall Study|Lost to Follow-up|8|||
27963420|NCT00887289|54620894|FG000|Overall Study|Other|20|||
27963421|NCT00833092|54620900|FG000|Overall Study|Withdrawal by Subject|2|||
27963422|NCT00833092|54620901|FG001|Overall Study|Withdrawal by Subject|3|||
27963423|NCT00833092|54620900|FG000|Overall Study|Protocol Violation|2|||
27963424|NCT00833092|54620901|FG001|Overall Study|Protocol Violation|1|||
27963425|NCT00833092|54620900|FG000|Overall Study|Diarrhea|0|||
27963426|NCT00833092|54620901|FG001|Overall Study|Diarrhea|2|||
27963427|NCT00833092|54620900|FG000|Overall Study|constipation|0|||
27963428|NCT00833092|54620901|FG001|Overall Study|constipation|1|||
27963429|NCT00823264|54620909|FG000|Overall Study|Protocol Violation|2|||
27963430|NCT00823264|54620910|FG001|Overall Study|Protocol Violation|0|||
27963431|NCT00832780|54620916|FG000|Overall Study|Death|16|||
27963432|NCT00832780|54620916|FG000|Overall Study|Lost to Follow-up|4|||
27963433|NCT00832780|54620916|FG000|Overall Study|no reason given|2|||
27963434|NCT00832780|54620916|FG000|Overall Study|other complicating condition|2|||
27963435|NCT00832780|54620916|FG000|Overall Study|Physician Decision|1|||
27963436|NCT00591838|54620925|FG000|Overall Study|Withdrawal by Subject|0|||
27963437|NCT00591838|54620926|FG001|Overall Study|Withdrawal by Subject|0|||
27963438|NCT00591838|54620927|FG002|Overall Study|Withdrawal by Subject|0|||
27963439|NCT00591838|54620928|FG003|Overall Study|Withdrawal by Subject|1|||
27963440|NCT00591838|54620929|FG004|Overall Study|Withdrawal by Subject|0|||
27963441|NCT00832624|54620942|FG000|Overall Study|Study Terminated|10|||
27963442|NCT00832078|54620946|FG000|Test Day 1-2 Period|Lack of Efficacy|0|||
27963443|NCT00832078|54620947|FG001|Test Day 1-2 Period|Lack of Efficacy|2|||
27963444|NCT00832078|54620946|FG000|Test Day 2 - 2 Period|Lack of Efficacy|1|||
27963445|NCT00832078|54620947|FG001|Test Day 2 - 2 Period|Lack of Efficacy|0|||
27963446|NCT00822172|54620955|FG000|Overall Study|Adverse Event|10|||
27963447|NCT00822172|54620956|FG001|Overall Study|Adverse Event|12|||
27963448|NCT00822172|54620955|FG000|Overall Study|Death|1|||
27963449|NCT00822172|54620956|FG001|Overall Study|Death|0|||
27963450|NCT00822172|54620955|FG000|Overall Study|Lost to Follow-up|3|||
27963451|NCT00822172|54620956|FG001|Overall Study|Lost to Follow-up|1|||
27963452|NCT00822172|54620955|FG000|Overall Study|Withdrawal by Subject|1|||
27963453|NCT00822172|54620956|FG001|Overall Study|Withdrawal by Subject|4|||
27963454|NCT00822172|54620955|FG000|Overall Study|site closed|0|||
27963455|NCT00822172|54620956|FG001|Overall Study|site closed|1|||
27963456|NCT00822172|54620955|FG000|Overall Study|Other|0|||
27963457|NCT00822172|54620956|FG001|Overall Study|Other|1|||
27963458|NCT00832000|54620962|FG000|Overall Study|Adverse Event|2|||
27963459|NCT00832000|54620963|FG001|Overall Study|Adverse Event|0|||
27963460|NCT00832000|54620962|FG000|Overall Study|Withdrawal by Subject|1|||
27855160|NCT01278745|54375545|FG002|Overall Study|Moves,enrollment in mx studies, et al.|5|||
27963461|NCT00832000|54620963|FG001|Overall Study|Withdrawal by Subject|0|||
27963462|NCT00832000|54620962|FG000|Overall Study|No calls to IVR in either period|1|||
27855161|NCT01278745|54375546|FG003|Overall Study|Moves,enrollment in mx studies, et al.|1|||
27855162|NCT03006926|54375556|FG000|Overall Study|Death|0|||
27855163|NCT03006926|54375557|FG001|Overall Study|Death|33|||
27963463|NCT00832000|54620963|FG001|Overall Study|No calls to IVR in either period|1|||
27963464|NCT00832000|54620962|FG000|Overall Study|No calls to IVR in period 2|2|||
27963465|NCT00832000|54620963|FG001|Overall Study|No calls to IVR in period 2|0|||
27963466|NCT00911508|54621000|FG000|Overall Study|Lost to Follow-up|27|||
27963467|NCT00911508|54621001|FG001|Overall Study|Lost to Follow-up|18|||
27963468|NCT00911508|54621000|FG000|Overall Study|Withdrawal by Subject|79|||
27963469|NCT00911508|54621001|FG001|Overall Study|Withdrawal by Subject|112|||
27963470|NCT00774397|54621027|FG000|Overall Study|Adverse Event|1|||
27963471|NCT00774397|54621028|FG001|Overall Study|Adverse Event|3|||
27963472|NCT00774397|54621029|FG002|Overall Study|Adverse Event|16|||
27963473|NCT00774397|54621030|FG003|Overall Study|Adverse Event|8|||
27963474|NCT00774397|54621031|FG004|Overall Study|Adverse Event|8|||
27963475|NCT00774397|54621032|FG005|Overall Study|Adverse Event|3|||
27963476|NCT00774397|54621033|FG006|Overall Study|Adverse Event|16|||
27963477|NCT00774397|54621027|FG000|Overall Study|Lack of Efficacy|11|||
27963478|NCT00774397|54621028|FG001|Overall Study|Lack of Efficacy|4|||
27963479|NCT00774397|54621029|FG002|Overall Study|Lack of Efficacy|5|||
27963480|NCT00774397|54621030|FG003|Overall Study|Lack of Efficacy|3|||
27963481|NCT00774397|54621031|FG004|Overall Study|Lack of Efficacy|27|||
27963482|NCT00774397|54621032|FG005|Overall Study|Lack of Efficacy|15|||
27963483|NCT00774397|54621033|FG006|Overall Study|Lack of Efficacy|9|||
27963484|NCT00774397|54621027|FG000|Overall Study|Protocol Violation|0|||
27963485|NCT00774397|54621028|FG001|Overall Study|Protocol Violation|1|||
27963486|NCT00774397|54621029|FG002|Overall Study|Protocol Violation|3|||
27963487|NCT00774397|54621030|FG003|Overall Study|Protocol Violation|1|||
27963488|NCT00774397|54621031|FG004|Overall Study|Protocol Violation|2|||
27963489|NCT00774397|54621032|FG005|Overall Study|Protocol Violation|1|||
27963490|NCT00774397|54621033|FG006|Overall Study|Protocol Violation|0|||
27963491|NCT00774397|54621027|FG000|Overall Study|Lost to Follow-up|0|||
27963492|NCT00774397|54621028|FG001|Overall Study|Lost to Follow-up|1|||
27963493|NCT00774397|54621029|FG002|Overall Study|Lost to Follow-up|1|||
27963494|NCT00774397|54621030|FG003|Overall Study|Lost to Follow-up|1|||
27963495|NCT00774397|54621031|FG004|Overall Study|Lost to Follow-up|0|||
27963496|NCT00774397|54621032|FG005|Overall Study|Lost to Follow-up|1|||
27963497|NCT00774397|54621033|FG006|Overall Study|Lost to Follow-up|0|||
27963498|NCT00774397|54621027|FG000|Overall Study|Refused to continue trial medication|1|||
27963499|NCT00774397|54621028|FG001|Overall Study|Refused to continue trial medication|3|||
27963500|NCT00774397|54621029|FG002|Overall Study|Refused to continue trial medication|2|||
27963501|NCT00774397|54621030|FG003|Overall Study|Refused to continue trial medication|2|||
27963502|NCT00774397|54621031|FG004|Overall Study|Refused to continue trial medication|6|||
27963503|NCT00774397|54621032|FG005|Overall Study|Refused to continue trial medication|2|||
27963504|NCT00774397|54621033|FG006|Overall Study|Refused to continue trial medication|3|||
27963505|NCT00774397|54621027|FG000|Overall Study|Not treated|0|||
27963506|NCT00774397|54621028|FG001|Overall Study|Not treated|0|||
27963507|NCT00774397|54621029|FG002|Overall Study|Not treated|0|||
27963508|NCT00774397|54621030|FG003|Overall Study|Not treated|0|||
27963509|NCT00774397|54621031|FG004|Overall Study|Not treated|1|||
27963510|NCT00774397|54621032|FG005|Overall Study|Not treated|0|||
27963511|NCT00774397|54621033|FG006|Overall Study|Not treated|1|||
27963512|NCT00774397|54621027|FG000|Overall Study|Other than those stated above|1|||
27963513|NCT00774397|54621028|FG001|Overall Study|Other than those stated above|1|||
27963514|NCT00774397|54621029|FG002|Overall Study|Other than those stated above|3|||
27963515|NCT00774397|54621030|FG003|Overall Study|Other than those stated above|2|||
27963516|NCT00774397|54621031|FG004|Overall Study|Other than those stated above|2|||
27963517|NCT00774397|54621032|FG005|Overall Study|Other than those stated above|0|||
27963518|NCT00774397|54621033|FG006|Overall Study|Other than those stated above|1|||
27963519|NCT00909870|54621088|FG000|Overall Study|Adverse Event|13|||
27963520|NCT00909870|54621089|FG001|Overall Study|Adverse Event|7|||
27963521|NCT00909870|54621088|FG000|Overall Study|Protocol Violation|1|||
27963522|NCT00909870|54621089|FG001|Overall Study|Protocol Violation|2|||
27963523|NCT00909870|54621088|FG000|Overall Study|Withdrawal by Subject|5|||
27963524|NCT00909870|54621089|FG001|Overall Study|Withdrawal by Subject|8|||
27963525|NCT00909870|54621088|FG000|Overall Study|Lost to Follow-up|3|||
27963526|NCT00909870|54621089|FG001|Overall Study|Lost to Follow-up|3|||
27963527|NCT00909870|54621088|FG000|Overall Study|Physician Decision|0|||
27963528|NCT00909870|54621089|FG001|Overall Study|Physician Decision|2|||
27963529|NCT00909870|54621088|FG000|Overall Study|Other|1|||
27963530|NCT00909870|54621089|FG001|Overall Study|Other|5|||
27963531|NCT00768469|54621098|FG000|Overall Study|Adverse Event|0|||
27963532|NCT00768469|54621099|FG001|Overall Study|Adverse Event|2|||
27963533|NCT00768469|54621098|FG000|Overall Study|Disease Progression|3|||
27963534|NCT00768469|54621099|FG001|Overall Study|Disease Progression|4|||
27963535|NCT00768469|54621098|FG000|Overall Study|Withdrawal by Subject|0|||
27963536|NCT00768469|54621099|FG001|Overall Study|Withdrawal by Subject|1|||
27963537|NCT00886821|54621120|FG000|Stage 2|Adverse Event|0|||
27963538|NCT00886821|54621121|FG001|Stage 2|Adverse Event|0|||
27963539|NCT00886821|54621122|FG002|Stage 2|Adverse Event|0|||
27963540|NCT00886821|54621123|FG003|Stage 2|Adverse Event|0|||
27963541|NCT00886821|54621124|FG004|Stage 2|Adverse Event|0|||
27963542|NCT00886821|54621125|FG005|Stage 2|Adverse Event|0|||
27963543|NCT00886821|54621126|FG006|Stage 2|Adverse Event|0|||
27963544|NCT00886821|54621127|FG007|Stage 2|Adverse Event|0|||
27963545|NCT00886821|54621128|FG008|Stage 2|Adverse Event|0|||
27963546|NCT00886821|54621129|FG009|Stage 2|Adverse Event|0|||
27963547|NCT00886821|54621130|FG010|Stage 2|Adverse Event|0|||
27963548|NCT00886821|54621131|FG011|Stage 2|Adverse Event|1|||
27963549|NCT00886821|54621132|FG012|Stage 2|Adverse Event|3|||
27963550|NCT00886821|54621133|FG013|Stage 2|Adverse Event|0|||
27963551|NCT00886821|54621120|FG000|Stage 2|Lost to Follow-up|0|||
27963552|NCT00886821|54621121|FG001|Stage 2|Lost to Follow-up|0|||
27963553|NCT00886821|54621122|FG002|Stage 2|Lost to Follow-up|0|||
27963554|NCT00886821|54621123|FG003|Stage 2|Lost to Follow-up|0|||
27963555|NCT00886821|54621124|FG004|Stage 2|Lost to Follow-up|0|||
27963556|NCT00886821|54621125|FG005|Stage 2|Lost to Follow-up|0|||
27963557|NCT00886821|54621126|FG006|Stage 2|Lost to Follow-up|0|||
27963558|NCT00886821|54621127|FG007|Stage 2|Lost to Follow-up|0|||
28082842|NCT00050960|54736762|FG001|Overall Study|Death|15|||
28082843|NCT03456856|54736768|FG000|Overall Study|Lost to Follow-up|2|||
28082844|NCT03456856|54736768|FG000|Overall Study|Withdrawal by Subject|1|||
28082845|NCT00058214|54736772|FG000|Overall Study|Adverse Event|1|||
28082846|NCT00097773|54736780|FG000|Overall Study|Lost to Follow-up|2|||
27963559|NCT00886821|54621128|FG008|Stage 2|Lost to Follow-up|0|||
27963560|NCT00886821|54621129|FG009|Stage 2|Lost to Follow-up|0|||
27963561|NCT00886821|54621130|FG010|Stage 2|Lost to Follow-up|0|||
27963562|NCT00886821|54621131|FG011|Stage 2|Lost to Follow-up|0|||
27963563|NCT00886821|54621132|FG012|Stage 2|Lost to Follow-up|2|||
27963564|NCT00886821|54621133|FG013|Stage 2|Lost to Follow-up|1|||
27963565|NCT00886743|54621177|FG000|Overall Study|Adverse Event|3|||
27963566|NCT00886743|54621177|FG000|Overall Study|Other|1|||
27963567|NCT00886587|54621183|FG000|Overall Study|Adverse Event|2|||
27963568|NCT00886587|54621184|FG001|Overall Study|Adverse Event|1|||
27963569|NCT00886587|54621183|FG000|Overall Study|Protocol Violation|2|||
27963570|NCT00886587|54621184|FG001|Overall Study|Protocol Violation|0|||
27963571|NCT00886587|54621183|FG000|Overall Study|Withdrawal by Subject|0|||
27963572|NCT00886587|54621184|FG001|Overall Study|Withdrawal by Subject|1|||
27963573|NCT00886119|54621190|FG000|Period 1|Did not meet inclusion criteria|1|||
27963574|NCT00886119|54621191|FG001|Period 1|Did not meet inclusion criteria|0|||
27963575|NCT00768079|54621200|FG000|Overall Study|Lost to Follow-up|2|||
27963576|NCT00768079|54621201|FG001|Overall Study|Lost to Follow-up|0|||
27963577|NCT00768079|54621202|FG002|Overall Study|Lost to Follow-up|4|||
27963578|NCT00768079|54621200|FG000|Overall Study|Participant incarcerated|0|||
27963579|NCT00768079|54621201|FG001|Overall Study|Participant incarcerated|1|||
27963580|NCT00768079|54621202|FG002|Overall Study|Participant incarcerated|0|||
27963581|NCT00767455|54621212|FG000|Overall Study|Investigator error|19|||
27963582|NCT00766831|54621218|FG000|Overall Study|Withdrawal by Subject|4|||
27963583|NCT00766831|54621218|FG000|Overall Study|Lost to Follow-up|3|||
27963584|NCT00766831|54621218|FG000|Overall Study|Adverse Event|20|||
27963585|NCT00766831|54621218|FG000|Overall Study|Protocol Violation|15|||
27963586|NCT00766831|54621218|FG000|Overall Study|Physician Decision|5|||
27963587|NCT00766831|54621218|FG000|Overall Study|Withdrawal of consent|26|||
27963588|NCT00766831|54621218|FG000|Overall Study|Non cooperation by participants|14|||
27963589|NCT00766831|54621218|FG000|Overall Study|Other|28|||
27963590|NCT00766675|54621222|FG000|Overall Study|Adverse Event|16|||
27963591|NCT00766675|54621222|FG000|Overall Study|Lost to Follow-up|2|||
27963592|NCT00766675|54621222|FG000|Overall Study|Withdrawal by Subject|11|||
27963593|NCT00766675|54621222|FG000|Overall Study|Protocol Violation|8|||
27963594|NCT00766675|54621222|FG000|Overall Study|Participant took prohibited medication|1|||
27963595|NCT00766675|54621222|FG000|Overall Study|Receive other anti-neoplastic treatment|1|||
27963596|NCT00766675|54621222|FG000|Overall Study|Insufficient therapy|1|||
27963597|NCT00766597|54621226|FG000|Overall Study|Unexpected closure of study|4|||
27963598|NCT00766597|54621226|FG000|Overall Study|Without CCR5-tropic virus|5|||
27963599|NCT00910962|54621235|FG000|Overall Study|Adverse Event|5|||
27963600|NCT00910962|54621236|FG001|Overall Study|Adverse Event|20|||
27963601|NCT00910962|54621237|FG002|Overall Study|Adverse Event|17|||
27963602|NCT00910962|54621235|FG000|Overall Study|Protocol Violation|1|||
27963603|NCT00910962|54621236|FG001|Overall Study|Protocol Violation|3|||
27963604|NCT00910962|54621237|FG002|Overall Study|Protocol Violation|3|||
27963605|NCT00910962|54621235|FG000|Overall Study|Lost to Follow-up|0|||
27963606|NCT00910962|54621236|FG001|Overall Study|Lost to Follow-up|3|||
27963607|NCT00910962|54621237|FG002|Overall Study|Lost to Follow-up|1|||
27963608|NCT00910962|54621235|FG000|Overall Study|Physician Decision|0|||
27963609|NCT00910962|54621236|FG001|Overall Study|Physician Decision|6|||
27963610|NCT00910962|54621237|FG002|Overall Study|Physician Decision|6|||
28082847|NCT00097773|54736781|FG001|Overall Study|Lost to Follow-up|2|||
27963611|NCT00910962|54621235|FG000|Overall Study|Withdrawal by Subject|25|||
27963612|NCT00910962|54621236|FG001|Overall Study|Withdrawal by Subject|32|||
27963613|NCT00910962|54621237|FG002|Overall Study|Withdrawal by Subject|32|||
28082848|NCT00097773|54736782|FG002|Overall Study|Lost to Follow-up|0|||
27832487|NCT01597505|54311752|FG000|Overall Study|Withdrawal by Subject|10|||
27963614|NCT00910962|54621235|FG000|Overall Study|Reached defined stopping criteria|12|||
27963615|NCT00910962|54621236|FG001|Overall Study|Reached defined stopping criteria|14|||
27963616|NCT00910962|54621237|FG002|Overall Study|Reached defined stopping criteria|17|||
27963617|NCT00773461|54621249|FG000|Overall Study|Adverse Event|1|||
27963618|NCT00773461|54621250|FG001|Overall Study|Adverse Event|3|||
27963619|NCT00773461|54621249|FG000|Overall Study|Withdrawal by Subject|4|||
27963620|NCT00773461|54621250|FG001|Overall Study|Withdrawal by Subject|1|||
28082849|NCT00097773|54736783|FG003|Overall Study|Lost to Follow-up|1|||
27963621|NCT00773383|54621257|FG000|Overall Study|Adverse Event|4|||
27963622|NCT00773383|54621257|FG000|Overall Study|Death|1|||
28082850|NCT00097773|54736780|FG000|Overall Study|Physician Decision|2|||
27963623|NCT00773383|54621257|FG000|Overall Study|Progression of Disease|23|||
28082851|NCT00097773|54736781|FG001|Overall Study|Physician Decision|2|||
27963624|NCT00773383|54621257|FG000|Overall Study|Other|2|||
27963625|NCT00773383|54621257|FG000|Overall Study|No study dose received|1|||
27963626|NCT00757003|54621265|FG000|Overall Study|Death|33|||
27963627|NCT00757003|54621265|FG000|Overall Study|Lost to Follow-up|9|||
27963628|NCT00757003|54621265|FG000|Overall Study|Withdrawal by Subject|4|||
27963629|NCT00757003|54621265|FG000|Overall Study|Surgically explanted|2|||
27963630|NCT00757003|54621265|FG000|Overall Study|Not implanted|1|||
27963631|NCT00766363|54621274|FG000|Overall Study|Withdrawal by Subject|1|||
27963632|NCT00766363|54621275|FG001|Overall Study|Withdrawal by Subject|0|||
27963633|NCT00766363|54621276|FG002|Overall Study|Withdrawal by Subject|0|||
27963634|NCT00766363|54621277|FG003|Overall Study|Withdrawal by Subject|0|||
27963635|NCT00766363|54621274|FG000|Overall Study|Adverse Event Prior to Randomization|0|||
27963636|NCT00766363|54621275|FG001|Overall Study|Adverse Event Prior to Randomization|1|||
27963637|NCT00766363|54621276|FG002|Overall Study|Adverse Event Prior to Randomization|0|||
27963638|NCT00766363|54621277|FG003|Overall Study|Adverse Event Prior to Randomization|0|||
27963639|NCT02636946|54621290|FG000|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|0|||
27963640|NCT02636946|54621291|FG001|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|1|||
27963641|NCT02636946|54621290|FG000|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
27963642|NCT02636946|54621291|FG001|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
27963643|NCT02636946|54621290|FG000|Cycle 1 (Day 1 to Week 15)|Protocol Violation|0|||
27963644|NCT02636946|54621291|FG001|Cycle 1 (Day 1 to Week 15)|Protocol Violation|1|||
27963645|NCT02636946|54621290|FG000|Cycle 1 (Day 1 to Week 15)|Reason not Specified|0|||
27963646|NCT02636946|54621291|FG001|Cycle 1 (Day 1 to Week 15)|Reason not Specified|1|||
27963647|NCT02636946|54621290|FG000|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
27963648|NCT02636946|54621291|FG001|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|2|||
27963649|NCT02636946|54621290|FG000|Cycle 2 (Week 16 to Week 31)|Adverse Event|2|||
27963650|NCT02636946|54621291|FG001|Cycle 2 (Week 16 to Week 31)|Adverse Event|1|||
27963651|NCT00766051|54621299|FG000|Overall Study|Withdrawal by Subject|2|||
27963652|NCT00766051|54621300|FG001|Overall Study|Withdrawal by Subject|0|||
27963653|NCT00909792|54621308|FG000|Period 1|Did not meet inclusion criteria|0|||
27963654|NCT00909792|54621309|FG001|Period 1|Did not meet inclusion criteria|1|||
27963655|NCT00909792|54621308|FG000|Period 2|Biomicroscopy|1|||
27963656|NCT00909792|54621309|FG001|Period 2|Biomicroscopy|0|||
27963657|NCT00909792|54621308|FG000|Period 2|Lost to Follow-up|0|||
27963658|NCT00909792|54621309|FG001|Period 2|Lost to Follow-up|1|||
27963659|NCT00765817|54621317|FG000|Overall Study|Adverse Event|13|||
27963660|NCT00765817|54621318|FG001|Overall Study|Adverse Event|1|||
27963661|NCT00765817|54621317|FG000|Overall Study|Death|0|||
27963662|NCT00765817|54621318|FG001|Overall Study|Death|1|||
27963663|NCT00765817|54621317|FG000|Overall Study|Entry criteria not met|2|||
27963664|NCT00765817|54621318|FG001|Overall Study|Entry criteria not met|2|||
27963665|NCT00765817|54621317|FG000|Overall Study|Loss of glucose control|0|||
27963666|NCT00765817|54621318|FG001|Overall Study|Loss of glucose control|2|||
27963667|NCT00765817|54621317|FG000|Overall Study|Lost to Follow-up|1|||
27963668|NCT00765817|54621318|FG001|Overall Study|Lost to Follow-up|3|||
27963669|NCT00765817|54621317|FG000|Overall Study|Physician Decision|2|||
27963670|NCT00765817|54621318|FG001|Overall Study|Physician Decision|1|||
27963671|NCT00765817|54621317|FG000|Overall Study|Protocol Violation|1|||
27963672|NCT00765817|54621318|FG001|Overall Study|Protocol Violation|1|||
27963673|NCT00765817|54621317|FG000|Overall Study|Subject decision|7|||
27963674|NCT00765817|54621318|FG001|Overall Study|Subject decision|11|||
27963675|NCT00772603|54621327|FG000|Overall Study|Withdrawal by Subject|11|||
27963676|NCT00772603|54621328|FG001|Overall Study|Withdrawal by Subject|10|||
27963677|NCT00772603|54621329|FG002|Overall Study|Withdrawal by Subject|6|||
27963678|NCT00772603|54621327|FG000|Overall Study|Adverse Event|37|||
27963679|NCT00772603|54621328|FG001|Overall Study|Adverse Event|18|||
27963680|NCT00772603|54621329|FG002|Overall Study|Adverse Event|10|||
27963681|NCT00772603|54621327|FG000|Overall Study|Subject Non-compliance|1|||
27963682|NCT00772603|54621328|FG001|Overall Study|Subject Non-compliance|6|||
27963683|NCT00772603|54621329|FG002|Overall Study|Subject Non-compliance|4|||
27963684|NCT00772603|54621327|FG000|Overall Study|Protocol Violation|0|||
27963685|NCT00772603|54621328|FG001|Overall Study|Protocol Violation|1|||
27963686|NCT00772603|54621329|FG002|Overall Study|Protocol Violation|1|||
27855164|NCT03006926|54375556|FG000|Overall Study|Ongoing Survival Follow-up|0|||
27963687|NCT00772603|54621327|FG000|Overall Study|Lost to Follow-up|1|||
27963688|NCT00772603|54621328|FG001|Overall Study|Lost to Follow-up|5|||
27963689|NCT00772603|54621329|FG002|Overall Study|Lost to Follow-up|2|||
27963690|NCT00772603|54621327|FG000|Overall Study|Physician Decision|0|||
27963691|NCT00772603|54621328|FG001|Overall Study|Physician Decision|0|||
27963692|NCT00772603|54621329|FG002|Overall Study|Physician Decision|1|||
27963693|NCT00772603|54621327|FG000|Overall Study|Other|2|||
27963694|NCT00772603|54621328|FG001|Overall Study|Other|0|||
27963695|NCT00772603|54621329|FG002|Overall Study|Other|2|||
27963696|NCT00772447|54621342|FG000|Overall Study|Withdrawal by Subject|9|||
27963697|NCT00772447|54621343|FG001|Overall Study|Withdrawal by Subject|5|||
27963698|NCT00772447|54621342|FG000|Overall Study|Physician Decision|4|||
28165162|NCT03016325|54835757|FG004|182-Day Follow-Up Period|Participant withdrew consent|1|||
27963699|NCT00772447|54621343|FG001|Overall Study|Physician Decision|8|||
27963700|NCT00772447|54621342|FG000|Overall Study|Lost to Follow-up|2|||
27963701|NCT00772447|54621343|FG001|Overall Study|Lost to Follow-up|4|||
27963702|NCT00772447|54621342|FG000|Overall Study|incorrect enrolment|3|||
27963703|NCT00772447|54621343|FG001|Overall Study|incorrect enrolment|4|||
27963704|NCT00772447|54621342|FG000|Overall Study|Protocol Violation|0|||
27963705|NCT00772447|54621343|FG001|Overall Study|Protocol Violation|1|||
27963706|NCT00772447|54621342|FG000|Overall Study|all others|2|||
27963707|NCT00772447|54621343|FG001|Overall Study|all others|2|||
27963708|NCT00765037|54621350|FG000|Overall Study|Lost to Follow-up|5|||
27963709|NCT00765037|54621350|FG000|Overall Study|Adverse Event|1|||
27963710|NCT00831844|54621364|FG000|Overall Study|Adverse Event|2|||
27963711|NCT00831844|54621365|FG001|Overall Study|Adverse Event|0|||
27963712|NCT00831844|54621366|FG002|Overall Study|Adverse Event|0|||
27963713|NCT00831844|54621367|FG003|Overall Study|Adverse Event|0|||
27963714|NCT00831844|54621368|FG004|Overall Study|Adverse Event|1|||
27963715|NCT00831844|54621369|FG005|Overall Study|Adverse Event|1|||
27963716|NCT00831844|54621370|FG006|Overall Study|Adverse Event|2|||
27963717|NCT00831844|54621371|FG007|Overall Study|Adverse Event|0|||
27963718|NCT00831844|54621372|FG008|Overall Study|Adverse Event|0|||
27963719|NCT00831844|54621373|FG009|Overall Study|Adverse Event|0|||
27963720|NCT00831844|54621364|FG000|Overall Study|Death|0|||
27963721|NCT00831844|54621365|FG001|Overall Study|Death|0|||
27963722|NCT00831844|54621366|FG002|Overall Study|Death|0|||
27963723|NCT00831844|54621367|FG003|Overall Study|Death|1|||
27963724|NCT00831844|54621368|FG004|Overall Study|Death|0|||
28082852|NCT00097773|54736782|FG002|Overall Study|Physician Decision|3|||
28082853|NCT00097773|54736783|FG003|Overall Study|Physician Decision|1|||
27963725|NCT00831844|54621369|FG005|Overall Study|Death|0|||
27963726|NCT00831844|54621370|FG006|Overall Study|Death|0|||
27963727|NCT00831844|54621371|FG007|Overall Study|Death|0|||
27963728|NCT00831844|54621372|FG008|Overall Study|Death|0|||
27963729|NCT00831844|54621373|FG009|Overall Study|Death|0|||
27963730|NCT00831844|54621364|FG000|Overall Study|Lack of Efficacy|8|||
27963731|NCT00831844|54621365|FG001|Overall Study|Lack of Efficacy|10|||
27963732|NCT00831844|54621366|FG002|Overall Study|Lack of Efficacy|15|||
27963733|NCT00831844|54621367|FG003|Overall Study|Lack of Efficacy|8|||
27963734|NCT00831844|54621368|FG004|Overall Study|Lack of Efficacy|11|||
27963735|NCT00831844|54621369|FG005|Overall Study|Lack of Efficacy|17|||
27963736|NCT00831844|54621370|FG006|Overall Study|Lack of Efficacy|8|||
27963737|NCT00831844|54621371|FG007|Overall Study|Lack of Efficacy|9|||
27963738|NCT00831844|54621372|FG008|Overall Study|Lack of Efficacy|7|||
27963739|NCT00831844|54621373|FG009|Overall Study|Lack of Efficacy|0|||
27963740|NCT00831844|54621364|FG000|Overall Study|Physician Decision|0|||
27963741|NCT00831844|54621365|FG001|Overall Study|Physician Decision|1|||
27963742|NCT00831844|54621366|FG002|Overall Study|Physician Decision|3|||
27963743|NCT00831844|54621367|FG003|Overall Study|Physician Decision|1|||
27963744|NCT00831844|54621368|FG004|Overall Study|Physician Decision|1|||
27963745|NCT00831844|54621369|FG005|Overall Study|Physician Decision|1|||
27963746|NCT00831844|54621370|FG006|Overall Study|Physician Decision|0|||
27963747|NCT00831844|54621371|FG007|Overall Study|Physician Decision|0|||
27963748|NCT00831844|54621372|FG008|Overall Study|Physician Decision|1|||
27963749|NCT00831844|54621373|FG009|Overall Study|Physician Decision|0|||
27963750|NCT00831844|54621364|FG000|Overall Study|Withdrawal by Subject|0|||
27963751|NCT00831844|54621365|FG001|Overall Study|Withdrawal by Subject|0|||
27963752|NCT00831844|54621366|FG002|Overall Study|Withdrawal by Subject|1|||
27963753|NCT00831844|54621367|FG003|Overall Study|Withdrawal by Subject|0|||
27963754|NCT00831844|54621368|FG004|Overall Study|Withdrawal by Subject|0|||
27963755|NCT00831844|54621369|FG005|Overall Study|Withdrawal by Subject|0|||
27963756|NCT00831844|54621370|FG006|Overall Study|Withdrawal by Subject|0|||
27963757|NCT00831844|54621371|FG007|Overall Study|Withdrawal by Subject|1|||
28082854|NCT00097773|54736780|FG000|Overall Study|Withdrawal by Subject|3|||
28082855|NCT00097773|54736781|FG001|Overall Study|Withdrawal by Subject|3|||
28082856|NCT00097773|54736782|FG002|Overall Study|Withdrawal by Subject|3|||
28082857|NCT00097773|54736783|FG003|Overall Study|Withdrawal by Subject|1|||
27963758|NCT00831844|54621372|FG008|Overall Study|Withdrawal by Subject|1|||
27963759|NCT00831844|54621373|FG009|Overall Study|Withdrawal by Subject|0|||
27963760|NCT00831844|54621364|FG000|Overall Study|Ineligible|0|||
27963761|NCT00831844|54621365|FG001|Overall Study|Ineligible|1|||
27963762|NCT00831844|54621366|FG002|Overall Study|Ineligible|1|||
27963763|NCT00831844|54621367|FG003|Overall Study|Ineligible|0|||
27963764|NCT00831844|54621368|FG004|Overall Study|Ineligible|1|||
27963765|NCT00831844|54621369|FG005|Overall Study|Ineligible|0|||
27963766|NCT00831844|54621370|FG006|Overall Study|Ineligible|0|||
27963767|NCT00831844|54621371|FG007|Overall Study|Ineligible|0|||
28082858|NCT00097773|54736780|FG000|Overall Study|Adverse Event|0|||
28082859|NCT00097773|54736781|FG001|Overall Study|Adverse Event|1|||
27963768|NCT00831844|54621372|FG008|Overall Study|Ineligible|0|||
27963769|NCT00831844|54621373|FG009|Overall Study|Ineligible|0|||
27963770|NCT00764881|54621397|FG000|Overall Study|Adverse Event|5|||
27963771|NCT00764881|54621398|FG001|Overall Study|Adverse Event|1|||
27963772|NCT00764881|54621397|FG000|Overall Study|Withdrawal by Subject|1|||
27963773|NCT00764881|54621398|FG001|Overall Study|Withdrawal by Subject|3|||
27963774|NCT00764881|54621397|FG000|Overall Study|Protocol Violation|2|||
27963775|NCT00764881|54621398|FG001|Overall Study|Protocol Violation|2|||
27963776|NCT00764881|54621397|FG000|Overall Study|Lost to Follow-up|2|||
27963777|NCT00764881|54621398|FG001|Overall Study|Lost to Follow-up|0|||
27963778|NCT00764881|54621397|FG000|Overall Study|Noncompliant|1|||
27963779|NCT00764881|54621398|FG001|Overall Study|Noncompliant|0|||
27963780|NCT00764881|54621397|FG000|Overall Study|Accidentally discontinued study drug|1|||
27963781|NCT00764881|54621398|FG001|Overall Study|Accidentally discontinued study drug|0|||
27963782|NCT00764881|54621397|FG000|Overall Study|Wished to become pregnant|1|||
27963783|NCT00764881|54621398|FG001|Overall Study|Wished to become pregnant|0|||
27963784|NCT00764881|54621397|FG000|Overall Study|Carcinoma detected|1|||
27963785|NCT00764881|54621398|FG001|Overall Study|Carcinoma detected|0|||
27963786|NCT00764881|54621397|FG000|Overall Study|Possibly noncompliant (study drug)|0|||
28082860|NCT00097773|54736782|FG002|Overall Study|Adverse Event|0|||
28082861|NCT00097773|54736783|FG003|Overall Study|Adverse Event|0|||
28082862|NCT00097773|54736780|FG000|Overall Study|Other|1|||
28082863|NCT00097773|54736781|FG001|Overall Study|Other|0|||
27963787|NCT00764881|54621398|FG001|Overall Study|Possibly noncompliant (study drug)|2|||
27963788|NCT00764881|54621397|FG000|Overall Study|no treatment or no observation|2|||
27963789|NCT00764881|54621398|FG001|Overall Study|no treatment or no observation|2|||
27963790|NCT00844558|54621406|FG000|Overall Study|Withdrawal by Subject|9|||
27963791|NCT00844558|54621407|FG001|Overall Study|Withdrawal by Subject|2|||
27963792|NCT00844558|54621406|FG000|Overall Study|Death|1|||
27963793|NCT00844558|54621407|FG001|Overall Study|Death|0|||
27963794|NCT00844558|54621406|FG000|Overall Study|Protocol Violation|1|||
27963795|NCT00844558|54621407|FG001|Overall Study|Protocol Violation|1|||
28082864|NCT00097773|54736782|FG002|Overall Study|Other|2|||
28082865|NCT00097773|54736783|FG003|Overall Study|Other|0|||
28082866|NCT03480022|54736800|FG000|Overall Study|Pregnancy|2|||
28082867|NCT03480022|54736801|FG001|Overall Study|Pregnancy|0|||
28082868|NCT03480022|54736800|FG000|Overall Study|Adverse Event|6|||
28082869|NCT03480022|54736801|FG001|Overall Study|Adverse Event|0|||
28082870|NCT03480022|54736800|FG000|Overall Study|Lack of Efficacy|0|||
28082871|NCT03480022|54736801|FG001|Overall Study|Lack of Efficacy|2|||
28082872|NCT03480022|54736800|FG000|Overall Study|Physician Decision|0|||
28082873|NCT03480022|54736801|FG001|Overall Study|Physician Decision|1|||
28082874|NCT03480022|54736800|FG000|Overall Study|Withdrawal by Subject|2|||
28082875|NCT03480022|54736801|FG001|Overall Study|Withdrawal by Subject|0|||
28082876|NCT03480022|54736800|FG000|Overall Study|Medication concerns|1|||
28082877|NCT03480022|54736801|FG001|Overall Study|Medication concerns|0|||
28082878|NCT03480022|54736800|FG000|Overall Study|Family member COVID exposure|0|||
28082879|NCT03480022|54736801|FG001|Overall Study|Family member COVID exposure|1|||
28082880|NCT03533608|54736807|FG000|Overall Study|Withdrawal by Subject|3|||
28082881|NCT03533608|54736807|FG000|Overall Study|Physician Decision|2|||
28082882|NCT00049322|54736814|FG000|Overall Study|disease burden|0|||
28082883|NCT00049322|54736815|FG001|Overall Study|disease burden|3|||
28082884|NCT00049322|54736814|FG000|Overall Study|Adverse Event|1|||
28082885|NCT00049322|54736815|FG001|Overall Study|Adverse Event|0|||
28082886|NCT00049322|54736814|FG000|Overall Study|refused angio|0|||
28082887|NCT00049322|54736815|FG001|Overall Study|refused angio|3|||
28082888|NCT03437512|54736825|FG000|Randomized|Withdrawal by Subject|0|||
28082889|NCT03437512|54736826|FG001|Randomized|Withdrawal by Subject|2|||
28082890|NCT03437512|54736825|FG000|Completed Study Follow up|Could not complete study due to COVID-19 research pause|2|||
28082891|NCT03437512|54736826|FG001|Completed Study Follow up|Could not complete study due to COVID-19 research pause|1|||
28082892|NCT00058058|54736832|FG000|Overall Study|Withdrawal by Subject|4|||
28082893|NCT00058058|54736832|FG000|Overall Study|Ineligible|20|||
28082894|NCT00058058|54736832|FG000|Overall Study|Claustrophobic|5|||
28082895|NCT00058058|54736832|FG000|Overall Study|technical issues|6|||
28082896|NCT00058058|54736832|FG000|Overall Study|Poor positioning, illness,pain|3|||
28082897|NCT03532048|54736839|FG000|Overall Study|Lost to Follow-up|12|||
28082898|NCT03532048|54736840|FG001|Overall Study|Lost to Follow-up|17|||
28082899|NCT03532048|54736839|FG000|Overall Study|Withdrawal by Subject|7|||
28082900|NCT03532048|54736840|FG001|Overall Study|Withdrawal by Subject|0|||
28082901|NCT00008138|54736846|FG000|Neoadjuvant Chemotherapy|Adverse Event|3|||
28082902|NCT00008138|54736846|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|3|||
27963796|NCT00844558|54621406|FG000|Overall Study|Lost to Follow-up|0|||
27963797|NCT00844558|54621407|FG001|Overall Study|Lost to Follow-up|1|||
27963798|NCT00844558|54621406|FG000|Overall Study|Physician Decision|1|||
27963799|NCT00844558|54621407|FG001|Overall Study|Physician Decision|0|||
27963800|NCT00772369|54621418|FG000|Overall Study|Did not return record release form|1|||
28082903|NCT00008138|54736846|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|6|||
27732563|NCT02630459|54180138|FG002|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
28082904|NCT00008138|54736846|FG000|Neoadjuvant Chemotherapy|not protocol specified|8|||
28082905|NCT00008138|54736846|FG000|Interval Debulking|Withdrawal by Subject|2|||
28082906|NCT00008138|54736846|FG000|Post-Cytoreduction Chemotherapy|Adverse Event|6|||
28082907|NCT00008138|54736846|FG000|Post-Cytoreduction Chemotherapy|Progression|1|||
28082908|NCT00008138|54736846|FG000|Post-Cytoreduction Chemotherapy|not protocol specified|1|||
28082909|NCT03436732|54736853|FG000|Overall Study|Not treated-enrolled in different study|1|||
27963801|NCT00821236|54621425|FG000|Overall Study|Lost to Follow-up|3|||
27963802|NCT00756457|54621435|FG000|Overall Study|Lost to Follow-up|1|||
27963803|NCT00756457|54621436|FG001|Overall Study|Lost to Follow-up|2|||
27963804|NCT00844480|54621460|FG000|Overall Study|Withdrawal by Subject|2|||
27963805|NCT00844480|54621461|FG001|Overall Study|Withdrawal by Subject|3|||
27963806|NCT00771901|54621470|FG000|Overall Study|Dissat w/# of study medication (40/day)|0|||
27963807|NCT00771901|54621471|FG001|Overall Study|Dissat w/# of study medication (40/day)|0|||
27963808|NCT00771901|54621472|FG002|Overall Study|Dissat w/# of study medication (40/day)|4|||
27963809|NCT00843856|54621482|FG000|Overall Study|Lost to Follow-up|1|||
27963810|NCT00843856|54621483|FG001|Overall Study|Lost to Follow-up|2|||
27963811|NCT00764491|54621491|FG000|Overall Study|Lost to Follow-up|35|||
27963812|NCT00764491|54621492|FG001|Overall Study|Lost to Follow-up|17|||
27963813|NCT00843778|54621498|FG000|Overall Study|Adverse Event|15|||
27963814|NCT00843778|54621498|FG000|Overall Study|Lack of Efficacy|14|||
27963815|NCT00843778|54621498|FG000|Overall Study|Loss of efficacy|2|||
27963816|NCT00843778|54621498|FG000|Overall Study|Withdrawal by Subject|4|||
27963817|NCT00910728|54621511|FG000|Overall Study|Lack of Efficacy|2|||
27963818|NCT00910728|54621512|FG001|Overall Study|Lack of Efficacy|3|||
27963819|NCT00910728|54621513|FG002|Overall Study|Lack of Efficacy|1|||
27963820|NCT00910728|54621514|FG003|Overall Study|Lack of Efficacy|2|||
27963821|NCT00910728|54621515|FG004|Overall Study|Lack of Efficacy|1|||
27963822|NCT00910728|54621516|FG005|Overall Study|Lack of Efficacy|0|||
27963823|NCT00910728|54621517|FG006|Overall Study|Lack of Efficacy|2|||
27963824|NCT00910728|54621518|FG007|Overall Study|Lack of Efficacy|2|||
27963825|NCT00910728|54621519|FG008|Overall Study|Lack of Efficacy|2|||
27963826|NCT00910728|54621511|FG000|Overall Study|Withdrawal by Subject|0|||
27963827|NCT00910728|54621512|FG001|Overall Study|Withdrawal by Subject|0|||
27963828|NCT00910728|54621513|FG002|Overall Study|Withdrawal by Subject|0|||
27963829|NCT00910728|54621514|FG003|Overall Study|Withdrawal by Subject|0|||
27963830|NCT00910728|54621515|FG004|Overall Study|Withdrawal by Subject|3|||
27963831|NCT00910728|54621516|FG005|Overall Study|Withdrawal by Subject|1|||
27963832|NCT00910728|54621517|FG006|Overall Study|Withdrawal by Subject|2|||
27963833|NCT00910728|54621518|FG007|Overall Study|Withdrawal by Subject|0|||
27963834|NCT00910728|54621519|FG008|Overall Study|Withdrawal by Subject|0|||
27963835|NCT00910728|54621511|FG000|Overall Study|(not specified)|2|||
27963836|NCT00910728|54621512|FG001|Overall Study|(not specified)|0|||
27963837|NCT00910728|54621513|FG002|Overall Study|(not specified)|1|||
27963838|NCT00910728|54621514|FG003|Overall Study|(not specified)|0|||
27963839|NCT00910728|54621515|FG004|Overall Study|(not specified)|1|||
27963840|NCT00910728|54621516|FG005|Overall Study|(not specified)|0|||
27963841|NCT00910728|54621517|FG006|Overall Study|(not specified)|0|||
27963842|NCT00910728|54621518|FG007|Overall Study|(not specified)|0|||
27963843|NCT00910728|54621519|FG008|Overall Study|(not specified)|0|||
27963844|NCT00910728|54621511|FG000|Overall Study|Adverse Event|2|||
27963845|NCT00910728|54621512|FG001|Overall Study|Adverse Event|0|||
27963846|NCT00910728|54621513|FG002|Overall Study|Adverse Event|1|||
27963847|NCT00910728|54621514|FG003|Overall Study|Adverse Event|1|||
27963848|NCT00910728|54621515|FG004|Overall Study|Adverse Event|0|||
27963849|NCT00910728|54621516|FG005|Overall Study|Adverse Event|0|||
27963850|NCT00910728|54621517|FG006|Overall Study|Adverse Event|2|||
27963851|NCT00910728|54621518|FG007|Overall Study|Adverse Event|1|||
27963852|NCT00910728|54621519|FG008|Overall Study|Adverse Event|1|||
27963853|NCT00820222|54621541|FG000|Overall Study|Lost to Follow-up|10|||
27963854|NCT00820222|54621542|FG001|Overall Study|Lost to Follow-up|9|||
27963855|NCT00820222|54621541|FG000|Overall Study|Withdrawal by Subject|19|||
27963856|NCT00820222|54621542|FG001|Overall Study|Withdrawal by Subject|21|||
27963857|NCT00820222|54621541|FG000|Overall Study|Physician Decision|93|||
27963858|NCT00820222|54621542|FG001|Overall Study|Physician Decision|88|||
28082910|NCT03436732|54736854|FG001|Overall Study|Not treated-enrolled in different study|0|||
28082911|NCT03436732|54736853|FG000|Overall Study|Off study after cycle 1|1|||
28082912|NCT03436732|54736854|FG001|Overall Study|Off study after cycle 1|0|||
27963859|NCT00820222|54621541|FG000|Overall Study|Sponsor Terminated Study|43|||
27963860|NCT00820222|54621542|FG001|Overall Study|Sponsor Terminated Study|65|||
27963861|NCT00820222|54621541|FG000|Overall Study|Unkown|11|||
27963862|NCT00820222|54621542|FG001|Overall Study|Unkown|7|||
27963863|NCT01039688|54621551|FG000|Overall Study|Adverse Event|38|||
27963864|NCT01039688|54621552|FG001|Overall Study|Adverse Event|39|||
27963865|NCT01039688|54621553|FG002|Overall Study|Adverse Event|24|||
27963866|NCT01039688|54621551|FG000|Overall Study|Lack of Efficacy|20|||
27963867|NCT01039688|54621552|FG001|Overall Study|Lack of Efficacy|11|||
28082913|NCT03436732|54736853|FG000|Overall Study|Adverse Event|2|||
27963868|NCT01039688|54621553|FG002|Overall Study|Lack of Efficacy|26|||
27963869|NCT01039688|54621551|FG000|Overall Study|Lost to Follow-up|11|||
27963870|NCT01039688|54621552|FG001|Overall Study|Lost to Follow-up|9|||
27963871|NCT01039688|54621553|FG002|Overall Study|Lost to Follow-up|5|||
27963872|NCT01039688|54621551|FG000|Overall Study|Other|13|||
28082914|NCT03436732|54736854|FG001|Overall Study|Adverse Event|0|||
28082915|NCT03436732|54736853|FG000|Overall Study|Death|0|||
28082916|NCT03436732|54736854|FG001|Overall Study|Death|1|||
28082917|NCT03436420|54736861|FG000|Overall Study|Lack of Efficacy|3|||
28082918|NCT00027560|54736865|FG000|Overall Study|Withdrawal by Subject|1|||
28082919|NCT03451084|54736875|FG000|Overall Study|Withdrawal by Subject|2|||
28082920|NCT03451084|54736876|FG001|Overall Study|Withdrawal by Subject|1|||
27963873|NCT01039688|54621552|FG001|Overall Study|Other|25|||
27963874|NCT01039688|54621553|FG002|Overall Study|Other|12|||
28082921|NCT03451084|54736877|FG002|Overall Study|Withdrawal by Subject|2|||
28082922|NCT03451084|54736878|FG003|Overall Study|Withdrawal by Subject|1|||
28082923|NCT03451084|54736875|FG000|Overall Study|Disease recurrence|0|||
28082924|NCT03451084|54736876|FG001|Overall Study|Disease recurrence|2|||
28082925|NCT03451084|54736877|FG002|Overall Study|Disease recurrence|0|||
28082926|NCT03451084|54736878|FG003|Overall Study|Disease recurrence|0|||
28082927|NCT03451084|54736875|FG000|Overall Study|Lack of Efficacy|0|||
28082928|NCT03451084|54736876|FG001|Overall Study|Lack of Efficacy|3|||
28082929|NCT03451084|54736877|FG002|Overall Study|Lack of Efficacy|0|||
28082930|NCT03451084|54736878|FG003|Overall Study|Lack of Efficacy|1|||
27732564|NCT02630459|54180139|FG003|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2|||
27732565|NCT02630459|54180140|FG004|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
27732566|NCT02630459|54180141|FG005|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
27732567|NCT02630459|54180142|FG006|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
27963875|NCT01039688|54621551|FG000|Overall Study|Withdrawal by Subject|23|||
27963876|NCT01039688|54621552|FG001|Overall Study|Withdrawal by Subject|27|||
27963877|NCT01039688|54621553|FG002|Overall Study|Withdrawal by Subject|13|||
27963878|NCT01039688|54621551|FG000|Overall Study|Death|2|||
27963879|NCT01039688|54621552|FG001|Overall Study|Death|0|||
27963880|NCT01039688|54621553|FG002|Overall Study|Death|0|||
27963881|NCT02237508|54621574|FG000|Overall Study|Withdrawal by Subject|0|||
27963882|NCT02237508|54621575|FG001|Overall Study|Withdrawal by Subject|2|||
27963883|NCT02237508|54621576|FG002|Overall Study|Withdrawal by Subject|0|||
27963884|NCT02237508|54621577|FG003|Overall Study|Withdrawal by Subject|1|||
27963885|NCT02237508|54621578|FG004|Overall Study|Withdrawal by Subject|0|||
27963886|NCT02237508|54621579|FG005|Overall Study|Withdrawal by Subject|1|||
27963887|NCT02237508|54621580|FG006|Overall Study|Withdrawal by Subject|1|||
27963888|NCT02237508|54621581|FG007|Overall Study|Withdrawal by Subject|0|||
27963889|NCT02237508|54621582|FG008|Overall Study|Withdrawal by Subject|1|||
27963890|NCT02237508|54621583|FG009|Overall Study|Withdrawal by Subject|0|||
27963891|NCT02237508|54621574|FG000|Overall Study|Physician Decision|0|||
27963892|NCT02237508|54621575|FG001|Overall Study|Physician Decision|1|||
27963893|NCT02237508|54621576|FG002|Overall Study|Physician Decision|0|||
27963894|NCT02237508|54621577|FG003|Overall Study|Physician Decision|0|||
27963895|NCT02237508|54621578|FG004|Overall Study|Physician Decision|0|||
27963896|NCT02237508|54621579|FG005|Overall Study|Physician Decision|0|||
27963897|NCT02237508|54621580|FG006|Overall Study|Physician Decision|0|||
27963898|NCT02237508|54621581|FG007|Overall Study|Physician Decision|0|||
27963899|NCT02237508|54621582|FG008|Overall Study|Physician Decision|0|||
27963900|NCT02237508|54621583|FG009|Overall Study|Physician Decision|0|||
27963901|NCT02237508|54621574|FG000|Overall Study|Protocol Violation|0|||
27732568|NCT02630459|54180143|FG007|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
27732569|NCT02630459|54180136|FG000|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
27732570|NCT02630459|54180137|FG001|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
27732571|NCT02630459|54180138|FG002|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1|||
27732572|NCT02630459|54180139|FG003|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
27732573|NCT02630459|54180140|FG004|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
27732574|NCT02630459|54180141|FG005|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
27732575|NCT02630459|54180142|FG006|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
27732576|NCT02630459|54180143|FG007|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
27732577|NCT02630459|54180136|FG000|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2|||
27732578|NCT02630459|54180137|FG001|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
27732579|NCT02630459|54180138|FG002|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4|||
27732580|NCT02630459|54180139|FG003|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
27732581|NCT02630459|54180140|FG004|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
27732582|NCT02630459|54180141|FG005|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
27855165|NCT03006926|54375557|FG001|Overall Study|Ongoing Survival Follow-up|26|||
27963902|NCT02237508|54621575|FG001|Overall Study|Protocol Violation|0|||
27963903|NCT02237508|54621576|FG002|Overall Study|Protocol Violation|1|||
27963904|NCT02237508|54621577|FG003|Overall Study|Protocol Violation|0|||
27963905|NCT02237508|54621578|FG004|Overall Study|Protocol Violation|0|||
27963906|NCT02237508|54621579|FG005|Overall Study|Protocol Violation|0|||
27963907|NCT02237508|54621580|FG006|Overall Study|Protocol Violation|0|||
28082931|NCT03451084|54736875|FG000|Overall Study|Death|1|||
28082932|NCT03451084|54736876|FG001|Overall Study|Death|0|||
28082933|NCT03451084|54736877|FG002|Overall Study|Death|2|||
28082934|NCT03451084|54736878|FG003|Overall Study|Death|0|||
28082935|NCT03451084|54736875|FG000|Overall Study|Physician Decision|0|||
27963908|NCT02237508|54621581|FG007|Overall Study|Protocol Violation|0|||
27963909|NCT02237508|54621582|FG008|Overall Study|Protocol Violation|0|||
27963910|NCT02237508|54621583|FG009|Overall Study|Protocol Violation|0|||
27963911|NCT00909090|54621603|FG000|Overall Study|Lost to Follow-up|17|||
27963912|NCT00909090|54621604|FG001|Overall Study|Lost to Follow-up|17|||
27963913|NCT00909480|54621615|FG000|Overall Study|Adverse Event|5|||
27963914|NCT00909480|54621616|FG001|Overall Study|Adverse Event|3|||
27963915|NCT00909480|54621615|FG000|Overall Study|Protocol Violation|6|||
27963916|NCT00909480|54621616|FG001|Overall Study|Protocol Violation|8|||
27963917|NCT00909480|54621615|FG000|Overall Study|Withdrawal criteria|9|||
27963918|NCT00909480|54621616|FG001|Overall Study|Withdrawal criteria|11|||
27963919|NCT00909480|54621615|FG000|Overall Study|Unclassified|18|||
27963920|NCT00909480|54621616|FG001|Overall Study|Unclassified|19|||
27963921|NCT01058096|54621624|FG000|Double-blind Treatment Phase|Adverse Event|11|||
27963922|NCT01058096|54621625|FG001|Double-blind Treatment Phase|Adverse Event|15|||
27963923|NCT01058096|54621624|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|16|||
27963924|NCT01058096|54621625|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|7|||
27963925|NCT01058096|54621624|FG000|Double-blind Treatment Phase|Protocol Violation|2|||
27963926|NCT01058096|54621625|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
27963927|NCT01058096|54621624|FG000|Double-blind Treatment Phase|Withdrawal of Consent|17|||
27963928|NCT01058096|54621625|FG001|Double-blind Treatment Phase|Withdrawal of Consent|26|||
27963929|NCT01058096|54621624|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
27963930|NCT01058096|54621625|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
27963931|NCT01058096|54621624|FG000|Double-blind Treatment Phase|Other Unspecified|2|||
27963932|NCT01058096|54621625|FG001|Double-blind Treatment Phase|Other Unspecified|0|||
27963933|NCT01057862|54621633|FG000|Overall Study|Withdrawal by Subject|1|||
27963934|NCT01057862|54621634|FG001|Overall Study|Withdrawal by Subject|2|||
27963935|NCT01038128|54621640|FG000|Overall Study|Lack of Efficacy|1|||
27963936|NCT01038128|54621640|FG000|Overall Study|Lost to Follow-up|1|||
27963937|NCT01038128|54621640|FG000|Overall Study|Withdrawal by Subject|2|||
27963938|NCT00842530|54621661|FG000|Overall Study|Serious adverse event|0|||
27963939|NCT00842530|54621662|FG001|Overall Study|Serious adverse event|6|||
27963940|NCT00842530|54621661|FG000|Overall Study|Other adverse event|6|||
27963941|NCT00842530|54621662|FG001|Overall Study|Other adverse event|1|||
27963942|NCT00842530|54621661|FG000|Overall Study|Protocol Violation|32|||
27963943|NCT00842530|54621662|FG001|Overall Study|Protocol Violation|14|||
27963944|NCT00842530|54621661|FG000|Overall Study|Lost to Follow-up|6|||
27963945|NCT00842530|54621662|FG001|Overall Study|Lost to Follow-up|8|||
27963946|NCT00842530|54621661|FG000|Overall Study|Withdrawal by Subject|73|||
27963947|NCT00842530|54621662|FG001|Overall Study|Withdrawal by Subject|28|||
27963948|NCT00819910|54621673|FG000|Overall Study|Adverse Event|0|||
27963949|NCT00819910|54621674|FG001|Overall Study|Adverse Event|0|||
27963950|NCT00819910|54621675|FG002|Overall Study|Adverse Event|2|||
27963951|NCT00819910|54621676|FG003|Overall Study|Adverse Event|1|||
27963952|NCT00819910|54621673|FG000|Overall Study|Withdrawal by Subject|1|||
27963953|NCT00819910|54621674|FG001|Overall Study|Withdrawal by Subject|1|||
27963954|NCT00819910|54621675|FG002|Overall Study|Withdrawal by Subject|1|||
27963955|NCT00819910|54621676|FG003|Overall Study|Withdrawal by Subject|0|||
27963956|NCT00819910|54621673|FG000|Overall Study|Lost to Follow-up|1|||
27963957|NCT00819910|54621674|FG001|Overall Study|Lost to Follow-up|0|||
27963958|NCT00819910|54621675|FG002|Overall Study|Lost to Follow-up|0|||
27963959|NCT00819910|54621676|FG003|Overall Study|Lost to Follow-up|0|||
27963960|NCT00830518|54621690|FG000|Overall Study|Progressive Disease|18|||
27963961|NCT00830518|54621691|FG001|Overall Study|Progressive Disease|8|||
27963962|NCT00830518|54621690|FG000|Overall Study|Symptomatic Deterioration|4|||
27963963|NCT00830518|54621691|FG001|Overall Study|Symptomatic Deterioration|1|||
27963964|NCT00830518|54621690|FG000|Overall Study|Adverse Event|14|||
27963965|NCT00830518|54621691|FG001|Overall Study|Adverse Event|1|||
27963966|NCT00830518|54621690|FG000|Overall Study|Withdrawal by Patient|2|||
27963967|NCT00830518|54621691|FG001|Overall Study|Withdrawal by Patient|0|||
27963968|NCT00830518|54621690|FG000|Overall Study|Reason not Specified|8|||
27963969|NCT00830518|54621691|FG001|Overall Study|Reason not Specified|1|||
27963970|NCT00908544|54621700|FG000|Overall Study|Withdrawal by Subject|2|||
27963971|NCT00908544|54621701|FG001|Overall Study|Withdrawal by Subject|4|||
27963972|NCT00908544|54621700|FG000|Overall Study|Lack of Efficacy|0|||
27963973|NCT00908544|54621701|FG001|Overall Study|Lack of Efficacy|1|||
27963974|NCT00908544|54621700|FG000|Overall Study|Pregnancy|1|||
27963975|NCT00908544|54621701|FG001|Overall Study|Pregnancy|0|||
27732583|NCT02630459|54180142|FG006|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
27732584|NCT02630459|54180143|FG007|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
27963976|NCT00908544|54621700|FG000|Overall Study|Relocation abroad|1|||
27963977|NCT00908544|54621701|FG001|Overall Study|Relocation abroad|1|||
27963978|NCT00908544|54621700|FG000|Overall Study|Unable to visit sutdy center|1|||
27963979|NCT00908544|54621701|FG001|Overall Study|Unable to visit sutdy center|0|||
27963980|NCT00830440|54621709|FG000|Overall Study|Protocol Violation|1|||
27963981|NCT00830440|54621710|FG001|Overall Study|Protocol Violation|0|||
27963982|NCT00830440|54621709|FG000|Overall Study|Withdrawal by Subject|1|||
27963983|NCT00830440|54621710|FG001|Overall Study|Withdrawal by Subject|0|||
27963984|NCT00830440|54621709|FG000|Overall Study|unsuccessful procedure|4|||
27963985|NCT00830440|54621710|FG001|Overall Study|unsuccessful procedure|0|||
27963986|NCT00830440|54621709|FG000|Overall Study|Adverse Event|2|||
27963987|NCT00830440|54621710|FG001|Overall Study|Adverse Event|0|||
27963988|NCT00908310|54621717|FG000|Overall Study|Death|37|||
27963989|NCT00908310|54621717|FG000|Overall Study|Withdrawal by Subject|7|||
27963990|NCT00908310|54621717|FG000|Overall Study|Lost to Follow-up|7|||
27963991|NCT00908310|54621717|FG000|Overall Study|Screening failure|5|||
27963992|NCT00908310|54621717|FG000|Overall Study|Other reasons|4|||
27963993|NCT00830128|54621721|FG000|Overall Study|Adverse Event|5|||
27963994|NCT00830128|54621721|FG000|Overall Study|Lack of Efficacy|7|||
27963995|NCT00830128|54621721|FG000|Overall Study|Protocol Violation|1|||
27963996|NCT00830128|54621721|FG000|Overall Study|Withdrawal by Subject|2|||
27963997|NCT00830128|54621721|FG000|Overall Study|Family obligation|1|||
27963998|NCT00830128|54621721|FG000|Overall Study|Relocation|1|||
27963999|NCT00830128|54621721|FG000|Overall Study|Work obligation|1|||
27964000|NCT00830128|54621721|FG000|Overall Study|Operating a vehicle|1|||
27964001|NCT00841906|54621727|FG000|Overall Study|Withdrawal by Subject|2|||
27964002|NCT00841906|54621728|FG001|Overall Study|Withdrawal by Subject|0|||
27964003|NCT00771667|54621740|FG000|Induction Phase|Adverse Event|5|||
27964004|NCT00771667|54621741|FG001|Induction Phase|Adverse Event|2|||
27964005|NCT00771667|54621742|FG002|Induction Phase|Adverse Event|4|||
27964006|NCT00771667|54621743|FG003|Induction Phase|Adverse Event|1|||
27964007|NCT00771667|54621744|FG004|Induction Phase|Adverse Event|0|||
27964008|NCT00771667|54621745|FG005|Induction Phase|Adverse Event|0|||
27964009|NCT00771667|54621746|FG006|Induction Phase|Adverse Event|0|||
27964010|NCT00771667|54621747|FG007|Induction Phase|Adverse Event|0|||
27832488|NCT01597505|54311753|FG001|Overall Study|Withdrawal by Subject|18|||
27832489|NCT01597505|54311752|FG000|Overall Study|Other|5|||
27832490|NCT01597505|54311753|FG001|Overall Study|Other|6|||
27832491|NCT01597505|54311752|FG000|Overall Study|Missing|1|||
27832492|NCT01597505|54311753|FG001|Overall Study|Missing|0|||
27832493|NCT01760447|54311792|FG000|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
27832494|NCT01760447|54311793|FG001|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
27832495|NCT01760447|54311794|FG002|Weeks 0-20|Consent withdrawn by Parent/Guardian|1|||
27832496|NCT01760447|54311795|FG003|Weeks 0-20|Consent withdrawn by Parent/Guardian|3|||
27855166|NCT03006926|54375556|FG000|Overall Study|Ongoing-on Treatment|0|||
27855167|NCT03006926|54375557|FG001|Overall Study|Ongoing-on Treatment|36|||
27855168|NCT03006926|54375556|FG000|Overall Study|Lost to Follow-up|0|||
27855169|NCT03006926|54375557|FG001|Overall Study|Lost to Follow-up|1|||
27964011|NCT00771667|54621748|FG008|Induction Phase|Adverse Event|0|||
27964012|NCT00771667|54621749|FG009|Induction Phase|Adverse Event|0|||
27964013|NCT00771667|54621740|FG000|Induction Phase|Lack of Efficacy|9|||
27964014|NCT00771667|54621741|FG001|Induction Phase|Lack of Efficacy|2|||
27964015|NCT00771667|54621742|FG002|Induction Phase|Lack of Efficacy|4|||
27964016|NCT00771667|54621743|FG003|Induction Phase|Lack of Efficacy|3|||
27964017|NCT00771667|54621744|FG004|Induction Phase|Lack of Efficacy|0|||
27964018|NCT00771667|54621745|FG005|Induction Phase|Lack of Efficacy|0|||
27964019|NCT00771667|54621746|FG006|Induction Phase|Lack of Efficacy|0|||
27964020|NCT00771667|54621747|FG007|Induction Phase|Lack of Efficacy|0|||
27964021|NCT00771667|54621748|FG008|Induction Phase|Lack of Efficacy|0|||
27964022|NCT00771667|54621749|FG009|Induction Phase|Lack of Efficacy|0|||
27964023|NCT00771667|54621740|FG000|Induction Phase|Lost to Follow-up|1|||
27964024|NCT00771667|54621741|FG001|Induction Phase|Lost to Follow-up|0|||
27964025|NCT00771667|54621742|FG002|Induction Phase|Lost to Follow-up|1|||
27964026|NCT00771667|54621743|FG003|Induction Phase|Lost to Follow-up|0|||
27964027|NCT00771667|54621744|FG004|Induction Phase|Lost to Follow-up|0|||
27964028|NCT00771667|54621745|FG005|Induction Phase|Lost to Follow-up|0|||
27964029|NCT00771667|54621746|FG006|Induction Phase|Lost to Follow-up|0|||
27964030|NCT00771667|54621747|FG007|Induction Phase|Lost to Follow-up|0|||
27964031|NCT00771667|54621748|FG008|Induction Phase|Lost to Follow-up|0|||
27964032|NCT00771667|54621749|FG009|Induction Phase|Lost to Follow-up|0|||
27964033|NCT00771667|54621740|FG000|Induction Phase|Other|4|||
27964034|NCT00771667|54621741|FG001|Induction Phase|Other|6|||
27832497|NCT01760447|54311792|FG000|Weeks 0-20|Withdrawal by Subject|2|||
27832498|NCT01760447|54311793|FG001|Weeks 0-20|Withdrawal by Subject|0|||
27964035|NCT00771667|54621742|FG002|Induction Phase|Other|3|||
27964036|NCT00771667|54621743|FG003|Induction Phase|Other|4|||
27964037|NCT00771667|54621744|FG004|Induction Phase|Other|0|||
27964038|NCT00771667|54621745|FG005|Induction Phase|Other|0|||
27964039|NCT00771667|54621746|FG006|Induction Phase|Other|0|||
27964040|NCT00771667|54621747|FG007|Induction Phase|Other|0|||
27964041|NCT00771667|54621748|FG008|Induction Phase|Other|0|||
27964042|NCT00771667|54621749|FG009|Induction Phase|Other|0|||
28082936|NCT03451084|54736876|FG001|Overall Study|Physician Decision|0|||
27832499|NCT01760447|54311794|FG002|Weeks 0-20|Withdrawal by Subject|1|||
27832500|NCT01760447|54311795|FG003|Weeks 0-20|Withdrawal by Subject|0|||
27964043|NCT00771667|54621740|FG000|Maintenance Phase|Adverse Event|0|||
27964044|NCT00771667|54621741|FG001|Maintenance Phase|Adverse Event|0|||
27964045|NCT00771667|54621742|FG002|Maintenance Phase|Adverse Event|0|||
27964046|NCT00771667|54621743|FG003|Maintenance Phase|Adverse Event|0|||
27964047|NCT00771667|54621744|FG004|Maintenance Phase|Adverse Event|1|||
27964048|NCT00771667|54621745|FG005|Maintenance Phase|Adverse Event|3|||
27964049|NCT00771667|54621746|FG006|Maintenance Phase|Adverse Event|5|||
27964050|NCT00771667|54621747|FG007|Maintenance Phase|Adverse Event|1|||
27964051|NCT00771667|54621748|FG008|Maintenance Phase|Adverse Event|8|||
27964052|NCT00771667|54621749|FG009|Maintenance Phase|Adverse Event|7|||
28082937|NCT03451084|54736877|FG002|Overall Study|Physician Decision|2|||
28082938|NCT03451084|54736878|FG003|Overall Study|Physician Decision|2|||
28082939|NCT03451084|54736875|FG000|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|3|||
28082940|NCT03451084|54736876|FG001|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
28082941|NCT03451084|54736877|FG002|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
28082942|NCT03451084|54736878|FG003|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|2|||
28082943|NCT03451006|54736890|FG000|Overall Study|Withdrawal by Subject|2|||
28082944|NCT03451006|54736891|FG001|Overall Study|Withdrawal by Subject|2|||
28082945|NCT03450070|54736897|FG000|Overall Study|Withdrawal by Subject|8|||
28082946|NCT03449758|54736901|FG000|Overall Study|Major protocol deviation|1|||
27964053|NCT00771667|54621740|FG000|Maintenance Phase|Lack of Efficacy|0|||
27964054|NCT00771667|54621741|FG001|Maintenance Phase|Lack of Efficacy|0|||
27964055|NCT00771667|54621742|FG002|Maintenance Phase|Lack of Efficacy|0|||
27964056|NCT00771667|54621743|FG003|Maintenance Phase|Lack of Efficacy|0|||
27964057|NCT00771667|54621744|FG004|Maintenance Phase|Lack of Efficacy|1|||
27964058|NCT00771667|54621745|FG005|Maintenance Phase|Lack of Efficacy|3|||
27964059|NCT00771667|54621746|FG006|Maintenance Phase|Lack of Efficacy|3|||
27964060|NCT00771667|54621747|FG007|Maintenance Phase|Lack of Efficacy|2|||
27964061|NCT00771667|54621748|FG008|Maintenance Phase|Lack of Efficacy|11|||
27964062|NCT00771667|54621749|FG009|Maintenance Phase|Lack of Efficacy|7|||
27964063|NCT00771667|54621740|FG000|Maintenance Phase|Other|0|||
27964064|NCT00771667|54621741|FG001|Maintenance Phase|Other|0|||
27964065|NCT00771667|54621742|FG002|Maintenance Phase|Other|0|||
27964066|NCT00771667|54621743|FG003|Maintenance Phase|Other|0|||
27964067|NCT00771667|54621744|FG004|Maintenance Phase|Other|0|||
27964068|NCT00771667|54621745|FG005|Maintenance Phase|Other|1|||
27964069|NCT00771667|54621746|FG006|Maintenance Phase|Other|2|||
27964070|NCT00771667|54621747|FG007|Maintenance Phase|Other|2|||
27964071|NCT00771667|54621748|FG008|Maintenance Phase|Other|3|||
27964072|NCT00771667|54621749|FG009|Maintenance Phase|Other|3|||
27964073|NCT00770965|54621771|FG000|Safety Set|Withdrawal by Subject|0|||
27964074|NCT00770965|54621772|FG001|Safety Set|Withdrawal by Subject|0|||
27964075|NCT00770965|54621773|FG002|Safety Set|Withdrawal by Subject|0|||
27964076|NCT00770965|54621774|FG003|Safety Set|Withdrawal by Subject|1|||
27964077|NCT00770965|54621771|FG000|Safety Set|Protocol deviation|0|||
27964078|NCT00770965|54621772|FG001|Safety Set|Protocol deviation|0|||
27964079|NCT00770965|54621773|FG002|Safety Set|Protocol deviation|1|||
27964080|NCT00770965|54621774|FG003|Safety Set|Protocol deviation|0|||
27964081|NCT00770965|54621771|FG000|Excluded Set|Administrative problems|14|||
27964082|NCT00770965|54621772|FG001|Excluded Set|Administrative problems|12|||
28082947|NCT03449758|54736901|FG000|Overall Study|Treatment inefficacy|5|||
27832501|NCT01760447|54311792|FG000|Weeks 0-20|Lost to Follow-up|1|||
27964083|NCT00770965|54621773|FG002|Excluded Set|Administrative problems|12|||
27964084|NCT00770965|54621774|FG003|Excluded Set|Administrative problems|10|||
27964085|NCT00770965|54621771|FG000|Excluded Set|Withdrawal by Subject|1|||
27964086|NCT00770965|54621772|FG001|Excluded Set|Withdrawal by Subject|1|||
27964087|NCT00770965|54621773|FG002|Excluded Set|Withdrawal by Subject|2|||
27964088|NCT00770965|54621774|FG003|Excluded Set|Withdrawal by Subject|3|||
27964089|NCT00763555|54621786|FG000|Overall Study|Adverse Event|2|||
27964090|NCT00763555|54621787|FG001|Overall Study|Adverse Event|1|||
27964091|NCT00763555|54621786|FG000|Overall Study|Withdrawal by Subject|2|||
27964092|NCT00763555|54621787|FG001|Overall Study|Withdrawal by Subject|6|||
27964093|NCT00763555|54621786|FG000|Overall Study|Lost to Follow-up|0|||
27964094|NCT00763555|54621787|FG001|Overall Study|Lost to Follow-up|3|||
27964095|NCT00763321|54621796|FG000|Open-label Period|Adverse Event|24|||
27964096|NCT00763321|54621797|FG001|Open-label Period|Adverse Event|0|||
27964097|NCT00763321|54621798|FG002|Open-label Period|Adverse Event|0|||
27832502|NCT01760447|54311793|FG001|Weeks 0-20|Lost to Follow-up|0|||
27832503|NCT01760447|54311794|FG002|Weeks 0-20|Lost to Follow-up|1|||
27832504|NCT01760447|54311795|FG003|Weeks 0-20|Lost to Follow-up|1|||
27832505|NCT01760447|54311792|FG000|Weeks 0-20|Randomized but not treated|0|||
27832506|NCT01760447|54311793|FG001|Weeks 0-20|Randomized but not treated|0|||
27964098|NCT00763321|54621796|FG000|Open-label Period|Lost to Follow-up|14|||
27964099|NCT00763321|54621797|FG001|Open-label Period|Lost to Follow-up|0|||
27964100|NCT00763321|54621798|FG002|Open-label Period|Lost to Follow-up|0|||
28082948|NCT03449758|54736901|FG000|Overall Study|Adverse Event|9|||
27832507|NCT01760447|54311794|FG002|Weeks 0-20|Randomized but not treated|2|||
27964101|NCT00763321|54621796|FG000|Open-label Period|Withdrawal by Subject|7|||
27964102|NCT00763321|54621797|FG001|Open-label Period|Withdrawal by Subject|0|||
27964103|NCT00763321|54621798|FG002|Open-label Period|Withdrawal by Subject|0|||
27964104|NCT00763321|54621796|FG000|Open-label Period|Subject noncompliant|7|||
27964105|NCT00763321|54621797|FG001|Open-label Period|Subject noncompliant|0|||
27964106|NCT00763321|54621798|FG002|Open-label Period|Subject noncompliant|0|||
27964107|NCT00763321|54621796|FG000|Open-label Period|Did not meet DB randomization criteria|5|||
27964108|NCT00763321|54621797|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
27964109|NCT00763321|54621798|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
27964110|NCT00763321|54621796|FG000|Open-label Period|Lack of Efficacy|2|||
27964111|NCT00763321|54621797|FG001|Open-label Period|Lack of Efficacy|0|||
27964112|NCT00763321|54621798|FG002|Open-label Period|Lack of Efficacy|0|||
27964113|NCT00763321|54621796|FG000|Open-label Period|Other|4|||
27964114|NCT00763321|54621797|FG001|Open-label Period|Other|0|||
27964115|NCT00763321|54621798|FG002|Open-label Period|Other|0|||
27964116|NCT00763321|54621796|FG000|Double-blind Period|Lack of Efficacy|0|||
27964117|NCT00763321|54621797|FG001|Double-blind Period|Lack of Efficacy|9|||
27964118|NCT00763321|54621798|FG002|Double-blind Period|Lack of Efficacy|17|||
27964119|NCT00763321|54621796|FG000|Double-blind Period|Adverse Event|0|||
27964120|NCT00763321|54621797|FG001|Double-blind Period|Adverse Event|4|||
27964121|NCT00763321|54621798|FG002|Double-blind Period|Adverse Event|4|||
27964122|NCT00763321|54621796|FG000|Double-blind Period|Lost to Follow-up|0|||
27964123|NCT00763321|54621797|FG001|Double-blind Period|Lost to Follow-up|4|||
27964124|NCT00763321|54621798|FG002|Double-blind Period|Lost to Follow-up|2|||
27964125|NCT00763321|54621796|FG000|Double-blind Period|Withdrawal by Subject|0|||
27964126|NCT00763321|54621797|FG001|Double-blind Period|Withdrawal by Subject|2|||
27964127|NCT00763321|54621798|FG002|Double-blind Period|Withdrawal by Subject|3|||
27964128|NCT00763321|54621796|FG000|Double-blind Period|Other|0|||
27964129|NCT00763321|54621797|FG001|Double-blind Period|Other|2|||
27964130|NCT00763321|54621798|FG002|Double-blind Period|Other|3|||
27964131|NCT00770653|54621807|FG000|Overall Study|Adverse Event|13|||
27964132|NCT00770653|54621808|FG001|Overall Study|Adverse Event|5|||
27964133|NCT00770653|54621807|FG000|Overall Study|Protocol Violation|8|||
27964134|NCT00770653|54621808|FG001|Overall Study|Protocol Violation|6|||
27964135|NCT00770653|54621807|FG000|Overall Study|Withdrawal by Subject|4|||
27964136|NCT00770653|54621808|FG001|Overall Study|Withdrawal by Subject|7|||
27964137|NCT00770653|54621807|FG000|Overall Study|Lack of Compliance|1|||
27964138|NCT00770653|54621808|FG001|Overall Study|Lack of Compliance|4|||
27964139|NCT00770653|54621807|FG000|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
27964140|NCT00770653|54621808|FG001|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
27964141|NCT00770653|54621807|FG000|Overall Study|Fasting Glucose > 240 mg/dL|2|||
27964142|NCT00770653|54621808|FG001|Overall Study|Fasting Glucose > 240 mg/dL|1|||
27964143|NCT00770653|54621807|FG000|Overall Study|> Three Moderate Hypoglycemic Episodes|0|||
27964144|NCT00770653|54621808|FG001|Overall Study|> Three Moderate Hypoglycemic Episodes|2|||
27964145|NCT00770653|54621807|FG000|Overall Study|Lost to Follow-up|1|||
27964146|NCT00770653|54621808|FG001|Overall Study|Lost to Follow-up|2|||
27964147|NCT00770653|54621807|FG000|Overall Study|Physician Decision|1|||
27964148|NCT00770653|54621808|FG001|Overall Study|Physician Decision|0|||
27964149|NCT00819052|54621816|FG000|Overall Study|Adverse Event|0|||
27964150|NCT00819052|54621817|FG001|Overall Study|Adverse Event|5|||
27964151|NCT00819052|54621816|FG000|Overall Study|Protocol Violation|1|||
27964152|NCT00819052|54621817|FG001|Overall Study|Protocol Violation|2|||
27964153|NCT00819052|54621816|FG000|Overall Study|Lost to Follow-up|1|||
27964154|NCT00819052|54621817|FG001|Overall Study|Lost to Follow-up|2|||
27964155|NCT00819052|54621816|FG000|Overall Study|Withdrawal by Subject|1|||
27964156|NCT00819052|54621817|FG001|Overall Study|Withdrawal by Subject|2|||
27964157|NCT00819052|54621816|FG000|Overall Study|Lack of Efficacy|1|||
27964158|NCT00819052|54621817|FG001|Overall Study|Lack of Efficacy|1|||
27964159|NCT00819052|54621816|FG000|Overall Study|Pregnancy|1|||
27964160|NCT00819052|54621817|FG001|Overall Study|Pregnancy|2|||
27964161|NCT00819052|54621816|FG000|Overall Study|Death or events leading to death|1|||
27964162|NCT00819052|54621817|FG001|Overall Study|Death or events leading to death|0|||
27964163|NCT00763009|54621826|FG000|Overall Study|Coronary Anatomy unsuitable|1|||
27964164|NCT00841672|54621833|FG000|Overall Study|Adverse Event|7|||
27964165|NCT00841672|54621834|FG001|Overall Study|Adverse Event|16|||
27964166|NCT00841672|54621833|FG000|Overall Study|Abnormal test procedure result(s)|0|||
27964167|NCT00841672|54621834|FG001|Overall Study|Abnormal test procedure result(s)|1|||
27964168|NCT00841672|54621833|FG000|Overall Study|Subject withdrew consent|2|||
27964169|NCT00841672|54621834|FG001|Overall Study|Subject withdrew consent|4|||
27964170|NCT00841672|54621833|FG000|Overall Study|Lost to Follow-up|1|||
27964171|NCT00841672|54621834|FG001|Overall Study|Lost to Follow-up|1|||
27964172|NCT00841672|54621833|FG000|Overall Study|Administrative problems|9|||
27964173|NCT00841672|54621834|FG001|Overall Study|Administrative problems|9|||
27964174|NCT00841672|54621833|FG000|Overall Study|Misrandomized|1|||
27964175|NCT00841672|54621834|FG001|Overall Study|Misrandomized|0|||
27964176|NCT00841672|54621833|FG000|Overall Study|Protocol Deviation|0|||
27964177|NCT00841672|54621834|FG001|Overall Study|Protocol Deviation|1|||
27964178|NCT00908232|54621840|FG000|Cycle 1 to 4|Death|5|||
27964179|NCT00908232|54621841|FG001|Cycle 1 to 4|Death|0|||
27964180|NCT00908232|54621842|FG002|Cycle 1 to 4|Death|0|||
27964181|NCT00908232|54621843|FG003|Cycle 1 to 4|Death|0|||
27964182|NCT00908232|54621840|FG000|Cycle 1 to 4|Withdrawal by Subject|4|||
28082949|NCT03449758|54736901|FG000|Overall Study|Consent withdrawal|1|||
28082950|NCT03449758|54736901|FG000|Overall Study|Other unspecified reason|3|||
28082951|NCT03449446|54736913|FG000|Overall Study|Randomized but Never Treated|0|||
28082952|NCT03449446|54736914|FG001|Overall Study|Randomized but Never Treated|0|||
28082953|NCT03449446|54736915|FG002|Overall Study|Randomized but Never Treated|1|||
28082954|NCT03449446|54736916|FG003|Overall Study|Randomized but Never Treated|1|||
28082955|NCT03449446|54736917|FG004|Overall Study|Randomized but Never Treated|1|||
28165163|NCT03016325|54835758|FG005|182-Day Follow-Up Period|Participant withdrew consent|0|||
27964183|NCT00908232|54621841|FG001|Cycle 1 to 4|Withdrawal by Subject|0|||
27964184|NCT00908232|54621842|FG002|Cycle 1 to 4|Withdrawal by Subject|0|||
27964185|NCT00908232|54621843|FG003|Cycle 1 to 4|Withdrawal by Subject|0|||
27964186|NCT00908232|54621840|FG000|Cycle 1 to 4|Progressive Disease|6|||
27964187|NCT00908232|54621841|FG001|Cycle 1 to 4|Progressive Disease|0|||
27964188|NCT00908232|54621842|FG002|Cycle 1 to 4|Progressive Disease|0|||
27964189|NCT00908232|54621843|FG003|Cycle 1 to 4|Progressive Disease|0|||
27964190|NCT00908232|54621840|FG000|Cycle 1 to 4|Adverse Event|12|||
27964191|NCT00908232|54621841|FG001|Cycle 1 to 4|Adverse Event|0|||
27964192|NCT00908232|54621842|FG002|Cycle 1 to 4|Adverse Event|0|||
27964193|NCT00908232|54621843|FG003|Cycle 1 to 4|Adverse Event|0|||
27964194|NCT00908232|54621840|FG000|Cycle 1 to 4|Other|1|||
27964195|NCT00908232|54621841|FG001|Cycle 1 to 4|Other|0|||
27964196|NCT00908232|54621842|FG002|Cycle 1 to 4|Other|0|||
27964197|NCT00908232|54621843|FG003|Cycle 1 to 4|Other|0|||
27964198|NCT00908232|54621840|FG000|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1|||
27964199|NCT00908232|54621841|FG001|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
27964200|NCT00908232|54621842|FG002|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
27964201|NCT00908232|54621843|FG003|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
27964202|NCT00908232|54621840|FG000|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5|||
27964203|NCT00908232|54621841|FG001|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
27964204|NCT00908232|54621842|FG002|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
27964205|NCT00908232|54621843|FG003|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
27964206|NCT00908232|54621840|FG000|Randomization (Cycle 5) to Cycle 8|Death|2|||
27964207|NCT00908232|54621841|FG001|Randomization (Cycle 5) to Cycle 8|Death|0|||
27964208|NCT00908232|54621842|FG002|Randomization (Cycle 5) to Cycle 8|Death|0|||
27964209|NCT00908232|54621843|FG003|Randomization (Cycle 5) to Cycle 8|Death|0|||
27964210|NCT00908232|54621840|FG000|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4|||
27964211|NCT00908232|54621841|FG001|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
27964212|NCT00908232|54621842|FG002|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1|||
27964213|NCT00908232|54621843|FG003|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
27964214|NCT00908232|54621840|FG000|Randomization (Cycle 5) to Cycle 8|Adverse Event|17|||
27964215|NCT00908232|54621841|FG001|Randomization (Cycle 5) to Cycle 8|Adverse Event|2|||
27964216|NCT00908232|54621842|FG002|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
27964217|NCT00908232|54621843|FG003|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
27964218|NCT00908232|54621840|FG000|Randomization (Cycle 5) to Cycle 8|Physician Decision|2|||
27964219|NCT00908232|54621841|FG001|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
27964220|NCT00908232|54621842|FG002|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
27964221|NCT00908232|54621843|FG003|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
27964222|NCT00908232|54621840|FG000|Randomization (Cycle 5) to Cycle 8|Other|3|||
27964223|NCT00908232|54621841|FG001|Randomization (Cycle 5) to Cycle 8|Other|1|||
27964224|NCT00908232|54621842|FG002|Randomization (Cycle 5) to Cycle 8|Other|0|||
27964225|NCT00908232|54621843|FG003|Randomization (Cycle 5) to Cycle 8|Other|0|||
27964226|NCT00908232|54621840|FG000|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1|||
27964227|NCT00908232|54621841|FG001|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
27964228|NCT00908232|54621842|FG002|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
27964229|NCT00908232|54621843|FG003|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
27964230|NCT00770341|54621852|FG000|Overall Study|Did not meet eligibility criteria|1|||
27964231|NCT00770341|54621853|FG001|Overall Study|Did not meet eligibility criteria|0|||
27964232|NCT00770341|54621854|FG002|Overall Study|Did not meet eligibility criteria|0|||
27964233|NCT00770341|54621852|FG000|Overall Study|Withdrawal by Subject|0|||
27964234|NCT00770341|54621853|FG001|Overall Study|Withdrawal by Subject|1|||
27964235|NCT00770341|54621854|FG002|Overall Study|Withdrawal by Subject|0|||
28082956|NCT03449446|54736918|FG005|Overall Study|Randomized but Never Treated|0|||
27964236|NCT00770341|54621852|FG000|Overall Study|Clinical Adverse Event|3|||
27964237|NCT00770341|54621853|FG001|Overall Study|Clinical Adverse Event|1|||
27964238|NCT00770341|54621854|FG002|Overall Study|Clinical Adverse Event|2|||
27964239|NCT00770341|54621852|FG000|Overall Study|Laboratory adverse event|3|||
27964240|NCT00770341|54621853|FG001|Overall Study|Laboratory adverse event|3|||
27964241|NCT00770341|54621854|FG002|Overall Study|Laboratory adverse event|0|||
27964242|NCT00770341|54621852|FG000|Overall Study|Lack of Efficacy|3|||
27964243|NCT00770341|54621853|FG001|Overall Study|Lack of Efficacy|0|||
27964244|NCT00770341|54621854|FG002|Overall Study|Lack of Efficacy|1|||
27964245|NCT00770341|54621852|FG000|Overall Study|Other|1|||
27964246|NCT00770341|54621853|FG001|Overall Study|Other|0|||
27964247|NCT00770341|54621854|FG002|Overall Study|Other|0|||
27964248|NCT00770341|54621852|FG000|Overall Study|Not treated|1|||
28082957|NCT03449446|54736919|FG006|Overall Study|Randomized but Never Treated|0|||
28082958|NCT03449446|54736913|FG000|Overall Study|Unknown Reason|33|||
27964249|NCT00770341|54621853|FG001|Overall Study|Not treated|0|||
27964250|NCT00770341|54621854|FG002|Overall Study|Not treated|0|||
27964251|NCT00762463|54621871|FG000|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
27964252|NCT00762463|54621872|FG001|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
27964253|NCT00762463|54621873|FG002|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
27964254|NCT00762463|54621874|FG003|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
27964255|NCT00762463|54621871|FG000|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3|||
27964256|NCT00762463|54621872|FG001|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4|||
27964257|NCT00762463|54621873|FG002|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
27964258|NCT00762463|54621874|FG003|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
27964259|NCT00762463|54621871|FG000|Double-blind Phase (Baseline to Week 6)|Adverse Event|2|||
27964260|NCT00762463|54621872|FG001|Double-blind Phase (Baseline to Week 6)|Adverse Event|4|||
28082959|NCT03449446|54736914|FG001|Overall Study|Unknown Reason|1|||
28082960|NCT03449446|54736915|FG002|Overall Study|Unknown Reason|1|||
28082961|NCT03449446|54736916|FG003|Overall Study|Unknown Reason|1|||
28082962|NCT03449446|54736917|FG004|Overall Study|Unknown Reason|2|||
28082963|NCT03449446|54736918|FG005|Overall Study|Unknown Reason|2|||
28082964|NCT03449446|54736919|FG006|Overall Study|Unknown Reason|0|||
27964261|NCT00762463|54621873|FG002|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
27964262|NCT00762463|54621874|FG003|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
27964263|NCT00762463|54621871|FG000|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4|||
27964264|NCT00762463|54621872|FG001|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1|||
27964265|NCT00762463|54621873|FG002|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
27964266|NCT00762463|54621874|FG003|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
27964267|NCT00762463|54621871|FG000|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
27964268|NCT00762463|54621872|FG001|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
27964269|NCT00762463|54621873|FG002|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
27964270|NCT00762463|54621874|FG003|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
27964271|NCT00762463|54621871|FG000|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
27964272|NCT00762463|54621872|FG001|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
27964273|NCT00762463|54621873|FG002|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0|||
27964274|NCT00762463|54621874|FG003|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
27964275|NCT00762463|54621871|FG000|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1|||
27964276|NCT00762463|54621872|FG001|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
27964277|NCT00762463|54621873|FG002|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3|||
27964278|NCT00762463|54621874|FG003|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
27964279|NCT00762463|54621871|FG000|Extension Phase (Week 6 to Week 12)|Other|0|||
27964280|NCT00762463|54621872|FG001|Extension Phase (Week 6 to Week 12)|Other|0|||
27964281|NCT00762463|54621873|FG002|Extension Phase (Week 6 to Week 12)|Other|0|||
27964282|NCT00762463|54621874|FG003|Extension Phase (Week 6 to Week 12)|Other|1|||
27964283|NCT00762385|54621887|FG000|First Intervention|Lens Issue|1|||
27964284|NCT00762385|54621888|FG001|First Intervention|Lens Issue|1|||
27964285|NCT00762385|54621887|FG000|First Intervention|Lost to Follow-up|0|||
27964286|NCT00762385|54621888|FG001|First Intervention|Lost to Follow-up|2|||
27964287|NCT00762385|54621887|FG000|First Intervention|Ineligible|1|||
27964288|NCT00762385|54621888|FG001|First Intervention|Ineligible|0|||
27964289|NCT00762385|54621887|FG000|First Intervention|Protocol Violation|0|||
27964290|NCT00762385|54621888|FG001|First Intervention|Protocol Violation|1|||
27964291|NCT00762385|54621887|FG000|Second Intervention|Protocol Violation|3|||
28082965|NCT03449446|54736913|FG000|Overall Study|Withdrew Consent|1|||
28082966|NCT03449446|54736914|FG001|Overall Study|Withdrew Consent|3|||
28082967|NCT03449446|54736915|FG002|Overall Study|Withdrew Consent|1|||
28082968|NCT03449446|54736916|FG003|Overall Study|Withdrew Consent|4|||
28082969|NCT03449446|54736917|FG004|Overall Study|Withdrew Consent|4|||
28082970|NCT03449446|54736918|FG005|Overall Study|Withdrew Consent|4|||
28082971|NCT03449446|54736919|FG006|Overall Study|Withdrew Consent|1|||
28082972|NCT03449446|54736913|FG000|Overall Study|Adverse Event|1|||
28165164|NCT03016325|54835759|FG006|182-Day Follow-Up Period|Participant withdrew consent|1|||
28165165|NCT03016325|54835760|FG007|182-Day Follow-Up Period|Participant withdrew consent|0|||
28165166|NCT03016325|54835753|FG000|182-Day Follow-Up Period|Alive, per Family doctor|0|||
28165167|NCT03016325|54835754|FG001|182-Day Follow-Up Period|Alive, per Family doctor|0|||
28165168|NCT03016325|54835755|FG002|182-Day Follow-Up Period|Alive, per Family doctor|0|||
28165169|NCT03016325|54835756|FG003|182-Day Follow-Up Period|Alive, per Family doctor|0|||
27964292|NCT00762385|54621888|FG001|Second Intervention|Protocol Violation|3|||
27964293|NCT00906282|54621897|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
27964294|NCT00906282|54621897|FG000|Preoperative Chemotherapy|Not surgical candidates, off study|10|||
27964295|NCT00906282|54621897|FG000|Preoperative Chemotherapy|Progressive disease|6|||
27964296|NCT00906282|54621897|FG000|Preoperative Chemotherapy|Toxicity|1|||
27964297|NCT00762229|54621904|FG000|Overall Study|Lost to Follow-up|1|||
27964298|NCT00762229|54621905|FG001|Overall Study|Lost to Follow-up|1|||
27964299|NCT00762229|54621904|FG000|Overall Study|did not recveive intervention|0|||
27964300|NCT00762229|54621905|FG001|Overall Study|did not recveive intervention|1|||
27964301|NCT00907374|54621913|FG000|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
27964302|NCT00907374|54621914|FG001|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
27964303|NCT00818662|54621924|FG000|Overall Study|Adverse Event|5|||
27964304|NCT00818662|54621925|FG001|Overall Study|Adverse Event|14|||
27964305|NCT00818662|54621926|FG002|Overall Study|Adverse Event|4|||
27964306|NCT00818662|54621927|FG003|Overall Study|Adverse Event|3|||
27964307|NCT00818662|54621924|FG000|Overall Study|Withdrawal by Subject|5|||
27964308|NCT00818662|54621925|FG001|Overall Study|Withdrawal by Subject|4|||
27964309|NCT00818662|54621926|FG002|Overall Study|Withdrawal by Subject|2|||
27964310|NCT00818662|54621927|FG003|Overall Study|Withdrawal by Subject|2|||
27964311|NCT00818662|54621924|FG000|Overall Study|Death|1|||
27964312|NCT00818662|54621925|FG001|Overall Study|Death|3|||
27964313|NCT00818662|54621926|FG002|Overall Study|Death|0|||
27964314|NCT00818662|54621927|FG003|Overall Study|Death|0|||
27964315|NCT00818662|54621924|FG000|Overall Study|Physician Decision|1|||
27964316|NCT00818662|54621925|FG001|Overall Study|Physician Decision|0|||
27964317|NCT00818662|54621926|FG002|Overall Study|Physician Decision|0|||
27964318|NCT00818662|54621927|FG003|Overall Study|Physician Decision|0|||
27964319|NCT00818662|54621924|FG000|Overall Study|Lost to Follow-up|0|||
27964320|NCT00818662|54621925|FG001|Overall Study|Lost to Follow-up|0|||
27964321|NCT00818662|54621926|FG002|Overall Study|Lost to Follow-up|0|||
27964322|NCT00818662|54621927|FG003|Overall Study|Lost to Follow-up|1|||
27964323|NCT00818662|54621924|FG000|Overall Study|Unwilling or Unable to Participate|4|||
27964324|NCT00818662|54621925|FG001|Overall Study|Unwilling or Unable to Participate|6|||
27964325|NCT00818662|54621926|FG002|Overall Study|Unwilling or Unable to Participate|2|||
27964326|NCT00818662|54621927|FG003|Overall Study|Unwilling or Unable to Participate|4|||
27964327|NCT00818662|54621924|FG000|Overall Study|Protocol Violation|1|||
27964328|NCT00818662|54621925|FG001|Overall Study|Protocol Violation|1|||
27964329|NCT00818662|54621926|FG002|Overall Study|Protocol Violation|0|||
27964330|NCT00818662|54621927|FG003|Overall Study|Protocol Violation|0|||
27964331|NCT00818662|54621924|FG000|Overall Study|Requires a Prohibited Medication|1|||
27964332|NCT00818662|54621925|FG001|Overall Study|Requires a Prohibited Medication|0|||
27964333|NCT00818662|54621926|FG002|Overall Study|Requires a Prohibited Medication|0|||
27964334|NCT00818662|54621927|FG003|Overall Study|Requires a Prohibited Medication|0|||
27964335|NCT00818662|54621924|FG000|Overall Study|Safety Risk|1|||
27964336|NCT00818662|54621925|FG001|Overall Study|Safety Risk|1|||
27964337|NCT00818662|54621926|FG002|Overall Study|Safety Risk|0|||
27964338|NCT00818662|54621927|FG003|Overall Study|Safety Risk|1|||
27964339|NCT00818662|54621924|FG000|Overall Study|Study Partner Unwilling or Unable|3|||
27964340|NCT00818662|54621925|FG001|Overall Study|Study Partner Unwilling or Unable|2|||
27964341|NCT00818662|54621926|FG002|Overall Study|Study Partner Unwilling or Unable|1|||
27964342|NCT00818662|54621927|FG003|Overall Study|Study Partner Unwilling or Unable|1|||
27964343|NCT00818662|54621924|FG000|Overall Study|Participant's health declined|0|||
27964344|NCT00818662|54621925|FG001|Overall Study|Participant's health declined|0|||
27964345|NCT00818662|54621926|FG002|Overall Study|Participant's health declined|0|||
27964346|NCT00818662|54621927|FG003|Overall Study|Participant's health declined|1|||
27964347|NCT00818662|54621924|FG000|Overall Study|Caregiver to pursue other treatment|0|||
27964348|NCT00818662|54621925|FG001|Overall Study|Caregiver to pursue other treatment|1|||
27964349|NCT00818662|54621926|FG002|Overall Study|Caregiver to pursue other treatment|0|||
27964350|NCT00818662|54621927|FG003|Overall Study|Caregiver to pursue other treatment|0|||
28082973|NCT03449446|54736914|FG001|Overall Study|Adverse Event|2|||
28082974|NCT03449446|54736915|FG002|Overall Study|Adverse Event|1|||
27732585|NCT02630459|54180136|FG000|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1|||
27964351|NCT00818662|54621924|FG000|Overall Study|Moving out of state|0|||
28082975|NCT03449446|54736916|FG003|Overall Study|Adverse Event|0|||
28082976|NCT03449446|54736917|FG004|Overall Study|Adverse Event|0|||
27855170|NCT03006926|54375556|FG000|Overall Study|Withdrawal by Subject|0|||
27964352|NCT00818662|54621925|FG001|Overall Study|Moving out of state|0|||
28082977|NCT03449446|54736918|FG005|Overall Study|Adverse Event|2|||
27964353|NCT00818662|54621926|FG002|Overall Study|Moving out of state|0|||
27964354|NCT00818662|54621927|FG003|Overall Study|Moving out of state|1|||
27964355|NCT00818662|54621924|FG000|Overall Study|Declined move to another study site|1|||
27964356|NCT00818662|54621925|FG001|Overall Study|Declined move to another study site|0|||
27964357|NCT00818662|54621926|FG002|Overall Study|Declined move to another study site|0|||
27964358|NCT00818662|54621927|FG003|Overall Study|Declined move to another study site|0|||
27964359|NCT00818662|54621924|FG000|Overall Study|Change in living situation|0|||
27964360|NCT00818662|54621925|FG001|Overall Study|Change in living situation|0|||
28082978|NCT03449446|54736919|FG006|Overall Study|Adverse Event|0|||
28082979|NCT03449446|54736913|FG000|Overall Study|Lost to Follow-up|0|||
28082980|NCT03449446|54736914|FG001|Overall Study|Lost to Follow-up|0|||
28082981|NCT03449446|54736915|FG002|Overall Study|Lost to Follow-up|2|||
28082982|NCT03449446|54736916|FG003|Overall Study|Lost to Follow-up|1|||
28082983|NCT03449446|54736917|FG004|Overall Study|Lost to Follow-up|3|||
28082984|NCT03449446|54736918|FG005|Overall Study|Lost to Follow-up|0|||
28082985|NCT03449446|54736919|FG006|Overall Study|Lost to Follow-up|0|||
28082986|NCT03449446|54736913|FG000|Overall Study|Investigator's Discretion|0|||
28082987|NCT03449446|54736914|FG001|Overall Study|Investigator's Discretion|1|||
28082988|NCT03449446|54736915|FG002|Overall Study|Investigator's Discretion|1|||
28082989|NCT03449446|54736916|FG003|Overall Study|Investigator's Discretion|2|||
28082990|NCT03449446|54736917|FG004|Overall Study|Investigator's Discretion|0|||
28082991|NCT03449446|54736918|FG005|Overall Study|Investigator's Discretion|0|||
28082992|NCT03449446|54736919|FG006|Overall Study|Investigator's Discretion|0|||
28165170|NCT03016325|54835757|FG004|182-Day Follow-Up Period|Alive, per Family doctor|1|||
27832508|NCT01760447|54311795|FG003|Weeks 0-20|Randomized but not treated|0|||
27832509|NCT01760447|54311792|FG000|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
27964361|NCT00818662|54621926|FG002|Overall Study|Change in living situation|0|||
27964362|NCT00818662|54621927|FG003|Overall Study|Change in living situation|1|||
27964363|NCT00818662|54621924|FG000|Overall Study|Study partner decision|0|||
27964364|NCT00818662|54621925|FG001|Overall Study|Study partner decision|0|||
27964365|NCT00818662|54621926|FG002|Overall Study|Study partner decision|0|||
27964366|NCT00818662|54621927|FG003|Overall Study|Study partner decision|1|||
27964367|NCT00818662|54621924|FG000|Overall Study|Admitted to long term nursing care|0|||
27964368|NCT00818662|54621925|FG001|Overall Study|Admitted to long term nursing care|1|||
27964369|NCT00818662|54621926|FG002|Overall Study|Admitted to long term nursing care|0|||
27964370|NCT00818662|54621927|FG003|Overall Study|Admitted to long term nursing care|0|||
27964371|NCT00903786|54621938|FG000|Overall Study|Physician Decision|6|||
27964372|NCT00903786|54621938|FG000|Overall Study|Lack of Efficacy|5|||
27964373|NCT00903786|54621938|FG000|Overall Study|Reason other than lack of efficacy|4|||
27964374|NCT00762073|54621947|FG000|Overall Study|Lack of Efficacy|1|||
27832510|NCT01760447|54311793|FG001|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
27832511|NCT01760447|54311794|FG002|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
27964375|NCT00762073|54621948|FG001|Overall Study|Lack of Efficacy|1|||
27964376|NCT00762073|54621949|FG002|Overall Study|Lack of Efficacy|0|||
27964377|NCT00762073|54621950|FG003|Overall Study|Lack of Efficacy|0|||
27964378|NCT00762073|54621947|FG000|Overall Study|Adverse Event|1|||
27964379|NCT00762073|54621948|FG001|Overall Study|Adverse Event|0|||
27964380|NCT00762073|54621949|FG002|Overall Study|Adverse Event|1|||
27964381|NCT00762073|54621950|FG003|Overall Study|Adverse Event|1|||
27964382|NCT00762073|54621947|FG000|Overall Study|Significant Subject Noncompliance|0|||
27964383|NCT00762073|54621948|FG001|Overall Study|Significant Subject Noncompliance|1|||
27964384|NCT00762073|54621949|FG002|Overall Study|Significant Subject Noncompliance|0|||
27964385|NCT00762073|54621950|FG003|Overall Study|Significant Subject Noncompliance|1|||
27964386|NCT00762073|54621947|FG000|Overall Study|Withdrawal by Subject|1|||
27964387|NCT00762073|54621948|FG001|Overall Study|Withdrawal by Subject|2|||
27964388|NCT00762073|54621949|FG002|Overall Study|Withdrawal by Subject|1|||
27964389|NCT00762073|54621950|FG003|Overall Study|Withdrawal by Subject|1|||
27964390|NCT00762073|54621947|FG000|Overall Study|Not on treatment for >/= 77 days|1|||
27964391|NCT00762073|54621948|FG001|Overall Study|Not on treatment for >/= 77 days|0|||
27964392|NCT00762073|54621949|FG002|Overall Study|Not on treatment for >/= 77 days|0|||
27964393|NCT00762073|54621950|FG003|Overall Study|Not on treatment for >/= 77 days|0|||
27964394|NCT00761761|54621969|FG000|Overall Study|Lost to Follow-up|3|||
27964395|NCT00761761|54621970|FG001|Overall Study|Lost to Follow-up|1|||
27964396|NCT00761761|54621969|FG000|Overall Study|Withdrawal by Subject|3|||
27964397|NCT00761761|54621970|FG001|Overall Study|Withdrawal by Subject|0|||
27964398|NCT00761605|54621978|FG000|Overall Study|Adverse Event|26|||
27964399|NCT00761605|54621978|FG000|Overall Study|Death|2|||
27964400|NCT00761605|54621978|FG000|Overall Study|Lack of Efficacy|26|||
27964401|NCT00761605|54621978|FG000|Overall Study|Lost to Follow-up|29|||
27964402|NCT00761605|54621978|FG000|Overall Study|Withdrawal by Subject|37|||
27964403|NCT00761605|54621978|FG000|Overall Study|Other|21|||
27964404|NCT00761527|54621986|FG000|Overall Study|Adverse Event|3|||
27964405|NCT00761527|54621986|FG000|Overall Study|Poor Compliance|8|||
27964406|NCT00761527|54621986|FG000|Overall Study|Lost to Follow-up|9|||
27964407|NCT00761527|54621986|FG000|Overall Study|Unknown reason|2|||
28082993|NCT03449446|54736913|FG000|Overall Study|Non Compliance with Study Drug|1|||
27964408|NCT00770029|54621992|FG000|Overall Study|Lost to Follow-up|2|||
27964409|NCT00770029|54621993|FG001|Overall Study|Lost to Follow-up|0|||
27964410|NCT00770029|54621992|FG000|Overall Study|Withdrawal by Subject|3|||
27964411|NCT00770029|54621993|FG001|Overall Study|Withdrawal by Subject|3|||
27964412|NCT00770029|54621992|FG000|Overall Study|Adverse Event|1|||
27964413|NCT00770029|54621993|FG001|Overall Study|Adverse Event|0|||
27964414|NCT00817414|54622004|FG000|Overall Study|Adverse Event|1|||
28082994|NCT03449446|54736914|FG001|Overall Study|Non Compliance with Study Drug|0|||
28082995|NCT03449446|54736915|FG002|Overall Study|Non Compliance with Study Drug|0|||
27964415|NCT00817414|54622005|FG001|Overall Study|Adverse Event|1|||
27964416|NCT00817414|54622006|FG002|Overall Study|Adverse Event|1|||
27964417|NCT00817414|54622007|FG003|Overall Study|Adverse Event|0|||
27964418|NCT00817414|54622008|FG004|Overall Study|Adverse Event|0|||
27964419|NCT00817414|54622004|FG000|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
27964420|NCT00817414|54622005|FG001|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|1|||
27964421|NCT00817414|54622006|FG002|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|2|||
27964422|NCT00817414|54622007|FG003|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|4|||
27964423|NCT00817414|54622008|FG004|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
27964424|NCT00817414|54622004|FG000|Overall Study|Withdrawal by Subject|1|||
27964425|NCT00817414|54622005|FG001|Overall Study|Withdrawal by Subject|1|||
27964426|NCT00817414|54622006|FG002|Overall Study|Withdrawal by Subject|0|||
27964427|NCT00817414|54622007|FG003|Overall Study|Withdrawal by Subject|0|||
27964428|NCT00817414|54622008|FG004|Overall Study|Withdrawal by Subject|0|||
27964429|NCT00817414|54622004|FG000|Overall Study|Lost to Follow-up|0|||
27964430|NCT00817414|54622005|FG001|Overall Study|Lost to Follow-up|0|||
27964431|NCT00817414|54622006|FG002|Overall Study|Lost to Follow-up|1|||
27964432|NCT00817414|54622007|FG003|Overall Study|Lost to Follow-up|1|||
27964433|NCT00817414|54622008|FG004|Overall Study|Lost to Follow-up|1|||
27964434|NCT00817414|54622004|FG000|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
27964435|NCT00817414|54622005|FG001|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
27964436|NCT00817414|54622006|FG002|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
27964437|NCT00817414|54622007|FG003|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|7|||
27964438|NCT00817414|54622008|FG004|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
27964439|NCT00817414|54622004|FG000|Overall Study|Protocol Violation|0|||
27964440|NCT00817414|54622005|FG001|Overall Study|Protocol Violation|0|||
27964441|NCT00817414|54622006|FG002|Overall Study|Protocol Violation|0|||
27964442|NCT00817414|54622007|FG003|Overall Study|Protocol Violation|0|||
27964443|NCT00817414|54622008|FG004|Overall Study|Protocol Violation|1|||
27964444|NCT00769561|54622027|FG000|Overall Study|Withdrawal by Subject|2|||
27964445|NCT00769561|54622028|FG001|Overall Study|Withdrawal by Subject|2|||
27964446|NCT00769561|54622027|FG000|Overall Study|Lost to Follow-up|1|||
27964447|NCT00769561|54622028|FG001|Overall Study|Lost to Follow-up|3|||
27964448|NCT00817336|54622036|FG000|Overall Study|Withdrawal by Subject|1|||
27964449|NCT00817336|54622037|FG001|Overall Study|Withdrawal by Subject|1|||
27964450|NCT00761215|54622045|FG000|Overall Study|Randomized but didn't receive drug|1|||
28082996|NCT03449446|54736916|FG003|Overall Study|Non Compliance with Study Drug|0|||
28082997|NCT03449446|54736917|FG004|Overall Study|Non Compliance with Study Drug|0|||
28082998|NCT03449446|54736918|FG005|Overall Study|Non Compliance with Study Drug|0|||
28082999|NCT03449446|54736919|FG006|Overall Study|Non Compliance with Study Drug|0|||
28083000|NCT03449446|54736913|FG000|Overall Study|Protocol Violation|0|||
28083001|NCT03449446|54736914|FG001|Overall Study|Protocol Violation|0|||
28083002|NCT03449446|54736915|FG002|Overall Study|Protocol Violation|0|||
28083003|NCT03449446|54736916|FG003|Overall Study|Protocol Violation|0|||
28083004|NCT03449446|54736917|FG004|Overall Study|Protocol Violation|1|||
28083005|NCT03449446|54736918|FG005|Overall Study|Protocol Violation|1|||
28083006|NCT03449446|54736919|FG006|Overall Study|Protocol Violation|0|||
28083007|NCT03449446|54736913|FG000|Overall Study|Death|0|||
28083008|NCT03449446|54736914|FG001|Overall Study|Death|0|||
28083009|NCT03449446|54736915|FG002|Overall Study|Death|0|||
28083010|NCT03449446|54736916|FG003|Overall Study|Death|0|||
28083011|NCT03449446|54736917|FG004|Overall Study|Death|1|||
28083012|NCT03449446|54736918|FG005|Overall Study|Death|0|||
28083013|NCT03449446|54736919|FG006|Overall Study|Death|0|||
28083014|NCT03449134|54736938|FG000|52-Week Treatment Period|Death|2|||
28083015|NCT03449134|54736939|FG001|52-Week Treatment Period|Death|1|||
28083016|NCT03449134|54736940|FG002|52-Week Treatment Period|Death|0|||
28083017|NCT03449134|54736938|FG000|52-Week Treatment Period|Lost to Follow-up|2|||
28083018|NCT03449134|54736939|FG001|52-Week Treatment Period|Lost to Follow-up|1|||
28083019|NCT03449134|54736940|FG002|52-Week Treatment Period|Lost to Follow-up|1|||
28083020|NCT03449134|54736938|FG000|52-Week Treatment Period|Physician Decision|2|||
28083021|NCT03449134|54736939|FG001|52-Week Treatment Period|Physician Decision|3|||
28083022|NCT03449134|54736940|FG002|52-Week Treatment Period|Physician Decision|3|||
28083023|NCT03449134|54736938|FG000|52-Week Treatment Period|Screen Failure|1|||
27855171|NCT03006926|54375557|FG001|Overall Study|Withdrawal by Subject|2|||
28083024|NCT03449134|54736939|FG001|52-Week Treatment Period|Screen Failure|0|||
28083025|NCT03449134|54736940|FG002|52-Week Treatment Period|Screen Failure|1|||
27964451|NCT00761215|54622046|FG001|Overall Study|Randomized but didn't receive drug|1|||
27964452|NCT00761215|54622047|FG002|Overall Study|Randomized but didn't receive drug|2|||
27964453|NCT00761215|54622045|FG000|Overall Study|Lost to Follow-up|6|||
27964454|NCT00761215|54622046|FG001|Overall Study|Lost to Follow-up|3|||
27964455|NCT00761215|54622047|FG002|Overall Study|Lost to Follow-up|6|||
27964456|NCT00761215|54622045|FG000|Overall Study|Withdrawal by Subject|1|||
28083026|NCT03449134|54736938|FG000|52-Week Treatment Period|Withdrawal by Subject|37|||
28083027|NCT03449134|54736939|FG001|52-Week Treatment Period|Withdrawal by Subject|39|||
28083028|NCT03449134|54736940|FG002|52-Week Treatment Period|Withdrawal by Subject|55|||
28083029|NCT03449134|54736938|FG000|52-Week Treatment Period|Site Closure|1|||
28083030|NCT03449134|54736939|FG001|52-Week Treatment Period|Site Closure|0|||
28083031|NCT03449134|54736940|FG002|52-Week Treatment Period|Site Closure|0|||
28083032|NCT03529162|54736953|FG000|Overall Study|Lost to Follow-up|2|||
28083033|NCT03529162|54736954|FG001|Overall Study|Lost to Follow-up|2|||
28083034|NCT03447730|54736965|FG000|Overall Study|Adverse Event|0|||
28083035|NCT03447730|54736966|FG001|Overall Study|Adverse Event|2|||
28083036|NCT03447730|54736967|FG002|Overall Study|Adverse Event|0|||
28083037|NCT03429556|54736979|FG000|Overall Study|Lost to Follow-up|0|||
28083038|NCT03429556|54736980|FG001|Overall Study|Lost to Follow-up|1|||
28083039|NCT03429556|54736981|FG002|Overall Study|Lost to Follow-up|0|||
28083040|NCT03429556|54736982|FG003|Overall Study|Lost to Follow-up|0|||
28083041|NCT03428152|54736994|FG000|Overall Study|Physician Decision|4|||
28083042|NCT03428152|54736995|FG001|Overall Study|Physician Decision|2|||
28083043|NCT03428152|54736994|FG000|Overall Study|Protocol Violation|3|||
28083044|NCT03428152|54736995|FG001|Overall Study|Protocol Violation|5|||
28083045|NCT03428152|54736994|FG000|Overall Study|Lack of Efficacy|0|||
28083046|NCT03428152|54736995|FG001|Overall Study|Lack of Efficacy|4|||
28083047|NCT03444766|54737001|FG000|Overall Study|Other Reasons|2|||
28083048|NCT03444766|54737001|FG000|Overall Study|Participant Withdrew Consent|5|||
28083049|NCT03444766|54737001|FG000|Overall Study|Lost to Follow-up|2|||
28083050|NCT03444766|54737001|FG000|Overall Study|Death|2|||
28083051|NCT03444766|54737001|FG000|Overall Study|Adverse Event Unrelated to Study Drug|6|||
28083052|NCT03444766|54737001|FG000|Overall Study|Disease Progression|49|||
28083053|NCT03426436|54737005|FG000|Overall Study|Incorrect lead placement|12|||
28083054|NCT03426436|54737005|FG000|Overall Study|Withdrawal by Subject|2|||
28083055|NCT03426436|54737005|FG000|Overall Study|Consent issue|1|||
28083056|NCT03426436|54737005|FG000|Overall Study|ECGs not saved|4|||
28083057|NCT03425188|54737009|FG000|Overall Study|Withdrawal by Subject|1|||
28083058|NCT03423238|54737016|FG000|Overall Study|Lost to Follow-up|1|||
28083059|NCT03423238|54737017|FG001|Overall Study|Lost to Follow-up|0|||
28083060|NCT03423238|54737016|FG000|Overall Study|Withdrawal by Subject|1|||
28083061|NCT03423238|54737017|FG001|Overall Study|Withdrawal by Subject|0|||
28083062|NCT02953678|54737024|FG000|Overall Study|Adverse Event|20|||
28083063|NCT02953678|54737024|FG000|Overall Study|Death|7|||
28083064|NCT02953678|54737024|FG000|Overall Study|Physician Decision|23|||
28083065|NCT02953678|54737024|FG000|Overall Study|Progressive Disease of GVHD|7|||
28083066|NCT02953678|54737024|FG000|Overall Study|Relapse of Underlying Malignancy|3|||
28083067|NCT02953678|54737024|FG000|Overall Study|Withdrawal by participant|3|||
28083068|NCT02953678|54737024|FG000|Overall Study|Includes 2 participants who discontinued ruxolitinib treatment because of clinical improvement|5|||
28083069|NCT02953678|54737024|FG000|Overall Study|Participants were transferred to commercial product.|3|||
28083070|NCT03412084|54737031|FG000|Overall Study|Withdrawal by Subject|2|||
28083071|NCT03412084|54737032|FG001|Overall Study|Withdrawal by Subject|0|||
28083072|NCT03412084|54737031|FG000|Overall Study|Participant moved|1|||
28083073|NCT03412084|54737032|FG001|Overall Study|Participant moved|0|||
28083074|NCT03412084|54737031|FG000|Overall Study|Lost to Follow-up|1|||
28083075|NCT03412084|54737032|FG001|Overall Study|Lost to Follow-up|1|||
28083076|NCT00090753|54737040|FG000|First Treatment Period|Adverse Event|20|||
28083077|NCT00090753|54737041|FG001|First Treatment Period|Adverse Event|8|||
28083078|NCT00090753|54737040|FG000|First Treatment Period|Death|88|||
28083079|NCT00090753|54737041|FG001|First Treatment Period|Death|62|||
28083080|NCT00090753|54737040|FG000|First Treatment Period|Lack of Efficacy|2|||
28083081|NCT00090753|54737041|FG001|First Treatment Period|Lack of Efficacy|1|||
28083082|NCT00090753|54737040|FG000|First Treatment Period|Refused Treatment|32|||
28083083|NCT00090753|54737041|FG001|First Treatment Period|Refused Treatment|25|||
28083084|NCT00090753|54737040|FG000|First Treatment Period|Lost to Follow-up|4|||
28083085|NCT00090753|54737041|FG001|First Treatment Period|Lost to Follow-up|4|||
28083086|NCT00090753|54737040|FG000|First Treatment Period|Renal Transplant|70|||
28083087|NCT00090753|54737041|FG001|First Treatment Period|Renal Transplant|50|||
28083088|NCT00090753|54737040|FG000|First Treatment Period|Mircera Commercialization|1|||
28083089|NCT00090753|54737041|FG001|First Treatment Period|Mircera Commercialization|0|||
28083090|NCT00090753|54737040|FG000|First Treatment Period|Other Unrelated to Safety and Efficacy|39|||
28083091|NCT00090753|54737041|FG001|First Treatment Period|Other Unrelated to Safety and Efficacy|28|||
28083092|NCT00090753|54737040|FG000|Extended Treatment Period|Adverse Event|11|||
28083093|NCT00090753|54737041|FG001|Extended Treatment Period|Adverse Event|0|||
28083094|NCT00090753|54737040|FG000|Extended Treatment Period|Death|58|||
28083095|NCT00090753|54737041|FG001|Extended Treatment Period|Death|30|||
28083096|NCT00090753|54737040|FG000|Extended Treatment Period|Lack of Efficacy|1|||
28083097|NCT00090753|54737041|FG001|Extended Treatment Period|Lack of Efficacy|0|||
28083098|NCT00090753|54737040|FG000|Extended Treatment Period|Refused Treatment|18|||
28083099|NCT00090753|54737041|FG001|Extended Treatment Period|Refused Treatment|12|||
28083100|NCT00090753|54737040|FG000|Extended Treatment Period|Lost to Follow-up|3|||
28083101|NCT00090753|54737041|FG001|Extended Treatment Period|Lost to Follow-up|1|||
28083102|NCT00090753|54737040|FG000|Extended Treatment Period|Renal Transplant|15|||
28083103|NCT00090753|54737041|FG001|Extended Treatment Period|Renal Transplant|12|||
28083104|NCT00090753|54737040|FG000|Extended Treatment Period|Mircera Commercialization|188|||
28083105|NCT00090753|54737041|FG001|Extended Treatment Period|Mircera Commercialization|93|||
28083106|NCT00090753|54737040|FG000|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65|||
28083107|NCT00090753|54737041|FG001|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43|||
28083108|NCT00048932|54737049|FG000|Double Blind Period (DB)|Administrative Reason By Sponsor|1|||
28083109|NCT00048932|54737050|FG001|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
28083110|NCT00048932|54737051|FG002|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
28083111|NCT00048932|54737049|FG000|Double Blind Period (DB)|Adverse Event|51|||
28083112|NCT00048932|54737050|FG001|Double Blind Period (DB)|Adverse Event|19|||
28083113|NCT00048932|54737051|FG002|Double Blind Period (DB)|Adverse Event|0|||
28083114|NCT00048932|54737049|FG000|Double Blind Period (DB)|Death|5|||
28083115|NCT00048932|54737050|FG001|Double Blind Period (DB)|Death|3|||
28083116|NCT00048932|54737051|FG002|Double Blind Period (DB)|Death|0|||
28083117|NCT00048932|54737049|FG000|Double Blind Period (DB)|Lack of Efficacy|26|||
28083118|NCT00048932|54737050|FG001|Double Blind Period (DB)|Lack of Efficacy|44|||
28083119|NCT00048932|54737051|FG002|Double Blind Period (DB)|Lack of Efficacy|0|||
28083120|NCT00048932|54737049|FG000|Double Blind Period (DB)|Lost to Follow-up|3|||
28083121|NCT00048932|54737050|FG001|Double Blind Period (DB)|Lost to Follow-up|4|||
28083122|NCT00048932|54737051|FG002|Double Blind Period (DB)|Lost to Follow-up|0|||
28083123|NCT00048932|54737049|FG000|Double Blind Period (DB)|Relocation|1|||
28083124|NCT00048932|54737050|FG001|Double Blind Period (DB)|Relocation|0|||
28083125|NCT00048932|54737051|FG002|Double Blind Period (DB)|Relocation|0|||
28083126|NCT00048932|54737049|FG000|Double Blind Period (DB)|Uncontrolled hypertension|0|||
28083127|NCT00048932|54737050|FG001|Double Blind Period (DB)|Uncontrolled hypertension|1|||
28083128|NCT00048932|54737051|FG002|Double Blind Period (DB)|Uncontrolled hypertension|0|||
28083129|NCT00048932|54737049|FG000|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1|||
28083130|NCT00048932|54737050|FG001|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
28083131|NCT00048932|54737051|FG002|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
28083132|NCT00048932|54737049|FG000|Double Blind Period (DB)|Pregnancy|1|||
28083133|NCT00048932|54737050|FG001|Double Blind Period (DB)|Pregnancy|0|||
28083134|NCT00048932|54737051|FG002|Double Blind Period (DB)|Pregnancy|0|||
28083135|NCT00048932|54737049|FG000|Double Blind Period (DB)|No Longer Meets Study Criteria|8|||
28083136|NCT00048932|54737050|FG001|Double Blind Period (DB)|No Longer Meets Study Criteria|2|||
28083137|NCT00048932|54737051|FG002|Double Blind Period (DB)|No Longer Meets Study Criteria|0|||
28083138|NCT00048932|54737049|FG000|Double Blind Period (DB)|Withdrawal by Subject|24|||
28083139|NCT00048932|54737050|FG001|Double Blind Period (DB)|Withdrawal by Subject|10|||
28083140|NCT00048932|54737051|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
28083141|NCT00048932|54737049|FG000|Double Blind Period (DB)|Poor/Non-Compliance|2|||
28083142|NCT00048932|54737050|FG001|Double Blind Period (DB)|Poor/Non-Compliance|4|||
28083143|NCT00048932|54737051|FG002|Double Blind Period (DB)|Poor/Non-Compliance|0|||
28083144|NCT00048932|54737049|FG000|Open Label Period (OL)|Death|0|||
28083145|NCT00048932|54737050|FG001|Open Label Period (OL)|Death|0|||
28083146|NCT00048932|54737051|FG002|Open Label Period (OL)|Death|25|||
28083147|NCT00048932|54737049|FG000|Open Label Period (OL)|Adverse Event|0|||
27964457|NCT00761215|54622046|FG001|Overall Study|Withdrawal by Subject|0|||
27964458|NCT00761215|54622047|FG002|Overall Study|Withdrawal by Subject|0|||
27964459|NCT00761215|54622045|FG000|Overall Study|Bacteremia|1|||
27964460|NCT00761215|54622046|FG001|Overall Study|Bacteremia|0|||
27964461|NCT00761215|54622047|FG002|Overall Study|Bacteremia|0|||
27964462|NCT05101122|54622080|FG000|Atomoxetine Only|Withdrawal by Subject|1|||
27964463|NCT05101122|54622080|FG000|AD313 40/2.5|Withdrawal by Subject|2|||
27964464|NCT05101122|54622080|FG000|AD313 80/5|Withdrawal by Subject|1|||
27964465|NCT05101122|54622080|FG000|AD313 80/10|Physician Decision|1|||
27964466|NCT05038163|54622102|FG000|Stage 1|Did not complete survey|374|||
27964467|NCT05038163|54622103|FG001|Stage 1|Did not complete survey|0|||
27964468|NCT05038163|54622104|FG002|Stage 1|Did not complete survey|0|||
27964469|NCT05038163|54622105|FG003|Stage 1|Did not complete survey|0|||
27964470|NCT05038163|54622106|FG004|Stage 1|Did not complete survey|0|||
27964471|NCT05038163|54622107|FG005|Stage 1|Did not complete survey|0|||
27964472|NCT05038163|54622102|FG000|Stage 2|Did not complete Stage 2 survey|0|||
27964473|NCT05038163|54622103|FG001|Stage 2|Did not complete Stage 2 survey|29|||
28083148|NCT00048932|54737050|FG001|Open Label Period (OL)|Adverse Event|0|||
28083149|NCT00048932|54737051|FG002|Open Label Period (OL)|Adverse Event|103|||
28083150|NCT00048932|54737049|FG000|Open Label Period (OL)|Lack of Efficacy|0|||
28083151|NCT00048932|54737050|FG001|Open Label Period (OL)|Lack of Efficacy|0|||
28083152|NCT00048932|54737051|FG002|Open Label Period (OL)|Lack of Efficacy|81|||
28083153|NCT00048932|54737049|FG000|Open Label Period (OL)|Lost to Follow-up|0|||
27964474|NCT05038163|54622104|FG002|Stage 2|Did not complete Stage 2 survey|30|||
27964475|NCT05038163|54622105|FG003|Stage 2|Did not complete Stage 2 survey|24|||
27964476|NCT05038163|54622106|FG004|Stage 2|Did not complete Stage 2 survey|21|||
27964477|NCT05038163|54622107|FG005|Stage 2|Did not complete Stage 2 survey|100|||
27964478|NCT04516746|54622135|FG000|Overall Study|Ongoing in the study at clinical DCO for the primary analysis.|21090|||
27964479|NCT04516746|54622136|FG001|Overall Study|Ongoing in the study at clinical DCO for the primary analysis.|10305|||
27964480|NCT04516746|54622135|FG000|Overall Study|Withdrawal by Subject|362|||
27964481|NCT04516746|54622136|FG001|Overall Study|Withdrawal by Subject|408|||
27964482|NCT04516746|54622135|FG000|Overall Study|Lost to Follow-up|157|||
27964483|NCT04516746|54622136|FG001|Overall Study|Lost to Follow-up|86|||
27964484|NCT04516746|54622135|FG000|Overall Study|Protocol deviation|18|||
27964485|NCT04516746|54622136|FG001|Overall Study|Protocol deviation|7|||
27964486|NCT04516746|54622135|FG000|Overall Study|Death|8|||
27964487|NCT04516746|54622136|FG001|Overall Study|Death|7|||
27964488|NCT04516746|54622135|FG000|Overall Study|Physician Decision|0|||
27964489|NCT04516746|54622136|FG001|Overall Study|Physician Decision|2|||
27964490|NCT04516746|54622135|FG000|Overall Study|Other|0|||
27964491|NCT04516746|54622136|FG001|Overall Study|Other|1|||
27964492|NCT04413617|54622166|FG000|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
27964493|NCT04413617|54622167|FG001|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
27964494|NCT04413617|54622168|FG002|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
27964495|NCT04413617|54622169|FG003|Overall Study|Refused to come for FU visit and was contacted by phone|1|||
27964496|NCT04413617|54622170|FG004|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
27964497|NCT04413617|54622166|FG000|Overall Study|Protocol Violation|0|||
27964498|NCT04413617|54622167|FG001|Overall Study|Protocol Violation|1|||
27964499|NCT04413617|54622168|FG002|Overall Study|Protocol Violation|0|||
27964500|NCT04413617|54622169|FG003|Overall Study|Protocol Violation|0|||
27964501|NCT04413617|54622170|FG004|Overall Study|Protocol Violation|1|||
27964502|NCT04413617|54622166|FG000|Overall Study|Lack of Efficacy|2|||
27964503|NCT04413617|54622167|FG001|Overall Study|Lack of Efficacy|0|||
27964504|NCT04413617|54622168|FG002|Overall Study|Lack of Efficacy|2|||
27964505|NCT04413617|54622169|FG003|Overall Study|Lack of Efficacy|1|||
27964506|NCT04413617|54622170|FG004|Overall Study|Lack of Efficacy|0|||
27964507|NCT04413617|54622166|FG000|Overall Study|Withdrawal by Subject|3|||
27964508|NCT04413617|54622167|FG001|Overall Study|Withdrawal by Subject|4|||
27964509|NCT04413617|54622168|FG002|Overall Study|Withdrawal by Subject|2|||
27964510|NCT04413617|54622169|FG003|Overall Study|Withdrawal by Subject|5|||
27964511|NCT04413617|54622170|FG004|Overall Study|Withdrawal by Subject|3|||
27964512|NCT04413617|54622166|FG000|Overall Study|Death|1|||
27964513|NCT04413617|54622167|FG001|Overall Study|Death|0|||
27964514|NCT04413617|54622168|FG002|Overall Study|Death|0|||
27964515|NCT04413617|54622169|FG003|Overall Study|Death|0|||
27964516|NCT04413617|54622170|FG004|Overall Study|Death|0|||
27964517|NCT04413617|54622166|FG000|Overall Study|Adverse Event|1|||
27964518|NCT04413617|54622167|FG001|Overall Study|Adverse Event|0|||
27964519|NCT04413617|54622168|FG002|Overall Study|Adverse Event|0|||
27964520|NCT04413617|54622169|FG003|Overall Study|Adverse Event|1|||
27964521|NCT04413617|54622170|FG004|Overall Study|Adverse Event|1|||
27964522|NCT04413617|54622166|FG000|Overall Study|COVID-19|0|||
27964523|NCT04413617|54622167|FG001|Overall Study|COVID-19|1|||
27964524|NCT04413617|54622168|FG002|Overall Study|COVID-19|0|||
27964525|NCT04413617|54622169|FG003|Overall Study|COVID-19|0|||
27964526|NCT04413617|54622170|FG004|Overall Study|COVID-19|0|||
27964527|NCT04055116|54622206|FG000|First Intervention|Physician Decision|2|||
27964528|NCT04055116|54622207|FG001|First Intervention|Physician Decision|7|||
27964529|NCT03512262|54622257|FG000|Overall Study|Adverse Event|8|||
27964530|NCT03512262|54622258|FG001|Overall Study|Adverse Event|3|||
27964531|NCT03512262|54622257|FG000|Overall Study|Death (non-treatment emergent)|1|||
27964532|NCT03512262|54622258|FG001|Overall Study|Death (non-treatment emergent)|0|||
27732586|NCT02630459|54180137|FG001|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
27732587|NCT02630459|54180138|FG002|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
27732588|NCT02630459|54180139|FG003|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
27732589|NCT02630459|54180140|FG004|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
27732590|NCT02630459|54180141|FG005|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
27732591|NCT02630459|54180142|FG006|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
27732592|NCT02630459|54180143|FG007|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
27732593|NCT02630459|54180136|FG000|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
27732594|NCT02630459|54180137|FG001|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
27964533|NCT03512262|54622257|FG000|Overall Study|Withdrawal by Subject|17|||
27964534|NCT03512262|54622258|FG001|Overall Study|Withdrawal by Subject|9|||
27964535|NCT03512262|54622257|FG000|Overall Study|Lost to Follow-up|7|||
27964536|NCT03512262|54622258|FG001|Overall Study|Lost to Follow-up|1|||
27964537|NCT03512262|54622257|FG000|Overall Study|Other than Specified|2|||
27964538|NCT03512262|54622258|FG001|Overall Study|Other than Specified|2|||
27964539|NCT03499600|54622266|FG000|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|21|||
27964540|NCT03499600|54622267|FG001|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|30|||
27964541|NCT03007979|54622281|FG000|Overall Study|Deemed not eligible prior to starting palbociclib|1|||
27964542|NCT02960893|54622287|FG000|Randomization Phase (8-week)|Adverse Event|5|||
27732595|NCT02630459|54180138|FG002|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
27732596|NCT02630459|54180139|FG003|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
27732597|NCT02630459|54180140|FG004|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4|||
27732598|NCT02630459|54180141|FG005|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1|||
27732599|NCT02630459|54180142|FG006|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
27732600|NCT02630459|54180143|FG007|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
27732601|NCT02630459|54180136|FG000|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
27732602|NCT02630459|54180137|FG001|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
27732603|NCT02630459|54180138|FG002|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
27732604|NCT02630459|54180139|FG003|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
27964543|NCT02960893|54622288|FG001|Randomization Phase (8-week)|Adverse Event|0|||
27964544|NCT02960893|54622287|FG000|Randomization Phase (8-week)|Withdrawal by Subject|2|||
27964545|NCT02960893|54622288|FG001|Randomization Phase (8-week)|Withdrawal by Subject|1|||
27964546|NCT02960893|54622287|FG000|Randomization Phase (8-week)|Reason Not Specified|0|||
27964547|NCT02960893|54622288|FG001|Randomization Phase (8-week)|Reason Not Specified|1|||
27964548|NCT02960893|54622287|FG000|Extension Phase (48-week)|Adverse Event|2|||
27964549|NCT02960893|54622288|FG001|Extension Phase (48-week)|Adverse Event|3|||
27964550|NCT02960893|54622287|FG000|Extension Phase (48-week)|Withdrawal by Subject|8|||
27964551|NCT02960893|54622288|FG001|Extension Phase (48-week)|Withdrawal by Subject|8|||
27964552|NCT02960893|54622287|FG000|Extension Phase (48-week)|Other Reason|2|||
27964553|NCT02960893|54622288|FG001|Extension Phase (48-week)|Other Reason|1|||
27964554|NCT02960893|54622287|FG000|Extension Phase (48-week)|Lost to Follow-up|1|||
27964555|NCT02960893|54622288|FG001|Extension Phase (48-week)|Lost to Follow-up|1|||
27964556|NCT02960893|54622287|FG000|Extension Phase (48-week)|Sponsors Decision|1|||
27964557|NCT02960893|54622288|FG001|Extension Phase (48-week)|Sponsors Decision|0|||
27964558|NCT02867813|54622303|FG000|Overall Study|Withdrawal by Subject|57|||
27964559|NCT02867813|54622304|FG001|Overall Study|Withdrawal by Subject|56|||
27964560|NCT02867813|54622303|FG000|Overall Study|Decision by Sponsor|7|||
27964561|NCT02867813|54622304|FG001|Overall Study|Decision by Sponsor|7|||
27964562|NCT02867813|54622303|FG000|Overall Study|Lost to Follow-up|91|||
27964563|NCT02867813|54622304|FG001|Overall Study|Lost to Follow-up|78|||
27964564|NCT02867813|54622303|FG000|Overall Study|Missing|2|||
27964565|NCT02867813|54622304|FG001|Overall Study|Missing|1|||
27964566|NCT02867813|54622303|FG000|Overall Study|Death|294|||
27964567|NCT02867813|54622304|FG001|Overall Study|Death|268|||
27964568|NCT02278055|54622316|FG000|Overall Study|Adverse Event|1|||
27964569|NCT02278055|54622316|FG000|Overall Study|Lost to Follow-up|1|||
27964570|NCT02278055|54622316|FG000|Overall Study|Withdrawal by Subject|2|||
27964571|NCT02278055|54622316|FG000|Overall Study|Progressive Disease|4|||
27964572|NCT02231879|54622322|FG000|Overall Study|Adverse Event|2|||
27964573|NCT02231879|54622323|FG001|Overall Study|Adverse Event|1|||
27964574|NCT02231879|54622322|FG000|Overall Study|Lack of Efficacy|0|||
27964575|NCT02231879|54622323|FG001|Overall Study|Lack of Efficacy|1|||
27964576|NCT01833806|54622344|FG000|Overall Study|Alternative treatment|2|||
27964577|NCT01833806|54622344|FG000|Overall Study|Death|5|||
27964578|NCT01833806|54622344|FG000|Overall Study|Physician Decision|1|||
27964579|NCT01833806|54622344|FG000|Overall Study|Lost to Follow-up|1|||
27964580|NCT01712490|54622350|FG000|Overall Study|Ongoing|601|||
28083154|NCT00048932|54737050|FG001|Open Label Period (OL)|Lost to Follow-up|0|||
28083155|NCT00048932|54737051|FG002|Open Label Period (OL)|Lost to Follow-up|27|||
28083156|NCT00048932|54737049|FG000|Open Label Period (OL)|Withdrawal by Subject|0|||
28083157|NCT00048932|54737050|FG001|Open Label Period (OL)|Withdrawal by Subject|0|||
27964581|NCT01712490|54622351|FG001|Overall Study|Ongoing|586|||
27964582|NCT01712490|54622350|FG000|Overall Study|Other|11|||
28083158|NCT00048932|54737051|FG002|Open Label Period (OL)|Withdrawal by Subject|117|||
28083159|NCT00048932|54737049|FG000|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
28083160|NCT00048932|54737050|FG001|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
28083161|NCT00048932|54737051|FG002|Open Label Period (OL)|No Longer Meets Study Criteria|5|||
28083162|NCT00048932|54737049|FG000|Open Label Period (OL)|Poor/Non-Compliance|0|||
28083163|NCT00048932|54737050|FG001|Open Label Period (OL)|Poor/Non-Compliance|0|||
28083164|NCT00048932|54737051|FG002|Open Label Period (OL)|Poor/Non-Compliance|13|||
28083165|NCT00048932|54737049|FG000|Open Label Period (OL)|Pregnancy|0|||
28083166|NCT00048932|54737050|FG001|Open Label Period (OL)|Pregnancy|0|||
27732605|NCT02630459|54180140|FG004|Open-Label Treatment Phase (OLTP)|Subject Request|24|||
27964583|NCT01712490|54622351|FG001|Overall Study|Other|11|||
27964584|NCT01712490|54622350|FG000|Overall Study|Withdrawal by Subject|36|||
27964585|NCT01712490|54622351|FG001|Overall Study|Withdrawal by Subject|44|||
27964586|NCT01712490|54622350|FG000|Overall Study|Lost to Follow-up|16|||
27964587|NCT01712490|54622351|FG001|Overall Study|Lost to Follow-up|29|||
27964588|NCT01439802|54622357|FG000|6 Weeks Postpartum Status|Lost to Follow-up|36|||
27964589|NCT01439802|54622357|FG000|6 Months Postpartum Status|Lost to Follow-up|12|||
27964590|NCT00816556|54622368|FG000|Overall Study|Adverse Event|1|||
27964591|NCT00816556|54622369|FG001|Overall Study|Adverse Event|1|||
28083167|NCT00048932|54737051|FG002|Open Label Period (OL)|Pregnancy|6|||
27964592|NCT00816556|54622370|FG002|Overall Study|Adverse Event|1|||
27964593|NCT00816556|54622368|FG000|Overall Study|Withdrawal by Subject|1|||
27964594|NCT00816556|54622369|FG001|Overall Study|Withdrawal by Subject|1|||
27964595|NCT00816556|54622370|FG002|Overall Study|Withdrawal by Subject|1|||
27964596|NCT00816556|54622368|FG000|Overall Study|Lost to Follow-up|0|||
27964597|NCT00816556|54622369|FG001|Overall Study|Lost to Follow-up|0|||
27964598|NCT00816556|54622370|FG002|Overall Study|Lost to Follow-up|1|||
27964599|NCT00760747|54622380|FG000|Study Period II|Adverse Event|3|||
27964600|NCT00760747|54622381|FG001|Study Period II|Adverse Event|4|||
27964601|NCT00760747|54622380|FG000|Study Period II|Lack of Efficacy|0|||
27964602|NCT00760747|54622381|FG001|Study Period II|Lack of Efficacy|6|||
27964603|NCT00760747|54622380|FG000|Study Period II|Parent/Caregiver Decision|3|||
28083168|NCT00048932|54737049|FG000|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
28083169|NCT00048932|54737050|FG001|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
27832512|NCT01760447|54311795|FG003|Weeks 20-54|Consent withdrawn by Parent/Guardian|0|||
27964604|NCT00760747|54622381|FG001|Study Period II|Parent/Caregiver Decision|0|||
27964605|NCT00760747|54622380|FG000|Study Period II|Protocol Violation|6|||
27964606|NCT00760747|54622381|FG001|Study Period II|Protocol Violation|3|||
27964607|NCT00760747|54622380|FG000|Study Period II|Withdrawal by Subject|1|||
27964608|NCT00760747|54622381|FG001|Study Period II|Withdrawal by Subject|0|||
27964609|NCT00760747|54622380|FG000|Study Period II|No drug administered|0|||
27964610|NCT00760747|54622381|FG001|Study Period II|No drug administered|1|||
27964611|NCT00760747|54622380|FG000|Study Period III|Adverse Event|1|||
27964612|NCT00760747|54622381|FG001|Study Period III|Adverse Event|0|||
27964613|NCT00760747|54622380|FG000|Study Period III|Lack of Efficacy|1|||
27964614|NCT00760747|54622381|FG001|Study Period III|Lack of Efficacy|0|||
27964615|NCT00760747|54622380|FG000|Study Period III|Parent/Caregiver Decision|0|||
27964616|NCT00760747|54622381|FG001|Study Period III|Parent/Caregiver Decision|1|||
27964617|NCT00760747|54622380|FG000|Study Period III|Protocol Violation|1|||
27964618|NCT00760747|54622381|FG001|Study Period III|Protocol Violation|1|||
27964619|NCT00760747|54622380|FG000|Study Period III|Physician Decision|0|||
27964620|NCT00760747|54622381|FG001|Study Period III|Physician Decision|1|||
27964621|NCT00760669|54622387|FG000|Overall Study|Not assessed for overall improvement|18|||
27964622|NCT00760669|54622387|FG000|Overall Study|Participants missing efficacy assessment|6|||
27964623|NCT00760669|54622387|FG000|Overall Study|Participants with overlapping cases|1|||
27964624|NCT00760669|54622387|FG000|Overall Study|Took drug before entering in contract|5|||
27964625|NCT00769483|54622397|FG000|Overall Study|Withdrawal by Subject|0|||
27964626|NCT00769483|54622398|FG001|Overall Study|Withdrawal by Subject|1|||
27964627|NCT00769483|54622399|FG002|Overall Study|Withdrawal by Subject|0|||
27964628|NCT00769483|54622400|FG003|Overall Study|Withdrawal by Subject|0|||
27964629|NCT00769483|54622401|FG004|Overall Study|Withdrawal by Subject|1|||
27964630|NCT00769483|54622402|FG005|Overall Study|Withdrawal by Subject|0|||
27964631|NCT00760513|54622420|FG000|Overall Study|Withdrawal by Subject|5|||
27964632|NCT00760513|54622421|FG001|Overall Study|Withdrawal by Subject|7|||
27964633|NCT00907296|54622439|FG000|Overall Study|Ineligibility Determined|1|||
27964634|NCT00907296|54622440|FG001|Overall Study|Ineligibility Determined|0|||
27964635|NCT00907296|54622441|FG002|Overall Study|Ineligibility Determined|0|||
27964636|NCT00907296|54622442|FG003|Overall Study|Ineligibility Determined|1|||
27964637|NCT00907296|54622443|FG004|Overall Study|Ineligibility Determined|0|||
27964638|NCT00907296|54622444|FG005|Overall Study|Ineligibility Determined|0|||
27964639|NCT00907296|54622445|FG006|Overall Study|Ineligibility Determined|0|||
27964640|NCT00907296|54622446|FG007|Overall Study|Ineligibility Determined|1|||
27964641|NCT00907296|54622447|FG008|Overall Study|Ineligibility Determined|0|||
27964642|NCT00907296|54622448|FG009|Overall Study|Ineligibility Determined|0|||
27964643|NCT00907296|54622439|FG000|Overall Study|Protocol Deviation|0|||
27964644|NCT00907296|54622440|FG001|Overall Study|Protocol Deviation|1|||
27964645|NCT00907296|54622441|FG002|Overall Study|Protocol Deviation|0|||
27964646|NCT00907296|54622442|FG003|Overall Study|Protocol Deviation|0|||
27964647|NCT00907296|54622443|FG004|Overall Study|Protocol Deviation|0|||
27964648|NCT00907296|54622444|FG005|Overall Study|Protocol Deviation|0|||
27964649|NCT00907296|54622445|FG006|Overall Study|Protocol Deviation|0|||
27964650|NCT00907296|54622446|FG007|Overall Study|Protocol Deviation|0|||
27964651|NCT00907296|54622447|FG008|Overall Study|Protocol Deviation|0|||
27964652|NCT00907296|54622448|FG009|Overall Study|Protocol Deviation|0|||
27964653|NCT00907296|54622439|FG000|Overall Study|Noncompliance|1|||
28083170|NCT00048932|54737051|FG002|Open Label Period (OL)|Administrative Reason By Sponsor|20|||
28083171|NCT00048932|54737049|FG000|Open Label Period (OL)|Investigator Retiring|0|||
28083172|NCT00048932|54737050|FG001|Open Label Period (OL)|Investigator Retiring|0|||
27964654|NCT00907296|54622440|FG001|Overall Study|Noncompliance|1|||
27964655|NCT00907296|54622441|FG002|Overall Study|Noncompliance|1|||
27964656|NCT00907296|54622442|FG003|Overall Study|Noncompliance|0|||
27964657|NCT00907296|54622443|FG004|Overall Study|Noncompliance|0|||
27964658|NCT00907296|54622444|FG005|Overall Study|Noncompliance|1|||
27964659|NCT00907296|54622445|FG006|Overall Study|Noncompliance|0|||
27964660|NCT00907296|54622446|FG007|Overall Study|Noncompliance|2|||
27964661|NCT00907296|54622447|FG008|Overall Study|Noncompliance|0|||
27964662|NCT00907296|54622448|FG009|Overall Study|Noncompliance|0|||
27964663|NCT00907296|54622439|FG000|Overall Study|Adverse Event|2|||
27964664|NCT00907296|54622440|FG001|Overall Study|Adverse Event|0|||
27964665|NCT00907296|54622441|FG002|Overall Study|Adverse Event|0|||
27964666|NCT00907296|54622442|FG003|Overall Study|Adverse Event|0|||
27964667|NCT00907296|54622443|FG004|Overall Study|Adverse Event|0|||
27964668|NCT00907296|54622444|FG005|Overall Study|Adverse Event|0|||
27964669|NCT00907296|54622445|FG006|Overall Study|Adverse Event|1|||
27964670|NCT00907296|54622446|FG007|Overall Study|Adverse Event|0|||
27964671|NCT00907296|54622447|FG008|Overall Study|Adverse Event|0|||
27964672|NCT00907296|54622448|FG009|Overall Study|Adverse Event|1|||
27964673|NCT00907296|54622439|FG000|Overall Study|Withdrawal by Subject|7|||
27964674|NCT00907296|54622440|FG001|Overall Study|Withdrawal by Subject|2|||
27964675|NCT00907296|54622441|FG002|Overall Study|Withdrawal by Subject|1|||
27964676|NCT00907296|54622442|FG003|Overall Study|Withdrawal by Subject|1|||
27964677|NCT00907296|54622443|FG004|Overall Study|Withdrawal by Subject|1|||
27964678|NCT00907296|54622444|FG005|Overall Study|Withdrawal by Subject|5|||
27964679|NCT00907296|54622445|FG006|Overall Study|Withdrawal by Subject|3|||
27964680|NCT00907296|54622446|FG007|Overall Study|Withdrawal by Subject|2|||
27964681|NCT00907296|54622447|FG008|Overall Study|Withdrawal by Subject|4|||
27964682|NCT00907296|54622448|FG009|Overall Study|Withdrawal by Subject|2|||
27964683|NCT00907296|54622439|FG000|Overall Study|Lost to Follow-up|9|||
27964684|NCT00907296|54622440|FG001|Overall Study|Lost to Follow-up|1|||
27964685|NCT00907296|54622441|FG002|Overall Study|Lost to Follow-up|0|||
27964686|NCT00907296|54622442|FG003|Overall Study|Lost to Follow-up|2|||
27964687|NCT00907296|54622443|FG004|Overall Study|Lost to Follow-up|0|||
27964688|NCT00907296|54622444|FG005|Overall Study|Lost to Follow-up|3|||
28083173|NCT00048932|54737051|FG002|Open Label Period (OL)|Investigator Retiring|2|||
28083174|NCT00048932|54737049|FG000|Open Label Period (OL)|Participant Transportation Issues|0|||
28083175|NCT00048932|54737050|FG001|Open Label Period (OL)|Participant Transportation Issues|0|||
28083176|NCT00048932|54737051|FG002|Open Label Period (OL)|Participant Transportation Issues|1|||
28083177|NCT00048932|54737049|FG000|Open Label Period (OL)|Participant Relocated|0|||
28083178|NCT00048932|54737050|FG001|Open Label Period (OL)|Participant Relocated|0|||
27964689|NCT00907296|54622445|FG006|Overall Study|Lost to Follow-up|2|||
27964690|NCT00907296|54622446|FG007|Overall Study|Lost to Follow-up|2|||
27964691|NCT00907296|54622447|FG008|Overall Study|Lost to Follow-up|0|||
27964692|NCT00907296|54622448|FG009|Overall Study|Lost to Follow-up|4|||
27964693|NCT00816400|54622479|FG000|Overall Study|Death|2|||
27964694|NCT00816400|54622480|FG001|Overall Study|Death|3|||
27964695|NCT00816400|54622481|FG002|Overall Study|Death|3|||
27964696|NCT00816400|54622482|FG003|Overall Study|Death|3|||
27964697|NCT00816400|54622483|FG004|Overall Study|Death|2|||
27964698|NCT00816400|54622484|FG005|Overall Study|Death|3|||
27964699|NCT00816400|54622485|FG006|Overall Study|Death|2|||
27964700|NCT00816400|54622486|FG007|Overall Study|Death|5|||
27964701|NCT00816400|54622487|FG008|Overall Study|Death|6|||
27964702|NCT00816400|54622479|FG000|Overall Study|In hospice care at the end of the study|0|||
27964703|NCT00816400|54622480|FG001|Overall Study|In hospice care at the end of the study|0|||
27964704|NCT00816400|54622481|FG002|Overall Study|In hospice care at the end of the study|2|||
27964705|NCT00816400|54622482|FG003|Overall Study|In hospice care at the end of the study|0|||
27964706|NCT00816400|54622483|FG004|Overall Study|In hospice care at the end of the study|0|||
27964707|NCT00816400|54622484|FG005|Overall Study|In hospice care at the end of the study|0|||
27964708|NCT00816400|54622485|FG006|Overall Study|In hospice care at the end of the study|0|||
27964709|NCT00816400|54622486|FG007|Overall Study|In hospice care at the end of the study|0|||
27964710|NCT00816400|54622487|FG008|Overall Study|In hospice care at the end of the study|0|||
27964711|NCT00906204|54622510|FG000|Primary Endpoint (Early Safety)|Physician Decision|1|||
27964712|NCT00906204|54622511|FG001|Primary Endpoint (Early Safety)|Physician Decision|0|||
27964713|NCT00906204|54622510|FG000|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0|||
27964714|NCT00906204|54622511|FG001|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1|||
27964715|NCT00906204|54622510|FG000|Primary Endpoint (Early Safety)|Withdrawal by Subject|1|||
27964716|NCT00906204|54622511|FG001|Primary Endpoint (Early Safety)|Withdrawal by Subject|0|||
27964717|NCT00906204|54622510|FG000|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
27964718|NCT00906204|54622511|FG001|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
28083179|NCT00048932|54737051|FG002|Open Label Period (OL)|Participant Relocated|6|||
28083180|NCT00048932|54737049|FG000|Open Label Period (OL)|Investigator Dosing the Trial|0|||
28083181|NCT00048932|54737050|FG001|Open Label Period (OL)|Investigator Dosing the Trial|0|||
27964719|NCT00906204|54622510|FG000|Secondary Endpoints (Long-term Safety)|Death|0|||
27964720|NCT00906204|54622511|FG001|Secondary Endpoints (Long-term Safety)|Death|1|||
27964721|NCT00905424|54622548|FG000|Overall Study|Lost to Follow-up|3|||
27964722|NCT00905424|54622549|FG001|Overall Study|Lost to Follow-up|3|||
28083182|NCT00048932|54737051|FG002|Open Label Period (OL)|Investigator Dosing the Trial|1|||
27964723|NCT00905424|54622548|FG000|Overall Study|Withdrawal by Subject|1|||
27964724|NCT00905424|54622549|FG001|Overall Study|Withdrawal by Subject|2|||
27964725|NCT00905424|54622548|FG000|Overall Study|Adverse Event|4|||
27964726|NCT00905424|54622549|FG001|Overall Study|Adverse Event|2|||
27964727|NCT00905424|54622548|FG000|Overall Study|Non-compliance with study medication|2|||
27964728|NCT00905424|54622549|FG001|Overall Study|Non-compliance with study medication|0|||
27964729|NCT00905424|54622548|FG000|Overall Study|Sponsor decision|1|||
27964730|NCT00905424|54622549|FG001|Overall Study|Sponsor decision|0|||
27964731|NCT00905424|54622548|FG000|Overall Study|Positive urine drug screen|0|||
27964732|NCT00905424|54622549|FG001|Overall Study|Positive urine drug screen|1|||
27964733|NCT00905424|54622548|FG000|Overall Study|Non-adherence to visit schedule|0|||
27964734|NCT00905424|54622549|FG001|Overall Study|Non-adherence to visit schedule|1|||
27964735|NCT00816166|54622559|FG000|Overall Study|Lost to Follow-up|6|||
27964736|NCT00816166|54622560|FG001|Overall Study|Lost to Follow-up|10|||
27964737|NCT00816166|54622559|FG000|Overall Study|Death|4|||
27964738|NCT00816166|54622560|FG001|Overall Study|Death|2|||
27964739|NCT00815308|54622566|FG000|Overall Study|Adverse Event|4|||
27964740|NCT00815308|54622566|FG000|Overall Study|Withdrawal by Subject|0|||
27964741|NCT00815308|54622566|FG000|Overall Study|Protocol Violation|6|||
27964742|NCT01039376|54622572|FG000|Overall Study|Lost to Follow-up|5|||
27964743|NCT01039376|54622573|FG001|Overall Study|Lost to Follow-up|12|||
27964744|NCT01039376|54622572|FG000|Overall Study|Physician Decision|15|||
27964745|NCT01039376|54622573|FG001|Overall Study|Physician Decision|10|||
27964746|NCT01039376|54622572|FG000|Overall Study|Withdrawal by Subject|20|||
27964747|NCT01039376|54622573|FG001|Overall Study|Withdrawal by Subject|32|||
27964748|NCT01039376|54622572|FG000|Overall Study|Study terminated by Sponsor|90|||
27964749|NCT01039376|54622573|FG001|Overall Study|Study terminated by Sponsor|72|||
27964750|NCT00905034|54622580|FG000|Overall Study|Withdrawal by Subject|1|||
27964751|NCT00828568|54622587|FG000|Randomized|Withdrawal by Subject|1|||
27964752|NCT00828568|54622588|FG001|Randomized|Withdrawal by Subject|0|||
27964753|NCT00828568|54622589|FG002|Randomized|Withdrawal by Subject|2|||
27964754|NCT00828568|54622587|FG000|Treated - Received at Least One Dose|Adverse Event|11|||
27964755|NCT00828568|54622588|FG001|Treated - Received at Least One Dose|Adverse Event|8|||
27964756|NCT00828568|54622589|FG002|Treated - Received at Least One Dose|Adverse Event|1|||
27964757|NCT00828568|54622587|FG000|Treated - Received at Least One Dose|Withdrawal by Subject|9|||
27964758|NCT00828568|54622588|FG001|Treated - Received at Least One Dose|Withdrawal by Subject|11|||
27964759|NCT00828568|54622589|FG002|Treated - Received at Least One Dose|Withdrawal by Subject|0|||
27964760|NCT00828568|54622587|FG000|Treated - Received at Least One Dose|Lost to Follow-up|1|||
27964761|NCT00828568|54622588|FG001|Treated - Received at Least One Dose|Lost to Follow-up|5|||
27964762|NCT00828568|54622589|FG002|Treated - Received at Least One Dose|Lost to Follow-up|1|||
27964763|NCT00828568|54622587|FG000|Treated - Received at Least One Dose|Protocol Violation|9|||
27964764|NCT00828568|54622588|FG001|Treated - Received at Least One Dose|Protocol Violation|5|||
27964765|NCT00828568|54622589|FG002|Treated - Received at Least One Dose|Protocol Violation|3|||
27964766|NCT01038752|54622600|FG000|Overall Study|Tumor Progression|2|||
27964767|NCT01038752|54622601|FG001|Overall Study|Tumor Progression|2|||
27964768|NCT01038752|54622600|FG000|Overall Study|Lost to Follow-up|3|||
27964769|NCT01038752|54622601|FG001|Overall Study|Lost to Follow-up|3|||
27964770|NCT00903630|54622610|FG000|Phase 2|Adverse Event|0|||
27964771|NCT00903630|54622611|FG001|Phase 2|Adverse Event|0|||
27964772|NCT00903630|54622612|FG002|Phase 2|Adverse Event|1|||
27964773|NCT01037114|54622622|FG000|Year 20|Others|1|||
27964774|NCT00840970|54622626|FG000|Overall Study|Adverse Event|0|||
27964775|NCT00840970|54622627|FG001|Overall Study|Adverse Event|0|||
27964776|NCT00840970|54622628|FG002|Overall Study|Adverse Event|1|||
27964777|NCT01054820|54622638|FG000|Overall Study|Withdrawal by Subject|2|||
27964778|NCT00840658|54622646|FG000|Overall Study|Death|2|||
27964779|NCT00840658|54622647|FG001|Overall Study|Death|2|||
27964780|NCT00840658|54622648|FG002|Overall Study|Death|3|||
27964781|NCT00840658|54622649|FG003|Overall Study|Death|3|||
27964782|NCT00840658|54622646|FG000|Overall Study|Lost to Follow-up|3|||
27964783|NCT00840658|54622647|FG001|Overall Study|Lost to Follow-up|1|||
27964784|NCT00840658|54622648|FG002|Overall Study|Lost to Follow-up|2|||
27964785|NCT00840658|54622649|FG003|Overall Study|Lost to Follow-up|1|||
27964786|NCT01036724|54622665|FG000|Overall Study|Adverse Event|1|||
27964787|NCT01036724|54622666|FG001|Overall Study|Adverse Event|2|||
27964788|NCT01036724|54622665|FG000|Overall Study|Lack of Efficacy|1|||
27964789|NCT01036724|54622666|FG001|Overall Study|Lack of Efficacy|1|||
27964790|NCT01036724|54622665|FG000|Overall Study|Protocol Violation|4|||
27964791|NCT01036724|54622666|FG001|Overall Study|Protocol Violation|5|||
27964792|NCT01052714|54622674|FG000|Overall Study|Adverse Event|6|||
27964793|NCT01052714|54622675|FG001|Overall Study|Adverse Event|3|||
27964794|NCT01052714|54622676|FG002|Overall Study|Adverse Event|0|||
27964795|NCT01052714|54622674|FG000|Overall Study|Death|1|||
27964796|NCT01052714|54622675|FG001|Overall Study|Death|2|||
27964797|NCT01052714|54622676|FG002|Overall Study|Death|0|||
27964798|NCT01052714|54622674|FG000|Overall Study|Lost to Follow-up|2|||
27964799|NCT01052714|54622675|FG001|Overall Study|Lost to Follow-up|3|||
27964800|NCT01052714|54622676|FG002|Overall Study|Lost to Follow-up|0|||
27964801|NCT01052714|54622674|FG000|Overall Study|Physician Decision|9|||
27964802|NCT01052714|54622675|FG001|Overall Study|Physician Decision|9|||
27964803|NCT01052714|54622676|FG002|Overall Study|Physician Decision|1|||
27964804|NCT01052714|54622674|FG000|Overall Study|Withdrawal by Subject|7|||
27964805|NCT01052714|54622675|FG001|Overall Study|Withdrawal by Subject|12|||
27964806|NCT01052714|54622676|FG002|Overall Study|Withdrawal by Subject|1|||
27964807|NCT01052480|54622693|FG000|Overall Study|Lost to Follow-up|3|||
27964808|NCT01052480|54622694|FG001|Overall Study|Lost to Follow-up|3|||
27964809|NCT01052480|54622693|FG000|Overall Study|Protocol Violation|1|||
27964810|NCT01052480|54622694|FG001|Overall Study|Protocol Violation|0|||
27964811|NCT01052480|54622693|FG000|Overall Study|Withdrawal by Subject|3|||
27964812|NCT01052480|54622694|FG001|Overall Study|Withdrawal by Subject|7|||
27964813|NCT01052480|54622693|FG000|Overall Study|Physician Decision|0|||
27964814|NCT01052480|54622694|FG001|Overall Study|Physician Decision|2|||
27964815|NCT01052480|54622693|FG000|Overall Study|Death|1|||
27964816|NCT01052480|54622694|FG001|Overall Study|Death|5|||
27964817|NCT00904722|54622700|FG000|Overall Study|Physician Decision|1|||
27964818|NCT01029782|54622706|FG000|Overall Study|Lost to Follow-up|2|||
27964819|NCT01029782|54622707|FG001|Overall Study|Lost to Follow-up|2|||
27964820|NCT01029782|54622706|FG000|Overall Study|Diagnosis changed|1|||
27964821|NCT01029782|54622707|FG001|Overall Study|Diagnosis changed|1|||
27964822|NCT01029782|54622706|FG000|Overall Study|Adverse Event|0|||
27964823|NCT01029782|54622707|FG001|Overall Study|Adverse Event|1|||
27964824|NCT01029782|54622706|FG000|Overall Study|Physician Decision|0|||
27964825|NCT01029782|54622707|FG001|Overall Study|Physician Decision|1|||
27964826|NCT01029782|54622706|FG000|Overall Study|Protocol Violation|0|||
27964827|NCT01029782|54622707|FG001|Overall Study|Protocol Violation|2|||
27964828|NCT01029782|54622706|FG000|Overall Study|Withdrawal by Subject|0|||
27964829|NCT01029782|54622707|FG001|Overall Study|Withdrawal by Subject|1|||
28083183|NCT00048932|54737049|FG000|Open Label Period (OL)|Site Closure|0|||
28083184|NCT00048932|54737050|FG001|Open Label Period (OL)|Site Closure|0|||
28083185|NCT00048932|54737051|FG002|Open Label Period (OL)|Site Closure|3|||
28083186|NCT00048932|54737049|FG000|Open Label Period (OL)|Trial Terminated|0|||
28083187|NCT00048932|54737050|FG001|Open Label Period (OL)|Trial Terminated|0|||
28083188|NCT00048932|54737051|FG002|Open Label Period (OL)|Trial Terminated|1|||
28083189|NCT00048932|54737049|FG000|Open Label Period (OL)|Difficult IV Access with Participant|0|||
28083190|NCT00048932|54737050|FG001|Open Label Period (OL)|Difficult IV Access with Participant|0|||
28083191|NCT00048932|54737051|FG002|Open Label Period (OL)|Difficult IV Access with Participant|1|||
28165171|NCT03016325|54835758|FG005|182-Day Follow-Up Period|Alive, per Family doctor|0|||
28165172|NCT03016325|54835759|FG006|182-Day Follow-Up Period|Alive, per Family doctor|0|||
28165173|NCT03016325|54835760|FG007|182-Day Follow-Up Period|Alive, per Family doctor|0|||
27964830|NCT01029704|54622722|FG000|Overall Study|Adverse Event|0|||
27964831|NCT01029704|54622723|FG001|Overall Study|Adverse Event|0|||
27964832|NCT01029704|54622724|FG002|Overall Study|Adverse Event|0|||
27964833|NCT01029704|54622725|FG003|Overall Study|Adverse Event|0|||
27964834|NCT01029704|54622726|FG004|Overall Study|Adverse Event|0|||
27964835|NCT01029704|54622727|FG005|Overall Study|Adverse Event|0|||
27964836|NCT01029704|54622728|FG006|Overall Study|Adverse Event|1|||
27964837|NCT01029704|54622729|FG007|Overall Study|Adverse Event|1|||
27964838|NCT01029704|54622730|FG008|Overall Study|Adverse Event|0|||
27964839|NCT01029704|54622722|FG000|Overall Study|Withdrawal by Subject|0|||
27964840|NCT01029704|54622723|FG001|Overall Study|Withdrawal by Subject|0|||
27964841|NCT01029704|54622724|FG002|Overall Study|Withdrawal by Subject|0|||
27964842|NCT01029704|54622725|FG003|Overall Study|Withdrawal by Subject|0|||
27964843|NCT01029704|54622726|FG004|Overall Study|Withdrawal by Subject|2|||
27964844|NCT01029704|54622727|FG005|Overall Study|Withdrawal by Subject|1|||
27964845|NCT01029704|54622728|FG006|Overall Study|Withdrawal by Subject|1|||
27964846|NCT01029704|54622729|FG007|Overall Study|Withdrawal by Subject|1|||
27964847|NCT01029704|54622730|FG008|Overall Study|Withdrawal by Subject|0|||
27964848|NCT01029704|54622722|FG000|Overall Study|Lost to Follow-up|0|||
27964849|NCT01029704|54622723|FG001|Overall Study|Lost to Follow-up|0|||
27964850|NCT01029704|54622724|FG002|Overall Study|Lost to Follow-up|0|||
27964851|NCT01029704|54622725|FG003|Overall Study|Lost to Follow-up|0|||
27964852|NCT01029704|54622726|FG004|Overall Study|Lost to Follow-up|0|||
27964853|NCT01029704|54622727|FG005|Overall Study|Lost to Follow-up|0|||
27964854|NCT01029704|54622728|FG006|Overall Study|Lost to Follow-up|1|||
27964855|NCT01029704|54622729|FG007|Overall Study|Lost to Follow-up|1|||
27964856|NCT01029704|54622730|FG008|Overall Study|Lost to Follow-up|1|||
27964857|NCT01029704|54622722|FG000|Overall Study|Lack of Efficacy|0|||
27964858|NCT01029704|54622723|FG001|Overall Study|Lack of Efficacy|0|||
28083192|NCT00048932|54737049|FG000|Open Label Period (OL)|Patient Decision|0|||
27964859|NCT01029704|54622724|FG002|Overall Study|Lack of Efficacy|0|||
27964860|NCT01029704|54622725|FG003|Overall Study|Lack of Efficacy|0|||
27964861|NCT01029704|54622726|FG004|Overall Study|Lack of Efficacy|2|||
27964862|NCT01029704|54622727|FG005|Overall Study|Lack of Efficacy|3|||
27964863|NCT01029704|54622728|FG006|Overall Study|Lack of Efficacy|1|||
27964864|NCT01029704|54622729|FG007|Overall Study|Lack of Efficacy|2|||
27964865|NCT01029704|54622730|FG008|Overall Study|Lack of Efficacy|0|||
27964866|NCT01029704|54622722|FG000|Overall Study|Withdrawn due to major protocol violation|0|||
28083193|NCT00048932|54737050|FG001|Open Label Period (OL)|Patient Decision|0|||
28165174|NCT03016325|54835753|FG000|182-Day Follow-Up Period|Alive, per civil unit|0|||
27964867|NCT01029704|54622723|FG001|Overall Study|Withdrawn due to major protocol violation|0|||
27964868|NCT01029704|54622724|FG002|Overall Study|Withdrawn due to major protocol violation|0|||
27964869|NCT01029704|54622725|FG003|Overall Study|Withdrawn due to major protocol violation|0|||
27964870|NCT01029704|54622726|FG004|Overall Study|Withdrawn due to major protocol violation|1|||
27964871|NCT01029704|54622727|FG005|Overall Study|Withdrawn due to major protocol violation|0|||
27964872|NCT01029704|54622728|FG006|Overall Study|Withdrawn due to major protocol violation|0|||
27964873|NCT01029704|54622729|FG007|Overall Study|Withdrawn due to major protocol violation|1|||
27964874|NCT01029704|54622730|FG008|Overall Study|Withdrawn due to major protocol violation|0|||
27964875|NCT00840034|54622752|FG000|Acute Treatment Phase|Adverse Event|6|||
27964876|NCT00840034|54622753|FG001|Acute Treatment Phase|Adverse Event|8|||
27964877|NCT00840034|54622752|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
27964878|NCT00840034|54622753|FG001|Acute Treatment Phase|Lack of Efficacy|0|||
27964879|NCT00840034|54622752|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
27964880|NCT00840034|54622753|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
27964881|NCT00840034|54622752|FG000|Acute Treatment Phase|Physician Decision|0|||
27964882|NCT00840034|54622753|FG001|Acute Treatment Phase|Physician Decision|1|||
27964883|NCT00840034|54622752|FG000|Acute Treatment Phase|Protocol Violation|2|||
27964884|NCT00840034|54622753|FG001|Acute Treatment Phase|Protocol Violation|4|||
27964885|NCT00840034|54622752|FG000|Acute Treatment Phase|Withdrawal by Subject|6|||
27964886|NCT00840034|54622753|FG001|Acute Treatment Phase|Withdrawal by Subject|11|||
27964887|NCT00840034|54622752|FG000|Taper Phase|Adverse Event|1|||
27964888|NCT00840034|54622753|FG001|Taper Phase|Adverse Event|0|||
27964889|NCT00840034|54622752|FG000|Taper Phase|Lost to Follow-up|1|||
27964890|NCT00840034|54622753|FG001|Taper Phase|Lost to Follow-up|1|||
27964891|NCT00840034|54622752|FG000|Taper Phase|Withdrawal by Subject|1|||
27964892|NCT00840034|54622753|FG001|Taper Phase|Withdrawal by Subject|1|||
27964893|NCT00813904|54622761|FG000|Overall Study|Death|1|||
27964894|NCT00839956|54622765|FG000|Overall Study|Adverse Event|2|||
27964895|NCT00839956|54622765|FG000|Overall Study|Lack of Efficacy|6|||
27964896|NCT00839956|54622765|FG000|Overall Study|Physician Decision|1|||
27964897|NCT00839956|54622765|FG000|Overall Study|Withdrawal by Subject|3|||
27964898|NCT00839800|54622771|FG000|Overall Study|Adverse Event|8|||
27964899|NCT00839800|54622772|FG001|Overall Study|Adverse Event|12|||
27964900|NCT00839800|54622771|FG000|Overall Study|Lost to Follow-up|31|||
27964901|NCT00839800|54622772|FG001|Overall Study|Lost to Follow-up|26|||
27964902|NCT00839800|54622771|FG000|Overall Study|Withdrawal by Subject|28|||
27964903|NCT00839800|54622772|FG001|Overall Study|Withdrawal by Subject|34|||
27964904|NCT00839800|54622771|FG000|Overall Study|Incorrect Enrolment|3|||
27964905|NCT00839800|54622772|FG001|Overall Study|Incorrect Enrolment|3|||
27964906|NCT00839800|54622771|FG000|Overall Study|Study-Specific Discontinuation Criteria|6|||
27964907|NCT00839800|54622772|FG001|Overall Study|Study-Specific Discontinuation Criteria|13|||
27964908|NCT00839800|54622771|FG000|Overall Study|Safety Reasons|2|||
27964909|NCT00839800|54622772|FG001|Overall Study|Safety Reasons|1|||
27964910|NCT00839800|54622771|FG000|Overall Study|Other|8|||
27964911|NCT00839800|54622772|FG001|Overall Study|Other|14|||
27964912|NCT00839800|54622771|FG000|Overall Study|Severe Non-Compliance to Protocol|7|||
27964913|NCT00839800|54622772|FG001|Overall Study|Severe Non-Compliance to Protocol|7|||
27964914|NCT00753415|54622806|FG000|Part A|Disease progression|1|||
27964915|NCT00753415|54622807|FG001|Part A|Disease progression|0|||
27964916|NCT00753415|54622808|FG002|Part A|Disease progression|1|||
27964917|NCT00753415|54622809|FG003|Part A|Disease progression|2|||
27964918|NCT00753415|54622810|FG004|Part A|Disease progression|0|||
27964919|NCT00753415|54622811|FG005|Part A|Disease progression|0|||
27964920|NCT00753415|54622812|FG006|Part A|Disease progression|0|||
27964921|NCT00753415|54622813|FG007|Part A|Disease progression|0|||
27964922|NCT00753415|54622814|FG008|Part A|Disease progression|0|||
27964923|NCT00753415|54622815|FG009|Part A|Disease progression|0|||
27964924|NCT00753415|54622806|FG000|Part A|Withdrawal by Subject|0|||
27964925|NCT00753415|54622807|FG001|Part A|Withdrawal by Subject|0|||
27964926|NCT00753415|54622808|FG002|Part A|Withdrawal by Subject|1|||
27964927|NCT00753415|54622809|FG003|Part A|Withdrawal by Subject|0|||
27964928|NCT00753415|54622810|FG004|Part A|Withdrawal by Subject|0|||
27964929|NCT00753415|54622811|FG005|Part A|Withdrawal by Subject|0|||
27964930|NCT00753415|54622812|FG006|Part A|Withdrawal by Subject|0|||
27964931|NCT00753415|54622813|FG007|Part A|Withdrawal by Subject|0|||
27964932|NCT00753415|54622814|FG008|Part A|Withdrawal by Subject|0|||
27964933|NCT00753415|54622815|FG009|Part A|Withdrawal by Subject|0|||
27964934|NCT00753415|54622806|FG000|Part B|Lost to Follow-up|0|||
27964935|NCT00753415|54622807|FG001|Part B|Lost to Follow-up|0|||
27964936|NCT00753415|54622808|FG002|Part B|Lost to Follow-up|0|||
27964937|NCT00753415|54622809|FG003|Part B|Lost to Follow-up|0|||
27964938|NCT00753415|54622810|FG004|Part B|Lost to Follow-up|0|||
27964939|NCT00753415|54622811|FG005|Part B|Lost to Follow-up|0|||
27964940|NCT00753415|54622812|FG006|Part B|Lost to Follow-up|0|||
27964941|NCT00753415|54622813|FG007|Part B|Lost to Follow-up|1|||
27964942|NCT00753415|54622814|FG008|Part B|Lost to Follow-up|1|||
27964943|NCT00753415|54622815|FG009|Part B|Lost to Follow-up|0|||
27964944|NCT00753415|54622806|FG000|Part B|Disease progression|0|||
27964945|NCT00753415|54622807|FG001|Part B|Disease progression|0|||
27964946|NCT00753415|54622808|FG002|Part B|Disease progression|0|||
27964947|NCT00753415|54622809|FG003|Part B|Disease progression|0|||
27964948|NCT00753415|54622810|FG004|Part B|Disease progression|0|||
27964949|NCT00753415|54622811|FG005|Part B|Disease progression|0|||
27964950|NCT00753415|54622812|FG006|Part B|Disease progression|0|||
28083194|NCT00048932|54737051|FG002|Open Label Period (OL)|Patient Decision|4|||
27732606|NCT02630459|54180141|FG005|Open-Label Treatment Phase (OLTP)|Subject Request|3|||
27732607|NCT02630459|54180142|FG006|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
27732608|NCT02630459|54180143|FG007|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
27732609|NCT02630459|54180136|FG000|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
27732610|NCT02630459|54180137|FG001|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
27732611|NCT02630459|54180138|FG002|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
27732612|NCT02630459|54180139|FG003|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
27732613|NCT02630459|54180140|FG004|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1|||
27732614|NCT02630459|54180141|FG005|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
27732615|NCT02630459|54180142|FG006|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
27732616|NCT02630459|54180143|FG007|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
27732617|NCT02573948|54180168|FG000|Longitudinal Cohort|Death|9|||
27732618|NCT02573948|54180168|FG000|Longitudinal Cohort|Lost to Follow-up|22|||
27732619|NCT02573948|54180168|FG000|Longitudinal Cohort|Incarcerated|25|||
27732620|NCT01464593|54180175|FG000|Overall Study|Study terminated early due to lack of enrollment|1|||
27732621|NCT01361711|54180179|FG000|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1|||
27732622|NCT01361711|54180179|FG000|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1|||
27732623|NCT01361711|54180179|FG000|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7|||
27732624|NCT01361711|54180179|FG000|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2|||
27732625|NCT01361711|54180179|FG000|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1|||
27732626|NCT01361711|54180179|FG000|Completed Week 18 of Treatment|Complete Remission|2|||
27732627|NCT01361711|54180179|FG000|Completed Week 18 of Treatment|Other|9|||
27732628|NCT01361711|54180179|FG000|10 Year Follow-up|Still in follow-up|22|||
27732629|NCT01361711|54180179|FG000|10 Year Follow-up|Death|7|||
27732630|NCT01361711|54180179|FG000|10 Year Follow-up|Developed new cancer|1|||
27732631|NCT01361711|54180179|FG000|10 Year Follow-up|Lost to Follow-up|2|||
27732632|NCT01361711|54180179|FG000|10 Year Follow-up|New treatment started|6|||
27732633|NCT01361711|54180179|FG000|10 Year Follow-up|Progressive Disease and New treatment started|11|||
27732634|NCT01361711|54180179|FG000|10 Year Follow-up|Progressive Disease|1|||
27732635|NCT02572388|54180187|FG000|Overall Study|Withdrawal by Subject|1|||
27732636|NCT02572388|54180188|FG001|Overall Study|Withdrawal by Subject|1|||
27732637|NCT02572388|54180189|FG002|Overall Study|Withdrawal by Subject|2|||
27732638|NCT02572388|54180190|FG003|Overall Study|Withdrawal by Subject|2|||
27732639|NCT02573870|54180202|FG000|Overall Study|Adverse Event|0|||
27732640|NCT02573870|54180203|FG001|Overall Study|Adverse Event|2|||
27732641|NCT02573870|54180202|FG000|Overall Study|Lack of Efficacy|0|||
27732642|NCT02573870|54180203|FG001|Overall Study|Lack of Efficacy|1|||
27732643|NCT02573870|54180202|FG000|Overall Study|Other: Reached defined stopping criteria|0|||
27732644|NCT02573870|54180203|FG001|Overall Study|Other: Reached defined stopping criteria|1|||
27732645|NCT02573870|54180202|FG000|Overall Study|Lost to Follow-up|0|||
27732646|NCT02573870|54180203|FG001|Overall Study|Lost to Follow-up|1|||
27732647|NCT02573870|54180202|FG000|Overall Study|Other: Fail to Meet Visit|0|||
27964951|NCT00753415|54622813|FG007|Part B|Disease progression|0|||
28083195|NCT00048932|54737049|FG000|Open Label Period (OL)|Participant Received Wrong Medication|0|||
28083196|NCT00048932|54737050|FG001|Open Label Period (OL)|Participant Received Wrong Medication|0|||
27732648|NCT02573870|54180203|FG001|Overall Study|Other: Fail to Meet Visit|2|||
27732649|NCT02572076|54180209|FG000|Overall Study|Protocol Violation|1|||
27732650|NCT02571452|54180215|FG000|Overall Study Treatment|Protocol Violation|0|||
27732651|NCT02571452|54180216|FG001|Overall Study Treatment|Protocol Violation|1|||
27732652|NCT02571452|54180215|FG000|Overall Study 6-Month Follow-up|Lost to Follow-up|4|||
27732653|NCT02571452|54180216|FG001|Overall Study 6-Month Follow-up|Lost to Follow-up|0|||
27732654|NCT02571452|54180215|FG000|Overall Study 6-Month Follow-up|Protocol Violation|1|||
27732655|NCT02571452|54180216|FG001|Overall Study 6-Month Follow-up|Protocol Violation|0|||
27732656|NCT02574260|54180222|FG000|Overall Study|Disease Progression|1|||
27732657|NCT02570126|54180228|FG000|Overall Study|Lost to Follow-up|2|||
27732658|NCT02570126|54180229|FG001|Overall Study|Lost to Follow-up|0|||
27964952|NCT00753415|54622814|FG008|Part B|Disease progression|2|||
27732659|NCT02570126|54180228|FG000|Overall Study|Unable To Arrange Visit 3|1|||
27732660|NCT02570126|54180229|FG001|Overall Study|Unable To Arrange Visit 3|0|||
27732661|NCT02570126|54180228|FG000|Overall Study|Violation Of Procedures GSK|0|||
27732662|NCT02570126|54180229|FG001|Overall Study|Violation Of Procedures GSK|1|||
27732663|NCT02570126|54180228|FG000|Overall Study|Protocol Violation|0|||
27832513|NCT01760447|54311792|FG000|Weeks 20-54|Withdrawal by Subject|2|||
27832514|NCT01760447|54311793|FG001|Weeks 20-54|Withdrawal by Subject|1|||
27964953|NCT00753415|54622815|FG009|Part B|Disease progression|1|||
27964954|NCT00754741|54622842|FG000|Overall Study|Died or disenrolled|57|||
27964955|NCT00754741|54622843|FG001|Overall Study|Died or disenrolled|69|||
28083197|NCT00048932|54737051|FG002|Open Label Period (OL)|Participant Received Wrong Medication|1|||
28083198|NCT00048932|54737049|FG000|Open Label Period (OL)|Participant Desires Pregnancy|0|||
28083199|NCT00048932|54737050|FG001|Open Label Period (OL)|Participant Desires Pregnancy|0|||
28083200|NCT00048932|54737051|FG002|Open Label Period (OL)|Participant Desires Pregnancy|2|||
28083201|NCT00048932|54737049|FG000|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
28083202|NCT00048932|54737050|FG001|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
28083203|NCT00048932|54737051|FG002|Open Label Period (OL)|Participant Missed Consecutive Doses|5|||
28083204|NCT00048932|54737049|FG000|Open Label Period (OL)|Medication Lost Efficacy|0|||
28083205|NCT00048932|54737050|FG001|Open Label Period (OL)|Medication Lost Efficacy|0|||
28083206|NCT00048932|54737051|FG002|Open Label Period (OL)|Medication Lost Efficacy|1|||
28083207|NCT00048932|54737049|FG000|Open Label Period (OL)|Investigator Decision|0|||
28083208|NCT00048932|54737050|FG001|Open Label Period (OL)|Investigator Decision|0|||
28083209|NCT00048932|54737051|FG002|Open Label Period (OL)|Investigator Decision|4|||
28083210|NCT00048932|54737049|FG000|Open Label Period (OL)|Site Staff Issues|0|||
27964956|NCT00754741|54622844|FG002|Overall Study|Died or disenrolled|54|||
27964957|NCT00752791|54622852|FG000|Overall Study|Adverse Event|7|||
27964958|NCT00752791|54622852|FG000|Overall Study|Withdrawal by Subject|1|||
27964959|NCT00752791|54622852|FG000|Overall Study|Physician Decision|1|||
27964960|NCT00752791|54622852|FG000|Overall Study|Death|1|||
27964961|NCT00752791|54622852|FG000|Overall Study|Renal transplant|3|||
27964962|NCT00752791|54622852|FG000|Overall Study|Switched to hemodialysis|2|||
27964963|NCT00752791|54622852|FG000|Overall Study|Protocol deviation|1|||
27964964|NCT00902304|54622863|FG000|Overall Study|Adverse Event|4|||
27964965|NCT00902304|54622864|FG001|Overall Study|Adverse Event|10|||
27964966|NCT00902304|54622865|FG002|Overall Study|Adverse Event|25|||
27964967|NCT00902304|54622863|FG000|Overall Study|Investigator discretion|3|||
27964968|NCT00902304|54622864|FG001|Overall Study|Investigator discretion|5|||
27964969|NCT00902304|54622865|FG002|Overall Study|Investigator discretion|13|||
27964970|NCT00902304|54622863|FG000|Overall Study|Lost to Follow-up|7|||
27964971|NCT00902304|54622864|FG001|Overall Study|Lost to Follow-up|7|||
27964972|NCT00902304|54622865|FG002|Overall Study|Lost to Follow-up|7|||
27964973|NCT00902304|54622863|FG000|Overall Study|Protocol Violation|9|||
27964974|NCT00902304|54622864|FG001|Overall Study|Protocol Violation|18|||
27964975|NCT00902304|54622865|FG002|Overall Study|Protocol Violation|20|||
27964976|NCT00902304|54622863|FG000|Overall Study|Withdrawal by Subject|32|||
27964977|NCT00902304|54622864|FG001|Overall Study|Withdrawal by Subject|22|||
27964978|NCT00902304|54622865|FG002|Overall Study|Withdrawal by Subject|43|||
27964979|NCT00902304|54622863|FG000|Overall Study|includes pregnancy|3|||
27964980|NCT00902304|54622864|FG001|Overall Study|includes pregnancy|9|||
27964981|NCT00902304|54622865|FG002|Overall Study|includes pregnancy|2|||
27964982|NCT00759109|54622876|FG000|Overall Study|Adverse Event|17|||
27964983|NCT00759109|54622877|FG001|Overall Study|Adverse Event|12|||
27964984|NCT00759109|54622876|FG000|Overall Study|Inability to comply|1|||
27964985|NCT00759109|54622877|FG001|Overall Study|Inability to comply|1|||
27964986|NCT00759109|54622876|FG000|Overall Study|Withdrawal by Subject|9|||
27964987|NCT00759109|54622877|FG001|Overall Study|Withdrawal by Subject|5|||
27964988|NCT00759109|54622876|FG000|Overall Study|Death|4|||
27964989|NCT00759109|54622877|FG001|Overall Study|Death|3|||
27964990|NCT00759109|54622876|FG000|Overall Study|Lost to Follow-up|4|||
27964991|NCT00759109|54622877|FG001|Overall Study|Lost to Follow-up|6|||
27964992|NCT00759109|54622876|FG000|Overall Study|Started new therapy|2|||
27964993|NCT00759109|54622877|FG001|Overall Study|Started new therapy|6|||
27964994|NCT00759109|54622876|FG000|Overall Study|HCV RNA negative|1|||
27964995|NCT00759109|54622877|FG001|Overall Study|HCV RNA negative|0|||
27964996|NCT00759109|54622876|FG000|Overall Study|Participant moved to a different city|0|||
27964997|NCT00759109|54622877|FG001|Overall Study|Participant moved to a different city|1|||
27964998|NCT00759109|54622876|FG000|Overall Study|Participant had a liver transplant|0|||
27964999|NCT00759109|54622877|FG001|Overall Study|Participant had a liver transplant|1|||
27965000|NCT00759109|54622876|FG000|Overall Study|Lost during study|1|||
27732664|NCT02570126|54180229|FG001|Overall Study|Protocol Violation|1|||
27855172|NCT01277887|54375619|FG000|Pre-Quit Treatment Phase|No longer interested in treatment|1|||
27965001|NCT00759109|54622877|FG001|Overall Study|Lost during study|0|||
27965002|NCT00759031|54622885|FG000|First Intervention (1 Day)|Physician Decision|1|||
27965003|NCT00759031|54622886|FG001|First Intervention (1 Day)|Physician Decision|0|||
27965004|NCT00759031|54622885|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
27965005|NCT00759031|54622886|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
28083211|NCT00048932|54737050|FG001|Open Label Period (OL)|Site Staff Issues|0|||
27965006|NCT00759031|54622885|FG000|First Intervention (1 Day)|Screening failure|1|||
27965007|NCT00759031|54622886|FG001|First Intervention (1 Day)|Screening failure|0|||
27965008|NCT00758485|54622894|FG000|Overall Study|Lost to Follow-up|0|||
27965009|NCT00758485|54622895|FG001|Overall Study|Lost to Follow-up|1|||
27965010|NCT00758485|54622894|FG000|Overall Study|Not Treated|1|||
27965011|NCT00758485|54622895|FG001|Overall Study|Not Treated|2|||
27965012|NCT00757783|54622904|FG000|Overall Study|Adverse Event|0|||
27965013|NCT00757783|54622905|FG001|Overall Study|Adverse Event|2|||
27965014|NCT00757783|54622904|FG000|Overall Study|Lost to Follow-up|1|||
27965015|NCT00757783|54622905|FG001|Overall Study|Lost to Follow-up|1|||
27965016|NCT00757783|54622904|FG000|Overall Study|Protocol Violation|1|||
27965017|NCT00757783|54622905|FG001|Overall Study|Protocol Violation|0|||
27965018|NCT00757783|54622904|FG000|Overall Study|Withdrawal by Subject|2|||
27965019|NCT00757783|54622905|FG001|Overall Study|Withdrawal by Subject|1|||
27965020|NCT00757783|54622904|FG000|Overall Study|Other|1|||
27965021|NCT00757783|54622905|FG001|Overall Study|Other|2|||
27965022|NCT00757705|54622911|FG000|Overall Study|Adverse Event|19|||
27965023|NCT00757705|54622911|FG000|Overall Study|Lost to Follow-up|16|||
27965024|NCT00757705|54622911|FG000|Overall Study|Withdrawal by Subject|25|||
27965025|NCT00757705|54622911|FG000|Overall Study|Insufficient Response|26|||
27965026|NCT00757705|54622911|FG000|Overall Study|Ineligible to continue|8|||
27965027|NCT00757705|54622911|FG000|Overall Study|Non-compliant|9|||
27965028|NCT00757705|54622911|FG000|Overall Study|Other|18|||
27965029|NCT00757627|54622915|FG000|Overall Study|Adverse Event|15|||
27965030|NCT00757627|54622915|FG000|Overall Study|Lack of Efficacy|10|||
27965031|NCT00757627|54622915|FG000|Overall Study|Lost to Follow-up|28|||
27965032|NCT00757627|54622915|FG000|Overall Study|Withdrawal by Subject|27|||
27965033|NCT00757627|54622915|FG000|Overall Study|Other|1|||
27965034|NCT01023308|54622926|FG000|Overall Study|Abnormal test proceedure results|3|||
27965035|NCT01023308|54622927|FG001|Overall Study|Abnormal test proceedure results|8|||
27965036|NCT01023308|54622926|FG000|Overall Study|Administrative problems|2|||
27965037|NCT01023308|54622927|FG001|Overall Study|Administrative problems|1|||
27965038|NCT01023308|54622926|FG000|Overall Study|Adverse Event|130|||
27965039|NCT01023308|54622927|FG001|Overall Study|Adverse Event|66|||
27965040|NCT01023308|54622926|FG000|Overall Study|Death|21|||
27965041|NCT01023308|54622927|FG001|Overall Study|Death|17|||
27965042|NCT01023308|54622926|FG000|Overall Study|Disease progression|82|||
27965043|NCT01023308|54622927|FG001|Overall Study|Disease progression|153|||
27965044|NCT01023308|54622926|FG000|Overall Study|New Cancer therapy|4|||
27965045|NCT01023308|54622927|FG001|Overall Study|New Cancer therapy|7|||
27965046|NCT01023308|54622926|FG000|Overall Study|Protocol Violation|3|||
27965047|NCT01023308|54622927|FG001|Overall Study|Protocol Violation|4|||
27965048|NCT01023308|54622926|FG000|Overall Study|Untreated|5|||
27965049|NCT01023308|54622927|FG001|Overall Study|Untreated|5|||
27965050|NCT01023308|54622926|FG000|Overall Study|Lost to Follow-up|1|||
27965051|NCT01023308|54622927|FG001|Overall Study|Lost to Follow-up|0|||
27965052|NCT01023308|54622926|FG000|Overall Study|Withdrawal by Subject|34|||
27965053|NCT01023308|54622927|FG001|Overall Study|Withdrawal by Subject|18|||
27965054|NCT01022996|54622933|FG000|Overall Study|Adverse Event|14|||
27965055|NCT01022996|54622933|FG000|Overall Study|Withdrawal by Subject|3|||
27965056|NCT01022996|54622933|FG000|Overall Study|Lost to Follow-up|1|||
27965057|NCT01022996|54622933|FG000|Overall Study|Administrative problems|6|||
27965058|NCT01022996|54622933|FG000|Overall Study|Disease Progression|32|||
27965059|NCT01022996|54622933|FG000|Overall Study|Protocol Violation|1|||
27965060|NCT00757237|54622939|FG000|Overall Study|Lost to Follow-up|0|||
27965061|NCT00757237|54622940|FG001|Overall Study|Lost to Follow-up|1|||
27965062|NCT00757237|54622939|FG000|Overall Study|Protocol Violation|0|||
27965063|NCT00757237|54622940|FG001|Overall Study|Protocol Violation|2|||
27965064|NCT00757237|54622939|FG000|Overall Study|Physician Decision|2|||
27965065|NCT00757237|54622940|FG001|Overall Study|Physician Decision|3|||
27965066|NCT00757237|54622939|FG000|Overall Study|Withdrawal by Subject|8|||
27965067|NCT00757237|54622940|FG001|Overall Study|Withdrawal by Subject|12|||
27965068|NCT00757237|54622939|FG000|Overall Study|Safety or Tolerability|3|||
27965069|NCT00757237|54622940|FG001|Overall Study|Safety or Tolerability|5|||
27965070|NCT00757237|54622939|FG000|Overall Study|Other|0|||
27965071|NCT00757237|54622940|FG001|Overall Study|Other|2|||
27965072|NCT01029392|54622948|FG000|Overall Study|Withdrawal by Subject|18|||
27965073|NCT01029392|54622949|FG001|Overall Study|Withdrawal by Subject|11|||
27965074|NCT01029392|54622948|FG000|Overall Study|Physician Decision|2|||
27965075|NCT01029392|54622949|FG001|Overall Study|Physician Decision|0|||
27965076|NCT00903006|54622961|FG000|Overall Study|Withdrawal by Subject|2|||
27965077|NCT00903006|54622962|FG001|Overall Study|Withdrawal by Subject|0|||
27965078|NCT00903006|54622963|FG002|Overall Study|Withdrawal by Subject|0|||
27965079|NCT00903006|54622964|FG003|Overall Study|Withdrawal by Subject|0|||
27965080|NCT00903006|54622961|FG000|Overall Study|Progressive Disease|0|||
27965081|NCT00903006|54622962|FG001|Overall Study|Progressive Disease|3|||
27965082|NCT00903006|54622963|FG002|Overall Study|Progressive Disease|1|||
27965083|NCT00903006|54622964|FG003|Overall Study|Progressive Disease|0|||
27965084|NCT00839332|54622977|FG000|Phase 1|Disease Progression|38|||
27965085|NCT00839332|54622978|FG001|Phase 1|Disease Progression|0|||
27965086|NCT00839332|54622979|FG002|Phase 1|Disease Progression|0|||
27965087|NCT00839332|54622977|FG000|Phase 1|Adverse Event|6|||
27965088|NCT00839332|54622978|FG001|Phase 1|Adverse Event|0|||
27965089|NCT00839332|54622979|FG002|Phase 1|Adverse Event|0|||
27965090|NCT00839332|54622977|FG000|Phase 1|Withdrawal by Subject|4|||
27965091|NCT00839332|54622978|FG001|Phase 1|Withdrawal by Subject|0|||
27965092|NCT00839332|54622979|FG002|Phase 1|Withdrawal by Subject|0|||
27965093|NCT00839332|54622977|FG000|Phase 1|Physician Decision|2|||
27965094|NCT00839332|54622978|FG001|Phase 1|Physician Decision|0|||
27965095|NCT00839332|54622979|FG002|Phase 1|Physician Decision|0|||
27965096|NCT00839332|54622977|FG000|Phase 2|Protocol Violation|0|||
27965097|NCT00839332|54622978|FG001|Phase 2|Protocol Violation|1|||
27965098|NCT00839332|54622979|FG002|Phase 2|Protocol Violation|0|||
27965099|NCT00839332|54622977|FG000|Phase 2|Disease Progression|0|||
27965100|NCT00839332|54622978|FG001|Phase 2|Disease Progression|46|||
27965101|NCT00839332|54622979|FG002|Phase 2|Disease Progression|21|||
27965102|NCT00839332|54622977|FG000|Phase 2|Adverse Event|0|||
27965103|NCT00839332|54622978|FG001|Phase 2|Adverse Event|8|||
27965104|NCT00839332|54622979|FG002|Phase 2|Adverse Event|6|||
27965105|NCT00839332|54622977|FG000|Phase 2|Death|0|||
27965106|NCT00839332|54622978|FG001|Phase 2|Death|4|||
27965107|NCT00839332|54622979|FG002|Phase 2|Death|2|||
27965108|NCT00839332|54622977|FG000|Phase 2|Withdrawal by Subject|0|||
27965109|NCT00839332|54622978|FG001|Phase 2|Withdrawal by Subject|5|||
27965110|NCT00839332|54622979|FG002|Phase 2|Withdrawal by Subject|8|||
27965111|NCT00839332|54622977|FG000|Phase 2|Physician Decision|0|||
27965112|NCT00839332|54622978|FG001|Phase 2|Physician Decision|4|||
27965113|NCT00839332|54622979|FG002|Phase 2|Physician Decision|1|||
27965114|NCT00839332|54622977|FG000|Phase 2|Lost to Follow-up|0|||
27965115|NCT00839332|54622978|FG001|Phase 2|Lost to Follow-up|0|||
27965116|NCT00839332|54622979|FG002|Phase 2|Lost to Follow-up|1|||
27965117|NCT00902850|54622990|FG000|Overall Study|Physician Decision|2|||
27965118|NCT00902850|54622991|FG001|Overall Study|Physician Decision|2|||
27965119|NCT00902538|54623000|FG000|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49|||
27965120|NCT00902538|54623001|FG001|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
27965121|NCT00902538|54623002|FG002|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
27965122|NCT00902538|54623003|FG003|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
27965123|NCT00902538|54623004|FG004|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
27965124|NCT00902538|54623005|FG005|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
27965125|NCT00902538|54623000|FG000|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30|||
27965126|NCT00902538|54623001|FG001|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
28083212|NCT00048932|54737051|FG002|Open Label Period (OL)|Site Staff Issues|2|||
28083213|NCT00048932|54737049|FG000|Open Label Period (OL)|Site Not Participating in Open Label|0|||
28083214|NCT00048932|54737050|FG001|Open Label Period (OL)|Site Not Participating in Open Label|0|||
28083215|NCT00048932|54737051|FG002|Open Label Period (OL)|Site Not Participating in Open Label|9|||
28083216|NCT00048932|54737049|FG000|Open Label Period (OL)|Participant Surgery|0|||
28083217|NCT00048932|54737050|FG001|Open Label Period (OL)|Participant Surgery|0|||
28083218|NCT00048932|54737051|FG002|Open Label Period (OL)|Participant Surgery|1|||
28083219|NCT00073983|54737060|FG000|Overall Study|not evaluable|1|||
28083220|NCT03812679|54737066|FG000|Overall Study|Adverse Event|2|||
28083221|NCT03812679|54737066|FG000|Overall Study|Missed >4 consecutive therapy days|1|||
28083222|NCT03812679|54737066|FG000|Overall Study|Renal transplant|1|||
28083223|NCT03812679|54737066|FG000|Overall Study|Withdrawal by Subject|1|||
28083224|NCT03812679|54737066|FG000|Overall Study|Termination of study|2|||
28083225|NCT03812679|54737066|FG000|Overall Study|Water device replacement|1|||
28083226|NCT02952820|54737073|FG000|Placebo-Controlled Treatment (6 Months)|Adverse Event|8|||
28083227|NCT02952820|54737074|FG001|Placebo-Controlled Treatment (6 Months)|Adverse Event|9|||
28083228|NCT02952820|54737075|FG002|Placebo-Controlled Treatment (6 Months)|Adverse Event|16|||
28083229|NCT02952820|54737073|FG000|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
28083230|NCT02952820|54737074|FG001|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
28083231|NCT02952820|54737075|FG002|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6|||
28083232|NCT02952820|54737073|FG000|Placebo-Controlled Treatment (6 Months)|Subject choice|15|||
28083233|NCT02952820|54737074|FG001|Placebo-Controlled Treatment (6 Months)|Subject choice|12|||
28083234|NCT02952820|54737075|FG002|Placebo-Controlled Treatment (6 Months)|Subject choice|17|||
28083235|NCT02952820|54737073|FG000|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17|||
28083236|NCT02952820|54737074|FG001|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12|||
28083237|NCT02952820|54737075|FG002|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11|||
28083238|NCT02952820|54737073|FG000|Placebo-Controlled Treatment (6 Months)|Other than specified|0|||
28165175|NCT03016325|54835754|FG001|182-Day Follow-Up Period|Alive, per civil unit|0|||
27965127|NCT00902538|54623002|FG002|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
27965128|NCT00902538|54623003|FG003|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
27965129|NCT00902538|54623004|FG004|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
27965130|NCT00902538|54623005|FG005|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
27965131|NCT00902538|54623000|FG000|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22|||
27965132|NCT00902538|54623001|FG001|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
27965133|NCT00902538|54623002|FG002|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
27965134|NCT00902538|54623003|FG003|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
27965135|NCT00902538|54623004|FG004|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
27965136|NCT00902538|54623005|FG005|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
27965137|NCT00902538|54623000|FG000|1-Single-blind, Run-in, Single-Treatment|Other Reason|13|||
27965138|NCT00902538|54623001|FG001|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
27965139|NCT00902538|54623002|FG002|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
27965140|NCT00902538|54623003|FG003|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
27965141|NCT00902538|54623004|FG004|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
27965142|NCT00902538|54623005|FG005|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
27965143|NCT00902538|54623000|FG000|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4|||
27965144|NCT00902538|54623001|FG001|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
27965145|NCT00902538|54623002|FG002|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
27965146|NCT00902538|54623003|FG003|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
27965147|NCT00902538|54623004|FG004|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
27965148|NCT00902538|54623005|FG005|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
27965149|NCT00902538|54623000|FG000|2-Randomized Double-blind 3 Treatments|Adverse Event|4|||
27965150|NCT00902538|54623001|FG001|2-Randomized Double-blind 3 Treatments|Adverse Event|2|||
27965151|NCT00902538|54623002|FG002|2-Randomized Double-blind 3 Treatments|Adverse Event|3|||
27965152|NCT00902538|54623003|FG003|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
27965153|NCT00902538|54623004|FG004|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
27965154|NCT00902538|54623005|FG005|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
27965155|NCT00902538|54623000|FG000|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
27965156|NCT00902538|54623001|FG001|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2|||
27965157|NCT00902538|54623002|FG002|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
27965158|NCT00902538|54623003|FG003|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
27965159|NCT00902538|54623004|FG004|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
27965160|NCT00902538|54623005|FG005|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
27965161|NCT00902538|54623000|FG000|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1|||
27965162|NCT00902538|54623001|FG001|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
27965163|NCT00902538|54623002|FG002|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2|||
27965164|NCT00902538|54623003|FG003|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
28083239|NCT02952820|54737074|FG001|Placebo-Controlled Treatment (6 Months)|Other than specified|14|||
28083240|NCT02952820|54737075|FG002|Placebo-Controlled Treatment (6 Months)|Other than specified|13|||
28083241|NCT02952820|54737073|FG000|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13|||
28083242|NCT02952820|54737074|FG001|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11|||
28083243|NCT02952820|54737075|FG002|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21|||
27965165|NCT00902538|54623004|FG004|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
27965166|NCT00902538|54623005|FG005|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
27965167|NCT00902538|54623000|FG000|2-Randomized Double-blind 3 Treatments|Other|2|||
27965168|NCT00902538|54623001|FG001|2-Randomized Double-blind 3 Treatments|Other|1|||
27965169|NCT00902538|54623002|FG002|2-Randomized Double-blind 3 Treatments|Other|0|||
27965170|NCT00902538|54623003|FG003|2-Randomized Double-blind 3 Treatments|Other|0|||
27965171|NCT00902538|54623004|FG004|2-Randomized Double-blind 3 Treatments|Other|0|||
27965172|NCT00902538|54623005|FG005|2-Randomized Double-blind 3 Treatments|Other|0|||
27965173|NCT00902538|54623000|FG000|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
27965174|NCT00902538|54623001|FG001|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
27965175|NCT00902538|54623002|FG002|2-Randomized Double-blind 3 Treatments|Protocol Violation|2|||
27965176|NCT00902538|54623003|FG003|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
27965177|NCT00902538|54623004|FG004|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
27965178|NCT00902538|54623005|FG005|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
27965179|NCT00902538|54623000|FG000|3-Single-blind, Single Treatment|Adverse Event|0|||
27965180|NCT00902538|54623001|FG001|3-Single-blind, Single Treatment|Adverse Event|5|||
27965181|NCT00902538|54623002|FG002|3-Single-blind, Single Treatment|Adverse Event|0|||
27965182|NCT00902538|54623003|FG003|3-Single-blind, Single Treatment|Adverse Event|0|||
27965183|NCT00902538|54623004|FG004|3-Single-blind, Single Treatment|Adverse Event|0|||
27965184|NCT00902538|54623005|FG005|3-Single-blind, Single Treatment|Adverse Event|0|||
27965185|NCT00902538|54623000|FG000|3-Single-blind, Single Treatment|Protocol Violation|0|||
27965186|NCT00902538|54623001|FG001|3-Single-blind, Single Treatment|Protocol Violation|5|||
27965187|NCT00902538|54623002|FG002|3-Single-blind, Single Treatment|Protocol Violation|0|||
27965188|NCT00902538|54623003|FG003|3-Single-blind, Single Treatment|Protocol Violation|0|||
27965189|NCT00902538|54623004|FG004|3-Single-blind, Single Treatment|Protocol Violation|0|||
27965190|NCT00902538|54623005|FG005|3-Single-blind, Single Treatment|Protocol Violation|0|||
27965191|NCT00902538|54623000|FG000|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
27965192|NCT00902538|54623001|FG001|3-Single-blind, Single Treatment|Withdrawal by Subject|4|||
27965193|NCT00902538|54623002|FG002|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
27965194|NCT00902538|54623003|FG003|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
27965195|NCT00902538|54623004|FG004|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
27965196|NCT00902538|54623005|FG005|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
27965197|NCT00902538|54623000|FG000|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
27965198|NCT00902538|54623001|FG001|3-Single-blind, Single Treatment|Lost to Follow-up|1|||
27965199|NCT00902538|54623002|FG002|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
27965200|NCT00902538|54623003|FG003|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
27965201|NCT00902538|54623004|FG004|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
27965202|NCT00902538|54623005|FG005|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
27965203|NCT00902538|54623000|FG000|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
27965204|NCT00902538|54623001|FG001|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
27965205|NCT00902538|54623002|FG002|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
27965206|NCT00902538|54623003|FG003|4-Randomized Double-blind 2 Treatments|Adverse Event|3|||
28083244|NCT02952820|54737073|FG000|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
28083245|NCT02952820|54737074|FG001|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
28083246|NCT02952820|54737075|FG002|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
28083247|NCT02952820|54737073|FG000|Active Treatment Period (6 Months)|Adverse Event|0|||
28083248|NCT02952820|54737074|FG001|Active Treatment Period (6 Months)|Adverse Event|6|||
28083249|NCT02952820|54737075|FG002|Active Treatment Period (6 Months)|Adverse Event|5|||
28083250|NCT02952820|54737073|FG000|Active Treatment Period (6 Months)|Lost to Follow-up|0|||
28083251|NCT02952820|54737074|FG001|Active Treatment Period (6 Months)|Lost to Follow-up|4|||
28083252|NCT02952820|54737075|FG002|Active Treatment Period (6 Months)|Lost to Follow-up|6|||
28083253|NCT02952820|54737073|FG000|Active Treatment Period (6 Months)|Subject choice|0|||
28083254|NCT02952820|54737074|FG001|Active Treatment Period (6 Months)|Subject choice|10|||
28083255|NCT02952820|54737075|FG002|Active Treatment Period (6 Months)|Subject choice|7|||
28083256|NCT02952820|54737073|FG000|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0|||
28083257|NCT02952820|54737074|FG001|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6|||
28083258|NCT02952820|54737075|FG002|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2|||
28083259|NCT02952820|54737073|FG000|Active Treatment Period (6 Months)|Withdrawal of consent|0|||
28083260|NCT02952820|54737074|FG001|Active Treatment Period (6 Months)|Withdrawal of consent|6|||
28083261|NCT02952820|54737075|FG002|Active Treatment Period (6 Months)|Withdrawal of consent|8|||
28083262|NCT02952820|54737073|FG000|Active Treatment Period (6 Months)|Other than specified|0|||
28083263|NCT02952820|54737074|FG001|Active Treatment Period (6 Months)|Other than specified|6|||
28083264|NCT02952820|54737075|FG002|Active Treatment Period (6 Months)|Other than specified|2|||
28083265|NCT02952820|54737073|FG000|Active Treatment Period (6 Months)|Not treated|0|||
28083266|NCT02952820|54737074|FG001|Active Treatment Period (6 Months)|Not treated|0|||
28083267|NCT02952820|54737075|FG002|Active Treatment Period (6 Months)|Not treated|1|||
27965207|NCT00902538|54623004|FG004|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
27965208|NCT00902538|54623005|FG005|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
27965209|NCT00902538|54623000|FG000|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
27965210|NCT00902538|54623001|FG001|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
27965211|NCT00902538|54623002|FG002|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
27965212|NCT00902538|54623003|FG003|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3|||
27965213|NCT00902538|54623004|FG004|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1|||
27965214|NCT00902538|54623005|FG005|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
27965215|NCT00902538|54623000|FG000|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
27965216|NCT00902538|54623001|FG001|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
27965217|NCT00902538|54623002|FG002|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
27965218|NCT00902538|54623003|FG003|4-Randomized Double-blind 2 Treatments|Protocol Violation|3|||
27965219|NCT00902538|54623004|FG004|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
27965220|NCT00902538|54623005|FG005|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
28083268|NCT00006392|54737090|FG000|Overall Study|Ineligible|11|||
28083269|NCT00006392|54737091|FG001|Overall Study|Ineligible|3|||
28083270|NCT00006392|54737092|FG002|Overall Study|Ineligible|5|||
27855173|NCT01277887|54375620|FG001|Pre-Quit Treatment Phase|No longer interested in treatment|0|||
27855174|NCT01277887|54375619|FG000|Pre-Quit Treatment Phase|Withdrawal by Subject|2|||
27855175|NCT01277887|54375620|FG001|Pre-Quit Treatment Phase|Withdrawal by Subject|0|||
27855176|NCT01277887|54375619|FG000|Post-Quit Treatment Phase|No longer interested in treatment|3|||
27855177|NCT01277887|54375620|FG001|Post-Quit Treatment Phase|No longer interested in treatment|5|||
27855178|NCT01276327|54375634|FG000|Overall Study|Adverse Event|1|||
27965221|NCT01036022|54623027|FG000|Overall Study|Adverse Event|1|||
27965222|NCT01036022|54623028|FG001|Overall Study|Adverse Event|3|||
27965223|NCT01036022|54623029|FG002|Overall Study|Adverse Event|2|||
27965224|NCT01036022|54623030|FG003|Overall Study|Adverse Event|1|||
27965225|NCT01036022|54623031|FG004|Overall Study|Adverse Event|0|||
28083271|NCT00006392|54737093|FG003|Overall Study|Ineligible|5|||
28083272|NCT00006392|54737090|FG000|Overall Study|Poor data/ppt mgmt, regulatory problems|156|||
28083273|NCT00006392|54737091|FG001|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
28165176|NCT03016325|54835755|FG002|182-Day Follow-Up Period|Alive, per civil unit|0|||
28165177|NCT03016325|54835756|FG003|182-Day Follow-Up Period|Alive, per civil unit|0|||
27965226|NCT01036022|54623032|FG005|Overall Study|Adverse Event|2|||
28083274|NCT00006392|54737092|FG002|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
28083275|NCT00006392|54737093|FG003|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
28083276|NCT00379769|54737107|FG000|Main Study|Death|57|||
28083277|NCT00379769|54737108|FG001|Main Study|Death|67|||
28083278|NCT00379769|54737109|FG002|Main Study|Death|54|||
28083279|NCT00379769|54737110|FG003|Main Study|Death|72|||
28083280|NCT00379769|54737111|FG004|Main Study|Death|0|||
27965227|NCT01036022|54623027|FG000|Overall Study|Lack of Efficacy|1|||
27965228|NCT01036022|54623028|FG001|Overall Study|Lack of Efficacy|1|||
27965229|NCT01036022|54623029|FG002|Overall Study|Lack of Efficacy|1|||
27965230|NCT01036022|54623030|FG003|Overall Study|Lack of Efficacy|0|||
27965231|NCT01036022|54623031|FG004|Overall Study|Lack of Efficacy|1|||
27965232|NCT01036022|54623032|FG005|Overall Study|Lack of Efficacy|1|||
27965233|NCT01036022|54623027|FG000|Overall Study|Physician Decision|0|||
27965234|NCT01036022|54623028|FG001|Overall Study|Physician Decision|0|||
27965235|NCT01036022|54623029|FG002|Overall Study|Physician Decision|1|||
27965236|NCT01036022|54623030|FG003|Overall Study|Physician Decision|0|||
27965237|NCT01036022|54623031|FG004|Overall Study|Physician Decision|0|||
27965238|NCT01036022|54623032|FG005|Overall Study|Physician Decision|0|||
27965239|NCT01036022|54623027|FG000|Overall Study|Withdrawal by Subject|0|||
27965240|NCT01036022|54623028|FG001|Overall Study|Withdrawal by Subject|0|||
27965241|NCT01036022|54623029|FG002|Overall Study|Withdrawal by Subject|0|||
27965242|NCT01036022|54623030|FG003|Overall Study|Withdrawal by Subject|1|||
27965243|NCT01036022|54623031|FG004|Overall Study|Withdrawal by Subject|2|||
27965244|NCT01036022|54623032|FG005|Overall Study|Withdrawal by Subject|0|||
27965245|NCT00752557|54623057|FG000|Overall Study|Withdrawal by Subject|4|||
27965246|NCT00752557|54623058|FG001|Overall Study|Withdrawal by Subject|3|||
27965247|NCT00752557|54623059|FG002|Overall Study|Withdrawal by Subject|3|||
27965248|NCT00752557|54623057|FG000|Overall Study|Unspecified resaons|0|||
27965249|NCT00752557|54623058|FG001|Overall Study|Unspecified resaons|2|||
27965250|NCT00752557|54623059|FG002|Overall Study|Unspecified resaons|2|||
27965251|NCT00752557|54623057|FG000|Overall Study|Lost to Follow-up|1|||
27965252|NCT00752557|54623058|FG001|Overall Study|Lost to Follow-up|0|||
27965253|NCT00752557|54623059|FG002|Overall Study|Lost to Follow-up|1|||
27965254|NCT00747643|54623071|FG000|Overall Study|Withdrawal by Subject|36|||
27965255|NCT00747643|54623072|FG001|Overall Study|Withdrawal by Subject|27|||
27965256|NCT01022762|54623080|FG000|Overall Study|Adverse Event|3|||
27965257|NCT01022762|54623081|FG001|Overall Study|Adverse Event|1|||
27965258|NCT01022762|54623080|FG000|Overall Study|Lack of Efficacy|0|||
27965259|NCT01022762|54623081|FG001|Overall Study|Lack of Efficacy|1|||
27965260|NCT01022762|54623080|FG000|Overall Study|Protocol Violation|7|||
27965261|NCT01022762|54623081|FG001|Overall Study|Protocol Violation|6|||
27965262|NCT01022762|54623080|FG000|Overall Study|Unclassified|12|||
27965263|NCT01022762|54623081|FG001|Overall Study|Unclassified|20|||
27965264|NCT01028378|54623087|FG000|Overall Study|Lost to Follow-up|12|||
27965265|NCT01028378|54623087|FG000|Overall Study|Withdrawal by Subject|1|||
27965266|NCT01028378|54623087|FG000|Overall Study|Adminstrative Reasons|4|||
27965267|NCT00747565|54623093|FG000|Overall Study|Withdrawal by Subject|10|||
27965268|NCT00747565|54623094|FG001|Overall Study|Withdrawal by Subject|6|||
27965269|NCT00747565|54623093|FG000|Overall Study|Lost to Follow-up|4|||
27965270|NCT00747565|54623094|FG001|Overall Study|Lost to Follow-up|1|||
27965271|NCT01028300|54623100|FG000|Overall Study|Study Terminated|4|||
28083281|NCT00379769|54737112|FG005|Main Study|Death|0|||
28083282|NCT00379769|54737107|FG000|Main Study|Adverse Event|5|||
28083283|NCT00379769|54737108|FG001|Main Study|Adverse Event|8|||
28083284|NCT00379769|54737109|FG002|Main Study|Adverse Event|10|||
28083285|NCT00379769|54737110|FG003|Main Study|Adverse Event|11|||
28083286|NCT00379769|54737111|FG004|Main Study|Adverse Event|0|||
28083287|NCT00379769|54737112|FG005|Main Study|Adverse Event|0|||
28083288|NCT00379769|54737107|FG000|Main Study|Lost to Follow-up|29|||
28083289|NCT00379769|54737108|FG001|Main Study|Lost to Follow-up|29|||
28083290|NCT00379769|54737109|FG002|Main Study|Lost to Follow-up|25|||
28083291|NCT00379769|54737110|FG003|Main Study|Lost to Follow-up|26|||
28083292|NCT00379769|54737111|FG004|Main Study|Lost to Follow-up|0|||
28083293|NCT00379769|54737112|FG005|Main Study|Lost to Follow-up|0|||
27965272|NCT00752089|54623104|FG000|Overall Study|Adverse Event|1|||
27965273|NCT00752089|54623104|FG000|Overall Study|Protocol Deviation|2|||
27965274|NCT00752089|54623104|FG000|Overall Study|Could not attend visit 9|1|||
27965275|NCT00752089|54623104|FG000|Overall Study|Not capable of wearing partial denture|1|||
27965276|NCT00752089|54623104|FG000|Overall Study|Cannot continue the study|1|||
27965277|NCT00751933|54623115|FG000|Overall Study|Withdrawal by Subject|0|||
27965278|NCT00751933|54623116|FG001|Overall Study|Withdrawal by Subject|1|||
28083294|NCT00379769|54737107|FG000|Main Study|Withdrawal by Subject|46|||
28083295|NCT00379769|54737108|FG001|Main Study|Withdrawal by Subject|56|||
27965279|NCT00751933|54623117|FG002|Overall Study|Withdrawal by Subject|0|||
28083296|NCT00379769|54737109|FG002|Main Study|Withdrawal by Subject|72|||
28083297|NCT00379769|54737110|FG003|Main Study|Withdrawal by Subject|70|||
28083298|NCT00379769|54737111|FG004|Main Study|Withdrawal by Subject|0|||
28083299|NCT00379769|54737112|FG005|Main Study|Withdrawal by Subject|0|||
27965280|NCT00751933|54623118|FG003|Overall Study|Withdrawal by Subject|0|||
27965281|NCT00751933|54623115|FG000|Overall Study|Physician Decision|0|||
27965282|NCT00751933|54623116|FG001|Overall Study|Physician Decision|0|||
27965283|NCT00751933|54623117|FG002|Overall Study|Physician Decision|1|||
27965284|NCT00751933|54623118|FG003|Overall Study|Physician Decision|1|||
27965285|NCT00751621|54623122|FG000|Overall Study|Adverse Event|1|||
27965286|NCT00751621|54623122|FG000|Overall Study|Withdrawal by Subject|1|||
27965287|NCT00751621|54623122|FG000|Overall Study|Subject moved to another country|1|||
27965288|NCT00751621|54623122|FG000|Overall Study|Poor adherence to asthma treatment|1|||
27965289|NCT01028222|54623130|FG000|Overall Study|Protocol deviation|1|||
27965290|NCT01028222|54623131|FG001|Overall Study|Protocol deviation|0|||
27965291|NCT01028222|54623130|FG000|Overall Study|Disease progression|33|||
27965292|NCT01028222|54623131|FG001|Overall Study|Disease progression|9|||
27965293|NCT01028222|54623130|FG000|Overall Study|Administrative problems|1|||
27965294|NCT01028222|54623131|FG001|Overall Study|Administrative problems|1|||
27965295|NCT01028222|54623130|FG000|Overall Study|Lost to Follow-up|0|||
27965296|NCT01028222|54623131|FG001|Overall Study|Lost to Follow-up|1|||
27965297|NCT01028222|54623130|FG000|Overall Study|Withdrawal by Subject|1|||
27965298|NCT01028222|54623131|FG001|Overall Study|Withdrawal by Subject|0|||
27965299|NCT01028222|54623130|FG000|Overall Study|Crossover to nilotinib w/out progression|0|||
27965300|NCT01028222|54623131|FG001|Overall Study|Crossover to nilotinib w/out progression|2|||
27965301|NCT01028222|54623130|FG000|Overall Study|Adverse Event|2|||
27965302|NCT01028222|54623131|FG001|Overall Study|Adverse Event|0|||
27965303|NCT00586495|54623138|FG000|Treatment Period|Adverse Event|11|||
27965304|NCT00586495|54623138|FG000|Treatment Period|Death|1|||
27965305|NCT00586495|54623138|FG000|Treatment Period|Protocol Violation|1|||
27965306|NCT00586495|54623138|FG000|Treatment Period|Withdrawal by Subject|1|||
27965307|NCT00586495|54623138|FG000|Treatment Period|Disease progression, recurrence/relapse|71|||
27965308|NCT00586495|54623138|FG000|Treatment Period|Switch to commercial drug|10|||
27965309|NCT00586495|54623138|FG000|Follow-up|Death|40|||
27965310|NCT00586495|54623138|FG000|Follow-up|Lost to Follow-up|1|||
27965311|NCT00586495|54623138|FG000|Follow-up|Withdrawal by Subject|4|||
27965312|NCT00586495|54623138|FG000|Follow-up|Protocol driven decision point|37|||
27965313|NCT00586495|54623138|FG000|Follow-up|Switch to commercial drug|10|||
27965314|NCT01027754|54623144|FG000|Overall Study|withdrew/lost to follow-up after interve|2|||
27965315|NCT01027754|54623145|FG001|Overall Study|withdrew/lost to follow-up after interve|3|||
27965316|NCT01027754|54623144|FG000|Overall Study|Withdrawal by Subject|0|||
27965317|NCT01027754|54623145|FG001|Overall Study|Withdrawal by Subject|5|||
27965318|NCT01034540|54623157|FG000|Overall Study|Adverse Event|0|||
27965319|NCT01034540|54623158|FG001|Overall Study|Adverse Event|1|||
27965320|NCT00774930|54623168|FG000|DB Phase|Early Roll Over (ERO) to IOL phase|11|||
27965321|NCT00774930|54623169|FG001|DB Phase|Early Roll Over (ERO) to IOL phase|12|||
27965322|NCT00774930|54623168|FG000|DB Phase|Adverse Event|1|||
27965323|NCT00774930|54623169|FG001|DB Phase|Adverse Event|2|||
27965324|NCT00774930|54623168|FG000|DB Phase|Subject Decision|1|||
27965325|NCT00774930|54623169|FG001|DB Phase|Subject Decision|5|||
27965326|NCT00774930|54623168|FG000|DB Phase|Sponsor Decision|0|||
27965327|NCT00774930|54623169|FG001|DB Phase|Sponsor Decision|1|||
27965328|NCT00774930|54623168|FG000|DB Phase|Disease Progression|1|||
27965329|NCT00774930|54623169|FG001|DB Phase|Disease Progression|1|||
27965330|NCT00774930|54623168|FG000|DB Phase|Started Nonprotocol Radiation therapy|0|||
27965331|NCT00774930|54623169|FG001|DB Phase|Started Nonprotocol Radiation therapy|1|||
27965332|NCT00774930|54623168|FG000|IOL Phase|Adverse Event|1|||
27965333|NCT00774930|54623169|FG001|IOL Phase|Adverse Event|1|||
27965334|NCT00774930|54623168|FG000|IOL Phase|Subject Decision|4|||
27965335|NCT00774930|54623169|FG001|IOL Phase|Subject Decision|3|||
27965336|NCT00774930|54623168|FG000|IOL Phase|Physician Decision|3|||
27965337|NCT00774930|54623169|FG001|IOL Phase|Physician Decision|2|||
27965338|NCT00774930|54623168|FG000|IOL Phase|Sponsor Decision|1|||
27965339|NCT00774930|54623169|FG001|IOL Phase|Sponsor Decision|0|||
27965340|NCT00774930|54623168|FG000|IOL Phase|Disease Progression|2|||
27965341|NCT00774930|54623169|FG001|IOL Phase|Disease Progression|1|||
27965342|NCT00774930|54623168|FG000|IOL Phase|Subject Consumed Prohibited Medication|1|||
27965343|NCT00774930|54623169|FG001|IOL Phase|Subject Consumed Prohibited Medication|0|||
27965344|NCT00774930|54623168|FG000|IOL Phase|Peptide Receptor Radionuclide Therapy|0|||
27965345|NCT00774930|54623169|FG001|IOL Phase|Peptide Receptor Radionuclide Therapy|1|||
27965346|NCT00774930|54623168|FG000|IOL Phase|Other|1|||
27965347|NCT00774930|54623169|FG001|IOL Phase|Other|0|||
27965348|NCT00774930|54623168|FG000|IOL Phase|Brain radiation|0|||
27965349|NCT00774930|54623169|FG001|IOL Phase|Brain radiation|1|||
27965350|NCT00774930|54623168|FG000|LTOLE Phase|Adverse Event|7|||
27965351|NCT00774930|54623169|FG001|LTOLE Phase|Adverse Event|3|||
27965352|NCT00774930|54623168|FG000|LTOLE Phase|Subject decision|0|||
27965353|NCT00774930|54623169|FG001|LTOLE Phase|Subject decision|5|||
27965354|NCT00774930|54623168|FG000|LTOLE Phase|Physician Decision|4|||
27965355|NCT00774930|54623169|FG001|LTOLE Phase|Physician Decision|1|||
27965356|NCT00774930|54623168|FG000|LTOLE Phase|Sponsor decision|2|||
27965357|NCT00774930|54623169|FG001|LTOLE Phase|Sponsor decision|1|||
27965358|NCT00774930|54623168|FG000|LTOLE Phase|Disease Progression|2|||
27965359|NCT00774930|54623169|FG001|LTOLE Phase|Disease Progression|5|||
27965360|NCT00774930|54623168|FG000|LTOLE Phase|Tumour Progression of Hepatic Metastases|0|||
27965361|NCT00774930|54623169|FG001|LTOLE Phase|Tumour Progression of Hepatic Metastases|1|||
27965362|NCT00774930|54623168|FG000|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0|||
27965363|NCT00774930|54623169|FG001|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1|||
27965364|NCT01027364|54623190|FG000|Overall Study|Adverse Event|1|||
27965365|NCT01027364|54623191|FG001|Overall Study|Adverse Event|0|||
27965366|NCT01027364|54623192|FG002|Overall Study|Adverse Event|1|||
27965367|NCT01027364|54623193|FG003|Overall Study|Adverse Event|0|||
27965368|NCT01027364|54623190|FG000|Overall Study|Lost to Follow-up|1|||
27965369|NCT01027364|54623191|FG001|Overall Study|Lost to Follow-up|0|||
27965370|NCT01027364|54623192|FG002|Overall Study|Lost to Follow-up|0|||
27965371|NCT01027364|54623193|FG003|Overall Study|Lost to Follow-up|0|||
27965372|NCT01027364|54623190|FG000|Overall Study|Protocol Violation|1|||
27965373|NCT01027364|54623191|FG001|Overall Study|Protocol Violation|0|||
27965374|NCT01027364|54623192|FG002|Overall Study|Protocol Violation|0|||
27965375|NCT01027364|54623193|FG003|Overall Study|Protocol Violation|1|||
27965376|NCT01027364|54623190|FG000|Overall Study|Withdrawal by Subject|1|||
27965377|NCT01027364|54623191|FG001|Overall Study|Withdrawal by Subject|2|||
27965378|NCT01027364|54623192|FG002|Overall Study|Withdrawal by Subject|0|||
27965379|NCT01027364|54623193|FG003|Overall Study|Withdrawal by Subject|0|||
27965380|NCT01027286|54623221|FG000|Overall Study|Unable to Obtain Required Blood Volume|1|||
27965381|NCT01027286|54623222|FG001|Overall Study|Unable to Obtain Required Blood Volume|0|||
27965382|NCT01027286|54623221|FG000|Overall Study|Lost to Follow-up|0|||
27965383|NCT01027286|54623222|FG001|Overall Study|Lost to Follow-up|1|||
27965384|NCT01026974|54623232|FG000|Overall Study|Withdrawal by Subject|0|||
27965385|NCT01026974|54623233|FG001|Overall Study|Withdrawal by Subject|1|||
27965386|NCT01026974|54623234|FG002|Overall Study|Withdrawal by Subject|7|||
27965387|NCT01026974|54623235|FG003|Overall Study|Withdrawal by Subject|2|||
27965388|NCT01026974|54623232|FG000|Overall Study|Lost to Follow-up|1|||
27965389|NCT01026974|54623233|FG001|Overall Study|Lost to Follow-up|1|||
27965390|NCT01026974|54623234|FG002|Overall Study|Lost to Follow-up|4|||
27965391|NCT01026974|54623235|FG003|Overall Study|Lost to Follow-up|0|||
27965392|NCT01026974|54623232|FG000|Overall Study|Adverse Event|0|||
27965393|NCT01026974|54623233|FG001|Overall Study|Adverse Event|0|||
27965394|NCT01026974|54623234|FG002|Overall Study|Adverse Event|0|||
27965395|NCT01026974|54623235|FG003|Overall Study|Adverse Event|1|||
27965396|NCT01026974|54623232|FG000|Overall Study|Inappropriate enrollment|0|||
27965397|NCT01026974|54623233|FG001|Overall Study|Inappropriate enrollment|0|||
27965398|NCT01026974|54623234|FG002|Overall Study|Inappropriate enrollment|1|||
27965399|NCT01026974|54623235|FG003|Overall Study|Inappropriate enrollment|0|||
27965400|NCT00897390|54623250|FG000|Overall Study|Adverse Event|2|||
27965401|NCT00897390|54623250|FG000|Overall Study|No Longer Met Study Criteria|1|||
27965402|NCT00897390|54623250|FG000|Overall Study|Personal Reasons|1|||
27965403|NCT00897390|54623250|FG000|Overall Study|Did not Return for the Clinic Visit|2|||
27965404|NCT01034462|54623263|FG000|Overall Study|Adverse Event|7|||
27965405|NCT01034462|54623264|FG001|Overall Study|Adverse Event|17|||
27965406|NCT01034462|54623263|FG000|Overall Study|Lack of Efficacy|4|||
27965407|NCT01034462|54623264|FG001|Overall Study|Lack of Efficacy|4|||
27965408|NCT01034462|54623263|FG000|Overall Study|Protocol Violation|10|||
27965409|NCT01034462|54623264|FG001|Overall Study|Protocol Violation|7|||
27965410|NCT01034462|54623263|FG000|Overall Study|Withdrawal by Subject|9|||
27965411|NCT01034462|54623264|FG001|Overall Study|Withdrawal by Subject|8|||
27965412|NCT01034462|54623263|FG000|Overall Study|Lost to Follow-up|14|||
27965413|NCT01034462|54623264|FG001|Overall Study|Lost to Follow-up|16|||
27965414|NCT01034462|54623263|FG000|Overall Study|Other reasons|1|||
27965415|NCT01034462|54623264|FG001|Overall Study|Other reasons|2|||
27965416|NCT01033448|54623272|FG000|Overall Study|Withdrawal by Subject|4|||
27965417|NCT01033448|54623272|FG000|Overall Study|Positive HCV-RNA at week 48|1|||
27965418|NCT01033448|54623272|FG000|Overall Study|Lost to Follow-up|3|||
28165178|NCT03016325|54835757|FG004|182-Day Follow-Up Period|Alive, per civil unit|1|||
28165179|NCT03016325|54835758|FG005|182-Day Follow-Up Period|Alive, per civil unit|0|||
28165180|NCT03016325|54835759|FG006|182-Day Follow-Up Period|Alive, per civil unit|0|||
27965419|NCT01033448|54623272|FG000|Overall Study|Withdrew due to other reasons|3|||
27965420|NCT01033448|54623272|FG000|Overall Study|Unknown disposition|1|||
27965421|NCT00746941|54623282|FG000|Overall Study|Death|2|||
27965422|NCT00746941|54623283|FG001|Overall Study|Death|0|||
27965423|NCT00746941|54623284|FG002|Overall Study|Death|0|||
27965424|NCT00746941|54623285|FG003|Overall Study|Death|6|||
28165181|NCT03016325|54835760|FG007|182-Day Follow-Up Period|Alive, per civil unit|0|||
28165182|NCT03016325|54835753|FG000|182-Day Follow-Up Period|Vital status collected via EMR|0|||
27965425|NCT00746941|54623282|FG000|Overall Study|Physician Decision|0|||
27965426|NCT00746941|54623283|FG001|Overall Study|Physician Decision|0|||
27965427|NCT00746941|54623284|FG002|Overall Study|Physician Decision|2|||
27965428|NCT00746941|54623285|FG003|Overall Study|Physician Decision|0|||
27965429|NCT00746941|54623282|FG000|Overall Study|Withdrawal by Subject|3|||
27965430|NCT00746941|54623283|FG001|Overall Study|Withdrawal by Subject|0|||
27965431|NCT00746941|54623284|FG002|Overall Study|Withdrawal by Subject|0|||
27965432|NCT00746941|54623285|FG003|Overall Study|Withdrawal by Subject|2|||
27965433|NCT00746941|54623282|FG000|Overall Study|Other, reason not provided|2|||
27965434|NCT00746941|54623283|FG001|Overall Study|Other, reason not provided|4|||
27965435|NCT00746941|54623284|FG002|Overall Study|Other, reason not provided|0|||
27965436|NCT00746941|54623285|FG003|Overall Study|Other, reason not provided|4|||
27965437|NCT00746941|54623282|FG000|Overall Study|Adverse Event|0|||
27965438|NCT00746941|54623283|FG001|Overall Study|Adverse Event|0|||
27965439|NCT00746941|54623284|FG002|Overall Study|Adverse Event|0|||
27965440|NCT00746941|54623285|FG003|Overall Study|Adverse Event|1|||
27965441|NCT00746785|54623297|FG000|Overall Study|Lost to Follow-up|29|||
27965442|NCT00746785|54623298|FG001|Overall Study|Lost to Follow-up|25|||
27965443|NCT00746785|54623299|FG002|Overall Study|Lost to Follow-up|27|||
27965444|NCT00750919|54623307|FG000|Overall Study|Adverse Event|9|||
27965445|NCT00750919|54623307|FG000|Overall Study|Withdrawal by Subject|1|||
27965446|NCT00750919|54623307|FG000|Overall Study|Lack of Efficacy|8|||
27965447|NCT00750919|54623307|FG000|Overall Study|Could not cooperate, unrelated to trial|4|||
27965448|NCT00750919|54623307|FG000|Overall Study|Other|36|||
27965449|NCT00746551|54623313|FG000|At Gestational Age of 36 Weeks|Lost to Follow-up|2|||
27965450|NCT00746551|54623314|FG001|At Gestational Age of 36 Weeks|Lost to Follow-up|4|||
27965451|NCT00746551|54623313|FG000|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9|||
27965452|NCT00746551|54623314|FG001|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7|||
27965453|NCT00746551|54623313|FG000|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6|||
27965454|NCT00746551|54623314|FG001|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8|||
27965455|NCT00753649|54623322|FG000|Overall Study|Migrated/moved from study area|1|||
27965456|NCT00753649|54623323|FG001|Overall Study|Migrated/moved from study area|0|||
27965457|NCT00753649|54623322|FG000|Overall Study|Lost to follow-up-incomplete vaccination|3|||
27965458|NCT00753649|54623323|FG001|Overall Study|Lost to follow-up-incomplete vaccination|0|||
27965459|NCT00753649|54623322|FG000|Overall Study|Lost to follow-up-complete vaccination|1|||
27965460|NCT00753649|54623323|FG001|Overall Study|Lost to follow-up-complete vaccination|0|||
27965461|NCT00753649|54623322|FG000|Overall Study|Protocol Violation|2|||
27965462|NCT00753649|54623323|FG001|Overall Study|Protocol Violation|0|||
27965463|NCT00750139|54623333|FG000|Overall Study|Adverse Event|1|||
27965464|NCT00750139|54623334|FG001|Overall Study|Adverse Event|2|||
27965465|NCT00750139|54623335|FG002|Overall Study|Adverse Event|0|||
27965466|NCT00750139|54623336|FG003|Overall Study|Adverse Event|1|||
27965467|NCT00750139|54623333|FG000|Overall Study|Lost to Follow-up|17|||
27965468|NCT00750139|54623334|FG001|Overall Study|Lost to Follow-up|12|||
27965469|NCT00750139|54623335|FG002|Overall Study|Lost to Follow-up|15|||
27965470|NCT00750139|54623336|FG003|Overall Study|Lost to Follow-up|6|||
27965471|NCT00750139|54623333|FG000|Overall Study|Withdrawal by Subject|3|||
27965472|NCT00750139|54623334|FG001|Overall Study|Withdrawal by Subject|2|||
27965473|NCT00750139|54623335|FG002|Overall Study|Withdrawal by Subject|6|||
27965474|NCT00750139|54623336|FG003|Overall Study|Withdrawal by Subject|2|||
27965475|NCT00750139|54623333|FG000|Overall Study|Physician Decision|1|||
27965476|NCT00750139|54623334|FG001|Overall Study|Physician Decision|1|||
27965477|NCT00750139|54623335|FG002|Overall Study|Physician Decision|0|||
27965478|NCT00750139|54623336|FG003|Overall Study|Physician Decision|0|||
27965479|NCT00750139|54623333|FG000|Overall Study|Non-compliance|1|||
27965480|NCT00750139|54623334|FG001|Overall Study|Non-compliance|0|||
27965481|NCT00750139|54623335|FG002|Overall Study|Non-compliance|1|||
27965482|NCT00750139|54623336|FG003|Overall Study|Non-compliance|3|||
27965483|NCT00750139|54623333|FG000|Overall Study|Termination by sponsor|4|||
27965484|NCT00750139|54623334|FG001|Overall Study|Termination by sponsor|0|||
27965485|NCT00750139|54623335|FG002|Overall Study|Termination by sponsor|0|||
27965486|NCT00750139|54623336|FG003|Overall Study|Termination by sponsor|1|||
27965487|NCT00750139|54623333|FG000|Overall Study|Non-specific|62|||
27965488|NCT00750139|54623334|FG001|Overall Study|Non-specific|42|||
27965489|NCT00750139|54623335|FG002|Overall Study|Non-specific|79|||
28083300|NCT00379769|54737107|FG000|Main Study|Moved to survival status follow-up only|27|||
28083301|NCT00379769|54737108|FG001|Main Study|Moved to survival status follow-up only|25|||
28083302|NCT00379769|54737109|FG002|Main Study|Moved to survival status follow-up only|32|||
28083303|NCT00379769|54737110|FG003|Main Study|Moved to survival status follow-up only|36|||
28083304|NCT00379769|54737111|FG004|Main Study|Moved to survival status follow-up only|0|||
28083305|NCT00379769|54737112|FG005|Main Study|Moved to survival status follow-up only|0|||
28083306|NCT00379769|54737107|FG000|Main Study|Participant moved|3|||
28083307|NCT00379769|54737108|FG001|Main Study|Participant moved|2|||
27965490|NCT00750139|54623336|FG003|Overall Study|Non-specific|33|||
27965491|NCT00750061|54623350|FG000|Overall Study|Adverse Event|2|||
27965492|NCT00750061|54623351|FG001|Overall Study|Adverse Event|0|||
27965493|NCT00750061|54623350|FG000|Overall Study|Withdrawal by Subject|0|||
27965494|NCT00750061|54623351|FG001|Overall Study|Withdrawal by Subject|1|||
27965495|NCT00750061|54623350|FG000|Overall Study|Physician Decision|0|||
27965496|NCT00750061|54623351|FG001|Overall Study|Physician Decision|1|||
27965497|NCT00744757|54623357|FG000|Overall Study|Objective disease progression|7|||
28083308|NCT00379769|54737109|FG002|Main Study|Participant moved|3|||
28083309|NCT00379769|54737110|FG003|Main Study|Participant moved|3|||
27965498|NCT00744757|54623357|FG000|Overall Study|Physician Decision|5|||
27965499|NCT00744757|54623357|FG000|Overall Study|Withdrawal by Subject|1|||
27965500|NCT00744757|54623357|FG000|Overall Study|Death|6|||
27965501|NCT00744757|54623357|FG000|Overall Study|Adverse Event|2|||
27965502|NCT00745849|54623361|FG000|First Intervention|Withdrawal by Subject|0|||
27965503|NCT00745849|54623362|FG001|First Intervention|Withdrawal by Subject|1|||
27965504|NCT00745849|54623361|FG000|First Intervention|Lost to Follow-up|1|||
27965505|NCT00745849|54623362|FG001|First Intervention|Lost to Follow-up|1|||
27965506|NCT00745849|54623361|FG000|Second Intervention|Lost to Follow-up|2|||
27965507|NCT00745849|54623362|FG001|Second Intervention|Lost to Follow-up|1|||
27965508|NCT00749203|54623379|FG000|no Infusion at Week 1|Lost to Follow-up|0|||
27965509|NCT00749203|54623380|FG001|no Infusion at Week 1|Lost to Follow-up|1|||
27965510|NCT00749203|54623379|FG000|no Infusion at Week 1|Withdrawal by Subject|0|||
27965511|NCT00749203|54623380|FG001|no Infusion at Week 1|Withdrawal by Subject|1|||
27965512|NCT00749203|54623379|FG000|no Infusion at Week 1|delayed-onset sedation|0|||
27965513|NCT00749203|54623380|FG001|no Infusion at Week 1|delayed-onset sedation|1|||
27965514|NCT00749203|54623379|FG000|no Infusion at Week 1|low baseline PTSD symptoms level|0|||
27965515|NCT00749203|54623380|FG001|no Infusion at Week 1|low baseline PTSD symptoms level|1|||
27965516|NCT00749203|54623379|FG000|Second Infusion at 2 Weeks|Protocol Violation|0|||
27965517|NCT00749203|54623380|FG001|Second Infusion at 2 Weeks|Protocol Violation|1|||
27965518|NCT00749203|54623379|FG000|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0|||
27965519|NCT00749203|54623380|FG001|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1|||
27965520|NCT00748969|54623388|FG000|Overall Study|Withdrawal by Subject|1|||
27965521|NCT00748969|54623389|FG001|Overall Study|Withdrawal by Subject|0|||
27965522|NCT00748969|54623388|FG000|Overall Study|Withdrawal by Subject|0|||
27965523|NCT00748969|54623389|FG001|Overall Study|Withdrawal by Subject|1|||
27965524|NCT00745615|54623399|FG000|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3|||
27965525|NCT00745615|54623400|FG001|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1|||
27965526|NCT00745615|54623401|FG002|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
27965527|NCT00745615|54623402|FG003|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4|||
27965528|NCT00745615|54623403|FG004|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
27965529|NCT00745615|54623404|FG005|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
27965530|NCT00745615|54623399|FG000|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
27965531|NCT00745615|54623400|FG001|Double-Blind Extension (36 Weeks)|Physician Decision|1|||
27965532|NCT00745615|54623401|FG002|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
27965533|NCT00745615|54623402|FG003|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
27965534|NCT00745615|54623403|FG004|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
27965535|NCT00745615|54623404|FG005|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
27965536|NCT00745615|54623399|FG000|Double-Blind Extension (36 Weeks)|Adverse Event|2|||
27965537|NCT00745615|54623400|FG001|Double-Blind Extension (36 Weeks)|Adverse Event|3|||
27965538|NCT00745615|54623401|FG002|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
27965539|NCT00745615|54623402|FG003|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
27965540|NCT00745615|54623403|FG004|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
27965541|NCT00745615|54623404|FG005|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
27965542|NCT00745615|54623399|FG000|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
27965543|NCT00745615|54623400|FG001|Double-Blind Extension (36 Weeks)|Pregnancy|1|||
27965544|NCT00745615|54623401|FG002|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
27965545|NCT00745615|54623402|FG003|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
27965546|NCT00745615|54623403|FG004|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
27965547|NCT00745615|54623404|FG005|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
27965548|NCT00745615|54623399|FG000|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
27965549|NCT00745615|54623400|FG001|Double-Blind Extension (36 Weeks)|Other Than Specified|1|||
27965550|NCT00745615|54623401|FG002|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
27965551|NCT00745615|54623402|FG003|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
27965552|NCT00745615|54623403|FG004|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
27965553|NCT00745615|54623404|FG005|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
27965554|NCT00745615|54623399|FG000|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
27965555|NCT00745615|54623400|FG001|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
27965556|NCT00745615|54623401|FG002|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
27965557|NCT00745615|54623402|FG003|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
27965558|NCT00745615|54623403|FG004|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
27965559|NCT00745615|54623404|FG005|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
27965560|NCT00745615|54623399|FG000|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
27965561|NCT00745615|54623400|FG001|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
27965562|NCT00745615|54623401|FG002|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
28083310|NCT00379769|54737111|FG004|Main Study|Participant moved|0|||
28083311|NCT00379769|54737112|FG005|Main Study|Participant moved|0|||
27965563|NCT00745615|54623402|FG003|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
27965564|NCT00745615|54623403|FG004|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
27965565|NCT00745615|54623404|FG005|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
27965566|NCT00745615|54623399|FG000|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
27965567|NCT00745615|54623400|FG001|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
27965568|NCT00745615|54623401|FG002|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
27965569|NCT00745615|54623402|FG003|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
27965570|NCT00745615|54623403|FG004|Open-Label (up to Approx 10.5 Years)|Physician Decision|9|||
27965571|NCT00745615|54623404|FG005|Open-Label (up to Approx 10.5 Years)|Physician Decision|11|||
28083312|NCT00379769|54737107|FG000|Main Study|Poor compliance|3|||
28083313|NCT00379769|54737108|FG001|Main Study|Poor compliance|2|||
28083314|NCT00379769|54737109|FG002|Main Study|Poor compliance|2|||
28083315|NCT00379769|54737110|FG003|Main Study|Poor compliance|1|||
28083316|NCT00379769|54737111|FG004|Main Study|Poor compliance|0|||
28083317|NCT00379769|54737112|FG005|Main Study|Poor compliance|0|||
28083318|NCT00379769|54737107|FG000|Main Study|Prohibited glucose lowering medication|0|||
28083319|NCT00379769|54737108|FG001|Main Study|Prohibited glucose lowering medication|3|||
28083320|NCT00379769|54737109|FG002|Main Study|Prohibited glucose lowering medication|0|||
28083321|NCT00379769|54737110|FG003|Main Study|Prohibited glucose lowering medication|1|||
28083322|NCT00379769|54737111|FG004|Main Study|Prohibited glucose lowering medication|0|||
28083323|NCT00379769|54737112|FG005|Main Study|Prohibited glucose lowering medication|0|||
27965572|NCT00745615|54623399|FG000|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
27965573|NCT00745615|54623400|FG001|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
27965574|NCT00745615|54623401|FG002|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
27965575|NCT00745615|54623402|FG003|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
27965576|NCT00745615|54623403|FG004|Open-Label (up to Approx 10.5 Years)|Adverse Event|2|||
28165183|NCT03016325|54835754|FG001|182-Day Follow-Up Period|Vital status collected via EMR|0|||
28165184|NCT03016325|54835755|FG002|182-Day Follow-Up Period|Vital status collected via EMR|0|||
28165185|NCT03016325|54835756|FG003|182-Day Follow-Up Period|Vital status collected via EMR|1|||
28165186|NCT03016325|54835757|FG004|182-Day Follow-Up Period|Vital status collected via EMR|0|||
27965577|NCT00745615|54623404|FG005|Open-Label (up to Approx 10.5 Years)|Adverse Event|8|||
27965578|NCT00745615|54623399|FG000|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
27965579|NCT00745615|54623400|FG001|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
27965580|NCT00745615|54623401|FG002|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
27965581|NCT00745615|54623402|FG003|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
27965582|NCT00745615|54623403|FG004|Open-Label (up to Approx 10.5 Years)|Pregnancy|2|||
27965583|NCT00745615|54623404|FG005|Open-Label (up to Approx 10.5 Years)|Pregnancy|5|||
27965584|NCT00745615|54623399|FG000|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
27965585|NCT00745615|54623400|FG001|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
27965586|NCT00745615|54623401|FG002|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
27965587|NCT00745615|54623402|FG003|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
27965588|NCT00745615|54623403|FG004|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1|||
27965589|NCT00745615|54623404|FG005|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3|||
27965590|NCT00745615|54623399|FG000|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
27965591|NCT00745615|54623400|FG001|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
28083324|NCT00379769|54737107|FG000|Main Study|Site closed|4|||
28083325|NCT00379769|54737108|FG001|Main Study|Site closed|4|||
28083326|NCT00379769|54737109|FG002|Main Study|Site closed|4|||
28083327|NCT00379769|54737110|FG003|Main Study|Site closed|8|||
28083328|NCT00379769|54737111|FG004|Main Study|Site closed|0|||
28083329|NCT00379769|54737112|FG005|Main Study|Site closed|0|||
28083330|NCT00379769|54737107|FG000|Main Study|Entry criteria violation|0|||
28083331|NCT00379769|54737108|FG001|Main Study|Entry criteria violation|0|||
28083332|NCT00379769|54737109|FG002|Main Study|Entry criteria violation|1|||
28083333|NCT00379769|54737110|FG003|Main Study|Entry criteria violation|1|||
28083334|NCT00379769|54737111|FG004|Main Study|Entry criteria violation|0|||
28083335|NCT00379769|54737112|FG005|Main Study|Entry criteria violation|0|||
28083336|NCT00379769|54737107|FG000|Main Study|Participant did not take study drug|0|||
28083337|NCT00379769|54737108|FG001|Main Study|Participant did not take study drug|0|||
28083338|NCT00379769|54737109|FG002|Main Study|Participant did not take study drug|1|||
28083339|NCT00379769|54737110|FG003|Main Study|Participant did not take study drug|0|||
28083340|NCT00379769|54737111|FG004|Main Study|Participant did not take study drug|0|||
28083341|NCT00379769|54737112|FG005|Main Study|Participant did not take study drug|0|||
27732665|NCT02570126|54180228|FG000|Overall Study|Withdrawal by Subject|3|||
27732666|NCT02570126|54180229|FG001|Overall Study|Withdrawal by Subject|7|||
27965592|NCT00745615|54623401|FG002|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
27965593|NCT00745615|54623402|FG003|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
28083342|NCT00379769|54737107|FG000|Main Study|Physician Decision|2|||
28083343|NCT00379769|54737108|FG001|Main Study|Physician Decision|2|||
28083344|NCT00379769|54737109|FG002|Main Study|Physician Decision|1|||
28083345|NCT00379769|54737110|FG003|Main Study|Physician Decision|1|||
27965594|NCT00745615|54623403|FG004|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
27965595|NCT00745615|54623404|FG005|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1|||
27965596|NCT00745615|54623399|FG000|Open-Label (up to Approx 10.5 Years)|Death|0|||
27965597|NCT00745615|54623400|FG001|Open-Label (up to Approx 10.5 Years)|Death|0|||
27965598|NCT00745615|54623401|FG002|Open-Label (up to Approx 10.5 Years)|Death|0|||
27965599|NCT00745615|54623402|FG003|Open-Label (up to Approx 10.5 Years)|Death|0|||
27965600|NCT00745615|54623403|FG004|Open-Label (up to Approx 10.5 Years)|Death|0|||
27965601|NCT00745615|54623404|FG005|Open-Label (up to Approx 10.5 Years)|Death|1|||
27965602|NCT00745615|54623399|FG000|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
27965603|NCT00745615|54623400|FG001|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
27965604|NCT00745615|54623401|FG002|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
27965605|NCT00745615|54623402|FG003|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
27965606|NCT00745615|54623403|FG004|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8|||
27965607|NCT00745615|54623404|FG005|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10|||
27965608|NCT00744523|54623418|FG000|30 Days After the Procedure|Insufficient follow-up|0|||
27965609|NCT00744523|54623419|FG001|30 Days After the Procedure|Insufficient follow-up|5|||
27965610|NCT04517253|54623430|FG000|Overall Study|Adverse Event|1|||
27965611|NCT04517253|54623431|FG001|Overall Study|Adverse Event|0|||
27965612|NCT04517253|54623432|FG002|Overall Study|Adverse Event|0|||
27965613|NCT04517253|54623430|FG000|Overall Study|Death|0|||
27965614|NCT04517253|54623431|FG001|Overall Study|Death|1|||
27965615|NCT04517253|54623432|FG002|Overall Study|Death|0|||
27965616|NCT00744991|54623442|FG000|Overall Study|Progressive Disease|11|||
27965617|NCT00744991|54623442|FG000|Overall Study|Withdrawal by Subject|8|||
27965618|NCT00744991|54623442|FG000|Overall Study|Physician Decision|3|||
27965619|NCT00744991|54623442|FG000|Overall Study|Adverse Event|2|||
27965620|NCT00744991|54623442|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
27965621|NCT00839254|54623466|FG000|Overall Study|Protocol Violation|0|||
27965622|NCT00839254|54623467|FG001|Overall Study|Protocol Violation|1|||
27965623|NCT00839254|54623468|FG002|Overall Study|Protocol Violation|1|||
27965624|NCT00839254|54623469|FG003|Overall Study|Protocol Violation|1|||
27965625|NCT00839254|54623470|FG004|Overall Study|Protocol Violation|0|||
28083346|NCT00379769|54737111|FG004|Main Study|Physician Decision|0|||
28083347|NCT00379769|54737112|FG005|Main Study|Physician Decision|0|||
28083348|NCT00379769|54737107|FG000|Main Study|Participant completed study at visit 27|1|||
28083349|NCT00379769|54737108|FG001|Main Study|Participant completed study at visit 27|0|||
28083350|NCT00379769|54737109|FG002|Main Study|Participant completed study at visit 27|0|||
28083351|NCT00379769|54737110|FG003|Main Study|Participant completed study at visit 27|0|||
28083352|NCT00379769|54737111|FG004|Main Study|Participant completed study at visit 27|0|||
28083353|NCT00379769|54737112|FG005|Main Study|Participant completed study at visit 27|0|||
28083354|NCT00379769|54737107|FG000|Main Study|Personal reasons|1|||
28083355|NCT00379769|54737108|FG001|Main Study|Personal reasons|0|||
28083356|NCT00379769|54737109|FG002|Main Study|Personal reasons|0|||
28083357|NCT00379769|54737110|FG003|Main Study|Personal reasons|0|||
28083358|NCT00379769|54737111|FG004|Main Study|Personal reasons|0|||
28083359|NCT00379769|54737112|FG005|Main Study|Personal reasons|0|||
28083360|NCT00379769|54737107|FG000|Main Study|Risk of heart failure|0|||
28083361|NCT00379769|54737108|FG001|Main Study|Risk of heart failure|1|||
28083362|NCT00379769|54737109|FG002|Main Study|Risk of heart failure|0|||
28083363|NCT00379769|54737110|FG003|Main Study|Risk of heart failure|0|||
28083364|NCT00379769|54737111|FG004|Main Study|Risk of heart failure|0|||
28083365|NCT00379769|54737112|FG005|Main Study|Risk of heart failure|0|||
28083366|NCT00379769|54737107|FG000|Main Study|Investigator refused to log temperature|0|||
28083367|NCT00379769|54737108|FG001|Main Study|Investigator refused to log temperature|0|||
28083368|NCT00379769|54737109|FG002|Main Study|Investigator refused to log temperature|1|||
28083369|NCT00379769|54737110|FG003|Main Study|Investigator refused to log temperature|0|||
28083370|NCT00379769|54737111|FG004|Main Study|Investigator refused to log temperature|0|||
28083371|NCT00379769|54737112|FG005|Main Study|Investigator refused to log temperature|0|||
28083372|NCT00379769|54737107|FG000|Main Study|Reason unspecified|0|||
28083373|NCT00379769|54737108|FG001|Main Study|Reason unspecified|0|||
28083374|NCT00379769|54737109|FG002|Main Study|Reason unspecified|1|||
28083375|NCT00379769|54737110|FG003|Main Study|Reason unspecified|0|||
28083376|NCT00379769|54737111|FG004|Main Study|Reason unspecified|0|||
28083377|NCT00379769|54737112|FG005|Main Study|Reason unspecified|0|||
28083378|NCT00379769|54737107|FG000|Observational Follow-up|Death|0|||
28165187|NCT03016325|54835758|FG005|182-Day Follow-Up Period|Vital status collected via EMR|0|||
27855179|NCT01276327|54375635|FG001|Overall Study|Adverse Event|3|||
27965626|NCT00839254|54623471|FG005|Overall Study|Protocol Violation|0|||
27965627|NCT00839254|54623472|FG006|Overall Study|Protocol Violation|1|||
27965628|NCT00839254|54623473|FG007|Overall Study|Protocol Violation|2|||
28083379|NCT00379769|54737108|FG001|Observational Follow-up|Death|0|||
27965629|NCT00839254|54623466|FG000|Overall Study|Physician Decision|0|||
28083380|NCT00379769|54737109|FG002|Observational Follow-up|Death|0|||
28083381|NCT00379769|54737110|FG003|Observational Follow-up|Death|0|||
28083382|NCT00379769|54737111|FG004|Observational Follow-up|Death|78|||
28083383|NCT00379769|54737112|FG005|Observational Follow-up|Death|70|||
28083384|NCT00379769|54737107|FG000|Observational Follow-up|Adverse Event|0|||
28083385|NCT00379769|54737108|FG001|Observational Follow-up|Adverse Event|0|||
28083386|NCT00379769|54737109|FG002|Observational Follow-up|Adverse Event|0|||
28083387|NCT00379769|54737110|FG003|Observational Follow-up|Adverse Event|0|||
28083388|NCT00379769|54737111|FG004|Observational Follow-up|Adverse Event|1|||
28083389|NCT00379769|54737112|FG005|Observational Follow-up|Adverse Event|0|||
28083390|NCT00379769|54737107|FG000|Observational Follow-up|Lost to Follow-up|0|||
28083391|NCT00379769|54737108|FG001|Observational Follow-up|Lost to Follow-up|0|||
28083392|NCT00379769|54737109|FG002|Observational Follow-up|Lost to Follow-up|0|||
28083393|NCT00379769|54737110|FG003|Observational Follow-up|Lost to Follow-up|0|||
28083394|NCT00379769|54737111|FG004|Observational Follow-up|Lost to Follow-up|25|||
28083395|NCT00379769|54737112|FG005|Observational Follow-up|Lost to Follow-up|27|||
28083396|NCT00379769|54737107|FG000|Observational Follow-up|Withdrawal by Subject|0|||
28083397|NCT00379769|54737108|FG001|Observational Follow-up|Withdrawal by Subject|0|||
28083398|NCT00379769|54737109|FG002|Observational Follow-up|Withdrawal by Subject|0|||
28083399|NCT00379769|54737110|FG003|Observational Follow-up|Withdrawal by Subject|0|||
28083400|NCT00379769|54737111|FG004|Observational Follow-up|Withdrawal by Subject|12|||
28083401|NCT00379769|54737112|FG005|Observational Follow-up|Withdrawal by Subject|12|||
27965630|NCT00839254|54623467|FG001|Overall Study|Physician Decision|1|||
27965631|NCT00839254|54623468|FG002|Overall Study|Physician Decision|0|||
27965632|NCT00839254|54623469|FG003|Overall Study|Physician Decision|0|||
27965633|NCT00839254|54623470|FG004|Overall Study|Physician Decision|0|||
27965634|NCT00839254|54623471|FG005|Overall Study|Physician Decision|0|||
27965635|NCT00839254|54623472|FG006|Overall Study|Physician Decision|0|||
27965636|NCT00839254|54623473|FG007|Overall Study|Physician Decision|1|||
27965637|NCT00839254|54623466|FG000|Overall Study|Wrong treatment number allocation|0|||
27965638|NCT00839254|54623467|FG001|Overall Study|Wrong treatment number allocation|1|||
27965639|NCT00839254|54623468|FG002|Overall Study|Wrong treatment number allocation|0|||
27965640|NCT00839254|54623469|FG003|Overall Study|Wrong treatment number allocation|0|||
27965641|NCT00839254|54623470|FG004|Overall Study|Wrong treatment number allocation|0|||
27965642|NCT00839254|54623471|FG005|Overall Study|Wrong treatment number allocation|1|||
27965643|NCT00839254|54623472|FG006|Overall Study|Wrong treatment number allocation|0|||
27965644|NCT00839254|54623473|FG007|Overall Study|Wrong treatment number allocation|0|||
27965645|NCT00839254|54623466|FG000|Overall Study|Adverse Event|12|||
27965646|NCT00839254|54623467|FG001|Overall Study|Adverse Event|6|||
27965647|NCT00839254|54623468|FG002|Overall Study|Adverse Event|3|||
27965648|NCT00839254|54623469|FG003|Overall Study|Adverse Event|5|||
27965649|NCT00839254|54623470|FG004|Overall Study|Adverse Event|2|||
27965650|NCT00839254|54623471|FG005|Overall Study|Adverse Event|1|||
27965651|NCT00839254|54623472|FG006|Overall Study|Adverse Event|0|||
27965652|NCT00839254|54623473|FG007|Overall Study|Adverse Event|1|||
27965653|NCT00839254|54623466|FG000|Overall Study|Withdrawal by Subject|87|||
27965654|NCT00839254|54623467|FG001|Overall Study|Withdrawal by Subject|53|||
27965655|NCT00839254|54623468|FG002|Overall Study|Withdrawal by Subject|54|||
27965656|NCT00839254|54623469|FG003|Overall Study|Withdrawal by Subject|32|||
27965657|NCT00839254|54623470|FG004|Overall Study|Withdrawal by Subject|27|||
27965658|NCT00839254|54623471|FG005|Overall Study|Withdrawal by Subject|15|||
27965659|NCT00839254|54623472|FG006|Overall Study|Withdrawal by Subject|22|||
27965660|NCT00839254|54623473|FG007|Overall Study|Withdrawal by Subject|9|||
27965661|NCT00839254|54623466|FG000|Overall Study|Wrong group allocation|0|||
27965662|NCT00839254|54623467|FG001|Overall Study|Wrong group allocation|0|||
27965663|NCT00839254|54623468|FG002|Overall Study|Wrong group allocation|0|||
27965664|NCT00839254|54623469|FG003|Overall Study|Wrong group allocation|0|||
27965665|NCT00839254|54623470|FG004|Overall Study|Wrong group allocation|0|||
27965666|NCT00839254|54623471|FG005|Overall Study|Wrong group allocation|0|||
27965667|NCT00839254|54623472|FG006|Overall Study|Wrong group allocation|1|||
27965668|NCT00839254|54623473|FG007|Overall Study|Wrong group allocation|0|||
27965669|NCT00839254|54623466|FG000|Overall Study|Parents wanted pneumococcal vaccine|1|||
27965670|NCT00839254|54623467|FG001|Overall Study|Parents wanted pneumococcal vaccine|0|||
27965671|NCT00839254|54623468|FG002|Overall Study|Parents wanted pneumococcal vaccine|0|||
27965672|NCT00839254|54623469|FG003|Overall Study|Parents wanted pneumococcal vaccine|0|||
27965673|NCT00839254|54623470|FG004|Overall Study|Parents wanted pneumococcal vaccine|0|||
27965674|NCT00839254|54623471|FG005|Overall Study|Parents wanted pneumococcal vaccine|1|||
27965675|NCT00839254|54623472|FG006|Overall Study|Parents wanted pneumococcal vaccine|0|||
27965676|NCT00839254|54623473|FG007|Overall Study|Parents wanted pneumococcal vaccine|0|||
27965677|NCT00839254|54623466|FG000|Overall Study|Withdrawn due to non-compliance|2|||
28083402|NCT00379769|54737107|FG000|Observational Follow-up|Entered into Another Clinical Trial|0|||
28165188|NCT03016325|54835759|FG006|182-Day Follow-Up Period|Vital status collected via EMR|0|||
28165189|NCT03016325|54835760|FG007|182-Day Follow-Up Period|Vital status collected via EMR|0|||
27965678|NCT00839254|54623467|FG001|Overall Study|Withdrawn due to non-compliance|0|||
27965679|NCT00839254|54623468|FG002|Overall Study|Withdrawn due to non-compliance|0|||
28083403|NCT00379769|54737108|FG001|Observational Follow-up|Entered into Another Clinical Trial|0|||
27965680|NCT00839254|54623469|FG003|Overall Study|Withdrawn due to non-compliance|0|||
27965681|NCT00839254|54623470|FG004|Overall Study|Withdrawn due to non-compliance|0|||
27965682|NCT00839254|54623471|FG005|Overall Study|Withdrawn due to non-compliance|0|||
27965683|NCT00839254|54623472|FG006|Overall Study|Withdrawn due to non-compliance|0|||
27965684|NCT00839254|54623473|FG007|Overall Study|Withdrawn due to non-compliance|0|||
27965685|NCT00839254|54623466|FG000|Overall Study|Lost to Follow-up|51|||
27965686|NCT00839254|54623467|FG001|Overall Study|Lost to Follow-up|30|||
27965687|NCT00839254|54623468|FG002|Overall Study|Lost to Follow-up|32|||
27965688|NCT00839254|54623469|FG003|Overall Study|Lost to Follow-up|24|||
27965689|NCT00839254|54623470|FG004|Overall Study|Lost to Follow-up|8|||
27965690|NCT00839254|54623471|FG005|Overall Study|Lost to Follow-up|8|||
27965691|NCT00839254|54623472|FG006|Overall Study|Lost to Follow-up|4|||
27965692|NCT00839254|54623473|FG007|Overall Study|Lost to Follow-up|2|||
27965693|NCT00586339|54623525|FG000|Overall Study|Withdrawal by Subject|1|||
27965694|NCT00586339|54623526|FG001|Overall Study|Withdrawal by Subject|3|||
27965695|NCT00586339|54623527|FG002|Overall Study|Withdrawal by Subject|1|||
27965696|NCT00586339|54623525|FG000|Overall Study|Migrated/moved from study area|3|||
27965697|NCT00586339|54623526|FG001|Overall Study|Migrated/moved from study area|2|||
27965698|NCT00586339|54623527|FG002|Overall Study|Migrated/moved from study area|4|||
27965699|NCT00586339|54623525|FG000|Overall Study|Lost to Follow-up|3|||
27965700|NCT00586339|54623526|FG001|Overall Study|Lost to Follow-up|2|||
27965701|NCT00586339|54623527|FG002|Overall Study|Lost to Follow-up|1|||
27965702|NCT00812968|54623535|FG000|Overall Study|Relapse after erythroid response|6|||
27965703|NCT00812968|54623535|FG000|Overall Study|Disease progression|1|||
27965704|NCT00812968|54623535|FG000|Overall Study|No further treatment required|1|||
27965705|NCT00812968|54623535|FG000|Overall Study|Study closed due to marketing approval|3|||
27965706|NCT00839098|54623544|FG000|Overall Study|Withdrawal by Subject|2|||
27965707|NCT00839098|54623545|FG001|Overall Study|Withdrawal by Subject|1|||
27965708|NCT00839098|54623546|FG002|Overall Study|Withdrawal by Subject|7|||
27965709|NCT00813748|54623556|FG000|Skin Test Substudy|Physician Decision|0|||
27965710|NCT00813748|54623557|FG001|Skin Test Substudy|Physician Decision|1|||
27965711|NCT00813592|54623565|FG000|Overall Study|Disease assessment was not completed per|2|||
27965712|NCT00813358|54623570|FG000|Overall Study|Death|32|||
27965713|NCT00813358|54623570|FG000|Overall Study|Lost to Follow-up|12|||
27965714|NCT00813358|54623570|FG000|Overall Study|other endpoints|5|||
28083404|NCT00379769|54737109|FG002|Observational Follow-up|Entered into Another Clinical Trial|0|||
28083405|NCT00379769|54737110|FG003|Observational Follow-up|Entered into Another Clinical Trial|0|||
28083406|NCT00379769|54737111|FG004|Observational Follow-up|Entered into Another Clinical Trial|18|||
28083407|NCT00379769|54737112|FG005|Observational Follow-up|Entered into Another Clinical Trial|22|||
28083408|NCT00379769|54737107|FG000|Observational Follow-up|Physician Decision|0|||
28083409|NCT00379769|54737108|FG001|Observational Follow-up|Physician Decision|0|||
28083410|NCT00379769|54737109|FG002|Observational Follow-up|Physician Decision|0|||
28083411|NCT00379769|54737110|FG003|Observational Follow-up|Physician Decision|0|||
28083412|NCT00379769|54737111|FG004|Observational Follow-up|Physician Decision|8|||
28083413|NCT00379769|54737112|FG005|Observational Follow-up|Physician Decision|8|||
28083414|NCT00379769|54737107|FG000|Observational Follow-up|Site Closed Early|0|||
27965715|NCT00813358|54623570|FG000|Overall Study|Withdrawal by Subject|20|||
27965716|NCT00812812|54623576|FG000|Overall Study|Adverse Event|2|||
27965717|NCT00812812|54623577|FG001|Overall Study|Adverse Event|1|||
27965718|NCT00812812|54623576|FG000|Overall Study|Lack of Efficacy|1|||
27965719|NCT00812812|54623577|FG001|Overall Study|Lack of Efficacy|0|||
27965720|NCT00812812|54623576|FG000|Overall Study|Lost to Follow-up|0|||
27965721|NCT00812812|54623577|FG001|Overall Study|Lost to Follow-up|1|||
27965722|NCT00812812|54623576|FG000|Overall Study|Withdrawal by Subject|0|||
27965723|NCT00812812|54623577|FG001|Overall Study|Withdrawal by Subject|2|||
27965724|NCT00810082|54623587|FG000|Overall Study|Lost to Follow-up|0|||
27965725|NCT00810082|54623588|FG001|Overall Study|Lost to Follow-up|4|||
27965726|NCT00748189|54623596|FG000|Overall Study|Death|99|||
27965727|NCT00748189|54623597|FG001|Overall Study|Death|84|||
27965728|NCT00748189|54623596|FG000|Overall Study|Withdrawal by Subject|23|||
27965729|NCT00748189|54623597|FG001|Overall Study|Withdrawal by Subject|29|||
27965730|NCT00748189|54623596|FG000|Overall Study|Physician Decision|16|||
27965731|NCT00748189|54623597|FG001|Overall Study|Physician Decision|5|||
28083415|NCT00379769|54737108|FG001|Observational Follow-up|Site Closed Early|0|||
28083416|NCT00379769|54737109|FG002|Observational Follow-up|Site Closed Early|0|||
28083417|NCT00379769|54737110|FG003|Observational Follow-up|Site Closed Early|0|||
27965732|NCT00748189|54623596|FG000|Overall Study|Lost to Follow-up|8|||
27965733|NCT00748189|54623597|FG001|Overall Study|Lost to Follow-up|15|||
27965734|NCT00748189|54623596|FG000|Overall Study|Study terminated by Sponsor|70|||
27965735|NCT00748189|54623597|FG001|Overall Study|Study terminated by Sponsor|79|||
27965736|NCT00744055|54623610|FG000|Overall Study|Withdrawal by Subject|6|||
27965737|NCT00744055|54623611|FG001|Overall Study|Withdrawal by Subject|9|||
27965738|NCT00744055|54623610|FG000|Overall Study|Lack of Efficacy|0|||
27965739|NCT00744055|54623611|FG001|Overall Study|Lack of Efficacy|1|||
27965740|NCT00744055|54623610|FG000|Overall Study|Physician Decision|0|||
27965741|NCT00744055|54623611|FG001|Overall Study|Physician Decision|2|||
27965742|NCT00744055|54623610|FG000|Overall Study|Protocol Violation|1|||
27965743|NCT00744055|54623611|FG001|Overall Study|Protocol Violation|1|||
27965744|NCT00744055|54623610|FG000|Overall Study|Lost to Follow-up|0|||
27965745|NCT00744055|54623611|FG001|Overall Study|Lost to Follow-up|1|||
27965746|NCT00748033|54623619|FG000|Overall Study|Adverse Event|0|||
27965747|NCT00748033|54623620|FG001|Overall Study|Adverse Event|1|||
27965748|NCT00735553|54623637|FG000|Overall Study|Study prematurely terminated|77|||
27965749|NCT00740779|54623648|FG000|Overall Study|Adverse Event|4|||
27965750|NCT00740779|54623649|FG001|Overall Study|Adverse Event|6|||
27965751|NCT00740779|54623650|FG002|Overall Study|Adverse Event|3|||
27965752|NCT00740779|54623648|FG000|Overall Study|Protocol Violation|1|||
27965753|NCT00740779|54623649|FG001|Overall Study|Protocol Violation|1|||
27965754|NCT00740779|54623650|FG002|Overall Study|Protocol Violation|1|||
27965755|NCT00740779|54623648|FG000|Overall Study|Lack of Efficacy|0|||
27965756|NCT00740779|54623649|FG001|Overall Study|Lack of Efficacy|0|||
27965757|NCT00740779|54623650|FG002|Overall Study|Lack of Efficacy|2|||
27965758|NCT00740779|54623648|FG000|Overall Study|Withdrawal by Subject|2|||
27965759|NCT00740779|54623649|FG001|Overall Study|Withdrawal by Subject|4|||
27965760|NCT00740779|54623650|FG002|Overall Study|Withdrawal by Subject|2|||
27965761|NCT00740779|54623648|FG000|Overall Study|Lost to Follow-up|2|||
28083418|NCT00379769|54737111|FG004|Observational Follow-up|Site Closed Early|6|||
28083419|NCT00379769|54737112|FG005|Observational Follow-up|Site Closed Early|7|||
28083420|NCT00379769|54737107|FG000|Observational Follow-up|Participant Moved|0|||
28083421|NCT00379769|54737108|FG001|Observational Follow-up|Participant Moved|0|||
28083422|NCT00379769|54737109|FG002|Observational Follow-up|Participant Moved|0|||
28083423|NCT00379769|54737110|FG003|Observational Follow-up|Participant Moved|0|||
28083424|NCT00379769|54737111|FG004|Observational Follow-up|Participant Moved|0|||
28083425|NCT00379769|54737112|FG005|Observational Follow-up|Participant Moved|1|||
27965762|NCT00740779|54623649|FG001|Overall Study|Lost to Follow-up|3|||
27965763|NCT00740779|54623650|FG002|Overall Study|Lost to Follow-up|5|||
27965764|NCT00735475|54623660|FG000|Overall Study|Adverse Event|0|||
27965765|NCT00735475|54623661|FG001|Overall Study|Adverse Event|1|||
27965766|NCT00735475|54623660|FG000|Overall Study|Death|1|||
27965767|NCT00735475|54623661|FG001|Overall Study|Death|1|||
27965768|NCT00735475|54623660|FG000|Overall Study|Lost to Follow-up|3|||
27965769|NCT00735475|54623661|FG001|Overall Study|Lost to Follow-up|3|||
27965770|NCT00735475|54623660|FG000|Overall Study|Physician Decision|0|||
27965771|NCT00735475|54623661|FG001|Overall Study|Physician Decision|1|||
28083426|NCT00379769|54737107|FG000|Observational Follow-up|Unknown; Reason Not Provided|0|||
28083427|NCT00379769|54737108|FG001|Observational Follow-up|Unknown; Reason Not Provided|0|||
28083428|NCT00379769|54737109|FG002|Observational Follow-up|Unknown; Reason Not Provided|0|||
28083429|NCT00379769|54737110|FG003|Observational Follow-up|Unknown; Reason Not Provided|0|||
27965772|NCT00735475|54623660|FG000|Overall Study|Withdrawal by Subject|4|||
27965773|NCT00735475|54623661|FG001|Overall Study|Withdrawal by Subject|5|||
27965774|NCT01026818|54623670|FG000|Screening Period|Entry Criteria Not Met|105|||
27965775|NCT01026818|54623671|FG001|Screening Period|Entry Criteria Not Met|0|||
27965776|NCT01026818|54623672|FG002|Screening Period|Entry Criteria Not Met|0|||
27965777|NCT01026818|54623673|FG003|Screening Period|Entry Criteria Not Met|0|||
27965778|NCT01026818|54623670|FG000|Screening Period|Withdrawal by Subject|49|||
27965779|NCT01026818|54623671|FG001|Screening Period|Withdrawal by Subject|0|||
27965780|NCT01026818|54623672|FG002|Screening Period|Withdrawal by Subject|0|||
27965781|NCT01026818|54623673|FG003|Screening Period|Withdrawal by Subject|0|||
27965782|NCT01026818|54623670|FG000|Screening Period|Protocol Deviation|3|||
27965783|NCT01026818|54623671|FG001|Screening Period|Protocol Deviation|0|||
27965784|NCT01026818|54623672|FG002|Screening Period|Protocol Deviation|0|||
27965785|NCT01026818|54623673|FG003|Screening Period|Protocol Deviation|0|||
27965786|NCT01026818|54623670|FG000|Screening Period|Adverse Event|2|||
27965787|NCT01026818|54623671|FG001|Screening Period|Adverse Event|0|||
27965788|NCT01026818|54623672|FG002|Screening Period|Adverse Event|0|||
27965789|NCT01026818|54623673|FG003|Screening Period|Adverse Event|0|||
27965790|NCT01026818|54623670|FG000|Screening Period|Physician Decision|1|||
28083430|NCT00379769|54737111|FG004|Observational Follow-up|Unknown; Reason Not Provided|1|||
28083431|NCT00379769|54737112|FG005|Observational Follow-up|Unknown; Reason Not Provided|1|||
28083432|NCT00006164|54737141|FG000|Overall Study|Withdrew or lost to follow-up|70|||
28083433|NCT00006164|54737142|FG001|Overall Study|Withdrew or lost to follow-up|81|||
27832515|NCT01760447|54311794|FG002|Weeks 20-54|Withdrawal by Subject|1|||
27832516|NCT01760447|54311795|FG003|Weeks 20-54|Withdrawal by Subject|2|||
27832517|NCT01760447|54311792|FG000|Weeks 20-54|Lost to Follow-up|0|||
27832518|NCT01760447|54311793|FG001|Weeks 20-54|Lost to Follow-up|0|||
27965791|NCT01026818|54623671|FG001|Screening Period|Physician Decision|0|||
27965792|NCT01026818|54623672|FG002|Screening Period|Physician Decision|0|||
27965793|NCT01026818|54623673|FG003|Screening Period|Physician Decision|0|||
27965794|NCT01026818|54623670|FG000|DB Treatment Period (Month 0 - 9)|Adverse Event|0|||
27965795|NCT01026818|54623671|FG001|DB Treatment Period (Month 0 - 9)|Adverse Event|10|||
27965796|NCT01026818|54623672|FG002|DB Treatment Period (Month 0 - 9)|Adverse Event|6|||
27965797|NCT01026818|54623673|FG003|DB Treatment Period (Month 0 - 9)|Adverse Event|4|||
28083434|NCT00378599|54737148|FG000|Overall Study|Adverse Event|38|||
28083435|NCT00378599|54737148|FG000|Overall Study|Protocol Violation|2|||
28083436|NCT00378599|54737148|FG000|Overall Study|Treatment failure|7|||
28083437|NCT00378599|54737148|FG000|Overall Study|Withdrawal by Subject|5|||
28083438|NCT00378209|54737152|FG000|Overall Study|Progressive disease|11|||
28083439|NCT00378209|54737152|FG000|Overall Study|Adverse Event|3|||
28083440|NCT00378209|54737152|FG000|Overall Study|Initiation of non-protocol therapy|3|||
27965798|NCT01026818|54623670|FG000|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0|||
27965799|NCT01026818|54623671|FG001|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7|||
27965800|NCT01026818|54623672|FG002|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
27965801|NCT01026818|54623673|FG003|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
27965802|NCT01026818|54623670|FG000|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0|||
27965803|NCT01026818|54623671|FG001|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3|||
27965804|NCT01026818|54623672|FG002|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2|||
27965805|NCT01026818|54623673|FG003|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6|||
27965806|NCT01026818|54623670|FG000|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
27965807|NCT01026818|54623671|FG001|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3|||
27965808|NCT01026818|54623672|FG002|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
27965809|NCT01026818|54623673|FG003|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4|||
27965810|NCT01026818|54623670|FG000|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0|||
27965811|NCT01026818|54623671|FG001|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2|||
27965812|NCT01026818|54623672|FG002|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9|||
27965813|NCT01026818|54623673|FG003|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7|||
27965814|NCT01026818|54623670|FG000|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
27965815|NCT01026818|54623671|FG001|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
27965816|NCT01026818|54623672|FG002|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1|||
27965817|NCT01026818|54623673|FG003|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2|||
27965818|NCT01026818|54623670|FG000|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0|||
27965819|NCT01026818|54623671|FG001|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
27965820|NCT01026818|54623672|FG002|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1|||
27965821|NCT01026818|54623673|FG003|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
27965822|NCT01026818|54623670|FG000|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0|||
27965823|NCT01026818|54623671|FG001|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
27965824|NCT01026818|54623672|FG002|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1|||
27965825|NCT01026818|54623673|FG003|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
27965826|NCT01026818|54623670|FG000|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
27965827|NCT01026818|54623671|FG001|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1|||
27965828|NCT01026818|54623672|FG002|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
27965829|NCT01026818|54623673|FG003|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
27965830|NCT01026818|54623670|FG000|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
27965831|NCT01026818|54623671|FG001|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1|||
27965832|NCT01026818|54623672|FG002|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
27965833|NCT01026818|54623673|FG003|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2|||
27965834|NCT01026818|54623670|FG000|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
27965835|NCT01026818|54623671|FG001|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
27965836|NCT01026818|54623672|FG002|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
27965837|NCT01026818|54623673|FG003|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
27965838|NCT01026818|54623670|FG000|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
27965839|NCT01026818|54623671|FG001|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1|||
27965840|NCT01026818|54623672|FG002|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
27965841|NCT01026818|54623673|FG003|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
27965842|NCT01026818|54623670|FG000|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
28083441|NCT00378209|54737152|FG000|Overall Study|Physician Decision|3|||
28083442|NCT00378209|54737152|FG000|Overall Study|Death|1|||
28083443|NCT00378209|54737152|FG000|Overall Study|Treatment delay|1|||
28083444|NCT03410992|54737159|FG000|Initial Treatment Period: up to Wk16|Adverse Event|0|||
28083445|NCT03410992|54737160|FG001|Initial Treatment Period: up to Wk16|Adverse Event|5|||
28083446|NCT03410992|54737161|FG002|Initial Treatment Period: up to Wk16|Adverse Event|0|||
28083447|NCT03410992|54737162|FG003|Initial Treatment Period: up to Wk16|Adverse Event|0|||
28083448|NCT03410992|54737163|FG004|Initial Treatment Period: up to Wk16|Adverse Event|0|||
28083449|NCT03410992|54737164|FG005|Initial Treatment Period: up to Wk16|Adverse Event|0|||
27965843|NCT01026818|54623671|FG001|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1|||
28083450|NCT03410992|54737165|FG006|Initial Treatment Period: up to Wk16|Adverse Event|0|||
28083451|NCT03410992|54737166|FG007|Initial Treatment Period: up to Wk16|Adverse Event|0|||
28083452|NCT03410992|54737167|FG008|Initial Treatment Period: up to Wk16|Adverse Event|0|||
28083453|NCT03410992|54737168|FG009|Initial Treatment Period: up to Wk16|Adverse Event|0|||
28083454|NCT03410992|54737169|FG010|Initial Treatment Period: up to Wk16|Adverse Event|0|||
28083455|NCT03410992|54737159|FG000|Initial Treatment Period: up to Wk16|Lack of Efficacy|2|||
28083456|NCT03410992|54737160|FG001|Initial Treatment Period: up to Wk16|Lack of Efficacy|1|||
28083457|NCT03410992|54737161|FG002|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
28083458|NCT03410992|54737162|FG003|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
28083459|NCT03410992|54737163|FG004|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
28083460|NCT03410992|54737164|FG005|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
28083461|NCT03410992|54737165|FG006|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
28083462|NCT03410992|54737166|FG007|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
28083463|NCT03410992|54737167|FG008|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
28083464|NCT03410992|54737168|FG009|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
28083465|NCT03410992|54737169|FG010|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
28083466|NCT03410992|54737159|FG000|Initial Treatment Period: up to Wk16|Lost to Follow-up|1|||
28083467|NCT03410992|54737160|FG001|Initial Treatment Period: up to Wk16|Lost to Follow-up|3|||
28083468|NCT03410992|54737161|FG002|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
27732667|NCT02755831|54180237|FG000|Overall Study|Lost to Follow-up|3|||
27732668|NCT02755831|54180238|FG001|Overall Study|Lost to Follow-up|3|||
27732669|NCT02573246|54180249|FG000|Overall Study|Lost to Follow-up|2|||
27732670|NCT02573246|54180250|FG001|Overall Study|Lost to Follow-up|0|||
27732671|NCT02573246|54180251|FG002|Overall Study|Lost to Follow-up|0|||
27965844|NCT01026818|54623672|FG002|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2|||
27965845|NCT01026818|54623673|FG003|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
27965846|NCT01026818|54623670|FG000|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
27965847|NCT01026818|54623671|FG001|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
27965848|NCT01026818|54623672|FG002|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
27965849|NCT01026818|54623673|FG003|Drug-Free Washout Period (Month 9-10.5)|Death|1|||
27965850|NCT01026818|54623670|FG000|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
27965851|NCT01026818|54623671|FG001|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2|||
27965852|NCT01026818|54623672|FG002|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
27965853|NCT01026818|54623673|FG003|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
27965854|NCT01026818|54623670|FG000|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
27965855|NCT01026818|54623671|FG001|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1|||
27965856|NCT01026818|54623672|FG002|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
27965857|NCT01026818|54623673|FG003|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
27965858|NCT01026818|54623670|FG000|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0|||
27965859|NCT01026818|54623671|FG001|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
27965860|NCT01026818|54623672|FG002|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2|||
27965861|NCT01026818|54623673|FG003|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
27965862|NCT01026818|54623670|FG000|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0|||
27732672|NCT02573246|54180252|FG003|Overall Study|Lost to Follow-up|0|||
27732673|NCT02573246|54180253|FG004|Overall Study|Lost to Follow-up|1|||
27732674|NCT02573246|54180249|FG000|Overall Study|Withdrawal by Subject|0|||
27732675|NCT02573246|54180250|FG001|Overall Study|Withdrawal by Subject|0|||
27732676|NCT02573246|54180251|FG002|Overall Study|Withdrawal by Subject|0|||
27732677|NCT02573246|54180252|FG003|Overall Study|Withdrawal by Subject|0|||
27732678|NCT02573246|54180253|FG004|Overall Study|Withdrawal by Subject|1|||
27732679|NCT02573246|54180249|FG000|Overall Study|Physician Decision|1|||
27732680|NCT02573246|54180250|FG001|Overall Study|Physician Decision|1|||
27732681|NCT02573246|54180251|FG002|Overall Study|Physician Decision|3|||
27732682|NCT02573246|54180252|FG003|Overall Study|Physician Decision|2|||
27732683|NCT02573246|54180253|FG004|Overall Study|Physician Decision|2|||
27732684|NCT02570750|54180272|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
27732685|NCT02570750|54180273|FG001|Overall Study|Inclusion/exclusion criteria deviation|0|||
27732686|NCT02570750|54180272|FG000|Overall Study|Protocol deviation|4|||
27732687|NCT02570750|54180273|FG001|Overall Study|Protocol deviation|2|||
27732688|NCT02570750|54180272|FG000|Overall Study|Withdrawal by Subject|5|||
27732689|NCT02570750|54180273|FG001|Overall Study|Withdrawal by Subject|0|||
27732690|NCT02570750|54180272|FG000|Overall Study|Lost to Follow-up|2|||
27732691|NCT02570750|54180273|FG001|Overall Study|Lost to Follow-up|2|||
27732692|NCT02570750|54180272|FG000|Overall Study|Adverse Event|2|||
27732693|NCT02570750|54180273|FG001|Overall Study|Adverse Event|1|||
27732694|NCT02573012|54180281|FG000|Overall Study|Adverse Event|5|||
27832519|NCT01760447|54311794|FG002|Weeks 20-54|Lost to Follow-up|1|||
27965863|NCT01026818|54623671|FG001|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
27965864|NCT01026818|54623672|FG002|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3|||
27965865|NCT01026818|54623673|FG003|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
27965866|NCT01026818|54623670|FG000|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
27965867|NCT01026818|54623671|FG001|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2|||
28083469|NCT03410992|54737162|FG003|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
27732695|NCT02573012|54180282|FG001|Overall Study|Adverse Event|5|||
27732696|NCT02573012|54180281|FG000|Overall Study|Lack of Efficacy|5|||
27732697|NCT02573012|54180282|FG001|Overall Study|Lack of Efficacy|4|||
27965868|NCT01026818|54623672|FG002|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
27965869|NCT01026818|54623673|FG003|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1|||
27965870|NCT00735397|54623685|FG000|Overall Study|Adverse Event|194|||
27965871|NCT00735397|54623685|FG000|Overall Study|Lost to Follow-up|33|||
27965872|NCT00735397|54623685|FG000|Overall Study|Participant choice|252|||
27965873|NCT00735397|54623685|FG000|Overall Study|Inadequate therapeutic effect|202|||
27965874|NCT00735397|54623685|FG000|Overall Study|Administrative/Other|502|||
27965875|NCT00735007|54623692|FG000|Overall Study|Adverse Event|4|||
27965876|NCT00735007|54623692|FG000|Overall Study|Protocol Violation|1|||
27965877|NCT00743509|54623696|FG000|Overall Study|Withdrawal by Subject|2|||
27965878|NCT00734929|54623702|FG000|Overall Study|Lost to Follow-up|1|||
27965879|NCT00734929|54623703|FG001|Overall Study|Lost to Follow-up|2|||
27965880|NCT00734929|54623702|FG000|Overall Study|No intervention/ screen fail|5|||
27965881|NCT00734929|54623703|FG001|Overall Study|No intervention/ screen fail|3|||
27965882|NCT00734851|54623711|FG000|Overall Study|Withdrawal by Subject|2|||
27965883|NCT00734851|54623711|FG000|Overall Study|Lost to Follow-up|1|||
27965884|NCT00734851|54623711|FG000|Overall Study|Physician Decision|18|||
27965885|NCT00734617|54623717|FG000|Overall Study|Adverse Event|4|||
27965886|NCT00734617|54623718|FG001|Overall Study|Adverse Event|7|||
27965887|NCT00734617|54623717|FG000|Overall Study|Withdrawal by Subject|103|||
27965888|NCT00734617|54623718|FG001|Overall Study|Withdrawal by Subject|95|||
27965889|NCT00743431|54623724|FG000|Overall Study|Toxicity|6|||
27965890|NCT00743431|54623724|FG000|Overall Study|Tumor progression|56|||
27965891|NCT00743431|54623724|FG000|Overall Study|Withdrawal by Subject|13|||
27965892|NCT00743431|54623724|FG000|Overall Study|Death|9|||
27965893|NCT00743431|54623724|FG000|Overall Study|Reason for discontinuation not specified|29|||
27965894|NCT00743431|54623724|FG000|Overall Study|No documentation available|13|||
28083470|NCT03410992|54737163|FG004|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
28083471|NCT03410992|54737164|FG005|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
28083472|NCT03410992|54737165|FG006|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
28083473|NCT03410992|54737166|FG007|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
28083474|NCT03410992|54737167|FG008|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
28083475|NCT03410992|54737168|FG009|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
28083476|NCT03410992|54737169|FG010|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
28083477|NCT03410992|54737159|FG000|Initial Treatment Period: up to Wk16|Withdrawal by Subject|1|||
28083478|NCT03410992|54737160|FG001|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
28083479|NCT03410992|54737161|FG002|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
28083480|NCT03410992|54737162|FG003|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
28083481|NCT03410992|54737163|FG004|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
28083482|NCT03410992|54737164|FG005|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
28083483|NCT03410992|54737165|FG006|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
28083484|NCT03410992|54737166|FG007|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
28083485|NCT03410992|54737167|FG008|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
28083486|NCT03410992|54737168|FG009|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
28083487|NCT03410992|54737169|FG010|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
28083488|NCT03410992|54737159|FG000|Week 16 Assessment|PASI90 Non-Response at Week 16|81|||
28083489|NCT03410992|54737160|FG001|Week 16 Assessment|PASI90 Non-Response at Week 16|23|||
28083490|NCT03410992|54737161|FG002|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
28083491|NCT03410992|54737162|FG003|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
28083492|NCT03410992|54737163|FG004|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
28083493|NCT03410992|54737164|FG005|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
28083494|NCT03410992|54737165|FG006|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
28083495|NCT03410992|54737166|FG007|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
28083496|NCT03410992|54737167|FG008|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
28083497|NCT03410992|54737168|FG009|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
28083498|NCT03410992|54737169|FG010|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
28083499|NCT03410992|54737159|FG000|Week 16 Assessment|Incorrect escapers|0|||
28083500|NCT03410992|54737160|FG001|Week 16 Assessment|Incorrect escapers|6|||
28083501|NCT03410992|54737161|FG002|Week 16 Assessment|Incorrect escapers|0|||
27732698|NCT02573012|54180281|FG000|Overall Study|Non-compliance|1|||
27965895|NCT00734539|54623730|FG000|Main Study|Death|33|||
28083502|NCT03410992|54737162|FG003|Week 16 Assessment|Incorrect escapers|0|||
27732699|NCT02573012|54180282|FG001|Overall Study|Non-compliance|2|||
27965896|NCT00734539|54623731|FG001|Main Study|Death|32|||
27965897|NCT00734539|54623730|FG000|Main Study|Physician Decision|2|||
27965898|NCT00734539|54623731|FG001|Main Study|Physician Decision|0|||
27965899|NCT00734539|54623730|FG000|Main Study|Withdrawal by Subject|1|||
27965900|NCT00734539|54623731|FG001|Main Study|Withdrawal by Subject|3|||
27965901|NCT00734539|54623730|FG000|Main Study|Enrolled in error; ineligible|1|||
27965902|NCT00734539|54623731|FG001|Main Study|Enrolled in error; ineligible|0|||
28083503|NCT03410992|54737163|FG004|Week 16 Assessment|Incorrect escapers|0|||
28083504|NCT03410992|54737164|FG005|Week 16 Assessment|Incorrect escapers|0|||
27832520|NCT01760447|54311795|FG003|Weeks 20-54|Lost to Follow-up|2|||
27965903|NCT00743275|54623742|FG000|Overall Study|Protocol Violation|0|||
27965904|NCT00743275|54623743|FG001|Overall Study|Protocol Violation|1|||
27965905|NCT00734149|54623749|FG000|Overall Study|Withdrawal by Subject|1|||
27965906|NCT00743197|54623757|FG000|Overall Study|Study terminated due to departure of PI.|1|||
27965907|NCT00743197|54623758|FG001|Overall Study|Study terminated due to departure of PI.|2|||
27965908|NCT00734071|54623766|FG000|Overall Study|Adverse Event|4|||
27965909|NCT00734071|54623767|FG001|Overall Study|Adverse Event|3|||
27965910|NCT00734071|54623766|FG000|Overall Study|Lack of Efficacy|3|||
27965911|NCT00734071|54623767|FG001|Overall Study|Lack of Efficacy|1|||
27965912|NCT00734071|54623766|FG000|Overall Study|Noncompliance|2|||
27965913|NCT00734071|54623767|FG001|Overall Study|Noncompliance|2|||
27965914|NCT00734071|54623766|FG000|Overall Study|Protocol Deviations|3|||
27965915|NCT00734071|54623767|FG001|Overall Study|Protocol Deviations|4|||
27965916|NCT00734071|54623766|FG000|Overall Study|Voluntary Withdrawal|9|||
27965917|NCT00734071|54623767|FG001|Overall Study|Voluntary Withdrawal|7|||
27965918|NCT00734071|54623766|FG000|Overall Study|Lost to Follow-up|16|||
27965919|NCT00734071|54623767|FG001|Overall Study|Lost to Follow-up|8|||
27965920|NCT00734071|54623766|FG000|Overall Study|Other|1|||
27965921|NCT00734071|54623767|FG001|Overall Study|Other|2|||
27965922|NCT00739297|54623773|FG000|First Washout Period of 4-7 Days|Adverse Event|0|||
27965923|NCT00739297|54623774|FG001|First Washout Period of 4-7 Days|Adverse Event|0|||
27965924|NCT00739297|54623775|FG002|First Washout Period of 4-7 Days|Adverse Event|0|||
27965925|NCT00739297|54623776|FG003|First Washout Period of 4-7 Days|Adverse Event|2|||
27965926|NCT00739297|54623777|FG004|First Washout Period of 4-7 Days|Adverse Event|0|||
27965927|NCT00739297|54623778|FG005|First Washout Period of 4-7 Days|Adverse Event|0|||
27965928|NCT00739297|54623779|FG006|First Washout Period of 4-7 Days|Adverse Event|2|||
27965929|NCT00739297|54623773|FG000|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
27965930|NCT00739297|54623774|FG001|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
27965931|NCT00739297|54623775|FG002|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
27965932|NCT00739297|54623776|FG003|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
27965933|NCT00739297|54623777|FG004|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
27965934|NCT00739297|54623778|FG005|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
27965935|NCT00739297|54623779|FG006|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
27965936|NCT00739063|54623795|FG000|Overall Study|Screen failures|8|||
27965937|NCT01026194|54623801|FG000|Period 1：Double Blind Period|Adverse Event|2|||
27965938|NCT01026194|54623802|FG001|Period 1：Double Blind Period|Adverse Event|1|||
27965939|NCT01026194|54623801|FG000|Period 1：Double Blind Period|Lack of Efficacy|1|||
27965940|NCT01026194|54623802|FG001|Period 1：Double Blind Period|Lack of Efficacy|0|||
27965941|NCT01026194|54623801|FG000|Period 1：Double Blind Period|Physician Decision|0|||
27965942|NCT01026194|54623802|FG001|Period 1：Double Blind Period|Physician Decision|4|||
27965943|NCT01026194|54623801|FG000|Period 2：Open-label Period|Adverse Event|4|||
27965944|NCT01026194|54623802|FG001|Period 2：Open-label Period|Adverse Event|5|||
27965945|NCT01026194|54623801|FG000|Period 2：Open-label Period|Physician Decision|3|||
27965946|NCT01026194|54623802|FG001|Period 2：Open-label Period|Physician Decision|1|||
27965947|NCT01026194|54623801|FG000|Period 2：Open-label Period|Withdrawal by Subject|0|||
27965948|NCT01026194|54623802|FG001|Period 2：Open-label Period|Withdrawal by Subject|4|||
27965949|NCT01033136|54623812|FG000|Follow-Up (3 Month)|Lost to Follow-up|2|||
27965950|NCT01033136|54623813|FG001|Follow-Up (3 Month)|Lost to Follow-up|2|||
27965951|NCT00738673|54623823|FG000|Overall Study|Adverse Event|1|||
27965952|NCT00738673|54623824|FG001|Overall Study|Adverse Event|0|||
27965953|NCT00738673|54623823|FG000|Overall Study|Lack of Efficacy|19|||
27965954|NCT00738673|54623824|FG001|Overall Study|Lack of Efficacy|8|||
27965955|NCT00738673|54623823|FG000|Overall Study|Protocol Violation|1|||
27965956|NCT00738673|54623824|FG001|Overall Study|Protocol Violation|2|||
27965957|NCT00738673|54623823|FG000|Overall Study|Withdrawal by Subject|3|||
27965958|NCT00738673|54623824|FG001|Overall Study|Withdrawal by Subject|1|||
27965959|NCT00811954|54623833|FG000|Overall Study|Death|10|||
27965960|NCT00811954|54623834|FG001|Overall Study|Death|6|||
27965961|NCT00811954|54623835|FG002|Overall Study|Death|13|||
27965962|NCT00811954|54623833|FG000|Overall Study|Lost to Follow-up|29|||
27965963|NCT00811954|54623834|FG001|Overall Study|Lost to Follow-up|23|||
27965964|NCT00811954|54623835|FG002|Overall Study|Lost to Follow-up|34|||
27965965|NCT00811954|54623833|FG000|Overall Study|Not able to get to clinic|28|||
27965966|NCT00811954|54623834|FG001|Overall Study|Not able to get to clinic|35|||
27965967|NCT00811954|54623835|FG002|Overall Study|Not able to get to clinic|30|||
27965968|NCT00811954|54623833|FG000|Overall Study|Not willing to adhere to requirements|12|||
27965969|NCT00811954|54623834|FG001|Overall Study|Not willing to adhere to requirements|2|||
27965970|NCT00811954|54623835|FG002|Overall Study|Not willing to adhere to requirements|16|||
27965971|NCT00811954|54623833|FG000|Overall Study|Withdraw consent prior study completion|4|||
27965972|NCT00811954|54623834|FG001|Overall Study|Withdraw consent prior study completion|6|||
27965973|NCT00811954|54623835|FG002|Overall Study|Withdraw consent prior study completion|5|||
27965974|NCT00811954|54623833|FG000|Overall Study|Site Closure|4|||
27965975|NCT00811954|54623834|FG001|Overall Study|Site Closure|0|||
27965976|NCT00811954|54623835|FG002|Overall Study|Site Closure|1|||
27965977|NCT00811954|54623833|FG000|Overall Study|Severe Debilitation|2|||
27965978|NCT00811954|54623834|FG001|Overall Study|Severe Debilitation|0|||
27965979|NCT00811954|54623835|FG002|Overall Study|Severe Debilitation|1|||
27965980|NCT00811954|54623833|FG000|Overall Study|Complete Protocol: No follow-up|0|||
27965981|NCT00811954|54623834|FG001|Overall Study|Complete Protocol: No follow-up|0|||
27965982|NCT00811954|54623835|FG002|Overall Study|Complete Protocol: No follow-up|1|||
27965983|NCT01032200|54623845|FG000|Overall Study|Death|1|||
27965984|NCT01032200|54623846|FG001|Overall Study|Death|1|||
27965985|NCT01032200|54623845|FG000|Overall Study|Withdrawal by Subject|1|||
27965986|NCT01032200|54623846|FG001|Overall Study|Withdrawal by Subject|3|||
27965987|NCT01032200|54623845|FG000|Overall Study|Toxicity|0|||
27965988|NCT01032200|54623846|FG001|Overall Study|Toxicity|2|||
27965989|NCT01032200|54623845|FG000|Overall Study|Progression|1|||
27965990|NCT01032200|54623846|FG001|Overall Study|Progression|0|||
27965991|NCT01032200|54623845|FG000|Overall Study|Multiple|1|||
27965992|NCT01032200|54623846|FG001|Overall Study|Multiple|1|||
27965993|NCT00738283|54623852|FG000|Overall Study|Death|1|||
27965994|NCT00738283|54623852|FG000|Overall Study|Transfer to another facility|2|||
27965995|NCT00738283|54623852|FG000|Overall Study|Discharge home prior to end of study|1|||
27965996|NCT00586105|54623865|FG000|Overall Study|Adverse Event|4|||
27965997|NCT00586105|54623865|FG000|Overall Study|Death|2|||
27965998|NCT00586105|54623865|FG000|Overall Study|Protocol Violation|1|||
27965999|NCT00586105|54623865|FG000|Overall Study|Withdrawal by Subject|3|||
27966000|NCT00586105|54623865|FG000|Overall Study|Disease progression|19|||
27966001|NCT00586105|54623865|FG000|Overall Study|Switched to commercial drug|9|||
27966002|NCT00586105|54623865|FG000|Overall Study|Reason not reported|1|||
27966003|NCT00743119|54623869|FG000|Overall Study|unreliable|3|||
27966004|NCT00743119|54623869|FG000|Overall Study|Withdrawal by Subject|1|||
27966005|NCT00733369|54623883|FG000|Overall Study|Lost to Follow-up|2|||
27966006|NCT00733369|54623884|FG001|Overall Study|Lost to Follow-up|1|||
27966007|NCT00733369|54623883|FG000|Overall Study|Adverse Event|4|||
27966008|NCT00733369|54623884|FG001|Overall Study|Adverse Event|4|||
27966009|NCT00733369|54623883|FG000|Overall Study|Protocol Violation|4|||
27966010|NCT00733369|54623884|FG001|Overall Study|Protocol Violation|4|||
27966011|NCT00813124|54623890|FG000|Overall Study|Death|2|||
27966012|NCT00813124|54623890|FG000|Overall Study|Ineligible - Participants did not received Azacytidine|9|||
27966013|NCT00813124|54623890|FG000|Overall Study|Withdrawal by Subject|1|||
27966014|NCT00733291|54623896|FG000|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1|||
27966015|NCT00733291|54623897|FG001|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
27966016|NCT00733291|54623898|FG002|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
27966017|NCT00733291|54623899|FG003|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
27966018|NCT00732199|54623912|FG000|Overall Study|Withdrawal by Subject|25|||
27966019|NCT00732199|54623913|FG001|Overall Study|Withdrawal by Subject|18|||
27966020|NCT00732199|54623912|FG000|Overall Study|sleep apnea, inadequate signals/sleep|9|||
27966021|NCT00732199|54623913|FG001|Overall Study|sleep apnea, inadequate signals/sleep|8|||
27966022|NCT00807040|54623924|FG000|Overall Study|Death|24|||
27966023|NCT00807040|54623925|FG001|Overall Study|Death|29|||
27966024|NCT00807040|54623924|FG000|Overall Study|Withdrawal by Subject|8|||
27966025|NCT00807040|54623925|FG001|Overall Study|Withdrawal by Subject|6|||
27966026|NCT00807040|54623924|FG000|Overall Study|Lost to Follow-up|4|||
27966027|NCT00807040|54623925|FG001|Overall Study|Lost to Follow-up|6|||
27966028|NCT00811720|54623933|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
27966029|NCT00811720|54623934|FG001|All Randomised Patients|Did not receive placebo/nalmefene|4|||
27966030|NCT00811720|54623933|FG000|All Treated Patients|Adverse Event|20|||
27966031|NCT00811720|54623934|FG001|All Treated Patients|Adverse Event|62|||
27966032|NCT00811720|54623933|FG000|All Treated Patients|Lack of Efficacy|22|||
27966033|NCT00811720|54623934|FG001|All Treated Patients|Lack of Efficacy|18|||
27966034|NCT00811720|54623933|FG000|All Treated Patients|Non-compliance|0|||
27966035|NCT00811720|54623934|FG001|All Treated Patients|Non-compliance|14|||
27966036|NCT00811720|54623933|FG000|All Treated Patients|Protocol Violation|9|||
27966037|NCT00811720|54623934|FG001|All Treated Patients|Protocol Violation|16|||
27966038|NCT00811720|54623933|FG000|All Treated Patients|Withdrawal by Subject|28|||
27966039|NCT00811720|54623934|FG001|All Treated Patients|Withdrawal by Subject|34|||
27966040|NCT00811720|54623933|FG000|All Treated Patients|Lost to Follow-up|10|||
27966041|NCT00811720|54623934|FG001|All Treated Patients|Lost to Follow-up|16|||
27966042|NCT00811720|54623933|FG000|All Treated Patients|Other Reason|7|||
27966043|NCT00811720|54623934|FG001|All Treated Patients|Other Reason|4|||
27966044|NCT04202679|54623942|FG000|Overall Study|Adverse Event|2|||
27966045|NCT04202679|54623943|FG001|Overall Study|Adverse Event|0|||
27966046|NCT04202679|54623942|FG000|Overall Study|Poor compliance to protocol|1|||
27966047|NCT04202679|54623943|FG001|Overall Study|Poor compliance to protocol|0|||
27966048|NCT04202679|54623942|FG000|Overall Study|Withdrawal by Subject|23|||
27966049|NCT04202679|54623943|FG001|Overall Study|Withdrawal by Subject|6|||
27966050|NCT00811642|54623950|FG000|Overall Study|Adverse Event|3|||
27966051|NCT00811642|54623950|FG000|Overall Study|Protocol Violation|1|||
27966052|NCT00811642|54623950|FG000|Overall Study|Death|2|||
27966053|NCT00811642|54623950|FG000|Overall Study|Withdrawal by Subject|7|||
27966054|NCT00811642|54623950|FG000|Overall Study|Cumulative use of antifungal agent|2|||
27966055|NCT00809926|54623956|FG000|Overall Study|Adverse Event|18|||
27966056|NCT00809926|54623957|FG001|Overall Study|Adverse Event|10|||
27966057|NCT00809926|54623956|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
27966058|NCT00809926|54623957|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
27966059|NCT00809926|54623956|FG000|Overall Study|Patient withdrew consent|8|||
27966060|NCT00809926|54623957|FG001|Overall Study|Patient withdrew consent|6|||
27966061|NCT00809926|54623956|FG000|Overall Study|Lost to Follow-up|2|||
27966062|NCT00809926|54623957|FG001|Overall Study|Lost to Follow-up|1|||
27966063|NCT00809926|54623956|FG000|Overall Study|Administrative Problems|0|||
27966064|NCT00809926|54623957|FG001|Overall Study|Administrative Problems|1|||
27966065|NCT00809926|54623956|FG000|Overall Study|Protocol deviation|0|||
27966066|NCT00809926|54623957|FG001|Overall Study|Protocol deviation|2|||
27966067|NCT00590980|54623963|FG000|Overall Study|Did not meet all inclusion criteria|10|||
27966068|NCT00590902|54623967|FG000|Overall Study|Death|1|||
27966069|NCT00590824|54623975|FG000|Overall Study|Disease could not be resected|0|||
27966070|NCT00590824|54623976|FG001|Overall Study|Disease could not be resected|2|||
27966071|NCT00590824|54623977|FG002|Overall Study|Disease could not be resected|1|||
27966072|NCT00590824|54623978|FG003|Overall Study|Disease could not be resected|0|||
27966073|NCT00590824|54623975|FG000|Overall Study|Adverse Event|0|||
27966074|NCT00590824|54623976|FG001|Overall Study|Adverse Event|0|||
27966075|NCT00590824|54623977|FG002|Overall Study|Adverse Event|0|||
27966076|NCT00590824|54623978|FG003|Overall Study|Adverse Event|1|||
27966077|NCT00590590|54623991|FG000|Overall Study|Lack of Efficacy|1|||
27966078|NCT00590590|54623992|FG001|Overall Study|Lack of Efficacy|2|||
27966079|NCT00590590|54623993|FG002|Overall Study|Lack of Efficacy|0|||
27966080|NCT00590590|54623991|FG000|Overall Study|Adverse Event|1|||
27966081|NCT00590590|54623992|FG001|Overall Study|Adverse Event|0|||
27966082|NCT00590590|54623993|FG002|Overall Study|Adverse Event|0|||
27966083|NCT00590590|54623991|FG000|Overall Study|Protocol Violation|0|||
27966084|NCT00590590|54623992|FG001|Overall Study|Protocol Violation|0|||
27966085|NCT00590590|54623993|FG002|Overall Study|Protocol Violation|2|||
27966086|NCT00590590|54623991|FG000|Overall Study|Lost to Follow-up|4|||
27966087|NCT00590590|54623992|FG001|Overall Study|Lost to Follow-up|1|||
27966088|NCT00590590|54623993|FG002|Overall Study|Lost to Follow-up|2|||
27966089|NCT00590590|54623991|FG000|Overall Study|Withdrawal by Subject|0|||
27966090|NCT00590590|54623992|FG001|Overall Study|Withdrawal by Subject|1|||
27966091|NCT00590590|54623993|FG002|Overall Study|Withdrawal by Subject|1|||
27966092|NCT00590590|54623991|FG000|Overall Study|Did not complete due to study closure|1|||
27966093|NCT00590590|54623992|FG001|Overall Study|Did not complete due to study closure|1|||
27966094|NCT00590590|54623993|FG002|Overall Study|Did not complete due to study closure|1|||
27966095|NCT00590590|54623991|FG000|Overall Study|Did not complete study|0|||
27966096|NCT00590590|54623992|FG001|Overall Study|Did not complete study|1|||
27966097|NCT00590590|54623993|FG002|Overall Study|Did not complete study|0|||
27966098|NCT00809614|54624003|FG000|Overall Study|Lack of Efficacy|2|||
27966099|NCT00809614|54624004|FG001|Overall Study|Lack of Efficacy|3|||
27966100|NCT00809614|54624003|FG000|Overall Study|Withdrawal by Subject|1|||
27966101|NCT00809614|54624004|FG001|Overall Study|Withdrawal by Subject|1|||
27966102|NCT00731731|54624013|FG000|Overall Study|Protocol Violation|0|||
27966103|NCT00731731|54624014|FG001|Overall Study|Protocol Violation|0|||
27966104|NCT00731731|54624015|FG002|Overall Study|Protocol Violation|1|||
27966105|NCT00731731|54624013|FG000|Overall Study|Cancel prior to treatment|0|||
27966106|NCT00731731|54624014|FG001|Overall Study|Cancel prior to treatment|0|||
27966107|NCT00731731|54624015|FG002|Overall Study|Cancel prior to treatment|2|||
27966108|NCT00806494|54624028|FG000|Overall Study|Adverse Event|29|||
27966109|NCT00806494|54624028|FG000|Overall Study|Lack of Efficacy|6|||
27966110|NCT00806494|54624028|FG000|Overall Study|Lost to Follow-up|10|||
27966111|NCT00806494|54624028|FG000|Overall Study|Other|30|||
27966112|NCT00806494|54624028|FG000|Overall Study|Withdrawal by Subject|5|||
27966113|NCT00806416|54624035|FG000|Period 1 - Part I|Adverse Event|0|||
27966114|NCT00806416|54624036|FG001|Period 1 - Part I|Adverse Event|1|||
27966115|NCT00806416|54624037|FG002|Period 1 - Part I|Adverse Event|0|||
27966116|NCT00806416|54624038|FG003|Period 1 - Part I|Adverse Event|0|||
27966117|NCT00806416|54624035|FG000|Period 1 - Part I|Lost to Follow-up|0|||
27966118|NCT00806416|54624036|FG001|Period 1 - Part I|Lost to Follow-up|2|||
27966119|NCT00806416|54624037|FG002|Period 1 - Part I|Lost to Follow-up|0|||
27966120|NCT00806416|54624038|FG003|Period 1 - Part I|Lost to Follow-up|0|||
27966121|NCT00806416|54624035|FG000|Period 1 - Part I|Withdrawal by Subject|3|||
27966122|NCT00806416|54624036|FG001|Period 1 - Part I|Withdrawal by Subject|1|||
27966123|NCT00806416|54624037|FG002|Period 1 - Part I|Withdrawal by Subject|0|||
27966124|NCT00806416|54624038|FG003|Period 1 - Part I|Withdrawal by Subject|0|||
27966125|NCT00806416|54624035|FG000|Period 1 - Part II|Withdrawal by Subject|0|||
27966126|NCT00806416|54624036|FG001|Period 1 - Part II|Withdrawal by Subject|0|||
27966127|NCT00806416|54624037|FG002|Period 1 - Part II|Withdrawal by Subject|0|||
27966128|NCT00806416|54624038|FG003|Period 1 - Part II|Withdrawal by Subject|2|||
27966129|NCT02724969|54624048|FG000|Overall Study|Lost to Follow-up|12|||
27966130|NCT02724969|54624049|FG001|Overall Study|Lost to Follow-up|6|||
27966131|NCT02724969|54624048|FG000|Overall Study|Withdrawal by Subject|3|||
27966132|NCT02724969|54624049|FG001|Overall Study|Withdrawal by Subject|3|||
27966133|NCT02724969|54624048|FG000|Overall Study|Infant demise|0|||
27966134|NCT02724969|54624049|FG001|Overall Study|Infant demise|2|||
27966135|NCT00811252|54624058|FG000|Overall Study|Adverse Event|6|||
27966136|NCT00811252|54624059|FG001|Overall Study|Adverse Event|10|||
27966137|NCT00811252|54624060|FG002|Overall Study|Adverse Event|15|||
27966138|NCT00811252|54624058|FG000|Overall Study|Lack of Efficacy|7|||
27966139|NCT00811252|54624059|FG001|Overall Study|Lack of Efficacy|2|||
27966140|NCT00811252|54624060|FG002|Overall Study|Lack of Efficacy|0|||
27966141|NCT00811252|54624058|FG000|Overall Study|Protocol Violation|3|||
27966142|NCT00811252|54624059|FG001|Overall Study|Protocol Violation|3|||
27966143|NCT00811252|54624060|FG002|Overall Study|Protocol Violation|2|||
27966144|NCT00811252|54624058|FG000|Overall Study|Withdrawal of Consent|1|||
27966145|NCT00811252|54624059|FG001|Overall Study|Withdrawal of Consent|2|||
27966146|NCT00811252|54624060|FG002|Overall Study|Withdrawal of Consent|2|||
27966147|NCT00811252|54624058|FG000|Overall Study|Lost to Follow-up|0|||
27966148|NCT00811252|54624059|FG001|Overall Study|Lost to Follow-up|0|||
27966149|NCT00811252|54624060|FG002|Overall Study|Lost to Follow-up|2|||
27966150|NCT00811252|54624058|FG000|Overall Study|Administrative or Other Reasons|0|||
27966151|NCT00811252|54624059|FG001|Overall Study|Administrative or Other Reasons|3|||
27966152|NCT00811252|54624060|FG002|Overall Study|Administrative or Other Reasons|2|||
27966153|NCT00736957|54624077|FG000|Overall Study|Adverse Event|43|||
27966154|NCT00736957|54624077|FG000|Overall Study|Withdrawal by Subject|49|||
27966155|NCT00736957|54624077|FG000|Overall Study|violation of eligibility criteria|2|||
27966156|NCT00736957|54624077|FG000|Overall Study|did not attend hospital appointments|1|||
27966157|NCT00736957|54624077|FG000|Overall Study|not eligible for Treatment Period I|22|||
27966158|NCT00736957|54624077|FG000|Overall Study|Physician Decision|5|||
27966159|NCT00736879|54624085|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
27966160|NCT00736879|54624086|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
27966161|NCT00736879|54624087|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
27966162|NCT00736879|54624088|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
27966163|NCT00736879|54624085|FG000|Double Blind Treatment Period|Adverse Event|0|||
27966164|NCT00736879|54624086|FG001|Double Blind Treatment Period|Adverse Event|1|||
27966165|NCT00736879|54624087|FG002|Double Blind Treatment Period|Adverse Event|1|||
27966166|NCT00736879|54624088|FG003|Double Blind Treatment Period|Adverse Event|0|||
27966167|NCT00736879|54624085|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
27966168|NCT00736879|54624086|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
27966169|NCT00736879|54624087|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
27966170|NCT00736879|54624088|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
27966171|NCT00736879|54624085|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
27966172|NCT00736879|54624086|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
27966173|NCT00736879|54624087|FG002|Double Blind Treatment Period|Lost to Follow-up|2|||
27966174|NCT00736879|54624088|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
27966175|NCT00736879|54624085|FG000|Double Blind Treatment Period|Poor non-compliance|0|||
27966176|NCT00736879|54624086|FG001|Double Blind Treatment Period|Poor non-compliance|0|||
27966177|NCT00736879|54624087|FG002|Double Blind Treatment Period|Poor non-compliance|1|||
27966178|NCT00736879|54624088|FG003|Double Blind Treatment Period|Poor non-compliance|1|||
27966179|NCT00736879|54624085|FG000|Double Blind Treatment Period|No longer met criteria|0|||
27966180|NCT00736879|54624086|FG001|Double Blind Treatment Period|No longer met criteria|1|||
27966181|NCT00736879|54624087|FG002|Double Blind Treatment Period|No longer met criteria|0|||
27966182|NCT00736879|54624088|FG003|Double Blind Treatment Period|No longer met criteria|0|||
27966183|NCT00736879|54624085|FG000|Double Blind Treatment Period|non-specified|0|||
27966184|NCT00736879|54624086|FG001|Double Blind Treatment Period|non-specified|1|||
27966185|NCT00736879|54624087|FG002|Double Blind Treatment Period|non-specified|0|||
27966186|NCT00736879|54624088|FG003|Double Blind Treatment Period|non-specified|0|||
27966187|NCT00736879|54624085|FG000|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
27966188|NCT00736879|54624086|FG001|Follow up Period - No Drug Treatment|Withdrawal by Subject|1|||
27966189|NCT00736879|54624087|FG002|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
27966190|NCT00736879|54624088|FG003|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
27966191|NCT00736879|54624085|FG000|Follow up Period - No Drug Treatment|non-specified|1|||
27966192|NCT00736879|54624086|FG001|Follow up Period - No Drug Treatment|non-specified|2|||
27966193|NCT00736879|54624087|FG002|Follow up Period - No Drug Treatment|non-specified|0|||
27966194|NCT00736879|54624088|FG003|Follow up Period - No Drug Treatment|non-specified|0|||
27966195|NCT00806260|54624107|FG000|Period 1 (1 Day)|Adverse Event|0|||
27966196|NCT00806260|54624108|FG001|Period 1 (1 Day)|Adverse Event|0|||
27966197|NCT00806260|54624109|FG002|Period 1 (1 Day)|Adverse Event|0|||
27966198|NCT00806260|54624110|FG003|Period 1 (1 Day)|Adverse Event|0|||
27966199|NCT00806260|54624111|FG004|Period 1 (1 Day)|Adverse Event|3|||
27966200|NCT00806260|54624112|FG005|Period 1 (1 Day)|Adverse Event|0|||
27966201|NCT00806260|54624107|FG000|Period 2|Adverse Event|0|||
27966202|NCT00806260|54624108|FG001|Period 2|Adverse Event|0|||
27966203|NCT00806260|54624109|FG002|Period 2|Adverse Event|0|||
27966204|NCT00806260|54624110|FG003|Period 2|Adverse Event|1|||
27966205|NCT00806260|54624111|FG004|Period 2|Adverse Event|0|||
27966206|NCT00806260|54624112|FG005|Period 2|Adverse Event|0|||
27966207|NCT00806260|54624107|FG000|Period 2|Protocol Violation|1|||
27966208|NCT00806260|54624108|FG001|Period 2|Protocol Violation|0|||
27966209|NCT00806260|54624109|FG002|Period 2|Protocol Violation|1|||
27966210|NCT00806260|54624110|FG003|Period 2|Protocol Violation|0|||
27966211|NCT00806260|54624111|FG004|Period 2|Protocol Violation|0|||
27966212|NCT00806260|54624112|FG005|Period 2|Protocol Violation|0|||
27966213|NCT00806260|54624107|FG000|Period 2|Need to take concomitant medication|1|||
27966214|NCT00806260|54624108|FG001|Period 2|Need to take concomitant medication|0|||
27966215|NCT00806260|54624109|FG002|Period 2|Need to take concomitant medication|0|||
27966216|NCT00806260|54624110|FG003|Period 2|Need to take concomitant medication|0|||
27966217|NCT00806260|54624111|FG004|Period 2|Need to take concomitant medication|0|||
27966218|NCT00806260|54624112|FG005|Period 2|Need to take concomitant medication|0|||
27966219|NCT00806260|54624107|FG000|Period 2|sponsor request|0|||
27966220|NCT00806260|54624108|FG001|Period 2|sponsor request|0|||
27966221|NCT00806260|54624109|FG002|Period 2|sponsor request|1|||
27966222|NCT00806260|54624110|FG003|Period 2|sponsor request|1|||
27966223|NCT00806260|54624111|FG004|Period 2|sponsor request|0|||
27966224|NCT00806260|54624112|FG005|Period 2|sponsor request|0|||
27966225|NCT00806260|54624107|FG000|Period 3|Protocol Violation|0|||
27966226|NCT00806260|54624108|FG001|Period 3|Protocol Violation|1|||
27966227|NCT00806260|54624109|FG002|Period 3|Protocol Violation|1|||
27966228|NCT00806260|54624110|FG003|Period 3|Protocol Violation|0|||
27966229|NCT00806260|54624111|FG004|Period 3|Protocol Violation|0|||
27966230|NCT00806260|54624112|FG005|Period 3|Protocol Violation|0|||
27966231|NCT00806260|54624107|FG000|Period 3|Pregnancy|1|||
27966232|NCT00806260|54624108|FG001|Period 3|Pregnancy|0|||
27966233|NCT00806260|54624109|FG002|Period 3|Pregnancy|0|||
27966234|NCT00806260|54624110|FG003|Period 3|Pregnancy|0|||
27966235|NCT00806260|54624111|FG004|Period 3|Pregnancy|0|||
27966236|NCT00806260|54624112|FG005|Period 3|Pregnancy|0|||
27966237|NCT00742885|54624126|FG000|Overall Study|Lost to Follow-up|1|||
27966238|NCT00742885|54624127|FG001|Overall Study|Lost to Follow-up|0|||
27966239|NCT00811174|54624136|FG000|Overall Study|Protocol Violation|2|||
27966240|NCT00811174|54624136|FG000|Overall Study|Sponsors Decision|1|||
27966241|NCT00730405|54624145|FG000|Overall Study-Treatment Phase|Adverse Event|5|||
27966242|NCT00730405|54624146|FG001|Overall Study-Treatment Phase|Adverse Event|10|||
27966243|NCT00730405|54624147|FG002|Overall Study-Treatment Phase|Adverse Event|4|||
27966244|NCT00730405|54624148|FG003|Overall Study-Treatment Phase|Adverse Event|8|||
27966245|NCT00730405|54624149|FG004|Overall Study-Treatment Phase|Adverse Event|4|||
27966246|NCT00730405|54624145|FG000|Overall Study-Treatment Phase|Lost to Follow-up|4|||
27966247|NCT00730405|54624146|FG001|Overall Study-Treatment Phase|Lost to Follow-up|5|||
27966248|NCT00730405|54624147|FG002|Overall Study-Treatment Phase|Lost to Follow-up|6|||
27966249|NCT00730405|54624148|FG003|Overall Study-Treatment Phase|Lost to Follow-up|4|||
27966250|NCT00730405|54624149|FG004|Overall Study-Treatment Phase|Lost to Follow-up|4|||
27966251|NCT00730405|54624145|FG000|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
27966252|NCT00730405|54624146|FG001|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
27966253|NCT00730405|54624147|FG002|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5|||
27966254|NCT00730405|54624148|FG003|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
27966255|NCT00730405|54624149|FG004|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
28083505|NCT03410992|54737165|FG006|Week 16 Assessment|Incorrect escapers|0|||
27855180|NCT01276327|54375634|FG000|Overall Study|Withdrawal by Subject|1|||
27855181|NCT01276327|54375635|FG001|Overall Study|Withdrawal by Subject|0|||
28083506|NCT03410992|54737166|FG007|Week 16 Assessment|Incorrect escapers|0|||
28083507|NCT03410992|54737167|FG008|Week 16 Assessment|Incorrect escapers|0|||
27966256|NCT00730405|54624145|FG000|Overall Study-Treatment Phase|Withdrawal by Subject|7|||
27966257|NCT00730405|54624146|FG001|Overall Study-Treatment Phase|Withdrawal by Subject|1|||
27966258|NCT00730405|54624147|FG002|Overall Study-Treatment Phase|Withdrawal by Subject|2|||
27966259|NCT00730405|54624148|FG003|Overall Study-Treatment Phase|Withdrawal by Subject|5|||
27966260|NCT00730405|54624149|FG004|Overall Study-Treatment Phase|Withdrawal by Subject|8|||
28083508|NCT03410992|54737168|FG009|Week 16 Assessment|Incorrect escapers|0|||
27966261|NCT00730405|54624145|FG000|Overall Study-Treatment Phase|Did not met eligibility|0|||
27966262|NCT00730405|54624146|FG001|Overall Study-Treatment Phase|Did not met eligibility|0|||
27966263|NCT00730405|54624147|FG002|Overall Study-Treatment Phase|Did not met eligibility|1|||
27966264|NCT00730405|54624148|FG003|Overall Study-Treatment Phase|Did not met eligibility|0|||
27966265|NCT00730405|54624149|FG004|Overall Study-Treatment Phase|Did not met eligibility|0|||
27966266|NCT00730405|54624145|FG000|Overall Study-Treatment Phase|Participant meets exclusion|0|||
27966267|NCT00730405|54624146|FG001|Overall Study-Treatment Phase|Participant meets exclusion|0|||
27966268|NCT00730405|54624147|FG002|Overall Study-Treatment Phase|Participant meets exclusion|1|||
27966269|NCT00730405|54624148|FG003|Overall Study-Treatment Phase|Participant meets exclusion|0|||
27966270|NCT00730405|54624149|FG004|Overall Study-Treatment Phase|Participant meets exclusion|0|||
27966271|NCT00730405|54624145|FG000|Overall Study-Treatment Phase|Prohibited concomitant medication|1|||
27966272|NCT00730405|54624146|FG001|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
27966273|NCT00730405|54624147|FG002|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
27966274|NCT00730405|54624148|FG003|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
27966275|NCT00730405|54624149|FG004|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
27966276|NCT00730405|54624145|FG000|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
27966277|NCT00730405|54624146|FG001|Overall Study-Treatment Phase|Withdrew from study treatment|1|||
27966278|NCT00730405|54624147|FG002|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
27966279|NCT00730405|54624148|FG003|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
27966280|NCT00730405|54624149|FG004|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
27966281|NCT00730405|54624145|FG000|Overall Study-Treatment Phase|Use of prohibited medication|0|||
27966282|NCT00730405|54624146|FG001|Overall Study-Treatment Phase|Use of prohibited medication|1|||
27966283|NCT00730405|54624147|FG002|Overall Study-Treatment Phase|Use of prohibited medication|0|||
27966284|NCT00730405|54624148|FG003|Overall Study-Treatment Phase|Use of prohibited medication|0|||
27966285|NCT00730405|54624149|FG004|Overall Study-Treatment Phase|Use of prohibited medication|2|||
27966286|NCT00730405|54624145|FG000|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
27966287|NCT00730405|54624146|FG001|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
27966288|NCT00730405|54624147|FG002|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1|||
27966289|NCT00730405|54624148|FG003|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
27966290|NCT00730405|54624149|FG004|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
27966291|NCT00730405|54624145|FG000|Overall Study-Treatment Phase|Misrandomized|0|||
27966292|NCT00730405|54624146|FG001|Overall Study-Treatment Phase|Misrandomized|1|||
27966293|NCT00730405|54624147|FG002|Overall Study-Treatment Phase|Misrandomized|0|||
27966294|NCT00730405|54624148|FG003|Overall Study-Treatment Phase|Misrandomized|0|||
27966295|NCT00730405|54624149|FG004|Overall Study-Treatment Phase|Misrandomized|0|||
27966296|NCT00730405|54624145|FG000|Overall Study-Treatment Phase|Study drug interrupted|0|||
27966297|NCT00730405|54624146|FG001|Overall Study-Treatment Phase|Study drug interrupted|1|||
27966298|NCT00730405|54624147|FG002|Overall Study-Treatment Phase|Study drug interrupted|0|||
27966299|NCT00730405|54624148|FG003|Overall Study-Treatment Phase|Study drug interrupted|0|||
27966300|NCT00730405|54624149|FG004|Overall Study-Treatment Phase|Study drug interrupted|0|||
27966301|NCT00730405|54624145|FG000|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
27966302|NCT00730405|54624146|FG001|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
27966303|NCT00730405|54624147|FG002|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
27966304|NCT00730405|54624148|FG003|Overall Study-Treatment Phase|Due to in-vitro fertilization|1|||
27966305|NCT00730405|54624149|FG004|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
27966306|NCT00730405|54624145|FG000|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
27966307|NCT00730405|54624146|FG001|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
27966308|NCT00730405|54624147|FG002|Overall Study-Treatment Phase|Protocol violation due to eligibility|1|||
27966309|NCT00730405|54624148|FG003|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
27966310|NCT00730405|54624149|FG004|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
27966311|NCT00730405|54624145|FG000|Overall Study-Treatment Phase|Change of location|0|||
27966312|NCT00730405|54624146|FG001|Overall Study-Treatment Phase|Change of location|0|||
27966313|NCT00730405|54624147|FG002|Overall Study-Treatment Phase|Change of location|0|||
27966314|NCT00730405|54624148|FG003|Overall Study-Treatment Phase|Change of location|1|||
27966315|NCT00730405|54624149|FG004|Overall Study-Treatment Phase|Change of location|0|||
27966316|NCT00730405|54624145|FG000|Overall Study-Treatment Phase|Pregnancy|0|||
27966317|NCT00730405|54624146|FG001|Overall Study-Treatment Phase|Pregnancy|1|||
27966318|NCT00730405|54624147|FG002|Overall Study-Treatment Phase|Pregnancy|0|||
27966319|NCT00730405|54624148|FG003|Overall Study-Treatment Phase|Pregnancy|0|||
27966320|NCT00730405|54624149|FG004|Overall Study-Treatment Phase|Pregnancy|0|||
27966321|NCT00730405|54624145|FG000|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
27966322|NCT00730405|54624146|FG001|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
27966323|NCT00730405|54624147|FG002|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
27966324|NCT00730405|54624148|FG003|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
27966325|NCT00730405|54624149|FG004|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1|||
27966326|NCT00730405|54624145|FG000|Overall Study-Treatment Phase|Atrial fibrillation history|1|||
27966327|NCT00730405|54624146|FG001|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
27966328|NCT00730405|54624147|FG002|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
27966329|NCT00730405|54624148|FG003|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
27732700|NCT02573012|54180281|FG000|Overall Study|Withdrawal by Subject|2|||
27966330|NCT00730405|54624149|FG004|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
27966331|NCT00730405|54624145|FG000|Overall Study-follow-up Phase|Adverse Event|2|||
27966332|NCT00730405|54624146|FG001|Overall Study-follow-up Phase|Adverse Event|6|||
27966333|NCT00730405|54624147|FG002|Overall Study-follow-up Phase|Adverse Event|2|||
27966334|NCT00730405|54624148|FG003|Overall Study-follow-up Phase|Adverse Event|3|||
27966335|NCT00730405|54624149|FG004|Overall Study-follow-up Phase|Adverse Event|4|||
27966336|NCT00730405|54624145|FG000|Overall Study-follow-up Phase|Lost to Follow-up|7|||
27966337|NCT00730405|54624146|FG001|Overall Study-follow-up Phase|Lost to Follow-up|6|||
27966338|NCT00730405|54624147|FG002|Overall Study-follow-up Phase|Lost to Follow-up|8|||
27966339|NCT00730405|54624148|FG003|Overall Study-follow-up Phase|Lost to Follow-up|4|||
27966340|NCT00730405|54624149|FG004|Overall Study-follow-up Phase|Lost to Follow-up|6|||
27966341|NCT00730405|54624145|FG000|Overall Study-follow-up Phase|Withdrawal by Subject|7|||
27966342|NCT00730405|54624146|FG001|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
27966343|NCT00730405|54624147|FG002|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
27966344|NCT00730405|54624148|FG003|Overall Study-follow-up Phase|Withdrawal by Subject|6|||
27966345|NCT00730405|54624149|FG004|Overall Study-follow-up Phase|Withdrawal by Subject|10|||
27966346|NCT00730405|54624145|FG000|Overall Study-follow-up Phase|Death|0|||
27966347|NCT00730405|54624146|FG001|Overall Study-follow-up Phase|Death|1|||
27966348|NCT00730405|54624147|FG002|Overall Study-follow-up Phase|Death|0|||
27966349|NCT00730405|54624148|FG003|Overall Study-follow-up Phase|Death|1|||
27966350|NCT00730405|54624149|FG004|Overall Study-follow-up Phase|Death|0|||
27966351|NCT00730405|54624145|FG000|Overall Study-follow-up Phase|Change of location|1|||
27966352|NCT00730405|54624146|FG001|Overall Study-follow-up Phase|Change of location|1|||
27966353|NCT00730405|54624147|FG002|Overall Study-follow-up Phase|Change of location|0|||
27966354|NCT00730405|54624148|FG003|Overall Study-follow-up Phase|Change of location|1|||
27966355|NCT00730405|54624149|FG004|Overall Study-follow-up Phase|Change of location|0|||
27966356|NCT00730405|54624145|FG000|Overall Study-follow-up Phase|Did not met eligibility|0|||
27966357|NCT00730405|54624146|FG001|Overall Study-follow-up Phase|Did not met eligibility|0|||
27966358|NCT00730405|54624147|FG002|Overall Study-follow-up Phase|Did not met eligibility|1|||
27966359|NCT00730405|54624148|FG003|Overall Study-follow-up Phase|Did not met eligibility|0|||
27966360|NCT00730405|54624149|FG004|Overall Study-follow-up Phase|Did not met eligibility|0|||
27966361|NCT00730405|54624145|FG000|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
27966362|NCT00730405|54624146|FG001|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
27966363|NCT00730405|54624147|FG002|Overall Study-follow-up Phase|Non-compliance with study treatment|1|||
27966364|NCT00730405|54624148|FG003|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
27966365|NCT00730405|54624149|FG004|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
27966366|NCT00730405|54624145|FG000|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
27966367|NCT00730405|54624146|FG001|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
27966368|NCT00730405|54624147|FG002|Overall Study-follow-up Phase|Participant meets exclusion criteria|1|||
27966369|NCT00730405|54624148|FG003|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
27966370|NCT00730405|54624149|FG004|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
27966371|NCT00730405|54624145|FG000|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
27966372|NCT00730405|54624146|FG001|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
27966373|NCT00730405|54624147|FG002|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
27966374|NCT00730405|54624148|FG003|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
27966375|NCT00730405|54624149|FG004|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1|||
27966376|NCT00730405|54624145|FG000|Overall Study-follow-up Phase|Prohibited concomitant medication|1|||
27966377|NCT00730405|54624146|FG001|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
28083509|NCT03410992|54737169|FG010|Week 16 Assessment|Incorrect escapers|0|||
28083510|NCT03410992|54737159|FG000|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
28083511|NCT03410992|54737160|FG001|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
28083512|NCT03410992|54737161|FG002|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
28083513|NCT03410992|54737162|FG003|Randomized-Withdrawal Period: up to Wk56|Adverse Event|3|||
28083514|NCT03410992|54737163|FG004|Randomized-Withdrawal Period: up to Wk56|Adverse Event|2|||
28083515|NCT03410992|54737164|FG005|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
28083516|NCT03410992|54737165|FG006|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
28083517|NCT03410992|54737166|FG007|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
28083518|NCT03410992|54737167|FG008|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
28083519|NCT03410992|54737168|FG009|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
28083520|NCT03410992|54737169|FG010|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
28083521|NCT03410992|54737159|FG000|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
27966378|NCT00730405|54624147|FG002|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
28083522|NCT03410992|54737160|FG001|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
28083523|NCT03410992|54737161|FG002|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
27855182|NCT00639002|54375757|FG000|Overall Study|Death|1|||
28083524|NCT03410992|54737162|FG003|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
28083525|NCT03410992|54737163|FG004|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|1|||
28083526|NCT03410992|54737164|FG005|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
28083527|NCT03410992|54737165|FG006|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
28083528|NCT03410992|54737166|FG007|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
28083529|NCT03410992|54737167|FG008|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
28083530|NCT03410992|54737168|FG009|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
27966379|NCT00730405|54624148|FG003|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
27966380|NCT00730405|54624149|FG004|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
27966381|NCT00730405|54624145|FG000|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
27966382|NCT00730405|54624146|FG001|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
27966383|NCT00730405|54624147|FG002|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
27966384|NCT00730405|54624148|FG003|Overall Study-follow-up Phase|Refused follow-up due to AE|1|||
27966385|NCT00730405|54624149|FG004|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
27966386|NCT00730405|54624145|FG000|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
27966387|NCT00730405|54624146|FG001|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
27966388|NCT00730405|54624147|FG002|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
27966389|NCT00730405|54624148|FG003|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
27966390|NCT00730405|54624149|FG004|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
27966391|NCT00730405|54624145|FG000|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
27966392|NCT00730405|54624146|FG001|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
27966393|NCT00730405|54624147|FG002|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
27966394|NCT00730405|54624148|FG003|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
27966395|NCT00730405|54624149|FG004|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
27966396|NCT00730405|54624145|FG000|Overall Study-follow-up Phase|Use of restricted medication|0|||
27966397|NCT00730405|54624146|FG001|Overall Study-follow-up Phase|Use of restricted medication|1|||
27966398|NCT00730405|54624147|FG002|Overall Study-follow-up Phase|Use of restricted medication|0|||
27966399|NCT00730405|54624148|FG003|Overall Study-follow-up Phase|Use of restricted medication|0|||
27966400|NCT00730405|54624149|FG004|Overall Study-follow-up Phase|Use of restricted medication|0|||
27966401|NCT00730405|54624145|FG000|Overall Study-follow-up Phase|Non-compliance|1|||
27966402|NCT00730405|54624146|FG001|Overall Study-follow-up Phase|Non-compliance|0|||
27966403|NCT00730405|54624147|FG002|Overall Study-follow-up Phase|Non-compliance|2|||
27966404|NCT00730405|54624148|FG003|Overall Study-follow-up Phase|Non-compliance|0|||
27966405|NCT00730405|54624149|FG004|Overall Study-follow-up Phase|Non-compliance|0|||
27966406|NCT00730405|54624145|FG000|Overall Study-follow-up Phase|Missing|0|||
27966407|NCT00730405|54624146|FG001|Overall Study-follow-up Phase|Missing|0|||
27966408|NCT00730405|54624147|FG002|Overall Study-follow-up Phase|Missing|2|||
27966409|NCT00730405|54624148|FG003|Overall Study-follow-up Phase|Missing|0|||
27966410|NCT00730405|54624149|FG004|Overall Study-follow-up Phase|Missing|0|||
27966411|NCT00730405|54624145|FG000|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
27966412|NCT00730405|54624146|FG001|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
27966413|NCT00730405|54624147|FG002|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
27966414|NCT00730405|54624148|FG003|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
27966415|NCT00730405|54624149|FG004|Overall Study-follow-up Phase|Use an exclusionary medication|1|||
27966416|NCT00730405|54624145|FG000|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
27966417|NCT00730405|54624146|FG001|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
27966418|NCT00730405|54624147|FG002|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1|||
27966419|NCT00730405|54624148|FG003|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
27966420|NCT00730405|54624149|FG004|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
27966421|NCT00730405|54624145|FG000|Overall Study-follow-up Phase|Mis-randomized|0|||
27966422|NCT00730405|54624146|FG001|Overall Study-follow-up Phase|Mis-randomized|1|||
27966423|NCT00730405|54624147|FG002|Overall Study-follow-up Phase|Mis-randomized|0|||
27966424|NCT00730405|54624148|FG003|Overall Study-follow-up Phase|Mis-randomized|0|||
27966425|NCT00730405|54624149|FG004|Overall Study-follow-up Phase|Mis-randomized|0|||
27966426|NCT00730405|54624145|FG000|Overall Study-follow-up Phase|Other Protocol violation|0|||
27966427|NCT00730405|54624146|FG001|Overall Study-follow-up Phase|Other Protocol violation|0|||
27966428|NCT00730405|54624147|FG002|Overall Study-follow-up Phase|Other Protocol violation|1|||
27966429|NCT00730405|54624148|FG003|Overall Study-follow-up Phase|Other Protocol violation|0|||
27966430|NCT00730405|54624149|FG004|Overall Study-follow-up Phase|Other Protocol violation|0|||
27966431|NCT00730405|54624145|FG000|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
27966432|NCT00730405|54624146|FG001|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
28083531|NCT03410992|54737169|FG010|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
27855183|NCT00639002|54375757|FG000|Overall Study|Adverse Event|1|||
27966433|NCT00730405|54624147|FG002|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
27966434|NCT00730405|54624148|FG003|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1|||
27966435|NCT00730405|54624149|FG004|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
27966436|NCT00730405|54624145|FG000|Overall Study-follow-up Phase|Atrial fibrillation history|1|||
27966437|NCT00730405|54624146|FG001|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
27966438|NCT00730405|54624147|FG002|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
27966439|NCT00730405|54624148|FG003|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
27966440|NCT00730405|54624149|FG004|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
27966441|NCT00736723|54624165|FG000|Overall Study|Withdrawal by Subject|4|||
27966442|NCT00736723|54624166|FG001|Overall Study|Withdrawal by Subject|3|||
27966443|NCT00736645|54624176|FG000|Overall Study|Adverse Event|0|||
27966444|NCT00736645|54624177|FG001|Overall Study|Adverse Event|2|||
27966445|NCT00736645|54624178|FG002|Overall Study|Adverse Event|0|||
27966446|NCT00736645|54624179|FG003|Overall Study|Adverse Event|0|||
27966447|NCT00736489|54624189|FG000|Period 1|Lost to Follow-up|1|||
27966448|NCT00736489|54624190|FG001|Period 1|Lost to Follow-up|0|||
27966449|NCT00736489|54624191|FG002|Period 1|Lost to Follow-up|0|||
27966450|NCT00736489|54624192|FG003|Period 1|Lost to Follow-up|0|||
27966451|NCT00736489|54624193|FG004|Period 1|Lost to Follow-up|0|||
27966452|NCT00736489|54624194|FG005|Period 1|Lost to Follow-up|0|||
27966453|NCT00736489|54624189|FG000|Period 1|Withdrawal by Subject|0|||
27966454|NCT00736489|54624190|FG001|Period 1|Withdrawal by Subject|0|||
27966455|NCT00736489|54624191|FG002|Period 1|Withdrawal by Subject|0|||
27966456|NCT00736489|54624192|FG003|Period 1|Withdrawal by Subject|0|||
27966457|NCT00736489|54624193|FG004|Period 1|Withdrawal by Subject|0|||
27966458|NCT00736489|54624194|FG005|Period 1|Withdrawal by Subject|1|||
27966459|NCT00730327|54624226|FG000|Overall Study|Lost to Follow-up|14|||
27966460|NCT00730327|54624227|FG001|Overall Study|Lost to Follow-up|16|||
27966461|NCT00730327|54624226|FG000|Overall Study|Adverse Event|8|||
27966462|NCT00730327|54624227|FG001|Overall Study|Adverse Event|1|||
27966463|NCT00730327|54624226|FG000|Overall Study|Withdrawal by Subject|3|||
27966464|NCT00730327|54624227|FG001|Overall Study|Withdrawal by Subject|13|||
27966465|NCT00730327|54624226|FG000|Overall Study|Subject withdrew (reason not specified)|2|||
27966466|NCT00730327|54624227|FG001|Overall Study|Subject withdrew (reason not specified)|7|||
27966467|NCT00742417|54624242|FG000|Randomized|Withdrawal by legal representative|0|||
27966468|NCT00742417|54624243|FG001|Randomized|Withdrawal by legal representative|1|||
27966469|NCT00742417|54624242|FG000|Randomized|Withdrawal by Subject|1|||
27966470|NCT00742417|54624243|FG001|Randomized|Withdrawal by Subject|0|||
27966471|NCT00742417|54624242|FG000|Randomized|Physician Decision|1|||
27966472|NCT00742417|54624243|FG001|Randomized|Physician Decision|0|||
27966473|NCT00742417|54624242|FG000|Intensive Period|Withdrawal by Subject|1|||
27966474|NCT00742417|54624243|FG001|Intensive Period|Withdrawal by Subject|1|||
27966475|NCT00742417|54624242|FG000|Intensive Period|Adverse Event|2|||
27966476|NCT00742417|54624243|FG001|Intensive Period|Adverse Event|0|||
27966477|NCT00811018|54624251|FG000|Overall Study|Additional Chronic Treatment|31|||
27966478|NCT00811018|54624251|FG000|Overall Study|Adverse Event|79|||
27966479|NCT00811018|54624251|FG000|Overall Study|Death|147|||
27966480|NCT00811018|54624251|FG000|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4|||
27966481|NCT00811018|54624251|FG000|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70|||
27966482|NCT00811018|54624251|FG000|Overall Study|Investigator Decision|57|||
27966483|NCT00811018|54624251|FG000|Overall Study|Lost to Follow-up|19|||
27966484|NCT00811018|54624251|FG000|Overall Study|Pregnancy|6|||
27966485|NCT00811018|54624251|FG000|Overall Study|Sponsor Decision|450|||
27966486|NCT00811018|54624251|FG000|Overall Study|Withdrawal by Subject|70|||
27966487|NCT00811018|54624251|FG000|Overall Study|WHO FC deterioration and 6MWD decrease|9|||
27966488|NCT00811018|54624251|FG000|Overall Study|Other|26|||
27966489|NCT00730171|54624260|FG000|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5|||
27966490|NCT00730171|54624260|FG000|Overall Study|Adverse Event|193|||
27966491|NCT00730171|54624260|FG000|Overall Study|Protocol Violation|48|||
28083532|NCT03410992|54737159|FG000|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
28083533|NCT03410992|54737160|FG001|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
28083534|NCT03410992|54737161|FG002|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
27966492|NCT00730171|54624260|FG000|Overall Study|Withdrawal by Subject|202|||
27966493|NCT00730171|54624260|FG000|Overall Study|Lost to Follow-up|121|||
27966494|NCT00730171|54624260|FG000|Overall Study|Insufficient Therapeutic Response|141|||
27966495|NCT00730171|54624260|FG000|Overall Study|Other|61|||
27966496|NCT00730015|54624271|FG000|Overall Study|Adverse Event|11|||
27966497|NCT00730015|54624272|FG001|Overall Study|Adverse Event|10|||
27966498|NCT00730015|54624273|FG002|Overall Study|Adverse Event|8|||
27966499|NCT00730015|54624271|FG000|Overall Study|Protocol Violation|2|||
27966500|NCT00730015|54624272|FG001|Overall Study|Protocol Violation|6|||
27966501|NCT00730015|54624273|FG002|Overall Study|Protocol Violation|4|||
27966502|NCT00730015|54624271|FG000|Overall Study|Withdrawal by Subject|12|||
27966503|NCT00730015|54624272|FG001|Overall Study|Withdrawal by Subject|12|||
27966504|NCT00730015|54624273|FG002|Overall Study|Withdrawal by Subject|8|||
28083535|NCT03410992|54737162|FG003|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
28083536|NCT03410992|54737163|FG004|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
28083537|NCT03410992|54737164|FG005|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|3|||
28083538|NCT03410992|54737165|FG006|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
28083539|NCT03410992|54737166|FG007|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
28083540|NCT03410992|54737167|FG008|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
28083541|NCT03410992|54737168|FG009|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
28083542|NCT03410992|54737169|FG010|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
28083543|NCT03410992|54737159|FG000|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
27966505|NCT00730015|54624271|FG000|Overall Study|Lost to Follow-up|4|||
27966506|NCT00730015|54624272|FG001|Overall Study|Lost to Follow-up|10|||
27966507|NCT00730015|54624273|FG002|Overall Study|Lost to Follow-up|3|||
27966508|NCT00730015|54624271|FG000|Overall Study|Lack of Efficacy|1|||
27966509|NCT00730015|54624272|FG001|Overall Study|Lack of Efficacy|2|||
27966510|NCT00730015|54624273|FG002|Overall Study|Lack of Efficacy|8|||
28083544|NCT03410992|54737160|FG001|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
27966511|NCT00730015|54624271|FG000|Overall Study|Other Reason|1|||
27966512|NCT00730015|54624272|FG001|Overall Study|Other Reason|0|||
27966513|NCT00730015|54624273|FG002|Overall Study|Other Reason|1|||
27966514|NCT00806026|54624292|FG000|Overall Study|Death|0|||
27966515|NCT00806026|54624293|FG001|Overall Study|Death|0|||
27966516|NCT00806026|54624294|FG002|Overall Study|Death|0|||
27966517|NCT00806026|54624295|FG003|Overall Study|Death|1|||
27966518|NCT00806026|54624296|FG004|Overall Study|Death|0|||
27966519|NCT00806026|54624297|FG005|Overall Study|Death|0|||
27966520|NCT00806026|54624292|FG000|Overall Study|Did not meet entrance criteria|4|||
27966521|NCT00806026|54624293|FG001|Overall Study|Did not meet entrance criteria|1|||
27966522|NCT00806026|54624294|FG002|Overall Study|Did not meet entrance criteria|2|||
27966523|NCT00806026|54624295|FG003|Overall Study|Did not meet entrance criteria|1|||
27966524|NCT00806026|54624296|FG004|Overall Study|Did not meet entrance criteria|0|||
27966525|NCT00806026|54624297|FG005|Overall Study|Did not meet entrance criteria|0|||
27966526|NCT00806026|54624292|FG000|Overall Study|Lack of Efficacy|5|||
27966527|NCT00806026|54624293|FG001|Overall Study|Lack of Efficacy|18|||
27966528|NCT00806026|54624294|FG002|Overall Study|Lack of Efficacy|13|||
28083545|NCT03410992|54737161|FG002|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
28083546|NCT03410992|54737162|FG003|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|67|||
28083547|NCT03410992|54737163|FG004|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|4|||
28083548|NCT03410992|54737164|FG005|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|7|||
28083549|NCT03410992|54737165|FG006|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
28083550|NCT03410992|54737166|FG007|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
28083551|NCT03410992|54737167|FG008|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
28083552|NCT03410992|54737168|FG009|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
28083553|NCT03410992|54737169|FG010|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
28083554|NCT03410992|54737159|FG000|Escape Treatment: 12 Weeks|Adverse Event|0|||
28083555|NCT03410992|54737160|FG001|Escape Treatment: 12 Weeks|Adverse Event|0|||
28083556|NCT03410992|54737161|FG002|Escape Treatment: 12 Weeks|Adverse Event|0|||
28083557|NCT03410992|54737162|FG003|Escape Treatment: 12 Weeks|Adverse Event|0|||
28083558|NCT03410992|54737163|FG004|Escape Treatment: 12 Weeks|Adverse Event|0|||
28083559|NCT03410992|54737164|FG005|Escape Treatment: 12 Weeks|Adverse Event|0|||
28083560|NCT03410992|54737165|FG006|Escape Treatment: 12 Weeks|Adverse Event|0|||
28083561|NCT03410992|54737166|FG007|Escape Treatment: 12 Weeks|Adverse Event|1|||
28083562|NCT03410992|54737167|FG008|Escape Treatment: 12 Weeks|Adverse Event|0|||
28083563|NCT03410992|54737168|FG009|Escape Treatment: 12 Weeks|Adverse Event|0|||
28083564|NCT03410992|54737169|FG010|Escape Treatment: 12 Weeks|Adverse Event|0|||
28083565|NCT03410992|54737159|FG000|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
28083566|NCT03410992|54737160|FG001|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
28083567|NCT03410992|54737161|FG002|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
28083568|NCT03410992|54737162|FG003|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
27966529|NCT00806026|54624295|FG003|Overall Study|Lack of Efficacy|4|||
27966530|NCT00806026|54624296|FG004|Overall Study|Lack of Efficacy|8|||
27732701|NCT02573012|54180282|FG001|Overall Study|Withdrawal by Subject|2|||
27966531|NCT00806026|54624297|FG005|Overall Study|Lack of Efficacy|7|||
27966532|NCT00806026|54624292|FG000|Overall Study|Lost to Follow-up|8|||
27966533|NCT00806026|54624293|FG001|Overall Study|Lost to Follow-up|15|||
27966534|NCT00806026|54624294|FG002|Overall Study|Lost to Follow-up|8|||
27966535|NCT00806026|54624295|FG003|Overall Study|Lost to Follow-up|2|||
27966536|NCT00806026|54624296|FG004|Overall Study|Lost to Follow-up|6|||
27966537|NCT00806026|54624297|FG005|Overall Study|Lost to Follow-up|6|||
27732702|NCT02573012|54180281|FG000|Overall Study|Study Ended per Protocol|1|||
27966538|NCT00806026|54624292|FG000|Overall Study|Withdrawal by Subject|14|||
27966539|NCT00806026|54624293|FG001|Overall Study|Withdrawal by Subject|17|||
27966540|NCT00806026|54624294|FG002|Overall Study|Withdrawal by Subject|9|||
27966541|NCT00806026|54624295|FG003|Overall Study|Withdrawal by Subject|2|||
27966542|NCT00806026|54624296|FG004|Overall Study|Withdrawal by Subject|5|||
27966543|NCT00806026|54624297|FG005|Overall Study|Withdrawal by Subject|3|||
27966544|NCT00806026|54624292|FG000|Overall Study|Other|3|||
27966545|NCT00806026|54624293|FG001|Overall Study|Other|6|||
27966546|NCT00806026|54624294|FG002|Overall Study|Other|8|||
27966547|NCT00806026|54624295|FG003|Overall Study|Other|2|||
27966548|NCT00806026|54624296|FG004|Overall Study|Other|0|||
27966549|NCT00806026|54624297|FG005|Overall Study|Other|4|||
27966550|NCT00806026|54624292|FG000|Overall Study|Protocol Violation|6|||
27966551|NCT00806026|54624293|FG001|Overall Study|Protocol Violation|9|||
27966552|NCT00806026|54624294|FG002|Overall Study|Protocol Violation|9|||
27966553|NCT00806026|54624295|FG003|Overall Study|Protocol Violation|0|||
27966554|NCT00806026|54624296|FG004|Overall Study|Protocol Violation|2|||
27966555|NCT00806026|54624297|FG005|Overall Study|Protocol Violation|3|||
27966556|NCT00806026|54624292|FG000|Overall Study|Adverse Event|52|||
27966557|NCT00806026|54624293|FG001|Overall Study|Adverse Event|35|||
27966558|NCT00806026|54624294|FG002|Overall Study|Adverse Event|44|||
27966559|NCT00806026|54624295|FG003|Overall Study|Adverse Event|17|||
27966560|NCT00806026|54624296|FG004|Overall Study|Adverse Event|9|||
27966561|NCT00806026|54624297|FG005|Overall Study|Adverse Event|9|||
27966562|NCT04026165|54624312|FG000|Run-in Placebo Period|Enrollment Error|13|||
27966563|NCT04026165|54624313|FG001|Run-in Placebo Period|Enrollment Error|0|||
27966564|NCT04026165|54624314|FG002|Run-in Placebo Period|Enrollment Error|0|||
27966565|NCT04026165|54624315|FG003|Run-in Placebo Period|Enrollment Error|0|||
27966566|NCT04026165|54624312|FG000|Run-in Placebo Period|Run-in Failure|4|||
27966567|NCT04026165|54624313|FG001|Run-in Placebo Period|Run-in Failure|0|||
27966568|NCT04026165|54624314|FG002|Run-in Placebo Period|Run-in Failure|0|||
27966569|NCT04026165|54624315|FG003|Run-in Placebo Period|Run-in Failure|0|||
27966570|NCT04026165|54624312|FG000|Run-in Placebo Period|Protocol Violation|2|||
27966571|NCT04026165|54624313|FG001|Run-in Placebo Period|Protocol Violation|0|||
27966572|NCT04026165|54624314|FG002|Run-in Placebo Period|Protocol Violation|0|||
27966573|NCT04026165|54624315|FG003|Run-in Placebo Period|Protocol Violation|0|||
27966574|NCT04026165|54624312|FG000|Run-in Placebo Period|Withdrew Consent|2|||
27966575|NCT04026165|54624313|FG001|Run-in Placebo Period|Withdrew Consent|0|||
27966576|NCT04026165|54624314|FG002|Run-in Placebo Period|Withdrew Consent|0|||
27966577|NCT04026165|54624315|FG003|Run-in Placebo Period|Withdrew Consent|0|||
27966578|NCT04026165|54624312|FG000|Run-in Placebo Period|Significant Non-Compliance with Study Drug|1|||
27966579|NCT04026165|54624313|FG001|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
27966580|NCT04026165|54624314|FG002|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
27966581|NCT04026165|54624315|FG003|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
27966582|NCT04026165|54624312|FG000|Run-in SEL Period|Run-in Failure|0|||
27966583|NCT04026165|54624313|FG001|Run-in SEL Period|Run-in Failure|26|||
27966584|NCT04026165|54624314|FG002|Run-in SEL Period|Run-in Failure|0|||
27966585|NCT04026165|54624315|FG003|Run-in SEL Period|Run-in Failure|0|||
27966586|NCT04026165|54624312|FG000|Run-in SEL Period|Withdrew Consent|0|||
27966587|NCT04026165|54624313|FG001|Run-in SEL Period|Withdrew Consent|10|||
27966588|NCT04026165|54624314|FG002|Run-in SEL Period|Withdrew Consent|0|||
27966589|NCT04026165|54624315|FG003|Run-in SEL Period|Withdrew Consent|0|||
27966590|NCT04026165|54624312|FG000|Run-in SEL Period|Enrollment Error|0|||
27966591|NCT04026165|54624313|FG001|Run-in SEL Period|Enrollment Error|4|||
28083569|NCT03410992|54737163|FG004|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
28083570|NCT03410992|54737164|FG005|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
28083571|NCT03410992|54737165|FG006|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
28083572|NCT03410992|54737166|FG007|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
27966592|NCT04026165|54624314|FG002|Run-in SEL Period|Enrollment Error|0|||
27966593|NCT04026165|54624315|FG003|Run-in SEL Period|Enrollment Error|0|||
28083573|NCT03410992|54737167|FG008|Escape Treatment: 12 Weeks|Withdrawal by Subject|1|||
27832521|NCT01732913|54311884|FG000|Overall Study|Study Terminated by Sponsor|105|||
27966594|NCT04026165|54624312|FG000|Run-in SEL Period|Protocol Violation|0|||
27966595|NCT04026165|54624313|FG001|Run-in SEL Period|Protocol Violation|3|||
27966596|NCT04026165|54624314|FG002|Run-in SEL Period|Protocol Violation|0|||
27966597|NCT04026165|54624315|FG003|Run-in SEL Period|Protocol Violation|0|||
27966598|NCT04026165|54624312|FG000|Run-in SEL Period|Investigator's Discretion|0|||
27966599|NCT04026165|54624313|FG001|Run-in SEL Period|Investigator's Discretion|2|||
27832522|NCT01732913|54311885|FG001|Overall Study|Study Terminated by Sponsor|55|||
27832523|NCT01732913|54311884|FG000|Overall Study|Withdrawal by Subject|27|||
27832524|NCT01732913|54311885|FG001|Overall Study|Withdrawal by Subject|4|||
27966600|NCT04026165|54624314|FG002|Run-in SEL Period|Investigator's Discretion|0|||
27966601|NCT04026165|54624315|FG003|Run-in SEL Period|Investigator's Discretion|0|||
27966602|NCT04026165|54624312|FG000|Run-in SEL Period|Death|0|||
28083574|NCT03410992|54737168|FG009|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
27966603|NCT04026165|54624313|FG001|Run-in SEL Period|Death|1|||
27966604|NCT04026165|54624314|FG002|Run-in SEL Period|Death|0|||
28083575|NCT03410992|54737169|FG010|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
28083576|NCT00377819|54737201|FG000|Overall Study|Adverse Event|2|||
27832525|NCT01732913|54311884|FG000|Overall Study|Physician Decision|14|||
27832526|NCT01732913|54311885|FG001|Overall Study|Physician Decision|7|||
27832527|NCT01732913|54311884|FG000|Overall Study|Other|7|||
27832528|NCT01732913|54311885|FG001|Overall Study|Other|1|||
27966605|NCT04026165|54624315|FG003|Run-in SEL Period|Death|0|||
27966606|NCT04026165|54624312|FG000|Randomized Period|Withdrew Consent|0|||
27966607|NCT04026165|54624313|FG001|Randomized Period|Withdrew Consent|0|||
27966608|NCT04026165|54624314|FG002|Randomized Period|Withdrew Consent|5|||
27966609|NCT04026165|54624315|FG003|Randomized Period|Withdrew Consent|8|||
27966610|NCT04026165|54624312|FG000|Randomized Period|Death|0|||
27966611|NCT04026165|54624313|FG001|Randomized Period|Death|0|||
27966612|NCT04026165|54624314|FG002|Randomized Period|Death|5|||
27966613|NCT04026165|54624315|FG003|Randomized Period|Death|7|||
27966614|NCT04026165|54624312|FG000|Randomized Period|Investigator's Discretion|0|||
27966615|NCT04026165|54624313|FG001|Randomized Period|Investigator's Discretion|0|||
27966616|NCT04026165|54624314|FG002|Randomized Period|Investigator's Discretion|2|||
27966617|NCT04026165|54624315|FG003|Randomized Period|Investigator's Discretion|2|||
27966618|NCT04026165|54624312|FG000|Randomized Period|Lost to Follow-up|0|||
27966619|NCT04026165|54624313|FG001|Randomized Period|Lost to Follow-up|0|||
27966620|NCT04026165|54624314|FG002|Randomized Period|Lost to Follow-up|2|||
27966621|NCT04026165|54624315|FG003|Randomized Period|Lost to Follow-up|2|||
27966622|NCT00805792|54624323|FG000|Overall Study|Death|3|||
27966623|NCT00805792|54624323|FG000|Overall Study|Lost to Follow-up|2|||
27966624|NCT00590044|54624329|FG000|Overall Study|Withdrawal by Subject|2|||
27966625|NCT00590044|54624330|FG001|Overall Study|Withdrawal by Subject|2|||
27966626|NCT00590044|54624329|FG000|Overall Study|wrong insulin arm assigned|1|||
27966627|NCT00590044|54624330|FG001|Overall Study|wrong insulin arm assigned|0|||
27966628|NCT00590044|54624329|FG000|Overall Study|Protocol Violation|1|||
27966629|NCT00590044|54624330|FG001|Overall Study|Protocol Violation|0|||
27966630|NCT00805480|54624343|FG000|Overall Study|Withdrawal by Subject|13|||
27966631|NCT00805480|54624344|FG001|Overall Study|Withdrawal by Subject|5|||
27966632|NCT00805480|54624345|FG002|Overall Study|Withdrawal by Subject|11|||
27966633|NCT00805480|54624346|FG003|Overall Study|Withdrawal by Subject|5|||
27966634|NCT00805480|54624343|FG000|Overall Study|Lost to Follow-up|1|||
27966635|NCT00805480|54624344|FG001|Overall Study|Lost to Follow-up|2|||
27966636|NCT00805480|54624345|FG002|Overall Study|Lost to Follow-up|0|||
27966637|NCT00805480|54624346|FG003|Overall Study|Lost to Follow-up|0|||
27966638|NCT00805480|54624343|FG000|Overall Study|Adverse Event|0|||
27966639|NCT00805480|54624344|FG001|Overall Study|Adverse Event|0|||
27966640|NCT00805480|54624345|FG002|Overall Study|Adverse Event|1|||
27966641|NCT00805480|54624346|FG003|Overall Study|Adverse Event|0|||
27966642|NCT00729937|54624362|FG000|Overall Study|Lost to Follow-up|49|||
27966643|NCT00729937|54624363|FG001|Overall Study|Lost to Follow-up|58|||
27966644|NCT00729937|54624364|FG002|Overall Study|Lost to Follow-up|18|||
27966645|NCT00729937|54624365|FG003|Overall Study|Lost to Follow-up|33|||
27966646|NCT00729937|54624366|FG004|Overall Study|Lost to Follow-up|18|||
27966647|NCT00729937|54624367|FG005|Overall Study|Lost to Follow-up|23|||
27966648|NCT00729937|54624362|FG000|Overall Study|Physician Decision|7|||
27966649|NCT00729937|54624363|FG001|Overall Study|Physician Decision|16|||
27966650|NCT00729937|54624364|FG002|Overall Study|Physician Decision|2|||
27966651|NCT00729937|54624365|FG003|Overall Study|Physician Decision|0|||
27966652|NCT00729937|54624366|FG004|Overall Study|Physician Decision|5|||
27966653|NCT00729937|54624367|FG005|Overall Study|Physician Decision|8|||
27966654|NCT00729937|54624362|FG000|Overall Study|Death|1|||
27966655|NCT00729937|54624363|FG001|Overall Study|Death|0|||
27966656|NCT00729937|54624364|FG002|Overall Study|Death|1|||
27966657|NCT00729937|54624365|FG003|Overall Study|Death|0|||
27966658|NCT00729937|54624366|FG004|Overall Study|Death|0|||
27966659|NCT00729937|54624367|FG005|Overall Study|Death|1|||
27966660|NCT00729937|54624362|FG000|Overall Study|Withdrawal by Subject|3|||
27966661|NCT00729937|54624363|FG001|Overall Study|Withdrawal by Subject|5|||
27966662|NCT00729937|54624364|FG002|Overall Study|Withdrawal by Subject|6|||
27966663|NCT00729937|54624365|FG003|Overall Study|Withdrawal by Subject|0|||
27966664|NCT00729937|54624366|FG004|Overall Study|Withdrawal by Subject|4|||
27966665|NCT00729937|54624367|FG005|Overall Study|Withdrawal by Subject|2|||
27832529|NCT01732913|54311884|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|3|||
27966666|NCT00729937|54624362|FG000|Overall Study|Randomized but not treated|12|||
27966667|NCT00729937|54624363|FG001|Overall Study|Randomized but not treated|6|||
27832530|NCT01732913|54311885|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|2|||
27832531|NCT01732835|54311916|FG000|6-month Primary Endpoint|Did not receive device|19|||
27966668|NCT00729937|54624364|FG002|Overall Study|Randomized but not treated|1|||
27966669|NCT00729937|54624365|FG003|Overall Study|Randomized but not treated|0|||
27966670|NCT00729937|54624366|FG004|Overall Study|Randomized but not treated|1|||
27966671|NCT00729937|54624367|FG005|Overall Study|Randomized but not treated|3|||
27966672|NCT00729937|54624362|FG000|Overall Study|Did not meet eligibility criteria|2|||
27966673|NCT00729937|54624363|FG001|Overall Study|Did not meet eligibility criteria|1|||
27966674|NCT00729937|54624364|FG002|Overall Study|Did not meet eligibility criteria|0|||
27966675|NCT00729937|54624365|FG003|Overall Study|Did not meet eligibility criteria|0|||
27966676|NCT00729937|54624366|FG004|Overall Study|Did not meet eligibility criteria|0|||
27966677|NCT00729937|54624367|FG005|Overall Study|Did not meet eligibility criteria|0|||
27966678|NCT00729937|54624362|FG000|Overall Study|Incarcerated|0|||
27966679|NCT00729937|54624363|FG001|Overall Study|Incarcerated|2|||
27966680|NCT00729937|54624364|FG002|Overall Study|Incarcerated|1|||
27966681|NCT00729937|54624365|FG003|Overall Study|Incarcerated|1|||
27966682|NCT00729937|54624366|FG004|Overall Study|Incarcerated|0|||
27966683|NCT00729937|54624367|FG005|Overall Study|Incarcerated|0|||
27966684|NCT00729859|54624384|FG000|Overall Study|Adverse Event|0|||
27966685|NCT00729859|54624385|FG001|Overall Study|Adverse Event|1|||
27966686|NCT00729859|54624386|FG002|Overall Study|Adverse Event|0|||
27966687|NCT00729859|54624384|FG000|Overall Study|Withdrawal by Subject|0|||
27966688|NCT00729859|54624385|FG001|Overall Study|Withdrawal by Subject|1|||
27966689|NCT00729859|54624386|FG002|Overall Study|Withdrawal by Subject|0|||
27966690|NCT00810394|54624402|FG000|Overall Study|Withdrawal by Subject|3|||
27966691|NCT00736333|54624406|FG000|Overall Study|Did Not Receive Drug or Not Documented|7|||
27966692|NCT00736333|54624406|FG000|Overall Study|Data Missing|2|||
27966693|NCT00736333|54624406|FG000|Overall Study|Tumor Progression|75|||
27966694|NCT00736333|54624406|FG000|Overall Study|Toxicity|6|||
27966695|NCT00736333|54624406|FG000|Overall Study|Withdrawal by Subject|10|||
27966696|NCT00736333|54624406|FG000|Overall Study|Death|7|||
27966697|NCT00736333|54624406|FG000|Overall Study|Other|4|||
27966698|NCT00736255|54624412|FG000|Overall Study|Adverse Event|1|||
27966699|NCT00736255|54624413|FG001|Overall Study|Adverse Event|0|||
27966700|NCT00736255|54624412|FG000|Overall Study|Physician Decision|1|||
27966701|NCT00736255|54624413|FG001|Overall Study|Physician Decision|0|||
27966702|NCT00736255|54624412|FG000|Overall Study|Non-compliance|1|||
27966703|NCT00736255|54624413|FG001|Overall Study|Non-compliance|1|||
27966704|NCT03920254|54624422|FG000|Overall Study|Adverse Event|1|||
27966705|NCT03920254|54624423|FG001|Overall Study|Adverse Event|0|||
27966706|NCT03920254|54624424|FG002|Overall Study|Adverse Event|0|||
27966707|NCT03920254|54624422|FG000|Overall Study|Physician Decision|0|||
27966708|NCT03920254|54624423|FG001|Overall Study|Physician Decision|1|||
27966709|NCT03920254|54624424|FG002|Overall Study|Physician Decision|2|||
27966710|NCT03920254|54624422|FG000|Overall Study|Study Terminated By Sponsor|12|||
27966711|NCT03920254|54624423|FG001|Overall Study|Study Terminated By Sponsor|17|||
27966712|NCT03920254|54624424|FG002|Overall Study|Study Terminated By Sponsor|12|||
27966713|NCT03920254|54624422|FG000|Overall Study|Withdrawal by Subject|0|||
27966714|NCT03920254|54624423|FG001|Overall Study|Withdrawal by Subject|0|||
27966715|NCT03920254|54624424|FG002|Overall Study|Withdrawal by Subject|1|||
27966716|NCT00729469|54624434|FG000|Overall Study|Adverse Event|14|||
27966717|NCT00729469|54624435|FG001|Overall Study|Adverse Event|25|||
27966718|NCT00729469|54624434|FG000|Overall Study|Lost to Follow-up|9|||
27966719|NCT00729469|54624435|FG001|Overall Study|Lost to Follow-up|9|||
27966720|NCT00729469|54624434|FG000|Overall Study|Protocol Violation|2|||
27966721|NCT00729469|54624435|FG001|Overall Study|Protocol Violation|1|||
27966722|NCT00729469|54624434|FG000|Overall Study|Withdrawal by Subject|19|||
27966723|NCT00729469|54624435|FG001|Overall Study|Withdrawal by Subject|8|||
27966724|NCT00729469|54624434|FG000|Overall Study|Other-Not mentioned|9|||
27966725|NCT00729469|54624435|FG001|Overall Study|Other-Not mentioned|4|||
27966726|NCT00742183|54624443|FG000|Overall Study|Adverse Event|2|||
27966727|NCT00742183|54624444|FG001|Overall Study|Adverse Event|2|||
27966728|NCT00742183|54624443|FG000|Overall Study|Death|1|||
27966729|NCT00742183|54624444|FG001|Overall Study|Death|0|||
27966730|NCT00742183|54624443|FG000|Overall Study|Physician Decision|0|||
27966731|NCT00742183|54624444|FG001|Overall Study|Physician Decision|2|||
27966732|NCT00742183|54624443|FG000|Overall Study|Lost to Follow-up|4|||
27966733|NCT00742183|54624444|FG001|Overall Study|Lost to Follow-up|4|||
27966734|NCT00742183|54624443|FG000|Overall Study|Required skin-graft|1|||
27966735|NCT00742183|54624444|FG001|Overall Study|Required skin-graft|1|||
27966736|NCT00742183|54624443|FG000|Overall Study|Withdrawal by Subject|1|||
27966737|NCT00742183|54624444|FG001|Overall Study|Withdrawal by Subject|0|||
27966738|NCT00742183|54624443|FG000|Overall Study|Lack of Efficacy|0|||
27966739|NCT00742183|54624444|FG001|Overall Study|Lack of Efficacy|3|||
27966740|NCT00808444|54624452|FG000|Overall Study|Withdrawal by Subject|1|||
27966741|NCT00808444|54624453|FG001|Overall Study|Withdrawal by Subject|0|||
27966742|NCT00808444|54624452|FG000|Overall Study|Lost to Follow-up|0|||
27966743|NCT00808444|54624453|FG001|Overall Study|Lost to Follow-up|1|||
27966744|NCT00742027|54624459|FG000|Overall Study|Disease Progression|76|||
27966745|NCT00742027|54624459|FG000|Overall Study|New Cancer Therapy|19|||
28165190|NCT03016325|54835753|FG000|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
28165191|NCT03016325|54835754|FG001|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1|||
27966746|NCT00742027|54624459|FG000|Overall Study|Withdrawal by Subject|18|||
27966747|NCT00742027|54624459|FG000|Overall Study|Death|7|||
27966748|NCT00742027|54624459|FG000|Overall Study|Lost to Follow-up|4|||
27966749|NCT00742027|54624459|FG000|Overall Study|Follow up Phase Completed As Per Protocol|2|||
27966750|NCT00742027|54624459|FG000|Overall Study|Missing|2|||
27966751|NCT00742027|54624459|FG000|Overall Study|Administrative Problems|1|||
27966752|NCT03996369|54624465|FG000|Overall Study|Protocol deviation|1|||
27966753|NCT03996369|54624466|FG001|Overall Study|Protocol deviation|1|||
27966754|NCT03996369|54624465|FG000|Overall Study|Physician Decision|4|||
27966755|NCT03996369|54624466|FG001|Overall Study|Physician Decision|2|||
27966756|NCT03996369|54624465|FG000|Overall Study|Participant decision|0|||
27966757|NCT03996369|54624466|FG001|Overall Study|Participant decision|1|||
27966758|NCT03996369|54624465|FG000|Overall Study|Lack of Efficacy|4|||
27966759|NCT03996369|54624466|FG001|Overall Study|Lack of Efficacy|0|||
27966760|NCT03996369|54624465|FG000|Overall Study|Adverse Event|9|||
27966761|NCT03996369|54624466|FG001|Overall Study|Adverse Event|0|||
27966762|NCT03996369|54624465|FG000|Overall Study|Withdrawal by Subject|6|||
27966763|NCT03996369|54624466|FG001|Overall Study|Withdrawal by Subject|8|||
27966764|NCT03996369|54624465|FG000|Overall Study|Didn't meet Inclusion/Exclusion criteria|1|||
27966765|NCT03996369|54624466|FG001|Overall Study|Didn't meet Inclusion/Exclusion criteria|0|||
27966766|NCT03996369|54624465|FG000|Overall Study|Lost to Follow-up|0|||
27966767|NCT03996369|54624466|FG001|Overall Study|Lost to Follow-up|1|||
27966768|NCT00808210|54624474|FG000|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3|||
27966769|NCT00808210|54624475|FG001|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7|||
27966770|NCT00808210|54624474|FG000|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6|||
27966771|NCT00808210|54624475|FG001|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2|||
27966772|NCT00808210|54624474|FG000|Double-Blind TX Period|Adverse Event|0|||
27966773|NCT00808210|54624475|FG001|Double-Blind TX Period|Adverse Event|1|||
27966774|NCT00808210|54624474|FG000|Double-Blind TX Period|Sponsor decision to terminate study|1|||
27966775|NCT00808210|54624475|FG001|Double-Blind TX Period|Sponsor decision to terminate study|1|||
27966776|NCT00808210|54624474|FG000|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
27966777|NCT00808210|54624475|FG001|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
27966778|NCT00808210|54624474|FG000|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9|||
27966779|NCT00808210|54624475|FG001|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4|||
27966780|NCT00736099|54624483|FG000|Overall Study|Adverse Event|61|||
27966781|NCT00736099|54624484|FG001|Overall Study|Adverse Event|18|||
27966782|NCT00736099|54624483|FG000|Overall Study|Protocol Violation|10|||
27966783|NCT00736099|54624484|FG001|Overall Study|Protocol Violation|4|||
27966784|NCT00736099|54624483|FG000|Overall Study|Lost to Follow-up|12|||
27966785|NCT00736099|54624484|FG001|Overall Study|Lost to Follow-up|5|||
27966786|NCT00736099|54624483|FG000|Overall Study|Withdrawal by Subject|42|||
27966787|NCT00736099|54624484|FG001|Overall Study|Withdrawal by Subject|13|||
27966788|NCT00736099|54624483|FG000|Overall Study|Lack of Efficacy|15|||
27966789|NCT00736099|54624484|FG001|Overall Study|Lack of Efficacy|8|||
27966790|NCT00736099|54624483|FG000|Overall Study|Other reason|43|||
27966791|NCT00736099|54624484|FG001|Overall Study|Other reason|10|||
27966792|NCT00735943|54624490|FG000|Overall Study|Lost to Follow-up|1|||
27966793|NCT00735943|54624490|FG000|Overall Study|Adverse Event|1|||
27966794|NCT00735709|54624498|FG000|Overall Study|Adverse Event|2|||
27966795|NCT00735709|54624499|FG001|Overall Study|Adverse Event|3|||
27966796|NCT00735709|54624500|FG002|Overall Study|Adverse Event|1|||
27966797|NCT00735709|54624501|FG003|Overall Study|Adverse Event|5|||
27966798|NCT00735709|54624498|FG000|Overall Study|Lack of Efficacy|8|||
27966799|NCT00735709|54624499|FG001|Overall Study|Lack of Efficacy|4|||
27966800|NCT00735709|54624500|FG002|Overall Study|Lack of Efficacy|2|||
27966801|NCT00735709|54624501|FG003|Overall Study|Lack of Efficacy|3|||
27966802|NCT00735709|54624498|FG000|Overall Study|Noncompliance|0|||
27966803|NCT00735709|54624499|FG001|Overall Study|Noncompliance|0|||
27966804|NCT00735709|54624500|FG002|Overall Study|Noncompliance|1|||
27966805|NCT00735709|54624501|FG003|Overall Study|Noncompliance|0|||
27966806|NCT00735709|54624498|FG000|Overall Study|Protocol deviations|1|||
27966807|NCT00735709|54624499|FG001|Overall Study|Protocol deviations|2|||
27966808|NCT00735709|54624500|FG002|Overall Study|Protocol deviations|1|||
27966809|NCT00735709|54624501|FG003|Overall Study|Protocol deviations|1|||
27966810|NCT00735709|54624498|FG000|Overall Study|Voluntary Withdrawal|1|||
27966811|NCT00735709|54624499|FG001|Overall Study|Voluntary Withdrawal|3|||
27966812|NCT00735709|54624500|FG002|Overall Study|Voluntary Withdrawal|5|||
27966813|NCT00735709|54624501|FG003|Overall Study|Voluntary Withdrawal|7|||
27966814|NCT00735709|54624498|FG000|Overall Study|Lost to Follow-up|0|||
27966815|NCT00735709|54624499|FG001|Overall Study|Lost to Follow-up|1|||
27966816|NCT00735709|54624500|FG002|Overall Study|Lost to Follow-up|1|||
27966817|NCT00735709|54624501|FG003|Overall Study|Lost to Follow-up|1|||
27966818|NCT00735709|54624498|FG000|Overall Study|Excluded medication|1|||
27966819|NCT00735709|54624499|FG001|Overall Study|Excluded medication|0|||
27966820|NCT00735709|54624500|FG002|Overall Study|Excluded medication|0|||
27966821|NCT00735709|54624501|FG003|Overall Study|Excluded medication|1|||
27966822|NCT00729157|54624511|FG000|Overall Study|Withdrawal by Subject|1|||
27832532|NCT01732835|54311916|FG000|6-month Primary Endpoint|Withdrawal by Subject|2|||
27832533|NCT01732835|54311916|FG000|6-month Primary Endpoint|Adverse Event|3|||
27966823|NCT00728689|54624517|FG000|Washout Period (Days 4 - 10)|Death in family|1|||
27966824|NCT00728689|54624518|FG001|Washout Period (Days 4 - 10)|Death in family|0|||
27966825|NCT00727909|54624526|FG000|Overall Study|Withdrawal by Subject|5|||
27966826|NCT00727909|54624527|FG001|Overall Study|Withdrawal by Subject|11|||
27966827|NCT00727909|54624528|FG002|Overall Study|Withdrawal by Subject|8|||
27966828|NCT00727909|54624529|FG003|Overall Study|Withdrawal by Subject|5|||
27966829|NCT00727909|54624526|FG000|Overall Study|Death|0|||
27966830|NCT00727909|54624527|FG001|Overall Study|Death|0|||
27966831|NCT00727909|54624528|FG002|Overall Study|Death|1|||
27966832|NCT00727909|54624529|FG003|Overall Study|Death|0|||
27966833|NCT00726895|54624533|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
27966834|NCT00726895|54624534|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
27966835|NCT00585325|54624543|FG000|Overall Study|Withdrawal by Subject|1|||
27966836|NCT00585325|54624544|FG001|Overall Study|Withdrawal by Subject|1|||
27966837|NCT00726661|54624552|FG000|Overall Study|Lost to Follow-up|36|||
27966838|NCT00726661|54624553|FG001|Overall Study|Lost to Follow-up|11|||
27966839|NCT00726661|54624552|FG000|Overall Study|Withdrawal by Subject|17|||
27966840|NCT00726661|54624553|FG001|Overall Study|Withdrawal by Subject|13|||
27966841|NCT00726661|54624552|FG000|Overall Study|Trial terminated by sponsor|214|||
27966842|NCT00726661|54624553|FG001|Overall Study|Trial terminated by sponsor|187|||
27966843|NCT00726661|54624552|FG000|Overall Study|Death|475|||
27966844|NCT00726661|54624553|FG001|Overall Study|Death|159|||
27966845|NCT00726661|54624552|FG000|Overall Study|Physician Decision|25|||
27966846|NCT00726661|54624553|FG001|Overall Study|Physician Decision|13|||
27966847|NCT00726661|54624552|FG000|Overall Study|Other|47|||
27966848|NCT00726661|54624553|FG001|Overall Study|Other|35|||
27966849|NCT00741091|54624569|FG000|Overall Study|Death|13|||
27966850|NCT00741091|54624569|FG000|Overall Study|Lost to Follow-up|16|||
27966851|NCT00741091|54624569|FG000|Overall Study|Withdrawal by Subject|6|||
27966852|NCT00741091|54624569|FG000|Overall Study|Missed Visit|22|||
27966853|NCT00741013|54624576|FG000|Overall Study|Adverse Event|1|||
27966854|NCT00741013|54624577|FG001|Overall Study|Adverse Event|0|||
27966855|NCT00741013|54624578|FG002|Overall Study|Adverse Event|0|||
27966856|NCT00741013|54624576|FG000|Overall Study|Withdrawal by Subject|0|||
27966857|NCT00741013|54624577|FG001|Overall Study|Withdrawal by Subject|0|||
27966858|NCT00741013|54624578|FG002|Overall Study|Withdrawal by Subject|1|||
27966859|NCT00741013|54624576|FG000|Overall Study|Discovered failed screen after enrolled|0|||
27966860|NCT00741013|54624577|FG001|Overall Study|Discovered failed screen after enrolled|2|||
27966861|NCT00741013|54624578|FG002|Overall Study|Discovered failed screen after enrolled|0|||
27966862|NCT00740857|54624589|FG000|Overall Study|Withdrawal by Subject|1|||
27966863|NCT00740857|54624590|FG001|Overall Study|Withdrawal by Subject|0|||
27966864|NCT00740857|54624591|FG002|Overall Study|Withdrawal by Subject|0|||
27966865|NCT00808132|54624604|FG000|Overall Study|Adverse Event|34|||
27966866|NCT00808132|54624605|FG001|Overall Study|Adverse Event|33|||
27966867|NCT00808132|54624606|FG002|Overall Study|Adverse Event|16|||
27966868|NCT00808132|54624607|FG003|Overall Study|Adverse Event|31|||
27966869|NCT00808132|54624608|FG004|Overall Study|Adverse Event|33|||
27966870|NCT00808132|54624604|FG000|Overall Study|Death|0|||
27966871|NCT00808132|54624605|FG001|Overall Study|Death|0|||
27966872|NCT00808132|54624606|FG002|Overall Study|Death|0|||
27966873|NCT00808132|54624607|FG003|Overall Study|Death|0|||
27966874|NCT00808132|54624608|FG004|Overall Study|Death|1|||
27966875|NCT00808132|54624604|FG000|Overall Study|Physician Decision|0|||
27966876|NCT00808132|54624605|FG001|Overall Study|Physician Decision|1|||
27966877|NCT00808132|54624606|FG002|Overall Study|Physician Decision|0|||
27966878|NCT00808132|54624607|FG003|Overall Study|Physician Decision|0|||
27966879|NCT00808132|54624608|FG004|Overall Study|Physician Decision|0|||
27966880|NCT00808132|54624604|FG000|Overall Study|Lost to Follow-up|8|||
27966881|NCT00808132|54624605|FG001|Overall Study|Lost to Follow-up|10|||
27966882|NCT00808132|54624606|FG002|Overall Study|Lost to Follow-up|11|||
27966883|NCT00808132|54624607|FG003|Overall Study|Lost to Follow-up|8|||
27966884|NCT00808132|54624608|FG004|Overall Study|Lost to Follow-up|9|||
27966885|NCT00808132|54624604|FG000|Overall Study|Protocol Violation|8|||
27966886|NCT00808132|54624605|FG001|Overall Study|Protocol Violation|9|||
27966887|NCT00808132|54624606|FG002|Overall Study|Protocol Violation|4|||
27966888|NCT00808132|54624607|FG003|Overall Study|Protocol Violation|9|||
27966889|NCT00808132|54624608|FG004|Overall Study|Protocol Violation|5|||
27966890|NCT00808132|54624604|FG000|Overall Study|Withdrawal by Subject|27|||
27966891|NCT00808132|54624605|FG001|Overall Study|Withdrawal by Subject|18|||
27966892|NCT00808132|54624606|FG002|Overall Study|Withdrawal by Subject|2|||
27966893|NCT00808132|54624607|FG003|Overall Study|Withdrawal by Subject|7|||
27966894|NCT00808132|54624608|FG004|Overall Study|Withdrawal by Subject|16|||
27966895|NCT00808132|54624604|FG000|Overall Study|Other|6|||
27966896|NCT00808132|54624605|FG001|Overall Study|Other|4|||
28083577|NCT00377819|54737202|FG001|Overall Study|Adverse Event|3|||
27966897|NCT00808132|54624606|FG002|Overall Study|Other|6|||
27966898|NCT00808132|54624607|FG003|Overall Study|Other|2|||
27966899|NCT00808132|54624608|FG004|Overall Study|Other|15|||
27966900|NCT00808132|54624604|FG000|Overall Study|Randomized, but not treated|10|||
27966901|NCT00808132|54624605|FG001|Overall Study|Randomized, but not treated|7|||
27966902|NCT00808132|54624606|FG002|Overall Study|Randomized, but not treated|9|||
28083578|NCT00377819|54737201|FG000|Overall Study|Withdrawal by Subject|10|||
27966903|NCT00808132|54624607|FG003|Overall Study|Randomized, but not treated|8|||
27966904|NCT00808132|54624608|FG004|Overall Study|Randomized, but not treated|9|||
27966905|NCT00808132|54624604|FG000|Overall Study|Unsatisfactory response|5|||
27966906|NCT00808132|54624605|FG001|Overall Study|Unsatisfactory response|6|||
27966907|NCT00808132|54624606|FG002|Overall Study|Unsatisfactory response|6|||
27966908|NCT00808132|54624607|FG003|Overall Study|Unsatisfactory response|4|||
27966909|NCT00808132|54624608|FG004|Overall Study|Unsatisfactory response|12|||
27966910|NCT00727441|54624623|FG000|Overall Study|Disease Progression|11|||
27966911|NCT00727441|54624624|FG001|Overall Study|Disease Progression|14|||
27966912|NCT00727441|54624625|FG002|Overall Study|Disease Progression|17|||
27966913|NCT00727441|54624623|FG000|Overall Study|Eligibility|7|||
27966914|NCT00727441|54624624|FG001|Overall Study|Eligibility|5|||
27966915|NCT00727441|54624625|FG002|Overall Study|Eligibility|7|||
27966916|NCT00727441|54624623|FG000|Overall Study|Death|0|||
27966917|NCT00727441|54624624|FG001|Overall Study|Death|1|||
27966918|NCT00727441|54624625|FG002|Overall Study|Death|1|||
27966919|NCT00727441|54624623|FG000|Overall Study|Physician Decision|0|||
27966920|NCT00727441|54624624|FG001|Overall Study|Physician Decision|1|||
27966921|NCT00727441|54624625|FG002|Overall Study|Physician Decision|0|||
27966922|NCT00727441|54624623|FG000|Overall Study|Withdrawal by Subject|0|||
27966923|NCT00727441|54624624|FG001|Overall Study|Withdrawal by Subject|1|||
27966924|NCT00727441|54624625|FG002|Overall Study|Withdrawal by Subject|0|||
27966925|NCT00717769|54624639|FG000|Overall Study|Adverse Event|9|||
27966926|NCT00717769|54624640|FG001|Overall Study|Adverse Event|6|||
27966927|NCT00717769|54624641|FG002|Overall Study|Adverse Event|1|||
27966928|NCT00717769|54624639|FG000|Overall Study|Lack of compliance|0|||
27966929|NCT00717769|54624640|FG001|Overall Study|Lack of compliance|2|||
27966930|NCT00717769|54624641|FG002|Overall Study|Lack of compliance|0|||
27966931|NCT00717769|54624639|FG000|Overall Study|Lost to Follow-up|3|||
27966932|NCT00717769|54624640|FG001|Overall Study|Lost to Follow-up|4|||
27966933|NCT00717769|54624641|FG002|Overall Study|Lost to Follow-up|0|||
27966934|NCT00717769|54624639|FG000|Overall Study|Lack of Efficacy|1|||
27966935|NCT00717769|54624640|FG001|Overall Study|Lack of Efficacy|2|||
27966936|NCT00717769|54624641|FG002|Overall Study|Lack of Efficacy|0|||
27966937|NCT00717769|54624639|FG000|Overall Study|Protocol Violation|0|||
27966938|NCT00717769|54624640|FG001|Overall Study|Protocol Violation|2|||
27966939|NCT00717769|54624641|FG002|Overall Study|Protocol Violation|0|||
27966940|NCT00717769|54624639|FG000|Overall Study|Sponsor decision|1|||
27966941|NCT00717769|54624640|FG001|Overall Study|Sponsor decision|0|||
27966942|NCT00717769|54624641|FG002|Overall Study|Sponsor decision|10|||
27966943|NCT00717769|54624639|FG000|Overall Study|Withdrew consent|2|||
27966944|NCT00717769|54624640|FG001|Overall Study|Withdrew consent|2|||
27966945|NCT00717769|54624641|FG002|Overall Study|Withdrew consent|0|||
27966946|NCT04153929|54624659|FG000|Overall Study|Other than listed|2|||
27966947|NCT04153929|54624660|FG001|Overall Study|Other than listed|2|||
27966948|NCT04153929|54624661|FG002|Overall Study|Other than listed|0|||
27966949|NCT04153929|54624662|FG003|Overall Study|Other than listed|1|||
27966950|NCT04153929|54624663|FG004|Overall Study|Other than listed|0|||
27966951|NCT04153929|54624664|FG005|Overall Study|Other than listed|2|||
27966952|NCT04153929|54624665|FG006|Overall Study|Other than listed|2|||
27966953|NCT04153929|54624666|FG007|Overall Study|Other than listed|1|||
27966954|NCT04153929|54624659|FG000|Overall Study|Lost to Follow-up|2|||
27966955|NCT04153929|54624660|FG001|Overall Study|Lost to Follow-up|1|||
27966956|NCT04153929|54624661|FG002|Overall Study|Lost to Follow-up|0|||
27966957|NCT04153929|54624662|FG003|Overall Study|Lost to Follow-up|1|||
27966958|NCT04153929|54624663|FG004|Overall Study|Lost to Follow-up|1|||
27966959|NCT04153929|54624664|FG005|Overall Study|Lost to Follow-up|0|||
27966960|NCT04153929|54624665|FG006|Overall Study|Lost to Follow-up|0|||
28165192|NCT03016325|54835755|FG002|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
28165193|NCT03016325|54835756|FG003|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
27966961|NCT04153929|54624666|FG007|Overall Study|Lost to Follow-up|0|||
27966962|NCT04153929|54624659|FG000|Overall Study|Withdrawal by Subject|3|||
27966963|NCT04153929|54624660|FG001|Overall Study|Withdrawal by Subject|1|||
27966964|NCT04153929|54624661|FG002|Overall Study|Withdrawal by Subject|0|||
27966965|NCT04153929|54624662|FG003|Overall Study|Withdrawal by Subject|3|||
27966966|NCT04153929|54624663|FG004|Overall Study|Withdrawal by Subject|1|||
27966967|NCT04153929|54624664|FG005|Overall Study|Withdrawal by Subject|0|||
27966968|NCT04153929|54624665|FG006|Overall Study|Withdrawal by Subject|1|||
27966969|NCT04153929|54624666|FG007|Overall Study|Withdrawal by Subject|0|||
27966970|NCT04153929|54624659|FG000|Overall Study|Protocol Violation|0|||
27966971|NCT04153929|54624660|FG001|Overall Study|Protocol Violation|0|||
27966972|NCT04153929|54624661|FG002|Overall Study|Protocol Violation|0|||
27966973|NCT04153929|54624662|FG003|Overall Study|Protocol Violation|0|||
28165194|NCT03016325|54835757|FG004|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
27966974|NCT04153929|54624663|FG004|Overall Study|Protocol Violation|0|||
27966975|NCT04153929|54624664|FG005|Overall Study|Protocol Violation|0|||
27966976|NCT04153929|54624665|FG006|Overall Study|Protocol Violation|1|||
27966977|NCT04153929|54624666|FG007|Overall Study|Protocol Violation|2|||
27966978|NCT04153929|54624659|FG000|Overall Study|Adverse Event|3|||
27966979|NCT04153929|54624660|FG001|Overall Study|Adverse Event|5|||
27966980|NCT04153929|54624661|FG002|Overall Study|Adverse Event|5|||
28083579|NCT00377819|54737202|FG001|Overall Study|Withdrawal by Subject|4|||
28083580|NCT00377819|54737201|FG000|Overall Study|Death|0|||
28083581|NCT00377819|54737202|FG001|Overall Study|Death|1|||
28083582|NCT00377819|54737201|FG000|Overall Study|Lost to Follow-up|0|||
28083583|NCT00377819|54737202|FG001|Overall Study|Lost to Follow-up|1|||
28083584|NCT00377819|54737201|FG000|Overall Study|Protocol Violation|1|||
28083585|NCT00377819|54737202|FG001|Overall Study|Protocol Violation|1|||
28083586|NCT03419962|54737208|FG000|Overall Study|Change to other medication|1|||
27966981|NCT04153929|54624662|FG003|Overall Study|Adverse Event|11|||
27966982|NCT04153929|54624663|FG004|Overall Study|Adverse Event|15|||
27966983|NCT04153929|54624664|FG005|Overall Study|Adverse Event|4|||
27966984|NCT04153929|54624665|FG006|Overall Study|Adverse Event|8|||
27966985|NCT04153929|54624666|FG007|Overall Study|Adverse Event|2|||
27966986|NCT04153929|54624659|FG000|Overall Study|Not treated|1|||
27966987|NCT04153929|54624660|FG001|Overall Study|Not treated|0|||
27966988|NCT04153929|54624661|FG002|Overall Study|Not treated|0|||
27966989|NCT04153929|54624662|FG003|Overall Study|Not treated|0|||
27966990|NCT04153929|54624663|FG004|Overall Study|Not treated|0|||
27966991|NCT04153929|54624664|FG005|Overall Study|Not treated|0|||
27966992|NCT04153929|54624665|FG006|Overall Study|Not treated|1|||
27966993|NCT04153929|54624666|FG007|Overall Study|Not treated|0|||
27966994|NCT00591214|54624684|FG000|Overall Study|Physician Decision|7|||
27966995|NCT00591214|54624684|FG000|Overall Study|Withdrawal by Subject|1|||
27966996|NCT00725725|54624691|FG000|Overall Study|Adverse Event|1|||
27966997|NCT00725725|54624692|FG001|Overall Study|Adverse Event|3|||
27966998|NCT00725725|54624693|FG002|Overall Study|Adverse Event|2|||
27966999|NCT00725725|54624691|FG000|Overall Study|Lost to Follow-up|2|||
27967000|NCT00725725|54624692|FG001|Overall Study|Lost to Follow-up|0|||
27967001|NCT00725725|54624693|FG002|Overall Study|Lost to Follow-up|2|||
27967002|NCT00725725|54624691|FG000|Overall Study|Withdrawal by Subject|1|||
27967003|NCT00725725|54624692|FG001|Overall Study|Withdrawal by Subject|0|||
27967004|NCT00725725|54624693|FG002|Overall Study|Withdrawal by Subject|1|||
27967005|NCT00725725|54624691|FG000|Overall Study|Protocol Violation|0|||
27967006|NCT00725725|54624692|FG001|Overall Study|Protocol Violation|1|||
27967007|NCT00725725|54624693|FG002|Overall Study|Protocol Violation|0|||
27967008|NCT00725101|54624701|FG000|Overall Study|Death|3|||
27967009|NCT00725101|54624701|FG000|Overall Study|Lost to Follow-up|353|||
27967010|NCT00725101|54624701|FG000|Overall Study|Protocol Violation|1|||
27967011|NCT00725101|54624701|FG000|Overall Study|Withdrawal by Subject|127|||
27967012|NCT00725101|54624701|FG000|Overall Study|not specified/no reason given|11|||
27967013|NCT00585169|54624705|FG000|Overall Study|Withdrawal by Subject|1|||
27967014|NCT00807742|54624713|FG000|Overall Study|Death|9|||
27967015|NCT00807742|54624714|FG001|Overall Study|Death|2|||
28083587|NCT03419962|54737208|FG000|Overall Study|Refusal of continuing with trial drug|1|||
28083588|NCT03419962|54737208|FG000|Overall Study|Lost to Follow-up|3|||
28083589|NCT03419962|54737208|FG000|Overall Study|Difficulty in inhaling the doses|1|||
28083590|NCT03419962|54737208|FG000|Overall Study|Missing completion data|31|||
28083591|NCT00377429|54737212|FG000|Overall Study|Withdrawal by Subject|5|||
27967016|NCT00807742|54624713|FG000|Overall Study|Withdrawal by Subject|2|||
27967017|NCT00807742|54624714|FG001|Overall Study|Withdrawal by Subject|1|||
27967018|NCT00807742|54624713|FG000|Overall Study|Lost to Follow-up|35|||
27967019|NCT00807742|54624714|FG001|Overall Study|Lost to Follow-up|51|||
27967020|NCT00724945|54624720|FG000|Period 1|non-compliance|1|||
27967021|NCT00724945|54624721|FG001|Period 1|non-compliance|0|||
27967022|NCT00724945|54624720|FG000|Period 1|Adverse Event|1|||
27967023|NCT00724945|54624721|FG001|Period 1|Adverse Event|1|||
27967024|NCT00724945|54624720|FG000|Period 1|Lost to Follow-up|1|||
27967025|NCT00724945|54624721|FG001|Period 1|Lost to Follow-up|0|||
27967026|NCT00724945|54624720|FG000|Period 2|lens comfort issue|3|||
27967027|NCT00724945|54624721|FG001|Period 2|lens comfort issue|0|||
27967028|NCT00724945|54624720|FG000|Period 2|lens physiology issue|1|||
28083592|NCT00377429|54737212|FG000|Overall Study|Adverse Event|8|||
28083593|NCT00377429|54737212|FG000|Overall Study|Physician Decision|1|||
27967029|NCT00724945|54624721|FG001|Period 2|lens physiology issue|0|||
27967030|NCT00803452|54624729|FG000|Overall Study|Adverse Event|0|||
27967031|NCT00803452|54624730|FG001|Overall Study|Adverse Event|2|||
27967032|NCT00803452|54624729|FG000|Overall Study|Lost to Follow-up|0|||
27967033|NCT00803452|54624730|FG001|Overall Study|Lost to Follow-up|3|||
27967034|NCT00589108|54624739|FG000|Overall Study|Lost to Follow-up|1|||
27967035|NCT00589108|54624740|FG001|Overall Study|Lost to Follow-up|1|||
28165195|NCT03016325|54835758|FG005|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
27967036|NCT00589108|54624741|FG002|Overall Study|Lost to Follow-up|1|||
27967037|NCT00589108|54624739|FG000|Overall Study|Death|3|||
27967038|NCT00589108|54624740|FG001|Overall Study|Death|3|||
27967039|NCT00589108|54624741|FG002|Overall Study|Death|4|||
27967040|NCT00717067|54624754|FG000|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
28083594|NCT00377429|54737212|FG000|Overall Study|Patient non-compliance|1|||
28083595|NCT00376961|54737216|FG000|Initial Registration|Adverse Event|1|||
28083596|NCT00376961|54737217|FG001|Initial Registration|Adverse Event|0|||
27967041|NCT00717067|54624755|FG001|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
27967042|NCT00717067|54624756|FG002|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1|||
27967043|NCT00717067|54624757|FG003|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
27967044|NCT00717067|54624758|FG004|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
27967045|NCT00802438|54624780|FG000|Overall Study|Screen Failure|20|||
27967046|NCT00802438|54624780|FG000|Overall Study|Withdrawal by Subject|7|||
27967047|NCT00802438|54624780|FG000|Overall Study|Physician Decision|1|||
27967048|NCT00588952|54624790|FG000|Overall Study|Adverse Event|0|||
27967049|NCT00588952|54624791|FG001|Overall Study|Adverse Event|2|||
27967050|NCT00588952|54624790|FG000|Overall Study|Withdrawal by Subject|3|||
27967051|NCT00588952|54624791|FG001|Overall Study|Withdrawal by Subject|5|||
27967052|NCT01021748|54624806|FG000|Overall Study|Adverse Event|2|||
27967053|NCT01021748|54624807|FG001|Overall Study|Adverse Event|1|||
27967054|NCT01021748|54624808|FG002|Overall Study|Adverse Event|2|||
27967055|NCT01021748|54624809|FG003|Overall Study|Adverse Event|0|||
27967056|NCT01021748|54624810|FG004|Overall Study|Adverse Event|2|||
27967057|NCT01021748|54624811|FG005|Overall Study|Adverse Event|0|||
27967058|NCT01021748|54624812|FG006|Overall Study|Adverse Event|1|||
27967059|NCT01021748|54624813|FG007|Overall Study|Adverse Event|0|||
27967060|NCT01021748|54624814|FG008|Overall Study|Adverse Event|7|||
27967061|NCT01021748|54624806|FG000|Overall Study|Physician Decision|1|||
27967062|NCT01021748|54624807|FG001|Overall Study|Physician Decision|0|||
27967063|NCT01021748|54624808|FG002|Overall Study|Physician Decision|1|||
27967064|NCT01021748|54624809|FG003|Overall Study|Physician Decision|1|||
27967065|NCT01021748|54624810|FG004|Overall Study|Physician Decision|0|||
27967066|NCT01021748|54624811|FG005|Overall Study|Physician Decision|0|||
27967067|NCT01021748|54624812|FG006|Overall Study|Physician Decision|1|||
27967068|NCT01021748|54624813|FG007|Overall Study|Physician Decision|1|||
27967069|NCT01021748|54624814|FG008|Overall Study|Physician Decision|2|||
27967070|NCT01021748|54624806|FG000|Overall Study|Progressive Disease|3|||
27967071|NCT01021748|54624807|FG001|Overall Study|Progressive Disease|3|||
27967072|NCT01021748|54624808|FG002|Overall Study|Progressive Disease|4|||
27967073|NCT01021748|54624809|FG003|Overall Study|Progressive Disease|6|||
27967074|NCT01021748|54624810|FG004|Overall Study|Progressive Disease|7|||
27967075|NCT01021748|54624811|FG005|Overall Study|Progressive Disease|3|||
27967076|NCT01021748|54624812|FG006|Overall Study|Progressive Disease|0|||
27967077|NCT01021748|54624813|FG007|Overall Study|Progressive Disease|5|||
27967078|NCT01021748|54624814|FG008|Overall Study|Progressive Disease|6|||
27967079|NCT01021748|54624806|FG000|Overall Study|Withdrawal by Subject|0|||
27967080|NCT01021748|54624807|FG001|Overall Study|Withdrawal by Subject|0|||
27967081|NCT01021748|54624808|FG002|Overall Study|Withdrawal by Subject|0|||
27967082|NCT01021748|54624809|FG003|Overall Study|Withdrawal by Subject|0|||
27967083|NCT01021748|54624810|FG004|Overall Study|Withdrawal by Subject|0|||
27967084|NCT01021748|54624811|FG005|Overall Study|Withdrawal by Subject|0|||
27967085|NCT01021748|54624812|FG006|Overall Study|Withdrawal by Subject|1|||
27967086|NCT01021748|54624813|FG007|Overall Study|Withdrawal by Subject|0|||
27967087|NCT01021748|54624814|FG008|Overall Study|Withdrawal by Subject|1|||
27967088|NCT01021748|54624806|FG000|Overall Study|Not Treated|0|||
27967089|NCT01021748|54624807|FG001|Overall Study|Not Treated|1|||
27967090|NCT01021748|54624808|FG002|Overall Study|Not Treated|0|||
27967091|NCT01021748|54624809|FG003|Overall Study|Not Treated|0|||
27967092|NCT01021748|54624810|FG004|Overall Study|Not Treated|0|||
27967093|NCT01021748|54624811|FG005|Overall Study|Not Treated|0|||
27967094|NCT01021748|54624812|FG006|Overall Study|Not Treated|0|||
27967095|NCT01021748|54624813|FG007|Overall Study|Not Treated|0|||
27967096|NCT01021748|54624814|FG008|Overall Study|Not Treated|0|||
27967097|NCT00802360|54624838|FG000|Overall Study|Stimulation failure|4|||
27967098|NCT00802360|54624839|FG001|Overall Study|Stimulation failure|0|||
27967099|NCT00802360|54624840|FG002|Overall Study|Stimulation failure|3|||
27967100|NCT00802360|54624841|FG003|Overall Study|Stimulation failure|3|||
27967101|NCT00802360|54624838|FG000|Overall Study|Inadequate number of oocytes retrieved|0|||
27967102|NCT00802360|54624839|FG001|Overall Study|Inadequate number of oocytes retrieved|0|||
27967103|NCT00802360|54624840|FG002|Overall Study|Inadequate number of oocytes retrieved|0|||
27967104|NCT00802360|54624841|FG003|Overall Study|Inadequate number of oocytes retrieved|1|||
27967105|NCT00802360|54624838|FG000|Overall Study|Cycle cancelled|0|||
27967106|NCT00802360|54624839|FG001|Overall Study|Cycle cancelled|1|||
28083597|NCT00376961|54737216|FG000|Initial Registration|Refusal Unrelated to Adverse Event|2|||
28083598|NCT00376961|54737217|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
27967107|NCT00802360|54624840|FG002|Overall Study|Cycle cancelled|1|||
27967108|NCT00802360|54624841|FG003|Overall Study|Cycle cancelled|1|||
27967109|NCT00802360|54624838|FG000|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
27967110|NCT00802360|54624839|FG001|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
27967111|NCT00802360|54624840|FG002|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
28083599|NCT00376961|54737216|FG000|Initial Registration|Progression/relapse|1|||
27967112|NCT00802360|54624841|FG003|Overall Study|Risk of ovarian hyperstimulation syndrom|1|||
27967113|NCT00802360|54624838|FG000|Overall Study|No positive serum pregnancy|17|||
27967114|NCT00802360|54624839|FG001|Overall Study|No positive serum pregnancy|20|||
27967115|NCT00802360|54624840|FG002|Overall Study|No positive serum pregnancy|14|||
27967116|NCT00802360|54624841|FG003|Overall Study|No positive serum pregnancy|10|||
27967117|NCT00802360|54624838|FG000|Overall Study|Pregnancy not confirmed by ultrasound|1|||
27967118|NCT00802360|54624839|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
27967119|NCT00802360|54624840|FG002|Overall Study|Pregnancy not confirmed by ultrasound|1|||
27967120|NCT00802360|54624841|FG003|Overall Study|Pregnancy not confirmed by ultrasound|0|||
27967121|NCT00802360|54624838|FG000|Overall Study|Pregnancy loss/miscarriage|0|||
27967122|NCT00802360|54624839|FG001|Overall Study|Pregnancy loss/miscarriage|2|||
27967123|NCT00802360|54624840|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
27967124|NCT00802360|54624841|FG003|Overall Study|Pregnancy loss/miscarriage|3|||
27967125|NCT00802360|54624838|FG000|Overall Study|Other|2|||
27967126|NCT00802360|54624839|FG001|Overall Study|Other|3|||
27967127|NCT00802360|54624840|FG002|Overall Study|Other|6|||
27967128|NCT00802360|54624841|FG003|Overall Study|Other|3|||
27967129|NCT01026038|54624856|FG000|Overall Study|Lost to Follow-up|1|||
27967130|NCT01026038|54624857|FG001|Overall Study|Lost to Follow-up|1|||
27967131|NCT01026038|54624858|FG002|Overall Study|Lost to Follow-up|0|||
27967132|NCT00801892|54624877|FG000|Main Study Period|Withdrawal by Subject|0|||
27967133|NCT00801892|54624878|FG001|Main Study Period|Withdrawal by Subject|1|||
27967134|NCT00801892|54624877|FG000|Sham Crossover Period|Lost to Follow-up|0|||
27967135|NCT00801892|54624878|FG001|Sham Crossover Period|Lost to Follow-up|2|||
27967136|NCT02680587|54624892|FG000|Overall Study|Withdrawal by Subject|1|||
27967137|NCT02680587|54624893|FG001|Overall Study|Withdrawal by Subject|0|||
27967138|NCT00589420|54624903|FG000|Overall Study|screen failure|1|||
27967139|NCT01025336|54624912|FG000|Overall Study|Protocol Violation|0|||
27967140|NCT01025336|54624913|FG001|Overall Study|Protocol Violation|0|||
27967141|NCT01025336|54624914|FG002|Overall Study|Protocol Violation|0|||
27967142|NCT01025336|54624915|FG003|Overall Study|Protocol Violation|2|||
27967143|NCT01025336|54624916|FG004|Overall Study|Protocol Violation|0|||
27967144|NCT00796978|54624950|FG000|Overall Study|Cardiac adverse event|5|||
27967145|NCT00796978|54624950|FG000|Overall Study|Adverse Event|4|||
27967146|NCT00796978|54624950|FG000|Overall Study|Withdrawal by Subject|3|||
27967147|NCT00796822|54624956|FG000|Overall Study|Lost to Follow-up|2|||
27967148|NCT00796822|54624957|FG001|Overall Study|Lost to Follow-up|0|||
27967149|NCT00796822|54624956|FG000|Overall Study|Adverse Event|1|||
27967150|NCT00796822|54624957|FG001|Overall Study|Adverse Event|0|||
27967151|NCT01020812|54624963|FG000|Overall Study|Physician Decision|1|||
27967152|NCT01020812|54624963|FG000|Overall Study|Withdrawal by Subject|1|||
27967153|NCT01020812|54624963|FG000|Overall Study|Protocol Violation|1|||
27967154|NCT01032044|54624969|FG000|Overall Study|Protocol Violation|14|||
27967155|NCT01032044|54624970|FG001|Overall Study|Protocol Violation|8|||
27967156|NCT01032044|54624969|FG000|Overall Study|Adverse Event|0|||
27967157|NCT01032044|54624970|FG001|Overall Study|Adverse Event|1|||
27967158|NCT01032044|54624969|FG000|Overall Study|Lost to Follow-up|11|||
27967159|NCT01032044|54624970|FG001|Overall Study|Lost to Follow-up|11|||
27967160|NCT01024946|54624976|FG000|Overall Study|Screen Failure|3|||
27967161|NCT01024946|54624976|FG000|Overall Study|Withdrawal by Subject|1|||
27967162|NCT01024946|54624976|FG000|Overall Study|Adverse Event|1|||
27967163|NCT00724867|54624980|FG000|Overall Study|Adverse Event|25|||
27967164|NCT00724867|54624980|FG000|Overall Study|Lack of Efficacy|14|||
28083600|NCT00376961|54737217|FG001|Initial Registration|Progression/relapse|0|||
28083601|NCT00376961|54737216|FG000|Initial Registration|Ineligible|3|||
28083602|NCT00376961|54737217|FG001|Initial Registration|Ineligible|0|||
28083603|NCT00376961|54737216|FG000|Maintenance|Adverse Event|0|||
28083604|NCT00376961|54737217|FG001|Maintenance|Adverse Event|1|||
28083605|NCT00376961|54737216|FG000|Maintenance|Refusal Unrelated to Adverse Event|0|||
28083606|NCT00376961|54737217|FG001|Maintenance|Refusal Unrelated to Adverse Event|1|||
28083607|NCT00376961|54737216|FG000|Maintenance|Progression/relapse|0|||
28083608|NCT00376961|54737217|FG001|Maintenance|Progression/relapse|18|||
28083609|NCT00376961|54737216|FG000|Maintenance|Ineligible|0|||
28083610|NCT00376961|54737217|FG001|Maintenance|Ineligible|3|||
28083611|NCT03418324|54737227|FG000|Overall Study|Death|0|||
28083612|NCT03418324|54737228|FG001|Overall Study|Death|1|||
28165196|NCT03016325|54835759|FG006|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
28165197|NCT03016325|54835760|FG007|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
28165198|NCT03016325|54835753|FG000|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
27967165|NCT00724867|54624980|FG000|Overall Study|Lost to Follow-up|12|||
27967166|NCT00724867|54624980|FG000|Overall Study|Non-compliance with study drug|6|||
27967167|NCT00724867|54624980|FG000|Overall Study|Physician Decision|17|||
27967168|NCT00724867|54624980|FG000|Overall Study|Protocol Violation|1|||
27967169|NCT00724867|54624980|FG000|Overall Study|Withdrawal by Subject|31|||
27967170|NCT00724867|54624980|FG000|Overall Study|Sponsor decision to end study|14|||
27967171|NCT00724867|54624980|FG000|Overall Study|Subject incarcerated|1|||
28083613|NCT03418324|54737227|FG000|Overall Study|Physician Decision|1|||
28083614|NCT03418324|54737228|FG001|Overall Study|Physician Decision|1|||
28083615|NCT00376259|54737236|FG000|Overall Study|Sponsor request - study termination|21|||
27967172|NCT00724867|54624980|FG000|Overall Study|Developed withdrawal criteria- pregnancy|4|||
28083616|NCT00376259|54737237|FG001|Overall Study|Sponsor request - study termination|21|||
27967173|NCT00724867|54624980|FG000|Overall Study|Subject moved out of state|1|||
27967174|NCT00724867|54624980|FG000|Overall Study|Elected to exit due to site closure|2|||
27967175|NCT00724711|54624989|FG000|Overall Study|Adverse Event|7|||
27967176|NCT00724711|54624990|FG001|Overall Study|Adverse Event|3|||
27967177|NCT00724711|54624989|FG000|Overall Study|Pregnancy|0|||
27967178|NCT00724711|54624990|FG001|Overall Study|Pregnancy|1|||
27967179|NCT00724711|54624989|FG000|Overall Study|Lack of Efficacy|0|||
27967180|NCT00724711|54624990|FG001|Overall Study|Lack of Efficacy|1|||
27967181|NCT00724711|54624989|FG000|Overall Study|Physician Decision|0|||
27967182|NCT00724711|54624990|FG001|Overall Study|Physician Decision|3|||
27967183|NCT00724711|54624989|FG000|Overall Study|Withdrawal by Subject|5|||
27967184|NCT00724711|54624990|FG001|Overall Study|Withdrawal by Subject|4|||
27967185|NCT00724711|54624989|FG000|Overall Study|Lost to Follow-up|4|||
27967186|NCT00724711|54624990|FG001|Overall Study|Lost to Follow-up|5|||
27967187|NCT00724711|54624989|FG000|Overall Study|Protocol Violation|1|||
27967188|NCT00724711|54624990|FG001|Overall Study|Protocol Violation|0|||
27967189|NCT01024244|54625001|FG000|Overall Study|Adverse Event|1|||
27967190|NCT01024244|54625002|FG001|Overall Study|Adverse Event|2|||
27967191|NCT01024244|54625003|FG002|Overall Study|Adverse Event|0|||
27967192|NCT01024244|54625004|FG003|Overall Study|Adverse Event|1|||
27967193|NCT01024244|54625005|FG004|Overall Study|Adverse Event|2|||
27967194|NCT01024244|54625001|FG000|Overall Study|Entry Criteria Not Met|0|||
27967195|NCT01024244|54625002|FG001|Overall Study|Entry Criteria Not Met|1|||
27967196|NCT01024244|54625003|FG002|Overall Study|Entry Criteria Not Met|0|||
27967197|NCT01024244|54625004|FG003|Overall Study|Entry Criteria Not Met|0|||
27967198|NCT01024244|54625005|FG004|Overall Study|Entry Criteria Not Met|0|||
27967199|NCT01024244|54625001|FG000|Overall Study|Lack of Efficacy|1|||
27967200|NCT01024244|54625002|FG001|Overall Study|Lack of Efficacy|0|||
27967201|NCT01024244|54625003|FG002|Overall Study|Lack of Efficacy|0|||
27967202|NCT01024244|54625004|FG003|Overall Study|Lack of Efficacy|0|||
27967203|NCT01024244|54625005|FG004|Overall Study|Lack of Efficacy|0|||
27967204|NCT01024244|54625001|FG000|Overall Study|Protocol Violation|1|||
27967205|NCT01024244|54625002|FG001|Overall Study|Protocol Violation|0|||
27967206|NCT01024244|54625003|FG002|Overall Study|Protocol Violation|0|||
27967207|NCT01024244|54625004|FG003|Overall Study|Protocol Violation|0|||
27967208|NCT01024244|54625005|FG004|Overall Study|Protocol Violation|2|||
27967209|NCT01024244|54625001|FG000|Overall Study|Sponsor Decision|14|||
27967210|NCT01024244|54625002|FG001|Overall Study|Sponsor Decision|7|||
27967211|NCT01024244|54625003|FG002|Overall Study|Sponsor Decision|14|||
27967212|NCT01024244|54625004|FG003|Overall Study|Sponsor Decision|12|||
27967213|NCT01024244|54625005|FG004|Overall Study|Sponsor Decision|10|||
27967214|NCT01024244|54625001|FG000|Overall Study|Withdrawal by Subject|0|||
27967215|NCT01024244|54625002|FG001|Overall Study|Withdrawal by Subject|1|||
27967216|NCT01024244|54625003|FG002|Overall Study|Withdrawal by Subject|0|||
27967217|NCT01024244|54625004|FG003|Overall Study|Withdrawal by Subject|0|||
27967218|NCT01024244|54625005|FG004|Overall Study|Withdrawal by Subject|0|||
27967219|NCT00721279|54625019|FG000|Overall Study|Lack of Efficacy|6|||
27967220|NCT00721279|54625020|FG001|Overall Study|Lack of Efficacy|3|||
27967221|NCT00721279|54625019|FG000|Overall Study|Tolerability insufficient|5|||
27967222|NCT00721279|54625020|FG001|Overall Study|Tolerability insufficient|2|||
27967223|NCT00721279|54625019|FG000|Overall Study|Withdrawal by Subject|13|||
27967224|NCT00721279|54625020|FG001|Overall Study|Withdrawal by Subject|3|||
27967225|NCT00721279|54625019|FG000|Overall Study|Other|12|||
27967226|NCT00721279|54625020|FG001|Overall Study|Other|16|||
27967227|NCT01030952|54625029|FG000|Overall Study|Protocol Violation|0|||
27967228|NCT01030952|54625030|FG001|Overall Study|Protocol Violation|1|||
27967229|NCT01030952|54625029|FG000|Overall Study|Informed consent withdrawal|1|||
27967230|NCT01030952|54625030|FG001|Overall Study|Informed consent withdrawal|0|||
27967231|NCT01030952|54625029|FG000|Overall Study|Lost to Follow-up|0|||
27967232|NCT01030952|54625030|FG001|Overall Study|Lost to Follow-up|1|||
27967233|NCT01030952|54625029|FG000|Overall Study|Unexplained|1|||
27967234|NCT01030952|54625030|FG001|Overall Study|Unexplained|1|||
27967235|NCT01030874|54625040|FG000|Overall Study|Withdrawal by Subject|1|||
27967236|NCT01030874|54625041|FG001|Overall Study|Withdrawal by Subject|0|||
27967237|NCT01030874|54625040|FG000|Overall Study|Discharged in first 2 weeks|17|||
27967238|NCT01030874|54625041|FG001|Overall Study|Discharged in first 2 weeks|16|||
27967239|NCT03611751|54625050|FG000|Pre-treatment|Randomized but not treated|1|||
27967240|NCT03611751|54625051|FG001|Pre-treatment|Randomized but not treated|1|||
27967241|NCT03611751|54625052|FG002|Pre-treatment|Randomized but not treated|0|||
27967242|NCT03611751|54625050|FG000|Treatment Week 0 - Week 16|Adverse Event|11|||
27967243|NCT03611751|54625051|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
27967244|NCT03611751|54625052|FG002|Treatment Week 0 - Week 16|Adverse Event|12|||
27967245|NCT03611751|54625050|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|6|||
27967246|NCT03611751|54625051|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|9|||
27967247|NCT03611751|54625052|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|4|||
27967248|NCT03611751|54625050|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|5|||
27967249|NCT03611751|54625051|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|6|||
27967250|NCT03611751|54625052|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
27967251|NCT03611751|54625050|FG000|Treatment Week 0 - Week 16|Non-compliance with protocol|5|||
27967252|NCT03611751|54625051|FG001|Treatment Week 0 - Week 16|Non-compliance with protocol|2|||
27967253|NCT03611751|54625052|FG002|Treatment Week 0 - Week 16|Non-compliance with protocol|1|||
27967254|NCT03611751|54625050|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|14|||
27967255|NCT03611751|54625051|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
27967256|NCT03611751|54625052|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
27967257|NCT03611751|54625050|FG000|Treatment Week 0 - Week 16|Other reasons|13|||
27967258|NCT03611751|54625051|FG001|Treatment Week 0 - Week 16|Other reasons|9|||
27967259|NCT03611751|54625052|FG002|Treatment Week 0 - Week 16|Other reasons|7|||
27967260|NCT03611751|54625050|FG000|Treatment Week 0 - Week 16|Pregnancy|0|||
27967261|NCT03611751|54625051|FG001|Treatment Week 0 - Week 16|Pregnancy|0|||
27967262|NCT03611751|54625052|FG002|Treatment Week 0 - Week 16|Pregnancy|1|||
27967263|NCT03611751|54625050|FG000|Treatment Week 0 - Week 16|Death|0|||
27967264|NCT03611751|54625051|FG001|Treatment Week 0 - Week 16|Death|0|||
27967265|NCT03611751|54625052|FG002|Treatment Week 0 - Week 16|Death|1|||
27967266|NCT03611751|54625050|FG000|Treatment Week 16 - Week 24|Adverse Event|7|||
27967267|NCT03611751|54625051|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
27967268|NCT03611751|54625052|FG002|Treatment Week 16 - Week 24|Adverse Event|2|||
27967269|NCT03611751|54625050|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|8|||
27967270|NCT03611751|54625051|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
27967271|NCT03611751|54625052|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|1|||
27967272|NCT03611751|54625050|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
27967273|NCT03611751|54625051|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
27967274|NCT03611751|54625052|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
27967275|NCT03611751|54625050|FG000|Treatment Week 16 - Week 24|Non-compliance with protocol|3|||
27967276|NCT03611751|54625051|FG001|Treatment Week 16 - Week 24|Non-compliance with protocol|0|||
27967277|NCT03611751|54625052|FG002|Treatment Week 16 - Week 24|Non-compliance with protocol|1|||
27967278|NCT03611751|54625050|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
27967279|NCT03611751|54625051|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
27967280|NCT03611751|54625052|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
28083617|NCT00376259|54737236|FG000|Overall Study|Patient request|1|||
27732703|NCT02573012|54180282|FG001|Overall Study|Study Ended per Protocol|0|||
27732704|NCT02573012|54180281|FG000|Overall Study|Physician Decision|1|||
27732705|NCT02573012|54180282|FG001|Overall Study|Physician Decision|2|||
27732706|NCT02752633|54180288|FG000|Overall Study|Withdrawal by Subject|1|||
27732707|NCT02752087|54180292|FG000|Washout|Physician Decision|1|||
27732708|NCT02752087|54180293|FG001|Washout|Physician Decision|0|||
27732709|NCT04766996|54180302|FG000|Overall Study|Withdrawal by Subject|1|||
27732710|NCT04766996|54180303|FG001|Overall Study|Withdrawal by Subject|0|||
27732711|NCT04766996|54180304|FG002|Overall Study|Withdrawal by Subject|13|||
27732712|NCT02563028|54180310|FG000|Overall Study|Lack of equipment|1|||
27732713|NCT02563028|54180310|FG000|Overall Study|Unable to elicit VEP post induction|1|||
27732714|NCT02192827|54180316|FG000|Overall Study|Lost to Follow-up|25|||
27732715|NCT02192827|54180317|FG001|Overall Study|Lost to Follow-up|27|||
27732716|NCT02192827|54180316|FG000|Overall Study|Given additional steroids with admission|13|||
27732717|NCT02192827|54180317|FG001|Overall Study|Given additional steroids with admission|11|||
27732718|NCT02562482|54180325|FG000|Overall Study|Enrolled, but did not receive product|4|||
27732719|NCT02562482|54180326|FG001|Overall Study|Enrolled, but did not receive product|0|||
27732720|NCT02562482|54180325|FG000|Overall Study|Lost to Follow-up|9|||
27732721|NCT02562482|54180326|FG001|Overall Study|Lost to Follow-up|6|||
27732722|NCT02562482|54180325|FG000|Overall Study|Moved from area|2|||
27732723|NCT02562482|54180326|FG001|Overall Study|Moved from area|3|||
27732724|NCT02562482|54180325|FG000|Overall Study|Withdrawal by Subject|5|||
27732725|NCT02562482|54180326|FG001|Overall Study|Withdrawal by Subject|3|||
27732726|NCT02562482|54180325|FG000|Overall Study|Physician Decision|1|||
27732727|NCT02562482|54180326|FG001|Overall Study|Physician Decision|3|||
27732728|NCT02562482|54180325|FG000|Overall Study|Illness/Injury unrelated to product|0|||
27732729|NCT02562482|54180326|FG001|Overall Study|Illness/Injury unrelated to product|1|||
27732730|NCT02568254|54180341|FG000|Period 2|Adverse Event|0|||
27732731|NCT02568254|54180342|FG001|Period 2|Adverse Event|0|||
27732732|NCT02568254|54180343|FG002|Period 2|Adverse Event|1|||
27732733|NCT02568254|54180344|FG003|Period 2|Adverse Event|0|||
27732734|NCT02568254|54180345|FG004|Period 2|Adverse Event|0|||
27967281|NCT03611751|54625050|FG000|Treatment Week 16 - Week 24|Other reasons|2|||
28083618|NCT00376259|54737237|FG001|Overall Study|Patient request|0|||
27732735|NCT02568254|54180346|FG005|Period 2|Adverse Event|0|||
27732736|NCT02568254|54180341|FG000|Period 3|Unstatisfactory Lens fitting|0|||
27967282|NCT03611751|54625051|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
28083619|NCT03410056|54737247|FG000|Overall Study|Decision by Sponsor|0|||
28083620|NCT03410056|54737248|FG001|Overall Study|Decision by Sponsor|0|||
27732737|NCT02568254|54180342|FG001|Period 3|Unstatisfactory Lens fitting|0|||
27732738|NCT02568254|54180343|FG002|Period 3|Unstatisfactory Lens fitting|0|||
27732739|NCT02568254|54180344|FG003|Period 3|Unstatisfactory Lens fitting|0|||
27732740|NCT02568254|54180345|FG004|Period 3|Unstatisfactory Lens fitting|1|||
27732741|NCT02568254|54180346|FG005|Period 3|Unstatisfactory Lens fitting|0|||
27967283|NCT03611751|54625052|FG002|Treatment Week 16 - Week 24|Other reasons|3|||
27967284|NCT03611751|54625050|FG000|Treatment Week 16 - Week 24|Pregnancy|1|||
27967285|NCT03611751|54625051|FG001|Treatment Week 16 - Week 24|Pregnancy|0|||
27967286|NCT03611751|54625052|FG002|Treatment Week 16 - Week 24|Pregnancy|1|||
27967287|NCT03611751|54625050|FG000|Treatment Week 24 - Week 52|Adverse Event|14|||
27967288|NCT03611751|54625051|FG001|Treatment Week 24 - Week 52|Adverse Event|7|||
27967289|NCT03611751|54625052|FG002|Treatment Week 24 - Week 52|Adverse Event|0|||
27967290|NCT03611751|54625050|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
27967291|NCT03611751|54625051|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
27967292|NCT03611751|54625052|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
27967293|NCT03611751|54625050|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|9|||
27967294|NCT03611751|54625051|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|4|||
27967295|NCT03611751|54625052|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
27967296|NCT03611751|54625050|FG000|Treatment Week 24 - Week 52|Non-compliance with protocol|2|||
27967297|NCT03611751|54625051|FG001|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
27967298|NCT03611751|54625052|FG002|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
27967299|NCT03611751|54625050|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|8|||
27967300|NCT03611751|54625051|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|6|||
27967301|NCT03611751|54625052|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
27967302|NCT03611751|54625050|FG000|Treatment Week 24 - Week 52|Other reasons|28|||
27967303|NCT03611751|54625051|FG001|Treatment Week 24 - Week 52|Other reasons|7|||
27967304|NCT03611751|54625052|FG002|Treatment Week 24 - Week 52|Other reasons|0|||
27967305|NCT03611751|54625050|FG000|Treatment Week 24 - Week 52|Pregnancy|0|||
27967306|NCT03611751|54625051|FG001|Treatment Week 24 - Week 52|Pregnancy|1|||
27967307|NCT03611751|54625052|FG002|Treatment Week 24 - Week 52|Pregnancy|0|||
27967308|NCT00721123|54625069|FG000|Overall Study|Adverse Event|96|||
27967309|NCT00721123|54625069|FG000|Overall Study|Death|10|||
27967310|NCT00721123|54625069|FG000|Overall Study|Insufficient Therapeutic Response|21|||
27967311|NCT00721123|54625069|FG000|Overall Study|Protocol Violation|1|||
27967312|NCT00721123|54625069|FG000|Overall Study|Refused Treatment|41|||
27967313|NCT00721123|54625069|FG000|Overall Study|Failure to Return|9|||
27967314|NCT00721123|54625069|FG000|Overall Study|Withdrawal by Subject|5|||
27967315|NCT00720499|54625089|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|2|||
27967316|NCT00720499|54625090|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
27967317|NCT00720499|54625089|FG000|Treatment Period 1 (4 Weeks)|Protocol Violation|1|||
27967318|NCT00720499|54625090|FG001|Treatment Period 1 (4 Weeks)|Protocol Violation|2|||
27967319|NCT00720499|54625089|FG000|Treatment Period 2 (4 Weeks)|Adverse Event|2|||
27967320|NCT00720499|54625090|FG001|Treatment Period 2 (4 Weeks)|Adverse Event|3|||
27967321|NCT00724243|54625097|FG000|Overall Study|Lack of Efficacy|10|||
27967322|NCT00724243|54625097|FG000|Overall Study|Adverse Event|5|||
27967323|NCT00720343|54625101|FG000|Overall Study|Physician Decision|3|||
27967324|NCT00720343|54625101|FG000|Overall Study|No data|3|||
27967325|NCT00720109|54625107|FG000|Induction Period|Did not meet eligibility criteria|3|||
27967326|NCT00720109|54625108|FG001|Induction Period|Did not meet eligibility criteria|0|||
27967327|NCT00720109|54625109|FG002|Induction Period|Did not meet eligibility criteria|0|||
27967328|NCT00720109|54625107|FG000|Induction Period|Bone Marrow Transplant|2|||
27967329|NCT00720109|54625108|FG001|Induction Period|Bone Marrow Transplant|0|||
27967330|NCT00720109|54625109|FG002|Induction Period|Bone Marrow Transplant|0|||
27967331|NCT00720109|54625107|FG000|Induction Period|Physician Decision|1|||
27967332|NCT00720109|54625108|FG001|Induction Period|Physician Decision|0|||
27967333|NCT00720109|54625109|FG002|Induction Period|Physician Decision|0|||
27967334|NCT00720109|54625107|FG000|Risk Stratification Period|Adverse Event|0|||
27967335|NCT00720109|54625108|FG001|Risk Stratification Period|Adverse Event|1|||
27967336|NCT00720109|54625109|FG002|Risk Stratification Period|Adverse Event|0|||
27967337|NCT00720109|54625107|FG000|Risk Stratification Period|Physician Decision|0|||
27967338|NCT00720109|54625108|FG001|Risk Stratification Period|Physician Decision|2|||
27967339|NCT00720109|54625109|FG002|Risk Stratification Period|Physician Decision|1|||
27967340|NCT00720109|54625107|FG000|Risk Stratification Period|Bone marrow transplant|0|||
27967341|NCT00720109|54625108|FG001|Risk Stratification Period|Bone marrow transplant|9|||
27967342|NCT00720109|54625109|FG002|Risk Stratification Period|Bone marrow transplant|7|||
27967343|NCT00720109|54625107|FG000|Risk Stratification Period|Disease progression or relapse|0|||
27967344|NCT00720109|54625108|FG001|Risk Stratification Period|Disease progression or relapse|2|||
27967345|NCT00720109|54625109|FG002|Risk Stratification Period|Disease progression or relapse|0|||
27967346|NCT00720109|54625107|FG000|Risk Stratification Period|Development of second malignant neoplasm|0|||
27967347|NCT00720109|54625108|FG001|Risk Stratification Period|Development of second malignant neoplasm|1|||
27967348|NCT00720109|54625109|FG002|Risk Stratification Period|Development of second malignant neoplasm|0|||
27967349|NCT01705977|54625120|FG000|Overall Study|Withdrawal by Subject|128|||
28083621|NCT03410056|54737249|FG002|Overall Study|Decision by Sponsor|3|||
28083622|NCT03410056|54737250|FG003|Overall Study|Decision by Sponsor|0|||
28083623|NCT03410056|54737251|FG004|Overall Study|Decision by Sponsor|0|||
27967350|NCT01705977|54625121|FG001|Overall Study|Withdrawal by Subject|128|||
27967351|NCT01705977|54625120|FG000|Overall Study|Adverse Event|57|||
27967352|NCT01705977|54625121|FG001|Overall Study|Adverse Event|49|||
27967353|NCT01705977|54625120|FG000|Overall Study|Protocol Violation|2|||
27967354|NCT01705977|54625121|FG001|Overall Study|Protocol Violation|4|||
27967355|NCT01705977|54625120|FG000|Overall Study|Site closure|3|||
27967356|NCT01705977|54625121|FG001|Overall Study|Site closure|2|||
27967357|NCT01705977|54625120|FG000|Overall Study|Lost to Follow-up|33|||
27967358|NCT01705977|54625121|FG001|Overall Study|Lost to Follow-up|37|||
27967359|NCT01705977|54625120|FG000|Overall Study|Physician Decision|48|||
27967360|NCT01705977|54625121|FG001|Overall Study|Physician Decision|38|||
27967361|NCT01705977|54625120|FG000|Overall Study|Missing study conclusion form|2|||
27967362|NCT01705977|54625121|FG001|Overall Study|Missing study conclusion form|2|||
27967363|NCT01015118|54625129|FG000|Overall Study|Protocol Violation|5|||
27967364|NCT01015118|54625130|FG001|Overall Study|Protocol Violation|6|||
27967365|NCT01015118|54625129|FG000|Overall Study|Withdrawal by Subject|103|||
27967366|NCT01015118|54625130|FG001|Overall Study|Withdrawal by Subject|27|||
27967367|NCT01015118|54625129|FG000|Overall Study|Other Adverse Event (AE)|141|||
27967368|NCT01015118|54625130|FG001|Overall Study|Other Adverse Event (AE)|33|||
27967369|NCT01015118|54625129|FG000|Overall Study|Worsening or AE of underlying disease|5|||
27967370|NCT01015118|54625130|FG001|Overall Study|Worsening or AE of underlying disease|4|||
27967371|NCT01015118|54625129|FG000|Overall Study|Progressive disease|364|||
27967372|NCT01015118|54625130|FG001|Overall Study|Progressive disease|229|||
27967373|NCT01015118|54625129|FG000|Overall Study|Not treated|9|||
27967374|NCT01015118|54625130|FG001|Overall Study|Not treated|5|||
27967375|NCT01015118|54625129|FG000|Overall Study|Other than stated above|42|||
27967376|NCT01015118|54625130|FG001|Overall Study|Other than stated above|23|||
27967377|NCT00800176|54625142|FG000|Overall Study|Adverse Event|2|||
27967378|NCT00800176|54625143|FG001|Overall Study|Adverse Event|1|||
27967379|NCT00800176|54625144|FG002|Overall Study|Adverse Event|0|||
27967380|NCT00800176|54625145|FG003|Overall Study|Adverse Event|2|||
27967381|NCT00800176|54625146|FG004|Overall Study|Adverse Event|1|||
27967382|NCT00800176|54625147|FG005|Overall Study|Adverse Event|1|||
27967383|NCT00800176|54625142|FG000|Overall Study|Refused treatment|3|||
27967384|NCT00800176|54625143|FG001|Overall Study|Refused treatment|2|||
27967385|NCT00800176|54625144|FG002|Overall Study|Refused treatment|0|||
27967386|NCT00800176|54625145|FG003|Overall Study|Refused treatment|0|||
27967387|NCT00800176|54625146|FG004|Overall Study|Refused treatment|1|||
27967388|NCT00800176|54625147|FG005|Overall Study|Refused treatment|4|||
27967389|NCT00800176|54625142|FG000|Overall Study|Failure to return|3|||
27967390|NCT00800176|54625143|FG001|Overall Study|Failure to return|3|||
27967391|NCT00800176|54625144|FG002|Overall Study|Failure to return|0|||
27967392|NCT00800176|54625145|FG003|Overall Study|Failure to return|2|||
27967393|NCT00800176|54625146|FG004|Overall Study|Failure to return|0|||
27967394|NCT00800176|54625147|FG005|Overall Study|Failure to return|0|||
28083624|NCT03410056|54737252|FG005|Overall Study|Decision by Sponsor|0|||
28083625|NCT03410056|54737253|FG006|Overall Study|Decision by Sponsor|0|||
28083626|NCT03410056|54737247|FG000|Overall Study|Withdrawal by Subject|0|||
28083627|NCT03410056|54737248|FG001|Overall Study|Withdrawal by Subject|2|||
28083628|NCT03410056|54737249|FG002|Overall Study|Withdrawal by Subject|5|||
28083629|NCT03410056|54737250|FG003|Overall Study|Withdrawal by Subject|5|||
28083630|NCT03410056|54737251|FG004|Overall Study|Withdrawal by Subject|0|||
28083631|NCT03410056|54737252|FG005|Overall Study|Withdrawal by Subject|0|||
28083632|NCT03410056|54737253|FG006|Overall Study|Withdrawal by Subject|0|||
28083633|NCT03409666|54737271|FG000|Overall Study|Physician Decision|0|||
28083634|NCT03409666|54737272|FG001|Overall Study|Physician Decision|1|||
28083635|NCT03409666|54737271|FG000|Overall Study|Protocol Violation|0|||
28083636|NCT03409666|54737272|FG001|Overall Study|Protocol Violation|3|||
28083637|NCT03440944|54737280|FG000|Overall Study|Physician Decision|1|||
28083638|NCT03440944|54737281|FG001|Overall Study|Physician Decision|0|||
28083639|NCT03440944|54737280|FG000|Overall Study|No Acceptable Vasculature|0|||
28083640|NCT03440944|54737281|FG001|Overall Study|No Acceptable Vasculature|1|||
28083641|NCT00365105|54737290|FG000|Overall Study|Protocol Violation|5|||
28083642|NCT00365105|54737291|FG001|Overall Study|Protocol Violation|8|||
28083643|NCT00399893|54737299|FG000|Overall Study|Withdrawal by Subject|1|||
28083644|NCT00399893|54737300|FG001|Overall Study|Withdrawal by Subject|0|||
27967395|NCT00800176|54625142|FG000|Overall Study|Other|1|||
27967396|NCT00800176|54625143|FG001|Overall Study|Other|0|||
27967397|NCT00800176|54625144|FG002|Overall Study|Other|0|||
27967398|NCT00800176|54625145|FG003|Overall Study|Other|0|||
27967399|NCT00800176|54625146|FG004|Overall Study|Other|2|||
27967400|NCT00800176|54625147|FG005|Overall Study|Other|0|||
28083645|NCT00048542|54737310|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
28083646|NCT00048542|54737311|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
28083647|NCT00048542|54737312|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
28083648|NCT00048542|54737313|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
27967401|NCT00715429|54625163|FG000|Overall Study|Did not complete the study diary|0|||
27967402|NCT00715429|54625164|FG001|Overall Study|Did not complete the study diary|1|||
28083649|NCT00048542|54737314|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
28083650|NCT00048542|54737315|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
28083651|NCT00048542|54737316|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
27967403|NCT00715117|54625186|FG000|Overall Study|Crohn's flare and rescue with steroids|0|||
27967404|NCT00715117|54625187|FG001|Overall Study|Crohn's flare and rescue with steroids|1|||
27967405|NCT00723229|54625200|FG000|First Intervention|Lost to Follow-up|7|||
27967406|NCT00723229|54625201|FG001|First Intervention|Lost to Follow-up|3|||
27967407|NCT01030718|54625216|FG000|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
27967408|NCT01030718|54625217|FG001|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
27967409|NCT01030718|54625218|FG002|Studies CA180-031 and -036 Combined|Insufficient effect|11|||
27967410|NCT01030718|54625216|FG000|Studies CA180-031 and -036 Combined|Adverse Event|3|||
27967411|NCT01030718|54625217|FG001|Studies CA180-031 and -036 Combined|Adverse Event|5|||
28083652|NCT00048542|54737317|FG007|Double-Blind Phase|Withdrawal by Subject|0|||
28083653|NCT00048542|54737310|FG000|Double-Blind Phase|Protocol Violation|0|||
28083654|NCT00048542|54737311|FG001|Double-Blind Phase|Protocol Violation|0|||
28083655|NCT00048542|54737312|FG002|Double-Blind Phase|Protocol Violation|1|||
28083656|NCT00048542|54737313|FG003|Double-Blind Phase|Protocol Violation|0|||
28083657|NCT00048542|54737314|FG004|Double-Blind Phase|Protocol Violation|0|||
28083658|NCT00048542|54737315|FG005|Double-Blind Phase|Protocol Violation|0|||
28083659|NCT00048542|54737316|FG006|Double-Blind Phase|Protocol Violation|0|||
28083660|NCT00048542|54737317|FG007|Double-Blind Phase|Protocol Violation|0|||
28083661|NCT00048542|54737310|FG000|Double-Blind Phase|Sponsor request or decision|2|||
28083662|NCT00048542|54737311|FG001|Double-Blind Phase|Sponsor request or decision|0|||
28083663|NCT00048542|54737312|FG002|Double-Blind Phase|Sponsor request or decision|0|||
27967412|NCT01030718|54625218|FG002|Studies CA180-031 and -036 Combined|Adverse Event|1|||
27967413|NCT01030718|54625216|FG000|Studies CA180-031 and -036 Combined|Death|0|||
28083664|NCT00048542|54737313|FG003|Double-Blind Phase|Sponsor request or decision|0|||
28083665|NCT00048542|54737314|FG004|Double-Blind Phase|Sponsor request or decision|0|||
28083666|NCT00048542|54737315|FG005|Double-Blind Phase|Sponsor request or decision|0|||
28083667|NCT00048542|54737316|FG006|Double-Blind Phase|Sponsor request or decision|0|||
28083668|NCT00048542|54737317|FG007|Double-Blind Phase|Sponsor request or decision|0|||
28083669|NCT00048542|54737310|FG000|Double-Blind Phase|Randomized in error|1|||
28083670|NCT00048542|54737311|FG001|Double-Blind Phase|Randomized in error|0|||
28083671|NCT00048542|54737312|FG002|Double-Blind Phase|Randomized in error|0|||
28083672|NCT00048542|54737313|FG003|Double-Blind Phase|Randomized in error|0|||
28083673|NCT00048542|54737314|FG004|Double-Blind Phase|Randomized in error|0|||
28083674|NCT00048542|54737315|FG005|Double-Blind Phase|Randomized in error|0|||
28083675|NCT00048542|54737316|FG006|Double-Blind Phase|Randomized in error|0|||
28083676|NCT00048542|54737317|FG007|Double-Blind Phase|Randomized in error|0|||
28083677|NCT00048542|54737310|FG000|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
28083678|NCT00048542|54737311|FG001|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
28083679|NCT00048542|54737312|FG002|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
28083680|NCT00048542|54737313|FG003|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
28083681|NCT00048542|54737314|FG004|Open-Label Extension BSA Phase|Withdrawal by Subject|3|||
28083682|NCT00048542|54737315|FG005|Open-Label Extension BSA Phase|Withdrawal by Subject|6|||
28083683|NCT00048542|54737316|FG006|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
28083684|NCT00048542|54737317|FG007|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
28083685|NCT00048542|54737310|FG000|Open-Label Extension BSA Phase|Protocol Violation|0|||
28083686|NCT00048542|54737311|FG001|Open-Label Extension BSA Phase|Protocol Violation|0|||
28083687|NCT00048542|54737312|FG002|Open-Label Extension BSA Phase|Protocol Violation|0|||
28083688|NCT00048542|54737313|FG003|Open-Label Extension BSA Phase|Protocol Violation|0|||
28083689|NCT00048542|54737314|FG004|Open-Label Extension BSA Phase|Protocol Violation|0|||
28083690|NCT00048542|54737315|FG005|Open-Label Extension BSA Phase|Protocol Violation|1|||
28083691|NCT00048542|54737316|FG006|Open-Label Extension BSA Phase|Protocol Violation|0|||
28165199|NCT03016325|54835754|FG001|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
28165200|NCT03016325|54835755|FG002|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
28165201|NCT03016325|54835756|FG003|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
28083692|NCT00048542|54737317|FG007|Open-Label Extension BSA Phase|Protocol Violation|0|||
28083693|NCT00048542|54737310|FG000|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
28083694|NCT00048542|54737311|FG001|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
28083695|NCT00048542|54737312|FG002|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
28165202|NCT03016325|54835757|FG004|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
28165203|NCT03016325|54835758|FG005|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5|||
27732742|NCT02567708|54180354|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
27732743|NCT02567708|54180355|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2|||
28083696|NCT00048542|54737313|FG003|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
28083697|NCT00048542|54737314|FG004|Open-Label Extension BSA Phase|Sponsor request or decision|5|||
28165204|NCT03016325|54835759|FG006|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3|||
28165205|NCT03016325|54835760|FG007|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4|||
27732744|NCT02567708|54180354|FG000|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0|||
27732745|NCT02567708|54180355|FG001|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1|||
27967414|NCT01030718|54625217|FG001|Studies CA180-031 and -036 Combined|Death|1|||
28083698|NCT00048542|54737315|FG005|Open-Label Extension BSA Phase|Sponsor request or decision|1|||
28083699|NCT00048542|54737316|FG006|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
28083700|NCT00048542|54737317|FG007|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
28083701|NCT00048542|54737310|FG000|Open-Label Extension BSA Phase|Adverse Event|0|||
27967415|NCT01030718|54625218|FG002|Studies CA180-031 and -036 Combined|Death|0|||
27967416|NCT01030718|54625216|FG000|Studies CA180-031 and -036 Combined|other reasons|0|||
27967417|NCT01030718|54625217|FG001|Studies CA180-031 and -036 Combined|other reasons|2|||
27967418|NCT01030718|54625218|FG002|Studies CA180-031 and -036 Combined|other reasons|0|||
27967419|NCT01030718|54625216|FG000|Study CA180-036 Only|insufficient effect|1|||
27967420|NCT01030718|54625217|FG001|Study CA180-036 Only|insufficient effect|1|||
27967421|NCT01030718|54625218|FG002|Study CA180-036 Only|insufficient effect|5|||
27967422|NCT01030718|54625216|FG000|Study CA180-036 Only|Adverse Event|2|||
27967423|NCT01030718|54625217|FG001|Study CA180-036 Only|Adverse Event|3|||
27967424|NCT01030718|54625218|FG002|Study CA180-036 Only|Adverse Event|0|||
27967425|NCT01030718|54625216|FG000|Study CA180-036 Only|Death|0|||
27967426|NCT01030718|54625217|FG001|Study CA180-036 Only|Death|1|||
27967427|NCT01030718|54625218|FG002|Study CA180-036 Only|Death|0|||
27967428|NCT01030718|54625216|FG000|Study CA180-036 Only|Other Reasons|0|||
27967429|NCT01030718|54625217|FG001|Study CA180-036 Only|Other Reasons|2|||
27967430|NCT01030718|54625218|FG002|Study CA180-036 Only|Other Reasons|0|||
27967431|NCT00722761|54625238|FG000|Overall Study|Lost to Follow-up|1|||
28083702|NCT00048542|54737311|FG001|Open-Label Extension BSA Phase|Adverse Event|0|||
28083703|NCT00048542|54737312|FG002|Open-Label Extension BSA Phase|Adverse Event|0|||
27967432|NCT00722761|54625239|FG001|Overall Study|Lost to Follow-up|4|||
27967433|NCT00722761|54625238|FG000|Overall Study|Withdrawal by Subject|5|||
27967434|NCT00722761|54625239|FG001|Overall Study|Withdrawal by Subject|2|||
27967435|NCT00719953|54625245|FG000|Overall Study|Adverse Event|4|||
27967436|NCT01019486|54625252|FG000|Overall Study|Withdrawal by Subject|1|||
27967437|NCT01019486|54625253|FG001|Overall Study|Withdrawal by Subject|1|||
27967438|NCT01019486|54625254|FG002|Overall Study|Withdrawal by Subject|1|||
27967439|NCT00714493|54625263|FG000|Overall Study|Adverse Event|11|||
27967440|NCT00714493|54625263|FG000|Overall Study|Death|3|||
27967441|NCT00714493|54625263|FG000|Overall Study|Lack of Efficacy|10|||
27967442|NCT00714493|54625263|FG000|Overall Study|Lost to Follow-up|3|||
27967443|NCT00714493|54625263|FG000|Overall Study|Protocol Violation|12|||
28083704|NCT00048542|54737313|FG003|Open-Label Extension BSA Phase|Adverse Event|0|||
28083705|NCT00048542|54737314|FG004|Open-Label Extension BSA Phase|Adverse Event|1|||
28083706|NCT00048542|54737315|FG005|Open-Label Extension BSA Phase|Adverse Event|1|||
28083707|NCT00048542|54737316|FG006|Open-Label Extension BSA Phase|Adverse Event|0|||
28083708|NCT00048542|54737317|FG007|Open-Label Extension BSA Phase|Adverse Event|0|||
28083709|NCT00048542|54737310|FG000|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
28083710|NCT00048542|54737311|FG001|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
28083711|NCT00048542|54737312|FG002|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
28083712|NCT00048542|54737313|FG003|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
28083713|NCT00048542|54737314|FG004|Open-Label Extension BSA Phase|Lack of Efficacy|3|||
28083714|NCT00048542|54737315|FG005|Open-Label Extension BSA Phase|Lack of Efficacy|1|||
27967444|NCT00714493|54625263|FG000|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8|||
27967445|NCT00714493|54625263|FG000|Overall Study|OTHER|2|||
27967446|NCT01019252|54625269|FG000|Initial CBT for ADHD vs. Wait List|Time constraints|2|||
27967447|NCT01019252|54625270|FG001|Initial CBT for ADHD vs. Wait List|Time constraints|0|||
27967448|NCT01019252|54625269|FG000|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1|||
27967449|NCT01019252|54625270|FG001|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0|||
27967450|NCT01019252|54625269|FG000|Wait List Cross-over to CBT for ADHD|Time constraints|0|||
27967451|NCT01019252|54625270|FG001|Wait List Cross-over to CBT for ADHD|Time constraints|2|||
28083715|NCT00048542|54737316|FG006|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
28083716|NCT00048542|54737317|FG007|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
28083717|NCT00048542|54737310|FG000|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
28083718|NCT00048542|54737311|FG001|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
28083719|NCT00048542|54737312|FG002|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
28083720|NCT00048542|54737313|FG003|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
28083721|NCT00048542|54737314|FG004|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
28083722|NCT00048542|54737315|FG005|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
27967452|NCT01019252|54625269|FG000|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0|||
28083723|NCT00048542|54737316|FG006|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6|||
28083724|NCT00048542|54737317|FG007|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3|||
27832534|NCT01732835|54311916|FG000|2-year Extended Follow-up|Withdrawal by Subject|1|||
27967453|NCT01019252|54625270|FG001|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5|||
27967454|NCT01013870|54625278|FG000|Overall Study|Lost to Follow-up|1|||
27967455|NCT01013870|54625279|FG001|Overall Study|Lost to Follow-up|3|||
28083725|NCT00048542|54737310|FG000|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
27967456|NCT01013792|54625287|FG000|Overall Study|Study suspended|2|||
28083726|NCT00048542|54737311|FG001|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
28083727|NCT00048542|54737312|FG002|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
28083728|NCT00048542|54737313|FG003|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
28083729|NCT00048542|54737314|FG004|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
28083730|NCT00048542|54737315|FG005|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
28083731|NCT00048542|54737316|FG006|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
28083732|NCT00048542|54737317|FG007|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
28083733|NCT00048542|54737310|FG000|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
28083734|NCT00048542|54737311|FG001|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
28083735|NCT00048542|54737312|FG002|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
28083736|NCT00048542|54737313|FG003|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
28083737|NCT00048542|54737314|FG004|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
28083738|NCT00048542|54737315|FG005|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
28083739|NCT00048542|54737316|FG006|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6|||
28083740|NCT00048542|54737317|FG007|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7|||
28083741|NCT00048542|54737310|FG000|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
28083742|NCT00048542|54737311|FG001|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
28083743|NCT00048542|54737312|FG002|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
28083744|NCT00048542|54737313|FG003|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
28083745|NCT00048542|54737314|FG004|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
28083746|NCT00048542|54737315|FG005|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
28083747|NCT00048542|54737316|FG006|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
28083748|NCT00048542|54737317|FG007|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
28083749|NCT00048542|54737310|FG000|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
28083750|NCT00048542|54737311|FG001|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
28083751|NCT00048542|54737312|FG002|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
27967457|NCT01013792|54625288|FG001|Overall Study|Study suspended|1|||
27967458|NCT01013792|54625287|FG000|Overall Study|Adverse Event|0|||
27967459|NCT01013792|54625288|FG001|Overall Study|Adverse Event|3|||
27967460|NCT01013792|54625287|FG000|Overall Study|Lost to Follow-up|0|||
27967461|NCT01013792|54625288|FG001|Overall Study|Lost to Follow-up|1|||
27967462|NCT01018862|54625297|FG000|Overall Study|Adverse Event|2|||
27967463|NCT01018862|54625298|FG001|Overall Study|Adverse Event|0|||
27967464|NCT01018862|54625299|FG002|Overall Study|Adverse Event|6|||
27967465|NCT01018862|54625297|FG000|Overall Study|Lack of Efficacy|1|||
27967466|NCT01018862|54625298|FG001|Overall Study|Lack of Efficacy|0|||
27967467|NCT01018862|54625299|FG002|Overall Study|Lack of Efficacy|2|||
27967468|NCT01018862|54625297|FG000|Overall Study|Lost to Follow-up|3|||
27967469|NCT01018862|54625298|FG001|Overall Study|Lost to Follow-up|1|||
27967470|NCT01018862|54625299|FG002|Overall Study|Lost to Follow-up|0|||
27967471|NCT01018862|54625297|FG000|Overall Study|Protocol Violation|1|||
27967472|NCT01018862|54625298|FG001|Overall Study|Protocol Violation|3|||
27967473|NCT01018862|54625299|FG002|Overall Study|Protocol Violation|3|||
27967474|NCT01018862|54625297|FG000|Overall Study|Withdrawal by Subject|1|||
27967475|NCT01018862|54625298|FG001|Overall Study|Withdrawal by Subject|2|||
27967476|NCT01018862|54625299|FG002|Overall Study|Withdrawal by Subject|1|||
27967477|NCT01018862|54625297|FG000|Overall Study|administrative problems|5|||
27967478|NCT01018862|54625298|FG001|Overall Study|administrative problems|4|||
27967479|NCT01018862|54625299|FG002|Overall Study|administrative problems|4|||
27967480|NCT01018394|54625309|FG000|Overall Study|Withdrawal by Subject|5|||
27967481|NCT01018394|54625310|FG001|Overall Study|Withdrawal by Subject|5|||
27967482|NCT01018394|54625309|FG000|Overall Study|Lost to Follow-up|4|||
27967483|NCT01018394|54625310|FG001|Overall Study|Lost to Follow-up|3|||
27967484|NCT01017146|54625318|FG000|Overall Study|Adverse Event|11|||
27967485|NCT01017146|54625319|FG001|Overall Study|Adverse Event|1|||
27967486|NCT01017146|54625318|FG000|Overall Study|Lost to Follow-up|14|||
27967487|NCT01017146|54625319|FG001|Overall Study|Lost to Follow-up|14|||
27967488|NCT01017146|54625318|FG000|Overall Study|Noncompliance with Study Product|1|||
27967489|NCT01017146|54625319|FG001|Overall Study|Noncompliance with Study Product|1|||
27967490|NCT01017146|54625318|FG000|Overall Study|Withdrawal by Subject|32|||
27967491|NCT01017146|54625319|FG001|Overall Study|Withdrawal by Subject|16|||
27967492|NCT01017146|54625318|FG000|Overall Study|Relocation|0|||
27967493|NCT01017146|54625319|FG001|Overall Study|Relocation|4|||
27967494|NCT01017146|54625318|FG000|Overall Study|Pregnancy|2|||
27967495|NCT01017146|54625319|FG001|Overall Study|Pregnancy|1|||
28083752|NCT00048542|54737313|FG003|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
28083753|NCT00048542|54737314|FG004|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
28165206|NCT02988115|54835783|FG000|Overall Study|Adverse Event|6|||
27967496|NCT01017146|54625318|FG000|Overall Study|Protocol Violation|2|||
27967497|NCT01017146|54625319|FG001|Overall Study|Protocol Violation|0|||
27967498|NCT01017146|54625318|FG000|Overall Study|Took Excluded Medication|2|||
27967499|NCT01017146|54625319|FG001|Overall Study|Took Excluded Medication|0|||
27967500|NCT01017146|54625318|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
27967501|NCT01017146|54625319|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
27967502|NCT01017146|54625318|FG000|Overall Study|Change in Work Situation|1|||
27967503|NCT01017146|54625319|FG001|Overall Study|Change in Work Situation|0|||
27967504|NCT01010750|54625331|FG000|Second Intervention|Adverse Event|0|||
27967505|NCT01010750|54625332|FG001|Second Intervention|Adverse Event|1|||
27967506|NCT01010750|54625333|FG002|Second Intervention|Adverse Event|0|||
27967507|NCT01010750|54625334|FG003|Second Intervention|Adverse Event|0|||
27967508|NCT01010750|54625335|FG004|Second Intervention|Adverse Event|0|||
27967509|NCT01010750|54625336|FG005|Second Intervention|Adverse Event|0|||
27967510|NCT01012622|54625344|FG000|Overall Study|Withdrawal by Subject|6|||
27967511|NCT01012622|54625344|FG000|Overall Study|Lost to Follow-up|5|||
27967512|NCT01012622|54625344|FG000|Overall Study|Adverse Event|7|||
27967513|NCT01012622|54625344|FG000|Overall Study|non-compliance with the drug|9|||
27967514|NCT01012622|54625344|FG000|Overall Study|Other|1|||
27967515|NCT01012622|54625344|FG000|Overall Study|screening failure|1|||
27967516|NCT01012622|54625344|FG000|Overall Study|withdrawal of consent by a parent|2|||
27967517|NCT00722371|54625355|FG000|Overall Study|Adverse Event|6|||
27967518|NCT00722371|54625356|FG001|Overall Study|Adverse Event|13|||
27967519|NCT00722371|54625357|FG002|Overall Study|Adverse Event|9|||
27967520|NCT00722371|54625358|FG003|Overall Study|Adverse Event|10|||
27967521|NCT00722371|54625359|FG004|Overall Study|Adverse Event|6|||
27967522|NCT00722371|54625360|FG005|Overall Study|Adverse Event|8|||
27967523|NCT00722371|54625361|FG006|Overall Study|Adverse Event|4|||
27967524|NCT00722371|54625355|FG000|Overall Study|Contraindication|0|||
27967525|NCT00722371|54625356|FG001|Overall Study|Contraindication|0|||
27967526|NCT00722371|54625357|FG002|Overall Study|Contraindication|1|||
27967527|NCT00722371|54625358|FG003|Overall Study|Contraindication|0|||
27967528|NCT00722371|54625359|FG004|Overall Study|Contraindication|0|||
27967529|NCT00722371|54625360|FG005|Overall Study|Contraindication|0|||
27967530|NCT00722371|54625361|FG006|Overall Study|Contraindication|0|||
27967531|NCT00722371|54625355|FG000|Overall Study|Creatinine / Creatinine clearance|2|||
27967532|NCT00722371|54625356|FG001|Overall Study|Creatinine / Creatinine clearance|1|||
27967533|NCT00722371|54625357|FG002|Overall Study|Creatinine / Creatinine clearance|2|||
27967534|NCT00722371|54625358|FG003|Overall Study|Creatinine / Creatinine clearance|3|||
27967535|NCT00722371|54625359|FG004|Overall Study|Creatinine / Creatinine clearance|2|||
27967536|NCT00722371|54625360|FG005|Overall Study|Creatinine / Creatinine clearance|1|||
27967537|NCT00722371|54625361|FG006|Overall Study|Creatinine / Creatinine clearance|1|||
27967538|NCT00722371|54625355|FG000|Overall Study|Excluded medication|0|||
27967539|NCT00722371|54625356|FG001|Overall Study|Excluded medication|1|||
27967540|NCT00722371|54625357|FG002|Overall Study|Excluded medication|1|||
27967541|NCT00722371|54625358|FG003|Overall Study|Excluded medication|0|||
27967542|NCT00722371|54625359|FG004|Overall Study|Excluded medication|0|||
27967543|NCT00722371|54625360|FG005|Overall Study|Excluded medication|0|||
27967544|NCT00722371|54625361|FG006|Overall Study|Excluded medication|1|||
27967545|NCT00722371|54625355|FG000|Overall Study|Hyperglycemia|2|||
27967546|NCT00722371|54625356|FG001|Overall Study|Hyperglycemia|6|||
27967547|NCT00722371|54625357|FG002|Overall Study|Hyperglycemia|4|||
27967548|NCT00722371|54625358|FG003|Overall Study|Hyperglycemia|2|||
27967549|NCT00722371|54625359|FG004|Overall Study|Hyperglycemia|5|||
27967550|NCT00722371|54625360|FG005|Overall Study|Hyperglycemia|1|||
27967551|NCT00722371|54625361|FG006|Overall Study|Hyperglycemia|1|||
27967552|NCT00722371|54625355|FG000|Overall Study|Hypoglycemia|1|||
27967553|NCT00722371|54625356|FG001|Overall Study|Hypoglycemia|0|||
27967554|NCT00722371|54625357|FG002|Overall Study|Hypoglycemia|0|||
27967555|NCT00722371|54625358|FG003|Overall Study|Hypoglycemia|0|||
27967556|NCT00722371|54625359|FG004|Overall Study|Hypoglycemia|0|||
27967557|NCT00722371|54625360|FG005|Overall Study|Hypoglycemia|0|||
28083754|NCT00048542|54737315|FG005|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
28083755|NCT00048542|54737316|FG006|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2|||
28083756|NCT00048542|54737317|FG007|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1|||
28083757|NCT00048542|54737310|FG000|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
28083758|NCT00048542|54737311|FG001|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
27855184|NCT00639002|54375757|FG000|Overall Study|Protocol Violation|1|||
27855185|NCT00639002|54375757|FG000|Overall Study|Disease progression|3|||
27855186|NCT00639002|54375757|FG000|Overall Study|Physician Decision|6|||
27855187|NCT00639002|54375757|FG000|Overall Study|Lack of Efficacy|1|||
27967558|NCT00722371|54625361|FG006|Overall Study|Hypoglycemia|0|||
27967559|NCT00722371|54625355|FG000|Overall Study|Lack of Efficacy|4|||
27967560|NCT00722371|54625356|FG001|Overall Study|Lack of Efficacy|6|||
27967561|NCT00722371|54625357|FG002|Overall Study|Lack of Efficacy|6|||
27967562|NCT00722371|54625358|FG003|Overall Study|Lack of Efficacy|6|||
27967563|NCT00722371|54625359|FG004|Overall Study|Lack of Efficacy|2|||
27967564|NCT00722371|54625360|FG005|Overall Study|Lack of Efficacy|3|||
27967565|NCT00722371|54625361|FG006|Overall Study|Lack of Efficacy|0|||
27967566|NCT00722371|54625355|FG000|Overall Study|Lost to Follow-up|11|||
27967567|NCT00722371|54625356|FG001|Overall Study|Lost to Follow-up|14|||
27967568|NCT00722371|54625357|FG002|Overall Study|Lost to Follow-up|21|||
28083759|NCT00048542|54737312|FG002|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
28083760|NCT00048542|54737313|FG003|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
28083761|NCT00048542|54737314|FG004|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
28083762|NCT00048542|54737315|FG005|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
28083763|NCT00048542|54737316|FG006|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5|||
28083764|NCT00048542|54737317|FG007|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8|||
28083765|NCT03814590|54737360|FG000|Overall Study|Adverse Event|0|||
28083766|NCT03814590|54737361|FG001|Overall Study|Adverse Event|0|||
28083767|NCT03814590|54737362|FG002|Overall Study|Adverse Event|0|||
28083768|NCT03814590|54737363|FG003|Overall Study|Adverse Event|0|||
28083769|NCT03814590|54737364|FG004|Overall Study|Adverse Event|0|||
28083770|NCT03814590|54737365|FG005|Overall Study|Adverse Event|1|||
28083771|NCT03814590|54737366|FG006|Overall Study|Adverse Event|1|||
27855188|NCT00638846|54375793|FG000|Overall Study|Adverse Event|0|||
27967569|NCT00722371|54625358|FG003|Overall Study|Lost to Follow-up|13|||
27967570|NCT00722371|54625359|FG004|Overall Study|Lost to Follow-up|8|||
28083772|NCT03814590|54737367|FG007|Overall Study|Adverse Event|1|||
27855189|NCT00638846|54375794|FG001|Overall Study|Adverse Event|1|||
27855190|NCT00638846|54375793|FG000|Overall Study|Lost to Follow-up|3|||
27855191|NCT00638846|54375794|FG001|Overall Study|Lost to Follow-up|2|||
27855192|NCT00638846|54375793|FG000|Overall Study|lens issue|1|||
27855193|NCT00638846|54375794|FG001|Overall Study|lens issue|3|||
27855194|NCT00638456|54375802|FG000|Overall Study|Withdrawal by Subject|6|||
27855195|NCT00638456|54375803|FG001|Overall Study|Withdrawal by Subject|2|||
27855196|NCT00638378|54375832|FG000|Overall Study|Death|2|||
27855197|NCT00638378|54375832|FG000|Overall Study|Adverse Event|1|||
27855198|NCT00638378|54375832|FG000|Overall Study|Disease progression|15|||
27855199|NCT00638378|54375832|FG000|Overall Study|Physician Decision|4|||
27855200|NCT03807349|54376009|FG000|Overall Study|Early Study Termination|9|||
27855201|NCT03802825|54376019|FG000|Overall Study|Lost to follow-up for intervention|12|||
27855202|NCT03802825|54376020|FG001|Overall Study|Lost to follow-up for intervention|3|||
27855203|NCT03802825|54376019|FG000|Overall Study|Received only 1 component of intervention|0|||
27855204|NCT03802825|54376020|FG001|Overall Study|Received only 1 component of intervention|13|||
27855205|NCT03808909|54376039|FG000|Overall Study|Lost to Follow-up|3|||
27855206|NCT03808909|54376040|FG001|Overall Study|Lost to Follow-up|0|||
27855207|NCT03802513|54376061|FG000|Overall Study|Lost to Follow-up|1|||
27855208|NCT01276223|54376252|FG000|Overall Study|Adverse Event|7|||
27855209|NCT01276223|54376253|FG001|Overall Study|Adverse Event|4|||
27855210|NCT01276223|54376254|FG002|Overall Study|Adverse Event|1|||
27855211|NCT01276223|54376252|FG000|Overall Study|Lost to Follow-up|0|||
27855212|NCT01276223|54376253|FG001|Overall Study|Lost to Follow-up|0|||
27855213|NCT01276223|54376254|FG002|Overall Study|Lost to Follow-up|1|||
27855214|NCT01276223|54376252|FG000|Overall Study|Other|0|||
27855215|NCT01276223|54376253|FG001|Overall Study|Other|0|||
27855216|NCT01276223|54376254|FG002|Overall Study|Other|1|||
27855217|NCT01276223|54376252|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|3|||
27855218|NCT01276223|54376253|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
27855219|NCT01276223|54376254|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
27855220|NCT01276223|54376252|FG000|Overall Study|Protocol Violation|1|||
27855221|NCT01276223|54376253|FG001|Overall Study|Protocol Violation|0|||
27855222|NCT01276223|54376254|FG002|Overall Study|Protocol Violation|0|||
27855223|NCT01275833|54376263|FG000|Overall Study|Study terminated|1|||
27855224|NCT01275833|54376264|FG001|Overall Study|Study terminated|1|||
27855225|NCT01275755|54376272|FG000|Double-blind Treatment Period|Adverse Event|0|||
27855226|NCT01275755|54376273|FG001|Double-blind Treatment Period|Adverse Event|2|||
27855227|NCT01275755|54376272|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
27855228|NCT01275755|54376273|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
27855229|NCT01275755|54376272|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
27855230|NCT01275755|54376273|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
27855231|NCT01275755|54376272|FG000|Run-out Placebo Period|Lost to Follow-up|1|||
27855232|NCT01275755|54376273|FG001|Run-out Placebo Period|Lost to Follow-up|0|||
27855233|NCT01275131|54376304|FG000|Period 1|Withdrawal by Subject|1|||
27855234|NCT01275131|54376305|FG001|Period 1|Withdrawal by Subject|0|||
27855235|NCT01275131|54376306|FG002|Period 1|Withdrawal by Subject|3|||
27855236|NCT01275131|54376307|FG003|Period 1|Withdrawal by Subject|2|||
27855237|NCT01275131|54376304|FG000|Period 1|Physician Decision|1|||
27855238|NCT01275131|54376305|FG001|Period 1|Physician Decision|0|||
27855239|NCT01275131|54376306|FG002|Period 1|Physician Decision|0|||
27855240|NCT01275131|54376307|FG003|Period 1|Physician Decision|0|||
27855241|NCT01275131|54376304|FG000|Period 2 (Crossover)|Adverse Event|0|||
28083773|NCT03814590|54737368|FG008|Overall Study|Adverse Event|0|||
27855242|NCT01275131|54376305|FG001|Period 2 (Crossover)|Adverse Event|1|||
27855243|NCT01275131|54376306|FG002|Period 2 (Crossover)|Adverse Event|0|||
27855244|NCT01275131|54376307|FG003|Period 2 (Crossover)|Adverse Event|0|||
27855245|NCT01275131|54376304|FG000|Period 2 (Crossover)|Withdrawal by Subject|1|||
28165207|NCT02988115|54835784|FG001|Overall Study|Adverse Event|1|||
27967571|NCT00722371|54625360|FG005|Overall Study|Lost to Follow-up|16|||
28083774|NCT03814590|54737369|FG009|Overall Study|Adverse Event|0|||
27967572|NCT00722371|54625361|FG006|Overall Study|Lost to Follow-up|13|||
27967573|NCT00722371|54625355|FG000|Overall Study|Physician Decision|5|||
27967574|NCT00722371|54625356|FG001|Overall Study|Physician Decision|2|||
27967575|NCT00722371|54625357|FG002|Overall Study|Physician Decision|2|||
27967576|NCT00722371|54625358|FG003|Overall Study|Physician Decision|5|||
27967577|NCT00722371|54625359|FG004|Overall Study|Physician Decision|2|||
27967578|NCT00722371|54625360|FG005|Overall Study|Physician Decision|3|||
27967579|NCT00722371|54625361|FG006|Overall Study|Physician Decision|4|||
27967580|NCT00722371|54625355|FG000|Overall Study|Pregnancy|1|||
27967581|NCT00722371|54625356|FG001|Overall Study|Pregnancy|1|||
27967582|NCT00722371|54625357|FG002|Overall Study|Pregnancy|0|||
27967583|NCT00722371|54625358|FG003|Overall Study|Pregnancy|0|||
27967584|NCT00722371|54625359|FG004|Overall Study|Pregnancy|0|||
27967585|NCT00722371|54625360|FG005|Overall Study|Pregnancy|1|||
27967586|NCT00722371|54625361|FG006|Overall Study|Pregnancy|0|||
27967587|NCT00722371|54625355|FG000|Overall Study|Protocol Violation|6|||
27967588|NCT00722371|54625356|FG001|Overall Study|Protocol Violation|1|||
27967589|NCT00722371|54625357|FG002|Overall Study|Protocol Violation|0|||
27967590|NCT00722371|54625358|FG003|Overall Study|Protocol Violation|1|||
27967591|NCT00722371|54625359|FG004|Overall Study|Protocol Violation|4|||
27967592|NCT00722371|54625360|FG005|Overall Study|Protocol Violation|2|||
27967593|NCT00722371|54625361|FG006|Overall Study|Protocol Violation|1|||
27967594|NCT00722371|54625355|FG000|Overall Study|Withdrawal by Subject|18|||
27967595|NCT00722371|54625356|FG001|Overall Study|Withdrawal by Subject|27|||
27967596|NCT00722371|54625357|FG002|Overall Study|Withdrawal by Subject|19|||
27967597|NCT00722371|54625358|FG003|Overall Study|Withdrawal by Subject|23|||
27967598|NCT00722371|54625359|FG004|Overall Study|Withdrawal by Subject|19|||
27967599|NCT00722371|54625360|FG005|Overall Study|Withdrawal by Subject|18|||
27967600|NCT00722371|54625361|FG006|Overall Study|Withdrawal by Subject|26|||
27967601|NCT00722137|54625379|FG000|Overall Study|Overt Disease Progression|5|||
27967602|NCT00722137|54625380|FG001|Overall Study|Overt Disease Progression|4|||
27967603|NCT00722137|54625379|FG000|Overall Study|Adverse Event|17|||
27967604|NCT00722137|54625380|FG001|Overall Study|Adverse Event|21|||
27967605|NCT00722137|54625379|FG000|Overall Study|Death|12|||
27967606|NCT00722137|54625380|FG001|Overall Study|Death|7|||
27967607|NCT00722137|54625379|FG000|Overall Study|Withdrawal by Subject|6|||
27967608|NCT00722137|54625380|FG001|Overall Study|Withdrawal by Subject|9|||
27967609|NCT00722137|54625379|FG000|Overall Study|Other Reason Unknown|3|||
27967610|NCT00722137|54625380|FG001|Overall Study|Other Reason Unknown|4|||
27967611|NCT00722137|54625379|FG000|Overall Study|Randomized But Not Treated|2|||
27967612|NCT00722137|54625380|FG001|Overall Study|Randomized But Not Treated|3|||
27967613|NCT00796666|54625394|FG000|Overall Study|Death|2|||
27967614|NCT00796666|54625395|FG001|Overall Study|Death|4|||
27967615|NCT00796666|54625394|FG000|Overall Study|Withdrawal by Subject|2|||
27967616|NCT00796666|54625395|FG001|Overall Study|Withdrawal by Subject|0|||
27967617|NCT00796666|54625394|FG000|Overall Study|Adverse Event|7|||
27967618|NCT00796666|54625395|FG001|Overall Study|Adverse Event|5|||
27967619|NCT00796666|54625394|FG000|Overall Study|Protocol Violation|1|||
27967620|NCT00796666|54625395|FG001|Overall Study|Protocol Violation|0|||
27967621|NCT00796666|54625394|FG000|Overall Study|Other|1|||
27967622|NCT00796666|54625395|FG001|Overall Study|Other|0|||
27967623|NCT00796666|54625394|FG000|Overall Study|Terminated by sponsor|53|||
27967624|NCT00796666|54625395|FG001|Overall Study|Terminated by sponsor|55|||
27967625|NCT00796666|54625394|FG000|Overall Study|Randomized and not treated|1|||
27967626|NCT00796666|54625395|FG001|Overall Study|Randomized and not treated|0|||
27967627|NCT00799708|54625404|FG000|Overall Study|non-compliance|1|||
27967628|NCT00799708|54625405|FG001|Overall Study|non-compliance|0|||
27967629|NCT00799708|54625406|FG002|Overall Study|non-compliance|0|||
27967630|NCT00796510|54625418|FG000|Overall Study|Death|1|||
27967631|NCT00796510|54625419|FG001|Overall Study|Death|0|||
27967632|NCT00796510|54625418|FG000|Overall Study|Study Terminated|2|||
28165208|NCT02988115|54835783|FG000|Overall Study|Sponsor Decision|5|||
28165209|NCT02988115|54835784|FG001|Overall Study|Sponsor Decision|2|||
27732746|NCT02567708|54180354|FG000|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2|||
27967633|NCT00796510|54625419|FG001|Overall Study|Study Terminated|0|||
27967634|NCT00588640|54625425|FG000|Overall Study|Physician Decision|1|||
27967635|NCT00588640|54625425|FG000|Overall Study|Ineligible Patient|1|||
27967636|NCT01016912|54625434|FG000|End of Treatment Period|Lack of Efficacy|0|||
27967637|NCT01016912|54625435|FG001|End of Treatment Period|Lack of Efficacy|1|||
27967638|NCT01016912|54625436|FG002|End of Treatment Period|Lack of Efficacy|0|||
27967639|NCT01016912|54625437|FG003|End of Treatment Period|Lack of Efficacy|4|||
27967640|NCT01016912|54625438|FG004|End of Treatment Period|Lack of Efficacy|4|||
27967641|NCT01016912|54625434|FG000|End of Treatment Period|Adverse Event|0|||
27967642|NCT01016912|54625435|FG001|End of Treatment Period|Adverse Event|1|||
27967643|NCT01016912|54625436|FG002|End of Treatment Period|Adverse Event|1|||
27967644|NCT01016912|54625437|FG003|End of Treatment Period|Adverse Event|0|||
27967645|NCT01016912|54625438|FG004|End of Treatment Period|Adverse Event|0|||
27967646|NCT01016912|54625434|FG000|End of Treatment Period|Completed double-blind period only|0|||
27967647|NCT01016912|54625435|FG001|End of Treatment Period|Completed double-blind period only|1|||
27967648|NCT01016912|54625436|FG002|End of Treatment Period|Completed double-blind period only|0|||
27967649|NCT01016912|54625437|FG003|End of Treatment Period|Completed double-blind period only|0|||
27967650|NCT01016912|54625438|FG004|End of Treatment Period|Completed double-blind period only|0|||
27967651|NCT01016912|54625434|FG000|Follow-up Period|Other reason|0|||
27967652|NCT01016912|54625435|FG001|Follow-up Period|Other reason|0|||
27967653|NCT01016912|54625436|FG002|Follow-up Period|Other reason|1|||
27967654|NCT01016912|54625437|FG003|Follow-up Period|Other reason|1|||
28083775|NCT03814590|54737370|FG010|Overall Study|Adverse Event|1|||
28083776|NCT03814590|54737371|FG011|Overall Study|Adverse Event|0|||
28083777|NCT03814590|54737372|FG012|Overall Study|Adverse Event|3|||
28083778|NCT03814590|54737373|FG013|Overall Study|Adverse Event|0|||
28083779|NCT03814590|54737360|FG000|Overall Study|Lost to Follow-up|0|||
28083780|NCT03814590|54737361|FG001|Overall Study|Lost to Follow-up|2|||
28083781|NCT03814590|54737362|FG002|Overall Study|Lost to Follow-up|1|||
28083782|NCT03814590|54737363|FG003|Overall Study|Lost to Follow-up|0|||
28083783|NCT03814590|54737364|FG004|Overall Study|Lost to Follow-up|1|||
28083784|NCT03814590|54737365|FG005|Overall Study|Lost to Follow-up|1|||
27967655|NCT01016912|54625438|FG004|Follow-up Period|Other reason|0|||
27967656|NCT00802672|54625473|FG000|Overall Study|Lack of fungal pathogen at baseline|56|||
27967657|NCT00802672|54625474|FG001|Overall Study|Lack of fungal pathogen at baseline|43|||
27967658|NCT00802672|54625475|FG002|Overall Study|Lack of fungal pathogen at baseline|25|||
27967659|NCT00802672|54625473|FG000|Overall Study|Adverse Event|1|||
27967660|NCT00802672|54625474|FG001|Overall Study|Adverse Event|1|||
27967661|NCT00802672|54625475|FG002|Overall Study|Adverse Event|1|||
27967662|NCT00802672|54625473|FG000|Overall Study|Protocol Violation|2|||
27967663|NCT00802672|54625474|FG001|Overall Study|Protocol Violation|1|||
27967664|NCT00802672|54625475|FG002|Overall Study|Protocol Violation|1|||
27967665|NCT00802672|54625473|FG000|Overall Study|Lost to Follow-up|5|||
27967666|NCT00802672|54625474|FG001|Overall Study|Lost to Follow-up|5|||
27967667|NCT00802672|54625475|FG002|Overall Study|Lost to Follow-up|3|||
27967668|NCT00802672|54625473|FG000|Overall Study|Withdrawal by Subject|1|||
27967669|NCT00802672|54625474|FG001|Overall Study|Withdrawal by Subject|1|||
27967670|NCT00802672|54625475|FG002|Overall Study|Withdrawal by Subject|2|||
27967671|NCT00802672|54625473|FG000|Overall Study|other|3|||
27967672|NCT00802672|54625474|FG001|Overall Study|other|1|||
27967673|NCT00802672|54625475|FG002|Overall Study|other|2|||
28083785|NCT03814590|54737366|FG006|Overall Study|Lost to Follow-up|1|||
28083786|NCT03814590|54737367|FG007|Overall Study|Lost to Follow-up|1|||
28083787|NCT03814590|54737368|FG008|Overall Study|Lost to Follow-up|0|||
28083788|NCT03814590|54737369|FG009|Overall Study|Lost to Follow-up|0|||
28083789|NCT03814590|54737370|FG010|Overall Study|Lost to Follow-up|1|||
28083790|NCT03814590|54737371|FG011|Overall Study|Lost to Follow-up|0|||
28165210|NCT02988115|54835783|FG000|Overall Study|Withdrawal by Subject|1|||
27967674|NCT00714415|54625485|FG000|Overall Study|Lack of Efficacy|1|||
27967675|NCT00714415|54625486|FG001|Overall Study|Lack of Efficacy|0|||
27967676|NCT00714415|54625485|FG000|Overall Study|Death|1|||
27967677|NCT00714415|54625486|FG001|Overall Study|Death|0|||
27967678|NCT00714259|54625492|FG000|Overall Study|Death|2|||
27967679|NCT00796120|54625498|FG000|Overall Study|Death|3|||
27967680|NCT00796120|54625499|FG001|Overall Study|Death|0|||
27967681|NCT00796120|54625498|FG000|Overall Study|Adverse Event|11|||
27967682|NCT00796120|54625499|FG001|Overall Study|Adverse Event|6|||
27967683|NCT00796120|54625498|FG000|Overall Study|Progressive disease|22|||
27967684|NCT00796120|54625499|FG001|Overall Study|Progressive disease|13|||
27967685|NCT00796120|54625498|FG000|Overall Study|Participant refusal|3|||
27967686|NCT00796120|54625499|FG001|Overall Study|Participant refusal|4|||
27967687|NCT00796120|54625498|FG000|Overall Study|Other|6|||
27967688|NCT00796120|54625499|FG001|Overall Study|Other|17|||
27967689|NCT00796120|54625498|FG000|Overall Study|Physician Decision|16|||
28083791|NCT03814590|54737372|FG012|Overall Study|Lost to Follow-up|0|||
28083792|NCT03814590|54737373|FG013|Overall Study|Lost to Follow-up|1|||
28083793|NCT03814590|54737360|FG000|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
28083794|NCT03814590|54737361|FG001|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
28165211|NCT02988115|54835784|FG001|Overall Study|Withdrawal by Subject|1|||
27967690|NCT00796120|54625499|FG001|Overall Study|Physician Decision|17|||
28165212|NCT02988115|54835783|FG000|Overall Study|Withdrawn by Mistake|1|||
28083795|NCT03814590|54737362|FG002|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
28083796|NCT03814590|54737363|FG003|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
28083797|NCT03814590|54737364|FG004|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
27967691|NCT00796120|54625498|FG000|Overall Study|Randomized but not treated|0|||
27967692|NCT00796120|54625499|FG001|Overall Study|Randomized but not treated|3|||
27967693|NCT00795886|54625505|FG000|Overall Study|Death|10|||
27967694|NCT00719563|54625512|FG000|Overall Study|Adverse Event|16|||
27967695|NCT00719563|54625513|FG001|Overall Study|Adverse Event|13|||
27967696|NCT00719563|54625512|FG000|Overall Study|Medical condition changed|3|||
27967697|NCT00719563|54625513|FG001|Overall Study|Medical condition changed|5|||
27967698|NCT00719563|54625512|FG000|Overall Study|Lack of Efficacy|3|||
27967699|NCT00719563|54625513|FG001|Overall Study|Lack of Efficacy|7|||
27967700|NCT00719563|54625512|FG000|Overall Study|Personal reasons|6|||
27967701|NCT00719563|54625513|FG001|Overall Study|Personal reasons|7|||
27967702|NCT00719563|54625512|FG000|Overall Study|Unknown reasons|4|||
27967703|NCT00719563|54625513|FG001|Overall Study|Unknown reasons|6|||
27967704|NCT00719563|54625512|FG000|Overall Study|Noncompliant|1|||
27967705|NCT00719563|54625513|FG001|Overall Study|Noncompliant|1|||
27967706|NCT00719563|54625512|FG000|Overall Study|Lost to Follow-up|5|||
27967707|NCT00719563|54625513|FG001|Overall Study|Lost to Follow-up|3|||
27967708|NCT00795184|54625520|FG000|Overall Study|Tissue sampling incomplete/conclusive|8|||
27967709|NCT00795184|54625521|FG001|Overall Study|Tissue sampling incomplete/conclusive|13|||
27967710|NCT00718861|54625532|FG000|Overall Study|Withdrawal by Subject|15|||
27967711|NCT00718861|54625533|FG001|Overall Study|Withdrawal by Subject|10|||
27967712|NCT00718861|54625532|FG000|Overall Study|Adverse Event|2|||
27967713|NCT00718861|54625533|FG001|Overall Study|Adverse Event|1|||
27967714|NCT00718861|54625532|FG000|Overall Study|Lost to Follow-up|2|||
27967715|NCT00718861|54625533|FG001|Overall Study|Lost to Follow-up|1|||
28165213|NCT02988115|54835784|FG001|Overall Study|Withdrawn by Mistake|0|||
28165214|NCT02988115|54835783|FG000|Overall Study|Lost to Follow-up|1|||
28165215|NCT02988115|54835784|FG001|Overall Study|Lost to Follow-up|0|||
28165216|NCT02921425|54835790|FG000|Overall Study|Protocol Violation|9|||
28165217|NCT03008915|54835794|FG000|Treatment 1|Withdrawal by Subject|0|||
28165218|NCT03008915|54835795|FG001|Treatment 1|Withdrawal by Subject|1|||
28165219|NCT02920957|54835806|FG000|First Intervention : 1 Month|Withdrawal by Subject|2|||
27855246|NCT01275131|54376305|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
27967716|NCT00718861|54625532|FG000|Overall Study|Administrative Problems|1|||
27967717|NCT00718861|54625533|FG001|Overall Study|Administrative Problems|1|||
27967718|NCT00718861|54625532|FG000|Overall Study|Death|1|||
27967719|NCT00718861|54625533|FG001|Overall Study|Death|5|||
27967720|NCT01016600|54625543|FG000|Overall Study|Did not start treatment|1|||
27967721|NCT01016600|54625544|FG001|Overall Study|Did not start treatment|0|||
27967722|NCT01016600|54625545|FG002|Overall Study|Did not start treatment|0|||
27967723|NCT01016600|54625546|FG003|Overall Study|Did not start treatment|0|||
27967724|NCT01016132|54625557|FG000|Overall Study|Discomfort|1|||
27967725|NCT01015820|54625563|FG000|Overall Study|Suboptimal measurements|1|||
27967726|NCT01015820|54625564|FG001|Overall Study|Suboptimal measurements|0|||
27967727|NCT01010204|54625587|FG000|Overall Study|Lost to Follow-up|2|||
27967728|NCT01010204|54625588|FG001|Overall Study|Lost to Follow-up|2|||
27967729|NCT01010204|54625587|FG000|Overall Study|Adverse Event|1|||
27967730|NCT01010204|54625588|FG001|Overall Study|Adverse Event|3|||
27967731|NCT01010204|54625587|FG000|Overall Study|Withdrawal by Subject|2|||
27967732|NCT01010204|54625588|FG001|Overall Study|Withdrawal by Subject|3|||
27967733|NCT01010204|54625587|FG000|Overall Study|psychiatric hospitalization|2|||
27967734|NCT01010204|54625588|FG001|Overall Study|psychiatric hospitalization|1|||
27967735|NCT00718549|54625594|FG000|Induction Phase|Disease Progression|1|||
27967736|NCT00718549|54625595|FG001|Induction Phase|Disease Progression|0|||
27967737|NCT00718549|54625596|FG002|Induction Phase|Disease Progression|0|||
27967738|NCT00718549|54625594|FG000|Induction Phase|Eligibility Criteria Violation|2|||
27967739|NCT00718549|54625595|FG001|Induction Phase|Eligibility Criteria Violation|0|||
27967740|NCT00718549|54625596|FG002|Induction Phase|Eligibility Criteria Violation|0|||
27967741|NCT00718549|54625594|FG000|Induction Phase|Early Termination - No Additional Info|59|||
27967742|NCT00718549|54625595|FG001|Induction Phase|Early Termination - No Additional Info|0|||
27967743|NCT00718549|54625596|FG002|Induction Phase|Early Termination - No Additional Info|0|||
27967744|NCT00718549|54625594|FG000|Maintenance/ Observation Phase|Early Termination - No Additional Info|0|||
27967745|NCT00718549|54625595|FG001|Maintenance/ Observation Phase|Early Termination - No Additional Info|15|||
27967746|NCT00718549|54625596|FG002|Maintenance/ Observation Phase|Early Termination - No Additional Info|8|||
27967747|NCT00718549|54625594|FG000|Maintenance/ Observation Phase|Death|0|||
27967748|NCT00718549|54625595|FG001|Maintenance/ Observation Phase|Death|1|||
27967749|NCT00718549|54625596|FG002|Maintenance/ Observation Phase|Death|2|||
27967750|NCT00718549|54625594|FG000|Maintenance/ Observation Phase|Lost to Follow-up|0|||
27967751|NCT00718549|54625595|FG001|Maintenance/ Observation Phase|Lost to Follow-up|4|||
27967752|NCT00718549|54625596|FG002|Maintenance/ Observation Phase|Lost to Follow-up|4|||
27967753|NCT00718549|54625594|FG000|Maintenance/ Observation Phase|Progression|0|||
28165220|NCT02920957|54835807|FG001|First Intervention : 1 Month|Withdrawal by Subject|0|||
27967754|NCT00718549|54625595|FG001|Maintenance/ Observation Phase|Progression|5|||
27967755|NCT00718549|54625596|FG002|Maintenance/ Observation Phase|Progression|14|||
27967756|NCT00718549|54625594|FG000|Maintenance/ Observation Phase|Relapse|0|||
27967757|NCT00718549|54625595|FG001|Maintenance/ Observation Phase|Relapse|3|||
27967758|NCT00718549|54625596|FG002|Maintenance/ Observation Phase|Relapse|2|||
27967759|NCT00793624|54625613|FG000|Overall Study|Adverse Event|18|||
27967760|NCT00793624|54625614|FG001|Overall Study|Adverse Event|16|||
27967761|NCT00793624|54625615|FG002|Overall Study|Adverse Event|15|||
27967762|NCT00793624|54625616|FG003|Overall Study|Adverse Event|20|||
27967763|NCT00793624|54625613|FG000|Overall Study|Lost to Follow-up|2|||
28165221|NCT02920957|54835806|FG000|First Intervention : 1 Month|Lost to Follow-up|1|||
27967764|NCT00793624|54625614|FG001|Overall Study|Lost to Follow-up|2|||
27967765|NCT00793624|54625615|FG002|Overall Study|Lost to Follow-up|4|||
27967766|NCT00793624|54625616|FG003|Overall Study|Lost to Follow-up|0|||
27967767|NCT00793624|54625613|FG000|Overall Study|Withdrawal by Subject|20|||
28083798|NCT03814590|54737365|FG005|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
28083799|NCT03814590|54737366|FG006|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
28083800|NCT03814590|54737367|FG007|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
28083801|NCT03814590|54737368|FG008|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
28083802|NCT03814590|54737369|FG009|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|1|||
28083803|NCT03814590|54737370|FG010|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
28083804|NCT03814590|54737371|FG011|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
28083805|NCT03814590|54737372|FG012|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
28083806|NCT03814590|54737373|FG013|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
28083807|NCT03814590|54737360|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
28083808|NCT03814590|54737361|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
28083809|NCT03814590|54737362|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
28083810|NCT03814590|54737363|FG003|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
28083811|NCT03814590|54737364|FG004|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
28165222|NCT02920957|54835807|FG001|First Intervention : 1 Month|Lost to Follow-up|0|||
27967768|NCT00793624|54625614|FG001|Overall Study|Withdrawal by Subject|9|||
27967769|NCT00793624|54625615|FG002|Overall Study|Withdrawal by Subject|11|||
27967770|NCT00793624|54625616|FG003|Overall Study|Withdrawal by Subject|14|||
27967771|NCT00793624|54625613|FG000|Overall Study|Lack of Efficacy|9|||
27967772|NCT00793624|54625614|FG001|Overall Study|Lack of Efficacy|2|||
27967773|NCT00793624|54625615|FG002|Overall Study|Lack of Efficacy|1|||
27967774|NCT00793624|54625616|FG003|Overall Study|Lack of Efficacy|3|||
27967775|NCT00793624|54625613|FG000|Overall Study|Non compliance with protocol|2|||
27967776|NCT00793624|54625614|FG001|Overall Study|Non compliance with protocol|3|||
27967777|NCT00793624|54625615|FG002|Overall Study|Non compliance with protocol|2|||
27967778|NCT00793624|54625616|FG003|Overall Study|Non compliance with protocol|3|||
27967779|NCT00793624|54625613|FG000|Overall Study|Other reason not described above|6|||
27967780|NCT00793624|54625614|FG001|Overall Study|Other reason not described above|4|||
27967781|NCT00793624|54625615|FG002|Overall Study|Other reason not described above|6|||
27967782|NCT00793624|54625616|FG003|Overall Study|Other reason not described above|3|||
27967783|NCT00794950|54625634|FG000|BCG Induction|Withdrawal by Subject|2|||
27967784|NCT00794950|54625634|FG000|BCG Induction|ineligible|3|||
27967785|NCT00794950|54625634|FG000|BCG Induction|noncompliant w. BCG|1|||
27967786|NCT00794950|54625634|FG000|BCG Induction|Adverse Event|1|||
27967787|NCT00794950|54625634|FG000|Beginning Sunitinib Treatment|cystectomy|5|||
27967788|NCT00794950|54625634|FG000|Beginning Sunitinib Treatment|Physician Decision|5|||
27967789|NCT00794950|54625634|FG000|Beginning Sunitinib Treatment|Withdrawal by Subject|1|||
27967790|NCT00794950|54625634|FG000|Beginning Sunitinib Treatment|Lost to Follow-up|1|||
27967791|NCT00793546|54625641|FG000|Overall Study|Death|3|||
27967792|NCT00793546|54625642|FG001|Overall Study|Death|0|||
27967793|NCT00793546|54625641|FG000|Overall Study|Lost to Follow-up|1|||
27967794|NCT00793546|54625642|FG001|Overall Study|Lost to Follow-up|0|||
27967795|NCT00793546|54625641|FG000|Overall Study|Withdrawal by Subject|1|||
27967796|NCT00793546|54625642|FG001|Overall Study|Withdrawal by Subject|1|||
27967797|NCT00793546|54625641|FG000|Overall Study|Study Terminated by Sponsor|8|||
27967798|NCT00793546|54625642|FG001|Overall Study|Study Terminated by Sponsor|27|||
27967799|NCT00793546|54625641|FG000|Overall Study|Other|1|||
27967800|NCT00793546|54625642|FG001|Overall Study|Other|0|||
27967801|NCT00798694|54625652|FG000|Overall Study|Lost to Follow-up|1|||
27967802|NCT00798694|54625653|FG001|Overall Study|Lost to Follow-up|1|||
27967803|NCT00798694|54625652|FG000|Overall Study|Physician Decision|1|||
27967804|NCT00798694|54625653|FG001|Overall Study|Physician Decision|0|||
27967805|NCT00718315|54625668|FG000|Overall Study|Adverse Event|1|||
27967806|NCT00718315|54625669|FG001|Overall Study|Adverse Event|2|||
27967807|NCT00718315|54625670|FG002|Overall Study|Adverse Event|3|||
27967808|NCT00718315|54625668|FG000|Overall Study|Death|6|||
27967809|NCT00718315|54625669|FG001|Overall Study|Death|6|||
27967810|NCT00718315|54625670|FG002|Overall Study|Death|5|||
27967811|NCT00718315|54625668|FG000|Overall Study|Lost to Follow-up|2|||
27967812|NCT00718315|54625669|FG001|Overall Study|Lost to Follow-up|3|||
27967813|NCT00718315|54625670|FG002|Overall Study|Lost to Follow-up|4|||
27967814|NCT00718315|54625668|FG000|Overall Study|Protocol Violation|5|||
27967815|NCT00718315|54625669|FG001|Overall Study|Protocol Violation|5|||
27967816|NCT00718315|54625670|FG002|Overall Study|Protocol Violation|3|||
27967817|NCT00718315|54625668|FG000|Overall Study|Erlotinib dose decreased|4|||
27967818|NCT00718315|54625669|FG001|Overall Study|Erlotinib dose decreased|3|||
27967819|NCT00718315|54625670|FG002|Overall Study|Erlotinib dose decreased|1|||
27967820|NCT00718315|54625668|FG000|Overall Study|Use of Minocyclin|1|||
27967821|NCT00718315|54625669|FG001|Overall Study|Use of Minocyclin|1|||
27967822|NCT00718315|54625670|FG002|Overall Study|Use of Minocyclin|1|||
27967823|NCT00718315|54625668|FG000|Overall Study|Disease progression|0|||
27967824|NCT00718315|54625669|FG001|Overall Study|Disease progression|1|||
27967825|NCT00718315|54625670|FG002|Overall Study|Disease progression|1|||
27967826|NCT00718315|54625668|FG000|Overall Study|Other|0|||
27967827|NCT00718315|54625669|FG001|Overall Study|Other|0|||
27967828|NCT00718315|54625670|FG002|Overall Study|Other|1|||
27967829|NCT00718315|54625668|FG000|Overall Study|Use of ATB and Corticoids|0|||
27967830|NCT00718315|54625669|FG001|Overall Study|Use of ATB and Corticoids|1|||
27967831|NCT00718315|54625670|FG002|Overall Study|Use of ATB and Corticoids|2|||
27967832|NCT00798304|54625681|FG000|Overall Study|Adverse Event|0|||
27967833|NCT00798304|54625682|FG001|Overall Study|Adverse Event|1|||
27967834|NCT00798304|54625683|FG002|Overall Study|Adverse Event|1|||
27967835|NCT00798304|54625681|FG000|Overall Study|Discontinuation by Sponsor|14|||
27967836|NCT00798304|54625682|FG001|Overall Study|Discontinuation by Sponsor|21|||
27967837|NCT00798304|54625683|FG002|Overall Study|Discontinuation by Sponsor|9|||
27967838|NCT00718237|54625693|FG000|Overall Study|Adverse Event|1|||
27967839|NCT00718237|54625694|FG001|Overall Study|Adverse Event|3|||
27967840|NCT00718237|54625693|FG000|Overall Study|Lost to Follow-up|2|||
27967841|NCT00718237|54625694|FG001|Overall Study|Lost to Follow-up|2|||
27967842|NCT00718237|54625693|FG000|Overall Study|Physician Decision|1|||
27967843|NCT00718237|54625694|FG001|Overall Study|Physician Decision|0|||
27967844|NCT00718237|54625693|FG000|Overall Study|Withdrawal by Subject|9|||
27967845|NCT00718237|54625694|FG001|Overall Study|Withdrawal by Subject|10|||
27967846|NCT00793780|54625704|FG000|Overall Study|Withdrawal by Subject|2|||
27967847|NCT00793780|54625705|FG001|Overall Study|Withdrawal by Subject|1|||
27967848|NCT02643303|54625720|FG000|Overall Study|Progressive Disease|4|||
27967849|NCT02643303|54625721|FG001|Overall Study|Progressive Disease|4|||
27967850|NCT02643303|54625722|FG002|Overall Study|Progressive Disease|1|||
27967851|NCT02643303|54625723|FG003|Overall Study|Progressive Disease|12|||
27967852|NCT02643303|54625724|FG004|Overall Study|Progressive Disease|6|||
27967853|NCT02643303|54625725|FG005|Overall Study|Progressive Disease|4|||
27967854|NCT02643303|54625726|FG006|Overall Study|Progressive Disease|8|||
27967855|NCT02643303|54625727|FG007|Overall Study|Progressive Disease|2|||
27967856|NCT02643303|54625728|FG008|Overall Study|Progressive Disease|6|||
27967857|NCT02643303|54625720|FG000|Overall Study|Adverse Event|0|||
27967858|NCT02643303|54625721|FG001|Overall Study|Adverse Event|1|||
27967859|NCT02643303|54625722|FG002|Overall Study|Adverse Event|0|||
27967860|NCT02643303|54625723|FG003|Overall Study|Adverse Event|0|||
27967861|NCT02643303|54625724|FG004|Overall Study|Adverse Event|1|||
27967862|NCT02643303|54625725|FG005|Overall Study|Adverse Event|0|||
27967863|NCT02643303|54625726|FG006|Overall Study|Adverse Event|0|||
27967864|NCT02643303|54625727|FG007|Overall Study|Adverse Event|0|||
27967865|NCT02643303|54625728|FG008|Overall Study|Adverse Event|0|||
27967866|NCT02643303|54625720|FG000|Overall Study|Withdrawal by Subject|0|||
27967867|NCT02643303|54625721|FG001|Overall Study|Withdrawal by Subject|0|||
27967868|NCT02643303|54625722|FG002|Overall Study|Withdrawal by Subject|0|||
27967869|NCT02643303|54625723|FG003|Overall Study|Withdrawal by Subject|1|||
27967870|NCT02643303|54625724|FG004|Overall Study|Withdrawal by Subject|0|||
27967871|NCT02643303|54625725|FG005|Overall Study|Withdrawal by Subject|0|||
28083812|NCT03814590|54737365|FG005|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
28083813|NCT03814590|54737366|FG006|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
28083814|NCT03814590|54737367|FG007|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
27967872|NCT02643303|54625726|FG006|Overall Study|Withdrawal by Subject|1|||
27967873|NCT02643303|54625727|FG007|Overall Study|Withdrawal by Subject|1|||
27967874|NCT02643303|54625728|FG008|Overall Study|Withdrawal by Subject|1|||
27967875|NCT00790036|54625750|FG000|Overall Study|Abnormal lab values|3|||
27967876|NCT00790036|54625751|FG001|Overall Study|Abnormal lab values|2|||
27967877|NCT00790036|54625750|FG000|Overall Study|Administrative problems|5|||
27967878|NCT00790036|54625751|FG001|Overall Study|Administrative problems|9|||
27967879|NCT00790036|54625750|FG000|Overall Study|Adverse Event|113|||
27967880|NCT00790036|54625751|FG001|Overall Study|Adverse Event|44|||
27967881|NCT00790036|54625750|FG000|Overall Study|Death|1|||
27967882|NCT00790036|54625751|FG001|Overall Study|Death|0|||
27967883|NCT00790036|54625750|FG000|Overall Study|Disease progression|24|||
27967884|NCT00790036|54625751|FG001|Overall Study|Disease progression|48|||
27967885|NCT00790036|54625750|FG000|Overall Study|Lost to Follow-up|1|||
27967886|NCT00790036|54625751|FG001|Overall Study|Lost to Follow-up|2|||
27967887|NCT00790036|54625750|FG000|Overall Study|Protocol Violation|10|||
27967888|NCT00790036|54625751|FG001|Overall Study|Protocol Violation|2|||
27967889|NCT00790036|54625750|FG000|Overall Study|Withdrawal by Subject|18|||
27967890|NCT00790036|54625751|FG001|Overall Study|Withdrawal by Subject|7|||
27967891|NCT00790036|54625750|FG000|Overall Study|Subject/guardian decision|20|||
27967892|NCT00790036|54625751|FG001|Overall Study|Subject/guardian decision|7|||
27967893|NCT00789958|54625758|FG000|Overall Study|Adverse Event|3|||
27967894|NCT00789958|54625758|FG000|Overall Study|Withdrawal by Subject|4|||
27967895|NCT00789958|54625758|FG000|Overall Study|Progression|3|||
27967896|NCT00789958|54625758|FG000|Overall Study|not protocol specified|1|||
27967897|NCT00789958|54625758|FG000|Overall Study|Not eligible/not analyzable|26|||
27855247|NCT01275131|54376306|FG002|Period 2 (Crossover)|Withdrawal by Subject|1|||
27855248|NCT01275131|54376307|FG003|Period 2 (Crossover)|Withdrawal by Subject|2|||
27855249|NCT01274429|54376336|FG000|Overall Study|Study closed do to lack of funding|5|||
27855250|NCT01273883|54376340|FG000|First Intervention|Adverse Event|2|||
27855251|NCT01273883|54376341|FG001|First Intervention|Adverse Event|1|||
27855252|NCT01273883|54376340|FG000|Second Intervention|Lost to Follow-up|1|||
27855253|NCT01273883|54376341|FG001|Second Intervention|Lost to Follow-up|1|||
27855254|NCT01273883|54376340|FG000|Second Intervention|Lack of Efficacy|1|||
27855255|NCT01273883|54376341|FG001|Second Intervention|Lack of Efficacy|0|||
27855256|NCT01273805|54376349|FG000|Overall Study|Radiologic PD or Symptom Deterioration|10|||
27855257|NCT01273805|54376350|FG001|Overall Study|Radiologic PD or Symptom Deterioration|10|||
27855258|NCT01273181|54376360|FG000|Phase I, Dose 1|Study termination|1|||
27855259|NCT01273181|54376361|FG001|Phase I, Dose 1|Study termination|0|||
27855260|NCT01273181|54376362|FG002|Phase I, Dose 1|Study termination|0|||
27855261|NCT01273181|54376363|FG003|Phase I, Dose 1|Study termination|0|||
27855262|NCT01273181|54376360|FG000|Phase I, Dose 2|Death during treatment|0|||
27855263|NCT01273181|54376361|FG001|Phase I, Dose 2|Death during treatment|1|||
27855264|NCT01273181|54376362|FG002|Phase I, Dose 2|Death during treatment|0|||
27855265|NCT01273181|54376363|FG003|Phase I, Dose 2|Death during treatment|0|||
27855266|NCT01273181|54376360|FG000|Phase 2, Dose 1|Study termination|0|||
27855267|NCT01273181|54376361|FG001|Phase 2, Dose 1|Study termination|0|||
27855268|NCT01273181|54376362|FG002|Phase 2, Dose 1|Study termination|1|||
27855269|NCT01273181|54376363|FG003|Phase 2, Dose 1|Study termination|0|||
27855270|NCT01273181|54376360|FG000|Phase 2, Dose 2|Death during treatment|0|||
27855271|NCT01273181|54376361|FG001|Phase 2, Dose 2|Death during treatment|0|||
27855272|NCT01273181|54376362|FG002|Phase 2, Dose 2|Death during treatment|0|||
27855273|NCT01273181|54376363|FG003|Phase 2, Dose 2|Death during treatment|1|||
27855274|NCT01272947|54376379|FG000|Overall Study|Abnormal Laboratory Value|2|||
27855275|NCT01272947|54376380|FG001|Overall Study|Abnormal Laboratory Value|2|||
27855276|NCT01279343|54376388|FG000|Overall Study|Did not receive treatment|2|||
27855277|NCT01279343|54376389|FG001|Overall Study|Did not receive treatment|6|||
27855278|NCT01278797|54376395|FG000|Period 1|Adverse Event|0|||
27855279|NCT01278797|54376396|FG001|Period 1|Adverse Event|1|||
27855280|NCT01278797|54376395|FG000|Period 1|Protocol Violation|1|||
27855281|NCT01278797|54376396|FG001|Period 1|Protocol Violation|0|||
27855282|NCT01272869|54376404|FG000|Period 2 (14 Days)|Adverse Event|1|||
27855283|NCT01272869|54376405|FG001|Period 2 (14 Days)|Adverse Event|0|||
27855284|NCT01272635|54376413|FG000|Overall Study|Lost to Follow-up|31|||
27855285|NCT01272635|54376414|FG001|Overall Study|Lost to Follow-up|20|||
27855286|NCT01272635|54376415|FG002|Overall Study|Lost to Follow-up|31|||
27855287|NCT01272635|54376416|FG003|Overall Study|Lost to Follow-up|23|||
27855288|NCT01272011|54376427|FG000|Overall Study|Withdrawal By Subject or Failed Screen|0|||
27855289|NCT01272011|54376428|FG001|Overall Study|Withdrawal By Subject or Failed Screen|2|||
27855290|NCT01272011|54376429|FG002|Overall Study|Withdrawal By Subject or Failed Screen|0|||
27967898|NCT00789880|54625770|FG000|Overall Study|Adverse Event|0|||
27967899|NCT00789880|54625771|FG001|Overall Study|Adverse Event|0|||
27967900|NCT00789880|54625772|FG002|Overall Study|Adverse Event|0|||
27967901|NCT00789880|54625773|FG003|Overall Study|Adverse Event|0|||
27967902|NCT00789880|54625774|FG004|Overall Study|Adverse Event|1|||
27967903|NCT00789880|54625775|FG005|Overall Study|Adverse Event|0|||
28083815|NCT03814590|54737368|FG008|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
28083816|NCT03814590|54737369|FG009|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
28083817|NCT03814590|54737370|FG010|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
28083818|NCT03814590|54737371|FG011|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
28083819|NCT03814590|54737372|FG012|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
28083820|NCT03814590|54737373|FG013|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
28083821|NCT03814590|54737360|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
28083822|NCT03814590|54737361|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
28083823|NCT03814590|54737362|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
27855291|NCT01270841|54376450|FG000|Overall Study|Adverse Event|0|||
27855292|NCT01270841|54376451|FG001|Overall Study|Adverse Event|1|||
27855293|NCT01270841|54376452|FG002|Overall Study|Adverse Event|0|||
27855294|NCT01270841|54376453|FG003|Overall Study|Adverse Event|3|||
27855295|NCT01270841|54376450|FG000|Overall Study|Withdrawal by Subject|3|||
27855296|NCT01270841|54376451|FG001|Overall Study|Withdrawal by Subject|2|||
27855297|NCT01270841|54376452|FG002|Overall Study|Withdrawal by Subject|3|||
27855298|NCT01270841|54376453|FG003|Overall Study|Withdrawal by Subject|3|||
27855299|NCT01270841|54376450|FG000|Overall Study|Lost to Follow-up|3|||
27967904|NCT00789880|54625770|FG000|Overall Study|Protocol Violation|0|||
27967905|NCT00789880|54625771|FG001|Overall Study|Protocol Violation|1|||
28083824|NCT03814590|54737363|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
28083825|NCT03814590|54737364|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
28083826|NCT03814590|54737365|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
28083827|NCT03814590|54737366|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
28083828|NCT03814590|54737367|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
28083829|NCT03814590|54737368|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
28083830|NCT03814590|54737369|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
28083831|NCT03814590|54737370|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
28083832|NCT03814590|54737371|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
28083833|NCT03814590|54737372|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
28083834|NCT03814590|54737373|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
28083835|NCT03814590|54737360|FG000|Overall Study|UNKNOWN REASON|0|||
27967906|NCT00789880|54625772|FG002|Overall Study|Protocol Violation|0|||
27967907|NCT00789880|54625773|FG003|Overall Study|Protocol Violation|1|||
27967908|NCT00789880|54625774|FG004|Overall Study|Protocol Violation|0|||
27967909|NCT00789880|54625775|FG005|Overall Study|Protocol Violation|0|||
27967910|NCT00789880|54625770|FG000|Overall Study|Withdrawal by Subject|1|||
27967911|NCT00789880|54625771|FG001|Overall Study|Withdrawal by Subject|0|||
27967912|NCT00789880|54625772|FG002|Overall Study|Withdrawal by Subject|0|||
27967913|NCT00789880|54625773|FG003|Overall Study|Withdrawal by Subject|0|||
27967914|NCT00789880|54625774|FG004|Overall Study|Withdrawal by Subject|2|||
27967915|NCT00789880|54625775|FG005|Overall Study|Withdrawal by Subject|0|||
27967916|NCT00792298|54625789|FG000|Treatment Period 1|Adverse Event|0|||
27967917|NCT00792298|54625790|FG001|Treatment Period 1|Adverse Event|1|||
27967918|NCT00792298|54625791|FG002|Treatment Period 1|Adverse Event|0|||
27967919|NCT00792298|54625792|FG003|Treatment Period 1|Adverse Event|1|||
27967920|NCT00792298|54625793|FG004|Treatment Period 1|Adverse Event|0|||
27967921|NCT00792298|54625794|FG005|Treatment Period 1|Adverse Event|1|||
27967922|NCT00792298|54625795|FG006|Treatment Period 1|Adverse Event|1|||
27967923|NCT00792298|54625796|FG007|Treatment Period 1|Adverse Event|0|||
27967924|NCT00792298|54625789|FG000|Treatment Period 1|Lack of Efficacy|0|||
27967925|NCT00792298|54625790|FG001|Treatment Period 1|Lack of Efficacy|0|||
27967926|NCT00792298|54625791|FG002|Treatment Period 1|Lack of Efficacy|1|||
27967927|NCT00792298|54625792|FG003|Treatment Period 1|Lack of Efficacy|0|||
27967928|NCT00792298|54625793|FG004|Treatment Period 1|Lack of Efficacy|0|||
27967929|NCT00792298|54625794|FG005|Treatment Period 1|Lack of Efficacy|0|||
27967930|NCT00792298|54625795|FG006|Treatment Period 1|Lack of Efficacy|0|||
27967931|NCT00792298|54625796|FG007|Treatment Period 1|Lack of Efficacy|0|||
27967932|NCT00792298|54625789|FG000|Treatment Period 1|Withdrawal by Subject|1|||
27967933|NCT00792298|54625790|FG001|Treatment Period 1|Withdrawal by Subject|0|||
27967934|NCT00792298|54625791|FG002|Treatment Period 1|Withdrawal by Subject|1|||
27967935|NCT00792298|54625792|FG003|Treatment Period 1|Withdrawal by Subject|2|||
27967936|NCT00792298|54625793|FG004|Treatment Period 1|Withdrawal by Subject|0|||
27967937|NCT00792298|54625794|FG005|Treatment Period 1|Withdrawal by Subject|2|||
27967938|NCT00792298|54625795|FG006|Treatment Period 1|Withdrawal by Subject|1|||
28083836|NCT03814590|54737361|FG001|Overall Study|UNKNOWN REASON|0|||
28083837|NCT03814590|54737362|FG002|Overall Study|UNKNOWN REASON|0|||
28083838|NCT03814590|54737363|FG003|Overall Study|UNKNOWN REASON|0|||
28083839|NCT03814590|54737364|FG004|Overall Study|UNKNOWN REASON|0|||
28083840|NCT03814590|54737365|FG005|Overall Study|UNKNOWN REASON|0|||
28083841|NCT03814590|54737366|FG006|Overall Study|UNKNOWN REASON|0|||
28083842|NCT03814590|54737367|FG007|Overall Study|UNKNOWN REASON|1|||
28083843|NCT03814590|54737368|FG008|Overall Study|UNKNOWN REASON|0|||
28083844|NCT03814590|54737369|FG009|Overall Study|UNKNOWN REASON|0|||
28083845|NCT03814590|54737370|FG010|Overall Study|UNKNOWN REASON|0|||
28083846|NCT03814590|54737371|FG011|Overall Study|UNKNOWN REASON|0|||
28083847|NCT03814590|54737372|FG012|Overall Study|UNKNOWN REASON|0|||
28083848|NCT03814590|54737373|FG013|Overall Study|UNKNOWN REASON|0|||
28083849|NCT00048074|54737416|FG000|Overall Study|Adverse Event|46|||
28083850|NCT00048074|54737417|FG001|Overall Study|Adverse Event|41|||
28083851|NCT00048074|54737418|FG002|Overall Study|Adverse Event|53|||
28083852|NCT00048074|54737416|FG000|Overall Study|Death|3|||
28083853|NCT00048074|54737417|FG001|Overall Study|Death|3|||
27832535|NCT01732835|54311916|FG000|2-year Extended Follow-up|Adverse Event|3|||
27967939|NCT00792298|54625796|FG007|Treatment Period 1|Withdrawal by Subject|0|||
28083854|NCT00048074|54737418|FG002|Overall Study|Death|2|||
28083855|NCT00048074|54737416|FG000|Overall Study|Lost to Follow-up|2|||
28083856|NCT00048074|54737417|FG001|Overall Study|Lost to Follow-up|6|||
27832536|NCT01732835|54311916|FG000|2-year Extended Follow-up|Death|1|||
27832537|NCT01759511|54311970|FG000|Overall Study|Adverse Event|4|||
27832538|NCT01759511|54311970|FG000|Overall Study|Death|2|||
27832539|NCT01759511|54311970|FG000|Overall Study|Lack of Efficacy|2|||
27832540|NCT01759511|54311970|FG000|Overall Study|Physician Decision|1|||
27967940|NCT00792298|54625789|FG000|Treatment Period 1|Lost to Follow-up|0|||
27967941|NCT00792298|54625790|FG001|Treatment Period 1|Lost to Follow-up|0|||
28083857|NCT00048074|54737418|FG002|Overall Study|Lost to Follow-up|6|||
28083858|NCT00048074|54737416|FG000|Overall Study|Withdrawal by Subject|28|||
28083859|NCT00048074|54737417|FG001|Overall Study|Withdrawal by Subject|30|||
28083860|NCT00048074|54737418|FG002|Overall Study|Withdrawal by Subject|35|||
28083861|NCT00048074|54737416|FG000|Overall Study|Protocol Violation|1|||
28083862|NCT00048074|54737417|FG001|Overall Study|Protocol Violation|3|||
28083863|NCT00048074|54737418|FG002|Overall Study|Protocol Violation|0|||
27967942|NCT00792298|54625791|FG002|Treatment Period 1|Lost to Follow-up|0|||
27967943|NCT00792298|54625792|FG003|Treatment Period 1|Lost to Follow-up|0|||
27967944|NCT00792298|54625793|FG004|Treatment Period 1|Lost to Follow-up|0|||
27967945|NCT00792298|54625794|FG005|Treatment Period 1|Lost to Follow-up|0|||
28083864|NCT00048074|54737416|FG000|Overall Study|Study participation was terminated|0|||
28083865|NCT00048074|54737417|FG001|Overall Study|Study participation was terminated|1|||
28083866|NCT00048074|54737418|FG002|Overall Study|Study participation was terminated|0|||
28083867|NCT00048074|54737416|FG000|Overall Study|Husband ill|0|||
28083868|NCT00048074|54737417|FG001|Overall Study|Husband ill|1|||
27732747|NCT02567708|54180355|FG001|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
27732748|NCT02567708|54180354|FG000|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
27732749|NCT02567708|54180355|FG001|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3|||
27967946|NCT00792298|54625795|FG006|Treatment Period 1|Lost to Follow-up|1|||
27967947|NCT00792298|54625796|FG007|Treatment Period 1|Lost to Follow-up|0|||
27967948|NCT00792298|54625789|FG000|Treatment Period 1|Physician Decision|0|||
27967949|NCT00792298|54625790|FG001|Treatment Period 1|Physician Decision|0|||
27967950|NCT00792298|54625791|FG002|Treatment Period 1|Physician Decision|0|||
27967951|NCT00792298|54625792|FG003|Treatment Period 1|Physician Decision|1|||
27967952|NCT00792298|54625793|FG004|Treatment Period 1|Physician Decision|0|||
27967953|NCT00792298|54625794|FG005|Treatment Period 1|Physician Decision|0|||
27967954|NCT00792298|54625795|FG006|Treatment Period 1|Physician Decision|1|||
27967955|NCT00792298|54625796|FG007|Treatment Period 1|Physician Decision|0|||
27967956|NCT00792298|54625789|FG000|Treatment Period 1|Protocol Violation|0|||
27967957|NCT00792298|54625790|FG001|Treatment Period 1|Protocol Violation|0|||
27967958|NCT00792298|54625791|FG002|Treatment Period 1|Protocol Violation|0|||
27967959|NCT00792298|54625792|FG003|Treatment Period 1|Protocol Violation|0|||
27967960|NCT00792298|54625793|FG004|Treatment Period 1|Protocol Violation|0|||
27967961|NCT00792298|54625794|FG005|Treatment Period 1|Protocol Violation|0|||
28083869|NCT00048074|54737418|FG002|Overall Study|Husband ill|0|||
27732750|NCT02562716|54180364|FG000|Overall Study|Adverse Event|7|||
27732751|NCT02562716|54180365|FG001|Overall Study|Adverse Event|14|||
27732752|NCT02562716|54180364|FG000|Overall Study|Withdrawal unrelated to AE|7|||
27732753|NCT02562716|54180365|FG001|Overall Study|Withdrawal unrelated to AE|1|||
27732754|NCT02562716|54180364|FG000|Overall Study|Progression|8|||
27732755|NCT02562716|54180365|FG001|Overall Study|Progression|10|||
27732756|NCT02562716|54180364|FG000|Overall Study|Death|2|||
27732757|NCT02562716|54180365|FG001|Overall Study|Death|1|||
27732758|NCT02562716|54180364|FG000|Overall Study|Not protocol specified|4|||
27732759|NCT02562716|54180365|FG001|Overall Study|Not protocol specified|2|||
27732760|NCT02751931|54180375|FG000|Overall Study|Adverse Event|3|||
27732761|NCT02751931|54180376|FG001|Overall Study|Adverse Event|0|||
27732762|NCT02751931|54180375|FG000|Overall Study|Other: Miscelleneous|10|||
27732763|NCT02751931|54180376|FG001|Overall Study|Other: Miscelleneous|8|||
27732764|NCT02561156|54180401|FG000|Part 2|Adverse Event|0|||
27732765|NCT02561156|54180402|FG001|Part 2|Adverse Event|0|||
27732766|NCT02561156|54180403|FG002|Part 2|Adverse Event|0|||
27732767|NCT02561156|54180404|FG003|Part 2|Adverse Event|0|||
27732768|NCT02561156|54180405|FG004|Part 2|Adverse Event|0|||
27732769|NCT02561156|54180406|FG005|Part 2|Adverse Event|0|||
27732770|NCT02561156|54180407|FG006|Part 2|Adverse Event|0|||
27732771|NCT02561156|54180408|FG007|Part 2|Adverse Event|0|||
27732772|NCT02561156|54180409|FG008|Part 2|Adverse Event|0|||
27732773|NCT02561156|54180410|FG009|Part 2|Adverse Event|0|||
27732774|NCT02561156|54180411|FG010|Part 2|Adverse Event|0|||
27732775|NCT02561156|54180412|FG011|Part 2|Adverse Event|1|||
27732776|NCT02561156|54180413|FG012|Part 2|Adverse Event|0|||
27732777|NCT02561078|54180459|FG000|Overall Study|Adverse Event|5|||
27732778|NCT02561078|54180460|FG001|Overall Study|Adverse Event|2|||
27732779|NCT02561078|54180459|FG000|Overall Study|Death|2|||
27732780|NCT02561078|54180460|FG001|Overall Study|Death|1|||
28083870|NCT00048074|54737416|FG000|Overall Study|Poor compliance|0|||
27732781|NCT02561078|54180459|FG000|Overall Study|Lost to Follow-up|2|||
28083871|NCT00048074|54737417|FG001|Overall Study|Poor compliance|1|||
27732782|NCT02561078|54180460|FG001|Overall Study|Lost to Follow-up|6|||
27732783|NCT02561078|54180459|FG000|Overall Study|Non-Compliance with Study Drug|6|||
27732784|NCT02561078|54180460|FG001|Overall Study|Non-Compliance with Study Drug|3|||
28083872|NCT00048074|54737418|FG002|Overall Study|Poor compliance|0|||
27732785|NCT02561078|54180459|FG000|Overall Study|Physician Decision|2|||
27732786|NCT02561078|54180460|FG001|Overall Study|Physician Decision|3|||
27855300|NCT01270841|54376451|FG001|Overall Study|Lost to Follow-up|1|||
27967962|NCT00792298|54625795|FG006|Treatment Period 1|Protocol Violation|0|||
27967963|NCT00792298|54625796|FG007|Treatment Period 1|Protocol Violation|1|||
27967964|NCT00792298|54625789|FG000|Washout|Adverse Event|0|||
28083873|NCT00048074|54737416|FG000|Overall Study|Out of station|0|||
27967965|NCT00792298|54625790|FG001|Washout|Adverse Event|0|||
27967966|NCT00792298|54625791|FG002|Washout|Adverse Event|0|||
27967967|NCT00792298|54625792|FG003|Washout|Adverse Event|0|||
27967968|NCT00792298|54625793|FG004|Washout|Adverse Event|0|||
27967969|NCT00792298|54625794|FG005|Washout|Adverse Event|1|||
27967970|NCT00792298|54625795|FG006|Washout|Adverse Event|0|||
27967971|NCT00792298|54625796|FG007|Washout|Adverse Event|0|||
27967972|NCT00792298|54625789|FG000|Washout|Withdrawal by Subject|0|||
27967973|NCT00792298|54625790|FG001|Washout|Withdrawal by Subject|0|||
27967974|NCT00792298|54625791|FG002|Washout|Withdrawal by Subject|1|||
27967975|NCT00792298|54625792|FG003|Washout|Withdrawal by Subject|0|||
27967976|NCT00792298|54625793|FG004|Washout|Withdrawal by Subject|0|||
27967977|NCT00792298|54625794|FG005|Washout|Withdrawal by Subject|1|||
27967978|NCT00792298|54625795|FG006|Washout|Withdrawal by Subject|0|||
27967979|NCT00792298|54625796|FG007|Washout|Withdrawal by Subject|0|||
27967980|NCT00792298|54625789|FG000|Treatment Period 2|Lack of Efficacy|0|||
27967981|NCT00792298|54625790|FG001|Treatment Period 2|Lack of Efficacy|0|||
27967982|NCT00792298|54625791|FG002|Treatment Period 2|Lack of Efficacy|0|||
27967983|NCT00792298|54625792|FG003|Treatment Period 2|Lack of Efficacy|0|||
27967984|NCT00792298|54625793|FG004|Treatment Period 2|Lack of Efficacy|1|||
27967985|NCT00792298|54625794|FG005|Treatment Period 2|Lack of Efficacy|0|||
27967986|NCT00792298|54625795|FG006|Treatment Period 2|Lack of Efficacy|0|||
27967987|NCT00792298|54625796|FG007|Treatment Period 2|Lack of Efficacy|0|||
27967988|NCT00792298|54625789|FG000|Treatment Period 2|Physician Decision|0|||
27967989|NCT00792298|54625790|FG001|Treatment Period 2|Physician Decision|0|||
27967990|NCT00792298|54625791|FG002|Treatment Period 2|Physician Decision|0|||
27967991|NCT00792298|54625792|FG003|Treatment Period 2|Physician Decision|0|||
27967992|NCT00792298|54625793|FG004|Treatment Period 2|Physician Decision|0|||
27967993|NCT00792298|54625794|FG005|Treatment Period 2|Physician Decision|0|||
27967994|NCT00792298|54625795|FG006|Treatment Period 2|Physician Decision|1|||
27967995|NCT00792298|54625796|FG007|Treatment Period 2|Physician Decision|0|||
27967996|NCT00792298|54625789|FG000|Treatment Period 2|Pregnancy|0|||
27967997|NCT00792298|54625790|FG001|Treatment Period 2|Pregnancy|0|||
27967998|NCT00792298|54625791|FG002|Treatment Period 2|Pregnancy|1|||
27967999|NCT00792298|54625792|FG003|Treatment Period 2|Pregnancy|0|||
27968000|NCT00792298|54625793|FG004|Treatment Period 2|Pregnancy|0|||
27968001|NCT00792298|54625794|FG005|Treatment Period 2|Pregnancy|0|||
27968002|NCT00792298|54625795|FG006|Treatment Period 2|Pregnancy|0|||
27968003|NCT00792298|54625796|FG007|Treatment Period 2|Pregnancy|0|||
27968004|NCT00792298|54625789|FG000|Treatment Period 2|Withdrawal by Subject|1|||
27968005|NCT00792298|54625790|FG001|Treatment Period 2|Withdrawal by Subject|1|||
27968006|NCT00792298|54625791|FG002|Treatment Period 2|Withdrawal by Subject|0|||
27968007|NCT00792298|54625792|FG003|Treatment Period 2|Withdrawal by Subject|2|||
27968008|NCT00792298|54625793|FG004|Treatment Period 2|Withdrawal by Subject|1|||
27968009|NCT00792298|54625794|FG005|Treatment Period 2|Withdrawal by Subject|0|||
27968010|NCT00792298|54625795|FG006|Treatment Period 2|Withdrawal by Subject|0|||
27968011|NCT00792298|54625796|FG007|Treatment Period 2|Withdrawal by Subject|2|||
27968012|NCT00718159|54625820|FG000|Overall Study|Progressive Disease|3|||
27968013|NCT00718159|54625821|FG001|Overall Study|Progressive Disease|3|||
27968014|NCT00718159|54625822|FG002|Overall Study|Progressive Disease|2|||
27968015|NCT00718159|54625823|FG003|Overall Study|Progressive Disease|0|||
27968016|NCT00718159|54625824|FG004|Overall Study|Progressive Disease|6|||
27968017|NCT00718159|54625825|FG005|Overall Study|Progressive Disease|0|||
27968018|NCT00718159|54625826|FG006|Overall Study|Progressive Disease|0|||
27968019|NCT00718159|54625820|FG000|Overall Study|Death due to Adverse Event|0|||
27968020|NCT00718159|54625821|FG001|Overall Study|Death due to Adverse Event|0|||
27968021|NCT00718159|54625822|FG002|Overall Study|Death due to Adverse Event|0|||
27968022|NCT00718159|54625823|FG003|Overall Study|Death due to Adverse Event|2|||
27968023|NCT00718159|54625824|FG004|Overall Study|Death due to Adverse Event|2|||
27968024|NCT00718159|54625825|FG005|Overall Study|Death due to Adverse Event|0|||
27968025|NCT00718159|54625826|FG006|Overall Study|Death due to Adverse Event|0|||
27968026|NCT00718159|54625820|FG000|Overall Study|Death due to Study Drug Toxicity|0|||
27968027|NCT00718159|54625821|FG001|Overall Study|Death due to Study Drug Toxicity|0|||
27968028|NCT00718159|54625822|FG002|Overall Study|Death due to Study Drug Toxicity|1|||
27968029|NCT00718159|54625823|FG003|Overall Study|Death due to Study Drug Toxicity|2|||
27968030|NCT00718159|54625824|FG004|Overall Study|Death due to Study Drug Toxicity|0|||
27968031|NCT00718159|54625825|FG005|Overall Study|Death due to Study Drug Toxicity|0|||
27968032|NCT00718159|54625826|FG006|Overall Study|Death due to Study Drug Toxicity|0|||
27968033|NCT00718159|54625820|FG000|Overall Study|Investigator Decision|0|||
27968034|NCT00718159|54625821|FG001|Overall Study|Investigator Decision|0|||
27968035|NCT00718159|54625822|FG002|Overall Study|Investigator Decision|0|||
27968036|NCT00718159|54625823|FG003|Overall Study|Investigator Decision|0|||
27968037|NCT00718159|54625824|FG004|Overall Study|Investigator Decision|0|||
27968038|NCT00718159|54625825|FG005|Overall Study|Investigator Decision|1|||
27968039|NCT00718159|54625826|FG006|Overall Study|Investigator Decision|1|||
27968040|NCT00718081|54625845|FG000|Overall Study|Adverse Event|0|||
27968041|NCT00718081|54625846|FG001|Overall Study|Adverse Event|1|||
28083874|NCT00048074|54737417|FG001|Overall Study|Out of station|1|||
27968042|NCT00718081|54625847|FG002|Overall Study|Adverse Event|0|||
27968043|NCT00718081|54625845|FG000|Overall Study|Lack of Efficacy|7|||
27968044|NCT00718081|54625846|FG001|Overall Study|Lack of Efficacy|3|||
27968045|NCT00718081|54625847|FG002|Overall Study|Lack of Efficacy|21|||
27968046|NCT00788710|54625858|FG000|Overall Study|Adverse Event|1|||
27968047|NCT00788710|54625859|FG001|Overall Study|Adverse Event|3|||
27968048|NCT00788710|54625860|FG002|Overall Study|Adverse Event|4|||
27968049|NCT00788710|54625858|FG000|Overall Study|Lack of Efficacy|0|||
27968050|NCT00788710|54625859|FG001|Overall Study|Lack of Efficacy|0|||
27968051|NCT00788710|54625860|FG002|Overall Study|Lack of Efficacy|1|||
27968052|NCT00788710|54625858|FG000|Overall Study|Lost to Follow-up|0|||
27968053|NCT00788710|54625859|FG001|Overall Study|Lost to Follow-up|1|||
27968054|NCT00788710|54625860|FG002|Overall Study|Lost to Follow-up|0|||
27968055|NCT00788710|54625858|FG000|Overall Study|Physician Decision|2|||
27968056|NCT00788710|54625859|FG001|Overall Study|Physician Decision|1|||
27968057|NCT00788710|54625860|FG002|Overall Study|Physician Decision|0|||
27968058|NCT00788710|54625858|FG000|Overall Study|Protocol Violation|0|||
27968059|NCT00788710|54625859|FG001|Overall Study|Protocol Violation|1|||
27968060|NCT00788710|54625860|FG002|Overall Study|Protocol Violation|1|||
27968061|NCT00788710|54625858|FG000|Overall Study|Withdrawal by Subject|2|||
27968062|NCT00788710|54625859|FG001|Overall Study|Withdrawal by Subject|2|||
27968063|NCT00788710|54625860|FG002|Overall Study|Withdrawal by Subject|0|||
27968064|NCT00787930|54625868|FG000|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3|||
27968065|NCT00588094|54625878|FG000|Overall Study|Adverse Event|3|||
27968066|NCT00588094|54625878|FG000|Overall Study|Progression of Disease|2|||
27968067|NCT03373383|54625887|FG000|Treatment Period: Wk0-16|Adverse Event|7|||
27968068|NCT03373383|54625888|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
27968069|NCT03373383|54625889|FG002|Treatment Period: Wk0-16|Adverse Event|11|||
27968070|NCT03373383|54625890|FG003|Treatment Period: Wk0-16|Adverse Event|15|||
27968071|NCT03373383|54625891|FG004|Treatment Period: Wk0-16|Adverse Event|21|||
27968072|NCT03373383|54625887|FG000|Treatment Period: Wk0-16|Lack of Efficacy|2|||
27968073|NCT03373383|54625888|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
27968074|NCT03373383|54625889|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
27968075|NCT03373383|54625890|FG003|Treatment Period: Wk0-16|Lack of Efficacy|0|||
27968076|NCT03373383|54625891|FG004|Treatment Period: Wk0-16|Lack of Efficacy|0|||
27968077|NCT03373383|54625887|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
27968078|NCT03373383|54625888|FG001|Treatment Period: Wk0-16|Protocol Violation|4|||
27968079|NCT03373383|54625889|FG002|Treatment Period: Wk0-16|Protocol Violation|2|||
27968080|NCT03373383|54625890|FG003|Treatment Period: Wk0-16|Protocol Violation|1|||
27968081|NCT03373383|54625891|FG004|Treatment Period: Wk0-16|Protocol Violation|0|||
27968082|NCT03373383|54625887|FG000|Treatment Period: Wk0-16|Lost to Follow-up|2|||
27968083|NCT03373383|54625888|FG001|Treatment Period: Wk0-16|Lost to Follow-up|0|||
27968084|NCT03373383|54625889|FG002|Treatment Period: Wk0-16|Lost to Follow-up|0|||
27968085|NCT03373383|54625890|FG003|Treatment Period: Wk0-16|Lost to Follow-up|0|||
27968086|NCT03373383|54625891|FG004|Treatment Period: Wk0-16|Lost to Follow-up|0|||
27968087|NCT03373383|54625887|FG000|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
27968088|NCT03373383|54625888|FG001|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
27968089|NCT03373383|54625889|FG002|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
27968090|NCT03373383|54625890|FG003|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
27968091|NCT03373383|54625891|FG004|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
27968092|NCT03373383|54625887|FG000|Treatment Period: Wk0-16|As advised by the sponsor|0|||
27968093|NCT03373383|54625888|FG001|Treatment Period: Wk0-16|As advised by the sponsor|1|||
27968094|NCT03373383|54625889|FG002|Treatment Period: Wk0-16|As advised by the sponsor|0|||
27968095|NCT03373383|54625890|FG003|Treatment Period: Wk0-16|As advised by the sponsor|0|||
27968096|NCT03373383|54625891|FG004|Treatment Period: Wk0-16|As advised by the sponsor|0|||
27968097|NCT03373383|54625887|FG000|Treatment Period: Wk0-16|By opinion of investigator|0|||
27968098|NCT03373383|54625888|FG001|Treatment Period: Wk0-16|By opinion of investigator|0|||
27968099|NCT03373383|54625889|FG002|Treatment Period: Wk0-16|By opinion of investigator|0|||
27968100|NCT03373383|54625890|FG003|Treatment Period: Wk0-16|By opinion of investigator|1|||
27968101|NCT03373383|54625891|FG004|Treatment Period: Wk0-16|By opinion of investigator|0|||
27968102|NCT03373383|54625887|FG000|Treatment Period: Wk0-16|Sponsor decision|0|||
27732787|NCT02561078|54180459|FG000|Overall Study|Withdrawal by Subject|13|||
27832541|NCT01759511|54311970|FG000|Overall Study|Progressive Disease|5|||
27968103|NCT03373383|54625888|FG001|Treatment Period: Wk0-16|Sponsor decision|0|||
27968104|NCT03373383|54625889|FG002|Treatment Period: Wk0-16|Sponsor decision|0|||
27968105|NCT03373383|54625890|FG003|Treatment Period: Wk0-16|Sponsor decision|1|||
27968106|NCT03373383|54625891|FG004|Treatment Period: Wk0-16|Sponsor decision|0|||
27968107|NCT03373383|54625887|FG000|Post-Treatment Period: Wk16-23|Participant decided not to roll over|1|||
27968108|NCT03373383|54625888|FG001|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
27968109|NCT03373383|54625889|FG002|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
27968110|NCT03373383|54625890|FG003|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
27968111|NCT03373383|54625891|FG004|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
27968112|NCT00784654|54625918|FG000|Open-Label Period (Non-Randomized)|Adverse Event|44|||
27968113|NCT00784654|54625919|FG001|Open-Label Period (Non-Randomized)|Adverse Event|0|||
27968114|NCT00784654|54625920|FG002|Open-Label Period (Non-Randomized)|Adverse Event|0|||
27968115|NCT00784654|54625918|FG000|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22|||
27968116|NCT00784654|54625919|FG001|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
27968117|NCT00784654|54625920|FG002|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
27968118|NCT00784654|54625918|FG000|Open-Label Period (Non-Randomized)|Lack of Efficacy|21|||
27968119|NCT00784654|54625919|FG001|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
27968120|NCT00784654|54625920|FG002|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
27968121|NCT00784654|54625918|FG000|Open-Label Period (Non-Randomized)|Lost to Follow-up|11|||
27968122|NCT00784654|54625919|FG001|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
27968123|NCT00784654|54625920|FG002|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
27968124|NCT00784654|54625918|FG000|Open-Label Period (Non-Randomized)|Protocol Violation|7|||
27968125|NCT00784654|54625919|FG001|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
27968126|NCT00784654|54625920|FG002|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
27968127|NCT00784654|54625918|FG000|Open-Label Period (Non-Randomized)|Mother is a drug addict|1|||
27968128|NCT00784654|54625919|FG001|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
27968129|NCT00784654|54625920|FG002|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
27968130|NCT00784654|54625918|FG000|Open-Label Period (Non-Randomized)|Decision of medical monitor|1|||
27968131|NCT00784654|54625919|FG001|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
27968132|NCT00784654|54625920|FG002|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
27968133|NCT00784654|54625918|FG000|Open-Label Period (Non-Randomized)|Home situation intolerable|1|||
27968134|NCT00784654|54625919|FG001|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
27968135|NCT00784654|54625920|FG002|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
27968136|NCT00784654|54625918|FG000|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1|||
27968137|NCT00784654|54625919|FG001|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
27968138|NCT00784654|54625920|FG002|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
27968139|NCT00784654|54625918|FG000|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1|||
27968140|NCT00784654|54625919|FG001|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
27968141|NCT00784654|54625920|FG002|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
27968142|NCT00784654|54625918|FG000|Open-Label Period (Non-Randomized)|Did not provide end of study page|1|||
27968143|NCT00784654|54625919|FG001|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
27968144|NCT00784654|54625920|FG002|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
27968145|NCT00784654|54625918|FG000|Randomized Withdrawal Period|Met relapse criteria per investigator|0|||
27968146|NCT00784654|54625919|FG001|Randomized Withdrawal Period|Met relapse criteria per investigator|8|||
27968147|NCT00784654|54625920|FG002|Randomized Withdrawal Period|Met relapse criteria per investigator|35|||
27968148|NCT00784654|54625918|FG000|Randomized Withdrawal Period|Lack of Efficacy|0|||
27968149|NCT00784654|54625919|FG001|Randomized Withdrawal Period|Lack of Efficacy|5|||
27968150|NCT00784654|54625920|FG002|Randomized Withdrawal Period|Lack of Efficacy|18|||
27968151|NCT00784654|54625918|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
27968152|NCT00784654|54625919|FG001|Randomized Withdrawal Period|Withdrawal by Subject|1|||
27968153|NCT00784654|54625920|FG002|Randomized Withdrawal Period|Withdrawal by Subject|7|||
27968154|NCT00784654|54625918|FG000|Randomized Withdrawal Period|Protocol Violation|0|||
27968155|NCT00784654|54625919|FG001|Randomized Withdrawal Period|Protocol Violation|2|||
27968156|NCT00784654|54625920|FG002|Randomized Withdrawal Period|Protocol Violation|1|||
27968157|NCT00784654|54625918|FG000|Randomized Withdrawal Period|Adverse Event|0|||
27968158|NCT00784654|54625919|FG001|Randomized Withdrawal Period|Adverse Event|1|||
27968159|NCT00784654|54625920|FG002|Randomized Withdrawal Period|Adverse Event|1|||
27968160|NCT00784654|54625918|FG000|Randomized Withdrawal Period|Did not complete a visit|0|||
27968161|NCT00784654|54625919|FG001|Randomized Withdrawal Period|Did not complete a visit|1|||
27968162|NCT00784654|54625920|FG002|Randomized Withdrawal Period|Did not complete a visit|0|||
27968163|NCT00784654|54625918|FG000|Randomized Withdrawal Period|Family reasons|0|||
27968164|NCT00784654|54625919|FG001|Randomized Withdrawal Period|Family reasons|0|||
27968165|NCT00784654|54625920|FG002|Randomized Withdrawal Period|Family reasons|1|||
27968166|NCT00787150|54625934|FG000|Overall Study|Adverse Event|4|||
27968167|NCT00787150|54625935|FG001|Overall Study|Adverse Event|4|||
27968168|NCT00787150|54625936|FG002|Overall Study|Adverse Event|4|||
27968169|NCT00787150|54625934|FG000|Overall Study|Physician Decision|1|||
27968170|NCT00787150|54625935|FG001|Overall Study|Physician Decision|2|||
27968171|NCT00787150|54625936|FG002|Overall Study|Physician Decision|1|||
27968172|NCT00787150|54625934|FG000|Overall Study|Withdrawal by Subject|2|||
27968173|NCT00787150|54625935|FG001|Overall Study|Withdrawal by Subject|1|||
27968174|NCT00787150|54625936|FG002|Overall Study|Withdrawal by Subject|0|||
27732788|NCT02561078|54180460|FG001|Overall Study|Withdrawal by Subject|10|||
27732789|NCT02567552|54180468|FG000|Overall Study|Adverse Event|0|||
27732790|NCT02567552|54180469|FG001|Overall Study|Adverse Event|1|||
27968175|NCT00787150|54625934|FG000|Overall Study|Dosing incorrect study durg|2|||
27968176|NCT00787150|54625935|FG001|Overall Study|Dosing incorrect study durg|0|||
27968177|NCT00787150|54625936|FG002|Overall Study|Dosing incorrect study durg|0|||
27968178|NCT00786838|54625946|FG000|Overall Study|Physician Decision|4|||
27968179|NCT00786838|54625946|FG000|Overall Study|Death|4|||
27968180|NCT00786838|54625946|FG000|Overall Study|Adverse Event|6|||
27968181|NCT00786838|54625946|FG000|Overall Study|Progressive disease|31|||
27968182|NCT00786838|54625946|FG000|Overall Study|Withdrawal by Subject|4|||
27968183|NCT00785980|54625955|FG000|7 Day Washout Period|Protocol Violation|3|||
27968184|NCT00791518|54625962|FG000|Overall Study|Protocol Violation|93|||
27968185|NCT00785512|54625983|FG000|Overall Study|Inclusion/Exclusion not meet|0|||
27968186|NCT00785512|54625984|FG001|Overall Study|Inclusion/Exclusion not meet|0|||
27968187|NCT00785512|54625983|FG000|Overall Study|Adverse Event|0|||
27968188|NCT00785512|54625984|FG001|Overall Study|Adverse Event|0|||
27968189|NCT00785512|54625983|FG000|Overall Study|Lack of Efficacy|0|||
27968190|NCT00785512|54625984|FG001|Overall Study|Lack of Efficacy|2|||
27968191|NCT00785512|54625983|FG000|Overall Study|Withdrawal by Subject|0|||
27968192|NCT00785512|54625984|FG001|Overall Study|Withdrawal by Subject|1|||
27968193|NCT00785512|54625983|FG000|Overall Study|Lost to Follow-up|3|||
27968194|NCT00785512|54625984|FG001|Overall Study|Lost to Follow-up|0|||
27968195|NCT00785512|54625983|FG000|Overall Study|Precedure Refused|0|||
27968196|NCT00785512|54625984|FG001|Overall Study|Precedure Refused|0|||
27968197|NCT00785512|54625983|FG000|Overall Study|IVRS Programing Error|0|||
27968198|NCT00785512|54625984|FG001|Overall Study|IVRS Programing Error|0|||
27968199|NCT00785512|54625983|FG000|Overall Study|Physician Decision|0|||
27968200|NCT00785512|54625984|FG001|Overall Study|Physician Decision|0|||
27968201|NCT00785512|54625983|FG000|Overall Study|Lack of compliance|0|||
27968202|NCT00785512|54625984|FG001|Overall Study|Lack of compliance|1|||
27968203|NCT00785356|54625994|FG000|Overall Study|Study prematurely terminated|8|||
27968204|NCT00785044|54626002|FG000|Overall Study|Dosed at non-participating sites|152|||
27968205|NCT00785044|54626002|FG000|Overall Study|Death|77|||
27968206|NCT00785044|54626002|FG000|Overall Study|Lost to Follow-up|266|||
27968207|NCT00785044|54626002|FG000|Overall Study|Withdrawal by Subject|1|||
27968208|NCT00784810|54626009|FG000|Overall Study|Adverse Event|32|||
27968209|NCT00784810|54626010|FG001|Overall Study|Adverse Event|20|||
27968210|NCT00784810|54626009|FG000|Overall Study|Lack of Efficacy|14|||
27968211|NCT00784810|54626010|FG001|Overall Study|Lack of Efficacy|11|||
27968212|NCT00784810|54626009|FG000|Overall Study|Withdrawal by Subject|11|||
27968213|NCT00784810|54626010|FG001|Overall Study|Withdrawal by Subject|9|||
27968214|NCT00784810|54626009|FG000|Overall Study|Administrative|5|||
27968215|NCT00784810|54626010|FG001|Overall Study|Administrative|8|||
27968216|NCT00784810|54626009|FG000|Overall Study|Lost to Follow-up|1|||
27968217|NCT00784810|54626010|FG001|Overall Study|Lost to Follow-up|1|||
27968218|NCT00791128|54626016|FG000|Overall Study|Adverse Event|4|||
27968219|NCT00791128|54626016|FG000|Overall Study|Device migration|2|||
27968220|NCT00791128|54626016|FG000|Overall Study|non-compliance by subject|2|||
27968221|NCT00791128|54626016|FG000|Overall Study|abdominal tumor, unrelated to device|1|||
27968222|NCT00776230|54626036|FG000|Overall Study|Lost to Follow-up|2|||
27968223|NCT00776230|54626037|FG001|Overall Study|Lost to Follow-up|1|||
27968224|NCT00776230|54626038|FG002|Overall Study|Lost to Follow-up|5|||
27968225|NCT00776230|54626036|FG000|Overall Study|Not vaccinated at Day 0|1|||
27968226|NCT00776230|54626037|FG001|Overall Study|Not vaccinated at Day 0|0|||
27968227|NCT00776230|54626038|FG002|Overall Study|Not vaccinated at Day 0|0|||
27968228|NCT00776230|54626036|FG000|Overall Study|Withdrawal by Subject|0|||
27968229|NCT00776230|54626037|FG001|Overall Study|Withdrawal by Subject|1|||
27968230|NCT00776230|54626038|FG002|Overall Study|Withdrawal by Subject|0|||
27968231|NCT00776230|54626036|FG000|Overall Study|Subject missed Visit 4|0|||
27968232|NCT00776230|54626037|FG001|Overall Study|Subject missed Visit 4|1|||
27968233|NCT00776230|54626038|FG002|Overall Study|Subject missed Visit 4|0|||
27968234|NCT00775606|54626048|FG000|Overall Study|Study sponsor terminated funding|3|||
27968235|NCT00775606|54626049|FG001|Overall Study|Study sponsor terminated funding|0|||
27968236|NCT02960763|54626068|FG000|Step 1|Withdrawal by Subject|10|||
28083875|NCT00048074|54737418|FG002|Overall Study|Out of station|1|||
28083876|NCT00048074|54737416|FG000|Overall Study|Social reasons|1|||
28083877|NCT00048074|54737417|FG001|Overall Study|Social reasons|0|||
28083878|NCT00048074|54737418|FG002|Overall Study|Social reasons|0|||
28083879|NCT03831191|54737430|FG000|Induction Period (16 Weeks)|Adverse Event|2|||
28083880|NCT03831191|54737431|FG001|Induction Period (16 Weeks)|Adverse Event|1|||
28083881|NCT03831191|54737432|FG002|Induction Period (16 Weeks)|Adverse Event|3|||
28083882|NCT03831191|54737433|FG003|Induction Period (16 Weeks)|Adverse Event|4|||
28083883|NCT03831191|54737434|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
28083884|NCT03831191|54737435|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
27968237|NCT02960763|54626069|FG001|Step 1|Withdrawal by Subject|8|||
28083885|NCT03831191|54737436|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
27968238|NCT02960763|54626070|FG002|Step 1|Withdrawal by Subject|13|||
27968239|NCT02960763|54626071|FG003|Step 1|Withdrawal by Subject|0|||
28083886|NCT03831191|54737437|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
28083887|NCT03831191|54737438|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
27968240|NCT02960763|54626072|FG004|Step 1|Withdrawal by Subject|0|||
27968241|NCT02960763|54626068|FG000|Step 1|Lost to Follow-up|7|||
27968242|NCT02960763|54626069|FG001|Step 1|Lost to Follow-up|9|||
27968243|NCT02960763|54626070|FG002|Step 1|Lost to Follow-up|12|||
27968244|NCT02960763|54626071|FG003|Step 1|Lost to Follow-up|0|||
27968245|NCT02960763|54626072|FG004|Step 1|Lost to Follow-up|0|||
27968246|NCT02960763|54626068|FG000|Step 1|Death|1|||
27968247|NCT02960763|54626069|FG001|Step 1|Death|1|||
27968248|NCT02960763|54626070|FG002|Step 1|Death|1|||
27968249|NCT02960763|54626071|FG003|Step 1|Death|0|||
27968250|NCT02960763|54626072|FG004|Step 1|Death|0|||
27968251|NCT02960763|54626068|FG000|Step 1|Investigator discretion|1|||
27968252|NCT02960763|54626069|FG001|Step 1|Investigator discretion|0|||
27968253|NCT02960763|54626070|FG002|Step 1|Investigator discretion|1|||
27968254|NCT02960763|54626071|FG003|Step 1|Investigator discretion|0|||
27968255|NCT02960763|54626072|FG004|Step 1|Investigator discretion|0|||
27968256|NCT02960763|54626068|FG000|Step 1|Other|0|||
27968257|NCT02960763|54626069|FG001|Step 1|Other|0|||
27968258|NCT02960763|54626070|FG002|Step 1|Other|1|||
27968259|NCT02960763|54626071|FG003|Step 1|Other|0|||
27968260|NCT02960763|54626072|FG004|Step 1|Other|0|||
27968261|NCT02960763|54626068|FG000|Step 2|Withdrawal by Subject|0|||
27968262|NCT02960763|54626069|FG001|Step 2|Withdrawal by Subject|0|||
27968263|NCT02960763|54626070|FG002|Step 2|Withdrawal by Subject|0|||
27968264|NCT02960763|54626071|FG003|Step 2|Withdrawal by Subject|7|||
27968265|NCT02960763|54626072|FG004|Step 2|Withdrawal by Subject|3|||
27968266|NCT02960763|54626068|FG000|Step 2|Lost to Follow-up|0|||
27968267|NCT02960763|54626069|FG001|Step 2|Lost to Follow-up|0|||
27968268|NCT02960763|54626070|FG002|Step 2|Lost to Follow-up|0|||
27968269|NCT02960763|54626071|FG003|Step 2|Lost to Follow-up|4|||
27968270|NCT02960763|54626072|FG004|Step 2|Lost to Follow-up|1|||
27968271|NCT02960763|54626068|FG000|Step 2|Investigator discretion|0|||
27968272|NCT02960763|54626069|FG001|Step 2|Investigator discretion|0|||
27968273|NCT02960763|54626070|FG002|Step 2|Investigator discretion|0|||
27968274|NCT02960763|54626071|FG003|Step 2|Investigator discretion|0|||
27968275|NCT02960763|54626072|FG004|Step 2|Investigator discretion|1|||
27968276|NCT00775528|54626084|FG000|Overall Study|Protocol Violation|1|||
27968277|NCT00775450|54626093|FG000|Overall Study|Serious Adverse Event|2|||
27968278|NCT00775450|54626094|FG001|Overall Study|Serious Adverse Event|0|||
27968279|NCT00775450|54626095|FG002|Overall Study|Serious Adverse Event|0|||
27968280|NCT00775450|54626096|FG003|Overall Study|Serious Adverse Event|0|||
27968281|NCT00775450|54626097|FG004|Overall Study|Serious Adverse Event|0|||
27968282|NCT00775450|54626093|FG000|Overall Study|Protocol Violation|0|||
27968283|NCT00775450|54626094|FG001|Overall Study|Protocol Violation|0|||
27968284|NCT00775450|54626095|FG002|Overall Study|Protocol Violation|0|||
27968285|NCT00775450|54626096|FG003|Overall Study|Protocol Violation|0|||
27968286|NCT00775450|54626097|FG004|Overall Study|Protocol Violation|1|||
27968287|NCT00775450|54626093|FG000|Overall Study|Withdrawal by Subject|1|||
27968288|NCT00775450|54626094|FG001|Overall Study|Withdrawal by Subject|0|||
27968289|NCT00775450|54626095|FG002|Overall Study|Withdrawal by Subject|0|||
27968290|NCT00775450|54626096|FG003|Overall Study|Withdrawal by Subject|0|||
27968291|NCT00775450|54626097|FG004|Overall Study|Withdrawal by Subject|1|||
27968292|NCT00775138|54626113|FG000|Overall Study|Withdrawal by Subject|0|||
27968293|NCT00775138|54626114|FG001|Overall Study|Withdrawal by Subject|0|||
27968294|NCT00775138|54626115|FG002|Overall Study|Withdrawal by Subject|2|||
27968295|NCT00775138|54626116|FG003|Overall Study|Withdrawal by Subject|2|||
27968296|NCT00775138|54626113|FG000|Overall Study|Adverse Event|0|||
27968297|NCT00775138|54626114|FG001|Overall Study|Adverse Event|0|||
27968298|NCT00775138|54626115|FG002|Overall Study|Adverse Event|1|||
27968299|NCT00775138|54626116|FG003|Overall Study|Adverse Event|0|||
27968300|NCT04605991|54626128|FG000|Overall Study|Adverse Event|5|||
27968301|NCT04605991|54626128|FG000|Overall Study|Lack of Efficacy|1|||
27968302|NCT04605991|54626128|FG000|Overall Study|Lost to Follow-up|8|||
27968303|NCT04605991|54626128|FG000|Overall Study|Physician Decision|4|||
27968304|NCT04605991|54626128|FG000|Overall Study|Withdrawal by Subject|14|||
27968305|NCT04605991|54626128|FG000|Overall Study|Non-compliance with study|1|||
27968306|NCT00783796|54626132|FG000|Overall Study|Did not receive any stent|4|||
27968307|NCT00783796|54626132|FG000|Overall Study|Received non-XIENCE V stent|1|||
28083888|NCT03831191|54737439|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
27968308|NCT00783796|54626132|FG000|Overall Study|Received commercial XIENCE V stent|1|||
27968309|NCT00783718|54626141|FG000|Induction Phase|Adverse Event|4|||
27968310|NCT00783718|54626142|FG001|Induction Phase|Adverse Event|0|||
27968311|NCT00783718|54626143|FG002|Induction Phase|Adverse Event|7|||
27968312|NCT00783718|54626144|FG003|Induction Phase|Adverse Event|0|||
27968313|NCT00783718|54626145|FG004|Induction Phase|Adverse Event|0|||
27968314|NCT00783718|54626146|FG005|Induction Phase|Adverse Event|0|||
27968315|NCT00783718|54626147|FG006|Induction Phase|Adverse Event|0|||
27968316|NCT00783718|54626141|FG000|Induction Phase|Protocol Violation|1|||
27968317|NCT00783718|54626142|FG001|Induction Phase|Protocol Violation|1|||
27968318|NCT00783718|54626143|FG002|Induction Phase|Protocol Violation|6|||
28083889|NCT03831191|54737440|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
27968319|NCT00783718|54626144|FG003|Induction Phase|Protocol Violation|0|||
27968320|NCT00783718|54626145|FG004|Induction Phase|Protocol Violation|0|||
27968321|NCT00783718|54626146|FG005|Induction Phase|Protocol Violation|0|||
27968322|NCT00783718|54626147|FG006|Induction Phase|Protocol Violation|0|||
27968323|NCT00783718|54626141|FG000|Induction Phase|Lack of Efficacy|5|||
27968324|NCT00783718|54626142|FG001|Induction Phase|Lack of Efficacy|2|||
27968325|NCT00783718|54626143|FG002|Induction Phase|Lack of Efficacy|14|||
27968326|NCT00783718|54626144|FG003|Induction Phase|Lack of Efficacy|0|||
27732791|NCT02561000|54180483|FG000|Overall Study|Withdrawal by Subject|2|||
27968327|NCT00783718|54626145|FG004|Induction Phase|Lack of Efficacy|0|||
28083890|NCT03831191|54737441|FG011|Induction Period (16 Weeks)|Adverse Event|0|||
27732792|NCT02561000|54180484|FG001|Overall Study|Withdrawal by Subject|3|||
27732793|NCT02561000|54180485|FG002|Overall Study|Withdrawal by Subject|0|||
27968328|NCT00783718|54626146|FG005|Induction Phase|Lack of Efficacy|0|||
27968329|NCT00783718|54626147|FG006|Induction Phase|Lack of Efficacy|0|||
27968330|NCT00783718|54626141|FG000|Induction Phase|Withdrawal by Subject|3|||
27968331|NCT00783718|54626142|FG001|Induction Phase|Withdrawal by Subject|4|||
27968332|NCT00783718|54626143|FG002|Induction Phase|Withdrawal by Subject|8|||
27968333|NCT00783718|54626144|FG003|Induction Phase|Withdrawal by Subject|0|||
27968334|NCT00783718|54626145|FG004|Induction Phase|Withdrawal by Subject|0|||
27968335|NCT00783718|54626146|FG005|Induction Phase|Withdrawal by Subject|0|||
27968336|NCT00783718|54626147|FG006|Induction Phase|Withdrawal by Subject|0|||
27968337|NCT00783718|54626141|FG000|Induction Phase|Lost to Follow-up|1|||
27968338|NCT00783718|54626142|FG001|Induction Phase|Lost to Follow-up|0|||
27968339|NCT00783718|54626143|FG002|Induction Phase|Lost to Follow-up|1|||
27968340|NCT00783718|54626144|FG003|Induction Phase|Lost to Follow-up|0|||
27968341|NCT00783718|54626145|FG004|Induction Phase|Lost to Follow-up|0|||
27968342|NCT00783718|54626146|FG005|Induction Phase|Lost to Follow-up|0|||
27968343|NCT00783718|54626147|FG006|Induction Phase|Lost to Follow-up|0|||
27968344|NCT00783718|54626141|FG000|Maintenance Phase|Adverse Event|12|||
27968345|NCT00783718|54626142|FG001|Maintenance Phase|Adverse Event|0|||
27968346|NCT00783718|54626143|FG002|Maintenance Phase|Adverse Event|0|||
27968347|NCT00783718|54626144|FG003|Maintenance Phase|Adverse Event|15|||
27968348|NCT00783718|54626145|FG004|Maintenance Phase|Adverse Event|7|||
27968349|NCT00783718|54626146|FG005|Maintenance Phase|Adverse Event|6|||
27968350|NCT00783718|54626147|FG006|Maintenance Phase|Adverse Event|16|||
27968351|NCT00783718|54626141|FG000|Maintenance Phase|Protocol Violation|1|||
27968352|NCT00783718|54626142|FG001|Maintenance Phase|Protocol Violation|0|||
27968353|NCT00783718|54626143|FG002|Maintenance Phase|Protocol Violation|0|||
27968354|NCT00783718|54626144|FG003|Maintenance Phase|Protocol Violation|0|||
27968355|NCT00783718|54626145|FG004|Maintenance Phase|Protocol Violation|0|||
27968356|NCT00783718|54626146|FG005|Maintenance Phase|Protocol Violation|0|||
27968357|NCT00783718|54626147|FG006|Maintenance Phase|Protocol Violation|2|||
27968358|NCT00783718|54626141|FG000|Maintenance Phase|Lack of Efficacy|83|||
27968359|NCT00783718|54626142|FG001|Maintenance Phase|Lack of Efficacy|0|||
27968360|NCT00783718|54626143|FG002|Maintenance Phase|Lack of Efficacy|0|||
27968361|NCT00783718|54626144|FG003|Maintenance Phase|Lack of Efficacy|61|||
27968362|NCT00783718|54626145|FG004|Maintenance Phase|Lack of Efficacy|31|||
27968363|NCT00783718|54626146|FG005|Maintenance Phase|Lack of Efficacy|33|||
27968364|NCT00783718|54626147|FG006|Maintenance Phase|Lack of Efficacy|155|||
27968365|NCT00783718|54626141|FG000|Maintenance Phase|Withdrawal by Subject|6|||
27968366|NCT00783718|54626142|FG001|Maintenance Phase|Withdrawal by Subject|0|||
27968367|NCT00783718|54626143|FG002|Maintenance Phase|Withdrawal by Subject|0|||
27968368|NCT00783718|54626144|FG003|Maintenance Phase|Withdrawal by Subject|2|||
27968369|NCT00783718|54626145|FG004|Maintenance Phase|Withdrawal by Subject|5|||
27968370|NCT00783718|54626146|FG005|Maintenance Phase|Withdrawal by Subject|2|||
27968371|NCT00783718|54626147|FG006|Maintenance Phase|Withdrawal by Subject|20|||
27968372|NCT00783718|54626141|FG000|Maintenance Phase|Lost to Follow-up|3|||
27968373|NCT00783718|54626142|FG001|Maintenance Phase|Lost to Follow-up|0|||
28083891|NCT03831191|54737442|FG012|Induction Period (16 Weeks)|Adverse Event|0|||
28083892|NCT03831191|54737443|FG013|Induction Period (16 Weeks)|Adverse Event|0|||
28083893|NCT03831191|54737444|FG014|Induction Period (16 Weeks)|Adverse Event|0|||
28083894|NCT03831191|54737430|FG000|Induction Period (16 Weeks)|Lack of Efficacy|2|||
28083895|NCT03831191|54737431|FG001|Induction Period (16 Weeks)|Lack of Efficacy|3|||
27732794|NCT02561000|54180483|FG000|Overall Study|Adverse Event|0|||
27968374|NCT00783718|54626143|FG002|Maintenance Phase|Lost to Follow-up|0|||
27968375|NCT00783718|54626144|FG003|Maintenance Phase|Lost to Follow-up|0|||
27968376|NCT00783718|54626145|FG004|Maintenance Phase|Lost to Follow-up|2|||
27968377|NCT00783718|54626146|FG005|Maintenance Phase|Lost to Follow-up|0|||
27968378|NCT00783718|54626147|FG006|Maintenance Phase|Lost to Follow-up|2|||
27968379|NCT00774748|54626166|FG000|Overall Study|Lost to Follow-up|3|||
27968380|NCT00587860|54626176|FG000|Overall Study|Lost to Follow-up|2|||
27968381|NCT00587860|54626177|FG001|Overall Study|Lost to Follow-up|2|||
27968382|NCT00587860|54626176|FG000|Overall Study|Withdrawal by Subject|3|||
28083896|NCT03831191|54737432|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
28083897|NCT03831191|54737433|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
28083898|NCT03831191|54737434|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
27968383|NCT00587860|54626177|FG001|Overall Study|Withdrawal by Subject|3|||
27968384|NCT00583453|54626185|FG000|Overall Study|discontinued intervention|0|||
27968385|NCT00583453|54626186|FG001|Overall Study|discontinued intervention|2|||
27968386|NCT00583219|54626194|FG000|Phase 2|Withdrawal by Subject|1|||
27968387|NCT01072175|54626214|FG000|Part A (Drug-Drug Interaction)|Death|1|||
27968388|NCT01072175|54626215|FG001|Part A (Drug-Drug Interaction)|Death|0|||
27968389|NCT01072175|54626216|FG002|Part A (Drug-Drug Interaction)|Death|0|||
27968390|NCT01072175|54626217|FG003|Part A (Drug-Drug Interaction)|Death|0|||
27968391|NCT01072175|54626218|FG004|Part A (Drug-Drug Interaction)|Death|0|||
27968392|NCT01072175|54626219|FG005|Part A (Drug-Drug Interaction)|Death|0|||
27968393|NCT01072175|54626220|FG006|Part A (Drug-Drug Interaction)|Death|0|||
27968394|NCT01072175|54626221|FG007|Part A (Drug-Drug Interaction)|Death|0|||
27968395|NCT01072175|54626222|FG008|Part A (Drug-Drug Interaction)|Death|0|||
27968396|NCT01072175|54626223|FG009|Part A (Drug-Drug Interaction)|Death|0|||
27968397|NCT01072175|54626224|FG010|Part A (Drug-Drug Interaction)|Death|0|||
27968398|NCT01072175|54626225|FG011|Part A (Drug-Drug Interaction)|Death|0|||
27968399|NCT01072175|54626226|FG012|Part A (Drug-Drug Interaction)|Death|0|||
27968400|NCT01072175|54626214|FG000|Part A (Drug-Drug Interaction)|Physician Decision|6|||
27968401|NCT01072175|54626215|FG001|Part A (Drug-Drug Interaction)|Physician Decision|0|||
27968402|NCT01072175|54626216|FG002|Part A (Drug-Drug Interaction)|Physician Decision|0|||
27968403|NCT01072175|54626217|FG003|Part A (Drug-Drug Interaction)|Physician Decision|0|||
27968404|NCT01072175|54626218|FG004|Part A (Drug-Drug Interaction)|Physician Decision|0|||
27968405|NCT01072175|54626219|FG005|Part A (Drug-Drug Interaction)|Physician Decision|0|||
27968406|NCT01072175|54626220|FG006|Part A (Drug-Drug Interaction)|Physician Decision|0|||
27968407|NCT01072175|54626221|FG007|Part A (Drug-Drug Interaction)|Physician Decision|0|||
27968408|NCT01072175|54626222|FG008|Part A (Drug-Drug Interaction)|Physician Decision|0|||
27968409|NCT01072175|54626223|FG009|Part A (Drug-Drug Interaction)|Physician Decision|0|||
27732795|NCT02561000|54180484|FG001|Overall Study|Adverse Event|1|||
27732796|NCT02561000|54180485|FG002|Overall Study|Adverse Event|0|||
27732797|NCT01663532|54180495|FG000|Overall Study|Lost to Follow-up|9|||
27732798|NCT01663532|54180496|FG001|Overall Study|Lost to Follow-up|10|||
27732799|NCT01663532|54180495|FG000|Overall Study|Adverse Event|7|||
27732800|NCT01663532|54180496|FG001|Overall Study|Adverse Event|13|||
27732801|NCT01663532|54180495|FG000|Overall Study|Met Withdrawal Criteria|7|||
27732802|NCT01663532|54180496|FG001|Overall Study|Met Withdrawal Criteria|6|||
27732803|NCT01663532|54180495|FG000|Overall Study|Physician Decision|1|||
27732804|NCT01663532|54180496|FG001|Overall Study|Physician Decision|1|||
27732805|NCT01663532|54180495|FG000|Overall Study|Withdrawal by Subject|35|||
27732806|NCT01663532|54180496|FG001|Overall Study|Withdrawal by Subject|17|||
27732807|NCT01663532|54180495|FG000|Overall Study|Lack of Efficacy|15|||
27732808|NCT01663532|54180496|FG001|Overall Study|Lack of Efficacy|60|||
27855301|NCT01270841|54376452|FG002|Overall Study|Lost to Follow-up|4|||
27855302|NCT01270841|54376453|FG003|Overall Study|Lost to Follow-up|2|||
27855303|NCT01270841|54376450|FG000|Overall Study|Physician Decision|0|||
27968410|NCT01072175|54626224|FG010|Part A (Drug-Drug Interaction)|Physician Decision|0|||
27968411|NCT01072175|54626225|FG011|Part A (Drug-Drug Interaction)|Physician Decision|0|||
27968412|NCT01072175|54626226|FG012|Part A (Drug-Drug Interaction)|Physician Decision|0|||
27968413|NCT01072175|54626214|FG000|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1|||
27968414|NCT01072175|54626215|FG001|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
27968415|NCT01072175|54626216|FG002|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
27968416|NCT01072175|54626217|FG003|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
27968417|NCT01072175|54626218|FG004|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
27968418|NCT01072175|54626219|FG005|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
27968419|NCT01072175|54626220|FG006|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
27968420|NCT01072175|54626221|FG007|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
27968421|NCT01072175|54626222|FG008|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
27968422|NCT01072175|54626223|FG009|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
27968423|NCT01072175|54626224|FG010|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
27968424|NCT01072175|54626225|FG011|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
27968425|NCT01072175|54626226|FG012|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
27968426|NCT01072175|54626214|FG000|Part B (Dose Escalation and Expansion)|Death|0|||
27968427|NCT01072175|54626215|FG001|Part B (Dose Escalation and Expansion)|Death|4|||
27968428|NCT01072175|54626216|FG002|Part B (Dose Escalation and Expansion)|Death|18|||
27968429|NCT01072175|54626217|FG003|Part B (Dose Escalation and Expansion)|Death|21|||
27968430|NCT01072175|54626218|FG004|Part B (Dose Escalation and Expansion)|Death|68|||
27968431|NCT01072175|54626219|FG005|Part B (Dose Escalation and Expansion)|Death|0|||
27968432|NCT01072175|54626220|FG006|Part B (Dose Escalation and Expansion)|Death|0|||
27732809|NCT02525939|54180504|FG000|Overall Study|Lost to Follow-up|27|||
27732810|NCT02525939|54180505|FG001|Overall Study|Lost to Follow-up|24|||
27732811|NCT02525939|54180504|FG000|Overall Study|Physician Decision|0|||
27855304|NCT01270841|54376451|FG001|Overall Study|Physician Decision|1|||
27968433|NCT01072175|54626221|FG007|Part B (Dose Escalation and Expansion)|Death|0|||
27732812|NCT02525939|54180505|FG001|Overall Study|Physician Decision|1|||
27968434|NCT01072175|54626222|FG008|Part B (Dose Escalation and Expansion)|Death|0|||
27968435|NCT01072175|54626223|FG009|Part B (Dose Escalation and Expansion)|Death|0|||
27968436|NCT01072175|54626224|FG010|Part B (Dose Escalation and Expansion)|Death|0|||
27968437|NCT01072175|54626225|FG011|Part B (Dose Escalation and Expansion)|Death|0|||
27968438|NCT01072175|54626226|FG012|Part B (Dose Escalation and Expansion)|Death|0|||
27968439|NCT01072175|54626214|FG000|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
27968440|NCT01072175|54626215|FG001|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
27968441|NCT01072175|54626216|FG002|Part B (Dose Escalation and Expansion)|Physician Decision|2|||
27968442|NCT01072175|54626217|FG003|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
27968443|NCT01072175|54626218|FG004|Part B (Dose Escalation and Expansion)|Physician Decision|4|||
27968444|NCT01072175|54626219|FG005|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
27968445|NCT01072175|54626220|FG006|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
27968446|NCT01072175|54626221|FG007|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
27968447|NCT01072175|54626222|FG008|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
27968448|NCT01072175|54626223|FG009|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
27968449|NCT01072175|54626224|FG010|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
27968450|NCT01072175|54626225|FG011|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
27968451|NCT01072175|54626226|FG012|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
27855305|NCT01270841|54376452|FG002|Overall Study|Physician Decision|0|||
27855306|NCT01270841|54376453|FG003|Overall Study|Physician Decision|0|||
27855307|NCT01270841|54376450|FG000|Overall Study|Did not qualify|6|||
27855308|NCT01270841|54376451|FG001|Overall Study|Did not qualify|3|||
27855309|NCT01270841|54376452|FG002|Overall Study|Did not qualify|4|||
27855310|NCT01270841|54376453|FG003|Overall Study|Did not qualify|5|||
27855311|NCT01270841|54376450|FG000|Overall Study|Protocol Violation|1|||
27855312|NCT01270841|54376451|FG001|Overall Study|Protocol Violation|5|||
27855313|NCT01270841|54376452|FG002|Overall Study|Protocol Violation|0|||
27855314|NCT01270841|54376453|FG003|Overall Study|Protocol Violation|0|||
27855315|NCT01270841|54376450|FG000|Overall Study|Enrolled in error|0|||
27855316|NCT01270841|54376451|FG001|Overall Study|Enrolled in error|1|||
27855317|NCT01270841|54376452|FG002|Overall Study|Enrolled in error|0|||
27855318|NCT01270841|54376453|FG003|Overall Study|Enrolled in error|0|||
27855319|NCT01270139|54376466|FG000|Overall Study|Adverse Event|8|||
27855320|NCT01270139|54376467|FG001|Overall Study|Adverse Event|17|||
27855321|NCT01270139|54376468|FG002|Overall Study|Adverse Event|18|||
27855322|NCT01270139|54376466|FG000|Overall Study|Lost to Follow-up|10|||
27855323|NCT01270139|54376467|FG001|Overall Study|Lost to Follow-up|9|||
27855324|NCT01270139|54376468|FG002|Overall Study|Lost to Follow-up|2|||
27855325|NCT01278407|54376486|FG000|Confirmatory Phase|Adverse Event|5|||
27855326|NCT01278407|54376487|FG001|Confirmatory Phase|Adverse Event|10|||
27855327|NCT01278407|54376488|FG002|Confirmatory Phase|Adverse Event|1|||
27855328|NCT01278407|54376489|FG003|Confirmatory Phase|Adverse Event|0|||
27855329|NCT01278407|54376490|FG004|Confirmatory Phase|Adverse Event|0|||
27855330|NCT01278407|54376486|FG000|Confirmatory Phase|Participant's Choice|3|||
27855331|NCT01278407|54376487|FG001|Confirmatory Phase|Participant's Choice|5|||
27855332|NCT01278407|54376488|FG002|Confirmatory Phase|Participant's Choice|3|||
27855333|NCT01278407|54376489|FG003|Confirmatory Phase|Participant's Choice|0|||
27855334|NCT01278407|54376490|FG004|Confirmatory Phase|Participant's Choice|0|||
27855335|NCT01278407|54376486|FG000|Confirmatory Phase|Other|1|||
27855336|NCT01278407|54376487|FG001|Confirmatory Phase|Other|1|||
27855337|NCT01278407|54376488|FG002|Confirmatory Phase|Other|2|||
27855338|NCT01278407|54376489|FG003|Confirmatory Phase|Other|0|||
27855339|NCT01278407|54376490|FG004|Confirmatory Phase|Other|0|||
27855340|NCT01278407|54376486|FG000|Extension Phase|Adverse Event|0|||
27855341|NCT01278407|54376487|FG001|Extension Phase|Adverse Event|0|||
27855342|NCT01278407|54376488|FG002|Extension Phase|Adverse Event|0|||
27855343|NCT01278407|54376489|FG003|Extension Phase|Adverse Event|7|||
27855344|NCT01278407|54376490|FG004|Extension Phase|Adverse Event|16|||
27855345|NCT01278407|54376486|FG000|Extension Phase|Participant's Choice|0|||
27855346|NCT01278407|54376487|FG001|Extension Phase|Participant's Choice|0|||
27855347|NCT01278407|54376488|FG002|Extension Phase|Participant's Choice|0|||
27968452|NCT01072175|54626214|FG000|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
27968453|NCT01072175|54626215|FG001|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
27968454|NCT01072175|54626216|FG002|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
27855348|NCT01278407|54376489|FG003|Extension Phase|Participant's Choice|4|||
27855349|NCT01278407|54376490|FG004|Extension Phase|Participant's Choice|11|||
27855350|NCT01278407|54376486|FG000|Extension Phase|Other|0|||
27855351|NCT01278407|54376487|FG001|Extension Phase|Other|0|||
27855352|NCT01278407|54376488|FG002|Extension Phase|Other|0|||
27855353|NCT01278407|54376489|FG003|Extension Phase|Other|1|||
27855354|NCT01278407|54376490|FG004|Extension Phase|Other|3|||
27855355|NCT01278173|54376500|FG000|Overall Study|Lack of Efficacy|13|||
27855356|NCT01278173|54376500|FG000|Overall Study|Adverse Event|8|||
27855357|NCT01278173|54376500|FG000|Overall Study|Administrative or other reason|4|||
27855358|NCT01278173|54376500|FG000|Overall Study|Protocol Violation|1|||
27855359|NCT01278173|54376500|FG000|Overall Study|Withdrawal by Subject|1|||
27968455|NCT01072175|54626217|FG003|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
27968456|NCT01072175|54626218|FG004|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6|||
27968457|NCT01072175|54626219|FG005|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
27968458|NCT01072175|54626220|FG006|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
27968459|NCT01072175|54626221|FG007|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
27968460|NCT01072175|54626222|FG008|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
27968461|NCT01072175|54626223|FG009|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
27968462|NCT01072175|54626224|FG010|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
27968463|NCT01072175|54626225|FG011|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
27968464|NCT01072175|54626226|FG012|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
27968465|NCT01072175|54626214|FG000|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
27968466|NCT01072175|54626215|FG001|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
27968467|NCT01072175|54626216|FG002|Part B (Dose Escalation and Expansion)|Study closed/terminated|3|||
27968468|NCT01072175|54626217|FG003|Part B (Dose Escalation and Expansion)|Study closed/terminated|2|||
27968469|NCT01072175|54626218|FG004|Part B (Dose Escalation and Expansion)|Study closed/terminated|10|||
27968470|NCT01072175|54626219|FG005|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
27968471|NCT01072175|54626220|FG006|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
27968472|NCT01072175|54626221|FG007|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
27968473|NCT01072175|54626222|FG008|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
27968474|NCT01072175|54626223|FG009|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
27968475|NCT01072175|54626224|FG010|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
27968476|NCT01072175|54626225|FG011|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
27968477|NCT01072175|54626226|FG012|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
27968478|NCT01072175|54626214|FG000|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
27968479|NCT01072175|54626215|FG001|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1|||
27968480|NCT01072175|54626216|FG002|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
27968481|NCT01072175|54626217|FG003|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3|||
27968482|NCT01072175|54626218|FG004|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6|||
28083899|NCT03831191|54737435|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
28083900|NCT03831191|54737436|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
28083901|NCT03831191|54737437|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
28083902|NCT03831191|54737438|FG008|Induction Period (16 Weeks)|Lack of Efficacy|0|||
28083903|NCT03831191|54737439|FG009|Induction Period (16 Weeks)|Lack of Efficacy|0|||
28083904|NCT03831191|54737440|FG010|Induction Period (16 Weeks)|Lack of Efficacy|0|||
28083905|NCT03831191|54737441|FG011|Induction Period (16 Weeks)|Lack of Efficacy|0|||
28083906|NCT03831191|54737442|FG012|Induction Period (16 Weeks)|Lack of Efficacy|0|||
28083907|NCT03831191|54737443|FG013|Induction Period (16 Weeks)|Lack of Efficacy|0|||
28083908|NCT03831191|54737444|FG014|Induction Period (16 Weeks)|Lack of Efficacy|0|||
28083909|NCT03831191|54737430|FG000|Induction Period (16 Weeks)|Pregnancy|0|||
28083910|NCT03831191|54737431|FG001|Induction Period (16 Weeks)|Pregnancy|0|||
28083911|NCT03831191|54737432|FG002|Induction Period (16 Weeks)|Pregnancy|1|||
28083912|NCT03831191|54737433|FG003|Induction Period (16 Weeks)|Pregnancy|0|||
28083913|NCT03831191|54737434|FG004|Induction Period (16 Weeks)|Pregnancy|0|||
28083914|NCT03831191|54737435|FG005|Induction Period (16 Weeks)|Pregnancy|0|||
27968483|NCT01072175|54626219|FG005|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
27968484|NCT01072175|54626220|FG006|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
27968485|NCT01072175|54626221|FG007|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
27968486|NCT01072175|54626222|FG008|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
27968487|NCT01072175|54626223|FG009|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
27968488|NCT01072175|54626224|FG010|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
27968489|NCT01072175|54626225|FG011|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
27968490|NCT01072175|54626226|FG012|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
27968491|NCT01072175|54626214|FG000|Part C (Phase II: Randomized Phase)|Death|0|||
27968492|NCT01072175|54626215|FG001|Part C (Phase II: Randomized Phase)|Death|0|||
27968493|NCT01072175|54626216|FG002|Part C (Phase II: Randomized Phase)|Death|0|||
27968494|NCT01072175|54626217|FG003|Part C (Phase II: Randomized Phase)|Death|0|||
27968495|NCT01072175|54626218|FG004|Part C (Phase II: Randomized Phase)|Death|0|||
27968496|NCT01072175|54626219|FG005|Part C (Phase II: Randomized Phase)|Death|44|||
27968497|NCT01072175|54626220|FG006|Part C (Phase II: Randomized Phase)|Death|34|||
27968498|NCT01072175|54626221|FG007|Part C (Phase II: Randomized Phase)|Death|39|||
27968499|NCT01072175|54626222|FG008|Part C (Phase II: Randomized Phase)|Death|0|||
27968500|NCT01072175|54626223|FG009|Part C (Phase II: Randomized Phase)|Death|0|||
27968501|NCT01072175|54626224|FG010|Part C (Phase II: Randomized Phase)|Death|0|||
28083915|NCT03831191|54737436|FG006|Induction Period (16 Weeks)|Pregnancy|0|||
28083916|NCT03831191|54737437|FG007|Induction Period (16 Weeks)|Pregnancy|0|||
28083917|NCT03831191|54737438|FG008|Induction Period (16 Weeks)|Pregnancy|0|||
28083918|NCT03831191|54737439|FG009|Induction Period (16 Weeks)|Pregnancy|0|||
27968502|NCT01072175|54626225|FG011|Part C (Phase II: Randomized Phase)|Death|0|||
27968503|NCT01072175|54626226|FG012|Part C (Phase II: Randomized Phase)|Death|0|||
27968504|NCT01072175|54626214|FG000|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
27968505|NCT01072175|54626215|FG001|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
27968506|NCT01072175|54626216|FG002|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
27968507|NCT01072175|54626217|FG003|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
27968508|NCT01072175|54626218|FG004|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
27968509|NCT01072175|54626219|FG005|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
27968510|NCT01072175|54626220|FG006|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
27968511|NCT01072175|54626221|FG007|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
27968512|NCT01072175|54626222|FG008|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
27968513|NCT01072175|54626223|FG009|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
27968514|NCT01072175|54626224|FG010|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
27968515|NCT01072175|54626225|FG011|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
27968516|NCT01072175|54626226|FG012|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
27968517|NCT01072175|54626214|FG000|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
27968518|NCT01072175|54626215|FG001|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
27968519|NCT01072175|54626216|FG002|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
27968520|NCT01072175|54626217|FG003|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
27968521|NCT01072175|54626218|FG004|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
27968522|NCT01072175|54626219|FG005|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
27968523|NCT01072175|54626220|FG006|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
27968524|NCT01072175|54626221|FG007|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
27968525|NCT01072175|54626222|FG008|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
27968526|NCT01072175|54626223|FG009|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
27968527|NCT01072175|54626224|FG010|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
27968528|NCT01072175|54626225|FG011|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
27968529|NCT01072175|54626226|FG012|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
27968530|NCT01072175|54626214|FG000|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
27968531|NCT01072175|54626215|FG001|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
27968532|NCT01072175|54626216|FG002|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
27968533|NCT01072175|54626217|FG003|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
27968534|NCT01072175|54626218|FG004|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
27968535|NCT01072175|54626219|FG005|Part C (Phase II: Randomized Phase)|Study closed/terminated|6|||
27968536|NCT01072175|54626220|FG006|Part C (Phase II: Randomized Phase)|Study closed/terminated|9|||
27968537|NCT01072175|54626221|FG007|Part C (Phase II: Randomized Phase)|Study closed/terminated|11|||
27968538|NCT01072175|54626222|FG008|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
27968539|NCT01072175|54626223|FG009|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
27968540|NCT01072175|54626224|FG010|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
27968541|NCT01072175|54626225|FG011|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
27968542|NCT01072175|54626226|FG012|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
27968543|NCT01072175|54626214|FG000|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
27968544|NCT01072175|54626215|FG001|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
27968545|NCT01072175|54626216|FG002|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
27968546|NCT01072175|54626217|FG003|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
27968547|NCT01072175|54626218|FG004|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
27968548|NCT01072175|54626219|FG005|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3|||
27968549|NCT01072175|54626220|FG006|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7|||
27968550|NCT01072175|54626221|FG007|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
27968551|NCT01072175|54626222|FG008|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
27968552|NCT01072175|54626223|FG009|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
27968553|NCT01072175|54626224|FG010|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
27968554|NCT01072175|54626225|FG011|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
27968555|NCT01072175|54626226|FG012|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
27968556|NCT01072175|54626214|FG000|Part C (Phase II: Crossover Phase [CP])|Death|0|||
27968557|NCT01072175|54626215|FG001|Part C (Phase II: Crossover Phase [CP])|Death|0|||
27968558|NCT01072175|54626216|FG002|Part C (Phase II: Crossover Phase [CP])|Death|0|||
27968559|NCT01072175|54626217|FG003|Part C (Phase II: Crossover Phase [CP])|Death|0|||
27968560|NCT01072175|54626218|FG004|Part C (Phase II: Crossover Phase [CP])|Death|0|||
27968561|NCT01072175|54626219|FG005|Part C (Phase II: Crossover Phase [CP])|Death|0|||
27968562|NCT01072175|54626220|FG006|Part C (Phase II: Crossover Phase [CP])|Death|0|||
27968563|NCT01072175|54626221|FG007|Part C (Phase II: Crossover Phase [CP])|Death|0|||
27968564|NCT01072175|54626222|FG008|Part C (Phase II: Crossover Phase [CP])|Death|37|||
27968565|NCT01072175|54626223|FG009|Part C (Phase II: Crossover Phase [CP])|Death|0|||
27968566|NCT01072175|54626224|FG010|Part C (Phase II: Crossover Phase [CP])|Death|0|||
27968567|NCT01072175|54626225|FG011|Part C (Phase II: Crossover Phase [CP])|Death|0|||
27968568|NCT01072175|54626226|FG012|Part C (Phase II: Crossover Phase [CP])|Death|0|||
27968569|NCT01072175|54626214|FG000|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
27968570|NCT01072175|54626215|FG001|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
27968571|NCT01072175|54626216|FG002|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
27968572|NCT01072175|54626217|FG003|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
27968573|NCT01072175|54626218|FG004|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
27968574|NCT01072175|54626219|FG005|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
27968575|NCT01072175|54626220|FG006|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
27968576|NCT01072175|54626221|FG007|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
27968577|NCT01072175|54626222|FG008|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1|||
27968578|NCT01072175|54626223|FG009|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
27968579|NCT01072175|54626224|FG010|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
27968580|NCT01072175|54626225|FG011|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
27968581|NCT01072175|54626226|FG012|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
27968582|NCT01072175|54626214|FG000|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
27968583|NCT01072175|54626215|FG001|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
27968584|NCT01072175|54626216|FG002|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
27968585|NCT01072175|54626217|FG003|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
27968586|NCT01072175|54626218|FG004|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
27968587|NCT01072175|54626219|FG005|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
27968588|NCT01072175|54626220|FG006|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
27968589|NCT01072175|54626221|FG007|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
27968590|NCT01072175|54626222|FG008|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4|||
27968591|NCT01072175|54626223|FG009|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
27968592|NCT01072175|54626224|FG010|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
27968593|NCT01072175|54626225|FG011|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
27968594|NCT01072175|54626226|FG012|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
27968595|NCT01072175|54626214|FG000|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
27968596|NCT01072175|54626215|FG001|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
27968597|NCT01072175|54626216|FG002|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
27968598|NCT01072175|54626217|FG003|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
27968599|NCT01072175|54626218|FG004|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
27968600|NCT01072175|54626219|FG005|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
27968601|NCT01072175|54626220|FG006|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
27968602|NCT01072175|54626221|FG007|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
28083919|NCT03831191|54737440|FG010|Induction Period (16 Weeks)|Pregnancy|0|||
28083920|NCT03831191|54737441|FG011|Induction Period (16 Weeks)|Pregnancy|0|||
28083921|NCT03831191|54737442|FG012|Induction Period (16 Weeks)|Pregnancy|0|||
28083922|NCT03831191|54737443|FG013|Induction Period (16 Weeks)|Pregnancy|0|||
28083923|NCT03831191|54737444|FG014|Induction Period (16 Weeks)|Pregnancy|0|||
27968603|NCT01072175|54626222|FG008|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3|||
27968604|NCT01072175|54626223|FG009|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
27968605|NCT01072175|54626224|FG010|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
27968606|NCT01072175|54626225|FG011|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
27968607|NCT01072175|54626226|FG012|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
27968608|NCT01072175|54626214|FG000|Part D (HPMC Capsules)|Death|0|||
27968609|NCT01072175|54626215|FG001|Part D (HPMC Capsules)|Death|0|||
27968610|NCT01072175|54626216|FG002|Part D (HPMC Capsules)|Death|0|||
27968611|NCT01072175|54626217|FG003|Part D (HPMC Capsules)|Death|0|||
27968612|NCT01072175|54626218|FG004|Part D (HPMC Capsules)|Death|0|||
27968613|NCT01072175|54626219|FG005|Part D (HPMC Capsules)|Death|0|||
28083924|NCT03831191|54737430|FG000|Induction Period (16 Weeks)|Protocol Violation|0|||
28083925|NCT03831191|54737431|FG001|Induction Period (16 Weeks)|Protocol Violation|0|||
28083926|NCT03831191|54737432|FG002|Induction Period (16 Weeks)|Protocol Violation|0|||
27855360|NCT01277861|54376533|FG000|Overall Study|Physician Decision|2|||
27968614|NCT01072175|54626220|FG006|Part D (HPMC Capsules)|Death|0|||
27968615|NCT01072175|54626221|FG007|Part D (HPMC Capsules)|Death|0|||
27968616|NCT01072175|54626222|FG008|Part D (HPMC Capsules)|Death|0|||
27968617|NCT01072175|54626223|FG009|Part D (HPMC Capsules)|Death|10|||
27968618|NCT01072175|54626224|FG010|Part D (HPMC Capsules)|Death|12|||
27968619|NCT01072175|54626225|FG011|Part D (HPMC Capsules)|Death|28|||
27968620|NCT01072175|54626226|FG012|Part D (HPMC Capsules)|Death|26|||
27968621|NCT01072175|54626214|FG000|Part D (HPMC Capsules)|Physician Decision|0|||
27968622|NCT01072175|54626215|FG001|Part D (HPMC Capsules)|Physician Decision|0|||
28083927|NCT03831191|54737433|FG003|Induction Period (16 Weeks)|Protocol Violation|2|||
28083928|NCT03831191|54737434|FG004|Induction Period (16 Weeks)|Protocol Violation|0|||
28083929|NCT03831191|54737435|FG005|Induction Period (16 Weeks)|Protocol Violation|0|||
27968623|NCT01072175|54626216|FG002|Part D (HPMC Capsules)|Physician Decision|0|||
27968624|NCT01072175|54626217|FG003|Part D (HPMC Capsules)|Physician Decision|0|||
27968625|NCT01072175|54626218|FG004|Part D (HPMC Capsules)|Physician Decision|0|||
27968626|NCT01072175|54626219|FG005|Part D (HPMC Capsules)|Physician Decision|0|||
27968627|NCT01072175|54626220|FG006|Part D (HPMC Capsules)|Physician Decision|0|||
27968628|NCT01072175|54626221|FG007|Part D (HPMC Capsules)|Physician Decision|0|||
27968629|NCT01072175|54626222|FG008|Part D (HPMC Capsules)|Physician Decision|0|||
27968630|NCT01072175|54626223|FG009|Part D (HPMC Capsules)|Physician Decision|0|||
27968631|NCT01072175|54626224|FG010|Part D (HPMC Capsules)|Physician Decision|1|||
27968632|NCT01072175|54626225|FG011|Part D (HPMC Capsules)|Physician Decision|1|||
27968633|NCT01072175|54626226|FG012|Part D (HPMC Capsules)|Physician Decision|1|||
27968634|NCT01072175|54626214|FG000|Part D (HPMC Capsules)|Lost to Follow-up|0|||
27968635|NCT01072175|54626215|FG001|Part D (HPMC Capsules)|Lost to Follow-up|0|||
27968636|NCT01072175|54626216|FG002|Part D (HPMC Capsules)|Lost to Follow-up|0|||
27968637|NCT01072175|54626217|FG003|Part D (HPMC Capsules)|Lost to Follow-up|0|||
27968638|NCT01072175|54626218|FG004|Part D (HPMC Capsules)|Lost to Follow-up|0|||
27968639|NCT01072175|54626219|FG005|Part D (HPMC Capsules)|Lost to Follow-up|0|||
27968640|NCT01072175|54626220|FG006|Part D (HPMC Capsules)|Lost to Follow-up|0|||
27968641|NCT01072175|54626221|FG007|Part D (HPMC Capsules)|Lost to Follow-up|0|||
27968642|NCT01072175|54626222|FG008|Part D (HPMC Capsules)|Lost to Follow-up|0|||
27968643|NCT01072175|54626223|FG009|Part D (HPMC Capsules)|Lost to Follow-up|0|||
27968644|NCT01072175|54626224|FG010|Part D (HPMC Capsules)|Lost to Follow-up|1|||
27968645|NCT01072175|54626225|FG011|Part D (HPMC Capsules)|Lost to Follow-up|1|||
27968646|NCT01072175|54626226|FG012|Part D (HPMC Capsules)|Lost to Follow-up|3|||
27968647|NCT01072175|54626214|FG000|Part D (HPMC Capsules)|Study closed/terminated|0|||
27968648|NCT01072175|54626215|FG001|Part D (HPMC Capsules)|Study closed/terminated|0|||
27968649|NCT01072175|54626216|FG002|Part D (HPMC Capsules)|Study closed/terminated|0|||
27968650|NCT01072175|54626217|FG003|Part D (HPMC Capsules)|Study closed/terminated|0|||
27968651|NCT01072175|54626218|FG004|Part D (HPMC Capsules)|Study closed/terminated|0|||
27968652|NCT01072175|54626219|FG005|Part D (HPMC Capsules)|Study closed/terminated|0|||
27968653|NCT01072175|54626220|FG006|Part D (HPMC Capsules)|Study closed/terminated|0|||
27968654|NCT01072175|54626221|FG007|Part D (HPMC Capsules)|Study closed/terminated|0|||
27968655|NCT01072175|54626222|FG008|Part D (HPMC Capsules)|Study closed/terminated|0|||
28083930|NCT03831191|54737436|FG006|Induction Period (16 Weeks)|Protocol Violation|0|||
28083931|NCT03831191|54737437|FG007|Induction Period (16 Weeks)|Protocol Violation|0|||
28083932|NCT03831191|54737438|FG008|Induction Period (16 Weeks)|Protocol Violation|0|||
27968656|NCT01072175|54626223|FG009|Part D (HPMC Capsules)|Study closed/terminated|2|||
27968657|NCT01072175|54626224|FG010|Part D (HPMC Capsules)|Study closed/terminated|1|||
27968658|NCT01072175|54626225|FG011|Part D (HPMC Capsules)|Study closed/terminated|10|||
27968659|NCT01072175|54626226|FG012|Part D (HPMC Capsules)|Study closed/terminated|9|||
27968660|NCT01072175|54626214|FG000|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
27968661|NCT01072175|54626215|FG001|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
27968662|NCT01072175|54626216|FG002|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
27968663|NCT01072175|54626217|FG003|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
27968664|NCT01072175|54626218|FG004|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
27968665|NCT01072175|54626219|FG005|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
27968666|NCT01072175|54626220|FG006|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
27968667|NCT01072175|54626221|FG007|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
27968668|NCT01072175|54626222|FG008|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
27968669|NCT01072175|54626223|FG009|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
27968670|NCT01072175|54626224|FG010|Part D (HPMC Capsules)|Withdrawal by Subject|1|||
27968671|NCT01072175|54626225|FG011|Part D (HPMC Capsules)|Withdrawal by Subject|3|||
27968672|NCT01072175|54626226|FG012|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
27968673|NCT01071317|54626260|FG000|Overall Study|Lost to Follow-up|2|||
27968674|NCT01071317|54626261|FG001|Overall Study|Lost to Follow-up|2|||
27968675|NCT00783094|54626278|FG000|Randomized Double-Blind Treatment Period|Adverse Event|4|||
27968676|NCT00783094|54626279|FG001|Randomized Double-Blind Treatment Period|Adverse Event|5|||
27968677|NCT00783094|54626280|FG002|Randomized Double-Blind Treatment Period|Adverse Event|5|||
27968678|NCT00783094|54626278|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|0|||
28083933|NCT03831191|54737439|FG009|Induction Period (16 Weeks)|Protocol Violation|0|||
28083934|NCT03831191|54737440|FG010|Induction Period (16 Weeks)|Protocol Violation|0|||
28083935|NCT03831191|54737441|FG011|Induction Period (16 Weeks)|Protocol Violation|0|||
28083936|NCT03831191|54737442|FG012|Induction Period (16 Weeks)|Protocol Violation|0|||
28083937|NCT03831191|54737443|FG013|Induction Period (16 Weeks)|Protocol Violation|0|||
28083938|NCT03831191|54737444|FG014|Induction Period (16 Weeks)|Protocol Violation|0|||
28083939|NCT03831191|54737430|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|7|||
27732813|NCT02525939|54180504|FG000|Overall Study|Withdrawal by Subject|24|||
27732814|NCT02525939|54180505|FG001|Overall Study|Withdrawal by Subject|39|||
27732815|NCT02525939|54180504|FG000|Overall Study|Death|180|||
27968679|NCT00783094|54626279|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|2|||
28083940|NCT03831191|54737431|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
27732816|NCT02525939|54180505|FG001|Overall Study|Death|179|||
27968680|NCT00783094|54626280|FG002|Randomized Double-Blind Treatment Period|Lack of Efficacy|1|||
27968681|NCT00783094|54626278|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0|||
27968682|NCT00783094|54626279|FG001|Randomized Double-Blind Treatment Period|Physician Decision|2|||
27968683|NCT00783094|54626280|FG002|Randomized Double-Blind Treatment Period|Physician Decision|0|||
27968684|NCT00783094|54626278|FG000|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
27968685|NCT00783094|54626279|FG001|Randomized Double-Blind Treatment Period|Protocol Violation|2|||
27968686|NCT00783094|54626280|FG002|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
27968687|NCT00783094|54626278|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
27968688|NCT00783094|54626279|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1|||
27968689|NCT00783094|54626280|FG002|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
27968690|NCT00783094|54626278|FG000|Open-Label Extension Period|Adverse Event|12|||
27968691|NCT00783094|54626279|FG001|Open-Label Extension Period|Adverse Event|7|||
27968692|NCT00783094|54626280|FG002|Open-Label Extension Period|Adverse Event|16|||
27968693|NCT00783094|54626278|FG000|Open-Label Extension Period|Death|0|||
27968694|NCT00783094|54626279|FG001|Open-Label Extension Period|Death|0|||
27968695|NCT00783094|54626280|FG002|Open-Label Extension Period|Death|1|||
27968696|NCT00783094|54626278|FG000|Open-Label Extension Period|Protocol Violation|4|||
27968697|NCT00783094|54626279|FG001|Open-Label Extension Period|Protocol Violation|5|||
27968698|NCT00783094|54626280|FG002|Open-Label Extension Period|Protocol Violation|7|||
27968699|NCT00783094|54626278|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
27968700|NCT00783094|54626279|FG001|Open-Label Extension Period|Withdrawal by Subject|1|||
27968701|NCT00783094|54626280|FG002|Open-Label Extension Period|Withdrawal by Subject|3|||
27968702|NCT00783094|54626278|FG000|Open-Label Extension Period|Physician Decision|4|||
27968703|NCT00783094|54626279|FG001|Open-Label Extension Period|Physician Decision|2|||
27968704|NCT00783094|54626280|FG002|Open-Label Extension Period|Physician Decision|3|||
27968705|NCT00783094|54626278|FG000|Open-Label Extension Period|Lack of Efficacy|1|||
27968706|NCT00783094|54626279|FG001|Open-Label Extension Period|Lack of Efficacy|4|||
27968707|NCT00783094|54626280|FG002|Open-Label Extension Period|Lack of Efficacy|0|||
27968708|NCT00790582|54626293|FG000|Overall Study|Death|14|||
27968709|NCT00790582|54626294|FG001|Overall Study|Death|32|||
27968710|NCT00790582|54626293|FG000|Overall Study|Physician Decision|7|||
27968711|NCT00790582|54626294|FG001|Overall Study|Physician Decision|1|||
27968712|NCT00790582|54626293|FG000|Overall Study|Lost to Follow-up|3|||
27968713|NCT00790582|54626294|FG001|Overall Study|Lost to Follow-up|3|||
27968714|NCT00790582|54626293|FG000|Overall Study|Withdrawal by Subject|7|||
27968715|NCT00790582|54626294|FG001|Overall Study|Withdrawal by Subject|51|||
27968716|NCT01048541|54626302|FG000|Overall Study|Withdrawal by Subject|1|||
27968717|NCT01048541|54626303|FG001|Overall Study|Withdrawal by Subject|0|||
27968718|NCT00774046|54626309|FG000|Screening|Not eligible|56|||
27968719|NCT00774046|54626309|FG000|Enrollment|Desired other therapy/refused|28|||
27968720|NCT00774046|54626309|FG000|Stem Cell Mobilization|Count too low (2), sudden death (1)|3|||
27968721|NCT01046903|54626313|FG000|Overall Study|Lost to Follow-up|16|||
27968722|NCT01046903|54626313|FG000|Overall Study|Adverse Event|4|||
27968723|NCT01046903|54626313|FG000|Overall Study|Withdrawal by Subject|3|||
27968724|NCT01046903|54626313|FG000|Overall Study|Other|5|||
27968725|NCT00773968|54626317|FG000|Overall Study|Adverse Event|2|||
27968726|NCT00773968|54626317|FG000|Overall Study|Death|1|||
27968727|NCT00773968|54626317|FG000|Overall Study|Failure to Return|2|||
27968728|NCT00773968|54626317|FG000|Overall Study|Lack of Efficacy|3|||
27968729|NCT00773968|54626317|FG000|Overall Study|Protocol Violation|1|||
27968730|NCT00773968|54626317|FG000|Overall Study|Withdrawal by Subject|11|||
27968731|NCT00773968|54626317|FG000|Overall Study|Screen Failure|17|||
27968732|NCT00773968|54626317|FG000|Overall Study|Other|8|||
27968733|NCT00782626|54626321|FG000|Overall Study|Adverse Event|1|||
28083941|NCT03831191|54737432|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
28083942|NCT03831191|54737433|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
28083943|NCT03831191|54737434|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
28083944|NCT03831191|54737435|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
27855361|NCT01277861|54376534|FG001|Overall Study|Physician Decision|2|||
27968734|NCT00782626|54626321|FG000|Overall Study|Progressive Disease|5|||
27968735|NCT00782626|54626321|FG000|Overall Study|Other Complicating Disease|1|||
28083945|NCT03831191|54737436|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
27855362|NCT01277549|54376561|FG000|Overall Study|Failed to meet eligibility criteria|13|||
27968736|NCT01071083|54626330|FG000|Overall Study|Adverse Event|1|||
27968737|NCT01071083|54626331|FG001|Overall Study|Adverse Event|0|||
27968738|NCT01071083|54626332|FG002|Overall Study|Adverse Event|1|||
27968739|NCT01071083|54626333|FG003|Overall Study|Adverse Event|0|||
27968740|NCT01071083|54626334|FG004|Overall Study|Adverse Event|1|||
27968741|NCT01071083|54626330|FG000|Overall Study|Withdrawal by Subject|3|||
27968742|NCT01071083|54626331|FG001|Overall Study|Withdrawal by Subject|0|||
27968743|NCT01071083|54626332|FG002|Overall Study|Withdrawal by Subject|2|||
27968744|NCT01071083|54626333|FG003|Overall Study|Withdrawal by Subject|0|||
27968745|NCT01071083|54626334|FG004|Overall Study|Withdrawal by Subject|3|||
27968746|NCT01071083|54626330|FG000|Overall Study|Physician Decision|1|||
27968747|NCT01071083|54626331|FG001|Overall Study|Physician Decision|0|||
27968748|NCT01071083|54626332|FG002|Overall Study|Physician Decision|0|||
27968749|NCT01071083|54626333|FG003|Overall Study|Physician Decision|1|||
27968750|NCT01071083|54626334|FG004|Overall Study|Physician Decision|1|||
27968751|NCT01071083|54626330|FG000|Overall Study|Early Rescue|1|||
27968752|NCT01071083|54626331|FG001|Overall Study|Early Rescue|0|||
27968753|NCT01071083|54626332|FG002|Overall Study|Early Rescue|0|||
27968754|NCT01071083|54626333|FG003|Overall Study|Early Rescue|0|||
27968755|NCT01071083|54626334|FG004|Overall Study|Early Rescue|1|||
27968756|NCT01071083|54626330|FG000|Overall Study|Subject Moved|0|||
27968757|NCT01071083|54626331|FG001|Overall Study|Subject Moved|1|||
27968758|NCT01071083|54626332|FG002|Overall Study|Subject Moved|0|||
27968759|NCT01071083|54626333|FG003|Overall Study|Subject Moved|0|||
27968760|NCT01071083|54626334|FG004|Overall Study|Subject Moved|0|||
27968761|NCT01071083|54626330|FG000|Overall Study|Images Not Usable (Motion)|0|||
27968762|NCT01071083|54626331|FG001|Overall Study|Images Not Usable (Motion)|1|||
27968763|NCT01071083|54626332|FG002|Overall Study|Images Not Usable (Motion)|0|||
27968764|NCT01071083|54626333|FG003|Overall Study|Images Not Usable (Motion)|0|||
27968765|NCT01071083|54626334|FG004|Overall Study|Images Not Usable (Motion)|0|||
27968766|NCT01071083|54626330|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
27968767|NCT01071083|54626331|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
27968768|NCT01071083|54626332|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
27968769|NCT01071083|54626333|FG003|Overall Study|Did Not Meet Eligibility Criteria|1|||
27968770|NCT01071083|54626334|FG004|Overall Study|Did Not Meet Eligibility Criteria|1|||
27968771|NCT01071083|54626330|FG000|Overall Study|Did Not Want Per Protocol Treatment|0|||
27968772|NCT01071083|54626331|FG001|Overall Study|Did Not Want Per Protocol Treatment|0|||
27968773|NCT01071083|54626332|FG002|Overall Study|Did Not Want Per Protocol Treatment|1|||
27968774|NCT01071083|54626333|FG003|Overall Study|Did Not Want Per Protocol Treatment|0|||
27968775|NCT01071083|54626334|FG004|Overall Study|Did Not Want Per Protocol Treatment|1|||
27968776|NCT01071083|54626330|FG000|Overall Study|Subject Refused to Continue|1|||
27968777|NCT01071083|54626331|FG001|Overall Study|Subject Refused to Continue|0|||
27968778|NCT01071083|54626332|FG002|Overall Study|Subject Refused to Continue|0|||
27968779|NCT01071083|54626333|FG003|Overall Study|Subject Refused to Continue|0|||
27968780|NCT01071083|54626334|FG004|Overall Study|Subject Refused to Continue|0|||
27968781|NCT01070771|54626346|FG000|Overall Study|Adverse Event|2|||
28165223|NCT02920957|54835806|FG000|First Intervention : 1 Month|Adverse Event|1|||
28165224|NCT02920957|54835807|FG001|First Intervention : 1 Month|Adverse Event|0|||
28165225|NCT02920957|54835806|FG000|Second Intervention: 1 Month|Lost to Follow-up|0|||
28165226|NCT02920957|54835807|FG001|Second Intervention: 1 Month|Lost to Follow-up|1|||
28165227|NCT03006887|54835824|FG000|Overall Study|Adverse Event|1|||
28165228|NCT02514772|54835830|FG000|Overall Study|Adverse Event|1|||
28165229|NCT02514772|54835831|FG001|Overall Study|Adverse Event|0|||
28165230|NCT02514772|54835830|FG000|Overall Study|Death|0|||
28165231|NCT02514772|54835831|FG001|Overall Study|Death|1|||
28165232|NCT02514772|54835830|FG000|Overall Study|Withdrawal by Subject|2|||
27855363|NCT01277549|54376562|FG001|Overall Study|Failed to meet eligibility criteria|9|||
27968782|NCT01070771|54626346|FG000|Overall Study|Protocol Violation|1|||
27968783|NCT01070381|54626351|FG000|Period 2, 1 Week of Wear|Handling|0|||
27968784|NCT01070381|54626352|FG001|Period 2, 1 Week of Wear|Handling|1|||
27968785|NCT01070381|54626351|FG000|Period 2, 1 Week of Wear|Unacceptable Vision|1|||
27968786|NCT01070381|54626352|FG001|Period 2, 1 Week of Wear|Unacceptable Vision|0|||
27968787|NCT01010126|54626373|FG000|Overall Study|Withdrawal by Subject|1|||
27968788|NCT01010126|54626374|FG001|Overall Study|Withdrawal by Subject|0|||
27968789|NCT01010126|54626375|FG002|Overall Study|Withdrawal by Subject|1|||
27968790|NCT01010126|54626376|FG003|Overall Study|Withdrawal by Subject|0|||
27968791|NCT01010126|54626377|FG004|Overall Study|Withdrawal by Subject|3|||
27968792|NCT01010126|54626378|FG005|Overall Study|Withdrawal by Subject|0|||
27968793|NCT01043705|54626395|FG000|Overall Study|Death|28|||
27968794|NCT01043705|54626396|FG001|Overall Study|Death|60|||
27968795|NCT01043705|54626397|FG002|Overall Study|Death|26|||
27968796|NCT01043705|54626395|FG000|Overall Study|Lost to Follow-up|27|||
28165233|NCT02514772|54835831|FG001|Overall Study|Withdrawal by Subject|1|||
27855364|NCT01277549|54376561|FG000|Overall Study|Withdrawal by Subject|1|||
27968797|NCT01043705|54626396|FG001|Overall Study|Lost to Follow-up|12|||
27968798|NCT01043705|54626397|FG002|Overall Study|Lost to Follow-up|0|||
27855365|NCT01277549|54376562|FG001|Overall Study|Withdrawal by Subject|3|||
27968799|NCT01043705|54626395|FG000|Overall Study|Multiple Reasons|4|||
27968800|NCT01043705|54626396|FG001|Overall Study|Multiple Reasons|7|||
27968801|NCT01043705|54626397|FG002|Overall Study|Multiple Reasons|0|||
27968802|NCT01043705|54626395|FG000|Overall Study|Protocol Violation|2|||
27968803|NCT01043705|54626396|FG001|Overall Study|Protocol Violation|1|||
27968804|NCT01043705|54626397|FG002|Overall Study|Protocol Violation|0|||
27968805|NCT01043705|54626395|FG000|Overall Study|Withdrawal by Subject|8|||
27968806|NCT01043705|54626396|FG001|Overall Study|Withdrawal by Subject|6|||
27968807|NCT01043705|54626397|FG002|Overall Study|Withdrawal by Subject|0|||
27968808|NCT01043705|54626395|FG000|Overall Study|Site Closure|8|||
28165234|NCT03000179|54835839|FG000|Overall Study|Lost to Follow-up|2|||
27968809|NCT01043705|54626396|FG001|Overall Study|Site Closure|0|||
27968810|NCT01043705|54626397|FG002|Overall Study|Site Closure|0|||
27968811|NCT01043705|54626395|FG000|Overall Study|Subsequent Procedure|9|||
27968812|NCT01043705|54626396|FG001|Overall Study|Subsequent Procedure|24|||
27968813|NCT01043705|54626397|FG002|Overall Study|Subsequent Procedure|29|||
27968814|NCT01043705|54626395|FG000|Overall Study|Adverse Event|0|||
27968815|NCT01043705|54626396|FG001|Overall Study|Adverse Event|2|||
27968816|NCT01043705|54626397|FG002|Overall Study|Adverse Event|0|||
27968817|NCT01043705|54626395|FG000|Overall Study|Screen Fail|21|||
27968818|NCT01043705|54626396|FG001|Overall Study|Screen Fail|0|||
27968819|NCT01043705|54626397|FG002|Overall Study|Screen Fail|0|||
27968820|NCT01043705|54626395|FG000|Overall Study|Other|0|||
27968821|NCT01043705|54626396|FG001|Overall Study|Other|19|||
27968822|NCT01043705|54626397|FG002|Overall Study|Other|25|||
27968823|NCT01070303|54626416|FG000|Overall Study|Adverse Event|39|||
27968824|NCT01070303|54626416|FG000|Overall Study|Withdrawal by Subject|20|||
27968825|NCT01070303|54626416|FG000|Overall Study|Lost to Follow-up|9|||
27968826|NCT01070303|54626416|FG000|Overall Study|Protocol Violation|0|||
27968827|NCT01070303|54626416|FG000|Overall Study|Lack of Efficacy|2|||
27968828|NCT01070303|54626416|FG000|Overall Study|Administrative Reason|1|||
27968829|NCT01070303|54626416|FG000|Overall Study|Other|18|||
27968830|NCT01009814|54626431|FG000|Overall Study|No longer met study criteria|1|||
27968831|NCT01009814|54626432|FG001|Overall Study|No longer met study criteria|1|||
28083946|NCT03831191|54737437|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
28083947|NCT03831191|54737438|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
28083948|NCT03831191|54737439|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
28083949|NCT03831191|54737440|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
28083950|NCT03831191|54737441|FG011|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
28083951|NCT03831191|54737442|FG012|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
28083952|NCT03831191|54737443|FG013|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
28083953|NCT03831191|54737444|FG014|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
28083954|NCT03831191|54737430|FG000|Induction Period (16 Weeks)|Study Terminated by Sponsor|12|||
28083955|NCT03831191|54737431|FG001|Induction Period (16 Weeks)|Study Terminated by Sponsor|15|||
28083956|NCT03831191|54737432|FG002|Induction Period (16 Weeks)|Study Terminated by Sponsor|16|||
28083957|NCT03831191|54737433|FG003|Induction Period (16 Weeks)|Study Terminated by Sponsor|13|||
28083958|NCT03831191|54737434|FG004|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
28083959|NCT03831191|54737435|FG005|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
28083960|NCT03831191|54737436|FG006|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
28083961|NCT03831191|54737437|FG007|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
28083962|NCT03831191|54737438|FG008|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
28083963|NCT03831191|54737439|FG009|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
28083964|NCT03831191|54737440|FG010|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
28083965|NCT03831191|54737441|FG011|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
28083966|NCT03831191|54737442|FG012|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
28083967|NCT03831191|54737443|FG013|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
28083968|NCT03831191|54737444|FG014|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
28083969|NCT03831191|54737430|FG000|Induction Period (16 Weeks)|Sponsor Decision|0|||
28083970|NCT03831191|54737431|FG001|Induction Period (16 Weeks)|Sponsor Decision|0|||
28083971|NCT03831191|54737432|FG002|Induction Period (16 Weeks)|Sponsor Decision|0|||
28083972|NCT03831191|54737433|FG003|Induction Period (16 Weeks)|Sponsor Decision|1|||
28083973|NCT03831191|54737434|FG004|Induction Period (16 Weeks)|Sponsor Decision|0|||
28083974|NCT03831191|54737435|FG005|Induction Period (16 Weeks)|Sponsor Decision|0|||
28083975|NCT03831191|54737436|FG006|Induction Period (16 Weeks)|Sponsor Decision|0|||
28083976|NCT03831191|54737437|FG007|Induction Period (16 Weeks)|Sponsor Decision|0|||
28083977|NCT03831191|54737438|FG008|Induction Period (16 Weeks)|Sponsor Decision|0|||
28083978|NCT03831191|54737439|FG009|Induction Period (16 Weeks)|Sponsor Decision|0|||
28083979|NCT03831191|54737440|FG010|Induction Period (16 Weeks)|Sponsor Decision|0|||
28083980|NCT03831191|54737441|FG011|Induction Period (16 Weeks)|Sponsor Decision|0|||
28083981|NCT03831191|54737442|FG012|Induction Period (16 Weeks)|Sponsor Decision|0|||
28083982|NCT03831191|54737443|FG013|Induction Period (16 Weeks)|Sponsor Decision|0|||
28083983|NCT03831191|54737444|FG014|Induction Period (16 Weeks)|Sponsor Decision|0|||
27968832|NCT01009814|54626433|FG002|Overall Study|No longer met study criteria|0|||
27968833|NCT01009814|54626434|FG003|Overall Study|No longer met study criteria|0|||
27968834|NCT01009814|54626435|FG004|Overall Study|No longer met study criteria|0|||
27968835|NCT03824587|54626453|FG000|Run-in Period|Screen Failure|0|||
27968836|NCT03824587|54626454|FG001|Run-in Period|Screen Failure|275|||
28083984|NCT03831191|54737430|FG000|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
28083985|NCT03831191|54737431|FG001|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
28083986|NCT03831191|54737432|FG002|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
28083987|NCT03831191|54737433|FG003|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
28083988|NCT03831191|54737434|FG004|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
27968837|NCT03824587|54626453|FG000|Treatment Period|Adverse Event|4|||
27968838|NCT03824587|54626454|FG001|Treatment Period|Adverse Event|1|||
27968839|NCT03824587|54626453|FG000|Treatment Period|Withdrawal by Subject|0|||
27968840|NCT03824587|54626454|FG001|Treatment Period|Withdrawal by Subject|1|||
27968841|NCT03824587|54626453|FG000|Treatment Period|Kidney Transplant|1|||
27968842|NCT03824587|54626454|FG001|Treatment Period|Kidney Transplant|1|||
27968843|NCT00773734|54626464|FG000|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5|||
27968844|NCT00773734|54626465|FG001|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1|||
27968845|NCT00773734|54626466|FG002|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8|||
27968846|NCT00773734|54626467|FG003|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10|||
27968847|NCT00773734|54626468|FG004|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
27968848|NCT00773734|54626469|FG005|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
27968849|NCT00773734|54626464|FG000|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4|||
27968850|NCT00773734|54626465|FG001|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3|||
27968851|NCT00773734|54626466|FG002|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
27968852|NCT00773734|54626467|FG003|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
27968853|NCT00773734|54626468|FG004|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
27968854|NCT00773734|54626469|FG005|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
27968855|NCT00773734|54626464|FG000|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
27968856|NCT00773734|54626465|FG001|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
27968857|NCT00773734|54626466|FG002|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6|||
27968858|NCT00773734|54626467|FG003|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4|||
27968859|NCT00773734|54626468|FG004|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
27968860|NCT00773734|54626469|FG005|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
27968861|NCT00773734|54626464|FG000|Core: Placebo Controlled Phase Week 0-16|Death|1|||
27968862|NCT00773734|54626465|FG001|Core: Placebo Controlled Phase Week 0-16|Death|0|||
27968863|NCT00773734|54626466|FG002|Core: Placebo Controlled Phase Week 0-16|Death|0|||
27968864|NCT00773734|54626467|FG003|Core: Placebo Controlled Phase Week 0-16|Death|0|||
27968865|NCT00773734|54626468|FG004|Core: Placebo Controlled Phase Week 0-16|Death|0|||
27968866|NCT00773734|54626469|FG005|Core: Placebo Controlled Phase Week 0-16|Death|0|||
27968867|NCT00773734|54626464|FG000|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2|||
27968868|NCT00773734|54626465|FG001|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
27968869|NCT00773734|54626466|FG002|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
27968870|NCT00773734|54626467|FG003|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1|||
27968871|NCT00773734|54626468|FG004|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
27968872|NCT00773734|54626469|FG005|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
27968873|NCT00773734|54626464|FG000|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1|||
27968874|NCT00773734|54626465|FG001|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3|||
27968875|NCT00773734|54626466|FG002|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4|||
27968876|NCT00773734|54626467|FG003|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
27968877|NCT00773734|54626468|FG004|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
27968878|NCT00773734|54626469|FG005|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
27968879|NCT00773734|54626464|FG000|Core: Placebo Controlled Phase Week 0-16|Other|1|||
27968880|NCT00773734|54626465|FG001|Core: Placebo Controlled Phase Week 0-16|Other|1|||
28083989|NCT03831191|54737435|FG005|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|5|||
28083990|NCT03831191|54737436|FG006|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|2|||
28083991|NCT03831191|54737437|FG007|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
28083992|NCT03831191|54737438|FG008|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|8|||
28083993|NCT03831191|54737439|FG009|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
28083994|NCT03831191|54737440|FG010|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
28083995|NCT03831191|54737441|FG011|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|7|||
28083996|NCT03831191|54737442|FG012|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
28083997|NCT03831191|54737443|FG013|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
28083998|NCT03831191|54737444|FG014|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|6|||
27832542|NCT01759511|54311970|FG000|Overall Study|Protocol-Specified Criteria for Withdraw|4|||
27832543|NCT01759511|54311970|FG000|Overall Study|Study Terminated by Sponsor|13|||
27968881|NCT00773734|54626466|FG002|Core: Placebo Controlled Phase Week 0-16|Other|1|||
27968882|NCT00773734|54626467|FG003|Core: Placebo Controlled Phase Week 0-16|Other|1|||
28083999|NCT03831191|54737430|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
28084000|NCT03831191|54737431|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
28084001|NCT03831191|54737432|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
28165235|NCT02920177|54835845|FG000|Overall Study|Withdrawal by Subject|1|||
27968883|NCT00773734|54626468|FG004|Core: Placebo Controlled Phase Week 0-16|Other|0|||
27968884|NCT00773734|54626469|FG005|Core: Placebo Controlled Phase Week 0-16|Other|0|||
28165236|NCT02920177|54835846|FG001|Overall Study|Withdrawal by Subject|1|||
28165237|NCT02920177|54835845|FG000|Overall Study|Physician Decision|1|||
28165238|NCT02920177|54835846|FG001|Overall Study|Physician Decision|0|||
28165239|NCT02920177|54835845|FG000|Overall Study|Lost to Follow-up|0|||
27968885|NCT00773734|54626464|FG000|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
27968886|NCT00773734|54626465|FG001|Core: Active Treatment Phase Week 16-24|Adverse Event|4|||
27968887|NCT00773734|54626466|FG002|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
27968888|NCT00773734|54626467|FG003|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
27968889|NCT00773734|54626468|FG004|Core: Active Treatment Phase Week 16-24|Adverse Event|1|||
27968890|NCT00773734|54626469|FG005|Core: Active Treatment Phase Week 16-24|Adverse Event|2|||
27968891|NCT00773734|54626464|FG000|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
27968892|NCT00773734|54626465|FG001|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
27968893|NCT00773734|54626466|FG002|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
27968894|NCT00773734|54626467|FG003|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1|||
27968895|NCT00773734|54626468|FG004|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
27968896|NCT00773734|54626469|FG005|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
27968897|NCT00773734|54626464|FG000|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
27968898|NCT00773734|54626465|FG001|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
27968899|NCT00773734|54626466|FG002|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
27968900|NCT00773734|54626467|FG003|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
27968901|NCT00773734|54626468|FG004|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
27968902|NCT00773734|54626469|FG005|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2|||
27968903|NCT00773734|54626464|FG000|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
27968904|NCT00773734|54626465|FG001|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
27968905|NCT00773734|54626466|FG002|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
27968906|NCT00773734|54626467|FG003|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
27968907|NCT00773734|54626468|FG004|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
27968908|NCT00773734|54626469|FG005|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
27968909|NCT00773734|54626464|FG000|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
27968910|NCT00773734|54626465|FG001|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
27968911|NCT00773734|54626466|FG002|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
27968912|NCT00773734|54626467|FG003|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
27968913|NCT00773734|54626468|FG004|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
27968914|NCT00773734|54626469|FG005|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
27968915|NCT00773734|54626464|FG000|Core: Active Treatment Phase Week 16-24|Other|0|||
27968916|NCT00773734|54626465|FG001|Core: Active Treatment Phase Week 16-24|Other|1|||
27968917|NCT00773734|54626466|FG002|Core: Active Treatment Phase Week 16-24|Other|0|||
27968918|NCT00773734|54626467|FG003|Core: Active Treatment Phase Week 16-24|Other|0|||
27968919|NCT00773734|54626468|FG004|Core: Active Treatment Phase Week 16-24|Other|0|||
27968920|NCT00773734|54626469|FG005|Core: Active Treatment Phase Week 16-24|Other|0|||
27968921|NCT00773734|54626464|FG000|Extension: Active Treatment Week 24-52|Adverse Event|0|||
27968922|NCT00773734|54626465|FG001|Extension: Active Treatment Week 24-52|Adverse Event|0|||
27968923|NCT00773734|54626466|FG002|Extension: Active Treatment Week 24-52|Adverse Event|0|||
27968924|NCT00773734|54626467|FG003|Extension: Active Treatment Week 24-52|Adverse Event|0|||
27968925|NCT00773734|54626468|FG004|Extension: Active Treatment Week 24-52|Adverse Event|2|||
27968926|NCT00773734|54626469|FG005|Extension: Active Treatment Week 24-52|Adverse Event|1|||
27968927|NCT00773734|54626464|FG000|Extension: Active Treatment Week 24-52|Lack of Efficacy|0|||
27968928|NCT00773734|54626465|FG001|Extension: Active Treatment Week 24-52|Lack of Efficacy|8|||
28084002|NCT03831191|54737433|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
28084003|NCT03831191|54737434|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
28084004|NCT03831191|54737435|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
28084005|NCT03831191|54737436|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
28084006|NCT03831191|54737437|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
28084007|NCT03831191|54737438|FG008|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
28084008|NCT03831191|54737439|FG009|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
28084009|NCT03831191|54737440|FG010|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
28084010|NCT03831191|54737441|FG011|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
28084011|NCT03831191|54737442|FG012|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
28084012|NCT03831191|54737443|FG013|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
28084013|NCT03831191|54737444|FG014|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
28084014|NCT03831191|54737430|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
27968929|NCT00773734|54626466|FG002|Extension: Active Treatment Week 24-52|Lack of Efficacy|10|||
27968930|NCT00773734|54626467|FG003|Extension: Active Treatment Week 24-52|Lack of Efficacy|3|||
27968931|NCT00773734|54626468|FG004|Extension: Active Treatment Week 24-52|Lack of Efficacy|1|||
28084015|NCT03831191|54737431|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
28084016|NCT03831191|54737432|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
27968932|NCT00773734|54626469|FG005|Extension: Active Treatment Week 24-52|Lack of Efficacy|2|||
27968933|NCT00773734|54626464|FG000|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0|||
27968934|NCT00773734|54626465|FG001|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
27968935|NCT00773734|54626466|FG002|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1|||
27968936|NCT00773734|54626467|FG003|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
27968937|NCT00773734|54626468|FG004|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
27968938|NCT00773734|54626469|FG005|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
27968939|NCT00773734|54626464|FG000|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
27968940|NCT00773734|54626465|FG001|Extension: Active Treatment Week 24-52|Lost to Follow-up|2|||
27968941|NCT00773734|54626466|FG002|Extension: Active Treatment Week 24-52|Lost to Follow-up|5|||
27968942|NCT00773734|54626467|FG003|Extension: Active Treatment Week 24-52|Lost to Follow-up|3|||
27968943|NCT00773734|54626468|FG004|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
27968944|NCT00773734|54626469|FG005|Extension: Active Treatment Week 24-52|Lost to Follow-up|1|||
27968945|NCT00773734|54626464|FG000|Extension: Active Treatment Week 24-52|Other|0|||
27968946|NCT00773734|54626465|FG001|Extension: Active Treatment Week 24-52|Other|0|||
27968947|NCT00773734|54626466|FG002|Extension: Active Treatment Week 24-52|Other|1|||
27968948|NCT00773734|54626467|FG003|Extension: Active Treatment Week 24-52|Other|2|||
27968949|NCT00773734|54626468|FG004|Extension: Active Treatment Week 24-52|Other|0|||
27968950|NCT00773734|54626469|FG005|Extension: Active Treatment Week 24-52|Other|1|||
27968951|NCT00773734|54626464|FG000|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
27968952|NCT00773734|54626465|FG001|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
27968953|NCT00773734|54626466|FG002|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
27968954|NCT00773734|54626467|FG003|LTE Period: Week 52 to 6 Years|Adverse Event|1|||
27968955|NCT00773734|54626468|FG004|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
27968956|NCT00773734|54626469|FG005|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
27968957|NCT00773734|54626464|FG000|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
27968958|NCT00773734|54626465|FG001|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
27968959|NCT00773734|54626466|FG002|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2|||
27968960|NCT00773734|54626467|FG003|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4|||
27968961|NCT00773734|54626468|FG004|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
27968962|NCT00773734|54626469|FG005|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
27968963|NCT00773734|54626464|FG000|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
27968964|NCT00773734|54626465|FG001|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
27968965|NCT00773734|54626466|FG002|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6|||
28084017|NCT03831191|54737433|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
28084018|NCT03831191|54737434|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
28165240|NCT02920177|54835846|FG001|Overall Study|Lost to Follow-up|1|||
28165241|NCT03006341|54835856|FG000|Overall Study|Not linked in the EMR|25069|||
28165242|NCT03006341|54835857|FG001|Overall Study|Not linked in the EMR|67505|||
28165243|NCT03006341|54835858|FG002|Overall Study|Not linked in the EMR|30993|||
27968966|NCT00773734|54626467|FG003|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3|||
27968967|NCT00773734|54626468|FG004|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
27968968|NCT00773734|54626469|FG005|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
27968969|NCT00773734|54626464|FG000|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
27968970|NCT00773734|54626465|FG001|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
27968971|NCT00773734|54626466|FG002|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
27968972|NCT00773734|54626467|FG003|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
27968973|NCT00773734|54626468|FG004|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
27968974|NCT00773734|54626469|FG005|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
27968975|NCT01009580|54626528|FG000|Overall Study|Adverse Event|4|||
27968976|NCT01009580|54626529|FG001|Overall Study|Adverse Event|4|||
27968977|NCT01009580|54626528|FG000|Overall Study|Lack of Efficacy|0|||
27968978|NCT01009580|54626529|FG001|Overall Study|Lack of Efficacy|1|||
27968979|NCT01009580|54626528|FG000|Overall Study|Protocol Violation|2|||
27968980|NCT01009580|54626529|FG001|Overall Study|Protocol Violation|3|||
27968981|NCT01009580|54626528|FG000|Overall Study|Withdrawal Criteria|4|||
27968982|NCT01009580|54626529|FG001|Overall Study|Withdrawal Criteria|6|||
27968983|NCT01009580|54626528|FG000|Overall Study|Unclassified|17|||
27968984|NCT01009580|54626529|FG001|Overall Study|Unclassified|21|||
27968985|NCT01009346|54626535|FG000|Overall Study|Adverse Event|4|||
27968986|NCT01001702|54626540|FG000|Overall Study|Lost to Follow-up|7|||
27968987|NCT01001702|54626540|FG000|Overall Study|Adverse Event|7|||
27968988|NCT01001702|54626540|FG000|Overall Study|Sponsor Discontinued Study|4|||
27968989|NCT01001702|54626540|FG000|Overall Study|Subject met Withdrawal Criteria|22|||
27968990|NCT01001702|54626540|FG000|Overall Study|Investigator withdrew Subject|10|||
28084019|NCT03831191|54737435|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
28084020|NCT03831191|54737436|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
28084021|NCT03831191|54737437|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
28084022|NCT03831191|54737438|FG008|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
28084023|NCT03831191|54737439|FG009|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
28084024|NCT03831191|54737440|FG010|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
28084025|NCT03831191|54737441|FG011|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
28084026|NCT03831191|54737442|FG012|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
28165244|NCT03006341|54835859|FG003|Overall Study|Not linked in the EMR|10685|||
27968991|NCT01001702|54626540|FG000|Overall Study|Withdrawal by Subject|19|||
27968992|NCT01001702|54626540|FG000|Overall Study|Lack of Efficacy per Investigator|3|||
27968993|NCT01070069|54626549|FG000|Overall Study|Death|1|||
27968994|NCT01070069|54626550|FG001|Overall Study|Death|0|||
27968995|NCT01070069|54626551|FG002|Overall Study|Death|2|||
27968996|NCT01070069|54626552|FG003|Overall Study|Death|0|||
28084027|NCT03831191|54737443|FG013|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
28084028|NCT03831191|54737444|FG014|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
28084029|NCT00005906|54737477|FG000|Overall Study|Lack of Efficacy|3|||
28084030|NCT00066690|54737484|FG000|Overall Study|Adverse Event|145|||
28084031|NCT00066690|54737485|FG001|Overall Study|Adverse Event|58|||
28084032|NCT00066690|54737486|FG002|Overall Study|Adverse Event|126|||
28084033|NCT00066690|54737484|FG000|Overall Study|Death|3|||
28084034|NCT00066690|54737485|FG001|Overall Study|Death|0|||
28084035|NCT00066690|54737486|FG002|Overall Study|Death|2|||
28084036|NCT00066690|54737484|FG000|Overall Study|Lack of Efficacy|114|||
28084037|NCT00066690|54737485|FG001|Overall Study|Lack of Efficacy|110|||
28084038|NCT00066690|54737486|FG002|Overall Study|Lack of Efficacy|76|||
28084039|NCT00066690|54737484|FG000|Overall Study|Lost to Follow-up|40|||
28084040|NCT00066690|54737485|FG001|Overall Study|Lost to Follow-up|21|||
28084041|NCT00066690|54737486|FG002|Overall Study|Lost to Follow-up|29|||
28084042|NCT00066690|54737484|FG000|Overall Study|Withdrawal by Subject|50|||
28084043|NCT00066690|54737485|FG001|Overall Study|Withdrawal by Subject|55|||
28084044|NCT00066690|54737486|FG002|Overall Study|Withdrawal by Subject|49|||
28084045|NCT00066690|54737484|FG000|Overall Study|Treatment Ongoing|246|||
28084046|NCT00066690|54737485|FG001|Overall Study|Treatment Ongoing|278|||
28084047|NCT00066690|54737486|FG002|Overall Study|Treatment Ongoing|282|||
28084048|NCT03409276|54737502|FG000|Overall Study|Withdrawal by Subject|0|||
28084049|NCT03409276|54737503|FG001|Overall Study|Withdrawal by Subject|0|||
28084050|NCT03409276|54737504|FG002|Overall Study|Withdrawal by Subject|0|||
28084051|NCT03409276|54737505|FG003|Overall Study|Withdrawal by Subject|0|||
28084052|NCT03409276|54737506|FG004|Overall Study|Withdrawal by Subject|1|||
28084053|NCT03409276|54737502|FG000|Overall Study|Lost to Follow-up|0|||
28084054|NCT03409276|54737503|FG001|Overall Study|Lost to Follow-up|0|||
28084055|NCT03409276|54737504|FG002|Overall Study|Lost to Follow-up|0|||
28084056|NCT03409276|54737505|FG003|Overall Study|Lost to Follow-up|2|||
28084057|NCT03409276|54737506|FG004|Overall Study|Lost to Follow-up|2|||
28084058|NCT00004562|54737524|FG000|Overall Study|Lost to Follow-up|102|||
28084059|NCT00004562|54737525|FG001|Overall Study|Lost to Follow-up|91|||
28084060|NCT00004412|54737534|FG000|Randomized Period|Moved to Crossover Period|3|||
28084061|NCT00004412|54737535|FG001|Randomized Period|Moved to Crossover Period|0|||
28084062|NCT00004412|54737536|FG002|Randomized Period|Moved to Crossover Period|0|||
28084063|NCT03440320|54737546|FG000|Overall Study|Withdrawal by Subject|0|||
28084064|NCT03440320|54737547|FG001|Overall Study|Withdrawal by Subject|1|||
28084065|NCT00004088|54737555|FG000|Overall Study|No C2 given due to study on hold by IRB|4|||
28084066|NCT00004088|54737555|FG000|Overall Study|Withdrawal by Subject|1|||
28084067|NCT00004088|54737555|FG000|Overall Study|Protocol Violation|3|||
28084068|NCT00004088|54737555|FG000|Overall Study|Physician Decision|1|||
28084069|NCT03439072|54737559|FG000|Overall Study|Withdrawal by Subject|2|||
28084070|NCT03439072|54737560|FG001|Overall Study|Withdrawal by Subject|3|||
28084071|NCT03439072|54737559|FG000|Overall Study|Physician Decision|0|||
28084072|NCT03439072|54737560|FG001|Overall Study|Physician Decision|1|||
28084073|NCT00078312|54737566|FG000|Overall Study|Adverse Event|43|||
28084074|NCT00078312|54737566|FG000|Overall Study|Lack of Efficacy|15|||
28084075|NCT00078312|54737566|FG000|Overall Study|Lost to Follow-up|41|||
28084076|NCT00078312|54737566|FG000|Overall Study|Physician Decision|9|||
28084077|NCT00078312|54737566|FG000|Overall Study|Protocol Violation|3|||
28084078|NCT00078312|54737566|FG000|Overall Study|Withdrawal by Subject|33|||
28084079|NCT00078312|54737566|FG000|Overall Study|Miscellaneous|33|||
28084080|NCT00003896|54737570|FG000|Overall Study|Adverse Event|16|||
28084081|NCT00003896|54737570|FG000|Overall Study|Withdrawal by Subject|1|||
28084082|NCT00003896|54737570|FG000|Overall Study|Lack of Efficacy|1|||
28084083|NCT00003896|54737570|FG000|Overall Study|Death|3|||
27832544|NCT01759511|54311970|FG000|Overall Study|Withdrawal by Subject|3|||
28084084|NCT00003896|54737570|FG000|Overall Study|not protocol specified|3|||
28084085|NCT00003896|54737570|FG000|Overall Study|ineligible|5|||
28084086|NCT00003830|54737577|FG000|Overall Study|No follow up data|3|||
27832545|NCT01732757|54311988|FG000|Overall Study|Lost to Follow-up|1|||
28084087|NCT00003830|54737578|FG001|Overall Study|No follow up data|0|||
28084088|NCT00003830|54737577|FG000|Overall Study|Sentinel node positive patients|829|||
28084089|NCT00003830|54737578|FG001|Overall Study|Sentinel node positive patients|793|||
28084090|NCT03407482|54737586|FG000|Overall Study|Adverse Event|12|||
28084091|NCT03407482|54737586|FG000|Overall Study|Disease Relapse|1|||
28084092|NCT03407482|54737586|FG000|Overall Study|Lost to Follow-up|1|||
28084093|NCT03407482|54737586|FG000|Overall Study|Non-Compliance With Study Drug|1|||
27732817|NCT02697591|54180542|FG000|Overall Study|Lost to Follow-up|0|||
27968997|NCT01070069|54626553|FG004|Overall Study|Death|1|||
28084094|NCT03407482|54737586|FG000|Overall Study|Pregnancy|2|||
28084095|NCT03407482|54737586|FG000|Overall Study|Protocol Violation|1|||
27968998|NCT01070069|54626549|FG000|Overall Study|Withdrawal by Subject|1|||
27968999|NCT01070069|54626550|FG001|Overall Study|Withdrawal by Subject|1|||
27969000|NCT01070069|54626551|FG002|Overall Study|Withdrawal by Subject|4|||
27969001|NCT01070069|54626552|FG003|Overall Study|Withdrawal by Subject|0|||
27969002|NCT01070069|54626553|FG004|Overall Study|Withdrawal by Subject|0|||
27969003|NCT01070069|54626549|FG000|Overall Study|Lost to Follow-up|4|||
27969004|NCT01070069|54626550|FG001|Overall Study|Lost to Follow-up|1|||
27969005|NCT01070069|54626551|FG002|Overall Study|Lost to Follow-up|0|||
27969006|NCT01070069|54626552|FG003|Overall Study|Lost to Follow-up|0|||
27969007|NCT01070069|54626553|FG004|Overall Study|Lost to Follow-up|3|||
27969008|NCT01068665|54626570|FG000|Overall Study|Adverse Event|5|||
27969009|NCT01068665|54626571|FG001|Overall Study|Adverse Event|4|||
27969010|NCT01068665|54626570|FG000|Overall Study|Lack of Efficacy|0|||
27969011|NCT01068665|54626571|FG001|Overall Study|Lack of Efficacy|2|||
27969012|NCT01068665|54626570|FG000|Overall Study|Protocol Violation|5|||
27969013|NCT01068665|54626571|FG001|Overall Study|Protocol Violation|2|||
27969014|NCT01068665|54626570|FG000|Overall Study|Withdrawal Criteria|3|||
27969015|NCT01068665|54626571|FG001|Overall Study|Withdrawal Criteria|9|||
27969016|NCT01068665|54626570|FG000|Overall Study|Other|17|||
27969017|NCT01068665|54626571|FG001|Overall Study|Other|12|||
27969018|NCT01001390|54626577|FG000|Overall Study|Failure to wear AFO device|2|||
27969019|NCT01001390|54626578|FG001|Overall Study|Failure to wear AFO device|0|||
27969020|NCT00772954|54626586|FG000|Overall Study|Adverse Event|0|||
27969021|NCT00772954|54626587|FG001|Overall Study|Adverse Event|0|||
27969022|NCT00772954|54626588|FG002|Overall Study|Adverse Event|1|||
27969023|NCT00781768|54626598|FG000|Overall Study|Not transplanted.|0|||
27969024|NCT00781768|54626599|FG001|Overall Study|Not transplanted.|2|||
27969025|NCT01005680|54626607|FG000|Overall Study|Lost to Follow-up|4|||
27969026|NCT01005680|54626608|FG001|Overall Study|Lost to Follow-up|6|||
27969027|NCT01005680|54626607|FG000|Overall Study|Withdrawal by Subject|1|||
27969028|NCT01005680|54626608|FG001|Overall Study|Withdrawal by Subject|4|||
27969029|NCT01005680|54626607|FG000|Overall Study|Physician Decision|1|||
27969030|NCT01005680|54626608|FG001|Overall Study|Physician Decision|1|||
27969031|NCT01005602|54626617|FG000|Overall Study|Excluded due to unreliable clinical data|1|||
27969032|NCT01005602|54626618|FG001|Overall Study|Excluded due to unreliable clinical data|0|||
27969033|NCT01068509|54626634|FG000|Overall Study|Death|0|||
27969034|NCT01068509|54626635|FG001|Overall Study|Death|0|||
27969035|NCT01068509|54626636|FG002|Overall Study|Death|1|||
27969036|NCT01068509|54626634|FG000|Overall Study|Disease Progression|5|||
27969037|NCT01068509|54626635|FG001|Overall Study|Disease Progression|20|||
27969038|NCT01068509|54626636|FG002|Overall Study|Disease Progression|18|||
27969039|NCT01068509|54626634|FG000|Overall Study|Lost to Follow-up|1|||
27969040|NCT01068509|54626635|FG001|Overall Study|Lost to Follow-up|0|||
27969041|NCT01068509|54626636|FG002|Overall Study|Lost to Follow-up|0|||
27969042|NCT01068509|54626634|FG000|Overall Study|Withdrew Consent|0|||
27969043|NCT01068509|54626635|FG001|Overall Study|Withdrew Consent|1|||
27969044|NCT01068509|54626636|FG002|Overall Study|Withdrew Consent|2|||
27969045|NCT01068509|54626634|FG000|Overall Study|Reason Not Specified|0|||
27969046|NCT01068509|54626635|FG001|Overall Study|Reason Not Specified|1|||
27969047|NCT01068509|54626636|FG002|Overall Study|Reason Not Specified|0|||
27969048|NCT01009034|54626643|FG000|Overall Study|Lost to Follow-up|2|||
27969049|NCT01009034|54626643|FG000|Overall Study|Withdrawal by Subject|2|||
27969050|NCT00768430|54626649|FG000|7 Day Endpoint|Withdrawal by Subject|2|||
27969051|NCT00768430|54626650|FG001|7 Day Endpoint|Withdrawal by Subject|3|||
27969052|NCT01064297|54626659|FG000|Overall Study|Lost to Follow-up|791|||
27969053|NCT01064297|54626660|FG001|Overall Study|Lost to Follow-up|48|||
27969054|NCT01064297|54626661|FG002|Overall Study|Lost to Follow-up|133|||
27969055|NCT00781456|54626678|FG000|Overall Study|Adverse Event|3|||
27969056|NCT00781456|54626679|FG001|Overall Study|Adverse Event|3|||
27969057|NCT00781456|54626678|FG000|Overall Study|Withdrawal by Subject|3|||
27969058|NCT00781456|54626679|FG001|Overall Study|Withdrawal by Subject|5|||
27969059|NCT00781456|54626678|FG000|Overall Study|Protocol Violation|4|||
27969060|NCT00781456|54626679|FG001|Overall Study|Protocol Violation|1|||
27969061|NCT00781456|54626678|FG000|Overall Study|Noncompliance With Protocol|1|||
27969062|NCT00781456|54626679|FG001|Overall Study|Noncompliance With Protocol|1|||
27969063|NCT00781456|54626678|FG000|Overall Study|Lost to Follow-up|10|||
27969064|NCT00781456|54626679|FG001|Overall Study|Lost to Follow-up|5|||
27969065|NCT00781456|54626678|FG000|Overall Study|Other Reason, Unknown|0|||
27969066|NCT00781456|54626679|FG001|Overall Study|Other Reason, Unknown|1|||
27969067|NCT00587158|54626687|FG000|Overall Study|Did not want to do 24 hr urine collect.|4|||
27969068|NCT00587158|54626688|FG001|Overall Study|Did not want to do 24 hr urine collect.|3|||
27969069|NCT00587158|54626687|FG000|Overall Study|Physician Decision|0|||
27969070|NCT00587158|54626688|FG001|Overall Study|Physician Decision|1|||
27969071|NCT00587158|54626687|FG000|Overall Study|Lost to Follow-up|1|||
27969072|NCT00587158|54626688|FG001|Overall Study|Lost to Follow-up|2|||
27969073|NCT00587158|54626687|FG000|Overall Study|Death|0|||
27969074|NCT00587158|54626688|FG001|Overall Study|Death|1|||
27969075|NCT00587158|54626687|FG000|Overall Study|Subject did not want to take study med|0|||
27969076|NCT00587158|54626688|FG001|Overall Study|Subject did not want to take study med|1|||
27969077|NCT00582907|54626694|FG000|1st Course|Withdrawal by Subject|1|||
27969078|NCT00582907|54626695|FG001|1st Course|Withdrawal by Subject|0|||
27969079|NCT00582907|54626696|FG002|1st Course|Withdrawal by Subject|0|||
27969080|NCT00582907|54626697|FG003|1st Course|Withdrawal by Subject|0|||
27969081|NCT00582907|54626694|FG000|1st Course|Lost to Follow-up|0|||
27969082|NCT00582907|54626695|FG001|1st Course|Lost to Follow-up|0|||
27969083|NCT00582907|54626696|FG002|1st Course|Lost to Follow-up|0|||
27969084|NCT00582907|54626697|FG003|1st Course|Lost to Follow-up|1|||
27969085|NCT00582907|54626694|FG000|2nd Course|Lack of Efficacy|1|||
27969086|NCT00582907|54626695|FG001|2nd Course|Lack of Efficacy|0|||
27969087|NCT00582907|54626696|FG002|2nd Course|Lack of Efficacy|0|||
27969088|NCT00582907|54626697|FG003|2nd Course|Lack of Efficacy|0|||
27969089|NCT01062113|54626706|FG000|Overall Study|Adverse Event|1|||
27969090|NCT01062113|54626707|FG001|Overall Study|Adverse Event|0|||
27969091|NCT01062113|54626708|FG002|Overall Study|Adverse Event|0|||
27969092|NCT01062113|54626706|FG000|Overall Study|Lack of Efficacy|38|||
27969093|NCT01062113|54626707|FG001|Overall Study|Lack of Efficacy|22|||
27969094|NCT01062113|54626708|FG002|Overall Study|Lack of Efficacy|31|||
27969095|NCT01062113|54626706|FG000|Overall Study|Withdrawal by Subject|1|||
28084096|NCT03407482|54737586|FG000|Overall Study|Study Terminated By Sponsor|106|||
28084097|NCT03407482|54737586|FG000|Overall Study|Withdrawal by Subject|6|||
28084098|NCT03407482|54737586|FG000|Overall Study|Data Entry Error|1|||
28084099|NCT00003782|54737593|FG000|Overall Study|No follow up data|30|||
28084100|NCT00003782|54737594|FG001|Overall Study|No follow up data|31|||
28084101|NCT00003782|54737595|FG002|Overall Study|No follow up data|26|||
28084102|NCT03389308|54737603|FG000|Overall Study|Withdrawal by Subject|5|||
28084103|NCT03389308|54737603|FG000|Overall Study|Lost to Follow-up|3|||
28084104|NCT03389308|54737603|FG000|Overall Study|Adverse Event|2|||
28084105|NCT03389308|54737603|FG000|Overall Study|Sponsor Request|2|||
28084106|NCT03407170|54737607|FG000|Overall Study|Adverse Event|1|||
28084107|NCT03406858|54737611|FG000|Overall Study|Failure to receive treatment drug.|1|||
28084108|NCT03406858|54737611|FG000|Overall Study|ineligible|1|||
28084109|NCT03406702|54737615|FG000|Overall Study|Missed Day 27 Dosing|1|||
28084110|NCT00003656|54737633|FG000|Overall Study|Adverse Event|0|||
28084111|NCT00003656|54737634|FG001|Overall Study|Adverse Event|1|||
28084112|NCT00003590|54737641|FG000|Overall Study|Ineligible Patient|1|||
28084113|NCT00003590|54737641|FG000|Overall Study|Adverse Event|7|||
28084114|NCT00003590|54737641|FG000|Overall Study|Withdrawal by Subject|1|||
28084115|NCT00003590|54737641|FG000|Overall Study|Lack of Efficacy|11|||
28084116|NCT00003590|54737641|FG000|Overall Study|Death|1|||
28084117|NCT00003590|54737641|FG000|Overall Study|Physician Decision|1|||
27832546|NCT01732757|54311989|FG001|Overall Study|Lost to Follow-up|0|||
27969096|NCT01062113|54626707|FG001|Overall Study|Withdrawal by Subject|0|||
27969097|NCT01062113|54626708|FG002|Overall Study|Withdrawal by Subject|0|||
27969098|NCT00772330|54626716|FG000|Overall Study|Lost to Follow-up|3|||
27969099|NCT01038869|54626723|FG000|Overall Study|Withdrawal by Subject|1|||
27969100|NCT01038869|54626723|FG000|Overall Study|Lost to Follow-up|6|||
27969101|NCT01038713|54626734|FG000|Overall Study|Patient to hospice|1|||
27969102|NCT01038713|54626735|FG001|Overall Study|Patient to hospice|1|||
27969103|NCT01038713|54626736|FG002|Overall Study|Patient to hospice|1|||
27969104|NCT01038713|54626734|FG000|Overall Study|Lost to Follow-up|3|||
27969105|NCT01038713|54626735|FG001|Overall Study|Lost to Follow-up|0|||
27969106|NCT01038713|54626736|FG002|Overall Study|Lost to Follow-up|0|||
28084118|NCT03416374|54737647|FG000|Between Treatment Period I and II|Other|0|||
28084119|NCT03416374|54737648|FG001|Between Treatment Period I and II|Other|9|||
28084120|NCT03416374|54737647|FG000|Treatment Period II|Lack of Efficacy|3|||
27832547|NCT01732757|54311990|FG002|Overall Study|Lost to Follow-up|0|||
27832548|NCT01758731|54311998|FG000|Overall Study|Physician Decision|1|||
27832549|NCT01606319|54312008|FG000|Overall Study|Lost to Follow-up|17|||
27832550|NCT01606319|54312009|FG001|Overall Study|Lost to Follow-up|14|||
27832551|NCT01606319|54312008|FG000|Overall Study|Withdrawal by Subject|9|||
27832552|NCT01606319|54312009|FG001|Overall Study|Withdrawal by Subject|12|||
27832553|NCT01606319|54312008|FG000|Overall Study|Physician Decision|1|||
27832554|NCT01606319|54312009|FG001|Overall Study|Physician Decision|2|||
27832555|NCT01606319|54312008|FG000|Overall Study|Lack of Efficacy|6|||
27832556|NCT01606319|54312009|FG001|Overall Study|Lack of Efficacy|8|||
27832557|NCT01606319|54312008|FG000|Overall Study|Adverse Event|1|||
27832558|NCT01606319|54312009|FG001|Overall Study|Adverse Event|4|||
27832559|NCT01757405|54312017|FG000|Overall Study|Lost to Follow-up|1|||
27832560|NCT01757405|54312018|FG001|Overall Study|Lost to Follow-up|1|||
27832561|NCT01757405|54312017|FG000|Overall Study|Withdrawal by Subject|0|||
28084121|NCT03416374|54737648|FG001|Treatment Period II|Lack of Efficacy|11|||
28084122|NCT03416374|54737647|FG000|Treatment Period II|Adverse Event|1|||
27832562|NCT01757405|54312018|FG001|Overall Study|Withdrawal by Subject|1|||
27832563|NCT01455597|54312024|FG000|Overall Study|Adverse Event|7|||
27832564|NCT01455597|54312025|FG001|Overall Study|Adverse Event|0|||
27969107|NCT01038713|54626734|FG000|Overall Study|Neuroendocrine Tumor|0|||
27969108|NCT01038713|54626735|FG001|Overall Study|Neuroendocrine Tumor|1|||
28084123|NCT03416374|54737648|FG001|Treatment Period II|Adverse Event|4|||
28084124|NCT03416374|54737647|FG000|Treatment Period II|Death|0|||
27969109|NCT01038713|54626736|FG002|Overall Study|Neuroendocrine Tumor|0|||
27969110|NCT01038713|54626734|FG000|Overall Study|died from PEP|0|||
27969111|NCT01038713|54626735|FG001|Overall Study|died from PEP|1|||
27969112|NCT01038713|54626736|FG002|Overall Study|died from PEP|0|||
27969113|NCT01038713|54626734|FG000|Overall Study|Autoimmune Pancreatitis|1|||
27969114|NCT01038713|54626735|FG001|Overall Study|Autoimmune Pancreatitis|0|||
27969115|NCT01038713|54626736|FG002|Overall Study|Autoimmune Pancreatitis|0|||
27969116|NCT00768040|54626746|FG000|Overall Study|Adverse Event|3|||
27969117|NCT00768040|54626747|FG001|Overall Study|Adverse Event|2|||
27969118|NCT00768040|54626746|FG000|Overall Study|Abnormal laboratory value|1|||
27969119|NCT00768040|54626747|FG001|Overall Study|Abnormal laboratory value|1|||
27969120|NCT00767806|54626755|FG000|Overall Study|Adverse Event|30|||
27969121|NCT00767806|54626756|FG001|Overall Study|Adverse Event|11|||
27969122|NCT00767806|54626755|FG000|Overall Study|Withdrawal by Subject|8|||
27969123|NCT00767806|54626756|FG001|Overall Study|Withdrawal by Subject|13|||
27969124|NCT00767806|54626755|FG000|Overall Study|Protocol Violation|6|||
27969125|NCT00767806|54626756|FG001|Overall Study|Protocol Violation|5|||
27969126|NCT00767806|54626755|FG000|Overall Study|Lack of Efficacy|1|||
27969127|NCT00767806|54626756|FG001|Overall Study|Lack of Efficacy|9|||
27969128|NCT00767806|54626755|FG000|Overall Study|Physician Decision|4|||
27969129|NCT00767806|54626756|FG001|Overall Study|Physician Decision|3|||
27969130|NCT00767806|54626755|FG000|Overall Study|Lost to Follow-up|1|||
27969131|NCT00767806|54626756|FG001|Overall Study|Lost to Follow-up|4|||
28084125|NCT03416374|54737648|FG001|Treatment Period II|Death|1|||
28084126|NCT03416374|54737647|FG000|Treatment Period II|Other|0|||
28084127|NCT03416374|54737648|FG001|Treatment Period II|Other|2|||
28084128|NCT03799952|54737659|FG000|Overall Study|Program was too easy, discontinued|1|||
28084129|NCT03799952|54737660|FG001|Overall Study|Program was too easy, discontinued|0|||
28084130|NCT03799952|54737659|FG000|Overall Study|Lost to Follow-up|0|||
28084131|NCT03799952|54737660|FG001|Overall Study|Lost to Follow-up|2|||
28084132|NCT00077766|54737668|FG000|Overall Study|Adverse Event|1|||
28084133|NCT00077766|54737669|FG001|Overall Study|Adverse Event|1|||
28084134|NCT00077766|54737668|FG000|Overall Study|Withdrawal by Subject|4|||
28084135|NCT00077766|54737669|FG001|Overall Study|Withdrawal by Subject|3|||
28084136|NCT00077766|54737668|FG000|Overall Study|Death|12|||
28084137|NCT00077766|54737669|FG001|Overall Study|Death|10|||
28084138|NCT00077766|54737668|FG000|Overall Study|Lost to Follow-up|2|||
28165245|NCT03935594|54835867|FG000|Overall Study|Physician Decision|3|||
27732818|NCT02697591|54180543|FG001|Overall Study|Lost to Follow-up|0|||
27732819|NCT02697591|54180544|FG002|Overall Study|Lost to Follow-up|0|||
27969132|NCT00767806|54626755|FG000|Overall Study|Entry Criteria Not Met|1|||
27969133|NCT00767806|54626756|FG001|Overall Study|Entry Criteria Not Met|1|||
27969134|NCT00767806|54626755|FG000|Overall Study|Sponsor Decision|0|||
27969135|NCT00767806|54626756|FG001|Overall Study|Sponsor Decision|1|||
27969136|NCT00780910|54626762|FG000|Overall Study|Adverse Event|2|||
27969137|NCT00767104|54626768|FG000|Overall Study|Lost to Follow-up|1|||
27969138|NCT00767104|54626769|FG001|Overall Study|Lost to Follow-up|2|||
27969139|NCT00771472|54626777|FG000|Overall Study|Physician Decision|2|||
27969140|NCT00771472|54626778|FG001|Overall Study|Physician Decision|3|||
27969141|NCT00771472|54626777|FG000|Overall Study|Progressive Disease|3|||
27969142|NCT00771472|54626778|FG001|Overall Study|Progressive Disease|1|||
27969143|NCT00771472|54626777|FG000|Overall Study|Protocol Violation|1|||
27969144|NCT00771472|54626778|FG001|Overall Study|Protocol Violation|0|||
27969145|NCT00771316|54626785|FG000|Overall Study|Adverse Event|0|||
27969146|NCT00771316|54626786|FG001|Overall Study|Adverse Event|1|||
27969147|NCT00771316|54626785|FG000|Overall Study|Patient withdrew consent|1|||
27969148|NCT00771316|54626786|FG001|Overall Study|Patient withdrew consent|0|||
27969149|NCT00771316|54626785|FG000|Overall Study|Discontinued due to early termination|1|||
27969150|NCT00771316|54626786|FG001|Overall Study|Discontinued due to early termination|0|||
27969151|NCT00770770|54626794|FG000|Overall Study|Lost to Follow-up|1|||
27969152|NCT00770770|54626795|FG001|Overall Study|Lost to Follow-up|0|||
27969153|NCT00770770|54626794|FG000|Overall Study|Withdrawal by Subject|1|||
27969154|NCT00770770|54626795|FG001|Overall Study|Withdrawal by Subject|0|||
27969155|NCT00770770|54626794|FG000|Overall Study|Death|0|||
27969156|NCT00770770|54626795|FG001|Overall Study|Death|1|||
27969157|NCT00770770|54626794|FG000|Overall Study|Study Terminated|8|||
27969158|NCT00770770|54626795|FG001|Overall Study|Study Terminated|0|||
27969159|NCT00766636|54626803|FG000|Overall Study|Withdrawal by Subject|1|||
28084139|NCT00077766|54737669|FG001|Overall Study|Lost to Follow-up|0|||
28084140|NCT00077766|54737668|FG000|Overall Study|Protocol Violation|1|||
28084141|NCT00077766|54737669|FG001|Overall Study|Protocol Violation|0|||
28165246|NCT02512042|54835875|FG000|Overall Study|Adverse Event|0|||
28165247|NCT02512042|54835876|FG001|Overall Study|Adverse Event|4|||
27969160|NCT00766636|54626804|FG001|Overall Study|Withdrawal by Subject|1|||
27969161|NCT00766636|54626803|FG000|Overall Study|Incomplete Treatment|0|||
27969162|NCT00766636|54626804|FG001|Overall Study|Incomplete Treatment|1|||
27969163|NCT00766636|54626803|FG000|Overall Study|Adverse Event|1|||
27969164|NCT00766636|54626804|FG001|Overall Study|Adverse Event|0|||
27969165|NCT00766636|54626803|FG000|Overall Study|Disease Progression|1|||
27969166|NCT00766636|54626804|FG001|Overall Study|Disease Progression|0|||
27969167|NCT00770692|54626814|FG000|Overall Study|Withdrawal by Subject|7|||
27969168|NCT00770692|54626815|FG001|Overall Study|Withdrawal by Subject|9|||
27969169|NCT00770692|54626816|FG002|Overall Study|Withdrawal by Subject|9|||
27969170|NCT00770692|54626817|FG003|Overall Study|Withdrawal by Subject|6|||
27969171|NCT00770692|54626814|FG000|Overall Study|Adverse Event|3|||
27969172|NCT00770692|54626815|FG001|Overall Study|Adverse Event|0|||
27969173|NCT00770692|54626816|FG002|Overall Study|Adverse Event|4|||
27969174|NCT00770692|54626817|FG003|Overall Study|Adverse Event|4|||
27969175|NCT00770692|54626814|FG000|Overall Study|Investigator judgment|2|||
27969176|NCT00770692|54626815|FG001|Overall Study|Investigator judgment|0|||
27969177|NCT00770692|54626816|FG002|Overall Study|Investigator judgment|1|||
27969178|NCT00770692|54626817|FG003|Overall Study|Investigator judgment|1|||
27969179|NCT03213691|54626827|FG000|Overall Study|Adverse Event|2|||
27969180|NCT03213691|54626827|FG000|Overall Study|Death|3|||
27969181|NCT03213691|54626827|FG000|Overall Study|Physician Decision|1|||
27969182|NCT03213691|54626827|FG000|Overall Study|Progressive Disease|14|||
27969183|NCT03213691|54626827|FG000|Overall Study|Ineligible|1|||
27969184|NCT02743819|54626835|FG000|Overall Study|Lack of Efficacy|5|||
27969185|NCT02743819|54626835|FG000|Overall Study|Death|2|||
27969186|NCT02743819|54626835|FG000|Overall Study|Adverse Event|1|||
27969187|NCT01004822|54626847|FG000|Overall Study|Objective progression or relapse|3|||
27969188|NCT01004822|54626848|FG001|Overall Study|Objective progression or relapse|3|||
28084142|NCT00077766|54737668|FG000|Overall Study|Kidney Transplantation|9|||
28084143|NCT00077766|54737669|FG001|Overall Study|Kidney Transplantation|5|||
28084144|NCT00077766|54737668|FG000|Overall Study|Transplantation|5|||
28084145|NCT00077766|54737669|FG001|Overall Study|Transplantation|1|||
28084146|NCT00077766|54737668|FG000|Overall Study|Investigators Discretion|1|||
28084147|NCT00077766|54737669|FG001|Overall Study|Investigators Discretion|0|||
28084148|NCT00077766|54737668|FG000|Overall Study|Participant's decision|1|||
28084149|NCT00077766|54737669|FG001|Overall Study|Participant's decision|0|||
28084150|NCT00077766|54737668|FG000|Overall Study|Dialysis Discontinued|1|||
28084151|NCT00077766|54737669|FG001|Overall Study|Dialysis Discontinued|0|||
28084152|NCT00077766|54737668|FG000|Overall Study|Dialysis|0|||
28084153|NCT00077766|54737669|FG001|Overall Study|Dialysis|1|||
28165248|NCT02512042|54835875|FG000|Overall Study|Withdrawal by Subject|6|||
28165249|NCT02512042|54835876|FG001|Overall Study|Withdrawal by Subject|6|||
28165250|NCT02512042|54835875|FG000|Overall Study|Non-compliance with study drug|1|||
28165251|NCT02512042|54835876|FG001|Overall Study|Non-compliance with study drug|2|||
28165252|NCT02512042|54835875|FG000|Overall Study|Lost to Follow-up|5|||
28165253|NCT02512042|54835876|FG001|Overall Study|Lost to Follow-up|2|||
28165254|NCT02512042|54835875|FG000|Overall Study|Other|11|||
28165255|NCT02512042|54835876|FG001|Overall Study|Other|11|||
28165256|NCT02911025|54835882|FG000|Overall Study|Lost to Follow-up|3|||
28165257|NCT02919475|54835891|FG000|Overall Study|Adverse Event|3|||
28165258|NCT02919475|54835892|FG001|Overall Study|Adverse Event|3|||
27969189|NCT01004822|54626849|FG002|Overall Study|Objective progression or relapse|0|||
27969190|NCT01004822|54626850|FG003|Overall Study|Objective progression or relapse|1|||
27969191|NCT01004822|54626851|FG004|Overall Study|Objective progression or relapse|2|||
27969192|NCT01004822|54626852|FG005|Overall Study|Objective progression or relapse|2|||
27969193|NCT01004822|54626853|FG006|Overall Study|Objective progression or relapse|1|||
27969194|NCT01004822|54626854|FG007|Overall Study|Objective progression or relapse|4|||
27969195|NCT01004822|54626847|FG000|Overall Study|Global deterioration of health status|0|||
27969196|NCT01004822|54626848|FG001|Overall Study|Global deterioration of health status|0|||
27969197|NCT01004822|54626849|FG002|Overall Study|Global deterioration of health status|0|||
27969198|NCT01004822|54626850|FG003|Overall Study|Global deterioration of health status|1|||
27969199|NCT01004822|54626851|FG004|Overall Study|Global deterioration of health status|0|||
27969200|NCT01004822|54626852|FG005|Overall Study|Global deterioration of health status|0|||
27969201|NCT01004822|54626853|FG006|Overall Study|Global deterioration of health status|1|||
27969202|NCT01004822|54626854|FG007|Overall Study|Global deterioration of health status|0|||
27969203|NCT01004822|54626847|FG000|Overall Study|No longer willing to continue|0|||
27969204|NCT01004822|54626848|FG001|Overall Study|No longer willing to continue|0|||
27969205|NCT01004822|54626849|FG002|Overall Study|No longer willing to continue|0|||
27969206|NCT01004822|54626850|FG003|Overall Study|No longer willing to continue|1|||
27969207|NCT01004822|54626851|FG004|Overall Study|No longer willing to continue|2|||
27969208|NCT01004822|54626852|FG005|Overall Study|No longer willing to continue|1|||
28165259|NCT02919475|54835893|FG002|Overall Study|Adverse Event|3|||
28165260|NCT02919475|54835894|FG003|Overall Study|Adverse Event|9|||
28165261|NCT02919475|54835895|FG004|Overall Study|Adverse Event|2|||
28165262|NCT02919475|54835891|FG000|Overall Study|Death|0|||
28165263|NCT02919475|54835892|FG001|Overall Study|Death|1|||
27969209|NCT01004822|54626853|FG006|Overall Study|No longer willing to continue|1|||
27969210|NCT01004822|54626854|FG007|Overall Study|No longer willing to continue|0|||
27969211|NCT01004822|54626847|FG000|Overall Study|Adverse Event|0|||
28165264|NCT02919475|54835893|FG002|Overall Study|Death|0|||
28165265|NCT02919475|54835894|FG003|Overall Study|Death|0|||
27969212|NCT01004822|54626848|FG001|Overall Study|Adverse Event|0|||
27969213|NCT01004822|54626849|FG002|Overall Study|Adverse Event|0|||
27969214|NCT01004822|54626850|FG003|Overall Study|Adverse Event|0|||
27969215|NCT01004822|54626851|FG004|Overall Study|Adverse Event|0|||
27969216|NCT01004822|54626852|FG005|Overall Study|Adverse Event|0|||
27969217|NCT01004822|54626853|FG006|Overall Study|Adverse Event|1|||
27969218|NCT01004822|54626854|FG007|Overall Study|Adverse Event|1|||
27969219|NCT01004822|54626847|FG000|Overall Study|Other|0|||
27969220|NCT01004822|54626848|FG001|Overall Study|Other|0|||
27969221|NCT01004822|54626849|FG002|Overall Study|Other|4|||
27969222|NCT01004822|54626850|FG003|Overall Study|Other|1|||
27969223|NCT01004822|54626851|FG004|Overall Study|Other|0|||
27969224|NCT01004822|54626852|FG005|Overall Study|Other|1|||
27855366|NCT01277549|54376561|FG000|Overall Study|Protocol Violation|10|||
27855367|NCT01277549|54376562|FG001|Overall Study|Protocol Violation|1|||
27855368|NCT01277549|54376561|FG000|Overall Study|Physician Decision|2|||
27855369|NCT01277549|54376562|FG001|Overall Study|Physician Decision|1|||
27855370|NCT01276847|54376574|FG000|Overall Study|Withdrawal by Subject|1|||
27855371|NCT01276847|54376575|FG001|Overall Study|Withdrawal by Subject|0|||
27855372|NCT01276847|54376576|FG002|Overall Study|Withdrawal by Subject|0|||
27855373|NCT01276457|54376608|FG000|Core Study|Adverse Event|6|||
27855374|NCT01276457|54376609|FG001|Core Study|Adverse Event|3|||
27855375|NCT01276457|54376608|FG000|Core Study|Lost to Follow-up|1|||
27855376|NCT01276457|54376609|FG001|Core Study|Lost to Follow-up|2|||
27855377|NCT01276457|54376608|FG000|Core Study|Administrative problems|1|||
27855378|NCT01276457|54376609|FG001|Core Study|Administrative problems|1|||
27855379|NCT01276457|54376608|FG000|Core Study|Death|2|||
27855380|NCT01276457|54376609|FG001|Core Study|Death|2|||
27855381|NCT01276457|54376608|FG000|Core Study|Lack of Efficacy|3|||
27969225|NCT01004822|54626853|FG006|Overall Study|Other|0|||
27969226|NCT01004822|54626854|FG007|Overall Study|Other|0|||
27969227|NCT01001234|54626879|FG000|Overall Study|Withdrawal by Subject|2|||
27969228|NCT01001234|54626880|FG001|Overall Study|Withdrawal by Subject|0|||
27969229|NCT01001234|54626881|FG002|Overall Study|Withdrawal by Subject|3|||
27969230|NCT01001234|54626882|FG003|Overall Study|Withdrawal by Subject|0|||
27969231|NCT01001234|54626883|FG004|Overall Study|Withdrawal by Subject|0|||
27969232|NCT01001234|54626879|FG000|Overall Study|Protocol Violation|34|||
27969233|NCT01001234|54626880|FG001|Overall Study|Protocol Violation|3|||
27969234|NCT01001234|54626881|FG002|Overall Study|Protocol Violation|19|||
27969235|NCT01001234|54626882|FG003|Overall Study|Protocol Violation|18|||
27969236|NCT01001234|54626883|FG004|Overall Study|Protocol Violation|0|||
27969237|NCT01001234|54626879|FG000|Overall Study|Lost to Follow-up|0|||
27969238|NCT01001234|54626880|FG001|Overall Study|Lost to Follow-up|0|||
27969239|NCT01001234|54626881|FG002|Overall Study|Lost to Follow-up|1|||
27969240|NCT01001234|54626882|FG003|Overall Study|Lost to Follow-up|2|||
27969241|NCT01001234|54626883|FG004|Overall Study|Lost to Follow-up|0|||
27969242|NCT01001234|54626879|FG000|Overall Study|Physician Decision|1|||
27969243|NCT01001234|54626880|FG001|Overall Study|Physician Decision|0|||
27969244|NCT01001234|54626881|FG002|Overall Study|Physician Decision|0|||
27969245|NCT01001234|54626882|FG003|Overall Study|Physician Decision|0|||
27969246|NCT01001234|54626883|FG004|Overall Study|Physician Decision|0|||
27969247|NCT01001234|54626879|FG000|Overall Study|Not Treated: Adverse Event|1|||
27969248|NCT01001234|54626880|FG001|Overall Study|Not Treated: Adverse Event|0|||
27969249|NCT01001234|54626881|FG002|Overall Study|Not Treated: Adverse Event|0|||
27969250|NCT01001234|54626882|FG003|Overall Study|Not Treated: Adverse Event|0|||
27969251|NCT01001234|54626883|FG004|Overall Study|Not Treated: Adverse Event|0|||
27969252|NCT01001234|54626879|FG000|Overall Study|Not Treated: Withdrawal by Subject|23|||
27969253|NCT01001234|54626880|FG001|Overall Study|Not Treated: Withdrawal by Subject|2|||
27969254|NCT01001234|54626881|FG002|Overall Study|Not Treated: Withdrawal by Subject|2|||
28084154|NCT00077766|54737668|FG000|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0|||
28084155|NCT00077766|54737669|FG001|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1|||
28084156|NCT00077766|54737668|FG000|Overall Study|Started Nocturnal Dialysis|0|||
28084157|NCT00077766|54737669|FG001|Overall Study|Started Nocturnal Dialysis|1|||
28084158|NCT00077766|54737668|FG000|Overall Study|Stop Dialysis|0|||
28084159|NCT00077766|54737669|FG001|Overall Study|Stop Dialysis|1|||
28084160|NCT00077766|54737668|FG000|Overall Study|Participants Vacation|2|||
28084161|NCT00077766|54737669|FG001|Overall Study|Participants Vacation|1|||
27732820|NCT02697591|54180545|FG003|Overall Study|Lost to Follow-up|0|||
27969255|NCT01001234|54626882|FG003|Overall Study|Not Treated: Withdrawal by Subject|0|||
27969256|NCT01001234|54626883|FG004|Overall Study|Not Treated: Withdrawal by Subject|0|||
27969257|NCT01001234|54626879|FG000|Overall Study|Not Treated: Protocol Violation|3|||
28084162|NCT03799718|54737676|FG000|Overall Study|Adverse Event|2|||
28084163|NCT03388138|54737682|FG000|Overall Study|Protocol Violation|1|||
27855382|NCT01276457|54376609|FG001|Core Study|Lack of Efficacy|12|||
27855383|NCT01276457|54376608|FG000|Extension Study|Lost to Follow-up|3|||
27855384|NCT01276457|54376609|FG001|Extension Study|Lost to Follow-up|0|||
27969258|NCT01001234|54626880|FG001|Overall Study|Not Treated: Protocol Violation|0|||
27855385|NCT01276457|54376608|FG000|Extension Study|Death|0|||
27855386|NCT01276457|54376609|FG001|Extension Study|Death|1|||
28084164|NCT03388138|54737683|FG001|Overall Study|Protocol Violation|0|||
28084165|NCT02952898|54737692|FG000|Overall Study|Withdrawal by Subject|10|||
28084166|NCT02952898|54737693|FG001|Overall Study|Withdrawal by Subject|8|||
28084167|NCT02952898|54737694|FG002|Overall Study|Withdrawal by Subject|8|||
28084168|NCT02952898|54737692|FG000|Overall Study|Adverse Event|8|||
27969259|NCT01001234|54626881|FG002|Overall Study|Not Treated: Protocol Violation|0|||
27969260|NCT01001234|54626882|FG003|Overall Study|Not Treated: Protocol Violation|0|||
27969261|NCT01001234|54626883|FG004|Overall Study|Not Treated: Protocol Violation|0|||
27969262|NCT01001234|54626879|FG000|Overall Study|Not Treated: Lost to Follow-up|53|||
27969263|NCT01001234|54626880|FG001|Overall Study|Not Treated: Lost to Follow-up|4|||
27969264|NCT01001234|54626881|FG002|Overall Study|Not Treated: Lost to Follow-up|7|||
27969265|NCT01001234|54626882|FG003|Overall Study|Not Treated: Lost to Follow-up|5|||
27969266|NCT01001234|54626883|FG004|Overall Study|Not Treated: Lost to Follow-up|0|||
27969267|NCT01001234|54626879|FG000|Overall Study|Not Treated: Pregnancy|3|||
27969268|NCT01001234|54626880|FG001|Overall Study|Not Treated: Pregnancy|0|||
27969269|NCT01001234|54626881|FG002|Overall Study|Not Treated: Pregnancy|0|||
27969270|NCT01001234|54626882|FG003|Overall Study|Not Treated: Pregnancy|0|||
27969271|NCT01001234|54626883|FG004|Overall Study|Not Treated: Pregnancy|0|||
27969272|NCT01001234|54626879|FG000|Overall Study|Not Treated: Physician Decision|37|||
27969273|NCT01001234|54626880|FG001|Overall Study|Not Treated: Physician Decision|4|||
27969274|NCT01001234|54626881|FG002|Overall Study|Not Treated: Physician Decision|0|||
27969275|NCT01001234|54626882|FG003|Overall Study|Not Treated: Physician Decision|0|||
27969276|NCT01001234|54626883|FG004|Overall Study|Not Treated: Physician Decision|0|||
27969277|NCT01001234|54626879|FG000|Overall Study|Not Treated: Lack of Qualifying Event|248|||
27969278|NCT01001234|54626880|FG001|Overall Study|Not Treated: Lack of Qualifying Event|13|||
27969279|NCT01001234|54626881|FG002|Overall Study|Not Treated: Lack of Qualifying Event|0|||
27969280|NCT01001234|54626882|FG003|Overall Study|Not Treated: Lack of Qualifying Event|0|||
27969281|NCT01001234|54626883|FG004|Overall Study|Not Treated: Lack of Qualifying Event|0|||
27969282|NCT01004510|54626889|FG000|Overall Study|Adverse Event|1|||
27969283|NCT02609503|54626893|FG000|Overall Study|Adverse Event|1|||
27969284|NCT02609503|54626893|FG000|Overall Study|Death|1|||
27969285|NCT02609503|54626893|FG000|Overall Study|Withdrawal by Subject|1|||
27969286|NCT02609503|54626893|FG000|Overall Study|Disease progression|1|||
27969287|NCT01004432|54626900|FG000|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20|||
27969288|NCT01004432|54626901|FG001|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
27969289|NCT01004432|54626902|FG002|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
27969290|NCT01004432|54626903|FG003|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
27969291|NCT01004432|54626904|FG004|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
27969292|NCT01004432|54626900|FG000|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29|||
27969293|NCT01004432|54626901|FG001|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
27969294|NCT01004432|54626902|FG002|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
27969295|NCT01004432|54626903|FG003|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
27969296|NCT01004432|54626904|FG004|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
27969297|NCT01004432|54626900|FG000|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17|||
27969298|NCT01004432|54626901|FG001|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
27969299|NCT01004432|54626902|FG002|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
27969300|NCT01004432|54626903|FG003|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
27969301|NCT01004432|54626904|FG004|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
27969302|NCT01004432|54626900|FG000|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15|||
27969303|NCT01004432|54626901|FG001|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
27969304|NCT01004432|54626902|FG002|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
28084169|NCT02952898|54737693|FG001|Overall Study|Adverse Event|8|||
27969305|NCT01004432|54626903|FG003|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
27969306|NCT01004432|54626904|FG004|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
27969307|NCT01004432|54626900|FG000|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2|||
28084170|NCT02952898|54737694|FG002|Overall Study|Adverse Event|3|||
28084171|NCT02952898|54737692|FG000|Overall Study|Lost to Follow-up|3|||
28084172|NCT02952898|54737693|FG001|Overall Study|Lost to Follow-up|2|||
28084173|NCT02952898|54737694|FG002|Overall Study|Lost to Follow-up|2|||
28084174|NCT02952898|54737692|FG000|Overall Study|Non-compliance with study drug|1|||
28084175|NCT02952898|54737693|FG001|Overall Study|Non-compliance with study drug|1|||
28084176|NCT02952898|54737694|FG002|Overall Study|Non-compliance with study drug|2|||
28165266|NCT02919475|54835895|FG004|Overall Study|Death|0|||
28165267|NCT02919475|54835891|FG000|Overall Study|Lost to Follow-up|0|||
28165268|NCT02919475|54835892|FG001|Overall Study|Lost to Follow-up|0|||
27732821|NCT02697591|54180546|FG004|Overall Study|Lost to Follow-up|0|||
27732822|NCT02697591|54180547|FG005|Overall Study|Lost to Follow-up|1|||
28165269|NCT02919475|54835893|FG002|Overall Study|Lost to Follow-up|0|||
28165270|NCT02919475|54835894|FG003|Overall Study|Lost to Follow-up|1|||
28165271|NCT02919475|54835895|FG004|Overall Study|Lost to Follow-up|0|||
28165272|NCT02919475|54835891|FG000|Overall Study|Withdrawal by Subject|2|||
27969308|NCT01004432|54626901|FG001|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
27969309|NCT01004432|54626902|FG002|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
27969310|NCT01004432|54626903|FG003|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
27969311|NCT01004432|54626904|FG004|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
27969312|NCT01004432|54626900|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
27969313|NCT01004432|54626901|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1|||
27969314|NCT01004432|54626902|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5|||
27969315|NCT01004432|54626903|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6|||
27969316|NCT01004432|54626904|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
27969317|NCT01004432|54626900|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
27969318|NCT01004432|54626901|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
27969319|NCT01004432|54626902|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
27969320|NCT01004432|54626903|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4|||
27969321|NCT01004432|54626904|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
27969322|NCT01004432|54626900|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
27969323|NCT01004432|54626901|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1|||
27969324|NCT01004432|54626902|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4|||
27969325|NCT01004432|54626903|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7|||
27969326|NCT01004432|54626904|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
27969327|NCT01004432|54626900|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
27969328|NCT01004432|54626901|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
27969329|NCT01004432|54626902|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
27969330|NCT01004432|54626903|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Death|1|||
27969331|NCT01004432|54626904|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
27969332|NCT01004432|54626900|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
27969333|NCT01004432|54626901|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2|||
27969334|NCT01004432|54626902|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24|||
27969335|NCT01004432|54626903|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37|||
27969336|NCT01004432|54626904|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
27969337|NCT01004432|54626900|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
27969338|NCT01004432|54626901|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
27969339|NCT01004432|54626902|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1|||
27969340|NCT01004432|54626903|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
27969341|NCT01004432|54626904|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
27969342|NCT01004432|54626900|FG000|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
27969343|NCT01004432|54626901|FG001|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
27969344|NCT01004432|54626902|FG002|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
27969345|NCT01004432|54626903|FG003|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
27969346|NCT01004432|54626904|FG004|OL Study Extension (Week 52 - 76)|Adverse Event|2|||
27969347|NCT01004432|54626900|FG000|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
27969348|NCT01004432|54626901|FG001|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
27969349|NCT01004432|54626902|FG002|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
27969350|NCT01004432|54626903|FG003|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
27969351|NCT01004432|54626904|FG004|OL Study Extension (Week 52 - 76)|Protocol Violation|4|||
27969352|NCT01004432|54626900|FG000|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
27969353|NCT01004432|54626901|FG001|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
27969354|NCT01004432|54626902|FG002|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
27969355|NCT01004432|54626903|FG003|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
27969356|NCT01004432|54626904|FG004|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2|||
27969357|NCT01004432|54626900|FG000|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
27969358|NCT01004432|54626901|FG001|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
27969359|NCT01004432|54626902|FG002|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
27969360|NCT01004432|54626903|FG003|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
27969361|NCT01004432|54626904|FG004|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10|||
27969362|NCT01000610|54626918|FG000|Overall Study|Adverse Event|1|||
27969363|NCT01000610|54626918|FG000|Overall Study|Lost to Follow-up|4|||
27969364|NCT01000610|54626918|FG000|Overall Study|Treatment failure|1|||
27969365|NCT01877655|54626924|FG000|Overall Study|Death|57|||
27969366|NCT01877655|54626925|FG001|Overall Study|Death|52|||
27969367|NCT01877655|54626924|FG000|Overall Study|Withdrawal by Subject|18|||
27969368|NCT01877655|54626925|FG001|Overall Study|Withdrawal by Subject|26|||
27969369|NCT01877655|54626924|FG000|Overall Study|Physician Decision|11|||
27969370|NCT01877655|54626925|FG001|Overall Study|Physician Decision|10|||
27855387|NCT01276457|54376608|FG000|Extension Study|Lack of Efficacy|3|||
27855388|NCT01276457|54376609|FG001|Extension Study|Lack of Efficacy|1|||
27855389|NCT01276379|54376699|FG000|Overall Study|Screening failure|40|||
27969371|NCT01877655|54626924|FG000|Overall Study|Miscellaneous|4|||
27969372|NCT01877655|54626925|FG001|Overall Study|Miscellaneous|4|||
27969373|NCT01877655|54626924|FG000|Overall Study|Randomized but Never Received Drug|8|||
27969374|NCT01877655|54626925|FG001|Overall Study|Randomized but Never Received Drug|5|||
27969375|NCT00586924|54626937|FG000|Overall Study|Adverse event/serious adverse event|0|||
27969376|NCT00586924|54626938|FG001|Overall Study|Adverse event/serious adverse event|0|||
27969377|NCT00586924|54626939|FG002|Overall Study|Adverse event/serious adverse event|0|||
27969378|NCT00586924|54626940|FG003|Overall Study|Adverse event/serious adverse event|1|||
27969379|NCT00586924|54626941|FG004|Overall Study|Adverse event/serious adverse event|0|||
27969380|NCT00586924|54626942|FG005|Overall Study|Adverse event/serious adverse event|2|||
27969381|NCT00586924|54626937|FG000|Overall Study|Initiation of alternative cancer therapy|0|||
27969382|NCT00586924|54626938|FG001|Overall Study|Initiation of alternative cancer therapy|0|||
27969383|NCT00586924|54626939|FG002|Overall Study|Initiation of alternative cancer therapy|0|||
27969384|NCT00586924|54626940|FG003|Overall Study|Initiation of alternative cancer therapy|0|||
27969385|NCT00586924|54626941|FG004|Overall Study|Initiation of alternative cancer therapy|0|||
27969386|NCT00586924|54626942|FG005|Overall Study|Initiation of alternative cancer therapy|1|||
27969387|NCT00586924|54626937|FG000|Overall Study|Disease progression|0|||
27969388|NCT00586924|54626938|FG001|Overall Study|Disease progression|0|||
27969389|NCT00586924|54626939|FG002|Overall Study|Disease progression|0|||
27969390|NCT00586924|54626940|FG003|Overall Study|Disease progression|1|||
27969391|NCT00586924|54626941|FG004|Overall Study|Disease progression|1|||
27969392|NCT00586924|54626942|FG005|Overall Study|Disease progression|0|||
27969393|NCT00586924|54626937|FG000|Overall Study|Development of neutralizing antibodies|2|||
27969394|NCT00586924|54626938|FG001|Overall Study|Development of neutralizing antibodies|2|||
27969395|NCT00586924|54626939|FG002|Overall Study|Development of neutralizing antibodies|2|||
27969396|NCT00586924|54626940|FG003|Overall Study|Development of neutralizing antibodies|0|||
27969397|NCT00586924|54626941|FG004|Overall Study|Development of neutralizing antibodies|0|||
27969398|NCT00586924|54626942|FG005|Overall Study|Development of neutralizing antibodies|22|||
27969399|NCT00586924|54626937|FG000|Overall Study|Complete response|0|||
27969400|NCT00586924|54626938|FG001|Overall Study|Complete response|1|||
27969401|NCT00586924|54626939|FG002|Overall Study|Complete response|0|||
27969402|NCT00586924|54626940|FG003|Overall Study|Complete response|0|||
27969403|NCT00586924|54626941|FG004|Overall Study|Complete response|2|||
27969404|NCT00586924|54626942|FG005|Overall Study|Complete response|2|||
27969405|NCT00586924|54626937|FG000|Overall Study|Other|1|||
27969406|NCT00586924|54626938|FG001|Overall Study|Other|0|||
27969407|NCT00586924|54626939|FG002|Overall Study|Other|1|||
27969408|NCT00586924|54626940|FG003|Overall Study|Other|1|||
27969409|NCT00586924|54626941|FG004|Overall Study|Other|1|||
27969410|NCT00586924|54626942|FG005|Overall Study|Other|6|||
27969411|NCT01000376|54626958|FG000|Cycle 1 Day 1|Adverse Event|1|||
27969412|NCT01000376|54626959|FG001|Cycle 1 Day 1|Adverse Event|0|||
27969413|NCT01000376|54626958|FG000|Cycle 1 Day 1|Progressive Disease|1|||
27969414|NCT01000376|54626959|FG001|Cycle 1 Day 1|Progressive Disease|0|||
27969415|NCT01038635|54626974|FG000|Overall Study|Disease Progression|2|||
27969416|NCT01038635|54626975|FG001|Overall Study|Disease Progression|0|||
27969417|NCT01038635|54626976|FG002|Overall Study|Disease Progression|0|||
27969418|NCT01038635|54626977|FG003|Overall Study|Disease Progression|0|||
27969419|NCT01038635|54626978|FG004|Overall Study|Disease Progression|0|||
27969420|NCT01038635|54626979|FG005|Overall Study|Disease Progression|0|||
27969421|NCT01038635|54626980|FG006|Overall Study|Disease Progression|1|||
27969422|NCT01038635|54626981|FG007|Overall Study|Disease Progression|4|||
27969423|NCT01038635|54626982|FG008|Overall Study|Disease Progression|0|||
27969424|NCT01038635|54626974|FG000|Overall Study|Death|0|||
27969425|NCT01038635|54626975|FG001|Overall Study|Death|0|||
27969426|NCT01038635|54626976|FG002|Overall Study|Death|0|||
27969427|NCT01038635|54626977|FG003|Overall Study|Death|0|||
27969428|NCT01038635|54626978|FG004|Overall Study|Death|1|||
27969429|NCT01038635|54626979|FG005|Overall Study|Death|0|||
27969430|NCT01038635|54626980|FG006|Overall Study|Death|1|||
27969431|NCT01038635|54626981|FG007|Overall Study|Death|1|||
27969432|NCT01038635|54626982|FG008|Overall Study|Death|2|||
27969433|NCT01000064|54627003|FG000|Overall Study|Withdrawal by Subject|1|||
27969434|NCT01000064|54627004|FG001|Overall Study|Withdrawal by Subject|1|||
27969435|NCT00766090|54627015|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
27969436|NCT00766090|54627016|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
27969437|NCT00766090|54627017|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
28084177|NCT00045734|54737702|FG000|Overall Study|Protocol Violation|1|||
28084178|NCT03387046|54737708|FG000|Overall Study|Adverse Event|1|||
27969438|NCT00766090|54627018|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
27969439|NCT00766090|54627019|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
27969440|NCT00766090|54627020|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
27969441|NCT00766090|54627021|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
27969442|NCT00766090|54627022|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
27969443|NCT00766090|54627023|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
27969444|NCT00766090|54627024|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
27969445|NCT00766090|54627025|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
27969446|NCT00766090|54627026|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
27969447|NCT00766090|54627015|FG000|Treatment Period 1 (28 Days)|Lack of Efficacy|2|||
28084179|NCT03387046|54737709|FG001|Overall Study|Adverse Event|1|||
28084180|NCT00045110|54737718|FG000|100mg Phase 1 Dose Escalalation|did not initiate treatment|0|||
28084181|NCT00045110|54737719|FG001|100mg Phase 1 Dose Escalalation|did not initiate treatment|2|||
28084182|NCT00045110|54737720|FG002|100mg Phase 1 Dose Escalalation|did not initiate treatment|1|||
28084183|NCT00045110|54737718|FG000|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
28084184|NCT00045110|54737719|FG001|100mg Phase 1 Dose Escalalation|prior treatment history|4|||
28084185|NCT00045110|54737720|FG002|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
28084186|NCT00045110|54737718|FG000|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
28084187|NCT00045110|54737719|FG001|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
28084188|NCT00045110|54737720|FG002|100mg Phase 1 Dose Escalalation|ineligible histology|1|||
28084189|NCT03353740|54737737|FG000|Overall Study|Images for these participants not viable|52|||
28084190|NCT00003476|54737741|FG000|Overall Study|Not evaluable|1|||
28084191|NCT00003470|54737745|FG000|Overall Study|Not evaluable|6|||
28084192|NCT03386344|54737752|FG000|Overall Study|Adverse Event|6|||
27732823|NCT02697591|54180548|FG006|Overall Study|Lost to Follow-up|1|||
27969448|NCT00766090|54627016|FG001|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
27969449|NCT00766090|54627017|FG002|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
27969450|NCT00766090|54627018|FG003|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
27969451|NCT00766090|54627019|FG004|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
27969452|NCT00766090|54627020|FG005|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
27969453|NCT00766090|54627021|FG006|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
27969454|NCT00766090|54627022|FG007|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
27969455|NCT00766090|54627023|FG008|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
27969456|NCT00766090|54627024|FG009|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
27969457|NCT00766090|54627025|FG010|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
27969458|NCT00766090|54627026|FG011|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
27969459|NCT00766090|54627015|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
27969460|NCT00766090|54627016|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
27969461|NCT00766090|54627017|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
27969462|NCT00766090|54627018|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
27969463|NCT00766090|54627019|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
27969464|NCT00766090|54627020|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
27969465|NCT00766090|54627021|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
27969466|NCT00766090|54627022|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
27969467|NCT00766090|54627023|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
27969468|NCT00766090|54627024|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
27969469|NCT00766090|54627025|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
27969470|NCT00766090|54627026|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
27969471|NCT00766090|54627015|FG000|Washout Period 1 (14 Days)|Protocol Violation|0|||
27969472|NCT00766090|54627016|FG001|Washout Period 1 (14 Days)|Protocol Violation|0|||
27969473|NCT00766090|54627017|FG002|Washout Period 1 (14 Days)|Protocol Violation|1|||
27969474|NCT00766090|54627018|FG003|Washout Period 1 (14 Days)|Protocol Violation|0|||
27969475|NCT00766090|54627019|FG004|Washout Period 1 (14 Days)|Protocol Violation|0|||
27969476|NCT00766090|54627020|FG005|Washout Period 1 (14 Days)|Protocol Violation|0|||
27969477|NCT00766090|54627021|FG006|Washout Period 1 (14 Days)|Protocol Violation|0|||
27969478|NCT00766090|54627022|FG007|Washout Period 1 (14 Days)|Protocol Violation|0|||
27969479|NCT00766090|54627023|FG008|Washout Period 1 (14 Days)|Protocol Violation|0|||
27969480|NCT00766090|54627024|FG009|Washout Period 1 (14 Days)|Protocol Violation|0|||
27969481|NCT00766090|54627025|FG010|Washout Period 1 (14 Days)|Protocol Violation|0|||
27969482|NCT00766090|54627026|FG011|Washout Period 1 (14 Days)|Protocol Violation|0|||
27969483|NCT00766090|54627015|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
27969484|NCT00766090|54627016|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
27969485|NCT00766090|54627017|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
27969486|NCT00766090|54627018|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
27969487|NCT00766090|54627019|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|2|||
27969488|NCT00766090|54627020|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
27969489|NCT00766090|54627021|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
27969490|NCT00766090|54627022|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
27969491|NCT00766090|54627023|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
27969492|NCT00766090|54627024|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
27969493|NCT00766090|54627025|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
27969494|NCT00766090|54627026|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
27969495|NCT00766090|54627015|FG000|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
27732824|NCT02697591|54180549|FG007|Overall Study|Lost to Follow-up|0|||
27732825|NCT02697591|54180550|FG008|Overall Study|Lost to Follow-up|0|||
27969496|NCT00766090|54627016|FG001|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
27969497|NCT00766090|54627017|FG002|Treatment Period 2 (28 Days)|Lack of Efficacy|1|||
27732826|NCT02697591|54180551|FG009|Overall Study|Lost to Follow-up|1|||
27969498|NCT00766090|54627018|FG003|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
27969499|NCT00766090|54627019|FG004|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
27969500|NCT00766090|54627020|FG005|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
27969501|NCT00766090|54627021|FG006|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
27969502|NCT00766090|54627022|FG007|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
27969503|NCT00766090|54627023|FG008|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
27969504|NCT00766090|54627024|FG009|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
27969505|NCT00766090|54627025|FG010|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
27969506|NCT00766090|54627026|FG011|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
27969507|NCT00766090|54627015|FG000|Washout Period 2 (14 Days)|Physician Decision|0|||
27969508|NCT00766090|54627016|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
27969509|NCT00766090|54627017|FG002|Washout Period 2 (14 Days)|Physician Decision|1|||
27969510|NCT00766090|54627018|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
27969511|NCT00766090|54627019|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
27969512|NCT00766090|54627020|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
27969513|NCT00766090|54627021|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
27969514|NCT00766090|54627022|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
27969515|NCT00766090|54627023|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
27969516|NCT00766090|54627024|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
27969517|NCT00766090|54627025|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
27969518|NCT00766090|54627026|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
27969519|NCT00766090|54627015|FG000|Treatment Period 3 (28 Days)|Protocol Violation|0|||
27969520|NCT00766090|54627016|FG001|Treatment Period 3 (28 Days)|Protocol Violation|0|||
27969521|NCT00766090|54627017|FG002|Treatment Period 3 (28 Days)|Protocol Violation|0|||
27969522|NCT00766090|54627018|FG003|Treatment Period 3 (28 Days)|Protocol Violation|0|||
27969523|NCT00766090|54627019|FG004|Treatment Period 3 (28 Days)|Protocol Violation|0|||
27969524|NCT00766090|54627020|FG005|Treatment Period 3 (28 Days)|Protocol Violation|1|||
27969525|NCT00766090|54627021|FG006|Treatment Period 3 (28 Days)|Protocol Violation|0|||
27969526|NCT00766090|54627022|FG007|Treatment Period 3 (28 Days)|Protocol Violation|0|||
27969527|NCT00766090|54627023|FG008|Treatment Period 3 (28 Days)|Protocol Violation|0|||
27969528|NCT00766090|54627024|FG009|Treatment Period 3 (28 Days)|Protocol Violation|0|||
27969529|NCT00766090|54627025|FG010|Treatment Period 3 (28 Days)|Protocol Violation|0|||
27969530|NCT00766090|54627026|FG011|Treatment Period 3 (28 Days)|Protocol Violation|0|||
27969531|NCT00766090|54627015|FG000|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
27969532|NCT00766090|54627016|FG001|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
27969533|NCT00766090|54627017|FG002|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
27969534|NCT00766090|54627018|FG003|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
27969535|NCT00766090|54627019|FG004|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
27969536|NCT00766090|54627020|FG005|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
27969537|NCT00766090|54627021|FG006|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
27969538|NCT00766090|54627022|FG007|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
27969539|NCT00766090|54627023|FG008|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
27969540|NCT00766090|54627024|FG009|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
27969541|NCT00766090|54627025|FG010|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
27969542|NCT00766090|54627026|FG011|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
27969543|NCT00766090|54627015|FG000|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
27969544|NCT00766090|54627016|FG001|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
27969545|NCT00766090|54627017|FG002|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
27969546|NCT00766090|54627018|FG003|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
27969547|NCT00766090|54627019|FG004|Treatment Period 3 (28 Days)|Lost to Follow-up|1|||
27969548|NCT00766090|54627020|FG005|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
27969549|NCT00766090|54627021|FG006|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
27969550|NCT00766090|54627022|FG007|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
27969551|NCT00766090|54627023|FG008|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
27969552|NCT00766090|54627024|FG009|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
27969553|NCT00766090|54627025|FG010|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
27969554|NCT00766090|54627026|FG011|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
27969555|NCT00580801|54627043|FG000|Overall Study|Physician Decision|1|||
27969556|NCT00580801|54627044|FG001|Overall Study|Physician Decision|0|||
27969557|NCT00580801|54627045|FG002|Overall Study|Physician Decision|0|||
27969558|NCT00580801|54627043|FG000|Overall Study|Adverse Event|2|||
27969559|NCT00580801|54627044|FG001|Overall Study|Adverse Event|0|||
27969560|NCT00580801|54627045|FG002|Overall Study|Adverse Event|0|||
27969561|NCT00580801|54627043|FG000|Overall Study|Lost to Follow-up|2|||
27969562|NCT00580801|54627044|FG001|Overall Study|Lost to Follow-up|0|||
27855390|NCT03809663|54376995|FG000|Overall Study|Decision by sponsor|24|||
27969563|NCT00580801|54627045|FG002|Overall Study|Lost to Follow-up|0|||
27969564|NCT00580801|54627043|FG000|Overall Study|Reached a virologic endpoint|0|||
27969565|NCT00580801|54627044|FG001|Overall Study|Reached a virologic endpoint|1|||
27855391|NCT03809663|54376996|FG001|Overall Study|Decision by sponsor|18|||
27855392|NCT03809663|54376997|FG002|Overall Study|Decision by sponsor|20|||
27969566|NCT00580801|54627045|FG002|Overall Study|Reached a virologic endpoint|2|||
27969567|NCT00580801|54627043|FG000|Overall Study|Participant non-compliant|0|||
27969568|NCT00580801|54627044|FG001|Overall Study|Participant non-compliant|0|||
27969569|NCT00580801|54627045|FG002|Overall Study|Participant non-compliant|1|||
27969570|NCT00580801|54627043|FG000|Overall Study|Travel|1|||
27969571|NCT00580801|54627044|FG001|Overall Study|Travel|0|||
27969572|NCT00580801|54627045|FG002|Overall Study|Travel|0|||
27969573|NCT01059539|54627053|FG000|Overall Study|Adverse Event|66|||
27969574|NCT01059539|54627053|FG000|Overall Study|Insufficient Therapeutic Response|26|||
27969575|NCT01059539|54627053|FG000|Overall Study|Protocol Violation|55|||
27969576|NCT01059539|54627053|FG000|Overall Study|Withdrawal of Consent|80|||
27969577|NCT01059539|54627053|FG000|Overall Study|Lost to Follow-up|42|||
27969578|NCT01059539|54627053|FG000|Overall Study|Reason Not Specified|2|||
27969579|NCT00999908|54627057|FG000|Treatment Period 1|Subject withdrew consent|2|||
27969580|NCT00999908|54627058|FG001|Treatment Period 1|Subject withdrew consent|0|||
27969581|NCT00999908|54627059|FG002|Treatment Period 1|Subject withdrew consent|0|||
27969582|NCT00999908|54627057|FG000|Treatment Period 2|Protocol Violation|1|||
27969583|NCT00999908|54627058|FG001|Treatment Period 2|Protocol Violation|0|||
27969584|NCT00999908|54627059|FG002|Treatment Period 2|Protocol Violation|0|||
27969585|NCT00580723|54627067|FG000|Overall Study|Did not want to participate in extension|3|||
27969586|NCT00580723|54627067|FG000|Overall Study|Lost to Follow-up|5|||
27969587|NCT00999596|54627071|FG000|Overall Study|Statistical population not required|101|||
27969588|NCT04676867|54627080|FG000|Overall Study|Screen failure|0|||
27969589|NCT04676867|54627081|FG001|Overall Study|Screen failure|0|||
27969590|NCT04676867|54627082|FG002|Overall Study|Screen failure|6|||
27969591|NCT04676867|54627083|FG003|Overall Study|Screen failure|2|||
27969592|NCT04676867|54627080|FG000|Overall Study|Death|0|||
27969593|NCT04676867|54627081|FG001|Overall Study|Death|0|||
27969594|NCT04676867|54627082|FG002|Overall Study|Death|1|||
27969595|NCT04676867|54627083|FG003|Overall Study|Death|0|||
27969596|NCT04676867|54627080|FG000|Overall Study|Withdrawal by Subject|2|||
27969597|NCT04676867|54627081|FG001|Overall Study|Withdrawal by Subject|2|||
27969598|NCT04676867|54627082|FG002|Overall Study|Withdrawal by Subject|4|||
27969599|NCT04676867|54627083|FG003|Overall Study|Withdrawal by Subject|4|||
27969600|NCT04676867|54627080|FG000|Overall Study|Lost to Follow-up|1|||
27969601|NCT04676867|54627081|FG001|Overall Study|Lost to Follow-up|0|||
27969602|NCT04676867|54627082|FG002|Overall Study|Lost to Follow-up|0|||
28084193|NCT03386344|54737753|FG001|Overall Study|Adverse Event|3|||
28084194|NCT03386344|54737754|FG002|Overall Study|Adverse Event|1|||
28084195|NCT03386344|54737752|FG000|Overall Study|Poor Compliance to Protocol|0|||
28084196|NCT03386344|54737753|FG001|Overall Study|Poor Compliance to Protocol|1|||
28084197|NCT03386344|54737754|FG002|Overall Study|Poor Compliance to Protocol|0|||
27969603|NCT04676867|54627083|FG003|Overall Study|Lost to Follow-up|0|||
27969604|NCT00770224|54627093|FG000|Step 1: Induction|Adverse Event|3|||
27969605|NCT00770224|54627094|FG001|Step 1: Induction|Adverse Event|0|||
27969606|NCT00770224|54627093|FG000|Step 1: Induction|Refusal unrelated to adverse event|6|||
27969607|NCT00770224|54627094|FG001|Step 1: Induction|Refusal unrelated to adverse event|0|||
27969608|NCT00770224|54627093|FG000|Step 1: Induction|Other reason not protocol specified|2|||
27969609|NCT00770224|54627094|FG001|Step 1: Induction|Other reason not protocol specified|0|||
27969610|NCT00770224|54627093|FG000|Step 1: Induction|Ineligible|2|||
27969611|NCT00770224|54627094|FG001|Step 1: Induction|Ineligible|0|||
27969612|NCT00770224|54627093|FG000|Step 1: Induction|No protocol treatment given|1|||
28084198|NCT03386344|54737752|FG000|Overall Study|Study Terminated by Sponsor|101|||
28084199|NCT03386344|54737753|FG001|Overall Study|Study Terminated by Sponsor|102|||
28084200|NCT03386344|54737754|FG002|Overall Study|Study Terminated by Sponsor|106|||
27855393|NCT03809663|54376998|FG003|Overall Study|Decision by sponsor|20|||
27855394|NCT03809663|54376999|FG004|Overall Study|Decision by sponsor|0|||
27855395|NCT03809663|54377000|FG005|Overall Study|Decision by sponsor|0|||
27855396|NCT03809663|54376995|FG000|Overall Study|Withdrawal by Subject|26|||
27855397|NCT03809663|54376996|FG001|Overall Study|Withdrawal by Subject|22|||
27855398|NCT03809663|54376997|FG002|Overall Study|Withdrawal by Subject|27|||
27855399|NCT03809663|54376998|FG003|Overall Study|Withdrawal by Subject|26|||
27855400|NCT03809663|54376999|FG004|Overall Study|Withdrawal by Subject|0|||
27855401|NCT03809663|54377000|FG005|Overall Study|Withdrawal by Subject|0|||
27855402|NCT03809663|54376995|FG000|Overall Study|Lost to Follow-up|1|||
27855403|NCT03809663|54376996|FG001|Overall Study|Lost to Follow-up|4|||
27855404|NCT03809663|54376997|FG002|Overall Study|Lost to Follow-up|1|||
27969613|NCT00770224|54627094|FG001|Step 1: Induction|No protocol treatment given|0|||
27969614|NCT00770224|54627093|FG000|Step 2: Maintenance|Adverse Event|0|||
27969615|NCT00770224|54627094|FG001|Step 2: Maintenance|Adverse Event|10|||
27969616|NCT00770224|54627093|FG000|Step 2: Maintenance|Refusal unrelated to adverse event|0|||
27969617|NCT00770224|54627094|FG001|Step 2: Maintenance|Refusal unrelated to adverse event|8|||
27969618|NCT00770224|54627093|FG000|Step 2: Maintenance|Progression/relapse|0|||
27969619|NCT00770224|54627094|FG001|Step 2: Maintenance|Progression/relapse|1|||
27969620|NCT00770224|54627093|FG000|Step 2: Maintenance|Death|0|||
27969621|NCT00770224|54627094|FG001|Step 2: Maintenance|Death|2|||
27855405|NCT03809663|54376998|FG003|Overall Study|Lost to Follow-up|1|||
27855406|NCT03809663|54376999|FG004|Overall Study|Lost to Follow-up|0|||
27855407|NCT03809663|54377000|FG005|Overall Study|Lost to Follow-up|0|||
27855408|NCT00249821|54377062|FG000|Overall Study|Technical problem|0|||
27855409|NCT00249821|54377063|FG001|Overall Study|Technical problem|1|||
27855410|NCT00248651|54377138|FG000|Overall Study|Withdrawal by Subject|28|||
27855411|NCT00248651|54377139|FG001|Overall Study|Withdrawal by Subject|40|||
27855412|NCT00248651|54377140|FG002|Overall Study|Withdrawal by Subject|32|||
27855413|NCT00248495|54377177|FG000|Overall Study|Withdrawal by Subject|1|||
27855414|NCT03802565|54377274|FG000|Overall Study|Adverse Event|0|||
27855415|NCT03802565|54377275|FG001|Overall Study|Adverse Event|1|||
27855416|NCT03802565|54377276|FG002|Overall Study|Adverse Event|2|||
27855417|NCT03802565|54377277|FG003|Overall Study|Adverse Event|1|||
27855418|NCT03802565|54377278|FG004|Overall Study|Adverse Event|1|||
27855419|NCT03802565|54377274|FG000|Overall Study|Withdrawal by Subject|2|||
27855420|NCT03802565|54377275|FG001|Overall Study|Withdrawal by Subject|2|||
27855421|NCT03802565|54377276|FG002|Overall Study|Withdrawal by Subject|2|||
27855422|NCT03802565|54377277|FG003|Overall Study|Withdrawal by Subject|0|||
27855423|NCT03802565|54377278|FG004|Overall Study|Withdrawal by Subject|1|||
27855424|NCT03802565|54377274|FG000|Overall Study|Protocol Violation|2|||
27855425|NCT03802565|54377275|FG001|Overall Study|Protocol Violation|1|||
27855426|NCT03802565|54377276|FG002|Overall Study|Protocol Violation|4|||
27855427|NCT03802565|54377277|FG003|Overall Study|Protocol Violation|5|||
27855428|NCT03802565|54377278|FG004|Overall Study|Protocol Violation|1|||
27855429|NCT03802565|54377274|FG000|Overall Study|Lost to Follow-up|0|||
27855430|NCT03802565|54377275|FG001|Overall Study|Lost to Follow-up|0|||
27855431|NCT03802565|54377276|FG002|Overall Study|Lost to Follow-up|1|||
27855432|NCT03802565|54377277|FG003|Overall Study|Lost to Follow-up|0|||
27855433|NCT03802565|54377278|FG004|Overall Study|Lost to Follow-up|0|||
27855434|NCT03802565|54377274|FG000|Overall Study|Subjects Related to Each Other|1|||
27855435|NCT03802565|54377275|FG001|Overall Study|Subjects Related to Each Other|0|||
27855436|NCT03802565|54377276|FG002|Overall Study|Subjects Related to Each Other|0|||
27855437|NCT03802565|54377277|FG003|Overall Study|Subjects Related to Each Other|2|||
27855438|NCT03802565|54377278|FG004|Overall Study|Subjects Related to Each Other|1|||
27855439|NCT03802565|54377274|FG000|Overall Study|Elevated Enzymes|0|||
27855440|NCT03802565|54377275|FG001|Overall Study|Elevated Enzymes|0|||
27855441|NCT03802565|54377276|FG002|Overall Study|Elevated Enzymes|0|||
27855442|NCT03802565|54377277|FG003|Overall Study|Elevated Enzymes|0|||
27855443|NCT03802565|54377278|FG004|Overall Study|Elevated Enzymes|2|||
27855444|NCT00245765|54377322|FG000|Overall Study|Adverse Event|1|||
27855445|NCT00245765|54377323|FG001|Overall Study|Adverse Event|1|||
27969622|NCT00770224|54627093|FG000|Step 2: Maintenance|Other reason not protocol specified|0|||
27969623|NCT00770224|54627094|FG001|Step 2: Maintenance|Other reason not protocol specified|7|||
27969624|NCT00770224|54627093|FG000|Step 2: Maintenance|Ineligible|0|||
27969625|NCT00770224|54627094|FG001|Step 2: Maintenance|Ineligible|2|||
27969626|NCT02399215|54627101|FG000|Overall Study|bowel obstruction (unrelated to dis-ease)|1|||
27969627|NCT02399215|54627101|FG000|Overall Study|Withdrawal by Subject|1|||
27855446|NCT00245765|54377324|FG002|Overall Study|Adverse Event|0|||
27969628|NCT01057589|54627105|FG000|Overall Study|Disease Progression|35|||
27969629|NCT01057589|54627105|FG000|Overall Study|Adverse Event|10|||
27969630|NCT01057589|54627105|FG000|Overall Study|Physician Decision|8|||
27969631|NCT01057589|54627105|FG000|Overall Study|Withdrawal by Subject|3|||
27969632|NCT01057589|54627105|FG000|Overall Study|Sponsor Decision|1|||
27969633|NCT01057589|54627105|FG000|Overall Study|Death|8|||
27969634|NCT01057589|54627105|FG000|Overall Study|Lost to Follow-up|1|||
27969635|NCT01716117|54627111|FG000|Overall Study|Death|5|||
27969636|NCT01716117|54627112|FG001|Overall Study|Death|2|||
27969637|NCT01716117|54627111|FG000|Overall Study|Withdrawal by Subject|2|||
27969638|NCT01716117|54627112|FG001|Overall Study|Withdrawal by Subject|0|||
27969639|NCT00579553|54627128|FG000|Overall Study|Lost to Follow-up|16|||
27969640|NCT00579553|54627129|FG001|Overall Study|Lost to Follow-up|13|||
27969641|NCT01650831|54627135|FG000|Overall Study|Screen failure|1|||
27855447|NCT00245765|54377322|FG000|Overall Study|Lack of Efficacy|14|||
27855448|NCT00245765|54377323|FG001|Overall Study|Lack of Efficacy|7|||
27855449|NCT00245765|54377324|FG002|Overall Study|Lack of Efficacy|0|||
27855450|NCT00245765|54377322|FG000|Overall Study|Lost to Follow-up|1|||
27969642|NCT00581893|54627143|FG000|Second Intervention (1 Month)|Lost to Follow-up|3|||
28084201|NCT03386344|54737752|FG000|Overall Study|Lost to Follow-up|3|||
27855451|NCT00245765|54377323|FG001|Overall Study|Lost to Follow-up|2|||
27855452|NCT00245765|54377324|FG002|Overall Study|Lost to Follow-up|0|||
27969643|NCT00581893|54627144|FG001|Second Intervention (1 Month)|Lost to Follow-up|2|||
27969644|NCT00770146|54627152|FG000|Treatment Period|Withdrawal by Subject|6|||
27969645|NCT00770146|54627153|FG001|Treatment Period|Withdrawal by Subject|13|||
27969646|NCT00770146|54627152|FG000|Treatment Period|Adverse Event|2|||
27969647|NCT00770146|54627153|FG001|Treatment Period|Adverse Event|26|||
27969648|NCT00770146|54627152|FG000|Treatment Period|Other|1|||
27855453|NCT00245765|54377322|FG000|Overall Study|Withdrawal by Subject|1|||
27855454|NCT00245765|54377323|FG001|Overall Study|Withdrawal by Subject|0|||
27855455|NCT00245765|54377324|FG002|Overall Study|Withdrawal by Subject|3|||
27855456|NCT00245765|54377322|FG000|Overall Study|Other reason|2|||
27969649|NCT00770146|54627153|FG001|Treatment Period|Other|5|||
27969650|NCT00770146|54627152|FG000|Treatment Period|Protocol non-compliance|0|||
27969651|NCT00770146|54627153|FG001|Treatment Period|Protocol non-compliance|1|||
27969652|NCT00770146|54627152|FG000|Follow-up Period|Withdrawal by Subject|7|||
27969653|NCT00770146|54627153|FG001|Follow-up Period|Withdrawal by Subject|13|||
27969654|NCT00770146|54627152|FG000|Follow-up Period|Adverse Event|0|||
27969655|NCT00770146|54627153|FG001|Follow-up Period|Adverse Event|2|||
27969656|NCT00770146|54627152|FG000|Follow-up Period|Other|4|||
27969657|NCT00770146|54627153|FG001|Follow-up Period|Other|5|||
27969658|NCT01056341|54627164|FG000|Overall Study|Treatment Intolerance|0|||
27969659|NCT01056341|54627165|FG001|Overall Study|Treatment Intolerance|2|||
27969660|NCT01056341|54627166|FG002|Overall Study|Treatment Intolerance|0|||
27969661|NCT01056341|54627167|FG003|Overall Study|Treatment Intolerance|2|||
27969662|NCT01056341|54627168|FG004|Overall Study|Treatment Intolerance|0|||
27969663|NCT01056341|54627164|FG000|Overall Study|Lack of Efficacy|32|||
27969664|NCT01056341|54627165|FG001|Overall Study|Lack of Efficacy|30|||
27969665|NCT01056341|54627166|FG002|Overall Study|Lack of Efficacy|7|||
27969666|NCT01056341|54627167|FG003|Overall Study|Lack of Efficacy|25|||
27969667|NCT01056341|54627168|FG004|Overall Study|Lack of Efficacy|9|||
27969668|NCT01056341|54627164|FG000|Overall Study|Other reasons|4|||
27969669|NCT01056341|54627165|FG001|Overall Study|Other reasons|4|||
27969670|NCT01056341|54627166|FG002|Overall Study|Other reasons|8|||
27969671|NCT01056341|54627167|FG003|Overall Study|Other reasons|9|||
27969672|NCT01056341|54627168|FG004|Overall Study|Other reasons|5|||
27969673|NCT00999518|54627191|FG000|Overall Study|Adverse Event|1|||
27969674|NCT00999518|54627192|FG001|Overall Study|Adverse Event|6|||
27969675|NCT00999518|54627193|FG002|Overall Study|Adverse Event|3|||
27969676|NCT00999518|54627194|FG003|Overall Study|Adverse Event|1|||
27969677|NCT00999518|54627195|FG004|Overall Study|Adverse Event|2|||
27969678|NCT00999518|54627191|FG000|Overall Study|Lack of Efficacy|2|||
27969679|NCT00999518|54627192|FG001|Overall Study|Lack of Efficacy|0|||
27969680|NCT00999518|54627193|FG002|Overall Study|Lack of Efficacy|0|||
27969681|NCT00999518|54627194|FG003|Overall Study|Lack of Efficacy|2|||
27969682|NCT00999518|54627195|FG004|Overall Study|Lack of Efficacy|2|||
27969683|NCT00999518|54627191|FG000|Overall Study|Lost to Follow-up|0|||
27969684|NCT00999518|54627192|FG001|Overall Study|Lost to Follow-up|0|||
27969685|NCT00999518|54627193|FG002|Overall Study|Lost to Follow-up|0|||
27969686|NCT00999518|54627194|FG003|Overall Study|Lost to Follow-up|4|||
27969687|NCT00999518|54627195|FG004|Overall Study|Lost to Follow-up|1|||
27969688|NCT00999518|54627191|FG000|Overall Study|Did not meet entrance criteria|0|||
27969689|NCT00999518|54627192|FG001|Overall Study|Did not meet entrance criteria|0|||
27969690|NCT00999518|54627193|FG002|Overall Study|Did not meet entrance criteria|0|||
27969691|NCT00999518|54627194|FG003|Overall Study|Did not meet entrance criteria|0|||
27969692|NCT00999518|54627195|FG004|Overall Study|Did not meet entrance criteria|1|||
27969693|NCT00999518|54627191|FG000|Overall Study|Study terminated by sponsor|10|||
28084202|NCT03386344|54737753|FG001|Overall Study|Lost to Follow-up|2|||
28084203|NCT03386344|54737754|FG002|Overall Study|Lost to Follow-up|1|||
28084204|NCT03386344|54737752|FG000|Overall Study|At the Participant's own Request|7|||
28084205|NCT03386344|54737753|FG001|Overall Study|At the Participant's own Request|7|||
28084206|NCT03386344|54737754|FG002|Overall Study|At the Participant's own Request|8|||
28084207|NCT03386344|54737752|FG000|Overall Study|Reason not Specified|0|||
28084208|NCT03386344|54737753|FG001|Overall Study|Reason not Specified|1|||
28084209|NCT03386344|54737754|FG002|Overall Study|Reason not Specified|0|||
28084210|NCT00399035|54737765|FG000|Overall Study|Death|289|||
28084211|NCT00399035|54737766|FG001|Overall Study|Death|141|||
28084212|NCT00399035|54737767|FG002|Overall Study|Death|234|||
28084213|NCT00399035|54737765|FG000|Overall Study|Lost to Follow-up|2|||
28084214|NCT00399035|54737766|FG001|Overall Study|Lost to Follow-up|1|||
28165273|NCT02919475|54835892|FG001|Overall Study|Withdrawal by Subject|3|||
28165274|NCT02919475|54835893|FG002|Overall Study|Withdrawal by Subject|1|||
28165275|NCT02919475|54835894|FG003|Overall Study|Withdrawal by Subject|2|||
28165276|NCT02919475|54835895|FG004|Overall Study|Withdrawal by Subject|2|||
28165277|NCT02919475|54835891|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
28165278|NCT02919475|54835892|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
27732827|NCT02697591|54180542|FG000|Overall Study|Withdrawal by Subject|1|||
28084215|NCT00399035|54737767|FG002|Overall Study|Lost to Follow-up|5|||
28084216|NCT00399035|54737765|FG000|Overall Study|Withdrawal by Subject|19|||
28084217|NCT00399035|54737766|FG001|Overall Study|Withdrawal by Subject|15|||
28084218|NCT00399035|54737767|FG002|Overall Study|Withdrawal by Subject|12|||
28084219|NCT00399035|54737765|FG000|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
28084220|NCT00399035|54737766|FG001|Overall Study|Incorrect enrolment/eligib not fulfilled|0|||
27969694|NCT00999518|54627192|FG001|Overall Study|Study terminated by sponsor|6|||
27969695|NCT00999518|54627193|FG002|Overall Study|Study terminated by sponsor|5|||
27969696|NCT00999518|54627194|FG003|Overall Study|Study terminated by sponsor|5|||
27969697|NCT00999518|54627195|FG004|Overall Study|Study terminated by sponsor|9|||
27969698|NCT00999518|54627191|FG000|Overall Study|Pregnancy|0|||
27969699|NCT00999518|54627192|FG001|Overall Study|Pregnancy|0|||
28084221|NCT00399035|54737767|FG002|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
27855457|NCT00245765|54377323|FG001|Overall Study|Other reason|0|||
27855458|NCT00245765|54377324|FG002|Overall Study|Other reason|1|||
27855459|NCT00245765|54377322|FG000|Overall Study|Other|13|||
27855460|NCT00245765|54377323|FG001|Overall Study|Other|4|||
27855461|NCT00245765|54377324|FG002|Overall Study|Other|4|||
27855462|NCT00245063|54377396|FG000|Overall Study|Adverse Event|6|||
27855463|NCT00245063|54377397|FG001|Overall Study|Adverse Event|5|||
27855464|NCT00245063|54377396|FG000|Overall Study|Death|1|||
27855465|NCT00245063|54377397|FG001|Overall Study|Death|0|||
27855466|NCT04329091|54377462|FG000|Overall Study|Physician Decision|5|||
27855467|NCT00244751|54377469|FG000|Overall Study|Adverse Event|7|||
27855468|NCT00244751|54377470|FG001|Overall Study|Adverse Event|7|||
27855469|NCT00244751|54377471|FG002|Overall Study|Adverse Event|5|||
27969700|NCT00999518|54627193|FG002|Overall Study|Pregnancy|1|||
27969701|NCT00999518|54627194|FG003|Overall Study|Pregnancy|0|||
27969702|NCT00999518|54627195|FG004|Overall Study|Pregnancy|0|||
27969703|NCT00999518|54627191|FG000|Overall Study|Protocol Violation|0|||
27969704|NCT00999518|54627192|FG001|Overall Study|Protocol Violation|1|||
27969705|NCT00999518|54627193|FG002|Overall Study|Protocol Violation|0|||
27969706|NCT00999518|54627194|FG003|Overall Study|Protocol Violation|0|||
27969707|NCT00999518|54627195|FG004|Overall Study|Protocol Violation|2|||
27969708|NCT00999518|54627191|FG000|Overall Study|Withdrawal by Subject|5|||
27969709|NCT00999518|54627192|FG001|Overall Study|Withdrawal by Subject|4|||
27969710|NCT00999518|54627193|FG002|Overall Study|Withdrawal by Subject|10|||
27969711|NCT00999518|54627194|FG003|Overall Study|Withdrawal by Subject|6|||
27969712|NCT00999518|54627195|FG004|Overall Study|Withdrawal by Subject|1|||
27969713|NCT00999518|54627191|FG000|Overall Study|Other|5|||
27969714|NCT00999518|54627192|FG001|Overall Study|Other|7|||
27969715|NCT00999518|54627193|FG002|Overall Study|Other|1|||
27969716|NCT00999518|54627194|FG003|Overall Study|Other|4|||
27969717|NCT00999518|54627195|FG004|Overall Study|Other|5|||
27969718|NCT00999518|54627191|FG000|Overall Study|Randomized but not Treated|1|||
27969719|NCT00999518|54627192|FG001|Overall Study|Randomized but not Treated|1|||
27969720|NCT00999518|54627193|FG002|Overall Study|Randomized but not Treated|2|||
27969721|NCT00999518|54627194|FG003|Overall Study|Randomized but not Treated|0|||
27969722|NCT00999518|54627195|FG004|Overall Study|Randomized but not Treated|1|||
27969723|NCT01056263|54627211|FG000|Overall Study|Adverse Event|12|||
27969724|NCT01056263|54627211|FG000|Overall Study|Death|1|||
27969725|NCT01056263|54627211|FG000|Overall Study|Withdrawal by Subject|1|||
27969726|NCT01056263|54627211|FG000|Overall Study|Lack of Efficacy|29|||
27969727|NCT01056263|54627211|FG000|Overall Study|Progressive disease|2|||
27969728|NCT01056263|54627211|FG000|Overall Study|Neoplasm progression|1|||
27969729|NCT01056263|54627211|FG000|Overall Study|Objective progression or relapse|1|||
27969730|NCT01056263|54627211|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|5|||
27969731|NCT01056107|54627219|FG000|Overall Study|Withdrawal by Subject|0|||
27969732|NCT01056107|54627220|FG001|Overall Study|Withdrawal by Subject|1|||
27969733|NCT01056107|54627221|FG002|Overall Study|Withdrawal by Subject|3|||
27969734|NCT01056107|54627222|FG003|Overall Study|Withdrawal by Subject|0|||
27969735|NCT01003886|54627232|FG000|Overall Study|Lack of Efficacy|5|||
27969736|NCT01003886|54627232|FG000|Overall Study|Lost to Follow-up|169|||
27969737|NCT01003886|54627232|FG000|Overall Study|Withdrawal by Subject|39|||
27969738|NCT01003886|54627232|FG000|Overall Study|Other|14|||
27969739|NCT01003886|54627232|FG000|Overall Study|Adverse Event|3|||
27969740|NCT01003184|54627238|FG000|Overall Study|Adverse Event|12|||
27969741|NCT01003184|54627239|FG001|Overall Study|Adverse Event|5|||
27969742|NCT01003184|54627238|FG000|Overall Study|Lost to Follow-up|1|||
27969743|NCT01003184|54627239|FG001|Overall Study|Lost to Follow-up|0|||
28084222|NCT00399035|54737765|FG000|Overall Study|Severe non-compliance with protocol|2|||
28084223|NCT00399035|54737766|FG001|Overall Study|Severe non-compliance with protocol|1|||
27969744|NCT01003184|54627238|FG000|Overall Study|Loss of glucose control|1|||
27969745|NCT01003184|54627239|FG001|Overall Study|Loss of glucose control|1|||
27969746|NCT01003184|54627238|FG000|Overall Study|Protocol Violation|3|||
27969747|NCT01003184|54627239|FG001|Overall Study|Protocol Violation|0|||
28084224|NCT00399035|54737767|FG002|Overall Study|Severe non-compliance with protocol|0|||
28084225|NCT00073749|54737781|FG000|Overall Study|Disease Progression|2|||
27855470|NCT00244751|54377469|FG000|Overall Study|Lost to Follow-up|0|||
27855471|NCT00244751|54377470|FG001|Overall Study|Lost to Follow-up|1|||
27855472|NCT00244751|54377471|FG002|Overall Study|Lost to Follow-up|0|||
27855473|NCT00244751|54377469|FG000|Overall Study|Protocol Violation|1|||
27855474|NCT00244751|54377470|FG001|Overall Study|Protocol Violation|0|||
27855475|NCT00244751|54377471|FG002|Overall Study|Protocol Violation|1|||
27969748|NCT01003184|54627238|FG000|Overall Study|Withdrawal by Subject|1|||
27969749|NCT01003184|54627239|FG001|Overall Study|Withdrawal by Subject|6|||
27969750|NCT01003184|54627238|FG000|Overall Study|Physician Decision|1|||
27969751|NCT01003184|54627239|FG001|Overall Study|Physician Decision|0|||
27855476|NCT00244751|54377469|FG000|Overall Study|Withdrawal by Subject|7|||
27969752|NCT01029353|54627249|FG000|Overall Study|Lost to Follow-up|4|||
27969753|NCT01029353|54627250|FG001|Overall Study|Lost to Follow-up|5|||
27969754|NCT01029353|54627251|FG002|Overall Study|Lost to Follow-up|5|||
27969755|NCT01029353|54627252|FG003|Overall Study|Lost to Follow-up|4|||
27969756|NCT01029353|54627249|FG000|Overall Study|Consent Withdrawn|2|||
27969757|NCT01029353|54627250|FG001|Overall Study|Consent Withdrawn|0|||
27969758|NCT01029353|54627251|FG002|Overall Study|Consent Withdrawn|0|||
27969759|NCT01029353|54627252|FG003|Overall Study|Consent Withdrawn|0|||
27969760|NCT01029353|54627249|FG000|Overall Study|Primary Outcome Indeterminate|1|||
27969761|NCT01029353|54627250|FG001|Overall Study|Primary Outcome Indeterminate|3|||
27969762|NCT01029353|54627251|FG002|Overall Study|Primary Outcome Indeterminate|2|||
27969763|NCT01029353|54627252|FG003|Overall Study|Primary Outcome Indeterminate|0|||
27969764|NCT01008410|54627264|FG000|Overall Study|Adverse Event|13|||
27969765|NCT01008410|54627265|FG001|Overall Study|Adverse Event|7|||
27969766|NCT01008410|54627264|FG000|Overall Study|Withdrawal by Subject|6|||
27969767|NCT01008410|54627265|FG001|Overall Study|Withdrawal by Subject|2|||
27969768|NCT01008410|54627264|FG000|Overall Study|Lost to Follow-up|1|||
27969769|NCT01008410|54627265|FG001|Overall Study|Lost to Follow-up|0|||
27969770|NCT01008410|54627264|FG000|Overall Study|Noncompliance|1|||
27969771|NCT01008410|54627265|FG001|Overall Study|Noncompliance|0|||
27969772|NCT01008410|54627264|FG000|Overall Study|Low Cortisol|2|||
27969773|NCT01008410|54627265|FG001|Overall Study|Low Cortisol|0|||
27969774|NCT01008410|54627264|FG000|Overall Study|Lack of Efficacy|2|||
27969775|NCT01008410|54627265|FG001|Overall Study|Lack of Efficacy|6|||
27969776|NCT01008410|54627264|FG000|Overall Study|Met Exclusion Criterion|0|||
27969777|NCT01008410|54627265|FG001|Overall Study|Met Exclusion Criterion|1|||
27969778|NCT01023269|54627271|FG000|Overall Study|early termination of the study|2|||
27969779|NCT01023269|54627272|FG001|Overall Study|early termination of the study|0|||
27969780|NCT01007942|54627304|FG000|Overall Study|Adverse Event|29|||
27969781|NCT01007942|54627305|FG001|Overall Study|Adverse Event|14|||
27969782|NCT01007942|54627304|FG000|Overall Study|Abnormal test procedure|0|||
27969783|NCT01007942|54627305|FG001|Overall Study|Abnormal test procedure|1|||
27969784|NCT01007942|54627304|FG000|Overall Study|Disease progression|217|||
27969785|NCT01007942|54627305|FG001|Overall Study|Disease progression|242|||
27969786|NCT01007942|54627304|FG000|Overall Study|New cancer therapy|5|||
27969787|NCT01007942|54627305|FG001|Overall Study|New cancer therapy|1|||
27969788|NCT01007942|54627304|FG000|Overall Study|Protocol Violation|1|||
27969789|NCT01007942|54627305|FG001|Overall Study|Protocol Violation|1|||
27969790|NCT01007942|54627304|FG000|Overall Study|Withdrawal by Subject|19|||
27969791|NCT01007942|54627305|FG001|Overall Study|Withdrawal by Subject|14|||
27969792|NCT01007942|54627304|FG000|Overall Study|Lost to Follow-up|1|||
27969793|NCT01007942|54627305|FG001|Overall Study|Lost to Follow-up|0|||
27969794|NCT01007942|54627304|FG000|Overall Study|Administrative problems|2|||
27969795|NCT01007942|54627305|FG001|Overall Study|Administrative problems|0|||
27969796|NCT01007942|54627304|FG000|Overall Study|Death|3|||
27969797|NCT01007942|54627305|FG001|Overall Study|Death|2|||
27969798|NCT01007942|54627304|FG000|Overall Study|Patients untreated|4|||
27969799|NCT01007942|54627305|FG001|Overall Study|Patients untreated|3|||
27969800|NCT01023035|54627318|FG000|Treatment Period|Adverse Event|27|||
27969801|NCT01023035|54627319|FG001|Treatment Period|Adverse Event|32|||
27969802|NCT01023035|54627320|FG002|Treatment Period|Adverse Event|50|||
27969803|NCT01023035|54627318|FG000|Treatment Period|Non-Medical Reasons|19|||
27969804|NCT01023035|54627319|FG001|Treatment Period|Non-Medical Reasons|22|||
27969805|NCT01023035|54627320|FG002|Treatment Period|Non-Medical Reasons|44|||
27969806|NCT01023035|54627318|FG000|Treatment Period|Treatment Failure|26|||
27969807|NCT01023035|54627319|FG001|Treatment Period|Treatment Failure|31|||
27969808|NCT01023035|54627320|FG002|Treatment Period|Treatment Failure|24|||
27969809|NCT01023035|54627318|FG000|Follow-up Period (up to Week 72)|Adverse Event|2|||
27969810|NCT01023035|54627319|FG001|Follow-up Period (up to Week 72)|Adverse Event|0|||
27969811|NCT01023035|54627320|FG002|Follow-up Period (up to Week 72)|Adverse Event|1|||
27969812|NCT01023035|54627318|FG000|Follow-up Period (up to Week 72)|Non-medical Reason|26|||
27969813|NCT01023035|54627319|FG001|Follow-up Period (up to Week 72)|Non-medical Reason|28|||
28084226|NCT00073749|54737782|FG001|Overall Study|Disease Progression|0|||
28084227|NCT00073749|54737783|FG002|Overall Study|Disease Progression|3|||
28084228|NCT00073749|54737784|FG003|Overall Study|Disease Progression|2|||
28084229|NCT00073749|54737785|FG004|Overall Study|Disease Progression|3|||
28084230|NCT00073749|54737786|FG005|Overall Study|Disease Progression|1|||
28084231|NCT00073749|54737787|FG006|Overall Study|Disease Progression|3|||
28084232|NCT00073749|54737781|FG000|Overall Study|Death|0|||
28084233|NCT00073749|54737782|FG001|Overall Study|Death|1|||
27969814|NCT01023035|54627320|FG002|Follow-up Period (up to Week 72)|Non-medical Reason|38|||
28084234|NCT00073749|54737783|FG002|Overall Study|Death|1|||
28084235|NCT00073749|54737784|FG003|Overall Study|Death|0|||
27969815|NCT01028651|54627330|FG000|Overall Study|Death|2|||
27969816|NCT01028651|54627330|FG000|Overall Study|Adverse Event|1|||
27969817|NCT01028027|54627338|FG000|Overall Study|Lost to Follow-up|4|||
27969818|NCT01028027|54627339|FG001|Overall Study|Lost to Follow-up|1|||
27969819|NCT01028027|54627338|FG000|Overall Study|Withdrawal by Subject|5|||
27969820|NCT01028027|54627339|FG001|Overall Study|Withdrawal by Subject|3|||
27969821|NCT01028027|54627338|FG000|Overall Study|Adverse Event|4|||
27969822|NCT01028027|54627339|FG001|Overall Study|Adverse Event|7|||
27969823|NCT01028027|54627338|FG000|Overall Study|Protocol Violation|3|||
27969824|NCT01028027|54627339|FG001|Overall Study|Protocol Violation|1|||
27969825|NCT01028027|54627338|FG000|Overall Study|Lack of Efficacy|0|||
27969826|NCT01028027|54627339|FG001|Overall Study|Lack of Efficacy|1|||
27969827|NCT01007552|54627345|FG000|Overall Study|Withdrawal by Subject|1|||
27969828|NCT01007396|54627349|FG000|Overall Study|Lost to Follow-up|47|||
27969829|NCT00998738|54627353|FG000|Overall Study|Uknown|1|||
27969830|NCT00997334|54627357|FG000|Overall Study|still on therapy|12|||
27969831|NCT00997334|54627357|FG000|Overall Study|Adverse Event|3|||
27969832|NCT00997334|54627357|FG000|Overall Study|Patient non-compliance|1|||
27969833|NCT00997334|54627357|FG000|Overall Study|Withdrawal by Subject|3|||
27969834|NCT00997334|54627357|FG000|Overall Study|Death|2|||
27969835|NCT00997334|54627357|FG000|Overall Study|Urgent Palliative Care|2|||
27969836|NCT00997334|54627357|FG000|Overall Study|No lesion amenable|1|||
27969837|NCT00997334|54627357|FG000|Overall Study|Ineligible|1|||
27969838|NCT00996944|54627363|FG000|Double-blind Treatment Period|Adverse Event|2|||
27969839|NCT00996944|54627364|FG001|Double-blind Treatment Period|Adverse Event|1|||
27969840|NCT00996944|54627363|FG000|Double-blind Treatment Period|Protocol Violation|1|||
27969841|NCT00996944|54627364|FG001|Double-blind Treatment Period|Protocol Violation|0|||
27969842|NCT00996944|54627363|FG000|Double-blind Treatment Period|Study Closed/Terminated|6|||
27969843|NCT00996944|54627364|FG001|Double-blind Treatment Period|Study Closed/Terminated|5|||
27969844|NCT00996944|54627363|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
27969845|NCT00996944|54627364|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
27969846|NCT00996944|54627363|FG000|Long-term Treatment Period|Study Closed/Terminated|12|||
27969847|NCT00996944|54627364|FG001|Long-term Treatment Period|Study Closed/Terminated|5|||
27969848|NCT01002482|54627374|FG000|Overall Study|Withdrawal by Subject|14|||
27969849|NCT01002482|54627375|FG001|Overall Study|Withdrawal by Subject|21|||
27969850|NCT01002482|54627374|FG000|Overall Study|Included twice|1|||
27969851|NCT01002482|54627375|FG001|Overall Study|Included twice|0|||
27969852|NCT01027949|54627381|FG000|Overall Study|Death|174|||
27969853|NCT01027949|54627381|FG000|Overall Study|Progressive Disease|163|||
27969854|NCT01027949|54627381|FG000|Overall Study|Adverse Event|172|||
27969855|NCT01027949|54627381|FG000|Overall Study|Withdrawal by Subject|113|||
27969856|NCT01027949|54627381|FG000|Overall Study|Lost to Follow-up|17|||
27969857|NCT01027949|54627381|FG000|Overall Study|Protocol Violation|13|||
27969858|NCT01027949|54627381|FG000|Overall Study|PI Decision|8|||
27969859|NCT01027949|54627381|FG000|Overall Study|Limited Study Drug Effectiveness|7|||
27969860|NCT01027949|54627381|FG000|Overall Study|Non-compliance with Study Procedures|7|||
27969861|NCT01027949|54627381|FG000|Overall Study|Lung Transplant|5|||
27969862|NCT01027949|54627381|FG000|Overall Study|Unable to Tolerate Study Drug|2|||
27969863|NCT01027949|54627381|FG000|Overall Study|Use of Excluded Medication|2|||
27969864|NCT01027949|54627381|FG000|Overall Study|Patient Self-discontinuation|1|||
27969865|NCT01027949|54627381|FG000|Overall Study|Pregnancy|1|||
27969866|NCT01027949|54627381|FG000|Overall Study|Surgery|1|||
27969867|NCT01038323|54627388|FG000|Overall Study|Withdrawal by Subject|3|||
27969868|NCT01038323|54627389|FG001|Overall Study|Withdrawal by Subject|2|||
27969869|NCT01038323|54627390|FG002|Overall Study|Withdrawal by Subject|4|||
27969870|NCT01027871|54627401|FG000|Overall Study|Physician Decision|1|||
27969871|NCT01027871|54627402|FG001|Overall Study|Physician Decision|5|||
27969872|NCT01027871|54627403|FG002|Overall Study|Physician Decision|0|||
27969873|NCT01027871|54627401|FG000|Overall Study|Protocol Violation|0|||
27969874|NCT01027871|54627402|FG001|Overall Study|Protocol Violation|2|||
27969875|NCT01027871|54627403|FG002|Overall Study|Protocol Violation|2|||
27969876|NCT01027871|54627401|FG000|Overall Study|Withdrawal by Subject|1|||
27969877|NCT01027871|54627402|FG001|Overall Study|Withdrawal by Subject|2|||
27969878|NCT01027871|54627403|FG002|Overall Study|Withdrawal by Subject|2|||
27969879|NCT01027871|54627401|FG000|Overall Study|Adverse Event|0|||
27969880|NCT01027871|54627402|FG001|Overall Study|Adverse Event|2|||
27969881|NCT01027871|54627403|FG002|Overall Study|Adverse Event|2|||
27969882|NCT01027871|54627401|FG000|Overall Study|Sponsor Decision|0|||
27969883|NCT01027871|54627402|FG001|Overall Study|Sponsor Decision|2|||
27969884|NCT01027871|54627403|FG002|Overall Study|Sponsor Decision|0|||
27969885|NCT01027871|54627401|FG000|Overall Study|Discontinued Prior to Treatment|0|||
27969886|NCT01027871|54627402|FG001|Overall Study|Discontinued Prior to Treatment|0|||
27969887|NCT01027871|54627403|FG002|Overall Study|Discontinued Prior to Treatment|1|||
27969888|NCT01021553|54627419|FG000|Overall Study|Adverse Event|1|||
27969889|NCT01021553|54627420|FG001|Overall Study|Adverse Event|0|||
27969890|NCT01021553|54627421|FG002|Overall Study|Adverse Event|0|||
27969891|NCT01021553|54627419|FG000|Overall Study|Lack of Efficacy|2|||
27969892|NCT01021553|54627420|FG001|Overall Study|Lack of Efficacy|2|||
27969893|NCT01021553|54627421|FG002|Overall Study|Lack of Efficacy|0|||
27969894|NCT01021553|54627419|FG000|Overall Study|Protocol Violation|0|||
27969895|NCT01021553|54627420|FG001|Overall Study|Protocol Violation|2|||
27969896|NCT01021553|54627421|FG002|Overall Study|Protocol Violation|2|||
27969897|NCT01021553|54627419|FG000|Overall Study|Lost to Follow-up|0|||
27969898|NCT01021553|54627420|FG001|Overall Study|Lost to Follow-up|0|||
27969899|NCT01021553|54627421|FG002|Overall Study|Lost to Follow-up|1|||
27969900|NCT01021553|54627419|FG000|Overall Study|Withdrawal by Subject|1|||
27969901|NCT01021553|54627420|FG001|Overall Study|Withdrawal by Subject|1|||
27969902|NCT01021553|54627421|FG002|Overall Study|Withdrawal by Subject|0|||
27969903|NCT01026389|54627436|FG000|Overall Study|Withdrawal by Subject|1|||
27969904|NCT01026389|54627437|FG001|Overall Study|Withdrawal by Subject|3|||
27969905|NCT01026389|54627436|FG000|Overall Study|change of treatment, patient moved|4|||
27969906|NCT01026389|54627437|FG001|Overall Study|change of treatment, patient moved|2|||
27969907|NCT01006616|54627447|FG000|Period 1 (6 Months)|Adverse Event|10|||
27969908|NCT01006616|54627448|FG001|Period 1 (6 Months)|Adverse Event|31|||
27969909|NCT01006616|54627449|FG002|Period 1 (6 Months)|Adverse Event|37|||
27969910|NCT01006616|54627450|FG003|Period 1 (6 Months)|Adverse Event|9|||
27969911|NCT01006616|54627447|FG000|Period 1 (6 Months)|Lack of Efficacy|3|||
27969912|NCT01006616|54627448|FG001|Period 1 (6 Months)|Lack of Efficacy|4|||
27969913|NCT01006616|54627449|FG002|Period 1 (6 Months)|Lack of Efficacy|0|||
27969914|NCT01006616|54627450|FG003|Period 1 (6 Months)|Lack of Efficacy|4|||
27969915|NCT01006616|54627447|FG000|Period 1 (6 Months)|Lost to Follow-up|0|||
27969916|NCT01006616|54627448|FG001|Period 1 (6 Months)|Lost to Follow-up|0|||
27969917|NCT01006616|54627449|FG002|Period 1 (6 Months)|Lost to Follow-up|1|||
27969918|NCT01006616|54627450|FG003|Period 1 (6 Months)|Lost to Follow-up|0|||
27969919|NCT01006616|54627447|FG000|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6|||
27969920|NCT01006616|54627448|FG001|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5|||
27969921|NCT01006616|54627449|FG002|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2|||
27969922|NCT01006616|54627450|FG003|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3|||
27969923|NCT01006616|54627447|FG000|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0|||
27969924|NCT01006616|54627448|FG001|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3|||
27969925|NCT01006616|54627449|FG002|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1|||
27969926|NCT01006616|54627450|FG003|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2|||
27969927|NCT01006616|54627447|FG000|Period 1 (6 Months)|Withdrawal by Subject|2|||
27969928|NCT01006616|54627448|FG001|Period 1 (6 Months)|Withdrawal by Subject|2|||
27969929|NCT01006616|54627449|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
27969930|NCT01006616|54627450|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
27969931|NCT01006616|54627447|FG000|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
27969932|NCT01006616|54627448|FG001|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7|||
27969933|NCT01006616|54627449|FG002|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
27969934|NCT01006616|54627450|FG003|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
27969935|NCT01006616|54627447|FG000|Period 1 (6 Months)|Noncompliance With Protocol|0|||
27969936|NCT01006616|54627448|FG001|Period 1 (6 Months)|Noncompliance With Protocol|2|||
27969937|NCT01006616|54627449|FG002|Period 1 (6 Months)|Noncompliance With Protocol|2|||
27969938|NCT01006616|54627450|FG003|Period 1 (6 Months)|Noncompliance With Protocol|3|||
27969939|NCT01006616|54627447|FG000|Period 1 (6 Months)|Not Treated|0|||
27969940|NCT01006616|54627448|FG001|Period 1 (6 Months)|Not Treated|0|||
27969941|NCT01006616|54627449|FG002|Period 1 (6 Months)|Not Treated|1|||
27969942|NCT01006616|54627450|FG003|Period 1 (6 Months)|Not Treated|1|||
27969943|NCT01006616|54627447|FG000|Period 2 (18 Months)|Adverse Event|6|||
27969944|NCT01006616|54627448|FG001|Period 2 (18 Months)|Adverse Event|6|||
27969945|NCT01006616|54627449|FG002|Period 2 (18 Months)|Adverse Event|6|||
27969946|NCT01006616|54627450|FG003|Period 2 (18 Months)|Adverse Event|4|||
27969947|NCT01006616|54627447|FG000|Period 2 (18 Months)|Lack of Efficacy|0|||
27969948|NCT01006616|54627448|FG001|Period 2 (18 Months)|Lack of Efficacy|0|||
27969949|NCT01006616|54627449|FG002|Period 2 (18 Months)|Lack of Efficacy|1|||
27969950|NCT01006616|54627450|FG003|Period 2 (18 Months)|Lack of Efficacy|2|||
27969951|NCT01006616|54627447|FG000|Period 2 (18 Months)|Lost to Follow-up|2|||
27969952|NCT01006616|54627448|FG001|Period 2 (18 Months)|Lost to Follow-up|0|||
27969953|NCT01006616|54627449|FG002|Period 2 (18 Months)|Lost to Follow-up|0|||
27969954|NCT01006616|54627450|FG003|Period 2 (18 Months)|Lost to Follow-up|0|||
27969955|NCT01006616|54627447|FG000|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
27969956|NCT01006616|54627448|FG001|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0|||
27969957|NCT01006616|54627449|FG002|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
27969958|NCT01006616|54627450|FG003|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2|||
27969959|NCT01006616|54627447|FG000|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0|||
27732828|NCT02697591|54180543|FG001|Overall Study|Withdrawal by Subject|1|||
27732829|NCT02697591|54180544|FG002|Overall Study|Withdrawal by Subject|2|||
27732830|NCT02697591|54180545|FG003|Overall Study|Withdrawal by Subject|1|||
27732831|NCT02697591|54180546|FG004|Overall Study|Withdrawal by Subject|7|||
27732832|NCT02697591|54180547|FG005|Overall Study|Withdrawal by Subject|6|||
27832565|NCT01455597|54312026|FG002|Overall Study|Adverse Event|5|||
27969960|NCT01006616|54627448|FG001|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6|||
27969961|NCT01006616|54627449|FG002|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1|||
27969962|NCT01006616|54627450|FG003|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2|||
27732833|NCT02697591|54180548|FG006|Overall Study|Withdrawal by Subject|9|||
27969963|NCT01006616|54627447|FG000|Period 2 (18 Months)|Withdrawal by Subject|1|||
27969964|NCT01006616|54627448|FG001|Period 2 (18 Months)|Withdrawal by Subject|4|||
27969965|NCT01006616|54627449|FG002|Period 2 (18 Months)|Withdrawal by Subject|0|||
27969966|NCT01006616|54627450|FG003|Period 2 (18 Months)|Withdrawal by Subject|1|||
27969967|NCT01006616|54627447|FG000|Period 2 (18 Months)|Noncompliance With Protocol|0|||
27969968|NCT01006616|54627448|FG001|Period 2 (18 Months)|Noncompliance With Protocol|1|||
27969969|NCT01006616|54627449|FG002|Period 2 (18 Months)|Noncompliance With Protocol|0|||
27969970|NCT01006616|54627450|FG003|Period 2 (18 Months)|Noncompliance With Protocol|1|||
27969971|NCT01006616|54627447|FG000|Period 2 (18 Months)|Study Terminated|63|||
27969972|NCT01006616|54627448|FG001|Period 2 (18 Months)|Study Terminated|46|||
27969973|NCT01006616|54627449|FG002|Period 2 (18 Months)|Study Terminated|44|||
27969974|NCT01006616|54627450|FG003|Period 2 (18 Months)|Study Terminated|70|||
27969975|NCT00996632|54627462|FG000|Overall Study|Physician Decision|0|||
27969976|NCT00996632|54627463|FG001|Overall Study|Physician Decision|0|||
27969977|NCT01025843|54627479|FG000|Washout 4|Withdrawal by Subject|0|||
27969978|NCT01025843|54627480|FG001|Washout 4|Withdrawal by Subject|0|||
27969979|NCT01025843|54627481|FG002|Washout 4|Withdrawal by Subject|1|||
27969980|NCT01025843|54627482|FG003|Washout 4|Withdrawal by Subject|1|||
27969981|NCT01025843|54627483|FG004|Washout 4|Withdrawal by Subject|0|||
27969982|NCT01025843|54627484|FG005|Washout 4|Withdrawal by Subject|0|||
27969983|NCT01025843|54627485|FG006|Washout 4|Withdrawal by Subject|0|||
27969984|NCT01025843|54627486|FG007|Washout 4|Withdrawal by Subject|0|||
27969985|NCT01025843|54627487|FG008|Washout 4|Withdrawal by Subject|0|||
27969986|NCT01025843|54627488|FG009|Washout 4|Withdrawal by Subject|0|||
27969987|NCT01036763|54627516|FG000|Overall Study|Adverse Event|25|||
27969988|NCT01036763|54627516|FG000|Overall Study|Lost to Follow-up|28|||
27969989|NCT01036763|54627516|FG000|Overall Study|Other reason (not specified)|40|||
27969990|NCT01021007|54627522|FG000|Overall Study|Lost to Follow-up|1|||
27969991|NCT01021007|54627523|FG001|Overall Study|Lost to Follow-up|1|||
27969992|NCT01021007|54627522|FG000|Overall Study|Adverse Event|1|||
27969993|NCT01021007|54627523|FG001|Overall Study|Adverse Event|3|||
27969994|NCT01020773|54627531|FG000|Overall Study|Withdrawal by Subject|4|||
27969995|NCT01020773|54627532|FG001|Overall Study|Withdrawal by Subject|3|||
27969996|NCT01020305|54627538|FG000|Overall Study|Adverse Event|2|||
27969997|NCT01036529|54627544|FG000|Overall Study|Adverse Event|0|||
27969998|NCT01036529|54627545|FG001|Overall Study|Adverse Event|1|||
27969999|NCT01036529|54627544|FG000|Overall Study|Lost to Follow-up|0|||
27970000|NCT01036529|54627545|FG001|Overall Study|Lost to Follow-up|1|||
27970001|NCT01036529|54627544|FG000|Overall Study|Physician Decision|1|||
27970002|NCT01036529|54627545|FG001|Overall Study|Physician Decision|0|||
27970003|NCT01036529|54627544|FG000|Overall Study|Withdrawal by Subject|1|||
27970004|NCT01036529|54627545|FG001|Overall Study|Withdrawal by Subject|1|||
27970005|NCT01036529|54627544|FG000|Overall Study|Sponsor study termination|11|||
27970006|NCT01036529|54627545|FG001|Overall Study|Sponsor study termination|12|||
27970007|NCT01024751|54627553|FG000|Enrolled Participants|Ineligible at baseline|3|||
27970008|NCT01024751|54627554|FG001|Enrolled Participants|Ineligible at baseline|4|||
27970009|NCT01024751|54627553|FG000|Eligible Participants|Withdrawal by Subject|0|||
27970010|NCT01024751|54627554|FG001|Eligible Participants|Withdrawal by Subject|1|||
27970011|NCT01024751|54627553|FG000|Eligible Participants|Lost to Follow-up|0|||
27970012|NCT01024751|54627554|FG001|Eligible Participants|Lost to Follow-up|1|||
27970013|NCT01024751|54627553|FG000|Eligible Participants|Ineligible|0|||
27970014|NCT01024751|54627554|FG001|Eligible Participants|Ineligible|1|||
27970015|NCT01019369|54627562|FG000|Overall Study|Lost to Follow-up|10|||
27970016|NCT01019369|54627563|FG001|Overall Study|Lost to Follow-up|6|||
27970017|NCT01019369|54627562|FG000|Overall Study|Withdrawal by Subject|0|||
27970018|NCT01019369|54627563|FG001|Overall Study|Withdrawal by Subject|1|||
27970019|NCT01019135|54627573|FG000|Overall Study|Did not receive allocated intervention|12|||
27970020|NCT01019135|54627574|FG001|Overall Study|Did not receive allocated intervention|6|||
27970021|NCT01019135|54627575|FG002|Overall Study|Did not receive allocated intervention|25|||
27970022|NCT01019135|54627573|FG000|Overall Study|Did not attend CR|8|||
27970023|NCT01019135|54627574|FG001|Overall Study|Did not attend CR|13|||
27970024|NCT01019135|54627575|FG002|Overall Study|Did not attend CR|6|||
27970025|NCT01018979|54627585|FG000|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3|||
27970026|NCT01018979|54627586|FG001|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9|||
27970027|NCT01018979|54627585|FG000|Overall Study|Not received at least one dose|0|||
27970028|NCT01018979|54627586|FG001|Overall Study|Not received at least one dose|1|||
27970029|NCT01572493|54627604|FG000|Overall Study|Physician Decision|1|||
27970030|NCT01572493|54627605|FG001|Overall Study|Physician Decision|0|||
27970031|NCT01572493|54627606|FG002|Overall Study|Physician Decision|0|||
27970032|NCT01572493|54627607|FG003|Overall Study|Physician Decision|0|||
27970033|NCT01572493|54627608|FG004|Overall Study|Physician Decision|0|||
27970034|NCT01572493|54627609|FG005|Overall Study|Physician Decision|0|||
27970035|NCT01572493|54627610|FG006|Overall Study|Physician Decision|0|||
27970036|NCT01572493|54627611|FG007|Overall Study|Physician Decision|0|||
27970037|NCT01572493|54627612|FG008|Overall Study|Physician Decision|0|||
27970038|NCT01572493|54627604|FG000|Overall Study|Switched to alternative treatment|0|||
27970039|NCT01572493|54627605|FG001|Overall Study|Switched to alternative treatment|1|||
27970040|NCT01572493|54627606|FG002|Overall Study|Switched to alternative treatment|2|||
27970041|NCT01572493|54627607|FG003|Overall Study|Switched to alternative treatment|1|||
27970042|NCT01572493|54627608|FG004|Overall Study|Switched to alternative treatment|2|||
27970043|NCT01572493|54627609|FG005|Overall Study|Switched to alternative treatment|0|||
27970044|NCT01572493|54627610|FG006|Overall Study|Switched to alternative treatment|2|||
27970045|NCT01572493|54627611|FG007|Overall Study|Switched to alternative treatment|0|||
27970046|NCT01572493|54627612|FG008|Overall Study|Switched to alternative treatment|2|||
27970047|NCT01572493|54627604|FG000|Overall Study|Death|0|||
27970048|NCT01572493|54627605|FG001|Overall Study|Death|0|||
27970049|NCT01572493|54627606|FG002|Overall Study|Death|0|||
27970050|NCT01572493|54627607|FG003|Overall Study|Death|1|||
27970051|NCT01572493|54627608|FG004|Overall Study|Death|0|||
27970052|NCT01572493|54627609|FG005|Overall Study|Death|1|||
27970053|NCT01572493|54627610|FG006|Overall Study|Death|0|||
27970054|NCT01572493|54627611|FG007|Overall Study|Death|0|||
27970055|NCT01572493|54627612|FG008|Overall Study|Death|0|||
27970056|NCT01572493|54627604|FG000|Overall Study|Adverse Event|0|||
27970057|NCT01572493|54627605|FG001|Overall Study|Adverse Event|0|||
27970058|NCT01572493|54627606|FG002|Overall Study|Adverse Event|0|||
27970059|NCT01572493|54627607|FG003|Overall Study|Adverse Event|0|||
27970060|NCT01572493|54627608|FG004|Overall Study|Adverse Event|0|||
27970061|NCT01572493|54627609|FG005|Overall Study|Adverse Event|0|||
27970062|NCT01572493|54627610|FG006|Overall Study|Adverse Event|1|||
27970063|NCT01572493|54627611|FG007|Overall Study|Adverse Event|0|||
27970064|NCT01572493|54627612|FG008|Overall Study|Adverse Event|0|||
27970065|NCT01018511|54627639|FG000|Overall Study|Not fulfilling eligibility criteria|6|||
27970066|NCT01018511|54627640|FG001|Overall Study|Not fulfilling eligibility criteria|7|||
27970067|NCT01018511|54627641|FG002|Overall Study|Not fulfilling eligibility criteria|7|||
27970068|NCT01018511|54627642|FG003|Overall Study|Not fulfilling eligibility criteria|3|||
27970069|NCT01018511|54627639|FG000|Overall Study|Adverse Event|5|||
27970070|NCT01018511|54627640|FG001|Overall Study|Adverse Event|9|||
27970071|NCT01018511|54627641|FG002|Overall Study|Adverse Event|13|||
27970072|NCT01018511|54627642|FG003|Overall Study|Adverse Event|10|||
27970073|NCT01018511|54627639|FG000|Overall Study|Lack of Efficacy|4|||
27970074|NCT01018511|54627640|FG001|Overall Study|Lack of Efficacy|1|||
27970075|NCT01018511|54627641|FG002|Overall Study|Lack of Efficacy|1|||
27970076|NCT01018511|54627642|FG003|Overall Study|Lack of Efficacy|2|||
27970077|NCT01018511|54627639|FG000|Overall Study|Withdrawal by Subject|6|||
27970078|NCT01018511|54627640|FG001|Overall Study|Withdrawal by Subject|5|||
27970079|NCT01018511|54627641|FG002|Overall Study|Withdrawal by Subject|11|||
27970080|NCT01018511|54627642|FG003|Overall Study|Withdrawal by Subject|9|||
27970081|NCT01018511|54627639|FG000|Overall Study|Lost to Follow-up|0|||
27970082|NCT01018511|54627640|FG001|Overall Study|Lost to Follow-up|0|||
27970083|NCT01018511|54627641|FG002|Overall Study|Lost to Follow-up|1|||
27970084|NCT01018511|54627642|FG003|Overall Study|Lost to Follow-up|0|||
27970085|NCT01018511|54627639|FG000|Overall Study|Protocol Violation|5|||
27970086|NCT01018511|54627640|FG001|Overall Study|Protocol Violation|8|||
27970087|NCT01018511|54627641|FG002|Overall Study|Protocol Violation|7|||
27970088|NCT01018511|54627642|FG003|Overall Study|Protocol Violation|9|||
27970089|NCT01018511|54627639|FG000|Overall Study|Miscellaneous|0|||
27970090|NCT01018511|54627640|FG001|Overall Study|Miscellaneous|2|||
27970091|NCT01018511|54627641|FG002|Overall Study|Miscellaneous|0|||
27970092|NCT01018511|54627642|FG003|Overall Study|Miscellaneous|0|||
28084236|NCT00073749|54737785|FG004|Overall Study|Death|0|||
28084237|NCT00073749|54737786|FG005|Overall Study|Death|0|||
28084238|NCT00073749|54737787|FG006|Overall Study|Death|29|||
28084239|NCT00073749|54737781|FG000|Overall Study|Adverse Event|0|||
28084240|NCT00073749|54737782|FG001|Overall Study|Adverse Event|3|||
28084241|NCT00073749|54737783|FG002|Overall Study|Adverse Event|6|||
28084242|NCT00073749|54737784|FG003|Overall Study|Adverse Event|4|||
28084243|NCT00073749|54737785|FG004|Overall Study|Adverse Event|2|||
28084244|NCT00073749|54737786|FG005|Overall Study|Adverse Event|1|||
27970093|NCT00996476|54627663|FG000|Overall Study|Withdrawal by Subject|1|||
27970094|NCT00996476|54627664|FG001|Overall Study|Withdrawal by Subject|2|||
27970095|NCT00996476|54627665|FG002|Overall Study|Withdrawal by Subject|1|||
27970096|NCT00996476|54627666|FG003|Overall Study|Withdrawal by Subject|0|||
27970097|NCT00996476|54627667|FG004|Overall Study|Withdrawal by Subject|1|||
28084245|NCT00073749|54737787|FG006|Overall Study|Adverse Event|0|||
28084246|NCT00073749|54737781|FG000|Overall Study|Physician Decision|0|||
27970098|NCT00996476|54627663|FG000|Overall Study|Adverse Event|0|||
27970099|NCT00996476|54627664|FG001|Overall Study|Adverse Event|1|||
27970100|NCT00996476|54627665|FG002|Overall Study|Adverse Event|0|||
27970101|NCT00996476|54627666|FG003|Overall Study|Adverse Event|0|||
27970102|NCT00996476|54627667|FG004|Overall Study|Adverse Event|1|||
27970103|NCT02269267|54627684|FG000|Overall Study|Death|5|||
27970104|NCT01017731|54627688|FG000|Overall Study|Lost to Follow-up|2|||
27970105|NCT01017731|54627688|FG000|Overall Study|Withdrawal by Subject|3|||
28084247|NCT00073749|54737782|FG001|Overall Study|Physician Decision|0|||
28084248|NCT00073749|54737783|FG002|Overall Study|Physician Decision|1|||
27970106|NCT01017731|54627688|FG000|Overall Study|Physician Decision|2|||
27970107|NCT01017731|54627688|FG000|Overall Study|Adverse Event|1|||
27970108|NCT01035905|54627695|FG000|Overall Study|Lack of Efficacy|1|||
27970109|NCT01035905|54627696|FG001|Overall Study|Lack of Efficacy|1|||
27970110|NCT00779584|54627720|FG000|Overall Study|Protocol Violation|0|||
27970111|NCT00779584|54627721|FG001|Overall Study|Protocol Violation|0|||
27970112|NCT00779584|54627722|FG002|Overall Study|Protocol Violation|0|||
27970113|NCT00779584|54627723|FG003|Overall Study|Protocol Violation|0|||
27970114|NCT00779584|54627724|FG004|Overall Study|Protocol Violation|0|||
27970115|NCT00779584|54627725|FG005|Overall Study|Protocol Violation|1|||
27970116|NCT00779584|54627726|FG006|Overall Study|Protocol Violation|0|||
27970117|NCT00779584|54627727|FG007|Overall Study|Protocol Violation|0|||
27970118|NCT00779584|54627728|FG008|Overall Study|Protocol Violation|0|||
27970119|NCT00779584|54627720|FG000|Overall Study|Withdrawal by Subject|1|||
27970120|NCT00779584|54627721|FG001|Overall Study|Withdrawal by Subject|1|||
27970121|NCT00779584|54627722|FG002|Overall Study|Withdrawal by Subject|2|||
27970122|NCT00779584|54627723|FG003|Overall Study|Withdrawal by Subject|0|||
27970123|NCT00779584|54627724|FG004|Overall Study|Withdrawal by Subject|0|||
27970124|NCT00779584|54627725|FG005|Overall Study|Withdrawal by Subject|2|||
27970125|NCT00779584|54627726|FG006|Overall Study|Withdrawal by Subject|1|||
27970126|NCT00779584|54627727|FG007|Overall Study|Withdrawal by Subject|0|||
27970127|NCT00779584|54627728|FG008|Overall Study|Withdrawal by Subject|0|||
27970128|NCT00779584|54627720|FG000|Overall Study|Lost to Follow-up|0|||
27970129|NCT00779584|54627721|FG001|Overall Study|Lost to Follow-up|0|||
27970130|NCT00779584|54627722|FG002|Overall Study|Lost to Follow-up|0|||
27970131|NCT00779584|54627723|FG003|Overall Study|Lost to Follow-up|0|||
28084249|NCT00073749|54737784|FG003|Overall Study|Physician Decision|0|||
28084250|NCT00073749|54737785|FG004|Overall Study|Physician Decision|0|||
28084251|NCT00073749|54737786|FG005|Overall Study|Physician Decision|2|||
28084252|NCT00073749|54737787|FG006|Overall Study|Physician Decision|0|||
27970132|NCT00779584|54627724|FG004|Overall Study|Lost to Follow-up|1|||
27970133|NCT00779584|54627725|FG005|Overall Study|Lost to Follow-up|0|||
27970134|NCT00779584|54627726|FG006|Overall Study|Lost to Follow-up|0|||
27970135|NCT00779584|54627727|FG007|Overall Study|Lost to Follow-up|0|||
27970136|NCT00779584|54627728|FG008|Overall Study|Lost to Follow-up|0|||
27970137|NCT00779584|54627720|FG000|Overall Study|Progression of Disease|0|||
27970138|NCT00779584|54627721|FG001|Overall Study|Progression of Disease|1|||
27970139|NCT00779584|54627722|FG002|Overall Study|Progression of Disease|2|||
27970140|NCT00779584|54627723|FG003|Overall Study|Progression of Disease|6|||
27970141|NCT00779584|54627724|FG004|Overall Study|Progression of Disease|5|||
27970142|NCT00779584|54627725|FG005|Overall Study|Progression of Disease|1|||
27970143|NCT00779584|54627726|FG006|Overall Study|Progression of Disease|4|||
27970144|NCT00779584|54627727|FG007|Overall Study|Progression of Disease|2|||
27970145|NCT00779584|54627728|FG008|Overall Study|Progression of Disease|1|||
27970146|NCT00779584|54627720|FG000|Overall Study|Adverse Event|1|||
27970147|NCT00779584|54627721|FG001|Overall Study|Adverse Event|0|||
27970148|NCT00779584|54627722|FG002|Overall Study|Adverse Event|2|||
27970149|NCT00779584|54627723|FG003|Overall Study|Adverse Event|0|||
27970150|NCT00779584|54627724|FG004|Overall Study|Adverse Event|0|||
27970151|NCT00779584|54627725|FG005|Overall Study|Adverse Event|0|||
27970152|NCT00779584|54627726|FG006|Overall Study|Adverse Event|2|||
27970153|NCT00779584|54627727|FG007|Overall Study|Adverse Event|1|||
27970154|NCT00779584|54627728|FG008|Overall Study|Adverse Event|1|||
27970155|NCT00779584|54627720|FG000|Overall Study|Symptomatic Deterioration|1|||
27970156|NCT00779584|54627721|FG001|Overall Study|Symptomatic Deterioration|1|||
27970157|NCT00779584|54627722|FG002|Overall Study|Symptomatic Deterioration|1|||
27970158|NCT00779584|54627723|FG003|Overall Study|Symptomatic Deterioration|0|||
27970159|NCT00779584|54627724|FG004|Overall Study|Symptomatic Deterioration|0|||
27970160|NCT00779584|54627725|FG005|Overall Study|Symptomatic Deterioration|1|||
27970161|NCT00779584|54627726|FG006|Overall Study|Symptomatic Deterioration|1|||
28084253|NCT00073749|54737781|FG000|Overall Study|Withdrawal by Subject|0|||
28084254|NCT00073749|54737782|FG001|Overall Study|Withdrawal by Subject|1|||
28084255|NCT00073749|54737783|FG002|Overall Study|Withdrawal by Subject|0|||
28084256|NCT00073749|54737784|FG003|Overall Study|Withdrawal by Subject|0|||
28084257|NCT00073749|54737785|FG004|Overall Study|Withdrawal by Subject|1|||
28084258|NCT00073749|54737786|FG005|Overall Study|Withdrawal by Subject|0|||
28084259|NCT00073749|54737787|FG006|Overall Study|Withdrawal by Subject|2|||
28084260|NCT00073749|54737781|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
28084261|NCT00073749|54737782|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
28084262|NCT00073749|54737783|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
27732834|NCT02697591|54180549|FG007|Overall Study|Withdrawal by Subject|1|||
27970162|NCT00779584|54627727|FG007|Overall Study|Symptomatic Deterioration|0|||
27970163|NCT00779584|54627728|FG008|Overall Study|Symptomatic Deterioration|0|||
27970164|NCT00779584|54627720|FG000|Overall Study|Ongoing in Study|0|||
27970165|NCT00779584|54627721|FG001|Overall Study|Ongoing in Study|0|||
27970166|NCT00779584|54627722|FG002|Overall Study|Ongoing in Study|0|||
27732835|NCT02697591|54180550|FG008|Overall Study|Withdrawal by Subject|6|||
27970167|NCT00779584|54627723|FG003|Overall Study|Ongoing in Study|0|||
28084263|NCT00073749|54737784|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
28084264|NCT00073749|54737785|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
28084265|NCT00073749|54737786|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
28084266|NCT00073749|54737787|FG006|Overall Study|Discontinuation of Study by Sponsor|4|||
28084267|NCT00073749|54737781|FG000|Overall Study|Lost to Follow-up|0|||
28084268|NCT00073749|54737782|FG001|Overall Study|Lost to Follow-up|0|||
27732836|NCT02697591|54180551|FG009|Overall Study|Withdrawal by Subject|10|||
27732837|NCT02697591|54180542|FG000|Overall Study|Physician Decision|1|||
27732838|NCT02697591|54180543|FG001|Overall Study|Physician Decision|0|||
27855477|NCT00244751|54377470|FG001|Overall Study|Withdrawal by Subject|5|||
27855478|NCT00244751|54377471|FG002|Overall Study|Withdrawal by Subject|3|||
27855479|NCT00244751|54377469|FG000|Overall Study|Elevated liver enzymes|1|||
27970168|NCT00779584|54627724|FG004|Overall Study|Ongoing in Study|1|||
27970169|NCT00779584|54627725|FG005|Overall Study|Ongoing in Study|1|||
27970170|NCT00779584|54627726|FG006|Overall Study|Ongoing in Study|0|||
27970171|NCT00779584|54627727|FG007|Overall Study|Ongoing in Study|0|||
27970172|NCT00779584|54627728|FG008|Overall Study|Ongoing in Study|0|||
27970173|NCT00995930|54627750|FG000|Overall Study|Protocol deviation|2|||
27970174|NCT00995930|54627751|FG001|Overall Study|Protocol deviation|5|||
27970175|NCT00995930|54627750|FG000|Overall Study|Death|0|||
27970176|NCT00995930|54627751|FG001|Overall Study|Death|1|||
27970177|NCT00995930|54627750|FG000|Overall Study|Administrative problems|4|||
27970178|NCT00995930|54627751|FG001|Overall Study|Administrative problems|2|||
27970179|NCT00995930|54627750|FG000|Overall Study|Lost to Follow-up|1|||
27970180|NCT00995930|54627751|FG001|Overall Study|Lost to Follow-up|2|||
27970181|NCT00995930|54627750|FG000|Overall Study|Withdrawal by Subject|3|||
27970182|NCT00995930|54627751|FG001|Overall Study|Withdrawal by Subject|4|||
27970183|NCT00995930|54627750|FG000|Overall Study|Adverse Event|11|||
27732839|NCT02697591|54180544|FG002|Overall Study|Physician Decision|0|||
27855480|NCT00244751|54377470|FG001|Overall Study|Elevated liver enzymes|0|||
27970184|NCT00995930|54627751|FG001|Overall Study|Adverse Event|14|||
27732840|NCT02697591|54180545|FG003|Overall Study|Physician Decision|0|||
27732841|NCT02697591|54180546|FG004|Overall Study|Physician Decision|1|||
27732842|NCT02697591|54180547|FG005|Overall Study|Physician Decision|2|||
27732843|NCT02697591|54180548|FG006|Overall Study|Physician Decision|0|||
27732844|NCT02697591|54180549|FG007|Overall Study|Physician Decision|0|||
27732845|NCT02697591|54180550|FG008|Overall Study|Physician Decision|1|||
27732846|NCT02697591|54180551|FG009|Overall Study|Physician Decision|1|||
27732847|NCT02697591|54180542|FG000|Overall Study|Death|2|||
27732848|NCT02697591|54180543|FG001|Overall Study|Death|3|||
27732849|NCT02697591|54180544|FG002|Overall Study|Death|1|||
27732850|NCT02697591|54180545|FG003|Overall Study|Death|1|||
27732851|NCT02697591|54180546|FG004|Overall Study|Death|4|||
27732852|NCT02697591|54180547|FG005|Overall Study|Death|5|||
27732853|NCT02697591|54180548|FG006|Overall Study|Death|3|||
27732854|NCT02697591|54180549|FG007|Overall Study|Death|1|||
27732855|NCT02697591|54180550|FG008|Overall Study|Death|1|||
27732856|NCT02697591|54180551|FG009|Overall Study|Death|5|||
27732857|NCT02697591|54180542|FG000|Overall Study|Reason not Specified|0|||
27732858|NCT02697591|54180543|FG001|Overall Study|Reason not Specified|0|||
27732859|NCT02697591|54180544|FG002|Overall Study|Reason not Specified|0|||
27732860|NCT02697591|54180545|FG003|Overall Study|Reason not Specified|1|||
27832566|NCT01455597|54312027|FG003|Overall Study|Adverse Event|1|||
27832567|NCT01455597|54312024|FG000|Overall Study|Lack of Efficacy|0|||
27832568|NCT01455597|54312025|FG001|Overall Study|Lack of Efficacy|1|||
27832569|NCT01455597|54312026|FG002|Overall Study|Lack of Efficacy|2|||
27832570|NCT01455597|54312027|FG003|Overall Study|Lack of Efficacy|0|||
27832571|NCT01455597|54312024|FG000|Overall Study|Lost to Follow-up|3|||
27832572|NCT01455597|54312025|FG001|Overall Study|Lost to Follow-up|0|||
27832573|NCT01455597|54312026|FG002|Overall Study|Lost to Follow-up|2|||
27832574|NCT01455597|54312027|FG003|Overall Study|Lost to Follow-up|1|||
27832575|NCT01455597|54312024|FG000|Overall Study|Withdrew Consent|6|||
27832576|NCT01455597|54312025|FG001|Overall Study|Withdrew Consent|5|||
27855481|NCT00244751|54377471|FG002|Overall Study|Elevated liver enzymes|0|||
27970185|NCT00779506|54627758|FG000|Overall Study|Screening Failed|2|||
27970186|NCT00779506|54627758|FG000|Overall Study|Adverse Event|4|||
27970187|NCT00779506|54627758|FG000|Overall Study|Lack of Efficacy|11|||
27970188|NCT00779506|54627758|FG000|Overall Study|Protocol Violation|5|||
28084269|NCT00073749|54737783|FG002|Overall Study|Lost to Follow-up|0|||
27732861|NCT02697591|54180546|FG004|Overall Study|Reason not Specified|1|||
27732862|NCT02697591|54180547|FG005|Overall Study|Reason not Specified|2|||
27732863|NCT02697591|54180548|FG006|Overall Study|Reason not Specified|3|||
27732864|NCT02697591|54180549|FG007|Overall Study|Reason not Specified|1|||
27732865|NCT02697591|54180550|FG008|Overall Study|Reason not Specified|1|||
27732866|NCT02697591|54180551|FG009|Overall Study|Reason not Specified|3|||
27732867|NCT02697435|54180576|FG000|Overall Study|Withdrawal by Subject|1|||
27832577|NCT01455597|54312026|FG002|Overall Study|Withdrew Consent|8|||
27832578|NCT01455597|54312027|FG003|Overall Study|Withdrew Consent|5|||
27832579|NCT01455597|54312024|FG000|Overall Study|Reason not Specified|1|||
27970189|NCT00779506|54627758|FG000|Overall Study|Withdrawal by Subject|6|||
27970190|NCT00779506|54627758|FG000|Overall Study|Lost to Follow-up|1|||
27970191|NCT00995774|54627764|FG000|Training Period 2|Withdrawal by Subject|2|||
27970192|NCT00995774|54627765|FG001|Training Period 2|Withdrawal by Subject|0|||
27970193|NCT00765388|54627771|FG000|Period 1|Lack of Efficacy|1|||
27970194|NCT00765388|54627772|FG001|Period 1|Lack of Efficacy|2|||
27970195|NCT00765388|54627771|FG000|Period 1|Lost to Follow-up|0|||
27970196|NCT00765388|54627772|FG001|Period 1|Lost to Follow-up|1|||
27970197|NCT00765388|54627771|FG000|Period 1|Herpes Zoster|0|||
27970198|NCT00765388|54627772|FG001|Period 1|Herpes Zoster|1|||
27970199|NCT00765388|54627771|FG000|Period 1|Hip operation|0|||
27970200|NCT00765388|54627772|FG001|Period 1|Hip operation|1|||
27970201|NCT00769132|54627787|FG000|Period 1|Adverse Event|1|||
27970202|NCT00769132|54627788|FG001|Period 1|Adverse Event|0|||
27970203|NCT00769132|54627789|FG002|Period 1|Adverse Event|0|||
27970204|NCT00769132|54627790|FG003|Period 1|Adverse Event|1|||
27970205|NCT00769132|54627787|FG000|Period 2|Withdrawal by Subject|0|||
27970206|NCT00769132|54627788|FG001|Period 2|Withdrawal by Subject|0|||
27970207|NCT00769132|54627789|FG002|Period 2|Withdrawal by Subject|0|||
27970208|NCT00769132|54627790|FG003|Period 2|Withdrawal by Subject|1|||
27970209|NCT00769132|54627787|FG000|Period 3|Withdrawal by Subject|1|||
27970210|NCT00769132|54627788|FG001|Period 3|Withdrawal by Subject|0|||
27970211|NCT00769132|54627789|FG002|Period 3|Withdrawal by Subject|0|||
27970212|NCT00769132|54627790|FG003|Period 3|Withdrawal by Subject|0|||
28084270|NCT00073749|54737784|FG003|Overall Study|Lost to Follow-up|0|||
28084271|NCT00073749|54737785|FG004|Overall Study|Lost to Follow-up|0|||
28084272|NCT00073749|54737786|FG005|Overall Study|Lost to Follow-up|0|||
28084273|NCT00073749|54737787|FG006|Overall Study|Lost to Follow-up|2|||
28084274|NCT00073749|54737781|FG000|Overall Study|Other|0|||
28084275|NCT00073749|54737782|FG001|Overall Study|Other|0|||
28084276|NCT00073749|54737783|FG002|Overall Study|Other|0|||
28084277|NCT00073749|54737784|FG003|Overall Study|Other|0|||
28084278|NCT00073749|54737785|FG004|Overall Study|Other|0|||
28084279|NCT00073749|54737786|FG005|Overall Study|Other|2|||
28084280|NCT00073749|54737787|FG006|Overall Study|Other|0|||
28084281|NCT00398567|54737809|FG000|Overall Study|Disease Progression|3|||
28084282|NCT00398567|54737810|FG001|Overall Study|Disease Progression|4|||
28084283|NCT00398567|54737811|FG002|Overall Study|Disease Progression|27|||
28084284|NCT00398567|54737809|FG000|Overall Study|Withdrawal by Subject|1|||
28084285|NCT00398567|54737810|FG001|Overall Study|Withdrawal by Subject|0|||
28084286|NCT00398567|54737811|FG002|Overall Study|Withdrawal by Subject|4|||
28084287|NCT00398567|54737809|FG000|Overall Study|Adverse Event|0|||
28084288|NCT00398567|54737810|FG001|Overall Study|Adverse Event|0|||
28084289|NCT00398567|54737811|FG002|Overall Study|Adverse Event|2|||
28084290|NCT00398567|54737809|FG000|Overall Study|Protocol Violation|0|||
28084291|NCT00398567|54737810|FG001|Overall Study|Protocol Violation|0|||
28084292|NCT00398567|54737811|FG002|Overall Study|Protocol Violation|1|||
28084293|NCT05249569|54737817|FG000|Overall Study|Sponsor pulled support for one of the study drugs.|1|||
28084294|NCT04779879|54737840|FG000|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
28084295|NCT04779879|54737841|FG001|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
28084296|NCT04779879|54737842|FG002|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
28084297|NCT04779879|54737843|FG003|Part B: Up to Week 36|Randomized, but did not receive treatment|1|||
28084298|NCT04779879|54737844|FG004|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
28084299|NCT04779879|54737845|FG005|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
27732868|NCT02697435|54180577|FG001|Overall Study|Withdrawal by Subject|0|||
27732869|NCT02697435|54180576|FG000|Overall Study|Physician Decision|0|||
27732870|NCT02697435|54180577|FG001|Overall Study|Physician Decision|4|||
27732871|NCT02174861|54180584|FG000|Overall Study|Decision by sponsor|8|||
27732872|NCT02174861|54180584|FG000|Overall Study|Withdrawal by Subject|124|||
27832580|NCT01455597|54312025|FG001|Overall Study|Reason not Specified|2|||
27832581|NCT01455597|54312026|FG002|Overall Study|Reason not Specified|3|||
27832582|NCT01455597|54312027|FG003|Overall Study|Reason not Specified|3|||
27832583|NCT01757171|54312050|FG000|Overall Study|Adverse Event|5|||
27832584|NCT01757171|54312051|FG001|Overall Study|Adverse Event|1|||
27832585|NCT01757171|54312050|FG000|Overall Study|Disease Progression|1|||
27970213|NCT00769132|54627787|FG000|Period 4|Withdrawal by Subject|0|||
27970214|NCT00769132|54627788|FG001|Period 4|Withdrawal by Subject|1|||
27970215|NCT00769132|54627789|FG002|Period 4|Withdrawal by Subject|0|||
27970216|NCT00769132|54627790|FG003|Period 4|Withdrawal by Subject|0|||
27970217|NCT00991952|54627802|FG000|Overall Study|Adverse Event|0|||
27970218|NCT00991952|54627803|FG001|Overall Study|Adverse Event|1|||
27970219|NCT00779038|54627809|FG000|Overall Study|Study Prematurely Terminated|13|||
28084300|NCT04779879|54737840|FG000|Part B: Up to Week 36|Withdrawal by Subject|0|||
28084301|NCT04779879|54737841|FG001|Part B: Up to Week 36|Withdrawal by Subject|0|||
28084302|NCT04779879|54737842|FG002|Part B: Up to Week 36|Withdrawal by Subject|0|||
28084303|NCT04779879|54737843|FG003|Part B: Up to Week 36|Withdrawal by Subject|1|||
27732873|NCT02174861|54180584|FG000|Overall Study|Lost to Follow-up|26|||
27732874|NCT00140855|54180590|FG000|Overall Study|Progressive disease|2|||
27832586|NCT01757171|54312051|FG001|Overall Study|Disease Progression|0|||
27832587|NCT01757171|54312050|FG000|Overall Study|Hospitalization|1|||
28084304|NCT04779879|54737844|FG004|Part B: Up to Week 36|Withdrawal by Subject|0|||
28084305|NCT04779879|54737845|FG005|Part B: Up to Week 36|Withdrawal by Subject|0|||
28084306|NCT04779879|54737840|FG000|Part C: Up to Week 36|Death|0|||
28084307|NCT04779879|54737841|FG001|Part C: Up to Week 36|Death|0|||
28084308|NCT04779879|54737842|FG002|Part C: Up to Week 36|Death|0|||
28084309|NCT04779879|54737843|FG003|Part C: Up to Week 36|Death|0|||
28084310|NCT04779879|54737844|FG004|Part C: Up to Week 36|Death|0|||
28084311|NCT04779879|54737845|FG005|Part C: Up to Week 36|Death|1|||
28084312|NCT04779879|54737840|FG000|Part C: Up to Week 36|Withdrawal by Subject|0|||
28084313|NCT04779879|54737841|FG001|Part C: Up to Week 36|Withdrawal by Subject|0|||
28084314|NCT04779879|54737842|FG002|Part C: Up to Week 36|Withdrawal by Subject|0|||
28084315|NCT04779879|54737843|FG003|Part C: Up to Week 36|Withdrawal by Subject|0|||
28084316|NCT04779879|54737844|FG004|Part C: Up to Week 36|Withdrawal by Subject|4|||
28084317|NCT04779879|54737845|FG005|Part C: Up to Week 36|Withdrawal by Subject|2|||
28165279|NCT02919475|54835893|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
27732875|NCT00700635|54180597|FG000|Overall Study|Adverse Event|1|||
27732876|NCT00700635|54180598|FG001|Overall Study|Adverse Event|0|||
27732877|NCT00700635|54180599|FG002|Overall Study|Adverse Event|0|||
27970220|NCT00765076|54627816|FG000|Overall Study|Adverse Event|1|||
27970221|NCT00765076|54627817|FG001|Overall Study|Adverse Event|0|||
27970222|NCT00765076|54627818|FG002|Overall Study|Adverse Event|0|||
27970223|NCT00765076|54627816|FG000|Overall Study|Withdrawal by Subject|0|||
27970224|NCT00765076|54627817|FG001|Overall Study|Withdrawal by Subject|0|||
27970225|NCT00765076|54627818|FG002|Overall Study|Withdrawal by Subject|1|||
27970226|NCT00994682|54627828|FG000|Double Bilnd|Withdrawal by Subject|5|||
27970227|NCT00994682|54627829|FG001|Double Bilnd|Withdrawal by Subject|6|||
27970228|NCT00994682|54627828|FG000|Double Bilnd|Lost to Follow-up|3|||
27970229|NCT00994682|54627829|FG001|Double Bilnd|Lost to Follow-up|3|||
27970230|NCT00994682|54627828|FG000|Double Bilnd|Adverse Event|1|||
27970231|NCT00994682|54627829|FG001|Double Bilnd|Adverse Event|0|||
27970232|NCT00994682|54627828|FG000|Pioglitazone Open Label|Withdrawal by Subject|4|||
27970233|NCT00994682|54627829|FG001|Pioglitazone Open Label|Withdrawal by Subject|4|||
27970234|NCT00994682|54627828|FG000|Pioglitazone Open Label|Lost to Follow-up|3|||
27970235|NCT00994682|54627829|FG001|Pioglitazone Open Label|Lost to Follow-up|2|||
27970236|NCT00994682|54627828|FG000|Pioglitazone Open Label|Physician Decision|6|||
27970237|NCT00994682|54627829|FG001|Pioglitazone Open Label|Physician Decision|1|||
27970238|NCT00768898|54627839|FG000|Overall Study|Unrelated injury|1|||
27970239|NCT00768898|54627839|FG000|Overall Study|Headache|1|||
27970240|NCT00994448|54627850|FG000|Overall Study|Adverse Event|1|||
27970241|NCT00994448|54627851|FG001|Overall Study|Adverse Event|0|||
27970242|NCT00994448|54627850|FG000|Overall Study|Lost to Follow-up|5|||
27970243|NCT00994448|54627851|FG001|Overall Study|Lost to Follow-up|1|||
28084318|NCT04535167|54737886|FG000|Treatment|Adverse Event|0|||
27732878|NCT00700635|54180597|FG000|Overall Study|Lost to Follow-up|1|||
27732879|NCT00700635|54180598|FG001|Overall Study|Lost to Follow-up|3|||
27732880|NCT00700635|54180599|FG002|Overall Study|Lost to Follow-up|0|||
27732881|NCT00700635|54180597|FG000|Overall Study|Protocol Violation|2|||
27732882|NCT00700635|54180598|FG001|Overall Study|Protocol Violation|2|||
27732883|NCT00700635|54180599|FG002|Overall Study|Protocol Violation|0|||
27732884|NCT00700635|54180597|FG000|Overall Study|Withdrawal by Subject|7|||
27732885|NCT00700635|54180598|FG001|Overall Study|Withdrawal by Subject|3|||
27732886|NCT00700635|54180599|FG002|Overall Study|Withdrawal by Subject|1|||
27732887|NCT02780687|54180609|FG000|Overall Study|Adverse Event|1|||
27732888|NCT02780687|54180610|FG001|Overall Study|Adverse Event|1|||
27732889|NCT02780687|54180609|FG000|Overall Study|Withdrawal by Subject|2|||
27732890|NCT02780687|54180610|FG001|Overall Study|Withdrawal by Subject|1|||
27732891|NCT02780687|54180609|FG000|Overall Study|Switched to commercial program (in CTP)|2|||
27732892|NCT02780687|54180610|FG001|Overall Study|Switched to commercial program (in CTP)|0|||
27732893|NCT02780687|54180609|FG000|Overall Study|progressive disease|29|||
27732894|NCT02780687|54180610|FG001|Overall Study|progressive disease|6|||
27732895|NCT02698371|54180615|FG000|All Participants Flow|Lost to Follow-up|3|||
27732896|NCT02698371|54180615|FG000|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3|||
27732897|NCT02698371|54180615|FG000|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3|||
27970244|NCT00994448|54627850|FG000|Overall Study|Withdrawal by Subject|1|||
28084319|NCT04535167|54737887|FG001|Treatment|Adverse Event|0|||
28084320|NCT04535167|54737888|FG002|Treatment|Adverse Event|0|||
27970245|NCT00994448|54627851|FG001|Overall Study|Withdrawal by Subject|1|||
27970246|NCT00994448|54627850|FG000|Overall Study|Physician Decision|1|||
28084321|NCT04535167|54737889|FG003|Treatment|Adverse Event|0|||
28084322|NCT04535167|54737890|FG004|Treatment|Adverse Event|0|||
28084323|NCT04535167|54737891|FG005|Treatment|Adverse Event|0|||
28084324|NCT04535167|54737892|FG006|Treatment|Adverse Event|1|||
28084325|NCT04535167|54737886|FG000|Follow-Up|Death|0|||
27732898|NCT02698371|54180615|FG000|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3|||
27732899|NCT02698371|54180615|FG000|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3|||
27732900|NCT02698371|54180615|FG000|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3|||
27970247|NCT00994448|54627851|FG001|Overall Study|Physician Decision|0|||
27970248|NCT00991406|54627857|FG000|Overall Study|One participant did not respond to FES.|1|||
27970249|NCT01017575|54627866|FG000|Overall Study|Lack of Efficacy|0|||
27970250|NCT01017575|54627867|FG001|Overall Study|Lack of Efficacy|1|||
27970251|NCT01017575|54627868|FG002|Overall Study|Lack of Efficacy|0|||
27970252|NCT01017575|54627869|FG003|Overall Study|Lack of Efficacy|1|||
27970253|NCT01017575|54627870|FG004|Overall Study|Lack of Efficacy|1|||
27970254|NCT01017575|54627866|FG000|Overall Study|Adverse Event|0|||
27970255|NCT01017575|54627867|FG001|Overall Study|Adverse Event|1|||
28084326|NCT04535167|54737887|FG001|Follow-Up|Death|0|||
28084327|NCT04535167|54737888|FG002|Follow-Up|Death|0|||
28084328|NCT04535167|54737889|FG003|Follow-Up|Death|0|||
28084329|NCT04535167|54737890|FG004|Follow-Up|Death|0|||
28084330|NCT04535167|54737891|FG005|Follow-Up|Death|0|||
28084331|NCT04535167|54737892|FG006|Follow-Up|Death|1|||
27970256|NCT01017575|54627868|FG002|Overall Study|Adverse Event|0|||
27970257|NCT01017575|54627869|FG003|Overall Study|Adverse Event|0|||
27970258|NCT01017575|54627870|FG004|Overall Study|Adverse Event|2|||
27970259|NCT01017575|54627866|FG000|Overall Study|Withdrawal by Subject|1|||
27970260|NCT01017575|54627867|FG001|Overall Study|Withdrawal by Subject|0|||
27970261|NCT01017575|54627868|FG002|Overall Study|Withdrawal by Subject|0|||
28084332|NCT04535167|54737886|FG000|Follow-Up|Lost to Follow-up|0|||
28084333|NCT04535167|54737887|FG001|Follow-Up|Lost to Follow-up|0|||
28084334|NCT04535167|54737888|FG002|Follow-Up|Lost to Follow-up|0|||
28084335|NCT04535167|54737889|FG003|Follow-Up|Lost to Follow-up|1|||
28084336|NCT04535167|54737890|FG004|Follow-Up|Lost to Follow-up|0|||
28084337|NCT04535167|54737891|FG005|Follow-Up|Lost to Follow-up|0|||
28084338|NCT04535167|54737892|FG006|Follow-Up|Lost to Follow-up|0|||
28084339|NCT04223791|54737910|FG000|Overall Study|Lost to Follow-up|0|||
28084340|NCT04223791|54737911|FG001|Overall Study|Lost to Follow-up|4|||
28084341|NCT04223791|54737910|FG000|Overall Study|Physician Decision|5|||
28084342|NCT04223791|54737911|FG001|Overall Study|Physician Decision|1|||
28084343|NCT04223791|54737910|FG000|Overall Study|Protocol Violation|1|||
28084344|NCT04223791|54737911|FG001|Overall Study|Protocol Violation|1|||
28084345|NCT04223791|54737910|FG000|Overall Study|Withdrawal by Subject|10|||
28084346|NCT04223791|54737911|FG001|Overall Study|Withdrawal by Subject|12|||
28084347|NCT04223791|54737910|FG000|Overall Study|Pregnancy|1|||
28084348|NCT04223791|54737911|FG001|Overall Study|Pregnancy|1|||
28084349|NCT04223791|54737910|FG000|Overall Study|Ongoing in Study|305|||
28084350|NCT04223791|54737911|FG001|Overall Study|Ongoing in Study|302|||
28084351|NCT04115293|54737919|FG000|Overall Study|Adverse Event|0|||
28084352|NCT04115293|54737920|FG001|Overall Study|Adverse Event|2|||
28084353|NCT04115293|54737919|FG000|Overall Study|Withdrawal by Subject|2|||
28084354|NCT04115293|54737920|FG001|Overall Study|Withdrawal by Subject|1|||
28084355|NCT04115293|54737919|FG000|Overall Study|Physician Decision|1|||
28084356|NCT04115293|54737920|FG001|Overall Study|Physician Decision|0|||
28084357|NCT04115293|54737919|FG000|Overall Study|Death|1|||
28084358|NCT04115293|54737920|FG001|Overall Study|Death|1|||
28084359|NCT04035499|54737926|FG000|Overall Study|Death|2|||
28165280|NCT02919475|54835894|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
27970262|NCT01017575|54627869|FG003|Overall Study|Withdrawal by Subject|0|||
27970263|NCT01017575|54627870|FG004|Overall Study|Withdrawal by Subject|0|||
27970264|NCT01017263|54627882|FG000|Overall Study|not eligible|12|||
27970265|NCT00768664|54627886|FG000|Overall Study|Death|57|||
27970266|NCT00768664|54627886|FG000|Overall Study|Lost to Follow-up|2|||
27970267|NCT00768664|54627886|FG000|Overall Study|Other|9|||
27970268|NCT00768664|54627886|FG000|Overall Study|Participant refused|1|||
27970269|NCT00778336|54627894|FG000|Index Procedure-Discharge|Death|6|||
27970270|NCT00778336|54627895|FG001|Index Procedure-Discharge|Death|3|||
27970271|NCT00778336|54627896|FG002|Index Procedure-Discharge|Death|2|||
27970272|NCT00778336|54627897|FG003|Index Procedure-Discharge|Death|0|||
27970273|NCT00778336|54627894|FG000|3 Month Follow Up|Lost to Follow-up|15|||
27970274|NCT00778336|54627895|FG001|3 Month Follow Up|Lost to Follow-up|20|||
28084360|NCT04035499|54737926|FG000|Overall Study|Withdrawal by Subject|1|||
28165281|NCT02919475|54835895|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
28165282|NCT01066897|54835909|FG000|Overall Study|Withdrawal by Subject|1|||
27970275|NCT00778336|54627896|FG002|3 Month Follow Up|Lost to Follow-up|3|||
28165283|NCT01066897|54835910|FG001|Overall Study|Withdrawal by Subject|0|||
28165284|NCT01066897|54835909|FG000|Overall Study|stopped study after developing the flu.|1|||
27970276|NCT00778336|54627897|FG003|3 Month Follow Up|Lost to Follow-up|0|||
27970277|NCT00778336|54627894|FG000|3 Month Follow Up|Death|8|||
27832588|NCT01757171|54312051|FG001|Overall Study|Hospitalization|0|||
27970278|NCT00778336|54627895|FG001|3 Month Follow Up|Death|3|||
27970279|NCT00778336|54627896|FG002|3 Month Follow Up|Death|2|||
27970280|NCT00778336|54627897|FG003|3 Month Follow Up|Death|0|||
27970281|NCT01253161|54627907|FG000|Overall Study|Adverse Event|1|||
28084361|NCT04031846|54737932|FG000|Overall Study|Lost to Follow-up|4|||
28084362|NCT04031846|54737933|FG001|Overall Study|Lost to Follow-up|4|||
28084363|NCT04031846|54737932|FG000|Overall Study|Physician Decision|0|||
28084364|NCT04031846|54737933|FG001|Overall Study|Physician Decision|1|||
28084365|NCT04031846|54737932|FG000|Overall Study|Protocol Violation|1|||
28084366|NCT04031846|54737933|FG001|Overall Study|Protocol Violation|1|||
27970282|NCT00581113|54627913|FG000|Overall Study|Withdrawal by Subject|0|||
27970283|NCT00581113|54627914|FG001|Overall Study|Withdrawal by Subject|1|||
27970284|NCT01016015|54627920|FG000|Overall Study|Not Treated|3|||
27970285|NCT01016015|54627920|FG000|Overall Study|Withdrawal by Subject|1|||
27970286|NCT01016015|54627920|FG000|Overall Study|Adverse Event|15|||
27970287|NCT01015703|54627929|FG000|Overall Study|Withdrawal by Subject|0|||
27970288|NCT01015703|54627930|FG001|Overall Study|Withdrawal by Subject|1|||
27970289|NCT01015703|54627931|FG002|Overall Study|Withdrawal by Subject|0|||
27970290|NCT01015703|54627932|FG003|Overall Study|Withdrawal by Subject|0|||
27970291|NCT01015703|54627933|FG004|Overall Study|Withdrawal by Subject|0|||
27970292|NCT01015703|54627929|FG000|Overall Study|Adverse Event|1|||
27970293|NCT01015703|54627930|FG001|Overall Study|Adverse Event|0|||
27970294|NCT01015703|54627931|FG002|Overall Study|Adverse Event|0|||
27970295|NCT01015703|54627932|FG003|Overall Study|Adverse Event|0|||
27970296|NCT01015703|54627933|FG004|Overall Study|Adverse Event|0|||
27970297|NCT01015703|54627929|FG000|Overall Study|Protocol Violation|1|||
27970298|NCT01015703|54627930|FG001|Overall Study|Protocol Violation|0|||
27970299|NCT01015703|54627931|FG002|Overall Study|Protocol Violation|0|||
27970300|NCT01015703|54627932|FG003|Overall Study|Protocol Violation|0|||
27970301|NCT01015703|54627933|FG004|Overall Study|Protocol Violation|0|||
27970302|NCT04439071|54627947|FG000|Overall Study|Lost to Follow-up|0|||
27970303|NCT04439071|54627948|FG001|Overall Study|Lost to Follow-up|3|||
27970304|NCT04439071|54627947|FG000|Overall Study|Withdrawal by Subject|3|||
27970305|NCT04439071|54627948|FG001|Overall Study|Withdrawal by Subject|8|||
27970306|NCT04439071|54627947|FG000|Overall Study|Death|6|||
27970307|NCT04439071|54627948|FG001|Overall Study|Death|4|||
27970308|NCT04439071|54627947|FG000|Overall Study|Other than specified|3|||
27970309|NCT04439071|54627948|FG001|Overall Study|Other than specified|3|||
27970310|NCT04439071|54627947|FG000|Overall Study|Randomized but not treated|2|||
27970311|NCT04439071|54627948|FG001|Overall Study|Randomized but not treated|0|||
27970312|NCT01017029|54627956|FG000|Overall Study|Lost to Follow-up|1|||
27970313|NCT01017029|54627957|FG001|Overall Study|Lost to Follow-up|0|||
28084367|NCT04031846|54737932|FG000|Overall Study|Withdrawal By Parent/Guardian|17|||
28084368|NCT04031846|54737933|FG001|Overall Study|Withdrawal By Parent/Guardian|17|||
28084369|NCT03915067|54737943|FG000|Overall Study|Adverse Event|0|||
28084370|NCT03915067|54737944|FG001|Overall Study|Adverse Event|0|||
28084371|NCT03915067|54737945|FG002|Overall Study|Adverse Event|1|||
28084372|NCT03915067|54737943|FG000|Overall Study|Withdrawal by Subject|4|||
28084373|NCT03915067|54737944|FG001|Overall Study|Withdrawal by Subject|3|||
28084374|NCT03915067|54737945|FG002|Overall Study|Withdrawal by Subject|0|||
28084375|NCT03915067|54737943|FG000|Overall Study|Lost to Follow-up|3|||
28084376|NCT03915067|54737944|FG001|Overall Study|Lost to Follow-up|2|||
28084377|NCT03915067|54737945|FG002|Overall Study|Lost to Follow-up|0|||
28084378|NCT03915067|54737943|FG000|Overall Study|Protocol Deviation|0|||
28084379|NCT03915067|54737944|FG001|Overall Study|Protocol Deviation|0|||
28084380|NCT03915067|54737945|FG002|Overall Study|Protocol Deviation|1|||
28084381|NCT03915067|54737943|FG000|Overall Study|Covid-19 Related Issues|2|||
28084382|NCT03915067|54737944|FG001|Overall Study|Covid-19 Related Issues|4|||
28084383|NCT03915067|54737945|FG002|Overall Study|Covid-19 Related Issues|4|||
28084384|NCT03915067|54737943|FG000|Overall Study|Randomized With Incorrect C-APPS|1|||
28084385|NCT03915067|54737944|FG001|Overall Study|Randomized With Incorrect C-APPS|0|||
28084386|NCT03915067|54737945|FG002|Overall Study|Randomized With Incorrect C-APPS|0|||
28084387|NCT03654404|54737953|FG000|Overall Study|Death|1|||
28084388|NCT03654404|54737953|FG000|Overall Study|Lost to Follow-up|2|||
28084389|NCT03654404|54737953|FG000|Overall Study|Withdrawal by Subject|5|||
28084390|NCT03602586|54737957|FG000|Overall Study|Withdrawal by Subject|3|||
28084391|NCT03447314|54738022|FG000|Part 1 (Up to 47 Months and 13 Days)|Death|6|||
28084392|NCT03447314|54738023|FG001|Part 1 (Up to 47 Months and 13 Days)|Death|5|||
28084393|NCT03447314|54738024|FG002|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
28084394|NCT03447314|54738025|FG003|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
28084395|NCT03447314|54738026|FG004|Part 1 (Up to 47 Months and 13 Days)|Death|1|||
28084396|NCT03447314|54738027|FG005|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
27970314|NCT01017029|54627956|FG000|Overall Study|Administrative problem|0|||
27970315|NCT01017029|54627957|FG001|Overall Study|Administrative problem|1|||
27970316|NCT01017029|54627956|FG000|Overall Study|Death|3|||
27970317|NCT01017029|54627957|FG001|Overall Study|Death|1|||
27970318|NCT00994214|54627967|FG000|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
27970319|NCT00994214|54627968|FG001|ITT (Intention-to-Treat) - Part A|Adverse Event|1|||
28084397|NCT03447314|54738028|FG006|Part 1 (Up to 47 Months and 13 Days)|Death|2|||
28165285|NCT01066897|54835910|FG001|Overall Study|stopped study after developing the flu.|0|||
27970320|NCT00994214|54627969|FG002|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
27970321|NCT00994214|54627970|FG003|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
27970322|NCT00994214|54627967|FG000|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
28084398|NCT03447314|54738029|FG007|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
28084399|NCT03447314|54738030|FG008|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
28165286|NCT02985541|54835917|FG000|Overall Study|Withdrawal by Subject|33|||
27970323|NCT00994214|54627968|FG001|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
27970324|NCT00994214|54627969|FG002|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
27970325|NCT00994214|54627970|FG003|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1|||
27970326|NCT00994214|54627967|FG000|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1|||
27970327|NCT00994214|54627968|FG001|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
27970328|NCT00994214|54627969|FG002|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
27970329|NCT00994214|54627970|FG003|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
27970330|NCT00994214|54627967|FG000|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
27970331|NCT00994214|54627968|FG001|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12|||
27970332|NCT00994214|54627969|FG002|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
27970333|NCT00994214|54627970|FG003|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14|||
27970334|NCT00994214|54627967|FG000|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
27970335|NCT00994214|54627968|FG001|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
27970336|NCT00994214|54627969|FG002|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
27970337|NCT00994214|54627970|FG003|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1|||
27970338|NCT00994214|54627967|FG000|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4|||
27970339|NCT00994214|54627968|FG001|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3|||
27970340|NCT00994214|54627969|FG002|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
27970341|NCT00994214|54627970|FG003|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
28084400|NCT03447314|54738031|FG009|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
28084401|NCT03447314|54738032|FG010|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
28084402|NCT03447314|54738033|FG011|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
28084403|NCT03447314|54738034|FG012|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
28084404|NCT03447314|54738035|FG013|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
28084405|NCT03447314|54738036|FG014|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
28084406|NCT03447314|54738037|FG015|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
28084407|NCT03447314|54738038|FG016|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
28084408|NCT03447314|54738039|FG017|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
28084409|NCT03447314|54738022|FG000|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
28084410|NCT03447314|54738023|FG001|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
28084411|NCT03447314|54738024|FG002|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
28084412|NCT03447314|54738025|FG003|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
28084413|NCT03447314|54738026|FG004|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
28084414|NCT03447314|54738027|FG005|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
28084415|NCT03447314|54738028|FG006|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
28084416|NCT03447314|54738029|FG007|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
28084417|NCT03447314|54738030|FG008|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
28084418|NCT03447314|54738031|FG009|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
28084419|NCT03447314|54738032|FG010|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
28084420|NCT03447314|54738033|FG011|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
28084421|NCT03447314|54738034|FG012|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
28084422|NCT03447314|54738035|FG013|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
28084423|NCT03447314|54738036|FG014|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
27970342|NCT01034657|54627998|FG000|Core Phase|Withdrawal by Subject|1|||
27970343|NCT01034657|54627999|FG001|Core Phase|Withdrawal by Subject|0|||
27970344|NCT01034657|54628000|FG002|Core Phase|Withdrawal by Subject|0|||
27970345|NCT01034657|54627998|FG000|Core Phase|Lack of Efficacy|2|||
27970346|NCT01034657|54627999|FG001|Core Phase|Lack of Efficacy|0|||
28084424|NCT03447314|54738037|FG015|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
28084425|NCT03447314|54738038|FG016|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
28084426|NCT03447314|54738039|FG017|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
28084427|NCT03447314|54738022|FG000|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
28084428|NCT03447314|54738023|FG001|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
27855482|NCT00244751|54377469|FG000|Overall Study|Lack of compliance with protocol|0|||
27855483|NCT00244751|54377470|FG001|Overall Study|Lack of compliance with protocol|1|||
27855484|NCT00244751|54377471|FG002|Overall Study|Lack of compliance with protocol|0|||
27855485|NCT00244751|54377469|FG000|Overall Study|Safety reasons|0|||
27855486|NCT00244751|54377470|FG001|Overall Study|Safety reasons|1|||
27855487|NCT00244751|54377471|FG002|Overall Study|Safety reasons|0|||
27855488|NCT00244751|54377469|FG000|Overall Study|Participant randomized by mistake|0|||
27855489|NCT00244751|54377470|FG001|Overall Study|Participant randomized by mistake|0|||
27855490|NCT00244751|54377471|FG002|Overall Study|Participant randomized by mistake|1|||
27855491|NCT00243659|54377513|FG000|Overall Study|Withdrawal by Subject|1|||
27855492|NCT00243659|54377514|FG001|Overall Study|Withdrawal by Subject|1|||
27855493|NCT00243659|54377513|FG000|Overall Study|Protocol Violation|1|||
27970347|NCT01034657|54628000|FG002|Core Phase|Lack of Efficacy|0|||
27970348|NCT01034657|54627998|FG000|Core Phase|Abnormal laboratory value|1|||
27970349|NCT01034657|54627999|FG001|Core Phase|Abnormal laboratory value|0|||
27970350|NCT01034657|54628000|FG002|Core Phase|Abnormal laboratory value|0|||
27970351|NCT01034657|54627998|FG000|Core Phase|Adverse Event|8|||
27970352|NCT01034657|54627999|FG001|Core Phase|Adverse Event|0|||
27970353|NCT01034657|54628000|FG002|Core Phase|Adverse Event|0|||
27970354|NCT01034657|54627998|FG000|Core Phase|Protocol Violation|2|||
27970355|NCT01034657|54627999|FG001|Core Phase|Protocol Violation|0|||
27970356|NCT01034657|54628000|FG002|Core Phase|Protocol Violation|0|||
27970357|NCT01034657|54627998|FG000|Randomized Phase|Withdrawal by Subject|0|||
27970358|NCT01034657|54627999|FG001|Randomized Phase|Withdrawal by Subject|2|||
27970359|NCT01034657|54628000|FG002|Randomized Phase|Withdrawal by Subject|0|||
27970360|NCT01034657|54627998|FG000|Randomized Phase|Lack of Efficacy|5|||
27970361|NCT01034657|54627999|FG001|Randomized Phase|Lack of Efficacy|1|||
27970362|NCT01034657|54628000|FG002|Randomized Phase|Lack of Efficacy|0|||
27970363|NCT01034657|54627998|FG000|Randomized Phase|Abnormal laboratory value|0|||
27970364|NCT01034657|54627999|FG001|Randomized Phase|Abnormal laboratory value|1|||
27970365|NCT01034657|54628000|FG002|Randomized Phase|Abnormal laboratory value|0|||
27970366|NCT01034657|54627998|FG000|Randomized Phase|Adverse Event|0|||
27970367|NCT01034657|54627999|FG001|Randomized Phase|Adverse Event|2|||
27970368|NCT01034657|54628000|FG002|Randomized Phase|Adverse Event|1|||
27970369|NCT01014767|54628014|FG000|Overall Study|PI left institution, data unavailable|12|||
27970370|NCT01014767|54628015|FG001|Overall Study|PI left institution, data unavailable|1|||
27970371|NCT01014767|54628016|FG002|Overall Study|PI left institution, data unavailable|4|||
27970372|NCT01014767|54628017|FG003|Overall Study|PI left institution, data unavailable|1|||
27970373|NCT02016781|54628029|FG000|Interim Look for Primary Analysis|Alive and on study|71|||
27970374|NCT02016781|54628030|FG001|Interim Look for Primary Analysis|Alive and on study|23|||
27970375|NCT02016781|54628029|FG000|Interim Look for Primary Analysis|Withdrawal by Subject|2|||
27970376|NCT02016781|54628030|FG001|Interim Look for Primary Analysis|Withdrawal by Subject|1|||
27970377|NCT02016781|54628029|FG000|Final Database Lock|Withdrawal by Subject|2|||
27970378|NCT02016781|54628030|FG001|Final Database Lock|Withdrawal by Subject|1|||
27970379|NCT02016781|54628029|FG000|Final Database Lock|Lost to Follow-up|11|||
27970380|NCT02016781|54628030|FG001|Final Database Lock|Lost to Follow-up|4|||
27970381|NCT02016781|54628029|FG000|Final Database Lock|Missing data|0|||
27970382|NCT02016781|54628030|FG001|Final Database Lock|Missing data|3|||
27970383|NCT01014689|54628038|FG000|Overall Study|Lack of Efficacy|0|||
27970384|NCT01014689|54628039|FG001|Overall Study|Lack of Efficacy|1|||
27970385|NCT01014689|54628038|FG000|Overall Study|Adverse Event|3|||
27970386|NCT01014689|54628039|FG001|Overall Study|Adverse Event|0|||
27970387|NCT01014689|54628038|FG000|Overall Study|Withdrawal by Subject|5|||
27970388|NCT01014689|54628039|FG001|Overall Study|Withdrawal by Subject|4|||
27970389|NCT01014689|54628038|FG000|Overall Study|Protocol Violation|1|||
27970390|NCT01014689|54628039|FG001|Overall Study|Protocol Violation|1|||
27970391|NCT01014689|54628038|FG000|Overall Study|Lost to Follow-up|3|||
27970392|NCT01014689|54628039|FG001|Overall Study|Lost to Follow-up|7|||
27970393|NCT01014689|54628038|FG000|Overall Study|Pregnancy|1|||
27970394|NCT01014689|54628039|FG001|Overall Study|Pregnancy|0|||
27970395|NCT01014533|54628047|FG000|Overall Study|Protocol Violation|3|||
27970396|NCT01014533|54628048|FG001|Overall Study|Protocol Violation|2|||
27970397|NCT01014533|54628047|FG000|Overall Study|Withdrawal by Subject|2|||
27970398|NCT01014533|54628048|FG001|Overall Study|Withdrawal by Subject|0|||
27970399|NCT01014533|54628047|FG000|Overall Study|unable to come to appointment|0|||
27970400|NCT01014533|54628048|FG001|Overall Study|unable to come to appointment|3|||
27970401|NCT01014143|54628071|FG000|Second Intervention|Lost to Follow-up|2|||
27970402|NCT01014143|54628072|FG001|Second Intervention|Lost to Follow-up|0|||
27970403|NCT01014143|54628073|FG002|Second Intervention|Lost to Follow-up|0|||
27970404|NCT01013753|54628081|FG000|Overall Study|Adverse Event|8|||
27970405|NCT01013753|54628081|FG000|Overall Study|Protocol Violation|3|||
27970406|NCT01013753|54628081|FG000|Overall Study|Lost to Follow-up|1|||
27970407|NCT01013753|54628081|FG000|Overall Study|Withdrawal by Subject|2|||
27970408|NCT01013753|54628081|FG000|Overall Study|Other|2|||
27855494|NCT00243659|54377514|FG001|Overall Study|Protocol Violation|2|||
27855495|NCT00243347|54377529|FG000|Overall Study|Lack of Efficacy|4|||
27855496|NCT00243347|54377529|FG000|Overall Study|Adverse Event|2|||
27855497|NCT00243347|54377529|FG000|Overall Study|Death|1|||
27855498|NCT00243347|54377529|FG000|Overall Study|Withdrawal by Subject|5|||
27855499|NCT00243347|54377529|FG000|Overall Study|Condition worsened|7|||
27855500|NCT00243269|54377537|FG000|Overall Study|Protocol Violation|2|||
27855501|NCT00243269|54377538|FG001|Overall Study|Protocol Violation|1|||
27855502|NCT00243269|54377539|FG002|Overall Study|Protocol Violation|0|||
27970409|NCT00757042|54628106|FG000|Overall Study|Lost to Follow-up|0|||
27970410|NCT00757042|54628107|FG001|Overall Study|Lost to Follow-up|0|||
27970411|NCT00757042|54628108|FG002|Overall Study|Lost to Follow-up|0|||
27855503|NCT00243269|54377540|FG003|Overall Study|Protocol Violation|1|||
27855504|NCT00243269|54377537|FG000|Overall Study|Lost to Follow-up|1|||
27855505|NCT00243269|54377538|FG001|Overall Study|Lost to Follow-up|0|||
27970412|NCT00757042|54628109|FG003|Overall Study|Lost to Follow-up|0|||
27970413|NCT00757042|54628110|FG004|Overall Study|Lost to Follow-up|0|||
27970414|NCT00757042|54628111|FG005|Overall Study|Lost to Follow-up|0|||
27970415|NCT00757042|54628112|FG006|Overall Study|Lost to Follow-up|0|||
27970416|NCT00757042|54628113|FG007|Overall Study|Lost to Follow-up|0|||
27970417|NCT00757042|54628114|FG008|Overall Study|Lost to Follow-up|1|||
27970418|NCT00757042|54628115|FG009|Overall Study|Lost to Follow-up|0|||
27970419|NCT00757042|54628116|FG010|Overall Study|Lost to Follow-up|0|||
27970420|NCT00757042|54628106|FG000|Overall Study|Ineligibility Determined|0|||
27970421|NCT00757042|54628107|FG001|Overall Study|Ineligibility Determined|0|||
27970422|NCT00757042|54628108|FG002|Overall Study|Ineligibility Determined|0|||
27970423|NCT00757042|54628109|FG003|Overall Study|Ineligibility Determined|0|||
27970424|NCT00757042|54628110|FG004|Overall Study|Ineligibility Determined|0|||
27970425|NCT00757042|54628111|FG005|Overall Study|Ineligibility Determined|0|||
27970426|NCT00757042|54628112|FG006|Overall Study|Ineligibility Determined|0|||
27970427|NCT00757042|54628113|FG007|Overall Study|Ineligibility Determined|0|||
27970428|NCT00757042|54628114|FG008|Overall Study|Ineligibility Determined|0|||
27970429|NCT00757042|54628115|FG009|Overall Study|Ineligibility Determined|0|||
27970430|NCT00757042|54628116|FG010|Overall Study|Ineligibility Determined|1|||
27970431|NCT00757042|54628106|FG000|Overall Study|Withdrawal by Subject|0|||
27970432|NCT00757042|54628107|FG001|Overall Study|Withdrawal by Subject|0|||
27970433|NCT00757042|54628108|FG002|Overall Study|Withdrawal by Subject|0|||
27970434|NCT00757042|54628109|FG003|Overall Study|Withdrawal by Subject|0|||
27970435|NCT00757042|54628110|FG004|Overall Study|Withdrawal by Subject|0|||
27970436|NCT00757042|54628111|FG005|Overall Study|Withdrawal by Subject|0|||
27970437|NCT00757042|54628112|FG006|Overall Study|Withdrawal by Subject|0|||
27970438|NCT00757042|54628113|FG007|Overall Study|Withdrawal by Subject|0|||
27970439|NCT00757042|54628114|FG008|Overall Study|Withdrawal by Subject|0|||
27970440|NCT00757042|54628115|FG009|Overall Study|Withdrawal by Subject|1|||
27970441|NCT00757042|54628116|FG010|Overall Study|Withdrawal by Subject|0|||
27970442|NCT01013597|54628147|FG000|Overall Study|Withdrawal by Subject|1|||
27970443|NCT01013285|54628166|FG000|Overall Study|Death|48|||
27970444|NCT01013285|54628167|FG001|Overall Study|Death|89|||
27970445|NCT01033643|54628177|FG000|Overall Study|Withdrew Consent|0|||
27970446|NCT01033643|54628178|FG001|Overall Study|Withdrew Consent|3|||
27970447|NCT01033643|54628179|FG002|Overall Study|Withdrew Consent|0|||
27970448|NCT01033643|54628180|FG003|Overall Study|Withdrew Consent|0|||
27970449|NCT01033643|54628181|FG004|Overall Study|Withdrew Consent|0|||
27970450|NCT01033643|54628182|FG005|Overall Study|Withdrew Consent|1|||
27970451|NCT01013207|54628196|FG000|CPAP Post Nexus (S9)|Lost to Follow-up|6|||
27970452|NCT01033487|54628200|FG000|Fourth Intervention Period|Adverse Event|0|||
27970453|NCT01033487|54628201|FG001|Fourth Intervention Period|Adverse Event|0|||
27970454|NCT01033487|54628202|FG002|Fourth Intervention Period|Adverse Event|0|||
27970455|NCT01033487|54628203|FG003|Fourth Intervention Period|Adverse Event|0|||
27970456|NCT01033487|54628204|FG004|Fourth Intervention Period|Adverse Event|0|||
28084429|NCT03447314|54738024|FG002|Part 1 (Up to 47 Months and 13 Days)|Disease progression|1|||
28084430|NCT03447314|54738025|FG003|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
28084431|NCT03447314|54738026|FG004|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
28084432|NCT03447314|54738027|FG005|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
28084433|NCT03447314|54738028|FG006|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
28084434|NCT03447314|54738029|FG007|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
27970457|NCT01033487|54628205|FG005|Fourth Intervention Period|Adverse Event|0|||
27970458|NCT01033487|54628206|FG006|Fourth Intervention Period|Adverse Event|0|||
27970459|NCT01033487|54628207|FG007|Fourth Intervention Period|Adverse Event|0|||
27970460|NCT01033487|54628208|FG008|Fourth Intervention Period|Adverse Event|1|||
27970461|NCT01033487|54628209|FG009|Fourth Intervention Period|Adverse Event|0|||
27970462|NCT01033019|54628225|FG000|Overall Study|Withdrawal by Subject|1|||
27970463|NCT01033019|54628226|FG001|Overall Study|Withdrawal by Subject|0|||
27970464|NCT00603447|54628240|FG000|Overall Study|Adverse Event|0|||
27970465|NCT00603447|54628241|FG001|Overall Study|Adverse Event|1|||
27970466|NCT00603447|54628242|FG002|Overall Study|Adverse Event|1|||
27970467|NCT00603447|54628243|FG003|Overall Study|Adverse Event|2|||
28084435|NCT03447314|54738030|FG008|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
28084436|NCT03447314|54738031|FG009|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
27855506|NCT00243269|54377539|FG002|Overall Study|Lost to Follow-up|1|||
27970468|NCT00603447|54628244|FG004|Overall Study|Adverse Event|1|||
27970469|NCT00603447|54628245|FG005|Overall Study|Adverse Event|2|||
27970470|NCT00603447|54628246|FG006|Overall Study|Adverse Event|10|||
27970471|NCT00603447|54628240|FG000|Overall Study|Other|0|||
27970472|NCT00603447|54628241|FG001|Overall Study|Other|0|||
27970473|NCT00603447|54628242|FG002|Overall Study|Other|1|||
27970474|NCT00603447|54628243|FG003|Overall Study|Other|0|||
27970475|NCT00603447|54628244|FG004|Overall Study|Other|3|||
27970476|NCT00603447|54628245|FG005|Overall Study|Other|0|||
27970477|NCT00603447|54628246|FG006|Overall Study|Other|13|||
27970478|NCT00603447|54628240|FG000|Overall Study|Withdrew Consent|0|||
27970479|NCT00603447|54628241|FG001|Overall Study|Withdrew Consent|2|||
27970480|NCT00603447|54628242|FG002|Overall Study|Withdrew Consent|0|||
27970481|NCT00603447|54628243|FG003|Overall Study|Withdrew Consent|0|||
27970482|NCT00603447|54628244|FG004|Overall Study|Withdrew Consent|1|||
27970483|NCT00603447|54628245|FG005|Overall Study|Withdrew Consent|0|||
27970484|NCT00603447|54628246|FG006|Overall Study|Withdrew Consent|1|||
27970485|NCT00778258|54628271|FG000|Overall Study|Adverse Event|1|||
27970486|NCT00778258|54628272|FG001|Overall Study|Adverse Event|0|||
27970487|NCT00778258|54628273|FG002|Overall Study|Adverse Event|0|||
27970488|NCT00778258|54628274|FG003|Overall Study|Adverse Event|0|||
27970489|NCT00778258|54628275|FG004|Overall Study|Adverse Event|0|||
27970490|NCT00778258|54628276|FG005|Overall Study|Adverse Event|1|||
27970491|NCT00778258|54628277|FG006|Overall Study|Adverse Event|0|||
27970492|NCT00778258|54628278|FG007|Overall Study|Adverse Event|0|||
27970493|NCT00778258|54628279|FG008|Overall Study|Adverse Event|0|||
27970494|NCT00778258|54628271|FG000|Overall Study|Lost to Follow-up|0|||
27970495|NCT00778258|54628272|FG001|Overall Study|Lost to Follow-up|0|||
27970496|NCT00778258|54628273|FG002|Overall Study|Lost to Follow-up|2|||
27970497|NCT00778258|54628274|FG003|Overall Study|Lost to Follow-up|0|||
27970498|NCT00778258|54628275|FG004|Overall Study|Lost to Follow-up|0|||
27970499|NCT00778258|54628276|FG005|Overall Study|Lost to Follow-up|3|||
27970500|NCT00778258|54628277|FG006|Overall Study|Lost to Follow-up|2|||
27970501|NCT00778258|54628278|FG007|Overall Study|Lost to Follow-up|2|||
27970502|NCT00778258|54628279|FG008|Overall Study|Lost to Follow-up|0|||
27970503|NCT00778258|54628271|FG000|Overall Study|Withdrawal by Subject|6|||
27970504|NCT00778258|54628272|FG001|Overall Study|Withdrawal by Subject|2|||
27970505|NCT00778258|54628273|FG002|Overall Study|Withdrawal by Subject|8|||
27970506|NCT00778258|54628274|FG003|Overall Study|Withdrawal by Subject|2|||
27970507|NCT00778258|54628275|FG004|Overall Study|Withdrawal by Subject|0|||
27970508|NCT00778258|54628276|FG005|Overall Study|Withdrawal by Subject|6|||
27970509|NCT00778258|54628277|FG006|Overall Study|Withdrawal by Subject|12|||
27970510|NCT00778258|54628278|FG007|Overall Study|Withdrawal by Subject|12|||
27970511|NCT00778258|54628279|FG008|Overall Study|Withdrawal by Subject|4|||
27970512|NCT00778258|54628271|FG000|Overall Study|New Contraindication|0|||
27970513|NCT00778258|54628272|FG001|Overall Study|New Contraindication|0|||
27970514|NCT00778258|54628273|FG002|Overall Study|New Contraindication|0|||
27970515|NCT00778258|54628274|FG003|Overall Study|New Contraindication|0|||
27970516|NCT00778258|54628275|FG004|Overall Study|New Contraindication|0|||
27970517|NCT00778258|54628276|FG005|Overall Study|New Contraindication|0|||
27970518|NCT00778258|54628277|FG006|Overall Study|New Contraindication|0|||
27970519|NCT00778258|54628278|FG007|Overall Study|New Contraindication|1|||
27970520|NCT00778258|54628279|FG008|Overall Study|New Contraindication|0|||
27970521|NCT00778258|54628271|FG000|Overall Study|Non-compliance|0|||
27970522|NCT00778258|54628272|FG001|Overall Study|Non-compliance|0|||
27970523|NCT00778258|54628273|FG002|Overall Study|Non-compliance|0|||
28084437|NCT03447314|54738032|FG010|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
28084438|NCT03447314|54738033|FG011|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
28084439|NCT03447314|54738034|FG012|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
28084440|NCT03447314|54738035|FG013|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
27732901|NCT02698371|54180615|FG000|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2|||
27970524|NCT00778258|54628274|FG003|Overall Study|Non-compliance|1|||
27970525|NCT00778258|54628275|FG004|Overall Study|Non-compliance|0|||
27970526|NCT00778258|54628276|FG005|Overall Study|Non-compliance|0|||
27970527|NCT00778258|54628277|FG006|Overall Study|Non-compliance|0|||
27970528|NCT00778258|54628278|FG007|Overall Study|Non-compliance|0|||
27970529|NCT00778258|54628279|FG008|Overall Study|Non-compliance|0|||
27970530|NCT00778258|54628271|FG000|Overall Study|Other|0|||
27970531|NCT00778258|54628272|FG001|Overall Study|Other|0|||
27970532|NCT00778258|54628273|FG002|Overall Study|Other|0|||
27970533|NCT00778258|54628274|FG003|Overall Study|Other|0|||
27970534|NCT00778258|54628275|FG004|Overall Study|Other|0|||
27970535|NCT00778258|54628276|FG005|Overall Study|Other|0|||
27970536|NCT00778258|54628277|FG006|Overall Study|Other|1|||
27970537|NCT00778258|54628278|FG007|Overall Study|Other|0|||
27970538|NCT00778258|54628279|FG008|Overall Study|Other|0|||
27970539|NCT00988208|54628307|FG000|Overall Study|Adverse Event|71|||
27970540|NCT00988208|54628308|FG001|Overall Study|Adverse Event|122|||
27970541|NCT00988208|54628307|FG000|Overall Study|Disease Progression|103|||
27970542|NCT00988208|54628308|FG001|Overall Study|Disease Progression|89|||
27970543|NCT00988208|54628307|FG000|Overall Study|Withdrawal by Subject|50|||
27970544|NCT00988208|54628308|FG001|Overall Study|Withdrawal by Subject|57|||
27970545|NCT00988208|54628307|FG000|Overall Study|Death|9|||
28084441|NCT03447314|54738036|FG014|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
28084442|NCT03447314|54738037|FG015|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
27970546|NCT00988208|54628308|FG001|Overall Study|Death|15|||
28084443|NCT03447314|54738038|FG016|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
27970547|NCT00988208|54628307|FG000|Overall Study|Lost to Follow-up|2|||
27970548|NCT00988208|54628308|FG001|Overall Study|Lost to Follow-up|3|||
27970549|NCT00988208|54628307|FG000|Overall Study|Protocol Violation|9|||
27970550|NCT00988208|54628308|FG001|Overall Study|Protocol Violation|2|||
27970551|NCT00988208|54628307|FG000|Overall Study|Sponsor Decision|102|||
27970552|NCT00988208|54628308|FG001|Overall Study|Sponsor Decision|78|||
27970553|NCT00988208|54628307|FG000|Overall Study|Clinical Progression|17|||
28084444|NCT03447314|54738039|FG017|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
28084445|NCT03447314|54738022|FG000|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
28084446|NCT03447314|54738023|FG001|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
28084447|NCT03447314|54738024|FG002|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|1|||
28084448|NCT03447314|54738025|FG003|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
28084449|NCT03447314|54738026|FG004|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
28084450|NCT03447314|54738027|FG005|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
28084451|NCT03447314|54738028|FG006|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
28084452|NCT03447314|54738029|FG007|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
28084453|NCT03447314|54738030|FG008|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
28084454|NCT03447314|54738031|FG009|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
28084455|NCT03447314|54738032|FG010|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
28165287|NCT02985541|54835917|FG000|Overall Study|Lost to Follow-up|26|||
28165288|NCT02985541|54835917|FG000|Overall Study|Adverse Event|27|||
28165289|NCT02985541|54835917|FG000|Overall Study|Physician Decision|2|||
28165290|NCT02985541|54835917|FG000|Overall Study|Pregnancy|2|||
28165291|NCT02985541|54835917|FG000|Overall Study|Wish for pregnancy|44|||
28165292|NCT02985541|54835917|FG000|Overall Study|Other reason|5|||
28165293|NCT02985541|54835917|FG000|Overall Study|Not valid for analysis|2|||
27732902|NCT02781311|54180634|FG000|Overall Study|Adverse Event|2|||
27970554|NCT00988208|54628308|FG001|Overall Study|Clinical Progression|16|||
27970555|NCT00988208|54628307|FG000|Overall Study|Biochemical Progression|21|||
27970556|NCT00988208|54628308|FG001|Overall Study|Biochemical Progression|7|||
27970557|NCT00988208|54628307|FG000|Overall Study|Clinical Deterioration|7|||
27970558|NCT00988208|54628308|FG001|Overall Study|Clinical Deterioration|14|||
27970559|NCT00988208|54628307|FG000|Overall Study|Subject Decision/Investigator Discretion|32|||
28084456|NCT03447314|54738033|FG011|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
28084457|NCT03447314|54738034|FG012|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
28084458|NCT03447314|54738035|FG013|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
28084459|NCT03447314|54738036|FG014|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
28084460|NCT03447314|54738037|FG015|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
28084461|NCT03447314|54738038|FG016|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
28084462|NCT03447314|54738039|FG017|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
28084463|NCT03447314|54738022|FG000|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
28084464|NCT03447314|54738023|FG001|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
28084465|NCT03447314|54738024|FG002|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
28084466|NCT03447314|54738025|FG003|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
28084467|NCT03447314|54738026|FG004|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
28084468|NCT03447314|54738027|FG005|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
28084469|NCT03447314|54738028|FG006|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
28084470|NCT03447314|54738029|FG007|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
28084471|NCT03447314|54738030|FG008|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
28084472|NCT03447314|54738031|FG009|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
28084473|NCT03447314|54738032|FG010|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|1|||
28084474|NCT03447314|54738033|FG011|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
28084475|NCT03447314|54738034|FG012|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
28165294|NCT02910037|54835930|FG000|Overall Study|Withdrawal by Subject|4|||
28165295|NCT02910037|54835930|FG000|Overall Study|Lost to Follow-up|6|||
28165296|NCT02511184|54835965|FG000|Overall Study|Death|1|||
27970560|NCT00988208|54628308|FG001|Overall Study|Subject Decision/Investigator Discretion|32|||
27970561|NCT00988208|54628307|FG000|Overall Study|Other|8|||
27970562|NCT00988208|54628308|FG001|Overall Study|Other|3|||
27970563|NCT00990704|54628316|FG000|Overall Study|Adverse Event|1|||
27970564|NCT00990704|54628317|FG001|Overall Study|Adverse Event|1|||
27970565|NCT00990704|54628316|FG000|Overall Study|Physician Decision|0|||
27970566|NCT00990704|54628317|FG001|Overall Study|Physician Decision|1|||
27970567|NCT04089553|54628325|FG000|Overall Study|Death|12|||
27970568|NCT04089553|54628326|FG001|Overall Study|Death|11|||
27970569|NCT04089553|54628325|FG000|Overall Study|Lost to Follow-up|2|||
27970570|NCT04089553|54628326|FG001|Overall Study|Lost to Follow-up|2|||
27970571|NCT04089553|54628325|FG000|Overall Study|Progressive disease|0|||
27970572|NCT04089553|54628326|FG001|Overall Study|Progressive disease|1|||
27732903|NCT02781311|54180635|FG001|Overall Study|Adverse Event|6|||
27970573|NCT04089553|54628325|FG000|Overall Study|Withdrawal by Subject|5|||
27970574|NCT04089553|54628326|FG001|Overall Study|Withdrawal by Subject|2|||
27970575|NCT04089553|54628325|FG000|Overall Study|Other|6|||
27970576|NCT04089553|54628326|FG001|Overall Study|Other|2|||
27970577|NCT00993668|54628335|FG000|Single-Blind Period|Adverse Event|1|||
27970578|NCT00993668|54628336|FG001|Single-Blind Period|Adverse Event|1|||
27970579|NCT00993668|54628335|FG000|Single-Blind Period|Lack of Efficacy|0|||
27970580|NCT00993668|54628336|FG001|Single-Blind Period|Lack of Efficacy|1|||
27970581|NCT00993668|54628335|FG000|Single-Blind Period|Lost to Follow-up|3|||
27970582|NCT00993668|54628336|FG001|Single-Blind Period|Lost to Follow-up|1|||
27970583|NCT00993668|54628335|FG000|Open-Label Period|Adverse Event|9|||
27970584|NCT00993668|54628336|FG001|Open-Label Period|Adverse Event|8|||
27970585|NCT00993668|54628335|FG000|Open-Label Period|Lack of Efficacy|4|||
27970586|NCT00993668|54628336|FG001|Open-Label Period|Lack of Efficacy|3|||
27970587|NCT00993668|54628335|FG000|Open-Label Period|Withdrawal by Subject|4|||
27970588|NCT00993668|54628336|FG001|Open-Label Period|Withdrawal by Subject|3|||
27970589|NCT00993668|54628335|FG000|Open-Label Period|Lost to Follow-up|6|||
27970590|NCT00993668|54628336|FG001|Open-Label Period|Lost to Follow-up|1|||
27970591|NCT00778102|54628345|FG000|Overall Study|Adverse Event|8|||
27970592|NCT00778102|54628346|FG001|Overall Study|Adverse Event|5|||
27970593|NCT00778102|54628345|FG000|Overall Study|Death|1|||
27970594|NCT00778102|54628346|FG001|Overall Study|Death|1|||
27970595|NCT00778102|54628345|FG000|Overall Study|Lost to Follow-up|1|||
27970596|NCT00778102|54628346|FG001|Overall Study|Lost to Follow-up|0|||
27970597|NCT00778102|54628345|FG000|Overall Study|Violation of Selection Criteria|1|||
27970598|NCT00778102|54628346|FG001|Overall Study|Violation of Selection Criteria|1|||
27970599|NCT00778102|54628345|FG000|Overall Study|Protocol Violation|0|||
27970600|NCT00778102|54628346|FG001|Overall Study|Protocol Violation|1|||
27970601|NCT00778102|54628345|FG000|Overall Study|Refused Treatment|2|||
27970602|NCT00778102|54628346|FG001|Overall Study|Refused Treatment|3|||
27970603|NCT00778102|54628345|FG000|Overall Study|Withdrawal by Subject|1|||
27970604|NCT00778102|54628346|FG001|Overall Study|Withdrawal by Subject|1|||
27970605|NCT00778102|54628345|FG000|Overall Study|Administrative Reason|7|||
27970606|NCT00778102|54628346|FG001|Overall Study|Administrative Reason|10|||
27970607|NCT00756886|54628354|FG000|Overall Study|Lost to Follow-up|1|||
27970608|NCT00756886|54628355|FG001|Overall Study|Lost to Follow-up|0|||
27970609|NCT00756886|54628354|FG000|Overall Study|Adverse Event|0|||
27970610|NCT00756886|54628355|FG001|Overall Study|Adverse Event|3|||
27970611|NCT00756886|54628354|FG000|Overall Study|Lack of Efficacy|1|||
27970612|NCT00756886|54628355|FG001|Overall Study|Lack of Efficacy|0|||
27970613|NCT00756886|54628354|FG000|Overall Study|Ineligible|9|||
27970614|NCT00756886|54628355|FG001|Overall Study|Ineligible|4|||
27970615|NCT00756730|54628363|FG000|Overall Study|discontinued due to rash prior to week 4|0|||
27970616|NCT00756730|54628364|FG001|Overall Study|discontinued due to rash prior to week 4|1|||
27970617|NCT00756730|54628363|FG000|Overall Study|persistent low-level viremmia|0|||
27970618|NCT00756730|54628364|FG001|Overall Study|persistent low-level viremmia|1|||
27970619|NCT00984620|54628372|FG000|Overall Study|Adverse Event|5|||
27970620|NCT00984620|54628373|FG001|Overall Study|Adverse Event|5|||
27970621|NCT00984620|54628372|FG000|Overall Study|Lost to Follow-up|1|||
27970622|NCT00984620|54628373|FG001|Overall Study|Lost to Follow-up|1|||
27970623|NCT00984620|54628372|FG000|Overall Study|Withdrawal by Subject|0|||
27970624|NCT00984620|54628373|FG001|Overall Study|Withdrawal by Subject|2|||
27970625|NCT00984620|54628372|FG000|Overall Study|reason other than listed above|0|||
27970626|NCT00984620|54628373|FG001|Overall Study|reason other than listed above|4|||
27970627|NCT00777946|54628384|FG000|Overall Study|Adverse Event|11|||
27970628|NCT00777946|54628385|FG001|Overall Study|Adverse Event|1|||
27970629|NCT00777946|54628386|FG002|Overall Study|Adverse Event|3|||
27970630|NCT00777946|54628384|FG000|Overall Study|Lack of Efficacy|0|||
27970631|NCT00777946|54628385|FG001|Overall Study|Lack of Efficacy|0|||
27970632|NCT00777946|54628386|FG002|Overall Study|Lack of Efficacy|9|||
27970633|NCT00777946|54628384|FG000|Overall Study|Condition no longer required study drug|1|||
27970634|NCT00777946|54628385|FG001|Overall Study|Condition no longer required study drug|0|||
27970635|NCT00777946|54628386|FG002|Overall Study|Condition no longer required study drug|0|||
27970636|NCT00777946|54628384|FG000|Overall Study|Patient withdrew consent|3|||
27970637|NCT00777946|54628385|FG001|Overall Study|Patient withdrew consent|2|||
28165297|NCT02511184|54835966|FG001|Overall Study|Death|0|||
28165298|NCT02511184|54835965|FG000|Overall Study|Lost to Follow-up|0|||
28165299|NCT02511184|54835966|FG001|Overall Study|Lost to Follow-up|1|||
27970638|NCT00777946|54628386|FG002|Overall Study|Patient withdrew consent|3|||
27970639|NCT00777946|54628384|FG000|Overall Study|Lost to Follow-up|3|||
27970640|NCT00777946|54628385|FG001|Overall Study|Lost to Follow-up|1|||
27970641|NCT00777946|54628386|FG002|Overall Study|Lost to Follow-up|0|||
28165300|NCT02511184|54835965|FG000|Overall Study|Study terminated by sponsor|1|||
28165301|NCT02511184|54835966|FG001|Overall Study|Study terminated by sponsor|5|||
27970642|NCT00777946|54628384|FG000|Overall Study|Protocol deviation|2|||
27970643|NCT00777946|54628385|FG001|Overall Study|Protocol deviation|1|||
27970644|NCT00777946|54628386|FG002|Overall Study|Protocol deviation|1|||
28165302|NCT02511184|54835965|FG000|Overall Study|Withdrawal by Subject|0|||
27970645|NCT00777946|54628384|FG000|Overall Study|Randomized in error|1|||
27970646|NCT00777946|54628385|FG001|Overall Study|Randomized in error|1|||
27970647|NCT00777946|54628386|FG002|Overall Study|Randomized in error|0|||
27970648|NCT00990314|54628394|FG000|Overall Study|Death|2|||
27970649|NCT00990314|54628394|FG000|Overall Study|Adverse Event|2|||
27970650|NCT00990314|54628394|FG000|Overall Study|Withdrawal by Subject|3|||
27970651|NCT00990314|54628394|FG000|Overall Study|Non-Compliance|1|||
27970652|NCT00990314|54628394|FG000|Overall Study|Physician Decision|3|||
27970653|NCT00990314|54628394|FG000|Overall Study|Lack of Efficacy|1|||
27970654|NCT00756652|54628400|FG000|Original Phase|Withdrawal by Subject|864|||
27970655|NCT00756652|54628401|FG001|Original Phase|Withdrawal by Subject|23|||
27970656|NCT00756652|54628400|FG000|Original Phase|Lost to Follow-up|601|||
27970657|NCT00756652|54628401|FG001|Original Phase|Lost to Follow-up|0|||
27970658|NCT00756652|54628400|FG000|Original Phase|Other Discontinuation|797|||
27970659|NCT00756652|54628401|FG001|Original Phase|Other Discontinuation|5|||
27970660|NCT00756652|54628400|FG000|Original Phase|Participant Noncompliance|18622|||
27970661|NCT00756652|54628401|FG001|Original Phase|Participant Noncompliance|424|||
27970662|NCT00756652|54628400|FG000|Original Phase|Unknown Discontinuation Reason|2|||
27970663|NCT00756652|54628401|FG001|Original Phase|Unknown Discontinuation Reason|0|||
27970664|NCT00756652|54628400|FG000|Original Phase|Participants without data|3259|||
27970665|NCT00756652|54628401|FG001|Original Phase|Participants without data|466|||
27970666|NCT00756652|54628400|FG000|Original Phase|Death|168|||
27970667|NCT00756652|54628401|FG001|Original Phase|Death|1|||
27970668|NCT00756652|54628400|FG000|Original Phase|Not due for F/U at Phase One closure|11076|||
27970669|NCT00756652|54628401|FG001|Original Phase|Not due for F/U at Phase One closure|2|||
27970670|NCT00756652|54628400|FG000|Re-Op Phase|Withdrawal by Subject|62|||
27970671|NCT00756652|54628401|FG001|Re-Op Phase|Withdrawal by Subject|0|||
27970672|NCT00756652|54628400|FG000|Re-Op Phase|Death|6|||
27970673|NCT00756652|54628401|FG001|Re-Op Phase|Death|0|||
27970674|NCT00756652|54628400|FG000|Re-Op Phase|Lost to Follow-up|340|||
27970675|NCT00756652|54628401|FG001|Re-Op Phase|Lost to Follow-up|0|||
27970676|NCT00756652|54628400|FG000|Re-Op Phase|Site Closed|2454|||
27970677|NCT00756652|54628401|FG001|Re-Op Phase|Site Closed|0|||
27970678|NCT00756652|54628400|FG000|Re-Op Phase|Withdrawn after explant|14|||
27970679|NCT00756652|54628401|FG001|Re-Op Phase|Withdrawn after explant|0|||
27970680|NCT00777556|54628405|FG000|Overall Study|Inappropriate self-selection|34|||
27970681|NCT00777556|54628405|FG000|Overall Study|Dispensed but did not use product|12|||
27970682|NCT00777556|54628405|FG000|Overall Study|Did not complete all 3 follow-up visits|20|||
27970683|NCT00602979|54628414|FG000|Overall Study|Lost to Follow-up|3|||
27970684|NCT00602979|54628415|FG001|Overall Study|Lost to Follow-up|2|||
27970685|NCT00602979|54628416|FG002|Overall Study|Lost to Follow-up|3|||
27970686|NCT00602979|54628417|FG003|Overall Study|Lost to Follow-up|2|||
27970687|NCT00602979|54628418|FG004|Overall Study|Lost to Follow-up|3|||
28084476|NCT03447314|54738035|FG013|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
28084477|NCT03447314|54738036|FG014|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
28084478|NCT03447314|54738037|FG015|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
28084479|NCT03447314|54738038|FG016|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
28084480|NCT03447314|54738039|FG017|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
28084481|NCT03447314|54738022|FG000|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
28084482|NCT03447314|54738023|FG001|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
28084483|NCT03447314|54738024|FG002|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
28084484|NCT03447314|54738025|FG003|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
28084485|NCT03447314|54738026|FG004|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
28084486|NCT03447314|54738027|FG005|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
28084487|NCT03447314|54738028|FG006|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
28084488|NCT03447314|54738029|FG007|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
28084489|NCT03447314|54738030|FG008|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
28084490|NCT03447314|54738031|FG009|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
28084491|NCT03447314|54738032|FG010|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
28084492|NCT03447314|54738033|FG011|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
28084493|NCT03447314|54738034|FG012|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
27970688|NCT00602979|54628414|FG000|Overall Study|Failed Intubation|0|||
27970689|NCT00602979|54628415|FG001|Overall Study|Failed Intubation|1|||
27970690|NCT00602979|54628416|FG002|Overall Study|Failed Intubation|0|||
27970691|NCT00602979|54628417|FG003|Overall Study|Failed Intubation|1|||
27970692|NCT00602979|54628418|FG004|Overall Study|Failed Intubation|0|||
27970693|NCT04081363|54628432|FG000|Overall Study|Withdrawal by Subject|1|||
27970694|NCT04081363|54628433|FG001|Overall Study|Withdrawal by Subject|0|||
27970695|NCT00993044|54628439|FG000|Irinotecan 50 mg|Physician Decision|1|||
27970696|NCT00777088|54628453|FG000|Overall Study|PED Treatment not attempted|1|||
27970697|NCT00763282|54628469|FG000|Overall Study|Withdrawal by Subject|6|||
28084494|NCT03447314|54738035|FG013|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
28084495|NCT03447314|54738036|FG014|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
28084496|NCT03447314|54738037|FG015|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
28084497|NCT03447314|54738038|FG016|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
28084498|NCT03447314|54738039|FG017|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
28084499|NCT03423121|54738082|FG000|Overall Study|Lost to Follow-up|2|||
28084500|NCT03423121|54738083|FG001|Overall Study|Lost to Follow-up|6|||
28084501|NCT03423121|54738082|FG000|Overall Study|Adverse Event|1|||
28084502|NCT03423121|54738083|FG001|Overall Study|Adverse Event|0|||
28084503|NCT03335475|54738091|FG000|Overall Study|Did not wear accelerometer|4|||
28084504|NCT03335475|54738092|FG001|Overall Study|Did not wear accelerometer|0|||
28084505|NCT03335475|54738091|FG000|Overall Study|Withdrawal by Subject|0|||
28084506|NCT03335475|54738092|FG001|Overall Study|Withdrawal by Subject|1|||
28084507|NCT03252756|54738100|FG000|Overall Study|Protocol Violation|2|||
28084508|NCT03252756|54738101|FG001|Overall Study|Protocol Violation|4|||
28084509|NCT03252756|54738100|FG000|Overall Study|COVID-19 Pandemic|1|||
28084510|NCT03252756|54738101|FG001|Overall Study|COVID-19 Pandemic|1|||
28084511|NCT03252756|54738100|FG000|Overall Study|Study Drug Expiration|0|||
28084512|NCT03252756|54738101|FG001|Overall Study|Study Drug Expiration|1|||
28084513|NCT03164356|54738113|FG000|Overall Study|Lost to Follow-up|1|||
28084514|NCT03164356|54738114|FG001|Overall Study|Lost to Follow-up|1|||
28084515|NCT03164356|54738115|FG002|Overall Study|Lost to Follow-up|2|||
28084516|NCT03164356|54738116|FG003|Overall Study|Lost to Follow-up|1|||
28084517|NCT03164356|54738113|FG000|Overall Study|Physician Decision|0|||
28084518|NCT03164356|54738114|FG001|Overall Study|Physician Decision|0|||
28084519|NCT03164356|54738115|FG002|Overall Study|Physician Decision|3|||
28084520|NCT03164356|54738116|FG003|Overall Study|Physician Decision|0|||
28084521|NCT03164356|54738113|FG000|Overall Study|Protocol Violation|2|||
28084522|NCT03164356|54738114|FG001|Overall Study|Protocol Violation|1|||
28084523|NCT03164356|54738115|FG002|Overall Study|Protocol Violation|0|||
28084524|NCT03164356|54738116|FG003|Overall Study|Protocol Violation|0|||
28084525|NCT03164356|54738113|FG000|Overall Study|Withdrawal by Subject|1|||
28084526|NCT03164356|54738114|FG001|Overall Study|Withdrawal by Subject|0|||
28084527|NCT03164356|54738115|FG002|Overall Study|Withdrawal by Subject|0|||
28084528|NCT03164356|54738116|FG003|Overall Study|Withdrawal by Subject|0|||
27970698|NCT00763282|54628470|FG001|Overall Study|Withdrawal by Subject|5|||
27970699|NCT00763282|54628469|FG000|Overall Study|Death|4|||
27970700|NCT00763282|54628470|FG001|Overall Study|Death|3|||
27970701|NCT00763282|54628469|FG000|Overall Study|Lost to Follow-up|22|||
27970702|NCT00763282|54628470|FG001|Overall Study|Lost to Follow-up|26|||
27970703|NCT00988598|54628480|FG000|Overall Study|Withdrawal by Subject|2|||
27970704|NCT00988598|54628481|FG001|Overall Study|Withdrawal by Subject|0|||
27970705|NCT00979628|54628490|FG000|Overall Study|received regimen < 24 hours|7|||
27970706|NCT00979628|54628491|FG001|Overall Study|received regimen < 24 hours|6|||
27970707|NCT00979628|54628492|FG002|Overall Study|received regimen < 24 hours|5|||
27970708|NCT00979628|54628490|FG000|Overall Study|received steroids|1|||
27970709|NCT00979628|54628491|FG001|Overall Study|received steroids|1|||
27970710|NCT00979628|54628492|FG002|Overall Study|received steroids|0|||
27970711|NCT00979628|54628490|FG000|Overall Study|transferred to ICU|1|||
27970712|NCT00979628|54628491|FG001|Overall Study|transferred to ICU|2|||
27970713|NCT00979628|54628492|FG002|Overall Study|transferred to ICU|1|||
27970714|NCT00762970|54628506|FG000|Overall Study|Withdrawal by Subject|7|||
27970715|NCT00762970|54628507|FG001|Overall Study|Withdrawal by Subject|4|||
27970716|NCT00762970|54628508|FG002|Overall Study|Withdrawal by Subject|0|||
27970717|NCT00762970|54628506|FG000|Overall Study|Protocol Violation|3|||
27970718|NCT00762970|54628507|FG001|Overall Study|Protocol Violation|1|||
27970719|NCT00762970|54628508|FG002|Overall Study|Protocol Violation|1|||
27970720|NCT00762970|54628506|FG000|Overall Study|Lost to Follow-up|1|||
27970721|NCT00762970|54628507|FG001|Overall Study|Lost to Follow-up|2|||
27970722|NCT00762970|54628508|FG002|Overall Study|Lost to Follow-up|0|||
27970723|NCT00762970|54628506|FG000|Overall Study|Difficulty of handling lens|1|||
27970724|NCT00762970|54628507|FG001|Overall Study|Difficulty of handling lens|2|||
27970725|NCT00762970|54628508|FG002|Overall Study|Difficulty of handling lens|0|||
27970726|NCT00988442|54628518|FG000|Overall Study|Death|1|||
27970727|NCT00988442|54628519|FG001|Overall Study|Death|2|||
27970728|NCT00988442|54628518|FG000|Overall Study|Lost to Follow-up|0|||
28084529|NCT03164356|54738113|FG000|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
28084530|NCT03164356|54738114|FG001|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
28084531|NCT03164356|54738115|FG002|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
28084532|NCT03164356|54738116|FG003|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
28084533|NCT03164356|54738113|FG000|Overall Study|Subject Incarcerated|0|||
28165303|NCT02511184|54835966|FG001|Overall Study|Withdrawal by Subject|1|||
28165304|NCT02984995|54835975|FG000|Overall Study|Required stem cell transplant|13|||
27970729|NCT00988442|54628519|FG001|Overall Study|Lost to Follow-up|1|||
27970730|NCT00988442|54628518|FG000|Overall Study|Early Study Closure|29|||
27970731|NCT00988442|54628519|FG001|Overall Study|Early Study Closure|25|||
27970732|NCT03258723|54628528|FG000|Overall Study|COVID Interruption of study|54|||
27970733|NCT03258723|54628528|FG000|Overall Study|Lost to Follow-up|8|||
27970734|NCT00992186|54628532|FG000|Overall Study|Withdrawal by Subject|2|||
27970735|NCT00992186|54628532|FG000|Overall Study|Protocol Violation|1|||
27970736|NCT00992186|54628532|FG000|Overall Study|Physician Decision|1|||
27970737|NCT00992186|54628532|FG000|Overall Study|Adverse Event|9|||
27970738|NCT00992186|54628532|FG000|Overall Study|Progressive Disease|30|||
28165305|NCT02984995|54835976|FG001|Overall Study|Required stem cell transplant|2|||
28165306|NCT02984995|54835975|FG000|Overall Study|Progressive disease|11|||
27732904|NCT02781311|54180636|FG002|Overall Study|Adverse Event|1|||
27970739|NCT00992186|54628532|FG000|Overall Study|Refusal To Receive Study Agent|3|||
27970740|NCT00992108|54628539|FG000|Overall Study|Lost to Follow-up|0|||
27970741|NCT00992108|54628540|FG001|Overall Study|Lost to Follow-up|1|||
27970742|NCT00752986|54628549|FG000|Overall Study|Withdrawal by Subject|2|||
27970743|NCT00752986|54628550|FG001|Overall Study|Withdrawal by Subject|1|||
27970744|NCT00752986|54628551|FG002|Overall Study|Withdrawal by Subject|2|||
27970745|NCT00752986|54628549|FG000|Overall Study|Protocol Violation|3|||
27970746|NCT00752986|54628550|FG001|Overall Study|Protocol Violation|0|||
27970747|NCT00752986|54628551|FG002|Overall Study|Protocol Violation|0|||
27970748|NCT03483103|54628559|FG000|Pre-Treatment Phase|Other reasons|1|||
27970749|NCT03483103|54628559|FG000|Pre-Treatment Phase|No longer meets eligibility criteria|4|||
27970750|NCT03483103|54628559|FG000|Pre-Treatment Phase|Disease-related complications|1|||
27970751|NCT03483103|54628559|FG000|Pre-Treatment Phase|Death|5|||
27970752|NCT03483103|54628559|FG000|Treatment Phase|Withdrawal by Subject|6|||
27970753|NCT03483103|54628559|FG000|Treatment Phase|Other reasons|2|||
27970754|NCT03483103|54628559|FG000|Treatment Phase|Death|20|||
27970755|NCT03483103|54628559|FG000|Treatment Phase|Ongoing in study|26|||
27970756|NCT03483103|54628559|FG000|Treatment Phase|Did not receive either JAR017 or nonconforming product|1|||
27970757|NCT03483103|54628559|FG000|Treatment Phase|Received nonconforming product|1|||
27970758|NCT00762892|54628565|FG000|Overall Study|Lost to Follow-up|2|||
27970759|NCT00762892|54628566|FG001|Overall Study|Lost to Follow-up|5|||
27970760|NCT00762892|54628565|FG000|Overall Study|Withdrawal by Subject|0|||
27970761|NCT00762892|54628566|FG001|Overall Study|Withdrawal by Subject|1|||
27970762|NCT00762892|54628565|FG000|Overall Study|Death|1|||
27970763|NCT00762892|54628566|FG001|Overall Study|Death|0|||
27970764|NCT00762892|54628565|FG000|Overall Study|Pregnancy|1|||
27970765|NCT00762892|54628566|FG001|Overall Study|Pregnancy|0|||
27970766|NCT00762892|54628565|FG000|Overall Study|Incarceration|1|||
27970767|NCT00762892|54628566|FG001|Overall Study|Incarceration|0|||
27970768|NCT00755716|54628575|FG000|Overall Study|Adverse Event|1|||
27970769|NCT00755716|54628576|FG001|Overall Study|Adverse Event|4|||
27970770|NCT00755716|54628577|FG002|Overall Study|Adverse Event|1|||
27970771|NCT00755716|54628575|FG000|Overall Study|Lack of Efficacy|2|||
27970772|NCT00755716|54628576|FG001|Overall Study|Lack of Efficacy|0|||
27970773|NCT00755716|54628577|FG002|Overall Study|Lack of Efficacy|0|||
27970774|NCT00755716|54628575|FG000|Overall Study|Lost to Follow-up|5|||
27970775|NCT00755716|54628576|FG001|Overall Study|Lost to Follow-up|3|||
27970776|NCT00755716|54628577|FG002|Overall Study|Lost to Follow-up|1|||
27970777|NCT00755716|54628575|FG000|Overall Study|work schedule issues|0|||
27970778|NCT00755716|54628576|FG001|Overall Study|work schedule issues|1|||
27970779|NCT00755716|54628577|FG002|Overall Study|work schedule issues|1|||
27970780|NCT00755326|54628587|FG000|Overall Study|Lost to Follow-up|2|||
28084534|NCT03164356|54738114|FG001|Overall Study|Subject Incarcerated|1|||
28084535|NCT03164356|54738115|FG002|Overall Study|Subject Incarcerated|0|||
28084536|NCT03164356|54738116|FG003|Overall Study|Subject Incarcerated|0|||
28084537|NCT03164356|54738113|FG000|Overall Study|Prosthetist unable to participate|0|||
28084538|NCT03164356|54738114|FG001|Overall Study|Prosthetist unable to participate|2|||
28084539|NCT03164356|54738115|FG002|Overall Study|Prosthetist unable to participate|1|||
28084540|NCT03164356|54738116|FG003|Overall Study|Prosthetist unable to participate|0|||
28084541|NCT02577406|54738147|FG000|Randomized Period|Death|1|||
28084542|NCT02577406|54738148|FG001|Randomized Period|Death|0|||
28165307|NCT02984995|54835976|FG001|Overall Study|Progressive disease|1|||
27970781|NCT00755326|54628588|FG001|Overall Study|Lost to Follow-up|3|||
27970782|NCT03084471|54628595|FG000|Overall Study|Development of study specific discontinuation criteria|2|||
27970783|NCT03084471|54628595|FG000|Overall Study|Condition under investigation worsened|84|||
27970784|NCT03084471|54628595|FG000|Overall Study|Lack of therapeutic response|2|||
27970785|NCT03084471|54628595|FG000|Overall Study|Protocol Violation|1|||
27970786|NCT03084471|54628595|FG000|Overall Study|Adverse Event|73|||
27970787|NCT03084471|54628595|FG000|Overall Study|Withdrawal by Subject|12|||
27970788|NCT03084471|54628595|FG000|Overall Study|Disease relapse|181|||
27970789|NCT03084471|54628595|FG000|Overall Study|Subjective disease progression|359|||
27970790|NCT03084471|54628595|FG000|Overall Study|Other (as recorded)|33|||
27970791|NCT03084471|54628595|FG000|Overall Study|Patients who were still on study treatment at Data Cutoff|120|||
27970792|NCT00754936|54628602|FG000|Overall Study|Lost to Follow-up|3|||
27970793|NCT00754936|54628602|FG000|Overall Study|Physician Decision|1|||
27970794|NCT00754936|54628602|FG000|Overall Study|Withdrawal by Subject|2|||
27970795|NCT00754936|54628602|FG000|Overall Study|Side Effects|3|||
27970796|NCT00754936|54628602|FG000|Overall Study|Inter-current medical events|3|||
27970797|NCT00762502|54628609|FG000|Baseline to Month 3 (Period 1)|Adverse Event|4|||
27970798|NCT00762502|54628610|FG001|Baseline to Month 3 (Period 1)|Adverse Event|3|||
27970799|NCT00762502|54628611|FG002|Baseline to Month 3 (Period 1)|Adverse Event|6|||
27970800|NCT00762502|54628609|FG000|Baseline to Month 3 (Period 1)|Lost to Follow-up|6|||
27970801|NCT00762502|54628610|FG001|Baseline to Month 3 (Period 1)|Lost to Follow-up|3|||
27970802|NCT00762502|54628611|FG002|Baseline to Month 3 (Period 1)|Lost to Follow-up|13|||
27970803|NCT00762502|54628609|FG000|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
27970804|NCT00762502|54628610|FG001|Month 3 to Month 6 (Period 2)|Pregnancy|1|||
27970805|NCT00762502|54628611|FG002|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
27970806|NCT00762268|54628619|FG000|Overall Study|Withdrawal by Subject|3|||
27970807|NCT00762268|54628620|FG001|Overall Study|Withdrawal by Subject|3|||
27970808|NCT00975884|54628628|FG000|Overall Study|Adverse Event|1|||
27970809|NCT00975884|54628629|FG001|Overall Study|Adverse Event|0|||
27970810|NCT00975884|54628628|FG000|Overall Study|Lost to Follow-up|5|||
27970811|NCT00975884|54628629|FG001|Overall Study|Lost to Follow-up|3|||
27970812|NCT00975884|54628628|FG000|Overall Study|Withdrawal by Subject|9|||
27970813|NCT00975884|54628629|FG001|Overall Study|Withdrawal by Subject|9|||
27970814|NCT00975884|54628628|FG000|Overall Study|Other|1|||
27970815|NCT00975884|54628629|FG001|Overall Study|Other|3|||
27970816|NCT00578227|54628648|FG000|Overall Study|Lost to Follow-up|0|||
27970817|NCT00578227|54628649|FG001|Overall Study|Lost to Follow-up|1|||
27970818|NCT00578227|54628650|FG002|Overall Study|Lost to Follow-up|1|||
27970819|NCT00578227|54628648|FG000|Overall Study|Withdrawal by Subject|5|||
27970820|NCT00578227|54628649|FG001|Overall Study|Withdrawal by Subject|1|||
27970821|NCT00578227|54628650|FG002|Overall Study|Withdrawal by Subject|3|||
27970822|NCT00978380|54628660|FG000|Overall Study|Protocol Violation|2|||
27970823|NCT00978380|54628660|FG000|Overall Study|Withdrawal criteria|9|||
27970824|NCT00978380|54628660|FG000|Overall Study|Unclassified|8|||
27970825|NCT00577993|54628668|FG000|Overall Study|Adverse Event|1|||
27970826|NCT00577993|54628669|FG001|Overall Study|Adverse Event|0|||
27970827|NCT00577993|54628670|FG002|Overall Study|Adverse Event|0|||
27970828|NCT00577993|54628668|FG000|Overall Study|Death|0|||
27970829|NCT00577993|54628669|FG001|Overall Study|Death|1|||
27970830|NCT00577993|54628670|FG002|Overall Study|Death|1|||
27970831|NCT00577993|54628668|FG000|Overall Study|Lack of Efficacy|0|||
27970832|NCT00577993|54628669|FG001|Overall Study|Lack of Efficacy|1|||
27970833|NCT00577993|54628670|FG002|Overall Study|Lack of Efficacy|0|||
27970834|NCT00577993|54628668|FG000|Overall Study|Protocol Violation|2|||
27970835|NCT00577993|54628669|FG001|Overall Study|Protocol Violation|3|||
27970836|NCT00577993|54628670|FG002|Overall Study|Protocol Violation|0|||
27970837|NCT00577993|54628668|FG000|Overall Study|Withdrawal by Subject|1|||
27970838|NCT00577993|54628669|FG001|Overall Study|Withdrawal by Subject|0|||
27970839|NCT00577993|54628670|FG002|Overall Study|Withdrawal by Subject|2|||
28084543|NCT02577406|54738147|FG000|Randomized Period|Other reasons|0|||
28084544|NCT02577406|54738148|FG001|Randomized Period|Other reasons|20|||
28084545|NCT02577406|54738147|FG000|Treatment Period|Transition to commercially available treatment|1|||
28084546|NCT02577406|54738148|FG001|Treatment Period|Transition to commercially available treatment|0|||
28084547|NCT02577406|54738147|FG000|Treatment Period|Progressive disease|47|||
28084548|NCT02577406|54738148|FG001|Treatment Period|Progressive disease|36|||
28084549|NCT02577406|54738147|FG000|Treatment Period|Death|36|||
28084550|NCT02577406|54738148|FG001|Treatment Period|Death|23|||
28084551|NCT02577406|54738147|FG000|Treatment Period|Other reasons|3|||
28084552|NCT02577406|54738148|FG001|Treatment Period|Other reasons|37|||
28084553|NCT02577406|54738147|FG000|Treatment Period|Withdrawal by Subject|10|||
28084554|NCT02577406|54738148|FG001|Treatment Period|Withdrawal by Subject|24|||
28084555|NCT02577406|54738147|FG000|Treatment Period|Adverse Event|17|||
28084556|NCT02577406|54738148|FG001|Treatment Period|Adverse Event|12|||
28084557|NCT02577406|54738147|FG000|Treatment Period|Disease relapse|27|||
28084558|NCT02577406|54738148|FG001|Treatment Period|Disease relapse|1|||
28084559|NCT02577406|54738147|FG000|Treatment Period|HSCT|6|||
28084560|NCT02577406|54738148|FG001|Treatment Period|HSCT|2|||
27970840|NCT00577993|54628668|FG000|Overall Study|Conversion|2|||
28165308|NCT02984995|54835975|FG000|Overall Study|Adverse Event|1|||
27970841|NCT00577993|54628669|FG001|Overall Study|Conversion|5|||
27970842|NCT00577993|54628670|FG002|Overall Study|Conversion|0|||
27970843|NCT00577993|54628668|FG000|Overall Study|Uninsured|1|||
27970844|NCT00577993|54628669|FG001|Overall Study|Uninsured|0|||
27970845|NCT00577993|54628670|FG002|Overall Study|Uninsured|0|||
27970846|NCT00975806|54628679|FG000|Overall Study|Adverse Event|2|||
27970847|NCT00975806|54628680|FG001|Overall Study|Adverse Event|1|||
27970848|NCT00975806|54628681|FG002|Overall Study|Adverse Event|2|||
27970849|NCT00975806|54628679|FG000|Overall Study|Disease Progression|1|||
27970850|NCT00975806|54628680|FG001|Overall Study|Disease Progression|5|||
27970851|NCT00975806|54628681|FG002|Overall Study|Disease Progression|1|||
27970852|NCT00975806|54628679|FG000|Overall Study|Withdrawal by Subject|1|||
28084561|NCT02577406|54738147|FG000|Treatment Period|Lost to Follow-up|0|||
28084562|NCT02577406|54738148|FG001|Treatment Period|Lost to Follow-up|1|||
28165309|NCT02984995|54835976|FG001|Overall Study|Adverse Event|0|||
27970853|NCT00975806|54628680|FG001|Overall Study|Withdrawal by Subject|0|||
27970854|NCT00975806|54628681|FG002|Overall Study|Withdrawal by Subject|0|||
27970855|NCT00975806|54628679|FG000|Overall Study|Death|0|||
27970856|NCT00975806|54628680|FG001|Overall Study|Death|1|||
27970857|NCT00975806|54628681|FG002|Overall Study|Death|0|||
27970858|NCT00975806|54628679|FG000|Overall Study|Physician decision and disease related|1|||
27970859|NCT00975806|54628680|FG001|Overall Study|Physician decision and disease related|0|||
27970860|NCT00975806|54628681|FG002|Overall Study|Physician decision and disease related|1|||
27970861|NCT00978068|54628693|FG000|Overall Study|Were Awaiting Initiation of ART|2|||
27970862|NCT00978068|54628694|FG001|Overall Study|Were Awaiting Initiation of ART|2|||
27970863|NCT00978068|54628693|FG000|Overall Study|Death|1|||
27970864|NCT00978068|54628694|FG001|Overall Study|Death|2|||
27970865|NCT00978068|54628693|FG000|Overall Study|Lost to Follow-up|1|||
27970866|NCT00978068|54628694|FG001|Overall Study|Lost to Follow-up|2|||
27970867|NCT00978068|54628693|FG000|Overall Study|Physician Decision|0|||
27970868|NCT00978068|54628694|FG001|Overall Study|Physician Decision|1|||
27970869|NCT00978068|54628693|FG000|Overall Study|Unable to Comply with Study|0|||
27970870|NCT00978068|54628694|FG001|Overall Study|Unable to Comply with Study|2|||
27970871|NCT00603525|54628706|FG000|DB Treatment Period (24 Weeks)|Adverse Event|3|||
27970872|NCT00603525|54628707|FG001|DB Treatment Period (24 Weeks)|Adverse Event|9|||
27970873|NCT00603525|54628708|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
28084563|NCT02577406|54738147|FG000|Treatment Period|Protocol Violation|0|||
28084564|NCT02577406|54738148|FG001|Treatment Period|Protocol Violation|1|||
28084565|NCT02059265|54738167|FG000|Overall Study|Ineligible|4|||
28084566|NCT01925131|54738177|FG000|Overall Study|Death|0|||
28084567|NCT01925131|54738178|FG001|Overall Study|Death|0|||
28084568|NCT01925131|54738179|FG002|Overall Study|Death|1|||
28084569|NCT01925131|54738180|FG003|Overall Study|Death|0|||
28084570|NCT01925131|54738181|FG004|Overall Study|Death|0|||
28084571|NCT01925131|54738182|FG005|Overall Study|Death|0|||
28084572|NCT01925131|54738177|FG000|Overall Study|Progression/Relapse|1|||
28084573|NCT01925131|54738178|FG001|Overall Study|Progression/Relapse|1|||
28084574|NCT01925131|54738179|FG002|Overall Study|Progression/Relapse|4|||
28084575|NCT01925131|54738180|FG003|Overall Study|Progression/Relapse|0|||
28084576|NCT01925131|54738181|FG004|Overall Study|Progression/Relapse|0|||
28084577|NCT01925131|54738182|FG005|Overall Study|Progression/Relapse|1|||
28084578|NCT01925131|54738177|FG000|Overall Study|Patient Refusal|1|||
28084579|NCT01925131|54738178|FG001|Overall Study|Patient Refusal|0|||
28084580|NCT01925131|54738179|FG002|Overall Study|Patient Refusal|0|||
28084581|NCT01925131|54738180|FG003|Overall Study|Patient Refusal|0|||
28084582|NCT01925131|54738181|FG004|Overall Study|Patient Refusal|0|||
28084583|NCT01925131|54738182|FG005|Overall Study|Patient Refusal|0|||
28084584|NCT01925131|54738177|FG000|Overall Study|Adverse Event|0|||
28084585|NCT01925131|54738178|FG001|Overall Study|Adverse Event|0|||
28084586|NCT01925131|54738179|FG002|Overall Study|Adverse Event|2|||
28084587|NCT01925131|54738180|FG003|Overall Study|Adverse Event|0|||
28084588|NCT01925131|54738181|FG004|Overall Study|Adverse Event|1|||
27970874|NCT00603525|54628706|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|7|||
27970875|NCT00603525|54628707|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
27970876|NCT00603525|54628708|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
27970877|NCT00603525|54628706|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
27970878|NCT00603525|54628707|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|2|||
27970879|NCT00603525|54628708|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
27970880|NCT00603525|54628706|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
27970881|NCT00603525|54628707|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|3|||
27970882|NCT00603525|54628708|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
27970883|NCT00603525|54628706|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
27970884|NCT00603525|54628707|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6|||
28084589|NCT01925131|54738182|FG005|Overall Study|Adverse Event|3|||
28084590|NCT01925131|54738177|FG000|Overall Study|Other - Not Protocol Specified|3|||
28084591|NCT01925131|54738178|FG001|Overall Study|Other - Not Protocol Specified|1|||
27970885|NCT00603525|54628708|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
27970886|NCT00603525|54628706|FG000|DB Treatment Period (24 Weeks)|Physician Decision|0|||
27970887|NCT00603525|54628707|FG001|DB Treatment Period (24 Weeks)|Physician Decision|1|||
27970888|NCT00603525|54628708|FG002|DB Treatment Period (24 Weeks)|Physician Decision|0|||
27970889|NCT00603525|54628706|FG000|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
27970890|NCT00603525|54628707|FG001|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1|||
27970891|NCT00603525|54628708|FG002|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
27970892|NCT00603525|54628706|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
28084592|NCT01925131|54738179|FG002|Overall Study|Other - Not Protocol Specified|2|||
28084593|NCT01925131|54738180|FG003|Overall Study|Other - Not Protocol Specified|5|||
28084594|NCT01925131|54738181|FG004|Overall Study|Other - Not Protocol Specified|10|||
28084595|NCT01925131|54738182|FG005|Overall Study|Other - Not Protocol Specified|6|||
28084596|NCT01809691|54738200|FG000|Overall Study|Currently on Treatment|192|||
28084597|NCT01809691|54738201|FG001|Overall Study|Currently on Treatment|100|||
27970893|NCT00603525|54628707|FG001|OL Treatment Period (120 Weeks)|Adverse Event|12|||
27970894|NCT00603525|54628708|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
27970895|NCT00603525|54628706|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
27970896|NCT00603525|54628707|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|13|||
27970897|NCT00603525|54628708|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
27970898|NCT00603525|54628706|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
27970899|NCT00603525|54628707|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|1|||
27970900|NCT00603525|54628708|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
27970901|NCT00603525|54628706|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
27970902|NCT00603525|54628707|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5|||
27970903|NCT00603525|54628708|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
27970904|NCT00603525|54628706|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
27970905|NCT00603525|54628707|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71|||
27970906|NCT00603525|54628708|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
27970907|NCT00603525|54628706|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
27970908|NCT00603525|54628707|FG001|OL Treatment Period (120 Weeks)|Physician Decision|2|||
27970909|NCT00603525|54628708|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
27970910|NCT00603525|54628706|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
27970911|NCT00603525|54628707|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8|||
27970912|NCT00603525|54628708|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
27970913|NCT00603525|54628706|FG000|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
27970914|NCT00603525|54628707|FG001|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
27970915|NCT00603525|54628708|FG002|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111|||
27970916|NCT00762034|54628721|FG000|Induction Period|Protocol Violation|1|||
27970917|NCT00762034|54628722|FG001|Induction Period|Protocol Violation|2|||
27970918|NCT00762034|54628721|FG000|Induction Period|Entry Criterion Not Met|12|||
27970919|NCT00762034|54628722|FG001|Induction Period|Entry Criterion Not Met|11|||
27970920|NCT00762034|54628721|FG000|Induction Period|Adverse Event|27|||
27970921|NCT00762034|54628722|FG001|Induction Period|Adverse Event|38|||
27970922|NCT00762034|54628721|FG000|Induction Period|Lost to Follow-up|1|||
27970923|NCT00762034|54628722|FG001|Induction Period|Lost to Follow-up|1|||
27970924|NCT00762034|54628721|FG000|Induction Period|Progressive Disease|73|||
27970925|NCT00762034|54628722|FG001|Induction Period|Progressive Disease|55|||
27970926|NCT00762034|54628721|FG000|Induction Period|Physician Decision|21|||
27970927|NCT00762034|54628722|FG001|Induction Period|Physician Decision|20|||
27970928|NCT00762034|54628721|FG000|Induction Period|Withdrawal by Subject|15|||
27970929|NCT00762034|54628722|FG001|Induction Period|Withdrawal by Subject|19|||
27970930|NCT00762034|54628721|FG000|Induction Period|Deaths Not Due to Study Disease|19|||
27970931|NCT00762034|54628722|FG001|Induction Period|Deaths Not Due to Study Disease|14|||
27970932|NCT00762034|54628721|FG000|Induction Period|Deaths Due to Study Disease|9|||
27970933|NCT00762034|54628722|FG001|Induction Period|Deaths Due to Study Disease|9|||
28084598|NCT01809691|54738200|FG000|Overall Study|No Protocol Treatment|10|||
28084599|NCT01809691|54738201|FG001|Overall Study|No Protocol Treatment|11|||
28084600|NCT01809691|54738200|FG000|Overall Study|Adverse Event|80|||
28084601|NCT01809691|54738201|FG001|Overall Study|Adverse Event|21|||
28084602|NCT01809691|54738200|FG000|Overall Study|Disease Progression|226|||
27970934|NCT00762034|54628721|FG000|Maintenance Period|Protocol Violation|1|||
27970935|NCT00762034|54628722|FG001|Maintenance Period|Protocol Violation|3|||
27970936|NCT00762034|54628721|FG000|Maintenance Period|Entry Criterion Not Met|0|||
27970937|NCT00762034|54628722|FG001|Maintenance Period|Entry Criterion Not Met|2|||
27970938|NCT00762034|54628721|FG000|Maintenance Period|Adverse Event|42|||
27970939|NCT00762034|54628722|FG001|Maintenance Period|Adverse Event|26|||
27970940|NCT00762034|54628721|FG000|Maintenance Period|Progressive Disease|186|||
27970941|NCT00762034|54628722|FG001|Maintenance Period|Progressive Disease|224|||
27970942|NCT00762034|54628721|FG000|Maintenance Period|Physician Decision|25|||
27970943|NCT00762034|54628722|FG001|Maintenance Period|Physician Decision|20|||
27970944|NCT00762034|54628721|FG000|Maintenance Period|Withdrawal by Subject|34|||
27970945|NCT00762034|54628722|FG001|Maintenance Period|Withdrawal by Subject|14|||
27970946|NCT00762034|54628721|FG000|Maintenance Period|Death not due to study disease|2|||
27970947|NCT00762034|54628722|FG001|Maintenance Period|Death not due to study disease|5|||
27970948|NCT00762034|54628721|FG000|Maintenance Period|Death due to study disease|3|||
27970949|NCT00762034|54628722|FG001|Maintenance Period|Death due to study disease|3|||
27970950|NCT00762034|54628721|FG000|Maintenance Period|Other|1|||
27970951|NCT00762034|54628722|FG001|Maintenance Period|Other|1|||
27970952|NCT00761956|54628754|FG000|Overall Study|Lost to Follow-up|6|||
27970953|NCT00761956|54628755|FG001|Overall Study|Lost to Follow-up|11|||
27970954|NCT00761956|54628754|FG000|Overall Study|Withdrawal by Subject|3|||
28084603|NCT01809691|54738201|FG001|Overall Study|Disease Progression|372|||
27855507|NCT00243269|54377540|FG003|Overall Study|Lost to Follow-up|3|||
27970955|NCT00761956|54628755|FG001|Overall Study|Withdrawal by Subject|8|||
28084604|NCT01809691|54738200|FG000|Overall Study|Death|26|||
28084605|NCT01809691|54738201|FG001|Overall Study|Death|13|||
27970956|NCT00761956|54628754|FG000|Overall Study|Death|0|||
27970957|NCT00761956|54628755|FG001|Overall Study|Death|1|||
27970958|NCT00761956|54628754|FG000|Overall Study|Adverse Event|26|||
27970959|NCT00761956|54628755|FG001|Overall Study|Adverse Event|34|||
27970960|NCT00754624|54628761|FG000|Overall Study|Adverse Event|16|||
27970961|NCT00754624|54628761|FG000|Overall Study|Death|1|||
27970962|NCT00754624|54628761|FG000|Overall Study|Physician Decision|8|||
27970963|NCT00754624|54628761|FG000|Overall Study|Protocol Violation|1|||
27970964|NCT00754624|54628761|FG000|Overall Study|Withdrawal by Subject|28|||
27970965|NCT00754624|54628761|FG000|Overall Study|Various|12|||
27970966|NCT00754624|54628761|FG000|Overall Study|Lost to Follow-up|3|||
27970967|NCT00586846|54628774|FG000|Overall Study|Physician Decision|1|||
27970968|NCT00586846|54628774|FG000|Overall Study|Death|1|||
27970969|NCT00586846|54628774|FG000|Overall Study|Evaluable for Toxicity Only|4|||
27970970|NCT00973700|54628783|FG000|Overall Study|Withdrawal by Subject|2|||
27970971|NCT00973700|54628784|FG001|Overall Study|Withdrawal by Subject|2|||
27970972|NCT00973700|54628785|FG002|Overall Study|Withdrawal by Subject|8|||
27970973|NCT00973700|54628786|FG003|Overall Study|Withdrawal by Subject|4|||
27970974|NCT00973700|54628787|FG004|Overall Study|Withdrawal by Subject|4|||
27970975|NCT00973700|54628783|FG000|Overall Study|Lost to Follow-up|5|||
27970976|NCT00973700|54628784|FG001|Overall Study|Lost to Follow-up|0|||
27970977|NCT00973700|54628785|FG002|Overall Study|Lost to Follow-up|1|||
27970978|NCT00973700|54628786|FG003|Overall Study|Lost to Follow-up|8|||
27970979|NCT00973700|54628787|FG004|Overall Study|Lost to Follow-up|5|||
27970980|NCT00973700|54628783|FG000|Overall Study|Inappropriate enrolment|0|||
27970981|NCT00973700|54628784|FG001|Overall Study|Inappropriate enrolment|0|||
27970982|NCT00973700|54628785|FG002|Overall Study|Inappropriate enrolment|0|||
27970983|NCT00973700|54628786|FG003|Overall Study|Inappropriate enrolment|4|||
27970984|NCT00973700|54628787|FG004|Overall Study|Inappropriate enrolment|0|||
27970985|NCT00973700|54628783|FG000|Overall Study|Unable to Classify|0|||
27970986|NCT00973700|54628784|FG001|Overall Study|Unable to Classify|0|||
27970987|NCT00973700|54628785|FG002|Overall Study|Unable to Classify|1|||
27970988|NCT00973700|54628786|FG003|Overall Study|Unable to Classify|2|||
27970989|NCT00973700|54628787|FG004|Overall Study|Unable to Classify|1|||
27970990|NCT00754390|54628814|FG000|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3|||
27970991|NCT00754390|54628814|FG000|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2|||
27970992|NCT00754390|54628814|FG000|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1|||
27970993|NCT00754390|54628814|FG000|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1|||
27970994|NCT00754234|54628821|FG000|Overall Study|Withdrawal by Subject|3|||
27970995|NCT00753922|54628829|FG000|Overall Study|Lost to Follow-up|155|||
27970996|NCT00753922|54628830|FG001|Overall Study|Lost to Follow-up|24|||
27970997|NCT00753922|54628831|FG002|Overall Study|Lost to Follow-up|28|||
27970998|NCT00753922|54628832|FG003|Overall Study|Lost to Follow-up|5|||
27970999|NCT00753922|54628829|FG000|Overall Study|Withdrawal by Subject|9|||
27971000|NCT00753922|54628830|FG001|Overall Study|Withdrawal by Subject|11|||
27971001|NCT00753922|54628831|FG002|Overall Study|Withdrawal by Subject|4|||
27971002|NCT00753922|54628832|FG003|Overall Study|Withdrawal by Subject|2|||
27971003|NCT00753922|54628829|FG000|Overall Study|Patient Non-compliance|55|||
27732905|NCT02781311|54180634|FG000|Overall Study|Withdrawal of Consent|11|||
27732906|NCT02781311|54180635|FG001|Overall Study|Withdrawal of Consent|12|||
27732907|NCT02781311|54180636|FG002|Overall Study|Withdrawal of Consent|2|||
27732908|NCT02781311|54180634|FG000|Overall Study|Lost to Follow-up|11|||
27732909|NCT02781311|54180635|FG001|Overall Study|Lost to Follow-up|8|||
27732910|NCT02781311|54180636|FG002|Overall Study|Lost to Follow-up|1|||
27732911|NCT02781311|54180634|FG000|Overall Study|Non-Compliance with Study Drug|2|||
27732912|NCT02781311|54180635|FG001|Overall Study|Non-Compliance with Study Drug|0|||
27732913|NCT02781311|54180636|FG002|Overall Study|Non-Compliance with Study Drug|0|||
27732914|NCT02564198|54180646|FG000|Overall Study|Withdrawal by Subject|2|||
27732915|NCT02564198|54180647|FG001|Overall Study|Withdrawal by Subject|4|||
27732916|NCT02564198|54180648|FG002|Overall Study|Withdrawal by Subject|0|||
27732917|NCT02564198|54180646|FG000|Overall Study|Adverse Event|0|||
27732918|NCT02564198|54180647|FG001|Overall Study|Adverse Event|1|||
27732919|NCT02564198|54180648|FG002|Overall Study|Adverse Event|0|||
27732920|NCT02564120|54180663|FG000|Overall Study|Did not return release forms|160|||
27732921|NCT02564120|54180663|FG000|Overall Study|Death|58|||
27732922|NCT02564120|54180663|FG000|Overall Study|Withdrawal by Subject|204|||
27732923|NCT02564120|54180663|FG000|Overall Study|Other medical condition|24|||
27732924|NCT00705783|54180679|FG000|Conversion Phase|Sponsor Discontinued Study|54|||
27732925|NCT00705783|54180680|FG001|Conversion Phase|Sponsor Discontinued Study|0|||
27732926|NCT00705783|54180681|FG002|Conversion Phase|Sponsor Discontinued Study|0|||
27855508|NCT00242567|54378764|FG000|Overall Study|Adverse Event|70|||
27855509|NCT00242567|54378765|FG001|Overall Study|Adverse Event|43|||
27855510|NCT00242567|54378764|FG000|Overall Study|Disease Progression|17|||
27971004|NCT00753922|54628830|FG001|Overall Study|Patient Non-compliance|22|||
27971005|NCT00753922|54628831|FG002|Overall Study|Patient Non-compliance|14|||
27971006|NCT00753922|54628832|FG003|Overall Study|Patient Non-compliance|11|||
27971007|NCT00753922|54628829|FG000|Overall Study|Patients Not Completing Visit|11|||
27832589|NCT01757171|54312050|FG000|Overall Study|ECOG decline|1|||
27832590|NCT01757171|54312051|FG001|Overall Study|ECOG decline|0|||
27832591|NCT01756235|54312057|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
27832592|NCT01730729|54312061|FG000|Overall Study|Adverse Event|1|||
27832593|NCT01730729|54312061|FG000|Overall Study|Death|1|||
27832594|NCT01730729|54312061|FG000|Overall Study|Progressive Disease|12|||
27832595|NCT01756157|54312065|FG000|First Intervention Period|Withdrawal by Subject|1|||
27832596|NCT01756157|54312066|FG001|First Intervention Period|Withdrawal by Subject|0|||
27832597|NCT01756157|54312065|FG000|First Intervention Period|Lost to Follow-up|0|||
27832598|NCT01756157|54312066|FG001|First Intervention Period|Lost to Follow-up|2|||
27832599|NCT01756079|54312072|FG000|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4|||
27832600|NCT01756079|54312072|FG000|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5|||
28084606|NCT01809691|54738200|FG000|Overall Study|Participant Refusal|70|||
28084607|NCT01809691|54738201|FG001|Overall Study|Participant Refusal|72|||
28084608|NCT01809691|54738200|FG000|Overall Study|Other, Not Specified|34|||
28084609|NCT01809691|54738201|FG001|Overall Study|Other, Not Specified|52|||
28084610|NCT01698918|54738207|FG000|First Line Treatment (Core+Extension)|Adverse Event|33|||
28084611|NCT01698918|54738207|FG000|First Line Treatment (Core+Extension)|Withdrawal by Subject|11|||
28084612|NCT01698918|54738207|FG000|First Line Treatment (Core+Extension)|Death|2|||
27832601|NCT01756079|54312072|FG000|Treatment / Follow-up: Week 4 to Week 72|No information available|2|||
27832602|NCT01756079|54312072|FG000|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20|||
27832603|NCT01756079|54312072|FG000|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4|||
27832604|NCT04967885|54312079|FG000|Week 1 Follow-Up|Lost to Follow-up|7|||
27832605|NCT04967885|54312080|FG001|Week 1 Follow-Up|Lost to Follow-up|4|||
27832606|NCT04967885|54312079|FG000|Week 2 Follow-Up|Lost to Follow-up|14|||
27832607|NCT04967885|54312080|FG001|Week 2 Follow-Up|Lost to Follow-up|6|||
27832608|NCT04967885|54312079|FG000|Week 3 Follow-Up|Lost to Follow-up|16|||
27832609|NCT04967885|54312080|FG001|Week 3 Follow-Up|Lost to Follow-up|11|||
27832610|NCT04967885|54312079|FG000|Week 4 Follow-Up|Lost to Follow-up|16|||
27832611|NCT04967885|54312080|FG001|Week 4 Follow-Up|Lost to Follow-up|10|||
27832612|NCT04967885|54312079|FG000|EMI-II Intervention|Lost to Follow-up|14|||
27832613|NCT04967885|54312080|FG001|EMI-II Intervention|Lost to Follow-up|10|||
27832614|NCT04571060|54312097|FG000|Overall Study|Lost to Follow-up from Randomization to Treatment|17|||
27832615|NCT04571060|54312098|FG001|Overall Study|Lost to Follow-up from Randomization to Treatment|9|||
27832616|NCT04571060|54312097|FG000|Overall Study|Never treated migraine|47|||
27832617|NCT04571060|54312098|FG001|Overall Study|Never treated migraine|36|||
27832618|NCT04571060|54312097|FG000|Overall Study|Protocol Violation|4|||
27832619|NCT04571060|54312098|FG001|Overall Study|Protocol Violation|2|||
27832620|NCT04571060|54312097|FG000|Overall Study|Withdrawal by Subject|6|||
27832621|NCT04571060|54312098|FG001|Overall Study|Withdrawal by Subject|2|||
28084613|NCT01698918|54738207|FG000|First Line Treatment (Core+Extension)|Disease progression|120|||
28084614|NCT01698918|54738207|FG000|First Line Treatment (Core+Extension)|Physician Decision|7|||
28084615|NCT01698918|54738207|FG000|Second Line Treatment (Core+Extension)|Adverse Event|3|||
28084616|NCT01698918|54738207|FG000|Second Line Treatment (Core+Extension)|Withdrawal by Subject|1|||
28084617|NCT01698918|54738207|FG000|Second Line Treatment (Core+Extension)|Death|1|||
28084618|NCT01698918|54738207|FG000|Second Line Treatment (Core+Extension)|Disease progression|38|||
28084619|NCT01698918|54738207|FG000|Second Line Treatment (Core+Extension)|Physician Decision|3|||
28084620|NCT01574274|54738222|FG000|Overall Study|Ineligible|0|||
28084621|NCT01574274|54738223|FG001|Overall Study|Ineligible|1|||
28084622|NCT01574274|54738222|FG000|Overall Study|Withdrawal of Consent During Induction|1|||
28084623|NCT01574274|54738223|FG001|Overall Study|Withdrawal of Consent During Induction|1|||
28084624|NCT01574274|54738222|FG000|Overall Study|Ph+ B-ALL|3|||
28084625|NCT01574274|54738223|FG001|Overall Study|Ph+ B-ALL|4|||
28084626|NCT01574274|54738222|FG000|Overall Study|Induction Death|2|||
28084627|NCT01574274|54738223|FG001|Overall Study|Induction Death|0|||
28084628|NCT01574274|54738222|FG000|Overall Study|Induction Failure|4|||
28084629|NCT01574274|54738223|FG001|Overall Study|Induction Failure|1|||
28084630|NCT01574274|54738222|FG000|Overall Study|Adverse Event|16|||
28084631|NCT01574274|54738223|FG001|Overall Study|Adverse Event|13|||
28084632|NCT01574274|54738222|FG000|Overall Study|Remission Death|1|||
28084633|NCT01574274|54738223|FG001|Overall Study|Remission Death|0|||
28084634|NCT01574274|54738222|FG000|Overall Study|Withdrawal from Treatment but Agrees to be Followed|2|||
28084635|NCT01574274|54738223|FG001|Overall Study|Withdrawal from Treatment but Agrees to be Followed|0|||
28084636|NCT01574274|54738222|FG000|Overall Study|Other, unknown|3|||
28084637|NCT01574274|54738223|FG001|Overall Study|Other, unknown|2|||
28084638|NCT01208974|54738229|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|1|||
28084639|NCT01208974|54738230|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
28084640|NCT01208974|54738231|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
27832622|NCT04571060|54312097|FG000|Overall Study|Lost to Follow-up from Treatment to End of Study|7|||
27832623|NCT04571060|54312098|FG001|Overall Study|Lost to Follow-up from Treatment to End of Study|0|||
27832624|NCT04426318|54312106|FG000|Overall Study|failed attention checks and had their data removed from analyses|2|||
27855511|NCT00242567|54378765|FG001|Overall Study|Disease Progression|22|||
28084641|NCT01208974|54738232|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
28084642|NCT01208974|54738229|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|1|||
28084643|NCT01208974|54738230|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
28084644|NCT01208974|54738231|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
28084645|NCT01208974|54738232|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
28084646|NCT01208974|54738229|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|1|||
28084647|NCT01208974|54738230|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
28084648|NCT01208974|54738231|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
28084649|NCT01208974|54738232|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
28084650|NCT00840177|54738242|FG000|Overall Study|Adverse Event|5|||
28084651|NCT00840177|54738243|FG001|Overall Study|Adverse Event|1|||
28084652|NCT00840177|54738244|FG002|Overall Study|Adverse Event|1|||
28084653|NCT00840177|54738242|FG000|Overall Study|Refusal unrelated to adverse events|1|||
28084654|NCT00840177|54738243|FG001|Overall Study|Refusal unrelated to adverse events|0|||
28084655|NCT00840177|54738244|FG002|Overall Study|Refusal unrelated to adverse events|1|||
28084656|NCT00840177|54738242|FG000|Overall Study|Progression/relapse|2|||
28084657|NCT00840177|54738243|FG001|Overall Study|Progression/relapse|0|||
28084658|NCT00840177|54738244|FG002|Overall Study|Progression/relapse|0|||
28084659|NCT00840177|54738242|FG000|Overall Study|Death|4|||
28084660|NCT00840177|54738243|FG001|Overall Study|Death|5|||
28084661|NCT00840177|54738244|FG002|Overall Study|Death|5|||
28084662|NCT00840177|54738242|FG000|Overall Study|not protocol specified|6|||
28084663|NCT00840177|54738243|FG001|Overall Study|not protocol specified|3|||
28084664|NCT00840177|54738244|FG002|Overall Study|not protocol specified|0|||
28084665|NCT00840177|54738242|FG000|Overall Study|Ineligible|0|||
28084666|NCT00840177|54738243|FG001|Overall Study|Ineligible|0|||
28084667|NCT00840177|54738244|FG002|Overall Study|Ineligible|3|||
28084668|NCT00840177|54738242|FG000|Overall Study|Did not start treatment|0|||
28084669|NCT00840177|54738243|FG001|Overall Study|Did not start treatment|0|||
28084670|NCT00840177|54738244|FG002|Overall Study|Did not start treatment|1|||
28084671|NCT01347580|54738254|FG000|Overall Study|Withdrawal by Subject|13|||
28084672|NCT01347580|54738255|FG001|Overall Study|Withdrawal by Subject|23|||
28084673|NCT01347580|54738254|FG000|Overall Study|Death|30|||
28084674|NCT01347580|54738255|FG001|Overall Study|Death|19|||
28084675|NCT01347580|54738254|FG000|Overall Study|Protocol Violation|10|||
28084676|NCT01347580|54738255|FG001|Overall Study|Protocol Violation|7|||
28084677|NCT01347580|54738254|FG000|Overall Study|Lost to Follow-up|3|||
28084678|NCT01347580|54738255|FG001|Overall Study|Lost to Follow-up|1|||
28084679|NCT01347580|54738254|FG000|Overall Study|Had other reason|9|||
28084680|NCT01347580|54738255|FG001|Overall Study|Had other reason|6|||
28084681|NCT00398411|54738263|FG000|Overall Study|Death|0|||
28084682|NCT00398411|54738264|FG001|Overall Study|Death|1|||
28084683|NCT03352414|54738272|FG000|Overall Study|Ineligible by operative criteria|12|||
27832625|NCT04426318|54312107|FG001|Overall Study|failed attention checks and had their data removed from analyses|2|||
27832626|NCT04356963|54312122|FG000|First Session|Withdrawal by Subject|1|||
27971008|NCT00753922|54628830|FG001|Overall Study|Patients Not Completing Visit|0|||
27971009|NCT00753922|54628831|FG002|Overall Study|Patients Not Completing Visit|1|||
27971010|NCT00753922|54628832|FG003|Overall Study|Patients Not Completing Visit|0|||
27971011|NCT00753922|54628829|FG000|Overall Study|Death|2|||
27971012|NCT00753922|54628830|FG001|Overall Study|Death|23|||
27971013|NCT00753922|54628831|FG002|Overall Study|Death|2|||
27971014|NCT00753922|54628832|FG003|Overall Study|Death|1|||
27971015|NCT00753922|54628829|FG000|Overall Study|Discontinuation Due to Explantation|14|||
27971016|NCT00753922|54628830|FG001|Overall Study|Discontinuation Due to Explantation|14|||
27971017|NCT00753922|54628831|FG002|Overall Study|Discontinuation Due to Explantation|14|||
27971018|NCT00753922|54628832|FG003|Overall Study|Discontinuation Due to Explantation|4|||
27971019|NCT00761176|54628844|FG000|Overall Study|Death|1|||
27971020|NCT00761176|54628845|FG001|Overall Study|Death|0|||
28084684|NCT03352414|54738273|FG001|Overall Study|Ineligible by operative criteria|10|||
28084685|NCT00364793|54738285|FG000|Overall Study|Adverse Event|2|||
28084686|NCT00364793|54738286|FG001|Overall Study|Adverse Event|0|||
28084687|NCT00364793|54738287|FG002|Overall Study|Adverse Event|0|||
28084688|NCT00364793|54738288|FG003|Overall Study|Adverse Event|0|||
28084689|NCT00364793|54738285|FG000|Overall Study|Death|1|||
28084690|NCT00364793|54738286|FG001|Overall Study|Death|0|||
28084691|NCT00364793|54738287|FG002|Overall Study|Death|1|||
28084692|NCT00364793|54738288|FG003|Overall Study|Death|0|||
28084693|NCT00364793|54738285|FG000|Overall Study|Lack of Efficacy|3|||
28084694|NCT00364793|54738286|FG001|Overall Study|Lack of Efficacy|3|||
28084695|NCT00364793|54738287|FG002|Overall Study|Lack of Efficacy|1|||
27832627|NCT04356963|54312122|FG000|Second Session|Withdrawal by Subject|3|||
27971021|NCT00761176|54628844|FG000|Overall Study|Withdrawal by Subject|1|||
27971022|NCT00761176|54628845|FG001|Overall Study|Withdrawal by Subject|1|||
27971023|NCT00760552|54628853|FG000|Overall Study|Death|2|||
28084696|NCT00364793|54738288|FG003|Overall Study|Lack of Efficacy|1|||
28084697|NCT00364793|54738285|FG000|Overall Study|Lost to Follow-up|1|||
28084698|NCT00364793|54738286|FG001|Overall Study|Lost to Follow-up|0|||
27971024|NCT00760552|54628854|FG001|Overall Study|Death|0|||
27971025|NCT00760552|54628853|FG000|Overall Study|Lost to Follow-up|11|||
27971026|NCT00760552|54628854|FG001|Overall Study|Lost to Follow-up|10|||
27971027|NCT00753766|54628862|FG000|Overall Study|Physician Decision|1|||
27971028|NCT00753766|54628863|FG001|Overall Study|Physician Decision|0|||
27971029|NCT00976898|54628870|FG000|Overall Study|Protocol Violation|1|||
27971030|NCT00976898|54628870|FG000|Overall Study|Adverse Event|1|||
27971031|NCT00976898|54628870|FG000|Overall Study|Physician Decision|1|||
27971032|NCT00976898|54628870|FG000|Overall Study|Liver Transplant|1|||
27971033|NCT00976898|54628870|FG000|Overall Study|Progressive Disease|1|||
27971034|NCT02620579|54628882|FG000|Overall Study|Physician Decision|0|||
27971035|NCT02620579|54628883|FG001|Overall Study|Physician Decision|0|||
27971036|NCT02620579|54628884|FG002|Overall Study|Physician Decision|0|||
27971037|NCT02620579|54628885|FG003|Overall Study|Physician Decision|1|||
27971038|NCT02620579|54628882|FG000|Overall Study|Withdrawal by Subject|0|||
27971039|NCT02620579|54628883|FG001|Overall Study|Withdrawal by Subject|1|||
27971040|NCT02620579|54628884|FG002|Overall Study|Withdrawal by Subject|1|||
28084699|NCT00364793|54738287|FG002|Overall Study|Lost to Follow-up|2|||
28084700|NCT00364793|54738288|FG003|Overall Study|Lost to Follow-up|0|||
28084701|NCT00364793|54738285|FG000|Overall Study|Poor or non-compliance|1|||
28084702|NCT00364793|54738286|FG001|Overall Study|Poor or non-compliance|1|||
28084703|NCT00364793|54738287|FG002|Overall Study|Poor or non-compliance|0|||
28084704|NCT00364793|54738288|FG003|Overall Study|Poor or non-compliance|1|||
27971041|NCT02620579|54628885|FG003|Overall Study|Withdrawal by Subject|0|||
27971042|NCT00753688|54628901|FG000|Overall Study|Death|102|||
27971043|NCT00753688|54628902|FG001|Overall Study|Death|203|||
27971044|NCT00753688|54628901|FG000|Overall Study|Missing|4|||
27971045|NCT00753688|54628902|FG001|Overall Study|Missing|9|||
27971046|NCT00753688|54628901|FG000|Overall Study|Participant Withdrew Consent|2|||
27971047|NCT00753688|54628902|FG001|Overall Study|Participant Withdrew Consent|2|||
27971048|NCT00753688|54628901|FG000|Overall Study|Ongoing - in Follow-up|15|||
27971049|NCT00753688|54628902|FG001|Overall Study|Ongoing - in Follow-up|31|||
27971050|NCT00753688|54628901|FG000|Overall Study|Adverse Event|0|||
27971051|NCT00753688|54628902|FG001|Overall Study|Adverse Event|1|||
27971052|NCT00586612|54628910|FG000|Primary Phase|Protocol Violation|1|||
27971053|NCT00586612|54628911|FG001|Primary Phase|Protocol Violation|0|||
27971054|NCT00586612|54628910|FG000|Primary Phase|Lost to Follow-up|0|||
27971055|NCT00586612|54628911|FG001|Primary Phase|Lost to Follow-up|1|||
27971056|NCT00586612|54628910|FG000|Primary Phase|Withdrawal by Subject|0|||
27971057|NCT00586612|54628911|FG001|Primary Phase|Withdrawal by Subject|2|||
27971058|NCT00586612|54628910|FG000|Booster Phase|Lost to Follow-up|3|||
27971059|NCT00586612|54628911|FG001|Booster Phase|Lost to Follow-up|1|||
27971060|NCT00586690|54628919|FG000|Overall Study|Death|2|||
27971061|NCT00586690|54628920|FG001|Overall Study|Death|0|||
27971062|NCT00586690|54628919|FG000|Overall Study|Disease Progression|10|||
27971063|NCT00586690|54628920|FG001|Overall Study|Disease Progression|0|||
27971064|NCT00586690|54628919|FG000|Overall Study|Adverse Event|1|||
27971065|NCT00586690|54628920|FG001|Overall Study|Adverse Event|0|||
27971066|NCT00586690|54628919|FG000|Overall Study|Lack of Efficacy|2|||
27971067|NCT00586690|54628920|FG001|Overall Study|Lack of Efficacy|0|||
27971068|NCT00586690|54628919|FG000|Overall Study|Lab can't accommodate|1|||
27971069|NCT00586690|54628920|FG001|Overall Study|Lab can't accommodate|0|||
27971070|NCT00976820|54628929|FG000|Overall Study|Lost to Follow-up|5|||
28084705|NCT00364793|54738285|FG000|Overall Study|No longer meets criteria|0|||
27971071|NCT00976820|54628930|FG001|Overall Study|Lost to Follow-up|16|||
27971072|NCT00976820|54628931|FG002|Overall Study|Lost to Follow-up|2|||
27971073|NCT00976820|54628932|FG003|Overall Study|Lost to Follow-up|3|||
27971074|NCT00976820|54628929|FG000|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
27971075|NCT00976820|54628930|FG001|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
27971076|NCT00976820|54628931|FG002|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
27971077|NCT00976820|54628932|FG003|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
27971078|NCT00976820|54628929|FG000|Overall Study|Withdrawal by Subject|2|||
27971079|NCT00976820|54628930|FG001|Overall Study|Withdrawal by Subject|4|||
27971080|NCT00976820|54628931|FG002|Overall Study|Withdrawal by Subject|1|||
28084706|NCT00364793|54738286|FG001|Overall Study|No longer meets criteria|0|||
28084707|NCT00364793|54738287|FG002|Overall Study|No longer meets criteria|0|||
28084708|NCT00364793|54738288|FG003|Overall Study|No longer meets criteria|1|||
28084709|NCT00364793|54738285|FG000|Overall Study|Withdrawal by Subject|0|||
28084710|NCT00364793|54738286|FG001|Overall Study|Withdrawal by Subject|1|||
27971081|NCT00976820|54628932|FG003|Overall Study|Withdrawal by Subject|4|||
27971082|NCT00760474|54628983|FG000|Period 1 (P1)|Discontinued then re-entered|1|||
27971083|NCT00760474|54628984|FG001|Period 1 (P1)|Discontinued then re-entered|1|||
27971084|NCT00760474|54628983|FG000|Placebo Washout Period|Other|0|||
27971085|NCT00760474|54628984|FG001|Placebo Washout Period|Other|1|||
27971086|NCT00760474|54628983|FG000|Period 2 (P2)|Lost to Follow-up|1|||
27971087|NCT00760474|54628984|FG001|Period 2 (P2)|Lost to Follow-up|0|||
27971088|NCT00760474|54628983|FG000|Period 2 (P2)|Adverse Event|0|||
27971089|NCT00760474|54628984|FG001|Period 2 (P2)|Adverse Event|1|||
28084711|NCT00364793|54738287|FG002|Overall Study|Withdrawal by Subject|0|||
28084712|NCT00364793|54738288|FG003|Overall Study|Withdrawal by Subject|0|||
28084713|NCT03351478|54738304|FG000|Overall Study|At the subject's own request|11|||
28084714|NCT03351478|54738305|FG001|Overall Study|At the subject's own request|12|||
28084715|NCT03351478|54738306|FG002|Overall Study|At the subject's own request|5|||
28084716|NCT03351478|54738304|FG000|Overall Study|Adverse Event|1|||
27971090|NCT00975416|54628993|FG000|Overall Study|early discharge from tx|3|||
27971091|NCT00975416|54628994|FG001|Overall Study|early discharge from tx|5|||
27971092|NCT00760084|54629001|FG000|Overall Study|Physician Decision|5|||
27971093|NCT00760084|54629001|FG000|Overall Study|Withdrawal by Subject|2|||
27971094|NCT00760084|54629001|FG000|Overall Study|Progressive Disease|3|||
27971095|NCT00752206|54629007|FG000|Overall Study|Disease progression|8|||
27971096|NCT00752206|54629008|FG001|Overall Study|Disease progression|11|||
27971097|NCT00752206|54629007|FG000|Overall Study|Pregnancy|1|||
27971098|NCT00752206|54629008|FG001|Overall Study|Pregnancy|0|||
27971099|NCT00752128|54629014|FG000|Overall Study|Withdrawal by Subject|4|||
27971100|NCT00976508|54629021|FG000|Overall Study|Death|7|||
27971101|NCT00976508|54629022|FG001|Overall Study|Death|1|||
27971102|NCT00976508|54629021|FG000|Overall Study|Lost to Follow-up|1|||
27971103|NCT00976508|54629022|FG001|Overall Study|Lost to Follow-up|0|||
27971104|NCT00976508|54629021|FG000|Overall Study|Withdrawal by Subject|1|||
27971105|NCT00976508|54629022|FG001|Overall Study|Withdrawal by Subject|0|||
27971106|NCT00976508|54629021|FG000|Overall Study|Disease Progression|4|||
27971107|NCT00976508|54629022|FG001|Overall Study|Disease Progression|4|||
27971108|NCT00976508|54629021|FG000|Overall Study|Subject Enrolled in Hospice|1|||
27971109|NCT00976508|54629022|FG001|Overall Study|Subject Enrolled in Hospice|0|||
27971110|NCT00976508|54629021|FG000|Overall Study|Terminated by the Sponsor|0|||
27971111|NCT00976508|54629022|FG001|Overall Study|Terminated by the Sponsor|1|||
27971112|NCT00973622|54629033|FG000|Overall Study|did not attend MRI|14|||
27971113|NCT00973622|54629034|FG001|Overall Study|did not attend MRI|3|||
27971114|NCT00973622|54629033|FG000|Overall Study|did not pass MRI screen|6|||
27971115|NCT00973622|54629034|FG001|Overall Study|did not pass MRI screen|0|||
27971116|NCT00973622|54629033|FG000|Overall Study|did not complete rTMS sessions|11|||
27971117|NCT00973622|54629034|FG001|Overall Study|did not complete rTMS sessions|2|||
27971118|NCT04044716|54629042|FG000|Overall Study|participant stopped treatment but submitted partial data.|1|||
27971119|NCT04044716|54629043|FG001|Overall Study|participant stopped treatment but submitted partial data.|0|||
27971120|NCT04044716|54629044|FG002|Overall Study|participant stopped treatment but submitted partial data.|0|||
27971121|NCT04044716|54629042|FG000|Overall Study|Lost to Follow-up|2|||
27971122|NCT04044716|54629043|FG001|Overall Study|Lost to Follow-up|3|||
27971123|NCT04044716|54629044|FG002|Overall Study|Lost to Follow-up|0|||
27971124|NCT00753454|54629051|FG000|Overall Study|Adverse Event|4|||
27971125|NCT00753454|54629051|FG000|Overall Study|Lack of Efficacy|1|||
27971126|NCT00753454|54629051|FG000|Overall Study|Lost to Follow-up|3|||
27971127|NCT00753454|54629051|FG000|Overall Study|Withdrawal by Subject|5|||
27971128|NCT00753454|54629051|FG000|Overall Study|Investigator Decision|1|||
27971129|NCT00976274|54629057|FG000|Overall Study|Lost to Follow-up|5|||
27971130|NCT00976274|54629058|FG001|Overall Study|Lost to Follow-up|5|||
27971131|NCT00976274|54629057|FG000|Overall Study|Withdrawal by Subject|1|||
27971132|NCT00976274|54629058|FG001|Overall Study|Withdrawal by Subject|1|||
27971133|NCT00976274|54629057|FG000|Overall Study|Physician Decision|1|||
27971134|NCT00976274|54629058|FG001|Overall Study|Physician Decision|2|||
27971135|NCT00759148|54629066|FG000|Overall Study|Adverse Event|1|||
27971136|NCT00759148|54629067|FG001|Overall Study|Adverse Event|6|||
27971137|NCT00759148|54629066|FG000|Overall Study|Withdrawal by Subject|3|||
27971138|NCT00759148|54629067|FG001|Overall Study|Withdrawal by Subject|7|||
27971139|NCT00759148|54629066|FG000|Overall Study|Lost to Follow-up|3|||
28084717|NCT03351478|54738305|FG001|Overall Study|Adverse Event|2|||
28084718|NCT03351478|54738306|FG002|Overall Study|Adverse Event|1|||
28084719|NCT03351478|54738304|FG000|Overall Study|Poor compliance to protocol|1|||
28084720|NCT03351478|54738305|FG001|Overall Study|Poor compliance to protocol|0|||
28084721|NCT03351478|54738306|FG002|Overall Study|Poor compliance to protocol|0|||
28084722|NCT03351478|54738304|FG000|Overall Study|Reason not Specified|1|||
28084723|NCT03351478|54738305|FG001|Overall Study|Reason not Specified|3|||
28084724|NCT03351478|54738306|FG002|Overall Study|Reason not Specified|0|||
28084725|NCT03351478|54738304|FG000|Overall Study|Lost to Follow-up|0|||
28084726|NCT03351478|54738305|FG001|Overall Study|Lost to Follow-up|0|||
27971140|NCT00759148|54629067|FG001|Overall Study|Lost to Follow-up|9|||
27971141|NCT00759148|54629066|FG000|Overall Study|Treatment Failure|6|||
27971142|NCT00759148|54629067|FG001|Overall Study|Treatment Failure|10|||
27971143|NCT00759148|54629066|FG000|Overall Study|Reason not given|1|||
27971144|NCT00759148|54629067|FG001|Overall Study|Reason not given|0|||
27971145|NCT02794285|54629077|FG000|Overall Study|Adverse Event|11|||
27971146|NCT02794285|54629078|FG001|Overall Study|Adverse Event|4|||
27971147|NCT02794285|54629079|FG002|Overall Study|Adverse Event|5|||
27971148|NCT02794285|54629080|FG003|Overall Study|Adverse Event|8|||
27971149|NCT02794285|54629077|FG000|Overall Study|Condition Under Investigation Improved|1|||
27971150|NCT02794285|54629078|FG001|Overall Study|Condition Under Investigation Improved|0|||
28084727|NCT03351478|54738306|FG002|Overall Study|Lost to Follow-up|1|||
28084728|NCT00363545|54738316|FG000|Overall Study|Serious Adverse Event|0|||
28084729|NCT00363545|54738317|FG001|Overall Study|Serious Adverse Event|1|||
28084730|NCT00363545|54738316|FG000|Overall Study|Withdrawal by Subject|12|||
28084731|NCT00363545|54738317|FG001|Overall Study|Withdrawal by Subject|15|||
28084732|NCT00363545|54738316|FG000|Overall Study|Migrated/moved from study area|3|||
28084733|NCT00363545|54738317|FG001|Overall Study|Migrated/moved from study area|6|||
28084734|NCT00363545|54738316|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|14|||
28084735|NCT00363545|54738317|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|18|||
28084736|NCT00363545|54738316|FG000|Overall Study|Lost to follow-up (complete vaccination)|14|||
28084737|NCT00363545|54738317|FG001|Overall Study|Lost to follow-up (complete vaccination)|17|||
28084738|NCT00363545|54738316|FG000|Overall Study|Others|1|||
27971151|NCT02794285|54629079|FG002|Overall Study|Condition Under Investigation Improved|0|||
27971152|NCT02794285|54629080|FG003|Overall Study|Condition Under Investigation Improved|0|||
28084739|NCT00363545|54738317|FG001|Overall Study|Others|0|||
28084740|NCT03351244|54738326|FG000|Overall Study|Adverse Event|7|||
28084741|NCT03351244|54738327|FG001|Overall Study|Adverse Event|11|||
27732927|NCT00705783|54180679|FG000|Conversion Phase|Lost to Follow-up|13|||
27732928|NCT00705783|54180680|FG001|Conversion Phase|Lost to Follow-up|0|||
27732929|NCT00705783|54180681|FG002|Conversion Phase|Lost to Follow-up|0|||
27732930|NCT00705783|54180679|FG000|Conversion Phase|Met Withdrawal Criteria|4|||
27732931|NCT00705783|54180680|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
27732932|NCT00705783|54180681|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
27732933|NCT00705783|54180679|FG000|Conversion Phase|Withdrawn by Investigator|4|||
27971153|NCT02794285|54629077|FG000|Overall Study|Condition Under Investigation Worsened|0|||
27971154|NCT02794285|54629078|FG001|Overall Study|Condition Under Investigation Worsened|2|||
27971155|NCT02794285|54629079|FG002|Overall Study|Condition Under Investigation Worsened|1|||
27971156|NCT02794285|54629080|FG003|Overall Study|Condition Under Investigation Worsened|0|||
27971157|NCT02794285|54629077|FG000|Overall Study|Death|2|||
27971158|NCT02794285|54629078|FG001|Overall Study|Death|1|||
27971159|NCT02794285|54629079|FG002|Overall Study|Death|2|||
27732934|NCT00705783|54180680|FG001|Conversion Phase|Withdrawn by Investigator|0|||
28084742|NCT03351244|54738328|FG002|Overall Study|Adverse Event|12|||
28084743|NCT03351244|54738326|FG000|Overall Study|Investigator's decision|0|||
28084744|NCT03351244|54738327|FG001|Overall Study|Investigator's decision|0|||
28084745|NCT03351244|54738328|FG002|Overall Study|Investigator's decision|2|||
28084746|NCT03351244|54738326|FG000|Overall Study|System error|0|||
28084747|NCT03351244|54738327|FG001|Overall Study|System error|0|||
28084748|NCT03351244|54738328|FG002|Overall Study|System error|2|||
28084749|NCT03351244|54738326|FG000|Overall Study|COVID-19 restrictions|3|||
28084750|NCT03351244|54738327|FG001|Overall Study|COVID-19 restrictions|0|||
28084751|NCT03351244|54738328|FG002|Overall Study|COVID-19 restrictions|1|||
28084752|NCT03351244|54738326|FG000|Overall Study|Non-compliance|2|||
28084753|NCT03351244|54738327|FG001|Overall Study|Non-compliance|5|||
28084754|NCT03351244|54738328|FG002|Overall Study|Non-compliance|0|||
28084755|NCT03351244|54738326|FG000|Overall Study|Withdrawal by Subject|11|||
28084756|NCT03351244|54738327|FG001|Overall Study|Withdrawal by Subject|16|||
28084757|NCT03351244|54738328|FG002|Overall Study|Withdrawal by Subject|13|||
28084758|NCT03351244|54738326|FG000|Overall Study|Lost to Follow-up|2|||
28084759|NCT03351244|54738327|FG001|Overall Study|Lost to Follow-up|6|||
28084760|NCT03351244|54738328|FG002|Overall Study|Lost to Follow-up|4|||
28084761|NCT03351244|54738326|FG000|Overall Study|Protocol Violation|2|||
28084762|NCT03351244|54738327|FG001|Overall Study|Protocol Violation|2|||
28084763|NCT03351244|54738328|FG002|Overall Study|Protocol Violation|0|||
28084764|NCT03386032|54738341|FG000|Overall Study|Lack of Efficacy|6|||
28084765|NCT03386032|54738342|FG001|Overall Study|Lack of Efficacy|2|||
28084766|NCT03386032|54738343|FG002|Overall Study|Lack of Efficacy|0|||
28084767|NCT03386032|54738341|FG000|Overall Study|Adverse Event|2|||
28084768|NCT03386032|54738342|FG001|Overall Study|Adverse Event|2|||
28084769|NCT03386032|54738343|FG002|Overall Study|Adverse Event|0|||
28084770|NCT03386032|54738341|FG000|Overall Study|Withdrawal by Subject|1|||
28084771|NCT03386032|54738342|FG001|Overall Study|Withdrawal by Subject|0|||
28084772|NCT03386032|54738343|FG002|Overall Study|Withdrawal by Subject|0|||
28165310|NCT02984683|54836000|FG000|Overall Study|Adverse Event|3|||
28165311|NCT02984683|54836001|FG001|Overall Study|Adverse Event|3|||
28165312|NCT02984683|54836000|FG000|Overall Study|Withdrawal by Subject|1|||
27832628|NCT04356963|54312122|FG000|Second Session|Lost to Follow-up|1|||
27971160|NCT02794285|54629080|FG003|Overall Study|Death|0|||
28084773|NCT03386032|54738341|FG000|Overall Study|Lost to Follow-up|9|||
28084774|NCT03386032|54738342|FG001|Overall Study|Lost to Follow-up|3|||
28084775|NCT03386032|54738343|FG002|Overall Study|Lost to Follow-up|0|||
28084776|NCT00077610|54738354|FG000|Overall Study|Adverse Event|9|||
28084777|NCT00077610|54738355|FG001|Overall Study|Adverse Event|7|||
28084778|NCT00077610|54738356|FG002|Overall Study|Adverse Event|1|||
28165313|NCT02984683|54836001|FG001|Overall Study|Withdrawal by Subject|0|||
28165314|NCT02984683|54836000|FG000|Overall Study|Disease progression|7|||
28165315|NCT02984683|54836001|FG001|Overall Study|Disease progression|9|||
28084779|NCT00077610|54738354|FG000|Overall Study|Lost to Follow-up|0|||
28084780|NCT00077610|54738355|FG001|Overall Study|Lost to Follow-up|1|||
27971161|NCT02794285|54629077|FG000|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
27971162|NCT02794285|54629078|FG001|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
27971163|NCT02794285|54629079|FG002|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
27971164|NCT02794285|54629080|FG003|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
27971165|NCT02794285|54629077|FG000|Overall Study|Failure to Meet Randomisation Criteria|0|||
27971166|NCT02794285|54629078|FG001|Overall Study|Failure to Meet Randomisation Criteria|0|||
27971167|NCT02794285|54629079|FG002|Overall Study|Failure to Meet Randomisation Criteria|1|||
27971168|NCT02794285|54629080|FG003|Overall Study|Failure to Meet Randomisation Criteria|0|||
27971169|NCT02794285|54629077|FG000|Overall Study|Lack of Efficacy|10|||
27971170|NCT02794285|54629078|FG001|Overall Study|Lack of Efficacy|6|||
27971171|NCT02794285|54629079|FG002|Overall Study|Lack of Efficacy|3|||
27971172|NCT02794285|54629080|FG003|Overall Study|Lack of Efficacy|3|||
27971173|NCT02794285|54629077|FG000|Overall Study|Lost to Follow-up|5|||
27971174|NCT02794285|54629078|FG001|Overall Study|Lost to Follow-up|6|||
27971175|NCT02794285|54629079|FG002|Overall Study|Lost to Follow-up|3|||
27971176|NCT02794285|54629080|FG003|Overall Study|Lost to Follow-up|1|||
27971177|NCT02794285|54629077|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
28084781|NCT00077610|54738356|FG002|Overall Study|Lost to Follow-up|2|||
28084782|NCT00077610|54738354|FG000|Overall Study|Withdrawal by Subject|4|||
28084783|NCT00077610|54738355|FG001|Overall Study|Withdrawal by Subject|10|||
28084784|NCT00077610|54738356|FG002|Overall Study|Withdrawal by Subject|6|||
28084785|NCT00077610|54738354|FG000|Overall Study|Death|17|||
28084786|NCT00077610|54738355|FG001|Overall Study|Death|13|||
28084787|NCT00077610|54738356|FG002|Overall Study|Death|13|||
28084788|NCT00077610|54738354|FG000|Overall Study|Renal transplant|12|||
27971178|NCT02794285|54629078|FG001|Overall Study|Severe Non-compliance to Protocol|2|||
27971179|NCT02794285|54629079|FG002|Overall Study|Severe Non-compliance to Protocol|1|||
27971180|NCT02794285|54629080|FG003|Overall Study|Severe Non-compliance to Protocol|0|||
27971181|NCT02794285|54629077|FG000|Overall Study|Withdrawal by Subject|38|||
27971182|NCT02794285|54629078|FG001|Overall Study|Withdrawal by Subject|29|||
27971183|NCT02794285|54629079|FG002|Overall Study|Withdrawal by Subject|20|||
27971184|NCT02794285|54629080|FG003|Overall Study|Withdrawal by Subject|12|||
27971185|NCT02794285|54629077|FG000|Overall Study|Missing|1|||
27971186|NCT02794285|54629078|FG001|Overall Study|Missing|0|||
27971187|NCT02794285|54629079|FG002|Overall Study|Missing|0|||
27971188|NCT02794285|54629080|FG003|Overall Study|Missing|0|||
27971189|NCT02794285|54629077|FG000|Overall Study|Due to COVID-19 Pandemic|7|||
27971190|NCT02794285|54629078|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
27971191|NCT02794285|54629079|FG002|Overall Study|Due to COVID-19 Pandemic|4|||
27971192|NCT02794285|54629080|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
27971193|NCT02794285|54629077|FG000|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
27971194|NCT02794285|54629078|FG001|Overall Study|Other - Not Due to COVID-19 Pandemic|6|||
27971195|NCT02794285|54629079|FG002|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
27971196|NCT02794285|54629080|FG003|Overall Study|Other - Not Due to COVID-19 Pandemic|1|||
27971197|NCT00970268|54629092|FG000|Overall Study|Withdrawal by Subject|12|||
27971198|NCT00970268|54629093|FG001|Overall Study|Withdrawal by Subject|19|||
27971199|NCT00970268|54629092|FG000|Overall Study|Adverse Event|15|||
27971200|NCT00970268|54629093|FG001|Overall Study|Adverse Event|12|||
27971201|NCT00970268|54629092|FG000|Overall Study|Lack of Efficacy|3|||
27971202|NCT00970268|54629093|FG001|Overall Study|Lack of Efficacy|6|||
27971203|NCT00970268|54629092|FG000|Overall Study|Protocol Violation|4|||
27971204|NCT00970268|54629093|FG001|Overall Study|Protocol Violation|7|||
27971205|NCT00970268|54629092|FG000|Overall Study|Other Reason|3|||
27971206|NCT00970268|54629093|FG001|Overall Study|Other Reason|1|||
27971207|NCT00970268|54629092|FG000|Overall Study|COPD Exacerbation|4|||
27971208|NCT00970268|54629093|FG001|Overall Study|COPD Exacerbation|2|||
27971209|NCT00970268|54629092|FG000|Overall Study|Lost to Follow-up|1|||
27971210|NCT00970268|54629093|FG001|Overall Study|Lost to Follow-up|2|||
27971211|NCT00970268|54629092|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
27971212|NCT00970268|54629093|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
27971213|NCT00969332|54629105|FG000|Overall Study|Physician Decision|8|||
27971214|NCT00969332|54629105|FG000|Overall Study|Withdrawal by Subject|3|||
27971215|NCT00968864|54629110|FG000|Overall Study|Protocol exception/ not evaluable|1|||
27971216|NCT00758680|54629128|FG000|Overall Study|Adverse Event|0|||
27971217|NCT00758680|54629129|FG001|Overall Study|Adverse Event|0|||
27971218|NCT00758680|54629130|FG002|Overall Study|Adverse Event|0|||
27971219|NCT00758680|54629131|FG003|Overall Study|Adverse Event|0|||
27971220|NCT00758680|54629132|FG004|Overall Study|Adverse Event|0|||
27971221|NCT00758680|54629133|FG005|Overall Study|Adverse Event|0|||
27971222|NCT00758680|54629134|FG006|Overall Study|Adverse Event|0|||
27971223|NCT00758680|54629135|FG007|Overall Study|Adverse Event|1|||
27971224|NCT00758680|54629136|FG008|Overall Study|Adverse Event|0|||
27971225|NCT00758680|54629137|FG009|Overall Study|Adverse Event|1|||
28084789|NCT00077610|54738355|FG001|Overall Study|Renal transplant|15|||
27971226|NCT00758680|54629128|FG000|Overall Study|Laboratory Adverse Event|0|||
27971227|NCT00758680|54629129|FG001|Overall Study|Laboratory Adverse Event|0|||
27971228|NCT00758680|54629130|FG002|Overall Study|Laboratory Adverse Event|0|||
27971229|NCT00758680|54629131|FG003|Overall Study|Laboratory Adverse Event|0|||
27971230|NCT00758680|54629132|FG004|Overall Study|Laboratory Adverse Event|0|||
27971231|NCT00758680|54629133|FG005|Overall Study|Laboratory Adverse Event|0|||
27971232|NCT00758680|54629134|FG006|Overall Study|Laboratory Adverse Event|0|||
27971233|NCT00758680|54629135|FG007|Overall Study|Laboratory Adverse Event|0|||
27971234|NCT00758680|54629136|FG008|Overall Study|Laboratory Adverse Event|1|||
27971235|NCT00758680|54629137|FG009|Overall Study|Laboratory Adverse Event|0|||
27971236|NCT00758680|54629128|FG000|Overall Study|Withdrawal by Subject|0|||
27971237|NCT00758680|54629129|FG001|Overall Study|Withdrawal by Subject|0|||
27971238|NCT00758680|54629130|FG002|Overall Study|Withdrawal by Subject|0|||
27971239|NCT00758680|54629131|FG003|Overall Study|Withdrawal by Subject|0|||
27971240|NCT00758680|54629132|FG004|Overall Study|Withdrawal by Subject|0|||
27971241|NCT00758680|54629133|FG005|Overall Study|Withdrawal by Subject|0|||
27971242|NCT00758680|54629134|FG006|Overall Study|Withdrawal by Subject|1|||
27971243|NCT00758680|54629135|FG007|Overall Study|Withdrawal by Subject|0|||
27971244|NCT00758680|54629136|FG008|Overall Study|Withdrawal by Subject|1|||
27971245|NCT00758680|54629137|FG009|Overall Study|Withdrawal by Subject|0|||
27971246|NCT00758602|54629162|FG000|Overall Study|Adverse Event|11|||
27971247|NCT00758602|54629163|FG001|Overall Study|Adverse Event|10|||
27971248|NCT00758602|54629162|FG000|Overall Study|Lost to Follow-up|4|||
27971249|NCT00758602|54629163|FG001|Overall Study|Lost to Follow-up|3|||
27971250|NCT00758602|54629162|FG000|Overall Study|Withdrawal by Subject|1|||
27971251|NCT00758602|54629163|FG001|Overall Study|Withdrawal by Subject|3|||
27971252|NCT00758602|54629162|FG000|Overall Study|Protocol Violation|0|||
27971253|NCT00758602|54629163|FG001|Overall Study|Protocol Violation|2|||
27971254|NCT00758602|54629162|FG000|Overall Study|Death|0|||
27971255|NCT00758602|54629163|FG001|Overall Study|Death|1|||
27971256|NCT00758602|54629162|FG000|Overall Study|Reason not specified|3|||
28084790|NCT00077610|54738356|FG002|Overall Study|Renal transplant|11|||
28084791|NCT00077610|54738354|FG000|Overall Study|Withdrew from dialysis care|5|||
28084792|NCT00077610|54738355|FG001|Overall Study|Withdrew from dialysis care|0|||
28084793|NCT00077610|54738356|FG002|Overall Study|Withdrew from dialysis care|3|||
27971257|NCT00758602|54629163|FG001|Overall Study|Reason not specified|3|||
27971258|NCT00711529|54629172|FG000|Overall Study|Protocol Violation|2|||
28084794|NCT00077610|54738354|FG000|Overall Study|Insufficient Therapeutic Response|1|||
28084795|NCT00077610|54738355|FG001|Overall Study|Insufficient Therapeutic Response|0|||
28084796|NCT00077610|54738356|FG002|Overall Study|Insufficient Therapeutic Response|0|||
28084797|NCT00077610|54738354|FG000|Overall Study|Multiple blood transfusions|0|||
28084798|NCT00077610|54738355|FG001|Overall Study|Multiple blood transfusions|0|||
27971259|NCT00711529|54629173|FG001|Overall Study|Protocol Violation|0|||
27971260|NCT00711529|54629172|FG000|Overall Study|Withdrawal by Subject|2|||
27971261|NCT00711529|54629173|FG001|Overall Study|Withdrawal by Subject|6|||
27971262|NCT00601419|54629179|FG000|Overall Study|Lost to Follow-up|3|||
27971263|NCT00601419|54629179|FG000|Overall Study|Missed Visits|1|||
27971264|NCT00712933|54629199|FG000|Overall Study|Adverse Event|69|||
27971265|NCT00712933|54629199|FG000|Overall Study|Lack of Efficacy|6|||
27971266|NCT00712933|54629199|FG000|Overall Study|Lost to Follow-up|22|||
27971267|NCT00712933|54629199|FG000|Overall Study|Non-compliance with study drug|13|||
27971268|NCT00712933|54629199|FG000|Overall Study|Other Pregnancy|37|||
27971269|NCT00712933|54629199|FG000|Overall Study|Sponsor decision|14|||
27971270|NCT00712933|54629199|FG000|Overall Study|Withdrew consent|4|||
28084799|NCT00077610|54738356|FG002|Overall Study|Multiple blood transfusions|1|||
28084800|NCT00077610|54738354|FG000|Overall Study|Principal Investigator's decision|1|||
28084801|NCT00077610|54738355|FG001|Overall Study|Principal Investigator's decision|0|||
28084802|NCT00077610|54738356|FG002|Overall Study|Principal Investigator's decision|1|||
28084803|NCT00077610|54738354|FG000|Overall Study|Worsening of health condition|1|||
28084804|NCT00077610|54738355|FG001|Overall Study|Worsening of health condition|1|||
28084805|NCT00077610|54738356|FG002|Overall Study|Worsening of health condition|0|||
28084806|NCT00077610|54738354|FG000|Overall Study|Given Epogen in hospital|1|||
28084807|NCT00077610|54738355|FG001|Overall Study|Given Epogen in hospital|0|||
28084808|NCT00077610|54738356|FG002|Overall Study|Given Epogen in hospital|0|||
27832629|NCT04356963|54312122|FG000|Third Session|Lost to Follow-up|6|||
27832630|NCT04356963|54312122|FG000|Third Session|Withdrawal by Subject|1|||
27971271|NCT00712933|54629199|FG000|Overall Study|Hip replacement surgery|1|||
27971272|NCT00712933|54629199|FG000|Overall Study|Involved in Clinical research|3|||
27971273|NCT00712933|54629199|FG000|Overall Study|Participant hospitalized|1|||
27971274|NCT00712933|54629199|FG000|Overall Study|Participant travelled overseas|2|||
27971275|NCT00712933|54629199|FG000|Overall Study|Death of patient|1|||
28084809|NCT00077610|54738354|FG000|Overall Study|Transferred to other unit|0|||
28084810|NCT00077610|54738355|FG001|Overall Study|Transferred to other unit|0|||
28084811|NCT00077610|54738356|FG002|Overall Study|Transferred to other unit|1|||
28084812|NCT00077610|54738354|FG000|Overall Study|Transferred to nursing home|0|||
27971276|NCT00712933|54629199|FG000|Overall Study|Other Physician decision|1|||
27971277|NCT00712933|54629199|FG000|Overall Study|Not committed to contraception|1|||
27971278|NCT00712933|54629199|FG000|Overall Study|Participant received medication|1|||
27971279|NCT00712933|54629199|FG000|Overall Study|Physician Decision|36|||
27971280|NCT00712933|54629199|FG000|Overall Study|Protocol Violation|4|||
27971281|NCT00712933|54629199|FG000|Overall Study|Withdrawal by Subject|151|||
27971282|NCT00712543|54629209|FG000|Day 8-14|Lost to Follow-up|0|||
27971283|NCT00712543|54629210|FG001|Day 8-14|Lost to Follow-up|2|||
27971284|NCT00709111|54629216|FG000|Overall Study|Withdrawal by Subject|1|||
27971285|NCT00709111|54629216|FG000|Overall Study|Unable to attend clinic visits|1|||
27971286|NCT00710749|54629220|FG000|First Intervention|Withdrawal by Subject|1|||
27971287|NCT00710749|54629221|FG001|First Intervention|Withdrawal by Subject|0|||
27971288|NCT00699907|54629241|FG000|Overall Study|Withdrawal by Subject|2|||
27971289|NCT00699907|54629242|FG001|Overall Study|Withdrawal by Subject|1|||
27971290|NCT00699907|54629243|FG002|Overall Study|Withdrawal by Subject|0|||
27971291|NCT00699907|54629241|FG000|Overall Study|No usable sample|0|||
27971292|NCT00699907|54629242|FG001|Overall Study|No usable sample|9|||
27971293|NCT00699907|54629243|FG002|Overall Study|No usable sample|8|||
27971294|NCT00710593|54629253|FG000|Overall Study|Incarceration|1|||
27971295|NCT00710593|54629254|FG001|Overall Study|Incarceration|0|||
27971296|NCT00710593|54629253|FG000|Overall Study|Unable to complete Wk 48 within window|2|||
27971297|NCT00710593|54629254|FG001|Overall Study|Unable to complete Wk 48 within window|0|||
27971298|NCT00710593|54629253|FG000|Overall Study|Lost to Follow-up|3|||
27971299|NCT00710593|54629254|FG001|Overall Study|Lost to Follow-up|1|||
27971300|NCT00710593|54629253|FG000|Overall Study|Moved out of area|1|||
27971301|NCT00710593|54629254|FG001|Overall Study|Moved out of area|0|||
27971302|NCT00710593|54629253|FG000|Overall Study|Failure to adhere or complete study eval|1|||
27971303|NCT00710593|54629254|FG001|Overall Study|Failure to adhere or complete study eval|1|||
27971304|NCT00710593|54629253|FG000|Overall Study|Protocol Violation|1|||
27971305|NCT00710593|54629254|FG001|Overall Study|Protocol Violation|1|||
27971306|NCT00710593|54629253|FG000|Overall Study|Prem disc vaccine, completed all visits|6|||
27971307|NCT00710593|54629254|FG001|Overall Study|Prem disc vaccine, completed all visits|2|||
27971308|NCT00599313|54629276|FG000|Overall Study|Adverse Event|19|||
27971309|NCT00599313|54629276|FG000|Overall Study|Disease Progression|12|||
27971310|NCT00599313|54629276|FG000|Overall Study|Patient Request|4|||
27971311|NCT00599313|54629276|FG000|Overall Study|Ineligible|1|||
27971312|NCT00708175|54629282|FG000|Overall Study|Adverse Event|4|||
28084813|NCT00077610|54738355|FG001|Overall Study|Transferred to nursing home|0|||
28084814|NCT00077610|54738356|FG002|Overall Study|Transferred to nursing home|1|||
28084815|NCT00077610|54738354|FG000|Overall Study|Transfer to satellite unit|1|||
28084816|NCT00077610|54738355|FG001|Overall Study|Transfer to satellite unit|0|||
28084817|NCT00077610|54738356|FG002|Overall Study|Transfer to satellite unit|0|||
28084818|NCT00077610|54738354|FG000|Overall Study|Transfer to other center for surgery|1|||
28084819|NCT00077610|54738355|FG001|Overall Study|Transfer to other center for surgery|0|||
28084820|NCT00077610|54738356|FG002|Overall Study|Transfer to other center for surgery|0|||
28084821|NCT00077610|54738354|FG000|Overall Study|Change in dialysis modality|1|||
28084822|NCT00077610|54738355|FG001|Overall Study|Change in dialysis modality|0|||
28084823|NCT00077610|54738356|FG002|Overall Study|Change in dialysis modality|0|||
28084824|NCT00077610|54738354|FG000|Overall Study|Relocation|0|||
28084825|NCT00077610|54738355|FG001|Overall Study|Relocation|8|||
28084826|NCT00077610|54738356|FG002|Overall Study|Relocation|5|||
28084827|NCT00077610|54738354|FG000|Overall Study|Financial issues|0|||
28084828|NCT00077610|54738355|FG001|Overall Study|Financial issues|1|||
28084829|NCT00077610|54738356|FG002|Overall Study|Financial issues|0|||
28084830|NCT00077610|54738354|FG000|Overall Study|Sponsors decision to withdraw|0|||
28084831|NCT00077610|54738355|FG001|Overall Study|Sponsors decision to withdraw|0|||
28084832|NCT00077610|54738356|FG002|Overall Study|Sponsors decision to withdraw|1|||
28084833|NCT03385564|54738373|FG000|Overall Study|Adverse Event|0|||
28084834|NCT03385564|54738374|FG001|Overall Study|Adverse Event|0|||
28084835|NCT03385564|54738375|FG002|Overall Study|Adverse Event|3|||
28084836|NCT03385564|54738376|FG003|Overall Study|Adverse Event|3|||
28084837|NCT03385564|54738373|FG000|Overall Study|Other than listed|0|||
27832631|NCT03941483|54312135|FG000|Overall Study|Miscellaneous|2|||
27832632|NCT03941483|54312136|FG001|Overall Study|Miscellaneous|3|||
27832633|NCT03941483|54312137|FG002|Overall Study|Miscellaneous|0|||
27832634|NCT03941483|54312135|FG000|Overall Study|Study Terminated by Sponsor|1|||
27832635|NCT03941483|54312136|FG001|Overall Study|Study Terminated by Sponsor|0|||
27832636|NCT03941483|54312137|FG002|Overall Study|Study Terminated by Sponsor|0|||
27832637|NCT03941483|54312135|FG000|Overall Study|Withdrawal by Subject|1|||
27832638|NCT03941483|54312136|FG001|Overall Study|Withdrawal by Subject|4|||
27971313|NCT00708175|54629283|FG001|Overall Study|Adverse Event|5|||
28084838|NCT03385564|54738374|FG001|Overall Study|Other than listed|0|||
28084839|NCT03385564|54738375|FG002|Overall Study|Other than listed|0|||
28084840|NCT03385564|54738376|FG003|Overall Study|Other than listed|5|||
27832639|NCT03941483|54312137|FG002|Overall Study|Withdrawal by Subject|1|||
27832640|NCT03941483|54312135|FG000|Overall Study|Lost to Follow-up|2|||
27971314|NCT00708175|54629282|FG000|Overall Study|Protocol Violation|2|||
27971315|NCT00708175|54629283|FG001|Overall Study|Protocol Violation|3|||
27832641|NCT03941483|54312136|FG001|Overall Study|Lost to Follow-up|1|||
27832642|NCT03941483|54312137|FG002|Overall Study|Lost to Follow-up|8|||
27832643|NCT03941483|54312135|FG000|Overall Study|Death|3|||
27832644|NCT03941483|54312136|FG001|Overall Study|Death|2|||
27832645|NCT03941483|54312137|FG002|Overall Study|Death|6|||
27832646|NCT03689855|54312173|FG000|Overall Study|Adverse Event|3|||
27832647|NCT03689855|54312173|FG000|Overall Study|Withdrawal by Subject|1|||
27832648|NCT03635996|54312186|FG000|Overall Study|Study terminated by Sponsor|94|||
27832649|NCT03635996|54312186|FG000|Overall Study|Withdrawal by Subject|20|||
27832650|NCT03635996|54312186|FG000|Overall Study|Ablation|26|||
27832651|NCT03635996|54312186|FG000|Overall Study|Adverse Event|7|||
27832652|NCT03635996|54312186|FG000|Overall Study|Physician Decision|3|||
27832653|NCT03635996|54312186|FG000|Overall Study|Prohibited medication|5|||
27832654|NCT03635996|54312186|FG000|Overall Study|Did not meet eligibility criteria|5|||
27832655|NCT03635996|54312186|FG000|Overall Study|Site closure (2), compliance with IP, directed by sponsor and site termination.|5|||
28084841|NCT03385564|54738373|FG000|Overall Study|Withdrawal by Subject|0|||
28084842|NCT03385564|54738374|FG001|Overall Study|Withdrawal by Subject|1|||
28084843|NCT03385564|54738375|FG002|Overall Study|Withdrawal by Subject|1|||
28084844|NCT03385564|54738376|FG003|Overall Study|Withdrawal by Subject|0|||
27832656|NCT03635996|54312186|FG000|Overall Study|Protocol Violation|1|||
27832657|NCT03635996|54312186|FG000|Overall Study|Lost to Follow-up|1|||
27832658|NCT03595878|54312193|FG000|Overall Study|Death|2|||
27832659|NCT03595878|54312194|FG001|Overall Study|Death|1|||
27971316|NCT00708175|54629282|FG000|Overall Study|Lost to Follow-up|5|||
27971317|NCT00708175|54629283|FG001|Overall Study|Lost to Follow-up|3|||
27971318|NCT00708175|54629282|FG000|Overall Study|Withdrawal by Subject|5|||
27971319|NCT00708175|54629283|FG001|Overall Study|Withdrawal by Subject|7|||
27971320|NCT00708175|54629282|FG000|Overall Study|BMD loss >7%|2|||
27971321|NCT00708175|54629283|FG001|Overall Study|BMD loss >7%|3|||
27971322|NCT00707239|54629292|FG000|Overall Study|Adverse Event|5|||
27971323|NCT00707239|54629293|FG001|Overall Study|Adverse Event|3|||
27971324|NCT00707239|54629294|FG002|Overall Study|Adverse Event|2|||
27971325|NCT00707239|54629292|FG000|Overall Study|Death|3|||
27971326|NCT00707239|54629293|FG001|Overall Study|Death|1|||
27971327|NCT00707239|54629294|FG002|Overall Study|Death|3|||
27971328|NCT00707239|54629292|FG000|Overall Study|Physician Decision|1|||
27971329|NCT00707239|54629293|FG001|Overall Study|Physician Decision|1|||
27971330|NCT00707239|54629294|FG002|Overall Study|Physician Decision|2|||
27971331|NCT00707239|54629292|FG000|Overall Study|Protocol Violation|0|||
27971332|NCT00707239|54629293|FG001|Overall Study|Protocol Violation|0|||
27971333|NCT00707239|54629294|FG002|Overall Study|Protocol Violation|1|||
27971334|NCT00707239|54629292|FG000|Overall Study|Lack of Efficacy|1|||
27971335|NCT00707239|54629293|FG001|Overall Study|Lack of Efficacy|2|||
27971336|NCT00707239|54629294|FG002|Overall Study|Lack of Efficacy|0|||
27971337|NCT00707239|54629292|FG000|Overall Study|Randomized, but not treated|1|||
27971338|NCT00707239|54629293|FG001|Overall Study|Randomized, but not treated|1|||
27971339|NCT00707239|54629294|FG002|Overall Study|Randomized, but not treated|1|||
27971340|NCT00707239|54629292|FG000|Overall Study|Other|8|||
27971341|NCT00707239|54629293|FG001|Overall Study|Other|3|||
27971342|NCT00707239|54629294|FG002|Overall Study|Other|5|||
27971343|NCT00968708|54629307|FG000|Overall Study|Adverse Event|169|||
27971344|NCT00968708|54629308|FG001|Overall Study|Adverse Event|150|||
27971345|NCT00968708|54629307|FG000|Overall Study|Major Protocol Deviation|0|||
27971346|NCT00968708|54629308|FG001|Overall Study|Major Protocol Deviation|1|||
27971347|NCT00968708|54629307|FG000|Overall Study|Lost to Follow-up|19|||
27971348|NCT00968708|54629308|FG001|Overall Study|Lost to Follow-up|11|||
28084845|NCT03385564|54738373|FG000|Overall Study|Lack of Efficacy|0|||
28084846|NCT03385564|54738374|FG001|Overall Study|Lack of Efficacy|0|||
28084847|NCT03385564|54738375|FG002|Overall Study|Lack of Efficacy|0|||
28084848|NCT03385564|54738376|FG003|Overall Study|Lack of Efficacy|1|||
28084849|NCT03385564|54738373|FG000|Overall Study|Death|0|||
28084850|NCT03385564|54738374|FG001|Overall Study|Death|0|||
28084851|NCT03385564|54738375|FG002|Overall Study|Death|1|||
27971349|NCT00968708|54629307|FG000|Overall Study|Voluntary Withdrawal|104|||
27971350|NCT00968708|54629308|FG001|Overall Study|Voluntary Withdrawal|101|||
27832660|NCT03595878|54312195|FG002|Overall Study|Death|0|||
27971351|NCT00968708|54629307|FG000|Overall Study|Investigator Discretion|0|||
27971352|NCT00968708|54629308|FG001|Overall Study|Investigator Discretion|1|||
27971353|NCT00968708|54629307|FG000|Overall Study|Other|26|||
27971354|NCT00968708|54629308|FG001|Overall Study|Other|34|||
28084852|NCT03385564|54738376|FG003|Overall Study|Death|0|||
28084853|NCT00066222|54738386|FG000|Overall Study|No protocol treatment received|1|||
27971355|NCT00967694|54629314|FG000|Overall Study|Withdrawal by Subject|6|||
27971356|NCT00967616|54629320|FG000|Overall Study|Adverse Event or Serious Adverse Event|2|||
27971357|NCT00967616|54629321|FG001|Overall Study|Adverse Event or Serious Adverse Event|17|||
27832661|NCT03595878|54312193|FG000|Overall Study|Disease progression|2|||
28084854|NCT00397943|54738395|FG000|Overall Study|Unspecified reasons|12|||
27832662|NCT03595878|54312194|FG001|Overall Study|Disease progression|1|||
27971358|NCT00967616|54629320|FG000|Overall Study|Death|0|||
28084855|NCT00397943|54738396|FG001|Overall Study|Unspecified reasons|9|||
28084856|NCT00397943|54738397|FG002|Overall Study|Unspecified reasons|0|||
28084857|NCT00397943|54738398|FG003|Overall Study|Unspecified reasons|0|||
28084858|NCT00397943|54738399|FG004|Overall Study|Unspecified reasons|0|||
28084859|NCT00066066|54738414|FG000|Overall Study|Lost to Follow-up|6|||
28084860|NCT00066066|54738415|FG001|Overall Study|Lost to Follow-up|4|||
28084861|NCT00066066|54738416|FG002|Overall Study|Lost to Follow-up|7|||
28084862|NCT00066066|54738417|FG003|Overall Study|Lost to Follow-up|4|||
28084863|NCT00066066|54738418|FG004|Overall Study|Lost to Follow-up|3|||
28084864|NCT00066066|54738419|FG005|Overall Study|Lost to Follow-up|5|||
28084865|NCT00363467|54738433|FG000|Overall Study|Physician Decision|1|||
28084866|NCT00397631|54738439|FG000|Overall Study|Adverse Event|5|||
28084867|NCT00397631|54738440|FG001|Overall Study|Adverse Event|6|||
28084868|NCT00397631|54738439|FG000|Overall Study|Lack of Efficacy|7|||
28084869|NCT00397631|54738440|FG001|Overall Study|Lack of Efficacy|10|||
27971359|NCT00967616|54629321|FG001|Overall Study|Death|3|||
27971360|NCT00967616|54629320|FG000|Overall Study|Withdrawal by Subject|8|||
27971361|NCT00967616|54629321|FG001|Overall Study|Withdrawal by Subject|4|||
27971362|NCT00967616|54629320|FG000|Overall Study|Progressive Disease|31|||
27971363|NCT00967616|54629321|FG001|Overall Study|Progressive Disease|18|||
27971364|NCT00967616|54629320|FG000|Overall Study|Other|8|||
27971365|NCT00967616|54629321|FG001|Overall Study|Other|8|||
27971366|NCT00967616|54629320|FG000|Overall Study|Protocol Violation|1|||
27971367|NCT00967616|54629321|FG001|Overall Study|Protocol Violation|0|||
27971368|NCT00971204|54629331|FG000|Overall Study|Did not meet all criteria-not treated|14|||
27971369|NCT00971204|54629331|FG000|Overall Study|Lost to Follow-up|10|||
27971370|NCT03107793|54629335|FG000|Induction Period (16 Weeks)|Adverse Event|5|||
27971371|NCT03107793|54629336|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
27971372|NCT03107793|54629337|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
27971373|NCT03107793|54629338|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
27971374|NCT03107793|54629339|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
27971375|NCT03107793|54629335|FG000|Induction Period (16 Weeks)|Physician Decision|1|||
27971376|NCT03107793|54629336|FG001|Induction Period (16 Weeks)|Physician Decision|0|||
27971377|NCT03107793|54629337|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
27971378|NCT03107793|54629338|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
27971379|NCT03107793|54629339|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
27971380|NCT03107793|54629335|FG000|Induction Period (16 Weeks)|Progressive disease|1|||
27971381|NCT03107793|54629336|FG001|Induction Period (16 Weeks)|Progressive disease|0|||
27971382|NCT03107793|54629337|FG002|Induction Period (16 Weeks)|Progressive disease|0|||
27971383|NCT03107793|54629338|FG003|Induction Period (16 Weeks)|Progressive disease|0|||
27971384|NCT03107793|54629339|FG004|Induction Period (16 Weeks)|Progressive disease|0|||
27971385|NCT03107793|54629335|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
27971386|NCT03107793|54629336|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
27971387|NCT03107793|54629337|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
27971388|NCT03107793|54629338|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
27971389|NCT03107793|54629339|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
27971390|NCT03107793|54629335|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
27971391|NCT03107793|54629336|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|6|||
27971392|NCT03107793|54629337|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|10|||
27971393|NCT03107793|54629338|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
27971394|NCT03107793|54629339|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
27971395|NCT03107793|54629335|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
27971396|NCT03107793|54629336|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
27971397|NCT03107793|54629337|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|2|||
27971398|NCT03107793|54629338|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
27971399|NCT03107793|54629339|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
27971400|NCT03107793|54629335|FG000|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
27971401|NCT03107793|54629336|FG001|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
27971402|NCT03107793|54629337|FG002|Maintenance Period (Week 16-Week 48)|Progressive disease|1|||
27971403|NCT03107793|54629338|FG003|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
27971404|NCT03107793|54629339|FG004|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
27971405|NCT03107793|54629335|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
27971406|NCT03107793|54629336|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|21|||
27971407|NCT03107793|54629337|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|8|||
27971408|NCT03107793|54629338|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
27971409|NCT03107793|54629339|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
28084870|NCT00397631|54738439|FG000|Overall Study|Lost to Follow-up|8|||
28084871|NCT00397631|54738440|FG001|Overall Study|Lost to Follow-up|9|||
28084872|NCT00397631|54738439|FG000|Overall Study|Physician Decision|2|||
28084873|NCT00397631|54738440|FG001|Overall Study|Physician Decision|0|||
28084874|NCT00397631|54738439|FG000|Overall Study|Protocol Violation|0|||
28084875|NCT00397631|54738440|FG001|Overall Study|Protocol Violation|1|||
28084876|NCT00397631|54738439|FG000|Overall Study|Withdrawal by Subject|7|||
27971410|NCT03107793|54629335|FG000|Maintenance Period (Week 16-Week 48)|Death|0|||
27971411|NCT03107793|54629336|FG001|Maintenance Period (Week 16-Week 48)|Death|2|||
27971412|NCT03107793|54629337|FG002|Maintenance Period (Week 16-Week 48)|Death|0|||
27832663|NCT03595878|54312195|FG002|Overall Study|Disease progression|2|||
27832664|NCT03168464|54312241|FG000|Overall Study|Death|9|||
27971413|NCT03107793|54629338|FG003|Maintenance Period (Week 16-Week 48)|Death|0|||
27971414|NCT03107793|54629339|FG004|Maintenance Period (Week 16-Week 48)|Death|0|||
27971415|NCT03107793|54629335|FG000|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
27971416|NCT03107793|54629336|FG001|Maintenance Period (Week 16-Week 48)|Disease relapse|2|||
27971417|NCT03107793|54629337|FG002|Maintenance Period (Week 16-Week 48)|Disease relapse|1|||
27971418|NCT03107793|54629338|FG003|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
27971419|NCT03107793|54629339|FG004|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
27971420|NCT03107793|54629335|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
27971421|NCT03107793|54629336|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
27971422|NCT03107793|54629337|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
27971423|NCT03107793|54629338|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
27971424|NCT03107793|54629339|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
27971425|NCT03107793|54629335|FG000|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
27971426|NCT03107793|54629336|FG001|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
27971427|NCT03107793|54629337|FG002|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
27971428|NCT03107793|54629338|FG003|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
27971429|NCT03107793|54629339|FG004|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
27971430|NCT03107793|54629335|FG000|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
27971431|NCT03107793|54629336|FG001|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
27971432|NCT03107793|54629337|FG002|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|1|||
27971433|NCT03107793|54629338|FG003|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
27971434|NCT03107793|54629339|FG004|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
27971435|NCT03107793|54629335|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
27971436|NCT03107793|54629336|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|12|||
27971437|NCT03107793|54629337|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
27971438|NCT03107793|54629338|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
27971439|NCT03107793|54629339|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
27971440|NCT03107793|54629335|FG000|Extension Period (Week 48- Week 104)|Adverse Event|0|||
27971441|NCT03107793|54629336|FG001|Extension Period (Week 48- Week 104)|Adverse Event|0|||
27971442|NCT03107793|54629337|FG002|Extension Period (Week 48- Week 104)|Adverse Event|0|||
27971443|NCT03107793|54629338|FG003|Extension Period (Week 48- Week 104)|Adverse Event|10|||
27971444|NCT03107793|54629339|FG004|Extension Period (Week 48- Week 104)|Adverse Event|3|||
27971445|NCT03107793|54629335|FG000|Extension Period (Week 48- Week 104)|Physician Decision|0|||
27971446|NCT03107793|54629336|FG001|Extension Period (Week 48- Week 104)|Physician Decision|0|||
27971447|NCT03107793|54629337|FG002|Extension Period (Week 48- Week 104)|Physician Decision|0|||
27971448|NCT03107793|54629338|FG003|Extension Period (Week 48- Week 104)|Physician Decision|0|||
27971449|NCT03107793|54629339|FG004|Extension Period (Week 48- Week 104)|Physician Decision|2|||
27971450|NCT03107793|54629335|FG000|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
27971451|NCT03107793|54629336|FG001|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
27971452|NCT03107793|54629337|FG002|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
27971453|NCT03107793|54629338|FG003|Extension Period (Week 48- Week 104)|Lack of Efficacy|8|||
27971454|NCT03107793|54629339|FG004|Extension Period (Week 48- Week 104)|Lack of Efficacy|9|||
27971455|NCT03107793|54629335|FG000|Extension Period (Week 48- Week 104)|Death|0|||
27971456|NCT03107793|54629336|FG001|Extension Period (Week 48- Week 104)|Death|0|||
27971457|NCT03107793|54629337|FG002|Extension Period (Week 48- Week 104)|Death|0|||
27971458|NCT03107793|54629338|FG003|Extension Period (Week 48- Week 104)|Death|0|||
27971459|NCT03107793|54629339|FG004|Extension Period (Week 48- Week 104)|Death|1|||
27971460|NCT03107793|54629335|FG000|Extension Period (Week 48- Week 104)|Disease relapse|0|||
27971461|NCT03107793|54629336|FG001|Extension Period (Week 48- Week 104)|Disease relapse|0|||
27971462|NCT03107793|54629337|FG002|Extension Period (Week 48- Week 104)|Disease relapse|0|||
27971463|NCT03107793|54629338|FG003|Extension Period (Week 48- Week 104)|Disease relapse|0|||
27971464|NCT03107793|54629339|FG004|Extension Period (Week 48- Week 104)|Disease relapse|3|||
27971465|NCT03107793|54629335|FG000|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
27971466|NCT03107793|54629336|FG001|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
27971467|NCT03107793|54629337|FG002|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
27971468|NCT03107793|54629338|FG003|Extension Period (Week 48- Week 104)|Lost to Follow-up|1|||
27971469|NCT03107793|54629339|FG004|Extension Period (Week 48- Week 104)|Lost to Follow-up|2|||
27971470|NCT03107793|54629335|FG000|Extension Period (Week 48- Week 104)|Pregnancy|0|||
27971471|NCT03107793|54629336|FG001|Extension Period (Week 48- Week 104)|Pregnancy|0|||
27971472|NCT03107793|54629337|FG002|Extension Period (Week 48- Week 104)|Pregnancy|0|||
27832665|NCT03168464|54312241|FG000|Overall Study|Progression of disease|6|||
27832666|NCT02818920|54312245|FG000|Overall Study|Unresectable|4|||
27971473|NCT03107793|54629338|FG003|Extension Period (Week 48- Week 104)|Pregnancy|2|||
27971474|NCT03107793|54629339|FG004|Extension Period (Week 48- Week 104)|Pregnancy|4|||
27971475|NCT03107793|54629335|FG000|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
27971476|NCT03107793|54629336|FG001|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
27971477|NCT03107793|54629337|FG002|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
27971478|NCT03107793|54629338|FG003|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
27971479|NCT03107793|54629339|FG004|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|1|||
27971480|NCT03107793|54629335|FG000|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
27971481|NCT03107793|54629336|FG001|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
27971482|NCT03107793|54629337|FG002|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
27971483|NCT03107793|54629338|FG003|Extension Period (Week 48- Week 104)|Non-compliance with study drug|1|||
27971484|NCT03107793|54629339|FG004|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
27971485|NCT03107793|54629335|FG000|Extension Period (Week 48- Week 104)|Other|0|||
27971486|NCT03107793|54629336|FG001|Extension Period (Week 48- Week 104)|Other|0|||
27971487|NCT03107793|54629337|FG002|Extension Period (Week 48- Week 104)|Other|0|||
27971488|NCT03107793|54629338|FG003|Extension Period (Week 48- Week 104)|Other|1|||
27971489|NCT03107793|54629339|FG004|Extension Period (Week 48- Week 104)|Other|3|||
27971490|NCT03107793|54629335|FG000|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
27971491|NCT03107793|54629336|FG001|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
27971492|NCT03107793|54629337|FG002|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
27971493|NCT03107793|54629338|FG003|Extension Period (Week 48- Week 104)|Withdrawal by Subject|5|||
27971494|NCT03107793|54629339|FG004|Extension Period (Week 48- Week 104)|Withdrawal by Subject|9|||
27971495|NCT00974090|54629350|FG000|Period 1: Double Blind Period|Adverse Event|2|||
27971496|NCT00974090|54629351|FG001|Period 1: Double Blind Period|Adverse Event|1|||
27971497|NCT00974090|54629350|FG000|Period 1: Double Blind Period|Physician Decision|1|||
27971498|NCT00974090|54629351|FG001|Period 1: Double Blind Period|Physician Decision|0|||
27971499|NCT00974090|54629350|FG000|Period 2: Open-label Period|Adverse Event|4|||
27971500|NCT00974090|54629351|FG001|Period 2: Open-label Period|Adverse Event|6|||
27971501|NCT00974090|54629350|FG000|Period 2: Open-label Period|Lack of Efficacy|3|||
27971502|NCT00974090|54629351|FG001|Period 2: Open-label Period|Lack of Efficacy|1|||
28084877|NCT00397631|54738440|FG001|Overall Study|Withdrawal by Subject|14|||
28084878|NCT00397631|54738439|FG000|Overall Study|protocol discontinuation criteria|1|||
28084879|NCT00397631|54738440|FG001|Overall Study|protocol discontinuation criteria|4|||
28084880|NCT00077376|54738446|FG000|Overall Study|Adverse Event|8|||
28084881|NCT00077376|54738446|FG000|Overall Study|Withdrawal by Subject|2|||
28084882|NCT00077376|54738446|FG000|Overall Study|Death|1|||
28084883|NCT00077376|54738446|FG000|Overall Study|Physician Decision|1|||
28084884|NCT00077376|54738446|FG000|Overall Study|Alternative therapy|5|||
28084885|NCT00077376|54738446|FG000|Overall Study|Complicating disease|1|||
28084886|NCT00077376|54738446|FG000|Overall Study|Still on treatment|1|||
28084887|NCT00077376|54738446|FG000|Overall Study|Symptomatic deterioration|1|||
28084888|NCT00077376|54738446|FG000|Overall Study|Surgery|1|||
28084889|NCT00077376|54738446|FG000|Overall Study|Insurance ran out|1|||
28084890|NCT03406156|54738452|FG000|Overall Study|Death|6|||
28084891|NCT03406156|54738453|FG001|Overall Study|Death|2|||
28084892|NCT03406156|54738452|FG000|Overall Study|Withdrawal by Subject|0|||
28084893|NCT03406156|54738453|FG001|Overall Study|Withdrawal by Subject|2|||
28084894|NCT03406156|54738452|FG000|Overall Study|COVID-19 infection|1|||
28084895|NCT03406156|54738453|FG001|Overall Study|COVID-19 infection|0|||
28084896|NCT03406156|54738452|FG000|Overall Study|Non-compliance with study procedures|0|||
28084897|NCT03406156|54738453|FG001|Overall Study|Non-compliance with study procedures|1|||
28084898|NCT03406156|54738452|FG000|Overall Study|Other, not specified|0|||
28084899|NCT03406156|54738453|FG001|Overall Study|Other, not specified|1|||
28084900|NCT00363311|54738463|FG000|Overall Study|Adverse Event|6|||
28084901|NCT00363311|54738464|FG001|Overall Study|Adverse Event|4|||
27732935|NCT00705783|54180681|FG002|Conversion Phase|Withdrawn by Investigator|0|||
27971503|NCT00974090|54629350|FG000|Period 2: Open-label Period|Physician Decision|0|||
27971504|NCT00974090|54629351|FG001|Period 2: Open-label Period|Physician Decision|3|||
27971505|NCT00974090|54629350|FG000|Period 2: Open-label Period|Withdrawal by Subject|1|||
28084902|NCT00363311|54738463|FG000|Overall Study|Lost to Follow-up|3|||
28084903|NCT00363311|54738464|FG001|Overall Study|Lost to Follow-up|0|||
28084904|NCT00363311|54738463|FG000|Overall Study|Protocol Violation|1|||
28084905|NCT00363311|54738464|FG001|Overall Study|Protocol Violation|2|||
28084906|NCT00363311|54738463|FG000|Overall Study|Withdrawal by Subject|12|||
28084907|NCT00363311|54738464|FG001|Overall Study|Withdrawal by Subject|6|||
28084908|NCT00363311|54738463|FG000|Overall Study|Physician Decision|1|||
28084909|NCT00363311|54738464|FG001|Overall Study|Physician Decision|1|||
28084910|NCT00363311|54738463|FG000|Overall Study|Sponsor Terminated Study|2|||
28084911|NCT00363311|54738464|FG001|Overall Study|Sponsor Terminated Study|2|||
28084912|NCT00363311|54738463|FG000|Overall Study|Disease Progression|46|||
28084913|NCT00363311|54738464|FG001|Overall Study|Disease Progression|26|||
27971506|NCT00974090|54629351|FG001|Period 2: Open-label Period|Withdrawal by Subject|0|||
27971507|NCT00971048|54629363|FG000|Overall Study|Protocol Violation|1|||
27971508|NCT00971048|54629364|FG001|Overall Study|Protocol Violation|2|||
27971509|NCT00971048|54629365|FG002|Overall Study|Protocol Violation|0|||
27971510|NCT00971048|54629366|FG003|Overall Study|Protocol Violation|1|||
27971511|NCT00971048|54629363|FG000|Overall Study|Adverse Event|0|||
27971512|NCT00971048|54629364|FG001|Overall Study|Adverse Event|0|||
27971513|NCT00971048|54629365|FG002|Overall Study|Adverse Event|1|||
27971514|NCT00971048|54629366|FG003|Overall Study|Adverse Event|0|||
27971515|NCT00971048|54629363|FG000|Overall Study|Physician Decision|0|||
27971516|NCT00971048|54629364|FG001|Overall Study|Physician Decision|0|||
27971517|NCT00971048|54629365|FG002|Overall Study|Physician Decision|0|||
27971518|NCT00971048|54629366|FG003|Overall Study|Physician Decision|1|||
27971519|NCT00699751|54629380|FG000|Period 1: Without/Before Drug Switch|Investigator Request|27|||
27971520|NCT00699751|54629381|FG001|Period 1: Without/Before Drug Switch|Investigator Request|27|||
27971521|NCT00699751|54629380|FG000|Period 1: Without/Before Drug Switch|Death|28|||
27971522|NCT00699751|54629381|FG001|Period 1: Without/Before Drug Switch|Death|29|||
27971523|NCT00699751|54629380|FG000|Period 1: Without/Before Drug Switch|Subject Request|43|||
27971524|NCT00699751|54629381|FG001|Period 1: Without/Before Drug Switch|Subject Request|23|||
27971525|NCT00699751|54629380|FG000|Period 1: Without/Before Drug Switch|Other|30|||
27971526|NCT00699751|54629381|FG001|Period 1: Without/Before Drug Switch|Other|20|||
27971527|NCT00699751|54629380|FG000|Period 1: Without/Before Drug Switch|Adverse Event|97|||
27971528|NCT00699751|54629381|FG001|Period 1: Without/Before Drug Switch|Adverse Event|63|||
27971529|NCT00699751|54629380|FG000|Period 2:Switched From Placebo to Xofigo|Adverse Event|0|||
27971530|NCT00699751|54629381|FG001|Period 2:Switched From Placebo to Xofigo|Adverse Event|4|||
28084914|NCT00363311|54738463|FG000|Overall Study|Non-Compliance|1|||
28084915|NCT00363311|54738464|FG001|Overall Study|Non-Compliance|1|||
28084916|NCT00363311|54738463|FG000|Overall Study|Participant Refused Biopsy|1|||
28084917|NCT00363311|54738464|FG001|Overall Study|Participant Refused Biopsy|0|||
28084918|NCT00363311|54738463|FG000|Overall Study|Prostate Volume/PSA Doubled|1|||
28084919|NCT00363311|54738464|FG001|Overall Study|Prostate Volume/PSA Doubled|0|||
28084920|NCT00363311|54738463|FG000|Overall Study|Participant Opted for Treatment|1|||
28084921|NCT00363311|54738464|FG001|Overall Study|Participant Opted for Treatment|0|||
28084922|NCT00363311|54738463|FG000|Overall Study|Participant Moved to Another Country|1|||
28084923|NCT00363311|54738464|FG001|Overall Study|Participant Moved to Another Country|0|||
28084924|NCT00363311|54738463|FG000|Overall Study|Participant Withdrew Waiting for Surgery|0|||
28084925|NCT00363311|54738464|FG001|Overall Study|Participant Withdrew Waiting for Surgery|1|||
28084926|NCT00363311|54738463|FG000|Overall Study|Withdrawn per Instructions of Monitor|0|||
28084927|NCT00363311|54738464|FG001|Overall Study|Withdrawn per Instructions of Monitor|1|||
27971531|NCT00699751|54629380|FG000|Period 2:Switched From Placebo to Xofigo|Investigator Request|0|||
27971532|NCT00699751|54629381|FG001|Period 2:Switched From Placebo to Xofigo|Investigator Request|1|||
28084928|NCT00363311|54738463|FG000|Overall Study|Participant Moved to Louisiana|0|||
28084929|NCT00363311|54738464|FG001|Overall Study|Participant Moved to Louisiana|1|||
28084930|NCT00362609|54738472|FG000|Overall Study|Withdrawal by Subject|0|||
28084931|NCT00362609|54738473|FG001|Overall Study|Withdrawal by Subject|1|||
28084932|NCT00362609|54738472|FG000|Overall Study|Protocol Violation|0|||
28084933|NCT00362609|54738473|FG001|Overall Study|Protocol Violation|1|||
28084934|NCT00362375|54738481|FG000|Overall Study|Lost to Follow-up|40|||
28084935|NCT00362375|54738482|FG001|Overall Study|Lost to Follow-up|35|||
28084936|NCT00362297|54738490|FG000|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0|||
28084937|NCT00362297|54738491|FG001|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4|||
28084938|NCT00065442|54738499|FG000|Overall Study|Lost to Follow-up|1|||
28084939|NCT00065442|54738500|FG001|Overall Study|Lost to Follow-up|1|||
28084940|NCT00065442|54738499|FG000|Overall Study|Death|121|||
28084941|NCT00065442|54738500|FG001|Overall Study|Death|210|||
28084942|NCT00065442|54738499|FG000|Overall Study|Withdrawal by Subject|3|||
27971533|NCT00699751|54629380|FG000|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0|||
28084943|NCT00065442|54738500|FG001|Overall Study|Withdrawal by Subject|9|||
28084944|NCT00090402|54738509|FG000|Overall Study|Death|1|||
28084945|NCT00090402|54738510|FG001|Overall Study|Death|1|||
28084946|NCT00090402|54738511|FG002|Overall Study|Death|0|||
28084947|NCT00090402|54738509|FG000|Overall Study|subject moved|0|||
28084948|NCT00090402|54738510|FG001|Overall Study|subject moved|1|||
28084949|NCT00090402|54738511|FG002|Overall Study|subject moved|0|||
28084950|NCT00090402|54738509|FG000|Overall Study|stopped taking study medication|1|||
28084951|NCT00090402|54738510|FG001|Overall Study|stopped taking study medication|0|||
28084952|NCT00090402|54738511|FG002|Overall Study|stopped taking study medication|1|||
28084953|NCT00361283|54738522|FG000|Overall Study|Lost to Follow-up|27|||
28084954|NCT00077064|54738528|FG000|Overall Study|Adverse Event|0|||
27971534|NCT00699751|54629381|FG001|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4|||
28084955|NCT00077064|54738529|FG001|Overall Study|Adverse Event|4|||
28084956|NCT00077064|54738528|FG000|Overall Study|Patient refusal|0|||
28084957|NCT00077064|54738529|FG001|Overall Study|Patient refusal|2|||
28084958|NCT00396383|54738536|FG000|Overall Study|Death|2|||
28084959|NCT00396383|54738536|FG000|Overall Study|Lost to Follow-up|1|||
28084960|NCT00395447|54738542|FG000|Overall Study|Death|37|||
28084961|NCT00395447|54738543|FG001|Overall Study|Death|32|||
28084962|NCT00395447|54738542|FG000|Overall Study|Lost to Follow-up|52|||
28084963|NCT00395447|54738543|FG001|Overall Study|Lost to Follow-up|43|||
28084964|NCT00395447|54738542|FG000|Overall Study|Withdrawal by Subject|24|||
28084965|NCT00395447|54738543|FG001|Overall Study|Withdrawal by Subject|19|||
28084966|NCT00395447|54738542|FG000|Overall Study|Withdrawl - Other (not subject)|8|||
28084967|NCT00395447|54738543|FG001|Overall Study|Withdrawl - Other (not subject)|17|||
28084968|NCT03404674|54738555|FG000|Overall Study|Inability to Attend Future Visits|0|||
28084969|NCT03404674|54738556|FG001|Overall Study|Inability to Attend Future Visits|1|||
28084970|NCT03404674|54738557|FG002|Overall Study|Inability to Attend Future Visits|1|||
28084971|NCT03404674|54738558|FG003|Overall Study|Inability to Attend Future Visits|0|||
28084972|NCT03404674|54738559|FG004|Overall Study|Inability to Attend Future Visits|0|||
28084973|NCT03404674|54738560|FG005|Overall Study|Inability to Attend Future Visits|0|||
28084974|NCT03404674|54738555|FG000|Overall Study|Behavioral Problems|0|||
28084975|NCT03404674|54738556|FG001|Overall Study|Behavioral Problems|0|||
28084976|NCT03404674|54738557|FG002|Overall Study|Behavioral Problems|1|||
28084977|NCT03404674|54738558|FG003|Overall Study|Behavioral Problems|0|||
28084978|NCT03404674|54738559|FG004|Overall Study|Behavioral Problems|0|||
28084979|NCT03404674|54738560|FG005|Overall Study|Behavioral Problems|0|||
28084980|NCT03404674|54738555|FG000|Overall Study|Started a Medication that Precluded Eligibility|0|||
28084981|NCT03404674|54738556|FG001|Overall Study|Started a Medication that Precluded Eligibility|0|||
28084982|NCT03404674|54738557|FG002|Overall Study|Started a Medication that Precluded Eligibility|0|||
28165316|NCT02909101|54836009|FG000|Overall Study|Lost to Follow-up|1|||
28165317|NCT02909101|54836010|FG001|Overall Study|Lost to Follow-up|1|||
28165318|NCT03004469|54836019|FG000|Overall Study|Adverse Event|6|||
28165319|NCT03004469|54836020|FG001|Overall Study|Adverse Event|4|||
28165320|NCT03004469|54836021|FG002|Overall Study|Adverse Event|6|||
28165321|NCT03004469|54836019|FG000|Overall Study|Lack of Efficacy|1|||
27732936|NCT00705783|54180679|FG000|Conversion Phase|Withdrew Consent|24|||
27855512|NCT00242567|54378764|FG000|Overall Study|Symptomatic deterioration|9|||
27855513|NCT00242567|54378765|FG001|Overall Study|Symptomatic deterioration|3|||
27855514|NCT00242567|54378764|FG000|Overall Study|Lack of Efficacy|2|||
27855515|NCT00242567|54378765|FG001|Overall Study|Lack of Efficacy|2|||
27971535|NCT00970502|54629388|FG000|Overall Study|Withdrawal by Subject|1|||
27971536|NCT00967226|54629398|FG000|Overall Study|Adverse Event|0|||
27971537|NCT00967226|54629399|FG001|Overall Study|Adverse Event|5|||
27971538|NCT00967226|54629398|FG000|Overall Study|Protocol Violation|2|||
27971539|NCT00967226|54629399|FG001|Overall Study|Protocol Violation|0|||
27971540|NCT00967226|54629398|FG000|Overall Study|Physician Decision|0|||
27971541|NCT00967226|54629399|FG001|Overall Study|Physician Decision|1|||
27971542|NCT00706381|54629433|FG000|Overall Study|Lost to Follow-up|0|||
27971543|NCT00706381|54629434|FG001|Overall Study|Lost to Follow-up|1|||
27971544|NCT00706381|54629435|FG002|Overall Study|Lost to Follow-up|1|||
27971545|NCT00706381|54629436|FG003|Overall Study|Lost to Follow-up|0|||
27971546|NCT00964886|54629453|FG000|Overall Study|Lost to Follow-up|2|||
27971547|NCT00964886|54629454|FG001|Overall Study|Lost to Follow-up|2|||
27971548|NCT00964886|54629455|FG002|Overall Study|Lost to Follow-up|6|||
27971549|NCT00964886|54629456|FG003|Overall Study|Lost to Follow-up|4|||
27971550|NCT00964886|54629453|FG000|Overall Study|Withdrawal by Subject|6|||
27971551|NCT00964886|54629454|FG001|Overall Study|Withdrawal by Subject|2|||
27971552|NCT00964886|54629455|FG002|Overall Study|Withdrawal by Subject|5|||
27971553|NCT00964886|54629456|FG003|Overall Study|Withdrawal by Subject|3|||
27971554|NCT00964886|54629453|FG000|Overall Study|Adverse Event|3|||
27971555|NCT00964886|54629454|FG001|Overall Study|Adverse Event|1|||
27971556|NCT00964886|54629455|FG002|Overall Study|Adverse Event|5|||
27971557|NCT00964886|54629456|FG003|Overall Study|Adverse Event|2|||
27971558|NCT00964886|54629453|FG000|Overall Study|Protocol Violation|0|||
27855516|NCT00242567|54378764|FG000|Overall Study|Lost to Follow-up|9|||
27855517|NCT00242567|54378765|FG001|Overall Study|Lost to Follow-up|19|||
27855518|NCT00242567|54378764|FG000|Overall Study|Withdrawal by Subject|33|||
27971559|NCT00964886|54629454|FG001|Overall Study|Protocol Violation|2|||
27971560|NCT00964886|54629455|FG002|Overall Study|Protocol Violation|0|||
27971561|NCT00964886|54629456|FG003|Overall Study|Protocol Violation|0|||
27971562|NCT00705757|54629473|FG000|Overall Study|Lack of Efficacy|5|||
28165322|NCT03004469|54836020|FG001|Overall Study|Lack of Efficacy|0|||
27971563|NCT00705757|54629474|FG001|Overall Study|Lack of Efficacy|1|||
27971564|NCT00705757|54629475|FG002|Overall Study|Lack of Efficacy|3|||
27732937|NCT00705783|54180680|FG001|Conversion Phase|Withdrew Consent|0|||
27971565|NCT00705757|54629473|FG000|Overall Study|Lost to Follow-up|7|||
27971566|NCT00705757|54629474|FG001|Overall Study|Lost to Follow-up|6|||
27732938|NCT00705783|54180681|FG002|Conversion Phase|Withdrew Consent|0|||
27971567|NCT00705757|54629475|FG002|Overall Study|Lost to Follow-up|6|||
27971568|NCT00705757|54629473|FG000|Overall Study|Withdrawal by Subject|1|||
28165323|NCT03004469|54836021|FG002|Overall Study|Lack of Efficacy|1|||
27732939|NCT00705783|54180679|FG000|Conversion Phase|Protocol Deviation|2|||
27971569|NCT00705757|54629474|FG001|Overall Study|Withdrawal by Subject|1|||
27971570|NCT00705757|54629475|FG002|Overall Study|Withdrawal by Subject|2|||
27971571|NCT00960752|54629503|FG000|Overall Study|Adverse Event|0|||
27971572|NCT00960752|54629504|FG001|Overall Study|Adverse Event|0|||
27971573|NCT00960752|54629505|FG002|Overall Study|Adverse Event|1|||
27971574|NCT00960752|54629503|FG000|Overall Study|Progression|0|||
27971575|NCT00960752|54629504|FG001|Overall Study|Progression|0|||
27971576|NCT00960752|54629505|FG002|Overall Study|Progression|1|||
27971577|NCT00758524|54629519|FG000|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
27971578|NCT00758524|54629520|FG001|Core Period (Week 0 to Week 8)|Lack of Efficacy|2|||
27971579|NCT00758524|54629521|FG002|Core Period (Week 0 to Week 8)|Lack of Efficacy|4|||
27971580|NCT00758524|54629522|FG003|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
27971581|NCT00758524|54629523|FG004|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
27971582|NCT00758524|54629524|FG005|Core Period (Week 0 to Week 8)|Lack of Efficacy|5|||
28084983|NCT03404674|54738558|FG003|Overall Study|Started a Medication that Precluded Eligibility|1|||
28084984|NCT03404674|54738559|FG004|Overall Study|Started a Medication that Precluded Eligibility|0|||
28084985|NCT03404674|54738560|FG005|Overall Study|Started a Medication that Precluded Eligibility|1|||
28084986|NCT00064662|54738577|FG000|Overall Study|Death|1|||
28084987|NCT00064662|54738578|FG001|Overall Study|Death|1|||
28084988|NCT00064662|54738577|FG000|Overall Study|Lost to Follow-up|57|||
28084989|NCT00064662|54738578|FG001|Overall Study|Lost to Follow-up|44|||
28084990|NCT00064662|54738577|FG000|Overall Study|Withdrawal by Subject|14|||
28084991|NCT00064662|54738578|FG001|Overall Study|Withdrawal by Subject|14|||
28084992|NCT00064662|54738577|FG000|Overall Study|Administratively withdrawn|2|||
28084993|NCT00064662|54738578|FG001|Overall Study|Administratively withdrawn|2|||
28084994|NCT03404518|54738586|FG000|Overall Study|Lost to Follow-up|28|||
28084995|NCT03404518|54738587|FG001|Overall Study|Lost to Follow-up|30|||
28084996|NCT03404518|54738586|FG000|Overall Study|Protocol Violation|13|||
28084997|NCT03404518|54738587|FG001|Overall Study|Protocol Violation|6|||
28084998|NCT03404206|54738596|FG000|Overall Study|Withdrawal by Subject|1|||
28084999|NCT03404206|54738597|FG001|Overall Study|Withdrawal by Subject|1|||
28085000|NCT03404206|54738598|FG002|Overall Study|Withdrawal by Subject|0|||
28085001|NCT03404206|54738596|FG000|Overall Study|Lost to Follow-up|3|||
28085002|NCT03404206|54738597|FG001|Overall Study|Lost to Follow-up|1|||
28085003|NCT03404206|54738598|FG002|Overall Study|Lost to Follow-up|0|||
28085004|NCT03403426|54738606|FG000|Overall Study|Death|1|||
28085005|NCT03403426|54738606|FG000|Overall Study|Lost to Follow-up|2|||
28085006|NCT00394901|54738614|FG000|Baseline Phase|Protocol Violation|0|||
28085007|NCT00394901|54738615|FG001|Baseline Phase|Protocol Violation|0|||
28085008|NCT00394901|54738616|FG002|Baseline Phase|Protocol Violation|1|||
28085009|NCT00394901|54738617|FG003|Baseline Phase|Protocol Violation|0|||
28085010|NCT00394901|54738614|FG000|Double-blind Phase|Adverse Event|5|||
28085011|NCT00394901|54738615|FG001|Double-blind Phase|Adverse Event|7|||
28085012|NCT00394901|54738616|FG002|Double-blind Phase|Adverse Event|16|||
28085013|NCT00394901|54738617|FG003|Double-blind Phase|Adverse Event|20|||
28085014|NCT00394901|54738614|FG000|Double-blind Phase|Lack of Efficacy|6|||
28085015|NCT00394901|54738615|FG001|Double-blind Phase|Lack of Efficacy|4|||
28085016|NCT00394901|54738616|FG002|Double-blind Phase|Lack of Efficacy|1|||
28085017|NCT00394901|54738617|FG003|Double-blind Phase|Lack of Efficacy|3|||
28085018|NCT00394901|54738614|FG000|Double-blind Phase|Withdrawal by Subject|2|||
28085019|NCT00394901|54738615|FG001|Double-blind Phase|Withdrawal by Subject|0|||
28085020|NCT00394901|54738616|FG002|Double-blind Phase|Withdrawal by Subject|0|||
28085021|NCT00394901|54738617|FG003|Double-blind Phase|Withdrawal by Subject|0|||
28085022|NCT00394901|54738614|FG000|Double-blind Phase|Lost to Follow-up|0|||
28085023|NCT00394901|54738615|FG001|Double-blind Phase|Lost to Follow-up|0|||
28085024|NCT00394901|54738616|FG002|Double-blind Phase|Lost to Follow-up|0|||
28085025|NCT00394901|54738617|FG003|Double-blind Phase|Lost to Follow-up|1|||
28085026|NCT00394901|54738614|FG000|Double-blind Phase|Protocol Violation|0|||
28085027|NCT00394901|54738615|FG001|Double-blind Phase|Protocol Violation|0|||
27971583|NCT00758524|54629525|FG006|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
27971584|NCT00758524|54629526|FG007|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
27971585|NCT00758524|54629527|FG008|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
27971586|NCT00758524|54629528|FG009|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
27971587|NCT00758524|54629529|FG010|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
27971588|NCT00758524|54629530|FG011|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
28085028|NCT00394901|54738616|FG002|Double-blind Phase|Protocol Violation|0|||
28085029|NCT00394901|54738617|FG003|Double-blind Phase|Protocol Violation|1|||
27971589|NCT00758524|54629531|FG012|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
27971590|NCT00758524|54629532|FG013|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
27971591|NCT00758524|54629533|FG014|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
27971592|NCT00758524|54629534|FG015|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
28085030|NCT00394901|54738614|FG000|Double-blind Phase|Death|1|||
28085031|NCT00394901|54738615|FG001|Double-blind Phase|Death|0|||
28085032|NCT00394901|54738616|FG002|Double-blind Phase|Death|0|||
28085033|NCT00394901|54738617|FG003|Double-blind Phase|Death|0|||
28085034|NCT00394901|54738614|FG000|Double-blind Phase|Subject's Personal Reason|1|||
28085035|NCT00394901|54738615|FG001|Double-blind Phase|Subject's Personal Reason|0|||
27971593|NCT00758524|54629535|FG016|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
27971594|NCT00758524|54629519|FG000|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
27971595|NCT00758524|54629520|FG001|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
27971596|NCT00758524|54629521|FG002|Core Period (Week 0 to Week 8)|Withdrawal by Subject|2|||
27971597|NCT00758524|54629522|FG003|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
27971598|NCT00758524|54629523|FG004|Core Period (Week 0 to Week 8)|Withdrawal by Subject|1|||
27971599|NCT00758524|54629524|FG005|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
27971600|NCT00758524|54629525|FG006|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
27971601|NCT00758524|54629526|FG007|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
27971602|NCT00758524|54629527|FG008|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
27971603|NCT00758524|54629528|FG009|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
27971604|NCT00758524|54629529|FG010|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
27971605|NCT00758524|54629530|FG011|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
27971606|NCT00758524|54629531|FG012|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
27971607|NCT00758524|54629532|FG013|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
27971608|NCT00758524|54629533|FG014|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
27971609|NCT00758524|54629534|FG015|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
27971610|NCT00758524|54629535|FG016|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
27971611|NCT00758524|54629519|FG000|Core Period (Week 0 to Week 8)|Adverse Event|2|||
27971612|NCT00758524|54629520|FG001|Core Period (Week 0 to Week 8)|Adverse Event|1|||
27971613|NCT00758524|54629521|FG002|Core Period (Week 0 to Week 8)|Adverse Event|1|||
27971614|NCT00758524|54629522|FG003|Core Period (Week 0 to Week 8)|Adverse Event|3|||
27971615|NCT00758524|54629523|FG004|Core Period (Week 0 to Week 8)|Adverse Event|2|||
27971616|NCT00758524|54629524|FG005|Core Period (Week 0 to Week 8)|Adverse Event|1|||
27971617|NCT00758524|54629525|FG006|Core Period (Week 0 to Week 8)|Adverse Event|0|||
27971618|NCT00758524|54629526|FG007|Core Period (Week 0 to Week 8)|Adverse Event|0|||
27971619|NCT00758524|54629527|FG008|Core Period (Week 0 to Week 8)|Adverse Event|0|||
27971620|NCT00758524|54629528|FG009|Core Period (Week 0 to Week 8)|Adverse Event|0|||
27971621|NCT00758524|54629529|FG010|Core Period (Week 0 to Week 8)|Adverse Event|0|||
27971622|NCT00758524|54629530|FG011|Core Period (Week 0 to Week 8)|Adverse Event|0|||
27971623|NCT00758524|54629531|FG012|Core Period (Week 0 to Week 8)|Adverse Event|0|||
27971624|NCT00758524|54629532|FG013|Core Period (Week 0 to Week 8)|Adverse Event|0|||
27971625|NCT00758524|54629533|FG014|Core Period (Week 0 to Week 8)|Adverse Event|0|||
28085036|NCT00394901|54738616|FG002|Double-blind Phase|Subject's Personal Reason|0|||
28085037|NCT00394901|54738617|FG003|Double-blind Phase|Subject's Personal Reason|1|||
28085038|NCT00394901|54738614|FG000|Double-blind Phase|Lack of Compliance|0|||
28085039|NCT00394901|54738615|FG001|Double-blind Phase|Lack of Compliance|3|||
28085040|NCT00394901|54738616|FG002|Double-blind Phase|Lack of Compliance|0|||
28085041|NCT00394901|54738617|FG003|Double-blind Phase|Lack of Compliance|0|||
28085042|NCT00394901|54738614|FG000|Double-blind Phase|Entry into another study was found|0|||
28085043|NCT00394901|54738615|FG001|Double-blind Phase|Entry into another study was found|0|||
28085044|NCT00394901|54738616|FG002|Double-blind Phase|Entry into another study was found|1|||
28085045|NCT00394901|54738617|FG003|Double-blind Phase|Entry into another study was found|0|||
28085046|NCT00394901|54738614|FG000|Double-blind Phase|Found not to meet entrance criteria|0|||
28085047|NCT00394901|54738615|FG001|Double-blind Phase|Found not to meet entrance criteria|0|||
28085048|NCT00394901|54738616|FG002|Double-blind Phase|Found not to meet entrance criteria|0|||
28085049|NCT00394901|54738617|FG003|Double-blind Phase|Found not to meet entrance criteria|1|||
28085050|NCT03349060|54738633|FG000|Overall Study|Adverse Event|9|||
28085051|NCT03349060|54738634|FG001|Overall Study|Adverse Event|9|||
28085052|NCT03349060|54738635|FG002|Overall Study|Adverse Event|7|||
28085053|NCT03349060|54738633|FG000|Overall Study|Lack of Efficacy|1|||
28085054|NCT03349060|54738634|FG001|Overall Study|Lack of Efficacy|0|||
27971626|NCT00758524|54629534|FG015|Core Period (Week 0 to Week 8)|Adverse Event|0|||
27971627|NCT00758524|54629535|FG016|Core Period (Week 0 to Week 8)|Adverse Event|0|||
27971628|NCT00758524|54629519|FG000|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
27971629|NCT00758524|54629520|FG001|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
27971630|NCT00758524|54629521|FG002|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
27971631|NCT00758524|54629522|FG003|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
27971632|NCT00758524|54629523|FG004|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
27971633|NCT00758524|54629524|FG005|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
27971634|NCT00758524|54629525|FG006|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
27971635|NCT00758524|54629526|FG007|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
27832667|NCT02818920|54312245|FG000|Overall Study|Progressed After Neoadjuvant Therapy|1|||
27832668|NCT02818920|54312245|FG000|Overall Study|Went Off Study Prior to Adjuvant Therapy|8|||
27971636|NCT00758524|54629527|FG008|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
27971637|NCT00758524|54629528|FG009|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
28085055|NCT03349060|54738635|FG002|Overall Study|Lack of Efficacy|2|||
28085056|NCT03349060|54738633|FG000|Overall Study|Lost to Follow-up|2|||
28085057|NCT03349060|54738634|FG001|Overall Study|Lost to Follow-up|1|||
28085058|NCT03349060|54738635|FG002|Overall Study|Lost to Follow-up|1|||
27971638|NCT00758524|54629529|FG010|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
27971639|NCT00758524|54629530|FG011|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
27971640|NCT00758524|54629531|FG012|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
27971641|NCT00758524|54629532|FG013|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
27971642|NCT00758524|54629533|FG014|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
27971643|NCT00758524|54629534|FG015|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
27971644|NCT00758524|54629535|FG016|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
27971645|NCT00758524|54629519|FG000|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
27971646|NCT00758524|54629520|FG001|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
27971647|NCT00758524|54629521|FG002|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
27971648|NCT00758524|54629522|FG003|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
27971649|NCT00758524|54629523|FG004|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
27971650|NCT00758524|54629524|FG005|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
27971651|NCT00758524|54629525|FG006|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
27971652|NCT00758524|54629526|FG007|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
27971653|NCT00758524|54629527|FG008|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
27971654|NCT00758524|54629528|FG009|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
27971655|NCT00758524|54629529|FG010|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
27971656|NCT00758524|54629530|FG011|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
27971657|NCT00758524|54629531|FG012|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
27971658|NCT00758524|54629532|FG013|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
27971659|NCT00758524|54629533|FG014|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
27971660|NCT00758524|54629534|FG015|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
27971661|NCT00758524|54629535|FG016|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
27971662|NCT00758524|54629519|FG000|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
27971663|NCT00758524|54629520|FG001|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
27971664|NCT00758524|54629521|FG002|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
27971665|NCT00758524|54629522|FG003|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
27971666|NCT00758524|54629523|FG004|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|1|||
27971667|NCT00758524|54629524|FG005|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
27971668|NCT00758524|54629525|FG006|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
27971669|NCT00758524|54629526|FG007|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
27971670|NCT00758524|54629527|FG008|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
27971671|NCT00758524|54629528|FG009|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
27971672|NCT00758524|54629529|FG010|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
27971673|NCT00758524|54629530|FG011|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
27971674|NCT00758524|54629531|FG012|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
27971675|NCT00758524|54629532|FG013|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
27971676|NCT00758524|54629533|FG014|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
27971677|NCT00758524|54629534|FG015|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
27971678|NCT00758524|54629535|FG016|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
27971679|NCT00758524|54629519|FG000|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
27971680|NCT00758524|54629520|FG001|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|1|||
27971681|NCT00758524|54629521|FG002|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
27971682|NCT00758524|54629522|FG003|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
27971683|NCT00758524|54629523|FG004|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
27971684|NCT00758524|54629524|FG005|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
27971685|NCT00758524|54629525|FG006|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
27971686|NCT00758524|54629526|FG007|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
27971687|NCT00758524|54629527|FG008|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
27971688|NCT00758524|54629528|FG009|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
27971689|NCT00758524|54629529|FG010|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
27971690|NCT00758524|54629530|FG011|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
27971691|NCT00758524|54629531|FG012|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
27971692|NCT00758524|54629532|FG013|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
27971693|NCT00758524|54629533|FG014|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
27971694|NCT00758524|54629534|FG015|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
27971695|NCT00758524|54629535|FG016|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
27971696|NCT00758524|54629519|FG000|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
27971697|NCT00758524|54629520|FG001|Core Period (Week 0 to Week 8)|Reason not Specified|1|||
27971698|NCT00758524|54629521|FG002|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
27971699|NCT00758524|54629522|FG003|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
27971700|NCT00758524|54629523|FG004|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
27971701|NCT00758524|54629524|FG005|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
27732940|NCT00705783|54180680|FG001|Conversion Phase|Protocol Deviation|0|||
27971702|NCT00758524|54629525|FG006|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
27971703|NCT00758524|54629526|FG007|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
27971704|NCT00758524|54629527|FG008|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
27971705|NCT00758524|54629528|FG009|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
27971706|NCT00758524|54629529|FG010|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
27971707|NCT00758524|54629530|FG011|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
27971708|NCT00758524|54629531|FG012|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
27971709|NCT00758524|54629532|FG013|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
27971710|NCT00758524|54629533|FG014|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
27971711|NCT00758524|54629534|FG015|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
27971712|NCT00758524|54629535|FG016|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
27971713|NCT00758524|54629519|FG000|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
27971714|NCT00758524|54629520|FG001|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
27971715|NCT00758524|54629521|FG002|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
27971716|NCT00758524|54629522|FG003|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
27971717|NCT00758524|54629523|FG004|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
27971718|NCT00758524|54629524|FG005|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
27971719|NCT00758524|54629525|FG006|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
27971720|NCT00758524|54629526|FG007|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
27971721|NCT00758524|54629527|FG008|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|2|||
27971722|NCT00758524|54629528|FG009|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
27971723|NCT00758524|54629529|FG010|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
27971724|NCT00758524|54629530|FG011|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
27971725|NCT00758524|54629531|FG012|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
27971726|NCT00758524|54629532|FG013|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
27971727|NCT00758524|54629533|FG014|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
27971728|NCT00758524|54629534|FG015|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
27971729|NCT00758524|54629535|FG016|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
27971730|NCT00758524|54629519|FG000|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
27971731|NCT00758524|54629520|FG001|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
28085059|NCT03349060|54738633|FG000|Overall Study|Protocol Violation|2|||
28085060|NCT03349060|54738634|FG001|Overall Study|Protocol Violation|2|||
28085061|NCT03349060|54738635|FG002|Overall Study|Protocol Violation|1|||
28085062|NCT03349060|54738633|FG000|Overall Study|Withdrawal by Subject|5|||
28085063|NCT03349060|54738634|FG001|Overall Study|Withdrawal by Subject|3|||
28085064|NCT03349060|54738635|FG002|Overall Study|Withdrawal by Subject|4|||
27855519|NCT00242567|54378765|FG001|Overall Study|Withdrawal by Subject|28|||
27855520|NCT00242567|54378764|FG000|Overall Study|Protocol Violation|12|||
27971732|NCT00758524|54629521|FG002|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
27971733|NCT00758524|54629522|FG003|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
27971734|NCT00758524|54629523|FG004|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
27971735|NCT00758524|54629524|FG005|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
27971736|NCT00758524|54629525|FG006|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|1|||
27971737|NCT00758524|54629526|FG007|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
27971738|NCT00758524|54629527|FG008|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
27971739|NCT00758524|54629528|FG009|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
27971740|NCT00758524|54629529|FG010|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
27971741|NCT00758524|54629530|FG011|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
27971742|NCT00758524|54629531|FG012|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
27971743|NCT00758524|54629532|FG013|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
27971744|NCT00758524|54629533|FG014|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
27971745|NCT00758524|54629534|FG015|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
27971746|NCT00758524|54629535|FG016|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
27971747|NCT00757588|54629575|FG000|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3|||
27971748|NCT00757588|54629576|FG001|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2|||
27971749|NCT00757588|54629575|FG000|Period 1: Short-term (24-week) Phase|Adverse Event|6|||
27971750|NCT00757588|54629576|FG001|Period 1: Short-term (24-week) Phase|Adverse Event|3|||
27971751|NCT00757588|54629575|FG000|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13|||
27971752|NCT00757588|54629576|FG001|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5|||
27971753|NCT00757588|54629575|FG000|Period 1: Short-term (24-week) Phase|Death|1|||
28085065|NCT03349060|54738633|FG000|Overall Study|Medication error,no linked adverse event|0|||
28085066|NCT03349060|54738634|FG001|Overall Study|Medication error,no linked adverse event|0|||
28165324|NCT03004469|54836019|FG000|Overall Study|Lost to Follow-up|23|||
28165325|NCT03004469|54836020|FG001|Overall Study|Lost to Follow-up|14|||
27855521|NCT00242567|54378765|FG001|Overall Study|Protocol Violation|12|||
27971754|NCT00757588|54629576|FG001|Period 1: Short-term (24-week) Phase|Death|0|||
27971755|NCT00757588|54629575|FG000|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3|||
27971756|NCT00757588|54629576|FG001|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5|||
27971757|NCT00757588|54629575|FG000|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5|||
27971758|NCT00757588|54629576|FG001|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1|||
27971759|NCT00757588|54629575|FG000|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5|||
27971760|NCT00757588|54629576|FG001|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0|||
27971761|NCT00757588|54629575|FG000|Period 1: Short-term (24-week) Phase|Other|0|||
27971762|NCT00757588|54629576|FG001|Period 1: Short-term (24-week) Phase|Other|1|||
27971763|NCT00757588|54629575|FG000|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1|||
27971764|NCT00757588|54629576|FG001|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0|||
27971765|NCT00757588|54629575|FG000|Period 2: Long-term (52-week) Phase|Adverse Event|4|||
27971766|NCT00757588|54629576|FG001|Period 2: Long-term (52-week) Phase|Adverse Event|0|||
27971767|NCT00757588|54629575|FG000|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4|||
27971768|NCT00757588|54629576|FG001|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2|||
27971769|NCT00757588|54629575|FG000|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
27971770|NCT00757588|54629576|FG001|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
27971771|NCT00757588|54629575|FG000|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5|||
27971772|NCT00757588|54629576|FG001|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2|||
27971773|NCT00757588|54629575|FG000|Period 2: Long-term (52-week) Phase|Pregnancy|1|||
27971774|NCT00757588|54629576|FG001|Period 2: Long-term (52-week) Phase|Pregnancy|0|||
27971775|NCT00757588|54629575|FG000|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5|||
27971776|NCT00757588|54629576|FG001|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4|||
27971777|NCT00757588|54629575|FG000|Period 2: Long-term (52-week) Phase|Other|1|||
27971778|NCT00757588|54629576|FG001|Period 2: Long-term (52-week) Phase|Other|0|||
27971779|NCT00744796|54629582|FG000|Post-Operative 6-9 Months|Lost to Follow-up|12|||
27971780|NCT00705679|54629591|FG000|Overall Study|Adverse Event|1|||
27971781|NCT00705679|54629592|FG001|Overall Study|Adverse Event|1|||
27971782|NCT00705679|54629593|FG002|Overall Study|Adverse Event|0|||
27971783|NCT00705679|54629594|FG003|Overall Study|Adverse Event|0|||
27971784|NCT00705679|54629595|FG004|Overall Study|Adverse Event|0|||
27971785|NCT00705679|54629591|FG000|Overall Study|Death|0|||
27971786|NCT00705679|54629592|FG001|Overall Study|Death|0|||
27971787|NCT00705679|54629593|FG002|Overall Study|Death|3|||
27971788|NCT00705679|54629594|FG003|Overall Study|Death|2|||
27971789|NCT00705679|54629595|FG004|Overall Study|Death|1|||
27971790|NCT00705679|54629591|FG000|Overall Study|Lost to Follow-up|32|||
27971791|NCT00705679|54629592|FG001|Overall Study|Lost to Follow-up|60|||
27971792|NCT00705679|54629593|FG002|Overall Study|Lost to Follow-up|44|||
27971793|NCT00705679|54629594|FG003|Overall Study|Lost to Follow-up|30|||
27971794|NCT00705679|54629595|FG004|Overall Study|Lost to Follow-up|35|||
27971795|NCT00705679|54629591|FG000|Overall Study|Physician Decision|0|||
27971796|NCT00705679|54629592|FG001|Overall Study|Physician Decision|1|||
27971797|NCT00705679|54629593|FG002|Overall Study|Physician Decision|0|||
27971798|NCT00705679|54629594|FG003|Overall Study|Physician Decision|1|||
27971799|NCT00705679|54629595|FG004|Overall Study|Physician Decision|0|||
27971800|NCT00705679|54629591|FG000|Overall Study|Withdrawal by Subject|32|||
27971801|NCT00705679|54629592|FG001|Overall Study|Withdrawal by Subject|77|||
27971802|NCT00705679|54629593|FG002|Overall Study|Withdrawal by Subject|68|||
27971803|NCT00705679|54629594|FG003|Overall Study|Withdrawal by Subject|47|||
27971804|NCT00705679|54629595|FG004|Overall Study|Withdrawal by Subject|33|||
27971805|NCT00751348|54629618|FG000|Overall Study|Withdrawal by Subject|5|||
27971806|NCT00751348|54629619|FG001|Overall Study|Withdrawal by Subject|2|||
27971807|NCT00751348|54629618|FG000|Overall Study|Migration from study area|1|||
27971808|NCT00751348|54629619|FG001|Overall Study|Migration from study area|0|||
27971809|NCT00751114|54629627|FG000|Overall Study|Adverse Event|2|||
27971810|NCT00751114|54629628|FG001|Overall Study|Adverse Event|4|||
27971811|NCT00751114|54629627|FG000|Overall Study|Protocol Violation|8|||
27971812|NCT00751114|54629628|FG001|Overall Study|Protocol Violation|9|||
27971813|NCT00751114|54629627|FG000|Overall Study|Withdrawal by Subject|9|||
27971814|NCT00751114|54629628|FG001|Overall Study|Withdrawal by Subject|4|||
27971815|NCT00751114|54629627|FG000|Overall Study|Lost to Follow-up|4|||
27971816|NCT00751114|54629628|FG001|Overall Study|Lost to Follow-up|7|||
27971817|NCT00751114|54629627|FG000|Overall Study|Lack of Efficacy|0|||
27971818|NCT00751114|54629628|FG001|Overall Study|Lack of Efficacy|7|||
27971819|NCT00751114|54629627|FG000|Overall Study|Not Treated|13|||
27971820|NCT00751114|54629628|FG001|Overall Study|Not Treated|1|||
27971821|NCT00751114|54629627|FG000|Overall Study|Out of country for 2 months|1|||
27971822|NCT00751114|54629628|FG001|Overall Study|Out of country for 2 months|0|||
27971823|NCT00751114|54629627|FG000|Overall Study|Move to another city|1|||
27971824|NCT00751114|54629628|FG001|Overall Study|Move to another city|0|||
27971825|NCT00960440|54629638|FG000|Overall Study|Death|0|||
27971826|NCT00960440|54629639|FG001|Overall Study|Death|0|||
28085067|NCT03349060|54738635|FG002|Overall Study|Medication error,no linked adverse event|1|||
27971827|NCT00960440|54629640|FG002|Overall Study|Death|0|||
27971828|NCT00960440|54629641|FG003|Overall Study|Death|1|||
27971829|NCT00960440|54629638|FG000|Overall Study|Adverse Event|12|||
27971830|NCT00960440|54629639|FG001|Overall Study|Adverse Event|12|||
27971831|NCT00960440|54629640|FG002|Overall Study|Adverse Event|4|||
27971832|NCT00960440|54629641|FG003|Overall Study|Adverse Event|4|||
27971833|NCT00960440|54629638|FG000|Overall Study|Lack of Efficacy|2|||
27971834|NCT00960440|54629639|FG001|Overall Study|Lack of Efficacy|5|||
27971835|NCT00960440|54629640|FG002|Overall Study|Lack of Efficacy|3|||
27971836|NCT00960440|54629641|FG003|Overall Study|Lack of Efficacy|8|||
27971837|NCT00960440|54629638|FG000|Overall Study|Protocol Violation|2|||
27971838|NCT00960440|54629639|FG001|Overall Study|Protocol Violation|8|||
27971839|NCT00960440|54629640|FG002|Overall Study|Protocol Violation|3|||
27971840|NCT00960440|54629641|FG003|Overall Study|Protocol Violation|4|||
27971841|NCT00960440|54629638|FG000|Overall Study|Withdrawal by Subject|9|||
27971842|NCT00960440|54629639|FG001|Overall Study|Withdrawal by Subject|5|||
27971843|NCT00960440|54629640|FG002|Overall Study|Withdrawal by Subject|2|||
27971844|NCT00960440|54629641|FG003|Overall Study|Withdrawal by Subject|1|||
28085068|NCT03349060|54738633|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
28085069|NCT03349060|54738634|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
28085070|NCT03349060|54738635|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
28085071|NCT03349060|54738633|FG000|Overall Study|Other|2|||
28085072|NCT03349060|54738634|FG001|Overall Study|Other|1|||
28085073|NCT03349060|54738635|FG002|Overall Study|Other|0|||
28085074|NCT03348904|54738646|FG000|Overall Study|Administrative reason by the sponsor|0|||
28085075|NCT03348904|54738647|FG001|Overall Study|Administrative reason by the sponsor|1|||
28085076|NCT03348904|54738648|FG002|Overall Study|Administrative reason by the sponsor|0|||
28085077|NCT00359021|54738658|FG000|Overall Study|Adverse Event|26|||
27732941|NCT00705783|54180681|FG002|Conversion Phase|Protocol Deviation|0|||
27732942|NCT00705783|54180679|FG000|Conversion Phase|Adverse Event|11|||
27732943|NCT00705783|54180680|FG001|Conversion Phase|Adverse Event|0|||
27732944|NCT00705783|54180681|FG002|Conversion Phase|Adverse Event|0|||
27732945|NCT00705783|54180679|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|13|||
27732946|NCT00705783|54180680|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
27732947|NCT00705783|54180681|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
27732948|NCT00705783|54180679|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|8|||
27732949|NCT00705783|54180680|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
27732950|NCT00705783|54180681|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
27732951|NCT00705783|54180679|FG000|Oral Stabilization Phase|Sponsor Discontinue Study|42|||
27732952|NCT00705783|54180680|FG001|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
27732953|NCT00705783|54180681|FG002|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
27732954|NCT00705783|54180679|FG000|Oral Stabilization Phase|Lost to Follow-up|7|||
27732955|NCT00705783|54180680|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
27732956|NCT00705783|54180681|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
27732957|NCT00705783|54180679|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|19|||
27732958|NCT00705783|54180680|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
27732959|NCT00705783|54180681|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
27732960|NCT00705783|54180679|FG000|Oral Stabilization Phase|Withdrawn by Investigator|12|||
27732961|NCT00705783|54180680|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
27732962|NCT00705783|54180681|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
27732963|NCT00705783|54180679|FG000|Oral Stabilization Phase|Withdrew Consent|29|||
27732964|NCT00705783|54180680|FG001|Oral Stabilization Phase|Withdrew Consent|0|||
27732965|NCT00705783|54180681|FG002|Oral Stabilization Phase|Withdrew Consent|0|||
27732966|NCT00705783|54180679|FG000|Oral Stabilization Phase|Adverse Event|14|||
27732967|NCT00705783|54180680|FG001|Oral Stabilization Phase|Adverse Event|0|||
27732968|NCT00705783|54180681|FG002|Oral Stabilization Phase|Adverse Event|0|||
27732969|NCT00705783|54180679|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7|||
27732970|NCT00705783|54180680|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
27732971|NCT00705783|54180681|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
27732972|NCT00705783|54180679|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4|||
27732973|NCT00705783|54180680|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
27832669|NCT02818920|54312245|FG000|Overall Study|Adverse Event|3|||
27832670|NCT02818920|54312245|FG000|Overall Study|Developed Other Disease|1|||
27832671|NCT02818920|54312245|FG000|Overall Study|Refused Further Treatment|1|||
27971845|NCT00960440|54629638|FG000|Overall Study|Other|1|||
27971846|NCT00960440|54629639|FG001|Overall Study|Other|1|||
28085078|NCT00359021|54738659|FG001|Overall Study|Adverse Event|8|||
28085079|NCT00359021|54738658|FG000|Overall Study|Subject Non-Compliant|1|||
27832672|NCT01454401|54312271|FG000|Overall Study|Death|1|||
27971847|NCT00960440|54629640|FG002|Overall Study|Other|1|||
27971848|NCT00960440|54629641|FG003|Overall Study|Other|0|||
27971849|NCT00964028|54629655|FG000|Overall Study|Withdrawal by Subject|0|||
27971850|NCT00964028|54629656|FG001|Overall Study|Withdrawal by Subject|1|||
27971851|NCT00960206|54629665|FG000|Overall Study|Death|7|||
27971852|NCT00960206|54629666|FG001|Overall Study|Death|4|||
27971853|NCT00960206|54629667|FG002|Overall Study|Death|1|||
27971854|NCT00960206|54629665|FG000|Overall Study|Unwilling/Unable to return|1|||
27971855|NCT00960206|54629666|FG001|Overall Study|Unwilling/Unable to return|2|||
27971856|NCT00960206|54629667|FG002|Overall Study|Unwilling/Unable to return|0|||
27971857|NCT00960206|54629665|FG000|Overall Study|Lost to Follow-up|8|||
27971858|NCT00960206|54629666|FG001|Overall Study|Lost to Follow-up|14|||
27971859|NCT00960206|54629667|FG002|Overall Study|Lost to Follow-up|8|||
27971860|NCT00960206|54629665|FG000|Overall Study|Withdrawal by Subject|2|||
27971861|NCT00960206|54629666|FG001|Overall Study|Withdrawal by Subject|4|||
27971862|NCT00960206|54629667|FG002|Overall Study|Withdrawal by Subject|0|||
27971863|NCT00960206|54629665|FG000|Overall Study|Revision of study component|2|||
27971864|NCT00960206|54629666|FG001|Overall Study|Revision of study component|2|||
27971865|NCT00960206|54629667|FG002|Overall Study|Revision of study component|2|||
27971866|NCT00960206|54629665|FG000|Overall Study|Missing 10 year data|20|||
27971867|NCT00960206|54629666|FG001|Overall Study|Missing 10 year data|1|||
27971868|NCT00960206|54629667|FG002|Overall Study|Missing 10 year data|1|||
27971869|NCT00751036|54629678|FG000|Overall Study|Disease Progression|28|||
27971870|NCT00751036|54629679|FG001|Overall Study|Disease Progression|29|||
27971871|NCT00751036|54629678|FG000|Overall Study|Adverse Event|6|||
27971872|NCT00751036|54629679|FG001|Overall Study|Adverse Event|4|||
27971873|NCT00751036|54629678|FG000|Overall Study|Administrative Problems|3|||
27971874|NCT00751036|54629679|FG001|Overall Study|Administrative Problems|4|||
27971875|NCT00751036|54629678|FG000|Overall Study|Withdrawal by Subject|5|||
27971876|NCT00751036|54629679|FG001|Overall Study|Withdrawal by Subject|2|||
27971877|NCT00751036|54629678|FG000|Overall Study|Death|3|||
27971878|NCT00751036|54629679|FG001|Overall Study|Death|3|||
27971879|NCT00751036|54629678|FG000|Overall Study|Lost to Follow-up|0|||
27971880|NCT00751036|54629679|FG001|Overall Study|Lost to Follow-up|1|||
27971881|NCT00751036|54629678|FG000|Overall Study|Protocol Violation|1|||
27971882|NCT00751036|54629679|FG001|Overall Study|Protocol Violation|0|||
27971883|NCT00751036|54629678|FG000|Overall Study|Missing end of Treatment Page|2|||
27971884|NCT00751036|54629679|FG001|Overall Study|Missing end of Treatment Page|3|||
27971885|NCT00961298|54629685|FG000|Two Week Placebo Run in|Withdrawal by Subject|1|||
27971886|NCT00961298|54629685|FG000|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2|||
27971887|NCT00961298|54629685|FG000|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1|||
28085080|NCT00359021|54738659|FG001|Overall Study|Subject Non-Compliant|2|||
28085081|NCT00359021|54738658|FG000|Overall Study|Subject Ineligible To Continue The Trial|1|||
27971888|NCT00744328|54629692|FG000|Overall Study|Lost to Follow-up|2|||
27971889|NCT00744328|54629693|FG001|Overall Study|Lost to Follow-up|5|||
27971890|NCT00744328|54629694|FG002|Overall Study|Lost to Follow-up|3|||
27971891|NCT00744328|54629692|FG000|Overall Study|Withdrawal by Subject|5|||
27971892|NCT00744328|54629693|FG001|Overall Study|Withdrawal by Subject|3|||
27971893|NCT00744328|54629694|FG002|Overall Study|Withdrawal by Subject|4|||
27971894|NCT00744328|54629692|FG000|Overall Study|Found ineligible after randomization|0|||
27971895|NCT00744328|54629693|FG001|Overall Study|Found ineligible after randomization|0|||
27971896|NCT00744328|54629694|FG002|Overall Study|Found ineligible after randomization|1|||
27971897|NCT03245840|54629704|FG000|Overall Study|Adverse Event|6|||
27971898|NCT03245840|54629705|FG001|Overall Study|Adverse Event|0|||
27971899|NCT03245840|54629704|FG000|Overall Study|Death|2|||
27971900|NCT03245840|54629705|FG001|Overall Study|Death|0|||
27971901|NCT03245840|54629704|FG000|Overall Study|Withdrawal by Subject|31|||
27971902|NCT03245840|54629705|FG001|Overall Study|Withdrawal by Subject|1|||
27971903|NCT03245840|54629704|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
27971904|NCT03245840|54629705|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
27971905|NCT03245840|54629704|FG000|Overall Study|Physician Decision|4|||
27971906|NCT03245840|54629705|FG001|Overall Study|Physician Decision|1|||
27971907|NCT03245840|54629704|FG000|Overall Study|Study Terminated by Sponsor|56|||
27971908|NCT03245840|54629705|FG001|Overall Study|Study Terminated by Sponsor|6|||
28085082|NCT00359021|54738659|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
28085083|NCT00359021|54738658|FG000|Overall Study|Subject Reached A Virologic Endpoint|45|||
27971909|NCT03245840|54629704|FG000|Overall Study|Site Terminated by Sponsor|4|||
27971910|NCT03245840|54629705|FG001|Overall Study|Site Terminated by Sponsor|0|||
27971911|NCT03245840|54629704|FG000|Overall Study|Lost to Follow-up|12|||
27971912|NCT03245840|54629705|FG001|Overall Study|Lost to Follow-up|2|||
27971913|NCT03245840|54629704|FG000|Overall Study|Pregnancy|2|||
27971914|NCT03245840|54629705|FG001|Overall Study|Pregnancy|0|||
27971915|NCT03245840|54629704|FG000|Overall Study|Non-Compliance with Study Drug|2|||
27971916|NCT03245840|54629705|FG001|Overall Study|Non-Compliance with Study Drug|0|||
27971917|NCT03245840|54629704|FG000|Overall Study|Not treated|1|||
27971918|NCT03245840|54629705|FG001|Overall Study|Not treated|1|||
27971919|NCT00959894|54629711|FG000|Overall Study|Lost to Follow-up|10|||
27971920|NCT00959894|54629711|FG000|Overall Study|Adverse Event|3|||
27971921|NCT00959894|54629711|FG000|Overall Study|Withdrawal by Subject|1|||
27971922|NCT00959894|54629711|FG000|Overall Study|Need for contraindicated medication|1|||
27971923|NCT00959894|54629711|FG000|Overall Study|Subject moved out of town|1|||
28165326|NCT03004469|54836021|FG002|Overall Study|Lost to Follow-up|6|||
28085084|NCT00359021|54738659|FG001|Overall Study|Subject Reached A Virologic Endpoint|32|||
28085085|NCT00359021|54738658|FG000|Overall Study|Withdrawal by Subject|2|||
28085086|NCT00359021|54738659|FG001|Overall Study|Withdrawal by Subject|9|||
28085087|NCT00359021|54738658|FG000|Overall Study|Lost to Follow-up|1|||
28085088|NCT00359021|54738659|FG001|Overall Study|Lost to Follow-up|0|||
28085089|NCT00359021|54738658|FG000|Overall Study|Other|4|||
28085090|NCT00359021|54738659|FG001|Overall Study|Other|1|||
27971924|NCT00750880|54629716|FG000|Overall Study|Adverse Event|76|||
27971925|NCT00750880|54629716|FG000|Overall Study|Death|4|||
27971926|NCT00750880|54629716|FG000|Overall Study|Lack of Efficacy|46|||
27971927|NCT00750880|54629716|FG000|Overall Study|Lost to Follow-up|10|||
27971928|NCT00750880|54629716|FG000|Overall Study|Protocol Violation|15|||
27971929|NCT00750880|54629716|FG000|Overall Study|Withdrawal by Subject|33|||
27971930|NCT00750880|54629716|FG000|Overall Study|Physician Decision|20|||
27971931|NCT00750880|54629716|FG000|Overall Study|Administrative|11|||
27971932|NCT00746590|54629721|FG000|Overall Study|Death|1|||
27971933|NCT01032629|54629728|FG000|Overall Study|Closed Site|21|||
27971934|NCT01032629|54629729|FG001|Overall Study|Closed Site|18|||
27971935|NCT01032629|54629730|FG002|Overall Study|Closed Site|16|||
27971936|NCT01032629|54629728|FG000|Overall Study|Withdrawal by Subject|50|||
27971937|NCT01032629|54629729|FG001|Overall Study|Withdrawal by Subject|36|||
27971938|NCT01032629|54629730|FG002|Overall Study|Withdrawal by Subject|35|||
27971939|NCT01032629|54629728|FG000|Overall Study|Lost to Follow-up|74|||
27971940|NCT01032629|54629729|FG001|Overall Study|Lost to Follow-up|47|||
27971941|NCT01032629|54629730|FG002|Overall Study|Lost to Follow-up|37|||
27971942|NCT00749944|54629741|FG000|Overall Study|Lost to Follow-up|2|||
27971943|NCT00749944|54629742|FG001|Overall Study|Lost to Follow-up|1|||
27971944|NCT00749944|54629741|FG000|Overall Study|Other|1|||
27971945|NCT00749944|54629742|FG001|Overall Study|Other|0|||
27971946|NCT00749944|54629741|FG000|Overall Study|Withdrawal by Subject|2|||
27971947|NCT00749944|54629742|FG001|Overall Study|Withdrawal by Subject|0|||
27971948|NCT00749398|54629748|FG000|Overall Study|Lack of Efficacy|7|||
27971949|NCT00749398|54629748|FG000|Overall Study|Adverse Event|4|||
27971950|NCT00749398|54629748|FG000|Overall Study|Serious adverse event|11|||
27971951|NCT00749398|54629748|FG000|Overall Study|Withdrawal by Subject|17|||
27971952|NCT00749398|54629748|FG000|Overall Study|Lost to Follow-up|11|||
27971953|NCT00749398|54629748|FG000|Overall Study|Reason not specified|2|||
27971954|NCT00749398|54629748|FG000|Overall Study|Unknown reason|1|||
27971955|NCT00746356|54629752|FG000|Overall Study|Withdrawal by Subject|2|||
27971956|NCT00746356|54629753|FG001|Overall Study|Withdrawal by Subject|3|||
27971957|NCT00746356|54629752|FG000|Overall Study|Death|7|||
27971958|NCT00746356|54629753|FG001|Overall Study|Death|3|||
27971959|NCT00746356|54629752|FG000|Overall Study|Lost to Follow-up|1|||
27971960|NCT00746356|54629753|FG001|Overall Study|Lost to Follow-up|0|||
27971961|NCT00746356|54629752|FG000|Overall Study|Removal of Device|0|||
27971962|NCT00746356|54629753|FG001|Overall Study|Removal of Device|1|||
27971963|NCT00746356|54629752|FG000|Overall Study|Patient relocated|1|||
27971964|NCT00746356|54629753|FG001|Overall Study|Patient relocated|0|||
27971965|NCT01012973|54629763|FG000|Overall Study|Adverse Event|5|||
27971966|NCT01012973|54629764|FG001|Overall Study|Adverse Event|5|||
27971967|NCT01012973|54629763|FG000|Overall Study|Lack of Efficacy|0|||
27971968|NCT01012973|54629764|FG001|Overall Study|Lack of Efficacy|5|||
27971969|NCT01012973|54629763|FG000|Overall Study|Lost to Follow-up|1|||
27971970|NCT01012973|54629764|FG001|Overall Study|Lost to Follow-up|0|||
27971971|NCT01012973|54629763|FG000|Overall Study|(Overseas travel - indefinite period)|1|||
28085091|NCT00359021|54738658|FG000|Overall Study|Pregnancy|1|||
28085092|NCT00359021|54738659|FG001|Overall Study|Pregnancy|0|||
28085093|NCT00360269|54738669|FG000|Overall Study|Lost to Follow-up|7|||
28085094|NCT00360269|54738670|FG001|Overall Study|Lost to Follow-up|9|||
28085095|NCT00360269|54738669|FG000|Overall Study|Physician Decision|1|||
28085096|NCT00360269|54738670|FG001|Overall Study|Physician Decision|2|||
28085097|NCT00360269|54738669|FG000|Overall Study|Adverse Event|1|||
28085098|NCT00360269|54738670|FG001|Overall Study|Adverse Event|0|||
28085099|NCT00360269|54738669|FG000|Overall Study|Withdrawal by Subject|1|||
27832673|NCT01454401|54312271|FG000|Overall Study|hospitalised|1|||
27971972|NCT01012973|54629764|FG001|Overall Study|(Overseas travel - indefinite period)|0|||
27971973|NCT01012973|54629763|FG000|Overall Study|Increase in vis. acuity, never injected|0|||
27971974|NCT01012973|54629764|FG001|Overall Study|Increase in vis. acuity, never injected|1|||
27971975|NCT01012973|54629763|FG000|Overall Study|Protocol Violation|5|||
27971976|NCT01012973|54629764|FG001|Overall Study|Protocol Violation|2|||
27971977|NCT01012973|54629763|FG000|Overall Study|Withdrawal by Subject|4|||
27971978|NCT01012973|54629764|FG001|Overall Study|Withdrawal by Subject|6|||
27971979|NCT00748540|54629774|FG000|Overall Study|Physician Decision|1|||
27971980|NCT01012739|54629778|FG000|Treatment Period 1|Adverse Event|0|||
27971981|NCT01012739|54629779|FG001|Treatment Period 1|Adverse Event|0|||
27971982|NCT01012739|54629780|FG002|Treatment Period 1|Adverse Event|0|||
27971983|NCT01012739|54629781|FG003|Treatment Period 1|Adverse Event|1|||
27971984|NCT01012739|54629778|FG000|Treatment Period 2|Abnormal test procedure results|0|||
28085100|NCT00360269|54738670|FG001|Overall Study|Withdrawal by Subject|1|||
28085101|NCT00076752|54738676|FG000|Overall Study|Death|2|||
27971985|NCT01012739|54629779|FG001|Treatment Period 2|Abnormal test procedure results|0|||
27971986|NCT01012739|54629780|FG002|Treatment Period 2|Abnormal test procedure results|0|||
27971987|NCT01012739|54629781|FG003|Treatment Period 2|Abnormal test procedure results|1|||
27971988|NCT00742924|54629796|FG000|Overall Study|Adverse Event|0|||
27971989|NCT00742924|54629797|FG001|Overall Study|Adverse Event|0|||
27971990|NCT00742924|54629798|FG002|Overall Study|Adverse Event|1|||
27971991|NCT00742924|54629799|FG003|Overall Study|Adverse Event|1|||
27971992|NCT00742924|54629796|FG000|Overall Study|Lack of Efficacy|5|||
27971993|NCT00742924|54629797|FG001|Overall Study|Lack of Efficacy|1|||
27971994|NCT00742924|54629798|FG002|Overall Study|Lack of Efficacy|2|||
27971995|NCT00742924|54629799|FG003|Overall Study|Lack of Efficacy|4|||
27971996|NCT00742924|54629796|FG000|Overall Study|Physician Decision|0|||
27971997|NCT00742924|54629797|FG001|Overall Study|Physician Decision|0|||
27971998|NCT00742924|54629798|FG002|Overall Study|Physician Decision|0|||
27971999|NCT00742924|54629799|FG003|Overall Study|Physician Decision|1|||
27972000|NCT00742924|54629796|FG000|Overall Study|Withdrawal by Subject|0|||
27972001|NCT00742924|54629797|FG001|Overall Study|Withdrawal by Subject|1|||
27972002|NCT00742924|54629798|FG002|Overall Study|Withdrawal by Subject|1|||
27972003|NCT00742924|54629799|FG003|Overall Study|Withdrawal by Subject|0|||
27972004|NCT00698815|54629812|FG000|Overall Study|Death|1|||
27972005|NCT00698815|54629813|FG001|Overall Study|Death|2|||
27972006|NCT00698815|54629814|FG002|Overall Study|Death|4|||
27972007|NCT00698815|54629812|FG000|Overall Study|Withdrawal by Subject|6|||
27972008|NCT00698815|54629813|FG001|Overall Study|Withdrawal by Subject|3|||
27972009|NCT00698815|54629814|FG002|Overall Study|Withdrawal by Subject|2|||
27972010|NCT00698815|54629812|FG000|Overall Study|MD discretion|2|||
27972011|NCT00698815|54629813|FG001|Overall Study|MD discretion|7|||
27972012|NCT00698815|54629814|FG002|Overall Study|MD discretion|2|||
27972013|NCT00698815|54629812|FG000|Overall Study|Did not receive protocol treatment|1|||
27972014|NCT00698815|54629813|FG001|Overall Study|Did not receive protocol treatment|2|||
27972015|NCT00698815|54629814|FG002|Overall Study|Did not receive protocol treatment|2|||
27972016|NCT00745498|54629825|FG000|Overall Study|Lost to Follow-up|1|||
27972017|NCT00745498|54629826|FG001|Overall Study|Lost to Follow-up|1|||
27972018|NCT00745498|54629827|FG002|Overall Study|Lost to Follow-up|3|||
27972019|NCT00745498|54629825|FG000|Overall Study|Injection of intravitreal silicone oil o|3|||
27972020|NCT00745498|54629826|FG001|Overall Study|Injection of intravitreal silicone oil o|4|||
27972021|NCT00745498|54629827|FG002|Overall Study|Injection of intravitreal silicone oil o|4|||
27972022|NCT00745498|54629825|FG000|Overall Study|Non-PDR related VH|0|||
27972023|NCT00745498|54629826|FG001|Overall Study|Non-PDR related VH|1|||
27972024|NCT00745498|54629827|FG002|Overall Study|Non-PDR related VH|1|||
27972025|NCT00745498|54629825|FG000|Overall Study|Edophthalmitis after preoperative IVB|1|||
27972026|NCT00745498|54629826|FG001|Overall Study|Edophthalmitis after preoperative IVB|0|||
27972027|NCT00745498|54629827|FG002|Overall Study|Edophthalmitis after preoperative IVB|0|||
27972028|NCT00744874|54629835|FG000|Overall Study|Lost to Follow-up|1|||
27972029|NCT00744874|54629835|FG000|Overall Study|Withdrawal by Subject|1|||
27972030|NCT00744874|54629835|FG000|Overall Study|Study Device not available at procedure|1|||
27972031|NCT00744874|54629835|FG000|Overall Study|Unable to accomodate schedule|1|||
27972032|NCT00576901|54629846|FG000|Overall Study|Withdrawal by Subject|1|||
27972033|NCT00576901|54629846|FG000|Overall Study|Disease course|1|||
27972034|NCT00576901|54629846|FG000|Overall Study|Protocol Violation|1|||
27972035|NCT00699283|54629852|FG000|Overall Study|Lack of Efficacy|15|||
27972036|NCT00699283|54629853|FG001|Overall Study|Lack of Efficacy|5|||
27972037|NCT00699283|54629852|FG000|Overall Study|Lost to Follow-up|2|||
27972038|NCT00699283|54629853|FG001|Overall Study|Lost to Follow-up|0|||
27972039|NCT00699283|54629852|FG000|Overall Study|Withdrawal by Subject|1|||
27972040|NCT00699283|54629853|FG001|Overall Study|Withdrawal by Subject|0|||
27972041|NCT00699283|54629852|FG000|Overall Study|Other Reason|5|||
27972042|NCT00699283|54629853|FG001|Overall Study|Other Reason|1|||
27972043|NCT00699283|54629852|FG000|Overall Study|SAE, non-fatal|1|||
27972044|NCT00699283|54629853|FG001|Overall Study|SAE, non-fatal|1|||
27972045|NCT00699283|54629852|FG000|Overall Study|AE, non-serious non-fatal|8|||
28085102|NCT00076752|54738676|FG000|Overall Study|Withdrawal per PI, PI put study on hold|1|||
28085103|NCT03384940|54738684|FG000|Overall Study|Progressive disease|36|||
27972046|NCT00699283|54629853|FG001|Overall Study|AE, non-serious non-fatal|1|||
27972047|NCT00699283|54629852|FG000|Overall Study|AE of unknown type|1|||
27972048|NCT00699283|54629853|FG001|Overall Study|AE of unknown type|0|||
27972049|NCT00740584|54629858|FG000|Overall Study|Withdrawal by Subject|1|||
27972050|NCT01023815|54629867|FG000|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144|||
27972051|NCT01023815|54629868|FG001|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
27972052|NCT01023815|54629869|FG002|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
27972053|NCT01023815|54629870|FG003|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
27972054|NCT01023815|54629867|FG000|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
27972055|NCT01023815|54629868|FG001|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
27972056|NCT01023815|54629869|FG002|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
27972057|NCT01023815|54629870|FG003|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
27972058|NCT01023815|54629867|FG000|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
27972059|NCT01023815|54629868|FG001|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
27972060|NCT01023815|54629869|FG002|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
27972061|NCT01023815|54629870|FG003|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
27972062|NCT01023815|54629867|FG000|Randomized Period (Day 90 to Month 12)|Administrative Problems|0|||
27972063|NCT01023815|54629868|FG001|Randomized Period (Day 90 to Month 12)|Administrative Problems|1|||
27972064|NCT01023815|54629869|FG002|Randomized Period (Day 90 to Month 12)|Administrative Problems|6|||
27972065|NCT01023815|54629870|FG003|Randomized Period (Day 90 to Month 12)|Administrative Problems|2|||
27972066|NCT01023815|54629867|FG000|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
27972067|NCT01023815|54629868|FG001|Randomized Period (Day 90 to Month 12)|Graft Loss|1|||
27972068|NCT01023815|54629869|FG002|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
27972069|NCT01023815|54629870|FG003|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
28085104|NCT03384940|54738685|FG001|Overall Study|Progressive disease|11|||
28085105|NCT03384940|54738686|FG002|Overall Study|Progressive disease|13|||
28085106|NCT03384940|54738684|FG000|Overall Study|Clinical progression|4|||
28085107|NCT03384940|54738685|FG001|Overall Study|Clinical progression|0|||
28085108|NCT03384940|54738686|FG002|Overall Study|Clinical progression|3|||
28085109|NCT03384940|54738684|FG000|Overall Study|Adverse Event|7|||
28085110|NCT03384940|54738685|FG001|Overall Study|Adverse Event|1|||
28085111|NCT03384940|54738686|FG002|Overall Study|Adverse Event|1|||
28085112|NCT03384940|54738684|FG000|Overall Study|Withdrawal by Subject|3|||
28085113|NCT03384940|54738685|FG001|Overall Study|Withdrawal by Subject|1|||
28085114|NCT03384940|54738686|FG002|Overall Study|Withdrawal by Subject|0|||
28085115|NCT03384940|54738684|FG000|Overall Study|Physician Decision|1|||
28085116|NCT03384940|54738685|FG001|Overall Study|Physician Decision|1|||
28085117|NCT03384940|54738686|FG002|Overall Study|Physician Decision|0|||
28085118|NCT03384940|54738684|FG000|Overall Study|Death|2|||
28085119|NCT03384940|54738685|FG001|Overall Study|Death|1|||
28085120|NCT03384940|54738686|FG002|Overall Study|Death|0|||
28085121|NCT03384940|54738684|FG000|Overall Study|Other|0|||
28085122|NCT03384940|54738685|FG001|Overall Study|Other|0|||
28085123|NCT03384940|54738686|FG002|Overall Study|Other|1|||
28085124|NCT00075582|54738696|FG000|Overall Study|Adverse Event|3|||
27732974|NCT00705783|54180681|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
27972070|NCT01023659|54629884|FG000|Overall Study|Lost to Follow-up|73|||
27972071|NCT01023659|54629885|FG001|Overall Study|Lost to Follow-up|228|||
27972072|NCT01023659|54629886|FG002|Overall Study|Lost to Follow-up|99|||
27972073|NCT00740116|54629897|FG000|Overall Study|Withdrawal by Subject|1|||
27972074|NCT00740116|54629898|FG001|Overall Study|Withdrawal by Subject|1|||
27972075|NCT00740116|54629897|FG000|Overall Study|Protocol Violation|1|||
27972076|NCT00740116|54629898|FG001|Overall Study|Protocol Violation|4|||
27972077|NCT00698581|54629908|FG000|Overall Study|Lack of Efficacy|23|||
27972078|NCT00698581|54629909|FG001|Overall Study|Lack of Efficacy|11|||
27972079|NCT00698581|54629908|FG000|Overall Study|Withdrawal by Subject|6|||
27972080|NCT00698581|54629909|FG001|Overall Study|Withdrawal by Subject|0|||
27972081|NCT00698581|54629908|FG000|Overall Study|Other reason|9|||
27972082|NCT00698581|54629909|FG001|Overall Study|Other reason|1|||
27972083|NCT00698581|54629908|FG000|Overall Study|SAE, non-fatal|1|||
27972084|NCT00698581|54629909|FG001|Overall Study|SAE, non-fatal|0|||
27972085|NCT00698581|54629908|FG000|Overall Study|AE, non-serious non-fatal|4|||
27972086|NCT00698581|54629909|FG001|Overall Study|AE, non-serious non-fatal|0|||
27972087|NCT00698581|54629908|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
27972088|NCT00698581|54629909|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
27972089|NCT00698581|54629908|FG000|Overall Study|AE of unknown type|1|||
27972090|NCT00698581|54629909|FG001|Overall Study|AE of unknown type|0|||
27972091|NCT01023581|54629923|FG000|Overall Study|Adverse Event|4|||
27972092|NCT01023581|54629924|FG001|Overall Study|Adverse Event|4|||
27972093|NCT01023581|54629925|FG002|Overall Study|Adverse Event|7|||
27972094|NCT01023581|54629926|FG003|Overall Study|Adverse Event|3|||
27972095|NCT01023581|54629927|FG004|Overall Study|Adverse Event|2|||
27972096|NCT01023581|54629928|FG005|Overall Study|Adverse Event|5|||
27972097|NCT01023581|54629929|FG006|Overall Study|Adverse Event|11|||
27972098|NCT01023581|54629923|FG000|Overall Study|Major protocol deviation|2|||
27972099|NCT01023581|54629924|FG001|Overall Study|Major protocol deviation|0|||
27972100|NCT01023581|54629925|FG002|Overall Study|Major protocol deviation|3|||
28085125|NCT00075582|54738697|FG001|Overall Study|Adverse Event|1|||
28085126|NCT00075582|54738696|FG000|Overall Study|Lack of Efficacy|4|||
27972101|NCT01023581|54629926|FG003|Overall Study|Major protocol deviation|0|||
27972102|NCT01023581|54629927|FG004|Overall Study|Major protocol deviation|0|||
27972103|NCT01023581|54629928|FG005|Overall Study|Major protocol deviation|0|||
28085127|NCT00075582|54738697|FG001|Overall Study|Lack of Efficacy|8|||
28085128|NCT00075582|54738696|FG000|Overall Study|Physician Decision|5|||
28085129|NCT00075582|54738697|FG001|Overall Study|Physician Decision|8|||
28085130|NCT00075582|54738696|FG000|Overall Study|Withdrawal by Subject|2|||
28085131|NCT00075582|54738697|FG001|Overall Study|Withdrawal by Subject|2|||
27972104|NCT01023581|54629929|FG006|Overall Study|Major protocol deviation|0|||
27972105|NCT01023581|54629923|FG000|Overall Study|Lost to Follow-up|4|||
27972106|NCT01023581|54629924|FG001|Overall Study|Lost to Follow-up|8|||
27972107|NCT01023581|54629925|FG002|Overall Study|Lost to Follow-up|7|||
27972108|NCT01023581|54629926|FG003|Overall Study|Lost to Follow-up|2|||
27972109|NCT01023581|54629927|FG004|Overall Study|Lost to Follow-up|5|||
27972110|NCT01023581|54629928|FG005|Overall Study|Lost to Follow-up|2|||
27972111|NCT01023581|54629929|FG006|Overall Study|Lost to Follow-up|2|||
27972112|NCT01023581|54629923|FG000|Overall Study|Withdrawal by Subject|13|||
27972113|NCT01023581|54629924|FG001|Overall Study|Withdrawal by Subject|8|||
27972114|NCT01023581|54629925|FG002|Overall Study|Withdrawal by Subject|16|||
27972115|NCT01023581|54629926|FG003|Overall Study|Withdrawal by Subject|10|||
27972116|NCT01023581|54629927|FG004|Overall Study|Withdrawal by Subject|6|||
27972117|NCT01023581|54629928|FG005|Overall Study|Withdrawal by Subject|8|||
27972118|NCT01023581|54629929|FG006|Overall Study|Withdrawal by Subject|5|||
27972119|NCT01023581|54629923|FG000|Overall Study|Pregnancy|0|||
27972120|NCT01023581|54629924|FG001|Overall Study|Pregnancy|0|||
27972121|NCT01023581|54629925|FG002|Overall Study|Pregnancy|0|||
27972122|NCT01023581|54629926|FG003|Overall Study|Pregnancy|2|||
27972123|NCT01023581|54629927|FG004|Overall Study|Pregnancy|0|||
27972124|NCT01023581|54629928|FG005|Overall Study|Pregnancy|1|||
27972125|NCT01023581|54629929|FG006|Overall Study|Pregnancy|0|||
27972126|NCT01023581|54629923|FG000|Overall Study|Lack of Efficacy|9|||
27972127|NCT01023581|54629924|FG001|Overall Study|Lack of Efficacy|3|||
27972128|NCT01023581|54629925|FG002|Overall Study|Lack of Efficacy|6|||
27972129|NCT01023581|54629926|FG003|Overall Study|Lack of Efficacy|2|||
27972130|NCT01023581|54629927|FG004|Overall Study|Lack of Efficacy|1|||
27972131|NCT01023581|54629928|FG005|Overall Study|Lack of Efficacy|2|||
27972132|NCT01023581|54629929|FG006|Overall Study|Lack of Efficacy|1|||
27972133|NCT01023581|54629923|FG000|Overall Study|Physician Decision|2|||
27972134|NCT01023581|54629924|FG001|Overall Study|Physician Decision|0|||
27972135|NCT01023581|54629925|FG002|Overall Study|Physician Decision|2|||
27972136|NCT01023581|54629926|FG003|Overall Study|Physician Decision|1|||
27972137|NCT01023581|54629927|FG004|Overall Study|Physician Decision|1|||
27972138|NCT01023581|54629928|FG005|Overall Study|Physician Decision|1|||
27972139|NCT01023581|54629929|FG006|Overall Study|Physician Decision|1|||
27972140|NCT01023581|54629923|FG000|Overall Study|Other|1|||
27972141|NCT01023581|54629924|FG001|Overall Study|Other|0|||
27972142|NCT01023581|54629925|FG002|Overall Study|Other|1|||
27972143|NCT01023581|54629926|FG003|Overall Study|Other|0|||
27972144|NCT01023581|54629927|FG004|Overall Study|Other|1|||
27972145|NCT01023581|54629928|FG005|Overall Study|Other|0|||
27972146|NCT01023581|54629929|FG006|Overall Study|Other|0|||
27972147|NCT00962780|54629947|FG000|Overall Study|Death|0|||
27972148|NCT00962780|54629948|FG001|Overall Study|Death|1|||
27972149|NCT00962780|54629947|FG000|Overall Study|Protocol Violation|9|||
27972150|NCT00962780|54629948|FG001|Overall Study|Protocol Violation|4|||
27972151|NCT00962780|54629947|FG000|Overall Study|Withdrawal by Subject|1|||
27972152|NCT00962780|54629948|FG001|Overall Study|Withdrawal by Subject|8|||
27972153|NCT00962780|54629947|FG000|Overall Study|Other|0|||
28085132|NCT00075582|54738696|FG000|Overall Study|Ineligible for study|36|||
28085133|NCT00075582|54738697|FG001|Overall Study|Ineligible for study|16|||
28085134|NCT00063258|54738709|FG000|Overall Study|Physician Decision|2|||
28085135|NCT00063258|54738710|FG001|Overall Study|Physician Decision|0|||
28085136|NCT00063258|54738709|FG000|Overall Study|Lack of Efficacy|2|||
28085137|NCT00063258|54738710|FG001|Overall Study|Lack of Efficacy|0|||
28085138|NCT00088530|54738718|FG000|Overall Study|Progressive/Relapsed Disease|28|||
28085139|NCT00088530|54738719|FG001|Overall Study|Progressive/Relapsed Disease|39|||
28085140|NCT00088530|54738718|FG000|Overall Study|Adverse Event|15|||
28085141|NCT00088530|54738719|FG001|Overall Study|Adverse Event|9|||
28085142|NCT00088530|54738718|FG000|Overall Study|Withdrawal by Subject|2|||
28085143|NCT00088530|54738719|FG001|Overall Study|Withdrawal by Subject|5|||
27972154|NCT00962780|54629948|FG001|Overall Study|Other|1|||
27972155|NCT00739882|54629962|FG000|Double-blind Period|Adverse Event|1|||
27972156|NCT00739882|54629963|FG001|Double-blind Period|Adverse Event|2|||
28085144|NCT00088530|54738718|FG000|Overall Study|Lost to Follow-up|2|||
28085145|NCT00088530|54738719|FG001|Overall Study|Lost to Follow-up|0|||
27972157|NCT00739882|54629962|FG000|Double-blind Period|Protocol Violation|1|||
27972158|NCT00739882|54629963|FG001|Double-blind Period|Protocol Violation|0|||
27972159|NCT00739882|54629962|FG000|Double-blind Period|Lack of Efficacy|1|||
27972160|NCT00739882|54629963|FG001|Double-blind Period|Lack of Efficacy|1|||
28085146|NCT00088530|54738718|FG000|Overall Study|Physician Decision|2|||
27972161|NCT00739882|54629962|FG000|Double-blind Period|Other|16|||
27972162|NCT00739882|54629963|FG001|Double-blind Period|Other|8|||
27972163|NCT00739882|54629962|FG000|Open-label Period|Adverse Event|1|||
27972164|NCT00739882|54629963|FG001|Open-label Period|Adverse Event|0|||
27972165|NCT00739882|54629962|FG000|Open-label Period|Other|9|||
27972166|NCT00739882|54629963|FG001|Open-label Period|Other|5|||
27972167|NCT00961220|54629971|FG000|Overall Study|Adverse Event|3|||
27972168|NCT00961220|54629971|FG000|Overall Study|Lack of Efficacy|1|||
27972169|NCT00961220|54629971|FG000|Overall Study|No IV access for O6BG|1|||
27972170|NCT00961220|54629971|FG000|Overall Study|O6BG no longer supplied|1|||
27972171|NCT00961220|54629971|FG000|Overall Study|Complete Response prior to 12 courses|1|||
27972172|NCT00734656|54629977|FG000|Lab Session 1|Withdrawal by Subject|2|||
27972173|NCT00734656|54629978|FG001|Lab Session 1|Withdrawal by Subject|0|||
27972174|NCT00734656|54629979|FG002|Lab Session 1|Withdrawal by Subject|0|||
27972175|NCT00734656|54629980|FG003|Lab Session 1|Withdrawal by Subject|0|||
27972176|NCT00734656|54629977|FG000|Washout 1|Withdrawal by Subject|1|||
27972177|NCT00734656|54629978|FG001|Washout 1|Withdrawal by Subject|5|||
27972178|NCT00734656|54629979|FG002|Washout 1|Withdrawal by Subject|2|||
27972179|NCT00734656|54629980|FG003|Washout 1|Withdrawal by Subject|3|||
27972180|NCT00734656|54629977|FG000|Lab Session 2|Withdrawal by Subject|1|||
27972181|NCT00734656|54629978|FG001|Lab Session 2|Withdrawal by Subject|0|||
27972182|NCT00734656|54629979|FG002|Lab Session 2|Withdrawal by Subject|0|||
27972183|NCT00734656|54629980|FG003|Lab Session 2|Withdrawal by Subject|1|||
27972184|NCT00734656|54629977|FG000|Washout 2|Withdrawal by Subject|1|||
27972185|NCT00734656|54629978|FG001|Washout 2|Withdrawal by Subject|1|||
27972186|NCT00734656|54629979|FG002|Washout 2|Withdrawal by Subject|1|||
27972187|NCT00734656|54629980|FG003|Washout 2|Withdrawal by Subject|0|||
27972188|NCT00734656|54629977|FG000|Washout 3|Withdrawal by Subject|1|||
27972189|NCT00734656|54629978|FG001|Washout 3|Withdrawal by Subject|0|||
27972190|NCT00734656|54629979|FG002|Washout 3|Withdrawal by Subject|0|||
27972191|NCT00734656|54629980|FG003|Washout 3|Withdrawal by Subject|1|||
27972192|NCT00734656|54629977|FG000|Lab Session 4|Withdrawal by Subject|0|||
27972193|NCT00734656|54629978|FG001|Lab Session 4|Withdrawal by Subject|0|||
27972194|NCT00734656|54629979|FG002|Lab Session 4|Withdrawal by Subject|0|||
27972195|NCT00734656|54629980|FG003|Lab Session 4|Withdrawal by Subject|1|||
27972196|NCT00961064|54629990|FG000|Initial Treatment (Weeks 1 - 20)|No Response|11|||
27972197|NCT00961064|54629990|FG000|Initial Treatment (Weeks 1 - 20)|Disease Progression|3|||
27972198|NCT00961064|54629990|FG000|Initial Treatment (Weeks 1 - 20)|Death|1|||
27972199|NCT00961064|54629990|FG000|Initial Treatment (Weeks 1 - 20)|Withdrawal by Subject|1|||
27972200|NCT00961064|54629990|FG000|Extended Access: Week 20 to Up to Year 5|Disease Progression|3|||
27972201|NCT00961064|54629990|FG000|Extended Access: Week 20 to Up to Year 5|Lost Response|1|||
27972202|NCT00961064|54629990|FG000|Extended Access: Week 20 to Up to Year 5|Non-compliant|1|||
27972203|NCT00961064|54629990|FG000|Extended Access: Week 20 to Up to Year 5|Withdrawal by Subject|2|||
27972204|NCT00739648|54629997|FG000|Overall Study|Adverse Event|3|||
27972205|NCT00739648|54629998|FG001|Overall Study|Adverse Event|15|||
27972206|NCT00739648|54629997|FG000|Overall Study|Withdrawal by Subject|13|||
27972207|NCT00739648|54629998|FG001|Overall Study|Withdrawal by Subject|25|||
27972208|NCT00739648|54629997|FG000|Overall Study|Lost to Follow-up|4|||
27972209|NCT00739648|54629998|FG001|Overall Study|Lost to Follow-up|7|||
27972210|NCT00739648|54629997|FG000|Overall Study|Death|2|||
27972211|NCT00739648|54629998|FG001|Overall Study|Death|0|||
27972212|NCT00739648|54629997|FG000|Overall Study|Do not know|4|||
27972213|NCT00739648|54629998|FG001|Overall Study|Do not know|6|||
27972214|NCT01032239|54630010|FG000|Overall Study|Lost to Follow-up|3|||
27972215|NCT01032239|54630011|FG001|Overall Study|Lost to Follow-up|2|||
27972216|NCT01032239|54630010|FG000|Overall Study|Withdrawal by Subject|2|||
27972217|NCT01032239|54630011|FG001|Overall Study|Withdrawal by Subject|3|||
27972218|NCT01032239|54630010|FG000|Overall Study|Death|1|||
27972219|NCT01032239|54630011|FG001|Overall Study|Death|0|||
27972220|NCT01032239|54630010|FG000|Overall Study|Protocol Violation|1|||
27972221|NCT01032239|54630011|FG001|Overall Study|Protocol Violation|0|||
27972222|NCT00734578|54630020|FG000|Overall Study|Adverse Event|4|||
27972223|NCT00734578|54630021|FG001|Overall Study|Adverse Event|6|||
27972224|NCT00734578|54630022|FG002|Overall Study|Adverse Event|1|||
27972225|NCT00734578|54630020|FG000|Overall Study|Protocol Violation|8|||
27972226|NCT00734578|54630021|FG001|Overall Study|Protocol Violation|6|||
27972227|NCT00734578|54630022|FG002|Overall Study|Protocol Violation|3|||
27972228|NCT00734578|54630020|FG000|Overall Study|Withdrawal by Subject|7|||
27972229|NCT00734578|54630021|FG001|Overall Study|Withdrawal by Subject|8|||
27972230|NCT00734578|54630022|FG002|Overall Study|Withdrawal by Subject|11|||
27972231|NCT00734578|54630020|FG000|Overall Study|Lost to Follow-up|9|||
27972232|NCT00734578|54630021|FG001|Overall Study|Lost to Follow-up|3|||
27972233|NCT00734578|54630022|FG002|Overall Study|Lost to Follow-up|5|||
27972234|NCT00734578|54630020|FG000|Overall Study|Lack of Efficacy|3|||
27972235|NCT00734578|54630021|FG001|Overall Study|Lack of Efficacy|2|||
27972236|NCT00734578|54630022|FG002|Overall Study|Lack of Efficacy|5|||
28085147|NCT00088530|54738719|FG001|Overall Study|Physician Decision|0|||
28085148|NCT00088530|54738718|FG000|Overall Study|Sponsor decision|0|||
27972237|NCT00734578|54630020|FG000|Overall Study|Randomized in error|1|||
27972238|NCT00734578|54630021|FG001|Overall Study|Randomized in error|0|||
27972239|NCT00734578|54630022|FG002|Overall Study|Randomized in error|0|||
27972240|NCT00734578|54630020|FG000|Overall Study|Exclusion criteria|1|||
27972241|NCT00734578|54630021|FG001|Overall Study|Exclusion criteria|0|||
28085149|NCT00088530|54738719|FG001|Overall Study|Sponsor decision|1|||
27972242|NCT00734578|54630022|FG002|Overall Study|Exclusion criteria|0|||
27972243|NCT00739102|54630030|FG000|Overall Study|Death|5|||
27972244|NCT00739102|54630030|FG000|Overall Study|Withdrawal by Subject|10|||
27972245|NCT00959192|54630038|FG000|Overall Study|Adverse Event|1|||
27972246|NCT00959192|54630039|FG001|Overall Study|Adverse Event|1|||
27972247|NCT00959192|54630040|FG002|Overall Study|Adverse Event|1|||
27972248|NCT00959192|54630041|FG003|Overall Study|Adverse Event|0|||
27972249|NCT00959192|54630038|FG000|Overall Study|Investigator Request|1|||
27972250|NCT00959192|54630039|FG001|Overall Study|Investigator Request|0|||
27972251|NCT00959192|54630040|FG002|Overall Study|Investigator Request|0|||
27972252|NCT00959192|54630041|FG003|Overall Study|Investigator Request|0|||
28085150|NCT00088530|54738718|FG000|Overall Study|Patient never treated|1|||
28085151|NCT00088530|54738719|FG001|Overall Study|Patient never treated|0|||
28085152|NCT00359801|54738727|FG000|Overall Study|Lost to Follow-up|72|||
28085153|NCT00359801|54738728|FG001|Overall Study|Lost to Follow-up|58|||
28085154|NCT00359801|54738727|FG000|Overall Study|Withdrawal by Subject|143|||
28085155|NCT00359801|54738728|FG001|Overall Study|Withdrawal by Subject|96|||
28085156|NCT00359801|54738727|FG000|Overall Study|Other|66|||
28085157|NCT00359801|54738728|FG001|Overall Study|Other|46|||
28085158|NCT00359801|54738727|FG000|Overall Study|Final Status Unknown: missing data|7|||
28085159|NCT00359801|54738728|FG001|Overall Study|Final Status Unknown: missing data|4|||
28085160|NCT00359801|54738727|FG000|Overall Study|Sponsor Decision|17|||
28085161|NCT00359801|54738728|FG001|Overall Study|Sponsor Decision|16|||
28085162|NCT00045032|54738737|FG000|Overall Study|Adverse Event/Intercurrent Illness|2|||
28085163|NCT00045032|54738738|FG001|Overall Study|Adverse Event/Intercurrent Illness|2|||
28085164|NCT00045032|54738739|FG002|Overall Study|Adverse Event/Intercurrent Illness|7|||
28085165|NCT00045032|54738737|FG000|Overall Study|Death|22|||
27972253|NCT00959192|54630038|FG000|Overall Study|Caregiver Request|0|||
27972254|NCT00959192|54630039|FG001|Overall Study|Caregiver Request|0|||
27972255|NCT00959192|54630040|FG002|Overall Study|Caregiver Request|2|||
27972256|NCT00959192|54630041|FG003|Overall Study|Caregiver Request|1|||
27972257|NCT00696787|54630055|FG000|Overall Study|Adverse Event|1|||
27972258|NCT00696787|54630056|FG001|Overall Study|Adverse Event|0|||
27972259|NCT00696787|54630057|FG002|Overall Study|Adverse Event|6|||
27972260|NCT00696787|54630055|FG000|Overall Study|Discontinuation by Sponsor|9|||
27972261|NCT00696787|54630056|FG001|Overall Study|Discontinuation by Sponsor|13|||
27972262|NCT00696787|54630057|FG002|Overall Study|Discontinuation by Sponsor|14|||
27972263|NCT00696787|54630055|FG000|Overall Study|Lack of Efficacy|0|||
27972264|NCT00696787|54630056|FG001|Overall Study|Lack of Efficacy|1|||
27972265|NCT00696787|54630057|FG002|Overall Study|Lack of Efficacy|0|||
27972266|NCT00696787|54630055|FG000|Overall Study|Lost to Follow-up|4|||
27972267|NCT00696787|54630056|FG001|Overall Study|Lost to Follow-up|0|||
27972268|NCT00696787|54630057|FG002|Overall Study|Lost to Follow-up|3|||
27972269|NCT00696787|54630055|FG000|Overall Study|Withdrawal by Subject|0|||
27972270|NCT00696787|54630056|FG001|Overall Study|Withdrawal by Subject|3|||
27972271|NCT00696787|54630057|FG002|Overall Study|Withdrawal by Subject|2|||
27972272|NCT00696787|54630055|FG000|Overall Study|Failed to return|1|||
27972273|NCT00696787|54630056|FG001|Overall Study|Failed to return|3|||
27972274|NCT00696787|54630057|FG002|Overall Study|Failed to return|1|||
27972275|NCT01012037|54630068|FG000|Overall Study|Adverse Event|0|||
27972276|NCT01012037|54630069|FG001|Overall Study|Adverse Event|8|||
27972277|NCT01012037|54630070|FG002|Overall Study|Adverse Event|3|||
27972278|NCT01012037|54630068|FG000|Overall Study|Protocol Violation|0|||
27972279|NCT01012037|54630069|FG001|Overall Study|Protocol Violation|3|||
27972280|NCT01012037|54630070|FG002|Overall Study|Protocol Violation|5|||
28085166|NCT00045032|54738738|FG001|Overall Study|Death|24|||
28085167|NCT00045032|54738739|FG002|Overall Study|Death|17|||
28085168|NCT00045032|54738737|FG000|Overall Study|Insufficient Therapeutic Response|542|||
28085169|NCT00045032|54738738|FG001|Overall Study|Insufficient Therapeutic Response|437|||
28085170|NCT00045032|54738739|FG002|Overall Study|Insufficient Therapeutic Response|445|||
28085171|NCT00045032|54738737|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
28085172|NCT00045032|54738738|FG001|Overall Study|Violation of Selection Criteria at Entry|6|||
28085173|NCT00045032|54738739|FG002|Overall Study|Violation of Selection Criteria at Entry|6|||
28085174|NCT00045032|54738737|FG000|Overall Study|Other Protocol Violation|2|||
28085175|NCT00045032|54738738|FG001|Overall Study|Other Protocol Violation|0|||
28085176|NCT00045032|54738739|FG002|Overall Study|Other Protocol Violation|1|||
28085177|NCT00045032|54738737|FG000|Overall Study|Refused/Did Not Cooperate/Withdrew|142|||
28085178|NCT00045032|54738738|FG001|Overall Study|Refused/Did Not Cooperate/Withdrew|93|||
28085179|NCT00045032|54738739|FG002|Overall Study|Refused/Did Not Cooperate/Withdrew|84|||
28085180|NCT00045032|54738737|FG000|Overall Study|Failure to Return|57|||
28085181|NCT00045032|54738738|FG001|Overall Study|Failure to Return|62|||
28085182|NCT00045032|54738739|FG002|Overall Study|Failure to Return|61|||
28085183|NCT00045032|54738737|FG000|Overall Study|Other|93|||
28085184|NCT00045032|54738738|FG001|Overall Study|Other|84|||
27972281|NCT01012037|54630068|FG000|Overall Study|Withdrawal by Subject|0|||
27972282|NCT01012037|54630069|FG001|Overall Study|Withdrawal by Subject|4|||
27972283|NCT01012037|54630070|FG002|Overall Study|Withdrawal by Subject|1|||
28085185|NCT00045032|54738739|FG002|Overall Study|Other|105|||
27972284|NCT01012037|54630068|FG000|Overall Study|Other reason (not specified)|1|||
27972285|NCT01012037|54630069|FG001|Overall Study|Other reason (not specified)|1|||
27972286|NCT01012037|54630070|FG002|Overall Study|Other reason (not specified)|1|||
27972287|NCT00734032|54630082|FG000|Overall Study|Adverse Event|0|||
27972288|NCT00734032|54630083|FG001|Overall Study|Adverse Event|1|||
27972289|NCT00734032|54630084|FG002|Overall Study|Adverse Event|0|||
27972290|NCT00734032|54630085|FG003|Overall Study|Adverse Event|0|||
27972291|NCT01010633|54630097|FG000|Overall Study|Adverse Event|1|||
27972292|NCT01010633|54630098|FG001|Overall Study|Adverse Event|1|||
27972293|NCT01010633|54630097|FG000|Overall Study|Protocol Violation|1|||
27972294|NCT01010633|54630098|FG001|Overall Study|Protocol Violation|2|||
27972295|NCT01010633|54630097|FG000|Overall Study|Withdrawal by Subject|2|||
27972296|NCT01010633|54630098|FG001|Overall Study|Withdrawal by Subject|1|||
27972297|NCT01010633|54630097|FG000|Overall Study|Investigator decision|0|||
27972298|NCT01010633|54630098|FG001|Overall Study|Investigator decision|1|||
27972299|NCT00733954|54630106|FG000|Overall Study|Lost to Follow-up|5|||
27972300|NCT00733954|54630107|FG001|Overall Study|Lost to Follow-up|2|||
27972301|NCT00733954|54630106|FG000|Overall Study|Protocol Violation|1|||
27972302|NCT00733954|54630107|FG001|Overall Study|Protocol Violation|0|||
27972303|NCT00733954|54630106|FG000|Overall Study|Withdrawal by Subject|2|||
27972304|NCT00733954|54630107|FG001|Overall Study|Withdrawal by Subject|0|||
27972305|NCT00733408|54630113|FG000|Overall Study|Adverse Event|4|||
27972306|NCT01010867|54630117|FG000|Overall Study|< 50% adherence to probiotic|1|||
27972307|NCT00576823|54630124|FG000|12-week Efficacy Phase|Parent's schedule issue|1|||
27972308|NCT00576823|54630125|FG001|12-week Efficacy Phase|Parent's schedule issue|0|||
27972309|NCT00576823|54630126|FG002|12-week Efficacy Phase|Parent's schedule issue|0|||
27972310|NCT00576823|54630124|FG000|40-week Safety Extension Phase|Lack of Efficacy|1|||
27972311|NCT00576823|54630125|FG001|40-week Safety Extension Phase|Lack of Efficacy|0|||
27972312|NCT00576823|54630126|FG002|40-week Safety Extension Phase|Lack of Efficacy|0|||
27972313|NCT00732940|54630139|FG000|Overall Study|Withdrawal by Subject|1|||
27972314|NCT00732940|54630140|FG001|Overall Study|Withdrawal by Subject|2|||
27972315|NCT00732940|54630139|FG000|Overall Study|Adverse Event|0|||
27972316|NCT00732940|54630140|FG001|Overall Study|Adverse Event|1|||
27972317|NCT00732940|54630139|FG000|Overall Study|Lost to Follow-up|1|||
27972318|NCT00732940|54630140|FG001|Overall Study|Lost to Follow-up|0|||
27972319|NCT00962390|54630150|FG000|Overall Study|Adverse Event|0|||
27972320|NCT00962390|54630151|FG001|Overall Study|Adverse Event|0|||
27972321|NCT00962390|54630152|FG002|Overall Study|Adverse Event|3|||
27972322|NCT00962390|54630153|FG003|Overall Study|Adverse Event|1|||
27972323|NCT00962390|54630150|FG000|Overall Study|Lost to Follow-up|2|||
27972324|NCT00962390|54630151|FG001|Overall Study|Lost to Follow-up|2|||
27972325|NCT00962390|54630152|FG002|Overall Study|Lost to Follow-up|0|||
27972326|NCT00962390|54630153|FG003|Overall Study|Lost to Follow-up|0|||
27972327|NCT00962390|54630150|FG000|Overall Study|Protocol Violation|1|||
27972328|NCT00962390|54630151|FG001|Overall Study|Protocol Violation|0|||
27972329|NCT00962390|54630152|FG002|Overall Study|Protocol Violation|0|||
27972330|NCT00962390|54630153|FG003|Overall Study|Protocol Violation|0|||
27972331|NCT00962390|54630150|FG000|Overall Study|Withdrawal by Subject|1|||
27972332|NCT00962390|54630151|FG001|Overall Study|Withdrawal by Subject|1|||
27972333|NCT00962390|54630152|FG002|Overall Study|Withdrawal by Subject|1|||
27972334|NCT00962390|54630153|FG003|Overall Study|Withdrawal by Subject|0|||
27972335|NCT00732472|54630167|FG000|Overall Study|Adverse Event|0|||
27972336|NCT00732472|54630168|FG001|Overall Study|Adverse Event|1|||
27972337|NCT00732472|54630169|FG002|Overall Study|Adverse Event|1|||
27972338|NCT00732472|54630170|FG003|Overall Study|Adverse Event|1|||
27972339|NCT00732472|54630167|FG000|Overall Study|Protocol Violation|0|||
27972340|NCT00732472|54630168|FG001|Overall Study|Protocol Violation|0|||
27972341|NCT00732472|54630169|FG002|Overall Study|Protocol Violation|0|||
27972342|NCT00732472|54630170|FG003|Overall Study|Protocol Violation|1|||
27972343|NCT00732472|54630167|FG000|Overall Study|Withdrawal by Subject|0|||
27972344|NCT00732472|54630168|FG001|Overall Study|Withdrawal by Subject|2|||
27972345|NCT00732472|54630169|FG002|Overall Study|Withdrawal by Subject|0|||
27972346|NCT00732472|54630170|FG003|Overall Study|Withdrawal by Subject|1|||
27972347|NCT00960986|54630185|FG000|Period 1 (Screening and Washout)|Adverse Event|1|||
27972348|NCT00960986|54630186|FG001|Period 1 (Screening and Washout)|Adverse Event|2|||
27972349|NCT00960986|54630187|FG002|Period 1 (Screening and Washout)|Adverse Event|1|||
27972350|NCT00960986|54630188|FG003|Period 1 (Screening and Washout)|Adverse Event|1|||
27972351|NCT00960986|54630185|FG000|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
27972352|NCT00960986|54630186|FG001|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
27972353|NCT00960986|54630187|FG002|Period 1 (Screening and Washout)|Lost to Follow-up|2|||
27972354|NCT00960986|54630188|FG003|Period 1 (Screening and Washout)|Lost to Follow-up|1|||
27972355|NCT00960986|54630185|FG000|Period 1 (Screening and Washout)|Protocol Violation|1|||
27972356|NCT00960986|54630186|FG001|Period 1 (Screening and Washout)|Protocol Violation|0|||
27972357|NCT00960986|54630187|FG002|Period 1 (Screening and Washout)|Protocol Violation|0|||
27972358|NCT00960986|54630188|FG003|Period 1 (Screening and Washout)|Protocol Violation|0|||
27972359|NCT00960986|54630185|FG000|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
27972360|NCT00960986|54630186|FG001|Period 1 (Screening and Washout)|Withdrawal by Subject|2|||
28085186|NCT00356915|54738752|FG000|Overall Study|Non compliance|1|||
27972361|NCT00960986|54630187|FG002|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
27972362|NCT00960986|54630188|FG003|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
27972363|NCT00960986|54630185|FG000|Period 3 (7-week Therapy Period)|Adverse Event|17|||
27972364|NCT00960986|54630186|FG001|Period 3 (7-week Therapy Period)|Adverse Event|15|||
27972365|NCT00960986|54630187|FG002|Period 3 (7-week Therapy Period)|Adverse Event|10|||
27972366|NCT00960986|54630188|FG003|Period 3 (7-week Therapy Period)|Adverse Event|12|||
27972367|NCT00960986|54630185|FG000|Period 3 (7-week Therapy Period)|Death|0|||
27972368|NCT00960986|54630186|FG001|Period 3 (7-week Therapy Period)|Death|0|||
27972369|NCT00960986|54630187|FG002|Period 3 (7-week Therapy Period)|Death|1|||
27972370|NCT00960986|54630188|FG003|Period 3 (7-week Therapy Period)|Death|0|||
27972371|NCT00960986|54630185|FG000|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
27972372|NCT00960986|54630186|FG001|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
27972373|NCT00960986|54630187|FG002|Period 3 (7-week Therapy Period)|Lost to Follow-up|1|||
27972374|NCT00960986|54630188|FG003|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
27972375|NCT00960986|54630185|FG000|Period 3 (7-week Therapy Period)|Protocol Violation|10|||
27972376|NCT00960986|54630186|FG001|Period 3 (7-week Therapy Period)|Protocol Violation|4|||
27972377|NCT00960986|54630187|FG002|Period 3 (7-week Therapy Period)|Protocol Violation|3|||
27972378|NCT00960986|54630188|FG003|Period 3 (7-week Therapy Period)|Protocol Violation|11|||
27972379|NCT00960986|54630185|FG000|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
27972380|NCT00960986|54630186|FG001|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
27972381|NCT00960986|54630187|FG002|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4|||
27972382|NCT00960986|54630188|FG003|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
27972383|NCT00960986|54630185|FG000|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
27972384|NCT00960986|54630186|FG001|Period 3 (7-week Therapy Period)|Lack of Efficacy|2|||
27972385|NCT00960986|54630187|FG002|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
27972386|NCT00960986|54630188|FG003|Period 3 (7-week Therapy Period)|Lack of Efficacy|0|||
27972387|NCT00732238|54630200|FG000|Overall Study|Bacteremia|4|||
27972388|NCT00732238|54630201|FG001|Overall Study|Bacteremia|1|||
27972389|NCT00732238|54630200|FG000|Overall Study|Asymptomatic bacteriuria|1|||
27972390|NCT00732238|54630201|FG001|Overall Study|Asymptomatic bacteriuria|0|||
27972391|NCT00958880|54630211|FG000|Overall Study|Lost to Follow-up|2|||
27972392|NCT00958880|54630212|FG001|Overall Study|Lost to Follow-up|2|||
27972393|NCT00732160|54630222|FG000|Overall Study|Adverse Event|1|||
27972394|NCT00732160|54630223|FG001|Overall Study|Adverse Event|0|||
27972395|NCT00732160|54630224|FG002|Overall Study|Adverse Event|1|||
27972396|NCT00732160|54630225|FG003|Overall Study|Adverse Event|1|||
27972397|NCT00732160|54630222|FG000|Overall Study|scheduling|4|||
27972398|NCT00732160|54630223|FG001|Overall Study|scheduling|4|||
28085187|NCT00356915|54738753|FG001|Overall Study|Non compliance|2|||
28085188|NCT00356915|54738754|FG002|Overall Study|Non compliance|1|||
28085189|NCT00356915|54738752|FG000|Overall Study|Protocol Violation|2|||
28085190|NCT00356915|54738753|FG001|Overall Study|Protocol Violation|3|||
28085191|NCT00356915|54738754|FG002|Overall Study|Protocol Violation|2|||
28085192|NCT00356915|54738752|FG000|Overall Study|Withdrawal by Subject|14|||
28085193|NCT00356915|54738753|FG001|Overall Study|Withdrawal by Subject|14|||
28085194|NCT00356915|54738754|FG002|Overall Study|Withdrawal by Subject|10|||
28085195|NCT00356915|54738752|FG000|Overall Study|Lack of Efficacy|0|||
28085196|NCT00356915|54738753|FG001|Overall Study|Lack of Efficacy|0|||
28085197|NCT00356915|54738754|FG002|Overall Study|Lack of Efficacy|3|||
28085198|NCT00356915|54738752|FG000|Overall Study|Lost to Follow-up|27|||
28085199|NCT00356915|54738753|FG001|Overall Study|Lost to Follow-up|34|||
28085200|NCT00356915|54738754|FG002|Overall Study|Lost to Follow-up|14|||
28085201|NCT00356915|54738752|FG000|Overall Study|Administrative Decision|0|||
28085202|NCT00356915|54738753|FG001|Overall Study|Administrative Decision|0|||
28085203|NCT00356915|54738754|FG002|Overall Study|Administrative Decision|1|||
28085204|NCT00356915|54738752|FG000|Overall Study|Physician Decision|0|||
28085205|NCT00356915|54738753|FG001|Overall Study|Physician Decision|2|||
28085206|NCT00356915|54738754|FG002|Overall Study|Physician Decision|0|||
28085207|NCT00356915|54738752|FG000|Overall Study|Adverse Event|21|||
28085208|NCT00356915|54738753|FG001|Overall Study|Adverse Event|31|||
28085209|NCT00356915|54738754|FG002|Overall Study|Adverse Event|8|||
28085210|NCT00356915|54738752|FG000|Overall Study|Miscellaneous reasons|11|||
28085211|NCT00356915|54738753|FG001|Overall Study|Miscellaneous reasons|8|||
27832674|NCT01454401|54312271|FG000|Overall Study|osteomyelitis|2|||
27972399|NCT00732160|54630224|FG002|Overall Study|scheduling|2|||
27972400|NCT00732160|54630225|FG003|Overall Study|scheduling|1|||
27972401|NCT00958724|54630235|FG000|Overall Study|Disease Progression|6|||
28085212|NCT00356915|54738754|FG002|Overall Study|Miscellaneous reasons|3|||
28085213|NCT00356759|54738770|FG000|Overall Study|Death|5|||
28085214|NCT00356759|54738771|FG001|Overall Study|Death|2|||
28085215|NCT00356759|54738770|FG000|Overall Study|Withdrawal by Subject|2|||
28085216|NCT00356759|54738771|FG001|Overall Study|Withdrawal by Subject|2|||
28085217|NCT00356759|54738770|FG000|Overall Study|Adverse Event|1|||
28085218|NCT00356759|54738771|FG001|Overall Study|Adverse Event|3|||
28085219|NCT00356759|54738770|FG000|Overall Study|Lost to Follow-up|1|||
28085220|NCT00356759|54738771|FG001|Overall Study|Lost to Follow-up|1|||
28085221|NCT00356759|54738770|FG000|Overall Study|Intercurrent disease or persistent extre|5|||
28085222|NCT00356759|54738771|FG001|Overall Study|Intercurrent disease or persistent extre|2|||
28085223|NCT03804710|54738779|FG000|Overall Study|Adverse Event|0|||
28085224|NCT03804710|54738780|FG001|Overall Study|Adverse Event|3|||
28085225|NCT03804710|54738779|FG000|Overall Study|Withdrawal by Subject|2|||
28085226|NCT03804710|54738780|FG001|Overall Study|Withdrawal by Subject|1|||
28085227|NCT03804710|54738779|FG000|Overall Study|Other|0|||
28085228|NCT03804710|54738780|FG001|Overall Study|Other|1|||
28085229|NCT00356603|54738792|FG000|Overall Study|Other|6|||
28085230|NCT00356603|54738793|FG001|Overall Study|Other|3|||
27972402|NCT00738400|54630241|FG000|Overall Study|Adverse Event|3|||
27972403|NCT00738400|54630242|FG001|Overall Study|Adverse Event|1|||
27972404|NCT00738400|54630241|FG000|Overall Study|Withdrawal by Subject|0|||
27972405|NCT00738400|54630242|FG001|Overall Study|Withdrawal by Subject|1|||
27972406|NCT00738400|54630241|FG000|Overall Study|Lack of Efficacy|0|||
27972407|NCT00738400|54630242|FG001|Overall Study|Lack of Efficacy|1|||
27972408|NCT00738400|54630241|FG000|Overall Study|Lost to Follow-up|0|||
27972409|NCT00738400|54630242|FG001|Overall Study|Lost to Follow-up|3|||
27972410|NCT00738400|54630241|FG000|Overall Study|Protocol Violation|1|||
27972411|NCT00738400|54630242|FG001|Overall Study|Protocol Violation|0|||
27972412|NCT00738400|54630241|FG000|Overall Study|Non-compliant with study medication|0|||
27972413|NCT00738400|54630242|FG001|Overall Study|Non-compliant with study medication|1|||
27972414|NCT01009463|54630252|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373|||
27972415|NCT01009463|54630253|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
27972416|NCT01009463|54630254|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
27972417|NCT01009463|54630255|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
27972418|NCT01009463|54630256|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
27972419|NCT01009463|54630252|FG000|4-week, Open-label Run-In Period|Adverse Event|10|||
27972420|NCT01009463|54630253|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
27972421|NCT01009463|54630254|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
27972422|NCT01009463|54630255|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
27972423|NCT01009463|54630256|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
27972424|NCT01009463|54630252|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
27972425|NCT01009463|54630253|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
27972426|NCT01009463|54630254|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
27972427|NCT01009463|54630255|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
27972428|NCT01009463|54630256|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
27972429|NCT01009463|54630252|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
28085231|NCT00002558|54738803|FG000|Overall Study|Withdrawal by Subject|0|||
28085232|NCT00002558|54738804|FG001|Overall Study|Withdrawal by Subject|1|||
28085233|NCT00002540|54738812|FG000|Overall Study|Cancer Before Rand. (Prostate Screening)|0|||
28085234|NCT00002540|54738813|FG001|Overall Study|Cancer Before Rand. (Prostate Screening)|25|||
28085235|NCT00002540|54738812|FG000|Overall Study|Died Before Randomization|2|||
28085236|NCT00002540|54738813|FG001|Overall Study|Died Before Randomization|6|||
28085237|NCT00002540|54738812|FG000|Overall Study|Died Before ASU (Control)|202|||
28085238|NCT00002540|54738813|FG001|Overall Study|Died Before ASU (Control)|0|||
28085239|NCT00002540|54738812|FG000|Overall Study|Refused ASU (Control)|597|||
28085240|NCT00002540|54738813|FG001|Overall Study|Refused ASU (Control)|0|||
28085241|NCT00002540|54738812|FG000|Overall Study|Refused Screen (Prostate Screening)|0|||
28085242|NCT00002540|54738813|FG001|Overall Study|Refused Screen (Prostate Screening)|2433|||
28085243|NCT00001880|54738819|FG000|Overall Study|Death|14|||
28085244|NCT00043550|54738826|FG000|Overall Study|Withdrawal by Subject|22|||
28085245|NCT00043550|54738827|FG001|Overall Study|Withdrawal by Subject|12|||
28085246|NCT00043550|54738828|FG002|Overall Study|Withdrawal by Subject|20|||
28085247|NCT00041756|54738841|FG000|Overall Study|Adverse Event|4|||
28085248|NCT00041756|54738842|FG001|Overall Study|Adverse Event|10|||
28085249|NCT00041756|54738843|FG002|Overall Study|Adverse Event|6|||
28085250|NCT00041756|54738844|FG003|Overall Study|Adverse Event|11|||
28085251|NCT00041756|54738845|FG004|Overall Study|Adverse Event|34|||
28085252|NCT00041756|54738841|FG000|Overall Study|Protocol Violation|1|||
28085253|NCT00041756|54738842|FG001|Overall Study|Protocol Violation|1|||
28085254|NCT00041756|54738843|FG002|Overall Study|Protocol Violation|2|||
28085255|NCT00041756|54738844|FG003|Overall Study|Protocol Violation|2|||
28085256|NCT00041756|54738845|FG004|Overall Study|Protocol Violation|1|||
28085257|NCT00041756|54738841|FG000|Overall Study|Withdrawal by Subject|3|||
28085258|NCT00041756|54738842|FG001|Overall Study|Withdrawal by Subject|3|||
28085259|NCT00041756|54738843|FG002|Overall Study|Withdrawal by Subject|4|||
27832675|NCT01454401|54312271|FG000|Overall Study|non-adherence|1|||
27972430|NCT01009463|54630253|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
28085260|NCT00041756|54738844|FG003|Overall Study|Withdrawal by Subject|2|||
28085261|NCT00041756|54738845|FG004|Overall Study|Withdrawal by Subject|3|||
28085262|NCT00041756|54738841|FG000|Overall Study|Lost to Follow-up|0|||
28085263|NCT00041756|54738842|FG001|Overall Study|Lost to Follow-up|1|||
27972431|NCT01009463|54630254|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
27972432|NCT01009463|54630255|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
27972433|NCT01009463|54630256|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
27972434|NCT01009463|54630252|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|50|||
27972435|NCT01009463|54630253|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
27972436|NCT01009463|54630254|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
27972437|NCT01009463|54630255|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
27972438|NCT01009463|54630256|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
27972439|NCT01009463|54630252|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
27972440|NCT01009463|54630253|FG001|52-week, Double-blind Treatment Period|Adverse Event|22|||
27972441|NCT01009463|54630254|FG002|52-week, Double-blind Treatment Period|Adverse Event|25|||
27972442|NCT01009463|54630255|FG003|52-week, Double-blind Treatment Period|Adverse Event|29|||
27972443|NCT01009463|54630256|FG004|52-week, Double-blind Treatment Period|Adverse Event|31|||
27972444|NCT01009463|54630252|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
27972445|NCT01009463|54630253|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|34|||
27972446|NCT01009463|54630254|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|18|||
27972447|NCT01009463|54630255|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|17|||
27972448|NCT01009463|54630256|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
27972449|NCT01009463|54630252|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
27972450|NCT01009463|54630253|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|24|||
27972451|NCT01009463|54630254|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
27972452|NCT01009463|54630255|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|11|||
27972453|NCT01009463|54630256|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|18|||
27972454|NCT01009463|54630252|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
27972455|NCT01009463|54630253|FG001|52-week, Double-blind Treatment Period|Protocol Violation|8|||
27972456|NCT01009463|54630254|FG002|52-week, Double-blind Treatment Period|Protocol Violation|7|||
27972457|NCT01009463|54630255|FG003|52-week, Double-blind Treatment Period|Protocol Violation|8|||
27972458|NCT01009463|54630256|FG004|52-week, Double-blind Treatment Period|Protocol Violation|7|||
27972459|NCT01009463|54630252|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
27972460|NCT01009463|54630253|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
27972461|NCT01009463|54630254|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14|||
27972462|NCT01009463|54630255|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
27972463|NCT01009463|54630256|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
27972464|NCT01009463|54630252|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
27972465|NCT01009463|54630253|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|2|||
27972466|NCT01009463|54630254|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
27972467|NCT01009463|54630255|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
27972468|NCT01009463|54630256|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
27972469|NCT01009463|54630252|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
27972470|NCT01009463|54630253|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|11|||
27972471|NCT01009463|54630254|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|7|||
27972472|NCT01009463|54630255|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
27972473|NCT01009463|54630256|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|5|||
27972474|NCT01009463|54630252|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
27972475|NCT01009463|54630253|FG001|52-week, Double-blind Treatment Period|Physician Decision|4|||
27972476|NCT01009463|54630254|FG002|52-week, Double-blind Treatment Period|Physician Decision|6|||
27972477|NCT01009463|54630255|FG003|52-week, Double-blind Treatment Period|Physician Decision|6|||
27972478|NCT01009463|54630256|FG004|52-week, Double-blind Treatment Period|Physician Decision|8|||
27972479|NCT00958568|54630267|FG000|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80|||
27972480|NCT00958568|54630268|FG001|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
27972481|NCT00958568|54630269|FG002|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
27972482|NCT00958568|54630270|FG003|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
27972483|NCT00958568|54630267|FG000|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44|||
27972484|NCT00958568|54630268|FG001|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
27972485|NCT00958568|54630269|FG002|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
27972486|NCT00958568|54630270|FG003|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
27972487|NCT00958568|54630267|FG000|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34|||
27972488|NCT00958568|54630268|FG001|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
27972489|NCT00958568|54630269|FG002|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
28165327|NCT03004469|54836019|FG000|Overall Study|Non-Compliance with Study Drug|2|||
28165328|NCT03004469|54836020|FG001|Overall Study|Non-Compliance with Study Drug|0|||
27732975|NCT00705783|54180679|FG000|Depot Stabilization Phase|Sponsor Discontinued Study|86|||
27832676|NCT01344018|54312277|FG000|Overall Study|Death|22|||
27832677|NCT01344018|54312278|FG001|Overall Study|Death|25|||
27972490|NCT00958568|54630270|FG003|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
28085264|NCT00041756|54738843|FG002|Overall Study|Lost to Follow-up|0|||
28085265|NCT00041756|54738844|FG003|Overall Study|Lost to Follow-up|1|||
28085266|NCT00041756|54738845|FG004|Overall Study|Lost to Follow-up|0|||
28085267|NCT00041756|54738841|FG000|Overall Study|Unable to meet protocol criteria|0|||
28085268|NCT00041756|54738842|FG001|Overall Study|Unable to meet protocol criteria|0|||
28085269|NCT00041756|54738843|FG002|Overall Study|Unable to meet protocol criteria|1|||
28085270|NCT00041756|54738844|FG003|Overall Study|Unable to meet protocol criteria|0|||
28085271|NCT00041756|54738845|FG004|Overall Study|Unable to meet protocol criteria|1|||
28085272|NCT00041756|54738841|FG000|Overall Study|Data Monitoring Committee Recommendation|0|||
28085273|NCT00041756|54738842|FG001|Overall Study|Data Monitoring Committee Recommendation|0|||
28085274|NCT00041756|54738843|FG002|Overall Study|Data Monitoring Committee Recommendation|0|||
28085275|NCT00041756|54738844|FG003|Overall Study|Data Monitoring Committee Recommendation|0|||
28085276|NCT00041756|54738845|FG004|Overall Study|Data Monitoring Committee Recommendation|21|||
28085277|NCT00041132|54738857|FG000|Overall Study|Adverse Event|19|||
28085278|NCT00041132|54738857|FG000|Overall Study|Death|1|||
28085279|NCT00041132|54738857|FG000|Overall Study|Not Eligible|7|||
28085280|NCT00041132|54738857|FG000|Overall Study|Withdrawal by Subject|1|||
27972491|NCT00958568|54630267|FG000|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39|||
27972492|NCT00958568|54630268|FG001|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
27972493|NCT00958568|54630269|FG002|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
27972494|NCT00958568|54630270|FG003|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
27972495|NCT00958568|54630267|FG000|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14|||
27972496|NCT00958568|54630268|FG001|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
27972497|NCT00958568|54630269|FG002|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
27972498|NCT00958568|54630270|FG003|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
27972499|NCT00958568|54630267|FG000|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13|||
27972500|NCT00958568|54630268|FG001|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
27972501|NCT00958568|54630269|FG002|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
27972502|NCT00958568|54630270|FG003|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
27972503|NCT00958568|54630267|FG000|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4|||
27972504|NCT00958568|54630268|FG001|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
27972505|NCT00958568|54630269|FG002|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
27972506|NCT00958568|54630270|FG003|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
27972507|NCT00958568|54630267|FG000|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8|||
27972508|NCT00958568|54630268|FG001|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
27972509|NCT00958568|54630269|FG002|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
27972510|NCT00958568|54630270|FG003|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
27972511|NCT00958568|54630267|FG000|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1|||
27972512|NCT00958568|54630268|FG001|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
27972513|NCT00958568|54630269|FG002|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
27972514|NCT00958568|54630270|FG003|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
27972515|NCT00958568|54630267|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
27972516|NCT00958568|54630268|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62|||
27972517|NCT00958568|54630269|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
27972518|NCT00958568|54630270|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
27972519|NCT00958568|54630267|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
27972520|NCT00958568|54630268|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30|||
27972521|NCT00958568|54630269|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
27972522|NCT00958568|54630270|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
27972523|NCT00958568|54630267|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
27972524|NCT00958568|54630268|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28|||
27972525|NCT00958568|54630269|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
27972526|NCT00958568|54630270|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
27972527|NCT00958568|54630267|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
27972528|NCT00958568|54630268|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41|||
27972529|NCT00958568|54630269|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
27972530|NCT00958568|54630270|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
27972531|NCT00958568|54630267|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
28085281|NCT00041132|54738857|FG000|Overall Study|Physician Decision|2|||
28085282|NCT00040742|54738865|FG000|Overall Study|Death|0|||
28085283|NCT00040742|54738866|FG001|Overall Study|Death|0|||
27972532|NCT00958568|54630268|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24|||
27972533|NCT00958568|54630269|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
28085284|NCT00040742|54738867|FG002|Overall Study|Death|1|||
28085285|NCT00040742|54738868|FG003|Overall Study|Death|0|||
28085286|NCT00040742|54738865|FG000|Overall Study|Adverse Event|15|||
27972534|NCT00958568|54630270|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
27972535|NCT00958568|54630267|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
27972536|NCT00958568|54630268|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9|||
27972537|NCT00958568|54630269|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
27972538|NCT00958568|54630270|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
27972539|NCT00958568|54630267|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
27972540|NCT00958568|54630268|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6|||
27972541|NCT00958568|54630269|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
27972542|NCT00958568|54630270|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
27972543|NCT00958568|54630267|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
27972544|NCT00958568|54630268|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5|||
27972545|NCT00958568|54630269|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
27972546|NCT00958568|54630270|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
27972547|NCT00958568|54630267|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
27972548|NCT00958568|54630268|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4|||
27972549|NCT00958568|54630269|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
27972550|NCT00958568|54630270|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
27972551|NCT00958568|54630267|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
27972552|NCT00958568|54630268|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1|||
27972553|NCT00958568|54630269|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
27972554|NCT00958568|54630270|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
27972555|NCT00958568|54630267|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
27972556|NCT00958568|54630268|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1|||
27972557|NCT00958568|54630269|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
27972558|NCT00958568|54630270|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
27972559|NCT00958568|54630267|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
27972560|NCT00958568|54630268|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
27972561|NCT00958568|54630269|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24|||
27972562|NCT00958568|54630270|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63|||
27972563|NCT00958568|54630267|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
27972564|NCT00958568|54630268|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
27972565|NCT00958568|54630269|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19|||
27972566|NCT00958568|54630270|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10|||
27972567|NCT00958568|54630267|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
27972568|NCT00958568|54630268|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
27972569|NCT00958568|54630269|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16|||
27972570|NCT00958568|54630270|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15|||
27972571|NCT00958568|54630267|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
27972572|NCT00958568|54630268|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
27972573|NCT00958568|54630269|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11|||
27972574|NCT00958568|54630270|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5|||
27972575|NCT00958568|54630267|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
27972576|NCT00958568|54630268|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
27972577|NCT00958568|54630269|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3|||
27972578|NCT00958568|54630270|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8|||
27972579|NCT00958568|54630267|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
27972580|NCT00958568|54630268|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
27972581|NCT00958568|54630269|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5|||
27972582|NCT00958568|54630270|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4|||
27972583|NCT00958568|54630267|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
27972584|NCT00958568|54630268|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
27972585|NCT00958568|54630269|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2|||
27972586|NCT00958568|54630270|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1|||
27972587|NCT00958568|54630267|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
27972588|NCT00958568|54630268|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
27972589|NCT00958568|54630269|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1|||
27972590|NCT00958568|54630270|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
27972591|NCT00958568|54630267|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
27972592|NCT00958568|54630268|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
27972593|NCT00958568|54630269|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1|||
27972594|NCT00958568|54630270|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
27972595|NCT00958412|54630281|FG000|Overall Study|Study prematurely terminated|18|||
27972596|NCT00958256|54630285|FG000|Overall Study|Adverse Event|3|||
27972597|NCT00696709|54630294|FG000|Overall Study|Withdrawal by Subject|1|||
27972598|NCT00696709|54630295|FG001|Overall Study|Withdrawal by Subject|2|||
27972599|NCT00696709|54630296|FG002|Overall Study|Withdrawal by Subject|1|||
27972600|NCT00696709|54630297|FG003|Overall Study|Withdrawal by Subject|4|||
27972601|NCT00696709|54630298|FG004|Overall Study|Withdrawal by Subject|3|||
27972602|NCT00696709|54630294|FG000|Overall Study|Protocol Violation|1|||
27972603|NCT00696709|54630295|FG001|Overall Study|Protocol Violation|0|||
27972604|NCT00696709|54630296|FG002|Overall Study|Protocol Violation|0|||
27972605|NCT00696709|54630297|FG003|Overall Study|Protocol Violation|0|||
27972606|NCT00696709|54630298|FG004|Overall Study|Protocol Violation|0|||
27972607|NCT00696709|54630294|FG000|Overall Study|Lost to Follow-up|1|||
27972608|NCT00696709|54630295|FG001|Overall Study|Lost to Follow-up|1|||
27972609|NCT00696709|54630296|FG002|Overall Study|Lost to Follow-up|0|||
27972610|NCT00696709|54630297|FG003|Overall Study|Lost to Follow-up|0|||
27972611|NCT00696709|54630298|FG004|Overall Study|Lost to Follow-up|0|||
27972612|NCT00696709|54630294|FG000|Overall Study|Adverse Event|0|||
28085287|NCT00040742|54738866|FG001|Overall Study|Adverse Event|16|||
28085288|NCT00040742|54738867|FG002|Overall Study|Adverse Event|21|||
27972613|NCT00696709|54630295|FG001|Overall Study|Adverse Event|0|||
27972614|NCT00696709|54630296|FG002|Overall Study|Adverse Event|0|||
27972615|NCT00696709|54630297|FG003|Overall Study|Adverse Event|1|||
27972616|NCT00696709|54630298|FG004|Overall Study|Adverse Event|0|||
28085289|NCT00040742|54738868|FG003|Overall Study|Adverse Event|9|||
28085290|NCT00040742|54738865|FG000|Overall Study|Withdrawal by Subject|7|||
28085291|NCT00040742|54738866|FG001|Overall Study|Withdrawal by Subject|15|||
28085292|NCT00040742|54738867|FG002|Overall Study|Withdrawal by Subject|10|||
27732976|NCT00705783|54180680|FG001|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
27732977|NCT00705783|54180681|FG002|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
28085293|NCT00040742|54738868|FG003|Overall Study|Withdrawal by Subject|13|||
28085294|NCT00040742|54738865|FG000|Overall Study|Chemotoxicity|4|||
28085295|NCT00040742|54738866|FG001|Overall Study|Chemotoxicity|3|||
28085296|NCT00040742|54738867|FG002|Overall Study|Chemotoxicity|5|||
28085297|NCT00040742|54738868|FG003|Overall Study|Chemotoxicity|2|||
28085298|NCT00040742|54738865|FG000|Overall Study|Incomplete Forms|6|||
28085299|NCT00040742|54738866|FG001|Overall Study|Incomplete Forms|10|||
28085300|NCT00040742|54738867|FG002|Overall Study|Incomplete Forms|4|||
28085301|NCT00040742|54738868|FG003|Overall Study|Incomplete Forms|5|||
28085302|NCT00040742|54738865|FG000|Overall Study|Other medical|7|||
28085303|NCT00040742|54738866|FG001|Overall Study|Other medical|5|||
28085304|NCT00040742|54738867|FG002|Overall Study|Other medical|5|||
28085305|NCT00040742|54738868|FG003|Overall Study|Other medical|5|||
28085306|NCT00040664|54738878|FG000|Overall Study|Adverse Event|12|||
28085307|NCT00040664|54738879|FG001|Overall Study|Adverse Event|3|||
28085308|NCT00040664|54738880|FG002|Overall Study|Adverse Event|2|||
27732978|NCT00705783|54180679|FG000|Depot Stabilization Phase|Lost to Follow-up|11|||
27732979|NCT00705783|54180680|FG001|Depot Stabilization Phase|Lost to Follow-up|0|||
27732980|NCT00705783|54180681|FG002|Depot Stabilization Phase|Lost to Follow-up|0|||
27732981|NCT00705783|54180679|FG000|Depot Stabilization Phase|Met Withdrawal Criteria|8|||
27732982|NCT00705783|54180680|FG001|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
27732983|NCT00705783|54180681|FG002|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
27732984|NCT00705783|54180679|FG000|Depot Stabilization Phase|Withdrawn by Investigator|9|||
27855522|NCT00242567|54378764|FG000|Overall Study|Use of an inhibitor of bone resorption|0|||
27855523|NCT00242567|54378765|FG001|Overall Study|Use of an inhibitor of bone resorption|2|||
27855524|NCT00242567|54378764|FG000|Overall Study|Other|14|||
27855525|NCT00242567|54378765|FG001|Overall Study|Other|9|||
27855526|NCT00241631|54378775|FG000|Run in (2 Weeks)|Physician Decision|3|||
27855527|NCT00241631|54378776|FG001|Run in (2 Weeks)|Physician Decision|3|||
27855528|NCT00241631|54378775|FG000|Phase 1 (4 Weeks)|sore throat|1|||
27855529|NCT00241631|54378776|FG001|Phase 1 (4 Weeks)|sore throat|0|||
27855530|NCT00241631|54378775|FG000|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
27855531|NCT00241631|54378776|FG001|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
27855532|NCT00241631|54378775|FG000|Phase 1 (4 Weeks)|Lost to Follow-up|3|||
27855533|NCT00241631|54378776|FG001|Phase 1 (4 Weeks)|Lost to Follow-up|0|||
27855534|NCT00241631|54378775|FG000|Phase 1 (4 Weeks)|Lack of Efficacy|0|||
27855535|NCT00241631|54378776|FG001|Phase 1 (4 Weeks)|Lack of Efficacy|1|||
27972617|NCT01006265|54630318|FG000|Overall Study|Lost to Follow-up|1|||
27972618|NCT01006265|54630319|FG001|Overall Study|Lost to Follow-up|0|||
27972619|NCT01006265|54630320|FG002|Overall Study|Lost to Follow-up|1|||
28085309|NCT00040664|54738881|FG003|Overall Study|Adverse Event|7|||
27855536|NCT00240071|54378791|FG000|Overall Study|Withdrawal by Subject|3|||
27972620|NCT01006265|54630321|FG003|Overall Study|Lost to Follow-up|0|||
27972621|NCT01006265|54630318|FG000|Overall Study|Withdrawal by Subject|4|||
27972622|NCT01006265|54630319|FG001|Overall Study|Withdrawal by Subject|7|||
27972623|NCT01006265|54630320|FG002|Overall Study|Withdrawal by Subject|5|||
28085310|NCT00040664|54738878|FG000|Overall Study|Lack of Efficacy|9|||
28085311|NCT00040664|54738879|FG001|Overall Study|Lack of Efficacy|2|||
28085312|NCT00040664|54738880|FG002|Overall Study|Lack of Efficacy|3|||
28085313|NCT00040664|54738881|FG003|Overall Study|Lack of Efficacy|4|||
27972624|NCT01006265|54630321|FG003|Overall Study|Withdrawal by Subject|5|||
27972625|NCT01006265|54630318|FG000|Overall Study|Administrative reason|1|||
27972626|NCT01006265|54630319|FG001|Overall Study|Administrative reason|2|||
27972627|NCT01006265|54630320|FG002|Overall Study|Administrative reason|3|||
27972628|NCT01006265|54630321|FG003|Overall Study|Administrative reason|0|||
27972629|NCT01008995|54630333|FG000|Controlled Period|Adverse Event|1|||
27972630|NCT01008995|54630334|FG001|Controlled Period|Adverse Event|2|||
28085314|NCT00040664|54738878|FG000|Overall Study|Insufficient CD4 response|1|||
28085315|NCT00040664|54738879|FG001|Overall Study|Insufficient CD4 response|0|||
28085316|NCT00040664|54738880|FG002|Overall Study|Insufficient CD4 response|1|||
28085317|NCT00040664|54738881|FG003|Overall Study|Insufficient CD4 response|0|||
28085318|NCT00040664|54738878|FG000|Overall Study|Lost to Follow-up|4|||
28085319|NCT00040664|54738879|FG001|Overall Study|Lost to Follow-up|2|||
28085320|NCT00040664|54738880|FG002|Overall Study|Lost to Follow-up|0|||
28085321|NCT00040664|54738881|FG003|Overall Study|Lost to Follow-up|2|||
28085322|NCT00040664|54738878|FG000|Overall Study|Protocol Violation|2|||
28085323|NCT00040664|54738879|FG001|Overall Study|Protocol Violation|1|||
28085324|NCT00040664|54738880|FG002|Overall Study|Protocol Violation|0|||
28085325|NCT00040664|54738881|FG003|Overall Study|Protocol Violation|1|||
28085326|NCT00040664|54738878|FG000|Overall Study|Withdrawal by Subject|7|||
28085327|NCT00040664|54738879|FG001|Overall Study|Withdrawal by Subject|0|||
28085328|NCT00040664|54738880|FG002|Overall Study|Withdrawal by Subject|3|||
28085329|NCT00040664|54738881|FG003|Overall Study|Withdrawal by Subject|4|||
28085330|NCT00040664|54738878|FG000|Overall Study|Pregnancy|3|||
28085331|NCT00040664|54738879|FG001|Overall Study|Pregnancy|0|||
28085332|NCT00040664|54738880|FG002|Overall Study|Pregnancy|0|||
28085333|NCT00040664|54738881|FG003|Overall Study|Pregnancy|3|||
28085334|NCT00040664|54738878|FG000|Overall Study|Medication adherence/compliance problems|8|||
28085335|NCT00040664|54738879|FG001|Overall Study|Medication adherence/compliance problems|2|||
28085336|NCT00040664|54738880|FG002|Overall Study|Medication adherence/compliance problems|1|||
28085337|NCT00040664|54738881|FG003|Overall Study|Medication adherence/compliance problems|5|||
27972631|NCT01008995|54630335|FG002|Controlled Period|Adverse Event|0|||
28085338|NCT00040664|54738878|FG000|Overall Study|Poor taste|2|||
28085339|NCT00040664|54738879|FG001|Overall Study|Poor taste|0|||
28085340|NCT00040664|54738880|FG002|Overall Study|Poor taste|2|||
28085341|NCT00040664|54738881|FG003|Overall Study|Poor taste|0|||
28085342|NCT00040664|54738878|FG000|Overall Study|Pharmacokinetic target not achieved|2|||
28085343|NCT00040664|54738879|FG001|Overall Study|Pharmacokinetic target not achieved|1|||
28085344|NCT00040664|54738880|FG002|Overall Study|Pharmacokinetic target not achieved|0|||
28085345|NCT00040664|54738881|FG003|Overall Study|Pharmacokinetic target not achieved|1|||
28085346|NCT00040664|54738878|FG000|Overall Study|Change of formulation|2|||
28165329|NCT03004469|54836021|FG002|Overall Study|Non-Compliance with Study Drug|0|||
28165330|NCT03004469|54836019|FG000|Overall Study|Protocol Violation|0|||
28165331|NCT03004469|54836020|FG001|Overall Study|Protocol Violation|0|||
28165332|NCT03004469|54836021|FG002|Overall Study|Protocol Violation|1|||
28165333|NCT03004469|54836019|FG000|Overall Study|Withdrawal by Subject|29|||
28165334|NCT03004469|54836020|FG001|Overall Study|Withdrawal by Subject|27|||
28165335|NCT03004469|54836021|FG002|Overall Study|Withdrawal by Subject|10|||
28165336|NCT03004469|54836019|FG000|Overall Study|Other unspecified reason|0|||
28165337|NCT03004469|54836020|FG001|Overall Study|Other unspecified reason|4|||
28165338|NCT03004469|54836021|FG002|Overall Study|Other unspecified reason|1|||
28165339|NCT02910713|54836030|FG000|Overall Study|Protocol Violation|2|||
28165340|NCT02910713|54836030|FG000|Overall Study|Subject Choice|4|||
28165341|NCT02910713|54836030|FG000|Overall Study|Received One Application|10|||
28165342|NCT02910713|54836030|FG000|Overall Study|Received Neither Application|18|||
28165343|NCT02910713|54836030|FG000|Overall Study|Enrollment cap|7|||
28165344|NCT02910713|54836030|FG000|Overall Study|Investigator Discretion|1|||
28165345|NCT02998541|54836038|FG000|Overall Study|Adverse Event|4|||
28165346|NCT02998541|54836039|FG001|Overall Study|Adverse Event|5|||
28165347|NCT02998541|54836040|FG002|Overall Study|Adverse Event|1|||
28165348|NCT02998541|54836038|FG000|Overall Study|Protocol Violation|1|||
27972632|NCT01008995|54630336|FG003|Controlled Period|Adverse Event|0|||
27972633|NCT01008995|54630333|FG000|Controlled Period|Other|2|||
28085347|NCT00040664|54738879|FG001|Overall Study|Change of formulation|2|||
28085348|NCT00040664|54738880|FG002|Overall Study|Change of formulation|0|||
28085349|NCT00040664|54738881|FG003|Overall Study|Change of formulation|0|||
27732985|NCT00705783|54180680|FG001|Depot Stabilization Phase|Withdrawn by Investigator|0|||
28085350|NCT00040664|54738878|FG000|Overall Study|Non-viability of oral suspension|1|||
28085351|NCT00040664|54738879|FG001|Overall Study|Non-viability of oral suspension|0|||
28085352|NCT00040664|54738880|FG002|Overall Study|Non-viability of oral suspension|1|||
28085353|NCT00040664|54738881|FG003|Overall Study|Non-viability of oral suspension|0|||
28085354|NCT02952586|54738901|FG000|Lead-In Phase (7 Days)|Death|0|||
28085355|NCT02952586|54738902|FG001|Lead-In Phase (7 Days)|Death|1|||
28085356|NCT02952586|54738901|FG000|Lead-In Phase (7 Days)|Adverse Event|3|||
28085357|NCT02952586|54738902|FG001|Lead-In Phase (7 Days)|Adverse Event|0|||
28165349|NCT02998541|54836039|FG001|Overall Study|Protocol Violation|0|||
28165350|NCT02998541|54836040|FG002|Overall Study|Protocol Violation|0|||
28165351|NCT02998541|54836038|FG000|Overall Study|Withdrawal by Subject|3|||
28165352|NCT02998541|54836039|FG001|Overall Study|Withdrawal by Subject|1|||
28165353|NCT02998541|54836040|FG002|Overall Study|Withdrawal by Subject|0|||
27972634|NCT01008995|54630334|FG001|Controlled Period|Other|1|||
27972635|NCT01008995|54630335|FG002|Controlled Period|Other|0|||
27972636|NCT01008995|54630336|FG003|Controlled Period|Other|0|||
27972637|NCT01008995|54630333|FG000|After Controlled Period|Adverse Event|0|||
27972638|NCT01008995|54630334|FG001|After Controlled Period|Adverse Event|0|||
27972639|NCT01008995|54630335|FG002|After Controlled Period|Adverse Event|1|||
27972640|NCT01008995|54630336|FG003|After Controlled Period|Adverse Event|1|||
27972641|NCT01008995|54630333|FG000|After Controlled Period|Other|0|||
27972642|NCT01008995|54630334|FG001|After Controlled Period|Other|0|||
27972643|NCT01008995|54630335|FG002|After Controlled Period|Other|1|||
27972644|NCT01008995|54630336|FG003|After Controlled Period|Other|0|||
27972645|NCT00957944|54630346|FG000|First Intervention- 24 Hours|Withdrawal by Subject|0|||
27972646|NCT00957944|54630347|FG001|First Intervention- 24 Hours|Withdrawal by Subject|1|||
27972647|NCT01005875|54630353|FG000|Overall Study|Death|3|||
27972648|NCT01005719|54630357|FG000|Period 1|Adverse Event|0|||
27972649|NCT01005719|54630358|FG001|Period 1|Adverse Event|0|||
27972650|NCT01005719|54630359|FG002|Period 1|Adverse Event|0|||
27972651|NCT01005719|54630360|FG003|Period 1|Adverse Event|1|||
27972652|NCT01005719|54630361|FG004|Period 1|Adverse Event|0|||
27972653|NCT01005719|54630362|FG005|Period 1|Adverse Event|0|||
27972654|NCT01005719|54630357|FG000|Period 1|Delay in completing study procedures|0|||
28165354|NCT02998541|54836038|FG000|Overall Study|Lost to Follow-up|0|||
28165355|NCT02998541|54836039|FG001|Overall Study|Lost to Follow-up|3|||
28165356|NCT02998541|54836040|FG002|Overall Study|Lost to Follow-up|1|||
28165357|NCT02998541|54836038|FG000|Overall Study|Physician Decision|0|||
28165358|NCT02998541|54836039|FG001|Overall Study|Physician Decision|0|||
27972655|NCT01005719|54630358|FG001|Period 1|Delay in completing study procedures|0|||
27972656|NCT01005719|54630359|FG002|Period 1|Delay in completing study procedures|0|||
27972657|NCT01005719|54630360|FG003|Period 1|Delay in completing study procedures|0|||
27972658|NCT01005719|54630361|FG004|Period 1|Delay in completing study procedures|0|||
27972659|NCT01005719|54630362|FG005|Period 1|Delay in completing study procedures|1|||
27972660|NCT01005719|54630357|FG000|Period 2|Adverse Event|0|||
27972661|NCT01005719|54630358|FG001|Period 2|Adverse Event|0|||
27972662|NCT01005719|54630359|FG002|Period 2|Adverse Event|0|||
27972663|NCT01005719|54630360|FG003|Period 2|Adverse Event|0|||
27972664|NCT01005719|54630361|FG004|Period 2|Adverse Event|1|||
27972665|NCT01005719|54630362|FG005|Period 2|Adverse Event|1|||
27972666|NCT00953576|54630373|FG000|Overall Study|Adverse Event|0|||
27972667|NCT00953576|54630374|FG001|Overall Study|Adverse Event|1|||
27972668|NCT00953576|54630373|FG000|Overall Study|Ineligible after Consent|2|||
27972669|NCT00953576|54630374|FG001|Overall Study|Ineligible after Consent|0|||
27972670|NCT01005329|54630389|FG000|Overall Study|Ineligible or received no protocol trt.|4|||
28085358|NCT02952586|54738901|FG000|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|0|||
28085359|NCT02952586|54738902|FG001|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|1|||
28085360|NCT02952586|54738901|FG000|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
28085361|NCT02952586|54738902|FG001|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
28085362|NCT02952586|54738901|FG000|CRT for Avelumab or Placebo (63 Days)|Death|5|||
28085363|NCT02952586|54738902|FG001|CRT for Avelumab or Placebo (63 Days)|Death|8|||
28085364|NCT02952586|54738901|FG000|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
28085365|NCT02952586|54738902|FG001|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
28085366|NCT02952586|54738901|FG000|CRT for Avelumab or Placebo (63 Days)|Physician Decision|2|||
27972671|NCT01005251|54630399|FG000|Overall Study|Withdrawal by Subject|2|||
27972672|NCT01005251|54630400|FG001|Overall Study|Withdrawal by Subject|5|||
28085367|NCT02952586|54738902|FG001|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1|||
28085368|NCT02952586|54738901|FG000|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|1|||
28085369|NCT02952586|54738902|FG001|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|0|||
28085370|NCT02952586|54738901|FG000|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10|||
28085371|NCT02952586|54738902|FG001|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4|||
28085372|NCT02952586|54738901|FG000|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
27972673|NCT01005251|54630401|FG002|Overall Study|Withdrawal by Subject|3|||
27972674|NCT01005251|54630402|FG003|Overall Study|Withdrawal by Subject|4|||
27972675|NCT01005251|54630403|FG004|Overall Study|Withdrawal by Subject|9|||
27972676|NCT01005251|54630399|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
27972677|NCT01005251|54630400|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
27972678|NCT01005251|54630401|FG002|Overall Study|Eligibility criteria not fulfilled|4|||
27972679|NCT01005251|54630402|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
27972680|NCT01005251|54630403|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
27972681|NCT01005251|54630399|FG000|Overall Study|Adverse Event|2|||
27972682|NCT01005251|54630400|FG001|Overall Study|Adverse Event|6|||
27972683|NCT01005251|54630401|FG002|Overall Study|Adverse Event|8|||
27972684|NCT01005251|54630402|FG003|Overall Study|Adverse Event|5|||
27972685|NCT01005251|54630403|FG004|Overall Study|Adverse Event|4|||
28085373|NCT02952586|54738902|FG001|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
28085374|NCT02952586|54738901|FG000|CRT for Avelumab or Placebo (63 Days)|Other|2|||
28085375|NCT02952586|54738902|FG001|CRT for Avelumab or Placebo (63 Days)|Other|1|||
28085376|NCT02952586|54738901|FG000|CRT for Cisplatin (63 Days)|Death|3|||
28085377|NCT02952586|54738902|FG001|CRT for Cisplatin (63 Days)|Death|8|||
28085378|NCT02952586|54738901|FG000|CRT for Cisplatin (63 Days)|Adverse Event|82|||
28085379|NCT02952586|54738902|FG001|CRT for Cisplatin (63 Days)|Adverse Event|81|||
28085380|NCT02952586|54738901|FG000|CRT for Cisplatin (63 Days)|Physician Decision|12|||
28085381|NCT02952586|54738902|FG001|CRT for Cisplatin (63 Days)|Physician Decision|10|||
28085382|NCT02952586|54738901|FG000|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|1|||
28085383|NCT02952586|54738902|FG001|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|0|||
28085384|NCT02952586|54738901|FG000|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11|||
28085385|NCT02952586|54738902|FG001|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3|||
28085386|NCT02952586|54738901|FG000|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
28085387|NCT02952586|54738902|FG001|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
28085388|NCT02952586|54738901|FG000|CRT for Cisplatin (63 Days)|Other|1|||
28085389|NCT02952586|54738902|FG001|CRT for Cisplatin (63 Days)|Other|1|||
28085390|NCT02952586|54738901|FG000|CRT for IMRT (63 Days)|Death|5|||
28085391|NCT02952586|54738902|FG001|CRT for IMRT (63 Days)|Death|8|||
28085392|NCT02952586|54738901|FG000|CRT for IMRT (63 Days)|Adverse Event|5|||
28085393|NCT02952586|54738902|FG001|CRT for IMRT (63 Days)|Adverse Event|5|||
28085394|NCT02952586|54738901|FG000|CRT for IMRT (63 Days)|Global Deterioration of Health Status|1|||
28085395|NCT02952586|54738902|FG001|CRT for IMRT (63 Days)|Global Deterioration of Health Status|0|||
28085396|NCT02952586|54738901|FG000|CRT for IMRT (63 Days)|Withdrawal by Subject|10|||
28085397|NCT02952586|54738902|FG001|CRT for IMRT (63 Days)|Withdrawal by Subject|6|||
28085398|NCT02952586|54738901|FG000|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
27972686|NCT01005251|54630399|FG000|Overall Study|Protocol Violation|1|||
27972687|NCT01005251|54630400|FG001|Overall Study|Protocol Violation|0|||
27972688|NCT01005251|54630401|FG002|Overall Study|Protocol Violation|0|||
27972689|NCT01005251|54630402|FG003|Overall Study|Protocol Violation|0|||
27972690|NCT01005251|54630403|FG004|Overall Study|Protocol Violation|2|||
27972691|NCT01005251|54630399|FG000|Overall Study|Developed study-specific withdrawal crit|2|||
27972692|NCT01005251|54630400|FG001|Overall Study|Developed study-specific withdrawal crit|0|||
27972693|NCT01005251|54630401|FG002|Overall Study|Developed study-specific withdrawal crit|3|||
27972694|NCT01005251|54630402|FG003|Overall Study|Developed study-specific withdrawal crit|0|||
27972695|NCT01005251|54630403|FG004|Overall Study|Developed study-specific withdrawal crit|1|||
27972696|NCT01005251|54630399|FG000|Overall Study|Lost to Follow-up|1|||
27972697|NCT01005251|54630400|FG001|Overall Study|Lost to Follow-up|4|||
27972698|NCT01005251|54630401|FG002|Overall Study|Lost to Follow-up|2|||
27972699|NCT01005251|54630402|FG003|Overall Study|Lost to Follow-up|0|||
27972700|NCT01005251|54630403|FG004|Overall Study|Lost to Follow-up|0|||
27972701|NCT01005251|54630399|FG000|Overall Study|Physician Decision|0|||
27972702|NCT01005251|54630400|FG001|Overall Study|Physician Decision|0|||
27972703|NCT01005251|54630401|FG002|Overall Study|Physician Decision|0|||
27972704|NCT01005251|54630402|FG003|Overall Study|Physician Decision|0|||
28085399|NCT02952586|54738902|FG001|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
28085400|NCT02952586|54738901|FG000|CRT for IMRT (63 Days)|Other|1|||
28085401|NCT02952586|54738902|FG001|CRT for IMRT (63 Days)|Other|0|||
28085402|NCT02952586|54738901|FG000|Maintenance Phase (12 Months)|Death|17|||
28085403|NCT02952586|54738902|FG001|Maintenance Phase (12 Months)|Death|11|||
28085404|NCT02952586|54738901|FG000|Maintenance Phase (12 Months)|Progressive disease|60|||
28085405|NCT02952586|54738902|FG001|Maintenance Phase (12 Months)|Progressive disease|54|||
28085406|NCT02952586|54738901|FG000|Maintenance Phase (12 Months)|Adverse Event|24|||
28085407|NCT02952586|54738902|FG001|Maintenance Phase (12 Months)|Adverse Event|21|||
28085408|NCT02952586|54738901|FG000|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
28085409|NCT02952586|54738902|FG001|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
28085410|NCT02952586|54738901|FG000|Maintenance Phase (12 Months)|Physician Decision|1|||
28085411|NCT02952586|54738902|FG001|Maintenance Phase (12 Months)|Physician Decision|1|||
28085412|NCT02952586|54738901|FG000|Maintenance Phase (12 Months)|Global Deterioration of Health Status|14|||
28085413|NCT02952586|54738902|FG001|Maintenance Phase (12 Months)|Global Deterioration of Health Status|5|||
28085414|NCT02952586|54738901|FG000|Maintenance Phase (12 Months)|Withdrawal by Subject|31|||
28085415|NCT02952586|54738902|FG001|Maintenance Phase (12 Months)|Withdrawal by Subject|25|||
28085416|NCT02952586|54738901|FG000|Maintenance Phase (12 Months)|Lost to Follow-up|1|||
28085417|NCT02952586|54738902|FG001|Maintenance Phase (12 Months)|Lost to Follow-up|2|||
28165359|NCT02998541|54836040|FG002|Overall Study|Physician Decision|3|||
28085418|NCT02952586|54738901|FG000|Maintenance Phase (12 Months)|Other|2|||
28085419|NCT02952586|54738902|FG001|Maintenance Phase (12 Months)|Other|1|||
28085420|NCT02952586|54738901|FG000|Maintenance Phase (12 Months)|Study Terminated by Sponsor|1|||
28165360|NCT02998541|54836038|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
27972705|NCT01005251|54630403|FG004|Overall Study|Physician Decision|2|||
27972706|NCT01005251|54630399|FG000|Overall Study|Patient moved|1|||
27972707|NCT01005251|54630400|FG001|Overall Study|Patient moved|0|||
27972708|NCT01005251|54630401|FG002|Overall Study|Patient moved|0|||
27972709|NCT01005251|54630402|FG003|Overall Study|Patient moved|0|||
27972710|NCT01005251|54630403|FG004|Overall Study|Patient moved|0|||
27972711|NCT01005251|54630399|FG000|Overall Study|Wrong drug dispensed|0|||
27972712|NCT01005251|54630400|FG001|Overall Study|Wrong drug dispensed|1|||
27972713|NCT01005251|54630401|FG002|Overall Study|Wrong drug dispensed|0|||
27972714|NCT01005251|54630402|FG003|Overall Study|Wrong drug dispensed|0|||
27972715|NCT01005251|54630403|FG004|Overall Study|Wrong drug dispensed|0|||
27972716|NCT01005251|54630399|FG000|Overall Study|Randomized in error|0|||
27972717|NCT01005251|54630400|FG001|Overall Study|Randomized in error|0|||
27972718|NCT01005251|54630401|FG002|Overall Study|Randomized in error|1|||
27972719|NCT01005251|54630402|FG003|Overall Study|Randomized in error|1|||
27972720|NCT01005251|54630403|FG004|Overall Study|Randomized in error|0|||
27972721|NCT01005251|54630399|FG000|Overall Study|Lack of Efficacy|0|||
27972722|NCT01005251|54630400|FG001|Overall Study|Lack of Efficacy|0|||
27972723|NCT01005251|54630401|FG002|Overall Study|Lack of Efficacy|1|||
27972724|NCT01005251|54630402|FG003|Overall Study|Lack of Efficacy|1|||
27972725|NCT01005251|54630403|FG004|Overall Study|Lack of Efficacy|0|||
27972726|NCT03048578|54630417|FG000|Overall Study|Withdrawal by Subject|5|||
27972727|NCT03048578|54630418|FG001|Overall Study|Withdrawal by Subject|6|||
27972728|NCT03048578|54630417|FG000|Overall Study|Lost to Follow-up|22|||
27972729|NCT03048578|54630418|FG001|Overall Study|Lost to Follow-up|10|||
28085421|NCT02952586|54738902|FG001|Maintenance Phase (12 Months)|Study Terminated by Sponsor|6|||
28085422|NCT02952586|54738901|FG000|Follow-Up Phase (90 Days)|Death|12|||
28085423|NCT02952586|54738902|FG001|Follow-Up Phase (90 Days)|Death|10|||
28085424|NCT02952586|54738901|FG000|Follow-Up Phase (90 Days)|Withdrawal by Subject|6|||
28085425|NCT02952586|54738902|FG001|Follow-Up Phase (90 Days)|Withdrawal by Subject|2|||
28085426|NCT02952586|54738901|FG000|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
28085427|NCT02952586|54738902|FG001|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
28085428|NCT02952586|54738901|FG000|Follow-Up Phase (90 Days)|Other|7|||
28085429|NCT02952586|54738902|FG001|Follow-Up Phase (90 Days)|Other|5|||
28085430|NCT02952586|54738901|FG000|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|32|||
28085431|NCT02952586|54738902|FG001|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|50|||
28085432|NCT02952586|54738901|FG000|LT Follow-up (up to 45 Months)|Death|51|||
28085433|NCT02952586|54738902|FG001|LT Follow-up (up to 45 Months)|Death|31|||
28085434|NCT02952586|54738901|FG000|LT Follow-up (up to 45 Months)|Withdrawal by Subject|7|||
28085435|NCT02952586|54738902|FG001|LT Follow-up (up to 45 Months)|Withdrawal by Subject|1|||
28085436|NCT02952586|54738901|FG000|LT Follow-up (up to 45 Months)|Lost to Follow-up|2|||
28085437|NCT02952586|54738902|FG001|LT Follow-up (up to 45 Months)|Lost to Follow-up|4|||
28085438|NCT02952586|54738901|FG000|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|187|||
28085439|NCT02952586|54738902|FG001|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|201|||
28085440|NCT03384316|54738911|FG000|Overall Study|Screen failure|0|||
28085441|NCT03384316|54738912|FG001|Overall Study|Screen failure|1|||
28085442|NCT03403192|54738924|FG000|Overall Study|Lost to Follow-up|1|||
28085443|NCT03403192|54738925|FG001|Overall Study|Lost to Follow-up|2|||
28085444|NCT03403192|54738926|FG002|Overall Study|Lost to Follow-up|0|||
28085445|NCT03403192|54738927|FG003|Overall Study|Lost to Follow-up|0|||
28085446|NCT03403192|54738924|FG000|Overall Study|Unable to respond|0|||
28085447|NCT03403192|54738925|FG001|Overall Study|Unable to respond|1|||
28085448|NCT03403192|54738926|FG002|Overall Study|Unable to respond|0|||
28085449|NCT03403192|54738927|FG003|Overall Study|Unable to respond|0|||
28085450|NCT03403192|54738924|FG000|Overall Study|Incomplete|3|||
28085451|NCT03403192|54738925|FG001|Overall Study|Incomplete|1|||
28085452|NCT03403192|54738926|FG002|Overall Study|Incomplete|3|||
28085453|NCT03403192|54738927|FG003|Overall Study|Incomplete|6|||
28085454|NCT00356525|54738941|FG000|Overall Study|Progressive Disease|8|||
28085455|NCT00356525|54738942|FG001|Overall Study|Progressive Disease|5|||
28085456|NCT00356525|54738943|FG002|Overall Study|Progressive Disease|4|||
28085457|NCT00356525|54738944|FG003|Overall Study|Progressive Disease|2|||
28085458|NCT00356525|54738941|FG000|Overall Study|Adverse Event|1|||
28085459|NCT00356525|54738942|FG001|Overall Study|Adverse Event|3|||
28085460|NCT00356525|54738943|FG002|Overall Study|Adverse Event|1|||
28085461|NCT00356525|54738944|FG003|Overall Study|Adverse Event|1|||
27732986|NCT00705783|54180681|FG002|Depot Stabilization Phase|Withdrawn by Investigator|0|||
28085462|NCT00356525|54738941|FG000|Overall Study|Lost to Follow-up|1|||
28085463|NCT00356525|54738942|FG001|Overall Study|Lost to Follow-up|0|||
28085464|NCT00356525|54738943|FG002|Overall Study|Lost to Follow-up|0|||
28085465|NCT00356525|54738944|FG003|Overall Study|Lost to Follow-up|0|||
28085466|NCT00356525|54738941|FG000|Overall Study|Physician Decision|2|||
28085467|NCT00356525|54738942|FG001|Overall Study|Physician Decision|2|||
28085468|NCT00356525|54738943|FG002|Overall Study|Physician Decision|2|||
28085469|NCT00356525|54738944|FG003|Overall Study|Physician Decision|1|||
28085470|NCT00356525|54738941|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
28085471|NCT00356525|54738942|FG001|Overall Study|Protocol Entry Criteria Not Met|0|||
27972730|NCT03048578|54630417|FG000|Overall Study|Adverse Event|1|||
27972731|NCT03048578|54630418|FG001|Overall Study|Adverse Event|2|||
27972732|NCT03048578|54630417|FG000|Overall Study|Terminated|3|||
27972733|NCT03048578|54630418|FG001|Overall Study|Terminated|2|||
27972734|NCT01008449|54630426|FG000|Overall Study|Lost to Follow-up|29|||
27972735|NCT01008449|54630427|FG001|Overall Study|Lost to Follow-up|19|||
27972736|NCT00696241|54630438|FG000|Overall Study|Adverse Event|11|||
27972737|NCT00696241|54630439|FG001|Overall Study|Adverse Event|3|||
27972738|NCT00696241|54630440|FG002|Overall Study|Adverse Event|6|||
27972739|NCT00696241|54630441|FG003|Overall Study|Adverse Event|4|||
27972740|NCT00696241|54630442|FG004|Overall Study|Adverse Event|5|||
27972741|NCT00696241|54630438|FG000|Overall Study|Protocol Violation|1|||
27972742|NCT00696241|54630439|FG001|Overall Study|Protocol Violation|1|||
27972743|NCT00696241|54630440|FG002|Overall Study|Protocol Violation|2|||
27972744|NCT00696241|54630441|FG003|Overall Study|Protocol Violation|0|||
27972745|NCT00696241|54630442|FG004|Overall Study|Protocol Violation|3|||
27972746|NCT00696241|54630438|FG000|Overall Study|Lost to Follow-up|1|||
27972747|NCT00696241|54630439|FG001|Overall Study|Lost to Follow-up|4|||
27972748|NCT00696241|54630440|FG002|Overall Study|Lost to Follow-up|1|||
27972749|NCT00696241|54630441|FG003|Overall Study|Lost to Follow-up|2|||
27972750|NCT00696241|54630442|FG004|Overall Study|Lost to Follow-up|0|||
27972751|NCT00696241|54630438|FG000|Overall Study|Withdrawal by Subject|4|||
27972752|NCT00696241|54630439|FG001|Overall Study|Withdrawal by Subject|8|||
27972753|NCT00696241|54630440|FG002|Overall Study|Withdrawal by Subject|6|||
27972754|NCT00696241|54630441|FG003|Overall Study|Withdrawal by Subject|1|||
27972755|NCT00696241|54630442|FG004|Overall Study|Withdrawal by Subject|0|||
27972756|NCT00696241|54630438|FG000|Overall Study|Lack of Efficacy|1|||
27972757|NCT00696241|54630439|FG001|Overall Study|Lack of Efficacy|5|||
27972758|NCT00696241|54630440|FG002|Overall Study|Lack of Efficacy|4|||
27972759|NCT00696241|54630441|FG003|Overall Study|Lack of Efficacy|5|||
27972760|NCT00696241|54630442|FG004|Overall Study|Lack of Efficacy|3|||
27972761|NCT00696241|54630438|FG000|Overall Study|Other|6|||
27972762|NCT00696241|54630439|FG001|Overall Study|Other|1|||
27972763|NCT00696241|54630440|FG002|Overall Study|Other|5|||
27972764|NCT00696241|54630441|FG003|Overall Study|Other|2|||
27972765|NCT00696241|54630442|FG004|Overall Study|Other|1|||
27972766|NCT00957008|54630458|FG000|Overall Study|Withdrawal by Subject|13|||
27972767|NCT00957008|54630459|FG001|Overall Study|Withdrawal by Subject|10|||
27972768|NCT00957008|54630460|FG002|Overall Study|Withdrawal by Subject|12|||
27972769|NCT00957008|54630461|FG003|Overall Study|Withdrawal by Subject|16|||
27972770|NCT00957008|54630458|FG000|Overall Study|Lost to Follow-up|3|||
27972771|NCT00957008|54630459|FG001|Overall Study|Lost to Follow-up|1|||
27972772|NCT00957008|54630460|FG002|Overall Study|Lost to Follow-up|3|||
27972773|NCT00957008|54630461|FG003|Overall Study|Lost to Follow-up|4|||
27972774|NCT00957008|54630458|FG000|Overall Study|Physician Decision|1|||
27972775|NCT00957008|54630459|FG001|Overall Study|Physician Decision|0|||
27972776|NCT00957008|54630460|FG002|Overall Study|Physician Decision|1|||
27972777|NCT00957008|54630461|FG003|Overall Study|Physician Decision|1|||
27972778|NCT00957008|54630458|FG000|Overall Study|Relocated; Family conflict|4|||
27972779|NCT00957008|54630459|FG001|Overall Study|Relocated; Family conflict|1|||
27972780|NCT00957008|54630460|FG002|Overall Study|Relocated; Family conflict|1|||
27972781|NCT00957008|54630461|FG003|Overall Study|Relocated; Family conflict|3|||
27972782|NCT00952484|54630478|FG000|Overall Study|Withdrawal by Subject|0|||
27972783|NCT00952484|54630479|FG001|Overall Study|Withdrawal by Subject|1|||
27972784|NCT00952484|54630480|FG002|Overall Study|Withdrawal by Subject|0|||
27972785|NCT00689611|54630491|FG000|Overall Study|Death|6|||
27972786|NCT00689611|54630492|FG001|Overall Study|Death|9|||
27972787|NCT00689611|54630491|FG000|Overall Study|Withdrawal by Subject|8|||
27972788|NCT00689611|54630492|FG001|Overall Study|Withdrawal by Subject|9|||
27972789|NCT00689611|54630491|FG000|Overall Study|Lost to Follow-up|27|||
27972790|NCT00689611|54630492|FG001|Overall Study|Lost to Follow-up|28|||
27972791|NCT00689299|54630501|FG000|Overall Study|Adverse Event|2|||
27972792|NCT00689299|54630502|FG001|Overall Study|Adverse Event|1|||
27972793|NCT00689299|54630503|FG002|Overall Study|Adverse Event|1|||
27972794|NCT00689299|54630501|FG000|Overall Study|Lost to Follow-up|0|||
27972795|NCT00689299|54630502|FG001|Overall Study|Lost to Follow-up|1|||
27972796|NCT00689299|54630503|FG002|Overall Study|Lost to Follow-up|1|||
27972797|NCT00689299|54630501|FG000|Overall Study|Withdrawal by Subject|4|||
27972798|NCT00689299|54630502|FG001|Overall Study|Withdrawal by Subject|1|||
27972799|NCT00689299|54630503|FG002|Overall Study|Withdrawal by Subject|3|||
28085472|NCT00356525|54738943|FG002|Overall Study|Protocol Entry Criteria Not Met|0|||
28085473|NCT00356525|54738944|FG003|Overall Study|Protocol Entry Criteria Not Met|0|||
27832678|NCT01344018|54312277|FG000|Overall Study|Lost to Follow-up|4|||
27972800|NCT00689299|54630501|FG000|Overall Study|Protocol Violation|1|||
27972801|NCT00689299|54630502|FG001|Overall Study|Protocol Violation|0|||
27972802|NCT00689299|54630503|FG002|Overall Study|Protocol Violation|0|||
27972803|NCT02506244|54630514|FG000|Overall Study|Did not undergo active monitoring|458|||
27972804|NCT02506244|54630515|FG001|Overall Study|Did not undergo active monitoring|459|||
27972805|NCT02506244|54630516|FG002|Overall Study|Did not undergo active monitoring|0|||
27972806|NCT00948974|54630526|FG000|Overall Study|Lost to Follow-up|23|||
27972807|NCT00948974|54630527|FG001|Overall Study|Lost to Follow-up|20|||
27972808|NCT01007435|54630537|FG000|Overall Study|Adverse Event|16|||
27972809|NCT01007435|54630538|FG001|Overall Study|Adverse Event|25|||
27972810|NCT01007435|54630539|FG002|Overall Study|Adverse Event|47|||
27972811|NCT01007435|54630540|FG003|Overall Study|Adverse Event|31|||
27972812|NCT01007435|54630537|FG000|Overall Study|Death|2|||
27972813|NCT01007435|54630538|FG001|Overall Study|Death|4|||
27972814|NCT01007435|54630539|FG002|Overall Study|Death|2|||
27972815|NCT01007435|54630540|FG003|Overall Study|Death|1|||
27972816|NCT01007435|54630537|FG000|Overall Study|Insufficient Therapeutic Response|21|||
27972817|NCT01007435|54630538|FG001|Overall Study|Insufficient Therapeutic Response|7|||
27972818|NCT01007435|54630539|FG002|Overall Study|Insufficient Therapeutic Response|2|||
27972819|NCT01007435|54630540|FG003|Overall Study|Insufficient Therapeutic Response|9|||
27972820|NCT01007435|54630537|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
27972821|NCT01007435|54630538|FG001|Overall Study|Violation of Selection Criteria at Entry|5|||
27972822|NCT01007435|54630539|FG002|Overall Study|Violation of Selection Criteria at Entry|2|||
27972823|NCT01007435|54630540|FG003|Overall Study|Violation of Selection Criteria at Entry|0|||
27972824|NCT01007435|54630537|FG000|Overall Study|Other Protocol Violation|2|||
27972825|NCT01007435|54630538|FG001|Overall Study|Other Protocol Violation|0|||
27972826|NCT01007435|54630539|FG002|Overall Study|Other Protocol Violation|1|||
27972827|NCT01007435|54630540|FG003|Overall Study|Other Protocol Violation|0|||
27972828|NCT01007435|54630537|FG000|Overall Study|Refused Treatment|13|||
27972829|NCT01007435|54630538|FG001|Overall Study|Refused Treatment|13|||
27972830|NCT01007435|54630539|FG002|Overall Study|Refused Treatment|5|||
27972831|NCT01007435|54630540|FG003|Overall Study|Refused Treatment|8|||
27972832|NCT01007435|54630537|FG000|Overall Study|Failure to Return|5|||
27972833|NCT01007435|54630538|FG001|Overall Study|Failure to Return|4|||
28085474|NCT00356525|54738941|FG000|Overall Study|Withdrawal by Subject|1|||
27732987|NCT00705783|54180679|FG000|Depot Stabilization Phase|Withdrew Consent|29|||
27732988|NCT00705783|54180680|FG001|Depot Stabilization Phase|Withdrew Consent|0|||
27732989|NCT00705783|54180681|FG002|Depot Stabilization Phase|Withdrew Consent|0|||
27732990|NCT00705783|54180679|FG000|Depot Stabilization Phase|Adverse Event|17|||
27732991|NCT00705783|54180680|FG001|Depot Stabilization Phase|Adverse Event|0|||
27732992|NCT00705783|54180681|FG002|Depot Stabilization Phase|Adverse Event|0|||
27732993|NCT00705783|54180679|FG000|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12|||
27732994|NCT00705783|54180680|FG001|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
27732995|NCT00705783|54180681|FG002|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
27732996|NCT00705783|54180679|FG000|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1|||
27732997|NCT00705783|54180680|FG001|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
27732998|NCT00705783|54180681|FG002|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
27732999|NCT00705783|54180679|FG000|Depot Maintenance Phase|Sponsor Discontinued Study|0|||
27733000|NCT00705783|54180680|FG001|Depot Maintenance Phase|Sponsor Discontinued Study|179|||
27733001|NCT00705783|54180681|FG002|Depot Maintenance Phase|Sponsor Discontinued Study|58|||
27733002|NCT00705783|54180679|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
27733003|NCT00705783|54180680|FG001|Depot Maintenance Phase|Lost to Follow-up|5|||
27733004|NCT00705783|54180681|FG002|Depot Maintenance Phase|Lost to Follow-up|3|||
27733005|NCT00705783|54180679|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
27733006|NCT00705783|54180680|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
27733007|NCT00705783|54180681|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
27733008|NCT00705783|54180679|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
27733009|NCT00705783|54180680|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
27733010|NCT00705783|54180681|FG002|Depot Maintenance Phase|Withdrawn by Investigator|6|||
27733011|NCT00705783|54180679|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
27733012|NCT00705783|54180680|FG001|Depot Maintenance Phase|Withdrew Consent|14|||
27733013|NCT00705783|54180681|FG002|Depot Maintenance Phase|Withdrew Consent|4|||
27733014|NCT00705783|54180679|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
27733015|NCT00705783|54180680|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
27733016|NCT00705783|54180681|FG002|Depot Maintenance Phase|Protocol Deviation|0|||
27733017|NCT00705783|54180679|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
27733018|NCT00705783|54180680|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|9|||
27733019|NCT00705783|54180681|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|5|||
27733020|NCT00705783|54180679|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
27733021|NCT00705783|54180680|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|11|||
27733022|NCT00705783|54180681|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
27733023|NCT00705783|54180679|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
27733024|NCT00705783|54180680|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|16|||
27855537|NCT03761277|54379788|FG000|Enrollment to Implant|Screen Failure|17|||
27972834|NCT01007435|54630539|FG002|Overall Study|Failure to Return|3|||
27972835|NCT01007435|54630540|FG003|Overall Study|Failure to Return|6|||
27972836|NCT01007435|54630537|FG000|Overall Study|Reason not Specified|1|||
27972837|NCT01007435|54630538|FG001|Overall Study|Reason not Specified|1|||
28085475|NCT00356525|54738942|FG001|Overall Study|Withdrawal by Subject|1|||
27972838|NCT01007435|54630539|FG002|Overall Study|Reason not Specified|2|||
27972839|NCT01007435|54630540|FG003|Overall Study|Reason not Specified|1|||
27972840|NCT00948896|54630558|FG000|Randomization to 24 Months of Age|Death|1|||
27972841|NCT00948896|54630559|FG001|Randomization to 24 Months of Age|Death|0|||
27972842|NCT00948896|54630560|FG002|Randomization to 24 Months of Age|Death|0|||
27972843|NCT00948896|54630561|FG003|Randomization to 24 Months of Age|Death|0|||
27972844|NCT00948896|54630562|FG004|Randomization to 24 Months of Age|Death|2|||
27972845|NCT00948896|54630563|FG005|Randomization to 24 Months of Age|Death|1|||
27972846|NCT00948896|54630564|FG006|Randomization to 24 Months of Age|Death|2|||
27972847|NCT00948896|54630565|FG007|Randomization to 24 Months of Age|Death|1|||
27972848|NCT00948896|54630558|FG000|Randomization to 24 Months of Age|Withdrawal by Subject|3|||
27972849|NCT00948896|54630559|FG001|Randomization to 24 Months of Age|Withdrawal by Subject|5|||
27972850|NCT00948896|54630560|FG002|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
27972851|NCT00948896|54630561|FG003|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
27972852|NCT00948896|54630562|FG004|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
27972853|NCT00948896|54630563|FG005|Randomization to 24 Months of Age|Withdrawal by Subject|1|||
27972854|NCT00948896|54630564|FG006|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
27972855|NCT00948896|54630565|FG007|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
27972856|NCT00948896|54630558|FG000|Randomization to 24 Months of Age|Lost to Follow-up|4|||
27972857|NCT00948896|54630559|FG001|Randomization to 24 Months of Age|Lost to Follow-up|4|||
27972858|NCT00948896|54630560|FG002|Randomization to 24 Months of Age|Lost to Follow-up|2|||
27972859|NCT00948896|54630561|FG003|Randomization to 24 Months of Age|Lost to Follow-up|5|||
27972860|NCT00948896|54630562|FG004|Randomization to 24 Months of Age|Lost to Follow-up|0|||
27972861|NCT00948896|54630563|FG005|Randomization to 24 Months of Age|Lost to Follow-up|0|||
27972862|NCT00948896|54630564|FG006|Randomization to 24 Months of Age|Lost to Follow-up|1|||
27972863|NCT00948896|54630565|FG007|Randomization to 24 Months of Age|Lost to Follow-up|0|||
27972864|NCT00948896|54630558|FG000|Randomization to 24 Months of Age|Protocol Violation|0|||
27972865|NCT00948896|54630559|FG001|Randomization to 24 Months of Age|Protocol Violation|1|||
27972866|NCT00948896|54630560|FG002|Randomization to 24 Months of Age|Protocol Violation|0|||
27972867|NCT00948896|54630561|FG003|Randomization to 24 Months of Age|Protocol Violation|1|||
27972868|NCT00948896|54630562|FG004|Randomization to 24 Months of Age|Protocol Violation|0|||
27972869|NCT00948896|54630563|FG005|Randomization to 24 Months of Age|Protocol Violation|0|||
27972870|NCT00948896|54630564|FG006|Randomization to 24 Months of Age|Protocol Violation|1|||
27972871|NCT00948896|54630565|FG007|Randomization to 24 Months of Age|Protocol Violation|1|||
27972872|NCT00948896|54630558|FG000|Randomization to 24 Months of Age|Moved out of Study Area|0|||
27972873|NCT00948896|54630559|FG001|Randomization to 24 Months of Age|Moved out of Study Area|3|||
27972874|NCT00948896|54630560|FG002|Randomization to 24 Months of Age|Moved out of Study Area|3|||
27972875|NCT00948896|54630561|FG003|Randomization to 24 Months of Age|Moved out of Study Area|1|||
27972876|NCT00948896|54630562|FG004|Randomization to 24 Months of Age|Moved out of Study Area|0|||
27972877|NCT00948896|54630563|FG005|Randomization to 24 Months of Age|Moved out of Study Area|2|||
27972878|NCT00948896|54630564|FG006|Randomization to 24 Months of Age|Moved out of Study Area|0|||
27972879|NCT00948896|54630565|FG007|Randomization to 24 Months of Age|Moved out of Study Area|0|||
27972880|NCT00948896|54630558|FG000|24 Months of Age to 36 Months of Age|Death|0|||
27972881|NCT00948896|54630559|FG001|24 Months of Age to 36 Months of Age|Death|2|||
27972882|NCT00948896|54630560|FG002|24 Months of Age to 36 Months of Age|Death|2|||
27972883|NCT00948896|54630561|FG003|24 Months of Age to 36 Months of Age|Death|0|||
27972884|NCT00948896|54630562|FG004|24 Months of Age to 36 Months of Age|Death|0|||
27972885|NCT00948896|54630563|FG005|24 Months of Age to 36 Months of Age|Death|1|||
27972886|NCT00948896|54630564|FG006|24 Months of Age to 36 Months of Age|Death|0|||
27972887|NCT00948896|54630565|FG007|24 Months of Age to 36 Months of Age|Death|0|||
27972888|NCT00948896|54630558|FG000|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
27972889|NCT00948896|54630559|FG001|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
27972890|NCT00948896|54630560|FG002|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
27972891|NCT00948896|54630561|FG003|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
27972892|NCT00948896|54630562|FG004|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
27972893|NCT00948896|54630563|FG005|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
27972894|NCT00948896|54630564|FG006|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
27733025|NCT00705783|54180681|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|40|||
27733026|NCT02694549|54180690|FG000|Overall Study|screen failures|2|||
27733027|NCT02782325|54180696|FG000|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4|||
27733028|NCT02782325|54180697|FG001|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2|||
27733029|NCT02782325|54180698|FG002|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0|||
27733030|NCT02782325|54180696|FG000|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
27832679|NCT01344018|54312278|FG001|Overall Study|Lost to Follow-up|7|||
27832680|NCT01320085|54312287|FG000|Overall Study|Treatment Ongoing|0|||
27832681|NCT01320085|54312288|FG001|Overall Study|Treatment Ongoing|13|||
27832682|NCT01320085|54312289|FG002|Overall Study|Treatment Ongoing|2|||
27832683|NCT01320085|54312287|FG000|Overall Study|Disease Progression|26|||
27972895|NCT00948896|54630565|FG007|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
27832684|NCT01320085|54312288|FG001|Overall Study|Disease Progression|86|||
27972896|NCT00948896|54630558|FG000|24 Months of Age to 36 Months of Age|Lost to Follow-up|2|||
27972897|NCT00948896|54630559|FG001|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
27972898|NCT00948896|54630560|FG002|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
27972899|NCT00948896|54630561|FG003|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
27972900|NCT00948896|54630562|FG004|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
27972901|NCT00948896|54630563|FG005|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
27972902|NCT00948896|54630564|FG006|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
27972903|NCT00948896|54630565|FG007|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
27972904|NCT00948896|54630558|FG000|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
27972905|NCT00948896|54630559|FG001|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
27972906|NCT00948896|54630560|FG002|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
27972907|NCT00948896|54630561|FG003|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
27972908|NCT00948896|54630562|FG004|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
27972909|NCT00948896|54630563|FG005|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
27972910|NCT00948896|54630564|FG006|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
27972911|NCT00948896|54630565|FG007|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
27972912|NCT00948896|54630558|FG000|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
28085476|NCT00356525|54738943|FG002|Overall Study|Withdrawal by Subject|0|||
28085477|NCT00356525|54738944|FG003|Overall Study|Withdrawal by Subject|3|||
28085478|NCT00356525|54738941|FG000|Overall Study|Death|0|||
28085479|NCT00356525|54738942|FG001|Overall Study|Death|0|||
28085480|NCT00356525|54738943|FG002|Overall Study|Death|0|||
28085481|NCT00356525|54738944|FG003|Overall Study|Death|1|||
28085482|NCT00356525|54738941|FG000|Overall Study|Sponsor Decision|0|||
28085483|NCT00356525|54738942|FG001|Overall Study|Sponsor Decision|0|||
28085484|NCT00356525|54738943|FG002|Overall Study|Sponsor Decision|0|||
28085485|NCT00356525|54738944|FG003|Overall Study|Sponsor Decision|1|||
28085486|NCT00356369|54738956|FG000|Active Phase|Withdrawal by Subject|2|||
28085487|NCT00356369|54738957|FG001|Active Phase|Withdrawal by Subject|1|||
28085488|NCT03383614|54738967|FG000|Overall Study|Withdrawal by Subject|0|||
28085489|NCT03383614|54738968|FG001|Overall Study|Withdrawal by Subject|1|||
28085490|NCT03383614|54738969|FG002|Overall Study|Withdrawal by Subject|0|||
28085491|NCT03383614|54738970|FG003|Overall Study|Withdrawal by Subject|0|||
28085492|NCT03403036|54738985|FG000|Overall Study|Lack of Efficacy|5|||
28085493|NCT00356135|54738992|FG000|Overall Study|Protocol Violation|1|||
28085494|NCT00356135|54738993|FG001|Overall Study|Protocol Violation|0|||
28085495|NCT00356135|54738994|FG002|Overall Study|Protocol Violation|0|||
28085496|NCT00356135|54738992|FG000|Overall Study|Adverse Event|1|||
28085497|NCT00356135|54738993|FG001|Overall Study|Adverse Event|0|||
28085498|NCT00356135|54738994|FG002|Overall Study|Adverse Event|0|||
28085499|NCT00356135|54738992|FG000|Overall Study|Lost to Follow-up|0|||
28085500|NCT00356135|54738993|FG001|Overall Study|Lost to Follow-up|0|||
28085501|NCT00356135|54738994|FG002|Overall Study|Lost to Follow-up|1|||
28085502|NCT00356135|54738992|FG000|Overall Study|Physician Decision|1|||
28085503|NCT00356135|54738993|FG001|Overall Study|Physician Decision|1|||
28085504|NCT00356135|54738994|FG002|Overall Study|Physician Decision|1|||
27832685|NCT01320085|54312289|FG002|Overall Study|Disease Progression|16|||
27972913|NCT00948896|54630559|FG001|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
27972914|NCT00948896|54630560|FG002|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
27972915|NCT00948896|54630561|FG003|24 Months of Age to 36 Months of Age|Moved out of Study Area|1|||
27972916|NCT00948896|54630562|FG004|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
27972917|NCT00948896|54630563|FG005|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
27972918|NCT00948896|54630564|FG006|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
27972919|NCT00948896|54630565|FG007|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
27972920|NCT01004159|54630587|FG000|Overall Study|Adverse Event|2|||
27972921|NCT01004159|54630587|FG000|Overall Study|Disease Progression|18|||
27972922|NCT00948818|54630593|FG000|Overall Study|Adverse Event|10|||
27972923|NCT00948818|54630594|FG001|Overall Study|Adverse Event|32|||
27972924|NCT00948818|54630593|FG000|Overall Study|Protocol Violation|9|||
27972925|NCT00948818|54630594|FG001|Overall Study|Protocol Violation|10|||
27972926|NCT00948818|54630593|FG000|Overall Study|Withdrawal by Subject|25|||
27972927|NCT00948818|54630594|FG001|Overall Study|Withdrawal by Subject|25|||
27972928|NCT00948818|54630593|FG000|Overall Study|Lost to Follow-up|10|||
27972929|NCT00948818|54630594|FG001|Overall Study|Lost to Follow-up|17|||
27972930|NCT00948818|54630593|FG000|Overall Study|Lack of Efficacy|4|||
27972931|NCT00948818|54630594|FG001|Overall Study|Lack of Efficacy|5|||
27972932|NCT00948818|54630593|FG000|Overall Study|Other Reason|4|||
27972933|NCT00948818|54630594|FG001|Overall Study|Other Reason|5|||
28085505|NCT00356135|54738992|FG000|Overall Study|Subject non-compliance|1|||
28085506|NCT00356135|54738993|FG001|Overall Study|Subject non-compliance|1|||
28085507|NCT00356135|54738994|FG002|Overall Study|Subject non-compliance|3|||
28085508|NCT03383146|54739006|FG000|Overall Study|Screen Failure|1|||
28085509|NCT03383146|54739007|FG001|Overall Study|Screen Failure|0|||
28085510|NCT03383146|54739006|FG000|Overall Study|Adverse Event|6|||
27855538|NCT03761277|54379788|FG000|Enrollment to Implant|Withdrawal by Subject|17|||
27855539|NCT03761277|54379788|FG000|Enrollment to Implant|Physician Decision|2|||
27855540|NCT03761277|54379788|FG000|Enrollment to Implant|Site Closure|3|||
27855541|NCT03761277|54379788|FG000|Enrollment to Implant|Sponsor Request|2|||
27855542|NCT03761277|54379788|FG000|Post-Implant to 6 Months|Adverse Event|2|||
27972934|NCT00948506|54630605|FG000|Overall Study|Withdrawal by Subject|3|||
27972935|NCT00948506|54630606|FG001|Overall Study|Withdrawal by Subject|1|||
27972936|NCT00955682|54630617|FG000|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
27972937|NCT00955682|54630618|FG001|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
27972938|NCT00689221|54630634|FG000|Overall Study|Ongoing at cut-off date|39|||
27972939|NCT00689221|54630635|FG001|Overall Study|Ongoing at cut-off date|36|||
27972940|NCT01875445|54630643|FG000|Overall Study|Lost to Follow-up|5|||
27972941|NCT01875445|54630644|FG001|Overall Study|Lost to Follow-up|0|||
27972942|NCT01875445|54630643|FG000|Overall Study|Withdrawal by Subject|2|||
27972943|NCT01875445|54630644|FG001|Overall Study|Withdrawal by Subject|0|||
27972944|NCT00688909|54630650|FG000|Overall Study|Adverse Event|28|||
27972945|NCT00688909|54630650|FG000|Overall Study|Patient withdrew consent|2|||
27972946|NCT00688909|54630650|FG000|Overall Study|Administrative problems|1|||
27972947|NCT00688909|54630650|FG000|Overall Study|Protocol Violation|2|||
27972948|NCT00948428|54630658|FG000|Overall Study|Withdrawal by Subject|6|||
27972949|NCT00948428|54630659|FG001|Overall Study|Withdrawal by Subject|12|||
27972950|NCT00948428|54630660|FG002|Overall Study|Withdrawal by Subject|7|||
27972951|NCT00948428|54630658|FG000|Overall Study|Adverse Event|6|||
27972952|NCT00948428|54630659|FG001|Overall Study|Adverse Event|3|||
27733031|NCT02782325|54180697|FG001|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
27733032|NCT02782325|54180698|FG002|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4|||
27733033|NCT02693691|54180706|FG000|Primary Endpoint Analysis (First 12M)|Death|30|||
27733034|NCT02693691|54180706|FG000|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12|||
27733035|NCT02693691|54180706|FG000|Primary Endpoint Analysis (First 12M)|Physician Decision|7|||
27733036|NCT02693691|54180706|FG000|Primary Endpoint Analysis (First 12M)|Adverse Event|1|||
27733037|NCT02693691|54180706|FG000|Extended Follow-Up (Until Last pt 12M)|Death|12|||
27972953|NCT00948428|54630660|FG002|Overall Study|Adverse Event|0|||
27972954|NCT00948428|54630658|FG000|Overall Study|Lost to Follow-up|2|||
27972955|NCT00948428|54630659|FG001|Overall Study|Lost to Follow-up|1|||
27972956|NCT00948428|54630660|FG002|Overall Study|Lost to Follow-up|1|||
27972957|NCT00948428|54630658|FG000|Overall Study|Death|2|||
27972958|NCT00948428|54630659|FG001|Overall Study|Death|0|||
27972959|NCT00948428|54630660|FG002|Overall Study|Death|0|||
27972960|NCT00948428|54630658|FG000|Overall Study|Intercurrent Illness|1|||
27972961|NCT00948428|54630659|FG001|Overall Study|Intercurrent Illness|0|||
27972962|NCT00948428|54630660|FG002|Overall Study|Intercurrent Illness|0|||
27972963|NCT00948428|54630658|FG000|Overall Study|Non-compliance|1|||
27972964|NCT00948428|54630659|FG001|Overall Study|Non-compliance|2|||
27972965|NCT00948428|54630660|FG002|Overall Study|Non-compliance|0|||
27972966|NCT00948194|54630670|FG000|Overall Study|Blood drawn using incorrect test tube; sample invalid|1|||
27972967|NCT00948194|54630671|FG001|Overall Study|Blood drawn using incorrect test tube; sample invalid|0|||
27972968|NCT00691483|54630679|FG000|Overall Study|Adverse Event|14|||
27972969|NCT00691483|54630680|FG001|Overall Study|Adverse Event|6|||
27972970|NCT00691483|54630679|FG000|Overall Study|Lost to Follow-up|17|||
27972971|NCT00691483|54630680|FG001|Overall Study|Lost to Follow-up|10|||
27972972|NCT00691483|54630679|FG000|Overall Study|Withdrawal by Subject|24|||
27972973|NCT00691483|54630680|FG001|Overall Study|Withdrawal by Subject|7|||
27972974|NCT00691483|54630679|FG000|Overall Study|Other known cause|6|||
27972975|NCT00691483|54630680|FG001|Overall Study|Other known cause|1|||
27972976|NCT00691483|54630679|FG000|Overall Study|Randomized by not treated|7|||
28085511|NCT03383146|54739007|FG001|Overall Study|Adverse Event|18|||
28085512|NCT03383146|54739006|FG000|Overall Study|Lack of Efficacy|0|||
27733038|NCT02693691|54180706|FG000|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11|||
27832686|NCT01320085|54312287|FG000|Overall Study|Adverse Event|12|||
27832687|NCT01320085|54312288|FG001|Overall Study|Adverse Event|14|||
27832688|NCT01320085|54312289|FG002|Overall Study|Adverse Event|5|||
27832689|NCT01320085|54312287|FG000|Overall Study|Withdrawal by Subject|2|||
27832690|NCT01320085|54312288|FG001|Overall Study|Withdrawal by Subject|4|||
27832691|NCT01320085|54312289|FG002|Overall Study|Withdrawal by Subject|1|||
27832692|NCT01320085|54312287|FG000|Overall Study|Protocol Deviation|1|||
27832693|NCT01320085|54312288|FG001|Overall Study|Protocol Deviation|0|||
27832694|NCT01320085|54312289|FG002|Overall Study|Protocol Deviation|1|||
27832695|NCT01755767|54312324|FG000|Overall Study|Progressive Disease|8|||
27832696|NCT01755767|54312325|FG001|Overall Study|Progressive Disease|7|||
27832697|NCT01755767|54312326|FG002|Overall Study|Progressive Disease|91|||
27832698|NCT01755767|54312327|FG003|Overall Study|Progressive Disease|43|||
27832699|NCT01755767|54312324|FG000|Overall Study|Clinical Disease Progression|4|||
27832700|NCT01755767|54312325|FG001|Overall Study|Clinical Disease Progression|2|||
27832701|NCT01755767|54312326|FG002|Overall Study|Clinical Disease Progression|29|||
27832702|NCT01755767|54312327|FG003|Overall Study|Clinical Disease Progression|20|||
27972977|NCT00691483|54630680|FG001|Overall Study|Randomized by not treated|1|||
27972978|NCT00691093|54630686|FG000|Overall Study|Adverse Event|1|||
27972979|NCT00691093|54630686|FG000|Overall Study|Lost to Follow-up|1|||
27972980|NCT00691093|54630686|FG000|Overall Study|Lack of Efficacy|1|||
27972981|NCT00691093|54630686|FG000|Overall Study|Ongoing at Date of Cut-Off|4|||
27972982|NCT00947882|54630699|FG000|Overall Study|Adverse Event|0|||
27972983|NCT00947882|54630700|FG001|Overall Study|Adverse Event|1|||
27972984|NCT00947882|54630701|FG002|Overall Study|Adverse Event|4|||
27972985|NCT00947882|54630702|FG003|Overall Study|Adverse Event|4|||
27972986|NCT00947882|54630699|FG000|Overall Study|Withdrawal by Subject|2|||
27972987|NCT00947882|54630700|FG001|Overall Study|Withdrawal by Subject|0|||
27972988|NCT00947882|54630701|FG002|Overall Study|Withdrawal by Subject|8|||
27972989|NCT00947882|54630702|FG003|Overall Study|Withdrawal by Subject|2|||
27972990|NCT00947882|54630699|FG000|Overall Study|Protocol Violation|0|||
27972991|NCT00947882|54630700|FG001|Overall Study|Protocol Violation|0|||
27972992|NCT00947882|54630701|FG002|Overall Study|Protocol Violation|1|||
27972993|NCT00947882|54630702|FG003|Overall Study|Protocol Violation|0|||
27972994|NCT00947882|54630699|FG000|Overall Study|Lost to Follow-up|0|||
27972995|NCT00947882|54630700|FG001|Overall Study|Lost to Follow-up|2|||
27972996|NCT00947882|54630701|FG002|Overall Study|Lost to Follow-up|1|||
27972997|NCT00947882|54630702|FG003|Overall Study|Lost to Follow-up|0|||
27972998|NCT00947882|54630699|FG000|Overall Study|Other/Unknown|10|||
27972999|NCT00947882|54630700|FG001|Overall Study|Other/Unknown|13|||
27973000|NCT00947882|54630701|FG002|Overall Study|Other/Unknown|3|||
27973001|NCT00947882|54630702|FG003|Overall Study|Other/Unknown|6|||
27973002|NCT00947882|54630699|FG000|Overall Study|Trial Terminated by Sponsor|62|||
27973003|NCT00947882|54630700|FG001|Overall Study|Trial Terminated by Sponsor|61|||
27973004|NCT00947882|54630701|FG002|Overall Study|Trial Terminated by Sponsor|62|||
27973005|NCT00947882|54630702|FG003|Overall Study|Trial Terminated by Sponsor|70|||
27973006|NCT00688753|54630713|FG000|Overall Study|Disease progression|55|||
27973007|NCT00688753|54630713|FG000|Overall Study|Missing|1|||
27973008|NCT00688753|54630713|FG000|Overall Study|Death|9|||
27973009|NCT00688753|54630713|FG000|Overall Study|Withdrawal by Subject|3|||
27973010|NCT00688753|54630713|FG000|Overall Study|Adverse Event|20|||
27973011|NCT00688753|54630713|FG000|Overall Study|Protocol Violation|1|||
27973012|NCT00688753|54630713|FG000|Overall Study|Lost to Follow-up|3|||
27973013|NCT00951080|54630719|FG000|Overall Study|Adverse Event|3|||
27973014|NCT00951080|54630720|FG001|Overall Study|Adverse Event|3|||
27973015|NCT00951080|54630719|FG000|Overall Study|Lost to Follow-up|0|||
27973016|NCT00951080|54630720|FG001|Overall Study|Lost to Follow-up|1|||
27973017|NCT00951080|54630719|FG000|Overall Study|Physician Decision|4|||
27973018|NCT00951080|54630720|FG001|Overall Study|Physician Decision|1|||
27973019|NCT00951080|54630719|FG000|Overall Study|Other|19|||
27973020|NCT00951080|54630720|FG001|Overall Study|Other|22|||
27973021|NCT00946322|54630726|FG000|Pre-treatment|participant failure to follow up|1|||
27973022|NCT00946322|54630726|FG000|Post-treatment|participant failure to follow up|2|||
27973023|NCT00950690|54630730|FG000|Overall Study|Death|4|||
27973024|NCT00950690|54630730|FG000|Overall Study|Adverse Event|15|||
27973025|NCT00950690|54630730|FG000|Overall Study|Lack of Efficacy|22|||
27973026|NCT00950690|54630730|FG000|Overall Study|Lost to Follow-up|40|||
27973027|NCT00950690|54630730|FG000|Overall Study|Other|163|||
27973028|NCT00694369|54630739|FG000|Overall Study|Adverse Event|0|||
27973029|NCT00694369|54630740|FG001|Overall Study|Adverse Event|1|||
27973030|NCT00694369|54630741|FG002|Overall Study|Adverse Event|0|||
27973031|NCT00694369|54630742|FG003|Overall Study|Adverse Event|1|||
27973032|NCT00694369|54630743|FG004|Overall Study|Adverse Event|3|||
27973033|NCT00694369|54630739|FG000|Overall Study|Lost to Follow-up|0|||
27973034|NCT00694369|54630740|FG001|Overall Study|Lost to Follow-up|0|||
27973035|NCT00694369|54630741|FG002|Overall Study|Lost to Follow-up|1|||
27832703|NCT01755767|54312324|FG000|Overall Study|Radiographic Disease Progression|9|||
27973036|NCT00694369|54630742|FG003|Overall Study|Lost to Follow-up|1|||
27973037|NCT00694369|54630743|FG004|Overall Study|Lost to Follow-up|0|||
27973038|NCT00694369|54630739|FG000|Overall Study|Physician Decision|0|||
27973039|NCT00694369|54630740|FG001|Overall Study|Physician Decision|0|||
27973040|NCT00694369|54630741|FG002|Overall Study|Physician Decision|0|||
27973041|NCT00694369|54630742|FG003|Overall Study|Physician Decision|0|||
27973042|NCT00694369|54630743|FG004|Overall Study|Physician Decision|1|||
27973043|NCT00694369|54630739|FG000|Overall Study|Protocol Violation|0|||
27973044|NCT00694369|54630740|FG001|Overall Study|Protocol Violation|1|||
27973045|NCT00694369|54630741|FG002|Overall Study|Protocol Violation|0|||
27832704|NCT01755767|54312325|FG001|Overall Study|Radiographic Disease Progression|4|||
27832705|NCT01755767|54312326|FG002|Overall Study|Radiographic Disease Progression|44|||
27832706|NCT01755767|54312327|FG003|Overall Study|Radiographic Disease Progression|27|||
27973046|NCT00694369|54630742|FG003|Overall Study|Protocol Violation|0|||
27973047|NCT00694369|54630743|FG004|Overall Study|Protocol Violation|0|||
27973048|NCT00694369|54630739|FG000|Overall Study|Withdrawal by Subject|1|||
27973049|NCT00694369|54630740|FG001|Overall Study|Withdrawal by Subject|1|||
27973050|NCT00694369|54630741|FG002|Overall Study|Withdrawal by Subject|1|||
27973051|NCT00694369|54630742|FG003|Overall Study|Withdrawal by Subject|1|||
28085513|NCT03383146|54739007|FG001|Overall Study|Lack of Efficacy|3|||
27973052|NCT00694369|54630743|FG004|Overall Study|Withdrawal by Subject|2|||
27973053|NCT03412747|54630758|FG000|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
27973054|NCT03412747|54630759|FG001|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
27973055|NCT03412747|54630760|FG002|Initial Treatment Period: Wk0-Wk16|Adverse Event|3|||
27973056|NCT03412747|54630758|FG000|Initial Treatment Period: Wk0-Wk16|Death|0|||
27973057|NCT03412747|54630759|FG001|Initial Treatment Period: Wk0-Wk16|Death|0|||
27973058|NCT03412747|54630760|FG002|Initial Treatment Period: Wk0-Wk16|Death|1|||
27973059|NCT03412747|54630758|FG000|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
27973060|NCT03412747|54630759|FG001|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
27973061|NCT03412747|54630760|FG002|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|1|||
27973062|NCT03412747|54630758|FG000|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
27973063|NCT03412747|54630759|FG001|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
27973064|NCT03412747|54630760|FG002|Initial Treatment Period: Wk0-Wk16|Protocol Violation|2|||
27973065|NCT03412747|54630758|FG000|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|0|||
27973066|NCT03412747|54630759|FG001|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|2|||
27973067|NCT03412747|54630760|FG002|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|1|||
27973068|NCT03412747|54630758|FG000|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|4|||
27973069|NCT03412747|54630759|FG001|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
27973070|NCT03412747|54630760|FG002|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
27973071|NCT03412747|54630758|FG000|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|1|||
27973072|NCT03412747|54630759|FG001|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
27973073|NCT03412747|54630760|FG002|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
27973074|NCT03412747|54630758|FG000|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|3|||
27973075|NCT03412747|54630759|FG001|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|1|||
27973076|NCT03412747|54630760|FG002|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|0|||
27973077|NCT03412747|54630758|FG000|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|1|||
27973078|NCT03412747|54630759|FG001|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
27973079|NCT03412747|54630760|FG002|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
27973080|NCT03412747|54630758|FG000|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
27973081|NCT03412747|54630759|FG001|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
27973082|NCT03412747|54630760|FG002|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|1|||
27973083|NCT03412747|54630758|FG000|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|1|||
27973084|NCT03412747|54630759|FG001|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
27973085|NCT03412747|54630760|FG002|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
27973086|NCT03412747|54630758|FG000|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|3|||
27973087|NCT03412747|54630759|FG001|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|4|||
27973088|NCT03412747|54630760|FG002|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|6|||
27973089|NCT03412747|54630758|FG000|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|0|||
27973090|NCT03412747|54630759|FG001|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
27973091|NCT03412747|54630760|FG002|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
27973092|NCT03412747|54630758|FG000|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|0|||
27973093|NCT03412747|54630759|FG001|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|2|||
27973094|NCT03412747|54630760|FG002|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|5|||
27973095|NCT03412747|54630758|FG000|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|3|||
27973096|NCT03412747|54630759|FG001|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|1|||
27973097|NCT03412747|54630760|FG002|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|4|||
27855543|NCT03761277|54379788|FG000|Post-Implant to 6 Months|Death|1|||
27855544|NCT03761277|54379788|FG000|Post-Implant to 6 Months|Site Closure|2|||
27855545|NCT03761277|54379788|FG000|6 Months to 12 Months|Completed Study under Protocol v3|25|||
27855546|NCT03761277|54379788|FG000|6 Months to 12 Months|Physician Decision|2|||
27855547|NCT03761277|54379788|FG000|6 Months to 12 Months|Withdrawal by Subject|1|||
27855548|NCT04099641|54379839|FG000|Overall Study|Death|46|||
27855549|NCT04099641|54379840|FG001|Overall Study|Death|12|||
27832707|NCT01755767|54312324|FG000|Overall Study|Adverse Event|6|||
27832708|NCT01755767|54312325|FG001|Overall Study|Adverse Event|0|||
27832709|NCT01755767|54312326|FG002|Overall Study|Adverse Event|28|||
27832710|NCT01755767|54312327|FG003|Overall Study|Adverse Event|11|||
27832711|NCT01755767|54312324|FG000|Overall Study|Death|1|||
27832712|NCT01755767|54312325|FG001|Overall Study|Death|2|||
27832713|NCT01755767|54312326|FG002|Overall Study|Death|15|||
27832714|NCT01755767|54312327|FG003|Overall Study|Death|4|||
27832715|NCT01755767|54312324|FG000|Overall Study|Subject Decision|0|||
27832716|NCT01755767|54312325|FG001|Overall Study|Subject Decision|0|||
27832717|NCT01755767|54312326|FG002|Overall Study|Subject Decision|10|||
27832718|NCT01755767|54312327|FG003|Overall Study|Subject Decision|3|||
27832719|NCT01755767|54312324|FG000|Overall Study|Withdrawal by Subject|0|||
27832720|NCT01755767|54312325|FG001|Overall Study|Withdrawal by Subject|0|||
27832721|NCT01755767|54312326|FG002|Overall Study|Withdrawal by Subject|2|||
27832722|NCT01755767|54312327|FG003|Overall Study|Withdrawal by Subject|1|||
27973098|NCT03412747|54630758|FG000|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
27973099|NCT03412747|54630759|FG001|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|1|||
27973100|NCT03412747|54630760|FG002|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
27973101|NCT00513019|54630780|FG000|Overall Study|Adverse Event|1|||
27973102|NCT00513019|54630781|FG001|Overall Study|Adverse Event|0|||
27973103|NCT00513019|54630780|FG000|Overall Study|Withdrawal by Subject|4|||
27973104|NCT00513019|54630781|FG001|Overall Study|Withdrawal by Subject|5|||
27973105|NCT00954512|54630802|FG000|Overall Study|Withdrawal by Subject|0|||
27973106|NCT00954512|54630803|FG001|Overall Study|Withdrawal by Subject|0|||
27973107|NCT00954512|54630804|FG002|Overall Study|Withdrawal by Subject|0|||
27973108|NCT00954512|54630805|FG003|Overall Study|Withdrawal by Subject|0|||
27973109|NCT00954512|54630806|FG004|Overall Study|Withdrawal by Subject|0|||
27973110|NCT00954512|54630807|FG005|Overall Study|Withdrawal by Subject|1|||
27973111|NCT00954512|54630802|FG000|Overall Study|Adverse Event|0|||
27973112|NCT00954512|54630803|FG001|Overall Study|Adverse Event|0|||
27973113|NCT00954512|54630804|FG002|Overall Study|Adverse Event|0|||
27973114|NCT00954512|54630805|FG003|Overall Study|Adverse Event|0|||
27973115|NCT00954512|54630806|FG004|Overall Study|Adverse Event|1|||
27973116|NCT00954512|54630807|FG005|Overall Study|Adverse Event|2|||
27973117|NCT00954512|54630802|FG000|Overall Study|Physician Decision|0|||
27973118|NCT00954512|54630803|FG001|Overall Study|Physician Decision|1|||
27973119|NCT00954512|54630804|FG002|Overall Study|Physician Decision|0|||
27973120|NCT00954512|54630805|FG003|Overall Study|Physician Decision|1|||
27973121|NCT00954512|54630806|FG004|Overall Study|Physician Decision|0|||
27973122|NCT00954512|54630807|FG005|Overall Study|Physician Decision|0|||
27973123|NCT00954512|54630802|FG000|Overall Study|Symptomatic Deterioration|0|||
27973124|NCT00954512|54630803|FG001|Overall Study|Symptomatic Deterioration|1|||
27973125|NCT00954512|54630804|FG002|Overall Study|Symptomatic Deterioration|0|||
27973126|NCT00954512|54630805|FG003|Overall Study|Symptomatic Deterioration|0|||
27973127|NCT00954512|54630806|FG004|Overall Study|Symptomatic Deterioration|2|||
27973128|NCT00954512|54630807|FG005|Overall Study|Symptomatic Deterioration|0|||
27973129|NCT00954512|54630802|FG000|Overall Study|Progression of Disease|2|||
27973130|NCT00954512|54630803|FG001|Overall Study|Progression of Disease|1|||
27973131|NCT00954512|54630804|FG002|Overall Study|Progression of Disease|0|||
27973132|NCT00954512|54630805|FG003|Overall Study|Progression of Disease|1|||
27973133|NCT00954512|54630806|FG004|Overall Study|Progression of Disease|1|||
27973134|NCT00954512|54630807|FG005|Overall Study|Progression of Disease|1|||
27973135|NCT00691015|54630820|FG000|Overall Study|Refused further treatment|1|||
27973136|NCT00950300|54630826|FG000|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6|||
27973137|NCT00950300|54630827|FG001|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15|||
27973138|NCT00950300|54630826|FG000|Neoadjuvant/Adjuvant Treatment Periods|Death|1|||
27973139|NCT00950300|54630827|FG001|Neoadjuvant/Adjuvant Treatment Periods|Death|3|||
27973140|NCT00950300|54630826|FG000|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3|||
27973141|NCT00950300|54630827|FG001|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0|||
27973142|NCT00950300|54630826|FG000|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2|||
27973143|NCT00950300|54630827|FG001|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1|||
27973144|NCT00950300|54630826|FG000|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1|||
27973145|NCT00950300|54630827|FG001|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0|||
27973146|NCT00950300|54630826|FG000|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4|||
27973147|NCT00950300|54630827|FG001|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5|||
27973148|NCT00950300|54630826|FG000|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2|||
27973149|NCT00950300|54630827|FG001|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1|||
27973150|NCT00950300|54630826|FG000|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12|||
27973151|NCT00950300|54630827|FG001|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11|||
27973152|NCT00950300|54630826|FG000|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10|||
27973153|NCT00950300|54630827|FG001|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5|||
27973154|NCT00950300|54630826|FG000|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
27973155|NCT00950300|54630827|FG001|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
27973156|NCT00950300|54630826|FG000|TFFU Period|Adverse Event or Intercurrent Illness|3|||
27973157|NCT00950300|54630827|FG001|TFFU Period|Adverse Event or Intercurrent Illness|4|||
27973158|NCT00950300|54630826|FG000|TFFU Period|Death|4|||
27973159|NCT00950300|54630827|FG001|TFFU Period|Death|1|||
27973160|NCT00950300|54630826|FG000|TFFU Period|Refused Treatment|10|||
27973161|NCT00950300|54630827|FG001|TFFU Period|Refused Treatment|11|||
27973162|NCT00950300|54630826|FG000|TFFU Period|Failure to Return|16|||
27973163|NCT00950300|54630827|FG001|TFFU Period|Failure to Return|16|||
27973164|NCT00950300|54630826|FG000|TFFU Period|Recurrence of Disease|63|||
27973165|NCT00950300|54630827|FG001|TFFU Period|Recurrence of Disease|72|||
27973166|NCT00950300|54630826|FG000|TFFU Period|Other|4|||
27973167|NCT00950300|54630827|FG001|TFFU Period|Other|3|||
27973168|NCT00950300|54630826|FG000|SFU Period|Death|44|||
27973169|NCT00950300|54630827|FG001|SFU Period|Death|42|||
27973170|NCT00950300|54630826|FG000|SFU Period|Lost to Follow-up|30|||
27733039|NCT02693691|54180706|FG000|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1|||
27733040|NCT04203667|54180710|FG000|Overall Study|Withdrawal by Subject|1|||
27733041|NCT04203667|54180710|FG000|Overall Study|Lost to Follow-up|1|||
27733042|NCT04203667|54180710|FG000|Overall Study|Death|1|||
27733043|NCT04203667|54180710|FG000|Overall Study|PI left center and never scheduled 90 day follow-up visit.|1|||
27733044|NCT02782169|54180717|FG000|Overall Study|Lost to Follow-up|1|||
27733045|NCT02782169|54180718|FG001|Overall Study|Lost to Follow-up|2|||
27733046|NCT02564042|54180730|FG000|Overall Study|Adverse Event|4|||
27733047|NCT02564042|54180731|FG001|Overall Study|Adverse Event|4|||
27733048|NCT02564042|54180732|FG002|Overall Study|Adverse Event|3|||
27733049|NCT02564042|54180733|FG003|Overall Study|Adverse Event|0|||
27733050|NCT02564042|54180734|FG004|Overall Study|Adverse Event|0|||
27733051|NCT02564042|54180735|FG005|Overall Study|Adverse Event|1|||
27733052|NCT02564042|54180730|FG000|Overall Study|Lost to Follow-up|1|||
27973171|NCT00950300|54630827|FG001|SFU Period|Lost to Follow-up|28|||
27973172|NCT00950300|54630826|FG000|SFU Period|Withdrawal by Subject|4|||
27973173|NCT00950300|54630827|FG001|SFU Period|Withdrawal by Subject|8|||
27973174|NCT00949988|54630834|FG000|Overall Study|Withdrawal by Subject|3|||
27973175|NCT00731692|54630841|FG000|Core Study (36 Months)|Lack of Efficacy|11|||
27973176|NCT00731692|54630842|FG001|Core Study (36 Months)|Lack of Efficacy|23|||
27973177|NCT00731692|54630843|FG002|Core Study (36 Months)|Lack of Efficacy|64|||
27973178|NCT00731692|54630841|FG000|Core Study (36 Months)|Physician Decision|1|||
27973179|NCT00731692|54630842|FG001|Core Study (36 Months)|Physician Decision|0|||
27973180|NCT00731692|54630843|FG002|Core Study (36 Months)|Physician Decision|2|||
27973181|NCT00731692|54630841|FG000|Core Study (36 Months)|Death|2|||
27973182|NCT00731692|54630842|FG001|Core Study (36 Months)|Death|1|||
28085514|NCT03383146|54739006|FG000|Overall Study|Withdrawal by Subject|20|||
28085515|NCT03383146|54739007|FG001|Overall Study|Withdrawal by Subject|36|||
28085516|NCT03383146|54739006|FG000|Overall Study|Lost to Follow-up|5|||
28085517|NCT03383146|54739007|FG001|Overall Study|Lost to Follow-up|15|||
28085518|NCT03383146|54739006|FG000|Overall Study|Death|0|||
28085519|NCT03383146|54739007|FG001|Overall Study|Death|2|||
28085520|NCT03383146|54739006|FG000|Overall Study|Physician Decision|0|||
28085521|NCT03383146|54739007|FG001|Overall Study|Physician Decision|1|||
28085522|NCT03383146|54739006|FG000|Overall Study|Protocol Deviation|1|||
28085523|NCT03383146|54739007|FG001|Overall Study|Protocol Deviation|8|||
28085524|NCT03383146|54739006|FG000|Overall Study|Study Terminated by the Sponsor|48|||
28085525|NCT03383146|54739007|FG001|Overall Study|Study Terminated by the Sponsor|95|||
28085526|NCT03383146|54739006|FG000|Overall Study|Reason not Specified|4|||
28085527|NCT03383146|54739007|FG001|Overall Study|Reason not Specified|6|||
28085528|NCT03616964|54739017|FG000|Overall Study|Adverse Event|15|||
28085529|NCT03616964|54739018|FG001|Overall Study|Adverse Event|10|||
28085530|NCT03616964|54739019|FG002|Overall Study|Adverse Event|16|||
28085531|NCT03616964|54739017|FG000|Overall Study|Death|3|||
28085532|NCT03616964|54739018|FG001|Overall Study|Death|0|||
28085533|NCT03616964|54739019|FG002|Overall Study|Death|4|||
28085534|NCT03616964|54739017|FG000|Overall Study|Lack of Efficacy|4|||
28085535|NCT03616964|54739018|FG001|Overall Study|Lack of Efficacy|8|||
28085536|NCT03616964|54739019|FG002|Overall Study|Lack of Efficacy|8|||
28085537|NCT03616964|54739017|FG000|Overall Study|Lost to Follow-up|2|||
28085538|NCT03616964|54739018|FG001|Overall Study|Lost to Follow-up|1|||
28085539|NCT03616964|54739019|FG002|Overall Study|Lost to Follow-up|3|||
28085540|NCT03616964|54739017|FG000|Overall Study|Withdrawal by Subject|18|||
28085541|NCT03616964|54739018|FG001|Overall Study|Withdrawal by Subject|14|||
28085542|NCT03616964|54739019|FG002|Overall Study|Withdrawal by Subject|21|||
28085543|NCT03616964|54739017|FG000|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
28085544|NCT03616964|54739018|FG001|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
28085545|NCT03616964|54739019|FG002|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
28085546|NCT03616964|54739017|FG000|Overall Study|Sponsor's Decision|1|||
27973183|NCT00731692|54630843|FG002|Core Study (36 Months)|Death|2|||
27973184|NCT00731692|54630841|FG000|Core Study (36 Months)|Lost to Follow-up|1|||
28085547|NCT03616964|54739018|FG001|Overall Study|Sponsor's Decision|0|||
28085548|NCT03616964|54739019|FG002|Overall Study|Sponsor's Decision|0|||
28085549|NCT03616964|54739017|FG000|Overall Study|Physician Decision|0|||
28085550|NCT03616964|54739018|FG001|Overall Study|Physician Decision|2|||
28085551|NCT03616964|54739019|FG002|Overall Study|Physician Decision|0|||
28085552|NCT03616964|54739017|FG000|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
28085553|NCT03616964|54739018|FG001|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|1|||
27733053|NCT02564042|54180731|FG001|Overall Study|Lost to Follow-up|1|||
27733054|NCT02564042|54180732|FG002|Overall Study|Lost to Follow-up|1|||
27973185|NCT00731692|54630842|FG001|Core Study (36 Months)|Lost to Follow-up|3|||
27973186|NCT00731692|54630843|FG002|Core Study (36 Months)|Lost to Follow-up|3|||
28085554|NCT03616964|54739019|FG002|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
27733055|NCT02564042|54180733|FG003|Overall Study|Lost to Follow-up|0|||
28085555|NCT03616964|54739017|FG000|Overall Study|Protocol Violation|0|||
28085556|NCT03616964|54739018|FG001|Overall Study|Protocol Violation|1|||
28085557|NCT03616964|54739019|FG002|Overall Study|Protocol Violation|0|||
27973187|NCT00731692|54630841|FG000|Core Study (36 Months)|Administrative|2|||
27973188|NCT00731692|54630842|FG001|Core Study (36 Months)|Administrative|2|||
27973189|NCT00731692|54630843|FG002|Core Study (36 Months)|Administrative|6|||
27973190|NCT00731692|54630841|FG000|Core Study (36 Months)|Abnormal Test Procedure Result|4|||
27973191|NCT00731692|54630842|FG001|Core Study (36 Months)|Abnormal Test Procedure Result|3|||
27973192|NCT00731692|54630843|FG002|Core Study (36 Months)|Abnormal Test Procedure Result|5|||
27973193|NCT00731692|54630841|FG000|Core Study (36 Months)|Protocol Violation|4|||
27973194|NCT00731692|54630842|FG001|Core Study (36 Months)|Protocol Violation|5|||
27973195|NCT00731692|54630843|FG002|Core Study (36 Months)|Protocol Violation|8|||
27973196|NCT00731692|54630841|FG000|Core Study (36 Months)|Abnormal Lab values|6|||
27973197|NCT00731692|54630842|FG001|Core Study (36 Months)|Abnormal Lab values|19|||
27973198|NCT00731692|54630843|FG002|Core Study (36 Months)|Abnormal Lab values|5|||
27973199|NCT00731692|54630841|FG000|Core Study (36 Months)|Adverse Event|25|||
27973200|NCT00731692|54630842|FG001|Core Study (36 Months)|Adverse Event|28|||
27973201|NCT00731692|54630843|FG002|Core Study (36 Months)|Adverse Event|29|||
27973202|NCT00731692|54630841|FG000|Core Study (36 Months)|Withdrawal by Subject|12|||
27973203|NCT00731692|54630842|FG001|Core Study (36 Months)|Withdrawal by Subject|32|||
27973204|NCT00731692|54630843|FG002|Core Study (36 Months)|Withdrawal by Subject|46|||
27973205|NCT00731692|54630841|FG000|Extension Phase|Admin Problems: Terminated # patients|69|||
27973206|NCT00731692|54630842|FG001|Extension Phase|Admin Problems: Terminated # patients|189|||
27973207|NCT00731692|54630843|FG002|Extension Phase|Admin Problems: Terminated # patients|277|||
27973208|NCT00731692|54630841|FG000|Extension Phase|Abnormal test procedure|0|||
27973209|NCT00731692|54630842|FG001|Extension Phase|Abnormal test procedure|0|||
27973210|NCT00731692|54630843|FG002|Extension Phase|Abnormal test procedure|1|||
27973211|NCT00731692|54630841|FG000|Extension Phase|Abnormal lab values|0|||
27973212|NCT00731692|54630842|FG001|Extension Phase|Abnormal lab values|0|||
27973213|NCT00731692|54630843|FG002|Extension Phase|Abnormal lab values|1|||
27973214|NCT00731692|54630841|FG000|Extension Phase|Lost to Follow-up|0|||
27973215|NCT00731692|54630842|FG001|Extension Phase|Lost to Follow-up|1|||
27973216|NCT00731692|54630843|FG002|Extension Phase|Lost to Follow-up|4|||
27973217|NCT00731692|54630841|FG000|Extension Phase|Withdrawal by Subject|4|||
27973218|NCT00731692|54630842|FG001|Extension Phase|Withdrawal by Subject|5|||
27973219|NCT00731692|54630843|FG002|Extension Phase|Withdrawal by Subject|3|||
27973220|NCT00731692|54630841|FG000|Extension Phase|Adverse Event|1|||
27973221|NCT00731692|54630842|FG001|Extension Phase|Adverse Event|1|||
27973222|NCT00731692|54630843|FG002|Extension Phase|Adverse Event|15|||
27973223|NCT00687193|54630865|FG000|Overall Study|Adverse Event|0|||
27973224|NCT00687193|54630866|FG001|Overall Study|Adverse Event|1|||
27973225|NCT00687193|54630867|FG002|Overall Study|Adverse Event|2|||
27973226|NCT00687193|54630868|FG003|Overall Study|Adverse Event|3|||
27973227|NCT00687193|54630869|FG004|Overall Study|Adverse Event|0|||
27973228|NCT00687193|54630870|FG005|Overall Study|Adverse Event|2|||
27973229|NCT00687193|54630865|FG000|Overall Study|Lack of Efficacy|1|||
27973230|NCT00687193|54630866|FG001|Overall Study|Lack of Efficacy|1|||
27973231|NCT00687193|54630867|FG002|Overall Study|Lack of Efficacy|0|||
27973232|NCT00687193|54630868|FG003|Overall Study|Lack of Efficacy|0|||
27973233|NCT00687193|54630869|FG004|Overall Study|Lack of Efficacy|0|||
27973234|NCT00687193|54630870|FG005|Overall Study|Lack of Efficacy|2|||
27973235|NCT00687193|54630865|FG000|Overall Study|Protocol Violation|1|||
27973236|NCT00687193|54630866|FG001|Overall Study|Protocol Violation|2|||
27973237|NCT00687193|54630867|FG002|Overall Study|Protocol Violation|0|||
27973238|NCT00687193|54630868|FG003|Overall Study|Protocol Violation|1|||
27973239|NCT00687193|54630869|FG004|Overall Study|Protocol Violation|2|||
27973240|NCT00687193|54630870|FG005|Overall Study|Protocol Violation|0|||
27973241|NCT00730912|54630890|FG000|Overall Study|Discontinued|0|||
27973242|NCT00730912|54630891|FG001|Overall Study|Discontinued|0|||
27973243|NCT00730912|54630892|FG002|Overall Study|Discontinued|1|||
27973244|NCT00737698|54630903|FG000|Overall Study|Withdrawal by Subject|6|||
27973245|NCT00737698|54630904|FG001|Overall Study|Withdrawal by Subject|5|||
27973246|NCT00737698|54630905|FG002|Overall Study|Withdrawal by Subject|3|||
27973247|NCT00737698|54630903|FG000|Overall Study|Death|0|||
27973248|NCT00737698|54630904|FG001|Overall Study|Death|0|||
27973249|NCT00737698|54630905|FG002|Overall Study|Death|1|||
27973250|NCT00730756|54630915|FG000|Overall Study|Adverse Event|2|||
27973251|NCT00730756|54630916|FG001|Overall Study|Adverse Event|0|||
27973252|NCT00730756|54630915|FG000|Overall Study|Lack of Efficacy|1|||
27973253|NCT00730756|54630916|FG001|Overall Study|Lack of Efficacy|1|||
27733056|NCT02564042|54180734|FG004|Overall Study|Lost to Follow-up|1|||
27832723|NCT01755767|54312324|FG000|Overall Study|Other|0|||
27973254|NCT00730756|54630915|FG000|Overall Study|Protocol Deviation|1|||
27973255|NCT00730756|54630916|FG001|Overall Study|Protocol Deviation|2|||
27973256|NCT00730756|54630915|FG000|Overall Study|Lost to Follow-up|0|||
27973257|NCT00730756|54630916|FG001|Overall Study|Lost to Follow-up|1|||
27973258|NCT00730756|54630915|FG000|Overall Study|Withdrew Consent|0|||
27973259|NCT00730756|54630916|FG001|Overall Study|Withdrew Consent|1|||
27973260|NCT00730132|54630922|FG000|Overall Study|Protocol Violation|154|||
27973261|NCT00730132|54630922|FG000|Overall Study|Death|1|||
27973262|NCT00737464|54630929|FG000|Overall Study|Adverse Event|1|||
27973263|NCT00737464|54630929|FG000|Overall Study|Death|6|||
27973264|NCT00737464|54630929|FG000|Overall Study|Other - Failure to Return|1|||
27973265|NCT00737464|54630929|FG000|Overall Study|Refused Treatment / Withdrew Consent|6|||
27973266|NCT00737464|54630929|FG000|Overall Study|Other reasons|4|||
27973267|NCT00729586|54630935|FG000|Overall Study|Ineligible|0|||
27973268|NCT00729586|54630936|FG001|Overall Study|Ineligible|1|||
27973269|NCT00729586|54630935|FG000|Overall Study|never treated|1|||
27973270|NCT00729586|54630936|FG001|Overall Study|never treated|0|||
27973271|NCT00949910|54630943|FG000|Overall Study|Progressive Disease|3750|||
27973272|NCT00949910|54630943|FG000|Overall Study|Symptomatic Deterioration|1088|||
27973273|NCT00949910|54630943|FG000|Overall Study|Lost to Follow-up|100|||
27973274|NCT00949910|54630943|FG000|Overall Study|Study Drug-Related Adverse Event|315|||
27973275|NCT00949910|54630943|FG000|Overall Study|Participant Refusal|390|||
27973276|NCT00949910|54630943|FG000|Overall Study|Death Due to Malignant Disease|456|||
27973277|NCT00949910|54630943|FG000|Overall Study|Death Due to Progression/Deterioration|4|||
27973278|NCT00949910|54630943|FG000|Overall Study|Death Due to Adverse Event|115|||
27973279|NCT00949910|54630943|FG000|Overall Study|Death Due to Toxicity|3|||
27973280|NCT00949910|54630943|FG000|Overall Study|Death from Unknown Cause|5|||
27973281|NCT00949910|54630943|FG000|Overall Study|Unspecified Progression/Deterioration|13|||
27973282|NCT00949910|54630943|FG000|Overall Study|Switched to Compassionate/Other Use|174|||
27973283|NCT00949910|54630943|FG000|Overall Study|Switched to Commercial Treatment|4|||
27973284|NCT00949910|54630943|FG000|Overall Study|Violation of Eligibility|23|||
27973285|NCT00949910|54630943|FG000|Overall Study|Logistical Reasons|13|||
27973286|NCT00949910|54630943|FG000|Overall Study|Non-Compliance|10|||
27973287|NCT00949910|54630943|FG000|Overall Study|Prolonged Dosing Interruption|4|||
27973288|NCT00949910|54630943|FG000|Overall Study|Adverse Event|83|||
27973289|NCT00949910|54630943|FG000|Overall Study|Serious Adverse Event|6|||
27973290|NCT00949910|54630943|FG000|Overall Study|Physician/Participant Decision|7|||
27973291|NCT00949910|54630943|FG000|Overall Study|Other|4|||
27973292|NCT00949910|54630943|FG000|Overall Study|No Data|9|||
27973293|NCT00686959|54630949|FG000|Overall Study|Participants censored (no death events)|124|||
27973294|NCT00686959|54630950|FG001|Overall Study|Participants censored (no death events)|117|||
27973295|NCT00946088|54630958|FG000|Overall Study|Withdrawal by Subject|0|||
27973296|NCT00946088|54630959|FG001|Overall Study|Withdrawal by Subject|1|||
27973297|NCT00736996|54630970|FG000|Overall Study|Lost to Follow-up|1|||
27973298|NCT00736996|54630971|FG001|Overall Study|Lost to Follow-up|9|||
27973299|NCT00736996|54630972|FG002|Overall Study|Lost to Follow-up|2|||
27973300|NCT00728962|54630986|FG000|Implant Placement Surgery|Adverse Event|8|||
27832724|NCT01755767|54312325|FG001|Overall Study|Other|0|||
27832725|NCT01755767|54312326|FG002|Overall Study|Other|2|||
27832726|NCT01755767|54312327|FG003|Overall Study|Other|3|||
27973301|NCT00728962|54630986|FG000|Implant Placement Surgery|Lost to Follow-up|1|||
28085558|NCT03616964|54739017|FG000|Overall Study|Due to Epidemic/Pandemic|0|||
28085559|NCT03616964|54739018|FG001|Overall Study|Due to Epidemic/Pandemic|1|||
28085560|NCT03616964|54739019|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
28085561|NCT03616964|54739017|FG000|Overall Study|Randomized but Never Treated|1|||
28085562|NCT03616964|54739018|FG001|Overall Study|Randomized but Never Treated|1|||
28085563|NCT03616964|54739019|FG002|Overall Study|Randomized but Never Treated|1|||
28085564|NCT00350519|54739031|FG000|Overall Study|Death|0|||
28085565|NCT00350519|54739032|FG001|Overall Study|Death|1|||
28085566|NCT00350519|54739031|FG000|Overall Study|Physician Decision|0|||
28085567|NCT00350519|54739032|FG001|Overall Study|Physician Decision|1|||
28085568|NCT00350519|54739031|FG000|Overall Study|Protocol Violation|1|||
28085569|NCT00350519|54739032|FG001|Overall Study|Protocol Violation|2|||
28085570|NCT00350519|54739031|FG000|Overall Study|Withdrawal by Subject|3|||
27973302|NCT00728962|54630986|FG000|Implant Placement Surgery|Protocol Violation|1|||
27973303|NCT00728962|54630986|FG000|Permanent Prosthesis Placement|Adverse Event|3|||
27973304|NCT00728962|54630986|FG000|Two Year Post Placement Follow-up|Lost to Follow-up|3|||
27973305|NCT00954122|54630990|FG000|Overall Study|Withdrawal by Subject|5|||
27973306|NCT00954122|54630990|FG000|Overall Study|Adverse Event|1|||
27973307|NCT00954122|54630990|FG000|Overall Study|Safety Reason|1|||
27973308|NCT00586066|54630997|FG000|Overall Study|Lost to Follow-up|6|||
27973309|NCT00586066|54630998|FG001|Overall Study|Lost to Follow-up|3|||
27973310|NCT00586066|54630997|FG000|Overall Study|Lack of Efficacy|5|||
27973311|NCT00586066|54630998|FG001|Overall Study|Lack of Efficacy|3|||
27973312|NCT00586066|54630997|FG000|Overall Study|Adverse Event|2|||
27832727|NCT01755767|54312324|FG000|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
28085571|NCT00350519|54739032|FG001|Overall Study|Withdrawal by Subject|2|||
28085572|NCT03382912|54739040|FG000|Overall Study|Physician Decision|0|||
27832728|NCT01755767|54312325|FG001|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
27973313|NCT00586066|54630998|FG001|Overall Study|Adverse Event|2|||
27973314|NCT00586066|54630997|FG000|Overall Study|Physician Decision|1|||
27973315|NCT00586066|54630998|FG001|Overall Study|Physician Decision|0|||
27973316|NCT00586066|54630997|FG000|Overall Study|Withdrawal of consent|4|||
27973317|NCT00586066|54630998|FG001|Overall Study|Withdrawal of consent|2|||
27973318|NCT01186016|54631006|FG000|Overall Study|Withdrawal by Subject|46|||
28085573|NCT03382912|54739041|FG001|Overall Study|Physician Decision|1|||
27832729|NCT01755767|54312326|FG002|Overall Study|Ongoing Treatment as of 06 Jan 2017|5|||
27832730|NCT01755767|54312327|FG003|Overall Study|Ongoing Treatment as of 06 Jan 2017|2|||
27832731|NCT01730339|54312423|FG000|Overall Study|Withdrawal by Subject|3|||
27832732|NCT01730339|54312424|FG001|Overall Study|Withdrawal by Subject|2|||
27832733|NCT01730339|54312423|FG000|Overall Study|Lost to Follow-up|1|||
27832734|NCT01730339|54312424|FG001|Overall Study|Lost to Follow-up|1|||
27973319|NCT01186016|54631007|FG001|Overall Study|Withdrawal by Subject|29|||
27973320|NCT00728884|54631013|FG000|Permanent Prosthesis Placement|Lost to Follow-up|13|||
27973321|NCT00728884|54631013|FG000|One Year Post Placement Follow-up|Lost to Follow-up|4|||
27973322|NCT00728494|54631019|FG000|Overall Study|Adverse Event|7|||
27973323|NCT00728494|54631020|FG001|Overall Study|Adverse Event|0|||
27973324|NCT00728494|54631019|FG000|Overall Study|Withdrawal by Subject|0|||
27973325|NCT00728494|54631020|FG001|Overall Study|Withdrawal by Subject|2|||
27973326|NCT00728494|54631019|FG000|Overall Study|Lack of Efficacy|2|||
27973327|NCT00728494|54631020|FG001|Overall Study|Lack of Efficacy|4|||
27973328|NCT00728494|54631019|FG000|Overall Study|No data available|0|||
27973329|NCT00728494|54631020|FG001|Overall Study|No data available|1|||
27973330|NCT00728416|54631028|FG000|Overall Study|Adverse Event|1|||
27973331|NCT00728416|54631029|FG001|Overall Study|Adverse Event|1|||
27973332|NCT00728416|54631028|FG000|Overall Study|Treatment Failure|0|||
27973333|NCT00728416|54631029|FG001|Overall Study|Treatment Failure|1|||
27973334|NCT00728416|54631028|FG000|Overall Study|Withdrawal by Subject|1|||
27973335|NCT00728416|54631029|FG001|Overall Study|Withdrawal by Subject|0|||
27973336|NCT00728182|54631037|FG000|Overall Study|Adverse Event|1|||
27973337|NCT00728182|54631038|FG001|Overall Study|Adverse Event|0|||
27973338|NCT00728182|54631037|FG000|Overall Study|Lost to Follow-up|2|||
27973339|NCT00728182|54631038|FG001|Overall Study|Lost to Follow-up|0|||
27973340|NCT00728182|54631037|FG000|Overall Study|Death|0|||
27973341|NCT00728182|54631038|FG001|Overall Study|Death|2|||
27973342|NCT00728182|54631037|FG000|Overall Study|Protocol Noncompliance|0|||
27973343|NCT00728182|54631038|FG001|Overall Study|Protocol Noncompliance|1|||
27973344|NCT00941330|54631048|FG000|Overall Study|Other|1|||
27973345|NCT00941330|54631049|FG001|Overall Study|Other|0|||
27973346|NCT00941330|54631048|FG000|Overall Study|Physician Decision|0|||
27973347|NCT00941330|54631049|FG001|Overall Study|Physician Decision|2|||
27973348|NCT00736450|54631055|FG000|Overall Study|Not ABC gene eligible|19|||
27973349|NCT00736450|54631055|FG000|Overall Study|Withdrawal by Subject|5|||
27973350|NCT00736450|54631055|FG000|Overall Study|Physician Decision|1|||
27973351|NCT00686881|54631061|FG000|Overall Study|Withdrawal by Subject|11|||
27973352|NCT00686881|54631062|FG001|Overall Study|Withdrawal by Subject|18|||
27973353|NCT00686881|54631061|FG000|Overall Study|Lost to Follow-up|0|||
27973354|NCT00686881|54631062|FG001|Overall Study|Lost to Follow-up|1|||
27973355|NCT00686881|54631061|FG000|Overall Study|Treatment-related adverse event|10|||
27973356|NCT00686881|54631062|FG001|Overall Study|Treatment-related adverse event|9|||
27973357|NCT00686881|54631061|FG000|Overall Study|Met discontinuation criteria|5|||
27973358|NCT00686881|54631062|FG001|Overall Study|Met discontinuation criteria|0|||
27973359|NCT00686881|54631061|FG000|Overall Study|Onset of malignant tumor|11|||
27973360|NCT00686881|54631062|FG001|Overall Study|Onset of malignant tumor|11|||
27973361|NCT00686881|54631061|FG000|Overall Study|Lack of Efficacy|4|||
27973362|NCT00686881|54631062|FG001|Overall Study|Lack of Efficacy|3|||
27973363|NCT00686881|54631061|FG000|Overall Study|Physician Decision|1|||
27973364|NCT00686881|54631062|FG001|Overall Study|Physician Decision|0|||
27973365|NCT00686881|54631061|FG000|Overall Study|Circumstances of site|1|||
27973366|NCT00686881|54631062|FG001|Overall Study|Circumstances of site|1|||
27973367|NCT00686881|54631061|FG000|Overall Study|Did not meet protocol eligibility|1|||
27973368|NCT00686881|54631062|FG001|Overall Study|Did not meet protocol eligibility|0|||
27973369|NCT00686881|54631061|FG000|Overall Study|Irregular visits|1|||
27973370|NCT00686881|54631062|FG001|Overall Study|Irregular visits|0|||
27973371|NCT00686881|54631061|FG000|Overall Study|Study discontinuation|35|||
27973372|NCT00686881|54631062|FG001|Overall Study|Study discontinuation|32|||
27973373|NCT00686881|54631061|FG000|Overall Study|Never received study drug|2|||
27973374|NCT00686881|54631062|FG001|Overall Study|Never received study drug|6|||
27973375|NCT00727714|54631070|FG000|Overall Study|Lost to Follow-up|2|||
27973376|NCT00727558|54631076|FG000|Overall Study|Lens issue|0|||
27973377|NCT00727558|54631077|FG001|Overall Study|Lens issue|1|||
27973378|NCT00727558|54631076|FG000|Overall Study|Adverse Event|0|||
27973379|NCT00727558|54631077|FG001|Overall Study|Adverse Event|1|||
27973380|NCT00727558|54631076|FG000|Overall Study|Subject unable to return for follow-up|1|||
27832735|NCT01730339|54312423|FG000|Overall Study|Un-specified|1|||
27973381|NCT00727558|54631077|FG001|Overall Study|Subject unable to return for follow-up|1|||
27973382|NCT00727558|54631076|FG000|Overall Study|Lost to Follow-up|1|||
27973383|NCT00727558|54631077|FG001|Overall Study|Lost to Follow-up|0|||
27973384|NCT00688597|54631086|FG000|Overall Study|Adverse Event|2|||
27973385|NCT00688597|54631087|FG001|Overall Study|Adverse Event|0|||
27973386|NCT00688597|54631088|FG002|Overall Study|Adverse Event|0|||
27973387|NCT00688597|54631086|FG000|Overall Study|Physician Decision|1|||
27973388|NCT00688597|54631087|FG001|Overall Study|Physician Decision|0|||
27832736|NCT01730339|54312424|FG001|Overall Study|Un-specified|0|||
27973389|NCT00688597|54631088|FG002|Overall Study|Physician Decision|0|||
27973390|NCT00735904|54631096|FG000|Overall Study|Adverse Event|3|||
27973391|NCT00735904|54631096|FG000|Overall Study|Death|20|||
27973392|NCT00735904|54631096|FG000|Overall Study|Protocol Violation|1|||
27973393|NCT00735904|54631096|FG000|Overall Study|Withdrawal by Subject|1|||
27973394|NCT00735904|54631096|FG000|Overall Study|Study Terminated by Sponsor|5|||
27973395|NCT00735904|54631096|FG000|Overall Study|Other|8|||
27973396|NCT00688519|54631102|FG000|Overall Study|Adverse Event|2|||
27973397|NCT00688519|54631103|FG001|Overall Study|Adverse Event|3|||
27973398|NCT00688519|54631102|FG000|Overall Study|Lost to Follow-up|3|||
27973399|NCT00688519|54631103|FG001|Overall Study|Lost to Follow-up|3|||
27973400|NCT00688519|54631102|FG000|Overall Study|Lack of Efficacy|3|||
27973401|NCT00688519|54631103|FG001|Overall Study|Lack of Efficacy|1|||
27973402|NCT00688519|54631102|FG000|Overall Study|Withdrawal by Subject|7|||
27973403|NCT00688519|54631103|FG001|Overall Study|Withdrawal by Subject|6|||
27973404|NCT00688519|54631102|FG000|Overall Study|Prohibited medication|1|||
27973405|NCT00688519|54631103|FG001|Overall Study|Prohibited medication|0|||
27973406|NCT00688519|54631102|FG000|Overall Study|Non-compliance|0|||
27973407|NCT00688519|54631103|FG001|Overall Study|Non-compliance|1|||
27973408|NCT00688519|54631102|FG000|Overall Study|Subject moved out of state|1|||
27973409|NCT00688519|54631103|FG001|Overall Study|Subject moved out of state|0|||
27973410|NCT00688519|54631102|FG000|Overall Study|Investigator decision|1|||
27973411|NCT00688519|54631103|FG001|Overall Study|Investigator decision|0|||
27973412|NCT00688519|54631102|FG000|Overall Study|Subject moved out of area|1|||
27973413|NCT00688519|54631103|FG001|Overall Study|Subject moved out of area|0|||
27973414|NCT00688519|54631102|FG000|Overall Study|Pregnancy|0|||
27973415|NCT00688519|54631103|FG001|Overall Study|Pregnancy|1|||
27973416|NCT00721630|54631109|FG000|Overall Study|Participant found to be ineligible|1|||
27973417|NCT00686725|54631115|FG000|Overall Study|Adverse Event|1|||
27973418|NCT00686725|54631116|FG001|Overall Study|Adverse Event|1|||
27973419|NCT00686725|54631115|FG000|Overall Study|Progressive Disease|17|||
27973420|NCT00686725|54631116|FG001|Overall Study|Progressive Disease|23|||
27973421|NCT00686725|54631115|FG000|Overall Study|Lost to Follow-up|7|||
27973422|NCT00686725|54631116|FG001|Overall Study|Lost to Follow-up|5|||
27973423|NCT00686725|54631115|FG000|Overall Study|Death|6|||
27973424|NCT00686725|54631116|FG001|Overall Study|Death|3|||
27973425|NCT00686725|54631115|FG000|Overall Study|Withdrawal by Subject|13|||
27973426|NCT00686725|54631116|FG001|Overall Study|Withdrawal by Subject|4|||
27973427|NCT00686725|54631115|FG000|Overall Study|Protocol Violation|1|||
27973428|NCT00686725|54631116|FG001|Overall Study|Protocol Violation|3|||
27973429|NCT00686725|54631115|FG000|Overall Study|Other|1|||
27973430|NCT00686725|54631116|FG001|Overall Study|Other|3|||
27973431|NCT00727402|54631122|FG000|Overall Study|Physician Decision|116|||
27973432|NCT00727246|54631130|FG000|Overall Study|could not complete MRI|0|||
27973433|NCT00727246|54631131|FG001|Overall Study|could not complete MRI|1|||
27973434|NCT00727246|54631132|FG002|Overall Study|could not complete MRI|0|||
27973435|NCT00727246|54631133|FG003|Overall Study|could not complete MRI|1|||
27973436|NCT00727246|54631130|FG000|Overall Study|incidental finding|0|||
27973437|NCT00727246|54631131|FG001|Overall Study|incidental finding|0|||
27973438|NCT00727246|54631132|FG002|Overall Study|incidental finding|0|||
27973439|NCT00727246|54631133|FG003|Overall Study|incidental finding|1|||
27973440|NCT00727246|54631130|FG000|Overall Study|withdrawn|0|||
27973441|NCT00727246|54631131|FG001|Overall Study|withdrawn|0|||
27973442|NCT00727246|54631132|FG002|Overall Study|withdrawn|1|||
27973443|NCT00727246|54631133|FG003|Overall Study|withdrawn|0|||
27973444|NCT00686647|54631143|FG000|Overall Study|Lost to Follow-up|1|||
27973445|NCT00686647|54631143|FG000|Overall Study|Death|1|||
27973446|NCT00687973|54631150|FG000|Overall Study|Adverse Event|18|||
27973447|NCT00687973|54631151|FG001|Overall Study|Adverse Event|28|||
27973448|NCT00687973|54631150|FG000|Overall Study|Lack of Efficacy|2|||
27973449|NCT00687973|54631151|FG001|Overall Study|Lack of Efficacy|3|||
27973450|NCT00687973|54631150|FG000|Overall Study|Protocol Violation|1|||
27973451|NCT00687973|54631151|FG001|Overall Study|Protocol Violation|2|||
27973452|NCT00687973|54631150|FG000|Overall Study|Administrative Reasons|0|||
27973453|NCT00687973|54631151|FG001|Overall Study|Administrative Reasons|2|||
27973454|NCT00687973|54631150|FG000|Overall Study|Withdrawal by Subject|3|||
27973455|NCT00687973|54631151|FG001|Overall Study|Withdrawal by Subject|3|||
27973456|NCT00721396|54631162|FG000|Overall Study|Adverse Event|4|||
27973457|NCT00721396|54631163|FG001|Overall Study|Adverse Event|7|||
27973458|NCT00721396|54631164|FG002|Overall Study|Adverse Event|2|||
27973459|NCT00721396|54631165|FG003|Overall Study|Adverse Event|0|||
27973460|NCT00721396|54631162|FG000|Overall Study|Withdrawal by Subject|12|||
27973461|NCT00721396|54631163|FG001|Overall Study|Withdrawal by Subject|15|||
27973462|NCT00721396|54631164|FG002|Overall Study|Withdrawal by Subject|3|||
27973463|NCT00721396|54631165|FG003|Overall Study|Withdrawal by Subject|7|||
27973464|NCT00721396|54631162|FG000|Overall Study|Lost to Follow-up|7|||
27973465|NCT00721396|54631163|FG001|Overall Study|Lost to Follow-up|9|||
27973466|NCT00721396|54631164|FG002|Overall Study|Lost to Follow-up|3|||
27973467|NCT00721396|54631165|FG003|Overall Study|Lost to Follow-up|3|||
27973468|NCT00721396|54631162|FG000|Overall Study|Protocol Violation|4|||
27973469|NCT00721396|54631163|FG001|Overall Study|Protocol Violation|3|||
27973470|NCT00721396|54631164|FG002|Overall Study|Protocol Violation|1|||
27973471|NCT00721396|54631165|FG003|Overall Study|Protocol Violation|0|||
27973472|NCT00721396|54631162|FG000|Overall Study|Inappropriate enrollment|0|||
27973473|NCT00721396|54631163|FG001|Overall Study|Inappropriate enrollment|2|||
27973474|NCT00721396|54631164|FG002|Overall Study|Inappropriate enrollment|0|||
27973475|NCT00721396|54631165|FG003|Overall Study|Inappropriate enrollment|0|||
27973476|NCT00721396|54631162|FG000|Overall Study|Administrative reason|3|||
27973477|NCT00721396|54631163|FG001|Overall Study|Administrative reason|0|||
27973478|NCT00721396|54631164|FG002|Overall Study|Administrative reason|1|||
27973479|NCT00721396|54631165|FG003|Overall Study|Administrative reason|0|||
27973480|NCT00943826|54631182|FG000|Concurrent Phase|Adverse Event|50|||
27973481|NCT00943826|54631183|FG001|Concurrent Phase|Adverse Event|27|||
27973482|NCT00943826|54631182|FG000|Concurrent Phase|Withdrew consent|3|||
27973483|NCT00943826|54631183|FG001|Concurrent Phase|Withdrew consent|7|||
27973484|NCT00943826|54631182|FG000|Concurrent Phase|Refused treatment/Did not cooperate|5|||
27973485|NCT00943826|54631183|FG001|Concurrent Phase|Refused treatment/Did not cooperate|7|||
27973486|NCT00943826|54631182|FG000|Concurrent Phase|Administrative reasons|2|||
27973487|NCT00943826|54631183|FG001|Concurrent Phase|Administrative reasons|1|||
27973488|NCT00943826|54631182|FG000|Concurrent Phase|Protocol Violation|1|||
27973489|NCT00943826|54631183|FG001|Concurrent Phase|Protocol Violation|0|||
27973490|NCT00943826|54631182|FG000|Maintenance Phase|Adverse Event|31|||
27973491|NCT00943826|54631183|FG001|Maintenance Phase|Adverse Event|30|||
27973492|NCT00943826|54631182|FG000|Maintenance Phase|Withdrew consent|2|||
27973493|NCT00943826|54631183|FG001|Maintenance Phase|Withdrew consent|4|||
27973494|NCT00943826|54631182|FG000|Maintenance Phase|Refused treatment/Did not cooperate|6|||
27973495|NCT00943826|54631183|FG001|Maintenance Phase|Refused treatment/Did not cooperate|3|||
27973496|NCT00943826|54631182|FG000|Maintenance Phase|Administrative reasons|4|||
27973497|NCT00943826|54631183|FG001|Maintenance Phase|Administrative reasons|1|||
27973498|NCT00943826|54631182|FG000|Maintenance Phase|Failure to return|0|||
27973499|NCT00943826|54631183|FG001|Maintenance Phase|Failure to return|1|||
27973500|NCT00943826|54631182|FG000|Monotherapy Phase|Adverse Event|42|||
27973501|NCT00943826|54631183|FG001|Monotherapy Phase|Adverse Event|5|||
27973502|NCT00943826|54631182|FG000|Monotherapy Phase|Administrative reasons|11|||
28085574|NCT03382912|54739040|FG000|Overall Study|Sponsor Decision|6|||
28085575|NCT03382912|54739041|FG001|Overall Study|Sponsor Decision|6|||
28085576|NCT03382912|54739040|FG000|Overall Study|Withdrawal by Subject|0|||
28085577|NCT03382912|54739041|FG001|Overall Study|Withdrawal by Subject|5|||
28085578|NCT00350207|54739050|FG000|Overall Study|Adverse Event|5|||
28085579|NCT00350207|54739051|FG001|Overall Study|Adverse Event|2|||
28085580|NCT00350207|54739052|FG002|Overall Study|Adverse Event|2|||
28085581|NCT00350207|54739050|FG000|Overall Study|Lack of Efficacy|1|||
28085582|NCT00350207|54739051|FG001|Overall Study|Lack of Efficacy|0|||
28085583|NCT00350207|54739052|FG002|Overall Study|Lack of Efficacy|2|||
28085584|NCT00350207|54739050|FG000|Overall Study|Lost to Follow-up|1|||
28085585|NCT00350207|54739051|FG001|Overall Study|Lost to Follow-up|0|||
28085586|NCT00350207|54739052|FG002|Overall Study|Lost to Follow-up|1|||
28085587|NCT00350207|54739050|FG000|Overall Study|Withdrawal by Subject|0|||
28085588|NCT00350207|54739051|FG001|Overall Study|Withdrawal by Subject|1|||
28085589|NCT00350207|54739052|FG002|Overall Study|Withdrawal by Subject|1|||
28085590|NCT00350207|54739050|FG000|Overall Study|Other|1|||
28085591|NCT00350207|54739051|FG001|Overall Study|Other|3|||
28085592|NCT00350207|54739052|FG002|Overall Study|Other|1|||
28085593|NCT00349973|54739062|FG000|Overall Study|Adverse Event|3|||
28085594|NCT00349973|54739063|FG001|Overall Study|Adverse Event|3|||
28085595|NCT00349973|54739062|FG000|Overall Study|Withdrawal by Subject|1|||
28085596|NCT00349973|54739063|FG001|Overall Study|Withdrawal by Subject|0|||
28085597|NCT03187262|54739069|FG000|Induction|Lack of Efficacy|2|||
27973503|NCT00943826|54631183|FG001|Monotherapy Phase|Administrative reasons|5|||
27973504|NCT00943826|54631182|FG000|Monotherapy Phase|Refused treatment/ Did not cooperate|8|||
28085598|NCT03187262|54739069|FG000|Induction|Progressive Disease|4|||
28085599|NCT03187262|54739069|FG000|Consolidation|Progressive Disease|5|||
28085600|NCT03381196|54739075|FG000|Overall Study|Withdrawal by Subject|7|||
28085601|NCT03381196|54739076|FG001|Overall Study|Withdrawal by Subject|7|||
28085602|NCT03381196|54739075|FG000|Overall Study|Other|0|||
28085603|NCT03381196|54739076|FG001|Overall Study|Other|1|||
28085604|NCT03381196|54739075|FG000|Overall Study|Lost to Follow-up|5|||
28085605|NCT03381196|54739076|FG001|Overall Study|Lost to Follow-up|4|||
28085606|NCT03381196|54739075|FG000|Overall Study|Death|0|||
28085607|NCT03381196|54739076|FG001|Overall Study|Death|1|||
28085608|NCT03381196|54739075|FG000|Overall Study|Adverse Event|1|||
28085609|NCT03381196|54739076|FG001|Overall Study|Adverse Event|0|||
27973505|NCT00943826|54631183|FG001|Monotherapy Phase|Refused treatment/ Did not cooperate|2|||
27973506|NCT00943826|54631182|FG000|Monotherapy Phase|Withdrew Consent|2|||
27973507|NCT00943826|54631183|FG001|Monotherapy Phase|Withdrew Consent|3|||
27973508|NCT00943826|54631182|FG000|Monotherapy Phase|Failure to return|2|||
28085610|NCT03381196|54739075|FG000|Overall Study|Randomized, not treated|3|||
28085611|NCT03381196|54739076|FG001|Overall Study|Randomized, not treated|6|||
27973509|NCT00943826|54631183|FG001|Monotherapy Phase|Failure to return|1|||
27973510|NCT00943826|54631182|FG000|After Primary Overall Survival Analysis|Adverse Event|11|||
27973511|NCT00943826|54631183|FG001|After Primary Overall Survival Analysis|Adverse Event|0|||
27973512|NCT00943826|54631182|FG000|After Primary Overall Survival Analysis|Administrative reasons|10|||
27973513|NCT00943826|54631183|FG001|After Primary Overall Survival Analysis|Administrative reasons|16|||
27973514|NCT00943826|54631182|FG000|After Primary Overall Survival Analysis|Progression of Disease|2|||
28085612|NCT02950558|54739084|FG000|Overall Study|Lost to Follow-up|2|||
28085613|NCT02950558|54739085|FG001|Overall Study|Lost to Follow-up|0|||
28085614|NCT03345472|54739092|FG000|Implant to 3 Months|Withdrawal by Subject|2|||
28085615|NCT03345472|54739092|FG000|Implant to 3 Months|Physician Decision|1|||
28085616|NCT03345472|54739092|FG000|Implant to 3 Months|Adverse Event|1|||
28085617|NCT03345472|54739092|FG000|3 Months to 12 Months|Physician Decision|3|||
28085618|NCT03345472|54739092|FG000|3 Months to 12 Months|Lost to Follow-up|2|||
28085619|NCT03345472|54739092|FG000|3 Months to 12 Months|Withdrawal by Subject|1|||
28085620|NCT03345472|54739092|FG000|3 Months to 12 Months|Adverse Event|1|||
28085621|NCT03345472|54739092|FG000|3 Months to 12 Months|Death|1|||
28085622|NCT00349349|54739099|FG000|Overall Study|Adverse Event|5|||
28085623|NCT00349349|54739100|FG001|Overall Study|Adverse Event|6|||
28085624|NCT00349349|54739101|FG002|Overall Study|Adverse Event|2|||
28085625|NCT00349349|54739099|FG000|Overall Study|Withdrawal by Subject|5|||
28085626|NCT00349349|54739100|FG001|Overall Study|Withdrawal by Subject|2|||
28085627|NCT00349349|54739101|FG002|Overall Study|Withdrawal by Subject|1|||
28085628|NCT00349349|54739099|FG000|Overall Study|Withdrawn due to Disease Progression|27|||
28085629|NCT00349349|54739100|FG001|Overall Study|Withdrawn due to Disease Progression|37|||
28085630|NCT00349349|54739101|FG002|Overall Study|Withdrawn due to Disease Progression|1|||
28085631|NCT00349349|54739099|FG000|Overall Study|Death|13|||
28085632|NCT00349349|54739100|FG001|Overall Study|Death|10|||
28085633|NCT00349349|54739101|FG002|Overall Study|Death|1|||
28085634|NCT00349349|54739099|FG000|Overall Study|Other Treatment Selected|2|||
28085635|NCT00349349|54739100|FG001|Overall Study|Other Treatment Selected|0|||
28085636|NCT00349349|54739101|FG002|Overall Study|Other Treatment Selected|0|||
28085637|NCT00349349|54739099|FG000|Overall Study|Participant Reduced General Condition|0|||
28085638|NCT00349349|54739100|FG001|Overall Study|Participant Reduced General Condition|1|||
28085639|NCT00349349|54739101|FG002|Overall Study|Participant Reduced General Condition|0|||
28085640|NCT00349349|54739099|FG000|Overall Study|Physician Decision|1|||
28085641|NCT00349349|54739100|FG001|Overall Study|Physician Decision|2|||
28085642|NCT00349349|54739101|FG002|Overall Study|Physician Decision|1|||
28085643|NCT00349349|54739099|FG000|Overall Study|No Response|0|||
28085644|NCT00349349|54739100|FG001|Overall Study|No Response|3|||
28085645|NCT00349349|54739101|FG002|Overall Study|No Response|0|||
28085646|NCT00349349|54739099|FG000|Overall Study|New Malignancy (Bladder Cancer)|0|||
28085647|NCT00349349|54739100|FG001|Overall Study|New Malignancy (Bladder Cancer)|1|||
28085648|NCT00349349|54739101|FG002|Overall Study|New Malignancy (Bladder Cancer)|0|||
28085649|NCT02950480|54739113|FG000|Overall Study|Withdrawal by Subject|1|||
28085650|NCT02950480|54739114|FG001|Overall Study|Withdrawal by Subject|0|||
28085651|NCT00348881|54739122|FG000|Overall Study|Lost to Follow-up|12|||
28085652|NCT00348881|54739123|FG001|Overall Study|Lost to Follow-up|6|||
28085653|NCT00348881|54739122|FG000|Overall Study|Withdrawal by Subject|3|||
28085654|NCT00348881|54739123|FG001|Overall Study|Withdrawal by Subject|4|||
28085655|NCT00348881|54739122|FG000|Overall Study|Adverse Event|2|||
28085656|NCT00348881|54739123|FG001|Overall Study|Adverse Event|0|||
28085657|NCT00348881|54739122|FG000|Overall Study|Serious Adverse Event|0|||
28085658|NCT00348881|54739123|FG001|Overall Study|Serious Adverse Event|2|||
28085659|NCT03376516|54739133|FG000|Overall Study|Not treated|1|||
28085660|NCT03376516|54739133|FG000|Overall Study|Consent withdrawn|1|||
28085661|NCT03797144|54739159|FG000|Enrollment|Protocol Violation|4|||
28085662|NCT03797144|54739160|FG001|Enrollment|Protocol Violation|1|||
28085663|NCT03797144|54739159|FG000|Surgery|Protocol Violation|1|||
28085664|NCT03797144|54739160|FG001|Surgery|Protocol Violation|0|||
28085665|NCT03797144|54739159|FG000|3 Month|Early termination cut-off date|2|||
28085666|NCT03797144|54739160|FG001|3 Month|Early termination cut-off date|0|||
28085667|NCT03797144|54739159|FG000|12 Month|Early termination cut-off date|8|||
28085668|NCT03797144|54739160|FG001|12 Month|Early termination cut-off date|9|||
28085669|NCT03797144|54739159|FG000|24 Month|Early termination cut-off date|1|||
28085670|NCT03797144|54739160|FG001|24 Month|Early termination cut-off date|1|||
28085671|NCT00347009|54739167|FG000|Overall Study|Death|1|||
28085672|NCT00347009|54739167|FG000|Overall Study|Adverse Event|6|||
28085673|NCT00347009|54739167|FG000|Overall Study|Withdrawal by Subject|3|||
28085674|NCT00347009|54739167|FG000|Overall Study|Physician Decision|5|||
28085675|NCT00347009|54739167|FG000|Overall Study|Lost to Follow-up|4|||
28085676|NCT00347009|54739167|FG000|Overall Study|Protocol Violation|2|||
28085677|NCT00347009|54739167|FG000|Overall Study|Adverse Laboratory Experience|1|||
28085678|NCT00347009|54739167|FG000|Overall Study|Insufficient Viral Suppression|3|||
28085679|NCT00347009|54739167|FG000|Overall Study|Increased ALT/HBV DNA|1|||
28085680|NCT00347009|54739167|FG000|Overall Study|Serious Adverse Event|1|||
28085681|NCT00346775|54739175|FG000|Period 1: Intervention Period 1|Lost to Follow-up|1|||
27973515|NCT00943826|54631183|FG001|After Primary Overall Survival Analysis|Progression of Disease|4|||
27973516|NCT00943826|54631182|FG000|After Primary Overall Survival Analysis|Withdrew Consent|4|||
27973517|NCT00943826|54631183|FG001|After Primary Overall Survival Analysis|Withdrew Consent|0|||
27973518|NCT01004003|54631199|FG000|Overall Study|Progressive disease|2|||
27973519|NCT01004003|54631200|FG001|Overall Study|Progressive disease|1|||
27973520|NCT01004003|54631201|FG002|Overall Study|Progressive disease|1|||
27973521|NCT01004003|54631202|FG003|Overall Study|Progressive disease|0|||
27973522|NCT01004003|54631203|FG004|Overall Study|Progressive disease|2|||
27973523|NCT01004003|54631204|FG005|Overall Study|Progressive disease|1|||
27973524|NCT01004003|54631205|FG006|Overall Study|Progressive disease|1|||
27973525|NCT01004003|54631206|FG007|Overall Study|Progressive disease|39|||
27973526|NCT01004003|54631207|FG008|Overall Study|Progressive disease|22|||
27973527|NCT01004003|54631199|FG000|Overall Study|Adverse Event|4|||
27973528|NCT01004003|54631200|FG001|Overall Study|Adverse Event|2|||
27973529|NCT01004003|54631201|FG002|Overall Study|Adverse Event|3|||
27973530|NCT01004003|54631202|FG003|Overall Study|Adverse Event|3|||
27973531|NCT01004003|54631203|FG004|Overall Study|Adverse Event|2|||
27973532|NCT01004003|54631204|FG005|Overall Study|Adverse Event|2|||
27973533|NCT01004003|54631205|FG006|Overall Study|Adverse Event|7|||
27973534|NCT01004003|54631206|FG007|Overall Study|Adverse Event|21|||
27973535|NCT01004003|54631207|FG008|Overall Study|Adverse Event|6|||
27973536|NCT01004003|54631199|FG000|Overall Study|Refused to continue taking trial med.|0|||
27973537|NCT01004003|54631200|FG001|Overall Study|Refused to continue taking trial med.|0|||
27973538|NCT01004003|54631201|FG002|Overall Study|Refused to continue taking trial med.|0|||
27973539|NCT01004003|54631202|FG003|Overall Study|Refused to continue taking trial med.|0|||
27973540|NCT01004003|54631203|FG004|Overall Study|Refused to continue taking trial med.|0|||
27973541|NCT01004003|54631204|FG005|Overall Study|Refused to continue taking trial med.|0|||
27973542|NCT01004003|54631205|FG006|Overall Study|Refused to continue taking trial med.|0|||
27973543|NCT01004003|54631206|FG007|Overall Study|Refused to continue taking trial med.|0|||
27973544|NCT01004003|54631207|FG008|Overall Study|Refused to continue taking trial med.|2|||
27973545|NCT01004003|54631199|FG000|Overall Study|Other|0|||
27973546|NCT01004003|54631200|FG001|Overall Study|Other|0|||
27973547|NCT01004003|54631201|FG002|Overall Study|Other|0|||
27973548|NCT01004003|54631202|FG003|Overall Study|Other|0|||
27973549|NCT01004003|54631203|FG004|Overall Study|Other|0|||
27973550|NCT01004003|54631204|FG005|Overall Study|Other|1|||
27973551|NCT01004003|54631205|FG006|Overall Study|Other|0|||
28085682|NCT00346775|54739176|FG001|Period 1: Intervention Period 1|Lost to Follow-up|1|||
28085683|NCT00346775|54739175|FG000|Period 1: Intervention Period 1|Protocol Violation|3|||
28085684|NCT00346775|54739176|FG001|Period 1: Intervention Period 1|Protocol Violation|2|||
28085685|NCT00346775|54739175|FG000|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1|||
28085686|NCT00346775|54739176|FG001|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0|||
28085687|NCT00346697|54739188|FG000|Overall Study|Lost to Follow-up|0|||
28085688|NCT00346697|54739189|FG001|Overall Study|Lost to Follow-up|1|||
28085689|NCT03400852|54739199|FG000|Blinded Treatment Period|Physician Decision|0|||
28085690|NCT03400852|54739200|FG001|Blinded Treatment Period|Physician Decision|1|||
28085691|NCT03400852|54739201|FG002|Blinded Treatment Period|Physician Decision|0|||
28085692|NCT03400852|54739199|FG000|Blinded Treatment Period|Adverse Event|1|||
28085693|NCT03400852|54739200|FG001|Blinded Treatment Period|Adverse Event|1|||
28085694|NCT03400852|54739201|FG002|Blinded Treatment Period|Adverse Event|0|||
28085695|NCT03400852|54739199|FG000|Blinded Treatment Period|Study terminated by sponsor|8|||
27973552|NCT01004003|54631206|FG007|Overall Study|Other|0|||
27973553|NCT01004003|54631207|FG008|Overall Study|Other|0|||
28085696|NCT03400852|54739200|FG001|Blinded Treatment Period|Study terminated by sponsor|4|||
28085697|NCT03400852|54739201|FG002|Blinded Treatment Period|Study terminated by sponsor|0|||
28085698|NCT03400852|54739199|FG000|Open Label Period|Physician Decision|0|||
28085699|NCT03400852|54739200|FG001|Open Label Period|Physician Decision|0|||
28085700|NCT03400852|54739201|FG002|Open Label Period|Physician Decision|1|||
28085701|NCT03400852|54739199|FG000|Open Label Period|Study terminated by sponsor|0|||
28085702|NCT03400852|54739200|FG001|Open Label Period|Study terminated by sponsor|0|||
28085703|NCT03400852|54739201|FG002|Open Label Period|Study terminated by sponsor|21|||
28085704|NCT03398356|54739212|FG000|Before Treatment|Lost to Follow-up|1|||
28085705|NCT03398356|54739213|FG001|Before Treatment|Lost to Follow-up|2|||
28165361|NCT02998541|54836039|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
28165362|NCT02998541|54836040|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
27733057|NCT02564042|54180735|FG005|Overall Study|Lost to Follow-up|1|||
27733058|NCT02564042|54180730|FG000|Overall Study|Physician Decision|1|||
27973554|NCT00943670|54631229|FG000|Single-agent Trastuzumab Emtansine|Physician Decision|2|||
27973555|NCT00943670|54631229|FG000|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3|||
27973556|NCT00943670|54631229|FG000|Single-agent Trastuzumab Emtansine|Systemic progression|15|||
27973557|NCT00943670|54631229|FG000|Single-agent Trastuzumab Emtansine|Adverse Event|2|||
27973558|NCT00943670|54631229|FG000|Single-agent Trastuzumab Emtansine|Early progressive disease|20|||
27973559|NCT00943670|54631229|FG000|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1|||
28085706|NCT03398356|54739214|FG002|Before Treatment|Lost to Follow-up|0|||
28085707|NCT03398356|54739212|FG000|Before Treatment|drug intolerance|2|||
28085708|NCT03398356|54739213|FG001|Before Treatment|drug intolerance|1|||
28085709|NCT03398356|54739214|FG002|Before Treatment|drug intolerance|0|||
28085710|NCT03398356|54739212|FG000|Before Treatment|Withdrawal by Subject|0|||
28085711|NCT03398356|54739213|FG001|Before Treatment|Withdrawal by Subject|5|||
28085712|NCT03398356|54739214|FG002|Before Treatment|Withdrawal by Subject|0|||
28085713|NCT03398356|54739212|FG000|Before Treatment|Physician Decision|0|||
28085714|NCT03398356|54739213|FG001|Before Treatment|Physician Decision|0|||
28085715|NCT03398356|54739214|FG002|Before Treatment|Physician Decision|11|||
28085716|NCT03398356|54739212|FG000|After 6 Weeks of Treatment|Physician Decision|0|||
28085717|NCT03398356|54739213|FG001|After 6 Weeks of Treatment|Physician Decision|2|||
28085718|NCT03398356|54739214|FG002|After 6 Weeks of Treatment|Physician Decision|0|||
28085719|NCT00346151|54739222|FG000|Overall Study|Withdrawal by Subject|3|||
28085720|NCT00130286|54739230|FG000|Overall Study|Withdrawal by Subject|0|||
28085721|NCT00130286|54739231|FG001|Overall Study|Withdrawal by Subject|1|||
28085722|NCT00130286|54739232|FG002|Overall Study|Withdrawal by Subject|2|||
28085723|NCT00130286|54739233|FG003|Overall Study|Withdrawal by Subject|2|||
28085724|NCT00130286|54739230|FG000|Overall Study|Adverse Event|0|||
28085725|NCT00130286|54739231|FG001|Overall Study|Adverse Event|0|||
28085726|NCT00130286|54739232|FG002|Overall Study|Adverse Event|2|||
28085727|NCT00130286|54739233|FG003|Overall Study|Adverse Event|0|||
28085728|NCT00130286|54739230|FG000|Overall Study|Missing lab specimens|0|||
28085729|NCT00130286|54739231|FG001|Overall Study|Missing lab specimens|2|||
28085730|NCT00130286|54739232|FG002|Overall Study|Missing lab specimens|0|||
28085731|NCT00130286|54739233|FG003|Overall Study|Missing lab specimens|0|||
28085732|NCT00346073|54739245|FG000|Overall Study|Serious Adverse Event|2|||
28085733|NCT00346073|54739246|FG001|Overall Study|Serious Adverse Event|0|||
28085734|NCT00346073|54739245|FG000|Overall Study|Lost to Follow-up|39|||
28085735|NCT00346073|54739246|FG001|Overall Study|Lost to Follow-up|24|||
28085736|NCT03374488|54739254|FG000|Overall Study|Death|13|||
28085737|NCT03374488|54739255|FG001|Overall Study|Death|13|||
28085738|NCT03374488|54739254|FG000|Overall Study|Withdrawal by Subject|3|||
28085739|NCT03374488|54739255|FG001|Overall Study|Withdrawal by Subject|1|||
28085740|NCT03374488|54739254|FG000|Overall Study|Physician Decision|3|||
28085741|NCT03374488|54739255|FG001|Overall Study|Physician Decision|0|||
28085742|NCT00345683|54739264|FG000|Overall Study|Lost to Follow-up|19|||
28085743|NCT00345683|54739265|FG001|Overall Study|Lost to Follow-up|7|||
28085744|NCT00345683|54739264|FG000|Overall Study|Other|6|||
28085745|NCT00345683|54739265|FG001|Overall Study|Other|2|||
28085746|NCT03828383|54739273|FG000|Overall Study|Lost to Follow-up|3|||
28085747|NCT03828383|54739274|FG001|Overall Study|Lost to Follow-up|2|||
28085748|NCT03828383|54739273|FG000|Overall Study|Withdrawal by Subject|4|||
28085749|NCT03828383|54739274|FG001|Overall Study|Withdrawal by Subject|5|||
28085750|NCT00345605|54739280|FG000|Arm 1|Adverse Event|0|||
28085751|NCT00345605|54739281|FG001|Arm 1|Adverse Event|1|||
28085752|NCT00345605|54739280|FG000|Arm 2, Opposite Treatment|Adverse Event|1|||
28165363|NCT02998151|54836048|FG000|Overall Study|Withdrawal by Subject|3|||
28165364|NCT02998151|54836048|FG000|Overall Study|Participant declined to re-enroll for baclofen|8|||
28165365|NCT02998151|54836048|FG000|Overall Study|Participant was not offered acamprosate; acamprosate was discontinued and replaced with baclofen|13|||
28165366|NCT01066819|54836079|FG000|Overall Study|Adverse Event|18|||
28165367|NCT01066819|54836080|FG001|Overall Study|Adverse Event|1|||
28165368|NCT01066819|54836081|FG002|Overall Study|Adverse Event|6|||
28165369|NCT01066819|54836082|FG003|Overall Study|Adverse Event|0|||
28165370|NCT01066819|54836083|FG004|Overall Study|Adverse Event|0|||
28085753|NCT00345605|54739281|FG001|Arm 2, Opposite Treatment|Adverse Event|0|||
28165371|NCT01066819|54836084|FG005|Overall Study|Adverse Event|0|||
28165372|NCT01066819|54836079|FG000|Overall Study|Death|5|||
28165373|NCT01066819|54836080|FG001|Overall Study|Death|0|||
28165374|NCT01066819|54836081|FG002|Overall Study|Death|1|||
27733059|NCT02564042|54180731|FG001|Overall Study|Physician Decision|0|||
27832737|NCT01754753|54312481|FG000|Overall Study|Study close|43|||
27832738|NCT01754753|54312482|FG001|Overall Study|Study close|44|||
28085754|NCT03394924|54739292|FG000|Overall Study|Adverse Event|0|||
28085755|NCT03394924|54739293|FG001|Overall Study|Adverse Event|5|||
28085756|NCT03394924|54739294|FG002|Overall Study|Adverse Event|0|||
28085757|NCT03394924|54739292|FG000|Overall Study|Withdrawal by Subject|2|||
28085758|NCT03394924|54739293|FG001|Overall Study|Withdrawal by Subject|0|||
28085759|NCT03394924|54739294|FG002|Overall Study|Withdrawal by Subject|0|||
28085760|NCT03394924|54739292|FG000|Overall Study|Lost to Follow-up|0|||
28085761|NCT03394924|54739293|FG001|Overall Study|Lost to Follow-up|1|||
28085762|NCT03394924|54739294|FG002|Overall Study|Lost to Follow-up|0|||
28085763|NCT03394924|54739292|FG000|Overall Study|Did not meet all inclusion criteria|1|||
28165375|NCT01066819|54836082|FG003|Overall Study|Death|0|||
28165376|NCT01066819|54836083|FG004|Overall Study|Death|0|||
28165377|NCT01066819|54836084|FG005|Overall Study|Death|0|||
28165378|NCT01066819|54836079|FG000|Overall Study|Lack of Efficacy|22|||
28165379|NCT01066819|54836080|FG001|Overall Study|Lack of Efficacy|1|||
28165380|NCT01066819|54836081|FG002|Overall Study|Lack of Efficacy|2|||
28165381|NCT01066819|54836082|FG003|Overall Study|Lack of Efficacy|1|||
28165382|NCT01066819|54836083|FG004|Overall Study|Lack of Efficacy|0|||
28165383|NCT01066819|54836084|FG005|Overall Study|Lack of Efficacy|0|||
28165384|NCT01066819|54836079|FG000|Overall Study|Physician Decision|6|||
28165385|NCT01066819|54836080|FG001|Overall Study|Physician Decision|2|||
28165386|NCT01066819|54836081|FG002|Overall Study|Physician Decision|3|||
28165387|NCT01066819|54836082|FG003|Overall Study|Physician Decision|0|||
27973560|NCT00943670|54631229|FG000|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4|||
27973561|NCT00943670|54631229|FG000|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6|||
27973562|NCT00943670|54631229|FG000|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2|||
27973563|NCT00943670|54631229|FG000|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5|||
27973564|NCT00938366|54631246|FG000|Overall Study|Withdrawal by Subject|1|||
27973565|NCT00938366|54631247|FG001|Overall Study|Withdrawal by Subject|0|||
27973566|NCT00943592|54631253|FG000|Overall Study|Death|3|||
27973567|NCT00943124|54631257|FG000|Period 1|Withdrawal by Subject|1|||
27973568|NCT00943124|54631258|FG001|Period 1|Withdrawal by Subject|1|||
27973569|NCT00943124|54631257|FG000|Period 1|Did Not Follow Study Procedures|1|||
27973570|NCT00943124|54631258|FG001|Period 1|Did Not Follow Study Procedures|0|||
27973571|NCT00943124|54631257|FG000|Period 1|Personal Reasons|0|||
27973572|NCT00943124|54631258|FG001|Period 1|Personal Reasons|1|||
27973573|NCT00492050|54631264|FG000|Overall Study|Adverse Event|1|||
27973574|NCT00492050|54631264|FG000|Overall Study|Lack of Efficacy|1|||
27973575|NCT00492050|54631264|FG000|Overall Study|Withdrawal by Subject|3|||
27973576|NCT00492050|54631264|FG000|Overall Study|Unable to collect SCT|2|||
27973577|NCT00492050|54631264|FG000|Overall Study|Progressive Disease|2|||
27973578|NCT00726622|54631270|FG000|Overall Study|Withdrawal by Subject|16|||
27973579|NCT00726622|54631271|FG001|Overall Study|Withdrawal by Subject|2|||
27973580|NCT00726622|54631270|FG000|Overall Study|Physician Decision|0|||
27973581|NCT00726622|54631271|FG001|Overall Study|Physician Decision|1|||
27973582|NCT00726622|54631270|FG000|Overall Study|Metastasis|2|||
27973583|NCT00726622|54631271|FG001|Overall Study|Metastasis|0|||
27973584|NCT00940316|54631280|FG000|Reached First Response at 8 Weeks|Adverse Event|2|||
27973585|NCT00940316|54631281|FG001|Reached First Response at 8 Weeks|Adverse Event|1|||
27973586|NCT00940316|54631282|FG002|Reached First Response at 8 Weeks|Adverse Event|0|||
27973587|NCT00940316|54631280|FG000|Reached First Response at 8 Weeks|Progressive disease|1|||
27973588|NCT00940316|54631281|FG001|Reached First Response at 8 Weeks|Progressive disease|3|||
27973589|NCT00940316|54631282|FG002|Reached First Response at 8 Weeks|Progressive disease|0|||
27973590|NCT00940316|54631280|FG000|Moved on to be Treated Cycle 5|Adverse Event|2|||
27973591|NCT00940316|54631281|FG001|Moved on to be Treated Cycle 5|Adverse Event|0|||
27973592|NCT00940316|54631282|FG002|Moved on to be Treated Cycle 5|Adverse Event|0|||
27973593|NCT00940316|54631280|FG000|Treated After Cycle 5|Adverse Event|0|||
27973594|NCT00940316|54631281|FG001|Treated After Cycle 5|Adverse Event|0|||
27973595|NCT00940316|54631282|FG002|Treated After Cycle 5|Adverse Event|1|||
27973596|NCT00940316|54631280|FG000|Treated After Cycle 5|Progressive disease|0|||
27973597|NCT00940316|54631281|FG001|Treated After Cycle 5|Progressive disease|1|||
27973598|NCT00940316|54631282|FG002|Treated After Cycle 5|Progressive disease|0|||
27973599|NCT00726388|54631298|FG000|Overall Study|Withdrawal by Subject|5|||
27973600|NCT00726388|54631298|FG000|Overall Study|Adverse Event|3|||
27973601|NCT00726388|54631298|FG000|Overall Study|Lost to Follow-up|10|||
27973602|NCT00726388|54631298|FG000|Overall Study|Participants Non-compliant With Study Procedures|5|||
27973603|NCT00726388|54631298|FG000|Overall Study|Other|5|||
27973604|NCT00726388|54631298|FG000|Overall Study|Enrolled, Not Treated|79|||
27973605|NCT00572455|54631316|FG000|Stage I (14 Days)|Adverse Event|0|||
27973606|NCT00572455|54631317|FG001|Stage I (14 Days)|Adverse Event|0|||
27973607|NCT00572455|54631318|FG002|Stage I (14 Days)|Adverse Event|0|||
28085764|NCT03394924|54739293|FG001|Overall Study|Did not meet all inclusion criteria|0|||
28085765|NCT03394924|54739294|FG002|Overall Study|Did not meet all inclusion criteria|0|||
28085766|NCT00345293|54739304|FG000|Overall Study|Unable to access line for sample|1|||
28085767|NCT00345293|54739305|FG001|Overall Study|Unable to access line for sample|0|||
28085768|NCT00345293|54739304|FG000|Overall Study|Withdrawal by Subject|1|||
28085769|NCT00345293|54739305|FG001|Overall Study|Withdrawal by Subject|0|||
28085770|NCT00355121|54739314|FG000|Overall Study|Did not receive study vaccine|1|||
28085771|NCT00355121|54739315|FG001|Overall Study|Did not receive study vaccine|0|||
28165388|NCT01066819|54836083|FG004|Overall Study|Physician Decision|0|||
28165389|NCT01066819|54836084|FG005|Overall Study|Physician Decision|0|||
27855550|NCT04099641|54379839|FG000|Overall Study|Lost to Follow-up|1|||
27973608|NCT00572455|54631319|FG003|Stage I (14 Days)|Adverse Event|0|||
27973609|NCT00572455|54631320|FG004|Stage I (14 Days)|Adverse Event|0|||
27973610|NCT00572455|54631321|FG005|Stage I (14 Days)|Adverse Event|3|||
27973611|NCT00572455|54631322|FG006|Stage I (14 Days)|Adverse Event|0|||
27973612|NCT00572455|54631323|FG007|Stage I (14 Days)|Adverse Event|0|||
27973613|NCT00572455|54631324|FG008|Stage I (14 Days)|Adverse Event|0|||
28165390|NCT01066819|54836079|FG000|Overall Study|Protocol Violation|12|||
27973614|NCT00572455|54631325|FG009|Stage I (14 Days)|Adverse Event|0|||
27973615|NCT00572455|54631326|FG010|Stage I (14 Days)|Adverse Event|0|||
27973616|NCT00572455|54631327|FG011|Stage I (14 Days)|Adverse Event|0|||
27973617|NCT00572455|54631328|FG012|Stage I (14 Days)|Adverse Event|0|||
27973618|NCT00572455|54631329|FG013|Stage I (14 Days)|Adverse Event|0|||
27973619|NCT00572455|54631316|FG000|Stage I (14 Days)|Other|0|||
27973620|NCT00572455|54631317|FG001|Stage I (14 Days)|Other|0|||
27973621|NCT00572455|54631318|FG002|Stage I (14 Days)|Other|0|||
27973622|NCT00572455|54631319|FG003|Stage I (14 Days)|Other|0|||
27973623|NCT00572455|54631320|FG004|Stage I (14 Days)|Other|1|||
27973624|NCT00572455|54631321|FG005|Stage I (14 Days)|Other|0|||
27973625|NCT00572455|54631322|FG006|Stage I (14 Days)|Other|0|||
28085772|NCT00355121|54739316|FG002|Overall Study|Did not receive study vaccine|1|||
28085773|NCT00355121|54739314|FG000|Overall Study|Adverse Event|0|||
28085774|NCT00355121|54739315|FG001|Overall Study|Adverse Event|1|||
28085775|NCT00355121|54739316|FG002|Overall Study|Adverse Event|0|||
28085776|NCT00355121|54739314|FG000|Overall Study|Protocol Violation|7|||
28085777|NCT00355121|54739315|FG001|Overall Study|Protocol Violation|9|||
28085778|NCT00355121|54739316|FG002|Overall Study|Protocol Violation|1|||
28085779|NCT00355121|54739314|FG000|Overall Study|Lost to Follow-up|4|||
28085780|NCT00355121|54739315|FG001|Overall Study|Lost to Follow-up|7|||
27973626|NCT00572455|54631323|FG007|Stage I (14 Days)|Other|0|||
27973627|NCT00572455|54631324|FG008|Stage I (14 Days)|Other|0|||
27973628|NCT00572455|54631325|FG009|Stage I (14 Days)|Other|0|||
27973629|NCT00572455|54631326|FG010|Stage I (14 Days)|Other|0|||
27973630|NCT00572455|54631327|FG011|Stage I (14 Days)|Other|0|||
27973631|NCT00572455|54631328|FG012|Stage I (14 Days)|Other|0|||
27973632|NCT00572455|54631329|FG013|Stage I (14 Days)|Other|0|||
27973633|NCT00572455|54631316|FG000|Stage II (28 Days)|Adverse Event|0|||
27973634|NCT00572455|54631317|FG001|Stage II (28 Days)|Adverse Event|0|||
27973635|NCT00572455|54631318|FG002|Stage II (28 Days)|Adverse Event|0|||
27973636|NCT00572455|54631319|FG003|Stage II (28 Days)|Adverse Event|0|||
27973637|NCT00572455|54631320|FG004|Stage II (28 Days)|Adverse Event|0|||
27973638|NCT00572455|54631321|FG005|Stage II (28 Days)|Adverse Event|0|||
27973639|NCT00572455|54631322|FG006|Stage II (28 Days)|Adverse Event|0|||
27973640|NCT00572455|54631323|FG007|Stage II (28 Days)|Adverse Event|0|||
27973641|NCT00572455|54631324|FG008|Stage II (28 Days)|Adverse Event|1|||
27973642|NCT00572455|54631325|FG009|Stage II (28 Days)|Adverse Event|3|||
27973643|NCT00572455|54631326|FG010|Stage II (28 Days)|Adverse Event|3|||
27973644|NCT00572455|54631327|FG011|Stage II (28 Days)|Adverse Event|4|||
27973645|NCT00572455|54631328|FG012|Stage II (28 Days)|Adverse Event|5|||
27973646|NCT00572455|54631329|FG013|Stage II (28 Days)|Adverse Event|1|||
27973647|NCT00572455|54631316|FG000|Stage II (28 Days)|Death|0|||
27973648|NCT00572455|54631317|FG001|Stage II (28 Days)|Death|0|||
27973649|NCT00572455|54631318|FG002|Stage II (28 Days)|Death|0|||
27973650|NCT00572455|54631319|FG003|Stage II (28 Days)|Death|0|||
27973651|NCT00572455|54631320|FG004|Stage II (28 Days)|Death|0|||
27973652|NCT00572455|54631321|FG005|Stage II (28 Days)|Death|0|||
27973653|NCT00572455|54631322|FG006|Stage II (28 Days)|Death|0|||
27973654|NCT00572455|54631323|FG007|Stage II (28 Days)|Death|0|||
27973655|NCT00572455|54631324|FG008|Stage II (28 Days)|Death|1|||
27973656|NCT00572455|54631325|FG009|Stage II (28 Days)|Death|0|||
27973657|NCT00572455|54631326|FG010|Stage II (28 Days)|Death|0|||
27973658|NCT00572455|54631327|FG011|Stage II (28 Days)|Death|0|||
27973659|NCT00572455|54631328|FG012|Stage II (28 Days)|Death|0|||
27973660|NCT00572455|54631329|FG013|Stage II (28 Days)|Death|0|||
27973661|NCT00572455|54631316|FG000|Stage II (28 Days)|Withdrawal by Subject|0|||
27973662|NCT00572455|54631317|FG001|Stage II (28 Days)|Withdrawal by Subject|0|||
27973663|NCT00572455|54631318|FG002|Stage II (28 Days)|Withdrawal by Subject|0|||
27973664|NCT00572455|54631319|FG003|Stage II (28 Days)|Withdrawal by Subject|0|||
27973665|NCT00572455|54631320|FG004|Stage II (28 Days)|Withdrawal by Subject|0|||
27973666|NCT00572455|54631321|FG005|Stage II (28 Days)|Withdrawal by Subject|0|||
27973667|NCT00572455|54631322|FG006|Stage II (28 Days)|Withdrawal by Subject|0|||
27973668|NCT00572455|54631323|FG007|Stage II (28 Days)|Withdrawal by Subject|1|||
27973669|NCT00572455|54631324|FG008|Stage II (28 Days)|Withdrawal by Subject|0|||
27973670|NCT00572455|54631325|FG009|Stage II (28 Days)|Withdrawal by Subject|0|||
27973671|NCT00572455|54631326|FG010|Stage II (28 Days)|Withdrawal by Subject|2|||
27973672|NCT00572455|54631327|FG011|Stage II (28 Days)|Withdrawal by Subject|0|||
28085781|NCT00355121|54739316|FG002|Overall Study|Lost to Follow-up|1|||
27733060|NCT02564042|54180732|FG002|Overall Study|Physician Decision|0|||
27973673|NCT00572455|54631328|FG012|Stage II (28 Days)|Withdrawal by Subject|0|||
27973674|NCT00572455|54631329|FG013|Stage II (28 Days)|Withdrawal by Subject|0|||
27973675|NCT00572455|54631316|FG000|Stage II (28 Days)|Other|0|||
27973676|NCT00572455|54631317|FG001|Stage II (28 Days)|Other|0|||
27973677|NCT00572455|54631318|FG002|Stage II (28 Days)|Other|0|||
27973678|NCT00572455|54631319|FG003|Stage II (28 Days)|Other|0|||
27973679|NCT00572455|54631320|FG004|Stage II (28 Days)|Other|0|||
27973680|NCT00572455|54631321|FG005|Stage II (28 Days)|Other|0|||
27973681|NCT00572455|54631322|FG006|Stage II (28 Days)|Other|0|||
27973682|NCT00572455|54631323|FG007|Stage II (28 Days)|Other|0|||
27973683|NCT00572455|54631324|FG008|Stage II (28 Days)|Other|1|||
28085782|NCT00355121|54739314|FG000|Overall Study|Withdrawal by Subject|9|||
27973684|NCT00572455|54631325|FG009|Stage II (28 Days)|Other|0|||
27973685|NCT00572455|54631326|FG010|Stage II (28 Days)|Other|0|||
27973686|NCT00572455|54631327|FG011|Stage II (28 Days)|Other|0|||
27973687|NCT00572455|54631328|FG012|Stage II (28 Days)|Other|0|||
27973688|NCT00572455|54631329|FG013|Stage II (28 Days)|Other|0|||
27973689|NCT00572455|54631316|FG000|Stage II (28 Days)|Randomized, but not treated|0|||
27973690|NCT00572455|54631317|FG001|Stage II (28 Days)|Randomized, but not treated|0|||
27973691|NCT00572455|54631318|FG002|Stage II (28 Days)|Randomized, but not treated|0|||
27973692|NCT00572455|54631319|FG003|Stage II (28 Days)|Randomized, but not treated|0|||
27973693|NCT00572455|54631320|FG004|Stage II (28 Days)|Randomized, but not treated|0|||
27973694|NCT00572455|54631321|FG005|Stage II (28 Days)|Randomized, but not treated|0|||
27973695|NCT00572455|54631322|FG006|Stage II (28 Days)|Randomized, but not treated|0|||
27973696|NCT00572455|54631323|FG007|Stage II (28 Days)|Randomized, but not treated|0|||
27973697|NCT00572455|54631324|FG008|Stage II (28 Days)|Randomized, but not treated|0|||
27973698|NCT00572455|54631325|FG009|Stage II (28 Days)|Randomized, but not treated|0|||
27973699|NCT00572455|54631326|FG010|Stage II (28 Days)|Randomized, but not treated|0|||
27973700|NCT00572455|54631327|FG011|Stage II (28 Days)|Randomized, but not treated|0|||
27973701|NCT00572455|54631328|FG012|Stage II (28 Days)|Randomized, but not treated|0|||
27973702|NCT00572455|54631329|FG013|Stage II (28 Days)|Randomized, but not treated|1|||
27973703|NCT01003691|54631363|FG000|Overall Study|Adverse Event|0|||
27973704|NCT01003691|54631364|FG001|Overall Study|Adverse Event|0|||
27973705|NCT01003691|54631365|FG002|Overall Study|Adverse Event|0|||
27973706|NCT01003691|54631366|FG003|Overall Study|Adverse Event|1|||
27973707|NCT00686335|54631377|FG000|Run-in Period|Adverse Event|1|||
27973708|NCT00686335|54631377|FG000|Run-in Period|asthma exacerbation|1|||
27973709|NCT00686335|54631377|FG000|Run-in Period|violation of inclusion/exclusion criteri|3|||
27973710|NCT01002989|54631383|FG000|Overall Study|exclusion criteria, no consent|5|||
27973711|NCT00685945|54631387|FG000|L-NMMA + Bradykinin|Physician Decision|1|||
27973712|NCT01007123|54631401|FG000|Overall Study|Adverse Event|3|||
27973713|NCT01007123|54631402|FG001|Overall Study|Adverse Event|4|||
27973714|NCT01007123|54631403|FG002|Overall Study|Adverse Event|7|||
27973715|NCT01007123|54631404|FG003|Overall Study|Adverse Event|1|||
27973716|NCT01007123|54631401|FG000|Overall Study|Lack of Efficacy|1|||
27973717|NCT01007123|54631402|FG001|Overall Study|Lack of Efficacy|0|||
27973718|NCT01007123|54631403|FG002|Overall Study|Lack of Efficacy|1|||
27973719|NCT01007123|54631404|FG003|Overall Study|Lack of Efficacy|4|||
27973720|NCT01007123|54631401|FG000|Overall Study|Protocol Violation|1|||
27973721|NCT01007123|54631402|FG001|Overall Study|Protocol Violation|1|||
27973722|NCT01007123|54631403|FG002|Overall Study|Protocol Violation|2|||
27973723|NCT01007123|54631404|FG003|Overall Study|Protocol Violation|1|||
27973724|NCT01007123|54631401|FG000|Overall Study|Withdrawal by Subject|1|||
27973725|NCT01007123|54631402|FG001|Overall Study|Withdrawal by Subject|0|||
27973726|NCT01007123|54631403|FG002|Overall Study|Withdrawal by Subject|1|||
27973727|NCT01007123|54631404|FG003|Overall Study|Withdrawal by Subject|0|||
27973728|NCT01007123|54631401|FG000|Overall Study|Lost to Follow-up|0|||
27973729|NCT01007123|54631402|FG001|Overall Study|Lost to Follow-up|1|||
27973730|NCT01007123|54631403|FG002|Overall Study|Lost to Follow-up|0|||
27973731|NCT01007123|54631404|FG003|Overall Study|Lost to Follow-up|0|||
27973732|NCT00687739|54631419|FG000|Overall Study|Lost to Follow-up|2|||
27973733|NCT00687739|54631420|FG001|Overall Study|Lost to Follow-up|2|||
27973734|NCT00687739|54631421|FG002|Overall Study|Lost to Follow-up|1|||
27973735|NCT00687739|54631422|FG003|Overall Study|Lost to Follow-up|2|||
27973736|NCT00687739|54631419|FG000|Overall Study|Adverse Event|0|||
27973737|NCT00687739|54631420|FG001|Overall Study|Adverse Event|1|||
27973738|NCT00687739|54631421|FG002|Overall Study|Adverse Event|1|||
27973739|NCT00687739|54631422|FG003|Overall Study|Adverse Event|0|||
27973740|NCT01006889|54631434|FG000|Overall Study|Withdrawal by Subject|3|||
27973741|NCT01001429|54631441|FG000|Overall Study|surgery cancelled|0|||
27973742|NCT01001429|54631442|FG001|Overall Study|surgery cancelled|1|||
27973743|NCT01000961|54631472|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
27973744|NCT01000961|54631473|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
27973745|NCT01000961|54631472|FG000|First Intervention (3 Weeks)|Infection after pre-planned surgery|0|||
27973746|NCT01000961|54631473|FG001|First Intervention (3 Weeks)|Infection after pre-planned surgery|1|||
27973747|NCT01000805|54631483|FG000|Overall Study|Adverse Event|21|||
27973748|NCT01000805|54631484|FG001|Overall Study|Adverse Event|9|||
27973749|NCT01000805|54631483|FG000|Overall Study|Lack of Efficacy|5|||
27973750|NCT01000805|54631484|FG001|Overall Study|Lack of Efficacy|16|||
27973751|NCT01000805|54631483|FG000|Overall Study|Lost to Follow-up|16|||
27973752|NCT01000805|54631484|FG001|Overall Study|Lost to Follow-up|21|||
28165391|NCT01066819|54836080|FG001|Overall Study|Protocol Violation|6|||
28165392|NCT01066819|54836081|FG002|Overall Study|Protocol Violation|0|||
27973753|NCT01000805|54631483|FG000|Overall Study|Physician Decision|0|||
27973754|NCT01000805|54631484|FG001|Overall Study|Physician Decision|1|||
27973755|NCT01000805|54631483|FG000|Overall Study|Protocol Violation|12|||
27973756|NCT01000805|54631484|FG001|Overall Study|Protocol Violation|8|||
27973757|NCT01000805|54631483|FG000|Overall Study|Withdrawal by Subject|16|||
27973758|NCT01000805|54631484|FG001|Overall Study|Withdrawal by Subject|6|||
27973759|NCT01000805|54631483|FG000|Overall Study|Sponsor Decision|0|||
27973760|NCT01000805|54631484|FG001|Overall Study|Sponsor Decision|1|||
27973761|NCT00684307|54631496|FG000|Overall Study|Adverse Event|11|||
27973762|NCT00684307|54631497|FG001|Overall Study|Adverse Event|6|||
27973763|NCT00684307|54631498|FG002|Overall Study|Adverse Event|15|||
27973764|NCT00684307|54631499|FG003|Overall Study|Adverse Event|16|||
27973765|NCT00684307|54631500|FG004|Overall Study|Adverse Event|8|||
27973766|NCT00684307|54631496|FG000|Overall Study|Development of increasing Liver Function|0|||
27973767|NCT00684307|54631497|FG001|Overall Study|Development of increasing Liver Function|2|||
27973768|NCT00684307|54631498|FG002|Overall Study|Development of increasing Liver Function|0|||
27973769|NCT00684307|54631499|FG003|Overall Study|Development of increasing Liver Function|1|||
27973770|NCT00684307|54631500|FG004|Overall Study|Development of increasing Liver Function|0|||
27973771|NCT00684307|54631496|FG000|Overall Study|Fullfillment of exclusion criteria|1|||
27973772|NCT00684307|54631497|FG001|Overall Study|Fullfillment of exclusion criteria|0|||
27973773|NCT00684307|54631498|FG002|Overall Study|Fullfillment of exclusion criteria|0|||
27973774|NCT00684307|54631499|FG003|Overall Study|Fullfillment of exclusion criteria|3|||
27973775|NCT00684307|54631500|FG004|Overall Study|Fullfillment of exclusion criteria|1|||
27973776|NCT00684307|54631496|FG000|Overall Study|Incorrect enrolment or randomization|4|||
27973777|NCT00684307|54631497|FG001|Overall Study|Incorrect enrolment or randomization|0|||
27973778|NCT00684307|54631498|FG002|Overall Study|Incorrect enrolment or randomization|0|||
27973779|NCT00684307|54631499|FG003|Overall Study|Incorrect enrolment or randomization|0|||
27973780|NCT00684307|54631500|FG004|Overall Study|Incorrect enrolment or randomization|0|||
27973781|NCT00684307|54631496|FG000|Overall Study|Interupted IP for more than 7 days|0|||
27973782|NCT00684307|54631497|FG001|Overall Study|Interupted IP for more than 7 days|4|||
27973783|NCT00684307|54631498|FG002|Overall Study|Interupted IP for more than 7 days|1|||
27973784|NCT00684307|54631499|FG003|Overall Study|Interupted IP for more than 7 days|3|||
27973785|NCT00684307|54631500|FG004|Overall Study|Interupted IP for more than 7 days|3|||
27973786|NCT00684307|54631496|FG000|Overall Study|Severe non compliance to protocol|1|||
27973787|NCT00684307|54631497|FG001|Overall Study|Severe non compliance to protocol|0|||
27973788|NCT00684307|54631498|FG002|Overall Study|Severe non compliance to protocol|0|||
27973789|NCT00684307|54631499|FG003|Overall Study|Severe non compliance to protocol|1|||
27973790|NCT00684307|54631500|FG004|Overall Study|Severe non compliance to protocol|2|||
27973791|NCT00684307|54631496|FG000|Overall Study|Participant not willing to continue|7|||
27973792|NCT00684307|54631497|FG001|Overall Study|Participant not willing to continue|10|||
27973793|NCT00684307|54631498|FG002|Overall Study|Participant not willing to continue|11|||
27973794|NCT00684307|54631499|FG003|Overall Study|Participant not willing to continue|5|||
27973795|NCT00684307|54631500|FG004|Overall Study|Participant not willing to continue|8|||
27973796|NCT00684307|54631496|FG000|Overall Study|Criteria from the CSR|0|||
27973797|NCT00684307|54631497|FG001|Overall Study|Criteria from the CSR|0|||
27973798|NCT00684307|54631498|FG002|Overall Study|Criteria from the CSR|1|||
27973799|NCT00684307|54631499|FG003|Overall Study|Criteria from the CSR|3|||
27973800|NCT00684307|54631500|FG004|Overall Study|Criteria from the CSR|3|||
27973801|NCT00683917|54631515|FG000|Overall Study|Study prematurely terminated|10|||
27973802|NCT00687271|54631527|FG000|Overall Study|Adverse Event|1|||
27973803|NCT00687271|54631528|FG001|Overall Study|Adverse Event|3|||
27973804|NCT00687271|54631529|FG002|Overall Study|Adverse Event|1|||
27973805|NCT00687271|54631530|FG003|Overall Study|Adverse Event|0|||
27973806|NCT00687271|54631527|FG000|Overall Study|Lost to Follow-up|0|||
28085783|NCT00355121|54739315|FG001|Overall Study|Withdrawal by Subject|10|||
28085784|NCT00355121|54739316|FG002|Overall Study|Withdrawal by Subject|2|||
28085785|NCT00355121|54739314|FG000|Overall Study|Serious adverse events|0|||
28085786|NCT00355121|54739315|FG001|Overall Study|Serious adverse events|2|||
28085787|NCT00355121|54739316|FG002|Overall Study|Serious adverse events|0|||
28085788|NCT00343889|54739329|FG000|Overall Study|Lost to Follow-up|2|||
28085789|NCT00343889|54739330|FG001|Overall Study|Lost to Follow-up|0|||
28085790|NCT00343889|54739329|FG000|Overall Study|Withdrawal by Subject|0|||
28085791|NCT00343889|54739330|FG001|Overall Study|Withdrawal by Subject|1|||
27855551|NCT04099641|54379840|FG001|Overall Study|Lost to Follow-up|0|||
27855552|NCT04099641|54379839|FG000|Overall Study|Withdrawal by Subject|2|||
27855553|NCT04099641|54379840|FG001|Overall Study|Withdrawal by Subject|0|||
27855554|NCT03123393|54379966|FG000|Overall Study|Study Terminated by Sponsor|6|||
27855555|NCT03123393|54379967|FG001|Overall Study|Study Terminated by Sponsor|9|||
27855556|NCT03123393|54379966|FG000|Overall Study|Withdrawal by Subject|2|||
27855557|NCT03123393|54379967|FG001|Overall Study|Withdrawal by Subject|1|||
27855558|NCT03123393|54379966|FG000|Overall Study|Reason not Specified|13|||
27855559|NCT03123393|54379967|FG001|Overall Study|Reason not Specified|13|||
27973807|NCT00687271|54631528|FG001|Overall Study|Lost to Follow-up|1|||
27973808|NCT00687271|54631529|FG002|Overall Study|Lost to Follow-up|0|||
27973809|NCT00687271|54631530|FG003|Overall Study|Lost to Follow-up|0|||
27855560|NCT02834247|54380598|FG000|Dose Escalation Phase|Study Terminated by Sponsor|1|||
27855561|NCT02834247|54380599|FG001|Dose Escalation Phase|Study Terminated by Sponsor|2|||
27855562|NCT02834247|54380600|FG002|Dose Escalation Phase|Study Terminated by Sponsor|0|||
27855563|NCT02834247|54380601|FG003|Dose Escalation Phase|Study Terminated by Sponsor|0|||
27855564|NCT02834247|54380598|FG000|Dose Escalation Phase|Death|5|||
27973810|NCT00687271|54631527|FG000|Overall Study|Protocol Violation|2|||
27973811|NCT00687271|54631528|FG001|Overall Study|Protocol Violation|1|||
28085792|NCT00343889|54739329|FG000|Overall Study|Protocol Violation|1|||
28085793|NCT00343889|54739330|FG001|Overall Study|Protocol Violation|0|||
28085794|NCT00354341|54739338|FG000|Overall Study|Adverse Event|1|||
28085795|NCT00354341|54739339|FG001|Overall Study|Adverse Event|0|||
27973812|NCT00687271|54631529|FG002|Overall Study|Protocol Violation|1|||
27973813|NCT00687271|54631530|FG003|Overall Study|Protocol Violation|0|||
27973814|NCT00687271|54631527|FG000|Overall Study|Withdrawal by Subject|0|||
27973815|NCT00687271|54631528|FG001|Overall Study|Withdrawal by Subject|1|||
27973816|NCT00687271|54631529|FG002|Overall Study|Withdrawal by Subject|3|||
27973817|NCT00687271|54631530|FG003|Overall Study|Withdrawal by Subject|0|||
27973818|NCT04617275|54631548|FG000|Treatment Period|Adverse Event|1|||
27973819|NCT04617275|54631549|FG001|Treatment Period|Adverse Event|6|||
27973820|NCT04617275|54631550|FG002|Treatment Period|Adverse Event|4|||
27973821|NCT04617275|54631551|FG003|Treatment Period|Adverse Event|6|||
27973822|NCT04617275|54631552|FG004|Treatment Period|Adverse Event|7|||
27973823|NCT04617275|54631553|FG005|Treatment Period|Adverse Event|8|||
27973824|NCT04617275|54631554|FG006|Treatment Period|Adverse Event|0|||
27973825|NCT04617275|54631555|FG007|Treatment Period|Adverse Event|12|||
27973826|NCT04617275|54631548|FG000|Treatment Period|Lost to Follow-up|0|||
27973827|NCT04617275|54631549|FG001|Treatment Period|Lost to Follow-up|0|||
27973828|NCT04617275|54631550|FG002|Treatment Period|Lost to Follow-up|2|||
27973829|NCT04617275|54631551|FG003|Treatment Period|Lost to Follow-up|0|||
27973830|NCT04617275|54631552|FG004|Treatment Period|Lost to Follow-up|0|||
27973831|NCT04617275|54631553|FG005|Treatment Period|Lost to Follow-up|3|||
27973832|NCT04617275|54631554|FG006|Treatment Period|Lost to Follow-up|0|||
27973833|NCT04617275|54631555|FG007|Treatment Period|Lost to Follow-up|2|||
27973834|NCT04617275|54631548|FG000|Treatment Period|No longer meets eligibility criteria|0|||
27973835|NCT04617275|54631549|FG001|Treatment Period|No longer meets eligibility criteria|0|||
27973836|NCT04617275|54631550|FG002|Treatment Period|No longer meets eligibility criteria|0|||
27973837|NCT04617275|54631551|FG003|Treatment Period|No longer meets eligibility criteria|1|||
27973838|NCT04617275|54631552|FG004|Treatment Period|No longer meets eligibility criteria|0|||
27973839|NCT04617275|54631553|FG005|Treatment Period|No longer meets eligibility criteria|0|||
27973840|NCT04617275|54631554|FG006|Treatment Period|No longer meets eligibility criteria|0|||
27973841|NCT04617275|54631555|FG007|Treatment Period|No longer meets eligibility criteria|0|||
27973842|NCT04617275|54631548|FG000|Treatment Period|Other|0|||
27973843|NCT04617275|54631549|FG001|Treatment Period|Other|1|||
27973844|NCT04617275|54631550|FG002|Treatment Period|Other|0|||
27973845|NCT04617275|54631551|FG003|Treatment Period|Other|0|||
27973846|NCT04617275|54631552|FG004|Treatment Period|Other|0|||
27973847|NCT04617275|54631553|FG005|Treatment Period|Other|0|||
27973848|NCT04617275|54631554|FG006|Treatment Period|Other|0|||
27973849|NCT04617275|54631555|FG007|Treatment Period|Other|0|||
27973850|NCT04617275|54631548|FG000|Treatment Period|Withdrawal by Subject|2|||
27973851|NCT04617275|54631549|FG001|Treatment Period|Withdrawal by Subject|0|||
27973852|NCT04617275|54631550|FG002|Treatment Period|Withdrawal by Subject|0|||
27973853|NCT04617275|54631551|FG003|Treatment Period|Withdrawal by Subject|2|||
27973854|NCT04617275|54631552|FG004|Treatment Period|Withdrawal by Subject|2|||
27973855|NCT04617275|54631553|FG005|Treatment Period|Withdrawal by Subject|0|||
27973856|NCT04617275|54631554|FG006|Treatment Period|Withdrawal by Subject|1|||
28085796|NCT00354341|54739338|FG000|Overall Study|Death|0|||
27973857|NCT04617275|54631555|FG007|Treatment Period|Withdrawal by Subject|2|||
27973858|NCT04617275|54631548|FG000|Follow-up Period|Adverse Event|1|||
27973859|NCT04617275|54631549|FG001|Follow-up Period|Adverse Event|1|||
27973860|NCT04617275|54631550|FG002|Follow-up Period|Adverse Event|2|||
27973861|NCT04617275|54631551|FG003|Follow-up Period|Adverse Event|3|||
27973862|NCT04617275|54631552|FG004|Follow-up Period|Adverse Event|4|||
27973863|NCT04617275|54631553|FG005|Follow-up Period|Adverse Event|3|||
27973864|NCT04617275|54631554|FG006|Follow-up Period|Adverse Event|0|||
27973865|NCT04617275|54631555|FG007|Follow-up Period|Adverse Event|3|||
27973866|NCT04617275|54631548|FG000|Follow-up Period|Lost to Follow-up|0|||
27973867|NCT04617275|54631549|FG001|Follow-up Period|Lost to Follow-up|1|||
27973868|NCT04617275|54631550|FG002|Follow-up Period|Lost to Follow-up|2|||
28085797|NCT00354341|54739339|FG001|Overall Study|Death|2|||
28085798|NCT00354341|54739338|FG000|Overall Study|Refused treatment|1|||
28165393|NCT01066819|54836082|FG003|Overall Study|Protocol Violation|0|||
28165394|NCT01066819|54836083|FG004|Overall Study|Protocol Violation|0|||
28165395|NCT01066819|54836084|FG005|Overall Study|Protocol Violation|0|||
27973869|NCT04617275|54631551|FG003|Follow-up Period|Lost to Follow-up|0|||
27973870|NCT04617275|54631552|FG004|Follow-up Period|Lost to Follow-up|0|||
27973871|NCT04617275|54631553|FG005|Follow-up Period|Lost to Follow-up|4|||
27973872|NCT04617275|54631554|FG006|Follow-up Period|Lost to Follow-up|0|||
27973873|NCT04617275|54631555|FG007|Follow-up Period|Lost to Follow-up|3|||
27973874|NCT04617275|54631548|FG000|Follow-up Period|No longer meets eligibility criteria|0|||
27973875|NCT04617275|54631549|FG001|Follow-up Period|No longer meets eligibility criteria|0|||
27973876|NCT04617275|54631550|FG002|Follow-up Period|No longer meets eligibility criteria|0|||
28085799|NCT00354341|54739339|FG001|Overall Study|Refused treatment|2|||
28085800|NCT00354341|54739338|FG000|Overall Study|Failure to return|0|||
27973877|NCT04617275|54631551|FG003|Follow-up Period|No longer meets eligibility criteria|1|||
27973878|NCT04617275|54631552|FG004|Follow-up Period|No longer meets eligibility criteria|0|||
27973879|NCT04617275|54631553|FG005|Follow-up Period|No longer meets eligibility criteria|0|||
27973880|NCT04617275|54631554|FG006|Follow-up Period|No longer meets eligibility criteria|0|||
27973881|NCT04617275|54631555|FG007|Follow-up Period|No longer meets eligibility criteria|0|||
27973882|NCT04617275|54631548|FG000|Follow-up Period|Other|0|||
27973883|NCT04617275|54631549|FG001|Follow-up Period|Other|1|||
27973884|NCT04617275|54631550|FG002|Follow-up Period|Other|0|||
27973885|NCT04617275|54631551|FG003|Follow-up Period|Other|0|||
27973886|NCT04617275|54631552|FG004|Follow-up Period|Other|0|||
27973887|NCT04617275|54631553|FG005|Follow-up Period|Other|0|||
27973888|NCT04617275|54631554|FG006|Follow-up Period|Other|0|||
27973889|NCT04617275|54631555|FG007|Follow-up Period|Other|0|||
27973890|NCT04617275|54631548|FG000|Follow-up Period|Withdrawal by Subject|2|||
27973891|NCT04617275|54631549|FG001|Follow-up Period|Withdrawal by Subject|0|||
27973892|NCT04617275|54631550|FG002|Follow-up Period|Withdrawal by Subject|0|||
27973893|NCT04617275|54631551|FG003|Follow-up Period|Withdrawal by Subject|2|||
27973894|NCT04617275|54631552|FG004|Follow-up Period|Withdrawal by Subject|2|||
27973895|NCT04617275|54631553|FG005|Follow-up Period|Withdrawal by Subject|0|||
27973896|NCT04617275|54631554|FG006|Follow-up Period|Withdrawal by Subject|1|||
27973897|NCT04617275|54631555|FG007|Follow-up Period|Withdrawal by Subject|2|||
27973898|NCT01031537|54631590|FG000|Overall Study|medical reasons not related to study|3|||
27973899|NCT01031537|54631590|FG000|Overall Study|Lack of Efficacy|1|||
27973900|NCT01031537|54631590|FG000|Overall Study|retired from NIH, met exclusion criteria|1|||
27973901|NCT01031537|54631590|FG000|Overall Study|moved, met exclusion criteria|10|||
27973902|NCT01031537|54631590|FG000|Overall Study|Withdrawal by Subject|5|||
27973903|NCT01031537|54631590|FG000|Overall Study|PI removal, no longer met eligibility|12|||
27973904|NCT01031381|54631594|FG000|Overall Study|Physician Decision|3|||
27973905|NCT01031381|54631594|FG000|Overall Study|Withdrawal by Subject|6|||
27973906|NCT00685399|54631606|FG000|Treatment Period 1|Withdrawal by Subject|2|||
27973907|NCT00685399|54631607|FG001|Treatment Period 1|Withdrawal by Subject|0|||
27973908|NCT00685399|54631608|FG002|Treatment Period 1|Withdrawal by Subject|0|||
27973909|NCT00685399|54631609|FG003|Treatment Period 1|Withdrawal by Subject|0|||
27973910|NCT00685399|54631610|FG004|Treatment Period 1|Withdrawal by Subject|0|||
27973911|NCT00685399|54631611|FG005|Treatment Period 1|Withdrawal by Subject|0|||
27973912|NCT00685399|54631612|FG006|Treatment Period 1|Withdrawal by Subject|0|||
27973913|NCT00685399|54631613|FG007|Treatment Period 1|Withdrawal by Subject|0|||
27973914|NCT00685399|54631606|FG000|Treatment Period 1|Protocol Violation|1|||
27973915|NCT00685399|54631607|FG001|Treatment Period 1|Protocol Violation|0|||
27973916|NCT00685399|54631608|FG002|Treatment Period 1|Protocol Violation|0|||
28085801|NCT00354341|54739339|FG001|Overall Study|Failure to return|1|||
28085802|NCT00354341|54739338|FG000|Overall Study|Other|1|||
28085803|NCT00354341|54739339|FG001|Overall Study|Other|2|||
28085804|NCT00354107|54739345|FG000|Overall Study|Adverse Event|2|||
28085805|NCT00354107|54739345|FG000|Overall Study|Physician Decision|2|||
28085806|NCT00354107|54739345|FG000|Overall Study|Withdrawal by Subject|1|||
28085807|NCT00354029|54739351|FG000|Overall Study|Protocol Violation|4|||
28085808|NCT00354029|54739352|FG001|Overall Study|Protocol Violation|2|||
28085809|NCT00353873|54739360|FG000|Overall Study|Protocol Violation|1|||
28085810|NCT00353873|54739361|FG001|Overall Study|Protocol Violation|2|||
28085811|NCT00353873|54739360|FG000|Overall Study|Exacerbation|1|||
28085812|NCT00353873|54739361|FG001|Overall Study|Exacerbation|0|||
28085813|NCT00353873|54739360|FG000|Overall Study|Adverse Event|1|||
27973917|NCT00685399|54631609|FG003|Treatment Period 1|Protocol Violation|0|||
27973918|NCT00685399|54631610|FG004|Treatment Period 1|Protocol Violation|0|||
27973919|NCT00685399|54631611|FG005|Treatment Period 1|Protocol Violation|0|||
27973920|NCT00685399|54631612|FG006|Treatment Period 1|Protocol Violation|0|||
27973921|NCT00685399|54631613|FG007|Treatment Period 1|Protocol Violation|0|||
27973922|NCT00685399|54631606|FG000|Treatment Period 1|Administrative|2|||
27973923|NCT00685399|54631607|FG001|Treatment Period 1|Administrative|0|||
27973924|NCT00685399|54631608|FG002|Treatment Period 1|Administrative|0|||
27973925|NCT00685399|54631609|FG003|Treatment Period 1|Administrative|0|||
27973926|NCT00685399|54631610|FG004|Treatment Period 1|Administrative|0|||
27973927|NCT00685399|54631611|FG005|Treatment Period 1|Administrative|0|||
27973928|NCT00685399|54631612|FG006|Treatment Period 1|Administrative|0|||
27973929|NCT00685399|54631613|FG007|Treatment Period 1|Administrative|0|||
27973930|NCT00685399|54631606|FG000|Treatment Period 1|Lack of Efficacy|1|||
27973931|NCT00685399|54631607|FG001|Treatment Period 1|Lack of Efficacy|0|||
27973932|NCT00685399|54631608|FG002|Treatment Period 1|Lack of Efficacy|0|||
27973933|NCT00685399|54631609|FG003|Treatment Period 1|Lack of Efficacy|0|||
27973934|NCT00685399|54631610|FG004|Treatment Period 1|Lack of Efficacy|0|||
27973935|NCT00685399|54631611|FG005|Treatment Period 1|Lack of Efficacy|0|||
27973936|NCT00685399|54631612|FG006|Treatment Period 1|Lack of Efficacy|0|||
27973937|NCT00685399|54631613|FG007|Treatment Period 1|Lack of Efficacy|0|||
28085814|NCT00353873|54739361|FG001|Overall Study|Adverse Event|0|||
28085815|NCT00353873|54739360|FG000|Overall Study|Physician Decision|2|||
28085816|NCT00353873|54739361|FG001|Overall Study|Physician Decision|0|||
28085817|NCT00353873|54739360|FG000|Overall Study|Withdrawal by Subject|1|||
28085818|NCT00353873|54739361|FG001|Overall Study|Withdrawal by Subject|1|||
28085819|NCT03796676|54739370|FG000|Overall Study|Adverse Event|2|||
28085820|NCT03796676|54739371|FG001|Overall Study|Adverse Event|1|||
28085821|NCT03796676|54739372|FG002|Overall Study|Adverse Event|2|||
28085822|NCT03796676|54739370|FG000|Overall Study|Lost to Follow-up|2|||
28085823|NCT03796676|54739371|FG001|Overall Study|Lost to Follow-up|1|||
28085824|NCT03796676|54739372|FG002|Overall Study|Lost to Follow-up|0|||
28085825|NCT03796676|54739370|FG000|Overall Study|Protocol Violation|0|||
28085826|NCT03796676|54739371|FG001|Overall Study|Protocol Violation|0|||
28085827|NCT03796676|54739372|FG002|Overall Study|Protocol Violation|1|||
28085828|NCT03796676|54739370|FG000|Overall Study|Withdrawal by Subject|1|||
28085829|NCT03796676|54739371|FG001|Overall Study|Withdrawal by Subject|1|||
28085830|NCT03796676|54739372|FG002|Overall Study|Withdrawal by Subject|0|||
28085831|NCT03796676|54739370|FG000|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|1|||
28085832|NCT03796676|54739371|FG001|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
28085833|NCT03796676|54739372|FG002|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
28085834|NCT03342898|54739386|FG000|Overall Study|Adverse Event|3|||
28085835|NCT03342898|54739387|FG001|Overall Study|Adverse Event|1|||
28085836|NCT03342898|54739388|FG002|Overall Study|Adverse Event|0|||
28085837|NCT03342898|54739386|FG000|Overall Study|Lost to Follow-up|44|||
28085838|NCT03342898|54739387|FG001|Overall Study|Lost to Follow-up|40|||
28085839|NCT03342898|54739388|FG002|Overall Study|Lost to Follow-up|42|||
28085840|NCT03342898|54739386|FG000|Overall Study|Withdrawal of Consent|5|||
28085841|NCT03342898|54739387|FG001|Overall Study|Withdrawal of Consent|9|||
28085842|NCT03342898|54739388|FG002|Overall Study|Withdrawal of Consent|11|||
28085843|NCT03342898|54739386|FG000|Overall Study|Death|0|||
28085844|NCT03342898|54739387|FG001|Overall Study|Death|1|||
28085845|NCT03342898|54739388|FG002|Overall Study|Death|1|||
28085846|NCT03342898|54739386|FG000|Overall Study|Reason not Specified|2|||
28085847|NCT03342898|54739387|FG001|Overall Study|Reason not Specified|2|||
28085848|NCT03342898|54739388|FG002|Overall Study|Reason not Specified|0|||
28085849|NCT00339833|54739398|FG000|Overall Study|Withdrawal by Subject|1|||
28085850|NCT00339833|54739399|FG001|Overall Study|Withdrawal by Subject|2|||
28085851|NCT00339833|54739398|FG000|Overall Study|toothache|0|||
28085852|NCT00339833|54739399|FG001|Overall Study|toothache|1|||
28085853|NCT00339833|54739398|FG000|Overall Study|indigestion|0|||
28085854|NCT00339833|54739399|FG001|Overall Study|indigestion|1|||
28085855|NCT00339833|54739398|FG000|Overall Study|Chest pain|0|||
28085856|NCT00339833|54739399|FG001|Overall Study|Chest pain|1|||
28085857|NCT00339833|54739398|FG000|Overall Study|minor infection|0|||
28085858|NCT00339833|54739399|FG001|Overall Study|minor infection|1|||
28085859|NCT00339833|54739398|FG000|Overall Study|Poor venous access|2|||
28085860|NCT00339833|54739399|FG001|Overall Study|Poor venous access|2|||
28085861|NCT00339833|54739398|FG000|Overall Study|anaemia or excess drop in glycaemia|2|||
28085862|NCT00339833|54739399|FG001|Overall Study|anaemia or excess drop in glycaemia|0|||
28085863|NCT00339833|54739398|FG000|Overall Study|Error in data records|1|||
28085864|NCT00339833|54739399|FG001|Overall Study|Error in data records|0|||
28085865|NCT03793556|54739407|FG000|Overall Study|Withdrawal by Subject|12|||
28085866|NCT03793556|54739408|FG001|Overall Study|Withdrawal by Subject|1|||
28085867|NCT03793556|54739407|FG000|Overall Study|Lost to Follow-up|1|||
28085868|NCT03793556|54739408|FG001|Overall Study|Lost to Follow-up|1|||
28085869|NCT03392194|54739419|FG000|Overall Study|Withdrawal by Subject|1|||
28085870|NCT03392194|54739420|FG001|Overall Study|Withdrawal by Subject|2|||
28085871|NCT03392194|54739419|FG000|Overall Study|Conflicts with personal schedule|1|||
28085872|NCT03392194|54739420|FG001|Overall Study|Conflicts with personal schedule|0|||
28085873|NCT03828617|54739430|FG000|Overall Study|Lost to Follow-up|22|||
28085874|NCT03828617|54739431|FG001|Overall Study|Lost to Follow-up|12|||
28085875|NCT03828617|54739432|FG002|Overall Study|Lost to Follow-up|23|||
28085876|NCT03828617|54739433|FG003|Overall Study|Lost to Follow-up|7|||
28085877|NCT03828617|54739430|FG000|Overall Study|No longer met eligibility criteria|0|||
28085878|NCT03828617|54739431|FG001|Overall Study|No longer met eligibility criteria|1|||
28085879|NCT03828617|54739432|FG002|Overall Study|No longer met eligibility criteria|1|||
28085880|NCT03828617|54739433|FG003|Overall Study|No longer met eligibility criteria|3|||
28085881|NCT03828617|54739430|FG000|Overall Study|Protocol Violation|0|||
28085882|NCT03828617|54739431|FG001|Overall Study|Protocol Violation|2|||
27973938|NCT00685399|54631606|FG000|Treatment Period 2|Administrative Problems|0|||
27973939|NCT00685399|54631607|FG001|Treatment Period 2|Administrative Problems|2|||
28085883|NCT03828617|54739432|FG002|Overall Study|Protocol Violation|0|||
28085884|NCT03828617|54739433|FG003|Overall Study|Protocol Violation|0|||
28085885|NCT03828617|54739430|FG000|Overall Study|Withdrawal by Subject|2|||
28085886|NCT03828617|54739431|FG001|Overall Study|Withdrawal by Subject|0|||
28085887|NCT03828617|54739432|FG002|Overall Study|Withdrawal by Subject|2|||
28085888|NCT03828617|54739433|FG003|Overall Study|Withdrawal by Subject|0|||
28085889|NCT03391960|54739442|FG000|Overall Study|Protocol Violation|0|||
28085890|NCT03391960|54739443|FG001|Overall Study|Protocol Violation||||
28085891|NCT03390166|54739469|FG000|Overall Study|Death|0|||
28085892|NCT03390166|54739470|FG001|Overall Study|Death|1|||
28085893|NCT03390166|54739469|FG000|Overall Study|Lost to Follow-up|6|||
28085894|NCT03390166|54739470|FG001|Overall Study|Lost to Follow-up|4|||
28085895|NCT03390166|54739469|FG000|Overall Study|Physician Decision|2|||
28085896|NCT03390166|54739470|FG001|Overall Study|Physician Decision|1|||
28085897|NCT03390166|54739469|FG000|Overall Study|Move from study area|3|||
28085898|NCT03390166|54739470|FG001|Overall Study|Move from study area|2|||
28085899|NCT03390166|54739469|FG000|Overall Study|To militarycamp for conscript|1|||
28085900|NCT03390166|54739470|FG001|Overall Study|To militarycamp for conscript|0|||
28085901|NCT03390166|54739469|FG000|Overall Study|To drug therapy course|0|||
28085902|NCT03390166|54739470|FG001|Overall Study|To drug therapy course|1|||
28085903|NCT03390166|54739469|FG000|Overall Study|Move to work oversea|0|||
28085904|NCT03390166|54739470|FG001|Overall Study|Move to work oversea|1|||
28085905|NCT03828539|54739478|FG000|Overall Study|Adverse Event|3|||
28085906|NCT03828539|54739479|FG001|Overall Study|Adverse Event|12|||
28085907|NCT03828539|54739478|FG000|Overall Study|Patient's/guardian's decision|3|||
28085908|NCT03828539|54739479|FG001|Overall Study|Patient's/guardian's decision|5|||
28085909|NCT03828539|54739478|FG000|Overall Study|Lost to Follow-up|4|||
28085910|NCT03828539|54739479|FG001|Overall Study|Lost to Follow-up|2|||
28085911|NCT03828539|54739478|FG000|Overall Study|Protocol Violation|3|||
28085912|NCT03828539|54739479|FG001|Overall Study|Protocol Violation|2|||
28085913|NCT03828539|54739478|FG000|Overall Study|Withdrawal of informed consent|2|||
28085914|NCT03828539|54739479|FG001|Overall Study|Withdrawal of informed consent|1|||
28085915|NCT03828539|54739478|FG000|Overall Study|New therapy for study indication|1|||
28085916|NCT03828539|54739479|FG001|Overall Study|New therapy for study indication|0|||
28085917|NCT03336502|54739487|FG000|Overall Study|Physician Decision|0|||
28085918|NCT03336502|54739488|FG001|Overall Study|Physician Decision|1|||
28085919|NCT03336502|54739487|FG000|Overall Study|Prohibited Drugs|1|||
28085920|NCT03336502|54739488|FG001|Overall Study|Prohibited Drugs|1|||
28085921|NCT03336502|54739487|FG000|Overall Study|Death|1|||
28085922|NCT03336502|54739488|FG001|Overall Study|Death|2|||
28085923|NCT03336502|54739487|FG000|Overall Study|Adverse Event|2|||
28085924|NCT03336502|54739488|FG001|Overall Study|Adverse Event|5|||
28085925|NCT00338741|54739496|FG000|Overall Study|Lost to Follow-up|2|||
28085926|NCT00338741|54739497|FG001|Overall Study|Lost to Follow-up|0|||
28085927|NCT03370510|54739505|FG000|Overall Study|COVID-19|2|||
28085928|NCT03370510|54739506|FG001|Overall Study|COVID-19|0|||
28085929|NCT00351611|54739514|FG000|Overall Study|Adverse Event|11|||
28085930|NCT00351611|54739515|FG001|Overall Study|Adverse Event|3|||
28085931|NCT00351611|54739514|FG000|Overall Study|Death|1|||
28085932|NCT00351611|54739515|FG001|Overall Study|Death|0|||
28085933|NCT00351611|54739514|FG000|Overall Study|Lost to Follow-up|1|||
28085934|NCT00351611|54739515|FG001|Overall Study|Lost to Follow-up|0|||
28085935|NCT00351611|54739514|FG000|Overall Study|No Longer Willing to Participate in Study|0|||
28085936|NCT00351611|54739515|FG001|Overall Study|No Longer Willing to Participate in Study|5|||
28085937|NCT00351611|54739514|FG000|Overall Study|Other|1|||
28085938|NCT00351611|54739515|FG001|Overall Study|Other|0|||
28085939|NCT00351611|54739514|FG000|Overall Study|Protocol Violation|0|||
28085940|NCT00351611|54739515|FG001|Overall Study|Protocol Violation|2|||
28085941|NCT00351533|54739523|FG000|Overall Study|Extubated before first BAL|1|||
28085942|NCT00351533|54739524|FG001|Overall Study|Extubated before first BAL|0|||
28085943|NCT00351533|54739523|FG000|Overall Study|Lost to Follow-up|1|||
28085944|NCT00351533|54739524|FG001|Overall Study|Lost to Follow-up|3|||
28085945|NCT00351533|54739523|FG000|Overall Study|Physician Decision|0|||
28085946|NCT00351533|54739524|FG001|Overall Study|Physician Decision|1|||
28085947|NCT00351533|54739523|FG000|Overall Study|Withdrawal by Subject|0|||
28085948|NCT00351533|54739524|FG001|Overall Study|Withdrawal by Subject|1|||
28085949|NCT00351377|54739530|FG000|Overall Study|Adverse Event|5|||
28085950|NCT00351377|54739530|FG000|Overall Study|Death|1|||
28085951|NCT00351377|54739530|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
28085952|NCT00337727|54739536|FG000|Overall Study|Adverse Event|5|||
28085953|NCT00337727|54739537|FG001|Overall Study|Adverse Event|3|||
28085954|NCT00337727|54739536|FG000|Overall Study|Lost to Follow-up|5|||
28085955|NCT00337727|54739537|FG001|Overall Study|Lost to Follow-up|4|||
28085956|NCT00337727|54739536|FG000|Overall Study|Physician Decision|1|||
28085957|NCT00337727|54739537|FG001|Overall Study|Physician Decision|0|||
28085958|NCT00337727|54739536|FG000|Overall Study|Protocol Violation|4|||
28085959|NCT00337727|54739537|FG001|Overall Study|Protocol Violation|0|||
28085960|NCT00337727|54739536|FG000|Overall Study|Withdrawal by Subject|3|||
28085961|NCT00337727|54739537|FG001|Overall Study|Withdrawal by Subject|5|||
28085962|NCT00324233|54739545|FG000|First Period|unable to insert catheter|1|||
28085963|NCT00324233|54739546|FG001|First Period|unable to insert catheter|0|||
28085964|NCT00324233|54739545|FG000|Second Period|unable to insert catheter|1|||
28165396|NCT01066819|54836079|FG000|Overall Study|Withdrawal by Subject|29|||
28165397|NCT01066819|54836080|FG001|Overall Study|Withdrawal by Subject|11|||
28085965|NCT00324233|54739546|FG001|Second Period|unable to insert catheter|1|||
28085966|NCT00324233|54739545|FG000|Second Period|Protocol Violation|4|||
28085967|NCT00324233|54739546|FG001|Second Period|Protocol Violation|6|||
28085968|NCT03335566|54739554|FG000|Overall Study|Adverse Event|0|||
28085969|NCT03335566|54739555|FG001|Overall Study|Adverse Event|1|||
28085970|NCT03335566|54739554|FG000|Overall Study|Lost to Follow-up|1|||
28085971|NCT03335566|54739555|FG001|Overall Study|Lost to Follow-up|0|||
28085972|NCT03335566|54739554|FG000|Overall Study|Technical Problems|1|||
28085973|NCT03335566|54739555|FG001|Overall Study|Technical Problems|0|||
28085974|NCT03335566|54739554|FG000|Overall Study|Protocol Violation|1|||
28085975|NCT03335566|54739555|FG001|Overall Study|Protocol Violation|0|||
28085976|NCT03335566|54739554|FG000|Overall Study|Other than specified above|1|||
28085977|NCT03335566|54739555|FG001|Overall Study|Other than specified above|2|||
28085978|NCT03369418|54739563|FG000|Overall Study|Withdrawal by Subject|3|||
28085979|NCT03369418|54739564|FG001|Overall Study|Withdrawal by Subject|3|||
28085980|NCT03334630|54739572|FG000|Overall Study|Withdrawal by Subject|7|||
28085981|NCT03334630|54739573|FG001|Overall Study|Withdrawal by Subject|7|||
28085982|NCT03334630|54739572|FG000|Overall Study|Lost to Follow-up|3|||
28085983|NCT03334630|54739573|FG001|Overall Study|Lost to Follow-up|1|||
28085984|NCT03334630|54739572|FG000|Overall Study|Adverse Event|0|||
28085985|NCT03334630|54739573|FG001|Overall Study|Adverse Event|1|||
28085986|NCT03334630|54739572|FG000|Overall Study|Physician Decision|1|||
28085987|NCT03334630|54739573|FG001|Overall Study|Physician Decision|1|||
28085988|NCT03334630|54739572|FG000|Overall Study|Enrollment closed|2|||
28085989|NCT03334630|54739573|FG001|Overall Study|Enrollment closed|1|||
28085990|NCT03334630|54739572|FG000|Overall Study|Subject not treated with study ablation due to technical difficulties|0|||
28085991|NCT03334630|54739573|FG001|Overall Study|Subject not treated with study ablation due to technical difficulties|1|||
28085992|NCT03334630|54739572|FG000|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
28085993|NCT03334630|54739573|FG001|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
28085994|NCT03368170|54739581|FG000|Overall Study|Adverse Event|2|||
28085995|NCT03368170|54739582|FG001|Overall Study|Adverse Event|1|||
28165398|NCT01066819|54836081|FG002|Overall Study|Withdrawal by Subject|6|||
27973940|NCT00685399|54631608|FG002|Treatment Period 2|Administrative Problems|1|||
27973941|NCT00685399|54631609|FG003|Treatment Period 2|Administrative Problems|0|||
27973942|NCT00685399|54631610|FG004|Treatment Period 2|Administrative Problems|0|||
27973943|NCT00685399|54631611|FG005|Treatment Period 2|Administrative Problems|0|||
27973944|NCT00685399|54631612|FG006|Treatment Period 2|Administrative Problems|0|||
27973945|NCT00685399|54631613|FG007|Treatment Period 2|Administrative Problems|0|||
27973946|NCT00685399|54631606|FG000|Treatment Period 2|Withdrawal by Subject|0|||
27973947|NCT00685399|54631607|FG001|Treatment Period 2|Withdrawal by Subject|0|||
27973948|NCT00685399|54631608|FG002|Treatment Period 2|Withdrawal by Subject|0|||
27973949|NCT00685399|54631609|FG003|Treatment Period 2|Withdrawal by Subject|0|||
27973950|NCT00685399|54631610|FG004|Treatment Period 2|Withdrawal by Subject|0|||
27973951|NCT00685399|54631611|FG005|Treatment Period 2|Withdrawal by Subject|0|||
27973952|NCT00685399|54631612|FG006|Treatment Period 2|Withdrawal by Subject|0|||
27973953|NCT00685399|54631613|FG007|Treatment Period 2|Withdrawal by Subject|2|||
27973954|NCT00685399|54631606|FG000|Treatment Period 2|Adverse Event|0|||
27973955|NCT00685399|54631607|FG001|Treatment Period 2|Adverse Event|0|||
27973956|NCT00685399|54631608|FG002|Treatment Period 2|Adverse Event|0|||
27973957|NCT00685399|54631609|FG003|Treatment Period 2|Adverse Event|0|||
27973958|NCT00685399|54631610|FG004|Treatment Period 2|Adverse Event|0|||
27973959|NCT00685399|54631611|FG005|Treatment Period 2|Adverse Event|1|||
27973960|NCT00685399|54631612|FG006|Treatment Period 2|Adverse Event|0|||
27973961|NCT00685399|54631613|FG007|Treatment Period 2|Adverse Event|0|||
27973962|NCT00685399|54631606|FG000|Treatment Period 2|Lack of Efficacy|0|||
27973963|NCT00685399|54631607|FG001|Treatment Period 2|Lack of Efficacy|10|||
27973964|NCT00685399|54631608|FG002|Treatment Period 2|Lack of Efficacy|2|||
27973965|NCT00685399|54631609|FG003|Treatment Period 2|Lack of Efficacy|0|||
27973966|NCT00685399|54631610|FG004|Treatment Period 2|Lack of Efficacy|0|||
27973967|NCT00685399|54631611|FG005|Treatment Period 2|Lack of Efficacy|1|||
27973968|NCT00685399|54631612|FG006|Treatment Period 2|Lack of Efficacy|0|||
27973969|NCT00685399|54631613|FG007|Treatment Period 2|Lack of Efficacy|0|||
27973970|NCT00685399|54631606|FG000|Extension|Administrative Issues|0|||
27973971|NCT00685399|54631607|FG001|Extension|Administrative Issues|0|||
27973972|NCT00685399|54631608|FG002|Extension|Administrative Issues|0|||
27973973|NCT00685399|54631609|FG003|Extension|Administrative Issues|1|||
28085996|NCT00324155|54739590|FG000|Enrolled and Randomized|No longer met study criteria|3|||
28085997|NCT00324155|54739591|FG001|Enrolled and Randomized|No longer met study criteria|0|||
28085998|NCT00324155|54739590|FG000|Enrolled and Randomized|Lost to Follow-up|0|||
27973974|NCT00685399|54631610|FG004|Extension|Administrative Issues|0|||
27973975|NCT00685399|54631611|FG005|Extension|Administrative Issues|0|||
27973976|NCT00685399|54631612|FG006|Extension|Administrative Issues|0|||
27973977|NCT00685399|54631613|FG007|Extension|Administrative Issues|0|||
28085999|NCT00324155|54739591|FG001|Enrolled and Randomized|Lost to Follow-up|1|||
28086000|NCT00324155|54739590|FG000|Received Treatment in Induction Phase|Disease Progression|88|||
28165399|NCT01066819|54836082|FG003|Overall Study|Withdrawal by Subject|0|||
27973978|NCT00685399|54631606|FG000|Extension|Withdrawal by Subject|0|||
28086001|NCT00324155|54739591|FG001|Received Treatment in Induction Phase|Disease Progression|152|||
28086002|NCT00324155|54739590|FG000|Received Treatment in Induction Phase|Study Drug Toxicity|83|||
27973979|NCT00685399|54631607|FG001|Extension|Withdrawal by Subject|0|||
27973980|NCT00685399|54631608|FG002|Extension|Withdrawal by Subject|0|||
27973981|NCT00685399|54631609|FG003|Extension|Withdrawal by Subject|1|||
27973982|NCT00685399|54631610|FG004|Extension|Withdrawal by Subject|0|||
27973983|NCT00685399|54631611|FG005|Extension|Withdrawal by Subject|0|||
27973984|NCT00685399|54631612|FG006|Extension|Withdrawal by Subject|0|||
27973985|NCT00685399|54631613|FG007|Extension|Withdrawal by Subject|0|||
27973986|NCT00685399|54631606|FG000|Extension|Protocol Violation|0|||
27973987|NCT00685399|54631607|FG001|Extension|Protocol Violation|0|||
27973988|NCT00685399|54631608|FG002|Extension|Protocol Violation|0|||
27973989|NCT00685399|54631609|FG003|Extension|Protocol Violation|1|||
27973990|NCT00685399|54631610|FG004|Extension|Protocol Violation|0|||
27973991|NCT00685399|54631611|FG005|Extension|Protocol Violation|0|||
27973992|NCT00685399|54631612|FG006|Extension|Protocol Violation|0|||
27973993|NCT00685399|54631613|FG007|Extension|Protocol Violation|0|||
27973994|NCT00685399|54631606|FG000|Extension|Lack of Efficacy|0|||
27973995|NCT00685399|54631607|FG001|Extension|Lack of Efficacy|0|||
27973996|NCT00685399|54631608|FG002|Extension|Lack of Efficacy|0|||
27973997|NCT00685399|54631609|FG003|Extension|Lack of Efficacy|2|||
27973998|NCT00685399|54631610|FG004|Extension|Lack of Efficacy|0|||
27733061|NCT02564042|54180733|FG003|Overall Study|Physician Decision|1|||
27733062|NCT02564042|54180734|FG004|Overall Study|Physician Decision|0|||
27733063|NCT02564042|54180735|FG005|Overall Study|Physician Decision|0|||
27733064|NCT02564042|54180730|FG000|Overall Study|Withdrawal by Subject|5|||
27733065|NCT02564042|54180731|FG001|Overall Study|Withdrawal by Subject|3|||
27733066|NCT02564042|54180732|FG002|Overall Study|Withdrawal by Subject|2|||
27733067|NCT02564042|54180733|FG003|Overall Study|Withdrawal by Subject|2|||
27733068|NCT02564042|54180734|FG004|Overall Study|Withdrawal by Subject|10|||
27733069|NCT02564042|54180735|FG005|Overall Study|Withdrawal by Subject|12|||
27733070|NCT02695719|54180768|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
27733071|NCT02695719|54180769|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
27733072|NCT02695719|54180768|FG000|Overall Study|Significant Protocol Deviation|0|||
27733073|NCT02695719|54180769|FG001|Overall Study|Significant Protocol Deviation|1|||
27733074|NCT02695719|54180768|FG000|Overall Study|Voluntary Withdrawal|1|||
27733075|NCT02695719|54180769|FG001|Overall Study|Voluntary Withdrawal|0|||
27733076|NCT02563106|54180786|FG000|Overall Study|Withdrawal by Subject|7|||
27733077|NCT02563106|54180787|FG001|Overall Study|Withdrawal by Subject|8|||
27733078|NCT02563106|54180786|FG000|Overall Study|Adverse Event|17|||
27733079|NCT02563106|54180787|FG001|Overall Study|Adverse Event|15|||
27733080|NCT02563106|54180786|FG000|Overall Study|Protocol Violation|1|||
27855565|NCT02834247|54380599|FG001|Dose Escalation Phase|Death|6|||
27855566|NCT02834247|54380600|FG002|Dose Escalation Phase|Death|5|||
27855567|NCT02834247|54380601|FG003|Dose Escalation Phase|Death|0|||
27855568|NCT02834247|54380598|FG000|Dose Escalation Phase|Lost to Follow-up|0|||
27733081|NCT02563106|54180787|FG001|Overall Study|Protocol Violation|0|||
27733082|NCT02563106|54180786|FG000|Overall Study|Use of non-permitted concurrent therapy|1|||
27733083|NCT02563106|54180787|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
27733084|NCT02563106|54180786|FG000|Overall Study|Lost to Follow-up|3|||
27733085|NCT02563106|54180787|FG001|Overall Study|Lost to Follow-up|2|||
27733086|NCT02563106|54180786|FG000|Overall Study|Physician Decision|3|||
27733087|NCT02563106|54180787|FG001|Overall Study|Physician Decision|1|||
27733088|NCT02563106|54180786|FG000|Overall Study|Other reason - not specified|2|||
27733089|NCT02563106|54180787|FG001|Overall Study|Other reason - not specified|1|||
27733090|NCT02691741|54180795|FG000|Overall Study|Adverse Event|0|||
27733091|NCT02691741|54180796|FG001|Overall Study|Adverse Event|2|||
27733092|NCT02691741|54180795|FG000|Overall Study|Lost to Follow-up|1|||
27733093|NCT02691741|54180796|FG001|Overall Study|Lost to Follow-up|0|||
27733094|NCT02691741|54180795|FG000|Overall Study|Physician Decision|0|||
27733095|NCT02691741|54180796|FG001|Overall Study|Physician Decision|1|||
27733096|NCT02691741|54180795|FG000|Overall Study|Withdrawal by Subject|0|||
27733097|NCT02691741|54180796|FG001|Overall Study|Withdrawal by Subject|4|||
27733098|NCT02691507|54180809|FG000|Overall Study|Missed Visit 3|0|||
27733099|NCT02691507|54180810|FG001|Overall Study|Missed Visit 3|1|||
27733100|NCT04579393|54180818|FG000|Overall Study|Withdrawal by Subject|2|||
27855569|NCT02834247|54380599|FG001|Dose Escalation Phase|Lost to Follow-up|1|||
27973999|NCT00685399|54631611|FG005|Extension|Lack of Efficacy|0|||
27974000|NCT00685399|54631612|FG006|Extension|Lack of Efficacy|0|||
27733101|NCT04579393|54180819|FG001|Overall Study|Withdrawal by Subject|2|||
27733102|NCT04579393|54180818|FG000|Overall Study|Death|1|||
27733103|NCT04579393|54180819|FG001|Overall Study|Death|3|||
27733104|NCT02776553|54180828|FG000|Overall Study|Lost to Follow-up|1|||
27733105|NCT02776553|54180829|FG001|Overall Study|Lost to Follow-up|0|||
27733106|NCT02776553|54180828|FG000|Overall Study|got liver transplant|1|||
27733107|NCT02776553|54180829|FG001|Overall Study|got liver transplant|2|||
27733108|NCT02776553|54180828|FG000|Overall Study|had other surgery|1|||
27733109|NCT02776553|54180829|FG001|Overall Study|had other surgery|0|||
27733110|NCT02776553|54180828|FG000|Overall Study|Protocol Violation|0|||
27974001|NCT00685399|54631613|FG007|Extension|Lack of Efficacy|0|||
27974002|NCT00685399|54631606|FG000|Extension|Adverse Event|0|||
27974003|NCT00685399|54631607|FG001|Extension|Adverse Event|0|||
27974004|NCT00685399|54631608|FG002|Extension|Adverse Event|0|||
27974005|NCT00685399|54631609|FG003|Extension|Adverse Event|2|||
27974006|NCT00685399|54631610|FG004|Extension|Adverse Event|0|||
27974007|NCT00685399|54631611|FG005|Extension|Adverse Event|0|||
27974008|NCT00685399|54631612|FG006|Extension|Adverse Event|0|||
27974009|NCT00685399|54631613|FG007|Extension|Adverse Event|0|||
27974010|NCT00685165|54631640|FG000|Washout Period of 14 Days|Adverse Event|1|||
27974011|NCT00685165|54631641|FG001|Washout Period of 14 Days|Adverse Event|0|||
27974012|NCT00683449|54631652|FG000|Overall Study|Lost to Follow-up|0|||
27974013|NCT00683449|54631653|FG001|Overall Study|Lost to Follow-up|1|||
27974014|NCT00683449|54631654|FG002|Overall Study|Lost to Follow-up|0|||
27974015|NCT00683449|54631655|FG003|Overall Study|Lost to Follow-up|0|||
27974016|NCT00683449|54631656|FG004|Overall Study|Lost to Follow-up|0|||
27974017|NCT00683293|54631675|FG000|Overall Study|Withdrawal by Subject|2|||
27974018|NCT00683293|54631676|FG001|Overall Study|Withdrawal by Subject|3|||
27974019|NCT00726232|54631688|FG000|Initial Phase (Dose-finding)|Death|0|||
27974020|NCT00726232|54631689|FG001|Initial Phase (Dose-finding)|Death|0|||
27974021|NCT00726232|54631690|FG002|Initial Phase (Dose-finding)|Death|0|||
27974022|NCT00726232|54631691|FG003|Initial Phase (Dose-finding)|Death|0|||
27974023|NCT00726232|54631692|FG004|Initial Phase (Dose-finding)|Death|1|||
27974024|NCT00726232|54631693|FG005|Initial Phase (Dose-finding)|Death|0|||
27974025|NCT00726232|54631694|FG006|Initial Phase (Dose-finding)|Death|0|||
27974026|NCT00726232|54631695|FG007|Initial Phase (Dose-finding)|Death|0|||
27974027|NCT00726232|54631688|FG000|Initial Phase (Dose-finding)|Adverse Event|2|||
27974028|NCT00726232|54631689|FG001|Initial Phase (Dose-finding)|Adverse Event|2|||
27974029|NCT00726232|54631690|FG002|Initial Phase (Dose-finding)|Adverse Event|2|||
27974030|NCT00726232|54631691|FG003|Initial Phase (Dose-finding)|Adverse Event|1|||
27974031|NCT00726232|54631692|FG004|Initial Phase (Dose-finding)|Adverse Event|7|||
27974032|NCT00726232|54631693|FG005|Initial Phase (Dose-finding)|Adverse Event|3|||
27974033|NCT00726232|54631694|FG006|Initial Phase (Dose-finding)|Adverse Event|0|||
27974034|NCT00726232|54631695|FG007|Initial Phase (Dose-finding)|Adverse Event|0|||
27974035|NCT00726232|54631688|FG000|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
27974036|NCT00726232|54631689|FG001|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
27974037|NCT00726232|54631690|FG002|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
27974038|NCT00726232|54631691|FG003|Initial Phase (Dose-finding)|Withdrawal by Subject|1|||
27974039|NCT00726232|54631692|FG004|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
27974040|NCT00726232|54631693|FG005|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
27974041|NCT00726232|54631694|FG006|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
27974042|NCT00726232|54631695|FG007|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
27974043|NCT00726232|54631688|FG000|Initial Phase (Dose-finding)|Disease progression|3|||
27974044|NCT00726232|54631689|FG001|Initial Phase (Dose-finding)|Disease progression|1|||
27974045|NCT00726232|54631690|FG002|Initial Phase (Dose-finding)|Disease progression|0|||
27974046|NCT00726232|54631691|FG003|Initial Phase (Dose-finding)|Disease progression|0|||
28086003|NCT00324155|54739591|FG001|Received Treatment in Induction Phase|Study Drug Toxicity|10|||
28086004|NCT00324155|54739590|FG000|Received Treatment in Induction Phase|Death|8|||
28086005|NCT00324155|54739591|FG001|Received Treatment in Induction Phase|Death|15|||
28086006|NCT00324155|54739590|FG000|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9|||
28086007|NCT00324155|54739591|FG001|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8|||
28086008|NCT00324155|54739590|FG000|Received Treatment in Induction Phase|Adverse Event|6|||
28086009|NCT00324155|54739591|FG001|Received Treatment in Induction Phase|Adverse Event|7|||
28086010|NCT00324155|54739590|FG000|Received Treatment in Induction Phase|Withdrawal by Subject|6|||
28086011|NCT00324155|54739591|FG001|Received Treatment in Induction Phase|Withdrawal by Subject|5|||
28086012|NCT00324155|54739590|FG000|Received Treatment in Induction Phase|Physician Decision|2|||
28086013|NCT00324155|54739591|FG001|Received Treatment in Induction Phase|Physician Decision|0|||
28086014|NCT00324155|54739590|FG000|Received Treatment in Maintenance Phase|Disease Progression|26|||
28086015|NCT00324155|54739591|FG001|Received Treatment in Maintenance Phase|Disease Progression|41|||
28086016|NCT00324155|54739590|FG000|Received Treatment in Maintenance Phase|Study Drug Toxicity|4|||
28086017|NCT00324155|54739591|FG001|Received Treatment in Maintenance Phase|Study Drug Toxicity|0|||
28165400|NCT01066819|54836083|FG004|Overall Study|Withdrawal by Subject|0|||
27974047|NCT00726232|54631692|FG004|Initial Phase (Dose-finding)|Disease progression|0|||
27974048|NCT00726232|54631693|FG005|Initial Phase (Dose-finding)|Disease progression|0|||
27974049|NCT00726232|54631694|FG006|Initial Phase (Dose-finding)|Disease progression|0|||
27974050|NCT00726232|54631695|FG007|Initial Phase (Dose-finding)|Disease progression|0|||
27974051|NCT00726232|54631688|FG000|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
27974052|NCT00726232|54631689|FG001|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
27974053|NCT00726232|54631690|FG002|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
27974054|NCT00726232|54631691|FG003|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
27832739|NCT01754753|54312481|FG000|Overall Study|Lost to Follow-up|9|||
27832740|NCT01754753|54312482|FG001|Overall Study|Lost to Follow-up|5|||
28086018|NCT00324155|54739590|FG000|Received Treatment in Maintenance Phase|Withdrawal by Subject|1|||
28086019|NCT00324155|54739591|FG001|Received Treatment in Maintenance Phase|Withdrawal by Subject|3|||
27974055|NCT00726232|54631692|FG004|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9|||
27974056|NCT00726232|54631693|FG005|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
27974057|NCT00726232|54631694|FG006|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
27974058|NCT00726232|54631695|FG007|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
27974059|NCT00726232|54631688|FG000|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
27974060|NCT00726232|54631689|FG001|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
27974061|NCT00726232|54631690|FG002|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
27974062|NCT00726232|54631691|FG003|Initial Phase (Dose-finding)|Per Investigator: lack of response|2|||
27974063|NCT00726232|54631692|FG004|Initial Phase (Dose-finding)|Per Investigator: lack of response|4|||
27974064|NCT00726232|54631693|FG005|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
27974065|NCT00726232|54631694|FG006|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
27974066|NCT00726232|54631695|FG007|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
27733111|NCT02776553|54180829|FG001|Overall Study|Protocol Violation|1|||
27733112|NCT02690727|54180835|FG000|Overall Study|Adverse Event|2|||
27733113|NCT02690727|54180836|FG001|Overall Study|Adverse Event|2|||
27733114|NCT02777333|54180846|FG000|Overall Study|Withdrawal by Subject|0|||
27733115|NCT02777333|54180847|FG001|Overall Study|Withdrawal by Subject|1|||
27733116|NCT02777333|54180846|FG000|Overall Study|Lost to Follow-up|0|||
27733117|NCT02777333|54180847|FG001|Overall Study|Lost to Follow-up|1|||
27733118|NCT02695329|54180855|FG000|Overall Study|Adverse Event|1|||
27733119|NCT02695329|54180856|FG001|Overall Study|Adverse Event|0|||
27733120|NCT02695329|54180855|FG000|Overall Study|Poor X-ray quality for measurement|4|||
27733121|NCT02695329|54180856|FG001|Overall Study|Poor X-ray quality for measurement|5|||
27733122|NCT02690649|54180864|FG000|Overall Study|Withdrawal by Subject|1|||
27733123|NCT02690649|54180865|FG001|Overall Study|Withdrawal by Subject|1|||
27733124|NCT02690649|54180864|FG000|Overall Study|Protocol Violation|0|||
27733125|NCT02690649|54180865|FG001|Overall Study|Protocol Violation|3|||
27733126|NCT01358864|54180881|FG000|Overall Study|Adverse Event|0|||
28086020|NCT00324155|54739590|FG000|Received Treatment in Maintenance Phase|Adverse Event|0|||
28086021|NCT00324155|54739591|FG001|Received Treatment in Maintenance Phase|Adverse Event|3|||
28086022|NCT00324155|54739590|FG000|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1|||
28086023|NCT00324155|54739591|FG001|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0|||
28086024|NCT00324155|54739590|FG000|Follow-up Phase|On-going participants still on drug|11|||
28086025|NCT00324155|54739591|FG001|Follow-up Phase|On-going participants still on drug|6|||
28086026|NCT03334396|54739618|FG000|Overall Study|Adverse Event|1|||
28086027|NCT03334396|54739619|FG001|Overall Study|Adverse Event|0|||
28086028|NCT03334396|54739620|FG002|Overall Study|Adverse Event|1|||
28086029|NCT03334396|54739621|FG003|Overall Study|Adverse Event|0|||
27733127|NCT01358864|54180882|FG001|Overall Study|Adverse Event|6|||
27733128|NCT01358864|54180883|FG002|Overall Study|Adverse Event|9|||
27733129|NCT01358864|54180884|FG003|Overall Study|Adverse Event|0|||
27974067|NCT00726232|54631688|FG000|Initial Phase (Dose-finding)|Unspecified reason|1|||
27974068|NCT00726232|54631689|FG001|Initial Phase (Dose-finding)|Unspecified reason|0|||
27974069|NCT00726232|54631690|FG002|Initial Phase (Dose-finding)|Unspecified reason|0|||
27974070|NCT00726232|54631691|FG003|Initial Phase (Dose-finding)|Unspecified reason|0|||
27974071|NCT00726232|54631692|FG004|Initial Phase (Dose-finding)|Unspecified reason|0|||
27974072|NCT00726232|54631693|FG005|Initial Phase (Dose-finding)|Unspecified reason|0|||
27974073|NCT00726232|54631694|FG006|Initial Phase (Dose-finding)|Unspecified reason|0|||
27974074|NCT00726232|54631695|FG007|Initial Phase (Dose-finding)|Unspecified reason|0|||
27974075|NCT00726232|54631688|FG000|Expansion Phase|Death|0|||
27974076|NCT00726232|54631689|FG001|Expansion Phase|Death|0|||
27974077|NCT00726232|54631690|FG002|Expansion Phase|Death|0|||
27974078|NCT00726232|54631691|FG003|Expansion Phase|Death|0|||
27974079|NCT00726232|54631692|FG004|Expansion Phase|Death|0|||
27974080|NCT00726232|54631693|FG005|Expansion Phase|Death|0|||
27974081|NCT00726232|54631694|FG006|Expansion Phase|Death|0|||
27974082|NCT00726232|54631695|FG007|Expansion Phase|Death|1|||
27974083|NCT00726232|54631688|FG000|Expansion Phase|Adverse Event|0|||
27974084|NCT00726232|54631689|FG001|Expansion Phase|Adverse Event|0|||
28086030|NCT03334396|54739622|FG004|Overall Study|Adverse Event|0|||
28086031|NCT03334396|54739623|FG005|Overall Study|Adverse Event|0|||
27733130|NCT01358864|54180885|FG004|Overall Study|Adverse Event|4|||
27733131|NCT01358864|54180886|FG005|Overall Study|Adverse Event|8|||
27733132|NCT01358864|54180887|FG006|Overall Study|Adverse Event|12|||
27733133|NCT01358864|54180888|FG007|Overall Study|Adverse Event|7|||
27974085|NCT00726232|54631690|FG002|Expansion Phase|Adverse Event|0|||
27974086|NCT00726232|54631691|FG003|Expansion Phase|Adverse Event|0|||
27974087|NCT00726232|54631692|FG004|Expansion Phase|Adverse Event|0|||
27974088|NCT00726232|54631693|FG005|Expansion Phase|Adverse Event|0|||
28086032|NCT03334396|54739624|FG006|Overall Study|Adverse Event|0|||
28165401|NCT01066819|54836084|FG005|Overall Study|Withdrawal by Subject|0|||
27974089|NCT00726232|54631694|FG006|Expansion Phase|Adverse Event|6|||
27974090|NCT00726232|54631695|FG007|Expansion Phase|Adverse Event|11|||
27974091|NCT00726232|54631688|FG000|Expansion Phase|Withdrawal by Subject|0|||
27974092|NCT00726232|54631689|FG001|Expansion Phase|Withdrawal by Subject|0|||
27974093|NCT00726232|54631690|FG002|Expansion Phase|Withdrawal by Subject|0|||
27974094|NCT00726232|54631691|FG003|Expansion Phase|Withdrawal by Subject|0|||
27974095|NCT00726232|54631692|FG004|Expansion Phase|Withdrawal by Subject|0|||
27974096|NCT00726232|54631693|FG005|Expansion Phase|Withdrawal by Subject|0|||
27974097|NCT00726232|54631694|FG006|Expansion Phase|Withdrawal by Subject|2|||
27974098|NCT00726232|54631695|FG007|Expansion Phase|Withdrawal by Subject|3|||
27974099|NCT00726232|54631688|FG000|Expansion Phase|Disease progression|0|||
27974100|NCT00726232|54631689|FG001|Expansion Phase|Disease progression|0|||
27974101|NCT00726232|54631690|FG002|Expansion Phase|Disease progression|0|||
27974102|NCT00726232|54631691|FG003|Expansion Phase|Disease progression|0|||
27974103|NCT00726232|54631692|FG004|Expansion Phase|Disease progression|0|||
27974104|NCT00726232|54631693|FG005|Expansion Phase|Disease progression|0|||
27974105|NCT00726232|54631694|FG006|Expansion Phase|Disease progression|4|||
27974106|NCT00726232|54631695|FG007|Expansion Phase|Disease progression|0|||
27974107|NCT00726232|54631688|FG000|Expansion Phase|Termination of the trial by sponsor|0|||
27974108|NCT00726232|54631689|FG001|Expansion Phase|Termination of the trial by sponsor|0|||
28086033|NCT03334396|54739625|FG007|Overall Study|Adverse Event|0|||
28086034|NCT03334396|54739618|FG000|Overall Study|Lack of Efficacy|10|||
28086035|NCT03334396|54739619|FG001|Overall Study|Lack of Efficacy|4|||
28086036|NCT03334396|54739620|FG002|Overall Study|Lack of Efficacy|1|||
28086037|NCT03334396|54739621|FG003|Overall Study|Lack of Efficacy|3|||
28086038|NCT03334396|54739622|FG004|Overall Study|Lack of Efficacy|1|||
28086039|NCT03334396|54739623|FG005|Overall Study|Lack of Efficacy|0|||
28086040|NCT03334396|54739624|FG006|Overall Study|Lack of Efficacy|0|||
28086041|NCT03334396|54739625|FG007|Overall Study|Lack of Efficacy|1|||
28086042|NCT03334396|54739618|FG000|Overall Study|Lost to Follow-up|0|||
28086043|NCT03334396|54739619|FG001|Overall Study|Lost to Follow-up|0|||
28086044|NCT03334396|54739620|FG002|Overall Study|Lost to Follow-up|1|||
28086045|NCT03334396|54739621|FG003|Overall Study|Lost to Follow-up|0|||
28086046|NCT03334396|54739622|FG004|Overall Study|Lost to Follow-up|0|||
28086047|NCT03334396|54739623|FG005|Overall Study|Lost to Follow-up|0|||
28086048|NCT03334396|54739624|FG006|Overall Study|Lost to Follow-up|1|||
28086049|NCT03334396|54739625|FG007|Overall Study|Lost to Follow-up|0|||
28086050|NCT03334396|54739618|FG000|Overall Study|Physician Decision|1|||
28086051|NCT03334396|54739619|FG001|Overall Study|Physician Decision|0|||
28086052|NCT03334396|54739620|FG002|Overall Study|Physician Decision|0|||
28086053|NCT03334396|54739621|FG003|Overall Study|Physician Decision|0|||
27974109|NCT00726232|54631690|FG002|Expansion Phase|Termination of the trial by sponsor|0|||
27974110|NCT00726232|54631691|FG003|Expansion Phase|Termination of the trial by sponsor|0|||
27974111|NCT00726232|54631692|FG004|Expansion Phase|Termination of the trial by sponsor|0|||
27974112|NCT00726232|54631693|FG005|Expansion Phase|Termination of the trial by sponsor|0|||
28086054|NCT03334396|54739622|FG004|Overall Study|Physician Decision|0|||
28086055|NCT03334396|54739623|FG005|Overall Study|Physician Decision|0|||
28086056|NCT03334396|54739624|FG006|Overall Study|Physician Decision|0|||
28086057|NCT03334396|54739625|FG007|Overall Study|Physician Decision|0|||
28086058|NCT03334396|54739618|FG000|Overall Study|Withdrawal by Subject|10|||
28086059|NCT03334396|54739619|FG001|Overall Study|Withdrawal by Subject|5|||
28086060|NCT03334396|54739620|FG002|Overall Study|Withdrawal by Subject|7|||
28086061|NCT03334396|54739621|FG003|Overall Study|Withdrawal by Subject|2|||
28086062|NCT03334396|54739622|FG004|Overall Study|Withdrawal by Subject|2|||
28086063|NCT03334396|54739623|FG005|Overall Study|Withdrawal by Subject|1|||
28086064|NCT03334396|54739624|FG006|Overall Study|Withdrawal by Subject|2|||
28086065|NCT03334396|54739625|FG007|Overall Study|Withdrawal by Subject|0|||
28086066|NCT03334396|54739618|FG000|Overall Study|Pregnancy|0|||
28086067|NCT03334396|54739619|FG001|Overall Study|Pregnancy|1|||
28086068|NCT03334396|54739620|FG002|Overall Study|Pregnancy|0|||
28086069|NCT03334396|54739621|FG003|Overall Study|Pregnancy|0|||
28086070|NCT03334396|54739622|FG004|Overall Study|Pregnancy|0|||
28086071|NCT03334396|54739623|FG005|Overall Study|Pregnancy|0|||
28086072|NCT03334396|54739624|FG006|Overall Study|Pregnancy|0|||
28086073|NCT03334396|54739625|FG007|Overall Study|Pregnancy|0|||
28086074|NCT03334396|54739618|FG000|Overall Study|Ineligible|0|||
28086075|NCT03334396|54739619|FG001|Overall Study|Ineligible|1|||
28086076|NCT03334396|54739620|FG002|Overall Study|Ineligible|0|||
28086077|NCT03334396|54739621|FG003|Overall Study|Ineligible|0|||
28165402|NCT01066819|54836079|FG000|Overall Study|Administrative|6|||
28086078|NCT03334396|54739622|FG004|Overall Study|Ineligible|0|||
28086079|NCT03334396|54739623|FG005|Overall Study|Ineligible|0|||
28086080|NCT03334396|54739624|FG006|Overall Study|Ineligible|0|||
28086081|NCT03334396|54739625|FG007|Overall Study|Ineligible|0|||
28086082|NCT03334396|54739618|FG000|Overall Study|Started New Job|1|||
28086083|NCT03334396|54739619|FG001|Overall Study|Started New Job|0|||
28086084|NCT03334396|54739620|FG002|Overall Study|Started New Job|0|||
28086085|NCT03334396|54739621|FG003|Overall Study|Started New Job|0|||
28086086|NCT03334396|54739622|FG004|Overall Study|Started New Job|0|||
27974113|NCT00726232|54631694|FG006|Expansion Phase|Termination of the trial by sponsor|10|||
27974114|NCT00726232|54631695|FG007|Expansion Phase|Termination of the trial by sponsor|16|||
27974115|NCT00726232|54631688|FG000|Expansion Phase|Per Investigator: lack of response|0|||
27974116|NCT00726232|54631689|FG001|Expansion Phase|Per Investigator: lack of response|0|||
27974117|NCT00726232|54631690|FG002|Expansion Phase|Per Investigator: lack of response|0|||
27974118|NCT00726232|54631691|FG003|Expansion Phase|Per Investigator: lack of response|0|||
27974119|NCT00726232|54631692|FG004|Expansion Phase|Per Investigator: lack of response|0|||
27974120|NCT00726232|54631693|FG005|Expansion Phase|Per Investigator: lack of response|0|||
27974121|NCT00726232|54631694|FG006|Expansion Phase|Per Investigator: lack of response|1|||
27974122|NCT00726232|54631695|FG007|Expansion Phase|Per Investigator: lack of response|7|||
27974123|NCT00726232|54631688|FG000|Expansion Phase|Unspecified reason|0|||
27974124|NCT00726232|54631689|FG001|Expansion Phase|Unspecified reason|0|||
28086087|NCT03334396|54739623|FG005|Overall Study|Started New Job|0|||
28086088|NCT03334396|54739624|FG006|Overall Study|Started New Job|0|||
28086089|NCT03334396|54739625|FG007|Overall Study|Started New Job|0|||
28086090|NCT03338998|54739644|FG000|Treatment Period|Withdrawal by Subject|1|||
28086091|NCT03338998|54739645|FG001|Treatment Period|Withdrawal by Subject|1|||
28086092|NCT03338998|54739644|FG000|Treatment Period|Adverse Event|0|||
28086093|NCT03338998|54739645|FG001|Treatment Period|Adverse Event|2|||
28086094|NCT03338998|54739644|FG000|Treatment Period|Protocol deviation|1|||
28086095|NCT03338998|54739645|FG001|Treatment Period|Protocol deviation|0|||
28086096|NCT03338998|54739644|FG000|Treatment Period|Physician Decision|2|||
28086097|NCT03338998|54739645|FG001|Treatment Period|Physician Decision|0|||
28086098|NCT03338998|54739644|FG000|Treatment Period|Subject failed swallow test|4|||
28086099|NCT03338998|54739645|FG001|Treatment Period|Subject failed swallow test|0|||
28086100|NCT03338998|54739644|FG000|Safety Follow-Up Period|Adverse Event|0|||
28086101|NCT03338998|54739645|FG001|Safety Follow-Up Period|Adverse Event|1|||
28086102|NCT03338998|54739644|FG000|Safety Follow-Up Period|Protocol deviation|1|||
28086103|NCT03338998|54739645|FG001|Safety Follow-Up Period|Protocol deviation|0|||
28086104|NCT03338998|54739644|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
28086105|NCT03338998|54739645|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
28086106|NCT03338296|54739654|FG000|Overall Study|Adverse Event|0|||
28086107|NCT03338296|54739655|FG001|Overall Study|Adverse Event|1|||
28086108|NCT03338296|54739654|FG000|Overall Study|Withdrawal by Subject|14|||
28086109|NCT03338296|54739655|FG001|Overall Study|Withdrawal by Subject|13|||
28086110|NCT03338296|54739654|FG000|Overall Study|Lost to Follow-up|10|||
28086111|NCT03338296|54739655|FG001|Overall Study|Lost to Follow-up|10|||
28086112|NCT03338296|54739654|FG000|Overall Study|Study Terminated by Sponsor|77|||
28086113|NCT03338296|54739655|FG001|Overall Study|Study Terminated by Sponsor|76|||
28086114|NCT03338296|54739654|FG000|Overall Study|Other|2|||
28086115|NCT03338296|54739655|FG001|Overall Study|Other|7|||
28086116|NCT03338296|54739654|FG000|Overall Study|Missing|0|||
28086117|NCT03338296|54739655|FG001|Overall Study|Missing|1|||
28086118|NCT03338062|54739663|FG000|Overall Study|Alternative Therapy|1|||
28086119|NCT03338062|54739664|FG001|Overall Study|Alternative Therapy|0|||
28086120|NCT03364192|54739671|FG000|Overall Study|Ineligible|10|||
28086121|NCT03364192|54739671|FG000|Overall Study|Withdrawal by Subject|5|||
28086122|NCT03364192|54739671|FG000|Overall Study|Lost to Follow-up|1|||
28086123|NCT03783962|54739678|FG000|Overall Study|Lost to Follow-up|3|||
28086124|NCT03783962|54739679|FG001|Overall Study|Lost to Follow-up|6|||
28086125|NCT03783962|54739678|FG000|Overall Study|Protocol Violation|0|||
28086126|NCT03783962|54739679|FG001|Overall Study|Protocol Violation|1|||
28086127|NCT03361228|54739687|FG000|Overall Study|Other|1|||
28086128|NCT03361228|54739688|FG001|Overall Study|Other|1|||
28086129|NCT03361228|54739687|FG000|Overall Study|Death|3|||
28086130|NCT03361228|54739688|FG001|Overall Study|Death|0|||
28086131|NCT03359590|54739694|FG000|First Intervention|Withdrawal by Subject|1|||
28086132|NCT03359590|54739695|FG001|First Intervention|Withdrawal by Subject|1|||
28086133|NCT03359590|54739694|FG000|First Intervention|Protocol Violation|0|||
28086134|NCT03359590|54739695|FG001|First Intervention|Protocol Violation|1|||
28086135|NCT05085964|54739703|FG000|Overall Study|Premature termination of study|21|||
28086136|NCT05085964|54739704|FG001|Overall Study|Premature termination of study|0|||
28086137|NCT02891200|54739713|FG000|Overall Study|Lost to Follow-up|31|||
28086138|NCT02891200|54739714|FG001|Overall Study|Lost to Follow-up|36|||
28086139|NCT02891200|54739713|FG000|Overall Study|Death|10|||
28086140|NCT02891200|54739714|FG001|Overall Study|Death|9|||
28086141|NCT02891200|54739713|FG000|Overall Study|Withdrawal by Subject|1|||
28086142|NCT02891200|54739714|FG001|Overall Study|Withdrawal by Subject|4|||
28086143|NCT02946580|54739722|FG000|Overall Study|Withdrawal by Subject|1|||
28086144|NCT02946580|54739723|FG001|Overall Study|Withdrawal by Subject|2|||
28086145|NCT02946580|54739722|FG000|Overall Study|Adverse Event|0|||
28165403|NCT01066819|54836080|FG001|Overall Study|Administrative|4|||
28086146|NCT02946580|54739723|FG001|Overall Study|Adverse Event|2|||
28086147|NCT02946580|54739722|FG000|Overall Study|Did not undergo posterior spinal fusion|0|||
28086148|NCT02946580|54739723|FG001|Overall Study|Did not undergo posterior spinal fusion|1|||
28086149|NCT00323609|54739731|FG000|Overall Study|Death|16|||
27974125|NCT00726232|54631690|FG002|Expansion Phase|Unspecified reason|0|||
27974126|NCT00726232|54631691|FG003|Expansion Phase|Unspecified reason|0|||
27974127|NCT00726232|54631692|FG004|Expansion Phase|Unspecified reason|0|||
27974128|NCT00726232|54631693|FG005|Expansion Phase|Unspecified reason|0|||
27974129|NCT00726232|54631694|FG006|Expansion Phase|Unspecified reason|1|||
27974130|NCT00726232|54631695|FG007|Expansion Phase|Unspecified reason|0|||
27974131|NCT00720382|54631716|FG000|Overall Study|Adverse Event|54|||
27974132|NCT00720382|54631717|FG001|Overall Study|Adverse Event|17|||
27974133|NCT00720382|54631716|FG000|Overall Study|Lack of Efficacy|18|||
27974134|NCT00720382|54631717|FG001|Overall Study|Lack of Efficacy|7|||
27974135|NCT00720382|54631716|FG000|Overall Study|Non-Compliance|15|||
27974136|NCT00720382|54631717|FG001|Overall Study|Non-Compliance|5|||
27974137|NCT00720382|54631716|FG000|Overall Study|Withdrawal by Subject|47|||
27974138|NCT00720382|54631717|FG001|Overall Study|Withdrawal by Subject|11|||
27974139|NCT00720382|54631716|FG000|Overall Study|Lost to Follow-up|28|||
27974140|NCT00720382|54631717|FG001|Overall Study|Lost to Follow-up|14|||
27974141|NCT00720382|54631716|FG000|Overall Study|administrative|14|||
27974142|NCT00720382|54631717|FG001|Overall Study|administrative|5|||
27974143|NCT00720226|54631725|FG000|Overall Study|Withdrawal by Subject|7|||
27974144|NCT00720226|54631726|FG001|Overall Study|Withdrawal by Subject|4|||
27974145|NCT00725920|54631734|FG000|Overall Study|Lack of Efficacy|3|||
27974146|NCT00725920|54631735|FG001|Overall Study|Lack of Efficacy|6|||
27974147|NCT00725842|54631741|FG000|Overall Study|Lost to Follow-up|19|||
27974148|NCT00725842|54631741|FG000|Overall Study|Death|1|||
27974149|NCT00725842|54631741|FG000|Overall Study|Positive HCV-RNA at Visit 2|13|||
27974150|NCT00725842|54631741|FG000|Overall Study|Consent date prior to study start date|5|||
27974151|NCT00725842|54631741|FG000|Overall Study|Inclusion criterion not met|1|||
27974152|NCT00725842|54631741|FG000|Overall Study|No Visit 1 data|1|||
27974153|NCT00725764|54631745|FG000|Overall Study|Withdrawal by Subject|2|||
27974154|NCT00725764|54631745|FG000|Overall Study|Physician Decision|1|||
27974155|NCT00725764|54631745|FG000|Overall Study|Progressive Disease|7|||
27974156|NCT00725764|54631745|FG000|Overall Study|Lost to Follow-up|1|||
27974157|NCT00725764|54631745|FG000|Overall Study|Death|1|||
27974158|NCT00725764|54631745|FG000|Overall Study|Participant non compliant with protocol|1|||
27974159|NCT00725764|54631745|FG000|Overall Study|Decline in performance status|1|||
27974160|NCT00725608|54631750|FG000|Overall Study|Lost to Follow-up|60|||
27974161|NCT00725608|54631750|FG000|Overall Study|Adverse Event|14|||
27974162|NCT00725608|54631750|FG000|Overall Study|Individual reasons|86|||
27974163|NCT00725608|54631750|FG000|Overall Study|Other|7|||
27974164|NCT00725452|54631754|FG000|Overall Study|Adverse Event|3|||
27974165|NCT00725452|54631754|FG000|Overall Study|Lack of Efficacy|2|||
27974166|NCT00725452|54631754|FG000|Overall Study|Reason not specified|1|||
27974167|NCT00725452|54631754|FG000|Overall Study|Physician Decision|1|||
27974168|NCT00725452|54631754|FG000|Overall Study|Withdrawal by Subject|3|||
27974169|NCT00725452|54631754|FG000|Overall Study|Lost to Follow-up|1|||
27974170|NCT00725296|54631758|FG000|Overall Study|Adverse Event|11|||
27974171|NCT00725296|54631758|FG000|Overall Study|Lack of Efficacy|7|||
27974172|NCT00725296|54631758|FG000|Overall Study|Withdrawal by Subject|3|||
27974173|NCT00725296|54631758|FG000|Overall Study|Non-Compliance|2|||
27974174|NCT00725296|54631758|FG000|Overall Study|Lost to Follow-up|1|||
27974175|NCT00725296|54631758|FG000|Overall Study|Other|38|||
27974176|NCT00719680|54631763|FG000|Overall Study|Adverse Event|1|||
27974177|NCT00719680|54631763|FG000|Overall Study|Lost to Follow-up|1|||
27974178|NCT00719680|54631763|FG000|Overall Study|Withdrawal by Subject|3|||
27974179|NCT00719212|54631767|FG000|Overall Study|Death|41|||
27974180|NCT00719212|54631767|FG000|Overall Study|Lost to Follow-up|2|||
27974181|NCT00719212|54631767|FG000|Overall Study|Withdrawal by Subject|1|||
27974182|NCT00585052|54631771|FG000|Overall Study|Withdrawal by Subject|1|||
27974183|NCT00724282|54631775|FG000|Overall Study|Withdrawal by Subject|3|||
27974184|NCT00724282|54631775|FG000|Overall Study|Physician Decision|1|||
27974185|NCT00724126|54631781|FG000|Overall Study|Adverse Event|2|||
27974186|NCT00724126|54631782|FG001|Overall Study|Adverse Event|0|||
28165404|NCT01066819|54836081|FG002|Overall Study|Administrative|2|||
28165405|NCT01066819|54836082|FG003|Overall Study|Administrative|0|||
27974187|NCT00724126|54631781|FG000|Overall Study|Withdrawal by Subject|8|||
27974188|NCT00724126|54631782|FG001|Overall Study|Withdrawal by Subject|6|||
27974189|NCT00724126|54631781|FG000|Overall Study|Lost to Follow-up|6|||
27974190|NCT00724126|54631782|FG001|Overall Study|Lost to Follow-up|6|||
27974191|NCT00724126|54631781|FG000|Overall Study|Noncompliance|2|||
27974192|NCT00724126|54631782|FG001|Overall Study|Noncompliance|1|||
27974193|NCT00724126|54631781|FG000|Overall Study|Subject randomized although ineligible|1|||
27974194|NCT00724126|54631782|FG001|Overall Study|Subject randomized although ineligible|1|||
27974195|NCT00724126|54631781|FG000|Overall Study|Subject had to leave vicinity of site|0|||
27974196|NCT00724126|54631782|FG001|Overall Study|Subject had to leave vicinity of site|1|||
27974197|NCT00723892|54631790|FG000|Overall Study|Participant not tracked|33|||
27974198|NCT00723892|54631791|FG001|Overall Study|Participant not tracked|35|||
27974199|NCT00723892|54631790|FG000|Overall Study|Virological criterion|24|||
27974200|NCT00723892|54631791|FG001|Overall Study|Virological criterion|9|||
27974201|NCT00723892|54631790|FG000|Overall Study|Withdrawal by Subject|6|||
27974202|NCT00723892|54631791|FG001|Overall Study|Withdrawal by Subject|9|||
27974203|NCT00723892|54631790|FG000|Overall Study|End planned|11|||
27974204|NCT00723892|54631791|FG001|Overall Study|End planned|7|||
27974205|NCT00723892|54631790|FG000|Overall Study|Bad tolerance|5|||
27974206|NCT00723892|54631791|FG001|Overall Study|Bad tolerance|5|||
27974207|NCT00723892|54631790|FG000|Overall Study|Multiple reasons|17|||
27974208|NCT00723892|54631791|FG001|Overall Study|Multiple reasons|12|||
27974209|NCT00723892|54631790|FG000|Overall Study|Other|6|||
27974210|NCT00723892|54631791|FG001|Overall Study|Other|3|||
27974211|NCT00723892|54631790|FG000|Overall Study|Study end|1|||
27974212|NCT00723892|54631791|FG001|Overall Study|Study end|3|||
27974213|NCT00723892|54631790|FG000|Overall Study|Weight loss|1|||
27974214|NCT00723892|54631791|FG001|Overall Study|Weight loss|3|||
27974215|NCT00723892|54631790|FG000|Overall Study|Alcohol abuse|0|||
27974216|NCT00723892|54631791|FG001|Overall Study|Alcohol abuse|1|||
27974217|NCT00723892|54631790|FG000|Overall Study|Intercurrent infection|2|||
27974218|NCT00723892|54631791|FG001|Overall Study|Intercurrent infection|0|||
27974219|NCT00723892|54631790|FG000|Overall Study|Drug addiction|1|||
27974220|NCT00723892|54631791|FG001|Overall Study|Drug addiction|0|||
27974221|NCT00718666|54631800|FG000|Booster Phase Year 5|No active participation request|0|||
27974222|NCT00718666|54631801|FG001|Booster Phase Year 5|No active participation request|0|||
27974223|NCT00718666|54631802|FG002|Booster Phase Year 5|No active participation request|1|||
27974224|NCT00718666|54631800|FG000|Booster Phase Year 5|Declined v-4 serology|1|||
27974225|NCT00718666|54631801|FG001|Booster Phase Year 5|Declined v-4 serology|0|||
27974226|NCT00718666|54631802|FG002|Booster Phase Year 5|Declined v-4 serology|0|||
27974227|NCT00718666|54631800|FG000|Booster Phase Year 5|Withdrawal by Subject|0|||
27974228|NCT00718666|54631801|FG001|Booster Phase Year 5|Withdrawal by Subject|0|||
27974229|NCT00718666|54631802|FG002|Booster Phase Year 5|Withdrawal by Subject|1|||
27974230|NCT00718666|54631800|FG000|Booster Phase Year 5|Lost to Follow-up|1|||
27974231|NCT00718666|54631801|FG001|Booster Phase Year 5|Lost to Follow-up|0|||
27974232|NCT00718666|54631802|FG002|Booster Phase Year 5|Lost to Follow-up|4|||
27974233|NCT03950440|54631823|FG000|Overall Study|Death|8|||
27974234|NCT03950440|54631824|FG001|Overall Study|Death|2|||
27974235|NCT03950440|54631825|FG002|Overall Study|Death|1|||
27974236|NCT00718510|54631835|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
27974237|NCT00718510|54631836|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
27974238|NCT00718510|54631835|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
27974239|NCT00718510|54631836|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
27974240|NCT00585286|54631842|FG000|Overall Study|Lost to Follow-up|1|||
27974241|NCT00723190|54631846|FG000|Overall Study|Withdrawal by Subject|45|||
27974242|NCT00723190|54631846|FG000|Overall Study|Lost to Follow-up|37|||
27974243|NCT00723190|54631846|FG000|Overall Study|Adverse Event|18|||
27974244|NCT00723190|54631846|FG000|Overall Study|Lack of Efficacy|16|||
27974245|NCT00723190|54631846|FG000|Overall Study|Protocol Violation|15|||
27974246|NCT00723190|54631846|FG000|Overall Study|Other-Premature Discontinuation|9|||
27974247|NCT00723190|54631846|FG000|Overall Study|Other-Not included in safety population|2|||
27974248|NCT00722800|54631852|FG000|Overall Study|Withdrawal by Subject|1|||
27974249|NCT00722800|54631853|FG001|Overall Study|Withdrawal by Subject|0|||
27974250|NCT00722800|54631852|FG000|Overall Study|Physician Decision|1|||
27974251|NCT00722800|54631853|FG001|Overall Study|Physician Decision|0|||
27974252|NCT00718042|54631865|FG000|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
27974253|NCT00718042|54631866|FG001|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
27974254|NCT00718042|54631867|FG002|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
27974255|NCT00718042|54631868|FG003|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
27974256|NCT00718042|54631869|FG004|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2|||
27974257|NCT00718042|54631870|FG005|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
28086150|NCT00323609|54739732|FG001|Overall Study|Death|21|||
28086151|NCT00323609|54739733|FG002|Overall Study|Death|0|||
28086152|NCT00323609|54739734|FG003|Overall Study|Death|0|||
28086153|NCT00323609|54739731|FG000|Overall Study|Lost to Follow-up|9|||
28086154|NCT00323609|54739732|FG001|Overall Study|Lost to Follow-up|10|||
28086155|NCT00323609|54739733|FG002|Overall Study|Lost to Follow-up|0|||
28086156|NCT00323609|54739734|FG003|Overall Study|Lost to Follow-up|0|||
28086157|NCT00323609|54739731|FG000|Overall Study|Physician Decision|2|||
28086158|NCT00323609|54739732|FG001|Overall Study|Physician Decision|0|||
28086159|NCT00323609|54739733|FG002|Overall Study|Physician Decision|0|||
28086160|NCT00323609|54739734|FG003|Overall Study|Physician Decision|1|||
28165406|NCT01066819|54836083|FG004|Overall Study|Administrative|0|||
28165407|NCT01066819|54836084|FG005|Overall Study|Administrative|0|||
27974258|NCT00718042|54631865|FG000|ABBOTT PRISM Chagas Testing|Protocol Violation|64|||
27974259|NCT00718042|54631866|FG001|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
27974260|NCT00718042|54631867|FG002|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
28086161|NCT00323609|54739731|FG000|Overall Study|Withdrawal by Subject|11|||
28086162|NCT00323609|54739732|FG001|Overall Study|Withdrawal by Subject|23|||
28086163|NCT00323609|54739733|FG002|Overall Study|Withdrawal by Subject|4|||
28165408|NCT01066819|54836079|FG000|Overall Study|Not met inclusion/exclusion criteria|1|||
28086164|NCT00323609|54739734|FG003|Overall Study|Withdrawal by Subject|4|||
28086165|NCT00323609|54739731|FG000|Overall Study|Other non-VCF-related medical condition|3|||
28086166|NCT00323609|54739732|FG001|Overall Study|Other non-VCF-related medical condition|2|||
28086167|NCT00323609|54739733|FG002|Overall Study|Other non-VCF-related medical condition|0|||
28086168|NCT00323609|54739734|FG003|Overall Study|Other non-VCF-related medical condition|0|||
28086169|NCT00323609|54739731|FG000|Overall Study|Sponsor discontinued trial|29|||
28086170|NCT00323609|54739732|FG001|Overall Study|Sponsor discontinued trial|29|||
28086171|NCT00323609|54739733|FG002|Overall Study|Sponsor discontinued trial|0|||
28086172|NCT00323609|54739734|FG003|Overall Study|Sponsor discontinued trial|0|||
28086173|NCT00323609|54739731|FG000|Overall Study|Unrelenting or severe back pain|1|||
28086174|NCT00323609|54739732|FG001|Overall Study|Unrelenting or severe back pain|1|||
28086175|NCT00323609|54739733|FG002|Overall Study|Unrelenting or severe back pain|0|||
28086176|NCT00323609|54739734|FG003|Overall Study|Unrelenting or severe back pain|0|||
28086177|NCT00323609|54739731|FG000|Overall Study|Logistical withdrawal|9|||
28086178|NCT00323609|54739732|FG001|Overall Study|Logistical withdrawal|5|||
28086179|NCT00323609|54739733|FG002|Overall Study|Logistical withdrawal|0|||
28086180|NCT00323609|54739734|FG003|Overall Study|Logistical withdrawal|1|||
28086181|NCT00323609|54739731|FG000|Overall Study|Other reason|11|||
28086182|NCT00323609|54739732|FG001|Overall Study|Other reason|8|||
28086183|NCT00323609|54739733|FG002|Overall Study|Other reason|4|||
28086184|NCT00323609|54739734|FG003|Overall Study|Other reason|9|||
28086185|NCT04598152|54739740|FG000|Overall Study|Lost to Follow-up|0|||
28086186|NCT04598152|54739741|FG001|Overall Study|Lost to Follow-up|1|||
28086187|NCT00323297|54739749|FG000|Part A (Double Blind Randomized)|Reason unspecified|0|||
28086188|NCT00323297|54739750|FG001|Part A (Double Blind Randomized)|Reason unspecified|1|||
28086189|NCT00323297|54739749|FG000|Part A (Double Blind Randomized)|Death|0|||
28086190|NCT00323297|54739750|FG001|Part A (Double Blind Randomized)|Death|1|||
28086191|NCT00323297|54739749|FG000|Part A (Double Blind Randomized)|Protocol Violation|1|||
28086192|NCT00323297|54739750|FG001|Part A (Double Blind Randomized)|Protocol Violation|3|||
28086193|NCT00323297|54739749|FG000|Part A (Double Blind Randomized)|Unrelated adverse event|1|||
28086194|NCT00323297|54739750|FG001|Part A (Double Blind Randomized)|Unrelated adverse event|0|||
28086195|NCT00323297|54739749|FG000|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1|||
28086196|NCT00323297|54739750|FG001|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0|||
27974261|NCT00718042|54631868|FG003|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
27974262|NCT00718042|54631869|FG004|ABBOTT PRISM Chagas Testing|Protocol Violation|36|||
27974263|NCT00718042|54631870|FG005|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
27974264|NCT00718042|54631865|FG000|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
27974265|NCT00718042|54631866|FG001|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
27974266|NCT00718042|54631867|FG002|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
27974267|NCT00718042|54631868|FG003|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
27974268|NCT00718042|54631869|FG004|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
27974269|NCT00718042|54631870|FG005|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
27974270|NCT00718042|54631865|FG000|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
27974271|NCT00718042|54631866|FG001|ABBOTT PRISM Chagas Testing|No result on comparator assay|1|||
27974272|NCT00718042|54631867|FG002|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
27974273|NCT00718042|54631868|FG003|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
27974274|NCT00718042|54631869|FG004|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
27974275|NCT00718042|54631870|FG005|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
27974276|NCT00718042|54631865|FG000|Donor Follow-up|Lost to Follow-up|13|||
27974277|NCT00718042|54631866|FG001|Donor Follow-up|Lost to Follow-up|0|||
27974278|NCT00718042|54631867|FG002|Donor Follow-up|Lost to Follow-up|0|||
27974279|NCT00718042|54631868|FG003|Donor Follow-up|Lost to Follow-up|0|||
27974280|NCT00718042|54631869|FG004|Donor Follow-up|Lost to Follow-up|19|||
28086197|NCT00323297|54739749|FG000|Part A (Double Blind Randomized)|Related adverse event|2|||
28086198|NCT00323297|54739750|FG001|Part A (Double Blind Randomized)|Related adverse event|2|||
28086199|NCT00323297|54739749|FG000|Part B (Open-label)|Death|0|||
28086200|NCT00323297|54739750|FG001|Part B (Open-label)|Death|1|||
28086201|NCT00323297|54739749|FG000|Part B (Open-label)|Reason unspecified|0|||
28086202|NCT00323297|54739750|FG001|Part B (Open-label)|Reason unspecified|1|||
28086203|NCT00323297|54739749|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
28086204|NCT00323297|54739750|FG001|Part B (Open-label)|Withdrawal by Subject|3|||
28086205|NCT00323297|54739749|FG000|Part B (Open-label)|Lack of Efficacy|3|||
28086206|NCT00323297|54739750|FG001|Part B (Open-label)|Lack of Efficacy|1|||
28086207|NCT00323297|54739749|FG000|Part B (Open-label)|Adverse Event|5|||
28086208|NCT00323297|54739750|FG001|Part B (Open-label)|Adverse Event|5|||
28086209|NCT00323297|54739749|FG000|Part B (Open-label)|Protocol Violation|0|||
28086210|NCT00323297|54739750|FG001|Part B (Open-label)|Protocol Violation|1|||
28086211|NCT00323063|54739758|FG000|Overall Study|Adverse Event|1|||
28086212|NCT00323063|54739759|FG001|Overall Study|Adverse Event|0|||
28086213|NCT00323063|54739758|FG000|Overall Study|brain mets discovered prior to treatment|1|||
28086214|NCT00323063|54739759|FG001|Overall Study|brain mets discovered prior to treatment|0|||
28086215|NCT00322049|54739769|FG000|Overall Study|Moved out of area|0|||
28086216|NCT00322049|54739770|FG001|Overall Study|Moved out of area|0|||
28086217|NCT00322049|54739771|FG002|Overall Study|Moved out of area|0|||
28086218|NCT00322049|54739772|FG003|Overall Study|Moved out of area|1|||
28086219|NCT00322049|54739769|FG000|Overall Study|Infected with Dengue during study|0|||
28086220|NCT00322049|54739770|FG001|Overall Study|Infected with Dengue during study|1|||
28086221|NCT00322049|54739771|FG002|Overall Study|Infected with Dengue during study|0|||
28086222|NCT00322049|54739772|FG003|Overall Study|Infected with Dengue during study|0|||
28086223|NCT00321893|54739793|FG000|Overall Study|Non-Compliance/Refusal|16|||
28086224|NCT00321893|54739794|FG001|Overall Study|Non-Compliance/Refusal|10|||
28086225|NCT00321893|54739793|FG000|Overall Study|Lost to Follow-up|2|||
28086226|NCT00321893|54739794|FG001|Overall Study|Lost to Follow-up|1|||
28086227|NCT00321893|54739793|FG000|Overall Study|Adverse Event|6|||
28086228|NCT00321893|54739794|FG001|Overall Study|Adverse Event|3|||
28086229|NCT00371345|54739802|FG000|Overall Study|Disease Progression|21|||
28086230|NCT00371345|54739803|FG001|Overall Study|Disease Progression|35|||
28086231|NCT00371345|54739802|FG000|Overall Study|Study Drug Toxicity|1|||
28086232|NCT00371345|54739803|FG001|Overall Study|Study Drug Toxicity|7|||
28086233|NCT00371345|54739802|FG000|Overall Study|Adverse event(AE Unrelated to Study Drug|1|||
28086234|NCT00371345|54739803|FG001|Overall Study|Adverse event(AE Unrelated to Study Drug|2|||
28086235|NCT00371345|54739802|FG000|Overall Study|Participant Request|1|||
28086236|NCT00371345|54739803|FG001|Overall Study|Participant Request|1|||
28086237|NCT00371345|54739802|FG000|Overall Study|Participant Withdrew Consent|0|||
28086238|NCT00371345|54739803|FG001|Overall Study|Participant Withdrew Consent|1|||
28086239|NCT00321737|54739826|FG000|Overall Study|Relapse of Erosive Esophagitis|76|||
28086240|NCT00321737|54739827|FG001|Overall Study|Relapse of Erosive Esophagitis|25|||
28086241|NCT00321737|54739828|FG002|Overall Study|Relapse of Erosive Esophagitis|19|||
28086242|NCT00321737|54739826|FG000|Overall Study|Adverse Event|11|||
28086243|NCT00321737|54739827|FG001|Overall Study|Adverse Event|3|||
28086244|NCT00321737|54739828|FG002|Overall Study|Adverse Event|6|||
28086245|NCT00321737|54739826|FG000|Overall Study|Lost to Follow-up|5|||
28086246|NCT00321737|54739827|FG001|Overall Study|Lost to Follow-up|5|||
28086247|NCT00321737|54739828|FG002|Overall Study|Lost to Follow-up|6|||
28086248|NCT00321737|54739826|FG000|Overall Study|Withdrawal by Subject|19|||
28086249|NCT00321737|54739827|FG001|Overall Study|Withdrawal by Subject|12|||
28086250|NCT00321737|54739828|FG002|Overall Study|Withdrawal by Subject|17|||
28086251|NCT00321737|54739826|FG000|Overall Study|Protocol Violation|0|||
28086252|NCT00321737|54739827|FG001|Overall Study|Protocol Violation|0|||
28086253|NCT00321737|54739828|FG002|Overall Study|Protocol Violation|1|||
28086254|NCT00321737|54739826|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
28086255|NCT00321737|54739827|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
28086256|NCT00321737|54739828|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
28086257|NCT00321737|54739826|FG000|Overall Study|Possible Barrett's Esophagus|2|||
28086258|NCT00321737|54739827|FG001|Overall Study|Possible Barrett's Esophagus|1|||
28086259|NCT00321737|54739828|FG002|Overall Study|Possible Barrett's Esophagus|1|||
28086260|NCT00321737|54739826|FG000|Overall Study|Therapeutic Failure|6|||
28086261|NCT00321737|54739827|FG001|Overall Study|Therapeutic Failure|0|||
28086262|NCT00321737|54739828|FG002|Overall Study|Therapeutic Failure|2|||
28086263|NCT00321737|54739826|FG000|Overall Study|Pregnancy|0|||
28086264|NCT00321737|54739827|FG001|Overall Study|Pregnancy|2|||
28086265|NCT00321737|54739828|FG002|Overall Study|Pregnancy|0|||
28086266|NCT00321737|54739826|FG000|Overall Study|Noncompliance|2|||
28086267|NCT00321737|54739827|FG001|Overall Study|Noncompliance|0|||
28086268|NCT00321737|54739828|FG002|Overall Study|Noncompliance|0|||
28086269|NCT00321737|54739826|FG000|Overall Study|Subject Request/ Subject Unavailable|0|||
28086270|NCT00321737|54739827|FG001|Overall Study|Subject Request/ Subject Unavailable|0|||
28086271|NCT00321737|54739828|FG002|Overall Study|Subject Request/ Subject Unavailable|2|||
28165409|NCT01066819|54836080|FG001|Overall Study|Not met inclusion/exclusion criteria|0|||
27974281|NCT00718042|54631870|FG005|Donor Follow-up|Lost to Follow-up|0|||
27974282|NCT00741598|54631884|FG000|Overall Study|Lost to Follow-up|3|||
27974283|NCT00741598|54631885|FG001|Overall Study|Lost to Follow-up|4|||
27974284|NCT00741598|54631884|FG000|Overall Study|Lack of Efficacy|1|||
27974285|NCT00741598|54631885|FG001|Overall Study|Lack of Efficacy|2|||
27974286|NCT00741598|54631884|FG000|Overall Study|Physician Decision|1|||
27974287|NCT00741598|54631885|FG001|Overall Study|Physician Decision|1|||
27974288|NCT00741598|54631884|FG000|Overall Study|Pregnancy|1|||
28165410|NCT01066819|54836081|FG002|Overall Study|Not met inclusion/exclusion criteria|0|||
28165411|NCT01066819|54836082|FG003|Overall Study|Not met inclusion/exclusion criteria|0|||
27974289|NCT00741598|54631885|FG001|Overall Study|Pregnancy|0|||
27974290|NCT00741598|54631884|FG000|Overall Study|Withdrawal by Subject|3|||
27974291|NCT00741598|54631885|FG001|Overall Study|Withdrawal by Subject|2|||
28165412|NCT01066819|54836083|FG004|Overall Study|Not met inclusion/exclusion criteria|0|||
28165413|NCT01066819|54836084|FG005|Overall Study|Not met inclusion/exclusion criteria|0|||
28165414|NCT01066819|54836079|FG000|Overall Study|Early termination|2|||
27974292|NCT00717886|54631892|FG000|Overall Study|Withdrawal by Subject|3|||
27974293|NCT00717886|54631892|FG000|Overall Study|Treatment Failure|1|||
27974294|NCT00741286|54631898|FG000|Overall Study|Lost to Follow-up|15|||
27974295|NCT00741286|54631899|FG001|Overall Study|Lost to Follow-up|10|||
27974296|NCT00741286|54631898|FG000|Overall Study|Adverse Event|1|||
27974297|NCT00741286|54631899|FG001|Overall Study|Adverse Event|6|||
27974298|NCT00741286|54631898|FG000|Overall Study|Protocol Violation|3|||
27974299|NCT00741286|54631899|FG001|Overall Study|Protocol Violation|2|||
27974300|NCT00741286|54631898|FG000|Overall Study|Primary Outcome|1|||
27974301|NCT00741286|54631899|FG001|Overall Study|Primary Outcome|1|||
27974302|NCT00716482|54631905|FG000|Overall Study|Lost to Follow-up|6|||
27974303|NCT00716482|54631905|FG000|Overall Study|Inadequate acquisition or analysis|50|||
27974304|NCT00716482|54631905|FG000|Overall Study|no pathology obtained|10|||
27974305|NCT00716482|54631905|FG000|Overall Study|technical/machine error|28|||
27974306|NCT00716482|54631905|FG000|Overall Study|inclusion/exclusion criteria not met|25|||
27974307|NCT00716092|54631918|FG000|Overall Study|Other incl. Lack of Efficacy|2|||
27974308|NCT00716092|54631919|FG001|Overall Study|Other incl. Lack of Efficacy|1|||
27974309|NCT00716092|54631920|FG002|Overall Study|Other incl. Lack of Efficacy|0|||
27974310|NCT00715624|54631930|FG000|Overall Study|Adverse Event|12|||
27974311|NCT00715624|54631931|FG001|Overall Study|Adverse Event|37|||
27974312|NCT00715624|54631930|FG000|Overall Study|Lack of Efficacy|11|||
27974313|NCT00715624|54631931|FG001|Overall Study|Lack of Efficacy|11|||
27974314|NCT00715624|54631930|FG000|Overall Study|Lost to Follow-up|1|||
27974315|NCT00715624|54631931|FG001|Overall Study|Lost to Follow-up|2|||
27974316|NCT00715624|54631930|FG000|Overall Study|Protocol Violation|1|||
27974317|NCT00715624|54631931|FG001|Overall Study|Protocol Violation|0|||
27974318|NCT00715624|54631930|FG000|Overall Study|Withdrawal by Subject|11|||
28086272|NCT00320801|54739838|FG000|Open-label Run-in Period|Withdrawal by Subject|2|||
28086273|NCT00320801|54739839|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
28086274|NCT00320801|54739840|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
28086275|NCT00320801|54739841|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
28086276|NCT00320801|54739838|FG000|Open-label Run-in Period|Adverse Event|33|||
28086277|NCT00320801|54739839|FG001|Open-label Run-in Period|Adverse Event|0|||
27974319|NCT00715624|54631931|FG001|Overall Study|Withdrawal by Subject|25|||
27974320|NCT00715624|54631930|FG000|Overall Study|Familial and personal reasons|10|||
27974321|NCT00715624|54631931|FG001|Overall Study|Familial and personal reasons|22|||
27974322|NCT00715624|54631930|FG000|Overall Study|Poor compliance|6|||
27974323|NCT00715624|54631931|FG001|Overall Study|Poor compliance|13|||
27974324|NCT00715624|54631930|FG000|Overall Study|Sponsor decision|0|||
27974325|NCT00715624|54631931|FG001|Overall Study|Sponsor decision|4|||
27974326|NCT00715624|54631930|FG000|Overall Study|Incorrect randomization (not treated)|0|||
27974327|NCT00715624|54631931|FG001|Overall Study|Incorrect randomization (not treated)|1|||
27974328|NCT00715624|54631930|FG000|Overall Study|Other|0|||
27974329|NCT00715624|54631931|FG001|Overall Study|Other|1|||
27974330|NCT00576199|54631937|FG000|Overall Study|Adverse Event|12|||
27974331|NCT00576199|54631937|FG000|Overall Study|Insufficient Therapeutic Response|14|||
27974332|NCT00576199|54631937|FG000|Overall Study|Refused Treatment|2|||
27974333|NCT00576199|54631937|FG000|Overall Study|Reason Unspecified|2|||
27974334|NCT00715078|54631944|FG000|Overall Study|Death|29|||
27974335|NCT00715078|54631945|FG001|Overall Study|Death|36|||
27974336|NCT00715078|54631946|FG002|Overall Study|Death|36|||
27974337|NCT00715078|54631944|FG000|Overall Study|Withdrawal by Subject|1|||
27974338|NCT00715078|54631945|FG001|Overall Study|Withdrawal by Subject|0|||
27974339|NCT00715078|54631946|FG002|Overall Study|Withdrawal by Subject|1|||
27974340|NCT00715078|54631944|FG000|Overall Study|Unable to start due to disease prog.|0|||
27974341|NCT00715078|54631945|FG001|Overall Study|Unable to start due to disease prog.|0|||
27974342|NCT00715078|54631946|FG002|Overall Study|Unable to start due to disease prog.|1|||
27974343|NCT00679627|54631956|FG000|Overall Study|Death|41|||
27974344|NCT00679627|54631957|FG001|Overall Study|Death|29|||
27974345|NCT00679627|54631956|FG000|Overall Study|Adverse Event|43|||
27974346|NCT00679627|54631957|FG001|Overall Study|Adverse Event|53|||
27974347|NCT00679627|54631956|FG000|Overall Study|Withdrawal by Subject|168|||
27974348|NCT00679627|54631957|FG001|Overall Study|Withdrawal by Subject|172|||
27974349|NCT00679627|54631956|FG000|Overall Study|Lost to Follow-up|22|||
27974350|NCT00679627|54631957|FG001|Overall Study|Lost to Follow-up|26|||
27974351|NCT00679627|54631956|FG000|Overall Study|Early Study Closure|425|||
27974352|NCT00679627|54631957|FG001|Overall Study|Early Study Closure|405|||
27974353|NCT00714688|54631966|FG000|Overall Study|Lack of Efficacy|14|||
27974354|NCT00714688|54631967|FG001|Overall Study|Lack of Efficacy|1|||
27974355|NCT00714688|54631968|FG002|Overall Study|Lack of Efficacy|4|||
27974356|NCT00714688|54631966|FG000|Overall Study|Withdrawal by Subject|4|||
27974357|NCT00714688|54631967|FG001|Overall Study|Withdrawal by Subject|3|||
27974358|NCT00714688|54631968|FG002|Overall Study|Withdrawal by Subject|3|||
27974359|NCT00714688|54631966|FG000|Overall Study|Lost to Follow-up|5|||
27974360|NCT00714688|54631967|FG001|Overall Study|Lost to Follow-up|2|||
27974361|NCT00714688|54631968|FG002|Overall Study|Lost to Follow-up|0|||
27974362|NCT00714688|54631966|FG000|Overall Study|Adverse Event|2|||
27974363|NCT00714688|54631967|FG001|Overall Study|Adverse Event|15|||
28086278|NCT00320801|54739840|FG002|Open-label Run-in Period|Adverse Event|0|||
27974364|NCT00714688|54631968|FG002|Overall Study|Adverse Event|19|||
27974365|NCT00714688|54631966|FG000|Overall Study|Subject Non-compliant|3|||
27974366|NCT00714688|54631967|FG001|Overall Study|Subject Non-compliant|5|||
27974367|NCT00714688|54631968|FG002|Overall Study|Subject Non-compliant|5|||
27974368|NCT00714688|54631966|FG000|Overall Study|Ineligible to Continue the Study|0|||
27974369|NCT00714688|54631967|FG001|Overall Study|Ineligible to Continue the Study|1|||
27974370|NCT00714688|54631968|FG002|Overall Study|Ineligible to Continue the Study|1|||
27974371|NCT00714688|54631966|FG000|Overall Study|Sponsor's Decision|0|||
27974372|NCT00714688|54631967|FG001|Overall Study|Sponsor's Decision|2|||
27974373|NCT00714688|54631968|FG002|Overall Study|Sponsor's Decision|0|||
27974374|NCT00714688|54631966|FG000|Overall Study|Other|1|||
27974375|NCT00714688|54631967|FG001|Overall Study|Other|6|||
27974376|NCT00714688|54631968|FG002|Overall Study|Other|5|||
27974377|NCT00679549|54631978|FG000|Overall Study|dropout|2|||
27974378|NCT00679549|54631979|FG001|Overall Study|dropout|4|||
27974379|NCT00679549|54631978|FG000|Overall Study|missing outcome echocardiograms|4|||
27974380|NCT00679549|54631979|FG001|Overall Study|missing outcome echocardiograms|5|||
27974381|NCT01031069|54631989|FG000|Overall Study|Serious Adverse Event|0|||
27974382|NCT01031069|54631990|FG001|Overall Study|Serious Adverse Event|1|||
27974383|NCT01031069|54631991|FG002|Overall Study|Serious Adverse Event|0|||
27974384|NCT01031069|54631992|FG003|Overall Study|Serious Adverse Event|0|||
27974385|NCT01031069|54631989|FG000|Overall Study|Withdrawal by Subject|2|||
27974386|NCT01031069|54631990|FG001|Overall Study|Withdrawal by Subject|3|||
27974387|NCT01031069|54631991|FG002|Overall Study|Withdrawal by Subject|18|||
27974388|NCT01031069|54631992|FG003|Overall Study|Withdrawal by Subject|18|||
27974389|NCT01031069|54631989|FG000|Overall Study|Migrated/moved from study area|1|||
27974390|NCT01031069|54631990|FG001|Overall Study|Migrated/moved from study area|2|||
27974391|NCT01031069|54631991|FG002|Overall Study|Migrated/moved from study area|1|||
27974392|NCT01031069|54631992|FG003|Overall Study|Migrated/moved from study area|1|||
27974393|NCT01031069|54631989|FG000|Overall Study|Lost to Follow-up|9|||
27974394|NCT01031069|54631990|FG001|Overall Study|Lost to Follow-up|5|||
27974395|NCT01031069|54631991|FG002|Overall Study|Lost to Follow-up|21|||
27974396|NCT01031069|54631992|FG003|Overall Study|Lost to Follow-up|15|||
27974397|NCT01031069|54631989|FG000|Overall Study|Other|0|||
27974398|NCT01031069|54631990|FG001|Overall Study|Other|0|||
27974399|NCT01031069|54631991|FG002|Overall Study|Other|1|||
27974400|NCT01031069|54631992|FG003|Overall Study|Other|0|||
27974401|NCT00679081|54632004|FG000|Overall Study|Lost to Follow-up|1|||
27974402|NCT00682435|54632012|FG000|Overall Study|Insufficient data|5|||
27974403|NCT00682435|54632012|FG000|Overall Study|Erroneously enrolled twice|2|||
27974404|NCT00713830|54632018|FG000|Overall Study|Adverse Event|23|||
27974405|NCT00713830|54632019|FG001|Overall Study|Adverse Event|71|||
27974406|NCT00713830|54632018|FG000|Overall Study|Lack of Efficacy|24|||
27974407|NCT00713830|54632019|FG001|Overall Study|Lack of Efficacy|16|||
27974408|NCT00713830|54632018|FG000|Overall Study|Lost to Follow-up|2|||
27974409|NCT00713830|54632019|FG001|Overall Study|Lost to Follow-up|9|||
27974410|NCT00713830|54632018|FG000|Overall Study|Withdrawal by Subject|13|||
28086279|NCT00320801|54739841|FG003|Open-label Run-in Period|Adverse Event|0|||
28086280|NCT00320801|54739838|FG000|Open-label Run-in Period|Administrative|10|||
28086281|NCT00320801|54739839|FG001|Open-label Run-in Period|Administrative|0|||
28086282|NCT00320801|54739840|FG002|Open-label Run-in Period|Administrative|0|||
28086283|NCT00320801|54739841|FG003|Open-label Run-in Period|Administrative|0|||
28086284|NCT00320801|54739838|FG000|Open-label Run-in Period|Lack of Efficacy|44|||
28086285|NCT00320801|54739839|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
28086286|NCT00320801|54739840|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
28086287|NCT00320801|54739841|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
28086288|NCT00320801|54739838|FG000|Open-label Run-in Period|Lost to Follow-up|2|||
28086289|NCT00320801|54739839|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
28086290|NCT00320801|54739840|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
28086291|NCT00320801|54739841|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
28086292|NCT00320801|54739838|FG000|Open-label Run-in Period|Did not qualify|1|||
28086293|NCT00320801|54739839|FG001|Open-label Run-in Period|Did not qualify|0|||
28086294|NCT00320801|54739840|FG002|Open-label Run-in Period|Did not qualify|0|||
28086295|NCT00320801|54739841|FG003|Open-label Run-in Period|Did not qualify|0|||
28086296|NCT00320801|54739838|FG000|Double-blind Phase|Withdrawal by Subject|0|||
28086297|NCT00320801|54739839|FG001|Double-blind Phase|Withdrawal by Subject|0|||
28086298|NCT00320801|54739840|FG002|Double-blind Phase|Withdrawal by Subject|1|||
28086299|NCT00320801|54739841|FG003|Double-blind Phase|Withdrawal by Subject|0|||
28086300|NCT00320801|54739838|FG000|Double-blind Phase|Adverse Event|0|||
28086301|NCT00320801|54739839|FG001|Double-blind Phase|Adverse Event|2|||
28165415|NCT01066819|54836080|FG001|Overall Study|Early termination|0|||
27974411|NCT00713830|54632019|FG001|Overall Study|Withdrawal by Subject|23|||
27974412|NCT00713830|54632018|FG000|Overall Study|Poor Compliance to Protocol|7|||
28086302|NCT00320801|54739840|FG002|Double-blind Phase|Adverse Event|8|||
27974413|NCT00713830|54632019|FG001|Overall Study|Poor Compliance to Protocol|14|||
28086303|NCT00320801|54739841|FG003|Double-blind Phase|Adverse Event|0|||
27974414|NCT00713830|54632018|FG000|Overall Study|Familial and Personal Reasons|9|||
28086304|NCT00320801|54739838|FG000|Double-blind Phase|Administrative|0|||
28086305|NCT00320801|54739839|FG001|Double-blind Phase|Administrative|0|||
28086306|NCT00320801|54739840|FG002|Double-blind Phase|Administrative|4|||
27974415|NCT00713830|54632019|FG001|Overall Study|Familial and Personal Reasons|34|||
27974416|NCT00713830|54632018|FG000|Overall Study|Sponsor Decision|4|||
27974417|NCT00713830|54632019|FG001|Overall Study|Sponsor Decision|10|||
27974418|NCT00681811|54632027|FG000|Overall Study|Adverse Event|1|||
27974419|NCT00681811|54632028|FG001|Overall Study|Adverse Event|1|||
27974420|NCT00681811|54632027|FG000|Overall Study|Withdrawal by Subject|2|||
27974421|NCT00681811|54632028|FG001|Overall Study|Withdrawal by Subject|2|||
27974422|NCT00681811|54632027|FG000|Overall Study|Non-compliance|0|||
27974423|NCT00681811|54632028|FG001|Overall Study|Non-compliance|1|||
27974424|NCT00681187|54632047|FG000|Overall Study|Withdrawal by Subject|1|||
27974425|NCT00681187|54632048|FG001|Overall Study|Withdrawal by Subject|0|||
27974426|NCT00681187|54632047|FG000|Overall Study|Death|0|||
27974427|NCT00681187|54632048|FG001|Overall Study|Death|1|||
27974428|NCT00681187|54632047|FG000|Overall Study|Adverse Event|0|||
27974429|NCT00681187|54632048|FG001|Overall Study|Adverse Event|1|||
27974430|NCT00681109|54632070|FG000|Overall Study|Lost to Follow-up|2|||
27974431|NCT00681109|54632071|FG001|Overall Study|Lost to Follow-up|6|||
27733134|NCT01358864|54180881|FG000|Overall Study|Lack of Efficacy|26|||
27733135|NCT01358864|54180882|FG001|Overall Study|Lack of Efficacy|3|||
27733136|NCT01358864|54180883|FG002|Overall Study|Lack of Efficacy|4|||
27733137|NCT01358864|54180884|FG003|Overall Study|Lack of Efficacy|19|||
27733138|NCT01358864|54180885|FG004|Overall Study|Lack of Efficacy|7|||
27974432|NCT00681109|54632072|FG002|Overall Study|Lost to Follow-up|0|||
27974433|NCT00680407|54632086|FG000|Overall Study|Lost to Follow-up|3|||
27974434|NCT00680407|54632087|FG001|Overall Study|Lost to Follow-up|3|||
27974435|NCT00680407|54632088|FG002|Overall Study|Lost to Follow-up|1|||
27974436|NCT00680407|54632086|FG000|Overall Study|Withdrawal by Subject|5|||
27974437|NCT00680407|54632087|FG001|Overall Study|Withdrawal by Subject|2|||
27974438|NCT00680407|54632088|FG002|Overall Study|Withdrawal by Subject|2|||
27974439|NCT00677365|54632100|FG000|Overall Study|Adverse Event|2|||
27974440|NCT00677365|54632101|FG001|Overall Study|Adverse Event|1|||
27974441|NCT00677365|54632102|FG002|Overall Study|Adverse Event|1|||
27974442|NCT00677365|54632103|FG003|Overall Study|Adverse Event|2|||
27974443|NCT00677365|54632100|FG000|Overall Study|Withdrawal by Subject|0|||
27974444|NCT00677365|54632101|FG001|Overall Study|Withdrawal by Subject|0|||
27974445|NCT00677365|54632102|FG002|Overall Study|Withdrawal by Subject|1|||
27974446|NCT00677365|54632103|FG003|Overall Study|Withdrawal by Subject|0|||
27974447|NCT00677365|54632100|FG000|Overall Study|Other reason|0|||
27974448|NCT00677365|54632101|FG001|Overall Study|Other reason|0|||
27974449|NCT00677365|54632102|FG002|Overall Study|Other reason|0|||
27974450|NCT00677365|54632103|FG003|Overall Study|Other reason|1|||
27974451|NCT00680017|54632115|FG000|Overall Study|Adverse Event|13|||
27974452|NCT00680017|54632116|FG001|Overall Study|Adverse Event|7|||
27974453|NCT00680017|54632115|FG000|Overall Study|Withdrawal by Subject|2|||
27974454|NCT00680017|54632116|FG001|Overall Study|Withdrawal by Subject|5|||
27974455|NCT00680017|54632115|FG000|Overall Study|Lost to Follow-up|2|||
27974456|NCT00680017|54632116|FG001|Overall Study|Lost to Follow-up|0|||
27974457|NCT00676663|54632124|FG000|Overall Study|Death|43|||
27974458|NCT00676663|54632125|FG001|Overall Study|Death|27|||
27974459|NCT00676663|54632124|FG000|Overall Study|Withdrew Consent|1|||
27974460|NCT00676663|54632125|FG001|Overall Study|Withdrew Consent|8|||
27974461|NCT00676663|54632124|FG000|Overall Study|Lost to Follow-up|1|||
27974462|NCT00676663|54632125|FG001|Overall Study|Lost to Follow-up|3|||
27974463|NCT00678691|54632135|FG000|Overall Study|Adverse Event|6|||
27974464|NCT00678691|54632136|FG001|Overall Study|Adverse Event|4|||
27974465|NCT00679939|54632144|FG000|52-Week Double-Blind (DB) Period|Withdrew Consent|17|||
28086307|NCT00320801|54739841|FG003|Double-blind Phase|Administrative|0|||
28086308|NCT00320801|54739838|FG000|Double-blind Phase|Lack of Efficacy|0|||
28086309|NCT00320801|54739839|FG001|Double-blind Phase|Lack of Efficacy|9|||
28086310|NCT00320801|54739840|FG002|Double-blind Phase|Lack of Efficacy|1|||
28086311|NCT00320801|54739841|FG003|Double-blind Phase|Lack of Efficacy|0|||
28086312|NCT00320801|54739838|FG000|Extension Phase|Withdrawal by Subject|0|||
28086313|NCT00320801|54739839|FG001|Extension Phase|Withdrawal by Subject|0|||
28086314|NCT00320801|54739840|FG002|Extension Phase|Withdrawal by Subject|0|||
28086315|NCT00320801|54739841|FG003|Extension Phase|Withdrawal by Subject|6|||
28086316|NCT00320801|54739838|FG000|Extension Phase|Adverse Event|0|||
27974466|NCT00679939|54632145|FG001|52-Week Double-Blind (DB) Period|Withdrew Consent|13|||
27974467|NCT00679939|54632144|FG000|52-Week Double-Blind (DB) Period|Adverse Event|14|||
27974468|NCT00679939|54632145|FG001|52-Week Double-Blind (DB) Period|Adverse Event|12|||
28086317|NCT00320801|54739839|FG001|Extension Phase|Adverse Event|0|||
28165416|NCT01066819|54836081|FG002|Overall Study|Early termination|0|||
27733139|NCT01358864|54180886|FG005|Overall Study|Lack of Efficacy|4|||
27974469|NCT00679939|54632144|FG000|52-Week Double-Blind (DB) Period|Investigator Discretion|5|||
27974470|NCT00679939|54632145|FG001|52-Week Double-Blind (DB) Period|Investigator Discretion|0|||
27974471|NCT00679939|54632144|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|1|||
28086318|NCT00320801|54739840|FG002|Extension Phase|Adverse Event|0|||
28086319|NCT00320801|54739841|FG003|Extension Phase|Adverse Event|8|||
28086320|NCT00320801|54739838|FG000|Extension Phase|Administrative|0|||
28086321|NCT00320801|54739839|FG001|Extension Phase|Administrative|0|||
28086322|NCT00320801|54739840|FG002|Extension Phase|Administrative|0|||
28086323|NCT00320801|54739841|FG003|Extension Phase|Administrative|29|||
28086324|NCT00320801|54739838|FG000|Extension Phase|Lack of Efficacy|0|||
28086325|NCT00320801|54739839|FG001|Extension Phase|Lack of Efficacy|0|||
28086326|NCT00320801|54739840|FG002|Extension Phase|Lack of Efficacy|0|||
28086327|NCT00320801|54739841|FG003|Extension Phase|Lack of Efficacy|2|||
28086328|NCT00320801|54739838|FG000|Extension Phase|Lost to Follow-up|0|||
27974472|NCT00679939|54632145|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
27974473|NCT00679939|54632144|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
27974474|NCT00679939|54632145|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|2|||
27974475|NCT00679939|54632144|FG000|24-Week Open-Label (OL) Period|Adverse Event|0|||
27974476|NCT00679939|54632145|FG001|24-Week Open-Label (OL) Period|Adverse Event|1|||
27974477|NCT00679939|54632144|FG000|24-Week Open-Label (OL) Period|Protocol Violation|1|||
27974478|NCT00679939|54632145|FG001|24-Week Open-Label (OL) Period|Protocol Violation|1|||
27974479|NCT00679939|54632144|FG000|24-Week Open-Label (OL) Period|Met Stopping Criteria|3|||
27974480|NCT00679939|54632145|FG001|24-Week Open-Label (OL) Period|Met Stopping Criteria|1|||
27974481|NCT00679939|54632144|FG000|24-Week Open-Label (OL) Period|Physician Decision|1|||
27974482|NCT00679939|54632145|FG001|24-Week Open-Label (OL) Period|Physician Decision|0|||
27974483|NCT00679939|54632144|FG000|24-Week Open-Label (OL) Period|Withdrawal by Subject|2|||
27974484|NCT00679939|54632145|FG001|24-Week Open-Label (OL) Period|Withdrawal by Subject|1|||
27974485|NCT00673933|54632155|FG000|Overall Study|Withdrawal by Subject|2|||
27974486|NCT00673933|54632155|FG000|Overall Study|Lost to Follow-up|1|||
27974487|NCT00571519|54632168|FG000|Overall Study|Subject withdrew consent|0|||
27974488|NCT00571519|54632169|FG001|Overall Study|Subject withdrew consent|1|||
27974489|NCT00571519|54632170|FG002|Overall Study|Subject withdrew consent|0|||
27974490|NCT00571519|54632171|FG003|Overall Study|Subject withdrew consent|2|||
27974491|NCT00571519|54632172|FG004|Overall Study|Subject withdrew consent|1|||
27974492|NCT00571519|54632173|FG005|Overall Study|Subject withdrew consent|1|||
27974493|NCT00571519|54632174|FG006|Overall Study|Subject withdrew consent|2|||
27974494|NCT00571519|54632168|FG000|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
27974495|NCT00571519|54632169|FG001|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
27974496|NCT00571519|54632170|FG002|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
27974497|NCT00571519|54632171|FG003|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
27974498|NCT00571519|54632172|FG004|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
27974499|NCT00571519|54632173|FG005|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
27974500|NCT00571519|54632174|FG006|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
27974501|NCT00571519|54632168|FG000|Overall Study|Therapeutic failure/lack of efficacy|0|||
27974502|NCT00571519|54632169|FG001|Overall Study|Therapeutic failure/lack of efficacy|1|||
27974503|NCT00571519|54632170|FG002|Overall Study|Therapeutic failure/lack of efficacy|0|||
27974504|NCT00571519|54632171|FG003|Overall Study|Therapeutic failure/lack of efficacy|0|||
27974505|NCT00571519|54632172|FG004|Overall Study|Therapeutic failure/lack of efficacy|0|||
27974506|NCT00571519|54632173|FG005|Overall Study|Therapeutic failure/lack of efficacy|0|||
27974507|NCT00571519|54632174|FG006|Overall Study|Therapeutic failure/lack of efficacy|0|||
27974508|NCT00571519|54632168|FG000|Overall Study|Termination of study by Sponsor|2|||
27974509|NCT00571519|54632169|FG001|Overall Study|Termination of study by Sponsor|7|||
27974510|NCT00571519|54632170|FG002|Overall Study|Termination of study by Sponsor|10|||
27974511|NCT00571519|54632171|FG003|Overall Study|Termination of study by Sponsor|24|||
27974512|NCT00571519|54632172|FG004|Overall Study|Termination of study by Sponsor|8|||
27974513|NCT00571519|54632173|FG005|Overall Study|Termination of study by Sponsor|9|||
27974514|NCT00571519|54632174|FG006|Overall Study|Termination of study by Sponsor|22|||
27974515|NCT00571519|54632168|FG000|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
27974516|NCT00571519|54632169|FG001|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
27974517|NCT00571519|54632170|FG002|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1|||
27974518|NCT00571519|54632171|FG003|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
27974519|NCT00571519|54632172|FG004|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
27974520|NCT00571519|54632173|FG005|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
28086329|NCT00320801|54739839|FG001|Extension Phase|Lost to Follow-up|0|||
28086330|NCT00320801|54739840|FG002|Extension Phase|Lost to Follow-up|0|||
28086331|NCT00320801|54739841|FG003|Extension Phase|Lost to Follow-up|3|||
28086332|NCT00320489|54739853|FG000|Overall Study|Adverse Event|26|||
28086333|NCT00320489|54739854|FG001|Overall Study|Adverse Event|25|||
28086334|NCT00320489|54739853|FG000|Overall Study|Clinical Relapse|26|||
28086335|NCT00320489|54739854|FG001|Overall Study|Clinical Relapse|20|||
28086336|NCT00320489|54739853|FG000|Overall Study|Death|0|||
28086337|NCT00320489|54739854|FG001|Overall Study|Death|2|||
28086338|NCT00320489|54739853|FG000|Overall Study|Entry Criteria Exclusion|2|||
28165417|NCT01066819|54836082|FG003|Overall Study|Early termination|0|||
28086339|NCT00320489|54739854|FG001|Overall Study|Entry Criteria Exclusion|4|||
28086340|NCT00320489|54739853|FG000|Overall Study|Lack of Efficacy|16|||
28086341|NCT00320489|54739854|FG001|Overall Study|Lack of Efficacy|7|||
28086342|NCT00320489|54739853|FG000|Overall Study|Lost to Follow-up|21|||
28086343|NCT00320489|54739854|FG001|Overall Study|Lost to Follow-up|22|||
28086344|NCT00320489|54739853|FG000|Overall Study|Physician Decision|8|||
28086345|NCT00320489|54739854|FG001|Overall Study|Physician Decision|8|||
28086346|NCT00320489|54739853|FG000|Overall Study|Protocol Violation|4|||
28086347|NCT00320489|54739854|FG001|Overall Study|Protocol Violation|4|||
28086348|NCT00320489|54739853|FG000|Overall Study|Sponsor Decision|3|||
28086349|NCT00320489|54739854|FG001|Overall Study|Sponsor Decision|3|||
28086350|NCT00320489|54739853|FG000|Overall Study|Withdrawal by Subject|39|||
28086351|NCT00320489|54739854|FG001|Overall Study|Withdrawal by Subject|41|||
28086352|NCT03928028|54739863|FG000|Overall Study|Physician Decision|9|||
28086353|NCT03928028|54739864|FG001|Overall Study|Physician Decision|6|||
28086354|NCT03928028|54739865|FG002|Overall Study|Physician Decision|3|||
28086355|NCT03928028|54739863|FG000|Overall Study|Withdrawal by Subject|12|||
27974521|NCT00571519|54632174|FG006|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
27974522|NCT00676195|54632190|FG000|Overall Study|Lost to Follow-up|1|||
27974523|NCT00676195|54632190|FG000|Overall Study|Adverse Event|1|||
27974524|NCT00676195|54632190|FG000|Overall Study|Physician Decision|1|||
27974525|NCT00675103|54632195|FG000|Overall Study|Lack of Efficacy|2|||
27974526|NCT00675103|54632195|FG000|Overall Study|Adverse Event|1|||
28086356|NCT03928028|54739864|FG001|Overall Study|Withdrawal by Subject|3|||
28086357|NCT03928028|54739865|FG002|Overall Study|Withdrawal by Subject|3|||
28086358|NCT00320411|54739873|FG000|Overall Study|No investigational product admin.|4|||
28086359|NCT00320255|54739883|FG000|Overall Study|Lack of Efficacy|1|||
28086360|NCT00320255|54739884|FG001|Overall Study|Lack of Efficacy|0|||
28086361|NCT00320255|54739885|FG002|Overall Study|Lack of Efficacy|0|||
28086362|NCT00320255|54739886|FG003|Overall Study|Lack of Efficacy|0|||
28086363|NCT00320255|54739887|FG004|Overall Study|Lack of Efficacy|0|||
28086364|NCT00320255|54739888|FG005|Overall Study|Lack of Efficacy|0|||
28086365|NCT00320255|54739883|FG000|Overall Study|Adverse Event|5|||
28086366|NCT00320255|54739884|FG001|Overall Study|Adverse Event|2|||
28086367|NCT00320255|54739885|FG002|Overall Study|Adverse Event|3|||
28086368|NCT00320255|54739886|FG003|Overall Study|Adverse Event|2|||
28086369|NCT00320255|54739887|FG004|Overall Study|Adverse Event|0|||
28086370|NCT00320255|54739888|FG005|Overall Study|Adverse Event|0|||
28086371|NCT00320255|54739883|FG000|Overall Study|Withdrawal by Subject|1|||
28086372|NCT00320255|54739884|FG001|Overall Study|Withdrawal by Subject|2|||
28086373|NCT00320255|54739885|FG002|Overall Study|Withdrawal by Subject|2|||
28086374|NCT00320255|54739886|FG003|Overall Study|Withdrawal by Subject|4|||
28086375|NCT00320255|54739887|FG004|Overall Study|Withdrawal by Subject|0|||
28086376|NCT00320255|54739888|FG005|Overall Study|Withdrawal by Subject|0|||
28086377|NCT00320255|54739883|FG000|Overall Study|Poor compliance/noncompliance|1|||
28086378|NCT00320255|54739884|FG001|Overall Study|Poor compliance/noncompliance|1|||
28086379|NCT00320255|54739885|FG002|Overall Study|Poor compliance/noncompliance|0|||
28086380|NCT00320255|54739886|FG003|Overall Study|Poor compliance/noncompliance|1|||
28086381|NCT00320255|54739887|FG004|Overall Study|Poor compliance/noncompliance|0|||
28086382|NCT00320255|54739888|FG005|Overall Study|Poor compliance/noncompliance|0|||
28086383|NCT00320255|54739883|FG000|Overall Study|No longer meets study criteria|0|||
28086384|NCT00320255|54739884|FG001|Overall Study|No longer meets study criteria|0|||
28086385|NCT00320255|54739885|FG002|Overall Study|No longer meets study criteria|0|||
28086386|NCT00320255|54739886|FG003|Overall Study|No longer meets study criteria|1|||
28086387|NCT00320255|54739887|FG004|Overall Study|No longer meets study criteria|0|||
28086388|NCT00320255|54739888|FG005|Overall Study|No longer meets study criteria|0|||
28086389|NCT00320255|54739883|FG000|Overall Study|Other|3|||
28086390|NCT00320255|54739884|FG001|Overall Study|Other|2|||
28086391|NCT00320255|54739885|FG002|Overall Study|Other|1|||
28086392|NCT00320255|54739886|FG003|Overall Study|Other|0|||
28086393|NCT00320255|54739887|FG004|Overall Study|Other|0|||
28086394|NCT00320255|54739888|FG005|Overall Study|Other|0|||
28086395|NCT00370331|54739905|FG000|Overall Study|Adverse Event|4|||
28086396|NCT00370331|54739906|FG001|Overall Study|Adverse Event|13|||
28086397|NCT00370331|54739905|FG000|Overall Study|Withdrawal by Subject|2|||
28086398|NCT00370331|54739906|FG001|Overall Study|Withdrawal by Subject|4|||
28086399|NCT00370331|54739905|FG000|Overall Study|Lost to Follow-up|0|||
28086400|NCT00370331|54739906|FG001|Overall Study|Lost to Follow-up|3|||
28086401|NCT00370331|54739905|FG000|Overall Study|Lack of Efficacy|0|||
28086402|NCT00370331|54739906|FG001|Overall Study|Lack of Efficacy|1|||
28086403|NCT00370331|54739905|FG000|Overall Study|Non-compliance|0|||
28165418|NCT01066819|54836083|FG004|Overall Study|Early termination|0|||
27855570|NCT02834247|54380600|FG002|Dose Escalation Phase|Lost to Follow-up|0|||
28086404|NCT00370331|54739906|FG001|Overall Study|Non-compliance|1|||
28086405|NCT00370331|54739905|FG000|Overall Study|Protocol Violation|1|||
28086406|NCT00370331|54739906|FG001|Overall Study|Protocol Violation|1|||
28086407|NCT02962960|54739915|FG000|Overall Study|Withdrawal by Subject|1|||
28165419|NCT01066819|54836084|FG005|Overall Study|Early termination|0|||
27974527|NCT00675025|54632201|FG000|Overall Study|Study Terminated by Sponsor|38|||
27974528|NCT00675025|54632202|FG001|Overall Study|Study Terminated by Sponsor|42|||
27974529|NCT00675025|54632201|FG000|Overall Study|Adverse Event|6|||
27974530|NCT00675025|54632202|FG001|Overall Study|Adverse Event|11|||
27974531|NCT00675025|54632201|FG000|Overall Study|Lost to Follow-up|6|||
27974532|NCT00675025|54632202|FG001|Overall Study|Lost to Follow-up|4|||
27974533|NCT00675025|54632201|FG000|Overall Study|Withdrawal by Subject|4|||
27974534|NCT00675025|54632202|FG001|Overall Study|Withdrawal by Subject|6|||
27974535|NCT00678379|54632220|FG000|Overall Study|Injection performed after tonsillectomy|2|||
27974536|NCT00678379|54632221|FG001|Overall Study|Injection performed after tonsillectomy|0|||
27974537|NCT00678379|54632222|FG002|Overall Study|Injection performed after tonsillectomy|1|||
27974538|NCT00678379|54632220|FG000|Overall Study|Incomplete Data|4|||
27974539|NCT00678379|54632221|FG001|Overall Study|Incomplete Data|3|||
27974540|NCT00678379|54632222|FG002|Overall Study|Incomplete Data|3|||
27974541|NCT00674323|54632233|FG000|Overall Study|Adverse Event|0|||
27974542|NCT00674323|54632234|FG001|Overall Study|Adverse Event|1|||
27974543|NCT00674323|54632235|FG002|Overall Study|Adverse Event|0|||
27974544|NCT00674323|54632233|FG000|Overall Study|Protocol Violation|1|||
27974545|NCT00674323|54632234|FG001|Overall Study|Protocol Violation|0|||
28086408|NCT02962960|54739916|FG001|Overall Study|Withdrawal by Subject|1|||
28086409|NCT02962960|54739917|FG002|Overall Study|Withdrawal by Subject|0|||
28086410|NCT02962960|54739915|FG000|Overall Study|Adverse Event|1|||
27974546|NCT00674323|54632235|FG002|Overall Study|Protocol Violation|0|||
27974547|NCT00678301|54632245|FG000|Overall Study|Non-compliance with study procedures|0|||
27974548|NCT00678301|54632246|FG001|Overall Study|Non-compliance with study procedures|1|||
27974549|NCT00678301|54632245|FG000|Overall Study|Adverse Event|1|||
27974550|NCT00678301|54632246|FG001|Overall Study|Adverse Event|0|||
27974551|NCT00678301|54632245|FG000|Overall Study|Withdrawal by Subject|4|||
28086411|NCT02962960|54739916|FG001|Overall Study|Adverse Event|1|||
28086412|NCT02962960|54739917|FG002|Overall Study|Adverse Event|0|||
28086413|NCT02962960|54739915|FG000|Overall Study|Protocol Violation|1|||
28086414|NCT02962960|54739916|FG001|Overall Study|Protocol Violation|0|||
28086415|NCT02962960|54739917|FG002|Overall Study|Protocol Violation|0|||
28086416|NCT00369941|54739929|FG000|Overall Study|Never Treated|1|||
28086417|NCT00369941|54739930|FG001|Overall Study|Never Treated|2|||
28086418|NCT00369941|54739929|FG000|Overall Study|Adverse Event|14|||
28086419|NCT00369941|54739930|FG001|Overall Study|Adverse Event|28|||
28086420|NCT00369941|54739929|FG000|Overall Study|Lack of Efficacy|6|||
28086421|NCT00369941|54739930|FG001|Overall Study|Lack of Efficacy|10|||
28086422|NCT00369941|54739929|FG000|Overall Study|Lost to Follow-up|12|||
27733140|NCT01358864|54180887|FG006|Overall Study|Lack of Efficacy|49|||
27974552|NCT00678301|54632246|FG001|Overall Study|Withdrawal by Subject|0|||
27974553|NCT00678301|54632245|FG000|Overall Study|Lost to Follow-up|3|||
27974554|NCT00678301|54632246|FG001|Overall Study|Lost to Follow-up|1|||
27974555|NCT00939770|54632260|FG000|Overall Study|Adverse Event|1|||
27974556|NCT00939770|54632261|FG001|Overall Study|Adverse Event|1|||
27974557|NCT00939770|54632262|FG002|Overall Study|Adverse Event|0|||
27974558|NCT00939770|54632263|FG003|Overall Study|Adverse Event|0|||
27974559|NCT00939770|54632264|FG004|Overall Study|Adverse Event|6|||
27974560|NCT00939770|54632265|FG005|Overall Study|Adverse Event|2|||
27974561|NCT00939770|54632266|FG006|Overall Study|Adverse Event|1|||
27974562|NCT00939770|54632267|FG007|Overall Study|Adverse Event|1|||
27974563|NCT00939770|54632260|FG000|Overall Study|Lack of Efficacy|4|||
27974564|NCT00939770|54632261|FG001|Overall Study|Lack of Efficacy|6|||
27974565|NCT00939770|54632262|FG002|Overall Study|Lack of Efficacy|13|||
27974566|NCT00939770|54632263|FG003|Overall Study|Lack of Efficacy|9|||
27974567|NCT00939770|54632264|FG004|Overall Study|Lack of Efficacy|16|||
27974568|NCT00939770|54632265|FG005|Overall Study|Lack of Efficacy|8|||
27974569|NCT00939770|54632266|FG006|Overall Study|Lack of Efficacy|11|||
27974570|NCT00939770|54632267|FG007|Overall Study|Lack of Efficacy|1|||
27974571|NCT00939770|54632260|FG000|Overall Study|Lost to Follow-up|0|||
27974572|NCT00939770|54632261|FG001|Overall Study|Lost to Follow-up|0|||
27974573|NCT00939770|54632262|FG002|Overall Study|Lost to Follow-up|0|||
27974574|NCT00939770|54632263|FG003|Overall Study|Lost to Follow-up|0|||
27974575|NCT00939770|54632264|FG004|Overall Study|Lost to Follow-up|1|||
27974576|NCT00939770|54632265|FG005|Overall Study|Lost to Follow-up|0|||
27974577|NCT00939770|54632266|FG006|Overall Study|Lost to Follow-up|0|||
27974578|NCT00939770|54632267|FG007|Overall Study|Lost to Follow-up|0|||
27974579|NCT00939770|54632260|FG000|Overall Study|Physician Decision|0|||
27974580|NCT00939770|54632261|FG001|Overall Study|Physician Decision|0|||
27974581|NCT00939770|54632262|FG002|Overall Study|Physician Decision|2|||
27974582|NCT00939770|54632263|FG003|Overall Study|Physician Decision|0|||
28086423|NCT00369941|54739930|FG001|Overall Study|Lost to Follow-up|22|||
28086424|NCT00369941|54739929|FG000|Overall Study|Protocol Violation|5|||
28086425|NCT00369941|54739930|FG001|Overall Study|Protocol Violation|3|||
28086426|NCT00369941|54739929|FG000|Overall Study|Withdrawal by Subject|5|||
27974583|NCT00939770|54632264|FG004|Overall Study|Physician Decision|7|||
27974584|NCT00939770|54632265|FG005|Overall Study|Physician Decision|1|||
27974585|NCT00939770|54632266|FG006|Overall Study|Physician Decision|0|||
27974586|NCT00939770|54632267|FG007|Overall Study|Physician Decision|6|||
27974587|NCT00939770|54632260|FG000|Overall Study|Protocol Violation|0|||
27974588|NCT00939770|54632261|FG001|Overall Study|Protocol Violation|0|||
27974589|NCT00939770|54632262|FG002|Overall Study|Protocol Violation|0|||
27974590|NCT00939770|54632263|FG003|Overall Study|Protocol Violation|0|||
27974591|NCT00939770|54632264|FG004|Overall Study|Protocol Violation|1|||
27974592|NCT00939770|54632265|FG005|Overall Study|Protocol Violation|0|||
27974593|NCT00939770|54632266|FG006|Overall Study|Protocol Violation|0|||
27974594|NCT00939770|54632267|FG007|Overall Study|Protocol Violation|0|||
27974595|NCT00939770|54632260|FG000|Overall Study|Withdrawal by Subject|0|||
27974596|NCT00939770|54632261|FG001|Overall Study|Withdrawal by Subject|1|||
27974597|NCT00939770|54632262|FG002|Overall Study|Withdrawal by Subject|5|||
27974598|NCT00939770|54632263|FG003|Overall Study|Withdrawal by Subject|2|||
27974599|NCT00939770|54632264|FG004|Overall Study|Withdrawal by Subject|6|||
27974600|NCT00939770|54632265|FG005|Overall Study|Withdrawal by Subject|0|||
27974601|NCT00939770|54632266|FG006|Overall Study|Withdrawal by Subject|2|||
27974602|NCT00939770|54632267|FG007|Overall Study|Withdrawal by Subject|2|||
27974603|NCT00939692|54632300|FG000|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1|||
27974604|NCT00939692|54632301|FG001|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0|||
27974605|NCT00939692|54632300|FG000|Period 2 - Second Intervent - 5 Days|Protocol Violation|0|||
27974606|NCT00939692|54632301|FG001|Period 2 - Second Intervent - 5 Days|Protocol Violation|1|||
27974607|NCT04672252|54632309|FG000|Overall Study|Protocol Violation|1|||
27974608|NCT04672252|54632310|FG001|Overall Study|Protocol Violation|0|||
27974609|NCT00584740|54632318|FG000|Overall Study|Adverse Event|1|||
27974610|NCT00584740|54632319|FG001|Overall Study|Adverse Event|1|||
27974611|NCT00584740|54632318|FG000|Overall Study|Lack of Efficacy|8|||
27974612|NCT00584740|54632319|FG001|Overall Study|Lack of Efficacy|2|||
27974613|NCT00584740|54632318|FG000|Overall Study|Withdrawal by Subject|3|||
27974614|NCT00584740|54632319|FG001|Overall Study|Withdrawal by Subject|2|||
27974615|NCT00584740|54632318|FG000|Overall Study|Lost to Follow-up|0|||
27974616|NCT00584740|54632319|FG001|Overall Study|Lost to Follow-up|1|||
27974617|NCT00942968|54632325|FG000|Overall Study|Adverse Event|60|||
27974618|NCT00942968|54632325|FG000|Overall Study|Death|76|||
27974619|NCT00942968|54632325|FG000|Overall Study|Protocol Violation|9|||
27974620|NCT00942968|54632325|FG000|Overall Study|Lost to Follow-up|4|||
27974621|NCT00942968|54632325|FG000|Overall Study|Withdrawal by Subject|44|||
27974622|NCT00942968|54632325|FG000|Overall Study|Sponsor request|5|||
27974623|NCT00942968|54632325|FG000|Overall Study|Physician Decision|11|||
27974624|NCT00942968|54632325|FG000|Overall Study|Progression of disease|12|||
27974625|NCT00942968|54632325|FG000|Overall Study|Inferior vena cava filter placement|4|||
27974626|NCT00942968|54632325|FG000|Overall Study|Pulmonary embolism (PE)|1|||
27974627|NCT00942968|54632325|FG000|Overall Study|Participant required pancreatic biopsy|1|||
27974628|NCT00942968|54632325|FG000|Overall Study|Deep vein thrombosis (DVT)|2|||
27974629|NCT00942734|54632329|FG000|Overall Study|Adverse Event|2|||
27974630|NCT00942734|54632329|FG000|Overall Study|Protocol Violation|3|||
27974631|NCT00942734|54632329|FG000|Overall Study|Disease Progression|2|||
27974632|NCT00942734|54632329|FG000|Overall Study|Physician Decision|1|||
27974633|NCT00584194|54632333|FG000|Overall Study|Other|135|||
27974634|NCT00942422|54632337|FG000|Overall Study|Withdrawal by Subject|1|||
27974635|NCT00942422|54632337|FG000|Overall Study|Death|1|||
27974636|NCT00942422|54632337|FG000|Overall Study|Progressive diease|1|||
27974637|NCT00677833|54632345|FG000|Overall Study|Withdrawal by Subject|4|||
27974638|NCT00677833|54632346|FG001|Overall Study|Withdrawal by Subject|0|||
27974639|NCT00677833|54632347|FG002|Overall Study|Withdrawal by Subject|1|||
27974640|NCT00677833|54632348|FG003|Overall Study|Withdrawal by Subject|3|||
27974641|NCT00677833|54632345|FG000|Overall Study|Lost to Follow-up|0|||
27974642|NCT00677833|54632346|FG001|Overall Study|Lost to Follow-up|0|||
27974643|NCT00677833|54632347|FG002|Overall Study|Lost to Follow-up|1|||
27974644|NCT00677833|54632348|FG003|Overall Study|Lost to Follow-up|0|||
27974645|NCT00942266|54632358|FG000|Overall Study|Withdrawal by Subject|1|||
27974646|NCT00942266|54632359|FG001|Overall Study|Withdrawal by Subject|0|||
28086427|NCT00369941|54739930|FG001|Overall Study|Withdrawal by Subject|18|||
28086428|NCT00369941|54739929|FG000|Overall Study|Pregnancy|4|||
27733141|NCT01358864|54180888|FG007|Overall Study|Lack of Efficacy|44|||
27974647|NCT00942266|54632358|FG000|Overall Study|Adverse Event|2|||
27974648|NCT00942266|54632359|FG001|Overall Study|Adverse Event|1|||
27974649|NCT00942266|54632358|FG000|Overall Study|Disease Progression|38|||
27974650|NCT00942266|54632359|FG001|Overall Study|Disease Progression|11|||
27974651|NCT00942266|54632358|FG000|Overall Study|Failure to thrive and pt withdrawal|0|||
27974652|NCT00942266|54632359|FG001|Overall Study|Failure to thrive and pt withdrawal|1|||
28086429|NCT00369941|54739930|FG001|Overall Study|Pregnancy|2|||
28086430|NCT00369941|54739929|FG000|Overall Study|Completed, Did Not Enter Extension|5|||
28086431|NCT00369941|54739930|FG001|Overall Study|Completed, Did Not Enter Extension|6|||
28086432|NCT00369941|54739929|FG000|Overall Study|Moved|11|||
27974653|NCT00942266|54632358|FG000|Overall Study|Intercurrent illness|0|||
27974654|NCT00942266|54632359|FG001|Overall Study|Intercurrent illness|1|||
27974655|NCT00942266|54632358|FG000|Overall Study|Physician Decision|2|||
28086433|NCT00369941|54739930|FG001|Overall Study|Moved|5|||
27974656|NCT00942266|54632359|FG001|Overall Study|Physician Decision|0|||
27974657|NCT00942266|54632358|FG000|Overall Study|medical deterioration (pneumonia)|0|||
27974658|NCT00942266|54632359|FG001|Overall Study|medical deterioration (pneumonia)|1|||
27974659|NCT00942188|54632369|FG000|Overall Study|Adverse Event|0|||
27974660|NCT00942188|54632370|FG001|Overall Study|Adverse Event|3|||
27974661|NCT00942188|54632371|FG002|Overall Study|Adverse Event|2|||
27974662|NCT00942188|54632372|FG003|Overall Study|Adverse Event|0|||
27974663|NCT00942188|54632369|FG000|Overall Study|Lack of Efficacy|0|||
27974664|NCT00942188|54632370|FG001|Overall Study|Lack of Efficacy|0|||
27974665|NCT00942188|54632371|FG002|Overall Study|Lack of Efficacy|0|||
27974666|NCT00942188|54632372|FG003|Overall Study|Lack of Efficacy|1|||
27974667|NCT00942188|54632369|FG000|Overall Study|Protocol Violation|1|||
27974668|NCT00942188|54632370|FG001|Overall Study|Protocol Violation|1|||
27974669|NCT00942188|54632371|FG002|Overall Study|Protocol Violation|0|||
27974670|NCT00942188|54632372|FG003|Overall Study|Protocol Violation|0|||
27974671|NCT00942188|54632369|FG000|Overall Study|Lost to Follow-up|2|||
27974672|NCT00942188|54632370|FG001|Overall Study|Lost to Follow-up|1|||
27974673|NCT00942188|54632371|FG002|Overall Study|Lost to Follow-up|2|||
27974674|NCT00942188|54632372|FG003|Overall Study|Lost to Follow-up|0|||
27974675|NCT00942188|54632369|FG000|Overall Study|Withdrawal by Subject|1|||
27974676|NCT00942188|54632370|FG001|Overall Study|Withdrawal by Subject|3|||
27974677|NCT00942188|54632371|FG002|Overall Study|Withdrawal by Subject|4|||
27974678|NCT00942188|54632372|FG003|Overall Study|Withdrawal by Subject|2|||
27974679|NCT00942188|54632369|FG000|Overall Study|Physician Decision|0|||
27974680|NCT00942188|54632370|FG001|Overall Study|Physician Decision|0|||
27974681|NCT00942188|54632371|FG002|Overall Study|Physician Decision|1|||
27974682|NCT00942188|54632372|FG003|Overall Study|Physician Decision|0|||
27974683|NCT00942188|54632369|FG000|Overall Study|Sponsor Decision|0|||
27974684|NCT00942188|54632370|FG001|Overall Study|Sponsor Decision|2|||
27974685|NCT00942188|54632371|FG002|Overall Study|Sponsor Decision|0|||
27974686|NCT00942188|54632372|FG003|Overall Study|Sponsor Decision|1|||
27974687|NCT00673231|54632386|FG000|Overall Study|Withdrawal by Subject|14|||
27974688|NCT00673231|54632387|FG001|Overall Study|Withdrawal by Subject|10|||
27974689|NCT00673231|54632388|FG002|Overall Study|Withdrawal by Subject|8|||
27974690|NCT00673231|54632389|FG003|Overall Study|Withdrawal by Subject|6|||
27974691|NCT00673231|54632386|FG000|Overall Study|Adverse Event|6|||
27974692|NCT00673231|54632387|FG001|Overall Study|Adverse Event|5|||
27974693|NCT00673231|54632388|FG002|Overall Study|Adverse Event|9|||
27974694|NCT00673231|54632389|FG003|Overall Study|Adverse Event|6|||
27974695|NCT00673231|54632386|FG000|Overall Study|Lost to Follow-up|1|||
27974696|NCT00673231|54632387|FG001|Overall Study|Lost to Follow-up|2|||
27974697|NCT00673231|54632388|FG002|Overall Study|Lost to Follow-up|1|||
27974698|NCT00673231|54632389|FG003|Overall Study|Lost to Follow-up|2|||
27974699|NCT00673231|54632386|FG000|Overall Study|Death|0|||
27974700|NCT00673231|54632387|FG001|Overall Study|Death|0|||
27974701|NCT00673231|54632388|FG002|Overall Study|Death|1|||
27974702|NCT00673231|54632389|FG003|Overall Study|Death|0|||
27974703|NCT00673231|54632386|FG000|Overall Study|Study criteria,compliance,safety, other|8|||
27974704|NCT00673231|54632387|FG001|Overall Study|Study criteria,compliance,safety, other|5|||
27733142|NCT01358864|54180881|FG000|Overall Study|Lost to Follow-up|0|||
27974705|NCT00673231|54632388|FG002|Overall Study|Study criteria,compliance,safety, other|7|||
28086434|NCT00369941|54739929|FG000|Overall Study|Treatment with Prohibited Medication|3|||
28086435|NCT00369941|54739930|FG001|Overall Study|Treatment with Prohibited Medication|1|||
28086436|NCT00369941|54739929|FG000|Overall Study|Employment Interfered with Study Visits|1|||
28086437|NCT00369941|54739930|FG001|Overall Study|Employment Interfered with Study Visits|0|||
28086438|NCT00369941|54739929|FG000|Overall Study|Study Site Terminated|2|||
28086439|NCT00369941|54739930|FG001|Overall Study|Study Site Terminated|0|||
28086440|NCT00369941|54739929|FG000|Overall Study|Miscellaneous|3|||
28086441|NCT00369941|54739930|FG001|Overall Study|Miscellaneous|3|||
27974706|NCT00673231|54632389|FG003|Overall Study|Study criteria,compliance,safety, other|4|||
27974707|NCT00672841|54632401|FG000|Overall Study|Comfort care|1|||
27974708|NCT00672841|54632402|FG001|Overall Study|Comfort care|4|||
27974709|NCT00672841|54632401|FG000|Overall Study|icteric specimens|0|||
28086442|NCT00319553|54739939|FG000|Overall Study|Protocol Violation|1|||
28086443|NCT00319553|54739940|FG001|Overall Study|Protocol Violation|2|||
28086444|NCT00319553|54739939|FG000|Overall Study|Lost to Follow-up|2|||
28086445|NCT00319553|54739940|FG001|Overall Study|Lost to Follow-up|1|||
27733143|NCT01358864|54180882|FG001|Overall Study|Lost to Follow-up|0|||
27974710|NCT00672841|54632402|FG001|Overall Study|icteric specimens|3|||
27974711|NCT00672841|54632401|FG000|Overall Study|Antifungal therapy, negative glucan|0|||
27974712|NCT00672841|54632402|FG001|Overall Study|Antifungal therapy, negative glucan|4|||
27974713|NCT00672841|54632401|FG000|Overall Study|Adverse Event|0|||
27974714|NCT00672841|54632402|FG001|Overall Study|Adverse Event|3|||
27974715|NCT00672841|54632401|FG000|Overall Study|Pregnancy|0|||
27974716|NCT00672841|54632402|FG001|Overall Study|Pregnancy|1|||
27974717|NCT00673465|54632411|FG000|Part 1/Period 1 (United States)|Protocol Violation|0|||
27974718|NCT00673465|54632412|FG001|Part 1/Period 1 (United States)|Protocol Violation|0|||
27974719|NCT00673465|54632413|FG002|Part 1/Period 1 (United States)|Protocol Violation|0|||
27974720|NCT00673465|54632414|FG003|Part 1/Period 1 (United States)|Protocol Violation|0|||
27974721|NCT00673465|54632415|FG004|Part 1/Period 1 (United States)|Protocol Violation|1|||
27974722|NCT00673465|54632416|FG005|Part 1/Period 1 (United States)|Protocol Violation|1|||
27974723|NCT00673465|54632417|FG006|Part 1/Period 1 (United States)|Protocol Violation|0|||
27974724|NCT00673465|54632418|FG007|Part 1/Period 1 (United States)|Protocol Violation|0|||
27974725|NCT00673465|54632419|FG008|Part 1/Period 1 (United States)|Protocol Violation|0|||
27974726|NCT00673465|54632420|FG009|Part 1/Period 1 (United States)|Protocol Violation|0|||
28165420|NCT01066819|54836079|FG000|Overall Study|Failed to return|298|||
28165421|NCT01066819|54836080|FG001|Overall Study|Failed to return|107|||
28165422|NCT01066819|54836081|FG002|Overall Study|Failed to return|68|||
28165423|NCT01066819|54836082|FG003|Overall Study|Failed to return|7|||
28165424|NCT01066819|54836083|FG004|Overall Study|Failed to return|2|||
28165425|NCT01066819|54836084|FG005|Overall Study|Failed to return|3|||
28165426|NCT01066819|54836079|FG000|Overall Study|Lab test not done|9|||
28165427|NCT01066819|54836080|FG001|Overall Study|Lab test not done|0|||
27974727|NCT00673465|54632421|FG010|Part 1/Period 1 (United States)|Protocol Violation|0|||
27974728|NCT00673465|54632422|FG011|Part 1/Period 1 (United States)|Protocol Violation|0|||
27974729|NCT00673465|54632411|FG000|Part 1/Period 2 (United States)|Protocol Violation|0|||
27974730|NCT00673465|54632412|FG001|Part 1/Period 2 (United States)|Protocol Violation|0|||
27974731|NCT00673465|54632413|FG002|Part 1/Period 2 (United States)|Protocol Violation|0|||
27974732|NCT00673465|54632414|FG003|Part 1/Period 2 (United States)|Protocol Violation|0|||
27974733|NCT00673465|54632415|FG004|Part 1/Period 2 (United States)|Protocol Violation|1|||
27974734|NCT00673465|54632416|FG005|Part 1/Period 2 (United States)|Protocol Violation|0|||
27974735|NCT00673465|54632417|FG006|Part 1/Period 2 (United States)|Protocol Violation|0|||
27974736|NCT00673465|54632418|FG007|Part 1/Period 2 (United States)|Protocol Violation|0|||
27974737|NCT00673465|54632419|FG008|Part 1/Period 2 (United States)|Protocol Violation|0|||
27974738|NCT00673465|54632420|FG009|Part 1/Period 2 (United States)|Protocol Violation|0|||
27974739|NCT00673465|54632421|FG010|Part 1/Period 2 (United States)|Protocol Violation|0|||
27974740|NCT00673465|54632422|FG011|Part 1/Period 2 (United States)|Protocol Violation|0|||
27974741|NCT00941798|54632432|FG000|Overall Study|Withdrawal by Subject|72|||
27974742|NCT00941798|54632433|FG001|Overall Study|Withdrawal by Subject|74|||
27974743|NCT00941798|54632432|FG000|Overall Study|Adverse Event|43|||
27974744|NCT00941798|54632433|FG001|Overall Study|Adverse Event|23|||
27974745|NCT00941798|54632432|FG000|Overall Study|Lost to Follow-up|29|||
27974746|NCT00941798|54632433|FG001|Overall Study|Lost to Follow-up|23|||
27974747|NCT00941798|54632432|FG000|Overall Study|Protocol Violation|17|||
27974748|NCT00941798|54632433|FG001|Overall Study|Protocol Violation|20|||
27974749|NCT00941798|54632432|FG000|Overall Study|Administrative problems|13|||
27974750|NCT00941798|54632433|FG001|Overall Study|Administrative problems|23|||
27974751|NCT00941798|54632432|FG000|Overall Study|Lack of Efficacy|10|||
27974752|NCT00941798|54632433|FG001|Overall Study|Lack of Efficacy|17|||
27974753|NCT00941798|54632432|FG000|Overall Study|Patient's inability to use device|6|||
27974754|NCT00941798|54632433|FG001|Overall Study|Patient's inability to use device|1|||
27974755|NCT00941798|54632432|FG000|Overall Study|Abnormal test procedure results|3|||
27974756|NCT00941798|54632433|FG001|Overall Study|Abnormal test procedure results|1|||
27974757|NCT00941798|54632432|FG000|Overall Study|Abnormal laboratory values|1|||
27974758|NCT00941798|54632433|FG001|Overall Study|Abnormal laboratory values|2|||
27974759|NCT00941798|54632432|FG000|Overall Study|Death|0|||
27974760|NCT00941798|54632433|FG001|Overall Study|Death|1|||
27974761|NCT00583102|54632439|FG000|Overall Study|Adverse Event|3|||
27974762|NCT05208866|54632447|FG000|Maintenance Treatment Period|Sponsor Termination of Study|1|||
27974763|NCT04745351|54632462|FG000|Overall Study|Death|51|||
27974764|NCT04745351|54632463|FG001|Overall Study|Death|25|||
27974765|NCT04745351|54632462|FG000|Overall Study|Lost to Follow-up|9|||
27974766|NCT04745351|54632463|FG001|Overall Study|Lost to Follow-up|3|||
27974767|NCT04745351|54632462|FG000|Overall Study|Randomized but Never Treated|3|||
27974768|NCT04745351|54632463|FG001|Overall Study|Randomized but Never Treated|3|||
27974769|NCT04745351|54632462|FG000|Overall Study|Adverse Event|4|||
27974770|NCT04745351|54632463|FG001|Overall Study|Adverse Event|0|||
27974771|NCT04745351|54632462|FG000|Overall Study|Withdrew Consent|1|||
27974772|NCT04745351|54632463|FG001|Overall Study|Withdrew Consent|2|||
27974773|NCT04745351|54632462|FG000|Overall Study|Investigator's Discretion|2|||
27974774|NCT04745351|54632463|FG001|Overall Study|Investigator's Discretion|0|||
27974775|NCT04745351|54632462|FG000|Overall Study|Protocol Violation|1|||
27974776|NCT04745351|54632463|FG001|Overall Study|Protocol Violation|0|||
27974777|NCT04576455|54632480|FG000|Overall Study|Ongoing in the Study|122|||
27974778|NCT04576455|54632481|FG001|Overall Study|Ongoing in the Study|135|||
27974779|NCT04576455|54632480|FG000|Overall Study|Death|18|||
27974780|NCT04576455|54632481|FG001|Overall Study|Death|12|||
27974781|NCT04576455|54632480|FG000|Overall Study|Lost to Follow-up|1|||
27974782|NCT04576455|54632481|FG001|Overall Study|Lost to Follow-up|0|||
28165428|NCT01066819|54836081|FG002|Overall Study|Lab test not done|2|||
27974783|NCT04576455|54632480|FG000|Overall Study|Withdrawal by Subject|10|||
27974784|NCT04576455|54632481|FG001|Overall Study|Withdrawal by Subject|5|||
28165429|NCT01066819|54836082|FG003|Overall Study|Lab test not done|1|||
28165430|NCT01066819|54836083|FG004|Overall Study|Lab test not done|0|||
28165431|NCT01066819|54836084|FG005|Overall Study|Lab test not done|0|||
28165432|NCT01066819|54836079|FG000|Overall Study|Miscellaneous|28|||
28165433|NCT01066819|54836080|FG001|Overall Study|Miscellaneous|10|||
28165434|NCT01066819|54836081|FG002|Overall Study|Miscellaneous|18|||
28165435|NCT01066819|54836082|FG003|Overall Study|Miscellaneous|1|||
28165436|NCT01066819|54836083|FG004|Overall Study|Miscellaneous|0|||
28165437|NCT01066819|54836084|FG005|Overall Study|Miscellaneous|0|||
28165438|NCT01066819|54836079|FG000|Overall Study|Non responders|123|||
28165439|NCT01066819|54836080|FG001|Overall Study|Non responders|2|||
28165440|NCT01066819|54836081|FG002|Overall Study|Non responders|7|||
27974785|NCT04427501|54632498|FG000|Overall Study|Death|0|||
27974786|NCT04427501|54632499|FG001|Overall Study|Death|0|||
27974787|NCT04427501|54632500|FG002|Overall Study|Death|0|||
27974788|NCT04427501|54632501|FG003|Overall Study|Death|0|||
27974789|NCT04427501|54632502|FG004|Overall Study|Death|0|||
27974790|NCT04427501|54632503|FG005|Overall Study|Death|15|||
27974791|NCT04427501|54632504|FG006|Overall Study|Death|0|||
27974792|NCT04427501|54632505|FG007|Overall Study|Death|0|||
27974793|NCT04427501|54632506|FG008|Overall Study|Death|0|||
27974794|NCT04427501|54632507|FG009|Overall Study|Death|0|||
27974795|NCT04427501|54632498|FG000|Overall Study|Lost to Follow-up|5|||
27974796|NCT04427501|54632499|FG001|Overall Study|Lost to Follow-up|1|||
27974797|NCT04427501|54632500|FG002|Overall Study|Lost to Follow-up|2|||
27974798|NCT04427501|54632501|FG003|Overall Study|Lost to Follow-up|0|||
27974799|NCT04427501|54632502|FG004|Overall Study|Lost to Follow-up|2|||
27974800|NCT04427501|54632503|FG005|Overall Study|Lost to Follow-up|11|||
27974801|NCT04427501|54632504|FG006|Overall Study|Lost to Follow-up|10|||
27974802|NCT04427501|54632505|FG007|Overall Study|Lost to Follow-up|10|||
27974803|NCT04427501|54632506|FG008|Overall Study|Lost to Follow-up|2|||
27974804|NCT04427501|54632507|FG009|Overall Study|Lost to Follow-up|5|||
27974805|NCT04427501|54632498|FG000|Overall Study|Physician Decision|0|||
27974806|NCT04427501|54632499|FG001|Overall Study|Physician Decision|3|||
27974807|NCT04427501|54632500|FG002|Overall Study|Physician Decision|0|||
27974808|NCT04427501|54632501|FG003|Overall Study|Physician Decision|0|||
27974809|NCT04427501|54632502|FG004|Overall Study|Physician Decision|0|||
27974810|NCT04427501|54632503|FG005|Overall Study|Physician Decision|0|||
27974811|NCT04427501|54632504|FG006|Overall Study|Physician Decision|2|||
27974812|NCT04427501|54632505|FG007|Overall Study|Physician Decision|0|||
27974813|NCT04427501|54632506|FG008|Overall Study|Physician Decision|0|||
27974814|NCT04427501|54632507|FG009|Overall Study|Physician Decision|0|||
27974815|NCT04427501|54632498|FG000|Overall Study|Withdrawal by Subject|9|||
27974816|NCT04427501|54632499|FG001|Overall Study|Withdrawal by Subject|2|||
27974817|NCT04427501|54632500|FG002|Overall Study|Withdrawal by Subject|2|||
27974818|NCT04427501|54632501|FG003|Overall Study|Withdrawal by Subject|3|||
27974819|NCT04427501|54632502|FG004|Overall Study|Withdrawal by Subject|7|||
27974820|NCT04427501|54632503|FG005|Overall Study|Withdrawal by Subject|25|||
27974821|NCT04427501|54632504|FG006|Overall Study|Withdrawal by Subject|15|||
27974822|NCT04427501|54632505|FG007|Overall Study|Withdrawal by Subject|7|||
27974823|NCT04427501|54632506|FG008|Overall Study|Withdrawal by Subject|4|||
27974824|NCT04427501|54632507|FG009|Overall Study|Withdrawal by Subject|1|||
27974825|NCT04427501|54632498|FG000|Overall Study|Other - as reported by the investigator|1|||
28086446|NCT00319553|54739939|FG000|Overall Study|Withdrawal by Subject|1|||
28086447|NCT00319553|54739940|FG001|Overall Study|Withdrawal by Subject|1|||
28086448|NCT00369785|54739948|FG000|Overall Study|Physician Decision|3|||
28086449|NCT00369785|54739949|FG001|Overall Study|Physician Decision|2|||
28086450|NCT00369785|54739948|FG000|Overall Study|Death|1|||
28086451|NCT00369785|54739949|FG001|Overall Study|Death|2|||
28086452|NCT00369785|54739948|FG000|Overall Study|Withdrawal by Subject|7|||
28086453|NCT00369785|54739949|FG001|Overall Study|Withdrawal by Subject|6|||
28086454|NCT00369785|54739948|FG000|Overall Study|Toxicity|6|||
28086455|NCT00369785|54739949|FG001|Overall Study|Toxicity|4|||
28086456|NCT00369785|54739948|FG000|Overall Study|Never started|0|||
28086457|NCT00369785|54739949|FG001|Overall Study|Never started|2|||
28165441|NCT01066819|54836082|FG003|Overall Study|Non responders|2|||
27974826|NCT04427501|54632499|FG001|Overall Study|Other - as reported by the investigator|0|||
27974827|NCT04427501|54632500|FG002|Overall Study|Other - as reported by the investigator|0|||
27974828|NCT04427501|54632501|FG003|Overall Study|Other - as reported by the investigator|0|||
28086458|NCT00369785|54739948|FG000|Overall Study|Progression|4|||
28086459|NCT00369785|54739949|FG001|Overall Study|Progression|4|||
28165442|NCT01066819|54836083|FG004|Overall Study|Non responders|0|||
27733144|NCT01358864|54180883|FG002|Overall Study|Lost to Follow-up|1|||
28086460|NCT00369785|54739948|FG000|Overall Study|Multiple reasons|6|||
28165443|NCT01066819|54836084|FG005|Overall Study|Non responders|1|||
27974829|NCT04427501|54632502|FG004|Overall Study|Other - as reported by the investigator|0|||
27974830|NCT04427501|54632503|FG005|Overall Study|Other - as reported by the investigator|6|||
27974831|NCT04427501|54632504|FG006|Overall Study|Other - as reported by the investigator|6|||
28086461|NCT00369785|54739949|FG001|Overall Study|Multiple reasons|5|||
28165444|NCT01066819|54836079|FG000|Overall Study|Not categorised|9|||
27974832|NCT04427501|54632505|FG007|Overall Study|Other - as reported by the investigator|0|||
27974833|NCT04427501|54632506|FG008|Overall Study|Other - as reported by the investigator|0|||
27974834|NCT04427501|54632507|FG009|Overall Study|Other - as reported by the investigator|0|||
27974835|NCT03439124|54632559|FG000|Overall Study|Adverse Event|2|||
27974836|NCT03439124|54632560|FG001|Overall Study|Adverse Event|0|||
27974837|NCT03439124|54632559|FG000|Overall Study|Lost to Follow-up|1|||
27974838|NCT03439124|54632560|FG001|Overall Study|Lost to Follow-up|0|||
27974839|NCT03439124|54632559|FG000|Overall Study|Other reasons|1|||
27974840|NCT03439124|54632560|FG001|Overall Study|Other reasons|0|||
27974841|NCT03212989|54632579|FG000|Overall Study|Physician Decision|8|||
27974842|NCT03200548|54632587|FG000|Overall Study|Withdrawal by Subject|5|||
27974843|NCT03200548|54632588|FG001|Overall Study|Withdrawal by Subject|11|||
27974844|NCT03200548|54632589|FG002|Overall Study|Withdrawal by Subject|7|||
27974845|NCT03200548|54632590|FG003|Overall Study|Withdrawal by Subject|6|||
27974846|NCT03158688|54632602|FG000|Overall Study|Withdrawal by Subject|14|||
28086462|NCT00369707|54739955|FG000|Induction Part B (2 Cycles)|Adverse Event|3|||
28086463|NCT00369707|54739955|FG000|Induction Part B (2 Cycles)|Withdrawal by Subject|2|||
28086464|NCT00369707|54739955|FG000|Induction Part B (2 Cycles)|Inadequate response/MD decision|1|||
28086465|NCT00369707|54739955|FG000|Induction Part B (2 Cycles)|Progressive disease|1|||
28086466|NCT00369707|54739955|FG000|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2|||
28086467|NCT00369707|54739955|FG000|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2|||
28086468|NCT00369707|54739955|FG000|Maintenance Period (up to 4 Cycles)|Progressive disease|4|||
28086469|NCT00369707|54739955|FG000|Follow up for 2 Years After Treatment|Death|1|||
27733145|NCT01358864|54180884|FG003|Overall Study|Lost to Follow-up|0|||
27733146|NCT01358864|54180885|FG004|Overall Study|Lost to Follow-up|0|||
27733147|NCT01358864|54180886|FG005|Overall Study|Lost to Follow-up|0|||
27733148|NCT01358864|54180887|FG006|Overall Study|Lost to Follow-up|0|||
27733149|NCT01358864|54180888|FG007|Overall Study|Lost to Follow-up|1|||
27733150|NCT01358864|54180881|FG000|Overall Study|Withdrawal by Subject|3|||
27733151|NCT01358864|54180882|FG001|Overall Study|Withdrawal by Subject|4|||
27733152|NCT01358864|54180883|FG002|Overall Study|Withdrawal by Subject|2|||
27733153|NCT01358864|54180884|FG003|Overall Study|Withdrawal by Subject|0|||
27733154|NCT01358864|54180885|FG004|Overall Study|Withdrawal by Subject|0|||
27733155|NCT01358864|54180886|FG005|Overall Study|Withdrawal by Subject|1|||
27733156|NCT01358864|54180887|FG006|Overall Study|Withdrawal by Subject|1|||
27733157|NCT01358864|54180888|FG007|Overall Study|Withdrawal by Subject|3|||
27733158|NCT01358864|54180881|FG000|Overall Study|Other reason not defined above|2|||
27733159|NCT01358864|54180882|FG001|Overall Study|Other reason not defined above|0|||
27733160|NCT01358864|54180883|FG002|Overall Study|Other reason not defined above|0|||
27733161|NCT01358864|54180884|FG003|Overall Study|Other reason not defined above|0|||
27733162|NCT01358864|54180885|FG004|Overall Study|Other reason not defined above|0|||
27733163|NCT01358864|54180886|FG005|Overall Study|Other reason not defined above|0|||
27733164|NCT01358864|54180887|FG006|Overall Study|Other reason not defined above|2|||
27733165|NCT01358864|54180888|FG007|Overall Study|Other reason not defined above|0|||
27733166|NCT01358864|54180881|FG000|Overall Study|Not treated|0|||
27733167|NCT01358864|54180882|FG001|Overall Study|Not treated|0|||
27733168|NCT01358864|54180883|FG002|Overall Study|Not treated|0|||
27733169|NCT01358864|54180884|FG003|Overall Study|Not treated|0|||
27733170|NCT01358864|54180885|FG004|Overall Study|Not treated|0|||
27733171|NCT01358864|54180886|FG005|Overall Study|Not treated|0|||
27733172|NCT01358864|54180887|FG006|Overall Study|Not treated|1|||
27733173|NCT01358864|54180888|FG007|Overall Study|Not treated|0|||
27733174|NCT02750761|54180914|FG000|Overall Study|Lost to Follow-up|0|||
27733175|NCT02750761|54180915|FG001|Overall Study|Lost to Follow-up|0|||
27733176|NCT02750761|54180916|FG002|Overall Study|Lost to Follow-up|1|||
27733177|NCT02750761|54180917|FG003|Overall Study|Lost to Follow-up|0|||
27733178|NCT02750761|54180918|FG004|Overall Study|Lost to Follow-up|0|||
27733179|NCT02750761|54180919|FG005|Overall Study|Lost to Follow-up|0|||
27733180|NCT02688933|54180962|FG000|Overall Study|Adverse Event|3|||
27733181|NCT02688933|54180963|FG001|Overall Study|Adverse Event|1|||
27733182|NCT02688933|54180962|FG000|Overall Study|Lack of Efficacy|2|||
27733183|NCT02688933|54180963|FG001|Overall Study|Lack of Efficacy|2|||
27733184|NCT02688933|54180962|FG000|Overall Study|Poor compliance to protocol|7|||
27733185|NCT02688933|54180963|FG001|Overall Study|Poor compliance to protocol|4|||
28086470|NCT00369707|54739955|FG000|Follow up for 2 Years After Treatment|Other|2|||
28086471|NCT02943460|54739962|FG000|Blinded Study Phase|Adverse Event|3|||
28086472|NCT02943460|54739963|FG001|Blinded Study Phase|Adverse Event|0|||
27733186|NCT02688933|54180962|FG000|Overall Study|Hypoglycemia|2|||
27733187|NCT02688933|54180963|FG001|Overall Study|Hypoglycemia|0|||
27733188|NCT02688933|54180962|FG000|Overall Study|Other than Specified|14|||
27733189|NCT02688933|54180963|FG001|Overall Study|Other than Specified|25|||
27733190|NCT02688933|54180962|FG000|Overall Study|Lost to Follow-up|1|||
27733191|NCT02688933|54180963|FG001|Overall Study|Lost to Follow-up|5|||
27733192|NCT03626545|54180984|FG000|Overall Study|Progressive disease|3|||
27733193|NCT03626545|54180985|FG001|Overall Study|Progressive disease|82|||
27733194|NCT03626545|54180986|FG002|Overall Study|Progressive disease|85|||
27974847|NCT03158688|54632603|FG001|Overall Study|Withdrawal by Subject|28|||
27974848|NCT03158688|54632602|FG000|Overall Study|Decision by sponsor|13|||
27974849|NCT03158688|54632603|FG001|Overall Study|Decision by sponsor|37|||
27974850|NCT03158688|54632602|FG000|Overall Study|Lost to Follow-up|4|||
27974851|NCT03158688|54632603|FG001|Overall Study|Lost to Follow-up|3|||
27974852|NCT03158688|54632602|FG000|Overall Study|Death|74|||
27974853|NCT03158688|54632603|FG001|Overall Study|Death|142|||
27974854|NCT03138733|54632611|FG000|Overall Study|Death|17|||
27974855|NCT03138733|54632612|FG001|Overall Study|Death|18|||
27974856|NCT03138733|54632611|FG000|Overall Study|Withdrawal by Subject|11|||
27974857|NCT03138733|54632612|FG001|Overall Study|Withdrawal by Subject|6|||
27974858|NCT03138733|54632611|FG000|Overall Study|Lost to Follow-up|3|||
27974859|NCT03138733|54632612|FG001|Overall Study|Lost to Follow-up|2|||
27974860|NCT03138733|54632611|FG000|Overall Study|Adverse Event|1|||
27974861|NCT03138733|54632612|FG001|Overall Study|Adverse Event|0|||
27974862|NCT03138733|54632611|FG000|Overall Study|Protocol Violation|1|||
27974863|NCT03138733|54632612|FG001|Overall Study|Protocol Violation|3|||
27974864|NCT03138733|54632611|FG000|Overall Study|Administrative or logistical reason|1|||
27974865|NCT03138733|54632612|FG001|Overall Study|Administrative or logistical reason|0|||
27974866|NCT03138733|54632611|FG000|Overall Study|The patient was transferred to another hospital|1|||
27974867|NCT03138733|54632612|FG001|Overall Study|The patient was transferred to another hospital|0|||
27974868|NCT03137173|54632620|FG000|Overall Study|Withdrawal by Subject|8|||
27974869|NCT03137173|54632621|FG001|Overall Study|Withdrawal by Subject|13|||
27974870|NCT03137173|54632620|FG000|Overall Study|Death|1|||
27974871|NCT03137173|54632621|FG001|Overall Study|Death|3|||
27974872|NCT03137173|54632620|FG000|Overall Study|Physician Decision|1|||
27974873|NCT03137173|54632621|FG001|Overall Study|Physician Decision|0|||
27974874|NCT03137173|54632620|FG000|Overall Study|Lost to Follow-up|13|||
27974875|NCT03137173|54632621|FG001|Overall Study|Lost to Follow-up|18|||
27974876|NCT03137173|54632620|FG000|Overall Study|Other reasons|3|||
27974877|NCT03137173|54632621|FG001|Overall Study|Other reasons|2|||
27974878|NCT02087423|54632647|FG000|Overall Study|Withdrawal by Subject|20|||
27974879|NCT02087423|54632648|FG001|Overall Study|Withdrawal by Subject|20|||
27974880|NCT02087423|54632649|FG002|Overall Study|Withdrawal by Subject|3|||
27974881|NCT02087423|54632647|FG000|Overall Study|Death|68|||
27974882|NCT02087423|54632648|FG001|Overall Study|Death|207|||
27974883|NCT02087423|54632649|FG002|Overall Study|Death|40|||
27974884|NCT02087423|54632647|FG000|Overall Study|Lost to Follow-up|0|||
27974885|NCT02087423|54632648|FG001|Overall Study|Lost to Follow-up|2|||
27974886|NCT02087423|54632649|FG002|Overall Study|Lost to Follow-up|0|||
27974887|NCT02087423|54632647|FG000|Overall Study|Terminated from study at final DCO|23|||
27974888|NCT02087423|54632648|FG001|Overall Study|Terminated from study at final DCO|36|||
27974889|NCT02087423|54632649|FG002|Overall Study|Terminated from study at final DCO|25|||
27974890|NCT01575808|54632683|FG000|Overall Study|Death|2|||
27974891|NCT01575808|54632684|FG001|Overall Study|Death|0|||
27974892|NCT01575808|54632683|FG000|Overall Study|Withdrawal by Subject|1|||
27974893|NCT01575808|54632684|FG001|Overall Study|Withdrawal by Subject|0|||
27974894|NCT01546753|54632694|FG000|Overall Study|anxiety|1|||
27974895|NCT01546753|54632695|FG001|Overall Study|anxiety|1|||
27974896|NCT01546753|54632694|FG000|Overall Study|diagnosis of ulcerative colitis|1|||
27974897|NCT01546753|54632695|FG001|Overall Study|diagnosis of ulcerative colitis|0|||
27974898|NCT00680901|54632710|FG000|Overall Study|Lost to Follow-up|8|||
27974899|NCT00680901|54632711|FG001|Overall Study|Lost to Follow-up|8|||
27974900|NCT00680901|54632710|FG000|Overall Study|Withdrawal by Subject|4|||
27974901|NCT00680901|54632711|FG001|Overall Study|Withdrawal by Subject|13|||
27974902|NCT00680901|54632710|FG000|Overall Study|Physician Decision|0|||
27974903|NCT00680901|54632711|FG001|Overall Study|Physician Decision|1|||
27974904|NCT00680901|54632710|FG000|Overall Study|Ongoing: On Study Treatment|16|||
27974905|NCT00680901|54632711|FG001|Overall Study|Ongoing: On Study Treatment|13|||
27974906|NCT00680901|54632710|FG000|Overall Study|Ongoing: In Follow Up|45|||
27974907|NCT00680901|54632711|FG001|Overall Study|Ongoing: In Follow Up|41|||
27974908|NCT00941720|54632717|FG000|Overall Study|Withdrawal by Subject|1|||
27974909|NCT00941720|54632717|FG000|Overall Study|Insurance denied participation|11|||
27974910|NCT00941720|54632717|FG000|Overall Study|ineligible|2|||
27974911|NCT00933686|54632723|FG000|Overall Study|Protocol Violation|0|||
28165445|NCT01066819|54836080|FG001|Overall Study|Not categorised|2|||
27974912|NCT00933686|54632724|FG001|Overall Study|Protocol Violation|1|||
27974913|NCT00933686|54632723|FG000|Overall Study|Lost to Follow-up|2|||
27974914|NCT00933686|54632724|FG001|Overall Study|Lost to Follow-up|2|||
27974915|NCT00933686|54632723|FG000|Overall Study|Withdrawal by Subject|6|||
27974916|NCT00933686|54632724|FG001|Overall Study|Withdrawal by Subject|5|||
27974917|NCT00933686|54632723|FG000|Overall Study|Adverse Event|1|||
27974918|NCT00933686|54632724|FG001|Overall Study|Adverse Event|1|||
27974919|NCT00933686|54632723|FG000|Overall Study|Physician Decision|1|||
28165446|NCT01066819|54836081|FG002|Overall Study|Not categorised|6|||
27974920|NCT00933686|54632724|FG001|Overall Study|Physician Decision|0|||
27974921|NCT00933686|54632723|FG000|Overall Study|Failure to show up at endpoint visits|0|||
27974922|NCT00933686|54632724|FG001|Overall Study|Failure to show up at endpoint visits|2|||
27974923|NCT00937040|54632732|FG000|Overall Study|Adverse Event|5|||
27974924|NCT00937040|54632733|FG001|Overall Study|Adverse Event|8|||
27974925|NCT00937040|54632732|FG000|Overall Study|Lost to Follow-up|12|||
27974926|NCT00937040|54632733|FG001|Overall Study|Lost to Follow-up|12|||
27974927|NCT00937040|54632732|FG000|Overall Study|Protocol Violation|3|||
27974928|NCT00937040|54632733|FG001|Overall Study|Protocol Violation|0|||
27974929|NCT00937040|54632732|FG000|Overall Study|Withdrawal by Subject|13|||
27974930|NCT00937040|54632733|FG001|Overall Study|Withdrawal by Subject|7|||
27974931|NCT00937040|54632732|FG000|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3|||
27974932|NCT00937040|54632733|FG001|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2|||
27974933|NCT00937040|54632732|FG000|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5|||
27974934|NCT00937040|54632733|FG001|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8|||
27974935|NCT00673387|54632747|FG000|Overall Study|Withdrawal by Subject|15|||
27974936|NCT00673387|54632748|FG001|Overall Study|Withdrawal by Subject|16|||
27974937|NCT00673387|54632749|FG002|Overall Study|Withdrawal by Subject|20|||
27974938|NCT00673387|54632750|FG003|Overall Study|Withdrawal by Subject|16|||
27974939|NCT00673387|54632751|FG004|Overall Study|Withdrawal by Subject|18|||
27974940|NCT00673387|54632752|FG005|Overall Study|Withdrawal by Subject|21|||
27974941|NCT00673387|54632753|FG006|Overall Study|Withdrawal by Subject|15|||
27974942|NCT00673387|54632754|FG007|Overall Study|Withdrawal by Subject|21|||
27974943|NCT00673387|54632747|FG000|Overall Study|Adverse Event|3|||
27974944|NCT00673387|54632748|FG001|Overall Study|Adverse Event|1|||
27974945|NCT00673387|54632749|FG002|Overall Study|Adverse Event|5|||
27974946|NCT00673387|54632750|FG003|Overall Study|Adverse Event|2|||
27974947|NCT00673387|54632751|FG004|Overall Study|Adverse Event|6|||
27974948|NCT00673387|54632752|FG005|Overall Study|Adverse Event|2|||
27974949|NCT00673387|54632753|FG006|Overall Study|Adverse Event|5|||
27974950|NCT00673387|54632754|FG007|Overall Study|Adverse Event|5|||
27974951|NCT00673387|54632747|FG000|Overall Study|Physician Decision|0|||
27974952|NCT00673387|54632748|FG001|Overall Study|Physician Decision|0|||
27974953|NCT00673387|54632749|FG002|Overall Study|Physician Decision|0|||
27974954|NCT00673387|54632750|FG003|Overall Study|Physician Decision|0|||
27974955|NCT00673387|54632751|FG004|Overall Study|Physician Decision|0|||
27974956|NCT00673387|54632752|FG005|Overall Study|Physician Decision|5|||
27974957|NCT00673387|54632753|FG006|Overall Study|Physician Decision|1|||
27974958|NCT00673387|54632754|FG007|Overall Study|Physician Decision|1|||
27974959|NCT00673387|54632747|FG000|Overall Study|Protocol Violation|3|||
27974960|NCT00673387|54632748|FG001|Overall Study|Protocol Violation|0|||
27974961|NCT00673387|54632749|FG002|Overall Study|Protocol Violation|1|||
27974962|NCT00673387|54632750|FG003|Overall Study|Protocol Violation|2|||
27974963|NCT00673387|54632751|FG004|Overall Study|Protocol Violation|0|||
27855571|NCT02834247|54380601|FG003|Dose Escalation Phase|Lost to Follow-up|0|||
27855572|NCT02834247|54380598|FG000|Dose Escalation Phase|Withdrawal by Subject|2|||
27974964|NCT00673387|54632752|FG005|Overall Study|Protocol Violation|1|||
27974965|NCT00673387|54632753|FG006|Overall Study|Protocol Violation|1|||
27974966|NCT00673387|54632754|FG007|Overall Study|Protocol Violation|3|||
27974967|NCT00673387|54632747|FG000|Overall Study|Lost to Follow-up|8|||
27974968|NCT00673387|54632748|FG001|Overall Study|Lost to Follow-up|6|||
27974969|NCT00673387|54632749|FG002|Overall Study|Lost to Follow-up|5|||
27974970|NCT00673387|54632750|FG003|Overall Study|Lost to Follow-up|6|||
27974971|NCT00673387|54632751|FG004|Overall Study|Lost to Follow-up|6|||
27974972|NCT00673387|54632752|FG005|Overall Study|Lost to Follow-up|5|||
27974973|NCT00673387|54632753|FG006|Overall Study|Lost to Follow-up|8|||
27974974|NCT00673387|54632754|FG007|Overall Study|Lost to Follow-up|5|||
27974975|NCT00933608|54632784|FG000|Overall Study|Adverse Event|4|||
27974976|NCT00933608|54632785|FG001|Overall Study|Adverse Event|2|||
27974977|NCT00933608|54632784|FG000|Overall Study|Physician Decision|1|||
27974978|NCT00933608|54632785|FG001|Overall Study|Physician Decision|0|||
27974979|NCT00574951|54632791|FG000|Overall Study|Ineligible - improper prior treatment|1|||
27974980|NCT01557751|54632795|FG000|Overall Study|Physician Decision|3|||
27974981|NCT00936884|54632801|FG000|Double-blind|Withdrawal by Subject|6|||
27855573|NCT02834247|54380599|FG001|Dose Escalation Phase|Withdrawal by Subject|2|||
27974982|NCT00936884|54632802|FG001|Double-blind|Withdrawal by Subject|4|||
27974983|NCT00936884|54632803|FG002|Double-blind|Withdrawal by Subject|0|||
27855574|NCT02834247|54380600|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
27974984|NCT00936884|54632801|FG000|Double-blind|Death|2|||
27974985|NCT00936884|54632802|FG001|Double-blind|Death|1|||
27974986|NCT00936884|54632803|FG002|Double-blind|Death|0|||
27974987|NCT00936884|54632801|FG000|Double-blind|Lack of Efficacy|1|||
27974988|NCT00936884|54632802|FG001|Double-blind|Lack of Efficacy|1|||
27974989|NCT00936884|54632803|FG002|Double-blind|Lack of Efficacy|0|||
27974990|NCT00936884|54632801|FG000|Double-blind|Adverse Event|1|||
27974991|NCT00936884|54632802|FG001|Double-blind|Adverse Event|0|||
27974992|NCT00936884|54632803|FG002|Double-blind|Adverse Event|0|||
27974993|NCT00936884|54632801|FG000|Double-blind|Physician Decision|1|||
27974994|NCT00936884|54632802|FG001|Double-blind|Physician Decision|0|||
27974995|NCT00936884|54632803|FG002|Double-blind|Physician Decision|0|||
27974996|NCT00936884|54632801|FG000|Double-blind|No post baseline diary entry|1|||
27974997|NCT00936884|54632802|FG001|Double-blind|No post baseline diary entry|0|||
27974998|NCT00936884|54632803|FG002|Double-blind|No post baseline diary entry|0|||
27974999|NCT00936884|54632801|FG000|Double-blind|Did not receive study drug|0|||
27975000|NCT00936884|54632802|FG001|Double-blind|Did not receive study drug|1|||
27975001|NCT00936884|54632803|FG002|Double-blind|Did not receive study drug|0|||
27975002|NCT00668863|54632819|FG000|Overall Study|Objective Progression or Relapse|42|||
27975003|NCT00668863|54632819|FG000|Overall Study|Adverse Event|13|||
27975004|NCT00668863|54632819|FG000|Overall Study|Study Terminated by Sponsor|8|||
27975005|NCT00668863|54632819|FG000|Overall Study|Global Deterioration of Health Status|4|||
27975006|NCT00668863|54632819|FG000|Overall Study|Withdrawal by Subject|1|||
27975007|NCT00668863|54632819|FG000|Overall Study|Surgery|1|||
27975008|NCT00668863|54632819|FG000|Overall Study|Subject's work scheduling problem|1|||
27975009|NCT00668863|54632819|FG000|Overall Study|Physician Decision|1|||
27975010|NCT00935012|54632823|FG000|Overall Study|Death|19|||
27975011|NCT00935012|54632823|FG000|Overall Study|Withdrawal by Subject|3|||
27975012|NCT00935012|54632823|FG000|Overall Study|Other|5|||
27975013|NCT00935012|54632823|FG000|Overall Study|Adverse Event|2|||
27975014|NCT00932360|54632827|FG000|Washout (One Week)|Withdrawal by Subject|0|||
27975015|NCT00932360|54632828|FG001|Washout (One Week)|Withdrawal by Subject|0|||
27975016|NCT00932360|54632829|FG002|Washout (One Week)|Withdrawal by Subject|0|||
28086473|NCT02943460|54739964|FG002|Blinded Study Phase|Adverse Event|0|||
28086474|NCT02943460|54739962|FG000|Blinded Study Phase|Withdrew Consent|0|||
28086475|NCT02943460|54739963|FG001|Blinded Study Phase|Withdrew Consent|1|||
28086476|NCT02943460|54739964|FG002|Blinded Study Phase|Withdrew Consent|0|||
28086477|NCT02943460|54739962|FG000|Open Label Extension (OLE) Phase|Adverse Event|2|||
27975017|NCT00932360|54632830|FG003|Washout (One Week)|Withdrawal by Subject|0|||
27975018|NCT00932360|54632831|FG004|Washout (One Week)|Withdrawal by Subject|2|||
27975019|NCT00932360|54632832|FG005|Washout (One Week)|Withdrawal by Subject|0|||
27975020|NCT00668707|54632848|FG000|Overall Study|Cancer Recurrence|58|||
27975021|NCT00668707|54632849|FG001|Overall Study|Cancer Recurrence|58|||
27975022|NCT00668707|54632848|FG000|Overall Study|Withdrawal by Subject|117|||
27975023|NCT00668707|54632849|FG001|Overall Study|Withdrawal by Subject|100|||
27975024|NCT00668707|54632848|FG000|Overall Study|Lost to Follow-up|3|||
27975025|NCT00668707|54632849|FG001|Overall Study|Lost to Follow-up|6|||
27975026|NCT00668707|54632848|FG000|Overall Study|Protocol Violation|10|||
27975027|NCT00668707|54632849|FG001|Overall Study|Protocol Violation|12|||
27975028|NCT00668707|54632848|FG000|Overall Study|Death|11|||
27975029|NCT00668707|54632849|FG001|Overall Study|Death|4|||
27975030|NCT00668395|54632863|FG000|Overall Study|Withdrawal by Subject|4|||
27975031|NCT00668395|54632864|FG001|Overall Study|Withdrawal by Subject|4|||
27975032|NCT00668395|54632865|FG002|Overall Study|Withdrawal by Subject|1|||
27975033|NCT00668395|54632863|FG000|Overall Study|Adverse Event|1|||
27975034|NCT00668395|54632864|FG001|Overall Study|Adverse Event|1|||
27975035|NCT00668395|54632865|FG002|Overall Study|Adverse Event|0|||
27975036|NCT00668395|54632863|FG000|Overall Study|Physician Decision|1|||
27975037|NCT00668395|54632864|FG001|Overall Study|Physician Decision|1|||
28086478|NCT02943460|54739963|FG001|Open Label Extension (OLE) Phase|Adverse Event|5|||
28086479|NCT02943460|54739964|FG002|Open Label Extension (OLE) Phase|Adverse Event|2|||
28086480|NCT02943460|54739962|FG000|Open Label Extension (OLE) Phase|Withdrew Consent|2|||
28086481|NCT02943460|54739963|FG001|Open Label Extension (OLE) Phase|Withdrew Consent|1|||
28086482|NCT02943460|54739964|FG002|Open Label Extension (OLE) Phase|Withdrew Consent|0|||
28086483|NCT02943460|54739962|FG000|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
28165447|NCT01066819|54836082|FG003|Overall Study|Not categorised|1|||
28165448|NCT01066819|54836083|FG004|Overall Study|Not categorised|0|||
28165449|NCT01066819|54836084|FG005|Overall Study|Not categorised|0|||
28165450|NCT01066819|54836079|FG000|Overall Study|Relapse|16|||
28165451|NCT01066819|54836080|FG001|Overall Study|Relapse|4|||
28165452|NCT01066819|54836081|FG002|Overall Study|Relapse|3|||
28165453|NCT01066819|54836082|FG003|Overall Study|Relapse|0|||
28165454|NCT01066819|54836083|FG004|Overall Study|Relapse|0|||
28165455|NCT01066819|54836084|FG005|Overall Study|Relapse|0|||
28165456|NCT01066819|54836079|FG000|Overall Study|Results not available|1|||
27975038|NCT00668395|54632865|FG002|Overall Study|Physician Decision|0|||
27975039|NCT00668317|54632873|FG000|Overall Study|Adverse Event|2|||
27975040|NCT00670111|54632894|FG000|Enrollment to One Month|Testing Failure|0|||
27975041|NCT00670111|54632895|FG001|Enrollment to One Month|Testing Failure|0|||
27975042|NCT00670111|54632896|FG002|Enrollment to One Month|Testing Failure|13|||
27975043|NCT00670111|54632894|FG000|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
27975044|NCT00670111|54632895|FG001|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
27975045|NCT00670111|54632896|FG002|Enrollment to One Month|Ebrolled Patients but not Implanted|6|||
27975046|NCT00670111|54632894|FG000|Enrollment to One Month|Physician Decision|1|||
27975047|NCT00670111|54632895|FG001|Enrollment to One Month|Physician Decision|0|||
28165457|NCT01066819|54836080|FG001|Overall Study|Results not available|0|||
28165458|NCT01066819|54836081|FG002|Overall Study|Results not available|0|||
28165459|NCT01066819|54836082|FG003|Overall Study|Results not available|0|||
28165460|NCT01066819|54836083|FG004|Overall Study|Results not available|0|||
28165461|NCT01066819|54836084|FG005|Overall Study|Results not available|0|||
28165462|NCT01066819|54836079|FG000|Overall Study|Screen failure|1|||
28086484|NCT02943460|54739963|FG001|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
28086485|NCT02943460|54739964|FG002|Open Label Extension (OLE) Phase|Investigator's Discretion|0|||
28086486|NCT03768206|54739975|FG000|Overall Study|Lost to Follow-up|2|||
28086487|NCT03768206|54739976|FG001|Overall Study|Lost to Follow-up|1|||
28086488|NCT03768206|54739975|FG000|Overall Study|Withdrawal by Subject|0|||
28086489|NCT03768206|54739976|FG001|Overall Study|Withdrawal by Subject|1|||
27975048|NCT00670111|54632896|FG002|Enrollment to One Month|Physician Decision|0|||
27975049|NCT00672139|54632906|FG000|Overall Study|Death|14|||
27975050|NCT00672139|54632907|FG001|Overall Study|Death|23|||
27975051|NCT00672139|54632906|FG000|Overall Study|Withdrawal by Subject|2|||
27975052|NCT00672139|54632907|FG001|Overall Study|Withdrawal by Subject|11|||
27975053|NCT00672139|54632906|FG000|Overall Study|Adverse Event|4|||
27975054|NCT00672139|54632907|FG001|Overall Study|Adverse Event|7|||
27975055|NCT00672139|54632906|FG000|Overall Study|Physician Decision|2|||
27975056|NCT00672139|54632907|FG001|Overall Study|Physician Decision|0|||
27975057|NCT00672139|54632906|FG000|Overall Study|Lack of Efficacy|4|||
27975058|NCT00672139|54632907|FG001|Overall Study|Lack of Efficacy|1|||
27975059|NCT00672139|54632906|FG000|Overall Study|Protocol Violation|1|||
27975060|NCT00672139|54632907|FG001|Overall Study|Protocol Violation|1|||
27975061|NCT00672139|54632906|FG000|Overall Study|hospice discharge, caregiver requests|3|||
27975062|NCT00672139|54632907|FG001|Overall Study|hospice discharge, caregiver requests|2|||
27975063|NCT00570739|54632917|FG000|Overall Study|Adverse Event|8|||
27975064|NCT00570739|54632918|FG001|Overall Study|Adverse Event|6|||
27975065|NCT00570739|54632919|FG002|Overall Study|Adverse Event|2|||
27975066|NCT00570739|54632920|FG003|Overall Study|Adverse Event|2|||
27975067|NCT00570739|54632917|FG000|Overall Study|Lost to Follow-up|4|||
27975068|NCT00570739|54632918|FG001|Overall Study|Lost to Follow-up|5|||
27975069|NCT00570739|54632919|FG002|Overall Study|Lost to Follow-up|4|||
27975070|NCT00570739|54632920|FG003|Overall Study|Lost to Follow-up|1|||
27975071|NCT00570739|54632917|FG000|Overall Study|Physician Decision|1|||
27975072|NCT00570739|54632918|FG001|Overall Study|Physician Decision|1|||
27975073|NCT00570739|54632919|FG002|Overall Study|Physician Decision|0|||
27975074|NCT00570739|54632920|FG003|Overall Study|Physician Decision|0|||
27975075|NCT00570739|54632917|FG000|Overall Study|Withdrawal by Subject|7|||
27975076|NCT00570739|54632918|FG001|Overall Study|Withdrawal by Subject|7|||
27975077|NCT00570739|54632919|FG002|Overall Study|Withdrawal by Subject|3|||
27975078|NCT00570739|54632920|FG003|Overall Study|Withdrawal by Subject|5|||
27975079|NCT00570739|54632917|FG000|Overall Study|Required restricted medication|0|||
27975080|NCT00570739|54632918|FG001|Overall Study|Required restricted medication|0|||
27975081|NCT00570739|54632919|FG002|Overall Study|Required restricted medication|1|||
27975082|NCT00570739|54632920|FG003|Overall Study|Required restricted medication|0|||
27975083|NCT00570739|54632917|FG000|Overall Study|Met discontinuation criteria|1|||
27975084|NCT00570739|54632918|FG001|Overall Study|Met discontinuation criteria|0|||
27975085|NCT00570739|54632919|FG002|Overall Study|Met discontinuation criteria|1|||
27975086|NCT00570739|54632920|FG003|Overall Study|Met discontinuation criteria|1|||
27975087|NCT00570739|54632917|FG000|Overall Study|Other|0|||
27975088|NCT00570739|54632918|FG001|Overall Study|Other|2|||
28086490|NCT03767894|54739983|FG000|Overall Study|Withdrawal by Subject|1|||
28086491|NCT03766646|54739989|FG000|Overall Study|Withdrawal by Subject|1|||
28086492|NCT03766646|54739990|FG001|Overall Study|Withdrawal by Subject|0|||
28086493|NCT03766646|54739989|FG000|Overall Study|Protocol Violation|0|||
28086494|NCT03766646|54739990|FG001|Overall Study|Protocol Violation|3|||
28086495|NCT03765164|54739998|FG000|Pre-intervention|Withdrawal by Subject|5|||
28086496|NCT03765164|54739999|FG001|Pre-intervention|Withdrawal by Subject|6|||
28086497|NCT00369629|54740005|FG000|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
28086498|NCT00369629|54740006|FG001|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
28165463|NCT01066819|54836080|FG001|Overall Study|Screen failure|0|||
28165464|NCT01066819|54836081|FG002|Overall Study|Screen failure|0|||
28165465|NCT01066819|54836082|FG003|Overall Study|Screen failure|0|||
28165466|NCT01066819|54836083|FG004|Overall Study|Screen failure|0|||
28165467|NCT01066819|54836084|FG005|Overall Study|Screen failure|0|||
28165468|NCT01066819|54836079|FG000|Overall Study|Spontaneous cure|1|||
27975089|NCT00570739|54632919|FG002|Overall Study|Other|5|||
27975090|NCT00570739|54632920|FG003|Overall Study|Other|3|||
27975091|NCT03689530|54632952|FG000|Overall Study|Withdrawal by Subject|53|||
27975092|NCT03689530|54632953|FG001|Overall Study|Withdrawal by Subject|16|||
27975093|NCT04188106|54632959|FG000|Overall Study|Lost to Follow-up|5|||
27975094|NCT04188106|54632959|FG000|Overall Study|Non-Compliance|1|||
27975095|NCT00669955|54632967|FG000|Overall Study|Adverse Event|3|||
27975096|NCT00669955|54632968|FG001|Overall Study|Adverse Event|5|||
27975097|NCT00669955|54632967|FG000|Overall Study|Death|0|||
28165469|NCT01066819|54836080|FG001|Overall Study|Spontaneous cure|0|||
28165470|NCT01066819|54836081|FG002|Overall Study|Spontaneous cure|0|||
28165471|NCT01066819|54836082|FG003|Overall Study|Spontaneous cure|0|||
28165472|NCT01066819|54836083|FG004|Overall Study|Spontaneous cure|0|||
28165473|NCT01066819|54836084|FG005|Overall Study|Spontaneous cure|0|||
27975098|NCT00669955|54632968|FG001|Overall Study|Death|1|||
27975099|NCT00669955|54632967|FG000|Overall Study|Withdrawal by Subject|2|||
27975100|NCT00669955|54632968|FG001|Overall Study|Withdrawal by Subject|3|||
27975101|NCT00669955|54632967|FG000|Overall Study|Lost to Follow-up|5|||
27975102|NCT00669955|54632968|FG001|Overall Study|Lost to Follow-up|7|||
27975103|NCT00669955|54632967|FG000|Overall Study|Protocol Violation|2|||
27975104|NCT00669955|54632968|FG001|Overall Study|Protocol Violation|7|||
27975105|NCT00669955|54632967|FG000|Overall Study|Investigator Sponsor Judgement|0|||
27975106|NCT00669955|54632968|FG001|Overall Study|Investigator Sponsor Judgement|1|||
27975107|NCT00669955|54632967|FG000|Overall Study|not compliant with study drug/visit|2|||
27975108|NCT00669955|54632968|FG001|Overall Study|not compliant with study drug/visit|3|||
27975109|NCT00671749|54632974|FG000|Overall Study|Adverse Event|2|||
27975110|NCT00671749|54632974|FG000|Overall Study|Withdrawal by Subject|4|||
27975111|NCT00671749|54632974|FG000|Overall Study|Protocol Violation|1|||
27975112|NCT00671749|54632974|FG000|Overall Study|Lost to Follow-up|1|||
27975113|NCT00669877|54632978|FG000|Overall Study|Disease Progression/Death|4|||
27975114|NCT00882999|54632989|FG000|Overall Study|Adverse Event|0|||
27975115|NCT00882999|54632990|FG001|Overall Study|Adverse Event|0|||
27975116|NCT00882999|54632991|FG002|Overall Study|Adverse Event|0|||
27975117|NCT00882999|54632992|FG003|Overall Study|Adverse Event|0|||
27975118|NCT00882999|54632993|FG004|Overall Study|Adverse Event|1|||
27975119|NCT00882999|54632994|FG005|Overall Study|Adverse Event|0|||
27975120|NCT00882999|54632995|FG006|Overall Study|Adverse Event|0|||
27975121|NCT00882999|54632989|FG000|Overall Study|Death|0|||
27975122|NCT00882999|54632990|FG001|Overall Study|Death|1|||
27975123|NCT00882999|54632991|FG002|Overall Study|Death|0|||
27975124|NCT00882999|54632992|FG003|Overall Study|Death|0|||
28086499|NCT00369629|54740007|FG002|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
28086500|NCT00369629|54740008|FG003|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
28086501|NCT00369629|54740005|FG000|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
28086502|NCT00369629|54740006|FG001|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
28086503|NCT00369629|54740007|FG002|Treated 2 Cycles/Reached First Response|Adverse Event|1|||
28086504|NCT00369629|54740008|FG003|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
28086505|NCT00369629|54740005|FG000|Treated 2 Cycles/Reached First Response|Progressive disease|2|||
28086506|NCT00369629|54740006|FG001|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
28165474|NCT01066819|54836079|FG000|Overall Study|Treatment never started|85|||
28086507|NCT00369629|54740007|FG002|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
28086508|NCT00369629|54740008|FG003|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
28086509|NCT00369629|54740005|FG000|Moved on to 4 More Cycles|Progressive Disease|0|||
28086510|NCT00369629|54740006|FG001|Moved on to 4 More Cycles|Progressive Disease|0|||
28086511|NCT00369629|54740007|FG002|Moved on to 4 More Cycles|Progressive Disease|1|||
28086512|NCT00369629|54740008|FG003|Moved on to 4 More Cycles|Progressive Disease|0|||
28086513|NCT00369629|54740005|FG000|Completed 4 More Cycles|Withdrawal by Subject|2|||
28086514|NCT00369629|54740006|FG001|Completed 4 More Cycles|Withdrawal by Subject|1|||
28086515|NCT00369629|54740007|FG002|Completed 4 More Cycles|Withdrawal by Subject|0|||
28086516|NCT00369629|54740008|FG003|Completed 4 More Cycles|Withdrawal by Subject|0|||
28086517|NCT00369629|54740005|FG000|Completed 4 More Cycles|Progressive disease|2|||
28086518|NCT00369629|54740006|FG001|Completed 4 More Cycles|Progressive disease|1|||
28086519|NCT00369629|54740007|FG002|Completed 4 More Cycles|Progressive disease|2|||
28086520|NCT00369629|54740008|FG003|Completed 4 More Cycles|Progressive disease|0|||
28086521|NCT00369629|54740005|FG000|Follow up for 1 Year|Death|2|||
28086522|NCT00369629|54740006|FG001|Follow up for 1 Year|Death|1|||
28086523|NCT00369629|54740007|FG002|Follow up for 1 Year|Death|1|||
28086524|NCT00369629|54740008|FG003|Follow up for 1 Year|Death|0|||
28086525|NCT00369629|54740005|FG000|Follow up for 1 Year|Lost to Follow-up|0|||
28086526|NCT00369629|54740006|FG001|Follow up for 1 Year|Lost to Follow-up|1|||
28086527|NCT00369629|54740007|FG002|Follow up for 1 Year|Lost to Follow-up|0|||
28086528|NCT00369629|54740008|FG003|Follow up for 1 Year|Lost to Follow-up|0|||
28086529|NCT00369629|54740005|FG000|Follow up for 1 Year|stopped being followed as study closed|0|||
28165475|NCT01066819|54836080|FG001|Overall Study|Treatment never started|19|||
28165476|NCT01066819|54836081|FG002|Overall Study|Treatment never started|19|||
28165477|NCT01066819|54836082|FG003|Overall Study|Treatment never started|3|||
28165478|NCT01066819|54836083|FG004|Overall Study|Treatment never started|2|||
28165479|NCT01066819|54836084|FG005|Overall Study|Treatment never started|2|||
27975125|NCT00882999|54632993|FG004|Overall Study|Death|0|||
28086530|NCT00369629|54740006|FG001|Follow up for 1 Year|stopped being followed as study closed|0|||
28086531|NCT00369629|54740007|FG002|Follow up for 1 Year|stopped being followed as study closed|2|||
28165480|NCT01066819|54836079|FG000|Overall Study|Treatment stopped|12|||
28165481|NCT01066819|54836080|FG001|Overall Study|Treatment stopped|1|||
28165482|NCT01066819|54836081|FG002|Overall Study|Treatment stopped|2|||
27975126|NCT00882999|54632994|FG005|Overall Study|Death|0|||
27975127|NCT00882999|54632995|FG006|Overall Study|Death|0|||
27975128|NCT00882999|54632989|FG000|Overall Study|Withdrawal by Subject|7|||
27975129|NCT00882999|54632990|FG001|Overall Study|Withdrawal by Subject|6|||
27975130|NCT00882999|54632991|FG002|Overall Study|Withdrawal by Subject|3|||
28165483|NCT01066819|54836082|FG003|Overall Study|Treatment stopped|1|||
28165484|NCT01066819|54836083|FG004|Overall Study|Treatment stopped|0|||
27975131|NCT00882999|54632992|FG003|Overall Study|Withdrawal by Subject|3|||
27975132|NCT00882999|54632993|FG004|Overall Study|Withdrawal by Subject|6|||
28086532|NCT00369629|54740008|FG003|Follow up for 1 Year|stopped being followed as study closed|0|||
28165485|NCT01066819|54836084|FG005|Overall Study|Treatment stopped|0|||
28165486|NCT01066819|54836079|FG000|Overall Study|Other|5|||
28165487|NCT01066819|54836080|FG001|Overall Study|Other|1|||
28165488|NCT01066819|54836081|FG002|Overall Study|Other|1|||
28165489|NCT01066819|54836082|FG003|Overall Study|Other|0|||
28165490|NCT01066819|54836083|FG004|Overall Study|Other|0|||
28165491|NCT01066819|54836084|FG005|Overall Study|Other|0|||
28165492|NCT04056299|54836098|FG000|Overall Study|Sponsor discontinued study|3|||
28165493|NCT04056299|54836099|FG001|Overall Study|Sponsor discontinued study|3|||
28165494|NCT04057937|54836107|FG000|Placebo-controlled Phase|Adverse Event|3|||
28165495|NCT04057937|54836108|FG001|Placebo-controlled Phase|Adverse Event|0|||
28165496|NCT04057937|54836107|FG000|Active-treatment Phase|Withdrawal by Subject|1|||
28165497|NCT04057937|54836108|FG001|Active-treatment Phase|Withdrawal by Subject|0|||
28165498|NCT04057937|54836107|FG000|Active-treatment Phase|Pregnancy|0|||
28165499|NCT04057937|54836108|FG001|Active-treatment Phase|Pregnancy|1|||
28165500|NCT04057937|54836107|FG000|Active-treatment Phase|Physician Decision|0|||
28165501|NCT04057937|54836108|FG001|Active-treatment Phase|Physician Decision|1|||
28165502|NCT01069523|54836117|FG000|Overall Study|Withdrawal by Subject|4|||
28165503|NCT01069523|54836118|FG001|Overall Study|Withdrawal by Subject|7|||
28165504|NCT01069289|54836128|FG000|Overall Study|Withdrawal by Subject|15|||
28165505|NCT01069289|54836129|FG001|Overall Study|Withdrawal by Subject|26|||
28165506|NCT01069289|54836128|FG000|Overall Study|Adverse Event|21|||
28165507|NCT01069289|54836129|FG001|Overall Study|Adverse Event|28|||
28165508|NCT01069289|54836128|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
28165509|NCT01069289|54836129|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
28165510|NCT01069289|54836128|FG000|Overall Study|Severe non-compliance to protocol|3|||
28165511|NCT01069289|54836129|FG001|Overall Study|Severe non-compliance to protocol|2|||
28165512|NCT01069289|54836128|FG000|Overall Study|Due to deteriorating health condition|1|||
28165513|NCT01069289|54836129|FG001|Overall Study|Due to deteriorating health condition|0|||
28165514|NCT02510794|54836148|FG000|Overall Study|Adverse Event|0|||
28165515|NCT02510794|54836149|FG001|Overall Study|Adverse Event|1|||
28165516|NCT02510794|54836150|FG002|Overall Study|Adverse Event|0|||
28165517|NCT02510794|54836151|FG003|Overall Study|Adverse Event|0|||
28165518|NCT02510794|54836148|FG000|Overall Study|Death|1|||
28165519|NCT02510794|54836149|FG001|Overall Study|Death|2|||
28165520|NCT02510794|54836150|FG002|Overall Study|Death|1|||
28165521|NCT02510794|54836151|FG003|Overall Study|Death|1|||
28165522|NCT02510794|54836148|FG000|Overall Study|Lack of Efficacy|3|||
28165523|NCT02510794|54836149|FG001|Overall Study|Lack of Efficacy|1|||
28165524|NCT02510794|54836150|FG002|Overall Study|Lack of Efficacy|1|||
28165525|NCT02510794|54836151|FG003|Overall Study|Lack of Efficacy|0|||
28165526|NCT02510794|54836148|FG000|Overall Study|Participant moved out of the area|0|||
28165527|NCT02510794|54836149|FG001|Overall Study|Participant moved out of the area|0|||
28165528|NCT02510794|54836150|FG002|Overall Study|Participant moved out of the area|0|||
28086533|NCT02469064|54740020|FG000|Overall Study|Request not to receive intervention.|1|||
28086534|NCT02469064|54740021|FG001|Overall Study|Request not to receive intervention.|3|||
28086535|NCT02446912|54740030|FG000|Overall Study|Adverse Event|3|||
28086536|NCT02446912|54740031|FG001|Overall Study|Adverse Event|13|||
28086537|NCT02446912|54740032|FG002|Overall Study|Adverse Event|5|||
28086538|NCT02446912|54740030|FG000|Overall Study|Condition under investigation worsened|0|||
28086539|NCT02446912|54740031|FG001|Overall Study|Condition under investigation worsened|1|||
28086540|NCT02446912|54740032|FG002|Overall Study|Condition under investigation worsened|1|||
28086541|NCT02446912|54740030|FG000|Overall Study|Study-specific withdrawal criteria|1|||
28086542|NCT02446912|54740031|FG001|Overall Study|Study-specific withdrawal criteria|0|||
28086543|NCT02446912|54740032|FG002|Overall Study|Study-specific withdrawal criteria|0|||
28086544|NCT02446912|54740030|FG000|Overall Study|Lack of Efficacy|1|||
28086545|NCT02446912|54740031|FG001|Overall Study|Lack of Efficacy|4|||
28086546|NCT02446912|54740032|FG002|Overall Study|Lack of Efficacy|7|||
28086547|NCT02446912|54740030|FG000|Overall Study|Lost to Follow-up|0|||
28086548|NCT02446912|54740031|FG001|Overall Study|Lost to Follow-up|0|||
28086549|NCT02446912|54740032|FG002|Overall Study|Lost to Follow-up|2|||
28165529|NCT02510794|54836151|FG003|Overall Study|Participant moved out of the area|1|||
28165530|NCT02510794|54836148|FG000|Overall Study|Physician Decision|3|||
28165531|NCT02510794|54836149|FG001|Overall Study|Physician Decision|0|||
28165532|NCT02510794|54836150|FG002|Overall Study|Physician Decision|0|||
28165533|NCT02510794|54836151|FG003|Overall Study|Physician Decision|0|||
28165534|NCT02510794|54836148|FG000|Overall Study|Protocol Violation|0|||
28086550|NCT02446912|54740030|FG000|Overall Study|Severe non-compliance to protocol|1|||
28165535|NCT02510794|54836149|FG001|Overall Study|Protocol Violation|0|||
28165536|NCT02510794|54836150|FG002|Overall Study|Protocol Violation|1|||
28165537|NCT02510794|54836151|FG003|Overall Study|Protocol Violation|0|||
28165538|NCT02510794|54836148|FG000|Overall Study|Withdrawal by Subject|1|||
27975133|NCT00882999|54632994|FG005|Overall Study|Withdrawal by Subject|5|||
27975134|NCT00882999|54632995|FG006|Overall Study|Withdrawal by Subject|5|||
27975135|NCT00882999|54632989|FG000|Overall Study|Lost to Follow-up|0|||
27975136|NCT00882999|54632990|FG001|Overall Study|Lost to Follow-up|1|||
27975137|NCT00882999|54632991|FG002|Overall Study|Lost to Follow-up|1|||
27975138|NCT00882999|54632992|FG003|Overall Study|Lost to Follow-up|2|||
27975139|NCT00882999|54632993|FG004|Overall Study|Lost to Follow-up|1|||
27975140|NCT00882999|54632994|FG005|Overall Study|Lost to Follow-up|1|||
27975141|NCT00882999|54632995|FG006|Overall Study|Lost to Follow-up|2|||
27975142|NCT00882999|54632989|FG000|Overall Study|Physician Decision|1|||
27975143|NCT00882999|54632990|FG001|Overall Study|Physician Decision|0|||
27975144|NCT00882999|54632991|FG002|Overall Study|Physician Decision|0|||
27975145|NCT00882999|54632992|FG003|Overall Study|Physician Decision|0|||
27975146|NCT00882999|54632993|FG004|Overall Study|Physician Decision|0|||
27975147|NCT00882999|54632994|FG005|Overall Study|Physician Decision|1|||
27975148|NCT00882999|54632995|FG006|Overall Study|Physician Decision|1|||
27975149|NCT00671437|54633018|FG000|Overall Study|Progressive disease before C1 week 8|8|||
27975150|NCT00671437|54633018|FG000|Overall Study|Cutaneous SCC of head and neck|3|||
27975151|NCT00671437|54633018|FG000|Overall Study|Adverse Event|3|||
27975152|NCT00671437|54633018|FG000|Overall Study|Ineligible post-hoc|1|||
27975153|NCT00882921|54633030|FG000|Overall Study|Death|2|||
27975154|NCT00882921|54633030|FG000|Overall Study|Other|3|||
27975155|NCT00882921|54633030|FG000|Overall Study|Lost to Follow-up|2|||
27975156|NCT00882921|54633030|FG000|Overall Study|Termination By Investigator|3|||
27975157|NCT00882921|54633030|FG000|Overall Study|Withdrawal Of Consent|1|||
27975158|NCT00582712|54633035|FG000|Overall Study|Adverse Event|1|||
27975159|NCT00582712|54633035|FG000|Overall Study|Lack of Efficacy|1|||
27975160|NCT00582712|54633035|FG000|Overall Study|Withdrawal by Subject|1|||
27975161|NCT00582712|54633035|FG000|Overall Study|Complicating disease requiring treatment|1|||
27975162|NCT00582790|54633039|FG000|Overall Study|Rapid progression of disease|1|||
27975163|NCT00881751|54633046|FG000|Overall Study|Physician Decision|0|||
27975164|NCT00881751|54633047|FG001|Overall Study|Physician Decision|1|||
27975165|NCT00881751|54633046|FG000|Overall Study|Adverse Event|0|||
27975166|NCT00881751|54633047|FG001|Overall Study|Adverse Event|2|||
28086551|NCT02446912|54740031|FG001|Overall Study|Severe non-compliance to protocol|0|||
28086552|NCT02446912|54740032|FG002|Overall Study|Severe non-compliance to protocol|1|||
28086553|NCT02446912|54740030|FG000|Overall Study|Withdrawal by Subject|10|||
28086554|NCT02446912|54740031|FG001|Overall Study|Withdrawal by Subject|15|||
28086555|NCT02446912|54740032|FG002|Overall Study|Withdrawal by Subject|15|||
28086556|NCT02446912|54740030|FG000|Overall Study|Miscellaneous|2|||
28086557|NCT02446912|54740031|FG001|Overall Study|Miscellaneous|2|||
28086558|NCT02446912|54740032|FG002|Overall Study|Miscellaneous|4|||
27975167|NCT00881751|54633046|FG000|Overall Study|Withdrawal by Subject|0|||
27975168|NCT00881751|54633047|FG001|Overall Study|Withdrawal by Subject|2|||
27975169|NCT00934856|54633059|FG000|Feasibility Part|Progressive disease|4|||
27975170|NCT00934856|54633060|FG001|Feasibility Part|Progressive disease|4|||
27975171|NCT00934856|54633061|FG002|Feasibility Part|Progressive disease|2|||
27975172|NCT00934856|54633062|FG003|Feasibility Part|Progressive disease|3|||
27975173|NCT00934856|54633063|FG004|Feasibility Part|Progressive disease|0|||
27975174|NCT00934856|54633064|FG005|Feasibility Part|Progressive disease|0|||
27975175|NCT00934856|54633059|FG000|Feasibility Part|Physician Decision|0|||
27975176|NCT00934856|54633060|FG001|Feasibility Part|Physician Decision|0|||
27975177|NCT00934856|54633061|FG002|Feasibility Part|Physician Decision|1|||
27975178|NCT00934856|54633062|FG003|Feasibility Part|Physician Decision|0|||
27975179|NCT00934856|54633063|FG004|Feasibility Part|Physician Decision|0|||
27975180|NCT00934856|54633064|FG005|Feasibility Part|Physician Decision|0|||
27975181|NCT00934856|54633059|FG000|Feasibility Part|Adverse Event|1|||
27975182|NCT00934856|54633060|FG001|Feasibility Part|Adverse Event|1|||
27975183|NCT00934856|54633061|FG002|Feasibility Part|Adverse Event|0|||
27975184|NCT00934856|54633062|FG003|Feasibility Part|Adverse Event|1|||
27975185|NCT00934856|54633063|FG004|Feasibility Part|Adverse Event|0|||
27975186|NCT00934856|54633064|FG005|Feasibility Part|Adverse Event|2|||
27975187|NCT00934856|54633059|FG000|Feasibility Part|Withdrawal by Subject|0|||
27975188|NCT00934856|54633060|FG001|Feasibility Part|Withdrawal by Subject|0|||
27975189|NCT00934856|54633061|FG002|Feasibility Part|Withdrawal by Subject|0|||
28086559|NCT00736840|54740040|FG000|Overall Study|Lost to Follow-up|13|||
28086560|NCT00318461|54740049|FG000|Double-Blind, 6 Months|Adverse Event|11|||
28086561|NCT00318461|54740050|FG001|Double-Blind, 6 Months|Adverse Event|23|||
27975190|NCT00934856|54633062|FG003|Feasibility Part|Withdrawal by Subject|1|||
27975191|NCT00934856|54633063|FG004|Feasibility Part|Withdrawal by Subject|0|||
27975192|NCT00934856|54633064|FG005|Feasibility Part|Withdrawal by Subject|1|||
27975193|NCT00934856|54633059|FG000|Extension Part|Adverse Event|0|||
27975194|NCT00934856|54633060|FG001|Extension Part|Adverse Event|0|||
27975195|NCT00934856|54633061|FG002|Extension Part|Adverse Event|0|||
27975196|NCT00934856|54633062|FG003|Extension Part|Adverse Event|1|||
27975197|NCT00934856|54633063|FG004|Extension Part|Adverse Event|4|||
28086562|NCT00318461|54740051|FG002|Double-Blind, 6 Months|Adverse Event|29|||
28086563|NCT00318461|54740052|FG003|Double-Blind, 6 Months|Adverse Event|2|||
27975198|NCT00934856|54633064|FG005|Extension Part|Adverse Event|4|||
27975199|NCT00934856|54633059|FG000|Extension Part|Progressive disease|0|||
27975200|NCT00934856|54633060|FG001|Extension Part|Progressive disease|0|||
27975201|NCT00934856|54633061|FG002|Extension Part|Progressive disease|0|||
27975202|NCT00934856|54633062|FG003|Extension Part|Progressive disease|1|||
27975203|NCT00934856|54633063|FG004|Extension Part|Progressive disease|0|||
27975204|NCT00934856|54633064|FG005|Extension Part|Progressive disease|0|||
27975205|NCT00934856|54633059|FG000|Extension Part|Non-compliance with drug|0|||
27975206|NCT00934856|54633060|FG001|Extension Part|Non-compliance with drug|0|||
27975207|NCT00934856|54633061|FG002|Extension Part|Non-compliance with drug|0|||
27975208|NCT00934856|54633062|FG003|Extension Part|Non-compliance with drug|0|||
27975209|NCT00934856|54633063|FG004|Extension Part|Non-compliance with drug|0|||
27975210|NCT00934856|54633064|FG005|Extension Part|Non-compliance with drug|1|||
27975211|NCT00934700|54633098|FG000|Overall Study|missing scan|5|||
27975212|NCT00934700|54633099|FG001|Overall Study|missing scan|9|||
27975213|NCT00934700|54633098|FG000|Overall Study|Death|8|||
27975214|NCT00934700|54633099|FG001|Overall Study|Death|3|||
27975215|NCT00930176|54633106|FG000|Overall Study|Death|1|||
27975216|NCT00669409|54633116|FG000|Part 2|Withdrawal by Subject|0|||
27975217|NCT00669409|54633117|FG001|Part 2|Withdrawal by Subject|0|||
27975218|NCT00669409|54633118|FG002|Part 2|Withdrawal by Subject|0|||
27975219|NCT00669409|54633119|FG003|Part 2|Withdrawal by Subject|0|||
27975220|NCT00669409|54633120|FG004|Part 2|Withdrawal by Subject|0|||
27975221|NCT00669409|54633121|FG005|Part 2|Withdrawal by Subject|0|||
27975222|NCT00669409|54633122|FG006|Part 2|Withdrawal by Subject|0|||
27975223|NCT00669409|54633123|FG007|Part 2|Withdrawal by Subject|0|||
27975224|NCT00669409|54633124|FG008|Part 2|Withdrawal by Subject|0|||
27975225|NCT00669409|54633125|FG009|Part 2|Withdrawal by Subject|1|||
27975226|NCT00669409|54633126|FG010|Part 2|Withdrawal by Subject|0|||
27975227|NCT00669331|54633155|FG000|Randomisation to First Dose|Adverse Event|1|||
27975228|NCT00669331|54633156|FG001|Randomisation to First Dose|Adverse Event|0|||
27975229|NCT00669331|54633155|FG000|Randomisation to First Dose|Protocol Violation|1|||
27975230|NCT00669331|54633156|FG001|Randomisation to First Dose|Protocol Violation|0|||
27975231|NCT00669331|54633155|FG000|Randomisation to First Dose|Withdrawal by Subject|3|||
27975232|NCT00669331|54633156|FG001|Randomisation to First Dose|Withdrawal by Subject|2|||
27975233|NCT00669331|54633155|FG000|Randomisation to First Dose|Lost to Follow-up|2|||
27975234|NCT00669331|54633156|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
27975235|NCT00669331|54633155|FG000|Randomisation to First Dose|Death|1|||
27975236|NCT00669331|54633156|FG001|Randomisation to First Dose|Death|0|||
27975237|NCT00669331|54633155|FG000|Randomisation to First Dose|Sponsor decision|0|||
27975238|NCT00669331|54633156|FG001|Randomisation to First Dose|Sponsor decision|1|||
27975239|NCT00669331|54633155|FG000|Randomisation to First Dose|Randomised in error|3|||
27975240|NCT00669331|54633156|FG001|Randomisation to First Dose|Randomised in error|10|||
27975241|NCT00669331|54633155|FG000|Blinded Treatment Period|Adverse Event|16|||
27975242|NCT00669331|54633156|FG001|Blinded Treatment Period|Adverse Event|10|||
27975243|NCT00669331|54633155|FG000|Blinded Treatment Period|Protocol Violation|1|||
27975244|NCT00669331|54633156|FG001|Blinded Treatment Period|Protocol Violation|1|||
27975245|NCT00669331|54633155|FG000|Blinded Treatment Period|Withdrawal by Subject|17|||
27975246|NCT00669331|54633156|FG001|Blinded Treatment Period|Withdrawal by Subject|19|||
27975247|NCT00669331|54633155|FG000|Blinded Treatment Period|Lost to Follow-up|3|||
27975248|NCT00669331|54633156|FG001|Blinded Treatment Period|Lost to Follow-up|2|||
27975249|NCT00669331|54633155|FG000|Blinded Treatment Period|Death|0|||
27975250|NCT00669331|54633156|FG001|Blinded Treatment Period|Death|2|||
27975251|NCT00669331|54633155|FG000|Blinded Treatment Period|Physician Decision|3|||
27975252|NCT00669331|54633156|FG001|Blinded Treatment Period|Physician Decision|3|||
27975253|NCT00669331|54633155|FG000|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
27975254|NCT00669331|54633156|FG001|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
27975255|NCT00932126|54633164|FG000|Overall Study|Adverse Event|0|||
27975256|NCT00932126|54633165|FG001|Overall Study|Adverse Event|0|||
28086564|NCT00318461|54740053|FG004|Double-Blind, 6 Months|Adverse Event|8|||
28086565|NCT00318461|54740049|FG000|Double-Blind, 6 Months|Lack of Efficacy|19|||
27975257|NCT00932126|54633166|FG002|Overall Study|Adverse Event|0|||
27975258|NCT00932126|54633167|FG003|Overall Study|Adverse Event|0|||
27975259|NCT00932126|54633168|FG004|Overall Study|Adverse Event|0|||
27975260|NCT00932126|54633169|FG005|Overall Study|Adverse Event|0|||
27975261|NCT00932126|54633170|FG006|Overall Study|Adverse Event|1|||
27975262|NCT00932126|54633171|FG007|Overall Study|Adverse Event|2|||
27975263|NCT00932126|54633164|FG000|Overall Study|Protocol Violation|0|||
27975264|NCT00932126|54633165|FG001|Overall Study|Protocol Violation|0|||
27975265|NCT00932126|54633166|FG002|Overall Study|Protocol Violation|0|||
27975266|NCT00932126|54633167|FG003|Overall Study|Protocol Violation|0|||
27975267|NCT00932126|54633168|FG004|Overall Study|Protocol Violation|1|||
27975268|NCT00932126|54633169|FG005|Overall Study|Protocol Violation|0|||
27975269|NCT00932126|54633170|FG006|Overall Study|Protocol Violation|0|||
27975270|NCT00932126|54633171|FG007|Overall Study|Protocol Violation|0|||
27975271|NCT00932126|54633164|FG000|Overall Study|Withdrawal by Subject|0|||
27975272|NCT00932126|54633165|FG001|Overall Study|Withdrawal by Subject|0|||
27975273|NCT00932126|54633166|FG002|Overall Study|Withdrawal by Subject|1|||
27975274|NCT00932126|54633167|FG003|Overall Study|Withdrawal by Subject|0|||
27975275|NCT00932126|54633168|FG004|Overall Study|Withdrawal by Subject|0|||
27975276|NCT00932126|54633169|FG005|Overall Study|Withdrawal by Subject|0|||
27975277|NCT00932126|54633170|FG006|Overall Study|Withdrawal by Subject|0|||
27975278|NCT00932126|54633171|FG007|Overall Study|Withdrawal by Subject|1|||
27975279|NCT00932126|54633164|FG000|Overall Study|Objective progression or relapse|3|||
27975280|NCT00932126|54633165|FG001|Overall Study|Objective progression or relapse|3|||
27975281|NCT00932126|54633166|FG002|Overall Study|Objective progression or relapse|2|||
27975282|NCT00932126|54633167|FG003|Overall Study|Objective progression or relapse|3|||
27975283|NCT00932126|54633168|FG004|Overall Study|Objective progression or relapse|3|||
27975284|NCT00932126|54633169|FG005|Overall Study|Objective progression or relapse|3|||
27975285|NCT00932126|54633170|FG006|Overall Study|Objective progression or relapse|3|||
27975286|NCT00932126|54633171|FG007|Overall Study|Objective progression or relapse|5|||
27975287|NCT00932126|54633164|FG000|Overall Study|Other|0|||
27975288|NCT00932126|54633165|FG001|Overall Study|Other|0|||
27975289|NCT00932126|54633166|FG002|Overall Study|Other|0|||
27975290|NCT00932126|54633167|FG003|Overall Study|Other|0|||
27975291|NCT00932126|54633168|FG004|Overall Study|Other|1|||
27975292|NCT00932126|54633169|FG005|Overall Study|Other|0|||
27975293|NCT00932126|54633170|FG006|Overall Study|Other|1|||
27975294|NCT00932126|54633171|FG007|Overall Study|Other|2|||
27975295|NCT00667225|54633193|FG000|Overall Study|Subject had no more lesions to treat.|1|||
27975296|NCT00667225|54633194|FG001|Overall Study|Subject had no more lesions to treat.|0|||
27975297|NCT00667225|54633193|FG000|Overall Study|Lost to Follow-up|0|||
27975298|NCT00667225|54633194|FG001|Overall Study|Lost to Follow-up|1|||
27975299|NCT00929864|54633202|FG000|Overall Study|Death|1|||
27975300|NCT00929864|54633203|FG001|Overall Study|Death|1|||
27975301|NCT00929864|54633202|FG000|Overall Study|Adverse Event|11|||
27975302|NCT00929864|54633203|FG001|Overall Study|Adverse Event|30|||
27975303|NCT00929864|54633202|FG000|Overall Study|Lack of Efficacy|19|||
27975304|NCT00929864|54633203|FG001|Overall Study|Lack of Efficacy|16|||
27975305|NCT00929864|54633202|FG000|Overall Study|Lost to Follow-up|7|||
27975306|NCT00929864|54633203|FG001|Overall Study|Lost to Follow-up|12|||
27975307|NCT00929864|54633202|FG000|Overall Study|Withdrawal by Subject|20|||
27975308|NCT00929864|54633203|FG001|Overall Study|Withdrawal by Subject|9|||
27975309|NCT00929864|54633202|FG000|Overall Study|No longer met criteria|2|||
27975310|NCT00929864|54633203|FG001|Overall Study|No longer met criteria|1|||
27975311|NCT00929864|54633202|FG000|Overall Study|Poor or non-compliance|3|||
27975312|NCT00929864|54633203|FG001|Overall Study|Poor or non-compliance|3|||
27975313|NCT00929864|54633202|FG000|Overall Study|Pregnancy|0|||
27975314|NCT00929864|54633203|FG001|Overall Study|Pregnancy|3|||
27975315|NCT00929864|54633202|FG000|Overall Study|Administrative reason by Sponsor|1|||
27975316|NCT00929864|54633203|FG001|Overall Study|Administrative reason by Sponsor|1|||
27975317|NCT00929864|54633202|FG000|Overall Study|Non-specified|2|||
27975318|NCT00929864|54633203|FG001|Overall Study|Non-specified|7|||
27975319|NCT00597753|54633211|FG000|Overall Study|Adverse Event|6|||
28086566|NCT00318461|54740050|FG001|Double-Blind, 6 Months|Lack of Efficacy|8|||
28086567|NCT00318461|54740051|FG002|Double-Blind, 6 Months|Lack of Efficacy|13|||
28086568|NCT00318461|54740052|FG003|Double-Blind, 6 Months|Lack of Efficacy|29|||
28086569|NCT00318461|54740053|FG004|Double-Blind, 6 Months|Lack of Efficacy|9|||
28086570|NCT00318461|54740049|FG000|Double-Blind, 6 Months|Protocol Violation|2|||
28086571|NCT00318461|54740050|FG001|Double-Blind, 6 Months|Protocol Violation|4|||
28086572|NCT00318461|54740051|FG002|Double-Blind, 6 Months|Protocol Violation|4|||
28086573|NCT00318461|54740052|FG003|Double-Blind, 6 Months|Protocol Violation|4|||
28086574|NCT00318461|54740053|FG004|Double-Blind, 6 Months|Protocol Violation|5|||
28086575|NCT00318461|54740049|FG000|Double-Blind, 6 Months|Lost to follow up|0|||
28086576|NCT00318461|54740050|FG001|Double-Blind, 6 Months|Lost to follow up|1|||
27975320|NCT00597753|54633212|FG001|Overall Study|Adverse Event|2|||
27975321|NCT00597753|54633211|FG000|Overall Study|Death|55|||
27975322|NCT00597753|54633212|FG001|Overall Study|Death|29|||
27975323|NCT00597753|54633211|FG000|Overall Study|Lack of Efficacy|2|||
27975324|NCT00597753|54633212|FG001|Overall Study|Lack of Efficacy|0|||
27975325|NCT00597753|54633211|FG000|Overall Study|Lost to Follow-up|10|||
27975326|NCT00597753|54633212|FG001|Overall Study|Lost to Follow-up|3|||
27975327|NCT00597753|54633211|FG000|Overall Study|Physician Decision|5|||
27975328|NCT00597753|54633212|FG001|Overall Study|Physician Decision|1|||
27975329|NCT00597753|54633211|FG000|Overall Study|Pregnancy|1|||
27975330|NCT00597753|54633212|FG001|Overall Study|Pregnancy|0|||
27975331|NCT00597753|54633211|FG000|Overall Study|Withdrawal by Subject|35|||
28086577|NCT00318461|54740051|FG002|Double-Blind, 6 Months|Lost to follow up|0|||
28086578|NCT00318461|54740052|FG003|Double-Blind, 6 Months|Lost to follow up|0|||
28086579|NCT00318461|54740053|FG004|Double-Blind, 6 Months|Lost to follow up|0|||
27975332|NCT00597753|54633212|FG001|Overall Study|Withdrawal by Subject|12|||
27975333|NCT00597753|54633211|FG000|Overall Study|Discontinued Dialysis|0|||
27975334|NCT00597753|54633212|FG001|Overall Study|Discontinued Dialysis|1|||
27975335|NCT00597753|54633211|FG000|Overall Study|Never dosed|2|||
27975336|NCT00597753|54633212|FG001|Overall Study|Never dosed|0|||
27975337|NCT00597753|54633211|FG000|Overall Study|Noncompliance|2|||
27975338|NCT00597753|54633212|FG001|Overall Study|Noncompliance|1|||
28086580|NCT00318461|54740049|FG000|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
28086581|NCT00318461|54740050|FG001|Double-Blind, 6 Months|Poor compliance/Non-compliance|1|||
28086582|NCT00318461|54740051|FG002|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
28086583|NCT00318461|54740052|FG003|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
28086584|NCT00318461|54740053|FG004|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
28086585|NCT00318461|54740049|FG000|Double-Blind, 6 Months|Consent withdrawn|0|||
28086586|NCT00318461|54740050|FG001|Double-Blind, 6 Months|Consent withdrawn|3|||
28086587|NCT00318461|54740051|FG002|Double-Blind, 6 Months|Consent withdrawn|4|||
27975339|NCT00597753|54633211|FG000|Overall Study|Relocation|17|||
27975340|NCT00597753|54633212|FG001|Overall Study|Relocation|6|||
28086588|NCT00318461|54740052|FG003|Double-Blind, 6 Months|Consent withdrawn|10|||
28086589|NCT00318461|54740053|FG004|Double-Blind, 6 Months|Consent withdrawn|4|||
28086590|NCT00318461|54740049|FG000|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
28086591|NCT00318461|54740050|FG001|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
28086592|NCT00318461|54740051|FG002|Double-Blind, 6 Months|Subject decision/No wish to continue|1|||
28086593|NCT00318461|54740052|FG003|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
28086594|NCT00318461|54740053|FG004|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
28086595|NCT00318461|54740049|FG000|Double-Blind, 6 Months|Move|0|||
28086596|NCT00318461|54740050|FG001|Double-Blind, 6 Months|Move|1|||
28086597|NCT00318461|54740051|FG002|Double-Blind, 6 Months|Move|0|||
28086598|NCT00318461|54740052|FG003|Double-Blind, 6 Months|Move|0|||
28086599|NCT00318461|54740053|FG004|Double-Blind, 6 Months|Move|0|||
28086600|NCT00318461|54740049|FG000|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
28086601|NCT00318461|54740050|FG001|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
28086602|NCT00318461|54740051|FG002|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
28086603|NCT00318461|54740052|FG003|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
28086604|NCT00318461|54740053|FG004|Double-Blind, 6 Months|Tendency to low blood glucose levels|1|||
28086605|NCT00318461|54740049|FG000|Double-Blind, 6 Months|FPG exceeds limits/too high|1|||
28086606|NCT00318461|54740050|FG001|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
28086607|NCT00318461|54740051|FG002|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
28086608|NCT00318461|54740052|FG003|Double-Blind, 6 Months|FPG exceeds limits/too high|2|||
28086609|NCT00318461|54740053|FG004|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
28086610|NCT00318461|54740049|FG000|Double-Blind, 6 Months|Work commitment|0|||
28086611|NCT00318461|54740050|FG001|Double-Blind, 6 Months|Work commitment|0|||
28086612|NCT00318461|54740051|FG002|Double-Blind, 6 Months|Work commitment|0|||
27975341|NCT00597753|54633211|FG000|Overall Study|Renal transplant|10|||
27975342|NCT00597753|54633212|FG001|Overall Study|Renal transplant|3|||
27975343|NCT00597753|54633211|FG000|Overall Study|Site closed by sponsor|19|||
27975344|NCT00597753|54633212|FG001|Overall Study|Site closed by sponsor|7|||
27975345|NCT00597753|54633211|FG000|Overall Study|Site elected to close|2|||
27975346|NCT00597753|54633212|FG001|Overall Study|Site elected to close|4|||
27975347|NCT00665431|54633221|FG000|Overall Study|Adverse Event|16|||
27975348|NCT00665431|54633222|FG001|Overall Study|Adverse Event|22|||
27975349|NCT00665431|54633223|FG002|Overall Study|Adverse Event|6|||
27975350|NCT00665431|54633221|FG000|Overall Study|Withdrawal by Subject|17|||
27975351|NCT00665431|54633222|FG001|Overall Study|Withdrawal by Subject|25|||
27975352|NCT00665431|54633223|FG002|Overall Study|Withdrawal by Subject|15|||
27975353|NCT00665431|54633221|FG000|Overall Study|Lost to Follow-up|3|||
27975354|NCT00665431|54633222|FG001|Overall Study|Lost to Follow-up|3|||
27975355|NCT00665431|54633223|FG002|Overall Study|Lost to Follow-up|1|||
27975356|NCT00665431|54633221|FG000|Overall Study|Other|4|||
27975357|NCT00665431|54633222|FG001|Overall Study|Other|7|||
27975358|NCT00665431|54633223|FG002|Overall Study|Other|2|||
28086613|NCT00318461|54740052|FG003|Double-Blind, 6 Months|Work commitment|0|||
28086614|NCT00318461|54740053|FG004|Double-Blind, 6 Months|Work commitment|1|||
28086615|NCT00318461|54740049|FG000|Double-Blind, 6 Months|Investigator decision|0|||
28086616|NCT00318461|54740050|FG001|Double-Blind, 6 Months|Investigator decision|0|||
28086617|NCT00318461|54740051|FG002|Double-Blind, 6 Months|Investigator decision|0|||
27832741|NCT01729871|54312490|FG000|Overall Study|Adverse Event|7|||
27975359|NCT00934622|54633231|FG000|Overall Study|Lost to Follow-up|7|||
27975360|NCT00934622|54633231|FG000|Overall Study|2nd Intraoperative exclusion criteria|1|||
27975361|NCT00881361|54633237|FG000|Overall Study|Terminated prior to surgery|27|||
27975362|NCT00881361|54633238|FG001|Overall Study|Terminated prior to surgery|7|||
28086618|NCT00318461|54740052|FG003|Double-Blind, 6 Months|Investigator decision|0|||
28086619|NCT00318461|54740053|FG004|Double-Blind, 6 Months|Investigator decision|1|||
28086620|NCT00318461|54740049|FG000|Double-Blind, 6 Months|Lack of time|1|||
28086621|NCT00318461|54740050|FG001|Double-Blind, 6 Months|Lack of time|0|||
27975363|NCT00881361|54633239|FG002|Overall Study|Terminated prior to surgery|0|||
27975364|NCT00881361|54633237|FG000|Overall Study|Ineligible|17|||
27975365|NCT00881361|54633238|FG001|Overall Study|Ineligible|2|||
28086622|NCT00318461|54740051|FG002|Double-Blind, 6 Months|Lack of time|0|||
28086623|NCT00318461|54740052|FG003|Double-Blind, 6 Months|Lack of time|0|||
28086624|NCT00318461|54740053|FG004|Double-Blind, 6 Months|Lack of time|0|||
28086625|NCT00318461|54740049|FG000|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
28086626|NCT00318461|54740050|FG001|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
28086627|NCT00318461|54740051|FG002|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
28086628|NCT00318461|54740052|FG003|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
28086629|NCT00318461|54740053|FG004|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2|||
28086630|NCT00318461|54740049|FG000|Double-Blind, 6 Months|Hyperglicaemia|0|||
28086631|NCT00318461|54740050|FG001|Double-Blind, 6 Months|Hyperglicaemia|0|||
28086632|NCT00318461|54740051|FG002|Double-Blind, 6 Months|Hyperglicaemia|0|||
27975366|NCT00881361|54633239|FG002|Overall Study|Ineligible|2|||
27975367|NCT01000727|54633250|FG000|Overall Study|Lost to Follow-up|41|||
27975368|NCT01000727|54633251|FG001|Overall Study|Lost to Follow-up|43|||
27975369|NCT01000727|54633250|FG000|Overall Study|Withdrawal by Subject|111|||
27975370|NCT01000727|54633251|FG001|Overall Study|Withdrawal by Subject|109|||
27975371|NCT01000727|54633250|FG000|Overall Study|Study closed/terminated|23|||
27975372|NCT01000727|54633251|FG001|Overall Study|Study closed/terminated|24|||
27975373|NCT00881205|54633261|FG000|Overall Study|Adverse Event|8|||
27975374|NCT00881205|54633262|FG001|Overall Study|Adverse Event|3|||
27975375|NCT00881205|54633261|FG000|Overall Study|Withdrawal by Subject|1|||
27975376|NCT00881205|54633262|FG001|Overall Study|Withdrawal by Subject|2|||
27975377|NCT00881205|54633261|FG000|Overall Study|Lost to Follow-up|0|||
27975378|NCT00881205|54633262|FG001|Overall Study|Lost to Follow-up|1|||
27975379|NCT00881205|54633261|FG000|Overall Study|Administrative problems|1|||
27975380|NCT00881205|54633262|FG001|Overall Study|Administrative problems|1|||
27975381|NCT00881205|54633261|FG000|Overall Study|Condition no longer requires drug|1|||
27975382|NCT00881205|54633262|FG001|Overall Study|Condition no longer requires drug|0|||
27975383|NCT00879879|54633269|FG000|Overall Study|Death|1|||
27975384|NCT00879879|54633269|FG000|Overall Study|Withdrawal by Subject|1|||
27975385|NCT00879879|54633269|FG000|Overall Study|Physician Decision|1|||
27975386|NCT00661999|54633278|FG000|Overall Study|Adverse Event|11|||
27975387|NCT00661999|54633279|FG001|Overall Study|Adverse Event|5|||
27975388|NCT00661999|54633280|FG002|Overall Study|Adverse Event|8|||
27975389|NCT00661999|54633278|FG000|Overall Study|Death|8|||
27975390|NCT00661999|54633279|FG001|Overall Study|Death|6|||
27975391|NCT00661999|54633280|FG002|Overall Study|Death|3|||
27975392|NCT00661999|54633278|FG000|Overall Study|Other Reasons|5|||
27975393|NCT00661999|54633279|FG001|Overall Study|Other Reasons|12|||
27975394|NCT00661999|54633280|FG002|Overall Study|Other Reasons|23|||
27975395|NCT00661999|54633278|FG000|Overall Study|Withdrawal by Subject|30|||
27975396|NCT00661999|54633279|FG001|Overall Study|Withdrawal by Subject|23|||
27975397|NCT00661999|54633280|FG002|Overall Study|Withdrawal by Subject|14|||
27975398|NCT00661999|54633278|FG000|Overall Study|Alternative Treatment|1|||
27975399|NCT00661999|54633279|FG001|Overall Study|Alternative Treatment|0|||
27975400|NCT00661999|54633280|FG002|Overall Study|Alternative Treatment|0|||
27975401|NCT00661999|54633278|FG000|Overall Study|Other Medical Problems|4|||
27975402|NCT00661999|54633279|FG001|Overall Study|Other Medical Problems|4|||
27975403|NCT00661999|54633280|FG002|Overall Study|Other Medical Problems|9|||
27975404|NCT00665353|54633288|FG000|Study Step 1|Adverse Event|1|||
27975405|NCT00665353|54633288|FG000|Study Step 1|Withdrawal by Subject|2|||
27975406|NCT00665353|54633288|FG000|Study Step 2|Lost to Follow-up|2|||
27975407|NCT00665353|54633288|FG000|Study Step 2|Lack of Efficacy|12|||
27975408|NCT00597207|54633294|FG000|Overall Study|Lost to Follow-up|5|||
27975409|NCT00597207|54633295|FG001|Overall Study|Lost to Follow-up|7|||
27975410|NCT00879645|54633305|FG000|Overall Study|Adverse Event|1|||
27975411|NCT00879645|54633306|FG001|Overall Study|Adverse Event|0|||
27975412|NCT00879645|54633307|FG002|Overall Study|Adverse Event|0|||
27975413|NCT00879645|54633308|FG003|Overall Study|Adverse Event|0|||
27975414|NCT00664105|54633318|FG000|Overall Study|Death|3|||
27975415|NCT00664105|54633318|FG000|Overall Study|Withdrawal by Subject|5|||
27975416|NCT00664105|54633318|FG000|Overall Study|Adverse Event|9|||
28086633|NCT00318461|54740052|FG003|Double-Blind, 6 Months|Hyperglicaemia|1|||
28086634|NCT00318461|54740053|FG004|Double-Blind, 6 Months|Hyperglicaemia|0|||
27975417|NCT00664105|54633318|FG000|Overall Study|Disease progression|7|||
27975418|NCT00661687|54633323|FG000|Overall Study|Study related symptoms and complaints|5|||
27975419|NCT00661687|54633323|FG000|Overall Study|Positive slit lamp findings|4|||
27975420|NCT00661687|54633323|FG000|Overall Study|Inability to maintain wearing schedule|3|||
27975421|NCT00661687|54633323|FG000|Overall Study|Physician Decision|1|||
28086635|NCT00318461|54740049|FG000|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
28086636|NCT00318461|54740050|FG001|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
28086637|NCT00318461|54740051|FG002|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
27975422|NCT00661687|54633323|FG000|Overall Study|Adverse Event|2|||
27975423|NCT00596817|54633332|FG000|Open-label Period|Adverse Event|0|||
27975424|NCT00596817|54633333|FG001|Open-label Period|Adverse Event|49|||
27975425|NCT00596817|54633332|FG000|Open-label Period|Lack of Efficacy|0|||
27975426|NCT00596817|54633333|FG001|Open-label Period|Lack of Efficacy|33|||
27975427|NCT00596817|54633332|FG000|Open-label Period|Other Reasons|0|||
27975428|NCT00596817|54633333|FG001|Open-label Period|Other Reasons|65|||
27975429|NCT00596817|54633332|FG000|Open-label Period to Double-blind Period|Adverse Event|0|||
27975430|NCT00596817|54633333|FG001|Open-label Period to Double-blind Period|Adverse Event|5|||
27975431|NCT00596817|54633332|FG000|Open-label Period to Double-blind Period|Lack of Efficacy|0|||
27975432|NCT00596817|54633333|FG001|Open-label Period to Double-blind Period|Lack of Efficacy|24|||
27975433|NCT00596817|54633332|FG000|Open-label Period to Double-blind Period|Not Eligible|0|||
27975434|NCT00596817|54633333|FG001|Open-label Period to Double-blind Period|Not Eligible|49|||
27975435|NCT00596817|54633332|FG000|Open-label Period to Double-blind Period|Other Reasons|0|||
27975436|NCT00596817|54633333|FG001|Open-label Period to Double-blind Period|Other Reasons|14|||
27975437|NCT00596817|54633332|FG000|Double-blind Period|Adverse Event|5|||
27975438|NCT00596817|54633333|FG001|Double-blind Period|Adverse Event|16|||
27975439|NCT00596817|54633332|FG000|Double-blind Period|Lack of Efficacy|52|||
27975440|NCT00596817|54633333|FG001|Double-blind Period|Lack of Efficacy|28|||
27975441|NCT00596817|54633332|FG000|Double-blind Period|Non-compliance With Study Product|3|||
27975442|NCT00596817|54633333|FG001|Double-blind Period|Non-compliance With Study Product|4|||
27975443|NCT00596817|54633332|FG000|Double-blind Period|Protocol Violation|11|||
27975444|NCT00596817|54633333|FG001|Double-blind Period|Protocol Violation|8|||
27975445|NCT00596817|54633332|FG000|Double-blind Period|Withdrawal of Consent|7|||
27975446|NCT00596817|54633333|FG001|Double-blind Period|Withdrawal of Consent|3|||
27975447|NCT00596817|54633332|FG000|Double-blind Period|Lost to Follow-up|0|||
27975448|NCT00596817|54633333|FG001|Double-blind Period|Lost to Follow-up|2|||
27975449|NCT00596817|54633332|FG000|Double-blind Period|Other Reasons|10|||
27975450|NCT00596817|54633333|FG001|Double-blind Period|Other Reasons|18|||
27975451|NCT01000649|54633344|FG000|Overall Study|Adverse Event|5|||
27975452|NCT01000649|54633345|FG001|Overall Study|Adverse Event|1|||
27975453|NCT01000649|54633346|FG002|Overall Study|Adverse Event|2|||
27975454|NCT01000649|54633347|FG003|Overall Study|Adverse Event|4|||
27975455|NCT01000649|54633344|FG000|Overall Study|Lost to Follow-up|0|||
27975456|NCT01000649|54633345|FG001|Overall Study|Lost to Follow-up|2|||
27975457|NCT01000649|54633346|FG002|Overall Study|Lost to Follow-up|0|||
27975458|NCT01000649|54633347|FG003|Overall Study|Lost to Follow-up|2|||
27975459|NCT00879411|54633356|FG000|Overall Study|lost to follow-up (non-AE)|162|||
27975460|NCT01000493|54633362|FG000|Overall Study|Adverse Event|3|||
27975461|NCT01000493|54633363|FG001|Overall Study|Adverse Event|6|||
27975462|NCT01000493|54633362|FG000|Overall Study|Lack of Efficacy|1|||
27975463|NCT01000493|54633363|FG001|Overall Study|Lack of Efficacy|1|||
27975464|NCT01000493|54633362|FG000|Overall Study|Protocol Violation|1|||
27975465|NCT01000493|54633363|FG001|Overall Study|Protocol Violation|8|||
27975466|NCT01000493|54633362|FG000|Overall Study|Study closed/terminated|25|||
27975467|NCT01000493|54633363|FG001|Overall Study|Study closed/terminated|23|||
27975468|NCT01000493|54633362|FG000|Overall Study|Lost to Follow-up|5|||
27975469|NCT01000493|54633363|FG001|Overall Study|Lost to Follow-up|9|||
27975470|NCT01000493|54633362|FG000|Overall Study|Physician Decision|1|||
27975471|NCT01000493|54633363|FG001|Overall Study|Physician Decision|1|||
27975472|NCT01000493|54633362|FG000|Overall Study|Withdrawal by Subject|3|||
27975473|NCT01000493|54633363|FG001|Overall Study|Withdrawal by Subject|7|||
27975474|NCT00666757|54633371|FG000|Overall Study|Lost to Follow-up|39|||
27975475|NCT00666757|54633372|FG001|Overall Study|Lost to Follow-up|35|||
27975476|NCT00666757|54633371|FG000|Overall Study|Protocol Violation|23|||
27975477|NCT00666757|54633372|FG001|Overall Study|Protocol Violation|24|||
27975478|NCT00666757|54633371|FG000|Overall Study|Adverse Event|22|||
27975479|NCT00666757|54633372|FG001|Overall Study|Adverse Event|12|||
27975480|NCT00666757|54633371|FG000|Overall Study|Withdrawal by Subject|13|||
27975481|NCT00666757|54633372|FG001|Overall Study|Withdrawal by Subject|17|||
27975482|NCT00666757|54633371|FG000|Overall Study|Lack of Efficacy|3|||
27975483|NCT00666757|54633372|FG001|Overall Study|Lack of Efficacy|6|||
27975484|NCT00666757|54633371|FG000|Overall Study|Physician Decision|0|||
27975485|NCT00666757|54633372|FG001|Overall Study|Physician Decision|2|||
27975486|NCT00666757|54633371|FG000|Overall Study|Sponsor decision|0|||
27975487|NCT00666757|54633372|FG001|Overall Study|Sponsor decision|1|||
27975488|NCT01000337|54633383|FG000|Overall Study|Lost to Follow-up|4|||
27975489|NCT01000337|54633384|FG001|Overall Study|Lost to Follow-up|3|||
27975490|NCT00666679|54633392|FG000|First Intervention|Lost to Follow-up|1|||
27975491|NCT00666679|54633393|FG001|First Intervention|Lost to Follow-up|0|||
27975492|NCT00666679|54633392|FG000|First Intervention|Protocol Violation|1|||
27975493|NCT00666679|54633393|FG001|First Intervention|Protocol Violation|0|||
27975494|NCT00666679|54633392|FG000|First Intervention|Withdrawal by Subject|1|||
27975495|NCT00666679|54633393|FG001|First Intervention|Withdrawal by Subject|0|||
27975496|NCT00666679|54633392|FG000|First Intervention|Randomized did not start treatment|1|||
27975497|NCT00666679|54633393|FG001|First Intervention|Randomized did not start treatment|1|||
27975498|NCT00666679|54633392|FG000|Washout Period of 1 Week|Lost to Follow-up|0|||
27975499|NCT00666679|54633393|FG001|Washout Period of 1 Week|Lost to Follow-up|1|||
27975500|NCT00666679|54633392|FG000|Washout Period of 1 Week|Protocol Violation|0|||
27975501|NCT00666679|54633393|FG001|Washout Period of 1 Week|Protocol Violation|1|||
27975502|NCT00666679|54633392|FG000|Second Intervention|Adverse Event|1|||
27975503|NCT00666679|54633393|FG001|Second Intervention|Adverse Event|0|||
27975504|NCT00666679|54633392|FG000|Second Intervention|Death|0|||
27975505|NCT00666679|54633393|FG001|Second Intervention|Death|1|||
27975506|NCT00595413|54633403|FG000|Overall Study|Adverse Event|0|||
27975507|NCT00595413|54633404|FG001|Overall Study|Adverse Event|2|||
27975508|NCT00595413|54633405|FG002|Overall Study|Adverse Event|1|||
27975509|NCT00595413|54633406|FG003|Overall Study|Adverse Event|1|||
27975510|NCT00595413|54633403|FG000|Overall Study|Lost to Follow-up|2|||
27975511|NCT00595413|54633404|FG001|Overall Study|Lost to Follow-up|2|||
27975512|NCT00595413|54633405|FG002|Overall Study|Lost to Follow-up|1|||
27975513|NCT00595413|54633406|FG003|Overall Study|Lost to Follow-up|3|||
27975514|NCT00595413|54633403|FG000|Overall Study|Death|0|||
27975515|NCT00595413|54633404|FG001|Overall Study|Death|0|||
27975516|NCT00595413|54633405|FG002|Overall Study|Death|1|||
27975517|NCT00595413|54633406|FG003|Overall Study|Death|0|||
27975518|NCT00595413|54633403|FG000|Overall Study|Other|5|||
27975519|NCT00595413|54633404|FG001|Overall Study|Other|1|||
28165539|NCT02510794|54836149|FG001|Overall Study|Withdrawal by Subject|2|||
27733195|NCT03626545|54180984|FG000|Overall Study|Adverse Event|3|||
27975520|NCT00595413|54633405|FG002|Overall Study|Other|5|||
27975521|NCT00595413|54633406|FG003|Overall Study|Other|0|||
27975522|NCT01000025|54633418|FG000|Overall Study|Adverse Event|43|||
27975523|NCT01000025|54633419|FG001|Overall Study|Adverse Event|2|||
27975524|NCT01000025|54633418|FG000|Overall Study|Withdrawal by Subject|13|||
27975525|NCT01000025|54633419|FG001|Overall Study|Withdrawal by Subject|8|||
27975526|NCT01000025|54633418|FG000|Overall Study|Death|23|||
27975527|NCT01000025|54633419|FG001|Overall Study|Death|13|||
27975528|NCT01000025|54633418|FG000|Overall Study|Lack of Efficacy|363|||
27975529|NCT01000025|54633419|FG001|Overall Study|Lack of Efficacy|208|||
27975530|NCT01000025|54633418|FG000|Overall Study|Intercurrent Illness|26|||
27975531|NCT01000025|54633419|FG001|Overall Study|Intercurrent Illness|7|||
27975532|NCT00595335|54633427|FG000|Baseline to Six Months|Withdrawal by Subject|0|||
27975533|NCT00595335|54633428|FG001|Baseline to Six Months|Withdrawal by Subject|1|||
27975534|NCT00595335|54633427|FG000|Baseline to Six Months|Disease Progression|1|||
27975535|NCT00595335|54633428|FG001|Baseline to Six Months|Disease Progression|1|||
27975536|NCT00595335|54633427|FG000|Baseline to Six Months|Adverse Event|1|||
27975537|NCT00595335|54633428|FG001|Baseline to Six Months|Adverse Event|0|||
27975538|NCT00595335|54633427|FG000|Six Months to Twelve Months|Withdrawal by Subject|0|||
27975539|NCT00595335|54633428|FG001|Six Months to Twelve Months|Withdrawal by Subject|1|||
27975540|NCT00595335|54633427|FG000|Six Months to Twelve Months|Disease Progression|1|||
27975541|NCT00595335|54633428|FG001|Six Months to Twelve Months|Disease Progression|0|||
27975542|NCT00661609|54633438|FG000|Overall Study|Adverse Event|4|||
27975543|NCT00661609|54633438|FG000|Overall Study|Death|20|||
27975544|NCT00661609|54633438|FG000|Overall Study|Withdrawal by Subject|2|||
27975545|NCT00661609|54633438|FG000|Overall Study|PI Decision|1|||
27975546|NCT00661609|54633438|FG000|Overall Study|Survival follow up stage discontinued|11|||
27975547|NCT00661609|54633438|FG000|Overall Study|Disease progression|3|||
27975548|NCT00661531|54633442|FG000|Overall Study|Withdrawal by Subject|3|||
27975549|NCT00998309|54633446|FG000|Overall Study|Protocol Violation|4|||
27975550|NCT00999713|54633500|FG000|Overall Study|Physician Decision|2|||
27975551|NCT00999713|54633501|FG001|Overall Study|Physician Decision|0|||
27975552|NCT00997373|54633509|FG000|Overall Study|Withdrawal by Subject|5|||
27975553|NCT00997373|54633510|FG001|Overall Study|Withdrawal by Subject|0|||
27975554|NCT00997373|54633509|FG000|Overall Study|wrong tumor type|4|||
27975555|NCT00997373|54633510|FG001|Overall Study|wrong tumor type|0|||
27975556|NCT00997373|54633509|FG000|Overall Study|could not have hysterectomy|6|||
27975557|NCT00997373|54633510|FG001|Overall Study|could not have hysterectomy|0|||
27975558|NCT00663871|54633518|FG000|Overall Study|Lost to Follow-up|5|||
27975559|NCT00663871|54633519|FG001|Overall Study|Lost to Follow-up|5|||
27975560|NCT00663871|54633518|FG000|Overall Study|Withdrawal by Subject|5|||
27975561|NCT00663871|54633519|FG001|Overall Study|Withdrawal by Subject|2|||
27975562|NCT04152447|54633529|FG000|Overall Study|Lost to Follow-up|1|||
27975563|NCT04152447|54633530|FG001|Overall Study|Lost to Follow-up|0|||
27975564|NCT04152447|54633529|FG000|Overall Study|Treatment plan switched to an ineligible criteria|1|||
27975565|NCT04152447|54633530|FG001|Overall Study|Treatment plan switched to an ineligible criteria|1|||
27975566|NCT04152447|54633529|FG000|Overall Study|Withdrawal by Subject|0|||
27975567|NCT04152447|54633530|FG001|Overall Study|Withdrawal by Subject|1|||
27975568|NCT04152447|54633529|FG000|Overall Study|Found ineligible after enrolling|1|||
27975569|NCT04152447|54633530|FG001|Overall Study|Found ineligible after enrolling|1|||
27975570|NCT04152447|54633529|FG000|Overall Study|Did not receive VR headset in time.|0|||
27733196|NCT03626545|54180985|FG001|Overall Study|Adverse Event|13|||
27733197|NCT03626545|54180986|FG002|Overall Study|Adverse Event|10|||
27975571|NCT04152447|54633530|FG001|Overall Study|Did not receive VR headset in time.|2|||
27975572|NCT00996593|54633536|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7|||
27975573|NCT00996593|54633536|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3|||
27975574|NCT00996593|54633536|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|22|||
27733198|NCT03626545|54180984|FG000|Overall Study|Physician Decision|1|||
27975575|NCT00996593|54633536|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
27975576|NCT00996593|54633536|FG000|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6|||
27975577|NCT00996593|54633536|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3|||
27975578|NCT00996593|54633536|FG000|Dosimetric and Therapeutic Treatment|Non-compliance|1|||
28086638|NCT00318461|54740052|FG003|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
28086639|NCT00318461|54740053|FG004|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1|||
27975579|NCT00996593|54633536|FG000|Long-Term Follow-Up|Withdrawal by Subject|2|||
27975580|NCT00996593|54633536|FG000|Long-Term Follow-Up|Site Closed|1|||
27975581|NCT00570661|54633540|FG000|Overall Study|Disease worsening|5|||
27975582|NCT00570661|54633540|FG000|Overall Study|Unmet criterion of sufficient therapeutic response|1|||
27975583|NCT00570661|54633540|FG000|Overall Study|Adverse Event|1|||
27975584|NCT00934544|54633547|FG000|Primary Endpoint Analysis (Interim)|Adverse Event|12|||
27975585|NCT00934544|54633548|FG001|Primary Endpoint Analysis (Interim)|Adverse Event|4|||
27975586|NCT00934544|54633549|FG002|Primary Endpoint Analysis (Interim)|Adverse Event|0|||
27975587|NCT00934544|54633547|FG000|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2|||
27975588|NCT00934544|54633548|FG001|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9|||
27975589|NCT00934544|54633549|FG002|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0|||
27975590|NCT00934544|54633547|FG000|Primary Endpoint Analysis (Interim)|Protocol Violation|2|||
28086640|NCT00318461|54740049|FG000|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
28086641|NCT00318461|54740050|FG001|Double-Blind, 6 Months|Fear of experiencing AE again|1|||
28086642|NCT00318461|54740051|FG002|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
28086643|NCT00318461|54740052|FG003|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
28086644|NCT00318461|54740053|FG004|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
28086645|NCT00318461|54740049|FG000|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19|||
28086646|NCT00318461|54740050|FG001|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14|||
28086647|NCT00318461|54740051|FG002|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27|||
28086648|NCT00318461|54740052|FG003|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11|||
28086649|NCT00318461|54740053|FG004|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22|||
28086650|NCT00318461|54740049|FG000|Open-Label Extension, 18 Months|Adverse Event|11|||
28086651|NCT00318461|54740050|FG001|Open-Label Extension, 18 Months|Adverse Event|8|||
28086652|NCT00318461|54740051|FG002|Open-Label Extension, 18 Months|Adverse Event|6|||
28086653|NCT00318461|54740052|FG003|Open-Label Extension, 18 Months|Adverse Event|1|||
28086654|NCT00318461|54740053|FG004|Open-Label Extension, 18 Months|Adverse Event|6|||
28086655|NCT00318461|54740049|FG000|Open-Label Extension, 18 Months|Lack of Efficacy|41|||
28086656|NCT00318461|54740050|FG001|Open-Label Extension, 18 Months|Lack of Efficacy|33|||
28086657|NCT00318461|54740051|FG002|Open-Label Extension, 18 Months|Lack of Efficacy|37|||
28086658|NCT00318461|54740052|FG003|Open-Label Extension, 18 Months|Lack of Efficacy|27|||
28086659|NCT00318461|54740053|FG004|Open-Label Extension, 18 Months|Lack of Efficacy|63|||
28086660|NCT00318461|54740049|FG000|Open-Label Extension, 18 Months|Protocol Violation|7|||
28086661|NCT00318461|54740050|FG001|Open-Label Extension, 18 Months|Protocol Violation|5|||
27975591|NCT00934544|54633548|FG001|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
27975592|NCT00934544|54633549|FG002|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
27975593|NCT00934544|54633547|FG000|Primary Endpoint Analysis (Interim)|Disease Progression|1|||
27975594|NCT00934544|54633548|FG001|Primary Endpoint Analysis (Interim)|Disease Progression|3|||
27975595|NCT00934544|54633549|FG002|Primary Endpoint Analysis (Interim)|Disease Progression|0|||
27975596|NCT00934544|54633547|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2|||
27975597|NCT00934544|54633548|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
27975598|NCT00934544|54633549|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
27975599|NCT00934544|54633547|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
28086662|NCT00318461|54740051|FG002|Open-Label Extension, 18 Months|Protocol Violation|3|||
28086663|NCT00318461|54740052|FG003|Open-Label Extension, 18 Months|Protocol Violation|4|||
28086664|NCT00318461|54740053|FG004|Open-Label Extension, 18 Months|Protocol Violation|6|||
28086665|NCT03764072|54740080|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
28165540|NCT02510794|54836150|FG002|Overall Study|Withdrawal by Subject|4|||
28165541|NCT02510794|54836151|FG003|Overall Study|Withdrawal by Subject|3|||
28165542|NCT02510014|54836176|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
28165543|NCT02510014|54836177|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
28165544|NCT02510014|54836176|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1|||
28165545|NCT02510014|54836177|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0|||
28165546|NCT02510014|54836176|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44|||
28086666|NCT03764072|54740081|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
27975600|NCT00934544|54633548|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1|||
27975601|NCT00934544|54633549|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
27975602|NCT00934544|54633547|FG000|Primary Endpoint Analysis (Interim)|Other reasons|7|||
27975603|NCT00934544|54633548|FG001|Primary Endpoint Analysis (Interim)|Other reasons|7|||
27975604|NCT00934544|54633549|FG002|Primary Endpoint Analysis (Interim)|Other reasons|0|||
27975605|NCT00934544|54633547|FG000|Primary Endpoint Analysis (Interim)|Entered extension phase|29|||
27975606|NCT00934544|54633548|FG001|Primary Endpoint Analysis (Interim)|Entered extension phase|18|||
27975607|NCT00934544|54633549|FG002|Primary Endpoint Analysis (Interim)|Entered extension phase|0|||
27975608|NCT00934544|54633547|FG000|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16|||
28086667|NCT03764072|54740082|FG002|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
28086668|NCT03764072|54740083|FG003|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
28086669|NCT03764072|54740084|FG004|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
27975609|NCT00934544|54633548|FG001|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9|||
27975610|NCT00934544|54633549|FG002|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6|||
27975611|NCT00934544|54633547|FG000|Overall Disposition at 5 Year Follow-up|Adverse Event|35|||
27975612|NCT00934544|54633548|FG001|Overall Disposition at 5 Year Follow-up|Adverse Event|5|||
27975613|NCT00934544|54633549|FG002|Overall Disposition at 5 Year Follow-up|Adverse Event|10|||
27975614|NCT00934544|54633547|FG000|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10|||
27975615|NCT00934544|54633548|FG001|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9|||
27975616|NCT00934544|54633549|FG002|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0|||
27975617|NCT00934544|54633547|FG000|Overall Disposition at 5 Year Follow-up|Protocol Violation|2|||
27975618|NCT00934544|54633548|FG001|Overall Disposition at 5 Year Follow-up|Protocol Violation|0|||
27975619|NCT00934544|54633549|FG002|Overall Disposition at 5 Year Follow-up|Protocol Violation|5|||
27975620|NCT00934544|54633547|FG000|Overall Disposition at 5 Year Follow-up|Disease progression|32|||
27975621|NCT00934544|54633548|FG001|Overall Disposition at 5 Year Follow-up|Disease progression|4|||
27975622|NCT00934544|54633549|FG002|Overall Disposition at 5 Year Follow-up|Disease progression|7|||
27975623|NCT00934544|54633547|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4|||
27975624|NCT00934544|54633548|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0|||
27975625|NCT00934544|54633549|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1|||
27975626|NCT00934544|54633547|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
27975627|NCT00934544|54633548|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1|||
27975628|NCT00934544|54633549|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
27975629|NCT00934544|54633547|FG000|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8|||
27975630|NCT00934544|54633548|FG001|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0|||
27975631|NCT00934544|54633549|FG002|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5|||
27975632|NCT00999167|54633568|FG000|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4|||
27975633|NCT00999167|54633569|FG001|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
27975634|NCT00999167|54633570|FG002|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
27975635|NCT00999167|54633568|FG000|Part A: Open Label Safety run-in|Adverse Event|3|||
27975636|NCT00999167|54633569|FG001|Part A: Open Label Safety run-in|Adverse Event|0|||
27975637|NCT00999167|54633570|FG002|Part A: Open Label Safety run-in|Adverse Event|0|||
27975638|NCT00999167|54633568|FG000|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0|||
27975639|NCT00999167|54633569|FG001|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19|||
27975640|NCT00999167|54633570|FG002|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16|||
27975641|NCT00999167|54633568|FG000|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0|||
27975642|NCT00999167|54633569|FG001|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7|||
27975643|NCT00999167|54633570|FG002|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4|||
27975644|NCT00999167|54633568|FG000|Part B: Randomized, Placebo Controlled|Adverse Event|0|||
27975645|NCT00999167|54633569|FG001|Part B: Randomized, Placebo Controlled|Adverse Event|6|||
27975646|NCT00999167|54633570|FG002|Part B: Randomized, Placebo Controlled|Adverse Event|1|||
27975647|NCT00999167|54633568|FG000|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
27975648|NCT00999167|54633569|FG001|Part B: Randomized, Placebo Controlled|Noncompliance|1|||
27975649|NCT00999167|54633570|FG002|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
27975650|NCT00999167|54633568|FG000|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
27975651|NCT00999167|54633569|FG001|Part B: Randomized, Placebo Controlled|Physician Decision|1|||
27975652|NCT00999167|54633570|FG002|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
27975653|NCT00999167|54633568|FG000|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
27975654|NCT00999167|54633569|FG001|Part B: Randomized, Placebo Controlled|Physician stopped drug|1|||
27975655|NCT00999167|54633570|FG002|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
27975656|NCT00570505|54633580|FG000|Overall Study|Adverse Event|7|||
27975657|NCT00570505|54633580|FG000|Overall Study|Withdrawal by Subject|7|||
27975658|NCT00570505|54633580|FG000|Overall Study|Lost to Follow-up|23|||
27975659|NCT00570505|54633580|FG000|Overall Study|Other loss to follow-up|4|||
27975660|NCT00931892|54633586|FG000|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|0|||
28086670|NCT03764072|54740085|FG005|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
28086671|NCT03764072|54740080|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
27855575|NCT02834247|54380601|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
27975661|NCT00931892|54633587|FG001|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|1|||
27975662|NCT00666211|54633635|FG000|Overall Study|Withdrawal by Subject|10|||
27975663|NCT00666211|54633636|FG001|Overall Study|Withdrawal by Subject|13|||
27975664|NCT00666211|54633635|FG000|Overall Study|went off medication, no more pain|1|||
27975665|NCT00666211|54633636|FG001|Overall Study|went off medication, no more pain|0|||
27975666|NCT00666211|54633635|FG000|Overall Study|patient non-compliant|6|||
27975667|NCT00666211|54633636|FG001|Overall Study|patient non-compliant|6|||
27975668|NCT00666211|54633635|FG000|Overall Study|disease progression|1|||
27975669|NCT00666211|54633636|FG001|Overall Study|disease progression|8|||
27975670|NCT00666211|54633635|FG000|Overall Study|Lost to Follow-up|2|||
27975671|NCT00666211|54633636|FG001|Overall Study|Lost to Follow-up|0|||
27975672|NCT00666211|54633635|FG000|Overall Study|toxicity|0|||
27975673|NCT00666211|54633636|FG001|Overall Study|toxicity|2|||
27975674|NCT00666211|54633635|FG000|Overall Study|hospital admission|0|||
27975675|NCT00666211|54633636|FG001|Overall Study|hospital admission|5|||
27975676|NCT00666211|54633635|FG000|Overall Study|Death|0|||
27975677|NCT00666211|54633636|FG001|Overall Study|Death|2|||
27975678|NCT00666211|54633635|FG000|Overall Study|off tx for other complicating disease|0|||
27975679|NCT00666211|54633636|FG001|Overall Study|off tx for other complicating disease|1|||
27975680|NCT00666211|54633635|FG000|Overall Study|Physician Decision|0|||
27975681|NCT00666211|54633636|FG001|Overall Study|Physician Decision|1|||
27975682|NCT00878709|54633644|FG000|Overall Study|Withdrawal by Subject|197|||
27975683|NCT00878709|54633645|FG001|Overall Study|Withdrawal by Subject|120|||
27975684|NCT00878709|54633644|FG000|Overall Study|Lost to Follow-up|35|||
27975685|NCT00878709|54633645|FG001|Overall Study|Lost to Follow-up|33|||
27975686|NCT00878709|54633644|FG000|Overall Study|Other Reasons|93|||
27975687|NCT00878709|54633645|FG001|Overall Study|Other Reasons|84|||
27975688|NCT00927758|54633652|FG000|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
27975689|NCT00927758|54633653|FG001|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
27975690|NCT00927758|54633654|FG002|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
27975691|NCT00927758|54633655|FG003|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
27975692|NCT00927758|54633656|FG004|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
27975693|NCT00927758|54633657|FG005|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
27975694|NCT00927758|54633652|FG000|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
27975695|NCT00927758|54633653|FG001|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
27975696|NCT00927758|54633654|FG002|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
27975697|NCT00927758|54633655|FG003|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
27975698|NCT00927758|54633656|FG004|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
27975699|NCT00927758|54633657|FG005|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
27975700|NCT00927368|54633668|FG000|Overall Study|enrollment in another study|1|||
27975701|NCT00927368|54633669|FG001|Overall Study|enrollment in another study|1|||
27975702|NCT00927368|54633670|FG002|Overall Study|enrollment in another study|2|||
27975703|NCT00927368|54633668|FG000|Overall Study|Lost to Follow-up|4|||
27975704|NCT00927368|54633669|FG001|Overall Study|Lost to Follow-up|0|||
27975705|NCT00927368|54633670|FG002|Overall Study|Lost to Follow-up|0|||
27975706|NCT00927368|54633668|FG000|Overall Study|equipment failure|1|||
27975707|NCT00927368|54633669|FG001|Overall Study|equipment failure|0|||
27975708|NCT00927368|54633670|FG002|Overall Study|equipment failure|0|||
27975709|NCT00927368|54633668|FG000|Overall Study|ineligible post randomization|0|||
27975710|NCT00927368|54633669|FG001|Overall Study|ineligible post randomization|3|||
27975711|NCT00927368|54633670|FG002|Overall Study|ineligible post randomization|1|||
27975712|NCT00927368|54633668|FG000|Overall Study|cancellation of surgery|0|||
27975713|NCT00927368|54633669|FG001|Overall Study|cancellation of surgery|1|||
27975714|NCT00927368|54633670|FG002|Overall Study|cancellation of surgery|2|||
27975715|NCT00662857|54633678|FG000|Washout 1 (3 - 14 Days)|Physician Decision|0|||
27975716|NCT00662857|54633679|FG001|Washout 1 (3 - 14 Days)|Physician Decision|1|||
27975717|NCT00662857|54633678|FG000|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0|||
27975718|NCT00662857|54633679|FG001|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1|||
27975719|NCT00662857|54633678|FG000|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1|||
27975720|NCT00662857|54633679|FG001|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0|||
27975721|NCT00878553|54633692|FG000|Sleep Study|Withdrawal by Subject|2|||
27975722|NCT00878553|54633693|FG001|Sleep Study|Withdrawal by Subject|0|||
28086672|NCT03764072|54740081|FG001|Overall Study|Withdrawal of consent (for other reason)|0|||
27975723|NCT00878553|54633694|FG002|Sleep Study|Withdrawal by Subject|0|||
27975724|NCT00878553|54633695|FG003|Sleep Study|Withdrawal by Subject|0|||
28086673|NCT03764072|54740082|FG002|Overall Study|Withdrawal of consent (for other reason)|0|||
27975725|NCT00878553|54633696|FG004|Sleep Study|Withdrawal by Subject|0|||
27975726|NCT00878553|54633692|FG000|Sleep Study|Lost to Follow-up|1|||
27975727|NCT00878553|54633693|FG001|Sleep Study|Lost to Follow-up|0|||
27975728|NCT00878553|54633694|FG002|Sleep Study|Lost to Follow-up|0|||
27975729|NCT00878553|54633695|FG003|Sleep Study|Lost to Follow-up|0|||
28086674|NCT03764072|54740083|FG003|Overall Study|Withdrawal of consent (for other reason)|0|||
27975730|NCT00878553|54633696|FG004|Sleep Study|Lost to Follow-up|0|||
27975731|NCT00878553|54633692|FG000|Sleep Study|car accident|1|||
27975732|NCT00878553|54633693|FG001|Sleep Study|car accident|0|||
27975733|NCT00878553|54633694|FG002|Sleep Study|car accident|0|||
27975734|NCT00878553|54633695|FG003|Sleep Study|car accident|0|||
27975735|NCT00878553|54633696|FG004|Sleep Study|car accident|0|||
27975736|NCT00878553|54633692|FG000|Sleep Study|family emergency|1|||
27975737|NCT00878553|54633693|FG001|Sleep Study|family emergency|0|||
27975738|NCT00878553|54633694|FG002|Sleep Study|family emergency|0|||
27975739|NCT00878553|54633695|FG003|Sleep Study|family emergency|0|||
27975740|NCT00878553|54633696|FG004|Sleep Study|family emergency|0|||
27975741|NCT00878553|54633692|FG000|PK Study|Withdrawal by Subject|0|||
27975742|NCT00878553|54633693|FG001|PK Study|Withdrawal by Subject|0|||
27975743|NCT00878553|54633694|FG002|PK Study|Withdrawal by Subject|0|||
27975744|NCT00878553|54633695|FG003|PK Study|Withdrawal by Subject|1|||
27975745|NCT00878553|54633696|FG004|PK Study|Withdrawal by Subject|0|||
27975746|NCT00996437|54633715|FG000|Overall Study|Death|1|||
27975747|NCT00996437|54633716|FG001|Overall Study|Death|0|||
27975748|NCT00996437|54633715|FG000|Overall Study|Dropped|2|||
27975749|NCT00996437|54633716|FG001|Overall Study|Dropped|2|||
27975750|NCT00996437|54633715|FG000|Overall Study|Missed|2|||
27975751|NCT00996437|54633716|FG001|Overall Study|Missed|5|||
27975752|NCT00662311|54633725|FG000|Overall Study|Respiratory Infection|1|||
27975753|NCT00662311|54633726|FG001|Overall Study|Respiratory Infection|0|||
27975754|NCT00662311|54633727|FG002|Overall Study|Respiratory Infection|0|||
27975755|NCT00929708|54633740|FG000|Overall Study|Protocol Violation|2|||
27975756|NCT00929708|54633741|FG001|Overall Study|Protocol Violation|1|||
27975757|NCT00929708|54633742|FG002|Overall Study|Protocol Violation|1|||
27975758|NCT00929708|54633743|FG003|Overall Study|Protocol Violation|1|||
27975759|NCT00929708|54633744|FG004|Overall Study|Protocol Violation|1|||
27975760|NCT00929708|54633740|FG000|Overall Study|Withdrawal by Subject|2|||
27975761|NCT00929708|54633741|FG001|Overall Study|Withdrawal by Subject|0|||
27975762|NCT00929708|54633742|FG002|Overall Study|Withdrawal by Subject|0|||
27975763|NCT00929708|54633743|FG003|Overall Study|Withdrawal by Subject|2|||
27975764|NCT00929708|54633744|FG004|Overall Study|Withdrawal by Subject|1|||
27975765|NCT00929708|54633740|FG000|Overall Study|Adverse Event|0|||
27975766|NCT00929708|54633741|FG001|Overall Study|Adverse Event|0|||
27975767|NCT00929708|54633742|FG002|Overall Study|Adverse Event|0|||
27975768|NCT00929708|54633743|FG003|Overall Study|Adverse Event|0|||
27975769|NCT00929708|54633744|FG004|Overall Study|Adverse Event|3|||
27975770|NCT00929708|54633740|FG000|Overall Study|Physician Decision|0|||
27975771|NCT00929708|54633741|FG001|Overall Study|Physician Decision|2|||
27975772|NCT00929708|54633742|FG002|Overall Study|Physician Decision|2|||
27975773|NCT00929708|54633743|FG003|Overall Study|Physician Decision|2|||
27975774|NCT00929708|54633744|FG004|Overall Study|Physician Decision|1|||
27975775|NCT00929708|54633740|FG000|Overall Study|Lost to Follow-up|0|||
27975776|NCT00929708|54633741|FG001|Overall Study|Lost to Follow-up|0|||
27975777|NCT00929708|54633742|FG002|Overall Study|Lost to Follow-up|0|||
27975778|NCT00929708|54633743|FG003|Overall Study|Lost to Follow-up|1|||
27975779|NCT00929708|54633744|FG004|Overall Study|Lost to Follow-up|0|||
27975780|NCT00996281|54633758|FG000|Overall Study|Adverse Event|75|||
27975781|NCT00996281|54633759|FG001|Overall Study|Adverse Event|37|||
27975782|NCT00996281|54633758|FG000|Overall Study|Major Protocol Deviation|6|||
27975783|NCT00996281|54633759|FG001|Overall Study|Major Protocol Deviation|7|||
27975784|NCT00996281|54633758|FG000|Overall Study|Lost to Follow-up|14|||
27975785|NCT00996281|54633759|FG001|Overall Study|Lost to Follow-up|16|||
27975786|NCT00996281|54633758|FG000|Overall Study|Withdrawal by Subject|31|||
27975787|NCT00996281|54633759|FG001|Overall Study|Withdrawal by Subject|20|||
27975788|NCT00996281|54633758|FG000|Overall Study|Lack of Efficacy|0|||
27975789|NCT00996281|54633759|FG001|Overall Study|Lack of Efficacy|2|||
27975790|NCT00996281|54633758|FG000|Overall Study|Other|5|||
27975791|NCT00996281|54633759|FG001|Overall Study|Other|7|||
27975792|NCT00996203|54633765|FG000|Overall Study|Adverse Event|3|||
27975793|NCT00996203|54633765|FG000|Overall Study|Lost to Follow-up|1|||
27975794|NCT00996203|54633765|FG000|Overall Study|Lack of Efficacy|1|||
27975795|NCT00996203|54633765|FG000|Overall Study|Protocol Violation|2|||
27975796|NCT00877929|54633772|FG000|Overall Study|Adverse Event|11|||
27975797|NCT00877929|54633773|FG001|Overall Study|Adverse Event|20|||
27975798|NCT00877929|54633772|FG000|Overall Study|Protocol Violation|3|||
27975799|NCT00877929|54633773|FG001|Overall Study|Protocol Violation|3|||
27975800|NCT00877929|54633772|FG000|Overall Study|Lost to Follow-up|0|||
27975801|NCT00877929|54633773|FG001|Overall Study|Lost to Follow-up|1|||
27975802|NCT00877929|54633772|FG000|Overall Study|Withdrawal by Subject|4|||
27975803|NCT00877929|54633773|FG001|Overall Study|Withdrawal by Subject|4|||
27975804|NCT00877929|54633772|FG000|Overall Study|Lack of Efficacy|0|||
27975805|NCT00877929|54633773|FG001|Overall Study|Lack of Efficacy|1|||
27975806|NCT00877929|54633772|FG000|Overall Study|Other reason (not specified)|2|||
27975807|NCT00877929|54633773|FG001|Overall Study|Other reason (not specified)|6|||
27975808|NCT00931268|54633783|FG000|Overall Study|Lost to Follow-up|6|||
27975809|NCT00996125|54633789|FG000|Overall Study|Adverse Event|0|||
27975810|NCT00996125|54633790|FG001|Overall Study|Adverse Event|2|||
27975811|NCT00996125|54633789|FG000|Overall Study|Lost to Follow-up|1|||
27975812|NCT00996125|54633790|FG001|Overall Study|Lost to Follow-up|6|||
27975813|NCT00996125|54633789|FG000|Overall Study|Withdrawal by Subject|4|||
27975814|NCT00996125|54633790|FG001|Overall Study|Withdrawal by Subject|3|||
27975815|NCT04211363|54633798|FG000|Overall Study|Adverse Event|5|||
27975816|NCT04211363|54633799|FG001|Overall Study|Adverse Event|2|||
27975817|NCT04211363|54633798|FG000|Overall Study|Physician Decision|0|||
27975818|NCT04211363|54633799|FG001|Overall Study|Physician Decision|1|||
27975819|NCT04211363|54633798|FG000|Overall Study|Protocol Violation|1|||
27975820|NCT04211363|54633799|FG001|Overall Study|Protocol Violation|0|||
27975821|NCT04211363|54633798|FG000|Overall Study|Pregnancy|1|||
27975822|NCT04211363|54633799|FG001|Overall Study|Pregnancy|0|||
27975823|NCT04211363|54633798|FG000|Overall Study|Lost to Follow-up|12|||
27975824|NCT04211363|54633799|FG001|Overall Study|Lost to Follow-up|4|||
27975825|NCT04211363|54633798|FG000|Overall Study|Withdrawal by Subject|11|||
27975826|NCT04211363|54633799|FG001|Overall Study|Withdrawal by Subject|11|||
27975827|NCT04211363|54633798|FG000|Overall Study|Other|1|||
27975828|NCT04211363|54633799|FG001|Overall Study|Other|2|||
27975829|NCT00995345|54633810|FG000|Overall Study|Withdrawal by Subject|4|||
27975830|NCT00995345|54633811|FG001|Overall Study|Withdrawal by Subject|2|||
27975831|NCT00995345|54633812|FG002|Overall Study|Withdrawal by Subject|1|||
27975832|NCT00995345|54633813|FG003|Overall Study|Withdrawal by Subject|3|||
27975833|NCT00995345|54633814|FG004|Overall Study|Withdrawal by Subject|1|||
27975834|NCT00995345|54633810|FG000|Overall Study|Adverse Event|3|||
27975835|NCT00995345|54633811|FG001|Overall Study|Adverse Event|1|||
27975836|NCT00995345|54633812|FG002|Overall Study|Adverse Event|2|||
27975837|NCT00995345|54633813|FG003|Overall Study|Adverse Event|0|||
27975838|NCT00995345|54633814|FG004|Overall Study|Adverse Event|1|||
27975839|NCT00995345|54633810|FG000|Overall Study|Lost to Follow-up|2|||
27975840|NCT00995345|54633811|FG001|Overall Study|Lost to Follow-up|2|||
27975841|NCT00995345|54633812|FG002|Overall Study|Lost to Follow-up|2|||
27975842|NCT00995345|54633813|FG003|Overall Study|Lost to Follow-up|1|||
27975843|NCT00995345|54633814|FG004|Overall Study|Lost to Follow-up|0|||
27975844|NCT00995345|54633810|FG000|Overall Study|all other reasons combined|2|||
27975845|NCT00995345|54633811|FG001|Overall Study|all other reasons combined|2|||
27975846|NCT00995345|54633812|FG002|Overall Study|all other reasons combined|2|||
27975847|NCT00995345|54633813|FG003|Overall Study|all other reasons combined|1|||
27975848|NCT00995345|54633814|FG004|Overall Study|all other reasons combined|3|||
27975849|NCT00660907|54633828|FG000|Overall Study|Incorrect Enrollment|1|||
27975850|NCT00660907|54633829|FG001|Overall Study|Incorrect Enrollment|1|||
27975851|NCT00660907|54633828|FG000|Overall Study|Adverse Event|33|||
27975852|NCT00660907|54633829|FG001|Overall Study|Adverse Event|19|||
27975853|NCT00660907|54633828|FG000|Overall Study|Subject No Longer Meets Study Criteria|6|||
27975854|NCT00660907|54633829|FG001|Overall Study|Subject No Longer Meets Study Criteria|27|||
27975855|NCT00660907|54633828|FG000|Overall Study|Withdrawal by Subject|23|||
27975856|NCT00660907|54633829|FG001|Overall Study|Withdrawal by Subject|32|||
27975857|NCT00660907|54633828|FG000|Overall Study|Lost to Follow-up|3|||
27975858|NCT00660907|54633829|FG001|Overall Study|Lost to Follow-up|3|||
27975859|NCT00660907|54633828|FG000|Overall Study|Poor/Non-Compliance|5|||
27975860|NCT00660907|54633829|FG001|Overall Study|Poor/Non-Compliance|1|||
27975861|NCT00660907|54633828|FG000|Overall Study|Safety|1|||
27975862|NCT00660907|54633829|FG001|Overall Study|Safety|0|||
27975863|NCT00660907|54633828|FG000|Overall Study|Death|1|||
27975864|NCT00660907|54633829|FG001|Overall Study|Death|3|||
27975865|NCT00660907|54633828|FG000|Overall Study|Various|11|||
27975866|NCT00660907|54633829|FG001|Overall Study|Various|8|||
27975867|NCT00877773|54633835|FG000|Overall Study|Disease Progression|44|||
27975868|NCT00659815|54633841|FG000|Overall Study|Study related symptoms and complaints|2|||
27975869|NCT00659815|54633842|FG001|Overall Study|Study related symptoms and complaints|1|||
27975870|NCT00659815|54633841|FG000|Overall Study|Inability to maintain wearing schedule|1|||
27975871|NCT00659815|54633842|FG001|Overall Study|Inability to maintain wearing schedule|2|||
27975872|NCT00659815|54633841|FG000|Overall Study|Withdrawal by Subject|1|||
27975873|NCT00659815|54633842|FG001|Overall Study|Withdrawal by Subject|1|||
27975874|NCT00994643|54633848|FG000|Overall Study|Withdrawal by Subject|1|||
27975875|NCT00660829|54633854|FG000|Overall Study|Adverse Event|3|||
27975876|NCT00660829|54633855|FG001|Overall Study|Adverse Event|4|||
27975877|NCT00660829|54633854|FG000|Overall Study|Lack of Efficacy|2|||
27975878|NCT00660829|54633855|FG001|Overall Study|Lack of Efficacy|3|||
27975879|NCT00660829|54633854|FG000|Overall Study|Non-Compliance|0|||
27975880|NCT00660829|54633855|FG001|Overall Study|Non-Compliance|4|||
27975881|NCT00660829|54633854|FG000|Overall Study|Withdrawal by Subject|1|||
27975882|NCT00660829|54633855|FG001|Overall Study|Withdrawal by Subject|2|||
27975883|NCT00660829|54633854|FG000|Overall Study|Lost to Follow-up|3|||
27975884|NCT00660829|54633855|FG001|Overall Study|Lost to Follow-up|2|||
27975885|NCT00660829|54633854|FG000|Overall Study|Other|9|||
27975886|NCT00660829|54633855|FG001|Overall Study|Other|4|||
27975887|NCT00877383|54633863|FG000|Overall Study|Adverse Event|13|||
27975888|NCT00877383|54633864|FG001|Overall Study|Adverse Event|14|||
27975889|NCT00877383|54633863|FG000|Overall Study|Lost to Follow-up|5|||
27975890|NCT00877383|54633864|FG001|Overall Study|Lost to Follow-up|3|||
27975891|NCT00877383|54633863|FG000|Overall Study|Subject withdrew consent|3|||
27975892|NCT00877383|54633864|FG001|Overall Study|Subject withdrew consent|12|||
27975893|NCT00877383|54633863|FG000|Overall Study|Subject no longer requires study drug|2|||
27975894|NCT00877383|54633864|FG001|Overall Study|Subject no longer requires study drug|0|||
27975895|NCT00877383|54633863|FG000|Overall Study|Administrative problems|2|||
27975896|NCT00877383|54633864|FG001|Overall Study|Administrative problems|0|||
27975897|NCT00877383|54633863|FG000|Overall Study|Protocol deviation|2|||
27975898|NCT00877383|54633864|FG001|Overall Study|Protocol deviation|6|||
27975899|NCT00877383|54633863|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
27975900|NCT00877383|54633864|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
27975901|NCT00877383|54633863|FG000|Overall Study|Death|1|||
27975902|NCT00877383|54633864|FG001|Overall Study|Death|2|||
27975903|NCT00993473|54633872|FG000|Overall Study|Adverse Event|0|||
27975904|NCT00993473|54633873|FG001|Overall Study|Adverse Event|2|||
27975905|NCT00993473|54633872|FG000|Overall Study|Protocol Violation|1|||
27975906|NCT00993473|54633873|FG001|Overall Study|Protocol Violation|2|||
27975907|NCT00993473|54633872|FG000|Overall Study|Lost to Follow-up|1|||
27975908|NCT00993473|54633873|FG001|Overall Study|Lost to Follow-up|0|||
27975909|NCT00993473|54633872|FG000|Overall Study|Withdrawal by Subject|1|||
27975910|NCT00993473|54633873|FG001|Overall Study|Withdrawal by Subject|5|||
27975911|NCT00993473|54633872|FG000|Overall Study|Technical problem with CGM device|0|||
27975912|NCT00993473|54633873|FG001|Overall Study|Technical problem with CGM device|1|||
27975913|NCT00993473|54633872|FG000|Overall Study|Family event|1|||
27975914|NCT00993473|54633873|FG001|Overall Study|Family event|0|||
27975915|NCT00660595|54633881|FG000|Overall Study|Lost to Follow-up|0|||
27975916|NCT00660595|54633882|FG001|Overall Study|Lost to Follow-up|1|||
27975917|NCT00660595|54633881|FG000|Overall Study|Did not consent to participate in study|12|||
27975918|NCT00660595|54633882|FG001|Overall Study|Did not consent to participate in study|8|||
27975919|NCT00660595|54633881|FG000|Overall Study|Participant left hospital|1|||
27975920|NCT00660595|54633882|FG001|Overall Study|Participant left hospital|0|||
27975921|NCT00660595|54633881|FG000|Overall Study|Non Specified reasons|5|||
27975922|NCT00660595|54633882|FG001|Overall Study|Non Specified reasons|0|||
27975923|NCT00929240|54633888|FG000|Initial Treatment Phase|Adverse Event|31|||
27975924|NCT00929240|54633889|FG001|Initial Treatment Phase|Adverse Event|0|||
27975925|NCT00929240|54633890|FG002|Initial Treatment Phase|Adverse Event|0|||
27975926|NCT00929240|54633888|FG000|Initial Treatment Phase|Disease progression|41|||
27975927|NCT00929240|54633889|FG001|Initial Treatment Phase|Disease progression|0|||
27975928|NCT00929240|54633890|FG002|Initial Treatment Phase|Disease progression|0|||
27975929|NCT00929240|54633888|FG000|Initial Treatment Phase|Withdrawal by Subject|13|||
27975930|NCT00929240|54633889|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
27975931|NCT00929240|54633890|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
27975932|NCT00929240|54633888|FG000|Initial Treatment Phase|Protocol Violation|5|||
27975933|NCT00929240|54633889|FG001|Initial Treatment Phase|Protocol Violation|0|||
27975934|NCT00929240|54633890|FG002|Initial Treatment Phase|Protocol Violation|0|||
27975935|NCT00929240|54633888|FG000|Initial Treatment Phase|Death|2|||
27975936|NCT00929240|54633889|FG001|Initial Treatment Phase|Death|0|||
27975937|NCT00929240|54633890|FG002|Initial Treatment Phase|Death|0|||
27975938|NCT00929240|54633888|FG000|Initial Treatment Phase|Health authority/Study termination|3|||
27975939|NCT00929240|54633889|FG001|Initial Treatment Phase|Health authority/Study termination|0|||
27975940|NCT00929240|54633890|FG002|Initial Treatment Phase|Health authority/Study termination|0|||
27975941|NCT00929240|54633888|FG000|Initial Treatment Phase|Physician Decision|4|||
27975942|NCT00929240|54633889|FG001|Initial Treatment Phase|Physician Decision|0|||
27975943|NCT00929240|54633890|FG002|Initial Treatment Phase|Physician Decision|0|||
27975944|NCT00929240|54633888|FG000|Maintenance Phase|Disease progression|0|||
27975945|NCT00929240|54633889|FG001|Maintenance Phase|Disease progression|73|||
27975946|NCT00929240|54633890|FG002|Maintenance Phase|Disease progression|60|||
27975947|NCT00929240|54633888|FG000|Maintenance Phase|Adverse Event|0|||
27975948|NCT00929240|54633889|FG001|Maintenance Phase|Adverse Event|9|||
27975949|NCT00929240|54633890|FG002|Maintenance Phase|Adverse Event|12|||
27975950|NCT00929240|54633888|FG000|Maintenance Phase|Withdrawal by Subject|0|||
27975951|NCT00929240|54633889|FG001|Maintenance Phase|Withdrawal by Subject|2|||
27975952|NCT00929240|54633890|FG002|Maintenance Phase|Withdrawal by Subject|6|||
27975953|NCT00929240|54633888|FG000|Maintenance Phase|Protocol Violation|0|||
27975954|NCT00929240|54633889|FG001|Maintenance Phase|Protocol Violation|1|||
27975955|NCT00929240|54633890|FG002|Maintenance Phase|Protocol Violation|0|||
27855576|NCT02834247|54380598|FG000|Dose Expansion Phase|Study Terminated by Sponsor|0|||
27855577|NCT02834247|54380599|FG001|Dose Expansion Phase|Study Terminated by Sponsor|0|||
27855578|NCT02834247|54380600|FG002|Dose Expansion Phase|Study Terminated by Sponsor|0|||
27855579|NCT02834247|54380601|FG003|Dose Expansion Phase|Study Terminated by Sponsor|7|||
27855580|NCT02834247|54380598|FG000|Dose Expansion Phase|Death|0|||
27975956|NCT00929240|54633888|FG000|Maintenance Phase|Health authority/Study termination|0|||
27975957|NCT00929240|54633889|FG001|Maintenance Phase|Health authority/Study termination|1|||
27975958|NCT00929240|54633890|FG002|Maintenance Phase|Health authority/Study termination|2|||
27975959|NCT00929240|54633888|FG000|Maintenance Phase|Physician Decision|0|||
27975960|NCT00929240|54633889|FG001|Maintenance Phase|Physician Decision|2|||
27975961|NCT00929240|54633890|FG002|Maintenance Phase|Physician Decision|1|||
27975962|NCT00929240|54633888|FG000|Maintenance Phase|Change of treatment|0|||
27975963|NCT00929240|54633889|FG001|Maintenance Phase|Change of treatment|4|||
27975964|NCT00929240|54633890|FG002|Maintenance Phase|Change of treatment|0|||
27975965|NCT00929240|54633888|FG000|Maintenance Phase|Treatment ongoing at study closure|0|||
27975966|NCT00929240|54633889|FG001|Maintenance Phase|Treatment ongoing at study closure|0|||
27975967|NCT00929240|54633890|FG002|Maintenance Phase|Treatment ongoing at study closure|10|||
27975968|NCT00929240|54633888|FG000|Maintenance Phase|Participant not treated|0|||
27975969|NCT00929240|54633889|FG001|Maintenance Phase|Participant not treated|2|||
28086675|NCT03764072|54740084|FG004|Overall Study|Withdrawal of consent (for other reason)|0|||
28086676|NCT03764072|54740085|FG005|Overall Study|Withdrawal of consent (for other reason)|1|||
28086677|NCT03764072|54740080|FG000|Overall Study|Lost to Follow-up|0|||
28086678|NCT03764072|54740081|FG001|Overall Study|Lost to Follow-up|0|||
27975970|NCT00929240|54633890|FG002|Maintenance Phase|Participant not treated|0|||
27975971|NCT00993317|54633901|FG000|Overall Study|Adverse Event|2|||
27975972|NCT00993317|54633902|FG001|Overall Study|Adverse Event|4|||
27975973|NCT00993317|54633901|FG000|Overall Study|Lack of Efficacy|18|||
27975974|NCT00993317|54633902|FG001|Overall Study|Lack of Efficacy|18|||
27975975|NCT00993317|54633901|FG000|Overall Study|Withdrawal by Subject|0|||
27975976|NCT00993317|54633902|FG001|Overall Study|Withdrawal by Subject|2|||
27975977|NCT00993317|54633901|FG000|Overall Study|Investigator's opinion|0|||
27975978|NCT00993317|54633902|FG001|Overall Study|Investigator's opinion|1|||
27975979|NCT00993317|54633901|FG000|Overall Study|Early study termination at the site|1|||
27975980|NCT00993317|54633902|FG001|Overall Study|Early study termination at the site|0|||
28086679|NCT03764072|54740082|FG002|Overall Study|Lost to Follow-up|0|||
28086680|NCT03764072|54740083|FG003|Overall Study|Lost to Follow-up|0|||
28086681|NCT03764072|54740084|FG004|Overall Study|Lost to Follow-up|1|||
28165547|NCT02510014|54836177|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3|||
28165548|NCT02510014|54836176|FG000|Run-In Period (Days -14 to Day -1)|Physician Decision|0|||
28165549|NCT02510014|54836177|FG001|Run-In Period (Days -14 to Day -1)|Physician Decision|1|||
28165550|NCT02510014|54836176|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22|||
27733199|NCT03626545|54180985|FG001|Overall Study|Physician Decision|18|||
27733200|NCT03626545|54180986|FG002|Overall Study|Physician Decision|14|||
27733201|NCT03626545|54180984|FG000|Overall Study|Subject Decision|0|||
27733202|NCT03626545|54180985|FG001|Overall Study|Subject Decision|5|||
27733203|NCT03626545|54180986|FG002|Overall Study|Subject Decision|5|||
27733204|NCT03626545|54180984|FG000|Overall Study|Death|1|||
27733205|NCT03626545|54180985|FG001|Overall Study|Death|1|||
27733206|NCT03626545|54180986|FG002|Overall Study|Death|1|||
27733207|NCT03626545|54180984|FG000|Overall Study|Protocol Deviation|0|||
27733208|NCT03626545|54180985|FG001|Overall Study|Protocol Deviation|1|||
27733209|NCT03626545|54180986|FG002|Overall Study|Protocol Deviation|1|||
27733210|NCT03626545|54180984|FG000|Overall Study|Guardian Decision|0|||
27733211|NCT03626545|54180985|FG001|Overall Study|Guardian Decision|0|||
27733212|NCT03626545|54180986|FG002|Overall Study|Guardian Decision|1|||
27733213|NCT02688621|54181002|FG000|Overall Study|Pregnancy|1|||
27733214|NCT02688621|54181003|FG001|Overall Study|Pregnancy|3|||
27733215|NCT02688621|54181002|FG000|Overall Study|Lost to Follow-up|38|||
27733216|NCT02688621|54181003|FG001|Overall Study|Lost to Follow-up|15|||
27733217|NCT02688621|54181002|FG000|Overall Study|Withdrawal by Subject|1|||
27733218|NCT02688621|54181003|FG001|Overall Study|Withdrawal by Subject|0|||
27975981|NCT01030133|54633910|FG000|Overall Study|failed to experience pain at level 7/10|2|||
28165551|NCT02510014|54836177|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3|||
28165552|NCT02510014|54836176|FG000|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7|||
28165553|NCT02510014|54836177|FG001|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1|||
28165554|NCT02510014|54836176|FG000|Run-In Period (Days -14 to Day -1)|Protocol Violation|2|||
28165555|NCT02510014|54836177|FG001|Run-In Period (Days -14 to Day -1)|Protocol Violation|0|||
28165556|NCT02510014|54836176|FG000|Run-In Period (Days -14 to Day -1)|Other|19|||
28165557|NCT02510014|54836177|FG001|Run-In Period (Days -14 to Day -1)|Other|1|||
28165558|NCT02510014|54836176|FG000|Treatment Period|Adverse Event|11|||
28165559|NCT02510014|54836177|FG001|Treatment Period|Adverse Event|4|||
28165560|NCT02510014|54836176|FG000|Treatment Period|Withdrawal symptoms|3|||
28165561|NCT02510014|54836177|FG001|Treatment Period|Withdrawal symptoms|0|||
28165562|NCT02510014|54836176|FG000|Treatment Period|Lost to Follow-up|80|||
28165563|NCT02510014|54836177|FG001|Treatment Period|Lost to Follow-up|19|||
28165564|NCT02510014|54836176|FG000|Treatment Period|Physician Decision|5|||
28086682|NCT03764072|54740085|FG005|Overall Study|Lost to Follow-up|0|||
28165565|NCT02510014|54836177|FG001|Treatment Period|Physician Decision|0|||
27975982|NCT01030133|54633911|FG001|Overall Study|failed to experience pain at level 7/10|2|||
28086683|NCT03333928|54740107|FG000|Initial Dosing Period (Period 1)|Protocol Violation|0|||
27733219|NCT04227704|54181015|FG000|Overall Study|due to anesthesia being changed to general anesthesia|0|||
27733220|NCT04227704|54181016|FG001|Overall Study|due to anesthesia being changed to general anesthesia|1|||
27733221|NCT04227704|54181017|FG002|Overall Study|due to anesthesia being changed to general anesthesia|0|||
27975983|NCT00877071|54633921|FG000|Overall Study|disease progression|2|||
27975984|NCT00987389|54633927|FG000|Overall Study|Ineligible|0|||
27975985|NCT00987389|54633928|FG001|Overall Study|Ineligible|3|||
27975986|NCT00987389|54633929|FG002|Overall Study|Ineligible|0|||
27975987|NCT00987389|54633930|FG003|Overall Study|Ineligible|0|||
27975988|NCT00987389|54633927|FG000|Overall Study|Lost to Follow-up|4|||
27975989|NCT00987389|54633928|FG001|Overall Study|Lost to Follow-up|1|||
27975990|NCT00987389|54633929|FG002|Overall Study|Lost to Follow-up|3|||
27975991|NCT00987389|54633930|FG003|Overall Study|Lost to Follow-up|1|||
27975992|NCT00987389|54633927|FG000|Overall Study|Withdrawal by Subject|4|||
27975993|NCT00987389|54633928|FG001|Overall Study|Withdrawal by Subject|3|||
27975994|NCT00987389|54633929|FG002|Overall Study|Withdrawal by Subject|2|||
27975995|NCT00987389|54633930|FG003|Overall Study|Withdrawal by Subject|1|||
27975996|NCT00987389|54633927|FG000|Overall Study|Withdrawn from Treatment|0|||
27975997|NCT00987389|54633928|FG001|Overall Study|Withdrawn from Treatment|1|||
27975998|NCT00987389|54633929|FG002|Overall Study|Withdrawn from Treatment|0|||
27975999|NCT00987389|54633930|FG003|Overall Study|Withdrawn from Treatment|0|||
27976000|NCT00987389|54633927|FG000|Overall Study|Multiple different reasons|1|||
27976001|NCT00987389|54633928|FG001|Overall Study|Multiple different reasons|0|||
27976002|NCT00987389|54633929|FG002|Overall Study|Multiple different reasons|3|||
27976003|NCT00987389|54633930|FG003|Overall Study|Multiple different reasons|1|||
27976004|NCT00929162|54633940|FG000|Overall Study|Adverse Event|8|||
27976005|NCT00929162|54633941|FG001|Overall Study|Adverse Event|5|||
27976006|NCT00929162|54633940|FG000|Overall Study|Withdrawal by Subject|3|||
27976007|NCT00929162|54633941|FG001|Overall Study|Withdrawal by Subject|1|||
27976008|NCT00929162|54633940|FG000|Overall Study|Protocol Violation|32|||
27976009|NCT00929162|54633941|FG001|Overall Study|Protocol Violation|30|||
27976010|NCT00929162|54633940|FG000|Overall Study|Other termination reason|5|||
27976011|NCT00929162|54633941|FG001|Overall Study|Other termination reason|6|||
27976012|NCT00992459|54633949|FG000|Overall Study|Withdrawal by Subject|0|||
27976013|NCT00992459|54633950|FG001|Overall Study|Withdrawal by Subject|1|||
27976014|NCT00992459|54633949|FG000|Overall Study|Adverse Event|1|||
27976015|NCT00992459|54633950|FG001|Overall Study|Adverse Event|0|||
27976016|NCT00930722|54633956|FG000|Overall Study|Lost to Follow-up|16|||
27976017|NCT00930722|54633956|FG000|Overall Study|No longer willing to participate|9|||
27976018|NCT00930722|54633956|FG000|Overall Study|Study terminated by sponsor|2|||
27976019|NCT00992225|54633960|FG000|Overall Study|Entry Criteria Not Met|8|||
27976020|NCT00992225|54633960|FG000|Overall Study|Adverse Event|2|||
27976021|NCT00659581|54633964|FG000|Overall Study|Adverse Event|1006|||
27976022|NCT00659581|54633964|FG000|Overall Study|Lack of Efficacy|1183|||
27976023|NCT00659581|54633964|FG000|Overall Study|Other|6393|||
27976024|NCT00991289|54633968|FG000|Overall Study|Adverse Event|1|||
27976025|NCT00991289|54633968|FG000|Overall Study|Physician Decision|2|||
27976026|NCT00991289|54633968|FG000|Overall Study|Withdrawal by Subject|3|||
27976027|NCT00991289|54633968|FG000|Overall Study|Lost to Follow-up|4|||
27976028|NCT00991289|54633968|FG000|Overall Study|Protocol Violation|2|||
27976029|NCT00930644|54633972|FG000|Overall Study|Withdrawal by Subject|4|||
27976030|NCT00930644|54633972|FG000|Overall Study|Physician Decision|2|||
27976031|NCT00930644|54633972|FG000|Overall Study|Death|1|||
27976032|NCT00930644|54633972|FG000|Overall Study|Adverse Event|16|||
27976033|NCT00990821|54633993|FG000|Overall Study|Withdrawal by Subject|0|||
27976034|NCT00990821|54633994|FG001|Overall Study|Withdrawal by Subject|2|||
27976035|NCT00990821|54633995|FG002|Overall Study|Withdrawal by Subject|0|||
27976036|NCT00990821|54633996|FG003|Overall Study|Withdrawal by Subject|0|||
27976037|NCT00990821|54633997|FG004|Overall Study|Withdrawal by Subject|3|||
27976038|NCT00990821|54633998|FG005|Overall Study|Withdrawal by Subject|3|||
27976039|NCT00990821|54633999|FG006|Overall Study|Withdrawal by Subject|1|||
27976040|NCT00990821|54634000|FG007|Overall Study|Withdrawal by Subject|0|||
27976041|NCT00990821|54634001|FG008|Overall Study|Withdrawal by Subject|0|||
27976042|NCT00990821|54634002|FG009|Overall Study|Withdrawal by Subject|1|||
27976043|NCT00990821|54634003|FG010|Overall Study|Withdrawal by Subject|3|||
27976044|NCT00990821|54634004|FG011|Overall Study|Withdrawal by Subject|5|||
27976045|NCT00990821|54634005|FG012|Overall Study|Withdrawal by Subject|2|||
27976046|NCT00990821|54634006|FG013|Overall Study|Withdrawal by Subject|1|||
27976047|NCT00990665|54634023|FG000|Overall Study|Unsuccessful Implant|8|||
27976048|NCT00990665|54634023|FG000|Overall Study|Death|29|||
27976049|NCT00990665|54634023|FG000|Overall Study|Heart Transplant|1|||
27976050|NCT00990665|54634023|FG000|Overall Study|Withdrawal by Subject|6|||
27976051|NCT00990665|54634023|FG000|Overall Study|Lost to Follow-up|1|||
27976052|NCT00990665|54634023|FG000|Overall Study|System Explant|3|||
27976053|NCT00658567|54634032|FG000|Overall Study|Adverse Event|5|||
27976054|NCT00658567|54634033|FG001|Overall Study|Adverse Event|2|||
27976055|NCT00658567|54634034|FG002|Overall Study|Adverse Event|3|||
27976056|NCT00658567|54634032|FG000|Overall Study|Voluntary Withdrawal of Consent|2|||
27976057|NCT00658567|54634033|FG001|Overall Study|Voluntary Withdrawal of Consent|0|||
27976058|NCT00658567|54634034|FG002|Overall Study|Voluntary Withdrawal of Consent|2|||
27976059|NCT00658567|54634032|FG000|Overall Study|Physician Decision|0|||
27976060|NCT00658567|54634033|FG001|Overall Study|Physician Decision|1|||
27976061|NCT00658567|54634034|FG002|Overall Study|Physician Decision|0|||
27976062|NCT00658567|54634032|FG000|Overall Study|At Discretion of Sponsor|1|||
27976063|NCT00658567|54634033|FG001|Overall Study|At Discretion of Sponsor|1|||
27976064|NCT00658567|54634034|FG002|Overall Study|At Discretion of Sponsor|1|||
27976065|NCT00875433|54634042|FG000|Overall Study|Progressive disease|41|||
27976066|NCT00875433|54634042|FG000|Overall Study|Other Adverse Event|14|||
27976067|NCT00875433|54634042|FG000|Overall Study|Withdrawal by Subject|2|||
27976068|NCT00875433|54634042|FG000|Overall Study|Other|3|||
27976069|NCT00985985|54634050|FG000|Overall Study|Adverse Event|4|||
27976070|NCT00985985|54634051|FG001|Overall Study|Adverse Event|2|||
27976071|NCT00985985|54634052|FG002|Overall Study|Adverse Event|2|||
27976072|NCT00985985|54634053|FG003|Overall Study|Adverse Event|2|||
27976073|NCT00985985|54634050|FG000|Overall Study|Lost to Follow-up|4|||
27976074|NCT00985985|54634051|FG001|Overall Study|Lost to Follow-up|11|||
27976075|NCT00985985|54634052|FG002|Overall Study|Lost to Follow-up|2|||
27976076|NCT00985985|54634053|FG003|Overall Study|Lost to Follow-up|3|||
27976077|NCT00985985|54634050|FG000|Overall Study|Protocol Violation|1|||
27976078|NCT00985985|54634051|FG001|Overall Study|Protocol Violation|2|||
27976079|NCT00985985|54634052|FG002|Overall Study|Protocol Violation|0|||
27976080|NCT00985985|54634053|FG003|Overall Study|Protocol Violation|1|||
27976081|NCT00985985|54634050|FG000|Overall Study|Lack of Efficacy|5|||
27976082|NCT00985985|54634051|FG001|Overall Study|Lack of Efficacy|6|||
27976083|NCT00985985|54634052|FG002|Overall Study|Lack of Efficacy|1|||
27976084|NCT00985985|54634053|FG003|Overall Study|Lack of Efficacy|3|||
27976085|NCT00985985|54634050|FG000|Overall Study|Withdrawal by Subject|4|||
27976086|NCT00985985|54634051|FG001|Overall Study|Withdrawal by Subject|2|||
27976087|NCT00985985|54634052|FG002|Overall Study|Withdrawal by Subject|2|||
27976088|NCT00985985|54634053|FG003|Overall Study|Withdrawal by Subject|2|||
27976089|NCT00985985|54634050|FG000|Overall Study|Other Reason|6|||
27976090|NCT00985985|54634051|FG001|Overall Study|Other Reason|1|||
27976091|NCT00985985|54634052|FG002|Overall Study|Other Reason|4|||
27976092|NCT00985985|54634053|FG003|Overall Study|Other Reason|2|||
27976093|NCT00923936|54634070|FG000|Overall Study|progressive disease on study|2|||
27976094|NCT00923936|54634071|FG001|Overall Study|progressive disease on study|1|||
27976095|NCT00923936|54634070|FG000|Overall Study|Adverse Event|2|||
27976096|NCT00923936|54634071|FG001|Overall Study|Adverse Event|1|||
27976097|NCT00923936|54634070|FG000|Overall Study|Lost to follow up|2|||
27976098|NCT00923936|54634071|FG001|Overall Study|Lost to follow up|0|||
27976099|NCT00923936|54634070|FG000|Overall Study|Continuing in follow up period|2|||
27976100|NCT00923936|54634071|FG001|Overall Study|Continuing in follow up period|1|||
27976101|NCT00924950|54634079|FG000|Overall Study|Lost to Follow-up|2|||
27976102|NCT00988637|54634088|FG000|Overall Study|Lost to Follow-up|2|||
27976103|NCT00988637|54634089|FG001|Overall Study|Lost to Follow-up|1|||
27976104|NCT00988637|54634088|FG000|Overall Study|Withdrawal by Subject|1|||
27976105|NCT00988637|54634089|FG001|Overall Study|Withdrawal by Subject|1|||
27976106|NCT00988637|54634088|FG000|Overall Study|non-compliance with study drug|0|||
27976107|NCT00988637|54634089|FG001|Overall Study|non-compliance with study drug|1|||
27976108|NCT00923702|54634100|FG000|Overall Study|Ongoing enrollment|0|||
27976109|NCT00923702|54634101|FG001|Overall Study|Ongoing enrollment|0|||
27976110|NCT00923702|54634102|FG002|Overall Study|Ongoing enrollment|0|||
27976111|NCT00923702|54634103|FG003|Overall Study|Ongoing enrollment|0|||
27976112|NCT00923702|54634104|FG004|Overall Study|Ongoing enrollment|354|||
27976113|NCT00923156|54634119|FG000|Overall Study|Adverse Event|0|||
27976114|NCT00923156|54634120|FG001|Overall Study|Adverse Event|2|||
27976115|NCT00923156|54634121|FG002|Overall Study|Adverse Event|1|||
27976116|NCT00923156|54634119|FG000|Overall Study|Abnormal laboratory values|0|||
28086684|NCT03333928|54740108|FG001|Initial Dosing Period (Period 1)|Protocol Violation|0|||
28086685|NCT03333928|54740109|FG002|Initial Dosing Period (Period 1)|Protocol Violation|1|||
28086686|NCT03333928|54740107|FG000|Initial Dosing Period (Period 1)|Withdrawal by Subject|0|||
28086687|NCT03333928|54740108|FG001|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
28086688|NCT03333928|54740109|FG002|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
27733222|NCT04227704|54181015|FG000|Overall Study|due to C/S being cancelled|1|||
27733223|NCT04227704|54181016|FG001|Overall Study|due to C/S being cancelled|0|||
27976117|NCT00923156|54634120|FG001|Overall Study|Abnormal laboratory values|0|||
27976118|NCT00923156|54634121|FG002|Overall Study|Abnormal laboratory values|1|||
27976119|NCT00923156|54634119|FG000|Overall Study|Withdrawal by Subject|0|||
27976120|NCT00923156|54634120|FG001|Overall Study|Withdrawal by Subject|1|||
27976121|NCT00923156|54634121|FG002|Overall Study|Withdrawal by Subject|0|||
27976122|NCT00923156|54634119|FG000|Overall Study|Death|0|||
27976123|NCT00923156|54634120|FG001|Overall Study|Death|1|||
27976124|NCT00923156|54634121|FG002|Overall Study|Death|0|||
27976125|NCT00923156|54634119|FG000|Overall Study|Lack of Efficacy|0|||
27976126|NCT00923156|54634120|FG001|Overall Study|Lack of Efficacy|0|||
27976127|NCT00923156|54634121|FG002|Overall Study|Lack of Efficacy|1|||
27976128|NCT00874731|54634129|FG000|Part 1, Day 1: Placebo|Disease Progression|1|||
27976129|NCT00874731|54634130|FG001|Part 1, Day 1: Placebo|Disease Progression|0|||
27976130|NCT00874731|54634131|FG002|Part 1, Day 1: Placebo|Disease Progression|0|||
27976131|NCT00874731|54634129|FG000|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
27976132|NCT00874731|54634130|FG001|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
27976133|NCT00874731|54634131|FG002|Part 2: Ridaforolimus 40 mg|Adverse Event|3|||
27976134|NCT00874731|54634129|FG000|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
27976135|NCT00874731|54634130|FG001|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
27976136|NCT00874731|54634131|FG002|Part 2: Ridaforolimus 40 mg|Disease Progression|19|||
27976137|NCT00924638|54634141|FG000|Overall Study|Death|3|||
27976138|NCT00924638|54634142|FG001|Overall Study|Death|2|||
27976139|NCT00924638|54634141|FG000|Overall Study|Lost to Follow-up|1|||
27976140|NCT00924638|54634142|FG001|Overall Study|Lost to Follow-up|1|||
27976141|NCT00924638|54634141|FG000|Overall Study|Withdrawal by Subject|5|||
27976142|NCT00924638|54634142|FG001|Overall Study|Withdrawal by Subject|7|||
27976143|NCT00924638|54634141|FG000|Overall Study|Physician Decision|3|||
27976144|NCT00924638|54634142|FG001|Overall Study|Physician Decision|3|||
27976145|NCT00874497|54634150|FG000|Overall Study|Lost to Follow-up|2|||
27976146|NCT00874497|54634151|FG001|Overall Study|Lost to Follow-up|4|||
27976147|NCT00874497|54634150|FG000|Overall Study|Adverse Event|9|||
27976148|NCT00874497|54634151|FG001|Overall Study|Adverse Event|4|||
27976149|NCT00874497|54634150|FG000|Overall Study|Sponsor Discontinued Trial|7|||
27976150|NCT00874497|54634151|FG001|Overall Study|Sponsor Discontinued Trial|3|||
27976151|NCT00874497|54634150|FG000|Overall Study|Met Withdrawal Criteria|4|||
27976152|NCT00874497|54634151|FG001|Overall Study|Met Withdrawal Criteria|2|||
27976153|NCT00874497|54634150|FG000|Overall Study|Physician Decision|1|||
27976154|NCT00874497|54634151|FG001|Overall Study|Physician Decision|1|||
27976155|NCT00874497|54634150|FG000|Overall Study|Withdrawal by Subject|5|||
27976156|NCT00874497|54634151|FG001|Overall Study|Withdrawal by Subject|4|||
27976157|NCT00924560|54634160|FG000|Overall Study|Did Not Meet Protocol Requirements|4|||
27976158|NCT00924560|54634161|FG001|Overall Study|Did Not Meet Protocol Requirements|2|||
27976159|NCT00924560|54634162|FG002|Overall Study|Did Not Meet Protocol Requirements|1|||
27976160|NCT00924560|54634160|FG000|Overall Study|Non Compliance with the Protocol|20|||
27976161|NCT00924560|54634161|FG001|Overall Study|Non Compliance with the Protocol|15|||
27976162|NCT00924560|54634162|FG002|Overall Study|Non Compliance with the Protocol|4|||
27976163|NCT00924560|54634160|FG000|Overall Study|Physician Decision|2|||
27976164|NCT00924560|54634161|FG001|Overall Study|Physician Decision|3|||
27976165|NCT00924560|54634162|FG002|Overall Study|Physician Decision|4|||
27976166|NCT00924560|54634160|FG000|Overall Study|Withdrawal by Subject|50|||
27976167|NCT00924560|54634161|FG001|Overall Study|Withdrawal by Subject|44|||
27976168|NCT00924560|54634162|FG002|Overall Study|Withdrawal by Subject|18|||
27976169|NCT00924560|54634160|FG000|Overall Study|Adverse Event|39|||
27976170|NCT00924560|54634161|FG001|Overall Study|Adverse Event|33|||
27976171|NCT00924560|54634162|FG002|Overall Study|Adverse Event|0|||
27976172|NCT00924560|54634160|FG000|Overall Study|Pregnancy|5|||
27976173|NCT00924560|54634161|FG001|Overall Study|Pregnancy|7|||
28086689|NCT03333928|54740107|FG000|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
28086690|NCT03333928|54740108|FG001|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|0|||
28086691|NCT03333928|54740109|FG002|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
28086692|NCT03333928|54740107|FG000|Initial Dosing Period (Period 1)|Adverse Event|0|||
28086693|NCT03333928|54740108|FG001|Initial Dosing Period (Period 1)|Adverse Event|3|||
28086694|NCT03333928|54740109|FG002|Initial Dosing Period (Period 1)|Adverse Event|1|||
27976174|NCT00924560|54634162|FG002|Overall Study|Pregnancy|1|||
27976175|NCT00924560|54634160|FG000|Overall Study|Lost to Follow-up|78|||
27976176|NCT00924560|54634161|FG001|Overall Study|Lost to Follow-up|94|||
28086695|NCT03333928|54740107|FG000|Dose-controlled Extension (Period 2)|Adverse Event|2|||
28086696|NCT03333928|54740108|FG001|Dose-controlled Extension (Period 2)|Adverse Event|1|||
28086697|NCT03333928|54740109|FG002|Dose-controlled Extension (Period 2)|Adverse Event|0|||
28086698|NCT03333928|54740107|FG000|Dose-controlled Extension (Period 2)|Lost to Follow-up|1|||
28086699|NCT03333928|54740108|FG001|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
28086700|NCT03333928|54740109|FG002|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
28086701|NCT03333928|54740107|FG000|Randomized Withdrawal (Period 3)|Adverse Event|1|||
28086702|NCT03333928|54740108|FG001|Randomized Withdrawal (Period 3)|Adverse Event|0|||
28086703|NCT03333928|54740109|FG002|Randomized Withdrawal (Period 3)|Adverse Event|0|||
28086704|NCT03333928|54740107|FG000|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
27832742|NCT01729871|54312491|FG001|Overall Study|Adverse Event|7|||
27976177|NCT00924560|54634162|FG002|Overall Study|Lost to Follow-up|45|||
27976178|NCT00924560|54634160|FG000|Overall Study|Miscellaneous Reasons|13|||
27976179|NCT00924560|54634161|FG001|Overall Study|Miscellaneous Reasons|10|||
27976180|NCT00924560|54634162|FG002|Overall Study|Miscellaneous Reasons|10|||
27832743|NCT01729871|54312490|FG000|Overall Study|Death|0|||
27976181|NCT00923078|54634175|FG000|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
27976182|NCT00923078|54634176|FG001|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
27976183|NCT00923078|54634177|FG002|First Intervention (Weeks 1-4)|Withdrawal by Subject|0|||
27976184|NCT00923078|54634175|FG000|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
27976185|NCT00923078|54634176|FG001|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
27976186|NCT00923078|54634177|FG002|First Intervention (Weeks 1-4)|No intervention per protocol|20|||
27976187|NCT00978731|54634188|FG000|Overall Study|Death|4|||
27976188|NCT00978731|54634189|FG001|Overall Study|Death|1|||
27976189|NCT00978731|54634190|FG002|Overall Study|Death|1|||
27976190|NCT00978731|54634191|FG003|Overall Study|Death|0|||
27976191|NCT00978731|54634188|FG000|Overall Study|Lost to Follow-up|0|||
27976192|NCT00978731|54634189|FG001|Overall Study|Lost to Follow-up|0|||
27976193|NCT00978731|54634190|FG002|Overall Study|Lost to Follow-up|0|||
27976194|NCT00978731|54634191|FG003|Overall Study|Lost to Follow-up|1|||
27976195|NCT00978731|54634188|FG000|Overall Study|Adverse Event|5|||
27976196|NCT00978731|54634189|FG001|Overall Study|Adverse Event|2|||
27976197|NCT00978731|54634190|FG002|Overall Study|Adverse Event|0|||
27976198|NCT00978731|54634191|FG003|Overall Study|Adverse Event|0|||
27976199|NCT00978731|54634188|FG000|Overall Study|Participant's request|1|||
27976200|NCT00978731|54634189|FG001|Overall Study|Participant's request|0|||
27976201|NCT00978731|54634190|FG002|Overall Study|Participant's request|0|||
27976202|NCT00978731|54634191|FG003|Overall Study|Participant's request|0|||
27976203|NCT00978731|54634188|FG000|Overall Study|Administrative reason|3|||
27976204|NCT00978731|54634189|FG001|Overall Study|Administrative reason|3|||
27976205|NCT00978731|54634190|FG002|Overall Study|Administrative reason|1|||
27976206|NCT00978731|54634191|FG003|Overall Study|Administrative reason|0|||
27976207|NCT00978731|54634188|FG000|Overall Study|Deterioration without progression|0|||
27976208|NCT00978731|54634189|FG001|Overall Study|Deterioration without progression|1|||
27976209|NCT00978731|54634190|FG002|Overall Study|Deterioration without progression|0|||
27976210|NCT00978731|54634191|FG003|Overall Study|Deterioration without progression|0|||
27976211|NCT00978731|54634188|FG000|Overall Study|Disease progression/relapse|5|||
27976212|NCT00978731|54634189|FG001|Overall Study|Disease progression/relapse|4|||
27976213|NCT00978731|54634190|FG002|Overall Study|Disease progression/relapse|2|||
27976214|NCT00978731|54634191|FG003|Overall Study|Disease progression/relapse|2|||
27976215|NCT00978731|54634188|FG000|Overall Study|Study closure|3|||
27976216|NCT00978731|54634189|FG001|Overall Study|Study closure|4|||
27976217|NCT00978731|54634190|FG002|Overall Study|Study closure|1|||
27976218|NCT00978731|54634191|FG003|Overall Study|Study closure|1|||
27976219|NCT00978731|54634188|FG000|Overall Study|No response|1|||
27976220|NCT00978731|54634189|FG001|Overall Study|No response|0|||
27976221|NCT00978731|54634190|FG002|Overall Study|No response|0|||
27976222|NCT00978731|54634191|FG003|Overall Study|No response|0|||
27976223|NCT05056870|54634205|FG000|Period 1|Site COVID-19 Related|3|||
27976224|NCT05056870|54634206|FG001|Period 1|Site COVID-19 Related|3|||
27976225|NCT05056870|54634205|FG000|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
27976226|NCT05056870|54634206|FG001|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
27976227|NCT05056870|54634205|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
27976228|NCT05056870|54634206|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
27976229|NCT05056870|54634205|FG000|Period 2|COVID-19 Related|1|||
27976230|NCT05056870|54634206|FG001|Period 2|COVID-19 Related|0|||
27976231|NCT05056870|54634205|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
27976232|NCT05056870|54634206|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
27976233|NCT04488822|54634230|FG000|Overall Study|Adverse Event|8|||
27976234|NCT04488822|54634230|FG000|Overall Study|Withdrawal by Subject|1|||
27976235|NCT04396626|54634243|FG000|Overall Study|Premature termination of study|975|||
27976236|NCT04242186|54634247|FG000|Overall Study|Death|5|||
27976237|NCT03934216|54634254|FG000|Randomization|Randomized in Error|1|||
27976238|NCT03934216|54634255|FG001|Randomization|Randomized in Error|1|||
27976239|NCT03934216|54634254|FG000|Treatment Period|Adverse Event|10|||
27976240|NCT03934216|54634255|FG001|Treatment Period|Adverse Event|3|||
27976241|NCT03934216|54634254|FG000|Treatment Period|Withdrawal by Participant|6|||
27976242|NCT03934216|54634255|FG001|Treatment Period|Withdrawal by Participant|2|||
27976243|NCT03934216|54634254|FG000|Treatment Period|Other Reasons|2|||
27976244|NCT03934216|54634255|FG001|Treatment Period|Other Reasons|2|||
27976245|NCT03183128|54634301|FG000|Overall Study|Adverse Event|1|||
27976246|NCT03183128|54634302|FG001|Overall Study|Adverse Event|2|||
27976247|NCT03183128|54634301|FG000|Overall Study|Withdrawal by Subject|1|||
27976248|NCT03183128|54634302|FG001|Overall Study|Withdrawal by Subject|8|||
27976249|NCT03183128|54634301|FG000|Overall Study|Protocol Violation|2|||
27976250|NCT03183128|54634302|FG001|Overall Study|Protocol Violation|0|||
27976251|NCT03183128|54634301|FG000|Overall Study|Lack of Efficacy|4|||
27976252|NCT03183128|54634302|FG001|Overall Study|Lack of Efficacy|27|||
27976253|NCT03183128|54634301|FG000|Overall Study|Lost to Follow-up|1|||
27976254|NCT03183128|54634302|FG001|Overall Study|Lost to Follow-up|0|||
27976255|NCT03183128|54634301|FG000|Overall Study|Death|2|||
27976256|NCT03183128|54634302|FG001|Overall Study|Death|0|||
27832744|NCT01729871|54312491|FG001|Overall Study|Death|1|||
27976257|NCT03183128|54634301|FG000|Overall Study|Physician Decision|1|||
27976258|NCT03183128|54634302|FG001|Overall Study|Physician Decision|0|||
27976259|NCT02308488|54634344|FG000|Overall Study|Withdrawal by Subject|2|||
27976260|NCT02159950|54634350|FG000|Overall Study|Adverse Event|0|||
27976261|NCT02159950|54634351|FG001|Overall Study|Adverse Event|1|||
27976262|NCT02159950|54634350|FG000|Overall Study|Progression|0|||
27976263|NCT02159950|54634351|FG001|Overall Study|Progression|1|||
27976264|NCT02152137|54634357|FG000|Overall Study|Withdrawal by Subject|1|||
27976265|NCT02152137|54634357|FG000|Overall Study|Originally assigned to Arm B|3|||
27976266|NCT02007512|54634365|FG000|Double Blind Treatment Period|Adverse Event|4|||
27976267|NCT02007512|54634366|FG001|Double Blind Treatment Period|Adverse Event|2|||
27976268|NCT02007512|54634367|FG002|Double Blind Treatment Period|Adverse Event|6|||
27976269|NCT02007512|54634368|FG003|Double Blind Treatment Period|Adverse Event|2|||
27976270|NCT02007512|54634365|FG000|Double Blind Treatment Period|Death|1|||
27976271|NCT02007512|54634366|FG001|Double Blind Treatment Period|Death|0|||
27976272|NCT02007512|54634367|FG002|Double Blind Treatment Period|Death|0|||
27976273|NCT02007512|54634368|FG003|Double Blind Treatment Period|Death|0|||
27976274|NCT02007512|54634365|FG000|Double Blind Treatment Period|Disease progression|44|||
27976275|NCT02007512|54634366|FG001|Double Blind Treatment Period|Disease progression|49|||
27976276|NCT02007512|54634367|FG002|Double Blind Treatment Period|Disease progression|45|||
27976277|NCT02007512|54634368|FG003|Double Blind Treatment Period|Disease progression|51|||
28086705|NCT03333928|54740108|FG001|Randomized Withdrawal (Period 3)|Lost to Follow-up|0|||
28086706|NCT03333928|54740109|FG002|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
27976278|NCT02007512|54634365|FG000|Double Blind Treatment Period|Withdrawal by Subject|4|||
27976279|NCT02007512|54634366|FG001|Double Blind Treatment Period|Withdrawal by Subject|2|||
27976280|NCT02007512|54634367|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
27976281|NCT02007512|54634368|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
27976282|NCT02007512|54634365|FG000|Double Blind Treatment Period|Protocol Violation|0|||
27976283|NCT02007512|54634366|FG001|Double Blind Treatment Period|Protocol Violation|0|||
27976284|NCT02007512|54634367|FG002|Double Blind Treatment Period|Protocol Violation|0|||
27976285|NCT02007512|54634368|FG003|Double Blind Treatment Period|Protocol Violation|1|||
27976286|NCT02007512|54634365|FG000|Double Blind Treatment Period|Other|0|||
27976287|NCT02007512|54634366|FG001|Double Blind Treatment Period|Other|0|||
27976288|NCT02007512|54634367|FG002|Double Blind Treatment Period|Other|1|||
27976289|NCT02007512|54634368|FG003|Double Blind Treatment Period|Other|2|||
27976290|NCT02007512|54634365|FG000|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|10|||
27976291|NCT02007512|54634366|FG001|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|11|||
27976292|NCT02007512|54634367|FG002|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|5|||
27976293|NCT02007512|54634368|FG003|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|1|||
27976294|NCT02007512|54634365|FG000|Open Label Treatment Period|Adverse Event|0|||
27976295|NCT02007512|54634366|FG001|Open Label Treatment Period|Adverse Event|1|||
27976296|NCT02007512|54634367|FG002|Open Label Treatment Period|Adverse Event|0|||
27976297|NCT02007512|54634368|FG003|Open Label Treatment Period|Adverse Event|0|||
27976298|NCT02007512|54634365|FG000|Open Label Treatment Period|Other|0|||
27976299|NCT02007512|54634366|FG001|Open Label Treatment Period|Other|0|||
27976300|NCT02007512|54634367|FG002|Open Label Treatment Period|Other|0|||
27976301|NCT02007512|54634368|FG003|Open Label Treatment Period|Other|1|||
27976302|NCT02007512|54634365|FG000|Open Label Treatment Period|Disease progression|0|||
27976303|NCT02007512|54634366|FG001|Open Label Treatment Period|Disease progression|17|||
27976304|NCT02007512|54634367|FG002|Open Label Treatment Period|Disease progression|0|||
27976305|NCT02007512|54634368|FG003|Open Label Treatment Period|Disease progression|11|||
27976306|NCT02007512|54634365|FG000|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
27976307|NCT02007512|54634366|FG001|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|3|||
27976308|NCT02007512|54634367|FG002|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
27976309|NCT02007512|54634368|FG003|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
27976310|NCT01984346|54634383|FG000|Overall Study|Physician Decision|4|||
27976311|NCT01984346|54634384|FG001|Overall Study|Physician Decision|2|||
27976312|NCT01984346|54634383|FG000|Overall Study|Withdrawal by Subject|2|||
27976313|NCT01984346|54634384|FG001|Overall Study|Withdrawal by Subject|2|||
27976314|NCT01984346|54634383|FG000|Overall Study|Enrollment Closed|8|||
27976315|NCT01984346|54634384|FG001|Overall Study|Enrollment Closed|1|||
27976316|NCT01984346|54634383|FG000|Overall Study|Insurance Coverage|1|||
27976317|NCT01984346|54634384|FG001|Overall Study|Insurance Coverage|0|||
27976318|NCT01984346|54634383|FG000|Overall Study|Intra-operative Exclusion|2|||
27976319|NCT01984346|54634384|FG001|Overall Study|Intra-operative Exclusion|0|||
27976320|NCT01942135|54634392|FG000|Overall Study|Adverse Event|9|||
27976321|NCT01942135|54634393|FG001|Overall Study|Adverse Event|3|||
27976322|NCT01942135|54634392|FG000|Overall Study|Global deterioration of health status|8|||
27976323|NCT01942135|54634393|FG001|Overall Study|Global deterioration of health status|3|||
27976324|NCT01942135|54634392|FG000|Overall Study|Randomized Not Treated|2|||
27976325|NCT01942135|54634393|FG001|Overall Study|Randomized Not Treated|2|||
27976326|NCT01942135|54634392|FG000|Overall Study|Death|0|||
27976327|NCT01942135|54634393|FG001|Overall Study|Death|1|||
27976328|NCT01942135|54634392|FG000|Overall Study|ObjectiveProgression+Progressive Disease|85|||
27976329|NCT01942135|54634393|FG001|Overall Study|ObjectiveProgression+Progressive Disease|87|||
28086707|NCT02945410|54740131|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
27976330|NCT01942135|54634392|FG000|Overall Study|Participant Refused toContinue Treatment|1|||
27976331|NCT01942135|54634393|FG001|Overall Study|Participant Refused toContinue Treatment|1|||
27976332|NCT01942135|54634392|FG000|Overall Study|Withdrawal by Subject|4|||
27976333|NCT01942135|54634393|FG001|Overall Study|Withdrawal by Subject|2|||
27976334|NCT01942135|54634392|FG000|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|238|||
27976335|NCT01942135|54634393|FG001|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|75|||
27976336|NCT01889238|54634399|FG000|Overall Study|Treatment ongoing|9|||
27976337|NCT01696968|54634422|FG000|Overall Study|Cancer Before Rand. (Lung Screening)|0|||
27976338|NCT01696968|54634423|FG001|Overall Study|Cancer Before Rand. (Lung Screening)|8|||
27976339|NCT01696968|54634422|FG000|Overall Study|Died Before Randomization|3|||
27976340|NCT01696968|54634423|FG001|Overall Study|Died Before Randomization|8|||
28086708|NCT02945410|54740132|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|3|||
28086709|NCT02945410|54740133|FG002|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
28086710|NCT02945410|54740134|FG003|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
28086711|NCT02945410|54740135|FG004|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
28086712|NCT02945410|54740136|FG005|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
28086713|NCT02945410|54740131|FG000|Intervention 1 (5 Days)|Adverse Event|1|||
28086714|NCT02945410|54740132|FG001|Intervention 1 (5 Days)|Adverse Event|0|||
28086715|NCT02945410|54740133|FG002|Intervention 1 (5 Days)|Adverse Event|0|||
28086716|NCT02945410|54740134|FG003|Intervention 1 (5 Days)|Adverse Event|0|||
28086717|NCT02945410|54740135|FG004|Intervention 1 (5 Days)|Adverse Event|0|||
28165566|NCT02510014|54836176|FG000|Treatment Period|Withdrawal by Subject|67|||
27733224|NCT04227704|54181017|FG002|Overall Study|due to C/S being cancelled|0|||
27733225|NCT03530293|54181027|FG000|Pre-randomization|Adverse Event|12|||
27976341|NCT01696968|54634422|FG000|Overall Study|Died Before ASU (Control)|278|||
27976342|NCT01696968|54634423|FG001|Overall Study|Died Before ASU (Control)|0|||
27976343|NCT01696968|54634422|FG000|Overall Study|Refused ASU (Control)|920|||
27976344|NCT01696968|54634423|FG001|Overall Study|Refused ASU (Control)|0|||
27976345|NCT01696968|54634422|FG000|Overall Study|Refused Screen (Lung Screening)|0|||
27976346|NCT01696968|54634423|FG001|Overall Study|Refused Screen (Lung Screening)|6796|||
27976347|NCT00978341|54634435|FG000|Washout Period of 2 Weeks|Adverse Event|1|||
27976348|NCT00978341|54634436|FG001|Washout Period of 2 Weeks|Adverse Event|0|||
27976349|NCT00978029|54634446|FG000|Overall Study|Adverse Event|1|||
27976350|NCT00978029|54634447|FG001|Overall Study|Adverse Event|2|||
27976351|NCT00978029|54634448|FG002|Overall Study|Adverse Event|5|||
27976352|NCT00978029|54634446|FG000|Overall Study|Withdrawal by Subject|0|||
27976353|NCT00978029|54634447|FG001|Overall Study|Withdrawal by Subject|0|||
27976354|NCT00978029|54634448|FG002|Overall Study|Withdrawal by Subject|1|||
27976355|NCT00978029|54634446|FG000|Overall Study|Protocol Violation|0|||
27976356|NCT00978029|54634447|FG001|Overall Study|Protocol Violation|1|||
27976357|NCT00978029|54634448|FG002|Overall Study|Protocol Violation|0|||
27976358|NCT00871377|54634456|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
27976359|NCT00871377|54634457|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
27733226|NCT03530293|54181028|FG001|Pre-randomization|Adverse Event|0|||
27733227|NCT03530293|54181029|FG002|Pre-randomization|Adverse Event|0|||
27733228|NCT03530293|54181027|FG000|Pre-randomization|Protocol Violation|2|||
27733229|NCT03530293|54181028|FG001|Pre-randomization|Protocol Violation|0|||
27976360|NCT00871377|54634458|FG002|First Intervention (10 Weeks)|Withdrawal by Subject|1|||
27976361|NCT00871377|54634459|FG003|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
27976362|NCT00871377|54634460|FG004|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
27976363|NCT00871377|54634461|FG005|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
27976364|NCT00871377|54634456|FG000|First Intervention (10 Weeks)|Lost to Follow-up|0|||
27976365|NCT00871377|54634457|FG001|First Intervention (10 Weeks)|Lost to Follow-up|0|||
27976366|NCT00871377|54634458|FG002|First Intervention (10 Weeks)|Lost to Follow-up|0|||
27976367|NCT00871377|54634459|FG003|First Intervention (10 Weeks)|Lost to Follow-up|0|||
27976368|NCT00871377|54634460|FG004|First Intervention (10 Weeks)|Lost to Follow-up|0|||
27976369|NCT00871377|54634461|FG005|First Intervention (10 Weeks)|Lost to Follow-up|1|||
27976370|NCT00871377|54634456|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
27976371|NCT00871377|54634457|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
27976372|NCT00871377|54634458|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
27976373|NCT00871377|54634459|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
27976374|NCT00871377|54634460|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
27976375|NCT00871377|54634461|FG005|Washout (6 Weeks)|Withdrawal by Subject|0|||
27976376|NCT00871377|54634456|FG000|Washout (6 Weeks)|Withdrawal by Subject|0|||
27976377|NCT00871377|54634457|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
27976378|NCT00871377|54634458|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
27976379|NCT00871377|54634459|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
27976380|NCT00871377|54634460|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
27976381|NCT00871377|54634461|FG005|Washout (6 Weeks)|Withdrawal by Subject|1|||
27976382|NCT00871377|54634456|FG000|Third Intervention (10 Weeks)|Death|0|||
28086718|NCT02945410|54740136|FG005|Intervention 1 (5 Days)|Adverse Event|1|||
28086719|NCT02945410|54740131|FG000|Washout 1 (14 Days)|Withdrawal by Subject|0|||
28086720|NCT02945410|54740132|FG001|Washout 1 (14 Days)|Withdrawal by Subject|0|||
27976383|NCT00871377|54634457|FG001|Third Intervention (10 Weeks)|Death|0|||
27976384|NCT00871377|54634458|FG002|Third Intervention (10 Weeks)|Death|0|||
27976385|NCT00871377|54634459|FG003|Third Intervention (10 Weeks)|Death|1|||
27976386|NCT00871377|54634460|FG004|Third Intervention (10 Weeks)|Death|0|||
27976387|NCT00871377|54634461|FG005|Third Intervention (10 Weeks)|Death|0|||
27976388|NCT00977561|54634471|FG000|Overall Study|Death|3|||
27976389|NCT00977561|54634472|FG001|Overall Study|Death|2|||
27976390|NCT00977561|54634471|FG000|Overall Study|Study terminated|0|||
27976391|NCT00977561|54634472|FG001|Overall Study|Study terminated|2|||
27976392|NCT00977561|54634471|FG000|Overall Study|Other|2|||
27976393|NCT00977561|54634472|FG001|Overall Study|Other|0|||
27976394|NCT00594165|54634480|FG000|Overall Study|Major protocol violation|1|||
27976395|NCT00594165|54634480|FG000|Overall Study|Lack of Efficacy|12|||
27976396|NCT00594165|54634480|FG000|Overall Study|Adverse Event|52|||
27976397|NCT00594165|54634480|FG000|Overall Study|Unsatisfactory compliance of subject|6|||
27976398|NCT00594165|54634480|FG000|Overall Study|Subject withdrew consent|27|||
27976399|NCT00594165|54634480|FG000|Overall Study|Study ended per sponsor|102|||
27976400|NCT00594165|54634480|FG000|Overall Study|Lost to Follow-up|4|||
27976401|NCT00594165|54634480|FG000|Overall Study|Other: PI discretion|5|||
27976402|NCT00594165|54634480|FG000|Overall Study|Other: Subject moving|3|||
27976403|NCT00594165|54634480|FG000|Overall Study|Other: Brain surgery controlled symptoms|1|||
27976404|NCT00594165|54634480|FG000|Overall Study|Other: House bound; can't get to clinic|1|||
27976405|NCT00594165|54634480|FG000|Overall Study|Other: Subject enrolled in other trial|1|||
27976406|NCT00594165|54634480|FG000|Overall Study|Other: Site terminated participation|2|||
27976407|NCT00975923|54634486|FG000|Overall Study|Withdrawal by Subject|0|||
27976408|NCT00975923|54634487|FG001|Overall Study|Withdrawal by Subject|1|||
27976409|NCT00928070|54634496|FG000|Overall Study|Lost to Follow-up|1|||
27976410|NCT00928070|54634497|FG001|Overall Study|Lost to Follow-up|2|||
27976411|NCT00928070|54634496|FG000|Overall Study|Withdrawal by Subject|10|||
27976412|NCT00928070|54634497|FG001|Overall Study|Withdrawal by Subject|3|||
27976413|NCT00928070|54634496|FG000|Overall Study|Adverse Event|14|||
27976414|NCT00928070|54634497|FG001|Overall Study|Adverse Event|26|||
27976415|NCT00928070|54634496|FG000|Overall Study|Lack of Efficacy|9|||
27976416|NCT00928070|54634497|FG001|Overall Study|Lack of Efficacy|5|||
27976417|NCT00928070|54634496|FG000|Overall Study|Did not meet entrance criteria|16|||
27976418|NCT00928070|54634497|FG001|Overall Study|Did not meet entrance criteria|9|||
27976419|NCT00928070|54634496|FG000|Overall Study|Protocol Violation|6|||
27976420|NCT00928070|54634497|FG001|Overall Study|Protocol Violation|5|||
27976421|NCT00928070|54634496|FG000|Overall Study|Randomized but not treated|2|||
27976422|NCT00928070|54634497|FG001|Overall Study|Randomized but not treated|2|||
27976423|NCT00928070|54634496|FG000|Overall Study|Other|5|||
27976424|NCT00928070|54634497|FG001|Overall Study|Other|5|||
27976425|NCT00924404|54634505|FG000|Overall Study|Lost to Follow-up|6|||
27976426|NCT00924404|54634506|FG001|Overall Study|Lost to Follow-up|4|||
27976427|NCT00976937|54634514|FG000|Overall Study|Adverse Event|4|||
27976428|NCT00976937|54634515|FG001|Overall Study|Adverse Event|5|||
27976429|NCT00976937|54634514|FG000|Overall Study|Lost to Follow-up|2|||
27976430|NCT00976937|54634515|FG001|Overall Study|Lost to Follow-up|1|||
27976431|NCT00976937|54634514|FG000|Overall Study|Withdrawal by Subject|5|||
27976432|NCT00976937|54634515|FG001|Overall Study|Withdrawal by Subject|3|||
27976433|NCT00976937|54634514|FG000|Overall Study|Poor compliance to protocol|3|||
27976434|NCT00976937|54634515|FG001|Overall Study|Poor compliance to protocol|0|||
27976435|NCT00976937|54634514|FG000|Overall Study|Personal and Familial Reason|2|||
27976436|NCT00976937|54634515|FG001|Overall Study|Personal and Familial Reason|2|||
27976437|NCT00976703|54634523|FG000|Overall Study|Physician Decision|1|||
27976438|NCT00976703|54634524|FG001|Overall Study|Physician Decision|1|||
27976439|NCT00976703|54634523|FG000|Overall Study|ineligible for study|2|||
27976440|NCT00976703|54634524|FG001|Overall Study|ineligible for study|2|||
27976441|NCT00975689|54634532|FG000|Overall Study|Adverse Event|0|||
27976442|NCT00975689|54634533|FG001|Overall Study|Adverse Event|3|||
27976443|NCT00975689|54634532|FG000|Overall Study|Withdrawal by Subject|1|||
27976444|NCT00975689|54634533|FG001|Overall Study|Withdrawal by Subject|0|||
27976445|NCT00975689|54634532|FG000|Overall Study|Physician Decision|1|||
27976446|NCT00975689|54634533|FG001|Overall Study|Physician Decision|0|||
27976447|NCT00922766|54634539|FG000|Overall Study|Death|3|||
27976448|NCT00922766|54634539|FG000|Overall Study|Withdrawal by Subject|2|||
27976449|NCT00922766|54634539|FG000|Overall Study|Other|1|||
27976450|NCT00922766|54634539|FG000|Overall Study|Adverse Event|1|||
27976451|NCT00917852|54634543|FG000|Overall Study|Death|6|||
27976452|NCT00976391|54634550|FG000|Treatment Period (52 Weeks)|Adverse Event|16|||
27976453|NCT00976391|54634551|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
27976454|NCT00976391|54634550|FG000|Treatment Period (52 Weeks)|Protocol Violation|1|||
27976455|NCT00976391|54634551|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
27976456|NCT00976391|54634550|FG000|Treatment Period (52 Weeks)|Noncompliance|4|||
27976457|NCT00976391|54634551|FG001|Treatment Period (52 Weeks)|Noncompliance|4|||
28086721|NCT02945410|54740133|FG002|Washout 1 (14 Days)|Withdrawal by Subject|2|||
27976458|NCT00976391|54634550|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|10|||
27976459|NCT00976391|54634551|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|8|||
27976460|NCT00976391|54634550|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|9|||
27976461|NCT00976391|54634551|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|19|||
27976462|NCT00976391|54634550|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
27976463|NCT00976391|54634551|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
27976464|NCT00976391|54634550|FG000|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0|||
27976465|NCT00976391|54634551|FG001|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4|||
27976466|NCT00976391|54634550|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
27976467|NCT00976391|54634551|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
27976468|NCT00976391|54634550|FG000|Follow-up Period (8 Weeks)|Adverse Event|3|||
27976469|NCT00976391|54634551|FG001|Follow-up Period (8 Weeks)|Adverse Event|1|||
27976470|NCT00976391|54634550|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
27976471|NCT00976391|54634551|FG001|Follow-up Period (8 Weeks)|Noncompliance|2|||
27976472|NCT00976391|54634550|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|14|||
27976473|NCT00976391|54634551|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
27976474|NCT00976391|54634550|FG000|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6|||
27976475|NCT00976391|54634551|FG001|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8|||
27976476|NCT00976391|54634550|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
27976477|NCT00976391|54634551|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|7|||
27976478|NCT00976391|54634550|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
27976479|NCT00976391|54634551|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
27976480|NCT00917462|54634557|FG000|Overall Study|Clinical Deterioration|1|||
27976481|NCT00979901|54634565|FG000|Overall Study|Adverse Event|1|||
27976482|NCT00979901|54634566|FG001|Overall Study|Adverse Event|3|||
27976483|NCT00979901|54634567|FG002|Overall Study|Adverse Event|9|||
27976484|NCT00979901|54634568|FG003|Overall Study|Adverse Event|2|||
27976485|NCT00979901|54634565|FG000|Overall Study|Lack of Efficacy|8|||
27976486|NCT00979901|54634566|FG001|Overall Study|Lack of Efficacy|4|||
27976487|NCT00979901|54634567|FG002|Overall Study|Lack of Efficacy|9|||
27976488|NCT00979901|54634568|FG003|Overall Study|Lack of Efficacy|0|||
27976489|NCT00979901|54634565|FG000|Overall Study|Lost to Follow-up|1|||
27976490|NCT00979901|54634566|FG001|Overall Study|Lost to Follow-up|1|||
27976491|NCT00979901|54634567|FG002|Overall Study|Lost to Follow-up|2|||
27976492|NCT00979901|54634568|FG003|Overall Study|Lost to Follow-up|0|||
27976493|NCT00979901|54634565|FG000|Overall Study|Protocol Violation|2|||
27976494|NCT00979901|54634566|FG001|Overall Study|Protocol Violation|2|||
27976495|NCT00979901|54634567|FG002|Overall Study|Protocol Violation|7|||
27976496|NCT00979901|54634568|FG003|Overall Study|Protocol Violation|1|||
27976497|NCT00979901|54634565|FG000|Overall Study|Withdrawal by Subject|2|||
27976498|NCT00979901|54634566|FG001|Overall Study|Withdrawal by Subject|1|||
27976499|NCT00979901|54634567|FG002|Overall Study|Withdrawal by Subject|1|||
27976500|NCT00979901|54634568|FG003|Overall Study|Withdrawal by Subject|1|||
27976501|NCT00979901|54634565|FG000|Overall Study|Noncompliance|1|||
27976502|NCT00979901|54634566|FG001|Overall Study|Noncompliance|0|||
27976503|NCT00979901|54634567|FG002|Overall Study|Noncompliance|0|||
27976504|NCT00979901|54634568|FG003|Overall Study|Noncompliance|0|||
27976505|NCT00979901|54634565|FG000|Overall Study|out-of-state|1|||
27976506|NCT00979901|54634566|FG001|Overall Study|out-of-state|0|||
27976507|NCT00979901|54634567|FG002|Overall Study|out-of-state|0|||
27976508|NCT00979901|54634568|FG003|Overall Study|out-of-state|0|||
27976509|NCT00979901|54634565|FG000|Overall Study|vacation|1|||
27976510|NCT00979901|54634566|FG001|Overall Study|vacation|0|||
27976511|NCT00979901|54634567|FG002|Overall Study|vacation|0|||
27976512|NCT00979901|54634568|FG003|Overall Study|vacation|0|||
27976513|NCT00979901|54634565|FG000|Overall Study|elevated lab values pre-randomization|1|||
27976514|NCT00979901|54634566|FG001|Overall Study|elevated lab values pre-randomization|0|||
27976515|NCT00979901|54634567|FG002|Overall Study|elevated lab values pre-randomization|0|||
27976516|NCT00979901|54634568|FG003|Overall Study|elevated lab values pre-randomization|0|||
27976517|NCT00979901|54634565|FG000|Overall Study|Discontinued in Error|0|||
27976518|NCT00979901|54634566|FG001|Overall Study|Discontinued in Error|1|||
27976519|NCT00979901|54634567|FG002|Overall Study|Discontinued in Error|0|||
27976520|NCT00979901|54634568|FG003|Overall Study|Discontinued in Error|0|||
27976521|NCT00979901|54634565|FG000|Overall Study|Left Country|0|||
27976522|NCT00979901|54634566|FG001|Overall Study|Left Country|0|||
27976523|NCT00979901|54634567|FG002|Overall Study|Left Country|1|||
27976524|NCT00979901|54634568|FG003|Overall Study|Left Country|0|||
27976525|NCT00979901|54634565|FG000|Overall Study|Treatment Group Terminated by Sponsor|0|||
27976526|NCT00979901|54634566|FG001|Overall Study|Treatment Group Terminated by Sponsor|0|||
27976527|NCT00979901|54634567|FG002|Overall Study|Treatment Group Terminated by Sponsor|0|||
27976528|NCT00979901|54634568|FG003|Overall Study|Treatment Group Terminated by Sponsor|112|||
27976529|NCT00975611|54634577|FG000|Overall Study|Screen Fail|16|||
27976530|NCT00975611|54634577|FG000|Overall Study|Physician Decision|1|||
27976531|NCT00970307|54634584|FG000|Overall Study|Serious Adverse Event|1|||
27976532|NCT00970307|54634585|FG001|Overall Study|Serious Adverse Event|0|||
27976533|NCT00970307|54634586|FG002|Overall Study|Serious Adverse Event|0|||
27976534|NCT00970307|54634584|FG000|Overall Study|Withdrawal by Subject|2|||
27976535|NCT00970307|54634585|FG001|Overall Study|Withdrawal by Subject|3|||
27976536|NCT00970307|54634586|FG002|Overall Study|Withdrawal by Subject|2|||
27976537|NCT00917384|54634596|FG000|Overall Study|Lost to Follow-up|4|||
27976538|NCT00917384|54634597|FG001|Overall Study|Lost to Follow-up|2|||
27976539|NCT00917384|54634596|FG000|Overall Study|Withdrawal by Subject|10|||
27976540|NCT00917384|54634597|FG001|Overall Study|Withdrawal by Subject|2|||
27976541|NCT00864513|54634603|FG000|Overall Study|Withdrawal by Subject|3|||
27976542|NCT00917150|54634611|FG000|Overall Study|Adverse Event|12|||
27976543|NCT00917150|54634612|FG001|Overall Study|Adverse Event|7|||
27976544|NCT00917150|54634613|FG002|Overall Study|Adverse Event|12|||
27976545|NCT00917150|54634614|FG003|Overall Study|Adverse Event|11|||
27976546|NCT00917150|54634611|FG000|Overall Study|Death|1|||
27976547|NCT00917150|54634612|FG001|Overall Study|Death|4|||
27976548|NCT00917150|54634613|FG002|Overall Study|Death|3|||
27976549|NCT00917150|54634614|FG003|Overall Study|Death|2|||
27976550|NCT00917150|54634611|FG000|Overall Study|Lost to Follow-up|1|||
27976551|NCT00917150|54634612|FG001|Overall Study|Lost to Follow-up|0|||
27976552|NCT00917150|54634613|FG002|Overall Study|Lost to Follow-up|4|||
27976553|NCT00917150|54634614|FG003|Overall Study|Lost to Follow-up|2|||
27976554|NCT00917150|54634611|FG000|Overall Study|Physician Decision|0|||
27976555|NCT00917150|54634612|FG001|Overall Study|Physician Decision|2|||
27976556|NCT00917150|54634613|FG002|Overall Study|Physician Decision|0|||
27976557|NCT00917150|54634614|FG003|Overall Study|Physician Decision|1|||
27976558|NCT00917150|54634611|FG000|Overall Study|Protocol Violation|5|||
27976559|NCT00917150|54634612|FG001|Overall Study|Protocol Violation|5|||
27976560|NCT00917150|54634613|FG002|Overall Study|Protocol Violation|3|||
27976561|NCT00917150|54634614|FG003|Overall Study|Protocol Violation|5|||
27976562|NCT00917150|54634611|FG000|Overall Study|Withdrawal by Subject|15|||
27976563|NCT00917150|54634612|FG001|Overall Study|Withdrawal by Subject|16|||
27976564|NCT00917150|54634613|FG002|Overall Study|Withdrawal by Subject|18|||
27976565|NCT00917150|54634614|FG003|Overall Study|Withdrawal by Subject|11|||
27976566|NCT00917150|54634611|FG000|Overall Study|Other than specified|3|||
27976567|NCT00917150|54634612|FG001|Overall Study|Other than specified|3|||
27976568|NCT00917150|54634613|FG002|Overall Study|Other than specified|2|||
27976569|NCT00917150|54634614|FG003|Overall Study|Other than specified|2|||
27976570|NCT00659425|54634634|FG000|Overall Study|Disease progression|1|||
27976571|NCT00659425|54634635|FG001|Overall Study|Disease progression|0|||
27976572|NCT00659425|54634636|FG002|Overall Study|Disease progression|0|||
27976573|NCT00659425|54634637|FG003|Overall Study|Disease progression|1|||
27976574|NCT00659425|54634638|FG004|Overall Study|Disease progression|0|||
27976575|NCT00659425|54634639|FG005|Overall Study|Disease progression|2|||
27976576|NCT00659425|54634640|FG006|Overall Study|Disease progression|4|||
27976577|NCT00659425|54634641|FG007|Overall Study|Disease progression|3|||
27976578|NCT00659425|54634642|FG008|Overall Study|Disease progression|5|||
27976579|NCT00659425|54634643|FG009|Overall Study|Disease progression|3|||
27976580|NCT00659425|54634634|FG000|Overall Study|Death|0|||
27976581|NCT00659425|54634635|FG001|Overall Study|Death|0|||
27976582|NCT00659425|54634636|FG002|Overall Study|Death|0|||
27976583|NCT00659425|54634637|FG003|Overall Study|Death|1|||
27976584|NCT00659425|54634638|FG004|Overall Study|Death|0|||
27976585|NCT00659425|54634639|FG005|Overall Study|Death|0|||
27976586|NCT00659425|54634640|FG006|Overall Study|Death|1|||
27976587|NCT00659425|54634641|FG007|Overall Study|Death|0|||
27976588|NCT00659425|54634642|FG008|Overall Study|Death|0|||
27976589|NCT00659425|54634643|FG009|Overall Study|Death|0|||
27976590|NCT00659425|54634634|FG000|Overall Study|Adverse Event|0|||
27976591|NCT00659425|54634635|FG001|Overall Study|Adverse Event|0|||
27976592|NCT00659425|54634636|FG002|Overall Study|Adverse Event|0|||
27976593|NCT00659425|54634637|FG003|Overall Study|Adverse Event|0|||
27976594|NCT00659425|54634638|FG004|Overall Study|Adverse Event|0|||
27976595|NCT00659425|54634639|FG005|Overall Study|Adverse Event|1|||
27976596|NCT00659425|54634640|FG006|Overall Study|Adverse Event|0|||
27976597|NCT00659425|54634641|FG007|Overall Study|Adverse Event|3|||
27976598|NCT00659425|54634642|FG008|Overall Study|Adverse Event|1|||
27976599|NCT00659425|54634643|FG009|Overall Study|Adverse Event|4|||
27976600|NCT00659425|54634634|FG000|Overall Study|Investigator Discretion|0|||
27976601|NCT00659425|54634635|FG001|Overall Study|Investigator Discretion|0|||
27976602|NCT00659425|54634636|FG002|Overall Study|Investigator Discretion|0|||
27976603|NCT00659425|54634637|FG003|Overall Study|Investigator Discretion|0|||
27976604|NCT00659425|54634638|FG004|Overall Study|Investigator Discretion|0|||
27976605|NCT00659425|54634639|FG005|Overall Study|Investigator Discretion|1|||
27976606|NCT00659425|54634640|FG006|Overall Study|Investigator Discretion|0|||
27976607|NCT00659425|54634641|FG007|Overall Study|Investigator Discretion|3|||
27976608|NCT00659425|54634642|FG008|Overall Study|Investigator Discretion|0|||
27976609|NCT00659425|54634643|FG009|Overall Study|Investigator Discretion|0|||
27976610|NCT00659425|54634634|FG000|Overall Study|Other|0|||
27976611|NCT00659425|54634635|FG001|Overall Study|Other|1|||
27976612|NCT00659425|54634636|FG002|Overall Study|Other|1|||
27976613|NCT00659425|54634637|FG003|Overall Study|Other|2|||
27976614|NCT00659425|54634638|FG004|Overall Study|Other|4|||
27976615|NCT00659425|54634639|FG005|Overall Study|Other|0|||
27976616|NCT00659425|54634640|FG006|Overall Study|Other|3|||
27976617|NCT00659425|54634641|FG007|Overall Study|Other|2|||
28086722|NCT02945410|54740134|FG003|Washout 1 (14 Days)|Withdrawal by Subject|0|||
28086723|NCT02945410|54740135|FG004|Washout 1 (14 Days)|Withdrawal by Subject|1|||
28086724|NCT02945410|54740136|FG005|Washout 1 (14 Days)|Withdrawal by Subject|0|||
28086725|NCT02945254|54740146|FG000|Overall Study|Lost to Follow-up|1|||
28086726|NCT02945254|54740147|FG001|Overall Study|Lost to Follow-up|0|||
27976618|NCT00659425|54634642|FG008|Overall Study|Other|0|||
27976619|NCT00659425|54634643|FG009|Overall Study|Other|6|||
27976620|NCT00656851|54634680|FG000|Overall Study|Withdrawal by Subject|0|||
28086727|NCT02945254|54740146|FG000|Overall Study|Withdrawal by Subject|1|||
28086728|NCT02945254|54740147|FG001|Overall Study|Withdrawal by Subject|0|||
28086729|NCT02943070|54740165|FG000|Overall Study|Physician Decision|1|||
28086730|NCT02943070|54740165|FG000|Overall Study|Adverse Event|2|||
28086731|NCT02943070|54740165|FG000|Overall Study|Death|2|||
28086732|NCT02943070|54740165|FG000|Overall Study|Withdrawal by Subject|3|||
28086733|NCT02943070|54740165|FG000|Overall Study|Lost to Follow-up|4|||
28086734|NCT02943070|54740165|FG000|Overall Study|Retreatment or TURP|13|||
28086735|NCT02943070|54740165|FG000|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18|||
28086736|NCT03332212|54740189|FG000|Overall Study|Not treated|0|||
28086737|NCT03332212|54740190|FG001|Overall Study|Not treated|1|||
28086738|NCT03332212|54740191|FG002|Overall Study|Not treated|0|||
28086739|NCT03332212|54740192|FG003|Overall Study|Not treated|0|||
28086740|NCT03332212|54740189|FG000|Overall Study|Adverse Event|0|||
28165567|NCT02510014|54836177|FG001|Treatment Period|Withdrawal by Subject|24|||
28165568|NCT02510014|54836176|FG000|Treatment Period|Withdrawn by the investigator|7|||
27976621|NCT00656851|54634681|FG001|Overall Study|Withdrawal by Subject|4|||
27976622|NCT00656617|54634687|FG000|Overall Study|Adverse Event|1|||
27976623|NCT00656617|54634687|FG000|Overall Study|Death|2|||
27976624|NCT00656617|54634687|FG000|Overall Study|Insurance Issues|2|||
27976625|NCT00656617|54634687|FG000|Overall Study|Move to different clinical trial|2|||
27976626|NCT04797637|54634694|FG000|Overall Study|Lost to Follow-up|23|||
27976627|NCT04797637|54634695|FG001|Overall Study|Lost to Follow-up|32|||
27976628|NCT04797637|54634694|FG000|Overall Study|Withdrawal by Subject|0|||
27976629|NCT04797637|54634695|FG001|Overall Study|Withdrawal by Subject|1|||
27976630|NCT00659269|54634703|FG000|Overall Study|Physician Decision|1|||
27976631|NCT00659269|54634704|FG001|Overall Study|Physician Decision|1|||
27976632|NCT00658333|54634721|FG000|Overall Study|Adverse Event|2|||
27976633|NCT00658333|54634722|FG001|Overall Study|Adverse Event|1|||
27976634|NCT00658879|54634728|FG000|Overall Study|Protocol Violation|1|||
27976635|NCT00570037|54634734|FG000|Overall Study|Could not reach for 6-8 week contact|44|||
27976636|NCT00570037|54634735|FG001|Overall Study|Could not reach for 6-8 week contact|69|||
27976637|NCT00863655|54634743|FG000|Overall Study|Protocol Violation|4|||
27976638|NCT00863655|54634744|FG001|Overall Study|Protocol Violation|0|||
27976639|NCT00863655|54634743|FG000|Overall Study|Adverse Event|52|||
27976640|NCT00863655|54634744|FG001|Overall Study|Adverse Event|8|||
27976641|NCT00863655|54634743|FG000|Overall Study|Withdrawal by Subject|47|||
27976642|NCT00863655|54634744|FG001|Overall Study|Withdrawal by Subject|7|||
27976643|NCT00863655|54634743|FG000|Overall Study|Administrative problems|1|||
27976644|NCT00863655|54634744|FG001|Overall Study|Administrative problems|0|||
27976645|NCT00863655|54634743|FG000|Overall Study|Death|7|||
27976646|NCT00863655|54634744|FG001|Overall Study|Death|1|||
27976647|NCT00863655|54634743|FG000|Overall Study|New cancer therapy|5|||
27976648|NCT00863655|54634744|FG001|Overall Study|New cancer therapy|1|||
27976649|NCT00863655|54634743|FG000|Overall Study|Disease progression|364|||
27976650|NCT00863655|54634744|FG001|Overall Study|Disease progression|221|||
27976651|NCT00863655|54634743|FG000|Overall Study|Treatment completed as per protocol|5|||
27976652|NCT00863655|54634744|FG001|Overall Study|Treatment completed as per protocol|1|||
27976653|NCT00658723|54634752|FG000|Overall Study|Lost to Follow-up|0|||
27976654|NCT00658723|54634753|FG001|Overall Study|Lost to Follow-up|2|||
27976655|NCT00658723|54634754|FG002|Overall Study|Lost to Follow-up|2|||
27976656|NCT00658723|54634752|FG000|Overall Study|Death|2|||
27976657|NCT00658723|54634753|FG001|Overall Study|Death|1|||
27976658|NCT00658723|54634754|FG002|Overall Study|Death|4|||
27976659|NCT00658723|54634752|FG000|Overall Study|Scheduling Issue|1|||
27976660|NCT00658723|54634753|FG001|Overall Study|Scheduling Issue|1|||
27976661|NCT00658723|54634754|FG002|Overall Study|Scheduling Issue|0|||
27976662|NCT00658723|54634752|FG000|Overall Study|Withdrawal by Subject|1|||
27976663|NCT00658723|54634753|FG001|Overall Study|Withdrawal by Subject|0|||
27976664|NCT00658723|54634754|FG002|Overall Study|Withdrawal by Subject|1|||
27976665|NCT00593385|54634765|FG000|Overall Study|Death|14|||
27976666|NCT00593385|54634765|FG000|Overall Study|Lost to Follow-up|17|||
28086741|NCT03332212|54740190|FG001|Overall Study|Adverse Event|0|||
28086742|NCT03332212|54740191|FG002|Overall Study|Adverse Event|0|||
27976667|NCT00593385|54634765|FG000|Overall Study|Withdrawal by Subject|9|||
27976668|NCT00658021|54634774|FG000|28-Week Treatment Period|Adverse Event|3|||
27976669|NCT00658021|54634775|FG001|28-Week Treatment Period|Adverse Event|1|||
27976670|NCT00658021|54634776|FG002|28-Week Treatment Period|Adverse Event|0|||
27976671|NCT00658021|54634774|FG000|28-Week Treatment Period|Developed study withdrawal criteria|0|||
27976672|NCT00658021|54634775|FG001|28-Week Treatment Period|Developed study withdrawal criteria|2|||
27976673|NCT00658021|54634776|FG002|28-Week Treatment Period|Developed study withdrawal criteria|0|||
27976674|NCT00658021|54634774|FG000|28-Week Treatment Period|Protocol Violation|0|||
27976675|NCT00658021|54634775|FG001|28-Week Treatment Period|Protocol Violation|2|||
27976676|NCT00658021|54634776|FG002|28-Week Treatment Period|Protocol Violation|1|||
27976677|NCT00658021|54634774|FG000|28-Week Treatment Period|Withdrawal by Subject|1|||
27976678|NCT00658021|54634775|FG001|28-Week Treatment Period|Withdrawal by Subject|1|||
27976679|NCT00658021|54634776|FG002|28-Week Treatment Period|Withdrawal by Subject|3|||
27976680|NCT00658021|54634774|FG000|28-Week Treatment Period|Physician Decision|1|||
27976681|NCT00658021|54634775|FG001|28-Week Treatment Period|Physician Decision|2|||
27976682|NCT00658021|54634776|FG002|28-Week Treatment Period|Physician Decision|1|||
27976683|NCT00658021|54634774|FG000|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
27976684|NCT00658021|54634775|FG001|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
27976685|NCT00658021|54634776|FG002|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
27976686|NCT00658021|54634774|FG000|28-Week Treatment Period|Loss of glucose control|1|||
27976687|NCT00658021|54634775|FG001|28-Week Treatment Period|Loss of glucose control|1|||
27976688|NCT00658021|54634776|FG002|28-Week Treatment Period|Loss of glucose control|10|||
27976689|NCT00658021|54634774|FG000|28-Week Treatment Period|Other|2|||
27976690|NCT00658021|54634775|FG001|28-Week Treatment Period|Other|3|||
27976691|NCT00658021|54634776|FG002|28-Week Treatment Period|Other|1|||
27976692|NCT00658021|54634774|FG000|28-Week Treatment Period|Did not receive treatment|2|||
27976693|NCT00658021|54634775|FG001|28-Week Treatment Period|Did not receive treatment|0|||
27976694|NCT00658021|54634776|FG002|28-Week Treatment Period|Did not receive treatment|0|||
27976695|NCT00658021|54634774|FG000|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
27976696|NCT00658021|54634775|FG001|Long-term Safety Follow-up Period|Withdrawal by Subject|1|||
27976697|NCT00658021|54634776|FG002|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
27976698|NCT00658021|54634774|FG000|Long-term Safety Follow-up Period|Physician Decision|0|||
27976699|NCT00658021|54634775|FG001|Long-term Safety Follow-up Period|Physician Decision|2|||
27976700|NCT00658021|54634776|FG002|Long-term Safety Follow-up Period|Physician Decision|0|||
27976701|NCT00920816|54634790|FG000|Overall Study|Death|116|||
27976702|NCT00920816|54634791|FG001|Overall Study|Death|63|||
27976703|NCT00920816|54634792|FG002|Overall Study|Death|8|||
27976704|NCT00920816|54634793|FG003|Overall Study|Death|3|||
27976705|NCT00920816|54634790|FG000|Overall Study|Participant refused continued treatment for reason other than adverse events|11|||
27976706|NCT00920816|54634791|FG001|Overall Study|Participant refused continued treatment for reason other than adverse events|5|||
27976707|NCT00920816|54634792|FG002|Overall Study|Participant refused continued treatment for reason other than adverse events|1|||
27976708|NCT00920816|54634793|FG003|Overall Study|Participant refused continued treatment for reason other than adverse events|0|||
27976709|NCT00920816|54634790|FG000|Overall Study|Global deterioration of health status|2|||
27976710|NCT00920816|54634791|FG001|Overall Study|Global deterioration of health status|0|||
27976711|NCT00920816|54634792|FG002|Overall Study|Global deterioration of health status|0|||
27976712|NCT00920816|54634793|FG003|Overall Study|Global deterioration of health status|0|||
27976713|NCT00920816|54634790|FG000|Overall Study|Objective progression or relapse|6|||
27976714|NCT00920816|54634791|FG001|Overall Study|Objective progression or relapse|2|||
27976715|NCT00920816|54634792|FG002|Overall Study|Objective progression or relapse|0|||
27976716|NCT00920816|54634793|FG003|Overall Study|Objective progression or relapse|0|||
27976717|NCT00920816|54634790|FG000|Overall Study|Other|26|||
27976718|NCT00920816|54634791|FG001|Overall Study|Other|15|||
27976719|NCT00920816|54634792|FG002|Overall Study|Other|1|||
27976720|NCT00920816|54634793|FG003|Overall Study|Other|2|||
27976721|NCT00920816|54634790|FG000|Overall Study|Lost to Follow-up|11|||
27976722|NCT00920816|54634791|FG001|Overall Study|Lost to Follow-up|2|||
27976723|NCT00920816|54634792|FG002|Overall Study|Lost to Follow-up|0|||
27976724|NCT00920816|54634793|FG003|Overall Study|Lost to Follow-up|0|||
27976725|NCT00920816|54634790|FG000|Overall Study|Adverse Event|1|||
27976726|NCT00920816|54634791|FG001|Overall Study|Adverse Event|1|||
27976727|NCT00920816|54634792|FG002|Overall Study|Adverse Event|1|||
27976728|NCT00920816|54634793|FG003|Overall Study|Adverse Event|0|||
27976729|NCT00920816|54634790|FG000|Overall Study|Data not disclosed due to lack of HGRAC filings|16|||
27976730|NCT00920816|54634791|FG001|Overall Study|Data not disclosed due to lack of HGRAC filings|8|||
27976731|NCT00920816|54634792|FG002|Overall Study|Data not disclosed due to lack of HGRAC filings|124|||
27976732|NCT00920816|54634793|FG003|Overall Study|Data not disclosed due to lack of HGRAC filings|64|||
27976733|NCT00920816|54634790|FG000|Overall Study|Randomized but not treated|3|||
27976734|NCT00920816|54634791|FG001|Overall Study|Randomized but not treated|0|||
27976735|NCT00920816|54634792|FG002|Overall Study|Randomized but not treated|0|||
27976736|NCT00920816|54634793|FG003|Overall Study|Randomized but not treated|0|||
27976737|NCT00657709|54634808|FG000|Overall Study|AE or Death|7|||
27976738|NCT00657709|54634809|FG001|Overall Study|AE or Death|7|||
27976739|NCT00657709|54634810|FG002|Overall Study|AE or Death|6|||
27976740|NCT00657709|54634811|FG003|Overall Study|AE or Death|7|||
28086743|NCT03332212|54740192|FG003|Overall Study|Adverse Event|1|||
28086744|NCT03332212|54740189|FG000|Overall Study|worsening of disease under study|1|||
28086745|NCT03332212|54740190|FG001|Overall Study|worsening of disease under study|1|||
28086746|NCT03332212|54740191|FG002|Overall Study|worsening of disease under study|0|||
28086747|NCT03332212|54740192|FG003|Overall Study|worsening of disease under study|0|||
28086748|NCT03331666|54740202|FG000|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
28086749|NCT03331666|54740203|FG001|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
28086750|NCT03331042|54740213|FG000|Overall Study|Protocol Violation|1|||
28086751|NCT03331042|54740214|FG001|Overall Study|Protocol Violation|0|||
28086752|NCT03331042|54740215|FG002|Overall Study|Protocol Violation|0|||
28086753|NCT03331042|54740216|FG003|Overall Study|Protocol Violation|0|||
28086754|NCT03331042|54740213|FG000|Overall Study|Physician Decision|0|||
28086755|NCT03331042|54740214|FG001|Overall Study|Physician Decision|0|||
28086756|NCT03331042|54740215|FG002|Overall Study|Physician Decision|1|||
28086757|NCT03331042|54740216|FG003|Overall Study|Physician Decision|0|||
28086758|NCT03331042|54740213|FG000|Overall Study|Lost to Follow-up|0|||
27976741|NCT00657709|54634812|FG004|Overall Study|AE or Death|1|||
27976742|NCT00657709|54634808|FG000|Overall Study|Withdrawal by Subject|7|||
27976743|NCT00657709|54634809|FG001|Overall Study|Withdrawal by Subject|15|||
27976744|NCT00657709|54634810|FG002|Overall Study|Withdrawal by Subject|15|||
27976745|NCT00657709|54634811|FG003|Overall Study|Withdrawal by Subject|5|||
27976746|NCT00657709|54634812|FG004|Overall Study|Withdrawal by Subject|9|||
27976747|NCT00657709|54634808|FG000|Overall Study|Lost to Follow-up|9|||
27976748|NCT00657709|54634809|FG001|Overall Study|Lost to Follow-up|9|||
27976749|NCT00657709|54634810|FG002|Overall Study|Lost to Follow-up|7|||
27976750|NCT00657709|54634811|FG003|Overall Study|Lost to Follow-up|1|||
27976751|NCT00657709|54634812|FG004|Overall Study|Lost to Follow-up|21|||
27976752|NCT00657709|54634808|FG000|Overall Study|Protocol Violation|0|||
27976753|NCT00657709|54634809|FG001|Overall Study|Protocol Violation|2|||
27976754|NCT00657709|54634810|FG002|Overall Study|Protocol Violation|0|||
27976755|NCT00657709|54634811|FG003|Overall Study|Protocol Violation|1|||
27976756|NCT00657709|54634812|FG004|Overall Study|Protocol Violation|2|||
27976757|NCT00915356|54634839|FG000|Overall Study|Withdrawal by Subject|1|||
27976758|NCT00915356|54634840|FG001|Overall Study|Withdrawal by Subject|0|||
27976759|NCT00915356|54634841|FG002|Overall Study|Withdrawal by Subject|0|||
27976760|NCT00915356|54634842|FG003|Overall Study|Withdrawal by Subject|0|||
27976761|NCT00915356|54634843|FG004|Overall Study|Withdrawal by Subject|0|||
27976762|NCT00657553|54634857|FG000|Overall Study|low accrual, no analysis run|5|||
27976763|NCT00657553|54634858|FG001|Overall Study|low accrual, no analysis run|5|||
28086759|NCT03331042|54740214|FG001|Overall Study|Lost to Follow-up|0|||
28086760|NCT03331042|54740215|FG002|Overall Study|Lost to Follow-up|0|||
28086761|NCT03331042|54740216|FG003|Overall Study|Lost to Follow-up|1|||
28086762|NCT03762668|54740234|FG000|Period 1, First Week of Wear|Withdrawal by Subject|0|||
28086763|NCT03762668|54740235|FG001|Period 1, First Week of Wear|Withdrawal by Subject|1|||
28086764|NCT03762200|54740241|FG000|Overall Study|Death|2|||
28086765|NCT03329404|54740247|FG000|Overall Study|The study was suspended.|1|||
28086766|NCT03329404|54740248|FG001|Overall Study|The study was suspended.|4|||
28086767|NCT03478930|54740256|FG000|Overall Study|Adverse Event|0|||
28086768|NCT03478930|54740257|FG001|Overall Study|Adverse Event|1|||
28086769|NCT03478930|54740256|FG000|Overall Study|Lack of Efficacy|3|||
28086770|NCT03478930|54740257|FG001|Overall Study|Lack of Efficacy|3|||
28086771|NCT03478930|54740256|FG000|Overall Study|Withdrawal by Subject|6|||
28086772|NCT03478930|54740257|FG001|Overall Study|Withdrawal by Subject|5|||
28086773|NCT03038438|54740263|FG000|Overall Study|Death|3|||
28086774|NCT03038438|54740263|FG000|Overall Study|Lost to Follow-up|8|||
28086775|NCT03038438|54740263|FG000|Overall Study|Subject Incarcerated, Moved, or Refused|4|||
28086776|NCT03038438|54740263|FG000|Overall Study|Withdrawal by Subject|5|||
28086777|NCT03038438|54740263|FG000|Overall Study|No 36-Month Follow-Up|18|||
28086778|NCT03523000|54740267|FG000|Overall Study|Withdrawal by Subject|3|||
28086779|NCT03523000|54740268|FG001|Overall Study|Withdrawal by Subject|0|||
28086780|NCT03523000|54740267|FG000|Overall Study|Unsuccessful trial|2|||
28086781|NCT03523000|54740268|FG001|Overall Study|Unsuccessful trial|0|||
28086782|NCT03327220|54740279|FG000|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|1|||
28086783|NCT03327220|54740280|FG001|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|2|||
27976764|NCT00862719|54634868|FG000|Overall Study|Disease Progression|5|||
28086784|NCT03327220|54740279|FG000|Overall Study|Investigator Decision|2|||
28086785|NCT03327220|54740280|FG001|Overall Study|Investigator Decision|0|||
28086786|NCT03327220|54740279|FG000|Overall Study|Missed Visit 6 (Week 6 Visit)|0|||
28086787|NCT03327220|54740280|FG001|Overall Study|Missed Visit 6 (Week 6 Visit)|1|||
28086788|NCT03327220|54740279|FG000|Overall Study|Fungal infection|1|||
27976765|NCT00862719|54634869|FG001|Overall Study|Disease Progression|0|||
27976766|NCT00862719|54634870|FG002|Overall Study|Disease Progression|1|||
27976767|NCT00862719|54634871|FG003|Overall Study|Disease Progression|0|||
27976768|NCT00862719|54634868|FG000|Overall Study|Death|5|||
27976769|NCT00862719|54634869|FG001|Overall Study|Death|6|||
27832745|NCT01729871|54312490|FG000|Overall Study|Lack of Efficacy|0|||
28086789|NCT03327220|54740280|FG001|Overall Study|Fungal infection|0|||
28086790|NCT03327220|54740279|FG000|Overall Study|Discharged to Rehabilitation|0|||
27976770|NCT00862719|54634870|FG002|Overall Study|Death|1|||
27976771|NCT00862719|54634871|FG003|Overall Study|Death|1|||
27976772|NCT00862719|54634868|FG000|Overall Study|Engraftment failure|0|||
28086791|NCT03327220|54740280|FG001|Overall Study|Discharged to Rehabilitation|1|||
28086792|NCT03327220|54740279|FG000|Overall Study|Missing|1|||
28086793|NCT03327220|54740280|FG001|Overall Study|Missing|0|||
28086794|NCT00318149|54740292|FG000|Overall Study|Adverse Event|0|||
28086795|NCT00318149|54740293|FG001|Overall Study|Adverse Event|0|||
28086796|NCT00318149|54740294|FG002|Overall Study|Adverse Event|0|||
28086797|NCT00318149|54740295|FG003|Overall Study|Adverse Event|0|||
28086798|NCT00318149|54740296|FG004|Overall Study|Adverse Event|0|||
28086799|NCT00318149|54740297|FG005|Overall Study|Adverse Event|2|||
28086800|NCT00317603|54740313|FG000|Overall Study|Progressive Disease|3|||
28086801|NCT03326518|54740320|FG000|Overall Study|Protocol Violation|1|||
28086802|NCT03326518|54740321|FG001|Overall Study|Protocol Violation|0|||
28086803|NCT03326518|54740322|FG002|Overall Study|Protocol Violation|0|||
28086804|NCT03326518|54740320|FG000|Overall Study|Withdrawal by Subject|1|||
28086805|NCT03326518|54740321|FG001|Overall Study|Withdrawal by Subject|0|||
28086806|NCT03326518|54740322|FG002|Overall Study|Withdrawal by Subject|0|||
28086807|NCT03326518|54740320|FG000|Overall Study|Lost to Follow-up|1|||
28086808|NCT03326518|54740321|FG001|Overall Study|Lost to Follow-up|0|||
28086809|NCT03326518|54740322|FG002|Overall Study|Lost to Follow-up|1|||
28086810|NCT00317369|54740333|FG000|Overall Study|Adverse Event|2|||
28086811|NCT00317369|54740334|FG001|Overall Study|Adverse Event|1|||
28086812|NCT00317369|54740335|FG002|Overall Study|Adverse Event|0|||
28086813|NCT00317369|54740333|FG000|Overall Study|Lack of Efficacy|0|||
28086814|NCT00317369|54740334|FG001|Overall Study|Lack of Efficacy|1|||
28086815|NCT00317369|54740335|FG002|Overall Study|Lack of Efficacy|1|||
28086816|NCT00317369|54740333|FG000|Overall Study|Withdrawal by Subject|0|||
28086817|NCT00317369|54740334|FG001|Overall Study|Withdrawal by Subject|0|||
28086818|NCT00317369|54740335|FG002|Overall Study|Withdrawal by Subject|1|||
28086819|NCT03325894|54740345|FG000|Overall Study|Adverse Event|2|||
28086820|NCT03325894|54740346|FG001|Overall Study|Adverse Event|3|||
28086821|NCT03325894|54740345|FG000|Overall Study|Protocol Violation|1|||
28086822|NCT03325894|54740346|FG001|Overall Study|Protocol Violation|2|||
28086823|NCT03325894|54740345|FG000|Overall Study|Withdrawal by Subject|10|||
28086824|NCT03325894|54740346|FG001|Overall Study|Withdrawal by Subject|6|||
28086825|NCT03325894|54740345|FG000|Overall Study|Lost to Follow-up|4|||
28086826|NCT03325894|54740346|FG001|Overall Study|Lost to Follow-up|9|||
28086827|NCT03325894|54740345|FG000|Overall Study|Lack of Efficacy|8|||
28086828|NCT03325894|54740346|FG001|Overall Study|Lack of Efficacy|14|||
28086829|NCT03325894|54740345|FG000|Overall Study|Study Terminated by Sponsor|38|||
28086830|NCT03325894|54740346|FG001|Overall Study|Study Terminated by Sponsor|43|||
28086831|NCT03325894|54740345|FG000|Overall Study|Other (Not received Treatment)|1|||
28086832|NCT03325894|54740346|FG001|Overall Study|Other (Not received Treatment)|0|||
28086833|NCT01239368|54740365|FG000|Overall Study|Principal investigator discretion|1|||
28086834|NCT01239368|54740366|FG001|Overall Study|Principal investigator discretion|0|||
28086835|NCT01239368|54740367|FG002|Overall Study|Principal investigator discretion|0|||
28086836|NCT01239368|54740368|FG003|Overall Study|Principal investigator discretion|0|||
28086837|NCT01239368|54740369|FG004|Overall Study|Principal investigator discretion|1|||
28086838|NCT01239368|54740370|FG005|Overall Study|Principal investigator discretion|2|||
28086839|NCT01239368|54740371|FG006|Overall Study|Principal investigator discretion|0|||
28086840|NCT01239368|54740372|FG007|Overall Study|Principal investigator discretion|0|||
28086841|NCT01239368|54740373|FG008|Overall Study|Principal investigator discretion|0|||
28086842|NCT01239368|54740374|FG009|Overall Study|Principal investigator discretion|1|||
28086843|NCT01239368|54740365|FG000|Overall Study|Disease progression on study|1|||
28086844|NCT01239368|54740366|FG001|Overall Study|Disease progression on study|1|||
28086845|NCT01239368|54740367|FG002|Overall Study|Disease progression on study|1|||
28086846|NCT01239368|54740368|FG003|Overall Study|Disease progression on study|1|||
28086847|NCT01239368|54740369|FG004|Overall Study|Disease progression on study|4|||
28086848|NCT01239368|54740370|FG005|Overall Study|Disease progression on study|2|||
27976773|NCT00862719|54634869|FG001|Overall Study|Engraftment failure|0|||
27976774|NCT00862719|54634870|FG002|Overall Study|Engraftment failure|1|||
27976775|NCT00862719|54634871|FG003|Overall Study|Engraftment failure|0|||
27976776|NCT00862719|54634868|FG000|Overall Study|Veno-Occlusive Disease|0|||
27976777|NCT00862719|54634869|FG001|Overall Study|Veno-Occlusive Disease|0|||
27976778|NCT00862719|54634870|FG002|Overall Study|Veno-Occlusive Disease|1|||
28086849|NCT01239368|54740371|FG006|Overall Study|Disease progression on study|5|||
28086850|NCT01239368|54740372|FG007|Overall Study|Disease progression on study|0|||
28086851|NCT01239368|54740373|FG008|Overall Study|Disease progression on study|0|||
28086852|NCT01239368|54740374|FG009|Overall Study|Disease progression on study|2|||
28086853|NCT01239368|54740365|FG000|Overall Study|Refused further treatment|0|||
27855581|NCT02834247|54380599|FG001|Dose Expansion Phase|Death|0|||
28086854|NCT01239368|54740366|FG001|Overall Study|Refused further treatment|0|||
27976779|NCT00862719|54634871|FG003|Overall Study|Veno-Occlusive Disease|0|||
27976780|NCT00862641|54634885|FG000|Overall Study|Randomized, but drug not received|1|||
27976781|NCT00862641|54634886|FG001|Overall Study|Randomized, but drug not received|4|||
27976782|NCT00862641|54634887|FG002|Overall Study|Randomized, but drug not received|1|||
27976783|NCT00862641|54634888|FG003|Overall Study|Randomized, but drug not received|4|||
27976784|NCT00861471|54634898|FG000|Overall Study|Withdrawal by Subject|1|||
27976785|NCT00861471|54634898|FG000|Overall Study|Adverse Event|2|||
27976786|NCT00861471|54634898|FG000|Overall Study|Lack of Efficacy|3|||
27976787|NCT00861471|54634898|FG000|Overall Study|treatment for lumbar laminectomy|1|||
27976788|NCT00861471|54634898|FG000|Overall Study|Physician Decision|2|||
27976789|NCT00860067|54634905|FG000|Overall Study|Lost to Follow-up|46|||
27976790|NCT00860067|54634906|FG001|Overall Study|Lost to Follow-up|9|||
27976791|NCT00860067|54634907|FG002|Overall Study|Lost to Follow-up|9|||
27976792|NCT00860067|54634905|FG000|Overall Study|Withdrawal by Subject|4|||
27976793|NCT00860067|54634906|FG001|Overall Study|Withdrawal by Subject|0|||
27976794|NCT00860067|54634907|FG002|Overall Study|Withdrawal by Subject|0|||
27976795|NCT00860067|54634905|FG000|Overall Study|Pregnancy|1|||
27976796|NCT00860067|54634906|FG001|Overall Study|Pregnancy|0|||
27976797|NCT00860067|54634907|FG002|Overall Study|Pregnancy|0|||
27976798|NCT00858117|54634918|FG000|Treatment on Study|Adverse Event|2|||
27976799|NCT00858117|54634918|FG000|Follow up for 5 Years|Death|4|||
27976800|NCT00858117|54634918|FG000|Follow up for 5 Years|No further data collected for study|9|||
27976801|NCT00652951|54634925|FG000|Booster Phase|Adverse event, non-fatal|0|||
27976802|NCT00652951|54634926|FG001|Booster Phase|Adverse event, non-fatal|1|||
27976803|NCT00652951|54634927|FG002|Booster Phase|Adverse event, non-fatal|0|||
27976804|NCT00652951|54634925|FG000|Booster Phase|Other|1|||
27976805|NCT00652951|54634926|FG001|Booster Phase|Other|0|||
27976806|NCT00652951|54634927|FG002|Booster Phase|Other|0|||
27976807|NCT00848211|54634939|FG000|Overall Study|Protocol Violation|0|||
27976808|NCT00848211|54634940|FG001|Overall Study|Protocol Violation|1|||
27976809|NCT00848211|54634941|FG002|Overall Study|Protocol Violation|1|||
27976810|NCT00848211|54634942|FG003|Overall Study|Protocol Violation|0|||
27976811|NCT00848211|54634939|FG000|Overall Study|Adverse Event|0|||
27976812|NCT00848211|54634940|FG001|Overall Study|Adverse Event|0|||
27976813|NCT00848211|54634941|FG002|Overall Study|Adverse Event|0|||
27976814|NCT00848211|54634942|FG003|Overall Study|Adverse Event|0|||
27976815|NCT00592683|54634954|FG000|Overall Study|Found ineligible|0|||
27976816|NCT00592683|54634955|FG001|Overall Study|Found ineligible|1|||
27976817|NCT00592683|54634954|FG000|Overall Study|Withdrawal by Subject|1|||
27976818|NCT00592683|54634955|FG001|Overall Study|Withdrawal by Subject|0|||
27976819|NCT00592683|54634954|FG000|Overall Study|Adverse Event|0|||
27976820|NCT00592683|54634955|FG001|Overall Study|Adverse Event|2|||
27976821|NCT00592683|54634954|FG000|Overall Study|Protocol Violation|1|||
27976822|NCT00592683|54634955|FG001|Overall Study|Protocol Violation|0|||
27976823|NCT00592683|54634954|FG000|Overall Study|Study drug expired|1|||
27976824|NCT00592683|54634955|FG001|Overall Study|Study drug expired|0|||
27976825|NCT00592683|54634954|FG000|Overall Study|Other|1|||
27976826|NCT00592683|54634955|FG001|Overall Study|Other|0|||
27976827|NCT00592683|54634954|FG000|Overall Study|Lost to Follow-up|0|||
27976828|NCT00592683|54634955|FG001|Overall Study|Lost to Follow-up|1|||
27976829|NCT00847665|54634963|FG000|Overall Study|Withdrawal by Subject|1|||
27976830|NCT00847665|54634964|FG001|Overall Study|Withdrawal by Subject|0|||
27976831|NCT00916370|54634972|FG000|Overall Study|Death|3|||
27976832|NCT00916370|54634973|FG001|Overall Study|Death|1|||
27976833|NCT00916370|54634972|FG000|Overall Study|Withdrawal by Subject|2|||
27855582|NCT02834247|54380600|FG002|Dose Expansion Phase|Death|0|||
27855583|NCT02834247|54380601|FG003|Dose Expansion Phase|Death|8|||
27855584|NCT02834247|54380598|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
27855585|NCT02834247|54380599|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
27855586|NCT02834247|54380600|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
27855587|NCT02834247|54380601|FG003|Dose Expansion Phase|Lost to Follow-up|1|||
27855588|NCT02834247|54380598|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
27855589|NCT02834247|54380599|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
27976834|NCT00916370|54634973|FG001|Overall Study|Withdrawal by Subject|0|||
27976835|NCT00916370|54634972|FG000|Overall Study|Physician Decision|0|||
27733230|NCT03530293|54181029|FG002|Pre-randomization|Protocol Violation|0|||
27976836|NCT00916370|54634973|FG001|Overall Study|Physician Decision|1|||
27976837|NCT00847197|54634982|FG000|Overall Study|Adverse Event|21|||
27976838|NCT00847197|54634983|FG001|Overall Study|Adverse Event|3|||
27976839|NCT00847197|54634982|FG000|Overall Study|Protocol Violation|0|||
27976840|NCT00847197|54634983|FG001|Overall Study|Protocol Violation|1|||
27976841|NCT00847197|54634982|FG000|Overall Study|Withdrawal by Subject|3|||
27976842|NCT00847197|54634983|FG001|Overall Study|Withdrawal by Subject|1|||
27733231|NCT03530293|54181027|FG000|Pre-randomization|Study Terminated by Sponsor|5|||
27976843|NCT00654901|54634993|FG000|Overall Study|Lost to Follow-up|1|||
27976844|NCT00654901|54634994|FG001|Overall Study|Lost to Follow-up|0|||
27976845|NCT00654901|54634995|FG002|Overall Study|Lost to Follow-up|1|||
27976846|NCT00654901|54634996|FG003|Overall Study|Lost to Follow-up|0|||
27976847|NCT00654901|54634993|FG000|Overall Study|Withdrawal by Subject|3|||
27976848|NCT00654901|54634994|FG001|Overall Study|Withdrawal by Subject|0|||
27976849|NCT00654901|54634995|FG002|Overall Study|Withdrawal by Subject|1|||
27976850|NCT00654901|54634996|FG003|Overall Study|Withdrawal by Subject|0|||
27976851|NCT00846807|54635006|FG000|Overall Study|Adverse Event|270|||
27976852|NCT00846807|54635006|FG000|Overall Study|Lost to Follow-up|94|||
27976853|NCT00846807|54635006|FG000|Overall Study|Withdrawal by Subject|56|||
27976854|NCT00846807|54635006|FG000|Overall Study|Non compliant with European label|7|||
27976855|NCT00846807|54635006|FG000|Overall Study|Switch to other anticoagulants|89|||
27976856|NCT00846807|54635006|FG000|Overall Study|No prescription after hospital discharge|56|||
27976857|NCT00846807|54635006|FG000|Overall Study|Other|60|||
27976858|NCT00846495|54635012|FG000|Overall Study|Lost to Follow-up|1|||
27976859|NCT00846495|54635013|FG001|Overall Study|Lost to Follow-up|0|||
27976860|NCT00846495|54635012|FG000|Overall Study|Adverse Event|5|||
27976861|NCT00846495|54635013|FG001|Overall Study|Adverse Event|1|||
27976862|NCT00846495|54635012|FG000|Overall Study|Lack of Efficacy|1|||
27976863|NCT00846495|54635013|FG001|Overall Study|Lack of Efficacy|2|||
27976864|NCT00846495|54635012|FG000|Overall Study|Physician Decision|1|||
27976865|NCT00846495|54635013|FG001|Overall Study|Physician Decision|0|||
27976866|NCT00654745|54635019|FG000|Overall Study|Adverse Event|12|||
27976867|NCT00654745|54635019|FG000|Overall Study|Lost to Follow-up|7|||
27976868|NCT00654745|54635019|FG000|Overall Study|Protocol Violation|11|||
27976869|NCT00654745|54635019|FG000|Overall Study|Withdrawal by Subject|10|||
27976870|NCT00654745|54635019|FG000|Overall Study|poor ABPM, noncompliance, lab MAs|3|||
27976871|NCT00846027|54635029|FG000|Overall Study|Death|3|||
27976872|NCT00846027|54635029|FG000|Overall Study|Disease Progression|30|||
27976873|NCT00846027|54635029|FG000|Overall Study|Toxicity|12|||
27976874|NCT00846027|54635029|FG000|Overall Study|Patient Decision|7|||
27976875|NCT00846027|54635029|FG000|Overall Study|Investigator Discretion|29|||
27976876|NCT00846027|54635029|FG000|Overall Study|Protocol Violation|2|||
27976877|NCT00846027|54635029|FG000|Overall Study|Subject Not Treated|7|||
27976878|NCT00646399|54635035|FG000|Overall Study|Death|63|||
27976879|NCT00646399|54635036|FG001|Overall Study|Death|53|||
27976880|NCT00646399|54635035|FG000|Overall Study|Withdrawal by Subject|9|||
27976881|NCT00646399|54635036|FG001|Overall Study|Withdrawal by Subject|10|||
27976882|NCT00646399|54635035|FG000|Overall Study|Other Reason|11|||
27976883|NCT00646399|54635036|FG001|Overall Study|Other Reason|11|||
27976884|NCT00652327|54635044|FG000|Overall Study|Adverse Event|0|||
27976885|NCT00652327|54635045|FG001|Overall Study|Adverse Event|2|||
27976886|NCT00652327|54635044|FG000|Overall Study|Lost to Follow-up|0|||
27976887|NCT00652327|54635045|FG001|Overall Study|Lost to Follow-up|3|||
27976888|NCT00645853|54635053|FG000|Overall Study|Adverse Event|18|||
27976889|NCT00645853|54635054|FG001|Overall Study|Adverse Event|7|||
27976890|NCT00645853|54635053|FG000|Overall Study|AZ study closure in Hungary|60|||
27976891|NCT00645853|54635054|FG001|Overall Study|AZ study closure in Hungary|40|||
27976892|NCT00645853|54635053|FG000|Overall Study|Withdrawal by Subject|5|||
27976893|NCT00645853|54635054|FG001|Overall Study|Withdrawal by Subject|2|||
27976894|NCT00645853|54635053|FG000|Overall Study|Protocol Violation|0|||
27976895|NCT00645853|54635054|FG001|Overall Study|Protocol Violation|2|||
27976896|NCT00645853|54635053|FG000|Overall Study|Discontinuation criteria|2|||
27976897|NCT00645853|54635054|FG001|Overall Study|Discontinuation criteria|2|||
27976898|NCT00645853|54635053|FG000|Overall Study|recall of ICF, planned operation, death|7|||
27976899|NCT00645853|54635054|FG001|Overall Study|recall of ICF, planned operation, death|4|||
27976900|NCT00652093|54635066|FG000|Overall Study|Withdrawal by Subject|0|||
27976901|NCT00652093|54635067|FG001|Overall Study|Withdrawal by Subject|0|||
27976902|NCT00652093|54635068|FG002|Overall Study|Withdrawal by Subject|1|||
27976903|NCT00652093|54635069|FG003|Overall Study|Withdrawal by Subject|0|||
27976904|NCT00652093|54635070|FG004|Overall Study|Withdrawal by Subject|1|||
27976905|NCT00652093|54635071|FG005|Overall Study|Withdrawal by Subject|0|||
27976906|NCT00652093|54635066|FG000|Overall Study|Physician Decision|0|||
27976907|NCT00652093|54635067|FG001|Overall Study|Physician Decision|0|||
27976908|NCT00652093|54635068|FG002|Overall Study|Physician Decision|0|||
27976909|NCT00652093|54635069|FG003|Overall Study|Physician Decision|0|||
27976910|NCT00652093|54635070|FG004|Overall Study|Physician Decision|1|||
27976911|NCT00652093|54635071|FG005|Overall Study|Physician Decision|0|||
27976912|NCT00651937|54635087|FG000|Overall Study|Withdrawal by Subject|4|||
27976913|NCT00651937|54635088|FG001|Overall Study|Withdrawal by Subject|1|||
27976914|NCT00654355|54635096|FG000|Overall Study|Lost to Follow-up|2|||
27976915|NCT00654355|54635097|FG001|Overall Study|Lost to Follow-up|2|||
27976916|NCT00651313|54635105|FG000|Overall Study|Adverse Event|0|||
27976917|NCT00651313|54635106|FG001|Overall Study|Adverse Event|1|||
27976918|NCT00651313|54635105|FG000|Overall Study|Withdrawal by Subject|3|||
27976919|NCT00651313|54635106|FG001|Overall Study|Withdrawal by Subject|1|||
27976920|NCT00651313|54635105|FG000|Overall Study|Lost to Follow-up|1|||
27976921|NCT00651313|54635106|FG001|Overall Study|Lost to Follow-up|1|||
27976922|NCT00651313|54635105|FG000|Overall Study|Adminstrative Discontinuation|2|||
27976923|NCT00651313|54635106|FG001|Overall Study|Adminstrative Discontinuation|3|||
27976924|NCT00969761|54635124|FG000|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
27976925|NCT00969761|54635125|FG001|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
27976926|NCT00969761|54635126|FG002|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
27976927|NCT00969761|54635127|FG003|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
27976928|NCT00969761|54635128|FG004|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
27976929|NCT00969761|54635129|FG005|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
27976930|NCT00969761|54635130|FG006|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
27976931|NCT00969761|54635131|FG007|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
27976932|NCT00969761|54635132|FG008|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
27976933|NCT00969761|54635133|FG009|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
27976934|NCT00969761|54635134|FG010|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
27976935|NCT00969761|54635135|FG011|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
27976936|NCT00969761|54635124|FG000|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
27976937|NCT00969761|54635125|FG001|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
27976938|NCT00969761|54635126|FG002|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1|||
27976939|NCT00969761|54635127|FG003|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
27976940|NCT00969761|54635128|FG004|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
27976941|NCT00969761|54635129|FG005|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
27976942|NCT00969761|54635130|FG006|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
27976943|NCT00969761|54635131|FG007|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
27976944|NCT00969761|54635132|FG008|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
27976945|NCT00969761|54635133|FG009|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
27976946|NCT00969761|54635134|FG010|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
27976947|NCT00969761|54635135|FG011|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
27976948|NCT00969761|54635124|FG000|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
27976949|NCT00969761|54635125|FG001|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
27976950|NCT00969761|54635126|FG002|Discont. Before Start of Treat. Cycle 2|Other adverse events|1|||
27976951|NCT00969761|54635127|FG003|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
27976952|NCT00969761|54635128|FG004|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
27976953|NCT00969761|54635129|FG005|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
27976954|NCT00969761|54635130|FG006|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
27976955|NCT00969761|54635131|FG007|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
27976956|NCT00969761|54635132|FG008|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
27976957|NCT00969761|54635133|FG009|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
27976958|NCT00969761|54635134|FG010|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
27976959|NCT00969761|54635135|FG011|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
27976960|NCT00969761|54635124|FG000|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
27976961|NCT00969761|54635125|FG001|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
27976962|NCT00969761|54635126|FG002|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
27976963|NCT00969761|54635127|FG003|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
27976964|NCT00969761|54635128|FG004|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
27976965|NCT00969761|54635129|FG005|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
27976966|NCT00969761|54635130|FG006|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
27976967|NCT00969761|54635131|FG007|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
27976968|NCT00969761|54635132|FG008|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1|||
28086855|NCT01239368|54740367|FG002|Overall Study|Refused further treatment|0|||
28086856|NCT01239368|54740368|FG003|Overall Study|Refused further treatment|0|||
28086857|NCT01239368|54740369|FG004|Overall Study|Refused further treatment|0|||
28086858|NCT01239368|54740370|FG005|Overall Study|Refused further treatment|0|||
28086859|NCT01239368|54740371|FG006|Overall Study|Refused further treatment|0|||
28086860|NCT01239368|54740372|FG007|Overall Study|Refused further treatment|0|||
28086861|NCT01239368|54740373|FG008|Overall Study|Refused further treatment|0|||
28086862|NCT01239368|54740374|FG009|Overall Study|Refused further treatment|1|||
28086863|NCT01239368|54740365|FG000|Overall Study|Death|0|||
28086864|NCT01239368|54740366|FG001|Overall Study|Death|0|||
28086865|NCT01239368|54740367|FG002|Overall Study|Death|0|||
28086866|NCT01239368|54740368|FG003|Overall Study|Death|0|||
28086867|NCT01239368|54740369|FG004|Overall Study|Death|0|||
28086868|NCT01239368|54740370|FG005|Overall Study|Death|0|||
27976969|NCT00969761|54635133|FG009|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
27976970|NCT00969761|54635134|FG010|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
27976971|NCT00969761|54635135|FG011|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
28086869|NCT01239368|54740371|FG006|Overall Study|Death|1|||
28086870|NCT01239368|54740372|FG007|Overall Study|Death|0|||
28086871|NCT01239368|54740373|FG008|Overall Study|Death|0|||
28086872|NCT01239368|54740374|FG009|Overall Study|Death|0|||
27976972|NCT00969761|54635124|FG000|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
27976973|NCT00969761|54635125|FG001|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
27976974|NCT00969761|54635126|FG002|Treated in and Beyond Treat. Cycle 2|Progressive disease|10|||
27976975|NCT00969761|54635127|FG003|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
27976976|NCT00969761|54635128|FG004|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
27976977|NCT00969761|54635129|FG005|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
27976978|NCT00969761|54635130|FG006|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
27976979|NCT00969761|54635131|FG007|Treated in and Beyond Treat. Cycle 2|Progressive disease|6|||
27976980|NCT00969761|54635132|FG008|Treated in and Beyond Treat. Cycle 2|Progressive disease|9|||
27976981|NCT00969761|54635133|FG009|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
27976982|NCT00969761|54635134|FG010|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
27976983|NCT00969761|54635135|FG011|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
27976984|NCT00969761|54635124|FG000|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
27976985|NCT00969761|54635125|FG001|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
27976986|NCT00969761|54635126|FG002|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
27976987|NCT00969761|54635127|FG003|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
27976988|NCT00969761|54635128|FG004|Treated in and Beyond Treat. Cycle 2|Other adverse events|1|||
27976989|NCT00969761|54635129|FG005|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
27976990|NCT00969761|54635130|FG006|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
27976991|NCT00969761|54635131|FG007|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
27976992|NCT00969761|54635132|FG008|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
27976993|NCT00969761|54635133|FG009|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
27976994|NCT00969761|54635134|FG010|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
27976995|NCT00969761|54635135|FG011|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
27976996|NCT00845871|54635161|FG000|Assessment Period|Adverse Event|2|||
27976997|NCT00845871|54635161|FG000|Assessment Period|Abnormal laboratory values|1|||
27976998|NCT00845871|54635161|FG000|Assessment Period|Abnormal test procedure results|1|||
27976999|NCT00845871|54635161|FG000|Assessment Period|Patient withdrew consent|3|||
27977000|NCT00915278|54635191|FG000|Overall Study|Death|1|||
28086873|NCT02903420|54740416|FG000|Overall Study|Death|3|||
28086874|NCT00369161|54740426|FG000|Overall Study|Adverse Event|15|||
28086875|NCT00369161|54740427|FG001|Overall Study|Adverse Event|13|||
28086876|NCT00369161|54740426|FG000|Overall Study|Abnormal laboratory value|0|||
28086877|NCT00369161|54740427|FG001|Overall Study|Abnormal laboratory value|1|||
28086878|NCT00369161|54740426|FG000|Overall Study|Lack of Efficacy|3|||
28086879|NCT00369161|54740427|FG001|Overall Study|Lack of Efficacy|1|||
28086880|NCT00369161|54740426|FG000|Overall Study|Protocol Violation|0|||
28086881|NCT00369161|54740427|FG001|Overall Study|Protocol Violation|2|||
28086882|NCT00369161|54740426|FG000|Overall Study|Withdrawal by Subject|2|||
28086883|NCT00369161|54740427|FG001|Overall Study|Withdrawal by Subject|3|||
28086884|NCT00369161|54740426|FG000|Overall Study|Death|1|||
28086885|NCT00369161|54740427|FG001|Overall Study|Death|2|||
28086886|NCT00369161|54740426|FG000|Overall Study|Graft loss|4|||
28086887|NCT00369161|54740427|FG001|Overall Study|Graft loss|0|||
28086888|NCT00369161|54740426|FG000|Overall Study|Administrative Problem|2|||
28086889|NCT00369161|54740427|FG001|Overall Study|Administrative Problem|2|||
28086890|NCT00337571|54740437|FG000|Overall Study|Lack of Efficacy|3|||
28086891|NCT00337571|54740438|FG001|Overall Study|Lack of Efficacy|0|||
28086892|NCT00337571|54740439|FG002|Overall Study|Lack of Efficacy|0|||
28086893|NCT00337571|54740440|FG003|Overall Study|Lack of Efficacy|0|||
28086894|NCT00337571|54740437|FG000|Overall Study|Adverse Event|4|||
28086895|NCT00337571|54740438|FG001|Overall Study|Adverse Event|5|||
28086896|NCT00337571|54740439|FG002|Overall Study|Adverse Event|8|||
28086897|NCT00337571|54740440|FG003|Overall Study|Adverse Event|4|||
28086898|NCT00337571|54740437|FG000|Overall Study|Withdrawal by Subject|2|||
28086899|NCT00337571|54740438|FG001|Overall Study|Withdrawal by Subject|2|||
28086900|NCT00337571|54740439|FG002|Overall Study|Withdrawal by Subject|1|||
28086901|NCT00337571|54740440|FG003|Overall Study|Withdrawal by Subject|0|||
28086902|NCT00337571|54740437|FG000|Overall Study|Lost to Follow-up|3|||
28086903|NCT00337571|54740438|FG001|Overall Study|Lost to Follow-up|1|||
28086904|NCT00337571|54740439|FG002|Overall Study|Lost to Follow-up|0|||
28086905|NCT00337571|54740440|FG003|Overall Study|Lost to Follow-up|1|||
27977001|NCT00915278|54635192|FG001|Overall Study|Death|0|||
27977002|NCT00915278|54635193|FG002|Overall Study|Death|0|||
27977003|NCT00915278|54635194|FG003|Overall Study|Death|0|||
27977004|NCT00915278|54635195|FG004|Overall Study|Death|0|||
27977005|NCT00915278|54635196|FG005|Overall Study|Death|0|||
28086906|NCT00337571|54740437|FG000|Overall Study|Poor/noncompliance|1|||
28086907|NCT00337571|54740438|FG001|Overall Study|Poor/noncompliance|1|||
28086908|NCT00337571|54740439|FG002|Overall Study|Poor/noncompliance|1|||
28086909|NCT00337571|54740440|FG003|Overall Study|Poor/noncompliance|1|||
28086910|NCT00337571|54740437|FG000|Overall Study|No longer met study criteria|1|||
27977006|NCT00915278|54635191|FG000|Overall Study|Lost to Follow-up|0|||
28086911|NCT00337571|54740438|FG001|Overall Study|No longer met study criteria|0|||
28086912|NCT00337571|54740439|FG002|Overall Study|No longer met study criteria|0|||
28086913|NCT00337571|54740440|FG003|Overall Study|No longer met study criteria|0|||
28086914|NCT00337571|54740437|FG000|Overall Study|High Potassium level|0|||
28086915|NCT00337571|54740438|FG001|Overall Study|High Potassium level|0|||
28086916|NCT00337571|54740439|FG002|Overall Study|High Potassium level|0|||
28086917|NCT00337571|54740440|FG003|Overall Study|High Potassium level|1|||
28086918|NCT00368927|54740452|FG000|Overall Study|Lost to Follow-up|2|||
28086919|NCT00368927|54740453|FG001|Overall Study|Lost to Follow-up|0|||
28086920|NCT00368927|54740452|FG000|Overall Study|Adverse Event|1|||
28086921|NCT00368927|54740453|FG001|Overall Study|Adverse Event|1|||
28086922|NCT00368927|54740452|FG000|Overall Study|Withdrawal by Subject|1|||
28086923|NCT00368927|54740453|FG001|Overall Study|Withdrawal by Subject|2|||
28086924|NCT00368927|54740452|FG000|Overall Study|Physician Decision|1|||
28086925|NCT00368927|54740453|FG001|Overall Study|Physician Decision|0|||
28086926|NCT00316589|54740476|FG000|Overall Study|Withdrawal by Subject|0|||
28086927|NCT00316589|54740477|FG001|Overall Study|Withdrawal by Subject|5|||
28086928|NCT00316589|54740478|FG002|Overall Study|Withdrawal by Subject|0|||
28086929|NCT00316589|54740479|FG003|Overall Study|Withdrawal by Subject|1|||
28086930|NCT00316589|54740476|FG000|Overall Study|Subject unwilling/unable to comply|0|||
28086931|NCT00316589|54740477|FG001|Overall Study|Subject unwilling/unable to comply|6|||
28086932|NCT00316589|54740478|FG002|Overall Study|Subject unwilling/unable to comply|0|||
28086933|NCT00316589|54740479|FG003|Overall Study|Subject unwilling/unable to comply|2|||
28086934|NCT00316589|54740476|FG000|Overall Study|Adverse Event|1|||
28086935|NCT00316589|54740477|FG001|Overall Study|Adverse Event|0|||
28086936|NCT00316589|54740478|FG002|Overall Study|Adverse Event|0|||
28086937|NCT00316589|54740479|FG003|Overall Study|Adverse Event|1|||
28086938|NCT00316589|54740476|FG000|Overall Study|Physician Decision|0|||
28086939|NCT00316589|54740477|FG001|Overall Study|Physician Decision|1|||
28086940|NCT00316589|54740478|FG002|Overall Study|Physician Decision|0|||
28086941|NCT00316589|54740479|FG003|Overall Study|Physician Decision|0|||
28086942|NCT00316589|54740476|FG000|Overall Study|Other reason|0|||
28086943|NCT00316589|54740477|FG001|Overall Study|Other reason|12|||
28086944|NCT00316589|54740478|FG002|Overall Study|Other reason|1|||
28086945|NCT00316589|54740479|FG003|Overall Study|Other reason|1|||
28086946|NCT00316277|54740493|FG000|Phase 1 (12 Weeks)|Lost to Follow-up|88|||
28086947|NCT00316277|54740494|FG001|Phase 1 (12 Weeks)|Lost to Follow-up|75|||
28086948|NCT00316277|54740493|FG000|Phase 1 (12 Weeks)|Investigator-initiated termination|2|||
28086949|NCT00316277|54740494|FG001|Phase 1 (12 Weeks)|Investigator-initiated termination|0|||
28086950|NCT00316277|54740493|FG000|Phase 1 (12 Weeks)|Eligible for Phase 2|220|||
28086951|NCT00316277|54740494|FG001|Phase 1 (12 Weeks)|Eligible for Phase 2|225|||
28086952|NCT00316277|54740493|FG000|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19|||
28086953|NCT00316277|54740494|FG001|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18|||
28086954|NCT00316277|54740493|FG000|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0|||
28086955|NCT00316277|54740494|FG001|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1|||
28086956|NCT00368849|54740508|FG000|Overall Study|Withdrawal by Subject|0|||
28165569|NCT02510014|54836177|FG001|Treatment Period|Withdrawn by the investigator|1|||
28165570|NCT02510014|54836176|FG000|Treatment Period|Protocol Violation|4|||
28165571|NCT02510014|54836177|FG001|Treatment Period|Protocol Violation|4|||
28165572|NCT02510014|54836176|FG000|Treatment Period|Incarceration, pregnancy, misc|29|||
28165573|NCT02510014|54836177|FG001|Treatment Period|Incarceration, pregnancy, misc|5|||
27855590|NCT02834247|54380600|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
27977007|NCT00915278|54635192|FG001|Overall Study|Lost to Follow-up|1|||
27977008|NCT00915278|54635193|FG002|Overall Study|Lost to Follow-up|0|||
27977009|NCT00915278|54635194|FG003|Overall Study|Lost to Follow-up|0|||
27977010|NCT00915278|54635195|FG004|Overall Study|Lost to Follow-up|0|||
27977011|NCT00915278|54635196|FG005|Overall Study|Lost to Follow-up|0|||
27977012|NCT00915278|54635191|FG000|Overall Study|Withdrawal by Subject|0|||
27977013|NCT00915278|54635192|FG001|Overall Study|Withdrawal by Subject|1|||
27977014|NCT00915278|54635193|FG002|Overall Study|Withdrawal by Subject|0|||
27977015|NCT00915278|54635194|FG003|Overall Study|Withdrawal by Subject|0|||
27977016|NCT00915278|54635195|FG004|Overall Study|Withdrawal by Subject|1|||
27977017|NCT00915278|54635196|FG005|Overall Study|Withdrawal by Subject|4|||
28086957|NCT00368849|54740509|FG001|Overall Study|Withdrawal by Subject|1|||
28086958|NCT00368849|54740508|FG000|Overall Study|Physician Decision|0|||
28086959|NCT00368849|54740509|FG001|Overall Study|Physician Decision|1|||
28086960|NCT00316199|54740516|FG000|Overall Study|Adverse Event|2|||
28086961|NCT00316199|54740516|FG000|Overall Study|Death|8|||
28086962|NCT00316199|54740516|FG000|Overall Study|Lost to Follow-up|2|||
28086963|NCT00316121|54740522|FG000|Overall Study|Death|1|||
28165574|NCT02509312|54836185|FG000|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|5|||
28086964|NCT00316121|54740523|FG001|Overall Study|Death|0|||
27977018|NCT00915278|54635191|FG000|Overall Study|Adverse Event|4|||
28086965|NCT00316121|54740522|FG000|Overall Study|Lost to Follow-up|14|||
28086966|NCT00316121|54740523|FG001|Overall Study|Lost to Follow-up|8|||
28086967|NCT00316121|54740522|FG000|Overall Study|Withdrawal by Subject|2|||
28086968|NCT00316121|54740523|FG001|Overall Study|Withdrawal by Subject|0|||
27977019|NCT00915278|54635192|FG001|Overall Study|Adverse Event|1|||
28086969|NCT00316121|54740522|FG000|Overall Study|Reason is missing|1|||
27977020|NCT00915278|54635193|FG002|Overall Study|Adverse Event|0|||
27977021|NCT00915278|54635194|FG003|Overall Study|Adverse Event|0|||
27977022|NCT00915278|54635195|FG004|Overall Study|Adverse Event|0|||
27977023|NCT00915278|54635196|FG005|Overall Study|Adverse Event|0|||
27977024|NCT00915278|54635191|FG000|Overall Study|Progressive disease/clinical progression|0|||
27977025|NCT00915278|54635192|FG001|Overall Study|Progressive disease/clinical progression|0|||
27977026|NCT00915278|54635193|FG002|Overall Study|Progressive disease/clinical progression|0|||
27977027|NCT00915278|54635194|FG003|Overall Study|Progressive disease/clinical progression|3|||
27977028|NCT00915278|54635195|FG004|Overall Study|Progressive disease/clinical progression|1|||
27977029|NCT00915278|54635196|FG005|Overall Study|Progressive disease/clinical progression|2|||
27977030|NCT00915278|54635191|FG000|Overall Study|Infusion related AEs|0|||
27977031|NCT00915278|54635192|FG001|Overall Study|Infusion related AEs|0|||
27977032|NCT00915278|54635193|FG002|Overall Study|Infusion related AEs|0|||
27977033|NCT00915278|54635194|FG003|Overall Study|Infusion related AEs|0|||
27977034|NCT00915278|54635195|FG004|Overall Study|Infusion related AEs|0|||
27977035|NCT00915278|54635196|FG005|Overall Study|Infusion related AEs|2|||
27977036|NCT00915278|54635191|FG000|Overall Study|Admission to hospice|0|||
27977037|NCT00915278|54635192|FG001|Overall Study|Admission to hospice|0|||
27977038|NCT00915278|54635193|FG002|Overall Study|Admission to hospice|1|||
27977039|NCT00915278|54635194|FG003|Overall Study|Admission to hospice|0|||
27977040|NCT00915278|54635195|FG004|Overall Study|Admission to hospice|0|||
27977041|NCT00915278|54635196|FG005|Overall Study|Admission to hospice|0|||
27977042|NCT00844857|54635212|FG000|Overall Study|Adverse Event|24|||
27977043|NCT00844857|54635213|FG001|Overall Study|Adverse Event|5|||
27977044|NCT00844857|54635212|FG000|Overall Study|Sponsor Decision|1|||
27977045|NCT00844857|54635213|FG001|Overall Study|Sponsor Decision|1|||
27977046|NCT00844857|54635212|FG000|Overall Study|Physician Decision|2|||
27977047|NCT00844857|54635213|FG001|Overall Study|Physician Decision|0|||
27977048|NCT00844857|54635212|FG000|Overall Study|Parent/Caregiver Decision|6|||
27977049|NCT00844857|54635213|FG001|Overall Study|Parent/Caregiver Decision|2|||
27977050|NCT00844857|54635212|FG000|Overall Study|Withdrawal by Subject|8|||
27977051|NCT00844857|54635213|FG001|Overall Study|Withdrawal by Subject|7|||
27977052|NCT00844857|54635212|FG000|Overall Study|Protocol Violation|6|||
27977053|NCT00844857|54635213|FG001|Overall Study|Protocol Violation|0|||
27977054|NCT00844857|54635212|FG000|Overall Study|Lack of Efficacy|5|||
28086970|NCT00316121|54740523|FG001|Overall Study|Reason is missing|0|||
27977055|NCT00844857|54635213|FG001|Overall Study|Lack of Efficacy|5|||
27977056|NCT00844857|54635212|FG000|Overall Study|Clinical Relapse|0|||
27977057|NCT00844857|54635213|FG001|Overall Study|Clinical Relapse|1|||
27977058|NCT00844857|54635212|FG000|Overall Study|Entry Criteria Not Met|0|||
27977059|NCT00844857|54635213|FG001|Overall Study|Entry Criteria Not Met|1|||
27977060|NCT00844857|54635212|FG000|Overall Study|Lost to Follow-up|2|||
27977061|NCT00844857|54635213|FG001|Overall Study|Lost to Follow-up|3|||
27977062|NCT00844857|54635212|FG000|Overall Study|Did Not Take Study Drug|3|||
27977063|NCT00844857|54635213|FG001|Overall Study|Did Not Take Study Drug|1|||
27977064|NCT00844857|54635212|FG000|Overall Study|Good Clinical Practice Violations|21|||
27977065|NCT00844857|54635213|FG001|Overall Study|Good Clinical Practice Violations|11|||
27977066|NCT00569803|54635230|FG000|Overall Study|Lost to Follow-up|1|||
27977067|NCT00569803|54635231|FG001|Overall Study|Lost to Follow-up|0|||
27977068|NCT00569803|54635232|FG002|Overall Study|Lost to Follow-up|0|||
27977069|NCT00569803|54635233|FG003|Overall Study|Lost to Follow-up|0|||
27977070|NCT00569803|54635234|FG004|Overall Study|Lost to Follow-up|0|||
27977071|NCT00569803|54635235|FG005|Overall Study|Lost to Follow-up|0|||
27977072|NCT00569803|54635236|FG006|Overall Study|Lost to Follow-up|0|||
27977073|NCT00569803|54635237|FG007|Overall Study|Lost to Follow-up|0|||
27977074|NCT00569803|54635230|FG000|Overall Study|injection syringe leaked during dosing|0|||
27977075|NCT00569803|54635231|FG001|Overall Study|injection syringe leaked during dosing|0|||
27977076|NCT00569803|54635232|FG002|Overall Study|injection syringe leaked during dosing|0|||
27977077|NCT00569803|54635233|FG003|Overall Study|injection syringe leaked during dosing|1|||
27977078|NCT00569803|54635234|FG004|Overall Study|injection syringe leaked during dosing|0|||
27977079|NCT00569803|54635235|FG005|Overall Study|injection syringe leaked during dosing|0|||
27977080|NCT00569803|54635236|FG006|Overall Study|injection syringe leaked during dosing|0|||
27977081|NCT00569803|54635237|FG007|Overall Study|injection syringe leaked during dosing|0|||
27977082|NCT00569803|54635230|FG000|Overall Study|Withdrawal by Subject|0|||
27977083|NCT00569803|54635231|FG001|Overall Study|Withdrawal by Subject|0|||
27977084|NCT00569803|54635232|FG002|Overall Study|Withdrawal by Subject|0|||
27977085|NCT00569803|54635233|FG003|Overall Study|Withdrawal by Subject|0|||
27977086|NCT00569803|54635234|FG004|Overall Study|Withdrawal by Subject|0|||
27977087|NCT00569803|54635235|FG005|Overall Study|Withdrawal by Subject|0|||
27977088|NCT00569803|54635236|FG006|Overall Study|Withdrawal by Subject|0|||
27977089|NCT00569803|54635237|FG007|Overall Study|Withdrawal by Subject|1|||
27977090|NCT00920426|54635262|FG000|ITZ111451|Adverse Event|1|||
27977091|NCT00920426|54635263|FG001|ITZ111451|Adverse Event|0|||
27977092|NCT00920426|54635264|FG002|ITZ111451|Adverse Event|0|||
27977093|NCT00920426|54635265|FG003|ITZ111451|Adverse Event|0|||
27977094|NCT00644995|54635279|FG000|Overall Study|Lost to Follow-up|1|||
27977095|NCT00644995|54635280|FG001|Overall Study|Lost to Follow-up|4|||
27977096|NCT00644995|54635279|FG000|Overall Study|Refused|1|||
27977097|NCT00644995|54635280|FG001|Overall Study|Refused|0|||
27977098|NCT00914966|54635288|FG000|Step 1: 1500 Units|Withdrawal by Subject|1|||
27977099|NCT00914966|54635288|FG000|Step 1: 1500 Units|Physician Decision|1|||
27977100|NCT00914966|54635288|FG000|Step 2: 2000 Units|Withdrawal by Subject|1|||
27977101|NCT00914810|54635299|FG000|Overall Study|Withdrawal by Subject|1|||
27977102|NCT00914810|54635300|FG001|Overall Study|Withdrawal by Subject|0|||
27977103|NCT00914810|54635299|FG000|Overall Study|Relocated out of state|1|||
27977104|NCT00914810|54635300|FG001|Overall Study|Relocated out of state|0|||
27977105|NCT00914810|54635299|FG000|Overall Study|Hospitalized and unable to follow up.|0|||
27977106|NCT00914810|54635300|FG001|Overall Study|Hospitalized and unable to follow up.|1|||
27977107|NCT00644917|54635306|FG000|Overall Study|Withdrawal by Subject|2|||
27977108|NCT00914732|54635317|FG000|Overall Study|Lost to Follow-up|6|||
27977109|NCT00914732|54635318|FG001|Overall Study|Lost to Follow-up|7|||
27977110|NCT00914732|54635319|FG002|Overall Study|Lost to Follow-up|9|||
27977111|NCT00914732|54635317|FG000|Overall Study|Withdrawal by Subject|3|||
27977112|NCT00914732|54635318|FG001|Overall Study|Withdrawal by Subject|0|||
27977113|NCT00914732|54635319|FG002|Overall Study|Withdrawal by Subject|2|||
27977114|NCT00914732|54635317|FG000|Overall Study|Adverse Event|1|||
27977115|NCT00914732|54635318|FG001|Overall Study|Adverse Event|0|||
27977116|NCT00914732|54635319|FG002|Overall Study|Adverse Event|0|||
27977117|NCT00844545|54635328|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
27977118|NCT00844545|54635328|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
27977119|NCT00844545|54635328|FG000|Extension Treatment Period|Adverse Event|2|||
27977120|NCT00844545|54635328|FG000|Post Treatment Period|Withdrawal by Subject|1|||
27977121|NCT00651157|54635333|FG000|Overall Study|Death|1|||
27977122|NCT00651157|54635333|FG000|Overall Study|Protocol Violation|1|||
27977123|NCT00843843|54635339|FG000|Overall Study|Physician Decision|1|||
27977124|NCT00843843|54635340|FG001|Overall Study|Physician Decision|1|||
27977125|NCT00843843|54635339|FG000|Overall Study|Protocol Violation|1|||
27977126|NCT00843843|54635340|FG001|Overall Study|Protocol Violation|1|||
27977127|NCT00650845|54635348|FG000|Overall Study|Withdrawal by Subject|5|||
27977128|NCT00650845|54635349|FG001|Overall Study|Withdrawal by Subject|0|||
27977129|NCT00650845|54635348|FG000|Overall Study|Protocol Violation|0|||
27977130|NCT00650845|54635349|FG001|Overall Study|Protocol Violation|13|||
27977131|NCT00842985|54635356|FG000|Screening|Did not meet entrance requirements|27|||
27977132|NCT00842985|54635356|FG000|First Intervention|Withdrawal by Subject|3|||
27977133|NCT00842985|54635356|FG000|First Intervention|Protocol Violation|3|||
27977134|NCT00842985|54635356|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
27977135|NCT00842985|54635356|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
27977136|NCT00842829|54635365|FG000|Dose Titration Period|Adverse Event|11|||
27977137|NCT00842829|54635366|FG001|Dose Titration Period|Adverse Event|10|||
27977138|NCT00842829|54635367|FG002|Dose Titration Period|Adverse Event|0|||
27977139|NCT00842829|54635365|FG000|Dose Titration Period|Lack of Efficacy|4|||
27977140|NCT00842829|54635366|FG001|Dose Titration Period|Lack of Efficacy|1|||
27977141|NCT00842829|54635367|FG002|Dose Titration Period|Lack of Efficacy|0|||
27977142|NCT00842829|54635365|FG000|Dose Titration Period|Unstable persistent cancer pain|1|||
27977143|NCT00842829|54635366|FG001|Dose Titration Period|Unstable persistent cancer pain|0|||
27977144|NCT00842829|54635367|FG002|Dose Titration Period|Unstable persistent cancer pain|0|||
27977145|NCT00842829|54635365|FG000|Dose Titration Period|Withdrawal by Subject|2|||
27977146|NCT00842829|54635366|FG001|Dose Titration Period|Withdrawal by Subject|6|||
27977147|NCT00842829|54635367|FG002|Dose Titration Period|Withdrawal by Subject|0|||
27977148|NCT00842829|54635365|FG000|Dose Titration Period|Other|5|||
27977149|NCT00842829|54635366|FG001|Dose Titration Period|Other|4|||
27977150|NCT00842829|54635367|FG002|Dose Titration Period|Other|0|||
27977151|NCT00842829|54635365|FG000|Dose Titration Period|Non-compliance to study procedures|1|||
27977152|NCT00842829|54635366|FG001|Dose Titration Period|Non-compliance to study procedures|1|||
28165575|NCT02509312|54836186|FG001|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|3|||
28165576|NCT02509312|54836185|FG000|Overall Study|Obstetrician refusal|0|||
28165577|NCT02509312|54836186|FG001|Overall Study|Obstetrician refusal|1|||
28165578|NCT02509312|54836185|FG000|Overall Study|Patient elected for TOLAC|1|||
28165579|NCT02509312|54836186|FG001|Overall Study|Patient elected for TOLAC|0|||
27832746|NCT01729871|54312491|FG001|Overall Study|Lack of Efficacy|1|||
27977153|NCT00842829|54635367|FG002|Dose Titration Period|Non-compliance to study procedures|0|||
27977154|NCT00842829|54635365|FG000|Dose Titration Period|Non-compliance to study drug|2|||
27977155|NCT00842829|54635366|FG001|Dose Titration Period|Non-compliance to study drug|1|||
27977156|NCT00842829|54635367|FG002|Dose Titration Period|Non-compliance to study drug|0|||
27977157|NCT00842829|54635365|FG000|Treatment Period|Adverse Event|0|||
27977158|NCT00842829|54635366|FG001|Treatment Period|Adverse Event|0|||
27977159|NCT00842829|54635367|FG002|Treatment Period|Adverse Event|15|||
27977160|NCT00842829|54635365|FG000|Treatment Period|Lack of Efficacy|0|||
27977161|NCT00842829|54635366|FG001|Treatment Period|Lack of Efficacy|0|||
27977162|NCT00842829|54635367|FG002|Treatment Period|Lack of Efficacy|6|||
27977163|NCT00842829|54635365|FG000|Treatment Period|Unstable persistent cancer pain|0|||
27977164|NCT00842829|54635366|FG001|Treatment Period|Unstable persistent cancer pain|0|||
27977165|NCT00842829|54635367|FG002|Treatment Period|Unstable persistent cancer pain|5|||
27977166|NCT00842829|54635365|FG000|Treatment Period|Withdrawal by Subject|0|||
27977167|NCT00842829|54635366|FG001|Treatment Period|Withdrawal by Subject|0|||
27977168|NCT00842829|54635367|FG002|Treatment Period|Withdrawal by Subject|11|||
27977169|NCT00842829|54635365|FG000|Treatment Period|Consistently >4 BTP episodes daily|0|||
27977170|NCT00842829|54635366|FG001|Treatment Period|Consistently >4 BTP episodes daily|0|||
27977171|NCT00842829|54635367|FG002|Treatment Period|Consistently >4 BTP episodes daily|1|||
27977172|NCT00842829|54635365|FG000|Treatment Period|Protocol Violation|0|||
27977173|NCT00842829|54635366|FG001|Treatment Period|Protocol Violation|0|||
27977174|NCT00842829|54635367|FG002|Treatment Period|Protocol Violation|2|||
27977175|NCT00842829|54635365|FG000|Treatment Period|Other|0|||
27977176|NCT00842829|54635366|FG001|Treatment Period|Other|0|||
27977177|NCT00842829|54635367|FG002|Treatment Period|Other|18|||
27977178|NCT00842829|54635365|FG000|Treatment Period|Non-compliance to study procedures|0|||
27977179|NCT00842829|54635366|FG001|Treatment Period|Non-compliance to study procedures|0|||
27977180|NCT00842829|54635367|FG002|Treatment Period|Non-compliance to study procedures|4|||
27977181|NCT00842829|54635365|FG000|Treatment Period|Unclear completion status|0|||
27977182|NCT00842829|54635366|FG001|Treatment Period|Unclear completion status|0|||
27977183|NCT00842829|54635367|FG002|Treatment Period|Unclear completion status|1|||
27977184|NCT00842829|54635365|FG000|Continuation Period|Adverse Event|0|||
27977185|NCT00842829|54635366|FG001|Continuation Period|Adverse Event|0|||
27977186|NCT00842829|54635367|FG002|Continuation Period|Adverse Event|32|||
27977187|NCT00842829|54635365|FG000|Continuation Period|Lack of Efficacy|0|||
27977188|NCT00842829|54635366|FG001|Continuation Period|Lack of Efficacy|0|||
27977189|NCT00842829|54635367|FG002|Continuation Period|Lack of Efficacy|6|||
27977190|NCT00842829|54635365|FG000|Continuation Period|Unstable persistent cancer pain|0|||
27977191|NCT00842829|54635366|FG001|Continuation Period|Unstable persistent cancer pain|0|||
27977192|NCT00842829|54635367|FG002|Continuation Period|Unstable persistent cancer pain|3|||
27977193|NCT00842829|54635365|FG000|Continuation Period|Withdrawal by Subject|0|||
27977194|NCT00842829|54635366|FG001|Continuation Period|Withdrawal by Subject|0|||
27977195|NCT00842829|54635367|FG002|Continuation Period|Withdrawal by Subject|10|||
27977196|NCT00842829|54635365|FG000|Continuation Period|Other|0|||
27977197|NCT00842829|54635366|FG001|Continuation Period|Other|0|||
27977198|NCT00842829|54635367|FG002|Continuation Period|Other|7|||
27977199|NCT00842829|54635365|FG000|Continuation Period|Non-compliance to study procedures|0|||
27977200|NCT00842829|54635366|FG001|Continuation Period|Non-compliance to study procedures|0|||
27977201|NCT00842829|54635367|FG002|Continuation Period|Non-compliance to study procedures|2|||
27977202|NCT00842829|54635365|FG000|Continuation Period|Non-compliance to study drug|0|||
27977203|NCT00842829|54635366|FG001|Continuation Period|Non-compliance to study drug|0|||
27977204|NCT00842829|54635367|FG002|Continuation Period|Non-compliance to study drug|1|||
27977205|NCT00653263|54635379|FG000|Overall Study|Withdrawal by Subject|1|||
27977206|NCT00653263|54635379|FG000|Overall Study|Physician Decision|1|||
27977207|NCT00842361|54635385|FG000|Overall Study|Protocol Violation|1|||
27977208|NCT00842361|54635386|FG001|Overall Study|Protocol Violation|0|||
27977209|NCT00842361|54635385|FG000|Overall Study|Unclassified|0|||
27977210|NCT00842361|54635386|FG001|Overall Study|Unclassified|2|||
27977211|NCT00841035|54635392|FG000|Phase 1 Overall Study|Physician Decision|13|||
27977212|NCT00642811|54635403|FG000|Overall Study|Adverse Event|2|||
27977213|NCT00642811|54635404|FG001|Overall Study|Adverse Event|3|||
27977214|NCT00642811|54635405|FG002|Overall Study|Adverse Event|0|||
27977215|NCT00642811|54635406|FG003|Overall Study|Adverse Event|0|||
27977216|NCT00642811|54635407|FG004|Overall Study|Adverse Event|0|||
27977217|NCT00642811|54635408|FG005|Overall Study|Adverse Event|1|||
27977218|NCT00642811|54635403|FG000|Overall Study|Developement of discontinuation criteria|0|||
27977219|NCT00642811|54635404|FG001|Overall Study|Developement of discontinuation criteria|0|||
27977220|NCT00642811|54635405|FG002|Overall Study|Developement of discontinuation criteria|0|||
28165580|NCT02509312|54836185|FG000|Overall Study|Cesarean deemed stat|1|||
28165581|NCT02509312|54836186|FG001|Overall Study|Cesarean deemed stat|0|||
27733232|NCT03530293|54181028|FG001|Pre-randomization|Study Terminated by Sponsor|0|||
27832747|NCT01729871|54312490|FG000|Overall Study|Physician Decision|0|||
27977221|NCT00642811|54635406|FG003|Overall Study|Developement of discontinuation criteria|0|||
27977222|NCT00642811|54635407|FG004|Overall Study|Developement of discontinuation criteria|1|||
27977223|NCT00642811|54635408|FG005|Overall Study|Developement of discontinuation criteria|0|||
27977224|NCT00642811|54635403|FG000|Overall Study|Severe Non-compliance to protocol|1|||
27977225|NCT00642811|54635404|FG001|Overall Study|Severe Non-compliance to protocol|0|||
27977226|NCT00642811|54635405|FG002|Overall Study|Severe Non-compliance to protocol|0|||
27977227|NCT00642811|54635406|FG003|Overall Study|Severe Non-compliance to protocol|0|||
27977228|NCT00642811|54635407|FG004|Overall Study|Severe Non-compliance to protocol|0|||
27977229|NCT00642811|54635408|FG005|Overall Study|Severe Non-compliance to protocol|0|||
27977230|NCT00642811|54635403|FG000|Overall Study|Other|0|||
27977231|NCT00642811|54635404|FG001|Overall Study|Other|1|||
27977232|NCT00642811|54635405|FG002|Overall Study|Other|0|||
27977233|NCT00642811|54635406|FG003|Overall Study|Other|1|||
27977234|NCT00642811|54635407|FG004|Overall Study|Other|0|||
27977235|NCT00642811|54635408|FG005|Overall Study|Other|0|||
27977236|NCT00838929|54635425|FG000|Overall Study|Protocol Violation|0|||
27977237|NCT00838929|54635426|FG001|Overall Study|Protocol Violation|1|||
27977238|NCT00838929|54635427|FG002|Overall Study|Protocol Violation|0|||
27977239|NCT00838929|54635425|FG000|Overall Study|Disease progression|0|||
27977240|NCT00838929|54635426|FG001|Overall Study|Disease progression|2|||
27977241|NCT00838929|54635427|FG002|Overall Study|Disease progression|1|||
27977242|NCT00916058|54635440|FG000|Phase 1|Screen Failure|0|||
27977243|NCT00916058|54635441|FG001|Phase 1|Screen Failure|0|||
27977244|NCT00916058|54635442|FG002|Phase 1|Screen Failure|0|||
27977245|NCT00916058|54635443|FG003|Phase 1|Screen Failure|0|||
27977246|NCT00916058|54635444|FG004|Phase 1|Screen Failure|0|||
27977247|NCT00916058|54635445|FG005|Phase 1|Screen Failure|1|||
27977248|NCT00916058|54635446|FG006|Phase 1|Screen Failure|0|||
27977249|NCT00916058|54635440|FG000|Phase 2|Screen Failure|0|||
27977250|NCT00916058|54635441|FG001|Phase 2|Screen Failure|0|||
27977251|NCT00916058|54635442|FG002|Phase 2|Screen Failure|0|||
27977252|NCT00916058|54635443|FG003|Phase 2|Screen Failure|0|||
28086971|NCT00316121|54740522|FG000|Overall Study|Subject relocated|1|||
28086972|NCT00316121|54740523|FG001|Overall Study|Subject relocated|1|||
28086973|NCT00316121|54740522|FG000|Overall Study|Subject refused to return|1|||
28086974|NCT00316121|54740523|FG001|Overall Study|Subject refused to return|0|||
28086975|NCT00316121|54740522|FG000|Overall Study|Subject no show for visit x 3|1|||
28086976|NCT00316121|54740523|FG001|Overall Study|Subject no show for visit x 3|0|||
28086977|NCT00316121|54740522|FG000|Overall Study|Subject did not have 24 month visit|1|||
28086978|NCT00316121|54740523|FG001|Overall Study|Subject did not have 24 month visit|0|||
28086979|NCT00337103|54740542|FG000|Overall Study|Progressive Disease|414|||
28086980|NCT00337103|54740543|FG001|Overall Study|Progressive Disease|410|||
28086981|NCT00337103|54740542|FG000|Overall Study|Adverse Event|45|||
28086982|NCT00337103|54740543|FG001|Overall Study|Adverse Event|59|||
28086983|NCT00337103|54740542|FG000|Overall Study|Subject Choice|34|||
28086984|NCT00337103|54740543|FG001|Overall Study|Subject Choice|27|||
28086985|NCT00337103|54740542|FG000|Overall Study|Clinical Progression|27|||
28086986|NCT00337103|54740543|FG001|Overall Study|Clinical Progression|24|||
27977253|NCT00916058|54635444|FG004|Phase 2|Screen Failure|0|||
27977254|NCT00916058|54635445|FG005|Phase 2|Screen Failure|0|||
27977255|NCT00916058|54635446|FG006|Phase 2|Screen Failure|3|||
27977256|NCT00912782|54635466|FG000|Overall Study|Death|2|||
27977257|NCT00912782|54635467|FG001|Overall Study|Death|1|||
27977258|NCT00912782|54635466|FG000|Overall Study|Lost to Follow-up|0|||
27977259|NCT00912782|54635467|FG001|Overall Study|Lost to Follow-up|1|||
27977260|NCT00912782|54635466|FG000|Overall Study|Did not receive vascular access type|1|||
27977261|NCT00912782|54635467|FG001|Overall Study|Did not receive vascular access type|2|||
27977262|NCT00912782|54635466|FG000|Overall Study|Relocated before study completion|0|||
27977263|NCT00912782|54635467|FG001|Overall Study|Relocated before study completion|1|||
27977264|NCT03444038|54635473|FG000|Overall Study|Adverse Event|12|||
27977265|NCT03444038|54635473|FG000|Overall Study|Withdrawal by Subject|7|||
27977266|NCT03444038|54635473|FG000|Overall Study|Lost to Follow-up|1|||
27977267|NCT03444038|54635473|FG000|Overall Study|Physician Decision|2|||
27977268|NCT03444038|54635473|FG000|Overall Study|Lack of Efficacy|7|||
27977269|NCT00911534|54635479|FG000|Overall Study|Adverse Event|4|||
27977270|NCT00911534|54635480|FG001|Overall Study|Adverse Event|4|||
27977271|NCT00911534|54635479|FG000|Overall Study|Lost to Follow-up|2|||
27977272|NCT00911534|54635480|FG001|Overall Study|Lost to Follow-up|4|||
27977273|NCT00911534|54635479|FG000|Overall Study|Withdrawal by Subject|2|||
27977274|NCT00911534|54635480|FG001|Overall Study|Withdrawal by Subject|1|||
27977275|NCT00911534|54635479|FG000|Overall Study|Lack of Efficacy|4|||
27977276|NCT00911534|54635480|FG001|Overall Study|Lack of Efficacy|1|||
27977277|NCT00911534|54635479|FG000|Overall Study|Withdrawal of consent|1|||
28086987|NCT00337103|54740542|FG000|Overall Study|Physician Decision|15|||
28165582|NCT02509312|54836185|FG000|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|0|||
27977278|NCT00911534|54635480|FG001|Overall Study|Withdrawal of consent|4|||
27977279|NCT00911534|54635479|FG000|Overall Study|Other|2|||
27977280|NCT00911534|54635480|FG001|Overall Study|Other|2|||
27977281|NCT00911300|54635488|FG000|Overall Study|Primary Endpoint Component Occurred|1|||
27977282|NCT00911300|54635489|FG001|Overall Study|Primary Endpoint Component Occurred|2|||
27977283|NCT00911300|54635488|FG000|Overall Study|Death|1|||
27977284|NCT00911300|54635489|FG001|Overall Study|Death|0|||
27977285|NCT00911300|54635488|FG000|Overall Study|Thrombus Persistant in Second TEE|3|||
27977286|NCT00911300|54635489|FG001|Overall Study|Thrombus Persistant in Second TEE|7|||
27977287|NCT00911300|54635488|FG000|Overall Study|Adverse Event|14|||
27977288|NCT00911300|54635489|FG001|Overall Study|Adverse Event|6|||
27977289|NCT00911300|54635488|FG000|Overall Study|Protocol Violation|3|||
28086988|NCT00337103|54740543|FG001|Overall Study|Physician Decision|14|||
28086989|NCT00337103|54740542|FG000|Overall Study|Withdrawal by Subject|8|||
28086990|NCT00337103|54740543|FG001|Overall Study|Withdrawal by Subject|5|||
27977290|NCT00911300|54635489|FG001|Overall Study|Protocol Violation|2|||
27977291|NCT00911300|54635488|FG000|Overall Study|Consent Withdrawn|4|||
27977292|NCT00911300|54635489|FG001|Overall Study|Consent Withdrawn|12|||
27977293|NCT00911300|54635488|FG000|Overall Study|Coronary Angiography Performed|1|||
27977294|NCT00911300|54635489|FG001|Overall Study|Coronary Angiography Performed|0|||
27977295|NCT00911300|54635488|FG000|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
27977296|NCT00911300|54635489|FG001|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
27977297|NCT00911300|54635488|FG000|Overall Study|Received Commercial Treatment|1|||
27977298|NCT00911300|54635489|FG001|Overall Study|Received Commercial Treatment|0|||
27977299|NCT00911300|54635488|FG000|Overall Study|Recurrent Tachyarrhythmia|1|||
27977300|NCT00911300|54635489|FG001|Overall Study|Recurrent Tachyarrhythmia|1|||
27977301|NCT00911300|54635488|FG000|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
27977302|NCT00911300|54635489|FG001|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
27977303|NCT00911300|54635488|FG000|Overall Study|Nurse Unavailable in Participant's City|1|||
27977304|NCT00911300|54635489|FG001|Overall Study|Nurse Unavailable in Participant's City|0|||
27977305|NCT00911300|54635488|FG000|Overall Study|CV Unsuccessful; Phenprocoumon Received|1|||
27977306|NCT00911300|54635489|FG001|Overall Study|CV Unsuccessful; Phenprocoumon Received|0|||
27977307|NCT00911300|54635488|FG000|Overall Study|Participant Could Not Stay in Hospital|0|||
27977308|NCT00911300|54635489|FG001|Overall Study|Participant Could Not Stay in Hospital|1|||
27977309|NCT00911300|54635488|FG000|Overall Study|Investigator's Decision; New AF Episode|0|||
27977310|NCT00911300|54635489|FG001|Overall Study|Investigator's Decision; New AF Episode|1|||
27977311|NCT00911300|54635488|FG000|Overall Study|International Normalized Ratio Too High|0|||
27977312|NCT00911300|54635489|FG001|Overall Study|International Normalized Ratio Too High|1|||
27977313|NCT00911300|54635488|FG000|Overall Study|Participant Refused Hospital Consulation|0|||
27977314|NCT00911300|54635489|FG001|Overall Study|Participant Refused Hospital Consulation|1|||
27977315|NCT00911300|54635488|FG000|Overall Study|Underlying Disease (Myocarditis)|0|||
27977316|NCT00911300|54635489|FG001|Overall Study|Underlying Disease (Myocarditis)|1|||
27977317|NCT00911300|54635488|FG000|Overall Study|Physician Decision|0|||
27977318|NCT00911300|54635489|FG001|Overall Study|Physician Decision|1|||
27977319|NCT00911300|54635488|FG000|Overall Study|Treatment Stopped by Mistake|0|||
27977320|NCT00911300|54635489|FG001|Overall Study|Treatment Stopped by Mistake|1|||
27977321|NCT00911300|54635488|FG000|Overall Study|Randomized; No Study Medication Received|0|||
27977322|NCT00911300|54635489|FG001|Overall Study|Randomized; No Study Medication Received|2|||
27977323|NCT00911144|54635498|FG000|Overall Study|Withdrawal by Subject|16|||
27977324|NCT00911144|54635499|FG001|Overall Study|Withdrawal by Subject|5|||
27977325|NCT00910988|54635509|FG000|Overall Study|Lost to Follow-up|2|||
27977326|NCT00910988|54635510|FG001|Overall Study|Lost to Follow-up|4|||
27977327|NCT00910988|54635511|FG002|Overall Study|Lost to Follow-up|3|||
27977328|NCT00910988|54635512|FG003|Overall Study|Lost to Follow-up|0|||
27977329|NCT00644059|54635541|FG000|Overall Study|Lost to Follow-up|37|||
27977330|NCT00644059|54635542|FG001|Overall Study|Lost to Follow-up|34|||
27977331|NCT00644059|54635543|FG002|Overall Study|Lost to Follow-up|16|||
27977332|NCT00644059|54635541|FG000|Overall Study|Withdrawal by Subject|52|||
27977333|NCT00644059|54635542|FG001|Overall Study|Withdrawal by Subject|60|||
27977334|NCT00644059|54635543|FG002|Overall Study|Withdrawal by Subject|30|||
27977335|NCT00644059|54635541|FG000|Overall Study|Adverse Event|8|||
27977336|NCT00644059|54635542|FG001|Overall Study|Adverse Event|5|||
27977337|NCT00644059|54635543|FG002|Overall Study|Adverse Event|1|||
27977338|NCT00644059|54635541|FG000|Overall Study|Inappropriate Enrollment|1|||
27977339|NCT00644059|54635542|FG001|Overall Study|Inappropriate Enrollment|3|||
27977340|NCT00644059|54635543|FG002|Overall Study|Inappropriate Enrollment|0|||
27977341|NCT00644059|54635541|FG000|Overall Study|Protocol Deviation/violation|20|||
27977342|NCT00644059|54635542|FG001|Overall Study|Protocol Deviation/violation|19|||
27977343|NCT00644059|54635543|FG002|Overall Study|Protocol Deviation/violation|15|||
27977344|NCT00644059|54635541|FG000|Overall Study|Unable to classify|6|||
27977345|NCT00644059|54635542|FG001|Overall Study|Unable to classify|2|||
27977346|NCT00644059|54635543|FG002|Overall Study|Unable to classify|3|||
27977347|NCT00643279|54635594|FG000|Overall Study|Death|13|||
27977348|NCT00643279|54635595|FG001|Overall Study|Death|11|||
27977349|NCT00643279|54635594|FG000|Overall Study|Withdrawal by Subject|3|||
27977350|NCT00643279|54635595|FG001|Overall Study|Withdrawal by Subject|0|||
27977351|NCT00643279|54635594|FG000|Overall Study|Lost to Follow-up|0|||
27977352|NCT00643279|54635595|FG001|Overall Study|Lost to Follow-up|1|||
27977353|NCT00643279|54635594|FG000|Overall Study|Physician Decision|0|||
27977354|NCT00643279|54635595|FG001|Overall Study|Physician Decision|1|||
27977355|NCT00910910|54635605|FG000|Overall Study|Adverse Event|63|||
27977356|NCT00910910|54635606|FG001|Overall Study|Adverse Event|35|||
27977357|NCT00910910|54635605|FG000|Overall Study|PD without histologic change|27|||
27977358|NCT00910910|54635606|FG001|Overall Study|PD without histologic change|23|||
27832748|NCT01729871|54312491|FG001|Overall Study|Physician Decision|2|||
27977359|NCT00910910|54635605|FG000|Overall Study|PD with histologic change|0|||
27977360|NCT00910910|54635606|FG001|Overall Study|PD with histologic change|2|||
27977361|NCT00910910|54635605|FG000|Overall Study|Withdrawal by Subject|7|||
27977362|NCT00910910|54635606|FG001|Overall Study|Withdrawal by Subject|5|||
27977363|NCT00910910|54635605|FG000|Overall Study|Lost to Follow-up|2|||
27977364|NCT00910910|54635606|FG001|Overall Study|Lost to Follow-up|2|||
27977365|NCT00910910|54635605|FG000|Overall Study|Death|9|||
27977366|NCT00910910|54635606|FG001|Overall Study|Death|3|||
27977367|NCT00910910|54635605|FG000|Overall Study|Protocol Violation|2|||
27977368|NCT00910910|54635606|FG001|Overall Study|Protocol Violation|2|||
27977369|NCT00910910|54635605|FG000|Overall Study|Completed 13 cycles of treatment|0|||
27977370|NCT00910910|54635606|FG001|Overall Study|Completed 13 cycles of treatment|118|||
27977371|NCT00910910|54635605|FG000|Overall Study|Other|114|||
27977372|NCT00910910|54635606|FG001|Overall Study|Other|32|||
27977373|NCT00910910|54635605|FG000|Overall Study|Untreated before cycle 1|1|||
27977374|NCT00910910|54635606|FG001|Overall Study|Untreated before cycle 1|2|||
27977375|NCT00911768|54635614|FG000|Overall Study|Protocol Violation|5|||
27977376|NCT00911768|54635615|FG001|Overall Study|Protocol Violation|4|||
27977377|NCT00911768|54635614|FG000|Overall Study|Withdrawal by Subject|1|||
27977378|NCT00911768|54635615|FG001|Overall Study|Withdrawal by Subject|0|||
27977379|NCT00909038|54635621|FG000|Overall Study|Protocol Violation|187|||
27977380|NCT00909038|54635621|FG000|Overall Study|Non-evaluable Subjects|230|||
27977381|NCT00909428|54635628|FG000|Overall Study|Lost to Follow-up|13|||
27977382|NCT00909428|54635629|FG001|Overall Study|Lost to Follow-up|10|||
27977383|NCT00909428|54635630|FG002|Overall Study|Lost to Follow-up|9|||
27977384|NCT00908960|54635640|FG000|Overall Study|Presence VTE dx or Absent VTE eval|1|||
27977385|NCT00908960|54635641|FG001|Overall Study|Presence VTE dx or Absent VTE eval|1|||
27977386|NCT00908960|54635642|FG002|Overall Study|Presence VTE dx or Absent VTE eval|2|||
27977387|NCT00650767|54635660|FG000|Overall Study|Adverse Event|0|||
27977388|NCT00650767|54635661|FG001|Overall Study|Adverse Event|3|||
27977389|NCT00650767|54635662|FG002|Overall Study|Adverse Event|10|||
27977390|NCT00650767|54635663|FG003|Overall Study|Adverse Event|8|||
27977391|NCT00650767|54635660|FG000|Overall Study|Death|1|||
27977392|NCT00650767|54635661|FG001|Overall Study|Death|0|||
27977393|NCT00650767|54635662|FG002|Overall Study|Death|0|||
27977394|NCT00650767|54635663|FG003|Overall Study|Death|0|||
27977395|NCT00650767|54635660|FG000|Overall Study|Withdrawal by Subject|2|||
27977396|NCT00650767|54635661|FG001|Overall Study|Withdrawal by Subject|4|||
27977397|NCT00650767|54635662|FG002|Overall Study|Withdrawal by Subject|3|||
27977398|NCT00650767|54635663|FG003|Overall Study|Withdrawal by Subject|3|||
27977399|NCT00650767|54635660|FG000|Overall Study|Lost to Follow-up|1|||
27977400|NCT00650767|54635661|FG001|Overall Study|Lost to Follow-up|1|||
27977401|NCT00650767|54635662|FG002|Overall Study|Lost to Follow-up|1|||
27977402|NCT00650767|54635663|FG003|Overall Study|Lost to Follow-up|0|||
27977403|NCT00650767|54635660|FG000|Overall Study|Other|1|||
27977404|NCT00650767|54635661|FG001|Overall Study|Other|1|||
27977405|NCT00650767|54635662|FG002|Overall Study|Other|0|||
27977406|NCT00650767|54635663|FG003|Overall Study|Other|0|||
27977407|NCT00973349|54635689|FG000|Overall Study|Adverse Event|0|||
27977408|NCT00973349|54635690|FG001|Overall Study|Adverse Event|0|||
27977409|NCT00973349|54635691|FG002|Overall Study|Adverse Event|0|||
27977410|NCT00973349|54635692|FG003|Overall Study|Adverse Event|0|||
27977411|NCT00973349|54635693|FG004|Overall Study|Adverse Event|1|||
27977412|NCT00973349|54635694|FG005|Overall Study|Adverse Event|0|||
27977413|NCT00973349|54635695|FG006|Overall Study|Adverse Event|0|||
27977414|NCT00973349|54635696|FG007|Overall Study|Adverse Event|0|||
27977415|NCT00973349|54635697|FG008|Overall Study|Adverse Event|1|||
27977416|NCT00973349|54635698|FG009|Overall Study|Adverse Event|0|||
27977417|NCT00973349|54635699|FG010|Overall Study|Adverse Event|0|||
27977418|NCT00973349|54635700|FG011|Overall Study|Adverse Event|0|||
27977419|NCT00973349|54635701|FG012|Overall Study|Adverse Event|0|||
27977420|NCT00973349|54635702|FG013|Overall Study|Adverse Event|0|||
27977421|NCT00973349|54635703|FG014|Overall Study|Adverse Event|1|||
27977422|NCT00973349|54635704|FG015|Overall Study|Adverse Event|0|||
27977423|NCT00973349|54635689|FG000|Overall Study|Withdrawal by Subject|1|||
27977424|NCT00973349|54635690|FG001|Overall Study|Withdrawal by Subject|2|||
27977425|NCT00973349|54635691|FG002|Overall Study|Withdrawal by Subject|2|||
27977426|NCT00973349|54635692|FG003|Overall Study|Withdrawal by Subject|3|||
27977427|NCT00973349|54635693|FG004|Overall Study|Withdrawal by Subject|2|||
27977428|NCT00973349|54635694|FG005|Overall Study|Withdrawal by Subject|0|||
27977429|NCT00973349|54635695|FG006|Overall Study|Withdrawal by Subject|2|||
27977430|NCT00973349|54635696|FG007|Overall Study|Withdrawal by Subject|2|||
27977431|NCT00973349|54635697|FG008|Overall Study|Withdrawal by Subject|0|||
27977432|NCT00973349|54635698|FG009|Overall Study|Withdrawal by Subject|2|||
27977433|NCT00973349|54635699|FG010|Overall Study|Withdrawal by Subject|0|||
27977434|NCT00973349|54635700|FG011|Overall Study|Withdrawal by Subject|1|||
27977435|NCT00973349|54635701|FG012|Overall Study|Withdrawal by Subject|0|||
27977436|NCT00973349|54635702|FG013|Overall Study|Withdrawal by Subject|0|||
27977437|NCT00973349|54635703|FG014|Overall Study|Withdrawal by Subject|0|||
27977438|NCT00973349|54635704|FG015|Overall Study|Withdrawal by Subject|0|||
27977439|NCT00973349|54635689|FG000|Overall Study|Lost to Follow-up|3|||
27977440|NCT00973349|54635690|FG001|Overall Study|Lost to Follow-up|1|||
27977441|NCT00973349|54635691|FG002|Overall Study|Lost to Follow-up|2|||
27977442|NCT00973349|54635692|FG003|Overall Study|Lost to Follow-up|2|||
27977443|NCT00973349|54635693|FG004|Overall Study|Lost to Follow-up|1|||
27733233|NCT03530293|54181029|FG002|Pre-randomization|Study Terminated by Sponsor|0|||
27733234|NCT03530293|54181027|FG000|Pre-randomization|Withdrawal by Subject|5|||
27733235|NCT03530293|54181028|FG001|Pre-randomization|Withdrawal by Subject|0|||
27977444|NCT00973349|54635694|FG005|Overall Study|Lost to Follow-up|3|||
27977445|NCT00973349|54635695|FG006|Overall Study|Lost to Follow-up|0|||
27977446|NCT00973349|54635696|FG007|Overall Study|Lost to Follow-up|1|||
27977447|NCT00973349|54635697|FG008|Overall Study|Lost to Follow-up|2|||
27977448|NCT00973349|54635698|FG009|Overall Study|Lost to Follow-up|1|||
27977449|NCT00973349|54635699|FG010|Overall Study|Lost to Follow-up|0|||
27977450|NCT00973349|54635700|FG011|Overall Study|Lost to Follow-up|1|||
27977451|NCT00973349|54635701|FG012|Overall Study|Lost to Follow-up|0|||
27977452|NCT00973349|54635702|FG013|Overall Study|Lost to Follow-up|0|||
27977453|NCT00973349|54635703|FG014|Overall Study|Lost to Follow-up|0|||
27977454|NCT00973349|54635704|FG015|Overall Study|Lost to Follow-up|1|||
27977455|NCT00973349|54635689|FG000|Overall Study|Inappropriate enrolment|0|||
27977456|NCT00973349|54635690|FG001|Overall Study|Inappropriate enrolment|0|||
27977457|NCT00973349|54635691|FG002|Overall Study|Inappropriate enrolment|1|||
27977458|NCT00973349|54635692|FG003|Overall Study|Inappropriate enrolment|0|||
27977459|NCT00973349|54635693|FG004|Overall Study|Inappropriate enrolment|0|||
27977460|NCT00973349|54635694|FG005|Overall Study|Inappropriate enrolment|0|||
27977461|NCT00973349|54635695|FG006|Overall Study|Inappropriate enrolment|0|||
27977462|NCT00973349|54635696|FG007|Overall Study|Inappropriate enrolment|0|||
27977463|NCT00973349|54635697|FG008|Overall Study|Inappropriate enrolment|0|||
27977464|NCT00973349|54635698|FG009|Overall Study|Inappropriate enrolment|2|||
27977465|NCT00973349|54635699|FG010|Overall Study|Inappropriate enrolment|0|||
27977466|NCT00973349|54635700|FG011|Overall Study|Inappropriate enrolment|0|||
27977467|NCT00973349|54635701|FG012|Overall Study|Inappropriate enrolment|1|||
27977468|NCT00973349|54635702|FG013|Overall Study|Inappropriate enrolment|0|||
27977469|NCT00973349|54635703|FG014|Overall Study|Inappropriate enrolment|1|||
27977470|NCT00973349|54635704|FG015|Overall Study|Inappropriate enrolment|1|||
27977471|NCT00973349|54635689|FG000|Overall Study|Protocol Violation|0|||
27977472|NCT00973349|54635690|FG001|Overall Study|Protocol Violation|0|||
27977473|NCT00973349|54635691|FG002|Overall Study|Protocol Violation|0|||
27977474|NCT00973349|54635692|FG003|Overall Study|Protocol Violation|0|||
27977475|NCT00973349|54635693|FG004|Overall Study|Protocol Violation|0|||
27977476|NCT00973349|54635694|FG005|Overall Study|Protocol Violation|0|||
27977477|NCT00973349|54635695|FG006|Overall Study|Protocol Violation|0|||
27977478|NCT00973349|54635696|FG007|Overall Study|Protocol Violation|0|||
27977479|NCT00973349|54635697|FG008|Overall Study|Protocol Violation|1|||
27977480|NCT00973349|54635698|FG009|Overall Study|Protocol Violation|0|||
27977481|NCT00973349|54635699|FG010|Overall Study|Protocol Violation|0|||
27977482|NCT00973349|54635700|FG011|Overall Study|Protocol Violation|0|||
27977483|NCT00973349|54635701|FG012|Overall Study|Protocol Violation|0|||
27977484|NCT00973349|54635702|FG013|Overall Study|Protocol Violation|0|||
27977485|NCT00973349|54635703|FG014|Overall Study|Protocol Violation|0|||
27977486|NCT00973349|54635704|FG015|Overall Study|Protocol Violation|0|||
27733236|NCT03530293|54181029|FG002|Pre-randomization|Withdrawal by Subject|0|||
27733237|NCT03530293|54181027|FG000|Randomized Withdrawal Period / Follow-up|Adverse Event|0|||
27733238|NCT03530293|54181028|FG001|Randomized Withdrawal Period / Follow-up|Adverse Event|2|||
27733239|NCT03530293|54181029|FG002|Randomized Withdrawal Period / Follow-up|Adverse Event|4|||
27733240|NCT03530293|54181027|FG000|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
27733241|NCT03530293|54181028|FG001|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
27733242|NCT03530293|54181029|FG002|Randomized Withdrawal Period / Follow-up|Protocol Violation|1|||
27733243|NCT03530293|54181027|FG000|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|0|||
27733244|NCT03530293|54181028|FG001|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|3|||
27733245|NCT03530293|54181029|FG002|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|2|||
27733246|NCT03530293|54181027|FG000|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
27733247|NCT03530293|54181028|FG001|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|2|||
27733248|NCT03530293|54181029|FG002|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
27733249|NCT03530293|54181027|FG000|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|0|||
27733250|NCT03530293|54181028|FG001|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
27977487|NCT00973349|54635689|FG000|Overall Study|Unable to classify|0|||
27977488|NCT00973349|54635690|FG001|Overall Study|Unable to classify|0|||
27977489|NCT00973349|54635691|FG002|Overall Study|Unable to classify|0|||
27977490|NCT00973349|54635692|FG003|Overall Study|Unable to classify|0|||
27977491|NCT00973349|54635693|FG004|Overall Study|Unable to classify|1|||
27977492|NCT00973349|54635694|FG005|Overall Study|Unable to classify|1|||
27733251|NCT03530293|54181029|FG002|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
27733252|NCT03335371|54181058|FG000|Overall Study|Lost to Follow-up|0|||
27977493|NCT00973349|54635695|FG006|Overall Study|Unable to classify|0|||
27977494|NCT00973349|54635696|FG007|Overall Study|Unable to classify|0|||
27977495|NCT00973349|54635697|FG008|Overall Study|Unable to classify|0|||
27977496|NCT00973349|54635698|FG009|Overall Study|Unable to classify|1|||
28086991|NCT00337103|54740542|FG000|Overall Study|Other|5|||
28086992|NCT00337103|54740543|FG001|Overall Study|Other|6|||
27977497|NCT00973349|54635699|FG010|Overall Study|Unable to classify|0|||
27977498|NCT00973349|54635700|FG011|Overall Study|Unable to classify|0|||
27977499|NCT00973349|54635701|FG012|Overall Study|Unable to classify|0|||
27977500|NCT00973349|54635702|FG013|Overall Study|Unable to classify|0|||
27977501|NCT00973349|54635703|FG014|Overall Study|Unable to classify|0|||
27977502|NCT00973349|54635704|FG015|Overall Study|Unable to classify|0|||
27977503|NCT00643201|54635732|FG000|Randomized, Completed 6 Months of Study|Death|20|||
27977504|NCT00643201|54635733|FG001|Randomized, Completed 6 Months of Study|Death|26|||
27977505|NCT00643201|54635732|FG000|Randomized, Completed 6 Months of Study|Adverse Event|150|||
27977506|NCT00643201|54635733|FG001|Randomized, Completed 6 Months of Study|Adverse Event|182|||
27977507|NCT00643201|54635732|FG000|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
27977508|NCT00643201|54635733|FG001|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
27977509|NCT00643201|54635732|FG000|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
27977510|NCT00643201|54635733|FG001|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
27977511|NCT00643201|54635732|FG000|Randomized, Completed 6 Months of Study|Poor or non-compliance|20|||
27977512|NCT00643201|54635733|FG001|Randomized, Completed 6 Months of Study|Poor or non-compliance|23|||
27977513|NCT00643201|54635732|FG000|Randomized, Completed 6 Months of Study|Pregnancy|3|||
27977514|NCT00643201|54635733|FG001|Randomized, Completed 6 Months of Study|Pregnancy|2|||
27977515|NCT00643201|54635732|FG000|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13|||
27977516|NCT00643201|54635733|FG001|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9|||
27977517|NCT00643201|54635732|FG000|Randomized, Completed 6 Months of Study|Administrative reason|1|||
27977518|NCT00643201|54635733|FG001|Randomized, Completed 6 Months of Study|Administrative reason|1|||
27977519|NCT00643201|54635732|FG000|Randomized, Completed 6 Months of Study|Other|107|||
27977520|NCT00643201|54635733|FG001|Randomized, Completed 6 Months of Study|Other|107|||
27977521|NCT00643201|54635732|FG000|Completed Study Follow Up|Death|28|||
27977522|NCT00643201|54635733|FG001|Completed Study Follow Up|Death|34|||
27977523|NCT00643201|54635732|FG000|Completed Study Follow Up|Withdrawal by Subject|23|||
27977524|NCT00643201|54635733|FG001|Completed Study Follow Up|Withdrawal by Subject|29|||
27977525|NCT00643201|54635732|FG000|Completed Study Follow Up|Lost to Follow-up|18|||
27977526|NCT00643201|54635733|FG001|Completed Study Follow Up|Lost to Follow-up|16|||
27977527|NCT00643201|54635732|FG000|Completed Study Follow Up|non-specified|1|||
27977528|NCT00643201|54635733|FG001|Completed Study Follow Up|non-specified|0|||
27977529|NCT00643123|54635743|FG000|Overall Study|Lost to Follow-up|4|||
27977530|NCT00643123|54635744|FG001|Overall Study|Lost to Follow-up|0|||
27977531|NCT00643123|54635743|FG000|Overall Study|Withdrawal by Subject|1|||
27977532|NCT00643123|54635744|FG001|Overall Study|Withdrawal by Subject|1|||
27977533|NCT00968981|54635753|FG000|Overall Study|Adverse Event|2|||
27977534|NCT00968981|54635754|FG001|Overall Study|Adverse Event|0|||
27977535|NCT00968981|54635755|FG002|Overall Study|Adverse Event|0|||
27977536|NCT00968981|54635753|FG000|Overall Study|Disease Progression|14|||
27977537|NCT00968981|54635754|FG001|Overall Study|Disease Progression|16|||
27977538|NCT00968981|54635755|FG002|Overall Study|Disease Progression|13|||
27977539|NCT00968981|54635753|FG000|Overall Study|Lost to Follow-up|0|||
27977540|NCT00968981|54635754|FG001|Overall Study|Lost to Follow-up|0|||
27977541|NCT00968981|54635755|FG002|Overall Study|Lost to Follow-up|1|||
27977542|NCT00968981|54635753|FG000|Overall Study|Physician Decision|5|||
27977543|NCT00968981|54635754|FG001|Overall Study|Physician Decision|3|||
27977544|NCT00968981|54635755|FG002|Overall Study|Physician Decision|5|||
27977545|NCT00968981|54635753|FG000|Overall Study|Withdrawal by Subject|1|||
27977546|NCT00968981|54635754|FG001|Overall Study|Withdrawal by Subject|3|||
27977547|NCT00968981|54635755|FG002|Overall Study|Withdrawal by Subject|3|||
27977548|NCT00641719|54635766|FG000|Overall Study|Lack of Efficacy|1|||
27977549|NCT00641719|54635767|FG001|Overall Study|Lack of Efficacy|2|||
27977550|NCT00641719|54635766|FG000|Overall Study|Adverse Event|24|||
27977551|NCT00641719|54635767|FG001|Overall Study|Adverse Event|29|||
27977552|NCT00641719|54635766|FG000|Overall Study|Withdrawal by Subject|4|||
27977553|NCT00641719|54635767|FG001|Overall Study|Withdrawal by Subject|4|||
27977554|NCT00641719|54635766|FG000|Overall Study|Reason Not Specified|1|||
27977555|NCT00641719|54635767|FG001|Overall Study|Reason Not Specified|2|||
27977556|NCT00648895|54635775|FG000|Overall Study|Lack of Efficacy|0|||
27977557|NCT00648895|54635776|FG001|Overall Study|Lack of Efficacy|1|||
28086993|NCT00337103|54740542|FG000|Overall Study|Entry Criteria Not Met|4|||
28086994|NCT00337103|54740543|FG001|Overall Study|Entry Criteria Not Met|1|||
27977558|NCT00975221|54635784|FG000|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2|||
27977559|NCT00975221|54635785|FG001|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3|||
28086995|NCT00337103|54740542|FG000|Overall Study|Lost to Follow-up|1|||
28086996|NCT00337103|54740543|FG001|Overall Study|Lost to Follow-up|2|||
28086997|NCT00337103|54740542|FG000|Overall Study|Death|1|||
27977560|NCT00975221|54635784|FG000|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1|||
27977561|NCT00975221|54635785|FG001|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0|||
27977562|NCT00975221|54635784|FG000|Titration Phase (Weeks 1-12)|Other|0|||
27977563|NCT00975221|54635785|FG001|Titration Phase (Weeks 1-12)|Other|1|||
27977564|NCT00975221|54635784|FG000|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0|||
27977565|NCT00975221|54635785|FG001|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1|||
27977566|NCT00975221|54635784|FG000|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
27977567|NCT00975221|54635785|FG001|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
27977568|NCT00975221|54635784|FG000|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1|||
27977569|NCT00975221|54635785|FG001|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0|||
27977570|NCT00972179|54635800|FG000|Overall Study|Noncompliance|1|||
27977571|NCT00972179|54635801|FG001|Overall Study|Noncompliance|0|||
27977572|NCT00972179|54635802|FG002|Overall Study|Noncompliance|0|||
27977573|NCT00972179|54635803|FG003|Overall Study|Noncompliance|0|||
27977574|NCT00972179|54635804|FG004|Overall Study|Noncompliance|1|||
27977575|NCT00972179|54635805|FG005|Overall Study|Noncompliance|0|||
27977576|NCT00972179|54635806|FG006|Overall Study|Noncompliance|1|||
27977577|NCT00972179|54635800|FG000|Overall Study|Withdrawal by Subject|0|||
27977578|NCT00972179|54635801|FG001|Overall Study|Withdrawal by Subject|3|||
27977579|NCT00972179|54635802|FG002|Overall Study|Withdrawal by Subject|0|||
27977580|NCT00972179|54635803|FG003|Overall Study|Withdrawal by Subject|1|||
27977581|NCT00972179|54635804|FG004|Overall Study|Withdrawal by Subject|0|||
27977582|NCT00972179|54635805|FG005|Overall Study|Withdrawal by Subject|0|||
27977583|NCT00972179|54635806|FG006|Overall Study|Withdrawal by Subject|2|||
27977584|NCT00972179|54635800|FG000|Overall Study|Administrative Decision|0|||
27977585|NCT00972179|54635801|FG001|Overall Study|Administrative Decision|0|||
27977586|NCT00972179|54635802|FG002|Overall Study|Administrative Decision|0|||
27977587|NCT00972179|54635803|FG003|Overall Study|Administrative Decision|0|||
27977588|NCT00972179|54635804|FG004|Overall Study|Administrative Decision|1|||
27977589|NCT00972179|54635805|FG005|Overall Study|Administrative Decision|0|||
27977590|NCT00972179|54635806|FG006|Overall Study|Administrative Decision|0|||
27977591|NCT00972179|54635800|FG000|Overall Study|Lost to Follow-up|0|||
27977592|NCT00972179|54635801|FG001|Overall Study|Lost to Follow-up|0|||
27977593|NCT00972179|54635802|FG002|Overall Study|Lost to Follow-up|1|||
27977594|NCT00972179|54635803|FG003|Overall Study|Lost to Follow-up|0|||
27977595|NCT00972179|54635804|FG004|Overall Study|Lost to Follow-up|0|||
27977596|NCT00972179|54635805|FG005|Overall Study|Lost to Follow-up|3|||
27977597|NCT00972179|54635806|FG006|Overall Study|Lost to Follow-up|1|||
27977598|NCT00906698|54635832|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
27977599|NCT00906698|54635833|FG001|Overall Study|Dose-limiting toxicity (DLT)|6|||
27977600|NCT00906698|54635834|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
27977601|NCT00906698|54635835|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
27977602|NCT00906698|54635836|FG004|Overall Study|Dose-limiting toxicity (DLT)|1|||
27977603|NCT00906698|54635837|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
27977604|NCT00906698|54635832|FG000|Overall Study|Adverse Event|0|||
27977605|NCT00906698|54635833|FG001|Overall Study|Adverse Event|0|||
27977606|NCT00906698|54635834|FG002|Overall Study|Adverse Event|2|||
27977607|NCT00906698|54635835|FG003|Overall Study|Adverse Event|0|||
27977608|NCT00906698|54635836|FG004|Overall Study|Adverse Event|4|||
27977609|NCT00906698|54635837|FG005|Overall Study|Adverse Event|1|||
27977610|NCT00906698|54635832|FG000|Overall Study|Disease progression|3|||
27977611|NCT00906698|54635833|FG001|Overall Study|Disease progression|12|||
28086998|NCT00337103|54740543|FG001|Overall Study|Death|0|||
28086999|NCT00415532|54740552|FG000|Treatment Period|Adverse Event|2|||
28087000|NCT00415532|54740553|FG001|Treatment Period|Adverse Event|3|||
28087001|NCT00415532|54740552|FG000|Treatment Period|Death|2|||
28087002|NCT00415532|54740553|FG001|Treatment Period|Death|1|||
28087003|NCT00415532|54740552|FG000|Treatment Period|Lost to Follow-up|1|||
28087004|NCT00415532|54740553|FG001|Treatment Period|Lost to Follow-up|1|||
28087005|NCT00415532|54740552|FG000|Treatment Period|Protocol Violation|1|||
28087006|NCT00415532|54740553|FG001|Treatment Period|Protocol Violation|0|||
28087007|NCT00415532|54740552|FG000|Treatment Period|Withdrawal by Subject|6|||
28087008|NCT00415532|54740553|FG001|Treatment Period|Withdrawal by Subject|6|||
28087009|NCT00415532|54740552|FG000|Treatment Period|Other|2|||
28087010|NCT00415532|54740553|FG001|Treatment Period|Other|2|||
28087011|NCT00415532|54740552|FG000|Treatment Period|Ineligibility determined|1|||
28165583|NCT02509312|54836186|FG001|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|1|||
28165584|NCT02509156|54836196|FG000|Randomized Phase|Death|1|||
28087012|NCT00415532|54740553|FG001|Treatment Period|Ineligibility determined|1|||
28165585|NCT02509156|54836197|FG001|Randomized Phase|Death|0|||
28165586|NCT02509156|54836196|FG000|Randomized Phase|Withdrawal by Subject|1|||
27977612|NCT00906698|54635834|FG002|Overall Study|Disease progression|4|||
27977613|NCT00906698|54635835|FG003|Overall Study|Disease progression|4|||
27977614|NCT00906698|54635836|FG004|Overall Study|Disease progression|12|||
27977615|NCT00906698|54635837|FG005|Overall Study|Disease progression|4|||
27977616|NCT00906698|54635832|FG000|Overall Study|Withdrawal by Subject|0|||
27977617|NCT00906698|54635833|FG001|Overall Study|Withdrawal by Subject|0|||
27977618|NCT00906698|54635834|FG002|Overall Study|Withdrawal by Subject|0|||
28087013|NCT00415532|54740552|FG000|Treatment Period|Noncompliance|1|||
28087014|NCT00415532|54740553|FG001|Treatment Period|Noncompliance|1|||
28165587|NCT02509156|54836197|FG001|Randomized Phase|Withdrawal by Subject|1|||
27977619|NCT00906698|54635835|FG003|Overall Study|Withdrawal by Subject|0|||
27977620|NCT00906698|54635836|FG004|Overall Study|Withdrawal by Subject|1|||
27977621|NCT00906698|54635837|FG005|Overall Study|Withdrawal by Subject|0|||
27977622|NCT00906698|54635832|FG000|Overall Study|incl. non compliance, lost to follow-up|0|||
27977623|NCT00906698|54635833|FG001|Overall Study|incl. non compliance, lost to follow-up|1|||
27977624|NCT00906698|54635834|FG002|Overall Study|incl. non compliance, lost to follow-up|0|||
27977625|NCT00906698|54635835|FG003|Overall Study|incl. non compliance, lost to follow-up|0|||
27977626|NCT00906698|54635836|FG004|Overall Study|incl. non compliance, lost to follow-up|0|||
27977627|NCT00906698|54635837|FG005|Overall Study|incl. non compliance, lost to follow-up|0|||
27977628|NCT00972023|54635869|FG000|Overall Study|Withdrawal by Subject|1|||
27977629|NCT00971945|54635875|FG000|Overall Study|Progressive Disease|3|||
27977630|NCT00971945|54635875|FG000|Overall Study|Change in treatment policy|1|||
27977631|NCT00971945|54635875|FG000|Overall Study|Other reasons|2|||
27977632|NCT00971867|54635879|FG000|Overall Study|Adverse Event|4|||
27977633|NCT00971867|54635879|FG000|Overall Study|Participant Withdrew Consent|1|||
27977634|NCT00971867|54635879|FG000|Overall Study|Disease Progression|6|||
27977635|NCT00971321|54635885|FG000|Up to Month 7|Withdrawal by Subject|1|||
27977636|NCT00971321|54635886|FG001|Up to Month 7|Withdrawal by Subject|0|||
27977637|NCT00971321|54635885|FG000|Up to Month 7|Migrated/moved from study area|3|||
27977638|NCT00971321|54635886|FG001|Up to Month 7|Migrated/moved from study area|2|||
27977639|NCT00971321|54635885|FG000|Up to Month 11-12|Withdrawal by Subject|2|||
27733253|NCT03335371|54181059|FG001|Overall Study|Lost to Follow-up|0|||
27733254|NCT03335371|54181060|FG002|Overall Study|Lost to Follow-up|0|||
27733255|NCT03335371|54181061|FG003|Overall Study|Lost to Follow-up|0|||
27977640|NCT00971321|54635886|FG001|Up to Month 11-12|Withdrawal by Subject|1|||
27977641|NCT00971321|54635885|FG000|Up to Month 11-12|Migrated/moved from study area|2|||
27977642|NCT00971321|54635886|FG001|Up to Month 11-12|Migrated/moved from study area|2|||
27977643|NCT00971321|54635885|FG000|Up to Month 11-12|Lost to Follow-up|1|||
27977644|NCT00971321|54635886|FG001|Up to Month 11-12|Lost to Follow-up|0|||
27977645|NCT00648739|54635892|FG000|Overall Study|Adverse Event|1|||
27977646|NCT00648739|54635893|FG001|Overall Study|Adverse Event|0|||
27977647|NCT00648739|54635894|FG002|Overall Study|Adverse Event|1|||
27977648|NCT00648739|54635895|FG003|Overall Study|Adverse Event|2|||
27977649|NCT00648739|54635896|FG004|Overall Study|Adverse Event|1|||
27977650|NCT00648739|54635897|FG005|Overall Study|Adverse Event|0|||
27977651|NCT00648739|54635898|FG006|Overall Study|Adverse Event|0|||
27977652|NCT00648739|54635892|FG000|Overall Study|Withdrawal by Subject|1|||
27977653|NCT00648739|54635893|FG001|Overall Study|Withdrawal by Subject|0|||
27977654|NCT00648739|54635894|FG002|Overall Study|Withdrawal by Subject|1|||
27977655|NCT00648739|54635895|FG003|Overall Study|Withdrawal by Subject|0|||
27977656|NCT00648739|54635896|FG004|Overall Study|Withdrawal by Subject|0|||
27977657|NCT00648739|54635897|FG005|Overall Study|Withdrawal by Subject|2|||
27977658|NCT00648739|54635898|FG006|Overall Study|Withdrawal by Subject|0|||
27977659|NCT00648739|54635892|FG000|Overall Study|Lack of Efficacy|0|||
27977660|NCT00648739|54635893|FG001|Overall Study|Lack of Efficacy|0|||
27977661|NCT00648739|54635894|FG002|Overall Study|Lack of Efficacy|0|||
27977662|NCT00648739|54635895|FG003|Overall Study|Lack of Efficacy|0|||
27977663|NCT00648739|54635896|FG004|Overall Study|Lack of Efficacy|1|||
27977664|NCT00648739|54635897|FG005|Overall Study|Lack of Efficacy|2|||
27977665|NCT00648739|54635898|FG006|Overall Study|Lack of Efficacy|0|||
27977666|NCT00648739|54635892|FG000|Overall Study|Investigator Considered it Advisable|0|||
27977667|NCT00648739|54635893|FG001|Overall Study|Investigator Considered it Advisable|0|||
27977668|NCT00648739|54635894|FG002|Overall Study|Investigator Considered it Advisable|0|||
27977669|NCT00648739|54635895|FG003|Overall Study|Investigator Considered it Advisable|0|||
27977670|NCT00648739|54635896|FG004|Overall Study|Investigator Considered it Advisable|0|||
27977671|NCT00648739|54635897|FG005|Overall Study|Investigator Considered it Advisable|1|||
27977672|NCT00648739|54635898|FG006|Overall Study|Investigator Considered it Advisable|1|||
27977673|NCT00648739|54635892|FG000|Overall Study|Death|0|||
27977674|NCT00648739|54635893|FG001|Overall Study|Death|1|||
27977675|NCT00648739|54635894|FG002|Overall Study|Death|0|||
28087015|NCT00415532|54740552|FG000|Treatment Period|Requirement for alternative therapy|1|||
28087016|NCT00415532|54740553|FG001|Treatment Period|Requirement for alternative therapy|0|||
28087017|NCT00415532|54740552|FG000|Safety Follow Up Period|Adverse Event|1|||
28087018|NCT00415532|54740553|FG001|Safety Follow Up Period|Adverse Event|3|||
28087019|NCT00415532|54740552|FG000|Safety Follow Up Period|Death|3|||
28087020|NCT00415532|54740553|FG001|Safety Follow Up Period|Death|0|||
28087021|NCT00415532|54740552|FG000|Safety Follow Up Period|Withdrawal by Subject|2|||
28087022|NCT00415532|54740553|FG001|Safety Follow Up Period|Withdrawal by Subject|3|||
28165588|NCT01654666|54836206|FG000|Overall Study|Protocol Violation|7|||
27855591|NCT02834247|54380601|FG003|Dose Expansion Phase|Withdrawal by Subject|1|||
27977676|NCT00648739|54635895|FG003|Overall Study|Death|0|||
27977677|NCT00648739|54635896|FG004|Overall Study|Death|0|||
27977678|NCT00648739|54635897|FG005|Overall Study|Death|0|||
27977679|NCT00648739|54635898|FG006|Overall Study|Death|0|||
28087023|NCT00415532|54740552|FG000|Safety Follow Up Period|Other|1|||
27977680|NCT00648739|54635892|FG000|Overall Study|Positive Human Anti-human Antibody|0|||
27977681|NCT00648739|54635893|FG001|Overall Study|Positive Human Anti-human Antibody|0|||
27977682|NCT00648739|54635894|FG002|Overall Study|Positive Human Anti-human Antibody|1|||
27977683|NCT00648739|54635895|FG003|Overall Study|Positive Human Anti-human Antibody|0|||
27977684|NCT00648739|54635896|FG004|Overall Study|Positive Human Anti-human Antibody|0|||
27977685|NCT00648739|54635897|FG005|Overall Study|Positive Human Anti-human Antibody|0|||
27977686|NCT00648739|54635898|FG006|Overall Study|Positive Human Anti-human Antibody|0|||
27977687|NCT00648739|54635892|FG000|Overall Study|Follow-up Visits Not Completed|0|||
27977688|NCT00648739|54635893|FG001|Overall Study|Follow-up Visits Not Completed|1|||
27977689|NCT00648739|54635894|FG002|Overall Study|Follow-up Visits Not Completed|0|||
27977690|NCT00648739|54635895|FG003|Overall Study|Follow-up Visits Not Completed|0|||
27977691|NCT00648739|54635896|FG004|Overall Study|Follow-up Visits Not Completed|0|||
27977692|NCT00648739|54635897|FG005|Overall Study|Follow-up Visits Not Completed|0|||
27977693|NCT00648739|54635898|FG006|Overall Study|Follow-up Visits Not Completed|0|||
27977694|NCT00648037|54635919|FG000|Overall Study|Not Treated|1|||
27977695|NCT00648037|54635919|FG000|Overall Study|Withdrawal by Subject|1|||
27977696|NCT00648037|54635919|FG000|Overall Study|Adverse Event|11|||
27977697|NCT00648037|54635919|FG000|Overall Study|Relapse|2|||
27977698|NCT00648037|54635919|FG000|Overall Study|Other|1|||
27977699|NCT00627523|54635925|FG000|Overall Study|Lack of Efficacy|1|||
27977700|NCT00627523|54635926|FG001|Overall Study|Lack of Efficacy|0|||
27977701|NCT00627523|54635925|FG000|Overall Study|Withdrawal by Subject|0|||
27977702|NCT00627523|54635926|FG001|Overall Study|Withdrawal by Subject|2|||
27977703|NCT00627523|54635925|FG000|Overall Study|Other|1|||
27977704|NCT00627523|54635926|FG001|Overall Study|Other|0|||
27977705|NCT00640393|54635932|FG000|Part 1|Lost to Follow-up|2|||
27977706|NCT00640393|54635933|FG001|Part 1|Lost to Follow-up|0|||
27977707|NCT00640393|54635934|FG002|Part 1|Lost to Follow-up|0|||
27977708|NCT00640393|54635932|FG000|Part 1|Withdrawal by Subject|3|||
27977709|NCT00640393|54635933|FG001|Part 1|Withdrawal by Subject|0|||
27977710|NCT00640393|54635934|FG002|Part 1|Withdrawal by Subject|0|||
27977711|NCT00640393|54635932|FG000|Randomization|Withdrawn per protocol|17|||
27977712|NCT00640393|54635933|FG001|Randomization|Withdrawn per protocol|0|||
27977713|NCT00640393|54635934|FG002|Randomization|Withdrawn per protocol|0|||
27977714|NCT00640393|54635932|FG000|Randomization|Never randomized by site|2|||
27977715|NCT00640393|54635933|FG001|Randomization|Never randomized by site|0|||
27977716|NCT00640393|54635934|FG002|Randomization|Never randomized by site|0|||
27977717|NCT00640393|54635932|FG000|Part 2|Lost to Follow-up|0|||
27977718|NCT00640393|54635933|FG001|Part 2|Lost to Follow-up|2|||
27977719|NCT00640393|54635934|FG002|Part 2|Lost to Follow-up|2|||
27977720|NCT00640393|54635932|FG000|Part 2|Withdrawal by Subject|0|||
27977721|NCT00640393|54635933|FG001|Part 2|Withdrawal by Subject|6|||
27977722|NCT00640393|54635934|FG002|Part 2|Withdrawal by Subject|1|||
27977723|NCT00640393|54635932|FG000|Part 2|Non-adherence|0|||
27977724|NCT00640393|54635933|FG001|Part 2|Non-adherence|1|||
27977725|NCT00640393|54635934|FG002|Part 2|Non-adherence|0|||
27977726|NCT00640393|54635932|FG000|Part 2|Adverse Event|0|||
27977727|NCT00640393|54635933|FG001|Part 2|Adverse Event|1|||
27977728|NCT00640393|54635934|FG002|Part 2|Adverse Event|0|||
27977729|NCT00907478|54635945|FG000|Overall Study|Ineligibility determined|0|||
27977730|NCT00907478|54635946|FG001|Overall Study|Ineligibility determined|0|||
27977731|NCT00907478|54635947|FG002|Overall Study|Ineligibility determined|1|||
27977732|NCT00907478|54635945|FG000|Overall Study|Noncompliance|0|||
27977733|NCT00907478|54635946|FG001|Overall Study|Noncompliance|0|||
28087024|NCT00415532|54740553|FG001|Safety Follow Up Period|Other|4|||
28087025|NCT00415532|54740552|FG000|Safety Follow Up Period|Ineligibility determined|1|||
28087026|NCT00415532|54740553|FG001|Safety Follow Up Period|Ineligibility determined|1|||
28087027|NCT00415532|54740552|FG000|Safety Follow Up Period|Noncompliance|1|||
28087028|NCT00415532|54740553|FG001|Safety Follow Up Period|Noncompliance|0|||
28087029|NCT00415532|54740552|FG000|Safety Follow Up Period|Requirement for alternative therapy|0|||
28087030|NCT00415532|54740553|FG001|Safety Follow Up Period|Requirement for alternative therapy|1|||
28087031|NCT00315731|54740559|FG000|Overall Study|Lost to Follow-up|1|||
28087032|NCT00315731|54740559|FG000|Overall Study|Death|5|||
28087033|NCT00062868|54740586|FG000|Dose Level 1|Death|2|||
27977734|NCT00907478|54635947|FG002|Overall Study|Noncompliance|1|||
27977735|NCT00907478|54635945|FG000|Overall Study|Adverse Event|3|||
27977736|NCT00907478|54635946|FG001|Overall Study|Adverse Event|1|||
27977737|NCT00907478|54635947|FG002|Overall Study|Adverse Event|2|||
27977738|NCT00907478|54635945|FG000|Overall Study|Withdrawal by Subject|8|||
27977739|NCT00907478|54635946|FG001|Overall Study|Withdrawal by Subject|9|||
27977740|NCT00907478|54635947|FG002|Overall Study|Withdrawal by Subject|6|||
27977741|NCT00907478|54635945|FG000|Overall Study|Requirement for alternative therapy|1|||
27977742|NCT00907478|54635946|FG001|Overall Study|Requirement for alternative therapy|2|||
27977743|NCT00907478|54635947|FG002|Overall Study|Requirement for alternative therapy|3|||
27977744|NCT00907478|54635945|FG000|Overall Study|Physician Decision|2|||
27977745|NCT00907478|54635946|FG001|Overall Study|Physician Decision|0|||
27977746|NCT00907478|54635947|FG002|Overall Study|Physician Decision|3|||
27977747|NCT00907478|54635945|FG000|Overall Study|Death|4|||
27977748|NCT00907478|54635946|FG001|Overall Study|Death|2|||
27977749|NCT00907478|54635947|FG002|Overall Study|Death|1|||
27977750|NCT00907478|54635945|FG000|Overall Study|Protocol-specified criteria|5|||
27977751|NCT00907478|54635946|FG001|Overall Study|Protocol-specified criteria|2|||
27977752|NCT00907478|54635947|FG002|Overall Study|Protocol-specified criteria|3|||
27977753|NCT00907478|54635945|FG000|Overall Study|Pregnancy|0|||
27977754|NCT00907478|54635946|FG001|Overall Study|Pregnancy|1|||
27977755|NCT00907478|54635947|FG002|Overall Study|Pregnancy|1|||
27977756|NCT00907478|54635945|FG000|Overall Study|Lost to Follow-up|1|||
27977757|NCT00907478|54635946|FG001|Overall Study|Lost to Follow-up|0|||
27977758|NCT00907478|54635947|FG002|Overall Study|Lost to Follow-up|0|||
27977759|NCT00907478|54635945|FG000|Overall Study|Other|3|||
27977760|NCT00907478|54635946|FG001|Overall Study|Other|0|||
27977761|NCT00907478|54635947|FG002|Overall Study|Other|1|||
27977762|NCT00627445|54635959|FG000|Overall Study|Adverse Event|3|||
27977763|NCT00627445|54635960|FG001|Overall Study|Adverse Event|3|||
27977764|NCT00627445|54635959|FG000|Overall Study|Lack of Efficacy|0|||
27977765|NCT00627445|54635960|FG001|Overall Study|Lack of Efficacy|1|||
27977766|NCT00627445|54635959|FG000|Overall Study|Other|6|||
27977767|NCT00627445|54635960|FG001|Overall Study|Other|8|||
27977768|NCT00905840|54635968|FG000|Overall Study|Lost to Follow-up|11|||
27977769|NCT00905840|54635968|FG000|Overall Study|Death|3|||
27977770|NCT00905840|54635968|FG000|Overall Study|Withdrawal by Subject|1|||
27977771|NCT00905840|54635968|FG000|Overall Study|Adverse Event|1|||
27977772|NCT00626821|54635975|FG000|Overall Study|Adverse Event|44|||
27977773|NCT00626821|54635975|FG000|Overall Study|Protocol Violation|33|||
27977774|NCT00626821|54635975|FG000|Overall Study|Withdrawal by Subject|10|||
27977775|NCT00626821|54635975|FG000|Overall Study|Physician Decision|9|||
27977776|NCT00626821|54635975|FG000|Overall Study|Product dysfunction|21|||
27977777|NCT00626821|54635975|FG000|Overall Study|other/unknown reason|104|||
27977778|NCT00625183|54635979|FG000|Overall Study|Disease Progression|1|||
27977779|NCT00904982|54635989|FG000|Overall Study|Withdrawal by Subject|2|||
27977780|NCT00904982|54635990|FG001|Overall Study|Withdrawal by Subject|0|||
27977781|NCT00904982|54635991|FG002|Overall Study|Withdrawal by Subject|0|||
27977782|NCT00904982|54635992|FG003|Overall Study|Withdrawal by Subject|0|||
27977783|NCT00640315|54636004|FG000|Overall Study|Withdrawal by Subject|0|||
27977784|NCT00640315|54636005|FG001|Overall Study|Withdrawal by Subject|1|||
27977785|NCT00904748|54636011|FG000|Overall Study|Withdrawal by Subject|1|||
27977786|NCT00904748|54636012|FG001|Overall Study|Withdrawal by Subject|1|||
27977787|NCT00904748|54636013|FG002|Overall Study|Withdrawal by Subject|1|||
27977788|NCT00904748|54636014|FG003|Overall Study|Withdrawal by Subject|2|||
27977789|NCT00904748|54636015|FG004|Overall Study|Withdrawal by Subject|0|||
27977790|NCT00904748|54636016|FG005|Overall Study|Withdrawal by Subject|0|||
27977791|NCT00904748|54636011|FG000|Overall Study|Adverse Event|0|||
27977792|NCT00904748|54636012|FG001|Overall Study|Adverse Event|0|||
27977793|NCT00904748|54636013|FG002|Overall Study|Adverse Event|0|||
27977794|NCT00904748|54636014|FG003|Overall Study|Adverse Event|0|||
27977795|NCT00904748|54636015|FG004|Overall Study|Adverse Event|1|||
27977796|NCT00904748|54636016|FG005|Overall Study|Adverse Event|0|||
27977797|NCT00574405|54636027|FG000|Overall Study|Withdrawal by Subject|3|||
27977798|NCT00574405|54636028|FG001|Overall Study|Withdrawal by Subject|2|||
27977799|NCT00971243|54636039|FG000|Double Blind Period|Adverse Event|2|||
27977800|NCT00971243|54636040|FG001|Double Blind Period|Adverse Event|3|||
27977801|NCT00971243|54636041|FG002|Double Blind Period|Adverse Event|2|||
27977802|NCT00971243|54636042|FG003|Double Blind Period|Adverse Event|2|||
27977803|NCT00971243|54636043|FG004|Double Blind Period|Adverse Event|3|||
27977804|NCT00971243|54636039|FG000|Double Blind Period|Lost to Follow-up|0|||
27977805|NCT00971243|54636040|FG001|Double Blind Period|Lost to Follow-up|1|||
27977806|NCT00971243|54636041|FG002|Double Blind Period|Lost to Follow-up|1|||
27977807|NCT00971243|54636042|FG003|Double Blind Period|Lost to Follow-up|0|||
27977808|NCT00971243|54636043|FG004|Double Blind Period|Lost to Follow-up|1|||
27977809|NCT00971243|54636039|FG000|Double Blind Period|Physician Decision|10|||
27977810|NCT00971243|54636040|FG001|Double Blind Period|Physician Decision|6|||
27977811|NCT00971243|54636041|FG002|Double Blind Period|Physician Decision|7|||
27977812|NCT00971243|54636042|FG003|Double Blind Period|Physician Decision|6|||
27977813|NCT00971243|54636043|FG004|Double Blind Period|Physician Decision|7|||
27977814|NCT00971243|54636039|FG000|Double Blind Period|Protocol Violation|2|||
27977815|NCT00971243|54636040|FG001|Double Blind Period|Protocol Violation|0|||
27977816|NCT00971243|54636041|FG002|Double Blind Period|Protocol Violation|3|||
27977817|NCT00971243|54636042|FG003|Double Blind Period|Protocol Violation|2|||
27855592|NCT01839331|54381889|FG000|Overall Study|Early Termination|3|||
27977818|NCT00971243|54636043|FG004|Double Blind Period|Protocol Violation|2|||
27977819|NCT00971243|54636039|FG000|Double Blind Period|Withdrawal by Subject|4|||
27977820|NCT00971243|54636040|FG001|Double Blind Period|Withdrawal by Subject|1|||
27977821|NCT00971243|54636041|FG002|Double Blind Period|Withdrawal by Subject|4|||
28087034|NCT00062868|54740587|FG001|Dose Level 1|Death|0|||
27977822|NCT00971243|54636042|FG003|Double Blind Period|Withdrawal by Subject|4|||
27977823|NCT00971243|54636043|FG004|Double Blind Period|Withdrawal by Subject|4|||
27977824|NCT00971243|54636039|FG000|Double Blind Period|Other reasons|1|||
27977825|NCT00971243|54636040|FG001|Double Blind Period|Other reasons|0|||
27977826|NCT00971243|54636041|FG002|Double Blind Period|Other reasons|2|||
27977827|NCT00971243|54636042|FG003|Double Blind Period|Other reasons|0|||
27977828|NCT00971243|54636043|FG004|Double Blind Period|Other reasons|1|||
27977829|NCT00971243|54636039|FG000|Open-label Period|Adverse Event|1|||
27977830|NCT00971243|54636040|FG001|Open-label Period|Adverse Event|0|||
27977831|NCT00971243|54636041|FG002|Open-label Period|Adverse Event|1|||
27977832|NCT00971243|54636042|FG003|Open-label Period|Adverse Event|1|||
27977833|NCT00971243|54636043|FG004|Open-label Period|Adverse Event|0|||
27977834|NCT00971243|54636039|FG000|Open-label Period|Physician Decision|5|||
27977835|NCT00971243|54636040|FG001|Open-label Period|Physician Decision|9|||
27977836|NCT00971243|54636041|FG002|Open-label Period|Physician Decision|3|||
27977837|NCT00971243|54636042|FG003|Open-label Period|Physician Decision|7|||
27977838|NCT00971243|54636043|FG004|Open-label Period|Physician Decision|2|||
27977839|NCT00971243|54636039|FG000|Open-label Period|Protocol Violation|1|||
28087035|NCT00062868|54740588|FG002|Dose Level 1|Death|0|||
28087036|NCT00062868|54740589|FG003|Dose Level 1|Death|2|||
28087037|NCT00062868|54740590|FG004|Dose Level 1|Death|0|||
28087038|NCT00062868|54740591|FG005|Dose Level 1|Death|0|||
28087039|NCT00062868|54740592|FG006|Dose Level 1|Death|3|||
28087040|NCT00062868|54740593|FG007|Dose Level 1|Death|0|||
28087041|NCT00062868|54740594|FG008|Dose Level 1|Death|0|||
28087042|NCT00062868|54740595|FG009|Dose Level 1|Death|0|||
27977840|NCT00971243|54636040|FG001|Open-label Period|Protocol Violation|1|||
27977841|NCT00971243|54636041|FG002|Open-label Period|Protocol Violation|1|||
27977842|NCT00971243|54636042|FG003|Open-label Period|Protocol Violation|0|||
27977843|NCT00971243|54636043|FG004|Open-label Period|Protocol Violation|1|||
27977844|NCT00971243|54636039|FG000|Open-label Period|Withdrawal by Subject|1|||
27977845|NCT00971243|54636040|FG001|Open-label Period|Withdrawal by Subject|0|||
27977846|NCT00971243|54636041|FG002|Open-label Period|Withdrawal by Subject|0|||
27977847|NCT00971243|54636042|FG003|Open-label Period|Withdrawal by Subject|2|||
27977848|NCT00971243|54636043|FG004|Open-label Period|Withdrawal by Subject|1|||
27977849|NCT00971243|54636039|FG000|Open-label Period|Other reason|0|||
27977850|NCT00971243|54636040|FG001|Open-label Period|Other reason|0|||
27977851|NCT00971243|54636041|FG002|Open-label Period|Other reason|0|||
27977852|NCT00971243|54636042|FG003|Open-label Period|Other reason|0|||
27977853|NCT00971243|54636043|FG004|Open-label Period|Other reason|2|||
27977854|NCT00568555|54636057|FG000|Overall Study|Withdrawal by Subject|1|||
27977855|NCT00568555|54636058|FG001|Overall Study|Withdrawal by Subject|1|||
27977856|NCT00904670|54636066|FG000|Open Label Phase|Withdrawal by Subject|2|||
27977857|NCT00904670|54636067|FG001|Open Label Phase|Withdrawal by Subject|0|||
27977858|NCT00904670|54636066|FG000|Open Label Phase|Adverse Event|2|||
27977859|NCT00904670|54636067|FG001|Open Label Phase|Adverse Event|0|||
27977860|NCT00904670|54636066|FG000|Open Label Phase|Lack of Efficacy|1|||
27977861|NCT00904670|54636067|FG001|Open Label Phase|Lack of Efficacy|0|||
27977862|NCT00904670|54636066|FG000|Open Label Phase|Lost to Follow-up|1|||
27977863|NCT00904670|54636067|FG001|Open Label Phase|Lost to Follow-up|0|||
27977864|NCT00638443|54636075|FG000|First Intervention|Adverse Event|2|||
27977865|NCT00638443|54636076|FG001|First Intervention|Adverse Event|1|||
27977866|NCT00636181|54636087|FG000|Overall Study|Withdrawal by Subject|8|||
27977867|NCT00636181|54636088|FG001|Overall Study|Withdrawal by Subject|6|||
27977868|NCT00636181|54636089|FG002|Overall Study|Withdrawal by Subject|10|||
27977869|NCT00968669|54636101|FG000|Overall Study|Lost to Follow-up|5|||
27977870|NCT00968669|54636102|FG001|Overall Study|Lost to Follow-up|2|||
27977871|NCT00968669|54636103|FG002|Overall Study|Lost to Follow-up|1|||
27977872|NCT00968669|54636104|FG003|Overall Study|Lost to Follow-up|4|||
27977873|NCT00968669|54636101|FG000|Overall Study|Withdrawal by Subject|9|||
27977874|NCT00968669|54636102|FG001|Overall Study|Withdrawal by Subject|7|||
27977875|NCT00968669|54636103|FG002|Overall Study|Withdrawal by Subject|5|||
27977876|NCT00968669|54636104|FG003|Overall Study|Withdrawal by Subject|3|||
28087043|NCT00062868|54740596|FG010|Dose Level 1|Death|0|||
27977877|NCT00968669|54636101|FG000|Overall Study|Pregnancy|0|||
27977878|NCT00968669|54636102|FG001|Overall Study|Pregnancy|0|||
27977879|NCT00968669|54636103|FG002|Overall Study|Pregnancy|2|||
28087044|NCT00062868|54740597|FG011|Dose Level 1|Death|0|||
28087045|NCT00062868|54740598|FG012|Dose Level 1|Death|0|||
27977880|NCT00968669|54636104|FG003|Overall Study|Pregnancy|0|||
27977881|NCT00968669|54636101|FG000|Overall Study|AE|1|||
27977882|NCT00968669|54636102|FG001|Overall Study|AE|0|||
27977883|NCT00968669|54636103|FG002|Overall Study|AE|0|||
27977884|NCT00968669|54636104|FG003|Overall Study|AE|0|||
28087046|NCT00062868|54740599|FG013|Dose Level 1|Death|0|||
28087047|NCT00062868|54740600|FG014|Dose Level 1|Death|0|||
27977885|NCT00968669|54636101|FG000|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
27977886|NCT00968669|54636102|FG001|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
27977887|NCT00968669|54636103|FG002|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
27977888|NCT00968669|54636104|FG003|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1|||
27977889|NCT00968669|54636101|FG000|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1|||
28087048|NCT00062868|54740601|FG015|Dose Level 1|Death|0|||
28087049|NCT00062868|54740602|FG016|Dose Level 1|Death|0|||
27855593|NCT01839331|54381890|FG001|Overall Study|Early Termination|0|||
27855594|NCT01839331|54381891|FG002|Overall Study|Early Termination|1|||
27855595|NCT01839331|54381892|FG003|Overall Study|Early Termination|2|||
27855596|NCT01839331|54381889|FG000|Overall Study|Protocol Violation|1|||
27855597|NCT01839331|54381890|FG001|Overall Study|Protocol Violation|6|||
27977890|NCT00968669|54636102|FG001|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
27977891|NCT00968669|54636103|FG002|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
27977892|NCT00968669|54636104|FG003|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
27977893|NCT00968669|54636101|FG000|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1|||
27977894|NCT00968669|54636102|FG001|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
27977895|NCT00968669|54636103|FG002|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
27977896|NCT00968669|54636104|FG003|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
27977897|NCT00968669|54636101|FG000|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
27977898|NCT00968669|54636102|FG001|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
27977899|NCT00968669|54636103|FG002|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1|||
27977900|NCT00968669|54636104|FG003|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
27977901|NCT00968669|54636101|FG000|Overall Study|EARLY WITHDRAWAL|0|||
27977902|NCT00968669|54636102|FG001|Overall Study|EARLY WITHDRAWAL|1|||
27977903|NCT00968669|54636103|FG002|Overall Study|EARLY WITHDRAWAL|0|||
27977904|NCT00968669|54636104|FG003|Overall Study|EARLY WITHDRAWAL|0|||
27977905|NCT00968669|54636101|FG000|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
27977906|NCT00968669|54636102|FG001|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
27977907|NCT00968669|54636103|FG002|Overall Study|ERROR IN HADS ADMINISTRATION|1|||
27977908|NCT00968669|54636104|FG003|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
27977909|NCT00968669|54636101|FG000|Overall Study|INEGIBILITY TO PERFORM VISIT|1|||
27977910|NCT00968669|54636102|FG001|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
27977911|NCT00968669|54636103|FG002|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
27977912|NCT00968669|54636104|FG003|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
27855598|NCT01839331|54381891|FG002|Overall Study|Protocol Violation|4|||
27855599|NCT01839331|54381892|FG003|Overall Study|Protocol Violation|3|||
27855600|NCT02733042|54382038|FG000|Treatment Period|Adverse Event|1|||
27855601|NCT02733042|54382039|FG001|Treatment Period|Adverse Event|0|||
27855602|NCT02733042|54382040|FG002|Treatment Period|Adverse Event|1|||
27855603|NCT02733042|54382041|FG003|Treatment Period|Adverse Event|1|||
27855604|NCT02733042|54382042|FG004|Treatment Period|Adverse Event|0|||
27855605|NCT02733042|54382043|FG005|Treatment Period|Adverse Event|0|||
27855606|NCT02733042|54382044|FG006|Treatment Period|Adverse Event|0|||
27855607|NCT02733042|54382045|FG007|Treatment Period|Adverse Event|0|||
27855608|NCT02733042|54382046|FG008|Treatment Period|Adverse Event|0|||
27855609|NCT02733042|54382047|FG009|Treatment Period|Adverse Event|0|||
27855610|NCT02733042|54382048|FG010|Treatment Period|Adverse Event|2|||
27977913|NCT00968669|54636101|FG000|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
27977914|NCT00968669|54636102|FG001|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1|||
27977915|NCT00968669|54636103|FG002|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
27977916|NCT00968669|54636104|FG003|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
27977917|NCT00968669|54636101|FG000|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
27977918|NCT00968669|54636102|FG001|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1|||
27977919|NCT00968669|54636103|FG002|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
27977920|NCT00968669|54636104|FG003|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
27977921|NCT00968669|54636101|FG000|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
27977922|NCT00968669|54636102|FG001|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1|||
27977923|NCT00968669|54636103|FG002|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
27977924|NCT00968669|54636104|FG003|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
27977925|NCT00968669|54636101|FG000|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
27977926|NCT00968669|54636102|FG001|Overall Study|PATIENT WILL BE WORKING ABROAD|1|||
27977927|NCT00968669|54636103|FG002|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
27977928|NCT00968669|54636104|FG003|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
27977929|NCT00968669|54636101|FG000|Overall Study|SPONSOR DECISION|0|||
27977930|NCT00968669|54636102|FG001|Overall Study|SPONSOR DECISION|1|||
27977931|NCT00968669|54636103|FG002|Overall Study|SPONSOR DECISION|0|||
27977932|NCT00968669|54636104|FG003|Overall Study|SPONSOR DECISION|0|||
27977933|NCT00968669|54636101|FG000|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
27977934|NCT00968669|54636102|FG001|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
27855611|NCT02733042|54382049|FG011|Treatment Period|Adverse Event|2|||
27855612|NCT02733042|54382050|FG012|Treatment Period|Adverse Event|0|||
27977935|NCT00968669|54636103|FG002|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1|||
27977936|NCT00968669|54636104|FG003|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
27977937|NCT00968669|54636101|FG000|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
28087050|NCT00062868|54740603|FG017|Dose Level 1|Death|0|||
27855613|NCT02733042|54382051|FG013|Treatment Period|Adverse Event|2|||
27855614|NCT02733042|54382052|FG014|Treatment Period|Adverse Event|0|||
27855615|NCT02733042|54382053|FG015|Treatment Period|Adverse Event|0|||
27855616|NCT02733042|54382054|FG016|Treatment Period|Adverse Event|0|||
27855617|NCT02733042|54382055|FG017|Treatment Period|Adverse Event|1|||
27977938|NCT00968669|54636102|FG001|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1|||
27977939|NCT00968669|54636103|FG002|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
27977940|NCT00968669|54636104|FG003|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
27977941|NCT00968669|54636101|FG000|Overall Study|SUBJECT INCARCERATED|0|||
27977942|NCT00968669|54636102|FG001|Overall Study|SUBJECT INCARCERATED|1|||
27977943|NCT00968669|54636103|FG002|Overall Study|SUBJECT INCARCERATED|0|||
27977944|NCT00968669|54636104|FG003|Overall Study|SUBJECT INCARCERATED|0|||
27977945|NCT00968669|54636101|FG000|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
27977946|NCT00968669|54636102|FG001|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1|||
27977947|NCT00968669|54636103|FG002|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
27977948|NCT00968669|54636104|FG003|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
27977949|NCT00968669|54636101|FG000|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
27977950|NCT00968669|54636102|FG001|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
27977951|NCT00968669|54636103|FG002|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
27977952|NCT00968669|54636104|FG003|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1|||
27977953|NCT00568399|54636114|FG000|Overall Study|Death|2|||
27977954|NCT00568399|54636114|FG000|Overall Study|Adverse Event|5|||
27977955|NCT00568399|54636114|FG000|Overall Study|Withdrawal by Subject|8|||
27977956|NCT00975143|54636120|FG000|Overall Study|Adverse Event|19|||
27977957|NCT00975143|54636121|FG001|Overall Study|Adverse Event|15|||
27977958|NCT00975143|54636120|FG000|Overall Study|Withdrawal by Subject|15|||
27977959|NCT00975143|54636121|FG001|Overall Study|Withdrawal by Subject|15|||
27977960|NCT00975143|54636120|FG000|Overall Study|Lost to Follow-up|20|||
27977961|NCT00975143|54636121|FG001|Overall Study|Lost to Follow-up|16|||
27977962|NCT00975143|54636120|FG000|Overall Study|Non-compliance|5|||
27977963|NCT00975143|54636121|FG001|Overall Study|Non-compliance|8|||
27977964|NCT00975143|54636120|FG000|Overall Study|Physician Decision|1|||
27977965|NCT00975143|54636121|FG001|Overall Study|Physician Decision|2|||
27977966|NCT00975143|54636120|FG000|Overall Study|Details not available|10|||
27977967|NCT00975143|54636121|FG001|Overall Study|Details not available|4|||
27977968|NCT00974675|54636144|FG000|Overall Study|Adverse Event|2|||
27977969|NCT00974675|54636145|FG001|Overall Study|Adverse Event|1|||
27977970|NCT00974675|54636146|FG002|Overall Study|Adverse Event|1|||
27977971|NCT00974675|54636147|FG003|Overall Study|Adverse Event|1|||
27977972|NCT00974675|54636144|FG000|Overall Study|Physician Decision|0|||
27977973|NCT00974675|54636145|FG001|Overall Study|Physician Decision|0|||
27977974|NCT00974675|54636146|FG002|Overall Study|Physician Decision|1|||
27977975|NCT00974675|54636147|FG003|Overall Study|Physician Decision|0|||
27977976|NCT00974675|54636144|FG000|Overall Study|Participant on holiday; unable to attend|0|||
27977977|NCT00974675|54636145|FG001|Overall Study|Participant on holiday; unable to attend|0|||
27977978|NCT00974675|54636146|FG002|Overall Study|Participant on holiday; unable to attend|0|||
27855618|NCT02733042|54382056|FG018|Treatment Period|Adverse Event|0|||
27855619|NCT02733042|54382038|FG000|Treatment Period|Progressive Disease|2|||
27855620|NCT02733042|54382039|FG001|Treatment Period|Progressive Disease|1|||
27855621|NCT02733042|54382040|FG002|Treatment Period|Progressive Disease|3|||
27855622|NCT02733042|54382041|FG003|Treatment Period|Progressive Disease|1|||
27855623|NCT02733042|54382042|FG004|Treatment Period|Progressive Disease|1|||
27855624|NCT02733042|54382043|FG005|Treatment Period|Progressive Disease|3|||
27855625|NCT02733042|54382044|FG006|Treatment Period|Progressive Disease|0|||
27855626|NCT02733042|54382045|FG007|Treatment Period|Progressive Disease|3|||
27855627|NCT02733042|54382046|FG008|Treatment Period|Progressive Disease|3|||
27855628|NCT02733042|54382047|FG009|Treatment Period|Progressive Disease|0|||
27855629|NCT02733042|54382048|FG010|Treatment Period|Progressive Disease|2|||
27855630|NCT02733042|54382049|FG011|Treatment Period|Progressive Disease|2|||
27855631|NCT02733042|54382050|FG012|Treatment Period|Progressive Disease|8|||
27855632|NCT02733042|54382051|FG013|Treatment Period|Progressive Disease|1|||
27855633|NCT02733042|54382052|FG014|Treatment Period|Progressive Disease|4|||
27855634|NCT02733042|54382053|FG015|Treatment Period|Progressive Disease|7|||
27855635|NCT02733042|54382054|FG016|Treatment Period|Progressive Disease|2|||
27855636|NCT02733042|54382055|FG017|Treatment Period|Progressive Disease|3|||
27855637|NCT02733042|54382056|FG018|Treatment Period|Progressive Disease|4|||
27855638|NCT02733042|54382038|FG000|Treatment Period|Withdrawal by Subject|0|||
27855639|NCT02733042|54382039|FG001|Treatment Period|Withdrawal by Subject|1|||
27855640|NCT02733042|54382040|FG002|Treatment Period|Withdrawal by Subject|2|||
27855641|NCT02733042|54382041|FG003|Treatment Period|Withdrawal by Subject|1|||
27855642|NCT02733042|54382042|FG004|Treatment Period|Withdrawal by Subject|0|||
27855643|NCT02733042|54382043|FG005|Treatment Period|Withdrawal by Subject|0|||
27855644|NCT02733042|54382044|FG006|Treatment Period|Withdrawal by Subject|0|||
27855645|NCT02733042|54382045|FG007|Treatment Period|Withdrawal by Subject|0|||
27855646|NCT02733042|54382046|FG008|Treatment Period|Withdrawal by Subject|1|||
27977979|NCT00974675|54636147|FG003|Overall Study|Participant on holiday; unable to attend|1|||
27977980|NCT00634933|54636160|FG000|Part A: Baseline to Week 24|Adverse Event|4|||
27977981|NCT00634933|54636161|FG001|Part A: Baseline to Week 24|Adverse Event|4|||
27977982|NCT00634933|54636162|FG002|Part A: Baseline to Week 24|Adverse Event|8|||
27855647|NCT02733042|54382047|FG009|Treatment Period|Withdrawal by Subject|1|||
27977983|NCT00634933|54636163|FG003|Part A: Baseline to Week 24|Adverse Event|0|||
27977984|NCT00634933|54636164|FG004|Part A: Baseline to Week 24|Adverse Event|0|||
27977985|NCT00634933|54636160|FG000|Part A: Baseline to Week 24|Death|1|||
27977986|NCT00634933|54636161|FG001|Part A: Baseline to Week 24|Death|0|||
27977987|NCT00634933|54636162|FG002|Part A: Baseline to Week 24|Death|0|||
27977988|NCT00634933|54636163|FG003|Part A: Baseline to Week 24|Death|0|||
27977989|NCT00634933|54636164|FG004|Part A: Baseline to Week 24|Death|0|||
27977990|NCT00634933|54636160|FG000|Part A: Baseline to Week 24|Failed to Return|1|||
27977991|NCT00634933|54636161|FG001|Part A: Baseline to Week 24|Failed to Return|0|||
27977992|NCT00634933|54636162|FG002|Part A: Baseline to Week 24|Failed to Return|0|||
27977993|NCT00634933|54636163|FG003|Part A: Baseline to Week 24|Failed to Return|0|||
27977994|NCT00634933|54636164|FG004|Part A: Baseline to Week 24|Failed to Return|0|||
27977995|NCT00634933|54636160|FG000|Part A: Baseline to Week 24|Investigator Request|1|||
27977996|NCT00634933|54636161|FG001|Part A: Baseline to Week 24|Investigator Request|1|||
27977997|NCT00634933|54636162|FG002|Part A: Baseline to Week 24|Investigator Request|1|||
27977998|NCT00634933|54636163|FG003|Part A: Baseline to Week 24|Investigator Request|0|||
27977999|NCT00634933|54636164|FG004|Part A: Baseline to Week 24|Investigator Request|0|||
27978000|NCT00634933|54636160|FG000|Part A: Baseline to Week 24|Lost to Follow-up|0|||
27978001|NCT00634933|54636161|FG001|Part A: Baseline to Week 24|Lost to Follow-up|1|||
27978002|NCT00634933|54636162|FG002|Part A: Baseline to Week 24|Lost to Follow-up|1|||
27978003|NCT00634933|54636163|FG003|Part A: Baseline to Week 24|Lost to Follow-up|0|||
27978004|NCT00634933|54636164|FG004|Part A: Baseline to Week 24|Lost to Follow-up|0|||
27978005|NCT00634933|54636160|FG000|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
27978006|NCT00634933|54636161|FG001|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
27978007|NCT00634933|54636162|FG002|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
27978008|NCT00634933|54636163|FG003|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
27978009|NCT00634933|54636164|FG004|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
27978010|NCT00634933|54636160|FG000|Part A: Baseline to Week 24|Lack of Efficacy|3|||
27978011|NCT00634933|54636161|FG001|Part A: Baseline to Week 24|Lack of Efficacy|1|||
27978012|NCT00634933|54636162|FG002|Part A: Baseline to Week 24|Lack of Efficacy|0|||
27978013|NCT00634933|54636163|FG003|Part A: Baseline to Week 24|Lack of Efficacy|0|||
27978014|NCT00634933|54636164|FG004|Part A: Baseline to Week 24|Lack of Efficacy|0|||
27978015|NCT00634933|54636160|FG000|Part A: Baseline to Week 24|Other|1|||
27978016|NCT00634933|54636161|FG001|Part A: Baseline to Week 24|Other|8|||
27978017|NCT00634933|54636162|FG002|Part A: Baseline to Week 24|Other|5|||
27978018|NCT00634933|54636163|FG003|Part A: Baseline to Week 24|Other|0|||
27978019|NCT00634933|54636164|FG004|Part A: Baseline to Week 24|Other|0|||
27978020|NCT00634933|54636160|FG000|Between Part A and Part B|Physician Decision|0|||
27978021|NCT00634933|54636161|FG001|Between Part A and Part B|Physician Decision|1|||
27978022|NCT00634933|54636162|FG002|Between Part A and Part B|Physician Decision|0|||
27978023|NCT00634933|54636163|FG003|Between Part A and Part B|Physician Decision|0|||
27855648|NCT02733042|54382048|FG010|Treatment Period|Withdrawal by Subject|0|||
27855649|NCT02733042|54382049|FG011|Treatment Period|Withdrawal by Subject|2|||
27855650|NCT02733042|54382050|FG012|Treatment Period|Withdrawal by Subject|1|||
27855651|NCT02733042|54382051|FG013|Treatment Period|Withdrawal by Subject|1|||
27978024|NCT00634933|54636164|FG004|Between Part A and Part B|Physician Decision|0|||
28087051|NCT00062868|54740604|FG018|Dose Level 1|Death|7|||
28087052|NCT00062868|54740605|FG019|Dose Level 1|Death|0|||
28087053|NCT00062868|54740606|FG020|Dose Level 1|Death|1|||
28087054|NCT00062868|54740586|FG000|Dose Level 1|Lost to Follow-up|0|||
28087055|NCT00062868|54740587|FG001|Dose Level 1|Lost to Follow-up|0|||
28087056|NCT00062868|54740588|FG002|Dose Level 1|Lost to Follow-up|0|||
28087057|NCT00062868|54740589|FG003|Dose Level 1|Lost to Follow-up|0|||
28087058|NCT00062868|54740590|FG004|Dose Level 1|Lost to Follow-up|0|||
28087059|NCT00062868|54740591|FG005|Dose Level 1|Lost to Follow-up|0|||
28087060|NCT00062868|54740592|FG006|Dose Level 1|Lost to Follow-up|0|||
28087061|NCT00062868|54740593|FG007|Dose Level 1|Lost to Follow-up|0|||
28087062|NCT00062868|54740594|FG008|Dose Level 1|Lost to Follow-up|0|||
28087063|NCT00062868|54740595|FG009|Dose Level 1|Lost to Follow-up|0|||
28087064|NCT00062868|54740596|FG010|Dose Level 1|Lost to Follow-up|0|||
28087065|NCT00062868|54740597|FG011|Dose Level 1|Lost to Follow-up|0|||
28087066|NCT00062868|54740598|FG012|Dose Level 1|Lost to Follow-up|1|||
28087067|NCT00062868|54740599|FG013|Dose Level 1|Lost to Follow-up|0|||
28087068|NCT00062868|54740600|FG014|Dose Level 1|Lost to Follow-up|0|||
28087069|NCT00062868|54740601|FG015|Dose Level 1|Lost to Follow-up|0|||
28087070|NCT00062868|54740602|FG016|Dose Level 1|Lost to Follow-up|0|||
27733256|NCT03335371|54181062|FG004|Overall Study|Lost to Follow-up|1|||
27978025|NCT00634933|54636160|FG000|Part B: Week 24 to Week 52|Adverse Event|0|||
27978026|NCT00634933|54636161|FG001|Part B: Week 24 to Week 52|Adverse Event|1|||
28087071|NCT00062868|54740603|FG017|Dose Level 1|Lost to Follow-up|0|||
28087072|NCT00062868|54740604|FG018|Dose Level 1|Lost to Follow-up|2|||
27855652|NCT02733042|54382052|FG014|Treatment Period|Withdrawal by Subject|0|||
27978027|NCT00634933|54636162|FG002|Part B: Week 24 to Week 52|Adverse Event|1|||
27978028|NCT00634933|54636163|FG003|Part B: Week 24 to Week 52|Adverse Event|1|||
28087073|NCT00062868|54740605|FG019|Dose Level 1|Lost to Follow-up|0|||
28087074|NCT00062868|54740606|FG020|Dose Level 1|Lost to Follow-up|1|||
27978029|NCT00634933|54636164|FG004|Part B: Week 24 to Week 52|Adverse Event|0|||
27978030|NCT00634933|54636160|FG000|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0|||
27978031|NCT00634933|54636161|FG001|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11|||
27978032|NCT00634933|54636162|FG002|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14|||
27978033|NCT00634933|54636163|FG003|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3|||
27978034|NCT00634933|54636164|FG004|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7|||
27978035|NCT00634933|54636160|FG000|Part B: Week 24 to Week 52|Physician Decision|0|||
27978036|NCT00634933|54636161|FG001|Part B: Week 24 to Week 52|Physician Decision|1|||
27978037|NCT00634933|54636162|FG002|Part B: Week 24 to Week 52|Physician Decision|1|||
27978038|NCT00634933|54636163|FG003|Part B: Week 24 to Week 52|Physician Decision|0|||
27978039|NCT00634933|54636164|FG004|Part B: Week 24 to Week 52|Physician Decision|0|||
27978040|NCT00634933|54636160|FG000|Part B: Week 24 to Week 52|Protocol Violation|0|||
27978041|NCT00634933|54636161|FG001|Part B: Week 24 to Week 52|Protocol Violation|0|||
27978042|NCT00634933|54636162|FG002|Part B: Week 24 to Week 52|Protocol Violation|0|||
27978043|NCT00634933|54636163|FG003|Part B: Week 24 to Week 52|Protocol Violation|0|||
27978044|NCT00634933|54636164|FG004|Part B: Week 24 to Week 52|Protocol Violation|1|||
28165589|NCT01654666|54836207|FG001|Overall Study|Protocol Violation|4|||
28165590|NCT01654666|54836208|FG002|Overall Study|Protocol Violation|8|||
27832749|NCT01729871|54312490|FG000|Overall Study|Protocol Violation|1|||
27978045|NCT00634933|54636160|FG000|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
27978046|NCT00634933|54636161|FG001|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
27978047|NCT00634933|54636162|FG002|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
27978048|NCT00634933|54636163|FG003|Part B: Week 24 to Week 52|Withdrawal by Subject|2|||
27978049|NCT00634933|54636164|FG004|Part B: Week 24 to Week 52|Withdrawal by Subject|1|||
27978050|NCT00634933|54636160|FG000|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
27978051|NCT00634933|54636161|FG001|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
27978052|NCT00634933|54636162|FG002|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
27978053|NCT00634933|54636163|FG003|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
27978054|NCT00634933|54636164|FG004|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
27978055|NCT00634933|54636160|FG000|Part B: Week 24 to Week 52|Other|0|||
27978056|NCT00634933|54636161|FG001|Part B: Week 24 to Week 52|Other|0|||
27978057|NCT00634933|54636162|FG002|Part B: Week 24 to Week 52|Other|5|||
27978058|NCT00634933|54636163|FG003|Part B: Week 24 to Week 52|Other|0|||
27978059|NCT00634933|54636164|FG004|Part B: Week 24 to Week 52|Other|1|||
27978060|NCT00967499|54636178|FG000|Overall Study|Adverse Event|0|||
27978061|NCT00967499|54636179|FG001|Overall Study|Adverse Event|1|||
27978062|NCT00967499|54636178|FG000|Overall Study|Protocol Violation|1|||
27978063|NCT00967499|54636179|FG001|Overall Study|Protocol Violation|0|||
27978064|NCT00967499|54636178|FG000|Overall Study|Sponsor Decision|1|||
27978065|NCT00967499|54636179|FG001|Overall Study|Sponsor Decision|0|||
27978066|NCT00967499|54636178|FG000|Overall Study|Randomized but not treated|63|||
27978067|NCT00967499|54636179|FG001|Overall Study|Randomized but not treated|59|||
27978068|NCT03909971|54636187|FG000|Overall Study|Other Reasons Not Specified|0|||
27978069|NCT03909971|54636188|FG001|Overall Study|Other Reasons Not Specified|1|||
27978070|NCT03909971|54636187|FG000|Overall Study|Global Deterioration of Health Status|2|||
27978071|NCT03909971|54636188|FG001|Overall Study|Global Deterioration of Health Status|1|||
27978072|NCT03909971|54636187|FG000|Overall Study|Progressive Disease|6|||
27978073|NCT03909971|54636188|FG001|Overall Study|Progressive Disease|14|||
27978074|NCT03909971|54636187|FG000|Overall Study|Death|2|||
27978075|NCT03909971|54636188|FG001|Overall Study|Death|6|||
27978076|NCT00967343|54636195|FG000|Overall Study|Study termination by sponsor|12|||
27978077|NCT00967343|54636195|FG000|Overall Study|Death|24|||
27978078|NCT00967343|54636195|FG000|Overall Study|Relapse|1|||
27978079|NCT00967343|54636195|FG000|Overall Study|Lost to Follow-up|1|||
27978080|NCT00973973|54636201|FG000|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1|||
27978081|NCT00973973|54636202|FG001|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3|||
27978082|NCT00973973|54636201|FG000|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1|||
27978083|NCT00973973|54636202|FG001|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0|||
27978084|NCT00973973|54636201|FG000|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1|||
27978085|NCT00973973|54636202|FG001|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3|||
27978086|NCT00973973|54636201|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1|||
27978087|NCT00973973|54636202|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0|||
28087075|NCT00062868|54740586|FG000|Dose Level 2|Death|0|||
28087076|NCT00062868|54740587|FG001|Dose Level 2|Death|3|||
28087077|NCT00062868|54740588|FG002|Dose Level 2|Death|0|||
28087078|NCT00062868|54740589|FG003|Dose Level 2|Death|0|||
28087079|NCT00062868|54740590|FG004|Dose Level 2|Death|2|||
28087080|NCT00062868|54740591|FG005|Dose Level 2|Death|0|||
28087081|NCT00062868|54740592|FG006|Dose Level 2|Death|0|||
27978088|NCT00973973|54636201|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
27978089|NCT00973973|54636202|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
28087082|NCT00062868|54740593|FG007|Dose Level 2|Death|0|||
28087083|NCT00062868|54740594|FG008|Dose Level 2|Death|0|||
28087084|NCT00062868|54740595|FG009|Dose Level 2|Death|0|||
27978090|NCT00973973|54636201|FG000|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
27978091|NCT00973973|54636202|FG001|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
27978092|NCT00973973|54636201|FG000|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1|||
27978093|NCT00973973|54636202|FG001|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2|||
27978094|NCT00973973|54636201|FG000|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1|||
27978095|NCT00973973|54636202|FG001|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0|||
27978096|NCT00973973|54636201|FG000|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1|||
27978097|NCT00973973|54636202|FG001|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0|||
27978098|NCT00973973|54636201|FG000|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1|||
27978099|NCT00973973|54636202|FG001|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3|||
27978100|NCT00973973|54636201|FG000|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1|||
27978101|NCT00973973|54636202|FG001|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0|||
27978102|NCT00973973|54636201|FG000|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1|||
27978103|NCT00973973|54636202|FG001|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0|||
27978104|NCT00633139|54636211|FG000|Overall Study|Non compliance|0|||
27978105|NCT00633139|54636212|FG001|Overall Study|Non compliance|0|||
27978106|NCT00633139|54636213|FG002|Overall Study|Non compliance|1|||
27978107|NCT00633139|54636211|FG000|Overall Study|Withdrawal by Subject|0|||
27978108|NCT00633139|54636212|FG001|Overall Study|Withdrawal by Subject|1|||
27978109|NCT00633139|54636213|FG002|Overall Study|Withdrawal by Subject|0|||
27978110|NCT00965081|54636223|FG000|Overall Study|Adverse Event|14|||
27978111|NCT00965081|54636224|FG001|Overall Study|Adverse Event|9|||
27978112|NCT00965081|54636223|FG000|Overall Study|Lack of Efficacy|2|||
27978113|NCT00965081|54636224|FG001|Overall Study|Lack of Efficacy|5|||
27978114|NCT00965081|54636223|FG000|Overall Study|Lost to Follow-up|4|||
27978115|NCT00965081|54636224|FG001|Overall Study|Lost to Follow-up|5|||
27978116|NCT00965081|54636223|FG000|Overall Study|Physician Decision|2|||
27978117|NCT00965081|54636224|FG001|Overall Study|Physician Decision|0|||
27978118|NCT00965081|54636223|FG000|Overall Study|Protocol Violation|2|||
27978119|NCT00965081|54636224|FG001|Overall Study|Protocol Violation|5|||
27978120|NCT00965081|54636223|FG000|Overall Study|Sponsor Decision|1|||
27978121|NCT00965081|54636224|FG001|Overall Study|Sponsor Decision|0|||
27978122|NCT00965081|54636223|FG000|Overall Study|Withdrawal by Subject|4|||
27978123|NCT00965081|54636224|FG001|Overall Study|Withdrawal by Subject|7|||
27978124|NCT00965081|54636223|FG000|Overall Study|Switched to Rescue Arm|5|||
27978125|NCT00965081|54636224|FG001|Overall Study|Switched to Rescue Arm|12|||
27978126|NCT00961649|54636235|FG000|Overall Study|Adverse Event|4|||
27978127|NCT00961649|54636236|FG001|Overall Study|Adverse Event|0|||
27978128|NCT00961649|54636237|FG002|Overall Study|Adverse Event|0|||
27978129|NCT00961649|54636238|FG003|Overall Study|Adverse Event|2|||
27978130|NCT00961649|54636235|FG000|Overall Study|Inadequate control of IOP|0|||
27978131|NCT00961649|54636236|FG001|Overall Study|Inadequate control of IOP|0|||
27978132|NCT00961649|54636237|FG002|Overall Study|Inadequate control of IOP|0|||
27978133|NCT00961649|54636238|FG003|Overall Study|Inadequate control of IOP|1|||
27978134|NCT00961649|54636235|FG000|Overall Study|Patient has travel plans during holidays|0|||
27978135|NCT00961649|54636236|FG001|Overall Study|Patient has travel plans during holidays|0|||
27978136|NCT00961649|54636237|FG002|Overall Study|Patient has travel plans during holidays|1|||
27978137|NCT00961649|54636238|FG003|Overall Study|Patient has travel plans during holidays|0|||
27978138|NCT00961649|54636235|FG000|Overall Study|Patient left to Mexico-family emergency|1|||
27978139|NCT00961649|54636236|FG001|Overall Study|Patient left to Mexico-family emergency|0|||
27978140|NCT00961649|54636237|FG002|Overall Study|Patient left to Mexico-family emergency|0|||
27978141|NCT00961649|54636238|FG003|Overall Study|Patient left to Mexico-family emergency|0|||
27978142|NCT00961649|54636235|FG000|Overall Study|Study terminated by sponsor|4|||
27978143|NCT00961649|54636236|FG001|Overall Study|Study terminated by sponsor|4|||
27978144|NCT00961649|54636237|FG002|Overall Study|Study terminated by sponsor|4|||
27978145|NCT00961649|54636238|FG003|Overall Study|Study terminated by sponsor|1|||
27978146|NCT00632125|54636248|FG000|Overall Study|Death|82|||
27978147|NCT00632125|54636248|FG000|Overall Study|Withdrawal by Subject|44|||
27978148|NCT00632125|54636248|FG000|Overall Study|Adverse Event|36|||
27978149|NCT00632125|54636248|FG000|Overall Study|Renal transplantation|17|||
27978150|NCT00632125|54636248|FG000|Overall Study|Need for systemic immunosuppressive medi|8|||
27978151|NCT00632125|54636248|FG000|Overall Study|Non-compliance|8|||
27978152|NCT00632125|54636248|FG000|Overall Study|Development of uncontrolled hypertension|5|||
27978153|NCT00632125|54636248|FG000|Overall Study|Moved to other dialysis unit, etc.|102|||
27978154|NCT00903968|54636254|FG000|Overall Study|Adverse Event|0|||
27978155|NCT00903968|54636255|FG001|Overall Study|Adverse Event|0|||
27978156|NCT00903968|54636256|FG002|Overall Study|Adverse Event|0|||
27978157|NCT00903968|54636257|FG003|Overall Study|Adverse Event|0|||
27978158|NCT00903968|54636258|FG004|Overall Study|Adverse Event|0|||
28165591|NCT01654666|54836206|FG000|Overall Study|Lost to Follow-up|4|||
28165592|NCT01654666|54836207|FG001|Overall Study|Lost to Follow-up|5|||
27978159|NCT00903968|54636259|FG005|Overall Study|Adverse Event|0|||
28165593|NCT01654666|54836208|FG002|Overall Study|Lost to Follow-up|5|||
27978160|NCT00903968|54636260|FG006|Overall Study|Adverse Event|1|||
27978161|NCT00903968|54636261|FG007|Overall Study|Adverse Event|8|||
27978162|NCT00903968|54636254|FG000|Overall Study|DLT|0|||
27978163|NCT00903968|54636255|FG001|Overall Study|DLT|0|||
27978164|NCT00903968|54636256|FG002|Overall Study|DLT|0|||
27978165|NCT00903968|54636257|FG003|Overall Study|DLT|0|||
27978166|NCT00903968|54636258|FG004|Overall Study|DLT|0|||
27978167|NCT00903968|54636259|FG005|Overall Study|DLT|0|||
27978168|NCT00903968|54636260|FG006|Overall Study|DLT|2|||
27978169|NCT00903968|54636261|FG007|Overall Study|DLT|0|||
27978170|NCT00903968|54636254|FG000|Overall Study|Withdrawal by Subject|1|||
27978171|NCT00903968|54636255|FG001|Overall Study|Withdrawal by Subject|0|||
27978172|NCT00903968|54636256|FG002|Overall Study|Withdrawal by Subject|1|||
27978173|NCT00903968|54636257|FG003|Overall Study|Withdrawal by Subject|0|||
28087085|NCT00062868|54740596|FG010|Dose Level 2|Death|1|||
28087086|NCT00062868|54740597|FG011|Dose Level 2|Death|0|||
28087087|NCT00062868|54740598|FG012|Dose Level 2|Death|0|||
28087088|NCT00062868|54740599|FG013|Dose Level 2|Death|0|||
28087089|NCT00062868|54740600|FG014|Dose Level 2|Death|0|||
28087090|NCT00062868|54740601|FG015|Dose Level 2|Death|0|||
28087091|NCT00062868|54740602|FG016|Dose Level 2|Death|2|||
28087092|NCT00062868|54740603|FG017|Dose Level 2|Death|0|||
28087093|NCT00062868|54740604|FG018|Dose Level 2|Death|0|||
28087094|NCT00062868|54740605|FG019|Dose Level 2|Death|0|||
28087095|NCT00062868|54740606|FG020|Dose Level 2|Death|0|||
28087096|NCT00062868|54740586|FG000|Dose Level 2|Lost to Follow-up|0|||
28087097|NCT00062868|54740587|FG001|Dose Level 2|Lost to Follow-up|0|||
28087098|NCT00062868|54740588|FG002|Dose Level 2|Lost to Follow-up|0|||
28087099|NCT00062868|54740589|FG003|Dose Level 2|Lost to Follow-up|0|||
28087100|NCT00062868|54740590|FG004|Dose Level 2|Lost to Follow-up|0|||
28087101|NCT00062868|54740591|FG005|Dose Level 2|Lost to Follow-up|0|||
28087102|NCT00062868|54740592|FG006|Dose Level 2|Lost to Follow-up|0|||
28087103|NCT00062868|54740593|FG007|Dose Level 2|Lost to Follow-up|0|||
28087104|NCT00062868|54740594|FG008|Dose Level 2|Lost to Follow-up|0|||
28087105|NCT00062868|54740595|FG009|Dose Level 2|Lost to Follow-up|0|||
28087106|NCT00062868|54740596|FG010|Dose Level 2|Lost to Follow-up|0|||
28087107|NCT00062868|54740597|FG011|Dose Level 2|Lost to Follow-up|0|||
28087108|NCT00062868|54740598|FG012|Dose Level 2|Lost to Follow-up|0|||
28087109|NCT00062868|54740599|FG013|Dose Level 2|Lost to Follow-up|1|||
28087110|NCT00062868|54740600|FG014|Dose Level 2|Lost to Follow-up|0|||
28087111|NCT00062868|54740601|FG015|Dose Level 2|Lost to Follow-up|0|||
28087112|NCT00062868|54740602|FG016|Dose Level 2|Lost to Follow-up|1|||
28087113|NCT00062868|54740603|FG017|Dose Level 2|Lost to Follow-up|0|||
28087114|NCT00062868|54740604|FG018|Dose Level 2|Lost to Follow-up|0|||
28087115|NCT00062868|54740605|FG019|Dose Level 2|Lost to Follow-up|0|||
28087116|NCT00062868|54740606|FG020|Dose Level 2|Lost to Follow-up|0|||
28087117|NCT00062868|54740586|FG000|Dose Level 3|Death|0|||
28087118|NCT00062868|54740587|FG001|Dose Level 3|Death|0|||
28087119|NCT00062868|54740588|FG002|Dose Level 3|Death|0|||
28087120|NCT00062868|54740589|FG003|Dose Level 3|Death|0|||
28087121|NCT00062868|54740590|FG004|Dose Level 3|Death|0|||
28165594|NCT01654666|54836206|FG000|Overall Study|Withdrawal by Subject|4|||
28165595|NCT01654666|54836207|FG001|Overall Study|Withdrawal by Subject|4|||
28165596|NCT01654666|54836208|FG002|Overall Study|Withdrawal by Subject|1|||
28165597|NCT02519842|54836218|FG000|Base Study: Cycle 1|Screening Failure|1|||
28165598|NCT02519842|54836219|FG001|Base Study: Cycle 1|Screening Failure|1|||
28165599|NCT02519842|54836220|FG002|Base Study: Cycle 1|Screening Failure|0|||
28165600|NCT02519842|54836218|FG000|Base Study: Cycle 1|Adverse Event|1|||
28165601|NCT02519842|54836219|FG001|Base Study: Cycle 1|Adverse Event|0|||
28165602|NCT02519842|54836220|FG002|Base Study: Cycle 1|Adverse Event|0|||
28165603|NCT02519842|54836218|FG000|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
28165604|NCT02519842|54836219|FG001|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1|||
28165605|NCT02519842|54836220|FG002|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
27733257|NCT03335371|54181058|FG000|Overall Study|Withdrawal by Subject|0|||
28087122|NCT00062868|54740591|FG005|Dose Level 3|Death|0|||
28087123|NCT00062868|54740592|FG006|Dose Level 3|Death|0|||
28087124|NCT00062868|54740593|FG007|Dose Level 3|Death|0|||
28165606|NCT02519842|54836218|FG000|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
28165607|NCT02519842|54836219|FG001|Base Study: Cycle 1|Non-compliance with Study Drug|1|||
27733258|NCT03335371|54181059|FG001|Overall Study|Withdrawal by Subject|0|||
27978174|NCT00903968|54636258|FG004|Overall Study|Withdrawal by Subject|1|||
27978175|NCT00903968|54636259|FG005|Overall Study|Withdrawal by Subject|1|||
27978176|NCT00903968|54636260|FG006|Overall Study|Withdrawal by Subject|0|||
27978177|NCT00903968|54636261|FG007|Overall Study|Withdrawal by Subject|4|||
28087125|NCT00062868|54740594|FG008|Dose Level 3|Death|0|||
28087126|NCT00062868|54740595|FG009|Dose Level 3|Death|0|||
28087127|NCT00062868|54740596|FG010|Dose Level 3|Death|0|||
28087128|NCT00062868|54740597|FG011|Dose Level 3|Death|1|||
28087129|NCT00062868|54740598|FG012|Dose Level 3|Death|0|||
28087130|NCT00062868|54740599|FG013|Dose Level 3|Death|0|||
28087131|NCT00062868|54740600|FG014|Dose Level 3|Death|0|||
28087132|NCT00062868|54740601|FG015|Dose Level 3|Death|0|||
28165608|NCT02519842|54836220|FG002|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
28165609|NCT02519842|54836218|FG000|Optional Extension: Cycles 2-6|Physician Decision|0|||
28087133|NCT00062868|54740602|FG016|Dose Level 3|Death|0|||
28087134|NCT00062868|54740603|FG017|Dose Level 3|Death|1|||
28087135|NCT00062868|54740604|FG018|Dose Level 3|Death|0|||
28087136|NCT00062868|54740605|FG019|Dose Level 3|Death|0|||
28165610|NCT02519842|54836219|FG001|Optional Extension: Cycles 2-6|Physician Decision|0|||
28087137|NCT00062868|54740606|FG020|Dose Level 3|Death|0|||
28087138|NCT00062868|54740586|FG000|Dose Level 3|Lost to Follow-up|0|||
28087139|NCT00062868|54740587|FG001|Dose Level 3|Lost to Follow-up|0|||
28087140|NCT00062868|54740588|FG002|Dose Level 3|Lost to Follow-up|0|||
28087141|NCT00062868|54740589|FG003|Dose Level 3|Lost to Follow-up|0|||
28087142|NCT00062868|54740590|FG004|Dose Level 3|Lost to Follow-up|0|||
28087143|NCT00062868|54740591|FG005|Dose Level 3|Lost to Follow-up|0|||
28087144|NCT00062868|54740592|FG006|Dose Level 3|Lost to Follow-up|0|||
28087145|NCT00062868|54740593|FG007|Dose Level 3|Lost to Follow-up|0|||
28087146|NCT00062868|54740594|FG008|Dose Level 3|Lost to Follow-up|0|||
28087147|NCT00062868|54740595|FG009|Dose Level 3|Lost to Follow-up|0|||
28087148|NCT00062868|54740596|FG010|Dose Level 3|Lost to Follow-up|0|||
28087149|NCT00062868|54740597|FG011|Dose Level 3|Lost to Follow-up|0|||
28087150|NCT00062868|54740598|FG012|Dose Level 3|Lost to Follow-up|0|||
28087151|NCT00062868|54740599|FG013|Dose Level 3|Lost to Follow-up|0|||
28087152|NCT00062868|54740600|FG014|Dose Level 3|Lost to Follow-up|1|||
28087153|NCT00062868|54740601|FG015|Dose Level 3|Lost to Follow-up|0|||
28087154|NCT00062868|54740602|FG016|Dose Level 3|Lost to Follow-up|0|||
28087155|NCT00062868|54740603|FG017|Dose Level 3|Lost to Follow-up|0|||
28087156|NCT00062868|54740604|FG018|Dose Level 3|Lost to Follow-up|0|||
28087157|NCT00062868|54740605|FG019|Dose Level 3|Lost to Follow-up|0|||
28087158|NCT00062868|54740606|FG020|Dose Level 3|Lost to Follow-up|0|||
28087159|NCT00062868|54740586|FG000|Dose Level 3|Withdrew|0|||
28087160|NCT00062868|54740587|FG001|Dose Level 3|Withdrew|0|||
28087161|NCT00062868|54740588|FG002|Dose Level 3|Withdrew|2|||
28087162|NCT00062868|54740589|FG003|Dose Level 3|Withdrew|0|||
28087163|NCT00062868|54740590|FG004|Dose Level 3|Withdrew|0|||
28087164|NCT00062868|54740591|FG005|Dose Level 3|Withdrew|0|||
28087165|NCT00062868|54740592|FG006|Dose Level 3|Withdrew|0|||
28087166|NCT00062868|54740593|FG007|Dose Level 3|Withdrew|0|||
28087167|NCT00062868|54740594|FG008|Dose Level 3|Withdrew|0|||
28087168|NCT00062868|54740595|FG009|Dose Level 3|Withdrew|0|||
28087169|NCT00062868|54740596|FG010|Dose Level 3|Withdrew|0|||
28087170|NCT00062868|54740597|FG011|Dose Level 3|Withdrew|0|||
28087171|NCT00062868|54740598|FG012|Dose Level 3|Withdrew|0|||
28087172|NCT00062868|54740599|FG013|Dose Level 3|Withdrew|0|||
28087173|NCT00062868|54740600|FG014|Dose Level 3|Withdrew|0|||
28087174|NCT00062868|54740601|FG015|Dose Level 3|Withdrew|0|||
28087175|NCT00062868|54740602|FG016|Dose Level 3|Withdrew|0|||
28087176|NCT00062868|54740603|FG017|Dose Level 3|Withdrew|0|||
28087177|NCT00062868|54740604|FG018|Dose Level 3|Withdrew|0|||
28087178|NCT00062868|54740605|FG019|Dose Level 3|Withdrew|0|||
28087179|NCT00062868|54740606|FG020|Dose Level 3|Withdrew|0|||
28087180|NCT00075504|54740652|FG000|Overall Study|Withdrawal by Subject|9|||
28087181|NCT00075504|54740653|FG001|Overall Study|Withdrawal by Subject|7|||
28087182|NCT00062166|54740659|FG000|Overall Study|Withdrawal by Subject|6|||
28087183|NCT00087438|54740664|FG000|Overall Study|Ineligible / No protocol treatment|4|||
28087184|NCT00321464|54740672|FG000|Overall Study|Death|169|||
28087185|NCT00321464|54740673|FG001|Overall Study|Death|174|||
28087186|NCT00321464|54740672|FG000|Overall Study|Disease progression|124|||
28087187|NCT00321464|54740673|FG001|Overall Study|Disease progression|124|||
28087188|NCT00321464|54740672|FG000|Overall Study|Withdrawal by Subject|117|||
28087189|NCT00321464|54740673|FG001|Overall Study|Withdrawal by Subject|118|||
28087190|NCT00321464|54740672|FG000|Overall Study|Participant request|57|||
28087191|NCT00321464|54740673|FG001|Overall Study|Participant request|61|||
28087192|NCT00321464|54740672|FG000|Overall Study|Adverse Event|43|||
28165611|NCT02519842|54836220|FG002|Optional Extension: Cycles 2-6|Physician Decision|5|||
28087193|NCT00321464|54740673|FG001|Overall Study|Adverse Event|28|||
28087194|NCT00321464|54740672|FG000|Overall Study|Physician Decision|15|||
28087195|NCT00321464|54740673|FG001|Overall Study|Physician Decision|14|||
28087196|NCT00321464|54740672|FG000|Overall Study|Noncompliance|4|||
28165612|NCT02519842|54836218|FG000|Optional Extension: Cycles 2-6|Adverse Event|0|||
28087197|NCT00321464|54740673|FG001|Overall Study|Noncompliance|10|||
28087198|NCT00321464|54740672|FG000|Overall Study|Lost to Follow-up|7|||
28087199|NCT00321464|54740673|FG001|Overall Study|Lost to Follow-up|8|||
28087200|NCT00321464|54740672|FG000|Overall Study|Protocol deviation|0|||
28087201|NCT00321464|54740673|FG001|Overall Study|Protocol deviation|2|||
28087202|NCT00321464|54740672|FG000|Overall Study|Ineligibility determined|2|||
28087203|NCT00321464|54740673|FG001|Overall Study|Ineligibility determined|1|||
28087204|NCT00321464|54740672|FG000|Overall Study|Other|21|||
28087205|NCT00321464|54740673|FG001|Overall Study|Other|18|||
28087206|NCT02889796|54740683|FG000|Overall Study|Withdrew Consent|18|||
28087207|NCT02889796|54740684|FG001|Overall Study|Withdrew Consent|29|||
28087208|NCT02889796|54740685|FG002|Overall Study|Withdrew Consent|20|||
28087209|NCT02889796|54740686|FG003|Overall Study|Withdrew Consent|1|||
27978178|NCT00903968|54636254|FG000|Overall Study|Non-Compliance|0|||
27978179|NCT00903968|54636255|FG001|Overall Study|Non-Compliance|0|||
27978180|NCT00903968|54636256|FG002|Overall Study|Non-Compliance|0|||
27978181|NCT00903968|54636257|FG003|Overall Study|Non-Compliance|0|||
27978182|NCT00903968|54636258|FG004|Overall Study|Non-Compliance|0|||
27978183|NCT00903968|54636259|FG005|Overall Study|Non-Compliance|1|||
27978184|NCT00903968|54636260|FG006|Overall Study|Non-Compliance|0|||
27978185|NCT00903968|54636261|FG007|Overall Study|Non-Compliance|0|||
27978186|NCT00903968|54636254|FG000|Overall Study|Physician Decision|0|||
27978187|NCT00903968|54636255|FG001|Overall Study|Physician Decision|0|||
27978188|NCT00903968|54636256|FG002|Overall Study|Physician Decision|0|||
27978189|NCT00903968|54636257|FG003|Overall Study|Physician Decision|0|||
27978190|NCT00903968|54636258|FG004|Overall Study|Physician Decision|0|||
27978191|NCT00903968|54636259|FG005|Overall Study|Physician Decision|1|||
27978192|NCT00903968|54636260|FG006|Overall Study|Physician Decision|0|||
27978193|NCT00903968|54636261|FG007|Overall Study|Physician Decision|0|||
27978194|NCT00903968|54636254|FG000|Overall Study|Progressive Disease|2|||
27978195|NCT00903968|54636255|FG001|Overall Study|Progressive Disease|3|||
27978196|NCT00903968|54636256|FG002|Overall Study|Progressive Disease|2|||
27978197|NCT00903968|54636257|FG003|Overall Study|Progressive Disease|3|||
27978198|NCT00903968|54636258|FG004|Overall Study|Progressive Disease|3|||
27978199|NCT00903968|54636259|FG005|Overall Study|Progressive Disease|3|||
27978200|NCT00903968|54636260|FG006|Overall Study|Progressive Disease|0|||
27978201|NCT00903968|54636261|FG007|Overall Study|Progressive Disease|18|||
27978202|NCT00903968|54636254|FG000|Overall Study|Lack of Efficacy|0|||
27978203|NCT00903968|54636255|FG001|Overall Study|Lack of Efficacy|0|||
27978204|NCT00903968|54636256|FG002|Overall Study|Lack of Efficacy|0|||
27978205|NCT00903968|54636257|FG003|Overall Study|Lack of Efficacy|0|||
27978206|NCT00903968|54636258|FG004|Overall Study|Lack of Efficacy|0|||
27978207|NCT00903968|54636259|FG005|Overall Study|Lack of Efficacy|0|||
27978208|NCT00903968|54636260|FG006|Overall Study|Lack of Efficacy|0|||
27978209|NCT00903968|54636261|FG007|Overall Study|Lack of Efficacy|3|||
27978210|NCT00903344|54636284|FG000|Overall Study|Pregnancy|2|||
27978211|NCT00903344|54636285|FG001|Overall Study|Pregnancy|3|||
27978212|NCT00903344|54636284|FG000|Overall Study|Lost to Follow-up|3|||
27978213|NCT00903344|54636285|FG001|Overall Study|Lost to Follow-up|0|||
27978214|NCT00903032|54636293|FG000|Overall Study|Withdrawal by Subject|5|||
27978215|NCT00903032|54636294|FG001|Overall Study|Withdrawal by Subject|3|||
28087210|NCT02889796|54740687|FG004|Overall Study|Withdrew Consent|2|||
28087211|NCT02889796|54740688|FG005|Overall Study|Withdrew Consent|35|||
27978216|NCT00903032|54636293|FG000|Overall Study|Lost to Follow-up|2|||
27978217|NCT00903032|54636294|FG001|Overall Study|Lost to Follow-up|2|||
27978218|NCT00902564|54636309|FG000|Overall Study|Withdrawal by Subject|2|||
27978219|NCT00626197|54636316|FG000|Overall Study|Did not cooperate|2|||
28087212|NCT02889796|54740683|FG000|Overall Study|Investigator's Discretion|10|||
28087213|NCT02889796|54740684|FG001|Overall Study|Investigator's Discretion|9|||
28087214|NCT02889796|54740685|FG002|Overall Study|Investigator's Discretion|10|||
28087215|NCT02889796|54740686|FG003|Overall Study|Investigator's Discretion|3|||
28087216|NCT02889796|54740687|FG004|Overall Study|Investigator's Discretion|0|||
28087217|NCT02889796|54740688|FG005|Overall Study|Investigator's Discretion|15|||
28087218|NCT02889796|54740683|FG000|Overall Study|Adverse Event|17|||
28087219|NCT02889796|54740684|FG001|Overall Study|Adverse Event|8|||
27855653|NCT02733042|54382053|FG015|Treatment Period|Withdrawal by Subject|0|||
27855654|NCT02733042|54382054|FG016|Treatment Period|Withdrawal by Subject|0|||
27978220|NCT00626197|54636317|FG001|Overall Study|Did not cooperate|6|||
27978221|NCT00626197|54636318|FG002|Overall Study|Did not cooperate|1|||
27978222|NCT00626197|54636316|FG000|Overall Study|Failure to return|6|||
27978223|NCT00626197|54636317|FG001|Overall Study|Failure to return|5|||
27978224|NCT00626197|54636318|FG002|Overall Study|Failure to return|6|||
27978225|NCT00626197|54636316|FG000|Overall Study|Adverse event, serious fatal|3|||
27978226|NCT00626197|54636317|FG001|Overall Study|Adverse event, serious fatal|6|||
27978227|NCT00626197|54636318|FG002|Overall Study|Adverse event, serious fatal|6|||
27978228|NCT00626197|54636316|FG000|Overall Study|Adverse Event|1|||
27978229|NCT00626197|54636317|FG001|Overall Study|Adverse Event|1|||
28087220|NCT02889796|54740685|FG002|Overall Study|Adverse Event|8|||
27978230|NCT00626197|54636318|FG002|Overall Study|Adverse Event|2|||
27978231|NCT00626197|54636316|FG000|Overall Study|Withdrawal by Subject|17|||
27978232|NCT00626197|54636317|FG001|Overall Study|Withdrawal by Subject|17|||
27978233|NCT00626197|54636318|FG002|Overall Study|Withdrawal by Subject|7|||
27978234|NCT00626197|54636316|FG000|Overall Study|Administrative reasons|15|||
27978235|NCT00626197|54636317|FG001|Overall Study|Administrative reasons|19|||
27978236|NCT00626197|54636318|FG002|Overall Study|Administrative reasons|55|||
27978237|NCT00626275|54636332|FG000|Part A - Treatment Period 1|Adverse Event|1|||
28087221|NCT02889796|54740686|FG003|Overall Study|Adverse Event|4|||
27978238|NCT00626275|54636333|FG001|Part A - Treatment Period 1|Adverse Event|0|||
27978239|NCT00626275|54636334|FG002|Part A - Treatment Period 1|Adverse Event|0|||
27978240|NCT00626275|54636335|FG003|Part A - Treatment Period 1|Adverse Event|0|||
28087222|NCT02889796|54740687|FG004|Overall Study|Adverse Event|1|||
27978241|NCT00626275|54636336|FG004|Part A - Treatment Period 1|Adverse Event|0|||
27978242|NCT00626275|54636337|FG005|Part A - Treatment Period 1|Adverse Event|0|||
27978243|NCT00626275|54636338|FG006|Part A - Treatment Period 1|Adverse Event|0|||
27978244|NCT00626275|54636339|FG007|Part A - Treatment Period 1|Adverse Event|0|||
27978245|NCT00626275|54636332|FG000|Part A - Treatment Period 1|Withdrawal by Subject|0|||
27978246|NCT00626275|54636333|FG001|Part A - Treatment Period 1|Withdrawal by Subject|0|||
27978247|NCT00626275|54636334|FG002|Part A - Treatment Period 1|Withdrawal by Subject|1|||
27978248|NCT00626275|54636335|FG003|Part A - Treatment Period 1|Withdrawal by Subject|0|||
27978249|NCT00626275|54636336|FG004|Part A - Treatment Period 1|Withdrawal by Subject|0|||
27978250|NCT00626275|54636337|FG005|Part A - Treatment Period 1|Withdrawal by Subject|0|||
27978251|NCT00626275|54636338|FG006|Part A - Treatment Period 1|Withdrawal by Subject|0|||
27978252|NCT00626275|54636339|FG007|Part A - Treatment Period 1|Withdrawal by Subject|0|||
27978253|NCT00626275|54636332|FG000|Part B|Lost to Follow-up|0|||
27978254|NCT00626275|54636333|FG001|Part B|Lost to Follow-up|0|||
27978255|NCT00626275|54636334|FG002|Part B|Lost to Follow-up|0|||
27978256|NCT00626275|54636335|FG003|Part B|Lost to Follow-up|0|||
27978257|NCT00626275|54636336|FG004|Part B|Lost to Follow-up|0|||
27978258|NCT00626275|54636337|FG005|Part B|Lost to Follow-up|0|||
27978259|NCT00626275|54636338|FG006|Part B|Lost to Follow-up|1|||
27978260|NCT00626275|54636339|FG007|Part B|Lost to Follow-up|0|||
27978261|NCT00626275|54636332|FG000|Part B|Withdrawal by Subject|0|||
27978262|NCT00626275|54636333|FG001|Part B|Withdrawal by Subject|0|||
27978263|NCT00626275|54636334|FG002|Part B|Withdrawal by Subject|0|||
27978264|NCT00626275|54636335|FG003|Part B|Withdrawal by Subject|0|||
27978265|NCT00626275|54636336|FG004|Part B|Withdrawal by Subject|0|||
27978266|NCT00626275|54636337|FG005|Part B|Withdrawal by Subject|0|||
27978267|NCT00626275|54636338|FG006|Part B|Withdrawal by Subject|0|||
27978268|NCT00626275|54636339|FG007|Part B|Withdrawal by Subject|1|||
27978269|NCT00623935|54636353|FG000|Overall Study|Death|1|||
27978270|NCT00623935|54636353|FG000|Overall Study|Patient Declined Transplant|1|||
27978271|NCT00623779|54636360|FG000|Overall Study|Adverse Event|1|||
27978272|NCT00623779|54636361|FG001|Overall Study|Adverse Event|3|||
28087223|NCT02889796|54740688|FG005|Overall Study|Adverse Event|7|||
28087224|NCT02889796|54740683|FG000|Overall Study|Lost to Follow-up|5|||
28087225|NCT02889796|54740684|FG001|Overall Study|Lost to Follow-up|7|||
27978273|NCT00623779|54636362|FG002|Overall Study|Adverse Event|0|||
27978274|NCT00623779|54636360|FG000|Overall Study|Criteria from CSR|2|||
27978275|NCT00623779|54636361|FG001|Overall Study|Criteria from CSR|0|||
27978276|NCT00623779|54636362|FG002|Overall Study|Criteria from CSR|1|||
27978277|NCT00629707|54636393|FG000|Overall Study|Withdrawal by Subject|0|||
27978278|NCT00629707|54636394|FG001|Overall Study|Withdrawal by Subject|1|||
27978279|NCT00629707|54636393|FG000|Overall Study|Physician Decision|0|||
27978280|NCT00629707|54636394|FG001|Overall Study|Physician Decision|1|||
27978281|NCT00902330|54636402|FG000|Overall Study|Too overwhelmed by treatment|2|||
27978282|NCT00902330|54636403|FG001|Overall Study|Too overwhelmed by treatment|5|||
27978283|NCT00902330|54636402|FG000|Overall Study|Adverse Event|1|||
27978284|NCT00902330|54636403|FG001|Overall Study|Adverse Event|0|||
27978285|NCT00902330|54636402|FG000|Overall Study|No post baseline data|1|||
27978286|NCT00902330|54636403|FG001|Overall Study|No post baseline data|0|||
27978287|NCT00901394|54636440|FG000|Overall Study|Physician Decision|1|||
27978288|NCT00901394|54636441|FG001|Overall Study|Physician Decision|1|||
27978289|NCT00901394|54636442|FG002|Overall Study|Physician Decision|2|||
27978290|NCT00896532|54636458|FG000|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
27978291|NCT00896532|54636459|FG001|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
27978292|NCT00896532|54636460|FG002|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
27978293|NCT00896532|54636461|FG003|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
27978294|NCT00896532|54636462|FG004|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
28087226|NCT02889796|54740685|FG002|Overall Study|Lost to Follow-up|2|||
28087227|NCT02889796|54740686|FG003|Overall Study|Lost to Follow-up|0|||
28087228|NCT02889796|54740687|FG004|Overall Study|Lost to Follow-up|2|||
28087229|NCT02889796|54740688|FG005|Overall Study|Lost to Follow-up|6|||
28087230|NCT02889796|54740683|FG000|Overall Study|Protocol Violation|0|||
28087231|NCT02889796|54740684|FG001|Overall Study|Protocol Violation|1|||
27978295|NCT00896532|54636463|FG005|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
27978296|NCT00896532|54636464|FG006|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
27978297|NCT00896532|54636465|FG007|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
27978298|NCT00896532|54636466|FG008|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
27978299|NCT00896532|54636467|FG009|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
27978300|NCT00896532|54636468|FG010|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
27978301|NCT00896532|54636469|FG011|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
27978302|NCT00896532|54636470|FG012|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
27978303|NCT00896532|54636471|FG013|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
27978304|NCT00896532|54636472|FG014|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
28087232|NCT02889796|54740685|FG002|Overall Study|Protocol Violation|3|||
28087233|NCT02889796|54740686|FG003|Overall Study|Protocol Violation|0|||
28087234|NCT02889796|54740687|FG004|Overall Study|Protocol Violation|0|||
27978305|NCT00896532|54636473|FG015|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
27978306|NCT00896532|54636474|FG016|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
27978307|NCT00896532|54636475|FG017|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
27978308|NCT00896532|54636476|FG018|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
27978309|NCT00896532|54636477|FG019|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
27978310|NCT00896532|54636478|FG020|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
27978311|NCT00896532|54636479|FG021|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
27978312|NCT00896532|54636480|FG022|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
27978313|NCT00896532|54636458|FG000|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
27978314|NCT00896532|54636459|FG001|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
28087235|NCT02889796|54740688|FG005|Overall Study|Protocol Violation|4|||
28087236|NCT02889796|54740683|FG000|Overall Study|Non-compliance With Study Drug|0|||
28087237|NCT02889796|54740684|FG001|Overall Study|Non-compliance With Study Drug|2|||
28087238|NCT02889796|54740685|FG002|Overall Study|Non-compliance With Study Drug|0|||
28087239|NCT02889796|54740686|FG003|Overall Study|Non-compliance With Study Drug|0|||
28087240|NCT02889796|54740687|FG004|Overall Study|Non-compliance With Study Drug|1|||
28087241|NCT02889796|54740688|FG005|Overall Study|Non-compliance With Study Drug|2|||
28087242|NCT02889796|54740683|FG000|Overall Study|Death|1|||
28087243|NCT02889796|54740684|FG001|Overall Study|Death|1|||
28087244|NCT02889796|54740685|FG002|Overall Study|Death|0|||
28087245|NCT02889796|54740686|FG003|Overall Study|Death|1|||
28087246|NCT02889796|54740687|FG004|Overall Study|Death|0|||
28087247|NCT02889796|54740688|FG005|Overall Study|Death|1|||
28087248|NCT02889796|54740683|FG000|Overall Study|Pregnancy|0|||
28087249|NCT02889796|54740684|FG001|Overall Study|Pregnancy|1|||
28087250|NCT02889796|54740685|FG002|Overall Study|Pregnancy|1|||
28087251|NCT02889796|54740686|FG003|Overall Study|Pregnancy|0|||
28087252|NCT02889796|54740687|FG004|Overall Study|Pregnancy|0|||
28087253|NCT02889796|54740688|FG005|Overall Study|Pregnancy|0|||
28087254|NCT02889796|54740683|FG000|Overall Study|Randomized but not Dosed|2|||
28087255|NCT02889796|54740684|FG001|Overall Study|Randomized but not Dosed|0|||
28087256|NCT02889796|54740685|FG002|Overall Study|Randomized but not Dosed|0|||
28087257|NCT02889796|54740686|FG003|Overall Study|Randomized but not Dosed|0|||
28087258|NCT02889796|54740687|FG004|Overall Study|Randomized but not Dosed|0|||
28087259|NCT02889796|54740688|FG005|Overall Study|Randomized but not Dosed|2|||
27978315|NCT00896532|54636460|FG002|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
27978316|NCT00896532|54636461|FG003|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
27978317|NCT00896532|54636462|FG004|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
27978318|NCT00896532|54636463|FG005|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
27978319|NCT00896532|54636464|FG006|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
27978320|NCT00896532|54636465|FG007|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
27978321|NCT00896532|54636466|FG008|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
27978322|NCT00896532|54636467|FG009|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
27978323|NCT00896532|54636468|FG010|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
27978324|NCT00896532|54636469|FG011|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
27978325|NCT00896532|54636470|FG012|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
27978326|NCT00896532|54636471|FG013|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
27978327|NCT00896532|54636472|FG014|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
27978328|NCT00896532|54636473|FG015|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
27978329|NCT00896532|54636474|FG016|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
27978330|NCT00896532|54636475|FG017|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
27978331|NCT00896532|54636476|FG018|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
27978332|NCT00896532|54636477|FG019|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
27978333|NCT00896532|54636478|FG020|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
27978334|NCT00896532|54636479|FG021|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
27978335|NCT00896532|54636480|FG022|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
27978336|NCT00896532|54636458|FG000|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
27978337|NCT00896532|54636459|FG001|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3|||
27978338|NCT00896532|54636460|FG002|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
27978339|NCT00896532|54636461|FG003|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
27978340|NCT00896532|54636462|FG004|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5|||
27978341|NCT00896532|54636463|FG005|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
28087260|NCT02889562|54740713|FG000|Overall Study|Physician Decision|0|||
28087261|NCT02889562|54740714|FG001|Overall Study|Physician Decision|1|||
28087262|NCT02889562|54740713|FG000|Overall Study|Withdrawal by Subject|0|||
28087263|NCT02889562|54740714|FG001|Overall Study|Withdrawal by Subject|1|||
28087264|NCT03323164|54740722|FG000|Overall Study|Poor quality imaging/scans|2|||
28087265|NCT03323164|54740723|FG001|Overall Study|Poor quality imaging/scans|2|||
28087266|NCT03323086|54740735|FG000|Overall Study|Lost to Follow-up|3|||
28087267|NCT03323086|54740736|FG001|Overall Study|Lost to Follow-up|2|||
27978342|NCT00896532|54636464|FG006|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
27978343|NCT00896532|54636465|FG007|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
27978344|NCT00896532|54636466|FG008|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
27978345|NCT00896532|54636467|FG009|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
27978346|NCT00896532|54636468|FG010|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
27978347|NCT00896532|54636469|FG011|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
27978348|NCT00896532|54636470|FG012|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
27978349|NCT00896532|54636471|FG013|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
27978350|NCT00896532|54636472|FG014|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
27978351|NCT00896532|54636473|FG015|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
27978352|NCT00896532|54636474|FG016|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
27978353|NCT00896532|54636475|FG017|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
27978354|NCT00896532|54636476|FG018|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
27978355|NCT00896532|54636477|FG019|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
27978356|NCT00896532|54636478|FG020|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
27978357|NCT00896532|54636479|FG021|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
27978358|NCT00896532|54636480|FG022|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
27978359|NCT00896532|54636458|FG000|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
27978360|NCT00896532|54636459|FG001|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
27978361|NCT00896532|54636460|FG002|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2|||
27978362|NCT00896532|54636461|FG003|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
27978363|NCT00896532|54636462|FG004|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1|||
27978364|NCT00896532|54636463|FG005|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
27978365|NCT00896532|54636464|FG006|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
27978366|NCT00896532|54636465|FG007|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
27978367|NCT00896532|54636466|FG008|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
27978368|NCT00896532|54636467|FG009|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
27978369|NCT00896532|54636468|FG010|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
27978370|NCT00896532|54636469|FG011|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
27978371|NCT00896532|54636470|FG012|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
27978372|NCT00896532|54636471|FG013|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
28087268|NCT02888080|54740744|FG000|Overall Study|Subject / Guardian decision|1|||
28087269|NCT02888080|54740745|FG001|Overall Study|Subject / Guardian decision|3|||
28087270|NCT02888080|54740744|FG000|Overall Study|New Therapy for study indication|1|||
28087271|NCT02888080|54740745|FG001|Overall Study|New Therapy for study indication|0|||
28087272|NCT02888080|54740744|FG000|Overall Study|Lack of Efficacy|0|||
28087273|NCT02888080|54740745|FG001|Overall Study|Lack of Efficacy|1|||
28087274|NCT02888080|54740744|FG000|Overall Study|Adverse Event|0|||
28087275|NCT02888080|54740745|FG001|Overall Study|Adverse Event|1|||
28087276|NCT03322462|54740751|FG000|Overall Study|Technical difficulties|2|||
28087277|NCT03322462|54740751|FG000|Overall Study|Other|1|||
28087278|NCT00086580|54740759|FG000|Treatment Period|Disease progression|9|||
28087279|NCT00086580|54740760|FG001|Treatment Period|Disease progression|8|||
27733259|NCT03335371|54181060|FG002|Overall Study|Withdrawal by Subject|0|||
27733260|NCT03335371|54181061|FG003|Overall Study|Withdrawal by Subject|0|||
27733261|NCT03335371|54181062|FG004|Overall Study|Withdrawal by Subject|1|||
28087280|NCT00086580|54740759|FG000|Treatment Period|Unable to comply with protocol|3|||
28087281|NCT00086580|54740760|FG001|Treatment Period|Unable to comply with protocol|1|||
28087282|NCT00086580|54740759|FG000|Treatment Period|Withdrawal by Subject|7|||
28087283|NCT00086580|54740760|FG001|Treatment Period|Withdrawal by Subject|8|||
28087284|NCT00086580|54740759|FG000|Treatment Period|Physician Decision|13|||
28087285|NCT00086580|54740760|FG001|Treatment Period|Physician Decision|7|||
28087286|NCT00086580|54740759|FG000|Treatment Period|AE - not treatment related|7|||
28087287|NCT00086580|54740760|FG001|Treatment Period|AE - not treatment related|7|||
28087288|NCT00086580|54740759|FG000|Treatment Period|Toxicity - treatment related|15|||
28087289|NCT00086580|54740760|FG001|Treatment Period|Toxicity - treatment related|15|||
28087290|NCT00086580|54740759|FG000|Treatment Period|Anemia or thrombocytopenia|1|||
27733262|NCT03335371|54181058|FG000|Overall Study|Randomization Error|0|||
27733263|NCT03335371|54181059|FG001|Overall Study|Randomization Error|0|||
27978373|NCT00896532|54636472|FG014|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
27978374|NCT00896532|54636473|FG015|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
28087291|NCT00086580|54740760|FG001|Treatment Period|Anemia or thrombocytopenia|4|||
28087292|NCT00086580|54740759|FG000|Treatment Period|Death|5|||
28087293|NCT00086580|54740760|FG001|Treatment Period|Death|7|||
28087294|NCT00086580|54740759|FG000|Treatment Period|Other|5|||
28087295|NCT00086580|54740760|FG001|Treatment Period|Other|3|||
28087296|NCT00086580|54740759|FG000|Follow-up Period|Disease progression|72|||
28087297|NCT00086580|54740760|FG001|Follow-up Period|Disease progression|99|||
27978375|NCT00896532|54636474|FG016|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
27978376|NCT00896532|54636475|FG017|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
27978377|NCT00896532|54636476|FG018|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
27978378|NCT00896532|54636477|FG019|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
27978379|NCT00896532|54636478|FG020|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
27978380|NCT00896532|54636479|FG021|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
27978381|NCT00896532|54636480|FG022|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
27978382|NCT00896532|54636458|FG000|Months 1-24: Romosozumab Treatment Phase|Death|1|||
27978383|NCT00896532|54636459|FG001|Months 1-24: Romosozumab Treatment Phase|Death|0|||
27978384|NCT00896532|54636460|FG002|Months 1-24: Romosozumab Treatment Phase|Death|0|||
27978385|NCT00896532|54636461|FG003|Months 1-24: Romosozumab Treatment Phase|Death|1|||
27978386|NCT00896532|54636462|FG004|Months 1-24: Romosozumab Treatment Phase|Death|0|||
27978387|NCT00896532|54636463|FG005|Months 1-24: Romosozumab Treatment Phase|Death|0|||
27978388|NCT00896532|54636464|FG006|Months 1-24: Romosozumab Treatment Phase|Death|0|||
27978389|NCT00896532|54636465|FG007|Months 1-24: Romosozumab Treatment Phase|Death|0|||
27978390|NCT00896532|54636466|FG008|Months 1-24: Romosozumab Treatment Phase|Death|0|||
27978391|NCT00896532|54636467|FG009|Months 1-24: Romosozumab Treatment Phase|Death|0|||
27978392|NCT00896532|54636468|FG010|Months 1-24: Romosozumab Treatment Phase|Death|0|||
27978393|NCT00896532|54636469|FG011|Months 1-24: Romosozumab Treatment Phase|Death|0|||
27978394|NCT00896532|54636470|FG012|Months 1-24: Romosozumab Treatment Phase|Death|0|||
27978395|NCT00896532|54636471|FG013|Months 1-24: Romosozumab Treatment Phase|Death|0|||
27978396|NCT00896532|54636472|FG014|Months 1-24: Romosozumab Treatment Phase|Death|0|||
27978397|NCT00896532|54636473|FG015|Months 1-24: Romosozumab Treatment Phase|Death|0|||
27978398|NCT00896532|54636474|FG016|Months 1-24: Romosozumab Treatment Phase|Death|0|||
27978399|NCT00896532|54636475|FG017|Months 1-24: Romosozumab Treatment Phase|Death|0|||
27978400|NCT00896532|54636476|FG018|Months 1-24: Romosozumab Treatment Phase|Death|0|||
27978401|NCT00896532|54636477|FG019|Months 1-24: Romosozumab Treatment Phase|Death|0|||
27978402|NCT00896532|54636478|FG020|Months 1-24: Romosozumab Treatment Phase|Death|0|||
27978403|NCT00896532|54636479|FG021|Months 1-24: Romosozumab Treatment Phase|Death|0|||
27978404|NCT00896532|54636480|FG022|Months 1-24: Romosozumab Treatment Phase|Death|0|||
27978405|NCT00896532|54636458|FG000|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
27978406|NCT00896532|54636459|FG001|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
27978407|NCT00896532|54636460|FG002|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1|||
27978408|NCT00896532|54636461|FG003|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
27978409|NCT00896532|54636462|FG004|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
27978410|NCT00896532|54636463|FG005|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
27978411|NCT00896532|54636464|FG006|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
27978412|NCT00896532|54636465|FG007|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
27978413|NCT00896532|54636466|FG008|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
27978414|NCT00896532|54636467|FG009|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
27978415|NCT00896532|54636468|FG010|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
27978416|NCT00896532|54636469|FG011|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
27978417|NCT00896532|54636470|FG012|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
27978418|NCT00896532|54636471|FG013|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
27978419|NCT00896532|54636472|FG014|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
27978420|NCT00896532|54636473|FG015|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
27978421|NCT00896532|54636474|FG016|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
27978422|NCT00896532|54636475|FG017|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
27978423|NCT00896532|54636476|FG018|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
27978424|NCT00896532|54636477|FG019|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
27978425|NCT00896532|54636478|FG020|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
27978426|NCT00896532|54636479|FG021|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
27978427|NCT00896532|54636480|FG022|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
27978428|NCT00896532|54636458|FG000|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
27978429|NCT00896532|54636459|FG001|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
27978430|NCT00896532|54636460|FG002|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1|||
27978431|NCT00896532|54636461|FG003|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
27978432|NCT00896532|54636462|FG004|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
27978433|NCT00896532|54636463|FG005|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
27978434|NCT00896532|54636464|FG006|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
27978435|NCT00896532|54636465|FG007|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
27978436|NCT00896532|54636466|FG008|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
27832750|NCT01729871|54312491|FG001|Overall Study|Protocol Violation|0|||
27978437|NCT00896532|54636467|FG009|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
27978438|NCT00896532|54636468|FG010|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
27978439|NCT00896532|54636469|FG011|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
27978440|NCT00896532|54636470|FG012|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
27978441|NCT00896532|54636471|FG013|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
27832751|NCT01729871|54312490|FG000|Overall Study|Withdrawal by Subject|0|||
27832752|NCT01729871|54312491|FG001|Overall Study|Withdrawal by Subject|3|||
27832753|NCT01729871|54312490|FG000|Overall Study|Other|4|||
27832754|NCT01729871|54312491|FG001|Overall Study|Other|9|||
27832755|NCT01729559|54312499|FG000|Overall Study|Protocol Violation|31|||
27832756|NCT01729559|54312500|FG001|Overall Study|Protocol Violation|28|||
27832757|NCT01728779|54312519|FG000|Overall Study|Withdrawal by Subject|1|||
27832758|NCT01728623|54312530|FG000|Overall Study|Disease progression|26|||
27832759|NCT01728623|54312530|FG000|Overall Study|Adverse Event|1|||
27832760|NCT01728623|54312530|FG000|Overall Study|Withdrawal by Subject|1|||
27832761|NCT01754129|54312537|FG000|Overall Study|Death|13|||
27832762|NCT01754129|54312537|FG000|Overall Study|Duodopa discontinuation|9|||
27978442|NCT00896532|54636472|FG014|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
27978443|NCT00896532|54636473|FG015|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
27978444|NCT00896532|54636474|FG016|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
27978445|NCT00896532|54636475|FG017|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
27978446|NCT00896532|54636476|FG018|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
27978447|NCT00896532|54636477|FG019|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
27978448|NCT00896532|54636478|FG020|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
27978449|NCT00896532|54636479|FG021|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
27978450|NCT00896532|54636480|FG022|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
27978451|NCT00896532|54636458|FG000|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
27978452|NCT00896532|54636459|FG001|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
27978453|NCT00896532|54636460|FG002|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
27978454|NCT00896532|54636461|FG003|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1|||
27978455|NCT00896532|54636462|FG004|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
27978456|NCT00896532|54636463|FG005|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
27978457|NCT00896532|54636464|FG006|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
27978458|NCT00896532|54636465|FG007|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
27978459|NCT00896532|54636466|FG008|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
27978460|NCT00896532|54636467|FG009|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
27978461|NCT00896532|54636468|FG010|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
27978462|NCT00896532|54636469|FG011|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
27978463|NCT00896532|54636470|FG012|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
27978464|NCT00896532|54636471|FG013|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
27978465|NCT00896532|54636472|FG014|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
27978466|NCT00896532|54636473|FG015|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
27978467|NCT00896532|54636474|FG016|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
27978468|NCT00896532|54636475|FG017|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
27978469|NCT00896532|54636476|FG018|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
27978470|NCT00896532|54636477|FG019|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
27978471|NCT00896532|54636478|FG020|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
27978472|NCT00896532|54636479|FG021|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
27978473|NCT00896532|54636480|FG022|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
27978474|NCT00896532|54636458|FG000|Months 1-24: Romosozumab Treatment Phase|Other|0|||
27978475|NCT00896532|54636459|FG001|Months 1-24: Romosozumab Treatment Phase|Other|1|||
27978476|NCT00896532|54636460|FG002|Months 1-24: Romosozumab Treatment Phase|Other|0|||
27978477|NCT00896532|54636461|FG003|Months 1-24: Romosozumab Treatment Phase|Other|1|||
27978478|NCT00896532|54636462|FG004|Months 1-24: Romosozumab Treatment Phase|Other|1|||
27978479|NCT00896532|54636463|FG005|Months 1-24: Romosozumab Treatment Phase|Other|0|||
27978480|NCT00896532|54636464|FG006|Months 1-24: Romosozumab Treatment Phase|Other|0|||
27978481|NCT00896532|54636465|FG007|Months 1-24: Romosozumab Treatment Phase|Other|0|||
27978482|NCT00896532|54636466|FG008|Months 1-24: Romosozumab Treatment Phase|Other|0|||
27978483|NCT00896532|54636467|FG009|Months 1-24: Romosozumab Treatment Phase|Other|0|||
27978484|NCT00896532|54636468|FG010|Months 1-24: Romosozumab Treatment Phase|Other|0|||
27978485|NCT00896532|54636469|FG011|Months 1-24: Romosozumab Treatment Phase|Other|0|||
27978486|NCT00896532|54636470|FG012|Months 1-24: Romosozumab Treatment Phase|Other|0|||
27978487|NCT00896532|54636471|FG013|Months 1-24: Romosozumab Treatment Phase|Other|0|||
27978488|NCT00896532|54636472|FG014|Months 1-24: Romosozumab Treatment Phase|Other|0|||
27978489|NCT00896532|54636473|FG015|Months 1-24: Romosozumab Treatment Phase|Other|0|||
27978490|NCT00896532|54636474|FG016|Months 1-24: Romosozumab Treatment Phase|Other|0|||
27832763|NCT01754129|54312537|FG000|Overall Study|Lost to Follow-up|7|||
27832764|NCT01754129|54312537|FG000|Overall Study|Withdrew consent|1|||
27978491|NCT00896532|54636475|FG017|Months 1-24: Romosozumab Treatment Phase|Other|0|||
27978492|NCT00896532|54636476|FG018|Months 1-24: Romosozumab Treatment Phase|Other|0|||
27978493|NCT00896532|54636477|FG019|Months 1-24: Romosozumab Treatment Phase|Other|0|||
27978494|NCT00896532|54636478|FG020|Months 1-24: Romosozumab Treatment Phase|Other|0|||
27978495|NCT00896532|54636479|FG021|Months 1-24: Romosozumab Treatment Phase|Other|0|||
27978496|NCT00896532|54636480|FG022|Months 1-24: Romosozumab Treatment Phase|Other|0|||
27978497|NCT00896532|54636458|FG000|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
27978498|NCT00896532|54636459|FG001|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
27978499|NCT00896532|54636460|FG002|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
27978500|NCT00896532|54636461|FG003|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
27978501|NCT00896532|54636462|FG004|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
27978502|NCT00896532|54636463|FG005|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
27978503|NCT00896532|54636464|FG006|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
27978504|NCT00896532|54636465|FG007|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
27978505|NCT00896532|54636466|FG008|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1|||
27978506|NCT00896532|54636467|FG009|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
27978507|NCT00896532|54636468|FG010|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
27978508|NCT00896532|54636469|FG011|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
27978509|NCT00896532|54636470|FG012|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
27978510|NCT00896532|54636471|FG013|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
27978511|NCT00896532|54636472|FG014|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
28087298|NCT00086580|54740759|FG000|Follow-up Period|Unable to comply with protocol|5|||
28087299|NCT00086580|54740760|FG001|Follow-up Period|Unable to comply with protocol|0|||
28087300|NCT00086580|54740759|FG000|Follow-up Period|Withdrawal by Subject|6|||
28087301|NCT00086580|54740760|FG001|Follow-up Period|Withdrawal by Subject|6|||
28087302|NCT00086580|54740759|FG000|Follow-up Period|Physician Decision|0|||
28087303|NCT00086580|54740760|FG001|Follow-up Period|Physician Decision|1|||
28087304|NCT00086580|54740759|FG000|Follow-up Period|AE - not related|1|||
28087305|NCT00086580|54740760|FG001|Follow-up Period|AE - not related|0|||
28087306|NCT00086580|54740759|FG000|Follow-up Period|Death|13|||
28087307|NCT00086580|54740760|FG001|Follow-up Period|Death|7|||
28087308|NCT00086580|54740759|FG000|Follow-up Period|Other|7|||
28087309|NCT00086580|54740760|FG001|Follow-up Period|Other|6|||
28087310|NCT00086580|54740759|FG000|Observation Period|Unable to comply with protocol|1|||
28087311|NCT00086580|54740760|FG001|Observation Period|Unable to comply with protocol|1|||
28087312|NCT00086580|54740759|FG000|Observation Period|Withdrawal by Subject|4|||
28087313|NCT00086580|54740760|FG001|Observation Period|Withdrawal by Subject|2|||
28087314|NCT00086580|54740759|FG000|Observation Period|Death|33|||
28087315|NCT00086580|54740760|FG001|Observation Period|Death|55|||
28087316|NCT00086580|54740759|FG000|Observation Period|Other|8|||
28087317|NCT00086580|54740760|FG001|Observation Period|Other|7|||
28087318|NCT00086502|54740768|FG000|Overall Study|Adverse Event|11|||
28087319|NCT00086502|54740769|FG001|Overall Study|Adverse Event|2|||
28087320|NCT00086502|54740768|FG000|Overall Study|Lack of Efficacy|0|||
28087321|NCT00086502|54740769|FG001|Overall Study|Lack of Efficacy|2|||
28087322|NCT00086502|54740768|FG000|Overall Study|Lost to Follow-up|3|||
28087323|NCT00086502|54740769|FG001|Overall Study|Lost to Follow-up|1|||
28087324|NCT00086502|54740768|FG000|Overall Study|Physician Decision|1|||
28087325|NCT00086502|54740769|FG001|Overall Study|Physician Decision|1|||
28087326|NCT00086502|54740768|FG000|Overall Study|Pregnancy|0|||
28087327|NCT00086502|54740769|FG001|Overall Study|Pregnancy|1|||
28087328|NCT00086502|54740768|FG000|Overall Study|Protocol Violation|3|||
28087329|NCT00086502|54740769|FG001|Overall Study|Protocol Violation|3|||
28087330|NCT00086502|54740768|FG000|Overall Study|Withdrawal by Subject|5|||
28087331|NCT00086502|54740769|FG001|Overall Study|Withdrawal by Subject|6|||
28087332|NCT00086502|54740768|FG000|Overall Study|Patient Moved|1|||
28087333|NCT00086502|54740769|FG001|Overall Study|Patient Moved|1|||
28087334|NCT00086502|54740768|FG000|Overall Study|Protocol Discontinuation Criteria|1|||
28087335|NCT00086502|54740769|FG001|Overall Study|Protocol Discontinuation Criteria|3|||
28087336|NCT00086502|54740768|FG000|Overall Study|Patient Accidentally Unblinded|1|||
28087337|NCT00086502|54740769|FG001|Overall Study|Patient Accidentally Unblinded|0|||
28087338|NCT03826667|54740775|FG000|Overall Study|Protocol deviation|21|||
28087339|NCT03636542|54740787|FG000|Overall Study|Lost to Follow-up|1|||
28087340|NCT03636542|54740788|FG001|Overall Study|Lost to Follow-up|1|||
27978512|NCT00896532|54636473|FG015|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
27978513|NCT00896532|54636474|FG016|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
28087341|NCT03636542|54740787|FG000|Overall Study|Physician Decision|0|||
28087342|NCT03636542|54740788|FG001|Overall Study|Physician Decision|1|||
27832765|NCT01754129|54312537|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
28087343|NCT03636542|54740787|FG000|Overall Study|Withdrawal by Subject|1|||
28087344|NCT03636542|54740788|FG001|Overall Study|Withdrawal by Subject|0|||
28087345|NCT03305770|54740796|FG000|Overall Study|Physician Decision - prior to dispense|0|||
28087346|NCT03305770|54740797|FG001|Overall Study|Physician Decision - prior to dispense|1|||
28087347|NCT03305770|54740796|FG000|Overall Study|Subject moved|1|||
28087348|NCT03305770|54740797|FG001|Overall Study|Subject moved|0|||
28087349|NCT00086190|54740808|FG000|Overall Study|Adverse Event|6|||
28087350|NCT00086190|54740809|FG001|Overall Study|Adverse Event|2|||
27733264|NCT03335371|54181060|FG002|Overall Study|Randomization Error|1|||
27733265|NCT03335371|54181061|FG003|Overall Study|Randomization Error|0|||
27733266|NCT03335371|54181062|FG004|Overall Study|Randomization Error|0|||
27733267|NCT01662986|54181090|FG000|Overall Study|Adverse Event|5|||
27733268|NCT01662986|54181091|FG001|Overall Study|Adverse Event|4|||
27733269|NCT01662986|54181090|FG000|Overall Study|Protocol Violation|2|||
27733270|NCT01662986|54181091|FG001|Overall Study|Protocol Violation|3|||
27733271|NCT01662986|54181090|FG000|Overall Study|Lost to Follow-up|5|||
27733272|NCT01662986|54181091|FG001|Overall Study|Lost to Follow-up|4|||
27733273|NCT01662986|54181090|FG000|Overall Study|Withdrawal by Subject|2|||
27733274|NCT01662986|54181091|FG001|Overall Study|Withdrawal by Subject|2|||
27733275|NCT01662986|54181090|FG000|Overall Study|Not Treated|1|||
27733276|NCT01662986|54181091|FG001|Overall Study|Not Treated|0|||
27733277|NCT01662986|54181090|FG000|Overall Study|Other than stated above|3|||
27733278|NCT01662986|54181091|FG001|Overall Study|Other than stated above|0|||
27733279|NCT01337167|54181099|FG000|Infant Series|Adverse Event|1|||
27733280|NCT01337167|54181100|FG001|Infant Series|Adverse Event|1|||
27733281|NCT01337167|54181099|FG000|Infant Series|Death|1|||
27733282|NCT01337167|54181100|FG001|Infant Series|Death|1|||
27733283|NCT01337167|54181099|FG000|Infant Series|Lost to Follow-up|13|||
27733284|NCT01337167|54181100|FG001|Infant Series|Lost to Follow-up|7|||
27733285|NCT01337167|54181099|FG000|Infant Series|Non-compliance with study drug|2|||
27733286|NCT01337167|54181100|FG001|Infant Series|Non-compliance with study drug|1|||
27733287|NCT01337167|54181099|FG000|Infant Series|Physician Decision|3|||
27733288|NCT01337167|54181100|FG001|Infant Series|Physician Decision|1|||
27733289|NCT01337167|54181099|FG000|Infant Series|Protocol Violation|22|||
27733290|NCT01337167|54181100|FG001|Infant Series|Protocol Violation|9|||
27733291|NCT01337167|54181099|FG000|Infant Series|Withdrawal by Subject|15|||
27733292|NCT01337167|54181100|FG001|Infant Series|Withdrawal by Subject|4|||
27733293|NCT01337167|54181099|FG000|Infant Series|Randomized but not vaccinated|5|||
27733294|NCT01337167|54181100|FG001|Infant Series|Randomized but not vaccinated|3|||
27733295|NCT01337167|54181099|FG000|Interim Period|Lost to Follow-up|51|||
27733296|NCT01337167|54181100|FG001|Interim Period|Lost to Follow-up|23|||
27733297|NCT01337167|54181099|FG000|Interim Period|Non-compliance with study drug|1|||
27733298|NCT01337167|54181100|FG001|Interim Period|Non-compliance with study drug|0|||
27733299|NCT01337167|54181099|FG000|Interim Period|Physician Decision|6|||
27733300|NCT01337167|54181100|FG001|Interim Period|Physician Decision|3|||
27733301|NCT01337167|54181099|FG000|Interim Period|Protocol Violation|5|||
27733302|NCT01337167|54181100|FG001|Interim Period|Protocol Violation|3|||
27733303|NCT01337167|54181099|FG000|Interim Period|Withdrawal by Subject|18|||
27733304|NCT01337167|54181100|FG001|Interim Period|Withdrawal by Subject|10|||
27733305|NCT01337167|54181099|FG000|Interim Period|Other protocol criterion not met|0|||
27733306|NCT01337167|54181100|FG001|Interim Period|Other protocol criterion not met|1|||
27733307|NCT01337167|54181099|FG000|Toddler Vaccinations|Lost to Follow-up|11|||
27733308|NCT01337167|54181100|FG001|Toddler Vaccinations|Lost to Follow-up|12|||
27733309|NCT01337167|54181099|FG000|Toddler Vaccinations|Protocol Violation|0|||
27733310|NCT01337167|54181100|FG001|Toddler Vaccinations|Protocol Violation|1|||
27733311|NCT01337167|54181099|FG000|Toddler Vaccinations|Withdrawal by Subject|3|||
27733312|NCT01337167|54181100|FG001|Toddler Vaccinations|Withdrawal by Subject|0|||
27733313|NCT01338025|54181108|FG000|Overall Study|Unexpected closure of study|10|||
27733314|NCT01338025|54181109|FG001|Overall Study|Unexpected closure of study|9|||
27733315|NCT01338025|54181108|FG000|Overall Study|Withdrawal by Subject|0|||
27733316|NCT01338025|54181109|FG001|Overall Study|Withdrawal by Subject|2|||
27733317|NCT01338025|54181108|FG000|Overall Study|Found ineligible after starting|1|||
27733318|NCT01338025|54181109|FG001|Overall Study|Found ineligible after starting|0|||
27733319|NCT02559206|54181153|FG000|Overall Study|Adverse Event|0|||
27733320|NCT02559206|54181154|FG001|Overall Study|Adverse Event|4|||
27733321|NCT02559206|54181155|FG002|Overall Study|Adverse Event|1|||
27733322|NCT02559206|54181156|FG003|Overall Study|Adverse Event|5|||
27733323|NCT02559206|54181157|FG004|Overall Study|Adverse Event|3|||
27733324|NCT02559206|54181158|FG005|Overall Study|Adverse Event|0|||
27733325|NCT02559206|54181159|FG006|Overall Study|Adverse Event|1|||
27733326|NCT02559206|54181160|FG007|Overall Study|Adverse Event|0|||
27832766|NCT01728077|54312550|FG000|Overall Study|Lack of Efficacy|3|||
27832767|NCT01728077|54312551|FG001|Overall Study|Lack of Efficacy|1|||
27733327|NCT02559206|54181153|FG000|Overall Study|Protocol Violation|1|||
27733328|NCT02559206|54181154|FG001|Overall Study|Protocol Violation|0|||
27733329|NCT02559206|54181155|FG002|Overall Study|Protocol Violation|1|||
27733330|NCT02559206|54181156|FG003|Overall Study|Protocol Violation|0|||
27733331|NCT02559206|54181157|FG004|Overall Study|Protocol Violation|0|||
27733332|NCT02559206|54181158|FG005|Overall Study|Protocol Violation|2|||
27733333|NCT02559206|54181159|FG006|Overall Study|Protocol Violation|0|||
27733334|NCT02559206|54181160|FG007|Overall Study|Protocol Violation|0|||
27733335|NCT02559206|54181153|FG000|Overall Study|Withdrawal by Subject|3|||
28087351|NCT00086190|54740810|FG002|Overall Study|Adverse Event|2|||
28087352|NCT00086190|54740808|FG000|Overall Study|Withdrawal by Subject|0|||
28087353|NCT00086190|54740809|FG001|Overall Study|Withdrawal by Subject|2|||
28165613|NCT02519842|54836219|FG001|Optional Extension: Cycles 2-6|Adverse Event|0|||
28165614|NCT02519842|54836220|FG002|Optional Extension: Cycles 2-6|Adverse Event|1|||
28165615|NCT02519842|54836218|FG000|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
28165616|NCT02519842|54836219|FG001|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
28165617|NCT02519842|54836220|FG002|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3|||
28165618|NCT02519842|54836218|FG000|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
28165619|NCT02519842|54836219|FG001|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
28165620|NCT02519842|54836220|FG002|Optional Extension: Cycles 2-6|Withdrawal by Subject|1|||
28165621|NCT02519842|54836218|FG000|Optional Extension: Cycles 2-6|Death|0|||
28165622|NCT02519842|54836219|FG001|Optional Extension: Cycles 2-6|Death|0|||
27978514|NCT00896532|54636475|FG017|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
27978515|NCT00896532|54636476|FG018|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
27978516|NCT00896532|54636477|FG019|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
28087354|NCT00086190|54740810|FG002|Overall Study|Withdrawal by Subject|2|||
28087355|NCT00086190|54740808|FG000|Overall Study|Protocol Violation|1|||
28087356|NCT00086190|54740809|FG001|Overall Study|Protocol Violation|0|||
28087357|NCT00086190|54740810|FG002|Overall Study|Protocol Violation|0|||
28087358|NCT00086190|54740808|FG000|Overall Study|Moved|1|||
28087359|NCT00086190|54740809|FG001|Overall Study|Moved|0|||
28087360|NCT00086190|54740810|FG002|Overall Study|Moved|0|||
28087361|NCT00086190|54740808|FG000|Overall Study|Worsening depression|0|||
27978517|NCT00896532|54636478|FG020|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
27978518|NCT00896532|54636479|FG021|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
27978519|NCT00896532|54636480|FG022|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
27978520|NCT00896532|54636458|FG000|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
27978521|NCT00896532|54636459|FG001|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
27978522|NCT00896532|54636460|FG002|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
27978523|NCT00896532|54636461|FG003|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
27978524|NCT00896532|54636462|FG004|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
27978525|NCT00896532|54636463|FG005|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
27978526|NCT00896532|54636464|FG006|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
27978527|NCT00896532|54636465|FG007|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
27978528|NCT00896532|54636466|FG008|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
28087362|NCT00086190|54740809|FG001|Overall Study|Worsening depression|0|||
28087363|NCT00086190|54740810|FG002|Overall Study|Worsening depression|2|||
28087364|NCT03320824|54740820|FG000|Overall Study|Withdrawal by Subject|8|||
28087365|NCT03320824|54740821|FG001|Overall Study|Withdrawal by Subject|1|||
28087366|NCT03320824|54740820|FG000|Overall Study|Lost to Follow-up|10|||
28087367|NCT03320824|54740821|FG001|Overall Study|Lost to Follow-up|1|||
27978529|NCT00896532|54636467|FG009|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
27978530|NCT00896532|54636468|FG010|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
27978531|NCT00896532|54636469|FG011|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
27978532|NCT00896532|54636470|FG012|Months 24-36: Denosumab Extension Phase|Noncompliance|1|||
27978533|NCT00896532|54636471|FG013|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
27978534|NCT00896532|54636472|FG014|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
27978535|NCT00896532|54636473|FG015|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
27978536|NCT00896532|54636474|FG016|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
27978537|NCT00896532|54636475|FG017|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
27978538|NCT00896532|54636476|FG018|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
27978539|NCT00896532|54636477|FG019|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
27978540|NCT00896532|54636478|FG020|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
27978541|NCT00896532|54636479|FG021|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
27978542|NCT00896532|54636480|FG022|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
27978543|NCT00896532|54636458|FG000|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
27978544|NCT00896532|54636459|FG001|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
27978545|NCT00896532|54636460|FG002|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
28087368|NCT03320824|54740820|FG000|Overall Study|moved out of state|0|||
28087369|NCT03320824|54740821|FG001|Overall Study|moved out of state|1|||
28087370|NCT03320824|54740820|FG000|Overall Study|could not complete final visit|0|||
28087371|NCT03320824|54740821|FG001|Overall Study|could not complete final visit|1|||
28087372|NCT03275350|54740833|FG000|Overall Study|Lost to Follow-up|4|||
28087373|NCT03275350|54740834|FG001|Overall Study|Lost to Follow-up|6|||
28087374|NCT03275350|54740833|FG000|Overall Study|Death|2|||
28087375|NCT03275350|54740834|FG001|Overall Study|Death|1|||
28087376|NCT03275350|54740833|FG000|Overall Study|Physician Decision|1|||
28087377|NCT03275350|54740834|FG001|Overall Study|Physician Decision|0|||
28165623|NCT02519842|54836220|FG002|Optional Extension: Cycles 2-6|Death|1|||
27978546|NCT00896532|54636461|FG003|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
27978547|NCT00896532|54636462|FG004|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
27978548|NCT00896532|54636463|FG005|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
27978549|NCT00896532|54636464|FG006|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
27978550|NCT00896532|54636465|FG007|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
27978551|NCT00896532|54636466|FG008|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
27978552|NCT00896532|54636467|FG009|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
27978553|NCT00896532|54636468|FG010|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
27978554|NCT00896532|54636469|FG011|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
27978555|NCT00896532|54636470|FG012|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
27978556|NCT00896532|54636471|FG013|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
27978557|NCT00896532|54636472|FG014|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
27978558|NCT00896532|54636473|FG015|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
27978559|NCT00896532|54636474|FG016|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
27978560|NCT00896532|54636475|FG017|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
27978561|NCT00896532|54636476|FG018|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
27978562|NCT00896532|54636477|FG019|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
27978563|NCT00896532|54636478|FG020|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
27978564|NCT00896532|54636479|FG021|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
27978565|NCT00896532|54636480|FG022|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
27978566|NCT00896532|54636458|FG000|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
27978567|NCT00896532|54636459|FG001|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
27978568|NCT00896532|54636460|FG002|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
27978569|NCT00896532|54636461|FG003|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
27978570|NCT00896532|54636462|FG004|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
27978571|NCT00896532|54636463|FG005|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
27978572|NCT00896532|54636464|FG006|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
27978573|NCT00896532|54636465|FG007|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
27978574|NCT00896532|54636466|FG008|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
27978575|NCT00896532|54636467|FG009|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
27978576|NCT00896532|54636468|FG010|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
27978577|NCT00896532|54636469|FG011|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
27978578|NCT00896532|54636470|FG012|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
27978579|NCT00896532|54636471|FG013|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
27978580|NCT00896532|54636472|FG014|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
27978581|NCT00896532|54636473|FG015|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
27978582|NCT00896532|54636474|FG016|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
27978583|NCT00896532|54636475|FG017|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
27978584|NCT00896532|54636476|FG018|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
27978585|NCT00896532|54636477|FG019|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
27978586|NCT00896532|54636478|FG020|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
27978587|NCT00896532|54636479|FG021|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
27978588|NCT00896532|54636480|FG022|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
27978589|NCT00896532|54636458|FG000|Months 24-36: Denosumab Extension Phase|Other|0|||
27978590|NCT00896532|54636459|FG001|Months 24-36: Denosumab Extension Phase|Other|0|||
27978591|NCT00896532|54636460|FG002|Months 24-36: Denosumab Extension Phase|Other|0|||
27978592|NCT00896532|54636461|FG003|Months 24-36: Denosumab Extension Phase|Other|0|||
27978593|NCT00896532|54636462|FG004|Months 24-36: Denosumab Extension Phase|Other|0|||
27978594|NCT00896532|54636463|FG005|Months 24-36: Denosumab Extension Phase|Other|0|||
27978595|NCT00896532|54636464|FG006|Months 24-36: Denosumab Extension Phase|Other|0|||
27978596|NCT00896532|54636465|FG007|Months 24-36: Denosumab Extension Phase|Other|0|||
27978597|NCT00896532|54636466|FG008|Months 24-36: Denosumab Extension Phase|Other|0|||
27978598|NCT00896532|54636467|FG009|Months 24-36: Denosumab Extension Phase|Other|0|||
27978599|NCT00896532|54636468|FG010|Months 24-36: Denosumab Extension Phase|Other|1|||
27978600|NCT00896532|54636469|FG011|Months 24-36: Denosumab Extension Phase|Other|2|||
27978601|NCT00896532|54636470|FG012|Months 24-36: Denosumab Extension Phase|Other|2|||
27978602|NCT00896532|54636471|FG013|Months 24-36: Denosumab Extension Phase|Other|1|||
27978603|NCT00896532|54636472|FG014|Months 24-36: Denosumab Extension Phase|Other|0|||
27978604|NCT00896532|54636473|FG015|Months 24-36: Denosumab Extension Phase|Other|0|||
27978605|NCT00896532|54636474|FG016|Months 24-36: Denosumab Extension Phase|Other|0|||
27978606|NCT00896532|54636475|FG017|Months 24-36: Denosumab Extension Phase|Other|0|||
27978607|NCT00896532|54636476|FG018|Months 24-36: Denosumab Extension Phase|Other|0|||
27978608|NCT00896532|54636477|FG019|Months 24-36: Denosumab Extension Phase|Other|0|||
27978609|NCT00896532|54636478|FG020|Months 24-36: Denosumab Extension Phase|Other|0|||
27978610|NCT00896532|54636479|FG021|Months 24-36: Denosumab Extension Phase|Other|0|||
28087378|NCT03275350|54740833|FG000|Overall Study|Incarcerated|1|||
27978611|NCT00896532|54636480|FG022|Months 24-36: Denosumab Extension Phase|Other|0|||
27978612|NCT00896532|54636458|FG000|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
27978613|NCT00896532|54636459|FG001|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
27978614|NCT00896532|54636460|FG002|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
27978615|NCT00896532|54636461|FG003|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
27978616|NCT00896532|54636462|FG004|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
27978617|NCT00896532|54636463|FG005|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
27978618|NCT00896532|54636464|FG006|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
27978619|NCT00896532|54636465|FG007|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
27978620|NCT00896532|54636466|FG008|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
27978621|NCT00896532|54636467|FG009|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
27978622|NCT00896532|54636468|FG010|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
27978623|NCT00896532|54636469|FG011|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
27978624|NCT00896532|54636470|FG012|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
27978625|NCT00896532|54636471|FG013|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
27978626|NCT00896532|54636472|FG014|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
27978627|NCT00896532|54636473|FG015|Months 36-48: Romosozumab Retreatment|Adverse Event|1|||
27978628|NCT00896532|54636474|FG016|Months 36-48: Romosozumab Retreatment|Adverse Event|3|||
27978629|NCT00896532|54636475|FG017|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
27978630|NCT00896532|54636476|FG018|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
27978631|NCT00896532|54636477|FG019|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
27978632|NCT00896532|54636478|FG020|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
27978633|NCT00896532|54636479|FG021|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
27978634|NCT00896532|54636480|FG022|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
27978635|NCT00896532|54636458|FG000|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
27978636|NCT00896532|54636459|FG001|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
27978637|NCT00896532|54636460|FG002|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
27978638|NCT00896532|54636461|FG003|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
27978639|NCT00896532|54636462|FG004|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
27978640|NCT00896532|54636463|FG005|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
27978641|NCT00896532|54636464|FG006|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
27978642|NCT00896532|54636465|FG007|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
27978643|NCT00896532|54636466|FG008|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
27978644|NCT00896532|54636467|FG009|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
27978645|NCT00896532|54636468|FG010|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
27978646|NCT00896532|54636469|FG011|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
27978647|NCT00896532|54636470|FG012|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
27978648|NCT00896532|54636471|FG013|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
27978649|NCT00896532|54636472|FG014|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
27978650|NCT00896532|54636473|FG015|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1|||
27978651|NCT00896532|54636474|FG016|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
27978652|NCT00896532|54636475|FG017|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
27978653|NCT00896532|54636476|FG018|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
28087379|NCT03275350|54740834|FG001|Overall Study|Incarcerated|1|||
28087380|NCT03319732|54740841|FG000|Overall Study|Adverse Event|40|||
28087381|NCT03319732|54740841|FG000|Overall Study|Withdrawal by Subject|50|||
28087382|NCT03319732|54740841|FG000|Overall Study|MS relapse|10|||
28087383|NCT03319732|54740841|FG000|Overall Study|reason not specified|5|||
28087384|NCT03304522|54740848|FG000|Overall Study|Adverse Event|0|||
28087385|NCT03304522|54740849|FG001|Overall Study|Adverse Event|4|||
28087386|NCT03304522|54740848|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
28087387|NCT03304522|54740849|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
28087388|NCT03304522|54740848|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
28087389|NCT03304522|54740849|FG001|Overall Study|Withdrawal of consent (for other reason)|2|||
28087390|NCT03304522|54740848|FG000|Overall Study|Other|0|||
28087391|NCT03304522|54740849|FG001|Overall Study|Other|1|||
28087392|NCT03315286|54740857|FG000|Overall Study|Lost to Follow-up|0|||
28087393|NCT03315286|54740858|FG001|Overall Study|Lost to Follow-up|3|||
28087394|NCT03315286|54740857|FG000|Overall Study|Withdrawal by Subject|1|||
27978654|NCT00896532|54636477|FG019|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
27978655|NCT00896532|54636478|FG020|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
27978656|NCT00896532|54636479|FG021|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
27978657|NCT00896532|54636480|FG022|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
27978658|NCT00896532|54636458|FG000|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
28087395|NCT03315286|54740858|FG001|Overall Study|Withdrawal by Subject|0|||
28087396|NCT03315286|54740857|FG000|Overall Study|Protocol Violation|0|||
28087397|NCT03315286|54740858|FG001|Overall Study|Protocol Violation|1|||
28087398|NCT03273946|54740864|FG000|Overall Study|Withdrawal by Subject|5|||
28087399|NCT03273946|54740864|FG000|Overall Study|Unwillingness of the guardian|1|||
28087400|NCT03273946|54740864|FG000|Overall Study|Participant refused to use the drug|2|||
28087401|NCT03273946|54740864|FG000|Overall Study|Participant relative refused to use drug|1|||
28087402|NCT00314951|54740870|FG000|Treatment|Didn't meet criteria for mITT population|16|||
28087403|NCT00314951|54740871|FG001|Treatment|Didn't meet criteria for mITT population|11|||
28087404|NCT00314951|54740870|FG000|Follow-up|mITT failure|44|||
28087405|NCT00314951|54740871|FG001|Follow-up|mITT failure|34|||
28087406|NCT00085644|54740879|FG000|Double-Blind Period|Adverse Event|5|||
28087407|NCT00085644|54740880|FG001|Double-Blind Period|Adverse Event|2|||
28087408|NCT00085644|54740881|FG002|Double-Blind Period|Adverse Event|0|||
28087409|NCT00085644|54740879|FG000|Double-Blind Period|Withdrawal by Subject|3|||
28087410|NCT00085644|54740880|FG001|Double-Blind Period|Withdrawal by Subject|0|||
28087411|NCT00085644|54740881|FG002|Double-Blind Period|Withdrawal by Subject|0|||
28087412|NCT00085644|54740879|FG000|Double-Blind Period|Lost to Follow-up|2|||
28087413|NCT00085644|54740880|FG001|Double-Blind Period|Lost to Follow-up|1|||
27733336|NCT02559206|54181154|FG001|Overall Study|Withdrawal by Subject|3|||
27978659|NCT00896532|54636459|FG001|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
27978660|NCT00896532|54636460|FG002|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
27978661|NCT00896532|54636461|FG003|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
27978662|NCT00896532|54636462|FG004|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
27978663|NCT00896532|54636463|FG005|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
27978664|NCT00896532|54636464|FG006|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
27978665|NCT00896532|54636465|FG007|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
27978666|NCT00896532|54636466|FG008|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
27978667|NCT00896532|54636467|FG009|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
27978668|NCT00896532|54636468|FG010|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
27978669|NCT00896532|54636469|FG011|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
27978670|NCT00896532|54636470|FG012|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
27978671|NCT00896532|54636471|FG013|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
27978672|NCT00896532|54636472|FG014|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
27978673|NCT00896532|54636473|FG015|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
27978674|NCT00896532|54636474|FG016|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1|||
27978675|NCT00896532|54636475|FG017|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
27978676|NCT00896532|54636476|FG018|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
27978677|NCT00896532|54636477|FG019|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
27978678|NCT00896532|54636478|FG020|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
27978679|NCT00896532|54636479|FG021|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
27978680|NCT00896532|54636480|FG022|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
27978681|NCT00896532|54636458|FG000|Months 36-48: Romosozumab Retreatment|Other|0|||
27978682|NCT00896532|54636459|FG001|Months 36-48: Romosozumab Retreatment|Other|0|||
27978683|NCT00896532|54636460|FG002|Months 36-48: Romosozumab Retreatment|Other|0|||
27978684|NCT00896532|54636461|FG003|Months 36-48: Romosozumab Retreatment|Other|0|||
27978685|NCT00896532|54636462|FG004|Months 36-48: Romosozumab Retreatment|Other|0|||
27978686|NCT00896532|54636463|FG005|Months 36-48: Romosozumab Retreatment|Other|0|||
27978687|NCT00896532|54636464|FG006|Months 36-48: Romosozumab Retreatment|Other|0|||
27978688|NCT00896532|54636465|FG007|Months 36-48: Romosozumab Retreatment|Other|0|||
27978689|NCT00896532|54636466|FG008|Months 36-48: Romosozumab Retreatment|Other|0|||
27978690|NCT00896532|54636467|FG009|Months 36-48: Romosozumab Retreatment|Other|0|||
27978691|NCT00896532|54636468|FG010|Months 36-48: Romosozumab Retreatment|Other|0|||
27978692|NCT00896532|54636469|FG011|Months 36-48: Romosozumab Retreatment|Other|0|||
27978693|NCT00896532|54636470|FG012|Months 36-48: Romosozumab Retreatment|Other|0|||
27978694|NCT00896532|54636471|FG013|Months 36-48: Romosozumab Retreatment|Other|0|||
27978695|NCT00896532|54636472|FG014|Months 36-48: Romosozumab Retreatment|Other|0|||
27978696|NCT00896532|54636473|FG015|Months 36-48: Romosozumab Retreatment|Other|0|||
27978697|NCT00896532|54636474|FG016|Months 36-48: Romosozumab Retreatment|Other|0|||
27978698|NCT00896532|54636475|FG017|Months 36-48: Romosozumab Retreatment|Other|1|||
27978699|NCT00896532|54636476|FG018|Months 36-48: Romosozumab Retreatment|Other|0|||
27978700|NCT00896532|54636477|FG019|Months 36-48: Romosozumab Retreatment|Other|0|||
27978701|NCT00896532|54636478|FG020|Months 36-48: Romosozumab Retreatment|Other|0|||
27978702|NCT00896532|54636479|FG021|Months 36-48: Romosozumab Retreatment|Other|0|||
27978703|NCT00896532|54636480|FG022|Months 36-48: Romosozumab Retreatment|Other|0|||
27978704|NCT00896532|54636458|FG000|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
27978705|NCT00896532|54636459|FG001|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
27978706|NCT00896532|54636460|FG002|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
27978707|NCT00896532|54636461|FG003|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
28087414|NCT00085644|54740881|FG002|Double-Blind Period|Lost to Follow-up|0|||
28087415|NCT00085644|54740879|FG000|Double-Blind Period|Lack/loss of efficacy|2|||
27733337|NCT02559206|54181155|FG002|Overall Study|Withdrawal by Subject|1|||
27978708|NCT00896532|54636462|FG004|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
27978709|NCT00896532|54636463|FG005|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
27978710|NCT00896532|54636464|FG006|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
27978711|NCT00896532|54636465|FG007|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
27978712|NCT00896532|54636466|FG008|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
27978713|NCT00896532|54636467|FG009|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
27978714|NCT00896532|54636468|FG010|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
27978715|NCT00896532|54636469|FG011|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
27978716|NCT00896532|54636470|FG012|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
27978717|NCT00896532|54636471|FG013|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
27978718|NCT00896532|54636472|FG014|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
27978719|NCT00896532|54636473|FG015|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
27978720|NCT00896532|54636474|FG016|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1|||
27978721|NCT00896532|54636475|FG017|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
27978722|NCT00896532|54636476|FG018|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
27978723|NCT00896532|54636477|FG019|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
27978724|NCT00896532|54636478|FG020|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
27978725|NCT00896532|54636479|FG021|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
27978726|NCT00896532|54636480|FG022|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
27978727|NCT00896532|54636458|FG000|Months 48-72: Follow-on Phase|Death|0|||
27978728|NCT00896532|54636459|FG001|Months 48-72: Follow-on Phase|Death|0|||
27978729|NCT00896532|54636460|FG002|Months 48-72: Follow-on Phase|Death|0|||
27978730|NCT00896532|54636461|FG003|Months 48-72: Follow-on Phase|Death|0|||
27978731|NCT00896532|54636462|FG004|Months 48-72: Follow-on Phase|Death|0|||
27978732|NCT00896532|54636463|FG005|Months 48-72: Follow-on Phase|Death|0|||
27978733|NCT00896532|54636464|FG006|Months 48-72: Follow-on Phase|Death|0|||
27978734|NCT00896532|54636465|FG007|Months 48-72: Follow-on Phase|Death|0|||
27978735|NCT00896532|54636466|FG008|Months 48-72: Follow-on Phase|Death|0|||
27978736|NCT00896532|54636467|FG009|Months 48-72: Follow-on Phase|Death|0|||
27978737|NCT00896532|54636468|FG010|Months 48-72: Follow-on Phase|Death|0|||
27978738|NCT00896532|54636469|FG011|Months 48-72: Follow-on Phase|Death|0|||
27978739|NCT00896532|54636470|FG012|Months 48-72: Follow-on Phase|Death|0|||
27978740|NCT00896532|54636471|FG013|Months 48-72: Follow-on Phase|Death|0|||
27978741|NCT00896532|54636472|FG014|Months 48-72: Follow-on Phase|Death|0|||
28165624|NCT02519842|54836218|FG000|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
28165625|NCT02519842|54836219|FG001|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
28165626|NCT02519842|54836220|FG002|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2|||
28165627|NCT02519842|54836218|FG000|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
28165628|NCT02519842|54836219|FG001|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
28165629|NCT02519842|54836220|FG002|Optional Extension: Cycles 2-6|Completed Chemotherapy|13|||
28165630|NCT02519842|54836218|FG000|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
28165631|NCT02519842|54836219|FG001|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
28165632|NCT02519842|54836220|FG002|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1|||
28165633|NCT02519842|54836218|FG000|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
28165634|NCT02519842|54836219|FG001|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
27978742|NCT00896532|54636473|FG015|Months 48-72: Follow-on Phase|Death|0|||
27978743|NCT00896532|54636474|FG016|Months 48-72: Follow-on Phase|Death|0|||
27978744|NCT00896532|54636475|FG017|Months 48-72: Follow-on Phase|Death|0|||
27978745|NCT00896532|54636476|FG018|Months 48-72: Follow-on Phase|Death|1|||
27978746|NCT00896532|54636477|FG019|Months 48-72: Follow-on Phase|Death|0|||
27978747|NCT00896532|54636478|FG020|Months 48-72: Follow-on Phase|Death|0|||
27978748|NCT00896532|54636479|FG021|Months 48-72: Follow-on Phase|Death|0|||
27978749|NCT00896532|54636480|FG022|Months 48-72: Follow-on Phase|Death|0|||
27978750|NCT00896532|54636458|FG000|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
27978751|NCT00896532|54636459|FG001|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
27978752|NCT00896532|54636460|FG002|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
27978753|NCT00896532|54636461|FG003|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
27978754|NCT00896532|54636462|FG004|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
27978755|NCT00896532|54636463|FG005|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
27978756|NCT00896532|54636464|FG006|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
27978757|NCT00896532|54636465|FG007|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
27978758|NCT00896532|54636466|FG008|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
27978759|NCT00896532|54636467|FG009|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
27978760|NCT00896532|54636468|FG010|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
27978761|NCT00896532|54636469|FG011|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
27978762|NCT00896532|54636470|FG012|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
27978763|NCT00896532|54636471|FG013|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
27978764|NCT00896532|54636472|FG014|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
27978765|NCT00896532|54636473|FG015|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
27978766|NCT00896532|54636474|FG016|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
27978767|NCT00896532|54636475|FG017|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
27978768|NCT00896532|54636476|FG018|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
27978769|NCT00896532|54636477|FG019|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
27978770|NCT00896532|54636478|FG020|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
27978771|NCT00896532|54636479|FG021|Months 48-72: Follow-on Phase|Ineligibility Determined|1|||
27978772|NCT00896532|54636480|FG022|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
27978773|NCT00896532|54636458|FG000|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
27978774|NCT00896532|54636459|FG001|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
27978775|NCT00896532|54636460|FG002|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
27978776|NCT00896532|54636461|FG003|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
27978777|NCT00896532|54636462|FG004|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
27978778|NCT00896532|54636463|FG005|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
27978779|NCT00896532|54636464|FG006|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
27978780|NCT00896532|54636465|FG007|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
27978781|NCT00896532|54636466|FG008|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
27978782|NCT00896532|54636467|FG009|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
27978783|NCT00896532|54636468|FG010|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
27978784|NCT00896532|54636469|FG011|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
27978785|NCT00896532|54636470|FG012|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
27978786|NCT00896532|54636471|FG013|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
27978787|NCT00896532|54636472|FG014|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
27978788|NCT00896532|54636473|FG015|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
27978789|NCT00896532|54636474|FG016|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
27978790|NCT00896532|54636475|FG017|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
27978791|NCT00896532|54636476|FG018|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
27978792|NCT00896532|54636477|FG019|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
27978793|NCT00896532|54636478|FG020|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
27978794|NCT00896532|54636479|FG021|Months 48-72: Follow-on Phase|Withdrawal by Subject|1|||
28087416|NCT00085644|54740880|FG001|Double-Blind Period|Lack/loss of efficacy|2|||
28087417|NCT00085644|54740881|FG002|Double-Blind Period|Lack/loss of efficacy|0|||
28087418|NCT00085644|54740879|FG000|Double-Blind Period|Contemplating pregnancy|1|||
28087419|NCT00085644|54740880|FG001|Double-Blind Period|Contemplating pregnancy|0|||
28087420|NCT00085644|54740881|FG002|Double-Blind Period|Contemplating pregnancy|0|||
28087421|NCT00085644|54740879|FG000|Double-Blind Period|Undiagnosed pre-existing condition|0|||
28087422|NCT00085644|54740880|FG001|Double-Blind Period|Undiagnosed pre-existing condition|1|||
28087423|NCT00085644|54740881|FG002|Double-Blind Period|Undiagnosed pre-existing condition|0|||
28087424|NCT00085644|54740879|FG000|Open-Label Period|Adverse Event|0|||
28087425|NCT00085644|54740880|FG001|Open-Label Period|Adverse Event|0|||
28087426|NCT00085644|54740881|FG002|Open-Label Period|Adverse Event|38|||
28087427|NCT00085644|54740879|FG000|Open-Label Period|Withdrawal by Subject|0|||
28087428|NCT00085644|54740880|FG001|Open-Label Period|Withdrawal by Subject|0|||
28087429|NCT00085644|54740881|FG002|Open-Label Period|Withdrawal by Subject|29|||
28165635|NCT02519842|54836220|FG002|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2|||
27978795|NCT00896532|54636480|FG022|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
27978796|NCT00574873|54636529|FG000|Overall Study|Withdrawal by Subject|18|||
27978797|NCT00574873|54636530|FG001|Overall Study|Withdrawal by Subject|19|||
27978798|NCT00574873|54636529|FG000|Overall Study|Investigator request|18|||
27978799|NCT00574873|54636530|FG001|Overall Study|Investigator request|8|||
27978800|NCT00574873|54636529|FG000|Overall Study|Death|15|||
27978801|NCT00574873|54636530|FG001|Overall Study|Death|14|||
27978802|NCT00574873|54636529|FG000|Overall Study|Lost to Follow-up|14|||
27978803|NCT00574873|54636530|FG001|Overall Study|Lost to Follow-up|5|||
27978804|NCT00574873|54636529|FG000|Overall Study|Other|40|||
27978805|NCT00574873|54636530|FG001|Overall Study|Other|4|||
27978806|NCT00574873|54636529|FG000|Overall Study|Discontinuation of study by sponsor|5|||
27978807|NCT00574873|54636530|FG001|Overall Study|Discontinuation of study by sponsor|199|||
27978808|NCT00574873|54636529|FG000|Overall Study|Blank, site closed per local regulations|2|||
27978809|NCT00574873|54636530|FG001|Overall Study|Blank, site closed per local regulations|2|||
27978810|NCT00574873|54636529|FG000|Overall Study|Extension Study|126|||
27978811|NCT00574873|54636530|FG001|Overall Study|Extension Study|0|||
27978812|NCT00902174|54636538|FG000|Overall Study|Adverse Event|27|||
27978813|NCT00902174|54636539|FG001|Overall Study|Adverse Event|7|||
27978814|NCT00902174|54636538|FG000|Overall Study|Lack of Efficacy|1|||
27978815|NCT00902174|54636539|FG001|Overall Study|Lack of Efficacy|5|||
28165636|NCT02509078|54836230|FG000|Overall Study|Protocol Violation|1|||
27978816|NCT00902174|54636538|FG000|Overall Study|Death|2|||
27978817|NCT00902174|54636539|FG001|Overall Study|Death|2|||
27978818|NCT00902174|54636538|FG000|Overall Study|Withdrawal by Subject|2|||
28087430|NCT00085644|54740879|FG000|Open-Label Period|Lost to Follow-up|0|||
28087431|NCT00085644|54740880|FG001|Open-Label Period|Lost to Follow-up|0|||
28087432|NCT00085644|54740881|FG002|Open-Label Period|Lost to Follow-up|13|||
28087433|NCT00085644|54740879|FG000|Open-Label Period|Lack of Efficacy|0|||
27733338|NCT02559206|54181156|FG003|Overall Study|Withdrawal by Subject|3|||
27978819|NCT00902174|54636539|FG001|Overall Study|Withdrawal by Subject|1|||
27978820|NCT00902174|54636538|FG000|Overall Study|Abnormal labs|1|||
27978821|NCT00902174|54636539|FG001|Overall Study|Abnormal labs|1|||
27978822|NCT00902174|54636538|FG000|Overall Study|Protocol Violation|1|||
27978823|NCT00902174|54636539|FG001|Overall Study|Protocol Violation|1|||
27978824|NCT00902174|54636538|FG000|Overall Study|Administration problem|0|||
27978825|NCT00902174|54636539|FG001|Overall Study|Administration problem|1|||
27978826|NCT00623623|54636563|FG000|Overall Study|Previous enrolment into this study|1|||
27978827|NCT00623623|54636564|FG001|Overall Study|Previous enrolment into this study|1|||
27978828|NCT00896454|54636570|FG000|Overall Study|Death|10|||
27978829|NCT00896454|54636570|FG000|Overall Study|Adverse Event|8|||
27978830|NCT00896454|54636570|FG000|Overall Study|Disease Progression|5|||
27978831|NCT00896454|54636570|FG000|Overall Study|Other|4|||
27978832|NCT00896454|54636570|FG000|Overall Study|Requirement for alternative therapy|3|||
27978833|NCT00896454|54636570|FG000|Overall Study|Ongoing in study|2|||
27978834|NCT00896454|54636570|FG000|Overall Study|Withdrawal by Subject|1|||
27978835|NCT00629239|54636576|FG000|Overall Study|Adverse Event|7|||
27978836|NCT00629239|54636577|FG001|Overall Study|Adverse Event|4|||
27978837|NCT00629239|54636576|FG000|Overall Study|Physician Decision|1|||
27978838|NCT00629239|54636577|FG001|Overall Study|Physician Decision|0|||
27978839|NCT00625807|54636585|FG000|Overall Study|schedule conflict|2|||
27978840|NCT00625807|54636586|FG001|Overall Study|schedule conflict|8|||
27978841|NCT00629083|54636596|FG000|Overall Study|Adverse Event|0|||
27978842|NCT00629083|54636597|FG001|Overall Study|Adverse Event|2|||
27978843|NCT00629083|54636596|FG000|Overall Study|Lack of Efficacy|3|||
27978844|NCT00629083|54636597|FG001|Overall Study|Lack of Efficacy|1|||
27978845|NCT00629083|54636596|FG000|Overall Study|Withdrawal by Subject|10|||
27978846|NCT00629083|54636597|FG001|Overall Study|Withdrawal by Subject|2|||
27978847|NCT00629083|54636596|FG000|Overall Study|Lost to Follow-up|12|||
27978848|NCT00629083|54636597|FG001|Overall Study|Lost to Follow-up|8|||
27978849|NCT00629083|54636596|FG000|Overall Study|Moved out of country/state|2|||
27978850|NCT00629083|54636597|FG001|Overall Study|Moved out of country/state|1|||
27978851|NCT00629083|54636596|FG000|Overall Study|Refused to return for 12 month visit|1|||
27978852|NCT00629083|54636597|FG001|Overall Study|Refused to return for 12 month visit|0|||
27978853|NCT00901628|54636607|FG000|Overall Study|disconnection of catheter|4|||
27978854|NCT00901628|54636608|FG001|Overall Study|disconnection of catheter|8|||
27978855|NCT00901628|54636607|FG000|Overall Study|disconnection of drain|0|||
27978856|NCT00901628|54636608|FG001|Overall Study|disconnection of drain|1|||
27978857|NCT00901628|54636607|FG000|Overall Study|peroneal nerve palsy|0|||
27978858|NCT00901628|54636608|FG001|Overall Study|peroneal nerve palsy|1|||
27978859|NCT00623545|54636614|FG000|Overall Study|Adverse Event|6|||
27978860|NCT00623545|54636614|FG000|Overall Study|Withdrawal by Subject|4|||
27978861|NCT00628927|54636621|FG000|Overall Study|Problems performing blood draw|6|||
27978862|NCT00628927|54636622|FG001|Overall Study|Problems performing blood draw|0|||
27978863|NCT00628927|54636621|FG000|Overall Study|Lost to Follow-up|1|||
27978864|NCT00628927|54636622|FG001|Overall Study|Lost to Follow-up|0|||
27978865|NCT00628927|54636621|FG000|Overall Study|Equipment failure|1|||
27978866|NCT00628927|54636622|FG001|Overall Study|Equipment failure|0|||
27978867|NCT00623467|54636633|FG000|Overall Study|Lost to Follow-up|1|||
27978868|NCT00623467|54636633|FG000|Overall Study|Protocol Violation|4|||
27978869|NCT00623467|54636633|FG000|Overall Study|Withdrawal by Subject|2|||
27978870|NCT00838539|54636651|FG000|Overall Study|Disease Progression|2|||
27978871|NCT00838539|54636652|FG001|Overall Study|Disease Progression|4|||
27978872|NCT00838539|54636653|FG002|Overall Study|Disease Progression|3|||
27978873|NCT00838539|54636654|FG003|Overall Study|Disease Progression|2|||
27978874|NCT00838539|54636655|FG004|Overall Study|Disease Progression|4|||
27978875|NCT00838539|54636656|FG005|Overall Study|Disease Progression|2|||
27978876|NCT00838539|54636657|FG006|Overall Study|Disease Progression|3|||
27978877|NCT00838539|54636658|FG007|Overall Study|Disease Progression|4|||
27978878|NCT00838539|54636659|FG008|Overall Study|Disease Progression|4|||
27978879|NCT00838539|54636660|FG009|Overall Study|Disease Progression|5|||
27733339|NCT02559206|54181157|FG004|Overall Study|Withdrawal by Subject|5|||
27978880|NCT00838539|54636661|FG010|Overall Study|Disease Progression|1|||
27978881|NCT00838539|54636662|FG011|Overall Study|Disease Progression|4|||
27978882|NCT00838539|54636651|FG000|Overall Study|Adverse Event|1|||
27978883|NCT00838539|54636652|FG001|Overall Study|Adverse Event|1|||
27978884|NCT00838539|54636653|FG002|Overall Study|Adverse Event|1|||
27978885|NCT00838539|54636654|FG003|Overall Study|Adverse Event|1|||
27978886|NCT00838539|54636655|FG004|Overall Study|Adverse Event|2|||
27978887|NCT00838539|54636656|FG005|Overall Study|Adverse Event|1|||
27978888|NCT00838539|54636657|FG006|Overall Study|Adverse Event|0|||
28087434|NCT00085644|54740880|FG001|Open-Label Period|Lack of Efficacy|0|||
28087435|NCT00085644|54740881|FG002|Open-Label Period|Lack of Efficacy|15|||
28087436|NCT00085644|54740879|FG000|Open-Label Period|Pregnancy|0|||
28087437|NCT00085644|54740880|FG001|Open-Label Period|Pregnancy|0|||
28087438|NCT00085644|54740881|FG002|Open-Label Period|Pregnancy|3|||
28087439|NCT00085644|54740879|FG000|Open-Label Period|Contemplating pregnancy|0|||
28087440|NCT00085644|54740880|FG001|Open-Label Period|Contemplating pregnancy|0|||
28087441|NCT00085644|54740881|FG002|Open-Label Period|Contemplating pregnancy|3|||
28087442|NCT00085644|54740879|FG000|Open-Label Period|Protocol Violation|0|||
28087443|NCT00085644|54740880|FG001|Open-Label Period|Protocol Violation|0|||
28087444|NCT00085644|54740881|FG002|Open-Label Period|Protocol Violation|4|||
28087445|NCT00085644|54740879|FG000|Open-Label Period|Personal reason|0|||
28087446|NCT00085644|54740880|FG001|Open-Label Period|Personal reason|0|||
28087447|NCT00085644|54740881|FG002|Open-Label Period|Personal reason|4|||
28087448|NCT03315208|54740890|FG000|Overall Study|Lost to Follow-up|11|||
27978889|NCT00838539|54636658|FG007|Overall Study|Adverse Event|2|||
27978890|NCT00838539|54636659|FG008|Overall Study|Adverse Event|0|||
27978891|NCT00838539|54636660|FG009|Overall Study|Adverse Event|1|||
27978892|NCT00838539|54636661|FG010|Overall Study|Adverse Event|2|||
27978893|NCT00838539|54636662|FG011|Overall Study|Adverse Event|0|||
27978894|NCT00838539|54636651|FG000|Overall Study|Withdrawal by Subject|0|||
27978895|NCT00838539|54636652|FG001|Overall Study|Withdrawal by Subject|1|||
27978896|NCT00838539|54636653|FG002|Overall Study|Withdrawal by Subject|0|||
27978897|NCT00838539|54636654|FG003|Overall Study|Withdrawal by Subject|0|||
27978898|NCT00838539|54636655|FG004|Overall Study|Withdrawal by Subject|0|||
27978899|NCT00838539|54636656|FG005|Overall Study|Withdrawal by Subject|0|||
27978900|NCT00838539|54636657|FG006|Overall Study|Withdrawal by Subject|0|||
27978901|NCT00838539|54636658|FG007|Overall Study|Withdrawal by Subject|0|||
27978902|NCT00838539|54636659|FG008|Overall Study|Withdrawal by Subject|0|||
27978903|NCT00838539|54636660|FG009|Overall Study|Withdrawal by Subject|1|||
27978904|NCT00838539|54636661|FG010|Overall Study|Withdrawal by Subject|2|||
27978905|NCT00838539|54636662|FG011|Overall Study|Withdrawal by Subject|0|||
27978906|NCT00838539|54636651|FG000|Overall Study|Death|0|||
27978907|NCT00838539|54636652|FG001|Overall Study|Death|0|||
27978908|NCT00838539|54636653|FG002|Overall Study|Death|0|||
27978909|NCT00838539|54636654|FG003|Overall Study|Death|0|||
27978910|NCT00838539|54636655|FG004|Overall Study|Death|0|||
27978911|NCT00838539|54636656|FG005|Overall Study|Death|0|||
27978912|NCT00838539|54636657|FG006|Overall Study|Death|1|||
27978913|NCT00838539|54636658|FG007|Overall Study|Death|0|||
27978914|NCT00838539|54636659|FG008|Overall Study|Death|0|||
27978915|NCT00838539|54636660|FG009|Overall Study|Death|0|||
27978916|NCT00838539|54636661|FG010|Overall Study|Death|0|||
27978917|NCT00838539|54636662|FG011|Overall Study|Death|0|||
27978918|NCT00838539|54636651|FG000|Overall Study|Physician Decision|0|||
27978919|NCT00838539|54636652|FG001|Overall Study|Physician Decision|0|||
27978920|NCT00838539|54636653|FG002|Overall Study|Physician Decision|0|||
27978921|NCT00838539|54636654|FG003|Overall Study|Physician Decision|0|||
27978922|NCT00838539|54636655|FG004|Overall Study|Physician Decision|0|||
27978923|NCT00838539|54636656|FG005|Overall Study|Physician Decision|0|||
27978924|NCT00838539|54636657|FG006|Overall Study|Physician Decision|0|||
27978925|NCT00838539|54636658|FG007|Overall Study|Physician Decision|0|||
27978926|NCT00838539|54636659|FG008|Overall Study|Physician Decision|1|||
27978927|NCT00838539|54636660|FG009|Overall Study|Physician Decision|0|||
27978928|NCT00838539|54636661|FG010|Overall Study|Physician Decision|0|||
27978929|NCT00838539|54636662|FG011|Overall Study|Physician Decision|0|||
27978930|NCT00838539|54636651|FG000|Overall Study|Clinical Progression|0|||
27978931|NCT00838539|54636652|FG001|Overall Study|Clinical Progression|0|||
27978932|NCT00838539|54636653|FG002|Overall Study|Clinical Progression|0|||
27978933|NCT00838539|54636654|FG003|Overall Study|Clinical Progression|0|||
27978934|NCT00838539|54636655|FG004|Overall Study|Clinical Progression|0|||
27978935|NCT00838539|54636656|FG005|Overall Study|Clinical Progression|0|||
27978936|NCT00838539|54636657|FG006|Overall Study|Clinical Progression|1|||
27978937|NCT00838539|54636658|FG007|Overall Study|Clinical Progression|0|||
28087449|NCT03315208|54740891|FG001|Overall Study|Lost to Follow-up|6|||
27978938|NCT00838539|54636659|FG008|Overall Study|Clinical Progression|0|||
27978939|NCT00838539|54636660|FG009|Overall Study|Clinical Progression|0|||
27978940|NCT00838539|54636661|FG010|Overall Study|Clinical Progression|0|||
27978941|NCT00838539|54636662|FG011|Overall Study|Clinical Progression|0|||
27978942|NCT00838539|54636651|FG000|Overall Study|Symptomatic Deterioration|0|||
28087450|NCT03315208|54740890|FG000|Overall Study|Withdrawal by Subject|2|||
28087451|NCT03315208|54740891|FG001|Overall Study|Withdrawal by Subject|0|||
27978943|NCT00838539|54636652|FG001|Overall Study|Symptomatic Deterioration|0|||
27978944|NCT00838539|54636653|FG002|Overall Study|Symptomatic Deterioration|1|||
27978945|NCT00838539|54636654|FG003|Overall Study|Symptomatic Deterioration|1|||
27978946|NCT00838539|54636655|FG004|Overall Study|Symptomatic Deterioration|0|||
27978947|NCT00838539|54636656|FG005|Overall Study|Symptomatic Deterioration|1|||
28087452|NCT00314795|54740898|FG000|Overall Study|Adverse Event|8|||
27978948|NCT00838539|54636657|FG006|Overall Study|Symptomatic Deterioration|0|||
27978949|NCT00838539|54636658|FG007|Overall Study|Symptomatic Deterioration|0|||
27978950|NCT00838539|54636659|FG008|Overall Study|Symptomatic Deterioration|0|||
27978951|NCT00838539|54636660|FG009|Overall Study|Symptomatic Deterioration|1|||
28087453|NCT00314795|54740898|FG000|Overall Study|Death|4|||
27832768|NCT01728077|54312550|FG000|Overall Study|Lost to Follow-up|1|||
27832769|NCT01728077|54312551|FG001|Overall Study|Lost to Follow-up|0|||
27832770|NCT01728077|54312550|FG000|Overall Study|Subject choice|2|||
27832771|NCT01728077|54312551|FG001|Overall Study|Subject choice|3|||
28087454|NCT00314795|54740898|FG000|Overall Study|Reason not Specified|3|||
28087455|NCT00314795|54740898|FG000|Overall Study|Renal Transplant|3|||
28087456|NCT00314795|54740898|FG000|Overall Study|Participants Withdrew Consent|2|||
28087457|NCT00314327|54740902|FG000|Overall Study|Withdrawal by Subject|1|||
28087458|NCT00336479|54740910|FG000|Overall Study|Adverse Event|8|||
28087459|NCT00336479|54740911|FG001|Overall Study|Adverse Event|11|||
28087460|NCT00336479|54740912|FG002|Overall Study|Adverse Event|18|||
28087461|NCT00336479|54740913|FG003|Overall Study|Adverse Event|4|||
28087462|NCT00336479|54740910|FG000|Overall Study|Noncompliant|1|||
28087463|NCT00336479|54740911|FG001|Overall Study|Noncompliant|7|||
28087464|NCT00336479|54740912|FG002|Overall Study|Noncompliant|3|||
28087465|NCT00336479|54740913|FG003|Overall Study|Noncompliant|0|||
28087466|NCT00336479|54740910|FG000|Overall Study|Physician Decision|2|||
28087467|NCT00336479|54740911|FG001|Overall Study|Physician Decision|3|||
28087468|NCT00336479|54740912|FG002|Overall Study|Physician Decision|1|||
28087469|NCT00336479|54740913|FG003|Overall Study|Physician Decision|0|||
28087470|NCT00336479|54740910|FG000|Overall Study|Lost to Follow-up|3|||
28087471|NCT00336479|54740911|FG001|Overall Study|Lost to Follow-up|2|||
28087472|NCT00336479|54740912|FG002|Overall Study|Lost to Follow-up|0|||
28087473|NCT00336479|54740913|FG003|Overall Study|Lost to Follow-up|0|||
28087474|NCT00336479|54740910|FG000|Overall Study|Withdrawal by Subject|3|||
28087475|NCT00336479|54740911|FG001|Overall Study|Withdrawal by Subject|2|||
28087476|NCT00336479|54740912|FG002|Overall Study|Withdrawal by Subject|3|||
28087477|NCT00336479|54740913|FG003|Overall Study|Withdrawal by Subject|0|||
28087478|NCT00336479|54740910|FG000|Overall Study|Other|0|||
28087479|NCT00336479|54740911|FG001|Overall Study|Other|0|||
28087480|NCT00336479|54740912|FG002|Overall Study|Other|1|||
28087481|NCT00336479|54740913|FG003|Overall Study|Other|0|||
28087482|NCT00336479|54740910|FG000|Overall Study|Virologic Stopping Rule|20|||
28087483|NCT00336479|54740911|FG001|Overall Study|Virologic Stopping Rule|0|||
28087484|NCT00336479|54740912|FG002|Overall Study|Virologic Stopping Rule|0|||
28087485|NCT00336479|54740913|FG003|Overall Study|Virologic Stopping Rule|0|||
28087486|NCT00314249|54740926|FG000|Overall Study|Adverse Event|73|||
28087487|NCT00314249|54740927|FG001|Overall Study|Adverse Event|94|||
28087488|NCT00314249|54740926|FG000|Overall Study|Lack of Efficacy|33|||
28087489|NCT00314249|54740927|FG001|Overall Study|Lack of Efficacy|24|||
28087490|NCT00314249|54740926|FG000|Overall Study|Withdrawal by Subject|21|||
28087491|NCT00314249|54740927|FG001|Overall Study|Withdrawal by Subject|28|||
28087492|NCT00314249|54740926|FG000|Overall Study|Lost to Follow-up|15|||
28087493|NCT00314249|54740927|FG001|Overall Study|Lost to Follow-up|9|||
28087494|NCT00314249|54740926|FG000|Overall Study|Physician Decision|1|||
28087495|NCT00314249|54740927|FG001|Overall Study|Physician Decision|1|||
28087496|NCT00314249|54740926|FG000|Overall Study|Withdrawn for other reasons|4|||
28087497|NCT00314249|54740927|FG001|Overall Study|Withdrawn for other reasons|1|||
28087498|NCT00314249|54740926|FG000|Overall Study|Non-Compliant|5|||
28165637|NCT02509078|54836231|FG001|Overall Study|Protocol Violation|1|||
28165638|NCT02993783|54836241|FG000|Overall Study|Reason not Specified|6|||
28165639|NCT02993783|54836242|FG001|Overall Study|Reason not Specified|9|||
28165640|NCT02993471|54836248|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1|||
28165641|NCT02993471|54836248|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1|||
28165642|NCT02988713|54836270|FG000|Overall Study|Withdrawal by Subject|1|||
28165643|NCT02988713|54836270|FG000|Overall Study|Subject's failure to meet study inclusion or exclusion criteria after enrollment|2|||
28165644|NCT01068743|54836274|FG000|Period 3|Adverse Event|0|||
27832772|NCT01728077|54312550|FG000|Overall Study|Death|0|||
28087499|NCT00314249|54740927|FG001|Overall Study|Non-Compliant|6|||
28087500|NCT03315130|54740936|FG000|Main Portion (12 Weeks)|Subject withdrew consent|0|||
28087501|NCT03315130|54740937|FG001|Main Portion (12 Weeks)|Subject withdrew consent|1|||
28087502|NCT03315130|54740938|FG002|Main Portion (12 Weeks)|Subject withdrew consent|0|||
28087503|NCT03315130|54740939|FG003|Main Portion (12 Weeks)|Subject withdrew consent|0|||
28087504|NCT03315130|54740936|FG000|Main Portion (12 Weeks)|Lost to Follow-up|0|||
28087505|NCT03315130|54740937|FG001|Main Portion (12 Weeks)|Lost to Follow-up|1|||
28087506|NCT03315130|54740938|FG002|Main Portion (12 Weeks)|Lost to Follow-up|0|||
28165645|NCT01068743|54836275|FG001|Period 3|Adverse Event|1|||
27832773|NCT01728077|54312551|FG001|Overall Study|Death|1|||
27832774|NCT01728077|54312550|FG000|Overall Study|Patient moving|1|||
28087507|NCT03315130|54740939|FG003|Main Portion (12 Weeks)|Lost to Follow-up|0|||
28087508|NCT03315130|54740936|FG000|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|1|||
28087509|NCT03315130|54740937|FG001|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
27832775|NCT01728077|54312551|FG001|Overall Study|Patient moving|0|||
27832776|NCT01728077|54312550|FG000|Overall Study|Non compliance|1|||
27832777|NCT01728077|54312551|FG001|Overall Study|Non compliance|0|||
27832778|NCT01606007|54312570|FG000|Overall Study|Reason 'Other' in the protocol|0|||
27832779|NCT01606007|54312571|FG001|Overall Study|Reason 'Other' in the protocol|1|||
27832780|NCT01606007|54312572|FG002|Overall Study|Reason 'Other' in the protocol|1|||
27832781|NCT01606007|54312570|FG000|Overall Study|Pregnancy|0|||
27832782|NCT01606007|54312571|FG001|Overall Study|Pregnancy|1|||
27832783|NCT01606007|54312572|FG002|Overall Study|Pregnancy|1|||
27832784|NCT01606007|54312570|FG000|Overall Study|Withdrawal by Subject|8|||
27832785|NCT01606007|54312571|FG001|Overall Study|Withdrawal by Subject|6|||
27855655|NCT02733042|54382055|FG017|Treatment Period|Withdrawal by Subject|0|||
27855656|NCT02733042|54382056|FG018|Treatment Period|Withdrawal by Subject|0|||
27978952|NCT00838539|54636661|FG010|Overall Study|Symptomatic Deterioration|0|||
27978953|NCT00838539|54636662|FG011|Overall Study|Symptomatic Deterioration|0|||
27978954|NCT00837759|54636702|FG000|Overall Study|Protocol Violation|3|||
27855657|NCT02733042|54382038|FG000|Treatment Period|Other|0|||
27855658|NCT02733042|54382039|FG001|Treatment Period|Other|0|||
27855659|NCT02733042|54382040|FG002|Treatment Period|Other|1|||
27855660|NCT02733042|54382041|FG003|Treatment Period|Other|0|||
27855661|NCT02733042|54382042|FG004|Treatment Period|Other|0|||
27855662|NCT02733042|54382043|FG005|Treatment Period|Other|0|||
27855663|NCT02733042|54382044|FG006|Treatment Period|Other|0|||
27855664|NCT02733042|54382045|FG007|Treatment Period|Other|0|||
27855665|NCT02733042|54382046|FG008|Treatment Period|Other|0|||
27855666|NCT02733042|54382047|FG009|Treatment Period|Other|1|||
27855667|NCT02733042|54382048|FG010|Treatment Period|Other|1|||
27855668|NCT02733042|54382049|FG011|Treatment Period|Other|0|||
27855669|NCT02733042|54382050|FG012|Treatment Period|Other|0|||
27855670|NCT02733042|54382051|FG013|Treatment Period|Other|0|||
27855671|NCT02733042|54382052|FG014|Treatment Period|Other|0|||
27855672|NCT02733042|54382053|FG015|Treatment Period|Other|1|||
27855673|NCT02733042|54382054|FG016|Treatment Period|Other|0|||
27855674|NCT02733042|54382055|FG017|Treatment Period|Other|1|||
27855675|NCT02733042|54382056|FG018|Treatment Period|Other|0|||
27855676|NCT02733042|54382038|FG000|Treatment Period|Ongoing on Assigned Treatment|0|||
27978955|NCT00837759|54636702|FG000|Overall Study|Lost to Follow-up|1|||
27978956|NCT00891774|54636706|FG000|Overall Study|Lost to Follow-up|5|||
27978957|NCT00891774|54636706|FG000|Overall Study|Illness (Self/Mother)|3|||
27978958|NCT00891774|54636706|FG000|Overall Study|Withdrawal by Subject|2|||
27978959|NCT00891774|54636706|FG000|Overall Study|Protocol Violation|4|||
27978960|NCT05421754|54636710|FG000|Overall Study|Technical issue with sensor|1|||
27978961|NCT04913675|54636726|FG000|Overall Study|Death|0|||
27978962|NCT04913675|54636727|FG001|Overall Study|Death|2|||
27978963|NCT04913675|54636728|FG002|Overall Study|Death|2|||
27978964|NCT04913675|54636726|FG000|Overall Study|Lost to Follow-up|12|||
27978965|NCT04913675|54636727|FG001|Overall Study|Lost to Follow-up|8|||
27978966|NCT04913675|54636728|FG002|Overall Study|Lost to Follow-up|4|||
27978967|NCT04913675|54636726|FG000|Overall Study|Physician Decision|0|||
27978968|NCT04913675|54636727|FG001|Overall Study|Physician Decision|1|||
27978969|NCT04913675|54636728|FG002|Overall Study|Physician Decision|1|||
27978970|NCT04913675|54636726|FG000|Overall Study|Withdrawal by Subject|25|||
27978971|NCT04913675|54636727|FG001|Overall Study|Withdrawal by Subject|33|||
27978972|NCT04913675|54636728|FG002|Overall Study|Withdrawal by Subject|12|||
27978973|NCT04644276|54636747|FG000|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
27978974|NCT04644276|54636748|FG001|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
27978975|NCT04644276|54636749|FG002|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|1|||
27978976|NCT03845296|54636778|FG000|Overall Study|On Treatment|2|||
27978977|NCT03845296|54636779|FG001|Overall Study|On Treatment|1|||
27978978|NCT03845296|54636778|FG000|Overall Study|Adverse Event|4|||
27978979|NCT03845296|54636779|FG001|Overall Study|Adverse Event|11|||
27978980|NCT03845296|54636778|FG000|Overall Study|Refusal unrelated to adverse event|0|||
27978981|NCT03845296|54636779|FG001|Overall Study|Refusal unrelated to adverse event|1|||
27978982|NCT03845296|54636778|FG000|Overall Study|Progression/relapse|14|||
27978983|NCT03845296|54636779|FG001|Overall Study|Progression/relapse|18|||
27978984|NCT03845296|54636778|FG000|Overall Study|Death|4|||
27978985|NCT03845296|54636779|FG001|Overall Study|Death|0|||
27855677|NCT02733042|54382039|FG001|Treatment Period|Ongoing on Assigned Treatment|0|||
27832786|NCT01606007|54312572|FG002|Overall Study|Withdrawal by Subject|1|||
27832787|NCT01606007|54312570|FG000|Overall Study|Adverse Event|0|||
27832788|NCT01606007|54312571|FG001|Overall Study|Adverse Event|1|||
27832789|NCT01606007|54312572|FG002|Overall Study|Adverse Event|1|||
27855678|NCT02733042|54382040|FG002|Treatment Period|Ongoing on Assigned Treatment|0|||
27855679|NCT02733042|54382041|FG003|Treatment Period|Ongoing on Assigned Treatment|0|||
27855680|NCT02733042|54382042|FG004|Treatment Period|Ongoing on Assigned Treatment|3|||
27855681|NCT02733042|54382043|FG005|Treatment Period|Ongoing on Assigned Treatment|0|||
27855682|NCT02733042|54382044|FG006|Treatment Period|Ongoing on Assigned Treatment|0|||
27978986|NCT03845296|54636778|FG000|Overall Study|Other - not protocol specified|1|||
27978987|NCT03845296|54636779|FG001|Overall Study|Other - not protocol specified|3|||
27978988|NCT02115282|54636826|FG000|Overall Study|Disease progression during treatment|216|||
27978989|NCT02115282|54636827|FG001|Overall Study|Disease progression during treatment|229|||
27978990|NCT02115282|54636826|FG000|Overall Study|Adverse Event|49|||
27978991|NCT02115282|54636827|FG001|Overall Study|Adverse Event|23|||
27978992|NCT02115282|54636826|FG000|Overall Study|Death|1|||
27978993|NCT02115282|54636827|FG001|Overall Study|Death|3|||
27978994|NCT02115282|54636826|FG000|Overall Study|Alternative therapy|1|||
27978995|NCT02115282|54636827|FG001|Overall Study|Alternative therapy|1|||
27978996|NCT02115282|54636826|FG000|Overall Study|Complicating disease|0|||
27978997|NCT02115282|54636827|FG001|Overall Study|Complicating disease|3|||
27978998|NCT02115282|54636826|FG000|Overall Study|Withdrawal by Subject|12|||
27978999|NCT02115282|54636827|FG001|Overall Study|Withdrawal by Subject|10|||
27979000|NCT02115282|54636826|FG000|Overall Study|Symptomatic progression/deterioration|7|||
27979001|NCT02115282|54636827|FG001|Overall Study|Symptomatic progression/deterioration|18|||
27979002|NCT02115282|54636826|FG000|Overall Study|Non-compliance|5|||
27979003|NCT02115282|54636827|FG001|Overall Study|Non-compliance|1|||
27979004|NCT02115282|54636826|FG000|Overall Study|Protocol Violation|2|||
27979005|NCT02115282|54636827|FG001|Overall Study|Protocol Violation|2|||
27979006|NCT02115282|54636826|FG000|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
27979007|NCT02115282|54636827|FG001|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
27979008|NCT02115282|54636826|FG000|Overall Study|Not start protocol therapy|9|||
27979009|NCT02115282|54636827|FG001|Overall Study|Not start protocol therapy|10|||
27979010|NCT01596621|54636835|FG000|Overall Study|Death|4|||
27979011|NCT01596621|54636835|FG000|Overall Study|Withdrawal by Subject|9|||
28087510|NCT03315130|54740938|FG002|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
28087511|NCT03315130|54740939|FG003|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
28087512|NCT03315130|54740936|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
28087513|NCT03315130|54740937|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|1|||
28087514|NCT03315130|54740938|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
28087515|NCT03315130|54740939|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
28087516|NCT03315130|54740936|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
28087517|NCT03315130|54740937|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|1|||
28087518|NCT03315130|54740938|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
28087519|NCT03315130|54740939|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
27979012|NCT01596621|54636835|FG000|Overall Study|Disease Progression|49|||
27979013|NCT01596621|54636835|FG000|Overall Study|Lost to Follow-up|3|||
27979014|NCT01596621|54636835|FG000|Overall Study|Other than specified|13|||
28087520|NCT03315130|54740936|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
28087521|NCT03315130|54740937|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|2|||
28165646|NCT01068743|54836276|FG002|Period 3|Adverse Event|0|||
28165647|NCT01068743|54836277|FG003|Period 3|Adverse Event|0|||
28165648|NCT02992691|54836290|FG000|Overall Study|Adverse Event|2|||
28165649|NCT02992691|54836290|FG000|Overall Study|Withdrawal by Subject|1|||
28165650|NCT02921087|54836307|FG000|Overall Study|Withdrawal by Subject|0|||
28165651|NCT02921087|54836308|FG001|Overall Study|Withdrawal by Subject|1|||
28165652|NCT02907619|54836327|FG000|Overall Study|Study terminated by sponsor|18|||
28165653|NCT02907619|54836328|FG001|Overall Study|Study terminated by sponsor|18|||
28165654|NCT02907619|54836329|FG002|Overall Study|Study terminated by sponsor|19|||
28165655|NCT02907619|54836327|FG000|Overall Study|Death|0|||
28165656|NCT02907619|54836328|FG001|Overall Study|Death|0|||
28165657|NCT02907619|54836329|FG002|Overall Study|Death|1|||
28165658|NCT02907619|54836327|FG000|Overall Study|Withdrawal by Subject|1|||
28165659|NCT02907619|54836328|FG001|Overall Study|Withdrawal by Subject|1|||
28165660|NCT02907619|54836329|FG002|Overall Study|Withdrawal by Subject|0|||
28165661|NCT02907619|54836327|FG000|Overall Study|Other|0|||
28165662|NCT02907619|54836328|FG001|Overall Study|Other|1|||
28165663|NCT02907619|54836329|FG002|Overall Study|Other|0|||
28165664|NCT02986373|54836339|FG000|Overall Study|Adverse Event|4|||
28165665|NCT02986373|54836339|FG000|Overall Study|Lost to Follow-up|1|||
28165666|NCT02986373|54836339|FG000|Overall Study|Withdrawal by Subject|10|||
28165667|NCT02986373|54836339|FG000|Overall Study|Other|24|||
28165668|NCT02986139|54836345|FG000|Overall Study|Sponsor Decision|1|||
28165669|NCT02986139|54836346|FG001|Overall Study|Sponsor Decision|2|||
27979015|NCT01337245|54636839|FG000|Overall Study|Lost to Follow-up|1|||
28165670|NCT02986139|54836345|FG000|Overall Study|Withdrawal by Subject|0|||
28165671|NCT02986139|54836346|FG001|Overall Study|Withdrawal by Subject|1|||
28165672|NCT02986139|54836345|FG000|Overall Study|Lost to Follow-up|0|||
28165673|NCT02986139|54836346|FG001|Overall Study|Lost to Follow-up|1|||
27979016|NCT00566098|54636849|FG000|Collection of MILs|Withdrawal by Subject|1|||
27979017|NCT00566098|54636849|FG000|Collection of MILs|Relapsed|1|||
27979018|NCT00566098|54636849|FG000|Generation of MILs Product|Relapsed|1|||
28165674|NCT02989805|54836358|FG000|Overall Study|invalid consent|6|||
28165675|NCT02989805|54836359|FG001|Overall Study|invalid consent|4|||
27979019|NCT00566098|54636849|FG000|Administration of ASCT+MILs|Death|10|||
28087522|NCT03315130|54740938|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
28087523|NCT03315130|54740939|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|1|||
28087524|NCT03273166|54740959|FG000|Overall Study|Withdrawn prior to Completion|31|||
27979020|NCT00566098|54636849|FG000|Administration of ASCT+MILs|Lack of Efficacy|8|||
27979021|NCT00248287|54636856|FG000|Overall Study|Adverse Event|11|||
27979022|NCT00248287|54636857|FG001|Overall Study|Adverse Event|10|||
27979023|NCT00248287|54636856|FG000|Overall Study|Death|1|||
27979024|NCT00248287|54636857|FG001|Overall Study|Death|0|||
27979025|NCT00248287|54636856|FG000|Overall Study|Lost to Follow-up|0|||
27979026|NCT00248287|54636857|FG001|Overall Study|Lost to Follow-up|1|||
27979027|NCT00248287|54636856|FG000|Overall Study|Investigator Request|4|||
27979028|NCT00248287|54636857|FG001|Overall Study|Investigator Request|3|||
27979029|NCT00248287|54636856|FG000|Overall Study|Patient Request|5|||
27979030|NCT00248287|54636857|FG001|Overall Study|Patient Request|3|||
27979031|NCT00248287|54636856|FG000|Overall Study|Other|3|||
27979032|NCT00248287|54636857|FG001|Overall Study|Other|2|||
27979033|NCT00837213|54636865|FG000|Overall Study|Lost to Follow-up|3|||
27979034|NCT00837213|54636866|FG001|Overall Study|Lost to Follow-up|2|||
27979035|NCT00837213|54636865|FG000|Overall Study|Withdrawal by Subject|2|||
27979036|NCT00837213|54636866|FG001|Overall Study|Withdrawal by Subject|2|||
27979037|NCT00837213|54636865|FG000|Overall Study|not stated|1|||
27979038|NCT00837213|54636866|FG001|Overall Study|not stated|1|||
27979039|NCT00902486|54636876|FG000|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
27979040|NCT00902486|54636877|FG001|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
27979041|NCT00902486|54636878|FG002|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
27979042|NCT00902486|54636879|FG003|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
27979043|NCT00902486|54636880|FG004|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
27979044|NCT00902486|54636881|FG005|Treatment Period (Weeks 0 Through 12)|Adverse Event|2|||
27979045|NCT00902486|54636876|FG000|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1|||
27979046|NCT00902486|54636877|FG001|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
27979047|NCT00902486|54636878|FG002|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
28087525|NCT03314662|54740967|FG000|Overall Study|Withdrawal by Subject|1|||
28087526|NCT03314662|54740968|FG001|Overall Study|Withdrawal by Subject|1|||
27979048|NCT00902486|54636879|FG003|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
27979049|NCT00902486|54636880|FG004|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
27979050|NCT00902486|54636881|FG005|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2|||
28087527|NCT03314662|54740969|FG002|Overall Study|Withdrawal by Subject|1|||
28087528|NCT03314662|54740967|FG000|Overall Study|Lost to Follow-up|5|||
27855683|NCT02733042|54382045|FG007|Treatment Period|Ongoing on Assigned Treatment|0|||
27855684|NCT02733042|54382046|FG008|Treatment Period|Ongoing on Assigned Treatment|0|||
27855685|NCT02733042|54382047|FG009|Treatment Period|Ongoing on Assigned Treatment|8|||
27855686|NCT02733042|54382048|FG010|Treatment Period|Ongoing on Assigned Treatment|4|||
27979051|NCT00902486|54636876|FG000|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
27979052|NCT00902486|54636877|FG001|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
28087529|NCT03314662|54740968|FG001|Overall Study|Lost to Follow-up|4|||
28087530|NCT03314662|54740969|FG002|Overall Study|Lost to Follow-up|4|||
28087531|NCT03314662|54740967|FG000|Overall Study|Death|2|||
28087532|NCT03314662|54740968|FG001|Overall Study|Death|0|||
28087533|NCT03314662|54740969|FG002|Overall Study|Death|0|||
28087534|NCT03271528|54740987|FG000|Medication Dispense/Exposure Period 1|Adverse Event|1|||
28087535|NCT03271528|54740988|FG001|Medication Dispense/Exposure Period 1|Adverse Event|0|||
28087536|NCT03271528|54740987|FG000|Medication Dispense/Exposure Period 1|Protocol Violation|1|||
28087537|NCT03271528|54740988|FG001|Medication Dispense/Exposure Period 1|Protocol Violation|0|||
28087538|NCT03271528|54740987|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
28087539|NCT03271528|54740988|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
28087540|NCT03271528|54740987|FG000|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|0|||
28087541|NCT03271528|54740988|FG001|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|1|||
28087542|NCT03271528|54740987|FG000|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
28087543|NCT03271528|54740988|FG001|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
28087544|NCT03271528|54740987|FG000|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|1|||
28087545|NCT03271528|54740988|FG001|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|0|||
28087546|NCT03271528|54740987|FG000|Medication Dispense/Exposure Period 2|Lost to Follow-up|1|||
27979053|NCT00902486|54636878|FG002|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
27979054|NCT00902486|54636879|FG003|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
27979055|NCT00902486|54636880|FG004|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
28087547|NCT03271528|54740988|FG001|Medication Dispense/Exposure Period 2|Lost to Follow-up|0|||
27855687|NCT02733042|54382049|FG011|Treatment Period|Ongoing on Assigned Treatment|0|||
27855688|NCT02733042|54382050|FG012|Treatment Period|Ongoing on Assigned Treatment|0|||
27979056|NCT00902486|54636881|FG005|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
27979057|NCT00902486|54636876|FG000|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
27979058|NCT00902486|54636877|FG001|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
27979059|NCT00902486|54636878|FG002|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
27979060|NCT00902486|54636879|FG003|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1|||
27979061|NCT00902486|54636880|FG004|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
27979062|NCT00902486|54636881|FG005|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
27979063|NCT00902486|54636876|FG000|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
27979064|NCT00902486|54636877|FG001|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
27979065|NCT00902486|54636878|FG002|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
27979066|NCT00902486|54636879|FG003|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1|||
27979067|NCT00902486|54636880|FG004|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
27979068|NCT00902486|54636881|FG005|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
27979069|NCT00902486|54636876|FG000|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
27979070|NCT00902486|54636877|FG001|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
27979071|NCT00902486|54636878|FG002|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
27979072|NCT00902486|54636879|FG003|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
27979073|NCT00902486|54636880|FG004|Extension Period (Weeks 12 Through 24)|Adverse Event|1|||
27979074|NCT00902486|54636881|FG005|Extension Period (Weeks 12 Through 24)|Adverse Event|2|||
27979075|NCT00902486|54636876|FG000|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
27979076|NCT00902486|54636877|FG001|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
27979077|NCT00902486|54636878|FG002|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
27979078|NCT00902486|54636879|FG003|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
27979079|NCT00902486|54636880|FG004|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
27979080|NCT00902486|54636881|FG005|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
27979081|NCT00902486|54636876|FG000|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
27979082|NCT00902486|54636877|FG001|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
27979083|NCT00902486|54636878|FG002|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
27979084|NCT00902486|54636879|FG003|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
27979085|NCT00902486|54636880|FG004|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
27979086|NCT00902486|54636881|FG005|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1|||
27979087|NCT00902486|54636876|FG000|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
27979088|NCT00902486|54636877|FG001|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
27979089|NCT00902486|54636878|FG002|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
27979090|NCT00902486|54636879|FG003|Extension Period (Weeks 12 Through 24)|Disease Progression|1|||
27979091|NCT00902486|54636880|FG004|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
27979092|NCT00902486|54636881|FG005|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
27979093|NCT00902486|54636876|FG000|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
27979094|NCT00902486|54636877|FG001|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
27979095|NCT00902486|54636878|FG002|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1|||
27979096|NCT00902486|54636879|FG003|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
27979097|NCT00902486|54636880|FG004|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
27979098|NCT00902486|54636881|FG005|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
27979099|NCT00902486|54636876|FG000|Follow-up (After Week 24)|Lost to Follow-up|0|||
27979100|NCT00902486|54636877|FG001|Follow-up (After Week 24)|Lost to Follow-up|0|||
27979101|NCT00902486|54636878|FG002|Follow-up (After Week 24)|Lost to Follow-up|0|||
27979102|NCT00902486|54636879|FG003|Follow-up (After Week 24)|Lost to Follow-up|1|||
27979103|NCT00902486|54636880|FG004|Follow-up (After Week 24)|Lost to Follow-up|0|||
27979104|NCT00902486|54636881|FG005|Follow-up (After Week 24)|Lost to Follow-up|0|||
28087548|NCT03301714|54740997|FG000|Overall Study|Lost to Follow-up|10|||
28087549|NCT03301714|54740998|FG001|Overall Study|Lost to Follow-up|4|||
28087550|NCT03301714|54740999|FG002|Overall Study|Lost to Follow-up|4|||
28087551|NCT03301714|54740997|FG000|Overall Study|Did not receive allocated intervention|0|||
28087552|NCT03301714|54740998|FG001|Overall Study|Did not receive allocated intervention|2|||
28087553|NCT03301714|54740999|FG002|Overall Study|Did not receive allocated intervention|3|||
28087554|NCT03299686|54741012|FG000|Treatment Epoch|Subject/Guardian Decision|2|||
28087555|NCT03299686|54741013|FG001|Treatment Epoch|Subject/Guardian Decision|0|||
28087556|NCT03299686|54741012|FG000|Treatment Epoch|Physician Decision|1|||
28087557|NCT03299686|54741013|FG001|Treatment Epoch|Physician Decision|0|||
28087558|NCT03299686|54741012|FG000|Treatment Epoch|Adverse Event|8|||
28087559|NCT03299686|54741013|FG001|Treatment Epoch|Adverse Event|4|||
27733340|NCT02559206|54181158|FG005|Overall Study|Withdrawal by Subject|4|||
27733341|NCT02559206|54181159|FG006|Overall Study|Withdrawal by Subject|1|||
27733342|NCT02559206|54181160|FG007|Overall Study|Withdrawal by Subject|2|||
27733343|NCT02559206|54181153|FG000|Overall Study|Lost to Follow-up|3|||
27733344|NCT02559206|54181154|FG001|Overall Study|Lost to Follow-up|5|||
27733345|NCT02559206|54181155|FG002|Overall Study|Lost to Follow-up|3|||
27979105|NCT00836745|54636911|FG000|Overall Study|Death|2|||
27979106|NCT00836745|54636911|FG000|Overall Study|Lost to Follow-up|10|||
27979107|NCT00836745|54636911|FG000|Overall Study|Adverse Event|3|||
27979108|NCT00836745|54636911|FG000|Overall Study|Objective progression or relapse|4|||
27979109|NCT00836745|54636911|FG000|Overall Study|Other|2|||
27979110|NCT00891618|54636915|FG000|Overall Study|Withdrawal by Subject|1|||
27979111|NCT00836589|54636919|FG000|Overall Study|Lost to Follow-up|246|||
27979112|NCT00836589|54636919|FG000|Overall Study|Death|429|||
27979113|NCT00836589|54636919|FG000|Overall Study|Withdrawal by Subject or Physician|591|||
27979114|NCT00574795|54636931|FG000|Infant Series|Withdrawal by Subject|2|||
28087560|NCT03299686|54741012|FG000|Follow-up Epoch|Subject/Guardian Decision|0|||
28087561|NCT03299686|54741013|FG001|Follow-up Epoch|Subject/Guardian Decision|1|||
27979115|NCT00574795|54636931|FG000|Infant Series|Protocol Violation|2|||
27979116|NCT00574795|54636931|FG000|Infant Series|Adverse Event|1|||
27979117|NCT00574795|54636931|FG000|After Infant Series|Withdrawal by Subject|1|||
27979118|NCT00574795|54636931|FG000|After Infant Series|Adverse Event|2|||
27979119|NCT00574795|54636931|FG000|Toddler Dose|Withdrawal by Subject|1|||
27979120|NCT02297516|54636948|FG000|Single Treatment Phase (6 Months)|Medical reason|1|||
27979121|NCT02297516|54636949|FG001|Single Treatment Phase (6 Months)|Medical reason|0|||
27979122|NCT02297516|54636948|FG000|Single Treatment Phase (6 Months)|Protocol Violation|0|||
28087562|NCT03462758|54741021|FG000|Overall Study|Chose no or other method of contraception|20|||
28087563|NCT03462758|54741022|FG001|Overall Study|Chose no or other method of contraception|23|||
28087564|NCT03462758|54741021|FG000|Overall Study|Lost to follow-up before IUD placement|14|||
28087565|NCT03462758|54741022|FG001|Overall Study|Lost to follow-up before IUD placement|12|||
28087566|NCT03462758|54741021|FG000|Overall Study|Unsuccessful IUD placement attempt|3|||
28087567|NCT03462758|54741022|FG001|Overall Study|Unsuccessful IUD placement attempt|3|||
28087568|NCT03462758|54741021|FG000|Overall Study|Medical contraindication|2|||
28087569|NCT03462758|54741022|FG001|Overall Study|Medical contraindication|2|||
28087570|NCT03462758|54741021|FG000|Overall Study|Lost to follow-up after IUD placement|17|||
28087571|NCT03462758|54741022|FG001|Overall Study|Lost to follow-up after IUD placement|14|||
28087572|NCT00075270|54741030|FG000|Overall Study|Withdrawal by Subject|28|||
28087573|NCT00075270|54741031|FG001|Overall Study|Withdrawal by Subject|21|||
28087574|NCT00075270|54741030|FG000|Overall Study|Lost to Follow-up|25|||
28087575|NCT00075270|54741031|FG001|Overall Study|Lost to Follow-up|28|||
28087576|NCT00075270|54741030|FG000|Overall Study|Protocol Violation|0|||
28087577|NCT00075270|54741031|FG001|Overall Study|Protocol Violation|2|||
28087578|NCT00075270|54741030|FG000|Overall Study|Death|198|||
28087579|NCT00075270|54741031|FG001|Overall Study|Death|215|||
28087580|NCT00075270|54741030|FG000|Overall Study|Other/Unknown|9|||
28087581|NCT00075270|54741031|FG001|Overall Study|Other/Unknown|5|||
28087582|NCT00075270|54741030|FG000|Overall Study|Missing|26|||
28087583|NCT00075270|54741031|FG001|Overall Study|Missing|13|||
28087584|NCT00074958|54741038|FG000|Overall Study|Adverse Event|1|||
27733346|NCT02559206|54181156|FG003|Overall Study|Lost to Follow-up|3|||
27733347|NCT02559206|54181157|FG004|Overall Study|Lost to Follow-up|2|||
27979123|NCT02297516|54636949|FG001|Single Treatment Phase (6 Months)|Protocol Violation|2|||
27979124|NCT02297516|54636948|FG000|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0|||
27979125|NCT02297516|54636949|FG001|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1|||
27979126|NCT00836277|54636962|FG000|Overall Study|Not evaluable for response|6|||
27979127|NCT00835731|54636968|FG000|Overall Study|Withdrawal by Subject|1|||
27979128|NCT00835731|54636969|FG001|Overall Study|Withdrawal by Subject|0|||
27979129|NCT00835731|54636968|FG000|Overall Study|Physician Decision|1|||
27979130|NCT00835731|54636969|FG001|Overall Study|Physician Decision|1|||
27979131|NCT00835341|54636977|FG000|Overall Study|Lost to Follow-up|3|||
27979132|NCT00835341|54636978|FG001|Overall Study|Lost to Follow-up|12|||
27979133|NCT00574249|54636986|FG000|Overall Study|Adverse Event|6|||
27979134|NCT00574249|54636987|FG001|Overall Study|Adverse Event|18|||
27979135|NCT00574249|54636986|FG000|Overall Study|Lack of Efficacy|5|||
27979136|NCT00574249|54636987|FG001|Overall Study|Lack of Efficacy|3|||
27979137|NCT00574249|54636986|FG000|Overall Study|Lost to Follow-up|4|||
27979138|NCT00574249|54636987|FG001|Overall Study|Lost to Follow-up|3|||
27979139|NCT00574249|54636986|FG000|Overall Study|Protocol Violation|5|||
27979140|NCT00574249|54636987|FG001|Overall Study|Protocol Violation|2|||
27979141|NCT00574249|54636986|FG000|Overall Study|History of carcinoma|1|||
27979142|NCT00574249|54636987|FG001|Overall Study|History of carcinoma|0|||
27979143|NCT00574249|54636986|FG000|Overall Study|Withdrawal by Subject|3|||
27979144|NCT00574249|54636987|FG001|Overall Study|Withdrawal by Subject|0|||
28087585|NCT03298984|54741046|FG000|Overall Study|Physician Decision|1|||
28087586|NCT03298984|54741047|FG001|Overall Study|Physician Decision|0|||
28087587|NCT03298984|54741048|FG002|Overall Study|Physician Decision|0|||
28087588|NCT03298984|54741049|FG003|Overall Study|Physician Decision|6|||
28087589|NCT03298984|54741046|FG000|Overall Study|Lack of Efficacy|0|||
27979145|NCT00574249|54636986|FG000|Overall Study|Physician Decision|1|||
27979146|NCT00574249|54636987|FG001|Overall Study|Physician Decision|0|||
27979147|NCT00574249|54636986|FG000|Overall Study|Pregnancy|1|||
27979148|NCT00574249|54636987|FG001|Overall Study|Pregnancy|0|||
27979149|NCT00574249|54636986|FG000|Overall Study|Excluded by company|0|||
28087590|NCT03298984|54741047|FG001|Overall Study|Lack of Efficacy|1|||
28087591|NCT03298984|54741048|FG002|Overall Study|Lack of Efficacy|1|||
27979150|NCT00574249|54636987|FG001|Overall Study|Excluded by company|1|||
27979151|NCT00574249|54636986|FG000|Overall Study|PPD test taken twice|0|||
27979152|NCT00574249|54636987|FG001|Overall Study|PPD test taken twice|1|||
27979153|NCT00891228|54636996|FG000|Overall Study|Adverse Event|0|||
27979154|NCT00891228|54636997|FG001|Overall Study|Adverse Event|2|||
27979155|NCT00891228|54636998|FG002|Overall Study|Adverse Event|3|||
27979156|NCT00891228|54636996|FG000|Overall Study|Withdrawal by Subject|2|||
27979157|NCT00891228|54636997|FG001|Overall Study|Withdrawal by Subject|4|||
27979158|NCT00891228|54636998|FG002|Overall Study|Withdrawal by Subject|5|||
27979159|NCT00891228|54636996|FG000|Overall Study|Protocol Violation|3|||
27979160|NCT00891228|54636997|FG001|Overall Study|Protocol Violation|1|||
27979161|NCT00891228|54636998|FG002|Overall Study|Protocol Violation|2|||
27979162|NCT00891228|54636996|FG000|Overall Study|Physician Decision|2|||
27979163|NCT00891228|54636997|FG001|Overall Study|Physician Decision|1|||
27979164|NCT00891228|54636998|FG002|Overall Study|Physician Decision|0|||
27979165|NCT00891228|54636996|FG000|Overall Study|Lost to Follow-up|4|||
27979166|NCT00891228|54636997|FG001|Overall Study|Lost to Follow-up|4|||
27979167|NCT00891228|54636998|FG002|Overall Study|Lost to Follow-up|5|||
27979168|NCT00891228|54636996|FG000|Overall Study|Pregnancy|0|||
27979169|NCT00891228|54636997|FG001|Overall Study|Pregnancy|1|||
27979170|NCT00891228|54636998|FG002|Overall Study|Pregnancy|0|||
27979171|NCT00896168|54637008|FG000|Overall Study|Adverse Event|4|||
27979172|NCT00896168|54637009|FG001|Overall Study|Adverse Event|7|||
27979173|NCT00896168|54637008|FG000|Overall Study|Treatment failure|8|||
27979174|NCT00896168|54637009|FG001|Overall Study|Treatment failure|10|||
27979175|NCT00896168|54637008|FG000|Overall Study|Lost to Follow-up|1|||
27979176|NCT00896168|54637009|FG001|Overall Study|Lost to Follow-up|1|||
27979177|NCT00896168|54637008|FG000|Overall Study|Other|1|||
27979178|NCT00896168|54637009|FG001|Overall Study|Other|1|||
27979179|NCT00833703|54637017|FG000|Overall Study|Parent(s)/guardian(s)'s request|0|||
27979180|NCT00833703|54637018|FG001|Overall Study|Parent(s)/guardian(s)'s request|1|||
27979181|NCT00833547|54637026|FG000|Overall Study|Withdrawal by Subject|2|||
27979182|NCT00833547|54637027|FG001|Overall Study|Withdrawal by Subject|2|||
27979183|NCT00833469|54637033|FG000|Overall Study|Withdrawal by Subject|1|||
27979184|NCT00833469|54637033|FG000|Overall Study|Lost to Follow-up|1|||
27979185|NCT00832377|54637037|FG000|Overall Study|Protocol Violation|1|||
27979186|NCT00892008|54637041|FG000|Overall Study|Death|5|||
27979187|NCT00892008|54637041|FG000|Overall Study|Lack of Efficacy|3|||
27979188|NCT00892008|54637041|FG000|Overall Study|Lost to Follow-up|142|||
27979189|NCT00892008|54637041|FG000|Overall Study|Other|378|||
27979190|NCT00892008|54637041|FG000|Overall Study|Adverse Event|37|||
27979191|NCT00623233|54637045|FG000|Overall Study|Adverse Event|10|||
27979192|NCT00623233|54637045|FG000|Overall Study|Physician Decision|10|||
27979193|NCT00623233|54637045|FG000|Overall Study|Lost to Follow-up|1|||
27979194|NCT00623233|54637045|FG000|Overall Study|Withdrawal by Subject|3|||
27979195|NCT03369236|54637060|FG000|Double-blind Treatment Period|Accidental unblinding|0|||
27979196|NCT03369236|54637061|FG001|Double-blind Treatment Period|Accidental unblinding|1|||
27979197|NCT03369236|54637060|FG000|Open-label Extension Period|Lack of Efficacy|2|||
27979198|NCT03369236|54637061|FG001|Open-label Extension Period|Lack of Efficacy|1|||
27979199|NCT03369236|54637060|FG000|Open-label Extension Period|Adverse Event|0|||
27979200|NCT03369236|54637061|FG001|Open-label Extension Period|Adverse Event|1|||
27979201|NCT03369236|54637060|FG000|Open-label Extension Period|Sponsor decision to close study|3|||
27979202|NCT03369236|54637061|FG001|Open-label Extension Period|Sponsor decision to close study|4|||
27979203|NCT00621751|54637075|FG000|Overall Study|Adverse Event|0|||
27979204|NCT00621751|54637076|FG001|Overall Study|Adverse Event|1|||
27979205|NCT00891930|54637093|FG000|Part 1: Panitumumab +Irinotecan|Death|38|||
27979206|NCT00891930|54637093|FG000|Part 1: Panitumumab +Irinotecan|Withdrawal by Subject|1|||
27979207|NCT00891930|54637093|FG000|Part 1: Panitumumab +Irinotecan|Lost to Follow-up|1|||
27979208|NCT00891930|54637093|FG000|Part 2: Panitumumab + Ganitumab|Death|30|||
27979209|NCT00891930|54637093|FG000|Part 2: Panitumumab + Ganitumab|Withdrawal by Subject|1|||
27979210|NCT00895622|54637104|FG000|Overall Study|Protocol Violation|5|||
27979211|NCT00895622|54637105|FG001|Overall Study|Protocol Violation|4|||
27979212|NCT00895622|54637106|FG002|Overall Study|Protocol Violation|4|||
27979213|NCT00891462|54637125|FG000|Overall Study|Withdrawal by Subject|9|||
27979214|NCT00891462|54637126|FG001|Overall Study|Withdrawal by Subject|6|||
27979215|NCT00891462|54637127|FG002|Overall Study|Withdrawal by Subject|7|||
27979216|NCT00891462|54637125|FG000|Overall Study|Adverse Event|7|||
27979217|NCT00891462|54637126|FG001|Overall Study|Adverse Event|8|||
27979218|NCT00891462|54637127|FG002|Overall Study|Adverse Event|7|||
27979219|NCT00891462|54637125|FG000|Overall Study|Lack of Efficacy|10|||
27979220|NCT00891462|54637126|FG001|Overall Study|Lack of Efficacy|5|||
27979221|NCT00891462|54637127|FG002|Overall Study|Lack of Efficacy|1|||
27979222|NCT00891462|54637125|FG000|Overall Study|COPD exacerbation|7|||
27979223|NCT00891462|54637126|FG001|Overall Study|COPD exacerbation|4|||
27979224|NCT00891462|54637127|FG002|Overall Study|COPD exacerbation|1|||
27979225|NCT00891462|54637125|FG000|Overall Study|Other Reason|2|||
27979226|NCT00891462|54637126|FG001|Overall Study|Other Reason|5|||
27979227|NCT00891462|54637127|FG002|Overall Study|Other Reason|3|||
27979228|NCT00891462|54637125|FG000|Overall Study|Protocol Violation|2|||
27979229|NCT00891462|54637126|FG001|Overall Study|Protocol Violation|1|||
27979230|NCT00891462|54637127|FG002|Overall Study|Protocol Violation|3|||
27979231|NCT00891462|54637125|FG000|Overall Study|Inclusion/exclusion criteria|0|||
27979232|NCT00891462|54637126|FG001|Overall Study|Inclusion/exclusion criteria|2|||
27979233|NCT00891462|54637127|FG002|Overall Study|Inclusion/exclusion criteria|2|||
27979234|NCT00891462|54637125|FG000|Overall Study|Lost to Follow-up|0|||
27979235|NCT00891462|54637126|FG001|Overall Study|Lost to Follow-up|2|||
27979236|NCT00891462|54637127|FG002|Overall Study|Lost to Follow-up|0|||
27979237|NCT00900146|54637142|FG000|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
27979238|NCT00900146|54637143|FG001|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
27979239|NCT00900146|54637144|FG002|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5|||
27979240|NCT00900146|54637145|FG003|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1|||
27979241|NCT00900146|54637146|FG004|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9|||
27979242|NCT00900146|54637142|FG000|Dose Finding: Period II (4 Months)|Lost to Follow-up|2|||
27979243|NCT00900146|54637143|FG001|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
27979244|NCT00900146|54637144|FG002|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
27979245|NCT00900146|54637145|FG003|Dose Finding: Period II (4 Months)|Lost to Follow-up|1|||
27979246|NCT00900146|54637146|FG004|Dose Finding: Period II (4 Months)|Lost to Follow-up|3|||
27979247|NCT00900146|54637142|FG000|Dose Finding: Period II (4 Months)|Administrative problems|1|||
27979248|NCT00900146|54637143|FG001|Dose Finding: Period II (4 Months)|Administrative problems|0|||
27979249|NCT00900146|54637144|FG002|Dose Finding: Period II (4 Months)|Administrative problems|0|||
27979250|NCT00900146|54637145|FG003|Dose Finding: Period II (4 Months)|Administrative problems|0|||
27979251|NCT00900146|54637146|FG004|Dose Finding: Period II (4 Months)|Administrative problems|0|||
27979252|NCT00900146|54637142|FG000|Intermediate: Period III|Withdrawal by Subject|0|||
27979253|NCT00900146|54637143|FG001|Intermediate: Period III|Withdrawal by Subject|1|||
27979254|NCT00900146|54637144|FG002|Intermediate: Period III|Withdrawal by Subject|0|||
27979255|NCT00900146|54637145|FG003|Intermediate: Period III|Withdrawal by Subject|0|||
27979256|NCT00900146|54637146|FG004|Intermediate: Period III|Withdrawal by Subject|3|||
27979257|NCT00900146|54637142|FG000|Intermediate: Period III|Lost to Follow-up|2|||
27979258|NCT00900146|54637143|FG001|Intermediate: Period III|Lost to Follow-up|0|||
27979259|NCT00900146|54637144|FG002|Intermediate: Period III|Lost to Follow-up|0|||
27979260|NCT00900146|54637145|FG003|Intermediate: Period III|Lost to Follow-up|0|||
27979261|NCT00900146|54637146|FG004|Intermediate: Period III|Lost to Follow-up|1|||
27979262|NCT00900146|54637142|FG000|Intermediate: Period III|Administrative problems|85|||
27979263|NCT00900146|54637143|FG001|Intermediate: Period III|Administrative problems|92|||
27979264|NCT00900146|54637144|FG002|Intermediate: Period III|Administrative problems|84|||
27979265|NCT00900146|54637145|FG003|Intermediate: Period III|Administrative problems|90|||
27979266|NCT00900146|54637146|FG004|Intermediate: Period III|Administrative problems|163|||
27979267|NCT00895310|54637158|FG000|Overall Study|Withdrawal by Subject|1|||
27979268|NCT00895154|54637164|FG000|Overall Study|Lost to Follow-up|1|||
27979269|NCT00895154|54637165|FG001|Overall Study|Lost to Follow-up|1|||
27979270|NCT00895154|54637164|FG000|Overall Study|Withdrawal by Subject|0|||
27979271|NCT00895154|54637165|FG001|Overall Study|Withdrawal by Subject|1|||
27979272|NCT00888654|54637171|FG000|Overall Study|Problems swallowing oral meds.|1|||
27979273|NCT00888654|54637171|FG000|Overall Study|Not enough oral meds before surgery|3|||
27979274|NCT00888654|54637171|FG000|Overall Study|Surgery aborted|2|||
27979275|NCT00888654|54637171|FG000|Overall Study|Withdrawal by Subject|1|||
27979276|NCT00888654|54637171|FG000|Overall Study|Inelig. due to contraindication of med|1|||
27979277|NCT00888654|54637171|FG000|Overall Study|Change in surg date|1|||
27979278|NCT00888654|54637171|FG000|Overall Study|Stopped meds due to headaches|1|||
28087592|NCT03298984|54741049|FG003|Overall Study|Lack of Efficacy|4|||
28087593|NCT03298984|54741046|FG000|Overall Study|Relapsed disease (following remission)|0|||
28087594|NCT03298984|54741047|FG001|Overall Study|Relapsed disease (following remission)|0|||
28087595|NCT03298984|54741048|FG002|Overall Study|Relapsed disease (following remission)|1|||
28087596|NCT03298984|54741049|FG003|Overall Study|Relapsed disease (following remission)|1|||
28087597|NCT03298984|54741046|FG000|Overall Study|Adverse Event|0|||
28087598|NCT03298984|54741047|FG001|Overall Study|Adverse Event|0|||
27979279|NCT00899678|54637178|FG000|Induction Period (Weeks 0 to 6)|Adverse Event|6|||
27979280|NCT00899678|54637179|FG001|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
27979281|NCT00899678|54637180|FG002|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
27979282|NCT00899678|54637178|FG000|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17|||
27979283|NCT00899678|54637179|FG001|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
27979284|NCT00899678|54637180|FG002|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
27979285|NCT00899678|54637178|FG000|Induction Period (Weeks 0 to 6)|Protocol Violation|1|||
27979286|NCT00899678|54637179|FG001|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
27979287|NCT00899678|54637180|FG002|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
28087599|NCT03298984|54741048|FG002|Overall Study|Adverse Event|0|||
28087600|NCT03298984|54741049|FG003|Overall Study|Adverse Event|1|||
28087601|NCT03298984|54741046|FG000|Overall Study|Death|0|||
28087602|NCT03298984|54741047|FG001|Overall Study|Death|0|||
27979288|NCT00899678|54637178|FG000|Induction Period (Weeks 0 to 6)|Other reason|1|||
27979289|NCT00899678|54637179|FG001|Induction Period (Weeks 0 to 6)|Other reason|0|||
27979290|NCT00899678|54637180|FG002|Induction Period (Weeks 0 to 6)|Other reason|0|||
27979291|NCT00899678|54637178|FG000|Maintenance Period (Weeks 8 to 62)|Adverse Event|0|||
27979292|NCT00899678|54637179|FG001|Maintenance Period (Weeks 8 to 62)|Adverse Event|10|||
27979293|NCT00899678|54637180|FG002|Maintenance Period (Weeks 8 to 62)|Adverse Event|5|||
27979294|NCT00899678|54637178|FG000|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0|||
27979295|NCT00899678|54637179|FG001|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11|||
27979296|NCT00899678|54637180|FG002|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18|||
27979297|NCT00899678|54637178|FG000|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0|||
27979298|NCT00899678|54637179|FG001|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
27979299|NCT00899678|54637180|FG002|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
27979300|NCT00899678|54637178|FG000|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0|||
27979301|NCT00899678|54637179|FG001|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1|||
27979302|NCT00899678|54637180|FG002|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2|||
27979303|NCT00899678|54637178|FG000|Maintenance Period (Weeks 8 to 62)|Other reason|0|||
27979304|NCT00899678|54637179|FG001|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
27979305|NCT00899678|54637180|FG002|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
27979306|NCT00887484|54637188|FG000|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1|||
27979307|NCT00887484|54637188|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
27979308|NCT00887484|54637188|FG000|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1|||
27979309|NCT00886938|54637197|FG000|Overall Study|Adverse Event|1|||
27979310|NCT00886938|54637197|FG000|Overall Study|Withdrawal by Subject|1|||
27979311|NCT00620659|54637201|FG000|Treatment Period 1|Adverse Event|1|||
27979312|NCT00620659|54637202|FG001|Treatment Period 1|Adverse Event|0|||
27979313|NCT00620659|54637203|FG002|Treatment Period 1|Adverse Event|0|||
27979314|NCT00620659|54637204|FG003|Treatment Period 1|Adverse Event|3|||
27979315|NCT00620659|54637205|FG004|Treatment Period 1|Adverse Event|0|||
27979316|NCT00620659|54637206|FG005|Treatment Period 1|Adverse Event|0|||
27979317|NCT00620659|54637201|FG000|Treatment Period 1|Protocol Violation|1|||
27979318|NCT00620659|54637202|FG001|Treatment Period 1|Protocol Violation|0|||
27979319|NCT00620659|54637203|FG002|Treatment Period 1|Protocol Violation|0|||
27979320|NCT00620659|54637204|FG003|Treatment Period 1|Protocol Violation|0|||
27979321|NCT00620659|54637205|FG004|Treatment Period 1|Protocol Violation|0|||
27979322|NCT00620659|54637206|FG005|Treatment Period 1|Protocol Violation|0|||
27979323|NCT00620659|54637201|FG000|Treatment Period 1|Withdrawal by Subject|1|||
27979324|NCT00620659|54637202|FG001|Treatment Period 1|Withdrawal by Subject|0|||
27979325|NCT00620659|54637203|FG002|Treatment Period 1|Withdrawal by Subject|1|||
27979326|NCT00620659|54637204|FG003|Treatment Period 1|Withdrawal by Subject|0|||
27979327|NCT00620659|54637205|FG004|Treatment Period 1|Withdrawal by Subject|1|||
27979328|NCT00620659|54637206|FG005|Treatment Period 1|Withdrawal by Subject|0|||
27979329|NCT00620659|54637201|FG000|Placebo Washout Period 1|Withdrawal by Subject|0|||
27979330|NCT00620659|54637202|FG001|Placebo Washout Period 1|Withdrawal by Subject|0|||
27979331|NCT00620659|54637203|FG002|Placebo Washout Period 1|Withdrawal by Subject|0|||
27979332|NCT00620659|54637204|FG003|Placebo Washout Period 1|Withdrawal by Subject|1|||
27979333|NCT00620659|54637205|FG004|Placebo Washout Period 1|Withdrawal by Subject|0|||
27979334|NCT00620659|54637206|FG005|Placebo Washout Period 1|Withdrawal by Subject|0|||
27979335|NCT00620659|54637201|FG000|Treatment Period 2|Adverse Event|0|||
27979336|NCT00620659|54637202|FG001|Treatment Period 2|Adverse Event|3|||
27979337|NCT00620659|54637203|FG002|Treatment Period 2|Adverse Event|0|||
27979338|NCT00620659|54637204|FG003|Treatment Period 2|Adverse Event|0|||
27979339|NCT00620659|54637205|FG004|Treatment Period 2|Adverse Event|2|||
27979340|NCT00620659|54637206|FG005|Treatment Period 2|Adverse Event|0|||
27979341|NCT00620659|54637201|FG000|Treatment Period 2|Withdrawal by Subject|0|||
27979342|NCT00620659|54637202|FG001|Treatment Period 2|Withdrawal by Subject|0|||
27979343|NCT00620659|54637203|FG002|Treatment Period 2|Withdrawal by Subject|1|||
27979344|NCT00620659|54637204|FG003|Treatment Period 2|Withdrawal by Subject|0|||
27979345|NCT00620659|54637205|FG004|Treatment Period 2|Withdrawal by Subject|3|||
27979346|NCT00620659|54637206|FG005|Treatment Period 2|Withdrawal by Subject|0|||
27979347|NCT00620659|54637201|FG000|Placebo Washout Period 2|Adverse Event|2|||
27979348|NCT00620659|54637202|FG001|Placebo Washout Period 2|Adverse Event|0|||
27979349|NCT00620659|54637203|FG002|Placebo Washout Period 2|Adverse Event|0|||
27979350|NCT00620659|54637204|FG003|Placebo Washout Period 2|Adverse Event|0|||
27979351|NCT00620659|54637205|FG004|Placebo Washout Period 2|Adverse Event|0|||
27979352|NCT00620659|54637206|FG005|Placebo Washout Period 2|Adverse Event|0|||
27979353|NCT00620659|54637201|FG000|Treatment Period 3|Adverse Event|0|||
28087603|NCT03298984|54741048|FG002|Overall Study|Death|0|||
28087604|NCT03298984|54741049|FG003|Overall Study|Death|2|||
27979354|NCT00620659|54637202|FG001|Treatment Period 3|Adverse Event|2|||
27979355|NCT00620659|54637203|FG002|Treatment Period 3|Adverse Event|0|||
28087605|NCT03298984|54741046|FG000|Overall Study|Insurance Company Decision|0|||
28087606|NCT03298984|54741047|FG001|Overall Study|Insurance Company Decision|0|||
28087607|NCT03298984|54741048|FG002|Overall Study|Insurance Company Decision|0|||
28087608|NCT03298984|54741049|FG003|Overall Study|Insurance Company Decision|1|||
27979356|NCT00620659|54637204|FG003|Treatment Period 3|Adverse Event|0|||
27979357|NCT00620659|54637205|FG004|Treatment Period 3|Adverse Event|0|||
27979358|NCT00620659|54637206|FG005|Treatment Period 3|Adverse Event|0|||
27979359|NCT00620659|54637201|FG000|Treatment Period 3|Withdrawal by Subject|0|||
27979360|NCT00620659|54637202|FG001|Treatment Period 3|Withdrawal by Subject|0|||
27979361|NCT00620659|54637203|FG002|Treatment Period 3|Withdrawal by Subject|0|||
27979362|NCT00620659|54637204|FG003|Treatment Period 3|Withdrawal by Subject|1|||
27979363|NCT00620659|54637205|FG004|Treatment Period 3|Withdrawal by Subject|0|||
27979364|NCT00620659|54637206|FG005|Treatment Period 3|Withdrawal by Subject|0|||
27979365|NCT00894686|54637219|FG000|Overall Study|Withdrawal by Subject|50|||
27979366|NCT00894686|54637219|FG000|Overall Study|Physician Decision|1|||
27979367|NCT00894686|54637219|FG000|Overall Study|Other|5|||
27979368|NCT00885846|54637226|FG000|Overall Study|Withdrawal by Subject|2|||
27979369|NCT00885846|54637227|FG001|Overall Study|Withdrawal by Subject|5|||
27979370|NCT00885846|54637228|FG002|Overall Study|Withdrawal by Subject|2|||
27979371|NCT00621517|54637238|FG000|Overall Study|Lost to Follow-up|3|||
27979372|NCT00621517|54637239|FG001|Overall Study|Lost to Follow-up|3|||
27979373|NCT00621517|54637238|FG000|Overall Study|Withdrawal by Subject|3|||
27979374|NCT00621517|54637239|FG001|Overall Study|Withdrawal by Subject|4|||
27979375|NCT00621517|54637238|FG000|Overall Study|Adverse Event|1|||
27979376|NCT00621517|54637239|FG001|Overall Study|Adverse Event|0|||
27979377|NCT00573937|54637247|FG000|Overall Study|Study Terminated|0|||
27979378|NCT00573937|54637248|FG001|Overall Study|Study Terminated|1|||
27979379|NCT00573859|54637254|FG000|Medication Versus Placebo|Scheduling conflicts|12|||
27979380|NCT00573859|54637254|FG000|Smoking Versus Abstinence|Scheduling conflicts|12|||
27979381|NCT00831441|54637260|FG000|Randomized|Death|82|||
27979382|NCT00831441|54637261|FG001|Randomized|Death|81|||
27979383|NCT00831441|54637260|FG000|Randomized|Adverse Event|248|||
27979384|NCT00831441|54637261|FG001|Randomized|Adverse Event|321|||
27979385|NCT00831441|54637260|FG000|Randomized|Emergency procedure|2|||
27979386|NCT00831441|54637261|FG001|Randomized|Emergency procedure|2|||
27979387|NCT00831441|54637260|FG000|Randomized|Elective procedure|26|||
27979388|NCT00831441|54637261|FG001|Randomized|Elective procedure|25|||
27979389|NCT00831441|54637260|FG000|Randomized|Physician Decision|26|||
27979390|NCT00831441|54637261|FG001|Randomized|Physician Decision|35|||
27979391|NCT00831441|54637260|FG000|Randomized|No longer met criteria|13|||
27979392|NCT00831441|54637261|FG001|Randomized|No longer met criteria|19|||
27979393|NCT00831441|54637260|FG000|Randomized|Withdrawal by Subject|178|||
27979394|NCT00831441|54637261|FG001|Randomized|Withdrawal by Subject|212|||
27979395|NCT00831441|54637260|FG000|Randomized|Lost to Follow-up|26|||
27979396|NCT00831441|54637261|FG001|Randomized|Lost to Follow-up|35|||
27979397|NCT00831441|54637260|FG000|Randomized|Administrative reason by sponsor|2780|||
27979398|NCT00831441|54637261|FG001|Randomized|Administrative reason by sponsor|2671|||
27979399|NCT00831441|54637260|FG000|Randomized|poor/non-compliance|30|||
27979400|NCT00831441|54637261|FG001|Randomized|poor/non-compliance|38|||
27979401|NCT00831441|54637260|FG000|Randomized|non-specified|276|||
27979402|NCT00831441|54637261|FG001|Randomized|non-specified|266|||
27979403|NCT00831441|54637260|FG000|Follow Up (30 Days)|Withdrawal by Subject|41|||
27979404|NCT00831441|54637261|FG001|Follow Up (30 Days)|Withdrawal by Subject|34|||
27979405|NCT00831441|54637260|FG000|Follow Up (30 Days)|Lost to Follow-up|13|||
27979406|NCT00831441|54637261|FG001|Follow Up (30 Days)|Lost to Follow-up|27|||
27979407|NCT00831441|54637260|FG000|Follow Up (30 Days)|Death|63|||
27979408|NCT00831441|54637261|FG001|Follow Up (30 Days)|Death|86|||
27979409|NCT00831441|54637260|FG000|Follow Up (30 Days)|non-specified|16|||
27979410|NCT00831441|54637261|FG001|Follow Up (30 Days)|non-specified|26|||
27979411|NCT00831441|54637260|FG000|Follow Up (30 Days)|missing end of study status|0|||
27979412|NCT00831441|54637261|FG001|Follow Up (30 Days)|missing end of study status|1|||
27979413|NCT00831129|54637270|FG000|Overall Study|Adverse Event|0|||
28087609|NCT02940574|54741062|FG000|From Study Start to 1-month Follow-up|Withdrawal by Subject|1|||
28087610|NCT02940574|54741063|FG001|From Study Start to 1-month Follow-up|Withdrawal by Subject|0|||
28087611|NCT02940574|54741062|FG000|1-year Follow-up|Lost to Follow-up|3|||
28087612|NCT02940574|54741063|FG001|1-year Follow-up|Lost to Follow-up|4|||
27832790|NCT01606007|54312570|FG000|Overall Study|discontinue study treatment|0|||
28087613|NCT03606512|54741075|FG000|Overall Study|Lost to Follow-up|0|||
27979414|NCT00831129|54637271|FG001|Overall Study|Adverse Event|1|||
27979415|NCT00831129|54637270|FG000|Overall Study|9 lost to follow-up reasons uknown|0|||
27979416|NCT00831129|54637271|FG001|Overall Study|9 lost to follow-up reasons uknown|9|||
27979417|NCT00620113|54637281|FG000|Overall Study|Adverse Event|3|||
27979418|NCT00620113|54637282|FG001|Overall Study|Adverse Event|2|||
27979419|NCT00620113|54637283|FG002|Overall Study|Adverse Event|2|||
27979420|NCT00620113|54637284|FG003|Overall Study|Adverse Event|1|||
27979421|NCT00620113|54637281|FG000|Overall Study|Lack of Efficacy|2|||
27979422|NCT00620113|54637282|FG001|Overall Study|Lack of Efficacy|3|||
27979423|NCT00620113|54637283|FG002|Overall Study|Lack of Efficacy|0|||
27979424|NCT00620113|54637284|FG003|Overall Study|Lack of Efficacy|2|||
27979425|NCT00620113|54637281|FG000|Overall Study|Physician Decision|1|||
27979426|NCT00620113|54637282|FG001|Overall Study|Physician Decision|0|||
27979427|NCT00620113|54637283|FG002|Overall Study|Physician Decision|0|||
28087614|NCT03606512|54741076|FG001|Overall Study|Lost to Follow-up|1|||
27979428|NCT00620113|54637284|FG003|Overall Study|Physician Decision|2|||
27979429|NCT00620113|54637281|FG000|Overall Study|Protocol Violation|2|||
27979430|NCT00620113|54637282|FG001|Overall Study|Protocol Violation|1|||
27979431|NCT00620113|54637283|FG002|Overall Study|Protocol Violation|0|||
27979432|NCT00620113|54637284|FG003|Overall Study|Protocol Violation|0|||
27979433|NCT00620113|54637281|FG000|Overall Study|Withdrawal by Subject|5|||
27979434|NCT00620113|54637282|FG001|Overall Study|Withdrawal by Subject|1|||
27979435|NCT00620113|54637283|FG002|Overall Study|Withdrawal by Subject|3|||
27979436|NCT00620113|54637284|FG003|Overall Study|Withdrawal by Subject|5|||
27979437|NCT00830115|54637294|FG000|Overall Study|Adverse Event|2|||
27979438|NCT00830115|54637294|FG000|Overall Study|Improvement/recovery|1|||
27979439|NCT00830037|54637302|FG000|Overall Study|Withdrawal by Subject|2|||
27979440|NCT00830037|54637303|FG001|Overall Study|Withdrawal by Subject|3|||
27979441|NCT00830037|54637302|FG000|Overall Study|Lost to Follow-up|1|||
27979442|NCT00830037|54637303|FG001|Overall Study|Lost to Follow-up|2|||
27979443|NCT00830037|54637302|FG000|Overall Study|Active when terminated by DSMB|15|||
27979444|NCT00830037|54637303|FG001|Overall Study|Active when terminated by DSMB|14|||
27979445|NCT00829413|54637309|FG000|Overall Study|No study drug admimnistered|13|||
27979446|NCT00829413|54637309|FG000|Overall Study|Training Patients|67|||
27979447|NCT00829413|54637309|FG000|Overall Study|No truth standard procedure available|9|||
27979448|NCT00829413|54637309|FG000|Overall Study|Technically inadequate truth standard|2|||
27979449|NCT00829413|54637309|FG000|Overall Study|Indeterminate diagnosis from truth stand|3|||
27979450|NCT00829179|54637320|FG000|Overall Study|Withdrawal by Subject|1|||
27979451|NCT00591591|54637326|FG000|Overall Study|Withdrawal by Subject|1|||
27979452|NCT00591591|54637327|FG001|Overall Study|Withdrawal by Subject|37|||
27979453|NCT00591591|54637326|FG000|Overall Study|Lack of Efficacy|10|||
27979454|NCT00591591|54637327|FG001|Overall Study|Lack of Efficacy|2|||
27979455|NCT00828945|54637333|FG000|Overall Study|Death|4|||
27979456|NCT00828945|54637333|FG000|Overall Study|Participant was missing|1|||
27979457|NCT00828945|54637333|FG000|Overall Study|Other|36|||
27979458|NCT00966875|54637346|FG000|Part A|Adverse Event|2|||
27979459|NCT00966875|54637347|FG001|Part A|Adverse Event|1|||
27979460|NCT00966875|54637348|FG002|Part A|Adverse Event|0|||
27979461|NCT00966875|54637349|FG003|Part A|Adverse Event|1|||
27979462|NCT00966875|54637350|FG004|Part A|Adverse Event|0|||
27979463|NCT00966875|54637351|FG005|Part A|Adverse Event|1|||
27979464|NCT00966875|54637352|FG006|Part A|Adverse Event|0|||
27979465|NCT00966875|54637353|FG007|Part A|Adverse Event|3|||
27979466|NCT00966875|54637354|FG008|Part A|Adverse Event|3|||
27979467|NCT00966875|54637346|FG000|Part A|Entry Criteria|0|||
27979468|NCT00966875|54637347|FG001|Part A|Entry Criteria|0|||
27979469|NCT00966875|54637348|FG002|Part A|Entry Criteria|0|||
27979470|NCT00966875|54637349|FG003|Part A|Entry Criteria|0|||
27979471|NCT00966875|54637350|FG004|Part A|Entry Criteria|0|||
27979472|NCT00966875|54637351|FG005|Part A|Entry Criteria|2|||
27979473|NCT00966875|54637352|FG006|Part A|Entry Criteria|0|||
27979474|NCT00966875|54637353|FG007|Part A|Entry Criteria|0|||
27979475|NCT00966875|54637354|FG008|Part A|Entry Criteria|0|||
27979476|NCT00966875|54637346|FG000|Part A|Lack of Efficacy|0|||
27979477|NCT00966875|54637347|FG001|Part A|Lack of Efficacy|1|||
27979478|NCT00966875|54637348|FG002|Part A|Lack of Efficacy|0|||
27979479|NCT00966875|54637349|FG003|Part A|Lack of Efficacy|0|||
27979480|NCT00966875|54637350|FG004|Part A|Lack of Efficacy|0|||
27979481|NCT00966875|54637351|FG005|Part A|Lack of Efficacy|0|||
27979482|NCT00966875|54637352|FG006|Part A|Lack of Efficacy|4|||
27979483|NCT00966875|54637353|FG007|Part A|Lack of Efficacy|0|||
27979484|NCT00966875|54637354|FG008|Part A|Lack of Efficacy|0|||
27979485|NCT00966875|54637346|FG000|Part A|Lost to Follow-up|2|||
27979486|NCT00966875|54637347|FG001|Part A|Lost to Follow-up|0|||
27979487|NCT00966875|54637348|FG002|Part A|Lost to Follow-up|0|||
27979488|NCT00966875|54637349|FG003|Part A|Lost to Follow-up|0|||
27979489|NCT00966875|54637350|FG004|Part A|Lost to Follow-up|0|||
27979490|NCT00966875|54637351|FG005|Part A|Lost to Follow-up|1|||
27979491|NCT00966875|54637352|FG006|Part A|Lost to Follow-up|0|||
27979492|NCT00966875|54637353|FG007|Part A|Lost to Follow-up|0|||
27979493|NCT00966875|54637354|FG008|Part A|Lost to Follow-up|0|||
27979494|NCT00966875|54637346|FG000|Part A|Parent/Caregiver Decision|0|||
27979495|NCT00966875|54637347|FG001|Part A|Parent/Caregiver Decision|0|||
27979496|NCT00966875|54637348|FG002|Part A|Parent/Caregiver Decision|0|||
27979497|NCT00966875|54637349|FG003|Part A|Parent/Caregiver Decision|1|||
27979498|NCT00966875|54637350|FG004|Part A|Parent/Caregiver Decision|0|||
27979499|NCT00966875|54637351|FG005|Part A|Parent/Caregiver Decision|0|||
27979500|NCT00966875|54637352|FG006|Part A|Parent/Caregiver Decision|0|||
27979501|NCT00966875|54637353|FG007|Part A|Parent/Caregiver Decision|0|||
27979502|NCT00966875|54637354|FG008|Part A|Parent/Caregiver Decision|0|||
27979503|NCT00966875|54637346|FG000|Part A|Physician Decision|0|||
27979504|NCT00966875|54637347|FG001|Part A|Physician Decision|0|||
27979505|NCT00966875|54637348|FG002|Part A|Physician Decision|0|||
27979506|NCT00966875|54637349|FG003|Part A|Physician Decision|0|||
27979507|NCT00966875|54637350|FG004|Part A|Physician Decision|1|||
27979508|NCT00966875|54637351|FG005|Part A|Physician Decision|0|||
27979509|NCT00966875|54637352|FG006|Part A|Physician Decision|1|||
27979510|NCT00966875|54637353|FG007|Part A|Physician Decision|0|||
27979511|NCT00966875|54637354|FG008|Part A|Physician Decision|2|||
27979512|NCT00966875|54637346|FG000|Part A|Sponsor Decision|0|||
27979513|NCT00966875|54637347|FG001|Part A|Sponsor Decision|0|||
27979514|NCT00966875|54637348|FG002|Part A|Sponsor Decision|1|||
27979515|NCT00966875|54637349|FG003|Part A|Sponsor Decision|0|||
27979516|NCT00966875|54637350|FG004|Part A|Sponsor Decision|1|||
27979517|NCT00966875|54637351|FG005|Part A|Sponsor Decision|0|||
27979518|NCT00966875|54637352|FG006|Part A|Sponsor Decision|0|||
27979519|NCT00966875|54637353|FG007|Part A|Sponsor Decision|2|||
27979520|NCT00966875|54637354|FG008|Part A|Sponsor Decision|1|||
27979521|NCT00966875|54637346|FG000|Part A|Withdrawal by Subject|2|||
27979522|NCT00966875|54637347|FG001|Part A|Withdrawal by Subject|2|||
27979523|NCT00966875|54637348|FG002|Part A|Withdrawal by Subject|1|||
27979524|NCT00966875|54637349|FG003|Part A|Withdrawal by Subject|1|||
27979525|NCT00966875|54637350|FG004|Part A|Withdrawal by Subject|3|||
27979526|NCT00966875|54637351|FG005|Part A|Withdrawal by Subject|0|||
27979527|NCT00966875|54637352|FG006|Part A|Withdrawal by Subject|5|||
27979528|NCT00966875|54637353|FG007|Part A|Withdrawal by Subject|1|||
27979529|NCT00966875|54637354|FG008|Part A|Withdrawal by Subject|1|||
27979530|NCT00966875|54637346|FG000|Part A|Protocol Violation|0|||
27979531|NCT00966875|54637347|FG001|Part A|Protocol Violation|0|||
27979532|NCT00966875|54637348|FG002|Part A|Protocol Violation|0|||
27979533|NCT00966875|54637349|FG003|Part A|Protocol Violation|0|||
27979534|NCT00966875|54637350|FG004|Part A|Protocol Violation|0|||
27979535|NCT00966875|54637351|FG005|Part A|Protocol Violation|0|||
27979536|NCT00966875|54637352|FG006|Part A|Protocol Violation|2|||
27979537|NCT00966875|54637353|FG007|Part A|Protocol Violation|1|||
27979538|NCT00966875|54637354|FG008|Part A|Protocol Violation|1|||
27979539|NCT00966875|54637346|FG000|Part B|Adverse Event|0|||
27979540|NCT00966875|54637347|FG001|Part B|Adverse Event|1|||
27979541|NCT00966875|54637348|FG002|Part B|Adverse Event|1|||
27979542|NCT00966875|54637349|FG003|Part B|Adverse Event|0|||
27979543|NCT00966875|54637350|FG004|Part B|Adverse Event|1|||
27979544|NCT00966875|54637351|FG005|Part B|Adverse Event|0|||
27979545|NCT00966875|54637352|FG006|Part B|Adverse Event|5|||
27979546|NCT00966875|54637353|FG007|Part B|Adverse Event|2|||
27979547|NCT00966875|54637354|FG008|Part B|Adverse Event|2|||
27979548|NCT00966875|54637346|FG000|Part B|Death|0|||
27979549|NCT00966875|54637347|FG001|Part B|Death|0|||
27979550|NCT00966875|54637348|FG002|Part B|Death|1|||
27979551|NCT00966875|54637349|FG003|Part B|Death|0|||
27979552|NCT00966875|54637350|FG004|Part B|Death|0|||
27979553|NCT00966875|54637351|FG005|Part B|Death|0|||
27979554|NCT00966875|54637352|FG006|Part B|Death|0|||
27979555|NCT00966875|54637353|FG007|Part B|Death|1|||
27979556|NCT00966875|54637354|FG008|Part B|Death|0|||
27979557|NCT00966875|54637346|FG000|Part B|Lack of Efficacy|2|||
27979558|NCT00966875|54637347|FG001|Part B|Lack of Efficacy|1|||
27979559|NCT00966875|54637348|FG002|Part B|Lack of Efficacy|1|||
27979560|NCT00966875|54637349|FG003|Part B|Lack of Efficacy|1|||
27979561|NCT00966875|54637350|FG004|Part B|Lack of Efficacy|2|||
27979562|NCT00966875|54637351|FG005|Part B|Lack of Efficacy|3|||
27979563|NCT00966875|54637352|FG006|Part B|Lack of Efficacy|12|||
27979564|NCT00966875|54637353|FG007|Part B|Lack of Efficacy|9|||
27979565|NCT00966875|54637354|FG008|Part B|Lack of Efficacy|6|||
27979566|NCT00966875|54637346|FG000|Part B|Lost to Follow-up|0|||
27979567|NCT00966875|54637347|FG001|Part B|Lost to Follow-up|0|||
27979568|NCT00966875|54637348|FG002|Part B|Lost to Follow-up|0|||
27979569|NCT00966875|54637349|FG003|Part B|Lost to Follow-up|1|||
27979570|NCT00966875|54637350|FG004|Part B|Lost to Follow-up|0|||
27979571|NCT00966875|54637351|FG005|Part B|Lost to Follow-up|0|||
27979572|NCT00966875|54637352|FG006|Part B|Lost to Follow-up|0|||
27733348|NCT02559206|54181158|FG005|Overall Study|Lost to Follow-up|5|||
27733349|NCT02559206|54181159|FG006|Overall Study|Lost to Follow-up|1|||
27979573|NCT00966875|54637353|FG007|Part B|Lost to Follow-up|0|||
27979574|NCT00966875|54637354|FG008|Part B|Lost to Follow-up|1|||
27979575|NCT00966875|54637346|FG000|Part B|Physician Decision|0|||
27979576|NCT00966875|54637347|FG001|Part B|Physician Decision|0|||
27979577|NCT00966875|54637348|FG002|Part B|Physician Decision|1|||
27979578|NCT00966875|54637349|FG003|Part B|Physician Decision|0|||
27979579|NCT00966875|54637350|FG004|Part B|Physician Decision|2|||
27979580|NCT00966875|54637351|FG005|Part B|Physician Decision|1|||
27733350|NCT02559206|54181160|FG007|Overall Study|Lost to Follow-up|4|||
27979581|NCT00966875|54637352|FG006|Part B|Physician Decision|0|||
27979582|NCT00966875|54637353|FG007|Part B|Physician Decision|0|||
27979583|NCT00966875|54637354|FG008|Part B|Physician Decision|2|||
27979584|NCT00966875|54637346|FG000|Part B|Sponsor Decision|1|||
27979585|NCT00966875|54637347|FG001|Part B|Sponsor Decision|0|||
27979586|NCT00966875|54637348|FG002|Part B|Sponsor Decision|0|||
27979587|NCT00966875|54637349|FG003|Part B|Sponsor Decision|0|||
27979588|NCT00966875|54637350|FG004|Part B|Sponsor Decision|0|||
27979589|NCT00966875|54637351|FG005|Part B|Sponsor Decision|1|||
27979590|NCT00966875|54637352|FG006|Part B|Sponsor Decision|0|||
27979591|NCT00966875|54637353|FG007|Part B|Sponsor Decision|2|||
27979592|NCT00966875|54637354|FG008|Part B|Sponsor Decision|1|||
27979593|NCT00966875|54637346|FG000|Part B|Withdrawal by Subject|2|||
27979594|NCT00966875|54637347|FG001|Part B|Withdrawal by Subject|1|||
27979595|NCT00966875|54637348|FG002|Part B|Withdrawal by Subject|2|||
27979596|NCT00966875|54637349|FG003|Part B|Withdrawal by Subject|1|||
27979597|NCT00966875|54637350|FG004|Part B|Withdrawal by Subject|2|||
27979598|NCT00966875|54637351|FG005|Part B|Withdrawal by Subject|1|||
27979599|NCT00966875|54637352|FG006|Part B|Withdrawal by Subject|4|||
27979600|NCT00966875|54637353|FG007|Part B|Withdrawal by Subject|5|||
27979601|NCT00966875|54637354|FG008|Part B|Withdrawal by Subject|5|||
27979602|NCT00966875|54637346|FG000|Part B|Entry Criteria|0|||
27979603|NCT00966875|54637347|FG001|Part B|Entry Criteria|0|||
27979604|NCT00966875|54637348|FG002|Part B|Entry Criteria|0|||
27979605|NCT00966875|54637349|FG003|Part B|Entry Criteria|0|||
27979606|NCT00966875|54637350|FG004|Part B|Entry Criteria|0|||
27979607|NCT00966875|54637351|FG005|Part B|Entry Criteria|0|||
27979608|NCT00966875|54637352|FG006|Part B|Entry Criteria|1|||
27979609|NCT00966875|54637353|FG007|Part B|Entry Criteria|0|||
27979610|NCT00966875|54637354|FG008|Part B|Entry Criteria|1|||
27979611|NCT00828711|54637430|FG000|Overall Study|Lost to Follow-up|1|||
27979612|NCT00828711|54637431|FG001|Overall Study|Lost to Follow-up|0|||
27979613|NCT00828711|54637432|FG002|Overall Study|Lost to Follow-up|0|||
27979614|NCT00966719|54637442|FG000|Overall Study|Lost to Follow-up|6|||
27979615|NCT00966719|54637443|FG001|Overall Study|Lost to Follow-up|11|||
27979616|NCT00818649|54637449|FG000|Overall Study|Declining performance status|2|||
27979617|NCT00818649|54637449|FG000|Overall Study|Unrelated hip fracture-unable to proceed|1|||
28087615|NCT03606512|54741075|FG000|Overall Study|'moved from study area|0|||
28087616|NCT03606512|54741076|FG001|Overall Study|'moved from study area|1|||
28087617|NCT03760250|54741098|FG000|Overall Study|Withdrawal by Subject|1|||
28087618|NCT03760250|54741098|FG000|Overall Study|Physician Decision|1|||
28087619|NCT03757988|54741102|FG000|Overall Study|Withdrawal by Subject|1|||
28087620|NCT00313781|54741109|FG000|Before Crossover|Death|22|||
28087621|NCT00313781|54741110|FG001|Before Crossover|Death|8|||
28087622|NCT00313781|54741111|FG002|Before Crossover|Death|0|||
28087623|NCT00313781|54741109|FG000|Before Crossover|Lost to Follow-up|0|||
28087624|NCT00313781|54741110|FG001|Before Crossover|Lost to Follow-up|3|||
27979618|NCT00818649|54637449|FG000|Overall Study|Adverse Event|1|||
27979619|NCT00961571|54637454|FG000|Overall Study|Physician Decision|39|||
27979620|NCT00964223|54637458|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
27979621|NCT00620815|54637466|FG000|Overall Study|Adverse Event|1|||
27979622|NCT00620815|54637467|FG001|Overall Study|Adverse Event|1|||
27979623|NCT00620815|54637468|FG002|Overall Study|Adverse Event|2|||
27979624|NCT00620815|54637466|FG000|Overall Study|Withdrawal by Subject|1|||
27979625|NCT00620815|54637467|FG001|Overall Study|Withdrawal by Subject|2|||
27979626|NCT00620815|54637468|FG002|Overall Study|Withdrawal by Subject|0|||
27979627|NCT00620815|54637466|FG000|Overall Study|Lost to Follow-up|1|||
27979628|NCT00620815|54637467|FG001|Overall Study|Lost to Follow-up|6|||
27979629|NCT00620815|54637468|FG002|Overall Study|Lost to Follow-up|3|||
27979630|NCT00620815|54637466|FG000|Overall Study|Inappropriate enrolment|0|||
27979631|NCT00620815|54637467|FG001|Overall Study|Inappropriate enrolment|0|||
27979632|NCT00620815|54637468|FG002|Overall Study|Inappropriate enrolment|1|||
27979633|NCT00620815|54637466|FG000|Overall Study|Protocol Violation|1|||
27979634|NCT00620815|54637467|FG001|Overall Study|Protocol Violation|2|||
27979635|NCT00620815|54637468|FG002|Overall Study|Protocol Violation|1|||
27979636|NCT03372941|54637494|FG000|Overall Study|Lost to Follow-up|2|||
27979637|NCT03372941|54637495|FG001|Overall Study|Lost to Follow-up|4|||
27979638|NCT00619957|54637503|FG000|Month 24 Double-Blind|Adverse Event|9|||
27979639|NCT00619957|54637504|FG001|Month 24 Double-Blind|Adverse Event|7|||
27979640|NCT00619957|54637503|FG000|Month 24 Double-Blind|Protocol Violation|1|||
27979641|NCT00619957|54637504|FG001|Month 24 Double-Blind|Protocol Violation|0|||
27979642|NCT00619957|54637503|FG000|Month 24 Double-Blind|Withdrawal by Subject|7|||
27979643|NCT00619957|54637504|FG001|Month 24 Double-Blind|Withdrawal by Subject|9|||
27979644|NCT00619957|54637503|FG000|Month 24 Double-Blind|Lost to Follow-up|1|||
27979645|NCT00619957|54637504|FG001|Month 24 Double-Blind|Lost to Follow-up|0|||
28087625|NCT00313781|54741111|FG002|Before Crossover|Lost to Follow-up|0|||
28087626|NCT00313781|54741109|FG000|Before Crossover|Withdrawal by Subject|3|||
28165676|NCT02907463|54836365|FG000|Overall Study|Lost to Follow-up|17|||
28165677|NCT02907463|54836365|FG000|Overall Study|Death|10|||
27979646|NCT00619957|54637503|FG000|Month 24 Double-Blind|Did not take any study medication|0|||
28087627|NCT00313781|54741110|FG001|Before Crossover|Withdrawal by Subject|1|||
28087628|NCT00313781|54741111|FG002|Before Crossover|Withdrawal by Subject|0|||
28165678|NCT02907463|54836365|FG000|Overall Study|Withdrawal by Subject|4|||
28165679|NCT02907463|54836365|FG000|Overall Study|MIS Approach was not used|2|||
27979647|NCT00619957|54637504|FG001|Month 24 Double-Blind|Did not take any study medication|1|||
27979648|NCT00619957|54637503|FG000|Month 48 Open-Label|Adverse Event|4|||
27979649|NCT00619957|54637504|FG001|Month 48 Open-Label|Adverse Event|4|||
27979650|NCT00619957|54637503|FG000|Month 48 Open-Label|Lost to Follow-up|2|||
27979651|NCT00619957|54637504|FG001|Month 48 Open-Label|Lost to Follow-up|4|||
27979652|NCT00619957|54637503|FG000|Month 48 Open-Label|Withdrawal by Subject|6|||
28087629|NCT00313781|54741109|FG000|Before Crossover|Other|45|||
28087630|NCT00313781|54741110|FG001|Before Crossover|Other|30|||
28087631|NCT00313781|54741111|FG002|Before Crossover|Other|0|||
28087632|NCT00313781|54741109|FG000|Before Crossover|Crossover|0|||
27979653|NCT00619957|54637504|FG001|Month 48 Open-Label|Withdrawal by Subject|9|||
28087633|NCT00313781|54741110|FG001|Before Crossover|Crossover|37|||
27832791|NCT01606007|54312571|FG001|Overall Study|discontinue study treatment|2|||
27832792|NCT01606007|54312572|FG002|Overall Study|discontinue study treatment|1|||
27832793|NCT01606007|54312570|FG000|Overall Study|Lost to Follow-up|6|||
27832794|NCT01606007|54312571|FG001|Overall Study|Lost to Follow-up|8|||
27832795|NCT01606007|54312572|FG002|Overall Study|Lost to Follow-up|5|||
27832796|NCT01606007|54312570|FG000|Overall Study|Poor/Non-compliance|1|||
27832797|NCT01606007|54312571|FG001|Overall Study|Poor/Non-compliance|0|||
27832798|NCT01606007|54312572|FG002|Overall Study|Poor/Non-compliance|0|||
27832799|NCT01753193|54312651|FG000|Overall Study|Withdrawal by Subject|23|||
27832800|NCT01753193|54312651|FG000|Overall Study|Lost to Follow-up|6|||
27832801|NCT01753193|54312651|FG000|Overall Study|Death|1|||
27832802|NCT01753193|54312651|FG000|Overall Study|Other|16|||
27832803|NCT01727297|54312698|FG000|Overall Study|Death|13|||
27832804|NCT01727297|54312699|FG001|Overall Study|Death|0|||
27832805|NCT01727297|54312698|FG000|Overall Study|Protocol Violation|1|||
27832806|NCT01727297|54312699|FG001|Overall Study|Protocol Violation|10|||
27832807|NCT01727297|54312698|FG000|Overall Study|Adverse Event|3|||
27832808|NCT01727297|54312699|FG001|Overall Study|Adverse Event|1|||
27832809|NCT01727297|54312698|FG000|Overall Study|Lost to Follow-up|11|||
27832810|NCT01727297|54312699|FG001|Overall Study|Lost to Follow-up|0|||
27832811|NCT01727297|54312698|FG000|Overall Study|Withdrawal by Subject|26|||
27832812|NCT01727297|54312699|FG001|Overall Study|Withdrawal by Subject|27|||
27832813|NCT01727297|54312698|FG000|Overall Study|Physician Decision|19|||
27832814|NCT01727297|54312699|FG001|Overall Study|Physician Decision|5|||
27832815|NCT01727297|54312698|FG000|Overall Study|Other (e.g. AF detection pre-implant)|29|||
27832816|NCT01727297|54312699|FG001|Overall Study|Other (e.g. AF detection pre-implant)|8|||
27832817|NCT01753115|54312715|FG000|Overall Study|Lost to Follow-up|3|||
27832818|NCT01753115|54312716|FG001|Overall Study|Lost to Follow-up|6|||
27832819|NCT01753115|54312717|FG002|Overall Study|Lost to Follow-up|8|||
27832820|NCT01753115|54312715|FG000|Overall Study|Withdrawal by Subject|6|||
27832821|NCT01753115|54312716|FG001|Overall Study|Withdrawal by Subject|5|||
27832822|NCT01753115|54312717|FG002|Overall Study|Withdrawal by Subject|6|||
27832823|NCT01753115|54312715|FG000|Overall Study|Subject non-compliant|3|||
27832824|NCT01753115|54312716|FG001|Overall Study|Subject non-compliant|3|||
27832825|NCT01753115|54312717|FG002|Overall Study|Subject non-compliant|0|||
28087634|NCT00313781|54741111|FG002|Before Crossover|Crossover|0|||
28087635|NCT00313781|54741109|FG000|Before Crossover|Randomized, not treated|5|||
28087636|NCT00313781|54741110|FG001|Before Crossover|Randomized, not treated|0|||
28087637|NCT00313781|54741111|FG002|Before Crossover|Randomized, not treated|0|||
28087638|NCT00313781|54741109|FG000|After Crossover|Death|0|||
28087639|NCT00313781|54741110|FG001|After Crossover|Death|0|||
27832826|NCT01753115|54312715|FG000|Overall Study|Used excluded drug|0|||
27832827|NCT01753115|54312716|FG001|Overall Study|Used excluded drug|1|||
27832828|NCT01753115|54312717|FG002|Overall Study|Used excluded drug|0|||
27832829|NCT01727141|54312738|FG000|Overall Study|Physician Decision|0|||
27832830|NCT01727141|54312739|FG001|Overall Study|Physician Decision|1|||
27832831|NCT01727141|54312740|FG002|Overall Study|Physician Decision|0|||
27832832|NCT01727141|54312741|FG003|Overall Study|Physician Decision|2|||
27832833|NCT01727141|54312738|FG000|Overall Study|Lost to Follow-up|0|||
27832834|NCT01727141|54312739|FG001|Overall Study|Lost to Follow-up|2|||
27832835|NCT01727141|54312740|FG002|Overall Study|Lost to Follow-up|0|||
28087640|NCT00313781|54741111|FG002|After Crossover|Death|6|||
28087641|NCT00313781|54741109|FG000|After Crossover|Withdrawal by Subject|0|||
28087642|NCT00313781|54741110|FG001|After Crossover|Withdrawal by Subject|0|||
28087643|NCT00313781|54741111|FG002|After Crossover|Withdrawal by Subject|3|||
28087644|NCT00313781|54741109|FG000|After Crossover|Other|0|||
28087645|NCT00313781|54741110|FG001|After Crossover|Other|0|||
28087646|NCT00313781|54741111|FG002|After Crossover|Other|18|||
28087647|NCT00368537|54741122|FG000|Randomization|No study drug dosed|13|||
28087648|NCT00368537|54741123|FG001|Randomization|No study drug dosed|6|||
28087649|NCT00368537|54741122|FG000|Baseline Participants|Lost to Follow-up|16|||
27832836|NCT01727141|54312741|FG003|Overall Study|Lost to Follow-up|0|||
27832837|NCT01727141|54312738|FG000|Overall Study|Death|0|||
27832838|NCT01727141|54312739|FG001|Overall Study|Death|1|||
28087650|NCT00368537|54741123|FG001|Baseline Participants|Lost to Follow-up|17|||
28087651|NCT00368537|54741122|FG000|Baseline Participants|Withdrawal by Subject|6|||
27832839|NCT01727141|54312740|FG002|Overall Study|Death|1|||
27832840|NCT01727141|54312741|FG003|Overall Study|Death|1|||
27832841|NCT01727141|54312738|FG000|Overall Study|Protocol deviation|1|||
27832842|NCT01727141|54312739|FG001|Overall Study|Protocol deviation|1|||
27832843|NCT01727141|54312740|FG002|Overall Study|Protocol deviation|0|||
27832844|NCT01727141|54312741|FG003|Overall Study|Protocol deviation|1|||
27832845|NCT01727141|54312738|FG000|Overall Study|Withdrawal by Subject|4|||
27832846|NCT01727141|54312739|FG001|Overall Study|Withdrawal by Subject|4|||
27832847|NCT01727141|54312740|FG002|Overall Study|Withdrawal by Subject|2|||
27979654|NCT00961415|54637514|FG000|Induction Treatment Phase|Withdrawal by Subject|11|||
28087652|NCT00368537|54741123|FG001|Baseline Participants|Withdrawal by Subject|4|||
28087653|NCT00368537|54741122|FG000|Baseline Participants|Death|1|||
27832848|NCT01727141|54312741|FG003|Overall Study|Withdrawal by Subject|11|||
27832849|NCT01726517|54312765|FG000|Overall Study|Withdrawal by Subject|0|||
27832850|NCT01726517|54312766|FG001|Overall Study|Withdrawal by Subject|0|||
27832851|NCT01726517|54312767|FG002|Overall Study|Withdrawal by Subject|1|||
27832852|NCT01726517|54312768|FG003|Overall Study|Withdrawal by Subject|0|||
27979655|NCT00961415|54637515|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
27979656|NCT00961415|54637516|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
27979657|NCT00961415|54637514|FG000|Induction Treatment Phase|Death|77|||
27979658|NCT00961415|54637515|FG001|Induction Treatment Phase|Death|0|||
27979659|NCT00961415|54637516|FG002|Induction Treatment Phase|Death|0|||
27979660|NCT00961415|54637514|FG000|Induction Treatment Phase|Protocol Violation|1|||
27979661|NCT00961415|54637515|FG001|Induction Treatment Phase|Protocol Violation|0|||
27979662|NCT00961415|54637516|FG002|Induction Treatment Phase|Protocol Violation|0|||
27979663|NCT00961415|54637514|FG000|Induction Treatment Phase|Physician Decision|2|||
27979664|NCT00961415|54637515|FG001|Induction Treatment Phase|Physician Decision|0|||
27979665|NCT00961415|54637516|FG002|Induction Treatment Phase|Physician Decision|0|||
27979666|NCT00961415|54637514|FG000|Induction Treatment Phase|Didn't meet maintenance phase criteria|27|||
27979667|NCT00961415|54637515|FG001|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
27979668|NCT00961415|54637516|FG002|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
27979669|NCT00961415|54637514|FG000|Induction Treatment Phase|Other Reason|5|||
27979670|NCT00961415|54637515|FG001|Induction Treatment Phase|Other Reason|0|||
27979671|NCT00961415|54637516|FG002|Induction Treatment Phase|Other Reason|0|||
27979672|NCT00961415|54637514|FG000|Maintenance Treatment Phase|Death|0|||
27979673|NCT00961415|54637515|FG001|Maintenance Treatment Phase|Death|42|||
27979674|NCT00961415|54637516|FG002|Maintenance Treatment Phase|Death|34|||
27979675|NCT00961415|54637514|FG000|Maintenance Treatment Phase|Investigators decision|0|||
27979676|NCT00961415|54637515|FG001|Maintenance Treatment Phase|Investigators decision|2|||
27979677|NCT00961415|54637516|FG002|Maintenance Treatment Phase|Investigators decision|0|||
27979678|NCT00961415|54637514|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
27979679|NCT00961415|54637515|FG001|Maintenance Treatment Phase|Withdrawal by Subject|3|||
27979680|NCT00961415|54637516|FG002|Maintenance Treatment Phase|Withdrawal by Subject|8|||
27979681|NCT00961415|54637514|FG000|Maintenance Treatment Phase|Other reason|0|||
27979682|NCT00961415|54637515|FG001|Maintenance Treatment Phase|Other reason|1|||
27979683|NCT00961415|54637516|FG002|Maintenance Treatment Phase|Other reason|3|||
27979684|NCT00963599|54637534|FG000|Overall Study|Adverse Event|2|||
27979685|NCT00963599|54637535|FG001|Overall Study|Adverse Event|0|||
27979686|NCT00963599|54637536|FG002|Overall Study|Adverse Event|1|||
27979687|NCT00963599|54637537|FG003|Overall Study|Adverse Event|2|||
27979688|NCT00963599|54637534|FG000|Overall Study|Lack of Efficacy|0|||
27979689|NCT00963599|54637535|FG001|Overall Study|Lack of Efficacy|2|||
27979690|NCT00963599|54637536|FG002|Overall Study|Lack of Efficacy|1|||
27979691|NCT00963599|54637537|FG003|Overall Study|Lack of Efficacy|4|||
27979692|NCT00963599|54637534|FG000|Overall Study|Lost to Follow-up|0|||
27979693|NCT00963599|54637535|FG001|Overall Study|Lost to Follow-up|1|||
27979694|NCT00963599|54637536|FG002|Overall Study|Lost to Follow-up|1|||
27979695|NCT00963599|54637537|FG003|Overall Study|Lost to Follow-up|1|||
27979696|NCT00963599|54637534|FG000|Overall Study|Protocol Violation|2|||
27979697|NCT00963599|54637535|FG001|Overall Study|Protocol Violation|2|||
27979698|NCT00963599|54637536|FG002|Overall Study|Protocol Violation|3|||
27979699|NCT00963599|54637537|FG003|Overall Study|Protocol Violation|4|||
27979700|NCT00963599|54637534|FG000|Overall Study|Withdrawal by Subject|2|||
27979701|NCT00963599|54637535|FG001|Overall Study|Withdrawal by Subject|1|||
27979702|NCT00963599|54637536|FG002|Overall Study|Withdrawal by Subject|3|||
27979703|NCT00963599|54637537|FG003|Overall Study|Withdrawal by Subject|3|||
27979704|NCT00619801|54637549|FG000|Overall Study|Lack of Efficacy|0|||
27979705|NCT00619801|54637550|FG001|Overall Study|Lack of Efficacy|1|||
27979706|NCT00619801|54637549|FG000|Overall Study|Withdrawal by Subject|1|||
27979707|NCT00619801|54637550|FG001|Overall Study|Withdrawal by Subject|1|||
27979708|NCT00619801|54637549|FG000|Overall Study|Loss of efficacy|0|||
27979709|NCT00619801|54637550|FG001|Overall Study|Loss of efficacy|1|||
27979710|NCT00962741|54637556|FG000|Overall Study|Failed to return|3|||
27979711|NCT00962741|54637556|FG000|Overall Study|Lost to Follow-up|2|||
27979712|NCT00962741|54637556|FG000|Overall Study|Withdrawal by Subject|1|||
27979713|NCT00962741|54637556|FG000|Overall Study|Lack of Efficacy|1|||
27979714|NCT00962741|54637556|FG000|Overall Study|drug ineffective+prohibited drug taken|1|||
27979715|NCT00619645|54637560|FG000|Overall Study|Adverse Event|1|||
27979716|NCT00619177|54637564|FG000|Overall Study|Adverse Event|18|||
27979717|NCT00619177|54637564|FG000|Overall Study|Lost to Follow-up|2|||
27979718|NCT00619177|54637564|FG000|Overall Study|Lack of Efficacy|1|||
27979719|NCT00619177|54637564|FG000|Overall Study|Missing termination information|481|||
27832853|NCT01726517|54312769|FG004|Overall Study|Withdrawal by Subject|0|||
27979720|NCT00619177|54637564|FG000|Overall Study|Not specified reasons|6|||
27979721|NCT00818259|54637575|FG000|Part I|Withdrawal by Subject|1|||
27979722|NCT00818259|54637576|FG001|Part I|Withdrawal by Subject|0|||
27979723|NCT00818259|54637577|FG002|Part I|Withdrawal by Subject|0|||
27979724|NCT00818259|54637578|FG003|Part I|Withdrawal by Subject|0|||
27979725|NCT00818259|54637579|FG004|Part I|Withdrawal by Subject|0|||
27979726|NCT00818259|54637580|FG005|Part I|Withdrawal by Subject|0|||
27979727|NCT00818259|54637581|FG006|Part I|Withdrawal by Subject|0|||
27979728|NCT00818259|54637582|FG007|Part I|Withdrawal by Subject|0|||
27979729|NCT00818259|54637583|FG008|Part I|Withdrawal by Subject|0|||
27979730|NCT00818259|54637575|FG000|Part II|Physician Decision|0|||
27979731|NCT00818259|54637576|FG001|Part II|Physician Decision|0|||
27979732|NCT00818259|54637577|FG002|Part II|Physician Decision|1|||
27979733|NCT00818259|54637578|FG003|Part II|Physician Decision|0|||
27979734|NCT00818259|54637579|FG004|Part II|Physician Decision|0|||
27979735|NCT00818259|54637580|FG005|Part II|Physician Decision|0|||
27979736|NCT00818259|54637581|FG006|Part II|Physician Decision|0|||
27979737|NCT00818259|54637582|FG007|Part II|Physician Decision|0|||
27979738|NCT00818259|54637583|FG008|Part II|Physician Decision|0|||
27979739|NCT00818259|54637575|FG000|Part II|Lack of Efficacy|0|||
27979740|NCT00818259|54637576|FG001|Part II|Lack of Efficacy|0|||
27979741|NCT00818259|54637577|FG002|Part II|Lack of Efficacy|0|||
27979742|NCT00818259|54637578|FG003|Part II|Lack of Efficacy|1|||
27979743|NCT00818259|54637579|FG004|Part II|Lack of Efficacy|0|||
27979744|NCT00818259|54637580|FG005|Part II|Lack of Efficacy|0|||
27979745|NCT00818259|54637581|FG006|Part II|Lack of Efficacy|0|||
27979746|NCT00818259|54637582|FG007|Part II|Lack of Efficacy|0|||
27979747|NCT00818259|54637583|FG008|Part II|Lack of Efficacy|0|||
27979748|NCT00818259|54637575|FG000|Part II|Not Treated|0|||
27979749|NCT00818259|54637576|FG001|Part II|Not Treated|0|||
27979750|NCT00818259|54637577|FG002|Part II|Not Treated|0|||
27979751|NCT00818259|54637578|FG003|Part II|Not Treated|1|||
27979752|NCT00818259|54637579|FG004|Part II|Not Treated|0|||
27979753|NCT00818259|54637580|FG005|Part II|Not Treated|0|||
27979754|NCT00818259|54637581|FG006|Part II|Not Treated|0|||
27979755|NCT00818259|54637582|FG007|Part II|Not Treated|0|||
27979756|NCT00818259|54637583|FG008|Part II|Not Treated|0|||
27979757|NCT00818259|54637575|FG000|Part IV|Physician Decision|0|||
27979758|NCT00818259|54637576|FG001|Part IV|Physician Decision|0|||
27979759|NCT00818259|54637577|FG002|Part IV|Physician Decision|0|||
27979760|NCT00818259|54637578|FG003|Part IV|Physician Decision|0|||
27979761|NCT00818259|54637579|FG004|Part IV|Physician Decision|0|||
27979762|NCT00818259|54637580|FG005|Part IV|Physician Decision|1|||
27979763|NCT00818259|54637581|FG006|Part IV|Physician Decision|0|||
28087654|NCT00368537|54741123|FG001|Baseline Participants|Death|2|||
28087655|NCT00368537|54741122|FG000|Baseline Participants|No susceptibility|1|||
28087656|NCT00368537|54741123|FG001|Baseline Participants|No susceptibility|0|||
28087657|NCT00368537|54741122|FG000|Baseline Participants|Patient uncompliant|0|||
28087658|NCT00368537|54741123|FG001|Baseline Participants|Patient uncompliant|1|||
28087659|NCT00313703|54741133|FG000|Overall Study|Lost to Follow-up|11|||
28087660|NCT00313703|54741134|FG001|Overall Study|Lost to Follow-up|2|||
28087661|NCT00313703|54741135|FG002|Overall Study|Lost to Follow-up|5|||
28087662|NCT00313703|54741136|FG003|Overall Study|Lost to Follow-up|12|||
28087663|NCT00313313|54741149|FG000|Overall Study|Lack of Efficacy|14|||
28087664|NCT00313313|54741150|FG001|Overall Study|Lack of Efficacy|9|||
28087665|NCT00313313|54741151|FG002|Overall Study|Lack of Efficacy|20|||
28087666|NCT00313313|54741149|FG000|Overall Study|Withdrawal of consent by subject|18|||
28087667|NCT00313313|54741150|FG001|Overall Study|Withdrawal of consent by subject|17|||
28087668|NCT00313313|54741151|FG002|Overall Study|Withdrawal of consent by subject|31|||
28087669|NCT00313313|54741149|FG000|Overall Study|Lost to Follow-up|10|||
28087670|NCT00313313|54741150|FG001|Overall Study|Lost to Follow-up|7|||
28087671|NCT00313313|54741151|FG002|Overall Study|Lost to Follow-up|9|||
28087672|NCT00313313|54741149|FG000|Overall Study|Adverse Event|15|||
28087673|NCT00313313|54741150|FG001|Overall Study|Adverse Event|16|||
28087674|NCT00313313|54741151|FG002|Overall Study|Adverse Event|12|||
28087675|NCT00313313|54741149|FG000|Overall Study|Physician Decision|2|||
27979764|NCT00818259|54637582|FG007|Part IV|Physician Decision|0|||
27979765|NCT00818259|54637583|FG008|Part IV|Physician Decision|0|||
27979766|NCT00818259|54637575|FG000|Part V|Adverse Event|0|||
27979767|NCT00818259|54637576|FG001|Part V|Adverse Event|0|||
27979768|NCT00818259|54637577|FG002|Part V|Adverse Event|0|||
27979769|NCT00818259|54637578|FG003|Part V|Adverse Event|0|||
27979770|NCT00818259|54637579|FG004|Part V|Adverse Event|0|||
27979771|NCT00818259|54637580|FG005|Part V|Adverse Event|0|||
27979772|NCT00818259|54637581|FG006|Part V|Adverse Event|0|||
28087676|NCT00313313|54741150|FG001|Overall Study|Physician Decision|6|||
28087677|NCT00313313|54741151|FG002|Overall Study|Physician Decision|4|||
28087678|NCT00313313|54741149|FG000|Overall Study|Poor/Noncompliance|3|||
28087679|NCT00313313|54741150|FG001|Overall Study|Poor/Noncompliance|6|||
27979773|NCT00818259|54637582|FG007|Part V|Adverse Event|1|||
27979774|NCT00818259|54637583|FG008|Part V|Adverse Event|0|||
27979775|NCT00619099|54637601|FG000|Overall Study|Progressive Disease|7|||
27979776|NCT00619099|54637602|FG001|Overall Study|Progressive Disease|5|||
27979777|NCT00619099|54637601|FG000|Overall Study|Allogeneic Bone Marrow Transplantation|2|||
27979778|NCT00619099|54637602|FG001|Overall Study|Allogeneic Bone Marrow Transplantation|1|||
27979779|NCT00619099|54637601|FG000|Overall Study|Adverse Event|4|||
28087680|NCT00313313|54741151|FG002|Overall Study|Poor/Noncompliance|2|||
28087681|NCT00313313|54741149|FG000|Overall Study|Pregnancy|1|||
28087682|NCT00313313|54741150|FG001|Overall Study|Pregnancy|2|||
28087683|NCT00313313|54741151|FG002|Overall Study|Pregnancy|0|||
28087684|NCT00313313|54741149|FG000|Overall Study|Death|0|||
27979780|NCT00619099|54637602|FG001|Overall Study|Adverse Event|3|||
27979781|NCT00619099|54637601|FG000|Overall Study|Emergence of Clinically Significant Lab|1|||
27979782|NCT00619099|54637602|FG001|Overall Study|Emergence of Clinically Significant Lab|2|||
27979783|NCT00619099|54637601|FG000|Overall Study|Withdrawal by Subject|10|||
27979784|NCT00619099|54637602|FG001|Overall Study|Withdrawal by Subject|2|||
27979785|NCT00619099|54637601|FG000|Overall Study|Physician Decision|9|||
27979786|NCT00619099|54637602|FG001|Overall Study|Physician Decision|6|||
27979787|NCT00962585|54637612|FG000|Overall Study|Adverse Event|0|||
27979788|NCT00962585|54637613|FG001|Overall Study|Adverse Event|2|||
27979789|NCT00962585|54637614|FG002|Overall Study|Adverse Event|1|||
27979790|NCT00962585|54637615|FG003|Overall Study|Adverse Event|0|||
27979791|NCT00962585|54637612|FG000|Overall Study|Lost to Follow-up|3|||
27979792|NCT00962585|54637613|FG001|Overall Study|Lost to Follow-up|0|||
27979793|NCT00962585|54637614|FG002|Overall Study|Lost to Follow-up|1|||
27979794|NCT00962585|54637615|FG003|Overall Study|Lost to Follow-up|0|||
27979795|NCT00962585|54637612|FG000|Overall Study|Protocol Violation|0|||
27979796|NCT00962585|54637613|FG001|Overall Study|Protocol Violation|0|||
27979797|NCT00962585|54637614|FG002|Overall Study|Protocol Violation|1|||
27979798|NCT00962585|54637615|FG003|Overall Study|Protocol Violation|0|||
27979799|NCT00962585|54637612|FG000|Overall Study|Withdrawal by Subject|1|||
27979800|NCT00962585|54637613|FG001|Overall Study|Withdrawal by Subject|0|||
27979801|NCT00962585|54637614|FG002|Overall Study|Withdrawal by Subject|0|||
27979802|NCT00962585|54637615|FG003|Overall Study|Withdrawal by Subject|0|||
27979803|NCT00962585|54637612|FG000|Overall Study|Withdrew Consent|2|||
27979804|NCT00962585|54637613|FG001|Overall Study|Withdrew Consent|0|||
27979805|NCT00962585|54637614|FG002|Overall Study|Withdrew Consent|0|||
27979806|NCT00962585|54637615|FG003|Overall Study|Withdrew Consent|0|||
27979807|NCT00621985|54637627|FG000|Dexamethasone Admission|Adverse Event|1|||
27979808|NCT00961259|54637637|FG000|Washout Period of 7 Days|due to concomitant medication used|0|||
27979809|NCT00961259|54637638|FG001|Washout Period of 7 Days|due to concomitant medication used|1|||
27979810|NCT00961259|54637639|FG002|Washout Period of 7 Days|due to concomitant medication used|0|||
27979811|NCT00961181|54637648|FG000|Overall Study|Death|2|||
27979812|NCT00961181|54637648|FG000|Overall Study|Withdrawal by Subject|2|||
27979813|NCT00961181|54637648|FG000|Overall Study|Lost to Follow-up|1|||
27979814|NCT00817635|54637657|FG000|Overall Study|Adverse Event|1|||
27979815|NCT00817635|54637658|FG001|Overall Study|Adverse Event|0|||
27979816|NCT00817635|54637659|FG002|Overall Study|Adverse Event|0|||
27979817|NCT00817635|54637660|FG003|Overall Study|Adverse Event|1|||
27979818|NCT00817635|54637661|FG004|Overall Study|Adverse Event|1|||
27979819|NCT00817635|54637657|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
27979820|NCT00817635|54637658|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
27979821|NCT00817635|54637659|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
27979822|NCT00817635|54637660|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
27979823|NCT00817635|54637661|FG004|Overall Study|Abnormal Laboratory Value(s)|1|||
27979824|NCT00817635|54637657|FG000|Overall Study|Withdrawal by Subject|2|||
27979825|NCT00817635|54637658|FG001|Overall Study|Withdrawal by Subject|1|||
27979826|NCT00817635|54637659|FG002|Overall Study|Withdrawal by Subject|0|||
27979827|NCT00817635|54637660|FG003|Overall Study|Withdrawal by Subject|1|||
27979828|NCT00817635|54637661|FG004|Overall Study|Withdrawal by Subject|2|||
27979829|NCT00817635|54637657|FG000|Overall Study|Lost to Follow-up|0|||
27979830|NCT00817635|54637658|FG001|Overall Study|Lost to Follow-up|1|||
27979831|NCT00817635|54637659|FG002|Overall Study|Lost to Follow-up|0|||
27979832|NCT00817635|54637660|FG003|Overall Study|Lost to Follow-up|1|||
27979833|NCT00817635|54637661|FG004|Overall Study|Lost to Follow-up|0|||
27979834|NCT00817635|54637657|FG000|Overall Study|Administrative Problems|0|||
27979835|NCT00817635|54637658|FG001|Overall Study|Administrative Problems|0|||
27979836|NCT00817635|54637659|FG002|Overall Study|Administrative Problems|0|||
28087685|NCT00313313|54741150|FG001|Overall Study|Death|0|||
28087686|NCT00313313|54741151|FG002|Overall Study|Death|2|||
28087687|NCT00313313|54741149|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
27979837|NCT00817635|54637660|FG003|Overall Study|Administrative Problems|0|||
28087688|NCT00313313|54741150|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
27733351|NCT02559206|54181153|FG000|Overall Study|Lack of Efficacy|1|||
27733352|NCT02559206|54181154|FG001|Overall Study|Lack of Efficacy|0|||
27733353|NCT02559206|54181155|FG002|Overall Study|Lack of Efficacy|3|||
27733354|NCT02559206|54181156|FG003|Overall Study|Lack of Efficacy|2|||
27979838|NCT00817635|54637661|FG004|Overall Study|Administrative Problems|1|||
27979839|NCT00817635|54637657|FG000|Overall Study|Protocol Violation|5|||
28087689|NCT00313313|54741151|FG002|Overall Study|Subject No Longer Meets Study Criteria|2|||
27733355|NCT02559206|54181157|FG004|Overall Study|Lack of Efficacy|2|||
27979840|NCT00817635|54637658|FG001|Overall Study|Protocol Violation|1|||
27979841|NCT00817635|54637659|FG002|Overall Study|Protocol Violation|3|||
27979842|NCT00817635|54637660|FG003|Overall Study|Protocol Violation|2|||
27733356|NCT02559206|54181158|FG005|Overall Study|Lack of Efficacy|3|||
27733357|NCT02559206|54181159|FG006|Overall Study|Lack of Efficacy|3|||
27979843|NCT00817635|54637661|FG004|Overall Study|Protocol Violation|3|||
27979844|NCT00817479|54637682|FG000|Overall Study|Physician Decision|1|||
27979845|NCT00817479|54637683|FG001|Overall Study|Physician Decision|1|||
27979846|NCT00961961|54637693|FG000|Phase I|Withdrawal by Subject|7|||
27979847|NCT00961961|54637694|FG001|Phase I|Withdrawal by Subject|0|||
27979848|NCT00961961|54637695|FG002|Phase I|Withdrawal by Subject|0|||
27979849|NCT00961961|54637696|FG003|Phase I|Withdrawal by Subject|0|||
27979850|NCT00961961|54637693|FG000|Phase I|Lost to Follow-up|10|||
27733358|NCT02559206|54181160|FG007|Overall Study|Lack of Efficacy|3|||
27733359|NCT02559206|54181153|FG000|Overall Study|Other Not Specified|0|||
27979851|NCT00961961|54637694|FG001|Phase I|Lost to Follow-up|0|||
27979852|NCT00961961|54637695|FG002|Phase I|Lost to Follow-up|0|||
27979853|NCT00961961|54637696|FG003|Phase I|Lost to Follow-up|0|||
27979854|NCT00961961|54637693|FG000|Phase I|Lack of Efficacy|94|||
27979855|NCT00961961|54637694|FG001|Phase I|Lack of Efficacy|0|||
27979856|NCT00961961|54637695|FG002|Phase I|Lack of Efficacy|0|||
27979857|NCT00961961|54637696|FG003|Phase I|Lack of Efficacy|0|||
27979858|NCT00961961|54637693|FG000|Phase I|Adverse Event|7|||
27979859|NCT00961961|54637694|FG001|Phase I|Adverse Event|0|||
27979860|NCT00961961|54637695|FG002|Phase I|Adverse Event|0|||
27979861|NCT00961961|54637696|FG003|Phase I|Adverse Event|0|||
27979862|NCT00961961|54637693|FG000|Phase I|Physician Decision|8|||
27979863|NCT00961961|54637694|FG001|Phase I|Physician Decision|0|||
27979864|NCT00961961|54637695|FG002|Phase I|Physician Decision|0|||
27979865|NCT00961961|54637696|FG003|Phase I|Physician Decision|0|||
27979866|NCT00961961|54637693|FG000|Phase II|Lost to Follow-up|0|||
27979867|NCT00961961|54637694|FG001|Phase II|Lost to Follow-up|0|||
27979868|NCT00961961|54637695|FG002|Phase II|Lost to Follow-up|10|||
27979869|NCT00961961|54637696|FG003|Phase II|Lost to Follow-up|7|||
27979870|NCT00961961|54637693|FG000|Phase II|Adverse Event|0|||
27979871|NCT00961961|54637694|FG001|Phase II|Adverse Event|0|||
27979872|NCT00961961|54637695|FG002|Phase II|Adverse Event|0|||
27979873|NCT00961961|54637696|FG003|Phase II|Adverse Event|1|||
27979874|NCT00961961|54637693|FG000|Phase II|Physician Decision|0|||
27979875|NCT00961961|54637694|FG001|Phase II|Physician Decision|0|||
27979876|NCT00961961|54637695|FG002|Phase II|Physician Decision|1|||
27979877|NCT00961961|54637696|FG003|Phase II|Physician Decision|0|||
27979878|NCT00961961|54637693|FG000|Phase II|Withdrawal by Subject|0|||
27979879|NCT00961961|54637694|FG001|Phase II|Withdrawal by Subject|0|||
27979880|NCT00961961|54637695|FG002|Phase II|Withdrawal by Subject|1|||
27979881|NCT00961961|54637696|FG003|Phase II|Withdrawal by Subject|0|||
27979882|NCT00817089|54637720|FG000|First Alcohol Challenge|Lost to Follow-up|0|||
27979883|NCT00817089|54637721|FG001|First Alcohol Challenge|Lost to Follow-up|0|||
27979884|NCT00817089|54637722|FG002|First Alcohol Challenge|Lost to Follow-up|0|||
27979885|NCT00817089|54637723|FG003|First Alcohol Challenge|Lost to Follow-up|1|||
27979886|NCT00817089|54637720|FG000|Second Alcohol Challenge|Lost to Follow-up|0|||
27979887|NCT00817089|54637721|FG001|Second Alcohol Challenge|Lost to Follow-up|1|||
27979888|NCT00817089|54637722|FG002|Second Alcohol Challenge|Lost to Follow-up|0|||
27979889|NCT00817089|54637723|FG003|Second Alcohol Challenge|Lost to Follow-up|0|||
27979890|NCT00815919|54637737|FG000|Overall Study|Unrelated Fungal Infection|1|||
27979891|NCT00815919|54637737|FG000|Overall Study|AML Relapse|1|||
27979892|NCT00815919|54637737|FG000|Overall Study|Lack of Efficacy|2|||
27979893|NCT00957905|54637743|FG000|Part B|Not Treated|0|||
27979894|NCT00957905|54637744|FG001|Part B|Not Treated|1|||
27979895|NCT00957905|54637743|FG000|Part B|Physician Decision|0|||
27979896|NCT00957905|54637744|FG001|Part B|Physician Decision|1|||
27979897|NCT00957905|54637743|FG000|Part B|Death|0|||
27979898|NCT00957905|54637744|FG001|Part B|Death|1|||
27979899|NCT00957905|54637743|FG000|Part B|Protocol Violation|0|||
27979900|NCT00957905|54637744|FG001|Part B|Protocol Violation|1|||
27979901|NCT00960323|54637750|FG000|Atorvastatin Alone|Withdrawal by Subject|1|||
27979902|NCT00617929|54637758|FG000|Overall Study|Physician Decision|1|||
27979903|NCT00815295|54637765|FG000|Overall Study|Cetuximab hypersensitivity reaction|0|||
27979904|NCT00815295|54637766|FG001|Overall Study|Cetuximab hypersensitivity reaction|1|||
27979905|NCT00815295|54637767|FG002|Overall Study|Cetuximab hypersensitivity reaction|3|||
27979906|NCT00814983|54637777|FG000|Overall Study|Screen failure|1|||
27979907|NCT00814983|54637778|FG001|Overall Study|Screen failure|0|||
27979908|NCT00814983|54637777|FG000|Overall Study|Withdrawal by Subject|1|||
27733360|NCT02559206|54181154|FG001|Overall Study|Other Not Specified|0|||
27979909|NCT00814983|54637778|FG001|Overall Study|Withdrawal by Subject|0|||
27979910|NCT00814983|54637777|FG000|Overall Study|Graft failure|1|||
27979911|NCT00814983|54637778|FG001|Overall Study|Graft failure|0|||
27733361|NCT02559206|54181155|FG002|Overall Study|Other Not Specified|0|||
27979912|NCT00960869|54637786|FG000|Overall Study|Adverse Event|17|||
27979913|NCT00960869|54637787|FG001|Overall Study|Adverse Event|26|||
27979914|NCT00960869|54637786|FG000|Overall Study|Withdrawal by Subject|16|||
27979915|NCT00960869|54637787|FG001|Overall Study|Withdrawal by Subject|14|||
27979916|NCT00960869|54637786|FG000|Overall Study|Lost to Follow-up|1|||
27979917|NCT00960869|54637787|FG001|Overall Study|Lost to Follow-up|4|||
27979918|NCT00960869|54637786|FG000|Overall Study|Misc|19|||
27979919|NCT00960869|54637787|FG001|Overall Study|Misc|18|||
27979920|NCT00618787|54637795|FG000|Overall Study|Adverse Event|0|||
27979921|NCT00618787|54637796|FG001|Overall Study|Adverse Event|1|||
27979922|NCT00618787|54637795|FG000|Overall Study|Withdrawal by Subject|2|||
27979923|NCT00618787|54637796|FG001|Overall Study|Withdrawal by Subject|1|||
27979924|NCT00618787|54637795|FG000|Overall Study|Lost to Follow-up|1|||
27979925|NCT00618787|54637796|FG001|Overall Study|Lost to Follow-up|0|||
27979926|NCT00813813|54637804|FG000|Overall Study|Withdrawal by Subject|1|||
27979927|NCT00813813|54637805|FG001|Overall Study|Withdrawal by Subject|1|||
27979928|NCT00813813|54637804|FG000|Overall Study|Lost to Follow-up|2|||
27979929|NCT00813813|54637805|FG001|Overall Study|Lost to Follow-up|7|||
27979930|NCT00813813|54637804|FG000|Overall Study|Other|0|||
28087690|NCT00312845|54741161|FG000|Overall Study|Adverse Event|19|||
28087691|NCT00312845|54741162|FG001|Overall Study|Adverse Event|5|||
28087692|NCT00312845|54741161|FG000|Overall Study|Death|2|||
28087693|NCT00312845|54741162|FG001|Overall Study|Death|2|||
28087694|NCT00312845|54741161|FG000|Overall Study|Withdrawal by Subject|14|||
28087695|NCT00312845|54741162|FG001|Overall Study|Withdrawal by Subject|6|||
28087696|NCT00312845|54741161|FG000|Overall Study|Disease Progression|56|||
28087697|NCT00312845|54741162|FG001|Overall Study|Disease Progression|77|||
28087698|NCT00312845|54741161|FG000|Overall Study|Lost to Follow-up|2|||
28087699|NCT00312845|54741162|FG001|Overall Study|Lost to Follow-up|0|||
28087700|NCT00312845|54741161|FG000|Overall Study|Other|6|||
28087701|NCT00312845|54741162|FG001|Overall Study|Other|5|||
28087702|NCT00368069|54741170|FG000|Overall Study|Adverse Event|5|||
28087703|NCT00368069|54741171|FG001|Overall Study|Adverse Event|2|||
28087704|NCT00368069|54741170|FG000|Overall Study|Lack of Efficacy|0|||
28087705|NCT00368069|54741171|FG001|Overall Study|Lack of Efficacy|1|||
28087706|NCT00368069|54741170|FG000|Overall Study|Lost to Follow-up|1|||
28087707|NCT00368069|54741171|FG001|Overall Study|Lost to Follow-up|0|||
28087708|NCT00368069|54741170|FG000|Overall Study|Protocol Violation|0|||
28087709|NCT00368069|54741171|FG001|Overall Study|Protocol Violation|2|||
28087710|NCT00368069|54741170|FG000|Overall Study|Withdrawal of Consent|2|||
28165680|NCT02907463|54836365|FG000|Overall Study|Not Implanted with Study Device|2|||
28165681|NCT02907463|54836365|FG000|Overall Study|Device Explanted|1|||
28165682|NCT02907463|54836365|FG000|Overall Study|Missing Exit Form|1|||
28165683|NCT02906917|54836379|FG000|Initiation Period (Week 0-26)|Unclassified|1|||
28165684|NCT02906917|54836380|FG001|Initiation Period (Week 0-26)|Unclassified|3|||
28165685|NCT02906917|54836379|FG000|Initiation Period (Week 0-26)|Adverse Event|1|||
28165686|NCT02906917|54836380|FG001|Initiation Period (Week 0-26)|Adverse Event|0|||
28165687|NCT02906917|54836379|FG000|Initiation Period (Week 0-26)|Lost to Follow-up|1|||
28165688|NCT02906917|54836380|FG001|Initiation Period (Week 0-26)|Lost to Follow-up|4|||
28165689|NCT02906917|54836379|FG000|Initiation Period (Week 0-26)|Withdrawal by Subject|3|||
28165690|NCT02906917|54836380|FG001|Initiation Period (Week 0-26)|Withdrawal by Subject|4|||
28165691|NCT02906917|54836379|FG000|Intensification Period (Week 26-38)|Unclassified|3|||
28165692|NCT02906917|54836380|FG001|Intensification Period (Week 26-38)|Unclassified|2|||
28165693|NCT02906917|54836379|FG000|Intensification Period (Week 26-38)|Adverse Event|0|||
28165694|NCT02906917|54836380|FG001|Intensification Period (Week 26-38)|Adverse Event|2|||
28165695|NCT02906917|54836379|FG000|Intensification Period (Week 26-38)|Lost to Follow-up|3|||
28165696|NCT02906917|54836380|FG001|Intensification Period (Week 26-38)|Lost to Follow-up|1|||
28165697|NCT02906917|54836379|FG000|Intensification Period (Week 26-38)|Withdrawal by Subject|3|||
28165698|NCT02906917|54836380|FG001|Intensification Period (Week 26-38)|Withdrawal by Subject|2|||
28165699|NCT02982187|54836388|FG000|Overall Study|Withdrawal by Subject|0|||
28165700|NCT02982187|54836389|FG001|Overall Study|Withdrawal by Subject|0|||
28165701|NCT02982187|54836390|FG002|Overall Study|Withdrawal by Subject|0|||
28165702|NCT02982187|54836391|FG003|Overall Study|Withdrawal by Subject|0|||
28165703|NCT02982187|54836392|FG004|Overall Study|Withdrawal by Subject|0|||
28165704|NCT02982187|54836393|FG005|Overall Study|Withdrawal by Subject|0|||
28165705|NCT02982187|54836394|FG006|Overall Study|Withdrawal by Subject|1|||
28165706|NCT02982187|54836395|FG007|Overall Study|Withdrawal by Subject|0|||
28165707|NCT02981953|54836405|FG000|Overall Study|Death|9|||
28165708|NCT02981953|54836405|FG000|Overall Study|Withdrawal by Subject|1|||
27733362|NCT02559206|54181156|FG003|Overall Study|Other Not Specified|1|||
27979931|NCT00813813|54637805|FG001|Overall Study|Other|1|||
27979932|NCT00960011|54637813|FG000|Overall Study|Death|5|||
27979933|NCT00960011|54637814|FG001|Overall Study|Death|0|||
27979934|NCT00960011|54637813|FG000|Overall Study|Lost to Follow-up|6|||
28087711|NCT00368069|54741171|FG001|Overall Study|Withdrawal of Consent|1|||
28087712|NCT00368069|54741170|FG000|Overall Study|no blood sampling possible|0|||
28087713|NCT00368069|54741171|FG001|Overall Study|no blood sampling possible|1|||
28087714|NCT00367991|54741179|FG000|Overall Study|Withdrawal by Subject|1|||
28087715|NCT00367991|54741180|FG001|Overall Study|Withdrawal by Subject|1|||
28087716|NCT00367991|54741179|FG000|Overall Study|Adverse Event|1|||
27979935|NCT00960011|54637814|FG001|Overall Study|Lost to Follow-up|2|||
28165709|NCT02981953|54836405|FG000|Overall Study|Withdrawal to non-compliance|1|||
27979936|NCT00617851|54637858|FG000|Overall Study|Death|0|||
27733363|NCT02559206|54181157|FG004|Overall Study|Other Not Specified|0|||
27979937|NCT00617851|54637859|FG001|Overall Study|Death|0|||
27979938|NCT00617851|54637860|FG002|Overall Study|Death|0|||
27979939|NCT00617851|54637861|FG003|Overall Study|Death|1|||
27979940|NCT00617851|54637858|FG000|Overall Study|Withdrawal by Subject|14|||
27979941|NCT00617851|54637859|FG001|Overall Study|Withdrawal by Subject|7|||
27979942|NCT00617851|54637860|FG002|Overall Study|Withdrawal by Subject|12|||
27979943|NCT00617851|54637861|FG003|Overall Study|Withdrawal by Subject|4|||
28165710|NCT01066585|54836421|FG000|Overall Study|Protocol Violation|1|||
27979944|NCT00617851|54637858|FG000|Overall Study|Lost to Follow-up|27|||
27979945|NCT00617851|54637859|FG001|Overall Study|Lost to Follow-up|29|||
27979946|NCT00617851|54637860|FG002|Overall Study|Lost to Follow-up|31|||
27979947|NCT00617851|54637861|FG003|Overall Study|Lost to Follow-up|19|||
27979948|NCT00617851|54637858|FG000|Overall Study|Inappropriate Enrollment|5|||
27979949|NCT00617851|54637859|FG001|Overall Study|Inappropriate Enrollment|4|||
27979950|NCT00617851|54637860|FG002|Overall Study|Inappropriate Enrollment|1|||
27979951|NCT00617851|54637861|FG003|Overall Study|Inappropriate Enrollment|1|||
27979952|NCT00617851|54637858|FG000|Overall Study|Unable to classify|1|||
27979953|NCT00617851|54637859|FG001|Overall Study|Unable to classify|0|||
27979954|NCT00617851|54637860|FG002|Overall Study|Unable to classify|1|||
27979955|NCT00617851|54637861|FG003|Overall Study|Unable to classify|0|||
27979956|NCT00812955|54637885|FG000|Overall Study|Adverse Event|7|||
27979957|NCT00812955|54637886|FG001|Overall Study|Adverse Event|6|||
27979958|NCT00812955|54637887|FG002|Overall Study|Adverse Event|3|||
27979959|NCT00812955|54637888|FG003|Overall Study|Adverse Event|4|||
27979960|NCT00812955|54637885|FG000|Overall Study|Lost to Follow-up|2|||
27979961|NCT00812955|54637886|FG001|Overall Study|Lost to Follow-up|1|||
27979962|NCT00812955|54637887|FG002|Overall Study|Lost to Follow-up|1|||
27979963|NCT00812955|54637888|FG003|Overall Study|Lost to Follow-up|2|||
27979964|NCT00812955|54637885|FG000|Overall Study|Withdrawal by Subject|1|||
27979965|NCT00812955|54637886|FG001|Overall Study|Withdrawal by Subject|0|||
27979966|NCT00812955|54637887|FG002|Overall Study|Withdrawal by Subject|1|||
27979967|NCT00812955|54637888|FG003|Overall Study|Withdrawal by Subject|2|||
27979968|NCT00812955|54637885|FG000|Overall Study|randomized in error|0|||
27979969|NCT00812955|54637886|FG001|Overall Study|randomized in error|0|||
27979970|NCT00812955|54637887|FG002|Overall Study|randomized in error|1|||
27979971|NCT00812955|54637888|FG003|Overall Study|randomized in error|0|||
27979972|NCT00619489|54637904|FG000|Overall Study|Adverse Event|0|||
27979973|NCT00619489|54637905|FG001|Overall Study|Adverse Event|7|||
27979974|NCT00619489|54637904|FG000|Overall Study|Withdrawal by Subject|1|||
27979975|NCT00619489|54637905|FG001|Overall Study|Withdrawal by Subject|1|||
27979976|NCT00619489|54637904|FG000|Overall Study|Lack of Efficacy|0|||
27979977|NCT00619489|54637905|FG001|Overall Study|Lack of Efficacy|11|||
27979978|NCT00619489|54637904|FG000|Overall Study|Rolled over to Study C13008 (NCT00790933|22|||
27979979|NCT00619489|54637905|FG001|Overall Study|Rolled over to Study C13008 (NCT00790933|15|||
27979980|NCT00959699|54637913|FG000|Treatment Period|Adverse Event|3|||
27979981|NCT00959699|54637914|FG001|Treatment Period|Adverse Event|13|||
27979982|NCT00959699|54637913|FG000|Treatment Period|Lack of Efficacy|15|||
27979983|NCT00959699|54637914|FG001|Treatment Period|Lack of Efficacy|6|||
27979984|NCT00959699|54637913|FG000|Treatment Period|Lost to Follow-up|0|||
27979985|NCT00959699|54637914|FG001|Treatment Period|Lost to Follow-up|1|||
27979986|NCT00959699|54637913|FG000|Treatment Period|Withdrawal by Subject|1|||
27979987|NCT00959699|54637914|FG001|Treatment Period|Withdrawal by Subject|3|||
27979988|NCT00959699|54637913|FG000|Treatment Period|Non-Compliance with Protocol|0|||
27979989|NCT00959699|54637914|FG001|Treatment Period|Non-Compliance with Protocol|1|||
27979990|NCT00959699|54637913|FG000|Treatment Period|Did not receive treatment|0|||
27979991|NCT00959699|54637914|FG001|Treatment Period|Did not receive treatment|1|||
27979992|NCT00959699|54637913|FG000|Treatment Period|Futility/crossover to boceprevir|4|||
27979993|NCT00959699|54637914|FG001|Treatment Period|Futility/crossover to boceprevir|0|||
27979994|NCT00959699|54637913|FG000|Follow-up Period|Lost to Follow-up|3|||
27979995|NCT00959699|54637914|FG001|Follow-up Period|Lost to Follow-up|2|||
27979996|NCT00959699|54637913|FG000|Follow-up Period|Withdrawal by Subject|3|||
27979997|NCT00959699|54637914|FG001|Follow-up Period|Withdrawal by Subject|4|||
27979998|NCT00617773|54637921|FG000|Overall Study|Physician Decision|1|||
27979999|NCT00617773|54637921|FG000|Overall Study|Lack of compliance with the protocol|1|||
27980000|NCT00617773|54637921|FG000|Overall Study|Withdrawal by Subject|1|||
27980001|NCT00617773|54637921|FG000|Overall Study|Death|1|||
27980002|NCT00617773|54637921|FG000|Overall Study|Progressive disease|19|||
27980003|NCT00617773|54637921|FG000|Overall Study|Protocol Violation|1|||
27980004|NCT00956813|54637927|FG000|Flaxseed and Placebo|Withdrawal by Subject|5|||
27980005|NCT00956813|54637928|FG001|Flaxseed and Placebo|Withdrawal by Subject|4|||
27980006|NCT00956813|54637927|FG000|Flaxseed and Placebo|Ineligible|3|||
27980007|NCT00956813|54637928|FG001|Flaxseed and Placebo|Ineligible|1|||
27980008|NCT00955955|54637938|FG000|Overall Study|Lost to Follow-up|2|||
27980009|NCT00955955|54637939|FG001|Overall Study|Lost to Follow-up|0|||
27980010|NCT00955955|54637940|FG002|Overall Study|Lost to Follow-up|0|||
28165711|NCT01066585|54836422|FG001|Overall Study|Protocol Violation|0|||
27980011|NCT00955721|54637956|FG000|Overall Study|Physician Decision|1|||
27980012|NCT00955721|54637957|FG001|Overall Study|Physician Decision|0|||
27980013|NCT00955721|54637956|FG000|Overall Study|Death|1|||
27980014|NCT00955721|54637957|FG001|Overall Study|Death|0|||
27980015|NCT00955721|54637956|FG000|Overall Study|Withdrawal by Subject|1|||
27980016|NCT00955721|54637957|FG001|Overall Study|Withdrawal by Subject|0|||
27980017|NCT00573469|54637967|FG000|Overall Study|Adverse Event|1|||
27980018|NCT00573469|54637968|FG001|Overall Study|Adverse Event|1|||
27980019|NCT00573469|54637969|FG002|Overall Study|Adverse Event|1|||
27980020|NCT00573469|54637967|FG000|Overall Study|Withdrawal by Subject|0|||
27980021|NCT00573469|54637968|FG001|Overall Study|Withdrawal by Subject|2|||
27980022|NCT00573469|54637969|FG002|Overall Study|Withdrawal by Subject|0|||
27980023|NCT00573469|54637967|FG000|Overall Study|Other|5|||
27980024|NCT00573469|54637968|FG001|Overall Study|Other|1|||
27980025|NCT00573469|54637969|FG002|Overall Study|Other|3|||
27980026|NCT00812565|54637985|FG000|Overall Study|Did Not Receive Study Medication|1|||
27980027|NCT00812565|54637986|FG001|Overall Study|Did Not Receive Study Medication|1|||
27980028|NCT00812565|54637987|FG002|Overall Study|Did Not Receive Study Medication|0|||
27980029|NCT00812565|54637988|FG003|Overall Study|Did Not Receive Study Medication|0|||
27980030|NCT00812565|54637989|FG004|Overall Study|Did Not Receive Study Medication|0|||
27980031|NCT00812565|54637990|FG005|Overall Study|Did Not Receive Study Medication|0|||
27980032|NCT00812565|54637991|FG006|Overall Study|Did Not Receive Study Medication|0|||
27980033|NCT00812565|54637992|FG007|Overall Study|Did Not Receive Study Medication|0|||
27980034|NCT00812565|54637985|FG000|Overall Study|Adverse Event|0|||
27980035|NCT00812565|54637986|FG001|Overall Study|Adverse Event|0|||
27980036|NCT00812565|54637987|FG002|Overall Study|Adverse Event|0|||
27980037|NCT00812565|54637988|FG003|Overall Study|Adverse Event|2|||
27980038|NCT00812565|54637989|FG004|Overall Study|Adverse Event|0|||
27980039|NCT00812565|54637990|FG005|Overall Study|Adverse Event|0|||
27980040|NCT00812565|54637991|FG006|Overall Study|Adverse Event|0|||
27980041|NCT00812565|54637992|FG007|Overall Study|Adverse Event|1|||
27980042|NCT00812565|54637985|FG000|Overall Study|Did Not Come to Study Visit|1|||
27980043|NCT00812565|54637986|FG001|Overall Study|Did Not Come to Study Visit|0|||
27980044|NCT00812565|54637987|FG002|Overall Study|Did Not Come to Study Visit|0|||
27980045|NCT00812565|54637988|FG003|Overall Study|Did Not Come to Study Visit|0|||
27980046|NCT00812565|54637989|FG004|Overall Study|Did Not Come to Study Visit|0|||
27980047|NCT00812565|54637990|FG005|Overall Study|Did Not Come to Study Visit|0|||
27980048|NCT00812565|54637991|FG006|Overall Study|Did Not Come to Study Visit|0|||
27980049|NCT00812565|54637992|FG007|Overall Study|Did Not Come to Study Visit|0|||
27980050|NCT00812565|54637985|FG000|Overall Study|Withdrawal of Consent|1|||
27980051|NCT00812565|54637986|FG001|Overall Study|Withdrawal of Consent|0|||
27980052|NCT00812565|54637987|FG002|Overall Study|Withdrawal of Consent|0|||
27980053|NCT00812565|54637988|FG003|Overall Study|Withdrawal of Consent|0|||
27980054|NCT00812565|54637989|FG004|Overall Study|Withdrawal of Consent|1|||
27980055|NCT00812565|54637990|FG005|Overall Study|Withdrawal of Consent|0|||
27980056|NCT00812565|54637991|FG006|Overall Study|Withdrawal of Consent|0|||
27980057|NCT00812565|54637992|FG007|Overall Study|Withdrawal of Consent|0|||
27980058|NCT00812565|54637985|FG000|Overall Study|Reason Not Specified|0|||
27980059|NCT00812565|54637986|FG001|Overall Study|Reason Not Specified|0|||
27980060|NCT00812565|54637987|FG002|Overall Study|Reason Not Specified|0|||
27980061|NCT00812565|54637988|FG003|Overall Study|Reason Not Specified|0|||
27980062|NCT00812565|54637989|FG004|Overall Study|Reason Not Specified|0|||
27980063|NCT00812565|54637990|FG005|Overall Study|Reason Not Specified|1|||
27980064|NCT00812565|54637991|FG006|Overall Study|Reason Not Specified|0|||
27980065|NCT00812565|54637992|FG007|Overall Study|Reason Not Specified|0|||
27980066|NCT00812487|54638012|FG000|Overall Study|Lost to Follow-up|2|||
27980067|NCT00812487|54638013|FG001|Overall Study|Lost to Follow-up|0|||
27980068|NCT00812487|54638012|FG000|Overall Study|Withdrawal by Subject|3|||
27980069|NCT00812487|54638013|FG001|Overall Study|Withdrawal by Subject|2|||
27980070|NCT00812487|54638012|FG000|Overall Study|Transfer to ICU prior to intervention|1|||
27980071|NCT00812487|54638013|FG001|Overall Study|Transfer to ICU prior to intervention|0|||
27980072|NCT00812487|54638012|FG000|Overall Study|Protocol Violation|0|||
27980073|NCT00812487|54638013|FG001|Overall Study|Protocol Violation|1|||
27980074|NCT00617461|54638023|FG000|First Treatment Intervention Period|Adverse Event|2|||
27980075|NCT00617461|54638024|FG001|First Treatment Intervention Period|Adverse Event|0|||
27980076|NCT00617461|54638023|FG000|First Treatment Intervention Period|Lack of Efficacy|1|||
27980077|NCT00617461|54638024|FG001|First Treatment Intervention Period|Lack of Efficacy|0|||
27980078|NCT00617461|54638023|FG000|First Treatment Intervention Period|Protocol Violation|2|||
27980079|NCT00617461|54638024|FG001|First Treatment Intervention Period|Protocol Violation|1|||
27980080|NCT00617461|54638023|FG000|First Treatment Intervention Period|Lost to Follow-up|0|||
27980081|NCT00617461|54638024|FG001|First Treatment Intervention Period|Lost to Follow-up|1|||
27980082|NCT00617461|54638023|FG000|First Treatment Intervention Period|Investigator Discretion|1|||
27980083|NCT00617461|54638024|FG001|First Treatment Intervention Period|Investigator Discretion|1|||
27980084|NCT00617461|54638023|FG000|First Treatment Intervention Period|Withdrawal by Subject|4|||
27980085|NCT00617461|54638024|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
27980086|NCT00617461|54638023|FG000|4-Day Crossover Period|Withdrawal by Subject|1|||
27980087|NCT00617461|54638024|FG001|4-Day Crossover Period|Withdrawal by Subject|0|||
27980088|NCT00617461|54638023|FG000|Second Treatment Intervention Period|Adverse Event|0|||
27980089|NCT00617461|54638024|FG001|Second Treatment Intervention Period|Adverse Event|1|||
27980090|NCT00617461|54638023|FG000|Second Treatment Intervention Period|Lack of Efficacy|0|||
27980091|NCT00617461|54638024|FG001|Second Treatment Intervention Period|Lack of Efficacy|3|||
27980092|NCT00617461|54638023|FG000|6-Day Down-Titration Period|Withdrawal by Subject|1|||
27980093|NCT00617461|54638024|FG001|6-Day Down-Titration Period|Withdrawal by Subject|0|||
27980094|NCT00617461|54638023|FG000|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1|||
27980095|NCT00617461|54638024|FG001|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2|||
27980096|NCT00812331|54638051|FG000|Overall Study|Adverse Event|1|||
27980097|NCT00812331|54638052|FG001|Overall Study|Adverse Event|0|||
27980098|NCT00812331|54638053|FG002|Overall Study|Adverse Event|0|||
27980099|NCT00812331|54638054|FG003|Overall Study|Adverse Event|0|||
27980100|NCT00812331|54638055|FG004|Overall Study|Adverse Event|0|||
27980101|NCT00812253|54638065|FG000|Overall Study|Withdrawal by Subject|3|||
27980102|NCT00812253|54638066|FG001|Overall Study|Withdrawal by Subject|2|||
27980103|NCT00812253|54638065|FG000|Overall Study|Protocol Violation|1|||
27980104|NCT00812253|54638066|FG001|Overall Study|Protocol Violation|1|||
27980105|NCT00812253|54638065|FG000|Overall Study|Lost to Follow-up|2|||
27980106|NCT00812253|54638066|FG001|Overall Study|Lost to Follow-up|0|||
27980107|NCT00616759|54638074|FG000|Overall Study|Physician Decision|2|||
27980108|NCT00616759|54638075|FG001|Overall Study|Physician Decision|0|||
27980109|NCT00616759|54638074|FG000|Overall Study|Withdrawal by Subject|1|||
27980110|NCT00616759|54638075|FG001|Overall Study|Withdrawal by Subject|2|||
27980111|NCT00812097|54638085|FG000|Overall Study|Death|3|||
27980112|NCT00812097|54638086|FG001|Overall Study|Death|10|||
27980113|NCT00812097|54638087|FG002|Overall Study|Death|3|||
27980114|NCT00812097|54638088|FG003|Overall Study|Death|3|||
27980115|NCT00812097|54638085|FG000|Overall Study|Withdrawal by Subject|14|||
27980116|NCT00812097|54638086|FG001|Overall Study|Withdrawal by Subject|12|||
27980117|NCT00812097|54638087|FG002|Overall Study|Withdrawal by Subject|8|||
27980118|NCT00812097|54638088|FG003|Overall Study|Withdrawal by Subject|2|||
27980119|NCT00812097|54638085|FG000|Overall Study|Lost to Follow-up|90|||
27980120|NCT00812097|54638086|FG001|Overall Study|Lost to Follow-up|14|||
27980121|NCT00812097|54638087|FG002|Overall Study|Lost to Follow-up|17|||
27980122|NCT00812097|54638088|FG003|Overall Study|Lost to Follow-up|5|||
27980123|NCT00812097|54638085|FG000|Overall Study|Explantation of study device(s)|27|||
27980124|NCT00812097|54638086|FG001|Overall Study|Explantation of study device(s)|29|||
28087717|NCT00367991|54741180|FG001|Overall Study|Adverse Event|1|||
28087718|NCT00367835|54741188|FG000|Overall Study|Adverse Event|14|||
28087719|NCT00367835|54741189|FG001|Overall Study|Adverse Event|1|||
28087720|NCT00367835|54741188|FG000|Overall Study|Protocol Violation|1|||
28087721|NCT00367835|54741189|FG001|Overall Study|Protocol Violation|7|||
28087722|NCT00367835|54741188|FG000|Overall Study|Withdrawal by Subject|7|||
28087723|NCT00367835|54741189|FG001|Overall Study|Withdrawal by Subject|6|||
28087724|NCT00367835|54741188|FG000|Overall Study|Lost to Follow-up|1|||
28087725|NCT00367835|54741189|FG001|Overall Study|Lost to Follow-up|4|||
28087726|NCT00367835|54741188|FG000|Overall Study|Lack of Efficacy|3|||
28087727|NCT00367835|54741189|FG001|Overall Study|Lack of Efficacy|12|||
28087728|NCT00367835|54741188|FG000|Overall Study|Subject in juvenile detention center|1|||
28087729|NCT00367835|54741189|FG001|Overall Study|Subject in juvenile detention center|0|||
28087730|NCT00367835|54741188|FG000|Overall Study|refused blood collection|1|||
28087731|NCT00367835|54741189|FG001|Overall Study|refused blood collection|0|||
28087732|NCT00367835|54741188|FG000|Overall Study|Did not respond to calls|1|||
28087733|NCT00367835|54741189|FG001|Overall Study|Did not respond to calls|0|||
28165712|NCT01066585|54836421|FG000|Overall Study|Withdrawal by Subject|0|||
28165713|NCT01066585|54836422|FG001|Overall Study|Withdrawal by Subject|3|||
28165714|NCT02980783|54836428|FG000|Overall Study|Lost to Follow-up|1|||
28165715|NCT02980705|54836434|FG000|Overall Study|Adverse Event|0|||
27980125|NCT00812097|54638087|FG002|Overall Study|Explantation of study device(s)|14|||
27980126|NCT00812097|54638088|FG003|Overall Study|Explantation of study device(s)|20|||
27980127|NCT00812097|54638085|FG000|Overall Study|Unknown reasons and patient/doctor moves|111|||
27980128|NCT00812097|54638086|FG001|Overall Study|Unknown reasons and patient/doctor moves|24|||
27980129|NCT00812097|54638087|FG002|Overall Study|Unknown reasons and patient/doctor moves|15|||
27980130|NCT00812097|54638088|FG003|Overall Study|Unknown reasons and patient/doctor moves|5|||
27980131|NCT00811941|54638100|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
28087734|NCT00367835|54741188|FG000|Overall Study|History of lead poisoning|0|||
28087735|NCT00367835|54741189|FG001|Overall Study|History of lead poisoning|1|||
28087736|NCT03267940|54741201|FG000|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1|||
28087737|NCT03267940|54741202|FG001|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2|||
28087738|NCT03267940|54741203|FG002|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
28087739|NCT03267940|54741204|FG003|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
28087740|NCT03267940|54741205|FG004|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
28165716|NCT02980705|54836435|FG001|Overall Study|Adverse Event|1|||
28087741|NCT03267940|54741206|FG005|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
28087742|NCT03267940|54741201|FG000|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
28087743|NCT03267940|54741202|FG001|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1|||
28087744|NCT03267940|54741203|FG002|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
28087745|NCT03267940|54741204|FG003|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
28087746|NCT03267940|54741205|FG004|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
28087747|NCT03267940|54741206|FG005|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
28087748|NCT03267940|54741201|FG000|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
28087749|NCT03267940|54741202|FG001|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1|||
28087750|NCT03267940|54741203|FG002|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
28087751|NCT03267940|54741204|FG003|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
28087752|NCT03267940|54741205|FG004|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
28087753|NCT03267940|54741206|FG005|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
28087754|NCT03267940|54741201|FG000|Run-in Portion (Max. Exposure: 508 Days)|Death|7|||
28165717|NCT02980705|54836434|FG000|Overall Study|Withdrawal by Subject|6|||
28165718|NCT02980705|54836435|FG001|Overall Study|Withdrawal by Subject|9|||
28087755|NCT03267940|54741202|FG001|Run-in Portion (Max. Exposure: 508 Days)|Death|3|||
28087756|NCT03267940|54741203|FG002|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
28087757|NCT03267940|54741204|FG003|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
28087758|NCT03267940|54741205|FG004|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
28087759|NCT03267940|54741206|FG005|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
28087760|NCT03267940|54741201|FG000|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
28087761|NCT03267940|54741202|FG001|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
28087762|NCT03267940|54741203|FG002|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
28087763|NCT03267940|54741204|FG003|Expansion (Maximum Exposure: 421 Days)|Other than specified|3|||
28087764|NCT03267940|54741205|FG004|Expansion (Maximum Exposure: 421 Days)|Other than specified|2|||
28087765|NCT03267940|54741206|FG005|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
28087766|NCT03267940|54741201|FG000|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
28087767|NCT03267940|54741202|FG001|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
28087768|NCT03267940|54741203|FG002|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
28087769|NCT03267940|54741204|FG003|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1|||
28087770|NCT03267940|54741205|FG004|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
28087771|NCT03267940|54741206|FG005|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
28087772|NCT03267940|54741201|FG000|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
28087773|NCT03267940|54741202|FG001|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
28087774|NCT03267940|54741203|FG002|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2|||
28087775|NCT03267940|54741204|FG003|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
28087776|NCT03267940|54741205|FG004|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
28165719|NCT02980705|54836434|FG000|Overall Study|withdrew participation|0|||
28165720|NCT02980705|54836435|FG001|Overall Study|withdrew participation|1|||
28165721|NCT02980705|54836434|FG000|Overall Study|Lost to Follow-up|2|||
28165722|NCT02980705|54836435|FG001|Overall Study|Lost to Follow-up|0|||
28165723|NCT02989649|54836442|FG000|Overall Study|Patient/Investigator's Decision to Stop|403|||
28165724|NCT02989649|54836442|FG000|Overall Study|Adverse Event/Adverse Drug Reaction|1|||
28165725|NCT02989649|54836442|FG000|Overall Study|Lost For Observation During Study|3|||
28165726|NCT02989649|54836442|FG000|Overall Study|Reason Not Specified|13|||
28165727|NCT02905435|54836446|FG000|Overall Study|Death|2|||
28165728|NCT02905435|54836446|FG000|Overall Study|Physician Decision|1|||
28165729|NCT02905435|54836446|FG000|Overall Study|Lost to Follow-up|4|||
28165730|NCT02978833|54836453|FG000|Overall Study|Study terminated|1|||
28165731|NCT02978833|54836454|FG001|Overall Study|Study terminated|1|||
28165732|NCT01067339|54836463|FG000|Overall Study|Withdrawal by Subject|6|||
28165733|NCT01067339|54836464|FG001|Overall Study|Withdrawal by Subject|5|||
28165734|NCT02573259|54836477|FG000|Overall Study|Death|1|||
28165735|NCT02573259|54836478|FG001|Overall Study|Death|6|||
28165736|NCT02573259|54836479|FG002|Overall Study|Death|5|||
28165737|NCT02573259|54836480|FG003|Overall Study|Death|6|||
28165738|NCT02573259|54836481|FG004|Overall Study|Death|9|||
28165739|NCT02573259|54836482|FG005|Overall Study|Death|32|||
27832854|NCT01752023|54312783|FG000|Overall Study|Physician Decision|2|||
27832855|NCT01752023|54312784|FG001|Overall Study|Physician Decision|1|||
27832856|NCT01726049|54312796|FG000|Overall Study|Death|1|||
27832857|NCT01726049|54312797|FG001|Overall Study|Death|1|||
27832858|NCT01726049|54312796|FG000|Overall Study|Adverse Event|4|||
27832859|NCT01726049|54312797|FG001|Overall Study|Adverse Event|1|||
27832860|NCT01726049|54312796|FG000|Overall Study|refused second HC|0|||
27832861|NCT01726049|54312797|FG001|Overall Study|refused second HC|2|||
27832862|NCT01605617|54312818|FG000|First Intervention|Adverse Event|0|||
27832863|NCT01605617|54312819|FG001|First Intervention|Adverse Event|1|||
28087777|NCT03267940|54741206|FG005|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
28087778|NCT03267940|54741201|FG000|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
28087779|NCT03267940|54741202|FG001|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
28087780|NCT03267940|54741203|FG002|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7|||
28087781|NCT03267940|54741204|FG003|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4|||
28165740|NCT02573259|54836483|FG006|Overall Study|Death|21|||
28165741|NCT02573259|54836477|FG000|Overall Study|Lost to Follow-up|0|||
28165742|NCT02573259|54836478|FG001|Overall Study|Lost to Follow-up|0|||
28165743|NCT02573259|54836479|FG002|Overall Study|Lost to Follow-up|0|||
28165744|NCT02573259|54836480|FG003|Overall Study|Lost to Follow-up|0|||
28165745|NCT02573259|54836481|FG004|Overall Study|Lost to Follow-up|0|||
28165746|NCT02573259|54836482|FG005|Overall Study|Lost to Follow-up|2|||
28165747|NCT02573259|54836483|FG006|Overall Study|Lost to Follow-up|1|||
28165748|NCT02573259|54836477|FG000|Overall Study|Participant refused further follow-up|0|||
28165749|NCT02573259|54836478|FG001|Overall Study|Participant refused further follow-up|2|||
28087782|NCT03267940|54741205|FG004|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5|||
28087783|NCT03267940|54741206|FG005|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3|||
28087784|NCT03267940|54741201|FG000|Expansion (Maximum Exposure: 421 Days)|Death|0|||
28087785|NCT03267940|54741202|FG001|Expansion (Maximum Exposure: 421 Days)|Death|0|||
28087786|NCT03267940|54741203|FG002|Expansion (Maximum Exposure: 421 Days)|Death|10|||
28165750|NCT02573259|54836479|FG002|Overall Study|Participant refused further follow-up|1|||
28165751|NCT02573259|54836480|FG003|Overall Study|Participant refused further follow-up|0|||
28165752|NCT02573259|54836481|FG004|Overall Study|Participant refused further follow-up|3|||
28165753|NCT02573259|54836482|FG005|Overall Study|Participant refused further follow-up|20|||
28087787|NCT03267940|54741204|FG003|Expansion (Maximum Exposure: 421 Days)|Death|13|||
28087788|NCT03267940|54741205|FG004|Expansion (Maximum Exposure: 421 Days)|Death|0|||
28087789|NCT03267940|54741206|FG005|Expansion (Maximum Exposure: 421 Days)|Death|6|||
28087790|NCT03296566|54741226|FG000|Overall Study|Lost to Follow-up|19|||
28087791|NCT03296566|54741227|FG001|Overall Study|Lost to Follow-up|46|||
28087792|NCT03296566|54741226|FG000|Overall Study|Withdrawal by Subject|0|||
28087793|NCT03296566|54741227|FG001|Overall Study|Withdrawal by Subject|3|||
28087794|NCT03755882|54741233|FG000|Period 1|Protocol Violation|1|||
28087795|NCT03755882|54741234|FG001|Period 1|Protocol Violation|0|||
28087796|NCT03755882|54741233|FG000|Period 1|Unsatisfactory Lens Fitting Test Article|3|||
28087797|NCT03755882|54741234|FG001|Period 1|Unsatisfactory Lens Fitting Test Article|0|||
28087798|NCT00312377|54741242|FG000|Overall Study|Death|403|||
28087799|NCT00312377|54741243|FG001|Overall Study|Death|418|||
28087800|NCT00312377|54741242|FG000|Overall Study|Withdrawal by Subject|23|||
28165754|NCT02573259|54836483|FG006|Overall Study|Participant refused further follow-up|7|||
28165755|NCT02573259|54836477|FG000|Overall Study|Other|0|||
28165756|NCT02573259|54836478|FG001|Overall Study|Other|0|||
28165757|NCT02573259|54836479|FG002|Overall Study|Other|0|||
28165758|NCT02573259|54836480|FG003|Overall Study|Other|0|||
28165759|NCT02573259|54836481|FG004|Overall Study|Other|1|||
28165760|NCT02573259|54836482|FG005|Overall Study|Other|4|||
28165761|NCT02573259|54836483|FG006|Overall Study|Other|5|||
28087801|NCT00312377|54741243|FG001|Overall Study|Withdrawal by Subject|30|||
28087802|NCT00312377|54741242|FG000|Overall Study|Lost to Follow-up|9|||
28087803|NCT00312377|54741243|FG001|Overall Study|Lost to Follow-up|12|||
28087804|NCT00312377|54741242|FG000|Overall Study|Non-compliance|0|||
28087805|NCT00312377|54741243|FG001|Overall Study|Non-compliance|2|||
28087806|NCT00312377|54741242|FG000|Overall Study|Randomised but never received treatment|6|||
28087807|NCT00312377|54741243|FG001|Overall Study|Randomised but never received treatment|6|||
28087808|NCT00312377|54741242|FG000|Overall Study|Discontinue treatment survival follow up|202|||
28087809|NCT00312377|54741243|FG001|Overall Study|Discontinue treatment survival follow up|200|||
28087810|NCT00312377|54741242|FG000|Overall Study|Site ended participation in study|1|||
28087811|NCT00312377|54741243|FG001|Overall Study|Site ended participation in study|0|||
28087812|NCT03295318|54741252|FG000|Overall Study|Withdrawal by Subject prior to initial vaccination|1|||
28087813|NCT03295318|54741253|FG001|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
28087814|NCT03295318|54741254|FG002|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
28087815|NCT03295318|54741252|FG000|Overall Study|Death|1|||
28087816|NCT03295318|54741253|FG001|Overall Study|Death|1|||
28087817|NCT03295318|54741254|FG002|Overall Study|Death|1|||
28087818|NCT03295318|54741252|FG000|Overall Study|Protocol Violation|4|||
28087819|NCT03295318|54741253|FG001|Overall Study|Protocol Violation|3|||
28087820|NCT03295318|54741254|FG002|Overall Study|Protocol Violation|3|||
28087821|NCT03295318|54741252|FG000|Overall Study|Withdrawal by Subject|0|||
28087822|NCT03295318|54741253|FG001|Overall Study|Withdrawal by Subject|0|||
28165762|NCT02977507|54836520|FG000|Overall Study|Protocol Deviation|1|||
28165763|NCT02977507|54836521|FG001|Overall Study|Protocol Deviation|0|||
28165764|NCT02977507|54836520|FG000|Overall Study|Lost to Follow-up|1|||
27733364|NCT02559206|54181158|FG005|Overall Study|Other Not Specified|0|||
28165765|NCT02977507|54836521|FG001|Overall Study|Lost to Follow-up|0|||
27733365|NCT02559206|54181159|FG006|Overall Study|Other Not Specified|0|||
28087823|NCT03295318|54741254|FG002|Overall Study|Withdrawal by Subject|1|||
28087824|NCT03295318|54741252|FG000|Overall Study|Subject discontinued due to travel|0|||
28087825|NCT03295318|54741253|FG001|Overall Study|Subject discontinued due to travel|1|||
28087826|NCT03295318|54741254|FG002|Overall Study|Subject discontinued due to travel|0|||
28087827|NCT03311230|54741284|FG000|Overall Study|Withdrawal by Subject|1|||
28087828|NCT03311230|54741285|FG001|Overall Study|Withdrawal by Subject|4|||
28087829|NCT03311230|54741286|FG002|Overall Study|Withdrawal by Subject|2|||
28087830|NCT03311230|54741287|FG003|Overall Study|Withdrawal by Subject|7|||
28087831|NCT03311230|54741284|FG000|Overall Study|Unrelated injury|0|||
28087832|NCT03311230|54741285|FG001|Overall Study|Unrelated injury|1|||
28087833|NCT03311230|54741286|FG002|Overall Study|Unrelated injury|0|||
28087834|NCT03311230|54741287|FG003|Overall Study|Unrelated injury|0|||
28087835|NCT00312221|54741300|FG000|Open-label Run-in Period|Withdrawal by Subject|6|||
28087836|NCT00312221|54741301|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
28087837|NCT00312221|54741302|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
28087838|NCT00312221|54741303|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
28087839|NCT00312221|54741300|FG000|Open-label Run-in Period|Adverse Event|74|||
28087840|NCT00312221|54741301|FG001|Open-label Run-in Period|Adverse Event|0|||
28087841|NCT00312221|54741302|FG002|Open-label Run-in Period|Adverse Event|0|||
28087842|NCT00312221|54741303|FG003|Open-label Run-in Period|Adverse Event|0|||
28087843|NCT00312221|54741300|FG000|Open-label Run-in Period|Lost to Follow-up|5|||
28087844|NCT00312221|54741301|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
28087845|NCT00312221|54741302|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
28087846|NCT00312221|54741303|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
28087847|NCT00312221|54741300|FG000|Open-label Run-in Period|Administrative|42|||
28087848|NCT00312221|54741301|FG001|Open-label Run-in Period|Administrative|0|||
28087849|NCT00312221|54741302|FG002|Open-label Run-in Period|Administrative|0|||
28087850|NCT00312221|54741303|FG003|Open-label Run-in Period|Administrative|0|||
28087851|NCT00312221|54741300|FG000|Open-label Run-in Period|Lack of Efficacy|102|||
28087852|NCT00312221|54741301|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
28087853|NCT00312221|54741302|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
28087854|NCT00312221|54741303|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
28087855|NCT00312221|54741300|FG000|Open-label Run-in Period|Did not qualify|5|||
28087856|NCT00312221|54741301|FG001|Open-label Run-in Period|Did not qualify|0|||
28087857|NCT00312221|54741302|FG002|Open-label Run-in Period|Did not qualify|0|||
28087858|NCT00312221|54741303|FG003|Open-label Run-in Period|Did not qualify|0|||
28087859|NCT00312221|54741300|FG000|Double-blind Phase|Withdrawal by Subject|0|||
28087860|NCT00312221|54741301|FG001|Double-blind Phase|Withdrawal by Subject|6|||
28087861|NCT00312221|54741302|FG002|Double-blind Phase|Withdrawal by Subject|8|||
28087862|NCT00312221|54741303|FG003|Double-blind Phase|Withdrawal by Subject|7|||
28087863|NCT00312221|54741300|FG000|Double-blind Phase|Adverse Event|0|||
28087864|NCT00312221|54741301|FG001|Double-blind Phase|Adverse Event|10|||
28087865|NCT00312221|54741302|FG002|Double-blind Phase|Adverse Event|19|||
28087866|NCT00312221|54741303|FG003|Double-blind Phase|Adverse Event|18|||
28087867|NCT00312221|54741300|FG000|Double-blind Phase|Lost to Follow-up|0|||
28087868|NCT00312221|54741301|FG001|Double-blind Phase|Lost to Follow-up|0|||
28087869|NCT00312221|54741302|FG002|Double-blind Phase|Lost to Follow-up|2|||
28087870|NCT00312221|54741303|FG003|Double-blind Phase|Lost to Follow-up|2|||
28087871|NCT00312221|54741300|FG000|Double-blind Phase|Administrative|0|||
28087872|NCT00312221|54741301|FG001|Double-blind Phase|Administrative|26|||
28087873|NCT00312221|54741302|FG002|Double-blind Phase|Administrative|37|||
28087874|NCT00312221|54741303|FG003|Double-blind Phase|Administrative|33|||
28087875|NCT00312221|54741300|FG000|Double-blind Phase|Lack of Efficacy|0|||
28087876|NCT00312221|54741301|FG001|Double-blind Phase|Lack of Efficacy|17|||
28087877|NCT00312221|54741302|FG002|Double-blind Phase|Lack of Efficacy|6|||
28087878|NCT00312221|54741303|FG003|Double-blind Phase|Lack of Efficacy|10|||
28087879|NCT03294538|54741327|FG000|Overall Study|Adverse Event|0|||
28087880|NCT03294538|54741328|FG001|Overall Study|Adverse Event|1|||
28087881|NCT03294538|54741329|FG002|Overall Study|Adverse Event|1|||
28087882|NCT03294538|54741327|FG000|Overall Study|Lost to Follow-up|1|||
28087883|NCT03294538|54741328|FG001|Overall Study|Lost to Follow-up|0|||
28087884|NCT03294538|54741329|FG002|Overall Study|Lost to Follow-up|0|||
28087885|NCT03294538|54741327|FG000|Overall Study|Outside of Visit Window|4|||
28087886|NCT03294538|54741328|FG001|Overall Study|Outside of Visit Window|4|||
28087887|NCT03294538|54741329|FG002|Overall Study|Outside of Visit Window|1|||
27832864|NCT01605617|54312818|FG000|Washout Period of 4 Weeks|Study Terminated|2|||
28087888|NCT03265600|54741339|FG000|Overall Study|Lost to Follow-up|17|||
28087889|NCT03265600|54741340|FG001|Overall Study|Lost to Follow-up|5|||
28087890|NCT03265600|54741339|FG000|Overall Study|Withdrawal by Subject|4|||
28087891|NCT03265600|54741340|FG001|Overall Study|Withdrawal by Subject|2|||
28087892|NCT03265600|54741339|FG000|Overall Study|Partially completed 8 wk or 24 wk survey|3|||
28087893|NCT03265600|54741340|FG001|Overall Study|Partially completed 8 wk or 24 wk survey|5|||
28087894|NCT00335153|54741346|FG000|Nasojejunal (NJ) Test Period|Adverse Event|5|||
28087895|NCT00335153|54741346|FG000|Nasojejunal (NJ) Test Period|Lack of Efficacy|5|||
28087896|NCT00335153|54741346|FG000|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12|||
28087897|NCT00335153|54741346|FG000|Nasojejunal (NJ) Test Period|Administrative|1|||
28087898|NCT00335153|54741346|FG000|Nasojejunal (NJ) Test Period|Protocol Violation|7|||
28087899|NCT00335153|54741346|FG000|Post-PEG-J Long-Term Treatment Period|Adverse Event|22|||
28087900|NCT00335153|54741346|FG000|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2|||
28087901|NCT00335153|54741346|FG000|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13|||
28087902|NCT00335153|54741346|FG000|Post-PEG-J Long-Term Treatment Period|Administrative|13|||
28087903|NCT00335153|54741346|FG000|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2|||
28087904|NCT03265132|54741352|FG000|Overall Study|Adverse Event|0|||
28087905|NCT03265132|54741353|FG001|Overall Study|Adverse Event|1|||
28087906|NCT03265132|54741352|FG000|Overall Study|Lack of Efficacy|0|||
28087907|NCT03265132|54741353|FG001|Overall Study|Lack of Efficacy|2|||
28087908|NCT03265132|54741352|FG000|Overall Study|Progressive disease|0|||
28087909|NCT03265132|54741353|FG001|Overall Study|Progressive disease|2|||
28087910|NCT03265132|54741352|FG000|Overall Study|Withdrawal by Subject|0|||
28087911|NCT03265132|54741353|FG001|Overall Study|Withdrawal by Subject|1|||
28087912|NCT02939950|54741363|FG000|Overall Study|Lost to Follow-up|13|||
28087913|NCT02939950|54741364|FG001|Overall Study|Lost to Follow-up|16|||
28087914|NCT02939950|54741363|FG000|Overall Study|Positive slit lamp findings|0|||
28087915|NCT02939950|54741364|FG001|Overall Study|Positive slit lamp findings|1|||
28087916|NCT02939950|54741363|FG000|Overall Study|Chalazion upper lid|0|||
28087917|NCT02939950|54741364|FG001|Overall Study|Chalazion upper lid|1|||
28087918|NCT02939950|54741363|FG000|Overall Study|Lack of motivation|0|||
28087919|NCT02939950|54741364|FG001|Overall Study|Lack of motivation|2|||
28087920|NCT02939950|54741363|FG000|Overall Study|Unacceptable distance lens visual acuity|1|||
28087921|NCT02939950|54741364|FG001|Overall Study|Unacceptable distance lens visual acuity|1|||
28087922|NCT02939950|54741363|FG000|Overall Study|Military orders|1|||
28087923|NCT02939950|54741364|FG001|Overall Study|Military orders|0|||
28087924|NCT02939950|54741363|FG000|Overall Study|Participant Relocated|5|||
28087925|NCT02939950|54741364|FG001|Overall Study|Participant Relocated|3|||
28087926|NCT02939950|54741363|FG000|Overall Study|Study related symptoms|8|||
28087927|NCT02939950|54741364|FG001|Overall Study|Study related symptoms|8|||
28087928|NCT02939950|54741363|FG000|Overall Study|Unacceptable lens movement|2|||
28087929|NCT02939950|54741364|FG001|Overall Study|Unacceptable lens movement|0|||
28087930|NCT02939950|54741363|FG000|Overall Study|Protocol Violation|6|||
28087931|NCT02939950|54741364|FG001|Overall Study|Protocol Violation|3|||
28087932|NCT02939950|54741363|FG000|Overall Study|Physician Decision|2|||
28087933|NCT02939950|54741364|FG001|Overall Study|Physician Decision|0|||
28087934|NCT02939950|54741363|FG000|Overall Study|Pregnancy|6|||
28087935|NCT02939950|54741364|FG001|Overall Study|Pregnancy|7|||
28087936|NCT02939950|54741363|FG000|Overall Study|Withdrawal by Subject|12|||
28087937|NCT02939950|54741364|FG001|Overall Study|Withdrawal by Subject|28|||
28087938|NCT02939950|54741363|FG000|Overall Study|Adverse Event|7|||
28087939|NCT02939950|54741364|FG001|Overall Study|Adverse Event|3|||
28087940|NCT02939950|54741363|FG000|Overall Study|Randomized, not dispensed|1|||
28087941|NCT02939950|54741364|FG001|Overall Study|Randomized, not dispensed|0|||
28087942|NCT02939950|54741363|FG000|Overall Study|Ineligible at Baseline|2|||
28087943|NCT02939950|54741364|FG001|Overall Study|Ineligible at Baseline|8|||
28087944|NCT03753542|54741372|FG000|Overall Study|Lost to Follow-up|9|||
28087945|NCT03753542|54741373|FG001|Overall Study|Lost to Follow-up|14|||
28087946|NCT03292588|54741381|FG000|Overall Study|Death|1|||
28165766|NCT02976103|54836530|FG000|Overall Study|Withdrawal by Subject|1|||
28165767|NCT02976103|54836531|FG001|Overall Study|Withdrawal by Subject|0|||
28087947|NCT03292588|54741382|FG001|Overall Study|Death|0|||
28087948|NCT03292588|54741381|FG000|Overall Study|Lost to Follow-up|12|||
28087949|NCT03292588|54741382|FG001|Overall Study|Lost to Follow-up|16|||
28087950|NCT03292588|54741381|FG000|Overall Study|Physician Decision|0|||
28087951|NCT03292588|54741382|FG001|Overall Study|Physician Decision|1|||
28087952|NCT03292588|54741381|FG000|Overall Study|Withdrawal by Subject|4|||
28087953|NCT03292588|54741382|FG001|Overall Study|Withdrawal by Subject|4|||
28087954|NCT03292588|54741381|FG000|Overall Study|Move out of town|1|||
28087955|NCT03292588|54741382|FG001|Overall Study|Move out of town|0|||
28087956|NCT03292588|54741381|FG000|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
28087957|NCT03292588|54741382|FG001|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
28087958|NCT03752528|54741390|FG000|Part A|Lost to Follow-up|1|||
28087959|NCT03752528|54741390|FG000|Part A|Protocol Violation|1|||
28087960|NCT03752528|54741390|FG000|Part B|Protocol Violation|1|||
28087961|NCT03752528|54741390|FG000|Part B|Study terminated by sponsor|3|||
28087962|NCT00334295|54741397|FG000|Overall Study|Patients received fewer than 3 injection|5|||
28087963|NCT03292432|54741403|FG000|Overall Study|Lost to Follow-up|11|||
28087964|NCT03292432|54741404|FG001|Overall Study|Lost to Follow-up|8|||
28087965|NCT03292432|54741403|FG000|Overall Study|Death|2|||
28087966|NCT03292432|54741404|FG001|Overall Study|Death|1|||
28165768|NCT02976103|54836530|FG000|Overall Study|Lost to Follow-up|12|||
27733366|NCT02559206|54181160|FG007|Overall Study|Other Not Specified|0|||
28087967|NCT03292432|54741403|FG000|Overall Study|Withdrawal by Subject|1|||
28087968|NCT03292432|54741404|FG001|Overall Study|Withdrawal by Subject|2|||
28087969|NCT03292432|54741403|FG000|Overall Study|Site closed before any data collected|1|||
28087970|NCT03292432|54741404|FG001|Overall Study|Site closed before any data collected|0|||
28087971|NCT03291808|54741410|FG000|Overall Study|Lost to Follow-up|6|||
28087972|NCT03291808|54741410|FG000|Overall Study|Research burden|4|||
28087973|NCT03263806|54741416|FG000|Overall Study|Elevated Troponin (failed screen)|1|||
28087974|NCT03263806|54741417|FG001|Overall Study|Elevated Troponin (failed screen)|0|||
28087975|NCT03263806|54741416|FG000|Overall Study|Withdrawal by Subject|0|||
28087976|NCT03263806|54741417|FG001|Overall Study|Withdrawal by Subject|1|||
28087977|NCT03263806|54741416|FG000|Overall Study|Study Termination|5|||
28087978|NCT03263806|54741417|FG001|Overall Study|Study Termination|6|||
28087979|NCT03751280|54741425|FG000|Overall Study|Adverse Event|0|||
28165769|NCT02976103|54836531|FG001|Overall Study|Lost to Follow-up|8|||
28165770|NCT01066039|54836538|FG000|Overall Study|Adverse Event|6|||
28165771|NCT01066039|54836538|FG000|Overall Study|Withdrawal by Subject|17|||
28165772|NCT01066039|54836538|FG000|Overall Study|Protocol Violation|2|||
28165773|NCT01066039|54836538|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|9|||
28087980|NCT03751280|54741426|FG001|Overall Study|Adverse Event|1|||
28087981|NCT03751280|54741425|FG000|Overall Study|Lost to Follow-up|3|||
28087982|NCT03751280|54741426|FG001|Overall Study|Lost to Follow-up|5|||
28087983|NCT03751280|54741425|FG000|Overall Study|Physician Decision|0|||
28087984|NCT03751280|54741426|FG001|Overall Study|Physician Decision|2|||
28087985|NCT03751280|54741425|FG000|Overall Study|Protocol Violation|0|||
28087986|NCT03751280|54741426|FG001|Overall Study|Protocol Violation|2|||
28087987|NCT03751280|54741425|FG000|Overall Study|Withdrawal by Subject|5|||
28087988|NCT03751280|54741426|FG001|Overall Study|Withdrawal by Subject|2|||
28087989|NCT00311363|54741436|FG000|24-Week Single-Blind Treatment Period|Adverse Event|42|||
28087990|NCT00311363|54741437|FG001|24-Week Single-Blind Treatment Period|Adverse Event|0|||
28087991|NCT00311363|54741438|FG002|24-Week Single-Blind Treatment Period|Adverse Event|0|||
28087992|NCT00311363|54741436|FG000|24-Week Single-Blind Treatment Period|Lack of Efficacy|13|||
28087993|NCT00311363|54741437|FG001|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
28087994|NCT00311363|54741438|FG002|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
28087995|NCT00311363|54741436|FG000|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27|||
28087996|NCT00311363|54741437|FG001|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
28087997|NCT00311363|54741438|FG002|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
28087998|NCT00311363|54741436|FG000|24-Week Single-Blind Treatment Period|Lost to Follow-up|12|||
28165774|NCT01066039|54836538|FG000|Overall Study|Investigator's Request|1|||
28165775|NCT01066039|54836538|FG000|Overall Study|Dropout due to Insulin Administration|1|||
28165776|NCT01066039|54836538|FG000|Overall Study|Additional Antihypertensive Required|4|||
28165777|NCT01066039|54836538|FG000|Overall Study|Volunteer Failed to Make the Next Visit|2|||
28165778|NCT01066039|54836538|FG000|Overall Study|Failure to Control Blood Pressure|1|||
28165779|NCT01066039|54836538|FG000|Overall Study|Drug/Dose Adjustment Required|1|||
28165780|NCT02919995|54836548|FG000|Overall Study|Adverse Event|0|||
28165781|NCT02919995|54836549|FG001|Overall Study|Adverse Event|0|||
28165782|NCT02919995|54836550|FG002|Overall Study|Adverse Event|0|||
28165783|NCT02919995|54836551|FG003|Overall Study|Adverse Event|0|||
28165784|NCT02919995|54836552|FG004|Overall Study|Adverse Event|0|||
27733367|NCT02558894|54181180|FG000|Overall Study|Death; any cause, entire study duration|28|||
28087999|NCT00311363|54741437|FG001|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
28088000|NCT00311363|54741438|FG002|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
28088001|NCT00311363|54741436|FG000|24-Week Single-Blind Treatment Period|Protocol Violation|8|||
28088002|NCT00311363|54741437|FG001|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
28088003|NCT00311363|54741438|FG002|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
28088004|NCT00311363|54741436|FG000|24-Week Single-Blind Treatment Period|Elective Surgery|1|||
28088005|NCT00311363|54741437|FG001|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
28088006|NCT00311363|54741438|FG002|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
28088007|NCT00311363|54741436|FG000|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1|||
28088008|NCT00311363|54741437|FG001|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
28088009|NCT00311363|54741438|FG002|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
28088010|NCT00311363|54741436|FG000|24-Week Single-Blind Treatment Period|Pregnancy|1|||
28088011|NCT00311363|54741437|FG001|24-Week Single-Blind Treatment Period|Pregnancy|0|||
28088012|NCT00311363|54741438|FG002|24-Week Single-Blind Treatment Period|Pregnancy|0|||
28088013|NCT00311363|54741436|FG000|24-Week Single-Blind Treatment Period|Death|1|||
28088014|NCT00311363|54741437|FG001|24-Week Single-Blind Treatment Period|Death|0|||
28088015|NCT00311363|54741438|FG002|24-Week Single-Blind Treatment Period|Death|0|||
28165785|NCT02919995|54836553|FG005|Overall Study|Adverse Event|1|||
28165786|NCT02919761|54836561|FG000|Part 1: Open Label|Withdrawal by Subject|12|||
28165787|NCT02919761|54836562|FG001|Part 1: Open Label|Withdrawal by Subject|0|||
28165788|NCT02919761|54836563|FG002|Part 1: Open Label|Withdrawal by Subject|0|||
28165789|NCT02919761|54836561|FG000|Part 1: Open Label|Adverse Event|1|||
27733368|NCT02558894|54181181|FG001|Overall Study|Death; any cause, entire study duration|31|||
28088016|NCT00311363|54741436|FG000|12-Week Double-Blind Treatment Period|Adverse Event|0|||
28088017|NCT00311363|54741437|FG001|12-Week Double-Blind Treatment Period|Adverse Event|3|||
28165790|NCT02919761|54836562|FG001|Part 1: Open Label|Adverse Event|0|||
28165791|NCT02919761|54836563|FG002|Part 1: Open Label|Adverse Event|0|||
28165792|NCT02919761|54836561|FG000|Part 1: Open Label|Lost to Follow-up|1|||
28165793|NCT02919761|54836562|FG001|Part 1: Open Label|Lost to Follow-up|0|||
28165794|NCT02919761|54836563|FG002|Part 1: Open Label|Lost to Follow-up|0|||
28165795|NCT02919761|54836561|FG000|Part 1: Open Label|Met withdrawal criteria|5|||
28165796|NCT02919761|54836562|FG001|Part 1: Open Label|Met withdrawal criteria|0|||
28165797|NCT02919761|54836563|FG002|Part 1: Open Label|Met withdrawal criteria|0|||
28165798|NCT02919761|54836561|FG000|Part 1: Open Label|Did Not Achieve Lda At Week 12|2|||
28165799|NCT02919761|54836562|FG001|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
28165800|NCT02919761|54836563|FG002|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
28165801|NCT02919761|54836561|FG000|Part 1: Open Label|Dose Greater Than 20mg/Week|1|||
28165802|NCT02919761|54836562|FG001|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
28165803|NCT02919761|54836563|FG002|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
28165804|NCT02919761|54836561|FG000|Part 1: Open Label|did not meet inclusion criteria 8|1|||
28165805|NCT02919761|54836562|FG001|Part 1: Open Label|did not meet inclusion criteria 8|0|||
28165806|NCT02919761|54836563|FG002|Part 1: Open Label|did not meet inclusion criteria 8|0|||
28165807|NCT02919761|54836561|FG000|Part 1: Open Label|Termination by Sponsor|1|||
28165808|NCT02919761|54836562|FG001|Part 1: Open Label|Termination by Sponsor|0|||
28165809|NCT02919761|54836563|FG002|Part 1: Open Label|Termination by Sponsor|0|||
28165810|NCT02919761|54836561|FG000|Part 2: Double-blind|Withdrawal by Subject|0|||
28165811|NCT02919761|54836562|FG001|Part 2: Double-blind|Withdrawal by Subject|0|||
27733369|NCT02558894|54181180|FG000|Overall Study|Withdrawal by Subject|2|||
27832865|NCT01605617|54312819|FG001|Washout Period of 4 Weeks|Study Terminated|1|||
28088018|NCT00311363|54741438|FG002|12-Week Double-Blind Treatment Period|Adverse Event|0|||
28088019|NCT00311363|54741436|FG000|12-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
28088020|NCT00311363|54741437|FG001|12-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
28088021|NCT00311363|54741438|FG002|12-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
28088022|NCT00311363|54741436|FG000|12-Week Double-Blind Treatment Period|Lack of Efficacy|0|||
28088023|NCT00311363|54741437|FG001|12-Week Double-Blind Treatment Period|Lack of Efficacy|6|||
28088024|NCT00311363|54741438|FG002|12-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
28088025|NCT00311363|54741436|FG000|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0|||
28088026|NCT00311363|54741437|FG001|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2|||
28088027|NCT00311363|54741438|FG002|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4|||
28088028|NCT00311363|54741436|FG000|12-Week Double-Blind Treatment Period|Protocol Violation|0|||
28088029|NCT00311363|54741437|FG001|12-Week Double-Blind Treatment Period|Protocol Violation|1|||
28088030|NCT00311363|54741438|FG002|12-Week Double-Blind Treatment Period|Protocol Violation|2|||
28088031|NCT00311363|54741436|FG000|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
28165812|NCT02919761|54836563|FG002|Part 2: Double-blind|Withdrawal by Subject|2|||
27980132|NCT00811941|54638101|FG001|All Randomised Patients|Did not receive placebo/nalmefene|8|||
27980133|NCT00811941|54638100|FG000|All Treated Patients|Adverse Event|2|||
27980134|NCT00811941|54638101|FG001|All Treated Patients|Adverse Event|43|||
27980135|NCT00811941|54638100|FG000|All Treated Patients|Lack of Efficacy|2|||
27980136|NCT00811941|54638101|FG001|All Treated Patients|Lack of Efficacy|3|||
27980137|NCT00811941|54638100|FG000|All Treated Patients|Non-compliance|1|||
27980138|NCT00811941|54638101|FG001|All Treated Patients|Non-compliance|8|||
27980139|NCT00811941|54638100|FG000|All Treated Patients|Protocol Violation|5|||
27980140|NCT00811941|54638101|FG001|All Treated Patients|Protocol Violation|17|||
27980141|NCT00811941|54638100|FG000|All Treated Patients|Withdrawal by Subject|35|||
27980142|NCT00811941|54638101|FG001|All Treated Patients|Withdrawal by Subject|94|||
27980143|NCT00811941|54638100|FG000|All Treated Patients|Lost to Follow-up|3|||
27980144|NCT00811941|54638101|FG001|All Treated Patients|Lost to Follow-up|12|||
27980145|NCT00811941|54638100|FG000|All Treated Patients|Other Reason|4|||
27980146|NCT00811941|54638101|FG001|All Treated Patients|Other Reason|14|||
27980147|NCT00811473|54638109|FG000|Overall Study|Adverse Event|3|||
27980148|NCT00811473|54638110|FG001|Overall Study|Adverse Event|12|||
27980149|NCT00811473|54638109|FG000|Overall Study|Lost to Follow-up|5|||
27980150|NCT00811473|54638110|FG001|Overall Study|Lost to Follow-up|1|||
27980151|NCT00811473|54638109|FG000|Overall Study|Withdrawal by Subject|2|||
27980152|NCT00811473|54638110|FG001|Overall Study|Withdrawal by Subject|4|||
27980153|NCT00811473|54638109|FG000|Overall Study|Severe non-compliance to protocol|2|||
27980154|NCT00811473|54638110|FG001|Overall Study|Severe non-compliance to protocol|4|||
27980155|NCT00811473|54638109|FG000|Overall Study|Lack of therapeutic response|4|||
27980156|NCT00811473|54638110|FG001|Overall Study|Lack of therapeutic response|1|||
27980157|NCT00811473|54638109|FG000|Overall Study|Condition under investigation worsened|1|||
28165813|NCT02919761|54836561|FG000|Part 2: Double-blind|Adverse Event|0|||
28165814|NCT02919761|54836562|FG001|Part 2: Double-blind|Adverse Event|1|||
27980158|NCT00811473|54638110|FG001|Overall Study|Condition under investigation worsened|3|||
27980159|NCT00811473|54638109|FG000|Overall Study|Other 2|4|||
27980160|NCT00811473|54638110|FG001|Overall Study|Other 2|1|||
27980161|NCT00811473|54638109|FG000|Overall Study|Incorrect Enrollment|1|||
27980162|NCT00811473|54638110|FG001|Overall Study|Incorrect Enrollment|0|||
27980163|NCT00811473|54638109|FG000|Overall Study|Safety Reasons|1|||
27980164|NCT00811473|54638110|FG001|Overall Study|Safety Reasons|0|||
27980165|NCT00617305|54638123|FG000|Overall Study|Adverse Event|4|||
28088032|NCT00311363|54741437|FG001|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1|||
28088033|NCT00311363|54741438|FG002|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
28088034|NCT00333983|54741451|FG000|Overall Study|Lost to Follow-up|2|||
28088035|NCT00333983|54741452|FG001|Overall Study|Lost to Follow-up|1|||
28088036|NCT00333983|54741453|FG002|Overall Study|Lost to Follow-up|0|||
28088037|NCT00333983|54741451|FG000|Overall Study|Adverse Event|1|||
28088038|NCT00333983|54741452|FG001|Overall Study|Adverse Event|1|||
28088039|NCT00333983|54741453|FG002|Overall Study|Adverse Event|1|||
28088040|NCT00333983|54741451|FG000|Overall Study|Withdrawal by Subject|0|||
28088041|NCT00333983|54741452|FG001|Overall Study|Withdrawal by Subject|3|||
28088042|NCT00333983|54741453|FG002|Overall Study|Withdrawal by Subject|1|||
28088043|NCT03262012|54741465|FG000|Overall Study|Withdrawal by Subject|15|||
28088044|NCT03262012|54741466|FG001|Overall Study|Withdrawal by Subject|13|||
28088045|NCT03262012|54741467|FG002|Overall Study|Withdrawal by Subject|8|||
28088046|NCT03262012|54741468|FG003|Overall Study|Withdrawal by Subject|7|||
28088047|NCT03262012|54741465|FG000|Overall Study|Adverse Event|10|||
28088048|NCT03262012|54741466|FG001|Overall Study|Adverse Event|12|||
28088049|NCT03262012|54741467|FG002|Overall Study|Adverse Event|4|||
28088050|NCT03262012|54741468|FG003|Overall Study|Adverse Event|6|||
28088051|NCT03262012|54741465|FG000|Overall Study|Physician Decision|2|||
28088052|NCT03262012|54741466|FG001|Overall Study|Physician Decision|5|||
28088053|NCT03262012|54741467|FG002|Overall Study|Physician Decision|1|||
28088054|NCT03262012|54741468|FG003|Overall Study|Physician Decision|0|||
28088055|NCT03262012|54741465|FG000|Overall Study|Lack of Efficacy|0|||
28088056|NCT03262012|54741466|FG001|Overall Study|Lack of Efficacy|5|||
28088057|NCT03262012|54741467|FG002|Overall Study|Lack of Efficacy|1|||
28088058|NCT03262012|54741468|FG003|Overall Study|Lack of Efficacy|2|||
28088059|NCT03262012|54741465|FG000|Overall Study|Protocol Discontinuation Criteria|0|||
28088060|NCT03262012|54741466|FG001|Overall Study|Protocol Discontinuation Criteria|1|||
28088061|NCT03262012|54741467|FG002|Overall Study|Protocol Discontinuation Criteria|0|||
28088062|NCT03262012|54741468|FG003|Overall Study|Protocol Discontinuation Criteria|0|||
28088063|NCT03288142|54741480|FG000|Overall Study|Lost to Follow-up|22|||
28088064|NCT03288142|54741481|FG001|Overall Study|Lost to Follow-up|15|||
28088065|NCT00310817|54741493|FG000|Overall Study|AE or Death|3|||
28088066|NCT00310817|54741494|FG001|Overall Study|AE or Death|1|||
28088067|NCT00310817|54741495|FG002|Overall Study|AE or Death|0|||
28088068|NCT00310817|54741496|FG003|Overall Study|AE or Death|0|||
28088069|NCT00310817|54741493|FG000|Overall Study|Withdrawal by Subject|1|||
28088070|NCT00310817|54741494|FG001|Overall Study|Withdrawal by Subject|4|||
28088071|NCT00310817|54741495|FG002|Overall Study|Withdrawal by Subject|6|||
28088072|NCT00310817|54741496|FG003|Overall Study|Withdrawal by Subject|7|||
28088073|NCT00310817|54741493|FG000|Overall Study|Lost to Follow-up|2|||
28088074|NCT00310817|54741494|FG001|Overall Study|Lost to Follow-up|1|||
28088075|NCT00310817|54741495|FG002|Overall Study|Lost to Follow-up|0|||
28088076|NCT00310817|54741496|FG003|Overall Study|Lost to Follow-up|0|||
28088077|NCT00310817|54741493|FG000|Overall Study|Inappropriate Enrollment|1|||
28088078|NCT00310817|54741494|FG001|Overall Study|Inappropriate Enrollment|0|||
28088079|NCT00310817|54741495|FG002|Overall Study|Inappropriate Enrollment|1|||
28088080|NCT00310817|54741496|FG003|Overall Study|Inappropriate Enrollment|0|||
28088081|NCT00310817|54741493|FG000|Overall Study|Protocol Violation|1|||
28088082|NCT00310817|54741494|FG001|Overall Study|Protocol Violation|1|||
28088083|NCT00310817|54741495|FG002|Overall Study|Protocol Violation|1|||
28088084|NCT00310817|54741496|FG003|Overall Study|Protocol Violation|1|||
28088085|NCT00310817|54741493|FG000|Overall Study|Unable to classify|3|||
28088086|NCT00310817|54741494|FG001|Overall Study|Unable to classify|1|||
28088087|NCT00310817|54741495|FG002|Overall Study|Unable to classify|0|||
28088088|NCT00310817|54741496|FG003|Overall Study|Unable to classify|0|||
28088089|NCT02940886|54741541|FG000|Overall Study|Adverse Event|7|||
28088090|NCT02940886|54741542|FG001|Overall Study|Adverse Event|3|||
28088091|NCT02940886|54741541|FG000|Overall Study|Protocol Violation|0|||
28088092|NCT02940886|54741542|FG001|Overall Study|Protocol Violation|2|||
28088093|NCT02940886|54741541|FG000|Overall Study|Withdrawal by Subject|28|||
28088094|NCT02940886|54741542|FG001|Overall Study|Withdrawal by Subject|20|||
28088095|NCT02940886|54741541|FG000|Overall Study|Death|1|||
28165815|NCT02919761|54836563|FG002|Part 2: Double-blind|Adverse Event|0|||
28088096|NCT02940886|54741542|FG001|Overall Study|Death|0|||
28088097|NCT02940886|54741541|FG000|Overall Study|Lack of Efficacy|1|||
28088098|NCT02940886|54741542|FG001|Overall Study|Lack of Efficacy|0|||
27980166|NCT00617305|54638124|FG001|Overall Study|Adverse Event|0|||
28088099|NCT02940886|54741541|FG000|Overall Study|Lost to Follow-up|49|||
28088100|NCT02940886|54741542|FG001|Overall Study|Lost to Follow-up|21|||
28088101|NCT02940886|54741541|FG000|Overall Study|Physician Decision|9|||
28088102|NCT02940886|54741542|FG001|Overall Study|Physician Decision|4|||
28088103|NCT02940886|54741541|FG000|Overall Study|Sponsor decision|0|||
28088104|NCT02940886|54741542|FG001|Overall Study|Sponsor decision|1|||
28088105|NCT02940886|54741541|FG000|Overall Study|No treatment|7|||
28088106|NCT02940886|54741542|FG001|Overall Study|No treatment|2|||
28088107|NCT02940886|54741541|FG000|Overall Study|Enrolment error|0|||
28088108|NCT02940886|54741542|FG001|Overall Study|Enrolment error|1|||
28088109|NCT03285958|54741552|FG000|Overall Study|Lost to Follow-up|1|||
28088110|NCT03285958|54741553|FG001|Overall Study|Lost to Follow-up|1|||
28088111|NCT03285958|54741552|FG000|Overall Study|Withdrawal by Subject|1|||
28088112|NCT03285958|54741553|FG001|Overall Study|Withdrawal by Subject|0|||
28088113|NCT03285958|54741552|FG000|Overall Study|Not able to attend required orientation|3|||
28088114|NCT03285958|54741553|FG001|Overall Study|Not able to attend required orientation|0|||
28088115|NCT03285646|54741562|FG000|Overall Study|Adverse Event|1|||
28088116|NCT03285646|54741563|FG001|Overall Study|Adverse Event|0|||
28088117|NCT03285646|54741562|FG000|Overall Study|Withdrawal by Subject|10|||
28088118|NCT03285646|54741563|FG001|Overall Study|Withdrawal by Subject|2|||
28088119|NCT03285646|54741562|FG000|Overall Study|Lost to Follow-up|2|||
28088120|NCT03285646|54741563|FG001|Overall Study|Lost to Follow-up|1|||
28088121|NCT03285646|54741562|FG000|Overall Study|Investigator/Sponsor Decision|0|||
28088122|NCT03285646|54741563|FG001|Overall Study|Investigator/Sponsor Decision|1|||
28088123|NCT03309202|54741574|FG000|Overall Study|Lost to Follow-up|1|||
28088124|NCT03309202|54741575|FG001|Overall Study|Lost to Follow-up|0|||
28088125|NCT03309202|54741576|FG002|Overall Study|Lost to Follow-up|0|||
28088126|NCT03309202|54741577|FG003|Overall Study|Lost to Follow-up|0|||
28088127|NCT00074490|54741592|FG000|Overall Study|Progressive malignancy|0|||
28088128|NCT00074490|54741593|FG001|Overall Study|Progressive malignancy|7|||
28088129|NCT00074490|54741594|FG002|Overall Study|Progressive malignancy|0|||
28088130|NCT00074490|54741595|FG003|Overall Study|Progressive malignancy|0|||
28088131|NCT00074490|54741596|FG004|Overall Study|Progressive malignancy|3|||
28088132|NCT00074490|54741597|FG005|Overall Study|Progressive malignancy|0|||
28088133|NCT03285490|54741612|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
28088134|NCT03285490|54741613|FG001|Recurrence Follow-up Period|Withdrawal by Subject|1|||
28088135|NCT03285490|54741612|FG000|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|18|||
28088136|NCT03285490|54741613|FG001|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|60|||
28088137|NCT02939716|54741620|FG000|Overall Study|scanner failure|0|||
28088138|NCT02939716|54741621|FG001|Overall Study|scanner failure|0|||
28088139|NCT02939716|54741622|FG002|Overall Study|scanner failure|0|||
28088140|NCT02939716|54741623|FG003|Overall Study|scanner failure|1|||
28088141|NCT02939716|54741624|FG004|Overall Study|scanner failure|1|||
28088142|NCT02939716|54741625|FG005|Overall Study|scanner failure|1|||
28088143|NCT00367133|54741654|FG000|2 Years|Death|20|||
28088144|NCT00367133|54741655|FG001|2 Years|Death|12|||
28088145|NCT00367133|54741656|FG002|2 Years|Death|12|||
28088146|NCT00367133|54741654|FG000|2 Years|Dropped|34|||
28088147|NCT00367133|54741655|FG001|2 Years|Dropped|19|||
28088148|NCT00367133|54741656|FG002|2 Years|Dropped|33|||
28088149|NCT00367133|54741654|FG000|2 Years|Missed visit|4|||
28088150|NCT00367133|54741655|FG001|2 Years|Missed visit|5|||
28088151|NCT00367133|54741656|FG002|2 Years|Missed visit|4|||
28088152|NCT00367055|54741666|FG000|Overall Study|Adverse Event|6|||
28088153|NCT00367055|54741667|FG001|Overall Study|Adverse Event|3|||
28088154|NCT00367055|54741666|FG000|Overall Study|Patient's Willing|3|||
28088155|NCT00367055|54741667|FG001|Overall Study|Patient's Willing|2|||
28088156|NCT00367055|54741666|FG000|Overall Study|Lack of Efficacy|1|||
28088157|NCT00367055|54741667|FG001|Overall Study|Lack of Efficacy|2|||
28088158|NCT00367055|54741666|FG000|Overall Study|Lost to Follow-up|1|||
28088159|NCT00367055|54741667|FG001|Overall Study|Lost to Follow-up|1|||
28088160|NCT00367055|54741666|FG000|Overall Study|Protocol Violation|0|||
28088161|NCT00367055|54741667|FG001|Overall Study|Protocol Violation|1|||
28088162|NCT00367055|54741666|FG000|Overall Study|Stopping Criterion Met|0|||
28088163|NCT00367055|54741667|FG001|Overall Study|Stopping Criterion Met|1|||
28088164|NCT00367055|54741666|FG000|Overall Study|Participant Living too Far from Hospital|0|||
28088165|NCT00367055|54741667|FG001|Overall Study|Participant Living too Far from Hospital|1|||
28088166|NCT00057330|54741675|FG000|Overall Study|Adverse Event|9|||
28088167|NCT00057330|54741676|FG001|Overall Study|Adverse Event|12|||
28088168|NCT00057330|54741675|FG000|Overall Study|Death|1|||
28088169|NCT00057330|54741676|FG001|Overall Study|Death|0|||
28088170|NCT00057330|54741675|FG000|Overall Study|Protocol Violation|1|||
28165816|NCT02919761|54836561|FG000|Part 2: Double-blind|Lost to Follow-up|0|||
28165817|NCT02919761|54836562|FG001|Part 2: Double-blind|Lost to Follow-up|0|||
27980167|NCT00617305|54638125|FG002|Overall Study|Adverse Event|0|||
28088171|NCT00057330|54741676|FG001|Overall Study|Protocol Violation|1|||
28088172|NCT00057330|54741675|FG000|Overall Study|Withdrawal by Subject|115|||
28088173|NCT00057330|54741676|FG001|Overall Study|Withdrawal by Subject|84|||
28088174|NCT00057330|54741675|FG000|Overall Study|Lost to Follow-up|745|||
28088175|NCT00057330|54741676|FG001|Overall Study|Lost to Follow-up|617|||
28088176|NCT00057330|54741675|FG000|Overall Study|Physician Decision|1|||
28088177|NCT00057330|54741676|FG001|Overall Study|Physician Decision|0|||
28088178|NCT00057330|54741675|FG000|Overall Study|Other|260|||
28088179|NCT00057330|54741676|FG001|Overall Study|Other|206|||
28088180|NCT03283696|54741684|FG000|Overall Study|Physician Decision|5|||
28088181|NCT03283696|54741685|FG001|Overall Study|Physician Decision|6|||
28088182|NCT03283696|54741684|FG000|Overall Study|Withdrawal by Subject|2|||
28088183|NCT03283696|54741685|FG001|Overall Study|Withdrawal by Subject|0|||
28088184|NCT02939560|54741691|FG000|Overall Study|Withdrawal by Subject|2|||
28088185|NCT02939560|54741691|FG000|Overall Study|Protocol Violation|1|||
28088186|NCT03748706|54741695|FG000|Overall Study|Lost to Follow-up|1|||
28088187|NCT03747302|54741701|FG000|Overall Study|Withdrawal by Subject|1|||
27733370|NCT02558894|54181181|FG001|Overall Study|Withdrawal by Subject|1|||
28165818|NCT02919761|54836563|FG002|Part 2: Double-blind|Lost to Follow-up|3|||
28165819|NCT02919761|54836561|FG000|Part 2: Double-blind|Met withdrawal criteria|0|||
28165820|NCT02919761|54836562|FG001|Part 2: Double-blind|Met withdrawal criteria|1|||
28165821|NCT02919761|54836563|FG002|Part 2: Double-blind|Met withdrawal criteria|2|||
28165822|NCT02919761|54836561|FG000|Part 2: Double-blind|Worsening of disease activity|0|||
28165823|NCT02919761|54836562|FG001|Part 2: Double-blind|Worsening of disease activity|4|||
27733371|NCT02558894|54181180|FG000|Overall Study|Closure of Part A|2|||
27733372|NCT02558894|54181181|FG001|Overall Study|Closure of Part A|1|||
27733373|NCT02688387|54181191|FG000|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
27733374|NCT02688387|54181192|FG001|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
27733375|NCT02688387|54181193|FG002|Part 1, Period 1 (up to 6 Days)|Adverse Event|1|||
27733376|NCT02688387|54181194|FG003|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
27733377|NCT02688387|54181195|FG004|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
27733378|NCT02688387|54181196|FG005|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
27733379|NCT02688387|54181197|FG006|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
27733380|NCT02688387|54181198|FG007|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
27733381|NCT02688387|54181199|FG008|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
27733382|NCT02688387|54181200|FG009|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
27733383|NCT02688387|54181201|FG010|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
27733384|NCT02688387|54181202|FG011|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
27733385|NCT02688387|54181203|FG012|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
27733386|NCT02688387|54181204|FG013|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
27733387|NCT02688387|54181205|FG014|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
27733388|NCT02688387|54181206|FG015|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
27733389|NCT02688387|54181207|FG016|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
27733390|NCT02688387|54181208|FG017|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
27733391|NCT02688387|54181209|FG018|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
27733392|NCT02688387|54181210|FG019|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
27733393|NCT02688387|54181211|FG020|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
27733394|NCT02688387|54181212|FG021|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
27733395|NCT02688387|54181191|FG000|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27733396|NCT02688387|54181192|FG001|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27733397|NCT02688387|54181193|FG002|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27733398|NCT02688387|54181194|FG003|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
27733399|NCT02688387|54181195|FG004|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27733400|NCT02688387|54181196|FG005|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27733401|NCT02688387|54181197|FG006|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27733402|NCT02688387|54181198|FG007|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27733403|NCT02688387|54181199|FG008|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27733404|NCT02688387|54181200|FG009|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27733405|NCT02688387|54181201|FG010|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27733406|NCT02688387|54181202|FG011|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27733407|NCT02688387|54181203|FG012|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
28165824|NCT02919761|54836563|FG002|Part 2: Double-blind|Worsening of disease activity|10|||
28165825|NCT02919761|54836561|FG000|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
28165826|NCT02919761|54836562|FG001|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
28165827|NCT02919761|54836563|FG002|Part 2: Double-blind|Did not meet LDA at Week 16|1|||
28165828|NCT02919761|54836561|FG000|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
28165829|NCT02919761|54836562|FG001|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
27733408|NCT02688387|54181204|FG013|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27733409|NCT02688387|54181205|FG014|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27980168|NCT00617305|54638123|FG000|Overall Study|Death|1|||
28088188|NCT03747302|54741702|FG001|Overall Study|Withdrawal by Subject|2|||
28088189|NCT00056862|54741712|FG000|Overall Study|Protocol Violation|1|||
28165830|NCT02919761|54836563|FG002|Part 2: Double-blind|Did not meet LDA at Week 20|1|||
28165831|NCT02919761|54836561|FG000|Part 2: Double-blind|Discontinued exclusion 16|0|||
28165832|NCT02919761|54836562|FG001|Part 2: Double-blind|Discontinued exclusion 16|0|||
27733410|NCT02688387|54181206|FG015|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27733411|NCT02688387|54181207|FG016|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27733412|NCT02688387|54181208|FG017|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27733413|NCT02688387|54181209|FG018|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
28088190|NCT00056862|54741713|FG001|Overall Study|Protocol Violation|0|||
28088191|NCT00056316|54741721|FG000|Overall Study|Withdrawal by Subject|2|||
28088192|NCT00056316|54741722|FG001|Overall Study|Withdrawal by Subject|2|||
28088193|NCT00056316|54741721|FG000|Overall Study|Death/NH placement of pt|1|||
28088194|NCT00056316|54741722|FG001|Overall Study|Death/NH placement of pt|1|||
28088195|NCT03308968|54741731|FG000|Double-Blind Period (12 Weeks)|Adverse Event|3|||
28088196|NCT03308968|54741732|FG001|Double-Blind Period (12 Weeks)|Adverse Event|1|||
28088197|NCT03308968|54741733|FG002|Double-Blind Period (12 Weeks)|Adverse Event|4|||
28088198|NCT03308968|54741731|FG000|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
28088199|NCT03308968|54741732|FG001|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
28088200|NCT03308968|54741733|FG002|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3|||
28088201|NCT03308968|54741731|FG000|Double-Blind Period (12 Weeks)|Protocol Violation|6|||
28088202|NCT03308968|54741732|FG001|Double-Blind Period (12 Weeks)|Protocol Violation|0|||
28088203|NCT03308968|54741733|FG002|Double-Blind Period (12 Weeks)|Protocol Violation|2|||
28088204|NCT03308968|54741731|FG000|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
28088205|NCT03308968|54741732|FG001|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
28088206|NCT03308968|54741733|FG002|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0|||
28088207|NCT03308968|54741731|FG000|Double-Blind Period (12 Weeks)|Lost to Follow-up|1|||
28088208|NCT03308968|54741732|FG001|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
28088209|NCT03308968|54741733|FG002|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
28088210|NCT03308968|54741731|FG000|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
28088211|NCT03308968|54741732|FG001|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
28088212|NCT03308968|54741733|FG002|Double-Blind Period (12 Weeks)|Lack of Efficacy|0|||
28088213|NCT03308968|54741731|FG000|Double-Blind Period (12 Weeks)|Other than specified|1|||
28088214|NCT03308968|54741732|FG001|Double-Blind Period (12 Weeks)|Other than specified|0|||
28088215|NCT03308968|54741733|FG002|Double-Blind Period (12 Weeks)|Other than specified|2|||
28088216|NCT03308968|54741731|FG000|Open-Label Period (12 Weeks)|Other than specified|1|||
28088217|NCT03308968|54741732|FG001|Open-Label Period (12 Weeks)|Other than specified|2|||
28088218|NCT03308968|54741733|FG002|Open-Label Period (12 Weeks)|Other than specified|1|||
28088219|NCT03308968|54741731|FG000|Open-Label Period (12 Weeks)|Adverse Event|4|||
28088220|NCT03308968|54741732|FG001|Open-Label Period (12 Weeks)|Adverse Event|1|||
28088221|NCT03308968|54741733|FG002|Open-Label Period (12 Weeks)|Adverse Event|1|||
28088222|NCT03308968|54741731|FG000|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
28088223|NCT03308968|54741732|FG001|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
28088224|NCT03308968|54741733|FG002|Open-Label Period (12 Weeks)|Withdrawal by Subject|7|||
28088225|NCT03308968|54741731|FG000|Open-Label Period (12 Weeks)|Protocol Violation|0|||
28088226|NCT03308968|54741732|FG001|Open-Label Period (12 Weeks)|Protocol Violation|1|||
28088227|NCT03308968|54741733|FG002|Open-Label Period (12 Weeks)|Protocol Violation|1|||
28088228|NCT03308968|54741731|FG000|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
28088229|NCT03308968|54741732|FG001|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
28088230|NCT03308968|54741733|FG002|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1|||
28088231|NCT03308968|54741731|FG000|Open-Label Period (12 Weeks)|Lost to Follow-up|0|||
28088232|NCT03308968|54741732|FG001|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
28088233|NCT03308968|54741733|FG002|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
28088234|NCT03308968|54741731|FG000|Open-Label Period (12 Weeks)|Lack of Efficacy|1|||
28088235|NCT03308968|54741732|FG001|Open-Label Period (12 Weeks)|Lack of Efficacy|2|||
28088236|NCT03308968|54741733|FG002|Open-Label Period (12 Weeks)|Lack of Efficacy|0|||
28088237|NCT02940730|54741746|FG000|Intervention 2|Physician Decision|7|||
28088238|NCT02940730|54741747|FG001|Intervention 2|Physician Decision|0|||
28088239|NCT03741062|54741755|FG000|Overall Study|Protocol Violation|1|||
28088240|NCT03741062|54741756|FG001|Overall Study|Protocol Violation|0|||
28088241|NCT03281668|54741762|FG000|Overall Study|Physician Decision|1|||
28088242|NCT03281668|54741762|FG000|Overall Study|scheduling conflict, family circumstance|2|||
28088243|NCT03281668|54741762|FG000|Overall Study|Withdrawal by Subject|4|||
28088244|NCT03281668|54741762|FG000|Overall Study|Lost to Follow-up|1|||
28088245|NCT03307252|54741777|FG000|Part 2, Period 1|Treatment not received|0|||
28088246|NCT03307252|54741778|FG001|Part 2, Period 1|Treatment not received|0|||
28088247|NCT03307252|54741779|FG002|Part 2, Period 1|Treatment not received|0|||
28088248|NCT03307252|54741780|FG003|Part 2, Period 1|Treatment not received|0|||
28088249|NCT03307252|54741781|FG004|Part 2, Period 1|Treatment not received|0|||
28088250|NCT03307252|54741782|FG005|Part 2, Period 1|Treatment not received|1|||
28088251|NCT03307252|54741783|FG006|Part 2, Period 1|Treatment not received|0|||
28088252|NCT03307252|54741784|FG007|Part 2, Period 1|Treatment not received|0|||
28088253|NCT03307252|54741785|FG008|Part 2, Period 1|Treatment not received|0|||
28088254|NCT03307252|54741786|FG009|Part 2, Period 1|Treatment not received|0|||
28088255|NCT03307252|54741787|FG010|Part 2, Period 1|Treatment not received|0|||
28088256|NCT03307252|54741777|FG000|Part 2, Period 3|Other than listed|0|||
28088257|NCT03307252|54741778|FG001|Part 2, Period 3|Other than listed|0|||
28088258|NCT03307252|54741779|FG002|Part 2, Period 3|Other than listed|0|||
28088259|NCT03307252|54741780|FG003|Part 2, Period 3|Other than listed|0|||
28088260|NCT03307252|54741781|FG004|Part 2, Period 3|Other than listed|1|||
28088261|NCT03307252|54741782|FG005|Part 2, Period 3|Other than listed|0|||
27980169|NCT00617305|54638124|FG001|Overall Study|Death|0|||
27980170|NCT00617305|54638125|FG002|Overall Study|Death|0|||
27980171|NCT00617305|54638123|FG000|Overall Study|Physician Decision|1|||
27980172|NCT00617305|54638124|FG001|Overall Study|Physician Decision|0|||
27980173|NCT00617305|54638125|FG002|Overall Study|Physician Decision|0|||
27980174|NCT00617305|54638123|FG000|Overall Study|Protocol Violation|1|||
27980175|NCT00617305|54638124|FG001|Overall Study|Protocol Violation|0|||
27980176|NCT00617305|54638125|FG002|Overall Study|Protocol Violation|1|||
27980177|NCT00617305|54638123|FG000|Overall Study|Withdrawal by Subject|1|||
27980178|NCT00617305|54638124|FG001|Overall Study|Withdrawal by Subject|0|||
27980179|NCT00617305|54638125|FG002|Overall Study|Withdrawal by Subject|0|||
27980180|NCT00811395|54638142|FG000|Extension Treatment|Adverse Event|1|||
27980181|NCT00811395|54638143|FG001|Extension Treatment|Adverse Event|2|||
27980182|NCT00811395|54638144|FG002|Extension Treatment|Adverse Event|2|||
27980183|NCT00811395|54638145|FG003|Extension Treatment|Adverse Event|2|||
27980184|NCT00811395|54638146|FG004|Extension Treatment|Adverse Event|0|||
27980185|NCT00811395|54638147|FG005|Extension Treatment|Adverse Event|1|||
27980186|NCT00811395|54638142|FG000|Extension Treatment|Progressive disease|1|||
27980187|NCT00811395|54638143|FG001|Extension Treatment|Progressive disease|1|||
27980188|NCT00811395|54638144|FG002|Extension Treatment|Progressive disease|0|||
27980189|NCT00811395|54638145|FG003|Extension Treatment|Progressive disease|0|||
27980190|NCT00811395|54638146|FG004|Extension Treatment|Progressive disease|0|||
27980191|NCT00811395|54638147|FG005|Extension Treatment|Progressive disease|0|||
27980192|NCT00811395|54638142|FG000|Extension Treatment|Participant did not wish to continue|0|||
27980193|NCT00811395|54638143|FG001|Extension Treatment|Participant did not wish to continue|3|||
27980194|NCT00811395|54638144|FG002|Extension Treatment|Participant did not wish to continue|0|||
27980195|NCT00811395|54638145|FG003|Extension Treatment|Participant did not wish to continue|1|||
27980196|NCT00811395|54638146|FG004|Extension Treatment|Participant did not wish to continue|0|||
27980197|NCT00811395|54638147|FG005|Extension Treatment|Participant did not wish to continue|1|||
27980198|NCT00811395|54638142|FG000|Extension Treatment|Other than above|0|||
27980199|NCT00811395|54638143|FG001|Extension Treatment|Other than above|0|||
27980200|NCT00811395|54638144|FG002|Extension Treatment|Other than above|1|||
27980201|NCT00811395|54638145|FG003|Extension Treatment|Other than above|0|||
27980202|NCT00811395|54638146|FG004|Extension Treatment|Other than above|0|||
27980203|NCT00811395|54638147|FG005|Extension Treatment|Other than above|0|||
27980204|NCT00955409|54638174|FG000|Overall Study|Lack of Efficacy|1|||
27980205|NCT00955409|54638175|FG001|Overall Study|Lack of Efficacy|0|||
27980206|NCT00955409|54638176|FG002|Overall Study|Lack of Efficacy|0|||
27980207|NCT00955409|54638177|FG003|Overall Study|Lack of Efficacy|0|||
27980208|NCT00955409|54638178|FG004|Overall Study|Lack of Efficacy|0|||
28165833|NCT02919761|54836563|FG002|Part 2: Double-blind|Discontinued exclusion 16|2|||
28165834|NCT02910167|54836574|FG000|Overall Study|Adverse Event|1|||
28165835|NCT02910167|54836574|FG000|Overall Study|Lost to Follow-up|18|||
28165836|NCT01067105|54836578|FG000|Overall Study|Adverse Event|14|||
28165837|NCT01067105|54836578|FG000|Overall Study|Protocol Violation|48|||
28165838|NCT01067105|54836578|FG000|Overall Study|Withdrawal by Subject|36|||
28165839|NCT01067105|54836578|FG000|Overall Study|Lost to Follow-up|6|||
28165840|NCT01067105|54836578|FG000|Overall Study|Physician Decision|6|||
28165841|NCT01067105|54836578|FG000|Overall Study|Other|31|||
28165842|NCT02910089|54836588|FG000|Overall Study|Lost insurance eligibility|22|||
28165843|NCT02910089|54836589|FG001|Overall Study|Lost insurance eligibility|16|||
28165844|NCT02985515|54836597|FG000|Olfaction Testing|Lost to Follow-up|0|||
28165845|NCT02985515|54836598|FG001|Olfaction Testing|Lost to Follow-up|5|||
28165846|NCT02985515|54836597|FG000|Olfaction Testing|Protocol Violation|0|||
28165847|NCT02985515|54836598|FG001|Olfaction Testing|Protocol Violation|3|||
28165848|NCT02910011|54836611|FG000|Overall Study|Physician Decision|2|||
28165849|NCT02908841|54836619|FG000|Overall Study|Physician Decision|4|||
27980209|NCT00955409|54638179|FG005|Overall Study|Lack of Efficacy|0|||
27980210|NCT00955409|54638180|FG006|Overall Study|Lack of Efficacy|0|||
27980211|NCT00955409|54638181|FG007|Overall Study|Lack of Efficacy|0|||
27980212|NCT00955409|54638182|FG008|Overall Study|Lack of Efficacy|0|||
27980213|NCT00955409|54638183|FG009|Overall Study|Lack of Efficacy|0|||
28088262|NCT03307252|54741783|FG006|Part 2, Period 3|Other than listed|0|||
28088263|NCT03307252|54741784|FG007|Part 2, Period 3|Other than listed|0|||
28088264|NCT03307252|54741785|FG008|Part 2, Period 3|Other than listed|0|||
28088265|NCT03307252|54741786|FG009|Part 2, Period 3|Other than listed|0|||
28088266|NCT03307252|54741787|FG010|Part 2, Period 3|Other than listed|0|||
28088267|NCT03307252|54741777|FG000|Part 2, Period 4|Other than listed|0|||
28088268|NCT03307252|54741778|FG001|Part 2, Period 4|Other than listed|0|||
28088269|NCT03307252|54741779|FG002|Part 2, Period 4|Other than listed|0|||
28088270|NCT03307252|54741780|FG003|Part 2, Period 4|Other than listed|0|||
28088271|NCT03307252|54741781|FG004|Part 2, Period 4|Other than listed|0|||
28165850|NCT02908841|54836620|FG001|Overall Study|Physician Decision|0|||
28165851|NCT02909153|54836631|FG000|Overall Study|Withdrawal by Subject|0|||
28165852|NCT02909153|54836632|FG001|Overall Study|Withdrawal by Subject|1|||
28165853|NCT02909153|54836633|FG002|Overall Study|Withdrawal by Subject|0|||
28165854|NCT02909153|54836634|FG003|Overall Study|Withdrawal by Subject|0|||
28165855|NCT02909153|54836635|FG004|Overall Study|Withdrawal by Subject|0|||
28165856|NCT02908529|54836647|FG000|Overall Study|Lost to Follow-up|0|||
28165857|NCT02908529|54836648|FG001|Overall Study|Lost to Follow-up|2|||
28165858|NCT02984267|54836658|FG000|Overall Study|Protocol Violation|1|||
28165859|NCT02984267|54836659|FG001|Overall Study|Protocol Violation|0|||
28165860|NCT02984267|54836658|FG000|Overall Study|Withdrawal by Subject|0|||
28165861|NCT02984267|54836659|FG001|Overall Study|Withdrawal by Subject|1|||
28165862|NCT02675751|54836665|FG000|Overall Study|Lost to Follow-up|16|||
28165863|NCT02974855|54836682|FG000|Overall Study|Adverse Event|0|||
28165864|NCT02974855|54836683|FG001|Overall Study|Adverse Event|1|||
28165865|NCT02974855|54836684|FG002|Overall Study|Adverse Event|0|||
28165866|NCT02974855|54836685|FG003|Overall Study|Adverse Event|1|||
28165867|NCT00455403|54836710|FG000|Overall Study|Lost to Follow-up|2|||
28165868|NCT00455403|54836711|FG001|Overall Study|Lost to Follow-up|1|||
28165869|NCT00455403|54836710|FG000|Overall Study|Withdrawal by Subject|1|||
28165870|NCT00455403|54836711|FG001|Overall Study|Withdrawal by Subject|3|||
28165871|NCT00455403|54836710|FG000|Overall Study|Protocol Violation|0|||
28165872|NCT00455403|54836711|FG001|Overall Study|Protocol Violation|2|||
28165873|NCT02979613|54836719|FG000|Double-Blind Phase|Withdrew Consent|2|||
28165874|NCT02979613|54836720|FG001|Double-Blind Phase|Withdrew Consent|4|||
28165875|NCT02979613|54836719|FG000|Double-Blind Phase|Pregnancy|2|||
28165876|NCT02979613|54836720|FG001|Double-Blind Phase|Pregnancy|2|||
28165877|NCT02979613|54836719|FG000|Double-Blind Phase|Adverse Event|2|||
28165878|NCT02979613|54836720|FG001|Double-Blind Phase|Adverse Event|0|||
28165879|NCT02979613|54836719|FG000|Double-Blind Phase|Lost to Follow-up|1|||
28165880|NCT02979613|54836720|FG001|Double-Blind Phase|Lost to Follow-up|1|||
28165881|NCT02979613|54836719|FG000|Double-Blind Phase|Protocol Violation|1|||
28165882|NCT02979613|54836720|FG001|Double-Blind Phase|Protocol Violation|1|||
28165883|NCT02979613|54836719|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
28165884|NCT02979613|54836720|FG001|Double-Blind Phase|Randomized but Never Treated|0|||
28165885|NCT02979613|54836719|FG000|Open-Label Extension (OLE) Phase|Withdrew Consent|2|||
27855689|NCT02733042|54382051|FG013|Treatment Period|Ongoing on Assigned Treatment|0|||
27855690|NCT02733042|54382052|FG014|Treatment Period|Ongoing on Assigned Treatment|0|||
27855691|NCT02733042|54382053|FG015|Treatment Period|Ongoing on Assigned Treatment|0|||
27855692|NCT02733042|54382054|FG016|Treatment Period|Ongoing on Assigned Treatment|0|||
27855693|NCT02733042|54382055|FG017|Treatment Period|Ongoing on Assigned Treatment|0|||
27855694|NCT02733042|54382056|FG018|Treatment Period|Ongoing on Assigned Treatment|1|||
27855695|NCT02733042|54382038|FG000|Treatment Period|Death|0|||
27980214|NCT00955409|54638174|FG000|Overall Study|Withdrawal by Subject|1|||
27980215|NCT00955409|54638175|FG001|Overall Study|Withdrawal by Subject|0|||
27980216|NCT00955409|54638176|FG002|Overall Study|Withdrawal by Subject|5|||
27980217|NCT00955409|54638177|FG003|Overall Study|Withdrawal by Subject|2|||
27980218|NCT00955409|54638178|FG004|Overall Study|Withdrawal by Subject|0|||
27980219|NCT00955409|54638179|FG005|Overall Study|Withdrawal by Subject|0|||
27980220|NCT00955409|54638180|FG006|Overall Study|Withdrawal by Subject|2|||
27980221|NCT00955409|54638181|FG007|Overall Study|Withdrawal by Subject|0|||
27980222|NCT00955409|54638182|FG008|Overall Study|Withdrawal by Subject|1|||
27980223|NCT00955409|54638183|FG009|Overall Study|Withdrawal by Subject|0|||
27980224|NCT00955409|54638174|FG000|Overall Study|Caregiver Request|2|||
27980225|NCT00955409|54638175|FG001|Overall Study|Caregiver Request|0|||
27980226|NCT00955409|54638176|FG002|Overall Study|Caregiver Request|6|||
27980227|NCT00955409|54638177|FG003|Overall Study|Caregiver Request|5|||
27980228|NCT00955409|54638178|FG004|Overall Study|Caregiver Request|0|||
27980229|NCT00955409|54638179|FG005|Overall Study|Caregiver Request|2|||
27980230|NCT00955409|54638180|FG006|Overall Study|Caregiver Request|3|||
27980231|NCT00955409|54638181|FG007|Overall Study|Caregiver Request|1|||
27980232|NCT00955409|54638182|FG008|Overall Study|Caregiver Request|3|||
27980233|NCT00955409|54638183|FG009|Overall Study|Caregiver Request|0|||
27980234|NCT00955409|54638174|FG000|Overall Study|Investigator Request|0|||
27980235|NCT00955409|54638175|FG001|Overall Study|Investigator Request|0|||
27980236|NCT00955409|54638176|FG002|Overall Study|Investigator Request|1|||
27980237|NCT00955409|54638177|FG003|Overall Study|Investigator Request|0|||
27980238|NCT00955409|54638178|FG004|Overall Study|Investigator Request|0|||
27980239|NCT00955409|54638179|FG005|Overall Study|Investigator Request|0|||
27980240|NCT00955409|54638180|FG006|Overall Study|Investigator Request|0|||
27980241|NCT00955409|54638181|FG007|Overall Study|Investigator Request|0|||
27980242|NCT00955409|54638182|FG008|Overall Study|Investigator Request|0|||
28165886|NCT02979613|54836720|FG001|Open-Label Extension (OLE) Phase|Withdrew Consent|4|||
28165887|NCT02979613|54836719|FG000|Open-Label Extension (OLE) Phase|Adverse Event|1|||
28165888|NCT02979613|54836720|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
28165889|NCT02979613|54836719|FG000|Open-Label Extension (OLE) Phase|Death|0|||
28165890|NCT02979613|54836720|FG001|Open-Label Extension (OLE) Phase|Death|1|||
28165891|NCT02979613|54836719|FG000|Open-Label Extension (OLE) Phase|Investigator's Discretion|0|||
28165892|NCT02979613|54836720|FG001|Open-Label Extension (OLE) Phase|Investigator's Discretion|1|||
28165893|NCT01064167|54836730|FG000|Overall Study|Protocol Violation|14|||
28165894|NCT01064167|54836731|FG001|Overall Study|Protocol Violation|15|||
28165895|NCT02974543|54836739|FG000|Overall Study|Withdrawal by Subject|1|||
28165896|NCT02974543|54836740|FG001|Overall Study|Withdrawal by Subject|0|||
28165897|NCT01064947|54836754|FG000|Overall Study|negative culture|41|||
28165898|NCT02974153|54836765|FG000|Overall Study|Adverse Event|6|||
28165899|NCT02974153|54836766|FG001|Overall Study|Adverse Event|0|||
28165900|NCT02974153|54836767|FG002|Overall Study|Adverse Event|1|||
28165901|NCT02974153|54836765|FG000|Overall Study|Lack of Efficacy|6|||
28165902|NCT02974153|54836766|FG001|Overall Study|Lack of Efficacy|5|||
28165903|NCT02974153|54836767|FG002|Overall Study|Lack of Efficacy|10|||
28165904|NCT02974153|54836765|FG000|Overall Study|Lost to Follow-up|9|||
28165905|NCT02974153|54836766|FG001|Overall Study|Lost to Follow-up|10|||
28165906|NCT02974153|54836767|FG002|Overall Study|Lost to Follow-up|17|||
28165907|NCT02974153|54836765|FG000|Overall Study|Physician Decision|0|||
28165908|NCT02974153|54836766|FG001|Overall Study|Physician Decision|2|||
28165909|NCT02974153|54836767|FG002|Overall Study|Physician Decision|1|||
28165910|NCT02974153|54836765|FG000|Overall Study|Withdrawal by Subject|9|||
28165911|NCT02974153|54836766|FG001|Overall Study|Withdrawal by Subject|16|||
28165912|NCT02974153|54836767|FG002|Overall Study|Withdrawal by Subject|11|||
28165913|NCT02974153|54836765|FG000|Overall Study|Study Burden|8|||
28165914|NCT02974153|54836766|FG001|Overall Study|Study Burden|7|||
28165915|NCT02974153|54836767|FG002|Overall Study|Study Burden|3|||
28165916|NCT02974153|54836765|FG000|Overall Study|Other|14|||
28165917|NCT02974153|54836766|FG001|Overall Study|Other|8|||
28165918|NCT02974153|54836767|FG002|Overall Study|Other|7|||
28165919|NCT02508532|54836782|FG000|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
28165920|NCT02508532|54836783|FG001|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
28165921|NCT02508532|54836784|FG002|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
28165922|NCT02508532|54836785|FG003|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
28165923|NCT02508532|54836786|FG004|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
28165924|NCT02508532|54836787|FG005|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
28165925|NCT02508532|54836788|FG006|Part 1 - Dose Determining Period|did not complete >21 days of treatment|1|||
28165926|NCT02508532|54836789|FG007|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
28165927|NCT02508532|54836790|FG008|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
28165928|NCT02508532|54836782|FG000|Part 1 - Dose Determining Period|Not Evaluable|0|||
28165929|NCT02508532|54836783|FG001|Part 1 - Dose Determining Period|Not Evaluable|0|||
28165930|NCT02508532|54836784|FG002|Part 1 - Dose Determining Period|Not Evaluable|0|||
28165931|NCT02508532|54836785|FG003|Part 1 - Dose Determining Period|Not Evaluable|0|||
28165932|NCT02508532|54836786|FG004|Part 1 - Dose Determining Period|Not Evaluable|0|||
28165933|NCT02508532|54836787|FG005|Part 1 - Dose Determining Period|Not Evaluable|0|||
28165934|NCT02508532|54836788|FG006|Part 1 - Dose Determining Period|Not Evaluable|0|||
28165935|NCT02508532|54836789|FG007|Part 1 - Dose Determining Period|Not Evaluable|1|||
28165936|NCT02508532|54836790|FG008|Part 1 - Dose Determining Period|Not Evaluable|0|||
27980243|NCT00955409|54638183|FG009|Overall Study|Investigator Request|0|||
27980244|NCT00955409|54638174|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
27980245|NCT00955409|54638175|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
27980246|NCT00955409|54638176|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
27980247|NCT00955409|54638177|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
27980248|NCT00955409|54638178|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
27980249|NCT00955409|54638179|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
27980250|NCT00955409|54638180|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
27980251|NCT00955409|54638181|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
27980252|NCT00955409|54638182|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
27980253|NCT00955409|54638183|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
27980254|NCT00955409|54638174|FG000|Overall Study|Lost to Follow-up|0|||
27980255|NCT00955409|54638175|FG001|Overall Study|Lost to Follow-up|0|||
27980256|NCT00955409|54638176|FG002|Overall Study|Lost to Follow-up|1|||
27980257|NCT00955409|54638177|FG003|Overall Study|Lost to Follow-up|0|||
27980258|NCT00955409|54638178|FG004|Overall Study|Lost to Follow-up|0|||
27980259|NCT00955409|54638179|FG005|Overall Study|Lost to Follow-up|0|||
27980260|NCT00955409|54638180|FG006|Overall Study|Lost to Follow-up|1|||
28165937|NCT02508532|54836782|FG000|Part 2 - Treatment|Disease Progression|0|||
27733414|NCT02688387|54181210|FG019|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27980261|NCT00955409|54638181|FG007|Overall Study|Lost to Follow-up|0|||
27980262|NCT00955409|54638182|FG008|Overall Study|Lost to Follow-up|0|||
28165938|NCT02508532|54836783|FG001|Part 2 - Treatment|Disease Progression|0|||
28165939|NCT02508532|54836784|FG002|Part 2 - Treatment|Disease Progression|0|||
28165940|NCT02508532|54836785|FG003|Part 2 - Treatment|Disease Progression|0|||
28165941|NCT02508532|54836786|FG004|Part 2 - Treatment|Disease Progression|0|||
28165942|NCT02508532|54836787|FG005|Part 2 - Treatment|Disease Progression|0|||
28165943|NCT02508532|54836788|FG006|Part 2 - Treatment|Disease Progression|0|||
28165944|NCT02508532|54836789|FG007|Part 2 - Treatment|Disease Progression|0|||
28165945|NCT02508532|54836790|FG008|Part 2 - Treatment|Disease Progression|118|||
28165946|NCT02508532|54836782|FG000|Part 2 - Treatment|Adverse Event|0|||
28165947|NCT02508532|54836783|FG001|Part 2 - Treatment|Adverse Event|0|||
28165948|NCT02508532|54836784|FG002|Part 2 - Treatment|Adverse Event|0|||
28165949|NCT02508532|54836785|FG003|Part 2 - Treatment|Adverse Event|0|||
28165950|NCT02508532|54836786|FG004|Part 2 - Treatment|Adverse Event|0|||
28165951|NCT02508532|54836787|FG005|Part 2 - Treatment|Adverse Event|0|||
28165952|NCT02508532|54836788|FG006|Part 2 - Treatment|Adverse Event|0|||
28165953|NCT02508532|54836789|FG007|Part 2 - Treatment|Adverse Event|0|||
28165954|NCT02508532|54836790|FG008|Part 2 - Treatment|Adverse Event|49|||
28165955|NCT02508532|54836782|FG000|Part 2 - Treatment|Physician Decision|0|||
28165956|NCT02508532|54836783|FG001|Part 2 - Treatment|Physician Decision|0|||
28165957|NCT02508532|54836784|FG002|Part 2 - Treatment|Physician Decision|0|||
28165958|NCT02508532|54836785|FG003|Part 2 - Treatment|Physician Decision|0|||
28165959|NCT02508532|54836786|FG004|Part 2 - Treatment|Physician Decision|0|||
28165960|NCT02508532|54836787|FG005|Part 2 - Treatment|Physician Decision|0|||
28165961|NCT02508532|54836788|FG006|Part 2 - Treatment|Physician Decision|0|||
28165962|NCT02508532|54836789|FG007|Part 2 - Treatment|Physician Decision|0|||
28165963|NCT02508532|54836790|FG008|Part 2 - Treatment|Physician Decision|12|||
28165964|NCT02508532|54836782|FG000|Part 2 - Treatment|Administrative|0|||
28165965|NCT02508532|54836783|FG001|Part 2 - Treatment|Administrative|0|||
28165966|NCT02508532|54836784|FG002|Part 2 - Treatment|Administrative|0|||
28165967|NCT02508532|54836785|FG003|Part 2 - Treatment|Administrative|0|||
28165968|NCT02508532|54836786|FG004|Part 2 - Treatment|Administrative|0|||
28165969|NCT02508532|54836787|FG005|Part 2 - Treatment|Administrative|0|||
28165970|NCT02508532|54836788|FG006|Part 2 - Treatment|Administrative|0|||
28165971|NCT02508532|54836789|FG007|Part 2 - Treatment|Administrative|0|||
28165972|NCT02508532|54836790|FG008|Part 2 - Treatment|Administrative|3|||
28165973|NCT02508532|54836782|FG000|Part 2 - Treatment|Sponsor Decision|0|||
28165974|NCT02508532|54836783|FG001|Part 2 - Treatment|Sponsor Decision|0|||
28165975|NCT02508532|54836784|FG002|Part 2 - Treatment|Sponsor Decision|0|||
28165976|NCT02508532|54836785|FG003|Part 2 - Treatment|Sponsor Decision|0|||
28165977|NCT02508532|54836786|FG004|Part 2 - Treatment|Sponsor Decision|0|||
28165978|NCT02508532|54836787|FG005|Part 2 - Treatment|Sponsor Decision|0|||
28165979|NCT02508532|54836788|FG006|Part 2 - Treatment|Sponsor Decision|0|||
28165980|NCT02508532|54836789|FG007|Part 2 - Treatment|Sponsor Decision|0|||
28165981|NCT02508532|54836790|FG008|Part 2 - Treatment|Sponsor Decision|28|||
28165982|NCT02508532|54836782|FG000|Part 2 - Treatment|Death|0|||
28165983|NCT02508532|54836783|FG001|Part 2 - Treatment|Death|0|||
28165984|NCT02508532|54836784|FG002|Part 2 - Treatment|Death|0|||
28165985|NCT02508532|54836785|FG003|Part 2 - Treatment|Death|0|||
28165986|NCT02508532|54836786|FG004|Part 2 - Treatment|Death|0|||
28165987|NCT02508532|54836787|FG005|Part 2 - Treatment|Death|0|||
28165988|NCT02508532|54836788|FG006|Part 2 - Treatment|Death|0|||
28165989|NCT02508532|54836789|FG007|Part 2 - Treatment|Death|0|||
28165990|NCT02508532|54836790|FG008|Part 2 - Treatment|Death|1|||
28165991|NCT02508532|54836782|FG000|Part 2 - Treatment|Withdrawal by Subject|0|||
28165992|NCT02508532|54836783|FG001|Part 2 - Treatment|Withdrawal by Subject|0|||
28165993|NCT02508532|54836784|FG002|Part 2 - Treatment|Withdrawal by Subject|0|||
28165994|NCT02508532|54836785|FG003|Part 2 - Treatment|Withdrawal by Subject|0|||
28165995|NCT02508532|54836786|FG004|Part 2 - Treatment|Withdrawal by Subject|0|||
28165996|NCT02508532|54836787|FG005|Part 2 - Treatment|Withdrawal by Subject|0|||
28165997|NCT02508532|54836788|FG006|Part 2 - Treatment|Withdrawal by Subject|0|||
28165998|NCT02508532|54836789|FG007|Part 2 - Treatment|Withdrawal by Subject|0|||
28165999|NCT02508532|54836790|FG008|Part 2 - Treatment|Withdrawal by Subject|6|||
28166000|NCT02508532|54836782|FG000|Part 1 and Part 2 End of Study|Disease Progression|2|||
28166001|NCT02508532|54836783|FG001|Part 1 and Part 2 End of Study|Disease Progression|0|||
28166002|NCT02508532|54836784|FG002|Part 1 and Part 2 End of Study|Disease Progression|0|||
28166003|NCT02508532|54836785|FG003|Part 1 and Part 2 End of Study|Disease Progression|0|||
28166004|NCT02508532|54836786|FG004|Part 1 and Part 2 End of Study|Disease Progression|0|||
28166005|NCT02508532|54836787|FG005|Part 1 and Part 2 End of Study|Disease Progression|0|||
28166006|NCT02508532|54836788|FG006|Part 1 and Part 2 End of Study|Disease Progression|0|||
28166007|NCT02508532|54836789|FG007|Part 1 and Part 2 End of Study|Disease Progression|1|||
28166008|NCT02508532|54836790|FG008|Part 1 and Part 2 End of Study|Disease Progression|6|||
28166009|NCT02508532|54836782|FG000|Part 1 and Part 2 End of Study|Adverse Event|1|||
28166010|NCT02508532|54836783|FG001|Part 1 and Part 2 End of Study|Adverse Event|0|||
27733415|NCT02688387|54181211|FG020|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27855696|NCT02733042|54382039|FG001|Treatment Period|Death|0|||
28166011|NCT02508532|54836784|FG002|Part 1 and Part 2 End of Study|Adverse Event|1|||
28166012|NCT02508532|54836785|FG003|Part 1 and Part 2 End of Study|Adverse Event|0|||
28166013|NCT02508532|54836786|FG004|Part 1 and Part 2 End of Study|Adverse Event|0|||
28166014|NCT02508532|54836787|FG005|Part 1 and Part 2 End of Study|Adverse Event|0|||
28166015|NCT02508532|54836788|FG006|Part 1 and Part 2 End of Study|Adverse Event|0|||
28166016|NCT02508532|54836789|FG007|Part 1 and Part 2 End of Study|Adverse Event|0|||
28166017|NCT02508532|54836790|FG008|Part 1 and Part 2 End of Study|Adverse Event|2|||
28166018|NCT02508532|54836782|FG000|Part 1 and Part 2 End of Study|Death|0|||
28166019|NCT02508532|54836783|FG001|Part 1 and Part 2 End of Study|Death|4|||
28166020|NCT02508532|54836784|FG002|Part 1 and Part 2 End of Study|Death|2|||
28166021|NCT02508532|54836785|FG003|Part 1 and Part 2 End of Study|Death|4|||
28166022|NCT02508532|54836786|FG004|Part 1 and Part 2 End of Study|Death|3|||
28166023|NCT02508532|54836787|FG005|Part 1 and Part 2 End of Study|Death|0|||
28166024|NCT02508532|54836788|FG006|Part 1 and Part 2 End of Study|Death|0|||
28166025|NCT02508532|54836789|FG007|Part 1 and Part 2 End of Study|Death|1|||
28166026|NCT02508532|54836790|FG008|Part 1 and Part 2 End of Study|Death|111|||
28166027|NCT02508532|54836782|FG000|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
28166028|NCT02508532|54836783|FG001|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
28166029|NCT02508532|54836784|FG002|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
28166030|NCT02508532|54836785|FG003|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
28166031|NCT02508532|54836786|FG004|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
28166032|NCT02508532|54836787|FG005|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
28166033|NCT02508532|54836788|FG006|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
28166034|NCT02508532|54836789|FG007|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
28166035|NCT02508532|54836790|FG008|Part 1 and Part 2 End of Study|Lost to Follow-up|6|||
28166036|NCT02508532|54836782|FG000|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
28166037|NCT02508532|54836783|FG001|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
28166038|NCT02508532|54836784|FG002|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
28166039|NCT02508532|54836785|FG003|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
28166040|NCT02508532|54836786|FG004|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
28166041|NCT02508532|54836787|FG005|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
28166042|NCT02508532|54836788|FG006|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
28166043|NCT02508532|54836789|FG007|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
28166044|NCT02508532|54836790|FG008|Part 1 and Part 2 End of Study|Withdrawal by Subject|15|||
28166045|NCT02508532|54836782|FG000|Part 1 and Part 2 End of Study|Physician Decision|0|||
28166046|NCT02508532|54836783|FG001|Part 1 and Part 2 End of Study|Physician Decision|0|||
28166047|NCT02508532|54836784|FG002|Part 1 and Part 2 End of Study|Physician Decision|1|||
28166048|NCT02508532|54836785|FG003|Part 1 and Part 2 End of Study|Physician Decision|0|||
28166049|NCT02508532|54836786|FG004|Part 1 and Part 2 End of Study|Physician Decision|1|||
28166050|NCT02508532|54836787|FG005|Part 1 and Part 2 End of Study|Physician Decision|0|||
28166051|NCT02508532|54836788|FG006|Part 1 and Part 2 End of Study|Physician Decision|0|||
28166052|NCT02508532|54836789|FG007|Part 1 and Part 2 End of Study|Physician Decision|0|||
28166053|NCT02508532|54836790|FG008|Part 1 and Part 2 End of Study|Physician Decision|8|||
28166054|NCT02508532|54836782|FG000|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
28166055|NCT02508532|54836783|FG001|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
28166056|NCT02508532|54836784|FG002|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
28166057|NCT02508532|54836785|FG003|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
28166058|NCT02508532|54836786|FG004|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
28166059|NCT02508532|54836787|FG005|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
28166060|NCT02508532|54836788|FG006|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
28166061|NCT02508532|54836789|FG007|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
28166062|NCT02508532|54836790|FG008|Part 1 and Part 2 End of Study|Initiation of another therapy|1|||
28166063|NCT02508532|54836782|FG000|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
28166064|NCT02508532|54836783|FG001|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
28166065|NCT02508532|54836784|FG002|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
28166066|NCT02508532|54836785|FG003|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
28166067|NCT02508532|54836786|FG004|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
28166068|NCT02508532|54836787|FG005|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
28166069|NCT02508532|54836788|FG006|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
28166070|NCT02508532|54836789|FG007|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
28166071|NCT02508532|54836790|FG008|Part 1 and Part 2 End of Study|Sponsor Decision|68|||
28166072|NCT02918071|54836819|FG000|Overall Study|Withdrawal by Subject|2|||
28166073|NCT02918071|54836819|FG000|Overall Study|Lost to Follow-up|1|||
28166074|NCT02507752|54836823|FG000|Overall Study|Adverse Event|1|||
28166075|NCT02507752|54836823|FG000|Overall Study|Protocol Violation|6|||
28166076|NCT02507752|54836823|FG000|Overall Study|Lost to Follow-up|7|||
28166077|NCT02507752|54836823|FG000|Overall Study|Infusion reaction at first infusion|1|||
27733416|NCT02688387|54181212|FG021|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27855697|NCT02733042|54382040|FG002|Treatment Period|Death|0|||
27855698|NCT02733042|54382041|FG003|Treatment Period|Death|0|||
27855699|NCT02733042|54382042|FG004|Treatment Period|Death|0|||
27855700|NCT02733042|54382043|FG005|Treatment Period|Death|0|||
27980263|NCT00955409|54638183|FG009|Overall Study|Lost to Follow-up|0|||
28166078|NCT02507752|54836823|FG000|Overall Study|Participant didn't perform visit Week 12|1|||
28166079|NCT02507752|54836823|FG000|Overall Study|Participant didn't perform visit Week 24|1|||
28166080|NCT02506816|54836827|FG000|Overall Study|Adverse Event|3|||
28166081|NCT02506036|54836833|FG000|First Intervention (4-6 Weeks)|Death|1|||
28166082|NCT02506036|54836834|FG001|First Intervention (4-6 Weeks)|Death|0|||
27855701|NCT02733042|54382044|FG006|Treatment Period|Death|1|||
28166083|NCT02506036|54836833|FG000|First Intervention (4-6 Weeks)|Lost to Follow-up|0|||
28166084|NCT02506036|54836834|FG001|First Intervention (4-6 Weeks)|Lost to Follow-up|1|||
28166085|NCT02506036|54836833|FG000|First Intervention (4-6 Weeks)|Withdrawal by Subject|0|||
28166086|NCT02506036|54836834|FG001|First Intervention (4-6 Weeks)|Withdrawal by Subject|1|||
28166087|NCT01063855|54836842|FG000|Overall Study|Adverse Event|4|||
28166088|NCT01063855|54836843|FG001|Overall Study|Adverse Event|4|||
28166089|NCT01063855|54836842|FG000|Overall Study|Death|0|||
28166090|NCT01063855|54836843|FG001|Overall Study|Death|1|||
28166091|NCT01063855|54836842|FG000|Overall Study|Lost to Follow-up|8|||
28166092|NCT01063855|54836843|FG001|Overall Study|Lost to Follow-up|4|||
28166093|NCT01063855|54836842|FG000|Overall Study|Pregnancy|1|||
28166094|NCT01063855|54836843|FG001|Overall Study|Pregnancy|0|||
28166095|NCT01063855|54836842|FG000|Overall Study|Lack of Efficacy|0|||
28166096|NCT01063855|54836843|FG001|Overall Study|Lack of Efficacy|1|||
28166097|NCT01063855|54836842|FG000|Overall Study|Withdrawal by Subject|11|||
28166098|NCT01063855|54836843|FG001|Overall Study|Withdrawal by Subject|8|||
27980264|NCT00955409|54638174|FG000|Overall Study|Failed to Return|2|||
27980265|NCT00955409|54638175|FG001|Overall Study|Failed to Return|0|||
27980266|NCT00955409|54638176|FG002|Overall Study|Failed to Return|0|||
27980267|NCT00955409|54638177|FG003|Overall Study|Failed to Return|0|||
27980268|NCT00955409|54638178|FG004|Overall Study|Failed to Return|0|||
27980269|NCT00955409|54638179|FG005|Overall Study|Failed to Return|0|||
27980270|NCT00955409|54638180|FG006|Overall Study|Failed to Return|0|||
27980271|NCT00955409|54638181|FG007|Overall Study|Failed to Return|2|||
27980272|NCT00955409|54638182|FG008|Overall Study|Failed to Return|0|||
27980273|NCT00955409|54638183|FG009|Overall Study|Failed to Return|0|||
28166099|NCT01063855|54836842|FG000|Overall Study|Reason not specified|13|||
28166100|NCT01063855|54836843|FG001|Overall Study|Reason not specified|11|||
28166101|NCT01063153|54836855|FG000|Overall Study|Found Ineligible During Screening|2|||
28166102|NCT01063153|54836856|FG001|Overall Study|Found Ineligible During Screening|0|||
27980274|NCT00955409|54638174|FG000|Overall Study|Adverse Event (AE)|2|||
27980275|NCT00955409|54638175|FG001|Overall Study|Adverse Event (AE)|0|||
27980276|NCT00955409|54638176|FG002|Overall Study|Adverse Event (AE)|0|||
27980277|NCT00955409|54638177|FG003|Overall Study|Adverse Event (AE)|0|||
27980278|NCT00955409|54638178|FG004|Overall Study|Adverse Event (AE)|0|||
27980279|NCT00955409|54638179|FG005|Overall Study|Adverse Event (AE)|1|||
27980280|NCT00955409|54638180|FG006|Overall Study|Adverse Event (AE)|2|||
27980281|NCT00955409|54638181|FG007|Overall Study|Adverse Event (AE)|0|||
27980282|NCT00955409|54638182|FG008|Overall Study|Adverse Event (AE)|2|||
27980283|NCT00955409|54638183|FG009|Overall Study|Adverse Event (AE)|0|||
28166103|NCT01063153|54836855|FG000|Overall Study|Lost to Follow-up|0|||
27733417|NCT02688387|54181191|FG000|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
27733418|NCT02688387|54181192|FG001|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1|||
27733419|NCT02688387|54181193|FG002|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
27733420|NCT02688387|54181194|FG003|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
27733421|NCT02688387|54181195|FG004|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
27733422|NCT02688387|54181196|FG005|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
27733423|NCT02688387|54181197|FG006|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
27733424|NCT02688387|54181198|FG007|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
27733425|NCT02688387|54181199|FG008|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
27733426|NCT02688387|54181200|FG009|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
27733427|NCT02688387|54181201|FG010|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
27733428|NCT02688387|54181202|FG011|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
27733429|NCT02688387|54181203|FG012|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
27733430|NCT02688387|54181204|FG013|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
27733431|NCT02688387|54181205|FG014|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
27733432|NCT02688387|54181206|FG015|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
27733433|NCT02688387|54181207|FG016|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
27855702|NCT02733042|54382045|FG007|Treatment Period|Death|0|||
27855703|NCT02733042|54382046|FG008|Treatment Period|Death|1|||
27980284|NCT00955409|54638174|FG000|Overall Study|Reason not Specified|2|||
27980285|NCT00955409|54638175|FG001|Overall Study|Reason not Specified|1|||
27980286|NCT00955409|54638176|FG002|Overall Study|Reason not Specified|13|||
27980287|NCT00955409|54638177|FG003|Overall Study|Reason not Specified|1|||
27980288|NCT00955409|54638178|FG004|Overall Study|Reason not Specified|2|||
27980289|NCT00955409|54638179|FG005|Overall Study|Reason not Specified|0|||
28166104|NCT01063153|54836856|FG001|Overall Study|Lost to Follow-up|7|||
27980290|NCT00955409|54638180|FG006|Overall Study|Reason not Specified|16|||
28166105|NCT01063153|54836855|FG000|Overall Study|Withdrawal by Subject|0|||
28166106|NCT01063153|54836856|FG001|Overall Study|Withdrawal by Subject|1|||
28166107|NCT01063153|54836855|FG000|Overall Study|Physician Decision|0|||
28166108|NCT01063153|54836856|FG001|Overall Study|Physician Decision|4|||
28166109|NCT01062841|54836868|FG000|Overall Study|Indwelling Device Removed|41|||
27980291|NCT00955409|54638181|FG007|Overall Study|Reason not Specified|0|||
27980292|NCT00955409|54638182|FG008|Overall Study|Reason not Specified|8|||
27980293|NCT00955409|54638183|FG009|Overall Study|Reason not Specified|1|||
27980294|NCT00615901|54638209|FG000|Overall Study|Withdrawal by Subject|2|||
27980295|NCT00615901|54638209|FG000|Overall Study|Adverse Event|7|||
27980296|NCT00616603|54638221|FG000|Overall Study|Physician Decision|2|||
27980297|NCT00616603|54638222|FG001|Overall Study|Physician Decision|0|||
27980298|NCT00616603|54638223|FG002|Overall Study|Physician Decision|2|||
27980299|NCT00810693|54638234|FG000|Treatment Period|Adverse Event|8|||
28166110|NCT01062841|54836869|FG001|Overall Study|Indwelling Device Removed|48|||
28166111|NCT01062841|54836868|FG000|Overall Study|Death|3|||
28166112|NCT01062841|54836869|FG001|Overall Study|Death|5|||
28166113|NCT01062841|54836868|FG000|Overall Study|Withdrawal by Subject|2|||
28166114|NCT01062841|54836869|FG001|Overall Study|Withdrawal by Subject|0|||
28166115|NCT01062841|54836868|FG000|Overall Study|Withdrawal by Study|3|||
28166116|NCT01062841|54836869|FG001|Overall Study|Withdrawal by Study|0|||
28166117|NCT02505334|54836877|FG000|Main Treatment Period|Adverse Event|3|||
28166118|NCT02505334|54836878|FG001|Main Treatment Period|Adverse Event|3|||
28166119|NCT02505334|54836877|FG000|Main Treatment Period|Lack of Efficacy|7|||
28166120|NCT02505334|54836878|FG001|Main Treatment Period|Lack of Efficacy|17|||
28166121|NCT02505334|54836877|FG000|Main Treatment Period|Protocol Violation|0|||
28166122|NCT02505334|54836878|FG001|Main Treatment Period|Protocol Violation|1|||
28166123|NCT02505334|54836877|FG000|Main Treatment Period|Withdrawal by Subject|1|||
27980300|NCT00810693|54638235|FG001|Treatment Period|Adverse Event|1|||
27980301|NCT00810693|54638236|FG002|Treatment Period|Adverse Event|7|||
27980302|NCT00810693|54638234|FG000|Treatment Period|Death|0|||
27980303|NCT00810693|54638235|FG001|Treatment Period|Death|1|||
27980304|NCT00810693|54638236|FG002|Treatment Period|Death|2|||
27980305|NCT00810693|54638234|FG000|Treatment Period|Lack of Efficacy|0|||
27980306|NCT00810693|54638235|FG001|Treatment Period|Lack of Efficacy|0|||
27980307|NCT00810693|54638236|FG002|Treatment Period|Lack of Efficacy|1|||
27980308|NCT00810693|54638234|FG000|Treatment Period|Lost to Follow-up|1|||
27980309|NCT00810693|54638235|FG001|Treatment Period|Lost to Follow-up|0|||
27980310|NCT00810693|54638236|FG002|Treatment Period|Lost to Follow-up|0|||
27980311|NCT00810693|54638234|FG000|Treatment Period|Non-compliance|1|||
27980312|NCT00810693|54638235|FG001|Treatment Period|Non-compliance|0|||
27980313|NCT00810693|54638236|FG002|Treatment Period|Non-compliance|0|||
27980314|NCT00810693|54638234|FG000|Treatment Period|Protocol Violation|1|||
27980315|NCT00810693|54638235|FG001|Treatment Period|Protocol Violation|2|||
27980316|NCT00810693|54638236|FG002|Treatment Period|Protocol Violation|2|||
27980317|NCT00810693|54638234|FG000|Treatment Period|Withdrawal by Subject|6|||
27980318|NCT00810693|54638235|FG001|Treatment Period|Withdrawal by Subject|2|||
27980319|NCT00810693|54638236|FG002|Treatment Period|Withdrawal by Subject|3|||
27980320|NCT00810693|54638234|FG000|Treatment Period|Not treated|0|||
27980321|NCT00810693|54638235|FG001|Treatment Period|Not treated|1|||
27980322|NCT00810693|54638236|FG002|Treatment Period|Not treated|1|||
27980323|NCT00810693|54638234|FG000|Follow-up Period (FUP)|Adverse Event|3|||
27980324|NCT00810693|54638235|FG001|Follow-up Period (FUP)|Adverse Event|1|||
27980325|NCT00810693|54638236|FG002|Follow-up Period (FUP)|Adverse Event|1|||
27980326|NCT00810693|54638234|FG000|Follow-up Period (FUP)|Death|2|||
27980327|NCT00810693|54638235|FG001|Follow-up Period (FUP)|Death|0|||
27980328|NCT00810693|54638236|FG002|Follow-up Period (FUP)|Death|1|||
27980329|NCT00810693|54638234|FG000|Follow-up Period (FUP)|Lost to Follow-up|1|||
27980330|NCT00810693|54638235|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
27980331|NCT00810693|54638236|FG002|Follow-up Period (FUP)|Lost to Follow-up|2|||
27980332|NCT00810693|54638234|FG000|Follow-up Period (FUP)|Protocol Violation|0|||
27980333|NCT00810693|54638235|FG001|Follow-up Period (FUP)|Protocol Violation|1|||
27980334|NCT00810693|54638236|FG002|Follow-up Period (FUP)|Protocol Violation|0|||
27980335|NCT00810693|54638234|FG000|Follow-up Period (FUP)|Withdrawal by Subject|2|||
27980336|NCT00810693|54638235|FG001|Follow-up Period (FUP)|Withdrawal by Subject|1|||
27980337|NCT00810693|54638236|FG002|Follow-up Period (FUP)|Withdrawal by Subject|0|||
27980338|NCT00573313|54638248|FG000|Overall Study|Protocol Violation|5|||
27980339|NCT00573313|54638249|FG001|Overall Study|Protocol Violation|0|||
28166124|NCT02505334|54836878|FG001|Main Treatment Period|Withdrawal by Subject|8|||
27733434|NCT02688387|54181208|FG017|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
27980340|NCT00573313|54638250|FG002|Overall Study|Protocol Violation|6|||
28166125|NCT02505334|54836877|FG000|Main Treatment Period|Unclassified|4|||
28166126|NCT02505334|54836878|FG001|Main Treatment Period|Unclassified|10|||
27980341|NCT00573313|54638251|FG003|Overall Study|Protocol Violation|0|||
27980342|NCT00953615|54638258|FG000|Overall Study|Adverse Event|1|||
27980343|NCT00810615|54638264|FG000|Overall Study|Withdrawal by Subject|1|||
27980344|NCT00810615|54638265|FG001|Overall Study|Withdrawal by Subject|1|||
27980345|NCT00573391|54638285|FG000|Overall Study|study stopped|2|||
27980346|NCT00573391|54638286|FG001|Overall Study|study stopped|2|||
27980347|NCT00573391|54638285|FG000|Overall Study|Death|1|||
27980348|NCT00573391|54638286|FG001|Overall Study|Death|0|||
28166127|NCT02505334|54836877|FG000|Extension Treatment Period|Adverse Event|5|||
28166128|NCT02505334|54836878|FG001|Extension Treatment Period|Adverse Event|0|||
27980349|NCT00590967|54638294|FG000|Overall Study|Withdrawal by Subject|1|||
27980350|NCT00590967|54638295|FG001|Overall Study|Withdrawal by Subject|1|||
27980351|NCT00590967|54638294|FG000|Overall Study|Ineligible|1|||
27980352|NCT00590967|54638295|FG001|Overall Study|Ineligible|0|||
27980353|NCT00590967|54638294|FG000|Overall Study|Poor performance status|0|||
27980354|NCT00590967|54638295|FG001|Overall Study|Poor performance status|1|||
27980355|NCT00590967|54638294|FG000|Overall Study|Non-compliant|0|||
27980356|NCT00590967|54638295|FG001|Overall Study|Non-compliant|2|||
27980357|NCT00590967|54638294|FG000|Overall Study|Did not sign consent form|0|||
27980358|NCT00590967|54638295|FG001|Overall Study|Did not sign consent form|1|||
27980359|NCT00590967|54638294|FG000|Overall Study|Did not receive chemo per protocol|1|||
27980360|NCT00590967|54638295|FG001|Overall Study|Did not receive chemo per protocol|0|||
27980361|NCT00590577|54638305|FG000|Overall Study|Lack of Efficacy|31|||
27980362|NCT00590577|54638306|FG001|Overall Study|Lack of Efficacy|28|||
27980363|NCT00590577|54638307|FG002|Overall Study|Lack of Efficacy|23|||
27980364|NCT00590577|54638308|FG003|Overall Study|Lack of Efficacy|45|||
27980365|NCT00590577|54638305|FG000|Overall Study|Withdrawal by Subject|23|||
27980366|NCT00590577|54638306|FG001|Overall Study|Withdrawal by Subject|28|||
27980367|NCT00590577|54638307|FG002|Overall Study|Withdrawal by Subject|30|||
27980368|NCT00590577|54638308|FG003|Overall Study|Withdrawal by Subject|26|||
27980369|NCT00590577|54638305|FG000|Overall Study|Adverse Event|10|||
27980370|NCT00590577|54638306|FG001|Overall Study|Adverse Event|10|||
27980371|NCT00590577|54638307|FG002|Overall Study|Adverse Event|13|||
27980372|NCT00590577|54638308|FG003|Overall Study|Adverse Event|11|||
27980373|NCT00590577|54638305|FG000|Overall Study|Lost to Follow-up|12|||
27980374|NCT00590577|54638306|FG001|Overall Study|Lost to Follow-up|6|||
27980375|NCT00590577|54638307|FG002|Overall Study|Lost to Follow-up|6|||
27980376|NCT00590577|54638308|FG003|Overall Study|Lost to Follow-up|9|||
27980377|NCT00590577|54638305|FG000|Overall Study|Pregnancy|0|||
27980378|NCT00590577|54638306|FG001|Overall Study|Pregnancy|1|||
27980379|NCT00590577|54638307|FG002|Overall Study|Pregnancy|0|||
27980380|NCT00590577|54638308|FG003|Overall Study|Pregnancy|0|||
27980381|NCT00590577|54638305|FG000|Overall Study|Various reasons|1|||
27980382|NCT00590577|54638306|FG001|Overall Study|Various reasons|3|||
27980383|NCT00590577|54638307|FG002|Overall Study|Various reasons|1|||
27980384|NCT00590577|54638308|FG003|Overall Study|Various reasons|2|||
27980385|NCT00614575|54638318|FG000|Overall Study|Adverse Event|106|||
27980386|NCT00614575|54638318|FG000|Overall Study|Lost to Follow-up|55|||
27980387|NCT00614575|54638318|FG000|Overall Study|Lack of Efficacy|14|||
27980388|NCT00614575|54638318|FG000|Overall Study|Withdrawal by Subject|6|||
27980389|NCT00614575|54638318|FG000|Overall Study|Death|3|||
27980390|NCT00614575|54638318|FG000|Overall Study|Physician Decision|2|||
27980391|NCT00614575|54638318|FG000|Overall Study|No data were collected.|18|||
27980392|NCT00614575|54638318|FG000|Overall Study|Irregularly enrolled patients|23|||
27980393|NCT00614575|54638318|FG000|Overall Study|No treatment|1|||
27980394|NCT00805935|54638326|FG000|Overall Study|Stimulation Failure|1|||
27980395|NCT00805935|54638327|FG001|Overall Study|Stimulation Failure|5|||
27980396|NCT00805935|54638328|FG002|Overall Study|Stimulation Failure|2|||
27980397|NCT00805935|54638329|FG003|Overall Study|Stimulation Failure|2|||
27980398|NCT00805935|54638326|FG000|Overall Study|Cycle cancelled|0|||
27980399|NCT00805935|54638327|FG001|Overall Study|Cycle cancelled|0|||
28088272|NCT03307252|54741782|FG005|Part 2, Period 4|Other than listed|0|||
28088273|NCT03307252|54741783|FG006|Part 2, Period 4|Other than listed|1|||
28088274|NCT03307252|54741784|FG007|Part 2, Period 4|Other than listed|0|||
28088275|NCT03307252|54741785|FG008|Part 2, Period 4|Other than listed|0|||
28088276|NCT03307252|54741786|FG009|Part 2, Period 4|Other than listed|0|||
28088277|NCT03307252|54741787|FG010|Part 2, Period 4|Other than listed|0|||
28088278|NCT03307252|54741777|FG000|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
28088279|NCT03307252|54741778|FG001|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
28088280|NCT03307252|54741779|FG002|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
28088281|NCT03307252|54741780|FG003|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
28088282|NCT03307252|54741781|FG004|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
28166129|NCT02505334|54836877|FG000|Extension Treatment Period|Lack of Efficacy|4|||
28166130|NCT02505334|54836878|FG001|Extension Treatment Period|Lack of Efficacy|0|||
28166131|NCT02505334|54836877|FG000|Extension Treatment Period|Withdrawal by Subject|6|||
27980400|NCT00805935|54638328|FG002|Overall Study|Cycle cancelled|2|||
27980401|NCT00805935|54638329|FG003|Overall Study|Cycle cancelled|0|||
27980402|NCT00805935|54638326|FG000|Overall Study|Cycle cancellation for risk of OHSS|1|||
27980403|NCT00805935|54638327|FG001|Overall Study|Cycle cancellation for risk of OHSS|0|||
27980404|NCT00805935|54638328|FG002|Overall Study|Cycle cancellation for risk of OHSS|1|||
27980405|NCT00805935|54638329|FG003|Overall Study|Cycle cancellation for risk of OHSS|0|||
27980406|NCT00805935|54638326|FG000|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
27980407|NCT00805935|54638327|FG001|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
27980408|NCT00805935|54638328|FG002|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
27980409|NCT00805935|54638329|FG003|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1|||
27980410|NCT00805935|54638326|FG000|Overall Study|Lost to Follow-up|1|||
28088283|NCT03307252|54741782|FG005|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
28088284|NCT03307252|54741783|FG006|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
28088285|NCT03307252|54741784|FG007|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
28088286|NCT03307252|54741785|FG008|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
28088287|NCT03307252|54741786|FG009|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
28088288|NCT03307252|54741787|FG010|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1|||
28088289|NCT03307174|54741805|FG000|Overall Study|Unplanned ICU Administrion|5|||
28088290|NCT03307174|54741806|FG001|Overall Study|Unplanned ICU Administrion|3|||
28088291|NCT03307174|54741805|FG000|Overall Study|Aborted Surgery|1|||
28088292|NCT03307174|54741806|FG001|Overall Study|Aborted Surgery|2|||
28088293|NCT03307174|54741805|FG000|Overall Study|Hypotension|6|||
28088294|NCT03307174|54741806|FG001|Overall Study|Hypotension|0|||
28088295|NCT03307174|54741805|FG000|Overall Study|Nonfunctional epidural|1|||
28088296|NCT03307174|54741806|FG001|Overall Study|Nonfunctional epidural|1|||
28088297|NCT03307174|54741805|FG000|Overall Study|Planned epidural removal|1|||
28088298|NCT03307174|54741806|FG001|Overall Study|Planned epidural removal|0|||
28088299|NCT03307174|54741805|FG000|Overall Study|Intrathecal catheter placement|0|||
28088300|NCT03307174|54741806|FG001|Overall Study|Intrathecal catheter placement|1|||
28088301|NCT03258814|54741814|FG000|Overall Study|Early Termination|4|||
28088302|NCT03258814|54741815|FG001|Overall Study|Early Termination|3|||
28088303|NCT03258814|54741816|FG002|Overall Study|Early Termination|10|||
28088304|NCT03257410|54741825|FG000|Overall Study|Adverse Event|2|||
28088305|NCT03257410|54741826|FG001|Overall Study|Adverse Event|3|||
28088306|NCT03257410|54741825|FG000|Overall Study|Protocol Violation|1|||
28088307|NCT03257410|54741826|FG001|Overall Study|Protocol Violation|2|||
28088308|NCT03257410|54741825|FG000|Overall Study|Lost to Follow-up|1|||
28166132|NCT02505334|54836878|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
27980411|NCT00805935|54638327|FG001|Overall Study|Lost to Follow-up|0|||
27980412|NCT00805935|54638328|FG002|Overall Study|Lost to Follow-up|0|||
28088309|NCT03257410|54741826|FG001|Overall Study|Lost to Follow-up|0|||
28166133|NCT02505334|54836877|FG000|Extension Treatment Period|Unclassified|3|||
28166134|NCT02505334|54836878|FG001|Extension Treatment Period|Unclassified|0|||
28166135|NCT01062061|54836884|FG000|Overall Study|Enrolled more than once|2|||
27733435|NCT02688387|54181209|FG018|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
27733436|NCT02688387|54181210|FG019|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
27733437|NCT02688387|54181211|FG020|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
27733438|NCT02688387|54181212|FG021|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
27733439|NCT02688387|54181191|FG000|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
27733440|NCT02688387|54181192|FG001|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
27733441|NCT02688387|54181193|FG002|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
27733442|NCT02688387|54181194|FG003|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
27733443|NCT02688387|54181195|FG004|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
27733444|NCT02688387|54181196|FG005|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
27733445|NCT02688387|54181197|FG006|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
27733446|NCT02688387|54181198|FG007|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
27733447|NCT02688387|54181199|FG008|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
27832866|NCT01751867|54312836|FG000|Overall Study|Completed treatment,dropped in follow-up|4|||
27832867|NCT01751867|54312837|FG001|Overall Study|Completed treatment,dropped in follow-up|8|||
28166136|NCT01062061|54836884|FG000|Overall Study|Investigated before study start|13|||
28166137|NCT01062061|54836884|FG000|Overall Study|Outside chief indications|10|||
28166138|NCT01062061|54836884|FG000|Overall Study|Failed to meet inclusion criteria|2|||
28166139|NCT02504320|54836896|FG000|Treatment Period 1|Positive Drug Screen|0|||
28166140|NCT02504320|54836897|FG001|Treatment Period 1|Positive Drug Screen|0|||
28166141|NCT02504320|54836898|FG002|Treatment Period 1|Positive Drug Screen|1|||
28166142|NCT02504320|54836899|FG003|Treatment Period 1|Positive Drug Screen|0|||
28166143|NCT02504320|54836896|FG000|Treatment Period 2|Positive Drug Screen|0|||
28166144|NCT02504320|54836897|FG001|Treatment Period 2|Positive Drug Screen|1|||
28166145|NCT02504320|54836898|FG002|Treatment Period 2|Positive Drug Screen|0|||
28166146|NCT02504320|54836899|FG003|Treatment Period 2|Positive Drug Screen|0|||
28166147|NCT02504320|54836896|FG000|Treatment Period 3|Positive Drug Screen|0|||
28166148|NCT02504320|54836897|FG001|Treatment Period 3|Positive Drug Screen|0|||
28166149|NCT02504320|54836898|FG002|Treatment Period 3|Positive Drug Screen|0|||
28166150|NCT02504320|54836899|FG003|Treatment Period 3|Positive Drug Screen|1|||
28166151|NCT02504320|54836896|FG000|Treatment Period 3|Adverse Event|0|||
28166152|NCT02504320|54836897|FG001|Treatment Period 3|Adverse Event|0|||
27832868|NCT01751867|54312836|FG000|Overall Study|Diease Progression|4|||
27832869|NCT01751867|54312837|FG001|Overall Study|Diease Progression|18|||
28166153|NCT02504320|54836898|FG002|Treatment Period 3|Adverse Event|1|||
28166154|NCT02504320|54836899|FG003|Treatment Period 3|Adverse Event|0|||
28166155|NCT01061671|54836911|FG000|Overall Study|Withdrawal by Subject|16|||
28166156|NCT01061671|54836912|FG001|Overall Study|Withdrawal by Subject|20|||
27855704|NCT02733042|54382047|FG009|Treatment Period|Death|0|||
27855705|NCT02733042|54382048|FG010|Treatment Period|Death|1|||
27855706|NCT02733042|54382049|FG011|Treatment Period|Death|0|||
27855707|NCT02733042|54382050|FG012|Treatment Period|Death|0|||
27855708|NCT02733042|54382051|FG013|Treatment Period|Death|0|||
27855709|NCT02733042|54382052|FG014|Treatment Period|Death|1|||
27855710|NCT02733042|54382053|FG015|Treatment Period|Death|2|||
27855711|NCT02733042|54382054|FG016|Treatment Period|Death|0|||
28088310|NCT03257410|54741825|FG000|Overall Study|Withdrawal by Subject|1|||
28088311|NCT03257410|54741826|FG001|Overall Study|Withdrawal by Subject|2|||
28088312|NCT03257410|54741825|FG000|Overall Study|Physician Decision|1|||
28088313|NCT03257410|54741826|FG001|Overall Study|Physician Decision|1|||
28088314|NCT03257410|54741825|FG000|Overall Study|Renal transplantation|2|||
28088315|NCT03257410|54741826|FG001|Overall Study|Renal transplantation|0|||
28088316|NCT03257410|54741825|FG000|Overall Study|Switch to peritoneal dialysis|1|||
28088317|NCT03257410|54741826|FG001|Overall Study|Switch to peritoneal dialysis|0|||
28088318|NCT03257410|54741825|FG000|Overall Study|Death|3|||
28088319|NCT03257410|54741826|FG001|Overall Study|Death|2|||
28088320|NCT03257410|54741825|FG000|Overall Study|Change to another dialysis center|2|||
28088321|NCT03257410|54741826|FG001|Overall Study|Change to another dialysis center|2|||
28088322|NCT03257410|54741825|FG000|Overall Study|Missing 3 consecutive study treatments|5|||
28088323|NCT03257410|54741826|FG001|Overall Study|Missing 3 consecutive study treatments|6|||
28088324|NCT03257410|54741825|FG000|Overall Study|Miscellaneous|2|||
28088325|NCT03257410|54741826|FG001|Overall Study|Miscellaneous|2|||
28088326|NCT03257410|54741825|FG000|Overall Study|Other|0|||
28088327|NCT03257410|54741826|FG001|Overall Study|Other|1|||
28088328|NCT00056160|54741834|FG000|Up to Unblinding (07 Jun 2005)|Adverse Event|35|||
28088329|NCT00056160|54741835|FG001|Up to Unblinding (07 Jun 2005)|Adverse Event|18|||
28088330|NCT00056160|54741834|FG000|Up to Unblinding (07 Jun 2005)|Progression of disease|57|||
28088331|NCT00056160|54741835|FG001|Up to Unblinding (07 Jun 2005)|Progression of disease|124|||
28088332|NCT00056160|54741834|FG000|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3|||
28088333|NCT00056160|54741835|FG001|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5|||
28088334|NCT00056160|54741834|FG000|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
28088335|NCT00056160|54741835|FG001|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
28088336|NCT00056160|54741834|FG000|Up to Unblinding (07 Jun 2005)|Death|2|||
28088337|NCT00056160|54741835|FG001|Up to Unblinding (07 Jun 2005)|Death|1|||
28088338|NCT00056160|54741834|FG000|Up to Unblinding (07 Jun 2005)|Other|8|||
28088339|NCT00056160|54741835|FG001|Up to Unblinding (07 Jun 2005)|Other|7|||
28088340|NCT00056160|54741834|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44|||
28088341|NCT00056160|54741835|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0|||
28088342|NCT00056160|54741834|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87|||
28088343|NCT00056160|54741835|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0|||
28088344|NCT00056160|54741834|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3|||
28088345|NCT00056160|54741835|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0|||
28088346|NCT00056160|54741834|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11|||
28088347|NCT00056160|54741835|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0|||
28088348|NCT00056160|54741834|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Death|5|||
28088349|NCT00056160|54741835|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Death|0|||
28088350|NCT00056160|54741834|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Other|21|||
28088351|NCT00056160|54741835|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Other|0|||
28088352|NCT00056160|54741834|FG000|Final Follow-up|Transferred into expanded access study.|3|||
28088353|NCT00056160|54741835|FG001|Final Follow-up|Transferred into expanded access study.|0|||
28088354|NCT00056160|54741834|FG000|Final Follow-up|Transferred into RevAssist Program|2|||
28088355|NCT00056160|54741835|FG001|Final Follow-up|Transferred into RevAssist Program|0|||
28088356|NCT00056160|54741834|FG000|Final Follow-up|Adverse Event|1|||
28088357|NCT00056160|54741835|FG001|Final Follow-up|Adverse Event|0|||
28088358|NCT00061932|54741843|FG000|Overall Study|Withdrawal by Subject|13|||
28088359|NCT00061932|54741844|FG001|Overall Study|Withdrawal by Subject|4|||
28088360|NCT03280264|54741851|FG000|Overall Study|Adverse Event|1|||
28088361|NCT03280264|54741851|FG000|Overall Study|Physician Decision|1|||
28088362|NCT03280264|54741851|FG000|Overall Study|Withdrawal by Subject|1|||
28088363|NCT00060840|54741858|FG000|Overall Study|Change in surgical plan|2|||
28088364|NCT00060840|54741859|FG001|Overall Study|Change in surgical plan|6|||
28088365|NCT00060840|54741858|FG000|Overall Study|Death|0|||
28088366|NCT00060840|54741859|FG001|Overall Study|Death|1|||
28088367|NCT00060840|54741858|FG000|Overall Study|Withdrawal by Subject|0|||
28166157|NCT01061671|54836911|FG000|Overall Study|Lost to Follow-up|3|||
27855712|NCT02733042|54382055|FG017|Treatment Period|Death|0|||
28166158|NCT01061671|54836912|FG001|Overall Study|Lost to Follow-up|5|||
27855713|NCT02733042|54382056|FG018|Treatment Period|Death|0|||
27855714|NCT02733042|54382038|FG000|Follow-up Period|Ongoing on Follow-up|2|||
27855715|NCT02733042|54382039|FG001|Follow-up Period|Ongoing on Follow-up|2|||
27855716|NCT02733042|54382040|FG002|Follow-up Period|Ongoing on Follow-up|4|||
28088368|NCT00060840|54741859|FG001|Overall Study|Withdrawal by Subject|1|||
28166159|NCT01061671|54836911|FG000|Overall Study|Death|28|||
28088369|NCT00060840|54741858|FG000|Overall Study|Subinvestigator unavailable|0|||
28088370|NCT00060840|54741859|FG001|Overall Study|Subinvestigator unavailable|1|||
28088371|NCT00060840|54741858|FG000|Overall Study|Physician Decision|1|||
28088372|NCT00060840|54741859|FG001|Overall Study|Physician Decision|0|||
28088373|NCT00060840|54741858|FG000|Overall Study|Other|1|||
28088374|NCT00060840|54741859|FG001|Overall Study|Other|0|||
28088375|NCT03280108|54741867|FG000|Overall Study|Lost to Follow-up|2|||
28088376|NCT03280108|54741868|FG001|Overall Study|Lost to Follow-up|0|||
28088377|NCT00059202|54741881|FG000|Overall Study|Withdrawal by Subject|5|||
28088378|NCT00059202|54741882|FG001|Overall Study|Withdrawal by Subject|9|||
28088379|NCT00059202|54741881|FG000|Overall Study|Protocol Violation|1|||
28088380|NCT00059202|54741882|FG001|Overall Study|Protocol Violation|3|||
28088381|NCT00059202|54741881|FG000|Overall Study|drug toxicity|0|||
28088382|NCT00059202|54741882|FG001|Overall Study|drug toxicity|3|||
28088383|NCT03278626|54741891|FG000|Overall Study|Death|2|||
28088384|NCT03278626|54741891|FG000|Overall Study|Toxicity|1|||
28088385|NCT03278626|54741891|FG000|Overall Study|Disease Progression|2|||
28088386|NCT03277846|54741897|FG000|Overall Study|Inpatient stay too brief|12|||
28088387|NCT03277846|54741898|FG001|Overall Study|Inpatient stay too brief|11|||
28088388|NCT00073008|54741906|FG000|Overall Study|Missing|6|||
28088389|NCT00073008|54741907|FG001|Overall Study|Missing|6|||
28088390|NCT00073008|54741906|FG000|Overall Study|Withdrawal by Subject|2|||
28088391|NCT00073008|54741907|FG001|Overall Study|Withdrawal by Subject|2|||
28088392|NCT00073008|54741906|FG000|Overall Study|Lost to Follow-up|1|||
28088393|NCT00073008|54741907|FG001|Overall Study|Lost to Follow-up|3|||
28088394|NCT00073008|54741906|FG000|Overall Study|Death|46|||
28088395|NCT00073008|54741907|FG001|Overall Study|Death|47|||
28088396|NCT00073008|54741906|FG000|Overall Study|"Other selected on Case Report Form"|7|||
28088397|NCT00073008|54741907|FG001|Overall Study|"Other selected on Case Report Form"|5|||
28088398|NCT00058422|54741913|FG000|Overall Study|Not treated|2|||
28088399|NCT00072384|54741917|FG000|Overall Study|Physician Decision|1|||
28088400|NCT00072384|54741917|FG000|Overall Study|Ineligible|8|||
28088401|NCT00054132|54741923|FG000|Overall Study|Not Treated|1|||
28088402|NCT00071760|54741928|FG000|Overall Study|Adverse Event|3|||
28088403|NCT00071760|54741928|FG000|Overall Study|Lost to Follow-up|4|||
28088404|NCT00071760|54741928|FG000|Overall Study|Protocol Violation|1|||
28088405|NCT00071760|54741928|FG000|Overall Study|Withdrawal by Subject|3|||
28088406|NCT00071760|54741928|FG000|Overall Study|Insufficient Viral Load Response|3|||
28088407|NCT00071760|54741928|FG000|Overall Study|Pulmonary Tuberculosis|1|||
28088408|NCT00071760|54741928|FG000|Overall Study|Unavailability of RTV|8|||
28088409|NCT00071760|54741928|FG000|Overall Study|Relocation|1|||
28088410|NCT00071760|54741928|FG000|Overall Study|Investigator's Recommendation (Rec.)|4|||
28088411|NCT00071760|54741928|FG000|Overall Study|Study Team Rec./Resistance|1|||
28088412|NCT00071760|54741928|FG000|Overall Study|Ongoing|25|||
28088413|NCT00053898|54741940|FG000|Overall Study|No follow-up data from any source|9|||
28088414|NCT00053898|54741941|FG001|Overall Study|No follow-up data from any source|12|||
28088415|NCT00053898|54741940|FG000|Overall Study|Follow-up from telephone contact only|5|||
28088416|NCT00053898|54741941|FG001|Overall Study|Follow-up from telephone contact only|1|||
28088417|NCT03256552|54741977|FG000|Overall Study|Protocol Violation|1|||
28088418|NCT03256552|54741977|FG000|Overall Study|Physician Decision|1|||
28088419|NCT03256552|54741977|FG000|Overall Study|Adverse Event|1|||
28088420|NCT03256552|54741977|FG000|Overall Study|Withdrawal by Subject|2|||
28088421|NCT00071058|54741987|FG000|Overall Study|brain tumor-removed from study|1|||
28088422|NCT00053352|54741994|FG000|Overall Study|Lost to Follow-up|0|||
28088423|NCT00053352|54741995|FG001|Overall Study|Lost to Follow-up|1|||
28088424|NCT00053352|54741994|FG000|Overall Study|Physician Decision|11|||
28088425|NCT00053352|54741995|FG001|Overall Study|Physician Decision|1|||
28088426|NCT00053352|54741994|FG000|Overall Study|Withdrawal by Subject|1|||
28088427|NCT00053352|54741995|FG001|Overall Study|Withdrawal by Subject|0|||
28088428|NCT00053352|54741994|FG000|Overall Study|Ineligible|8|||
28088429|NCT00053352|54741995|FG001|Overall Study|Ineligible|8|||
28088430|NCT00053352|54741994|FG000|Overall Study|Disease at new site|1|||
28088431|NCT00053352|54741995|FG001|Overall Study|Disease at new site|0|||
28088432|NCT03245398|54742004|FG000|Overall Study|Travelled to another island|1|||
28088433|NCT03245398|54742005|FG001|Overall Study|Travelled to another island|0|||
28088434|NCT03244618|54742015|FG000|Overall Study|Lost to Follow-up|3|||
28088435|NCT03244618|54742016|FG001|Overall Study|Lost to Follow-up|4|||
28088436|NCT03244618|54742015|FG000|Overall Study|Protocol Violation|4|||
28088437|NCT03244618|54742016|FG001|Overall Study|Protocol Violation|3|||
28088438|NCT03244618|54742015|FG000|Overall Study|Withdrawal by Subject|0|||
28088439|NCT03244618|54742016|FG001|Overall Study|Withdrawal by Subject|2|||
28088440|NCT00052962|54742024|FG000|Overall Study|Not evaluable|0|||
28088441|NCT00052962|54742025|FG001|Overall Study|Not evaluable|2|||
28088442|NCT00052962|54742024|FG000|Overall Study|Not randomized/not evaluable|1|||
28088443|NCT00052962|54742025|FG001|Overall Study|Not randomized/not evaluable|0|||
28088444|NCT00051636|54742033|FG000|Period 1 - Core|Adverse Event|2|||
28088445|NCT00051636|54742034|FG001|Period 1 - Core|Adverse Event|2|||
28088446|NCT00051636|54742033|FG000|Period 1 - Core|Protocol Violation|1|||
28088447|NCT00051636|54742034|FG001|Period 1 - Core|Protocol Violation|0|||
28088448|NCT00051636|54742033|FG000|Period 1 - Core|Withdrawal by Subject|1|||
28088449|NCT00051636|54742034|FG001|Period 1 - Core|Withdrawal by Subject|2|||
28088450|NCT00051636|54742033|FG000|Period 1 - Core|Lost to Follow-up|0|||
28088451|NCT00051636|54742034|FG001|Period 1 - Core|Lost to Follow-up|2|||
27980413|NCT00805935|54638329|FG003|Overall Study|Lost to Follow-up|0|||
27980414|NCT00805935|54638326|FG000|Overall Study|No positive serum pregnancy|8|||
27980415|NCT00805935|54638327|FG001|Overall Study|No positive serum pregnancy|7|||
28088452|NCT00051636|54742033|FG000|Period 2- Extended Observation Period|Lost to Follow-up|5|||
28088453|NCT00051636|54742034|FG001|Period 2- Extended Observation Period|Lost to Follow-up|4|||
28088454|NCT00051636|54742033|FG000|Period 2- Extended Observation Period|withdrew for nonclinical reason|12|||
28088455|NCT00051636|54742034|FG001|Period 2- Extended Observation Period|withdrew for nonclinical reason|7|||
28088456|NCT00051636|54742033|FG000|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9|||
28088457|NCT00051636|54742034|FG001|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2|||
28088458|NCT00051636|54742033|FG000|Period 2- Extended Observation Period|Death|4|||
28088459|NCT00051636|54742034|FG001|Period 2- Extended Observation Period|Death|5|||
28088460|NCT00051636|54742033|FG000|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40|||
28088461|NCT00051636|54742034|FG001|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12|||
28088462|NCT03255382|54742042|FG000|Overall Study|Adverse Event|3|||
28088463|NCT03255382|54742043|FG001|Overall Study|Adverse Event|0|||
28088464|NCT03255382|54742042|FG000|Overall Study|Lost to Follow-up|2|||
28088465|NCT03255382|54742043|FG001|Overall Study|Lost to Follow-up|0|||
28088466|NCT03255382|54742042|FG000|Overall Study|Withdrawal by Subject|2|||
28088467|NCT03255382|54742043|FG001|Overall Study|Withdrawal by Subject|0|||
28088468|NCT03255382|54742042|FG000|Overall Study|Other|6|||
28088469|NCT03255382|54742043|FG001|Overall Study|Other|0|||
28088470|NCT03254602|54742050|FG000|Overall Study|Lost to Follow-up|4|||
28088471|NCT00038142|54742056|FG000|Overall Study|Ineligible|1|||
28088472|NCT00038142|54742057|FG001|Overall Study|Ineligible|0|||
28088473|NCT00038142|54742056|FG000|Overall Study|Progressive Disease|11|||
28088474|NCT00038142|54742057|FG001|Overall Study|Progressive Disease|7|||
28088475|NCT00038142|54742056|FG000|Overall Study|Death|1|||
28088476|NCT00038142|54742057|FG001|Overall Study|Death|0|||
28088477|NCT00038142|54742056|FG000|Overall Study|Adverse Event|1|||
28088478|NCT00038142|54742057|FG001|Overall Study|Adverse Event|0|||
28088479|NCT00038142|54742056|FG000|Overall Study|Unknown Reason|8|||
28088480|NCT00038142|54742057|FG001|Overall Study|Unknown Reason|0|||
28088481|NCT00366899|54742065|FG000|Infant Series|Withdrawal by Subject|4|||
28088482|NCT00366899|54742066|FG001|Infant Series|Withdrawal by Subject|7|||
28088483|NCT00366899|54742065|FG000|Infant Series|Protocol Violation|2|||
28088484|NCT00366899|54742066|FG001|Infant Series|Protocol Violation|1|||
28088485|NCT00366899|54742065|FG000|Infant Series|Failed to return|1|||
28088486|NCT00366899|54742066|FG001|Infant Series|Failed to return|1|||
28088487|NCT00366899|54742065|FG000|Infant Series|Lost to Follow-up|0|||
28088488|NCT00366899|54742066|FG001|Infant Series|Lost to Follow-up|2|||
28088489|NCT00366899|54742065|FG000|Infant Series|Adverse Event|0|||
28088490|NCT00366899|54742066|FG001|Infant Series|Adverse Event|1|||
28088491|NCT00366899|54742065|FG000|Infant Series|Physician Decision|1|||
28088492|NCT00366899|54742066|FG001|Infant Series|Physician Decision|0|||
27980416|NCT00805935|54638328|FG002|Overall Study|No positive serum pregnancy|6|||
27980417|NCT00805935|54638329|FG003|Overall Study|No positive serum pregnancy|5|||
27980418|NCT00805935|54638326|FG000|Overall Study|Pregnancy not confirmed by ultrasound|0|||
27980419|NCT00805935|54638327|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
27980420|NCT00805935|54638328|FG002|Overall Study|Pregnancy not confirmed by ultrasound|0|||
27980421|NCT00805935|54638329|FG003|Overall Study|Pregnancy not confirmed by ultrasound|1|||
27980422|NCT00805935|54638326|FG000|Overall Study|Pregnancy loss/miscarriage|2|||
27980423|NCT00805935|54638327|FG001|Overall Study|Pregnancy loss/miscarriage|0|||
27980424|NCT00805935|54638328|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
27980425|NCT00805935|54638329|FG003|Overall Study|Pregnancy loss/miscarriage|0|||
27980426|NCT00805935|54638326|FG000|Overall Study|Biochemical pregnancy|0|||
27980427|NCT00805935|54638327|FG001|Overall Study|Biochemical pregnancy|1|||
27980428|NCT00805935|54638328|FG002|Overall Study|Biochemical pregnancy|0|||
27980429|NCT00805935|54638329|FG003|Overall Study|Biochemical pregnancy|0|||
27980430|NCT00805935|54638326|FG000|Overall Study|Chemical pregnancy|0|||
28088493|NCT00366899|54742065|FG000|Infant Series|Randomized but not consented|1|||
27832870|NCT01751867|54312836|FG000|Overall Study|Adverse Event|8|||
27832871|NCT01751867|54312837|FG001|Overall Study|Adverse Event|15|||
27980431|NCT00805935|54638327|FG001|Overall Study|Chemical pregnancy|5|||
28088494|NCT00366899|54742066|FG001|Infant Series|Randomized but not consented|0|||
28088495|NCT00366899|54742065|FG000|After Infant Series|Lost to Follow-up|4|||
28088496|NCT00366899|54742066|FG001|After Infant Series|Lost to Follow-up|3|||
28088497|NCT00366899|54742065|FG000|After Infant Series|Withdrawal by Subject|1|||
28088498|NCT00366899|54742066|FG001|After Infant Series|Withdrawal by Subject|4|||
28088499|NCT00366899|54742065|FG000|After Infant Series|Adverse Event|1|||
27980432|NCT00805935|54638328|FG002|Overall Study|Chemical pregnancy|3|||
27980433|NCT00805935|54638329|FG003|Overall Study|Chemical pregnancy|2|||
28088500|NCT00366899|54742066|FG001|After Infant Series|Adverse Event|2|||
28088501|NCT00366899|54742065|FG000|After Infant Series|Protocol Violation|1|||
28088502|NCT00366899|54742066|FG001|After Infant Series|Protocol Violation|0|||
28088503|NCT00366899|54742065|FG000|Toddler Dose|Withdrawal by Subject|1|||
28088504|NCT00366899|54742066|FG001|Toddler Dose|Withdrawal by Subject|1|||
28088505|NCT00366899|54742065|FG000|Toddler Dose|Protocol Violation|1|||
28088506|NCT00366899|54742066|FG001|Toddler Dose|Protocol Violation|0|||
28088507|NCT03254134|54742100|FG000|Overall Study|Not eligible patients|599|||
28088508|NCT03254134|54742101|FG001|Overall Study|Not eligible patients|3630|||
28088509|NCT00037830|54742110|FG000|Overall Study|Adverse Event|2|||
28088510|NCT00037830|54742111|FG001|Overall Study|Adverse Event|0|||
28088511|NCT00037830|54742112|FG002|Overall Study|Adverse Event|0|||
28088512|NCT00037830|54742110|FG000|Overall Study|Withdrawal by Subject|4|||
28088513|NCT00037830|54742111|FG001|Overall Study|Withdrawal by Subject|5|||
28088514|NCT00037830|54742112|FG002|Overall Study|Withdrawal by Subject|1|||
28088515|NCT00037830|54742110|FG000|Overall Study|Protocol Violation|2|||
28088516|NCT00037830|54742111|FG001|Overall Study|Protocol Violation|2|||
28088517|NCT00037830|54742112|FG002|Overall Study|Protocol Violation|0|||
28088518|NCT00037830|54742110|FG000|Overall Study|Unrelated Medical Problem|2|||
28088519|NCT00037830|54742111|FG001|Overall Study|Unrelated Medical Problem|0|||
28088520|NCT00037830|54742112|FG002|Overall Study|Unrelated Medical Problem|0|||
28088521|NCT03242434|54742122|FG000|Overall Study|Death|0|||
28088522|NCT03242434|54742123|FG001|Overall Study|Death|2|||
28088523|NCT02939014|54742132|FG000|Overall Study|Lost to Follow-up|1|||
28088524|NCT02939014|54742133|FG001|Overall Study|Lost to Follow-up|0|||
28088525|NCT02939014|54742132|FG000|Overall Study|Death|4|||
28088526|NCT02939014|54742133|FG001|Overall Study|Death|3|||
28088527|NCT00051558|54742142|FG000|Overall Study|Adverse Event|30|||
28088528|NCT00051558|54742143|FG001|Overall Study|Adverse Event|18|||
28088529|NCT00051558|54742142|FG000|Overall Study|Withdrawal by Subject|29|||
28088530|NCT00051558|54742143|FG001|Overall Study|Withdrawal by Subject|42|||
28088531|NCT00051558|54742142|FG000|Overall Study|Death|9|||
28088532|NCT00051558|54742143|FG001|Overall Study|Death|15|||
28088533|NCT00051558|54742142|FG000|Overall Study|Lost to Follow-up|4|||
28088534|NCT00051558|54742143|FG001|Overall Study|Lost to Follow-up|13|||
28088535|NCT00051558|54742142|FG000|Overall Study|Protocol Violation|3|||
28088536|NCT00051558|54742143|FG001|Overall Study|Protocol Violation|4|||
28088537|NCT00051558|54742142|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
28088538|NCT00051558|54742143|FG001|Overall Study|Protocol Entry Criteria Unmet|2|||
28088539|NCT00051558|54742142|FG000|Overall Study|Sponsor Decision|6|||
28088540|NCT00051558|54742143|FG001|Overall Study|Sponsor Decision|1|||
28088541|NCT00051558|54742142|FG000|Overall Study|Other|2|||
28088542|NCT00051558|54742143|FG001|Overall Study|Other|1|||
28088543|NCT00051558|54742142|FG000|Overall Study|Significant Lab Value|2|||
28088544|NCT00051558|54742143|FG001|Overall Study|Significant Lab Value|0|||
28088545|NCT00051558|54742142|FG000|Overall Study|Physician Decision|5|||
28088546|NCT00051558|54742143|FG001|Overall Study|Physician Decision|0|||
28088547|NCT03251482|54742154|FG000|Overall Study|Withdrawal by Subject|0|||
28088548|NCT03251482|54742155|FG001|Overall Study|Withdrawal by Subject|1|||
28088549|NCT03251482|54742156|FG002|Overall Study|Withdrawal by Subject|0|||
28088550|NCT03251482|54742157|FG003|Overall Study|Withdrawal by Subject|0|||
28088551|NCT03251482|54742158|FG004|Overall Study|Withdrawal by Subject|0|||
28088552|NCT03249454|54742170|FG000|Overall Study|Withdrawal by Subject|0|||
28088553|NCT03249454|54742171|FG001|Overall Study|Withdrawal by Subject|0|||
28088554|NCT03249454|54742172|FG002|Overall Study|Withdrawal by Subject|0|||
28088555|NCT03249454|54742173|FG003|Overall Study|Withdrawal by Subject|0|||
28088556|NCT03249454|54742174|FG004|Overall Study|Withdrawal by Subject|0|||
28088557|NCT03249454|54742175|FG005|Overall Study|Withdrawal by Subject|0|||
28088558|NCT03249454|54742176|FG006|Overall Study|Withdrawal by Subject|0|||
28088559|NCT03249454|54742177|FG007|Overall Study|Withdrawal by Subject|0|||
28088560|NCT03249454|54742178|FG008|Overall Study|Withdrawal by Subject|0|||
28088561|NCT03249454|54742179|FG009|Overall Study|Withdrawal by Subject|1|||
28088562|NCT03249454|54742180|FG010|Overall Study|Withdrawal by Subject|1|||
28088563|NCT03732248|54742193|FG000|Overall Study|Withdrawal by Subject|1|||
28088564|NCT03732248|54742194|FG001|Overall Study|Withdrawal by Subject|0|||
28088565|NCT00310037|54742202|FG000|Overall Study|Adverse Event|7|||
28088566|NCT00310037|54742203|FG001|Overall Study|Adverse Event|14|||
28088567|NCT00310037|54742202|FG000|Overall Study|Withdrawal by Subject|4|||
28088568|NCT00310037|54742203|FG001|Overall Study|Withdrawal by Subject|3|||
28088569|NCT00310037|54742202|FG000|Overall Study|Progression|6|||
28088570|NCT00310037|54742203|FG001|Overall Study|Progression|0|||
28088571|NCT00310037|54742202|FG000|Overall Study|Non-protocol treatment|1|||
28088572|NCT00310037|54742203|FG001|Overall Study|Non-protocol treatment|0|||
28088573|NCT00309959|54742209|FG000|Overall Study|Ineligible - no prior chemotherapy|2|||
28088574|NCT03238924|54742220|FG000|Overall Study|Withdrawal by Subject|2|||
28088575|NCT03238924|54742221|FG001|Overall Study|Withdrawal by Subject|2|||
28088576|NCT03247816|54742227|FG000|Overall Study|Adverse Event|12|||
28088577|NCT03247816|54742227|FG000|Overall Study|Physician Decision|3|||
28088578|NCT03247816|54742227|FG000|Overall Study|Lack of Efficacy|1|||
28088579|NCT03247816|54742227|FG000|Overall Study|Lost to Follow-up|10|||
28088580|NCT03247816|54742227|FG000|Overall Study|Missing Feraccru stop date|3|||
28088581|NCT00333359|54742245|FG000|Overall Study|Adverse Event|29|||
28088582|NCT00333359|54742246|FG001|Overall Study|Adverse Event|35|||
28088583|NCT00333359|54742245|FG000|Overall Study|Withdrawal by Subject|19|||
28088584|NCT00333359|54742246|FG001|Overall Study|Withdrawal by Subject|37|||
28088585|NCT00333359|54742245|FG000|Overall Study|Physician Decision|2|||
28088586|NCT00333359|54742246|FG001|Overall Study|Physician Decision|2|||
28088587|NCT00333359|54742245|FG000|Overall Study|Protocol Non-compliance|2|||
28088588|NCT00333359|54742246|FG001|Overall Study|Protocol Non-compliance|8|||
28088589|NCT00333359|54742245|FG000|Overall Study|Lost to Follow-up|15|||
28088590|NCT00333359|54742246|FG001|Overall Study|Lost to Follow-up|25|||
28088591|NCT00333359|54742245|FG000|Overall Study|Termination or Withdrawal by Sponsor|1|||
28088592|NCT00333359|54742246|FG001|Overall Study|Termination or Withdrawal by Sponsor|1|||
28088593|NCT00333359|54742245|FG000|Overall Study|Treatment Failure|3|||
28088594|NCT00333359|54742246|FG001|Overall Study|Treatment Failure|8|||
28088595|NCT00333359|54742245|FG000|Overall Study|Withdrew before Receiving One Dose|2|||
28088596|NCT00333359|54742246|FG001|Overall Study|Withdrew before Receiving One Dose|6|||
28088597|NCT03246724|54742258|FG000|Overall Study|Withdrawal by Subject|5|||
28088598|NCT03246724|54742259|FG001|Overall Study|Withdrawal by Subject|2|||
28088599|NCT03246724|54742260|FG002|Overall Study|Withdrawal by Subject|4|||
28088600|NCT03246724|54742261|FG003|Overall Study|Withdrawal by Subject|2|||
28088601|NCT03246724|54742258|FG000|Overall Study|Ineligible on day of surgery|7|||
28088602|NCT03246724|54742259|FG001|Overall Study|Ineligible on day of surgery|2|||
28088603|NCT03246724|54742260|FG002|Overall Study|Ineligible on day of surgery|0|||
28088604|NCT03246724|54742261|FG003|Overall Study|Ineligible on day of surgery|3|||
28088605|NCT03246724|54742258|FG000|Overall Study|Study completed before surgical date|2|||
28088606|NCT03246724|54742259|FG001|Overall Study|Study completed before surgical date|1|||
28088607|NCT03246724|54742260|FG002|Overall Study|Study completed before surgical date|8|||
28088608|NCT03246724|54742261|FG003|Overall Study|Study completed before surgical date|1|||
28088609|NCT03246724|54742258|FG000|Overall Study|Transferred to other arm|0|||
28088610|NCT03246724|54742259|FG001|Overall Study|Transferred to other arm|0|||
28088611|NCT03246724|54742260|FG002|Overall Study|Transferred to other arm|1|||
28088612|NCT03246724|54742261|FG003|Overall Study|Transferred to other arm|0|||
28088613|NCT03246724|54742258|FG000|Overall Study|Unable to obtain medication timely|0|||
28088614|NCT03246724|54742259|FG001|Overall Study|Unable to obtain medication timely|2|||
28088615|NCT03246724|54742260|FG002|Overall Study|Unable to obtain medication timely|2|||
28088616|NCT03246724|54742261|FG003|Overall Study|Unable to obtain medication timely|1|||
28088617|NCT03246724|54742258|FG000|Overall Study|Re-consented to participate|0|||
28088618|NCT03246724|54742259|FG001|Overall Study|Re-consented to participate|0|||
28088619|NCT03246724|54742260|FG002|Overall Study|Re-consented to participate|0|||
28088620|NCT03246724|54742261|FG003|Overall Study|Re-consented to participate|1|||
28088621|NCT03246646|54742273|FG000|Overall Study|deemed ineligible and administratively withdrawn|1|||
28088622|NCT03246646|54742274|FG001|Overall Study|deemed ineligible and administratively withdrawn|0|||
28088623|NCT03246646|54742273|FG000|Overall Study|Withdrawal by Subject|3|||
27733448|NCT02688387|54181200|FG009|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
27733449|NCT02688387|54181201|FG010|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
27733450|NCT02688387|54181202|FG011|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
27733451|NCT02688387|54181203|FG012|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
27733452|NCT02688387|54181204|FG013|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
27733453|NCT02688387|54181205|FG014|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
27733454|NCT02688387|54181206|FG015|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
27733455|NCT02688387|54181207|FG016|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
27733456|NCT02688387|54181208|FG017|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
27733457|NCT02688387|54181209|FG018|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
27733458|NCT02688387|54181210|FG019|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
27733459|NCT02688387|54181211|FG020|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
27733460|NCT02688387|54181212|FG021|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
27733461|NCT02688387|54181191|FG000|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1|||
28088624|NCT03246646|54742274|FG001|Overall Study|Withdrawal by Subject|0|||
28088625|NCT03246646|54742273|FG000|Overall Study|Lost to Follow-up|7|||
28088626|NCT03246646|54742274|FG001|Overall Study|Lost to Follow-up|0|||
28088627|NCT01347112|54742282|FG000|Overall Study|Withdrawal by Subject|1|||
28088628|NCT01347112|54742283|FG001|Overall Study|Withdrawal by Subject|7|||
28088629|NCT01347112|54742282|FG000|Overall Study|Lost to Follow-up|3|||
28088630|NCT01347112|54742283|FG001|Overall Study|Lost to Follow-up|5|||
28088631|NCT00308711|54742293|FG000|Overall Study|Withdrawal by Subject|1|||
28088632|NCT00308711|54742294|FG001|Overall Study|Withdrawal by Subject|0|||
28166160|NCT01061671|54836912|FG001|Overall Study|Death|30|||
28088633|NCT00308711|54742295|FG002|Overall Study|Withdrawal by Subject|1|||
28088634|NCT00308711|54742293|FG000|Overall Study|Protocol Violation|0|||
28088635|NCT00308711|54742294|FG001|Overall Study|Protocol Violation|1|||
28088636|NCT00308711|54742295|FG002|Overall Study|Protocol Violation|1|||
28088637|NCT00308711|54742293|FG000|Overall Study|Lost to Follow-up|0|||
28088638|NCT00308711|54742294|FG001|Overall Study|Lost to Follow-up|1|||
28088639|NCT00308711|54742295|FG002|Overall Study|Lost to Follow-up|0|||
28088640|NCT00308711|54742293|FG000|Overall Study|Baby not born within 7 days of treatment|1|||
28088641|NCT00308711|54742294|FG001|Overall Study|Baby not born within 7 days of treatment|2|||
28088642|NCT00308711|54742295|FG002|Overall Study|Baby not born within 7 days of treatment|2|||
28088643|NCT00308711|54742293|FG000|Overall Study|Subject incarcerated, data not allowed|0|||
28088644|NCT00308711|54742294|FG001|Overall Study|Subject incarcerated, data not allowed|0|||
28088645|NCT00308711|54742295|FG002|Overall Study|Subject incarcerated, data not allowed|1|||
28088646|NCT00308555|54742305|FG000|Overall Study|Withdrawal by Subject|1|||
28088647|NCT00308555|54742306|FG001|Overall Study|Withdrawal by Subject|0|||
28088648|NCT00308555|54742305|FG000|Overall Study|Physician Decision|2|||
28088649|NCT00308555|54742306|FG001|Overall Study|Physician Decision|0|||
28088650|NCT00050778|54742315|FG000|Overall Study|Adverse Event|13|||
28088651|NCT00050778|54742316|FG001|Overall Study|Adverse Event|3|||
28088652|NCT00050778|54742317|FG002|Overall Study|Adverse Event|2|||
28088653|NCT00050778|54742315|FG000|Overall Study|Death|0|||
28088654|NCT00050778|54742316|FG001|Overall Study|Death|1|||
28088655|NCT00050778|54742317|FG002|Overall Study|Death|1|||
28088656|NCT00050778|54742315|FG000|Overall Study|Lack of Efficacy|16|||
28088657|NCT00050778|54742316|FG001|Overall Study|Lack of Efficacy|2|||
28088658|NCT00050778|54742317|FG002|Overall Study|Lack of Efficacy|2|||
28088659|NCT00050778|54742315|FG000|Overall Study|Lost to Follow-up|0|||
28088660|NCT00050778|54742316|FG001|Overall Study|Lost to Follow-up|2|||
27980434|NCT00805935|54638326|FG000|Overall Study|Ectopic pregnancy|0|||
27980435|NCT00805935|54638327|FG001|Overall Study|Ectopic pregnancy|0|||
27980436|NCT00805935|54638328|FG002|Overall Study|Ectopic pregnancy|1|||
27980437|NCT00805935|54638329|FG003|Overall Study|Ectopic pregnancy|0|||
27980438|NCT00805935|54638326|FG000|Overall Study|Serious Adverse Event-congenital anomaly|0|||
27980439|NCT00805935|54638327|FG001|Overall Study|Serious Adverse Event-congenital anomaly|1|||
27980440|NCT00805935|54638328|FG002|Overall Study|Serious Adverse Event-congenital anomaly|0|||
27980441|NCT00805935|54638329|FG003|Overall Study|Serious Adverse Event-congenital anomaly|0|||
27980442|NCT00805545|54638343|FG000|Overall Study|Protocol Violation|3|||
28088661|NCT00050778|54742317|FG002|Overall Study|Lost to Follow-up|4|||
28088662|NCT00050778|54742315|FG000|Overall Study|Physician Decision|3|||
28088663|NCT00050778|54742316|FG001|Overall Study|Physician Decision|0|||
28088664|NCT00050778|54742317|FG002|Overall Study|Physician Decision|2|||
28088665|NCT00050778|54742315|FG000|Overall Study|Protocol Violation|2|||
28088666|NCT00050778|54742316|FG001|Overall Study|Protocol Violation|0|||
28088667|NCT00050778|54742317|FG002|Overall Study|Protocol Violation|1|||
28088668|NCT00050778|54742315|FG000|Overall Study|Withdrawal by Subject|6|||
28088669|NCT00050778|54742316|FG001|Overall Study|Withdrawal by Subject|8|||
28088670|NCT00050778|54742317|FG002|Overall Study|Withdrawal by Subject|4|||
28088671|NCT00050778|54742315|FG000|Overall Study|Randomized but not treated|4|||
28088672|NCT00050778|54742316|FG001|Overall Study|Randomized but not treated|5|||
28088673|NCT00050778|54742317|FG002|Overall Study|Randomized but not treated|2|||
28088674|NCT00050778|54742315|FG000|Overall Study|Familial and personal reasons|1|||
28088675|NCT00050778|54742316|FG001|Overall Study|Familial and personal reasons|0|||
28088676|NCT00050778|54742317|FG002|Overall Study|Familial and personal reasons|0|||
28088677|NCT00050622|54742327|FG000|Overall Study|Adverse Event|1|||
28088678|NCT00308087|54742353|FG000|Overall Study|Progressive Disease|19|||
28088679|NCT00308087|54742354|FG001|Overall Study|Progressive Disease|21|||
28088680|NCT00308087|54742353|FG000|Overall Study|Study Closure|11|||
28088681|NCT00308087|54742354|FG001|Overall Study|Study Closure|12|||
28088682|NCT00308087|54742353|FG000|Overall Study|Withdrawal by Subject|2|||
28088683|NCT00308087|54742354|FG001|Overall Study|Withdrawal by Subject|1|||
28088684|NCT00308087|54742353|FG000|Overall Study|Other|4|||
28088685|NCT00308087|54742354|FG001|Overall Study|Other|3|||
28088686|NCT00307931|54742360|FG000|Overall Study|Adverse Event|1|||
28088687|NCT02796170|54742366|FG000|Overall Study|Lost to Follow-up|3|||
28088688|NCT02796170|54742367|FG001|Overall Study|Lost to Follow-up|0|||
28088689|NCT00049842|54742375|FG000|Treatment Phase|Adverse Event|47|||
28088690|NCT00049842|54742376|FG001|Treatment Phase|Adverse Event|12|||
28088691|NCT00049842|54742375|FG000|Treatment Phase|Withdrawal by Subject|35|||
28088692|NCT00049842|54742376|FG001|Treatment Phase|Withdrawal by Subject|46|||
28088693|NCT00049842|54742375|FG000|Treatment Phase|Non-compliance with protocol|7|||
28088694|NCT00049842|54742376|FG001|Treatment Phase|Non-compliance with protocol|8|||
28088695|NCT00049842|54742375|FG000|Treatment Phase|Lost to Follow-up|4|||
28088696|NCT00049842|54742376|FG001|Treatment Phase|Lost to Follow-up|8|||
27980443|NCT00805545|54638344|FG001|Overall Study|Protocol Violation|2|||
28088697|NCT00049842|54742375|FG000|Treatment Phase|Administrative|0|||
28088698|NCT00049842|54742376|FG001|Treatment Phase|Administrative|3|||
28088699|NCT00049842|54742375|FG000|Treatment Phase|Did not meet protocol eligibility|0|||
28088700|NCT00049842|54742376|FG001|Treatment Phase|Did not meet protocol eligibility|1|||
28088701|NCT00049842|54742375|FG000|Follow-up Phase|Adverse Event|6|||
28088702|NCT00049842|54742376|FG001|Follow-up Phase|Adverse Event|1|||
28088703|NCT00049842|54742375|FG000|Follow-up Phase|Other|1|||
28088704|NCT00049842|54742376|FG001|Follow-up Phase|Other|4|||
28088705|NCT00307151|54742386|FG000|Overall Study|Death|4|||
28088706|NCT00307151|54742387|FG001|Overall Study|Death|3|||
28088707|NCT00307151|54742388|FG002|Overall Study|Death|10|||
27733462|NCT02688387|54181192|FG001|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
27733463|NCT02688387|54181193|FG002|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
27733464|NCT02688387|54181194|FG003|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
27733465|NCT02688387|54181195|FG004|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
27733466|NCT02688387|54181196|FG005|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
27980444|NCT00805545|54638343|FG000|Overall Study|Protocol Violation|3|||
28088708|NCT00307151|54742389|FG003|Overall Study|Death|3|||
28088709|NCT00307151|54742386|FG000|Overall Study|Severe debilitation, unable to continue|1|||
28088710|NCT00307151|54742387|FG001|Overall Study|Severe debilitation, unable to continue|0|||
28088711|NCT00307151|54742388|FG002|Overall Study|Severe debilitation, unable to continue|0|||
28088712|NCT00307151|54742389|FG003|Overall Study|Severe debilitation, unable to continue|0|||
28088713|NCT00307151|54742386|FG000|Overall Study|Subject unable to get to clinic|1|||
28088714|NCT00307151|54742387|FG001|Overall Study|Subject unable to get to clinic|0|||
28088715|NCT00307151|54742388|FG002|Overall Study|Subject unable to get to clinic|6|||
28088716|NCT00307151|54742389|FG003|Overall Study|Subject unable to get to clinic|2|||
28088717|NCT00307151|54742386|FG000|Overall Study|Withdrew consent|0|||
28088718|NCT00307151|54742387|FG001|Overall Study|Withdrew consent|1|||
28088719|NCT00307151|54742388|FG002|Overall Study|Withdrew consent|1|||
28088720|NCT00307151|54742389|FG003|Overall Study|Withdrew consent|3|||
28088721|NCT00307151|54742386|FG000|Overall Study|Not willing to adhere to study reqs|2|||
28088722|NCT00307151|54742387|FG001|Overall Study|Not willing to adhere to study reqs|0|||
28088723|NCT00307151|54742388|FG002|Overall Study|Not willing to adhere to study reqs|2|||
28088724|NCT00307151|54742389|FG003|Overall Study|Not willing to adhere to study reqs|2|||
28088725|NCT00307151|54742386|FG000|Overall Study|Clinic unable to contact subject|3|||
28088726|NCT00307151|54742387|FG001|Overall Study|Clinic unable to contact subject|3|||
28088727|NCT00307151|54742388|FG002|Overall Study|Clinic unable to contact subject|1|||
28088728|NCT00307151|54742389|FG003|Overall Study|Clinic unable to contact subject|1|||
28088729|NCT02654132|54742401|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
27733467|NCT02688387|54181197|FG006|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
27980445|NCT00805545|54638344|FG001|Overall Study|Protocol Violation|1|||
27980446|NCT00590031|54638376|FG000|Overall Study|Adverse Event|3|||
27980447|NCT00590031|54638376|FG000|Overall Study|Withdrawal by Subject|1|||
27980448|NCT00590031|54638376|FG000|Overall Study|Metastatic Disease|1|||
27980449|NCT00590031|54638376|FG000|Overall Study|Admin Hold|1|||
27980450|NCT00615199|54638384|FG000|Overall Study|Adverse Event|3|||
27980451|NCT00615199|54638385|FG001|Overall Study|Adverse Event|1|||
27980452|NCT00615199|54638386|FG002|Overall Study|Adverse Event|1|||
27980453|NCT00615199|54638387|FG003|Overall Study|Adverse Event|0|||
27980454|NCT00615199|54638384|FG000|Overall Study|Lack of Efficacy|2|||
27980455|NCT00615199|54638385|FG001|Overall Study|Lack of Efficacy|0|||
27980456|NCT00615199|54638386|FG002|Overall Study|Lack of Efficacy|0|||
27980457|NCT00615199|54638387|FG003|Overall Study|Lack of Efficacy|1|||
27980458|NCT00615199|54638384|FG000|Overall Study|Lost to Follow-up|1|||
27980459|NCT00615199|54638385|FG001|Overall Study|Lost to Follow-up|0|||
27980460|NCT00615199|54638386|FG002|Overall Study|Lost to Follow-up|0|||
27980461|NCT00615199|54638387|FG003|Overall Study|Lost to Follow-up|0|||
27980462|NCT00615199|54638384|FG000|Overall Study|Other|0|||
27980463|NCT00615199|54638385|FG001|Overall Study|Other|0|||
27980464|NCT00615199|54638386|FG002|Overall Study|Other|0|||
27980465|NCT00615199|54638387|FG003|Overall Study|Other|1|||
27980466|NCT00615199|54638384|FG000|Overall Study|Withdrawal by Subject|2|||
27980467|NCT00615199|54638385|FG001|Overall Study|Withdrawal by Subject|1|||
27980468|NCT00615199|54638386|FG002|Overall Study|Withdrawal by Subject|0|||
27980469|NCT00615199|54638387|FG003|Overall Study|Withdrawal by Subject|0|||
27980470|NCT00613951|54638400|FG000|Overall Study|Adverse Event|1|||
27980471|NCT00613951|54638401|FG001|Overall Study|Adverse Event|0|||
27980472|NCT00613951|54638402|FG002|Overall Study|Adverse Event|1|||
27832872|NCT01751867|54312836|FG000|Overall Study|Poor Compliance|0|||
28088730|NCT02654132|54742402|FG001|Pre-Treatment Period|Participant Withdrew Consent|2|||
28088731|NCT02654132|54742401|FG000|Treatment Period|Disease progression|43|||
28088732|NCT02654132|54742402|FG001|Treatment Period|Disease progression|38|||
27832873|NCT01751867|54312837|FG001|Overall Study|Poor Compliance|5|||
27980473|NCT00613951|54638400|FG000|Overall Study|Lack of Efficacy|0|||
27980474|NCT00613951|54638401|FG001|Overall Study|Lack of Efficacy|1|||
27980475|NCT00613951|54638402|FG002|Overall Study|Lack of Efficacy|1|||
27980476|NCT00613951|54638400|FG000|Overall Study|Protocol Violation|1|||
27980477|NCT00613951|54638401|FG001|Overall Study|Protocol Violation|1|||
27980478|NCT00613951|54638402|FG002|Overall Study|Protocol Violation|1|||
27980479|NCT00613951|54638400|FG000|Overall Study|Unclassified|5|||
27980480|NCT00613951|54638401|FG001|Overall Study|Unclassified|3|||
27980481|NCT00613951|54638402|FG002|Overall Study|Unclassified|2|||
27980482|NCT00805467|54638417|FG000|Overall Study|Lack of Efficacy|0|||
27980483|NCT00805467|54638418|FG001|Overall Study|Lack of Efficacy|8|||
27980484|NCT00805467|54638419|FG002|Overall Study|Lack of Efficacy|13|||
27980485|NCT00805467|54638420|FG003|Overall Study|Lack of Efficacy|86|||
27980486|NCT00805467|54638417|FG000|Overall Study|Lost to Follow-up|0|||
27980487|NCT00805467|54638418|FG001|Overall Study|Lost to Follow-up|1|||
27980488|NCT00805467|54638419|FG002|Overall Study|Lost to Follow-up|7|||
28088733|NCT02654132|54742401|FG000|Treatment Period|Adverse Event unrelated to study drug|6|||
28088734|NCT02654132|54742402|FG001|Treatment Period|Adverse Event unrelated to study drug|9|||
28088735|NCT02654132|54742401|FG000|Treatment Period|Other reasons|4|||
28088736|NCT02654132|54742402|FG001|Treatment Period|Other reasons|2|||
28088737|NCT02654132|54742401|FG000|Treatment Period|Study drug toxicity|2|||
28088738|NCT02654132|54742402|FG001|Treatment Period|Study drug toxicity|2|||
28088739|NCT02654132|54742401|FG000|Treatment Period|Withdrawal by Subject|2|||
28088740|NCT02654132|54742402|FG001|Treatment Period|Withdrawal by Subject|1|||
28088741|NCT02654132|54742401|FG000|Treatment Period|Maximum Clinical Benefit|0|||
28088742|NCT02654132|54742402|FG001|Treatment Period|Maximum Clinical Benefit|2|||
28088743|NCT02654132|54742401|FG000|Treatment Period|Participant request to discontinue|2|||
28088744|NCT02654132|54742402|FG001|Treatment Period|Participant request to discontinue|0|||
28088745|NCT02654132|54742401|FG000|Treatment Period|Administrative reasons by sponsor|0|||
28088746|NCT02654132|54742402|FG001|Treatment Period|Administrative reasons by sponsor|1|||
28088747|NCT02654132|54742401|FG000|Treatment Period|Death|1|||
28088748|NCT02654132|54742402|FG001|Treatment Period|Death|0|||
28088749|NCT03241342|54742411|FG000|Overall Study|Adverse Event|5|||
28088750|NCT03241342|54742412|FG001|Overall Study|Adverse Event|8|||
28088751|NCT03241342|54742413|FG002|Overall Study|Adverse Event|4|||
28088752|NCT03241342|54742411|FG000|Overall Study|Lack of Efficacy|0|||
28088753|NCT03241342|54742412|FG001|Overall Study|Lack of Efficacy|0|||
28088754|NCT03241342|54742413|FG002|Overall Study|Lack of Efficacy|1|||
28088755|NCT03241342|54742411|FG000|Overall Study|noncompliance with study drug|2|||
28088756|NCT03241342|54742412|FG001|Overall Study|noncompliance with study drug|1|||
28088757|NCT03241342|54742413|FG002|Overall Study|noncompliance with study drug|1|||
28088758|NCT03241342|54742411|FG000|Overall Study|sponsor decision|0|||
28088759|NCT03241342|54742412|FG001|Overall Study|sponsor decision|1|||
28088760|NCT03241342|54742413|FG002|Overall Study|sponsor decision|2|||
28088761|NCT03241342|54742411|FG000|Overall Study|not reported|15|||
28088762|NCT03241342|54742412|FG001|Overall Study|not reported|21|||
28088763|NCT03241342|54742413|FG002|Overall Study|not reported|19|||
28088764|NCT00306995|54742428|FG000|Study Part I|Withdrawal by Subject|0|||
28088765|NCT00306995|54742429|FG001|Study Part I|Withdrawal by Subject|0|||
28088766|NCT00306995|54742430|FG002|Study Part I|Withdrawal by Subject|0|||
28088767|NCT00306995|54742431|FG003|Study Part I|Withdrawal by Subject|0|||
28088768|NCT00306995|54742432|FG004|Study Part I|Withdrawal by Subject|0|||
28088769|NCT00306995|54742433|FG005|Study Part I|Withdrawal by Subject|0|||
28088770|NCT00306995|54742434|FG006|Study Part I|Withdrawal by Subject|1|||
28088771|NCT00306995|54742428|FG000|Study Part II for Subset 2|Serious Adverse Event|0|||
27832874|NCT01751867|54312836|FG000|Overall Study|Withdrawal by Subject|3|||
27832875|NCT01751867|54312837|FG001|Overall Study|Withdrawal by Subject|1|||
27832876|NCT01751867|54312836|FG000|Overall Study|Physician Decision|4|||
27832877|NCT01751867|54312837|FG001|Overall Study|Physician Decision|7|||
27832878|NCT01751867|54312836|FG000|Overall Study|Protocol Violation|0|||
27832879|NCT01751867|54312837|FG001|Overall Study|Protocol Violation|2|||
27832880|NCT01751867|54312836|FG000|Overall Study|Death|0|||
27832881|NCT01751867|54312837|FG001|Overall Study|Death|5|||
27832882|NCT01751867|54312836|FG000|Overall Study|Other|11|||
27832883|NCT01751867|54312837|FG001|Overall Study|Other|37|||
27832884|NCT01751867|54312836|FG000|Overall Study|Randomized but not treated.|2|||
28088772|NCT00306995|54742429|FG001|Study Part II for Subset 2|Serious Adverse Event|1|||
28088773|NCT00306995|54742430|FG002|Study Part II for Subset 2|Serious Adverse Event|0|||
28088774|NCT00306995|54742431|FG003|Study Part II for Subset 2|Serious Adverse Event|0|||
28088775|NCT00306995|54742432|FG004|Study Part II for Subset 2|Serious Adverse Event|0|||
28088776|NCT00306995|54742433|FG005|Study Part II for Subset 2|Serious Adverse Event|0|||
28088777|NCT00306995|54742434|FG006|Study Part II for Subset 2|Serious Adverse Event|0|||
28088778|NCT00121108|54742481|FG000|Overall Study|Lost to Follow-up|10|||
28088779|NCT00121108|54742482|FG001|Overall Study|Lost to Follow-up|22|||
27832885|NCT01751867|54312837|FG001|Overall Study|Randomized but not treated.|1|||
27832886|NCT01751165|54312863|FG000|Overall Study|Adverse event, serious fatal|1|||
28088780|NCT00121108|54742481|FG000|Overall Study|Withdrawal by Subject|106|||
28088781|NCT00121108|54742482|FG001|Overall Study|Withdrawal by Subject|195|||
28088782|NCT00121108|54742481|FG000|Overall Study|Death|5|||
27832887|NCT01751165|54312864|FG001|Overall Study|Adverse event, serious fatal|0|||
27980489|NCT00805467|54638420|FG003|Overall Study|Lost to Follow-up|21|||
27980490|NCT00805467|54638417|FG000|Overall Study|Withdrawal by Subject|0|||
27980491|NCT00805467|54638418|FG001|Overall Study|Withdrawal by Subject|6|||
27980492|NCT00805467|54638419|FG002|Overall Study|Withdrawal by Subject|45|||
28088783|NCT00121108|54742482|FG001|Overall Study|Death|8|||
28088784|NCT02387996|54742489|FG000|Overall Study|Disease Progression|167|||
28088785|NCT02387996|54742489|FG000|Overall Study|Study Drug Toxicity|31|||
28088786|NCT02387996|54742489|FG000|Overall Study|Adverse Event Unrelated to Study Drug|39|||
28088787|NCT02387996|54742489|FG000|Overall Study|Participant Request to Discontinue Treatment|20|||
28088788|NCT02387996|54742489|FG000|Overall Study|Subject Withdrew Consent|5|||
28088789|NCT02387996|54742489|FG000|Overall Study|Lost to Follow-up|1|||
28088790|NCT02387996|54742489|FG000|Overall Study|Poor/Non-Compliance|1|||
28088791|NCT02387996|54742489|FG000|Overall Study|Other Reasons|5|||
28088792|NCT02387996|54742489|FG000|Overall Study|Death|1|||
28088793|NCT03212326|54742493|FG000|Overall Study|Physician Decision|4|||
28088794|NCT03229486|54742499|FG000|Overall Study|Protocol Violation|0|||
27832888|NCT01751165|54312865|FG002|Overall Study|Adverse event, serious fatal|1|||
27832889|NCT01751165|54312863|FG000|Overall Study|Withdrawal by Subject|0|||
27832890|NCT01751165|54312864|FG001|Overall Study|Withdrawal by Subject|0|||
27832891|NCT01751165|54312865|FG002|Overall Study|Withdrawal by Subject|1|||
27832892|NCT01751165|54312863|FG000|Overall Study|Serious adverse event|0|||
27832893|NCT01751165|54312864|FG001|Overall Study|Serious adverse event|2|||
27832894|NCT01751165|54312865|FG002|Overall Study|Serious adverse event|0|||
27832895|NCT01751165|54312863|FG000|Overall Study|Lost to Follow-up|1|||
27832896|NCT01751165|54312864|FG001|Overall Study|Lost to Follow-up|1|||
27832897|NCT01751165|54312865|FG002|Overall Study|Lost to Follow-up|1|||
27832898|NCT01751087|54312890|FG000|Overall Study|Withdrawal by Subject|1|||
27832899|NCT01751087|54312891|FG001|Overall Study|Withdrawal by Subject|0|||
27832900|NCT01751087|54312892|FG002|Overall Study|Withdrawal by Subject|0|||
27832901|NCT01751087|54312890|FG000|Overall Study|Physician Decision|0|||
27832902|NCT01751087|54312891|FG001|Overall Study|Physician Decision|0|||
27832903|NCT01751087|54312892|FG002|Overall Study|Physician Decision|1|||
27832904|NCT01750697|54312900|FG000|Overall Study|Transferred Back to Local Hospital|1|||
27832905|NCT01750697|54312900|FG000|Overall Study|Physician and Family Decision|1|||
27832906|NCT01750697|54312900|FG000|Overall Study|Transferred to Adult Services|5|||
27832907|NCT01750697|54312900|FG000|Overall Study|Physician Decision|1|||
27832908|NCT01750697|54312900|FG000|Overall Study|Withdrawal by Subject|1|||
27832909|NCT01750229|54312911|FG000|Randomized Crossover Phase|Adverse Event|1|||
27832910|NCT01750229|54312911|FG000|Randomized Crossover Phase|Withdrawal by Subject|1|||
27832911|NCT01750229|54312911|FG000|Long-term Follow-up Phase|Adverse Event|2|||
27832912|NCT01750229|54312911|FG000|Long-term Follow-up Phase|Withdrawal by Subject|1|||
27832913|NCT01724489|54312923|FG000|Overall Study|Adverse Event|8|||
27832914|NCT01724489|54312924|FG001|Overall Study|Adverse Event|3|||
27832915|NCT01724489|54312923|FG000|Overall Study|Surgery, medication|1|||
27832916|NCT01724489|54312924|FG001|Overall Study|Surgery, medication|1|||
27832917|NCT01724489|54312923|FG000|Overall Study|Lost to Follow-up|1|||
27832918|NCT01724489|54312924|FG001|Overall Study|Lost to Follow-up|2|||
27832919|NCT01724489|54312923|FG000|Overall Study|Withdrawal by Subject|6|||
27832920|NCT01724489|54312924|FG001|Overall Study|Withdrawal by Subject|6|||
27980493|NCT00805467|54638420|FG003|Overall Study|Withdrawal by Subject|50|||
27980494|NCT00805467|54638417|FG000|Overall Study|Protocol Violation|0|||
27980495|NCT00805467|54638418|FG001|Overall Study|Protocol Violation|3|||
27980496|NCT00805467|54638419|FG002|Overall Study|Protocol Violation|0|||
27980497|NCT00805467|54638420|FG003|Overall Study|Protocol Violation|5|||
27980498|NCT00805467|54638417|FG000|Overall Study|Adverse Event|0|||
27980499|NCT00805467|54638418|FG001|Overall Study|Adverse Event|13|||
27980500|NCT00805467|54638419|FG002|Overall Study|Adverse Event|26|||
27980501|NCT00805467|54638420|FG003|Overall Study|Adverse Event|57|||
27980502|NCT00805467|54638417|FG000|Overall Study|Death|0|||
27980503|NCT00805467|54638418|FG001|Overall Study|Death|2|||
27980504|NCT00805467|54638419|FG002|Overall Study|Death|7|||
27980505|NCT00805467|54638420|FG003|Overall Study|Death|5|||
27980506|NCT00805467|54638417|FG000|Overall Study|Physician Decision|0|||
27980507|NCT00805467|54638418|FG001|Overall Study|Physician Decision|1|||
27980508|NCT00805467|54638419|FG002|Overall Study|Physician Decision|2|||
27980509|NCT00805467|54638420|FG003|Overall Study|Physician Decision|6|||
27832921|NCT01724177|54312939|FG000|Overall Study|Adverse Event|8|||
27832922|NCT01724177|54312939|FG000|Overall Study|Progressive disease or Relapsed Disease|16|||
27832923|NCT01724177|54312939|FG000|Overall Study|Nervous participant|1|||
27832924|NCT01724177|54312939|FG000|Overall Study|Serious Adverse Event Related|1|||
27832925|NCT04378270|54312958|FG000|Overall Study|Lack of Efficacy|1|||
27980510|NCT00805467|54638417|FG000|Overall Study|Not reported|0|||
28088795|NCT03229486|54742500|FG001|Overall Study|Protocol Violation|1|||
28088796|NCT01779050|54742508|FG000|Overall Study|Withdrawal by Subject|1|||
28088797|NCT01779050|54742509|FG001|Overall Study|Withdrawal by Subject|0|||
27832926|NCT04378270|54312958|FG000|Overall Study|Withdrawal by Subject|1|||
27832927|NCT04378270|54312958|FG000|Overall Study|Screen Failure|1|||
27980511|NCT00805467|54638418|FG001|Overall Study|Not reported|0|||
27980512|NCT00805467|54638419|FG002|Overall Study|Not reported|3|||
27980513|NCT00805467|54638420|FG003|Overall Study|Not reported|7|||
27980514|NCT00958841|54638430|FG000|Overall Study|Abnormal laboratory value(s)|1|||
27980515|NCT00958841|54638430|FG000|Overall Study|Abnormal test procedure result(s)|3|||
27832928|NCT04378270|54312958|FG000|Overall Study|University Required, Research Covid Shut Down|2|||
27832929|NCT01724021|54312964|FG000|Overall Study|Adverse Event|11|||
27832930|NCT01724021|54312965|FG001|Overall Study|Adverse Event|6|||
27832931|NCT01724021|54312964|FG000|Overall Study|Death|46|||
27832932|NCT01724021|54312965|FG001|Overall Study|Death|58|||
27832933|NCT01724021|54312964|FG000|Overall Study|Participant request/ Withdrew consent|18|||
27832934|NCT01724021|54312965|FG001|Overall Study|Participant request/ Withdrew consent|14|||
27832935|NCT01724021|54312964|FG000|Overall Study|Lost to Follow-up|15|||
27832936|NCT01724021|54312965|FG001|Overall Study|Lost to Follow-up|15|||
27832937|NCT01724021|54312964|FG000|Overall Study|Reason Not Specified|36|||
27832938|NCT01724021|54312965|FG001|Overall Study|Reason Not Specified|39|||
27832939|NCT01724021|54312964|FG000|Overall Study|Missing|1|||
27832940|NCT01724021|54312965|FG001|Overall Study|Missing|1|||
27832941|NCT01723397|54312979|FG000|Study Period 1|Protocol Violation|0|||
27832942|NCT01723397|54312980|FG001|Study Period 1|Protocol Violation|1|||
27832943|NCT01723397|54312979|FG000|Study Period 2|Protocol Violation|0|||
27832944|NCT01723397|54312980|FG001|Study Period 2|Protocol Violation|1|||
27832945|NCT01723163|54312988|FG000|Treatment Phase|Withdrawal by Subject|14|||
27832946|NCT01723163|54312989|FG001|Treatment Phase|Withdrawal by Subject|6|||
27832947|NCT01723163|54312988|FG000|Treatment Phase|Withdrawal by PI|5|||
27832948|NCT01723163|54312989|FG001|Treatment Phase|Withdrawal by PI|1|||
27832949|NCT01723163|54312988|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
27832950|NCT01723163|54312989|FG001|3-Month Follow-up|Withdrawal by Subject|0|||
27832951|NCT01723163|54312988|FG000|3-Month Follow-up|Unable to Contact|12|||
27832952|NCT01723163|54312989|FG001|3-Month Follow-up|Unable to Contact|19|||
27832953|NCT01723163|54312988|FG000|6-Month Follow-up|Death|1|||
27832954|NCT01723163|54312989|FG001|6-Month Follow-up|Death|0|||
27832955|NCT01723163|54312988|FG000|6-Month Follow-up|Unable to Contact|17|||
27832956|NCT01723163|54312989|FG001|6-Month Follow-up|Unable to Contact|15|||
27832957|NCT01723163|54312988|FG000|12-Month Follow-up|Death|1|||
27832958|NCT01723163|54312989|FG001|12-Month Follow-up|Death|0|||
27832959|NCT01723163|54312988|FG000|12-Month Follow-up|Unable to Contact|23|||
27832960|NCT01723163|54312989|FG001|12-Month Follow-up|Unable to Contact|28|||
27832961|NCT01722071|54312999|FG000|Overall Study|Protocol Violation|1|||
27832962|NCT01722071|54313000|FG001|Overall Study|Protocol Violation|0|||
27832963|NCT01721759|54313006|FG000|Treatment Period|Disease Progression|85|||
27832964|NCT01721759|54313006|FG000|Treatment Period|Study drug toxicity|14|||
27832965|NCT01721759|54313006|FG000|Treatment Period|Death|1|||
27832966|NCT01721759|54313006|FG000|Treatment Period|Adverse event unrelated to study drug|11|||
27832967|NCT01721759|54313006|FG000|Treatment Period|Participant request to withdraw|3|||
27832968|NCT01721759|54313006|FG000|Treatment Period|Other Reasons|3|||
27832969|NCT01721759|54313006|FG000|End of Study Period|Participant Withdrew Consent|5|||
27832970|NCT01721759|54313006|FG000|End of Study Period|Death|101|||
27832971|NCT01721759|54313006|FG000|End of Study Period|Lost to Follow-up|1|||
27832972|NCT01721759|54313006|FG000|End of Study Period|Other Reasons|10|||
27832973|NCT01721369|54313015|FG000|Overall Study|Not initial etiological diagnosis|12|||
27832974|NCT01721057|54313077|FG000|Treatment Period|Withdrawal by Subject|11|||
27832975|NCT01721057|54313078|FG001|Treatment Period|Withdrawal by Subject|5|||
27832976|NCT01721057|54313079|FG002|Treatment Period|Withdrawal by Subject|8|||
27832977|NCT01721057|54313080|FG003|Treatment Period|Withdrawal by Subject|0|||
27832978|NCT01721057|54313081|FG004|Treatment Period|Withdrawal by Subject|0|||
27832979|NCT01721057|54313082|FG005|Treatment Period|Withdrawal by Subject|0|||
27832980|NCT01721057|54313083|FG006|Treatment Period|Withdrawal by Subject|0|||
27832981|NCT01721057|54313077|FG000|Treatment Period|Adverse Event|7|||
27832982|NCT01721057|54313078|FG001|Treatment Period|Adverse Event|10|||
27832983|NCT01721057|54313079|FG002|Treatment Period|Adverse Event|12|||
27832984|NCT01721057|54313080|FG003|Treatment Period|Adverse Event|0|||
27832985|NCT01721057|54313081|FG004|Treatment Period|Adverse Event|0|||
27832986|NCT01721057|54313082|FG005|Treatment Period|Adverse Event|0|||
27832987|NCT01721057|54313083|FG006|Treatment Period|Adverse Event|0|||
27832988|NCT01721057|54313077|FG000|Treatment Period|Lack of Efficacy|7|||
27832989|NCT01721057|54313078|FG001|Treatment Period|Lack of Efficacy|3|||
27832990|NCT01721057|54313079|FG002|Treatment Period|Lack of Efficacy|0|||
27832991|NCT01721057|54313080|FG003|Treatment Period|Lack of Efficacy|0|||
27832992|NCT01721057|54313081|FG004|Treatment Period|Lack of Efficacy|0|||
27832993|NCT01721057|54313082|FG005|Treatment Period|Lack of Efficacy|0|||
27832994|NCT01721057|54313083|FG006|Treatment Period|Lack of Efficacy|0|||
28088798|NCT00306527|54742519|FG000|Overall Study|Lost to Follow-up|3|||
27733468|NCT02688387|54181198|FG007|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
27832995|NCT01721057|54313077|FG000|Treatment Period|Lost to Follow-up|1|||
27832996|NCT01721057|54313078|FG001|Treatment Period|Lost to Follow-up|0|||
27832997|NCT01721057|54313079|FG002|Treatment Period|Lost to Follow-up|0|||
27832998|NCT01721057|54313080|FG003|Treatment Period|Lost to Follow-up|0|||
27832999|NCT01721057|54313081|FG004|Treatment Period|Lost to Follow-up|0|||
27833000|NCT01721057|54313082|FG005|Treatment Period|Lost to Follow-up|0|||
27833001|NCT01721057|54313083|FG006|Treatment Period|Lost to Follow-up|0|||
27833002|NCT01721057|54313077|FG000|Treatment Period|Physician Decision|0|||
27833003|NCT01721057|54313078|FG001|Treatment Period|Physician Decision|1|||
27833004|NCT01721057|54313079|FG002|Treatment Period|Physician Decision|3|||
27833005|NCT01721057|54313080|FG003|Treatment Period|Physician Decision|0|||
27833006|NCT01721057|54313081|FG004|Treatment Period|Physician Decision|0|||
27833007|NCT01721057|54313082|FG005|Treatment Period|Physician Decision|0|||
27833008|NCT01721057|54313083|FG006|Treatment Period|Physician Decision|0|||
27833009|NCT01721057|54313077|FG000|Treatment Period|Death|2|||
27833010|NCT01721057|54313078|FG001|Treatment Period|Death|0|||
27833011|NCT01721057|54313079|FG002|Treatment Period|Death|0|||
27833012|NCT01721057|54313080|FG003|Treatment Period|Death|0|||
27833013|NCT01721057|54313081|FG004|Treatment Period|Death|0|||
27833014|NCT01721057|54313082|FG005|Treatment Period|Death|0|||
27833015|NCT01721057|54313083|FG006|Treatment Period|Death|0|||
27833016|NCT01721057|54313077|FG000|Rescue Period|Adverse Event|0|||
27833017|NCT01721057|54313078|FG001|Rescue Period|Adverse Event|0|||
27833018|NCT01721057|54313079|FG002|Rescue Period|Adverse Event|0|||
27833019|NCT01721057|54313080|FG003|Rescue Period|Adverse Event|1|||
27833020|NCT01721057|54313081|FG004|Rescue Period|Adverse Event|0|||
27833021|NCT01721057|54313082|FG005|Rescue Period|Adverse Event|0|||
27833022|NCT01721057|54313083|FG006|Rescue Period|Adverse Event|0|||
27833023|NCT01721057|54313077|FG000|Rescue Period|Lack of Efficacy|0|||
27833024|NCT01721057|54313078|FG001|Rescue Period|Lack of Efficacy|0|||
27833025|NCT01721057|54313079|FG002|Rescue Period|Lack of Efficacy|0|||
27833026|NCT01721057|54313080|FG003|Rescue Period|Lack of Efficacy|2|||
27833027|NCT01721057|54313081|FG004|Rescue Period|Lack of Efficacy|0|||
27833028|NCT01721057|54313082|FG005|Rescue Period|Lack of Efficacy|0|||
27833029|NCT01721057|54313083|FG006|Rescue Period|Lack of Efficacy|0|||
27833030|NCT04570384|54313112|FG000|Overall Study|Adverse Event|2|||
27833031|NCT04570384|54313113|FG001|Overall Study|Adverse Event|1|||
27833032|NCT04570384|54313112|FG000|Overall Study|Death|2|||
27833033|NCT04570384|54313113|FG001|Overall Study|Death|5|||
27833034|NCT04570384|54313112|FG000|Overall Study|Lost to Follow-up|1|||
27833035|NCT04570384|54313113|FG001|Overall Study|Lost to Follow-up|0|||
27833036|NCT04570384|54313112|FG000|Overall Study|Other|1|||
27833037|NCT04570384|54313113|FG001|Overall Study|Other|0|||
27833038|NCT04570384|54313112|FG000|Overall Study|Protocol Violation|0|||
27833039|NCT04570384|54313113|FG001|Overall Study|Protocol Violation|1|||
27833040|NCT04570384|54313112|FG000|Overall Study|Sponsor Decision|1|||
27833041|NCT04570384|54313113|FG001|Overall Study|Sponsor Decision|0|||
27833042|NCT04570384|54313112|FG000|Overall Study|Withdrawal by Subject|4|||
27833043|NCT04570384|54313113|FG001|Overall Study|Withdrawal by Subject|2|||
27833044|NCT02563522|54313166|FG000|Overall Study|Adverse Event|2|||
27833045|NCT02563522|54313167|FG001|Overall Study|Adverse Event|3|||
27833046|NCT02563522|54313166|FG000|Overall Study|Lost to Follow-up|1|||
27833047|NCT02563522|54313167|FG001|Overall Study|Lost to Follow-up|0|||
27833048|NCT02563522|54313166|FG000|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|1|||
27833049|NCT02563522|54313167|FG001|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|2|||
27833050|NCT02180724|54313175|FG000|Overall Study|Death|26|||
27833051|NCT02180724|54313176|FG001|Overall Study|Death|1|||
27833052|NCT02180724|54313175|FG000|Overall Study|Lost to Follow-up|3|||
27833053|NCT02180724|54313176|FG001|Overall Study|Lost to Follow-up|1|||
27833054|NCT02180724|54313175|FG000|Overall Study|Withdrawal by Subject|4|||
27833055|NCT02180724|54313176|FG001|Overall Study|Withdrawal by Subject|2|||
27833056|NCT02180724|54313175|FG000|Overall Study|PI Decision|5|||
27833057|NCT02180724|54313176|FG001|Overall Study|PI Decision|2|||
27833058|NCT02180724|54313175|FG000|Overall Study|Study terminated by sponsor|54|||
27833059|NCT02180724|54313176|FG001|Overall Study|Study terminated by sponsor|8|||
27833060|NCT03578146|54313203|FG000|Overall Study|Did Not Receive Treatment|1|||
27833061|NCT03578146|54313204|FG001|Overall Study|Did Not Receive Treatment|0|||
27833062|NCT03578146|54313205|FG002|Overall Study|Did Not Receive Treatment|0|||
27833063|NCT03578146|54313206|FG003|Overall Study|Did Not Receive Treatment|0|||
27833064|NCT03578146|54313207|FG004|Overall Study|Did Not Receive Treatment|0|||
27833065|NCT03578146|54313208|FG005|Overall Study|Did Not Receive Treatment|2|||
27855717|NCT02733042|54382041|FG003|Follow-up Period|Ongoing on Follow-up|2|||
28088799|NCT00306527|54742520|FG001|Overall Study|Lost to Follow-up|4|||
27833066|NCT03578146|54313203|FG000|Overall Study|Lost to Follow-up|0|||
27833067|NCT03578146|54313204|FG001|Overall Study|Lost to Follow-up|1|||
27833068|NCT03578146|54313205|FG002|Overall Study|Lost to Follow-up|1|||
27855718|NCT02733042|54382042|FG004|Follow-up Period|Ongoing on Follow-up|0|||
27855719|NCT02733042|54382043|FG005|Follow-up Period|Ongoing on Follow-up|0|||
28088800|NCT00306527|54742521|FG002|Overall Study|Lost to Follow-up|3|||
27833069|NCT03578146|54313206|FG003|Overall Study|Lost to Follow-up|0|||
27833070|NCT03578146|54313207|FG004|Overall Study|Lost to Follow-up|0|||
27833071|NCT03578146|54313208|FG005|Overall Study|Lost to Follow-up|1|||
27833072|NCT02716896|54313224|FG000|Overall Study|Physician Decision|0|||
27833073|NCT02716896|54313225|FG001|Overall Study|Physician Decision|1|||
27833074|NCT02715726|54313280|FG000|Overall Study|Adverse Event|2|||
27833075|NCT02715726|54313281|FG001|Overall Study|Adverse Event|6|||
27833076|NCT02715726|54313280|FG000|Overall Study|Protocol Violation|1|||
27833077|NCT02715726|54313281|FG001|Overall Study|Protocol Violation|0|||
27833078|NCT02715726|54313280|FG000|Overall Study|Death|2|||
27833079|NCT02715726|54313281|FG001|Overall Study|Death|1|||
27833080|NCT02715726|54313280|FG000|Overall Study|Participant moved|1|||
27833081|NCT02715726|54313281|FG001|Overall Study|Participant moved|3|||
27833082|NCT02715726|54313280|FG000|Overall Study|Other than specified above|11|||
27833083|NCT02715726|54313281|FG001|Overall Study|Other than specified above|15|||
27833084|NCT02715726|54313280|FG000|Overall Study|Randomized but not treated|1|||
27833085|NCT02715726|54313281|FG001|Overall Study|Randomized but not treated|2|||
27833086|NCT04248816|54313294|FG000|Overall Study|Ineligible post-randomization|7|||
27833087|NCT04248816|54313295|FG001|Overall Study|Ineligible post-randomization|21|||
27833088|NCT04248816|54313296|FG002|Overall Study|Ineligible post-randomization|25|||
27833089|NCT02314156|54313333|FG000|Overall Study|Adverse Event|1|||
27833090|NCT02314156|54313334|FG001|Overall Study|Adverse Event|0|||
27833091|NCT02314156|54313333|FG000|Overall Study|Withdrawal by Subject|1|||
27833092|NCT02314156|54313334|FG001|Overall Study|Withdrawal by Subject|0|||
27855720|NCT02733042|54382044|FG006|Follow-up Period|Ongoing on Follow-up|0|||
27855721|NCT02733042|54382045|FG007|Follow-up Period|Ongoing on Follow-up|1|||
27980516|NCT00958841|54638430|FG000|Overall Study|Administrative problems|1|||
28166161|NCT00709995|54836920|FG000|Overall Study|Adverse Event|4|||
28166162|NCT00709995|54836921|FG001|Overall Study|Adverse Event|2|||
28166163|NCT00709995|54836920|FG000|Overall Study|Withdrawal by Subject|1|||
27733469|NCT02688387|54181199|FG008|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
27733470|NCT02688387|54181200|FG009|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
27733471|NCT02688387|54181201|FG010|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
27733472|NCT02688387|54181202|FG011|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
27733473|NCT02688387|54181203|FG012|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
27733474|NCT02688387|54181204|FG013|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
27733475|NCT02688387|54181205|FG014|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
27733476|NCT02688387|54181206|FG015|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
27733477|NCT02688387|54181207|FG016|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
27733478|NCT02688387|54181208|FG017|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
27733479|NCT02688387|54181209|FG018|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
27733480|NCT02688387|54181210|FG019|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
27733481|NCT02688387|54181211|FG020|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
27733482|NCT02688387|54181212|FG021|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
27733483|NCT02688387|54181191|FG000|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
27733484|NCT02688387|54181192|FG001|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
27733485|NCT02688387|54181193|FG002|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
27733486|NCT02688387|54181194|FG003|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
27733487|NCT02688387|54181195|FG004|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
27733488|NCT02688387|54181196|FG005|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
27733489|NCT02688387|54181197|FG006|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
27733490|NCT02688387|54181198|FG007|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
27733491|NCT02688387|54181199|FG008|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
27733492|NCT02688387|54181200|FG009|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
27733493|NCT02688387|54181201|FG010|Part 2, Period 1 (up to 6 Days)|Adverse Event|1|||
27733494|NCT02688387|54181202|FG011|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
27733495|NCT02688387|54181203|FG012|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
27733496|NCT02688387|54181204|FG013|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
27733497|NCT02688387|54181205|FG014|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
27733498|NCT02688387|54181206|FG015|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
27733499|NCT02688387|54181207|FG016|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
27733500|NCT02688387|54181208|FG017|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
27733501|NCT02688387|54181209|FG018|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
27733502|NCT02688387|54181210|FG019|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
27733503|NCT02688387|54181211|FG020|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
27733504|NCT02688387|54181212|FG021|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
28166164|NCT00709995|54836921|FG001|Overall Study|Withdrawal by Subject|3|||
28166165|NCT02503540|54836930|FG000|Overall Study|Death|2|||
28166166|NCT02503540|54836930|FG000|Overall Study|Withdrawal by Subject|1|||
27733505|NCT02688387|54181191|FG000|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27733506|NCT02688387|54181192|FG001|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27733507|NCT02688387|54181193|FG002|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27833093|NCT04034238|54313529|FG000|Dose Escalation Phase|Withdrawal by Subject|1|||
27833094|NCT04034238|54313530|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
27980517|NCT00958841|54638430|FG000|Overall Study|Adverse Event|8|||
27980518|NCT00958841|54638430|FG000|Overall Study|New cancer therapy|5|||
27980519|NCT00958841|54638430|FG000|Overall Study|Withdrawal by Subject|1|||
27733508|NCT02688387|54181194|FG003|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27980520|NCT00958841|54638430|FG000|Overall Study|Unsatisfactory therapeutic effect|22|||
27980521|NCT00958841|54638430|FG000|Overall Study|Completed M6/did not enter extension|27|||
28166167|NCT02502526|54836937|FG000|Overall Study|Lost to Follow-up|2|||
28088801|NCT00306527|54742522|FG003|Overall Study|Lost to Follow-up|0|||
28088802|NCT00306527|54742519|FG000|Overall Study|Withdrawal by Subject|2|||
28088803|NCT00306527|54742520|FG001|Overall Study|Withdrawal by Subject|3|||
28088804|NCT00306527|54742521|FG002|Overall Study|Withdrawal by Subject|0|||
28088805|NCT00306527|54742522|FG003|Overall Study|Withdrawal by Subject|3|||
28088806|NCT00306527|54742519|FG000|Overall Study|Adverse Event|0|||
28088807|NCT00306527|54742520|FG001|Overall Study|Adverse Event|0|||
28166168|NCT02502526|54836938|FG001|Overall Study|Lost to Follow-up|2|||
28166169|NCT02502526|54836939|FG002|Overall Study|Lost to Follow-up|3|||
28166170|NCT02502526|54836937|FG000|Overall Study|Withdrawal by Subject|0|||
28166171|NCT02502526|54836938|FG001|Overall Study|Withdrawal by Subject|1|||
28166172|NCT02502526|54836939|FG002|Overall Study|Withdrawal by Subject|1|||
28166173|NCT02502526|54836937|FG000|Overall Study|Disqualified due to cataract grading|0|||
28166174|NCT02502526|54836938|FG001|Overall Study|Disqualified due to cataract grading|0|||
28166175|NCT02502526|54836939|FG002|Overall Study|Disqualified due to cataract grading|1|||
27733509|NCT02688387|54181195|FG004|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27733510|NCT02688387|54181196|FG005|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27733511|NCT02688387|54181197|FG006|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27733512|NCT02688387|54181198|FG007|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27733513|NCT02688387|54181199|FG008|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27733514|NCT02688387|54181200|FG009|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27733515|NCT02688387|54181201|FG010|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27733516|NCT02688387|54181202|FG011|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27733517|NCT02688387|54181203|FG012|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27733518|NCT02688387|54181204|FG013|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27733519|NCT02688387|54181205|FG014|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
27733520|NCT02688387|54181206|FG015|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27733521|NCT02688387|54181207|FG016|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27733522|NCT02688387|54181208|FG017|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27733523|NCT02688387|54181209|FG018|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27733524|NCT02688387|54181210|FG019|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27733525|NCT02688387|54181211|FG020|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27733526|NCT02688387|54181212|FG021|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27733527|NCT02688387|54181191|FG000|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
27733528|NCT02688387|54181192|FG001|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
27733529|NCT02688387|54181193|FG002|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
27733530|NCT02688387|54181194|FG003|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
27733531|NCT02688387|54181195|FG004|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
27733532|NCT02688387|54181196|FG005|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
27733533|NCT02688387|54181197|FG006|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
27733534|NCT02688387|54181198|FG007|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
27733535|NCT02688387|54181199|FG008|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
27733536|NCT02688387|54181200|FG009|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
27733537|NCT02688387|54181201|FG010|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
27733538|NCT02688387|54181202|FG011|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
27733539|NCT02688387|54181203|FG012|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
27733540|NCT02688387|54181204|FG013|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
27733541|NCT02688387|54181205|FG014|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
27733542|NCT02688387|54181206|FG015|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
27733543|NCT02688387|54181207|FG016|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
27733544|NCT02688387|54181208|FG017|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
27733545|NCT02688387|54181209|FG018|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
27733546|NCT02688387|54181210|FG019|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
27733547|NCT02688387|54181211|FG020|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1|||
27733548|NCT02688387|54181212|FG021|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
27733549|NCT02688387|54181191|FG000|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
27733550|NCT02688387|54181192|FG001|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
27733551|NCT02688387|54181193|FG002|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
27733552|NCT02688387|54181194|FG003|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
27733553|NCT02688387|54181195|FG004|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
27733554|NCT02688387|54181196|FG005|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
27733555|NCT02688387|54181197|FG006|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
28088808|NCT00306527|54742521|FG002|Overall Study|Adverse Event|1|||
28088809|NCT00306527|54742522|FG003|Overall Study|Adverse Event|1|||
28088810|NCT00306527|54742519|FG000|Overall Study|Death|1|||
28088811|NCT00306527|54742520|FG001|Overall Study|Death|0|||
28166176|NCT02502526|54836937|FG000|Overall Study|Enrollment suspension|4|||
28166177|NCT02502526|54836938|FG001|Overall Study|Enrollment suspension|1|||
28088812|NCT00306527|54742521|FG002|Overall Study|Death|1|||
28088813|NCT00306527|54742522|FG003|Overall Study|Death|2|||
28088814|NCT00306293|54742536|FG000|Period 1 (Day 1 to Day 60)|Adverse Event|1|||
28088815|NCT00306293|54742537|FG001|Period 1 (Day 1 to Day 60)|Adverse Event|0|||
28088816|NCT00306293|54742536|FG000|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3|||
28088817|NCT00306293|54742537|FG001|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4|||
28088818|NCT00306293|54742536|FG000|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
28088819|NCT00306293|54742537|FG001|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
28088820|NCT00306293|54742536|FG000|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
28088821|NCT00306293|54742537|FG001|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
28088822|NCT00306293|54742536|FG000|Period 2 (Day 67 to Day 126 )|Adverse Event|1|||
28088823|NCT00306293|54742537|FG001|Period 2 (Day 67 to Day 126 )|Adverse Event|0|||
28088824|NCT00306293|54742536|FG000|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1|||
28088825|NCT00306293|54742537|FG001|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0|||
28088826|NCT00306293|54742536|FG000|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0|||
28088827|NCT00306293|54742537|FG001|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1|||
28088828|NCT00306293|54742536|FG000|Period 2 (Day 67 to Day 126 )|Pregnancy|1|||
28088829|NCT00306293|54742537|FG001|Period 2 (Day 67 to Day 126 )|Pregnancy|0|||
28088830|NCT00294671|54742547|FG000|Overall Study|Lack of Efficacy|11|||
28088831|NCT00294671|54742548|FG001|Overall Study|Lack of Efficacy|23|||
28088832|NCT00294671|54742547|FG000|Overall Study|Liver transplant|7|||
28088833|NCT00294671|54742548|FG001|Overall Study|Liver transplant|9|||
28088834|NCT00294671|54742547|FG000|Overall Study|Drug related adverse event (AE)|4|||
28088835|NCT00294671|54742548|FG001|Overall Study|Drug related adverse event (AE)|2|||
28088836|NCT00294671|54742547|FG000|Overall Study|Non-drug related AE|3|||
28088837|NCT00294671|54742548|FG001|Overall Study|Non-drug related AE|2|||
28088838|NCT00294671|54742547|FG000|Overall Study|Lost to Follow-up|1|||
28088839|NCT00294671|54742548|FG001|Overall Study|Lost to Follow-up|3|||
27980522|NCT00958841|54638430|FG000|Overall Study|Discontinued prior to M*|28|||
28088840|NCT00294671|54742547|FG000|Overall Study|Non-compliance|1|||
28088841|NCT00294671|54742548|FG001|Overall Study|Non-compliance|0|||
28166178|NCT02502526|54836939|FG002|Overall Study|Enrollment suspension|1|||
28166179|NCT02972515|54836948|FG000|Overall Study|Lost to Follow-up|78|||
28166180|NCT02972359|54836952|FG000|Overall Study|Incl. criteria not met/Exclusion met|2|||
28166181|NCT02972359|54836952|FG000|Overall Study|Lack of Efficacy|1|||
28088842|NCT00294671|54742547|FG000|Overall Study|Death|0|||
28088843|NCT00294671|54742548|FG001|Overall Study|Death|1|||
28088844|NCT01495598|54742554|FG000|Overall Study|Death during follow up period|2|||
28088845|NCT01495598|54742554|FG000|Overall Study|Death on study|1|||
28088846|NCT01495598|54742554|FG000|Overall Study|Lost to Follow-up|3|||
28088847|NCT01495598|54742554|FG000|Overall Study|Physician Decision|8|||
28088848|NCT02937454|54742585|FG000|Overall Study|Adverse Event|0|||
28088849|NCT02937454|54742586|FG001|Overall Study|Adverse Event|1|||
28088850|NCT02937454|54742585|FG000|Overall Study|Death|98|||
28088851|NCT02937454|54742586|FG001|Overall Study|Death|95|||
28088852|NCT02937454|54742585|FG000|Overall Study|Lost to Follow-up|1|||
28088853|NCT02937454|54742586|FG001|Overall Study|Lost to Follow-up|1|||
28088854|NCT02937454|54742585|FG000|Overall Study|Physician Decision|0|||
28088855|NCT02937454|54742586|FG001|Overall Study|Physician Decision|1|||
28088856|NCT02937454|54742585|FG000|Overall Study|Protocol Violation|6|||
28088857|NCT02937454|54742586|FG001|Overall Study|Protocol Violation|10|||
28088858|NCT02937454|54742585|FG000|Overall Study|Withdrawal by Subject|27|||
28088859|NCT02937454|54742586|FG001|Overall Study|Withdrawal by Subject|15|||
28088860|NCT02937454|54742585|FG000|Overall Study|Other|8|||
28088861|NCT02937454|54742586|FG001|Overall Study|Other|5|||
28088862|NCT03211858|54742605|FG000|Overall Study|Adverse Event|8|||
28088863|NCT03211858|54742606|FG001|Overall Study|Adverse Event|6|||
28088864|NCT03211858|54742605|FG000|Overall Study|Lack of Efficacy|0|||
28088865|NCT03211858|54742606|FG001|Overall Study|Lack of Efficacy|4|||
28088866|NCT03211858|54742605|FG000|Overall Study|Poor compliance to protocol|6|||
28088867|NCT03211858|54742606|FG001|Overall Study|Poor compliance to protocol|2|||
27980523|NCT03927105|54638493|FG000|Overall Study|Death|1|||
28088868|NCT03211858|54742605|FG000|Overall Study|Non-serious Hypoglycemia|1|||
28088869|NCT03211858|54742606|FG001|Overall Study|Non-serious Hypoglycemia|0|||
28088870|NCT03211858|54742605|FG000|Overall Study|Other than specified above|22|||
28088871|NCT03211858|54742606|FG001|Overall Study|Other than specified above|21|||
28166182|NCT02972359|54836952|FG000|Overall Study|Adverse Event|4|||
28166183|NCT02972359|54836952|FG000|Overall Study|Death|1|||
28166184|NCT02972359|54836952|FG000|Overall Study|Withdrawal by Subject|30|||
28166185|NCT02972359|54836952|FG000|Overall Study|Protocol Violation|1|||
28088872|NCT03211156|54742618|FG000|Overall Study|Withdrawal by Subject|0|||
28088873|NCT03211156|54742619|FG001|Overall Study|Withdrawal by Subject|2|||
28088874|NCT03211156|54742618|FG000|Overall Study|Lost to Follow-up|1|||
28088875|NCT03211156|54742619|FG001|Overall Study|Lost to Follow-up|1|||
28088876|NCT03211156|54742618|FG000|Overall Study|Adverse Event|1|||
28088877|NCT03211156|54742619|FG001|Overall Study|Adverse Event|0|||
28088878|NCT04472494|54742627|FG000|Pre-treatment|Other reasons|2|||
28088879|NCT04472494|54742628|FG001|Pre-treatment|Other reasons|0|||
28088880|NCT04472494|54742627|FG000|Treatment|Death|5|||
28088881|NCT04472494|54742628|FG001|Treatment|Death|2|||
28088882|NCT04472494|54742627|FG000|Treatment|Hospital discharge|1|||
28088883|NCT04472494|54742628|FG001|Treatment|Hospital discharge|1|||
28088884|NCT04419506|54742638|FG000|Overall Study|Adverse Event|0|||
28088885|NCT04419506|54742639|FG001|Overall Study|Adverse Event|10|||
28088886|NCT04419506|54742640|FG002|Overall Study|Adverse Event|0|||
28088887|NCT04419506|54742641|FG003|Overall Study|Adverse Event|3|||
28088888|NCT04419506|54742638|FG000|Overall Study|Withdrawal by Subject|0|||
28088889|NCT04419506|54742639|FG001|Overall Study|Withdrawal by Subject|0|||
28088890|NCT04419506|54742640|FG002|Overall Study|Withdrawal by Subject|0|||
28088891|NCT04419506|54742641|FG003|Overall Study|Withdrawal by Subject|1|||
28088892|NCT04419506|54742638|FG000|Overall Study|poor-compliance|0|||
28088893|NCT04419506|54742639|FG001|Overall Study|poor-compliance|0|||
28088894|NCT04419506|54742640|FG002|Overall Study|poor-compliance|0|||
28088895|NCT04419506|54742641|FG003|Overall Study|poor-compliance|1|||
28088896|NCT03236506|54742654|FG000|Overall Study|Death|1|||
28088897|NCT03236506|54742655|FG001|Overall Study|Death|1|||
28088898|NCT03236506|54742656|FG002|Overall Study|Death|1|||
28088899|NCT03236506|54742654|FG000|Overall Study|Withdrawal by Subject|3|||
28088900|NCT03236506|54742655|FG001|Overall Study|Withdrawal by Subject|3|||
28088901|NCT03236506|54742656|FG002|Overall Study|Withdrawal by Subject|4|||
28088902|NCT03236506|54742654|FG000|Overall Study|Did not initiate treatment|2|||
28088903|NCT03236506|54742655|FG001|Overall Study|Did not initiate treatment|1|||
28088904|NCT03236506|54742656|FG002|Overall Study|Did not initiate treatment|2|||
28088905|NCT03227692|54742675|FG000|Overall Study|Protocol Violation|1|||
28088906|NCT03227692|54742676|FG001|Overall Study|Protocol Violation|1|||
28088907|NCT03227692|54742675|FG000|Overall Study|Lost to Follow-up|4|||
28088908|NCT03227692|54742676|FG001|Overall Study|Lost to Follow-up|2|||
28088909|NCT03227692|54742675|FG000|Overall Study|Adverse Event|0|||
28088910|NCT03227692|54742676|FG001|Overall Study|Adverse Event|2|||
28088911|NCT03210220|54742684|FG000|Overall Study|Physician Decision|1|||
28088912|NCT03210220|54742685|FG001|Overall Study|Physician Decision|0|||
28088913|NCT03209518|54742691|FG000|Overall Study|Case Report Forms Uncollected|1|||
28088914|NCT03209518|54742691|FG000|Overall Study|Protocol Deviation|1|||
28088915|NCT03725852|54742697|FG000|Overall Study|Death|1|||
28088916|NCT03725852|54742698|FG001|Overall Study|Death|0|||
28088917|NCT03725852|54742697|FG000|Overall Study|Withdrawal by Subject|1|||
28088918|NCT03725852|54742698|FG001|Overall Study|Withdrawal by Subject|0|||
28088919|NCT03725852|54742697|FG000|Overall Study|Travel restrictions due to COVID-19|2|||
28088920|NCT03725852|54742698|FG001|Overall Study|Travel restrictions due to COVID-19|0|||
28088921|NCT00304031|54742707|FG000|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144|||
28088922|NCT00304031|54742708|FG001|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
28088923|NCT00304031|54742709|FG002|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
28088924|NCT00304031|54742707|FG000|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48|||
28088925|NCT00304031|54742708|FG001|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
28088926|NCT00304031|54742709|FG002|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
28088927|NCT00304031|54742707|FG000|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19|||
28088928|NCT00304031|54742708|FG001|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
28088929|NCT00304031|54742709|FG002|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
28088930|NCT00304031|54742707|FG000|Concomitant RT+TMZ (Pre-randomization)|Death|18|||
28088931|NCT00304031|54742708|FG001|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
28088932|NCT00304031|54742709|FG002|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
28088933|NCT00304031|54742707|FG000|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15|||
28088934|NCT00304031|54742708|FG001|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
28088935|NCT00304031|54742709|FG002|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
28088936|NCT00304031|54742707|FG000|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10|||
28088937|NCT00304031|54742708|FG001|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
28088938|NCT00304031|54742709|FG002|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
28088939|NCT00304031|54742707|FG000|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1|||
28088940|NCT00304031|54742708|FG001|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
28088941|NCT00304031|54742709|FG002|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
28088942|NCT00304031|54742707|FG000|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37|||
27980524|NCT03927105|54638493|FG000|Overall Study|In observation for potential re-treatment|2|||
28088943|NCT00304031|54742708|FG001|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
28088944|NCT00304031|54742709|FG002|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
28088945|NCT00304031|54742707|FG000|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
28088946|NCT00304031|54742708|FG001|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
28088947|NCT00304031|54742709|FG002|Randomization to Adjuvant TMZ Arm|No follow-up collected|2|||
28088948|NCT00332189|54742724|FG000|Overall Study|Adverse Event|3|||
28088949|NCT00332189|54742724|FG000|Overall Study|Uncooperative/Noncompliant|3|||
28088950|NCT00332189|54742724|FG000|Overall Study|Withdrawal by Subject|9|||
28088951|NCT00332189|54742724|FG000|Overall Study|Lack of Efficacy|4|||
28088952|NCT00332189|54742724|FG000|Overall Study|Moved out of country|2|||
28088953|NCT00331799|54742729|FG000|Overall Study|Withdrawal by Subject|2|||
28088954|NCT00331799|54742729|FG000|Overall Study|Sedation|1|||
28088955|NCT00303719|54742735|FG000|Overall Study|Not evaluable, prior therapies|0|||
28088956|NCT00303719|54742736|FG001|Overall Study|Not evaluable, prior therapies|30|||
28088957|NCT00303719|54742735|FG000|Overall Study|Lost to Follow-up|0|||
28088958|NCT00303719|54742736|FG001|Overall Study|Lost to Follow-up|7|||
28088959|NCT00331409|54742743|FG000|Overall Study|Lack of Efficacy|4|||
28088960|NCT00303485|54742749|FG000|Overall Study|Adverse Event/Intercurrent Illness|0|||
28088961|NCT00303485|54742750|FG001|Overall Study|Adverse Event/Intercurrent Illness|1|||
28088962|NCT00303485|54742749|FG000|Overall Study|Failure to return|0|||
28088963|NCT00303485|54742750|FG001|Overall Study|Failure to return|1|||
28088964|NCT00303485|54742749|FG000|Overall Study|Withdrawal by Subject|1|||
28088965|NCT00303485|54742750|FG001|Overall Study|Withdrawal by Subject|0|||
28088966|NCT03235726|54742764|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
28088967|NCT03235726|54742765|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
28088968|NCT03235726|54742766|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
28088969|NCT03235726|54742767|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
28088970|NCT03235726|54742768|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1|||
28088971|NCT03235726|54742769|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
28088972|NCT03235726|54742770|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
28088973|NCT03235726|54742771|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
28088974|NCT03235726|54742772|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
28088975|NCT03235726|54742773|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
28088976|NCT03235726|54742764|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
28088977|NCT03235726|54742765|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
28088978|NCT03235726|54742766|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
28088979|NCT03235726|54742767|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
28088980|NCT03235726|54742768|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1|||
28088981|NCT03235726|54742769|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
28088982|NCT03235726|54742770|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
28088983|NCT03235726|54742771|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
28088984|NCT03235726|54742772|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
28088985|NCT03235726|54742773|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
28088986|NCT00303953|54742808|FG000|Overall Study|Ineligible|1|||
28088987|NCT00303953|54742808|FG000|Overall Study|Death|1|||
28088988|NCT00303953|54742808|FG000|Overall Study|Adverse Event|4|||
28088989|NCT00303953|54742808|FG000|Overall Study|Lack of Efficacy|12|||
28088990|NCT00303953|54742808|FG000|Overall Study|Physician Decision|1|||
28088991|NCT03723590|54742812|FG000|Overall Study|Withdrawal by Subject|3|||
28088992|NCT02935894|54742816|FG000|Overall Study|Subject dismissed|1|||
28088993|NCT03224182|54742822|FG000|Overall Study|Study Drug Not Instilled|6|||
28088994|NCT03224182|54742823|FG001|Overall Study|Study Drug Not Instilled|1|||
28088995|NCT03224182|54742822|FG000|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|22|||
28088996|NCT03224182|54742823|FG001|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|11|||
28088997|NCT03224182|54742822|FG000|Overall Study|Withdrew of Consent|4|||
28088998|NCT03224182|54742823|FG001|Overall Study|Withdrew of Consent|2|||
28088999|NCT03224182|54742822|FG000|Overall Study|Investigator Decision|3|||
28089000|NCT03224182|54742823|FG001|Overall Study|Investigator Decision|1|||
28089001|NCT03224182|54742822|FG000|Overall Study|Sponsor Decision|26|||
28089002|NCT03224182|54742823|FG001|Overall Study|Sponsor Decision|12|||
28089003|NCT03224182|54742822|FG000|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|4|||
28089004|NCT03224182|54742823|FG001|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|0|||
28089005|NCT03224182|54742822|FG000|Overall Study|Lost to Follow-up|1|||
28089006|NCT03224182|54742823|FG001|Overall Study|Lost to Follow-up|0|||
28089007|NCT03224182|54742822|FG000|Overall Study|Participant Had Recurrence|11|||
28089008|NCT03224182|54742823|FG001|Overall Study|Participant Had Recurrence|5|||
28089009|NCT03224182|54742822|FG000|Overall Study|Death|0|||
28089010|NCT03224182|54742823|FG001|Overall Study|Death|1|||
28089011|NCT03224182|54742822|FG000|Overall Study|Reason not Specified|3|||
28089012|NCT03224182|54742823|FG001|Overall Study|Reason not Specified|3|||
28089013|NCT03224182|54742822|FG000|Overall Study|Other|1|||
28166186|NCT02972359|54836952|FG000|Overall Study|Lost to Follow-up|26|||
28089014|NCT03224182|54742823|FG001|Overall Study|Other|0|||
28089015|NCT02935192|54742831|FG000|Overall Study|Withdrawal by Subject|8|||
28089016|NCT02935192|54742832|FG001|Overall Study|Withdrawal by Subject|4|||
28089017|NCT03722264|54742838|FG000|Overall Study|Physician Decision|3|||
28089018|NCT03722030|54742846|FG000|Overall Study|Withdrawal by Subject|1|||
28089019|NCT03722030|54742847|FG001|Overall Study|Withdrawal by Subject|0|||
28166187|NCT02972359|54836952|FG000|Overall Study|Other reasons|5|||
28089020|NCT03221842|54742854|FG000|Period 1 (Open-label)|Adverse Event|4|||
28089021|NCT03221842|54742855|FG001|Period 1 (Open-label)|Adverse Event|0|||
28089022|NCT03221842|54742854|FG000|Period 1 (Open-label)|Physician Decision|2|||
28089023|NCT03221842|54742855|FG001|Period 1 (Open-label)|Physician Decision|0|||
28089024|NCT03221842|54742854|FG000|Period 1 (Open-label)|Lost to Follow-up|1|||
28089025|NCT03221842|54742855|FG001|Period 1 (Open-label)|Lost to Follow-up|0|||
28089026|NCT03221842|54742854|FG000|Period 1 (Open-label)|Terminated by sponsor|1|||
28089027|NCT03221842|54742855|FG001|Period 1 (Open-label)|Terminated by sponsor|0|||
28089028|NCT03221842|54742854|FG000|Period 1 (Open-label)|Other|2|||
28089029|NCT03221842|54742855|FG001|Period 1 (Open-label)|Other|0|||
28089030|NCT03221842|54742854|FG000|Period 2 (Randomized, Blinded)|Death|0|||
28089031|NCT03221842|54742855|FG001|Period 2 (Randomized, Blinded)|Death|1|||
28089032|NCT03221842|54742854|FG000|Period 2 (Randomized, Blinded)|Lack of Efficacy|1|||
28089033|NCT03221842|54742855|FG001|Period 2 (Randomized, Blinded)|Lack of Efficacy|0|||
28089034|NCT03364738|54742865|FG000|Overall Study|Early termination due to Food and Drug Administration recall of rhPTH(1-84) (Natpara)|6|||
28089035|NCT03364738|54742865|FG000|Overall Study|Withdrawal by Subject|1|||
28089036|NCT03364738|54742865|FG000|Overall Study|Adverse Event|1|||
28089037|NCT00303329|54742872|FG000|Overall Study|Adverse Event|7|||
28089038|NCT00303329|54742873|FG001|Overall Study|Adverse Event|14|||
28089039|NCT00303329|54742872|FG000|Overall Study|Abnormal Laboratory Values|0|||
28089040|NCT00303329|54742873|FG001|Overall Study|Abnormal Laboratory Values|1|||
28089041|NCT00303329|54742872|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
28089042|NCT00303329|54742873|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
28089043|NCT00303329|54742872|FG000|Overall Study|Condition no longer requires study drug|0|||
28089044|NCT00303329|54742873|FG001|Overall Study|Condition no longer requires study drug|8|||
28089045|NCT00303329|54742872|FG000|Overall Study|Protocol Violation|3|||
28089046|NCT00303329|54742873|FG001|Overall Study|Protocol Violation|0|||
28089047|NCT00303329|54742872|FG000|Overall Study|Withdrawal by Subject|9|||
28089048|NCT00303329|54742873|FG001|Overall Study|Withdrawal by Subject|15|||
28089049|NCT00303329|54742872|FG000|Overall Study|Lost to Follow-up|0|||
28089050|NCT00303329|54742873|FG001|Overall Study|Lost to Follow-up|1|||
28089051|NCT00303329|54742872|FG000|Overall Study|Administrative problems|1|||
28089052|NCT00303329|54742873|FG001|Overall Study|Administrative problems|0|||
28089053|NCT00303329|54742872|FG000|Overall Study|Death|2|||
28089054|NCT00303329|54742873|FG001|Overall Study|Death|12|||
28089055|NCT00303329|54742872|FG000|Overall Study|Stopped at end of core|3|||
28089056|NCT00303329|54742873|FG001|Overall Study|Stopped at end of core|9|||
28089057|NCT00303329|54742872|FG000|Overall Study|Stopped at end of extension 1|1|||
28089058|NCT00303329|54742873|FG001|Overall Study|Stopped at end of extension 1|0|||
28089059|NCT00329849|54742881|FG000|Overall Study|Withdrawal by Subject|6|||
28089060|NCT00329849|54742882|FG001|Overall Study|Withdrawal by Subject|4|||
28089061|NCT02934178|54742894|FG000|Received Vaccination 2|Death|0|||
28089062|NCT02934178|54742895|FG001|Received Vaccination 2|Death|1|||
28089063|NCT02934178|54742894|FG000|Received Vaccination 3|Withdrawal by Subject|1|||
28089064|NCT02934178|54742895|FG001|Received Vaccination 3|Withdrawal by Subject|0|||
28089065|NCT00329303|54742904|FG000|Overall Study|Lack of Efficacy|1|||
28089066|NCT00329303|54742905|FG001|Overall Study|Lack of Efficacy|0|||
28089067|NCT00329303|54742904|FG000|Overall Study|Decision of the sponsor|0|||
28089068|NCT00329303|54742905|FG001|Overall Study|Decision of the sponsor|1|||
28089069|NCT00329303|54742904|FG000|Overall Study|Patient no longer available|1|||
28089070|NCT00329303|54742905|FG001|Overall Study|Patient no longer available|0|||
28089071|NCT00329303|54742904|FG000|Overall Study|Patient relocated|0|||
28089072|NCT00329303|54742905|FG001|Overall Study|Patient relocated|1|||
28089073|NCT03216850|54742912|FG000|Overall Study|Pre-analytical error|6|||
28089074|NCT00302159|54742916|FG000|Overall Study|pt declined before treatment started|1|||
28089075|NCT00302159|54742916|FG000|Overall Study|pt started Avastin|1|||
28089076|NCT00302081|54742924|FG000|Overall Study|Adverse Event|6|||
28089077|NCT00302081|54742925|FG001|Overall Study|Adverse Event|5|||
28089078|NCT00302081|54742926|FG002|Overall Study|Adverse Event|4|||
28089079|NCT00302081|54742924|FG000|Overall Study|Lost to Follow-up|21|||
28089080|NCT00302081|54742925|FG001|Overall Study|Lost to Follow-up|18|||
28089081|NCT00302081|54742926|FG002|Overall Study|Lost to Follow-up|28|||
28089082|NCT00302081|54742924|FG000|Overall Study|Withdrawal by Subject|8|||
28089083|NCT00302081|54742925|FG001|Overall Study|Withdrawal by Subject|12|||
28089084|NCT00302081|54742926|FG002|Overall Study|Withdrawal by Subject|8|||
27733556|NCT02688387|54181198|FG007|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
28089085|NCT00302081|54742924|FG000|Overall Study|Protocol Violation|5|||
28089086|NCT00302081|54742925|FG001|Overall Study|Protocol Violation|1|||
28089087|NCT00302081|54742926|FG002|Overall Study|Protocol Violation|2|||
28089088|NCT00302081|54742924|FG000|Overall Study|Lack of Efficacy|1|||
28089089|NCT00302081|54742925|FG001|Overall Study|Lack of Efficacy|0|||
28089090|NCT00302081|54742926|FG002|Overall Study|Lack of Efficacy|5|||
28089091|NCT00302081|54742924|FG000|Overall Study|Death|2|||
28089092|NCT00302081|54742925|FG001|Overall Study|Death|1|||
28166188|NCT02972359|54836952|FG000|Overall Study|Missing|1|||
27733557|NCT02688387|54181199|FG008|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
28089093|NCT00302081|54742926|FG002|Overall Study|Death|0|||
28089094|NCT00302081|54742924|FG000|Overall Study|Other|13|||
28089095|NCT00302081|54742925|FG001|Overall Study|Other|6|||
28089096|NCT00302081|54742926|FG002|Overall Study|Other|5|||
28089097|NCT00302003|54742934|FG000|Overall Study|Lack of Efficacy|62|||
28089098|NCT00302003|54742934|FG000|Overall Study|Lost to Follow-up|1|||
28089099|NCT00302003|54742934|FG000|Overall Study|Physician Decision|2|||
28089100|NCT00302003|54742934|FG000|Overall Study|Withdrawal by Subject|5|||
28089101|NCT00302003|54742934|FG000|Overall Study|Ineligible|9|||
28089102|NCT00302003|54742934|FG000|Overall Study|Protocol Violation|1|||
28089103|NCT00036270|54742940|FG000|Randomized to Study Treatment|Withdrawal by Subject|6|||
28089104|NCT00036270|54742941|FG001|Randomized to Study Treatment|Withdrawal by Subject|7|||
28089105|NCT00036270|54742940|FG000|Study Treatment to 5 Year Report|Ongoing|1081|||
28089106|NCT00036270|54742941|FG001|Study Treatment to 5 Year Report|Ongoing|736|||
28089107|NCT00036270|54742940|FG000|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507|||
28089108|NCT00036270|54742941|FG001|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447|||
28089109|NCT00036270|54742940|FG000|Study Treatment to 5 Year Report|Adverse Event|501|||
28089110|NCT00036270|54742941|FG001|Study Treatment to 5 Year Report|Adverse Event|782|||
28089111|NCT00036270|54742940|FG000|Study Treatment to 5 Year Report|Other|277|||
28089112|NCT00036270|54742941|FG001|Study Treatment to 5 Year Report|Other|288|||
28089113|NCT00036270|54742940|FG000|Study Treatment to 5 Year Report|Treatment refusal|113|||
28089114|NCT00036270|54742941|FG001|Study Treatment to 5 Year Report|Treatment refusal|208|||
28089115|NCT00036270|54742940|FG000|Study Treatment to 5 Year Report|Randomized but not treated|46|||
28089116|NCT00036270|54742941|FG001|Study Treatment to 5 Year Report|Randomized but not treated|54|||
28089117|NCT00036270|54742940|FG000|Study Treatment to 5 Year Report|Protocol Violation|23|||
28089118|NCT00036270|54742941|FG001|Study Treatment to 5 Year Report|Protocol Violation|91|||
28089119|NCT00036270|54742940|FG000|Study Treatment to 5 Year Report|Intercurrent illness|17|||
28089120|NCT00036270|54742941|FG001|Study Treatment to 5 Year Report|Intercurrent illness|29|||
28089121|NCT00036270|54742940|FG000|Study Treatment to 5 Year Report|Too early switch|0|||
28089122|NCT00036270|54742941|FG001|Study Treatment to 5 Year Report|Too early switch|103|||
28089123|NCT00036270|54742940|FG000|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0|||
28089124|NCT00036270|54742941|FG001|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750|||
28089125|NCT00301067|54742947|FG000|Completed DLT Period/1st Cycle|Progressive Disease|1|||
28089126|NCT00301067|54742948|FG001|Completed DLT Period/1st Cycle|Progressive Disease|0|||
28089127|NCT00301067|54742949|FG002|Completed DLT Period/1st Cycle|Progressive Disease|0|||
28089128|NCT00301067|54742950|FG003|Completed DLT Period/1st Cycle|Progressive Disease|1|||
28089129|NCT00301067|54742947|FG000|Reached 1st Response/2 Cycles|Progressive Disease|2|||
28089130|NCT00301067|54742948|FG001|Reached 1st Response/2 Cycles|Progressive Disease|1|||
28089131|NCT00301067|54742949|FG002|Reached 1st Response/2 Cycles|Progressive Disease|1|||
28089132|NCT00301067|54742950|FG003|Reached 1st Response/2 Cycles|Progressive Disease|2|||
28089133|NCT00301067|54742947|FG000|Completed 4 Cycles of Treatment|Progressive disease|1|||
28089134|NCT00301067|54742948|FG001|Completed 4 Cycles of Treatment|Progressive disease|1|||
28089135|NCT00301067|54742949|FG002|Completed 4 Cycles of Treatment|Progressive disease|2|||
28089136|NCT00301067|54742950|FG003|Completed 4 Cycles of Treatment|Progressive disease|5|||
28089137|NCT00301067|54742947|FG000|Completed 12 Cycles of Treatment|Progressive Disease|0|||
28089138|NCT00301067|54742948|FG001|Completed 12 Cycles of Treatment|Progressive Disease|1|||
28166189|NCT01060111|54836959|FG000|Overall Study|Adverse Event|9|||
28166190|NCT01060111|54836960|FG001|Overall Study|Adverse Event|5|||
28166191|NCT01060111|54836961|FG002|Overall Study|Adverse Event|18|||
28166192|NCT01060111|54836959|FG000|Overall Study|Lack of Efficacy|2|||
28166193|NCT01060111|54836960|FG001|Overall Study|Lack of Efficacy|1|||
28166194|NCT01060111|54836961|FG002|Overall Study|Lack of Efficacy|0|||
28166195|NCT01060111|54836959|FG000|Overall Study|Inappropriate participant|5|||
28166196|NCT01060111|54836960|FG001|Overall Study|Inappropriate participant|4|||
28166197|NCT01060111|54836961|FG002|Overall Study|Inappropriate participant|5|||
28166198|NCT01060111|54836959|FG000|Overall Study|Participants' evasion for hospital visit|0|||
28166199|NCT01060111|54836960|FG001|Overall Study|Participants' evasion for hospital visit|3|||
28166200|NCT01060111|54836961|FG002|Overall Study|Participants' evasion for hospital visit|2|||
28089139|NCT00301067|54742949|FG002|Completed 12 Cycles of Treatment|Progressive Disease|0|||
28089140|NCT00301067|54742950|FG003|Completed 12 Cycles of Treatment|Progressive Disease|1|||
28089141|NCT00301067|54742947|FG000|Completed 12 Cycles of Treatment|Adverse Event|0|||
28089142|NCT00301067|54742948|FG001|Completed 12 Cycles of Treatment|Adverse Event|0|||
28089143|NCT00301067|54742949|FG002|Completed 12 Cycles of Treatment|Adverse Event|0|||
28166201|NCT01060111|54836959|FG000|Overall Study|Participants' non-cooperation|8|||
28166202|NCT01060111|54836960|FG001|Overall Study|Participants' non-cooperation|6|||
28166203|NCT01060111|54836961|FG002|Overall Study|Participants' non-cooperation|6|||
27733558|NCT02688387|54181200|FG009|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
28089144|NCT00301067|54742950|FG003|Completed 12 Cycles of Treatment|Adverse Event|1|||
28166204|NCT01060111|54836959|FG000|Overall Study|Adverse event and insufficient effect|0|||
28166205|NCT01060111|54836960|FG001|Overall Study|Adverse event and insufficient effect|1|||
28089145|NCT00301067|54742947|FG000|Follow up Until Death|Alive at last data cut point|1|||
28089146|NCT00301067|54742948|FG001|Follow up Until Death|Alive at last data cut point|0|||
28089147|NCT00301067|54742949|FG002|Follow up Until Death|Alive at last data cut point|0|||
28089148|NCT00301067|54742950|FG003|Follow up Until Death|Alive at last data cut point|1|||
28089149|NCT00007020|54742961|FG000|Overall Study|Death|16|||
28089150|NCT00007020|54742961|FG000|Overall Study|Lost to Follow-up|13|||
28089151|NCT00007020|54742961|FG000|Overall Study|Pt withdrawn (worsening cholestasis)|1|||
28089152|NCT00007020|54742961|FG000|Overall Study|Pt withdrawn (liver transplant)|4|||
28089153|NCT00007020|54742961|FG000|Overall Study|Pt cared for by outside physician|4|||
28089154|NCT00007020|54742961|FG000|Overall Study|No evidence of treatment|6|||
28089155|NCT00300755|54742970|FG000|Overall Study|Adverse Event|1|||
28089156|NCT00300755|54742971|FG001|Overall Study|Adverse Event|2|||
28089157|NCT00300755|54742972|FG002|Overall Study|Adverse Event|1|||
28089158|NCT00300755|54742970|FG000|Overall Study|Withdrawal by Subject|0|||
28089159|NCT00300755|54742971|FG001|Overall Study|Withdrawal by Subject|2|||
28089160|NCT00300755|54742972|FG002|Overall Study|Withdrawal by Subject|0|||
28089161|NCT00300755|54742970|FG000|Overall Study|Protocol Violation|0|||
28089162|NCT00300755|54742971|FG001|Overall Study|Protocol Violation|0|||
28089163|NCT00300755|54742972|FG002|Overall Study|Protocol Violation|1|||
28089164|NCT00033540|54742980|FG000|Overall Study|Adverse Event|14|||
28089165|NCT00033540|54742980|FG000|Overall Study|Death|1|||
28089166|NCT00033540|54742980|FG000|Overall Study|Progression|26|||
28089167|NCT00033540|54742980|FG000|Overall Study|Withdrawal by Subject|6|||
28089168|NCT00033540|54742980|FG000|Overall Study|Other|5|||
28089169|NCT00033540|54742980|FG000|Overall Study|Ineligible|3|||
28089170|NCT00033540|54742980|FG000|Overall Study|Never received treatment|2|||
28089171|NCT00300365|54742987|FG000|Overall Study|Lost to Follow-up|1|||
28089172|NCT00300365|54742988|FG001|Overall Study|Lost to Follow-up|0|||
28089173|NCT00300365|54742987|FG000|Overall Study|Physician Decision|2|||
28089174|NCT00300365|54742988|FG001|Overall Study|Physician Decision|0|||
28089175|NCT00300365|54742987|FG000|Overall Study|Withdrawal by Subject|1|||
28089176|NCT00300365|54742988|FG001|Overall Study|Withdrawal by Subject|0|||
28089177|NCT00300365|54742987|FG000|Overall Study|Adverse Event|0|||
28089178|NCT00300365|54742988|FG001|Overall Study|Adverse Event|2|||
28089179|NCT00048048|54743003|FG000|Core Treatment|Withdrawal by Subject|0|||
28089180|NCT00048048|54743004|FG001|Core Treatment|Withdrawal by Subject|0|||
28089181|NCT00048048|54743005|FG002|Core Treatment|Withdrawal by Subject|1|||
28089182|NCT00048048|54743006|FG003|Core Treatment|Withdrawal by Subject|0|||
28089183|NCT00048048|54743007|FG004|Core Treatment|Withdrawal by Subject|0|||
28089184|NCT00048048|54743008|FG005|Core Treatment|Withdrawal by Subject|0|||
28089185|NCT00048048|54743009|FG006|Core Treatment|Withdrawal by Subject|0|||
28089186|NCT00048048|54743010|FG007|Core Treatment|Withdrawal by Subject|0|||
28089187|NCT00048048|54743011|FG008|Core Treatment|Withdrawal by Subject|0|||
28089188|NCT00048048|54743012|FG009|Core Treatment|Withdrawal by Subject|0|||
28089189|NCT00048048|54743013|FG010|Core Treatment|Withdrawal by Subject|0|||
28089190|NCT00048048|54743014|FG011|Core Treatment|Withdrawal by Subject|0|||
28089191|NCT00048048|54743003|FG000|Core Treatment|Adverse Event|0|||
28089192|NCT00048048|54743004|FG001|Core Treatment|Adverse Event|0|||
28089193|NCT00048048|54743005|FG002|Core Treatment|Adverse Event|0|||
28089194|NCT00048048|54743006|FG003|Core Treatment|Adverse Event|0|||
28089195|NCT00048048|54743007|FG004|Core Treatment|Adverse Event|0|||
28089196|NCT00048048|54743008|FG005|Core Treatment|Adverse Event|0|||
28089197|NCT00048048|54743009|FG006|Core Treatment|Adverse Event|0|||
28089198|NCT00048048|54743010|FG007|Core Treatment|Adverse Event|1|||
28089199|NCT00048048|54743011|FG008|Core Treatment|Adverse Event|0|||
28089200|NCT00048048|54743012|FG009|Core Treatment|Adverse Event|0|||
28089201|NCT00048048|54743013|FG010|Core Treatment|Adverse Event|0|||
28089202|NCT00048048|54743014|FG011|Core Treatment|Adverse Event|0|||
28089203|NCT00048048|54743003|FG000|Extension Year 1|Early withdrawals|0|||
28089204|NCT00048048|54743004|FG001|Extension Year 1|Early withdrawals|0|||
28089205|NCT00048048|54743005|FG002|Extension Year 1|Early withdrawals|0|||
28089206|NCT00048048|54743006|FG003|Extension Year 1|Early withdrawals|0|||
28089207|NCT00048048|54743007|FG004|Extension Year 1|Early withdrawals|0|||
28089208|NCT00048048|54743008|FG005|Extension Year 1|Early withdrawals|0|||
28089209|NCT00048048|54743009|FG006|Extension Year 1|Early withdrawals|0|||
28089210|NCT00048048|54743010|FG007|Extension Year 1|Early withdrawals|0|||
28089211|NCT00048048|54743011|FG008|Extension Year 1|Early withdrawals|0|||
28089212|NCT00048048|54743012|FG009|Extension Year 1|Early withdrawals|2|||
28089213|NCT00048048|54743013|FG010|Extension Year 1|Early withdrawals|2|||
28089214|NCT00048048|54743014|FG011|Extension Year 1|Early withdrawals|4|||
28089215|NCT00048048|54743003|FG000|Extension Year 2|Early withdrawals|0|||
28089216|NCT00048048|54743004|FG001|Extension Year 2|Early withdrawals|0|||
28089217|NCT00048048|54743005|FG002|Extension Year 2|Early withdrawals|0|||
28089218|NCT00048048|54743006|FG003|Extension Year 2|Early withdrawals|0|||
28089219|NCT00048048|54743007|FG004|Extension Year 2|Early withdrawals|0|||
28089220|NCT00048048|54743008|FG005|Extension Year 2|Early withdrawals|0|||
28089221|NCT00048048|54743009|FG006|Extension Year 2|Early withdrawals|0|||
28089222|NCT00048048|54743010|FG007|Extension Year 2|Early withdrawals|0|||
28089223|NCT00048048|54743011|FG008|Extension Year 2|Early withdrawals|0|||
28089224|NCT00048048|54743012|FG009|Extension Year 2|Early withdrawals|0|||
28089225|NCT00048048|54743013|FG010|Extension Year 2|Early withdrawals|4|||
28089226|NCT00048048|54743014|FG011|Extension Year 2|Early withdrawals|2|||
28089227|NCT00300053|54743044|FG000|Overall Study|Patient/Caregiver Preference|2|||
28089228|NCT00300053|54743045|FG001|Overall Study|Patient/Caregiver Preference|2|||
28089229|NCT00300053|54743046|FG002|Overall Study|Patient/Caregiver Preference|3|||
27980525|NCT03927105|54638493|FG000|Overall Study|Subject was never treated due to new medical problems causing ineligibility prior to treatment.|1|||
27980526|NCT00613327|54638497|FG000|Overall Study|Adverse Event|38|||
27980527|NCT00613327|54638497|FG000|Overall Study|Lost to Follow-up|8|||
27980528|NCT00613327|54638497|FG000|Overall Study|Withdrawal by Subject|6|||
27980529|NCT00613327|54638497|FG000|Overall Study|Protocol Violation|2|||
27980530|NCT00613327|54638497|FG000|Overall Study|Other|47|||
28089230|NCT00300053|54743044|FG000|Overall Study|Death|0|||
28089231|NCT00300053|54743045|FG001|Overall Study|Death|0|||
28089232|NCT00300053|54743046|FG002|Overall Study|Death|3|||
28089233|NCT00300053|54743044|FG000|Overall Study|Lost to Follow-up|0|||
28089234|NCT00300053|54743045|FG001|Overall Study|Lost to Follow-up|1|||
28089235|NCT00300053|54743046|FG002|Overall Study|Lost to Follow-up|0|||
28089236|NCT00299975|54743058|FG000|Overall Study|Adverse Event|1|||
28089237|NCT00299975|54743059|FG001|Overall Study|Adverse Event|0|||
28089238|NCT00299975|54743060|FG002|Overall Study|Adverse Event|2|||
28089239|NCT00299975|54743058|FG000|Overall Study|Pregnancy|0|||
28089240|NCT00299975|54743059|FG001|Overall Study|Pregnancy|0|||
28089241|NCT00299975|54743060|FG002|Overall Study|Pregnancy|1|||
28089242|NCT00299975|54743058|FG000|Overall Study|Lack of Efficacy|1|||
28089243|NCT00299975|54743059|FG001|Overall Study|Lack of Efficacy|0|||
28089244|NCT00299975|54743060|FG002|Overall Study|Lack of Efficacy|1|||
28089245|NCT00299975|54743058|FG000|Overall Study|Lost to Follow-up|1|||
28089246|NCT00299975|54743059|FG001|Overall Study|Lost to Follow-up|0|||
28089247|NCT00299975|54743060|FG002|Overall Study|Lost to Follow-up|0|||
28089248|NCT00299975|54743058|FG000|Overall Study|Withdrawal by Subject|0|||
28089249|NCT00299975|54743059|FG001|Overall Study|Withdrawal by Subject|1|||
28089250|NCT00299975|54743060|FG002|Overall Study|Withdrawal by Subject|3|||
28089251|NCT00299975|54743058|FG000|Overall Study|Physician Decision|0|||
28089252|NCT00299975|54743059|FG001|Overall Study|Physician Decision|0|||
28089253|NCT00299975|54743060|FG002|Overall Study|Physician Decision|1|||
28089254|NCT00004980|54743070|FG000|Overall Study|Withdrawal by Subject|1|||
28089255|NCT00004980|54743071|FG001|Overall Study|Withdrawal by Subject|0|||
28089256|NCT00004980|54743070|FG000|Overall Study|memory difficulties|1|||
28089257|NCT00004980|54743071|FG001|Overall Study|memory difficulties|1|||
28089258|NCT00004980|54743070|FG000|Overall Study|Physician Decision|0|||
28089259|NCT00004980|54743071|FG001|Overall Study|Physician Decision|1|||
28089260|NCT00326963|54743077|FG000|Overall Study|Adverse Event|2|||
28089261|NCT00326963|54743077|FG000|Overall Study|Injection site reaction|1|||
28089262|NCT00326963|54743077|FG000|Overall Study|Death|1|||
28089263|NCT00326963|54743077|FG000|Overall Study|Failure to return|10|||
28089264|NCT00326963|54743077|FG000|Overall Study|Withdrawal by Subject|10|||
28089265|NCT00326963|54743077|FG000|Overall Study|Refused treatment / did not cooperate|5|||
28089266|NCT00326963|54743077|FG000|Overall Study|Violation of selection criteria at entry|2|||
28089267|NCT00326963|54743077|FG000|Overall Study|Other protocol violation|1|||
28089268|NCT00326963|54743077|FG000|Overall Study|Administrative / other|1|||
28089269|NCT00326885|54743082|FG000|Overall Study|Adverse Event|1|||
28089270|NCT00326885|54743082|FG000|Overall Study|Withdrawal by Subject|3|||
28089271|NCT00326885|54743082|FG000|Overall Study|Physician Decision|1|||
28089272|NCT00326885|54743082|FG000|Overall Study|Hospice withdrew consent|2|||
28089273|NCT00326495|54743087|FG000|Overall Study|Switched to alternative treatment|1|||
28089274|NCT00326495|54743087|FG000|Overall Study|Disease progression before treatment|1|||
28089275|NCT00326495|54743087|FG000|Overall Study|Refused further treatment|2|||
28089276|NCT00326495|54743087|FG000|Overall Study|Subject off study before assessment|1|||
28089277|NCT00326417|54743093|FG000|Overall Study|Withdrawal by Subject|0|||
28089278|NCT00326417|54743094|FG001|Overall Study|Withdrawal by Subject|0|||
28089279|NCT00326417|54743095|FG002|Overall Study|Withdrawal by Subject|1|||
28089280|NCT00326417|54743096|FG003|Overall Study|Withdrawal by Subject|0|||
28089281|NCT00326417|54743093|FG000|Overall Study|Arm Closed|7|||
28089282|NCT00326417|54743094|FG001|Overall Study|Arm Closed|0|||
28089283|NCT00326417|54743095|FG002|Overall Study|Arm Closed|0|||
28089284|NCT00326417|54743096|FG003|Overall Study|Arm Closed|3|||
28089285|NCT00326417|54743093|FG000|Overall Study|Death|7|||
28089286|NCT00326417|54743094|FG001|Overall Study|Death|0|||
28089287|NCT00326417|54743095|FG002|Overall Study|Death|0|||
28089288|NCT00326417|54743096|FG003|Overall Study|Death|0|||
28089289|NCT03825341|54743106|FG000|Overall Study|Withdrawal by Subject|0|||
28089290|NCT03825341|54743107|FG001|Overall Study|Withdrawal by Subject|1|||
28089291|NCT00297479|54743118|FG000|Overall Study|Lost to Follow-up|37|||
28089292|NCT00297479|54743119|FG001|Overall Study|Lost to Follow-up|54|||
27980531|NCT00954941|54638503|FG000|Overall Study|Received treatment at home|1|||
28089293|NCT00297479|54743120|FG002|Overall Study|Lost to Follow-up|51|||
28089294|NCT00688870|54743130|FG000|Infant Series|Parent or legal guardian request|4|||
28089295|NCT00688870|54743131|FG001|Infant Series|Parent or legal guardian request|0|||
28089296|NCT00297167|54743141|FG000|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
28089297|NCT00297167|54743142|FG001|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
28089298|NCT00297167|54743143|FG002|Open-label Dose Normalization Period 1|Withdrawal by Subject|1|||
28089299|NCT00297167|54743141|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
28089300|NCT00297167|54743142|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
28089301|NCT00297167|54743143|FG002|Second Double-blind Intervention Period|Protocol Violation|0|||
28089302|NCT03216226|54743152|FG000|Overall Study|Adverse Event|3|||
28089303|NCT03216226|54743153|FG001|Overall Study|Adverse Event|0|||
28089304|NCT03216226|54743152|FG000|Overall Study|Protocol Violation|1|||
28089305|NCT03216226|54743153|FG001|Overall Study|Protocol Violation|3|||
28089306|NCT03216226|54743152|FG000|Overall Study|Patient unable to take time off work to come in for the third injection|1|||
28089307|NCT03216226|54743153|FG001|Overall Study|Patient unable to take time off work to come in for the third injection|0|||
28089308|NCT03216226|54743152|FG000|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0|||
28089309|NCT03216226|54743153|FG001|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1|||
28089310|NCT03216226|54743152|FG000|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0|||
28089311|NCT03216226|54743153|FG001|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1|||
28089312|NCT03215758|54743161|FG000|Overall Study|Technical Problems|1|||
28089313|NCT03215758|54743162|FG001|Overall Study|Technical Problems|0|||
28089314|NCT03215758|54743161|FG000|Overall Study|Protocol deviation|0|||
28089315|NCT03215758|54743162|FG001|Overall Study|Protocol deviation|1|||
28089316|NCT03215758|54743161|FG000|Overall Study|Physician Decision|0|||
28089317|NCT03215758|54743162|FG001|Overall Study|Physician Decision|1|||
28089318|NCT03215758|54743161|FG000|Overall Study|Death|0|||
28089319|NCT03215758|54743162|FG001|Overall Study|Death|1|||
28089320|NCT03215758|54743161|FG000|Overall Study|Adverse Event|1|||
28089321|NCT03215758|54743162|FG001|Overall Study|Adverse Event|2|||
28089322|NCT03215758|54743161|FG000|Overall Study|Subject/Guardian Decision|3|||
28089323|NCT03215758|54743162|FG001|Overall Study|Subject/Guardian Decision|3|||
28089324|NCT00290771|54743170|FG000|Overall Study|Disease progression|95|||
28089325|NCT00290771|54743171|FG001|Overall Study|Disease progression|73|||
28089326|NCT00290771|54743170|FG000|Overall Study|Death|11|||
28089327|NCT00290771|54743171|FG001|Overall Study|Death|10|||
28089328|NCT00290771|54743170|FG000|Overall Study|Adverse Event|12|||
28089329|NCT00290771|54743171|FG001|Overall Study|Adverse Event|6|||
28089330|NCT00290771|54743170|FG000|Overall Study|Withdrawal by Subject|5|||
28089331|NCT00290771|54743171|FG001|Overall Study|Withdrawal by Subject|6|||
28089332|NCT00290771|54743170|FG000|Overall Study|Administrative problems|2|||
28089333|NCT00290771|54743171|FG001|Overall Study|Administrative problems|1|||
28089334|NCT00290771|54743170|FG000|Overall Study|Protocol Violation|2|||
28089335|NCT00290771|54743171|FG001|Overall Study|Protocol Violation|0|||
28089336|NCT00290771|54743170|FG000|Overall Study|Lost to Follow-up|0|||
28089337|NCT00290771|54743171|FG001|Overall Study|Lost to Follow-up|1|||
28089338|NCT00274625|54743180|FG000|Overall Study|Lost to Follow-up|46|||
28089339|NCT00274625|54743181|FG001|Overall Study|Lost to Follow-up|54|||
28089340|NCT00274625|54743180|FG000|Overall Study|Excluded from analysis|14|||
27980532|NCT00954941|54638504|FG001|Overall Study|Received treatment at home|0|||
27980533|NCT00954941|54638503|FG000|Overall Study|Withdrawal by Subject|1|||
27980534|NCT00954941|54638504|FG001|Overall Study|Withdrawal by Subject|0|||
27980535|NCT00954941|54638503|FG000|Overall Study|Insurance Denial|2|||
27980536|NCT00954941|54638504|FG001|Overall Study|Insurance Denial|2|||
27980537|NCT00954941|54638503|FG000|Overall Study|Physician Decision|2|||
27980538|NCT00954941|54638504|FG001|Overall Study|Physician Decision|2|||
27980539|NCT00954941|54638503|FG000|Overall Study|Ineligible|2|||
27980540|NCT00954941|54638504|FG001|Overall Study|Ineligible|2|||
27980541|NCT00954941|54638503|FG000|Overall Study|Adverse Event|0|||
27980542|NCT00954941|54638504|FG001|Overall Study|Adverse Event|1|||
27980543|NCT00954707|54638510|FG000|Overall Study|Death|34|||
27980544|NCT00954707|54638510|FG000|Overall Study|Withdrawal by Subject|100|||
28089341|NCT00274625|54743181|FG001|Overall Study|Excluded from analysis|8|||
28089342|NCT00290693|54743187|FG000|Overall Study|Withdrawal by Subject|2|||
28089343|NCT03214666|54743198|FG000|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
28089344|NCT03214666|54743199|FG001|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
28089345|NCT03214666|54743200|FG002|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
28089346|NCT03214666|54743201|FG003|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
27980545|NCT00954707|54638510|FG000|Overall Study|Lost to Follow-up|33|||
27980546|NCT00589797|54638516|FG000|Overall Study|Death|1|||
27980547|NCT00589797|54638517|FG001|Overall Study|Death|0|||
27980548|NCT00589797|54638516|FG000|Overall Study|Lost to Follow-up|12|||
27980549|NCT00589797|54638517|FG001|Overall Study|Lost to Follow-up|9|||
27980550|NCT00589797|54638516|FG000|Overall Study|Physician Decision|8|||
28089347|NCT03214666|54743202|FG004|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|1|||
28089348|NCT03214666|54743203|FG005|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
28089349|NCT00274469|54743220|FG000|Overall Study|Death|63|||
28089350|NCT00274469|54743221|FG001|Overall Study|Death|74|||
28089351|NCT00274469|54743220|FG000|Overall Study|Did not consent to OS follow-up|16|||
28089352|NCT00274469|54743221|FG001|Overall Study|Did not consent to OS follow-up|19|||
28089353|NCT03214588|54743230|FG000|Overall Study|Adverse Event|1|||
28089354|NCT03214588|54743231|FG001|Overall Study|Adverse Event|0|||
28089355|NCT03214588|54743232|FG002|Overall Study|Adverse Event|2|||
28089356|NCT03214588|54743230|FG000|Overall Study|Reason Not Specified|0|||
28089357|NCT03214588|54743231|FG001|Overall Study|Reason Not Specified|1|||
28089358|NCT03214588|54743232|FG002|Overall Study|Reason Not Specified|0|||
28089359|NCT03166618|54743242|FG000|Overall Study|Study was Terminated|0|||
28089360|NCT03166618|54743243|FG001|Overall Study|Study was Terminated|1|||
28089361|NCT03162796|54743260|FG000|Placebo Controlled Period: Week 0 - 24|Other|0|||
28089362|NCT03162796|54743261|FG001|Placebo Controlled Period: Week 0 - 24|Other|1|||
28089363|NCT03162796|54743262|FG002|Placebo Controlled Period: Week 0 - 24|Other|1|||
28089364|NCT03162796|54743260|FG000|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1|||
28089365|NCT03162796|54743261|FG001|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
28089366|NCT03162796|54743262|FG002|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
28089367|NCT03162796|54743260|FG000|Placebo Controlled Period: Week 0 - 24|Death|1|||
28089368|NCT03162796|54743261|FG001|Placebo Controlled Period: Week 0 - 24|Death|0|||
27733559|NCT02688387|54181201|FG010|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
27733560|NCT02688387|54181202|FG011|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
27733561|NCT02688387|54181203|FG012|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
27733562|NCT02688387|54181204|FG013|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
27733563|NCT02688387|54181205|FG014|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
27733564|NCT02688387|54181206|FG015|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
27733565|NCT02688387|54181207|FG016|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
27733566|NCT02688387|54181208|FG017|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
27733567|NCT02688387|54181209|FG018|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
27733568|NCT02688387|54181210|FG019|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
27733569|NCT02688387|54181211|FG020|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
27733570|NCT02688387|54181212|FG021|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
27733571|NCT02688387|54181191|FG000|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
27733572|NCT02688387|54181192|FG001|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
27733573|NCT02688387|54181193|FG002|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
27733574|NCT02688387|54181194|FG003|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
27733575|NCT02688387|54181195|FG004|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
27733576|NCT02688387|54181196|FG005|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
27733577|NCT02688387|54181197|FG006|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
27733578|NCT02688387|54181198|FG007|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
27733579|NCT02688387|54181199|FG008|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
27733580|NCT02688387|54181200|FG009|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
27980551|NCT00589797|54638517|FG001|Overall Study|Physician Decision|3|||
27980552|NCT00589797|54638516|FG000|Overall Study|Withdrawal by Subject|6|||
27980553|NCT00589797|54638517|FG001|Overall Study|Withdrawal by Subject|5|||
27980554|NCT00589797|54638516|FG000|Overall Study|Non-Randomized Training Subjects|46|||
27980555|NCT00589797|54638517|FG001|Overall Study|Non-Randomized Training Subjects|6|||
27980556|NCT00613171|54638523|FG000|Overall Study|Adverse Event|7|||
27980557|NCT00613171|54638523|FG000|Overall Study|Withdrawal by Subject|3|||
27980558|NCT00613171|54638523|FG000|Overall Study|Reason not Specified|4|||
27980559|NCT00896480|54638528|FG000|Overall Study|Disease progression/recurrence|21|||
27980560|NCT00953225|54638537|FG000|Overall Study|Withdrawal by Subject|2|||
27980561|NCT00953225|54638538|FG001|Overall Study|Withdrawal by Subject|0|||
27980562|NCT00613015|54638550|FG000|Overall Study|Lost to Follow-up|0|||
27980563|NCT00613015|54638551|FG001|Overall Study|Lost to Follow-up|1|||
27980564|NCT00613015|54638552|FG002|Overall Study|Lost to Follow-up|3|||
27980565|NCT00613015|54638553|FG003|Overall Study|Lost to Follow-up|3|||
27980566|NCT00613015|54638554|FG004|Overall Study|Lost to Follow-up|2|||
27980567|NCT00613015|54638555|FG005|Overall Study|Lost to Follow-up|3|||
27980568|NCT00803595|54638572|FG000|Overall Study|Adverse Event|3|||
27980569|NCT00803595|54638573|FG001|Overall Study|Adverse Event|4|||
27980570|NCT00803595|54638574|FG002|Overall Study|Adverse Event|1|||
27980571|NCT00803595|54638572|FG000|Overall Study|Protocol Violation|7|||
28089369|NCT03162796|54743262|FG002|Placebo Controlled Period: Week 0 - 24|Death|0|||
28089370|NCT03162796|54743260|FG000|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1|||
27980572|NCT00803595|54638573|FG001|Overall Study|Protocol Violation|2|||
27980573|NCT00803595|54638574|FG002|Overall Study|Protocol Violation|12|||
27980574|NCT00803595|54638572|FG000|Overall Study|Withdrawal by Subject|5|||
28089371|NCT03162796|54743261|FG001|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
27980575|NCT00803595|54638573|FG001|Overall Study|Withdrawal by Subject|2|||
28089372|NCT03162796|54743262|FG002|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
28089373|NCT03162796|54743260|FG000|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3|||
28089374|NCT03162796|54743261|FG001|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
28089375|NCT03162796|54743262|FG002|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
28089376|NCT03162796|54743260|FG000|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4|||
28089377|NCT03162796|54743261|FG001|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
28089378|NCT03162796|54743262|FG002|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
28089379|NCT03162796|54743260|FG000|Placebo Controlled Period: Week 0 - 24|Adverse Event|2|||
28089380|NCT03162796|54743261|FG001|Placebo Controlled Period: Week 0 - 24|Adverse Event|3|||
27733581|NCT02688387|54181201|FG010|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
27733582|NCT02688387|54181202|FG011|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
27733583|NCT02688387|54181203|FG012|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
27733584|NCT02688387|54181204|FG013|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
27733585|NCT02688387|54181205|FG014|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
27733586|NCT02688387|54181206|FG015|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
27733587|NCT02688387|54181207|FG016|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
27733588|NCT02688387|54181208|FG017|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
27733589|NCT02688387|54181209|FG018|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
27733590|NCT02688387|54181210|FG019|Part 3B, Washout Period 3 (10 Days)|Study terminated|1|||
27733591|NCT02688387|54181211|FG020|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
28089381|NCT03162796|54743262|FG002|Placebo Controlled Period: Week 0 - 24|Adverse Event|1|||
28089382|NCT03162796|54743260|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
28089383|NCT03162796|54743261|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
28089384|NCT03162796|54743262|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
28089385|NCT03162796|54743260|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
28089386|NCT03162796|54743261|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
28089387|NCT03162796|54743262|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1|||
28089388|NCT03162796|54743260|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
28089389|NCT03162796|54743261|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|2|||
28089390|NCT03162796|54743262|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
28089391|NCT03162796|54743260|FG000|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
28089392|NCT03162796|54743261|FG001|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2|||
28089393|NCT03162796|54743262|FG002|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
28089394|NCT03162328|54743275|FG000|Screening Period|Did not meet inclusion/exclusion|21|||
28089395|NCT03162328|54743276|FG001|Screening Period|Did not meet inclusion/exclusion|0|||
28089396|NCT03162328|54743277|FG002|Screening Period|Did not meet inclusion/exclusion|0|||
28089397|NCT03162328|54743275|FG000|Screening Period|Withdrawal by Subject|1|||
28089398|NCT03162328|54743276|FG001|Screening Period|Withdrawal by Subject|0|||
28089399|NCT03162328|54743277|FG002|Screening Period|Withdrawal by Subject|0|||
28089400|NCT03162328|54743275|FG000|Study Period|Withdrawal by Subject|0|||
28089401|NCT03162328|54743276|FG001|Study Period|Withdrawal by Subject|0|||
28089402|NCT03162328|54743277|FG002|Study Period|Withdrawal by Subject|1|||
28089403|NCT00272987|54743291|FG000|Overall Study|Adverse Event|1|||
28089404|NCT00272987|54743292|FG001|Overall Study|Adverse Event|0|||
28089405|NCT00272987|54743293|FG002|Overall Study|Adverse Event|0|||
28089406|NCT00272987|54743291|FG000|Overall Study|Lost to Follow-up|3|||
28089407|NCT00272987|54743292|FG001|Overall Study|Lost to Follow-up|1|||
28089408|NCT00272987|54743293|FG002|Overall Study|Lost to Follow-up|1|||
28089409|NCT00272987|54743291|FG000|Overall Study|Withdrawal by Subject|1|||
28089410|NCT00272987|54743292|FG001|Overall Study|Withdrawal by Subject|0|||
28166206|NCT01060111|54836961|FG002|Overall Study|Adverse event and insufficient effect|0|||
28166207|NCT01060111|54836959|FG000|Overall Study|Participants' non-cooperation|1|||
28166208|NCT01060111|54836960|FG001|Overall Study|Participants' non-cooperation|0|||
28166209|NCT01060111|54836961|FG002|Overall Study|Participants' non-cooperation|0|||
28166210|NCT01060111|54836959|FG000|Overall Study|Other|2|||
28166211|NCT01060111|54836960|FG001|Overall Study|Other|3|||
28166212|NCT01060111|54836961|FG002|Overall Study|Other|4|||
27733592|NCT02688387|54181212|FG021|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
27733593|NCT02476201|54181258|FG000|Overall Study|Unable to program MPP|9|||
27733594|NCT02476201|54181258|FG000|Overall Study|Study echo not performed|5|||
27733595|NCT02476201|54181258|FG000|Overall Study|Adverse Event|4|||
27733596|NCT02476201|54181258|FG000|Overall Study|Death|2|||
27733597|NCT02476201|54181258|FG000|Overall Study|Lost to Follow-up|2|||
28089411|NCT00272987|54743293|FG002|Overall Study|Withdrawal by Subject|3|||
28089412|NCT00272987|54743291|FG000|Overall Study|Sponsor Terminated study|0|||
28089413|NCT00272987|54743292|FG001|Overall Study|Sponsor Terminated study|1|||
28089414|NCT00272987|54743293|FG002|Overall Study|Sponsor Terminated study|1|||
27733598|NCT02476201|54181258|FG000|Overall Study|MPP programmed to OFF|2|||
28089415|NCT00272987|54743291|FG000|Overall Study|Disease progression|1|||
28166213|NCT02969863|54836972|FG000|Overall Study|Physician Decision|1|||
28089416|NCT00272987|54743292|FG001|Overall Study|Disease progression|1|||
28089417|NCT00272987|54743293|FG002|Overall Study|Disease progression|2|||
28089418|NCT00272987|54743291|FG000|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2|||
28089419|NCT00272987|54743292|FG001|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1|||
28089420|NCT00272987|54743293|FG002|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4|||
28089421|NCT00272987|54743291|FG000|Overall Study|Death|1|||
28089422|NCT00272987|54743292|FG001|Overall Study|Death|0|||
28089423|NCT00272987|54743293|FG002|Overall Study|Death|0|||
28089424|NCT01730950|54743303|FG000|Overall Study|Protocol Violation|6|||
28089425|NCT01730950|54743304|FG001|Overall Study|Protocol Violation|6|||
28089426|NCT00271505|54743311|FG000|Overall Study|Screen Failure|3|||
28089427|NCT00271505|54743311|FG000|Overall Study|Adverse Event|1|||
28089428|NCT00271505|54743311|FG000|Overall Study|Death|1|||
28089429|NCT01642186|54743319|FG000|Overall Study|Death|0|||
28089430|NCT01642186|54743320|FG001|Overall Study|Death|2|||
28089431|NCT01642186|54743321|FG002|Overall Study|Death|2|||
28089432|NCT01642186|54743319|FG000|Overall Study|Lost to Follow-up|0|||
28089433|NCT01642186|54743320|FG001|Overall Study|Lost to Follow-up|0|||
28089434|NCT01642186|54743321|FG002|Overall Study|Lost to Follow-up|1|||
28089435|NCT00423514|54743331|FG000|Overall Study|Ineligible|1|||
28089436|NCT00423514|54743332|FG001|Overall Study|Ineligible|0|||
28089437|NCT00289991|54743340|FG000|Overall Study|Death|35|||
28089438|NCT00289991|54743341|FG001|Overall Study|Death|38|||
28089439|NCT00289991|54743340|FG000|Overall Study|Adverse Event|15|||
28166214|NCT02969863|54836973|FG001|Overall Study|Physician Decision|0|||
28166215|NCT02969863|54836974|FG002|Overall Study|Physician Decision|0|||
28166216|NCT02969863|54836975|FG003|Overall Study|Physician Decision|0|||
28166217|NCT02969863|54836976|FG004|Overall Study|Physician Decision|0|||
28166218|NCT02969863|54836977|FG005|Overall Study|Physician Decision|0|||
28166219|NCT02969707|54836993|FG000|Overall Study|Adverse Event|1|||
28166220|NCT02969707|54836994|FG001|Overall Study|Adverse Event|2|||
28166221|NCT02969707|54836993|FG000|Overall Study|Lost to Follow-up|3|||
28166222|NCT02969707|54836994|FG001|Overall Study|Lost to Follow-up|0|||
28166223|NCT02969707|54836993|FG000|Overall Study|Physician Decision|0|||
28166224|NCT02969707|54836994|FG001|Overall Study|Physician Decision|1|||
28166225|NCT02969707|54836993|FG000|Overall Study|Protocol Violation|1|||
28166226|NCT02969707|54836994|FG001|Overall Study|Protocol Violation|1|||
28166227|NCT02969707|54836993|FG000|Overall Study|Withdrawal by Subject|3|||
28166228|NCT02969707|54836994|FG001|Overall Study|Withdrawal by Subject|4|||
28166229|NCT02967055|54837005|FG000|Overall Study|Excluded|40|||
28166230|NCT02967055|54837005|FG000|Overall Study|Screen fail|3|||
28166231|NCT02967055|54837005|FG000|Overall Study|Lost to Follow-up|2|||
28166232|NCT02967055|54837005|FG000|Overall Study|Stopped due to side effects|3|||
28166233|NCT02967055|54837005|FG000|Overall Study|Stopped due to drug cost|1|||
28166234|NCT02904265|54837011|FG000|Overall Study|Physician Decision|1|||
28166235|NCT02904265|54837012|FG001|Overall Study|Physician Decision|2|||
28166236|NCT03461211|54837020|FG000|Overall Study|Adverse Event|1|||
28166237|NCT03461211|54837021|FG001|Overall Study|Adverse Event|1|||
28166238|NCT03461211|54837020|FG000|Overall Study|Lack of Efficacy|0|||
28166239|NCT03461211|54837021|FG001|Overall Study|Lack of Efficacy|1|||
28166240|NCT02967679|54837029|FG000|Overall Study|Adverse Event|1|||
28166241|NCT02966509|54837039|FG000|Baseline Satisfaction Survey|Withdrawal by Subject|2|||
28166242|NCT02966509|54837040|FG001|Baseline Satisfaction Survey|Withdrawal by Subject|3|||
28089440|NCT00289991|54743341|FG001|Overall Study|Adverse Event|13|||
28089441|NCT00289991|54743340|FG000|Overall Study|Failure of prophylaxis|1|||
28089442|NCT00289991|54743341|FG001|Overall Study|Failure of prophylaxis|1|||
28089443|NCT00289991|54743340|FG000|Overall Study|Fungal breakthrough infection|0|||
28089444|NCT00289991|54743341|FG001|Overall Study|Fungal breakthrough infection|1|||
28089445|NCT00289991|54743340|FG000|Overall Study|Lost to Follow-up|0|||
28166243|NCT02966509|54837039|FG000|Baseline Satisfaction Survey|Death|0|||
28089446|NCT00289991|54743341|FG001|Overall Study|Lost to Follow-up|1|||
28089447|NCT00289991|54743340|FG000|Overall Study|Withdrawal by Subject|2|||
28089448|NCT00289991|54743341|FG001|Overall Study|Withdrawal by Subject|12|||
28089449|NCT00289991|54743340|FG000|Overall Study|Other|5|||
28089450|NCT00289991|54743341|FG001|Overall Study|Other|14|||
28166244|NCT02966509|54837040|FG001|Baseline Satisfaction Survey|Death|1|||
28166245|NCT02966509|54837039|FG000|Baseline Satisfaction Survey|Lost to Follow-up|1|||
28166246|NCT02966509|54837040|FG001|Baseline Satisfaction Survey|Lost to Follow-up|1|||
28166247|NCT02966509|54837039|FG000|Baseline Satisfaction Survey|Refused to Answer|1|||
28089451|NCT00289913|54743352|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
28089452|NCT00289913|54743353|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
28089453|NCT00289913|54743354|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
28089454|NCT00289913|54743355|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
28166248|NCT02966509|54837040|FG001|Baseline Satisfaction Survey|Refused to Answer|2|||
28166249|NCT02966509|54837039|FG000|6 Month Satisfaction Decision Survey|Death|22|||
28166250|NCT02966509|54837040|FG001|6 Month Satisfaction Decision Survey|Death|25|||
28166251|NCT02966509|54837039|FG000|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2|||
28089455|NCT00289913|54743356|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
28089456|NCT00289913|54743352|FG000|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3|||
28089457|NCT00289913|54743353|FG001|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
28089458|NCT00289913|54743354|FG002|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
28089459|NCT00289913|54743355|FG003|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
28089460|NCT00289913|54743356|FG004|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1|||
28089461|NCT00289913|54743352|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
28089462|NCT00289913|54743353|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
28089463|NCT00289913|54743354|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
28089464|NCT00289913|54743355|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
28089465|NCT00289913|54743356|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
28089466|NCT00289913|54743352|FG000|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
28089467|NCT00289913|54743353|FG001|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
28089468|NCT00289913|54743354|FG002|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
28089469|NCT00289913|54743355|FG003|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
28089470|NCT00289913|54743356|FG004|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1|||
28089471|NCT00289913|54743352|FG000|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
28089472|NCT00289913|54743353|FG001|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
28089473|NCT00289913|54743354|FG002|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
28089474|NCT00289913|54743355|FG003|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1|||
28089475|NCT00289913|54743356|FG004|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
28089476|NCT00289913|54743352|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
28089477|NCT00289913|54743353|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2|||
28089478|NCT00289913|54743354|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
28089479|NCT00289913|54743355|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
28089480|NCT00289913|54743356|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
28089481|NCT00289913|54743352|FG000|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2|||
28089482|NCT00289913|54743353|FG001|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1|||
28089483|NCT00289913|54743354|FG002|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
28089484|NCT00289913|54743355|FG003|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
28089485|NCT00289913|54743356|FG004|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5|||
28089486|NCT00289913|54743352|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
28089487|NCT00289913|54743353|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8|||
28089488|NCT00289913|54743354|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5|||
28089489|NCT00289913|54743355|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6|||
28089490|NCT00289913|54743356|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
28089491|NCT00289913|54743352|FG000|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1|||
28089492|NCT00289913|54743353|FG001|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
28089493|NCT00289913|54743354|FG002|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2|||
28089494|NCT00289913|54743355|FG003|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
28089495|NCT00289913|54743356|FG004|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
28089496|NCT00289913|54743352|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
28089497|NCT00289913|54743353|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
28089498|NCT00289913|54743354|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
28089499|NCT00289913|54743355|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
28089500|NCT00289913|54743356|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
28089501|NCT00289913|54743352|FG000|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8|||
28089502|NCT00289913|54743353|FG001|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11|||
28089503|NCT00289913|54743354|FG002|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
28089504|NCT00289913|54743355|FG003|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
28089505|NCT00289913|54743356|FG004|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0|||
28089506|NCT00289913|54743352|FG000|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
27980576|NCT00803595|54638574|FG002|Overall Study|Withdrawal by Subject|3|||
27980577|NCT00953927|54638584|FG000|Overall Study|Lost to Follow-up|61|||
27980578|NCT00953927|54638585|FG001|Overall Study|Lost to Follow-up|65|||
27980579|NCT00953927|54638584|FG000|Overall Study|Withdrawal by Subject|36|||
27980580|NCT00953927|54638585|FG001|Overall Study|Withdrawal by Subject|25|||
27980581|NCT00953927|54638584|FG000|Overall Study|Death|7|||
27980582|NCT00953927|54638585|FG001|Overall Study|Death|4|||
27980583|NCT00953927|54638584|FG000|Overall Study|Other study discontinuation|1|||
27980584|NCT00953927|54638585|FG001|Overall Study|Other study discontinuation|1|||
27980585|NCT00611767|54638593|FG000|Overall Study|Withdrawal by Subject|4|||
27980586|NCT00611767|54638594|FG001|Overall Study|Withdrawal by Subject|1|||
27980587|NCT00611767|54638593|FG000|Overall Study|Thiopental not available|3|||
28089507|NCT00289913|54743353|FG001|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1|||
28089508|NCT00289913|54743354|FG002|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
28089509|NCT00289913|54743355|FG003|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
28089510|NCT00289913|54743356|FG004|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
28089511|NCT00289913|54743352|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3|||
28089512|NCT00289913|54743353|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
28089513|NCT00289913|54743354|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
28089514|NCT00289913|54743355|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
28089515|NCT00289913|54743356|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
28089516|NCT00289913|54743352|FG000|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
28089517|NCT00289913|54743353|FG001|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
28089518|NCT00289913|54743354|FG002|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
28089519|NCT00289913|54743355|FG003|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
28089520|NCT00289913|54743356|FG004|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
28089521|NCT00289913|54743352|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
28089522|NCT00289913|54743353|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
28089523|NCT00289913|54743354|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3|||
28089524|NCT00289913|54743355|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
28089525|NCT00289913|54743356|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
28089526|NCT00289913|54743352|FG000|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2|||
28089527|NCT00289913|54743353|FG001|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5|||
28089528|NCT00289913|54743354|FG002|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
28089529|NCT00289913|54743355|FG003|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3|||
28089530|NCT00289913|54743356|FG004|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
28089531|NCT00289913|54743352|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
28089532|NCT00289913|54743353|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1|||
28089533|NCT00289913|54743354|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2|||
28089534|NCT00289913|54743355|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
28089535|NCT00289913|54743356|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
28089536|NCT00289913|54743352|FG000|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1|||
28089537|NCT00289913|54743353|FG001|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
28089538|NCT00289913|54743354|FG002|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
28089539|NCT00289913|54743355|FG003|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
28089540|NCT00289913|54743356|FG004|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
28089541|NCT00289913|54743352|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
28089542|NCT00289913|54743353|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
28089543|NCT00289913|54743354|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
28089544|NCT00289913|54743355|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
28089545|NCT00289913|54743356|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7|||
28089546|NCT00289913|54743352|FG000|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
28089547|NCT00289913|54743353|FG001|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
28089548|NCT00289913|54743354|FG002|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
28089549|NCT00289913|54743355|FG003|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
28089550|NCT00289913|54743356|FG004|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11|||
28089551|NCT00289913|54743352|FG000|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
28089552|NCT00289913|54743353|FG001|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
28089553|NCT00289913|54743354|FG002|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
28089554|NCT00289913|54743355|FG003|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
28089555|NCT00289913|54743356|FG004|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6|||
28089556|NCT00289913|54743352|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
28089557|NCT00289913|54743353|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
28089558|NCT00289913|54743354|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
28089559|NCT00289913|54743355|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
28089560|NCT00289913|54743356|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7|||
28089561|NCT00289913|54743352|FG000|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
28089562|NCT00289913|54743353|FG001|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
28089563|NCT00289913|54743354|FG002|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
28089564|NCT00289913|54743355|FG003|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
28089565|NCT00289913|54743356|FG004|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9|||
28166252|NCT02966509|54837040|FG001|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3|||
28166253|NCT02966509|54837039|FG000|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
27733599|NCT02476201|54181258|FG000|Overall Study|Withdrawal by Subject|1|||
27733600|NCT02476201|54181258|FG000|Overall Study|Unsuccessful implant|1|||
28089566|NCT00289913|54743352|FG000|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
28089567|NCT00289913|54743353|FG001|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
28089568|NCT00289913|54743354|FG002|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
28089569|NCT00289913|54743355|FG003|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
28089570|NCT00289913|54743356|FG004|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
28089571|NCT00289913|54743352|FG000|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8|||
28089572|NCT00289913|54743353|FG001|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3|||
28089573|NCT00289913|54743354|FG002|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1|||
28089574|NCT00289913|54743355|FG003|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
28089575|NCT00289913|54743356|FG004|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
28089576|NCT00289913|54743352|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
28089577|NCT00289913|54743353|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
28089578|NCT00289913|54743354|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
28089579|NCT00289913|54743355|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
28089580|NCT00289913|54743356|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
28089581|NCT00289913|54743352|FG000|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
28089582|NCT00289913|54743353|FG001|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
28089583|NCT00289913|54743354|FG002|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
27980588|NCT00611767|54638594|FG001|Overall Study|Thiopental not available|0|||
27980589|NCT00611767|54638593|FG000|Overall Study|didn't like the medication|1|||
27980590|NCT00611767|54638594|FG001|Overall Study|didn't like the medication|1|||
28089584|NCT00289913|54743355|FG003|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
28089585|NCT00289913|54743356|FG004|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1|||
28089586|NCT00289913|54743352|FG000|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
28089587|NCT00289913|54743353|FG001|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2|||
28089588|NCT00289913|54743354|FG002|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0|||
28089589|NCT00289913|54743355|FG003|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
28089590|NCT00289913|54743356|FG004|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4|||
28089591|NCT00289913|54743352|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
28089592|NCT00289913|54743353|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
28089593|NCT00289913|54743354|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
28089594|NCT00289913|54743355|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
28089595|NCT00289913|54743356|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
28089596|NCT00289913|54743352|FG000|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
28089597|NCT00289913|54743353|FG001|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
28089598|NCT00289913|54743354|FG002|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
28089599|NCT00289913|54743355|FG003|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
28089600|NCT00289913|54743356|FG004|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1|||
28089601|NCT00289913|54743352|FG000|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
28089602|NCT00289913|54743353|FG001|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1|||
28089603|NCT00289913|54743354|FG002|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
28166254|NCT02966509|54837040|FG001|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
28166255|NCT02966509|54837039|FG000|6 Month Satisfaction Decision Survey|Refused to Answer|0|||
28166256|NCT02966509|54837040|FG001|6 Month Satisfaction Decision Survey|Refused to Answer|2|||
28166257|NCT02966509|54837039|FG000|6 Month Satisfaction Survey|Death|36|||
28166258|NCT02966509|54837040|FG001|6 Month Satisfaction Survey|Death|33|||
28166259|NCT02966509|54837039|FG000|6 Month Satisfaction Survey|Withdrawal by Subject|2|||
28166260|NCT02966509|54837040|FG001|6 Month Satisfaction Survey|Withdrawal by Subject|3|||
28166261|NCT02966509|54837039|FG000|6 Month Satisfaction Survey|Lost to Follow-up|1|||
28166262|NCT02966509|54837040|FG001|6 Month Satisfaction Survey|Lost to Follow-up|1|||
28166263|NCT02966509|54837039|FG000|6 Month Satisfaction Survey|Refused to Answer|8|||
28166264|NCT02966509|54837040|FG001|6 Month Satisfaction Survey|Refused to Answer|11|||
28166265|NCT02966509|54837039|FG000|End of Life Utilization and Cost 6 Month|Patient Still Alive|69|||
28166266|NCT02966509|54837040|FG001|End of Life Utilization and Cost 6 Month|Patient Still Alive|75|||
28166267|NCT02966509|54837039|FG000|End of Life Utilization and Cost 15month|Patient Still Alive|45|||
28166268|NCT02966509|54837040|FG001|End of Life Utilization and Cost 15month|Patient Still Alive|48|||
28166269|NCT02966353|54837046|FG000|Overall Study|Withdrawal by Subject|7|||
28166270|NCT02966353|54837046|FG000|Overall Study|Adverse Event|4|||
28166271|NCT02966353|54837046|FG000|Overall Study|Death|4|||
28166272|NCT02966353|54837046|FG000|Overall Study|Physician Decision|3|||
28166273|NCT02966353|54837046|FG000|Overall Study|Progressive disease|2|||
28166274|NCT02966353|54837046|FG000|Overall Study|Protocol deviation|2|||
28166275|NCT02965573|54837079|FG000|Overall Study|Lack of Efficacy|1|||
27833095|NCT04034238|54313531|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
27833096|NCT04034238|54313532|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
27980591|NCT00611767|54638593|FG000|Overall Study|Physician Decision|1|||
28089604|NCT00289913|54743355|FG003|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
28089605|NCT00289913|54743356|FG004|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
28089606|NCT00289289|54743374|FG000|Overall Study|Withdrawal by Subject|5|||
28089607|NCT00289289|54743375|FG001|Overall Study|Withdrawal by Subject|3|||
28089608|NCT00289289|54743376|FG002|Overall Study|Withdrawal by Subject|15|||
28089609|NCT00289289|54743374|FG000|Overall Study|Lost to Follow-up|1|||
28089610|NCT00289289|54743375|FG001|Overall Study|Lost to Follow-up|0|||
28089611|NCT00289289|54743376|FG002|Overall Study|Lost to Follow-up|1|||
28089612|NCT00289289|54743374|FG000|Overall Study|Death|4|||
28089613|NCT00289289|54743375|FG001|Overall Study|Death|2|||
28089614|NCT00289289|54743376|FG002|Overall Study|Death|5|||
28089615|NCT00289289|54743374|FG000|Overall Study|No implant attempted|0|||
28089616|NCT00289289|54743375|FG001|Overall Study|No implant attempted|0|||
28089617|NCT00289289|54743376|FG002|Overall Study|No implant attempted|1|||
28089618|NCT00289289|54743374|FG000|Overall Study|Physician Decision|1|||
28089619|NCT00289289|54743375|FG001|Overall Study|Physician Decision|0|||
28089620|NCT00289289|54743376|FG002|Overall Study|Physician Decision|6|||
28089621|NCT00289289|54743374|FG000|Overall Study|Non-study device implanted|2|||
28089622|NCT00289289|54743375|FG001|Overall Study|Non-study device implanted|1|||
28089623|NCT00289289|54743376|FG002|Overall Study|Non-study device implanted|3|||
28089624|NCT00289289|54743374|FG000|Overall Study|Did not meet inclusion/exclusion|0|||
28089625|NCT00289289|54743375|FG001|Overall Study|Did not meet inclusion/exclusion|0|||
28089626|NCT00289289|54743376|FG002|Overall Study|Did not meet inclusion/exclusion|6|||
28089627|NCT00289289|54743374|FG000|Overall Study|Other Exit Reason|6|||
28089628|NCT00289289|54743375|FG001|Overall Study|Other Exit Reason|4|||
28089629|NCT00289289|54743376|FG002|Overall Study|Other Exit Reason|12|||
28089630|NCT00270257|54743385|FG000|Overall Study|Data Safety Monitoring Board (DSMB) halt|412|||
28089631|NCT00270257|54743386|FG001|Overall Study|Data Safety Monitoring Board (DSMB) halt|424|||
28089632|NCT00269633|54743396|FG000|Overall Study|Withdrawal by Subject|1|||
28089633|NCT00269633|54743397|FG001|Overall Study|Withdrawal by Subject|0|||
28089634|NCT00269477|54743407|FG000|Overall Study|Protocol Violation|5|||
28089635|NCT00269477|54743408|FG001|Overall Study|Protocol Violation|5|||
28089636|NCT00269477|54743409|FG002|Overall Study|Protocol Violation|1|||
28089637|NCT00269477|54743410|FG003|Overall Study|Protocol Violation|0|||
28089638|NCT00269477|54743407|FG000|Overall Study|Missed post-vaccination blood draw|0|||
28089639|NCT00269477|54743408|FG001|Overall Study|Missed post-vaccination blood draw|1|||
28089640|NCT00269477|54743409|FG002|Overall Study|Missed post-vaccination blood draw|0|||
28089641|NCT00269477|54743410|FG003|Overall Study|Missed post-vaccination blood draw|0|||
28089642|NCT00269399|54743422|FG000|Overall Study|Lack of Efficacy|27|||
28089643|NCT00269399|54743423|FG001|Overall Study|Lack of Efficacy|10|||
28089644|NCT00269399|54743422|FG000|Overall Study|Adverse Event|10|||
28089645|NCT00269399|54743423|FG001|Overall Study|Adverse Event|4|||
28089646|NCT00269399|54743422|FG000|Overall Study|Withdrawal by Subject|2|||
28089647|NCT00269399|54743423|FG001|Overall Study|Withdrawal by Subject|5|||
28089648|NCT00269399|54743422|FG000|Overall Study|Negative Lab Result for C. difficile|2|||
28089649|NCT00269399|54743423|FG001|Overall Study|Negative Lab Result for C. difficile|3|||
28089650|NCT00269399|54743422|FG000|Overall Study|Other|0|||
28089651|NCT00269399|54743423|FG001|Overall Study|Other|4|||
28089652|NCT00269399|54743422|FG000|Overall Study|Development of exclusion criteria|0|||
28089653|NCT00269399|54743423|FG001|Overall Study|Development of exclusion criteria|1|||
28089654|NCT00269087|54743429|FG000|Overall Study|Adverse Event|20|||
28089655|NCT00269087|54743429|FG000|Overall Study|Withdrawal by Subject|1|||
28089656|NCT00269087|54743429|FG000|Overall Study|Exacerbation of COPD|13|||
28089657|NCT00289133|54743435|FG000|Overall Study|Non-study device implanted|12|||
28089658|NCT00289133|54743436|FG001|Overall Study|Non-study device implanted|0|||
28089659|NCT00289133|54743435|FG000|Overall Study|Protocol Violation|32|||
28089660|NCT00289133|54743436|FG001|Overall Study|Protocol Violation|38|||
28089661|NCT00289133|54743435|FG000|Overall Study|Withdrawal by Subject|9|||
28089662|NCT00289133|54743436|FG001|Overall Study|Withdrawal by Subject|10|||
28089663|NCT00289133|54743435|FG000|Overall Study|Death|5|||
28089664|NCT00289133|54743436|FG001|Overall Study|Death|10|||
28166276|NCT02965573|54837080|FG001|Overall Study|Lack of Efficacy|0|||
28166277|NCT02964325|54837088|FG000|Overall Study|Lost to Follow-up|3|||
28166278|NCT02964325|54837089|FG001|Overall Study|Lost to Follow-up|3|||
28166279|NCT02964325|54837088|FG000|Overall Study|Physician Decision|5|||
28166280|NCT02964325|54837089|FG001|Overall Study|Physician Decision|4|||
28166281|NCT02964325|54837088|FG000|Overall Study|Death|1|||
27980592|NCT00611767|54638594|FG001|Overall Study|Physician Decision|0|||
28089665|NCT00289133|54743435|FG000|Overall Study|Lost to Follow-up - Hurricane Katri|73|||
28089666|NCT00289133|54743436|FG001|Overall Study|Lost to Follow-up - Hurricane Katri|74|||
28089667|NCT00289133|54743435|FG000|Overall Study|Physician Decision|41|||
28089668|NCT00289133|54743436|FG001|Overall Study|Physician Decision|45|||
28089669|NCT00289133|54743435|FG000|Overall Study|Revision|8|||
28089670|NCT00289133|54743436|FG001|Overall Study|Revision|6|||
28089671|NCT00289133|54743435|FG000|Overall Study|Lost to Follow-up|92|||
28089672|NCT00289133|54743436|FG001|Overall Study|Lost to Follow-up|115|||
28089673|NCT00288587|54743448|FG000|Overall Study|Death|4|||
28089674|NCT00288587|54743449|FG001|Overall Study|Death|4|||
28089675|NCT00288587|54743448|FG000|Overall Study|Transplant|0|||
28089676|NCT00288587|54743449|FG001|Overall Study|Transplant|3|||
28089677|NCT00288587|54743448|FG000|Overall Study|Adverse Event|0|||
28089678|NCT00288587|54743449|FG001|Overall Study|Adverse Event|1|||
28089679|NCT00288587|54743448|FG000|Overall Study|Physician Decision|0|||
28089680|NCT00288587|54743449|FG001|Overall Study|Physician Decision|2|||
28089681|NCT00288587|54743448|FG000|Overall Study|Severe Aortic Stenosis|1|||
28089682|NCT00288587|54743449|FG001|Overall Study|Severe Aortic Stenosis|0|||
28089683|NCT00268463|54743457|FG000|Overall Study|study terminated due to low accrual|10|||
28089684|NCT00268463|54743458|FG001|Overall Study|study terminated due to low accrual|12|||
28089685|NCT00288509|54743464|FG000|Treatment Cycle 1|Adverse Event|1|||
28089686|NCT00288509|54743464|FG000|Treatment Cycle 1|Lack of Efficacy|1|||
28089687|NCT00288509|54743464|FG000|Treatment Cycle 1|Withdrawal by Subject|1|||
28089688|NCT00288509|54743464|FG000|Treatment Cycle 1|Lost to Follow-up|2|||
28089689|NCT00288509|54743464|FG000|Treatment Cycle 1|Treatment stopped according to protocol|1|||
28089690|NCT00288509|54743464|FG000|Treatment Cycle 2|Lack of Efficacy|1|||
28089691|NCT00288509|54743464|FG000|Treatment Cycle 2|Withdrawal by Subject|2|||
28089692|NCT00288509|54743464|FG000|Treatment Cycle 3|Lack of Efficacy|1|||
28089693|NCT00288509|54743464|FG000|Treatment Cycle 3|Withdrawal by Subject|1|||
28089694|NCT00288509|54743464|FG000|Treatment Cycle 3|Lost to Follow-up|2|||
28089695|NCT00288509|54743464|FG000|Treatment Cycle 3|Treatment stopped according to protocol|1|||
28089696|NCT00288509|54743464|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
28089697|NCT00288509|54743464|FG000|Treatment Cycle 4|Physician Decision|4|||
28089698|NCT00288509|54743464|FG000|Treatment Cycle 4|Treatment stopped according to protocol|1|||
28089699|NCT00266825|54743470|FG000|Completed Follow-Up|Lost to Follow-up|14|||
28089700|NCT00266825|54743471|FG001|Completed Follow-Up|Lost to Follow-up|19|||
28089701|NCT00266825|54743470|FG000|Completed Follow-Up|Withdrawal by Subject|11|||
28089702|NCT00266825|54743471|FG001|Completed Follow-Up|Withdrawal by Subject|5|||
28089703|NCT00265889|54743479|FG000|Overall Study|Physician Decision|1|||
28089704|NCT00265889|54743479|FG000|Overall Study|Protocol Violation|1|||
28089705|NCT00265889|54743479|FG000|Overall Study|Insurance denied the request|3|||
28089706|NCT02795182|54743487|FG000|Overall Study|Death|5|||
28089707|NCT02795182|54743488|FG001|Overall Study|Death|4|||
28089708|NCT02795182|54743489|FG002|Overall Study|Death|4|||
28089709|NCT02795182|54743490|FG003|Overall Study|Death|18|||
28089710|NCT02795182|54743487|FG000|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
28089711|NCT02795182|54743488|FG001|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
28089712|NCT02795182|54743489|FG002|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
28089713|NCT02795182|54743490|FG003|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|1|||
28089714|NCT02795182|54743487|FG000|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
28089715|NCT02795182|54743488|FG001|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
28089716|NCT02795182|54743489|FG002|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
28089717|NCT02795182|54743490|FG003|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|2|||
28089718|NCT02795182|54743487|FG000|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|3|||
28089719|NCT02795182|54743488|FG001|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|2|||
28089720|NCT02795182|54743489|FG002|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|0|||
28089721|NCT02795182|54743490|FG003|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|8|||
28089722|NCT02795182|54743487|FG000|Overall Study|Withdrawal by Subject|4|||
28089723|NCT02795182|54743488|FG001|Overall Study|Withdrawal by Subject|0|||
28089724|NCT02795182|54743489|FG002|Overall Study|Withdrawal by Subject|0|||
28089725|NCT02795182|54743490|FG003|Overall Study|Withdrawal by Subject|3|||
28089726|NCT02795182|54743487|FG000|Overall Study|Lost to Follow-up|0|||
28089727|NCT02795182|54743488|FG001|Overall Study|Lost to Follow-up|0|||
28089728|NCT02795182|54743489|FG002|Overall Study|Lost to Follow-up|1|||
28089729|NCT02795182|54743490|FG003|Overall Study|Lost to Follow-up|1|||
28089730|NCT02795182|54743487|FG000|Overall Study|Roll Over to Long Term Extension|3|||
28089731|NCT02795182|54743488|FG001|Overall Study|Roll Over to Long Term Extension|3|||
28089732|NCT02795182|54743489|FG002|Overall Study|Roll Over to Long Term Extension|2|||
28089733|NCT02795182|54743490|FG003|Overall Study|Roll Over to Long Term Extension|5|||
28089734|NCT02795182|54743487|FG000|Overall Study|Progressive Disease|0|||
28089735|NCT02795182|54743488|FG001|Overall Study|Progressive Disease|1|||
28089736|NCT02795182|54743489|FG002|Overall Study|Progressive Disease|0|||
28089737|NCT02795182|54743490|FG003|Overall Study|Progressive Disease|4|||
28089738|NCT02795182|54743487|FG000|Overall Study|Physician Decision|0|||
28089739|NCT02795182|54743488|FG001|Overall Study|Physician Decision|0|||
28089740|NCT02795182|54743489|FG002|Overall Study|Physician Decision|0|||
28089741|NCT02795182|54743490|FG003|Overall Study|Physician Decision|1|||
28089742|NCT03209362|54743509|FG000|Overall Study|Adverse Event|0|||
28089743|NCT03209362|54743510|FG001|Overall Study|Adverse Event|1|||
28089744|NCT03209362|54743509|FG000|Overall Study|Lost to Follow-up|0|||
28089745|NCT03209362|54743510|FG001|Overall Study|Lost to Follow-up|1|||
28089746|NCT03209362|54743509|FG000|Overall Study|Withdrawal by Subject|2|||
28089747|NCT03209362|54743510|FG001|Overall Study|Withdrawal by Subject|0|||
28089748|NCT03209362|54743509|FG000|Overall Study|Other|0|||
28089749|NCT03209362|54743510|FG001|Overall Study|Other|1|||
28089750|NCT02932462|54743518|FG000|Overall Study|Adverse Event|1|||
28089751|NCT02932462|54743519|FG001|Overall Study|Adverse Event|2|||
28089752|NCT02932462|54743518|FG000|Overall Study|Lost to Follow-up|4|||
28089753|NCT02932462|54743519|FG001|Overall Study|Lost to Follow-up|1|||
28089754|NCT02932462|54743518|FG000|Overall Study|Protocol Violation|0|||
28089755|NCT02932462|54743519|FG001|Overall Study|Protocol Violation|5|||
28089756|NCT02932462|54743518|FG000|Overall Study|Withdrawal by Subject|1|||
28089757|NCT02932462|54743519|FG001|Overall Study|Withdrawal by Subject|4|||
28089758|NCT02932462|54743518|FG000|Overall Study|Non-Compliance With Study Drug|0|||
28089759|NCT02932462|54743519|FG001|Overall Study|Non-Compliance With Study Drug|1|||
28089760|NCT02932462|54743518|FG000|Overall Study|Progressive Disease|1|||
28089761|NCT02932462|54743519|FG001|Overall Study|Progressive Disease|0|||
28089762|NCT03206788|54743527|FG000|Overall Study|Withdrawal by Subject|0|||
28089763|NCT03206788|54743528|FG001|Overall Study|Withdrawal by Subject|1|||
28089764|NCT03206788|54743527|FG000|Overall Study|Adverse Event|0|||
28089765|NCT03206788|54743528|FG001|Overall Study|Adverse Event|1|||
28089766|NCT03206788|54743527|FG000|Overall Study|Physician Decision|0|||
28089767|NCT03206788|54743528|FG001|Overall Study|Physician Decision|1|||
28089768|NCT03205150|54743537|FG000|Overall Study|Protocol deviation|1|||
28089769|NCT03205150|54743538|FG001|Overall Study|Protocol deviation|3|||
28089770|NCT03205150|54743539|FG002|Overall Study|Protocol deviation|0|||
28089771|NCT03205150|54743537|FG000|Overall Study|Patient/guardian decision|0|||
28089772|NCT03205150|54743538|FG001|Overall Study|Patient/guardian decision|3|||
28089773|NCT03205150|54743539|FG002|Overall Study|Patient/guardian decision|0|||
28089774|NCT03205150|54743537|FG000|Overall Study|Adverse Event|1|||
28089775|NCT03205150|54743538|FG001|Overall Study|Adverse Event|1|||
28089776|NCT03205150|54743539|FG002|Overall Study|Adverse Event|1|||
28089777|NCT03205150|54743537|FG000|Overall Study|Lost to Follow-up|0|||
28089778|NCT03205150|54743538|FG001|Overall Study|Lost to Follow-up|0|||
28089779|NCT03205150|54743539|FG002|Overall Study|Lost to Follow-up|1|||
28089780|NCT02932306|54743550|FG000|Overall Study|Withdrawal by Subject|16|||
28089781|NCT02932306|54743551|FG001|Overall Study|Withdrawal by Subject|25|||
28089782|NCT02932306|54743550|FG000|Overall Study|Adverse Event|3|||
28089783|NCT02932306|54743551|FG001|Overall Study|Adverse Event|0|||
28089784|NCT02932306|54743550|FG000|Overall Study|Pregnancy|2|||
28089785|NCT02932306|54743551|FG001|Overall Study|Pregnancy|0|||
28089786|NCT02932306|54743550|FG000|Overall Study|Protocol Violation|1|||
28089787|NCT02932306|54743551|FG001|Overall Study|Protocol Violation|1|||
28089788|NCT02932306|54743550|FG000|Overall Study|Noncompliance with Study Drug|1|||
28089789|NCT02932306|54743551|FG001|Overall Study|Noncompliance with Study Drug|1|||
28089790|NCT02932306|54743550|FG000|Overall Study|Lost to Follow-up|36|||
28089791|NCT02932306|54743551|FG001|Overall Study|Lost to Follow-up|40|||
28089792|NCT02932306|54743550|FG000|Overall Study|Withdrawal by Parent or Guardian|6|||
28089793|NCT02932306|54743551|FG001|Overall Study|Withdrawal by Parent or Guardian|8|||
28089794|NCT02932306|54743550|FG000|Overall Study|Lack of Efficacy|0|||
28089795|NCT02932306|54743551|FG001|Overall Study|Lack of Efficacy|2|||
28089796|NCT02932306|54743550|FG000|Overall Study|Worsening condition|2|||
28089797|NCT02932306|54743551|FG001|Overall Study|Worsening condition|0|||
28089798|NCT02932306|54743550|FG000|Overall Study|Withdrew due to burning,itching,stinging|1|||
28089799|NCT02932306|54743551|FG001|Overall Study|Withdrew due to burning,itching,stinging|0|||
28089800|NCT02932228|54743559|FG000|Overall Study|Death|8|||
28089801|NCT02932228|54743560|FG001|Overall Study|Death|23|||
28089802|NCT02932228|54743559|FG000|Overall Study|not eligible upon chart review|2|||
28089803|NCT02932228|54743560|FG001|Overall Study|not eligible upon chart review|5|||
28089804|NCT02931838|54743574|FG000|Overall Study|Reason not provided by investigator|1|||
28089805|NCT02931838|54743575|FG001|Overall Study|Reason not provided by investigator|0|||
28089806|NCT02931838|54743576|FG002|Overall Study|Reason not provided by investigator|1|||
28089807|NCT02931838|54743577|FG003|Overall Study|Reason not provided by investigator|0|||
28089808|NCT02931838|54743578|FG004|Overall Study|Reason not provided by investigator|0|||
28089809|NCT02931838|54743579|FG005|Overall Study|Reason not provided by investigator|0|||
28089810|NCT02931838|54743574|FG000|Overall Study|Poor/non-compliance|0|||
28089811|NCT02931838|54743575|FG001|Overall Study|Poor/non-compliance|0|||
28089812|NCT02931838|54743576|FG002|Overall Study|Poor/non-compliance|1|||
28089813|NCT02931838|54743577|FG003|Overall Study|Poor/non-compliance|0|||
28089814|NCT02931838|54743578|FG004|Overall Study|Poor/non-compliance|0|||
28089815|NCT02931838|54743579|FG005|Overall Study|Poor/non-compliance|0|||
27980593|NCT00803361|54638602|FG000|Overall Study|Adverse Event|13|||
28089816|NCT02931838|54743574|FG000|Overall Study|Lack of Efficacy|5|||
28089817|NCT02931838|54743575|FG001|Overall Study|Lack of Efficacy|4|||
28089818|NCT02931838|54743576|FG002|Overall Study|Lack of Efficacy|0|||
28089819|NCT02931838|54743577|FG003|Overall Study|Lack of Efficacy|0|||
28089820|NCT02931838|54743578|FG004|Overall Study|Lack of Efficacy|0|||
28089821|NCT02931838|54743579|FG005|Overall Study|Lack of Efficacy|1|||
27980594|NCT00803361|54638603|FG001|Overall Study|Adverse Event|3|||
28089822|NCT02931838|54743574|FG000|Overall Study|Lost to Follow-up|1|||
28089823|NCT02931838|54743575|FG001|Overall Study|Lost to Follow-up|0|||
28089824|NCT02931838|54743576|FG002|Overall Study|Lost to Follow-up|1|||
28089825|NCT02931838|54743577|FG003|Overall Study|Lost to Follow-up|1|||
28089826|NCT02931838|54743578|FG004|Overall Study|Lost to Follow-up|2|||
28089827|NCT02931838|54743579|FG005|Overall Study|Lost to Follow-up|0|||
28089828|NCT02931838|54743574|FG000|Overall Study|Subject request to discontinue treatment|4|||
28089829|NCT02931838|54743575|FG001|Overall Study|Subject request to discontinue treatment|3|||
28089830|NCT02931838|54743576|FG002|Overall Study|Subject request to discontinue treatment|3|||
28089831|NCT02931838|54743577|FG003|Overall Study|Subject request to discontinue treatment|0|||
28089832|NCT02931838|54743578|FG004|Overall Study|Subject request to discontinue treatment|1|||
28089833|NCT02931838|54743579|FG005|Overall Study|Subject request to discontinue treatment|0|||
28089834|NCT02931838|54743574|FG000|Overall Study|Withdrawal by Subject|1|||
28089835|NCT02931838|54743575|FG001|Overall Study|Withdrawal by Subject|2|||
28089836|NCT02931838|54743576|FG002|Overall Study|Withdrawal by Subject|0|||
28166282|NCT02964325|54837089|FG001|Overall Study|Death|3|||
28166283|NCT02964325|54837088|FG000|Overall Study|Withdrawal by Subject|2|||
28166284|NCT02964325|54837089|FG001|Overall Study|Withdrawal by Subject|1|||
28166285|NCT02964325|54837088|FG000|Overall Study|Did not require PLT transfusion, had HLA positive|10|||
28166286|NCT02964325|54837089|FG001|Overall Study|Did not require PLT transfusion, had HLA positive|12|||
28166287|NCT02964247|54837097|FG000|Overall Study|Lost to Follow-up|2|||
28166288|NCT02964247|54837098|FG001|Overall Study|Lost to Follow-up|0|||
28166289|NCT02964247|54837097|FG000|Overall Study|Withdrawal by Subject|1|||
28166290|NCT02964247|54837098|FG001|Overall Study|Withdrawal by Subject|2|||
28166291|NCT03654729|54837107|FG000|Overall Study|Death|9|||
28166292|NCT03654729|54837108|FG001|Overall Study|Death|9|||
28166293|NCT03654729|54837109|FG002|Overall Study|Death|16|||
28166294|NCT03654729|54837107|FG000|Overall Study|Withdrawal by Subject|8|||
28166295|NCT03654729|54837108|FG001|Overall Study|Withdrawal by Subject|6|||
28166296|NCT03654729|54837109|FG002|Overall Study|Withdrawal by Subject|4|||
28166297|NCT03654729|54837107|FG000|Overall Study|Study terminated by Sponsor|3|||
28166298|NCT03654729|54837108|FG001|Overall Study|Study terminated by Sponsor|5|||
28166299|NCT03654729|54837109|FG002|Overall Study|Study terminated by Sponsor|4|||
28166300|NCT03654729|54837107|FG000|Overall Study|Not reported|2|||
28166301|NCT03654729|54837108|FG001|Overall Study|Not reported|4|||
28166302|NCT03654729|54837109|FG002|Overall Study|Not reported|5|||
28166303|NCT03654729|54837107|FG000|Overall Study|Progressive disease|3|||
28166304|NCT03654729|54837108|FG001|Overall Study|Progressive disease|0|||
28166305|NCT03654729|54837109|FG002|Overall Study|Progressive disease|0|||
28166306|NCT03654729|54837107|FG000|Overall Study|Lost to Follow-up|2|||
28166307|NCT03654729|54837108|FG001|Overall Study|Lost to Follow-up|0|||
28166308|NCT03654729|54837109|FG002|Overall Study|Lost to Follow-up|0|||
28166309|NCT03654729|54837107|FG000|Overall Study|Physician Decision|2|||
28166310|NCT03654729|54837108|FG001|Overall Study|Physician Decision|0|||
28166311|NCT03654729|54837109|FG002|Overall Study|Physician Decision|0|||
28089837|NCT02931838|54743577|FG003|Overall Study|Withdrawal by Subject|1|||
28166312|NCT03654729|54837107|FG000|Overall Study|Protocol Violation|1|||
28166313|NCT03654729|54837108|FG001|Overall Study|Protocol Violation|1|||
28166314|NCT03654729|54837109|FG002|Overall Study|Protocol Violation|0|||
28166315|NCT03654729|54837107|FG000|Overall Study|Non-compliance with study drug|0|||
28166316|NCT03654729|54837108|FG001|Overall Study|Non-compliance with study drug|1|||
28166317|NCT03654729|54837109|FG002|Overall Study|Non-compliance with study drug|0|||
28166318|NCT03654729|54837107|FG000|Overall Study|Site terminated by Sponsor|1|||
28166319|NCT03654729|54837108|FG001|Overall Study|Site terminated by Sponsor|0|||
28166320|NCT03654729|54837109|FG002|Overall Study|Site terminated by Sponsor|0|||
28166321|NCT01377987|54837117|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
28166322|NCT01377987|54837118|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
28166323|NCT02898259|54837129|FG000|Overall Study|Adverse Event|0|||
28166324|NCT02898259|54837130|FG001|Overall Study|Adverse Event|0|||
27733601|NCT04112173|54181263|FG000|Overall Study|Study terminated due to COVID-19 pandemic|1|||
27733602|NCT02688153|54181269|FG000|Overall Study|Death|7|||
27733603|NCT02688153|54181270|FG001|Overall Study|Death|5|||
27833097|NCT04034238|54313529|FG000|Dose Escalation Phase|Screen failures|0|||
28166325|NCT02898259|54837131|FG002|Overall Study|Adverse Event|1|||
28166326|NCT02898259|54837132|FG003|Overall Study|Adverse Event|0|||
28166327|NCT02898259|54837133|FG004|Overall Study|Adverse Event|0|||
28166328|NCT02898259|54837129|FG000|Overall Study|Lack of Efficacy|1|||
28166329|NCT02898259|54837130|FG001|Overall Study|Lack of Efficacy|1|||
28166330|NCT02898259|54837131|FG002|Overall Study|Lack of Efficacy|3|||
28166331|NCT02898259|54837132|FG003|Overall Study|Lack of Efficacy|0|||
28166332|NCT02898259|54837133|FG004|Overall Study|Lack of Efficacy|0|||
28166333|NCT02898259|54837129|FG000|Overall Study|Lost to Follow-up|0|||
27733604|NCT02688153|54181269|FG000|Overall Study|Withdrawal by Subject|4|||
27833098|NCT04034238|54313530|FG001|Dose Escalation Phase|Screen failures|0|||
28089838|NCT02931838|54743578|FG004|Overall Study|Withdrawal by Subject|0|||
28166334|NCT02898259|54837130|FG001|Overall Study|Lost to Follow-up|0|||
28166335|NCT02898259|54837131|FG002|Overall Study|Lost to Follow-up|1|||
28089839|NCT02931838|54743579|FG005|Overall Study|Withdrawal by Subject|0|||
28089840|NCT02931838|54743574|FG000|Overall Study|Adverse Event|2|||
28089841|NCT02931838|54743575|FG001|Overall Study|Adverse Event|1|||
28089842|NCT02931838|54743576|FG002|Overall Study|Adverse Event|2|||
28089843|NCT02931838|54743577|FG003|Overall Study|Adverse Event|1|||
28089844|NCT02931838|54743578|FG004|Overall Study|Adverse Event|3|||
28089845|NCT02931838|54743579|FG005|Overall Study|Adverse Event|1|||
28089846|NCT03201562|54743601|FG000|Overall Study|Physician Decision|0|||
28089847|NCT03201562|54743602|FG001|Overall Study|Physician Decision|0|||
28089848|NCT03201562|54743603|FG002|Overall Study|Physician Decision|1|||
28089849|NCT03201562|54743601|FG000|Overall Study|Adverse Event|0|||
28089850|NCT03201562|54743602|FG001|Overall Study|Adverse Event|0|||
28089851|NCT03201562|54743603|FG002|Overall Study|Adverse Event|1|||
28089852|NCT03201562|54743601|FG000|Overall Study|Lost to Follow-up|0|||
28089853|NCT03201562|54743602|FG001|Overall Study|Lost to Follow-up|1|||
28089854|NCT03201562|54743603|FG002|Overall Study|Lost to Follow-up|2|||
28089855|NCT03200860|54743613|FG000|Overall Study|Withdrawal by Subject|1|||
28166336|NCT02898259|54837132|FG003|Overall Study|Lost to Follow-up|0|||
28166337|NCT02898259|54837133|FG004|Overall Study|Lost to Follow-up|0|||
28166338|NCT02898259|54837129|FG000|Overall Study|Transformation before study began|0|||
28166339|NCT02898259|54837130|FG001|Overall Study|Transformation before study began|0|||
28166340|NCT02898259|54837131|FG002|Overall Study|Transformation before study began|0|||
28166341|NCT02898259|54837132|FG003|Overall Study|Transformation before study began|1|||
28166342|NCT02898259|54837133|FG004|Overall Study|Transformation before study began|0|||
28166343|NCT02963935|54837148|FG000|Overall Study|Adverse Event|12|||
28166344|NCT02963935|54837149|FG001|Overall Study|Adverse Event|6|||
28166345|NCT02963935|54837148|FG000|Overall Study|Protocol Violation|2|||
28166346|NCT02963935|54837149|FG001|Overall Study|Protocol Violation|1|||
28166347|NCT02963935|54837148|FG000|Overall Study|Lack of Efficacy|0|||
28166348|NCT02963935|54837149|FG001|Overall Study|Lack of Efficacy|2|||
28166349|NCT02963935|54837148|FG000|Overall Study|Lost to Follow-up|1|||
28166350|NCT02963935|54837149|FG001|Overall Study|Lost to Follow-up|6|||
28166351|NCT02963935|54837148|FG000|Overall Study|Unclassified|13|||
28166352|NCT02963935|54837149|FG001|Overall Study|Unclassified|22|||
28166353|NCT02963701|54837157|FG000|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1|||
28166354|NCT02963701|54837158|FG001|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0|||
28166355|NCT01345591|54837164|FG000|Overall Study|Lost to Follow-up|1|||
28166356|NCT02961751|54837173|FG000|Overall Study|Lost to Follow-up|11|||
28166357|NCT02961751|54837173|FG000|Overall Study|Physician Decision|2|||
28166358|NCT02961751|54837173|FG000|Overall Study|Not Eligible at Enrollment|1|||
28166359|NCT02961751|54837173|FG000|Overall Study|Protocol Violation|1|||
28166360|NCT02963311|54837177|FG000|Overall Study|Withdrawal by Subject|1|||
28166361|NCT02963311|54837177|FG000|Overall Study|Screen Failure|4|||
28166362|NCT02962765|54837181|FG000|Overall Study|Protocol Violation|9|||
28166363|NCT02962765|54837181|FG000|Overall Study|Withdrawal by Subject|3|||
28166364|NCT02962765|54837181|FG000|Overall Study|Lost to Follow-up|1|||
28166365|NCT02962765|54837181|FG000|Overall Study|Death|1|||
28166366|NCT02962765|54837181|FG000|Overall Study|Limited access to study medication|3|||
28166367|NCT00965757|54837194|FG000|Double-blind Phase|Progression of concomitant disease|1|||
28166368|NCT00965757|54837195|FG001|Double-blind Phase|Progression of concomitant disease|2|||
28166369|NCT00965757|54837196|FG002|Double-blind Phase|Progression of concomitant disease|0|||
28166370|NCT00965757|54837197|FG003|Double-blind Phase|Progression of concomitant disease|0|||
28166371|NCT00965757|54837194|FG000|Double-blind Phase|Adverse drug reaction|2|||
28166372|NCT00965757|54837195|FG001|Double-blind Phase|Adverse drug reaction|1|||
28166373|NCT00965757|54837196|FG002|Double-blind Phase|Adverse drug reaction|0|||
28166374|NCT00965757|54837197|FG003|Double-blind Phase|Adverse drug reaction|0|||
28166375|NCT00965757|54837194|FG000|Double-blind Phase|Abnormal Laboratory Value|2|||
28166376|NCT00965757|54837195|FG001|Double-blind Phase|Abnormal Laboratory Value|0|||
28166377|NCT00965757|54837196|FG002|Double-blind Phase|Abnormal Laboratory Value|0|||
28089856|NCT03200860|54743614|FG001|Overall Study|Withdrawal by Subject|0|||
28166378|NCT00965757|54837197|FG003|Double-blind Phase|Abnormal Laboratory Value|0|||
28166379|NCT00965757|54837194|FG000|Double-blind Phase|Lack of Efficacy|7|||
28089857|NCT03198754|54743622|FG000|Overall Study|Withdrawal by Subject|5|||
28166380|NCT00965757|54837195|FG001|Double-blind Phase|Lack of Efficacy|11|||
28166381|NCT00965757|54837196|FG002|Double-blind Phase|Lack of Efficacy|0|||
28166382|NCT00965757|54837197|FG003|Double-blind Phase|Lack of Efficacy|0|||
28166383|NCT00965757|54837194|FG000|Double-blind Phase|Drug Refusal Due to Adverse Event|2|||
28166384|NCT00965757|54837195|FG001|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
28166385|NCT00965757|54837196|FG002|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
28166386|NCT00965757|54837197|FG003|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
28166387|NCT00965757|54837194|FG000|Double-blind Phase|Lost to Follow-up|0|||
27980595|NCT00803361|54638602|FG000|Overall Study|Lack of Efficacy|4|||
27980596|NCT00803361|54638603|FG001|Overall Study|Lack of Efficacy|13|||
28089858|NCT03198754|54743623|FG001|Overall Study|Withdrawal by Subject|4|||
28089859|NCT03198754|54743622|FG000|Overall Study|Lost to Follow-up|4|||
28089860|NCT03198754|54743623|FG001|Overall Study|Lost to Follow-up|3|||
28089861|NCT03198754|54743622|FG000|Overall Study|Ineligible|2|||
28089862|NCT03198754|54743623|FG001|Overall Study|Ineligible|1|||
28089863|NCT03198520|54743629|FG000|Overall Study|Physician Decision|2|||
28089864|NCT03198520|54743629|FG000|Overall Study|Protocol Violation|2|||
28089865|NCT03198520|54743629|FG000|Overall Study|Withdrawal by Subject|1|||
28089866|NCT03198520|54743629|FG000|Overall Study|Study Ended|1|||
28089867|NCT03194464|54743641|FG000|Overall Study|data not usable|2|||
28089868|NCT03192904|54743649|FG000|Overall Study|Physician Decision|3|||
28089869|NCT03192904|54743650|FG001|Overall Study|Physician Decision|1|||
28089870|NCT03192904|54743649|FG000|Overall Study|Lost to Follow-up|0|||
28089871|NCT03192904|54743650|FG001|Overall Study|Lost to Follow-up|1|||
28089872|NCT03268954|54743658|FG000|Overall Study|Ongoing|23|||
28089873|NCT03268954|54743659|FG001|Overall Study|Ongoing|31|||
28089874|NCT03268954|54743658|FG000|Overall Study|Adverse Event|53|||
28089875|NCT03268954|54743659|FG001|Overall Study|Adverse Event|62|||
28089876|NCT03268954|54743658|FG000|Overall Study|Withdrawal by Subject|25|||
28089877|NCT03268954|54743659|FG001|Overall Study|Withdrawal by Subject|16|||
28089878|NCT03268954|54743658|FG000|Overall Study|Progressive Disease|61|||
28089879|NCT03268954|54743659|FG001|Overall Study|Progressive Disease|48|||
28089880|NCT03268954|54743658|FG000|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|25|||
28089881|NCT03268954|54743659|FG001|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|30|||
28089882|NCT03268954|54743658|FG000|Overall Study|Reason not Specified|40|||
28089883|NCT03268954|54743659|FG001|Overall Study|Reason not Specified|40|||
28089884|NCT03188536|54743665|FG000|Overall Study|No relapse/refractoriness(last 6 months)|5|||
28089885|NCT03188536|54743665|FG000|Overall Study|Not participated/met inclusion criteria|1|||
28089886|NCT03187756|54743669|FG000|Overall Study|Termination of study|4|||
28089887|NCT03187132|54743675|FG000|Inpatient Trauma Only|Lost to Follow-up|3|||
28089888|NCT03187132|54743676|FG001|Inpatient Trauma Only|Lost to Follow-up|12|||
28089889|NCT03187132|54743675|FG000|Inpatient Trauma Only|socioeconomic burden|1|||
28089890|NCT03187132|54743676|FG001|Inpatient Trauma Only|socioeconomic burden|0|||
28089891|NCT03187132|54743675|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|0|||
28089892|NCT03187132|54743676|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|5|||
28089893|NCT03187132|54743675|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|1|||
28089894|NCT03187132|54743676|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|0|||
28089895|NCT03187132|54743675|FG000|Inpatient Trauma+Pain Clinic|Lost to Follow-up|2|||
28089896|NCT03187132|54743676|FG001|Inpatient Trauma+Pain Clinic|Lost to Follow-up|5|||
28089897|NCT03187132|54743675|FG000|Inpatient Trauma+Pain Clinic|Disease burden|1|||
28089898|NCT03187132|54743676|FG001|Inpatient Trauma+Pain Clinic|Disease burden|0|||
28089899|NCT03187132|54743675|FG000|Inpatient Trauma+Pain Clinic|Unhappy with allocation|0|||
28089900|NCT03187132|54743676|FG001|Inpatient Trauma+Pain Clinic|Unhappy with allocation|2|||
28089901|NCT03187132|54743675|FG000|Pain Clinic Only, Fully Remote|Lost to Follow-up|27|||
28089902|NCT03187132|54743676|FG001|Pain Clinic Only, Fully Remote|Lost to Follow-up|47|||
28089903|NCT03187132|54743675|FG000|Pain Clinic Only, Fully Remote|Disease burden|6|||
28089904|NCT03187132|54743676|FG001|Pain Clinic Only, Fully Remote|Disease burden|5|||
28089905|NCT03187132|54743675|FG000|Pain Clinic Only, Fully Remote|Language barrier|0|||
28089906|NCT03187132|54743676|FG001|Pain Clinic Only, Fully Remote|Language barrier|1|||
28089907|NCT03187132|54743675|FG000|Pain Clinic Only, Fully Remote|EMR|0|||
28089908|NCT03187132|54743676|FG001|Pain Clinic Only, Fully Remote|EMR|1|||
28089909|NCT03184558|54743682|FG000|Overall Study|Withdrawal by Subject|2|||
28089910|NCT03184558|54743682|FG000|Overall Study|Death|16|||
28089911|NCT03184558|54743682|FG000|Overall Study|Lost to Follow-up|2|||
28089912|NCT03184558|54743682|FG000|Overall Study|Other|9|||
28089913|NCT03183778|54743686|FG000|Overall Study|Withdrawn by Investigator (potassium in normal range)|1|||
28089914|NCT03182686|54743692|FG000|Overall Study|Lost to Follow-up|2|||
28089915|NCT03182686|54743693|FG001|Overall Study|Lost to Follow-up|0|||
28089916|NCT03182686|54743692|FG000|Overall Study|Adverse Event|2|||
28089917|NCT03182686|54743693|FG001|Overall Study|Adverse Event|0|||
28089918|NCT03182686|54743692|FG000|Overall Study|Withdrawal by Subject|3|||
28089919|NCT03182686|54743693|FG001|Overall Study|Withdrawal by Subject|0|||
28089920|NCT03181594|54743699|FG000|Initial Study Protocol (12-month FU)|Lost to Follow-up|4|||
28089921|NCT03181594|54743699|FG000|Initial Study Protocol (12-month FU)|Withdrawal by Subject|3|||
28089922|NCT03181594|54743699|FG000|Initial Study Protocol (12-month FU)|Physician Decision|1|||
28089923|NCT03181594|54743699|FG000|Initial Study Protocol (12-month FU)|Death|1|||
28089924|NCT03181594|54743699|FG000|Long-term Extension (15-24 Month FU)|Lost to Follow-up|3|||
28089925|NCT03181594|54743699|FG000|Long-term Extension (15-24 Month FU)|Death|2|||
28166388|NCT00965757|54837195|FG001|Double-blind Phase|Lost to Follow-up|1|||
28166389|NCT00965757|54837196|FG002|Double-blind Phase|Lost to Follow-up|0|||
28166390|NCT00965757|54837197|FG003|Double-blind Phase|Lost to Follow-up|0|||
27855722|NCT02733042|54382046|FG008|Follow-up Period|Ongoing on Follow-up|0|||
28089926|NCT03180736|54743705|FG000|Overall Study|Adverse Event|3|||
28089927|NCT03180736|54743706|FG001|Overall Study|Adverse Event|4|||
28089928|NCT03180736|54743705|FG000|Overall Study|Death|10|||
28089929|NCT03180736|54743706|FG001|Overall Study|Death|7|||
28089930|NCT03180736|54743705|FG000|Overall Study|Withdrawal by Subject|5|||
28089931|NCT03180736|54743706|FG001|Overall Study|Withdrawal by Subject|12|||
28089932|NCT03180736|54743705|FG000|Overall Study|Lost to Follow-up|1|||
28089933|NCT03180736|54743706|FG001|Overall Study|Lost to Follow-up|0|||
28089934|NCT03180736|54743705|FG000|Overall Study|Lack of Efficacy|66|||
28089935|NCT03180736|54743706|FG001|Overall Study|Lack of Efficacy|87|||
28089936|NCT03180736|54743705|FG000|Overall Study|Physician Decision|4|||
28089937|NCT03180736|54743706|FG001|Overall Study|Physician Decision|7|||
28089938|NCT03180736|54743705|FG000|Overall Study|randomized but not treated|2|||
28089939|NCT03180736|54743706|FG001|Overall Study|randomized but not treated|3|||
28089940|NCT03178942|54743719|FG000|Overall Study|Withdrawal by Subject|2|||
28089941|NCT03178942|54743720|FG001|Overall Study|Withdrawal by Subject|0|||
28089942|NCT03178942|54743719|FG000|Overall Study|Lost to Follow-up|1|||
28089943|NCT03178942|54743720|FG001|Overall Study|Lost to Follow-up|2|||
28089944|NCT03175198|54743726|FG000|Overall Study|Adverse Event|480|||
28089945|NCT03175198|54743726|FG000|Overall Study|No actual visit|120|||
28089946|NCT03175198|54743726|FG000|Overall Study|Registration rule not followed|4|||
28089947|NCT03175198|54743726|FG000|Overall Study|Patients received Prazaxa treatment before|5|||
28089948|NCT03175198|54743726|FG000|Overall Study|Other personal reason|509|||
28089949|NCT03175198|54743726|FG000|Overall Study|To take a contraindication/careful administration drug|8|||
28089950|NCT03175198|54743726|FG000|Overall Study|Lost to follow-up (changing hospital)|373|||
28089951|NCT03175198|54743726|FG000|Overall Study|Lost to follow-up (unknown reason)|146|||
28089952|NCT03175198|54743726|FG000|Overall Study|To conduct invasive treatment of operation|53|||
28089953|NCT03175198|54743726|FG000|Overall Study|Improvement of nonvalvular atrial fibrillation|629|||
28089954|NCT03175120|54743732|FG000|Overall Study|Adverse Event|2|||
28089955|NCT03175120|54743733|FG001|Overall Study|Adverse Event|2|||
28089956|NCT03175120|54743732|FG000|Overall Study|Protocol Violation|5|||
28089957|NCT03175120|54743733|FG001|Overall Study|Protocol Violation|2|||
28089958|NCT03175120|54743732|FG000|Overall Study|Lost to Follow-up|1|||
28089959|NCT03175120|54743733|FG001|Overall Study|Lost to Follow-up|0|||
28089960|NCT03175120|54743732|FG000|Overall Study|Withdrawal by Subject|2|||
28089961|NCT03175120|54743733|FG001|Overall Study|Withdrawal by Subject|5|||
28089962|NCT03175120|54743732|FG000|Overall Study|Other|2|||
28089963|NCT03175120|54743733|FG001|Overall Study|Other|3|||
28089964|NCT03172702|54743739|FG000|Overall Study|Adverse Event|9|||
28089965|NCT03172702|54743739|FG000|Overall Study|Death|2|||
28089966|NCT03172702|54743739|FG000|Overall Study|Study-specific Withdrawal Criteria|10|||
28089967|NCT03172702|54743739|FG000|Overall Study|Withdrawal by Subject|5|||
28089968|NCT03172702|54743739|FG000|Overall Study|Other|2|||
28089969|NCT03167242|54743756|FG000|Overall Study|Patient/Guardian Decision|0|||
28089970|NCT03167242|54743757|FG001|Overall Study|Patient/Guardian Decision|1|||
28089971|NCT03167242|54743758|FG002|Overall Study|Patient/Guardian Decision|2|||
28089972|NCT03167242|54743759|FG003|Overall Study|Patient/Guardian Decision|1|||
28089973|NCT03167242|54743760|FG004|Overall Study|Patient/Guardian Decision|1|||
28089974|NCT03167242|54743761|FG005|Overall Study|Patient/Guardian Decision|1|||
28089975|NCT03167242|54743762|FG006|Overall Study|Patient/Guardian Decision|0|||
28089976|NCT03167242|54743763|FG007|Overall Study|Patient/Guardian Decision|0|||
28089977|NCT03167242|54743764|FG008|Overall Study|Patient/Guardian Decision|0|||
28089978|NCT03167242|54743765|FG009|Overall Study|Patient/Guardian Decision|0|||
28089979|NCT03167242|54743766|FG010|Overall Study|Patient/Guardian Decision|1|||
28089980|NCT03167242|54743767|FG011|Overall Study|Patient/Guardian Decision|0|||
28089981|NCT03167242|54743756|FG000|Overall Study|Lost to Follow-up|0|||
28089982|NCT03167242|54743757|FG001|Overall Study|Lost to Follow-up|0|||
28089983|NCT03167242|54743758|FG002|Overall Study|Lost to Follow-up|1|||
28089984|NCT03167242|54743759|FG003|Overall Study|Lost to Follow-up|0|||
28089985|NCT03167242|54743760|FG004|Overall Study|Lost to Follow-up|0|||
28089986|NCT03167242|54743761|FG005|Overall Study|Lost to Follow-up|1|||
28089987|NCT03167242|54743762|FG006|Overall Study|Lost to Follow-up|2|||
28089988|NCT03167242|54743763|FG007|Overall Study|Lost to Follow-up|1|||
28089989|NCT03167242|54743764|FG008|Overall Study|Lost to Follow-up|0|||
28089990|NCT03167242|54743765|FG009|Overall Study|Lost to Follow-up|0|||
28089991|NCT03167242|54743766|FG010|Overall Study|Lost to Follow-up|1|||
28089992|NCT03167242|54743767|FG011|Overall Study|Lost to Follow-up|1|||
28089993|NCT03167242|54743756|FG000|Overall Study|Reason not provided|0|||
28089994|NCT03167242|54743757|FG001|Overall Study|Reason not provided|0|||
28089995|NCT03167242|54743758|FG002|Overall Study|Reason not provided|0|||
28089996|NCT03167242|54743759|FG003|Overall Study|Reason not provided|0|||
28089997|NCT03167242|54743760|FG004|Overall Study|Reason not provided|0|||
28089998|NCT03167242|54743761|FG005|Overall Study|Reason not provided|0|||
28089999|NCT03167242|54743762|FG006|Overall Study|Reason not provided|0|||
28090000|NCT03167242|54743763|FG007|Overall Study|Reason not provided|0|||
28090001|NCT03167242|54743764|FG008|Overall Study|Reason not provided|1|||
28090002|NCT03167242|54743765|FG009|Overall Study|Reason not provided|0|||
28090003|NCT03167242|54743766|FG010|Overall Study|Reason not provided|0|||
28090004|NCT03167242|54743767|FG011|Overall Study|Reason not provided|0|||
28090005|NCT03286426|54743803|FG000|Overall Study|Physician Decision|3|||
28090006|NCT02882152|54743822|FG000|Overall Study|Lost to Follow-up|1|||
28090007|NCT02882152|54743823|FG001|Overall Study|Lost to Follow-up|0|||
28090008|NCT00286091|54743831|FG000|Double-blind Treatment Phase|Withdrawal by Subject|103|||
28090009|NCT00286091|54743832|FG001|Double-blind Treatment Phase|Withdrawal by Subject|113|||
28090010|NCT00286091|54743831|FG000|Double-blind Treatment Phase|Protocol-Specified Criteria|307|||
28090011|NCT00286091|54743832|FG001|Double-blind Treatment Phase|Protocol-Specified Criteria|269|||
28090012|NCT00286091|54743831|FG000|Double-blind Treatment Phase|Death|58|||
28090013|NCT00286091|54743832|FG001|Double-blind Treatment Phase|Death|65|||
28090014|NCT00286091|54743831|FG000|Double-blind Treatment Phase|Adverse Event|28|||
28090015|NCT00286091|54743832|FG001|Double-blind Treatment Phase|Adverse Event|40|||
28090016|NCT00286091|54743831|FG000|Double-blind Treatment Phase|Disease Progression|22|||
28166391|NCT00965757|54837194|FG000|Double-blind Phase|Ineligible after Taking Study Drug|2|||
28166392|NCT00965757|54837195|FG001|Double-blind Phase|Ineligible after Taking Study Drug|3|||
28166393|NCT00965757|54837196|FG002|Double-blind Phase|Ineligible after Taking Study Drug|0|||
28166394|NCT00965757|54837197|FG003|Double-blind Phase|Ineligible after Taking Study Drug|0|||
28166395|NCT00965757|54837194|FG000|Double-blind Phase|Other|1|||
27855723|NCT02733042|54382047|FG009|Follow-up Period|Ongoing on Follow-up|2|||
27855724|NCT02733042|54382048|FG010|Follow-up Period|Ongoing on Follow-up|4|||
27855725|NCT02733042|54382049|FG011|Follow-up Period|Ongoing on Follow-up|9|||
27855726|NCT02733042|54382050|FG012|Follow-up Period|Ongoing on Follow-up|1|||
27855727|NCT02733042|54382051|FG013|Follow-up Period|Ongoing on Follow-up|3|||
27855728|NCT02733042|54382052|FG014|Follow-up Period|Ongoing on Follow-up|0|||
27855729|NCT02733042|54382053|FG015|Follow-up Period|Ongoing on Follow-up|0|||
27855730|NCT02733042|54382054|FG016|Follow-up Period|Ongoing on Follow-up|0|||
28090017|NCT00286091|54743832|FG001|Double-blind Treatment Phase|Disease Progression|35|||
28090018|NCT00286091|54743831|FG000|Double-blind Treatment Phase|Other|25|||
28090019|NCT00286091|54743832|FG001|Double-blind Treatment Phase|Other|33|||
28090020|NCT00286091|54743831|FG000|Double-blind Treatment Phase|Administrative Decision|20|||
28090021|NCT00286091|54743832|FG001|Double-blind Treatment Phase|Administrative Decision|21|||
28090022|NCT00286091|54743831|FG000|Double-blind Treatment Phase|Noncompliance|8|||
28090023|NCT00286091|54743832|FG001|Double-blind Treatment Phase|Noncompliance|8|||
28090024|NCT00286091|54743831|FG000|Double-blind Treatment Phase|Lost to Follow-up|11|||
28090025|NCT00286091|54743832|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
28090026|NCT00286091|54743831|FG000|Double-blind Treatment Phase|Protocol Deviation|1|||
28090027|NCT00286091|54743832|FG001|Double-blind Treatment Phase|Protocol Deviation|3|||
28090028|NCT00286091|54743831|FG000|Double-blind Treatment Phase|Ineligibility Determined|1|||
28090029|NCT00286091|54743832|FG001|Double-blind Treatment Phase|Ineligibility Determined|2|||
28090030|NCT00286091|54743831|FG000|Open-label Treatment Phase|Physician Decision|24|||
28090031|NCT00286091|54743832|FG001|Open-label Treatment Phase|Physician Decision|21|||
28090032|NCT00286091|54743831|FG000|Open-label Treatment Phase|Adverse Event|5|||
28090033|NCT00286091|54743832|FG001|Open-label Treatment Phase|Adverse Event|16|||
28090034|NCT00286091|54743831|FG000|Open-label Treatment Phase|Other|11|||
28090035|NCT00286091|54743832|FG001|Open-label Treatment Phase|Other|11|||
28090036|NCT00286091|54743831|FG000|Open-label Treatment Phase|Withdrawal by Subject|14|||
28090037|NCT00286091|54743832|FG001|Open-label Treatment Phase|Withdrawal by Subject|10|||
28090038|NCT00286091|54743831|FG000|Open-label Treatment Phase|Death|10|||
28090039|NCT00286091|54743832|FG001|Open-label Treatment Phase|Death|7|||
28090040|NCT00286091|54743831|FG000|Open-label Treatment Phase|Disease Progression|9|||
28090041|NCT00286091|54743832|FG001|Open-label Treatment Phase|Disease Progression|3|||
28090042|NCT00286091|54743831|FG000|Open-label Treatment Phase|Noncompliance|3|||
28090043|NCT00286091|54743832|FG001|Open-label Treatment Phase|Noncompliance|1|||
28090044|NCT00286091|54743831|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
28090045|NCT00286091|54743832|FG001|Open-label Treatment Phase|Lost to Follow-up|1|||
28090046|NCT00286091|54743831|FG000|Open-label Treatment Phase|Protocol-specified Criteria|1|||
28090047|NCT00286091|54743832|FG001|Open-label Treatment Phase|Protocol-specified Criteria|0|||
28090048|NCT00286091|54743831|FG000|Open-label Treatment Phase|Missing End of Study Information|0|||
28090049|NCT00286091|54743832|FG001|Open-label Treatment Phase|Missing End of Study Information|1|||
28090050|NCT00285857|54743840|FG000|Overall Study|Withdrawal by Subject|2|||
28090051|NCT00285857|54743840|FG000|Overall Study|Inadequate initial breast cytology|1|||
28090052|NCT00285857|54743840|FG000|Overall Study|Adverse Event|1|||
28090053|NCT00284141|54743849|FG000|Overall Study|Disease Progression / Lack of efficacy|51|||
28090054|NCT00284141|54743849|FG000|Overall Study|Adverse Event|19|||
28090055|NCT00284141|54743849|FG000|Overall Study|Participant's request|9|||
28090056|NCT00284141|54743849|FG000|Overall Study|Symptomatic / Clinical Progression|11|||
28166396|NCT00965757|54837195|FG001|Double-blind Phase|Other|0|||
28166397|NCT00965757|54837196|FG002|Double-blind Phase|Other|0|||
27733605|NCT02688153|54181270|FG001|Overall Study|Withdrawal by Subject|2|||
27855731|NCT02733042|54382055|FG017|Follow-up Period|Ongoing on Follow-up|1|||
27855732|NCT02733042|54382056|FG018|Follow-up Period|Ongoing on Follow-up|0|||
27855733|NCT02733042|54382038|FG000|Follow-up Period|Death|1|||
27855734|NCT02733042|54382039|FG001|Follow-up Period|Death|1|||
28090057|NCT00284141|54743849|FG000|Overall Study|Clinical deterioration / death|2|||
28090058|NCT00284141|54743849|FG000|Overall Study|General decline|1|||
28090059|NCT00284141|54743849|FG000|Overall Study|Pneumonia|1|||
28090060|NCT00284141|54743849|FG000|Overall Study|Did not take study medication|2|||
28166398|NCT00965757|54837197|FG003|Double-blind Phase|Other|0|||
28090061|NCT00284141|54743849|FG000|Overall Study|Ongoing treatment|2|||
28090062|NCT00265343|54743857|FG000|Overall Study|Adverse Event|10|||
28090063|NCT00265343|54743858|FG001|Overall Study|Adverse Event|7|||
28090064|NCT00265343|54743857|FG000|Overall Study|Withdrawal by Subject|3|||
28090065|NCT00265343|54743858|FG001|Overall Study|Withdrawal by Subject|9|||
28090066|NCT00265343|54743857|FG000|Overall Study|Other|8|||
28090067|NCT00265343|54743858|FG001|Overall Study|Other|3|||
28090068|NCT00283595|54743866|FG000|Overall Study|Withdrawal by Subject|1|||
28090069|NCT00283595|54743867|FG001|Overall Study|Withdrawal by Subject|2|||
28090070|NCT00265109|54743873|FG000|Overall Study|Withdrawal by Subject|5|||
28090071|NCT00265109|54743873|FG000|Overall Study|Adverse Event|1|||
28090072|NCT03235024|54743880|FG000|Overall Study|Adverse Event|2|||
28090073|NCT03235024|54743881|FG001|Overall Study|Adverse Event|2|||
28090074|NCT03235024|54743880|FG000|Overall Study|Death|1|||
28090075|NCT03235024|54743881|FG001|Overall Study|Death|0|||
28090076|NCT03235024|54743880|FG000|Overall Study|Lost to Follow-up|2|||
28090077|NCT03235024|54743881|FG001|Overall Study|Lost to Follow-up|5|||
28090078|NCT03235024|54743880|FG000|Overall Study|Protocol Violation|1|||
28090079|NCT03235024|54743881|FG001|Overall Study|Protocol Violation|0|||
28090080|NCT03235024|54743880|FG000|Overall Study|Withdrawal by Subject|0|||
28090081|NCT03235024|54743881|FG001|Overall Study|Withdrawal by Subject|3|||
28090082|NCT03233308|54743887|FG000|Overall Study|Adverse Event|1|||
28090083|NCT03233308|54743887|FG000|Overall Study|Protocol Violation|1|||
28090084|NCT00283439|54743902|FG000|Overall Study|Adverse Event|0|||
28090085|NCT00283439|54743903|FG001|Overall Study|Adverse Event|0|||
28090086|NCT00283439|54743904|FG002|Overall Study|Adverse Event|0|||
27855735|NCT02733042|54382040|FG002|Follow-up Period|Death|2|||
27855736|NCT02733042|54382041|FG003|Follow-up Period|Death|0|||
28090087|NCT00283439|54743905|FG003|Overall Study|Adverse Event|1|||
28090088|NCT00283439|54743902|FG000|Overall Study|Death|0|||
28090089|NCT00283439|54743903|FG001|Overall Study|Death|0|||
28090090|NCT00283439|54743904|FG002|Overall Study|Death|1|||
28090091|NCT00283439|54743905|FG003|Overall Study|Death|0|||
28090092|NCT00283439|54743902|FG000|Overall Study|Disease progression|0|||
28090093|NCT00283439|54743903|FG001|Overall Study|Disease progression|1|||
28090094|NCT00283439|54743904|FG002|Overall Study|Disease progression|0|||
28090095|NCT00283439|54743905|FG003|Overall Study|Disease progression|0|||
28090096|NCT00283439|54743902|FG000|Overall Study|Requirement for alternative therapy|1|||
28090097|NCT00283439|54743903|FG001|Overall Study|Requirement for alternative therapy|2|||
28090098|NCT00283439|54743904|FG002|Overall Study|Requirement for alternative therapy|5|||
28090099|NCT00283439|54743905|FG003|Overall Study|Requirement for alternative therapy|2|||
28090100|NCT00283439|54743902|FG000|Overall Study|Stem cell transplant|6|||
28090101|NCT00283439|54743903|FG001|Overall Study|Stem cell transplant|6|||
28090102|NCT00283439|54743904|FG002|Overall Study|Stem cell transplant|4|||
28090103|NCT00283439|54743905|FG003|Overall Study|Stem cell transplant|3|||
28090104|NCT00283439|54743902|FG000|Overall Study|Treatment discontinued|0|||
28090105|NCT00283439|54743903|FG001|Overall Study|Treatment discontinued|2|||
28090106|NCT00283439|54743904|FG002|Overall Study|Treatment discontinued|1|||
28090107|NCT00283439|54743905|FG003|Overall Study|Treatment discontinued|3|||
28090108|NCT00283439|54743902|FG000|Overall Study|Other|1|||
28090109|NCT00283439|54743903|FG001|Overall Study|Other|0|||
28090110|NCT00283439|54743904|FG002|Overall Study|Other|0|||
27855737|NCT02733042|54382042|FG004|Follow-up Period|Death|1|||
28090111|NCT00283439|54743905|FG003|Overall Study|Other|0|||
28166399|NCT00965757|54837194|FG000|Extension Phase|Progression of concomitant disease|0|||
28166400|NCT00965757|54837195|FG001|Extension Phase|Progression of concomitant disease|0|||
28166401|NCT00965757|54837196|FG002|Extension Phase|Progression of concomitant disease|4|||
28166402|NCT00965757|54837197|FG003|Extension Phase|Progression of concomitant disease|2|||
28166403|NCT00965757|54837194|FG000|Extension Phase|Adverse drug reaction|0|||
28166404|NCT00965757|54837195|FG001|Extension Phase|Adverse drug reaction|0|||
28166405|NCT00965757|54837196|FG002|Extension Phase|Adverse drug reaction|6|||
28166406|NCT00965757|54837197|FG003|Extension Phase|Adverse drug reaction|3|||
28166407|NCT00965757|54837194|FG000|Extension Phase|Abnormal Laboratory Value|0|||
28090112|NCT03233230|54743919|FG000|Overall Study|Adverse Event|6|||
28090113|NCT03233230|54743920|FG001|Overall Study|Adverse Event|3|||
28090114|NCT03233230|54743921|FG002|Overall Study|Adverse Event|6|||
28090115|NCT03233230|54743922|FG003|Overall Study|Adverse Event|3|||
28166408|NCT00965757|54837195|FG001|Extension Phase|Abnormal Laboratory Value|0|||
27855738|NCT02733042|54382043|FG005|Follow-up Period|Death|2|||
27855739|NCT02733042|54382044|FG006|Follow-up Period|Death|0|||
27855740|NCT02733042|54382045|FG007|Follow-up Period|Death|3|||
28090116|NCT03233230|54743919|FG000|Overall Study|Protocol Violation|1|||
28090117|NCT03233230|54743920|FG001|Overall Study|Protocol Violation|2|||
28090118|NCT03233230|54743921|FG002|Overall Study|Protocol Violation|1|||
28090119|NCT03233230|54743922|FG003|Overall Study|Protocol Violation|1|||
28090120|NCT03233230|54743919|FG000|Overall Study|Lack of Efficacy|1|||
28090121|NCT03233230|54743920|FG001|Overall Study|Lack of Efficacy|0|||
28090122|NCT03233230|54743921|FG002|Overall Study|Lack of Efficacy|0|||
28090123|NCT03233230|54743922|FG003|Overall Study|Lack of Efficacy|0|||
28090124|NCT03233230|54743919|FG000|Overall Study|Other|5|||
28090125|NCT03233230|54743920|FG001|Overall Study|Other|5|||
28090126|NCT03233230|54743921|FG002|Overall Study|Other|5|||
28090127|NCT03233230|54743922|FG003|Overall Study|Other|3|||
28090128|NCT03233230|54743919|FG000|Overall Study|Withdrawal by Subject|2|||
28166409|NCT00965757|54837196|FG002|Extension Phase|Abnormal Laboratory Value|6|||
27980597|NCT00803361|54638602|FG000|Overall Study|Lost to Follow-up|1|||
27980598|NCT00803361|54638603|FG001|Overall Study|Lost to Follow-up|2|||
27980599|NCT00803361|54638602|FG000|Overall Study|Physician Decision|1|||
27980600|NCT00803361|54638603|FG001|Overall Study|Physician Decision|0|||
28090129|NCT03233230|54743920|FG001|Overall Study|Withdrawal by Subject|2|||
28166410|NCT00965757|54837197|FG003|Extension Phase|Abnormal Laboratory Value|1|||
28166411|NCT00965757|54837194|FG000|Extension Phase|Lack of Efficacy|0|||
28166412|NCT00965757|54837195|FG001|Extension Phase|Lack of Efficacy|0|||
28166413|NCT00965757|54837196|FG002|Extension Phase|Lack of Efficacy|8|||
28166414|NCT00965757|54837197|FG003|Extension Phase|Lack of Efficacy|12|||
28166415|NCT00965757|54837194|FG000|Extension Phase|Drug Refusal Due to Adverse Event|0|||
28166416|NCT00965757|54837195|FG001|Extension Phase|Drug Refusal Due to Adverse Event|0|||
28166417|NCT00965757|54837196|FG002|Extension Phase|Drug Refusal Due to Adverse Event|4|||
28166418|NCT00965757|54837197|FG003|Extension Phase|Drug Refusal Due to Adverse Event|0|||
28166419|NCT00965757|54837194|FG000|Extension Phase|Lost to Follow-up|0|||
28166420|NCT00965757|54837195|FG001|Extension Phase|Lost to Follow-up|0|||
28166421|NCT00965757|54837196|FG002|Extension Phase|Lost to Follow-up|0|||
28166422|NCT00965757|54837197|FG003|Extension Phase|Lost to Follow-up|1|||
28166423|NCT00965757|54837194|FG000|Extension Phase|Ineligible after Taking Study Drug|0|||
28166424|NCT00965757|54837195|FG001|Extension Phase|Ineligible after Taking Study Drug|0|||
28166425|NCT00965757|54837196|FG002|Extension Phase|Ineligible after Taking Study Drug|3|||
27733606|NCT02688153|54181269|FG000|Overall Study|Valve Explant|1|||
27733607|NCT02688153|54181270|FG001|Overall Study|Valve Explant|0|||
27733608|NCT02688153|54181269|FG000|Overall Study|Conversion to Commercial Valve|3|||
27733609|NCT02688153|54181270|FG001|Overall Study|Conversion to Commercial Valve|0|||
27733610|NCT02687919|54181279|FG000|Overall Study|Withdrawal by Subject|6|||
27733611|NCT02687919|54181280|FG001|Overall Study|Withdrawal by Subject|6|||
27733612|NCT02687919|54181279|FG000|Overall Study|Protocol Violation|2|||
27733613|NCT02687919|54181280|FG001|Overall Study|Protocol Violation|0|||
27733614|NCT02687451|54181292|FG000|Overall Study|Withdrawal by Subject|1|||
27733615|NCT02687451|54181293|FG001|Overall Study|Withdrawal by Subject|0|||
27733616|NCT02687451|54181294|FG002|Overall Study|Withdrawal by Subject|0|||
27733617|NCT02687451|54181295|FG003|Overall Study|Withdrawal by Subject|0|||
27733618|NCT02687451|54181296|FG004|Overall Study|Withdrawal by Subject|0|||
27733619|NCT02687451|54181297|FG005|Overall Study|Withdrawal by Subject|1|||
27733620|NCT02557646|54181313|FG000|Overall Study|Adverse Event|40|||
27733621|NCT02557646|54181313|FG000|Overall Study|Death|1|||
27733622|NCT02557646|54181313|FG000|Overall Study|Lack of Efficacy|186|||
27733623|NCT02557646|54181313|FG000|Overall Study|Withdrawal by Subject|18|||
27733624|NCT02557646|54181313|FG000|Overall Study|Lost to Follow-up|17|||
27733625|NCT02557646|54181313|FG000|Overall Study|Other|14|||
27733626|NCT02679573|54181319|FG000|Overall Study|Adverse Event|13|||
27733627|NCT02679573|54181320|FG001|Overall Study|Adverse Event|6|||
28090130|NCT03233230|54743921|FG002|Overall Study|Withdrawal by Subject|0|||
28090131|NCT03233230|54743922|FG003|Overall Study|Withdrawal by Subject|1|||
28090132|NCT03233230|54743919|FG000|Overall Study|Lost to Follow-up|0|||
28090133|NCT03233230|54743920|FG001|Overall Study|Lost to Follow-up|3|||
28090134|NCT03233230|54743921|FG002|Overall Study|Lost to Follow-up|0|||
28090135|NCT03233230|54743922|FG003|Overall Study|Lost to Follow-up|0|||
28090136|NCT00283049|54743935|FG000|Overall Study|Adverse Event|6|||
28090137|NCT00283049|54743936|FG001|Overall Study|Adverse Event|1|||
28166426|NCT00965757|54837197|FG003|Extension Phase|Ineligible after Taking Study Drug|3|||
28166427|NCT00965757|54837194|FG000|Extension Phase|Protocol Violation|0|||
27980601|NCT00803361|54638602|FG000|Overall Study|Protocol Violation|2|||
28090138|NCT00283049|54743937|FG002|Overall Study|Adverse Event|4|||
28090139|NCT00283049|54743935|FG000|Overall Study|Protocol Violation|3|||
28090140|NCT00283049|54743936|FG001|Overall Study|Protocol Violation|0|||
28090141|NCT00283049|54743937|FG002|Overall Study|Protocol Violation|3|||
28090142|NCT00283049|54743935|FG000|Overall Study|Death|1|||
28166428|NCT00965757|54837195|FG001|Extension Phase|Protocol Violation|0|||
28166429|NCT00965757|54837196|FG002|Extension Phase|Protocol Violation|0|||
28166430|NCT00965757|54837197|FG003|Extension Phase|Protocol Violation|1|||
28166431|NCT00965757|54837194|FG000|Extension Phase|Other|0|||
28166432|NCT00965757|54837195|FG001|Extension Phase|Other|0|||
27733628|NCT02679573|54181319|FG000|Overall Study|Lack of Efficacy|12|||
27733629|NCT02679573|54181320|FG001|Overall Study|Lack of Efficacy|15|||
27733630|NCT02679573|54181319|FG000|Overall Study|Could not complete required study visits|6|||
27733631|NCT02679573|54181320|FG001|Overall Study|Could not complete required study visits|2|||
27733632|NCT02679573|54181319|FG000|Overall Study|Withdrawal by Subject|2|||
27980602|NCT00803361|54638603|FG001|Overall Study|Protocol Violation|4|||
28090143|NCT00283049|54743936|FG001|Overall Study|Death|1|||
28090144|NCT00283049|54743937|FG002|Overall Study|Death|1|||
28166433|NCT00965757|54837196|FG002|Extension Phase|Other|2|||
28166434|NCT00965757|54837197|FG003|Extension Phase|Other|1|||
28166435|NCT03072459|54837205|FG000|Overall Study|Device revised/removed|1|||
28166436|NCT03072459|54837205|FG000|Overall Study|Subject not able to return|1|||
28166437|NCT01067521|54837211|FG000|Double-Blind Placebo-Controlled Period|Death|0|||
28166438|NCT01067521|54837212|FG001|Double-Blind Placebo-Controlled Period|Death|1|||
28166439|NCT01067521|54837211|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|29|||
28166440|NCT01067521|54837212|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|6|||
28166441|NCT01067521|54837211|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34|||
28166442|NCT01067521|54837212|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17|||
28166443|NCT01067521|54837211|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
28166444|NCT01067521|54837212|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
28166445|NCT01067521|54837211|FG000|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4|||
28166446|NCT01067521|54837212|FG001|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1|||
28166447|NCT01067521|54837211|FG000|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2|||
28090145|NCT00283049|54743935|FG000|Overall Study|Lack of Efficacy|0|||
27980603|NCT00803361|54638602|FG000|Overall Study|Withdrawal by Subject|5|||
27980604|NCT00803361|54638603|FG001|Overall Study|Withdrawal by Subject|6|||
27980605|NCT00611533|54638609|FG000|First Intervention (6 Weeks)|Never started study|0|||
27980606|NCT00611533|54638610|FG001|First Intervention (6 Weeks)|Never started study|1|||
28090146|NCT00283049|54743936|FG001|Overall Study|Lack of Efficacy|1|||
28090147|NCT00283049|54743937|FG002|Overall Study|Lack of Efficacy|1|||
28090148|NCT00283049|54743935|FG000|Overall Study|Lost to Follow-up|4|||
28090149|NCT00283049|54743936|FG001|Overall Study|Lost to Follow-up|2|||
28090150|NCT00283049|54743937|FG002|Overall Study|Lost to Follow-up|5|||
28090151|NCT00283049|54743935|FG000|Overall Study|Withdrawal by Subject|26|||
28090152|NCT00283049|54743936|FG001|Overall Study|Withdrawal by Subject|24|||
28090153|NCT00283049|54743937|FG002|Overall Study|Withdrawal by Subject|19|||
28090154|NCT00283049|54743935|FG000|Overall Study|Discontinuation of Study|18|||
28090155|NCT00283049|54743936|FG001|Overall Study|Discontinuation of Study|16|||
28090156|NCT00283049|54743937|FG002|Overall Study|Discontinuation of Study|20|||
28090157|NCT00283049|54743935|FG000|Overall Study|No longer requires study treatment|0|||
28090158|NCT00283049|54743936|FG001|Overall Study|No longer requires study treatment|0|||
28090159|NCT00283049|54743937|FG002|Overall Study|No longer requires study treatment|1|||
28090160|NCT00264875|54743945|FG000|Overall Study|Adverse Event|6|||
28090161|NCT00264875|54743945|FG000|Overall Study|Lost to Follow-up|6|||
28090162|NCT00264875|54743945|FG000|Overall Study|Protocol Violation|11|||
28090163|NCT00264875|54743945|FG000|Overall Study|Withdrawal by Subject|7|||
28090164|NCT03152110|54743949|FG000|Overall Study|Withdrawal by Subject|3|||
28090165|NCT03151408|54743956|FG000|Overall Study|Adverse Event|24|||
28090166|NCT03151408|54743957|FG001|Overall Study|Adverse Event|23|||
28090167|NCT03151408|54743956|FG000|Overall Study|Death|46|||
28090168|NCT03151408|54743957|FG001|Overall Study|Death|26|||
28090169|NCT03151408|54743956|FG000|Overall Study|Physician Decision|13|||
28090170|NCT03151408|54743957|FG001|Overall Study|Physician Decision|19|||
28090171|NCT03151408|54743956|FG000|Overall Study|Withdrawal by Subject|16|||
28090172|NCT03151408|54743957|FG001|Overall Study|Withdrawal by Subject|20|||
28090173|NCT03151408|54743956|FG000|Overall Study|Progressive disease|45|||
28090174|NCT03151408|54743957|FG001|Overall Study|Progressive disease|61|||
28090175|NCT03151408|54743956|FG000|Overall Study|non-compliance by patient|1|||
28090176|NCT03151408|54743957|FG001|Overall Study|non-compliance by patient|0|||
28090177|NCT03151408|54743956|FG000|Overall Study|other reasons|56|||
28090178|NCT03151408|54743957|FG001|Overall Study|other reasons|52|||
28090179|NCT03151408|54743956|FG000|Overall Study|randomized and not treated|2|||
28090180|NCT03151408|54743957|FG001|Overall Study|randomized and not treated|2|||
28090181|NCT00546754|54743965|FG000|Overall Study|Serious Adverse Event|1|||
28090182|NCT00546754|54743966|FG001|Overall Study|Serious Adverse Event|1|||
28166448|NCT01067521|54837212|FG001|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0|||
28166449|NCT01067521|54837211|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|2|||
27980607|NCT00611533|54638609|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
28090183|NCT00546754|54743965|FG000|Overall Study|Adverse Event|11|||
28090184|NCT00546754|54743966|FG001|Overall Study|Adverse Event|16|||
28090185|NCT00546754|54743965|FG000|Overall Study|Lack of Efficacy|1|||
28090186|NCT00546754|54743966|FG001|Overall Study|Lack of Efficacy|1|||
28090187|NCT00546754|54743965|FG000|Overall Study|Lost to Follow-up|9|||
28166450|NCT01067521|54837212|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
28090188|NCT00546754|54743966|FG001|Overall Study|Lost to Follow-up|15|||
28090189|NCT00546754|54743965|FG000|Overall Study|Protocol Violation|3|||
28090190|NCT00546754|54743966|FG001|Overall Study|Protocol Violation|0|||
28090191|NCT00546754|54743965|FG000|Overall Study|Withdrawal by Subject|6|||
28090192|NCT00546754|54743966|FG001|Overall Study|Withdrawal by Subject|7|||
27980608|NCT00611533|54638610|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
28090193|NCT00546754|54743965|FG000|Overall Study|Dyspnea|1|||
28090194|NCT00546754|54743966|FG001|Overall Study|Dyspnea|0|||
28090195|NCT00546754|54743965|FG000|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1|||
28090196|NCT00546754|54743966|FG001|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0|||
28090197|NCT00546754|54743965|FG000|Overall Study|Hip Replacement|1|||
28090198|NCT00546754|54743966|FG001|Overall Study|Hip Replacement|0|||
28090199|NCT00546754|54743965|FG000|Overall Study|Suicide|1|||
28090200|NCT00546754|54743966|FG001|Overall Study|Suicide|0|||
28090201|NCT00546754|54743965|FG000|Overall Study|Missing Cooperation|1|||
28090202|NCT00546754|54743966|FG001|Overall Study|Missing Cooperation|0|||
28090203|NCT00546754|54743965|FG000|Overall Study|Elevated Creatinine and Potassium levels|0|||
28090204|NCT00546754|54743966|FG001|Overall Study|Elevated Creatinine and Potassium levels|1|||
28090205|NCT00546754|54743965|FG000|Overall Study|Patient's Decision|0|||
28090206|NCT00546754|54743966|FG001|Overall Study|Patient's Decision|1|||
28166451|NCT01067521|54837211|FG000|Double-Blind Placebo-Controlled Period|Pregnancy|7|||
28166452|NCT01067521|54837212|FG001|Double-Blind Placebo-Controlled Period|Pregnancy|4|||
28166453|NCT01067521|54837211|FG000|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5|||
28166454|NCT01067521|54837212|FG001|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1|||
28166455|NCT01067521|54837211|FG000|Open-Label Period|Death|3|||
28166456|NCT01067521|54837212|FG001|Open-Label Period|Death|1|||
28166457|NCT01067521|54837211|FG000|Open-Label Period|Adverse Event|30|||
28166458|NCT01067521|54837212|FG001|Open-Label Period|Adverse Event|28|||
28166459|NCT01067521|54837211|FG000|Open-Label Period|Withdrawal by Subject|160|||
28166460|NCT01067521|54837212|FG001|Open-Label Period|Withdrawal by Subject|88|||
28166461|NCT01067521|54837211|FG000|Open-Label Period|Physician Decision|13|||
28166462|NCT01067521|54837212|FG001|Open-Label Period|Physician Decision|11|||
28166463|NCT01067521|54837211|FG000|Open-Label Period|Non-compliance with study drug|5|||
28166464|NCT01067521|54837212|FG001|Open-Label Period|Non-compliance with study drug|0|||
28166465|NCT01067521|54837211|FG000|Open-Label Period|Protocol Violation|3|||
28166466|NCT01067521|54837212|FG001|Open-Label Period|Protocol Violation|0|||
28166467|NCT01067521|54837211|FG000|Open-Label Period|Pregnancy|14|||
28166468|NCT01067521|54837212|FG001|Open-Label Period|Pregnancy|8|||
28166469|NCT01067521|54837211|FG000|Open-Label Period|Teva requested subject to be withdrawn|5|||
28166470|NCT01067521|54837212|FG001|Open-Label Period|Teva requested subject to be withdrawn|2|||
28166471|NCT01067521|54837211|FG000|Open-Label Period|Lost to Follow-up|21|||
28166472|NCT01067521|54837212|FG001|Open-Label Period|Lost to Follow-up|20|||
28166473|NCT02735577|54837223|FG000|Disulfiram Treatment|Lost to Follow-up|1|||
28166474|NCT02735577|54837223|FG000|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2|||
28166475|NCT01345123|54837230|FG000|Overall Study|participants no longer with health plan|79|||
28166476|NCT01345123|54837231|FG001|Overall Study|participants no longer with health plan|85|||
28166477|NCT01345123|54837232|FG002|Overall Study|participants no longer with health plan|88|||
28166478|NCT02735421|54837241|FG000|Part A (Randomized): up to 24 Weeks|Adverse Event|2|||
28166479|NCT02735421|54837241|FG000|Part A (Randomized): up to 24 Weeks|Withdrawal by Subject|6|||
28166480|NCT02735421|54837241|FG000|Part A (Randomized): up to 24 Weeks|Lost to Follow-up|3|||
28166481|NCT02735421|54837241|FG000|Part A (Randomized): up to 24 Weeks|Inadequate compliance to treatment|1|||
28166482|NCT02735421|54837241|FG000|Part A (Randomized): up to 24 Weeks|Pregnancy|1|||
28166483|NCT02735421|54837241|FG000|Part 2 (Open Label): up to 48 Weeks|Withdrawal by Subject|1|||
28166484|NCT02735421|54837241|FG000|Part 2 (Open Label): up to 48 Weeks|Lost to Follow-up|3|||
28166485|NCT02983799|54837258|FG000|Overall Study|Withdrawn from study before data cut-off|28|||
28166486|NCT02983799|54837259|FG001|Overall Study|Withdrawn from study before data cut-off|12|||
28166487|NCT02983799|54837260|FG002|Overall Study|Withdrawn from study before data cut-off|23|||
28166488|NCT02983799|54837261|FG003|Overall Study|Withdrawn from study before data cut-off|25|||
28166489|NCT02983799|54837262|FG004|Overall Study|Withdrawn from study before data cut-off|1|||
28166490|NCT02983799|54837258|FG000|Overall Study|Death|20|||
28166491|NCT02983799|54837259|FG001|Overall Study|Death|5|||
28166492|NCT02983799|54837260|FG002|Overall Study|Death|23|||
28166493|NCT02983799|54837261|FG003|Overall Study|Death|47|||
28166494|NCT02983799|54837262|FG004|Overall Study|Death|7|||
28166495|NCT02983799|54837258|FG000|Overall Study|Withdrawal by Subject|1|||
28166496|NCT02983799|54837259|FG001|Overall Study|Withdrawal by Subject|0|||
28166497|NCT02983799|54837260|FG002|Overall Study|Withdrawal by Subject|3|||
28166498|NCT02983799|54837261|FG003|Overall Study|Withdrawal by Subject|4|||
28166499|NCT02983799|54837262|FG004|Overall Study|Withdrawal by Subject|1|||
28166500|NCT02983799|54837258|FG000|Overall Study|Protocol Violation|0|||
27855741|NCT02733042|54382046|FG008|Follow-up Period|Death|3|||
28166501|NCT02983799|54837259|FG001|Overall Study|Protocol Violation|1|||
28166502|NCT02983799|54837260|FG002|Overall Study|Protocol Violation|0|||
28166503|NCT02983799|54837261|FG003|Overall Study|Protocol Violation|0|||
28166504|NCT02983799|54837262|FG004|Overall Study|Protocol Violation|1|||
28166505|NCT02983799|54837258|FG000|Overall Study|Lost to Follow-up|1|||
28166506|NCT02983799|54837259|FG001|Overall Study|Lost to Follow-up|0|||
28166507|NCT02983799|54837260|FG002|Overall Study|Lost to Follow-up|1|||
28166508|NCT02983799|54837261|FG003|Overall Study|Lost to Follow-up|0|||
28090207|NCT00546754|54743965|FG000|Overall Study|Missing|14|||
28166509|NCT02983799|54837262|FG004|Overall Study|Lost to Follow-up|0|||
28166510|NCT02186847|54837280|FG000|Overall Study|Protocol Violation|3|||
28090208|NCT00546754|54743966|FG001|Overall Study|Missing|7|||
28090209|NCT00282347|54743974|FG000|Treatment Period|Death|2|||
28090210|NCT00282347|54743975|FG001|Treatment Period|Death|0|||
28090211|NCT00282347|54743974|FG000|Treatment Period|Lost to Follow-up|2|||
28090212|NCT00282347|54743975|FG001|Treatment Period|Lost to Follow-up|5|||
28090213|NCT00282347|54743974|FG000|Treatment Period|Withdrawal by Subject|1|||
28090214|NCT00282347|54743975|FG001|Treatment Period|Withdrawal by Subject|3|||
28090215|NCT00282347|54743974|FG000|Treatment Period|Physician Decision|0|||
28090216|NCT00282347|54743975|FG001|Treatment Period|Physician Decision|1|||
28090217|NCT00282347|54743974|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
28090218|NCT00282347|54743975|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
28090219|NCT00282347|54743974|FG000|Safety Follow-up Period|Withdrawal by Subject|2|||
28090220|NCT00282347|54743975|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
28090221|NCT00282347|54743974|FG000|Safety Follow-up Period|Physician Decision|1|||
28090222|NCT00282347|54743975|FG001|Safety Follow-up Period|Physician Decision|1|||
28166511|NCT02186847|54837281|FG001|Overall Study|Protocol Violation|0|||
28166512|NCT01066871|54837291|FG000|Overall Study|Lost to Follow-up|0|||
28166513|NCT01066871|54837292|FG001|Overall Study|Lost to Follow-up|2|||
28166514|NCT01066871|54837293|FG002|Overall Study|Lost to Follow-up|2|||
28166515|NCT01066871|54837294|FG003|Overall Study|Lost to Follow-up|0|||
28166516|NCT01066871|54837291|FG000|Overall Study|Protocol Violation|1|||
28166517|NCT01066871|54837292|FG001|Overall Study|Protocol Violation|0|||
28166518|NCT01066871|54837293|FG002|Overall Study|Protocol Violation|3|||
28090223|NCT00282347|54743974|FG000|Safety Follow-up Period|Protocol Deviation|0|||
28090224|NCT00282347|54743975|FG001|Safety Follow-up Period|Protocol Deviation|2|||
28090225|NCT00282347|54743974|FG000|B Cell Follow-up Period|Withdrawal by Subject|2|||
28090226|NCT00282347|54743975|FG001|B Cell Follow-up Period|Withdrawal by Subject|0|||
28090227|NCT00282347|54743974|FG000|B Cell Follow-up Period|Physician Decision|1|||
28090228|NCT00282347|54743975|FG001|B Cell Follow-up Period|Physician Decision|0|||
28090229|NCT00282347|54743974|FG000|B Cell Follow-up Period|Reason Not Specified|2|||
28090230|NCT00282347|54743975|FG001|B Cell Follow-up Period|Reason Not Specified|0|||
28090231|NCT00405964|54743985|FG000|Overall Study|Treatment Failure|17|||
28090232|NCT00405964|54743986|FG001|Overall Study|Treatment Failure|45|||
28090233|NCT00405964|54743985|FG000|Overall Study|Adverse Event|7|||
28166519|NCT01066871|54837294|FG003|Overall Study|Protocol Violation|2|||
28166520|NCT01066871|54837291|FG000|Overall Study|Lack of Efficacy|0|||
28090234|NCT00405964|54743986|FG001|Overall Study|Adverse Event|16|||
28090235|NCT00405964|54743985|FG000|Overall Study|Lost to Follow-up|5|||
28090236|NCT00405964|54743986|FG001|Overall Study|Lost to Follow-up|5|||
28090237|NCT00405964|54743985|FG000|Overall Study|Withdrawal by Subject|19|||
28090238|NCT00405964|54743986|FG001|Overall Study|Withdrawal by Subject|23|||
28090239|NCT00405964|54743985|FG000|Overall Study|Protocol Violation|11|||
28090240|NCT00405964|54743986|FG001|Overall Study|Protocol Violation|6|||
28090241|NCT00264797|54743994|FG000|Overall Study|Withdrawal by Subject|11|||
28090242|NCT00264797|54743995|FG001|Overall Study|Withdrawal by Subject|11|||
28090243|NCT00264797|54743994|FG000|Overall Study|Lost to Follow-up|9|||
28090244|NCT00264797|54743995|FG001|Overall Study|Lost to Follow-up|17|||
28090245|NCT00264797|54743994|FG000|Overall Study|Moved from area|3|||
28166521|NCT01066871|54837292|FG001|Overall Study|Lack of Efficacy|0|||
28166522|NCT01066871|54837293|FG002|Overall Study|Lack of Efficacy|0|||
28166523|NCT01066871|54837294|FG003|Overall Study|Lack of Efficacy|1|||
28166524|NCT01066871|54837291|FG000|Overall Study|Withdrawal by Subject|3|||
28166525|NCT01066871|54837292|FG001|Overall Study|Withdrawal by Subject|1|||
28166526|NCT01066871|54837293|FG002|Overall Study|Withdrawal by Subject|0|||
28166527|NCT01066871|54837294|FG003|Overall Study|Withdrawal by Subject|0|||
28166528|NCT01066871|54837291|FG000|Overall Study|Other|0|||
28166529|NCT01066871|54837292|FG001|Overall Study|Other|2|||
28166530|NCT01066871|54837293|FG002|Overall Study|Other|1|||
27733633|NCT02679573|54181320|FG001|Overall Study|Withdrawal by Subject|9|||
27733634|NCT02679573|54181319|FG000|Overall Study|Death|2|||
27833099|NCT04034238|54313531|FG002|Dose Escalation Phase|Screen failures|0|||
27980609|NCT00611533|54638609|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
27980610|NCT00611533|54638610|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
27980611|NCT00953147|54638629|FG000|Overall Study|Adverse Event|8|||
27980612|NCT00953147|54638630|FG001|Overall Study|Adverse Event|16|||
27980613|NCT00953147|54638631|FG002|Overall Study|Adverse Event|6|||
28090246|NCT00264797|54743995|FG001|Overall Study|Moved from area|1|||
28166531|NCT01066871|54837294|FG003|Overall Study|Other|2|||
28090247|NCT00264797|54743994|FG000|Overall Study|Practical Problems|2|||
28090248|NCT00264797|54743995|FG001|Overall Study|Practical Problems|3|||
28090249|NCT00264797|54743994|FG000|Overall Study|Incarceration|4|||
28090250|NCT00264797|54743995|FG001|Overall Study|Incarceration|5|||
28090251|NCT00264797|54743994|FG000|Overall Study|Pressure/advice from Outsiders|1|||
28090252|NCT00264797|54743995|FG001|Overall Study|Pressure/advice from Outsiders|1|||
28090253|NCT00264797|54743994|FG000|Overall Study|Feels treatment not necessary, not worki|0|||
28090254|NCT00264797|54743995|FG001|Overall Study|Feels treatment not necessary, not worki|1|||
27733635|NCT02679573|54181320|FG001|Overall Study|Death|0|||
27833100|NCT04034238|54313532|FG003|Dose Escalation Phase|Screen failures|2|||
27980614|NCT00953147|54638629|FG000|Overall Study|Protocol Violation|2|||
27980615|NCT00953147|54638630|FG001|Overall Study|Protocol Violation|8|||
27980616|NCT00953147|54638631|FG002|Overall Study|Protocol Violation|4|||
27980617|NCT00953147|54638629|FG000|Overall Study|Withdrawal by Subject|13|||
27980618|NCT00953147|54638630|FG001|Overall Study|Withdrawal by Subject|15|||
27980619|NCT00953147|54638631|FG002|Overall Study|Withdrawal by Subject|12|||
27980620|NCT00953147|54638629|FG000|Overall Study|Lost to Follow-up|8|||
27980621|NCT00953147|54638630|FG001|Overall Study|Lost to Follow-up|9|||
27980622|NCT00953147|54638631|FG002|Overall Study|Lost to Follow-up|4|||
28090255|NCT00264797|54743994|FG000|Overall Study|Other|3|||
28090256|NCT00264797|54743995|FG001|Overall Study|Other|4|||
28090257|NCT03148756|54744003|FG000|Overall Study|Study Terminated|0|||
28090258|NCT03148756|54744004|FG001|Overall Study|Study Terminated|1|||
28090259|NCT00282113|54744013|FG000|Overall Study|Removed at parents request|1|||
28166532|NCT02982863|54837314|FG000|Overall Study|Not eligible patients|809|||
28166533|NCT02982863|54837315|FG001|Overall Study|Not eligible patients|4261|||
28166534|NCT02982863|54837316|FG002|Overall Study|Not eligible patients|1852|||
28166535|NCT02982863|54837317|FG003|Overall Study|Not eligible patients|1400|||
28166536|NCT02982863|54837318|FG004|Overall Study|Not eligible patients|492|||
28166537|NCT04343651|54837361|FG000|Overall Study|Physician Decision|2|||
28166538|NCT04343651|54837362|FG001|Overall Study|Physician Decision|1|||
28166539|NCT04343651|54837361|FG000|Overall Study|Lost to Follow-up|2|||
28166540|NCT04343651|54837362|FG001|Overall Study|Lost to Follow-up|1|||
28166541|NCT04343651|54837361|FG000|Overall Study|Protocol Violation|4|||
28166542|NCT04343651|54837362|FG001|Overall Study|Protocol Violation|6|||
28166543|NCT04343651|54837361|FG000|Overall Study|Missing|3|||
28166544|NCT04343651|54837362|FG001|Overall Study|Missing|9|||
28166545|NCT04343651|54837361|FG000|Overall Study|Withdrawal by Subject|0|||
28166546|NCT04343651|54837362|FG001|Overall Study|Withdrawal by Subject|4|||
28166547|NCT04343651|54837361|FG000|Overall Study|Death|0|||
28166548|NCT04343651|54837362|FG001|Overall Study|Death|1|||
28166549|NCT04343651|54837361|FG000|Overall Study|Did not start treatment|1|||
28166550|NCT04343651|54837362|FG001|Overall Study|Did not start treatment|1|||
28166551|NCT04343651|54837361|FG000|Overall Study|Patient did not complete visits 3-6|0|||
28166552|NCT04343651|54837362|FG001|Overall Study|Patient did not complete visits 3-6|1|||
28166553|NCT02906579|54837370|FG000|Overall Study|Adverse Event|1|||
28166554|NCT02906579|54837370|FG000|Overall Study|Physician Decision|1|||
28166555|NCT01328535|54837390|FG000|Overall Study|Ineligible|1|||
28090260|NCT00282113|54744014|FG001|Overall Study|Removed at parents request|0|||
28090261|NCT00282113|54744015|FG002|Overall Study|Removed at parents request|0|||
28166556|NCT02905331|54837398|FG000|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1|||
28166557|NCT02905331|54837399|FG001|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
28166558|NCT02905331|54837400|FG002|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
28166559|NCT02905331|54837398|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2|||
28166560|NCT02905331|54837399|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
28166561|NCT02905331|54837400|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
28166562|NCT02905331|54837398|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
28166563|NCT02905331|54837399|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1|||
28166564|NCT02905331|54837400|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
28166565|NCT02905331|54837398|FG000|Active Treatment and Follow up (wk16-40)|Other|0|||
28166566|NCT02905331|54837399|FG001|Active Treatment and Follow up (wk16-40)|Other|6|||
28166567|NCT02905331|54837400|FG002|Active Treatment and Follow up (wk16-40)|Other|0|||
28166568|NCT02905331|54837398|FG000|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
28166569|NCT02905331|54837399|FG001|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2|||
28166570|NCT02905331|54837400|FG002|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
28166571|NCT02979197|54837411|FG000|Overall Study|Adverse Event|4|||
28166572|NCT02979197|54837412|FG001|Overall Study|Adverse Event|2|||
28166573|NCT02979197|54837413|FG002|Overall Study|Adverse Event|0|||
27980623|NCT00953147|54638629|FG000|Overall Study|Physician Decision|2|||
27980624|NCT00953147|54638630|FG001|Overall Study|Physician Decision|7|||
27980625|NCT00953147|54638631|FG002|Overall Study|Physician Decision|3|||
28090262|NCT00281957|54744025|FG000|Overall Study|Adverse Event|7|||
28090263|NCT00281957|54744026|FG001|Overall Study|Adverse Event|2|||
28090264|NCT00281957|54744025|FG000|Overall Study|Death|1|||
28090265|NCT00281957|54744026|FG001|Overall Study|Death|0|||
28090266|NCT00281957|54744025|FG000|Overall Study|Progression/relapse|47|||
28090267|NCT00281957|54744026|FG001|Overall Study|Progression/relapse|35|||
28090268|NCT00281957|54744025|FG000|Overall Study|Not protocol specified|8|||
28166574|NCT02979197|54837411|FG000|Overall Study|Protocol Violation|0|||
28166575|NCT02979197|54837412|FG001|Overall Study|Protocol Violation|1|||
27980626|NCT00953147|54638629|FG000|Overall Study|Other|4|||
28090269|NCT00281957|54744026|FG001|Overall Study|Not protocol specified|1|||
28090270|NCT00281957|54744025|FG000|Overall Study|Not eligible|1|||
28090271|NCT00281957|54744026|FG001|Overall Study|Not eligible|2|||
28090272|NCT00281957|54744025|FG000|Overall Study|Did not start treatment|3|||
28090273|NCT00281957|54744026|FG001|Overall Study|Did not start treatment|1|||
27855742|NCT02733042|54382047|FG009|Follow-up Period|Death|0|||
27855743|NCT02733042|54382048|FG010|Follow-up Period|Death|0|||
28090274|NCT00281957|54744025|FG000|Overall Study|Refusal unrelated to adverse events|0|||
28090275|NCT00281957|54744026|FG001|Overall Study|Refusal unrelated to adverse events|1|||
28090276|NCT00281099|54744036|FG000|Overall Study|Death|46|||
28090277|NCT00281099|54744037|FG001|Overall Study|Death|57|||
28090278|NCT00281099|54744036|FG000|Overall Study|Lost to Follow-up|10|||
28090279|NCT00281099|54744037|FG001|Overall Study|Lost to Follow-up|19|||
28090280|NCT00281099|54744036|FG000|Overall Study|Withdrawal by Subject|65|||
28090281|NCT00281099|54744037|FG001|Overall Study|Withdrawal by Subject|70|||
28090282|NCT00281099|54744036|FG000|Overall Study|Physician Decision|79|||
28090283|NCT00281099|54744037|FG001|Overall Study|Physician Decision|72|||
28090284|NCT00281099|54744036|FG000|Overall Study|Heart Transplant/Device Exit/Changeout|5|||
28090285|NCT00281099|54744037|FG001|Overall Study|Heart Transplant/Device Exit/Changeout|4|||
28090286|NCT00262925|54744044|FG000|Overall Study|Lack of Efficacy|3|||
28090287|NCT00262925|54744044|FG000|Overall Study|Adverse Event|4|||
28090288|NCT00262925|54744044|FG000|Overall Study|Death|2|||
28090289|NCT00262925|54744044|FG000|Overall Study|alternative therapy|1|||
28090290|NCT00262925|54744044|FG000|Overall Study|Other|1|||
28090291|NCT03720470|54744054|FG000|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
28090292|NCT03720470|54744055|FG001|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
28090293|NCT03720470|54744056|FG002|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
28090294|NCT03720470|54744057|FG003|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
28090295|NCT03720470|54744058|FG004|Treatment Period: First Part 16 Weeks|Adverse Event|8|||
28090296|NCT03720470|54744059|FG005|Treatment Period: First Part 16 Weeks|Adverse Event|6|||
28090297|NCT03720470|54744054|FG000|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
28090298|NCT03720470|54744055|FG001|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
28090299|NCT03720470|54744056|FG002|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
28090300|NCT03720470|54744057|FG003|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
28090301|NCT03720470|54744058|FG004|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
28090302|NCT03720470|54744059|FG005|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
28090303|NCT03720470|54744054|FG000|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
28090304|NCT03720470|54744055|FG001|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
28090305|NCT03720470|54744056|FG002|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
28090306|NCT03720470|54744057|FG003|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
28090307|NCT03720470|54744058|FG004|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
28090308|NCT03720470|54744059|FG005|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
28090309|NCT03720470|54744054|FG000|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
28090310|NCT03720470|54744055|FG001|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
28090311|NCT03720470|54744056|FG002|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
28090312|NCT03720470|54744057|FG003|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
28090313|NCT03720470|54744058|FG004|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
28090314|NCT03720470|54744059|FG005|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
28090315|NCT03720470|54744054|FG000|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
28090316|NCT03720470|54744055|FG001|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
28090317|NCT03720470|54744056|FG002|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
28090318|NCT03720470|54744057|FG003|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
28090319|NCT03720470|54744058|FG004|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
28090320|NCT03720470|54744059|FG005|Treatment Period: First Part 16 Weeks|Protocol deviation|1|||
28090321|NCT03720470|54744054|FG000|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5|||
28090322|NCT03720470|54744055|FG001|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
28090323|NCT03720470|54744056|FG002|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
28090324|NCT03720470|54744057|FG003|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9|||
28090325|NCT03720470|54744058|FG004|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3|||
28090326|NCT03720470|54744059|FG005|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6|||
28090327|NCT03720470|54744054|FG000|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
28090328|NCT03720470|54744055|FG001|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
28090329|NCT03720470|54744056|FG002|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
28090330|NCT03720470|54744057|FG003|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
28090331|NCT03720470|54744058|FG004|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
28090332|NCT03720470|54744059|FG005|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
27855744|NCT02733042|54382049|FG011|Follow-up Period|Death|0|||
28090333|NCT03720470|54744054|FG000|Treatment Period: First Part 16 Weeks|Other|1|||
28166576|NCT02979197|54837413|FG002|Overall Study|Protocol Violation|0|||
28166577|NCT02979197|54837411|FG000|Overall Study|Subject unable to commit to study dates|0|||
27855745|NCT02733042|54382050|FG012|Follow-up Period|Death|8|||
27855746|NCT02733042|54382051|FG013|Follow-up Period|Death|1|||
27855747|NCT02733042|54382052|FG014|Follow-up Period|Death|1|||
28090334|NCT03720470|54744055|FG001|Treatment Period: First Part 16 Weeks|Other|0|||
28090335|NCT03720470|54744056|FG002|Treatment Period: First Part 16 Weeks|Other|0|||
28090336|NCT03720470|54744057|FG003|Treatment Period: First Part 16 Weeks|Other|1|||
28090337|NCT03720470|54744058|FG004|Treatment Period: First Part 16 Weeks|Other|2|||
28090338|NCT03720470|54744059|FG005|Treatment Period: First Part 16 Weeks|Other|2|||
28090339|NCT03720470|54744054|FG000|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
28090340|NCT03720470|54744055|FG001|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
28090341|NCT03720470|54744056|FG002|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
28090342|NCT03720470|54744057|FG003|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
28090343|NCT03720470|54744058|FG004|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
28166578|NCT02979197|54837412|FG001|Overall Study|Subject unable to commit to study dates|1|||
28166579|NCT02979197|54837413|FG002|Overall Study|Subject unable to commit to study dates|0|||
28166580|NCT02982239|54837423|FG000|Overall Study|Lost to Follow-up|3|||
28166581|NCT02982239|54837424|FG001|Overall Study|Lost to Follow-up|2|||
28166582|NCT01066793|54837437|FG000|Overall Study|Death|4|||
28166583|NCT01066793|54837438|FG001|Overall Study|Death|1|||
28166584|NCT01066793|54837439|FG002|Overall Study|Death|1|||
28166585|NCT01066793|54837440|FG003|Overall Study|Death|0|||
28166586|NCT01066793|54837441|FG004|Overall Study|Death|0|||
28166587|NCT01066793|54837442|FG005|Overall Study|Death|0|||
28166588|NCT01066793|54837437|FG000|Overall Study|Lack of Efficacy|2|||
28166589|NCT01066793|54837438|FG001|Overall Study|Lack of Efficacy|1|||
28166590|NCT01066793|54837439|FG002|Overall Study|Lack of Efficacy|0|||
28166591|NCT01066793|54837440|FG003|Overall Study|Lack of Efficacy|0|||
28166592|NCT01066793|54837441|FG004|Overall Study|Lack of Efficacy|0|||
28166593|NCT01066793|54837442|FG005|Overall Study|Lack of Efficacy|0|||
28166594|NCT01066793|54837437|FG000|Overall Study|Lost to Follow-up|180|||
28166595|NCT01066793|54837438|FG001|Overall Study|Lost to Follow-up|39|||
28166596|NCT01066793|54837439|FG002|Overall Study|Lost to Follow-up|82|||
28166597|NCT01066793|54837440|FG003|Overall Study|Lost to Follow-up|16|||
28166598|NCT01066793|54837441|FG004|Overall Study|Lost to Follow-up|0|||
28166599|NCT01066793|54837442|FG005|Overall Study|Lost to Follow-up|1|||
28166600|NCT01066793|54837437|FG000|Overall Study|Physician Decision|3|||
27733636|NCT02679573|54181319|FG000|Overall Study|Physician Decision|2|||
27733637|NCT02679573|54181320|FG001|Overall Study|Physician Decision|4|||
27733638|NCT02679573|54181319|FG000|Overall Study|Lost to Follow-up|0|||
27733639|NCT02679573|54181320|FG001|Overall Study|Lost to Follow-up|3|||
27733640|NCT02685033|54181328|FG000|Overall Study|Withdrawal of Consent|0|||
27733641|NCT02685033|54181329|FG001|Overall Study|Withdrawal of Consent|1|||
27733642|NCT02685033|54181328|FG000|Overall Study|Lost to Follow-up|2|||
27733643|NCT02685033|54181329|FG001|Overall Study|Lost to Follow-up|1|||
27733644|NCT02685033|54181328|FG000|Overall Study|Adverse Event|1|||
27733645|NCT02685033|54181329|FG001|Overall Study|Adverse Event|0|||
27733646|NCT02684097|54181337|FG000|Overall Study|Lack of Efficacy|13|||
27733647|NCT02684097|54181338|FG001|Overall Study|Lack of Efficacy|6|||
27733648|NCT02555618|54181346|FG000|Overall Study|Sponsor's Circumstances|1|||
27733649|NCT02555618|54181347|FG001|Overall Study|Sponsor's Circumstances|0|||
27733650|NCT02557100|54181373|FG000|Single Blind Treatment Period|Lost to Follow-up|0|||
27733651|NCT02557100|54181374|FG001|Single Blind Treatment Period|Lost to Follow-up|1|||
27733652|NCT02557100|54181375|FG002|Single Blind Treatment Period|Lost to Follow-up|0|||
27733653|NCT02557100|54181373|FG000|Single Blind Treatment Period|Death|0|||
27733654|NCT02557100|54181374|FG001|Single Blind Treatment Period|Death|1|||
27733655|NCT02557100|54181375|FG002|Single Blind Treatment Period|Death|0|||
27733656|NCT02557100|54181373|FG000|Single Blind Treatment Period|Request to Discontinue|0|||
27733657|NCT02557100|54181374|FG001|Single Blind Treatment Period|Request to Discontinue|1|||
27733658|NCT02557100|54181375|FG002|Single Blind Treatment Period|Request to Discontinue|0|||
27733659|NCT02557100|54181373|FG000|Single Blind Treatment Period|Adverse Event|0|||
27733660|NCT02557100|54181374|FG001|Single Blind Treatment Period|Adverse Event|1|||
27733661|NCT02557100|54181375|FG002|Single Blind Treatment Period|Adverse Event|0|||
27733662|NCT02557100|54181373|FG000|Transition to Open Label|Entered Cumulative Abatacept Period|40|||
27733663|NCT02557100|54181374|FG001|Transition to Open Label|Entered Cumulative Abatacept Period|36|||
27980627|NCT00953147|54638630|FG001|Overall Study|Other|11|||
28166601|NCT01066793|54837438|FG001|Overall Study|Physician Decision|0|||
28166602|NCT01066793|54837439|FG002|Overall Study|Physician Decision|0|||
28166603|NCT01066793|54837440|FG003|Overall Study|Physician Decision|0|||
28166604|NCT01066793|54837441|FG004|Overall Study|Physician Decision|0|||
28166605|NCT01066793|54837442|FG005|Overall Study|Physician Decision|0|||
27733664|NCT02557100|54181375|FG002|Transition to Open Label|Entered Cumulative Abatacept Period|0|||
27733665|NCT02557100|54181373|FG000|Cumulative Abatacept Period|Other Reasons|0|||
28166606|NCT01066793|54837437|FG000|Overall Study|Protocol Violation|3|||
28166607|NCT01066793|54837438|FG001|Overall Study|Protocol Violation|2|||
27733666|NCT02557100|54181374|FG001|Cumulative Abatacept Period|Other Reasons|0|||
27733667|NCT02557100|54181375|FG002|Cumulative Abatacept Period|Other Reasons|1|||
28090344|NCT03720470|54744059|FG005|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1|||
28166608|NCT01066793|54837439|FG002|Overall Study|Protocol Violation|2|||
28090345|NCT03720470|54744054|FG000|Treatment Period: Final 4 Weeks|Adverse Event|0|||
28090346|NCT03720470|54744055|FG001|Treatment Period: Final 4 Weeks|Adverse Event|0|||
28090347|NCT03720470|54744056|FG002|Treatment Period: Final 4 Weeks|Adverse Event|0|||
28090348|NCT03720470|54744057|FG003|Treatment Period: Final 4 Weeks|Adverse Event|2|||
28090349|NCT03720470|54744058|FG004|Treatment Period: Final 4 Weeks|Adverse Event|1|||
28090350|NCT03720470|54744059|FG005|Treatment Period: Final 4 Weeks|Adverse Event|1|||
28090351|NCT03720470|54744054|FG000|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
28090352|NCT03720470|54744055|FG001|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
28090353|NCT03720470|54744056|FG002|Treatment Period: Final 4 Weeks|Lack of Efficacy|1|||
28090354|NCT03720470|54744057|FG003|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
28090355|NCT03720470|54744058|FG004|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
28090356|NCT03720470|54744059|FG005|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
28090357|NCT03720470|54744054|FG000|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
28090358|NCT03720470|54744055|FG001|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
28090359|NCT03720470|54744056|FG002|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
28090360|NCT03720470|54744057|FG003|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
28090361|NCT03720470|54744058|FG004|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
28090362|NCT03720470|54744059|FG005|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
28090363|NCT03720470|54744054|FG000|Treatment Period: Final 4 Weeks|Pregnancy|0|||
28090364|NCT03720470|54744055|FG001|Treatment Period: Final 4 Weeks|Pregnancy|0|||
28090365|NCT03720470|54744056|FG002|Treatment Period: Final 4 Weeks|Pregnancy|0|||
28090366|NCT03720470|54744057|FG003|Treatment Period: Final 4 Weeks|Pregnancy|0|||
28090367|NCT03720470|54744058|FG004|Treatment Period: Final 4 Weeks|Pregnancy|0|||
28090368|NCT03720470|54744059|FG005|Treatment Period: Final 4 Weeks|Pregnancy|1|||
28090369|NCT03720470|54744054|FG000|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
28090370|NCT03720470|54744055|FG001|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
28090371|NCT03720470|54744056|FG002|Treatment Period: Final 4 Weeks|Protocol Deviation|1|||
28090372|NCT03720470|54744057|FG003|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
28090373|NCT03720470|54744058|FG004|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
28090374|NCT03720470|54744059|FG005|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
28090375|NCT03720470|54744054|FG000|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
28090376|NCT03720470|54744055|FG001|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1|||
28090377|NCT03720470|54744056|FG002|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
28090378|NCT03720470|54744057|FG003|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
28090379|NCT03720470|54744058|FG004|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
28090380|NCT03720470|54744059|FG005|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
28090381|NCT03720470|54744054|FG000|Treatment Period: Final 4 Weeks|Other|0|||
28090382|NCT03720470|54744055|FG001|Treatment Period: Final 4 Weeks|Other|1|||
28090383|NCT03720470|54744056|FG002|Treatment Period: Final 4 Weeks|Other|0|||
28090384|NCT03720470|54744057|FG003|Treatment Period: Final 4 Weeks|Other|2|||
28090385|NCT03720470|54744058|FG004|Treatment Period: Final 4 Weeks|Other|1|||
28090386|NCT03720470|54744059|FG005|Treatment Period: Final 4 Weeks|Other|0|||
28090387|NCT00262847|54744082|FG000|Overall Study|Disease Progression|309|||
28090388|NCT00262847|54744083|FG001|Overall Study|Disease Progression|274|||
28090389|NCT00262847|54744084|FG002|Overall Study|Disease Progression|195|||
28090390|NCT00262847|54744082|FG000|Overall Study|Patient Refusal|41|||
28090391|NCT00262847|54744083|FG001|Overall Study|Patient Refusal|52|||
28090392|NCT00262847|54744084|FG002|Overall Study|Patient Refusal|47|||
28090393|NCT00262847|54744082|FG000|Overall Study|Adverse Event|74|||
28090394|NCT00262847|54744083|FG001|Overall Study|Adverse Event|88|||
28090395|NCT00262847|54744084|FG002|Overall Study|Adverse Event|108|||
28090396|NCT00262847|54744082|FG000|Overall Study|Death|8|||
28090397|NCT00262847|54744083|FG001|Overall Study|Death|8|||
28090398|NCT00262847|54744084|FG002|Overall Study|Death|11|||
28090399|NCT00262847|54744082|FG000|Overall Study|Concomitant disease|3|||
28090400|NCT00262847|54744083|FG001|Overall Study|Concomitant disease|2|||
28090401|NCT00262847|54744084|FG002|Overall Study|Concomitant disease|4|||
28090402|NCT00262847|54744082|FG000|Overall Study|Other Reasons|79|||
28090403|NCT00262847|54744083|FG001|Overall Study|Other Reasons|88|||
28090404|NCT00262847|54744084|FG002|Overall Study|Other Reasons|27|||
28090405|NCT00262847|54744082|FG000|Overall Study|Did not receive study treatment|4|||
28090406|NCT00262847|54744083|FG001|Overall Study|Did not receive study treatment|1|||
28090407|NCT00262847|54744084|FG002|Overall Study|Did not receive study treatment|4|||
28090408|NCT00280397|54744095|FG000|Overall Study|Adverse Event|1|||
28090409|NCT00262301|54744104|FG000|Double-blind Phase|Lost to Follow-up|1|||
28090410|NCT00262301|54744105|FG001|Double-blind Phase|Lost to Follow-up|0|||
28166609|NCT01066793|54837440|FG003|Overall Study|Protocol Violation|0|||
28090411|NCT00262301|54744106|FG002|Double-blind Phase|Lost to Follow-up|0|||
28090412|NCT00262301|54744104|FG000|Double-blind Phase|"worsening of HAE symptoms"|0|||
28090413|NCT00262301|54744105|FG001|Double-blind Phase|"worsening of HAE symptoms"|1|||
28090414|NCT00262301|54744106|FG002|Double-blind Phase|"worsening of HAE symptoms"|0|||
28090415|NCT00279305|54744116|FG000|Overall Study|Pregnancy|1|||
28090416|NCT00279305|54744117|FG001|Overall Study|Pregnancy|0|||
28166610|NCT01066793|54837441|FG004|Overall Study|Protocol Violation|0|||
28090417|NCT00279305|54744116|FG000|Overall Study|Withdrawal by Subject|2|||
28090418|NCT00279305|54744117|FG001|Overall Study|Withdrawal by Subject|0|||
28090419|NCT00279305|54744116|FG000|Overall Study|Dificulting establishing IV|1|||
28090420|NCT00279305|54744117|FG001|Overall Study|Dificulting establishing IV|0|||
28090421|NCT00279305|54744116|FG000|Overall Study|FDA Safety Alert|4|||
28090422|NCT00279305|54744117|FG001|Overall Study|FDA Safety Alert|1|||
28090423|NCT00278993|54744123|FG000|Overall Study|Adverse Event|24|||
28090424|NCT00278993|54744123|FG000|Overall Study|Withdrawal by Subject|5|||
28090425|NCT00278993|54744123|FG000|Overall Study|Progressive Disease|65|||
28090426|NCT00278993|54744123|FG000|Overall Study|Physician Decision|9|||
28090427|NCT00278993|54744123|FG000|Overall Study|Not Otherwise Specified|4|||
28090428|NCT00277355|54744129|FG000|Overall Study|Withdrawal by Subject|3|||
28090429|NCT00277355|54744130|FG001|Overall Study|Withdrawal by Subject|3|||
28090430|NCT00277355|54744129|FG000|Overall Study|Lost to Follow-up|2|||
28090431|NCT00277355|54744130|FG001|Overall Study|Lost to Follow-up|2|||
28090432|NCT00277355|54744129|FG000|Overall Study|Adverse Event|5|||
28090433|NCT00277355|54744130|FG001|Overall Study|Adverse Event|0|||
28090434|NCT00277355|54744129|FG000|Overall Study|Death|3|||
28090435|NCT00277355|54744130|FG001|Overall Study|Death|0|||
28090436|NCT00277355|54744129|FG000|Overall Study|Physician Decision|1|||
28090437|NCT00277355|54744130|FG001|Overall Study|Physician Decision|0|||
28090438|NCT00262223|54744139|FG000|Treatment Phase|Withdrawal by Subject|3|||
28090439|NCT00262223|54744140|FG001|Treatment Phase|Withdrawal by Subject|6|||
28090440|NCT00262223|54744139|FG000|Treatment Phase|Adverse Event|1|||
28090441|NCT00262223|54744140|FG001|Treatment Phase|Adverse Event|2|||
28090442|NCT00262223|54744139|FG000|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
28090443|NCT00262223|54744140|FG001|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
28090444|NCT00262223|54744139|FG000|6-month Post-treatment Follow-up|Lost to Follow-up|6|||
28090445|NCT00262223|54744140|FG001|6-month Post-treatment Follow-up|Lost to Follow-up|1|||
28090446|NCT00262223|54744139|FG000|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
28090447|NCT00262223|54744140|FG001|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
28090448|NCT00276419|54744149|FG000|First Intervention|Adverse Event|1|||
28090449|NCT00276419|54744150|FG001|First Intervention|Adverse Event|0|||
28090450|NCT00276419|54744149|FG000|First Intervention|Withdrawal by Subject|0|||
28090451|NCT00276419|54744150|FG001|First Intervention|Withdrawal by Subject|2|||
28090452|NCT00262067|54744171|FG000|Overall Study|Death|190|||
28090453|NCT00262067|54744172|FG001|Overall Study|Death|89|||
28090454|NCT00262067|54744173|FG002|Overall Study|Death|186|||
28090455|NCT00262067|54744174|FG003|Overall Study|Death|99|||
28090456|NCT00262067|54744171|FG000|Overall Study|Lost to Follow-up|5|||
28090457|NCT00262067|54744172|FG001|Overall Study|Lost to Follow-up|4|||
28090458|NCT00262067|54744173|FG002|Overall Study|Lost to Follow-up|7|||
28090459|NCT00262067|54744174|FG003|Overall Study|Lost to Follow-up|5|||
28090460|NCT00262067|54744171|FG000|Overall Study|Sponsor's Decision to Terminate Study|1|||
28090461|NCT00262067|54744172|FG001|Overall Study|Sponsor's Decision to Terminate Study|0|||
28090462|NCT00262067|54744173|FG002|Overall Study|Sponsor's Decision to Terminate Study|0|||
28090463|NCT00262067|54744174|FG003|Overall Study|Sponsor's Decision to Terminate Study|0|||
28090464|NCT00262067|54744171|FG000|Overall Study|Patient Withdrew for Survival Follow-up|23|||
28090465|NCT00262067|54744172|FG001|Overall Study|Patient Withdrew for Survival Follow-up|7|||
28090466|NCT00262067|54744173|FG002|Overall Study|Patient Withdrew for Survival Follow-up|23|||
28090467|NCT00262067|54744174|FG003|Overall Study|Patient Withdrew for Survival Follow-up|9|||
28090468|NCT00275561|54744186|FG000|Overall Study|Withdrawal by Subject|0|||
28090469|NCT00275561|54744187|FG001|Overall Study|Withdrawal by Subject|1|||
28090470|NCT00275561|54744186|FG000|Overall Study|Travel|1|||
28090471|NCT00275561|54744187|FG001|Overall Study|Travel|1|||
28090472|NCT00275561|54744186|FG000|Overall Study|Scheduling|1|||
28090473|NCT00275561|54744187|FG001|Overall Study|Scheduling|2|||
27855748|NCT02733042|54382053|FG015|Follow-up Period|Death|4|||
27855749|NCT02733042|54382054|FG016|Follow-up Period|Death|0|||
28090474|NCT00275561|54744186|FG000|Overall Study|Family Issues|0|||
28090475|NCT00275561|54744187|FG001|Overall Study|Family Issues|2|||
28090476|NCT00274937|54744197|FG000|Overall Study|Physician Decision|10|||
28090477|NCT00274937|54744197|FG000|Overall Study|Withdrawal by Subject|6|||
28090478|NCT00274937|54744197|FG000|Overall Study|Progressive Disease|4|||
28090479|NCT00251693|54744204|FG000|Overall Study|Adverse Event|17|||
27855750|NCT02733042|54382055|FG017|Follow-up Period|Death|1|||
28090480|NCT00251693|54744205|FG001|Overall Study|Adverse Event|9|||
28090481|NCT00251693|54744206|FG002|Overall Study|Adverse Event|9|||
28090482|NCT00251693|54744204|FG000|Overall Study|Protocol Violation|2|||
28090483|NCT00251693|54744205|FG001|Overall Study|Protocol Violation|0|||
27980628|NCT00953147|54638631|FG002|Overall Study|Other|13|||
27980629|NCT00803205|54638641|FG000|Overall Study|Adverse Event|7|||
28090484|NCT00251693|54744206|FG002|Overall Study|Protocol Violation|2|||
28090485|NCT00251693|54744204|FG000|Overall Study|Lost to Follow-up|12|||
27980630|NCT00803205|54638642|FG001|Overall Study|Adverse Event|2|||
28090486|NCT00251693|54744205|FG001|Overall Study|Lost to Follow-up|7|||
27855751|NCT02733042|54382056|FG018|Follow-up Period|Death|2|||
27980631|NCT00803205|54638641|FG000|Overall Study|Lost to Follow-up|1|||
28090487|NCT00251693|54744206|FG002|Overall Study|Lost to Follow-up|8|||
28090488|NCT00251693|54744204|FG000|Overall Study|Withdrawal by Subject|11|||
28090489|NCT00251693|54744205|FG001|Overall Study|Withdrawal by Subject|17|||
28090490|NCT00251693|54744206|FG002|Overall Study|Withdrawal by Subject|14|||
28090491|NCT00251693|54744204|FG000|Overall Study|Lack of Efficacy|0|||
28090492|NCT00251693|54744205|FG001|Overall Study|Lack of Efficacy|1|||
28090493|NCT00251693|54744206|FG002|Overall Study|Lack of Efficacy|0|||
28090494|NCT00251693|54744204|FG000|Overall Study|Inclusion/exclusion criteria not met|5|||
28090495|NCT00251693|54744205|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
28090496|NCT00251693|54744206|FG002|Overall Study|Inclusion/exclusion criteria not met|8|||
28090497|NCT00251693|54744204|FG000|Overall Study|Noncompliant|0|||
28090498|NCT00251693|54744205|FG001|Overall Study|Noncompliant|0|||
28090499|NCT00251693|54744206|FG002|Overall Study|Noncompliant|2|||
28090500|NCT00251693|54744204|FG000|Overall Study|Possible Barrett's esophagus|3|||
28090501|NCT00251693|54744205|FG001|Overall Study|Possible Barrett's esophagus|5|||
28090502|NCT00251693|54744206|FG002|Overall Study|Possible Barrett's esophagus|2|||
28090503|NCT00251693|54744204|FG000|Overall Study|Subject request/subject unavailable|1|||
28090504|NCT00251693|54744205|FG001|Overall Study|Subject request/subject unavailable|2|||
28090505|NCT00251693|54744206|FG002|Overall Study|Subject request/subject unavailable|0|||
28090506|NCT00251693|54744204|FG000|Overall Study|Abnormal laboratory findings|0|||
28090507|NCT00251693|54744205|FG001|Overall Study|Abnormal laboratory findings|0|||
28090508|NCT00251693|54744206|FG002|Overall Study|Abnormal laboratory findings|1|||
28090509|NCT00250835|54744214|FG000|Overall Study|Withdrawal by Subject|1|||
28090510|NCT03716024|54744224|FG000|Overall Study|Randomized, not Treated|7|||
28090511|NCT03716024|54744225|FG001|Overall Study|Randomized, not Treated|8|||
28090512|NCT03716024|54744224|FG000|Overall Study|Adverse Event|1|||
28090513|NCT03716024|54744225|FG001|Overall Study|Adverse Event|2|||
28090514|NCT03716024|54744224|FG000|Overall Study|Treatment Failure|1|||
28090515|NCT03716024|54744225|FG001|Overall Study|Treatment Failure|0|||
28090516|NCT03716024|54744224|FG000|Overall Study|Lost to Follow-up|2|||
28090517|NCT03716024|54744225|FG001|Overall Study|Lost to Follow-up|6|||
28090518|NCT03716024|54744224|FG000|Overall Study|Withdrawal by Subject|0|||
28090519|NCT03716024|54744225|FG001|Overall Study|Withdrawal by Subject|1|||
28090520|NCT03716024|54744224|FG000|Overall Study|Missing Reason|0|||
28090521|NCT03716024|54744225|FG001|Overall Study|Missing Reason|1|||
28090522|NCT00250679|54744234|FG000|Overall Study|Adverse Event|12|||
28090523|NCT00250679|54744235|FG001|Overall Study|Adverse Event|15|||
28090524|NCT00250679|54744236|FG002|Overall Study|Adverse Event|16|||
28090525|NCT00250679|54744234|FG000|Overall Study|Protocol Violation|2|||
28090526|NCT00250679|54744235|FG001|Overall Study|Protocol Violation|4|||
28090527|NCT00250679|54744236|FG002|Overall Study|Protocol Violation|3|||
28090528|NCT00250679|54744234|FG000|Overall Study|Withdrawal by Subject|15|||
28090529|NCT00250679|54744235|FG001|Overall Study|Withdrawal by Subject|18|||
28090530|NCT00250679|54744236|FG002|Overall Study|Withdrawal by Subject|15|||
28090531|NCT00250679|54744234|FG000|Overall Study|Lost to Follow-up|3|||
28090532|NCT00250679|54744235|FG001|Overall Study|Lost to Follow-up|4|||
28090533|NCT00250679|54744236|FG002|Overall Study|Lost to Follow-up|2|||
28090534|NCT00250679|54744234|FG000|Overall Study|Does Not Meet Entry Criteria|1|||
28090535|NCT00250679|54744235|FG001|Overall Study|Does Not Meet Entry Criteria|4|||
28090536|NCT00250679|54744236|FG002|Overall Study|Does Not Meet Entry Criteria|2|||
28090537|NCT00250679|54744234|FG000|Overall Study|Lack of Efficacy|0|||
28090538|NCT00250679|54744235|FG001|Overall Study|Lack of Efficacy|1|||
28090539|NCT00250679|54744236|FG002|Overall Study|Lack of Efficacy|3|||
28090540|NCT00250679|54744234|FG000|Overall Study|Technical Holter issues|1|||
28090541|NCT00250679|54744235|FG001|Overall Study|Technical Holter issues|0|||
28090542|NCT00250679|54744236|FG002|Overall Study|Technical Holter issues|2|||
28090543|NCT00250679|54744234|FG000|Overall Study|Moved|1|||
28090544|NCT00250679|54744235|FG001|Overall Study|Moved|1|||
28090545|NCT00250679|54744236|FG002|Overall Study|Moved|0|||
28090546|NCT00250679|54744234|FG000|Overall Study|Non-compliance|1|||
28090547|NCT00250679|54744235|FG001|Overall Study|Non-compliance|1|||
28090548|NCT00250679|54744236|FG002|Overall Study|Non-compliance|0|||
28090549|NCT00250679|54744234|FG000|Overall Study|various single events: hip surgery,diary|3|||
28090550|NCT00250679|54744235|FG001|Overall Study|various single events: hip surgery,diary|1|||
28090551|NCT00250679|54744236|FG002|Overall Study|various single events: hip surgery,diary|1|||
28090552|NCT00261833|54744246|FG000|Overall Study|Death|1|||
28090553|NCT00261833|54744247|FG001|Overall Study|Death|3|||
28090554|NCT00261833|54744246|FG000|Overall Study|Adverse Event|1|||
28090555|NCT00261833|54744247|FG001|Overall Study|Adverse Event|4|||
28090556|NCT00261833|54744246|FG000|Overall Study|Withdrawal by Subject|5|||
27855752|NCT02733042|54382038|FG000|Follow-up Period|Other|0|||
28090557|NCT00261833|54744247|FG001|Overall Study|Withdrawal by Subject|7|||
28090558|NCT00261833|54744246|FG000|Overall Study|Protocol Violation|0|||
28090559|NCT00261833|54744247|FG001|Overall Study|Protocol Violation|1|||
28166611|NCT01066793|54837442|FG005|Overall Study|Protocol Violation|0|||
28090560|NCT00261833|54744246|FG000|Overall Study|Suspicion of pulmonary cancer|0|||
28090561|NCT00261833|54744247|FG001|Overall Study|Suspicion of pulmonary cancer|1|||
28090562|NCT00261833|54744246|FG000|Overall Study|Lung transplantation|1|||
28090563|NCT00261833|54744247|FG001|Overall Study|Lung transplantation|1|||
28090564|NCT00261833|54744246|FG000|Overall Study|Missing reason|1|||
28090565|NCT00261833|54744247|FG001|Overall Study|Missing reason|0|||
28090566|NCT00261833|54744246|FG000|Overall Study|Not interested in being participant|0|||
28090567|NCT00261833|54744247|FG001|Overall Study|Not interested in being participant|1|||
28090568|NCT03713684|54744258|FG000|Overall Study|Adverse Event|1|||
28090569|NCT03713684|54744259|FG001|Overall Study|Adverse Event|3|||
28090570|NCT03713684|54744260|FG002|Overall Study|Adverse Event|1|||
28090571|NCT03713684|54744261|FG003|Overall Study|Adverse Event|0|||
28090572|NCT03713684|54744258|FG000|Overall Study|Poor compliance to protocol|2|||
28090573|NCT03713684|54744259|FG001|Overall Study|Poor compliance to protocol|1|||
28090574|NCT03713684|54744260|FG002|Overall Study|Poor compliance to protocol|0|||
28090575|NCT03713684|54744261|FG003|Overall Study|Poor compliance to protocol|1|||
28090576|NCT03713684|54744258|FG000|Overall Study|Withdrawal by Subject|14|||
28090577|NCT03713684|54744259|FG001|Overall Study|Withdrawal by Subject|6|||
28090578|NCT03713684|54744260|FG002|Overall Study|Withdrawal by Subject|14|||
28090579|NCT03713684|54744261|FG003|Overall Study|Withdrawal by Subject|16|||
28090580|NCT03713684|54744258|FG000|Overall Study|Other than specified|69|||
28090581|NCT03713684|54744259|FG001|Overall Study|Other than specified|77|||
28090582|NCT03713684|54744260|FG002|Overall Study|Other than specified|73|||
28090583|NCT03713684|54744261|FG003|Overall Study|Other than specified|70|||
28090584|NCT03711266|54744271|FG000|Overall Study|Lost to Follow-up|10|||
28090585|NCT03150862|54744283|FG000|Overall Study|Death|2|||
28090586|NCT03150862|54744284|FG001|Overall Study|Death|7|||
28090587|NCT03150862|54744285|FG002|Overall Study|Death|8|||
28090588|NCT03150862|54744286|FG003|Overall Study|Death|27|||
28090589|NCT03150862|54744287|FG004|Overall Study|Death|4|||
28090590|NCT03150862|54744288|FG005|Overall Study|Death|8|||
28090591|NCT03150862|54744289|FG006|Overall Study|Death|6|||
28090592|NCT03150862|54744290|FG007|Overall Study|Death|21|||
28090593|NCT03150862|54744283|FG000|Overall Study|Withdrawal by Subject|1|||
28090594|NCT03150862|54744284|FG001|Overall Study|Withdrawal by Subject|1|||
28090595|NCT03150862|54744285|FG002|Overall Study|Withdrawal by Subject|0|||
28090596|NCT03150862|54744286|FG003|Overall Study|Withdrawal by Subject|3|||
28090597|NCT03150862|54744287|FG004|Overall Study|Withdrawal by Subject|1|||
28090598|NCT03150862|54744288|FG005|Overall Study|Withdrawal by Subject|1|||
28090599|NCT03150862|54744289|FG006|Overall Study|Withdrawal by Subject|1|||
28090600|NCT03150862|54744290|FG007|Overall Study|Withdrawal by Subject|3|||
28090601|NCT03150862|54744283|FG000|Overall Study|Lost to Follow-up|0|||
28090602|NCT03150862|54744284|FG001|Overall Study|Lost to Follow-up|0|||
28090603|NCT03150862|54744285|FG002|Overall Study|Lost to Follow-up|1|||
28090604|NCT03150862|54744286|FG003|Overall Study|Lost to Follow-up|0|||
28090605|NCT03150862|54744287|FG004|Overall Study|Lost to Follow-up|0|||
28090606|NCT03150862|54744288|FG005|Overall Study|Lost to Follow-up|0|||
28090607|NCT03150862|54744289|FG006|Overall Study|Lost to Follow-up|0|||
28090608|NCT03150862|54744290|FG007|Overall Study|Lost to Follow-up|2|||
28090609|NCT03150862|54744283|FG000|Overall Study|Sponsor's decision|0|||
28090610|NCT03150862|54744284|FG001|Overall Study|Sponsor's decision|0|||
28090611|NCT03150862|54744285|FG002|Overall Study|Sponsor's decision|0|||
28090612|NCT03150862|54744286|FG003|Overall Study|Sponsor's decision|10|||
28090613|NCT03150862|54744287|FG004|Overall Study|Sponsor's decision|3|||
28090614|NCT03150862|54744288|FG005|Overall Study|Sponsor's decision|0|||
28090615|NCT03150862|54744289|FG006|Overall Study|Sponsor's decision|1|||
28090616|NCT03150862|54744290|FG007|Overall Study|Sponsor's decision|1|||
28090617|NCT03150862|54744283|FG000|Overall Study|Change in Methylation status|0|||
28090618|NCT03150862|54744284|FG001|Overall Study|Change in Methylation status|0|||
28090619|NCT03150862|54744285|FG002|Overall Study|Change in Methylation status|0|||
28090620|NCT03150862|54744286|FG003|Overall Study|Change in Methylation status|0|||
28166612|NCT01066793|54837437|FG000|Overall Study|Withdrawal by Subject|7|||
28166613|NCT01066793|54837438|FG001|Overall Study|Withdrawal by Subject|4|||
28166614|NCT01066793|54837439|FG002|Overall Study|Withdrawal by Subject|1|||
28166615|NCT01066793|54837440|FG003|Overall Study|Withdrawal by Subject|0|||
28090621|NCT03150862|54744287|FG004|Overall Study|Change in Methylation status|1|||
28090622|NCT03150862|54744288|FG005|Overall Study|Change in Methylation status|0|||
28090623|NCT03150862|54744289|FG006|Overall Study|Change in Methylation status|0|||
28090624|NCT03150862|54744290|FG007|Overall Study|Change in Methylation status|0|||
28090625|NCT03150862|54744283|FG000|Overall Study|Roll over in to Long Term Extension|0|||
28090626|NCT03150862|54744284|FG001|Overall Study|Roll over in to Long Term Extension|0|||
28166616|NCT01066793|54837441|FG004|Overall Study|Withdrawal by Subject|0|||
28166617|NCT01066793|54837442|FG005|Overall Study|Withdrawal by Subject|0|||
27855753|NCT02733042|54382039|FG001|Follow-up Period|Other|0|||
28090627|NCT03150862|54744285|FG002|Overall Study|Roll over in to Long Term Extension|0|||
28090628|NCT03150862|54744286|FG003|Overall Study|Roll over in to Long Term Extension|0|||
28090629|NCT03150862|54744287|FG004|Overall Study|Roll over in to Long Term Extension|0|||
28090630|NCT03150862|54744288|FG005|Overall Study|Roll over in to Long Term Extension|0|||
28166618|NCT01066793|54837437|FG000|Overall Study|Early Termination|3|||
28166619|NCT01066793|54837438|FG001|Overall Study|Early Termination|0|||
28090631|NCT03150862|54744289|FG006|Overall Study|Roll over in to Long Term Extension|0|||
28090632|NCT03150862|54744290|FG007|Overall Study|Roll over in to Long Term Extension|1|||
28090633|NCT03150862|54744283|FG000|Overall Study|Progressive Disease|0|||
28090634|NCT03150862|54744284|FG001|Overall Study|Progressive Disease|0|||
28090635|NCT03150862|54744285|FG002|Overall Study|Progressive Disease|0|||
28090636|NCT03150862|54744286|FG003|Overall Study|Progressive Disease|0|||
28090637|NCT03150862|54744287|FG004|Overall Study|Progressive Disease|0|||
28090638|NCT03150862|54744288|FG005|Overall Study|Progressive Disease|0|||
28090639|NCT03150862|54744289|FG006|Overall Study|Progressive Disease|0|||
28090640|NCT03150862|54744290|FG007|Overall Study|Progressive Disease|2|||
28090641|NCT00260429|54744319|FG000|Overall Study|failure to follow appointments|1|||
28166620|NCT01066793|54837439|FG002|Overall Study|Early Termination|0|||
28090642|NCT00260429|54744320|FG001|Overall Study|failure to follow appointments|0|||
28090643|NCT00260429|54744319|FG000|Overall Study|scheduled hand surgery|1|||
28090644|NCT00260429|54744320|FG001|Overall Study|scheduled hand surgery|0|||
28090645|NCT00379288|54744330|FG000|Overall Study|Adverse Event|5|||
28090646|NCT00379288|54744331|FG001|Overall Study|Adverse Event|6|||
28090647|NCT00379288|54744332|FG002|Overall Study|Adverse Event|2|||
28090648|NCT00379288|54744333|FG003|Overall Study|Adverse Event|0|||
28090649|NCT00379288|54744330|FG000|Overall Study|Treatment Failure|0|||
28166621|NCT01066793|54837440|FG003|Overall Study|Early Termination|0|||
28166622|NCT01066793|54837441|FG004|Overall Study|Early Termination|0|||
28166623|NCT01066793|54837442|FG005|Overall Study|Early Termination|0|||
28166624|NCT01066793|54837437|FG000|Overall Study|Lab test not done|7|||
28166625|NCT01066793|54837438|FG001|Overall Study|Lab test not done|0|||
28090650|NCT00379288|54744331|FG001|Overall Study|Treatment Failure|1|||
28090651|NCT00379288|54744332|FG002|Overall Study|Treatment Failure|0|||
28090652|NCT00379288|54744333|FG003|Overall Study|Treatment Failure|1|||
28090653|NCT00379288|54744330|FG000|Overall Study|Lost to Follow-up|3|||
28090654|NCT00379288|54744331|FG001|Overall Study|Lost to Follow-up|3|||
28090655|NCT00379288|54744332|FG002|Overall Study|Lost to Follow-up|2|||
28166626|NCT01066793|54837439|FG002|Overall Study|Lab test not done|0|||
28166627|NCT01066793|54837440|FG003|Overall Study|Lab test not done|1|||
28166628|NCT01066793|54837441|FG004|Overall Study|Lab test not done|0|||
27733668|NCT02557100|54181373|FG000|Cumulative Abatacept Period|Lost to Follow-up|0|||
28090656|NCT00379288|54744333|FG003|Overall Study|Lost to Follow-up|0|||
28090657|NCT00379288|54744330|FG000|Overall Study|Subject withdrew-unrelated to study drug|0|||
28090658|NCT00379288|54744331|FG001|Overall Study|Subject withdrew-unrelated to study drug|3|||
28090659|NCT00379288|54744332|FG002|Overall Study|Subject withdrew-unrelated to study drug|4|||
28090660|NCT00379288|54744333|FG003|Overall Study|Subject withdrew-unrelated to study drug|2|||
28090661|NCT00379288|54744330|FG000|Overall Study|Subject withdrew-related to study drug|1|||
28090662|NCT00379288|54744331|FG001|Overall Study|Subject withdrew-related to study drug|0|||
28090663|NCT00379288|54744332|FG002|Overall Study|Subject withdrew-related to study drug|0|||
28090664|NCT00379288|54744333|FG003|Overall Study|Subject withdrew-related to study drug|1|||
28090665|NCT00379288|54744330|FG000|Overall Study|Noncompliance with protocol|8|||
28090666|NCT00379288|54744331|FG001|Overall Study|Noncompliance with protocol|6|||
27733669|NCT02557100|54181374|FG001|Cumulative Abatacept Period|Lost to Follow-up|0|||
27733670|NCT02557100|54181375|FG002|Cumulative Abatacept Period|Lost to Follow-up|2|||
27980632|NCT00803205|54638642|FG001|Overall Study|Lost to Follow-up|0|||
27980633|NCT00803205|54638641|FG000|Overall Study|Withdrawal by Subject|9|||
27980634|NCT00803205|54638642|FG001|Overall Study|Withdrawal by Subject|9|||
27980635|NCT00803205|54638641|FG000|Overall Study|Physician Decision|1|||
27980636|NCT00803205|54638642|FG001|Overall Study|Physician Decision|0|||
28090667|NCT00379288|54744332|FG002|Overall Study|Noncompliance with protocol|2|||
27833101|NCT04034238|54313529|FG000|Dose Expansion Phase|Not treated due to study hold.|0|||
27833102|NCT04034238|54313530|FG001|Dose Expansion Phase|Not treated due to study hold.|0|||
27733671|NCT02557100|54181373|FG000|Cumulative Abatacept Period|Request to Discontinue|0|||
27733672|NCT02557100|54181374|FG001|Cumulative Abatacept Period|Request to Discontinue|0|||
27733673|NCT02557100|54181375|FG002|Cumulative Abatacept Period|Request to Discontinue|1|||
27733674|NCT01337635|54181385|FG000|Overall Study|Lost to Follow-up|0|||
27733675|NCT01337635|54181386|FG001|Overall Study|Lost to Follow-up|1|||
27733676|NCT02556710|54181394|FG000|Overall Study|Surgical treatment|3|||
27733677|NCT02556710|54181395|FG001|Overall Study|Surgical treatment|0|||
27733678|NCT02556710|54181394|FG000|Overall Study|Required proscribed pain medication|2|||
27833103|NCT04034238|54313531|FG002|Dose Expansion Phase|Not treated due to study hold.|0|||
27833104|NCT04034238|54313532|FG003|Dose Expansion Phase|Not treated due to study hold.|1|||
27855754|NCT02733042|54382040|FG002|Follow-up Period|Other|0|||
28090668|NCT00379288|54744333|FG003|Overall Study|Noncompliance with protocol|1|||
28090669|NCT00379288|54744330|FG000|Overall Study|Did not meet protocol eligibility|0|||
28090670|NCT00379288|54744331|FG001|Overall Study|Did not meet protocol eligibility|1|||
28090671|NCT00379288|54744332|FG002|Overall Study|Did not meet protocol eligibility|0|||
28090672|NCT00379288|54744333|FG003|Overall Study|Did not meet protocol eligibility|2|||
28166629|NCT01066793|54837442|FG005|Overall Study|Lab test not done|0|||
28166630|NCT01066793|54837437|FG000|Overall Study|Miscellaneous|4|||
28090673|NCT00379288|54744330|FG000|Overall Study|Administrative|2|||
28090674|NCT00379288|54744331|FG001|Overall Study|Administrative|2|||
28090675|NCT00379288|54744332|FG002|Overall Study|Administrative|0|||
28090676|NCT00379288|54744333|FG003|Overall Study|Administrative|1|||
28090677|NCT00243503|54744343|FG000|Overall Study|Adverse Event|11|||
28090678|NCT00243503|54744343|FG000|Overall Study|Withdrawal by Subject|1|||
28090679|NCT00243503|54744343|FG000|Overall Study|Lack of Efficacy|44|||
28090680|NCT00243503|54744343|FG000|Overall Study|Death|1|||
28090681|NCT00243503|54744343|FG000|Overall Study|Other|1|||
28090682|NCT00239837|54744350|FG000|Overall Study|Lost to Follow-up|3|||
28090683|NCT00239837|54744351|FG001|Overall Study|Lost to Follow-up|7|||
28090684|NCT00259649|54744359|FG000|Overall Study|Lost to Follow-up|7|||
28090685|NCT00259649|54744359|FG000|Overall Study|irregular menses|3|||
28090686|NCT03712280|54744367|FG000|Overall Study|Randomized, but not treated due to Adverse Event|0|||
28090687|NCT03712280|54744368|FG001|Overall Study|Randomized, but not treated due to Adverse Event|1|||
28090688|NCT03712280|54744369|FG002|Overall Study|Randomized, but not treated due to Adverse Event|0|||
28090689|NCT03712280|54744370|FG003|Overall Study|Randomized, but not treated due to Adverse Event|1|||
28090690|NCT03712280|54744367|FG000|Overall Study|Withdrawal by Participant or Caregiver|1|||
28090691|NCT03712280|54744368|FG001|Overall Study|Withdrawal by Participant or Caregiver|0|||
28090692|NCT03712280|54744369|FG002|Overall Study|Withdrawal by Participant or Caregiver|0|||
28090693|NCT03712280|54744370|FG003|Overall Study|Withdrawal by Participant or Caregiver|0|||
28090694|NCT03712280|54744367|FG000|Overall Study|Adverse Event|0|||
28166631|NCT01066793|54837438|FG001|Overall Study|Miscellaneous|5|||
28166632|NCT01066793|54837439|FG002|Overall Study|Miscellaneous|6|||
28166633|NCT01066793|54837440|FG003|Overall Study|Miscellaneous|0|||
28166634|NCT01066793|54837441|FG004|Overall Study|Miscellaneous|0|||
28166635|NCT01066793|54837442|FG005|Overall Study|Miscellaneous|0|||
28166636|NCT01066793|54837437|FG000|Overall Study|Non-responders|104|||
28166637|NCT01066793|54837438|FG001|Overall Study|Non-responders|5|||
28090695|NCT03712280|54744368|FG001|Overall Study|Adverse Event|0|||
28090696|NCT03712280|54744369|FG002|Overall Study|Adverse Event|1|||
28090697|NCT03712280|54744370|FG003|Overall Study|Adverse Event|0|||
28090698|NCT01345240|54744385|FG000|Overall Study|Adverse Event|3|||
28090699|NCT01345240|54744386|FG001|Overall Study|Adverse Event|5|||
28090700|NCT01345240|54744387|FG002|Overall Study|Adverse Event|4|||
28090701|NCT01345240|54744388|FG003|Overall Study|Adverse Event|2|||
28090702|NCT01345240|54744389|FG004|Overall Study|Adverse Event|1|||
28090703|NCT01345240|54744385|FG000|Overall Study|Lost to Follow-up|8|||
28090704|NCT01345240|54744386|FG001|Overall Study|Lost to Follow-up|9|||
28090705|NCT01345240|54744387|FG002|Overall Study|Lost to Follow-up|14|||
28090706|NCT01345240|54744388|FG003|Overall Study|Lost to Follow-up|7|||
28090707|NCT01345240|54744389|FG004|Overall Study|Lost to Follow-up|9|||
28090708|NCT03707912|54744421|FG000|Overall Study|Violation of inclusion criteria|1|||
28090709|NCT03707912|54744422|FG001|Overall Study|Violation of inclusion criteria|0|||
28090710|NCT02883244|54744430|FG000|Overall Study|Lost to Follow-up|0|||
28090711|NCT02883244|54744431|FG001|Overall Study|Lost to Follow-up|1|||
28090712|NCT02882854|54744439|FG000|Overall Study|Lost to Follow-up|1|||
28090713|NCT02882854|54744440|FG001|Overall Study|Lost to Follow-up|2|||
28090714|NCT02882854|54744439|FG000|Overall Study|Physician Decision|0|||
28090715|NCT02882854|54744440|FG001|Overall Study|Physician Decision|1|||
28166638|NCT01066793|54837439|FG002|Overall Study|Non-responders|11|||
28166639|NCT01066793|54837440|FG003|Overall Study|Non-responders|25|||
28166640|NCT01066793|54837441|FG004|Overall Study|Non-responders|0|||
28166641|NCT01066793|54837442|FG005|Overall Study|Non-responders|0|||
28166642|NCT01066793|54837437|FG000|Overall Study|Other|15|||
28166643|NCT01066793|54837438|FG001|Overall Study|Other|5|||
28166644|NCT01066793|54837439|FG002|Overall Study|Other|6|||
28166645|NCT01066793|54837440|FG003|Overall Study|Other|2|||
28166646|NCT01066793|54837441|FG004|Overall Study|Other|0|||
28166647|NCT01066793|54837442|FG005|Overall Study|Other|0|||
28166648|NCT01066793|54837437|FG000|Overall Study|Relapse|20|||
28166649|NCT01066793|54837438|FG001|Overall Study|Relapse|8|||
28166650|NCT01066793|54837439|FG002|Overall Study|Relapse|2|||
28166651|NCT01066793|54837440|FG003|Overall Study|Relapse|3|||
28166652|NCT01066793|54837441|FG004|Overall Study|Relapse|0|||
27733679|NCT02556710|54181395|FG001|Overall Study|Required proscribed pain medication|1|||
27733680|NCT02556710|54181394|FG000|Overall Study|Lack of Efficacy|1|||
28090716|NCT03707522|54744450|FG000|Overall Study|Lost to Follow-up|24|||
28090717|NCT03707522|54744451|FG001|Overall Study|Lost to Follow-up|27|||
28090718|NCT03707522|54744452|FG002|Overall Study|Lost to Follow-up|41|||
28090719|NCT03707522|54744453|FG003|Overall Study|Lost to Follow-up|36|||
28090720|NCT03150082|54744463|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1|||
28166653|NCT01066793|54837442|FG005|Overall Study|Relapse|0|||
28166654|NCT01066793|54837437|FG000|Overall Study|Result Not Available|1|||
28166655|NCT01066793|54837438|FG001|Overall Study|Result Not Available|0|||
28166656|NCT01066793|54837439|FG002|Overall Study|Result Not Available|0|||
28166657|NCT01066793|54837440|FG003|Overall Study|Result Not Available|0|||
28166658|NCT01066793|54837441|FG004|Overall Study|Result Not Available|0|||
28166659|NCT01066793|54837442|FG005|Overall Study|Result Not Available|0|||
28090721|NCT03150082|54744464|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
28090722|NCT03142750|54744492|FG000|Overall Study|Lost to Follow-up|4|||
28090723|NCT03142750|54744493|FG001|Overall Study|Lost to Follow-up|1|||
28090724|NCT03149848|54744503|FG000|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1|||
28090725|NCT03149848|54744503|FG000|Period 2 (Day 15 to Day 28)|Adverse Event|2|||
28090726|NCT03706040|54744513|FG000|Period A (Week 0 to Week 16)|Adverse Event|3|||
28090727|NCT03706040|54744514|FG001|Period A (Week 0 to Week 16)|Adverse Event|2|||
28090728|NCT03706040|54744515|FG002|Period A (Week 0 to Week 16)|Adverse Event|1|||
28090729|NCT03706040|54744516|FG003|Period A (Week 0 to Week 16)|Adverse Event|0|||
28090730|NCT03706040|54744517|FG004|Period A (Week 0 to Week 16)|Adverse Event|0|||
28090731|NCT03706040|54744518|FG005|Period A (Week 0 to Week 16)|Adverse Event|0|||
28090732|NCT03706040|54744519|FG006|Period A (Week 0 to Week 16)|Adverse Event|0|||
28090733|NCT03706040|54744513|FG000|Period A (Week 0 to Week 16)|Withdrew Consent|3|||
28090734|NCT03706040|54744514|FG001|Period A (Week 0 to Week 16)|Withdrew Consent|5|||
28090735|NCT03706040|54744515|FG002|Period A (Week 0 to Week 16)|Withdrew Consent|4|||
28090736|NCT03706040|54744516|FG003|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
28090737|NCT03706040|54744517|FG004|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
28090738|NCT03706040|54744518|FG005|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
28090739|NCT03706040|54744519|FG006|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
28090740|NCT03706040|54744513|FG000|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
28090741|NCT03706040|54744514|FG001|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
28090742|NCT03706040|54744515|FG002|Period A (Week 0 to Week 16)|Lost to Follow-up|4|||
28090743|NCT03706040|54744516|FG003|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
28090744|NCT03706040|54744517|FG004|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
28090745|NCT03706040|54744518|FG005|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
28090746|NCT03706040|54744519|FG006|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
28090747|NCT03706040|54744513|FG000|Period A (Week 0 to Week 16)|Other|2|||
28090748|NCT03706040|54744514|FG001|Period A (Week 0 to Week 16)|Other|0|||
28090749|NCT03706040|54744515|FG002|Period A (Week 0 to Week 16)|Other|2|||
28090750|NCT03706040|54744516|FG003|Period A (Week 0 to Week 16)|Other|0|||
28090751|NCT03706040|54744517|FG004|Period A (Week 0 to Week 16)|Other|0|||
28090752|NCT03706040|54744518|FG005|Period A (Week 0 to Week 16)|Other|0|||
28090753|NCT03706040|54744519|FG006|Period A (Week 0 to Week 16)|Other|0|||
28090754|NCT03706040|54744513|FG000|Period B (Week 16 to Week 52)|Adverse Event|0|||
28090755|NCT03706040|54744514|FG001|Period B (Week 16 to Week 52)|Adverse Event|0|||
28090756|NCT03706040|54744515|FG002|Period B (Week 16 to Week 52)|Adverse Event|0|||
28090757|NCT03706040|54744516|FG003|Period B (Week 16 to Week 52)|Adverse Event|1|||
28090758|NCT03706040|54744517|FG004|Period B (Week 16 to Week 52)|Adverse Event|2|||
28090759|NCT03706040|54744518|FG005|Period B (Week 16 to Week 52)|Adverse Event|3|||
28090760|NCT03706040|54744519|FG006|Period B (Week 16 to Week 52)|Adverse Event|0|||
28090761|NCT03706040|54744513|FG000|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
28090762|NCT03706040|54744514|FG001|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
28090763|NCT03706040|54744515|FG002|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
28090764|NCT03706040|54744516|FG003|Period B (Week 16 to Week 52)|Withdrew Consent|3|||
28090765|NCT03706040|54744517|FG004|Period B (Week 16 to Week 52)|Withdrew Consent|2|||
28090766|NCT03706040|54744518|FG005|Period B (Week 16 to Week 52)|Withdrew Consent|1|||
28090767|NCT03706040|54744519|FG006|Period B (Week 16 to Week 52)|Withdrew Consent|10|||
28090768|NCT03706040|54744513|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
28090769|NCT03706040|54744514|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
28090770|NCT03706040|54744515|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
28090771|NCT03706040|54744516|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
27733681|NCT02556710|54181395|FG001|Overall Study|Lack of Efficacy|0|||
27733682|NCT02556710|54181394|FG000|Overall Study|Worsening osteoarthritis|1|||
27733683|NCT02556710|54181395|FG001|Overall Study|Worsening osteoarthritis|0|||
27733684|NCT02556710|54181394|FG000|Overall Study|Moved out of state|1|||
27733685|NCT02556710|54181395|FG001|Overall Study|Moved out of state|0|||
27733686|NCT02556710|54181394|FG000|Overall Study|Missing reason|3|||
27733687|NCT02556710|54181395|FG001|Overall Study|Missing reason|1|||
27733688|NCT02556710|54181394|FG000|Overall Study|Pain as lack of efficacy|0|||
28090772|NCT03706040|54744517|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
28090773|NCT03706040|54744518|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
28090774|NCT03706040|54744519|FG006|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
28090775|NCT03706040|54744513|FG000|Period B (Week 16 to Week 52)|Other|0|||
27733689|NCT02556710|54181395|FG001|Overall Study|Pain as lack of efficacy|4|||
27855755|NCT02733042|54382041|FG003|Follow-up Period|Other|1|||
28090776|NCT03706040|54744514|FG001|Period B (Week 16 to Week 52)|Other|0|||
28090777|NCT03706040|54744515|FG002|Period B (Week 16 to Week 52)|Other|0|||
28090778|NCT03706040|54744516|FG003|Period B (Week 16 to Week 52)|Other|4|||
28090779|NCT03706040|54744517|FG004|Period B (Week 16 to Week 52)|Other|5|||
28090780|NCT03706040|54744518|FG005|Period B (Week 16 to Week 52)|Other|23|||
27733690|NCT02556632|54181406|FG000|Overall Study|Lost to Follow-up|1|||
27733691|NCT02556632|54181407|FG001|Overall Study|Lost to Follow-up|0|||
28090781|NCT03706040|54744519|FG006|Period B (Week 16 to Week 52)|Other|17|||
28090782|NCT03770000|54744540|FG000|Overall Study|Premature discontinuation due to PD|0|||
28090783|NCT03770000|54744541|FG001|Overall Study|Premature discontinuation due to PD|0|||
28090784|NCT03770000|54744542|FG002|Overall Study|Premature discontinuation due to PD|1|||
28090785|NCT03770000|54744543|FG003|Overall Study|Premature discontinuation due to PD|3|||
28090786|NCT03770000|54744544|FG004|Overall Study|Premature discontinuation due to PD|2|||
28090787|NCT03158272|54744563|FG000|Overall Study|Disease progression|3|||
28090788|NCT03158272|54744564|FG001|Overall Study|Disease progression|3|||
28090789|NCT03158272|54744565|FG002|Overall Study|Disease progression|4|||
28090790|NCT03158272|54744566|FG003|Overall Study|Disease progression|6|||
28090791|NCT03158272|54744563|FG000|Overall Study|Death|0|||
28090792|NCT03158272|54744564|FG001|Overall Study|Death|0|||
28090793|NCT03158272|54744565|FG002|Overall Study|Death|1|||
28090794|NCT03158272|54744566|FG003|Overall Study|Death|0|||
28090795|NCT03158272|54744563|FG000|Overall Study|Other reasons|0|||
28090796|NCT03158272|54744564|FG001|Overall Study|Other reasons|0|||
28090797|NCT03158272|54744565|FG002|Overall Study|Other reasons|1|||
28090798|NCT03158272|54744566|FG003|Overall Study|Other reasons|0|||
28090799|NCT03158272|54744563|FG000|Overall Study|Adverse event unrelated to the drug|0|||
28090800|NCT03158272|54744564|FG001|Overall Study|Adverse event unrelated to the drug|1|||
28090801|NCT03158272|54744565|FG002|Overall Study|Adverse event unrelated to the drug|0|||
28090802|NCT03158272|54744566|FG003|Overall Study|Adverse event unrelated to the drug|0|||
28090803|NCT03705494|54744580|FG000|Overall Study|Lost to Follow-up|2|||
28090804|NCT03705494|54744581|FG001|Overall Study|Lost to Follow-up|1|||
28090805|NCT03705494|54744580|FG000|Overall Study|Withdrawal by Subject|5|||
28090806|NCT03705494|54744581|FG001|Overall Study|Withdrawal by Subject|2|||
28090807|NCT01431508|54744587|FG000|Overall Study|Lack of Efficacy|1|||
28090808|NCT01431508|54744587|FG000|Overall Study|Unable to Follow Protocol Procedures|1|||
28090809|NCT00654628|54744591|FG000|6-week Active Treatment Period|Adverse Event|9|||
28090810|NCT00654628|54744591|FG000|6-week Active Treatment Period|Lost to Follow-up|10|||
28090811|NCT00654628|54744591|FG000|6-week Active Treatment Period|Transferred to branch hospital|1|||
28090812|NCT00654628|54744591|FG000|6-week Active Treatment Period|Out of window period|1|||
28090813|NCT00654628|54744591|FG000|6 -Week Extension Period (Single Site)|Adverse Event|4|||
28090814|NCT00654628|54744591|FG000|6 -Week Extension Period (Single Site)|Lost to Follow-up|1|||
28090815|NCT00536380|54744598|FG000|Overall Study|Adverse Event|0|||
28090816|NCT00536380|54744599|FG001|Overall Study|Adverse Event|2|||
28090817|NCT00536380|54744600|FG002|Overall Study|Adverse Event|2|||
28090818|NCT00536380|54744598|FG000|Overall Study|Lost to Follow-up|0|||
28090819|NCT00536380|54744599|FG001|Overall Study|Lost to Follow-up|0|||
28090820|NCT00536380|54744600|FG002|Overall Study|Lost to Follow-up|1|||
28090821|NCT00536380|54744598|FG000|Overall Study|Withdrawal unrelated to study drug|2|||
28090822|NCT00536380|54744599|FG001|Overall Study|Withdrawal unrelated to study drug|0|||
28090823|NCT00536380|54744600|FG002|Overall Study|Withdrawal unrelated to study drug|1|||
28090824|NCT00536380|54744598|FG000|Overall Study|Withdrawal related to study drug|7|||
28090825|NCT00536380|54744599|FG001|Overall Study|Withdrawal related to study drug|5|||
28090826|NCT00536380|54744600|FG002|Overall Study|Withdrawal related to study drug|2|||
28090827|NCT00536380|54744598|FG000|Overall Study|Noncompliance with protocol|3|||
28090828|NCT00536380|54744599|FG001|Overall Study|Noncompliance with protocol|2|||
28090829|NCT00536380|54744600|FG002|Overall Study|Noncompliance with protocol|2|||
28090830|NCT00536380|54744598|FG000|Overall Study|Did not meet protocol eligibility|0|||
28090831|NCT00536380|54744599|FG001|Overall Study|Did not meet protocol eligibility|0|||
28090832|NCT00536380|54744600|FG002|Overall Study|Did not meet protocol eligibility|1|||
28090833|NCT00536380|54744598|FG000|Overall Study|Administrative|0|||
28090834|NCT00536380|54744599|FG001|Overall Study|Administrative|0|||
28090835|NCT00536380|54744600|FG002|Overall Study|Administrative|1|||
28090836|NCT00496834|54744610|FG000|Overall Study|Withdrawal by Subject|4|||
28090837|NCT00496834|54744611|FG001|Overall Study|Withdrawal by Subject|6|||
28090838|NCT00496834|54744610|FG000|Overall Study|Contraindicated medication administered|0|||
28090839|NCT00496834|54744611|FG001|Overall Study|Contraindicated medication administered|1|||
28090840|NCT00496834|54744610|FG000|Overall Study|Inclusion/exclusion criteria not met|3|||
28090841|NCT00496834|54744611|FG001|Overall Study|Inclusion/exclusion criteria not met|2|||
28090842|NCT00496834|54744610|FG000|Overall Study|Adverse Event|5|||
28090843|NCT00496834|54744611|FG001|Overall Study|Adverse Event|3|||
28090844|NCT00496834|54744610|FG000|Overall Study|IP administration violation|2|||
28090845|NCT00496834|54744611|FG001|Overall Study|IP administration violation|0|||
28090846|NCT00496834|54744610|FG000|Overall Study|Lost to Follow-up|2|||
28090847|NCT00496834|54744611|FG001|Overall Study|Lost to Follow-up|0|||
28090848|NCT00496834|54744610|FG000|Overall Study|Blood Pressure control failure|2|||
28090849|NCT00496834|54744611|FG001|Overall Study|Blood Pressure control failure|1|||
28090850|NCT05244122|54744619|FG000|Overall Study|Withdrawal by Subject|318|||
28090851|NCT00166504|54744640|FG000|Overall Study|Adverse Event|3|||
27733692|NCT02556632|54181408|FG002|Overall Study|Lost to Follow-up|0|||
27855756|NCT02733042|54382042|FG004|Follow-up Period|Other|0|||
28090852|NCT00166504|54744641|FG001|Overall Study|Adverse Event|3|||
28090853|NCT00166504|54744640|FG000|Overall Study|Lost to Follow-up|1|||
28090854|NCT00166504|54744641|FG001|Overall Study|Lost to Follow-up|1|||
28090855|NCT00166504|54744640|FG000|Overall Study|Withdrawal by Subject|1|||
28090856|NCT00166504|54744641|FG001|Overall Study|Withdrawal by Subject|0|||
28090857|NCT03137992|54744647|FG000|Washout Period 1|Adverse Event|1|||
28090858|NCT03137992|54744648|FG001|Washout Period 1|Adverse Event|1|||
28090859|NCT03137992|54744649|FG002|Washout Period 1|Adverse Event|0|||
28090860|NCT03137992|54744650|FG003|Washout Period 1|Adverse Event|0|||
28090861|NCT03137992|54744651|FG004|Washout Period 1|Adverse Event|0|||
28090862|NCT03137992|54744652|FG005|Washout Period 1|Adverse Event|1|||
28090863|NCT03137992|54744647|FG000|Washout Period 1|Withdrawal by Subject|0|||
28090864|NCT03137992|54744648|FG001|Washout Period 1|Withdrawal by Subject|1|||
28090865|NCT03137992|54744649|FG002|Washout Period 1|Withdrawal by Subject|1|||
28090866|NCT03137992|54744650|FG003|Washout Period 1|Withdrawal by Subject|0|||
28090867|NCT03137992|54744651|FG004|Washout Period 1|Withdrawal by Subject|0|||
28090868|NCT03137992|54744652|FG005|Washout Period 1|Withdrawal by Subject|0|||
28090869|NCT03137992|54744647|FG000|Washout Period 1|Principal Investigator Discretion|0|||
28090870|NCT03137992|54744648|FG001|Washout Period 1|Principal Investigator Discretion|1|||
28090871|NCT03137992|54744649|FG002|Washout Period 1|Principal Investigator Discretion|0|||
28090872|NCT03137992|54744650|FG003|Washout Period 1|Principal Investigator Discretion|0|||
28090873|NCT03137992|54744651|FG004|Washout Period 1|Principal Investigator Discretion|0|||
28090874|NCT03137992|54744652|FG005|Washout Period 1|Principal Investigator Discretion|0|||
28090875|NCT03137992|54744647|FG000|Washout Period 1|COPD Exacerbation|1|||
28090876|NCT03137992|54744648|FG001|Washout Period 1|COPD Exacerbation|1|||
28090877|NCT03137992|54744649|FG002|Washout Period 1|COPD Exacerbation|1|||
28090878|NCT03137992|54744650|FG003|Washout Period 1|COPD Exacerbation|0|||
28090879|NCT03137992|54744651|FG004|Washout Period 1|COPD Exacerbation|1|||
28090880|NCT03137992|54744652|FG005|Washout Period 1|COPD Exacerbation|1|||
28090881|NCT03137992|54744647|FG000|Washout Period 1|Subject Noncompliance|1|||
28090882|NCT03137992|54744648|FG001|Washout Period 1|Subject Noncompliance|0|||
28090883|NCT03137992|54744649|FG002|Washout Period 1|Subject Noncompliance|0|||
28090884|NCT03137992|54744650|FG003|Washout Period 1|Subject Noncompliance|0|||
28090885|NCT03137992|54744651|FG004|Washout Period 1|Subject Noncompliance|1|||
28090886|NCT03137992|54744652|FG005|Washout Period 1|Subject Noncompliance|0|||
28090887|NCT03137992|54744647|FG000|Period 2 (Visit 3)|COPD Exacerbation|1|||
28090888|NCT03137992|54744648|FG001|Period 2 (Visit 3)|COPD Exacerbation|1|||
28090889|NCT03137992|54744649|FG002|Period 2 (Visit 3)|COPD Exacerbation|0|||
28090890|NCT03137992|54744650|FG003|Period 2 (Visit 3)|COPD Exacerbation|0|||
28090891|NCT03137992|54744651|FG004|Period 2 (Visit 3)|COPD Exacerbation|0|||
28090892|NCT03137992|54744652|FG005|Period 2 (Visit 3)|COPD Exacerbation|1|||
28090893|NCT03137992|54744647|FG000|Period 2 (Visit 3)|Did not meet continuation criteria|2|||
28090894|NCT03137992|54744648|FG001|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
28090895|NCT03137992|54744649|FG002|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
28090896|NCT03137992|54744650|FG003|Period 2 (Visit 3)|Did not meet continuation criteria|4|||
28090897|NCT03137992|54744651|FG004|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
28090898|NCT03137992|54744652|FG005|Period 2 (Visit 3)|Did not meet continuation criteria|7|||
28090899|NCT03137992|54744647|FG000|Period 2 (Visit 3)|Adverse Event|0|||
28090900|NCT03137992|54744648|FG001|Period 2 (Visit 3)|Adverse Event|1|||
28090901|NCT03137992|54744649|FG002|Period 2 (Visit 3)|Adverse Event|0|||
28090902|NCT03137992|54744650|FG003|Period 2 (Visit 3)|Adverse Event|0|||
28090903|NCT03137992|54744651|FG004|Period 2 (Visit 3)|Adverse Event|0|||
28090904|NCT03137992|54744652|FG005|Period 2 (Visit 3)|Adverse Event|0|||
28090905|NCT03137992|54744647|FG000|Period 2 (Visit 3)|Lost to Follow-up|0|||
28166660|NCT01066793|54837437|FG000|Overall Study|Treatment Interrupted|1|||
28166661|NCT01066793|54837438|FG001|Overall Study|Treatment Interrupted|1|||
28090906|NCT03137992|54744648|FG001|Period 2 (Visit 3)|Lost to Follow-up|0|||
28090907|NCT03137992|54744649|FG002|Period 2 (Visit 3)|Lost to Follow-up|0|||
28090908|NCT03137992|54744650|FG003|Period 2 (Visit 3)|Lost to Follow-up|1|||
28090909|NCT03137992|54744651|FG004|Period 2 (Visit 3)|Lost to Follow-up|0|||
28090910|NCT03137992|54744652|FG005|Period 2 (Visit 3)|Lost to Follow-up|0|||
28090911|NCT03137992|54744647|FG000|Period 2 (Visit 3)|Withdrawal by Subject|0|||
28090912|NCT03137992|54744648|FG001|Period 2 (Visit 3)|Withdrawal by Subject|2|||
28090913|NCT03137992|54744649|FG002|Period 2 (Visit 3)|Withdrawal by Subject|0|||
28090914|NCT03137992|54744650|FG003|Period 2 (Visit 3)|Withdrawal by Subject|0|||
28090915|NCT03137992|54744651|FG004|Period 2 (Visit 3)|Withdrawal by Subject|1|||
28090916|NCT03137992|54744652|FG005|Period 2 (Visit 3)|Withdrawal by Subject|0|||
28090917|NCT03137992|54744647|FG000|Washout Period 2|COPD Exacerbation|1|||
28090918|NCT03137992|54744648|FG001|Washout Period 2|COPD Exacerbation|1|||
28090919|NCT03137992|54744649|FG002|Washout Period 2|COPD Exacerbation|0|||
28090920|NCT03137992|54744650|FG003|Washout Period 2|COPD Exacerbation|0|||
28090921|NCT03137992|54744651|FG004|Washout Period 2|COPD Exacerbation|1|||
28090922|NCT03137992|54744652|FG005|Washout Period 2|COPD Exacerbation|0|||
28090923|NCT03137992|54744647|FG000|Washout Period 2|Subject Non-compliance|0|||
28090924|NCT03137992|54744648|FG001|Washout Period 2|Subject Non-compliance|1|||
28090925|NCT03137992|54744649|FG002|Washout Period 2|Subject Non-compliance|0|||
28166662|NCT01066793|54837439|FG002|Overall Study|Treatment Interrupted|0|||
28166663|NCT01066793|54837440|FG003|Overall Study|Treatment Interrupted|0|||
28166664|NCT01066793|54837441|FG004|Overall Study|Treatment Interrupted|0|||
28166665|NCT01066793|54837442|FG005|Overall Study|Treatment Interrupted|0|||
28166666|NCT01066793|54837437|FG000|Overall Study|Treatment Never Started|18|||
28166667|NCT01066793|54837438|FG001|Overall Study|Treatment Never Started|5|||
28166668|NCT01066793|54837439|FG002|Overall Study|Treatment Never Started|4|||
28166669|NCT01066793|54837440|FG003|Overall Study|Treatment Never Started|1|||
28166670|NCT01066793|54837441|FG004|Overall Study|Treatment Never Started|0|||
28166671|NCT01066793|54837442|FG005|Overall Study|Treatment Never Started|0|||
28090926|NCT03137992|54744650|FG003|Washout Period 2|Subject Non-compliance|0|||
28090927|NCT03137992|54744651|FG004|Washout Period 2|Subject Non-compliance|0|||
28090928|NCT03137992|54744652|FG005|Washout Period 2|Subject Non-compliance|0|||
28090929|NCT03137992|54744647|FG000|Washout Period 2|Adverse Event|0|||
28090930|NCT03137992|54744648|FG001|Washout Period 2|Adverse Event|0|||
28090931|NCT03137992|54744649|FG002|Washout Period 2|Adverse Event|0|||
28090932|NCT03137992|54744650|FG003|Washout Period 2|Adverse Event|1|||
28090933|NCT03137992|54744651|FG004|Washout Period 2|Adverse Event|1|||
28090934|NCT03137992|54744652|FG005|Washout Period 2|Adverse Event|0|||
28090935|NCT03137992|54744647|FG000|Washout Period 2|Withdrawal by Subject|1|||
28090936|NCT03137992|54744648|FG001|Washout Period 2|Withdrawal by Subject|0|||
28090937|NCT03137992|54744649|FG002|Washout Period 2|Withdrawal by Subject|0|||
28090938|NCT03137992|54744650|FG003|Washout Period 2|Withdrawal by Subject|0|||
28090939|NCT03137992|54744651|FG004|Washout Period 2|Withdrawal by Subject|1|||
28090940|NCT03137992|54744652|FG005|Washout Period 2|Withdrawal by Subject|0|||
28090941|NCT03137992|54744647|FG000|Washout Period 2|Sponsor Decision|0|||
28090942|NCT03137992|54744648|FG001|Washout Period 2|Sponsor Decision|0|||
28090943|NCT03137992|54744649|FG002|Washout Period 2|Sponsor Decision|0|||
28090944|NCT03137992|54744650|FG003|Washout Period 2|Sponsor Decision|0|||
28090945|NCT03137992|54744651|FG004|Washout Period 2|Sponsor Decision|0|||
28090946|NCT03137992|54744652|FG005|Washout Period 2|Sponsor Decision|1|||
28090947|NCT03137992|54744647|FG000|Period 3 (Visit 04)|Did not meet continuation criteria|6|||
28090948|NCT03137992|54744648|FG001|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
28090949|NCT03137992|54744649|FG002|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
28090950|NCT03137992|54744650|FG003|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
28090951|NCT03137992|54744651|FG004|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
28090952|NCT03137992|54744652|FG005|Period 3 (Visit 04)|Did not meet continuation criteria|3|||
28090953|NCT03137992|54744647|FG000|Period 3 (Visit 04)|Withdrawal by Subject|0|||
28090954|NCT03137992|54744648|FG001|Period 3 (Visit 04)|Withdrawal by Subject|2|||
28090955|NCT03137992|54744649|FG002|Period 3 (Visit 04)|Withdrawal by Subject|1|||
28090956|NCT03137992|54744650|FG003|Period 3 (Visit 04)|Withdrawal by Subject|0|||
28090957|NCT03137992|54744651|FG004|Period 3 (Visit 04)|Withdrawal by Subject|1|||
28090958|NCT03137992|54744652|FG005|Period 3 (Visit 04)|Withdrawal by Subject|0|||
28166672|NCT01066793|54837437|FG000|Overall Study|Treatment Stopped|2|||
28166673|NCT01066793|54837438|FG001|Overall Study|Treatment Stopped|1|||
28166674|NCT01066793|54837439|FG002|Overall Study|Treatment Stopped|0|||
28166675|NCT01066793|54837440|FG003|Overall Study|Treatment Stopped|1|||
28166676|NCT01066793|54837441|FG004|Overall Study|Treatment Stopped|0|||
28166677|NCT01066793|54837442|FG005|Overall Study|Treatment Stopped|0|||
28166678|NCT03985293|54837463|FG000|DOUBLE-BLIND TREATMENT|Adverse Event|5|||
28166679|NCT03985293|54837464|FG001|DOUBLE-BLIND TREATMENT|Adverse Event|2|||
28166680|NCT03985293|54837465|FG002|DOUBLE-BLIND TREATMENT|Adverse Event|3|||
28166681|NCT03985293|54837466|FG003|DOUBLE-BLIND TREATMENT|Adverse Event|8|||
28166682|NCT03985293|54837467|FG004|DOUBLE-BLIND TREATMENT|Adverse Event|15|||
28166683|NCT03985293|54837468|FG005|DOUBLE-BLIND TREATMENT|Adverse Event|24|||
28166684|NCT03985293|54837463|FG000|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
28166685|NCT03985293|54837464|FG001|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
28166686|NCT03985293|54837465|FG002|DOUBLE-BLIND TREATMENT|Lost to Follow-up|0|||
28166687|NCT03985293|54837466|FG003|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
28166688|NCT03985293|54837467|FG004|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
28166689|NCT03985293|54837468|FG005|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
28166690|NCT03985293|54837463|FG000|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
28166691|NCT03985293|54837464|FG001|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
28166692|NCT03985293|54837465|FG002|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
28166693|NCT03985293|54837466|FG003|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
28166694|NCT03985293|54837467|FG004|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
27733693|NCT02556632|54181406|FG000|Overall Study|Disliked Intervention|1|||
28090959|NCT03137992|54744647|FG000|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
28090960|NCT03137992|54744648|FG001|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
28166695|NCT03985293|54837468|FG005|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
28166696|NCT03985293|54837463|FG000|DOUBLE-BLIND TREATMENT|Other|1|||
28166697|NCT03985293|54837464|FG001|DOUBLE-BLIND TREATMENT|Other|2|||
28166698|NCT03985293|54837465|FG002|DOUBLE-BLIND TREATMENT|Other|0|||
28090961|NCT03137992|54744649|FG002|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
28090962|NCT03137992|54744650|FG003|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
28090963|NCT03137992|54744651|FG004|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
28090964|NCT03137992|54744652|FG005|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
28090965|NCT03137992|54744647|FG000|Part 2 (Open-label Extension)|COPD exacerbation|0|||
28090966|NCT03137992|54744648|FG001|Part 2 (Open-label Extension)|COPD exacerbation|0|||
28090967|NCT03137992|54744649|FG002|Part 2 (Open-label Extension)|COPD exacerbation|0|||
28090968|NCT03137992|54744650|FG003|Part 2 (Open-label Extension)|COPD exacerbation|1|||
28090969|NCT03137992|54744651|FG004|Part 2 (Open-label Extension)|COPD exacerbation|0|||
28090970|NCT03137992|54744652|FG005|Part 2 (Open-label Extension)|COPD exacerbation|0|||
28090971|NCT03137992|54744647|FG000|Part 2 (Open-label Extension)|Per study team|1|||
28090972|NCT03137992|54744648|FG001|Part 2 (Open-label Extension)|Per study team|0|||
28090973|NCT03137992|54744649|FG002|Part 2 (Open-label Extension)|Per study team|0|||
28090974|NCT03137992|54744650|FG003|Part 2 (Open-label Extension)|Per study team|0|||
28090975|NCT03137992|54744651|FG004|Part 2 (Open-label Extension)|Per study team|0|||
28090976|NCT03137992|54744652|FG005|Part 2 (Open-label Extension)|Per study team|0|||
28090977|NCT03137992|54744647|FG000|Part 2 (Open-label Extension)|Prohibited Medication|0|||
28090978|NCT03137992|54744648|FG001|Part 2 (Open-label Extension)|Prohibited Medication|0|||
28090979|NCT03137992|54744649|FG002|Part 2 (Open-label Extension)|Prohibited Medication|0|||
28090980|NCT03137992|54744650|FG003|Part 2 (Open-label Extension)|Prohibited Medication|0|||
28090981|NCT03137992|54744651|FG004|Part 2 (Open-label Extension)|Prohibited Medication|0|||
28090982|NCT03137992|54744652|FG005|Part 2 (Open-label Extension)|Prohibited Medication|1|||
28090983|NCT03704636|54744660|FG000|Overall Study|Inadequate Venous Flow|3|||
28090984|NCT05096312|54744675|FG000|Overall Study|Lost to Follow-up|2|||
28090985|NCT05096312|54744676|FG001|Overall Study|Lost to Follow-up|4|||
28090986|NCT05096312|54744675|FG000|Overall Study|Adverse Event|1|||
28090987|NCT05096312|54744676|FG001|Overall Study|Adverse Event|0|||
28090988|NCT04908488|54744684|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
28090989|NCT04908488|54744685|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
28090990|NCT04908488|54744684|FG000|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
28090991|NCT04908488|54744685|FG001|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
28090992|NCT04876274|54744696|FG000|Overall Study|Lost to Follow-up|9|||
28090993|NCT04876274|54744697|FG001|Overall Study|Lost to Follow-up|12|||
28090994|NCT04865354|54744705|FG000|First Wear Period (8 Days)|Withdrawal by Subject|1|||
28090995|NCT04865354|54744706|FG001|First Wear Period (8 Days)|Withdrawal by Subject|0|||
28090996|NCT04865354|54744705|FG000|First Wear Period (8 Days)|Lost to Follow-up|0|||
28090997|NCT04865354|54744706|FG001|First Wear Period (8 Days)|Lost to Follow-up|1|||
28090998|NCT04865354|54744705|FG000|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|1|||
28166699|NCT03985293|54837466|FG003|DOUBLE-BLIND TREATMENT|Other|2|||
28166700|NCT03985293|54837467|FG004|DOUBLE-BLIND TREATMENT|Other|1|||
28090999|NCT04865354|54744706|FG001|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|0|||
27733694|NCT02556632|54181407|FG001|Overall Study|Disliked Intervention|1|||
27980637|NCT00803205|54638641|FG000|Overall Study|Protocol Violation|1|||
28091000|NCT04860518|54744717|FG000|Overall Study|Screen Failure, patient was not dosed|1|||
28091001|NCT04860518|54744718|FG001|Overall Study|Screen Failure, patient was not dosed|1|||
28091002|NCT03110380|54744726|FG000|Double-Blind Treatment Phase|Withdrew Consent|10|||
28091003|NCT03110380|54744727|FG001|Double-Blind Treatment Phase|Withdrew Consent|16|||
28091004|NCT03110380|54744728|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
28091005|NCT03110380|54744729|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
28091006|NCT03110380|54744726|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
28091007|NCT03110380|54744727|FG001|Double-Blind Treatment Phase|Lost to Follow-up|3|||
28091008|NCT03110380|54744728|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
28091009|NCT03110380|54744729|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
28091010|NCT03110380|54744726|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
28091011|NCT03110380|54744727|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
28091012|NCT03110380|54744728|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
28091013|NCT03110380|54744729|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
28091014|NCT03110380|54744726|FG000|Double-Blind Treatment Phase|Investigator's Discretion|1|||
28091015|NCT03110380|54744727|FG001|Double-Blind Treatment Phase|Investigator's Discretion|3|||
28091016|NCT03110380|54744728|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
28091017|NCT03110380|54744729|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
28091018|NCT03110380|54744726|FG000|Double-Blind Treatment Phase|Death|2|||
28091019|NCT03110380|54744727|FG001|Double-Blind Treatment Phase|Death|1|||
28091020|NCT03110380|54744728|FG002|Double-Blind Treatment Phase|Death|0|||
28091021|NCT03110380|54744729|FG003|Double-Blind Treatment Phase|Death|0|||
28091022|NCT03110380|54744726|FG000|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
28091023|NCT03110380|54744727|FG001|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
28091024|NCT03110380|54744728|FG002|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
28166701|NCT03985293|54837468|FG005|DOUBLE-BLIND TREATMENT|Other|0|||
28166702|NCT03985293|54837463|FG000|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
28166703|NCT03985293|54837464|FG001|DOUBLE-BLIND TREATMENT|Protocol Violation|2|||
28091025|NCT03110380|54744729|FG003|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
28091026|NCT03110380|54744726|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
28091027|NCT03110380|54744727|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
28091028|NCT03110380|54744728|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
28091029|NCT03110380|54744729|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
28091030|NCT03110380|54744726|FG000|Double-Blind Treatment Phase|Randomized but not Treated|0|||
28091031|NCT03110380|54744727|FG001|Double-Blind Treatment Phase|Randomized but not Treated|2|||
28091032|NCT03110380|54744728|FG002|Double-Blind Treatment Phase|Randomized but not Treated|0|||
28091033|NCT03110380|54744729|FG003|Double-Blind Treatment Phase|Randomized but not Treated|0|||
28091034|NCT03110380|54744726|FG000|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
28091035|NCT03110380|54744727|FG001|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
28091036|NCT03110380|54744728|FG002|Open-label B/F/TAF Extension Phase|Lost to Follow-up|3|||
28091037|NCT03110380|54744729|FG003|Open-label B/F/TAF Extension Phase|Lost to Follow-up|1|||
28091038|NCT03110380|54744726|FG000|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
28091039|NCT03110380|54744727|FG001|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
28091040|NCT03110380|54744728|FG002|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
28091041|NCT03110380|54744729|FG003|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
28091042|NCT03110380|54744726|FG000|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
28091043|NCT03110380|54744727|FG001|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
28091044|NCT03110380|54744728|FG002|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
28091045|NCT03110380|54744729|FG003|Open-label B/F/TAF Extension Phase|Adverse Event|1|||
28091046|NCT04851314|54744739|FG000|Overall Study|Unable to complete research set-up procedures|0|||
28091047|NCT04851314|54744740|FG001|Overall Study|Unable to complete research set-up procedures|2|||
28091048|NCT04851314|54744739|FG000|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|3|||
28091049|NCT04851314|54744740|FG001|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|2|||
28091050|NCT04848662|54744748|FG000|Period 2 (Second Treatment Intervention)|Physician Decision|1|||
28091051|NCT04848662|54744749|FG001|Period 2 (Second Treatment Intervention)|Physician Decision|0|||
28091052|NCT03701516|54744755|FG000|Period 1|Lost to Follow-up|0|||
28091053|NCT03701516|54744756|FG001|Period 1|Lost to Follow-up|1|||
28091054|NCT03701516|54744755|FG000|Period 1|Adverse Event|0|||
28091055|NCT03701516|54744756|FG001|Period 1|Adverse Event|2|||
28091056|NCT03701516|54744755|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|2|||
28091057|NCT03701516|54744756|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
28091058|NCT03701516|54744755|FG000|Period 1|Non Compliance to Protocol|2|||
28091059|NCT03701516|54744756|FG001|Period 1|Non Compliance to Protocol|1|||
28091060|NCT03701516|54744755|FG000|Period 1|Withdrawal by Subject|0|||
28091061|NCT03701516|54744756|FG001|Period 1|Withdrawal by Subject|1|||
28091062|NCT03701516|54744755|FG000|Period 2|failed to meet all eligibility creiteria|1|||
28091063|NCT03701516|54744756|FG001|Period 2|failed to meet all eligibility creiteria|0|||
28091064|NCT03701516|54744755|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
28091065|NCT03701516|54744756|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
28091066|NCT03700892|54744764|FG000|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
28091067|NCT03700892|54744765|FG001|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|1|||
28091068|NCT03700892|54744766|FG002|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
28091069|NCT03700736|54744777|FG000|Overall Study|Pregnancy|1|||
28091070|NCT03700736|54744778|FG001|Overall Study|Pregnancy|1|||
28166704|NCT03985293|54837465|FG002|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
28166705|NCT03985293|54837466|FG003|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
28166706|NCT03985293|54837467|FG004|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
28166707|NCT03985293|54837468|FG005|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
28166708|NCT03985293|54837463|FG000|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
28166709|NCT03985293|54837464|FG001|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|4|||
28166710|NCT03985293|54837465|FG002|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|2|||
28166711|NCT03985293|54837466|FG003|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
28166712|NCT03985293|54837467|FG004|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|1|||
28166713|NCT03985293|54837468|FG005|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|7|||
27733695|NCT02556632|54181408|FG002|Overall Study|Disliked Intervention|1|||
27733696|NCT02556632|54181406|FG000|Overall Study|No Reason|1|||
27733697|NCT02556632|54181407|FG001|Overall Study|No Reason|0|||
27733698|NCT02556632|54181408|FG002|Overall Study|No Reason|1|||
27733699|NCT02556632|54181406|FG000|Overall Study|Personal Issues|0|||
27733700|NCT02556632|54181407|FG001|Overall Study|Personal Issues|1|||
27733701|NCT02556632|54181408|FG002|Overall Study|Personal Issues|1|||
27733702|NCT02556632|54181406|FG000|Overall Study|Changed Mind|0|||
27733703|NCT02556632|54181407|FG001|Overall Study|Changed Mind|1|||
27733704|NCT02556632|54181408|FG002|Overall Study|Changed Mind|0|||
27733705|NCT02556632|54181406|FG000|Overall Study|Withdrew (Unrelated Medical)|1|||
27733706|NCT02556632|54181407|FG001|Overall Study|Withdrew (Unrelated Medical)|0|||
27733707|NCT02556632|54181408|FG002|Overall Study|Withdrew (Unrelated Medical)|0|||
27855757|NCT02733042|54382043|FG005|Follow-up Period|Other|0|||
28091071|NCT03700736|54744777|FG000|Overall Study|Withdrawal by Subject|2|||
28091072|NCT03700736|54744778|FG001|Overall Study|Withdrawal by Subject|6|||
28091073|NCT04737278|54744789|FG000|Overall Study|Lost to Follow-up|1|||
28091074|NCT04737278|54744790|FG001|Overall Study|Lost to Follow-up|1|||
27980638|NCT00803205|54638642|FG001|Overall Study|Protocol Violation|1|||
27980639|NCT00803205|54638641|FG000|Overall Study|Medical Monitor Decision|1|||
27980640|NCT00803205|54638642|FG001|Overall Study|Medical Monitor Decision|0|||
27980641|NCT00803205|54638641|FG000|Overall Study|Acquired a Lung Infection|0|||
27980642|NCT00803205|54638642|FG001|Overall Study|Acquired a Lung Infection|1|||
27980643|NCT00803205|54638641|FG000|Overall Study|Sponsor Decision|0|||
28166714|NCT03985293|54837463|FG000|FOLLOW-UP|Lost to Follow-up|0|||
28166715|NCT03985293|54837464|FG001|FOLLOW-UP|Lost to Follow-up|0|||
28166716|NCT03985293|54837465|FG002|FOLLOW-UP|Lost to Follow-up|1|||
28166717|NCT03985293|54837466|FG003|FOLLOW-UP|Lost to Follow-up|0|||
28166718|NCT03985293|54837467|FG004|FOLLOW-UP|Lost to Follow-up|0|||
28166719|NCT03985293|54837468|FG005|FOLLOW-UP|Lost to Follow-up|0|||
28166720|NCT02980601|54837484|FG000|Overall Study|Lost to Follow-up|2|||
28166721|NCT02980601|54837485|FG001|Overall Study|Lost to Follow-up|2|||
28166722|NCT02980601|54837484|FG000|Overall Study|Death|0|||
28166723|NCT02980601|54837485|FG001|Overall Study|Death|1|||
28166724|NCT02980601|54837484|FG000|Overall Study|Graft loss|1|||
28166725|NCT02980601|54837485|FG001|Overall Study|Graft loss|0|||
28166726|NCT02980601|54837484|FG000|Overall Study|Failed to sign consent|2|||
28166727|NCT02980601|54837485|FG001|Overall Study|Failed to sign consent|0|||
28166728|NCT02980523|54837496|FG000|Overall Study|Lost to Follow-up|1|||
28166729|NCT02980523|54837497|FG001|Overall Study|Lost to Follow-up|4|||
28166730|NCT02980523|54837498|FG002|Overall Study|Lost to Follow-up|1|||
28166731|NCT02980523|54837499|FG003|Overall Study|Lost to Follow-up|2|||
28166732|NCT02980523|54837500|FG004|Overall Study|Lost to Follow-up|1|||
28166733|NCT02980523|54837496|FG000|Overall Study|Excluded from analysis|1|||
28166734|NCT02980523|54837497|FG001|Overall Study|Excluded from analysis|3|||
28166735|NCT02980523|54837498|FG002|Overall Study|Excluded from analysis|1|||
28166736|NCT02980523|54837499|FG003|Overall Study|Excluded from analysis|1|||
28166737|NCT02980523|54837500|FG004|Overall Study|Excluded from analysis|1|||
28091075|NCT04737278|54744789|FG000|Overall Study|Withdrawal by Subject|1|||
28091076|NCT04737278|54744790|FG001|Overall Study|Withdrawal by Subject|0|||
28091077|NCT04737278|54744789|FG000|Overall Study|Protocol Violation|1|||
28091078|NCT04737278|54744790|FG001|Overall Study|Protocol Violation|1|||
28091079|NCT04737278|54744789|FG000|Overall Study|failure to complete questionnaire|1|||
28091080|NCT04737278|54744790|FG001|Overall Study|failure to complete questionnaire|1|||
28166738|NCT02980523|54837496|FG000|Overall Study|Lack of Efficacy|1|||
28166739|NCT02980523|54837497|FG001|Overall Study|Lack of Efficacy|4|||
28166740|NCT02980523|54837498|FG002|Overall Study|Lack of Efficacy|4|||
28166741|NCT02980523|54837499|FG003|Overall Study|Lack of Efficacy|5|||
28166742|NCT02980523|54837500|FG004|Overall Study|Lack of Efficacy|8|||
28166743|NCT02980523|54837496|FG000|Overall Study|Did not receive intervention|0|||
28166744|NCT02980523|54837497|FG001|Overall Study|Did not receive intervention|0|||
28166745|NCT02980523|54837498|FG002|Overall Study|Did not receive intervention|0|||
28166746|NCT02980523|54837499|FG003|Overall Study|Did not receive intervention|1|||
28166747|NCT02980523|54837500|FG004|Overall Study|Did not receive intervention|0|||
28166748|NCT02980133|54837519|FG000|Overall Study|Other than specified|1|||
28166749|NCT02980133|54837520|FG001|Overall Study|Other than specified|1|||
28166750|NCT02980133|54837521|FG002|Overall Study|Other than specified|2|||
28166751|NCT02980133|54837522|FG003|Overall Study|Other than specified|2|||
28166752|NCT02980133|54837519|FG000|Overall Study|Lost to Follow-up|0|||
28166753|NCT02980133|54837520|FG001|Overall Study|Lost to Follow-up|0|||
28166754|NCT02980133|54837521|FG002|Overall Study|Lost to Follow-up|1|||
28166755|NCT02980133|54837522|FG003|Overall Study|Lost to Follow-up|3|||
28166756|NCT02980133|54837519|FG000|Overall Study|Protocol Violation|0|||
28166757|NCT02980133|54837520|FG001|Overall Study|Protocol Violation|1|||
28166758|NCT02980133|54837521|FG002|Overall Study|Protocol Violation|0|||
28166759|NCT02980133|54837522|FG003|Overall Study|Protocol Violation|0|||
28166760|NCT02980133|54837519|FG000|Overall Study|Withdrawal by parent/guardian|6|||
27733708|NCT02556632|54181406|FG000|Overall Study|Unrelated Adverse Event|1|||
27855758|NCT02733042|54382044|FG006|Follow-up Period|Other|0|||
28091081|NCT04725500|54744796|FG000|Screening|Screen Failure|26|||
28091082|NCT04725500|54744796|FG000|Screening|Withdrawal by Subject|1|||
28091083|NCT04725500|54744796|FG000|2 Week Take Home|Screen Fail|5|||
28091084|NCT04684394|54744802|FG000|Overall Study|Death|1|||
28091085|NCT04684394|54744803|FG001|Overall Study|Death|2|||
28091086|NCT04684394|54744802|FG000|Overall Study|Lost to Follow-up|1|||
28166761|NCT02980133|54837520|FG001|Overall Study|Withdrawal by parent/guardian|3|||
28166762|NCT02980133|54837521|FG002|Overall Study|Withdrawal by parent/guardian|3|||
28166763|NCT02980133|54837522|FG003|Overall Study|Withdrawal by parent/guardian|1|||
28166764|NCT02980133|54837519|FG000|Overall Study|Withdrawal by Subject|0|||
28166765|NCT02980133|54837520|FG001|Overall Study|Withdrawal by Subject|0|||
28166766|NCT02980133|54837521|FG002|Overall Study|Withdrawal by Subject|1|||
28091087|NCT04684394|54744803|FG001|Overall Study|Lost to Follow-up|0|||
28166767|NCT02980133|54837522|FG003|Overall Study|Withdrawal by Subject|0|||
28166768|NCT02979431|54837539|FG000|Overall Study|Parent/guardian withdrew consent|2|||
28166769|NCT02979431|54837540|FG001|Overall Study|Parent/guardian withdrew consent|1|||
28166770|NCT02979431|54837541|FG002|Overall Study|Parent/guardian withdrew consent|1|||
28166771|NCT02979431|54837542|FG003|Overall Study|Parent/guardian withdrew consent|1|||
28166772|NCT02979431|54837539|FG000|Overall Study|Randomized but received no study drug|1|||
28166773|NCT02979431|54837540|FG001|Overall Study|Randomized but received no study drug|1|||
28166774|NCT02979431|54837541|FG002|Overall Study|Randomized but received no study drug|0|||
28166775|NCT02979431|54837542|FG003|Overall Study|Randomized but received no study drug|0|||
28166776|NCT02979431|54837539|FG000|Overall Study|Adverse Event|0|||
28166777|NCT02979431|54837540|FG001|Overall Study|Adverse Event|0|||
28166778|NCT02979431|54837541|FG002|Overall Study|Adverse Event|1|||
28166779|NCT02979431|54837542|FG003|Overall Study|Adverse Event|0|||
28166780|NCT02979431|54837539|FG000|Overall Study|Subject left country after Day14|1|||
28166781|NCT02979431|54837540|FG001|Overall Study|Subject left country after Day14|0|||
28166782|NCT02979431|54837541|FG002|Overall Study|Subject left country after Day14|0|||
28166783|NCT02979431|54837542|FG003|Overall Study|Subject left country after Day14|0|||
28166784|NCT02978417|54837554|FG000|Overall Study|Lost to Follow-up|2|||
28166785|NCT02978417|54837555|FG001|Overall Study|Lost to Follow-up|2|||
28166786|NCT04368429|54837563|FG000|Overall Study|Adverse Event|1|||
28166787|NCT04368429|54837564|FG001|Overall Study|Adverse Event|0|||
28166788|NCT02733627|54837587|FG000|Overall Study|Adverse Event|0|||
28166789|NCT02733627|54837588|FG001|Overall Study|Adverse Event|1|||
28166790|NCT02733627|54837589|FG002|Overall Study|Adverse Event|1|||
28166791|NCT02733627|54837590|FG003|Overall Study|Adverse Event|0|||
28166792|NCT02733627|54837587|FG000|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
28166793|NCT02733627|54837588|FG001|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
28166794|NCT02733627|54837589|FG002|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|1|||
28166795|NCT02733627|54837590|FG003|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
28166796|NCT02958865|54837607|FG000|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
28166797|NCT02958865|54837608|FG001|Induction Period (Day 1 to Week 8)|Adverse Event|4|||
28166798|NCT02958865|54837609|FG002|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
28166799|NCT02958865|54837610|FG003|Induction Period (Day 1 to Week 8)|Adverse Event|5|||
28166800|NCT02958865|54837611|FG004|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
28166801|NCT02958865|54837612|FG005|Induction Period (Day 1 to Week 8)|Adverse Event|2|||
28166802|NCT02958865|54837613|FG006|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
28166803|NCT02958865|54837614|FG007|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
27833105|NCT04034238|54313529|FG000|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
28166804|NCT02958865|54837615|FG008|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
28166805|NCT02958865|54837616|FG009|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
28166806|NCT02958865|54837617|FG010|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
28166807|NCT02958865|54837618|FG011|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
28166808|NCT02958865|54837619|FG012|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
28166809|NCT02958865|54837620|FG013|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
28166810|NCT02958865|54837621|FG014|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
28166811|NCT02958865|54837622|FG015|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
28166812|NCT02958865|54837607|FG000|Induction Period (Day 1 to Week 8)|Death|0|||
28166813|NCT02958865|54837608|FG001|Induction Period (Day 1 to Week 8)|Death|1|||
28166814|NCT02958865|54837609|FG002|Induction Period (Day 1 to Week 8)|Death|0|||
28166815|NCT02958865|54837610|FG003|Induction Period (Day 1 to Week 8)|Death|0|||
28166816|NCT02958865|54837611|FG004|Induction Period (Day 1 to Week 8)|Death|0|||
28166817|NCT02958865|54837612|FG005|Induction Period (Day 1 to Week 8)|Death|0|||
28166818|NCT02958865|54837613|FG006|Induction Period (Day 1 to Week 8)|Death|0|||
28166819|NCT02958865|54837614|FG007|Induction Period (Day 1 to Week 8)|Death|0|||
28166820|NCT02958865|54837615|FG008|Induction Period (Day 1 to Week 8)|Death|0|||
28166821|NCT02958865|54837616|FG009|Induction Period (Day 1 to Week 8)|Death|0|||
28166822|NCT02958865|54837617|FG010|Induction Period (Day 1 to Week 8)|Death|0|||
28166823|NCT02958865|54837618|FG011|Induction Period (Day 1 to Week 8)|Death|0|||
28166824|NCT02958865|54837619|FG012|Induction Period (Day 1 to Week 8)|Death|0|||
28166825|NCT02958865|54837620|FG013|Induction Period (Day 1 to Week 8)|Death|0|||
28166826|NCT02958865|54837621|FG014|Induction Period (Day 1 to Week 8)|Death|0|||
27833106|NCT04034238|54313530|FG001|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
28166827|NCT02958865|54837622|FG015|Induction Period (Day 1 to Week 8)|Death|0|||
28166828|NCT02958865|54837607|FG000|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
28166829|NCT02958865|54837608|FG001|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
28166830|NCT02958865|54837609|FG002|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
28166831|NCT02958865|54837610|FG003|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
28166832|NCT02958865|54837611|FG004|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
27833107|NCT04034238|54313531|FG002|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|1|||
28166833|NCT02958865|54837612|FG005|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
28166834|NCT02958865|54837613|FG006|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
28166835|NCT02958865|54837614|FG007|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
28166836|NCT02958865|54837615|FG008|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
28166837|NCT02958865|54837616|FG009|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
28166838|NCT02958865|54837617|FG010|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
28166839|NCT02958865|54837618|FG011|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
28166840|NCT02958865|54837619|FG012|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
28166841|NCT02958865|54837620|FG013|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
28166842|NCT02958865|54837621|FG014|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
28166843|NCT02958865|54837622|FG015|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
28166844|NCT02958865|54837607|FG000|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|2|||
28166845|NCT02958865|54837608|FG001|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
28166846|NCT02958865|54837609|FG002|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|3|||
28166847|NCT02958865|54837610|FG003|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
28166848|NCT02958865|54837611|FG004|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
28166849|NCT02958865|54837612|FG005|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
28166850|NCT02958865|54837613|FG006|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
28166851|NCT02958865|54837614|FG007|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
28166852|NCT02958865|54837615|FG008|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
28166853|NCT02958865|54837616|FG009|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
28166854|NCT02958865|54837617|FG010|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
28166855|NCT02958865|54837618|FG011|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
28166856|NCT02958865|54837619|FG012|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
28166857|NCT02958865|54837620|FG013|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
28166858|NCT02958865|54837621|FG014|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
28166859|NCT02958865|54837622|FG015|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
28166860|NCT02958865|54837607|FG000|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
28166861|NCT02958865|54837608|FG001|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
28166862|NCT02958865|54837609|FG002|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
28166863|NCT02958865|54837610|FG003|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
28166864|NCT02958865|54837611|FG004|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
28166865|NCT02958865|54837612|FG005|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
28166866|NCT02958865|54837613|FG006|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
28166867|NCT02958865|54837614|FG007|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
28166868|NCT02958865|54837615|FG008|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
28166869|NCT02958865|54837616|FG009|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
28166870|NCT02958865|54837617|FG010|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
28166871|NCT02958865|54837618|FG011|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
28166872|NCT02958865|54837619|FG012|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
28166873|NCT02958865|54837620|FG013|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
28166874|NCT02958865|54837621|FG014|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
28166875|NCT02958865|54837622|FG015|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
28166876|NCT02958865|54837607|FG000|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
28166877|NCT02958865|54837608|FG001|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
28166878|NCT02958865|54837609|FG002|Induction Period (Day 1 to Week 8)|Protocol Violation|1|||
28166879|NCT02958865|54837610|FG003|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
28166880|NCT02958865|54837611|FG004|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
28166881|NCT02958865|54837612|FG005|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
28166882|NCT02958865|54837613|FG006|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
28166883|NCT02958865|54837614|FG007|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
28166884|NCT02958865|54837615|FG008|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
28166885|NCT02958865|54837616|FG009|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
28166886|NCT02958865|54837617|FG010|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
28166887|NCT02958865|54837618|FG011|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
28166888|NCT02958865|54837619|FG012|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
28166889|NCT02958865|54837620|FG013|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
28166890|NCT02958865|54837621|FG014|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
28166891|NCT02958865|54837622|FG015|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
28166892|NCT02958865|54837607|FG000|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
28166893|NCT02958865|54837608|FG001|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
28166894|NCT02958865|54837609|FG002|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
28166895|NCT02958865|54837610|FG003|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
28166896|NCT02958865|54837611|FG004|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
28166897|NCT02958865|54837612|FG005|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
28166898|NCT02958865|54837613|FG006|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
28166899|NCT02958865|54837614|FG007|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
28166900|NCT02958865|54837615|FG008|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
28166901|NCT02958865|54837616|FG009|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
28166902|NCT02958865|54837617|FG010|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
28166903|NCT02958865|54837618|FG011|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
28166904|NCT02958865|54837619|FG012|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
28166905|NCT02958865|54837620|FG013|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
28166906|NCT02958865|54837621|FG014|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
28166907|NCT02958865|54837622|FG015|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
28166908|NCT02958865|54837607|FG000|Induction Period (Day 1 to Week 8)|Other|0|||
28166909|NCT02958865|54837608|FG001|Induction Period (Day 1 to Week 8)|Other|0|||
28166910|NCT02958865|54837609|FG002|Induction Period (Day 1 to Week 8)|Other|1|||
28166911|NCT02958865|54837610|FG003|Induction Period (Day 1 to Week 8)|Other|2|||
28166912|NCT02958865|54837611|FG004|Induction Period (Day 1 to Week 8)|Other|0|||
28166913|NCT02958865|54837612|FG005|Induction Period (Day 1 to Week 8)|Other|1|||
28166914|NCT02958865|54837613|FG006|Induction Period (Day 1 to Week 8)|Other|0|||
28166915|NCT02958865|54837614|FG007|Induction Period (Day 1 to Week 8)|Other|0|||
28166916|NCT02958865|54837615|FG008|Induction Period (Day 1 to Week 8)|Other|0|||
28166917|NCT02958865|54837616|FG009|Induction Period (Day 1 to Week 8)|Other|0|||
28166918|NCT02958865|54837617|FG010|Induction Period (Day 1 to Week 8)|Other|0|||
28166919|NCT02958865|54837618|FG011|Induction Period (Day 1 to Week 8)|Other|0|||
28166920|NCT02958865|54837619|FG012|Induction Period (Day 1 to Week 8)|Other|0|||
28166921|NCT02958865|54837620|FG013|Induction Period (Day 1 to Week 8)|Other|0|||
28166922|NCT02958865|54837621|FG014|Induction Period (Day 1 to Week 8)|Other|0|||
28166923|NCT02958865|54837622|FG015|Induction Period (Day 1 to Week 8)|Other|0|||
28166924|NCT02958865|54837607|FG000|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
28166925|NCT02958865|54837608|FG001|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
28166926|NCT02958865|54837609|FG002|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
28166927|NCT02958865|54837610|FG003|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
28166928|NCT02958865|54837611|FG004|Induction Period (Day 1 to Week 8)|Lost to Follow-up|1|||
28166929|NCT02958865|54837612|FG005|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
28166930|NCT02958865|54837613|FG006|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
28166931|NCT02958865|54837614|FG007|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
28166932|NCT02958865|54837615|FG008|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
28166933|NCT02958865|54837616|FG009|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
28166934|NCT02958865|54837617|FG010|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
28166935|NCT02958865|54837618|FG011|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
28166936|NCT02958865|54837619|FG012|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
28166937|NCT02958865|54837620|FG013|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
28166938|NCT02958865|54837621|FG014|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
28166939|NCT02958865|54837622|FG015|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
28166940|NCT02958865|54837607|FG000|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
28166941|NCT02958865|54837608|FG001|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
28166942|NCT02958865|54837609|FG002|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
28166943|NCT02958865|54837610|FG003|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
28166944|NCT02958865|54837611|FG004|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
28166945|NCT02958865|54837612|FG005|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
28166946|NCT02958865|54837613|FG006|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
28166947|NCT02958865|54837614|FG007|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
27855759|NCT02733042|54382045|FG007|Follow-up Period|Other|0|||
28091088|NCT04684394|54744802|FG000|Overall Study|Withdrawal by Subject|2|||
28091089|NCT04684394|54744803|FG001|Overall Study|Withdrawal by Subject|0|||
28091090|NCT04684394|54744802|FG000|Overall Study|Study discontinued per Sponsor decision|25|||
28091091|NCT04684394|54744803|FG001|Overall Study|Study discontinued per Sponsor decision|13|||
28091092|NCT04674644|54744809|FG000|Overall Study|with missing data|37|||
28091093|NCT04668950|54744816|FG000|Overall Study|Started medication more than 7 days after symptom onset|18|||
28091094|NCT04668950|54744817|FG001|Overall Study|Started medication more than 7 days after symptom onset|14|||
28091095|NCT04668950|54744816|FG000|Overall Study|Could not confirm started study medication|15|||
28091096|NCT04668950|54744817|FG001|Overall Study|Could not confirm started study medication|15|||
28091097|NCT04668950|54744816|FG000|Overall Study|Could not confirm baseline status|6|||
28091098|NCT04668950|54744817|FG001|Overall Study|Could not confirm baseline status|2|||
28091099|NCT04668950|54744816|FG000|Overall Study|Drop out and did not start medication|15|||
28091100|NCT04668950|54744817|FG001|Overall Study|Drop out and did not start medication|17|||
28091101|NCT04668950|54744816|FG000|Overall Study|Deteriorated at or before baseline assessment|6|||
28091102|NCT04668950|54744817|FG001|Overall Study|Deteriorated at or before baseline assessment|9|||
28091103|NCT04668950|54744816|FG000|Overall Study|Other|2|||
28166948|NCT02958865|54837615|FG008|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
28166949|NCT02958865|54837616|FG009|Chronic Period (Week 8 to Week 32)|Adverse Event|2|||
28166950|NCT02958865|54837617|FG010|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
28166951|NCT02958865|54837618|FG011|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
28166952|NCT02958865|54837619|FG012|Chronic Period (Week 8 to Week 32)|Adverse Event|4|||
28166953|NCT02958865|54837620|FG013|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
28166954|NCT02958865|54837621|FG014|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
28166955|NCT02958865|54837622|FG015|Chronic Period (Week 8 to Week 32)|Adverse Event|5|||
28166956|NCT02958865|54837607|FG000|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
28166957|NCT02958865|54837608|FG001|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
28166958|NCT02958865|54837609|FG002|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
28166959|NCT02958865|54837610|FG003|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
28166960|NCT02958865|54837611|FG004|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
28166961|NCT02958865|54837612|FG005|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
28166962|NCT02958865|54837613|FG006|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
28166963|NCT02958865|54837614|FG007|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
28166964|NCT02958865|54837615|FG008|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
28166965|NCT02958865|54837616|FG009|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|1|||
28166966|NCT02958865|54837617|FG010|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
28166967|NCT02958865|54837618|FG011|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|5|||
28166968|NCT02958865|54837619|FG012|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
28166969|NCT02958865|54837620|FG013|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
28166970|NCT02958865|54837621|FG014|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
28166971|NCT02958865|54837622|FG015|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|8|||
28166972|NCT02958865|54837607|FG000|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
28091104|NCT04668950|54744817|FG001|Overall Study|Other|4|||
28091105|NCT03078478|54744825|FG000|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
28091106|NCT03078478|54744826|FG001|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
28091107|NCT03078478|54744825|FG000|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7|||
28091108|NCT03078478|54744826|FG001|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4|||
28091109|NCT03078478|54744825|FG000|Maintenance Period 1 (36 Weeks)|Death|3|||
28091110|NCT03078478|54744826|FG001|Maintenance Period 1 (36 Weeks)|Death|3|||
28091111|NCT03078478|54744825|FG000|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1|||
28091112|NCT03078478|54744826|FG001|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0|||
28091113|NCT03078478|54744825|FG000|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18|||
28091114|NCT03078478|54744826|FG001|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13|||
28091115|NCT03078478|54744825|FG000|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3|||
28091116|NCT03078478|54744826|FG001|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6|||
28091117|NCT03078478|54744825|FG000|Maintencance Period 2 (36 Weeks)|Death|4|||
28091118|NCT03078478|54744826|FG001|Maintencance Period 2 (36 Weeks)|Death|6|||
28091119|NCT03078478|54744825|FG000|Maintencance Period 2 (36 Weeks)|Not reconsenting|0|||
28091120|NCT03078478|54744826|FG001|Maintencance Period 2 (36 Weeks)|Not reconsenting|2|||
28091121|NCT03539458|54744832|FG000|Overall Study|Death|1|||
28091122|NCT02879578|54744839|FG000|Overall Study|Adverse Event|1|||
28091123|NCT02879578|54744840|FG001|Overall Study|Adverse Event|2|||
28091124|NCT02879578|54744841|FG002|Overall Study|Adverse Event|14|||
28091125|NCT02879578|54744839|FG000|Overall Study|Protocol Violation|0|||
28091126|NCT02879578|54744840|FG001|Overall Study|Protocol Violation|1|||
28091127|NCT02879578|54744841|FG002|Overall Study|Protocol Violation|1|||
28091128|NCT02879578|54744839|FG000|Overall Study|Withdrawal by Subject|8|||
28091129|NCT02879578|54744840|FG001|Overall Study|Withdrawal by Subject|6|||
28091130|NCT02879578|54744841|FG002|Overall Study|Withdrawal by Subject|9|||
28091131|NCT02879578|54744839|FG000|Overall Study|Lost to Follow-up|1|||
28091132|NCT02879578|54744840|FG001|Overall Study|Lost to Follow-up|0|||
28091133|NCT02879578|54744841|FG002|Overall Study|Lost to Follow-up|4|||
28091134|NCT02879578|54744839|FG000|Overall Study|Physician Decision|0|||
28091135|NCT02879578|54744840|FG001|Overall Study|Physician Decision|0|||
28091136|NCT02879578|54744841|FG002|Overall Study|Physician Decision|4|||
28091137|NCT00045942|54744858|FG000|PKC412A2104 (Core)|Withdrawal by Subject|1|||
28091138|NCT00045942|54744859|FG001|PKC412A2104 (Core)|Withdrawal by Subject|0|||
28091139|NCT00045942|54744860|FG002|PKC412A2104 (Core)|Withdrawal by Subject|0|||
28091140|NCT00045942|54744861|FG003|PKC412A2104 (Core)|Withdrawal by Subject|0|||
28166973|NCT02958865|54837608|FG001|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
28166974|NCT02958865|54837609|FG002|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
28166975|NCT02958865|54837610|FG003|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
28166976|NCT02958865|54837611|FG004|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
28166977|NCT02958865|54837612|FG005|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
28091141|NCT00045942|54744862|FG004|PKC412A2104 (Core)|Withdrawal by Subject|0|||
28091142|NCT00045942|54744863|FG005|PKC412A2104 (Core)|Withdrawal by Subject|0|||
28091143|NCT00045942|54744864|FG006|PKC412A2104 (Core)|Withdrawal by Subject|0|||
28166978|NCT02958865|54837613|FG006|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
28091144|NCT00045942|54744865|FG007|PKC412A2104 (Core)|Withdrawal by Subject|0|||
28091145|NCT00045942|54744866|FG008|PKC412A2104 (Core)|Withdrawal by Subject|0|||
28091146|NCT00045942|54744858|FG000|PKC412A2104 (Core)|Adverse Event|5|||
28091147|NCT00045942|54744859|FG001|PKC412A2104 (Core)|Adverse Event|0|||
28091148|NCT00045942|54744860|FG002|PKC412A2104 (Core)|Adverse Event|0|||
28091149|NCT00045942|54744861|FG003|PKC412A2104 (Core)|Adverse Event|0|||
28091150|NCT00045942|54744862|FG004|PKC412A2104 (Core)|Adverse Event|0|||
28091151|NCT00045942|54744863|FG005|PKC412A2104 (Core)|Adverse Event|0|||
28091152|NCT00045942|54744864|FG006|PKC412A2104 (Core)|Adverse Event|0|||
28091153|NCT00045942|54744865|FG007|PKC412A2104 (Core)|Adverse Event|0|||
28091154|NCT00045942|54744866|FG008|PKC412A2104 (Core)|Adverse Event|0|||
28091155|NCT00045942|54744858|FG000|PKC412A2104 (Core)|Lack of Efficacy|13|||
28091156|NCT00045942|54744859|FG001|PKC412A2104 (Core)|Lack of Efficacy|0|||
28091157|NCT00045942|54744860|FG002|PKC412A2104 (Core)|Lack of Efficacy|0|||
28091158|NCT00045942|54744861|FG003|PKC412A2104 (Core)|Lack of Efficacy|0|||
28091159|NCT00045942|54744862|FG004|PKC412A2104 (Core)|Lack of Efficacy|0|||
28091160|NCT00045942|54744863|FG005|PKC412A2104 (Core)|Lack of Efficacy|0|||
28091161|NCT00045942|54744864|FG006|PKC412A2104 (Core)|Lack of Efficacy|0|||
28091162|NCT00045942|54744865|FG007|PKC412A2104 (Core)|Lack of Efficacy|0|||
28091163|NCT00045942|54744866|FG008|PKC412A2104 (Core)|Lack of Efficacy|0|||
28091164|NCT00045942|54744858|FG000|PKC412A2104 (Core)|Death|1|||
28091165|NCT00045942|54744859|FG001|PKC412A2104 (Core)|Death|0|||
28091166|NCT00045942|54744860|FG002|PKC412A2104 (Core)|Death|0|||
28091167|NCT00045942|54744861|FG003|PKC412A2104 (Core)|Death|0|||
28091168|NCT00045942|54744862|FG004|PKC412A2104 (Core)|Death|0|||
28091169|NCT00045942|54744863|FG005|PKC412A2104 (Core)|Death|0|||
28091170|NCT00045942|54744864|FG006|PKC412A2104 (Core)|Death|0|||
28091171|NCT00045942|54744865|FG007|PKC412A2104 (Core)|Death|0|||
28091172|NCT00045942|54744866|FG008|PKC412A2104 (Core)|Death|0|||
28091173|NCT00045942|54744858|FG000|PKC412A2104E1|Withdrawal by Subject|0|||
28091174|NCT00045942|54744859|FG001|PKC412A2104E1|Withdrawal by Subject|0|||
28091175|NCT00045942|54744860|FG002|PKC412A2104E1|Withdrawal by Subject|2|||
28091176|NCT00045942|54744861|FG003|PKC412A2104E1|Withdrawal by Subject|5|||
28091177|NCT00045942|54744862|FG004|PKC412A2104E1|Withdrawal by Subject|2|||
28091178|NCT00045942|54744863|FG005|PKC412A2104E1|Withdrawal by Subject|0|||
28091179|NCT00045942|54744864|FG006|PKC412A2104E1|Withdrawal by Subject|0|||
28091180|NCT00045942|54744865|FG007|PKC412A2104E1|Withdrawal by Subject|0|||
28091181|NCT00045942|54744866|FG008|PKC412A2104E1|Withdrawal by Subject|0|||
28091182|NCT00045942|54744858|FG000|PKC412A2104E1|Condition no longer requires study drug|0|||
28091183|NCT00045942|54744859|FG001|PKC412A2104E1|Condition no longer requires study drug|1|||
27980644|NCT00803205|54638642|FG001|Overall Study|Sponsor Decision|1|||
27980645|NCT00952523|54638648|FG000|Overall Study|Withdrawal by Subject|7|||
27980646|NCT02232737|54638657|FG000|Overall Study|Lost to Follow-up|18|||
27980647|NCT02232737|54638658|FG001|Overall Study|Lost to Follow-up|28|||
27980648|NCT02232737|54638659|FG002|Overall Study|Lost to Follow-up|33|||
27980649|NCT02232737|54638657|FG000|Overall Study|Personal reasons|7|||
27980650|NCT02232737|54638658|FG001|Overall Study|Personal reasons|8|||
27980651|NCT02232737|54638659|FG002|Overall Study|Personal reasons|14|||
27980652|NCT02232737|54638657|FG000|Overall Study|Adverse Event|6|||
27980653|NCT02232737|54638658|FG001|Overall Study|Adverse Event|3|||
27980654|NCT02232737|54638659|FG002|Overall Study|Adverse Event|8|||
27980655|NCT02232737|54638657|FG000|Overall Study|Incarcerated|2|||
27980656|NCT02232737|54638658|FG001|Overall Study|Incarcerated|1|||
27980657|NCT02232737|54638659|FG002|Overall Study|Incarcerated|2|||
27980658|NCT02232737|54638657|FG000|Overall Study|Withdrawal by Subject|0|||
28091184|NCT00045942|54744860|FG002|PKC412A2104E1|Condition no longer requires study drug|1|||
28091185|NCT00045942|54744861|FG003|PKC412A2104E1|Condition no longer requires study drug|0|||
28091186|NCT00045942|54744862|FG004|PKC412A2104E1|Condition no longer requires study drug|1|||
28091187|NCT00045942|54744863|FG005|PKC412A2104E1|Condition no longer requires study drug|0|||
28091188|NCT00045942|54744864|FG006|PKC412A2104E1|Condition no longer requires study drug|0|||
28091189|NCT00045942|54744865|FG007|PKC412A2104E1|Condition no longer requires study drug|0|||
28091190|NCT00045942|54744866|FG008|PKC412A2104E1|Condition no longer requires study drug|0|||
28091191|NCT00045942|54744858|FG000|PKC412A2104E1|Lack of Efficacy|0|||
28091192|NCT00045942|54744859|FG001|PKC412A2104E1|Lack of Efficacy|11|||
28091193|NCT00045942|54744860|FG002|PKC412A2104E1|Lack of Efficacy|11|||
28091194|NCT00045942|54744861|FG003|PKC412A2104E1|Lack of Efficacy|23|||
28091195|NCT00045942|54744862|FG004|PKC412A2104E1|Lack of Efficacy|17|||
27980659|NCT02232737|54638658|FG001|Overall Study|Withdrawal by Subject|1|||
27980660|NCT02232737|54638659|FG002|Overall Study|Withdrawal by Subject|2|||
27980661|NCT02232737|54638657|FG000|Overall Study|Death|0|||
27980662|NCT02232737|54638658|FG001|Overall Study|Death|1|||
28091196|NCT00045942|54744863|FG005|PKC412A2104E1|Lack of Efficacy|0|||
28091197|NCT00045942|54744864|FG006|PKC412A2104E1|Lack of Efficacy|0|||
28091198|NCT00045942|54744865|FG007|PKC412A2104E1|Lack of Efficacy|0|||
28091199|NCT00045942|54744866|FG008|PKC412A2104E1|Lack of Efficacy|0|||
28091200|NCT00045942|54744858|FG000|PKC412A2104E1|Abnormal laboratory value|0|||
28091201|NCT00045942|54744859|FG001|PKC412A2104E1|Abnormal laboratory value|1|||
28091202|NCT00045942|54744860|FG002|PKC412A2104E1|Abnormal laboratory value|0|||
28091203|NCT00045942|54744861|FG003|PKC412A2104E1|Abnormal laboratory value|0|||
28091204|NCT00045942|54744862|FG004|PKC412A2104E1|Abnormal laboratory value|0|||
28091205|NCT00045942|54744863|FG005|PKC412A2104E1|Abnormal laboratory value|0|||
28091206|NCT00045942|54744864|FG006|PKC412A2104E1|Abnormal laboratory value|0|||
28091207|NCT00045942|54744865|FG007|PKC412A2104E1|Abnormal laboratory value|0|||
28091208|NCT00045942|54744866|FG008|PKC412A2104E1|Abnormal laboratory value|0|||
28091209|NCT00045942|54744858|FG000|PKC412A2104E1|Adverse Event|0|||
28091210|NCT00045942|54744859|FG001|PKC412A2104E1|Adverse Event|1|||
28091211|NCT00045942|54744860|FG002|PKC412A2104E1|Adverse Event|1|||
28091212|NCT00045942|54744861|FG003|PKC412A2104E1|Adverse Event|3|||
28091213|NCT00045942|54744862|FG004|PKC412A2104E1|Adverse Event|6|||
28166979|NCT02958865|54837614|FG007|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
28166980|NCT02958865|54837615|FG008|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
28166981|NCT02958865|54837616|FG009|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
28166982|NCT02958865|54837617|FG010|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
28166983|NCT02958865|54837618|FG011|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
28166984|NCT02958865|54837619|FG012|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
28166985|NCT02958865|54837620|FG013|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
28166986|NCT02958865|54837621|FG014|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
28091214|NCT00045942|54744863|FG005|PKC412A2104E1|Adverse Event|0|||
28091215|NCT00045942|54744864|FG006|PKC412A2104E1|Adverse Event|0|||
28091216|NCT00045942|54744865|FG007|PKC412A2104E1|Adverse Event|0|||
28091217|NCT00045942|54744866|FG008|PKC412A2104E1|Adverse Event|0|||
28091218|NCT00045942|54744858|FG000|PKC412A2104E1|Death|0|||
28091219|NCT00045942|54744859|FG001|PKC412A2104E1|Death|4|||
28091220|NCT00045942|54744860|FG002|PKC412A2104E1|Death|1|||
28091221|NCT00045942|54744861|FG003|PKC412A2104E1|Death|1|||
28091222|NCT00045942|54744862|FG004|PKC412A2104E1|Death|1|||
28091223|NCT00045942|54744863|FG005|PKC412A2104E1|Death|0|||
28091224|NCT00045942|54744864|FG006|PKC412A2104E1|Death|0|||
28091225|NCT00045942|54744865|FG007|PKC412A2104E1|Death|0|||
28091226|NCT00045942|54744866|FG008|PKC412A2104E1|Death|0|||
28091227|NCT00045942|54744858|FG000|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
28091228|NCT00045942|54744859|FG001|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
28091229|NCT00045942|54744860|FG002|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
28091230|NCT00045942|54744861|FG003|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
28091231|NCT00045942|54744862|FG004|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
28091232|NCT00045942|54744863|FG005|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
28091233|NCT00045942|54744864|FG006|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
28091234|NCT00045942|54744865|FG007|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
28091235|NCT00045942|54744866|FG008|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
28091236|NCT00045942|54744858|FG000|PKC412A2104E2|Lost to Follow-up|0|||
28091237|NCT00045942|54744859|FG001|PKC412A2104E2|Lost to Follow-up|0|||
28091238|NCT00045942|54744860|FG002|PKC412A2104E2|Lost to Follow-up|0|||
28091239|NCT00045942|54744861|FG003|PKC412A2104E2|Lost to Follow-up|0|||
28091240|NCT00045942|54744862|FG004|PKC412A2104E2|Lost to Follow-up|0|||
28091241|NCT00045942|54744863|FG005|PKC412A2104E2|Lost to Follow-up|0|||
28091242|NCT00045942|54744864|FG006|PKC412A2104E2|Lost to Follow-up|0|||
28091243|NCT00045942|54744865|FG007|PKC412A2104E2|Lost to Follow-up|3|||
28091244|NCT00045942|54744866|FG008|PKC412A2104E2|Lost to Follow-up|0|||
28091245|NCT00045942|54744858|FG000|PKC412A2104E2|Withdrawal by Subject|0|||
28091246|NCT00045942|54744859|FG001|PKC412A2104E2|Withdrawal by Subject|0|||
28091247|NCT00045942|54744860|FG002|PKC412A2104E2|Withdrawal by Subject|0|||
28091248|NCT00045942|54744861|FG003|PKC412A2104E2|Withdrawal by Subject|0|||
28166987|NCT02958865|54837622|FG015|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
28166988|NCT02958865|54837607|FG000|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
28166989|NCT02958865|54837608|FG001|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
28166990|NCT02958865|54837609|FG002|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
28166991|NCT02958865|54837610|FG003|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
28166992|NCT02958865|54837611|FG004|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
28166993|NCT02958865|54837612|FG005|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
28166994|NCT02958865|54837613|FG006|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
28166995|NCT02958865|54837614|FG007|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
28166996|NCT02958865|54837615|FG008|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
28166997|NCT02958865|54837616|FG009|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
28166998|NCT02958865|54837617|FG010|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
28091249|NCT00045942|54744862|FG004|PKC412A2104E2|Withdrawal by Subject|0|||
28166999|NCT02958865|54837618|FG011|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|1|||
28091250|NCT00045942|54744863|FG005|PKC412A2104E2|Withdrawal by Subject|1|||
28091251|NCT00045942|54744864|FG006|PKC412A2104E2|Withdrawal by Subject|0|||
28091252|NCT00045942|54744865|FG007|PKC412A2104E2|Withdrawal by Subject|1|||
28091253|NCT00045942|54744866|FG008|PKC412A2104E2|Withdrawal by Subject|0|||
28091254|NCT00045942|54744858|FG000|PKC412A2104E2|Lack of Efficacy|0|||
28091255|NCT00045942|54744859|FG001|PKC412A2104E2|Lack of Efficacy|0|||
28091256|NCT00045942|54744860|FG002|PKC412A2104E2|Lack of Efficacy|0|||
28167000|NCT02958865|54837619|FG012|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|6|||
28167001|NCT02958865|54837620|FG013|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
28091257|NCT00045942|54744861|FG003|PKC412A2104E2|Lack of Efficacy|0|||
28091258|NCT00045942|54744862|FG004|PKC412A2104E2|Lack of Efficacy|0|||
28091259|NCT00045942|54744863|FG005|PKC412A2104E2|Lack of Efficacy|3|||
28091260|NCT00045942|54744864|FG006|PKC412A2104E2|Lack of Efficacy|2|||
28091261|NCT00045942|54744865|FG007|PKC412A2104E2|Lack of Efficacy|2|||
28167002|NCT02958865|54837621|FG014|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
28167003|NCT02958865|54837622|FG015|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|2|||
28167004|NCT02958865|54837607|FG000|Chronic Period (Week 8 to Week 32)|Other|0|||
28167005|NCT02958865|54837608|FG001|Chronic Period (Week 8 to Week 32)|Other|0|||
28167006|NCT02958865|54837609|FG002|Chronic Period (Week 8 to Week 32)|Other|0|||
28167007|NCT02958865|54837610|FG003|Chronic Period (Week 8 to Week 32)|Other|0|||
28167008|NCT02958865|54837611|FG004|Chronic Period (Week 8 to Week 32)|Other|0|||
28167009|NCT02958865|54837612|FG005|Chronic Period (Week 8 to Week 32)|Other|0|||
28167010|NCT02958865|54837613|FG006|Chronic Period (Week 8 to Week 32)|Other|0|||
28167011|NCT02958865|54837614|FG007|Chronic Period (Week 8 to Week 32)|Other|1|||
28167012|NCT02958865|54837615|FG008|Chronic Period (Week 8 to Week 32)|Other|0|||
28167013|NCT02958865|54837616|FG009|Chronic Period (Week 8 to Week 32)|Other|1|||
28167014|NCT02958865|54837617|FG010|Chronic Period (Week 8 to Week 32)|Other|0|||
28167015|NCT02958865|54837618|FG011|Chronic Period (Week 8 to Week 32)|Other|0|||
28167016|NCT02958865|54837619|FG012|Chronic Period (Week 8 to Week 32)|Other|1|||
28167017|NCT02958865|54837620|FG013|Chronic Period (Week 8 to Week 32)|Other|0|||
28167018|NCT02958865|54837621|FG014|Chronic Period (Week 8 to Week 32)|Other|0|||
28167019|NCT02958865|54837622|FG015|Chronic Period (Week 8 to Week 32)|Other|1|||
28167020|NCT02958865|54837607|FG000|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
28167021|NCT02958865|54837608|FG001|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
28167022|NCT02958865|54837609|FG002|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
28167023|NCT02958865|54837610|FG003|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
28167024|NCT02958865|54837611|FG004|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
28167025|NCT02958865|54837612|FG005|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
28167026|NCT02958865|54837613|FG006|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
28167027|NCT02958865|54837614|FG007|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
28167028|NCT02958865|54837615|FG008|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
28167029|NCT02958865|54837616|FG009|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
28167030|NCT02958865|54837617|FG010|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
28167031|NCT02958865|54837618|FG011|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
28167032|NCT02958865|54837619|FG012|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
28167033|NCT02958865|54837620|FG013|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|1|||
28167034|NCT02958865|54837621|FG014|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
28167035|NCT02958865|54837622|FG015|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
28167036|NCT02958865|54837607|FG000|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
28167037|NCT02958865|54837608|FG001|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
28167038|NCT02958865|54837609|FG002|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
28167039|NCT02958865|54837610|FG003|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
28167040|NCT02958865|54837611|FG004|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
28167041|NCT02958865|54837612|FG005|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
28167042|NCT02958865|54837613|FG006|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
28167043|NCT02958865|54837614|FG007|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
28167044|NCT02958865|54837615|FG008|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
28167045|NCT02958865|54837616|FG009|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
28167046|NCT02958865|54837617|FG010|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
28091262|NCT00045942|54744866|FG008|PKC412A2104E2|Lack of Efficacy|6|||
28091263|NCT00045942|54744858|FG000|PKC412A2104E2|Adverse Event|0|||
28091264|NCT00045942|54744859|FG001|PKC412A2104E2|Adverse Event|0|||
28091265|NCT00045942|54744860|FG002|PKC412A2104E2|Adverse Event|0|||
28091266|NCT00045942|54744861|FG003|PKC412A2104E2|Adverse Event|0|||
28091267|NCT00045942|54744862|FG004|PKC412A2104E2|Adverse Event|0|||
28091268|NCT00045942|54744863|FG005|PKC412A2104E2|Adverse Event|4|||
28091269|NCT00045942|54744864|FG006|PKC412A2104E2|Adverse Event|3|||
28091270|NCT00045942|54744865|FG007|PKC412A2104E2|Adverse Event|1|||
28091271|NCT00045942|54744866|FG008|PKC412A2104E2|Adverse Event|0|||
28091272|NCT00045942|54744858|FG000|PKC412A2104E2|Death|0|||
28091273|NCT00045942|54744859|FG001|PKC412A2104E2|Death|0|||
28091274|NCT00045942|54744860|FG002|PKC412A2104E2|Death|0|||
28091275|NCT00045942|54744861|FG003|PKC412A2104E2|Death|0|||
28091276|NCT00045942|54744862|FG004|PKC412A2104E2|Death|0|||
28091277|NCT00045942|54744863|FG005|PKC412A2104E2|Death|1|||
28091278|NCT00045942|54744864|FG006|PKC412A2104E2|Death|2|||
28091279|NCT00045942|54744865|FG007|PKC412A2104E2|Death|0|||
28091280|NCT00045942|54744866|FG008|PKC412A2104E2|Death|0|||
28091281|NCT04386616|54744893|FG000|Overall Study|Death|22|||
28091282|NCT04386616|54744894|FG001|Overall Study|Death|22|||
28091283|NCT04386616|54744895|FG002|Overall Study|Death|21|||
28091284|NCT04386616|54744893|FG000|Overall Study|Lost to Follow-up|5|||
28091285|NCT04386616|54744894|FG001|Overall Study|Lost to Follow-up|8|||
28091286|NCT04386616|54744895|FG002|Overall Study|Lost to Follow-up|6|||
28091287|NCT04386616|54744893|FG000|Overall Study|Withdrawal by Subject|2|||
28091288|NCT04386616|54744894|FG001|Overall Study|Withdrawal by Subject|4|||
28091289|NCT04386616|54744895|FG002|Overall Study|Withdrawal by Subject|1|||
28091290|NCT04386616|54744893|FG000|Overall Study|Adverse Event|1|||
28091291|NCT04386616|54744894|FG001|Overall Study|Adverse Event|1|||
28091292|NCT04386616|54744895|FG002|Overall Study|Adverse Event|0|||
28091293|NCT00045708|54744915|FG000|Phase 1|early progressive disease|0|||
28091294|NCT00045708|54744916|FG001|Phase 1|early progressive disease|1|||
28091295|NCT00045708|54744917|FG002|Phase 1|early progressive disease|0|||
28091296|NCT00045630|54744934|FG000|Overall Study|Adverse Event|1|||
28091297|NCT00045630|54744934|FG000|Overall Study|Refusal unrelated to adverse event|1|||
28091298|NCT00045630|54744934|FG000|Overall Study|Progression/relapse|1|||
28091299|NCT00045630|54744934|FG000|Overall Study|Death|1|||
28091300|NCT00045630|54744934|FG000|Overall Study|Ineligible|2|||
28091301|NCT00003702|54744940|FG000|Overall Study|Ineligible cell types|2|||
28091302|NCT00003702|54744941|FG001|Overall Study|Ineligible cell types|2|||
28091303|NCT00003702|54744940|FG000|Overall Study|Did not meet criteria for persistence|8|||
28091304|NCT00003702|54744941|FG001|Overall Study|Did not meet criteria for persistence|5|||
28091305|NCT00003702|54744940|FG000|Overall Study|WHO score > 6|2|||
28091306|NCT00003702|54744941|FG001|Overall Study|WHO score > 6|1|||
28091307|NCT00003702|54744940|FG000|Overall Study|Inadequate documentation of disease|1|||
28091308|NCT00003702|54744941|FG001|Overall Study|Inadequate documentation of disease|3|||
28091309|NCT00031590|54744948|FG000|Overall Study|Adverse Event|1|||
28091310|NCT00031590|54744948|FG000|Overall Study|Withdrawal by parents|2|||
28091311|NCT00239681|54744955|FG000|Overall Study|Adverse Event|100|||
28091312|NCT00239681|54744956|FG001|Overall Study|Adverse Event|99|||
28091313|NCT00239681|54744955|FG000|Overall Study|Withdrawal by Subject|458|||
28091314|NCT00239681|54744956|FG001|Overall Study|Withdrawal by Subject|489|||
28091315|NCT00239681|54744955|FG000|Overall Study|Lost to Follow-up|28|||
28091316|NCT00239681|54744956|FG001|Overall Study|Lost to Follow-up|22|||
28091317|NCT00239681|54744955|FG000|Overall Study|Protocol Violation|4|||
28091318|NCT00239681|54744956|FG001|Overall Study|Protocol Violation|4|||
28091319|NCT00239681|54744955|FG000|Overall Study|Physician Decision|13|||
28091320|NCT00239681|54744956|FG001|Overall Study|Physician Decision|17|||
28091321|NCT00239681|54744955|FG000|Overall Study|No information chacked on CaseReportForm|90|||
28091322|NCT00239681|54744956|FG001|Overall Study|No information chacked on CaseReportForm|84|||
28091323|NCT02878330|54744964|FG000|Overall Study|Death|3|||
28091324|NCT02878330|54744965|FG001|Overall Study|Death|2|||
28091325|NCT02878330|54744964|FG000|Overall Study|Lost to Follow-up|11|||
28091326|NCT02878330|54744965|FG001|Overall Study|Lost to Follow-up|26|||
28091327|NCT02878330|54744964|FG000|Overall Study|Withdrawal by Subject|11|||
28091328|NCT02878330|54744965|FG001|Overall Study|Withdrawal by Subject|21|||
28091329|NCT02878330|54744964|FG000|Overall Study|Other|4|||
28091330|NCT02878330|54744965|FG001|Overall Study|Other|7|||
28091331|NCT00238433|54744972|FG000|Overall Study|Screen failure|1|||
28091332|NCT00238433|54744972|FG000|Overall Study|Lost to Follow-up|1|||
28091333|NCT00238433|54744972|FG000|Overall Study|Death|1|||
28091334|NCT00045162|54744979|FG000|Overall Study|Ineligible|12|||
28091335|NCT00045162|54744980|FG001|Overall Study|Ineligible|8|||
28091336|NCT00045162|54744979|FG000|Overall Study|Not treated|7|||
28091337|NCT00045162|54744980|FG001|Overall Study|Not treated|2|||
28091338|NCT00045162|54744979|FG000|Overall Study|Adverse Event|55|||
28091339|NCT00045162|54744980|FG001|Overall Study|Adverse Event|50|||
28091340|NCT00045162|54744979|FG000|Overall Study|Lack of Efficacy|32|||
28091341|NCT00045162|54744980|FG001|Overall Study|Lack of Efficacy|29|||
28091342|NCT00045162|54744979|FG000|Overall Study|Death|10|||
28091343|NCT00045162|54744980|FG001|Overall Study|Death|10|||
28091344|NCT00045162|54744979|FG000|Overall Study|Withdrawal by Subject|5|||
28091345|NCT00045162|54744980|FG001|Overall Study|Withdrawal by Subject|3|||
28091346|NCT00045162|54744979|FG000|Overall Study|Other|21|||
28091347|NCT00045162|54744980|FG001|Overall Study|Other|16|||
28091348|NCT02748616|54744986|FG000|Overall Study|Lost to Follow-up|1|||
28091349|NCT02748616|54744986|FG000|Overall Study|Withdrawal by Subject|2|||
27855760|NCT02733042|54382046|FG008|Follow-up Period|Other|0|||
27855761|NCT02733042|54382047|FG009|Follow-up Period|Other|0|||
28091350|NCT02748616|54744986|FG000|Overall Study|Physician Decision|2|||
28091351|NCT02748616|54744986|FG000|Overall Study|Did Not Complete Ursodial Course|2|||
28091352|NCT00238121|54744992|FG000|Overall Study|Withdrawal by Subject|1|||
28091353|NCT00238121|54744993|FG001|Overall Study|Withdrawal by Subject|1|||
28091354|NCT00238121|54744992|FG000|Overall Study|Adverse Event|2|||
28091355|NCT00238121|54744993|FG001|Overall Study|Adverse Event|1|||
28091356|NCT03139552|54744998|FG000|Overall Study|unable to attend tasting due to schedule|3|||
28091357|NCT03804918|54745009|FG000|Overall Study|Participant did not use the app|1|||
28091358|NCT03139240|54745017|FG000|Overall Study|Lost to Follow-up|0|||
28091359|NCT03139240|54745018|FG001|Overall Study|Lost to Follow-up|1|||
28091360|NCT03139240|54745019|FG002|Overall Study|Lost to Follow-up|1|||
28091361|NCT03139240|54745020|FG003|Overall Study|Lost to Follow-up|0|||
28091362|NCT00237809|54745032|FG000|Overall Study|Lost to Follow-up|11|||
28091363|NCT00237809|54745033|FG001|Overall Study|Lost to Follow-up|10|||
28091364|NCT00237809|54745034|FG002|Overall Study|Lost to Follow-up|9|||
28091365|NCT00237809|54745035|FG003|Overall Study|Lost to Follow-up|9|||
28091366|NCT00003498|54745045|FG000|Overall Study|Not evaluable.|4|||
28091367|NCT00003492|54745049|FG000|Overall Study|Not evaluable|6|||
28091368|NCT03136198|54745055|FG000|Overall Study|Withdrawal by Subject|0|||
28091369|NCT03136198|54745056|FG001|Overall Study|Withdrawal by Subject|1|||
28091370|NCT00042666|54745062|FG000|Overall Study|Adverse Event|2|||
28091371|NCT00042666|54745062|FG000|Overall Study|Death|4|||
28091372|NCT00042666|54745062|FG000|Overall Study|Protocol Violation|1|||
28091373|NCT00042666|54745062|FG000|Overall Study|Participant/Physician Perception|1|||
28167047|NCT02958865|54837618|FG011|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
28167048|NCT02958865|54837619|FG012|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
28167049|NCT02958865|54837620|FG013|Chronic Period (Week 8 to Week 32)|Protocol Violation|1|||
28167050|NCT02958865|54837621|FG014|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
28167051|NCT02958865|54837622|FG015|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
28167052|NCT02958865|54837607|FG000|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
28091374|NCT00042666|54745062|FG000|Overall Study|Progressive Disease|41|||
28091375|NCT00042666|54745062|FG000|Overall Study|Other|1|||
28091376|NCT00042666|54745062|FG000|Overall Study|Other|4|||
28091377|NCT00042432|54745069|FG000|Overall Study|Adverse Event|4|||
28091378|NCT00042432|54745070|FG001|Overall Study|Adverse Event|1|||
28091379|NCT00042432|54745069|FG000|Overall Study|Withdrawal by Subject|1|||
28091380|NCT00042432|54745070|FG001|Overall Study|Withdrawal by Subject|3|||
28091381|NCT00042432|54745069|FG000|Overall Study|Death|0|||
28091382|NCT00042432|54745070|FG001|Overall Study|Death|2|||
28091383|NCT00042432|54745069|FG000|Overall Study|Ineligibility determined|1|||
28091384|NCT00042432|54745070|FG001|Overall Study|Ineligibility determined|0|||
28091385|NCT00042432|54745069|FG000|Overall Study|Initiation of maintenance dialysis|1|||
28091386|NCT00042432|54745070|FG001|Overall Study|Initiation of maintenance dialysis|1|||
28167053|NCT02958865|54837608|FG001|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
28167054|NCT02958865|54837609|FG002|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
28167055|NCT02958865|54837610|FG003|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
28167056|NCT02958865|54837611|FG004|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
28167057|NCT02958865|54837612|FG005|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
28167058|NCT02958865|54837613|FG006|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
28167059|NCT02958865|54837614|FG007|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
28167060|NCT02958865|54837615|FG008|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
28167061|NCT02958865|54837616|FG009|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|1|||
28167062|NCT02958865|54837617|FG010|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
28091387|NCT00042432|54745069|FG000|Overall Study|Other|2|||
28091388|NCT00042432|54745070|FG001|Overall Study|Other|0|||
28091389|NCT00003474|54745076|FG000|Overall Study|Not Evaluable|14|||
28091390|NCT01542736|54745080|FG000|Overall Study|Death|1|||
28091391|NCT01346410|54745084|FG000|Overall Study|Death|1|||
28091392|NCT00003456|54745088|FG000|Overall Study|Not evaluable|8|||
28091393|NCT02719522|54745092|FG000|Overall Study|Implant Failure|4|||
28091394|NCT02719522|54745092|FG000|Overall Study|Death|2|||
28091395|NCT02719522|54745092|FG000|Overall Study|Lost to Follow-up|5|||
28091396|NCT00237185|54745098|FG000|Core|Adverse Event|3|||
28091397|NCT00237185|54745099|FG001|Core|Adverse Event|4|||
28091398|NCT00237185|54745098|FG000|Core|Abnormal laboratory value|0|||
28091399|NCT00237185|54745099|FG001|Core|Abnormal laboratory value|4|||
28091400|NCT00237185|54745098|FG000|Core|Abnormal test procedure results|1|||
28091401|NCT00237185|54745099|FG001|Core|Abnormal test procedure results|0|||
28091402|NCT00237185|54745098|FG000|Core|Lack of Efficacy|30|||
28091403|NCT00237185|54745099|FG001|Core|Lack of Efficacy|23|||
27833108|NCT04034238|54313532|FG003|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
27833109|NCT02716584|54313571|FG000|Overall Study|Lost to Follow-up|8|||
27833110|NCT02716584|54313572|FG001|Overall Study|Lost to Follow-up|5|||
27855762|NCT02733042|54382048|FG010|Follow-up Period|Other|0|||
28091404|NCT00237185|54745098|FG000|Core|Protocol Violation|1|||
28091405|NCT00237185|54745099|FG001|Core|Protocol Violation|1|||
28091406|NCT00237185|54745098|FG000|Core|Withdrawal by Subject|4|||
28091407|NCT00237185|54745099|FG001|Core|Withdrawal by Subject|4|||
28091408|NCT00237185|54745098|FG000|Core|Administrative problems|0|||
28091409|NCT00237185|54745099|FG001|Core|Administrative problems|1|||
28091410|NCT00237185|54745098|FG000|Core|Death|4|||
28091411|NCT00237185|54745099|FG001|Core|Death|0|||
28091412|NCT00237185|54745098|FG000|Core|Determined ineligible post randomization|1|||
28091413|NCT00237185|54745099|FG001|Core|Determined ineligible post randomization|0|||
28091414|NCT00237185|54745098|FG000|Extension|Adverse Event|1|||
28091415|NCT00237185|54745099|FG001|Extension|Adverse Event|0|||
28091416|NCT00237185|54745098|FG000|Extension|Abnormal laboratory value|0|||
28091417|NCT00237185|54745099|FG001|Extension|Abnormal laboratory value|1|||
28091418|NCT00237185|54745098|FG000|Extension|Lack of Efficacy|9|||
28091419|NCT00237185|54745099|FG001|Extension|Lack of Efficacy|14|||
28091420|NCT00237185|54745098|FG000|Extension|Condition no longer required study drug|0|||
28091421|NCT00237185|54745099|FG001|Extension|Condition no longer required study drug|1|||
28091422|NCT00237185|54745098|FG000|Extension|Withdrawal by Subject|3|||
28091423|NCT00237185|54745099|FG001|Extension|Withdrawal by Subject|2|||
28091424|NCT00237185|54745098|FG000|Extension|Lost to Follow-up|1|||
28091425|NCT00237185|54745099|FG001|Extension|Lost to Follow-up|0|||
28091426|NCT00237185|54745098|FG000|Extension|Administrative problems|1|||
28091427|NCT00237185|54745099|FG001|Extension|Administrative problems|0|||
28091428|NCT00237185|54745098|FG000|Extension|Death|1|||
28091429|NCT00237185|54745099|FG001|Extension|Death|1|||
28091430|NCT00003222|54745107|FG000|Overall Study|Physician Decision|0|||
28091431|NCT00003222|54745108|FG001|Overall Study|Physician Decision|1|||
28091432|NCT02877082|54745114|FG000|Overall Study|Trial was closed early|5|||
28091433|NCT02875834|54745122|FG000|Open-label Phase|Withdrawal by Subject|3|||
28167063|NCT02958865|54837618|FG011|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
28167064|NCT02958865|54837619|FG012|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
28167065|NCT02958865|54837620|FG013|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
28167066|NCT02958865|54837621|FG014|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
28167067|NCT02958865|54837622|FG015|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
28167068|NCT02958553|54837674|FG000|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1|||
28167069|NCT02958553|54837674|FG000|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2|||
28167070|NCT02501902|54837687|FG000|Overall Study|Subject Refused Further Follow-up|0|||
28167071|NCT02501902|54837688|FG001|Overall Study|Subject Refused Further Follow-up|0|||
28167072|NCT02501902|54837689|FG002|Overall Study|Subject Refused Further Follow-up|0|||
28167073|NCT02501902|54837690|FG003|Overall Study|Subject Refused Further Follow-up|0|||
28167074|NCT02501902|54837691|FG004|Overall Study|Subject Refused Further Follow-up|0|||
28167075|NCT02501902|54837692|FG005|Overall Study|Subject Refused Further Follow-up|0|||
28167076|NCT02501902|54837693|FG006|Overall Study|Subject Refused Further Follow-up|0|||
28167077|NCT02501902|54837694|FG007|Overall Study|Subject Refused Further Follow-up|1|||
28167078|NCT02501902|54837687|FG000|Overall Study|Study Terminated by Sponsor|0|||
28167079|NCT02501902|54837688|FG001|Overall Study|Study Terminated by Sponsor|3|||
28167080|NCT02501902|54837689|FG002|Overall Study|Study Terminated by Sponsor|0|||
28167081|NCT02501902|54837690|FG003|Overall Study|Study Terminated by Sponsor|1|||
28167082|NCT02501902|54837691|FG004|Overall Study|Study Terminated by Sponsor|1|||
28167083|NCT02501902|54837692|FG005|Overall Study|Study Terminated by Sponsor|0|||
28167084|NCT02501902|54837693|FG006|Overall Study|Study Terminated by Sponsor|2|||
28167085|NCT02501902|54837694|FG007|Overall Study|Study Terminated by Sponsor|4|||
28167086|NCT02501902|54837687|FG000|Overall Study|Death|3|||
28167087|NCT02501902|54837688|FG001|Overall Study|Death|4|||
28167088|NCT02501902|54837689|FG002|Overall Study|Death|4|||
28167089|NCT02501902|54837690|FG003|Overall Study|Death|10|||
28167090|NCT02501902|54837691|FG004|Overall Study|Death|10|||
28167091|NCT02501902|54837692|FG005|Overall Study|Death|11|||
28167092|NCT02501902|54837693|FG006|Overall Study|Death|7|||
28167093|NCT02501902|54837694|FG007|Overall Study|Death|15|||
28167094|NCT01955109|54837719|FG000|Overall Study|Adverse Event|2|||
28167095|NCT01955109|54837720|FG001|Overall Study|Adverse Event|0|||
28167096|NCT01955109|54837719|FG000|Overall Study|Participant unwilling to continue|35|||
28167097|NCT01955109|54837720|FG001|Overall Study|Participant unwilling to continue|7|||
28167098|NCT01955109|54837719|FG000|Overall Study|Physician Decision|2|||
28167099|NCT01955109|54837720|FG001|Overall Study|Physician Decision|0|||
28167100|NCT01955109|54837719|FG000|Overall Study|Lost to Follow-up|3|||
28167101|NCT01955109|54837720|FG001|Overall Study|Lost to Follow-up|1|||
28167102|NCT01955109|54837719|FG000|Overall Study|Non-compliance|3|||
28167103|NCT01955109|54837720|FG001|Overall Study|Non-compliance|1|||
28091434|NCT02875834|54745123|FG001|Open-label Phase|Withdrawal by Subject|0|||
28167104|NCT02500732|54837728|FG000|Overall Study|Physician Decision|0|||
28167105|NCT02500732|54837729|FG001|Overall Study|Physician Decision|1|||
28167106|NCT02518048|54837735|FG000|Overall Study|Withdrawal by Subject|1|||
28167107|NCT02499952|54837740|FG000|Overall Study|Lost to Follow-up|1|||
28167108|NCT02499952|54837740|FG000|Overall Study|Death|9|||
28167109|NCT02499406|54837744|FG000|Overall Study|missed 3 treatment sessions|4|||
28091435|NCT02875834|54745124|FG002|Open-label Phase|Withdrawal by Subject|0|||
28091436|NCT02875834|54745125|FG003|Open-label Phase|Withdrawal by Subject|0|||
28091437|NCT02875834|54745122|FG000|Open-label Phase|(Not collected)|4|||
28091438|NCT02875834|54745123|FG001|Open-label Phase|(Not collected)|0|||
28167110|NCT02499172|54837752|FG000|Overall Study|Financial reason|0|||
28167111|NCT02499172|54837753|FG001|Overall Study|Financial reason|0|||
27855763|NCT02733042|54382049|FG011|Follow-up Period|Other|0|||
28167112|NCT02499172|54837754|FG002|Overall Study|Financial reason|523|||
27855764|NCT02733042|54382050|FG012|Follow-up Period|Other|0|||
28091439|NCT02875834|54745124|FG002|Open-label Phase|(Not collected)|0|||
28091440|NCT02875834|54745125|FG003|Open-label Phase|(Not collected)|0|||
28091441|NCT02875834|54745122|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
28091442|NCT02875834|54745123|FG001|Randomized Treatment Phase|Withdrawal by Subject|3|||
28091443|NCT02875834|54745124|FG002|Randomized Treatment Phase|Withdrawal by Subject|1|||
28091444|NCT02875834|54745125|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
28091445|NCT02875834|54745122|FG000|Randomized Treatment Phase|Protocol Violation|0|||
28091446|NCT02875834|54745123|FG001|Randomized Treatment Phase|Protocol Violation|2|||
28091447|NCT02875834|54745124|FG002|Randomized Treatment Phase|Protocol Violation|0|||
28091448|NCT02875834|54745125|FG003|Randomized Treatment Phase|Protocol Violation|0|||
28091449|NCT02875834|54745122|FG000|Randomized Treatment Phase|(Not collected)|0|||
28091450|NCT02875834|54745123|FG001|Randomized Treatment Phase|(Not collected)|9|||
28091451|NCT02875834|54745124|FG002|Randomized Treatment Phase|(Not collected)|10|||
28091452|NCT02875834|54745125|FG003|Randomized Treatment Phase|(Not collected)|9|||
28091453|NCT02875366|54745137|FG000|Overall Study|Adverse Event|0|||
28091454|NCT02875366|54745138|FG001|Overall Study|Adverse Event|2|||
28091455|NCT02875366|54745137|FG000|Overall Study|Noncompliance|0|||
28091456|NCT02875366|54745138|FG001|Overall Study|Noncompliance|1|||
28091457|NCT00003102|54745147|FG000|Overall Study|Physician Decision|1|||
28091458|NCT00003102|54745148|FG001|Overall Study|Physician Decision|1|||
28091459|NCT00003102|54745149|FG002|Overall Study|Physician Decision|0|||
28091460|NCT00003102|54745147|FG000|Overall Study|Progressive Disease|0|||
28091461|NCT00003102|54745148|FG001|Overall Study|Progressive Disease|1|||
27980663|NCT02232737|54638659|FG002|Overall Study|Death|1|||
27980664|NCT02232737|54638657|FG000|Overall Study|Physician Decision|1|||
27980665|NCT02232737|54638658|FG001|Overall Study|Physician Decision|3|||
27980666|NCT02232737|54638659|FG002|Overall Study|Physician Decision|1|||
28091462|NCT00003102|54745149|FG002|Overall Study|Progressive Disease|0|||
28091463|NCT00003102|54745147|FG000|Overall Study|Adverse Event|0|||
28091464|NCT00003102|54745148|FG001|Overall Study|Adverse Event|1|||
28091465|NCT00003102|54745149|FG002|Overall Study|Adverse Event|1|||
28091466|NCT00003102|54745147|FG000|Overall Study|Death|0|||
28091467|NCT00003102|54745148|FG001|Overall Study|Death|0|||
28091468|NCT00003102|54745149|FG002|Overall Study|Death|1|||
28091469|NCT00002850|54745160|FG000|Overall Study|Death|4|||
28091470|NCT00002850|54745161|FG001|Overall Study|Death|1|||
28091471|NCT00002850|54745162|FG002|Overall Study|Death|3|||
28091472|NCT00002850|54745160|FG000|Overall Study|Protocol Violation|1|||
28091473|NCT00002850|54745161|FG001|Overall Study|Protocol Violation|0|||
28091474|NCT00002850|54745162|FG002|Overall Study|Protocol Violation|1|||
28091475|NCT00002850|54745160|FG000|Overall Study|Withdrawal by Subject|0|||
28091476|NCT00002850|54745161|FG001|Overall Study|Withdrawal by Subject|1|||
28091477|NCT00002850|54745162|FG002|Overall Study|Withdrawal by Subject|0|||
28091478|NCT00002766|54745172|FG000|Overall Study|Withdrawal by Subject|0|||
28091479|NCT00002766|54745173|FG001|Overall Study|Withdrawal by Subject|1|||
28091480|NCT00002766|54745172|FG000|Overall Study|Patient Not Treated|1|||
28091481|NCT00002766|54745173|FG001|Overall Study|Patient Not Treated|2|||
28091482|NCT00002766|54745172|FG000|Overall Study|Adverse Event|1|||
28091483|NCT00002766|54745173|FG001|Overall Study|Adverse Event|1|||
28091484|NCT00002766|54745172|FG000|Overall Study|Protocol Violation|1|||
28091485|NCT00002766|54745173|FG001|Overall Study|Protocol Violation|0|||
28091486|NCT02306122|54745186|FG000|Initial Physician Randomization|Physician Decision|0|||
28091487|NCT02306122|54745187|FG001|Initial Physician Randomization|Physician Decision|0|||
28091488|NCT02306122|54745188|FG002|Initial Physician Randomization|Physician Decision|0|||
28091489|NCT02306122|54745189|FG003|Initial Physician Randomization|Physician Decision|0|||
28091490|NCT02306122|54745190|FG004|Initial Physician Randomization|Physician Decision|0|||
28091491|NCT02306122|54745191|FG005|Initial Physician Randomization|Physician Decision|0|||
28091492|NCT02306122|54745192|FG006|Initial Physician Randomization|Physician Decision|0|||
28091493|NCT02306122|54745193|FG007|Initial Physician Randomization|Physician Decision|0|||
28091494|NCT02306122|54745194|FG008|Initial Physician Randomization|Physician Decision|1|||
28091495|NCT02306122|54745195|FG009|Initial Physician Randomization|Physician Decision|0|||
28091496|NCT02306122|54745196|FG010|Initial Physician Randomization|Physician Decision|0|||
28091497|NCT00001962|54745214|FG000|Overall Study|Lack of Efficacy|18|||
28091498|NCT00001962|54745214|FG000|Overall Study|Lack of Accrual|6|||
28091499|NCT00001962|54745214|FG000|Overall Study|Death|1|||
28091500|NCT00001962|54745214|FG000|Overall Study|Lost to Follow-up|2|||
28091501|NCT00001962|54745214|FG000|Overall Study|Adverse Event|1|||
28091502|NCT00028002|54745218|FG000|Overall Study|Withdrawal by Subject|3|||
28091503|NCT00028002|54745218|FG000|Overall Study|Ineligible|8|||
28091504|NCT00256997|54745225|FG000|Overall Study|Protocol Violation|1|||
27980667|NCT02232737|54638657|FG000|Overall Study|Protocol Violation|1|||
28091505|NCT00256997|54745226|FG001|Overall Study|Protocol Violation|4|||
28091506|NCT00256997|54745225|FG000|Overall Study|Lack of Efficacy|1|||
28091507|NCT00256997|54745226|FG001|Overall Study|Lack of Efficacy|4|||
28091508|NCT00256997|54745225|FG000|Overall Study|Death|2|||
27980668|NCT02232737|54638658|FG001|Overall Study|Protocol Violation|0|||
27980669|NCT02232737|54638659|FG002|Overall Study|Protocol Violation|1|||
28091509|NCT00256997|54745226|FG001|Overall Study|Death|0|||
28091510|NCT00256997|54745225|FG000|Overall Study|Adverse Event|4|||
28091511|NCT00256997|54745226|FG001|Overall Study|Adverse Event|0|||
28091512|NCT00256997|54745225|FG000|Overall Study|Lost to Follow-up|3|||
28091513|NCT00256997|54745226|FG001|Overall Study|Lost to Follow-up|5|||
27980670|NCT02232737|54638657|FG000|Overall Study|Reason unknown|1|||
27980671|NCT02232737|54638658|FG001|Overall Study|Reason unknown|0|||
27980672|NCT02232737|54638659|FG002|Overall Study|Reason unknown|0|||
27980673|NCT00952367|54638667|FG000|Overall Study|Withdrawal by Subject|2|||
27980674|NCT00952367|54638667|FG000|Overall Study|Noncoordination|1|||
27980675|NCT00952367|54638667|FG000|Overall Study|Protocol Violation|3|||
27980676|NCT00948857|54638673|FG000|Overall Study|Lost to Follow-up|1|||
27980677|NCT00948857|54638674|FG001|Overall Study|Lost to Follow-up|0|||
28091514|NCT00256997|54745225|FG000|Overall Study|Withdrawal by Subject|13|||
28091515|NCT00256997|54745226|FG001|Overall Study|Withdrawal by Subject|3|||
28091516|NCT00256997|54745225|FG000|Overall Study|Started but not treated|2|||
28091517|NCT00256997|54745226|FG001|Overall Study|Started but not treated|0|||
28091518|NCT00256997|54745225|FG000|Overall Study|Other|5|||
28091519|NCT00256997|54745226|FG001|Overall Study|Other|8|||
27733709|NCT02556632|54181407|FG001|Overall Study|Unrelated Adverse Event|0|||
27733710|NCT02556632|54181408|FG002|Overall Study|Unrelated Adverse Event|3|||
27733711|NCT02556632|54181406|FG000|Overall Study|Related Adverse Event|0|||
27733712|NCT02556632|54181407|FG001|Overall Study|Related Adverse Event|1|||
27733713|NCT02556632|54181408|FG002|Overall Study|Related Adverse Event|0|||
27733714|NCT02556632|54181406|FG000|Overall Study|Possibly Related Adverse Event|0|||
27733715|NCT02556632|54181407|FG001|Overall Study|Possibly Related Adverse Event|0|||
27733716|NCT02556632|54181408|FG002|Overall Study|Possibly Related Adverse Event|1|||
27733717|NCT02556632|54181406|FG000|Overall Study|Did Not Start RT|0|||
27733718|NCT02556632|54181407|FG001|Overall Study|Did Not Start RT|1|||
27833111|NCT02716194|54313653|FG000|Period 1 - ADVATE|Withdrawal by Subject|1|||
27833112|NCT02716194|54313654|FG001|Period 1 - ADVATE|Withdrawal by Subject|1|||
27833113|NCT02716194|54313655|FG002|Period 1 - ADVATE|Withdrawal by Subject|0|||
28091520|NCT00256997|54745225|FG000|Overall Study|End of Study (As Per Sponsor)|12|||
28091521|NCT00256997|54745226|FG001|Overall Study|End of Study (As Per Sponsor)|24|||
28091522|NCT00256997|54745225|FG000|Overall Study|Participant Non-compliant|3|||
28091523|NCT00256997|54745226|FG001|Overall Study|Participant Non-compliant|6|||
28091524|NCT00256997|54745225|FG000|Overall Study|Investigator Withdrew Participant|2|||
28091525|NCT00256997|54745226|FG001|Overall Study|Investigator Withdrew Participant|1|||
27833114|NCT03773484|54313725|FG000|Post-intervention|5 clinicians were excluded from analysis due to lack of prescribing data|5|||
27833115|NCT02715258|54313908|FG000|Overall Study|Withdrawal by Subject|6|||
27833116|NCT02715258|54313909|FG001|Overall Study|Withdrawal by Subject|1|||
27833117|NCT02715258|54313908|FG000|Overall Study|Lost to Follow-up|7|||
27833118|NCT02715258|54313909|FG001|Overall Study|Lost to Follow-up|1|||
27833119|NCT02715258|54313908|FG000|Overall Study|Terminated by Sponsor|0|||
27833120|NCT02715258|54313909|FG001|Overall Study|Terminated by Sponsor|1|||
28091526|NCT00027846|54745236|FG000|Overall Study|Lost to Follow-up|0|||
28091527|NCT00027846|54745237|FG001|Overall Study|Lost to Follow-up|41|||
28091528|NCT00027846|54745238|FG002|Overall Study|Lost to Follow-up|9|||
28091529|NCT00027846|54745236|FG000|Overall Study|Withdrawal by Subject|0|||
28091530|NCT00027846|54745237|FG001|Overall Study|Withdrawal by Subject|14|||
28091531|NCT00027846|54745238|FG002|Overall Study|Withdrawal by Subject|7|||
28091532|NCT00027846|54745236|FG000|Overall Study|Ineligible for study|2|||
28091533|NCT00027846|54745237|FG001|Overall Study|Ineligible for study|6|||
28167113|NCT02499172|54837755|FG003|Overall Study|Financial reason|436|||
28167114|NCT02499172|54837752|FG000|Overall Study|Lost to Follow-up|65|||
28167115|NCT02499172|54837753|FG001|Overall Study|Lost to Follow-up|64|||
28167116|NCT02499172|54837754|FG002|Overall Study|Lost to Follow-up|0|||
28167117|NCT02499172|54837755|FG003|Overall Study|Lost to Follow-up|0|||
28167118|NCT02498392|54837767|FG000|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|7|||
28167119|NCT02498392|54837768|FG001|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|0|||
28167120|NCT02498392|54837767|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|3|||
28167121|NCT02498392|54837768|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|0|||
27833121|NCT02715258|54313908|FG000|Overall Study|Death|0|||
27833122|NCT02715258|54313909|FG001|Overall Study|Death|1|||
27833123|NCT02715258|54313908|FG000|Overall Study|Subject non-compliant|1|||
27980678|NCT00948389|54638689|FG000|Overall Study|Disease Progression/Relapse/Death|3|||
27980679|NCT00948389|54638690|FG001|Overall Study|Disease Progression/Relapse/Death|3|||
27980680|NCT00948389|54638691|FG002|Overall Study|Disease Progression/Relapse/Death|7|||
27980681|NCT00948389|54638692|FG003|Overall Study|Disease Progression/Relapse/Death|8|||
27980682|NCT00948389|54638693|FG004|Overall Study|Disease Progression/Relapse/Death|1|||
28091534|NCT00027846|54745238|FG002|Overall Study|Ineligible for study|14|||
28091535|NCT00027846|54745236|FG000|Overall Study|Entry into another COG therapeutic study|0|||
28167122|NCT02498392|54837767|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|0|||
28091536|NCT00027846|54745237|FG001|Overall Study|Entry into another COG therapeutic study|5|||
28091537|NCT00027846|54745238|FG002|Overall Study|Entry into another COG therapeutic study|2|||
28091538|NCT00027846|54745236|FG000|Overall Study|Neuraxis dissemination during/after ther|0|||
28091539|NCT00027846|54745237|FG001|Overall Study|Neuraxis dissemination during/after ther|2|||
28091540|NCT00027846|54745238|FG002|Overall Study|Neuraxis dissemination during/after ther|5|||
28091541|NCT00027378|54745250|FG000|Overall Study|Physician Decision|0|||
28091542|NCT00027378|54745251|FG001|Overall Study|Physician Decision|3|||
28091543|NCT00235391|54745263|FG000|Overall Study|Adverse Event|4|||
28091544|NCT00235391|54745264|FG001|Overall Study|Adverse Event|5|||
28091545|NCT00235391|54745265|FG002|Overall Study|Adverse Event|10|||
28091546|NCT00235391|54745266|FG003|Overall Study|Adverse Event|72|||
28091547|NCT00235391|54745267|FG004|Overall Study|Adverse Event|5|||
28091548|NCT00235391|54745268|FG005|Overall Study|Adverse Event|2|||
28091549|NCT00235391|54745263|FG000|Overall Study|Abnormal laboratory value(s)|3|||
28091550|NCT00235391|54745264|FG001|Overall Study|Abnormal laboratory value(s)|5|||
28091551|NCT00235391|54745265|FG002|Overall Study|Abnormal laboratory value(s)|4|||
28091552|NCT00235391|54745266|FG003|Overall Study|Abnormal laboratory value(s)|27|||
28091553|NCT00235391|54745267|FG004|Overall Study|Abnormal laboratory value(s)|1|||
28091554|NCT00235391|54745268|FG005|Overall Study|Abnormal laboratory value(s)|2|||
28091555|NCT00235391|54745263|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
28091556|NCT00235391|54745264|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
28091557|NCT00235391|54745265|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
28091558|NCT00235391|54745266|FG003|Overall Study|Unsatisfactory therapeutic effect|17|||
28167123|NCT02498392|54837768|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|2|||
28167124|NCT02498392|54837767|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|0|||
28167125|NCT02498392|54837768|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|2|||
28167126|NCT02498392|54837767|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|2|||
28167127|NCT02498392|54837768|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|3|||
28167128|NCT02498392|54837767|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Other|1|||
28167129|NCT02498392|54837768|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Other|3|||
28167130|NCT03205605|54837776|FG000|Overall Study|Withdrawal by Subject|1|||
28167131|NCT02498236|54837794|FG000|Overall Study|Did not show for testing|1|||
28167132|NCT02498236|54837795|FG001|Overall Study|Did not show for testing|0|||
28167133|NCT02498236|54837796|FG002|Overall Study|Did not show for testing|0|||
28167134|NCT02498236|54837797|FG003|Overall Study|Did not show for testing|0|||
28167135|NCT02498236|54837798|FG004|Overall Study|Did not show for testing|0|||
28167136|NCT02498236|54837799|FG005|Overall Study|Did not show for testing|0|||
28167137|NCT02498236|54837800|FG006|Overall Study|Did not show for testing|0|||
28167138|NCT02498236|54837801|FG007|Overall Study|Did not show for testing|1|||
28167139|NCT02498236|54837794|FG000|Overall Study|Equipment failure|0|||
28167140|NCT02498236|54837795|FG001|Overall Study|Equipment failure|0|||
28167141|NCT02498236|54837796|FG002|Overall Study|Equipment failure|0|||
28167142|NCT02498236|54837797|FG003|Overall Study|Equipment failure|0|||
28167143|NCT02498236|54837798|FG004|Overall Study|Equipment failure|0|||
28167144|NCT02498236|54837799|FG005|Overall Study|Equipment failure|0|||
28167145|NCT02498236|54837800|FG006|Overall Study|Equipment failure|1|||
28167146|NCT02498236|54837801|FG007|Overall Study|Equipment failure|0|||
28167147|NCT02498236|54837794|FG000|Overall Study|Withdrawal by Subject|0|||
28167148|NCT02498236|54837795|FG001|Overall Study|Withdrawal by Subject|0|||
28167149|NCT02498236|54837796|FG002|Overall Study|Withdrawal by Subject|0|||
28167150|NCT02498236|54837797|FG003|Overall Study|Withdrawal by Subject|0|||
28167151|NCT02498236|54837798|FG004|Overall Study|Withdrawal by Subject|1|||
28167152|NCT02498236|54837799|FG005|Overall Study|Withdrawal by Subject|0|||
28167153|NCT02498236|54837800|FG006|Overall Study|Withdrawal by Subject|0|||
28167154|NCT02498236|54837801|FG007|Overall Study|Withdrawal by Subject|0|||
28167155|NCT02496676|54837824|FG000|Phase 1 - Period 1|Adverse Event|0|||
28167156|NCT02496676|54837825|FG001|Phase 1 - Period 1|Adverse Event|1|||
28167157|NCT02496676|54837824|FG000|Phase 2 - IV MgSO4|Adverse Event|0|||
28167158|NCT02496676|54837825|FG001|Phase 2 - IV MgSO4|Adverse Event|1|||
28167159|NCT02517268|54837841|FG000|Overall Study|Withdrawal by Subject|1|||
28167160|NCT02517268|54837842|FG001|Overall Study|Withdrawal by Subject|0|||
28167161|NCT01160211|54837851|FG000|Overall Study|ongoing|90|||
28167162|NCT01160211|54837852|FG001|Overall Study|ongoing|75|||
28167163|NCT01160211|54837853|FG002|Overall Study|ongoing|79|||
28167164|NCT01160211|54837851|FG000|Overall Study|Withdrawal by Subject|3|||
28167165|NCT01160211|54837852|FG001|Overall Study|Withdrawal by Subject|5|||
28167166|NCT01160211|54837853|FG002|Overall Study|Withdrawal by Subject|3|||
28167167|NCT01160211|54837851|FG000|Overall Study|Physician Decision|2|||
27733719|NCT02556632|54181408|FG002|Overall Study|Did Not Start RT|0|||
28091559|NCT00235391|54745267|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
28091560|NCT00235391|54745268|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
28091561|NCT00235391|54745263|FG000|Overall Study|Condition no longer requires treatment|3|||
28167168|NCT01160211|54837852|FG001|Overall Study|Physician Decision|0|||
28167169|NCT01160211|54837853|FG002|Overall Study|Physician Decision|0|||
28167170|NCT01160211|54837851|FG000|Overall Study|Lost to Follow-up|4|||
28167171|NCT01160211|54837852|FG001|Overall Study|Lost to Follow-up|7|||
28167172|NCT01160211|54837853|FG002|Overall Study|Lost to Follow-up|5|||
28091562|NCT00235391|54745264|FG001|Overall Study|Condition no longer requires treatment|0|||
28091563|NCT00235391|54745265|FG002|Overall Study|Condition no longer requires treatment|0|||
28091564|NCT00235391|54745266|FG003|Overall Study|Condition no longer requires treatment|11|||
28091565|NCT00235391|54745267|FG004|Overall Study|Condition no longer requires treatment|1|||
28091566|NCT00235391|54745268|FG005|Overall Study|Condition no longer requires treatment|0|||
28091567|NCT00235391|54745263|FG000|Overall Study|Protocol deviation|0|||
28091568|NCT00235391|54745264|FG001|Overall Study|Protocol deviation|0|||
28091569|NCT00235391|54745265|FG002|Overall Study|Protocol deviation|1|||
28091570|NCT00235391|54745266|FG003|Overall Study|Protocol deviation|11|||
28091571|NCT00235391|54745267|FG004|Overall Study|Protocol deviation|0|||
28091572|NCT00235391|54745268|FG005|Overall Study|Protocol deviation|0|||
28091573|NCT00235391|54745263|FG000|Overall Study|Withdrawal by Subject|2|||
28091574|NCT00235391|54745264|FG001|Overall Study|Withdrawal by Subject|3|||
28091575|NCT00235391|54745265|FG002|Overall Study|Withdrawal by Subject|3|||
28091576|NCT00235391|54745266|FG003|Overall Study|Withdrawal by Subject|61|||
28091577|NCT00235391|54745267|FG004|Overall Study|Withdrawal by Subject|5|||
28091578|NCT00235391|54745268|FG005|Overall Study|Withdrawal by Subject|0|||
28091579|NCT00235391|54745263|FG000|Overall Study|Lost to Follow-up|0|||
28091580|NCT00235391|54745264|FG001|Overall Study|Lost to Follow-up|3|||
28091581|NCT00235391|54745265|FG002|Overall Study|Lost to Follow-up|3|||
28091582|NCT00235391|54745266|FG003|Overall Study|Lost to Follow-up|16|||
28091583|NCT00235391|54745267|FG004|Overall Study|Lost to Follow-up|0|||
28091584|NCT00235391|54745268|FG005|Overall Study|Lost to Follow-up|0|||
28091585|NCT00235391|54745263|FG000|Overall Study|Administrative problems|0|||
28091586|NCT00235391|54745264|FG001|Overall Study|Administrative problems|0|||
28091587|NCT00235391|54745265|FG002|Overall Study|Administrative problems|0|||
28091588|NCT00235391|54745266|FG003|Overall Study|Administrative problems|1|||
28091589|NCT00235391|54745267|FG004|Overall Study|Administrative problems|0|||
28091590|NCT00235391|54745268|FG005|Overall Study|Administrative problems|0|||
28091591|NCT00235391|54745263|FG000|Overall Study|Death|0|||
28091592|NCT00235391|54745264|FG001|Overall Study|Death|0|||
28091593|NCT00235391|54745265|FG002|Overall Study|Death|1|||
28091594|NCT00235391|54745266|FG003|Overall Study|Death|4|||
28091595|NCT00235391|54745267|FG004|Overall Study|Death|0|||
28091596|NCT00235391|54745268|FG005|Overall Study|Death|0|||
28091597|NCT00234533|54745312|FG000|Overall Study|Withdrawal by Subject|6|||
28091598|NCT00234533|54745312|FG000|Overall Study|Adverse Event|2|||
28091599|NCT00234533|54745312|FG000|Overall Study|Enrolled but not treated|3|||
28091600|NCT00026208|54745319|FG000|Overall Study|Complications of auto accident|1|||
28091601|NCT00026208|54745320|FG001|Overall Study|Complications of auto accident|0|||
28091602|NCT00025662|54745326|FG000|Overall Study|Withdrawal by Subject|2|||
28091603|NCT00025662|54745326|FG000|Overall Study|Technical failure of manipulation|1|||
28091604|NCT00025506|54745330|FG000|Overall Study|Ineligible: clerical error|1|||
28091605|NCT00025506|54745330|FG000|Overall Study|Ineligible: wrong cell type|5|||
28091606|NCT00025506|54745330|FG000|Overall Study|Ineligible: inadequate pathology|2|||
28091607|NCT00025506|54745330|FG000|Overall Study|Never Treated|2|||
28091608|NCT00024258|54745339|FG000|Overall Study|Withdrawal by Subject|1|||
28091609|NCT00024258|54745339|FG000|Overall Study|Disease Progression|8|||
28091610|NCT00023712|54745345|FG000|Overall Study|Not platinum sensitive|1|||
28091611|NCT00023712|54745346|FG001|Overall Study|Not platinum sensitive|0|||
28091612|NCT00023712|54745345|FG000|Overall Study|Never treated|1|||
28091613|NCT00023712|54745346|FG001|Overall Study|Never treated|1|||
28091614|NCT00023322|54745362|FG000|Overall Study|Lost to Follow-up|1|||
28091615|NCT04640168|54745368|FG000|Overall Study|Withdrawal by Subject|8|||
28091616|NCT04640168|54745369|FG001|Overall Study|Withdrawal by Subject|7|||
28091617|NCT04640168|54745368|FG000|Overall Study|Lost to Follow-up|1|||
28091618|NCT04640168|54745369|FG001|Overall Study|Lost to Follow-up|0|||
28091619|NCT04640168|54745368|FG000|Overall Study|Enrolled but not treated|12|||
28091620|NCT04640168|54745369|FG001|Overall Study|Enrolled but not treated|12|||
28091621|NCT00022698|54745377|FG000|Overall Study|Adverse Event|5|||
28091622|NCT00022698|54745378|FG001|Overall Study|Adverse Event|9|||
28091623|NCT00022698|54745377|FG000|Overall Study|Death|0|||
28091624|NCT00022698|54745378|FG001|Overall Study|Death|2|||
28091625|NCT00022698|54745377|FG000|Overall Study|Failure to return|0|||
28091626|NCT00022698|54745378|FG001|Overall Study|Failure to return|1|||
28091627|NCT00022698|54745377|FG000|Overall Study|Refused treatment|0|||
28091628|NCT00022698|54745378|FG001|Overall Study|Refused treatment|2|||
28091629|NCT00022698|54745377|FG000|Overall Study|Insufficient therapeutic response|2|||
27733720|NCT02556632|54181406|FG000|Overall Study|Ineligible|0|||
27733721|NCT02556632|54181407|FG001|Overall Study|Ineligible|1|||
28091630|NCT00022698|54745378|FG001|Overall Study|Insufficient therapeutic response|14|||
28091631|NCT00022698|54745377|FG000|Overall Study|Administrative /other|1|||
28091632|NCT00022698|54745378|FG001|Overall Study|Administrative /other|7|||
28091633|NCT04625972|54745388|FG000|Overall Study|Physician Decision|1|||
28091634|NCT04625972|54745389|FG001|Overall Study|Physician Decision|0|||
28091635|NCT04625972|54745388|FG000|Overall Study|Protocol Violation|0|||
28091636|NCT04625972|54745389|FG001|Overall Study|Protocol Violation|1|||
28091637|NCT04625972|54745388|FG000|Overall Study|Ongoing in Study|741|||
28091638|NCT04625972|54745389|FG001|Overall Study|Ongoing in Study|369|||
28091639|NCT04625972|54745388|FG000|Overall Study|Lost to Follow-up|2|||
28091640|NCT04625972|54745389|FG001|Overall Study|Lost to Follow-up|0|||
28091641|NCT04625972|54745388|FG000|Overall Study|"Includes participants who discontinued early with reason other selected."|5|||
28091642|NCT04625972|54745389|FG001|Overall Study|"Includes participants who discontinued early with reason other selected."|2|||
28091643|NCT04625972|54745388|FG000|Overall Study|Withdrawal by Subject|7|||
28091644|NCT04625972|54745389|FG001|Overall Study|Withdrawal by Subject|3|||
28091645|NCT00234065|54745397|FG000|Overall Study|Adverse Event|268|||
28091646|NCT00234065|54745398|FG001|Overall Study|Adverse Event|166|||
28091647|NCT00234065|54745397|FG000|Overall Study|Withdrawal by Subject|73|||
28091648|NCT00234065|54745398|FG001|Overall Study|Withdrawal by Subject|56|||
28091649|NCT00234065|54745397|FG000|Overall Study|Physician Decision|23|||
28091650|NCT00234065|54745398|FG001|Overall Study|Physician Decision|22|||
28091651|NCT00234065|54745397|FG000|Overall Study|Not Classified|111|||
28091652|NCT00234065|54745398|FG001|Overall Study|Not Classified|112|||
28091653|NCT00233987|54745404|FG000|Overall Study|Withdrawal by Subject|1|||
28091654|NCT00233987|54745404|FG000|Overall Study|Lack of Efficacy|2|||
28091655|NCT00233987|54745404|FG000|Overall Study|Reason Under Review|1|||
28091656|NCT00233987|54745404|FG000|Overall Study|Other - Not Protocol Specified|5|||
28091657|NCT00233987|54745404|FG000|Overall Study|Eligible but No Treatment Received|2|||
28091658|NCT00233987|54745404|FG000|Overall Study|Ineligible|4|||
28091659|NCT04623242|54745413|FG000|Overall Study|Withdrawal by Subject|7|||
28091660|NCT04623242|54745414|FG001|Overall Study|Withdrawal by Subject|12|||
28091661|NCT04623242|54745415|FG002|Overall Study|Withdrawal by Subject|5|||
28091662|NCT04623242|54745416|FG003|Overall Study|Withdrawal by Subject|7|||
28091663|NCT04623242|54745417|FG004|Overall Study|Withdrawal by Subject|0|||
28091664|NCT04623242|54745413|FG000|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|6|||
28091665|NCT04623242|54745414|FG001|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|4|||
28091666|NCT04623242|54745415|FG002|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|5|||
28091667|NCT04623242|54745416|FG003|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|3|||
28091668|NCT04623242|54745417|FG004|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|0|||
28091669|NCT04623242|54745413|FG000|Overall Study|Subject unblinded to mutation status|0|||
28091670|NCT04623242|54745414|FG001|Overall Study|Subject unblinded to mutation status|0|||
28091671|NCT04623242|54745415|FG002|Overall Study|Subject unblinded to mutation status|0|||
28091672|NCT04623242|54745416|FG003|Overall Study|Subject unblinded to mutation status|13|||
28091673|NCT04623242|54745417|FG004|Overall Study|Subject unblinded to mutation status|0|||
28091674|NCT00233363|54745434|FG000|Overall Study|Adverse Event|1|||
28167173|NCT01064687|54837866|FG000|Overall Study|Adverse Event|9|||
28167174|NCT01064687|54837867|FG001|Overall Study|Adverse Event|4|||
28167175|NCT01064687|54837868|FG002|Overall Study|Adverse Event|10|||
28167176|NCT01064687|54837869|FG003|Overall Study|Adverse Event|3|||
28167177|NCT01064687|54837866|FG000|Overall Study|Death|1|||
28167178|NCT01064687|54837867|FG001|Overall Study|Death|1|||
28167179|NCT01064687|54837868|FG002|Overall Study|Death|0|||
28167180|NCT01064687|54837869|FG003|Overall Study|Death|0|||
28167181|NCT01064687|54837866|FG000|Overall Study|Entry Criteria Not Met|3|||
28167182|NCT01064687|54837867|FG001|Overall Study|Entry Criteria Not Met|0|||
28167183|NCT01064687|54837868|FG002|Overall Study|Entry Criteria Not Met|0|||
28167184|NCT01064687|54837869|FG003|Overall Study|Entry Criteria Not Met|0|||
28167185|NCT01064687|54837866|FG000|Overall Study|Lack of Efficacy|1|||
28167186|NCT01064687|54837867|FG001|Overall Study|Lack of Efficacy|0|||
28167187|NCT01064687|54837868|FG002|Overall Study|Lack of Efficacy|2|||
28167188|NCT01064687|54837869|FG003|Overall Study|Lack of Efficacy|3|||
28167189|NCT01064687|54837866|FG000|Overall Study|Lost to Follow-up|7|||
28167190|NCT01064687|54837867|FG001|Overall Study|Lost to Follow-up|10|||
28167191|NCT01064687|54837868|FG002|Overall Study|Lost to Follow-up|13|||
28167192|NCT01064687|54837869|FG003|Overall Study|Lost to Follow-up|5|||
28167193|NCT01064687|54837866|FG000|Overall Study|Physician Decision|2|||
28167194|NCT01064687|54837867|FG001|Overall Study|Physician Decision|2|||
28167195|NCT01064687|54837868|FG002|Overall Study|Physician Decision|0|||
28091675|NCT00233363|54745435|FG001|Overall Study|Adverse Event|2|||
28091676|NCT00233363|54745434|FG000|Overall Study|Lack of Efficacy|0|||
28091677|NCT00233363|54745435|FG001|Overall Study|Lack of Efficacy|2|||
28091678|NCT00233363|54745434|FG000|Overall Study|Withdrawal by Subject|1|||
28091679|NCT00233363|54745435|FG001|Overall Study|Withdrawal by Subject|1|||
28091680|NCT00233363|54745434|FG000|Overall Study|Aggravation of complication|1|||
28091681|NCT00233363|54745435|FG001|Overall Study|Aggravation of complication|0|||
28091682|NCT01147666|54745456|FG000|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
28167196|NCT01064687|54837869|FG003|Overall Study|Physician Decision|0|||
28167197|NCT01064687|54837866|FG000|Overall Study|Protocol Violation|1|||
28167198|NCT01064687|54837867|FG001|Overall Study|Protocol Violation|1|||
28167199|NCT01064687|54837868|FG002|Overall Study|Protocol Violation|0|||
28167200|NCT01064687|54837869|FG003|Overall Study|Protocol Violation|1|||
28167201|NCT01064687|54837866|FG000|Overall Study|Sponsor Decision|0|||
28167202|NCT01064687|54837867|FG001|Overall Study|Sponsor Decision|0|||
28091683|NCT01147666|54745457|FG001|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
28091684|NCT01147666|54745458|FG002|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
28091685|NCT01147666|54745459|FG003|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
28091686|NCT01147666|54745460|FG004|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
28091687|NCT01147666|54745461|FG005|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
28091688|NCT01147666|54745462|FG006|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
28091689|NCT01147666|54745463|FG007|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
28091690|NCT01147666|54745464|FG008|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
28091691|NCT01147666|54745465|FG009|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
28091692|NCT01147666|54745466|FG010|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
28091693|NCT01147666|54745467|FG011|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
28091694|NCT01147666|54745468|FG012|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
28091695|NCT01147666|54745469|FG013|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
28091696|NCT01147666|54745470|FG014|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
28091697|NCT01147666|54745456|FG000|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
28091698|NCT01147666|54745457|FG001|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
28091699|NCT01147666|54745458|FG002|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
28091700|NCT01147666|54745459|FG003|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
28091701|NCT01147666|54745460|FG004|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
28091702|NCT01147666|54745461|FG005|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
28091703|NCT01147666|54745462|FG006|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
28091704|NCT01147666|54745463|FG007|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
28091705|NCT01147666|54745464|FG008|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
28091706|NCT01147666|54745465|FG009|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
28091707|NCT01147666|54745466|FG010|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
28091708|NCT01147666|54745467|FG011|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
28091709|NCT01147666|54745468|FG012|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
28091710|NCT01147666|54745469|FG013|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
28091711|NCT01147666|54745470|FG014|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
28091712|NCT01147666|54745456|FG000|Dosing Period 1: 6-Week Treatment|Death|0|||
28091713|NCT01147666|54745457|FG001|Dosing Period 1: 6-Week Treatment|Death|0|||
28091714|NCT01147666|54745458|FG002|Dosing Period 1: 6-Week Treatment|Death|0|||
28091715|NCT01147666|54745459|FG003|Dosing Period 1: 6-Week Treatment|Death|0|||
28091716|NCT01147666|54745460|FG004|Dosing Period 1: 6-Week Treatment|Death|1|||
28091717|NCT01147666|54745461|FG005|Dosing Period 1: 6-Week Treatment|Death|1|||
28091718|NCT01147666|54745462|FG006|Dosing Period 1: 6-Week Treatment|Death|1|||
28091719|NCT01147666|54745463|FG007|Dosing Period 1: 6-Week Treatment|Death|0|||
28091720|NCT01147666|54745464|FG008|Dosing Period 1: 6-Week Treatment|Death|0|||
28091721|NCT01147666|54745465|FG009|Dosing Period 1: 6-Week Treatment|Death|0|||
28091722|NCT01147666|54745466|FG010|Dosing Period 1: 6-Week Treatment|Death|0|||
28091723|NCT01147666|54745467|FG011|Dosing Period 1: 6-Week Treatment|Death|0|||
28091724|NCT01147666|54745468|FG012|Dosing Period 1: 6-Week Treatment|Death|1|||
28091725|NCT01147666|54745469|FG013|Dosing Period 1: 6-Week Treatment|Death|0|||
28091726|NCT01147666|54745470|FG014|Dosing Period 1: 6-Week Treatment|Death|0|||
28091727|NCT01147666|54745456|FG000|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
28091728|NCT01147666|54745457|FG001|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
28091729|NCT01147666|54745458|FG002|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
28091730|NCT01147666|54745459|FG003|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
28091731|NCT01147666|54745460|FG004|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
28091732|NCT01147666|54745461|FG005|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
28091733|NCT01147666|54745462|FG006|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
28091734|NCT01147666|54745463|FG007|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
28091735|NCT01147666|54745464|FG008|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
28091736|NCT01147666|54745465|FG009|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
28091737|NCT01147666|54745466|FG010|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
28091738|NCT01147666|54745467|FG011|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
28091739|NCT01147666|54745468|FG012|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
28091740|NCT01147666|54745469|FG013|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
28091741|NCT01147666|54745470|FG014|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
28091742|NCT01147666|54745456|FG000|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
28091743|NCT01147666|54745457|FG001|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
28091744|NCT01147666|54745458|FG002|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
28091745|NCT01147666|54745459|FG003|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
28091746|NCT01147666|54745460|FG004|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
28091747|NCT01147666|54745461|FG005|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
28091748|NCT01147666|54745462|FG006|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
28091749|NCT01147666|54745463|FG007|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
28091750|NCT01147666|54745464|FG008|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
28091751|NCT01147666|54745465|FG009|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
28091752|NCT01147666|54745466|FG010|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
28091753|NCT01147666|54745467|FG011|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
28091754|NCT01147666|54745468|FG012|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
28091755|NCT01147666|54745469|FG013|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
28091756|NCT01147666|54745470|FG014|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
28091757|NCT01147666|54745456|FG000|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
28091758|NCT01147666|54745457|FG001|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
28091759|NCT01147666|54745458|FG002|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
27980683|NCT00948389|54638689|FG000|Overall Study|Thrombocytopenia, Grade 4|2|||
27980684|NCT00948389|54638690|FG001|Overall Study|Thrombocytopenia, Grade 4|0|||
27980685|NCT00948389|54638691|FG002|Overall Study|Thrombocytopenia, Grade 4|0|||
27980686|NCT00948389|54638692|FG003|Overall Study|Thrombocytopenia, Grade 4|1|||
27980687|NCT00948389|54638693|FG004|Overall Study|Thrombocytopenia, Grade 4|0|||
27980688|NCT00948389|54638689|FG000|Overall Study|Both Progression and Toxicity|1|||
27980689|NCT00948389|54638690|FG001|Overall Study|Both Progression and Toxicity|0|||
27980690|NCT00948389|54638691|FG002|Overall Study|Both Progression and Toxicity|0|||
27980691|NCT00948389|54638692|FG003|Overall Study|Both Progression and Toxicity|0|||
27980692|NCT00948389|54638693|FG004|Overall Study|Both Progression and Toxicity|0|||
27980693|NCT00948155|54638709|FG000|First Intervention 21 Days|Lost to Follow-up|2|||
27980694|NCT00948155|54638710|FG001|First Intervention 21 Days|Lost to Follow-up|2|||
28091760|NCT01147666|54745459|FG003|Dosing Period 1: 6-Week Treatment|Other than specified|1|||
28091761|NCT01147666|54745460|FG004|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
28091762|NCT01147666|54745461|FG005|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
28091763|NCT01147666|54745462|FG006|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
28091764|NCT01147666|54745463|FG007|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
28091765|NCT01147666|54745464|FG008|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
28091766|NCT01147666|54745465|FG009|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
28091767|NCT01147666|54745466|FG010|Dosing Period 1: 6-Week Treatment|Other than specified|2|||
28091768|NCT01147666|54745467|FG011|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
28091769|NCT01147666|54745468|FG012|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
28091770|NCT01147666|54745469|FG013|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
28091771|NCT01147666|54745470|FG014|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
28091772|NCT01147666|54745456|FG000|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
28091773|NCT01147666|54745457|FG001|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
28167203|NCT01064687|54837868|FG002|Overall Study|Sponsor Decision|3|||
28167204|NCT01064687|54837869|FG003|Overall Study|Sponsor Decision|0|||
28167205|NCT01064687|54837866|FG000|Overall Study|Withdrawal by Subject|9|||
28167206|NCT01064687|54837867|FG001|Overall Study|Withdrawal by Subject|7|||
28167207|NCT01064687|54837868|FG002|Overall Study|Withdrawal by Subject|12|||
28167208|NCT01064687|54837869|FG003|Overall Study|Withdrawal by Subject|5|||
28167209|NCT01064687|54837866|FG000|Overall Study|Treatment Noncompliance|1|||
28167210|NCT01064687|54837867|FG001|Overall Study|Treatment Noncompliance|1|||
28167211|NCT01064687|54837868|FG002|Overall Study|Treatment Noncompliance|1|||
28167212|NCT01064687|54837869|FG003|Overall Study|Treatment Noncompliance|0|||
28167213|NCT02493946|54837893|FG000|DB Period|Withdrawal by Subject|8|||
28167214|NCT02493946|54837894|FG001|DB Period|Withdrawal by Subject|5|||
28167215|NCT02493946|54837895|FG002|DB Period|Withdrawal by Subject|0|||
28167216|NCT02493946|54837893|FG000|Open Label Period|Withdrawal by Subject|0|||
28167217|NCT02493946|54837894|FG001|Open Label Period|Withdrawal by Subject|0|||
28167218|NCT02493946|54837895|FG002|Open Label Period|Withdrawal by Subject|74|||
28167219|NCT02493946|54837893|FG000|Open Label Period|Adverse Event|0|||
28167220|NCT02493946|54837894|FG001|Open Label Period|Adverse Event|0|||
28167221|NCT02493946|54837895|FG002|Open Label Period|Adverse Event|4|||
28167222|NCT02493946|54837893|FG000|Open Label Period|Lost to Follow-up|0|||
28167223|NCT02493946|54837894|FG001|Open Label Period|Lost to Follow-up|0|||
28167224|NCT02493946|54837895|FG002|Open Label Period|Lost to Follow-up|1|||
28167225|NCT02493946|54837893|FG000|Open Label Period|Investigator decision, non-compliance|0|||
28167226|NCT02493946|54837894|FG001|Open Label Period|Investigator decision, non-compliance|0|||
28167227|NCT02493946|54837895|FG002|Open Label Period|Investigator decision, non-compliance|2|||
28167228|NCT02493946|54837893|FG000|Open Label Period|Investigator decision, non-availability|0|||
28167229|NCT02493946|54837894|FG001|Open Label Period|Investigator decision, non-availability|0|||
27733722|NCT02556632|54181408|FG002|Overall Study|Ineligible|0|||
27733723|NCT02556632|54181406|FG000|Overall Study|Disliked Study Procedures|0|||
27980695|NCT00948155|54638709|FG000|Washout 14 Days|Lost to Follow-up|1|||
28091774|NCT01147666|54745458|FG002|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
28091775|NCT01147666|54745459|FG003|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
28167230|NCT02493946|54837895|FG002|Open Label Period|Investigator decision, non-availability|1|||
28167231|NCT02493946|54837893|FG000|Open Label Period|Pregnancy|0|||
28167232|NCT02493946|54837894|FG001|Open Label Period|Pregnancy|0|||
28167233|NCT02493946|54837895|FG002|Open Label Period|Pregnancy|3|||
28091776|NCT01147666|54745460|FG004|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
28091777|NCT01147666|54745461|FG005|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
28091778|NCT01147666|54745462|FG006|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
28091779|NCT01147666|54745463|FG007|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
28091780|NCT01147666|54745464|FG008|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
28091781|NCT01147666|54745465|FG009|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
28091782|NCT01147666|54745466|FG010|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
28091783|NCT01147666|54745467|FG011|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
28091784|NCT01147666|54745468|FG012|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
28091785|NCT01147666|54745469|FG013|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
28091786|NCT01147666|54745470|FG014|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
28091787|NCT01147666|54745456|FG000|Dosing Period 2: 19-Week Treatment|Death|0|||
28091788|NCT01147666|54745457|FG001|Dosing Period 2: 19-Week Treatment|Death|0|||
28091789|NCT01147666|54745458|FG002|Dosing Period 2: 19-Week Treatment|Death|0|||
28091790|NCT01147666|54745459|FG003|Dosing Period 2: 19-Week Treatment|Death|0|||
28091791|NCT01147666|54745460|FG004|Dosing Period 2: 19-Week Treatment|Death|1|||
28091792|NCT01147666|54745461|FG005|Dosing Period 2: 19-Week Treatment|Death|1|||
28091793|NCT01147666|54745462|FG006|Dosing Period 2: 19-Week Treatment|Death|1|||
28091794|NCT01147666|54745463|FG007|Dosing Period 2: 19-Week Treatment|Death|0|||
28091795|NCT01147666|54745464|FG008|Dosing Period 2: 19-Week Treatment|Death|0|||
28091796|NCT01147666|54745465|FG009|Dosing Period 2: 19-Week Treatment|Death|0|||
28091797|NCT01147666|54745466|FG010|Dosing Period 2: 19-Week Treatment|Death|0|||
28091798|NCT01147666|54745467|FG011|Dosing Period 2: 19-Week Treatment|Death|0|||
28091799|NCT01147666|54745468|FG012|Dosing Period 2: 19-Week Treatment|Death|1|||
28091800|NCT01147666|54745469|FG013|Dosing Period 2: 19-Week Treatment|Death|0|||
28091801|NCT01147666|54745470|FG014|Dosing Period 2: 19-Week Treatment|Death|0|||
28091802|NCT01147666|54745456|FG000|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
28091803|NCT01147666|54745457|FG001|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
28091804|NCT01147666|54745458|FG002|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
28091805|NCT01147666|54745459|FG003|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
28091806|NCT01147666|54745460|FG004|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|3|||
28091807|NCT01147666|54745461|FG005|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
28091808|NCT01147666|54745462|FG006|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
28091809|NCT01147666|54745463|FG007|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
28091810|NCT01147666|54745464|FG008|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
28091811|NCT01147666|54745465|FG009|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
28091812|NCT01147666|54745466|FG010|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
28091813|NCT01147666|54745467|FG011|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
28091814|NCT01147666|54745468|FG012|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
28091815|NCT01147666|54745469|FG013|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
28091816|NCT01147666|54745470|FG014|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
28091817|NCT01147666|54745456|FG000|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
28091818|NCT01147666|54745457|FG001|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
28091819|NCT01147666|54745458|FG002|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
28091820|NCT01147666|54745459|FG003|Dosing Period 2: 19-Week Treatment|Protocol Violation|1|||
28091821|NCT01147666|54745460|FG004|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
28091822|NCT01147666|54745461|FG005|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
28091823|NCT01147666|54745462|FG006|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
28091824|NCT01147666|54745463|FG007|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
28091825|NCT01147666|54745464|FG008|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
28091826|NCT01147666|54745465|FG009|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
28091827|NCT01147666|54745466|FG010|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
28091828|NCT01147666|54745467|FG011|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
28091829|NCT01147666|54745468|FG012|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
28091830|NCT01147666|54745469|FG013|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
28091831|NCT01147666|54745470|FG014|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
28091832|NCT01147666|54745456|FG000|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
28091833|NCT01147666|54745457|FG001|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
28091834|NCT01147666|54745458|FG002|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
28091835|NCT01147666|54745459|FG003|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
28091836|NCT01147666|54745460|FG004|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
28091837|NCT01147666|54745461|FG005|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
28091838|NCT01147666|54745462|FG006|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
28091839|NCT01147666|54745463|FG007|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
28091840|NCT01147666|54745464|FG008|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
28091841|NCT01147666|54745465|FG009|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
28091842|NCT01147666|54745466|FG010|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
28091843|NCT01147666|54745467|FG011|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
28091844|NCT01147666|54745468|FG012|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
28091845|NCT01147666|54745469|FG013|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
28091846|NCT01147666|54745470|FG014|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
28091847|NCT01147666|54745456|FG000|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
28091848|NCT01147666|54745457|FG001|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
28091849|NCT01147666|54745458|FG002|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
28091850|NCT01147666|54745459|FG003|Dosing Period 2: 19-Week Treatment|Other than specified|1|||
28091851|NCT01147666|54745460|FG004|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
28091852|NCT01147666|54745461|FG005|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
28091853|NCT01147666|54745462|FG006|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
28091854|NCT01147666|54745463|FG007|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
28091855|NCT01147666|54745464|FG008|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
28091856|NCT01147666|54745465|FG009|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
28091857|NCT01147666|54745466|FG010|Dosing Period 2: 19-Week Treatment|Other than specified|2|||
28091858|NCT01147666|54745467|FG011|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
28091859|NCT01147666|54745468|FG012|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
28091860|NCT01147666|54745469|FG013|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
28091861|NCT01147666|54745470|FG014|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
28091862|NCT01147666|54745456|FG000|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
28091863|NCT01147666|54745457|FG001|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
28091864|NCT01147666|54745458|FG002|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
28091865|NCT01147666|54745459|FG003|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
28091866|NCT01147666|54745460|FG004|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
28091867|NCT01147666|54745461|FG005|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
28091868|NCT01147666|54745462|FG006|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
28091869|NCT01147666|54745463|FG007|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
28091870|NCT01147666|54745464|FG008|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
28091871|NCT01147666|54745465|FG009|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
28091872|NCT01147666|54745466|FG010|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
28091873|NCT01147666|54745467|FG011|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
28091874|NCT01147666|54745468|FG012|Dosing Period 2: 19-Week Treatment|Adverse Event|1|||
28091875|NCT01147666|54745469|FG013|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
28091876|NCT01147666|54745470|FG014|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
28091877|NCT01147666|54745456|FG000|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
28091878|NCT01147666|54745457|FG001|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
28091879|NCT01147666|54745458|FG002|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
28091880|NCT01147666|54745459|FG003|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
28091881|NCT01147666|54745460|FG004|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
28091882|NCT01147666|54745461|FG005|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
28091883|NCT01147666|54745462|FG006|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
28091884|NCT01147666|54745463|FG007|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
28091885|NCT01147666|54745464|FG008|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
28091886|NCT01147666|54745465|FG009|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
28091887|NCT01147666|54745466|FG010|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
28091888|NCT01147666|54745467|FG011|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
28091889|NCT01147666|54745468|FG012|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
28091890|NCT01147666|54745469|FG013|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
28091891|NCT01147666|54745470|FG014|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
28091892|NCT00256295|54745532|FG000|Overall Study|Withdrawal by Subject|3|||
28091893|NCT00256295|54745532|FG000|Overall Study|Death|1|||
28091894|NCT02877004|54745539|FG000|Overall Study|Pregnancy|0|||
28091895|NCT02877004|54745540|FG001|Overall Study|Pregnancy|0|||
28091896|NCT02877004|54745541|FG002|Overall Study|Pregnancy|1|||
28091897|NCT04617860|54745571|FG000|Overall Study|Adverse Event|0|||
28091898|NCT04617860|54745572|FG001|Overall Study|Adverse Event|2|||
28091899|NCT04617860|54745573|FG002|Overall Study|Adverse Event|2|||
28091900|NCT04617860|54745571|FG000|Overall Study|Withdrawal by Subject|0|||
28091901|NCT04617860|54745572|FG001|Overall Study|Withdrawal by Subject|0|||
28091902|NCT04617860|54745573|FG002|Overall Study|Withdrawal by Subject|2|||
28091903|NCT04617860|54745571|FG000|Overall Study|Physician Decision|0|||
28091904|NCT04617860|54745572|FG001|Overall Study|Physician Decision|1|||
28091905|NCT04617860|54745573|FG002|Overall Study|Physician Decision|0|||
28091906|NCT04617860|54745571|FG000|Overall Study|Sponsor Decision|0|||
28167234|NCT02493946|54837893|FG000|Open Label Period|Site error|0|||
28167235|NCT02493946|54837894|FG001|Open Label Period|Site error|0|||
28091907|NCT04617860|54745572|FG001|Overall Study|Sponsor Decision|3|||
28091908|NCT04617860|54745573|FG002|Overall Study|Sponsor Decision|1|||
28167236|NCT02493946|54837895|FG002|Open Label Period|Site error|1|||
28091909|NCT04617860|54745571|FG000|Overall Study|Termination of Study by Sponsor|8|||
28091910|NCT04617860|54745572|FG001|Overall Study|Termination of Study by Sponsor|4|||
28091911|NCT04617860|54745573|FG002|Overall Study|Termination of Study by Sponsor|13|||
28091912|NCT04608500|54745585|FG000|Overall Study|Adverse Event|2|||
28091913|NCT04608500|54745586|FG001|Overall Study|Adverse Event|0|||
28091914|NCT04608500|54745585|FG000|Overall Study|Lost to Follow-up|15|||
28091915|NCT04608500|54745586|FG001|Overall Study|Lost to Follow-up|9|||
28091916|NCT04608500|54745585|FG000|Overall Study|Participant request|11|||
28091917|NCT04608500|54745586|FG001|Overall Study|Participant request|7|||
28091918|NCT04608500|54745585|FG000|Overall Study|Protocol Violation|1|||
28091919|NCT04608500|54745586|FG001|Overall Study|Protocol Violation|0|||
28091920|NCT04608500|54745585|FG000|Overall Study|Other|6|||
28091921|NCT04608500|54745586|FG001|Overall Study|Other|2|||
28091922|NCT04585646|54745592|FG000|First Intervention|Physician Decision|1|||
28091923|NCT04585646|54745593|FG001|First Intervention|Physician Decision|0|||
28091924|NCT04585646|54745592|FG000|First Intervention|Lost to Follow-up|0|||
28091925|NCT04585646|54745593|FG001|First Intervention|Lost to Follow-up|3|||
28091926|NCT04585646|54745592|FG000|First Intervention|Withdrawal by Subject|0|||
28091927|NCT04585646|54745593|FG001|First Intervention|Withdrawal by Subject|1|||
28091928|NCT04584788|54745609|FG000|Overall Study|Physician Decision|8|||
28091929|NCT04584788|54745609|FG000|Overall Study|Withdrawal by Subject|1|||
28091930|NCT04584788|54745609|FG000|Overall Study|Adverse Event|3|||
28091931|NCT04575038|54745615|FG000|Overall Study|Withdrawal by Subject|1|||
28091932|NCT04575038|54745616|FG001|Overall Study|Withdrawal by Subject|1|||
28091933|NCT03066622|54745624|FG000|Overall Study|Lost to Follow-up|24|||
28091934|NCT03066622|54745625|FG001|Overall Study|Lost to Follow-up|25|||
28091935|NCT03066622|54745624|FG000|Overall Study|Withdrawal by Subject|2|||
28091936|NCT03066622|54745625|FG001|Overall Study|Withdrawal by Subject|1|||
28091937|NCT04501952|54745657|FG000|Overall Study|Adverse Event|0|||
28091938|NCT04501952|54745658|FG001|Overall Study|Adverse Event|3|||
28091939|NCT04501952|54745657|FG000|Overall Study|Investigator's Discretion|0|||
28091940|NCT04501952|54745658|FG001|Overall Study|Investigator's Discretion|1|||
28091941|NCT04501952|54745657|FG000|Overall Study|Protocol Violation|1|||
28091942|NCT04501952|54745658|FG001|Overall Study|Protocol Violation|1|||
28091943|NCT04501952|54745657|FG000|Overall Study|Withdrew Consent|5|||
28091944|NCT04501952|54745658|FG001|Overall Study|Withdrew Consent|4|||
28091945|NCT04501952|54745657|FG000|Overall Study|Lost to Follow-up|7|||
28091946|NCT04501952|54745658|FG001|Overall Study|Lost to Follow-up|2|||
28091947|NCT04501952|54745657|FG000|Overall Study|Randomized and Never Treated|13|||
28091948|NCT04501952|54745658|FG001|Overall Study|Randomized and Never Treated|9|||
28091949|NCT02930122|54745676|FG000|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
28091950|NCT02930122|54745677|FG001|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
28091951|NCT03697460|54745684|FG000|Overall Study|Withdrawal by Subject|3|||
28091952|NCT00070018|54745688|FG000|Overall Study|Adverse Event|2|||
28091953|NCT00070018|54745688|FG000|Overall Study|Lack of Efficacy|1|||
28091954|NCT00070018|54745688|FG000|Overall Study|Withdrawal by Subject|1|||
28091955|NCT00231413|54745699|FG000|Overall Study|Non-serious AE|0|||
28091956|NCT00231413|54745700|FG001|Overall Study|Non-serious AE|0|||
28091957|NCT00231413|54745701|FG002|Overall Study|Non-serious AE|1|||
28167237|NCT01064531|54837905|FG000|Overall Study|Lost to Follow-up|0|||
28167238|NCT01064531|54837906|FG001|Overall Study|Lost to Follow-up|2|||
28167239|NCT01064531|54837905|FG000|Overall Study|Physician Decision|0|||
28091958|NCT00231413|54745702|FG003|Overall Study|Non-serious AE|0|||
28091959|NCT00231413|54745703|FG004|Overall Study|Non-serious AE|0|||
28091960|NCT00231413|54745704|FG005|Overall Study|Non-serious AE|0|||
28091961|NCT00231413|54745705|FG006|Overall Study|Non-serious AE|1|||
28091962|NCT00231413|54745699|FG000|Overall Study|Withdrawal by Subject|3|||
28091963|NCT00231413|54745700|FG001|Overall Study|Withdrawal by Subject|1|||
28167240|NCT01064531|54837906|FG001|Overall Study|Physician Decision|1|||
28167241|NCT01064531|54837905|FG000|Overall Study|Withdrawal by Subject|2|||
28167242|NCT01064531|54837906|FG001|Overall Study|Withdrawal by Subject|2|||
28167243|NCT01064531|54837905|FG000|Overall Study|Revision due to femoral stem loosening|1|||
28167244|NCT01064531|54837906|FG001|Overall Study|Revision due to femoral stem loosening|0|||
28167245|NCT01064531|54837905|FG000|Overall Study|Revision due to dislocation|0|||
28167246|NCT01064531|54837906|FG001|Overall Study|Revision due to dislocation|1|||
28167247|NCT01064531|54837905|FG000|Overall Study|Death|0|||
28167248|NCT01064531|54837906|FG001|Overall Study|Death|1|||
28167249|NCT02220855|54837912|FG000|Overall Study|Adverse Event|8|||
28167250|NCT02220855|54837912|FG000|Overall Study|Disease Progression|5|||
28091964|NCT00231413|54745701|FG002|Overall Study|Withdrawal by Subject|4|||
28091965|NCT00231413|54745702|FG003|Overall Study|Withdrawal by Subject|2|||
28091966|NCT00231413|54745703|FG004|Overall Study|Withdrawal by Subject|2|||
28091967|NCT00231413|54745704|FG005|Overall Study|Withdrawal by Subject|0|||
28091968|NCT00231413|54745705|FG006|Overall Study|Withdrawal by Subject|3|||
28167251|NCT02220855|54837912|FG000|Overall Study|Withdrawal by Subject|1|||
28167252|NCT02918279|54837918|FG000|Overall Study|Lost to Follow-up|3|||
28091969|NCT00231413|54745699|FG000|Overall Study|Migrated/moved from study area|0|||
28091970|NCT00231413|54745700|FG001|Overall Study|Migrated/moved from study area|0|||
28091971|NCT00231413|54745701|FG002|Overall Study|Migrated/moved from study area|1|||
28091972|NCT00231413|54745702|FG003|Overall Study|Migrated/moved from study area|0|||
28091973|NCT00231413|54745703|FG004|Overall Study|Migrated/moved from study area|0|||
28091974|NCT00231413|54745704|FG005|Overall Study|Migrated/moved from study area|1|||
28091975|NCT00231413|54745705|FG006|Overall Study|Migrated/moved from study area|0|||
28167253|NCT02918279|54837919|FG001|Overall Study|Lost to Follow-up|6|||
28167254|NCT02918279|54837918|FG000|Overall Study|Withdrawal by Subject|5|||
28167255|NCT02918279|54837919|FG001|Overall Study|Withdrawal by Subject|15|||
28167256|NCT02918279|54837918|FG000|Overall Study|Withdrawal by parent/guardian|2|||
28167257|NCT02918279|54837919|FG001|Overall Study|Withdrawal by parent/guardian|1|||
28167258|NCT02918279|54837918|FG000|Overall Study|Other|3|||
28167259|NCT02918279|54837919|FG001|Overall Study|Other|1|||
28167260|NCT02956837|54837929|FG000|Overall Study|Serious Adverse Events|0|||
28167261|NCT02956837|54837930|FG001|Overall Study|Serious Adverse Events|1|||
28167262|NCT02956837|54837931|FG002|Overall Study|Serious Adverse Events|0|||
28167263|NCT02956837|54837932|FG003|Overall Study|Serious Adverse Events|0|||
28167264|NCT02956837|54837929|FG000|Overall Study|Withdrawal by Subject|0|||
28167265|NCT02956837|54837930|FG001|Overall Study|Withdrawal by Subject|1|||
28167266|NCT02956837|54837931|FG002|Overall Study|Withdrawal by Subject|0|||
28167267|NCT02956837|54837932|FG003|Overall Study|Withdrawal by Subject|3|||
28167268|NCT02956837|54837929|FG000|Overall Study|Lost to Follow-up|0|||
28167269|NCT02956837|54837930|FG001|Overall Study|Lost to Follow-up|1|||
28167270|NCT02956837|54837931|FG002|Overall Study|Lost to Follow-up|2|||
27733724|NCT02556632|54181407|FG001|Overall Study|Disliked Study Procedures|0|||
27733725|NCT02556632|54181408|FG002|Overall Study|Disliked Study Procedures|1|||
27733726|NCT02556632|54181406|FG000|Overall Study|Treatment or Change Delay|0|||
27733727|NCT02556632|54181407|FG001|Overall Study|Treatment or Change Delay|0|||
27733728|NCT02556632|54181408|FG002|Overall Study|Treatment or Change Delay|1|||
27733729|NCT01662440|54181420|FG000|Overall Study|Adverse Event|1|||
27733730|NCT01662440|54181421|FG001|Overall Study|Adverse Event|0|||
27733731|NCT01662440|54181422|FG002|Overall Study|Adverse Event|0|||
27733732|NCT01662440|54181423|FG003|Overall Study|Adverse Event|1|||
27733733|NCT01662440|54181420|FG000|Overall Study|Death|0|||
27733734|NCT01662440|54181421|FG001|Overall Study|Death|1|||
27733735|NCT01662440|54181422|FG002|Overall Study|Death|0|||
27733736|NCT01662440|54181423|FG003|Overall Study|Death|0|||
27733737|NCT01662440|54181420|FG000|Overall Study|Lost to Follow-up|2|||
27733738|NCT01662440|54181421|FG001|Overall Study|Lost to Follow-up|2|||
27733739|NCT01662440|54181422|FG002|Overall Study|Lost to Follow-up|4|||
27733740|NCT01662440|54181423|FG003|Overall Study|Lost to Follow-up|1|||
27733741|NCT01662440|54181420|FG000|Overall Study|Subject moved to another country.|0|||
27733742|NCT01662440|54181421|FG001|Overall Study|Subject moved to another country.|1|||
27733743|NCT01662440|54181422|FG002|Overall Study|Subject moved to another country.|0|||
27733744|NCT01662440|54181423|FG003|Overall Study|Subject moved to another country.|0|||
27733745|NCT01662440|54181420|FG000|Overall Study|Protocol Violation|1|||
27733746|NCT01662440|54181421|FG001|Overall Study|Protocol Violation|0|||
27733747|NCT01662440|54181422|FG002|Overall Study|Protocol Violation|0|||
27733748|NCT01662440|54181423|FG003|Overall Study|Protocol Violation|0|||
27733749|NCT01662440|54181420|FG000|Overall Study|Withdrawal by Subject|5|||
27733750|NCT01662440|54181421|FG001|Overall Study|Withdrawal by Subject|2|||
27733751|NCT01662440|54181422|FG002|Overall Study|Withdrawal by Subject|2|||
27733752|NCT01662440|54181423|FG003|Overall Study|Withdrawal by Subject|2|||
27733753|NCT01662362|54181443|FG000|Overall Study|Lost to Follow-up|38|||
27733754|NCT02554682|54181458|FG000|Overall Study|Lost to Follow-up|11|||
27733755|NCT02554682|54181459|FG001|Overall Study|Lost to Follow-up|9|||
27733756|NCT02554682|54181460|FG002|Overall Study|Lost to Follow-up|4|||
27733757|NCT02554682|54181461|FG003|Overall Study|Lost to Follow-up|3|||
27733758|NCT02554682|54181462|FG004|Overall Study|Lost to Follow-up|2|||
27733759|NCT02554682|54181463|FG005|Overall Study|Lost to Follow-up|1|||
27733760|NCT02554682|54181464|FG006|Overall Study|Lost to Follow-up|6|||
27733761|NCT02554682|54181465|FG007|Overall Study|Lost to Follow-up|6|||
27733762|NCT02554682|54181466|FG008|Overall Study|Lost to Follow-up|2|||
27733763|NCT02554682|54181467|FG009|Overall Study|Lost to Follow-up|2|||
27733764|NCT02554682|54181458|FG000|Overall Study|Withdrawal by Subject|2|||
28167271|NCT02956837|54837932|FG003|Overall Study|Lost to Follow-up|0|||
28167272|NCT01063595|54837945|FG000|Enrolled in Study and Randomized|Reason not Specified|1|||
28167273|NCT01063595|54837946|FG001|Enrolled in Study and Randomized|Reason not Specified|0|||
27733765|NCT02554682|54181459|FG001|Overall Study|Withdrawal by Subject|1|||
27733766|NCT02554682|54181460|FG002|Overall Study|Withdrawal by Subject|0|||
27733767|NCT02554682|54181461|FG003|Overall Study|Withdrawal by Subject|0|||
27833124|NCT02715258|54313909|FG001|Overall Study|Subject non-compliant|1|||
27733768|NCT02554682|54181462|FG004|Overall Study|Withdrawal by Subject|0|||
28091976|NCT00231413|54745699|FG000|Overall Study|Lost to Follow-up|4|||
28091977|NCT00231413|54745700|FG001|Overall Study|Lost to Follow-up|4|||
28167274|NCT01063595|54837945|FG000|Enrolled in Study and Randomized|Adverse Event|0|||
28091978|NCT00231413|54745701|FG002|Overall Study|Lost to Follow-up|1|||
28091979|NCT00231413|54745702|FG003|Overall Study|Lost to Follow-up|1|||
28091980|NCT00231413|54745703|FG004|Overall Study|Lost to Follow-up|1|||
28091981|NCT00231413|54745704|FG005|Overall Study|Lost to Follow-up|4|||
28091982|NCT00231413|54745705|FG006|Overall Study|Lost to Follow-up|0|||
28091983|NCT00231413|54745699|FG000|Overall Study|Pregnancy|1|||
28091984|NCT00231413|54745700|FG001|Overall Study|Pregnancy|0|||
28091985|NCT00231413|54745701|FG002|Overall Study|Pregnancy|0|||
28091986|NCT00231413|54745702|FG003|Overall Study|Pregnancy|0|||
28091987|NCT00231413|54745703|FG004|Overall Study|Pregnancy|0|||
28091988|NCT00231413|54745704|FG005|Overall Study|Pregnancy|0|||
28091989|NCT00231413|54745705|FG006|Overall Study|Pregnancy|0|||
28091990|NCT04494646|54745723|FG000|Overall Study|Adverse Event|0|||
28091991|NCT04494646|54745724|FG001|Overall Study|Adverse Event|1|||
28091992|NCT04494646|54745723|FG000|Overall Study|Withdrawal by Subject|0|||
28091993|NCT04494646|54745724|FG001|Overall Study|Withdrawal by Subject|1|||
28091994|NCT04529096|54745732|FG000|Overall Study|Adverse Event|6|||
28091995|NCT04529096|54745733|FG001|Overall Study|Adverse Event|1|||
28091996|NCT04529096|54745732|FG000|Overall Study|Lack of Efficacy|1|||
28091997|NCT04529096|54745733|FG001|Overall Study|Lack of Efficacy|0|||
28091998|NCT04529096|54745732|FG000|Overall Study|Lost to Follow-up|1|||
28091999|NCT04529096|54745733|FG001|Overall Study|Lost to Follow-up|1|||
28092000|NCT04529096|54745732|FG000|Overall Study|Non-Compliance With Study Drug|0|||
28092001|NCT04529096|54745733|FG001|Overall Study|Non-Compliance With Study Drug|1|||
28092002|NCT04529096|54745732|FG000|Overall Study|Physician Decision|1|||
28092003|NCT04529096|54745733|FG001|Overall Study|Physician Decision|3|||
28092004|NCT04529096|54745732|FG000|Overall Study|Withdrawal by Subject|5|||
28092005|NCT04529096|54745733|FG001|Overall Study|Withdrawal by Subject|0|||
28092006|NCT00231179|54745741|FG000|Overall Study|Lost to Follow-up|21|||
28092007|NCT00231179|54745742|FG001|Overall Study|Lost to Follow-up|21|||
28092008|NCT00231179|54745741|FG000|Overall Study|Withdrawal by Subject|3|||
28092009|NCT00231179|54745742|FG001|Overall Study|Withdrawal by Subject|3|||
28092010|NCT00229931|54745750|FG000|Overall Study|Death|1|||
28092011|NCT00229931|54745751|FG001|Overall Study|Death|0|||
28092012|NCT00229931|54745750|FG000|Overall Study|Lost to Follow-up|3|||
28092013|NCT00229931|54745751|FG001|Overall Study|Lost to Follow-up|2|||
28092014|NCT03135028|54745757|FG000|Overall Study|Death|6|||
28092015|NCT03135028|54745757|FG000|Overall Study|Study Terminated by Sponsor|2|||
28092016|NCT03135028|54745757|FG000|Overall Study|Withdrew Consent|1|||
28092017|NCT00228917|54745769|FG000|Overall Study|Migrated/moved from study area|0|||
28092018|NCT00228917|54745770|FG001|Overall Study|Migrated/moved from study area|0|||
28092019|NCT00228917|54745771|FG002|Overall Study|Migrated/moved from study area|0|||
28092020|NCT00228917|54745772|FG003|Overall Study|Migrated/moved from study area|0|||
28092021|NCT00228917|54745773|FG004|Overall Study|Migrated/moved from study area|0|||
28092022|NCT00228917|54745774|FG005|Overall Study|Migrated/moved from study area|2|||
28092023|NCT00228917|54745775|FG006|Overall Study|Migrated/moved from study area|0|||
28092024|NCT00228917|54745776|FG007|Overall Study|Migrated/moved from study area|0|||
28092025|NCT00227903|54745792|FG000|Overall Study|Withdrawal by Subject|2|||
28092026|NCT00227903|54745793|FG001|Overall Study|Withdrawal by Subject|5|||
28092027|NCT00227903|54745792|FG000|Overall Study|Subject moved out of area|1|||
28092028|NCT00227903|54745793|FG001|Overall Study|Subject moved out of area|2|||
28092029|NCT00227903|54745792|FG000|Overall Study|Lost to Follow-up|1|||
28092030|NCT00227903|54745793|FG001|Overall Study|Lost to Follow-up|3|||
28092031|NCT00227903|54745792|FG000|Overall Study|Miscarriage|1|||
28092032|NCT00227903|54745793|FG001|Overall Study|Miscarriage|0|||
28092033|NCT04411628|54745803|FG000|Overall Study|Withdrawal by Subject|1|||
28092034|NCT04411628|54745804|FG001|Overall Study|Withdrawal by Subject|1|||
28092035|NCT04411628|54745805|FG002|Overall Study|Withdrawal by Subject|2|||
28092036|NCT04411628|54745806|FG003|Overall Study|Withdrawal by Subject|0|||
28092037|NCT04411628|54745803|FG000|Overall Study|Lost to Follow-up|0|||
28092038|NCT04411628|54745804|FG001|Overall Study|Lost to Follow-up|1|||
28092039|NCT04411628|54745805|FG002|Overall Study|Lost to Follow-up|0|||
28092040|NCT04411628|54745806|FG003|Overall Study|Lost to Follow-up|0|||
28092041|NCT00227591|54745819|FG000|Overall Study|Withdrawal by Subject|1|||
28092042|NCT04512482|54745825|FG000|Second Intervention (1 Day)|Protocol Violation|2|||
28092043|NCT04512482|54745826|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
28092044|NCT00226811|54745832|FG000|Overall Study|Death|8|||
28092045|NCT00226811|54745832|FG000|Overall Study|Adverse Event|11|||
28167275|NCT01063595|54837946|FG001|Enrolled in Study and Randomized|Adverse Event|1|||
28092046|NCT00226811|54745832|FG000|Overall Study|Lack of Efficacy|55|||
28092047|NCT00226811|54745832|FG000|Overall Study|Withdrawal by Subject|2|||
28092048|NCT02951052|54745838|FG000|Overall Study|Adverse Event|13|||
28092049|NCT02951052|54745839|FG001|Overall Study|Adverse Event|5|||
28092050|NCT02951052|54745838|FG000|Overall Study|Withdrawal by Subject|1|||
28092051|NCT02951052|54745839|FG001|Overall Study|Withdrawal by Subject|5|||
28092052|NCT02951052|54745838|FG000|Overall Study|Physician Decision|2|||
28092053|NCT02951052|54745839|FG001|Overall Study|Physician Decision|0|||
28092054|NCT02951052|54745838|FG000|Overall Study|Lost to Follow-up|1|||
28092055|NCT02951052|54745839|FG001|Overall Study|Lost to Follow-up|1|||
28092056|NCT02951052|54745838|FG000|Overall Study|Protocol-specified withdrawal criterion|1|||
28092057|NCT02951052|54745839|FG001|Overall Study|Protocol-specified withdrawal criterion|0|||
28092058|NCT02951052|54745838|FG000|Overall Study|Protocol Violation|5|||
28092059|NCT02951052|54745839|FG001|Overall Study|Protocol Violation|3|||
28092060|NCT02951052|54745838|FG000|Overall Study|Lack of Efficacy|3|||
28092061|NCT02951052|54745839|FG001|Overall Study|Lack of Efficacy|4|||
28092062|NCT02951052|54745838|FG000|Overall Study|Ongoing|1|||
28092063|NCT02951052|54745839|FG001|Overall Study|Ongoing|0|||
27733769|NCT02554682|54181463|FG005|Overall Study|Withdrawal by Subject|0|||
27733770|NCT02554682|54181464|FG006|Overall Study|Withdrawal by Subject|0|||
27733771|NCT02554682|54181465|FG007|Overall Study|Withdrawal by Subject|0|||
27733772|NCT02554682|54181466|FG008|Overall Study|Withdrawal by Subject|0|||
27733773|NCT02554682|54181467|FG009|Overall Study|Withdrawal by Subject|0|||
27733774|NCT02554682|54181458|FG000|Overall Study|Physician Decision|2|||
27733775|NCT02554682|54181459|FG001|Overall Study|Physician Decision|2|||
27733776|NCT02554682|54181460|FG002|Overall Study|Physician Decision|0|||
27733777|NCT02554682|54181461|FG003|Overall Study|Physician Decision|0|||
27733778|NCT02554682|54181462|FG004|Overall Study|Physician Decision|0|||
27733779|NCT02554682|54181463|FG005|Overall Study|Physician Decision|0|||
27733780|NCT02554682|54181464|FG006|Overall Study|Physician Decision|0|||
27733781|NCT02554682|54181465|FG007|Overall Study|Physician Decision|0|||
27733782|NCT02554682|54181466|FG008|Overall Study|Physician Decision|0|||
27733783|NCT02554682|54181467|FG009|Overall Study|Physician Decision|0|||
27733784|NCT00154063|54181503|FG000|Overall Study|Adverse Event|4|||
27733785|NCT00154063|54181504|FG001|Overall Study|Adverse Event|8|||
27733786|NCT00154063|54181503|FG000|Overall Study|Protocol Violation|1|||
27733787|NCT00154063|54181504|FG001|Overall Study|Protocol Violation|1|||
27733788|NCT00154063|54181503|FG000|Overall Study|Investigator or Sponsor Request|0|||
27733789|NCT00154063|54181504|FG001|Overall Study|Investigator or Sponsor Request|1|||
27733790|NCT00154063|54181503|FG000|Overall Study|Withdrawal by Subject|4|||
27733791|NCT00154063|54181504|FG001|Overall Study|Withdrawal by Subject|9|||
27733792|NCT00154063|54181503|FG000|Overall Study|Other|3|||
27733793|NCT00154063|54181504|FG001|Overall Study|Other|3|||
27733794|NCT02683941|54181516|FG000|Double-blind Phase|Adverse Event|0|||
27733795|NCT02683941|54181517|FG001|Double-blind Phase|Adverse Event|1|||
27733796|NCT02683941|54181516|FG000|Double-blind Phase|Withdrawal by Subject|4|||
27733797|NCT02683941|54181517|FG001|Double-blind Phase|Withdrawal by Subject|2|||
27733798|NCT02683941|54181516|FG000|Double-blind Phase|Lost to Follow-up|1|||
27733799|NCT02683941|54181517|FG001|Double-blind Phase|Lost to Follow-up|0|||
27733800|NCT02683941|54181516|FG000|Double-blind Phase|Disease Progression|5|||
27733801|NCT02683941|54181517|FG001|Double-blind Phase|Disease Progression|2|||
27733802|NCT02683941|54181516|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
27733803|NCT02683941|54181517|FG001|Open-label Treatment Phase|Withdrawal by Subject|2|||
27733804|NCT02683941|54181516|FG000|Open-label Treatment Phase|Disease Progression|1|||
27733805|NCT02683941|54181517|FG001|Open-label Treatment Phase|Disease Progression|2|||
27733806|NCT02683941|54181516|FG000|Open-label Treatment Phase|Study Termination by the Sponsor|18|||
27733807|NCT02683941|54181517|FG001|Open-label Treatment Phase|Study Termination by the Sponsor|9|||
27733808|NCT02683941|54181516|FG000|Open-label Treatment Phase|Other|1|||
27733809|NCT02683941|54181517|FG001|Open-label Treatment Phase|Other|0|||
27733810|NCT02683941|54181516|FG000|Open-label Follow-up Phase|Withdrawal by Subject|3|||
27733811|NCT02683941|54181517|FG001|Open-label Follow-up Phase|Withdrawal by Subject|3|||
27733812|NCT02683941|54181516|FG000|Open-label Follow-up Phase|Lost to Follow-up|1|||
27733813|NCT02683941|54181517|FG001|Open-label Follow-up Phase|Lost to Follow-up|0|||
27733814|NCT02683941|54181516|FG000|Open-label Follow-up Phase|Study Termination by the Sponsor|6|||
27733815|NCT02683941|54181517|FG001|Open-label Follow-up Phase|Study Termination by the Sponsor|4|||
27733816|NCT02683941|54181516|FG000|Open-label Follow-up Phase|Other|8|||
27733817|NCT02683941|54181517|FG001|Open-label Follow-up Phase|Other|1|||
27733818|NCT02678247|54181529|FG000|First Intervention (7 Weeks)|Withdrawal by Subject|0|||
27733819|NCT02678247|54181530|FG001|First Intervention (7 Weeks)|Withdrawal by Subject|2|||
27733820|NCT02678247|54181529|FG000|First Intervention (7 Weeks)|Adverse Event|1|||
27733821|NCT02678247|54181530|FG001|First Intervention (7 Weeks)|Adverse Event|2|||
28092064|NCT00226655|54745849|FG000|Overall Study|Death|13|||
27733822|NCT02678247|54181529|FG000|First Intervention (7 Weeks)|Physician Decision|1|||
27733823|NCT02678247|54181530|FG001|First Intervention (7 Weeks)|Physician Decision|0|||
27733824|NCT02678247|54181529|FG000|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
27733825|NCT02678247|54181530|FG001|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
27733826|NCT02678247|54181529|FG000|Second Intervention (7 Weeks)|Adverse Event|2|||
27733827|NCT02678247|54181530|FG001|Second Intervention (7 Weeks)|Adverse Event|1|||
27733828|NCT02678247|54181529|FG000|Second Intervention (7 Weeks)|Physician Decision|1|||
27733829|NCT02678247|54181530|FG001|Second Intervention (7 Weeks)|Physician Decision|0|||
27733830|NCT02683785|54181543|FG000|Overall Study|Withdrawal by Subject|1|||
27733831|NCT02683785|54181544|FG001|Overall Study|Withdrawal by Subject|1|||
28092065|NCT00226655|54745849|FG000|Overall Study|Withdrawal by Subject|15|||
28092066|NCT00226655|54745849|FG000|Overall Study|Adverse Event|35|||
28092067|NCT00226655|54745849|FG000|Overall Study|Physician Decision|6|||
28092068|NCT00226655|54745849|FG000|Overall Study|Clinical deterioration|10|||
28092069|NCT03124108|54745865|FG000|Overall Study|Adverse Event|0|||
28092070|NCT03124108|54745866|FG001|Overall Study|Adverse Event|1|||
28092071|NCT03124108|54745867|FG002|Overall Study|Adverse Event|0|||
28092072|NCT04475588|54745879|FG000|Overall Study|Adverse Event|2|||
28092073|NCT04475588|54745880|FG001|Overall Study|Adverse Event|0|||
28092074|NCT04353596|54745889|FG000|Overall Study|Protocol Violation|4|||
28092075|NCT04353596|54745890|FG001|Overall Study|Protocol Violation|4|||
28092076|NCT04353596|54745889|FG000|Overall Study|no evidence of recent SARS-CoV-2|1|||
28092077|NCT04353596|54745890|FG001|Overall Study|no evidence of recent SARS-CoV-2|3|||
28092078|NCT04350788|54745898|FG000|Overall Study|Lost to Follow-up|6|||
28092079|NCT04350788|54745899|FG001|Overall Study|Lost to Follow-up|2|||
28092080|NCT04350788|54745898|FG000|Overall Study|Withdrawal by Subject|2|||
28092081|NCT04350788|54745899|FG001|Overall Study|Withdrawal by Subject|4|||
28092082|NCT04350788|54745898|FG000|Overall Study|Protocol Violation|4|||
28092083|NCT04350788|54745899|FG001|Overall Study|Protocol Violation|0|||
28092084|NCT03852316|54745910|FG000|Overall Study|Protocol Violation|1|||
28092085|NCT03852316|54745910|FG000|Overall Study|Withdrawal by Subject|2|||
28092086|NCT03852316|54745910|FG000|Overall Study|Enrolled but Device not Utilized|1|||
28092087|NCT04335812|54745916|FG000|Overall Study|Withdrawal by Subject|1|||
28092088|NCT04335812|54745917|FG001|Overall Study|Withdrawal by Subject|3|||
28092089|NCT04335812|54745916|FG000|Overall Study|Lost to Follow-up|12|||
28092090|NCT04335812|54745917|FG001|Overall Study|Lost to Follow-up|12|||
28092091|NCT04335812|54745916|FG000|Overall Study|Did not engage in the intervention|22|||
28092092|NCT04335812|54745917|FG001|Overall Study|Did not engage in the intervention|18|||
28092093|NCT03127384|54745923|FG000|Overall Study|Lost to Follow-up|4|||
28092094|NCT03127384|54745923|FG000|Overall Study|Subject request|2|||
28092095|NCT04398134|54745950|FG000|Overall Study|Adverse Event|0|||
28092096|NCT04398134|54745951|FG001|Overall Study|Adverse Event|0|||
28092097|NCT04398134|54745952|FG002|Overall Study|Adverse Event|1|||
28092098|NCT04398134|54745953|FG003|Overall Study|Adverse Event|0|||
28092099|NCT04398134|54745950|FG000|Overall Study|Withdrawal by Subject|2|||
28092100|NCT04398134|54745951|FG001|Overall Study|Withdrawal by Subject|0|||
28092101|NCT04398134|54745952|FG002|Overall Study|Withdrawal by Subject|0|||
28092102|NCT04398134|54745953|FG003|Overall Study|Withdrawal by Subject|1|||
28092103|NCT04398134|54745950|FG000|Overall Study|Study Terminated by Sponsor|30|||
28167276|NCT01063595|54837945|FG000|Enrolled in Study and Randomized|Withdrawn by the Investigator|0|||
28167277|NCT01063595|54837946|FG001|Enrolled in Study and Randomized|Withdrawn by the Investigator|1|||
28167278|NCT01063595|54837945|FG000|First Intervention|Adverse Event|1|||
28167279|NCT01063595|54837946|FG001|First Intervention|Adverse Event|4|||
28167280|NCT01063595|54837945|FG000|First Intervention|Withdrawal by Subject|1|||
28167281|NCT01063595|54837946|FG001|First Intervention|Withdrawal by Subject|0|||
28167282|NCT01063595|54837945|FG000|First Intervention|Reason not Specified|0|||
28167283|NCT01063595|54837946|FG001|First Intervention|Reason not Specified|1|||
28167284|NCT01063283|54837954|FG000|Cycle 1|Adverse Event|2|||
28167285|NCT01063283|54837955|FG001|Cycle 1|Adverse Event|0|||
27733832|NCT02683785|54181543|FG000|Overall Study|Lost to Follow-up|0|||
27733833|NCT02683785|54181544|FG001|Overall Study|Lost to Follow-up|1|||
27733834|NCT02683785|54181543|FG000|Overall Study|Adverse Event|0|||
27733835|NCT02683785|54181544|FG001|Overall Study|Adverse Event|2|||
27733836|NCT02543294|54181552|FG000|Overall Study|Lost to Follow-up|3|||
27733837|NCT02543294|54181552|FG000|Overall Study|Physician Decision|2|||
28167286|NCT01063283|54837956|FG002|Cycle 1|Adverse Event|0|||
27733838|NCT02543294|54181552|FG000|Overall Study|Withdrawal by Subject|7|||
27733839|NCT02728076|54181557|FG000|Overall Study|Physician Decision|4|||
27733840|NCT02551874|54181563|FG000|Overall Study|Lost to Follow-up|0|||
27833125|NCT02715258|54313908|FG000|Overall Study|GCP violation|2|||
28167287|NCT01063283|54837954|FG000|Cycle 1|Technical failure in data collection|1|||
28167288|NCT01063283|54837955|FG001|Cycle 1|Technical failure in data collection|0|||
28167289|NCT01063283|54837956|FG002|Cycle 1|Technical failure in data collection|0|||
28092104|NCT04398134|54745951|FG001|Overall Study|Study Terminated by Sponsor|11|||
28092105|NCT04398134|54745952|FG002|Overall Study|Study Terminated by Sponsor|32|||
28092106|NCT04398134|54745953|FG003|Overall Study|Study Terminated by Sponsor|11|||
28092107|NCT03122860|54745969|FG000|Overall Study|Discontinued Before Treatment|1|||
28092108|NCT03122860|54745970|FG001|Overall Study|Discontinued Before Treatment|1|||
28092109|NCT03122860|54745971|FG002|Overall Study|Discontinued Before Treatment|2|||
28092110|NCT03122860|54745972|FG003|Overall Study|Discontinued Before Treatment|0|||
28167290|NCT01062971|54837964|FG000|Overall Study|Protocol Violation|1|||
28167291|NCT01062971|54837965|FG001|Overall Study|Protocol Violation|3|||
28167292|NCT01062971|54837964|FG000|Overall Study|Lost to Follow-up|3|||
27733841|NCT02551874|54181564|FG001|Overall Study|Lost to Follow-up|2|||
28092111|NCT03122860|54745973|FG004|Overall Study|Discontinued Before Treatment|1|||
27733842|NCT02551874|54181563|FG000|Overall Study|Pregnancy|0|||
27733843|NCT02551874|54181564|FG001|Overall Study|Pregnancy|1|||
27833126|NCT02715258|54313909|FG001|Overall Study|GCP violation|1|||
28092112|NCT03122860|54745974|FG005|Overall Study|Discontinued Before Treatment|0|||
28092113|NCT03122860|54745969|FG000|Overall Study|Adverse Event|1|||
28092114|NCT03122860|54745970|FG001|Overall Study|Adverse Event|0|||
28092115|NCT03122860|54745971|FG002|Overall Study|Adverse Event|1|||
28092116|NCT03122860|54745972|FG003|Overall Study|Adverse Event|1|||
28092117|NCT03122860|54745973|FG004|Overall Study|Adverse Event|0|||
28092118|NCT03122860|54745974|FG005|Overall Study|Adverse Event|0|||
28092119|NCT03122860|54745969|FG000|Overall Study|Lost to Follow-up|5|||
28092120|NCT03122860|54745970|FG001|Overall Study|Lost to Follow-up|2|||
28092121|NCT03122860|54745971|FG002|Overall Study|Lost to Follow-up|3|||
28092122|NCT03122860|54745972|FG003|Overall Study|Lost to Follow-up|3|||
28092123|NCT03122860|54745973|FG004|Overall Study|Lost to Follow-up|5|||
28092124|NCT03122860|54745974|FG005|Overall Study|Lost to Follow-up|4|||
28092125|NCT03122860|54745969|FG000|Overall Study|Subject Non-Compliance|0|||
28092126|NCT03122860|54745970|FG001|Overall Study|Subject Non-Compliance|0|||
28092127|NCT03122860|54745971|FG002|Overall Study|Subject Non-Compliance|1|||
28092128|NCT03122860|54745972|FG003|Overall Study|Subject Non-Compliance|0|||
28092129|NCT03122860|54745973|FG004|Overall Study|Subject Non-Compliance|0|||
28092130|NCT03122860|54745974|FG005|Overall Study|Subject Non-Compliance|0|||
28092131|NCT03122860|54745969|FG000|Overall Study|Withdrawal by Subject|3|||
28092132|NCT03122860|54745970|FG001|Overall Study|Withdrawal by Subject|2|||
28092133|NCT03122860|54745971|FG002|Overall Study|Withdrawal by Subject|5|||
28092134|NCT03122860|54745972|FG003|Overall Study|Withdrawal by Subject|7|||
28092135|NCT03122860|54745973|FG004|Overall Study|Withdrawal by Subject|9|||
28092136|NCT03122860|54745974|FG005|Overall Study|Withdrawal by Subject|8|||
28092137|NCT03798366|54745991|FG000|Overall Study|Lost to Follow-up|0|||
28092138|NCT03798366|54745992|FG001|Overall Study|Lost to Follow-up|1|||
28092139|NCT04327388|54746001|FG000|Overall Study|Adverse Event|17|||
28092140|NCT04327388|54746002|FG001|Overall Study|Adverse Event|18|||
28092141|NCT04327388|54746003|FG002|Overall Study|Adverse Event|9|||
28092142|NCT04327388|54746001|FG000|Overall Study|Other|1|||
28092143|NCT04327388|54746002|FG001|Overall Study|Other|2|||
28092144|NCT04327388|54746003|FG002|Overall Study|Other|0|||
28092145|NCT04327388|54746001|FG000|Overall Study|Randomized and not treated|2|||
28092146|NCT04327388|54746002|FG001|Overall Study|Randomized and not treated|0|||
28092147|NCT04327388|54746003|FG002|Overall Study|Randomized and not treated|2|||
28092148|NCT03796728|54746011|FG000|Overall Study|Lost to Follow-up|8|||
28092149|NCT03796728|54746011|FG000|Overall Study|Reason not Specified|16|||
28092150|NCT00352534|54746017|FG000|Initial Staging|Ineligible|8|||
28092151|NCT00352534|54746018|FG001|Initial Staging|Ineligible|9|||
28092152|NCT00352534|54746019|FG002|Initial Staging|Ineligible|0|||
28092153|NCT00352534|54746020|FG003|Initial Staging|Ineligible|0|||
28092154|NCT00352534|54746021|FG004|Initial Staging|Ineligible|0|||
28092155|NCT00352534|54746022|FG005|Initial Staging|Ineligible|0|||
28092156|NCT00352534|54746023|FG006|Initial Staging|Ineligible|0|||
28092157|NCT00352534|54746017|FG000|Final Risk Group Assignment|Lack of Efficacy|0|||
28092158|NCT00352534|54746018|FG001|Final Risk Group Assignment|Lack of Efficacy|0|||
28092159|NCT00352534|54746019|FG002|Final Risk Group Assignment|Lack of Efficacy|0|||
28092160|NCT00352534|54746020|FG003|Final Risk Group Assignment|Lack of Efficacy|2|||
28092161|NCT00352534|54746021|FG004|Final Risk Group Assignment|Lack of Efficacy|1|||
28092162|NCT00352534|54746022|FG005|Final Risk Group Assignment|Lack of Efficacy|19|||
28092163|NCT00352534|54746023|FG006|Final Risk Group Assignment|Lack of Efficacy|0|||
28092164|NCT00352534|54746017|FG000|Final Risk Group Assignment|Physician Decision|0|||
28092165|NCT00352534|54746018|FG001|Final Risk Group Assignment|Physician Decision|0|||
28092166|NCT00352534|54746019|FG002|Final Risk Group Assignment|Physician Decision|0|||
28092167|NCT00352534|54746020|FG003|Final Risk Group Assignment|Physician Decision|0|||
28092168|NCT00352534|54746021|FG004|Final Risk Group Assignment|Physician Decision|0|||
28092169|NCT00352534|54746022|FG005|Final Risk Group Assignment|Physician Decision|8|||
28092170|NCT00352534|54746023|FG006|Final Risk Group Assignment|Physician Decision|0|||
28092171|NCT00352534|54746017|FG000|Final Risk Group Assignment|Withdrawal by Subject|0|||
27733844|NCT02551874|54181563|FG000|Overall Study|Reason not reported|10|||
28092172|NCT00352534|54746018|FG001|Final Risk Group Assignment|Withdrawal by Subject|0|||
28092173|NCT00352534|54746019|FG002|Final Risk Group Assignment|Withdrawal by Subject|0|||
28092174|NCT00352534|54746020|FG003|Final Risk Group Assignment|Withdrawal by Subject|0|||
28092175|NCT00352534|54746021|FG004|Final Risk Group Assignment|Withdrawal by Subject|0|||
28092176|NCT00352534|54746022|FG005|Final Risk Group Assignment|Withdrawal by Subject|3|||
28092177|NCT00352534|54746023|FG006|Final Risk Group Assignment|Withdrawal by Subject|0|||
28092178|NCT00352534|54746017|FG000|Final Risk Group Assignment|Ineligible|0|||
28092179|NCT00352534|54746018|FG001|Final Risk Group Assignment|Ineligible|0|||
28092180|NCT00352534|54746019|FG002|Final Risk Group Assignment|Ineligible|3|||
28092181|NCT00352534|54746020|FG003|Final Risk Group Assignment|Ineligible|1|||
28092182|NCT00352534|54746021|FG004|Final Risk Group Assignment|Ineligible|0|||
28092183|NCT00352534|54746022|FG005|Final Risk Group Assignment|Ineligible|13|||
28092184|NCT00352534|54746023|FG006|Final Risk Group Assignment|Ineligible|0|||
27733845|NCT02551874|54181564|FG001|Overall Study|Reason not reported|4|||
27855765|NCT02733042|54382051|FG013|Follow-up Period|Other|0|||
28092185|NCT00352534|54746017|FG000|Final Risk Group Assignment|Enrollment onto another COG study|0|||
28092186|NCT00352534|54746018|FG001|Final Risk Group Assignment|Enrollment onto another COG study|0|||
28092187|NCT00352534|54746019|FG002|Final Risk Group Assignment|Enrollment onto another COG study|0|||
28092188|NCT00352534|54746020|FG003|Final Risk Group Assignment|Enrollment onto another COG study|0|||
28092189|NCT00352534|54746021|FG004|Final Risk Group Assignment|Enrollment onto another COG study|0|||
28092190|NCT00352534|54746022|FG005|Final Risk Group Assignment|Enrollment onto another COG study|0|||
28092191|NCT00352534|54746023|FG006|Final Risk Group Assignment|Enrollment onto another COG study|28|||
28167293|NCT01062971|54837965|FG001|Overall Study|Lost to Follow-up|4|||
28167294|NCT01348165|54837978|FG000|Overall Study|Adverse Event|0|||
28167295|NCT01348165|54837979|FG001|Overall Study|Adverse Event|0|||
28167296|NCT01348165|54837980|FG002|Overall Study|Adverse Event|0|||
28167297|NCT01348165|54837981|FG003|Overall Study|Adverse Event|0|||
28167298|NCT01348165|54837982|FG004|Overall Study|Adverse Event|0|||
28167299|NCT01348165|54837983|FG005|Overall Study|Adverse Event|0|||
28167300|NCT01348165|54837984|FG006|Overall Study|Adverse Event|1|||
28167301|NCT02493868|54838004|FG000|Induction Phase: DE Participants|Adverse Event|22|||
28167302|NCT02493868|54838005|FG001|Induction Phase: DE Participants|Adverse Event|0|||
28167303|NCT02493868|54838004|FG000|Induction Phase: DE Participants|Lost to Follow-up|1|||
28167304|NCT02493868|54838005|FG001|Induction Phase: DE Participants|Lost to Follow-up|0|||
28167305|NCT02493868|54838004|FG000|Induction Phase: DE Participants|Lack of Efficacy|2|||
28167306|NCT02493868|54838005|FG001|Induction Phase: DE Participants|Lack of Efficacy|0|||
28167307|NCT02493868|54838004|FG000|Induction Phase: DE Participants|Protocol Violation|2|||
28167308|NCT02493868|54838005|FG001|Induction Phase: DE Participants|Protocol Violation|0|||
28167309|NCT02493868|54838004|FG000|Induction Phase: DE Participants|Withdrawal by Subject|15|||
28167310|NCT02493868|54838005|FG001|Induction Phase: DE Participants|Withdrawal by Subject|0|||
27733846|NCT02551874|54181563|FG000|Overall Study|Did not receive randomized treatment|0|||
27733847|NCT02551874|54181564|FG001|Overall Study|Did not receive randomized treatment|7|||
27733848|NCT02551874|54181563|FG000|Overall Study|Did not enter long-term study|18|||
27733849|NCT02551874|54181564|FG001|Overall Study|Did not enter long-term study|25|||
27733850|NCT02682927|54181589|FG000|Overall Study|Adverse Event|0|||
27733851|NCT02682927|54181590|FG001|Overall Study|Adverse Event|0|||
27733852|NCT02682927|54181591|FG002|Overall Study|Adverse Event|5|||
27733853|NCT02682927|54181592|FG003|Overall Study|Adverse Event|1|||
27733854|NCT02682927|54181593|FG004|Overall Study|Adverse Event|0|||
27733855|NCT02682927|54181594|FG005|Overall Study|Adverse Event|2|||
27733856|NCT02682927|54181589|FG000|Overall Study|Death|0|||
27733857|NCT02682927|54181590|FG001|Overall Study|Death|0|||
27733858|NCT02682927|54181591|FG002|Overall Study|Death|0|||
27733859|NCT02682927|54181592|FG003|Overall Study|Death|1|||
27733860|NCT02682927|54181593|FG004|Overall Study|Death|0|||
27733861|NCT02682927|54181594|FG005|Overall Study|Death|0|||
27733862|NCT02682927|54181589|FG000|Overall Study|Lack of Efficacy|1|||
27733863|NCT02682927|54181590|FG001|Overall Study|Lack of Efficacy|0|||
27733864|NCT02682927|54181591|FG002|Overall Study|Lack of Efficacy|0|||
27733865|NCT02682927|54181592|FG003|Overall Study|Lack of Efficacy|1|||
27733866|NCT02682927|54181593|FG004|Overall Study|Lack of Efficacy|0|||
27733867|NCT02682927|54181594|FG005|Overall Study|Lack of Efficacy|0|||
27733868|NCT02682927|54181589|FG000|Overall Study|Other|0|||
27733869|NCT02682927|54181590|FG001|Overall Study|Other|0|||
27733870|NCT02682927|54181591|FG002|Overall Study|Other|0|||
27733871|NCT02682927|54181592|FG003|Overall Study|Other|2|||
27733872|NCT02682927|54181593|FG004|Overall Study|Other|0|||
27733873|NCT02682927|54181594|FG005|Overall Study|Other|0|||
27733874|NCT02682927|54181589|FG000|Overall Study|Withdrawal by Subject|2|||
27733875|NCT02682927|54181590|FG001|Overall Study|Withdrawal by Subject|0|||
27733876|NCT02682927|54181591|FG002|Overall Study|Withdrawal by Subject|1|||
27733877|NCT02682927|54181592|FG003|Overall Study|Withdrawal by Subject|0|||
27733878|NCT02682927|54181593|FG004|Overall Study|Withdrawal by Subject|1|||
27733879|NCT02682927|54181594|FG005|Overall Study|Withdrawal by Subject|1|||
27833127|NCT02714868|54313934|FG000|Overall Study|Withdrawal by Subject|3|||
27833128|NCT02714868|54313935|FG001|Overall Study|Withdrawal by Subject|0|||
28092192|NCT00352534|54746017|FG000|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
28167311|NCT02493868|54838004|FG000|Induction Phase: DE Participants|Not meet criteria to continue next phase|114|||
28167312|NCT02493868|54838005|FG001|Induction Phase: DE Participants|Not meet criteria to continue next phase|0|||
28167313|NCT02493868|54838004|FG000|Induction Phase: DE Participants|Other|8|||
28167314|NCT02493868|54838005|FG001|Induction Phase: DE Participants|Other|0|||
27733880|NCT02550938|54181618|FG000|Overall Study|Lost to Follow-up|8|||
27733881|NCT02550938|54181619|FG001|Overall Study|Lost to Follow-up|7|||
27733882|NCT02550938|54181620|FG002|Overall Study|Lost to Follow-up|12|||
27733883|NCT02550938|54181621|FG003|Overall Study|Lost to Follow-up|11|||
27733884|NCT02769065|54181661|FG000|Overall Study|Voluntary Withdrawal|1|||
27733885|NCT02769065|54181662|FG001|Overall Study|Voluntary Withdrawal|0|||
27733886|NCT02769065|54181663|FG002|Overall Study|Voluntary Withdrawal|0|||
27733887|NCT02769065|54181664|FG003|Overall Study|Voluntary Withdrawal|0|||
27733888|NCT02769065|54181665|FG004|Overall Study|Voluntary Withdrawal|0|||
28092193|NCT00352534|54746018|FG001|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
28092194|NCT00352534|54746019|FG002|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
28092195|NCT00352534|54746020|FG003|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
28092196|NCT00352534|54746021|FG004|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
28092197|NCT00352534|54746022|FG005|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
27733889|NCT02769065|54181666|FG005|Overall Study|Voluntary Withdrawal|0|||
27733890|NCT02769065|54181667|FG006|Overall Study|Voluntary Withdrawal|0|||
27733891|NCT02769065|54181668|FG007|Overall Study|Voluntary Withdrawal|0|||
27733892|NCT02769065|54181669|FG008|Overall Study|Voluntary Withdrawal|0|||
27733893|NCT02769065|54181670|FG009|Overall Study|Voluntary Withdrawal|0|||
27733894|NCT02769065|54181671|FG010|Overall Study|Voluntary Withdrawal|0|||
27733895|NCT02769065|54181672|FG011|Overall Study|Voluntary Withdrawal|0|||
27733896|NCT02769065|54181673|FG012|Overall Study|Voluntary Withdrawal|0|||
27733897|NCT02769065|54181674|FG013|Overall Study|Voluntary Withdrawal|0|||
27733898|NCT02769065|54181675|FG014|Overall Study|Voluntary Withdrawal|0|||
27733899|NCT02769065|54181676|FG015|Overall Study|Voluntary Withdrawal|0|||
27733900|NCT02769065|54181677|FG016|Overall Study|Voluntary Withdrawal|0|||
27733901|NCT02769065|54181678|FG017|Overall Study|Voluntary Withdrawal|0|||
27733902|NCT02769065|54181679|FG018|Overall Study|Voluntary Withdrawal|0|||
27733903|NCT02769065|54181680|FG019|Overall Study|Voluntary Withdrawal|0|||
27733904|NCT02769065|54181681|FG020|Overall Study|Voluntary Withdrawal|0|||
27733905|NCT02769065|54181682|FG021|Overall Study|Voluntary Withdrawal|0|||
27733906|NCT02769065|54181683|FG022|Overall Study|Voluntary Withdrawal|0|||
27733907|NCT02769065|54181684|FG023|Overall Study|Voluntary Withdrawal|0|||
28167315|NCT02493868|54838004|FG000|Optimization Phase: DE+TE Participants|Adverse Event|5|||
28167316|NCT02493868|54838005|FG001|Optimization Phase: DE+TE Participants|Adverse Event|0|||
28167317|NCT02493868|54838004|FG000|Optimization Phase: DE+TE Participants|Lost to Follow-up|2|||
28167318|NCT02493868|54838005|FG001|Optimization Phase: DE+TE Participants|Lost to Follow-up|1|||
28167319|NCT02493868|54838004|FG000|Optimization Phase: DE+TE Participants|Lack of Efficacy|8|||
28167320|NCT02493868|54838005|FG001|Optimization Phase: DE+TE Participants|Lack of Efficacy|0|||
27733908|NCT02769065|54181685|FG024|Overall Study|Voluntary Withdrawal|0|||
27733909|NCT02769065|54181686|FG025|Overall Study|Voluntary Withdrawal|0|||
27733910|NCT02769065|54181687|FG026|Overall Study|Voluntary Withdrawal|0|||
27733911|NCT02769065|54181688|FG027|Overall Study|Voluntary Withdrawal|0|||
28167321|NCT02493868|54838004|FG000|Optimization Phase: DE+TE Participants|Protocol Violation|4|||
28167322|NCT02493868|54838005|FG001|Optimization Phase: DE+TE Participants|Protocol Violation|1|||
28167323|NCT02493868|54838004|FG000|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8|||
28167324|NCT02493868|54838005|FG001|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3|||
28167325|NCT02493868|54838004|FG000|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14|||
28167326|NCT02493868|54838005|FG001|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5|||
28167327|NCT02493868|54838004|FG000|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107|||
28167328|NCT02493868|54838005|FG001|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20|||
28167329|NCT02493868|54838004|FG000|Optimization Phase: DE+TE Participants|Other|10|||
28167330|NCT02493868|54838005|FG001|Optimization Phase: DE+TE Participants|Other|2|||
28167331|NCT02493868|54838004|FG000|Maintenance Phase: DE+TE Participants|Adverse Event|1|||
28167332|NCT02493868|54838005|FG001|Maintenance Phase: DE+TE Participants|Adverse Event|4|||
28167333|NCT02493868|54838004|FG000|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1|||
28167334|NCT02493868|54838005|FG001|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0|||
27733912|NCT02769065|54181689|FG028|Overall Study|Voluntary Withdrawal|0|||
27733913|NCT02769065|54181690|FG029|Overall Study|Voluntary Withdrawal|0|||
27733914|NCT02769065|54181661|FG000|Overall Study|Reason Not Specified|0|||
27733915|NCT02769065|54181662|FG001|Overall Study|Reason Not Specified|0|||
27733916|NCT02769065|54181663|FG002|Overall Study|Reason Not Specified|0|||
28092198|NCT00352534|54746023|FG006|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11|||
28092199|NCT00352534|54746017|FG000|Final Risk Group Assignment|Death|0|||
28092200|NCT00352534|54746018|FG001|Final Risk Group Assignment|Death|0|||
28092201|NCT00352534|54746019|FG002|Final Risk Group Assignment|Death|0|||
28092202|NCT00352534|54746020|FG003|Final Risk Group Assignment|Death|0|||
28092203|NCT00352534|54746021|FG004|Final Risk Group Assignment|Death|0|||
28092204|NCT00352534|54746022|FG005|Final Risk Group Assignment|Death|2|||
28092205|NCT00352534|54746023|FG006|Final Risk Group Assignment|Death|0|||
28092206|NCT04323800|54746035|FG000|Overall Study|Withdrawal by Subject|4|||
28092207|NCT04323800|54746036|FG001|Overall Study|Withdrawal by Subject|4|||
28092208|NCT04323800|54746035|FG000|Overall Study|Incomplete transfusion|1|||
27733917|NCT02769065|54181664|FG003|Overall Study|Reason Not Specified|0|||
27733918|NCT02769065|54181665|FG004|Overall Study|Reason Not Specified|0|||
27733919|NCT02769065|54181666|FG005|Overall Study|Reason Not Specified|0|||
27733920|NCT02769065|54181667|FG006|Overall Study|Reason Not Specified|1|||
27733921|NCT02769065|54181668|FG007|Overall Study|Reason Not Specified|0|||
27855766|NCT02733042|54382052|FG014|Follow-up Period|Other|0|||
27980696|NCT00948155|54638710|FG001|Washout 14 Days|Lost to Follow-up|2|||
28092209|NCT04323800|54746036|FG001|Overall Study|Incomplete transfusion|0|||
28092210|NCT04323800|54746035|FG000|Overall Study|Other|0|||
28092211|NCT04323800|54746036|FG001|Overall Study|Other|1|||
28092212|NCT04323800|54746035|FG000|Overall Study|Positive RT-PCR at transfusion|1|||
28092213|NCT04323800|54746036|FG001|Overall Study|Positive RT-PCR at transfusion|1|||
28092214|NCT04321460|54746044|FG000|Overall Study|Participants who had no defecation or no data about it|1|||
28092215|NCT04321460|54746045|FG001|Overall Study|Participants who had no defecation or no data about it|1|||
28092216|NCT03122548|54746051|FG000|Overall Study|Death|2|||
28092217|NCT03122548|54746051|FG000|Overall Study|Progression - subject went into hospice|1|||
28092218|NCT03122548|54746051|FG000|Overall Study|Study Terminated by Sponsor|2|||
28167335|NCT02493868|54838004|FG000|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
28167336|NCT02493868|54838005|FG001|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
28167337|NCT02493868|54838004|FG000|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5|||
28167338|NCT02493868|54838005|FG001|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7|||
28167339|NCT02493868|54838004|FG000|Maintenance Phase: DE+TE Participants|Pregnancy|1|||
28167340|NCT02493868|54838005|FG001|Maintenance Phase: DE+TE Participants|Pregnancy|0|||
28167341|NCT02493868|54838004|FG000|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0|||
28167342|NCT02493868|54838005|FG001|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1|||
28167343|NCT02493868|54838004|FG000|Maintenance Phase: DE+TE Participants|Other|4|||
28167344|NCT02493868|54838005|FG001|Maintenance Phase: DE+TE Participants|Other|9|||
28167345|NCT02493868|54838004|FG000|Follow-up Phase|Lost to Follow-up|1|||
28167346|NCT02493868|54838005|FG001|Follow-up Phase|Lost to Follow-up|0|||
28167347|NCT02493868|54838004|FG000|Follow-up Phase|Withdrawal by Subject|3|||
28167348|NCT02493868|54838005|FG001|Follow-up Phase|Withdrawal by Subject|0|||
28167349|NCT02493868|54838004|FG000|Follow-up Phase|Investigator Decision|5|||
28167350|NCT02493868|54838005|FG001|Follow-up Phase|Investigator Decision|1|||
28167351|NCT02493868|54838004|FG000|Follow-up Phase|Other|2|||
28167352|NCT02493868|54838005|FG001|Follow-up Phase|Other|1|||
28167353|NCT02516410|54838019|FG000|Overall Study|Adverse Event|0|||
28167354|NCT02516410|54838020|FG001|Overall Study|Adverse Event|1|||
28167355|NCT02516410|54838019|FG000|Overall Study|Withdrawal by Subject|0|||
28167356|NCT02516410|54838020|FG001|Overall Study|Withdrawal by Subject|1|||
28167357|NCT02493712|54838030|FG000|Overall Study|Withdrawal by Subject|1|||
28167358|NCT02493712|54838031|FG001|Overall Study|Withdrawal by Subject|0|||
28167359|NCT02493712|54838032|FG002|Overall Study|Withdrawal by Subject|2|||
28167360|NCT02493712|54838030|FG000|Overall Study|Protocol Violation|0|||
28167361|NCT02493712|54838031|FG001|Overall Study|Protocol Violation|0|||
28167362|NCT02493712|54838032|FG002|Overall Study|Protocol Violation|1|||
28167363|NCT02493712|54838030|FG000|Overall Study|Lost to Follow-up|1|||
28167364|NCT02493712|54838031|FG001|Overall Study|Lost to Follow-up|0|||
28167365|NCT02493712|54838032|FG002|Overall Study|Lost to Follow-up|0|||
28167366|NCT02493712|54838030|FG000|Overall Study|Physician Decision|0|||
28167367|NCT02493712|54838031|FG001|Overall Study|Physician Decision|1|||
28167368|NCT02493712|54838032|FG002|Overall Study|Physician Decision|0|||
28167369|NCT02493712|54838030|FG000|Overall Study|Lack of Efficacy|0|||
28167370|NCT02493712|54838031|FG001|Overall Study|Lack of Efficacy|5|||
28167371|NCT02493712|54838032|FG002|Overall Study|Lack of Efficacy|3|||
28167372|NCT02516332|54838043|FG000|Overall Study|Withdrawal by Subject|2|||
28167373|NCT02516332|54838044|FG001|Overall Study|Withdrawal by Subject|1|||
28167374|NCT02516332|54838045|FG002|Overall Study|Withdrawal by Subject|2|||
28167375|NCT02483572|54838055|FG000|Overall Study|Withdrawal by Subject|1|||
28167376|NCT02483572|54838056|FG001|Overall Study|Withdrawal by Subject|0|||
28167377|NCT02483572|54838055|FG000|Overall Study|Lost to Follow-up|1|||
28167378|NCT02483572|54838056|FG001|Overall Study|Lost to Follow-up|0|||
28167379|NCT02483572|54838055|FG000|Overall Study|Physician Decision|0|||
28167380|NCT02483572|54838056|FG001|Overall Study|Physician Decision|1|||
28167381|NCT01062425|54838064|FG000|Overall Study|Protocol Violation|3|||
28167382|NCT01062425|54838065|FG001|Overall Study|Protocol Violation|6|||
28167383|NCT01060553|54838071|FG000|Overall Study|Lost to Follow-up|3|||
28167384|NCT01060553|54838072|FG001|Overall Study|Lost to Follow-up|5|||
28167385|NCT01060553|54838071|FG000|Overall Study|Withdrawal by Subject|5|||
28167386|NCT01060553|54838072|FG001|Overall Study|Withdrawal by Subject|5|||
28167387|NCT01060553|54838071|FG000|Overall Study|Lack of Efficacy|1|||
28167388|NCT01060553|54838072|FG001|Overall Study|Lack of Efficacy|0|||
28167389|NCT02491684|54838079|FG000|Treatment Phase|Adverse Event|2|||
28167390|NCT02491684|54838080|FG001|Treatment Phase|Adverse Event|2|||
28092219|NCT04459598|54746057|FG000|Overall Study|Adverse Event|1|||
28167391|NCT02491684|54838079|FG000|Treatment Phase|Incorrect randomisation|1|||
28167392|NCT02491684|54838080|FG001|Treatment Phase|Incorrect randomisation|0|||
28167393|NCT02491684|54838079|FG000|Treatment Phase|Investigator and Sponsor decision|0|||
28167394|NCT02491684|54838080|FG001|Treatment Phase|Investigator and Sponsor decision|1|||
28167395|NCT01061723|54838092|FG000|Overall Study|Adverse Event|0|||
28167396|NCT01061723|54838093|FG001|Overall Study|Adverse Event|2|||
28167397|NCT01061723|54838094|FG002|Overall Study|Adverse Event|5|||
28167398|NCT01061723|54838095|FG003|Overall Study|Adverse Event|5|||
28167399|NCT01061723|54838096|FG004|Overall Study|Adverse Event|2|||
28092220|NCT04459598|54746058|FG001|Overall Study|Adverse Event|1|||
28092221|NCT02929498|54746067|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3|||
28092222|NCT02929498|54746068|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
28092223|NCT02929498|54746069|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
28092224|NCT02929498|54746067|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Death|2|||
28092225|NCT02929498|54746068|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
28092226|NCT02929498|54746069|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
28092227|NCT03792672|54746075|FG000|Washout Period 3 (10 Days)|Withdrawal by Subject|1|||
28092228|NCT03792672|54746076|FG001|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
28092229|NCT03792672|54746077|FG002|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
28092230|NCT03792672|54746078|FG003|Washout Period 3 (10 Days)|Withdrawal by Subject|2|||
28092231|NCT03792672|54746079|FG004|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
28092232|NCT03792672|54746080|FG005|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
28092233|NCT03792672|54746075|FG000|Washout Period 3 (10 Days)|Physician Decision|0|||
28092234|NCT03792672|54746076|FG001|Washout Period 3 (10 Days)|Physician Decision|0|||
28092235|NCT03792672|54746077|FG002|Washout Period 3 (10 Days)|Physician Decision|1|||
28092236|NCT03792672|54746078|FG003|Washout Period 3 (10 Days)|Physician Decision|0|||
28092237|NCT03792672|54746079|FG004|Washout Period 3 (10 Days)|Physician Decision|0|||
27833129|NCT02714868|54313934|FG000|Overall Study|PI withdrawal safety risk self/others|1|||
27833130|NCT02714868|54313935|FG001|Overall Study|PI withdrawal safety risk self/others|0|||
27833131|NCT02714868|54313934|FG000|Overall Study|PI withdraw did not meet inclusion|1|||
27833132|NCT02714868|54313935|FG001|Overall Study|PI withdraw did not meet inclusion|0|||
27833133|NCT02713542|54314250|FG000|Overall Study|Use of prohibited medication|14|||
27833134|NCT02713542|54314251|FG001|Overall Study|Use of prohibited medication|5|||
27833135|NCT02713542|54314250|FG000|Overall Study|Withdrawal by Subject|4|||
27833136|NCT02713542|54314251|FG001|Overall Study|Withdrawal by Subject|1|||
27833137|NCT03548220|54314335|FG000|Overall Study|Lost to Follow-up|1|||
27833138|NCT03548220|54314336|FG001|Overall Study|Lost to Follow-up|0|||
27833139|NCT03548220|54314337|FG002|Overall Study|Lost to Follow-up|0|||
27833140|NCT03548220|54314338|FG003|Overall Study|Lost to Follow-up|0|||
27833141|NCT02712996|54314373|FG000|Second Intervention (Study Days 43-84)|Adverse Event|0|||
27833142|NCT02712996|54314374|FG001|Second Intervention (Study Days 43-84)|Adverse Event|1|||
27833143|NCT00701064|54314481|FG000|Overall Study|Protocol Violation|1|||
27833144|NCT00701064|54314482|FG001|Overall Study|Protocol Violation|1|||
27833145|NCT00701064|54314481|FG000|Overall Study|Withdrawal by Subject|1|||
27833146|NCT00701064|54314482|FG001|Overall Study|Withdrawal by Subject|1|||
27833147|NCT00701064|54314481|FG000|Overall Study|initiated other PTSD treatment|2|||
27833148|NCT00701064|54314482|FG001|Overall Study|initiated other PTSD treatment|2|||
27833149|NCT01748825|54314621|FG000|Dose Escalation|Refused further treatment|2|||
27833150|NCT01748825|54314622|FG001|Dose Escalation|Refused further treatment|2|||
27833151|NCT01748825|54314623|FG002|Dose Escalation|Refused further treatment|0|||
27833152|NCT01748825|54314624|FG003|Dose Escalation|Refused further treatment|0|||
27833153|NCT01748825|54314625|FG004|Dose Escalation|Refused further treatment|1|||
27833154|NCT01748825|54314626|FG005|Dose Escalation|Refused further treatment|2|||
27833155|NCT01748825|54314627|FG006|Dose Escalation|Refused further treatment|0|||
27833156|NCT01748825|54314628|FG007|Dose Escalation|Refused further treatment|0|||
27833157|NCT01748825|54314629|FG008|Dose Escalation|Refused further treatment|0|||
27833158|NCT01748825|54314630|FG009|Dose Escalation|Refused further treatment|0|||
27833159|NCT01748825|54314621|FG000|Dose Escalation|Switched to alternative treatment|0|||
27833160|NCT01748825|54314622|FG001|Dose Escalation|Switched to alternative treatment|0|||
27833161|NCT01748825|54314623|FG002|Dose Escalation|Switched to alternative treatment|0|||
27833162|NCT01748825|54314624|FG003|Dose Escalation|Switched to alternative treatment|1|||
27833163|NCT01748825|54314625|FG004|Dose Escalation|Switched to alternative treatment|0|||
27833164|NCT01748825|54314626|FG005|Dose Escalation|Switched to alternative treatment|0|||
27833165|NCT01748825|54314627|FG006|Dose Escalation|Switched to alternative treatment|0|||
27833166|NCT01748825|54314628|FG007|Dose Escalation|Switched to alternative treatment|0|||
27833167|NCT01748825|54314629|FG008|Dose Escalation|Switched to alternative treatment|0|||
28092238|NCT03792672|54746080|FG005|Washout Period 3 (10 Days)|Physician Decision|0|||
28092239|NCT03792672|54746075|FG000|Treatment Period 4 (2 Days)|Other|1|||
28092240|NCT03792672|54746076|FG001|Treatment Period 4 (2 Days)|Other|0|||
28092241|NCT03792672|54746077|FG002|Treatment Period 4 (2 Days)|Other|0|||
28092242|NCT03792672|54746078|FG003|Treatment Period 4 (2 Days)|Other|0|||
28092243|NCT03792672|54746079|FG004|Treatment Period 4 (2 Days)|Other|0|||
28092244|NCT03792672|54746080|FG005|Treatment Period 4 (2 Days)|Other|0|||
28092245|NCT03120676|54746095|FG000|Overall Study|Not treated|1|||
28092246|NCT03120520|54746103|FG000|Overall Study|Lost to Follow-up|1|||
27833168|NCT01748825|54314630|FG009|Dose Escalation|Switched to alternative treatment|0|||
27833169|NCT01748825|54314621|FG000|Dose Escalation|Adverse Event|0|||
27833170|NCT01748825|54314622|FG001|Dose Escalation|Adverse Event|0|||
27833171|NCT01748825|54314623|FG002|Dose Escalation|Adverse Event|0|||
27833172|NCT01748825|54314624|FG003|Dose Escalation|Adverse Event|0|||
27833173|NCT01748825|54314625|FG004|Dose Escalation|Adverse Event|0|||
27833174|NCT01748825|54314626|FG005|Dose Escalation|Adverse Event|0|||
28092247|NCT03120520|54746104|FG001|Overall Study|Lost to Follow-up|1|||
28092248|NCT03120520|54746105|FG002|Overall Study|Lost to Follow-up|1|||
28092249|NCT03120520|54746106|FG003|Overall Study|Lost to Follow-up|1|||
28092250|NCT03120520|54746103|FG000|Overall Study|Withdrawal by Subject|3|||
28092251|NCT03120520|54746104|FG001|Overall Study|Withdrawal by Subject|2|||
28092252|NCT03120520|54746105|FG002|Overall Study|Withdrawal by Subject|3|||
28092253|NCT03120520|54746106|FG003|Overall Study|Withdrawal by Subject|2|||
28092254|NCT03120520|54746103|FG000|Overall Study|Other|0|||
28092255|NCT03120520|54746104|FG001|Overall Study|Other|1|||
28092256|NCT03120520|54746105|FG002|Overall Study|Other|0|||
28092257|NCT03120520|54746106|FG003|Overall Study|Other|0|||
28092258|NCT03787212|54746116|FG000|Period 1|Study Termination|2|||
28092259|NCT03787212|54746117|FG001|Period 1|Study Termination|2|||
28092260|NCT03125200|54746130|FG000|Overall Study|Study Termination|0|||
28092261|NCT03125200|54746131|FG001|Overall Study|Study Termination|0|||
28092262|NCT03125200|54746132|FG002|Overall Study|Study Termination|0|||
28092263|NCT03125200|54746133|FG003|Overall Study|Study Termination|1|||
28092264|NCT03125200|54746134|FG004|Overall Study|Study Termination|1|||
28092265|NCT03125200|54746135|FG005|Overall Study|Study Termination|2|||
28092266|NCT03125200|54746136|FG006|Overall Study|Study Termination|1|||
28092267|NCT03125200|54746130|FG000|Overall Study|Clinical Progression|0|||
28092268|NCT03125200|54746131|FG001|Overall Study|Clinical Progression|0|||
28092269|NCT03125200|54746132|FG002|Overall Study|Clinical Progression|0|||
28092270|NCT03125200|54746133|FG003|Overall Study|Clinical Progression|1|||
28092271|NCT03125200|54746134|FG004|Overall Study|Clinical Progression|0|||
28092272|NCT03125200|54746135|FG005|Overall Study|Clinical Progression|1|||
28092273|NCT03125200|54746136|FG006|Overall Study|Clinical Progression|0|||
28092274|NCT03125200|54746130|FG000|Overall Study|Progressive Disease|2|||
28092275|NCT03125200|54746131|FG001|Overall Study|Progressive Disease|1|||
28092276|NCT03125200|54746132|FG002|Overall Study|Progressive Disease|2|||
28092277|NCT03125200|54746133|FG003|Overall Study|Progressive Disease|1|||
28092278|NCT03125200|54746134|FG004|Overall Study|Progressive Disease|2|||
28092279|NCT03125200|54746135|FG005|Overall Study|Progressive Disease|0|||
28092280|NCT03125200|54746136|FG006|Overall Study|Progressive Disease|1|||
28092281|NCT03125200|54746130|FG000|Overall Study|Lack of Efficacy|0|||
28092282|NCT03125200|54746131|FG001|Overall Study|Lack of Efficacy|0|||
28092283|NCT03125200|54746132|FG002|Overall Study|Lack of Efficacy|0|||
28092284|NCT03125200|54746133|FG003|Overall Study|Lack of Efficacy|1|||
28092285|NCT03125200|54746134|FG004|Overall Study|Lack of Efficacy|0|||
28092286|NCT03125200|54746135|FG005|Overall Study|Lack of Efficacy|0|||
28092287|NCT03125200|54746136|FG006|Overall Study|Lack of Efficacy|0|||
28092288|NCT03125200|54746130|FG000|Overall Study|Toxicity|0|||
28092289|NCT03125200|54746131|FG001|Overall Study|Toxicity|0|||
28092290|NCT03125200|54746132|FG002|Overall Study|Toxicity|0|||
28167400|NCT01061723|54838097|FG005|Overall Study|Adverse Event|6|||
28167401|NCT01061723|54838092|FG000|Overall Study|Lack of Efficacy|2|||
28167402|NCT01061723|54838093|FG001|Overall Study|Lack of Efficacy|3|||
28167403|NCT01061723|54838094|FG002|Overall Study|Lack of Efficacy|4|||
28167404|NCT01061723|54838095|FG003|Overall Study|Lack of Efficacy|2|||
27855767|NCT02733042|54382053|FG015|Follow-up Period|Other|0|||
27855768|NCT02733042|54382054|FG016|Follow-up Period|Other|0|||
27855769|NCT02733042|54382055|FG017|Follow-up Period|Other|0|||
27855770|NCT02733042|54382056|FG018|Follow-up Period|Other|0|||
27855771|NCT02733042|54382038|FG000|Follow-up Period|Withdrawal by Subject|0|||
27855772|NCT02733042|54382039|FG001|Follow-up Period|Withdrawal by Subject|0|||
27855773|NCT02733042|54382040|FG002|Follow-up Period|Withdrawal by Subject|0|||
27855774|NCT02733042|54382041|FG003|Follow-up Period|Withdrawal by Subject|0|||
27855775|NCT02733042|54382042|FG004|Follow-up Period|Withdrawal by Subject|0|||
27855776|NCT02733042|54382043|FG005|Follow-up Period|Withdrawal by Subject|0|||
27855777|NCT02733042|54382044|FG006|Follow-up Period|Withdrawal by Subject|0|||
27855778|NCT02733042|54382045|FG007|Follow-up Period|Withdrawal by Subject|0|||
28167405|NCT01061723|54838096|FG004|Overall Study|Lack of Efficacy|1|||
28167406|NCT01061723|54838097|FG005|Overall Study|Lack of Efficacy|1|||
28167407|NCT01061723|54838092|FG000|Overall Study|Randomized but not treated|0|||
27855779|NCT02733042|54382046|FG008|Follow-up Period|Withdrawal by Subject|1|||
28092291|NCT03125200|54746133|FG003|Overall Study|Toxicity|1|||
28167408|NCT01061723|54838093|FG001|Overall Study|Randomized but not treated|0|||
28092292|NCT03125200|54746134|FG004|Overall Study|Toxicity|0|||
28167409|NCT01061723|54838094|FG002|Overall Study|Randomized but not treated|0|||
27855780|NCT02733042|54382047|FG009|Follow-up Period|Withdrawal by Subject|0|||
27855781|NCT02733042|54382048|FG010|Follow-up Period|Withdrawal by Subject|1|||
27855782|NCT02733042|54382049|FG011|Follow-up Period|Withdrawal by Subject|0|||
27855783|NCT02733042|54382050|FG012|Follow-up Period|Withdrawal by Subject|0|||
28092293|NCT03125200|54746135|FG005|Overall Study|Toxicity|0|||
28092294|NCT03125200|54746136|FG006|Overall Study|Toxicity|0|||
28092295|NCT03125200|54746130|FG000|Overall Study|Consent Withdrawn by Subject|0|||
28092296|NCT03125200|54746131|FG001|Overall Study|Consent Withdrawn by Subject|1|||
28092297|NCT03125200|54746132|FG002|Overall Study|Consent Withdrawn by Subject|0|||
28092298|NCT03125200|54746133|FG003|Overall Study|Consent Withdrawn by Subject|0|||
27833175|NCT01748825|54314627|FG006|Dose Escalation|Adverse Event|1|||
28092299|NCT03125200|54746134|FG004|Overall Study|Consent Withdrawn by Subject|1|||
28092300|NCT03125200|54746135|FG005|Overall Study|Consent Withdrawn by Subject|0|||
28092301|NCT03125200|54746136|FG006|Overall Study|Consent Withdrawn by Subject|1|||
28092302|NCT03132220|54746157|FG000|Overall Study|Lost to Follow-up|17|||
28092303|NCT03132220|54746158|FG001|Overall Study|Lost to Follow-up|8|||
28092304|NCT03132220|54746157|FG000|Overall Study|Withdrawal by Subject|1|||
28092305|NCT03132220|54746158|FG001|Overall Study|Withdrawal by Subject|4|||
28092306|NCT03119662|54746166|FG000|Overall Study|Withdrawal by Subject|0|||
28092307|NCT03119662|54746167|FG001|Overall Study|Withdrawal by Subject|1|||
28092308|NCT02728804|54746173|FG000|Overall Study|Ineligible|3|||
28092309|NCT02728804|54746173|FG000|Overall Study|Did not complete baseline questionnaire|9|||
28092310|NCT02728804|54746173|FG000|Overall Study|Death|99|||
28092311|NCT02699554|54746189|FG000|Overall Study|Lost to Follow-up|9|||
28092312|NCT03783780|54746203|FG000|Overall Study|Withdrawn prior to completion|1|||
28092313|NCT03783702|54746210|FG000|Overall Study|Lost to Follow-up|6|||
28092314|NCT03783702|54746211|FG001|Overall Study|Lost to Follow-up|8|||
28092315|NCT03783702|54746210|FG000|Overall Study|Protocol Violation|1|||
28092316|NCT03783702|54746211|FG001|Overall Study|Protocol Violation|3|||
28092317|NCT03575572|54746219|FG000|Overall Study|Withdrawal by Subject|2|||
28092318|NCT03575572|54746219|FG000|Overall Study|Physician Decision|2|||
28092319|NCT03116698|54746245|FG000|Overall Study|Adverse Event|1|||
28092320|NCT03116698|54746246|FG001|Overall Study|Adverse Event|1|||
28092321|NCT03116698|54746247|FG002|Overall Study|Adverse Event|1|||
28092322|NCT03116698|54746248|FG003|Overall Study|Adverse Event|0|||
28092323|NCT03116698|54746245|FG000|Overall Study|Withdrawal by Subject|1|||
28092324|NCT03116698|54746246|FG001|Overall Study|Withdrawal by Subject|4|||
28092325|NCT03116698|54746247|FG002|Overall Study|Withdrawal by Subject|5|||
28092326|NCT03116698|54746248|FG003|Overall Study|Withdrawal by Subject|2|||
28092327|NCT03116698|54746245|FG000|Overall Study|Lost to Follow-up|2|||
28092328|NCT03116698|54746246|FG001|Overall Study|Lost to Follow-up|0|||
28092329|NCT03116698|54746247|FG002|Overall Study|Lost to Follow-up|0|||
28092330|NCT03116698|54746248|FG003|Overall Study|Lost to Follow-up|0|||
28092331|NCT03116698|54746245|FG000|Overall Study|Physician Decision|1|||
28092332|NCT03116698|54746246|FG001|Overall Study|Physician Decision|1|||
28092333|NCT03116698|54746247|FG002|Overall Study|Physician Decision|0|||
28092334|NCT03116698|54746248|FG003|Overall Study|Physician Decision|0|||
28092335|NCT03116698|54746245|FG000|Overall Study|Protocol Violation|1|||
28092336|NCT03116698|54746246|FG001|Overall Study|Protocol Violation|0|||
28092337|NCT03116698|54746247|FG002|Overall Study|Protocol Violation|0|||
28092338|NCT03116698|54746248|FG003|Overall Study|Protocol Violation|0|||
28092339|NCT03116698|54746245|FG000|Overall Study|Death|0|||
28092340|NCT03116698|54746246|FG001|Overall Study|Death|0|||
28092341|NCT03116698|54746247|FG002|Overall Study|Death|2|||
28092342|NCT03116698|54746248|FG003|Overall Study|Death|0|||
28092343|NCT03116152|54746260|FG000|Overall Study|Disease Progression|49|||
28092344|NCT03116152|54746261|FG001|Overall Study|Disease Progression|47|||
28092345|NCT03116152|54746260|FG000|Overall Study|Death|5|||
28092346|NCT03116152|54746261|FG001|Overall Study|Death|2|||
28092347|NCT03116152|54746260|FG000|Overall Study|Adverse Event|21|||
28092348|NCT03116152|54746261|FG001|Overall Study|Adverse Event|7|||
28092349|NCT03116152|54746260|FG000|Overall Study|Protocol Violation|2|||
28092350|NCT03116152|54746261|FG001|Overall Study|Protocol Violation|2|||
28092351|NCT03116152|54746260|FG000|Overall Study|Withdrawal by Subject|0|||
28092352|NCT03116152|54746261|FG001|Overall Study|Withdrawal by Subject|1|||
28092353|NCT03116152|54746260|FG000|Overall Study|Physician Decision|3|||
28092354|NCT03116152|54746261|FG001|Overall Study|Physician Decision|2|||
28092355|NCT03116152|54746260|FG000|Overall Study|other|11|||
28092356|NCT03116152|54746261|FG001|Overall Study|other|34|||
28167410|NCT01061723|54838095|FG003|Overall Study|Randomized but not treated|0|||
28167411|NCT01061723|54838096|FG004|Overall Study|Randomized but not treated|0|||
28167412|NCT01061723|54838097|FG005|Overall Study|Randomized but not treated|1|||
28092357|NCT00226499|54746272|FG000|Overall Study|Adverse Event|10|||
28167413|NCT01061723|54838092|FG000|Overall Study|Other than specified above|2|||
28167414|NCT01061723|54838093|FG001|Overall Study|Other than specified above|1|||
28167415|NCT01061723|54838094|FG002|Overall Study|Other than specified above|1|||
28167416|NCT01061723|54838095|FG003|Overall Study|Other than specified above|1|||
28167417|NCT01061723|54838096|FG004|Overall Study|Other than specified above|0|||
28167418|NCT01061723|54838097|FG005|Overall Study|Other than specified above|1|||
27833176|NCT01748825|54314628|FG007|Dose Escalation|Adverse Event|0|||
28092358|NCT00226499|54746273|FG001|Overall Study|Adverse Event|6|||
27833177|NCT01748825|54314629|FG008|Dose Escalation|Adverse Event|0|||
28092359|NCT00226499|54746274|FG002|Overall Study|Adverse Event|3|||
28092360|NCT00226499|54746272|FG000|Overall Study|Others|1064|||
28092361|NCT00226499|54746273|FG001|Overall Study|Others|1066|||
28092362|NCT00226499|54746274|FG002|Overall Study|Others|356|||
28092363|NCT01400776|54746288|FG000|Overall Study|Adverse Event|7|||
28092364|NCT01400776|54746289|FG001|Overall Study|Adverse Event|2|||
28092365|NCT01400776|54746290|FG002|Overall Study|Adverse Event|9|||
28167419|NCT01061567|54838116|FG000|Overall Study|Adverse Event|32|||
28092366|NCT01400776|54746291|FG003|Overall Study|Adverse Event|2|||
28092367|NCT01400776|54746288|FG000|Overall Study|Lost to Follow-up|1|||
28092368|NCT01400776|54746289|FG001|Overall Study|Lost to Follow-up|0|||
28092369|NCT01400776|54746290|FG002|Overall Study|Lost to Follow-up|4|||
28092370|NCT01400776|54746291|FG003|Overall Study|Lost to Follow-up|1|||
28092371|NCT01400776|54746288|FG000|Overall Study|Withdrew Consent|4|||
28092372|NCT01400776|54746289|FG001|Overall Study|Withdrew Consent|2|||
28092373|NCT01400776|54746290|FG002|Overall Study|Withdrew Consent|6|||
28092374|NCT01400776|54746291|FG003|Overall Study|Withdrew Consent|1|||
28092375|NCT01400776|54746288|FG000|Overall Study|Protocol Deviation|6|||
28092376|NCT01400776|54746289|FG001|Overall Study|Protocol Deviation|1|||
28092377|NCT01400776|54746290|FG002|Overall Study|Protocol Deviation|5|||
28092378|NCT01400776|54746291|FG003|Overall Study|Protocol Deviation|2|||
28092379|NCT01400776|54746288|FG000|Overall Study|Reason not Specified|3|||
28092380|NCT01400776|54746289|FG001|Overall Study|Reason not Specified|0|||
28092381|NCT01400776|54746290|FG002|Overall Study|Reason not Specified|4|||
28092382|NCT01400776|54746291|FG003|Overall Study|Reason not Specified|3|||
28092383|NCT03131596|54746303|FG000|Overall Study|Protocol Violation|3|||
28092384|NCT03131596|54746304|FG001|Overall Study|Protocol Violation|3|||
28092385|NCT03131596|54746303|FG000|Overall Study|Lost to Follow-up|3|||
28092386|NCT03131596|54746304|FG001|Overall Study|Lost to Follow-up|0|||
28092387|NCT00255047|54746318|FG000|Overall Study|Serious Adverse Events|2|||
28092388|NCT00255047|54746319|FG001|Overall Study|Serious Adverse Events|1|||
28092389|NCT00255047|54746320|FG002|Overall Study|Serious Adverse Events|2|||
28092390|NCT00255047|54746321|FG003|Overall Study|Serious Adverse Events|1|||
28092391|NCT00255047|54746318|FG000|Overall Study|Adverse Event|0|||
28092392|NCT00255047|54746319|FG001|Overall Study|Adverse Event|3|||
28092393|NCT00255047|54746320|FG002|Overall Study|Adverse Event|2|||
28092394|NCT00255047|54746321|FG003|Overall Study|Adverse Event|1|||
28092395|NCT00255047|54746318|FG000|Overall Study|Protocol Violation|13|||
28092396|NCT00255047|54746319|FG001|Overall Study|Protocol Violation|13|||
28092397|NCT00255047|54746320|FG002|Overall Study|Protocol Violation|16|||
28092398|NCT00255047|54746321|FG003|Overall Study|Protocol Violation|20|||
28092399|NCT00255047|54746318|FG000|Overall Study|Lost to Follow-up|9|||
28092400|NCT00255047|54746319|FG001|Overall Study|Lost to Follow-up|8|||
28092401|NCT00255047|54746320|FG002|Overall Study|Lost to Follow-up|5|||
28092402|NCT00255047|54746321|FG003|Overall Study|Lost to Follow-up|6|||
28092403|NCT00255047|54746318|FG000|Overall Study|Withdrawal by Subject|24|||
28092404|NCT00255047|54746319|FG001|Overall Study|Withdrawal by Subject|23|||
28092405|NCT00255047|54746320|FG002|Overall Study|Withdrawal by Subject|25|||
28092406|NCT00255047|54746321|FG003|Overall Study|Withdrawal by Subject|18|||
28092407|NCT00225251|54746333|FG000|Overall Study|Withdrawal by Subject|1|||
28092408|NCT00225251|54746334|FG001|Overall Study|Withdrawal by Subject|1|||
28092409|NCT00254501|54746342|FG000|Overall Study|Lost to Follow-up|1|||
28092410|NCT00254501|54746343|FG001|Overall Study|Lost to Follow-up|1|||
28092411|NCT00253643|54746355|FG000|Overall Study|Withdrawal by Subject|0|||
28092412|NCT00253643|54746356|FG001|Overall Study|Withdrawal by Subject|0|||
28092413|NCT00253643|54746357|FG002|Overall Study|Withdrawal by Subject|1|||
28092414|NCT00253643|54746358|FG003|Overall Study|Withdrawal by Subject|1|||
28092415|NCT00253643|54746355|FG000|Overall Study|Non-Compliance|0|||
28092416|NCT00253643|54746356|FG001|Overall Study|Non-Compliance|0|||
28092417|NCT00253643|54746357|FG002|Overall Study|Non-Compliance|0|||
28092418|NCT00253643|54746358|FG003|Overall Study|Non-Compliance|2|||
28092419|NCT00221195|54746370|FG000|Therapy 1 (Months 1-6)|Withdrawal by Subject|3|||
28092420|NCT00221195|54746371|FG001|Therapy 1 (Months 1-6)|Withdrawal by Subject|1|||
28092421|NCT00221195|54746370|FG000|Therapy 1 (Months 1-6)|Lost to Follow-up|0|||
28167420|NCT01061567|54838116|FG000|Overall Study|Death|2|||
28167421|NCT01061567|54838116|FG000|Overall Study|Lack of Efficacy|3|||
28167422|NCT01061567|54838116|FG000|Overall Study|Lost to Follow-up|24|||
28167423|NCT01061567|54838116|FG000|Overall Study|Protocol Violation|1|||
28167424|NCT01061567|54838116|FG000|Overall Study|Withdrawal by Subject|11|||
28167425|NCT01061567|54838116|FG000|Overall Study|Other reason than stated above|3|||
28167426|NCT01061333|54838120|FG000|Period 4: 20-day Washout|Discontinued by Study Team|0|||
27733922|NCT02769065|54181669|FG008|Overall Study|Reason Not Specified|0|||
28092422|NCT00221195|54746371|FG001|Therapy 1 (Months 1-6)|Lost to Follow-up|1|||
28092423|NCT00221195|54746370|FG000|Washout Period (Months 7-9)|Death|0|||
28092424|NCT00221195|54746371|FG001|Washout Period (Months 7-9)|Death|1|||
28092425|NCT00221195|54746370|FG000|Therapy 2 (Months 10-15)|Death|1|||
28092426|NCT00221195|54746371|FG001|Therapy 2 (Months 10-15)|Death|0|||
28092427|NCT00221195|54746370|FG000|Therapy 2 (Months 10-15)|Adverse Event|1|||
28092428|NCT00221195|54746371|FG001|Therapy 2 (Months 10-15)|Adverse Event|0|||
28092429|NCT00220805|54746380|FG000|Overall Study|Adverse Event|1|||
28092430|NCT00220805|54746381|FG001|Overall Study|Adverse Event|3|||
28092431|NCT00220805|54746380|FG000|Overall Study|Withdrawal by Subject|3|||
27733923|NCT02769065|54181670|FG009|Overall Study|Reason Not Specified|0|||
28092432|NCT00220805|54746381|FG001|Overall Study|Withdrawal by Subject|0|||
28092433|NCT00220805|54746380|FG000|Overall Study|Lack of Efficacy|1|||
28167427|NCT01061333|54838121|FG001|Period 4: 20-day Washout|Discontinued by Study Team|1|||
28092434|NCT00220805|54746381|FG001|Overall Study|Lack of Efficacy|0|||
28092435|NCT00220805|54746380|FG000|Overall Study|Develop. of choroidal neovascularization|3|||
28092436|NCT00220805|54746381|FG001|Overall Study|Develop. of choroidal neovascularization|8|||
28092437|NCT00220727|54746389|FG000|Second Infusion (Week <6)|Pt did not meet study requirement|1|||
28092438|NCT00220727|54746390|FG001|Second Infusion (Week <6)|Pt did not meet study requirement|0|||
28092439|NCT04495816|54746400|FG000|Overall Study|Lost to Follow-up|10|||
28092440|NCT04495816|54746401|FG001|Overall Study|Lost to Follow-up|4|||
28092441|NCT04495816|54746400|FG000|Overall Study|Withdrawal by Subject|3|||
28092442|NCT04495816|54746401|FG001|Overall Study|Withdrawal by Subject|5|||
28092443|NCT03971357|54746409|FG000|Overall Study|Lack of Efficacy|0|||
28092444|NCT03971357|54746410|FG001|Overall Study|Lack of Efficacy|1|||
28092445|NCT04310566|54746416|FG000|Period 1|Study Termination due to COVID-19|15|||
28092446|NCT04310566|54746417|FG001|Period 1|Study Termination due to COVID-19|17|||
28092447|NCT04310566|54746416|FG000|Period 1|Protocol Violation|0|||
28092448|NCT04310566|54746417|FG001|Period 1|Protocol Violation|1|||
28092449|NCT04310566|54746416|FG000|Period 1|Subject no longer meets eligbility criteria|0|||
28092450|NCT04310566|54746417|FG001|Period 1|Subject no longer meets eligbility criteria|1|||
28092451|NCT04310566|54746416|FG000|Period 1|Lost to Follow-up|1|||
28092452|NCT04310566|54746417|FG001|Period 1|Lost to Follow-up|0|||
28092453|NCT04310566|54746416|FG000|Period 1|Withdrawal by Subject|0|||
28092454|NCT04310566|54746417|FG001|Period 1|Withdrawal by Subject|1|||
28092455|NCT04310566|54746416|FG000|Period 2|Study Termination|7|||
28167428|NCT02489968|54838134|FG000|Open-label Treatment Period|Adverse Event|14|||
28167429|NCT02489968|54838135|FG001|Open-label Treatment Period|Adverse Event|7|||
28167430|NCT02489968|54838136|FG002|Open-label Treatment Period|Adverse Event|0|||
28167431|NCT02489968|54838137|FG003|Open-label Treatment Period|Adverse Event|0|||
28167432|NCT02489968|54838138|FG004|Open-label Treatment Period|Adverse Event|0|||
28167433|NCT02489968|54838139|FG005|Open-label Treatment Period|Adverse Event|0|||
28167434|NCT02489968|54838134|FG000|Open-label Treatment Period|Protocol Violation|2|||
28167435|NCT02489968|54838135|FG001|Open-label Treatment Period|Protocol Violation|2|||
28167436|NCT02489968|54838136|FG002|Open-label Treatment Period|Protocol Violation|0|||
28167437|NCT02489968|54838137|FG003|Open-label Treatment Period|Protocol Violation|0|||
28167438|NCT02489968|54838138|FG004|Open-label Treatment Period|Protocol Violation|0|||
28167439|NCT02489968|54838139|FG005|Open-label Treatment Period|Protocol Violation|0|||
28167440|NCT02489968|54838134|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
28167441|NCT02489968|54838135|FG001|Open-label Treatment Period|Lost to Follow-up|3|||
28167442|NCT02489968|54838136|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
28167443|NCT02489968|54838137|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
28167444|NCT02489968|54838138|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
28167445|NCT02489968|54838139|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
28167446|NCT02489968|54838134|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
28167447|NCT02489968|54838135|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
28092456|NCT04310566|54746417|FG001|Period 2|Study Termination|5|||
28092457|NCT00252239|54746427|FG000|Overall Study|Withdrawal by Subject|1|||
28092458|NCT00252239|54746428|FG001|Overall Study|Withdrawal by Subject|0|||
28092459|NCT00252239|54746429|FG002|Overall Study|Withdrawal by Subject|0|||
28092460|NCT00252239|54746430|FG003|Overall Study|Withdrawal by Subject|1|||
28092461|NCT00252239|54746427|FG000|Overall Study|Lost to Follow-up|0|||
28092462|NCT00252239|54746428|FG001|Overall Study|Lost to Follow-up|0|||
28092463|NCT00252239|54746429|FG002|Overall Study|Lost to Follow-up|2|||
28092464|NCT00252239|54746430|FG003|Overall Study|Lost to Follow-up|0|||
28167448|NCT02489968|54838136|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
28167449|NCT02489968|54838137|FG003|Open-label Treatment Period|Withdrawal by Subject|0|||
28167450|NCT02489968|54838138|FG004|Open-label Treatment Period|Withdrawal by Subject|0|||
28167451|NCT02489968|54838139|FG005|Open-label Treatment Period|Withdrawal by Subject|0|||
28167452|NCT02489968|54838134|FG000|Open-label Treatment Period|Other than specified above|204|||
28167453|NCT02489968|54838135|FG001|Open-label Treatment Period|Other than specified above|189|||
28167454|NCT02489968|54838136|FG002|Open-label Treatment Period|Other than specified above|0|||
28167455|NCT02489968|54838137|FG003|Open-label Treatment Period|Other than specified above|0|||
27733924|NCT02769065|54181671|FG010|Overall Study|Reason Not Specified|0|||
27733925|NCT02769065|54181672|FG011|Overall Study|Reason Not Specified|0|||
27980697|NCT00958217|54638720|FG000|Overall Study|Death|2|||
27980698|NCT00958217|54638721|FG001|Overall Study|Death|1|||
28092465|NCT03103906|54746442|FG000|Overall Study|Adverse Event|2|||
28092466|NCT03103906|54746443|FG001|Overall Study|Adverse Event|3|||
28167456|NCT02489968|54838138|FG004|Open-label Treatment Period|Other than specified above|0|||
27980699|NCT00958217|54638720|FG000|Overall Study|Withdrawal by Subject|4|||
28092467|NCT03103906|54746442|FG000|Overall Study|Other|2|||
28092468|NCT03103906|54746443|FG001|Overall Study|Other|0|||
28092469|NCT04799158|54746453|FG000|Run-In Period|Adverse Event|6|||
28092470|NCT04799158|54746454|FG001|Run-In Period|Adverse Event|0|||
28167457|NCT02489968|54838139|FG005|Open-label Treatment Period|Other than specified above|0|||
28167458|NCT02489968|54838134|FG000|Double-blind Treatment Period|Adverse Event|0|||
28167459|NCT02489968|54838135|FG001|Double-blind Treatment Period|Adverse Event|0|||
28167460|NCT02489968|54838136|FG002|Double-blind Treatment Period|Adverse Event|2|||
28167461|NCT02489968|54838137|FG003|Double-blind Treatment Period|Adverse Event|6|||
28167462|NCT02489968|54838138|FG004|Double-blind Treatment Period|Adverse Event|4|||
28167463|NCT02489968|54838139|FG005|Double-blind Treatment Period|Adverse Event|5|||
28167464|NCT02489968|54838134|FG000|Double-blind Treatment Period|Protocol Violation|0|||
27980700|NCT00958217|54638721|FG001|Overall Study|Withdrawal by Subject|3|||
27980701|NCT00958217|54638720|FG000|Overall Study|Lost to Follow-up|17|||
27980702|NCT00958217|54638721|FG001|Overall Study|Lost to Follow-up|19|||
27980703|NCT00958217|54638720|FG000|Overall Study|Moved out of area|1|||
27980704|NCT00958217|54638721|FG001|Overall Study|Moved out of area|1|||
27980705|NCT00958217|54638720|FG000|Overall Study|Inpatient hospitalization|0|||
27980706|NCT00958217|54638721|FG001|Overall Study|Inpatient hospitalization|1|||
27980707|NCT00891020|54638731|FG000|24 Week Treatment Period|Adverse event or intercurrent illness|11|||
27980708|NCT00891020|54638732|FG001|24 Week Treatment Period|Adverse event or intercurrent illness|32|||
27980709|NCT00891020|54638733|FG002|24 Week Treatment Period|Adverse event or intercurrent illness|17|||
27980710|NCT00891020|54638731|FG000|24 Week Treatment Period|Death|0|||
28092471|NCT04799158|54746455|FG002|Run-In Period|Adverse Event|0|||
28167465|NCT02489968|54838135|FG001|Double-blind Treatment Period|Protocol Violation|0|||
28167466|NCT02489968|54838136|FG002|Double-blind Treatment Period|Protocol Violation|0|||
28167467|NCT02489968|54838137|FG003|Double-blind Treatment Period|Protocol Violation|0|||
28167468|NCT02489968|54838138|FG004|Double-blind Treatment Period|Protocol Violation|1|||
28167469|NCT02489968|54838139|FG005|Double-blind Treatment Period|Protocol Violation|1|||
28092472|NCT04799158|54746456|FG003|Run-In Period|Adverse Event|0|||
28092473|NCT04799158|54746457|FG004|Run-In Period|Adverse Event|0|||
28092474|NCT04799158|54746453|FG000|Run-In Period|Lost to Follow-up|4|||
28092475|NCT04799158|54746454|FG001|Run-In Period|Lost to Follow-up|0|||
28092476|NCT04799158|54746455|FG002|Run-In Period|Lost to Follow-up|0|||
28092477|NCT04799158|54746456|FG003|Run-In Period|Lost to Follow-up|0|||
28092478|NCT04799158|54746457|FG004|Run-In Period|Lost to Follow-up|0|||
28092479|NCT04799158|54746453|FG000|Run-In Period|Significant Protocol Deviation|1|||
28092480|NCT04799158|54746454|FG001|Run-In Period|Significant Protocol Deviation|0|||
28092481|NCT04799158|54746455|FG002|Run-In Period|Significant Protocol Deviation|0|||
28092482|NCT04799158|54746456|FG003|Run-In Period|Significant Protocol Deviation|0|||
28092483|NCT04799158|54746457|FG004|Run-In Period|Significant Protocol Deviation|0|||
28092484|NCT04799158|54746453|FG000|Run-In Period|Withdrawal by Subject|11|||
28092485|NCT04799158|54746454|FG001|Run-In Period|Withdrawal by Subject|0|||
28092486|NCT04799158|54746455|FG002|Run-In Period|Withdrawal by Subject|0|||
28092487|NCT04799158|54746456|FG003|Run-In Period|Withdrawal by Subject|0|||
28092488|NCT04799158|54746457|FG004|Run-In Period|Withdrawal by Subject|0|||
28092489|NCT04799158|54746453|FG000|Run-In Period|Miscellaneous|3|||
28092490|NCT04799158|54746454|FG001|Run-In Period|Miscellaneous|0|||
28092491|NCT04799158|54746455|FG002|Run-In Period|Miscellaneous|0|||
28092492|NCT04799158|54746456|FG003|Run-In Period|Miscellaneous|0|||
28092493|NCT04799158|54746457|FG004|Run-In Period|Miscellaneous|0|||
28092494|NCT04799158|54746453|FG000|Run-In Period|Did not meet On-Demand Eligibility Criteria|226|||
28092495|NCT04799158|54746454|FG001|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
28092496|NCT04799158|54746455|FG002|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
28092497|NCT04799158|54746456|FG003|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
28167470|NCT02489968|54838134|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
28167471|NCT02489968|54838135|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
28167472|NCT02489968|54838136|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
28167473|NCT02489968|54838137|FG003|Double-blind Treatment Period|Withdrawal by Subject|2|||
28167474|NCT02489968|54838138|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
28167475|NCT02489968|54838139|FG005|Double-blind Treatment Period|Withdrawal by Subject|2|||
28167476|NCT02489968|54838134|FG000|Double-blind Treatment Period|Other than specified above|0|||
28167477|NCT02489968|54838135|FG001|Double-blind Treatment Period|Other than specified above|0|||
28167478|NCT02489968|54838136|FG002|Double-blind Treatment Period|Other than specified above|0|||
28167479|NCT02489968|54838137|FG003|Double-blind Treatment Period|Other than specified above|0|||
28167480|NCT02489968|54838138|FG004|Double-blind Treatment Period|Other than specified above|1|||
27733926|NCT02769065|54181673|FG012|Overall Study|Reason Not Specified|0|||
27733927|NCT02769065|54181674|FG013|Overall Study|Reason Not Specified|0|||
27733928|NCT02769065|54181675|FG014|Overall Study|Reason Not Specified|0|||
27733929|NCT02769065|54181676|FG015|Overall Study|Reason Not Specified|0|||
27980711|NCT00891020|54638732|FG001|24 Week Treatment Period|Death|2|||
28092498|NCT04799158|54746457|FG004|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
28092499|NCT04799158|54746453|FG000|On-Demand Treatment Period|Adverse Event|0|||
28092500|NCT04799158|54746454|FG001|On-Demand Treatment Period|Adverse Event|1|||
27733930|NCT02769065|54181677|FG016|Overall Study|Reason Not Specified|0|||
28092501|NCT04799158|54746455|FG002|On-Demand Treatment Period|Adverse Event|0|||
28092502|NCT04799158|54746456|FG003|On-Demand Treatment Period|Adverse Event|0|||
28167481|NCT02489968|54838139|FG005|Double-blind Treatment Period|Other than specified above|0|||
28167482|NCT02483416|54838153|FG000|Overall Study|Other reason|0|||
28167483|NCT02483416|54838154|FG001|Overall Study|Other reason|1|||
28167484|NCT02483416|54838153|FG000|Overall Study|Treatment stop|3|||
28167485|NCT02483416|54838154|FG001|Overall Study|Treatment stop|0|||
28167486|NCT01061177|54838161|FG000|Overall Study|Adverse Event|117|||
28167487|NCT01061177|54838161|FG000|Overall Study|Withdrawal by Subject|27|||
28167488|NCT01061177|54838161|FG000|Overall Study|Disease progression|17|||
28167489|NCT01061177|54838161|FG000|Overall Study|Protocol Violation|11|||
28167490|NCT01061177|54838161|FG000|Overall Study|Lost to Follow-up|9|||
28167491|NCT01061177|54838161|FG000|Overall Study|New cancer therapy|9|||
28167492|NCT01061177|54838161|FG000|Overall Study|Abnormal laboratory values|6|||
28167493|NCT01061177|54838161|FG000|Overall Study|Abnormal test procedure results|4|||
28167494|NCT01061177|54838161|FG000|Overall Study|Administratie problems|4|||
28167495|NCT01061177|54838161|FG000|Overall Study|Death|4|||
28167496|NCT02481934|54838165|FG000|Overall Study|Death|2|||
28167497|NCT02973425|54838171|FG000|Overall Study|Lost to Follow-up|49|||
28167498|NCT02973425|54838172|FG001|Overall Study|Lost to Follow-up|53|||
28167499|NCT02489500|54838181|FG000|Overall Study|Death|1|||
28167500|NCT02489500|54838182|FG001|Overall Study|Death|1|||
28167501|NCT02732847|54838190|FG000|Overall Study|some filled early|42|||
28167502|NCT02732847|54838191|FG001|Overall Study|some filled early|42|||
28167503|NCT02489344|54838197|FG000|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1|||
28092503|NCT04799158|54746457|FG004|On-Demand Treatment Period|Adverse Event|1|||
28092504|NCT04799158|54746453|FG000|On-Demand Treatment Period|Lost to Follow-up|0|||
28092505|NCT04799158|54746454|FG001|On-Demand Treatment Period|Lost to Follow-up|0|||
28092506|NCT04799158|54746455|FG002|On-Demand Treatment Period|Lost to Follow-up|0|||
28092507|NCT04799158|54746456|FG003|On-Demand Treatment Period|Lost to Follow-up|0|||
28092508|NCT04799158|54746457|FG004|On-Demand Treatment Period|Lost to Follow-up|1|||
28092509|NCT04799158|54746453|FG000|On-Demand Treatment Period|Significant Protocol Deviation|0|||
28092510|NCT04799158|54746454|FG001|On-Demand Treatment Period|Significant Protocol Deviation|0|||
28092511|NCT04799158|54746455|FG002|On-Demand Treatment Period|Significant Protocol Deviation|0|||
28092512|NCT04799158|54746456|FG003|On-Demand Treatment Period|Significant Protocol Deviation|1|||
28092513|NCT04799158|54746457|FG004|On-Demand Treatment Period|Significant Protocol Deviation|0|||
28092514|NCT04799158|54746453|FG000|On-Demand Treatment Period|Withdrawal by Subject|0|||
28092515|NCT04799158|54746454|FG001|On-Demand Treatment Period|Withdrawal by Subject|0|||
28092516|NCT04799158|54746455|FG002|On-Demand Treatment Period|Withdrawal by Subject|0|||
28092517|NCT04799158|54746456|FG003|On-Demand Treatment Period|Withdrawal by Subject|1|||
28167504|NCT02489344|54838197|FG000|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1|||
28167505|NCT02489344|54838197|FG000|LTS14116 (Extension Study): 31 Months|Adverse Event|1|||
28167506|NCT02489344|54838197|FG000|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2|||
28167507|NCT02488330|54838201|FG000|Overall Study|Adverse Event|1|||
28167508|NCT02488330|54838201|FG000|Overall Study|Physician Decision|2|||
28167509|NCT02488330|54838201|FG000|Overall Study|Death|2|||
28167510|NCT02488330|54838201|FG000|Overall Study|Disease Progression|3|||
28167511|NCT02488330|54838201|FG000|Overall Study|Study Termination by Sponsor|4|||
28167512|NCT02481310|54838208|FG000|Follow up|Still in follow up|0|||
28167513|NCT02481310|54838209|FG001|Follow up|Still in follow up|3|||
28167514|NCT02481310|54838210|FG002|Follow up|Still in follow up|0|||
28167515|NCT02480764|54838217|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
28167516|NCT02480764|54838218|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
28167517|NCT02480764|54838219|FG002|Overall Study|Pretreatment Event/Adverse Event|3|||
28167518|NCT02480764|54838217|FG000|Overall Study|Major Protocol Deviation|1|||
28167519|NCT02480764|54838218|FG001|Overall Study|Major Protocol Deviation|4|||
28167520|NCT02480764|54838219|FG002|Overall Study|Major Protocol Deviation|3|||
28167521|NCT02480764|54838217|FG000|Overall Study|Lost to Follow-up|0|||
28167522|NCT02480764|54838218|FG001|Overall Study|Lost to Follow-up|1|||
28167523|NCT02480764|54838219|FG002|Overall Study|Lost to Follow-up|2|||
28167524|NCT02480764|54838217|FG000|Overall Study|Voluntary Withdrawal|6|||
28167525|NCT02480764|54838218|FG001|Overall Study|Voluntary Withdrawal|5|||
28167526|NCT02480764|54838219|FG002|Overall Study|Voluntary Withdrawal|10|||
28167527|NCT02480764|54838217|FG000|Overall Study|Lack of Efficacy|0|||
28167528|NCT02480764|54838218|FG001|Overall Study|Lack of Efficacy|3|||
28167529|NCT02480764|54838219|FG002|Overall Study|Lack of Efficacy|3|||
27833178|NCT01748825|54314630|FG009|Dose Escalation|Adverse Event|0|||
27833179|NCT01748825|54314621|FG000|Dose Expansion|Refused further treatment|0|||
28167530|NCT02480764|54838217|FG000|Overall Study|Reason not Specified|0|||
27833180|NCT01748825|54314622|FG001|Dose Expansion|Refused further treatment|0|||
28092518|NCT04799158|54746457|FG004|On-Demand Treatment Period|Withdrawal by Subject|0|||
28092519|NCT04799158|54746453|FG000|On-Demand Treatment Period|Lack of Efficacy|0|||
28167531|NCT02480764|54838218|FG001|Overall Study|Reason not Specified|1|||
28167532|NCT02480764|54838219|FG002|Overall Study|Reason not Specified|0|||
28167533|NCT02487472|54838227|FG000|Overall Study|Did not complete telephonic interviews|9|||
28167534|NCT02487472|54838227|FG000|Overall Study|Other|2|||
28167535|NCT02451670|54838235|FG000|Overall Study|Did not have qualifying follow-up visit.|714|||
28167536|NCT02451670|54838236|FG001|Overall Study|Did not have qualifying follow-up visit.|696|||
28167537|NCT02486692|54838244|FG000|Overall Study|did not login for randomization|4|||
28092520|NCT04799158|54746454|FG001|On-Demand Treatment Period|Lack of Efficacy|0|||
28092521|NCT04799158|54746455|FG002|On-Demand Treatment Period|Lack of Efficacy|0|||
28092522|NCT04799158|54746456|FG003|On-Demand Treatment Period|Lack of Efficacy|0|||
28092523|NCT04799158|54746457|FG004|On-Demand Treatment Period|Lack of Efficacy|1|||
28092524|NCT04799158|54746453|FG000|On-Demand Treatment Period|Miscellaneous|0|||
28167538|NCT02486692|54838245|FG001|Overall Study|did not login for randomization|7|||
28167539|NCT01060007|54838262|FG000|Overall Study|Withdrawal by Subject|1|||
28167540|NCT01060007|54838262|FG000|Overall Study|Inevaluable for response at surgery|3|||
28167541|NCT02971163|54838271|FG000|Overall Study|Lost to Follow-up|4|||
28092525|NCT04799158|54746454|FG001|On-Demand Treatment Period|Miscellaneous|0|||
28092526|NCT04799158|54746455|FG002|On-Demand Treatment Period|Miscellaneous|0|||
28092527|NCT04799158|54746456|FG003|On-Demand Treatment Period|Miscellaneous|0|||
28092528|NCT04799158|54746457|FG004|On-Demand Treatment Period|Miscellaneous|1|||
28092529|NCT01319422|54746470|FG000|Overall Study|Withdrawal by Subject|1|||
28092530|NCT01319422|54746471|FG001|Overall Study|Withdrawal by Subject|0|||
28092531|NCT03102034|54746479|FG000|Overall Study|Withdrawal by Subject|1|||
28092532|NCT03102034|54746480|FG001|Overall Study|Withdrawal by Subject|0|||
28092533|NCT03774576|54746486|FG000|Period 2|Adverse Event|1|||
28092534|NCT02928952|54746497|FG000|Overall Study|Lost to Follow-up|5|||
28092535|NCT02928952|54746498|FG001|Overall Study|Lost to Follow-up|5|||
28092536|NCT02928952|54746497|FG000|Overall Study|Withdrawal by Subject|5|||
28092537|NCT02928952|54746498|FG001|Overall Study|Withdrawal by Subject|1|||
28167542|NCT02971163|54838272|FG001|Overall Study|Lost to Follow-up|2|||
28167543|NCT02971007|54838281|FG000|Overall Study|Adverse Event|1|||
28167544|NCT02971007|54838282|FG001|Overall Study|Adverse Event|0|||
28167545|NCT02971007|54838283|FG002|Overall Study|Adverse Event|0|||
28167546|NCT02971007|54838281|FG000|Overall Study|Lost to Follow-up|0|||
28167547|NCT02971007|54838282|FG001|Overall Study|Lost to Follow-up|1|||
28167548|NCT02971007|54838283|FG002|Overall Study|Lost to Follow-up|1|||
28167549|NCT02971007|54838281|FG000|Overall Study|Withdrawal by Subject|0|||
28167550|NCT02971007|54838282|FG001|Overall Study|Withdrawal by Subject|1|||
28167551|NCT02971007|54838283|FG002|Overall Study|Withdrawal by Subject|0|||
28167552|NCT02971007|54838281|FG000|Overall Study|Patient had yeast at Day 5 visit|1|||
28167553|NCT02971007|54838282|FG001|Overall Study|Patient had yeast at Day 5 visit|0|||
28167554|NCT02971007|54838283|FG002|Overall Study|Patient had yeast at Day 5 visit|0|||
28167555|NCT02971007|54838281|FG000|Overall Study|Patient discontinued study drug|0|||
28167556|NCT02971007|54838282|FG001|Overall Study|Patient discontinued study drug|1|||
28167557|NCT02971007|54838283|FG002|Overall Study|Patient discontinued study drug|0|||
28167558|NCT03881553|54838294|FG000|Overall Study|Discharged prior to participation|1|||
28167559|NCT03881553|54838295|FG001|Overall Study|Discharged prior to participation|1|||
28167560|NCT03881553|54838296|FG002|Overall Study|Discharged prior to participation|0|||
28167561|NCT03881553|54838294|FG000|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
28167562|NCT03881553|54838295|FG001|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
28167563|NCT03881553|54838296|FG002|Overall Study|Developed infection prior to participation--excluded per protocol criteria|1|||
28167564|NCT02970929|54838304|FG000|Overall Study|Adverse Event|18|||
28167565|NCT02970929|54838304|FG000|Overall Study|Lack of Efficacy|8|||
28167566|NCT02970929|54838304|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|1|||
28167567|NCT02970929|54838304|FG000|Overall Study|INVESTIGATOR CONSIDERS SUBJECT CLINICALLY UNSTABLE, NOT APPROPRIATE FOR DISCHARGE TO AN OUTPATIENT|1|||
28167568|NCT02970929|54838304|FG000|Overall Study|SPONSOR REQUEST THAT SUBJECT BE WITHDRAWN DUE TO POSITIVE DRUG RESULTS AND FOR THE SUBJECT'S SAFETY|1|||
28167569|NCT02970929|54838304|FG000|Overall Study|LOST TO FOLLOWUP|6|||
28092538|NCT02928952|54746497|FG000|Overall Study|Physician Decision|0|||
28092539|NCT02928952|54746498|FG001|Overall Study|Physician Decision|1|||
28092540|NCT03773796|54746504|FG000|Overall Study|Adverse Event|1|||
28092541|NCT03773796|54746504|FG000|Overall Study|Withdrawal by Subject|1|||
28092542|NCT03773796|54746504|FG000|Overall Study|Lack of Efficacy|1|||
28092543|NCT02927938|54746512|FG000|Overall Study|Death|0|||
28092544|NCT02927938|54746513|FG001|Overall Study|Death|1|||
28092545|NCT02927938|54746514|FG002|Overall Study|Death|0|||
28092546|NCT02927938|54746515|FG003|Overall Study|Death|4|||
28167570|NCT02970929|54838304|FG000|Overall Study|MOVED OUT OF STATE|1|||
28167571|NCT02970929|54838304|FG000|Overall Study|Withdrawal by Subject|16|||
28167572|NCT02970305|54838321|FG000|Overall Study|Adverse Event|10|||
28167573|NCT02970305|54838322|FG001|Overall Study|Adverse Event|6|||
28092547|NCT02927938|54746512|FG000|Overall Study|Early Study Termination|1|||
28092548|NCT02927938|54746513|FG001|Overall Study|Early Study Termination|5|||
28092549|NCT02927938|54746514|FG002|Overall Study|Early Study Termination|4|||
28092550|NCT02927938|54746515|FG003|Overall Study|Early Study Termination|3|||
28092551|NCT03765138|54746523|FG000|Overall Study|Lost to Follow-up|1|||
28092552|NCT03768726|54746530|FG000|Treatment Phase|Adverse Event|2|||
28167574|NCT02970305|54838321|FG000|Overall Study|Lack of Efficacy|1|||
28167575|NCT02970305|54838322|FG001|Overall Study|Lack of Efficacy|1|||
27833181|NCT01748825|54314623|FG002|Dose Expansion|Refused further treatment|0|||
28092553|NCT03768726|54746531|FG001|Treatment Phase|Adverse Event|2|||
28092554|NCT03768726|54746530|FG000|Treatment Phase|Lost to Follow-up|1|||
28092555|NCT03768726|54746531|FG001|Treatment Phase|Lost to Follow-up|0|||
28092556|NCT03768726|54746530|FG000|Treatment Phase|Withdrawal By Parent/Guardian|2|||
27733931|NCT02769065|54181678|FG017|Overall Study|Reason Not Specified|0|||
27733932|NCT02769065|54181679|FG018|Overall Study|Reason Not Specified|0|||
27733933|NCT02769065|54181680|FG019|Overall Study|Reason Not Specified|0|||
27733934|NCT02769065|54181681|FG020|Overall Study|Reason Not Specified|0|||
27733935|NCT02769065|54181682|FG021|Overall Study|Reason Not Specified|0|||
28167576|NCT02970305|54838321|FG000|Overall Study|Noncompliance with study drug|2|||
28167577|NCT02970305|54838322|FG001|Overall Study|Noncompliance with study drug|4|||
27733936|NCT02769065|54181683|FG022|Overall Study|Reason Not Specified|0|||
27733937|NCT02769065|54181684|FG023|Overall Study|Reason Not Specified|0|||
27733938|NCT02769065|54181685|FG024|Overall Study|Reason Not Specified|0|||
27733939|NCT02769065|54181686|FG025|Overall Study|Reason Not Specified|0|||
27733940|NCT02769065|54181687|FG026|Overall Study|Reason Not Specified|0|||
27733941|NCT02769065|54181688|FG027|Overall Study|Reason Not Specified|0|||
27733942|NCT02769065|54181689|FG028|Overall Study|Reason Not Specified|0|||
27733943|NCT02769065|54181690|FG029|Overall Study|Reason Not Specified|0|||
27733944|NCT02769065|54181661|FG000|Overall Study|Pre-treatment Event/Adverse Event|0|||
27733945|NCT02769065|54181662|FG001|Overall Study|Pre-treatment Event/Adverse Event|0|||
27733946|NCT02769065|54181663|FG002|Overall Study|Pre-treatment Event/Adverse Event|0|||
27733947|NCT02769065|54181664|FG003|Overall Study|Pre-treatment Event/Adverse Event|0|||
27733948|NCT02769065|54181665|FG004|Overall Study|Pre-treatment Event/Adverse Event|0|||
27733949|NCT02769065|54181666|FG005|Overall Study|Pre-treatment Event/Adverse Event|0|||
27733950|NCT02769065|54181667|FG006|Overall Study|Pre-treatment Event/Adverse Event|0|||
27733951|NCT02769065|54181668|FG007|Overall Study|Pre-treatment Event/Adverse Event|0|||
27733952|NCT02769065|54181669|FG008|Overall Study|Pre-treatment Event/Adverse Event|0|||
27733953|NCT02769065|54181670|FG009|Overall Study|Pre-treatment Event/Adverse Event|0|||
27733954|NCT02769065|54181671|FG010|Overall Study|Pre-treatment Event/Adverse Event|1|||
27733955|NCT02769065|54181672|FG011|Overall Study|Pre-treatment Event/Adverse Event|0|||
27733956|NCT02769065|54181673|FG012|Overall Study|Pre-treatment Event/Adverse Event|0|||
27733957|NCT02769065|54181674|FG013|Overall Study|Pre-treatment Event/Adverse Event|0|||
27733958|NCT02769065|54181675|FG014|Overall Study|Pre-treatment Event/Adverse Event|0|||
27733959|NCT02769065|54181676|FG015|Overall Study|Pre-treatment Event/Adverse Event|0|||
28167578|NCT02970305|54838321|FG000|Overall Study|Protocol Violation|2|||
28167579|NCT02970305|54838322|FG001|Overall Study|Protocol Violation|2|||
28167580|NCT02970305|54838321|FG000|Overall Study|Withdrawal by Subject|12|||
28167581|NCT02970305|54838322|FG001|Overall Study|Withdrawal by Subject|11|||
27733960|NCT02769065|54181677|FG016|Overall Study|Pre-treatment Event/Adverse Event|0|||
27733961|NCT02769065|54181678|FG017|Overall Study|Pre-treatment Event/Adverse Event|0|||
27733962|NCT02769065|54181679|FG018|Overall Study|Pre-treatment Event/Adverse Event|0|||
27733963|NCT02769065|54181680|FG019|Overall Study|Pre-treatment Event/Adverse Event|0|||
27733964|NCT02769065|54181681|FG020|Overall Study|Pre-treatment Event/Adverse Event|0|||
27733965|NCT02769065|54181682|FG021|Overall Study|Pre-treatment Event/Adverse Event|0|||
27733966|NCT02769065|54181683|FG022|Overall Study|Pre-treatment Event/Adverse Event|0|||
27733967|NCT02769065|54181684|FG023|Overall Study|Pre-treatment Event/Adverse Event|0|||
27733968|NCT02769065|54181685|FG024|Overall Study|Pre-treatment Event/Adverse Event|0|||
27733969|NCT02769065|54181686|FG025|Overall Study|Pre-treatment Event/Adverse Event|0|||
27733970|NCT02769065|54181687|FG026|Overall Study|Pre-treatment Event/Adverse Event|0|||
27733971|NCT02769065|54181688|FG027|Overall Study|Pre-treatment Event/Adverse Event|0|||
27733972|NCT02769065|54181689|FG028|Overall Study|Pre-treatment Event/Adverse Event|0|||
27733973|NCT02769065|54181690|FG029|Overall Study|Pre-treatment Event/Adverse Event|0|||
27980712|NCT00891020|54638733|FG002|24 Week Treatment Period|Death|0|||
28092557|NCT03768726|54746531|FG001|Treatment Phase|Withdrawal By Parent/Guardian|0|||
28092558|NCT03768726|54746530|FG000|Treatment Phase|Withdrawal by Subject|3|||
28092559|NCT03768726|54746531|FG001|Treatment Phase|Withdrawal by Subject|1|||
28092560|NCT03768726|54746530|FG000|Follow-Up|Adverse Event|2|||
28092561|NCT03768726|54746531|FG001|Follow-Up|Adverse Event|2|||
28092562|NCT03768726|54746530|FG000|Follow-Up|Withdrawal By Parent/Guardian|1|||
28167582|NCT02970305|54838321|FG000|Overall Study|Not further specified|1|||
28167583|NCT02970305|54838322|FG001|Overall Study|Not further specified|2|||
28167584|NCT02970305|54838321|FG000|Overall Study|Lost to Follow-up|1|||
28167585|NCT02970305|54838322|FG001|Overall Study|Lost to Follow-up|2|||
27733974|NCT02681523|54181783|FG000|Overall Study|Adverse Event|1|||
27733975|NCT02681523|54181783|FG000|Overall Study|Patient Non-compliance|1|||
27733976|NCT02540954|54181789|FG000|Overall Study|Physician Decision|3|||
27733977|NCT02540954|54181790|FG001|Overall Study|Physician Decision|1|||
27733978|NCT02540954|54181789|FG000|Overall Study|Withdrawal by Subject|6|||
27733979|NCT02540954|54181790|FG001|Overall Study|Withdrawal by Subject|5|||
27733980|NCT02540954|54181789|FG000|Overall Study|Lost to Follow-up|1|||
27733981|NCT02540954|54181790|FG001|Overall Study|Lost to Follow-up|1|||
27733982|NCT02540954|54181789|FG000|Overall Study|Adverse Event|4|||
27733983|NCT02540954|54181790|FG001|Overall Study|Adverse Event|2|||
28092563|NCT03768726|54746531|FG001|Follow-Up|Withdrawal By Parent/Guardian|1|||
28167586|NCT03654651|54838339|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
28092564|NCT03768726|54746530|FG000|Follow-Up|Withdrawal by Subject|2|||
28092565|NCT03768726|54746531|FG001|Follow-Up|Withdrawal by Subject|0|||
28092566|NCT03768726|54746530|FG000|Follow-Up|Other|1|||
28092567|NCT03768726|54746531|FG001|Follow-Up|Other|0|||
28092568|NCT03769896|54746539|FG000|Open-label Phase|Lack of Efficacy|5|||
28092569|NCT03769896|54746540|FG001|Open-label Phase|Lack of Efficacy|0|||
28092570|NCT03769896|54746539|FG000|Open-label Phase|Adverse Event|3|||
28167587|NCT03654651|54838340|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
28167588|NCT02022033|54838351|FG000|Overall Study|Physician Decision|1|||
28167589|NCT03505671|54838357|FG000|Overall Study|Withdrawal by Subject|2|||
28167590|NCT03505671|54838358|FG001|Overall Study|Withdrawal by Subject|1|||
28167591|NCT03505671|54838357|FG000|Overall Study|Lost to Follow-up|1|||
28167592|NCT03505671|54838358|FG001|Overall Study|Lost to Follow-up|0|||
28167593|NCT01103349|54838379|FG000|Overall Study|Adverse Event|8|||
28167594|NCT01103349|54838380|FG001|Overall Study|Adverse Event|5|||
28167595|NCT01103349|54838381|FG002|Overall Study|Adverse Event|3|||
28167596|NCT01103349|54838379|FG000|Overall Study|Consent withdrawn|1|||
28167597|NCT01103349|54838380|FG001|Overall Study|Consent withdrawn|0|||
28167598|NCT01103349|54838381|FG002|Overall Study|Consent withdrawn|0|||
28167599|NCT01103349|54838379|FG000|Overall Study|Incorrectly included in the trial|1|||
28167600|NCT01103349|54838380|FG001|Overall Study|Incorrectly included in the trial|0|||
28167601|NCT01103349|54838381|FG002|Overall Study|Incorrectly included in the trial|0|||
28167602|NCT01103349|54838379|FG000|Overall Study|Withdrawal by Subject|1|||
28167603|NCT01103349|54838380|FG001|Overall Study|Withdrawal by Subject|1|||
28167604|NCT01103349|54838381|FG002|Overall Study|Withdrawal by Subject|0|||
28092571|NCT03769896|54746540|FG001|Open-label Phase|Adverse Event|0|||
28092572|NCT03769896|54746539|FG000|Open-label Phase|Withdrawal by Subject|1|||
28092573|NCT03769896|54746540|FG001|Open-label Phase|Withdrawal by Subject|0|||
28092574|NCT05047601|54746550|FG000|Overall Study|Lost to Follow-up|9|||
28092575|NCT05047601|54746551|FG001|Overall Study|Lost to Follow-up|11|||
28092576|NCT05047601|54746552|FG002|Overall Study|Lost to Follow-up|7|||
28092577|NCT05047601|54746550|FG000|Overall Study|Withdrawal by Subject|25|||
28092578|NCT05047601|54746551|FG001|Overall Study|Withdrawal by Subject|36|||
28092579|NCT05047601|54746552|FG002|Overall Study|Withdrawal by Subject|23|||
28092580|NCT05047601|54746550|FG000|Overall Study|Other|10|||
28092581|NCT05047601|54746551|FG001|Overall Study|Other|6|||
28092582|NCT05047601|54746552|FG002|Overall Study|Other|5|||
28092583|NCT04658784|54746566|FG000|6-month Follow-up|Lost to Follow-up|2|||
28092584|NCT04658784|54746567|FG001|6-month Follow-up|Lost to Follow-up|5|||
28092585|NCT04606394|54746573|FG000|Overall Study|Withdrawal by Subject|3|||
28092586|NCT04606394|54746573|FG000|Overall Study|Exclusion criteria screen failure|12|||
28092587|NCT04585451|54746587|FG000|Overall Study|Withdrawal by Subject|26|||
28092588|NCT04585451|54746588|FG001|Overall Study|Withdrawal by Subject|0|||
28092589|NCT04362189|54746613|FG000|Overall Study|Lost to Follow-up|0|||
28092590|NCT04362189|54746614|FG001|Overall Study|Lost to Follow-up|1|||
28092591|NCT04362189|54746613|FG000|Overall Study|Withdrawal by Subject|1|||
28092592|NCT04362189|54746614|FG001|Overall Study|Withdrawal by Subject|0|||
28092593|NCT04362189|54746613|FG000|Overall Study|FDA Clinical Hold|7|||
28092594|NCT04362189|54746614|FG001|Overall Study|FDA Clinical Hold|2|||
28167605|NCT01103349|54838379|FG000|Overall Study|did not want to take trial medication|0|||
28167606|NCT01103349|54838380|FG001|Overall Study|did not want to take trial medication|1|||
28092595|NCT04362189|54746613|FG000|Overall Study|Discharge or Transfer to other Hospital|3|||
28092596|NCT04362189|54746614|FG001|Overall Study|Discharge or Transfer to other Hospital|0|||
28092597|NCT04362189|54746613|FG000|Overall Study|Adverse Event|0|||
28092598|NCT04362189|54746614|FG001|Overall Study|Adverse Event|2|||
28092599|NCT04362189|54746613|FG000|Overall Study|Death|4|||
28092600|NCT04362189|54746614|FG001|Overall Study|Death|1|||
28092601|NCT04181788|54746688|FG000|TREATMENT|Adverse Event|0|||
28092602|NCT04181788|54746689|FG001|TREATMENT|Adverse Event|2|||
28092603|NCT04181788|54746690|FG002|TREATMENT|Adverse Event|1|||
28092604|NCT04181788|54746691|FG003|TREATMENT|Adverse Event|0|||
28092605|NCT04181788|54746692|FG004|TREATMENT|Adverse Event|1|||
28092606|NCT04181788|54746693|FG005|TREATMENT|Adverse Event|3|||
28092607|NCT04181788|54746688|FG000|TREATMENT|Death|0|||
28092608|NCT04181788|54746689|FG001|TREATMENT|Death|0|||
28092609|NCT04181788|54746690|FG002|TREATMENT|Death|0|||
28092610|NCT04181788|54746691|FG003|TREATMENT|Death|0|||
28092611|NCT04181788|54746692|FG004|TREATMENT|Death|8|||
28092612|NCT04181788|54746693|FG005|TREATMENT|Death|8|||
28092613|NCT04181788|54746688|FG000|TREATMENT|Physician Decision|0|||
28092614|NCT04181788|54746689|FG001|TREATMENT|Physician Decision|0|||
28167607|NCT01103349|54838381|FG002|Overall Study|did not want to take trial medication|0|||
27733984|NCT02540954|54181789|FG000|Overall Study|Death|0|||
28092615|NCT04181788|54746690|FG002|TREATMENT|Physician Decision|0|||
28092616|NCT04181788|54746691|FG003|TREATMENT|Physician Decision|0|||
28092617|NCT04181788|54746692|FG004|TREATMENT|Physician Decision|0|||
28092618|NCT04181788|54746693|FG005|TREATMENT|Physician Decision|1|||
28092619|NCT04181788|54746688|FG000|TREATMENT|Progressive disease|3|||
28167608|NCT01103349|54838379|FG000|Overall Study|forgot to take medication|0|||
28167609|NCT01103349|54838380|FG001|Overall Study|forgot to take medication|0|||
28092620|NCT04181788|54746689|FG001|TREATMENT|Progressive disease|3|||
28092621|NCT04181788|54746690|FG002|TREATMENT|Progressive disease|5|||
28092622|NCT04181788|54746691|FG003|TREATMENT|Progressive disease|7|||
28092623|NCT04181788|54746692|FG004|TREATMENT|Progressive disease|20|||
28092624|NCT04181788|54746693|FG005|TREATMENT|Progressive disease|38|||
28092625|NCT04181788|54746688|FG000|TREATMENT|Global deterioration of health status|0|||
28167610|NCT01103349|54838381|FG002|Overall Study|forgot to take medication|1|||
28167611|NCT02959177|54838392|FG000|Double-Blind Treatment Phase|Adverse Event|5|||
28167612|NCT02959177|54838393|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
28167613|NCT02959177|54838394|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
28167614|NCT02959177|54838392|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
28167615|NCT02959177|54838393|FG001|Double-Blind Treatment Phase|Physician Decision|0|||
28167616|NCT02959177|54838394|FG002|Double-Blind Treatment Phase|Physician Decision|0|||
28167617|NCT02959177|54838392|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
28167618|NCT02959177|54838393|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
28167619|NCT02959177|54838394|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
28167620|NCT02959177|54838392|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
28167621|NCT02959177|54838393|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
28167622|NCT02959177|54838394|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
28167623|NCT02959177|54838392|FG000|Follow-up Post Treatment Phase|Lost to Follow-up|1|||
28167624|NCT02959177|54838393|FG001|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
28167625|NCT02959177|54838394|FG002|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
28167626|NCT02959177|54838392|FG000|Follow-up Post Treatment Phase|Adverse Event|0|||
28092626|NCT04181788|54746689|FG001|TREATMENT|Global deterioration of health status|2|||
28092627|NCT04181788|54746690|FG002|TREATMENT|Global deterioration of health status|0|||
28092628|NCT04181788|54746691|FG003|TREATMENT|Global deterioration of health status|0|||
27733985|NCT02540954|54181790|FG001|Overall Study|Death|3|||
27733986|NCT02540954|54181789|FG000|Overall Study|Treatment failure|1|||
27733987|NCT02540954|54181790|FG001|Overall Study|Treatment failure|0|||
27733988|NCT02540954|54181789|FG000|Overall Study|Other reason|4|||
27733989|NCT02540954|54181790|FG001|Overall Study|Other reason|2|||
27733990|NCT02658812|54181796|FG000|Overall Study|Disease Progression|7|||
27733991|NCT02658812|54181796|FG000|Overall Study|Unrelated to study treatment|1|||
27733992|NCT02658812|54181796|FG000|Overall Study|Adverse Event|1|||
27733993|NCT02680665|54181800|FG000|Overall Study|No visit after the first prescription|5|||
27733994|NCT00154375|54181806|FG000|Overall Study|Unsatisfactory therapeutic effect|25|||
27733995|NCT00154375|54181807|FG001|Overall Study|Unsatisfactory therapeutic effect|26|||
27733996|NCT00154375|54181806|FG000|Overall Study|Adverse Event|18|||
27733997|NCT00154375|54181807|FG001|Overall Study|Adverse Event|20|||
27733998|NCT00154375|54181806|FG000|Overall Study|Withdrawal by Subject|14|||
27733999|NCT00154375|54181807|FG001|Overall Study|Withdrawal by Subject|10|||
27734000|NCT00154375|54181806|FG000|Overall Study|Death|5|||
27734001|NCT00154375|54181807|FG001|Overall Study|Death|13|||
27734002|NCT00154375|54181806|FG000|Overall Study|Study drug no longer required|5|||
27734003|NCT00154375|54181807|FG001|Overall Study|Study drug no longer required|3|||
27734004|NCT00154375|54181806|FG000|Overall Study|Lost to Follow-up|2|||
27734005|NCT00154375|54181807|FG001|Overall Study|Lost to Follow-up|1|||
27855784|NCT02733042|54382051|FG013|Follow-up Period|Withdrawal by Subject|0|||
27980713|NCT00891020|54638731|FG000|24 Week Treatment Period|Insufficient therapeutic response|6|||
27980714|NCT00891020|54638732|FG001|24 Week Treatment Period|Insufficient therapeutic response|9|||
27980715|NCT00891020|54638733|FG002|24 Week Treatment Period|Insufficient therapeutic response|15|||
28167627|NCT02959177|54838393|FG001|Follow-up Post Treatment Phase|Adverse Event|1|||
28167628|NCT02959177|54838394|FG002|Follow-up Post Treatment Phase|Adverse Event|0|||
28167629|NCT02959177|54838392|FG000|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
28167630|NCT02959177|54838393|FG001|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
28167631|NCT02959177|54838394|FG002|Follow-up Post Treatment Phase|Withdrawal by Subject|2|||
28167632|NCT04706403|54838411|FG000|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
28167633|NCT04706403|54838412|FG001|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
28167634|NCT04706403|54838413|FG002|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
28092629|NCT04181788|54746692|FG004|TREATMENT|Global deterioration of health status|2|||
28167635|NCT04706403|54838414|FG003|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
28167636|NCT04706403|54838415|FG004|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|2|||
28167637|NCT02983617|54838429|FG000|Overall Study|Adverse Event|0|||
27734006|NCT00154375|54181806|FG000|Overall Study|Abnormal laboratory value(s)|0|||
27734007|NCT00154375|54181807|FG001|Overall Study|Abnormal laboratory value(s)|2|||
27734008|NCT00154375|54181806|FG000|Overall Study|Protocol Violation|0|||
27734009|NCT00154375|54181807|FG001|Overall Study|Protocol Violation|1|||
28167638|NCT02983617|54838430|FG001|Overall Study|Adverse Event|7|||
28167639|NCT02983617|54838429|FG000|Overall Study|Death|0|||
28167640|NCT02983617|54838430|FG001|Overall Study|Death|1|||
28167641|NCT02983617|54838429|FG000|Overall Study|Investigator's Discretion|0|||
28092630|NCT04181788|54746693|FG005|TREATMENT|Global deterioration of health status|8|||
28092631|NCT04181788|54746688|FG000|TREATMENT|Withdrawal by Subject|1|||
28092632|NCT04181788|54746689|FG001|TREATMENT|Withdrawal by Subject|2|||
28092633|NCT04181788|54746690|FG002|TREATMENT|Withdrawal by Subject|0|||
28092634|NCT04181788|54746691|FG003|TREATMENT|Withdrawal by Subject|0|||
28092635|NCT04181788|54746692|FG004|TREATMENT|Withdrawal by Subject|3|||
28092636|NCT04181788|54746693|FG005|TREATMENT|Withdrawal by Subject|5|||
28167642|NCT02983617|54838430|FG001|Overall Study|Investigator's Discretion|1|||
28167643|NCT02873689|54838438|FG000|Overall Study|Lack of Efficacy|1|||
28167644|NCT02873689|54838439|FG001|Overall Study|Lack of Efficacy|0|||
28167645|NCT02873689|54838438|FG000|Overall Study|Withdrawal by Subject|2|||
28167646|NCT02873689|54838439|FG001|Overall Study|Withdrawal by Subject|2|||
28167647|NCT02873689|54838438|FG000|Overall Study|Protocol Violation|1|||
28167648|NCT02873689|54838439|FG001|Overall Study|Protocol Violation|0|||
28167649|NCT02873689|54838438|FG000|Overall Study|Adverse Event|2|||
28167650|NCT02873689|54838439|FG001|Overall Study|Adverse Event|2|||
28167651|NCT02873689|54838438|FG000|Overall Study|Randomized but not Treated|1|||
28167652|NCT02873689|54838439|FG001|Overall Study|Randomized but not Treated|1|||
28167653|NCT02901431|54838453|FG000|PK Part|Adverse Event|0|||
28167654|NCT02901431|54838454|FG001|PK Part|Adverse Event|1|||
28167655|NCT02901431|54838455|FG002|PK Part|Adverse Event|0|||
27734010|NCT00154375|54181806|FG000|Overall Study|Suspected progression of disease|44|||
27734011|NCT00154375|54181807|FG001|Overall Study|Suspected progression of disease|30|||
27734012|NCT02765399|54181816|FG000|Overall Study|Nausea|1|||
27734013|NCT02765399|54181817|FG001|Overall Study|Nausea|0|||
27734014|NCT02676765|54181825|FG000|Overall Study|Lost to Follow-up|0|||
28167656|NCT02901431|54838456|FG003|PK Part|Adverse Event|0|||
28167657|NCT02901431|54838457|FG004|PK Part|Adverse Event|0|||
28167658|NCT02901431|54838458|FG005|PK Part|Adverse Event|0|||
28167659|NCT02901431|54838459|FG006|PK Part|Adverse Event|0|||
28167660|NCT02901431|54838460|FG007|PK Part|Adverse Event|0|||
28167661|NCT02901431|54838461|FG008|PK Part|Adverse Event|0|||
27734015|NCT02676765|54181826|FG001|Overall Study|Lost to Follow-up|1|||
27734016|NCT02680041|54181832|FG000|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8|||
27734017|NCT02680041|54181832|FG000|Overall Study|Lost to Follow-up|2|||
27734018|NCT02547974|54181841|FG000|Overall Study|Withdrawal by Subject|1|||
27734019|NCT02547974|54181842|FG001|Overall Study|Withdrawal by Subject|0|||
27734020|NCT02547974|54181843|FG002|Overall Study|Withdrawal by Subject|0|||
27734021|NCT02547974|54181844|FG003|Overall Study|Withdrawal by Subject|0|||
27734022|NCT00154297|54181859|FG000|Overall Study|Death|5|||
27734023|NCT00154297|54181860|FG001|Overall Study|Death|2|||
27734024|NCT00154297|54181859|FG000|Overall Study|Withdrawal by Subject|0|||
27734025|NCT00154297|54181860|FG001|Overall Study|Withdrawal by Subject|5|||
27734026|NCT00154297|54181859|FG000|Overall Study|Lost to Follow-up|3|||
27734027|NCT00154297|54181860|FG001|Overall Study|Lost to Follow-up|0|||
27734028|NCT02679729|54181875|FG000|Overall Study|Lost to Follow-up|0|||
27734029|NCT02679729|54181876|FG001|Overall Study|Lost to Follow-up|1|||
27734030|NCT02679729|54181877|FG002|Overall Study|Lost to Follow-up|0|||
27734031|NCT02679729|54181878|FG003|Overall Study|Lost to Follow-up|0|||
27734032|NCT02679729|54181879|FG004|Overall Study|Lost to Follow-up|1|||
27734033|NCT02679729|54181880|FG005|Overall Study|Lost to Follow-up|0|||
27734034|NCT02679729|54181881|FG006|Overall Study|Lost to Follow-up|0|||
27734035|NCT02679729|54181882|FG007|Overall Study|Lost to Follow-up|0|||
28092637|NCT04181788|54746688|FG000|TREATMENT|Other unspecified|0|||
28167662|NCT02901431|54838462|FG009|PK Part|Adverse Event|0|||
28167663|NCT02901431|54838463|FG010|PK Part|Adverse Event|0|||
28167664|NCT02901431|54838464|FG011|PK Part|Adverse Event|0|||
28167665|NCT02901431|54838465|FG012|PK Part|Adverse Event|0|||
28167666|NCT02901431|54838453|FG000|PK Part|Lost to Follow-up|0|||
28167667|NCT02901431|54838454|FG001|PK Part|Lost to Follow-up|0|||
28167668|NCT02901431|54838455|FG002|PK Part|Lost to Follow-up|1|||
28167669|NCT02901431|54838456|FG003|PK Part|Lost to Follow-up|0|||
28167670|NCT02901431|54838457|FG004|PK Part|Lost to Follow-up|0|||
28167671|NCT02901431|54838458|FG005|PK Part|Lost to Follow-up|0|||
28167672|NCT02901431|54838459|FG006|PK Part|Lost to Follow-up|0|||
28167673|NCT02901431|54838460|FG007|PK Part|Lost to Follow-up|0|||
27734036|NCT02679729|54181883|FG008|Overall Study|Lost to Follow-up|0|||
27734037|NCT02679729|54181875|FG000|Overall Study|Participant decision|0|||
27734038|NCT02679729|54181876|FG001|Overall Study|Participant decision|1|||
27833182|NCT01748825|54314624|FG003|Dose Expansion|Refused further treatment|0|||
27833183|NCT01748825|54314625|FG004|Dose Expansion|Refused further treatment|0|||
27734039|NCT02679729|54181877|FG002|Overall Study|Participant decision|0|||
27833184|NCT01748825|54314626|FG005|Dose Expansion|Refused further treatment|0|||
28092638|NCT04181788|54746689|FG001|TREATMENT|Other unspecified|0|||
28092639|NCT04181788|54746690|FG002|TREATMENT|Other unspecified|0|||
28092640|NCT04181788|54746691|FG003|TREATMENT|Other unspecified|0|||
28167674|NCT02901431|54838461|FG008|PK Part|Lost to Follow-up|0|||
28167675|NCT02901431|54838462|FG009|PK Part|Lost to Follow-up|0|||
28167676|NCT02901431|54838463|FG010|PK Part|Lost to Follow-up|0|||
28167677|NCT02901431|54838464|FG011|PK Part|Lost to Follow-up|0|||
28167678|NCT02901431|54838465|FG012|PK Part|Lost to Follow-up|0|||
28092641|NCT04181788|54746692|FG004|TREATMENT|Other unspecified|0|||
28092642|NCT04181788|54746693|FG005|TREATMENT|Other unspecified|2|||
28092643|NCT04181788|54746688|FG000|TREATMENT|Ongoing|0|||
28092644|NCT04181788|54746689|FG001|TREATMENT|Ongoing|3|||
28092645|NCT04181788|54746690|FG002|TREATMENT|Ongoing|0|||
28092646|NCT04181788|54746691|FG003|TREATMENT|Ongoing|5|||
28092647|NCT04181788|54746692|FG004|TREATMENT|Ongoing|7|||
28092648|NCT04181788|54746693|FG005|TREATMENT|Ongoing|15|||
28092649|NCT04181788|54746688|FG000|FOLLOW-UP|Death|0|||
28092650|NCT04181788|54746689|FG001|FOLLOW-UP|Death|0|||
28092651|NCT04181788|54746690|FG002|FOLLOW-UP|Death|1|||
28092652|NCT04181788|54746691|FG003|FOLLOW-UP|Death|2|||
28092653|NCT04181788|54746692|FG004|FOLLOW-UP|Death|8|||
28092654|NCT04181788|54746693|FG005|FOLLOW-UP|Death|20|||
28092655|NCT04181788|54746688|FG000|FOLLOW-UP|Lost to Follow-up|0|||
28092656|NCT04181788|54746689|FG001|FOLLOW-UP|Lost to Follow-up|0|||
28092657|NCT04181788|54746690|FG002|FOLLOW-UP|Lost to Follow-up|0|||
28092658|NCT04181788|54746691|FG003|FOLLOW-UP|Lost to Follow-up|0|||
28092659|NCT04181788|54746692|FG004|FOLLOW-UP|Lost to Follow-up|0|||
28092660|NCT04181788|54746693|FG005|FOLLOW-UP|Lost to Follow-up|2|||
28092661|NCT04181788|54746688|FG000|FOLLOW-UP|Withdrawal by Subject|0|||
28092662|NCT04181788|54746689|FG001|FOLLOW-UP|Withdrawal by Subject|0|||
28092663|NCT04181788|54746690|FG002|FOLLOW-UP|Withdrawal by Subject|0|||
28092664|NCT04181788|54746691|FG003|FOLLOW-UP|Withdrawal by Subject|0|||
28092665|NCT04181788|54746692|FG004|FOLLOW-UP|Withdrawal by Subject|1|||
28092666|NCT04181788|54746693|FG005|FOLLOW-UP|Withdrawal by Subject|0|||
28092667|NCT04181788|54746688|FG000|FOLLOW-UP|Other unspecified|0|||
28092668|NCT04181788|54746689|FG001|FOLLOW-UP|Other unspecified|1|||
28092669|NCT04181788|54746690|FG002|FOLLOW-UP|Other unspecified|0|||
28092670|NCT04181788|54746691|FG003|FOLLOW-UP|Other unspecified|0|||
28092671|NCT04181788|54746692|FG004|FOLLOW-UP|Other unspecified|0|||
28092672|NCT04181788|54746693|FG005|FOLLOW-UP|Other unspecified|3|||
28092673|NCT04181788|54746688|FG000|FOLLOW-UP|Ongoing|0|||
28092674|NCT04181788|54746689|FG001|FOLLOW-UP|Ongoing|0|||
28092675|NCT04181788|54746690|FG002|FOLLOW-UP|Ongoing|1|||
28092676|NCT04181788|54746691|FG003|FOLLOW-UP|Ongoing|3|||
28092677|NCT04181788|54746692|FG004|FOLLOW-UP|Ongoing|2|||
28092678|NCT04181788|54746693|FG005|FOLLOW-UP|Ongoing|2|||
28092679|NCT04120194|54746716|FG000|Overall Study|Lost to Follow-up|11|||
28092680|NCT04120194|54746717|FG001|Overall Study|Lost to Follow-up|8|||
28092681|NCT04120194|54746716|FG000|Overall Study|Adverse Event|4|||
28092682|NCT04120194|54746717|FG001|Overall Study|Adverse Event|5|||
28092683|NCT04120194|54746716|FG000|Overall Study|Voluntary withdrawal unrelated to adverse event|1|||
28092684|NCT04120194|54746717|FG001|Overall Study|Voluntary withdrawal unrelated to adverse event|2|||
28092685|NCT04120194|54746716|FG000|Overall Study|Miscellaneous|4|||
28092686|NCT04120194|54746717|FG001|Overall Study|Miscellaneous|5|||
28092687|NCT04050670|54746723|FG000|Period 3|Physician Decision|0|||
28092688|NCT04050670|54746724|FG001|Period 3|Physician Decision|1|||
28092689|NCT04050670|54746725|FG002|Period 3|Physician Decision|0|||
28092690|NCT04016714|54746748|FG000|Overall Study|Death|1|||
28092691|NCT04016714|54746749|FG001|Overall Study|Death|0|||
28092692|NCT04016714|54746748|FG000|Overall Study|Lost to Follow-up|3|||
28092693|NCT04016714|54746749|FG001|Overall Study|Lost to Follow-up|1|||
28092694|NCT04016714|54746748|FG000|Overall Study|Physician Decision|3|||
28092695|NCT04016714|54746749|FG001|Overall Study|Physician Decision|3|||
28092696|NCT04016714|54746748|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
28092697|NCT04016714|54746749|FG001|Overall Study|Withdrawal by Parent/Guardian|12|||
28092698|NCT03997409|54746758|FG000|Overall Study|Protocol Violation|1|||
28092699|NCT03997409|54746759|FG001|Overall Study|Protocol Violation|1|||
28092700|NCT03997409|54746760|FG002|Overall Study|Protocol Violation|0|||
28092701|NCT03997409|54746758|FG000|Overall Study|Withdrawal by Subject|3|||
28092702|NCT03997409|54746759|FG001|Overall Study|Withdrawal by Subject|0|||
28092703|NCT03997409|54746760|FG002|Overall Study|Withdrawal by Subject|0|||
28092704|NCT03997409|54746758|FG000|Overall Study|Lost to Follow-up|0|||
28092705|NCT03997409|54746759|FG001|Overall Study|Lost to Follow-up|0|||
28092706|NCT03997409|54746760|FG002|Overall Study|Lost to Follow-up|1|||
28092707|NCT03946124|54746768|FG000|Overall Study|Withdrawal by Subject|19|||
28092708|NCT03812029|54746777|FG000|Overall Study|Protocol Violation|1|||
28092709|NCT03812029|54746778|FG001|Overall Study|Protocol Violation|0|||
28092710|NCT03812029|54746779|FG002|Overall Study|Protocol Violation|0|||
28092711|NCT03812029|54746780|FG003|Overall Study|Protocol Violation|1|||
28092712|NCT03812029|54746781|FG004|Overall Study|Protocol Violation|0|||
28092713|NCT03812029|54746777|FG000|Overall Study|Withdrawal by Subject|1|||
28092714|NCT03812029|54746778|FG001|Overall Study|Withdrawal by Subject|0|||
28092715|NCT03812029|54746779|FG002|Overall Study|Withdrawal by Subject|0|||
28092716|NCT03812029|54746780|FG003|Overall Study|Withdrawal by Subject|2|||
28092717|NCT03812029|54746781|FG004|Overall Study|Withdrawal by Subject|2|||
28092718|NCT03812029|54746777|FG000|Overall Study|Stopping rules|0|||
28092719|NCT03812029|54746778|FG001|Overall Study|Stopping rules|1|||
28092720|NCT03812029|54746779|FG002|Overall Study|Stopping rules|0|||
28092721|NCT03812029|54746780|FG003|Overall Study|Stopping rules|0|||
28092722|NCT03812029|54746781|FG004|Overall Study|Stopping rules|0|||
28092723|NCT03812029|54746777|FG000|Overall Study|Adverse Event|0|||
28092724|NCT03812029|54746778|FG001|Overall Study|Adverse Event|9|||
28092725|NCT03812029|54746779|FG002|Overall Study|Adverse Event|0|||
28092726|NCT03812029|54746780|FG003|Overall Study|Adverse Event|3|||
28092727|NCT03812029|54746781|FG004|Overall Study|Adverse Event|5|||
28092728|NCT03812029|54746777|FG000|Overall Study|Lost to Follow-up|0|||
28092729|NCT03812029|54746778|FG001|Overall Study|Lost to Follow-up|0|||
28092730|NCT03812029|54746779|FG002|Overall Study|Lost to Follow-up|0|||
28092731|NCT03812029|54746780|FG003|Overall Study|Lost to Follow-up|0|||
28092732|NCT03812029|54746781|FG004|Overall Study|Lost to Follow-up|3|||
28092733|NCT03747575|54746799|FG000|Overall Study|Withdrawal by Subject|6|||
28092734|NCT03747575|54746800|FG001|Overall Study|Withdrawal by Subject|3|||
28092735|NCT03747575|54746799|FG000|Overall Study|Lost to Follow-up|3|||
28092736|NCT03747575|54746800|FG001|Overall Study|Lost to Follow-up|3|||
28167679|NCT02901431|54838453|FG000|PK Part|Pending IMC/SOC Dose Confirmation|2|||
28167680|NCT02901431|54838454|FG001|PK Part|Pending IMC/SOC Dose Confirmation|0|||
28167681|NCT02901431|54838455|FG002|PK Part|Pending IMC/SOC Dose Confirmation|0|||
28167682|NCT02901431|54838456|FG003|PK Part|Pending IMC/SOC Dose Confirmation|0|||
28167683|NCT02901431|54838457|FG004|PK Part|Pending IMC/SOC Dose Confirmation|0|||
28167684|NCT02901431|54838458|FG005|PK Part|Pending IMC/SOC Dose Confirmation|0|||
28167685|NCT02901431|54838459|FG006|PK Part|Pending IMC/SOC Dose Confirmation|0|||
28167686|NCT02901431|54838460|FG007|PK Part|Pending IMC/SOC Dose Confirmation|0|||
28167687|NCT02901431|54838461|FG008|PK Part|Pending IMC/SOC Dose Confirmation|0|||
28167688|NCT02901431|54838462|FG009|PK Part|Pending IMC/SOC Dose Confirmation|0|||
28167689|NCT02901431|54838463|FG010|PK Part|Pending IMC/SOC Dose Confirmation|0|||
28167690|NCT02901431|54838464|FG011|PK Part|Pending IMC/SOC Dose Confirmation|0|||
28167691|NCT02901431|54838465|FG012|PK Part|Pending IMC/SOC Dose Confirmation|0|||
28167692|NCT02901431|54838453|FG000|PK Part|Pending dose confirmation|0|||
28167693|NCT02901431|54838454|FG001|PK Part|Pending dose confirmation|1|||
28167694|NCT02901431|54838455|FG002|PK Part|Pending dose confirmation|0|||
28167695|NCT02901431|54838456|FG003|PK Part|Pending dose confirmation|0|||
28167696|NCT02901431|54838457|FG004|PK Part|Pending dose confirmation|0|||
28167697|NCT02901431|54838458|FG005|PK Part|Pending dose confirmation|0|||
28167698|NCT02901431|54838459|FG006|PK Part|Pending dose confirmation|0|||
28167699|NCT02901431|54838460|FG007|PK Part|Pending dose confirmation|0|||
28167700|NCT02901431|54838461|FG008|PK Part|Pending dose confirmation|0|||
28167701|NCT02901431|54838462|FG009|PK Part|Pending dose confirmation|0|||
28167702|NCT02901431|54838463|FG010|PK Part|Pending dose confirmation|0|||
28167703|NCT02901431|54838464|FG011|PK Part|Pending dose confirmation|0|||
28167704|NCT02901431|54838465|FG012|PK Part|Pending dose confirmation|0|||
28092737|NCT03747575|54746799|FG000|Overall Study|Adverse Event|0|||
28092738|NCT03747575|54746800|FG001|Overall Study|Adverse Event|1|||
28092739|NCT03657043|54746809|FG000|Overall Study|Withdrawal by Subject|1|||
28092740|NCT03657043|54746810|FG001|Overall Study|Withdrawal by Subject|1|||
28092741|NCT03657043|54746811|FG002|Overall Study|Withdrawal by Subject|0|||
28092742|NCT03657043|54746812|FG003|Overall Study|Withdrawal by Subject|0|||
28092743|NCT03657043|54746813|FG004|Overall Study|Withdrawal by Subject|4|||
28092744|NCT03657043|54746809|FG000|Overall Study|Study closure by Sponsor|0|||
28092745|NCT03657043|54746810|FG001|Overall Study|Study closure by Sponsor|2|||
28092746|NCT03657043|54746811|FG002|Overall Study|Study closure by Sponsor|0|||
28092747|NCT03657043|54746812|FG003|Overall Study|Study closure by Sponsor|0|||
28092748|NCT03657043|54746813|FG004|Overall Study|Study closure by Sponsor|17|||
28092749|NCT03657043|54746809|FG000|Overall Study|Lost to Follow-up|0|||
28092750|NCT03657043|54746810|FG001|Overall Study|Lost to Follow-up|0|||
28092751|NCT03657043|54746811|FG002|Overall Study|Lost to Follow-up|0|||
28092752|NCT03657043|54746812|FG003|Overall Study|Lost to Follow-up|0|||
28092753|NCT03657043|54746813|FG004|Overall Study|Lost to Follow-up|4|||
28092754|NCT03657043|54746809|FG000|Overall Study|Death|6|||
28092755|NCT03657043|54746810|FG001|Overall Study|Death|5|||
28092756|NCT03657043|54746811|FG002|Overall Study|Death|0|||
28092757|NCT03657043|54746812|FG003|Overall Study|Death|0|||
28092758|NCT03657043|54746813|FG004|Overall Study|Death|53|||
28092759|NCT03657043|54746809|FG000|Overall Study|Met exclusion criteria after enrollment|1|||
28092760|NCT03657043|54746810|FG001|Overall Study|Met exclusion criteria after enrollment|0|||
28092761|NCT03657043|54746811|FG002|Overall Study|Met exclusion criteria after enrollment|0|||
28092762|NCT03657043|54746812|FG003|Overall Study|Met exclusion criteria after enrollment|0|||
28092763|NCT03657043|54746813|FG004|Overall Study|Met exclusion criteria after enrollment|0|||
28092764|NCT03657043|54746809|FG000|Overall Study|Adverse Event|0|||
28092765|NCT03657043|54746810|FG001|Overall Study|Adverse Event|0|||
28092766|NCT03657043|54746811|FG002|Overall Study|Adverse Event|0|||
28167705|NCT02901431|54838453|FG000|PK Part|8 weeks of treatment ran out|2|||
28167706|NCT02901431|54838454|FG001|PK Part|8 weeks of treatment ran out|0|||
28167707|NCT02901431|54838455|FG002|PK Part|8 weeks of treatment ran out|0|||
28167708|NCT02901431|54838456|FG003|PK Part|8 weeks of treatment ran out|0|||
28167709|NCT02901431|54838457|FG004|PK Part|8 weeks of treatment ran out|0|||
28167710|NCT02901431|54838458|FG005|PK Part|8 weeks of treatment ran out|0|||
28167711|NCT02901431|54838459|FG006|PK Part|8 weeks of treatment ran out|0|||
28167712|NCT02901431|54838460|FG007|PK Part|8 weeks of treatment ran out|0|||
28167713|NCT02901431|54838461|FG008|PK Part|8 weeks of treatment ran out|0|||
28092767|NCT03657043|54746812|FG003|Overall Study|Adverse Event|0|||
28092768|NCT03657043|54746813|FG004|Overall Study|Adverse Event|2|||
28092769|NCT03657043|54746809|FG000|Overall Study|Withdrawal - subsequent treatment|0|||
28092770|NCT03657043|54746810|FG001|Overall Study|Withdrawal - subsequent treatment|0|||
28092771|NCT03657043|54746811|FG002|Overall Study|Withdrawal - subsequent treatment|0|||
28167714|NCT02901431|54838462|FG009|PK Part|8 weeks of treatment ran out|0|||
28167715|NCT02901431|54838463|FG010|PK Part|8 weeks of treatment ran out|0|||
28167716|NCT02901431|54838464|FG011|PK Part|8 weeks of treatment ran out|0|||
28167717|NCT02901431|54838465|FG012|PK Part|8 weeks of treatment ran out|0|||
28167718|NCT02901431|54838453|FG000|PK Part|Stopped treatment after 8 weeks|1|||
28167719|NCT02901431|54838454|FG001|PK Part|Stopped treatment after 8 weeks|0|||
28167720|NCT02901431|54838455|FG002|PK Part|Stopped treatment after 8 weeks|1|||
28167721|NCT02901431|54838456|FG003|PK Part|Stopped treatment after 8 weeks|0|||
28167722|NCT02901431|54838457|FG004|PK Part|Stopped treatment after 8 weeks|0|||
28167723|NCT02901431|54838458|FG005|PK Part|Stopped treatment after 8 weeks|0|||
28167724|NCT02901431|54838459|FG006|PK Part|Stopped treatment after 8 weeks|0|||
28167725|NCT02901431|54838460|FG007|PK Part|Stopped treatment after 8 weeks|0|||
28167726|NCT02901431|54838461|FG008|PK Part|Stopped treatment after 8 weeks|0|||
28167727|NCT02901431|54838462|FG009|PK Part|Stopped treatment after 8 weeks|0|||
28167728|NCT02901431|54838463|FG010|PK Part|Stopped treatment after 8 weeks|0|||
28167729|NCT02901431|54838464|FG011|PK Part|Stopped treatment after 8 weeks|0|||
28167730|NCT02901431|54838465|FG012|PK Part|Stopped treatment after 8 weeks|0|||
28167731|NCT02901431|54838453|FG000|PK Part|Stopped on Sponsor instruction pending dose confirmation|1|||
28167732|NCT02901431|54838454|FG001|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
28167733|NCT02901431|54838455|FG002|PK Part|Stopped on Sponsor instruction pending dose confirmation|4|||
27734040|NCT02679729|54181878|FG003|Overall Study|Participant decision|0|||
27734041|NCT02679729|54181879|FG004|Overall Study|Participant decision|0|||
27734042|NCT02679729|54181880|FG005|Overall Study|Participant decision|0|||
27734043|NCT02679729|54181881|FG006|Overall Study|Participant decision|1|||
27734044|NCT02679729|54181882|FG007|Overall Study|Participant decision|0|||
27734045|NCT02679729|54181883|FG008|Overall Study|Participant decision|0|||
27734046|NCT02765165|54181922|FG000|Treatment Period|Progressive disease|3|||
27734047|NCT02765165|54181923|FG001|Treatment Period|Progressive disease|2|||
27734048|NCT02765165|54181924|FG002|Treatment Period|Progressive disease|3|||
27734049|NCT02765165|54181925|FG003|Treatment Period|Progressive disease|3|||
27734050|NCT02765165|54181926|FG004|Treatment Period|Progressive disease|4|||
27734051|NCT02765165|54181927|FG005|Treatment Period|Progressive disease|2|||
28092772|NCT03657043|54746812|FG003|Overall Study|Withdrawal - subsequent treatment|0|||
27734052|NCT02765165|54181928|FG006|Treatment Period|Progressive disease|2|||
27734053|NCT02765165|54181922|FG000|Treatment Period|Physician Decision|0|||
27734054|NCT02765165|54181923|FG001|Treatment Period|Physician Decision|1|||
27734055|NCT02765165|54181924|FG002|Treatment Period|Physician Decision|0|||
27734056|NCT02765165|54181925|FG003|Treatment Period|Physician Decision|0|||
27734057|NCT02765165|54181926|FG004|Treatment Period|Physician Decision|0|||
27734058|NCT02765165|54181927|FG005|Treatment Period|Physician Decision|0|||
27734059|NCT02765165|54181928|FG006|Treatment Period|Physician Decision|0|||
27734060|NCT02765165|54181922|FG000|Treatment Period|Adverse Event|0|||
27734061|NCT02765165|54181923|FG001|Treatment Period|Adverse Event|1|||
27734062|NCT02765165|54181924|FG002|Treatment Period|Adverse Event|0|||
27734063|NCT02765165|54181925|FG003|Treatment Period|Adverse Event|0|||
27734064|NCT02765165|54181926|FG004|Treatment Period|Adverse Event|0|||
27734065|NCT02765165|54181927|FG005|Treatment Period|Adverse Event|0|||
27734066|NCT02765165|54181928|FG006|Treatment Period|Adverse Event|0|||
27734067|NCT02765165|54181922|FG000|Treatment Period|Withdrawal by Subject|0|||
27734068|NCT02765165|54181923|FG001|Treatment Period|Withdrawal by Subject|0|||
27734069|NCT02765165|54181924|FG002|Treatment Period|Withdrawal by Subject|0|||
27734070|NCT02765165|54181925|FG003|Treatment Period|Withdrawal by Subject|0|||
27734071|NCT02765165|54181926|FG004|Treatment Period|Withdrawal by Subject|2|||
27734072|NCT02765165|54181927|FG005|Treatment Period|Withdrawal by Subject|0|||
27734073|NCT02765165|54181928|FG006|Treatment Period|Withdrawal by Subject|0|||
27734074|NCT02765165|54181922|FG000|Treatment Period|Study terminated|0|||
27734075|NCT02765165|54181923|FG001|Treatment Period|Study terminated|0|||
27734076|NCT02765165|54181924|FG002|Treatment Period|Study terminated|0|||
28092773|NCT03657043|54746813|FG004|Overall Study|Withdrawal - subsequent treatment|1|||
28092774|NCT03657043|54746809|FG000|Overall Study|Withdrawal - declined follow-up|0|||
28092775|NCT03657043|54746810|FG001|Overall Study|Withdrawal - declined follow-up|0|||
28092776|NCT03657043|54746811|FG002|Overall Study|Withdrawal - declined follow-up|0|||
28092777|NCT03657043|54746812|FG003|Overall Study|Withdrawal - declined follow-up|0|||
27734077|NCT02765165|54181925|FG003|Treatment Period|Study terminated|0|||
27734078|NCT02765165|54181926|FG004|Treatment Period|Study terminated|0|||
27734079|NCT02765165|54181927|FG005|Treatment Period|Study terminated|1|||
28167734|NCT02901431|54838456|FG003|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
28167735|NCT02901431|54838457|FG004|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
28167736|NCT02901431|54838458|FG005|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
28092778|NCT03657043|54746813|FG004|Overall Study|Withdrawal - declined follow-up|1|||
28092779|NCT03646669|54746823|FG000|Overall Study|Withdrawal by Subject|5|||
28092780|NCT03646669|54746824|FG001|Overall Study|Withdrawal by Subject|0|||
28092781|NCT03631706|54746832|FG000|Overall Study|Randomized, not treated|1|||
28092782|NCT03631706|54746833|FG001|Overall Study|Randomized, not treated|0|||
28092783|NCT03631706|54746832|FG000|Overall Study|Treatment ongoing|26|||
28092784|NCT03631706|54746833|FG001|Overall Study|Treatment ongoing|57|||
28092785|NCT03631706|54746832|FG000|Overall Study|Off treatment (Treatment completed and discontinued) and in follow up)|65|||
28092786|NCT03631706|54746833|FG001|Overall Study|Off treatment (Treatment completed and discontinued) and in follow up)|41|||
28092787|NCT03619876|54746841|FG000|Overall Study|Withdrawal by Subject|1|||
28092788|NCT03619876|54746842|FG001|Overall Study|Withdrawal by Subject|2|||
28092789|NCT03619876|54746841|FG000|Overall Study|Withdrawal due to incidental finding|0|||
28092790|NCT03619876|54746842|FG001|Overall Study|Withdrawal due to incidental finding|2|||
28092791|NCT03526861|54746864|FG000|Initial Treatment Period|Not dosed|1|||
28092792|NCT03526861|54746865|FG001|Initial Treatment Period|Not dosed|1|||
28167737|NCT02901431|54838459|FG006|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
28167738|NCT02901431|54838460|FG007|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
28167739|NCT02901431|54838461|FG008|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
28167740|NCT02901431|54838462|FG009|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
28167741|NCT02901431|54838463|FG010|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
28167742|NCT02901431|54838464|FG011|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
28167743|NCT02901431|54838465|FG012|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
28092793|NCT03526861|54746866|FG002|Initial Treatment Period|Not dosed|1|||
28092794|NCT03526861|54746867|FG003|Initial Treatment Period|Not dosed|0|||
28092795|NCT03526861|54746868|FG004|Initial Treatment Period|Not dosed|0|||
28092796|NCT03526861|54746869|FG005|Initial Treatment Period|Not dosed|0|||
28092797|NCT03526861|54746870|FG006|Initial Treatment Period|Not dosed|0|||
28092798|NCT03526861|54746871|FG007|Initial Treatment Period|Not dosed|0|||
28092799|NCT03526861|54746872|FG008|Initial Treatment Period|Not dosed|0|||
28092800|NCT03526861|54746864|FG000|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|3|||
28092801|NCT03526861|54746865|FG001|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
28092802|NCT03526861|54746866|FG002|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|5|||
28092803|NCT03526861|54746867|FG003|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
28167744|NCT02901431|54838453|FG000|PK Part|Discontinued per Sponsor|0|||
28167745|NCT02901431|54838454|FG001|PK Part|Discontinued per Sponsor|3|||
27734080|NCT02765165|54181928|FG006|Treatment Period|Study terminated|2|||
28092804|NCT03526861|54746868|FG004|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
28092805|NCT03526861|54746869|FG005|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
28092806|NCT03526861|54746870|FG006|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
28092807|NCT03526861|54746871|FG007|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
28092808|NCT03526861|54746872|FG008|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
28092809|NCT03526861|54746864|FG000|Initial Treatment Period|Subject discontinued IMP before Week 16|3|||
28092810|NCT03526861|54746865|FG001|Initial Treatment Period|Subject discontinued IMP before Week 16|5|||
28092811|NCT03526861|54746866|FG002|Initial Treatment Period|Subject discontinued IMP before Week 16|8|||
28092812|NCT03526861|54746867|FG003|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
28092813|NCT03526861|54746868|FG004|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
28092814|NCT03526861|54746869|FG005|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
28092815|NCT03526861|54746870|FG006|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
28092816|NCT03526861|54746871|FG007|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
28092817|NCT03526861|54746872|FG008|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
28092818|NCT03526861|54746864|FG000|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
28092819|NCT03526861|54746865|FG001|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
28092820|NCT03526861|54746866|FG002|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
28092821|NCT03526861|54746867|FG003|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
28092822|NCT03526861|54746868|FG004|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
28092823|NCT03526861|54746869|FG005|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
28092824|NCT03526861|54746870|FG006|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
28092825|NCT03526861|54746871|FG007|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
28092826|NCT03526861|54746872|FG008|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
27734081|NCT02765165|54181922|FG000|Post-treatment Follow-up|Death|1|||
27734082|NCT02765165|54181923|FG001|Post-treatment Follow-up|Death|2|||
28092827|NCT03526861|54746864|FG000|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
28092828|NCT03526861|54746865|FG001|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
28092829|NCT03526861|54746866|FG002|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
28092830|NCT03526861|54746867|FG003|Maintenance Treatment Period|Subject transferred to open-label treatment|6|||
28092831|NCT03526861|54746868|FG004|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
28092832|NCT03526861|54746869|FG005|Maintenance Treatment Period|Subject transferred to open-label treatment|4|||
28092833|NCT03526861|54746870|FG006|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
28092834|NCT03526861|54746871|FG007|Maintenance Treatment Period|Subject transferred to open-label treatment|2|||
28092835|NCT03526861|54746872|FG008|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
28092836|NCT03526861|54746864|FG000|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
28092837|NCT03526861|54746865|FG001|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
28092838|NCT03526861|54746866|FG002|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
28092839|NCT03526861|54746867|FG003|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
28092840|NCT03526861|54746868|FG004|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
28092841|NCT03526861|54746869|FG005|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
28092842|NCT03526861|54746870|FG006|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
28092843|NCT03526861|54746871|FG007|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
28092844|NCT03526861|54746872|FG008|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
28092845|NCT03526861|54746864|FG000|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
28092846|NCT03526861|54746865|FG001|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
28092847|NCT03526861|54746866|FG002|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
28092848|NCT03526861|54746867|FG003|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
28092849|NCT03526861|54746868|FG004|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
28092850|NCT03526861|54746869|FG005|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
28092851|NCT03526861|54746870|FG006|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
28167746|NCT02901431|54838455|FG002|PK Part|Discontinued per Sponsor|0|||
28167747|NCT02901431|54838456|FG003|PK Part|Discontinued per Sponsor|0|||
28167748|NCT02901431|54838457|FG004|PK Part|Discontinued per Sponsor|0|||
28167749|NCT02901431|54838458|FG005|PK Part|Discontinued per Sponsor|0|||
28167750|NCT02901431|54838459|FG006|PK Part|Discontinued per Sponsor|0|||
28167751|NCT02901431|54838460|FG007|PK Part|Discontinued per Sponsor|0|||
28167752|NCT02901431|54838461|FG008|PK Part|Discontinued per Sponsor|0|||
28167753|NCT02901431|54838462|FG009|PK Part|Discontinued per Sponsor|0|||
28167754|NCT02901431|54838463|FG010|PK Part|Discontinued per Sponsor|0|||
28167755|NCT02901431|54838464|FG011|PK Part|Discontinued per Sponsor|0|||
28167756|NCT02901431|54838465|FG012|PK Part|Discontinued per Sponsor|0|||
28167757|NCT02901431|54838453|FG000|PK Part|Withdrawal by Subject|1|||
28167758|NCT02901431|54838454|FG001|PK Part|Withdrawal by Subject|1|||
28092852|NCT03526861|54746871|FG007|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
28092853|NCT03526861|54746872|FG008|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|19|||
28092854|NCT03526861|54746864|FG000|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
28092855|NCT03526861|54746865|FG001|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
28092856|NCT03526861|54746866|FG002|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
28092857|NCT03526861|54746867|FG003|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
28092858|NCT03526861|54746868|FG004|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
28092859|NCT03526861|54746869|FG005|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
28167759|NCT02901431|54838455|FG002|PK Part|Withdrawal by Subject|3|||
28167760|NCT02901431|54838456|FG003|PK Part|Withdrawal by Subject|0|||
28167761|NCT02901431|54838457|FG004|PK Part|Withdrawal by Subject|0|||
28167762|NCT02901431|54838458|FG005|PK Part|Withdrawal by Subject|0|||
28167763|NCT02901431|54838459|FG006|PK Part|Withdrawal by Subject|0|||
28167764|NCT02901431|54838460|FG007|PK Part|Withdrawal by Subject|0|||
28167765|NCT02901431|54838461|FG008|PK Part|Withdrawal by Subject|0|||
28167766|NCT02901431|54838462|FG009|PK Part|Withdrawal by Subject|0|||
28167767|NCT02901431|54838463|FG010|PK Part|Withdrawal by Subject|0|||
27980716|NCT00891020|54638731|FG000|24 Week Treatment Period|Failure to return|4|||
27980717|NCT00891020|54638732|FG001|24 Week Treatment Period|Failure to return|5|||
27980718|NCT00891020|54638733|FG002|24 Week Treatment Period|Failure to return|5|||
27980719|NCT00891020|54638731|FG000|24 Week Treatment Period|Violation of selection criteria at entry|1|||
27980720|NCT00891020|54638732|FG001|24 Week Treatment Period|Violation of selection criteria at entry|0|||
28092860|NCT03526861|54746870|FG006|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
28092861|NCT03526861|54746871|FG007|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
28092862|NCT03526861|54746872|FG008|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|1|||
28092863|NCT03526861|54746864|FG000|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
28092864|NCT03526861|54746865|FG001|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
28092865|NCT03526861|54746866|FG002|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
28092866|NCT03526861|54746867|FG003|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
28092867|NCT03526861|54746868|FG004|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
28092868|NCT03526861|54746869|FG005|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
28092869|NCT03526861|54746870|FG006|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
28092870|NCT03526861|54746871|FG007|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
28092871|NCT03526861|54746872|FG008|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|8|||
28092872|NCT03515811|54746894|FG000|Overall Study|Lost to Follow-up|2|||
28092873|NCT03515811|54746895|FG001|Overall Study|Lost to Follow-up|1|||
28092874|NCT03515811|54746894|FG000|Overall Study|Protocol Violation|1|||
28092875|NCT03515811|54746895|FG001|Overall Study|Protocol Violation|1|||
28092876|NCT03515811|54746894|FG000|Overall Study|Death|1|||
28092877|NCT03515811|54746895|FG001|Overall Study|Death|1|||
28092878|NCT03515811|54746894|FG000|Overall Study|Withdrawal by Subject|0|||
28092879|NCT03515811|54746895|FG001|Overall Study|Withdrawal by Subject|2|||
28167768|NCT02901431|54838464|FG011|PK Part|Withdrawal by Subject|0|||
28167769|NCT02901431|54838465|FG012|PK Part|Withdrawal by Subject|0|||
28167770|NCT02901431|54838453|FG000|Main Treatment Part|Adverse Event|0|||
28167771|NCT02901431|54838454|FG001|Main Treatment Part|Adverse Event|0|||
28167772|NCT02901431|54838455|FG002|Main Treatment Part|Adverse Event|0|||
28167773|NCT02901431|54838456|FG003|Main Treatment Part|Adverse Event|3|||
28167774|NCT02901431|54838457|FG004|Main Treatment Part|Adverse Event|3|||
28167775|NCT02901431|54838458|FG005|Main Treatment Part|Adverse Event|4|||
28167776|NCT02901431|54838459|FG006|Main Treatment Part|Adverse Event|1|||
28167777|NCT02901431|54838460|FG007|Main Treatment Part|Adverse Event|0|||
28167778|NCT02901431|54838461|FG008|Main Treatment Part|Adverse Event|0|||
28167779|NCT02901431|54838462|FG009|Main Treatment Part|Adverse Event|0|||
28167780|NCT02901431|54838463|FG010|Main Treatment Part|Adverse Event|0|||
28167781|NCT02901431|54838464|FG011|Main Treatment Part|Adverse Event|0|||
28167782|NCT02901431|54838465|FG012|Main Treatment Part|Adverse Event|0|||
28167783|NCT02901431|54838453|FG000|Main Treatment Part|Lack of Efficacy|0|||
28092880|NCT03515811|54746894|FG000|Overall Study|Technical Problems|1|||
28092881|NCT03515811|54746895|FG001|Overall Study|Technical Problems|0|||
28092882|NCT03515811|54746894|FG000|Overall Study|Subject Unable to Return for Follow-Up|0|||
28092883|NCT03515811|54746895|FG001|Overall Study|Subject Unable to Return for Follow-Up|2|||
28167784|NCT02901431|54838454|FG001|Main Treatment Part|Lack of Efficacy|0|||
28167785|NCT02901431|54838455|FG002|Main Treatment Part|Lack of Efficacy|0|||
28167786|NCT02901431|54838456|FG003|Main Treatment Part|Lack of Efficacy|1|||
28167787|NCT02901431|54838457|FG004|Main Treatment Part|Lack of Efficacy|0|||
28167788|NCT02901431|54838458|FG005|Main Treatment Part|Lack of Efficacy|0|||
28167789|NCT02901431|54838459|FG006|Main Treatment Part|Lack of Efficacy|0|||
27833185|NCT01748825|54314627|FG006|Dose Expansion|Refused further treatment|0|||
27833186|NCT01748825|54314628|FG007|Dose Expansion|Refused further treatment|0|||
28167790|NCT02901431|54838460|FG007|Main Treatment Part|Lack of Efficacy|0|||
28167791|NCT02901431|54838461|FG008|Main Treatment Part|Lack of Efficacy|0|||
28167792|NCT02901431|54838462|FG009|Main Treatment Part|Lack of Efficacy|0|||
28167793|NCT02901431|54838463|FG010|Main Treatment Part|Lack of Efficacy|0|||
28167794|NCT02901431|54838464|FG011|Main Treatment Part|Lack of Efficacy|0|||
28167795|NCT02901431|54838465|FG012|Main Treatment Part|Lack of Efficacy|0|||
27833187|NCT01748825|54314629|FG008|Dose Expansion|Refused further treatment|1|||
27833188|NCT01748825|54314630|FG009|Dose Expansion|Refused further treatment|1|||
27833189|NCT01748825|54314621|FG000|Dose Expansion|Switched to alternative treatment|0|||
27833190|NCT01748825|54314622|FG001|Dose Expansion|Switched to alternative treatment|0|||
27833191|NCT01748825|54314623|FG002|Dose Expansion|Switched to alternative treatment|0|||
27833192|NCT01748825|54314624|FG003|Dose Expansion|Switched to alternative treatment|0|||
27980721|NCT00891020|54638733|FG002|24 Week Treatment Period|Violation of selection criteria at entry|2|||
28167796|NCT02901431|54838453|FG000|Main Treatment Part|Lost to Follow-up|0|||
28167797|NCT02901431|54838454|FG001|Main Treatment Part|Lost to Follow-up|0|||
28167798|NCT02901431|54838455|FG002|Main Treatment Part|Lost to Follow-up|0|||
27833193|NCT01748825|54314625|FG004|Dose Expansion|Switched to alternative treatment|0|||
27833194|NCT01748825|54314626|FG005|Dose Expansion|Switched to alternative treatment|0|||
28092884|NCT03515811|54746894|FG000|Overall Study|COVID-19|0|||
28092885|NCT03515811|54746895|FG001|Overall Study|COVID-19|1|||
28092886|NCT03510884|54746908|FG000|Double-blind Period (up to Week 24)|Adverse Event|0|||
28092887|NCT03510884|54746909|FG001|Double-blind Period (up to Week 24)|Adverse Event|0|||
28092888|NCT03510884|54746910|FG002|Double-blind Period (up to Week 24)|Adverse Event|0|||
28092889|NCT03510884|54746911|FG003|Double-blind Period (up to Week 24)|Adverse Event|2|||
28092890|NCT03510884|54746908|FG000|Double-blind Period (up to Week 24)|Participant moved|0|||
28092891|NCT03510884|54746909|FG001|Double-blind Period (up to Week 24)|Participant moved|1|||
28092892|NCT03510884|54746910|FG002|Double-blind Period (up to Week 24)|Participant moved|0|||
28092893|NCT03510884|54746911|FG003|Double-blind Period (up to Week 24)|Participant moved|0|||
28092894|NCT03510884|54746908|FG000|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
28092895|NCT03510884|54746909|FG001|Double-blind Period (up to Week 24)|Life events made continuing too difficult|1|||
28167799|NCT02901431|54838456|FG003|Main Treatment Part|Lost to Follow-up|3|||
28167800|NCT02901431|54838457|FG004|Main Treatment Part|Lost to Follow-up|1|||
28167801|NCT02901431|54838458|FG005|Main Treatment Part|Lost to Follow-up|2|||
28167802|NCT02901431|54838459|FG006|Main Treatment Part|Lost to Follow-up|3|||
28167803|NCT02901431|54838460|FG007|Main Treatment Part|Lost to Follow-up|0|||
28167804|NCT02901431|54838461|FG008|Main Treatment Part|Lost to Follow-up|0|||
28167805|NCT02901431|54838462|FG009|Main Treatment Part|Lost to Follow-up|0|||
28167806|NCT02901431|54838463|FG010|Main Treatment Part|Lost to Follow-up|0|||
28167807|NCT02901431|54838464|FG011|Main Treatment Part|Lost to Follow-up|0|||
28167808|NCT02901431|54838465|FG012|Main Treatment Part|Lost to Follow-up|0|||
28167809|NCT02901431|54838453|FG000|Main Treatment Part|Withdrawal by Caregiver|0|||
28167810|NCT02901431|54838454|FG001|Main Treatment Part|Withdrawal by Caregiver|0|||
28167811|NCT02901431|54838455|FG002|Main Treatment Part|Withdrawal by Caregiver|0|||
28167812|NCT02901431|54838456|FG003|Main Treatment Part|Withdrawal by Caregiver|0|||
28167813|NCT02901431|54838457|FG004|Main Treatment Part|Withdrawal by Caregiver|0|||
28167814|NCT02901431|54838458|FG005|Main Treatment Part|Withdrawal by Caregiver|1|||
28167815|NCT02901431|54838459|FG006|Main Treatment Part|Withdrawal by Caregiver|0|||
28167816|NCT02901431|54838460|FG007|Main Treatment Part|Withdrawal by Caregiver|0|||
28167817|NCT02901431|54838461|FG008|Main Treatment Part|Withdrawal by Caregiver|0|||
28167818|NCT02901431|54838462|FG009|Main Treatment Part|Withdrawal by Caregiver|0|||
28167819|NCT02901431|54838463|FG010|Main Treatment Part|Withdrawal by Caregiver|0|||
28167820|NCT02901431|54838464|FG011|Main Treatment Part|Withdrawal by Caregiver|0|||
28167821|NCT02901431|54838465|FG012|Main Treatment Part|Withdrawal by Caregiver|0|||
28167822|NCT02901431|54838453|FG000|Main Treatment Part|Physician Decision|0|||
28167823|NCT02901431|54838454|FG001|Main Treatment Part|Physician Decision|0|||
28167824|NCT02901431|54838455|FG002|Main Treatment Part|Physician Decision|0|||
28167825|NCT02901431|54838456|FG003|Main Treatment Part|Physician Decision|1|||
28167826|NCT02901431|54838457|FG004|Main Treatment Part|Physician Decision|0|||
28167827|NCT02901431|54838458|FG005|Main Treatment Part|Physician Decision|0|||
28167828|NCT02901431|54838459|FG006|Main Treatment Part|Physician Decision|1|||
28167829|NCT02901431|54838460|FG007|Main Treatment Part|Physician Decision|0|||
28167830|NCT02901431|54838461|FG008|Main Treatment Part|Physician Decision|0|||
28167831|NCT02901431|54838462|FG009|Main Treatment Part|Physician Decision|0|||
28167832|NCT02901431|54838463|FG010|Main Treatment Part|Physician Decision|0|||
28167833|NCT02901431|54838464|FG011|Main Treatment Part|Physician Decision|0|||
28167834|NCT02901431|54838465|FG012|Main Treatment Part|Physician Decision|0|||
28167835|NCT02901431|54838453|FG000|Main Treatment Part|Withdrawal by Subject|0|||
28167836|NCT02901431|54838454|FG001|Main Treatment Part|Withdrawal by Subject|0|||
28167837|NCT02901431|54838455|FG002|Main Treatment Part|Withdrawal by Subject|0|||
28167838|NCT02901431|54838456|FG003|Main Treatment Part|Withdrawal by Subject|18|||
28167839|NCT02901431|54838457|FG004|Main Treatment Part|Withdrawal by Subject|3|||
28167840|NCT02901431|54838458|FG005|Main Treatment Part|Withdrawal by Subject|5|||
28167841|NCT02901431|54838459|FG006|Main Treatment Part|Withdrawal by Subject|6|||
28167842|NCT02901431|54838460|FG007|Main Treatment Part|Withdrawal by Subject|0|||
28167843|NCT02901431|54838461|FG008|Main Treatment Part|Withdrawal by Subject|0|||
28167844|NCT02901431|54838462|FG009|Main Treatment Part|Withdrawal by Subject|0|||
28167845|NCT02901431|54838463|FG010|Main Treatment Part|Withdrawal by Subject|0|||
28167846|NCT02901431|54838464|FG011|Main Treatment Part|Withdrawal by Subject|0|||
28167847|NCT02901431|54838465|FG012|Main Treatment Part|Withdrawal by Subject|0|||
28167848|NCT02901431|54838453|FG000|Open Label Part|Adverse Event|0|||
28167849|NCT02901431|54838454|FG001|Open Label Part|Adverse Event|0|||
28167850|NCT02901431|54838455|FG002|Open Label Part|Adverse Event|0|||
28167851|NCT02901431|54838456|FG003|Open Label Part|Adverse Event|0|||
28167852|NCT02901431|54838457|FG004|Open Label Part|Adverse Event|0|||
28167853|NCT02901431|54838458|FG005|Open Label Part|Adverse Event|0|||
28167854|NCT02901431|54838459|FG006|Open Label Part|Adverse Event|0|||
28167855|NCT02901431|54838460|FG007|Open Label Part|Adverse Event|0|||
28167856|NCT02901431|54838461|FG008|Open Label Part|Adverse Event|4|||
28167857|NCT02901431|54838462|FG009|Open Label Part|Adverse Event|4|||
28167858|NCT02901431|54838463|FG010|Open Label Part|Adverse Event|0|||
28167859|NCT02901431|54838464|FG011|Open Label Part|Adverse Event|4|||
28167860|NCT02901431|54838465|FG012|Open Label Part|Adverse Event|1|||
28092896|NCT03510884|54746910|FG002|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
28092897|NCT03510884|54746911|FG003|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
28092898|NCT03510884|54746908|FG000|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
28092899|NCT03510884|54746909|FG001|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|2|||
28092900|NCT03510884|54746910|FG002|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
28092901|NCT03510884|54746911|FG003|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
28092902|NCT03510884|54746908|FG000|Double-blind Period (up to Week 24)|Other than specified above|0|||
28092903|NCT03510884|54746909|FG001|Double-blind Period (up to Week 24)|Other than specified above|0|||
28092904|NCT03510884|54746910|FG002|Double-blind Period (up to Week 24)|Other than specified above|1|||
28092905|NCT03510884|54746911|FG003|Double-blind Period (up to Week 24)|Other than specified above|1|||
28092906|NCT03510884|54746908|FG000|Open Label Period (up to Week 104)|Adverse Event|1|||
28092907|NCT03510884|54746909|FG001|Open Label Period (up to Week 104)|Adverse Event|0|||
28092908|NCT03510884|54746910|FG002|Open Label Period (up to Week 104)|Adverse Event|0|||
28092909|NCT03510884|54746911|FG003|Open Label Period (up to Week 104)|Adverse Event|0|||
28092910|NCT03510884|54746908|FG000|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
28092911|NCT03510884|54746909|FG001|Open Label Period (up to Week 104)|Lack of Efficacy|1|||
28092912|NCT03510884|54746910|FG002|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
28092913|NCT03510884|54746911|FG003|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
28092914|NCT03510884|54746908|FG000|Open Label Period (up to Week 104)|Participant moved|1|||
28092915|NCT03510884|54746909|FG001|Open Label Period (up to Week 104)|Participant moved|0|||
28092916|NCT03510884|54746910|FG002|Open Label Period (up to Week 104)|Participant moved|1|||
28092917|NCT03510884|54746911|FG003|Open Label Period (up to Week 104)|Participant moved|0|||
28092918|NCT03510884|54746908|FG000|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
28092919|NCT03510884|54746909|FG001|Open Label Period (up to Week 104)|Life events made continuing too difficult|1|||
28092920|NCT03510884|54746910|FG002|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
28092921|NCT03510884|54746911|FG003|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
28092922|NCT03510884|54746908|FG000|Open Label Period (up to Week 104)|Other than specified above|1|||
28092923|NCT03510884|54746909|FG001|Open Label Period (up to Week 104)|Other than specified above|1|||
28092924|NCT03510884|54746910|FG002|Open Label Period (up to Week 104)|Other than specified above|0|||
28092925|NCT03510884|54746911|FG003|Open Label Period (up to Week 104)|Other than specified above|0|||
28092926|NCT03488472|54746949|FG000|Overall Study|disease progression additional mets|1|||
28092927|NCT03456453|54746955|FG000|Overall Study|Withdrawal by Subject|2|||
28092928|NCT03456453|54746956|FG001|Overall Study|Withdrawal by Subject|0|||
28092929|NCT03456453|54746955|FG000|Overall Study|Not released to community|1|||
28167861|NCT02901431|54838453|FG000|Open Label Part|Lost to Follow-up|0|||
28167862|NCT02901431|54838454|FG001|Open Label Part|Lost to Follow-up|0|||
28167863|NCT02901431|54838455|FG002|Open Label Part|Lost to Follow-up|0|||
28167864|NCT02901431|54838456|FG003|Open Label Part|Lost to Follow-up|0|||
28167865|NCT02901431|54838457|FG004|Open Label Part|Lost to Follow-up|0|||
28167866|NCT02901431|54838458|FG005|Open Label Part|Lost to Follow-up|0|||
28167867|NCT02901431|54838459|FG006|Open Label Part|Lost to Follow-up|0|||
28167868|NCT02901431|54838460|FG007|Open Label Part|Lost to Follow-up|0|||
28167869|NCT02901431|54838461|FG008|Open Label Part|Lost to Follow-up|2|||
28167870|NCT02901431|54838462|FG009|Open Label Part|Lost to Follow-up|2|||
28167871|NCT02901431|54838463|FG010|Open Label Part|Lost to Follow-up|1|||
27734083|NCT02765165|54181924|FG002|Post-treatment Follow-up|Death|1|||
27734084|NCT02765165|54181925|FG003|Post-treatment Follow-up|Death|1|||
28092930|NCT03456453|54746956|FG001|Overall Study|Not released to community|5|||
28092931|NCT03456453|54746955|FG000|Overall Study|Lost to Follow-up|0|||
28092932|NCT03456453|54746956|FG001|Overall Study|Lost to Follow-up|2|||
28092933|NCT03455829|54746967|FG000|Overall Study|Death|2|||
28092934|NCT03455829|54746968|FG001|Overall Study|Death|3|||
28092935|NCT03455829|54746969|FG002|Overall Study|Death|2|||
28092936|NCT03455829|54746970|FG003|Overall Study|Death|4|||
28092937|NCT03455829|54746971|FG004|Overall Study|Death|2|||
28092938|NCT03455829|54746967|FG000|Overall Study|Study terminated and patients did not have progressive disease or died|5|||
28092939|NCT03455829|54746968|FG001|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
28092940|NCT03455829|54746969|FG002|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
28092941|NCT03455829|54746970|FG003|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
28092942|NCT03455829|54746971|FG004|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
28092943|NCT03455829|54746967|FG000|Overall Study|Disease progression|0|||
28092944|NCT03455829|54746968|FG001|Overall Study|Disease progression|0|||
28092945|NCT03455829|54746969|FG002|Overall Study|Disease progression|0|||
28092946|NCT03455829|54746970|FG003|Overall Study|Disease progression|1|||
28092947|NCT03455829|54746971|FG004|Overall Study|Disease progression|1|||
28092948|NCT03441334|54746985|FG000|Overall Study|Withdrawal by Subject|1|||
28167872|NCT02901431|54838464|FG011|Open Label Part|Lost to Follow-up|1|||
28092949|NCT03441334|54746986|FG001|Overall Study|Withdrawal by Subject|0|||
28092950|NCT03429244|54747017|FG000|Overall Study|Withdrawal by Subject|2|||
28092951|NCT03429244|54747018|FG001|Overall Study|Withdrawal by Subject|1|||
28092952|NCT03429244|54747019|FG002|Overall Study|Withdrawal by Subject|1|||
28092953|NCT03370276|54747035|FG000|Overall Study|Death|0|||
28092954|NCT03370276|54747036|FG001|Overall Study|Death|2|||
28092955|NCT03370276|54747037|FG002|Overall Study|Death|5|||
28092956|NCT03250117|54747045|FG000|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|1|||
28092957|NCT03250117|54747046|FG001|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
28092958|NCT03250117|54747047|FG002|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
28167873|NCT02901431|54838465|FG012|Open Label Part|Lost to Follow-up|1|||
28167874|NCT02901431|54838453|FG000|Open Label Part|Physician Decision|0|||
28167875|NCT02901431|54838454|FG001|Open Label Part|Physician Decision|0|||
28167876|NCT02901431|54838455|FG002|Open Label Part|Physician Decision|0|||
28167877|NCT02901431|54838456|FG003|Open Label Part|Physician Decision|0|||
28167878|NCT02901431|54838457|FG004|Open Label Part|Physician Decision|0|||
28092959|NCT03250117|54747048|FG003|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
28092960|NCT03230838|54747054|FG000|Overall Study|Withdrawal by Subject|3|||
28092961|NCT03230838|54747055|FG001|Overall Study|Withdrawal by Subject|0|||
28092962|NCT03230838|54747054|FG000|Overall Study|Temperature excursion|1|||
28092963|NCT03230838|54747055|FG001|Overall Study|Temperature excursion|0|||
28092964|NCT03217136|54747063|FG000|Overall Study|Lost to Follow-up|2|||
28092965|NCT03217136|54747064|FG001|Overall Study|Lost to Follow-up|1|||
28092966|NCT03217136|54747063|FG000|Overall Study|Site Randomized Participant in Error|0|||
28092967|NCT03217136|54747064|FG001|Overall Study|Site Randomized Participant in Error|1|||
28092968|NCT03217136|54747063|FG000|Overall Study|Did Not Meet Criteria after Randomization|0|||
28092969|NCT03217136|54747064|FG001|Overall Study|Did Not Meet Criteria after Randomization|1|||
28092970|NCT03217136|54747063|FG000|Overall Study|Dispensing Error|1|||
28092971|NCT03217136|54747064|FG001|Overall Study|Dispensing Error|0|||
28092972|NCT03217136|54747063|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
28092973|NCT03217136|54747064|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
28092974|NCT03213665|54747070|FG000|Overall Study|Adverse Event|1|||
28092975|NCT03213665|54747070|FG000|Overall Study|Physician Decision|2|||
28092976|NCT03213665|54747070|FG000|Overall Study|Withdrawal by Subject|3|||
28167879|NCT02901431|54838458|FG005|Open Label Part|Physician Decision|0|||
28167880|NCT02901431|54838459|FG006|Open Label Part|Physician Decision|0|||
28167881|NCT02901431|54838460|FG007|Open Label Part|Physician Decision|0|||
28167882|NCT02901431|54838461|FG008|Open Label Part|Physician Decision|1|||
28167883|NCT02901431|54838462|FG009|Open Label Part|Physician Decision|1|||
28167884|NCT02901431|54838463|FG010|Open Label Part|Physician Decision|0|||
28092977|NCT03213665|54747070|FG000|Overall Study|Progressive Disease|13|||
28167885|NCT02901431|54838464|FG011|Open Label Part|Physician Decision|0|||
28167886|NCT02901431|54838465|FG012|Open Label Part|Physician Decision|0|||
28167887|NCT02901431|54838453|FG000|Open Label Part|Study Terminated By Sponsor|0|||
28167888|NCT02901431|54838454|FG001|Open Label Part|Study Terminated By Sponsor|0|||
28092978|NCT03179761|54747076|FG000|Overall Study|Death|2|||
28092979|NCT03179761|54747077|FG001|Overall Study|Death|5|||
28092980|NCT03179761|54747076|FG000|Overall Study|Lost to Follow-up|2|||
28092981|NCT03179761|54747077|FG001|Overall Study|Lost to Follow-up|2|||
28092982|NCT03179761|54747076|FG000|Overall Study|Protocol Violation|1|||
28092983|NCT03179761|54747077|FG001|Overall Study|Protocol Violation|0|||
28092984|NCT03179761|54747076|FG000|Overall Study|Withdrawal by Subject|1|||
28092985|NCT03179761|54747077|FG001|Overall Study|Withdrawal by Subject|4|||
28092986|NCT03179761|54747076|FG000|Overall Study|Investigator Request|0|||
28092987|NCT03179761|54747077|FG001|Overall Study|Investigator Request|2|||
28092988|NCT03173248|54747085|FG000|Overall Study|Death|28|||
28092989|NCT03173248|54747086|FG001|Overall Study|Death|46|||
28092990|NCT03173248|54747085|FG000|Overall Study|Lost to Follow-up|0|||
28092991|NCT03173248|54747086|FG001|Overall Study|Lost to Follow-up|1|||
28092992|NCT03173248|54747085|FG000|Overall Study|Withdrawal by Subject|6|||
28092993|NCT03173248|54747086|FG001|Overall Study|Withdrawal by Subject|4|||
28092994|NCT03173248|54747085|FG000|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|38|||
28092995|NCT03173248|54747086|FG001|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|23|||
28092996|NCT03155841|54747094|FG000|Overall Study|Protocol Violation|3|||
28092997|NCT03155841|54747095|FG001|Overall Study|Protocol Violation|4|||
28092998|NCT03122886|54747103|FG000|Overall Study|Withdrawal by Subject|1|||
28092999|NCT03122886|54747104|FG001|Overall Study|Withdrawal by Subject|2|||
28093000|NCT03114891|54747114|FG000|First Treatment Round|Lost to Follow-up|0|||
28093001|NCT03114891|54747115|FG001|First Treatment Round|Lost to Follow-up|1|||
28093002|NCT03114891|54747116|FG002|First Treatment Round|Lost to Follow-up|1|||
28093003|NCT03114891|54747117|FG003|First Treatment Round|Lost to Follow-up|0|||
28167889|NCT02901431|54838455|FG002|Open Label Part|Study Terminated By Sponsor|0|||
28167890|NCT02901431|54838456|FG003|Open Label Part|Study Terminated By Sponsor|0|||
28167891|NCT02901431|54838457|FG004|Open Label Part|Study Terminated By Sponsor|0|||
28093004|NCT03114891|54747114|FG000|First Treatment Round|Withdrawal by Subject|0|||
28093005|NCT03114891|54747115|FG001|First Treatment Round|Withdrawal by Subject|2|||
28093006|NCT03114891|54747116|FG002|First Treatment Round|Withdrawal by Subject|0|||
28093007|NCT03114891|54747117|FG003|First Treatment Round|Withdrawal by Subject|1|||
28093008|NCT03114891|54747114|FG000|3 Week Break|Lost to Follow-up|1|||
28093009|NCT03114891|54747115|FG001|3 Week Break|Lost to Follow-up|0|||
28093010|NCT03114891|54747116|FG002|3 Week Break|Lost to Follow-up|0|||
28093011|NCT03114891|54747117|FG003|3 Week Break|Lost to Follow-up|1|||
28093012|NCT03114891|54747114|FG000|3 Week Break|Withdrawal by Subject|0|||
28093013|NCT03114891|54747115|FG001|3 Week Break|Withdrawal by Subject|1|||
28093014|NCT03114891|54747116|FG002|3 Week Break|Withdrawal by Subject|0|||
28093015|NCT03114891|54747117|FG003|3 Week Break|Withdrawal by Subject|0|||
28093016|NCT03114891|54747114|FG000|Second Treatment Round|Lost to Follow-up|1|||
28093017|NCT03114891|54747115|FG001|Second Treatment Round|Lost to Follow-up|0|||
28093018|NCT03114891|54747116|FG002|Second Treatment Round|Lost to Follow-up|0|||
28093019|NCT03114891|54747117|FG003|Second Treatment Round|Lost to Follow-up|0|||
28093020|NCT03114891|54747114|FG000|Second Treatment Round|Physician Decision|1|||
28093021|NCT03114891|54747115|FG001|Second Treatment Round|Physician Decision|0|||
28093022|NCT03114891|54747116|FG002|Second Treatment Round|Physician Decision|0|||
28093023|NCT03114891|54747117|FG003|Second Treatment Round|Physician Decision|0|||
28093024|NCT03057847|54747159|FG000|Overall Study|Lost to Follow-up|16|||
28093025|NCT02946463|54747187|FG000|Primary Evaluation Period|Physician Decision|0|||
28093026|NCT02946463|54747188|FG001|Primary Evaluation Period|Physician Decision|1|||
28093027|NCT02946463|54747187|FG000|Primary Evaluation Period|Withdrawal by Subject|0|||
28093028|NCT02946463|54747188|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
28093029|NCT02928224|54747198|FG000|Overall Study|Randomized, Not Treated|0|||
28093030|NCT02928224|54747199|FG001|Overall Study|Randomized, Not Treated|2|||
28093031|NCT02928224|54747200|FG002|Overall Study|Randomized, Not Treated|4|||
28093032|NCT02928224|54747201|FG003|Overall Study|Randomized, Not Treated|28|||
28093033|NCT02928224|54747198|FG000|Overall Study|Treatment Ongoing|6|||
28093034|NCT02928224|54747199|FG001|Overall Study|Treatment Ongoing|78|||
28167892|NCT02901431|54838458|FG005|Open Label Part|Study Terminated By Sponsor|0|||
28167893|NCT02901431|54838459|FG006|Open Label Part|Study Terminated By Sponsor|0|||
28167894|NCT02901431|54838460|FG007|Open Label Part|Study Terminated By Sponsor|0|||
28167895|NCT02901431|54838461|FG008|Open Label Part|Study Terminated By Sponsor|35|||
28167896|NCT02901431|54838462|FG009|Open Label Part|Study Terminated By Sponsor|12|||
28167897|NCT02901431|54838463|FG010|Open Label Part|Study Terminated By Sponsor|21|||
28167898|NCT02901431|54838464|FG011|Open Label Part|Study Terminated By Sponsor|31|||
28167899|NCT02901431|54838465|FG012|Open Label Part|Study Terminated By Sponsor|0|||
28167900|NCT02901431|54838453|FG000|Open Label Part|Withdrawal by Subject|0|||
28167901|NCT02901431|54838454|FG001|Open Label Part|Withdrawal by Subject|0|||
28167902|NCT02901431|54838455|FG002|Open Label Part|Withdrawal by Subject|0|||
28167903|NCT02901431|54838456|FG003|Open Label Part|Withdrawal by Subject|0|||
28167904|NCT02901431|54838457|FG004|Open Label Part|Withdrawal by Subject|0|||
28167905|NCT02901431|54838458|FG005|Open Label Part|Withdrawal by Subject|0|||
28167906|NCT02901431|54838459|FG006|Open Label Part|Withdrawal by Subject|0|||
28167907|NCT02901431|54838460|FG007|Open Label Part|Withdrawal by Subject|0|||
28167908|NCT02901431|54838461|FG008|Open Label Part|Withdrawal by Subject|6|||
28167909|NCT02901431|54838462|FG009|Open Label Part|Withdrawal by Subject|5|||
28167910|NCT02901431|54838463|FG010|Open Label Part|Withdrawal by Subject|7|||
28167911|NCT02901431|54838464|FG011|Open Label Part|Withdrawal by Subject|3|||
28167912|NCT02901431|54838465|FG012|Open Label Part|Withdrawal by Subject|1|||
28167913|NCT02873377|54838492|FG000|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
28167914|NCT02873377|54838493|FG001|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
28167915|NCT02873377|54838492|FG000|Period Title 3: 6 Months Follow up|Lost to Follow-up|15|||
28167916|NCT02873377|54838493|FG001|Period Title 3: 6 Months Follow up|Lost to Follow-up|23|||
28167917|NCT02966795|54838502|FG000|Overall Study|Patient Left the Country|0|||
27734085|NCT02765165|54181926|FG004|Post-treatment Follow-up|Death|1|||
27734086|NCT02765165|54181927|FG005|Post-treatment Follow-up|Death|1|||
27833195|NCT01748825|54314627|FG006|Dose Expansion|Switched to alternative treatment|0|||
27833196|NCT01748825|54314628|FG007|Dose Expansion|Switched to alternative treatment|0|||
28093035|NCT02928224|54747200|FG002|Overall Study|Treatment Ongoing|78|||
28093036|NCT02928224|54747201|FG003|Overall Study|Treatment Ongoing|37|||
27833197|NCT01748825|54314629|FG008|Dose Expansion|Switched to alternative treatment|0|||
27833198|NCT01748825|54314630|FG009|Dose Expansion|Switched to alternative treatment|1|||
28093037|NCT02928224|54747198|FG000|Overall Study|Progressive Disease|23|||
28093038|NCT02928224|54747199|FG001|Overall Study|Progressive Disease|104|||
28093039|NCT02928224|54747200|FG002|Overall Study|Progressive Disease|101|||
28093040|NCT02928224|54747201|FG003|Overall Study|Progressive Disease|103|||
28093041|NCT02928224|54747198|FG000|Overall Study|Adverse Event|2|||
28167918|NCT02966795|54838503|FG001|Overall Study|Patient Left the Country|1|||
28167919|NCT02873221|54838511|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
28167920|NCT02873221|54838512|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
28167921|NCT02873221|54838513|FG002|Treatment Period|Other Miscellaneous Reasons|1|||
28093042|NCT02928224|54747199|FG001|Overall Study|Adverse Event|11|||
28093043|NCT02928224|54747200|FG002|Overall Study|Adverse Event|11|||
28093044|NCT02928224|54747201|FG003|Overall Study|Adverse Event|10|||
28093045|NCT02928224|54747198|FG000|Overall Study|Changes in Patient's Condition|3|||
28093046|NCT02928224|54747199|FG001|Overall Study|Changes in Patient's Condition|9|||
28093047|NCT02928224|54747200|FG002|Overall Study|Changes in Patient's Condition|9|||
28093048|NCT02928224|54747201|FG003|Overall Study|Changes in Patient's Condition|13|||
28093049|NCT02928224|54747198|FG000|Overall Study|Death|1|||
28093050|NCT02928224|54747199|FG001|Overall Study|Death|7|||
28093051|NCT02928224|54747200|FG002|Overall Study|Death|5|||
28093052|NCT02928224|54747201|FG003|Overall Study|Death|11|||
28093053|NCT02928224|54747198|FG000|Overall Study|Withdrawal by Subject|1|||
28093054|NCT02928224|54747199|FG001|Overall Study|Withdrawal by Subject|4|||
28093055|NCT02928224|54747200|FG002|Overall Study|Withdrawal by Subject|3|||
28093056|NCT02928224|54747201|FG003|Overall Study|Withdrawal by Subject|9|||
28167922|NCT02873221|54838511|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
28167923|NCT02873221|54838512|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
28093057|NCT02928224|54747198|FG000|Overall Study|Dose Interruptions>28|1|||
28093058|NCT02928224|54747199|FG001|Overall Study|Dose Interruptions>28|2|||
28093059|NCT02928224|54747200|FG002|Overall Study|Dose Interruptions>28|2|||
28093060|NCT02928224|54747201|FG003|Overall Study|Dose Interruptions>28|4|||
28093061|NCT02928224|54747198|FG000|Overall Study|Patient Decision to Discontinue Drug|0|||
28093062|NCT02928224|54747199|FG001|Overall Study|Patient Decision to Discontinue Drug|2|||
28093063|NCT02928224|54747200|FG002|Overall Study|Patient Decision to Discontinue Drug|2|||
28167924|NCT02873221|54838513|FG002|Treatment Period|Non-Compliance with Study Drug|2|||
28167925|NCT02873221|54838511|FG000|Treatment Period|Protocol Violation|2|||
28167926|NCT02873221|54838512|FG001|Treatment Period|Protocol Violation|5|||
28167927|NCT02873221|54838513|FG002|Treatment Period|Protocol Violation|8|||
28167928|NCT02873221|54838511|FG000|Treatment Period|Pregnancy|4|||
28167929|NCT02873221|54838512|FG001|Treatment Period|Pregnancy|6|||
28167930|NCT02873221|54838513|FG002|Treatment Period|Pregnancy|3|||
28167931|NCT02873221|54838511|FG000|Treatment Period|Lack of Qualifying Event|0|||
28167932|NCT02873221|54838512|FG001|Treatment Period|Lack of Qualifying Event|3|||
28167933|NCT02873221|54838513|FG002|Treatment Period|Lack of Qualifying Event|1|||
28167934|NCT02873221|54838511|FG000|Treatment Period|Withdrawal of Consent|52|||
28167935|NCT02873221|54838512|FG001|Treatment Period|Withdrawal of Consent|51|||
28167936|NCT02873221|54838513|FG002|Treatment Period|Withdrawal of Consent|41|||
28167937|NCT02873221|54838511|FG000|Treatment Period|Lack of Efficacy|0|||
28167938|NCT02873221|54838512|FG001|Treatment Period|Lack of Efficacy|17|||
28167939|NCT02873221|54838513|FG002|Treatment Period|Lack of Efficacy|12|||
28093064|NCT02928224|54747201|FG003|Overall Study|Patient Decision to Discontinue Drug|4|||
28093065|NCT02928224|54747198|FG000|Overall Study|Physician Decision|0|||
28093066|NCT02928224|54747199|FG001|Overall Study|Physician Decision|2|||
28093067|NCT02928224|54747200|FG002|Overall Study|Physician Decision|4|||
28093068|NCT02928224|54747201|FG003|Overall Study|Physician Decision|2|||
28093069|NCT02928224|54747198|FG000|Overall Study|not listed|0|||
27734087|NCT02765165|54181928|FG006|Post-treatment Follow-up|Death|0|||
27734088|NCT02765165|54181922|FG000|Post-treatment Follow-up|Lost to Follow-up|0|||
27734089|NCT02765165|54181923|FG001|Post-treatment Follow-up|Lost to Follow-up|0|||
27734090|NCT02765165|54181924|FG002|Post-treatment Follow-up|Lost to Follow-up|0|||
28093070|NCT02928224|54747199|FG001|Overall Study|not listed|3|||
28093071|NCT02928224|54747200|FG002|Overall Study|not listed|1|||
28093072|NCT02928224|54747201|FG003|Overall Study|not listed|0|||
28093073|NCT02872116|54747242|FG000|Pre-Treatment|Disease Progression|0|||
28093074|NCT02872116|54747243|FG001|Pre-Treatment|Disease Progression|1|||
28093075|NCT02872116|54747244|FG002|Pre-Treatment|Disease Progression|0|||
28093076|NCT02872116|54747242|FG000|Pre-Treatment|Adverse event unrelated to study drug|0|||
28093077|NCT02872116|54747243|FG001|Pre-Treatment|Adverse event unrelated to study drug|2|||
27734091|NCT02765165|54181925|FG003|Post-treatment Follow-up|Lost to Follow-up|1|||
27734092|NCT02765165|54181926|FG004|Post-treatment Follow-up|Lost to Follow-up|0|||
28093078|NCT02872116|54747244|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
27734093|NCT02765165|54181927|FG005|Post-treatment Follow-up|Lost to Follow-up|0|||
27734094|NCT02765165|54181928|FG006|Post-treatment Follow-up|Lost to Follow-up|0|||
27734095|NCT02765165|54181922|FG000|Post-treatment Follow-up|Site terminated by sponsor|0|||
27734096|NCT02765165|54181923|FG001|Post-treatment Follow-up|Site terminated by sponsor|0|||
28093079|NCT02872116|54747242|FG000|Pre-Treatment|Participants request to discontinue study treatment|0|||
28093080|NCT02872116|54747243|FG001|Pre-Treatment|Participants request to discontinue study treatment|2|||
28093081|NCT02872116|54747244|FG002|Pre-Treatment|Participants request to discontinue study treatment|0|||
28093082|NCT02872116|54747242|FG000|Pre-Treatment|Participant withdrew consent|2|||
28093083|NCT02872116|54747243|FG001|Pre-Treatment|Participant withdrew consent|20|||
28093084|NCT02872116|54747244|FG002|Pre-Treatment|Participant withdrew consent|3|||
28167940|NCT02873221|54838511|FG000|Treatment Period|Adverse Event|4|||
28167941|NCT02873221|54838512|FG001|Treatment Period|Adverse Event|9|||
28167942|NCT02873221|54838513|FG002|Treatment Period|Adverse Event|11|||
28167943|NCT02873221|54838511|FG000|Treatment Period|Lost to Follow-up|26|||
28167944|NCT02873221|54838512|FG001|Treatment Period|Lost to Follow-up|30|||
28167945|NCT02873221|54838513|FG002|Treatment Period|Lost to Follow-up|26|||
28167946|NCT02873221|54838511|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
28167947|NCT02873221|54838512|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|2|||
28167948|NCT02873221|54838513|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
28167949|NCT02873221|54838511|FG000|Safety Follow-up Period|Protocol Violation|0|||
28167950|NCT02873221|54838512|FG001|Safety Follow-up Period|Protocol Violation|0|||
28167951|NCT02873221|54838513|FG002|Safety Follow-up Period|Protocol Violation|1|||
28167952|NCT02873221|54838511|FG000|Safety Follow-up Period|Lost to Follow-up|3|||
28167953|NCT02873221|54838512|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
28167954|NCT02873221|54838513|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
27734097|NCT02765165|54181924|FG002|Post-treatment Follow-up|Site terminated by sponsor|1|||
27734098|NCT02765165|54181925|FG003|Post-treatment Follow-up|Site terminated by sponsor|0|||
27734099|NCT02765165|54181926|FG004|Post-treatment Follow-up|Site terminated by sponsor|0|||
27734100|NCT02765165|54181927|FG005|Post-treatment Follow-up|Site terminated by sponsor|0|||
27734101|NCT02765165|54181928|FG006|Post-treatment Follow-up|Site terminated by sponsor|0|||
27734102|NCT02765165|54181922|FG000|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
27734103|NCT02765165|54181923|FG001|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
27734104|NCT02765165|54181924|FG002|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
27734105|NCT02765165|54181925|FG003|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
27734106|NCT02765165|54181926|FG004|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
28093085|NCT02872116|54747242|FG000|Pre-Treatment|Participant no longer meets study criteria|4|||
27734107|NCT02765165|54181927|FG005|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
27734108|NCT02765165|54181928|FG006|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
27734109|NCT02765165|54181922|FG000|Post-treatment Follow-up|Withdrawal by Subject|0|||
27734110|NCT02765165|54181923|FG001|Post-treatment Follow-up|Withdrawal by Subject|1|||
27734111|NCT02765165|54181924|FG002|Post-treatment Follow-up|Withdrawal by Subject|0|||
27734112|NCT02765165|54181925|FG003|Post-treatment Follow-up|Withdrawal by Subject|0|||
27734113|NCT02765165|54181926|FG004|Post-treatment Follow-up|Withdrawal by Subject|0|||
27734114|NCT02765165|54181927|FG005|Post-treatment Follow-up|Withdrawal by Subject|0|||
27734115|NCT02765165|54181928|FG006|Post-treatment Follow-up|Withdrawal by Subject|0|||
27734116|NCT02765165|54181922|FG000|Post-treatment Follow-up|Study terminated by the sponsor|0|||
27734117|NCT02765165|54181923|FG001|Post-treatment Follow-up|Study terminated by the sponsor|0|||
27734118|NCT02765165|54181924|FG002|Post-treatment Follow-up|Study terminated by the sponsor|0|||
27734119|NCT02765165|54181925|FG003|Post-treatment Follow-up|Study terminated by the sponsor|0|||
27734120|NCT02765165|54181926|FG004|Post-treatment Follow-up|Study terminated by the sponsor|2|||
27734121|NCT02765165|54181927|FG005|Post-treatment Follow-up|Study terminated by the sponsor|2|||
27734122|NCT02765165|54181928|FG006|Post-treatment Follow-up|Study terminated by the sponsor|1|||
27734123|NCT02675907|54181950|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
27734124|NCT02675907|54181951|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
27734125|NCT02675907|54181950|FG000|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
27734126|NCT02675907|54181951|FG001|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
28093086|NCT02872116|54747243|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
28093087|NCT02872116|54747244|FG002|Pre-Treatment|Participant no longer meets study criteria|0|||
28093088|NCT02872116|54747242|FG000|Pre-Treatment|Other reasons|1|||
28093089|NCT02872116|54747243|FG001|Pre-Treatment|Other reasons|2|||
28093090|NCT02872116|54747244|FG002|Pre-Treatment|Other reasons|2|||
28093091|NCT02872116|54747242|FG000|Treatment|Death|122|||
28093092|NCT02872116|54747243|FG001|Treatment|Death|94|||
28093093|NCT02872116|54747244|FG002|Treatment|Death|68|||
28093094|NCT02872116|54747242|FG000|Treatment|Lost to Follow-up|5|||
28093095|NCT02872116|54747243|FG001|Treatment|Lost to Follow-up|7|||
28093096|NCT02872116|54747244|FG002|Treatment|Lost to Follow-up|3|||
28093097|NCT02872116|54747242|FG000|Treatment|Participant withdrew consent|20|||
28093098|NCT02872116|54747243|FG001|Treatment|Participant withdrew consent|40|||
28093099|NCT02872116|54747244|FG002|Treatment|Participant withdrew consent|8|||
28093100|NCT02872116|54747242|FG000|Treatment|Other reasons|12|||
28093101|NCT02872116|54747243|FG001|Treatment|Other reasons|12|||
28093102|NCT02872116|54747244|FG002|Treatment|Other reasons|5|||
28093103|NCT02860039|54747258|FG000|Overall Study|Death|4|||
28093104|NCT02860039|54747259|FG001|Overall Study|Death|0|||
28093105|NCT02860039|54747258|FG000|Overall Study|Lost to Follow-up|2|||
28167955|NCT02873221|54838511|FG000|Safety Follow-up Period|Withdrawal of Consent|4|||
28167956|NCT02873221|54838512|FG001|Safety Follow-up Period|Withdrawal of Consent|10|||
28167957|NCT02873221|54838513|FG002|Safety Follow-up Period|Withdrawal of Consent|8|||
28167958|NCT02968979|54838521|FG000|Overall Study|Protocol Violation|7|||
27734127|NCT02675907|54181950|FG000|Study Overall|Lack of Efficacy|1|||
27734128|NCT02675907|54181951|FG001|Study Overall|Lack of Efficacy|0|||
27734129|NCT02675907|54181950|FG000|Study Overall|Withdrawal by Subject|2|||
28093106|NCT02860039|54747259|FG001|Overall Study|Lost to Follow-up|2|||
28093107|NCT02860039|54747258|FG000|Overall Study|Protocol Violation|3|||
28167959|NCT02968979|54838521|FG000|Overall Study|Withdrawal by Subject|1|||
28093108|NCT02860039|54747259|FG001|Overall Study|Protocol Violation|1|||
28093109|NCT02860039|54747258|FG000|Overall Study|Withdrawal by Subject|1|||
28093110|NCT02860039|54747259|FG001|Overall Study|Withdrawal by Subject|0|||
28093111|NCT02860039|54747258|FG000|Overall Study|Not otherwise eligible|1|||
28093112|NCT02860039|54747259|FG001|Overall Study|Not otherwise eligible|1|||
28093113|NCT02761694|54747289|FG000|Overall Study|Lack of Efficacy|0|||
28093114|NCT02761694|54747290|FG001|Overall Study|Lack of Efficacy|0|||
28093115|NCT02761694|54747291|FG002|Overall Study|Lack of Efficacy|0|||
28093116|NCT02761694|54747292|FG003|Overall Study|Lack of Efficacy|0|||
28093117|NCT02761694|54747293|FG004|Overall Study|Lack of Efficacy|0|||
28093118|NCT02761694|54747294|FG005|Overall Study|Lack of Efficacy|0|||
28093119|NCT02761694|54747295|FG006|Overall Study|Lack of Efficacy|6|||
28093120|NCT02761694|54747296|FG007|Overall Study|Lack of Efficacy|0|||
28093121|NCT02761694|54747297|FG008|Overall Study|Lack of Efficacy|0|||
28093122|NCT02761694|54747298|FG009|Overall Study|Lack of Efficacy|1|||
28093123|NCT02761694|54747299|FG010|Overall Study|Lack of Efficacy|1|||
28093124|NCT02761694|54747300|FG011|Overall Study|Lack of Efficacy|4|||
28093125|NCT02761694|54747289|FG000|Overall Study|Death|0|||
28093126|NCT02761694|54747290|FG001|Overall Study|Death|0|||
28093127|NCT02761694|54747291|FG002|Overall Study|Death|0|||
28093128|NCT02761694|54747292|FG003|Overall Study|Death|0|||
28093129|NCT02761694|54747293|FG004|Overall Study|Death|0|||
28093130|NCT02761694|54747294|FG005|Overall Study|Death|0|||
28093131|NCT02761694|54747295|FG006|Overall Study|Death|2|||
28093132|NCT02761694|54747296|FG007|Overall Study|Death|0|||
28167960|NCT02966015|54838573|FG000|Inclusion Visit|did not answer questionnaire|8|||
28167961|NCT02966015|54838574|FG001|Inclusion Visit|did not answer questionnaire|3|||
28167962|NCT02968433|54838580|FG000|Overall Study|Withdrawal by Subject|1|||
28167963|NCT02872285|54838592|FG000|Overall Study|Withdrawal by Subject|2|||
28093133|NCT02761694|54747297|FG008|Overall Study|Death|2|||
28093134|NCT02761694|54747298|FG009|Overall Study|Death|2|||
28093135|NCT02761694|54747299|FG010|Overall Study|Death|1|||
28167964|NCT02872285|54838593|FG001|Overall Study|Withdrawal by Subject|0|||
28167965|NCT02872285|54838592|FG000|Overall Study|Lost to Follow-up|2|||
28167966|NCT02872285|54838593|FG001|Overall Study|Lost to Follow-up|2|||
28167967|NCT02872285|54838592|FG000|Overall Study|Discontinued due to back surgery|1|||
28167968|NCT02872285|54838593|FG001|Overall Study|Discontinued due to back surgery|0|||
27734130|NCT02675907|54181951|FG001|Study Overall|Withdrawal by Subject|2|||
28093136|NCT02761694|54747300|FG011|Overall Study|Death|0|||
28093137|NCT02761694|54747289|FG000|Overall Study|Physician Decision|0|||
28093138|NCT02761694|54747290|FG001|Overall Study|Physician Decision|0|||
28093139|NCT02761694|54747291|FG002|Overall Study|Physician Decision|0|||
28093140|NCT02761694|54747292|FG003|Overall Study|Physician Decision|0|||
28093141|NCT02761694|54747293|FG004|Overall Study|Physician Decision|0|||
28093142|NCT02761694|54747294|FG005|Overall Study|Physician Decision|0|||
28093143|NCT02761694|54747295|FG006|Overall Study|Physician Decision|1|||
28093144|NCT02761694|54747296|FG007|Overall Study|Physician Decision|0|||
28093145|NCT02761694|54747297|FG008|Overall Study|Physician Decision|0|||
28093146|NCT02761694|54747298|FG009|Overall Study|Physician Decision|0|||
28093147|NCT02761694|54747299|FG010|Overall Study|Physician Decision|0|||
27734131|NCT02675907|54181950|FG000|Study Overall|Lost to Follow-up|0|||
27734132|NCT02675907|54181951|FG001|Study Overall|Lost to Follow-up|2|||
27734133|NCT02675517|54181957|FG000|Overall Study|No evaluable PF-10 questionnaire at all|8|||
27734134|NCT02675517|54181957|FG000|Overall Study|Evaluable PF-10 questionnaire at visit1|151|||
27734135|NCT02764775|54181961|FG000|Overall Study|Death|1|||
27734136|NCT02764775|54181961|FG000|Overall Study|Lost to Follow-up|2|||
27734137|NCT02764775|54181961|FG000|Overall Study|Withdrawal by Subject|3|||
27734138|NCT02774681|54181965|FG000|Treatment on Study|Progressive Disease|7|||
27734139|NCT02774681|54181965|FG000|Follow-Up for 3 Years|Death|11|||
27734140|NCT02774681|54181965|FG000|Follow-Up for 3 Years|Withdrawal by Subject|1|||
27734141|NCT02547428|54181971|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|8|||
28093148|NCT02761694|54747300|FG011|Overall Study|Physician Decision|0|||
28093149|NCT02761694|54747289|FG000|Overall Study|Withdrawal by Subject|0|||
28093150|NCT02761694|54747290|FG001|Overall Study|Withdrawal by Subject|0|||
28093151|NCT02761694|54747291|FG002|Overall Study|Withdrawal by Subject|0|||
28093152|NCT02761694|54747292|FG003|Overall Study|Withdrawal by Subject|1|||
28167969|NCT02871739|54838603|FG000|Overall Study|Lost to Follow-up|3|||
28167970|NCT02871739|54838604|FG001|Overall Study|Lost to Follow-up|2|||
28167971|NCT02871739|54838605|FG002|Overall Study|Lost to Follow-up|0|||
28093153|NCT02761694|54747293|FG004|Overall Study|Withdrawal by Subject|0|||
28093154|NCT02761694|54747294|FG005|Overall Study|Withdrawal by Subject|0|||
28093155|NCT02761694|54747295|FG006|Overall Study|Withdrawal by Subject|4|||
28093156|NCT02761694|54747296|FG007|Overall Study|Withdrawal by Subject|0|||
28167972|NCT02871739|54838606|FG003|Overall Study|Lost to Follow-up|2|||
28167973|NCT02896361|54838616|FG000|Third Intervention (2 Weeks)|Protocol Violation|1|||
28093157|NCT02761694|54747297|FG008|Overall Study|Withdrawal by Subject|2|||
28093158|NCT02761694|54747298|FG009|Overall Study|Withdrawal by Subject|1|||
28093159|NCT02761694|54747299|FG010|Overall Study|Withdrawal by Subject|0|||
28093160|NCT02761694|54747300|FG011|Overall Study|Withdrawal by Subject|0|||
28093161|NCT02761694|54747289|FG000|Overall Study|Lost to Follow-up|0|||
28093162|NCT02761694|54747290|FG001|Overall Study|Lost to Follow-up|0|||
27734142|NCT02547428|54181972|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|1|||
27734143|NCT02547428|54181971|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
27734144|NCT02547428|54181972|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
27734145|NCT02547428|54181971|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
28167974|NCT02896361|54838617|FG001|Third Intervention (2 Weeks)|Protocol Violation|0|||
27734146|NCT02547428|54181972|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
27734147|NCT02547428|54181971|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|1|||
27734148|NCT02547428|54181972|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|3|||
27734149|NCT02547428|54181971|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|0|||
27734150|NCT02547428|54181972|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|3|||
27734151|NCT02547428|54181971|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|0|||
27734152|NCT02547428|54181972|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|3|||
27734153|NCT02547428|54181971|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|0|||
27734154|NCT02547428|54181972|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|1|||
27734155|NCT02547428|54181971|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|1|||
27734156|NCT02547428|54181972|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|0|||
27734157|NCT01374087|54181987|FG000|Overall Study|Adverse Event|1|||
28167975|NCT02896361|54838618|FG002|Third Intervention (2 Weeks)|Protocol Violation|0|||
28167976|NCT02896361|54838616|FG000|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
27734158|NCT01374087|54181988|FG001|Overall Study|Adverse Event|0|||
27734159|NCT01374087|54181987|FG000|Overall Study|Disease progression|2|||
27734160|NCT01374087|54181988|FG001|Overall Study|Disease progression|2|||
27734161|NCT01374087|54181987|FG000|Overall Study|Study discontinued|13|||
27734162|NCT01374087|54181988|FG001|Overall Study|Study discontinued|13|||
27734163|NCT00152971|54181997|FG000|Overall Study|Adverse Event|12|||
27734164|NCT00152971|54181998|FG001|Overall Study|Adverse Event|10|||
27734165|NCT00152971|54181999|FG002|Overall Study|Adverse Event|9|||
27734166|NCT00152971|54181997|FG000|Overall Study|Protocol Violation|10|||
27734167|NCT00152971|54181998|FG001|Overall Study|Protocol Violation|11|||
27734168|NCT00152971|54181999|FG002|Overall Study|Protocol Violation|8|||
27734169|NCT00152971|54181997|FG000|Overall Study|Lost to Follow-up|17|||
27734170|NCT00152971|54181998|FG001|Overall Study|Lost to Follow-up|14|||
27734171|NCT00152971|54181999|FG002|Overall Study|Lost to Follow-up|13|||
27734172|NCT00152971|54181997|FG000|Overall Study|Withdrawal by Subject|9|||
27734173|NCT00152971|54181998|FG001|Overall Study|Withdrawal by Subject|8|||
27734174|NCT00152971|54181999|FG002|Overall Study|Withdrawal by Subject|14|||
27734175|NCT00152971|54181997|FG000|Overall Study|Other|3|||
27734176|NCT00152971|54181998|FG001|Overall Study|Other|5|||
27734177|NCT00152971|54181999|FG002|Overall Study|Other|5|||
27734178|NCT00152971|54181997|FG000|Treatment|Adverse Event|49|||
27734179|NCT00152971|54181998|FG001|Treatment|Adverse Event|40|||
27734180|NCT00152971|54181999|FG002|Treatment|Adverse Event|54|||
27734181|NCT00152971|54181997|FG000|Treatment|Protocol Violation|8|||
27734182|NCT00152971|54181998|FG001|Treatment|Protocol Violation|6|||
27734183|NCT00152971|54181999|FG002|Treatment|Protocol Violation|10|||
27734184|NCT00152971|54181997|FG000|Treatment|Lost to Follow-up|1|||
27734185|NCT00152971|54181998|FG001|Treatment|Lost to Follow-up|2|||
27734186|NCT00152971|54181999|FG002|Treatment|Lost to Follow-up|1|||
27734187|NCT00152971|54181997|FG000|Treatment|Withdrawal by Subject|4|||
27734188|NCT00152971|54181998|FG001|Treatment|Withdrawal by Subject|4|||
27734189|NCT00152971|54181999|FG002|Treatment|Withdrawal by Subject|5|||
27734190|NCT00152971|54181997|FG000|Treatment|Other|9|||
27734191|NCT00152971|54181998|FG001|Treatment|Other|11|||
28093163|NCT02761694|54747291|FG002|Overall Study|Lost to Follow-up|0|||
28093164|NCT02761694|54747292|FG003|Overall Study|Lost to Follow-up|0|||
28093165|NCT02761694|54747293|FG004|Overall Study|Lost to Follow-up|0|||
28093166|NCT02761694|54747294|FG005|Overall Study|Lost to Follow-up|0|||
28093167|NCT02761694|54747295|FG006|Overall Study|Lost to Follow-up|1|||
28167977|NCT02896361|54838617|FG001|Third Intervention (2 Weeks)|emergenge of several new painful regions|1|||
28167978|NCT02896361|54838618|FG002|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
28167979|NCT02962739|54838641|FG000|Overall Study|Withdrawal by Subject|0|||
28167980|NCT02962739|54838642|FG001|Overall Study|Withdrawal by Subject|1|||
28167981|NCT02962739|54838643|FG002|Overall Study|Withdrawal by Subject|0|||
28167982|NCT02962739|54838644|FG003|Overall Study|Withdrawal by Subject|0|||
28167983|NCT02962739|54838645|FG004|Overall Study|Withdrawal by Subject|0|||
28093168|NCT02761694|54747296|FG007|Overall Study|Lost to Follow-up|0|||
28093169|NCT02761694|54747297|FG008|Overall Study|Lost to Follow-up|0|||
28167984|NCT02962739|54838646|FG005|Overall Study|Withdrawal by Subject|0|||
27734192|NCT00152971|54181999|FG002|Treatment|Other|10|||
27734193|NCT02538614|54182007|FG000|Overall Study|Progressive Disease|2|||
27734194|NCT04620135|54182015|FG000|Study Completion|Adverse Event|2|||
27734195|NCT04620135|54182016|FG001|Study Completion|Adverse Event|3|||
27833199|NCT01748825|54314621|FG000|Dose Expansion|Adverse Event|0|||
28093170|NCT02761694|54747298|FG009|Overall Study|Lost to Follow-up|0|||
28093171|NCT02761694|54747299|FG010|Overall Study|Lost to Follow-up|0|||
28093172|NCT02761694|54747300|FG011|Overall Study|Lost to Follow-up|1|||
28093173|NCT02761694|54747289|FG000|Overall Study|Adverse Event|0|||
28093174|NCT02761694|54747290|FG001|Overall Study|Adverse Event|0|||
28093175|NCT02761694|54747291|FG002|Overall Study|Adverse Event|0|||
28093176|NCT02761694|54747292|FG003|Overall Study|Adverse Event|0|||
28093177|NCT02761694|54747293|FG004|Overall Study|Adverse Event|0|||
28093178|NCT02761694|54747294|FG005|Overall Study|Adverse Event|0|||
28093179|NCT02761694|54747295|FG006|Overall Study|Adverse Event|1|||
28093180|NCT02761694|54747296|FG007|Overall Study|Adverse Event|0|||
28093181|NCT02761694|54747297|FG008|Overall Study|Adverse Event|1|||
28093182|NCT02761694|54747298|FG009|Overall Study|Adverse Event|0|||
28093183|NCT02761694|54747299|FG010|Overall Study|Adverse Event|0|||
28093184|NCT02761694|54747300|FG011|Overall Study|Adverse Event|1|||
28093185|NCT02761694|54747289|FG000|Overall Study|Other|4|||
28093186|NCT02761694|54747290|FG001|Overall Study|Other|4|||
28093187|NCT02761694|54747291|FG002|Overall Study|Other|1|||
28093188|NCT02761694|54747292|FG003|Overall Study|Other|2|||
28093189|NCT02761694|54747293|FG004|Overall Study|Other|3|||
28093190|NCT02761694|54747294|FG005|Overall Study|Other|3|||
28167985|NCT02962739|54838641|FG000|Overall Study|Protocol Violation|0|||
28167986|NCT02962739|54838642|FG001|Overall Study|Protocol Violation|0|||
28167987|NCT02962739|54838643|FG002|Overall Study|Protocol Violation|1|||
28167988|NCT02962739|54838644|FG003|Overall Study|Protocol Violation|0|||
28167989|NCT02962739|54838645|FG004|Overall Study|Protocol Violation|1|||
28167990|NCT02962739|54838646|FG005|Overall Study|Protocol Violation|0|||
28167991|NCT01344629|54838654|FG000|Crossover Period 2|Withdrawal by Subject|0|||
28167992|NCT01344629|54838655|FG001|Crossover Period 2|Withdrawal by Subject|1|||
28093191|NCT02761694|54747295|FG006|Overall Study|Other|18|||
28093192|NCT02761694|54747296|FG007|Overall Study|Other|8|||
28093193|NCT02761694|54747297|FG008|Overall Study|Other|0|||
28093194|NCT02761694|54747298|FG009|Overall Study|Other|1|||
28093195|NCT02761694|54747299|FG010|Overall Study|Other|1|||
28093196|NCT02761694|54747300|FG011|Overall Study|Other|0|||
28093197|NCT02726386|54747329|FG000|Overall Study|Adverse Event|17|||
28093198|NCT02726386|54747330|FG001|Overall Study|Adverse Event|20|||
28093199|NCT02726386|54747329|FG000|Overall Study|Withdrawal by Subject|14|||
28093200|NCT02726386|54747330|FG001|Overall Study|Withdrawal by Subject|28|||
28093201|NCT02726386|54747329|FG000|Overall Study|Other reasons|7|||
28093202|NCT02726386|54747330|FG001|Overall Study|Other reasons|8|||
28093203|NCT02574481|54747352|FG000|Overall Study|Withdrawal by Subject|29|||
28093204|NCT02574481|54747353|FG001|Overall Study|Withdrawal by Subject|15|||
28093205|NCT02574481|54747354|FG002|Overall Study|Withdrawal by Subject|4|||
28093206|NCT02574481|54747355|FG003|Overall Study|Withdrawal by Subject|1|||
28093207|NCT02574481|54747352|FG000|Overall Study|Adverse Event|5|||
28093208|NCT02574481|54747353|FG001|Overall Study|Adverse Event|1|||
28167993|NCT01092117|54838661|FG000|Index Procedure to 1 Month|Death|1|||
28167994|NCT01092117|54838661|FG000|1 Month|Death|1|||
28167995|NCT01092117|54838661|FG000|1 Month|Withdrawal by Subject|1|||
27855785|NCT02733042|54382052|FG014|Follow-up Period|Withdrawal by Subject|0|||
28093209|NCT02574481|54747354|FG002|Overall Study|Adverse Event|1|||
28093210|NCT02574481|54747355|FG003|Overall Study|Adverse Event|0|||
28093211|NCT02574481|54747352|FG000|Overall Study|Visit Missed|15|||
28093212|NCT02574481|54747353|FG001|Overall Study|Visit Missed|7|||
28093213|NCT02574481|54747354|FG002|Overall Study|Visit Missed|5|||
28093214|NCT02574481|54747355|FG003|Overall Study|Visit Missed|0|||
28093215|NCT02574481|54747352|FG000|Overall Study|Other|7|||
28093216|NCT02574481|54747353|FG001|Overall Study|Other|2|||
28093217|NCT02574481|54747354|FG002|Overall Study|Other|0|||
28093218|NCT02574481|54747355|FG003|Overall Study|Other|0|||
28093219|NCT02574481|54747352|FG000|Overall Study|Death|48|||
28093220|NCT02574481|54747353|FG001|Overall Study|Death|26|||
28093221|NCT02574481|54747354|FG002|Overall Study|Death|12|||
28093222|NCT02574481|54747355|FG003|Overall Study|Death|4|||
28167996|NCT01092117|54838661|FG000|1 Month|Lost to Follow-up|1|||
27855786|NCT02733042|54382053|FG015|Follow-up Period|Withdrawal by Subject|1|||
28093223|NCT02574481|54747352|FG000|Overall Study|Physician Decision|5|||
28093224|NCT02574481|54747353|FG001|Overall Study|Physician Decision|2|||
28167997|NCT01092117|54838661|FG000|6 Months|Death|2|||
28167998|NCT01092117|54838661|FG000|6 Months|Withdrawal by Subject|3|||
28167999|NCT01092117|54838661|FG000|12 Month|Death|11|||
28093225|NCT02574481|54747354|FG002|Overall Study|Physician Decision|0|||
28093226|NCT02574481|54747355|FG003|Overall Study|Physician Decision|0|||
28093227|NCT02574481|54747352|FG000|Overall Study|Lost to Follow-up|5|||
28093228|NCT02574481|54747353|FG001|Overall Study|Lost to Follow-up|1|||
28093229|NCT02574481|54747354|FG002|Overall Study|Lost to Follow-up|3|||
28093230|NCT02574481|54747355|FG003|Overall Study|Lost to Follow-up|0|||
28093231|NCT02438722|54747370|FG000|Overall Study|Adverse Event|12|||
28093232|NCT02438722|54747371|FG001|Overall Study|Adverse Event|9|||
28093233|NCT02438722|54747370|FG000|Overall Study|Refusal unrelated to AE|2|||
28168000|NCT01092117|54838661|FG000|12 Month|Withdrawal by Subject|2|||
27734196|NCT04620135|54182015|FG000|Study Completion|Withdrawal by Subject|2|||
27734197|NCT04620135|54182016|FG001|Study Completion|Withdrawal by Subject|0|||
27734198|NCT02552966|54182022|FG000|Overall Study|Lost to Follow-up|2|||
27734199|NCT02552966|54182022|FG000|Overall Study|Withdrawal by Subject|3|||
27734200|NCT02552888|54182028|FG000|Overall Study|Lost to Follow-up|1|||
27734201|NCT02552888|54182029|FG001|Overall Study|Lost to Follow-up|1|||
27734202|NCT01373931|54182048|FG000|Lead-in Period|Adverse Event|2|||
27734203|NCT01373931|54182049|FG001|Lead-in Period|Adverse Event|0|||
27734204|NCT01373931|54182048|FG000|Period 1|Adverse Event|2|||
27734205|NCT01373931|54182049|FG001|Period 1|Adverse Event|0|||
27734206|NCT01373931|54182048|FG000|Period 1|Withdrawal by Subject|0|||
27734207|NCT01373931|54182049|FG001|Period 1|Withdrawal by Subject|2|||
27734208|NCT02552732|54182056|FG000|Overall Study|Lost to Follow-up|2|||
27734209|NCT02552732|54182056|FG000|Overall Study|Physician Decision|1|||
27734210|NCT02552732|54182056|FG000|Overall Study|Day 1 SpO2 > 96%|1|||
27734211|NCT02552732|54182056|FG000|Overall Study|Withdrawal by Subject|6|||
27734212|NCT02547038|54182063|FG000|Overall Study|Lost to Follow-up|3|||
27734213|NCT02547038|54182064|FG001|Overall Study|Lost to Follow-up|2|||
27734214|NCT02764697|54182070|FG000|Overall Study|Lack of Efficacy|3|||
27734215|NCT02673489|54182076|FG000|Treatment Period|Lost to Follow-up|3|||
27734216|NCT02673489|54182077|FG001|Treatment Period|Lost to Follow-up|0|||
27734217|NCT02673489|54182076|FG000|Treatment Period|Participant request to discontinue|1|||
27734218|NCT02673489|54182077|FG001|Treatment Period|Participant request to discontinue|1|||
27734219|NCT02673489|54182076|FG000|Treatment Period|Participant moved to another province|1|||
27734220|NCT02673489|54182077|FG001|Treatment Period|Participant moved to another province|0|||
27734221|NCT02673489|54182076|FG000|Treatment Period|Participant was incarcerated|0|||
27734222|NCT02673489|54182077|FG001|Treatment Period|Participant was incarcerated|1|||
27734223|NCT02673489|54182076|FG000|Treatment Period|Adverse Event|0|||
27734224|NCT02673489|54182077|FG001|Treatment Period|Adverse Event|1|||
27734225|NCT02673489|54182076|FG000|Follow Up Period|Unable to return for week 24 follow-up|0|||
27734226|NCT02673489|54182077|FG001|Follow Up Period|Unable to return for week 24 follow-up|1|||
27734227|NCT02673489|54182076|FG000|Follow Up Period|Unable to return for follow-up|0|||
27734228|NCT02673489|54182077|FG001|Follow Up Period|Unable to return for follow-up|1|||
27734229|NCT02772809|54182084|FG000|Overall Study|not completed some tasks|6|||
27734230|NCT02537678|54182095|FG000|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|4|||
27734231|NCT02537678|54182096|FG001|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|3|||
27734232|NCT02537678|54182095|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
27734233|NCT02537678|54182096|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
27734234|NCT02537678|54182095|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|6|||
27734235|NCT02537678|54182096|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|5|||
27734236|NCT02537678|54182095|FG000|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|2|||
27734237|NCT02537678|54182096|FG001|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|3|||
27734238|NCT02537678|54182095|FG000|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|14|||
27734239|NCT02537678|54182096|FG001|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|6|||
27734240|NCT02537678|54182095|FG000|Post-treatment to 6 Month Assessment|Lost to Follow-up|8|||
27734241|NCT02537678|54182096|FG001|Post-treatment to 6 Month Assessment|Lost to Follow-up|7|||
27734242|NCT02537678|54182095|FG000|6 Month to 12 Month Assessment|Lost to Follow-up|0|||
27734243|NCT02537678|54182096|FG001|6 Month to 12 Month Assessment|Lost to Follow-up|1|||
27734244|NCT02766023|54182108|FG000|Overall Study|Lost to Follow-up|23|||
27734245|NCT02766023|54182109|FG001|Overall Study|Lost to Follow-up|11|||
27734246|NCT02766023|54182108|FG000|Overall Study|Pregnancy|1|||
27734247|NCT02766023|54182109|FG001|Overall Study|Pregnancy|0|||
27734248|NCT02766023|54182108|FG000|Overall Study|Adverse Event|1|||
27734249|NCT02766023|54182109|FG001|Overall Study|Adverse Event|0|||
27734250|NCT02766023|54182108|FG000|Overall Study|Withdrawal by Subject|4|||
27734251|NCT02766023|54182109|FG001|Overall Study|Withdrawal by Subject|5|||
27734252|NCT02766023|54182108|FG000|Overall Study|Physician Decision|1|||
27734253|NCT02766023|54182109|FG001|Overall Study|Physician Decision|0|||
27734254|NCT02766023|54182108|FG000|Overall Study|Not Eligible at Enrollment|0|||
27734255|NCT02766023|54182109|FG001|Overall Study|Not Eligible at Enrollment|1|||
27734256|NCT02764229|54182115|FG000|Overall Study|Withdrawal by Subject|15|||
27734257|NCT02764229|54182115|FG000|Overall Study|Adverse Event|9|||
27734258|NCT02764229|54182115|FG000|Overall Study|Physician Decision|5|||
27734259|NCT02764229|54182115|FG000|Overall Study|Lost to Follow-up|3|||
27734260|NCT02764229|54182115|FG000|Overall Study|Lack of Efficacy|1|||
27734261|NCT02764229|54182115|FG000|Overall Study|Study Stopped by Sponsor|69|||
27734262|NCT02537522|54182119|FG000|Phase I - Contralateral|Subject no longer eligible|15|||
27734263|NCT02537522|54182120|FG001|Phase I - Contralateral|Subject no longer eligible|7|||
27734264|NCT02537522|54182121|FG002|Phase I - Contralateral|Subject no longer eligible|0|||
27833200|NCT01748825|54314622|FG001|Dose Expansion|Adverse Event|0|||
27833201|NCT01748825|54314623|FG002|Dose Expansion|Adverse Event|0|||
27833202|NCT01748825|54314624|FG003|Dose Expansion|Adverse Event|0|||
28093234|NCT02438722|54747371|FG001|Overall Study|Refusal unrelated to AE|5|||
28093235|NCT02438722|54747370|FG000|Overall Study|Disease progression/relapse|46|||
28093236|NCT02438722|54747371|FG001|Overall Study|Disease progression/relapse|51|||
28093237|NCT02438722|54747370|FG000|Overall Study|Death|0|||
28093238|NCT02438722|54747371|FG001|Overall Study|Death|3|||
28168001|NCT01092117|54838661|FG000|12 Month|Lost to Follow-up|1|||
28168002|NCT01092117|54838661|FG000|Year 2|Death|5|||
28168003|NCT01092117|54838661|FG000|Year 2|Withdrawal by Subject|4|||
28093239|NCT02438722|54747370|FG000|Overall Study|Physician Decision|2|||
28093240|NCT02438722|54747371|FG001|Overall Study|Physician Decision|2|||
28093241|NCT02438722|54747370|FG000|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|1|||
28093242|NCT02438722|54747371|FG001|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|0|||
28093243|NCT02438722|54747370|FG000|Overall Study|Withdrawal by Subject|0|||
28093244|NCT02438722|54747371|FG001|Overall Study|Withdrawal by Subject|1|||
28093245|NCT02438722|54747370|FG000|Overall Study|On protocol treatment|15|||
28093246|NCT02438722|54747371|FG001|Overall Study|On protocol treatment|14|||
28093247|NCT02438722|54747370|FG000|Overall Study|Did not receive protocol treatment|5|||
28168004|NCT01092117|54838661|FG000|Year 2|Lost to Follow-up|1|||
28168005|NCT01092117|54838661|FG000|Year 3|Death|7|||
28168006|NCT01092117|54838661|FG000|Year 3|Withdrawal by Subject|9|||
28168007|NCT01092117|54838661|FG000|Year 3|Lost to Follow-up|3|||
28168008|NCT01092117|54838661|FG000|Year 4|Death|8|||
28168009|NCT01092117|54838661|FG000|Year 4|Withdrawal by Subject|4|||
28168010|NCT01092117|54838661|FG000|Year 4|Lost to Follow-up|4|||
28168011|NCT01065779|54838674|FG000|Overall Study|Duplicate Investigation|1|||
28168012|NCT01065779|54838674|FG000|Overall Study|Investigation Before Contract Date|37|||
28168013|NCT01065779|54838674|FG000|Overall Study|Non-enrollment Period Administration|10|||
28168014|NCT01065779|54838674|FG000|Overall Study|Not Administered With Study Drug|17|||
28168015|NCT01065779|54838674|FG000|Overall Study|Failed to Follow-up|10|||
28168016|NCT01065779|54838674|FG000|Overall Study|Inclusion Criteria Violation|7|||
28168017|NCT02963441|54838678|FG000|Overall Study|Protocol violation or withdrawn|8|||
28093248|NCT02438722|54747371|FG001|Overall Study|Did not receive protocol treatment|0|||
28093249|NCT02426658|54747377|FG000|Overall Study|Withdrawal by Subject|1|||
28093250|NCT02426658|54747377|FG000|Overall Study|Patient expired before treatment|2|||
28093251|NCT02376829|54747392|FG000|Overall Study|Withdrawal by Subject|27|||
28093252|NCT02376829|54747393|FG001|Overall Study|Withdrawal by Subject|44|||
28093253|NCT02297438|54747402|FG000|Overall Study|Death|79|||
28093254|NCT02297438|54747403|FG001|Overall Study|Death|86|||
28093255|NCT02297438|54747402|FG000|Overall Study|Lost to Follow-up|9|||
28093256|NCT02297438|54747403|FG001|Overall Study|Lost to Follow-up|7|||
28093257|NCT02297438|54747402|FG000|Overall Study|Withdrawal by Subject|7|||
28093258|NCT02297438|54747403|FG001|Overall Study|Withdrawal by Subject|0|||
28168018|NCT02963441|54838678|FG000|Overall Study|Ungradeable by FPRC or IDx|40|||
28168019|NCT02963441|54838678|FG000|Overall Study|IDx-DR insufficient quality|33|||
27734265|NCT02537522|54182122|FG003|Phase I - Contralateral|Subject no longer eligible|0|||
27734266|NCT02537522|54182119|FG000|Phase I - Contralateral|Withdrawal by Subject|0|||
27734267|NCT02537522|54182120|FG001|Phase I - Contralateral|Withdrawal by Subject|1|||
27734268|NCT02537522|54182121|FG002|Phase I - Contralateral|Withdrawal by Subject|0|||
27734269|NCT02537522|54182122|FG003|Phase I - Contralateral|Withdrawal by Subject|0|||
27734270|NCT02537522|54182119|FG000|Phase I - Contralateral|incorrect randomization|0|||
27734271|NCT02537522|54182120|FG001|Phase I - Contralateral|incorrect randomization|1|||
27734272|NCT02537522|54182121|FG002|Phase I - Contralateral|incorrect randomization|0|||
27734273|NCT02537522|54182122|FG003|Phase I - Contralateral|incorrect randomization|0|||
27734274|NCT02537522|54182119|FG000|Phase I - Contralateral|unsatisfactory lens fitting|0|||
27734275|NCT02537522|54182120|FG001|Phase I - Contralateral|unsatisfactory lens fitting|1|||
27734276|NCT02537522|54182121|FG002|Phase I - Contralateral|unsatisfactory lens fitting|0|||
27734277|NCT02537522|54182122|FG003|Phase I - Contralateral|unsatisfactory lens fitting|0|||
27734278|NCT02537522|54182119|FG000|Phase II - Period 1 Bilateral|Adverse Event|0|||
27734279|NCT02537522|54182120|FG001|Phase II - Period 1 Bilateral|Adverse Event|0|||
27734280|NCT02537522|54182121|FG002|Phase II - Period 1 Bilateral|Adverse Event|0|||
27734281|NCT02537522|54182122|FG003|Phase II - Period 1 Bilateral|Adverse Event|1|||
27734282|NCT02536976|54182130|FG000|Overall Study|Physician Decision|0|||
27734283|NCT02536976|54182131|FG001|Overall Study|Physician Decision|1|||
27734284|NCT02672553|54182141|FG000|Overall Study|Death|3|||
28093259|NCT02297438|54747402|FG000|Overall Study|Other|9|||
28093260|NCT02297438|54747403|FG001|Overall Study|Other|5|||
28093261|NCT02297438|54747402|FG000|Overall Study|Ongoing|65|||
28093262|NCT02297438|54747403|FG001|Overall Study|Ongoing|73|||
28093263|NCT02297139|54747411|FG000|Overall Study|Disease progression|0|||
28093264|NCT02297139|54747412|FG001|Overall Study|Disease progression|1|||
28093265|NCT02297139|54747411|FG000|Overall Study|Study drug toxicity|0|||
28168020|NCT01345253|54838685|FG000|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22|||
28168021|NCT01345253|54838686|FG001|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27|||
28168022|NCT01345253|54838685|FG000|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11|||
28168023|NCT01345253|54838686|FG001|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7|||
28168024|NCT01345253|54838685|FG000|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1|||
28168025|NCT01345253|54838686|FG001|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5|||
28168026|NCT01345253|54838685|FG000|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6|||
28168027|NCT01345253|54838686|FG001|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1|||
28168028|NCT01345253|54838685|FG000|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3|||
28168029|NCT01345253|54838686|FG001|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8|||
28168030|NCT01345253|54838685|FG000|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4|||
28168031|NCT01345253|54838686|FG001|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12|||
28093266|NCT02297139|54747412|FG001|Overall Study|Study drug toxicity|4|||
28093267|NCT02297139|54747411|FG000|Overall Study|Participant request to discontinue study treatment|0|||
28093268|NCT02297139|54747412|FG001|Overall Study|Participant request to discontinue study treatment|1|||
28093269|NCT02297139|54747411|FG000|Overall Study|Maximum clinical benefit|1|||
28093270|NCT02297139|54747412|FG001|Overall Study|Maximum clinical benefit|0|||
28093271|NCT02297139|54747411|FG000|Overall Study|Administrative reason by sponsor|0|||
28093272|NCT02297139|54747412|FG001|Overall Study|Administrative reason by sponsor|2|||
28168032|NCT01345253|54838685|FG000|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9|||
28168033|NCT01345253|54838686|FG001|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19|||
28168034|NCT01345253|54838685|FG000|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7|||
28168035|NCT01345253|54838686|FG001|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18|||
28168036|NCT01345253|54838685|FG000|Open-label Phase (Up to Year 5 Week 44)|Death|0|||
28168037|NCT01345253|54838686|FG001|Open-label Phase (Up to Year 5 Week 44)|Death|1|||
28168038|NCT01345253|54838685|FG000|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3|||
28168039|NCT01345253|54838686|FG001|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7|||
28168040|NCT01345253|54838685|FG000|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2|||
28168041|NCT01345253|54838686|FG001|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5|||
28168042|NCT01345253|54838685|FG000|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4|||
28168043|NCT01345253|54838686|FG001|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6|||
28168044|NCT01345253|54838685|FG000|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11|||
28168045|NCT01345253|54838686|FG001|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24|||
28168046|NCT01345253|54838685|FG000|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37|||
28168047|NCT01345253|54838686|FG001|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82|||
28168048|NCT01345253|54838685|FG000|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
28093273|NCT02297139|54747411|FG000|Overall Study|Other reasons|0|||
28093274|NCT02297139|54747412|FG001|Overall Study|Other reasons|8|||
28093275|NCT02142959|54747421|FG000|Overall Study|Adverse Event|1|||
28093276|NCT02142959|54747422|FG001|Overall Study|Adverse Event|0|||
28093277|NCT02142959|54747423|FG002|Overall Study|Adverse Event|0|||
27734285|NCT02672553|54182142|FG001|Overall Study|Death|5|||
28168049|NCT01345253|54838686|FG001|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
27734286|NCT02672553|54182141|FG000|Overall Study|Valve Explant|1|||
27734287|NCT02672553|54182142|FG001|Overall Study|Valve Explant|0|||
27734288|NCT02672553|54182141|FG000|Overall Study|Conversion to Commercial Valve|3|||
27734289|NCT02672553|54182142|FG001|Overall Study|Conversion to Commercial Valve|0|||
27734290|NCT02672553|54182141|FG000|Overall Study|Withdrawal by Subject|3|||
27734291|NCT02672553|54182142|FG001|Overall Study|Withdrawal by Subject|3|||
27734292|NCT02672553|54182141|FG000|Overall Study|Intraoperative screen failure|2|||
27734293|NCT02672553|54182142|FG001|Overall Study|Intraoperative screen failure|0|||
27734294|NCT01373229|54182149|FG000|Overall Study|Death|3|||
27734295|NCT01373229|54182149|FG000|Overall Study|Physician Decision|3|||
27734296|NCT02671461|54182156|FG000|Treatment|Adverse Event|0|||
27734297|NCT02671461|54182157|FG001|Treatment|Adverse Event|0|||
27734298|NCT02671461|54182158|FG002|Treatment|Adverse Event|1|||
27734299|NCT02671461|54182156|FG000|Treatment|Administrative Reason by Sponsor|1|||
27734300|NCT02671461|54182157|FG001|Treatment|Administrative Reason by Sponsor|3|||
27734301|NCT02671461|54182158|FG002|Treatment|Administrative Reason by Sponsor|4|||
27734302|NCT02671461|54182156|FG000|Treatment|Randomized, not treated|1|||
27734303|NCT02671461|54182157|FG001|Treatment|Randomized, not treated|0|||
27734304|NCT02671461|54182158|FG002|Treatment|Randomized, not treated|0|||
27734305|NCT02671461|54182156|FG000|Follow-up|Withdrawal by Subject|1|||
27734306|NCT02671461|54182157|FG001|Follow-up|Withdrawal by Subject|0|||
27734307|NCT02671461|54182158|FG002|Follow-up|Withdrawal by Subject|0|||
27734308|NCT02671461|54182156|FG000|Follow-up|Lost to Follow-up|0|||
27734309|NCT02671461|54182157|FG001|Follow-up|Lost to Follow-up|0|||
28093278|NCT02142959|54747421|FG000|Overall Study|Death|0|||
28093279|NCT02142959|54747422|FG001|Overall Study|Death|1|||
28168050|NCT02477800|54838697|FG000|Placebo-Controlled Period|Adverse Event|16|||
28093280|NCT02142959|54747423|FG002|Overall Study|Death|0|||
28168051|NCT02477800|54838698|FG001|Placebo-Controlled Period|Adverse Event|25|||
28168052|NCT02477800|54838699|FG002|Placebo-Controlled Period|Adverse Event|28|||
27734310|NCT02671461|54182158|FG002|Follow-up|Lost to Follow-up|1|||
27734311|NCT02671461|54182156|FG000|Follow-up|Administrative Reason by Sponsor|0|||
27734312|NCT02671461|54182157|FG001|Follow-up|Administrative Reason by Sponsor|1|||
28093281|NCT02142959|54747421|FG000|Overall Study|Withdrawal by Subject|3|||
28093282|NCT02142959|54747422|FG001|Overall Study|Withdrawal by Subject|1|||
28093283|NCT02142959|54747423|FG002|Overall Study|Withdrawal by Subject|3|||
28093284|NCT02142959|54747421|FG000|Overall Study|Administrative Reasons|1|||
28093285|NCT02142959|54747422|FG001|Overall Study|Administrative Reasons|0|||
28093286|NCT02142959|54747423|FG002|Overall Study|Administrative Reasons|1|||
28093287|NCT02142959|54747421|FG000|Overall Study|Missing|0|||
28093288|NCT02142959|54747422|FG001|Overall Study|Missing|1|||
27734313|NCT02671461|54182158|FG002|Follow-up|Administrative Reason by Sponsor|0|||
27734314|NCT02535416|54182175|FG000|Overall Study|Family bereavement overseas|1|||
27734315|NCT02535416|54182176|FG001|Overall Study|Family bereavement overseas|0|||
27734316|NCT02535416|54182177|FG002|Overall Study|Family bereavement overseas|0|||
27734317|NCT02535416|54182178|FG003|Overall Study|Family bereavement overseas|0|||
27734318|NCT02535416|54182179|FG004|Overall Study|Family bereavement overseas|0|||
27734319|NCT02535416|54182180|FG005|Overall Study|Family bereavement overseas|0|||
27734320|NCT02535416|54182181|FG006|Overall Study|Family bereavement overseas|0|||
27734321|NCT02535416|54182182|FG007|Overall Study|Family bereavement overseas|0|||
27734322|NCT02535416|54182183|FG008|Overall Study|Family bereavement overseas|0|||
27734323|NCT02670915|54182233|FG000|Overall Study|Withdrawal by Subject|0|||
27734324|NCT02670915|54182234|FG001|Overall Study|Withdrawal by Subject|1|||
27734325|NCT02670915|54182235|FG002|Overall Study|Withdrawal by Subject|4|||
27734326|NCT02670915|54182233|FG000|Overall Study|Withdrawal by parent/guardian|4|||
27734327|NCT02670915|54182234|FG001|Overall Study|Withdrawal by parent/guardian|4|||
27734328|NCT02670915|54182235|FG002|Overall Study|Withdrawal by parent/guardian|1|||
27734329|NCT02670915|54182233|FG000|Overall Study|Unclassified|0|||
27734330|NCT02670915|54182234|FG001|Overall Study|Unclassified|3|||
27734331|NCT02670915|54182235|FG002|Overall Study|Unclassified|0|||
27734332|NCT02545868|54182246|FG000|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|33|||
27734333|NCT02545868|54182247|FG001|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|35|||
27734334|NCT02545868|54182248|FG002|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|34|||
27734335|NCT02764151|54182265|FG000|Overall Study|Subject refused further follow-up|0|||
27734336|NCT02764151|54182266|FG001|Overall Study|Subject refused further follow-up|0|||
27734337|NCT02764151|54182267|FG002|Overall Study|Subject refused further follow-up|0|||
27734338|NCT02764151|54182268|FG003|Overall Study|Subject refused further follow-up|1|||
27734339|NCT02764151|54182265|FG000|Overall Study|Other|0|||
27734340|NCT02764151|54182266|FG001|Overall Study|Other|0|||
27734341|NCT02764151|54182267|FG002|Overall Study|Other|0|||
27734342|NCT02764151|54182268|FG003|Overall Study|Other|2|||
27734343|NCT02545322|54182278|FG000|Overall Study|Withdrawal by Subject|3|||
27734344|NCT02763215|54182282|FG000|Overall Study|Participants withdrew from study|3|||
27734345|NCT02763215|54182282|FG000|Overall Study|Missed visit|1|||
27734346|NCT02763215|54182282|FG000|Overall Study|Visit outside visit-window|1|||
27734347|NCT02763215|54182282|FG000|Overall Study|Death|1|||
27734348|NCT02763215|54182282|FG000|Overall Study|Lost to Follow-up|1|||
27734349|NCT02770547|54182301|FG000|Overall Study|Patient non-compliant|1|||
27734350|NCT02770547|54182302|FG001|Overall Study|Patient non-compliant|0|||
27734351|NCT02770547|54182301|FG000|Overall Study|Adverse Event|0|||
27734352|NCT02770547|54182302|FG001|Overall Study|Adverse Event|1|||
27734353|NCT01661972|54182310|FG000|Overall Study|Adverse Event|1|||
27734354|NCT01661972|54182311|FG001|Overall Study|Adverse Event|2|||
27734355|NCT01661972|54182310|FG000|Overall Study|Death during Treatment period|1|||
27734356|NCT01661972|54182311|FG001|Overall Study|Death during Treatment period|1|||
27734357|NCT01661972|54182310|FG000|Overall Study|Withdrawal by Subject|0|||
27734358|NCT01661972|54182311|FG001|Overall Study|Withdrawal by Subject|1|||
27734359|NCT00888355|54182323|FG000|Overall Study|Adverse Event|10|||
27734360|NCT00888355|54182324|FG001|Overall Study|Adverse Event|0|||
27734361|NCT00888355|54182325|FG002|Overall Study|Adverse Event|3|||
27734362|NCT00888355|54182326|FG003|Overall Study|Adverse Event|3|||
27734363|NCT00888355|54182323|FG000|Overall Study|Lack of Efficacy|9|||
27734364|NCT00888355|54182324|FG001|Overall Study|Lack of Efficacy|2|||
27734365|NCT00888355|54182325|FG002|Overall Study|Lack of Efficacy|5|||
27734366|NCT00888355|54182326|FG003|Overall Study|Lack of Efficacy|2|||
27734367|NCT00888355|54182323|FG000|Overall Study|Lost to Follow-up|0|||
27734368|NCT00888355|54182324|FG001|Overall Study|Lost to Follow-up|2|||
27734369|NCT00888355|54182325|FG002|Overall Study|Lost to Follow-up|2|||
27734370|NCT00888355|54182326|FG003|Overall Study|Lost to Follow-up|0|||
27734371|NCT00888355|54182323|FG000|Overall Study|Protocol Violation|3|||
27734372|NCT00888355|54182324|FG001|Overall Study|Protocol Violation|2|||
27734373|NCT00888355|54182325|FG002|Overall Study|Protocol Violation|1|||
27734374|NCT00888355|54182326|FG003|Overall Study|Protocol Violation|2|||
27734375|NCT00888355|54182323|FG000|Overall Study|Withdrawal by Subject|0|||
27734376|NCT00888355|54182324|FG001|Overall Study|Withdrawal by Subject|3|||
28093289|NCT02142959|54747423|FG002|Overall Study|Missing|0|||
27734377|NCT00888355|54182325|FG002|Overall Study|Withdrawal by Subject|1|||
27734378|NCT00888355|54182326|FG003|Overall Study|Withdrawal by Subject|3|||
27833203|NCT01748825|54314625|FG004|Dose Expansion|Adverse Event|0|||
27833204|NCT01748825|54314626|FG005|Dose Expansion|Adverse Event|0|||
28168053|NCT02477800|54838700|FG003|Placebo-Controlled Period|Adverse Event|0|||
27734379|NCT00794677|54182334|FG000|First Intervention|Withdrawal by Subject|2|||
27734380|NCT00794677|54182335|FG001|First Intervention|Withdrawal by Subject|0|||
27734381|NCT02770391|54182339|FG000|Overall Study|Lost to Follow-up|2|||
27734382|NCT02770391|54182339|FG000|Overall Study|Withdrawal by Subject|1|||
27734383|NCT02770391|54182339|FG000|Overall Study|Surgery delayed unevaluable|2|||
27734384|NCT02770391|54182339|FG000|Overall Study|Treatment discontinued due to treatment inturruption|1|||
27734385|NCT02536508|54182346|FG000|Overall Study|Withdrawal by Subject|18|||
27833205|NCT01748825|54314627|FG006|Dose Expansion|Adverse Event|0|||
27833206|NCT01748825|54314628|FG007|Dose Expansion|Adverse Event|0|||
27833207|NCT01748825|54314629|FG008|Dose Expansion|Adverse Event|0|||
27833208|NCT01748825|54314630|FG009|Dose Expansion|Adverse Event|3|||
27833209|NCT01748825|54314621|FG000|Dose Expansion|Physician Decision|0|||
27833210|NCT01748825|54314622|FG001|Dose Expansion|Physician Decision|0|||
27734386|NCT02536508|54182347|FG001|Overall Study|Withdrawal by Subject|13|||
27734387|NCT02536508|54182348|FG002|Overall Study|Withdrawal by Subject|7|||
27734388|NCT02536508|54182346|FG000|Overall Study|Adverse Event|14|||
27734389|NCT02536508|54182347|FG001|Overall Study|Adverse Event|13|||
27734390|NCT02536508|54182348|FG002|Overall Study|Adverse Event|6|||
27734391|NCT02536508|54182346|FG000|Overall Study|Lost to Follow-up|12|||
27734392|NCT02536508|54182347|FG001|Overall Study|Lost to Follow-up|4|||
27734393|NCT02536508|54182348|FG002|Overall Study|Lost to Follow-up|0|||
27734394|NCT02536508|54182346|FG000|Overall Study|Lack of Efficacy|3|||
27734395|NCT02536508|54182347|FG001|Overall Study|Lack of Efficacy|5|||
27734396|NCT02536508|54182348|FG002|Overall Study|Lack of Efficacy|4|||
27734397|NCT02536508|54182346|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
27734398|NCT02536508|54182347|FG001|Overall Study|Protocol Discontinuation Criteria|2|||
27734399|NCT02536508|54182348|FG002|Overall Study|Protocol Discontinuation Criteria|2|||
27734400|NCT02536508|54182346|FG000|Overall Study|Physician Decision|0|||
27734401|NCT02536508|54182347|FG001|Overall Study|Physician Decision|4|||
27734402|NCT02536508|54182348|FG002|Overall Study|Physician Decision|2|||
27734403|NCT02536508|54182346|FG000|Overall Study|Major Protocol Deviation|2|||
27734404|NCT02536508|54182347|FG001|Overall Study|Major Protocol Deviation|2|||
27734405|NCT02536508|54182348|FG002|Overall Study|Major Protocol Deviation|2|||
27734406|NCT02536508|54182346|FG000|Overall Study|Administrative Reasons|0|||
27734407|NCT02536508|54182347|FG001|Overall Study|Administrative Reasons|1|||
27734408|NCT02536508|54182348|FG002|Overall Study|Administrative Reasons|0|||
27734409|NCT00103259|54182365|FG000|Overall Study|Death|3|||
27734410|NCT00103259|54182366|FG001|Overall Study|Death|2|||
27734411|NCT00103259|54182365|FG000|Overall Study|Withdrawal by Subject|2|||
27734412|NCT00103259|54182366|FG001|Overall Study|Withdrawal by Subject|3|||
27734413|NCT00103259|54182365|FG000|Overall Study|alternative therapy|1|||
27734414|NCT00103259|54182366|FG001|Overall Study|alternative therapy|0|||
27734415|NCT00103259|54182365|FG000|Overall Study|other (reasons were not specified)|2|||
27734416|NCT00103259|54182366|FG001|Overall Study|other (reasons were not specified)|1|||
27734417|NCT00103259|54182365|FG000|Overall Study|ineligible/no protocol therapy|4|||
27734418|NCT00103259|54182366|FG001|Overall Study|ineligible/no protocol therapy|6|||
27734419|NCT02544152|54182376|FG000|Overall Study|Adverse Event|0|||
27734420|NCT02544152|54182377|FG001|Overall Study|Adverse Event|4|||
27734421|NCT02544152|54182376|FG000|Overall Study|Withdrawal by Subject|0|||
27734422|NCT02544152|54182377|FG001|Overall Study|Withdrawal by Subject|3|||
27734423|NCT02544152|54182376|FG000|Overall Study|Other|1|||
27734424|NCT02544152|54182377|FG001|Overall Study|Other|0|||
27734425|NCT02534324|54182385|FG000|Overall Study|Protocol Violation|4|||
27734426|NCT02534324|54182386|FG001|Overall Study|Protocol Violation|1|||
27734427|NCT02534324|54182385|FG000|Overall Study|Lost to Follow-up|20|||
27734428|NCT02534324|54182386|FG001|Overall Study|Lost to Follow-up|7|||
27734429|NCT02534324|54182385|FG000|Overall Study|Adverse Event|1|||
27734430|NCT02534324|54182386|FG001|Overall Study|Adverse Event|0|||
27734431|NCT02761733|54182396|FG000|Overall Study|Death|3|||
27734432|NCT02761733|54182397|FG001|Overall Study|Death|5|||
27734433|NCT02761733|54182398|FG002|Overall Study|Death|1|||
27833211|NCT01748825|54314623|FG002|Dose Expansion|Physician Decision|0|||
27833212|NCT01748825|54314624|FG003|Dose Expansion|Physician Decision|0|||
27833213|NCT01748825|54314625|FG004|Dose Expansion|Physician Decision|0|||
28093290|NCT02142959|54747421|FG000|Overall Study|Treatment changed from radiation treatment to chemo|0|||
28093291|NCT02142959|54747422|FG001|Overall Study|Treatment changed from radiation treatment to chemo|0|||
28093292|NCT02142959|54747423|FG002|Overall Study|Treatment changed from radiation treatment to chemo|1|||
28093293|NCT02142959|54747421|FG000|Overall Study|Patient didn't complete end of study visit|0|||
28093294|NCT02142959|54747422|FG001|Overall Study|Patient didn't complete end of study visit|0|||
28093295|NCT02142959|54747423|FG002|Overall Study|Patient didn't complete end of study visit|1|||
28093296|NCT02100722|54747442|FG000|Overall Study|Withdrawal pre-procedure|4|||
28093297|NCT02100722|54747443|FG001|Overall Study|Withdrawal pre-procedure|9|||
28093298|NCT02100722|54747442|FG000|Overall Study|Withdrawal post-procedure|0|||
28093299|NCT02100722|54747443|FG001|Overall Study|Withdrawal post-procedure|3|||
28093300|NCT02100722|54747442|FG000|Overall Study|Lost to Follow-up|2|||
28093301|NCT02100722|54747443|FG001|Overall Study|Lost to Follow-up|2|||
28093302|NCT02100722|54747442|FG000|Overall Study|Continuing on study|751|||
28093303|NCT02100722|54747443|FG001|Overall Study|Continuing on study|729|||
28093304|NCT02028988|54747459|FG000|Overall Study|Withdrawal by Subject|2|||
28093305|NCT02004236|54747466|FG000|Overall Study|Lack of Efficacy|0|||
28093306|NCT02004236|54747467|FG001|Overall Study|Lack of Efficacy|0|||
28168054|NCT02477800|54838701|FG004|Placebo-Controlled Period|Adverse Event|0|||
28093307|NCT02004236|54747468|FG002|Overall Study|Lack of Efficacy|16|||
28093308|NCT01974440|54747479|FG000|Overall Study|Lost to Follow-up|8|||
28093309|NCT01974440|54747480|FG001|Overall Study|Lost to Follow-up|7|||
28093310|NCT01974440|54747479|FG000|Overall Study|Withdrawal by Subject|20|||
28093311|NCT01974440|54747480|FG001|Overall Study|Withdrawal by Subject|19|||
28093312|NCT01974440|54747479|FG000|Overall Study|Ongoing|112|||
28093313|NCT01974440|54747480|FG001|Overall Study|Ongoing|116|||
28093314|NCT01959139|54747490|FG000|Phase II|Disease progression|0|||
28093315|NCT01959139|54747491|FG001|Phase II|Disease progression|0|||
28093316|NCT01959139|54747492|FG002|Phase II|Disease progression|26|||
28093317|NCT01959139|54747493|FG003|Phase II|Disease progression|34|||
28093318|NCT01959139|54747490|FG000|Phase II|Adverse Event|0|||
28093319|NCT01959139|54747491|FG001|Phase II|Adverse Event|0|||
28093320|NCT01959139|54747492|FG002|Phase II|Adverse Event|10|||
28168055|NCT02477800|54838702|FG005|Placebo-Controlled Period|Adverse Event|0|||
28168056|NCT02477800|54838703|FG006|Placebo-Controlled Period|Adverse Event|0|||
28168057|NCT02477800|54838697|FG000|Placebo-Controlled Period|Change of Treatment|1|||
28168058|NCT02477800|54838698|FG001|Placebo-Controlled Period|Change of Treatment|2|||
28168059|NCT02477800|54838699|FG002|Placebo-Controlled Period|Change of Treatment|1|||
28168060|NCT02477800|54838700|FG003|Placebo-Controlled Period|Change of Treatment|0|||
28168061|NCT02477800|54838701|FG004|Placebo-Controlled Period|Change of Treatment|0|||
27734434|NCT02761733|54182399|FG003|Overall Study|Death|1|||
27734435|NCT02761733|54182396|FG000|Overall Study|Lost to Follow-up|6|||
27734436|NCT02761733|54182397|FG001|Overall Study|Lost to Follow-up|7|||
27734437|NCT02761733|54182398|FG002|Overall Study|Lost to Follow-up|0|||
27734438|NCT02761733|54182399|FG003|Overall Study|Lost to Follow-up|3|||
27734439|NCT02761733|54182396|FG000|Overall Study|Physician Decision|4|||
27734440|NCT02761733|54182397|FG001|Overall Study|Physician Decision|0|||
27734441|NCT02761733|54182398|FG002|Overall Study|Physician Decision|0|||
27734442|NCT02761733|54182399|FG003|Overall Study|Physician Decision|0|||
27734443|NCT02761733|54182396|FG000|Overall Study|Withdrawal by Subject|2|||
27734444|NCT02761733|54182397|FG001|Overall Study|Withdrawal by Subject|0|||
27734445|NCT02761733|54182398|FG002|Overall Study|Withdrawal by Subject|0|||
27734446|NCT02761733|54182399|FG003|Overall Study|Withdrawal by Subject|0|||
27734447|NCT02761733|54182396|FG000|Overall Study|Discharged from Study Site|10|||
27734448|NCT02761733|54182397|FG001|Overall Study|Discharged from Study Site|9|||
27734449|NCT02761733|54182398|FG002|Overall Study|Discharged from Study Site|25|||
27734450|NCT02761733|54182399|FG003|Overall Study|Discharged from Study Site|11|||
27734451|NCT02761733|54182396|FG000|Overall Study|Cognitive Impairment|5|||
27734452|NCT02761733|54182397|FG001|Overall Study|Cognitive Impairment|0|||
27734453|NCT02761733|54182398|FG002|Overall Study|Cognitive Impairment|1|||
27734454|NCT02761733|54182399|FG003|Overall Study|Cognitive Impairment|0|||
27734455|NCT03715465|54182411|FG000|Overall Study|Withdrawal by Subject|1|||
27734456|NCT03715465|54182412|FG001|Overall Study|Withdrawal by Subject|2|||
27734457|NCT00840073|54182420|FG000|Second Intervention|Missed 72 hour blood draw|1|||
27734458|NCT00840073|54182421|FG001|Second Intervention|Missed 72 hour blood draw|1|||
27734459|NCT00838279|54182427|FG000|Washout|Protocol Violation|1|||
27734460|NCT00838279|54182428|FG001|Washout|Protocol Violation|0|||
27734461|NCT00838279|54182427|FG000|Washout|Withdrawal by Subject|0|||
27734462|NCT00838279|54182428|FG001|Washout|Withdrawal by Subject|1|||
27734463|NCT02759939|54182436|FG000|Overall Study|Missing data on first outcome assessed|11|||
27734464|NCT02759939|54182437|FG001|Overall Study|Missing data on first outcome assessed|2|||
27734465|NCT02759939|54182438|FG002|Overall Study|Missing data on first outcome assessed|5|||
27734466|NCT02759939|54182439|FG003|Overall Study|Missing data on first outcome assessed|2|||
27734467|NCT02759939|54182436|FG000|Overall Study|Ineligible for T2 and T3|310|||
28093321|NCT01959139|54747493|FG003|Phase II|Adverse Event|11|||
28168062|NCT02477800|54838702|FG005|Placebo-Controlled Period|Change of Treatment|0|||
28168063|NCT02477800|54838703|FG006|Placebo-Controlled Period|Change of Treatment|0|||
27734468|NCT02759939|54182437|FG001|Overall Study|Ineligible for T2 and T3|179|||
27734469|NCT02759939|54182438|FG002|Overall Study|Ineligible for T2 and T3|366|||
27734470|NCT02759939|54182439|FG003|Overall Study|Ineligible for T2 and T3|391|||
27734471|NCT02759939|54182436|FG000|Overall Study|Lost to Follow-up|735|||
27734472|NCT02759939|54182437|FG001|Overall Study|Lost to Follow-up|791|||
27734473|NCT02759939|54182438|FG002|Overall Study|Lost to Follow-up|783|||
27734474|NCT02759939|54182439|FG003|Overall Study|Lost to Follow-up|650|||
27734475|NCT00835705|54182458|FG000|First Intervention|Difficulty with vein|1|||
28168064|NCT02477800|54838697|FG000|Placebo-Controlled Period|Consent Withdrawn|26|||
28168065|NCT02477800|54838698|FG001|Placebo-Controlled Period|Consent Withdrawn|16|||
28093322|NCT01959139|54747490|FG000|Phase II|Patient Refusal|0|||
28093323|NCT01959139|54747491|FG001|Phase II|Patient Refusal|0|||
28093324|NCT01959139|54747492|FG002|Phase II|Patient Refusal|5|||
28093325|NCT01959139|54747493|FG003|Phase II|Patient Refusal|4|||
28093326|NCT01959139|54747490|FG000|Phase II|Death|0|||
28093327|NCT01959139|54747491|FG001|Phase II|Death|0|||
28093328|NCT01959139|54747492|FG002|Phase II|Death|3|||
28093329|NCT01959139|54747493|FG003|Phase II|Death|1|||
28093330|NCT01959139|54747490|FG000|Phase II|Other/Unknown|0|||
28093331|NCT01959139|54747491|FG001|Phase II|Other/Unknown|0|||
28093332|NCT01959139|54747492|FG002|Phase II|Other/Unknown|8|||
28093333|NCT01959139|54747493|FG003|Phase II|Other/Unknown|5|||
28093334|NCT01959139|54747490|FG000|Phase II|On treatment|0|||
28093335|NCT01959139|54747491|FG001|Phase II|On treatment|0|||
28093336|NCT01959139|54747492|FG002|Phase II|On treatment|4|||
28093337|NCT01959139|54747493|FG003|Phase II|On treatment|0|||
28093338|NCT01784068|54747526|FG000|NTCS Phase|Adverse Event|5|||
28093339|NCT01784068|54747527|FG001|NTCS Phase|Adverse Event|0|||
28093340|NCT01784068|54747526|FG000|NTCS Phase|Physician Decision|2|||
28093341|NCT01784068|54747527|FG001|NTCS Phase|Physician Decision|0|||
28093342|NCT01784068|54747526|FG000|NTCS Phase|Patient/guardian decision|3|||
28093343|NCT01784068|54747527|FG001|NTCS Phase|Patient/guardian decision|0|||
28093344|NCT01784068|54747526|FG000|NTCS Phase|Death|2|||
28093345|NCT01784068|54747527|FG001|NTCS Phase|Death|0|||
28093346|NCT01784068|54747526|FG000|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203|||
28093347|NCT01784068|54747527|FG001|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0|||
28093348|NCT01784068|54747526|FG000|TFR Phase|Physician Decision|0|||
28093349|NCT01784068|54747527|FG001|TFR Phase|Physician Decision|1|||
28093350|NCT01784068|54747526|FG000|TFR Phase|Patient/guardian decision|0|||
28093351|NCT01784068|54747527|FG001|TFR Phase|Patient/guardian decision|3|||
28093352|NCT01784068|54747526|FG000|TFR Phase|Death|0|||
28093353|NCT01784068|54747527|FG001|TFR Phase|Death|1|||
28093354|NCT01784068|54747526|FG000|TFR Phase|Lack of Efficacy|0|||
28093355|NCT01784068|54747527|FG001|TFR Phase|Lack of Efficacy|88|||
28168066|NCT02477800|54838699|FG002|Placebo-Controlled Period|Consent Withdrawn|27|||
28168067|NCT02477800|54838700|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
28168068|NCT02477800|54838701|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
28168069|NCT02477800|54838702|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
28093356|NCT01642251|54747541|FG000|Overall Study|Progressive disease|0|||
28093357|NCT01642251|54747542|FG001|Overall Study|Progressive disease|0|||
28093358|NCT01642251|54747543|FG002|Overall Study|Progressive disease|3|||
28093359|NCT01642251|54747544|FG003|Overall Study|Progressive disease|3|||
28093360|NCT01642251|54747541|FG000|Overall Study|Adverse Event|0|||
28093361|NCT01642251|54747542|FG001|Overall Study|Adverse Event|0|||
28093362|NCT01642251|54747543|FG002|Overall Study|Adverse Event|5|||
28093363|NCT01642251|54747544|FG003|Overall Study|Adverse Event|4|||
28093364|NCT01642251|54747541|FG000|Overall Study|Death|0|||
28093365|NCT01642251|54747542|FG001|Overall Study|Death|0|||
28093366|NCT01642251|54747543|FG002|Overall Study|Death|1|||
28093367|NCT01642251|54747544|FG003|Overall Study|Death|3|||
28093368|NCT01642251|54747541|FG000|Overall Study|Withdrawal by Subject|0|||
28093369|NCT01642251|54747542|FG001|Overall Study|Withdrawal by Subject|0|||
28093370|NCT01642251|54747543|FG002|Overall Study|Withdrawal by Subject|1|||
28093371|NCT01642251|54747544|FG003|Overall Study|Withdrawal by Subject|3|||
28093372|NCT01642251|54747541|FG000|Overall Study|Alternative therapy|0|||
28093373|NCT01642251|54747542|FG001|Overall Study|Alternative therapy|0|||
28093374|NCT01642251|54747543|FG002|Overall Study|Alternative therapy|0|||
28093375|NCT01642251|54747544|FG003|Overall Study|Alternative therapy|2|||
28168070|NCT02477800|54838703|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
28168071|NCT02477800|54838697|FG000|Placebo-Controlled Period|Death|0|||
28168072|NCT02477800|54838698|FG001|Placebo-Controlled Period|Death|3|||
28168073|NCT02477800|54838699|FG002|Placebo-Controlled Period|Death|2|||
28168074|NCT02477800|54838700|FG003|Placebo-Controlled Period|Death|0|||
28168075|NCT02477800|54838701|FG004|Placebo-Controlled Period|Death|0|||
28168076|NCT02477800|54838702|FG005|Placebo-Controlled Period|Death|0|||
28168077|NCT02477800|54838703|FG006|Placebo-Controlled Period|Death|0|||
28168078|NCT02477800|54838697|FG000|Placebo-Controlled Period|Disease Progression|1|||
28168079|NCT02477800|54838698|FG001|Placebo-Controlled Period|Disease Progression|0|||
28168080|NCT02477800|54838699|FG002|Placebo-Controlled Period|Disease Progression|1|||
28168081|NCT02477800|54838700|FG003|Placebo-Controlled Period|Disease Progression|0|||
28168082|NCT02477800|54838701|FG004|Placebo-Controlled Period|Disease Progression|0|||
28093376|NCT01642251|54747541|FG000|Overall Study|Other complicating disease|0|||
28168083|NCT02477800|54838702|FG005|Placebo-Controlled Period|Disease Progression|0|||
28168084|NCT02477800|54838703|FG006|Placebo-Controlled Period|Disease Progression|0|||
28093377|NCT01642251|54747542|FG001|Overall Study|Other complicating disease|0|||
28093378|NCT01642251|54747543|FG002|Overall Study|Other complicating disease|1|||
28093379|NCT01642251|54747544|FG003|Overall Study|Other complicating disease|0|||
28093380|NCT01642251|54747541|FG000|Overall Study|Ineligible/never start protocol therapy|0|||
28093381|NCT01642251|54747542|FG001|Overall Study|Ineligible/never start protocol therapy|0|||
28093382|NCT01642251|54747543|FG002|Overall Study|Ineligible/never start protocol therapy|11|||
28093383|NCT01642251|54747544|FG003|Overall Study|Ineligible/never start protocol therapy|8|||
28168085|NCT02477800|54838697|FG000|Placebo-Controlled Period|Investigator Decision|3|||
28168086|NCT02477800|54838698|FG001|Placebo-Controlled Period|Investigator Decision|2|||
28168087|NCT02477800|54838699|FG002|Placebo-Controlled Period|Investigator Decision|1|||
28168088|NCT02477800|54838700|FG003|Placebo-Controlled Period|Investigator Decision|0|||
28168089|NCT02477800|54838701|FG004|Placebo-Controlled Period|Investigator Decision|0|||
28168090|NCT02477800|54838702|FG005|Placebo-Controlled Period|Investigator Decision|0|||
28093384|NCT01606137|54747553|FG000|Overall Study|Adverse Event|85|||
28168091|NCT02477800|54838703|FG006|Placebo-Controlled Period|Investigator Decision|0|||
28168092|NCT02477800|54838697|FG000|Placebo-Controlled Period|Lost to Follow-up|1|||
28168093|NCT02477800|54838698|FG001|Placebo-Controlled Period|Lost to Follow-up|3|||
28168094|NCT02477800|54838699|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
28168095|NCT02477800|54838700|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
28168096|NCT02477800|54838701|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
28168097|NCT02477800|54838702|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
28168098|NCT02477800|54838703|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
28168099|NCT02477800|54838697|FG000|Placebo-Controlled Period|Relocation|2|||
28168100|NCT02477800|54838698|FG001|Placebo-Controlled Period|Relocation|0|||
28168101|NCT02477800|54838699|FG002|Placebo-Controlled Period|Relocation|0|||
28168102|NCT02477800|54838700|FG003|Placebo-Controlled Period|Relocation|0|||
27734476|NCT00835705|54182459|FG001|First Intervention|Difficulty with vein|0|||
27734477|NCT00835705|54182458|FG000|Second Intervention|Difficulty with vein|1|||
27734478|NCT00835705|54182459|FG001|Second Intervention|Difficulty with vein|0|||
27734479|NCT02938520|54182465|FG000|Overall Study|On-going at the time of analysis|258|||
27734480|NCT02938520|54182466|FG001|Overall Study|On-going at the time of analysis|261|||
28093385|NCT01606137|54747553|FG000|Overall Study|Withdrawal by Subject|74|||
28093386|NCT01606137|54747553|FG000|Overall Study|Lack of Efficacy|56|||
27734481|NCT02938520|54182465|FG000|Overall Study|Physician Decision|2|||
27734482|NCT02938520|54182466|FG001|Overall Study|Physician Decision|5|||
27734483|NCT02938520|54182465|FG000|Overall Study|Lost to Follow-up|2|||
27734484|NCT02938520|54182466|FG001|Overall Study|Lost to Follow-up|2|||
27734485|NCT02938520|54182465|FG000|Overall Study|Withdrawal by Subject|7|||
27734486|NCT02938520|54182466|FG001|Overall Study|Withdrawal by Subject|7|||
27734487|NCT02938520|54182465|FG000|Overall Study|Protocol Violation|0|||
27734488|NCT02938520|54182466|FG001|Overall Study|Protocol Violation|1|||
27734489|NCT02938520|54182465|FG000|Overall Study|Lack of Efficacy|5|||
27734490|NCT02938520|54182466|FG001|Overall Study|Lack of Efficacy|3|||
27734491|NCT02938520|54182465|FG000|Overall Study|Adverse Event|9|||
27734492|NCT02938520|54182466|FG001|Overall Study|Adverse Event|4|||
27734493|NCT02759471|54182475|FG000|Overall Study|discomfort|2|||
27734494|NCT00835549|54182483|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
27734495|NCT00835549|54182484|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
27734496|NCT03945825|54182494|FG000|Overall Study|Enrolled but treatment not administered|0|||
27734497|NCT03945825|54182495|FG001|Overall Study|Enrolled but treatment not administered|0|||
27734498|NCT03945825|54182496|FG002|Overall Study|Enrolled but treatment not administered|0|||
27734499|NCT03945825|54182497|FG003|Overall Study|Enrolled but treatment not administered|0|||
27734500|NCT03945825|54182498|FG004|Overall Study|Enrolled but treatment not administered|1|||
27734501|NCT03945825|54182499|FG005|Overall Study|Enrolled but treatment not administered|0|||
27734502|NCT03945825|54182494|FG000|Overall Study|Lost to Follow-up|1|||
27734503|NCT03945825|54182495|FG001|Overall Study|Lost to Follow-up|5|||
27734504|NCT03945825|54182496|FG002|Overall Study|Lost to Follow-up|0|||
27734505|NCT03945825|54182497|FG003|Overall Study|Lost to Follow-up|1|||
27734506|NCT03945825|54182498|FG004|Overall Study|Lost to Follow-up|2|||
27734507|NCT03945825|54182499|FG005|Overall Study|Lost to Follow-up|2|||
27734508|NCT03945825|54182494|FG000|Overall Study|Withdrawal by Subject|1|||
27734509|NCT03945825|54182495|FG001|Overall Study|Withdrawal by Subject|0|||
27833214|NCT01748825|54314626|FG005|Dose Expansion|Physician Decision|0|||
27980722|NCT00891020|54638731|FG000|24 Week Treatment Period|Other protocol violation|1|||
28093387|NCT01606137|54747553|FG000|Overall Study|Lost to Follow-up|15|||
28093388|NCT01606137|54747553|FG000|Overall Study|Protocol Violation|1|||
28093389|NCT01606137|54747553|FG000|Overall Study|Patient non-compliance|9|||
28093390|NCT01606137|54747553|FG000|Overall Study|Death|1|||
28093391|NCT01606137|54747553|FG000|Overall Study|Decreased/no pain|4|||
28093392|NCT01606137|54747553|FG000|Overall Study|Issues with driving|4|||
28168103|NCT02477800|54838701|FG004|Placebo-Controlled Period|Relocation|0|||
28168104|NCT02477800|54838702|FG005|Placebo-Controlled Period|Relocation|0|||
27734510|NCT03945825|54182496|FG002|Overall Study|Withdrawal by Subject|1|||
27734511|NCT03945825|54182497|FG003|Overall Study|Withdrawal by Subject|1|||
27734512|NCT03945825|54182498|FG004|Overall Study|Withdrawal by Subject|0|||
27734513|NCT03945825|54182499|FG005|Overall Study|Withdrawal by Subject|1|||
27734514|NCT02759315|54182527|FG000|Overall Study|Adverse Event|0|||
27734515|NCT02759315|54182528|FG001|Overall Study|Adverse Event|0|||
27734516|NCT02759315|54182529|FG002|Overall Study|Adverse Event|0|||
27734517|NCT02759315|54182530|FG003|Overall Study|Adverse Event|1|||
27980723|NCT00891020|54638732|FG001|24 Week Treatment Period|Other protocol violation|1|||
28093393|NCT01606137|54747553|FG000|Overall Study|multiple sclerosis less stable|1|||
28093394|NCT01606137|54747553|FG000|Overall Study|Increased bilirubin|1|||
28093395|NCT01606137|54747553|FG000|Overall Study|Spray causes nausea|1|||
28093396|NCT01606137|54747553|FG000|Overall Study|Not enough improvement|4|||
28093397|NCT01606137|54747553|FG000|Overall Study|Wanted to try another treatment|1|||
28168105|NCT02477800|54838703|FG006|Placebo-Controlled Period|Relocation|0|||
28168106|NCT02477800|54838697|FG000|Placebo-Controlled Period|Site Terminated by Investigator|1|||
28168107|NCT02477800|54838698|FG001|Placebo-Controlled Period|Site Terminated by Investigator|1|||
28168108|NCT02477800|54838699|FG002|Placebo-Controlled Period|Site Terminated by Investigator|1|||
28168109|NCT02477800|54838700|FG003|Placebo-Controlled Period|Site Terminated by Investigator|0|||
28168110|NCT02477800|54838701|FG004|Placebo-Controlled Period|Site Terminated by Investigator|0|||
28093398|NCT01606137|54747553|FG000|Overall Study|Patient leaving country|1|||
28093399|NCT01606137|54747553|FG000|Overall Study|Personal reasons|1|||
28093400|NCT01606137|54747553|FG000|Overall Study|Unable to tolerate study med. taste|1|||
28093401|NCT01606137|54747553|FG000|Overall Study|Patient moving|1|||
28168111|NCT02477800|54838702|FG005|Placebo-Controlled Period|Site Terminated by Investigator|0|||
28168112|NCT02477800|54838703|FG006|Placebo-Controlled Period|Site Terminated by Investigator|0|||
28168113|NCT02477800|54838697|FG000|Placebo-Controlled Period|Site Terminated by Sponsor|2|||
28168114|NCT02477800|54838698|FG001|Placebo-Controlled Period|Site Terminated by Sponsor|1|||
28168115|NCT02477800|54838699|FG002|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
28168116|NCT02477800|54838700|FG003|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
28168117|NCT02477800|54838701|FG004|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
28168118|NCT02477800|54838702|FG005|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
28168119|NCT02477800|54838703|FG006|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
28168120|NCT02477800|54838697|FG000|Placebo-Controlled Period|Study Visit Burden|5|||
28093402|NCT01606137|54747553|FG000|Overall Study|Unable to collect consistent data|1|||
28093403|NCT01532518|54747560|FG000|Overall Study|Withdrawal by Subject|0|||
28093404|NCT01532518|54747561|FG001|Overall Study|Withdrawal by Subject|0|||
28168121|NCT02477800|54838698|FG001|Placebo-Controlled Period|Study Visit Burden|3|||
28168122|NCT02477800|54838699|FG002|Placebo-Controlled Period|Study Visit Burden|11|||
28168123|NCT02477800|54838700|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
28168124|NCT02477800|54838701|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
28168125|NCT02477800|54838702|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
28168126|NCT02477800|54838703|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
28168127|NCT02477800|54838697|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
28168128|NCT02477800|54838698|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|5|||
28168129|NCT02477800|54838699|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|3|||
28168130|NCT02477800|54838700|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
28168131|NCT02477800|54838701|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
28168132|NCT02477800|54838702|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
28168133|NCT02477800|54838703|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
28168134|NCT02477800|54838697|FG000|Placebo-Controlled Period|Reason not Specified|161|||
27734518|NCT02759315|54182531|FG004|Overall Study|Adverse Event|0|||
27734519|NCT02759315|54182527|FG000|Overall Study|Death|0|||
27734520|NCT02759315|54182528|FG001|Overall Study|Death|0|||
27734521|NCT02759315|54182529|FG002|Overall Study|Death|1|||
27734522|NCT02759315|54182530|FG003|Overall Study|Death|0|||
27734523|NCT02759315|54182531|FG004|Overall Study|Death|0|||
27734524|NCT02759315|54182527|FG000|Overall Study|Lost to Follow-up|2|||
27734525|NCT02759315|54182528|FG001|Overall Study|Lost to Follow-up|0|||
27734526|NCT02759315|54182529|FG002|Overall Study|Lost to Follow-up|4|||
27734527|NCT02759315|54182530|FG003|Overall Study|Lost to Follow-up|0|||
27734528|NCT02759315|54182531|FG004|Overall Study|Lost to Follow-up|0|||
27734529|NCT02759315|54182527|FG000|Overall Study|Protocol Violation|0|||
27734530|NCT02759315|54182528|FG001|Overall Study|Protocol Violation|1|||
27734531|NCT02759315|54182529|FG002|Overall Study|Protocol Violation|0|||
27734532|NCT02759315|54182530|FG003|Overall Study|Protocol Violation|0|||
27734533|NCT02759315|54182531|FG004|Overall Study|Protocol Violation|0|||
27734534|NCT02759315|54182527|FG000|Overall Study|Study terminated prior to completion|2|||
27734535|NCT02759315|54182528|FG001|Overall Study|Study terminated prior to completion|0|||
27734536|NCT02759315|54182529|FG002|Overall Study|Study terminated prior to completion|5|||
27734537|NCT02759315|54182530|FG003|Overall Study|Study terminated prior to completion|0|||
27734538|NCT02759315|54182531|FG004|Overall Study|Study terminated prior to completion|1|||
27734539|NCT00835081|54182547|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
27734540|NCT00835081|54182548|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
27734541|NCT02543918|54182554|FG000|Overall Study|Never treated|0|||
27734542|NCT02543918|54182555|FG001|Overall Study|Never treated|1|||
27734543|NCT02543918|54182554|FG000|Overall Study|Lost to Follow-up|1|||
27734544|NCT02543918|54182555|FG001|Overall Study|Lost to Follow-up|1|||
28093405|NCT01532518|54747562|FG002|Overall Study|Withdrawal by Subject|1|||
27734545|NCT02543918|54182554|FG000|Overall Study|Withdrawal by Subject|1|||
28093406|NCT00844285|54747590|FG000|Overall Study|Other|0|||
28093407|NCT00844285|54747591|FG001|Overall Study|Other|1|||
28168135|NCT02477800|54838698|FG001|Placebo-Controlled Period|Reason not Specified|161|||
28168136|NCT02477800|54838699|FG002|Placebo-Controlled Period|Reason not Specified|189|||
28093408|NCT00844285|54747592|FG002|Overall Study|Other|0|||
28093409|NCT00844285|54747590|FG000|Overall Study|Other than specified|95|||
28093410|NCT00844285|54747591|FG001|Overall Study|Other than specified|129|||
28093411|NCT00844285|54747592|FG002|Overall Study|Other than specified|12|||
28093412|NCT00844285|54747590|FG000|Overall Study|Site closure|256|||
28093413|NCT00844285|54747591|FG001|Overall Study|Site closure|450|||
28093414|NCT00844285|54747592|FG002|Overall Study|Site closure|50|||
28093415|NCT00844285|54747590|FG000|Overall Study|Follow-up < 8 years|16|||
27734546|NCT02543918|54182555|FG001|Overall Study|Withdrawal by Subject|1|||
27734547|NCT02543918|54182554|FG000|Overall Study|Adverse Event|1|||
27734548|NCT02543918|54182555|FG001|Overall Study|Adverse Event|1|||
27734549|NCT01372995|54182564|FG000|Overall Study|Spouse withdrew participant from study|0|||
27734550|NCT01372995|54182565|FG001|Overall Study|Spouse withdrew participant from study|1|||
27734551|NCT01372995|54182566|FG002|Overall Study|Spouse withdrew participant from study|0|||
27734552|NCT01372995|54182564|FG000|Overall Study|Physician Decision|0|||
27734553|NCT01372995|54182565|FG001|Overall Study|Physician Decision|0|||
27734554|NCT01372995|54182566|FG002|Overall Study|Physician Decision|1|||
27734555|NCT02757521|54182576|FG000|Overall Study|Adverse Event|1|||
27734556|NCT02757521|54182577|FG001|Overall Study|Adverse Event|0|||
27734557|NCT00834613|54182585|FG000|First Intervention|Protocol Violation|1|||
27734558|NCT00834613|54182586|FG001|First Intervention|Protocol Violation|0|||
27734559|NCT00834067|54182603|FG000|Washout of 21 Days|Protocol Violation|0|||
27734560|NCT00834067|54182604|FG001|Washout of 21 Days|Protocol Violation|1|||
27734561|NCT02758613|54182612|FG000|Treatment|Physician and Sponsor Decision|1|||
27734562|NCT02758613|54182613|FG001|Treatment|Physician and Sponsor Decision|0|||
27734563|NCT02758613|54182614|FG002|Treatment|Physician and Sponsor Decision|0|||
27734564|NCT02758613|54182615|FG003|Treatment|Physician and Sponsor Decision|0|||
27734565|NCT02758613|54182612|FG000|Treatment|Withdrawal by Subject|1|||
27734566|NCT02758613|54182613|FG001|Treatment|Withdrawal by Subject|0|||
27734567|NCT02758613|54182614|FG002|Treatment|Withdrawal by Subject|1|||
27734568|NCT02758613|54182615|FG003|Treatment|Withdrawal by Subject|0|||
27734569|NCT02758301|54182630|FG000|Overall Study|Death|12|||
27734570|NCT02758301|54182631|FG001|Overall Study|Death|0|||
27734571|NCT02758301|54182630|FG000|Overall Study|Physician Decision|10|||
27734572|NCT02758301|54182631|FG001|Overall Study|Physician Decision|1|||
27734573|NCT02758301|54182630|FG000|Overall Study|Withdrawal by Subject|5|||
27734574|NCT02758301|54182631|FG001|Overall Study|Withdrawal by Subject|6|||
27855787|NCT02733042|54382054|FG016|Follow-up Period|Withdrawal by Subject|0|||
27980724|NCT00891020|54638733|FG002|24 Week Treatment Period|Other protocol violation|2|||
28093416|NCT00844285|54747591|FG001|Overall Study|Follow-up < 8 years|23|||
28093417|NCT00844285|54747592|FG002|Overall Study|Follow-up < 8 years|4|||
28093418|NCT00844285|54747590|FG000|Overall Study|Protocol Violation|26|||
28093419|NCT00844285|54747591|FG001|Overall Study|Protocol Violation|28|||
28093420|NCT00844285|54747592|FG002|Overall Study|Protocol Violation|54|||
28093421|NCT00844285|54747590|FG000|Overall Study|Death|22|||
28093422|NCT00844285|54747591|FG001|Overall Study|Death|21|||
28093423|NCT00844285|54747592|FG002|Overall Study|Death|8|||
28093424|NCT00844285|54747590|FG000|Overall Study|Withdrew Consent|344|||
28093425|NCT00844285|54747591|FG001|Overall Study|Withdrew Consent|466|||
28093426|NCT00844285|54747592|FG002|Overall Study|Withdrew Consent|70|||
28093427|NCT00844285|54747590|FG000|Overall Study|Lost to Follow-up|330|||
28168137|NCT02477800|54838700|FG003|Placebo-Controlled Period|Reason not Specified|0|||
28168138|NCT02477800|54838701|FG004|Placebo-Controlled Period|Reason not Specified|0|||
28168139|NCT02477800|54838702|FG005|Placebo-Controlled Period|Reason not Specified|0|||
28168140|NCT02477800|54838703|FG006|Placebo-Controlled Period|Reason not Specified|0|||
28168141|NCT02477800|54838697|FG000|Long Term Extension Period|Adverse Event|0|||
28168142|NCT02477800|54838698|FG001|Long Term Extension Period|Adverse Event|0|||
28168143|NCT02477800|54838699|FG002|Long Term Extension Period|Adverse Event|0|||
28168144|NCT02477800|54838700|FG003|Long Term Extension Period|Adverse Event|6|||
28168145|NCT02477800|54838701|FG004|Long Term Extension Period|Adverse Event|2|||
27734575|NCT02758301|54182630|FG000|Overall Study|Lost to Follow-up|7|||
27855788|NCT02733042|54382055|FG017|Follow-up Period|Withdrawal by Subject|0|||
28093428|NCT00844285|54747591|FG001|Overall Study|Lost to Follow-up|486|||
28093429|NCT00844285|54747592|FG002|Overall Study|Lost to Follow-up|74|||
28093430|NCT00711646|54747620|FG000|Overall Study|Adverse Event|6|||
28168146|NCT02477800|54838702|FG005|Long Term Extension Period|Adverse Event|4|||
28168147|NCT02477800|54838703|FG006|Long Term Extension Period|Adverse Event|3|||
28168148|NCT02477800|54838697|FG000|Long Term Extension Period|Death|0|||
28168149|NCT02477800|54838698|FG001|Long Term Extension Period|Death|0|||
28168150|NCT02477800|54838699|FG002|Long Term Extension Period|Death|0|||
27734576|NCT02758301|54182631|FG001|Overall Study|Lost to Follow-up|0|||
27734577|NCT02758301|54182630|FG000|Overall Study|Protocol Violation|0|||
27734578|NCT02758301|54182631|FG001|Overall Study|Protocol Violation|1|||
28093431|NCT00711646|54747621|FG001|Overall Study|Adverse Event|1|||
28093432|NCT00711646|54747620|FG000|Overall Study|Withdrawal by Subject|4|||
28093433|NCT00711646|54747621|FG001|Overall Study|Withdrawal by Subject|0|||
28093434|NCT00711646|54747620|FG000|Overall Study|Protocol Violation|0|||
28168151|NCT02477800|54838700|FG003|Long Term Extension Period|Death|1|||
28093435|NCT00711646|54747621|FG001|Overall Study|Protocol Violation|1|||
28093436|NCT00711646|54747620|FG000|Overall Study|Lost to Follow-up|1|||
28093437|NCT00711646|54747621|FG001|Overall Study|Lost to Follow-up|0|||
28093438|NCT00711646|54747620|FG000|Overall Study|administrative decision|0|||
28093439|NCT00711646|54747621|FG001|Overall Study|administrative decision|1|||
28168152|NCT02477800|54838701|FG004|Long Term Extension Period|Death|1|||
28168153|NCT02477800|54838702|FG005|Long Term Extension Period|Death|1|||
28168154|NCT02477800|54838703|FG006|Long Term Extension Period|Death|2|||
28168155|NCT02477800|54838697|FG000|Long Term Extension Period|Consent Withdrawn|0|||
28168156|NCT02477800|54838698|FG001|Long Term Extension Period|Consent Withdrawn|0|||
28168157|NCT02477800|54838699|FG002|Long Term Extension Period|Consent Withdrawn|0|||
28168158|NCT02477800|54838700|FG003|Long Term Extension Period|Consent Withdrawn|10|||
28168159|NCT02477800|54838701|FG004|Long Term Extension Period|Consent Withdrawn|4|||
28168160|NCT02477800|54838702|FG005|Long Term Extension Period|Consent Withdrawn|13|||
27980725|NCT00891020|54638731|FG000|24 Week Treatment Period|Refused treatment/did not cooperate|3|||
27980726|NCT00891020|54638732|FG001|24 Week Treatment Period|Refused treatment/did not cooperate|2|||
27980727|NCT00891020|54638733|FG002|24 Week Treatment Period|Refused treatment/did not cooperate|1|||
27980728|NCT00891020|54638731|FG000|24 Week Treatment Period|Withdrew consent|6|||
27980729|NCT00891020|54638732|FG001|24 Week Treatment Period|Withdrew consent|3|||
28093440|NCT00711646|54747620|FG000|Overall Study|patient non-compliance|1|||
28093441|NCT00711646|54747621|FG001|Overall Study|patient non-compliance|0|||
28093442|NCT00640133|54747647|FG000|Open Label Phase (Month 4-12)|Lack of Efficacy|1|||
28168161|NCT02477800|54838703|FG006|Long Term Extension Period|Consent Withdrawn|16|||
28168162|NCT02477800|54838697|FG000|Long Term Extension Period|Disease Progression|0|||
28168163|NCT02477800|54838698|FG001|Long Term Extension Period|Disease Progression|0|||
28168164|NCT02477800|54838699|FG002|Long Term Extension Period|Disease Progression|0|||
28168165|NCT02477800|54838700|FG003|Long Term Extension Period|Disease Progression|3|||
28168166|NCT02477800|54838701|FG004|Long Term Extension Period|Disease Progression|1|||
28168167|NCT02477800|54838702|FG005|Long Term Extension Period|Disease Progression|1|||
28168168|NCT02477800|54838703|FG006|Long Term Extension Period|Disease Progression|0|||
28168169|NCT02477800|54838697|FG000|Long Term Extension Period|Investigator Decision|0|||
28168170|NCT02477800|54838698|FG001|Long Term Extension Period|Investigator Decision|0|||
28168171|NCT02477800|54838699|FG002|Long Term Extension Period|Investigator Decision|0|||
28168172|NCT02477800|54838700|FG003|Long Term Extension Period|Investigator Decision|0|||
28168173|NCT02477800|54838701|FG004|Long Term Extension Period|Investigator Decision|0|||
28168174|NCT02477800|54838702|FG005|Long Term Extension Period|Investigator Decision|0|||
28168175|NCT02477800|54838703|FG006|Long Term Extension Period|Investigator Decision|2|||
28168176|NCT02477800|54838697|FG000|Long Term Extension Period|Lost to Follow-up|0|||
28168177|NCT02477800|54838698|FG001|Long Term Extension Period|Lost to Follow-up|0|||
28168178|NCT02477800|54838699|FG002|Long Term Extension Period|Lost to Follow-up|0|||
28168179|NCT02477800|54838700|FG003|Long Term Extension Period|Lost to Follow-up|0|||
28168180|NCT02477800|54838701|FG004|Long Term Extension Period|Lost to Follow-up|1|||
28168181|NCT02477800|54838702|FG005|Long Term Extension Period|Lost to Follow-up|3|||
28168182|NCT02477800|54838703|FG006|Long Term Extension Period|Lost to Follow-up|0|||
28168183|NCT02477800|54838697|FG000|Long Term Extension Period|Site Terminated By Sponsor|0|||
28168184|NCT02477800|54838698|FG001|Long Term Extension Period|Site Terminated By Sponsor|0|||
28168185|NCT02477800|54838699|FG002|Long Term Extension Period|Site Terminated By Sponsor|0|||
28168186|NCT02477800|54838700|FG003|Long Term Extension Period|Site Terminated By Sponsor|0|||
28168187|NCT02477800|54838701|FG004|Long Term Extension Period|Site Terminated By Sponsor|0|||
28168188|NCT02477800|54838702|FG005|Long Term Extension Period|Site Terminated By Sponsor|2|||
27734579|NCT02669667|54182651|FG000|Overall Study|Lost to Follow-up|0|||
27734580|NCT02669667|54182652|FG001|Overall Study|Lost to Follow-up|0|||
27734581|NCT02669667|54182653|FG002|Overall Study|Lost to Follow-up|0|||
27734582|NCT02669667|54182654|FG003|Overall Study|Lost to Follow-up|0|||
27833215|NCT01748825|54314627|FG006|Dose Expansion|Physician Decision|0|||
27833216|NCT01748825|54314628|FG007|Dose Expansion|Physician Decision|0|||
28093443|NCT00640133|54747648|FG001|Open Label Phase (Month 4-12)|Lack of Efficacy|0|||
28093444|NCT00640133|54747647|FG000|Open Label Phase (Month 4-12)|Withdrawal by Subject|1|||
28093445|NCT00640133|54747648|FG001|Open Label Phase (Month 4-12)|Withdrawal by Subject|0|||
28093446|NCT00640133|54747647|FG000|Open Label Phase (Month 4-12)|Adverse Event|1|||
28093447|NCT00640133|54747648|FG001|Open Label Phase (Month 4-12)|Adverse Event|0|||
28093448|NCT00379340|54747675|FG000|Overall Study|Death|0|||
28093449|NCT00379340|54747676|FG001|Overall Study|Death|0|||
28093450|NCT00379340|54747677|FG002|Overall Study|Death|0|||
28093451|NCT00379340|54747678|FG003|Overall Study|Death|2|||
28093452|NCT00379340|54747679|FG004|Overall Study|Death|0|||
27734583|NCT02669667|54182655|FG004|Overall Study|Lost to Follow-up|0|||
27833217|NCT01748825|54314629|FG008|Dose Expansion|Physician Decision|1|||
27833218|NCT01748825|54314630|FG009|Dose Expansion|Physician Decision|0|||
28168189|NCT02477800|54838703|FG006|Long Term Extension Period|Site Terminated By Sponsor|1|||
28168190|NCT02477800|54838697|FG000|Long Term Extension Period|Study Visit Burden|0|||
28168191|NCT02477800|54838698|FG001|Long Term Extension Period|Study Visit Burden|0|||
28093453|NCT00379340|54747675|FG000|Overall Study|Lack of Efficacy|6|||
28093454|NCT00379340|54747676|FG001|Overall Study|Lack of Efficacy|1|||
28093455|NCT00379340|54747677|FG002|Overall Study|Lack of Efficacy|0|||
28093456|NCT00379340|54747678|FG003|Overall Study|Lack of Efficacy|4|||
28093457|NCT00379340|54747679|FG004|Overall Study|Lack of Efficacy|3|||
28093458|NCT00379340|54747675|FG000|Overall Study|Physician Decision|6|||
28093459|NCT00379340|54747676|FG001|Overall Study|Physician Decision|2|||
28093460|NCT00379340|54747677|FG002|Overall Study|Physician Decision|1|||
28093461|NCT00379340|54747678|FG003|Overall Study|Physician Decision|2|||
28093462|NCT00379340|54747679|FG004|Overall Study|Physician Decision|3|||
28093463|NCT00379340|54747675|FG000|Overall Study|Withdrawal by Subject|0|||
28093464|NCT00379340|54747676|FG001|Overall Study|Withdrawal by Subject|0|||
28093465|NCT00379340|54747677|FG002|Overall Study|Withdrawal by Subject|0|||
28093466|NCT00379340|54747678|FG003|Overall Study|Withdrawal by Subject|1|||
28093467|NCT00379340|54747679|FG004|Overall Study|Withdrawal by Subject|0|||
28093468|NCT00379340|54747675|FG000|Overall Study|Refusal of further protocol therapy|1|||
28093469|NCT00379340|54747676|FG001|Overall Study|Refusal of further protocol therapy|0|||
28093470|NCT00379340|54747677|FG002|Overall Study|Refusal of further protocol therapy|1|||
28093471|NCT00379340|54747678|FG003|Overall Study|Refusal of further protocol therapy|1|||
28093472|NCT00379340|54747679|FG004|Overall Study|Refusal of further protocol therapy|7|||
28093473|NCT00379340|54747675|FG000|Overall Study|On more than 1 tumor therapeutic study|0|||
28093474|NCT00379340|54747676|FG001|Overall Study|On more than 1 tumor therapeutic study|0|||
28093475|NCT00379340|54747677|FG002|Overall Study|On more than 1 tumor therapeutic study|0|||
28093476|NCT00379340|54747678|FG003|Overall Study|On more than 1 tumor therapeutic study|2|||
28093477|NCT00379340|54747679|FG004|Overall Study|On more than 1 tumor therapeutic study|0|||
28093478|NCT00379340|54747675|FG000|Overall Study|Delayed nephrectomy and anaplasia|0|||
28093479|NCT00379340|54747676|FG001|Overall Study|Delayed nephrectomy and anaplasia|0|||
28093480|NCT00379340|54747677|FG002|Overall Study|Delayed nephrectomy and anaplasia|0|||
28093481|NCT00379340|54747678|FG003|Overall Study|Delayed nephrectomy and anaplasia|1|||
28093482|NCT00379340|54747679|FG004|Overall Study|Delayed nephrectomy and anaplasia|1|||
28093483|NCT00301808|54747692|FG000|Overall Study|Adverse Event|5|||
28093484|NCT00301808|54747692|FG000|Overall Study|Death|3|||
28093485|NCT00301808|54747692|FG000|Overall Study|Lack of Efficacy|4|||
28093486|NCT04979858|54747720|FG000|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|1|||
28168192|NCT02477800|54838699|FG002|Long Term Extension Period|Study Visit Burden|0|||
27734584|NCT02669667|54182656|FG005|Overall Study|Lost to Follow-up|1|||
27734585|NCT02669667|54182657|FG006|Overall Study|Lost to Follow-up|0|||
27734586|NCT02669433|54182682|FG000|Overall Study|Protocol Violation|0|||
27734587|NCT02669433|54182683|FG001|Overall Study|Protocol Violation|4|||
27734588|NCT02669433|54182684|FG002|Overall Study|Protocol Violation|1|||
27734589|NCT02669433|54182682|FG000|Overall Study|Disease Progression|1|||
27734590|NCT02669433|54182683|FG001|Overall Study|Disease Progression|0|||
27734591|NCT02669433|54182684|FG002|Overall Study|Disease Progression|0|||
27734592|NCT02669433|54182682|FG000|Overall Study|Physician Decision|1|||
27734593|NCT02669433|54182683|FG001|Overall Study|Physician Decision|1|||
27734594|NCT02669433|54182684|FG002|Overall Study|Physician Decision|0|||
27734595|NCT02669433|54182682|FG000|Overall Study|Adverse Event|6|||
27734596|NCT02669433|54182683|FG001|Overall Study|Adverse Event|7|||
27734597|NCT02669433|54182684|FG002|Overall Study|Adverse Event|10|||
27734598|NCT02669433|54182682|FG000|Overall Study|Sponsor Termination|1|||
27734599|NCT02669433|54182683|FG001|Overall Study|Sponsor Termination|0|||
27734600|NCT02669433|54182684|FG002|Overall Study|Sponsor Termination|1|||
27734601|NCT02669433|54182682|FG000|Overall Study|Withdrawal by Subject|5|||
27734602|NCT02669433|54182683|FG001|Overall Study|Withdrawal by Subject|1|||
27734603|NCT02669433|54182684|FG002|Overall Study|Withdrawal by Subject|0|||
27734604|NCT02669433|54182682|FG000|Overall Study|Withdrawal by Caregiver|1|||
27734605|NCT02669433|54182683|FG001|Overall Study|Withdrawal by Caregiver|0|||
27734606|NCT02669433|54182684|FG002|Overall Study|Withdrawal by Caregiver|2|||
28168193|NCT02477800|54838700|FG003|Long Term Extension Period|Study Visit Burden|3|||
28168194|NCT02477800|54838701|FG004|Long Term Extension Period|Study Visit Burden|0|||
28168195|NCT02477800|54838702|FG005|Long Term Extension Period|Study Visit Burden|2|||
28168196|NCT02477800|54838703|FG006|Long Term Extension Period|Study Visit Burden|2|||
28168197|NCT02477800|54838697|FG000|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
28168198|NCT02477800|54838698|FG001|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
28168199|NCT02477800|54838699|FG002|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
27734607|NCT02669433|54182682|FG000|Overall Study|Death|0|||
27734608|NCT02669433|54182683|FG001|Overall Study|Death|1|||
28093487|NCT04979858|54747721|FG001|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|0|||
28093488|NCT04030598|54747769|FG000|Overall Study|Voluntary Withdrawal|0|||
28093489|NCT04030598|54747770|FG001|Overall Study|Voluntary Withdrawal|1|||
27734609|NCT02669433|54182684|FG002|Overall Study|Death|1|||
27734610|NCT02756819|54182692|FG000|Overall Study|Lost for observation|23|||
27734611|NCT02756819|54182692|FG000|Overall Study|Patient's unwillingness|16|||
27734612|NCT02756819|54182692|FG000|Overall Study|Insufficient efficacy|2|||
27734613|NCT02756819|54182692|FG000|Overall Study|Adverse Event|2|||
28093490|NCT04030598|54747771|FG002|Overall Study|Voluntary Withdrawal|0|||
28093491|NCT03830164|54747791|FG000|Overall Study|Adverse Event|0|||
28093492|NCT03830164|54747792|FG001|Overall Study|Adverse Event|2|||
28093493|NCT03830164|54747793|FG002|Overall Study|Adverse Event|0|||
28093494|NCT03830164|54747791|FG000|Overall Study|Lack of Efficacy|1|||
28093495|NCT03830164|54747792|FG001|Overall Study|Lack of Efficacy|5|||
28168200|NCT02477800|54838700|FG003|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
27734614|NCT02756819|54182692|FG000|Overall Study|Reason not Specified|9|||
27734615|NCT00829309|54182698|FG000|Washout: 7 Days|Protocol Violation|1|||
27734616|NCT00829309|54182699|FG001|Washout: 7 Days|Protocol Violation|0|||
27734617|NCT02669121|54182705|FG000|Overall Study|Adverse Event|4|||
27734618|NCT02669121|54182706|FG001|Overall Study|Adverse Event|5|||
27734619|NCT02669121|54182705|FG000|Overall Study|Lost to Follow-up|15|||
27734620|NCT02669121|54182706|FG001|Overall Study|Lost to Follow-up|27|||
27734621|NCT02669121|54182705|FG000|Overall Study|Withdrawal by Subject|132|||
27734622|NCT02669121|54182706|FG001|Overall Study|Withdrawal by Subject|140|||
27734623|NCT02669121|54182705|FG000|Overall Study|Pregnancy|0|||
27734624|NCT02669121|54182706|FG001|Overall Study|Pregnancy|1|||
27734625|NCT02669121|54182705|FG000|Overall Study|Discharged from US Military Active Service|117|||
27734626|NCT02669121|54182706|FG001|Overall Study|Discharged from US Military Active Service|91|||
27734627|NCT02669121|54182705|FG000|Overall Study|Reason not Specified|22|||
27734628|NCT02669121|54182706|FG001|Overall Study|Reason not Specified|18|||
27734629|NCT02743117|54182714|FG000|Overall Study|Lost to Follow-up|0|||
27734630|NCT02743117|54182715|FG001|Overall Study|Lost to Follow-up|1|||
27734631|NCT02743117|54182714|FG000|Overall Study|Other|1|||
27734632|NCT02743117|54182715|FG001|Overall Study|Other|0|||
27734633|NCT02669043|54182730|FG000|Overall Study|Didn't meet I/E criteria|4|||
27734634|NCT02760407|54182738|FG000|Overall Study|Death|2|||
27734635|NCT02760407|54182739|FG001|Overall Study|Death|3|||
27734636|NCT02760407|54182740|FG002|Overall Study|Death|1|||
27734637|NCT02760407|54182741|FG003|Overall Study|Death|1|||
27734638|NCT02760407|54182738|FG000|Overall Study|Lost to Follow-up|1|||
27734639|NCT02760407|54182739|FG001|Overall Study|Lost to Follow-up|7|||
27734640|NCT02760407|54182740|FG002|Overall Study|Lost to Follow-up|4|||
27734641|NCT02760407|54182741|FG003|Overall Study|Lost to Follow-up|6|||
27734642|NCT02760407|54182738|FG000|Overall Study|Withdrawal by Subject|25|||
27734643|NCT02760407|54182739|FG001|Overall Study|Withdrawal by Subject|31|||
27734644|NCT02760407|54182740|FG002|Overall Study|Withdrawal by Subject|37|||
27734645|NCT02760407|54182741|FG003|Overall Study|Withdrawal by Subject|25|||
27734646|NCT02760407|54182738|FG000|Overall Study|Violation of Eligibility criteria|0|||
27734647|NCT02760407|54182739|FG001|Overall Study|Violation of Eligibility criteria|0|||
27734648|NCT02760407|54182740|FG002|Overall Study|Violation of Eligibility criteria|1|||
27734649|NCT02760407|54182741|FG003|Overall Study|Violation of Eligibility criteria|1|||
27734650|NCT02760407|54182738|FG000|Overall Study|Personal reasons|0|||
27734651|NCT02760407|54182739|FG001|Overall Study|Personal reasons|0|||
27734652|NCT02760407|54182740|FG002|Overall Study|Personal reasons|0|||
27734653|NCT02760407|54182741|FG003|Overall Study|Personal reasons|1|||
27734654|NCT02760407|54182738|FG000|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|1|||
27734655|NCT02760407|54182739|FG001|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
27734656|NCT02760407|54182740|FG002|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
27734657|NCT02760407|54182741|FG003|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
27734658|NCT02760407|54182738|FG000|Overall Study|Use of prohibited Medication|0|||
27734659|NCT02760407|54182739|FG001|Overall Study|Use of prohibited Medication|0|||
27734660|NCT02760407|54182740|FG002|Overall Study|Use of prohibited Medication|1|||
27734661|NCT02760407|54182741|FG003|Overall Study|Use of prohibited Medication|0|||
28093496|NCT03830164|54747793|FG002|Overall Study|Lack of Efficacy|0|||
28093497|NCT03830164|54747791|FG000|Overall Study|Lost to Follow-up|0|||
28093498|NCT03830164|54747792|FG001|Overall Study|Lost to Follow-up|1|||
28093499|NCT03830164|54747793|FG002|Overall Study|Lost to Follow-up|0|||
28093500|NCT03830164|54747791|FG000|Overall Study|Withdrawal by Subject|1|||
28093501|NCT03830164|54747792|FG001|Overall Study|Withdrawal by Subject|0|||
28093502|NCT03830164|54747793|FG002|Overall Study|Withdrawal by Subject|0|||
28093503|NCT03777436|54747803|FG000|Placebo-controlled Phase|Adverse Event|8|||
28093504|NCT03777436|54747804|FG001|Placebo-controlled Phase|Adverse Event|10|||
28093505|NCT03777436|54747805|FG002|Placebo-controlled Phase|Adverse Event|0|||
28093506|NCT03777436|54747803|FG000|Placebo-controlled Phase|Lack of Efficacy|0|||
28093507|NCT03777436|54747804|FG001|Placebo-controlled Phase|Lack of Efficacy|1|||
28093508|NCT03777436|54747805|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
28093509|NCT03777436|54747803|FG000|Placebo-controlled Phase|Withdrawal by Subject|19|||
27734662|NCT02760407|54182738|FG000|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
27734663|NCT02760407|54182739|FG001|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
27734664|NCT02760407|54182740|FG002|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|1|||
27734665|NCT02760407|54182741|FG003|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
28168201|NCT02477800|54838701|FG004|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
28168202|NCT02477800|54838702|FG005|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
28168203|NCT02477800|54838703|FG006|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
28168204|NCT02477800|54838697|FG000|Long Term Extension Period|Reason not Specified|0|||
28168205|NCT02477800|54838698|FG001|Long Term Extension Period|Reason not Specified|0|||
28168206|NCT02477800|54838699|FG002|Long Term Extension Period|Reason not Specified|0|||
28168207|NCT02477800|54838700|FG003|Long Term Extension Period|Reason not Specified|126|||
28168208|NCT02477800|54838701|FG004|Long Term Extension Period|Reason not Specified|140|||
28168209|NCT02477800|54838702|FG005|Long Term Extension Period|Reason not Specified|270|||
28168210|NCT02477800|54838703|FG006|Long Term Extension Period|Reason not Specified|224|||
28168211|NCT02957747|54838717|FG000|Overall Study|Withdrawal by Subject|0|||
28168212|NCT02957747|54838718|FG001|Overall Study|Withdrawal by Subject|3|||
28168213|NCT02957747|54838717|FG000|Overall Study|Lost to Follow-up|10|||
27734666|NCT02760407|54182738|FG000|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|1|||
27734667|NCT02760407|54182739|FG001|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
27734668|NCT02760407|54182740|FG002|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
27734669|NCT02760407|54182741|FG003|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
27734670|NCT02760407|54182738|FG000|Overall Study|Investigator's Decision (Adverse Event)|0|||
27734671|NCT02760407|54182739|FG001|Overall Study|Investigator's Decision (Adverse Event)|1|||
27734672|NCT02760407|54182740|FG002|Overall Study|Investigator's Decision (Adverse Event)|0|||
27734673|NCT02760407|54182741|FG003|Overall Study|Investigator's Decision (Adverse Event)|0|||
27734674|NCT02760407|54182738|FG000|Overall Study|Inadequately Enrolled|0|||
27734675|NCT02760407|54182739|FG001|Overall Study|Inadequately Enrolled|0|||
27734676|NCT02760407|54182740|FG002|Overall Study|Inadequately Enrolled|0|||
27734677|NCT02760407|54182741|FG003|Overall Study|Inadequately Enrolled|1|||
27734678|NCT02760407|54182738|FG000|Overall Study|Withdrawal By PI's Decision|0|||
27734679|NCT02760407|54182739|FG001|Overall Study|Withdrawal By PI's Decision|1|||
27734680|NCT02760407|54182740|FG002|Overall Study|Withdrawal By PI's Decision|0|||
27734681|NCT02760407|54182741|FG003|Overall Study|Withdrawal By PI's Decision|0|||
27734682|NCT02760407|54182738|FG000|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
27734683|NCT02760407|54182739|FG001|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
27734684|NCT02760407|54182740|FG002|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
27734685|NCT02760407|54182741|FG003|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
27734686|NCT02760407|54182738|FG000|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
27734687|NCT02760407|54182739|FG001|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
27734688|NCT02760407|54182740|FG002|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|1|||
27734689|NCT02760407|54182741|FG003|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
27734690|NCT02760407|54182738|FG000|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|1|||
27734691|NCT02760407|54182739|FG001|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
27734692|NCT02760407|54182740|FG002|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
27734693|NCT02760407|54182741|FG003|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
27734694|NCT02760407|54182738|FG000|Overall Study|Study Treatment Was Terminated At The Site|0|||
27734695|NCT02760407|54182739|FG001|Overall Study|Study Treatment Was Terminated At The Site|0|||
27734696|NCT02760407|54182740|FG002|Overall Study|Study Treatment Was Terminated At The Site|1|||
27734697|NCT02760407|54182741|FG003|Overall Study|Study Treatment Was Terminated At The Site|0|||
27734698|NCT02760407|54182738|FG000|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|1|||
27734699|NCT02760407|54182739|FG001|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
27734700|NCT02760407|54182740|FG002|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
27833219|NCT01720667|54314692|FG000|Overall Study|Adverse Event|1|||
27833220|NCT01720667|54314693|FG001|Overall Study|Adverse Event|1|||
28093510|NCT03777436|54747804|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
28093511|NCT03777436|54747805|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
28093512|NCT03777436|54747803|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
28093513|NCT03777436|54747804|FG001|Placebo-controlled Phase|Non-compliance with study drug|2|||
28093514|NCT03777436|54747805|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
28093515|NCT03777436|54747803|FG000|Placebo-controlled Phase|Lost to Follow-up|7|||
28093516|NCT03777436|54747804|FG001|Placebo-controlled Phase|Lost to Follow-up|7|||
28093517|NCT03777436|54747805|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
28093518|NCT03777436|54747803|FG000|Placebo-controlled Phase|Physician Decision|0|||
28093519|NCT03777436|54747804|FG001|Placebo-controlled Phase|Physician Decision|1|||
28093520|NCT03777436|54747805|FG002|Placebo-controlled Phase|Physician Decision|0|||
28168214|NCT02957747|54838718|FG001|Overall Study|Lost to Follow-up|5|||
28168215|NCT01344161|54838727|FG000|Overall Study|Lost to Follow-up|4|||
28168216|NCT01344161|54838728|FG001|Overall Study|Lost to Follow-up|1|||
28168217|NCT01344161|54838727|FG000|Overall Study|Pregnancy|0|||
28168218|NCT01344161|54838728|FG001|Overall Study|Pregnancy|1|||
28168219|NCT01344161|54838727|FG000|Overall Study|Protocol Violation|1|||
28168220|NCT01344161|54838728|FG001|Overall Study|Protocol Violation|1|||
28168221|NCT02451358|54838738|FG000|Overall Study|Withdrawal by Subject|1|||
28168222|NCT02451358|54838739|FG001|Overall Study|Withdrawal by Subject|1|||
28168223|NCT02451358|54838740|FG002|Overall Study|Withdrawal by Subject|0|||
27980730|NCT00891020|54638733|FG002|24 Week Treatment Period|Withdrew consent|15|||
27980731|NCT00891020|54638731|FG000|24 Week Treatment Period|Administrative/Other|5|||
27980732|NCT00891020|54638732|FG001|24 Week Treatment Period|Administrative/Other|6|||
27980733|NCT00891020|54638733|FG002|24 Week Treatment Period|Administrative/Other|1|||
27980734|NCT00891020|54638731|FG000|Long-term Extension Period|Adverse Event|1|||
27980735|NCT00891020|54638732|FG001|Long-term Extension Period|Adverse Event|11|||
27980736|NCT00891020|54638733|FG002|Long-term Extension Period|Adverse Event|10|||
27980737|NCT00891020|54638731|FG000|Long-term Extension Period|Death|0|||
27980738|NCT00891020|54638732|FG001|Long-term Extension Period|Death|0|||
27980739|NCT00891020|54638733|FG002|Long-term Extension Period|Death|1|||
27980740|NCT00891020|54638731|FG000|Long-term Extension Period|Insufficient therapeutic response|3|||
28093521|NCT03777436|54747803|FG000|Placebo-controlled Phase|Due to COVID-19 control measures|1|||
28093522|NCT03777436|54747804|FG001|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
28093523|NCT03777436|54747805|FG002|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
28093524|NCT03777436|54747803|FG000|Apremilast Extension Phase|Adverse Event|0|||
28093525|NCT03777436|54747804|FG001|Apremilast Extension Phase|Adverse Event|0|||
28093526|NCT03777436|54747805|FG002|Apremilast Extension Phase|Adverse Event|6|||
28093527|NCT03777436|54747803|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
28093528|NCT03777436|54747804|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
28093529|NCT03777436|54747805|FG002|Apremilast Extension Phase|Lack of Efficacy|1|||
28093530|NCT03777436|54747803|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
28093531|NCT03777436|54747804|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
28093532|NCT03777436|54747805|FG002|Apremilast Extension Phase|Withdrawal by Subject|13|||
28093533|NCT03777436|54747803|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
28093534|NCT03777436|54747804|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
28093535|NCT03777436|54747805|FG002|Apremilast Extension Phase|Lost to Follow-up|7|||
28093536|NCT03777436|54747803|FG000|Apremilast Extension Phase|Miscellaneous|0|||
28093537|NCT03777436|54747804|FG001|Apremilast Extension Phase|Miscellaneous|0|||
28093538|NCT03777436|54747805|FG002|Apremilast Extension Phase|Miscellaneous|1|||
28093539|NCT03156023|54747821|FG000|Overall Study|Withdrawal by Subject|1|||
28093540|NCT03156023|54747822|FG001|Overall Study|Withdrawal by Subject|0|||
28093541|NCT03156023|54747823|FG002|Overall Study|Withdrawal by Subject|2|||
28093542|NCT03156023|54747824|FG003|Overall Study|Withdrawal by Subject|1|||
28093543|NCT03156023|54747825|FG004|Overall Study|Withdrawal by Subject|1|||
28093544|NCT03156023|54747821|FG000|Overall Study|Lost to Follow-up|0|||
28093545|NCT03156023|54747822|FG001|Overall Study|Lost to Follow-up|0|||
28093546|NCT03156023|54747823|FG002|Overall Study|Lost to Follow-up|0|||
28093547|NCT03156023|54747824|FG003|Overall Study|Lost to Follow-up|0|||
28093548|NCT03156023|54747825|FG004|Overall Study|Lost to Follow-up|1|||
28093549|NCT03025880|54747843|FG000|Overall Study|Adverse Event|1|||
28093550|NCT03025880|54747844|FG001|Overall Study|Adverse Event|0|||
28093551|NCT03025880|54747843|FG000|Overall Study|Death|1|||
28093552|NCT03025880|54747844|FG001|Overall Study|Death|1|||
28093553|NCT03025880|54747843|FG000|Overall Study|Withdrawal by Subject|0|||
28093554|NCT03025880|54747844|FG001|Overall Study|Withdrawal by Subject|1|||
28093555|NCT03025880|54747843|FG000|Overall Study|Physician Decision|0|||
28093556|NCT03025880|54747844|FG001|Overall Study|Physician Decision|1|||
28093557|NCT03025880|54747843|FG000|Overall Study|Progressive Disease|12|||
28093558|NCT03025880|54747844|FG001|Overall Study|Progressive Disease|19|||
28093559|NCT02027376|54747861|FG000|Overall Study|Death|1|||
28093560|NCT02027376|54747862|FG001|Overall Study|Death|0|||
28093561|NCT02027376|54747863|FG002|Overall Study|Death|0|||
28093562|NCT01924533|54747875|FG000|Overall Study|Death|181|||
28093563|NCT01924533|54747876|FG001|Overall Study|Death|200|||
28093564|NCT01924533|54747875|FG000|Overall Study|Lost to Follow-up|0|||
28093565|NCT01924533|54747876|FG001|Overall Study|Lost to Follow-up|1|||
28168224|NCT02451358|54838741|FG003|Overall Study|Withdrawal by Subject|0|||
28168225|NCT02451358|54838738|FG000|Overall Study|Protocol Violation|0|||
28168226|NCT02451358|54838739|FG001|Overall Study|Protocol Violation|1|||
28093566|NCT01924533|54747875|FG000|Overall Study|Withdrawal by Subject|7|||
28093567|NCT01924533|54747876|FG001|Overall Study|Withdrawal by Subject|3|||
28093568|NCT01924533|54747875|FG000|Overall Study|Other Eligibility criteria|1|||
28093569|NCT01924533|54747876|FG001|Overall Study|Other Eligibility criteria|1|||
28093570|NCT01606436|54747882|FG000|Overall Study|Withdrawal by Subject|0|||
28168227|NCT02451358|54838740|FG002|Overall Study|Protocol Violation|1|||
28168228|NCT02451358|54838741|FG003|Overall Study|Protocol Violation|0|||
27980741|NCT00891020|54638732|FG001|Long-term Extension Period|Insufficient therapeutic response|2|||
28168229|NCT02749721|54838751|FG000|Screening|Withdrawal by Subject|1|||
28168230|NCT02749721|54838751|FG000|Screening|Lost to Follow-up|2|||
28168231|NCT02749721|54838751|FG000|Screening|Protocol Violation|3|||
28168232|NCT02749721|54838751|FG000|8-week Open-Label Treatment Phase|Lost to Follow-up|2|||
28168233|NCT02749721|54838751|FG000|8-week Open-Label Treatment Phase|Withdrawal by Subject|1|||
28168234|NCT01348139|54838757|FG000|Period 1|Adverse Event|1|||
28168235|NCT01348139|54838758|FG001|Period 1|Adverse Event|0|||
28168236|NCT01348139|54838759|FG002|Period 1|Adverse Event|0|||
28168237|NCT01348139|54838760|FG003|Period 1|Adverse Event|0|||
28093571|NCT01606436|54747883|FG001|Overall Study|Withdrawal by Subject|0|||
28093572|NCT01606436|54747884|FG002|Overall Study|Withdrawal by Subject|1|||
28093573|NCT01606436|54747885|FG003|Overall Study|Withdrawal by Subject|1|||
28093574|NCT01606436|54747886|FG004|Overall Study|Withdrawal by Subject|1|||
28093575|NCT01606436|54747887|FG005|Overall Study|Withdrawal by Subject|0|||
28093576|NCT01606436|54747882|FG000|Overall Study|Adverse Event|0|||
28093577|NCT01606436|54747883|FG001|Overall Study|Adverse Event|0|||
28093578|NCT01606436|54747884|FG002|Overall Study|Adverse Event|1|||
28093579|NCT01606436|54747885|FG003|Overall Study|Adverse Event|0|||
28093580|NCT01606436|54747886|FG004|Overall Study|Adverse Event|0|||
28093581|NCT01606436|54747887|FG005|Overall Study|Adverse Event|0|||
28093582|NCT01606436|54747882|FG000|Overall Study|Sponsor Decision|0|||
28093583|NCT01606436|54747883|FG001|Overall Study|Sponsor Decision|0|||
28093584|NCT01606436|54747884|FG002|Overall Study|Sponsor Decision|0|||
28093585|NCT01606436|54747885|FG003|Overall Study|Sponsor Decision|1|||
28093586|NCT01606436|54747886|FG004|Overall Study|Sponsor Decision|0|||
28093587|NCT01606436|54747887|FG005|Overall Study|Sponsor Decision|0|||
28168238|NCT01348139|54838761|FG004|Period 1|Adverse Event|0|||
28168239|NCT01348139|54838762|FG005|Period 1|Adverse Event|0|||
28168240|NCT02868229|54838780|FG000|Overall Study|Adverse Event|1|||
28168241|NCT02868229|54838781|FG001|Overall Study|Adverse Event|0|||
28168242|NCT02868229|54838782|FG002|Overall Study|Adverse Event|0|||
28168243|NCT02868229|54838783|FG003|Overall Study|Adverse Event|1|||
28168244|NCT02868229|54838780|FG000|Overall Study|Death|0|||
28168245|NCT02868229|54838781|FG001|Overall Study|Death|0|||
28168246|NCT02868229|54838782|FG002|Overall Study|Death|1|||
28168247|NCT02868229|54838783|FG003|Overall Study|Death|1|||
28168248|NCT02868229|54838780|FG000|Overall Study|Missed dose|0|||
28168249|NCT02868229|54838781|FG001|Overall Study|Missed dose|0|||
28168250|NCT02868229|54838782|FG002|Overall Study|Missed dose|0|||
28168251|NCT02868229|54838783|FG003|Overall Study|Missed dose|3|||
28168252|NCT02956967|54838798|FG000|Overall Study|Adverse Event|3|||
28168253|NCT02956967|54838798|FG000|Overall Study|Reason non-related to neutropenia|10|||
28168254|NCT02956967|54838798|FG000|Overall Study|Lost to Follow-up|5|||
28168255|NCT02956967|54838798|FG000|Overall Study|Missing|1|||
28168256|NCT02956967|54838798|FG000|Overall Study|Termination of Nivestim administration|29|||
28168257|NCT02867995|54838822|FG000|Overall Study|Withdrawal by Subject|0|||
27734701|NCT02760407|54182741|FG003|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
27734702|NCT02760407|54182738|FG000|Overall Study|Inadequately enrolled patient refused to Follow-Up|1|||
27734703|NCT02760407|54182739|FG001|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
27734704|NCT02760407|54182740|FG002|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
27734705|NCT02760407|54182741|FG003|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
27734706|NCT02760407|54182738|FG000|Overall Study|Lack Of Efficacy Per PI|0|||
27734707|NCT02760407|54182739|FG001|Overall Study|Lack Of Efficacy Per PI|0|||
27734708|NCT02760407|54182740|FG002|Overall Study|Lack Of Efficacy Per PI|0|||
27734709|NCT02760407|54182741|FG003|Overall Study|Lack Of Efficacy Per PI|1|||
27734710|NCT02760407|54182738|FG000|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|1|||
27734711|NCT02760407|54182739|FG001|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
27734712|NCT02760407|54182740|FG002|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
27734713|NCT02760407|54182741|FG003|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
27734714|NCT02760407|54182738|FG000|Overall Study|Investigator recorded as Adverse Event|1|||
27734715|NCT02760407|54182739|FG001|Overall Study|Investigator recorded as Adverse Event|0|||
28093588|NCT00219557|54747898|FG000|Phase 1|Lack of Efficacy|3|||
28093589|NCT00219557|54747899|FG001|Phase 1|Lack of Efficacy|0|||
28093590|NCT00219557|54747900|FG002|Phase 1|Lack of Efficacy|0|||
28168258|NCT02867995|54838823|FG001|Overall Study|Withdrawal by Subject|1|||
28168259|NCT02867995|54838822|FG000|Overall Study|Lost to Follow-up|0|||
28093591|NCT00219557|54747898|FG000|Phase 1|Adverse Event|2|||
28093592|NCT00219557|54747899|FG001|Phase 1|Adverse Event|0|||
28093593|NCT00219557|54747900|FG002|Phase 1|Adverse Event|0|||
28093594|NCT00219557|54747898|FG000|Phase 1|Withdrawal by Subject|1|||
28093595|NCT00219557|54747899|FG001|Phase 1|Withdrawal by Subject|0|||
28168260|NCT02867995|54838823|FG001|Overall Study|Lost to Follow-up|2|||
28168261|NCT03392883|54838836|FG000|Overall Study|Lost to Follow-up|122|||
28168262|NCT03392883|54838837|FG001|Overall Study|Lost to Follow-up|13|||
28168263|NCT03392883|54838838|FG002|Overall Study|Lost to Follow-up|9|||
28168264|NCT03392883|54838836|FG000|Overall Study|Death|4|||
28168265|NCT03392883|54838837|FG001|Overall Study|Death|0|||
28093596|NCT00219557|54747900|FG002|Phase 1|Withdrawal by Subject|0|||
28093597|NCT00219557|54747898|FG000|Phase 1|Started chemotherapy at other institute|1|||
28093598|NCT00219557|54747899|FG001|Phase 1|Started chemotherapy at other institute|0|||
28093599|NCT00219557|54747900|FG002|Phase 1|Started chemotherapy at other institute|0|||
28093600|NCT00219557|54747898|FG000|Phase 2|Lack of Efficacy|0|||
28093601|NCT00219557|54747899|FG001|Phase 2|Lack of Efficacy|21|||
28093602|NCT00219557|54747900|FG002|Phase 2|Lack of Efficacy|15|||
28093603|NCT00219557|54747898|FG000|Phase 2|Adverse Event|0|||
28093604|NCT00219557|54747899|FG001|Phase 2|Adverse Event|22|||
28168266|NCT03392883|54838838|FG002|Overall Study|Death|0|||
28168267|NCT03392883|54838836|FG000|Overall Study|Lack of Efficacy|29|||
28168268|NCT03392883|54838837|FG001|Overall Study|Lack of Efficacy|0|||
28168269|NCT03392883|54838838|FG002|Overall Study|Lack of Efficacy|0|||
28093605|NCT00219557|54747900|FG002|Phase 2|Adverse Event|2|||
28093606|NCT00219557|54747898|FG000|Phase 2|Death|0|||
28093607|NCT00219557|54747899|FG001|Phase 2|Death|8|||
28093608|NCT00219557|54747900|FG002|Phase 2|Death|2|||
28093609|NCT00219557|54747898|FG000|Phase 2|Other|0|||
28093610|NCT00219557|54747899|FG001|Phase 2|Other|8|||
28093611|NCT00219557|54747900|FG002|Phase 2|Other|6|||
28093612|NCT00219557|54747898|FG000|Phase 2|Withdrawal by Subject|0|||
28093613|NCT00219557|54747899|FG001|Phase 2|Withdrawal by Subject|9|||
28093614|NCT00219557|54747900|FG002|Phase 2|Withdrawal by Subject|5|||
28168270|NCT03392883|54838836|FG000|Overall Study|Withdrawal by Subject|180|||
28168271|NCT03392883|54838837|FG001|Overall Study|Withdrawal by Subject|0|||
28168272|NCT03392883|54838838|FG002|Overall Study|Withdrawal by Subject|0|||
28168273|NCT03392883|54838836|FG000|Overall Study|Adverse Event|1|||
28168274|NCT03392883|54838837|FG001|Overall Study|Adverse Event|0|||
28168275|NCT03392883|54838838|FG002|Overall Study|Adverse Event|0|||
28093615|NCT00219557|54747898|FG000|Phase 2|Treatment not received|0|||
28093616|NCT00219557|54747899|FG001|Phase 2|Treatment not received|1|||
28093617|NCT00219557|54747900|FG002|Phase 2|Treatment not received|3|||
28093618|NCT00251927|54747915|FG000|Overall Study|Adverse Event|3|||
28093619|NCT00251927|54747916|FG001|Overall Study|Adverse Event|15|||
28093620|NCT00251927|54747915|FG000|Overall Study|Lack of Efficacy|22|||
28168276|NCT02748863|54838849|FG000|Treatment Period 1|Adverse Event|0|||
28168277|NCT02748863|54838850|FG001|Treatment Period 1|Adverse Event|1|||
28168278|NCT02748863|54838851|FG002|Treatment Period 1|Adverse Event|0|||
28168279|NCT02748863|54838852|FG003|Treatment Period 1|Adverse Event|0|||
27734716|NCT02760407|54182740|FG002|Overall Study|Investigator recorded as Adverse Event|2|||
27734717|NCT02760407|54182741|FG003|Overall Study|Investigator recorded as Adverse Event|0|||
27734718|NCT00805129|54182752|FG000|Overall Study|Not treated|1|||
27734719|NCT02668185|54182756|FG000|First Intervention (4 Weeks)|Physician Decision|2|||
27734720|NCT02668185|54182757|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
27734721|NCT02668185|54182756|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
27734722|NCT02668185|54182757|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
27734723|NCT02668185|54182756|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
27734724|NCT02668185|54182757|FG001|Washout Period (2 Weeks)|Physician Decision|2|||
27734725|NCT02668185|54182756|FG000|Second Intervention (4 Weeks)|Physician Decision|1|||
27734726|NCT02668185|54182757|FG001|Second Intervention (4 Weeks)|Physician Decision|3|||
27734727|NCT02742181|54182768|FG000|Overall Study|Physician Decision|1|||
27734728|NCT02742181|54182769|FG001|Overall Study|Physician Decision|0|||
27734729|NCT02742103|54182777|FG000|Overall Study|Protocol Violation|1|||
27734730|NCT02742103|54182778|FG001|Overall Study|Protocol Violation|0|||
27734731|NCT02742103|54182777|FG000|Overall Study|Death|2|||
27734732|NCT02742103|54182778|FG001|Overall Study|Death|2|||
27734733|NCT02742103|54182777|FG000|Overall Study|Adverse Event|1|||
27734734|NCT02742103|54182778|FG001|Overall Study|Adverse Event|0|||
27734735|NCT02742103|54182777|FG000|Overall Study|Moved to another town|0|||
27734736|NCT02742103|54182778|FG001|Overall Study|Moved to another town|1|||
27734737|NCT02742103|54182777|FG000|Overall Study|Withdrawal by Subject|5|||
27734738|NCT02742103|54182778|FG001|Overall Study|Withdrawal by Subject|2|||
27734739|NCT02741713|54182786|FG000|Overall Study|Surgery type changed intra-operatively|2|||
27734740|NCT02741713|54182787|FG001|Overall Study|Surgery type changed intra-operatively|1|||
27734741|NCT02663271|54182794|FG000|Overall Study|Withdrawal by Subject|5|||
27734742|NCT02663271|54182794|FG000|Overall Study|Lack of Efficacy|1|||
27734743|NCT02742649|54182801|FG000|Pre-Randomization Washout Period|Washout/Randomization Failure|5|||
27734744|NCT02742649|54182802|FG001|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
28093621|NCT00251927|54747916|FG001|Overall Study|Lack of Efficacy|16|||
28093622|NCT00251927|54747915|FG000|Overall Study|Lost to Follow-up|22|||
28168280|NCT02748863|54838853|FG004|Treatment Period 1|Adverse Event|0|||
28093623|NCT00251927|54747916|FG001|Overall Study|Lost to Follow-up|8|||
28093624|NCT00251927|54747915|FG000|Overall Study|Protocol Violation|1|||
28093625|NCT00251927|54747916|FG001|Overall Study|Protocol Violation|2|||
28093626|NCT00251927|54747915|FG000|Overall Study|Pregnancy|2|||
28093627|NCT00251927|54747916|FG001|Overall Study|Pregnancy|0|||
28168281|NCT02748863|54838849|FG000|Treatment Period 1|Lack of Efficacy|0|||
28168282|NCT02748863|54838850|FG001|Treatment Period 1|Lack of Efficacy|0|||
28168283|NCT02748863|54838851|FG002|Treatment Period 1|Lack of Efficacy|1|||
28093628|NCT00251927|54747915|FG000|Overall Study|Withdrawal by Subject|40|||
28093629|NCT00251927|54747916|FG001|Overall Study|Withdrawal by Subject|25|||
28093630|NCT00251927|54747915|FG000|Overall Study|Study-specific discont. achieved|13|||
28093631|NCT00251927|54747916|FG001|Overall Study|Study-specific discont. achieved|2|||
28093632|NCT00251927|54747915|FG000|Overall Study|Study procedure non-compliance|5|||
28093633|NCT00251927|54747916|FG001|Overall Study|Study procedure non-compliance|6|||
28093634|NCT00165503|54747923|FG000|Overall Study|Death|1|||
28093635|NCT00165503|54747923|FG000|Overall Study|Lost to Follow-up|12|||
28093636|NCT00165503|54747923|FG000|Overall Study|Unresectable|3|||
28168284|NCT02748863|54838852|FG003|Treatment Period 1|Lack of Efficacy|0|||
28168285|NCT02748863|54838853|FG004|Treatment Period 1|Lack of Efficacy|0|||
28168286|NCT02748863|54838849|FG000|Treatment Period 1|Withdrawal by Subject|0|||
28093637|NCT00162773|54747927|FG000|Overall Study|P.I, Left institution. Study terminated|22|||
28093638|NCT00209339|54747931|FG000|At 12 Months Follow-up|Withdrawal by Subject|8|||
28093639|NCT00209339|54747931|FG000|At 12 Months Follow-up|Death|1|||
28093640|NCT00209339|54747931|FG000|At 12 Months Follow-up|No MitraClip Device Implanted|6|||
28093641|NCT00209339|54747931|FG000|At 24 Months Follow-up|Withdrawal by Subject|4|||
28093642|NCT00209339|54747931|FG000|At 24 Months Follow-up|Withdrawal because of other reasons|6|||
28093643|NCT00209339|54747931|FG000|At 24 Months Follow-up|Death|1|||
28093644|NCT00209339|54747931|FG000|At 3 Years Follow-up|Withdrawal by Subject|1|||
28093645|NCT00209339|54747931|FG000|At 4 Years Follow-up|Withdrawal by Subject|4|||
28093646|NCT00209339|54747931|FG000|At 4 Years Follow-up|Death|1|||
28093647|NCT00209339|54747931|FG000|At 5 Years Follow-up|Withdrawal by Subject|2|||
28093648|NCT00209339|54747931|FG000|At 5 Years Follow-up|Withdrawal because of other reasons|5|||
28093649|NCT00209339|54747931|FG000|At 5 Years Follow-up|Death|1|||
28093650|NCT03823391|54747937|FG000|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
28093651|NCT03823391|54747938|FG001|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
28093652|NCT03823391|54747937|FG000|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|1|||
28093653|NCT03823391|54747938|FG001|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|0|||
28093654|NCT00161213|54747946|FG000|Overall Study|Withdrawal by Subject|1|||
28093655|NCT00161213|54747946|FG000|Overall Study|Evaluable for toxicity but not response|1|||
28093656|NCT00209027|54747952|FG000|Overall Study|study terminated|10|||
28093657|NCT00209027|54747953|FG001|Overall Study|study terminated|0|||
28093658|NCT00208325|54747963|FG000|Overall Study|Death|18|||
28168287|NCT02748863|54838850|FG001|Treatment Period 1|Withdrawal by Subject|1|||
28168288|NCT02748863|54838851|FG002|Treatment Period 1|Withdrawal by Subject|1|||
28168289|NCT02748863|54838852|FG003|Treatment Period 1|Withdrawal by Subject|0|||
28168290|NCT02748863|54838853|FG004|Treatment Period 1|Withdrawal by Subject|0|||
28168291|NCT02748863|54838849|FG000|Treatment Period 2|Lost to Follow-up|2|||
28168292|NCT02748863|54838850|FG001|Treatment Period 2|Lost to Follow-up|0|||
28168293|NCT02748863|54838851|FG002|Treatment Period 2|Lost to Follow-up|0|||
28168294|NCT02748863|54838852|FG003|Treatment Period 2|Lost to Follow-up|0|||
28168295|NCT02748863|54838853|FG004|Treatment Period 2|Lost to Follow-up|0|||
27734745|NCT02742649|54182803|FG002|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
27734746|NCT02742649|54182804|FG003|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
27734747|NCT02742649|54182805|FG004|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
27734748|NCT02742649|54182801|FG000|Double-Blind Treatment Period|Adverse Event|0|||
27734749|NCT02742649|54182802|FG001|Double-Blind Treatment Period|Adverse Event|1|||
27734750|NCT02742649|54182803|FG002|Double-Blind Treatment Period|Adverse Event|0|||
27734751|NCT02742649|54182804|FG003|Double-Blind Treatment Period|Adverse Event|0|||
27734752|NCT02742649|54182805|FG004|Double-Blind Treatment Period|Adverse Event|0|||
27734753|NCT02742649|54182801|FG000|Open-Label Period|Lost to Follow-up|0|||
27734754|NCT02742649|54182802|FG001|Open-Label Period|Lost to Follow-up|0|||
27734755|NCT02742649|54182803|FG002|Open-Label Period|Lost to Follow-up|0|||
27734756|NCT02742649|54182804|FG003|Open-Label Period|Lost to Follow-up|0|||
27734757|NCT02742649|54182805|FG004|Open-Label Period|Lost to Follow-up|1|||
27734758|NCT02665689|54182818|FG000|Overall Study|Adverse Event|1|||
27734759|NCT02665689|54182819|FG001|Overall Study|Adverse Event|0|||
27734760|NCT02665689|54182818|FG000|Overall Study|Trial termination|1|||
27734761|NCT02665689|54182819|FG001|Overall Study|Trial termination|1|||
27734762|NCT02665689|54182818|FG000|Overall Study|Lost to Follow-up|0|||
27734763|NCT02665689|54182819|FG001|Overall Study|Lost to Follow-up|1|||
28093659|NCT00208325|54747964|FG001|Overall Study|Death|19|||
28093660|NCT00208325|54747965|FG002|Overall Study|Death|7|||
28093661|NCT00208325|54747966|FG003|Overall Study|Death|5|||
28093662|NCT00208325|54747963|FG000|Overall Study|Withdrawal by Subject|0|||
28093663|NCT00208325|54747964|FG001|Overall Study|Withdrawal by Subject|1|||
28168296|NCT02748863|54838849|FG000|Treatment Period 2|Adverse Event|3|||
27734764|NCT02665455|54182825|FG000|Overall Study|Withdrawal by Subject|6|||
28168297|NCT02748863|54838850|FG001|Treatment Period 2|Adverse Event|2|||
28168298|NCT02748863|54838851|FG002|Treatment Period 2|Adverse Event|0|||
27734765|NCT02665455|54182825|FG000|Overall Study|Lost to Follow-up|1|||
27734766|NCT02665455|54182825|FG000|Overall Study|Adverse Event|1|||
27734767|NCT02665455|54182825|FG000|Overall Study|Protocol Violation|1|||
28093664|NCT00208325|54747965|FG002|Overall Study|Withdrawal by Subject|0|||
28093665|NCT00208325|54747966|FG003|Overall Study|Withdrawal by Subject|0|||
28093666|NCT00208325|54747963|FG000|Overall Study|Revision|4|||
28093667|NCT00208325|54747964|FG001|Overall Study|Revision|1|||
27734768|NCT02755805|54182831|FG000|Overall Study|Lost to Follow-up|1|||
27734769|NCT02755805|54182832|FG001|Overall Study|Lost to Follow-up|2|||
27734770|NCT02755805|54182831|FG000|Overall Study|Refused assessments|1|||
28168299|NCT02748863|54838852|FG003|Treatment Period 2|Adverse Event|2|||
28168300|NCT02748863|54838853|FG004|Treatment Period 2|Adverse Event|0|||
28168301|NCT02748863|54838849|FG000|Treatment Period 2|Lack of Efficacy|0|||
28168302|NCT02748863|54838850|FG001|Treatment Period 2|Lack of Efficacy|1|||
28168303|NCT02748863|54838851|FG002|Treatment Period 2|Lack of Efficacy|0|||
28168304|NCT02748863|54838852|FG003|Treatment Period 2|Lack of Efficacy|0|||
28168305|NCT02748863|54838853|FG004|Treatment Period 2|Lack of Efficacy|0|||
28168306|NCT02748863|54838849|FG000|Treatment Period 2|Pregnancy|0|||
28168307|NCT02748863|54838850|FG001|Treatment Period 2|Pregnancy|0|||
27734771|NCT02755805|54182832|FG001|Overall Study|Refused assessments|0|||
27734772|NCT02755805|54182831|FG000|Overall Study|Withdrawal by Subject|0|||
27734773|NCT02755805|54182832|FG001|Overall Study|Withdrawal by Subject|2|||
27734774|NCT02755649|54182841|FG000|Overall Study|Transitioned into OLE study|99|||
27734775|NCT02755649|54182842|FG001|Overall Study|Transitioned into OLE study|98|||
27734776|NCT02755649|54182843|FG002|Overall Study|Transitioned into OLE study|100|||
27734777|NCT02755649|54182841|FG000|Overall Study|Did Not Complete Follow-up Visits|1|||
27734778|NCT02755649|54182842|FG001|Overall Study|Did Not Complete Follow-up Visits|0|||
28093668|NCT00208325|54747965|FG002|Overall Study|Revision|0|||
28093669|NCT00208325|54747966|FG003|Overall Study|Revision|4|||
28093670|NCT00208325|54747963|FG000|Overall Study|Lost to Follow-up|1|||
28093671|NCT00208325|54747964|FG001|Overall Study|Lost to Follow-up|0|||
28093672|NCT00208325|54747965|FG002|Overall Study|Lost to Follow-up|2|||
28093673|NCT00208325|54747966|FG003|Overall Study|Lost to Follow-up|0|||
28093674|NCT00208325|54747963|FG000|Overall Study|Unsurfaced to Resurfaced Patella|4|||
28093675|NCT00208325|54747964|FG001|Overall Study|Unsurfaced to Resurfaced Patella|4|||
28093676|NCT00208325|54747965|FG002|Overall Study|Unsurfaced to Resurfaced Patella|1|||
28093677|NCT00208325|54747966|FG003|Overall Study|Unsurfaced to Resurfaced Patella|3|||
28093678|NCT00208325|54747963|FG000|Overall Study|Does not wish to Continue in Study|5|||
28093679|NCT00208325|54747964|FG001|Overall Study|Does not wish to Continue in Study|8|||
28168308|NCT02748863|54838851|FG002|Treatment Period 2|Pregnancy|0|||
28168309|NCT02748863|54838852|FG003|Treatment Period 2|Pregnancy|0|||
28168310|NCT02748863|54838853|FG004|Treatment Period 2|Pregnancy|1|||
28168311|NCT02865499|54838874|FG000|Baseline|Adverse Event|1|||
28168312|NCT02865499|54838874|FG000|Baseline|Withdrawal by Subject|1|||
28168313|NCT02870933|54838880|FG000|Overall Study|Death|2|||
28168314|NCT02870933|54838881|FG001|Overall Study|Death|1|||
28168315|NCT02870933|54838880|FG000|Overall Study|Withdrawal by Subject|0|||
28168316|NCT02870933|54838881|FG001|Overall Study|Withdrawal by Subject|1|||
28168317|NCT02864407|54838888|FG000|Overall Study|Protocol Violation|3|||
28168318|NCT02864407|54838888|FG000|Overall Study|Lost to Follow-up|115|||
28168319|NCT02864407|54838888|FG000|Overall Study|Not treated with Vahelva® Respimat®|1|||
28168320|NCT02864407|54838888|FG000|Overall Study|Were administered Vahelva® Respimat® prior to the consent date|3|||
28168321|NCT02864407|54838888|FG000|Overall Study|Consent prior to the contract date|1|||
28168322|NCT02873429|54838894|FG000|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10|||
28168323|NCT02873429|54838895|FG001|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1|||
28168324|NCT02873429|54838894|FG000|16 Weeks|Completed 6-8 week, missed 16 week|2|||
28168325|NCT02873429|54838895|FG001|16 Weeks|Completed 6-8 week, missed 16 week|2|||
28168326|NCT02873429|54838894|FG000|16 Weeks|Lost to Follow-up|3|||
28168327|NCT02873429|54838895|FG001|16 Weeks|Lost to Follow-up|0|||
28168328|NCT02486302|54838901|FG000|Overall Study|Discontinued prematurely|410|||
28168329|NCT02486302|54838901|FG000|Overall Study|Documentation not completed|255|||
28168330|NCT02486302|54838901|FG000|Overall Study|Excluded due to legal reasons|8|||
28168331|NCT02486302|54838901|FG000|Overall Study|Not treated|3|||
28168332|NCT02747875|54838916|FG000|Overall Study|Physician Decision|1|||
28168333|NCT02747875|54838917|FG001|Overall Study|Physician Decision|0|||
28168334|NCT02747875|54838916|FG000|Overall Study|Adverse Event|0|||
28168335|NCT02747875|54838917|FG001|Overall Study|Adverse Event|1|||
28168336|NCT02451124|54838943|FG000|Overall Study|Withdrawal by Subject|1|||
28168337|NCT02450578|54838955|FG000|Overall Study|ECG abnormality so not treated|1|||
28168338|NCT02450578|54838956|FG001|Overall Study|ECG abnormality so not treated|0|||
28168339|NCT02450578|54838957|FG002|Overall Study|ECG abnormality so not treated|0|||
28168340|NCT02450578|54838958|FG003|Overall Study|ECG abnormality so not treated|0|||
28168341|NCT02449018|54838985|FG000|Overall Study|Abnormal laboratory value|0|||
28168342|NCT02449018|54838986|FG001|Overall Study|Abnormal laboratory value|1|||
27734779|NCT02755649|54182843|FG002|Overall Study|Did Not Complete Follow-up Visits|0|||
28093680|NCT00208325|54747965|FG002|Overall Study|Does not wish to Continue in Study|3|||
28093681|NCT00208325|54747966|FG003|Overall Study|Does not wish to Continue in Study|2|||
28168343|NCT02449018|54838985|FG000|Overall Study|Administrative problems|1|||
28168344|NCT02449018|54838986|FG001|Overall Study|Administrative problems|0|||
28093682|NCT00208325|54747963|FG000|Overall Study|Other|2|||
28093683|NCT00208325|54747964|FG001|Overall Study|Other|1|||
28093684|NCT00208325|54747965|FG002|Overall Study|Other|1|||
28093685|NCT00208325|54747966|FG003|Overall Study|Other|0|||
28093686|NCT00208325|54747963|FG000|Overall Study|Mis-Randomized|17|||
28093687|NCT00208325|54747964|FG001|Overall Study|Mis-Randomized|20|||
28093688|NCT00208325|54747965|FG002|Overall Study|Mis-Randomized|0|||
28093689|NCT00208325|54747966|FG003|Overall Study|Mis-Randomized|0|||
28093690|NCT00160667|54747979|FG000|Overall Study|Adverse Event|3|||
28093691|NCT00160667|54747980|FG001|Overall Study|Adverse Event|1|||
28093692|NCT00160667|54747981|FG002|Overall Study|Adverse Event|4|||
28093693|NCT00160667|54747979|FG000|Overall Study|Withdrawal by Subject|2|||
28093694|NCT00160667|54747980|FG001|Overall Study|Withdrawal by Subject|0|||
28093695|NCT00160667|54747981|FG002|Overall Study|Withdrawal by Subject|1|||
28093696|NCT00160667|54747979|FG000|Overall Study|Lack of Efficacy|0|||
28093697|NCT00160667|54747980|FG001|Overall Study|Lack of Efficacy|1|||
28093698|NCT00160667|54747981|FG002|Overall Study|Lack of Efficacy|0|||
28093699|NCT00160667|54747979|FG000|Overall Study|Protocol Violation|0|||
28093700|NCT00160667|54747980|FG001|Overall Study|Protocol Violation|1|||
28093701|NCT00160667|54747981|FG002|Overall Study|Protocol Violation|0|||
28093702|NCT00160667|54747979|FG000|Overall Study|Patient decision|0|||
28093703|NCT00160667|54747980|FG001|Overall Study|Patient decision|0|||
28093704|NCT00160667|54747981|FG002|Overall Study|Patient decision|1|||
28093705|NCT00206375|54747993|FG000|Overall Study|Lost to Follow-up|1|||
28093706|NCT00206375|54747994|FG001|Overall Study|Lost to Follow-up|0|||
28093707|NCT00206375|54747995|FG002|Overall Study|Lost to Follow-up|0|||
28093708|NCT00206375|54747993|FG000|Overall Study|Withdrawal by Subject|2|||
28093709|NCT00206375|54747994|FG001|Overall Study|Withdrawal by Subject|1|||
28093710|NCT00206375|54747995|FG002|Overall Study|Withdrawal by Subject|3|||
28093711|NCT00206375|54747993|FG000|Overall Study|Study terminated due to lack of funds|0|||
28093712|NCT00206375|54747994|FG001|Overall Study|Study terminated due to lack of funds|1|||
28093713|NCT00206375|54747995|FG002|Overall Study|Study terminated due to lack of funds|1|||
28093714|NCT00160199|54748005|FG000|Overall Study|Adverse Event|5|||
28093715|NCT00160199|54748006|FG001|Overall Study|Adverse Event|14|||
28093716|NCT00160199|54748005|FG000|Overall Study|Lack of Efficacy|0|||
28093717|NCT00160199|54748006|FG001|Overall Study|Lack of Efficacy|1|||
28093718|NCT00160199|54748005|FG000|Overall Study|Lost to Follow-up|7|||
28093719|NCT00160199|54748006|FG001|Overall Study|Lost to Follow-up|7|||
28093720|NCT00160199|54748005|FG000|Overall Study|Withdrawal by Subject|4|||
28093721|NCT00160199|54748006|FG001|Overall Study|Withdrawal by Subject|6|||
28093722|NCT00160199|54748005|FG000|Overall Study|Administrative|0|||
28093723|NCT00160199|54748006|FG001|Overall Study|Administrative|1|||
28093724|NCT00160199|54748005|FG000|Overall Study|Protocol Violation|8|||
28093725|NCT00160199|54748006|FG001|Overall Study|Protocol Violation|8|||
28093726|NCT00157157|54748012|FG000|Overall Study|Withdrawal by Subject|6|||
28093727|NCT00157157|54748012|FG000|Overall Study|Physician Decision|1|||
28093728|NCT00157157|54748012|FG000|Overall Study|Lost to Follow-up|1|||
28093729|NCT00157157|54748012|FG000|Overall Study|Enrolled in another study|1|||
28093730|NCT00157157|54748012|FG000|Overall Study|Met exclusion criteria|1|||
28093731|NCT00157157|54748012|FG000|Overall Study|Inclusion not met- baseline FVIII value|1|||
28093732|NCT00203411|54748023|FG000|Follow-up|Progressive Disease|4|||
28093733|NCT00203021|54748030|FG000|Overall Study|Death|4|||
28093734|NCT00203021|54748031|FG001|Overall Study|Death|1|||
28093735|NCT00203021|54748030|FG000|Overall Study|Adverse Event|10|||
28168345|NCT02449018|54838985|FG000|Overall Study|Adverse Event|5|||
28168346|NCT02449018|54838986|FG001|Overall Study|Adverse Event|1|||
28168347|NCT02449018|54838985|FG000|Overall Study|Protocol deviation|4|||
28168348|NCT02449018|54838986|FG001|Overall Study|Protocol deviation|0|||
28168349|NCT02449018|54838985|FG000|Overall Study|Patient decision|2|||
28168350|NCT02449018|54838986|FG001|Overall Study|Patient decision|0|||
28168351|NCT02859415|54838994|FG000|Overall Study|Physician Decision|1|||
28168352|NCT02859415|54838995|FG001|Overall Study|Physician Decision|0|||
28168353|NCT02859415|54838994|FG000|Overall Study|Off treatment due to cardiac event|0|||
28168354|NCT02859415|54838995|FG001|Overall Study|Off treatment due to cardiac event|1|||
28168355|NCT02871791|54839005|FG000|Phase 1b|Death|0|||
28168356|NCT02871791|54839006|FG001|Phase 1b|Death|1|||
27855789|NCT02733042|54382056|FG018|Follow-up Period|Withdrawal by Subject|0|||
28093736|NCT00203021|54748031|FG001|Overall Study|Adverse Event|5|||
28093737|NCT00203021|54748030|FG000|Overall Study|Withdrawal by Subject|45|||
28093738|NCT00203021|54748031|FG001|Overall Study|Withdrawal by Subject|48|||
28093739|NCT00203021|54748030|FG000|Overall Study|Lost to Follow-up|9|||
28093740|NCT00203021|54748031|FG001|Overall Study|Lost to Follow-up|7|||
28093741|NCT00203021|54748030|FG000|Overall Study|Other than specified|11|||
28093742|NCT00203021|54748031|FG001|Overall Study|Other than specified|16|||
28093743|NCT00201851|54748040|FG000|Overall Study|Lost to Follow-up|2|||
28093744|NCT00201851|54748041|FG001|Overall Study|Lost to Follow-up|1|||
28093745|NCT00201851|54748042|FG002|Overall Study|Lost to Follow-up|0|||
28168357|NCT02871791|54839005|FG000|Phase 1b|progressive disease|6|||
28168358|NCT02871791|54839006|FG001|Phase 1b|progressive disease|2|||
28168359|NCT02871791|54839005|FG000|Phase 2|Death|1|||
28093746|NCT00201851|54748040|FG000|Overall Study|Ineligible post enrollment|6|||
28093747|NCT00201851|54748041|FG001|Overall Study|Ineligible post enrollment|1|||
28093748|NCT00201851|54748042|FG002|Overall Study|Ineligible post enrollment|1|||
28093749|NCT00200057|54748050|FG000|Overall Study|Lack of Efficacy|3|||
28093750|NCT00200057|54748050|FG000|Overall Study|Exited due to terminal illness of PI|2|||
28093751|NCT00200057|54748050|FG000|Overall Study|Withdrawal by Subject|1|||
28093752|NCT00200057|54748050|FG000|Overall Study|Change in medical condition|1|||
28093753|NCT00200057|54748050|FG000|Overall Study|Infection|1|||
28093754|NCT00200057|54748050|FG000|Overall Study|Death|1|||
28093755|NCT03129100|54748059|FG000|Lead-In Period (Period 1)|Adverse Event|2|||
28093756|NCT03129100|54748060|FG001|Lead-In Period (Period 1)|Adverse Event|6|||
27734780|NCT02755649|54182841|FG000|Overall Study|Physician Decision|0|||
27734781|NCT02755649|54182842|FG001|Overall Study|Physician Decision|0|||
27734782|NCT02755649|54182843|FG002|Overall Study|Physician Decision|2|||
27734783|NCT02755649|54182841|FG000|Overall Study|Withdrawal by Subject|0|||
27734784|NCT02755649|54182842|FG001|Overall Study|Withdrawal by Subject|1|||
27734785|NCT02755649|54182843|FG002|Overall Study|Withdrawal by Subject|0|||
27734786|NCT02755649|54182841|FG000|Overall Study|Undecided|1|||
27734787|NCT02755649|54182842|FG001|Overall Study|Undecided|0|||
27734788|NCT02755649|54182843|FG002|Overall Study|Undecided|0|||
27734789|NCT00151411|54182853|FG000|Overall Study|Lost to Follow-up|15|||
27734790|NCT00151411|54182854|FG001|Overall Study|Lost to Follow-up|19|||
27734791|NCT00151411|54182853|FG000|Overall Study|Withdrawal by Subject|12|||
27734792|NCT00151411|54182854|FG001|Overall Study|Withdrawal by Subject|20|||
27734793|NCT00151411|54182853|FG000|Overall Study|Adverse Event|6|||
27734794|NCT00151411|54182854|FG001|Overall Study|Adverse Event|0|||
27734795|NCT00151411|54182853|FG000|Overall Study|Pregnancy|0|||
27734796|NCT00151411|54182854|FG001|Overall Study|Pregnancy|4|||
27734797|NCT02662569|54182864|FG000|Overall Study|Withdrawal by Subject|6|||
27734798|NCT02662569|54182865|FG001|Overall Study|Withdrawal by Subject|1|||
27734799|NCT02662569|54182866|FG002|Overall Study|Withdrawal by Subject|6|||
27734800|NCT02662569|54182867|FG003|Overall Study|Withdrawal by Subject|4|||
27734801|NCT02662569|54182864|FG000|Overall Study|Lost to Follow-up|1|||
27734802|NCT02662569|54182865|FG001|Overall Study|Lost to Follow-up|0|||
27734803|NCT02662569|54182866|FG002|Overall Study|Lost to Follow-up|0|||
27734804|NCT02662569|54182867|FG003|Overall Study|Lost to Follow-up|0|||
27734805|NCT02741635|54182877|FG000|Overall Study|Withdrawal by Subject|1|||
27734806|NCT02753075|54182885|FG000|Overall Study|Adverse Event|2|||
27734807|NCT02753075|54182886|FG001|Overall Study|Adverse Event|1|||
27734808|NCT02753075|54182887|FG002|Overall Study|Adverse Event|0|||
27734809|NCT02753075|54182885|FG000|Overall Study|Lost to Follow-up|2|||
27734810|NCT02753075|54182886|FG001|Overall Study|Lost to Follow-up|0|||
27734811|NCT02753075|54182887|FG002|Overall Study|Lost to Follow-up|0|||
27734812|NCT02753075|54182885|FG000|Overall Study|Withdrawal of Consent|1|||
27734813|NCT02753075|54182886|FG001|Overall Study|Withdrawal of Consent|1|||
27734814|NCT02753075|54182887|FG002|Overall Study|Withdrawal of Consent|3|||
27734815|NCT02753075|54182885|FG000|Overall Study|Physician Decision|3|||
27734816|NCT02753075|54182886|FG001|Overall Study|Physician Decision|1|||
27734817|NCT02753075|54182887|FG002|Overall Study|Physician Decision|0|||
27734818|NCT02332720|54182919|FG000|Part A and Part B|Lost to Follow-up|1|||
27734819|NCT02332720|54182920|FG001|Part A and Part B|Lost to Follow-up|0|||
27734820|NCT02332720|54182921|FG002|Part A and Part B|Lost to Follow-up|0|||
27734821|NCT02332720|54182922|FG003|Part A and Part B|Lost to Follow-up|0|||
27734822|NCT02332720|54182923|FG004|Part A and Part B|Lost to Follow-up|0|||
27734823|NCT02332720|54182924|FG005|Part A and Part B|Lost to Follow-up|2|||
27734824|NCT02332720|54182925|FG006|Part A and Part B|Lost to Follow-up|1|||
27734825|NCT02332720|54182926|FG007|Part A and Part B|Lost to Follow-up|1|||
27734826|NCT02332720|54182927|FG008|Part A and Part B|Lost to Follow-up|0|||
27734827|NCT02332720|54182928|FG009|Part A and Part B|Lost to Follow-up|0|||
27734828|NCT02332720|54182929|FG010|Part A and Part B|Lost to Follow-up|0|||
27734829|NCT02332720|54182930|FG011|Part A and Part B|Lost to Follow-up|0|||
27734830|NCT02332720|54182931|FG012|Part A and Part B|Lost to Follow-up|0|||
27734831|NCT02332720|54182932|FG013|Part A and Part B|Lost to Follow-up|0|||
27734832|NCT02332720|54182933|FG014|Part A and Part B|Lost to Follow-up|0|||
28093757|NCT03129100|54748061|FG002|Lead-In Period (Period 1)|Adverse Event|0|||
28093758|NCT03129100|54748062|FG003|Lead-In Period (Period 1)|Adverse Event|0|||
27734833|NCT02332720|54182934|FG015|Part A and Part B|Lost to Follow-up|1|||
27734834|NCT02332720|54182935|FG016|Part A and Part B|Lost to Follow-up|0|||
27734835|NCT02332720|54182936|FG017|Part A and Part B|Lost to Follow-up|0|||
27734836|NCT02332720|54182937|FG018|Part A and Part B|Lost to Follow-up|0|||
27734837|NCT02332720|54182938|FG019|Part A and Part B|Lost to Follow-up|0|||
27734838|NCT02332720|54182939|FG020|Part A and Part B|Lost to Follow-up|0|||
27734839|NCT02332720|54182940|FG021|Part A and Part B|Lost to Follow-up|0|||
27734840|NCT02332720|54182941|FG022|Part A and Part B|Lost to Follow-up|0|||
27734841|NCT02332720|54182919|FG000|Part A and Part B|Adverse Event|0|||
28093759|NCT03129100|54748063|FG004|Lead-In Period (Period 1)|Adverse Event|0|||
27734842|NCT02332720|54182920|FG001|Part A and Part B|Adverse Event|0|||
27734843|NCT02332720|54182921|FG002|Part A and Part B|Adverse Event|0|||
28093760|NCT03129100|54748064|FG005|Lead-In Period (Period 1)|Adverse Event|0|||
28093761|NCT03129100|54748065|FG006|Lead-In Period (Period 1)|Adverse Event|0|||
28168360|NCT02871791|54839006|FG001|Phase 2|Death|0|||
28168361|NCT02871791|54839005|FG000|Phase 2|Lost to Follow-up|2|||
28168362|NCT02871791|54839006|FG001|Phase 2|Lost to Follow-up|0|||
28168363|NCT02871635|54839014|FG000|Overall Study|Primary lack of efficacy|4|||
28168364|NCT02871635|54839015|FG001|Overall Study|Primary lack of efficacy|4|||
28168365|NCT02871635|54839014|FG000|Overall Study|Protocol Violation|3|||
28168366|NCT02871635|54839015|FG001|Overall Study|Protocol Violation|1|||
28168367|NCT02871635|54839014|FG000|Overall Study|Lost to Follow-up|1|||
28093762|NCT03129100|54748066|FG007|Lead-In Period (Period 1)|Adverse Event|0|||
28168368|NCT02871635|54839015|FG001|Overall Study|Lost to Follow-up|2|||
28168369|NCT02871635|54839014|FG000|Overall Study|Pregnancy|0|||
28168370|NCT02871635|54839015|FG001|Overall Study|Pregnancy|2|||
28168371|NCT02871635|54839014|FG000|Overall Study|Physician Decision|1|||
28093763|NCT03129100|54748067|FG008|Lead-In Period (Period 1)|Adverse Event|0|||
28093764|NCT03129100|54748068|FG009|Lead-In Period (Period 1)|Adverse Event|0|||
28093765|NCT03129100|54748069|FG010|Lead-In Period (Period 1)|Adverse Event|0|||
28093766|NCT03129100|54748070|FG011|Lead-In Period (Period 1)|Adverse Event|0|||
28093767|NCT03129100|54748071|FG012|Lead-In Period (Period 1)|Adverse Event|0|||
28093768|NCT03129100|54748072|FG013|Lead-In Period (Period 1)|Adverse Event|0|||
28093769|NCT03129100|54748073|FG014|Lead-In Period (Period 1)|Adverse Event|0|||
28093770|NCT03129100|54748074|FG015|Lead-In Period (Period 1)|Adverse Event|0|||
28093771|NCT03129100|54748075|FG016|Lead-In Period (Period 1)|Adverse Event|0|||
28093772|NCT03129100|54748076|FG017|Lead-In Period (Period 1)|Adverse Event|0|||
28093773|NCT03129100|54748077|FG018|Lead-In Period (Period 1)|Adverse Event|0|||
28093774|NCT03129100|54748078|FG019|Lead-In Period (Period 1)|Adverse Event|0|||
28093775|NCT03129100|54748079|FG020|Lead-In Period (Period 1)|Adverse Event|0|||
28093776|NCT03129100|54748080|FG021|Lead-In Period (Period 1)|Adverse Event|0|||
28093777|NCT03129100|54748081|FG022|Lead-In Period (Period 1)|Adverse Event|0|||
28093778|NCT03129100|54748082|FG023|Lead-In Period (Period 1)|Adverse Event|0|||
28093779|NCT03129100|54748083|FG024|Lead-In Period (Period 1)|Adverse Event|0|||
28093780|NCT03129100|54748084|FG025|Lead-In Period (Period 1)|Adverse Event|0|||
28093781|NCT03129100|54748059|FG000|Lead-In Period (Period 1)|Lost to Follow-up|2|||
28093782|NCT03129100|54748060|FG001|Lead-In Period (Period 1)|Lost to Follow-up|0|||
28093783|NCT03129100|54748061|FG002|Lead-In Period (Period 1)|Lost to Follow-up|0|||
28093784|NCT03129100|54748062|FG003|Lead-In Period (Period 1)|Lost to Follow-up|0|||
28093785|NCT03129100|54748063|FG004|Lead-In Period (Period 1)|Lost to Follow-up|0|||
28093786|NCT03129100|54748064|FG005|Lead-In Period (Period 1)|Lost to Follow-up|0|||
28093787|NCT03129100|54748065|FG006|Lead-In Period (Period 1)|Lost to Follow-up|0|||
28093788|NCT03129100|54748066|FG007|Lead-In Period (Period 1)|Lost to Follow-up|0|||
28093789|NCT03129100|54748067|FG008|Lead-In Period (Period 1)|Lost to Follow-up|0|||
28093790|NCT03129100|54748068|FG009|Lead-In Period (Period 1)|Lost to Follow-up|0|||
28093791|NCT03129100|54748069|FG010|Lead-In Period (Period 1)|Lost to Follow-up|0|||
28093792|NCT03129100|54748070|FG011|Lead-In Period (Period 1)|Lost to Follow-up|0|||
28093793|NCT03129100|54748071|FG012|Lead-In Period (Period 1)|Lost to Follow-up|0|||
28093794|NCT03129100|54748072|FG013|Lead-In Period (Period 1)|Lost to Follow-up|0|||
28093795|NCT03129100|54748073|FG014|Lead-In Period (Period 1)|Lost to Follow-up|0|||
28093796|NCT03129100|54748074|FG015|Lead-In Period (Period 1)|Lost to Follow-up|0|||
28093797|NCT03129100|54748075|FG016|Lead-In Period (Period 1)|Lost to Follow-up|0|||
27734844|NCT02332720|54182922|FG003|Part A and Part B|Adverse Event|0|||
28168372|NCT02871635|54839015|FG001|Overall Study|Physician Decision|1|||
28168373|NCT02871635|54839014|FG000|Overall Study|Withdrawal by Subject|3|||
28168374|NCT02871635|54839015|FG001|Overall Study|Withdrawal by Subject|4|||
28168375|NCT02871635|54839014|FG000|Overall Study|Adverse Event|4|||
28168376|NCT02871635|54839015|FG001|Overall Study|Adverse Event|4|||
28168377|NCT02871635|54839014|FG000|Overall Study|Secondary lack of efficacy|2|||
27734845|NCT02332720|54182923|FG004|Part A and Part B|Adverse Event|0|||
27734846|NCT02332720|54182924|FG005|Part A and Part B|Adverse Event|0|||
27734847|NCT02332720|54182925|FG006|Part A and Part B|Adverse Event|0|||
27734848|NCT02332720|54182926|FG007|Part A and Part B|Adverse Event|0|||
27734849|NCT02332720|54182927|FG008|Part A and Part B|Adverse Event|0|||
28093798|NCT03129100|54748076|FG017|Lead-In Period (Period 1)|Lost to Follow-up|0|||
28093799|NCT03129100|54748077|FG018|Lead-In Period (Period 1)|Lost to Follow-up|0|||
27855790|NCT02859064|54382289|FG000|Overall Study|Progressive Disease|3|||
27855791|NCT02859064|54382289|FG000|Overall Study|Physician Decision|1|||
28093800|NCT03129100|54748078|FG019|Lead-In Period (Period 1)|Lost to Follow-up|0|||
28093801|NCT03129100|54748079|FG020|Lead-In Period (Period 1)|Lost to Follow-up|0|||
28093802|NCT03129100|54748080|FG021|Lead-In Period (Period 1)|Lost to Follow-up|0|||
28093803|NCT03129100|54748081|FG022|Lead-In Period (Period 1)|Lost to Follow-up|0|||
28168378|NCT02871635|54839015|FG001|Overall Study|Secondary lack of efficacy|1|||
27734850|NCT02332720|54182928|FG009|Part A and Part B|Adverse Event|0|||
27734851|NCT02332720|54182929|FG010|Part A and Part B|Adverse Event|0|||
27855792|NCT02859064|54382289|FG000|Overall Study|Withdrawal by Subject|1|||
28168379|NCT02477332|54839029|FG000|Overall Study|Adverse Event|0|||
28168380|NCT02477332|54839030|FG001|Overall Study|Adverse Event|1|||
28093804|NCT03129100|54748082|FG023|Lead-In Period (Period 1)|Lost to Follow-up|0|||
28093805|NCT03129100|54748083|FG024|Lead-In Period (Period 1)|Lost to Follow-up|0|||
28093806|NCT03129100|54748084|FG025|Lead-In Period (Period 1)|Lost to Follow-up|0|||
28093807|NCT03129100|54748059|FG000|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
28093808|NCT03129100|54748060|FG001|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
28093809|NCT03129100|54748061|FG002|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
28093810|NCT03129100|54748062|FG003|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
28093811|NCT03129100|54748063|FG004|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
28093812|NCT03129100|54748064|FG005|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
28093813|NCT03129100|54748065|FG006|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
28093814|NCT03129100|54748066|FG007|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
28093815|NCT03129100|54748067|FG008|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
28093816|NCT03129100|54748068|FG009|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
28093817|NCT03129100|54748069|FG010|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
28093818|NCT03129100|54748070|FG011|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
28093819|NCT03129100|54748071|FG012|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
28093820|NCT03129100|54748072|FG013|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
28093821|NCT03129100|54748073|FG014|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
28093822|NCT03129100|54748074|FG015|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
28093823|NCT03129100|54748075|FG016|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
28093824|NCT03129100|54748076|FG017|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
28093825|NCT03129100|54748077|FG018|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
28093826|NCT03129100|54748078|FG019|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
28093827|NCT03129100|54748079|FG020|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
28093828|NCT03129100|54748080|FG021|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
28093829|NCT03129100|54748081|FG022|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
28093830|NCT03129100|54748082|FG023|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
28093831|NCT03129100|54748083|FG024|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
28093832|NCT03129100|54748084|FG025|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
28093833|NCT03129100|54748059|FG000|Lead-In Period (Period 1)|Lack of Efficacy|3|||
28093834|NCT03129100|54748060|FG001|Lead-In Period (Period 1)|Lack of Efficacy|2|||
28093835|NCT03129100|54748061|FG002|Lead-In Period (Period 1)|Lack of Efficacy|0|||
28093836|NCT03129100|54748062|FG003|Lead-In Period (Period 1)|Lack of Efficacy|0|||
28093837|NCT03129100|54748063|FG004|Lead-In Period (Period 1)|Lack of Efficacy|0|||
28093838|NCT03129100|54748064|FG005|Lead-In Period (Period 1)|Lack of Efficacy|0|||
28093839|NCT03129100|54748065|FG006|Lead-In Period (Period 1)|Lack of Efficacy|0|||
28093840|NCT03129100|54748066|FG007|Lead-In Period (Period 1)|Lack of Efficacy|0|||
28093841|NCT03129100|54748067|FG008|Lead-In Period (Period 1)|Lack of Efficacy|0|||
28093842|NCT03129100|54748068|FG009|Lead-In Period (Period 1)|Lack of Efficacy|0|||
28093843|NCT03129100|54748069|FG010|Lead-In Period (Period 1)|Lack of Efficacy|0|||
28093844|NCT03129100|54748070|FG011|Lead-In Period (Period 1)|Lack of Efficacy|0|||
28093845|NCT03129100|54748071|FG012|Lead-In Period (Period 1)|Lack of Efficacy|0|||
28093846|NCT03129100|54748072|FG013|Lead-In Period (Period 1)|Lack of Efficacy|0|||
28093847|NCT03129100|54748073|FG014|Lead-In Period (Period 1)|Lack of Efficacy|0|||
28093848|NCT03129100|54748074|FG015|Lead-In Period (Period 1)|Lack of Efficacy|0|||
28093849|NCT03129100|54748075|FG016|Lead-In Period (Period 1)|Lack of Efficacy|0|||
28093850|NCT03129100|54748076|FG017|Lead-In Period (Period 1)|Lack of Efficacy|0|||
28093851|NCT03129100|54748077|FG018|Lead-In Period (Period 1)|Lack of Efficacy|0|||
28093852|NCT03129100|54748078|FG019|Lead-In Period (Period 1)|Lack of Efficacy|0|||
28093853|NCT03129100|54748079|FG020|Lead-In Period (Period 1)|Lack of Efficacy|0|||
28093854|NCT03129100|54748080|FG021|Lead-In Period (Period 1)|Lack of Efficacy|0|||
28093855|NCT03129100|54748081|FG022|Lead-In Period (Period 1)|Lack of Efficacy|0|||
28093856|NCT03129100|54748082|FG023|Lead-In Period (Period 1)|Lack of Efficacy|0|||
28093857|NCT03129100|54748083|FG024|Lead-In Period (Period 1)|Lack of Efficacy|0|||
28093858|NCT03129100|54748084|FG025|Lead-In Period (Period 1)|Lack of Efficacy|0|||
28093859|NCT03129100|54748059|FG000|Lead-In Period (Period 1)|Surgery Programmed|0|||
28168381|NCT02477332|54839031|FG002|Overall Study|Adverse Event|1|||
28168382|NCT02477332|54839032|FG003|Overall Study|Adverse Event|2|||
28168383|NCT02477332|54839033|FG004|Overall Study|Adverse Event|1|||
28168384|NCT02477332|54839034|FG005|Overall Study|Adverse Event|2|||
28168385|NCT02477332|54839029|FG000|Overall Study|Lack of Efficacy|1|||
28168386|NCT02477332|54839030|FG001|Overall Study|Lack of Efficacy|2|||
28168387|NCT02477332|54839031|FG002|Overall Study|Lack of Efficacy|1|||
28168388|NCT02477332|54839032|FG003|Overall Study|Lack of Efficacy|2|||
28093860|NCT03129100|54748060|FG001|Lead-In Period (Period 1)|Surgery Programmed|1|||
28093861|NCT03129100|54748061|FG002|Lead-In Period (Period 1)|Surgery Programmed|0|||
28168389|NCT02477332|54839033|FG004|Overall Study|Lack of Efficacy|1|||
28168390|NCT02477332|54839034|FG005|Overall Study|Lack of Efficacy|1|||
28168391|NCT02477332|54839029|FG000|Overall Study|Non-compliance with study treatment|0|||
27833221|NCT01720667|54314692|FG000|Overall Study|Withdrawal by Subject|3|||
27833222|NCT01720667|54314693|FG001|Overall Study|Withdrawal by Subject|0|||
27855793|NCT02859064|54382289|FG000|Overall Study|Death|1|||
28093862|NCT03129100|54748062|FG003|Lead-In Period (Period 1)|Surgery Programmed|0|||
28093863|NCT03129100|54748063|FG004|Lead-In Period (Period 1)|Surgery Programmed|0|||
28093864|NCT03129100|54748064|FG005|Lead-In Period (Period 1)|Surgery Programmed|0|||
28093865|NCT03129100|54748065|FG006|Lead-In Period (Period 1)|Surgery Programmed|0|||
28093866|NCT03129100|54748066|FG007|Lead-In Period (Period 1)|Surgery Programmed|0|||
28093867|NCT03129100|54748067|FG008|Lead-In Period (Period 1)|Surgery Programmed|0|||
28093868|NCT03129100|54748068|FG009|Lead-In Period (Period 1)|Surgery Programmed|0|||
28093869|NCT03129100|54748069|FG010|Lead-In Period (Period 1)|Surgery Programmed|0|||
28093870|NCT03129100|54748070|FG011|Lead-In Period (Period 1)|Surgery Programmed|0|||
28093871|NCT03129100|54748071|FG012|Lead-In Period (Period 1)|Surgery Programmed|0|||
28093872|NCT03129100|54748072|FG013|Lead-In Period (Period 1)|Surgery Programmed|0|||
28093873|NCT03129100|54748073|FG014|Lead-In Period (Period 1)|Surgery Programmed|0|||
28093874|NCT03129100|54748074|FG015|Lead-In Period (Period 1)|Surgery Programmed|0|||
28093875|NCT03129100|54748075|FG016|Lead-In Period (Period 1)|Surgery Programmed|0|||
28093876|NCT03129100|54748076|FG017|Lead-In Period (Period 1)|Surgery Programmed|0|||
28093877|NCT03129100|54748077|FG018|Lead-In Period (Period 1)|Surgery Programmed|0|||
28093878|NCT03129100|54748078|FG019|Lead-In Period (Period 1)|Surgery Programmed|0|||
28093879|NCT03129100|54748079|FG020|Lead-In Period (Period 1)|Surgery Programmed|0|||
28093880|NCT03129100|54748080|FG021|Lead-In Period (Period 1)|Surgery Programmed|0|||
28093881|NCT03129100|54748081|FG022|Lead-In Period (Period 1)|Surgery Programmed|0|||
28093882|NCT03129100|54748082|FG023|Lead-In Period (Period 1)|Surgery Programmed|0|||
28168392|NCT02477332|54839030|FG001|Overall Study|Non-compliance with study treatment|1|||
28168393|NCT02477332|54839031|FG002|Overall Study|Non-compliance with study treatment|2|||
28168394|NCT02477332|54839032|FG003|Overall Study|Non-compliance with study treatment|0|||
28168395|NCT02477332|54839033|FG004|Overall Study|Non-compliance with study treatment|0|||
27734852|NCT02332720|54182930|FG011|Part A and Part B|Adverse Event|0|||
27734853|NCT02332720|54182931|FG012|Part A and Part B|Adverse Event|0|||
27734854|NCT02332720|54182932|FG013|Part A and Part B|Adverse Event|0|||
27734855|NCT02332720|54182933|FG014|Part A and Part B|Adverse Event|0|||
27734856|NCT02332720|54182934|FG015|Part A and Part B|Adverse Event|0|||
27734857|NCT02332720|54182935|FG016|Part A and Part B|Adverse Event|0|||
27734858|NCT02332720|54182936|FG017|Part A and Part B|Adverse Event|1|||
28168396|NCT02477332|54839034|FG005|Overall Study|Non-compliance with study treatment|0|||
28168397|NCT02477332|54839029|FG000|Overall Study|Pregnancy|0|||
28168398|NCT02477332|54839030|FG001|Overall Study|Pregnancy|0|||
28168399|NCT02477332|54839031|FG002|Overall Study|Pregnancy|0|||
28168400|NCT02477332|54839032|FG003|Overall Study|Pregnancy|1|||
28168401|NCT02477332|54839033|FG004|Overall Study|Pregnancy|0|||
28168402|NCT02477332|54839034|FG005|Overall Study|Pregnancy|0|||
28168403|NCT02477332|54839029|FG000|Overall Study|Protocol Violation|2|||
28168404|NCT02477332|54839030|FG001|Overall Study|Protocol Violation|0|||
28168405|NCT02477332|54839031|FG002|Overall Study|Protocol Violation|3|||
28168406|NCT02477332|54839032|FG003|Overall Study|Protocol Violation|3|||
28168407|NCT02477332|54839033|FG004|Overall Study|Protocol Violation|1|||
28168408|NCT02477332|54839034|FG005|Overall Study|Protocol Violation|1|||
28168409|NCT02477332|54839029|FG000|Overall Study|Technical problems|0|||
28168410|NCT02477332|54839030|FG001|Overall Study|Technical problems|0|||
28168411|NCT02477332|54839031|FG002|Overall Study|Technical problems|1|||
27734859|NCT02332720|54182937|FG018|Part A and Part B|Adverse Event|0|||
27734860|NCT02332720|54182938|FG019|Part A and Part B|Adverse Event|0|||
27734861|NCT02332720|54182939|FG020|Part A and Part B|Adverse Event|0|||
27734862|NCT02332720|54182940|FG021|Part A and Part B|Adverse Event|0|||
27734863|NCT02332720|54182941|FG022|Part A and Part B|Adverse Event|0|||
27734864|NCT02332720|54182919|FG000|Part A and Part B|Physician Decision|0|||
27734865|NCT02332720|54182920|FG001|Part A and Part B|Physician Decision|0|||
27734866|NCT02332720|54182921|FG002|Part A and Part B|Physician Decision|0|||
27734867|NCT02332720|54182922|FG003|Part A and Part B|Physician Decision|0|||
27734868|NCT02332720|54182923|FG004|Part A and Part B|Physician Decision|0|||
27734869|NCT02332720|54182924|FG005|Part A and Part B|Physician Decision|0|||
27734870|NCT02332720|54182925|FG006|Part A and Part B|Physician Decision|0|||
27734871|NCT02332720|54182926|FG007|Part A and Part B|Physician Decision|0|||
27734872|NCT02332720|54182927|FG008|Part A and Part B|Physician Decision|0|||
27734873|NCT02332720|54182928|FG009|Part A and Part B|Physician Decision|0|||
28093883|NCT03129100|54748083|FG024|Lead-In Period (Period 1)|Surgery Programmed|0|||
28093884|NCT03129100|54748084|FG025|Lead-In Period (Period 1)|Surgery Programmed|0|||
27734874|NCT02332720|54182929|FG010|Part A and Part B|Physician Decision|0|||
27833223|NCT01720043|54314701|FG000|Overall Study|Withdrawal by Subject|1|||
28093885|NCT03129100|54748059|FG000|Period2 Extension Period (Group A and B)|Adverse Event|0|||
28168412|NCT02477332|54839032|FG003|Overall Study|Technical problems|0|||
28168413|NCT02477332|54839033|FG004|Overall Study|Technical problems|0|||
27734875|NCT02332720|54182930|FG011|Part A and Part B|Physician Decision|0|||
27734876|NCT02332720|54182931|FG012|Part A and Part B|Physician Decision|0|||
27734877|NCT02332720|54182932|FG013|Part A and Part B|Physician Decision|0|||
28168414|NCT02477332|54839034|FG005|Overall Study|Technical problems|0|||
28168415|NCT02477332|54839029|FG000|Overall Study|Lost to Follow-up|0|||
28168416|NCT02477332|54839030|FG001|Overall Study|Lost to Follow-up|0|||
28093886|NCT03129100|54748060|FG001|Period2 Extension Period (Group A and B)|Adverse Event|0|||
28093887|NCT03129100|54748061|FG002|Period2 Extension Period (Group A and B)|Adverse Event|2|||
28093888|NCT03129100|54748062|FG003|Period2 Extension Period (Group A and B)|Adverse Event|1|||
28093889|NCT03129100|54748063|FG004|Period2 Extension Period (Group A and B)|Adverse Event|0|||
28093890|NCT03129100|54748064|FG005|Period2 Extension Period (Group A and B)|Adverse Event|2|||
28093891|NCT03129100|54748065|FG006|Period2 Extension Period (Group A and B)|Adverse Event|0|||
28093892|NCT03129100|54748066|FG007|Period2 Extension Period (Group A and B)|Adverse Event|0|||
28093893|NCT03129100|54748067|FG008|Period2 Extension Period (Group A and B)|Adverse Event|0|||
28168417|NCT02477332|54839031|FG002|Overall Study|Lost to Follow-up|2|||
28168418|NCT02477332|54839032|FG003|Overall Study|Lost to Follow-up|0|||
28168419|NCT02477332|54839033|FG004|Overall Study|Lost to Follow-up|0|||
28168420|NCT02477332|54839034|FG005|Overall Study|Lost to Follow-up|0|||
28168421|NCT02477332|54839029|FG000|Overall Study|Physician Decision|0|||
28168422|NCT02477332|54839030|FG001|Overall Study|Physician Decision|0|||
28168423|NCT02477332|54839031|FG002|Overall Study|Physician Decision|1|||
28168424|NCT02477332|54839032|FG003|Overall Study|Physician Decision|3|||
28168425|NCT02477332|54839033|FG004|Overall Study|Physician Decision|0|||
28168426|NCT02477332|54839034|FG005|Overall Study|Physician Decision|1|||
28168427|NCT02477332|54839029|FG000|Overall Study|Withdrawal by Subject|0|||
28168428|NCT02477332|54839030|FG001|Overall Study|Withdrawal by Subject|3|||
28168429|NCT02477332|54839031|FG002|Overall Study|Withdrawal by Subject|1|||
28168430|NCT02477332|54839032|FG003|Overall Study|Withdrawal by Subject|2|||
28168431|NCT02477332|54839033|FG004|Overall Study|Withdrawal by Subject|1|||
28168432|NCT02477332|54839034|FG005|Overall Study|Withdrawal by Subject|0|||
28168433|NCT02477020|54839052|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
28168434|NCT02477020|54839053|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
28168435|NCT02477020|54839052|FG000|Overall Study|Voluntary Withdrawal|7|||
28168436|NCT02477020|54839053|FG001|Overall Study|Voluntary Withdrawal|16|||
28168437|NCT02477020|54839052|FG000|Overall Study|Reason not Specified|3|||
28168438|NCT02477020|54839053|FG001|Overall Study|Reason not Specified|1|||
28168439|NCT02477020|54839052|FG000|Overall Study|Lack of Efficacy|14|||
28168440|NCT02477020|54839053|FG001|Overall Study|Lack of Efficacy|5|||
28168441|NCT02862535|54839063|FG000|Overall Study|Death|7|||
28168442|NCT02862535|54839064|FG001|Overall Study|Death|3|||
28168443|NCT02862535|54839065|FG002|Overall Study|Death|2|||
28168444|NCT02862535|54839066|FG003|Overall Study|Death|5|||
28168445|NCT02862535|54839063|FG000|Overall Study|Study Terminated by Sponsor|1|||
28168446|NCT02862535|54839064|FG001|Overall Study|Study Terminated by Sponsor|3|||
28168447|NCT02862535|54839065|FG002|Overall Study|Study Terminated by Sponsor|8|||
28168448|NCT02862535|54839066|FG003|Overall Study|Study Terminated by Sponsor|5|||
28168449|NCT02862535|54839063|FG000|Overall Study|Enrolled, not Treated|1|||
28168450|NCT02862535|54839064|FG001|Overall Study|Enrolled, not Treated|0|||
28168451|NCT02862535|54839065|FG002|Overall Study|Enrolled, not Treated|0|||
28168452|NCT02862535|54839066|FG003|Overall Study|Enrolled, not Treated|1|||
28168453|NCT02448706|54839076|FG000|Overall Study|Withdrawal by Subject|4|||
28168454|NCT02448706|54839077|FG001|Overall Study|Withdrawal by Subject|3|||
28168455|NCT02448706|54839076|FG000|Overall Study|Protocol Violation|1|||
28168456|NCT02448706|54839077|FG001|Overall Study|Protocol Violation|1|||
28168457|NCT02868281|54839087|FG000|Overall Study|Adverse Event|2|||
28168458|NCT02868281|54839088|FG001|Overall Study|Adverse Event|2|||
28168459|NCT02868281|54839087|FG000|Overall Study|Protocol Violation|13|||
27833224|NCT00700752|54314705|FG000|First Intervention|Withdrawal by Subject|0|||
27833225|NCT00700752|54314706|FG001|First Intervention|Withdrawal by Subject|2|||
27833226|NCT01747811|54314723|FG000|Overall Study|Lack of Efficacy|2|||
27833227|NCT01747811|54314724|FG001|Overall Study|Lack of Efficacy|4|||
27833228|NCT01747655|54314732|FG000|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5|||
27833229|NCT01747655|54314733|FG001|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0|||
27833230|NCT01747655|54314732|FG000|PEG-J Period (Duodopa Treatment)|Patient Decision|8|||
27833231|NCT01747655|54314733|FG001|PEG-J Period (Duodopa Treatment)|Patient Decision|0|||
27833232|NCT01747655|54314732|FG000|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1|||
27833233|NCT01747655|54314733|FG001|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0|||
28093894|NCT03129100|54748068|FG009|Period2 Extension Period (Group A and B)|Adverse Event|0|||
28093895|NCT03129100|54748069|FG010|Period2 Extension Period (Group A and B)|Adverse Event|0|||
28168460|NCT02868281|54839088|FG001|Overall Study|Protocol Violation|10|||
28168461|NCT02868281|54839087|FG000|Overall Study|Lost to Follow-up|3|||
28168462|NCT02868281|54839088|FG001|Overall Study|Lost to Follow-up|6|||
27833234|NCT01718483|54314741|FG000|Overall Study|Withdrawal by Subject|14|||
27833235|NCT01718483|54314742|FG001|Overall Study|Withdrawal by Subject|12|||
27833236|NCT01718483|54314741|FG000|Overall Study|Adverse Event|5|||
28168463|NCT02868281|54839087|FG000|Overall Study|Withdrawal by Subject|11|||
28168464|NCT02868281|54839088|FG001|Overall Study|Withdrawal by Subject|15|||
28168465|NCT02868281|54839087|FG000|Overall Study|Physician Decision|2|||
28168466|NCT02868281|54839088|FG001|Overall Study|Physician Decision|0|||
28168467|NCT02868281|54839087|FG000|Overall Study|Had protocol-defined asthma exacerbation|8|||
28168468|NCT02868281|54839088|FG001|Overall Study|Had protocol-defined asthma exacerbation|8|||
28093896|NCT03129100|54748070|FG011|Period2 Extension Period (Group A and B)|Adverse Event|0|||
28093897|NCT03129100|54748071|FG012|Period2 Extension Period (Group A and B)|Adverse Event|0|||
28093898|NCT03129100|54748072|FG013|Period2 Extension Period (Group A and B)|Adverse Event|0|||
28093899|NCT03129100|54748073|FG014|Period2 Extension Period (Group A and B)|Adverse Event|0|||
28093900|NCT03129100|54748074|FG015|Period2 Extension Period (Group A and B)|Adverse Event|0|||
28093901|NCT03129100|54748075|FG016|Period2 Extension Period (Group A and B)|Adverse Event|0|||
28093902|NCT03129100|54748076|FG017|Period2 Extension Period (Group A and B)|Adverse Event|0|||
27833237|NCT01718483|54314742|FG001|Overall Study|Adverse Event|12|||
27734878|NCT02332720|54182933|FG014|Part A and Part B|Physician Decision|0|||
27734879|NCT02332720|54182934|FG015|Part A and Part B|Physician Decision|0|||
27734880|NCT02332720|54182935|FG016|Part A and Part B|Physician Decision|0|||
27734881|NCT02332720|54182936|FG017|Part A and Part B|Physician Decision|0|||
27734882|NCT02332720|54182937|FG018|Part A and Part B|Physician Decision|1|||
27734883|NCT02332720|54182938|FG019|Part A and Part B|Physician Decision|0|||
27734884|NCT02332720|54182939|FG020|Part A and Part B|Physician Decision|0|||
27734885|NCT02332720|54182940|FG021|Part A and Part B|Physician Decision|0|||
27734886|NCT02332720|54182941|FG022|Part A and Part B|Physician Decision|0|||
27734887|NCT02332720|54182919|FG000|Part A and Part B|Withdrawal by Subject|0|||
27734888|NCT02332720|54182920|FG001|Part A and Part B|Withdrawal by Subject|0|||
27734889|NCT02332720|54182921|FG002|Part A and Part B|Withdrawal by Subject|0|||
27734890|NCT02332720|54182922|FG003|Part A and Part B|Withdrawal by Subject|0|||
27734891|NCT02332720|54182923|FG004|Part A and Part B|Withdrawal by Subject|0|||
27734892|NCT02332720|54182924|FG005|Part A and Part B|Withdrawal by Subject|1|||
28168469|NCT02868281|54839087|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
28168470|NCT02868281|54839088|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
28168471|NCT02868281|54839087|FG000|Overall Study|Long journey/moving away|1|||
28168472|NCT02868281|54839088|FG001|Overall Study|Long journey/moving away|1|||
28168473|NCT02476006|54839094|FG000|Overall Study|Death|4|||
28168474|NCT02476006|54839094|FG000|Overall Study|Lack of treatment efficacy|2|||
28168475|NCT02476006|54839094|FG000|Overall Study|Pregnancy|1|||
28168476|NCT02476006|54839094|FG000|Overall Study|Participant did not wish to continue|39|||
28168477|NCT02476006|54839094|FG000|Overall Study|Adverse Event|41|||
28168478|NCT02476006|54839094|FG000|Overall Study|Poor compliance to study protocol|3|||
28168479|NCT02476006|54839094|FG000|Overall Study|Sponsor decision|6|||
28168480|NCT02476006|54839094|FG000|Overall Study|Lost to Follow-up|5|||
27734893|NCT02332720|54182925|FG006|Part A and Part B|Withdrawal by Subject|0|||
27734894|NCT02332720|54182926|FG007|Part A and Part B|Withdrawal by Subject|0|||
27833238|NCT01718483|54314741|FG000|Overall Study|Lost to Follow-up|8|||
28168481|NCT02476006|54839094|FG000|Overall Study|Physician Decision|5|||
28168482|NCT02476006|54839094|FG000|Overall Study|Study ended treatment not available|4|||
28168483|NCT02476006|54839094|FG000|Overall Study|Switched to commercial drug|4|||
28168484|NCT02476006|54839094|FG000|Overall Study|Excluded from study|1|||
28168485|NCT02476006|54839094|FG000|Overall Study|Protocol Violation|1|||
28168486|NCT02476006|54839094|FG000|Overall Study|Enrolled but not treated|4|||
28168487|NCT02475850|54839100|FG000|Overall Study|Death|155|||
28168488|NCT02475850|54839101|FG001|Overall Study|Death|141|||
28168489|NCT02475850|54839100|FG000|Overall Study|Lost to Follow-up|217|||
28168490|NCT02475850|54839101|FG001|Overall Study|Lost to Follow-up|188|||
28168491|NCT02475850|54839100|FG000|Overall Study|Withdrawal by Subject|221|||
28168492|NCT02475850|54839101|FG001|Overall Study|Withdrawal by Subject|155|||
28168493|NCT02419612|54839110|FG000|Short-term Treatment Period|Adverse Event|1|||
28168494|NCT02419612|54839111|FG001|Short-term Treatment Period|Adverse Event|1|||
28168495|NCT02419612|54839110|FG000|Short-term Treatment Period|Death|0|||
28168496|NCT02419612|54839111|FG001|Short-term Treatment Period|Death|2|||
28168497|NCT02419612|54839110|FG000|Short-term Treatment Period|Lost to Follow-up|6|||
28168498|NCT02419612|54839111|FG001|Short-term Treatment Period|Lost to Follow-up|6|||
28168499|NCT02419612|54839110|FG000|Short-term Treatment Period|Withdrawal by Subject|9|||
28168500|NCT02419612|54839111|FG001|Short-term Treatment Period|Withdrawal by Subject|9|||
28168501|NCT02419612|54839110|FG000|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
28168502|NCT02419612|54839111|FG001|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
28168503|NCT02419612|54839110|FG000|Short-term Treatment Period|Non-compliance with Study Drug|0|||
28168504|NCT02419612|54839111|FG001|Short-term Treatment Period|Non-compliance with Study Drug|2|||
28168505|NCT02419612|54839110|FG000|Short-term Treatment Period|Worsening of liver function|0|||
28168506|NCT02419612|54839111|FG001|Short-term Treatment Period|Worsening of liver function|1|||
27833239|NCT01718483|54314742|FG001|Overall Study|Lost to Follow-up|3|||
27833240|NCT01718483|54314741|FG000|Overall Study|Protocol Violation|4|||
28093903|NCT03129100|54748077|FG018|Period2 Extension Period (Group A and B)|Adverse Event|0|||
28093904|NCT03129100|54748078|FG019|Period2 Extension Period (Group A and B)|Adverse Event|0|||
28093905|NCT03129100|54748079|FG020|Period2 Extension Period (Group A and B)|Adverse Event|0|||
27734895|NCT02332720|54182927|FG008|Part A and Part B|Withdrawal by Subject|0|||
27833241|NCT01718483|54314742|FG001|Overall Study|Protocol Violation|2|||
27833242|NCT01718483|54314741|FG000|Overall Study|Other|1|||
27734896|NCT02332720|54182928|FG009|Part A and Part B|Withdrawal by Subject|0|||
27833243|NCT01718483|54314742|FG001|Overall Study|Other|4|||
27833244|NCT01718483|54314741|FG000|Overall Study|Pregnancy|1|||
27833245|NCT01718483|54314742|FG001|Overall Study|Pregnancy|1|||
27833246|NCT01718483|54314741|FG000|Overall Study|Lack of Efficacy|1|||
27833247|NCT01718483|54314742|FG001|Overall Study|Lack of Efficacy|0|||
27833248|NCT01717859|54314748|FG000|Overall Study|Adverse Event|5|||
27833249|NCT01717859|54314748|FG000|Overall Study|Moved out of state|1|||
27833250|NCT01717859|54314748|FG000|Overall Study|Patient concerned about mental health|1|||
27833251|NCT01717859|54314748|FG000|Overall Study|Lost to Follow-up|1|||
27833252|NCT01717859|54314748|FG000|Overall Study|Withdrawal by Subject|2|||
27833253|NCT01747499|54315041|FG000|Overall Study|Steroid refractory aGvHD|1|||
27833254|NCT01747499|54315042|FG001|Overall Study|Steroid refractory aGvHD|0|||
27833255|NCT01747499|54315043|FG002|Overall Study|Steroid refractory aGvHD|0|||
27833256|NCT01747499|54315044|FG003|Overall Study|Steroid refractory aGvHD|1|||
27833257|NCT01747499|54315045|FG004|Overall Study|Steroid refractory aGvHD|4|||
27833258|NCT01747499|54315041|FG000|Overall Study|Physician Decision|0|||
27833259|NCT01747499|54315042|FG001|Overall Study|Physician Decision|1|||
27833260|NCT01747499|54315043|FG002|Overall Study|Physician Decision|0|||
28093906|NCT03129100|54748080|FG021|Period2 Extension Period (Group A and B)|Adverse Event|0|||
28093907|NCT03129100|54748081|FG022|Period2 Extension Period (Group A and B)|Adverse Event|0|||
28093908|NCT03129100|54748082|FG023|Period2 Extension Period (Group A and B)|Adverse Event|0|||
28093909|NCT03129100|54748083|FG024|Period2 Extension Period (Group A and B)|Adverse Event|0|||
27855794|NCT01606176|54382328|FG000|Overall Study|Adverse Event|2|||
27855795|NCT01606176|54382329|FG001|Overall Study|Adverse Event|3|||
27855796|NCT01606176|54382328|FG000|Overall Study|Disease progression|1|||
28168507|NCT02419612|54839110|FG000|Short-term Treatment Period|Subject moved out of state|0|||
28168508|NCT02419612|54839111|FG001|Short-term Treatment Period|Subject moved out of state|1|||
28168509|NCT02419612|54839110|FG000|Long-term Treatment Period|Non-compliance with Study Drug|1|||
28168510|NCT02419612|54839111|FG001|Long-term Treatment Period|Non-compliance with Study Drug|1|||
28168511|NCT02419612|54839110|FG000|Long-term Treatment Period|Lost to Follow-up|6|||
28168512|NCT02419612|54839111|FG001|Long-term Treatment Period|Lost to Follow-up|4|||
28168513|NCT02419612|54839110|FG000|Long-term Treatment Period|Lack of Efficacy|1|||
28168514|NCT02419612|54839111|FG001|Long-term Treatment Period|Lack of Efficacy|1|||
28168515|NCT02419612|54839110|FG000|Long-term Treatment Period|Death|0|||
28168516|NCT02419612|54839111|FG001|Long-term Treatment Period|Death|1|||
28168517|NCT02419612|54839110|FG000|Long-term Treatment Period|Adverse Event|0|||
28168518|NCT02419612|54839111|FG001|Long-term Treatment Period|Adverse Event|5|||
27855797|NCT01606176|54382329|FG001|Overall Study|Disease progression|0|||
27855798|NCT01606176|54382328|FG000|Overall Study|Withdrawal by Subject|1|||
27855799|NCT01606176|54382329|FG001|Overall Study|Withdrawal by Subject|0|||
27855800|NCT01663896|54382395|FG000|Overall Study|Various reasons|43|||
27855801|NCT02576652|54382448|FG000|Overall Study|Withdrawal by Subject|2|||
27855802|NCT02575950|54382532|FG000|Overall Study|Withdrawal by Subject|0|||
27855803|NCT02575950|54382533|FG001|Overall Study|Withdrawal by Subject|0|||
27855804|NCT02575950|54382534|FG002|Overall Study|Withdrawal by Subject|0|||
27855805|NCT02575950|54382535|FG003|Overall Study|Withdrawal by Subject|2|||
27855806|NCT02575950|54382532|FG000|Overall Study|Lost to Follow-up|0|||
27855807|NCT02575950|54382533|FG001|Overall Study|Lost to Follow-up|1|||
27855808|NCT02575950|54382534|FG002|Overall Study|Lost to Follow-up|0|||
27855809|NCT02575950|54382535|FG003|Overall Study|Lost to Follow-up|3|||
27855810|NCT01049581|54382634|FG000|Overall Study|Lost to Follow-up|2|||
27855811|NCT01049581|54382635|FG001|Overall Study|Lost to Follow-up|1|||
27855812|NCT02571972|54382653|FG000|Overall Study|Protocol Violation|2|||
27855813|NCT02571972|54382653|FG000|Overall Study|Withdrawal by Subject|2|||
27855814|NCT02166905|54382751|FG000|Overall Study|Withdrawal by Subject|1|||
27855815|NCT02166905|54382752|FG001|Overall Study|Withdrawal by Subject|0|||
28093910|NCT03129100|54748084|FG025|Period2 Extension Period (Group A and B)|Adverse Event|0|||
28093911|NCT03129100|54748059|FG000|Period2 Extension Period (Group A and B)|Death|0|||
28093912|NCT03129100|54748060|FG001|Period2 Extension Period (Group A and B)|Death|0|||
28093913|NCT03129100|54748061|FG002|Period2 Extension Period (Group A and B)|Death|1|||
28093914|NCT03129100|54748062|FG003|Period2 Extension Period (Group A and B)|Death|0|||
28093915|NCT03129100|54748063|FG004|Period2 Extension Period (Group A and B)|Death|0|||
28093916|NCT03129100|54748064|FG005|Period2 Extension Period (Group A and B)|Death|0|||
28093917|NCT03129100|54748065|FG006|Period2 Extension Period (Group A and B)|Death|0|||
27833261|NCT01747499|54315044|FG003|Overall Study|Physician Decision|0|||
27833262|NCT01747499|54315045|FG004|Overall Study|Physician Decision|2|||
27855816|NCT02166905|54382753|FG002|Overall Study|Withdrawal by Subject|0|||
27855817|NCT02166905|54382754|FG003|Overall Study|Withdrawal by Subject|0|||
28168519|NCT02419612|54839110|FG000|Long-term Treatment Period|Other|4|||
27855818|NCT01501955|54382801|FG000|Overall Study|Withdrawal by Subject|1|||
28168520|NCT02419612|54839111|FG001|Long-term Treatment Period|Other|4|||
27855819|NCT01501955|54382802|FG001|Overall Study|Withdrawal by Subject|0|||
27855820|NCT01501955|54382801|FG000|Overall Study|Adverse Event|1|||
27833263|NCT01747499|54315041|FG000|Overall Study|Death|0|||
27833264|NCT01747499|54315042|FG001|Overall Study|Death|0|||
27833265|NCT01747499|54315043|FG002|Overall Study|Death|0|||
28168521|NCT02419612|54839110|FG000|Long-term Treatment Period|Subject Decision|2|||
28168522|NCT02419612|54839111|FG001|Long-term Treatment Period|Subject Decision|4|||
28168523|NCT02419612|54839110|FG000|Long-term Treatment Period|Withdrawal by Subject|8|||
28168524|NCT02419612|54839111|FG001|Long-term Treatment Period|Withdrawal by Subject|2|||
28168525|NCT02447848|54839117|FG000|Overall Study|Patient discharged|3|||
28168526|NCT02447848|54839117|FG000|Overall Study|Lack of Efficacy|4|||
28168527|NCT02447848|54839117|FG000|Overall Study|Withdrawal by Subject|4|||
28093918|NCT03129100|54748066|FG007|Period2 Extension Period (Group A and B)|Death|0|||
28093919|NCT03129100|54748067|FG008|Period2 Extension Period (Group A and B)|Death|0|||
28093920|NCT03129100|54748068|FG009|Period2 Extension Period (Group A and B)|Death|0|||
28093921|NCT03129100|54748069|FG010|Period2 Extension Period (Group A and B)|Death|0|||
28093922|NCT03129100|54748070|FG011|Period2 Extension Period (Group A and B)|Death|0|||
28093923|NCT03129100|54748071|FG012|Period2 Extension Period (Group A and B)|Death|0|||
28093924|NCT03129100|54748072|FG013|Period2 Extension Period (Group A and B)|Death|0|||
28093925|NCT03129100|54748073|FG014|Period2 Extension Period (Group A and B)|Death|0|||
28093926|NCT03129100|54748074|FG015|Period2 Extension Period (Group A and B)|Death|0|||
28093927|NCT03129100|54748075|FG016|Period2 Extension Period (Group A and B)|Death|0|||
28093928|NCT03129100|54748076|FG017|Period2 Extension Period (Group A and B)|Death|0|||
28093929|NCT03129100|54748077|FG018|Period2 Extension Period (Group A and B)|Death|0|||
28093930|NCT03129100|54748078|FG019|Period2 Extension Period (Group A and B)|Death|0|||
28093931|NCT03129100|54748079|FG020|Period2 Extension Period (Group A and B)|Death|0|||
28093932|NCT03129100|54748080|FG021|Period2 Extension Period (Group A and B)|Death|0|||
28093933|NCT03129100|54748081|FG022|Period2 Extension Period (Group A and B)|Death|0|||
28093934|NCT03129100|54748082|FG023|Period2 Extension Period (Group A and B)|Death|0|||
28093935|NCT03129100|54748083|FG024|Period2 Extension Period (Group A and B)|Death|0|||
28093936|NCT03129100|54748084|FG025|Period2 Extension Period (Group A and B)|Death|0|||
28093937|NCT03129100|54748059|FG000|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
28168528|NCT02418910|54839121|FG000|Overall Study|Lost to Follow-up|3|||
28168529|NCT02418910|54839121|FG000|Overall Study|Withdrawal by Subject|4|||
28168530|NCT02418754|54839137|FG000|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
28168531|NCT02418754|54839138|FG001|Period 1 (Day 1 to Week 12)|Adverse Event|2|||
28168532|NCT02418754|54839139|FG002|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
27734897|NCT02332720|54182929|FG010|Part A and Part B|Withdrawal by Subject|0|||
27734898|NCT02332720|54182930|FG011|Part A and Part B|Withdrawal by Subject|0|||
27734899|NCT02332720|54182931|FG012|Part A and Part B|Withdrawal by Subject|0|||
27734900|NCT02332720|54182932|FG013|Part A and Part B|Withdrawal by Subject|0|||
27734901|NCT02332720|54182933|FG014|Part A and Part B|Withdrawal by Subject|0|||
27734902|NCT02332720|54182934|FG015|Part A and Part B|Withdrawal by Subject|0|||
27734903|NCT02332720|54182935|FG016|Part A and Part B|Withdrawal by Subject|0|||
27734904|NCT02332720|54182936|FG017|Part A and Part B|Withdrawal by Subject|0|||
27734905|NCT02332720|54182937|FG018|Part A and Part B|Withdrawal by Subject|0|||
27734906|NCT02332720|54182938|FG019|Part A and Part B|Withdrawal by Subject|1|||
27734907|NCT02332720|54182939|FG020|Part A and Part B|Withdrawal by Subject|0|||
27734908|NCT02332720|54182940|FG021|Part A and Part B|Withdrawal by Subject|0|||
27734909|NCT02332720|54182941|FG022|Part A and Part B|Withdrawal by Subject|0|||
27734910|NCT02331394|54183013|FG000|Overall Study|Disease progression|1|||
27734911|NCT01645930|54183024|FG000|Overall Study|Participants Ongoing on Study Treatment|22|||
27734912|NCT01645930|54183024|FG000|Overall Study|Progressive Disease|12|||
27734913|NCT01645930|54183024|FG000|Overall Study|Adverse Event|4|||
27734914|NCT01645930|54183024|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
27734915|NCT01645930|54183024|FG000|Overall Study|Withdrawal by Participant|2|||
27734916|NCT01645930|54183024|FG000|Overall Study|Reason not Defined|1|||
27734917|NCT02299336|54183028|FG000|Overall Study|Withdrawal by Subject|11|||
27734918|NCT02299336|54183028|FG000|Overall Study|Adverse Event|1|||
27734919|NCT02299336|54183028|FG000|Overall Study|Death|1|||
27734920|NCT02299336|54183028|FG000|Overall Study|Lost to Follow-up|1|||
27734921|NCT02664441|54183034|FG000|Randomization|Withdrawal by Subject|0|||
27734922|NCT02664441|54183035|FG001|Randomization|Withdrawal by Subject|1|||
27833266|NCT01747499|54315044|FG003|Overall Study|Death|1|||
27833267|NCT01747499|54315045|FG004|Overall Study|Death|1|||
27833268|NCT01747499|54315041|FG000|Overall Study|Withdrawal by Subject|0|||
27833269|NCT01747499|54315042|FG001|Overall Study|Withdrawal by Subject|0|||
27833270|NCT01747499|54315043|FG002|Overall Study|Withdrawal by Subject|0|||
27833271|NCT01747499|54315044|FG003|Overall Study|Withdrawal by Subject|0|||
27833272|NCT01747499|54315045|FG004|Overall Study|Withdrawal by Subject|6|||
27855821|NCT01501955|54382802|FG001|Overall Study|Adverse Event|3|||
28093938|NCT03129100|54748060|FG001|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
28168533|NCT02418754|54839140|FG003|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
28168534|NCT02418754|54839141|FG004|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
28168535|NCT02418754|54839137|FG000|Period 1 (Day 1 to Week 12)|Death|1|||
27734923|NCT02664441|54183034|FG000|36-week Randomized Trial|Adverse Event|2|||
27734924|NCT02664441|54183035|FG001|36-week Randomized Trial|Adverse Event|0|||
27734925|NCT02664441|54183034|FG000|36-week Randomized Trial|Lost to Follow-up|1|||
27833273|NCT01747499|54315041|FG000|Overall Study|Developed AML and death|0|||
28093939|NCT03129100|54748061|FG002|Period2 Extension Period (Group A and B)|Withdrawal by Subject|13|||
28168536|NCT02418754|54839138|FG001|Period 1 (Day 1 to Week 12)|Death|0|||
28168537|NCT02418754|54839139|FG002|Period 1 (Day 1 to Week 12)|Death|0|||
28168538|NCT02418754|54839140|FG003|Period 1 (Day 1 to Week 12)|Death|0|||
28168539|NCT02418754|54839141|FG004|Period 1 (Day 1 to Week 12)|Death|0|||
28168540|NCT02418754|54839137|FG000|Period 1 (Day 1 to Week 12)|Physician Decision|1|||
28168541|NCT02418754|54839138|FG001|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
28168542|NCT02418754|54839139|FG002|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
28168543|NCT02418754|54839140|FG003|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
28093940|NCT03129100|54748062|FG003|Period2 Extension Period (Group A and B)|Withdrawal by Subject|5|||
28093941|NCT03129100|54748063|FG004|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
28168544|NCT02418754|54839141|FG004|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
28093942|NCT03129100|54748064|FG005|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
28093943|NCT03129100|54748065|FG006|Period2 Extension Period (Group A and B)|Withdrawal by Subject|2|||
28093944|NCT03129100|54748066|FG007|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
28093945|NCT03129100|54748067|FG008|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
28093946|NCT03129100|54748068|FG009|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
28093947|NCT03129100|54748069|FG010|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
28093948|NCT03129100|54748070|FG011|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
28093949|NCT03129100|54748071|FG012|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
28168545|NCT02418754|54839137|FG000|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
28168546|NCT02418754|54839138|FG001|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2|||
28168547|NCT02418754|54839139|FG002|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1|||
28168548|NCT02418754|54839140|FG003|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
28168549|NCT02418754|54839141|FG004|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
28168550|NCT02418754|54839137|FG000|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
28168551|NCT02418754|54839138|FG001|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
28168552|NCT02418754|54839139|FG002|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1|||
28168553|NCT02418754|54839140|FG003|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
28168554|NCT02418754|54839141|FG004|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
28168555|NCT02418754|54839137|FG000|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3|||
28168556|NCT02418754|54839138|FG001|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7|||
28168557|NCT02418754|54839139|FG002|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6|||
28168558|NCT02418754|54839140|FG003|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
28168559|NCT02418754|54839141|FG004|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
28168560|NCT02418754|54839137|FG000|Period 2 (Day 1 to Week 52/End of Study)|Death|1|||
28168561|NCT02418754|54839138|FG001|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
28168562|NCT02418754|54839139|FG002|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
28168563|NCT02418754|54839140|FG003|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
28168564|NCT02418754|54839141|FG004|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
28168565|NCT02418754|54839137|FG000|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
28168566|NCT02418754|54839138|FG001|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28|||
28168567|NCT02418754|54839139|FG002|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
28168568|NCT02418754|54839140|FG003|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21|||
28168569|NCT02418754|54839141|FG004|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24|||
28168570|NCT02418754|54839137|FG000|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3|||
27980742|NCT00891020|54638733|FG002|Long-term Extension Period|Insufficient therapeutic response|2|||
27980743|NCT00891020|54638731|FG000|Long-term Extension Period|Protocol Violation|0|||
28168571|NCT02418754|54839138|FG001|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
28168572|NCT02418754|54839139|FG002|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
28168573|NCT02418754|54839140|FG003|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1|||
28168574|NCT02418754|54839141|FG004|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0|||
28168575|NCT02418754|54839137|FG000|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0|||
28168576|NCT02418754|54839138|FG001|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
28168577|NCT02418754|54839139|FG002|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
28168578|NCT02418754|54839140|FG003|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
28168579|NCT02418754|54839141|FG004|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
28168580|NCT02418754|54839137|FG000|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
28168581|NCT02418754|54839138|FG001|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
28168582|NCT02418754|54839139|FG002|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
28168583|NCT02418754|54839140|FG003|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
28168584|NCT02418754|54839141|FG004|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
28168585|NCT02447458|54839157|FG000|Overall Study|Other|0|||
28168586|NCT02447458|54839158|FG001|Overall Study|Other|0|||
28168587|NCT02447458|54839159|FG002|Overall Study|Other|1|||
28168588|NCT02447458|54839160|FG003|Overall Study|Other|0|||
28168589|NCT02447458|54839161|FG004|Overall Study|Other|0|||
28093950|NCT03129100|54748072|FG013|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
28093951|NCT03129100|54748073|FG014|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
28093952|NCT03129100|54748074|FG015|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
28093953|NCT03129100|54748075|FG016|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
28093954|NCT03129100|54748076|FG017|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
28093955|NCT03129100|54748077|FG018|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
28093956|NCT03129100|54748078|FG019|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
28093957|NCT03129100|54748079|FG020|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
28168590|NCT02447458|54839162|FG005|Overall Study|Other|0|||
28093958|NCT03129100|54748080|FG021|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
28093959|NCT03129100|54748081|FG022|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
28093960|NCT03129100|54748082|FG023|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
28093961|NCT03129100|54748083|FG024|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
28168591|NCT02862457|54839188|FG000|Overall Study|Death|1|||
28168592|NCT02862457|54839189|FG001|Overall Study|Death|3|||
28168593|NCT02862457|54839190|FG002|Overall Study|Death|2|||
28168594|NCT02862457|54839191|FG003|Overall Study|Death|3|||
28168595|NCT02862457|54839192|FG004|Overall Study|Death|0|||
28168596|NCT02862457|54839193|FG005|Overall Study|Death|2|||
28093962|NCT03129100|54748084|FG025|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
28093963|NCT03129100|54748059|FG000|Period2 Extension Period (Group A and B)|Physician Decision|0|||
28093964|NCT03129100|54748060|FG001|Period2 Extension Period (Group A and B)|Physician Decision|0|||
28093965|NCT03129100|54748061|FG002|Period2 Extension Period (Group A and B)|Physician Decision|1|||
28093966|NCT03129100|54748062|FG003|Period2 Extension Period (Group A and B)|Physician Decision|0|||
28093967|NCT03129100|54748063|FG004|Period2 Extension Period (Group A and B)|Physician Decision|0|||
28093968|NCT03129100|54748064|FG005|Period2 Extension Period (Group A and B)|Physician Decision|0|||
28093969|NCT03129100|54748065|FG006|Period2 Extension Period (Group A and B)|Physician Decision|0|||
28093970|NCT03129100|54748066|FG007|Period2 Extension Period (Group A and B)|Physician Decision|0|||
28093971|NCT03129100|54748067|FG008|Period2 Extension Period (Group A and B)|Physician Decision|0|||
28093972|NCT03129100|54748068|FG009|Period2 Extension Period (Group A and B)|Physician Decision|0|||
28093973|NCT03129100|54748069|FG010|Period2 Extension Period (Group A and B)|Physician Decision|0|||
28093974|NCT03129100|54748070|FG011|Period2 Extension Period (Group A and B)|Physician Decision|0|||
28093975|NCT03129100|54748071|FG012|Period2 Extension Period (Group A and B)|Physician Decision|0|||
28168597|NCT02862457|54839194|FG006|Overall Study|Death|1|||
28168598|NCT02862457|54839188|FG000|Overall Study|Lost to Follow-up|1|||
28168599|NCT02862457|54839189|FG001|Overall Study|Lost to Follow-up|0|||
28168600|NCT02862457|54839190|FG002|Overall Study|Lost to Follow-up|0|||
28168601|NCT02862457|54839191|FG003|Overall Study|Lost to Follow-up|1|||
28168602|NCT02862457|54839192|FG004|Overall Study|Lost to Follow-up|0|||
28168603|NCT02862457|54839193|FG005|Overall Study|Lost to Follow-up|0|||
28168604|NCT02862457|54839194|FG006|Overall Study|Lost to Follow-up|0|||
28168605|NCT02862457|54839188|FG000|Overall Study|Withdrawal by Subject|0|||
28168606|NCT02862457|54839189|FG001|Overall Study|Withdrawal by Subject|0|||
28168607|NCT02862457|54839190|FG002|Overall Study|Withdrawal by Subject|1|||
28168608|NCT02862457|54839191|FG003|Overall Study|Withdrawal by Subject|0|||
27734926|NCT02664441|54183035|FG001|36-week Randomized Trial|Lost to Follow-up|0|||
27734927|NCT02664441|54183034|FG000|36-week Randomized Trial|Withdrawal by Subject|0|||
27734928|NCT02664441|54183035|FG001|36-week Randomized Trial|Withdrawal by Subject|3|||
27734929|NCT02664441|54183034|FG000|18-week Open Label Extension|Adverse Event|1|||
27734930|NCT02664441|54183035|FG001|18-week Open Label Extension|Adverse Event|0|||
27734931|NCT02664441|54183034|FG000|18-week Open Label Extension|Physician Decision|1|||
27734932|NCT02664441|54183035|FG001|18-week Open Label Extension|Physician Decision|0|||
27734933|NCT02664441|54183034|FG000|18-week Open Label Extension|Death|1|||
27734934|NCT02664441|54183035|FG001|18-week Open Label Extension|Death|0|||
27734935|NCT02664441|54183034|FG000|18-week Open Label Extension|Lost to Follow-up|0|||
27734936|NCT02664441|54183035|FG001|18-week Open Label Extension|Lost to Follow-up|1|||
27734937|NCT02298946|54183044|FG000|Overall Study|Did not receive treatment|2|||
27734938|NCT02298946|54183045|FG001|Overall Study|Did not receive treatment|0|||
27833274|NCT01747499|54315042|FG001|Overall Study|Developed AML and death|0|||
27833275|NCT01747499|54315043|FG002|Overall Study|Developed AML and death|0|||
27833276|NCT01747499|54315044|FG003|Overall Study|Developed AML and death|0|||
27833277|NCT01747499|54315045|FG004|Overall Study|Developed AML and death|1|||
28093976|NCT03129100|54748072|FG013|Period2 Extension Period (Group A and B)|Physician Decision|0|||
28168609|NCT02862457|54839192|FG004|Overall Study|Withdrawal by Subject|0|||
28168610|NCT02862457|54839193|FG005|Overall Study|Withdrawal by Subject|1|||
28168611|NCT02862457|54839194|FG006|Overall Study|Withdrawal by Subject|0|||
28168612|NCT02447302|54839221|FG000|Overall Study|Physician Decision|1|||
28168613|NCT02447302|54839222|FG001|Overall Study|Physician Decision|0|||
28168614|NCT02447302|54839223|FG002|Overall Study|Physician Decision|0|||
27734939|NCT02298946|54183044|FG000|Overall Study|Unevaluable|2|||
27734940|NCT02298946|54183045|FG001|Overall Study|Unevaluable|1|||
28093977|NCT03129100|54748073|FG014|Period2 Extension Period (Group A and B)|Physician Decision|0|||
28093978|NCT03129100|54748074|FG015|Period2 Extension Period (Group A and B)|Physician Decision|0|||
28168615|NCT02447302|54839221|FG000|Overall Study|Adverse Event|4|||
27734941|NCT02328040|54183052|FG000|First Intervention (2 Days)|Withdrawal by Subject|1|||
27734942|NCT02328040|54183053|FG001|First Intervention (2 Days)|Withdrawal by Subject|1|||
27734943|NCT01647958|54183061|FG000|Initial Study|Lost to Follow-up|2|||
27734944|NCT01647958|54183062|FG001|Initial Study|Lost to Follow-up|3|||
27734945|NCT01647958|54183061|FG000|Continuation Phase|treatment received during Overall Study|39|||
27734946|NCT01647958|54183062|FG001|Continuation Phase|treatment received during Overall Study|0|||
27734947|NCT01647958|54183061|FG000|Extended Follow-up Phase|Lost to Follow-up|8|||
27734948|NCT01647958|54183062|FG001|Extended Follow-up Phase|Lost to Follow-up|0|||
27734949|NCT02298868|54183077|FG000|Overall Study|Adverse Event|1|||
27734950|NCT02298868|54183077|FG000|Overall Study|Death|1|||
27734951|NCT02298868|54183077|FG000|Overall Study|Patient underwent transplant|1|||
27734952|NCT02327260|54183084|FG000|Overall Study|Lost to Follow-up|2|||
27734953|NCT02327260|54183085|FG001|Overall Study|Lost to Follow-up|3|||
27734954|NCT02327260|54183086|FG002|Overall Study|Lost to Follow-up|2|||
27734955|NCT02327260|54183084|FG000|Overall Study|invalid phone number|1|||
27734956|NCT02327260|54183085|FG001|Overall Study|invalid phone number|1|||
27734957|NCT02327260|54183086|FG002|Overall Study|invalid phone number|0|||
27734958|NCT02327260|54183084|FG000|Overall Study|non-adherence to protocol|2|||
27734959|NCT02327260|54183085|FG001|Overall Study|non-adherence to protocol|0|||
27734960|NCT02327260|54183086|FG002|Overall Study|non-adherence to protocol|0|||
27734961|NCT02327260|54183084|FG000|Overall Study|cognitive concerns|1|||
27734962|NCT02327260|54183085|FG001|Overall Study|cognitive concerns|0|||
27734963|NCT02327260|54183086|FG002|Overall Study|cognitive concerns|0|||
27734964|NCT02296840|54183097|FG000|Overall Study|Adverse Event|1|||
27734965|NCT02296840|54183098|FG001|Overall Study|Adverse Event|1|||
27734966|NCT02296840|54183097|FG000|Overall Study|Protocol Violation|2|||
27734967|NCT02296840|54183098|FG001|Overall Study|Protocol Violation|1|||
27734968|NCT02296840|54183097|FG000|Overall Study|Lost to Follow-up|6|||
27734969|NCT02296840|54183098|FG001|Overall Study|Lost to Follow-up|17|||
27734970|NCT02663895|54183107|FG000|Overall Study|Adverse Event|3|||
27734971|NCT02663895|54183107|FG000|Overall Study|Physician Decision|2|||
27734972|NCT02663895|54183107|FG000|Overall Study|Progressive Systemic Sclerosis (SSc)|1|||
27734973|NCT02663895|54183107|FG000|Overall Study|Withdrawal by Subject|1|||
27734974|NCT02663817|54183112|FG000|Overall Study|Screen failure|2|||
27734975|NCT01372605|54183120|FG000|Overall Study|Death|1|||
27734976|NCT01372605|54183121|FG001|Overall Study|Death|2|||
27734977|NCT01372605|54183120|FG000|Overall Study|Lost to Follow-up|2|||
27734978|NCT01372605|54183121|FG001|Overall Study|Lost to Follow-up|1|||
27734979|NCT01372605|54183120|FG000|Overall Study|Withdrawal by Subject|4|||
27734980|NCT01372605|54183121|FG001|Overall Study|Withdrawal by Subject|7|||
27734981|NCT01372605|54183120|FG000|Overall Study|Moved|3|||
27734982|NCT01372605|54183121|FG001|Overall Study|Moved|0|||
27734983|NCT01372605|54183120|FG000|Overall Study|Changed medical home|2|||
27734984|NCT01372605|54183121|FG001|Overall Study|Changed medical home|0|||
27734985|NCT02751983|54183129|FG000|Treatment|Stopped ACT, but Remained in study|2|||
27734986|NCT02751983|54183130|FG001|Treatment|Stopped ACT, but Remained in study|0|||
27734987|NCT02751983|54183129|FG000|Treatment|Discharged prior to beginning ACT|2|||
28093979|NCT03129100|54748075|FG016|Period2 Extension Period (Group A and B)|Physician Decision|0|||
28093980|NCT03129100|54748076|FG017|Period2 Extension Period (Group A and B)|Physician Decision|0|||
28093981|NCT03129100|54748077|FG018|Period2 Extension Period (Group A and B)|Physician Decision|0|||
28093982|NCT03129100|54748078|FG019|Period2 Extension Period (Group A and B)|Physician Decision|0|||
28093983|NCT03129100|54748079|FG020|Period2 Extension Period (Group A and B)|Physician Decision|0|||
28168616|NCT02447302|54839222|FG001|Overall Study|Adverse Event|3|||
28168617|NCT02447302|54839223|FG002|Overall Study|Adverse Event|0|||
28168618|NCT02447302|54839221|FG000|Overall Study|Withdrawal by Subject|0|||
28168619|NCT02447302|54839222|FG001|Overall Study|Withdrawal by Subject|1|||
28168620|NCT02447302|54839223|FG002|Overall Study|Withdrawal by Subject|5|||
28168621|NCT02447302|54839221|FG000|Overall Study|Sponsor Decision|0|||
28168622|NCT02447302|54839222|FG001|Overall Study|Sponsor Decision|0|||
28168623|NCT02447302|54839223|FG002|Overall Study|Sponsor Decision|1|||
28168624|NCT02454517|54839233|FG000|Overall Study|Withdrawal by Subject|3|||
28168625|NCT02454517|54839234|FG001|Overall Study|Withdrawal by Subject|0|||
28168626|NCT02454517|54839233|FG000|Overall Study|Lost to Follow-up|4|||
28168627|NCT02454517|54839234|FG001|Overall Study|Lost to Follow-up|7|||
28168628|NCT02454517|54839233|FG000|Overall Study|Discontinued Active surveillance and underwent treatment|1|||
28168629|NCT02454517|54839234|FG001|Overall Study|Discontinued Active surveillance and underwent treatment|2|||
27734988|NCT02751983|54183130|FG001|Treatment|Discharged prior to beginning ACT|0|||
27734989|NCT02751983|54183129|FG000|Post-Treatment Assessment|Lost to Follow-up|5|||
27734990|NCT02751983|54183130|FG001|Post-Treatment Assessment|Lost to Follow-up|0|||
27734991|NCT02751983|54183129|FG000|One-Month Follow-Up Assessments|Lost to Follow-up|14|||
27734992|NCT02751983|54183130|FG001|One-Month Follow-Up Assessments|Lost to Follow-up|12|||
28093984|NCT03129100|54748080|FG021|Period2 Extension Period (Group A and B)|Physician Decision|0|||
28093985|NCT03129100|54748081|FG022|Period2 Extension Period (Group A and B)|Physician Decision|0|||
28093986|NCT03129100|54748082|FG023|Period2 Extension Period (Group A and B)|Physician Decision|0|||
28093987|NCT03129100|54748083|FG024|Period2 Extension Period (Group A and B)|Physician Decision|0|||
28093988|NCT03129100|54748084|FG025|Period2 Extension Period (Group A and B)|Physician Decision|0|||
28093989|NCT03129100|54748059|FG000|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
28093990|NCT03129100|54748060|FG001|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
28093991|NCT03129100|54748061|FG002|Period2 Extension Period (Group A and B)|Lack of Efficacy|2|||
28093992|NCT03129100|54748062|FG003|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
28093993|NCT03129100|54748063|FG004|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
28093994|NCT03129100|54748064|FG005|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
28093995|NCT03129100|54748065|FG006|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
28093996|NCT03129100|54748066|FG007|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
28093997|NCT03129100|54748067|FG008|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
28093998|NCT03129100|54748068|FG009|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
28168630|NCT03861039|54839245|FG000|Overall Study|Adverse Event|2|||
28168631|NCT03861039|54839246|FG001|Overall Study|Adverse Event|5|||
28168632|NCT03861039|54839247|FG002|Overall Study|Adverse Event|11|||
28168633|NCT03861039|54839245|FG000|Overall Study|Withdrawal by Subject|1|||
27734993|NCT02751983|54183129|FG000|Three-Month Follow-Up Assessments|Lost to Follow-up|12|||
27734994|NCT02751983|54183130|FG001|Three-Month Follow-Up Assessments|Lost to Follow-up|16|||
27734995|NCT00232141|54183150|FG000|Overall Study|Adverse Event|9|||
27734996|NCT00232141|54183151|FG001|Overall Study|Adverse Event|4|||
27734997|NCT00232141|54183150|FG000|Overall Study|Lack of Efficacy|0|||
27734998|NCT00232141|54183151|FG001|Overall Study|Lack of Efficacy|3|||
27734999|NCT00232141|54183150|FG000|Overall Study|Lost to Follow-up|9|||
27735000|NCT00232141|54183151|FG001|Overall Study|Lost to Follow-up|6|||
27735001|NCT00232141|54183150|FG000|Overall Study|Other|8|||
27735002|NCT00232141|54183151|FG001|Overall Study|Other|10|||
27735003|NCT00232141|54183150|FG000|Overall Study|Withdrawal by Subject|5|||
27735004|NCT00232141|54183151|FG001|Overall Study|Withdrawal by Subject|3|||
27735005|NCT02741245|54183180|FG000|Overall Study|Adverse Event|0|||
27735006|NCT02741245|54183181|FG001|Overall Study|Adverse Event|0|||
28168634|NCT03861039|54839246|FG001|Overall Study|Withdrawal by Subject|3|||
28168635|NCT03861039|54839247|FG002|Overall Study|Withdrawal by Subject|4|||
28168636|NCT02731755|54839257|FG000|First Intervention|Withdrawal by Subject|0|||
28168637|NCT02731755|54839258|FG001|First Intervention|Withdrawal by Subject|2|||
28168638|NCT02866175|54839287|FG000|Overall Study|Adverse Event|56|||
28168639|NCT02866175|54839288|FG001|Overall Study|Adverse Event|54|||
28168640|NCT02866175|54839287|FG000|Overall Study|Withdrawal by Subject|31|||
28168641|NCT02866175|54839288|FG001|Overall Study|Withdrawal by Subject|52|||
28168642|NCT02866175|54839287|FG000|Overall Study|Death|30|||
28168643|NCT02866175|54839288|FG001|Overall Study|Death|23|||
28168644|NCT02866175|54839287|FG000|Overall Study|Other|7|||
28168645|NCT02866175|54839288|FG001|Overall Study|Other|14|||
28168646|NCT02866175|54839287|FG000|Overall Study|Progressive disease|1|||
28168647|NCT02866175|54839288|FG001|Overall Study|Progressive disease|1|||
28168648|NCT02866175|54839287|FG000|Overall Study|Lost to Follow-up|2|||
28168649|NCT02866175|54839288|FG001|Overall Study|Lost to Follow-up|0|||
28168650|NCT02866175|54839287|FG000|Overall Study|Lack of Efficacy|0|||
28168651|NCT02866175|54839288|FG001|Overall Study|Lack of Efficacy|1|||
28168652|NCT02866175|54839287|FG000|Overall Study|Physician Decision|3|||
28168653|NCT02866175|54839288|FG001|Overall Study|Physician Decision|15|||
28168654|NCT02866175|54839287|FG000|Overall Study|Did not receive treatment|5|||
28168655|NCT02866175|54839288|FG001|Overall Study|Did not receive treatment|15|||
28168656|NCT01336205|54839301|FG000|Overall Study|Other|22|||
28168657|NCT01336205|54839302|FG001|Overall Study|Other|9|||
28168658|NCT01336205|54839301|FG000|Overall Study|Lost to Follow-up|40|||
28168659|NCT01336205|54839302|FG001|Overall Study|Lost to Follow-up|20|||
28168660|NCT01336205|54839301|FG000|Overall Study|Study-Specific Withdrawal Criteria|16|||
28168661|NCT01336205|54839302|FG001|Overall Study|Study-Specific Withdrawal Criteria|7|||
28168662|NCT01336205|54839301|FG000|Overall Study|Lack of Efficacy|4|||
28168663|NCT01336205|54839302|FG001|Overall Study|Lack of Efficacy|0|||
27735007|NCT02741245|54183182|FG002|Overall Study|Adverse Event|0|||
27735008|NCT02741245|54183183|FG003|Overall Study|Adverse Event|2|||
27735009|NCT02741245|54183184|FG004|Overall Study|Adverse Event|2|||
28168664|NCT01336205|54839301|FG000|Overall Study|Severe noncompliance with protocol|9|||
28168665|NCT01336205|54839302|FG001|Overall Study|Severe noncompliance with protocol|2|||
27735010|NCT02741245|54183180|FG000|Overall Study|Protocol Violation|0|||
28093999|NCT03129100|54748069|FG010|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
28094000|NCT03129100|54748070|FG011|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
28168666|NCT01336205|54839301|FG000|Overall Study|Adverse Event|56|||
28168667|NCT01336205|54839302|FG001|Overall Study|Adverse Event|6|||
28168668|NCT01336205|54839301|FG000|Overall Study|Death|1|||
28168669|NCT01336205|54839302|FG001|Overall Study|Death|1|||
28094001|NCT03129100|54748071|FG012|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
28094002|NCT03129100|54748072|FG013|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
28094003|NCT03129100|54748073|FG014|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
28094004|NCT03129100|54748074|FG015|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
28094005|NCT03129100|54748075|FG016|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
28094006|NCT03129100|54748076|FG017|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
28094007|NCT03129100|54748077|FG018|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
28094008|NCT03129100|54748078|FG019|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
28094009|NCT03129100|54748079|FG020|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
28094010|NCT03129100|54748080|FG021|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
28094011|NCT03129100|54748081|FG022|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
28094012|NCT03129100|54748082|FG023|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
28094013|NCT03129100|54748083|FG024|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
28094014|NCT03129100|54748084|FG025|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
28094015|NCT03129100|54748059|FG000|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
28094016|NCT03129100|54748060|FG001|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
28094017|NCT03129100|54748061|FG002|Period2 Extension Period (Group A and B)|Lost to Follow-up|2|||
28094018|NCT03129100|54748062|FG003|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
28094019|NCT03129100|54748063|FG004|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
28094020|NCT03129100|54748064|FG005|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
28094021|NCT03129100|54748065|FG006|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
28094022|NCT03129100|54748066|FG007|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
28094023|NCT03129100|54748067|FG008|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
28094024|NCT03129100|54748068|FG009|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
28094025|NCT03129100|54748069|FG010|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
28094026|NCT03129100|54748070|FG011|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
28094027|NCT03129100|54748071|FG012|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
28094028|NCT03129100|54748072|FG013|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
28094029|NCT03129100|54748073|FG014|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
28094030|NCT03129100|54748074|FG015|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
28094031|NCT03129100|54748075|FG016|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
28094032|NCT03129100|54748076|FG017|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
28094033|NCT03129100|54748077|FG018|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
28094034|NCT03129100|54748078|FG019|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
28094035|NCT03129100|54748079|FG020|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
28094036|NCT03129100|54748080|FG021|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
28094037|NCT03129100|54748081|FG022|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
28094038|NCT03129100|54748082|FG023|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
28094039|NCT03129100|54748083|FG024|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
28094040|NCT03129100|54748084|FG025|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
28094041|NCT03129100|54748059|FG000|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
28094042|NCT03129100|54748060|FG001|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
28094043|NCT03129100|54748061|FG002|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
28094044|NCT03129100|54748062|FG003|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
28094045|NCT03129100|54748063|FG004|Period2 Extension Period (Group A and B)|Experienced Flare|5|||
28094046|NCT03129100|54748064|FG005|Period2 Extension Period (Group A and B)|Experienced Flare|6|||
28094047|NCT03129100|54748065|FG006|Period2 Extension Period (Group A and B)|Experienced Flare|19|||
28094048|NCT03129100|54748066|FG007|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
28094049|NCT03129100|54748067|FG008|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
28094050|NCT03129100|54748068|FG009|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
28094051|NCT03129100|54748069|FG010|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
28094052|NCT03129100|54748070|FG011|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
28094053|NCT03129100|54748071|FG012|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
28094054|NCT03129100|54748072|FG013|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
28094055|NCT03129100|54748073|FG014|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
28094056|NCT03129100|54748074|FG015|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
28094057|NCT03129100|54748075|FG016|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
28094058|NCT03129100|54748076|FG017|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
28094059|NCT03129100|54748077|FG018|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
28094060|NCT03129100|54748078|FG019|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
27735011|NCT02741245|54183181|FG001|Overall Study|Protocol Violation|1|||
27855822|NCT02574312|54382930|FG000|3 Months Follow-up|Withdrawal by Subject|1|||
28094061|NCT03129100|54748079|FG020|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
28094062|NCT03129100|54748080|FG021|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
28094063|NCT03129100|54748081|FG022|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
28094064|NCT03129100|54748082|FG023|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
27855823|NCT02574312|54382931|FG001|3 Months Follow-up|Withdrawal by Subject|0|||
27855824|NCT01049035|54382953|FG000|Overall Study|Serious adverse event|0|||
27735012|NCT02741245|54183182|FG002|Overall Study|Protocol Violation|0|||
27735013|NCT02741245|54183183|FG003|Overall Study|Protocol Violation|1|||
27735014|NCT02741245|54183184|FG004|Overall Study|Protocol Violation|0|||
27735015|NCT02741245|54183180|FG000|Overall Study|Withdrawal by Subject|0|||
27735016|NCT02741245|54183181|FG001|Overall Study|Withdrawal by Subject|0|||
27735017|NCT02741245|54183182|FG002|Overall Study|Withdrawal by Subject|0|||
27735018|NCT02741245|54183183|FG003|Overall Study|Withdrawal by Subject|1|||
27735019|NCT02741245|54183184|FG004|Overall Study|Withdrawal by Subject|0|||
27735020|NCT03227757|54183196|FG000|Overall Study|Death|7|||
27735021|NCT03227757|54183196|FG000|Overall Study|Withdrawal|5|||
27735022|NCT03227757|54183196|FG000|Overall Study|Missed visits|4|||
27735023|NCT02751827|54183203|FG000|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
27735024|NCT02751827|54183204|FG001|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
27735025|NCT02751827|54183205|FG002|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|1|||
27735026|NCT04896593|54183222|FG000|Overall Study|Withdrawal by Subject|2|||
27735027|NCT04896593|54183222|FG000|Overall Study|Lost to Follow-up|1|||
27735028|NCT04896593|54183222|FG000|Overall Study|Did not complete onboarding|2|||
27735029|NCT04601272|54183238|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
27735030|NCT04601272|54183239|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|3|||
27735031|NCT04601272|54183240|FG002|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
27735032|NCT04059484|54183259|FG000|Overall Study|Adverse Event|2|||
27735033|NCT04059484|54183260|FG001|Overall Study|Adverse Event|5|||
27735034|NCT04059484|54183259|FG000|Overall Study|Withdrawal by Subject|5|||
27735035|NCT04059484|54183260|FG001|Overall Study|Withdrawal by Subject|3|||
27735036|NCT04059484|54183259|FG000|Overall Study|Progressive disease|112|||
27735037|NCT04059484|54183260|FG001|Overall Study|Progressive disease|112|||
27735038|NCT04059484|54183259|FG000|Overall Study|Other|8|||
27735039|NCT04059484|54183260|FG001|Overall Study|Other|3|||
27735040|NCT04059484|54183259|FG000|Overall Study|Ongoing|20|||
27735041|NCT04059484|54183260|FG001|Overall Study|Ongoing|20|||
27735042|NCT03965091|54183272|FG000|Overall Study|Adverse Event|0|||
27735043|NCT03965091|54183273|FG001|Overall Study|Adverse Event|2|||
27735044|NCT03965091|54183274|FG002|Overall Study|Adverse Event|3|||
27735045|NCT03965091|54183272|FG000|Overall Study|Withdrawal by Subject|11|||
27735046|NCT03965091|54183273|FG001|Overall Study|Withdrawal by Subject|3|||
27735047|NCT03965091|54183274|FG002|Overall Study|Withdrawal by Subject|5|||
27735048|NCT03965091|54183272|FG000|Overall Study|Non-compliance with study drug|0|||
27735049|NCT03965091|54183273|FG001|Overall Study|Non-compliance with study drug|0|||
27735050|NCT03965091|54183274|FG002|Overall Study|Non-compliance with study drug|1|||
27735051|NCT03965091|54183272|FG000|Overall Study|Lost to Follow-up|1|||
27735052|NCT03965091|54183273|FG001|Overall Study|Lost to Follow-up|1|||
27735053|NCT03965091|54183274|FG002|Overall Study|Lost to Follow-up|1|||
27735054|NCT03965091|54183272|FG000|Overall Study|Lack of Efficacy|2|||
27735055|NCT03965091|54183273|FG001|Overall Study|Lack of Efficacy|0|||
27735056|NCT03965091|54183274|FG002|Overall Study|Lack of Efficacy|0|||
27735057|NCT03965091|54183272|FG000|Overall Study|Other than specified|9|||
27735058|NCT03965091|54183273|FG001|Overall Study|Other than specified|11|||
27735059|NCT03965091|54183274|FG002|Overall Study|Other than specified|8|||
27735060|NCT03359096|54183301|FG000|HGNS Washout (1 Week)|Withdrawal by Subject|0|||
27735061|NCT03359096|54183302|FG001|HGNS Washout (1 Week)|Withdrawal by Subject|1|||
27735062|NCT03359096|54183301|FG000|First Intervention (4 Weeks)|Death|1|||
27735063|NCT03359096|54183302|FG001|First Intervention (4 Weeks)|Death|0|||
27735064|NCT03359096|54183301|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
27855825|NCT01049035|54382954|FG001|Overall Study|Serious adverse event|1|||
28094065|NCT03129100|54748083|FG024|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
28094066|NCT03129100|54748084|FG025|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
28094067|NCT03129100|54748059|FG000|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
27735065|NCT03359096|54183302|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
27980744|NCT00891020|54638732|FG001|Long-term Extension Period|Protocol Violation|1|||
27980745|NCT00891020|54638733|FG002|Long-term Extension Period|Protocol Violation|1|||
27735068|NCT03019588|54183340|FG000|Overall Study|Death|44|||
27735069|NCT03019588|54183341|FG001|Overall Study|Death|46|||
27735070|NCT03019588|54183340|FG000|Overall Study|Study terminated by Sponsor|3|||
27735071|NCT03019588|54183341|FG001|Overall Study|Study terminated by Sponsor|1|||
27980746|NCT00891020|54638731|FG000|Long-term Extension Period|Refused treatment/did not cooperate|1|||
27855826|NCT01049035|54382955|FG002|Overall Study|Serious adverse event|1|||
27855827|NCT01049035|54382956|FG003|Overall Study|Serious adverse event|2|||
27855828|NCT01049035|54382957|FG004|Overall Study|Serious adverse event|0|||
27855829|NCT01049035|54382958|FG005|Overall Study|Serious adverse event|0|||
27855830|NCT01049035|54382959|FG006|Overall Study|Serious adverse event|0|||
27855831|NCT01049035|54382953|FG000|Overall Study|Other adverse event (AE)|0|||
27855832|NCT01049035|54382954|FG001|Overall Study|Other adverse event (AE)|0|||
27855833|NCT01049035|54382955|FG002|Overall Study|Other adverse event (AE)|0|||
27855834|NCT01049035|54382956|FG003|Overall Study|Other adverse event (AE)|1|||
27855835|NCT01049035|54382957|FG004|Overall Study|Other adverse event (AE)|0|||
27855836|NCT01049035|54382958|FG005|Overall Study|Other adverse event (AE)|0|||
27855837|NCT01049035|54382959|FG006|Overall Study|Other adverse event (AE)|0|||
27855838|NCT01049035|54382953|FG000|Overall Study|Non-compliance with the protocol|12|||
27855839|NCT01049035|54382954|FG001|Overall Study|Non-compliance with the protocol|6|||
27855840|NCT01049035|54382955|FG002|Overall Study|Non-compliance with the protocol|14|||
27855841|NCT01049035|54382956|FG003|Overall Study|Non-compliance with the protocol|5|||
27855842|NCT01049035|54382957|FG004|Overall Study|Non-compliance with the protocol|3|||
27855843|NCT01049035|54382958|FG005|Overall Study|Non-compliance with the protocol|4|||
27855844|NCT01049035|54382959|FG006|Overall Study|Non-compliance with the protocol|10|||
27855845|NCT01049035|54382953|FG000|Overall Study|Lost to Follow-up|5|||
27855846|NCT01049035|54382954|FG001|Overall Study|Lost to Follow-up|4|||
27855847|NCT01049035|54382955|FG002|Overall Study|Lost to Follow-up|4|||
27855848|NCT01049035|54382956|FG003|Overall Study|Lost to Follow-up|1|||
27855849|NCT01049035|54382957|FG004|Overall Study|Lost to Follow-up|0|||
27855850|NCT01049035|54382958|FG005|Overall Study|Lost to Follow-up|3|||
27855851|NCT01049035|54382959|FG006|Overall Study|Lost to Follow-up|3|||
27855852|NCT01049035|54382953|FG000|Overall Study|Voluntary withdrawal not due to an AE|16|||
28168670|NCT01336205|54839301|FG000|Overall Study|Eligibility Criteria Not Fulfilled|9|||
28168671|NCT01336205|54839302|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
28168672|NCT01336205|54839301|FG000|Overall Study|Withdrawal by Subject|72|||
28168673|NCT01336205|54839302|FG001|Overall Study|Withdrawal by Subject|38|||
28168674|NCT01336205|54839301|FG000|Overall Study|Did not receive treatment|4|||
28168675|NCT01336205|54839302|FG001|Overall Study|Did not receive treatment|0|||
28168676|NCT02865395|54839311|FG000|Overall Study|Physician Decision|6|||
28168677|NCT02865395|54839312|FG001|Overall Study|Physician Decision|10|||
28168678|NCT02865395|54839313|FG002|Overall Study|Physician Decision|7|||
28168679|NCT01123707|54839325|FG000|Overall Study|Lost to Follow-up|3|||
28168680|NCT01123707|54839326|FG001|Overall Study|Lost to Follow-up|1|||
28168681|NCT01123707|54839327|FG002|Overall Study|Lost to Follow-up|3|||
27855853|NCT01049035|54382954|FG001|Overall Study|Voluntary withdrawal not due to an AE|10|||
27855854|NCT01049035|54382955|FG002|Overall Study|Voluntary withdrawal not due to an AE|8|||
28168682|NCT01123707|54839328|FG003|Overall Study|Lost to Follow-up|2|||
28168683|NCT01123707|54839325|FG000|Overall Study|Adverse Event|5|||
28168684|NCT01123707|54839326|FG001|Overall Study|Adverse Event|7|||
28168685|NCT01123707|54839327|FG002|Overall Study|Adverse Event|5|||
28168686|NCT01123707|54839328|FG003|Overall Study|Adverse Event|3|||
28168687|NCT01123707|54839325|FG000|Overall Study|Sponsor Discontinued Study|30|||
28168688|NCT01123707|54839326|FG001|Overall Study|Sponsor Discontinued Study|24|||
27735072|NCT02455557|54183373|FG000|Overall Study|Withdrawal by Subject|2|||
27855855|NCT01049035|54382956|FG003|Overall Study|Voluntary withdrawal not due to an AE|2|||
27855856|NCT01049035|54382957|FG004|Overall Study|Voluntary withdrawal not due to an AE|1|||
27855857|NCT01049035|54382958|FG005|Overall Study|Voluntary withdrawal not due to an AE|5|||
27855858|NCT01049035|54382959|FG006|Overall Study|Voluntary withdrawal not due to an AE|2|||
27855859|NCT01048333|54382985|FG000|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
27855860|NCT01048333|54382986|FG001|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1|||
27855861|NCT01048333|54382987|FG002|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
27855862|NCT01048333|54382988|FG003|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
27855863|NCT01048333|54382989|FG004|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
27855864|NCT01048333|54382990|FG005|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
27855865|NCT02323113|54383005|FG000|Overall Study|Adverse Event|3|||
27855866|NCT02323113|54383006|FG001|Overall Study|Adverse Event|3|||
27980747|NCT00891020|54638732|FG001|Long-term Extension Period|Refused treatment/did not cooperate|6|||
27735073|NCT02270450|54183381|FG000|Overall Study|Refusal unrelated to adverse event|3|||
27855867|NCT02323113|54383007|FG002|Overall Study|Adverse Event|2|||
27855868|NCT02323113|54383008|FG003|Overall Study|Adverse Event|5|||
27855869|NCT02323113|54383009|FG004|Overall Study|Adverse Event|8|||
27855870|NCT02323113|54383010|FG005|Overall Study|Adverse Event|3|||
27980748|NCT00891020|54638733|FG002|Long-term Extension Period|Refused treatment/did not cooperate|4|||
28168689|NCT01123707|54839327|FG002|Overall Study|Sponsor Discontinued Study|25|||
28168690|NCT01123707|54839328|FG003|Overall Study|Sponsor Discontinued Study|40|||
28168691|NCT01123707|54839325|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
28168692|NCT01123707|54839326|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
28168693|NCT01123707|54839327|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
27855871|NCT02323113|54383011|FG006|Overall Study|Adverse Event|6|||
27855872|NCT02323113|54383012|FG007|Overall Study|Adverse Event|0|||
27855873|NCT02323113|54383005|FG000|Overall Study|Progressive Disease|0|||
27855874|NCT02323113|54383006|FG001|Overall Study|Progressive Disease|1|||
27855875|NCT02323113|54383007|FG002|Overall Study|Progressive Disease|1|||
27855876|NCT02323113|54383008|FG003|Overall Study|Progressive Disease|0|||
27855877|NCT02323113|54383009|FG004|Overall Study|Progressive Disease|0|||
27855878|NCT02323113|54383010|FG005|Overall Study|Progressive Disease|3|||
27855879|NCT02323113|54383011|FG006|Overall Study|Progressive Disease|0|||
27855880|NCT02323113|54383012|FG007|Overall Study|Progressive Disease|0|||
27855881|NCT02323113|54383005|FG000|Overall Study|Symptomatic Deterioration|0|||
28094068|NCT03129100|54748060|FG001|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
28094069|NCT03129100|54748061|FG002|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
28094070|NCT03129100|54748062|FG003|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
28094071|NCT03129100|54748063|FG004|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
28094072|NCT03129100|54748064|FG005|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
28094073|NCT03129100|54748065|FG006|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
28094074|NCT03129100|54748066|FG007|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
27735074|NCT02270450|54183382|FG001|Overall Study|Refusal unrelated to adverse event|1|||
27735075|NCT02270450|54183383|FG002|Overall Study|Refusal unrelated to adverse event|5|||
27735076|NCT02270450|54183384|FG003|Overall Study|Refusal unrelated to adverse event|14|||
27735077|NCT02270450|54183381|FG000|Overall Study|Progression/relapse|1|||
27735078|NCT02270450|54183382|FG001|Overall Study|Progression/relapse|2|||
27735079|NCT02270450|54183383|FG002|Overall Study|Progression/relapse|4|||
27735080|NCT02270450|54183384|FG003|Overall Study|Progression/relapse|9|||
27735081|NCT02270450|54183381|FG000|Overall Study|Death|19|||
27735082|NCT02270450|54183382|FG001|Overall Study|Death|19|||
27735083|NCT02270450|54183383|FG002|Overall Study|Death|31|||
27735084|NCT02270450|54183384|FG003|Overall Study|Death|59|||
27735085|NCT01570868|54183407|FG000|Overall Study|Adverse Event|8|||
27735086|NCT01570868|54183408|FG001|Overall Study|Adverse Event|1|||
27735087|NCT01570868|54183407|FG000|Overall Study|FDA Recommendation|23|||
27735088|NCT01570868|54183408|FG001|Overall Study|FDA Recommendation|3|||
27735089|NCT01570868|54183407|FG000|Overall Study|Physician Decision|10|||
27735090|NCT01570868|54183408|FG001|Overall Study|Physician Decision|4|||
27735091|NCT01570868|54183407|FG000|Overall Study|Lost to Follow-up|1|||
27735092|NCT01570868|54183408|FG001|Overall Study|Lost to Follow-up|0|||
27735093|NCT01570868|54183407|FG000|Overall Study|Withdrawal by Subject|1|||
27735094|NCT01570868|54183408|FG001|Overall Study|Withdrawal by Subject|0|||
27735095|NCT01565499|54183418|FG000|Overall Study|Physician Decision|1|||
27735096|NCT01565499|54183418|FG000|Overall Study|Adverse Event|5|||
27735097|NCT01565499|54183418|FG000|Overall Study|Withdrawal by Subject|2|||
27735098|NCT01036087|54183422|FG000|Overall Study|Adverse Event|2|||
27735099|NCT01036087|54183422|FG000|Overall Study|Lack of Efficacy|1|||
27735100|NCT00572156|54183439|FG000|Overall Study|Adverse Event|3|||
27735101|NCT00572156|54183440|FG001|Overall Study|Adverse Event|1|||
27735102|NCT00572156|54183441|FG002|Overall Study|Adverse Event|5|||
27735103|NCT00572156|54183442|FG003|Overall Study|Adverse Event|1|||
27735104|NCT00572156|54183439|FG000|Overall Study|Lost to Follow-up|1|||
27833278|NCT01747499|54315041|FG000|Overall Study|Determined not to be eligible|0|||
27833279|NCT01747499|54315042|FG001|Overall Study|Determined not to be eligible|0|||
27833280|NCT01747499|54315043|FG002|Overall Study|Determined not to be eligible|0|||
27833281|NCT01747499|54315044|FG003|Overall Study|Determined not to be eligible|0|||
27833282|NCT01747499|54315045|FG004|Overall Study|Determined not to be eligible|1|||
27833283|NCT01717391|54315077|FG000|Overall Study|Withdrawal by Subject|5|||
27833284|NCT01717391|54315077|FG000|Overall Study|Physician Decision|1|||
27833285|NCT01717391|54315077|FG000|Overall Study|FLT technical failure|3|||
27833286|NCT01746017|54315220|FG000|Period 1|Withdrawal by Subject|0|||
27833287|NCT01746017|54315221|FG001|Period 1|Withdrawal by Subject|0|||
27833288|NCT01746017|54315222|FG002|Period 1|Withdrawal by Subject|0|||
27855882|NCT02323113|54383006|FG001|Overall Study|Symptomatic Deterioration|0|||
28094075|NCT03129100|54748067|FG008|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
28094076|NCT03129100|54748068|FG009|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|1|||
28094077|NCT03129100|54748069|FG010|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
28094078|NCT03129100|54748070|FG011|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
28094079|NCT03129100|54748071|FG012|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
28094080|NCT03129100|54748072|FG013|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
28094081|NCT03129100|54748073|FG014|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
27735105|NCT00572156|54183440|FG001|Overall Study|Lost to Follow-up|1|||
27735106|NCT00572156|54183441|FG002|Overall Study|Lost to Follow-up|1|||
27735107|NCT00572156|54183442|FG003|Overall Study|Lost to Follow-up|0|||
27735108|NCT00572156|54183439|FG000|Overall Study|Protocol Violation|1|||
27735109|NCT00572156|54183440|FG001|Overall Study|Protocol Violation|2|||
27833289|NCT01746017|54315223|FG003|Period 1|Withdrawal by Subject|0|||
27833290|NCT01746017|54315224|FG004|Period 1|Withdrawal by Subject|0|||
27855883|NCT02323113|54383007|FG002|Overall Study|Symptomatic Deterioration|1|||
27735110|NCT00572156|54183441|FG002|Overall Study|Protocol Violation|0|||
27735111|NCT00572156|54183442|FG003|Overall Study|Protocol Violation|2|||
27735112|NCT00572156|54183439|FG000|Overall Study|Patient/Parent Decision|1|||
27735113|NCT00572156|54183440|FG001|Overall Study|Patient/Parent Decision|6|||
27735114|NCT00572156|54183441|FG002|Overall Study|Patient/Parent Decision|4|||
28168694|NCT01123707|54839328|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
28168695|NCT01123707|54839325|FG000|Overall Study|Investigator Withdrew Participant|0|||
28168696|NCT01123707|54839326|FG001|Overall Study|Investigator Withdrew Participant|1|||
27735115|NCT00572156|54183442|FG003|Overall Study|Patient/Parent Decision|3|||
27735116|NCT00572156|54183439|FG000|Overall Study|Sponsor Decision|20|||
27735117|NCT00572156|54183440|FG001|Overall Study|Sponsor Decision|16|||
27735118|NCT00572156|54183441|FG002|Overall Study|Sponsor Decision|17|||
28168697|NCT01123707|54839327|FG002|Overall Study|Investigator Withdrew Participant|1|||
28168698|NCT01123707|54839328|FG003|Overall Study|Investigator Withdrew Participant|1|||
28168699|NCT01123707|54839325|FG000|Overall Study|Subject Withdrew Consent|4|||
28168700|NCT01123707|54839326|FG001|Overall Study|Subject Withdrew Consent|5|||
28168701|NCT01123707|54839327|FG002|Overall Study|Subject Withdrew Consent|1|||
28168702|NCT01123707|54839328|FG003|Overall Study|Subject Withdrew Consent|2|||
27735119|NCT00572156|54183442|FG003|Overall Study|Sponsor Decision|19|||
27735120|NCT00447772|54183452|FG000|Overall Study|Lack of Efficacy|3|||
27735121|NCT00447772|54183452|FG000|Overall Study|Insufficient compliance|6|||
27735122|NCT00447772|54183452|FG000|Overall Study|Discontinuation of drug therapy|1|||
27735123|NCT00447772|54183452|FG000|Overall Study|Lost to Follow-up|9|||
27735124|NCT00447772|54183452|FG000|Overall Study|Withdrawal by Subject|1|||
27735125|NCT00447772|54183452|FG000|Overall Study|Unable to attend all study visits|2|||
27735126|NCT00447772|54183452|FG000|Overall Study|Adverse Event|1|||
27735127|NCT00447772|54183452|FG000|Overall Study|Patient relocated|1|||
27735128|NCT00447772|54183452|FG000|Overall Study|Incomplete documentation at visit 1|1|||
27735129|NCT00447772|54183452|FG000|Overall Study|Chemotherapy for lung cancer|1|||
27735130|NCT00447772|54183452|FG000|Overall Study|Premature re-injection required|1|||
27735131|NCT02296138|54183461|FG000|Overall Study|Adverse Event|348|||
27735132|NCT02296138|54183462|FG001|Overall Study|Adverse Event|259|||
27735133|NCT02296138|54183461|FG000|Overall Study|Lack of Efficacy|59|||
27735134|NCT02296138|54183462|FG001|Overall Study|Lack of Efficacy|37|||
27735135|NCT02296138|54183461|FG000|Overall Study|Protocol Violation|35|||
27735136|NCT02296138|54183462|FG001|Overall Study|Protocol Violation|36|||
27735137|NCT02296138|54183461|FG000|Overall Study|Lost to Follow-up|9|||
27735138|NCT02296138|54183462|FG001|Overall Study|Lost to Follow-up|12|||
27735139|NCT02296138|54183461|FG000|Overall Study|Withdrawal by Subject|184|||
27735140|NCT02296138|54183462|FG001|Overall Study|Withdrawal by Subject|131|||
27735141|NCT02296138|54183461|FG000|Overall Study|Not Treated|1|||
27735142|NCT02296138|54183462|FG001|Overall Study|Not Treated|1|||
27735143|NCT02296138|54183461|FG000|Overall Study|Patients with data irregularities|10|||
27735144|NCT02296138|54183462|FG001|Overall Study|Patients with data irregularities|11|||
27735145|NCT02296138|54183461|FG000|Overall Study|Other than specified|15|||
27735146|NCT02296138|54183462|FG001|Overall Study|Other than specified|13|||
27735147|NCT01306942|54183471|FG000|Phase I|Adverse Event|2|||
27735148|NCT01306942|54183472|FG001|Phase I|Adverse Event|2|||
27735149|NCT01306942|54183473|FG002|Phase I|Adverse Event|0|||
27735150|NCT01306942|54183474|FG003|Phase I|Adverse Event|0|||
27735151|NCT01306942|54183471|FG000|Phase I|Physician Decision|3|||
27735152|NCT01306942|54183472|FG001|Phase I|Physician Decision|1|||
27735153|NCT01306942|54183473|FG002|Phase I|Physician Decision|0|||
27735154|NCT01306942|54183474|FG003|Phase I|Physician Decision|0|||
27735155|NCT01306942|54183471|FG000|Phase II|Adverse Event|0|||
27735156|NCT01306942|54183472|FG001|Phase II|Adverse Event|0|||
27735157|NCT01306942|54183473|FG002|Phase II|Adverse Event|0|||
27735158|NCT01306942|54183474|FG003|Phase II|Adverse Event|6|||
27735159|NCT01306942|54183471|FG000|Phase II|Physician Decision|2|||
27735160|NCT01306942|54183472|FG001|Phase II|Physician Decision|0|||
27735161|NCT01306942|54183473|FG002|Phase II|Physician Decision|0|||
27735162|NCT01306942|54183474|FG003|Phase II|Physician Decision|5|||
27735163|NCT01306942|54183471|FG000|Phase II|Withdrawal by Subject|0|||
27735164|NCT01306942|54183472|FG001|Phase II|Withdrawal by Subject|0|||
27735165|NCT01306942|54183473|FG002|Phase II|Withdrawal by Subject|0|||
27735166|NCT01306942|54183474|FG003|Phase II|Withdrawal by Subject|2|||
27735167|NCT01306942|54183471|FG000|Phase II|Death|0|||
27735168|NCT01306942|54183472|FG001|Phase II|Death|0|||
27735169|NCT01306942|54183473|FG002|Phase II|Death|0|||
27735170|NCT01306942|54183474|FG003|Phase II|Death|1|||
28168703|NCT01123707|54839325|FG000|Overall Study|Lack of Efficacy|1|||
27735171|NCT01306942|54183471|FG000|Phase II|Not finished treatment|0|||
27735172|NCT01306942|54183472|FG001|Phase II|Not finished treatment|0|||
27735173|NCT01306942|54183473|FG002|Phase II|Not finished treatment|0|||
27735174|NCT01306942|54183474|FG003|Phase II|Not finished treatment|1|||
27735175|NCT01306942|54183471|FG000|Phase II|Protocol Violation|0|||
27735176|NCT01306942|54183472|FG001|Phase II|Protocol Violation|0|||
27735177|NCT01306942|54183473|FG002|Phase II|Protocol Violation|0|||
27735178|NCT01306942|54183474|FG003|Phase II|Protocol Violation|1|||
27735179|NCT02324842|54183489|FG000|Overall Study|Lost to Follow-up|1|||
27735180|NCT02324842|54183490|FG001|Overall Study|Lost to Follow-up|1|||
27735181|NCT02324842|54183491|FG002|Overall Study|Lost to Follow-up|2|||
27735182|NCT02295280|54183501|FG000|Overall Study|Adverse Event|0|||
27735183|NCT02295280|54183502|FG001|Overall Study|Adverse Event|1|||
27735184|NCT02294734|54183510|FG000|Overall Study|Adverse Event|5|||
27735185|NCT02294734|54183511|FG001|Overall Study|Adverse Event|5|||
27735186|NCT02294734|54183510|FG000|Overall Study|Met Protocol Defined Stopping Criteria|1|||
27833291|NCT01746017|54315225|FG005|Period 1|Withdrawal by Subject|0|||
27980749|NCT00891020|54638731|FG000|Long-term Extension Period|Failure to return|0|||
28094082|NCT03129100|54748074|FG015|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
28094083|NCT03129100|54748075|FG016|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
28094084|NCT03129100|54748076|FG017|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
28094085|NCT03129100|54748077|FG018|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
28094086|NCT03129100|54748078|FG019|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
28094087|NCT03129100|54748079|FG020|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
28094088|NCT03129100|54748080|FG021|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
28094089|NCT03129100|54748081|FG022|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
28094090|NCT03129100|54748082|FG023|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
28094091|NCT03129100|54748083|FG024|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
28094092|NCT03129100|54748084|FG025|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
28094093|NCT03129100|54748059|FG000|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
28168704|NCT01123707|54839326|FG001|Overall Study|Lack of Efficacy|2|||
28168705|NCT01123707|54839327|FG002|Overall Study|Lack of Efficacy|1|||
28168706|NCT01123707|54839328|FG003|Overall Study|Lack of Efficacy|0|||
28168707|NCT01123707|54839325|FG000|Overall Study|Subject Met Exclusion Criteria|0|||
28168708|NCT01123707|54839326|FG001|Overall Study|Subject Met Exclusion Criteria|0|||
28168709|NCT01123707|54839327|FG002|Overall Study|Subject Met Exclusion Criteria|2|||
28168710|NCT01123707|54839328|FG003|Overall Study|Subject Met Exclusion Criteria|1|||
28168711|NCT02755103|54839340|FG000|Overall Study|Lost to Follow-up|17|||
28168712|NCT02755103|54839341|FG001|Overall Study|Lost to Follow-up|15|||
28168713|NCT02755103|54839340|FG000|Overall Study|Death|0|||
28168714|NCT02755103|54839341|FG001|Overall Study|Death|1|||
28168715|NCT02755103|54839340|FG000|Overall Study|Physician Decision|0|||
28168716|NCT02755103|54839341|FG001|Overall Study|Physician Decision|1|||
28168717|NCT02755103|54839340|FG000|Overall Study|Pregnancy|0|||
28168718|NCT02755103|54839341|FG001|Overall Study|Pregnancy|1|||
28168719|NCT02755103|54839340|FG000|Overall Study|Withdrawal by Subject|3|||
28168720|NCT02755103|54839341|FG001|Overall Study|Withdrawal by Subject|0|||
28168721|NCT01258803|54839351|FG000|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
28168722|NCT01258803|54839352|FG001|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
28168723|NCT01258803|54839353|FG002|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
28168724|NCT01258803|54839354|FG003|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
28168725|NCT01258803|54839355|FG004|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
28168726|NCT01258803|54839356|FG005|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
28168727|NCT01258803|54839351|FG000|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
28168728|NCT01258803|54839352|FG001|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1|||
28168729|NCT01258803|54839353|FG002|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
28168730|NCT01258803|54839354|FG003|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
28168731|NCT01258803|54839355|FG004|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
28168732|NCT01258803|54839356|FG005|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
28168733|NCT01258803|54839351|FG000|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
28168734|NCT01258803|54839352|FG001|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
28168735|NCT01258803|54839353|FG002|Treatment Period 3 (1 Dose)|Protocol Violation|1|||
27833292|NCT01746017|54315226|FG006|Period 1|Withdrawal by Subject|1|||
27833293|NCT01746017|54315227|FG007|Period 1|Withdrawal by Subject|0|||
28094094|NCT03129100|54748060|FG001|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
28168736|NCT01258803|54839354|FG003|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
28168737|NCT01258803|54839355|FG004|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
27833294|NCT01746017|54315228|FG008|Period 1|Withdrawal by Subject|0|||
27833295|NCT01746017|54315229|FG009|Period 1|Withdrawal by Subject|0|||
27833296|NCT01746017|54315230|FG010|Period 1|Withdrawal by Subject|0|||
27833297|NCT01746017|54315220|FG000|Period 3|Withdrawal by Subject|0|||
27980750|NCT00891020|54638732|FG001|Long-term Extension Period|Failure to return|2|||
27980751|NCT00891020|54638733|FG002|Long-term Extension Period|Failure to return|3|||
27980752|NCT00891020|54638731|FG000|Long-term Extension Period|Administrative|1|||
27980753|NCT00891020|54638732|FG001|Long-term Extension Period|Administrative|2|||
28168738|NCT01258803|54839356|FG005|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
28168739|NCT02865083|54839372|FG000|Overall Study|Early Termination|3|||
28168740|NCT02865083|54839373|FG001|Overall Study|Early Termination|1|||
27735187|NCT02294734|54183511|FG001|Overall Study|Met Protocol Defined Stopping Criteria|0|||
27735188|NCT02294734|54183510|FG000|Overall Study|Lost to Follow-up|2|||
27833298|NCT01746017|54315221|FG001|Period 3|Withdrawal by Subject|0|||
27735189|NCT02294734|54183511|FG001|Overall Study|Lost to Follow-up|0|||
27735190|NCT02294734|54183510|FG000|Overall Study|Physician Decision|2|||
27735191|NCT02294734|54183511|FG001|Overall Study|Physician Decision|1|||
27735192|NCT02294734|54183510|FG000|Overall Study|Withdrawal by Subject|4|||
27735193|NCT02294734|54183511|FG001|Overall Study|Withdrawal by Subject|2|||
27735194|NCT02323204|54183532|FG000|Baseline Survey Completion|Withdrawal by Subject|10|||
27735195|NCT02323204|54183533|FG001|Baseline Survey Completion|Withdrawal by Subject|9|||
27735196|NCT02323204|54183534|FG002|Baseline Survey Completion|Withdrawal by Subject|5|||
27735197|NCT02323204|54183535|FG003|Baseline Survey Completion|Withdrawal by Subject|3|||
27735198|NCT02323204|54183532|FG000|6-week Follow-up Survey Completion|Lost to Follow-up|29|||
27735199|NCT02323204|54183533|FG001|6-week Follow-up Survey Completion|Lost to Follow-up|28|||
27735200|NCT02323204|54183534|FG002|6-week Follow-up Survey Completion|Lost to Follow-up|39|||
27735201|NCT02323204|54183535|FG003|6-week Follow-up Survey Completion|Lost to Follow-up|35|||
27735202|NCT02323204|54183532|FG000|6-week Follow-up Survey Completion|Withdrawal by Subject|12|||
27735203|NCT02323204|54183533|FG001|6-week Follow-up Survey Completion|Withdrawal by Subject|8|||
27735204|NCT02323204|54183534|FG002|6-week Follow-up Survey Completion|Withdrawal by Subject|3|||
27735205|NCT02323204|54183535|FG003|6-week Follow-up Survey Completion|Withdrawal by Subject|2|||
27735206|NCT02323204|54183532|FG000|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
27735207|NCT02323204|54183533|FG001|6-week Follow-up Intervention Booster|Lost to Follow-up|35|||
27735208|NCT02323204|54183534|FG002|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
27735209|NCT02323204|54183535|FG003|6-week Follow-up Intervention Booster|Lost to Follow-up|34|||
27735210|NCT02323204|54183532|FG000|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
27735211|NCT02323204|54183533|FG001|6-week Follow-up Intervention Booster|Withdrawal by Subject|8|||
27735212|NCT02323204|54183534|FG002|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
27735213|NCT02323204|54183535|FG003|6-week Follow-up Intervention Booster|Withdrawal by Subject|2|||
27735214|NCT02323204|54183532|FG000|3-month Follow-up Survey Completion|Lost to Follow-up|54|||
27735215|NCT02323204|54183533|FG001|3-month Follow-up Survey Completion|Lost to Follow-up|45|||
27735216|NCT02323204|54183534|FG002|3-month Follow-up Survey Completion|Lost to Follow-up|41|||
27735217|NCT02323204|54183535|FG003|3-month Follow-up Survey Completion|Lost to Follow-up|42|||
28168741|NCT00862251|54839382|FG000|Overall Study|Adverse Event|8|||
28168742|NCT00862251|54839383|FG001|Overall Study|Adverse Event|3|||
28168743|NCT00862251|54839384|FG002|Overall Study|Adverse Event|1|||
28168744|NCT00862251|54839382|FG000|Overall Study|Lost to Follow-up|0|||
28168745|NCT00862251|54839383|FG001|Overall Study|Lost to Follow-up|0|||
28168746|NCT00862251|54839384|FG002|Overall Study|Lost to Follow-up|1|||
28168747|NCT00862251|54839382|FG000|Overall Study|Protocol Violation|2|||
28168748|NCT00862251|54839383|FG001|Overall Study|Protocol Violation|0|||
28168749|NCT00862251|54839384|FG002|Overall Study|Protocol Violation|1|||
28168750|NCT00862251|54839382|FG000|Overall Study|Withdrawal by Subject|9|||
28168751|NCT00862251|54839383|FG001|Overall Study|Withdrawal by Subject|2|||
28168752|NCT00862251|54839384|FG002|Overall Study|Withdrawal by Subject|6|||
28168753|NCT02864381|54839413|FG000|Overall Study|Death|58|||
28168754|NCT02864381|54839414|FG001|Overall Study|Death|61|||
28168755|NCT02864381|54839413|FG000|Overall Study|Withdrew Consent|5|||
28168756|NCT02864381|54839414|FG001|Overall Study|Withdrew Consent|6|||
28168757|NCT02864381|54839413|FG000|Overall Study|Reason Unknown|7|||
28168758|NCT02864381|54839414|FG001|Overall Study|Reason Unknown|3|||
28168759|NCT02864381|54839413|FG000|Overall Study|Lost to Follow-up|1|||
28168760|NCT02864381|54839414|FG001|Overall Study|Lost to Follow-up|1|||
28168761|NCT02864381|54839413|FG000|Overall Study|Investigator's Discretion|1|||
28168762|NCT02864381|54839414|FG001|Overall Study|Investigator's Discretion|0|||
28168763|NCT02864381|54839413|FG000|Overall Study|Protocol Violation|0|||
28168764|NCT02864381|54839414|FG001|Overall Study|Protocol Violation|1|||
28168765|NCT02860169|54839422|FG000|Part A|Withdrawal by Subject|1|||
28168766|NCT02860169|54839422|FG000|Part A|Other (Screening failure)|6|||
28168767|NCT02860169|54839422|FG000|Part A|Other (Survey not completed)|3|||
28168768|NCT02860169|54839422|FG000|Part A|Other (did not completed consent)|1|||
28168769|NCT02860169|54839422|FG000|Part B|Other (Screening failure)|10|||
28168770|NCT02860169|54839422|FG000|Part B|Withdrawal by Subject|1|||
28168771|NCT02860169|54839422|FG000|Part C|Other (Screening failure)|1|||
28168772|NCT00409773|54839433|FG000|Overall Study|Adverse Event|3|||
28168773|NCT00409773|54839434|FG001|Overall Study|Adverse Event|4|||
28168774|NCT00409773|54839435|FG002|Overall Study|Adverse Event|4|||
27735218|NCT02323204|54183532|FG000|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
27735219|NCT02323204|54183533|FG001|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
27735220|NCT02323204|54183534|FG002|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
27735221|NCT02323204|54183535|FG003|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
27833299|NCT01746017|54315222|FG002|Period 3|Withdrawal by Subject|0|||
28168775|NCT00409773|54839436|FG003|Overall Study|Adverse Event|2|||
28168776|NCT00409773|54839437|FG004|Overall Study|Adverse Event|6|||
28168777|NCT00409773|54839433|FG000|Overall Study|Lost to Follow-up|6|||
28168778|NCT00409773|54839434|FG001|Overall Study|Lost to Follow-up|1|||
28168779|NCT00409773|54839435|FG002|Overall Study|Lost to Follow-up|2|||
28168780|NCT00409773|54839436|FG003|Overall Study|Lost to Follow-up|3|||
27735222|NCT02323204|54183532|FG000|6-month Follow-up Survey Completion|Lost to Follow-up|49|||
27735223|NCT02323204|54183533|FG001|6-month Follow-up Survey Completion|Lost to Follow-up|50|||
27735224|NCT02323204|54183534|FG002|6-month Follow-up Survey Completion|Lost to Follow-up|38|||
27735225|NCT02323204|54183535|FG003|6-month Follow-up Survey Completion|Lost to Follow-up|43|||
27735226|NCT02323204|54183532|FG000|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
27735227|NCT02323204|54183533|FG001|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
27735228|NCT02323204|54183534|FG002|6-month Follow-up Survey Completion|Withdrawal by Subject|3|||
27735229|NCT02323204|54183535|FG003|6-month Follow-up Survey Completion|Withdrawal by Subject|1|||
27735230|NCT02322892|54183547|FG000|Overall Study|Surgery cancelled|1|||
27735231|NCT02322892|54183548|FG001|Overall Study|Surgery cancelled|2|||
27735232|NCT02322892|54183547|FG000|Overall Study|Met exclusion criteria|0|||
27735233|NCT02322892|54183548|FG001|Overall Study|Met exclusion criteria|1|||
27735234|NCT02322892|54183547|FG000|Overall Study|Protocol Violation|1|||
27735235|NCT02322892|54183548|FG001|Overall Study|Protocol Violation|0|||
27735236|NCT03916081|54183557|FG000|Overall Study|Adverse Event|1|||
27735237|NCT03916081|54183558|FG001|Overall Study|Adverse Event|0|||
27735238|NCT03916081|54183559|FG002|Overall Study|Adverse Event|0|||
27735239|NCT03916081|54183557|FG000|Overall Study|Physician Decision|0|||
27735240|NCT03916081|54183558|FG001|Overall Study|Physician Decision|0|||
27735241|NCT03916081|54183559|FG002|Overall Study|Physician Decision|1|||
27735242|NCT03916081|54183557|FG000|Overall Study|Lost to Follow-up|0|||
27735243|NCT03916081|54183558|FG001|Overall Study|Lost to Follow-up|1|||
27735244|NCT03916081|54183559|FG002|Overall Study|Lost to Follow-up|0|||
27735245|NCT03916081|54183557|FG000|Overall Study|Withdrawal by Subject|3|||
28168781|NCT00409773|54839437|FG004|Overall Study|Lost to Follow-up|1|||
28168782|NCT00409773|54839433|FG000|Overall Study|Physician Decision|0|||
28168783|NCT00409773|54839434|FG001|Overall Study|Physician Decision|0|||
28168784|NCT00409773|54839435|FG002|Overall Study|Physician Decision|0|||
28168785|NCT00409773|54839436|FG003|Overall Study|Physician Decision|2|||
28168786|NCT00409773|54839437|FG004|Overall Study|Physician Decision|0|||
28168787|NCT00409773|54839433|FG000|Overall Study|Protocol Violation|0|||
28168788|NCT00409773|54839434|FG001|Overall Study|Protocol Violation|2|||
28168789|NCT00409773|54839435|FG002|Overall Study|Protocol Violation|3|||
28168790|NCT00409773|54839436|FG003|Overall Study|Protocol Violation|3|||
27735246|NCT03916081|54183558|FG001|Overall Study|Withdrawal by Subject|0|||
27735247|NCT03916081|54183559|FG002|Overall Study|Withdrawal by Subject|1|||
27735248|NCT03916081|54183557|FG000|Overall Study|Worsening of AD|0|||
27735249|NCT03916081|54183558|FG001|Overall Study|Worsening of AD|0|||
27735250|NCT03916081|54183559|FG002|Overall Study|Worsening of AD|1|||
27735251|NCT02739997|54183567|FG000|Overall Study|Death|1|||
27735252|NCT02739997|54183567|FG000|Overall Study|Withdrawal by Subject|1|||
27735253|NCT02221037|54183575|FG000|Overall Study|Physician Decision|0|||
27735254|NCT02221037|54183576|FG001|Overall Study|Physician Decision|0|||
27735255|NCT02221037|54183577|FG002|Overall Study|Physician Decision|1|||
27735256|NCT02221037|54183578|FG003|Overall Study|Physician Decision|0|||
27735257|NCT02704429|54183594|FG000|Part A: 24 Weeks|Adverse Event|3|||
27735258|NCT02704429|54183595|FG001|Part A: 24 Weeks|Adverse Event|0|||
27735259|NCT02704429|54183594|FG000|Part B: 28 Weeks|Worsening of pemphigus|0|||
27735260|NCT02704429|54183595|FG001|Part B: 28 Weeks|Worsening of pemphigus|1|||
27735261|NCT02751359|54183602|FG000|Overall Study|Lost to Follow-up|1|||
27735262|NCT02750813|54183621|FG000|Period 1, First 14 Days of Wear|Withdrawal by Subject|1|||
27735263|NCT02750813|54183622|FG001|Period 1, First 14 Days of Wear|Withdrawal by Subject|0|||
27735264|NCT02750813|54183621|FG000|Period 1, First 14 Days of Wear|Reason not given|0|||
27735265|NCT02750813|54183622|FG001|Period 1, First 14 Days of Wear|Reason not given|1|||
27735266|NCT00503035|54183638|FG000|Overall Study|Lost to Follow-up|2|||
27735267|NCT00503035|54183638|FG000|Overall Study|Physician Decision|3|||
27735268|NCT00503035|54183638|FG000|Overall Study|Ineligible|15|||
27735269|NCT03137381|54183647|FG000|Overall Study|Adverse Event|3|||
27735270|NCT03137381|54183648|FG001|Overall Study|Adverse Event|0|||
27735271|NCT03137381|54183649|FG002|Overall Study|Adverse Event|2|||
27735272|NCT03137381|54183650|FG003|Overall Study|Adverse Event|0|||
27735273|NCT03137381|54183647|FG000|Overall Study|Lost to Follow-up|2|||
27735274|NCT03137381|54183648|FG001|Overall Study|Lost to Follow-up|1|||
27735275|NCT03137381|54183649|FG002|Overall Study|Lost to Follow-up|1|||
27735276|NCT03137381|54183650|FG003|Overall Study|Lost to Follow-up|0|||
27735277|NCT03137381|54183647|FG000|Overall Study|Protocol deviation|1|||
27735278|NCT03137381|54183648|FG001|Overall Study|Protocol deviation|1|||
27735279|NCT03137381|54183649|FG002|Overall Study|Protocol deviation|0|||
27735280|NCT03137381|54183650|FG003|Overall Study|Protocol deviation|1|||
27735281|NCT03137381|54183647|FG000|Overall Study|Withdrawal by Investigator|0|||
27735282|NCT03137381|54183648|FG001|Overall Study|Withdrawal by Investigator|1|||
27735283|NCT03137381|54183649|FG002|Overall Study|Withdrawal by Investigator|1|||
27735284|NCT03137381|54183650|FG003|Overall Study|Withdrawal by Investigator|0|||
27735285|NCT03137381|54183647|FG000|Overall Study|Withdrawal by Subject|3|||
28168791|NCT00409773|54839437|FG004|Overall Study|Protocol Violation|1|||
27735286|NCT03137381|54183648|FG001|Overall Study|Withdrawal by Subject|4|||
27833300|NCT01746017|54315223|FG003|Period 3|Withdrawal by Subject|0|||
27735287|NCT03137381|54183649|FG002|Overall Study|Withdrawal by Subject|3|||
27735288|NCT03137381|54183650|FG003|Overall Study|Withdrawal by Subject|0|||
27735289|NCT03137381|54183647|FG000|Overall Study|Pregnancy|0|||
27735290|NCT03137381|54183648|FG001|Overall Study|Pregnancy|0|||
27735291|NCT03137381|54183649|FG002|Overall Study|Pregnancy|1|||
27735292|NCT03137381|54183650|FG003|Overall Study|Pregnancy|0|||
27735293|NCT02750501|54183677|FG000|Overall Study|Adverse Event|4|||
27735294|NCT02750501|54183677|FG000|Overall Study|Physician Decision|1|||
27735295|NCT02750501|54183677|FG000|Overall Study|Protocol Violation|1|||
27735296|NCT02750501|54183677|FG000|Overall Study|G-tube came out|1|||
27735297|NCT02750501|54183677|FG000|Overall Study|Non-compliant use of PERT|1|||
27735298|NCT01337297|54183691|FG000|Overall Study|They entered to single anodal tDCS|4|||
27735299|NCT01337297|54183692|FG001|Overall Study|They entered to single anodal tDCS|3|||
27735300|NCT01337297|54183691|FG000|Overall Study|Lost to Follow-up|1|||
27735301|NCT01337297|54183692|FG001|Overall Study|Lost to Follow-up|3|||
27735302|NCT02302963|54183700|FG000|Overall Study|Withdrawal by Subject|2|||
27735303|NCT02302963|54183701|FG001|Overall Study|Withdrawal by Subject|1|||
27735304|NCT02302963|54183700|FG000|Overall Study|Steroid injection|0|||
27735305|NCT02302963|54183701|FG001|Overall Study|Steroid injection|1|||
27735306|NCT02302963|54183700|FG000|Overall Study|Physician Decision|1|||
27735307|NCT02302963|54183701|FG001|Overall Study|Physician Decision|0|||
27735308|NCT04702997|54183709|FG000|Overall Study|Withdrawal by Subject|1|||
27735309|NCT04702997|54183710|FG001|Overall Study|Withdrawal by Subject|1|||
27735310|NCT03507439|54183731|FG000|Overall Study|Other|2|||
27735311|NCT03507439|54183732|FG001|Overall Study|Other|1|||
27735312|NCT03507439|54183731|FG000|Overall Study|Withdrawal by Subject|1|||
27735313|NCT03507439|54183732|FG001|Overall Study|Withdrawal by Subject|0|||
27735314|NCT03507439|54183731|FG000|Overall Study|Death|1|||
27735315|NCT03507439|54183732|FG001|Overall Study|Death|1|||
27735316|NCT03507127|54183740|FG000|Overall Study|Withdrawal by Subject|1|||
27735317|NCT03507127|54183741|FG001|Overall Study|Withdrawal by Subject|0|||
27735318|NCT03507127|54183740|FG000|Overall Study|Unable to meet smoking abstinence criterion|1|||
27735319|NCT03507127|54183741|FG001|Overall Study|Unable to meet smoking abstinence criterion|1|||
27735320|NCT02322190|54183764|FG000|Overall Study|Death on study|1|||
27735321|NCT02322190|54183765|FG001|Overall Study|Death on study|0|||
27735322|NCT02321800|54183781|FG000|Overall Study|Withdrawal by Subject|3|||
28168792|NCT00409773|54839433|FG000|Overall Study|Withdrawal by Subject|0|||
28168793|NCT00409773|54839434|FG001|Overall Study|Withdrawal by Subject|0|||
28168794|NCT00409773|54839435|FG002|Overall Study|Withdrawal by Subject|0|||
28168795|NCT00409773|54839436|FG003|Overall Study|Withdrawal by Subject|2|||
28168796|NCT00409773|54839437|FG004|Overall Study|Withdrawal by Subject|1|||
28168797|NCT00409773|54839433|FG000|Overall Study|Lack of Eligibility|0|||
28168798|NCT00409773|54839434|FG001|Overall Study|Lack of Eligibility|0|||
28168799|NCT00409773|54839435|FG002|Overall Study|Lack of Eligibility|0|||
28168800|NCT00409773|54839436|FG003|Overall Study|Lack of Eligibility|0|||
28168801|NCT00409773|54839437|FG004|Overall Study|Lack of Eligibility|1|||
28168802|NCT02861807|54839451|FG000|Overall Study|Lost to Follow-up|7|||
27735323|NCT02321800|54183782|FG001|Overall Study|Withdrawal by Subject|3|||
27735324|NCT02321800|54183781|FG000|Overall Study|Death|1|||
27735325|NCT02321800|54183782|FG001|Overall Study|Death|0|||
27735326|NCT02321800|54183781|FG000|Overall Study|Protocol Violation|1|||
27735327|NCT02321800|54183782|FG001|Overall Study|Protocol Violation|0|||
27735328|NCT02321800|54183781|FG000|Overall Study|Lost to Follow-up|10|||
27735329|NCT02321800|54183782|FG001|Overall Study|Lost to Follow-up|4|||
27735330|NCT02321800|54183781|FG000|Overall Study|Adverse Event|2|||
27735331|NCT02321800|54183782|FG001|Overall Study|Adverse Event|3|||
27735332|NCT02321800|54183781|FG000|Overall Study|Other, Miscellaneous|3|||
27735333|NCT02321800|54183782|FG001|Overall Study|Other, Miscellaneous|1|||
27735334|NCT02292784|54183828|FG000|Overall Study|Lost to Follow-up|1|||
27735335|NCT02292784|54183829|FG001|Overall Study|Lost to Follow-up|17|||
27735336|NCT02292784|54183830|FG002|Overall Study|Lost to Follow-up|18|||
27735337|NCT02292784|54183828|FG000|Overall Study|Withdrawal by Subject|0|||
27735338|NCT02292784|54183829|FG001|Overall Study|Withdrawal by Subject|3|||
27735339|NCT02292784|54183830|FG002|Overall Study|Withdrawal by Subject|3|||
27735340|NCT02320396|54183840|FG000|Overall Study|Adverse Event|2|||
27735341|NCT02320396|54183841|FG001|Overall Study|Adverse Event|2|||
27735342|NCT02320396|54183840|FG000|Overall Study|Pregnancy|0|||
27735343|NCT02320396|54183841|FG001|Overall Study|Pregnancy|1|||
27735344|NCT02320396|54183840|FG000|Overall Study|Protocol Violation|0|||
28168803|NCT02861807|54839452|FG001|Overall Study|Lost to Follow-up|6|||
28168804|NCT02861807|54839451|FG000|Overall Study|Withdrawal by Subject|5|||
27735345|NCT02320396|54183841|FG001|Overall Study|Protocol Violation|1|||
27735346|NCT02320396|54183840|FG000|Overall Study|Withdrawal by Subject|2|||
27735347|NCT02320396|54183841|FG001|Overall Study|Withdrawal by Subject|0|||
27735348|NCT02292238|54183849|FG000|Overall Study|Protocol Violation|1|||
27735349|NCT02292238|54183850|FG001|Overall Study|Protocol Violation|2|||
27735350|NCT02292238|54183849|FG000|Overall Study|Withdrawal by Subject|2|||
27735351|NCT02292238|54183850|FG001|Overall Study|Withdrawal by Subject|1|||
27735352|NCT02292238|54183849|FG000|Overall Study|Lost to Follow-up|1|||
27735353|NCT02292238|54183850|FG001|Overall Study|Lost to Follow-up|0|||
27735354|NCT02292238|54183849|FG000|Overall Study|Physician Decision|0|||
27735355|NCT02292238|54183850|FG001|Overall Study|Physician Decision|1|||
27735356|NCT02234843|54183887|FG000|Overall Study|Death|1|||
27735357|NCT02234843|54183888|FG001|Overall Study|Death|0|||
27735358|NCT02234843|54183889|FG002|Overall Study|Death|0|||
27735359|NCT02234843|54183890|FG003|Overall Study|Death|0|||
27735360|NCT02234843|54183891|FG004|Overall Study|Death|0|||
27735361|NCT02234843|54183892|FG005|Overall Study|Death|0|||
27735362|NCT02234843|54183893|FG006|Overall Study|Death|0|||
27735363|NCT02234843|54183894|FG007|Overall Study|Death|0|||
27735364|NCT02234843|54183895|FG008|Overall Study|Death|0|||
27735365|NCT02234843|54183896|FG009|Overall Study|Death|0|||
27735366|NCT02234843|54183887|FG000|Overall Study|Protocol Violation|1|||
27735367|NCT02234843|54183888|FG001|Overall Study|Protocol Violation|0|||
27735368|NCT02234843|54183889|FG002|Overall Study|Protocol Violation|1|||
27735369|NCT02234843|54183890|FG003|Overall Study|Protocol Violation|0|||
27735370|NCT02234843|54183891|FG004|Overall Study|Protocol Violation|0|||
27735371|NCT02234843|54183892|FG005|Overall Study|Protocol Violation|0|||
27735372|NCT02234843|54183893|FG006|Overall Study|Protocol Violation|0|||
28168805|NCT02861807|54839452|FG001|Overall Study|Withdrawal by Subject|8|||
28168806|NCT02858401|54839465|FG000|Overall Study|Withdrew Consent|0|||
28168807|NCT02858401|54839466|FG001|Overall Study|Withdrew Consent|0|||
28168808|NCT02858401|54839467|FG002|Overall Study|Withdrew Consent|0|||
28168809|NCT02858401|54839468|FG003|Overall Study|Withdrew Consent|0|||
28168810|NCT02858401|54839469|FG004|Overall Study|Withdrew Consent|0|||
28168811|NCT02858401|54839470|FG005|Overall Study|Withdrew Consent|1|||
28168812|NCT02858401|54839471|FG006|Overall Study|Withdrew Consent|0|||
28168813|NCT02858401|54839465|FG000|Overall Study|Lost to Follow-up|0|||
28168814|NCT02858401|54839466|FG001|Overall Study|Lost to Follow-up|1|||
28168815|NCT02858401|54839467|FG002|Overall Study|Lost to Follow-up|0|||
28168816|NCT02858401|54839468|FG003|Overall Study|Lost to Follow-up|0|||
28168817|NCT02858401|54839469|FG004|Overall Study|Lost to Follow-up|0|||
28168818|NCT02858401|54839470|FG005|Overall Study|Lost to Follow-up|0|||
28168819|NCT02858401|54839471|FG006|Overall Study|Lost to Follow-up|0|||
28168820|NCT02857283|54839498|FG000|First Exposure|Withdrawal by Subject|1|||
28168821|NCT02857283|54839499|FG001|First Exposure|Withdrawal by Subject|0|||
28168822|NCT02747927|54839517|FG000|Overall Study|Adverse Event|5|||
28168823|NCT02747927|54839518|FG001|Overall Study|Adverse Event|14|||
28168824|NCT02747927|54839517|FG000|Overall Study|Lost to Follow-up|22|||
28168825|NCT02747927|54839518|FG001|Overall Study|Lost to Follow-up|43|||
28168826|NCT02747927|54839517|FG000|Overall Study|Pregnancy|34|||
28168827|NCT02747927|54839518|FG001|Overall Study|Pregnancy|66|||
28168828|NCT02747927|54839517|FG000|Overall Study|Protocol Violation|2|||
28168829|NCT02747927|54839518|FG001|Overall Study|Protocol Violation|4|||
28168830|NCT02747927|54839517|FG000|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|147|||
28168831|NCT02747927|54839518|FG001|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|304|||
28168832|NCT02747927|54839517|FG000|Overall Study|Reason not Specified|11|||
28168833|NCT02747927|54839518|FG001|Overall Study|Reason not Specified|27|||
28168834|NCT02746679|54839526|FG000|Overall Study|Lost to Follow-up|4|||
28168835|NCT02746679|54839527|FG001|Overall Study|Lost to Follow-up|6|||
28168836|NCT02731131|54839535|FG000|Overall Study|Psychiatric Disorder|0|||
28168837|NCT02731131|54839536|FG001|Overall Study|Psychiatric Disorder|1|||
28168838|NCT02731131|54839535|FG000|Overall Study|Refused Therapy|0|||
28168839|NCT02731131|54839536|FG001|Overall Study|Refused Therapy|1|||
28168840|NCT02746705|54839544|FG000|Overall Study|Physician Decision|1|||
28168841|NCT02746705|54839545|FG001|Overall Study|Physician Decision|1|||
28168842|NCT02746705|54839544|FG000|Overall Study|Lost to Follow-up|1|||
28168843|NCT02746705|54839545|FG001|Overall Study|Lost to Follow-up|0|||
28168844|NCT02746705|54839544|FG000|Overall Study|outlier scores deemed not valid|0|||
28168845|NCT02746705|54839545|FG001|Overall Study|outlier scores deemed not valid|1|||
28168846|NCT02746627|54839554|FG000|Overall Study|Withdrawal by Subject|1|||
28168847|NCT02746627|54839555|FG001|Overall Study|Withdrawal by Subject|1|||
27735373|NCT02234843|54183894|FG007|Overall Study|Protocol Violation|0|||
27735374|NCT02234843|54183895|FG008|Overall Study|Protocol Violation|0|||
27735375|NCT02234843|54183896|FG009|Overall Study|Protocol Violation|0|||
27735376|NCT02234843|54183887|FG000|Overall Study|Efficacy outcome reached|2|||
27735377|NCT02234843|54183888|FG001|Overall Study|Efficacy outcome reached|0|||
27735378|NCT02234843|54183889|FG002|Overall Study|Efficacy outcome reached|0|||
27735379|NCT02234843|54183890|FG003|Overall Study|Efficacy outcome reached|0|||
28168848|NCT02746627|54839556|FG002|Overall Study|Withdrawal by Subject|1|||
28168849|NCT02856113|54839566|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
27735380|NCT02234843|54183891|FG004|Overall Study|Efficacy outcome reached|0|||
28168850|NCT02856113|54839567|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
28168851|NCT02856113|54839566|FG000|Overall Study|Significant Protocol Deviation|1|||
28168852|NCT02856113|54839567|FG001|Overall Study|Significant Protocol Deviation|0|||
27735381|NCT02234843|54183892|FG005|Overall Study|Efficacy outcome reached|2|||
27735382|NCT02234843|54183893|FG006|Overall Study|Efficacy outcome reached|0|||
28168853|NCT02856113|54839566|FG000|Overall Study|Lost to Follow-up|3|||
27735383|NCT02234843|54183894|FG007|Overall Study|Efficacy outcome reached|0|||
27735384|NCT02234843|54183895|FG008|Overall Study|Efficacy outcome reached|0|||
27735385|NCT02234843|54183896|FG009|Overall Study|Efficacy outcome reached|0|||
27735386|NCT02234843|54183887|FG000|Overall Study|Patient convenience|2|||
27735387|NCT02234843|54183888|FG001|Overall Study|Patient convenience|0|||
27735388|NCT02234843|54183889|FG002|Overall Study|Patient convenience|0|||
27735389|NCT02234843|54183890|FG003|Overall Study|Patient convenience|0|||
27735390|NCT02234843|54183891|FG004|Overall Study|Patient convenience|0|||
27735391|NCT02234843|54183892|FG005|Overall Study|Patient convenience|1|||
27735392|NCT02234843|54183893|FG006|Overall Study|Patient convenience|0|||
27735393|NCT02234843|54183894|FG007|Overall Study|Patient convenience|0|||
27735394|NCT02234843|54183895|FG008|Overall Study|Patient convenience|0|||
27735395|NCT02234843|54183896|FG009|Overall Study|Patient convenience|0|||
27735396|NCT02234843|54183887|FG000|Overall Study|Withdrawal by Subject|5|||
27735397|NCT02234843|54183888|FG001|Overall Study|Withdrawal by Subject|1|||
27735398|NCT02234843|54183889|FG002|Overall Study|Withdrawal by Subject|1|||
27735399|NCT02234843|54183890|FG003|Overall Study|Withdrawal by Subject|0|||
27735400|NCT02234843|54183891|FG004|Overall Study|Withdrawal by Subject|0|||
27735401|NCT02234843|54183892|FG005|Overall Study|Withdrawal by Subject|7|||
27735402|NCT02234843|54183893|FG006|Overall Study|Withdrawal by Subject|0|||
27735403|NCT02234843|54183894|FG007|Overall Study|Withdrawal by Subject|0|||
27735404|NCT02234843|54183895|FG008|Overall Study|Withdrawal by Subject|0|||
28094095|NCT03129100|54748061|FG002|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
28094096|NCT03129100|54748062|FG003|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
28094097|NCT03129100|54748063|FG004|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
28094098|NCT03129100|54748064|FG005|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
27735405|NCT02234843|54183896|FG009|Overall Study|Withdrawal by Subject|0|||
27735406|NCT02234843|54183887|FG000|Overall Study|Recovery|1|||
27735407|NCT02234843|54183888|FG001|Overall Study|Recovery|0|||
27735408|NCT02234843|54183889|FG002|Overall Study|Recovery|0|||
27735409|NCT02234843|54183890|FG003|Overall Study|Recovery|0|||
27735410|NCT02234843|54183891|FG004|Overall Study|Recovery|0|||
27735411|NCT02234843|54183892|FG005|Overall Study|Recovery|0|||
27735412|NCT02234843|54183893|FG006|Overall Study|Recovery|0|||
27735413|NCT02234843|54183894|FG007|Overall Study|Recovery|0|||
27735414|NCT02234843|54183895|FG008|Overall Study|Recovery|0|||
27735415|NCT02234843|54183896|FG009|Overall Study|Recovery|0|||
27735416|NCT02234843|54183887|FG000|Overall Study|Other|0|||
27735417|NCT02234843|54183888|FG001|Overall Study|Other|2|||
27735418|NCT02234843|54183889|FG002|Overall Study|Other|0|||
27735419|NCT02234843|54183890|FG003|Overall Study|Other|1|||
27735420|NCT02234843|54183891|FG004|Overall Study|Other|0|||
27735421|NCT02234843|54183892|FG005|Overall Study|Other|1|||
27735422|NCT02234843|54183893|FG006|Overall Study|Other|0|||
27735423|NCT02234843|54183894|FG007|Overall Study|Other|1|||
27735424|NCT02234843|54183895|FG008|Overall Study|Other|0|||
27735425|NCT02234843|54183896|FG009|Overall Study|Other|0|||
27735426|NCT02234843|54183887|FG000|Overall Study|Physician Decision|4|||
27735427|NCT02234843|54183888|FG001|Overall Study|Physician Decision|1|||
27735428|NCT02234843|54183889|FG002|Overall Study|Physician Decision|0|||
27735429|NCT02234843|54183890|FG003|Overall Study|Physician Decision|1|||
27735430|NCT02234843|54183891|FG004|Overall Study|Physician Decision|0|||
27735431|NCT02234843|54183892|FG005|Overall Study|Physician Decision|0|||
27735432|NCT02234843|54183893|FG006|Overall Study|Physician Decision|0|||
27735433|NCT02234843|54183894|FG007|Overall Study|Physician Decision|1|||
27735434|NCT02234843|54183895|FG008|Overall Study|Physician Decision|0|||
27735435|NCT02234843|54183896|FG009|Overall Study|Physician Decision|0|||
27735436|NCT02234843|54183887|FG000|Overall Study|Adverse Event|5|||
28094099|NCT03129100|54748065|FG006|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
28094100|NCT03129100|54748066|FG007|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
28094101|NCT03129100|54748067|FG008|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
28094102|NCT03129100|54748068|FG009|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
28094103|NCT03129100|54748069|FG010|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
27735437|NCT02234843|54183888|FG001|Overall Study|Adverse Event|1|||
27735438|NCT02234843|54183889|FG002|Overall Study|Adverse Event|1|||
27735439|NCT02234843|54183890|FG003|Overall Study|Adverse Event|3|||
27735440|NCT02234843|54183891|FG004|Overall Study|Adverse Event|2|||
27735441|NCT02234843|54183892|FG005|Overall Study|Adverse Event|1|||
27735442|NCT02234843|54183893|FG006|Overall Study|Adverse Event|0|||
27735443|NCT02234843|54183894|FG007|Overall Study|Adverse Event|0|||
28168854|NCT02856113|54839567|FG001|Overall Study|Lost to Follow-up|5|||
27735444|NCT02234843|54183895|FG008|Overall Study|Adverse Event|1|||
27735445|NCT02234843|54183896|FG009|Overall Study|Adverse Event|0|||
27735446|NCT02234843|54183887|FG000|Overall Study|Non-compliance with study drug|1|||
27735447|NCT02234843|54183888|FG001|Overall Study|Non-compliance with study drug|0|||
27735448|NCT02234843|54183889|FG002|Overall Study|Non-compliance with study drug|0|||
27735449|NCT02234843|54183890|FG003|Overall Study|Non-compliance with study drug|0|||
27735450|NCT02234843|54183891|FG004|Overall Study|Non-compliance with study drug|0|||
27735451|NCT02234843|54183892|FG005|Overall Study|Non-compliance with study drug|1|||
27735452|NCT02234843|54183893|FG006|Overall Study|Non-compliance with study drug|1|||
27735453|NCT02234843|54183894|FG007|Overall Study|Non-compliance with study drug|0|||
27735454|NCT02234843|54183895|FG008|Overall Study|Non-compliance with study drug|0|||
27735455|NCT02234843|54183896|FG009|Overall Study|Non-compliance with study drug|0|||
27735456|NCT02234843|54183887|FG000|Overall Study|Lost to Follow-up|0|||
27735457|NCT02234843|54183888|FG001|Overall Study|Lost to Follow-up|1|||
27735458|NCT02234843|54183889|FG002|Overall Study|Lost to Follow-up|0|||
27735459|NCT02234843|54183890|FG003|Overall Study|Lost to Follow-up|0|||
27735460|NCT02234843|54183891|FG004|Overall Study|Lost to Follow-up|0|||
27735461|NCT02234843|54183892|FG005|Overall Study|Lost to Follow-up|0|||
27735462|NCT02234843|54183893|FG006|Overall Study|Lost to Follow-up|1|||
27735463|NCT02234843|54183894|FG007|Overall Study|Lost to Follow-up|0|||
27735464|NCT02234843|54183895|FG008|Overall Study|Lost to Follow-up|0|||
27735465|NCT02234843|54183896|FG009|Overall Study|Lost to Follow-up|0|||
27735466|NCT02740231|54183933|FG000|Overall Study|Withdrawal by Subject|1|||
27735467|NCT02740231|54183934|FG001|Overall Study|Withdrawal by Subject|1|||
27735468|NCT02740231|54183935|FG002|Overall Study|Withdrawal by Subject|1|||
27735469|NCT02740231|54183936|FG003|Overall Study|Withdrawal by Subject|0|||
27735470|NCT02740231|54183933|FG000|Overall Study|Lack of Efficacy|0|||
27735471|NCT02740231|54183934|FG001|Overall Study|Lack of Efficacy|1|||
27735472|NCT02740231|54183935|FG002|Overall Study|Lack of Efficacy|0|||
27735473|NCT02740231|54183936|FG003|Overall Study|Lack of Efficacy|4|||
27735474|NCT02740231|54183933|FG000|Overall Study|Lost to Follow-up|1|||
27735475|NCT02740231|54183934|FG001|Overall Study|Lost to Follow-up|3|||
27735476|NCT02740231|54183935|FG002|Overall Study|Lost to Follow-up|0|||
27735477|NCT02740231|54183936|FG003|Overall Study|Lost to Follow-up|3|||
27735478|NCT02740231|54183933|FG000|Overall Study|Adverse Event|0|||
27735479|NCT02740231|54183934|FG001|Overall Study|Adverse Event|1|||
27735480|NCT02740231|54183935|FG002|Overall Study|Adverse Event|0|||
27735481|NCT02740231|54183936|FG003|Overall Study|Adverse Event|1|||
27735482|NCT02750345|54183946|FG000|Intervention 1|Adverse Event|0|||
27735483|NCT02750345|54183947|FG001|Intervention 1|Adverse Event|0|||
27735484|NCT02750345|54183948|FG002|Intervention 1|Adverse Event|0|||
27735485|NCT02750345|54183949|FG003|Intervention 1|Adverse Event|0|||
27735486|NCT02750345|54183950|FG004|Intervention 1|Adverse Event|1|||
27735487|NCT02750345|54183951|FG005|Intervention 1|Adverse Event|0|||
27735488|NCT02640625|54183961|FG000|Overall Study|Adverse Event|1|||
27735489|NCT01329263|54183968|FG000|Overall Study|Lost to Follow-up|4|||
27735490|NCT01329263|54183969|FG001|Overall Study|Lost to Follow-up|21|||
27735491|NCT01329263|54183968|FG000|Overall Study|Withdrawal by Subject|1|||
27735492|NCT01329263|54183969|FG001|Overall Study|Withdrawal by Subject|2|||
27735493|NCT02474329|54183977|FG000|Overall Study|Withdraw or did not contribute data.|13|||
27735494|NCT01388491|54183984|FG000|Overall Study|Adverse Event|10|||
27735495|NCT01388491|54183985|FG001|Overall Study|Adverse Event|9|||
27735496|NCT01388491|54183984|FG000|Overall Study|Sponsor Request|9|||
27735497|NCT01388491|54183985|FG001|Overall Study|Sponsor Request|7|||
27735498|NCT01388491|54183984|FG000|Overall Study|Withdrawal by Subject|6|||
27735499|NCT01388491|54183985|FG001|Overall Study|Withdrawal by Subject|10|||
27735500|NCT01388491|54183984|FG000|Overall Study|Lost to Follow-up|4|||
27735501|NCT01388491|54183985|FG001|Overall Study|Lost to Follow-up|3|||
27735502|NCT01388491|54183984|FG000|Overall Study|Protocol Violation|2|||
27735503|NCT01388491|54183985|FG001|Overall Study|Protocol Violation|0|||
27735504|NCT01388491|54183984|FG000|Overall Study|Noncompliance|2|||
27735505|NCT01388491|54183985|FG001|Overall Study|Noncompliance|0|||
27735506|NCT01388491|54183984|FG000|Overall Study|Pregnancy|1|||
27735507|NCT01388491|54183985|FG001|Overall Study|Pregnancy|0|||
27735508|NCT02749799|54183991|FG000|Overall Study|Adverse Event|2|||
27735509|NCT02749799|54183991|FG000|Overall Study|Lost to Follow-up|4|||
27735510|NCT02749799|54183991|FG000|Overall Study|Protocol Violation|1|||
27735511|NCT02749799|54183991|FG000|Overall Study|Withdrawal by Subject|1|||
27735512|NCT03253393|54183998|FG000|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|6|||
27735513|NCT03253393|54183999|FG001|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|7|||
27735514|NCT03253393|54184000|FG002|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|0|||
27735515|NCT03128671|54184016|FG000|Allocation|ICU discharge prior to intervention initiation|4|||
27735516|NCT03128671|54184017|FG001|Allocation|ICU discharge prior to intervention initiation|0|||
27735517|NCT03128671|54184016|FG000|Allocation|Death|1|||
27735518|NCT03128671|54184017|FG001|Allocation|Death|0|||
27735519|NCT03128671|54184016|FG000|Allocation|Withdrawal by Subject|4|||
27735520|NCT03128671|54184017|FG001|Allocation|Withdrawal by Subject|0|||
27735521|NCT03128671|54184016|FG000|Intervention|Withdrawal by Subject|11|||
27735522|NCT03128671|54184017|FG001|Intervention|Withdrawal by Subject|10|||
27735523|NCT03128671|54184016|FG000|Intervention|Palliative/hospice care initiated|9|||
27735524|NCT03128671|54184017|FG001|Intervention|Palliative/hospice care initiated|10|||
27735525|NCT03128671|54184016|FG000|Intervention|Death|13|||
27735526|NCT03128671|54184017|FG001|Intervention|Death|11|||
27735527|NCT03128671|54184016|FG000|Intervention|Interrupted by hurricane|1|||
27735528|NCT03128671|54184017|FG001|Intervention|Interrupted by hurricane|0|||
27735529|NCT03128671|54184016|FG000|Intervention|Physician Decision|2|||
27735530|NCT03128671|54184017|FG001|Intervention|Physician Decision|3|||
27735531|NCT02925338|54184028|FG000|Overall Study|Death|0|||
27735532|NCT02925338|54184029|FG001|Overall Study|Death|2|||
27735533|NCT02925338|54184030|FG002|Overall Study|Death|1|||
27735534|NCT02925338|54184031|FG003|Overall Study|Death|0|||
27735535|NCT02925338|54184032|FG004|Overall Study|Death|0|||
27735536|NCT02925338|54184028|FG000|Overall Study|Lost to Follow-up|30|||
27735537|NCT02925338|54184029|FG001|Overall Study|Lost to Follow-up|10|||
27735538|NCT02925338|54184030|FG002|Overall Study|Lost to Follow-up|1|||
27735539|NCT02925338|54184031|FG003|Overall Study|Lost to Follow-up|16|||
27735540|NCT02925338|54184032|FG004|Overall Study|Lost to Follow-up|3|||
27735541|NCT02925338|54184028|FG000|Overall Study|Withdrawal by Subject|3|||
27735542|NCT02925338|54184029|FG001|Overall Study|Withdrawal by Subject|0|||
27735543|NCT02925338|54184030|FG002|Overall Study|Withdrawal by Subject|3|||
27735544|NCT02925338|54184031|FG003|Overall Study|Withdrawal by Subject|2|||
27735545|NCT02925338|54184032|FG004|Overall Study|Withdrawal by Subject|2|||
27735546|NCT02925338|54184028|FG000|Overall Study|Missing|38|||
27735547|NCT02925338|54184029|FG001|Overall Study|Missing|27|||
27735548|NCT02925338|54184030|FG002|Overall Study|Missing|0|||
27735549|NCT02925338|54184031|FG003|Overall Study|Missing|3|||
27735550|NCT02925338|54184032|FG004|Overall Study|Missing|2|||
27735551|NCT02925338|54184028|FG000|Overall Study|Participant's Decision|11|||
27735552|NCT02925338|54184029|FG001|Overall Study|Participant's Decision|7|||
27735553|NCT02925338|54184030|FG002|Overall Study|Participant's Decision|3|||
27735554|NCT02925338|54184031|FG003|Overall Study|Participant's Decision|8|||
27735555|NCT02925338|54184032|FG004|Overall Study|Participant's Decision|1|||
27735556|NCT02925338|54184028|FG000|Overall Study|Treatment Discontinuation|144|||
27735557|NCT02925338|54184029|FG001|Overall Study|Treatment Discontinuation|65|||
27735558|NCT02925338|54184030|FG002|Overall Study|Treatment Discontinuation|56|||
27735559|NCT02925338|54184031|FG003|Overall Study|Treatment Discontinuation|131|||
27735560|NCT02925338|54184032|FG004|Overall Study|Treatment Discontinuation|22|||
27735561|NCT02543528|54184050|FG000|Adaptation Period|Unsatisfactory Lens Fitting|0|||
27735562|NCT02543528|54184051|FG001|Adaptation Period|Unsatisfactory Lens Fitting|0|||
28168855|NCT02856113|54839566|FG000|Overall Study|Voluntary Withdrawal|3|||
28168856|NCT02856113|54839567|FG001|Overall Study|Voluntary Withdrawal|5|||
27735563|NCT02543528|54184052|FG002|Adaptation Period|Unsatisfactory Lens Fitting|0|||
27735564|NCT02543528|54184053|FG003|Adaptation Period|Unsatisfactory Lens Fitting|0|||
27735565|NCT02543528|54184054|FG004|Adaptation Period|Unsatisfactory Lens Fitting|2|||
27735566|NCT02543528|54184050|FG000|Adaptation Period|Lens Handling Difficultes|0|||
27735567|NCT02543528|54184051|FG001|Adaptation Period|Lens Handling Difficultes|0|||
27735568|NCT02543528|54184052|FG002|Adaptation Period|Lens Handling Difficultes|0|||
27735569|NCT02543528|54184053|FG003|Adaptation Period|Lens Handling Difficultes|0|||
28168857|NCT02856113|54839566|FG000|Overall Study|Pregnancy|0|||
28168858|NCT02856113|54839567|FG001|Overall Study|Pregnancy|1|||
28168859|NCT02856113|54839566|FG000|Overall Study|Principal Investigator Discretion|2|||
28168860|NCT02856113|54839567|FG001|Overall Study|Principal Investigator Discretion|1|||
28168861|NCT02856113|54839566|FG000|Overall Study|Randomized but not Treated|1|||
28168862|NCT02856113|54839567|FG001|Overall Study|Randomized but not Treated|0|||
28168863|NCT02856113|54839566|FG000|Overall Study|Did not Complete Study but Contacted at Week 52|0|||
28168864|NCT02856113|54839567|FG001|Overall Study|Did not Complete Study but Contacted at Week 52|3|||
28168865|NCT02855411|54839574|FG000|Overall Study|Study terminated by sponsor|21|||
28168866|NCT02855411|54839574|FG000|Overall Study|Does not meet entrance criteria|14|||
27735570|NCT02543528|54184054|FG004|Adaptation Period|Lens Handling Difficultes|8|||
27735571|NCT02543528|54184050|FG000|Adaptation Period|Lost to Follow-up|0|||
27735572|NCT02543528|54184051|FG001|Adaptation Period|Lost to Follow-up|0|||
27735573|NCT02543528|54184052|FG002|Adaptation Period|Lost to Follow-up|0|||
27735574|NCT02543528|54184053|FG003|Adaptation Period|Lost to Follow-up|0|||
27735575|NCT02543528|54184054|FG004|Adaptation Period|Lost to Follow-up|14|||
27735576|NCT02543528|54184050|FG000|Adaptation Period|Adverse Event|0|||
27735577|NCT02543528|54184051|FG001|Adaptation Period|Adverse Event|0|||
27735578|NCT02543528|54184052|FG002|Adaptation Period|Adverse Event|0|||
27735579|NCT02543528|54184053|FG003|Adaptation Period|Adverse Event|0|||
27735580|NCT02543528|54184054|FG004|Adaptation Period|Adverse Event|2|||
27735581|NCT02543528|54184050|FG000|Extended Wear Period|Adverse Event|17|||
27735582|NCT02543528|54184051|FG001|Extended Wear Period|Adverse Event|11|||
27735583|NCT02543528|54184052|FG002|Extended Wear Period|Adverse Event|16|||
28094104|NCT03129100|54748070|FG011|Period3-Long-Term Extension Period A & B|Adverse Event|6|||
28094105|NCT03129100|54748071|FG012|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
28094106|NCT03129100|54748072|FG013|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
28094107|NCT03129100|54748073|FG014|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
28094108|NCT03129100|54748074|FG015|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
28094109|NCT03129100|54748075|FG016|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
28094110|NCT03129100|54748076|FG017|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
28168867|NCT02745145|54839581|FG000|Overall Study|Adverse Event|1|||
28168868|NCT02745145|54839582|FG001|Overall Study|Adverse Event|0|||
27735584|NCT02543528|54184053|FG003|Extended Wear Period|Adverse Event|3|||
27735585|NCT02543528|54184054|FG004|Extended Wear Period|Adverse Event|0|||
27735586|NCT02543528|54184050|FG000|Extended Wear Period|Missed too many scheduled visits|0|||
27735587|NCT02543528|54184051|FG001|Extended Wear Period|Missed too many scheduled visits|0|||
27735588|NCT02543528|54184052|FG002|Extended Wear Period|Missed too many scheduled visits|1|||
27735589|NCT02543528|54184053|FG003|Extended Wear Period|Missed too many scheduled visits|3|||
27735590|NCT02543528|54184054|FG004|Extended Wear Period|Missed too many scheduled visits|0|||
27735591|NCT02543528|54184050|FG000|Extended Wear Period|Unsatisfactory Lens Fitting|1|||
27735592|NCT02543528|54184051|FG001|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
27735593|NCT02543528|54184052|FG002|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
27735594|NCT02543528|54184053|FG003|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
27735595|NCT02543528|54184054|FG004|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
27735596|NCT02543528|54184050|FG000|Extended Wear Period|Lost to Follow-up|0|||
27735597|NCT02543528|54184051|FG001|Extended Wear Period|Lost to Follow-up|1|||
27735598|NCT02543528|54184052|FG002|Extended Wear Period|Lost to Follow-up|2|||
27735599|NCT02543528|54184053|FG003|Extended Wear Period|Lost to Follow-up|1|||
27735600|NCT02543528|54184054|FG004|Extended Wear Period|Lost to Follow-up|0|||
27735601|NCT02543528|54184050|FG000|Extended Wear Period|Withdrawal by Subject|10|||
27735602|NCT02543528|54184051|FG001|Extended Wear Period|Withdrawal by Subject|9|||
27735603|NCT02543528|54184052|FG002|Extended Wear Period|Withdrawal by Subject|4|||
27735604|NCT02543528|54184053|FG003|Extended Wear Period|Withdrawal by Subject|5|||
27735605|NCT02543528|54184054|FG004|Extended Wear Period|Withdrawal by Subject|0|||
27735606|NCT00156533|54184072|FG000|Overall Study|Withdrawn - Medication Expiration|0|||
27735607|NCT00156533|54184073|FG001|Overall Study|Withdrawn - Medication Expiration|2|||
27735608|NCT00156533|54184074|FG002|Overall Study|Withdrawn - Medication Expiration|1|||
27735609|NCT00156533|54184075|FG003|Overall Study|Withdrawn - Medication Expiration|0|||
27735610|NCT00156533|54184072|FG000|Overall Study|Withdrawal by Subject|1|||
27735611|NCT00156533|54184073|FG001|Overall Study|Withdrawal by Subject|0|||
27735612|NCT00156533|54184074|FG002|Overall Study|Withdrawal by Subject|0|||
27735613|NCT00156533|54184075|FG003|Overall Study|Withdrawal by Subject|1|||
27735614|NCT00156533|54184072|FG000|Overall Study|Failed Screening|1|||
27735615|NCT00156533|54184073|FG001|Overall Study|Failed Screening|0|||
27735616|NCT00156533|54184074|FG002|Overall Study|Failed Screening|1|||
27735617|NCT00156533|54184075|FG003|Overall Study|Failed Screening|1|||
27735618|NCT01660022|54184093|FG000|First Sequence (7 Days)|Withdrawal by Subject|0|||
27735619|NCT01660022|54184094|FG001|First Sequence (7 Days)|Withdrawal by Subject|1|||
27735620|NCT01660022|54184095|FG002|First Sequence (7 Days)|Withdrawal by Subject|0|||
27735621|NCT01660022|54184096|FG003|First Sequence (7 Days)|Withdrawal by Subject|1|||
27735622|NCT01660022|54184097|FG004|First Sequence (7 Days)|Withdrawal by Subject|0|||
27735623|NCT01660022|54184098|FG005|First Sequence (7 Days)|Withdrawal by Subject|0|||
27735624|NCT01660022|54184093|FG000|First Sequence (7 Days)|Adverse Event|0|||
27735625|NCT01660022|54184094|FG001|First Sequence (7 Days)|Adverse Event|0|||
27735626|NCT01660022|54184095|FG002|First Sequence (7 Days)|Adverse Event|0|||
27735627|NCT01660022|54184096|FG003|First Sequence (7 Days)|Adverse Event|0|||
27735628|NCT01660022|54184097|FG004|First Sequence (7 Days)|Adverse Event|1|||
27735629|NCT01660022|54184098|FG005|First Sequence (7 Days)|Adverse Event|3|||
27735630|NCT01660022|54184093|FG000|First Sequence (7 Days)|Protocol Violation|0|||
27735631|NCT01660022|54184094|FG001|First Sequence (7 Days)|Protocol Violation|0|||
27735632|NCT01660022|54184095|FG002|First Sequence (7 Days)|Protocol Violation|0|||
27735633|NCT01660022|54184096|FG003|First Sequence (7 Days)|Protocol Violation|0|||
27735634|NCT01660022|54184097|FG004|First Sequence (7 Days)|Protocol Violation|0|||
27735635|NCT01660022|54184098|FG005|First Sequence (7 Days)|Protocol Violation|1|||
27735636|NCT00156065|54184127|FG000|Overall Study|Enrolled But Never Received Treatment|1|||
27735637|NCT00156065|54184128|FG001|Overall Study|Enrolled But Never Received Treatment|1|||
27735638|NCT00156065|54184129|FG002|Overall Study|Enrolled But Never Received Treatment|0|||
27735639|NCT00156065|54184127|FG000|Overall Study|Adverse Event|8|||
27735640|NCT00156065|54184128|FG001|Overall Study|Adverse Event|11|||
27735641|NCT00156065|54184129|FG002|Overall Study|Adverse Event|4|||
27855884|NCT02323113|54383008|FG003|Overall Study|Symptomatic Deterioration|0|||
27855885|NCT02323113|54383009|FG004|Overall Study|Symptomatic Deterioration|1|||
28094111|NCT03129100|54748077|FG018|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
28094112|NCT03129100|54748078|FG019|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
27855886|NCT02323113|54383010|FG005|Overall Study|Symptomatic Deterioration|0|||
27855887|NCT02323113|54383011|FG006|Overall Study|Symptomatic Deterioration|0|||
27980754|NCT00891020|54638733|FG002|Long-term Extension Period|Administrative|2|||
27980755|NCT00611455|54638745|FG000|DB Treatment Period (24 Weeks)|Adverse Event|2|||
28094113|NCT03129100|54748079|FG020|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
28094114|NCT03129100|54748080|FG021|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
27735642|NCT00156065|54184127|FG000|Overall Study|Lack of Efficacy|2|||
27735643|NCT00156065|54184128|FG001|Overall Study|Lack of Efficacy|9|||
27735644|NCT00156065|54184129|FG002|Overall Study|Lack of Efficacy|3|||
27855888|NCT02323113|54383012|FG007|Overall Study|Symptomatic Deterioration|0|||
27735645|NCT00156065|54184127|FG000|Overall Study|Withdrawal by Subject|13|||
27735646|NCT00156065|54184128|FG001|Overall Study|Withdrawal by Subject|26|||
27735647|NCT00156065|54184129|FG002|Overall Study|Withdrawal by Subject|16|||
27735648|NCT00156065|54184127|FG000|Overall Study|Lost to Follow-up|5|||
27735649|NCT00156065|54184128|FG001|Overall Study|Lost to Follow-up|7|||
27735650|NCT00156065|54184129|FG002|Overall Study|Lost to Follow-up|1|||
27735651|NCT00156065|54184127|FG000|Overall Study|Other|2|||
27735652|NCT00156065|54184128|FG001|Overall Study|Other|9|||
27735653|NCT00156065|54184129|FG002|Overall Study|Other|3|||
28168869|NCT02745145|54839583|FG002|Overall Study|Adverse Event|0|||
28168870|NCT02745145|54839581|FG000|Overall Study|Death|0|||
28168871|NCT02745145|54839582|FG001|Overall Study|Death|1|||
28168872|NCT02745145|54839583|FG002|Overall Study|Death|0|||
27735654|NCT01554956|54184140|FG000|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
27735655|NCT01554956|54184141|FG001|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|1|||
27735656|NCT01554956|54184142|FG002|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
27735657|NCT01554956|54184140|FG000|Part 2 (Continuation Segment)|Withdrawal by Subject|0|||
28168873|NCT02745145|54839581|FG000|Overall Study|Progressive disease|0|||
28168874|NCT02745145|54839582|FG001|Overall Study|Progressive disease|0|||
28168875|NCT02745145|54839583|FG002|Overall Study|Progressive disease|1|||
28168876|NCT02745145|54839581|FG000|Overall Study|Withdrew consent|1|||
28168877|NCT02745145|54839582|FG001|Overall Study|Withdrew consent|1|||
28168878|NCT02745145|54839583|FG002|Overall Study|Withdrew consent|1|||
27735658|NCT01554956|54184141|FG001|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
27735659|NCT01554956|54184142|FG002|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
27735660|NCT01554956|54184140|FG000|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|2|||
27735661|NCT01554956|54184141|FG001|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|4|||
27735662|NCT01554956|54184142|FG002|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|0|||
27735663|NCT02138786|54184163|FG000|Overall Study|Adverse Event|0|||
27735664|NCT02138786|54184164|FG001|Overall Study|Adverse Event|2|||
27735665|NCT02138786|54184165|FG002|Overall Study|Adverse Event|1|||
27735666|NCT02138786|54184163|FG000|Overall Study|Death|1|||
27735667|NCT02138786|54184164|FG001|Overall Study|Death|7|||
27735668|NCT02138786|54184165|FG002|Overall Study|Death|2|||
27735669|NCT02138786|54184163|FG000|Overall Study|Disease Progression|1|||
27735670|NCT02138786|54184164|FG001|Overall Study|Disease Progression|1|||
27735671|NCT02138786|54184165|FG002|Overall Study|Disease Progression|3|||
27735672|NCT02138786|54184163|FG000|Overall Study|Withdrawal by Subject|1|||
27735673|NCT02138786|54184164|FG001|Overall Study|Withdrawal by Subject|2|||
27735674|NCT02138786|54184165|FG002|Overall Study|Withdrawal by Subject|0|||
27735675|NCT02138786|54184163|FG000|Overall Study|Patient's Wish|0|||
27735676|NCT02138786|54184164|FG001|Overall Study|Patient's Wish|2|||
28168879|NCT02745145|54839581|FG000|Overall Study|Study Termination|8|||
27735677|NCT02138786|54184165|FG002|Overall Study|Patient's Wish|0|||
27735678|NCT02138786|54184163|FG000|Overall Study|Sponsor Terminated Study|0|||
27735679|NCT02138786|54184164|FG001|Overall Study|Sponsor Terminated Study|1|||
27735680|NCT02138786|54184165|FG002|Overall Study|Sponsor Terminated Study|1|||
27735681|NCT02138786|54184163|FG000|Overall Study|Non-Compliance|0|||
27735682|NCT02138786|54184164|FG001|Overall Study|Non-Compliance|0|||
27735683|NCT02138786|54184165|FG002|Overall Study|Non-Compliance|1|||
27735684|NCT02529488|54184171|FG000|Overall Study|Adverse Event|1|||
27735685|NCT02529488|54184171|FG000|Overall Study|Death|3|||
27735686|NCT01329419|54184179|FG000|Overall Study|Protocol Violation|235|||
27735687|NCT01329341|54184184|FG000|Overall Study|Withdrawal by Subject|44|||
27735688|NCT02532764|54184198|FG000|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
27735689|NCT02532764|54184199|FG001|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
27735690|NCT02532764|54184200|FG002|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
27735691|NCT02532764|54184201|FG003|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
27735692|NCT02532764|54184202|FG004|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
27735693|NCT02532764|54184203|FG005|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
27735694|NCT02532764|54184204|FG006|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
27735695|NCT02532764|54184205|FG007|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
27735696|NCT02532764|54184206|FG008|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
27735697|NCT02532764|54184207|FG009|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
27833301|NCT01746017|54315224|FG004|Period 3|Withdrawal by Subject|0|||
27735698|NCT02528942|54184234|FG000|Overall Study|Did not meet imaging criteria|9|||
27735699|NCT02528942|54184234|FG000|Overall Study|Lost to Follow-up|25|||
27735700|NCT02527148|54184240|FG000|Overall Study|Did not receive study intervention|1|||
27735701|NCT02527148|54184241|FG001|Overall Study|Did not receive study intervention|0|||
27735702|NCT02291614|54184260|FG000|Overall Study|Lost to Follow-up|0|||
27833302|NCT01746017|54315225|FG005|Period 3|Withdrawal by Subject|1|||
28168880|NCT02745145|54839582|FG001|Overall Study|Study Termination|3|||
28168881|NCT02745145|54839583|FG002|Overall Study|Study Termination|7|||
28168882|NCT02854631|54839602|FG000|Overall Study|Adverse Event|1|||
27735703|NCT02291614|54184261|FG001|Overall Study|Lost to Follow-up|0|||
27735704|NCT02291614|54184262|FG002|Overall Study|Lost to Follow-up|0|||
27735705|NCT02291614|54184263|FG003|Overall Study|Lost to Follow-up|0|||
27735706|NCT02291614|54184264|FG004|Overall Study|Lost to Follow-up|0|||
27735707|NCT02291614|54184265|FG005|Overall Study|Lost to Follow-up|0|||
27735708|NCT02291614|54184266|FG006|Overall Study|Lost to Follow-up|0|||
27735709|NCT02291614|54184267|FG007|Overall Study|Lost to Follow-up|1|||
27735710|NCT02291614|54184268|FG008|Overall Study|Lost to Follow-up|0|||
27855889|NCT02323113|54383005|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
28094115|NCT03129100|54748081|FG022|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
27855890|NCT02323113|54383006|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
28094116|NCT03129100|54748082|FG023|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
28168883|NCT02854631|54839603|FG001|Overall Study|Adverse Event|2|||
28168884|NCT02854631|54839602|FG000|Overall Study|Withdrew Consent|3|||
28168885|NCT02854631|54839603|FG001|Overall Study|Withdrew Consent|2|||
28168886|NCT02854631|54839602|FG000|Overall Study|Investigator's Discretion|2|||
28168887|NCT02854631|54839603|FG001|Overall Study|Investigator's Discretion|0|||
28168888|NCT02854631|54839602|FG000|Overall Study|Death|12|||
28168889|NCT02854631|54839603|FG001|Overall Study|Death|8|||
28168890|NCT02854631|54839602|FG000|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2|||
28168891|NCT02854631|54839603|FG001|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0|||
28168892|NCT02854631|54839602|FG000|Overall Study|Protocol Violation|0|||
28168893|NCT02854631|54839603|FG001|Overall Study|Protocol Violation|1|||
28168894|NCT02854631|54839602|FG000|Overall Study|Subjects Randomized but Never Treated|2|||
28168895|NCT02854631|54839603|FG001|Overall Study|Subjects Randomized but Never Treated|0|||
28168896|NCT02854631|54839602|FG000|Overall Study|Lost to Follow-up|4|||
28168897|NCT02854631|54839603|FG001|Overall Study|Lost to Follow-up|2|||
28168898|NCT02855359|54839611|FG000|Overall Study|Death|2|||
28168899|NCT02855359|54839612|FG001|Overall Study|Death|2|||
28168900|NCT02855359|54839613|FG002|Overall Study|Death|0|||
28168901|NCT02855359|54839614|FG003|Overall Study|Death|0|||
28168902|NCT02855359|54839611|FG000|Overall Study|Study Termination by Sponsor|9|||
28168903|NCT02855359|54839612|FG001|Overall Study|Study Termination by Sponsor|11|||
28168904|NCT02855359|54839613|FG002|Overall Study|Study Termination by Sponsor|0|||
28168905|NCT02855359|54839614|FG003|Overall Study|Study Termination by Sponsor|0|||
28168906|NCT02853929|54839628|FG000|Overall Study|Lost to Follow-up|3|||
28168907|NCT02853929|54839629|FG001|Overall Study|Lost to Follow-up|0|||
28168908|NCT02853929|54839628|FG000|Overall Study|Withdrawal by Subject|1|||
28168909|NCT02853929|54839629|FG001|Overall Study|Withdrawal by Subject|0|||
28168910|NCT02853929|54839628|FG000|Overall Study|Subjects enrolled but not vaccinated|7|||
28168911|NCT02853929|54839629|FG001|Overall Study|Subjects enrolled but not vaccinated|4|||
28168912|NCT02730819|54839665|FG000|Overall Study|Lost to Follow-up|9|||
28168913|NCT02038946|54839669|FG000|Overall Study|Death|5|||
28168914|NCT02038946|54839669|FG000|Overall Study|Withdrawal by Subject|3|||
28168915|NCT02038946|54839669|FG000|Overall Study|Lost to Follow-up|2|||
28168916|NCT02038946|54839669|FG000|Overall Study|Other reasons|2|||
28168917|NCT03143829|54839675|FG000|Overall Study|Withdrawal by Subject|2|||
28168918|NCT03143829|54839676|FG001|Overall Study|Withdrawal by Subject|5|||
28168919|NCT03143829|54839675|FG000|Overall Study|Lost to Follow-up|0|||
28168920|NCT03143829|54839676|FG001|Overall Study|Lost to Follow-up|2|||
28168921|NCT03143829|54839675|FG000|Overall Study|Death|1|||
28094117|NCT03129100|54748083|FG024|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
28094118|NCT03129100|54748084|FG025|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
28094119|NCT03129100|54748059|FG000|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
28094120|NCT03129100|54748060|FG001|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
28094121|NCT03129100|54748061|FG002|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
28168922|NCT03143829|54839676|FG001|Overall Study|Death|1|||
28168923|NCT03143829|54839675|FG000|Overall Study|changed treatment, no longer eligible|2|||
28168924|NCT03143829|54839676|FG001|Overall Study|changed treatment, no longer eligible|2|||
28168925|NCT02853331|54839684|FG000|Overall Study|Death|59|||
27735711|NCT02291614|54184269|FG009|Overall Study|Lost to Follow-up|0|||
27735712|NCT02291614|54184270|FG010|Overall Study|Lost to Follow-up|0|||
27855891|NCT02323113|54383007|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
27855892|NCT02323113|54383008|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
27855893|NCT02323113|54383009|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
28168926|NCT02853331|54839685|FG001|Overall Study|Death|95|||
28168927|NCT02853331|54839684|FG000|Overall Study|Withdrawal by Subject|5|||
28168928|NCT02853331|54839685|FG001|Overall Study|Withdrawal by Subject|9|||
28168929|NCT02853331|54839684|FG000|Overall Study|Ongoing in study|368|||
28168930|NCT02853331|54839685|FG001|Overall Study|Ongoing in study|325|||
28168931|NCT05718466|54839693|FG000|Overall Study|Withdrawal by Subject|1|||
28168932|NCT05718466|54839694|FG001|Overall Study|Withdrawal by Subject|2|||
28168933|NCT05718466|54839693|FG000|Overall Study|Death|0|||
28168934|NCT05718466|54839694|FG001|Overall Study|Death|1|||
28168935|NCT04938453|54839702|FG000|Washout Period 1|Adverse Event|1|||
28168936|NCT04938453|54839703|FG001|Washout Period 1|Adverse Event|0|||
27735713|NCT02291614|54184260|FG000|Overall Study|Withdrawal by Subject|0|||
27735714|NCT02291614|54184261|FG001|Overall Study|Withdrawal by Subject|1|||
27735715|NCT02291614|54184262|FG002|Overall Study|Withdrawal by Subject|0|||
27735716|NCT02291614|54184263|FG003|Overall Study|Withdrawal by Subject|0|||
27735717|NCT02291614|54184264|FG004|Overall Study|Withdrawal by Subject|0|||
27735718|NCT02291614|54184265|FG005|Overall Study|Withdrawal by Subject|0|||
27735719|NCT02291614|54184266|FG006|Overall Study|Withdrawal by Subject|0|||
27735720|NCT02291614|54184267|FG007|Overall Study|Withdrawal by Subject|0|||
27735721|NCT02291614|54184268|FG008|Overall Study|Withdrawal by Subject|0|||
27735722|NCT02291614|54184269|FG009|Overall Study|Withdrawal by Subject|2|||
27735723|NCT02291614|54184270|FG010|Overall Study|Withdrawal by Subject|2|||
27735724|NCT02291614|54184260|FG000|Overall Study|Decision by sponsor|0|||
27735725|NCT02291614|54184261|FG001|Overall Study|Decision by sponsor|0|||
27735726|NCT02291614|54184262|FG002|Overall Study|Decision by sponsor|0|||
27735727|NCT02291614|54184263|FG003|Overall Study|Decision by sponsor|1|||
27735728|NCT02291614|54184264|FG004|Overall Study|Decision by sponsor|0|||
27735729|NCT02291614|54184265|FG005|Overall Study|Decision by sponsor|0|||
27735730|NCT02291614|54184266|FG006|Overall Study|Decision by sponsor|0|||
27735731|NCT02291614|54184267|FG007|Overall Study|Decision by sponsor|0|||
27735732|NCT02291614|54184268|FG008|Overall Study|Decision by sponsor|0|||
27735733|NCT02291614|54184269|FG009|Overall Study|Decision by sponsor|0|||
27735734|NCT02291614|54184270|FG010|Overall Study|Decision by sponsor|0|||
27735735|NCT02291614|54184260|FG000|Overall Study|Death|0|||
27735736|NCT02291614|54184261|FG001|Overall Study|Death|0|||
27735737|NCT02291614|54184262|FG002|Overall Study|Death|1|||
27735738|NCT02291614|54184263|FG003|Overall Study|Death|0|||
27735739|NCT02291614|54184264|FG004|Overall Study|Death|1|||
27735740|NCT02291614|54184265|FG005|Overall Study|Death|1|||
27735741|NCT02291614|54184266|FG006|Overall Study|Death|1|||
27735742|NCT02291614|54184267|FG007|Overall Study|Death|0|||
27735743|NCT02291614|54184268|FG008|Overall Study|Death|0|||
27735744|NCT02291614|54184269|FG009|Overall Study|Death|0|||
27735745|NCT02291614|54184270|FG010|Overall Study|Death|0|||
27735746|NCT02526524|54184306|FG000|Overall Study|Withdrawal by Subject|3|||
27735747|NCT02526524|54184307|FG001|Overall Study|Withdrawal by Subject|3|||
27735748|NCT02526524|54184308|FG002|Overall Study|Withdrawal by Subject|6|||
27735749|NCT02526524|54184309|FG003|Overall Study|Withdrawal by Subject|1|||
27735750|NCT02526524|54184310|FG004|Overall Study|Withdrawal by Subject|9|||
27735751|NCT02526524|54184311|FG005|Overall Study|Withdrawal by Subject|5|||
27735752|NCT02526524|54184306|FG000|Overall Study|Adverse Event|3|||
27735753|NCT02526524|54184307|FG001|Overall Study|Adverse Event|2|||
27735754|NCT02526524|54184308|FG002|Overall Study|Adverse Event|4|||
27735755|NCT02526524|54184309|FG003|Overall Study|Adverse Event|2|||
27735756|NCT02526524|54184310|FG004|Overall Study|Adverse Event|6|||
27735757|NCT02526524|54184311|FG005|Overall Study|Adverse Event|8|||
28094122|NCT03129100|54748062|FG003|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
28094123|NCT03129100|54748063|FG004|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
28094124|NCT03129100|54748064|FG005|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
28094125|NCT03129100|54748065|FG006|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
28094126|NCT03129100|54748066|FG007|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
28094127|NCT03129100|54748067|FG008|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
28094128|NCT03129100|54748068|FG009|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
28094129|NCT03129100|54748069|FG010|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
28094130|NCT03129100|54748070|FG011|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|12|||
28094131|NCT03129100|54748071|FG012|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|7|||
28094132|NCT03129100|54748072|FG013|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|4|||
28094133|NCT03129100|54748073|FG014|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|2|||
28094134|NCT03129100|54748074|FG015|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
28094135|NCT03129100|54748075|FG016|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
28094136|NCT03129100|54748076|FG017|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
28094137|NCT03129100|54748077|FG018|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
28094138|NCT03129100|54748078|FG019|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
28094139|NCT03129100|54748079|FG020|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
28094140|NCT03129100|54748080|FG021|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
28094141|NCT03129100|54748081|FG022|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
28094142|NCT03129100|54748082|FG023|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
28094143|NCT03129100|54748083|FG024|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
28094144|NCT03129100|54748084|FG025|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
28094145|NCT03129100|54748059|FG000|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
28094146|NCT03129100|54748060|FG001|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
28094147|NCT03129100|54748061|FG002|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
28094148|NCT03129100|54748062|FG003|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
28168937|NCT04938453|54839702|FG000|Washout Period 1|Physician Decision|0|||
28168938|NCT04938453|54839703|FG001|Washout Period 1|Physician Decision|1|||
28168939|NCT04590937|54839734|FG000|Period 2 - BI 730357+Cocktail|COVID-19 related|1|||
28168940|NCT04147260|54839762|FG000|Overall Study|Adverse Event|1|||
27735758|NCT02526524|54184306|FG000|Overall Study|Lost to Follow-up|2|||
27735759|NCT02526524|54184307|FG001|Overall Study|Lost to Follow-up|3|||
27735760|NCT02526524|54184308|FG002|Overall Study|Lost to Follow-up|8|||
27735761|NCT02526524|54184309|FG003|Overall Study|Lost to Follow-up|1|||
27735762|NCT02526524|54184310|FG004|Overall Study|Lost to Follow-up|2|||
27735763|NCT02526524|54184311|FG005|Overall Study|Lost to Follow-up|5|||
27735764|NCT02526524|54184306|FG000|Overall Study|Protocol Violation|3|||
27735765|NCT02526524|54184307|FG001|Overall Study|Protocol Violation|1|||
27735766|NCT02526524|54184308|FG002|Overall Study|Protocol Violation|5|||
27735767|NCT02526524|54184309|FG003|Overall Study|Protocol Violation|3|||
27735768|NCT02526524|54184310|FG004|Overall Study|Protocol Violation|4|||
27735769|NCT02526524|54184311|FG005|Overall Study|Protocol Violation|3|||
27735770|NCT02526524|54184306|FG000|Overall Study|Loss of Glucose Control|0|||
27735771|NCT02526524|54184307|FG001|Overall Study|Loss of Glucose Control|0|||
27735772|NCT02526524|54184308|FG002|Overall Study|Loss of Glucose Control|3|||
27735773|NCT02526524|54184309|FG003|Overall Study|Loss of Glucose Control|0|||
27735774|NCT02526524|54184310|FG004|Overall Study|Loss of Glucose Control|2|||
27735775|NCT02526524|54184311|FG005|Overall Study|Loss of Glucose Control|0|||
27735776|NCT02526524|54184306|FG000|Overall Study|Physician Decision|0|||
27735777|NCT02526524|54184307|FG001|Overall Study|Physician Decision|0|||
28168941|NCT04147260|54839763|FG001|Overall Study|Adverse Event|0|||
28168942|NCT04147260|54839764|FG002|Overall Study|Adverse Event|1|||
28168943|NCT04147260|54839765|FG003|Overall Study|Adverse Event|2|||
27735778|NCT02526524|54184308|FG002|Overall Study|Physician Decision|0|||
27735779|NCT02526524|54184309|FG003|Overall Study|Physician Decision|0|||
27735780|NCT02526524|54184310|FG004|Overall Study|Physician Decision|1|||
27735781|NCT02526524|54184311|FG005|Overall Study|Physician Decision|0|||
27735782|NCT02526524|54184306|FG000|Overall Study|Sponsor Decision|1|||
27735783|NCT02526524|54184307|FG001|Overall Study|Sponsor Decision|0|||
27735784|NCT02526524|54184308|FG002|Overall Study|Sponsor Decision|0|||
27735785|NCT02526524|54184309|FG003|Overall Study|Sponsor Decision|0|||
27735786|NCT02526524|54184310|FG004|Overall Study|Sponsor Decision|0|||
27735787|NCT02526524|54184311|FG005|Overall Study|Sponsor Decision|0|||
27735788|NCT02526290|54184325|FG000|Overall Study|Adverse Event|3|||
27735789|NCT02526290|54184325|FG000|Overall Study|Withdrawal by Subject|4|||
27735790|NCT02526290|54184325|FG000|Overall Study|Physician Decision|1|||
27735791|NCT02319148|54184332|FG000|Second Intervention Period|Adverse event (AE) related to study drug|0|||
27735792|NCT02319148|54184333|FG001|Second Intervention Period|Adverse event (AE) related to study drug|0|||
27735793|NCT02319148|54184334|FG002|Second Intervention Period|Adverse event (AE) related to study drug|1|||
27735794|NCT02319148|54184335|FG003|Second Intervention Period|Adverse event (AE) related to study drug|1|||
27735795|NCT02319148|54184332|FG000|Second Intervention Period|No longer willing to participate|0|||
27735796|NCT02319148|54184333|FG001|Second Intervention Period|No longer willing to participate|1|||
27735797|NCT02319148|54184334|FG002|Second Intervention Period|No longer willing to participate|0|||
27735798|NCT02319148|54184335|FG003|Second Intervention Period|No longer willing to participate|0|||
27735799|NCT02319148|54184332|FG000|Second Intervention Period|Other|0|||
27735800|NCT02319148|54184333|FG001|Second Intervention Period|Other|0|||
27735801|NCT02319148|54184334|FG002|Second Intervention Period|Other|0|||
27735802|NCT02319148|54184335|FG003|Second Intervention Period|Other|1|||
27833303|NCT01746017|54315226|FG006|Period 3|Withdrawal by Subject|0|||
27833304|NCT01746017|54315227|FG007|Period 3|Withdrawal by Subject|0|||
28094149|NCT03129100|54748063|FG004|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
28094150|NCT03129100|54748064|FG005|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
28094151|NCT03129100|54748065|FG006|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
28094152|NCT03129100|54748066|FG007|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
28094153|NCT03129100|54748067|FG008|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
28094154|NCT03129100|54748068|FG009|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
28094155|NCT03129100|54748069|FG010|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
28094156|NCT03129100|54748070|FG011|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
28094157|NCT03129100|54748071|FG012|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
28168944|NCT04147260|54839766|FG004|Overall Study|Adverse Event|0|||
28168945|NCT04147260|54839762|FG000|Overall Study|Withdrawal by Subject|0|||
27833305|NCT01746017|54315228|FG008|Period 3|Withdrawal by Subject|0|||
27735803|NCT02526212|54184356|FG000|Overall Study|Incarceration|1|||
27735804|NCT02526212|54184357|FG001|Overall Study|Incarceration|0|||
27735805|NCT02526212|54184356|FG000|Overall Study|Lost to Follow-up|1|||
27735806|NCT02526212|54184357|FG001|Overall Study|Lost to Follow-up|0|||
27735807|NCT02526212|54184356|FG000|Overall Study|Death|0|||
27735808|NCT02526212|54184357|FG001|Overall Study|Death|1|||
27735809|NCT02532374|54184363|FG000|Overall Study|Withdrawal by Subject|1|||
27735810|NCT02532374|54184363|FG000|Overall Study|Physician Decision|1|||
28168946|NCT04147260|54839763|FG001|Overall Study|Withdrawal by Subject|0|||
28168947|NCT04147260|54839764|FG002|Overall Study|Withdrawal by Subject|1|||
28168948|NCT04147260|54839765|FG003|Overall Study|Withdrawal by Subject|1|||
28168949|NCT04147260|54839766|FG004|Overall Study|Withdrawal by Subject|0|||
28168950|NCT04134728|54839783|FG000|Overall Study|Adverse Event|3|||
28168951|NCT04134728|54839784|FG001|Overall Study|Adverse Event|2|||
28168952|NCT04134728|54839785|FG002|Overall Study|Adverse Event|9|||
28168953|NCT04134728|54839786|FG003|Overall Study|Adverse Event|0|||
28168954|NCT04134728|54839787|FG004|Overall Study|Adverse Event|0|||
28168955|NCT04134728|54839788|FG005|Overall Study|Adverse Event|0|||
28168956|NCT04134728|54839783|FG000|Overall Study|Lack of Efficacy|3|||
28168957|NCT04134728|54839784|FG001|Overall Study|Lack of Efficacy|3|||
28168958|NCT04134728|54839785|FG002|Overall Study|Lack of Efficacy|1|||
28168959|NCT04134728|54839786|FG003|Overall Study|Lack of Efficacy|2|||
28168960|NCT04134728|54839787|FG004|Overall Study|Lack of Efficacy|0|||
28168961|NCT04134728|54839788|FG005|Overall Study|Lack of Efficacy|0|||
28168962|NCT04134728|54839783|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
28168963|NCT04134728|54839784|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
28168964|NCT04134728|54839785|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
28168965|NCT04134728|54839786|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
28168966|NCT04134728|54839787|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
28168967|NCT04134728|54839788|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
28168968|NCT04134728|54839783|FG000|Overall Study|Protocol Deviation|0|||
28168969|NCT04134728|54839784|FG001|Overall Study|Protocol Deviation|0|||
28168970|NCT04134728|54839785|FG002|Overall Study|Protocol Deviation|1|||
28168971|NCT04134728|54839786|FG003|Overall Study|Protocol Deviation|0|||
28168972|NCT04134728|54839787|FG004|Overall Study|Protocol Deviation|0|||
28168973|NCT04134728|54839788|FG005|Overall Study|Protocol Deviation|0|||
28168974|NCT04134728|54839783|FG000|Overall Study|Informed Consent Withdrawn|3|||
28168975|NCT04134728|54839784|FG001|Overall Study|Informed Consent Withdrawn|6|||
28168976|NCT04134728|54839785|FG002|Overall Study|Informed Consent Withdrawn|8|||
28168977|NCT04134728|54839786|FG003|Overall Study|Informed Consent Withdrawn|1|||
28168978|NCT04134728|54839787|FG004|Overall Study|Informed Consent Withdrawn|1|||
28168979|NCT04134728|54839788|FG005|Overall Study|Informed Consent Withdrawn|0|||
28168980|NCT04134728|54839783|FG000|Overall Study|Physician Decision|2|||
28168981|NCT04134728|54839784|FG001|Overall Study|Physician Decision|0|||
28168982|NCT04134728|54839785|FG002|Overall Study|Physician Decision|0|||
28168983|NCT04134728|54839786|FG003|Overall Study|Physician Decision|0|||
28168984|NCT04134728|54839787|FG004|Overall Study|Physician Decision|0|||
28168985|NCT04134728|54839788|FG005|Overall Study|Physician Decision|0|||
28168986|NCT04134728|54839783|FG000|Overall Study|Lost to Follow-up|1|||
28168987|NCT04134728|54839784|FG001|Overall Study|Lost to Follow-up|2|||
28168988|NCT04134728|54839785|FG002|Overall Study|Lost to Follow-up|1|||
28168989|NCT04134728|54839786|FG003|Overall Study|Lost to Follow-up|0|||
28168990|NCT04134728|54839787|FG004|Overall Study|Lost to Follow-up|0|||
28168991|NCT04134728|54839788|FG005|Overall Study|Lost to Follow-up|1|||
27735811|NCT02525744|54184375|FG000|Period 1|Physician Decision|0|||
28094158|NCT03129100|54748072|FG013|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
28094159|NCT03129100|54748073|FG014|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
28094160|NCT03129100|54748074|FG015|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
28094161|NCT03129100|54748075|FG016|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
28094162|NCT03129100|54748076|FG017|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
28094163|NCT03129100|54748077|FG018|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
28094164|NCT03129100|54748078|FG019|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
28094165|NCT03129100|54748079|FG020|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
28094166|NCT03129100|54748080|FG021|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
28094167|NCT03129100|54748081|FG022|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
28094168|NCT03129100|54748082|FG023|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
28094169|NCT03129100|54748083|FG024|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
28094170|NCT03129100|54748084|FG025|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
28094171|NCT03129100|54748059|FG000|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
28094172|NCT03129100|54748060|FG001|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
28094173|NCT03129100|54748061|FG002|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
28094174|NCT03129100|54748062|FG003|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
28168992|NCT04134728|54839783|FG000|Overall Study|Investigator Site Closed|0|||
28168993|NCT04134728|54839784|FG001|Overall Study|Investigator Site Closed|1|||
28168994|NCT04134728|54839785|FG002|Overall Study|Investigator Site Closed|1|||
28168995|NCT04134728|54839786|FG003|Overall Study|Investigator Site Closed|0|||
28168996|NCT04134728|54839787|FG004|Overall Study|Investigator Site Closed|0|||
28168997|NCT04134728|54839788|FG005|Overall Study|Investigator Site Closed|0|||
28168998|NCT03886272|54839822|FG000|Period 1|Withdrawal by Subject|0|||
28168999|NCT03886272|54839823|FG001|Period 1|Withdrawal by Subject|0|||
28169000|NCT03886272|54839824|FG002|Period 1|Withdrawal by Subject|0|||
27735812|NCT02525744|54184376|FG001|Period 1|Physician Decision|0|||
27735813|NCT02525744|54184377|FG002|Period 1|Physician Decision|1|||
27735814|NCT02525744|54184378|FG003|Period 1|Physician Decision|0|||
27735815|NCT02525744|54184375|FG000|Period 3|Adverse Event|0|||
27735816|NCT02525744|54184376|FG001|Period 3|Adverse Event|1|||
27735817|NCT02525744|54184377|FG002|Period 3|Adverse Event|0|||
27735818|NCT02525744|54184378|FG003|Period 3|Adverse Event|0|||
27735819|NCT02525744|54184375|FG000|Period 4|Withdrawal by Subject|1|||
27735820|NCT02525744|54184376|FG001|Period 4|Withdrawal by Subject|0|||
27735821|NCT02525744|54184377|FG002|Period 4|Withdrawal by Subject|0|||
27735822|NCT02525744|54184378|FG003|Period 4|Withdrawal by Subject|0|||
27735823|NCT02525744|54184375|FG000|Period 5|Physician Decision|1|||
27735824|NCT02525744|54184376|FG001|Period 5|Physician Decision|0|||
27735825|NCT02525744|54184377|FG002|Period 5|Physician Decision|0|||
27735826|NCT02525744|54184378|FG003|Period 5|Physician Decision|0|||
27735827|NCT00152477|54184391|FG000|Chemotherapy Period|Adverse Event|9|||
27735828|NCT00152477|54184392|FG001|Chemotherapy Period|Adverse Event|4|||
27735829|NCT00152477|54184393|FG002|Chemotherapy Period|Adverse Event|5|||
27735830|NCT00152477|54184391|FG000|Chemotherapy Period|Death|1|||
27735831|NCT00152477|54184392|FG001|Chemotherapy Period|Death|3|||
27735832|NCT00152477|54184393|FG002|Chemotherapy Period|Death|3|||
27735833|NCT00152477|54184391|FG000|Chemotherapy Period|Lack of Efficacy|4|||
27735834|NCT00152477|54184392|FG001|Chemotherapy Period|Lack of Efficacy|5|||
27735835|NCT00152477|54184393|FG002|Chemotherapy Period|Lack of Efficacy|6|||
27735836|NCT00152477|54184391|FG000|Chemotherapy Period|Lost to Follow-up|1|||
28169001|NCT03886272|54839825|FG003|Period 1|Withdrawal by Subject|0|||
28169002|NCT03886272|54839826|FG004|Period 1|Withdrawal by Subject|0|||
28169003|NCT03886272|54839827|FG005|Period 1|Withdrawal by Subject|1|||
28169004|NCT03886272|54839828|FG006|Period 1|Withdrawal by Subject|0|||
27735837|NCT00152477|54184392|FG001|Chemotherapy Period|Lost to Follow-up|0|||
27735838|NCT00152477|54184393|FG002|Chemotherapy Period|Lost to Follow-up|1|||
27735839|NCT00152477|54184391|FG000|Chemotherapy Period|Protocol Violation|1|||
27735840|NCT00152477|54184392|FG001|Chemotherapy Period|Protocol Violation|1|||
27735841|NCT00152477|54184393|FG002|Chemotherapy Period|Protocol Violation|0|||
27735842|NCT00152477|54184391|FG000|Chemotherapy Period|Withdrawal by Subject|5|||
27735843|NCT00152477|54184392|FG001|Chemotherapy Period|Withdrawal by Subject|1|||
27735844|NCT00152477|54184393|FG002|Chemotherapy Period|Withdrawal by Subject|0|||
27735845|NCT00152477|54184391|FG000|Chemotherapy Period|Progression of Disease|6|||
27735846|NCT00152477|54184392|FG001|Chemotherapy Period|Progression of Disease|8|||
27735847|NCT00152477|54184393|FG002|Chemotherapy Period|Progression of Disease|4|||
27735848|NCT00152477|54184391|FG000|Chemotherapy Period|Investigator decision|0|||
27735849|NCT00152477|54184392|FG001|Chemotherapy Period|Investigator decision|0|||
27735850|NCT00152477|54184393|FG002|Chemotherapy Period|Investigator decision|1|||
27735851|NCT00152477|54184391|FG000|Chemotherapy Period|Patient condition worsened|1|||
27735852|NCT00152477|54184392|FG001|Chemotherapy Period|Patient condition worsened|0|||
27735853|NCT00152477|54184393|FG002|Chemotherapy Period|Patient condition worsened|0|||
27735854|NCT00152477|54184391|FG000|Monotherapy Period|Adverse Event|1|||
27833306|NCT01746017|54315229|FG009|Period 3|Withdrawal by Subject|0|||
27833307|NCT01746017|54315230|FG010|Period 3|Withdrawal by Subject|0|||
27833308|NCT01717313|54315292|FG000|Phase A (Weeks 0 to 24)|Death|0|||
27833309|NCT01717313|54315293|FG001|Phase A (Weeks 0 to 24)|Death|1|||
28169005|NCT03732833|54839847|FG000|Overall Study|Adverse Event|0|||
28169006|NCT03732833|54839848|FG001|Overall Study|Adverse Event|3|||
28169007|NCT03732833|54839849|FG002|Overall Study|Adverse Event|1|||
28169008|NCT03732833|54839847|FG000|Overall Study|Withdrawal by Subject|11|||
28169009|NCT03732833|54839848|FG001|Overall Study|Withdrawal by Subject|13|||
28169010|NCT03732833|54839849|FG002|Overall Study|Withdrawal by Subject|8|||
28169011|NCT03732833|54839847|FG000|Overall Study|Lost to Follow-up|3|||
28169012|NCT03732833|54839848|FG001|Overall Study|Lost to Follow-up|5|||
28169013|NCT03732833|54839849|FG002|Overall Study|Lost to Follow-up|4|||
28169014|NCT03732833|54839847|FG000|Overall Study|Pregnancy|0|||
27735855|NCT00152477|54184392|FG001|Monotherapy Period|Adverse Event|0|||
27735856|NCT00152477|54184393|FG002|Monotherapy Period|Adverse Event|5|||
27735857|NCT00152477|54184391|FG000|Monotherapy Period|Death|2|||
27735858|NCT00152477|54184392|FG001|Monotherapy Period|Death|0|||
27735859|NCT00152477|54184393|FG002|Monotherapy Period|Death|1|||
27833310|NCT01717313|54315292|FG000|Phase A (Weeks 0 to 24)|Lost to Follow-up|1|||
27735860|NCT00152477|54184391|FG000|Monotherapy Period|Lack of Efficacy|7|||
27735861|NCT00152477|54184392|FG001|Monotherapy Period|Lack of Efficacy|16|||
27735862|NCT00152477|54184393|FG002|Monotherapy Period|Lack of Efficacy|10|||
27735863|NCT00152477|54184391|FG000|Monotherapy Period|Protocol Violation|0|||
27735864|NCT00152477|54184392|FG001|Monotherapy Period|Protocol Violation|1|||
27833311|NCT01717313|54315293|FG001|Phase A (Weeks 0 to 24)|Lost to Follow-up|3|||
27833312|NCT01717313|54315292|FG000|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12|||
28169015|NCT03732833|54839848|FG001|Overall Study|Pregnancy|2|||
28169016|NCT03732833|54839849|FG002|Overall Study|Pregnancy|0|||
28169017|NCT03732833|54839847|FG000|Overall Study|Physician Decision|2|||
28169018|NCT03732833|54839848|FG001|Overall Study|Physician Decision|3|||
28169019|NCT03732833|54839849|FG002|Overall Study|Physician Decision|1|||
27735865|NCT00152477|54184393|FG002|Monotherapy Period|Protocol Violation|0|||
27735866|NCT00152477|54184391|FG000|Monotherapy Period|Withdrawal by Subject|0|||
27735867|NCT00152477|54184392|FG001|Monotherapy Period|Withdrawal by Subject|0|||
27735868|NCT00152477|54184393|FG002|Monotherapy Period|Withdrawal by Subject|4|||
27735869|NCT00152477|54184391|FG000|Monotherapy Period|Progression of Disease|5|||
27735870|NCT00152477|54184392|FG001|Monotherapy Period|Progression of Disease|11|||
27735871|NCT00152477|54184393|FG002|Monotherapy Period|Progression of Disease|12|||
27735872|NCT00152477|54184391|FG000|Monotherapy Period|Patient decision|0|||
27735873|NCT00152477|54184392|FG001|Monotherapy Period|Patient decision|1|||
27735874|NCT00152477|54184393|FG002|Monotherapy Period|Patient decision|1|||
27735875|NCT00152477|54184391|FG000|Monotherapy Period|Study personel decision|0|||
27735876|NCT00152477|54184392|FG001|Monotherapy Period|Study personel decision|0|||
27735877|NCT00152477|54184393|FG002|Monotherapy Period|Study personel decision|1|||
27735878|NCT02525588|54184406|FG000|Overall Study|Death|3|||
27735879|NCT02525588|54184407|FG001|Overall Study|Death|1|||
27735880|NCT02525588|54184406|FG000|Overall Study|Lost to Follow-up|2|||
27735881|NCT02525588|54184407|FG001|Overall Study|Lost to Follow-up|0|||
27735882|NCT02525588|54184406|FG000|Overall Study|Withdrawal by Subject|1|||
27735883|NCT02525588|54184407|FG001|Overall Study|Withdrawal by Subject|1|||
27735884|NCT02525588|54184406|FG000|Overall Study|Adverse Event|0|||
27735885|NCT02525588|54184407|FG001|Overall Study|Adverse Event|1|||
27735886|NCT00153179|54184415|FG000|Study Visit Day 2|Withdrawal by Subject|1|||
27735887|NCT00153179|54184416|FG001|Study Visit Day 2|Withdrawal by Subject|0|||
27735888|NCT00153179|54184417|FG002|Study Visit Day 2|Withdrawal by Subject|2|||
27735889|NCT00153179|54184418|FG003|Study Visit Day 2|Withdrawal by Subject|2|||
27735890|NCT02531594|54184428|FG000|Overall Study|Withdrawal by Subject|7|||
27735891|NCT02531594|54184429|FG001|Overall Study|Withdrawal by Subject|8|||
27735892|NCT02743949|54184438|FG000|Overall Study|Adverse Event|0|||
27735893|NCT02743949|54184439|FG001|Overall Study|Adverse Event|0|||
27735894|NCT02743949|54184440|FG002|Overall Study|Adverse Event|2|||
27735895|NCT02743949|54184438|FG000|Overall Study|Significant Protocol Deviation|2|||
27735896|NCT02743949|54184439|FG001|Overall Study|Significant Protocol Deviation|0|||
27735897|NCT02743949|54184440|FG002|Overall Study|Significant Protocol Deviation|1|||
27735898|NCT02743949|54184438|FG000|Overall Study|Voluntary Withdrawal|2|||
27735899|NCT02743949|54184439|FG001|Overall Study|Voluntary Withdrawal|1|||
27735900|NCT02743949|54184440|FG002|Overall Study|Voluntary Withdrawal|0|||
27735901|NCT02531438|54184450|FG000|Overall Study|Adverse Event|7|||
27735902|NCT02531438|54184451|FG001|Overall Study|Adverse Event|9|||
27735903|NCT02531438|54184450|FG000|Overall Study|Lost to Follow-up|0|||
27735904|NCT02531438|54184451|FG001|Overall Study|Lost to Follow-up|3|||
27735905|NCT02531438|54184450|FG000|Overall Study|Withdrawal by Subject|7|||
27735906|NCT02531438|54184451|FG001|Overall Study|Withdrawal by Subject|8|||
27735907|NCT02531438|54184450|FG000|Overall Study|Physician Decision|0|||
27735908|NCT02531438|54184451|FG001|Overall Study|Physician Decision|1|||
27735909|NCT02531438|54184450|FG000|Overall Study|Death|6|||
27735910|NCT02531438|54184451|FG001|Overall Study|Death|3|||
27735911|NCT02531438|54184450|FG000|Overall Study|Randomized, but Not Treated|4|||
27735912|NCT02531438|54184451|FG001|Overall Study|Randomized, but Not Treated|0|||
27735913|NCT02531438|54184450|FG000|Overall Study|Missed EOT/PTE Visit|5|||
27735914|NCT02531438|54184451|FG001|Overall Study|Missed EOT/PTE Visit|2|||
27735915|NCT02531438|54184450|FG000|Overall Study|Randomized with Exclusion Criteria|1|||
27735916|NCT02531438|54184451|FG001|Overall Study|Randomized with Exclusion Criteria|0|||
27735917|NCT02289898|54184460|FG000|Overall Study|Death|5|||
27735918|NCT02289898|54184461|FG001|Overall Study|Death|4|||
27735919|NCT02289898|54184462|FG002|Overall Study|Death|3|||
27735920|NCT02289898|54184460|FG000|Overall Study|Physician Decision|2|||
27735921|NCT02289898|54184461|FG001|Overall Study|Physician Decision|5|||
27735922|NCT02289898|54184462|FG002|Overall Study|Physician Decision|2|||
27735923|NCT02289898|54184460|FG000|Overall Study|Withdrawal by Subject|0|||
27735924|NCT02289898|54184461|FG001|Overall Study|Withdrawal by Subject|4|||
27735925|NCT02289898|54184462|FG002|Overall Study|Withdrawal by Subject|1|||
27735926|NCT02289898|54184460|FG000|Overall Study|Adverse Event|3|||
27735927|NCT02289898|54184461|FG001|Overall Study|Adverse Event|5|||
27735928|NCT02289898|54184462|FG002|Overall Study|Adverse Event|5|||
27735929|NCT02289898|54184460|FG000|Overall Study|Disease progression|34|||
27735930|NCT02289898|54184461|FG001|Overall Study|Disease progression|28|||
27735931|NCT02289898|54184462|FG002|Overall Study|Disease progression|34|||
27735932|NCT02289898|54184460|FG000|Overall Study|Use of another anticancer therapy|0|||
27735933|NCT02289898|54184461|FG001|Overall Study|Use of another anticancer therapy|0|||
27735934|NCT02289898|54184462|FG002|Overall Study|Use of another anticancer therapy|1|||
27735935|NCT02289898|54184460|FG000|Overall Study|Other|8|||
27735936|NCT02289898|54184461|FG001|Overall Study|Other|7|||
27735937|NCT02289898|54184462|FG002|Overall Study|Other|10|||
27735938|NCT01660412|54184469|FG000|Overall Study|Protocol Violation|0|||
27735939|NCT01660412|54184470|FG001|Overall Study|Protocol Violation|3|||
27735940|NCT01659554|54184476|FG000|Overall Study|Study Termination|4|||
27735941|NCT01659320|54184480|FG000|Overall Study|Withdrawal by Subject|2|||
27735942|NCT01659320|54184480|FG000|Overall Study|Physician Decision|1|||
27735943|NCT01660334|54184484|FG000|Overall Study|Lost to Follow-up|1|||
27735944|NCT01660256|54184491|FG000|Overall Study|Adverse Event|4|||
27735945|NCT01660256|54184492|FG001|Overall Study|Adverse Event|0|||
27735946|NCT01660256|54184493|FG002|Overall Study|Adverse Event|2|||
27735947|NCT01660256|54184491|FG000|Overall Study|Withdrawal by Subject|1|||
27735948|NCT01660256|54184492|FG001|Overall Study|Withdrawal by Subject|0|||
27735949|NCT01660256|54184493|FG002|Overall Study|Withdrawal by Subject|2|||
27735950|NCT02034123|54184519|FG000|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
27735951|NCT02034123|54184520|FG001|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
27735952|NCT02034123|54184521|FG002|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
27735953|NCT02034123|54184522|FG003|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
27735954|NCT02034123|54184523|FG004|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
27735955|NCT02034123|54184524|FG005|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
27735956|NCT02034123|54184525|FG006|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
27735957|NCT02034123|54184526|FG007|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
27735958|NCT02034123|54184527|FG008|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
27735959|NCT02034123|54184528|FG009|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
27735960|NCT02034123|54184529|FG010|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
27735961|NCT02034123|54184530|FG011|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
27735962|NCT02034123|54184531|FG012|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
27735963|NCT02034123|54184532|FG013|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
27735964|NCT02034123|54184533|FG014|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
27735965|NCT02034123|54184534|FG015|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
27735966|NCT02034123|54184535|FG016|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
27735967|NCT02034123|54184536|FG017|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
27735968|NCT02034123|54184519|FG000|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
27735969|NCT02034123|54184520|FG001|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
27735970|NCT02034123|54184521|FG002|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
27735971|NCT02034123|54184522|FG003|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1|||
27735972|NCT02034123|54184523|FG004|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
27735973|NCT02034123|54184524|FG005|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
27735974|NCT02034123|54184525|FG006|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
27735975|NCT02034123|54184526|FG007|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
27735976|NCT02034123|54184527|FG008|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
27735977|NCT02034123|54184528|FG009|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
27735978|NCT02034123|54184529|FG010|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
27735979|NCT02034123|54184530|FG011|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
27735980|NCT02034123|54184531|FG012|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
27735981|NCT02034123|54184532|FG013|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
27735982|NCT02034123|54184533|FG014|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
27735983|NCT02034123|54184534|FG015|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
27735984|NCT02034123|54184535|FG016|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
27735985|NCT02034123|54184536|FG017|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
27735986|NCT02034123|54184519|FG000|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
27735987|NCT02034123|54184520|FG001|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
27735988|NCT02034123|54184521|FG002|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
27855894|NCT02323113|54383010|FG005|Overall Study|Unsatisfactory Therapeutic Response|2|||
27855895|NCT02323113|54383011|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
27855896|NCT02323113|54383012|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
27855897|NCT02323113|54383005|FG000|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
27855898|NCT02323113|54383006|FG001|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|1|||
27855899|NCT02323113|54383007|FG002|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
27855900|NCT02323113|54383008|FG003|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
27855901|NCT02323113|54383009|FG004|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
27855902|NCT02323113|54383010|FG005|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
27855903|NCT02323113|54383011|FG006|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
27855904|NCT02323113|54383012|FG007|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
27855905|NCT02281383|54383059|FG000|Overall Study|Progressive Disease|1|||
27855906|NCT02281383|54383059|FG000|Overall Study|Withdrawal by Subject|6|||
27980756|NCT00611455|54638746|FG001|DB Treatment Period (24 Weeks)|Adverse Event|8|||
27980757|NCT00611455|54638747|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
27980758|NCT00611455|54638745|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|2|||
27735989|NCT02034123|54184522|FG003|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
27735990|NCT02034123|54184523|FG004|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
27735991|NCT02034123|54184524|FG005|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
27735992|NCT02034123|54184525|FG006|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
27735993|NCT02034123|54184526|FG007|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
27735994|NCT02034123|54184527|FG008|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1|||
27735995|NCT02034123|54184528|FG009|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
27735996|NCT02034123|54184529|FG010|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
27735997|NCT02034123|54184530|FG011|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
27735998|NCT02034123|54184531|FG012|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
27735999|NCT02034123|54184532|FG013|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
27736000|NCT02034123|54184533|FG014|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
27736001|NCT02034123|54184534|FG015|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
27736002|NCT02034123|54184535|FG016|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
27736003|NCT02034123|54184536|FG017|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
27736004|NCT02034123|54184519|FG000|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
27736005|NCT02034123|54184520|FG001|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
27736006|NCT02034123|54184521|FG002|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
27736007|NCT02034123|54184522|FG003|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
27736008|NCT02034123|54184523|FG004|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
27736009|NCT02034123|54184524|FG005|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
27736010|NCT02034123|54184525|FG006|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
27736011|NCT02034123|54184526|FG007|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
27736012|NCT02034123|54184527|FG008|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
27736013|NCT02034123|54184528|FG009|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
27736014|NCT02034123|54184529|FG010|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
27736015|NCT02034123|54184530|FG011|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
27736016|NCT02034123|54184531|FG012|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
27736017|NCT02034123|54184532|FG013|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
27736018|NCT02034123|54184533|FG014|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
27736019|NCT02034123|54184534|FG015|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
27736020|NCT02034123|54184535|FG016|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
27736021|NCT02034123|54184536|FG017|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
27736022|NCT02318602|54184582|FG000|Overall Study|Adverse Event|0|||
27736023|NCT02318602|54184583|FG001|Overall Study|Adverse Event|1|||
27736024|NCT02318602|54184584|FG002|Overall Study|Adverse Event|1|||
27736025|NCT02318602|54184582|FG000|Overall Study|Withdrawal by Subject|0|||
27736026|NCT02318602|54184583|FG001|Overall Study|Withdrawal by Subject|3|||
27736027|NCT02318602|54184584|FG002|Overall Study|Withdrawal by Subject|0|||
27736028|NCT02318602|54184582|FG000|Overall Study|Death|1|||
27736029|NCT02318602|54184583|FG001|Overall Study|Death|0|||
28169020|NCT03732833|54839847|FG000|Overall Study|Covid-19 related and other reasons|2|||
28169021|NCT03732833|54839848|FG001|Overall Study|Covid-19 related and other reasons|7|||
28169022|NCT03732833|54839849|FG002|Overall Study|Covid-19 related and other reasons|3|||
28169023|NCT03493919|54839866|FG000|Overall Study|Other|2|||
28169024|NCT03493919|54839867|FG001|Overall Study|Other|0|||
28169025|NCT03493919|54839868|FG002|Overall Study|Other|1|||
28169026|NCT03493919|54839869|FG003|Overall Study|Other|0|||
28169027|NCT03493919|54839866|FG000|Overall Study|Withdrawal by Subject|9|||
28169028|NCT03493919|54839867|FG001|Overall Study|Withdrawal by Subject|3|||
28169029|NCT03493919|54839868|FG002|Overall Study|Withdrawal by Subject|1|||
28169030|NCT03493919|54839869|FG003|Overall Study|Withdrawal by Subject|1|||
28169031|NCT03493919|54839866|FG000|Overall Study|Lost to Follow-up|5|||
28169032|NCT03493919|54839867|FG001|Overall Study|Lost to Follow-up|0|||
28169033|NCT03493919|54839868|FG002|Overall Study|Lost to Follow-up|0|||
28169034|NCT03493919|54839869|FG003|Overall Study|Lost to Follow-up|3|||
28169035|NCT03493919|54839866|FG000|Overall Study|Adverse Event|0|||
28169036|NCT03493919|54839867|FG001|Overall Study|Adverse Event|1|||
27736030|NCT02318602|54184584|FG002|Overall Study|Death|0|||
27736031|NCT02318602|54184582|FG000|Overall Study|Guardian decision to withdraw|0|||
27736032|NCT02318602|54184583|FG001|Overall Study|Guardian decision to withdraw|0|||
27855907|NCT02281383|54383059|FG000|Overall Study|Protocol Violation|2|||
27855908|NCT02281383|54383059|FG000|Overall Study|Death|1|||
27855909|NCT02281383|54383059|FG000|Overall Study|Adverse Event|2|||
27855910|NCT01047553|54383065|FG000|Overall Study|Adverse Event|10|||
28169037|NCT03493919|54839868|FG002|Overall Study|Adverse Event|0|||
28169038|NCT03493919|54839869|FG003|Overall Study|Adverse Event|0|||
28169039|NCT03280628|54839887|FG000|Overall Study|Lost to Follow-up|8|||
28169040|NCT03280628|54839888|FG001|Overall Study|Lost to Follow-up|6|||
28169041|NCT03280628|54839889|FG002|Overall Study|Lost to Follow-up|11|||
28169042|NCT03194646|54839901|FG000|Overall Study|Adverse Event|24|||
28169043|NCT03194646|54839902|FG001|Overall Study|Adverse Event|25|||
28169044|NCT03194646|54839903|FG002|Overall Study|Adverse Event|14|||
28169045|NCT03194646|54839904|FG003|Overall Study|Adverse Event|17|||
28169046|NCT03194646|54839901|FG000|Overall Study|Lack of Efficacy|4|||
28169047|NCT03194646|54839902|FG001|Overall Study|Lack of Efficacy|2|||
28169048|NCT03194646|54839903|FG002|Overall Study|Lack of Efficacy|2|||
28169049|NCT03194646|54839904|FG003|Overall Study|Lack of Efficacy|12|||
28169050|NCT03194646|54839901|FG000|Overall Study|Lost to Follow-up|30|||
27833313|NCT01717313|54315293|FG001|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6|||
27855911|NCT01047553|54383066|FG001|Overall Study|Adverse Event|5|||
28169051|NCT03194646|54839902|FG001|Overall Study|Lost to Follow-up|22|||
28169052|NCT03194646|54839903|FG002|Overall Study|Lost to Follow-up|12|||
28169053|NCT03194646|54839904|FG003|Overall Study|Lost to Follow-up|35|||
28169054|NCT03194646|54839901|FG000|Overall Study|Non-compliance with study drug|4|||
28169055|NCT03194646|54839902|FG001|Overall Study|Non-compliance with study drug|0|||
27833314|NCT01717313|54315292|FG000|Phase A (Weeks 0 to 24)|Adverse Event|4|||
27833315|NCT01717313|54315293|FG001|Phase A (Weeks 0 to 24)|Adverse Event|2|||
27855912|NCT01047553|54383065|FG000|Overall Study|Withdrawal by Subject|4|||
27855913|NCT01047553|54383066|FG001|Overall Study|Withdrawal by Subject|2|||
27855914|NCT01047553|54383065|FG000|Overall Study|Development of Study-Specific Withdrawal|1|||
27855915|NCT01047553|54383066|FG001|Overall Study|Development of Study-Specific Withdrawal|1|||
27855916|NCT01047553|54383065|FG000|Overall Study|Lost to Follow-up|1|||
27855917|NCT01047553|54383066|FG001|Overall Study|Lost to Follow-up|0|||
27855918|NCT01047553|54383065|FG000|Overall Study|Sever Non-Compliance to Protocol|1|||
27855919|NCT01047553|54383066|FG001|Overall Study|Sever Non-Compliance to Protocol|0|||
27855920|NCT01047553|54383065|FG000|Overall Study|PI's decision|0|||
27855921|NCT01047553|54383066|FG001|Overall Study|PI's decision|1|||
27855922|NCT01047007|54383100|FG000|Overall Study|Adverse Event|0|||
27855923|NCT01047007|54383101|FG001|Overall Study|Adverse Event|2|||
27855924|NCT01047007|54383102|FG002|Overall Study|Adverse Event|1|||
27855925|NCT01047007|54383103|FG003|Overall Study|Adverse Event|0|||
27855926|NCT01047007|54383100|FG000|Overall Study|Progressive Disease|2|||
27855927|NCT01047007|54383101|FG001|Overall Study|Progressive Disease|4|||
27855928|NCT01047007|54383102|FG002|Overall Study|Progressive Disease|1|||
27855929|NCT01047007|54383103|FG003|Overall Study|Progressive Disease|0|||
27855930|NCT01046695|54383115|FG000|Overall Study|Subject had a pacemaker|0|||
27855931|NCT01046695|54383116|FG001|Overall Study|Subject had a pacemaker|1|||
27855932|NCT01046695|54383115|FG000|Overall Study|TENS interfered with the cardiac monitor|0|||
27855933|NCT01046695|54383116|FG001|Overall Study|TENS interfered with the cardiac monitor|1|||
27855934|NCT03304379|54383131|FG000|Overall Study|Protocol Violation|8|||
27855935|NCT03304379|54383132|FG001|Overall Study|Protocol Violation|10|||
27855936|NCT03304379|54383133|FG002|Overall Study|Protocol Violation|5|||
27855937|NCT03304379|54383134|FG003|Overall Study|Protocol Violation|0|||
27855938|NCT03304379|54383135|FG004|Overall Study|Protocol Violation|2|||
27855939|NCT03304379|54383131|FG000|Overall Study|Adverse Event|4|||
27855940|NCT03304379|54383132|FG001|Overall Study|Adverse Event|20|||
27855941|NCT03304379|54383133|FG002|Overall Study|Adverse Event|17|||
27855942|NCT03304379|54383134|FG003|Overall Study|Adverse Event|1|||
27855943|NCT03304379|54383135|FG004|Overall Study|Adverse Event|0|||
27855944|NCT03304379|54383131|FG000|Overall Study|Lack of Efficacy|17|||
27855945|NCT03304379|54383132|FG001|Overall Study|Lack of Efficacy|16|||
27855946|NCT03304379|54383133|FG002|Overall Study|Lack of Efficacy|20|||
27855947|NCT03304379|54383134|FG003|Overall Study|Lack of Efficacy|0|||
28169056|NCT03194646|54839903|FG002|Overall Study|Non-compliance with study drug|1|||
27833316|NCT01717313|54315292|FG000|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
27833317|NCT01717313|54315293|FG001|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
27833318|NCT01717313|54315292|FG000|Interphase|Completed Phase A Did Not Enter Phase B|1|||
27833319|NCT01717313|54315293|FG001|Interphase|Completed Phase A Did Not Enter Phase B|0|||
27833320|NCT01717313|54315292|FG000|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
27833321|NCT01717313|54315293|FG001|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
27855948|NCT03304379|54383135|FG004|Overall Study|Lack of Efficacy|0|||
27855949|NCT03304379|54383131|FG000|Overall Study|Physician Decision|6|||
27855950|NCT03304379|54383132|FG001|Overall Study|Physician Decision|10|||
27855951|NCT03304379|54383133|FG002|Overall Study|Physician Decision|6|||
27855952|NCT03304379|54383134|FG003|Overall Study|Physician Decision|9|||
27855953|NCT03304379|54383135|FG004|Overall Study|Physician Decision|10|||
27855954|NCT03304379|54383131|FG000|Overall Study|Withdrawal by Subject|26|||
27855955|NCT03304379|54383132|FG001|Overall Study|Withdrawal by Subject|58|||
27855956|NCT03304379|54383133|FG002|Overall Study|Withdrawal by Subject|66|||
27855957|NCT03304379|54383134|FG003|Overall Study|Withdrawal by Subject|3|||
27855958|NCT03304379|54383135|FG004|Overall Study|Withdrawal by Subject|5|||
27855959|NCT03304379|54383131|FG000|Overall Study|Lost to Follow-up|8|||
27855960|NCT03304379|54383132|FG001|Overall Study|Lost to Follow-up|24|||
28169057|NCT03194646|54839904|FG003|Overall Study|Non-compliance with study drug|1|||
28169058|NCT03194646|54839901|FG000|Overall Study|Other|87|||
28169059|NCT03194646|54839902|FG001|Overall Study|Other|67|||
28169060|NCT03194646|54839903|FG002|Overall Study|Other|34|||
28169061|NCT03194646|54839904|FG003|Overall Study|Other|31|||
28169062|NCT03194646|54839901|FG000|Overall Study|Physician Decision|7|||
28169063|NCT03194646|54839902|FG001|Overall Study|Physician Decision|9|||
28169064|NCT03194646|54839903|FG002|Overall Study|Physician Decision|5|||
28169065|NCT03194646|54839904|FG003|Overall Study|Physician Decision|4|||
28169066|NCT03194646|54839901|FG000|Overall Study|Pregnancy|4|||
28169067|NCT03194646|54839902|FG001|Overall Study|Pregnancy|5|||
28169068|NCT03194646|54839903|FG002|Overall Study|Pregnancy|1|||
28169069|NCT03194646|54839904|FG003|Overall Study|Pregnancy|2|||
28169070|NCT03194646|54839901|FG000|Overall Study|Protocol Violation|4|||
28169071|NCT03194646|54839902|FG001|Overall Study|Protocol Violation|2|||
28169072|NCT03194646|54839903|FG002|Overall Study|Protocol Violation|1|||
28169073|NCT03194646|54839904|FG003|Overall Study|Protocol Violation|1|||
28169074|NCT03194646|54839901|FG000|Overall Study|Site terminated by sponsor|0|||
28169075|NCT03194646|54839902|FG001|Overall Study|Site terminated by sponsor|0|||
28169076|NCT03194646|54839903|FG002|Overall Study|Site terminated by sponsor|2|||
28169077|NCT03194646|54839904|FG003|Overall Study|Site terminated by sponsor|0|||
28169078|NCT03194646|54839901|FG000|Overall Study|Study terminated by sponsor|60|||
28169079|NCT03194646|54839902|FG001|Overall Study|Study terminated by sponsor|61|||
28169080|NCT03194646|54839903|FG002|Overall Study|Study terminated by sponsor|30|||
28169081|NCT03194646|54839904|FG003|Overall Study|Study terminated by sponsor|34|||
27736033|NCT02318602|54184584|FG002|Overall Study|Guardian decision to withdraw|1|||
27736034|NCT02318368|54184600|FG000|Overall Study|Withdrawal by Subject|2|||
27736035|NCT02318368|54184601|FG001|Overall Study|Withdrawal by Subject|0|||
27736036|NCT02318368|54184600|FG000|Overall Study|Study terminated by the sponsor|5|||
27736037|NCT02318368|54184601|FG001|Overall Study|Study terminated by the sponsor|2|||
27736038|NCT02318368|54184600|FG000|Overall Study|Death|0|||
27736039|NCT02318368|54184601|FG001|Overall Study|Death|1|||
27736040|NCT02318134|54184609|FG000|Overall Study|Withdrawal by Subject|2|||
27736041|NCT02318134|54184610|FG001|Overall Study|Withdrawal by Subject|1|||
27736042|NCT02317510|54184620|FG000|Overall Study|Adverse Event|0|||
27736043|NCT02317510|54184621|FG001|Overall Study|Adverse Event|1|||
27736044|NCT02317432|54184632|FG000|Overall Study|Death|4|||
27736045|NCT02317432|54184633|FG001|Overall Study|Death|1|||
27736046|NCT02317432|54184632|FG000|Overall Study|Lost to Follow-up|0|||
27736047|NCT02317432|54184633|FG001|Overall Study|Lost to Follow-up|5|||
27736048|NCT02317432|54184632|FG000|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|27|||
27736049|NCT02317432|54184633|FG001|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|0|||
27736050|NCT00494234|54184641|FG000|Overall Study|Lack of Efficacy|12|||
27736051|NCT00494234|54184642|FG001|Overall Study|Lack of Efficacy|9|||
27736052|NCT00494234|54184641|FG000|Overall Study|Withdrawal by Subject|1|||
27736053|NCT00494234|54184642|FG001|Overall Study|Withdrawal by Subject|0|||
27855961|NCT03304379|54383133|FG002|Overall Study|Lost to Follow-up|35|||
27855962|NCT03304379|54383134|FG003|Overall Study|Lost to Follow-up|4|||
27855963|NCT03304379|54383135|FG004|Overall Study|Lost to Follow-up|0|||
27855964|NCT03304379|54383131|FG000|Overall Study|Death|1|||
27855965|NCT03304379|54383132|FG001|Overall Study|Death|2|||
28169082|NCT03194646|54839901|FG000|Overall Study|Withdrawal by Subject|74|||
28169083|NCT03194646|54839902|FG001|Overall Study|Withdrawal by Subject|75|||
28169084|NCT03194646|54839903|FG002|Overall Study|Withdrawal by Subject|36|||
27736054|NCT00494234|54184641|FG000|Overall Study|Death|2|||
27736055|NCT00494234|54184642|FG001|Overall Study|Death|1|||
27736056|NCT02289820|54184659|FG000|Overall Study|Withdrawal by Subject|2|||
27736057|NCT02289820|54184660|FG001|Overall Study|Withdrawal by Subject|1|||
27736058|NCT02289820|54184661|FG002|Overall Study|Withdrawal by Subject|2|||
27736059|NCT02289820|54184662|FG003|Overall Study|Withdrawal by Subject|1|||
27736060|NCT02289820|54184663|FG004|Overall Study|Withdrawal by Subject|0|||
27736061|NCT02289820|54184664|FG005|Overall Study|Withdrawal by Subject|0|||
27736062|NCT02289820|54184665|FG006|Overall Study|Withdrawal by Subject|1|||
27736063|NCT02289820|54184659|FG000|Overall Study|Death|0|||
27736064|NCT02289820|54184660|FG001|Overall Study|Death|0|||
27736065|NCT02289820|54184661|FG002|Overall Study|Death|1|||
27736066|NCT02289820|54184662|FG003|Overall Study|Death|0|||
28169085|NCT03194646|54839904|FG003|Overall Study|Withdrawal by Subject|131|||
28169086|NCT03194646|54839901|FG000|Overall Study|Missing|4|||
28169087|NCT03194646|54839902|FG001|Overall Study|Missing|0|||
28169088|NCT03194646|54839903|FG002|Overall Study|Missing|1|||
28169089|NCT03194646|54839904|FG003|Overall Study|Missing|12|||
28169090|NCT03058146|54839938|FG000|Overall Study|Withdrawal by Subject|4|||
28169091|NCT03058146|54839939|FG001|Overall Study|Withdrawal by Subject|1|||
27736067|NCT02289820|54184663|FG004|Overall Study|Death|0|||
27736068|NCT02289820|54184664|FG005|Overall Study|Death|0|||
27736069|NCT02289820|54184665|FG006|Overall Study|Death|0|||
27736070|NCT02289820|54184659|FG000|Overall Study|Lost to Follow-up|0|||
27736071|NCT02289820|54184660|FG001|Overall Study|Lost to Follow-up|0|||
27855966|NCT03304379|54383133|FG002|Overall Study|Death|0|||
27855967|NCT03304379|54383134|FG003|Overall Study|Death|0|||
27855968|NCT03304379|54383135|FG004|Overall Study|Death|0|||
27855969|NCT03304379|54383131|FG000|Overall Study|Other|0|||
27855970|NCT03304379|54383132|FG001|Overall Study|Other|1|||
27855971|NCT03304379|54383133|FG002|Overall Study|Other|0|||
27855972|NCT03304379|54383134|FG003|Overall Study|Other|0|||
28169092|NCT03058146|54839938|FG000|Overall Study|Coronavirus (COVID)-19 shutdown|0|||
28169093|NCT03058146|54839939|FG001|Overall Study|Coronavirus (COVID)-19 shutdown|1|||
28169094|NCT03057054|54839949|FG000|Overall Study|Death|4|||
28169095|NCT03057054|54839950|FG001|Overall Study|Death|4|||
28169096|NCT03057054|54839949|FG000|Overall Study|Withdrawal by Subject|6|||
28169097|NCT03057054|54839950|FG001|Overall Study|Withdrawal by Subject|3|||
27855973|NCT03304379|54383135|FG004|Overall Study|Other|0|||
27855974|NCT01044745|54383190|FG000|Overall Study|Ineiligible|2|||
27855975|NCT01044433|54383213|FG000|Overall Study|Lost to Follow-up|3|||
27855976|NCT01044433|54383213|FG000|Overall Study|Withdrawal by Subject|3|||
27855977|NCT01043185|54383222|FG000|Period 6 - Third Washout Period|Protocol Violation|0|||
27855978|NCT01043185|54383223|FG001|Period 6 - Third Washout Period|Protocol Violation|0|||
27855979|NCT01043185|54383224|FG002|Period 6 - Third Washout Period|Protocol Violation|0|||
27855980|NCT01043185|54383225|FG003|Period 6 - Third Washout Period|Protocol Violation|0|||
27855981|NCT01043185|54383226|FG004|Period 6 - Third Washout Period|Protocol Violation|0|||
27855982|NCT01043185|54383227|FG005|Period 6 - Third Washout Period|Protocol Violation|0|||
27855983|NCT01043185|54383228|FG006|Period 6 - Third Washout Period|Protocol Violation|0|||
27855984|NCT01043185|54383229|FG007|Period 6 - Third Washout Period|Protocol Violation|0|||
27855985|NCT01043185|54383230|FG008|Period 6 - Third Washout Period|Protocol Violation|1|||
27855986|NCT01043185|54383231|FG009|Period 6 - Third Washout Period|Protocol Violation|0|||
27855987|NCT01042093|54383256|FG000|Overall Study|Protocol Violation|2|||
27855988|NCT01042093|54383257|FG001|Overall Study|Protocol Violation|2|||
27855989|NCT01042093|54383258|FG002|Overall Study|Protocol Violation|2|||
27855990|NCT01042093|54383259|FG003|Overall Study|Protocol Violation|3|||
27855991|NCT01042093|54383256|FG000|Overall Study|Withdrawal by Subject|0|||
27855992|NCT01042093|54383257|FG001|Overall Study|Withdrawal by Subject|0|||
27855993|NCT01042093|54383258|FG002|Overall Study|Withdrawal by Subject|0|||
27855994|NCT01042093|54383259|FG003|Overall Study|Withdrawal by Subject|1|||
27855995|NCT01041859|54383289|FG000|Open-Label Titration|Adverse Event|69|||
27855996|NCT01041859|54383290|FG001|Open-Label Titration|Adverse Event|0|||
27855997|NCT01041859|54383291|FG002|Open-Label Titration|Adverse Event|0|||
27855998|NCT01041859|54383289|FG000|Open-Label Titration|Lack of Efficacy|3|||
27855999|NCT01041859|54383290|FG001|Open-Label Titration|Lack of Efficacy|0|||
27856000|NCT01041859|54383291|FG002|Open-Label Titration|Lack of Efficacy|0|||
27856001|NCT01041859|54383289|FG000|Open-Label Titration|Lost to Follow-up|1|||
27856002|NCT01041859|54383290|FG001|Open-Label Titration|Lost to Follow-up|0|||
27856003|NCT01041859|54383291|FG002|Open-Label Titration|Lost to Follow-up|0|||
27856004|NCT01041859|54383289|FG000|Open-Label Titration|Physician Decision|1|||
27856005|NCT01041859|54383290|FG001|Open-Label Titration|Physician Decision|0|||
27856006|NCT01041859|54383291|FG002|Open-Label Titration|Physician Decision|0|||
27856007|NCT01041859|54383289|FG000|Open-Label Titration|Protocol Violation|1|||
27856008|NCT01041859|54383290|FG001|Open-Label Titration|Protocol Violation|0|||
27856009|NCT01041859|54383291|FG002|Open-Label Titration|Protocol Violation|0|||
28169098|NCT03057054|54839949|FG000|Overall Study|Ineligible|1|||
28169099|NCT03057054|54839950|FG001|Overall Study|Ineligible|1|||
28169100|NCT03004443|54839958|FG000|Overall Study|Pregnancy|0|||
28169101|NCT03004443|54839959|FG001|Overall Study|Pregnancy|1|||
28169102|NCT02890355|54839967|FG000|Overall Study|Adverse Event|5|||
28169103|NCT02890355|54839968|FG001|Overall Study|Adverse Event|5|||
28169104|NCT02890355|54839967|FG000|Overall Study|Refusal unrelated to adverse event|5|||
28169105|NCT02890355|54839968|FG001|Overall Study|Refusal unrelated to adverse event|10|||
28169106|NCT02890355|54839967|FG000|Overall Study|Progression/relapse|46|||
28169107|NCT02890355|54839968|FG001|Overall Study|Progression/relapse|39|||
28169108|NCT02890355|54839967|FG000|Overall Study|Not protocol specified|3|||
28169109|NCT02890355|54839968|FG001|Overall Study|Not protocol specified|4|||
28169110|NCT02851511|54839980|FG000|Overall (Phase I + Phase II)|Physician Decision|18|||
28169111|NCT02851511|54839981|FG001|Overall (Phase I + Phase II)|Physician Decision|16|||
28169112|NCT02851511|54839982|FG002|Overall (Phase I + Phase II)|Physician Decision|0|||
28169113|NCT02851511|54839983|FG003|Overall (Phase I + Phase II)|Physician Decision|1|||
28169114|NCT02851511|54839980|FG000|Overall (Phase I + Phase II)|Withdrawal by Subject|20|||
28169115|NCT02851511|54839981|FG001|Overall (Phase I + Phase II)|Withdrawal by Subject|17|||
27856010|NCT01041859|54383289|FG000|Open-Label Titration|Other|7|||
27856011|NCT01041859|54383290|FG001|Open-Label Titration|Other|0|||
27856012|NCT01041859|54383291|FG002|Open-Label Titration|Other|0|||
27856013|NCT01041859|54383289|FG000|Open-Label Titration|Noncompliance With Study Drug|8|||
27856014|NCT01041859|54383290|FG001|Open-Label Titration|Noncompliance With Study Drug|0|||
27856015|NCT01041859|54383291|FG002|Open-Label Titration|Noncompliance With Study Drug|0|||
27856016|NCT01041859|54383289|FG000|Open-Label Titration|Withdrawal by Subject|11|||
27856017|NCT01041859|54383290|FG001|Open-Label Titration|Withdrawal by Subject|0|||
27856018|NCT01041859|54383291|FG002|Open-Label Titration|Withdrawal by Subject|0|||
27856019|NCT01041859|54383289|FG000|Double-Blind Maintenance|Adverse Event|0|||
28169116|NCT02851511|54839982|FG002|Overall (Phase I + Phase II)|Withdrawal by Subject|0|||
27736072|NCT02289820|54184661|FG002|Overall Study|Lost to Follow-up|3|||
27736073|NCT02289820|54184662|FG003|Overall Study|Lost to Follow-up|1|||
27736074|NCT02289820|54184663|FG004|Overall Study|Lost to Follow-up|0|||
27736075|NCT02289820|54184664|FG005|Overall Study|Lost to Follow-up|1|||
27736076|NCT02289820|54184665|FG006|Overall Study|Lost to Follow-up|1|||
27736077|NCT02289820|54184659|FG000|Overall Study|withdrawal of consent|0|||
27736078|NCT02289820|54184660|FG001|Overall Study|withdrawal of consent|1|||
27736079|NCT02289820|54184661|FG002|Overall Study|withdrawal of consent|0|||
27736080|NCT02289820|54184662|FG003|Overall Study|withdrawal of consent|0|||
27736081|NCT02289820|54184663|FG004|Overall Study|withdrawal of consent|0|||
27736082|NCT02289820|54184664|FG005|Overall Study|withdrawal of consent|0|||
27736083|NCT02289820|54184665|FG006|Overall Study|withdrawal of consent|0|||
27736084|NCT02289742|54184687|FG000|First Wear Period|Adverse event prior to treatment|0|||
27736085|NCT02289742|54184688|FG001|First Wear Period|Adverse event prior to treatment|1|||
27736086|NCT02289742|54184689|FG002|First Wear Period|Adverse event prior to treatment|0|||
27736087|NCT02289742|54184690|FG003|First Wear Period|Adverse event prior to treatment|0|||
27736088|NCT02289742|54184687|FG000|First Wear Period|Adverse Event|0|||
27736089|NCT02289742|54184688|FG001|First Wear Period|Adverse Event|0|||
27736090|NCT02289742|54184689|FG002|First Wear Period|Adverse Event|1|||
27736091|NCT02289742|54184690|FG003|First Wear Period|Adverse Event|0|||
27736092|NCT02289742|54184687|FG000|First Wear Period|Other prior to treatment|0|||
27736093|NCT02289742|54184688|FG001|First Wear Period|Other prior to treatment|0|||
27736094|NCT02289742|54184689|FG002|First Wear Period|Other prior to treatment|0|||
27736095|NCT02289742|54184690|FG003|First Wear Period|Other prior to treatment|1|||
27736096|NCT02289742|54184687|FG000|Third Wear Period|Adverse Event|0|||
27736097|NCT02289742|54184688|FG001|Third Wear Period|Adverse Event|1|||
27736098|NCT02289742|54184689|FG002|Third Wear Period|Adverse Event|0|||
27736099|NCT02289742|54184690|FG003|Third Wear Period|Adverse Event|0|||
27736100|NCT02289742|54184687|FG000|Third Wear Period|Reason not given|0|||
27736101|NCT02289742|54184688|FG001|Third Wear Period|Reason not given|0|||
27736102|NCT02289742|54184689|FG002|Third Wear Period|Reason not given|0|||
27736103|NCT02289742|54184690|FG003|Third Wear Period|Reason not given|1|||
27736104|NCT02289352|54184707|FG000|Overall Study|Withdrawal by Subject|1|||
27736105|NCT02289352|54184708|FG001|Overall Study|Withdrawal by Subject|1|||
27736106|NCT02289352|54184709|FG002|Overall Study|Withdrawal by Subject|0|||
27736107|NCT02315560|54184718|FG000|Overall Study|noncompliance by subjects|3|||
27736108|NCT02522624|54184724|FG000|Overall Study|Technical failure|1|||
27856020|NCT01041859|54383290|FG001|Double-Blind Maintenance|Adverse Event|23|||
27856021|NCT01041859|54383291|FG002|Double-Blind Maintenance|Adverse Event|13|||
27856022|NCT01041859|54383289|FG000|Double-Blind Maintenance|Lack of Efficacy|0|||
27856023|NCT01041859|54383290|FG001|Double-Blind Maintenance|Lack of Efficacy|3|||
27856024|NCT01041859|54383291|FG002|Double-Blind Maintenance|Lack of Efficacy|11|||
27856025|NCT01041859|54383289|FG000|Double-Blind Maintenance|Lost to Follow-up|0|||
27856026|NCT01041859|54383290|FG001|Double-Blind Maintenance|Lost to Follow-up|1|||
27856027|NCT01041859|54383291|FG002|Double-Blind Maintenance|Lost to Follow-up|0|||
27856028|NCT01041859|54383289|FG000|Double-Blind Maintenance|Physician Decision|0|||
27856029|NCT01041859|54383290|FG001|Double-Blind Maintenance|Physician Decision|2|||
27856030|NCT01041859|54383291|FG002|Double-Blind Maintenance|Physician Decision|1|||
27856031|NCT01041859|54383289|FG000|Double-Blind Maintenance|Protocol Violation|0|||
27856032|NCT01041859|54383290|FG001|Double-Blind Maintenance|Protocol Violation|1|||
27856033|NCT01041859|54383291|FG002|Double-Blind Maintenance|Protocol Violation|3|||
27856034|NCT01041859|54383289|FG000|Double-Blind Maintenance|Other|0|||
27856035|NCT01041859|54383290|FG001|Double-Blind Maintenance|Other|6|||
27856036|NCT01041859|54383291|FG002|Double-Blind Maintenance|Other|2|||
27856037|NCT01041859|54383289|FG000|Double-Blind Maintenance|Noncompliance With Study Drug|0|||
27856038|NCT01041859|54383290|FG001|Double-Blind Maintenance|Noncompliance With Study Drug|2|||
27856039|NCT01041859|54383291|FG002|Double-Blind Maintenance|Noncompliance With Study Drug|6|||
27856040|NCT01041859|54383289|FG000|Double-Blind Maintenance|Withdrawal by Subject|0|||
27736109|NCT02522624|54184725|FG001|Overall Study|Technical failure|0|||
27856041|NCT01041859|54383290|FG001|Double-Blind Maintenance|Withdrawal by Subject|8|||
27856042|NCT01041859|54383291|FG002|Double-Blind Maintenance|Withdrawal by Subject|9|||
27856043|NCT01040845|54383300|FG000|Overall Study|Withdrawal by Subject|1|||
27980759|NCT00611455|54638746|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
27736110|NCT02287402|54184731|FG000|Treatment Period|Adverse Event|17|||
27736111|NCT02287402|54184731|FG000|Treatment Period|Voluntary Withdrawal|10|||
27736112|NCT02287402|54184731|FG000|Follow-up|Lost to Follow-up|1|||
27736113|NCT02287402|54184731|FG000|Follow-up|Voluntary Withdrawal|2|||
27736114|NCT02314780|54184738|FG000|Overall Study|organizational reasons|0|||
27856044|NCT01040845|54383301|FG001|Overall Study|Withdrawal by Subject|1|||
27856045|NCT01040845|54383300|FG000|Overall Study|Physician Decision|1|||
27856046|NCT01040845|54383301|FG001|Overall Study|Physician Decision|0|||
27856047|NCT01040689|54383309|FG000|Overall Study|Adverse Event|0|||
27856048|NCT01040689|54383310|FG001|Overall Study|Adverse Event|0|||
27856049|NCT01040689|54383311|FG002|Overall Study|Adverse Event|2|||
27856050|NCT01040689|54383312|FG003|Overall Study|Adverse Event|4|||
27856051|NCT01040689|54383309|FG000|Overall Study|Lack of Efficacy|0|||
27856052|NCT01040689|54383310|FG001|Overall Study|Lack of Efficacy|0|||
28094175|NCT03129100|54748063|FG004|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
28094176|NCT03129100|54748064|FG005|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
28094177|NCT03129100|54748065|FG006|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
28094178|NCT03129100|54748066|FG007|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
28094179|NCT03129100|54748067|FG008|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
28169117|NCT02851511|54839983|FG003|Overall (Phase I + Phase II)|Withdrawal by Subject|3|||
28169118|NCT02851511|54839980|FG000|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|4|||
28169119|NCT02851511|54839981|FG001|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|5|||
28169120|NCT02851511|54839982|FG002|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
28169121|NCT02851511|54839983|FG003|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
28169122|NCT02851511|54839980|FG000|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
28169123|NCT02851511|54839981|FG001|Overall (Phase I + Phase II)|Lost to Follow-up|1|||
28169124|NCT02851511|54839982|FG002|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
28169125|NCT02851511|54839983|FG003|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
28169126|NCT02851511|54839980|FG000|Phase I|Physician Decision|0|||
28169127|NCT02851511|54839981|FG001|Phase I|Physician Decision|0|||
28169128|NCT02851511|54839982|FG002|Phase I|Physician Decision|0|||
28169129|NCT02851511|54839983|FG003|Phase I|Physician Decision|1|||
28169130|NCT02851511|54839980|FG000|Phase I|Withdrawal by Subject|2|||
28169131|NCT02851511|54839981|FG001|Phase I|Withdrawal by Subject|1|||
28169132|NCT02851511|54839982|FG002|Phase I|Withdrawal by Subject|0|||
28169133|NCT02851511|54839983|FG003|Phase I|Withdrawal by Subject|3|||
28169134|NCT02851511|54839980|FG000|Phase II|Physician Decision|18|||
28169135|NCT02851511|54839981|FG001|Phase II|Physician Decision|16|||
28169136|NCT02851511|54839982|FG002|Phase II|Physician Decision|0|||
28169137|NCT02851511|54839983|FG003|Phase II|Physician Decision|0|||
28169138|NCT02851511|54839980|FG000|Phase II|Withdrawal by Subject|18|||
28169139|NCT02851511|54839981|FG001|Phase II|Withdrawal by Subject|16|||
28169140|NCT02851511|54839982|FG002|Phase II|Withdrawal by Subject|0|||
28169141|NCT02851511|54839983|FG003|Phase II|Withdrawal by Subject|0|||
28169142|NCT02851511|54839980|FG000|Phase II|COVID-19 lockdown, no reason specified|4|||
28169143|NCT02851511|54839981|FG001|Phase II|COVID-19 lockdown, no reason specified|5|||
28169144|NCT02851511|54839982|FG002|Phase II|COVID-19 lockdown, no reason specified|0|||
28169145|NCT02851511|54839983|FG003|Phase II|COVID-19 lockdown, no reason specified|0|||
28169146|NCT02851511|54839980|FG000|Phase II|Lost to Follow-up|0|||
28169147|NCT02851511|54839981|FG001|Phase II|Lost to Follow-up|1|||
28169148|NCT02851511|54839982|FG002|Phase II|Lost to Follow-up|0|||
28169149|NCT02851511|54839983|FG003|Phase II|Lost to Follow-up|0|||
28169150|NCT02642042|54839993|FG000|Overall Study|Adverse Event|22|||
28169151|NCT02642042|54839993|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
28169152|NCT02642042|54839993|FG000|Overall Study|Progression/Relapse|28|||
28169153|NCT02642042|54839993|FG000|Overall Study|Death|1|||
28169154|NCT02642042|54839993|FG000|Overall Study|Not Protocol Specified|2|||
28169155|NCT02478320|54840008|FG000|Overall Study|Adverse Event|2|||
28169156|NCT02478320|54840009|FG001|Overall Study|Adverse Event|0|||
28169157|NCT02478320|54840008|FG000|Overall Study|Death|1|||
28169158|NCT02478320|54840009|FG001|Overall Study|Death|0|||
28169159|NCT02478320|54840008|FG000|Overall Study|Lack of Efficacy|4|||
28169160|NCT02478320|54840009|FG001|Overall Study|Lack of Efficacy|0|||
28169161|NCT02478320|54840008|FG000|Overall Study|Withdrawal by Subject|2|||
28169162|NCT02478320|54840009|FG001|Overall Study|Withdrawal by Subject|0|||
28169163|NCT02478320|54840008|FG000|Overall Study|Screen Failure|3|||
28169164|NCT02478320|54840009|FG001|Overall Study|Screen Failure|0|||
28169165|NCT02252042|54840043|FG000|Overall Study|Adverse Event|9|||
28169166|NCT02252042|54840044|FG001|Overall Study|Adverse Event|6|||
28169167|NCT02252042|54840043|FG000|Overall Study|Death|209|||
28169168|NCT02252042|54840044|FG001|Overall Study|Death|217|||
28169169|NCT02252042|54840043|FG000|Overall Study|Physician Decision|0|||
28169170|NCT02252042|54840044|FG001|Overall Study|Physician Decision|2|||
28094180|NCT03129100|54748068|FG009|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
28094181|NCT03129100|54748069|FG010|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
28169171|NCT02252042|54840043|FG000|Overall Study|Transferred to Extension Study|7|||
28169172|NCT02252042|54840044|FG001|Overall Study|Transferred to Extension Study|1|||
27856053|NCT01040689|54383311|FG002|Overall Study|Lack of Efficacy|1|||
27856054|NCT01040689|54383312|FG003|Overall Study|Lack of Efficacy|0|||
27856055|NCT01040689|54383309|FG000|Overall Study|Lost to Follow-up|1|||
28169173|NCT02252042|54840043|FG000|Overall Study|Did Not Continue on Extension Study|7|||
28169174|NCT02252042|54840044|FG001|Overall Study|Did Not Continue on Extension Study|2|||
28169175|NCT02252042|54840043|FG000|Overall Study|Withdrawal by Subject|15|||
28169176|NCT02252042|54840044|FG001|Overall Study|Withdrawal by Subject|20|||
28169177|NCT01886872|54840063|FG000|Overall Study|Ineligible|7|||
28169178|NCT01886872|54840064|FG001|Overall Study|Ineligible|4|||
27736115|NCT02314780|54184739|FG001|Overall Study|organizational reasons|2|||
27736116|NCT02314780|54184740|FG002|Overall Study|organizational reasons|0|||
27736117|NCT02314780|54184738|FG000|Overall Study|Adverse Event|0|||
27736118|NCT02314780|54184739|FG001|Overall Study|Adverse Event|1|||
27736119|NCT02314780|54184740|FG002|Overall Study|Adverse Event|0|||
27736120|NCT02288182|54184750|FG000|Overall Study|Adverse Event|0|||
27736121|NCT02288182|54184751|FG001|Overall Study|Adverse Event|1|||
27736122|NCT02288182|54184750|FG000|Overall Study|Lost to Follow-up|0|||
27833322|NCT01717313|54315292|FG000|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7|||
27833323|NCT01717313|54315293|FG001|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9|||
27833324|NCT01717313|54315292|FG000|Phase B (Weeks 24 to 54)|Lost to Follow-up|1|||
27833325|NCT01717313|54315293|FG001|Phase B (Weeks 24 to 54)|Lost to Follow-up|3|||
27833326|NCT01745393|54315305|FG000|Treatment to End-of-treatment Assessment|Lost to Follow-up|20|||
27833327|NCT01745393|54315306|FG001|Treatment to End-of-treatment Assessment|Lost to Follow-up|8|||
27833328|NCT01745393|54315305|FG000|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1|||
27833329|NCT01745393|54315306|FG001|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0|||
27833330|NCT01745393|54315305|FG000|12-month Follow-up|Lost to Follow-up|6|||
27833331|NCT01745393|54315306|FG001|12-month Follow-up|Lost to Follow-up|5|||
27833332|NCT01744691|54315337|FG000|Overall Study|Progressive Disease|18|||
27833333|NCT01744691|54315337|FG000|Overall Study|Unacceptable toxicity, AE or death|18|||
27833334|NCT01744691|54315337|FG000|Overall Study|Withdrawal of consent for treatment|3|||
27833335|NCT01744691|54315337|FG000|Overall Study|Physician Decision|4|||
27833336|NCT01716533|54315372|FG000|Overall Study|Failure of antibiotic treatment to treat|0|||
27833337|NCT01716533|54315373|FG001|Overall Study|Failure of antibiotic treatment to treat|0|||
27833338|NCT01716533|54315374|FG002|Overall Study|Failure of antibiotic treatment to treat|5|||
27833339|NCT01716533|54315375|FG003|Overall Study|Failure of antibiotic treatment to treat|0|||
27833340|NCT01716533|54315372|FG000|Overall Study|Withdrawal by Subject|0|||
27833341|NCT01716533|54315373|FG001|Overall Study|Withdrawal by Subject|0|||
27833342|NCT01716533|54315374|FG002|Overall Study|Withdrawal by Subject|0|||
27833343|NCT01716533|54315375|FG003|Overall Study|Withdrawal by Subject|5|||
27833344|NCT01716533|54315372|FG000|Overall Study|Death|0|||
27833345|NCT01716533|54315373|FG001|Overall Study|Death|0|||
27833346|NCT01716533|54315374|FG002|Overall Study|Death|0|||
27833347|NCT01716533|54315375|FG003|Overall Study|Death|2|||
27833348|NCT01716533|54315372|FG000|Overall Study|Immunosuppressants>14days past 6months|0|||
27833349|NCT01716533|54315373|FG001|Overall Study|Immunosuppressants>14days past 6months|0|||
27833350|NCT01716533|54315374|FG002|Overall Study|Immunosuppressants>14days past 6months|0|||
27833351|NCT01716533|54315375|FG003|Overall Study|Immunosuppressants>14days past 6months|1|||
27833352|NCT01375374|54315389|FG000|Overall Study|Adverse Event|1|||
27833353|NCT01743989|54315997|FG000|Treatment Phase|Unstable MR4.0|0|||
27833354|NCT01743989|54315998|FG001|Treatment Phase|Unstable MR4.0|6|||
27833355|NCT01743989|54315999|FG002|Treatment Phase|Unstable MR4.0|263|||
27833356|NCT01743989|54315997|FG000|Treatment Phase|Adverse Event|0|||
27833357|NCT01743989|54315998|FG001|Treatment Phase|Adverse Event|4|||
27833358|NCT01743989|54315999|FG002|Treatment Phase|Adverse Event|67|||
27833359|NCT01743989|54315997|FG000|Treatment Phase|Withdrawal by Subject|1|||
27833360|NCT01743989|54315998|FG001|Treatment Phase|Withdrawal by Subject|3|||
27833361|NCT01743989|54315999|FG002|Treatment Phase|Withdrawal by Subject|28|||
27833362|NCT01743989|54315997|FG000|Treatment Phase|Death|0|||
27736123|NCT02288182|54184751|FG001|Overall Study|Lost to Follow-up|1|||
27736124|NCT02286466|54184761|FG000|Overall Study|Death|1|||
27736125|NCT02286466|54184762|FG001|Overall Study|Death|3|||
27736126|NCT02286466|54184761|FG000|Overall Study|Withdrawal by Subject|5|||
27736127|NCT02286466|54184762|FG001|Overall Study|Withdrawal by Subject|2|||
27736128|NCT02286466|54184761|FG000|Overall Study|Lost to Follow-up|1|||
27736129|NCT02286466|54184762|FG001|Overall Study|Lost to Follow-up|4|||
27736130|NCT02286466|54184761|FG000|Overall Study|Declined Clinician Assessment|0|||
27736131|NCT02286466|54184762|FG001|Overall Study|Declined Clinician Assessment|1|||
27736132|NCT02313766|54184771|FG000|Overall Study|surgery cancelled|1|||
27736133|NCT02313766|54184772|FG001|Overall Study|surgery cancelled|0|||
27736134|NCT02313766|54184773|FG002|Overall Study|surgery cancelled|0|||
27833363|NCT01743989|54315998|FG001|Treatment Phase|Death|1|||
27833364|NCT01743989|54315999|FG002|Treatment Phase|Death|3|||
28094182|NCT03129100|54748070|FG011|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
27736135|NCT02313766|54184771|FG000|Overall Study|Lost to Follow-up|0|||
27833365|NCT01743989|54315997|FG000|Treatment Phase|Abnormal laboratory value(s)|0|||
27833366|NCT01743989|54315998|FG001|Treatment Phase|Abnormal laboratory value(s)|0|||
27736136|NCT02313766|54184772|FG001|Overall Study|Lost to Follow-up|2|||
27736137|NCT02313766|54184773|FG002|Overall Study|Lost to Follow-up|0|||
27736138|NCT02313766|54184771|FG000|Overall Study|Adverse Event|0|||
27736139|NCT02313766|54184772|FG001|Overall Study|Adverse Event|1|||
27736140|NCT02313766|54184773|FG002|Overall Study|Adverse Event|0|||
27736141|NCT01646398|54184783|FG000|Overall Study|Withdrawal by Subject|1|||
27833367|NCT01743989|54315999|FG002|Treatment Phase|Abnormal laboratory value(s)|3|||
27833368|NCT01743989|54315997|FG000|Treatment Phase|Protocol deviation|0|||
27736142|NCT01646398|54184784|FG001|Overall Study|Withdrawal by Subject|0|||
27736143|NCT01646320|54184792|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|3|||
27736144|NCT01646320|54184793|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|0|||
27736145|NCT01646320|54184792|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
27736146|NCT01646320|54184793|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1|||
27736147|NCT01646320|54184792|FG000|Short-term Period (Day 1 to Week 24)|Not reported|2|||
27736148|NCT01646320|54184793|FG001|Short-term Period (Day 1 to Week 24)|Not reported|2|||
27736149|NCT01646320|54184792|FG000|Short-term Period (Day 1 to Week 24)|Other|1|||
27736150|NCT01646320|54184793|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
27736151|NCT01646320|54184792|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
27736152|NCT01646320|54184793|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
27736153|NCT01646320|54184792|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2|||
27736154|NCT01646320|54184793|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
27736155|NCT01646320|54184792|FG000|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2|||
27736156|NCT01646320|54184793|FG001|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0|||
27736157|NCT01646320|54184792|FG000|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0|||
27736158|NCT01646320|54184793|FG001|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2|||
27736159|NCT01646320|54184792|FG000|Long-term Period (Weeks 24 to 52)|Adverse Event|4|||
27736160|NCT01646320|54184793|FG001|Long-term Period (Weeks 24 to 52)|Adverse Event|2|||
27736161|NCT01646320|54184792|FG000|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0|||
27736162|NCT01646320|54184793|FG001|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1|||
27736163|NCT01646320|54184792|FG000|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0|||
27736164|NCT01646320|54184793|FG001|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2|||
27736165|NCT02524730|54184799|FG000|Overall Study|Lost to Follow-up|5|||
27736166|NCT02524730|54184799|FG000|Overall Study|Withdrawal by Subject|18|||
27736167|NCT02524730|54184799|FG000|Overall Study|Death|10|||
27736168|NCT02524730|54184799|FG000|Overall Study|Adverse Event|8|||
27736169|NCT02524730|54184799|FG000|Overall Study|Protocol Violation|1|||
27736170|NCT02524730|54184799|FG000|Overall Study|Subjects received Scorpio NRG PS (Posterior Stabilizing)|4|||
27736171|NCT01658150|54184803|FG000|Overall Study|Withdrawal by Subject|1|||
27856056|NCT01040689|54383310|FG001|Overall Study|Lost to Follow-up|0|||
27856057|NCT01040689|54383311|FG002|Overall Study|Lost to Follow-up|0|||
27856058|NCT01040689|54383312|FG003|Overall Study|Lost to Follow-up|0|||
27980760|NCT00611455|54638747|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
27736172|NCT02285998|54184810|FG000|Overall Study|Adverse Event|9|||
27736173|NCT02285998|54184811|FG001|Overall Study|Adverse Event|8|||
27736174|NCT02285998|54184810|FG000|Overall Study|Physician Decision|1|||
27736175|NCT02285998|54184811|FG001|Overall Study|Physician Decision|2|||
27736176|NCT02285998|54184810|FG000|Overall Study|Lost to Follow-up|176|||
27736177|NCT02285998|54184811|FG001|Overall Study|Lost to Follow-up|172|||
27736178|NCT02285998|54184810|FG000|Overall Study|Withdrawal by Subject|53|||
27736179|NCT02285998|54184811|FG001|Overall Study|Withdrawal by Subject|61|||
27736180|NCT02285998|54184810|FG000|Overall Study|Other Reasons|7|||
27736181|NCT02285998|54184811|FG001|Overall Study|Other Reasons|10|||
27980761|NCT00611455|54638745|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|4|||
28169179|NCT01886872|54840065|FG002|Overall Study|Ineligible|12|||
28169180|NCT01708954|54840088|FG000|Step 1|Disease progression|26|||
28169181|NCT01708954|54840089|FG001|Step 1|Disease progression|17|||
28169182|NCT01708954|54840090|FG002|Step 1|Disease progression|14|||
28169183|NCT01708954|54840088|FG000|Step 1|Adverse Event|3|||
28169184|NCT01708954|54840089|FG001|Step 1|Adverse Event|11|||
28169185|NCT01708954|54840090|FG002|Step 1|Adverse Event|13|||
28169186|NCT01708954|54840088|FG000|Step 1|Death|3|||
28169187|NCT01708954|54840089|FG001|Step 1|Death|2|||
28169188|NCT01708954|54840090|FG002|Step 1|Death|3|||
28169189|NCT01708954|54840088|FG000|Step 1|Withdrawal by Subject|2|||
28169190|NCT01708954|54840089|FG001|Step 1|Withdrawal by Subject|5|||
28169191|NCT01708954|54840090|FG002|Step 1|Withdrawal by Subject|3|||
28169192|NCT01708954|54840088|FG000|Step 1|Other complicating disease|0|||
28169193|NCT01708954|54840089|FG001|Step 1|Other complicating disease|2|||
28169194|NCT01708954|54840090|FG002|Step 1|Other complicating disease|0|||
27736182|NCT01658072|54184819|FG000|Overall Study|Protocol Violation|4|||
27736183|NCT01658072|54184820|FG001|Overall Study|Protocol Violation|2|||
27736184|NCT02285920|54184830|FG000|Overall Study|Kidney transplantation|2|||
27736185|NCT02285920|54184831|FG001|Overall Study|Kidney transplantation|2|||
27736186|NCT02285920|54184832|FG002|Overall Study|Kidney transplantation|2|||
27736187|NCT02285920|54184833|FG003|Overall Study|Kidney transplantation|0|||
27736188|NCT02285920|54184830|FG000|Overall Study|Change to peritoneal dialysis|0|||
27856059|NCT01040689|54383309|FG000|Overall Study|Withdrawal by Subject|2|||
28169195|NCT01708954|54840088|FG000|Step 1|Crossed over to Step 2|2|||
28169196|NCT01708954|54840089|FG001|Step 1|Crossed over to Step 2|0|||
28169197|NCT01708954|54840090|FG002|Step 1|Crossed over to Step 2|0|||
28169198|NCT01708954|54840088|FG000|Step 1|Symptomatic deterioration|1|||
28169199|NCT01708954|54840089|FG001|Step 1|Symptomatic deterioration|0|||
28169200|NCT01708954|54840090|FG002|Step 1|Symptomatic deterioration|1|||
27736189|NCT02285920|54184831|FG001|Overall Study|Change to peritoneal dialysis|0|||
27736190|NCT02285920|54184832|FG002|Overall Study|Change to peritoneal dialysis|1|||
27736191|NCT02285920|54184833|FG003|Overall Study|Change to peritoneal dialysis|0|||
27736192|NCT02285920|54184830|FG000|Overall Study|Transfer to non-participating unit|0|||
27736193|NCT02285920|54184831|FG001|Overall Study|Transfer to non-participating unit|1|||
27736194|NCT02285920|54184832|FG002|Overall Study|Transfer to non-participating unit|0|||
27736195|NCT02285920|54184833|FG003|Overall Study|Transfer to non-participating unit|0|||
27736196|NCT02285920|54184830|FG000|Overall Study|Dialysis discontinuation|0|||
27736197|NCT02285920|54184831|FG001|Overall Study|Dialysis discontinuation|1|||
27736198|NCT02285920|54184832|FG002|Overall Study|Dialysis discontinuation|0|||
27736199|NCT02285920|54184833|FG003|Overall Study|Dialysis discontinuation|0|||
27736200|NCT02285920|54184830|FG000|Overall Study|Death|2|||
27736201|NCT02285920|54184831|FG001|Overall Study|Death|0|||
27736202|NCT02285920|54184832|FG002|Overall Study|Death|2|||
27736203|NCT02285920|54184833|FG003|Overall Study|Death|1|||
27736204|NCT02035137|54184846|FG000|Overall Study|Physician Decision|0|||
27736205|NCT02035137|54184847|FG001|Overall Study|Physician Decision|0|||
27736206|NCT02035137|54184848|FG002|Overall Study|Physician Decision|1|||
27736207|NCT02035137|54184846|FG000|Overall Study|Withdrawal by Subject|0|||
27736208|NCT02035137|54184847|FG001|Overall Study|Withdrawal by Subject|1|||
27736209|NCT02035137|54184848|FG002|Overall Study|Withdrawal by Subject|2|||
27736210|NCT02035137|54184846|FG000|Overall Study|Ineligible|0|||
27736211|NCT02035137|54184847|FG001|Overall Study|Ineligible|1|||
27736212|NCT02035137|54184848|FG002|Overall Study|Ineligible|2|||
27736213|NCT02035137|54184846|FG000|Overall Study|Disease progression prior to treatment start|2|||
27736214|NCT02035137|54184847|FG001|Overall Study|Disease progression prior to treatment start|0|||
27736215|NCT02035137|54184848|FG002|Overall Study|Disease progression prior to treatment start|0|||
27736216|NCT02522780|54184858|FG000|Overall Study|Consent withdrawn by subject|5|||
27736217|NCT02522780|54184859|FG001|Overall Study|Consent withdrawn by subject|7|||
27736218|NCT02522780|54184858|FG000|Overall Study|Protocol deviation|1|||
27736219|NCT02522780|54184859|FG001|Overall Study|Protocol deviation|3|||
27736220|NCT02522780|54184858|FG000|Overall Study|Subject refused endoscopic procedure|0|||
27736221|NCT02522780|54184859|FG001|Overall Study|Subject refused endoscopic procedure|1|||
27736222|NCT02522780|54184858|FG000|Overall Study|Adverse event, non-fatal|11|||
27736223|NCT02522780|54184859|FG001|Overall Study|Adverse event, non-fatal|16|||
27736224|NCT02285062|54184879|FG000|Pre-Treatment Period|Protocol Violation|0|||
27736225|NCT02285062|54184880|FG001|Pre-Treatment Period|Protocol Violation|2|||
27736226|NCT02285062|54184879|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
27736227|NCT02285062|54184880|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
27736228|NCT01352741|54184886|FG000|Open-label Tapentadol Titration Period|Protocol Violation|4|||
27736229|NCT01352741|54184887|FG001|Open-label Tapentadol Titration Period|Protocol Violation|0|||
27736230|NCT01352741|54184886|FG000|Open-label Tapentadol Titration Period|Lack of Efficacy|19|||
27736231|NCT01352741|54184887|FG001|Open-label Tapentadol Titration Period|Lack of Efficacy|0|||
27736232|NCT01352741|54184886|FG000|Open-label Tapentadol Titration Period|Adverse Event|34|||
27736233|NCT01352741|54184887|FG001|Open-label Tapentadol Titration Period|Adverse Event|0|||
27736234|NCT01352741|54184886|FG000|Open-label Tapentadol Titration Period|Withdrawal of consent|7|||
27736235|NCT01352741|54184887|FG001|Open-label Tapentadol Titration Period|Withdrawal of consent|0|||
27736236|NCT01352741|54184886|FG000|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5|||
27736237|NCT01352741|54184887|FG001|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0|||
27736238|NCT01352741|54184886|FG000|Open-label Tapentadol Titration Period|Other|4|||
27856060|NCT01040689|54383310|FG001|Overall Study|Withdrawal by Subject|1|||
27736239|NCT01352741|54184887|FG001|Open-label Tapentadol Titration Period|Other|0|||
27736240|NCT01352741|54184886|FG000|Double-blind Comparative Period|Protocol Violation|2|||
27736241|NCT01352741|54184887|FG001|Double-blind Comparative Period|Protocol Violation|0|||
27736242|NCT01352741|54184886|FG000|Double-blind Comparative Period|Lack of Efficacy|0|||
27736243|NCT01352741|54184887|FG001|Double-blind Comparative Period|Lack of Efficacy|3|||
27736244|NCT01352741|54184886|FG000|Double-blind Comparative Period|Adverse Event|16|||
27736245|NCT01352741|54184887|FG001|Double-blind Comparative Period|Adverse Event|17|||
27736246|NCT01352741|54184886|FG000|Double-blind Comparative Period|Lost to Follow-up|1|||
27856061|NCT01040689|54383311|FG002|Overall Study|Withdrawal by Subject|1|||
27856062|NCT01040689|54383312|FG003|Overall Study|Withdrawal by Subject|0|||
27856063|NCT01040689|54383309|FG000|Overall Study|Other reasons not listed above|0|||
27980762|NCT00611455|54638746|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
28094183|NCT03129100|54748071|FG012|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
28094184|NCT03129100|54748072|FG013|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
28094185|NCT03129100|54748073|FG014|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
27856064|NCT01040689|54383310|FG001|Overall Study|Other reasons not listed above|1|||
28094186|NCT03129100|54748074|FG015|Period3-Long-Term Extension Period A & B|Lack of Efficacy|1|||
28094187|NCT03129100|54748075|FG016|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
28094188|NCT03129100|54748076|FG017|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
27856065|NCT01040689|54383311|FG002|Overall Study|Other reasons not listed above|0|||
27736247|NCT01352741|54184887|FG001|Double-blind Comparative Period|Lost to Follow-up|0|||
27736248|NCT01352741|54184886|FG000|Double-blind Comparative Period|Death|0|||
27736249|NCT01352741|54184887|FG001|Double-blind Comparative Period|Death|1|||
27736250|NCT01352741|54184886|FG000|Double-blind Comparative Period|Withdrawal of consent|8|||
27736251|NCT01352741|54184887|FG001|Double-blind Comparative Period|Withdrawal of consent|3|||
27736252|NCT01352741|54184886|FG000|Double-blind Comparative Period|Other|1|||
27736253|NCT01352741|54184887|FG001|Double-blind Comparative Period|Other|2|||
27736254|NCT01352741|54184886|FG000|Open-Label Tapentadol Continuation Arm|Adverse Event|4|||
27736255|NCT01352741|54184887|FG001|Open-Label Tapentadol Continuation Arm|Adverse Event|0|||
27736256|NCT01352741|54184886|FG000|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1|||
27736257|NCT01352741|54184887|FG001|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0|||
27736258|NCT01352741|54184886|FG000|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2|||
27736259|NCT01352741|54184887|FG001|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0|||
27736260|NCT01352741|54184886|FG000|Open-Label Tapentadol Continuation Arm|Protocol Violation|1|||
27736261|NCT01352741|54184887|FG001|Open-Label Tapentadol Continuation Arm|Protocol Violation|0|||
27736262|NCT01657292|54184907|FG000|Overall Study|Adverse Event|6|||
27736263|NCT01657292|54184907|FG000|Overall Study|Withdrawal by Subject|2|||
28169201|NCT01708954|54840088|FG000|Step 1|Off-treatment reason not submitted|1|||
28169202|NCT01708954|54840089|FG001|Step 1|Off-treatment reason not submitted|1|||
28169203|NCT01708954|54840090|FG002|Step 1|Off-treatment reason not submitted|1|||
28169204|NCT01708954|54840088|FG000|Step 1|Ineligible or never received treatment|4|||
28169205|NCT01708954|54840089|FG001|Step 1|Ineligible or never received treatment|2|||
27736264|NCT01657292|54184907|FG000|Overall Study|Violation of eligibility criteria|1|||
27736265|NCT01657292|54184907|FG000|Overall Study|Change of therapy|1|||
27736266|NCT00905567|54184923|FG000|Washout|Withdrawal by Subject|0|||
27736267|NCT00905567|54184924|FG001|Washout|Withdrawal by Subject|1|||
27736268|NCT02282020|54184930|FG000|Overall Study|Objective Disease Progression|128|||
27736269|NCT02282020|54184931|FG001|Overall Study|Objective Disease Progression|30|||
27736270|NCT02282020|54184930|FG000|Overall Study|Adverse Event|18|||
27736271|NCT02282020|54184931|FG001|Overall Study|Adverse Event|15|||
27736272|NCT02282020|54184930|FG000|Overall Study|Withdrawal by Subject|7|||
27736273|NCT02282020|54184931|FG001|Overall Study|Withdrawal by Subject|10|||
27736274|NCT02282020|54184930|FG000|Overall Study|Miscellaneous|5|||
27736275|NCT02282020|54184931|FG001|Overall Study|Miscellaneous|19|||
27736276|NCT02282020|54184930|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
27736277|NCT02282020|54184931|FG001|Overall Study|Severe Non-compliance to Protocol|0|||
27736278|NCT02282020|54184930|FG000|Overall Study|Developed Discontinuation Criteria|0|||
27736279|NCT02282020|54184931|FG001|Overall Study|Developed Discontinuation Criteria|2|||
27736280|NCT02282020|54184930|FG000|Overall Study|Withdrew Consent Prior to Dosing|0|||
27856066|NCT01040689|54383312|FG003|Overall Study|Other reasons not listed above|0|||
28094189|NCT03129100|54748077|FG018|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
28094190|NCT03129100|54748078|FG019|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
28094191|NCT03129100|54748079|FG020|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
28094192|NCT03129100|54748080|FG021|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
28094193|NCT03129100|54748081|FG022|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
28094194|NCT03129100|54748082|FG023|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
28094195|NCT03129100|54748083|FG024|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
28094196|NCT03129100|54748084|FG025|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
28169206|NCT01708954|54840090|FG002|Step 1|Ineligible or never received treatment|8|||
28169207|NCT01708954|54840088|FG000|Step 2|Disease progression|9|||
28169208|NCT01708954|54840089|FG001|Step 2|Disease progression|4|||
28169209|NCT01708954|54840090|FG002|Step 2|Disease progression|0|||
28169210|NCT01708954|54840088|FG000|Step 2|Adverse Event|3|||
28169211|NCT01708954|54840089|FG001|Step 2|Adverse Event|2|||
28169212|NCT01708954|54840090|FG002|Step 2|Adverse Event|0|||
28169213|NCT01708954|54840088|FG000|Step 2|Withdrawal by Subject|1|||
28169214|NCT01708954|54840089|FG001|Step 2|Withdrawal by Subject|1|||
28169215|NCT01708954|54840090|FG002|Step 2|Withdrawal by Subject|0|||
28169216|NCT01708941|54840103|FG000|Overall Study|Adverse Event|4|||
28169217|NCT01708941|54840104|FG001|Overall Study|Adverse Event|6|||
28169218|NCT01708941|54840105|FG002|Overall Study|Adverse Event|1|||
28169219|NCT01708941|54840106|FG003|Overall Study|Adverse Event|0|||
28169220|NCT01708941|54840103|FG000|Overall Study|Death|1|||
28169221|NCT01708941|54840104|FG001|Overall Study|Death|1|||
28169222|NCT01708941|54840105|FG002|Overall Study|Death|2|||
28169223|NCT01708941|54840106|FG003|Overall Study|Death|14|||
28169224|NCT01708941|54840103|FG000|Overall Study|Withdrawal by Subject|1|||
27856067|NCT01047319|54383361|FG000|Overall Study|Teva requested participant withdrawal|3|||
28169225|NCT01708941|54840104|FG001|Overall Study|Withdrawal by Subject|0|||
28169226|NCT01708941|54840105|FG002|Overall Study|Withdrawal by Subject|3|||
28169227|NCT01708941|54840106|FG003|Overall Study|Withdrawal by Subject|4|||
28169228|NCT01708941|54840103|FG000|Overall Study|Disease progression|9|||
28169229|NCT01708941|54840104|FG001|Overall Study|Disease progression|10|||
28169230|NCT01708941|54840105|FG002|Overall Study|Disease progression|8|||
27736281|NCT02282020|54184931|FG001|Overall Study|Withdrew Consent Prior to Dosing|12|||
27736282|NCT02281552|54184947|FG000|Overall Study|Medication error|1|||
27736283|NCT02281552|54184948|FG001|Overall Study|Medication error|0|||
27736284|NCT02281552|54184947|FG000|Overall Study|Insufficient clinical response|0|||
27736285|NCT02281552|54184948|FG001|Overall Study|Insufficient clinical response|1|||
27736286|NCT02281552|54184947|FG000|Overall Study|Adverse Event|3|||
28169231|NCT01708941|54840106|FG003|Overall Study|Disease progression|0|||
28169232|NCT01708941|54840103|FG000|Overall Study|Alternative therapy|0|||
28169233|NCT01708941|54840104|FG001|Overall Study|Alternative therapy|0|||
28169234|NCT01708941|54840105|FG002|Overall Study|Alternative therapy|2|||
28169235|NCT01708941|54840106|FG003|Overall Study|Alternative therapy|0|||
28169236|NCT01708941|54840103|FG000|Overall Study|Ineligible and never started treatment|1|||
28169237|NCT01708941|54840104|FG001|Overall Study|Ineligible and never started treatment|0|||
28169238|NCT01708941|54840105|FG002|Overall Study|Ineligible and never started treatment|1|||
28169239|NCT01708941|54840106|FG003|Overall Study|Ineligible and never started treatment|0|||
28169240|NCT01708941|54840103|FG000|Overall Study|Never started treatment|2|||
28169241|NCT01708941|54840104|FG001|Overall Study|Never started treatment|1|||
28169242|NCT01708941|54840105|FG002|Overall Study|Never started treatment|0|||
28169243|NCT01708941|54840106|FG003|Overall Study|Never started treatment|0|||
28169244|NCT01708941|54840103|FG000|Overall Study|Ineligible|0|||
28169245|NCT01708941|54840104|FG001|Overall Study|Ineligible|0|||
28169246|NCT01708941|54840105|FG002|Overall Study|Ineligible|2|||
28169247|NCT01708941|54840106|FG003|Overall Study|Ineligible|0|||
28169248|NCT01274338|54840122|FG000|Overall Study|Lack of Efficacy|72|||
28169249|NCT01274338|54840123|FG001|Overall Study|Lack of Efficacy|108|||
28169250|NCT01274338|54840124|FG002|Overall Study|Lack of Efficacy|116|||
28169251|NCT01274338|54840125|FG003|Overall Study|Lack of Efficacy|0|||
28169252|NCT01274338|54840126|FG004|Overall Study|Lack of Efficacy|0|||
28169253|NCT01274338|54840127|FG005|Overall Study|Lack of Efficacy|0|||
28169254|NCT01274338|54840122|FG000|Overall Study|Adverse Event|272|||
28169255|NCT01274338|54840123|FG001|Overall Study|Adverse Event|105|||
27736287|NCT02281552|54184948|FG001|Overall Study|Adverse Event|9|||
27736288|NCT00890591|54184954|FG000|Overall Study|Lack of Efficacy|20|||
27736289|NCT02284906|54184963|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
27736290|NCT02284906|54184964|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
27736291|NCT02284906|54184965|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
27736292|NCT02284906|54184963|FG000|Overall Study|Major Protocol Deviation|0|||
27736293|NCT02284906|54184964|FG001|Overall Study|Major Protocol Deviation|1|||
27736294|NCT02284906|54184965|FG002|Overall Study|Major Protocol Deviation|0|||
27736295|NCT02284906|54184963|FG000|Overall Study|Voluntary Withdrawal|2|||
27736296|NCT02284906|54184964|FG001|Overall Study|Voluntary Withdrawal|4|||
27736297|NCT02284906|54184965|FG002|Overall Study|Voluntary Withdrawal|5|||
27736298|NCT02284906|54184963|FG000|Overall Study|Study Termination|0|||
27736299|NCT02284906|54184964|FG001|Overall Study|Study Termination|11|||
27736300|NCT02284906|54184965|FG002|Overall Study|Study Termination|14|||
27736301|NCT02284906|54184963|FG000|Overall Study|Reason not Specified|1|||
27736302|NCT02284906|54184964|FG001|Overall Study|Reason not Specified|1|||
27736303|NCT02284906|54184965|FG002|Overall Study|Reason not Specified|0|||
27736304|NCT02879305|54184975|FG000|Overall Study|Investigator Site Closed|55|||
27736305|NCT02879305|54184976|FG001|Overall Study|Investigator Site Closed|57|||
27736306|NCT02879305|54184975|FG000|Overall Study|Withdrawal by Subject|44|||
27736307|NCT02879305|54184976|FG001|Overall Study|Withdrawal by Subject|42|||
27833369|NCT01743989|54315998|FG001|Treatment Phase|Protocol deviation|0|||
27833370|NCT01743989|54315999|FG002|Treatment Phase|Protocol deviation|3|||
27833371|NCT01743989|54315997|FG000|Treatment Phase|Pregnancy|0|||
27833372|NCT01743989|54315998|FG001|Treatment Phase|Pregnancy|0|||
27833373|NCT01743989|54315999|FG002|Treatment Phase|Pregnancy|2|||
27833374|NCT01743989|54315997|FG000|Treatment Phase|Lost to Follow-up|0|||
27833375|NCT01743989|54315998|FG001|Treatment Phase|Lost to Follow-up|0|||
27833376|NCT01743989|54315999|FG002|Treatment Phase|Lost to Follow-up|2|||
27833377|NCT01743989|54315997|FG000|Treatment Phase|Abnormal test procedure result(s)|0|||
27833378|NCT01743989|54315998|FG001|Treatment Phase|Abnormal test procedure result(s)|0|||
27833379|NCT01743989|54315999|FG002|Treatment Phase|Abnormal test procedure result(s)|1|||
27833380|NCT01743989|54315997|FG000|Treatment Phase|Administrative problems|0|||
27833381|NCT01743989|54315998|FG001|Treatment Phase|Administrative problems|0|||
27833382|NCT01743989|54315999|FG002|Treatment Phase|Administrative problems|1|||
27980763|NCT00611455|54638747|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
28169256|NCT01274338|54840124|FG002|Overall Study|Adverse Event|180|||
27980764|NCT00611455|54638745|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
27980765|NCT00611455|54638746|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
28169257|NCT01274338|54840125|FG003|Overall Study|Adverse Event|1|||
28169258|NCT01274338|54840126|FG004|Overall Study|Adverse Event|0|||
27736308|NCT02879305|54184975|FG000|Overall Study|Lost to Follow-up|17|||
27736309|NCT02879305|54184976|FG001|Overall Study|Lost to Follow-up|12|||
27833383|NCT01743989|54315997|FG000|Treatment Phase|New cancer (CML) therapy|0|||
28169259|NCT01274338|54840127|FG005|Overall Study|Adverse Event|0|||
28169260|NCT01274338|54840122|FG000|Overall Study|Death|8|||
27736310|NCT02879305|54184975|FG000|Overall Study|Other|1|||
27736311|NCT02879305|54184976|FG001|Overall Study|Other|0|||
27736312|NCT02281318|54184984|FG000|Overall Study|Adverse Event|2|||
27736313|NCT02281318|54184985|FG001|Overall Study|Adverse Event|2|||
27736314|NCT02281318|54184984|FG000|Overall Study|Lack of Efficacy|2|||
27736315|NCT02281318|54184985|FG001|Overall Study|Lack of Efficacy|0|||
27736316|NCT02281318|54184984|FG000|Overall Study|Lost to Follow-up|2|||
27736317|NCT02281318|54184985|FG001|Overall Study|Lost to Follow-up|1|||
27736318|NCT02281318|54184984|FG000|Overall Study|Physician Decision|2|||
27736319|NCT02281318|54184985|FG001|Overall Study|Physician Decision|0|||
27736320|NCT02281318|54184984|FG000|Overall Study|Withdrawal by Subject|6|||
27736321|NCT02281318|54184985|FG001|Overall Study|Withdrawal by Subject|2|||
27736322|NCT01657760|54184993|FG000|Overall Study|Withdrawal by Subject|0|||
28169261|NCT01274338|54840123|FG001|Overall Study|Death|1|||
28169262|NCT01274338|54840124|FG002|Overall Study|Death|0|||
27736323|NCT01657760|54184994|FG001|Overall Study|Withdrawal by Subject|0|||
27736324|NCT01657760|54184995|FG002|Overall Study|Withdrawal by Subject|0|||
27736325|NCT01657760|54184996|FG003|Overall Study|Withdrawal by Subject|1|||
28169263|NCT01274338|54840125|FG003|Overall Study|Death|0|||
28169264|NCT01274338|54840126|FG004|Overall Study|Death|0|||
28169265|NCT01274338|54840127|FG005|Overall Study|Death|0|||
28169266|NCT01274338|54840122|FG000|Overall Study|Withdrawal by Subject|27|||
28169267|NCT01274338|54840123|FG001|Overall Study|Withdrawal by Subject|99|||
28169268|NCT01274338|54840124|FG002|Overall Study|Withdrawal by Subject|17|||
28169269|NCT01274338|54840125|FG003|Overall Study|Withdrawal by Subject|0|||
28169270|NCT01274338|54840126|FG004|Overall Study|Withdrawal by Subject|0|||
28169271|NCT01274338|54840127|FG005|Overall Study|Withdrawal by Subject|0|||
28169272|NCT01274338|54840122|FG000|Overall Study|Did not start treatment|8|||
28169273|NCT01274338|54840123|FG001|Overall Study|Did not start treatment|116|||
28169274|NCT01274338|54840124|FG002|Overall Study|Did not start treatment|7|||
28169275|NCT01274338|54840125|FG003|Overall Study|Did not start treatment|0|||
28169276|NCT01274338|54840126|FG004|Overall Study|Did not start treatment|0|||
28169277|NCT01274338|54840127|FG005|Overall Study|Did not start treatment|0|||
28169278|NCT01274338|54840122|FG000|Overall Study|Alternative therapy|0|||
28169279|NCT01274338|54840123|FG001|Overall Study|Alternative therapy|1|||
28169280|NCT01274338|54840124|FG002|Overall Study|Alternative therapy|0|||
28169281|NCT01274338|54840125|FG003|Overall Study|Alternative therapy|0|||
28169282|NCT01274338|54840126|FG004|Overall Study|Alternative therapy|0|||
28169283|NCT01274338|54840127|FG005|Overall Study|Alternative therapy|0|||
28169284|NCT01274338|54840122|FG000|Overall Study|Other complicating diseases|0|||
28169285|NCT01274338|54840123|FG001|Overall Study|Other complicating diseases|3|||
28169286|NCT01274338|54840124|FG002|Overall Study|Other complicating diseases|1|||
28169287|NCT01274338|54840125|FG003|Overall Study|Other complicating diseases|0|||
28169288|NCT01274338|54840126|FG004|Overall Study|Other complicating diseases|0|||
28169289|NCT01274338|54840127|FG005|Overall Study|Other complicating diseases|0|||
28169290|NCT01274338|54840122|FG000|Overall Study|Treatment arm was suspended due to toxicity|4|||
28169291|NCT01274338|54840123|FG001|Overall Study|Treatment arm was suspended due to toxicity|0|||
28169292|NCT01274338|54840124|FG002|Overall Study|Treatment arm was suspended due to toxicity|0|||
28169293|NCT01274338|54840125|FG003|Overall Study|Treatment arm was suspended due to toxicity|0|||
28169294|NCT01274338|54840126|FG004|Overall Study|Treatment arm was suspended due to toxicity|0|||
28169295|NCT01274338|54840127|FG005|Overall Study|Treatment arm was suspended due to toxicity|0|||
28169296|NCT01274338|54840122|FG000|Overall Study|Pregnancy|0|||
28169297|NCT01274338|54840123|FG001|Overall Study|Pregnancy|0|||
28169298|NCT01274338|54840124|FG002|Overall Study|Pregnancy|1|||
28169299|NCT01274338|54840125|FG003|Overall Study|Pregnancy|0|||
28169300|NCT01274338|54840126|FG004|Overall Study|Pregnancy|0|||
28169301|NCT01274338|54840127|FG005|Overall Study|Pregnancy|0|||
28169302|NCT01274338|54840122|FG000|Overall Study|Reason not reported|12|||
28169303|NCT01274338|54840123|FG001|Overall Study|Reason not reported|21|||
28169304|NCT01274338|54840124|FG002|Overall Study|Reason not reported|3|||
28169305|NCT01274338|54840125|FG003|Overall Study|Reason not reported|0|||
28169306|NCT01274338|54840126|FG004|Overall Study|Reason not reported|1|||
28169307|NCT01274338|54840127|FG005|Overall Study|Reason not reported|0|||
28169308|NCT01196390|54840142|FG000|Overall Study|Protocol Violation|4|||
28169309|NCT01196390|54840143|FG001|Overall Study|Protocol Violation|5|||
28169310|NCT01065454|54840155|FG000|Treatment|Adverse Event|7|||
28169311|NCT01065454|54840156|FG001|Treatment|Adverse Event|4|||
28169312|NCT01065454|54840157|FG002|Treatment|Adverse Event|3|||
28169313|NCT01065454|54840158|FG003|Treatment|Adverse Event|6|||
28169314|NCT01065454|54840155|FG000|Treatment|Death|1|||
28169315|NCT01065454|54840156|FG001|Treatment|Death|0|||
28169316|NCT01065454|54840157|FG002|Treatment|Death|0|||
28169317|NCT01065454|54840158|FG003|Treatment|Death|0|||
28169318|NCT01065454|54840155|FG000|Treatment|Non-compliance|1|||
28169319|NCT01065454|54840156|FG001|Treatment|Non-compliance|0|||
28169320|NCT01065454|54840157|FG002|Treatment|Non-compliance|0|||
27736326|NCT01657760|54184993|FG000|Overall Study|Physician Decision|1|||
27736327|NCT01657760|54184994|FG001|Overall Study|Physician Decision|1|||
28169321|NCT01065454|54840158|FG003|Treatment|Non-compliance|1|||
28169322|NCT01065454|54840155|FG000|Treatment|Protocol Decision|0|||
28169323|NCT01065454|54840156|FG001|Treatment|Protocol Decision|0|||
28169324|NCT01065454|54840157|FG002|Treatment|Protocol Decision|3|||
28169325|NCT01065454|54840158|FG003|Treatment|Protocol Decision|2|||
28169326|NCT01065454|54840155|FG000|Treatment|Protocol Violation|1|||
28169327|NCT01065454|54840156|FG001|Treatment|Protocol Violation|0|||
28169328|NCT01065454|54840157|FG002|Treatment|Protocol Violation|1|||
28169329|NCT01065454|54840158|FG003|Treatment|Protocol Violation|0|||
27736328|NCT01657760|54184995|FG002|Overall Study|Physician Decision|1|||
27736329|NCT01657760|54184996|FG003|Overall Study|Physician Decision|2|||
27736330|NCT02280304|54185023|FG000|Overall Study|Lost to Follow-up|7|||
27736331|NCT02280304|54185024|FG001|Overall Study|Lost to Follow-up|8|||
27736332|NCT02283658|54185044|FG000|Overall Study|Withdrawal by Subject|1|||
27736333|NCT02279524|54185071|FG000|Overall Study|Withdrawal by Subject|3|||
27736334|NCT02279524|54185072|FG001|Overall Study|Withdrawal by Subject|6|||
27736335|NCT02279524|54185073|FG002|Overall Study|Withdrawal by Subject|3|||
28169330|NCT01065454|54840155|FG000|Treatment|Withdrawal by Subject|3|||
28169331|NCT01065454|54840156|FG001|Treatment|Withdrawal by Subject|1|||
28169332|NCT01065454|54840157|FG002|Treatment|Withdrawal by Subject|2|||
28169333|NCT01065454|54840158|FG003|Treatment|Withdrawal by Subject|3|||
28169334|NCT01065454|54840155|FG000|Follow up|Adverse Event|1|||
28169335|NCT01065454|54840156|FG001|Follow up|Adverse Event|0|||
28169336|NCT01065454|54840157|FG002|Follow up|Adverse Event|0|||
28169337|NCT01065454|54840158|FG003|Follow up|Adverse Event|1|||
28169338|NCT01065454|54840155|FG000|Follow up|Death|0|||
28169339|NCT01065454|54840156|FG001|Follow up|Death|1|||
27736336|NCT02279524|54185071|FG000|Overall Study|Adverse Event|4|||
27736337|NCT02279524|54185072|FG001|Overall Study|Adverse Event|3|||
27736338|NCT02279524|54185073|FG002|Overall Study|Adverse Event|2|||
27736339|NCT02279524|54185071|FG000|Overall Study|Lost to Follow-up|1|||
28169340|NCT01065454|54840157|FG002|Follow up|Death|1|||
28169341|NCT01065454|54840158|FG003|Follow up|Death|0|||
27736340|NCT02279524|54185072|FG001|Overall Study|Lost to Follow-up|1|||
27736341|NCT02279524|54185073|FG002|Overall Study|Lost to Follow-up|0|||
27736342|NCT02279524|54185071|FG000|Overall Study|Disallowed medication|1|||
27736343|NCT02279524|54185072|FG001|Overall Study|Disallowed medication|1|||
28169342|NCT01065454|54840155|FG000|Follow up|Lost to Follow-up|0|||
28169343|NCT01065454|54840156|FG001|Follow up|Lost to Follow-up|0|||
28169344|NCT01065454|54840157|FG002|Follow up|Lost to Follow-up|0|||
28169345|NCT01065454|54840158|FG003|Follow up|Lost to Follow-up|1|||
28169346|NCT01065454|54840155|FG000|Follow up|Progressive disease|0|||
28169347|NCT01065454|54840156|FG001|Follow up|Progressive disease|0|||
28169348|NCT01065454|54840157|FG002|Follow up|Progressive disease|0|||
28169349|NCT01065454|54840158|FG003|Follow up|Progressive disease|1|||
28169350|NCT01065454|54840155|FG000|Follow up|Withdrawal by Subject|1|||
28169351|NCT01065454|54840156|FG001|Follow up|Withdrawal by Subject|1|||
28169352|NCT01065454|54840157|FG002|Follow up|Withdrawal by Subject|1|||
28169353|NCT01065454|54840158|FG003|Follow up|Withdrawal by Subject|0|||
28169354|NCT01065454|54840155|FG000|Follow up|study ongoing|37|||
28169355|NCT01065454|54840156|FG001|Follow up|study ongoing|22|||
28169356|NCT01065454|54840157|FG002|Follow up|study ongoing|15|||
27736344|NCT02279524|54185073|FG002|Overall Study|Disallowed medication|2|||
27736345|NCT02279524|54185071|FG000|Overall Study|Bariatric surgery|1|||
27736346|NCT02279524|54185072|FG001|Overall Study|Bariatric surgery|0|||
27736347|NCT02279524|54185073|FG002|Overall Study|Bariatric surgery|0|||
27736348|NCT02283268|54185081|FG000|Overall Study|Withdrawal by Subject|1|||
27736349|NCT00857285|54185095|FG000|Overall Study|Adverse Event|4|||
27736350|NCT00857285|54185096|FG001|Overall Study|Adverse Event|2|||
27736351|NCT00857285|54185095|FG000|Overall Study|Lack of Efficacy|0|||
27736352|NCT00857285|54185096|FG001|Overall Study|Lack of Efficacy|2|||
28094197|NCT03129100|54748059|FG000|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
28094198|NCT03129100|54748060|FG001|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
28094199|NCT03129100|54748061|FG002|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
28094200|NCT03129100|54748062|FG003|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
28094201|NCT03129100|54748063|FG004|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
28094202|NCT03129100|54748064|FG005|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
28094203|NCT03129100|54748065|FG006|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
28094204|NCT03129100|54748066|FG007|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
28094205|NCT03129100|54748067|FG008|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
28094206|NCT03129100|54748068|FG009|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
28094207|NCT03129100|54748069|FG010|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
28169357|NCT01065454|54840158|FG003|Follow up|study ongoing|41|||
28169358|NCT00769379|54840170|FG000|Overall Study|No follow up data mapped to Other.|3|||
28169359|NCT00769379|54840171|FG001|Overall Study|No follow up data mapped to Other.|13|||
27736353|NCT00857285|54185095|FG000|Overall Study|Protocol Violation|3|||
27736354|NCT00857285|54185096|FG001|Overall Study|Protocol Violation|1|||
27736355|NCT00857285|54185095|FG000|Overall Study|Withdrawal by Subject|4|||
28169360|NCT00588770|54840179|FG000|Overall Study|Disease progression|85|||
28169361|NCT00588770|54840180|FG001|Overall Study|Disease progression|68|||
27736356|NCT00857285|54185096|FG001|Overall Study|Withdrawal by Subject|0|||
27736357|NCT00857285|54185095|FG000|Overall Study|Randomization criteria not met|1|||
27736358|NCT00857285|54185096|FG001|Overall Study|Randomization criteria not met|1|||
27736359|NCT02278354|54185102|FG000|Overall Study|Lost to Follow-up|2|||
27736360|NCT02278354|54185103|FG001|Overall Study|Lost to Follow-up|2|||
28169362|NCT00588770|54840179|FG000|Overall Study|Adverse Event|29|||
28169363|NCT00588770|54840180|FG001|Overall Study|Adverse Event|58|||
28169364|NCT00588770|54840179|FG000|Overall Study|Death|13|||
28169365|NCT00588770|54840180|FG001|Overall Study|Death|22|||
28169366|NCT00588770|54840179|FG000|Overall Study|Withdrawal by Subject|15|||
28169367|NCT00588770|54840180|FG001|Overall Study|Withdrawal by Subject|25|||
28169368|NCT00588770|54840179|FG000|Overall Study|Alternative therapy|2|||
28169369|NCT00588770|54840180|FG001|Overall Study|Alternative therapy|4|||
28169370|NCT00588770|54840179|FG000|Overall Study|Other complicating disease|3|||
28169371|NCT00588770|54840180|FG001|Overall Study|Other complicating disease|2|||
28169372|NCT00588770|54840179|FG000|Overall Study|Not start protocol therapy|0|||
28169373|NCT00588770|54840180|FG001|Overall Study|Not start protocol therapy|9|||
28169374|NCT00588770|54840179|FG000|Overall Study|Lack of Efficacy|8|||
28169375|NCT00588770|54840180|FG001|Overall Study|Lack of Efficacy|10|||
28169376|NCT00588770|54840179|FG000|Overall Study|Physician discretion|2|||
28169377|NCT00588770|54840180|FG001|Overall Study|Physician discretion|0|||
28169378|NCT00588770|54840179|FG000|Overall Study|Patient non-compliance|2|||
28169379|NCT00588770|54840180|FG001|Overall Study|Patient non-compliance|2|||
28169380|NCT00378482|54840186|FG000|Overall Study|Lost to Follow-up|1|||
28169381|NCT00378482|54840186|FG000|Overall Study|Lack of Efficacy|8|||
27736361|NCT02278354|54185102|FG000|Overall Study|Withdrawal by Subject|0|||
27736362|NCT02278354|54185103|FG001|Overall Study|Withdrawal by Subject|1|||
27736363|NCT02278354|54185102|FG000|Overall Study|<10 professional fights|2|||
27736364|NCT02278354|54185103|FG001|Overall Study|<10 professional fights|0|||
27736365|NCT01657370|54185122|FG000|Overall Study|Withdrawal by Subject|0|||
27736366|NCT01657370|54185123|FG001|Overall Study|Withdrawal by Subject|0|||
28169382|NCT00378482|54840186|FG000|Overall Study|Subject or physician decision, or subject relocation to another city or region.|9|||
28169383|NCT00378482|54840186|FG000|Overall Study|Withdrawal by Subject|4|||
28169384|NCT00378482|54840186|FG000|Overall Study|Adverse Event|9|||
28169385|NCT05288673|54840193|FG000|Overall Study|Consent withdrawn by subject|0|||
28169386|NCT05288673|54840194|FG001|Overall Study|Consent withdrawn by subject|0|||
28169387|NCT05288673|54840195|FG002|Overall Study|Consent withdrawn by subject|1|||
28169388|NCT04604795|54840241|FG000|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
27736367|NCT01657370|54185124|FG002|Overall Study|Withdrawal by Subject|1|||
27736368|NCT01657370|54185125|FG003|Overall Study|Withdrawal by Subject|0|||
27833384|NCT01743989|54315998|FG001|Treatment Phase|New cancer (CML) therapy|1|||
27833385|NCT01743989|54315999|FG002|Treatment Phase|New cancer (CML) therapy|0|||
27833386|NCT01743989|54315997|FG000|Treatment Phase|Physician Decision|0|||
27833387|NCT01743989|54315998|FG001|Treatment Phase|Physician Decision|0|||
27833388|NCT01743989|54315999|FG002|Treatment Phase|Physician Decision|3|||
27833389|NCT01743989|54315997|FG000|Treatment Phase|Patient non-compliance to treatment|0|||
27833390|NCT01743989|54315998|FG001|Treatment Phase|Patient non-compliance to treatment|0|||
27833391|NCT01743989|54315999|FG002|Treatment Phase|Patient non-compliance to treatment|3|||
27833392|NCT01743989|54315997|FG000|Treatment Phase|Not randomized by mistake|0|||
27833393|NCT01743989|54315998|FG001|Treatment Phase|Not randomized by mistake|0|||
27833394|NCT01743989|54315999|FG002|Treatment Phase|Not randomized by mistake|1|||
27833395|NCT01743989|54315997|FG000|Treatment Phase|Included by mistake|0|||
27833396|NCT01743989|54315998|FG001|Treatment Phase|Included by mistake|0|||
27833397|NCT01743989|54315999|FG002|Treatment Phase|Included by mistake|1|||
27833398|NCT01743989|54315997|FG000|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|82|||
27833399|NCT01743989|54315998|FG001|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|59|||
27833400|NCT01743989|54315999|FG002|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|0|||
28094208|NCT03129100|54748070|FG011|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
28094209|NCT03129100|54748071|FG012|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|24|||
28094210|NCT03129100|54748072|FG013|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
28094211|NCT03129100|54748073|FG014|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|2|||
28094212|NCT03129100|54748074|FG015|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|8|||
28094213|NCT03129100|54748075|FG016|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
28094214|NCT03129100|54748076|FG017|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
28169389|NCT04604795|54840242|FG001|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
28169390|NCT04604795|54840243|FG002|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
28169391|NCT04604795|54840244|FG003|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
28169392|NCT04604795|54840245|FG004|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
28169393|NCT04604795|54840246|FG005|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
28169394|NCT04604795|54840247|FG006|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
27736369|NCT01657370|54185126|FG004|Overall Study|Withdrawal by Subject|0|||
27736370|NCT01657370|54185127|FG005|Overall Study|Withdrawal by Subject|1|||
27736371|NCT01657370|54185122|FG000|Overall Study|Physician Decision|2|||
27736372|NCT01657370|54185123|FG001|Overall Study|Physician Decision|3|||
27736373|NCT01657370|54185124|FG002|Overall Study|Physician Decision|1|||
27736374|NCT01657370|54185125|FG003|Overall Study|Physician Decision|2|||
27736375|NCT01657370|54185126|FG004|Overall Study|Physician Decision|5|||
27736376|NCT01657370|54185127|FG005|Overall Study|Physician Decision|0|||
27736377|NCT01657370|54185122|FG000|Overall Study|Lack of Qualifying Event|1|||
27736378|NCT01657370|54185123|FG001|Overall Study|Lack of Qualifying Event|0|||
27736379|NCT01657370|54185124|FG002|Overall Study|Lack of Qualifying Event|3|||
27736380|NCT01657370|54185125|FG003|Overall Study|Lack of Qualifying Event|2|||
27736381|NCT01657370|54185126|FG004|Overall Study|Lack of Qualifying Event|1|||
27736382|NCT01657370|54185127|FG005|Overall Study|Lack of Qualifying Event|2|||
27736383|NCT01657370|54185122|FG000|Overall Study|Adverse Event|0|||
28169395|NCT04604795|54840248|FG007|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
28169396|NCT04604795|54840249|FG008|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
28169397|NCT04604795|54840250|FG009|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
28169398|NCT04604795|54840241|FG000|Part B: Up to Day 14|Adverse Event|0|||
27736384|NCT01657370|54185123|FG001|Overall Study|Adverse Event|0|||
27736385|NCT01657370|54185124|FG002|Overall Study|Adverse Event|0|||
27736386|NCT01657370|54185125|FG003|Overall Study|Adverse Event|0|||
27736387|NCT01657370|54185126|FG004|Overall Study|Adverse Event|1|||
27736388|NCT01657370|54185127|FG005|Overall Study|Adverse Event|0|||
27736389|NCT01657370|54185122|FG000|Overall Study|Protocol Violation|1|||
27736390|NCT01657370|54185123|FG001|Overall Study|Protocol Violation|1|||
27736391|NCT01657370|54185124|FG002|Overall Study|Protocol Violation|1|||
27736392|NCT01657370|54185125|FG003|Overall Study|Protocol Violation|1|||
27736393|NCT01657370|54185126|FG004|Overall Study|Protocol Violation|0|||
27736394|NCT01657370|54185127|FG005|Overall Study|Protocol Violation|0|||
27736395|NCT01657370|54185122|FG000|Overall Study|Lost to Follow-up|2|||
27736396|NCT01657370|54185123|FG001|Overall Study|Lost to Follow-up|0|||
27736397|NCT01657370|54185124|FG002|Overall Study|Lost to Follow-up|1|||
27736398|NCT01657370|54185125|FG003|Overall Study|Lost to Follow-up|0|||
27736399|NCT01657370|54185126|FG004|Overall Study|Lost to Follow-up|0|||
27736400|NCT01657370|54185127|FG005|Overall Study|Lost to Follow-up|1|||
27736401|NCT00849797|54185169|FG000|First Intervention|bad veins|1|||
27736402|NCT00849797|54185170|FG001|First Intervention|bad veins|0|||
28169399|NCT04604795|54840242|FG001|Part B: Up to Day 14|Adverse Event|0|||
28169400|NCT04604795|54840243|FG002|Part B: Up to Day 14|Adverse Event|0|||
28169401|NCT04604795|54840244|FG003|Part B: Up to Day 14|Adverse Event|0|||
28169402|NCT04604795|54840245|FG004|Part B: Up to Day 14|Adverse Event|2|||
28169403|NCT04604795|54840246|FG005|Part B: Up to Day 14|Adverse Event|1|||
27736403|NCT00849797|54185169|FG000|First Intervention|Adverse Event|0|||
27736404|NCT00849797|54185170|FG001|First Intervention|Adverse Event|1|||
27736405|NCT00849797|54185169|FG000|Washout: One Week|Withdrawal by Subject|0|||
27736406|NCT00849797|54185170|FG001|Washout: One Week|Withdrawal by Subject|2|||
27736407|NCT00840203|54185191|FG000|First Intervention|Protocol Violation|1|||
27736408|NCT00840203|54185192|FG001|First Intervention|Protocol Violation|1|||
27736409|NCT00840203|54185191|FG000|Washout|Protocol Violation|1|||
27736410|NCT00840203|54185192|FG001|Washout|Protocol Violation|0|||
27736411|NCT00835991|54185198|FG000|First Intervention|Adverse Event|0|||
27736412|NCT00835991|54185199|FG001|First Intervention|Adverse Event|1|||
27736413|NCT00835991|54185198|FG000|Washout|Protocol Violation|0|||
27736414|NCT00835991|54185199|FG001|Washout|Protocol Violation|2|||
27833401|NCT01743989|54315997|FG000|TFR Phase|Adverse Event|0|||
27833402|NCT01743989|54315998|FG001|TFR Phase|Adverse Event|1|||
27736415|NCT00835991|54185198|FG000|Washout|Withdrawal by Subject|3|||
27736416|NCT00835991|54185199|FG001|Washout|Withdrawal by Subject|1|||
27736417|NCT02276872|54185206|FG000|Overall Study|Adverse Event|1|||
27736418|NCT02276872|54185207|FG001|Overall Study|Adverse Event|0|||
27736419|NCT02276872|54185208|FG002|Overall Study|Adverse Event|0|||
27736420|NCT00835367|54185223|FG000|Washout|Adverse Event|2|||
27833403|NCT01743989|54315999|FG002|TFR Phase|Adverse Event|0|||
27833404|NCT01743989|54315997|FG000|TFR Phase|Lost to Follow-up|0|||
27833405|NCT01743989|54315998|FG001|TFR Phase|Lost to Follow-up|2|||
28094215|NCT03129100|54748077|FG018|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
28094216|NCT03129100|54748078|FG019|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
28094217|NCT03129100|54748079|FG020|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
28094218|NCT03129100|54748080|FG021|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
28094219|NCT03129100|54748081|FG022|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
28094220|NCT03129100|54748082|FG023|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
28094221|NCT03129100|54748083|FG024|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
28094222|NCT03129100|54748084|FG025|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
28094223|NCT03129100|54748059|FG000|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
28094224|NCT03129100|54748060|FG001|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
28094225|NCT03129100|54748061|FG002|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
28094226|NCT03129100|54748062|FG003|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
28169404|NCT04604795|54840247|FG006|Part B: Up to Day 14|Adverse Event|0|||
28169405|NCT04604795|54840248|FG007|Part B: Up to Day 14|Adverse Event|0|||
27736421|NCT00835367|54185224|FG001|Washout|Adverse Event|0|||
27736422|NCT00835367|54185223|FG000|Washout|Withdrawal by Subject|1|||
27833406|NCT01743989|54315999|FG002|TFR Phase|Lost to Follow-up|0|||
27833407|NCT01743989|54315997|FG000|TFR Phase|Physician Decision|0|||
27833408|NCT01743989|54315998|FG001|TFR Phase|Physician Decision|1|||
27833409|NCT01743989|54315999|FG002|TFR Phase|Physician Decision|0|||
27833410|NCT01743989|54315997|FG000|TFR Phase|Logistical problems|0|||
27833411|NCT01743989|54315998|FG001|TFR Phase|Logistical problems|2|||
27833412|NCT01743989|54315999|FG002|TFR Phase|Logistical problems|0|||
27833413|NCT01743989|54315997|FG000|TFR Phase|Protocol deviation|0|||
27833414|NCT01743989|54315998|FG001|TFR Phase|Protocol deviation|1|||
27856068|NCT01047319|54383362|FG001|Overall Study|Teva requested participant withdrawal|0|||
27856069|NCT01047319|54383363|FG002|Overall Study|Teva requested participant withdrawal|1|||
27856070|NCT01047319|54383361|FG000|Overall Study|Protocol Violation|3|||
27856071|NCT01047319|54383362|FG001|Overall Study|Protocol Violation|2|||
27856072|NCT01047319|54383363|FG002|Overall Study|Protocol Violation|4|||
27856073|NCT01047319|54383361|FG000|Overall Study|Lack of Efficacy|4|||
27856074|NCT01047319|54383362|FG001|Overall Study|Lack of Efficacy|3|||
27856075|NCT01047319|54383363|FG002|Overall Study|Lack of Efficacy|3|||
27856076|NCT01047319|54383361|FG000|Overall Study|Death|5|||
27856077|NCT01047319|54383362|FG001|Overall Study|Death|1|||
27856078|NCT01047319|54383363|FG002|Overall Study|Death|5|||
27856079|NCT01047319|54383361|FG000|Overall Study|Pregnancy|13|||
27856080|NCT01047319|54383362|FG001|Overall Study|Pregnancy|8|||
27856081|NCT01047319|54383363|FG002|Overall Study|Pregnancy|8|||
27856082|NCT01047319|54383361|FG000|Overall Study|Physician Decision|12|||
27856083|NCT01047319|54383362|FG001|Overall Study|Physician Decision|9|||
27856084|NCT01047319|54383363|FG002|Overall Study|Physician Decision|10|||
27856085|NCT01047319|54383361|FG000|Overall Study|Lost to Follow-up|14|||
28169406|NCT04604795|54840249|FG008|Part B: Up to Day 14|Adverse Event|0|||
28169407|NCT04604795|54840250|FG009|Part B: Up to Day 14|Adverse Event|0|||
28169408|NCT04604795|54840241|FG000|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
28169409|NCT04604795|54840242|FG001|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
28169410|NCT04604795|54840243|FG002|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
28169411|NCT04604795|54840244|FG003|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
28169412|NCT04604795|54840245|FG004|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
28169413|NCT04604795|54840246|FG005|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
28169414|NCT04604795|54840247|FG006|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
28169415|NCT04604795|54840248|FG007|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
28169416|NCT04604795|54840249|FG008|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
28169417|NCT04604795|54840250|FG009|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|1|||
28169418|NCT04604795|54840241|FG000|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
28169419|NCT04604795|54840242|FG001|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
28169420|NCT04604795|54840243|FG002|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
28169421|NCT04604795|54840244|FG003|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
28169422|NCT04604795|54840245|FG004|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
28169423|NCT04604795|54840246|FG005|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
28169424|NCT04604795|54840247|FG006|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
28169425|NCT04604795|54840248|FG007|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
28169426|NCT04604795|54840249|FG008|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|1|||
28169427|NCT04604795|54840250|FG009|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
28169428|NCT04604795|54840241|FG000|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
28169429|NCT04604795|54840242|FG001|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
28169430|NCT04604795|54840243|FG002|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
28169431|NCT04604795|54840244|FG003|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
28169432|NCT04604795|54840245|FG004|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
28169433|NCT04604795|54840246|FG005|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
28169434|NCT04604795|54840247|FG006|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
27736423|NCT00835367|54185224|FG001|Washout|Withdrawal by Subject|0|||
27833415|NCT01743989|54315999|FG002|TFR Phase|Protocol deviation|0|||
27833416|NCT01743989|54315997|FG000|TFR Phase|Withdrawal by Subject|0|||
27736424|NCT00835367|54185223|FG000|Second Intervention|Adverse Event|1|||
27833417|NCT01743989|54315998|FG001|TFR Phase|Withdrawal by Subject|2|||
27833418|NCT01743989|54315999|FG002|TFR Phase|Withdrawal by Subject|0|||
27833419|NCT01743989|54315997|FG000|Re-treatment Phase|Adverse Event|8|||
27856086|NCT01047319|54383362|FG001|Overall Study|Lost to Follow-up|10|||
27856087|NCT01047319|54383363|FG002|Overall Study|Lost to Follow-up|10|||
27856088|NCT01047319|54383361|FG000|Overall Study|Adverse Event|16|||
27856089|NCT01047319|54383362|FG001|Overall Study|Adverse Event|27|||
27856090|NCT01047319|54383363|FG002|Overall Study|Adverse Event|21|||
27856091|NCT01047319|54383361|FG000|Overall Study|Withdrawal by Subject|77|||
27856092|NCT01047319|54383362|FG001|Overall Study|Withdrawal by Subject|75|||
27736425|NCT00835367|54185224|FG001|Second Intervention|Adverse Event|1|||
27736426|NCT02276560|54185231|FG000|Overall Study|Adverse Event|1|||
27736427|NCT02276560|54185232|FG001|Overall Study|Adverse Event|0|||
27736428|NCT02276560|54185233|FG002|Overall Study|Adverse Event|0|||
27736429|NCT02276482|54185243|FG000|Overall Study|Adverse Event|1|||
27736430|NCT02276482|54185244|FG001|Overall Study|Adverse Event|0|||
27736431|NCT02276482|54185243|FG000|Overall Study|Withdrawal by Subject|1|||
27736432|NCT02276482|54185244|FG001|Overall Study|Withdrawal by Subject|0|||
27736433|NCT02276482|54185243|FG000|Overall Study|Gram-negative infection|1|||
27736434|NCT02276482|54185244|FG001|Overall Study|Gram-negative infection|0|||
27736435|NCT02276482|54185243|FG000|Overall Study|Reason not specified|0|||
27736436|NCT02276482|54185244|FG001|Overall Study|Reason not specified|1|||
27736437|NCT00835211|54185262|FG000|First Intervention|Withdrawal by Subject|0|||
27736438|NCT00835211|54185263|FG001|First Intervention|Withdrawal by Subject|1|||
27736439|NCT00835211|54185262|FG000|Washout: 7 Days|Adverse Event|2|||
27736440|NCT00835211|54185263|FG001|Washout: 7 Days|Adverse Event|1|||
27736441|NCT00835211|54185262|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
27736442|NCT00835211|54185263|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
27736443|NCT00834743|54185276|FG000|Second Intervention|Withdrawal by Subject|1|||
27736444|NCT00834743|54185277|FG001|Second Intervention|Withdrawal by Subject|0|||
27736445|NCT00834587|54185283|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
27736446|NCT00834587|54185284|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
27736447|NCT00834431|54185290|FG000|First Intervention|Adverse Event|0|||
27736448|NCT00834431|54185291|FG001|First Intervention|Adverse Event|1|||
27736449|NCT00834431|54185290|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
27736450|NCT00834431|54185291|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
27736451|NCT00830219|54185311|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
27736452|NCT00830219|54185312|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
27736453|NCT02274766|54185318|FG000|Overall Study|Withdrawal by Subject|3|||
27736454|NCT02274766|54185319|FG001|Overall Study|Withdrawal by Subject|6|||
27736455|NCT02274766|54185318|FG000|Overall Study|Did Not Receive Study Drug|1|||
27736456|NCT02274766|54185319|FG001|Overall Study|Did Not Receive Study Drug|1|||
27736457|NCT02274766|54185318|FG000|Overall Study|Subject Unwilling to Proceed|0|||
27736458|NCT02274766|54185319|FG001|Overall Study|Subject Unwilling to Proceed|1|||
27736459|NCT02274766|54185318|FG000|Overall Study|Adverse Event|0|||
27736460|NCT02274766|54185319|FG001|Overall Study|Adverse Event|1|||
27736461|NCT00829673|54185327|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
28169435|NCT04604795|54840248|FG007|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
28169436|NCT04604795|54840249|FG008|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|1|||
27736462|NCT00829673|54185328|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
27736463|NCT02370238|54185334|FG000|Overall Study|Death|42|||
27736464|NCT02370238|54185335|FG001|Overall Study|Death|35|||
27736465|NCT02370238|54185334|FG000|Overall Study|Lost to Follow-up|1|||
27736466|NCT02370238|54185335|FG001|Overall Study|Lost to Follow-up|3|||
27736467|NCT02370238|54185334|FG000|Overall Study|Withdrawal by Subject|2|||
27736468|NCT02370238|54185335|FG001|Overall Study|Withdrawal by Subject|6|||
27736469|NCT02370238|54185334|FG000|Overall Study|Other|2|||
27736470|NCT02370238|54185335|FG001|Overall Study|Other|1|||
27736471|NCT02370160|54185345|FG000|Overall Study|Death|3|||
27736472|NCT02370160|54185346|FG001|Overall Study|Death|4|||
27736473|NCT02370160|54185347|FG002|Overall Study|Death|1|||
27736474|NCT02273908|54185362|FG000|Overall Study|Adverse Event|16|||
27736475|NCT02273908|54185363|FG001|Overall Study|Adverse Event|0|||
27980766|NCT00611455|54638747|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
27980767|NCT00611455|54638745|FG000|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
28094227|NCT03129100|54748063|FG004|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
28094228|NCT03129100|54748064|FG005|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
28094229|NCT03129100|54748065|FG006|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
28094230|NCT03129100|54748066|FG007|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
28094231|NCT03129100|54748067|FG008|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
28094232|NCT03129100|54748068|FG009|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
28094233|NCT03129100|54748069|FG010|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
28094234|NCT03129100|54748070|FG011|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
28094235|NCT03129100|54748071|FG012|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
27736476|NCT02273908|54185362|FG000|Overall Study|Lost to Follow-up|10|||
27736477|NCT02273908|54185363|FG001|Overall Study|Lost to Follow-up|1|||
27736478|NCT02273908|54185362|FG000|Overall Study|Did not meet entrance criteria|3|||
27736479|NCT02273908|54185363|FG001|Overall Study|Did not meet entrance criteria|2|||
27736480|NCT02273908|54185362|FG000|Overall Study|Withdrawal by Subject|4|||
27736481|NCT02273908|54185363|FG001|Overall Study|Withdrawal by Subject|2|||
27736482|NCT02273752|54185373|FG000|Overall Study|Trial was terminated early|2|||
27736483|NCT05180630|54185377|FG000|First Intervention|Physician Decision|0|||
27736484|NCT05180630|54185378|FG001|First Intervention|Physician Decision|0|||
27833420|NCT01743989|54315998|FG001|Re-treatment Phase|Adverse Event|4|||
27833421|NCT01743989|54315999|FG002|Re-treatment Phase|Adverse Event|0|||
27833422|NCT01743989|54315997|FG000|Re-treatment Phase|Death|1|||
27856093|NCT01047319|54383363|FG002|Overall Study|Withdrawal by Subject|87|||
27856094|NCT01047319|54383361|FG000|Overall Study|Study terminated by Sponsor|198|||
27856095|NCT01047319|54383362|FG001|Overall Study|Study terminated by Sponsor|215|||
27856096|NCT01047319|54383363|FG002|Overall Study|Study terminated by Sponsor|203|||
27856097|NCT00014911|54383680|FG000|Overall Study|Adverse Event|1|||
27856098|NCT00014911|54383680|FG000|Overall Study|Lost to Follow-up|1|||
27856099|NCT00014911|54383680|FG000|Overall Study|Withdrawal by Subject|6|||
27856100|NCT00014911|54383680|FG000|Overall Study|Unknown Reasons|2|||
27856101|NCT00014911|54383680|FG000|Overall Study|Immunosuppression-related Side Effects|1|||
27980768|NCT00611455|54638746|FG001|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
28169437|NCT04604795|54840250|FG009|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
28169438|NCT04604795|54840241|FG000|Part C: Period 5 (Day 1)|Adverse Event|0|||
28169439|NCT04604795|54840242|FG001|Part C: Period 5 (Day 1)|Adverse Event|0|||
28169440|NCT04604795|54840243|FG002|Part C: Period 5 (Day 1)|Adverse Event|0|||
28169441|NCT04604795|54840244|FG003|Part C: Period 5 (Day 1)|Adverse Event|0|||
28169442|NCT04604795|54840245|FG004|Part C: Period 5 (Day 1)|Adverse Event|0|||
28169443|NCT04604795|54840246|FG005|Part C: Period 5 (Day 1)|Adverse Event|0|||
28169444|NCT04604795|54840247|FG006|Part C: Period 5 (Day 1)|Adverse Event|0|||
28169445|NCT04604795|54840248|FG007|Part C: Period 5 (Day 1)|Adverse Event|0|||
28169446|NCT04604795|54840249|FG008|Part C: Period 5 (Day 1)|Adverse Event|1|||
28169447|NCT04604795|54840250|FG009|Part C: Period 5 (Day 1)|Adverse Event|0|||
28169448|NCT04314284|54840346|FG000|Overall Study|Withdrawal by Subject|4|||
28169449|NCT04314284|54840347|FG001|Overall Study|Withdrawal by Subject|7|||
28169450|NCT04314284|54840346|FG000|Overall Study|Consented but did not complete survey|0|||
28169451|NCT04314284|54840347|FG001|Overall Study|Consented but did not complete survey|6|||
28169452|NCT04246489|54840353|FG000|Overall Study|Ongoing at cut-off date|6|||
28169453|NCT04203823|54840359|FG000|Overall Study|Withdrawal by Subject|2|||
27736485|NCT05180630|54185379|FG002|First Intervention|Physician Decision|3|||
27736486|NCT02273596|54185388|FG000|24-Week Treatment Period|Adverse Event|3|||
27736487|NCT02273596|54185388|FG000|24-Week Treatment Period|Withdrawal by Participant Prior to First Dose|1|||
27736488|NCT02273596|54185388|FG000|24-Week Treatment Period|Participant was unable to Come|1|||
27736489|NCT02273596|54185388|FG000|24-Week Treatment Period|Physician Decision|1|||
27736490|NCT02273596|54185388|FG000|24-Week Treatment Period|Protocol Deviation|1|||
27736491|NCT02273596|54185388|FG000|Extension Period|Continued into Study WTX101-301 extension (NCT03403205).|19|||
27736492|NCT02273596|54185388|FG000|Extension Period|Participant Withdrew for Personal Reasons|1|||
27736493|NCT02273596|54185388|FG000|Extension Period|Lost to Follow-up|1|||
27736494|NCT02273596|54185388|FG000|Extension Period|Protocol Deviation|1|||
27736495|NCT01656200|54185398|FG000|Overall Study|Withdrawal by Subject|1|||
27736496|NCT02369848|54185402|FG000|Overall Study|Death|1|||
27736497|NCT02369848|54185402|FG000|Overall Study|Withdrawal by Subject|2|||
27736498|NCT02369848|54185402|FG000|Overall Study|Lost to Follow-up|1|||
27736499|NCT02368210|54185408|FG000|Overall Study|Withdrawal by Subject|1|||
27736500|NCT02368210|54185409|FG001|Overall Study|Withdrawal by Subject|0|||
27736501|NCT02368210|54185408|FG000|Overall Study|Adverse Event|0|||
27736502|NCT02368210|54185409|FG001|Overall Study|Adverse Event|1|||
27736503|NCT02273050|54185418|FG000|Overall Study|Adverse Event|4|||
27736504|NCT02273050|54185419|FG001|Overall Study|Adverse Event|3|||
27736505|NCT02273050|54185420|FG002|Overall Study|Adverse Event|3|||
27736506|NCT02273050|54185418|FG000|Overall Study|Death|0|||
27736507|NCT02273050|54185419|FG001|Overall Study|Death|0|||
27736508|NCT02273050|54185420|FG002|Overall Study|Death|1|||
27736509|NCT02273050|54185418|FG000|Overall Study|Dev. of study spec. withdrawal criteria|0|||
27736510|NCT02273050|54185419|FG001|Overall Study|Dev. of study spec. withdrawal criteria|1|||
27736511|NCT02273050|54185420|FG002|Overall Study|Dev. of study spec. withdrawal criteria|1|||
28094236|NCT03129100|54748072|FG013|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
28094237|NCT03129100|54748073|FG014|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
28094238|NCT03129100|54748074|FG015|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
28094239|NCT03129100|54748075|FG016|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
28094240|NCT03129100|54748076|FG017|Period 3 (Flare)|Escalated to IXE80Q2W|2|||
28094241|NCT03129100|54748077|FG018|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
28094242|NCT03129100|54748078|FG019|Period 3 (Flare)|Escalated to IXE80Q2W|3|||
28094243|NCT03129100|54748079|FG020|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
28169454|NCT04203823|54840360|FG001|Overall Study|Withdrawal by Subject|2|||
28169455|NCT04203823|54840359|FG000|Overall Study|Adverse Event|1|||
28169456|NCT04203823|54840360|FG001|Overall Study|Adverse Event|1|||
28169457|NCT04203823|54840359|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
28169458|NCT04203823|54840360|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
27736512|NCT02273050|54185418|FG000|Overall Study|Lack of Efficacy|0|||
27736513|NCT02273050|54185419|FG001|Overall Study|Lack of Efficacy|1|||
27736514|NCT02273050|54185420|FG002|Overall Study|Lack of Efficacy|1|||
27736515|NCT02273050|54185418|FG000|Overall Study|Withdrawal by Subject|17|||
27856102|NCT01049009|54384213|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
27856103|NCT01049009|54384214|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
27856104|NCT01049009|54384213|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
28169459|NCT03703466|54840413|FG000|Overall Study|Death|2|||
28169460|NCT03703466|54840414|FG001|Overall Study|Death|1|||
28169461|NCT03703466|54840415|FG002|Overall Study|Death|0|||
28169462|NCT03703466|54840413|FG000|Overall Study|Protocol Violation|1|||
28169463|NCT03703466|54840414|FG001|Overall Study|Protocol Violation|0|||
28169464|NCT03703466|54840415|FG002|Overall Study|Protocol Violation|0|||
28169465|NCT03703466|54840413|FG000|Overall Study|Withdrawal by Subject|0|||
27736516|NCT02273050|54185419|FG001|Overall Study|Withdrawal by Subject|14|||
27736517|NCT02273050|54185420|FG002|Overall Study|Withdrawal by Subject|16|||
27736518|NCT02273050|54185418|FG000|Overall Study|Lost to Follow-up|0|||
27736519|NCT02273050|54185419|FG001|Overall Study|Lost to Follow-up|2|||
27736520|NCT02273050|54185420|FG002|Overall Study|Lost to Follow-up|3|||
27736521|NCT02273050|54185418|FG000|Overall Study|Protocol Violation|3|||
27736522|NCT02273050|54185419|FG001|Overall Study|Protocol Violation|1|||
27736523|NCT02273050|54185420|FG002|Overall Study|Protocol Violation|4|||
27736524|NCT02272816|54185428|FG000|Overall Study|Adverse Event|1|||
27736525|NCT02271880|54185434|FG000|Overall Study|Premature discontinuation of study|3|||
27736526|NCT02271880|54185435|FG001|Overall Study|Premature discontinuation of study|4|||
27736527|NCT02367352|54185443|FG000|Overall Study|Progressive disease|7|||
27736528|NCT02367352|54185444|FG001|Overall Study|Progressive disease|0|||
27736529|NCT02367352|54185445|FG002|Overall Study|Progressive disease|0|||
27736530|NCT02367352|54185443|FG000|Overall Study|Participant Received Alternative Therapy|1|||
27736531|NCT02367352|54185444|FG001|Overall Study|Participant Received Alternative Therapy|0|||
27736532|NCT02367352|54185445|FG002|Overall Study|Participant Received Alternative Therapy|0|||
27736533|NCT02367352|54185443|FG000|Overall Study|Adverse Event|1|||
27736534|NCT02367352|54185444|FG001|Overall Study|Adverse Event|0|||
27736535|NCT02367352|54185445|FG002|Overall Study|Adverse Event|0|||
27736536|NCT02365636|54185454|FG000|Overall Study|Adverse Event|3|||
27736537|NCT02365636|54185455|FG001|Overall Study|Adverse Event|3|||
27736538|NCT02365636|54185456|FG002|Overall Study|Adverse Event|2|||
27736539|NCT02365636|54185454|FG000|Overall Study|Protocol Violation|1|||
27736540|NCT02365636|54185455|FG001|Overall Study|Protocol Violation|4|||
27736541|NCT02365636|54185456|FG002|Overall Study|Protocol Violation|0|||
27736542|NCT02365636|54185454|FG000|Overall Study|Lost to Follow-up|0|||
27736543|NCT02365636|54185455|FG001|Overall Study|Lost to Follow-up|0|||
27736544|NCT02365636|54185456|FG002|Overall Study|Lost to Follow-up|1|||
27736545|NCT02365636|54185454|FG000|Overall Study|Other|2|||
27736546|NCT02365636|54185455|FG001|Overall Study|Other|0|||
27833423|NCT01743989|54315998|FG001|Re-treatment Phase|Death|1|||
27833424|NCT01743989|54315999|FG002|Re-treatment Phase|Death|0|||
27833425|NCT01743989|54315997|FG000|Re-treatment Phase|Administrative problems|1|||
27980769|NCT00611455|54638747|FG002|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0|||
27980770|NCT00611455|54638745|FG000|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1|||
28169466|NCT03703466|54840414|FG001|Overall Study|Withdrawal by Subject|3|||
27736547|NCT02365636|54185456|FG002|Overall Study|Other|0|||
27736548|NCT01655498|54185464|FG000|Overall Study|Unrelated health issue|2|||
27736549|NCT01655498|54185464|FG000|Overall Study|Protocol Violation|2|||
27736550|NCT01655498|54185464|FG000|Overall Study|Withdrawal by Subject|1|||
27736551|NCT02270944|54185473|FG000|Overall Study|Lost to Follow-up|9|||
27736552|NCT02270944|54185474|FG001|Overall Study|Lost to Follow-up|4|||
27736553|NCT02270944|54185473|FG000|Overall Study|Withdrawal by Subject|2|||
27736554|NCT02270944|54185474|FG001|Overall Study|Withdrawal by Subject|1|||
27736555|NCT02365558|54185481|FG000|Period 1 (Day 1 Through Day 7)|Adverse Event|1|||
27736556|NCT02365558|54185482|FG001|Period 1 (Day 1 Through Day 7)|Adverse Event|0|||
27736557|NCT02365558|54185481|FG000|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0|||
27833426|NCT01743989|54315998|FG001|Re-treatment Phase|Administrative problems|1|||
27833427|NCT01743989|54315999|FG002|Re-treatment Phase|Administrative problems|0|||
27833428|NCT01743989|54315997|FG000|Re-treatment Phase|Withdrawal by Subject|5|||
27833429|NCT01743989|54315998|FG001|Re-treatment Phase|Withdrawal by Subject|1|||
27833430|NCT01743989|54315999|FG002|Re-treatment Phase|Withdrawal by Subject|0|||
27833431|NCT01743989|54315997|FG000|Re-treatment Phase|Unstable MR|1|||
27833432|NCT01743989|54315998|FG001|Re-treatment Phase|Unstable MR|0|||
27833433|NCT01743989|54315999|FG002|Re-treatment Phase|Unstable MR|0|||
27833434|NCT01743989|54315997|FG000|Re-treatment Phase|Physician Decision|0|||
27833435|NCT01743989|54315998|FG001|Re-treatment Phase|Physician Decision|1|||
27833436|NCT01743989|54315999|FG002|Re-treatment Phase|Physician Decision|0|||
27833437|NCT01743989|54315997|FG000|Re-treatment Phase|Lost to Follow-up|0|||
27833438|NCT01743989|54315998|FG001|Re-treatment Phase|Lost to Follow-up|1|||
27833439|NCT01743989|54315999|FG002|Re-treatment Phase|Lost to Follow-up|0|||
27833440|NCT01605461|54316032|FG000|Overall Study|Lost to Follow-up|3|||
27833441|NCT01605461|54316032|FG000|Overall Study|Withdrawal by Subject|1|||
27833442|NCT01742897|54316036|FG000|Overall Study|Adverse Event|3|||
27833443|NCT01742897|54316036|FG000|Overall Study|Withdrawal by Subject|1|||
27833444|NCT01742897|54316036|FG000|Overall Study|Other|1|||
27833445|NCT01715831|54316040|FG000|Overall Study|Adverse Event|1|||
27833446|NCT01741259|54316046|FG000|Overall Study|Protocol Violation|6|||
27980771|NCT00611455|54638746|FG001|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
27736558|NCT02365558|54185482|FG001|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1|||
27736559|NCT02365480|54185493|FG000|Overall Study|Withdrawal by Subject|2|||
27736560|NCT02365480|54185494|FG001|Overall Study|Withdrawal by Subject|0|||
27736561|NCT02270242|54185502|FG000|Overall Study|Withdrawal by Subject|18|||
27736562|NCT02270242|54185503|FG001|Overall Study|Withdrawal by Subject|25|||
27736563|NCT02270242|54185502|FG000|Overall Study|Lost to Follow-up|41|||
27736564|NCT02270242|54185503|FG001|Overall Study|Lost to Follow-up|27|||
27736565|NCT02270242|54185502|FG000|Overall Study|Physician Decision|0|||
27736566|NCT02270242|54185503|FG001|Overall Study|Physician Decision|1|||
27736567|NCT02364388|54185509|FG000|Overall Study|Protocol Violation|1|||
27736568|NCT02364388|54185509|FG000|Overall Study|Technical Failure|3|||
27736569|NCT02364388|54185509|FG000|Overall Study|No OA/US data|2|||
27736570|NCT02364388|54185509|FG000|Overall Study|No Biopsy|2|||
27736571|NCT02363686|54185513|FG000|Overall Study|Withdrawal by Subject|22|||
27736572|NCT02363686|54185513|FG000|Overall Study|incomplete FEES examinations|13|||
27736573|NCT02268916|54185519|FG000|Overall Study|Lost to Follow-up|1|||
27736574|NCT02268916|54185520|FG001|Overall Study|Lost to Follow-up|1|||
27736575|NCT02268916|54185519|FG000|Overall Study|Withdrawal by Subject|6|||
27736576|NCT02268916|54185520|FG001|Overall Study|Withdrawal by Subject|5|||
27736577|NCT02268916|54185519|FG000|Overall Study|Participant did not have diabetes|1|||
27736578|NCT02268916|54185520|FG001|Overall Study|Participant did not have diabetes|0|||
27736579|NCT02268916|54185519|FG000|Overall Study|Did not complete home monitoring activities after baseline visit|9|||
27736580|NCT02268916|54185520|FG001|Overall Study|Did not complete home monitoring activities after baseline visit|4|||
27736581|NCT02518490|54185527|FG000|Overall Study|Withdrawal by Subject|1|||
27736582|NCT02518490|54185528|FG001|Overall Study|Withdrawal by Subject|1|||
27736583|NCT01364870|54185538|FG000|Overall Study|Withdrawal by Subject|13|||
27736584|NCT01364870|54185539|FG001|Overall Study|Withdrawal by Subject|24|||
27736585|NCT01364870|54185540|FG002|Overall Study|Withdrawal by Subject|10|||
27736586|NCT01364870|54185538|FG000|Overall Study|Adverse Event|8|||
27736587|NCT01364870|54185539|FG001|Overall Study|Adverse Event|6|||
27736588|NCT01364870|54185540|FG002|Overall Study|Adverse Event|4|||
27736589|NCT01364870|54185538|FG000|Overall Study|Protocol Violation|1|||
27736590|NCT01364870|54185539|FG001|Overall Study|Protocol Violation|0|||
27736591|NCT01364870|54185540|FG002|Overall Study|Protocol Violation|0|||
27736592|NCT02268526|54185551|FG000|Overall Study|Adverse Event|0|||
27736593|NCT02268526|54185552|FG001|Overall Study|Adverse Event|2|||
27736594|NCT02268526|54185553|FG002|Overall Study|Adverse Event|1|||
27736595|NCT02268526|54185551|FG000|Overall Study|Death|1|||
27736596|NCT02268526|54185552|FG001|Overall Study|Death|11|||
27736597|NCT02268526|54185553|FG002|Overall Study|Death|0|||
27736598|NCT02268526|54185551|FG000|Overall Study|protocol deviation|0|||
27736599|NCT02268526|54185552|FG001|Overall Study|protocol deviation|1|||
27736600|NCT02268526|54185553|FG002|Overall Study|protocol deviation|0|||
27736601|NCT02268526|54185551|FG000|Overall Study|Physician Decision|0|||
27736602|NCT02268526|54185552|FG001|Overall Study|Physician Decision|0|||
27736603|NCT02268526|54185553|FG002|Overall Study|Physician Decision|1|||
27736604|NCT02268526|54185551|FG000|Overall Study|Subject/guardian decision|0|||
27736605|NCT02268526|54185552|FG001|Overall Study|Subject/guardian decision|7|||
27736606|NCT02268526|54185553|FG002|Overall Study|Subject/guardian decision|3|||
27736607|NCT02268214|54185566|FG000|Overall Study|Subject no longer meets study criteria|0|||
27736608|NCT02268214|54185567|FG001|Overall Study|Subject no longer meets study criteria|2|||
28094244|NCT03129100|54748080|FG021|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
28094245|NCT03129100|54748081|FG022|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
28094246|NCT03129100|54748082|FG023|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
28094247|NCT03129100|54748083|FG024|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
28094248|NCT03129100|54748084|FG025|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
28094249|NCT03129100|54748059|FG000|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
28094250|NCT03129100|54748060|FG001|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
27736609|NCT02268214|54185568|FG002|Overall Study|Subject no longer meets study criteria|0|||
27736610|NCT02268214|54185566|FG000|Overall Study|Pregnancy|2|||
27736611|NCT02268214|54185567|FG001|Overall Study|Pregnancy|2|||
27736612|NCT02268214|54185568|FG002|Overall Study|Pregnancy|1|||
27736613|NCT02268214|54185566|FG000|Overall Study|Lost to Follow-up|3|||
27736614|NCT02268214|54185567|FG001|Overall Study|Lost to Follow-up|3|||
27736615|NCT02268214|54185568|FG002|Overall Study|Lost to Follow-up|4|||
27736616|NCT02268214|54185566|FG000|Overall Study|Lack of Efficacy|1|||
27736617|NCT02268214|54185567|FG001|Overall Study|Lack of Efficacy|0|||
27736618|NCT02268214|54185568|FG002|Overall Study|Lack of Efficacy|2|||
27736619|NCT02268214|54185566|FG000|Overall Study|Adverse Event|11|||
27736620|NCT02268214|54185567|FG001|Overall Study|Adverse Event|14|||
27736621|NCT02268214|54185568|FG002|Overall Study|Adverse Event|9|||
27736622|NCT02268214|54185566|FG000|Overall Study|Withdrawal by Subject|4|||
27736623|NCT02268214|54185567|FG001|Overall Study|Withdrawal by Subject|5|||
28094251|NCT03129100|54748061|FG002|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
28094252|NCT03129100|54748062|FG003|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
28094253|NCT03129100|54748063|FG004|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
27736624|NCT02268214|54185568|FG002|Overall Study|Withdrawal by Subject|10|||
28169467|NCT03703466|54840415|FG002|Overall Study|Withdrawal by Subject|0|||
28169468|NCT03703466|54840413|FG000|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|1|||
27736625|NCT02268214|54185566|FG000|Overall Study|Subject request to discontinue treatment|10|||
27856105|NCT01049009|54384214|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
27856106|NCT01049009|54384213|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
27856107|NCT01049009|54384214|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3|||
27856108|NCT01049009|54384213|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|8|||
27856109|NCT01049009|54384214|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|7|||
27856110|NCT01047683|54384236|FG000|Overall Study|Adverse Event|3|||
27856111|NCT01047683|54384237|FG001|Overall Study|Adverse Event|1|||
27856112|NCT01047683|54384238|FG002|Overall Study|Adverse Event|0|||
27856113|NCT01047683|54384236|FG000|Overall Study|Withdrew Consent|1|||
27856114|NCT01047683|54384237|FG001|Overall Study|Withdrew Consent|4|||
27856115|NCT01047683|54384238|FG002|Overall Study|Withdrew Consent|2|||
27856116|NCT01047683|54384236|FG000|Overall Study|Lost to Follow-up|0|||
27856117|NCT01047683|54384237|FG001|Overall Study|Lost to Follow-up|1|||
27856118|NCT01047683|54384238|FG002|Overall Study|Lost to Follow-up|0|||
27856119|NCT01047683|54384236|FG000|Overall Study|Triglycerides >2000 mg/dL|1|||
27856120|NCT01047683|54384237|FG001|Overall Study|Triglycerides >2000 mg/dL|0|||
27856121|NCT01047683|54384238|FG002|Overall Study|Triglycerides >2000 mg/dL|1|||
27856122|NCT01047293|54384326|FG000|Overall Study|DLT criteria not fulfilled|1|||
27856123|NCT01047293|54384327|FG001|Overall Study|DLT criteria not fulfilled|1|||
27856124|NCT01047293|54384328|FG002|Overall Study|DLT criteria not fulfilled|0|||
27856125|NCT01047293|54384329|FG003|Overall Study|DLT criteria not fulfilled|0|||
27856126|NCT01045967|54384338|FG000|Second Intervention|Protocol Violation|0|||
27856127|NCT01045967|54384339|FG001|Second Intervention|Protocol Violation|1|||
27980772|NCT00611455|54638747|FG002|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
27980773|NCT00611455|54638745|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
27980774|NCT00611455|54638746|FG001|OL Treatment Period (120 Weeks)|Adverse Event|17|||
27980775|NCT00611455|54638747|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
27980776|NCT00611455|54638745|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
27980777|NCT00611455|54638746|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|9|||
27980778|NCT00611455|54638747|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
27980779|NCT00611455|54638745|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
27980780|NCT00611455|54638746|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|3|||
27980781|NCT00611455|54638747|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
27980782|NCT00611455|54638745|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
27980783|NCT00611455|54638746|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12|||
27980784|NCT00611455|54638747|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
27980785|NCT00611455|54638745|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
27980786|NCT00611455|54638746|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110|||
28094254|NCT03129100|54748064|FG005|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
28094255|NCT03129100|54748065|FG006|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
28094256|NCT03129100|54748066|FG007|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
28094257|NCT03129100|54748067|FG008|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
28094258|NCT03129100|54748068|FG009|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
28094259|NCT03129100|54748069|FG010|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
27980787|NCT00611455|54638747|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
27980788|NCT00611455|54638745|FG000|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
27980789|NCT00611455|54638746|FG001|OL Treatment Period (120 Weeks)|Lost to Follow-up|5|||
27980790|NCT00611455|54638747|FG002|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
27980791|NCT00611455|54638745|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
27980792|NCT00611455|54638746|FG001|OL Treatment Period (120 Weeks)|Physician Decision|5|||
27980793|NCT00611455|54638747|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
27980794|NCT00611455|54638745|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
28094260|NCT03129100|54748070|FG011|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
28094261|NCT03129100|54748071|FG012|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
28094262|NCT03129100|54748072|FG013|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
28094263|NCT03129100|54748073|FG014|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
28094264|NCT03129100|54748074|FG015|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
28094265|NCT03129100|54748075|FG016|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
28169469|NCT03703466|54840414|FG001|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|2|||
27736626|NCT02268214|54185567|FG001|Overall Study|Subject request to discontinue treatment|8|||
27856128|NCT01045421|54384925|FG000|Phase 1|Progressive Disease|0|||
27856129|NCT01045421|54384926|FG001|Phase 1|Progressive Disease|0|||
27856130|NCT01045421|54384927|FG002|Phase 1|Progressive Disease|0|||
27856131|NCT01045421|54384928|FG003|Phase 1|Progressive Disease|0|||
27856132|NCT01045421|54384929|FG004|Phase 1|Progressive Disease|1|||
27856133|NCT01045421|54384930|FG005|Phase 1|Progressive Disease|0|||
27856134|NCT01045421|54384931|FG006|Phase 1|Progressive Disease|0|||
27736627|NCT02268214|54185568|FG002|Overall Study|Subject request to discontinue treatment|6|||
27736628|NCT02268214|54185566|FG000|Overall Study|Poor/non-compliance|2|||
27736629|NCT02268214|54185567|FG001|Overall Study|Poor/non-compliance|1|||
27736630|NCT02268214|54185568|FG002|Overall Study|Poor/non-compliance|2|||
27736631|NCT02268214|54185566|FG000|Overall Study|Other reasons|7|||
27736632|NCT02268214|54185567|FG001|Overall Study|Other reasons|3|||
28169470|NCT03703466|54840415|FG002|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|2|||
28169471|NCT03248128|54840474|FG000|Overall Study|Lost to Follow-up|1|||
28169472|NCT03248128|54840475|FG001|Overall Study|Lost to Follow-up|0|||
28169473|NCT03248128|54840474|FG000|Overall Study|Withdrawal by Subject|16|||
28169474|NCT03248128|54840475|FG001|Overall Study|Withdrawal by Subject|14|||
28169475|NCT03248128|54840474|FG000|Overall Study|Site Closed|4|||
28169476|NCT03248128|54840475|FG001|Overall Study|Site Closed|3|||
28169477|NCT03248128|54840474|FG000|Overall Study|Randomized, but did not receive treatment|1|||
28169478|NCT03248128|54840475|FG001|Overall Study|Randomized, but did not receive treatment|3|||
28169479|NCT03193853|54840484|FG000|Overall Study|Death|6|||
28169480|NCT02802631|54840522|FG000|Overall Study|Withdrawal by Subject|1|||
28169481|NCT02802631|54840523|FG001|Overall Study|Withdrawal by Subject|0|||
28169482|NCT02802631|54840524|FG002|Overall Study|Withdrawal by Subject|0|||
28169483|NCT02802631|54840525|FG003|Overall Study|Withdrawal by Subject|0|||
27736633|NCT02268214|54185568|FG002|Overall Study|Other reasons|3|||
28169484|NCT02802631|54840526|FG004|Overall Study|Withdrawal by Subject|0|||
28169485|NCT02802631|54840527|FG005|Overall Study|Withdrawal by Subject|0|||
28169486|NCT02802631|54840528|FG006|Overall Study|Withdrawal by Subject|0|||
28169487|NCT02802631|54840529|FG007|Overall Study|Withdrawal by Subject|0|||
28169488|NCT02802631|54840522|FG000|Overall Study|Physician Decision|1|||
28169489|NCT02802631|54840523|FG001|Overall Study|Physician Decision|0|||
28169490|NCT02802631|54840524|FG002|Overall Study|Physician Decision|0|||
28169491|NCT02802631|54840525|FG003|Overall Study|Physician Decision|0|||
28169492|NCT02802631|54840526|FG004|Overall Study|Physician Decision|0|||
28169493|NCT02802631|54840527|FG005|Overall Study|Physician Decision|0|||
28169494|NCT02802631|54840528|FG006|Overall Study|Physician Decision|1|||
28169495|NCT02802631|54840529|FG007|Overall Study|Physician Decision|0|||
28169496|NCT02802631|54840522|FG000|Overall Study|Adverse Event|0|||
28169497|NCT02802631|54840523|FG001|Overall Study|Adverse Event|2|||
28169498|NCT02802631|54840524|FG002|Overall Study|Adverse Event|0|||
28169499|NCT02802631|54840525|FG003|Overall Study|Adverse Event|1|||
28169500|NCT02802631|54840526|FG004|Overall Study|Adverse Event|6|||
28169501|NCT02802631|54840527|FG005|Overall Study|Adverse Event|1|||
28169502|NCT02802631|54840528|FG006|Overall Study|Adverse Event|4|||
28169503|NCT02802631|54840529|FG007|Overall Study|Adverse Event|0|||
28169504|NCT02802631|54840522|FG000|Overall Study|Sponsor Decision|0|||
28169505|NCT02802631|54840523|FG001|Overall Study|Sponsor Decision|0|||
27736634|NCT02268214|54185566|FG000|Overall Study|Not entering long-term period|2|||
27736635|NCT02268214|54185567|FG001|Overall Study|Not entering long-term period|3|||
27736636|NCT02268214|54185568|FG002|Overall Study|Not entering long-term period|5|||
27736637|NCT02521376|54185580|FG000|Overall Study|Enrolled, But Not Treated|1|||
27980795|NCT00611455|54638746|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18|||
28094266|NCT03129100|54748076|FG017|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
28094267|NCT03129100|54748077|FG018|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
28094268|NCT03129100|54748078|FG019|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
28094269|NCT03129100|54748079|FG020|Period 3 (Dose Escalation)|Withdrawal by Subject|2|||
28094270|NCT03129100|54748080|FG021|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
28094271|NCT03129100|54748081|FG022|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
28094272|NCT03129100|54748082|FG023|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
28094273|NCT03129100|54748083|FG024|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
28094274|NCT03129100|54748084|FG025|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
28094275|NCT03129100|54748059|FG000|Period 3 (Dose Escalation)|Physician Decision|0|||
28094276|NCT03129100|54748060|FG001|Period 3 (Dose Escalation)|Physician Decision|0|||
28169506|NCT02802631|54840524|FG002|Overall Study|Sponsor Decision|6|||
28169507|NCT02802631|54840525|FG003|Overall Study|Sponsor Decision|0|||
28169508|NCT02802631|54840526|FG004|Overall Study|Sponsor Decision|2|||
28169509|NCT02802631|54840527|FG005|Overall Study|Sponsor Decision|0|||
28169510|NCT02802631|54840528|FG006|Overall Study|Sponsor Decision|0|||
28169511|NCT02802631|54840529|FG007|Overall Study|Sponsor Decision|4|||
28169512|NCT02754479|54840561|FG000|Overall Study|Lost to Follow-up|1|||
28169513|NCT02036476|54840574|FG000|Overall Study|Withdrawal by Subject|2|||
28169514|NCT02036476|54840574|FG000|Overall Study|Progressive Disease|4|||
28169515|NCT02036476|54840574|FG000|Overall Study|Unacceptable Toxicity|2|||
28169516|NCT01802632|54840595|FG000|Overall Study|Death|28|||
28169517|NCT01802632|54840596|FG001|Overall Study|Death|1|||
28169518|NCT01802632|54840597|FG002|Overall Study|Death|38|||
28169519|NCT01802632|54840598|FG003|Overall Study|Death|0|||
28169520|NCT01802632|54840599|FG004|Overall Study|Death|2|||
28169521|NCT01802632|54840600|FG005|Overall Study|Death|0|||
27736638|NCT02521376|54185581|FG001|Overall Study|Enrolled, But Not Treated|0|||
27980796|NCT00611455|54638747|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
27736639|NCT02521376|54185582|FG002|Overall Study|Enrolled, But Not Treated|0|||
27736640|NCT02521376|54185583|FG003|Overall Study|Enrolled, But Not Treated|0|||
28169522|NCT01802632|54840595|FG000|Overall Study|Withdrawal by Subject|4|||
28169523|NCT01802632|54840596|FG001|Overall Study|Withdrawal by Subject|2|||
28169524|NCT01802632|54840597|FG002|Overall Study|Withdrawal by Subject|7|||
28169525|NCT01802632|54840598|FG003|Overall Study|Withdrawal by Subject|3|||
28169526|NCT01802632|54840599|FG004|Overall Study|Withdrawal by Subject|0|||
28169527|NCT01802632|54840600|FG005|Overall Study|Withdrawal by Subject|1|||
28169528|NCT01802632|54840595|FG000|Overall Study|Objective Disease Progression|1|||
28169529|NCT01802632|54840596|FG001|Overall Study|Objective Disease Progression|12|||
28169530|NCT01802632|54840597|FG002|Overall Study|Objective Disease Progression|104|||
28169531|NCT01802632|54840598|FG003|Overall Study|Objective Disease Progression|6|||
28169532|NCT01802632|54840599|FG004|Overall Study|Objective Disease Progression|4|||
28169533|NCT01802632|54840600|FG005|Overall Study|Objective Disease Progression|4|||
28169534|NCT01802632|54840595|FG000|Overall Study|Ongoing Study at Data Cut-off|168|||
28169535|NCT01802632|54840596|FG001|Overall Study|Ongoing Study at Data Cut-off|16|||
28169536|NCT01802632|54840597|FG002|Overall Study|Ongoing Study at Data Cut-off|115|||
28169537|NCT01802632|54840598|FG003|Overall Study|Ongoing Study at Data Cut-off|50|||
28169538|NCT01802632|54840599|FG004|Overall Study|Ongoing Study at Data Cut-off|6|||
28169539|NCT01802632|54840600|FG005|Overall Study|Ongoing Study at Data Cut-off|22|||
28169540|NCT01802632|54840595|FG000|Overall Study|Other (not specified)|0|||
28169541|NCT01802632|54840596|FG001|Overall Study|Other (not specified)|0|||
28169542|NCT01802632|54840597|FG002|Overall Study|Other (not specified)|7|||
27736641|NCT02268058|54185605|FG000|Overall Study|Protocol Violation|1|||
27736642|NCT02268058|54185606|FG001|Overall Study|Protocol Violation|0|||
27736643|NCT02268058|54185607|FG002|Overall Study|Protocol Violation|0|||
27736644|NCT02268058|54185608|FG003|Overall Study|Protocol Violation|0|||
27736645|NCT02267824|54185620|FG000|Overall Study|Pregnancy|1|||
27736646|NCT02267824|54185621|FG001|Overall Study|Pregnancy|1|||
27736647|NCT02267824|54185620|FG000|Overall Study|Lost to Follow-up|4|||
28094277|NCT03129100|54748061|FG002|Period 3 (Dose Escalation)|Physician Decision|0|||
28094278|NCT03129100|54748062|FG003|Period 3 (Dose Escalation)|Physician Decision|0|||
28094279|NCT03129100|54748063|FG004|Period 3 (Dose Escalation)|Physician Decision|0|||
28094280|NCT03129100|54748064|FG005|Period 3 (Dose Escalation)|Physician Decision|0|||
28094281|NCT03129100|54748065|FG006|Period 3 (Dose Escalation)|Physician Decision|0|||
28094282|NCT03129100|54748066|FG007|Period 3 (Dose Escalation)|Physician Decision|0|||
28094283|NCT03129100|54748067|FG008|Period 3 (Dose Escalation)|Physician Decision|0|||
28094284|NCT03129100|54748068|FG009|Period 3 (Dose Escalation)|Physician Decision|0|||
28094285|NCT03129100|54748069|FG010|Period 3 (Dose Escalation)|Physician Decision|0|||
28094286|NCT03129100|54748070|FG011|Period 3 (Dose Escalation)|Physician Decision|0|||
28094287|NCT03129100|54748071|FG012|Period 3 (Dose Escalation)|Physician Decision|0|||
28094288|NCT03129100|54748072|FG013|Period 3 (Dose Escalation)|Physician Decision|0|||
28169543|NCT01802632|54840598|FG003|Overall Study|Other (not specified)|1|||
28169544|NCT01802632|54840599|FG004|Overall Study|Other (not specified)|0|||
28169545|NCT01802632|54840600|FG005|Overall Study|Other (not specified)|1|||
28169546|NCT00643994|54840647|FG000|Overall Study|Death|24|||
28169547|NCT00643994|54840647|FG000|Overall Study|Lost to Follow-up|72|||
28169548|NCT00643617|54840653|FG000|Overall Study|Death|6|||
28169549|NCT00643617|54840654|FG001|Overall Study|Death|9|||
28169550|NCT00643617|54840653|FG000|Overall Study|Lost to Follow-up|42|||
28169551|NCT00643617|54840654|FG001|Overall Study|Lost to Follow-up|51|||
28169552|NCT00504582|54840681|FG000|Overall Study|Lost to Follow-up|1|||
28169553|NCT00504582|54840682|FG001|Overall Study|Lost to Follow-up|0|||
28169554|NCT00504582|54840683|FG002|Overall Study|Lost to Follow-up|0|||
28169555|NCT00314366|54840706|FG000|Overall Study|not treated due to patient medical condi|1|||
28094289|NCT03129100|54748073|FG014|Period 3 (Dose Escalation)|Physician Decision|0|||
28094290|NCT03129100|54748074|FG015|Period 3 (Dose Escalation)|Physician Decision|0|||
28094291|NCT03129100|54748075|FG016|Period 3 (Dose Escalation)|Physician Decision|0|||
28094292|NCT03129100|54748076|FG017|Period 3 (Dose Escalation)|Physician Decision|0|||
28169556|NCT00314366|54840707|FG001|Overall Study|not treated due to patient medical condi|0|||
27736648|NCT02267824|54185621|FG001|Overall Study|Lost to Follow-up|0|||
27736649|NCT02267824|54185620|FG000|Overall Study|Protocol Violation|3|||
28094293|NCT03129100|54748077|FG018|Period 3 (Dose Escalation)|Physician Decision|0|||
28094294|NCT03129100|54748078|FG019|Period 3 (Dose Escalation)|Physician Decision|0|||
28169557|NCT01595061|54840716|FG000|Overall Study|Never Treated|3|||
28169558|NCT01595061|54840716|FG000|Overall Study|Inadequate Pathology|1|||
28169559|NCT02852005|54840737|FG000|Overall Study|Lost to Follow-up|0|||
28169560|NCT02852005|54840738|FG001|Overall Study|Lost to Follow-up|0|||
28169561|NCT02852005|54840739|FG002|Overall Study|Lost to Follow-up|0|||
28169562|NCT02852005|54840740|FG003|Overall Study|Lost to Follow-up|0|||
28169563|NCT02852005|54840741|FG004|Overall Study|Lost to Follow-up|1|||
28169564|NCT02852005|54840737|FG000|Overall Study|Withdrawal by Subject|1|||
27736650|NCT02267824|54185621|FG001|Overall Study|Protocol Violation|0|||
27736651|NCT02267824|54185620|FG000|Overall Study|Did Not Meet Initial Dental Criteria|2|||
27833447|NCT01741259|54316047|FG001|Overall Study|Protocol Violation|4|||
27736652|NCT02267824|54185621|FG001|Overall Study|Did Not Meet Initial Dental Criteria|0|||
27736653|NCT02267746|54185630|FG000|Overall Study|Adverse Event|0|||
27736654|NCT02267746|54185631|FG001|Overall Study|Adverse Event|2|||
27736655|NCT02267746|54185632|FG002|Overall Study|Adverse Event|1|||
27736656|NCT02267746|54185630|FG000|Overall Study|Protocol Violation|8|||
27736657|NCT02267746|54185631|FG001|Overall Study|Protocol Violation|7|||
27736658|NCT02267746|54185632|FG002|Overall Study|Protocol Violation|3|||
27736659|NCT02267746|54185630|FG000|Overall Study|Lack of Efficacy|11|||
27736660|NCT02267746|54185631|FG001|Overall Study|Lack of Efficacy|11|||
28169565|NCT02852005|54840738|FG001|Overall Study|Withdrawal by Subject|0|||
28169566|NCT02852005|54840739|FG002|Overall Study|Withdrawal by Subject|0|||
28169567|NCT02852005|54840740|FG003|Overall Study|Withdrawal by Subject|0|||
28169568|NCT02852005|54840741|FG004|Overall Study|Withdrawal by Subject|0|||
28169569|NCT02851615|54840757|FG000|Overall Study|Cognitive Issue|1|||
28169570|NCT02851615|54840758|FG001|Overall Study|Cognitive Issue|0|||
28169571|NCT02851615|54840757|FG000|Overall Study|Lost to Follow-up|0|||
28169572|NCT02851615|54840758|FG001|Overall Study|Lost to Follow-up|4|||
28169573|NCT02849743|54840776|FG000|First Intervention (8 Weeks)|Stopping Criteria Met|0|||
28169574|NCT02849743|54840777|FG001|First Intervention (8 Weeks)|Stopping Criteria Met|1|||
28169575|NCT02849743|54840776|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
28169576|NCT02849743|54840777|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
28169577|NCT02851069|54840812|FG000|Overall Study|Failure to Return|3|||
28169578|NCT02851069|54840812|FG000|Overall Study|Other|3|||
28169579|NCT02849509|54840824|FG000|Overall Study|Worsening of disease under study|1|||
28169580|NCT02849509|54840825|FG001|Overall Study|Worsening of disease under study|1|||
28169581|NCT02849509|54840826|FG002|Overall Study|Worsening of disease under study|1|||
28169582|NCT02849509|54840824|FG000|Overall Study|Worsening of other pre-existing disease|0|||
27736661|NCT02267746|54185632|FG002|Overall Study|Lack of Efficacy|15|||
27736662|NCT02267746|54185630|FG000|Overall Study|Protocol Violation|1|||
27736663|NCT02267746|54185631|FG001|Overall Study|Protocol Violation|2|||
27736664|NCT02267746|54185632|FG002|Overall Study|Protocol Violation|1|||
27736665|NCT02267746|54185630|FG000|Overall Study|Miscellaneous|1|||
27736666|NCT02267746|54185631|FG001|Overall Study|Miscellaneous|0|||
27736667|NCT02267746|54185632|FG002|Overall Study|Miscellaneous|1|||
27736668|NCT02362360|54185642|FG000|Period 1|Lack of Efficacy|1|||
27736669|NCT02362360|54185643|FG001|Period 1|Lack of Efficacy|0|||
27736670|NCT02362360|54185642|FG000|Period 1|Withdrawal by Subject|2|||
27736671|NCT02362360|54185643|FG001|Period 1|Withdrawal by Subject|1|||
27736672|NCT02362282|54185651|FG000|Overall Study|Withdrawal by Subject|1|||
27736673|NCT02362282|54185652|FG001|Overall Study|Withdrawal by Subject|0|||
27736674|NCT02361580|54185660|FG000|Overall Study|Lost to Follow-up|6|||
27736675|NCT02361580|54185661|FG001|Overall Study|Lost to Follow-up|3|||
27736676|NCT02520284|54185670|FG000|Blinded Induction Phase: Up to Week 8|Adverse Event|1|||
27736677|NCT02520284|54185671|FG001|Blinded Induction Phase: Up to Week 8|Adverse Event|3|||
27736678|NCT02520284|54185672|FG002|Blinded Induction Phase: Up to Week 8|Adverse Event|0|||
27736679|NCT02520284|54185670|FG000|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
27736680|NCT02520284|54185671|FG001|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
27736681|NCT02520284|54185672|FG002|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
27736682|NCT02520284|54185670|FG000|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
27736683|NCT02520284|54185671|FG001|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
27736684|NCT02520284|54185672|FG002|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1|||
27736685|NCT02520284|54185670|FG000|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17|||
27736686|NCT02520284|54185671|FG001|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11|||
27736687|NCT02520284|54185672|FG002|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15|||
27736688|NCT02520284|54185670|FG000|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
27736689|NCT02520284|54185671|FG001|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
27736690|NCT02520284|54185672|FG002|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3|||
27736691|NCT02520284|54185670|FG000|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
28094295|NCT03129100|54748079|FG020|Period 3 (Dose Escalation)|Physician Decision|1|||
28094296|NCT03129100|54748080|FG021|Period 3 (Dose Escalation)|Physician Decision|0|||
28094297|NCT03129100|54748081|FG022|Period 3 (Dose Escalation)|Physician Decision|0|||
28094298|NCT03129100|54748082|FG023|Period 3 (Dose Escalation)|Physician Decision|0|||
28094299|NCT03129100|54748083|FG024|Period 3 (Dose Escalation)|Physician Decision|0|||
28094300|NCT03129100|54748084|FG025|Period 3 (Dose Escalation)|Physician Decision|0|||
28169583|NCT02849509|54840825|FG001|Overall Study|Worsening of other pre-existing disease|1|||
28169584|NCT02849509|54840826|FG002|Overall Study|Worsening of other pre-existing disease|2|||
27736692|NCT02520284|54185671|FG001|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
27736693|NCT02520284|54185672|FG002|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0|||
28094301|NCT03129100|54748059|FG000|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
28094302|NCT03129100|54748060|FG001|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
27736694|NCT02520284|54185670|FG000|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
27856135|NCT01045421|54384932|FG007|Phase 1|Progressive Disease|0|||
28169585|NCT02849509|54840824|FG000|Overall Study|Other adverse event|36|||
28169586|NCT02849509|54840825|FG001|Overall Study|Other adverse event|41|||
27736695|NCT02520284|54185671|FG001|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2|||
27736696|NCT02520284|54185672|FG002|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
27736697|NCT02520284|54185670|FG000|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25|||
27736698|NCT02520284|54185671|FG001|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29|||
27736699|NCT02520284|54185672|FG002|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28|||
27736700|NCT02520284|54185670|FG000|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3|||
27736701|NCT02520284|54185671|FG001|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4|||
27736702|NCT02520284|54185672|FG002|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2|||
27736703|NCT02520284|54185670|FG000|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2|||
27736704|NCT02520284|54185671|FG001|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1|||
27736705|NCT02520284|54185672|FG002|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3|||
27736706|NCT02520284|54185670|FG000|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2|||
27736707|NCT02520284|54185671|FG001|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
27736708|NCT02520284|54185672|FG002|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
28094303|NCT03129100|54748061|FG002|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
28094304|NCT03129100|54748062|FG003|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
27736709|NCT02517866|54185686|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
27736710|NCT02517866|54185687|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
27736711|NCT02517866|54185688|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
27736712|NCT02517866|54185686|FG000|Overall Study|Significant Protocol Deviation|4|||
27736713|NCT02517866|54185687|FG001|Overall Study|Significant Protocol Deviation|1|||
27736714|NCT02517866|54185688|FG002|Overall Study|Significant Protocol Deviation|0|||
27736715|NCT02517866|54185686|FG000|Overall Study|Lost to Follow-up|1|||
27736716|NCT02517866|54185687|FG001|Overall Study|Lost to Follow-up|0|||
27736717|NCT02517866|54185688|FG002|Overall Study|Lost to Follow-up|0|||
27736718|NCT02517866|54185686|FG000|Overall Study|Voluntary Withdrawal|2|||
27736719|NCT02517866|54185687|FG001|Overall Study|Voluntary Withdrawal|2|||
27736720|NCT02517866|54185688|FG002|Overall Study|Voluntary Withdrawal|0|||
27736721|NCT02517866|54185686|FG000|Overall Study|Investigator Decision|2|||
27833448|NCT01741259|54316046|FG000|Overall Study|Withdrawal by Subject|0|||
27833449|NCT01741259|54316047|FG001|Overall Study|Withdrawal by Subject|2|||
27833450|NCT01715129|54316053|FG000|Overall Study|Adverse Event, fatal|1|||
27833451|NCT01715129|54316053|FG000|Overall Study|Lack of Efficacy|3|||
27833452|NCT01715129|54316053|FG000|Overall Study|Protocol Violation|1|||
27833453|NCT01715129|54316053|FG000|Overall Study|Consent Withdrawn|2|||
27833454|NCT01715129|54316053|FG000|Overall Study|Lost to Follow-up|1|||
28094305|NCT03129100|54748063|FG004|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
28094306|NCT03129100|54748064|FG005|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
28094307|NCT03129100|54748065|FG006|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
28094308|NCT03129100|54748066|FG007|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
28094309|NCT03129100|54748067|FG008|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
28094310|NCT03129100|54748068|FG009|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
28094311|NCT03129100|54748069|FG010|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
28094312|NCT03129100|54748070|FG011|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
28094313|NCT03129100|54748071|FG012|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
28094314|NCT03129100|54748072|FG013|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
28094315|NCT03129100|54748073|FG014|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
28094316|NCT03129100|54748074|FG015|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
28094317|NCT03129100|54748075|FG016|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
28094318|NCT03129100|54748076|FG017|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
28094319|NCT03129100|54748077|FG018|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
28094320|NCT03129100|54748078|FG019|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
28094321|NCT03129100|54748079|FG020|Period 3 (Dose Escalation)|Lack of Efficacy|1|||
28094322|NCT03129100|54748080|FG021|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
28094323|NCT03129100|54748081|FG022|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
28094324|NCT03129100|54748082|FG023|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
28094325|NCT03129100|54748083|FG024|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
28094326|NCT03129100|54748084|FG025|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
28094327|NCT03129100|54748059|FG000|Period 4 (Post Treatment Follow-up)|Death|0|||
27833455|NCT01715129|54316053|FG000|Overall Study|Other|1|||
27833456|NCT01740791|54316146|FG000|Overall Study|Randomized but never treated|5|||
27833457|NCT01740791|54316147|FG001|Overall Study|Randomized but never treated|3|||
28094328|NCT03129100|54748060|FG001|Period 4 (Post Treatment Follow-up)|Death|0|||
28169587|NCT02849509|54840826|FG002|Overall Study|Other adverse event|8|||
27736722|NCT02517866|54185687|FG001|Overall Study|Investigator Decision|1|||
27736723|NCT02517866|54185688|FG002|Overall Study|Investigator Decision|0|||
27736724|NCT02517866|54185686|FG000|Overall Study|Reason not specified|2|||
27736725|NCT02517866|54185687|FG001|Overall Study|Reason not specified|0|||
27736726|NCT02517866|54185688|FG002|Overall Study|Reason not specified|0|||
27736727|NCT02515994|54185700|FG000|Overall Study|Protocol Violation|3|||
27736728|NCT02515994|54185701|FG001|Overall Study|Protocol Violation|5|||
27736729|NCT02515994|54185700|FG000|Overall Study|No Longer Meets Eligibility Criteria|2|||
27736730|NCT02515994|54185701|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
27736731|NCT02515994|54185700|FG000|Overall Study|Adverse Event|3|||
27736732|NCT02515994|54185701|FG001|Overall Study|Adverse Event|1|||
27736733|NCT02515994|54185700|FG000|Overall Study|Withdrawal by Subject|2|||
27736734|NCT02515994|54185701|FG001|Overall Study|Withdrawal by Subject|0|||
27736735|NCT02516306|54185709|FG000|Period 2: Day 8 - 91|Protocol Violation|1|||
27736736|NCT02516306|54185710|FG001|Period 2: Day 8 - 91|Protocol Violation|2|||
27736737|NCT02516228|54185716|FG000|Overall Study|Lost to Follow-up|1|||
27736738|NCT02516228|54185716|FG000|Overall Study|Withdrawal by Subject|1|||
27736739|NCT02516228|54185716|FG000|Overall Study|Physician Decision|1|||
28169588|NCT02849509|54840824|FG000|Overall Study|Withdrawal by Subject|6|||
28169589|NCT02849509|54840825|FG001|Overall Study|Withdrawal by Subject|17|||
28169590|NCT02849509|54840826|FG002|Overall Study|Withdrawal by Subject|12|||
27736740|NCT02519504|54185722|FG000|Overall Study|Protocol Violation|6|||
27736741|NCT02519504|54185723|FG001|Overall Study|Protocol Violation|5|||
27736742|NCT02519504|54185722|FG000|Overall Study|Ineligible for direct testing|12|||
27736743|NCT02519504|54185723|FG001|Overall Study|Ineligible for direct testing|12|||
27736744|NCT02519504|54185722|FG000|Overall Study|Did not participate in direct testing|95|||
27736745|NCT02519504|54185723|FG001|Overall Study|Did not participate in direct testing|86|||
27736746|NCT02514824|54185731|FG000|Overall Study|Withdrawal by Subject|1|||
27736747|NCT02514824|54185732|FG001|Overall Study|Withdrawal by Subject|0|||
28169591|NCT02849509|54840824|FG000|Overall Study|Lost to Follow-up|27|||
28169592|NCT02849509|54840825|FG001|Overall Study|Lost to Follow-up|67|||
28169593|NCT02849509|54840826|FG002|Overall Study|Lost to Follow-up|36|||
28169594|NCT02849509|54840824|FG000|Overall Study|Other, reason not specified|14|||
27736748|NCT02514824|54185733|FG002|Overall Study|Withdrawal by Subject|0|||
27736749|NCT02514824|54185734|FG003|Overall Study|Withdrawal by Subject|0|||
27736750|NCT02514824|54185731|FG000|Overall Study|Dose-Limiting Toxicity|0|||
27736751|NCT02514824|54185732|FG001|Overall Study|Dose-Limiting Toxicity|1|||
27736752|NCT02514824|54185733|FG002|Overall Study|Dose-Limiting Toxicity|0|||
27736753|NCT02514824|54185734|FG003|Overall Study|Dose-Limiting Toxicity|0|||
27736754|NCT02514746|54185743|FG000|Overall Study|Chronically Ill|1|||
27736755|NCT02514746|54185744|FG001|Overall Study|Chronically Ill|2|||
27736756|NCT02514746|54185743|FG000|Overall Study|Physician Decision|4|||
27736757|NCT02514746|54185744|FG001|Overall Study|Physician Decision|2|||
27736758|NCT02514746|54185743|FG000|Overall Study|Withdrawal by Subject|12|||
27736759|NCT02514746|54185744|FG001|Overall Study|Withdrawal by Subject|10|||
27736760|NCT02514746|54185743|FG000|Overall Study|Other|5|||
27736761|NCT02514746|54185744|FG001|Overall Study|Other|1|||
27736762|NCT02483078|54185754|FG000|Part 1 One-week Randomized|Lost to Follow-up|0|||
27736763|NCT02483078|54185755|FG001|Part 1 One-week Randomized|Lost to Follow-up|1|||
27736764|NCT02483078|54185754|FG000|Part 2 Open Label Treatment Period|Non-medical|0|||
27736765|NCT02483078|54185755|FG001|Part 2 Open Label Treatment Period|Non-medical|1|||
27736766|NCT02483078|54185754|FG000|Part 2 Open Label Treatment Period|Withdrawal by Subject|0|||
27736767|NCT02483078|54185755|FG001|Part 2 Open Label Treatment Period|Withdrawal by Subject|1|||
27736768|NCT02483078|54185754|FG000|Part 2 Open Label Treatment Period|Subject non compliant|0|||
27856136|NCT01045421|54384933|FG008|Phase 1|Progressive Disease|0|||
27856137|NCT01045421|54384934|FG009|Phase 1|Progressive Disease|0|||
27856138|NCT01045421|54384935|FG010|Phase 1|Progressive Disease|0|||
28169595|NCT02849509|54840825|FG001|Overall Study|Other, reason not specified|29|||
28169596|NCT02849509|54840826|FG002|Overall Study|Other, reason not specified|25|||
27736769|NCT02483078|54185755|FG001|Part 2 Open Label Treatment Period|Subject non compliant|1|||
27736770|NCT02483078|54185754|FG000|Part 2 Open Label Treatment Period|Lost to Follow-up|0|||
27736771|NCT02483078|54185755|FG001|Part 2 Open Label Treatment Period|Lost to Follow-up|1|||
27736772|NCT02483078|54185754|FG000|Part 2 Open Label Treatment Period|Adverse Event|0|||
27736773|NCT02483078|54185755|FG001|Part 2 Open Label Treatment Period|Adverse Event|1|||
27736774|NCT02452190|54185769|FG000|Overall Study|Withdrawal by Sponsor|1|||
27736775|NCT02452190|54185770|FG001|Overall Study|Withdrawal by Sponsor|3|||
27736776|NCT02452190|54185769|FG000|Overall Study|Pregnancy|1|||
27736777|NCT02452190|54185770|FG001|Overall Study|Pregnancy|0|||
27736778|NCT02452190|54185769|FG000|Overall Study|Investigator's Decision|2|||
27736779|NCT02452190|54185770|FG001|Overall Study|Investigator's Decision|0|||
27736780|NCT02452190|54185769|FG000|Overall Study|Lack of Efficacy|3|||
27736781|NCT02452190|54185770|FG001|Overall Study|Lack of Efficacy|1|||
27736782|NCT02452190|54185769|FG000|Overall Study|Lost to Follow-up|4|||
27736783|NCT02452190|54185770|FG001|Overall Study|Lost to Follow-up|3|||
27736784|NCT02452190|54185769|FG000|Overall Study|Adverse Event|2|||
27736785|NCT02452190|54185770|FG001|Overall Study|Adverse Event|5|||
27736786|NCT02452190|54185769|FG000|Overall Study|Withdrawal by Subject|20|||
27736787|NCT02452190|54185770|FG001|Overall Study|Withdrawal by Subject|11|||
27736788|NCT02452190|54185769|FG000|Overall Study|Noncompliance with study drug|1|||
27736789|NCT02452190|54185770|FG001|Overall Study|Noncompliance with study drug|0|||
28169597|NCT02849509|54840824|FG000|Overall Study|No inform. on termination of Pradaxa/VKA|6|||
27736790|NCT02452190|54185769|FG000|Overall Study|Participant traveled abroad|1|||
27736791|NCT02452190|54185770|FG001|Overall Study|Participant traveled abroad|0|||
28169598|NCT02849509|54840825|FG001|Overall Study|No inform. on termination of Pradaxa/VKA|10|||
28169599|NCT02849509|54840826|FG002|Overall Study|No inform. on termination of Pradaxa/VKA|1|||
28169600|NCT02853305|54840839|FG000|Overall Study|Death|244|||
28169601|NCT02853305|54840840|FG001|Overall Study|Death|207|||
28169602|NCT02853305|54840841|FG002|Overall Study|Death|263|||
28169603|NCT02853305|54840839|FG000|Overall Study|Withdrawal by Subject|2|||
28169604|NCT02853305|54840840|FG001|Overall Study|Withdrawal by Subject|4|||
28169605|NCT02853305|54840841|FG002|Overall Study|Withdrawal by Subject|2|||
28169606|NCT02853305|54840839|FG000|Overall Study|Ongoing in Trial|105|||
28169607|NCT02853305|54840840|FG001|Overall Study|Ongoing in Trial|96|||
28169608|NCT02853305|54840841|FG002|Overall Study|Ongoing in Trial|87|||
28169609|NCT02848729|54840851|FG000|Overall Study|Withdrawal by Subject|1|||
28169610|NCT02848729|54840852|FG001|Overall Study|Withdrawal by Subject|0|||
28169611|NCT02848729|54840851|FG000|Overall Study|Emesis|15|||
28169612|NCT02848729|54840852|FG001|Overall Study|Emesis|11|||
28169613|NCT00158756|54840870|FG000|Overall Study|Withdrawal by Subject|5|||
28169614|NCT00158756|54840871|FG001|Overall Study|Withdrawal by Subject|0|||
28169615|NCT00158756|54840872|FG002|Overall Study|Withdrawal by Subject|6|||
28169616|NCT00158756|54840873|FG003|Overall Study|Withdrawal by Subject|1|||
28169617|NCT00158756|54840874|FG004|Overall Study|Withdrawal by Subject|3|||
28169618|NCT00158756|54840870|FG000|Overall Study|Adverse Event|0|||
28169619|NCT00158756|54840871|FG001|Overall Study|Adverse Event|0|||
28169620|NCT00158756|54840872|FG002|Overall Study|Adverse Event|1|||
28169621|NCT00158756|54840873|FG003|Overall Study|Adverse Event|0|||
28169622|NCT00158756|54840874|FG004|Overall Study|Adverse Event|0|||
28169623|NCT00158756|54840870|FG000|Overall Study|Serious adverse event|0|||
28169624|NCT00158756|54840871|FG001|Overall Study|Serious adverse event|0|||
28169625|NCT00158756|54840872|FG002|Overall Study|Serious adverse event|1|||
28169626|NCT00158756|54840873|FG003|Overall Study|Serious adverse event|0|||
28169627|NCT00158756|54840874|FG004|Overall Study|Serious adverse event|0|||
28169628|NCT02730195|54840886|FG000|Overall Study|Withdrawal by Subject|1|||
28169629|NCT02730351|54840894|FG000|Treatment Period 1 (2 Weeks)|Adverse Event|1|||
28169630|NCT02730351|54840895|FG001|Treatment Period 1 (2 Weeks)|Adverse Event|0|||
28169631|NCT02730351|54840894|FG000|Wash-out Period (2 Weeks)|Protocol Violation|0|||
28169632|NCT02730351|54840895|FG001|Wash-out Period (2 Weeks)|Protocol Violation|1|||
28169633|NCT02730351|54840894|FG000|Wash-out Period (2 Weeks)|Withdrawal by Subject|1|||
28169634|NCT02730351|54840895|FG001|Wash-out Period (2 Weeks)|Withdrawal by Subject|0|||
27736792|NCT02452190|54185769|FG000|Overall Study|Death|0|||
27736793|NCT02452190|54185770|FG001|Overall Study|Death|1|||
27736794|NCT02514122|54185778|FG000|Overall Study|Withdrawal by Subject|2|||
27736795|NCT02514122|54185779|FG001|Overall Study|Withdrawal by Subject|0|||
27736796|NCT00730639|54185790|FG000|Overall Study|Adverse Event|3|||
27736797|NCT00730639|54185791|FG001|Overall Study|Adverse Event|0|||
27736798|NCT00730639|54185792|FG002|Overall Study|Adverse Event|9|||
27856139|NCT01045421|54384925|FG000|Phase 1|Withdrawal by Subject|0|||
27856140|NCT01045421|54384926|FG001|Phase 1|Withdrawal by Subject|0|||
27856141|NCT01045421|54384927|FG002|Phase 1|Withdrawal by Subject|0|||
27856142|NCT01045421|54384928|FG003|Phase 1|Withdrawal by Subject|1|||
27856143|NCT01045421|54384929|FG004|Phase 1|Withdrawal by Subject|0|||
27856144|NCT01045421|54384930|FG005|Phase 1|Withdrawal by Subject|0|||
27856145|NCT01045421|54384931|FG006|Phase 1|Withdrawal by Subject|0|||
27856146|NCT01045421|54384932|FG007|Phase 1|Withdrawal by Subject|0|||
27856147|NCT01045421|54384933|FG008|Phase 1|Withdrawal by Subject|0|||
27856148|NCT01045421|54384934|FG009|Phase 1|Withdrawal by Subject|0|||
27856149|NCT01045421|54384935|FG010|Phase 1|Withdrawal by Subject|0|||
28169635|NCT02730351|54840894|FG000|Treatment Period 2 (2 Weeks)|Adverse Event|1|||
28169636|NCT02730351|54840895|FG001|Treatment Period 2 (2 Weeks)|Adverse Event|0|||
28169637|NCT02730351|54840894|FG000|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1|||
28169638|NCT02730351|54840895|FG001|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0|||
28169639|NCT01376349|54840904|FG000|Raondomized Treatment|Withdrawal by Subject|10|||
28169640|NCT01376349|54840905|FG001|Raondomized Treatment|Withdrawal by Subject|16|||
28169641|NCT01376349|54840906|FG002|Raondomized Treatment|Withdrawal by Subject|13|||
28169642|NCT01376349|54840904|FG000|Raondomized Treatment|Adverse Event|13|||
28169643|NCT01376349|54840905|FG001|Raondomized Treatment|Adverse Event|17|||
27736799|NCT00730639|54185793|FG003|Overall Study|Adverse Event|8|||
27736800|NCT00730639|54185794|FG004|Overall Study|Adverse Event|23|||
27736801|NCT00730639|54185790|FG000|Overall Study|Complete Response|0|||
27736802|NCT00730639|54185791|FG001|Overall Study|Complete Response|0|||
27736803|NCT00730639|54185792|FG002|Overall Study|Complete Response|2|||
27736804|NCT00730639|54185793|FG003|Overall Study|Complete Response|2|||
27736805|NCT00730639|54185794|FG004|Overall Study|Complete Response|1|||
27736806|NCT00730639|54185790|FG000|Overall Study|Completed Maximum Cycles|0|||
27856150|NCT01045421|54384925|FG000|Phase 2|Progressive Disease|0|||
28169644|NCT01376349|54840906|FG002|Raondomized Treatment|Adverse Event|14|||
28169645|NCT01376349|54840904|FG000|Raondomized Treatment|Unkown|1|||
28169646|NCT01376349|54840905|FG001|Raondomized Treatment|Unkown|2|||
28169647|NCT01376349|54840906|FG002|Raondomized Treatment|Unkown|1|||
28169648|NCT01376349|54840904|FG000|Raondomized Treatment|Alternative Treatment|0|||
28169649|NCT01376349|54840905|FG001|Raondomized Treatment|Alternative Treatment|0|||
28169650|NCT01376349|54840906|FG002|Raondomized Treatment|Alternative Treatment|1|||
28169651|NCT00158600|54840944|FG000|Overall Study|unable to commit time to study|0|||
28169652|NCT00158600|54840945|FG001|Overall Study|unable to commit time to study|1|||
28169653|NCT00158600|54840944|FG000|Overall Study|Adverse Event|2|||
28169654|NCT00158600|54840945|FG001|Overall Study|Adverse Event|1|||
28169655|NCT00158600|54840944|FG000|Overall Study|Death|1|||
28169656|NCT00158600|54840945|FG001|Overall Study|Death|0|||
28169657|NCT00158600|54840944|FG000|Overall Study|Withdrawal by Subject|2|||
28169658|NCT00158600|54840945|FG001|Overall Study|Withdrawal by Subject|2|||
28169659|NCT01680458|54840952|FG000|Overall Study|Protocol Violation|3|||
28169660|NCT04543136|54840956|FG000|Overall Study|Withdrawal by Subject|0|||
27736807|NCT00730639|54185791|FG001|Overall Study|Completed Maximum Cycles|0|||
27736808|NCT00730639|54185792|FG002|Overall Study|Completed Maximum Cycles|11|||
27736809|NCT00730639|54185793|FG003|Overall Study|Completed Maximum Cycles|3|||
27736810|NCT00730639|54185794|FG004|Overall Study|Completed Maximum Cycles|6|||
27736811|NCT00730639|54185790|FG000|Overall Study|Death|0|||
27736812|NCT00730639|54185791|FG001|Overall Study|Death|0|||
27736813|NCT00730639|54185792|FG002|Overall Study|Death|0|||
27736814|NCT00730639|54185793|FG003|Overall Study|Death|0|||
27736815|NCT00730639|54185794|FG004|Overall Study|Death|2|||
27736816|NCT00730639|54185790|FG000|Overall Study|Disease Progression|12|||
27736817|NCT00730639|54185791|FG001|Overall Study|Disease Progression|13|||
28169661|NCT04543136|54840957|FG001|Overall Study|Withdrawal by Subject|1|||
28169662|NCT04543136|54840958|FG002|Overall Study|Withdrawal by Subject|0|||
28169663|NCT04543136|54840959|FG003|Overall Study|Withdrawal by Subject|1|||
28169664|NCT04543136|54840960|FG004|Overall Study|Withdrawal by Subject|0|||
28169665|NCT04543136|54840961|FG005|Overall Study|Withdrawal by Subject|0|||
28169666|NCT00709761|54840969|FG000|Overall Study|Withdrawal by Subject|8|||
28169667|NCT00709761|54840969|FG000|Overall Study|study closed/terminated|17|||
28169668|NCT00709761|54840969|FG000|Overall Study|Lost to Follow-up|2|||
28169669|NCT02358031|54840982|FG000|Overall Study|Death|226|||
28169670|NCT02358031|54840983|FG001|Overall Study|Death|204|||
28169671|NCT02358031|54840984|FG002|Overall Study|Death|249|||
28169672|NCT02358031|54840982|FG000|Overall Study|Lost to Follow-up|0|||
28169673|NCT02358031|54840983|FG001|Overall Study|Lost to Follow-up|1|||
28169674|NCT02358031|54840984|FG002|Overall Study|Lost to Follow-up|1|||
28169675|NCT02358031|54840982|FG000|Overall Study|Withdrawal by Subject|14|||
28169676|NCT02358031|54840983|FG001|Overall Study|Withdrawal by Subject|12|||
28169677|NCT02358031|54840984|FG002|Overall Study|Withdrawal by Subject|17|||
28169678|NCT02358031|54840982|FG000|Overall Study|Ongoing in Study|61|||
28169679|NCT02358031|54840983|FG001|Overall Study|Ongoing in Study|64|||
28169680|NCT02358031|54840984|FG002|Overall Study|Ongoing in Study|33|||
28169681|NCT02848651|54840992|FG000|Overall Study|Death|85|||
28169682|NCT02848651|54840992|FG000|Overall Study|Lost to Follow-up|1|||
28169683|NCT02848651|54840992|FG000|Overall Study|Non-Compliance|1|||
28169684|NCT02848651|54840992|FG000|Overall Study|Symptomatic Deterioration|1|||
28169685|NCT02848651|54840992|FG000|Overall Study|Physician Decision|4|||
28169686|NCT02848651|54840992|FG000|Overall Study|Withdrawal by Subject|14|||
28169687|NCT00709059|54841012|FG000|Overall Study|Lost to Follow-up|34|||
28169688|NCT00709059|54841012|FG000|Overall Study|Withdrawal by Subject|19|||
28169689|NCT00709059|54841012|FG000|Overall Study|Physician Decision|7|||
28169690|NCT00709059|54841012|FG000|Overall Study|Disease complication|3|||
28169691|NCT00709059|54841012|FG000|Overall Study|Side effects|20|||
28169692|NCT00709059|54841012|FG000|Overall Study|Serious side effects|11|||
28169693|NCT01678898|54841019|FG000|PB-102-F01|Adverse Event|0|||
28169694|NCT01678898|54841020|FG001|PB-102-F01|Adverse Event|1|||
27736818|NCT00730639|54185792|FG002|Overall Study|Disease Progression|48|||
27736819|NCT00730639|54185793|FG003|Overall Study|Disease Progression|32|||
27833458|NCT01740791|54316148|FG002|Overall Study|Randomized but never treated|2|||
28169695|NCT01678898|54841021|FG002|PB-102-F01|Adverse Event|0|||
28169696|NCT01678898|54841019|FG000|PB-102-F01|Physician Decision|0|||
28169697|NCT01678898|54841020|FG001|PB-102-F01|Physician Decision|1|||
28169698|NCT01678898|54841021|FG002|PB-102-F01|Physician Decision|0|||
28169699|NCT01678820|54841041|FG000|Overall Study|Study Terminated by Sponsor|45|||
28169700|NCT01678820|54841042|FG001|Overall Study|Study Terminated by Sponsor|43|||
28169701|NCT01678820|54841043|FG002|Overall Study|Study Terminated by Sponsor|43|||
28169702|NCT01678820|54841041|FG000|Overall Study|Withdrawal by Subject|2|||
28169703|NCT01678820|54841042|FG001|Overall Study|Withdrawal by Subject|5|||
27736820|NCT00730639|54185794|FG004|Overall Study|Disease Progression|88|||
27736821|NCT00730639|54185790|FG000|Overall Study|non-specified|0|||
28169704|NCT01678820|54841043|FG002|Overall Study|Withdrawal by Subject|2|||
28169705|NCT01678820|54841041|FG000|Overall Study|Protocol Specified Criteria|2|||
28169706|NCT01678820|54841042|FG001|Overall Study|Protocol Specified Criteria|3|||
27736822|NCT00730639|54185791|FG001|Overall Study|non-specified|0|||
27736823|NCT00730639|54185792|FG002|Overall Study|non-specified|4|||
27736824|NCT00730639|54185793|FG003|Overall Study|non-specified|2|||
27736825|NCT00730639|54185794|FG004|Overall Study|non-specified|3|||
27736826|NCT00730639|54185790|FG000|Overall Study|Protocol Violation|0|||
27736827|NCT00730639|54185791|FG001|Overall Study|Protocol Violation|0|||
27736828|NCT00730639|54185792|FG002|Overall Study|Protocol Violation|1|||
27736829|NCT00730639|54185793|FG003|Overall Study|Protocol Violation|0|||
27736830|NCT00730639|54185794|FG004|Overall Study|Protocol Violation|0|||
27736831|NCT00730639|54185790|FG000|Overall Study|Withdrawal by Subject|0|||
27736832|NCT00730639|54185791|FG001|Overall Study|Withdrawal by Subject|0|||
27736833|NCT00730639|54185792|FG002|Overall Study|Withdrawal by Subject|6|||
27736834|NCT00730639|54185793|FG003|Overall Study|Withdrawal by Subject|3|||
27736835|NCT00730639|54185794|FG004|Overall Study|Withdrawal by Subject|4|||
27736836|NCT00730639|54185790|FG000|Overall Study|Treatment on-going|2|||
27736837|NCT00730639|54185791|FG001|Overall Study|Treatment on-going|5|||
27736838|NCT00730639|54185792|FG002|Overall Study|Treatment on-going|5|||
27736839|NCT00730639|54185793|FG003|Overall Study|Treatment on-going|4|||
27736840|NCT00730639|54185794|FG004|Overall Study|Treatment on-going|4|||
27736841|NCT02536339|54185817|FG000|Overall Study|Death|20|||
27736842|NCT02536339|54185817|FG000|Overall Study|Withdrawal by Subject|3|||
27736843|NCT02536339|54185817|FG000|Overall Study|Lost to Follow-up|2|||
27736844|NCT02536339|54185817|FG000|Overall Study|Treatment discontinued|2|||
27736845|NCT02536339|54185817|FG000|Overall Study|Physician Decision|1|||
27736846|NCT02743871|54185851|FG000|Overall Study|Lost to Follow-up|0|||
27736847|NCT02743871|54185852|FG001|Overall Study|Lost to Follow-up|0|||
27736848|NCT02743871|54185853|FG002|Overall Study|Lost to Follow-up|0|||
27736849|NCT02743871|54185854|FG003|Overall Study|Lost to Follow-up|1|||
27736850|NCT02743871|54185855|FG004|Overall Study|Lost to Follow-up|0|||
27736851|NCT02743871|54185856|FG005|Overall Study|Lost to Follow-up|0|||
27736852|NCT02743871|54185857|FG006|Overall Study|Lost to Follow-up|1|||
27736853|NCT02743871|54185858|FG007|Overall Study|Lost to Follow-up|0|||
27736854|NCT02743871|54185859|FG008|Overall Study|Lost to Follow-up|0|||
27736855|NCT02743871|54185860|FG009|Overall Study|Lost to Follow-up|0|||
27736856|NCT02743871|54185861|FG010|Overall Study|Lost to Follow-up|0|||
27736857|NCT02743871|54185862|FG011|Overall Study|Lost to Follow-up|2|||
27736858|NCT02743871|54185863|FG012|Overall Study|Lost to Follow-up|0|||
27833459|NCT01740791|54316149|FG003|Overall Study|Randomized but never treated|2|||
27833460|NCT01740791|54316150|FG004|Overall Study|Randomized but never treated|1|||
27833461|NCT01740791|54316151|FG005|Overall Study|Randomized but never treated|3|||
27833462|NCT01740791|54316146|FG000|Overall Study|Lost to Follow-up|2|||
27833463|NCT01740791|54316147|FG001|Overall Study|Lost to Follow-up|0|||
27833464|NCT01740791|54316148|FG002|Overall Study|Lost to Follow-up|2|||
27833465|NCT01740791|54316149|FG003|Overall Study|Lost to Follow-up|3|||
27833466|NCT01740791|54316150|FG004|Overall Study|Lost to Follow-up|2|||
27833467|NCT01740791|54316151|FG005|Overall Study|Lost to Follow-up|3|||
27833468|NCT01740791|54316146|FG000|Overall Study|Withdrew Consent|4|||
27833469|NCT01740791|54316147|FG001|Overall Study|Withdrew Consent|0|||
27856151|NCT01045421|54384926|FG001|Phase 2|Progressive Disease|0|||
27856152|NCT01045421|54384927|FG002|Phase 2|Progressive Disease|0|||
28094329|NCT03129100|54748061|FG002|Period 4 (Post Treatment Follow-up)|Death|0|||
28094330|NCT03129100|54748062|FG003|Period 4 (Post Treatment Follow-up)|Death|0|||
28094331|NCT03129100|54748063|FG004|Period 4 (Post Treatment Follow-up)|Death|0|||
28094332|NCT03129100|54748064|FG005|Period 4 (Post Treatment Follow-up)|Death|0|||
28094333|NCT03129100|54748065|FG006|Period 4 (Post Treatment Follow-up)|Death|0|||
28094334|NCT03129100|54748066|FG007|Period 4 (Post Treatment Follow-up)|Death|0|||
28094335|NCT03129100|54748067|FG008|Period 4 (Post Treatment Follow-up)|Death|0|||
28094336|NCT03129100|54748068|FG009|Period 4 (Post Treatment Follow-up)|Death|0|||
28094337|NCT03129100|54748069|FG010|Period 4 (Post Treatment Follow-up)|Death|0|||
28094338|NCT03129100|54748070|FG011|Period 4 (Post Treatment Follow-up)|Death|0|||
28094339|NCT03129100|54748071|FG012|Period 4 (Post Treatment Follow-up)|Death|0|||
28094340|NCT03129100|54748072|FG013|Period 4 (Post Treatment Follow-up)|Death|0|||
28094341|NCT03129100|54748073|FG014|Period 4 (Post Treatment Follow-up)|Death|0|||
28094342|NCT03129100|54748074|FG015|Period 4 (Post Treatment Follow-up)|Death|0|||
28094343|NCT03129100|54748075|FG016|Period 4 (Post Treatment Follow-up)|Death|0|||
28094344|NCT03129100|54748076|FG017|Period 4 (Post Treatment Follow-up)|Death|0|||
28094345|NCT03129100|54748077|FG018|Period 4 (Post Treatment Follow-up)|Death|0|||
28094346|NCT03129100|54748078|FG019|Period 4 (Post Treatment Follow-up)|Death|0|||
27736859|NCT02743871|54185864|FG013|Overall Study|Lost to Follow-up|0|||
27736860|NCT02743871|54185851|FG000|Overall Study|Withdrawal by Subject|0|||
27736861|NCT02743871|54185852|FG001|Overall Study|Withdrawal by Subject|0|||
27736862|NCT02743871|54185853|FG002|Overall Study|Withdrawal by Subject|0|||
27736863|NCT02743871|54185854|FG003|Overall Study|Withdrawal by Subject|0|||
27736864|NCT02743871|54185855|FG004|Overall Study|Withdrawal by Subject|0|||
27736865|NCT02743871|54185856|FG005|Overall Study|Withdrawal by Subject|0|||
27736866|NCT02743871|54185857|FG006|Overall Study|Withdrawal by Subject|0|||
27736867|NCT02743871|54185858|FG007|Overall Study|Withdrawal by Subject|0|||
27736868|NCT02743871|54185859|FG008|Overall Study|Withdrawal by Subject|0|||
27736869|NCT02743871|54185860|FG009|Overall Study|Withdrawal by Subject|0|||
27736870|NCT02743871|54185861|FG010|Overall Study|Withdrawal by Subject|1|||
27736871|NCT02743871|54185862|FG011|Overall Study|Withdrawal by Subject|0|||
27736872|NCT02743871|54185863|FG012|Overall Study|Withdrawal by Subject|12|||
27736873|NCT02743871|54185864|FG013|Overall Study|Withdrawal by Subject|6|||
27980797|NCT00611455|54638745|FG000|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
27980798|NCT00611455|54638746|FG001|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
27980799|NCT00611455|54638747|FG002|Follow-up Period (Approximately 2 Years)|Adverse Event|30|||
28094347|NCT03129100|54748079|FG020|Period 4 (Post Treatment Follow-up)|Death|0|||
28094348|NCT03129100|54748080|FG021|Period 4 (Post Treatment Follow-up)|Death|0|||
28094349|NCT03129100|54748081|FG022|Period 4 (Post Treatment Follow-up)|Death|0|||
28094350|NCT03129100|54748082|FG023|Period 4 (Post Treatment Follow-up)|Death|0|||
28094351|NCT03129100|54748083|FG024|Period 4 (Post Treatment Follow-up)|Death|1|||
28094352|NCT03129100|54748084|FG025|Period 4 (Post Treatment Follow-up)|Death|0|||
28094353|NCT03129100|54748059|FG000|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
28094354|NCT03129100|54748060|FG001|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
28094355|NCT03129100|54748061|FG002|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
28094356|NCT03129100|54748062|FG003|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
28094357|NCT03129100|54748063|FG004|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
28094358|NCT03129100|54748064|FG005|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
28169707|NCT01678820|54841043|FG002|Overall Study|Protocol Specified Criteria|1|||
27980800|NCT00611455|54638745|FG000|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
27980801|NCT00611455|54638746|FG001|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
27980802|NCT00611455|54638747|FG002|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12|||
27980803|NCT00611455|54638745|FG000|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
27980804|NCT00611455|54638746|FG001|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
27980805|NCT00611455|54638747|FG002|Follow-up Period (Approximately 2 Years)|Protocol Violation|4|||
27980806|NCT00611455|54638745|FG000|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
27980807|NCT00611455|54638746|FG001|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
27980808|NCT00611455|54638747|FG002|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23|||
27980809|NCT00611455|54638745|FG000|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
27980810|NCT00611455|54638746|FG001|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
27980811|NCT00611455|54638747|FG002|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80|||
27980812|NCT00611455|54638745|FG000|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
27980813|NCT00611455|54638746|FG001|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
27980814|NCT00611455|54638747|FG002|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13|||
27980815|NCT00611455|54638745|FG000|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
27980816|NCT00611455|54638746|FG001|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
27980817|NCT00611455|54638747|FG002|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49|||
27980818|NCT00952289|54638759|FG000|All Participants|Death|9|||
27980819|NCT00952289|54638760|FG001|All Participants|Death|9|||
27980820|NCT00952289|54638759|FG000|All Participants|Adverse Event|8|||
27980821|NCT00952289|54638760|FG001|All Participants|Adverse Event|8|||
27980822|NCT00952289|54638759|FG000|All Participants|Disease progression|3|||
27980823|NCT00952289|54638760|FG001|All Participants|Disease progression|12|||
27980824|NCT00952289|54638759|FG000|All Participants|Withdrawal by Subject|1|||
27980825|NCT00952289|54638760|FG001|All Participants|Withdrawal by Subject|10|||
27980826|NCT00952289|54638759|FG000|All Participants|Data lost during site relocation|0|||
27980827|NCT00952289|54638760|FG001|All Participants|Data lost during site relocation|1|||
27980828|NCT00952289|54638759|FG000|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0|||
27980829|NCT00952289|54638760|FG001|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19|||
27980830|NCT00952289|54638759|FG000|Patients Who Crossed Over to Ruxolitinib|Disease progression|0|||
27980831|NCT00952289|54638760|FG001|Patients Who Crossed Over to Ruxolitinib|Disease progression|15|||
27980832|NCT00952289|54638759|FG000|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0|||
27980833|NCT00952289|54638760|FG001|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11|||
27980834|NCT00952289|54638759|FG000|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0|||
27980835|NCT00952289|54638760|FG001|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2|||
27980836|NCT00952289|54638759|FG000|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0|||
27980837|NCT00952289|54638760|FG001|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7|||
27980838|NCT00947531|54638768|FG000|Overall Study|Withdrawal by Subject|10|||
27980839|NCT00947531|54638769|FG001|Overall Study|Withdrawal by Subject|7|||
27980840|NCT00947531|54638768|FG000|Overall Study|Administrative Reason|0|||
27980841|NCT00947531|54638769|FG001|Overall Study|Administrative Reason|1|||
28094359|NCT03129100|54748065|FG006|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
28094360|NCT03129100|54748066|FG007|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
28094361|NCT03129100|54748067|FG008|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
27736874|NCT02743871|54185851|FG000|Overall Study|Adverse Event|1|||
27736875|NCT02743871|54185852|FG001|Overall Study|Adverse Event|0|||
27736876|NCT02743871|54185853|FG002|Overall Study|Adverse Event|0|||
27736877|NCT02743871|54185854|FG003|Overall Study|Adverse Event|0|||
27736878|NCT02743871|54185855|FG004|Overall Study|Adverse Event|0|||
27736879|NCT02743871|54185856|FG005|Overall Study|Adverse Event|0|||
27736880|NCT02743871|54185857|FG006|Overall Study|Adverse Event|0|||
27736881|NCT02743871|54185858|FG007|Overall Study|Adverse Event|0|||
27736882|NCT02743871|54185859|FG008|Overall Study|Adverse Event|0|||
27736883|NCT02743871|54185860|FG009|Overall Study|Adverse Event|0|||
27736884|NCT02743871|54185861|FG010|Overall Study|Adverse Event|0|||
27736885|NCT02743871|54185862|FG011|Overall Study|Adverse Event|0|||
27736886|NCT02743871|54185863|FG012|Overall Study|Adverse Event|0|||
27736887|NCT02743871|54185864|FG013|Overall Study|Adverse Event|0|||
27736888|NCT02743871|54185851|FG000|Overall Study|Other|0|||
27736889|NCT02743871|54185852|FG001|Overall Study|Other|0|||
27736890|NCT02743871|54185853|FG002|Overall Study|Other|0|||
27736891|NCT02743871|54185854|FG003|Overall Study|Other|0|||
27736892|NCT02743871|54185855|FG004|Overall Study|Other|0|||
27736893|NCT02743871|54185856|FG005|Overall Study|Other|0|||
27736894|NCT02743871|54185857|FG006|Overall Study|Other|0|||
27736895|NCT02743871|54185858|FG007|Overall Study|Other|0|||
27736896|NCT02743871|54185859|FG008|Overall Study|Other|0|||
27736897|NCT02743871|54185860|FG009|Overall Study|Other|0|||
27736898|NCT02743871|54185861|FG010|Overall Study|Other|0|||
27736899|NCT02743871|54185862|FG011|Overall Study|Other|1|||
27736900|NCT02743871|54185863|FG012|Overall Study|Other|1|||
27736901|NCT02743871|54185864|FG013|Overall Study|Other|1|||
27736902|NCT02743871|54185851|FG000|Overall Study|Protocol Violation|0|||
27736903|NCT02743871|54185852|FG001|Overall Study|Protocol Violation|0|||
27736904|NCT02743871|54185853|FG002|Overall Study|Protocol Violation|0|||
27736905|NCT02743871|54185854|FG003|Overall Study|Protocol Violation|0|||
27736906|NCT02743871|54185855|FG004|Overall Study|Protocol Violation|0|||
27736907|NCT02743871|54185856|FG005|Overall Study|Protocol Violation|0|||
27736908|NCT02743871|54185857|FG006|Overall Study|Protocol Violation|0|||
27736909|NCT02743871|54185858|FG007|Overall Study|Protocol Violation|0|||
27736910|NCT02743871|54185859|FG008|Overall Study|Protocol Violation|0|||
27736911|NCT02743871|54185860|FG009|Overall Study|Protocol Violation|0|||
27736912|NCT02743871|54185861|FG010|Overall Study|Protocol Violation|0|||
27736913|NCT02743871|54185862|FG011|Overall Study|Protocol Violation|0|||
27736914|NCT02743871|54185863|FG012|Overall Study|Protocol Violation|2|||
27736915|NCT02743871|54185864|FG013|Overall Study|Protocol Violation|0|||
27736916|NCT01704547|54185906|FG000|Overall Study|Physician Decision|4|||
27736917|NCT01704547|54185906|FG000|Overall Study|Withdrawal by Subject|1|||
27736918|NCT00796523|54185926|FG000|Overall Study|Lost to Follow-up|9|||
27736919|NCT00796523|54185927|FG001|Overall Study|Lost to Follow-up|7|||
27736920|NCT01352585|54185942|FG000|Overall Study|Adverse Event|2|||
27736921|NCT01352585|54185943|FG001|Overall Study|Adverse Event|1|||
27736922|NCT01352585|54185942|FG000|Overall Study|Lost to Follow-up|1|||
27736923|NCT01352585|54185943|FG001|Overall Study|Lost to Follow-up|0|||
27736924|NCT01352585|54185942|FG000|Overall Study|Other|5|||
27736925|NCT01352585|54185943|FG001|Overall Study|Other|2|||
27736926|NCT01352507|54185952|FG000|Treatment Period 1|Adverse Event|3|||
27736927|NCT01352507|54185953|FG001|Treatment Period 1|Adverse Event|0|||
27736928|NCT01352507|54185952|FG000|Treatment Period 1|Lost to Follow-up|3|||
27736929|NCT01352507|54185953|FG001|Treatment Period 1|Lost to Follow-up|4|||
27736930|NCT01352507|54185952|FG000|Treatment Period 1|Withdrawal by Subject|7|||
27736931|NCT01352507|54185953|FG001|Treatment Period 1|Withdrawal by Subject|5|||
27736932|NCT01352507|54185952|FG000|Treatment Period 1|Physician Decision|1|||
27736933|NCT01352507|54185953|FG001|Treatment Period 1|Physician Decision|0|||
27736934|NCT01352507|54185952|FG000|Washout Period|Withdrawal by Subject|0|||
27736935|NCT01352507|54185953|FG001|Washout Period|Withdrawal by Subject|1|||
27736936|NCT01352507|54185952|FG000|Treatment Period 2|Entry Criteria Not Met|1|||
27736937|NCT01352507|54185953|FG001|Treatment Period 2|Entry Criteria Not Met|0|||
27736938|NCT01352507|54185952|FG000|Treatment Period 2|Withdrawal by Subject|4|||
27736939|NCT01352507|54185953|FG001|Treatment Period 2|Withdrawal by Subject|3|||
27736940|NCT01352507|54185952|FG000|Treatment Period 2|Lack of Efficacy|1|||
27736941|NCT01352507|54185953|FG001|Treatment Period 2|Lack of Efficacy|0|||
27736942|NCT02361346|54185974|FG000|Part 1 and 2 ( Up to Day 112)|Death|0|||
27736943|NCT02361346|54185975|FG001|Part 1 and 2 ( Up to Day 112)|Death|0|||
27736944|NCT02361346|54185976|FG002|Part 1 and 2 ( Up to Day 112)|Death|0|||
27736945|NCT02361346|54185977|FG003|Part 1 and 2 ( Up to Day 112)|Death|1|||
28169708|NCT01678820|54841041|FG000|Overall Study|Adverse Event|2|||
27736946|NCT02361346|54185978|FG004|Part 1 and 2 ( Up to Day 112)|Death|0|||
27736947|NCT02361346|54185979|FG005|Part 1 and 2 ( Up to Day 112)|Death|0|||
27736948|NCT02361346|54185980|FG006|Part 1 and 2 ( Up to Day 112)|Death|0|||
27736949|NCT02361346|54185981|FG007|Part 1 and 2 ( Up to Day 112)|Death|0|||
27736950|NCT02361346|54185982|FG008|Part 1 and 2 ( Up to Day 112)|Death|0|||
27736951|NCT02361346|54185974|FG000|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
27736952|NCT02361346|54185975|FG001|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
27736953|NCT02361346|54185976|FG002|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
27736954|NCT02361346|54185977|FG003|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
27736955|NCT02361346|54185978|FG004|Part 1 and 2 ( Up to Day 112)|Adverse Event|2|||
27736956|NCT02361346|54185979|FG005|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
27736957|NCT02361346|54185980|FG006|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
27736958|NCT02361346|54185981|FG007|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
27736959|NCT02361346|54185982|FG008|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
27736960|NCT02361346|54185974|FG000|Part 3 (Up to Day 112)|Adverse Event|0|||
27736961|NCT02361346|54185975|FG001|Part 3 (Up to Day 112)|Adverse Event|0|||
27736962|NCT02361346|54185976|FG002|Part 3 (Up to Day 112)|Adverse Event|0|||
27736963|NCT02361346|54185977|FG003|Part 3 (Up to Day 112)|Adverse Event|0|||
27736964|NCT02361346|54185978|FG004|Part 3 (Up to Day 112)|Adverse Event|0|||
27736965|NCT02361346|54185979|FG005|Part 3 (Up to Day 112)|Adverse Event|0|||
27736966|NCT02361346|54185980|FG006|Part 3 (Up to Day 112)|Adverse Event|0|||
27736967|NCT02361346|54185981|FG007|Part 3 (Up to Day 112)|Adverse Event|1|||
27736968|NCT02361346|54185982|FG008|Part 3 (Up to Day 112)|Adverse Event|0|||
27736969|NCT02361346|54185974|FG000|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
28094362|NCT03129100|54748068|FG009|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
28094363|NCT03129100|54748069|FG010|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
28094364|NCT03129100|54748070|FG011|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
28094365|NCT03129100|54748071|FG012|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
28094366|NCT03129100|54748072|FG013|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
28169709|NCT01678820|54841042|FG001|Overall Study|Adverse Event|2|||
28169710|NCT01678820|54841043|FG002|Overall Study|Adverse Event|2|||
28169711|NCT01678820|54841041|FG000|Overall Study|Lost to Follow-up|7|||
28169712|NCT01678820|54841042|FG001|Overall Study|Lost to Follow-up|2|||
28169713|NCT01678820|54841043|FG002|Overall Study|Lost to Follow-up|2|||
28169714|NCT01678820|54841041|FG000|Overall Study|Non-compliance with study drug|0|||
28169715|NCT01678820|54841042|FG001|Overall Study|Non-compliance with study drug|1|||
28169716|NCT01678820|54841043|FG002|Overall Study|Non-compliance with study drug|0|||
28169717|NCT01678820|54841041|FG000|Overall Study|Physician Decision|0|||
28169718|NCT01678820|54841042|FG001|Overall Study|Physician Decision|0|||
28169719|NCT01678820|54841043|FG002|Overall Study|Physician Decision|1|||
28169720|NCT01678820|54841041|FG000|Overall Study|Protocol Violation|4|||
28169721|NCT01678820|54841042|FG001|Overall Study|Protocol Violation|5|||
28169722|NCT01678820|54841043|FG002|Overall Study|Protocol Violation|4|||
28169723|NCT01678820|54841041|FG000|Overall Study|Not treated with double-blind study drug|0|||
28169724|NCT01678820|54841042|FG001|Overall Study|Not treated with double-blind study drug|2|||
28169725|NCT01678820|54841043|FG002|Overall Study|Not treated with double-blind study drug|2|||
28169726|NCT02660138|54841055|FG000|Overall Study|Adverse Event|0|||
28169727|NCT02660138|54841056|FG001|Overall Study|Adverse Event|3|||
28169728|NCT02660138|54841057|FG002|Overall Study|Adverse Event|2|||
28169729|NCT02660138|54841055|FG000|Overall Study|Lack of Efficacy|1|||
28169730|NCT02660138|54841056|FG001|Overall Study|Lack of Efficacy|2|||
28169731|NCT02660138|54841057|FG002|Overall Study|Lack of Efficacy|1|||
28169732|NCT02660138|54841055|FG000|Overall Study|Withdrawal by Subject|7|||
28169733|NCT02660138|54841056|FG001|Overall Study|Withdrawal by Subject|6|||
28169734|NCT02660138|54841057|FG002|Overall Study|Withdrawal by Subject|6|||
28169735|NCT02660138|54841055|FG000|Overall Study|Lost to Follow-up|4|||
28169736|NCT02660138|54841056|FG001|Overall Study|Lost to Follow-up|4|||
28169737|NCT02660138|54841057|FG002|Overall Study|Lost to Follow-up|1|||
28169738|NCT02660138|54841055|FG000|Overall Study|Sponsor Decision to Terminate Study|57|||
28169739|NCT02660138|54841056|FG001|Overall Study|Sponsor Decision to Terminate Study|57|||
28169740|NCT02660138|54841057|FG002|Overall Study|Sponsor Decision to Terminate Study|62|||
28169741|NCT02660138|54841055|FG000|Overall Study|Other|1|||
28169742|NCT02660138|54841056|FG001|Overall Study|Other|1|||
28169743|NCT02660138|54841057|FG002|Overall Study|Other|0|||
28169744|NCT02660138|54841055|FG000|Overall Study|Not treated|0|||
28094367|NCT03129100|54748073|FG014|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
28094368|NCT03129100|54748074|FG015|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
28094369|NCT03129100|54748075|FG016|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
28094370|NCT03129100|54748076|FG017|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
28094371|NCT03129100|54748077|FG018|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
28169745|NCT02660138|54841056|FG001|Overall Study|Not treated|1|||
28169746|NCT02660138|54841057|FG002|Overall Study|Not treated|0|||
28169747|NCT01603394|54841068|FG000|Overall Study|Adverse Event|1|||
28169748|NCT02729025|54841074|FG000|Overall Study|Sponsor Decision|0|||
28169749|NCT02729025|54841075|FG001|Overall Study|Sponsor Decision|1|||
28169750|NCT01603082|54841083|FG000|Overall Study|Adverse Event|0|||
28169751|NCT01603082|54841084|FG001|Overall Study|Adverse Event|1|||
28169752|NCT01603082|54841083|FG000|Overall Study|Withdrawal by Subject|1|||
27736970|NCT02361346|54185975|FG001|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
27736971|NCT02361346|54185976|FG002|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
28169753|NCT01603082|54841084|FG001|Overall Study|Withdrawal by Subject|0|||
28169754|NCT01603082|54841083|FG000|Overall Study|Failed inclusion criterion after dosed|1|||
27736972|NCT02361346|54185977|FG003|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
28169755|NCT01603082|54841084|FG001|Overall Study|Failed inclusion criterion after dosed|0|||
28169756|NCT02499835|54841094|FG000|Overall Study|Withdrawal by Subject|1|||
28169757|NCT02499835|54841095|FG001|Overall Study|Withdrawal by Subject|0|||
28169758|NCT02499835|54841096|FG002|Overall Study|Withdrawal by Subject|0|||
28169759|NCT02499835|54841097|FG003|Overall Study|Withdrawal by Subject|1|||
28169760|NCT02499835|54841094|FG000|Overall Study|Physician Decision|0|||
28169761|NCT02499835|54841095|FG001|Overall Study|Physician Decision|3|||
28169762|NCT02499835|54841096|FG002|Overall Study|Physician Decision|18|||
28169763|NCT02499835|54841097|FG003|Overall Study|Physician Decision|7|||
28169764|NCT02499835|54841094|FG000|Overall Study|Adverse Event|0|||
28169765|NCT02499835|54841095|FG001|Overall Study|Adverse Event|0|||
28169766|NCT02499835|54841096|FG002|Overall Study|Adverse Event|0|||
28169767|NCT02499835|54841097|FG003|Overall Study|Adverse Event|1|||
28169768|NCT02499835|54841094|FG000|Overall Study|Disease progression|2|||
28169769|NCT02499835|54841095|FG001|Overall Study|Disease progression|1|||
28169770|NCT02499835|54841096|FG002|Overall Study|Disease progression|0|||
28169771|NCT02499835|54841097|FG003|Overall Study|Disease progression|7|||
28169772|NCT02846779|54841116|FG000|Overall Study|Lost Enrollment|83|||
28169773|NCT02846779|54841117|FG001|Overall Study|Lost Enrollment|82|||
28169774|NCT02846779|54841118|FG002|Overall Study|Lost Enrollment|86|||
28169775|NCT02846779|54841116|FG000|Overall Study|Less than 31 days of follow-up|56|||
28169776|NCT02846779|54841117|FG001|Overall Study|Less than 31 days of follow-up|45|||
28169777|NCT02846779|54841118|FG002|Overall Study|Less than 31 days of follow-up|52|||
28169778|NCT00406393|54841128|FG000|Overall Study|Did not undergo transplantation|2|||
28169779|NCT00406393|54841129|FG001|Overall Study|Did not undergo transplantation|1|||
28169780|NCT02845375|54841138|FG000|Overall Study|upper airway obstruction|1|||
28169781|NCT02845375|54841139|FG001|Overall Study|upper airway obstruction|2|||
28169782|NCT02845375|54841140|FG002|Overall Study|upper airway obstruction|1|||
28169783|NCT02658734|54841148|FG000|Overall Study|Adverse Event|2|||
28169784|NCT02658734|54841148|FG000|Overall Study|Death|4|||
28169785|NCT02658734|54841148|FG000|Overall Study|Lost to Follow-up|7|||
28169786|NCT02658734|54841148|FG000|Overall Study|Withdrawal of Consent|16|||
28169787|NCT02658734|54841148|FG000|Overall Study|Disease Progression|28|||
28169788|NCT02844439|54841152|FG000|Overall Study|Withdrawal by Subject|1|||
28169789|NCT02844439|54841152|FG000|Overall Study|Lost to Follow-up|2|||
28169790|NCT02844439|54841152|FG000|Overall Study|Termination by Sponsor|4|||
28169791|NCT02844439|54841152|FG000|Overall Study|Death|28|||
28169792|NCT02844439|54841152|FG000|Overall Study|Other|5|||
28169793|NCT01677182|54841166|FG000|Overall Study|Adverse Event|2|||
28169794|NCT01677182|54841167|FG001|Overall Study|Adverse Event|1|||
28169795|NCT01677182|54841168|FG002|Overall Study|Adverse Event|8|||
28169796|NCT01677182|54841166|FG000|Overall Study|Protocol Violation|5|||
28169797|NCT01677182|54841167|FG001|Overall Study|Protocol Violation|1|||
28169798|NCT01677182|54841168|FG002|Overall Study|Protocol Violation|4|||
28169799|NCT01677182|54841166|FG000|Overall Study|Lost to Follow-up|4|||
27736973|NCT02361346|54185978|FG004|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
27736974|NCT02361346|54185979|FG005|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
27736975|NCT02361346|54185980|FG006|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
28094372|NCT03129100|54748078|FG019|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
28094373|NCT03129100|54748079|FG020|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
28094374|NCT03129100|54748080|FG021|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
28094375|NCT03129100|54748081|FG022|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
28094376|NCT03129100|54748082|FG023|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
28094377|NCT03129100|54748083|FG024|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
28094378|NCT03129100|54748084|FG025|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
28094379|NCT03129100|54748059|FG000|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
28094380|NCT03129100|54748060|FG001|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
28094381|NCT03129100|54748061|FG002|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
28094382|NCT03129100|54748062|FG003|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
28094383|NCT03129100|54748063|FG004|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
28094384|NCT03129100|54748064|FG005|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
28094385|NCT03129100|54748065|FG006|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
28094386|NCT03129100|54748066|FG007|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
28094387|NCT03129100|54748067|FG008|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
28094388|NCT03129100|54748068|FG009|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
28094389|NCT03129100|54748069|FG010|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
28094390|NCT03129100|54748070|FG011|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
28169800|NCT01677182|54841167|FG001|Overall Study|Lost to Follow-up|0|||
28169801|NCT01677182|54841168|FG002|Overall Study|Lost to Follow-up|3|||
28169802|NCT01677182|54841166|FG000|Overall Study|Withdrawal by Subject|7|||
28169803|NCT01677182|54841167|FG001|Overall Study|Withdrawal by Subject|12|||
28169804|NCT01677182|54841168|FG002|Overall Study|Withdrawal by Subject|10|||
28169805|NCT01677182|54841166|FG000|Overall Study|Study termination|12|||
28169806|NCT01677182|54841167|FG001|Overall Study|Study termination|9|||
27736976|NCT02361346|54185981|FG007|Part 3 (Up to Day 112)|Withdrawal by Subject|1|||
27736977|NCT02361346|54185982|FG008|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
27736978|NCT02361346|54185974|FG000|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
27736979|NCT02361346|54185975|FG001|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
27736980|NCT02361346|54185976|FG002|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
27736981|NCT02361346|54185977|FG003|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
27736982|NCT02361346|54185978|FG004|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
27736983|NCT02361346|54185979|FG005|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
27736984|NCT02361346|54185980|FG006|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
27736985|NCT02361346|54185981|FG007|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|7|||
27736986|NCT02361346|54185982|FG008|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
27736987|NCT02361346|54185974|FG000|Part 3 (Up to Day 112)|Clinical disease progression|0|||
27736988|NCT02361346|54185975|FG001|Part 3 (Up to Day 112)|Clinical disease progression|0|||
27856153|NCT01045421|54384928|FG003|Phase 2|Progressive Disease|0|||
27856154|NCT01045421|54384929|FG004|Phase 2|Progressive Disease|0|||
28094391|NCT03129100|54748071|FG012|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
28094392|NCT03129100|54748072|FG013|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
28094393|NCT03129100|54748073|FG014|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
28094394|NCT03129100|54748074|FG015|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
28094395|NCT03129100|54748075|FG016|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
28094396|NCT03129100|54748076|FG017|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
28094397|NCT03129100|54748077|FG018|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
28094398|NCT03129100|54748078|FG019|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
28094399|NCT03129100|54748079|FG020|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
28094400|NCT03129100|54748080|FG021|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
28094401|NCT03129100|54748081|FG022|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
28094402|NCT03129100|54748082|FG023|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|3|||
28094403|NCT03129100|54748083|FG024|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|20|||
28094404|NCT03129100|54748084|FG025|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|37|||
28094405|NCT03129100|54748059|FG000|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
28094406|NCT03129100|54748060|FG001|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
28094407|NCT03129100|54748061|FG002|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
28094408|NCT03129100|54748062|FG003|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
28094409|NCT03129100|54748063|FG004|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
28094410|NCT03129100|54748064|FG005|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
28094411|NCT03129100|54748065|FG006|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
28094412|NCT03129100|54748066|FG007|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
28094413|NCT03129100|54748067|FG008|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
28094414|NCT03129100|54748068|FG009|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
28094415|NCT03129100|54748069|FG010|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
28094416|NCT03129100|54748070|FG011|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
28094417|NCT03129100|54748071|FG012|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
28094418|NCT03129100|54748072|FG013|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
28094419|NCT03129100|54748073|FG014|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
28094420|NCT03129100|54748074|FG015|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
28094421|NCT03129100|54748075|FG016|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
28094422|NCT03129100|54748076|FG017|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
28094423|NCT03129100|54748077|FG018|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
28094424|NCT03129100|54748078|FG019|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
28094425|NCT03129100|54748079|FG020|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
28094426|NCT03129100|54748080|FG021|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
28094427|NCT03129100|54748081|FG022|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
27736989|NCT02361346|54185976|FG002|Part 3 (Up to Day 112)|Clinical disease progression|0|||
27833470|NCT01740791|54316148|FG002|Overall Study|Withdrew Consent|1|||
27833471|NCT01740791|54316149|FG003|Overall Study|Withdrew Consent|2|||
27833472|NCT01740791|54316150|FG004|Overall Study|Withdrew Consent|0|||
27833473|NCT01740791|54316151|FG005|Overall Study|Withdrew Consent|3|||
27833474|NCT01740791|54316146|FG000|Overall Study|Investigator's discretion|1|||
27833475|NCT01740791|54316147|FG001|Overall Study|Investigator's discretion|0|||
27833476|NCT01740791|54316148|FG002|Overall Study|Investigator's discretion|1|||
27833477|NCT01740791|54316149|FG003|Overall Study|Investigator's discretion|0|||
27833478|NCT01740791|54316150|FG004|Overall Study|Investigator's discretion|0|||
27833479|NCT01740791|54316151|FG005|Overall Study|Investigator's discretion|1|||
27833480|NCT01740791|54316146|FG000|Overall Study|Adverse Event|0|||
27833481|NCT01740791|54316147|FG001|Overall Study|Adverse Event|0|||
27833482|NCT01740791|54316148|FG002|Overall Study|Adverse Event|0|||
27833483|NCT01740791|54316149|FG003|Overall Study|Adverse Event|0|||
27736990|NCT02361346|54185977|FG003|Part 3 (Up to Day 112)|Clinical disease progression|0|||
27736991|NCT02361346|54185978|FG004|Part 3 (Up to Day 112)|Clinical disease progression|0|||
27736992|NCT02361346|54185979|FG005|Part 3 (Up to Day 112)|Clinical disease progression|0|||
27736993|NCT02361346|54185980|FG006|Part 3 (Up to Day 112)|Clinical disease progression|0|||
27736994|NCT02361346|54185981|FG007|Part 3 (Up to Day 112)|Clinical disease progression|2|||
27736995|NCT02361346|54185982|FG008|Part 3 (Up to Day 112)|Clinical disease progression|0|||
27736996|NCT02267278|54186024|FG000|Overall Study|Proceeded to transplantation (allo-HCT)|1|||
27736997|NCT02267278|54186024|FG000|Overall Study|transformation to acute leukemia (AML)|1|||
27736998|NCT02267278|54186024|FG000|Overall Study|Developed new cancer diagnoses|2|||
27736999|NCT02267278|54186024|FG000|Overall Study|prescribed prohibited medication|1|||
27737000|NCT02360098|54186030|FG000|Overall Study|Physician Decision|7|||
28169807|NCT01677182|54841168|FG002|Overall Study|Study termination|11|||
28169808|NCT01677182|54841166|FG000|Overall Study|Lack of Efficacy|3|||
28169809|NCT01677182|54841167|FG001|Overall Study|Lack of Efficacy|0|||
28169810|NCT01677182|54841168|FG002|Overall Study|Lack of Efficacy|1|||
28169811|NCT01677182|54841166|FG000|Overall Study|Other reasons|1|||
28169812|NCT01677182|54841167|FG001|Overall Study|Other reasons|5|||
28169813|NCT01677182|54841168|FG002|Overall Study|Other reasons|2|||
28169814|NCT02843659|54841179|FG000|Overall Study|Subject Withdrew Consent|0|||
28169815|NCT02843659|54841180|FG001|Overall Study|Subject Withdrew Consent|0|||
28169816|NCT02843659|54841181|FG002|Overall Study|Subject Withdrew Consent|1|||
28169817|NCT02843659|54841179|FG000|Overall Study|Administrative Reason by Sponsor|4|||
28169818|NCT02843659|54841180|FG001|Overall Study|Administrative Reason by Sponsor|5|||
28169819|NCT02843659|54841181|FG002|Overall Study|Administrative Reason by Sponsor|4|||
28169820|NCT02843659|54841179|FG000|Overall Study|Adverse Event|0|||
28169821|NCT02843659|54841180|FG001|Overall Study|Adverse Event|1|||
28169822|NCT02843659|54841181|FG002|Overall Study|Adverse Event|0|||
28169823|NCT00708435|54841191|FG000|Overall Study|Death / Serious Adverse Event|10|||
28169824|NCT00708435|54841192|FG001|Overall Study|Death / Serious Adverse Event|5|||
28169825|NCT00708435|54841191|FG000|Overall Study|Lost to Follow-up|9|||
28169826|NCT00708435|54841192|FG001|Overall Study|Lost to Follow-up|4|||
28169827|NCT00708435|54841191|FG000|Overall Study|Withdrawal by Subject|3|||
28169828|NCT00708435|54841192|FG001|Overall Study|Withdrawal by Subject|7|||
28169829|NCT00708435|54841191|FG000|Overall Study|Adverse Event|1|||
28169830|NCT00708435|54841192|FG001|Overall Study|Adverse Event|0|||
28169831|NCT00708435|54841191|FG000|Overall Study|Protocol Violation|0|||
28169832|NCT00708435|54841192|FG001|Overall Study|Protocol Violation|1|||
28169833|NCT00708435|54841191|FG000|Overall Study|Intervention by primary care physician|1|||
27737001|NCT02266888|54186041|FG000|Overall Study|Death|2|||
27737002|NCT02266888|54186042|FG001|Overall Study|Death|2|||
27833484|NCT01740791|54316150|FG004|Overall Study|Adverse Event|0|||
27833485|NCT01740791|54316151|FG005|Overall Study|Adverse Event|1|||
27833486|NCT01740323|54316208|FG000|Overall Study|Adverse Event|1|||
27833487|NCT01740323|54316209|FG001|Overall Study|Adverse Event|0|||
27833488|NCT01740323|54316208|FG000|Overall Study|Randomized but did not take study drug|1|||
27833489|NCT01740323|54316209|FG001|Overall Study|Randomized but did not take study drug|0|||
27833490|NCT01740089|54316227|FG000|First 12 Weeks of Treatment|Adverse Event|0|||
27833491|NCT01740089|54316228|FG001|First 12 Weeks of Treatment|Adverse Event|1|||
27833492|NCT01740089|54316229|FG002|First 12 Weeks of Treatment|Adverse Event|2|||
27833493|NCT01740089|54316227|FG000|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
27833494|NCT01740089|54316228|FG001|First 12 Weeks of Treatment|Withdrawal by Subject|1|||
27833495|NCT01740089|54316229|FG002|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
27856155|NCT01045421|54384930|FG005|Phase 2|Progressive Disease|0|||
27856156|NCT01045421|54384931|FG006|Phase 2|Progressive Disease|0|||
27856157|NCT01045421|54384932|FG007|Phase 2|Progressive Disease|1|||
27856158|NCT01045421|54384933|FG008|Phase 2|Progressive Disease|1|||
27856159|NCT01045421|54384934|FG009|Phase 2|Progressive Disease|1|||
27980842|NCT00947531|54638768|FG000|Overall Study|Adverse Event|2|||
27980843|NCT00947531|54638769|FG001|Overall Study|Adverse Event|2|||
28169834|NCT00708435|54841192|FG001|Overall Study|Intervention by primary care physician|0|||
28169835|NCT00708435|54841191|FG000|Overall Study|Refused hospitalization|1|||
27737003|NCT02266888|54186043|FG002|Overall Study|Death|4|||
27737004|NCT02266888|54186044|FG003|Overall Study|Death|2|||
27833496|NCT01740089|54316227|FG000|After 12 Weeks|Lack of Efficacy|3|||
27980844|NCT00947531|54638768|FG000|Overall Study|Lack of Efficacy|1|||
27737005|NCT02266888|54186041|FG000|Overall Study|Physician Decision|0|||
27737006|NCT02266888|54186042|FG001|Overall Study|Physician Decision|1|||
27737007|NCT02266888|54186043|FG002|Overall Study|Physician Decision|2|||
27737008|NCT02266888|54186044|FG003|Overall Study|Physician Decision|2|||
27737009|NCT02266888|54186041|FG000|Overall Study|Study Terminated|5|||
27737010|NCT02266888|54186042|FG001|Overall Study|Study Terminated|1|||
27737011|NCT02266888|54186043|FG002|Overall Study|Study Terminated|0|||
27833497|NCT01740089|54316228|FG001|After 12 Weeks|Lack of Efficacy|1|||
27833498|NCT01740089|54316229|FG002|After 12 Weeks|Lack of Efficacy|4|||
27833499|NCT01740089|54316227|FG000|After 12 Weeks|Adverse Event|2|||
27980845|NCT00947531|54638769|FG001|Overall Study|Lack of Efficacy|0|||
27737012|NCT02266888|54186044|FG003|Overall Study|Study Terminated|0|||
27737013|NCT02266888|54186041|FG000|Overall Study|No Longer Eligible|0|||
27737014|NCT02266888|54186042|FG001|Overall Study|No Longer Eligible|0|||
27737015|NCT02266888|54186043|FG002|Overall Study|No Longer Eligible|0|||
27737016|NCT02266888|54186044|FG003|Overall Study|No Longer Eligible|2|||
27737017|NCT02266888|54186041|FG000|Overall Study|Randomization Closed|0|||
27737018|NCT02266888|54186042|FG001|Overall Study|Randomization Closed|0|||
27737019|NCT02266888|54186043|FG002|Overall Study|Randomization Closed|4|||
27737020|NCT02266888|54186044|FG003|Overall Study|Randomization Closed|0|||
27737021|NCT02266888|54186041|FG000|Overall Study|Personnel unavailable at transplant|0|||
27737022|NCT02266888|54186042|FG001|Overall Study|Personnel unavailable at transplant|0|||
27737023|NCT02266888|54186043|FG002|Overall Study|Personnel unavailable at transplant|0|||
27737024|NCT02266888|54186044|FG003|Overall Study|Personnel unavailable at transplant|1|||
27737025|NCT02266888|54186041|FG000|Overall Study|Transfer of care|0|||
27737026|NCT02266888|54186042|FG001|Overall Study|Transfer of care|0|||
27737027|NCT02266888|54186043|FG002|Overall Study|Transfer of care|1|||
27737028|NCT02266888|54186044|FG003|Overall Study|Transfer of care|0|||
27737029|NCT01641952|54186052|FG000|Overall Study|Lost to Follow-up|28|||
28169836|NCT00708435|54841192|FG001|Overall Study|Refused hospitalization|0|||
28169837|NCT02841787|54841203|FG000|Overall Study|Lost to Follow-up|1|||
28169838|NCT02841787|54841204|FG001|Overall Study|Lost to Follow-up|0|||
28169839|NCT02841787|54841205|FG002|Overall Study|Lost to Follow-up|0|||
28169840|NCT02841787|54841203|FG000|Overall Study|Symptoms dropped below threshold|1|||
28169841|NCT02841787|54841204|FG001|Overall Study|Symptoms dropped below threshold|0|||
28169842|NCT02841787|54841205|FG002|Overall Study|Symptoms dropped below threshold|0|||
28169843|NCT02841787|54841203|FG000|Overall Study|Withdrawal by Subject|1|||
28169844|NCT02841787|54841204|FG001|Overall Study|Withdrawal by Subject|4|||
28169845|NCT02841787|54841205|FG002|Overall Study|Withdrawal by Subject|0|||
28169846|NCT01376037|54841215|FG000|Overall Study|Lost to Follow-up|0|||
28169847|NCT01376037|54841216|FG001|Overall Study|Lost to Follow-up|2|||
28169848|NCT02657408|54841224|FG000|Overall Study|Adverse Event|3|||
28169849|NCT02657408|54841225|FG001|Overall Study|Adverse Event|7|||
28169850|NCT02841709|54841231|FG000|5th Intervention|Adverse Event|2|||
28169851|NCT02841709|54841232|FG001|5th Intervention|Adverse Event|0|||
28169852|NCT02841709|54841233|FG002|5th Intervention|Adverse Event|0|||
28169853|NCT02841709|54841234|FG003|5th Intervention|Adverse Event|0|||
28169854|NCT02841709|54841235|FG004|5th Intervention|Adverse Event|2|||
28169855|NCT01353859|54841248|FG000|Overall Study|Adverse Event|3|||
27737030|NCT01641952|54186052|FG000|Overall Study|Adverse Event|6|||
27737031|NCT02359552|54186058|FG000|Overall Study|Lost to Follow-up|3|||
27737032|NCT02359552|54186059|FG001|Overall Study|Lost to Follow-up|4|||
27737033|NCT02743793|54186067|FG000|Overall Study|Death|1|||
27737034|NCT02743793|54186068|FG001|Overall Study|Death|1|||
27737035|NCT02743793|54186067|FG000|Overall Study|Withdrawal by Subject|0|||
27737036|NCT02743793|54186068|FG001|Overall Study|Withdrawal by Subject|1|||
27737037|NCT02743793|54186067|FG000|Overall Study|Screen Failure|4|||
27737038|NCT02743793|54186068|FG001|Overall Study|Screen Failure|0|||
27737039|NCT02743793|54186067|FG000|Overall Study|No Primary Care Physician|0|||
27737040|NCT02743793|54186068|FG001|Overall Study|No Primary Care Physician|1|||
27737041|NCT02743793|54186067|FG000|Overall Study|Travel/remote visits could not be performed at nursing facility|0|||
27737042|NCT02743793|54186068|FG001|Overall Study|Travel/remote visits could not be performed at nursing facility|1|||
27737043|NCT02743793|54186067|FG000|Overall Study|Study stopped due to COVID-19 pandemic|0|||
27737044|NCT02743793|54186068|FG001|Overall Study|Study stopped due to COVID-19 pandemic|32|||
27737045|NCT00152009|54186077|FG000|Overall Study|Adverse Event|9|||
27737046|NCT00152009|54186078|FG001|Overall Study|Adverse Event|13|||
27737047|NCT00152009|54186079|FG002|Overall Study|Adverse Event|20|||
27737048|NCT00152009|54186080|FG003|Overall Study|Adverse Event|1|||
27737049|NCT00152009|54186077|FG000|Overall Study|Protocol Violation|3|||
27737050|NCT00152009|54186078|FG001|Overall Study|Protocol Violation|0|||
27833500|NCT01740089|54316228|FG001|After 12 Weeks|Adverse Event|0|||
27833501|NCT01740089|54316229|FG002|After 12 Weeks|Adverse Event|5|||
27833502|NCT01740089|54316227|FG000|After 12 Weeks|Protocol Violation|1|||
27833503|NCT01740089|54316228|FG001|After 12 Weeks|Protocol Violation|1|||
28094428|NCT03129100|54748082|FG023|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
28094429|NCT03129100|54748083|FG024|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|2|||
28094430|NCT03129100|54748084|FG025|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
28094431|NCT03129100|54748059|FG000|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
28094432|NCT03129100|54748060|FG001|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
28094433|NCT03129100|54748061|FG002|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
28094434|NCT03129100|54748062|FG003|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
28169856|NCT01353859|54841248|FG000|Overall Study|Lack of Efficacy|1|||
28169857|NCT02850965|54841254|FG000|Overall Study|Other than listed|3|||
28169858|NCT02850965|54841255|FG001|Overall Study|Other than listed|4|||
28169859|NCT02850965|54841254|FG000|Overall Study|Protocol Violation|0|||
27737051|NCT00152009|54186079|FG002|Overall Study|Protocol Violation|0|||
27833504|NCT01740089|54316229|FG002|After 12 Weeks|Protocol Violation|1|||
27737052|NCT00152009|54186080|FG003|Overall Study|Protocol Violation|1|||
27737053|NCT00152009|54186077|FG000|Overall Study|Withdrawal by Subject|2|||
27737054|NCT00152009|54186078|FG001|Overall Study|Withdrawal by Subject|3|||
27737055|NCT00152009|54186079|FG002|Overall Study|Withdrawal by Subject|4|||
27737056|NCT00152009|54186080|FG003|Overall Study|Withdrawal by Subject|9|||
27737057|NCT00152009|54186077|FG000|Overall Study|Lost to Follow-up|2|||
28169860|NCT02850965|54841255|FG001|Overall Study|Protocol Violation|2|||
28169861|NCT02850965|54841254|FG000|Overall Study|Lost to Follow-up|5|||
28169862|NCT02850965|54841255|FG001|Overall Study|Lost to Follow-up|3|||
28169863|NCT02850965|54841254|FG000|Overall Study|Lack of Efficacy|4|||
28169864|NCT02850965|54841255|FG001|Overall Study|Lack of Efficacy|8|||
28169865|NCT02850965|54841254|FG000|Overall Study|Adverse Event|3|||
28169866|NCT02850965|54841255|FG001|Overall Study|Adverse Event|2|||
28169867|NCT02850965|54841254|FG000|Overall Study|Withdrawal by Subject|3|||
28169868|NCT02850965|54841255|FG001|Overall Study|Withdrawal by Subject|4|||
27737058|NCT00152009|54186078|FG001|Overall Study|Lost to Follow-up|4|||
27737059|NCT00152009|54186079|FG002|Overall Study|Lost to Follow-up|3|||
27737060|NCT00152009|54186080|FG003|Overall Study|Lost to Follow-up|3|||
27737061|NCT00152009|54186077|FG000|Overall Study|Lack of Efficacy|8|||
27737062|NCT00152009|54186078|FG001|Overall Study|Lack of Efficacy|6|||
27737063|NCT00152009|54186079|FG002|Overall Study|Lack of Efficacy|7|||
27737064|NCT00152009|54186080|FG003|Overall Study|Lack of Efficacy|15|||
27737065|NCT00152009|54186077|FG000|Overall Study|ECG abnormalities|2|||
27737066|NCT00152009|54186078|FG001|Overall Study|ECG abnormalities|2|||
27737067|NCT00152009|54186079|FG002|Overall Study|ECG abnormalities|2|||
27737068|NCT00152009|54186080|FG003|Overall Study|ECG abnormalities|1|||
27737069|NCT00152009|54186077|FG000|Overall Study|Sponsor's decision|3|||
27737070|NCT00152009|54186078|FG001|Overall Study|Sponsor's decision|3|||
27737071|NCT00152009|54186079|FG002|Overall Study|Sponsor's decision|1|||
27737072|NCT00152009|54186080|FG003|Overall Study|Sponsor's decision|3|||
27737073|NCT02265952|54186090|FG000|Open Label Extension (OLE) Period|Physician Decision|0|||
27737074|NCT02265952|54186091|FG001|Open Label Extension (OLE) Period|Physician Decision|7|||
27737075|NCT02265952|54186090|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
27737076|NCT02265952|54186091|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|1|||
27737077|NCT02265796|54186099|FG000|Overall Study|Death|1|||
27737078|NCT02265796|54186100|FG001|Overall Study|Death|0|||
27737079|NCT02265796|54186099|FG000|Overall Study|started on excluded medication|1|||
27737080|NCT02265796|54186100|FG001|Overall Study|started on excluded medication|0|||
27737081|NCT02265796|54186099|FG000|Overall Study|Withdrawal by Subject|1|||
27737082|NCT02265796|54186100|FG001|Overall Study|Withdrawal by Subject|1|||
27737083|NCT02357368|54186110|FG000|Overall Study|Lost to Follow-up|0|||
27737084|NCT02357368|54186111|FG001|Overall Study|Lost to Follow-up|0|||
27737085|NCT02357368|54186112|FG002|Overall Study|Lost to Follow-up|0|||
27737086|NCT02357368|54186113|FG003|Overall Study|Lost to Follow-up|1|||
27737087|NCT02357368|54186110|FG000|Overall Study|Pregnancy|3|||
27737088|NCT02357368|54186111|FG001|Overall Study|Pregnancy|2|||
27737089|NCT02357368|54186112|FG002|Overall Study|Pregnancy|0|||
27737090|NCT02357368|54186113|FG003|Overall Study|Pregnancy|0|||
27737091|NCT02357368|54186110|FG000|Overall Study|Withdrawal by Subject|3|||
27737092|NCT02357368|54186111|FG001|Overall Study|Withdrawal by Subject|1|||
27737093|NCT02357368|54186112|FG002|Overall Study|Withdrawal by Subject|1|||
27737094|NCT02357368|54186113|FG003|Overall Study|Withdrawal by Subject|2|||
27737095|NCT03287245|54186127|FG000|Overall Study|Study terminated by sponsor|3|||
27737096|NCT03287245|54186128|FG001|Overall Study|Study terminated by sponsor|0|||
27737097|NCT03287245|54186129|FG002|Overall Study|Study terminated by sponsor|3|||
28094435|NCT03129100|54748063|FG004|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
28094436|NCT03129100|54748064|FG005|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
28094437|NCT03129100|54748065|FG006|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
28094438|NCT03129100|54748066|FG007|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
28094439|NCT03129100|54748067|FG008|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
28094440|NCT03129100|54748068|FG009|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
28094441|NCT03129100|54748069|FG010|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
28094442|NCT03129100|54748070|FG011|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
28094443|NCT03129100|54748071|FG012|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
28094444|NCT03129100|54748072|FG013|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
28094445|NCT03129100|54748073|FG014|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
28094446|NCT03129100|54748074|FG015|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
28169869|NCT02850965|54841254|FG000|Overall Study|Physician Decision|0|||
28169870|NCT02850965|54841255|FG001|Overall Study|Physician Decision|1|||
27737098|NCT03287245|54186130|FG003|Overall Study|Study terminated by sponsor|1|||
27737099|NCT03287245|54186127|FG000|Overall Study|Adverse Event|1|||
27737100|NCT03287245|54186128|FG001|Overall Study|Adverse Event|0|||
27737101|NCT03287245|54186129|FG002|Overall Study|Adverse Event|0|||
27737102|NCT03287245|54186130|FG003|Overall Study|Adverse Event|0|||
27737103|NCT03287245|54186127|FG000|Overall Study|Withdrawal by Subject|8|||
28169871|NCT02850965|54841254|FG000|Overall Study|Randomized but not treated|0|||
28169872|NCT02850965|54841255|FG001|Overall Study|Randomized but not treated|1|||
28169873|NCT01375959|54841263|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
28169874|NCT01375959|54841264|FG001|First Intervention (6 Weeks)|Adverse Event|3|||
28169875|NCT01375959|54841263|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
28169876|NCT01375959|54841264|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
28169877|NCT01375959|54841263|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
28169878|NCT01375959|54841264|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
28169879|NCT00708201|54841274|FG000|Overall Study|Adverse Event|4|||
28169880|NCT00708201|54841275|FG001|Overall Study|Adverse Event|4|||
28169881|NCT00708201|54841274|FG000|Overall Study|Withdrawal by Subject|1|||
28169882|NCT00708201|54841275|FG001|Overall Study|Withdrawal by Subject|1|||
28169883|NCT00708201|54841274|FG000|Overall Study|Lost to Follow-up|2|||
28169884|NCT00708201|54841275|FG001|Overall Study|Lost to Follow-up|0|||
28169885|NCT00708201|54841274|FG000|Overall Study|Protocol Violation|0|||
28169886|NCT00708201|54841275|FG001|Overall Study|Protocol Violation|1|||
28169887|NCT02848313|54841283|FG000|Overall Study|Adverse Event|1|||
28169888|NCT02848313|54841284|FG001|Overall Study|Adverse Event|2|||
28169889|NCT02848313|54841283|FG000|Overall Study|Lack of Efficacy|0|||
28169890|NCT02848313|54841284|FG001|Overall Study|Lack of Efficacy|1|||
28169891|NCT02848313|54841283|FG000|Overall Study|Withdrawal by Subject|1|||
28169892|NCT02848313|54841284|FG001|Overall Study|Withdrawal by Subject|1|||
28169893|NCT02848313|54841283|FG000|Overall Study|Lost to follow up|1|||
28169894|NCT02848313|54841284|FG001|Overall Study|Lost to follow up|0|||
28169895|NCT02728089|54841290|FG000|Overall Study|Physician Decision|2|||
28169896|NCT02728089|54841290|FG000|Overall Study|Withdrawal by Subject|1|||
28169897|NCT02840461|54841297|FG000|Overall Study|Adverse Event|1|||
28169898|NCT02840461|54841298|FG001|Overall Study|Adverse Event|5|||
28169899|NCT02840461|54841299|FG002|Overall Study|Adverse Event|3|||
28169900|NCT02840461|54841297|FG000|Overall Study|Lost to Follow-up|10|||
28169901|NCT02840461|54841298|FG001|Overall Study|Lost to Follow-up|7|||
28169902|NCT02840461|54841299|FG002|Overall Study|Lost to Follow-up|6|||
28169903|NCT02840461|54841297|FG000|Overall Study|Non-Comliance with Dosing Requirements|0|||
28169904|NCT02840461|54841298|FG001|Overall Study|Non-Comliance with Dosing Requirements|1|||
28169905|NCT02840461|54841299|FG002|Overall Study|Non-Comliance with Dosing Requirements|0|||
28169906|NCT02840461|54841297|FG000|Overall Study|Protocol Violation|2|||
28169907|NCT02840461|54841298|FG001|Overall Study|Protocol Violation|3|||
28169908|NCT02840461|54841299|FG002|Overall Study|Protocol Violation|1|||
28169909|NCT02840461|54841297|FG000|Overall Study|Withdrawal by Subject|10|||
28169910|NCT02840461|54841298|FG001|Overall Study|Withdrawal by Subject|6|||
28169911|NCT02840461|54841299|FG002|Overall Study|Withdrawal by Subject|2|||
28169912|NCT02840461|54841297|FG000|Overall Study|Worsening of Symptom & Kit Error|0|||
28169913|NCT02840461|54841298|FG001|Overall Study|Worsening of Symptom & Kit Error|0|||
28169914|NCT02840461|54841299|FG002|Overall Study|Worsening of Symptom & Kit Error|2|||
28169915|NCT02839681|54841308|FG000|Overall Study|Death|2|||
28169916|NCT01676012|54841312|FG000|Overall Study|Adverse Event|2|||
28169917|NCT01676012|54841312|FG000|Overall Study|incomplete set of videos|1|||
28169918|NCT02727777|54841328|FG000|Overall Study|Screen Failure|2|||
28169919|NCT02727777|54841329|FG001|Overall Study|Screen Failure|0|||
28169920|NCT02727777|54841330|FG002|Overall Study|Screen Failure|0|||
28169921|NCT02727777|54841328|FG000|Overall Study|Progressive disease|2|||
28169922|NCT02727777|54841329|FG001|Overall Study|Progressive disease|0|||
27980846|NCT00947531|54638768|FG000|Overall Study|Other|1|||
27980847|NCT00947531|54638769|FG001|Overall Study|Other|1|||
27980848|NCT00612313|54638777|FG000|Overall Study|Withdrawal by Subject|6|||
27980849|NCT00612313|54638778|FG001|Overall Study|Withdrawal by Subject|9|||
28094447|NCT03129100|54748075|FG016|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
28094448|NCT03129100|54748076|FG017|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
28094449|NCT03129100|54748077|FG018|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
28094450|NCT03129100|54748078|FG019|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
28094451|NCT03129100|54748079|FG020|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
28094452|NCT03129100|54748080|FG021|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
28094453|NCT03129100|54748081|FG022|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
28094454|NCT03129100|54748082|FG023|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
28169923|NCT02727777|54841330|FG002|Overall Study|Progressive disease|0|||
28169924|NCT00707577|54841340|FG000|Overall Study|Withdrawal by Subject|3|||
28169925|NCT00707577|54841341|FG001|Overall Study|Withdrawal by Subject|2|||
28169926|NCT00707577|54841340|FG000|Overall Study|Lost to Follow-up|34|||
28169927|NCT00707577|54841341|FG001|Overall Study|Lost to Follow-up|25|||
28169928|NCT00707577|54841340|FG000|Overall Study|Left employment|13|||
28169929|NCT00707577|54841341|FG001|Overall Study|Left employment|10|||
27980850|NCT00612313|54638777|FG000|Overall Study|Lost to Follow-up|11|||
28169930|NCT00707577|54841340|FG000|Overall Study|Pregnancy|4|||
28169931|NCT00707577|54841341|FG001|Overall Study|Pregnancy|1|||
28169932|NCT01675622|54841349|FG000|Overall Study|Withdrawal by Subject|2|||
28169933|NCT01675622|54841350|FG001|Overall Study|Withdrawal by Subject|2|||
27980851|NCT00612313|54638778|FG001|Overall Study|Lost to Follow-up|4|||
27737104|NCT03287245|54186128|FG001|Overall Study|Withdrawal by Subject|3|||
27737105|NCT03287245|54186129|FG002|Overall Study|Withdrawal by Subject|3|||
27737106|NCT03287245|54186130|FG003|Overall Study|Withdrawal by Subject|0|||
27737107|NCT03287245|54186127|FG000|Overall Study|Physician Decision|3|||
27737108|NCT03287245|54186128|FG001|Overall Study|Physician Decision|2|||
27737109|NCT03287245|54186129|FG002|Overall Study|Physician Decision|0|||
27737110|NCT03287245|54186130|FG003|Overall Study|Physician Decision|0|||
27737111|NCT02262754|54186163|FG000|Overall Study|Adverse Event|3|||
27737112|NCT02262754|54186164|FG001|Overall Study|Adverse Event|4|||
27737113|NCT02262754|54186165|FG002|Overall Study|Adverse Event|0|||
27737114|NCT02262754|54186163|FG000|Overall Study|Lack of Efficacy|2|||
27737115|NCT02262754|54186164|FG001|Overall Study|Lack of Efficacy|0|||
27737116|NCT02262754|54186165|FG002|Overall Study|Lack of Efficacy|1|||
27737117|NCT02262754|54186163|FG000|Overall Study|Lost to Follow-up|0|||
27737118|NCT02262754|54186164|FG001|Overall Study|Lost to Follow-up|0|||
27737119|NCT02262754|54186165|FG002|Overall Study|Lost to Follow-up|1|||
27737120|NCT02262754|54186163|FG000|Overall Study|No longer meets eligibility criteria|0|||
27737121|NCT02262754|54186164|FG001|Overall Study|No longer meets eligibility criteria|1|||
27737122|NCT02262754|54186165|FG002|Overall Study|No longer meets eligibility criteria|0|||
27737123|NCT02262754|54186163|FG000|Overall Study|Study terminated by sponsor|5|||
27737124|NCT02262754|54186164|FG001|Overall Study|Study terminated by sponsor|4|||
27737125|NCT02262754|54186165|FG002|Overall Study|Study terminated by sponsor|4|||
27737126|NCT02262754|54186163|FG000|Overall Study|Protocol Violation|1|||
27737127|NCT02262754|54186164|FG001|Overall Study|Protocol Violation|0|||
27737128|NCT02262754|54186165|FG002|Overall Study|Protocol Violation|0|||
27737129|NCT02262754|54186163|FG000|Overall Study|Withdrawal by Subject|1|||
27737130|NCT02262754|54186164|FG001|Overall Study|Withdrawal by Subject|0|||
27737131|NCT02262754|54186165|FG002|Overall Study|Withdrawal by Subject|1|||
27737132|NCT02262754|54186163|FG000|Overall Study|Other|4|||
27737133|NCT02262754|54186164|FG001|Overall Study|Other|0|||
27737134|NCT02262754|54186165|FG002|Overall Study|Other|2|||
27737135|NCT02262364|54186175|FG000|Blood Draw for Device Processing|Insufficient blood could be drawn|1|||
27737136|NCT02261974|54186181|FG000|Overall Study|Withdrawal by Subject|3|||
27737137|NCT02261974|54186182|FG001|Overall Study|Withdrawal by Subject|2|||
27737138|NCT02261974|54186181|FG000|Overall Study|Pregnancy|0|||
27737139|NCT02261974|54186182|FG001|Overall Study|Pregnancy|1|||
27737140|NCT02261974|54186181|FG000|Overall Study|Missed treatment cut-off date|6|||
27737141|NCT02261974|54186182|FG001|Overall Study|Missed treatment cut-off date|3|||
27737142|NCT02261974|54186181|FG000|Overall Study|Received partial treatment; FU to 1 mo|3|||
27737143|NCT02261974|54186182|FG001|Overall Study|Received partial treatment; FU to 1 mo|1|||
27737144|NCT02261974|54186181|FG000|Overall Study|Lost to Follow-up|2|||
27737145|NCT02261974|54186182|FG001|Overall Study|Lost to Follow-up|0|||
27737146|NCT02261974|54186181|FG000|Overall Study|Adverse Event|1|||
27737147|NCT02261974|54186182|FG001|Overall Study|Adverse Event|0|||
27737148|NCT02356588|54186190|FG000|Overall Study|Lack of Efficacy|4|||
27737149|NCT02356588|54186191|FG001|Overall Study|Lack of Efficacy|10|||
27737150|NCT02356588|54186190|FG000|Overall Study|Adverse Event|0|||
27737151|NCT02356588|54186191|FG001|Overall Study|Adverse Event|2|||
27737152|NCT02356588|54186190|FG000|Overall Study|Withdrawal by Subject|1|||
27737153|NCT02356588|54186191|FG001|Overall Study|Withdrawal by Subject|0|||
27737154|NCT02356588|54186190|FG000|Overall Study|Protocol Violation|0|||
27737155|NCT02356588|54186191|FG001|Overall Study|Protocol Violation|1|||
27737156|NCT02355028|54186199|FG000|Overall Study|Adverse Event|2|||
27737157|NCT02355028|54186200|FG001|Overall Study|Adverse Event|0|||
27737158|NCT02355028|54186199|FG000|Overall Study|Withdrawal by Subject|1|||
27737159|NCT02355028|54186200|FG001|Overall Study|Withdrawal by Subject|1|||
27737160|NCT02355028|54186199|FG000|Overall Study|Deemed ineligible after randomization|8|||
27737161|NCT02355028|54186200|FG001|Overall Study|Deemed ineligible after randomization|4|||
27737162|NCT01643668|54186215|FG000|Overall Study|Death|1|||
27737163|NCT02260882|54186221|FG000|Overall Study|Protocol Violation|0|||
27737164|NCT02260882|54186222|FG001|Overall Study|Protocol Violation|1|||
27737165|NCT02260804|54186231|FG000|Induction Study Period|Protocol Violation|2|||
27737166|NCT02260804|54186232|FG001|Induction Study Period|Protocol Violation|0|||
27737167|NCT02260804|54186231|FG000|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|6|||
27737168|NCT02260804|54186232|FG001|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|9|||
27833505|NCT01740089|54316227|FG000|After 12 Weeks|Withdrawal by Subject|1|||
27833506|NCT01740089|54316228|FG001|After 12 Weeks|Withdrawal by Subject|1|||
28094455|NCT03129100|54748083|FG024|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
27737169|NCT02260804|54186231|FG000|1st Year of the Maintenance Period (MP1)|Adverse Event|3|||
27737170|NCT02260804|54186232|FG001|1st Year of the Maintenance Period (MP1)|Adverse Event|1|||
27737171|NCT02260804|54186231|FG000|1st Year of the Maintenance Period (MP1)|Physician Decision|1|||
27737172|NCT02260804|54186232|FG001|1st Year of the Maintenance Period (MP1)|Physician Decision|3|||
27737173|NCT02260804|54186231|FG000|1st Year of the Maintenance Period (MP1)|Protocol Violation|1|||
27833507|NCT01740089|54316229|FG002|After 12 Weeks|Withdrawal by Subject|1|||
27833508|NCT01739933|54316240|FG000|Overall Study|Death|89|||
27833509|NCT01739933|54316241|FG001|Overall Study|Death|86|||
27737174|NCT02260804|54186232|FG001|1st Year of the Maintenance Period (MP1)|Protocol Violation|0|||
27737175|NCT02260804|54186231|FG000|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|1|||
27737176|NCT02260804|54186232|FG001|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|0|||
27737177|NCT02260804|54186231|FG000|1st Year of the Maintenance Period (MP1)|Death|0|||
27737178|NCT02260804|54186232|FG001|1st Year of the Maintenance Period (MP1)|Death|1|||
27737179|NCT02260804|54186231|FG000|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|0|||
27856160|NCT01045421|54384935|FG010|Phase 2|Progressive Disease|1|||
27856161|NCT01045421|54384925|FG000|Phase 2|Death|0|||
27737180|NCT02260804|54186232|FG001|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|1|||
27737181|NCT02260804|54186231|FG000|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|6|||
27737182|NCT02260804|54186232|FG001|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|5|||
27737183|NCT02260804|54186231|FG000|2nd Year of the Maintenance Period (MP2)|Adverse Event|3|||
27737184|NCT02260804|54186232|FG001|2nd Year of the Maintenance Period (MP2)|Adverse Event|0|||
27737185|NCT02260804|54186231|FG000|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|0|||
27737186|NCT02260804|54186232|FG001|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|1|||
27737187|NCT02260648|54186241|FG000|Overall Study|Adverse Event|3|||
27737188|NCT02260648|54186242|FG001|Overall Study|Adverse Event|0|||
27737189|NCT02260648|54186243|FG002|Overall Study|Adverse Event|1|||
27737190|NCT02260648|54186241|FG000|Overall Study|Withdrawal by Subject|1|||
27737191|NCT02260648|54186242|FG001|Overall Study|Withdrawal by Subject|1|||
27737192|NCT02260648|54186243|FG002|Overall Study|Withdrawal by Subject|0|||
27737193|NCT02260648|54186241|FG000|Overall Study|Protocol Violation|1|||
27737194|NCT02260648|54186242|FG001|Overall Study|Protocol Violation|0|||
27737195|NCT02260648|54186243|FG002|Overall Study|Protocol Violation|0|||
27737196|NCT02260648|54186241|FG000|Overall Study|Discontinue Due to Study Termination|13|||
27737197|NCT02260648|54186242|FG001|Overall Study|Discontinue Due to Study Termination|12|||
27737198|NCT02260648|54186243|FG002|Overall Study|Discontinue Due to Study Termination|7|||
27737199|NCT02260492|54186254|FG000|Overall Study|Adverse Event|6|||
27737200|NCT02260492|54186255|FG001|Overall Study|Adverse Event|1|||
27737201|NCT02260492|54186256|FG002|Overall Study|Adverse Event|2|||
27737202|NCT02260492|54186254|FG000|Overall Study|Death|0|||
27737203|NCT02260492|54186255|FG001|Overall Study|Death|1|||
27737204|NCT02260492|54186256|FG002|Overall Study|Death|0|||
27737205|NCT02260492|54186254|FG000|Overall Study|Lost to Follow-up|12|||
27737206|NCT02260492|54186255|FG001|Overall Study|Lost to Follow-up|9|||
27737207|NCT02260492|54186256|FG002|Overall Study|Lost to Follow-up|0|||
27737208|NCT02260492|54186254|FG000|Overall Study|Physician Decision|2|||
27737209|NCT02260492|54186255|FG001|Overall Study|Physician Decision|0|||
27737210|NCT02260492|54186256|FG002|Overall Study|Physician Decision|1|||
27737211|NCT02260492|54186254|FG000|Overall Study|Withdrawal by Subject|3|||
27856162|NCT01045421|54384926|FG001|Phase 2|Death|0|||
27856163|NCT01045421|54384927|FG002|Phase 2|Death|0|||
27856164|NCT01045421|54384928|FG003|Phase 2|Death|0|||
27856165|NCT01045421|54384929|FG004|Phase 2|Death|0|||
27856166|NCT01045421|54384930|FG005|Phase 2|Death|0|||
27856167|NCT01045421|54384931|FG006|Phase 2|Death|0|||
27856168|NCT01045421|54384932|FG007|Phase 2|Death|1|||
27856169|NCT01045421|54384933|FG008|Phase 2|Death|1|||
28094456|NCT03129100|54748084|FG025|Period 4 (Post Treatment Follow-up)|Missed follow-up|1|||
28094457|NCT03129100|54748059|FG000|Period 4 (Post Treatment Follow-up)|Other|0|||
28094458|NCT03129100|54748060|FG001|Period 4 (Post Treatment Follow-up)|Other|0|||
28094459|NCT03129100|54748061|FG002|Period 4 (Post Treatment Follow-up)|Other|0|||
28094460|NCT03129100|54748062|FG003|Period 4 (Post Treatment Follow-up)|Other|0|||
28094461|NCT03129100|54748063|FG004|Period 4 (Post Treatment Follow-up)|Other|0|||
28094462|NCT03129100|54748064|FG005|Period 4 (Post Treatment Follow-up)|Other|0|||
28094463|NCT03129100|54748065|FG006|Period 4 (Post Treatment Follow-up)|Other|0|||
28094464|NCT03129100|54748066|FG007|Period 4 (Post Treatment Follow-up)|Other|0|||
28094465|NCT03129100|54748067|FG008|Period 4 (Post Treatment Follow-up)|Other|0|||
28094466|NCT03129100|54748068|FG009|Period 4 (Post Treatment Follow-up)|Other|0|||
27737212|NCT02260492|54186255|FG001|Overall Study|Withdrawal by Subject|2|||
27737213|NCT02260492|54186256|FG002|Overall Study|Withdrawal by Subject|2|||
27737214|NCT02260258|54186266|FG000|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2|||
27737215|NCT02260258|54186267|FG001|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1|||
27737216|NCT02260180|54186277|FG000|Overall Study|Adverse Event|2|||
27737217|NCT02260180|54186278|FG001|Overall Study|Adverse Event|0|||
27737218|NCT02260180|54186279|FG002|Overall Study|Adverse Event|1|||
27737219|NCT02353468|54186287|FG000|Overall Study|Study terminated|3|||
27737220|NCT02349412|54186293|FG000|Overall Study|Withdrawal by Subject|7|||
27737221|NCT02349412|54186294|FG001|Overall Study|Withdrawal by Subject|7|||
27737222|NCT02259400|54186302|FG000|Overall Study|Death|0|||
27737223|NCT02259400|54186303|FG001|Overall Study|Death|2|||
27737224|NCT01530997|54186309|FG000|Overall Study|Physician Decision|1|||
27856170|NCT01045421|54384934|FG009|Phase 2|Death|2|||
27856171|NCT01045421|54384935|FG010|Phase 2|Death|0|||
27856172|NCT01045421|54384925|FG000|Phase 2|Other|0|||
27856173|NCT01045421|54384926|FG001|Phase 2|Other|0|||
27737225|NCT01530997|54186309|FG000|Overall Study|Withdrawal by Subject|1|||
27737226|NCT02259088|54186322|FG000|Overall Study|Adverse Event|6|||
27737227|NCT02259088|54186323|FG001|Overall Study|Adverse Event|4|||
27737228|NCT02259088|54186322|FG000|Overall Study|Lost to Follow-up|2|||
27737229|NCT02259088|54186323|FG001|Overall Study|Lost to Follow-up|0|||
27737230|NCT02259088|54186322|FG000|Overall Study|Death|2|||
27737231|NCT02259088|54186323|FG001|Overall Study|Death|0|||
27737232|NCT02259088|54186322|FG000|Overall Study|Physician Decision|5|||
27737233|NCT02259088|54186323|FG001|Overall Study|Physician Decision|2|||
27737234|NCT02259088|54186322|FG000|Overall Study|Protocol deviation|5|||
27737235|NCT02259088|54186323|FG001|Overall Study|Protocol deviation|0|||
27737236|NCT02259088|54186322|FG000|Overall Study|Subject/guardian decision|8|||
27856174|NCT01045421|54384927|FG002|Phase 2|Other|0|||
27856175|NCT01045421|54384928|FG003|Phase 2|Other|0|||
27856176|NCT01045421|54384929|FG004|Phase 2|Other|0|||
27856177|NCT01045421|54384930|FG005|Phase 2|Other|0|||
27856178|NCT01045421|54384931|FG006|Phase 2|Other|0|||
27856179|NCT01045421|54384932|FG007|Phase 2|Other|3|||
27856180|NCT01045421|54384933|FG008|Phase 2|Other|0|||
27856181|NCT01045421|54384934|FG009|Phase 2|Other|0|||
27856182|NCT01045421|54384935|FG010|Phase 2|Other|1|||
27856183|NCT01042535|54384983|FG000|Overall Study|disease progression prior to treatment|3|||
27856184|NCT01042535|54384983|FG000|Overall Study|disease progression during treatment|3|||
27856185|NCT01042535|54384983|FG000|Overall Study|complications from other disease|2|||
27856186|NCT01041287|54384989|FG000|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
27856187|NCT01041287|54384990|FG001|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
27856188|NCT01041287|54384989|FG000|Treatment Period 2 (3 Months)|Adverse Event|0|||
27856189|NCT01041287|54384990|FG001|Treatment Period 2 (3 Months)|Adverse Event|2|||
27856190|NCT01040351|54385011|FG000|Overall Study|poor ovarian response|1|||
27856191|NCT01040351|54385012|FG001|Overall Study|poor ovarian response|2|||
27856192|NCT02049957|54385032|FG000|Overall Study|Progressive Disease|5|||
27856193|NCT02049957|54385033|FG001|Overall Study|Progressive Disease|4|||
27856194|NCT02049957|54385034|FG002|Overall Study|Progressive Disease|2|||
27856195|NCT02049957|54385035|FG003|Overall Study|Progressive Disease|2|||
27856196|NCT02049957|54385036|FG004|Overall Study|Progressive Disease|6|||
27856197|NCT02049957|54385037|FG005|Overall Study|Progressive Disease|35|||
27856198|NCT02049957|54385038|FG006|Overall Study|Progressive Disease|7|||
27856199|NCT02049957|54385039|FG007|Overall Study|Progressive Disease|26|||
27856200|NCT02049957|54385040|FG008|Overall Study|Progressive Disease|6|||
27856201|NCT02049957|54385032|FG000|Overall Study|Adverse Event|1|||
27856202|NCT02049957|54385033|FG001|Overall Study|Adverse Event|1|||
27856203|NCT02049957|54385034|FG002|Overall Study|Adverse Event|1|||
27856204|NCT02049957|54385035|FG003|Overall Study|Adverse Event|0|||
27856205|NCT02049957|54385036|FG004|Overall Study|Adverse Event|0|||
27856206|NCT02049957|54385037|FG005|Overall Study|Adverse Event|5|||
27856207|NCT02049957|54385038|FG006|Overall Study|Adverse Event|0|||
27856208|NCT02049957|54385039|FG007|Overall Study|Adverse Event|6|||
27856209|NCT02049957|54385040|FG008|Overall Study|Adverse Event|1|||
27856210|NCT02049957|54385032|FG000|Overall Study|Study Terminated by Sponsor|0|||
27856211|NCT02049957|54385033|FG001|Overall Study|Study Terminated by Sponsor|1|||
27856212|NCT02049957|54385034|FG002|Overall Study|Study Terminated by Sponsor|0|||
27856213|NCT02049957|54385035|FG003|Overall Study|Study Terminated by Sponsor|0|||
27856214|NCT02049957|54385036|FG004|Overall Study|Study Terminated by Sponsor|0|||
27856215|NCT02049957|54385037|FG005|Overall Study|Study Terminated by Sponsor|0|||
27856216|NCT02049957|54385038|FG006|Overall Study|Study Terminated by Sponsor|1|||
27856217|NCT02049957|54385039|FG007|Overall Study|Study Terminated by Sponsor|0|||
27856218|NCT02049957|54385040|FG008|Overall Study|Study Terminated by Sponsor|0|||
27856219|NCT02049957|54385032|FG000|Overall Study|Withdrawal by Subject|0|||
27856220|NCT02049957|54385033|FG001|Overall Study|Withdrawal by Subject|0|||
27856221|NCT02049957|54385034|FG002|Overall Study|Withdrawal by Subject|0|||
27856222|NCT02049957|54385035|FG003|Overall Study|Withdrawal by Subject|1|||
27856223|NCT02049957|54385036|FG004|Overall Study|Withdrawal by Subject|0|||
27737237|NCT02259088|54186323|FG001|Overall Study|Subject/guardian decision|8|||
27856224|NCT02049957|54385037|FG005|Overall Study|Withdrawal by Subject|2|||
27856225|NCT02049957|54385038|FG006|Overall Study|Withdrawal by Subject|0|||
27856226|NCT02049957|54385039|FG007|Overall Study|Withdrawal by Subject|3|||
27856227|NCT02049957|54385040|FG008|Overall Study|Withdrawal by Subject|1|||
27737238|NCT02880241|54186335|FG000|Overall Study|Lack of Efficacy|1|||
27737239|NCT02880241|54186336|FG001|Overall Study|Lack of Efficacy|0|||
27737240|NCT02880241|54186337|FG002|Overall Study|Lack of Efficacy|0|||
27737241|NCT02880241|54186338|FG003|Overall Study|Lack of Efficacy|0|||
27737242|NCT02880241|54186339|FG004|Overall Study|Lack of Efficacy|0|||
27737243|NCT02880241|54186340|FG005|Overall Study|Lack of Efficacy|0|||
27856228|NCT02049957|54385032|FG000|Overall Study|Physician Decision|0|||
27856229|NCT02049957|54385033|FG001|Overall Study|Physician Decision|0|||
27856230|NCT02049957|54385034|FG002|Overall Study|Physician Decision|0|||
27856231|NCT02049957|54385035|FG003|Overall Study|Physician Decision|0|||
27737244|NCT02259010|54186356|FG000|Overall Study|Didn't Completed Dosing; PK Assessment|5|||
27856232|NCT02049957|54385036|FG004|Overall Study|Physician Decision|0|||
27737245|NCT02021773|54186365|FG000|Overall Study|Adverse Event|1|||
28094467|NCT03129100|54748069|FG010|Period 4 (Post Treatment Follow-up)|Other|0|||
28094468|NCT03129100|54748070|FG011|Period 4 (Post Treatment Follow-up)|Other|0|||
28094469|NCT03129100|54748071|FG012|Period 4 (Post Treatment Follow-up)|Other|0|||
28094470|NCT03129100|54748072|FG013|Period 4 (Post Treatment Follow-up)|Other|0|||
28094471|NCT03129100|54748073|FG014|Period 4 (Post Treatment Follow-up)|Other|0|||
28094472|NCT03129100|54748074|FG015|Period 4 (Post Treatment Follow-up)|Other|0|||
28094473|NCT03129100|54748075|FG016|Period 4 (Post Treatment Follow-up)|Other|0|||
28094474|NCT03129100|54748076|FG017|Period 4 (Post Treatment Follow-up)|Other|0|||
28094475|NCT03129100|54748077|FG018|Period 4 (Post Treatment Follow-up)|Other|0|||
28094476|NCT03129100|54748078|FG019|Period 4 (Post Treatment Follow-up)|Other|0|||
28094477|NCT03129100|54748079|FG020|Period 4 (Post Treatment Follow-up)|Other|0|||
28094478|NCT03129100|54748080|FG021|Period 4 (Post Treatment Follow-up)|Other|0|||
28094479|NCT03129100|54748081|FG022|Period 4 (Post Treatment Follow-up)|Other|0|||
28094480|NCT03129100|54748082|FG023|Period 4 (Post Treatment Follow-up)|Other|0|||
28094481|NCT03129100|54748083|FG024|Period 4 (Post Treatment Follow-up)|Other|0|||
28094482|NCT03129100|54748084|FG025|Period 4 (Post Treatment Follow-up)|Other|2|||
28094483|NCT03101020|54748123|FG000|Overall Study|Lack of time to participate|1|||
28094484|NCT03101020|54748124|FG001|Overall Study|Lack of time to participate|0|||
28094485|NCT03101020|54748123|FG000|Overall Study|Ran over by a car|0|||
28094486|NCT03101020|54748124|FG001|Overall Study|Ran over by a car|1|||
28094487|NCT03101020|54748123|FG000|Overall Study|Withdrawal by Subject|0|||
28094488|NCT03101020|54748124|FG001|Overall Study|Withdrawal by Subject|2|||
28094489|NCT03100942|54748134|FG000|Randomized Treatment Period|Withdrew Consent|4|||
28094490|NCT03100942|54748135|FG001|Randomized Treatment Period|Withdrew Consent|5|||
28094491|NCT03100942|54748136|FG002|Randomized Treatment Period|Withdrew Consent|3|||
28094492|NCT03100942|54748137|FG003|Randomized Treatment Period|Withdrew Consent|3|||
28094493|NCT03100942|54748138|FG004|Randomized Treatment Period|Withdrew Consent|0|||
28094494|NCT03100942|54748139|FG005|Randomized Treatment Period|Withdrew Consent|0|||
28094495|NCT03100942|54748140|FG006|Randomized Treatment Period|Withdrew Consent|0|||
28094496|NCT03100942|54748134|FG000|Randomized Treatment Period|Adverse Event|5|||
28094497|NCT03100942|54748135|FG001|Randomized Treatment Period|Adverse Event|2|||
28094498|NCT03100942|54748136|FG002|Randomized Treatment Period|Adverse Event|1|||
28094499|NCT03100942|54748137|FG003|Randomized Treatment Period|Adverse Event|0|||
28094500|NCT03100942|54748138|FG004|Randomized Treatment Period|Adverse Event|0|||
28094501|NCT03100942|54748139|FG005|Randomized Treatment Period|Adverse Event|0|||
28094502|NCT03100942|54748140|FG006|Randomized Treatment Period|Adverse Event|0|||
28094503|NCT03100942|54748134|FG000|Randomized Treatment Period|Investigator's Discretion|2|||
28094504|NCT03100942|54748135|FG001|Randomized Treatment Period|Investigator's Discretion|1|||
28094505|NCT03100942|54748136|FG002|Randomized Treatment Period|Investigator's Discretion|0|||
28094506|NCT03100942|54748137|FG003|Randomized Treatment Period|Investigator's Discretion|0|||
28094507|NCT03100942|54748138|FG004|Randomized Treatment Period|Investigator's Discretion|0|||
28094508|NCT03100942|54748139|FG005|Randomized Treatment Period|Investigator's Discretion|0|||
28094509|NCT03100942|54748140|FG006|Randomized Treatment Period|Investigator's Discretion|0|||
28094510|NCT03100942|54748134|FG000|Randomized Treatment Period|Protocol Violation|0|||
28094511|NCT03100942|54748135|FG001|Randomized Treatment Period|Protocol Violation|1|||
28094512|NCT03100942|54748136|FG002|Randomized Treatment Period|Protocol Violation|1|||
28094513|NCT03100942|54748137|FG003|Randomized Treatment Period|Protocol Violation|1|||
28094514|NCT03100942|54748138|FG004|Randomized Treatment Period|Protocol Violation|0|||
28094515|NCT03100942|54748139|FG005|Randomized Treatment Period|Protocol Violation|0|||
27737246|NCT02021773|54186366|FG001|Overall Study|Adverse Event|4|||
27737247|NCT02021773|54186367|FG002|Overall Study|Adverse Event|3|||
27737248|NCT02021773|54186365|FG000|Overall Study|Lack of Efficacy|2|||
27737249|NCT02021773|54186366|FG001|Overall Study|Lack of Efficacy|2|||
27737250|NCT02021773|54186367|FG002|Overall Study|Lack of Efficacy|2|||
27737251|NCT02021773|54186365|FG000|Overall Study|Protocol Violation|2|||
27737252|NCT02021773|54186366|FG001|Overall Study|Protocol Violation|3|||
27833510|NCT01739933|54316240|FG000|Overall Study|Withdrawal by Subject|10|||
27833511|NCT01739933|54316241|FG001|Overall Study|Withdrawal by Subject|8|||
27833512|NCT01739933|54316240|FG000|Overall Study|Lost to Follow-up|3|||
27833513|NCT01739933|54316241|FG001|Overall Study|Lost to Follow-up|10|||
27833514|NCT01739933|54316240|FG000|Overall Study|Did not speak English required for neurospychological testing|4|||
27833515|NCT01739933|54316241|FG001|Overall Study|Did not speak English required for neurospychological testing|3|||
27833516|NCT01738919|54316258|FG000|Overall Study|Lost to Follow-up|1|||
27833517|NCT01738919|54316259|FG001|Overall Study|Lost to Follow-up|0|||
27833518|NCT01738919|54316258|FG000|Overall Study|Immigrated|0|||
27833519|NCT01738919|54316259|FG001|Overall Study|Immigrated|1|||
27737253|NCT02021773|54186367|FG002|Overall Study|Protocol Violation|1|||
27737254|NCT02021773|54186365|FG000|Overall Study|Withdrawal by Subject|3|||
27737255|NCT02021773|54186366|FG001|Overall Study|Withdrawal by Subject|4|||
27737256|NCT02021773|54186367|FG002|Overall Study|Withdrawal by Subject|5|||
27737257|NCT02021773|54186365|FG000|Overall Study|Lost to Follow-up|1|||
27737258|NCT02021773|54186366|FG001|Overall Study|Lost to Follow-up|3|||
27833520|NCT01738919|54316258|FG000|Overall Study|Withdrawal by Subject|0|||
27737259|NCT02021773|54186367|FG002|Overall Study|Lost to Follow-up|0|||
27737260|NCT02021773|54186365|FG000|Overall Study|Reason not specified|3|||
27737261|NCT02021773|54186366|FG001|Overall Study|Reason not specified|0|||
27737262|NCT02021773|54186367|FG002|Overall Study|Reason not specified|0|||
27737263|NCT00151775|54186380|FG000|Period 2 - Double-Blind Dose Response|Adverse Event|1|||
27737264|NCT00151775|54186381|FG001|Period 2 - Double-Blind Dose Response|Adverse Event|2|||
27737265|NCT00151775|54186382|FG002|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
27737266|NCT00151775|54186383|FG003|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
27737267|NCT00151775|54186384|FG004|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
27737268|NCT00151775|54186385|FG005|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
27737269|NCT00151775|54186386|FG006|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
27737270|NCT00151775|54186387|FG007|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
27737271|NCT00151775|54186388|FG008|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
27737272|NCT00151775|54186389|FG009|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
27737273|NCT00151775|54186390|FG010|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
27737274|NCT00151775|54186391|FG011|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
27737275|NCT00151775|54186380|FG000|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
27737276|NCT00151775|54186381|FG001|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
27737277|NCT00151775|54186382|FG002|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
27737278|NCT00151775|54186383|FG003|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
27737279|NCT00151775|54186384|FG004|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
27737280|NCT00151775|54186385|FG005|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
27737281|NCT00151775|54186386|FG006|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
27737282|NCT00151775|54186387|FG007|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
27737283|NCT00151775|54186388|FG008|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
27737284|NCT00151775|54186389|FG009|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
27737285|NCT00151775|54186390|FG010|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
27737286|NCT00151775|54186391|FG011|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
27737287|NCT00151775|54186380|FG000|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
27737288|NCT00151775|54186381|FG001|Period 2 - Double-Blind Dose Response|Protocol Violation|4|||
27737289|NCT00151775|54186382|FG002|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
27737290|NCT00151775|54186383|FG003|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
28094516|NCT03100942|54748140|FG006|Randomized Treatment Period|Protocol Violation|0|||
28094517|NCT03100942|54748134|FG000|Randomized Treatment Period|Lost to Follow-up|0|||
28094518|NCT03100942|54748135|FG001|Randomized Treatment Period|Lost to Follow-up|0|||
28094519|NCT03100942|54748136|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
28094520|NCT03100942|54748137|FG003|Randomized Treatment Period|Lost to Follow-up|0|||
28094521|NCT03100942|54748138|FG004|Randomized Treatment Period|Lost to Follow-up|0|||
28094522|NCT03100942|54748139|FG005|Randomized Treatment Period|Lost to Follow-up|0|||
28094523|NCT03100942|54748140|FG006|Randomized Treatment Period|Lost to Follow-up|0|||
28094524|NCT03100942|54748134|FG000|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
28094525|NCT03100942|54748135|FG001|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
28094526|NCT03100942|54748136|FG002|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
28094527|NCT03100942|54748137|FG003|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
28094528|NCT03100942|54748138|FG004|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
28094529|NCT03100942|54748139|FG005|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
28094530|NCT03100942|54748140|FG006|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
28094531|NCT03100942|54748134|FG000|Placebo Arm Re-Randomized|Withdrew Consent|0|||
28094532|NCT03100942|54748135|FG001|Placebo Arm Re-Randomized|Withdrew Consent|0|||
28094533|NCT03100942|54748136|FG002|Placebo Arm Re-Randomized|Withdrew Consent|0|||
28094534|NCT03100942|54748137|FG003|Placebo Arm Re-Randomized|Withdrew Consent|0|||
28094535|NCT03100942|54748138|FG004|Placebo Arm Re-Randomized|Withdrew Consent|0|||
28094536|NCT03100942|54748139|FG005|Placebo Arm Re-Randomized|Withdrew Consent|0|||
28094537|NCT03100942|54748140|FG006|Placebo Arm Re-Randomized|Withdrew Consent|1|||
28094538|NCT03099694|54748155|FG000|Overall Study|Withdrawal by Subject|11|||
28094539|NCT03099694|54748156|FG001|Overall Study|Withdrawal by Subject|13|||
28094540|NCT03099694|54748155|FG000|Overall Study|Lost to Follow-up|9|||
28094541|NCT03099694|54748156|FG001|Overall Study|Lost to Follow-up|5|||
28094542|NCT03099538|54748163|FG000|Overall Study|Lack of Efficacy|3|||
28094543|NCT03099304|54748172|FG000|DB Period: Day 1 to Week 24|Adverse Event|1|||
28094544|NCT03099304|54748173|FG001|DB Period: Day 1 to Week 24|Adverse Event|1|||
28169934|NCT01675622|54841349|FG000|Overall Study|Adverse Event|12|||
28169935|NCT01675622|54841350|FG001|Overall Study|Adverse Event|10|||
28169936|NCT01675622|54841349|FG000|Overall Study|Protocol Violation|4|||
28169937|NCT01675622|54841350|FG001|Overall Study|Protocol Violation|1|||
27737291|NCT00151775|54186384|FG004|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
27856233|NCT02049957|54385037|FG005|Overall Study|Physician Decision|1|||
27980852|NCT00890552|54638790|FG000|Enrollment and Pre-treatment|Death/ lost to follow up|1|||
27737292|NCT00151775|54186385|FG005|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
27737293|NCT00151775|54186386|FG006|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
28094545|NCT03099304|54748174|FG002|DB Period: Day 1 to Week 24|Adverse Event|0|||
28094546|NCT03099304|54748175|FG003|DB Period: Day 1 to Week 24|Adverse Event|0|||
28094547|NCT03099304|54748176|FG004|DB Period: Day 1 to Week 24|Adverse Event|1|||
28094548|NCT03099304|54748177|FG005|DB Period: Day 1 to Week 24|Adverse Event|0|||
28094549|NCT03099304|54748172|FG000|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
28094550|NCT03099304|54748173|FG001|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
28094551|NCT03099304|54748174|FG002|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
28094552|NCT03099304|54748175|FG003|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
28094553|NCT03099304|54748176|FG004|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
28094554|NCT03099304|54748177|FG005|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
28094555|NCT03099304|54748172|FG000|DB Period: Day 1 to Week 24|Reason not specified|0|||
28094556|NCT03099304|54748173|FG001|DB Period: Day 1 to Week 24|Reason not specified|0|||
28094557|NCT03099304|54748174|FG002|DB Period: Day 1 to Week 24|Reason not specified|0|||
28094558|NCT03099304|54748175|FG003|DB Period: Day 1 to Week 24|Reason not specified|1|||
28094559|NCT03099304|54748176|FG004|DB Period: Day 1 to Week 24|Reason not specified|0|||
28094560|NCT03099304|54748177|FG005|DB Period: Day 1 to Week 24|Reason not specified|0|||
28094561|NCT03099304|54748172|FG000|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
28094562|NCT03099304|54748173|FG001|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
28094563|NCT03099304|54748174|FG002|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
28094564|NCT03099304|54748175|FG003|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
28094565|NCT03099304|54748176|FG004|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
28094566|NCT03099304|54748177|FG005|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
28094567|NCT03099304|54748172|FG000|DB Period: Day 1 to Week 24|Protocol Violation|0|||
28094568|NCT03099304|54748173|FG001|DB Period: Day 1 to Week 24|Protocol Violation|0|||
28094569|NCT03099304|54748174|FG002|DB Period: Day 1 to Week 24|Protocol Violation|1|||
28094570|NCT03099304|54748175|FG003|DB Period: Day 1 to Week 24|Protocol Violation|1|||
28094571|NCT03099304|54748176|FG004|DB Period: Day 1 to Week 24|Protocol Violation|0|||
28094572|NCT03099304|54748177|FG005|DB Period: Day 1 to Week 24|Protocol Violation|0|||
28094573|NCT03099304|54748172|FG000|DB Period: Weeks 24 to 52|Protocol Violation|0|||
28094574|NCT03099304|54748173|FG001|DB Period: Weeks 24 to 52|Protocol Violation|0|||
28094575|NCT03099304|54748174|FG002|DB Period: Weeks 24 to 52|Protocol Violation|1|||
27856234|NCT02049957|54385038|FG006|Overall Study|Physician Decision|0|||
27856235|NCT02049957|54385039|FG007|Overall Study|Physician Decision|0|||
27856236|NCT02049957|54385040|FG008|Overall Study|Physician Decision|0|||
27856237|NCT00014495|54385303|FG000|Overall Study|Death|0|||
27856238|NCT00014495|54385304|FG001|Overall Study|Death|0|||
27856239|NCT00014495|54385305|FG002|Overall Study|Death|1|||
27856240|NCT00014495|54385306|FG003|Overall Study|Death|0|||
27856241|NCT00014495|54385303|FG000|Overall Study|Clinical deterioration|0|||
27856242|NCT00014495|54385304|FG001|Overall Study|Clinical deterioration|0|||
27856243|NCT00014495|54385305|FG002|Overall Study|Clinical deterioration|0|||
27856244|NCT00014495|54385306|FG003|Overall Study|Clinical deterioration|1|||
27737294|NCT00151775|54186387|FG007|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
27737295|NCT00151775|54186388|FG008|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
27737296|NCT00151775|54186389|FG009|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
27737297|NCT00151775|54186390|FG010|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
27856245|NCT01351623|54387341|FG000|Overall Study|Protocol Violation|2|||
27856246|NCT01351623|54387341|FG000|Overall Study|Adverse Event|4|||
27856247|NCT01351623|54387341|FG000|Overall Study|Withdrawal by Subject|1|||
27856248|NCT01351623|54387341|FG000|Overall Study|Death|2|||
27856249|NCT03670953|54387478|FG000|Dose Adjustment (Weeks 1- 3)|Adverse Event|4|||
28169938|NCT01675622|54841349|FG000|Overall Study|Lack of Efficacy|2|||
27856250|NCT03670953|54387479|FG001|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
27856251|NCT03670953|54387480|FG002|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
27856252|NCT03670953|54387481|FG003|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
27856253|NCT03670953|54387478|FG000|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|1|||
27856254|NCT03670953|54387479|FG001|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
28169939|NCT01675622|54841350|FG001|Overall Study|Lack of Efficacy|4|||
28169940|NCT01675622|54841349|FG000|Overall Study|Lost to Follow-up|1|||
28169941|NCT01675622|54841350|FG001|Overall Study|Lost to Follow-up|3|||
28169942|NCT01675622|54841349|FG000|Overall Study|Other|5|||
28169943|NCT01675622|54841350|FG001|Overall Study|Other|4|||
28169944|NCT02655224|54841358|FG000|Overall Study|Adverse Event|1|||
28169945|NCT02655224|54841359|FG001|Overall Study|Adverse Event|1|||
28169946|NCT01675544|54841365|FG000|Overall Study|Withdrawal by Subject|2|||
28169947|NCT02838901|54841408|FG000|Overall Study|Withdrawal by Subject|1|||
27856255|NCT03670953|54387480|FG002|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
28094576|NCT03099304|54748175|FG003|DB Period: Weeks 24 to 52|Protocol Violation|0|||
28169948|NCT02838901|54841409|FG001|Overall Study|Withdrawal by Subject|1|||
28169949|NCT02838901|54841408|FG000|Overall Study|Lost to Follow-up|1|||
27856256|NCT03670953|54387481|FG003|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
28169950|NCT02838901|54841409|FG001|Overall Study|Lost to Follow-up|1|||
28169951|NCT00706797|54841437|FG000|Overall Study|Lack of Efficacy|3|||
28169952|NCT00706797|54841438|FG001|Overall Study|Lack of Efficacy|0|||
28169953|NCT00706797|54841437|FG000|Overall Study|Adverse Event|0|||
28169954|NCT00706797|54841438|FG001|Overall Study|Adverse Event|3|||
28169955|NCT00706797|54841437|FG000|Overall Study|Withdrawal by Subject|8|||
28169956|NCT00706797|54841438|FG001|Overall Study|Withdrawal by Subject|1|||
28169957|NCT00706797|54841437|FG000|Overall Study|Death|1|||
27737298|NCT00151775|54186391|FG011|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
27737299|NCT00151775|54186380|FG000|Period 2 - Double-Blind Dose Response|Other|0|||
27737300|NCT00151775|54186381|FG001|Period 2 - Double-Blind Dose Response|Other|0|||
27737301|NCT00151775|54186382|FG002|Period 2 - Double-Blind Dose Response|Other|0|||
27737302|NCT00151775|54186383|FG003|Period 2 - Double-Blind Dose Response|Other|0|||
27737303|NCT00151775|54186384|FG004|Period 2 - Double-Blind Dose Response|Other|0|||
27737304|NCT00151775|54186385|FG005|Period 2 - Double-Blind Dose Response|Other|0|||
27737305|NCT00151775|54186386|FG006|Period 2 - Double-Blind Dose Response|Other|1|||
27737306|NCT00151775|54186387|FG007|Period 2 - Double-Blind Dose Response|Other|0|||
27737307|NCT00151775|54186388|FG008|Period 2 - Double-Blind Dose Response|Other|0|||
27737308|NCT00151775|54186389|FG009|Period 2 - Double-Blind Dose Response|Other|0|||
27980853|NCT00890552|54638790|FG000|On-treatment|Early prog disease/ death|10|||
27980854|NCT00946985|54638794|FG000|Stabilization Phase (25 Weeks)|Adverse Event|4|||
27737309|NCT00151775|54186390|FG010|Period 2 - Double-Blind Dose Response|Other|0|||
27737310|NCT00151775|54186391|FG011|Period 2 - Double-Blind Dose Response|Other|0|||
27737311|NCT00151775|54186380|FG000|Period 2 - Double-Blind Dose Response|non-compliance|0|||
27737312|NCT00151775|54186381|FG001|Period 2 - Double-Blind Dose Response|non-compliance|0|||
27737313|NCT00151775|54186382|FG002|Period 2 - Double-Blind Dose Response|non-compliance|0|||
27737314|NCT00151775|54186383|FG003|Period 2 - Double-Blind Dose Response|non-compliance|0|||
27737315|NCT00151775|54186384|FG004|Period 2 - Double-Blind Dose Response|non-compliance|0|||
27737316|NCT00151775|54186385|FG005|Period 2 - Double-Blind Dose Response|non-compliance|1|||
27737317|NCT00151775|54186386|FG006|Period 2 - Double-Blind Dose Response|non-compliance|0|||
27737318|NCT00151775|54186387|FG007|Period 2 - Double-Blind Dose Response|non-compliance|0|||
27737319|NCT00151775|54186388|FG008|Period 2 - Double-Blind Dose Response|non-compliance|0|||
27737320|NCT00151775|54186389|FG009|Period 2 - Double-Blind Dose Response|non-compliance|0|||
27737321|NCT00151775|54186390|FG010|Period 2 - Double-Blind Dose Response|non-compliance|0|||
27737322|NCT00151775|54186391|FG011|Period 2 - Double-Blind Dose Response|non-compliance|0|||
27737323|NCT00151775|54186380|FG000|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
27737324|NCT00151775|54186381|FG001|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
27737325|NCT00151775|54186382|FG002|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
27737326|NCT00151775|54186383|FG003|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
27980855|NCT00946985|54638794|FG000|Stabilization Phase (25 Weeks)|Lack of Efficacy|3|||
27980856|NCT00946985|54638794|FG000|Stabilization Phase (25 Weeks)|Lost to Follow-up|5|||
27980857|NCT00946985|54638794|FG000|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4|||
27980858|NCT00946985|54638794|FG000|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139|||
27737327|NCT00151775|54186384|FG004|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
27737328|NCT00151775|54186385|FG005|Period 2 - Double-Blind Dose Response|Physician Decision|1|||
27737329|NCT00151775|54186386|FG006|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
27737330|NCT00151775|54186387|FG007|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
27737331|NCT00151775|54186388|FG008|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
27737332|NCT00151775|54186389|FG009|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
27737333|NCT00151775|54186390|FG010|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
27737334|NCT00151775|54186391|FG011|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
27737335|NCT00151775|54186380|FG000|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
27980859|NCT00946985|54638794|FG000|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2|||
27980860|NCT00946985|54638794|FG000|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1|||
27980861|NCT00946985|54638794|FG000|Stabilization Phase (25 Weeks)|Patient Moved Away|2|||
27980862|NCT00946985|54638794|FG000|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2|||
27737336|NCT00151775|54186381|FG001|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
27737337|NCT00151775|54186382|FG002|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
27737338|NCT00151775|54186383|FG003|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
27737339|NCT00151775|54186384|FG004|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
27737340|NCT00151775|54186385|FG005|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
27737341|NCT00151775|54186386|FG006|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1|||
27737342|NCT00151775|54186387|FG007|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
27980863|NCT00611923|54638800|FG000|Overall Study|Withdrawal by Subject|2|||
27980864|NCT00611923|54638801|FG001|Overall Study|Withdrawal by Subject|2|||
27980865|NCT00609973|54638811|FG000|Overall Study|Adverse Event|2|||
28169958|NCT00706797|54841438|FG001|Overall Study|Death|0|||
28169959|NCT00706797|54841437|FG000|Overall Study|Discontinuation of study by sponsor|52|||
27980866|NCT00609973|54638812|FG001|Overall Study|Adverse Event|1|||
27980867|NCT00609973|54638811|FG000|Overall Study|Protocol Violation|4|||
27980868|NCT00609973|54638812|FG001|Overall Study|Protocol Violation|3|||
27980869|NCT00609973|54638811|FG000|Overall Study|Lost to Follow-up|2|||
27980870|NCT00609973|54638812|FG001|Overall Study|Lost to Follow-up|1|||
27980871|NCT00609973|54638811|FG000|Overall Study|Withdrawal by Subject|0|||
27980872|NCT00609973|54638812|FG001|Overall Study|Withdrawal by Subject|1|||
27980873|NCT00803049|54638822|FG000|Overall Study|Adverse Event|21|||
27980874|NCT00803049|54638823|FG001|Overall Study|Adverse Event|33|||
27980875|NCT00803049|54638824|FG002|Overall Study|Adverse Event|13|||
27980876|NCT00803049|54638825|FG003|Overall Study|Adverse Event|27|||
27980877|NCT00803049|54638822|FG000|Overall Study|Lack of Efficacy|10|||
27980878|NCT00803049|54638823|FG001|Overall Study|Lack of Efficacy|19|||
27980879|NCT00803049|54638824|FG002|Overall Study|Lack of Efficacy|6|||
27737343|NCT00151775|54186388|FG008|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
27737344|NCT00151775|54186389|FG009|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
27737345|NCT00151775|54186390|FG010|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
27737346|NCT00151775|54186391|FG011|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
27737347|NCT00151775|54186380|FG000|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
27737348|NCT00151775|54186381|FG001|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
27737349|NCT00151775|54186382|FG002|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
27737350|NCT00151775|54186383|FG003|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
27737351|NCT00151775|54186384|FG004|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
27737352|NCT00151775|54186385|FG005|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1|||
27737353|NCT00151775|54186386|FG006|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
27737354|NCT00151775|54186387|FG007|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
27737355|NCT00151775|54186388|FG008|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
27737356|NCT00151775|54186389|FG009|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
27737357|NCT00151775|54186390|FG010|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
27737358|NCT00151775|54186391|FG011|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
27737359|NCT00151775|54186380|FG000|Period 3: Double-blind, Withdrawal|Other|0|||
27737360|NCT00151775|54186381|FG001|Period 3: Double-blind, Withdrawal|Other|0|||
27737361|NCT00151775|54186382|FG002|Period 3: Double-blind, Withdrawal|Other|1|||
27737362|NCT00151775|54186383|FG003|Period 3: Double-blind, Withdrawal|Other|0|||
27737363|NCT00151775|54186384|FG004|Period 3: Double-blind, Withdrawal|Other|0|||
27737364|NCT00151775|54186385|FG005|Period 3: Double-blind, Withdrawal|Other|0|||
27737365|NCT00151775|54186386|FG006|Period 3: Double-blind, Withdrawal|Other|0|||
27980880|NCT00803049|54638825|FG003|Overall Study|Lack of Efficacy|13|||
27980881|NCT00803049|54638822|FG000|Overall Study|Lost to Follow-up|0|||
27980882|NCT00803049|54638823|FG001|Overall Study|Lost to Follow-up|2|||
27980883|NCT00803049|54638824|FG002|Overall Study|Lost to Follow-up|0|||
28094577|NCT03099304|54748176|FG004|DB Period: Weeks 24 to 52|Protocol Violation|0|||
28169960|NCT00706797|54841438|FG001|Overall Study|Discontinuation of study by sponsor|63|||
28169961|NCT00706797|54841437|FG000|Overall Study|Protocol Violation|3|||
27737366|NCT00151775|54186387|FG007|Period 3: Double-blind, Withdrawal|Other|1|||
27737367|NCT00151775|54186388|FG008|Period 3: Double-blind, Withdrawal|Other|0|||
28094578|NCT03099304|54748177|FG005|DB Period: Weeks 24 to 52|Protocol Violation|0|||
28094579|NCT03099304|54748172|FG000|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
28094580|NCT03099304|54748173|FG001|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
28094581|NCT03099304|54748174|FG002|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
27737368|NCT00151775|54186389|FG009|Period 3: Double-blind, Withdrawal|Other|0|||
27737369|NCT00151775|54186390|FG010|Period 3: Double-blind, Withdrawal|Other|0|||
28094582|NCT03099304|54748175|FG003|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
28094583|NCT03099304|54748176|FG004|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
28094584|NCT03099304|54748177|FG005|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
28094585|NCT03099304|54748172|FG000|DB Period: Weeks 24 to 52|Adverse Event|0|||
28094586|NCT03099304|54748173|FG001|DB Period: Weeks 24 to 52|Adverse Event|0|||
28094587|NCT03099304|54748174|FG002|DB Period: Weeks 24 to 52|Adverse Event|0|||
28094588|NCT03099304|54748175|FG003|DB Period: Weeks 24 to 52|Adverse Event|1|||
28169962|NCT00706797|54841438|FG001|Overall Study|Protocol Violation|2|||
27737370|NCT00151775|54186391|FG011|Period 3: Double-blind, Withdrawal|Other|0|||
27737371|NCT00151775|54186380|FG000|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
27737372|NCT00151775|54186381|FG001|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
27737373|NCT00151775|54186382|FG002|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
28169963|NCT00706797|54841437|FG000|Overall Study|Lost to Follow-up|1|||
28169964|NCT00706797|54841438|FG001|Overall Study|Lost to Follow-up|2|||
28169965|NCT00706797|54841437|FG000|Overall Study|Other|1|||
27737374|NCT00151775|54186383|FG003|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
27980884|NCT00803049|54638825|FG003|Overall Study|Lost to Follow-up|3|||
27980885|NCT00803049|54638822|FG000|Overall Study|Death|2|||
28169966|NCT00706797|54841438|FG001|Overall Study|Other|0|||
28169967|NCT00706641|54841444|FG000|Dasatinib Administration|Withdrawal by Subject|1|||
27737375|NCT00151775|54186384|FG004|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
27737376|NCT00151775|54186385|FG005|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
27737377|NCT00151775|54186386|FG006|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1|||
27737378|NCT00151775|54186387|FG007|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
27737379|NCT00151775|54186388|FG008|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
28169968|NCT00706641|54841444|FG000|Dasatinib Administration|Ineligible after start of therapy|1|||
28169969|NCT00706641|54841444|FG000|Radical Cystectomy|Deemed unresectable upon exploration|1|||
28169970|NCT01362530|54841450|FG000|Base Study (Cycle 1)|Adverse Event|2|||
28169971|NCT01362530|54841451|FG001|Base Study (Cycle 1)|Adverse Event|0|||
28169972|NCT01362530|54841450|FG000|Base Study (Cycle 1)|Physician Decision|0|||
28169973|NCT01362530|54841451|FG001|Base Study (Cycle 1)|Physician Decision|1|||
28169974|NCT01362530|54841450|FG000|Base Study (Cycle 1)|Protocol Violation|2|||
28169975|NCT01362530|54841451|FG001|Base Study (Cycle 1)|Protocol Violation|0|||
28169976|NCT01362530|54841450|FG000|Base Study (Cycle 1)|Withdrawal by Subject|1|||
28169977|NCT01362530|54841451|FG001|Base Study (Cycle 1)|Withdrawal by Subject|2|||
28169978|NCT01362530|54841450|FG000|Optional Extension (Cycles 2-6)|Adverse Event|2|||
28169979|NCT01362530|54841451|FG001|Optional Extension (Cycles 2-6)|Adverse Event|0|||
28169980|NCT01362530|54841450|FG000|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51|||
28169981|NCT01362530|54841451|FG001|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0|||
28169982|NCT01362530|54841450|FG000|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25|||
28169983|NCT01362530|54841451|FG001|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0|||
28169984|NCT01362530|54841450|FG000|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4|||
28169985|NCT01362530|54841451|FG001|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0|||
27737380|NCT00151775|54186389|FG009|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
27737381|NCT00151775|54186390|FG010|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
27737382|NCT00151775|54186391|FG011|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
27737383|NCT00151775|54186380|FG000|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
27737384|NCT00151775|54186381|FG001|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
27737385|NCT00151775|54186382|FG002|Period 3: Double-blind, Withdrawal|Adverse Event|1|||
27737386|NCT00151775|54186383|FG003|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
27737387|NCT00151775|54186384|FG004|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
27737388|NCT00151775|54186385|FG005|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
27737389|NCT00151775|54186386|FG006|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
27737390|NCT00151775|54186387|FG007|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
27737391|NCT00151775|54186388|FG008|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
27737392|NCT00151775|54186389|FG009|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
27737393|NCT00151775|54186390|FG010|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
27737394|NCT00151775|54186391|FG011|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
27737395|NCT00151775|54186380|FG000|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
27737396|NCT00151775|54186381|FG001|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
27737397|NCT00151775|54186382|FG002|Period 3: Double-blind, Withdrawal|Protocol Violation|1|||
27737398|NCT00151775|54186383|FG003|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
27737399|NCT00151775|54186384|FG004|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
27737400|NCT00151775|54186385|FG005|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
27737401|NCT00151775|54186386|FG006|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
27737402|NCT00151775|54186387|FG007|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
28169986|NCT01362530|54841450|FG000|Optional Extension (Cycles 2-6)|Lack of Efficacy|1|||
28169987|NCT01362530|54841451|FG001|Optional Extension (Cycles 2-6)|Lack of Efficacy|0|||
28169988|NCT01362530|54841450|FG000|Optional Extension (Cycles 2-6)|Lost to Follow-up|1|||
28169989|NCT01362530|54841451|FG001|Optional Extension (Cycles 2-6)|Lost to Follow-up|0|||
28169990|NCT01362530|54841450|FG000|Optional Extension (Cycles 2-6)|Physician Decision|19|||
28169991|NCT01362530|54841451|FG001|Optional Extension (Cycles 2-6)|Physician Decision|0|||
28169992|NCT01362530|54841450|FG000|Optional Extension (Cycles 2-6)|Protocol Violation|4|||
28169993|NCT01362530|54841451|FG001|Optional Extension (Cycles 2-6)|Protocol Violation|0|||
28169994|NCT01362530|54841450|FG000|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18|||
28169995|NCT01362530|54841451|FG001|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0|||
28169996|NCT02654054|54841461|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
28169997|NCT02654054|54841462|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
28169998|NCT02654054|54841463|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
28169999|NCT02654054|54841461|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
28170000|NCT02654054|54841462|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
28170001|NCT02654054|54841463|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
28170002|NCT02654054|54841461|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
28170003|NCT02654054|54841462|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
28170004|NCT02654054|54841463|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
28170005|NCT02654054|54841461|FG000|Post-Treatment Follow-Up Period|Other|1|||
27737403|NCT00151775|54186388|FG008|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
27737404|NCT00151775|54186389|FG009|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
27737405|NCT00151775|54186390|FG010|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
27737406|NCT00151775|54186391|FG011|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
27737407|NCT00151775|54186380|FG000|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
27737408|NCT00151775|54186381|FG001|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
27737409|NCT00151775|54186382|FG002|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
27737410|NCT00151775|54186383|FG003|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
28170006|NCT02654054|54841462|FG001|Post-Treatment Follow-Up Period|Other|0|||
28170007|NCT02654054|54841463|FG002|Post-Treatment Follow-Up Period|Other|4|||
28170008|NCT02654054|54841461|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
28170009|NCT02654054|54841462|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
27737411|NCT00151775|54186384|FG004|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
27737412|NCT00151775|54186385|FG005|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
27737413|NCT00151775|54186386|FG006|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
27737414|NCT00151775|54186387|FG007|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
27856257|NCT03670953|54387478|FG000|Dose Adjustment (Weeks 1- 3)|Protocol Violation|6|||
27856258|NCT03670953|54387479|FG001|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
28094589|NCT03099304|54748176|FG004|DB Period: Weeks 24 to 52|Adverse Event|1|||
28170010|NCT02654054|54841463|FG002|Post-Treatment Follow-Up Period|Non-Compliance|4|||
28170011|NCT02653664|54841484|FG000|Post-Treatment|Withdrawal by Subject|6|||
28170012|NCT02653664|54841485|FG001|Post-Treatment|Withdrawal by Subject|5|||
28170013|NCT02653664|54841486|FG002|Post-Treatment|Withdrawal by Subject|7|||
28170014|NCT02653664|54841484|FG000|Post-Treatment|Lost to Follow-up|8|||
28170015|NCT02653664|54841485|FG001|Post-Treatment|Lost to Follow-up|1|||
28170016|NCT02653664|54841486|FG002|Post-Treatment|Lost to Follow-up|7|||
28170017|NCT02653664|54841484|FG000|3 Month Follow-Up|Withdrawal by Subject|9|||
28170018|NCT02653664|54841485|FG001|3 Month Follow-Up|Withdrawal by Subject|5|||
28170019|NCT02653664|54841486|FG002|3 Month Follow-Up|Withdrawal by Subject|9|||
28170020|NCT02653664|54841484|FG000|3 Month Follow-Up|Lost to Follow-up|9|||
28094590|NCT03099304|54748177|FG005|DB Period: Weeks 24 to 52|Adverse Event|0|||
28094591|NCT03099304|54748172|FG000|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
28094592|NCT03099304|54748173|FG001|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
28094593|NCT03099304|54748174|FG002|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
28170021|NCT02653664|54841485|FG001|3 Month Follow-Up|Lost to Follow-up|8|||
28094594|NCT03099304|54748175|FG003|DB Period: Weeks 24 to 52|Withdrawal by Subject|4|||
28094595|NCT03099304|54748176|FG004|DB Period: Weeks 24 to 52|Withdrawal by Subject|1|||
27856259|NCT03670953|54387480|FG002|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
27856260|NCT03670953|54387481|FG003|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
27856261|NCT03670953|54387478|FG000|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|9|||
27856262|NCT03670953|54387479|FG001|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
28094596|NCT03099304|54748177|FG005|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
28094597|NCT03099304|54748172|FG000|DB Period: Weeks 24 to 52|Reason not specified|0|||
28094598|NCT03099304|54748173|FG001|DB Period: Weeks 24 to 52|Reason not specified|0|||
28094599|NCT03099304|54748174|FG002|DB Period: Weeks 24 to 52|Reason not specified|0|||
28094600|NCT03099304|54748175|FG003|DB Period: Weeks 24 to 52|Reason not specified|1|||
28094601|NCT03099304|54748176|FG004|DB Period: Weeks 24 to 52|Reason not specified|0|||
28094602|NCT03099304|54748177|FG005|DB Period: Weeks 24 to 52|Reason not specified|0|||
28094603|NCT03099304|54748172|FG000|104-week Open-Label Extension Period|Adverse Event|0|||
28094604|NCT03099304|54748173|FG001|104-week Open-Label Extension Period|Adverse Event|0|||
28094605|NCT03099304|54748174|FG002|104-week Open-Label Extension Period|Adverse Event|1|||
28094606|NCT03099304|54748175|FG003|104-week Open-Label Extension Period|Adverse Event|0|||
28094607|NCT03099304|54748176|FG004|104-week Open-Label Extension Period|Adverse Event|0|||
28094608|NCT03099304|54748177|FG005|104-week Open-Label Extension Period|Adverse Event|0|||
28094609|NCT03099304|54748172|FG000|104-week Open-Label Extension Period|Lost to Follow-up|0|||
28094610|NCT03099304|54748173|FG001|104-week Open-Label Extension Period|Lost to Follow-up|0|||
28094611|NCT03099304|54748174|FG002|104-week Open-Label Extension Period|Lost to Follow-up|3|||
28094612|NCT03099304|54748175|FG003|104-week Open-Label Extension Period|Lost to Follow-up|2|||
28094613|NCT03099304|54748176|FG004|104-week Open-Label Extension Period|Lost to Follow-up|1|||
28094614|NCT03099304|54748177|FG005|104-week Open-Label Extension Period|Lost to Follow-up|6|||
28094615|NCT03099304|54748172|FG000|104-week Open-Label Extension Period|Physician Decision|0|||
28094616|NCT03099304|54748173|FG001|104-week Open-Label Extension Period|Physician Decision|0|||
28094617|NCT03099304|54748174|FG002|104-week Open-Label Extension Period|Physician Decision|0|||
28094618|NCT03099304|54748175|FG003|104-week Open-Label Extension Period|Physician Decision|0|||
28094619|NCT03099304|54748176|FG004|104-week Open-Label Extension Period|Physician Decision|1|||
28170022|NCT02653664|54841486|FG002|3 Month Follow-Up|Lost to Follow-up|16|||
28170023|NCT02653664|54841484|FG000|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
28170024|NCT02653664|54841485|FG001|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
27856263|NCT03670953|54387480|FG002|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
27737415|NCT00151775|54186388|FG008|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
27737416|NCT00151775|54186389|FG009|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
27737417|NCT00151775|54186390|FG010|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
27737418|NCT00151775|54186391|FG011|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1|||
27737419|NCT00151775|54186380|FG000|Period 4: Open Label|Increased blood pressure|0|||
27737420|NCT00151775|54186381|FG001|Period 4: Open Label|Increased blood pressure|0|||
27737421|NCT00151775|54186382|FG002|Period 4: Open Label|Increased blood pressure|0|||
27833521|NCT01738919|54316259|FG001|Overall Study|Withdrawal by Subject|1|||
27833522|NCT01738919|54316258|FG000|Overall Study|Not treated in accordance to guidelines|0|||
27833523|NCT01738919|54316259|FG001|Overall Study|Not treated in accordance to guidelines|1|||
27980886|NCT00803049|54638823|FG001|Overall Study|Death|1|||
27980887|NCT00803049|54638824|FG002|Overall Study|Death|0|||
27980888|NCT00803049|54638825|FG003|Overall Study|Death|2|||
27980889|NCT00803049|54638822|FG000|Overall Study|Progressive Disease|6|||
27980890|NCT00803049|54638823|FG001|Overall Study|Progressive Disease|10|||
27980891|NCT00803049|54638824|FG002|Overall Study|Progressive Disease|6|||
27980892|NCT00803049|54638825|FG003|Overall Study|Progressive Disease|6|||
28170025|NCT02653664|54841486|FG002|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
28170026|NCT02653664|54841484|FG000|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|3|||
28170027|NCT02653664|54841485|FG001|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
28170028|NCT02653664|54841486|FG002|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
28170029|NCT02653664|54841484|FG000|6 Month Follow-Up|Withdrawal by Subject|13|||
28170030|NCT02653664|54841485|FG001|6 Month Follow-Up|Withdrawal by Subject|7|||
28170031|NCT02653664|54841486|FG002|6 Month Follow-Up|Withdrawal by Subject|14|||
28170032|NCT02653664|54841484|FG000|6 Month Follow-Up|Lost to Follow-up|10|||
28170033|NCT02653664|54841485|FG001|6 Month Follow-Up|Lost to Follow-up|11|||
28170034|NCT02653664|54841486|FG002|6 Month Follow-Up|Lost to Follow-up|9|||
28170035|NCT02653664|54841484|FG000|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
27980893|NCT00803049|54638822|FG000|Overall Study|Withdrawal by Subject|19|||
28170036|NCT02653664|54841485|FG001|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
28170037|NCT02653664|54841486|FG002|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
28170038|NCT02653664|54841484|FG000|6 Month Follow-Up|Subject Declined Assessment Period|0|||
28170039|NCT02653664|54841485|FG001|6 Month Follow-Up|Subject Declined Assessment Period|1|||
28170040|NCT02653664|54841486|FG002|6 Month Follow-Up|Subject Declined Assessment Period|0|||
28170041|NCT02488629|54841504|FG000|Overall Study|Lack of Efficacy|3|||
27980894|NCT00803049|54638823|FG001|Overall Study|Withdrawal by Subject|43|||
27980895|NCT00803049|54638824|FG002|Overall Study|Withdrawal by Subject|16|||
27980896|NCT00803049|54638825|FG003|Overall Study|Withdrawal by Subject|44|||
27980897|NCT00803049|54638822|FG000|Overall Study|Protocol Violation|0|||
27980898|NCT00803049|54638823|FG001|Overall Study|Protocol Violation|1|||
27980899|NCT00803049|54638824|FG002|Overall Study|Protocol Violation|1|||
27980900|NCT00803049|54638825|FG003|Overall Study|Protocol Violation|0|||
27980901|NCT00803049|54638822|FG000|Overall Study|Randomized and Not Treated|0|||
27980902|NCT00803049|54638823|FG001|Overall Study|Randomized and Not Treated|0|||
27980903|NCT00803049|54638824|FG002|Overall Study|Randomized and Not Treated|0|||
27980904|NCT00803049|54638825|FG003|Overall Study|Randomized and Not Treated|2|||
27980905|NCT00803049|54638822|FG000|Overall Study|Other than Specified Above|3|||
27980906|NCT00803049|54638823|FG001|Overall Study|Other than Specified Above|9|||
27980907|NCT00803049|54638824|FG002|Overall Study|Other than Specified Above|2|||
27980908|NCT00803049|54638825|FG003|Overall Study|Other than Specified Above|5|||
27980909|NCT00890084|54638835|FG000|Overall Study|Adverse Event|16|||
27980910|NCT00890084|54638835|FG000|Overall Study|Lost to Follow-up|126|||
27980911|NCT00802893|54638848|FG000|Overall Study|study terminated|3|||
27980912|NCT00608569|54638869|FG000|Overall Study|Death|4|||
27980913|NCT00608569|54638870|FG001|Overall Study|Death|3|||
27980914|NCT00608569|54638869|FG000|Overall Study|Lost to Follow-up|4|||
27980915|NCT00608569|54638870|FG001|Overall Study|Lost to Follow-up|5|||
27980916|NCT00608569|54638869|FG000|Overall Study|Withdrawal by Subject|1|||
28170042|NCT02488629|54841505|FG001|Overall Study|Lack of Efficacy|1|||
28170043|NCT02488629|54841506|FG002|Overall Study|Lack of Efficacy|0|||
28170044|NCT02488629|54841507|FG003|Overall Study|Lack of Efficacy|0|||
28170045|NCT02488629|54841504|FG000|Overall Study|Withdrawal by Subject|0|||
28170046|NCT02488629|54841505|FG001|Overall Study|Withdrawal by Subject|1|||
28170047|NCT02488629|54841506|FG002|Overall Study|Withdrawal by Subject|0|||
28170048|NCT02488629|54841507|FG003|Overall Study|Withdrawal by Subject|0|||
27980917|NCT00608569|54638870|FG001|Overall Study|Withdrawal by Subject|0|||
27980918|NCT00608569|54638869|FG000|Overall Study|Adverse Event|1|||
27980919|NCT00608569|54638870|FG001|Overall Study|Adverse Event|0|||
27980920|NCT00608569|54638869|FG000|Overall Study|Unable to adhere with study requirements|0|||
27980921|NCT00608569|54638870|FG001|Overall Study|Unable to adhere with study requirements|1|||
28170049|NCT02727699|54841518|FG000|Overall Study|Adverse Event|2|||
28170050|NCT02727699|54841519|FG001|Overall Study|Adverse Event|0|||
28170051|NCT02727699|54841518|FG000|Overall Study|Withdrawal by Subject|5|||
27980922|NCT00610675|54638876|FG000|Overall Study|Untreated|4|||
28094620|NCT03099304|54748177|FG005|104-week Open-Label Extension Period|Physician Decision|0|||
28094621|NCT03099304|54748172|FG000|104-week Open-Label Extension Period|Pregnancy|0|||
28094622|NCT03099304|54748173|FG001|104-week Open-Label Extension Period|Pregnancy|0|||
28094623|NCT03099304|54748174|FG002|104-week Open-Label Extension Period|Pregnancy|0|||
28094624|NCT03099304|54748175|FG003|104-week Open-Label Extension Period|Pregnancy|0|||
28094625|NCT03099304|54748176|FG004|104-week Open-Label Extension Period|Pregnancy|0|||
28094626|NCT03099304|54748177|FG005|104-week Open-Label Extension Period|Pregnancy|1|||
28094627|NCT03099304|54748172|FG000|104-week Open-Label Extension Period|Protocol Violation|0|||
28094628|NCT03099304|54748173|FG001|104-week Open-Label Extension Period|Protocol Violation|0|||
28170052|NCT02727699|54841519|FG001|Overall Study|Withdrawal by Subject|3|||
28170053|NCT02727699|54841518|FG000|Overall Study|Protocol Violation|0|||
28170054|NCT02727699|54841519|FG001|Overall Study|Protocol Violation|1|||
28170055|NCT02727699|54841518|FG000|Overall Study|Physician Decision|0|||
28170056|NCT02727699|54841519|FG001|Overall Study|Physician Decision|1|||
28170057|NCT02727699|54841518|FG000|Overall Study|Lost to Follow-up|1|||
28170058|NCT02727699|54841519|FG001|Overall Study|Lost to Follow-up|0|||
28170059|NCT02727699|54841518|FG000|Overall Study|Sponsor Decision|1|||
28170060|NCT02727699|54841519|FG001|Overall Study|Sponsor Decision|0|||
28170061|NCT03576716|54841527|FG000|Overall Study|Withdrawal by Subject|0|||
28170062|NCT03576716|54841528|FG001|Overall Study|Withdrawal by Subject|1|||
28170063|NCT02847637|54841547|FG000|Overall Study|Withdrawal by Subject|0|||
28170064|NCT02847637|54841548|FG001|Overall Study|Withdrawal by Subject|1|||
28170065|NCT02847637|54841549|FG002|Overall Study|Withdrawal by Subject|1|||
28170066|NCT02847637|54841550|FG003|Overall Study|Withdrawal by Subject|0|||
28170067|NCT02847637|54841547|FG000|Overall Study|Lost to Follow-up|1|||
28170068|NCT02847637|54841548|FG001|Overall Study|Lost to Follow-up|1|||
28170069|NCT02847637|54841549|FG002|Overall Study|Lost to Follow-up|0|||
28170070|NCT02847637|54841550|FG003|Overall Study|Lost to Follow-up|0|||
28170071|NCT02652260|54841576|FG000|Overall Study|Pregnancy|0|||
28170072|NCT02652260|54841577|FG001|Overall Study|Pregnancy|1|||
28170073|NCT02652260|54841576|FG000|Overall Study|Withdrawal by Subject|0|||
28170074|NCT02652260|54841577|FG001|Overall Study|Withdrawal by Subject|1|||
28170075|NCT00706095|54841589|FG000|Overall Study|Progressive Disease|4|||
28170076|NCT00706095|54841590|FG001|Overall Study|Progressive Disease|5|||
28170077|NCT00706095|54841591|FG002|Overall Study|Progressive Disease|3|||
28170078|NCT00706095|54841589|FG000|Overall Study|Clinical Progression|1|||
28170079|NCT00706095|54841590|FG001|Overall Study|Clinical Progression|2|||
28170080|NCT00706095|54841591|FG002|Overall Study|Clinical Progression|2|||
28170081|NCT00706095|54841589|FG000|Overall Study|Withdrawal by Subject|1|||
28170082|NCT00706095|54841590|FG001|Overall Study|Withdrawal by Subject|0|||
28170083|NCT00706095|54841591|FG002|Overall Study|Withdrawal by Subject|0|||
28170084|NCT02837731|54841601|FG000|Allocation|Admitted to General Floor|3|||
28170085|NCT02837731|54841602|FG001|Allocation|Admitted to General Floor|4|||
28170086|NCT02837731|54841601|FG000|Allocation|Immediate surgery/withdrew|2|||
28170087|NCT02837731|54841602|FG001|Allocation|Immediate surgery/withdrew|0|||
28170088|NCT02837731|54841601|FG000|Allocation|Diabetic Ketoacidosis/withdrew|1|||
28170089|NCT02837731|54841602|FG001|Allocation|Diabetic Ketoacidosis/withdrew|0|||
27737422|NCT00151775|54186383|FG003|Period 4: Open Label|Increased blood pressure|0|||
27737423|NCT00151775|54186384|FG004|Period 4: Open Label|Increased blood pressure|1|||
27737424|NCT00151775|54186385|FG005|Period 4: Open Label|Increased blood pressure|0|||
27737425|NCT00151775|54186386|FG006|Period 4: Open Label|Increased blood pressure|0|||
27737426|NCT00151775|54186387|FG007|Period 4: Open Label|Increased blood pressure|0|||
27737427|NCT00151775|54186388|FG008|Period 4: Open Label|Increased blood pressure|0|||
27737428|NCT00151775|54186389|FG009|Period 4: Open Label|Increased blood pressure|1|||
27737429|NCT00151775|54186390|FG010|Period 4: Open Label|Increased blood pressure|0|||
27737430|NCT00151775|54186391|FG011|Period 4: Open Label|Increased blood pressure|0|||
28094629|NCT03099304|54748174|FG002|104-week Open-Label Extension Period|Protocol Violation|0|||
28094630|NCT03099304|54748175|FG003|104-week Open-Label Extension Period|Protocol Violation|0|||
28094631|NCT03099304|54748176|FG004|104-week Open-Label Extension Period|Protocol Violation|0|||
28094632|NCT03099304|54748177|FG005|104-week Open-Label Extension Period|Protocol Violation|1|||
28094633|NCT03099304|54748172|FG000|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
28094634|NCT03099304|54748173|FG001|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
28094635|NCT03099304|54748174|FG002|104-week Open-Label Extension Period|Withdrawal by Subject|9|||
28170090|NCT02837731|54841601|FG000|Allocation|Withdrawal by Subject|2|||
28170091|NCT02837731|54841602|FG001|Allocation|Withdrawal by Subject|0|||
28170092|NCT02837731|54841601|FG000|Allocation|Device not available|1|||
28170093|NCT02837731|54841602|FG001|Allocation|Device not available|0|||
28170094|NCT02837731|54841601|FG000|Allocation|Protocol not implemented|7|||
28170095|NCT02837731|54841602|FG001|Allocation|Protocol not implemented|0|||
28170096|NCT02837731|54841601|FG000|Allocation|Moribund/Do not resuscitate|2|||
28170097|NCT02837731|54841602|FG001|Allocation|Moribund/Do not resuscitate|0|||
28170098|NCT02837731|54841601|FG000|Allocation|Did not meet sepsis criteria|1|||
28170099|NCT02837731|54841602|FG001|Allocation|Did not meet sepsis criteria|2|||
28170100|NCT02837731|54841601|FG000|Allocation|Known aortic abnormalities|0|||
28170101|NCT02837731|54841602|FG001|Allocation|Known aortic abnormalities|1|||
28170102|NCT02836873|54841610|FG000|Overall Study|Protocol Violation|0|||
28170103|NCT02836873|54841611|FG001|Overall Study|Protocol Violation|1|||
28170104|NCT02836873|54841610|FG000|Overall Study|Adverse Event|1|||
27737431|NCT00151775|54186380|FG000|Period 4: Open Label|Withdrawal by Subject|0|||
27737432|NCT00151775|54186381|FG001|Period 4: Open Label|Withdrawal by Subject|0|||
27737433|NCT00151775|54186382|FG002|Period 4: Open Label|Withdrawal by Subject|0|||
27737434|NCT00151775|54186383|FG003|Period 4: Open Label|Withdrawal by Subject|0|||
27737435|NCT00151775|54186384|FG004|Period 4: Open Label|Withdrawal by Subject|5|||
27737436|NCT00151775|54186385|FG005|Period 4: Open Label|Withdrawal by Subject|0|||
27737437|NCT00151775|54186386|FG006|Period 4: Open Label|Withdrawal by Subject|0|||
27737438|NCT00151775|54186387|FG007|Period 4: Open Label|Withdrawal by Subject|0|||
27737439|NCT00151775|54186388|FG008|Period 4: Open Label|Withdrawal by Subject|0|||
27737440|NCT00151775|54186389|FG009|Period 4: Open Label|Withdrawal by Subject|2|||
27737441|NCT00151775|54186390|FG010|Period 4: Open Label|Withdrawal by Subject|0|||
27737442|NCT00151775|54186391|FG011|Period 4: Open Label|Withdrawal by Subject|0|||
27737443|NCT00151775|54186380|FG000|Period 4: Open Label|Adverse Event|0|||
27737444|NCT00151775|54186381|FG001|Period 4: Open Label|Adverse Event|0|||
27737445|NCT00151775|54186382|FG002|Period 4: Open Label|Adverse Event|0|||
27737446|NCT00151775|54186383|FG003|Period 4: Open Label|Adverse Event|0|||
27737447|NCT00151775|54186384|FG004|Period 4: Open Label|Adverse Event|1|||
27737448|NCT00151775|54186385|FG005|Period 4: Open Label|Adverse Event|0|||
27737449|NCT00151775|54186386|FG006|Period 4: Open Label|Adverse Event|0|||
27737450|NCT00151775|54186387|FG007|Period 4: Open Label|Adverse Event|0|||
27737451|NCT00151775|54186388|FG008|Period 4: Open Label|Adverse Event|0|||
27737452|NCT00151775|54186389|FG009|Period 4: Open Label|Adverse Event|2|||
27737453|NCT00151775|54186390|FG010|Period 4: Open Label|Adverse Event|0|||
27737454|NCT00151775|54186391|FG011|Period 4: Open Label|Adverse Event|0|||
27737455|NCT00151775|54186380|FG000|Period 4: Open Label|Lost to Follow-up|0|||
27737456|NCT00151775|54186381|FG001|Period 4: Open Label|Lost to Follow-up|0|||
27737457|NCT00151775|54186382|FG002|Period 4: Open Label|Lost to Follow-up|0|||
27737458|NCT00151775|54186383|FG003|Period 4: Open Label|Lost to Follow-up|0|||
27737459|NCT00151775|54186384|FG004|Period 4: Open Label|Lost to Follow-up|17|||
27737460|NCT00151775|54186385|FG005|Period 4: Open Label|Lost to Follow-up|0|||
27737461|NCT00151775|54186386|FG006|Period 4: Open Label|Lost to Follow-up|0|||
27737462|NCT00151775|54186387|FG007|Period 4: Open Label|Lost to Follow-up|0|||
27737463|NCT00151775|54186388|FG008|Period 4: Open Label|Lost to Follow-up|0|||
27980923|NCT00610675|54638876|FG000|Overall Study|Adverse Event|67|||
27980924|NCT00610675|54638876|FG000|Overall Study|Insufficient Effect|31|||
27980925|NCT00610675|54638876|FG000|Overall Study|Withdrawal by Subject|28|||
28094636|NCT03099304|54748175|FG003|104-week Open-Label Extension Period|Withdrawal by Subject|10|||
27737464|NCT00151775|54186389|FG009|Period 4: Open Label|Lost to Follow-up|7|||
27737465|NCT00151775|54186390|FG010|Period 4: Open Label|Lost to Follow-up|0|||
27737466|NCT00151775|54186391|FG011|Period 4: Open Label|Lost to Follow-up|0|||
27737467|NCT00151775|54186380|FG000|Period 4: Open Label|Non-compliance with protocol|0|||
27737468|NCT00151775|54186381|FG001|Period 4: Open Label|Non-compliance with protocol|0|||
27737469|NCT00151775|54186382|FG002|Period 4: Open Label|Non-compliance with protocol|0|||
27737470|NCT00151775|54186383|FG003|Period 4: Open Label|Non-compliance with protocol|0|||
27737471|NCT00151775|54186384|FG004|Period 4: Open Label|Non-compliance with protocol|4|||
27737472|NCT00151775|54186385|FG005|Period 4: Open Label|Non-compliance with protocol|0|||
27737473|NCT00151775|54186386|FG006|Period 4: Open Label|Non-compliance with protocol|0|||
27737474|NCT00151775|54186387|FG007|Period 4: Open Label|Non-compliance with protocol|0|||
27737475|NCT00151775|54186388|FG008|Period 4: Open Label|Non-compliance with protocol|0|||
27737476|NCT00151775|54186389|FG009|Period 4: Open Label|Non-compliance with protocol|4|||
27737477|NCT00151775|54186390|FG010|Period 4: Open Label|Non-compliance with protocol|0|||
27737478|NCT00151775|54186391|FG011|Period 4: Open Label|Non-compliance with protocol|0|||
27737479|NCT00151775|54186380|FG000|Period 4: Open Label|Other|0|||
28094637|NCT03099304|54748176|FG004|104-week Open-Label Extension Period|Withdrawal by Subject|13|||
28094638|NCT03099304|54748177|FG005|104-week Open-Label Extension Period|Withdrawal by Subject|15|||
28094639|NCT03099304|54748172|FG000|104-week Open-Label Extension Period|Other Reason not specified|0|||
28094640|NCT03099304|54748173|FG001|104-week Open-Label Extension Period|Other Reason not specified|0|||
28094641|NCT03099304|54748174|FG002|104-week Open-Label Extension Period|Other Reason not specified|4|||
28094642|NCT03099304|54748175|FG003|104-week Open-Label Extension Period|Other Reason not specified|1|||
28094643|NCT03099304|54748176|FG004|104-week Open-Label Extension Period|Other Reason not specified|1|||
28094644|NCT03099304|54748177|FG005|104-week Open-Label Extension Period|Other Reason not specified|0|||
28170105|NCT02836873|54841611|FG001|Overall Study|Adverse Event|4|||
28170106|NCT02836873|54841610|FG000|Overall Study|Withdrawal by Subject|2|||
28170107|NCT02836873|54841611|FG001|Overall Study|Withdrawal by Subject|2|||
27737480|NCT00151775|54186381|FG001|Period 4: Open Label|Other|0|||
27737481|NCT00151775|54186382|FG002|Period 4: Open Label|Other|0|||
27737482|NCT00151775|54186383|FG003|Period 4: Open Label|Other|0|||
27980926|NCT00610675|54638876|FG000|Overall Study|Reasons unrelated to trial|27|||
28170108|NCT02836873|54841610|FG000|Overall Study|Lost to Follow-up|1|||
28170109|NCT02836873|54841611|FG001|Overall Study|Lost to Follow-up|3|||
28170110|NCT02836873|54841610|FG000|Overall Study|Physician Decision|0|||
28170111|NCT02836873|54841611|FG001|Overall Study|Physician Decision|1|||
28170112|NCT02836873|54841610|FG000|Overall Study|Other|1|||
28170113|NCT02836873|54841611|FG001|Overall Study|Other|0|||
28170114|NCT02836249|54841619|FG000|Overall Study|Randomized but Never Treated|0|||
27856264|NCT03670953|54387481|FG003|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
27856265|NCT03670953|54387478|FG000|Dose Adjustment (Weeks 1- 3)|Miscellaneous|21|||
27856266|NCT03670953|54387479|FG001|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
27856267|NCT03670953|54387480|FG002|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
27856268|NCT03670953|54387481|FG003|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
27856269|NCT03670953|54387478|FG000|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
27856270|NCT03670953|54387479|FG001|Dose Conversion (Weeks 4 - 7)|Adverse Event|35|||
27856271|NCT03670953|54387480|FG002|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
27856272|NCT03670953|54387481|FG003|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
27856273|NCT03670953|54387478|FG000|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
27856274|NCT03670953|54387479|FG001|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|10|||
27856275|NCT03670953|54387480|FG002|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
28094645|NCT03097588|54748204|FG000|Overall Study|Adverse Event|1|||
28094646|NCT01631214|54748210|FG000|Overall Study|Withdrawal by Subject|276|||
28094647|NCT01631214|54748211|FG001|Overall Study|Withdrawal by Subject|290|||
28094648|NCT01631214|54748210|FG000|Overall Study|Death|113|||
28094649|NCT01631214|54748211|FG001|Overall Study|Death|106|||
28094650|NCT01631214|54748210|FG000|Overall Study|Lost to Follow-up|54|||
28094651|NCT01631214|54748211|FG001|Overall Study|Lost to Follow-up|40|||
27856276|NCT03670953|54387481|FG003|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
27856277|NCT03670953|54387478|FG000|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
27856278|NCT03670953|54387479|FG001|Dose Conversion (Weeks 4 - 7)|Protocol Violation|1|||
27856279|NCT03670953|54387480|FG002|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
27856280|NCT03670953|54387481|FG003|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
27856281|NCT03670953|54387478|FG000|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
27856282|NCT03670953|54387479|FG001|Dose Conversion (Weeks 4 - 7)|Non compliance|2|||
27856283|NCT03670953|54387480|FG002|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
27856284|NCT03670953|54387481|FG003|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
27856285|NCT03670953|54387478|FG000|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
27856286|NCT03670953|54387479|FG001|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|1|||
27856287|NCT03670953|54387480|FG002|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
27856288|NCT03670953|54387481|FG003|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
27856289|NCT03670953|54387478|FG000|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
27856290|NCT03670953|54387479|FG001|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|32|||
27856291|NCT03670953|54387480|FG002|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
27856292|NCT03670953|54387481|FG003|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
27856293|NCT03670953|54387478|FG000|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
27856294|NCT03670953|54387479|FG001|Dose Conversion (Weeks 4 - 7)|Miscellaneous|2|||
27856295|NCT03670953|54387480|FG002|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
27856296|NCT03670953|54387481|FG003|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
27856297|NCT03670953|54387478|FG000|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
27856298|NCT03670953|54387479|FG001|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
27856299|NCT03670953|54387480|FG002|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|14|||
27980927|NCT00610675|54638876|FG000|Overall Study|Lack of Compliance|7|||
27980928|NCT00610675|54638876|FG000|Overall Study|Lost to Follow-up|31|||
28094652|NCT01631214|54748210|FG000|Overall Study|Adverse Event|45|||
28094653|NCT01631214|54748211|FG001|Overall Study|Adverse Event|45|||
28094654|NCT01631214|54748210|FG000|Overall Study|Other|22|||
28094655|NCT01631214|54748211|FG001|Overall Study|Other|19|||
28094656|NCT01631214|54748210|FG000|Overall Study|Noncompliance|16|||
28094657|NCT01631214|54748211|FG001|Overall Study|Noncompliance|15|||
28094658|NCT01631214|54748210|FG000|Overall Study|Requirement for Alternative Therapy|8|||
28094659|NCT01631214|54748211|FG001|Overall Study|Requirement for Alternative Therapy|3|||
28094660|NCT01631214|54748210|FG000|Overall Study|Protocol Deviation|4|||
28094661|NCT01631214|54748211|FG001|Overall Study|Protocol Deviation|3|||
28094662|NCT01631214|54748210|FG000|Overall Study|Ineligibility determined|5|||
28094663|NCT01631214|54748211|FG001|Overall Study|Ineligibility determined|2|||
28094664|NCT01631214|54748210|FG000|Overall Study|Administrative Decision|1|||
28094665|NCT01631214|54748211|FG001|Overall Study|Administrative Decision|0|||
28094666|NCT03093454|54748221|FG000|Overall Study|Withdrawal by Subject|1|||
28094667|NCT03093454|54748222|FG001|Overall Study|Withdrawal by Subject|1|||
28094668|NCT03093454|54748221|FG000|Overall Study|Scheduling conflict|3|||
28094669|NCT03093454|54748222|FG001|Overall Study|Scheduling conflict|1|||
28170115|NCT02836249|54841620|FG001|Overall Study|Randomized but Never Treated|1|||
28094670|NCT03093454|54748221|FG000|Overall Study|Physician Decision|2|||
28170116|NCT02836249|54841619|FG000|Overall Study|Pregnancy|2|||
28170117|NCT02836249|54841620|FG001|Overall Study|Pregnancy|0|||
28170118|NCT02836249|54841619|FG000|Overall Study|Withdrew Consent|0|||
28170119|NCT02836249|54841620|FG001|Overall Study|Withdrew Consent|1|||
28170120|NCT02836249|54841619|FG000|Overall Study|Lost to Follow-up|0|||
27737483|NCT00151775|54186384|FG004|Period 4: Open Label|Other|1|||
28170121|NCT02836249|54841620|FG001|Overall Study|Lost to Follow-up|1|||
28170122|NCT02836249|54841619|FG000|Overall Study|Still on Study|121|||
28170123|NCT02836249|54841620|FG001|Overall Study|Still on Study|55|||
28170124|NCT01342081|54841638|FG000|Overall Study|Did not receive allocated intervention|0|||
28170125|NCT01342081|54841639|FG001|Overall Study|Did not receive allocated intervention|0|||
28170126|NCT01342081|54841640|FG002|Overall Study|Did not receive allocated intervention|1|||
28170127|NCT01342081|54841638|FG000|Overall Study|Adverse Event|1|||
28170128|NCT01342081|54841639|FG001|Overall Study|Adverse Event|0|||
28170129|NCT01342081|54841640|FG002|Overall Study|Adverse Event|0|||
28170130|NCT01342081|54841638|FG000|Overall Study|Physician Decision|0|||
28170131|NCT01342081|54841639|FG001|Overall Study|Physician Decision|1|||
28170132|NCT01342081|54841640|FG002|Overall Study|Physician Decision|0|||
28170133|NCT01342081|54841638|FG000|Overall Study|Withdrawal by Subject|1|||
28170134|NCT01342081|54841639|FG001|Overall Study|Withdrawal by Subject|1|||
28170135|NCT01342081|54841640|FG002|Overall Study|Withdrawal by Subject|0|||
28170136|NCT01341457|54841650|FG000|Overall Study|Adverse Event|2|||
28170137|NCT01341457|54841651|FG001|Overall Study|Adverse Event|0|||
28170138|NCT02832037|54841663|FG000|Overall Study|Administrative reasons|0|||
28170139|NCT02832037|54841664|FG001|Overall Study|Administrative reasons|0|||
28170140|NCT02832037|54841665|FG002|Overall Study|Administrative reasons|1|||
27737484|NCT00151775|54186385|FG005|Period 4: Open Label|Other|0|||
27737485|NCT00151775|54186386|FG006|Period 4: Open Label|Other|0|||
27737486|NCT00151775|54186387|FG007|Period 4: Open Label|Other|0|||
27737487|NCT00151775|54186388|FG008|Period 4: Open Label|Other|0|||
27737488|NCT00151775|54186389|FG009|Period 4: Open Label|Other|3|||
27737489|NCT00151775|54186390|FG010|Period 4: Open Label|Other|0|||
27737490|NCT00151775|54186391|FG011|Period 4: Open Label|Other|0|||
27737491|NCT00151775|54186380|FG000|Period 4: Open Label|Physician Decision|0|||
27737492|NCT00151775|54186381|FG001|Period 4: Open Label|Physician Decision|0|||
27737493|NCT00151775|54186382|FG002|Period 4: Open Label|Physician Decision|0|||
27737494|NCT00151775|54186383|FG003|Period 4: Open Label|Physician Decision|0|||
27737495|NCT00151775|54186384|FG004|Period 4: Open Label|Physician Decision|0|||
27737496|NCT00151775|54186385|FG005|Period 4: Open Label|Physician Decision|0|||
27737497|NCT00151775|54186386|FG006|Period 4: Open Label|Physician Decision|0|||
27856300|NCT03670953|54387481|FG003|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|3|||
28170141|NCT02832037|54841666|FG003|Overall Study|Administrative reasons|0|||
28170142|NCT02832037|54841667|FG004|Overall Study|Administrative reasons|0|||
28170143|NCT02832037|54841663|FG000|Overall Study|Protocol Violation|3|||
28170144|NCT02832037|54841664|FG001|Overall Study|Protocol Violation|0|||
28170145|NCT02832037|54841665|FG002|Overall Study|Protocol Violation|4|||
27856301|NCT03670953|54387478|FG000|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
27856302|NCT03670953|54387479|FG001|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
27856303|NCT03670953|54387480|FG002|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|5|||
27856304|NCT03670953|54387481|FG003|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|8|||
27856305|NCT03670953|54387478|FG000|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
27856306|NCT03670953|54387479|FG001|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
27856307|NCT03670953|54387480|FG002|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|3|||
27856308|NCT03670953|54387481|FG003|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|1|||
27856309|NCT03670953|54387478|FG000|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
28094671|NCT03093454|54748222|FG001|Overall Study|Physician Decision|1|||
28094672|NCT00468130|54748243|FG000|Overall Study|Adverse Event|2|||
28094673|NCT00468130|54748244|FG001|Overall Study|Adverse Event|1|||
28094674|NCT00468130|54748243|FG000|Overall Study|Withdrawal by Subject|0|||
28094675|NCT00468130|54748244|FG001|Overall Study|Withdrawal by Subject|1|||
28094676|NCT00911820|54748254|FG000|Overall Study|RECIST progression|12|||
28094677|NCT00911820|54748255|FG001|Overall Study|RECIST progression|8|||
28094678|NCT00911820|54748254|FG000|Overall Study|Adverse Event|8|||
28094679|NCT00911820|54748255|FG001|Overall Study|Adverse Event|8|||
28094680|NCT00911820|54748254|FG000|Overall Study|Clinical Progression|7|||
28094681|NCT00911820|54748255|FG001|Overall Study|Clinical Progression|5|||
28094682|NCT00911820|54748254|FG000|Overall Study|Physician Decision|5|||
28170146|NCT02832037|54841666|FG003|Overall Study|Protocol Violation|1|||
28170147|NCT02832037|54841667|FG004|Overall Study|Protocol Violation|2|||
28170148|NCT02832037|54841663|FG000|Overall Study|Lost to Follow-up|2|||
27737498|NCT00151775|54186387|FG007|Period 4: Open Label|Physician Decision|0|||
27737499|NCT00151775|54186388|FG008|Period 4: Open Label|Physician Decision|0|||
27737500|NCT00151775|54186389|FG009|Period 4: Open Label|Physician Decision|2|||
28094683|NCT00911820|54748255|FG001|Overall Study|Physician Decision|9|||
28094684|NCT00911820|54748254|FG000|Overall Study|Decline in Performance Status|4|||
28170149|NCT02832037|54841664|FG001|Overall Study|Lost to Follow-up|0|||
28170150|NCT02832037|54841665|FG002|Overall Study|Lost to Follow-up|3|||
28170151|NCT02832037|54841666|FG003|Overall Study|Lost to Follow-up|0|||
27737501|NCT00151775|54186390|FG010|Period 4: Open Label|Physician Decision|0|||
28170152|NCT02832037|54841667|FG004|Overall Study|Lost to Follow-up|5|||
27737502|NCT00151775|54186391|FG011|Period 4: Open Label|Physician Decision|0|||
27737503|NCT00151775|54186380|FG000|Period 4: Open Label|Protocol Violation|0|||
27737504|NCT00151775|54186381|FG001|Period 4: Open Label|Protocol Violation|0|||
27737505|NCT00151775|54186382|FG002|Period 4: Open Label|Protocol Violation|0|||
27737506|NCT00151775|54186383|FG003|Period 4: Open Label|Protocol Violation|0|||
27737507|NCT00151775|54186384|FG004|Period 4: Open Label|Protocol Violation|1|||
27737508|NCT00151775|54186385|FG005|Period 4: Open Label|Protocol Violation|0|||
27737509|NCT00151775|54186386|FG006|Period 4: Open Label|Protocol Violation|0|||
27737510|NCT00151775|54186387|FG007|Period 4: Open Label|Protocol Violation|0|||
27737511|NCT00151775|54186388|FG008|Period 4: Open Label|Protocol Violation|0|||
27737512|NCT00151775|54186389|FG009|Period 4: Open Label|Protocol Violation|0|||
27737513|NCT00151775|54186390|FG010|Period 4: Open Label|Protocol Violation|0|||
27737514|NCT00151775|54186391|FG011|Period 4: Open Label|Protocol Violation|0|||
27737515|NCT02258464|54186434|FG000|Overall Study|Progressive disease (PD)|9|||
27737516|NCT02258464|54186435|FG001|Overall Study|Progressive disease (PD)|17|||
27737517|NCT02258464|54186434|FG000|Overall Study|Study drug never administered|1|||
27737518|NCT02258464|54186435|FG001|Overall Study|Study drug never administered|1|||
27737519|NCT02258464|54186434|FG000|Overall Study|AE not related to clinical PD|1|||
27737520|NCT02258464|54186435|FG001|Overall Study|AE not related to clinical PD|3|||
27737521|NCT02258464|54186434|FG000|Overall Study|Withdrawal by Subject|5|||
27737522|NCT02258464|54186435|FG001|Overall Study|Withdrawal by Subject|4|||
27737523|NCT02258464|54186434|FG000|Overall Study|AE related to clinical PD|1|||
27737524|NCT02258464|54186435|FG001|Overall Study|AE related to clinical PD|0|||
27737525|NCT02682901|54186443|FG000|Overall Study|Adverse Event|10|||
27737526|NCT02682901|54186444|FG001|Overall Study|Adverse Event|3|||
27737527|NCT02682901|54186443|FG000|Overall Study|Lack of Efficacy|0|||
27737528|NCT02682901|54186444|FG001|Overall Study|Lack of Efficacy|1|||
27737529|NCT02258074|54186454|FG000|Overall Study|Withdrawal by Subject|1|||
27737530|NCT02258074|54186455|FG001|Overall Study|Withdrawal by Subject|0|||
27737531|NCT02258074|54186456|FG002|Overall Study|Withdrawal by Subject|0|||
27737532|NCT02258074|54186457|FG003|Overall Study|Withdrawal by Subject|0|||
27737533|NCT01643044|54186469|FG000|Overall Study|Lost to Follow-up|1|||
27737534|NCT01643044|54186470|FG001|Overall Study|Lost to Follow-up|1|||
27737535|NCT01643044|54186469|FG000|Overall Study|Miscarried baby|2|||
27737536|NCT01643044|54186470|FG001|Overall Study|Miscarried baby|2|||
27737537|NCT01643044|54186469|FG000|Overall Study|Delivered outside of hospital|1|||
27737538|NCT01643044|54186470|FG001|Overall Study|Delivered outside of hospital|2|||
27737539|NCT01642732|54186476|FG000|Overall Study|Withdrawal by Subject|1|||
27737540|NCT02257684|54186480|FG000|Overall Study|Adverse Event|2|||
27737541|NCT02257684|54186480|FG000|Overall Study|Lack of Efficacy|1|||
27737542|NCT02257684|54186480|FG000|Overall Study|Sponsor's Decision|1|||
27737543|NCT02190721|54186487|FG000|Overall Study|Patient was out of the city|0|||
27737544|NCT02190721|54186488|FG001|Overall Study|Patient was out of the city|1|||
27737545|NCT02190721|54186489|FG002|Overall Study|Patient was out of the city|0|||
27737546|NCT00581477|54186497|FG000|Overall Study|Physician Decision|2|||
27737547|NCT02348008|54186513|FG000|Overall Study|Adverse Event|2|||
27737548|NCT02348008|54186514|FG001|Overall Study|Adverse Event|3|||
27737549|NCT02348008|54186515|FG002|Overall Study|Adverse Event|3|||
27737550|NCT02348008|54186513|FG000|Overall Study|Disease Progression|1|||
27737551|NCT02348008|54186514|FG001|Overall Study|Disease Progression|5|||
27737552|NCT02348008|54186515|FG002|Overall Study|Disease Progression|16|||
27737553|NCT02348008|54186513|FG000|Overall Study|Withdrawal by Subject|0|||
27737554|NCT02348008|54186514|FG001|Overall Study|Withdrawal by Subject|1|||
27737555|NCT02348008|54186515|FG002|Overall Study|Withdrawal by Subject|0|||
27737556|NCT02348008|54186513|FG000|Overall Study|Symptomatic Deterioration|0|||
27737557|NCT02348008|54186514|FG001|Overall Study|Symptomatic Deterioration|1|||
28094685|NCT00911820|54748255|FG001|Overall Study|Decline in Performance Status|2|||
28094686|NCT00911820|54748254|FG000|Overall Study|Withdrawal by Subject|3|||
28094687|NCT00911820|54748255|FG001|Overall Study|Withdrawal by Subject|4|||
28094688|NCT00911820|54748254|FG000|Overall Study|Death|1|||
28094689|NCT00911820|54748255|FG001|Overall Study|Death|2|||
28094690|NCT00911820|54748254|FG000|Overall Study|Pursue surgery|1|||
28094691|NCT00911820|54748255|FG001|Overall Study|Pursue surgery|1|||
28094692|NCT00911820|54748254|FG000|Overall Study|Pursue Radiation|1|||
28094693|NCT00911820|54748255|FG001|Overall Study|Pursue Radiation|0|||
28094694|NCT00911820|54748254|FG000|Overall Study|Still on Therapy|2|||
28094695|NCT00911820|54748255|FG001|Overall Study|Still on Therapy|2|||
28094696|NCT00911820|54748254|FG000|Overall Study|Pathology Not Confirmed|1|||
28094697|NCT00911820|54748255|FG001|Overall Study|Pathology Not Confirmed|0|||
28170153|NCT02832037|54841663|FG000|Overall Study|Withdrawal by Subject|9|||
28170154|NCT02832037|54841664|FG001|Overall Study|Withdrawal by Subject|8|||
28170155|NCT02832037|54841665|FG002|Overall Study|Withdrawal by Subject|0|||
27737558|NCT02348008|54186515|FG002|Overall Study|Symptomatic Deterioration|0|||
27737559|NCT04962022|54186521|FG000|Period 1|Withdrawal by Subject|1|||
28094698|NCT00911820|54748254|FG000|Overall Study|Withdraw before Receive Treatment|0|||
27737560|NCT04962022|54186522|FG001|Period 1|Withdrawal by Subject|0|||
27737561|NCT04210843|54186574|FG000|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|134|||
27737562|NCT04210843|54186575|FG001|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|322|||
27737563|NCT04210843|54186574|FG000|First Half Treatment Period (52 Weeks)|Subject decision|11|||
27737564|NCT04210843|54186575|FG001|First Half Treatment Period (52 Weeks)|Subject decision|28|||
27737565|NCT04210843|54186574|FG000|First Half Treatment Period (52 Weeks)|Lost to Follow-up|4|||
27737566|NCT04210843|54186575|FG001|First Half Treatment Period (52 Weeks)|Lost to Follow-up|2|||
27737567|NCT04210843|54186574|FG000|First Half Treatment Period (52 Weeks)|Adverse Event|1|||
27737568|NCT04210843|54186575|FG001|First Half Treatment Period (52 Weeks)|Adverse Event|11|||
27737569|NCT04210843|54186574|FG000|First Half Treatment Period (52 Weeks)|Physician Decision|0|||
27737570|NCT04210843|54186575|FG001|First Half Treatment Period (52 Weeks)|Physician Decision|3|||
27737571|NCT04210843|54186574|FG000|First Half Treatment Period (52 Weeks)|Protocol deviation|0|||
27737572|NCT04210843|54186575|FG001|First Half Treatment Period (52 Weeks)|Protocol deviation|3|||
27833524|NCT01712399|54316280|FG000|Overall Study|Lost to Follow-up|1|||
28094699|NCT00911820|54748255|FG001|Overall Study|Withdraw before Receive Treatment|2|||
28094700|NCT00246324|54748270|FG000|Overall Study|Withdrawal by Subject|1|||
28094701|NCT04234984|54748276|FG000|Follow-up at 6 Weeks|Lost to Follow-up|2|||
28094702|NCT04234984|54748276|FG000|Follow-up at the Second Time Point|Death|1|||
28094703|NCT04234984|54748276|FG000|Follow-up at the Second Time Point|Mentally unable to fill in the questionnaire|1|||
28094704|NCT03922750|54748290|FG000|Overall Study|Unclassified|0|||
28094705|NCT03922750|54748291|FG001|Overall Study|Unclassified|0|||
28094706|NCT03922750|54748292|FG002|Overall Study|Unclassified|1|||
28094707|NCT03922750|54748290|FG000|Overall Study|Adverse Event|0|||
28094708|NCT03922750|54748291|FG001|Overall Study|Adverse Event|1|||
28094709|NCT03922750|54748292|FG002|Overall Study|Adverse Event|0|||
28094710|NCT04634253|54748314|FG000|Overall Study|Adverse Event|1|||
28094711|NCT04634253|54748315|FG001|Overall Study|Adverse Event|1|||
28094712|NCT04634253|54748316|FG002|Overall Study|Adverse Event|0|||
28094713|NCT04634253|54748314|FG000|Overall Study|Physician Decision|0|||
28094714|NCT04634253|54748315|FG001|Overall Study|Physician Decision|1|||
28094715|NCT04634253|54748316|FG002|Overall Study|Physician Decision|0|||
28094716|NCT04634253|54748314|FG000|Overall Study|Withdrawal by Subject|1|||
28094717|NCT04634253|54748315|FG001|Overall Study|Withdrawal by Subject|0|||
28094718|NCT04634253|54748316|FG002|Overall Study|Withdrawal by Subject|3|||
28094719|NCT04154904|54748386|FG000|At Home Period (28 Days)|Withdrawal by Subject|0|||
28094720|NCT04154904|54748387|FG001|At Home Period (28 Days)|Withdrawal by Subject|0|||
28094721|NCT04154904|54748388|FG002|At Home Period (28 Days)|Withdrawal by Subject|1|||
28094722|NCT03725982|54748437|FG000|First Intervention|Withdrawal by Subject|0|||
28094723|NCT03725982|54748438|FG001|First Intervention|Withdrawal by Subject|1|||
28094724|NCT03725982|54748437|FG000|First Intervention|Physician Decision|1|||
28094725|NCT03725982|54748438|FG001|First Intervention|Physician Decision|1|||
28094726|NCT03354273|54748517|FG000|Overall Study|Adverse Event|5|||
28094727|NCT03354273|54748517|FG000|Overall Study|Screen Failure|21|||
28094728|NCT03354273|54748517|FG000|Overall Study|Withdrawal by Subject|34|||
28094729|NCT03354273|54748517|FG000|Overall Study|Technical Problems|30|||
28094730|NCT03354273|54748517|FG000|Overall Study|Lost to Follow-up|4|||
28094731|NCT03354273|54748517|FG000|Overall Study|Investigator Decision|3|||
28094732|NCT03354273|54748517|FG000|Overall Study|Investigational Medicinal Product (IMP) Supply Issues|21|||
28094733|NCT03354273|54748517|FG000|Overall Study|Issues With Performing Invasive Coronary Angiography (ICA)|20|||
28094734|NCT03354273|54748517|FG000|Overall Study|COVID-19 Restrictions|9|||
28094735|NCT03354273|54748517|FG000|Overall Study|Other|5|||
28094736|NCT03282123|54748528|FG000|Overall Study|Withdrawal by Subject|5|||
28094737|NCT02759185|54748556|FG000|Stage 1|Adverse Event|0|||
28094738|NCT02759185|54748557|FG001|Stage 1|Adverse Event|1|||
28094739|NCT02759185|54748558|FG002|Stage 1|Adverse Event|3|||
28094740|NCT02759185|54748559|FG003|Stage 1|Adverse Event|0|||
28094741|NCT02759185|54748560|FG004|Stage 1|Adverse Event|0|||
28094742|NCT02759185|54748561|FG005|Stage 1|Adverse Event|0|||
28094743|NCT02759185|54748562|FG006|Stage 1|Adverse Event|0|||
28094744|NCT02759185|54748556|FG000|Stage 1|Withdrawal by Subject|1|||
28094745|NCT02759185|54748557|FG001|Stage 1|Withdrawal by Subject|0|||
28094746|NCT02759185|54748558|FG002|Stage 1|Withdrawal by Subject|0|||
28094747|NCT02759185|54748559|FG003|Stage 1|Withdrawal by Subject|0|||
28094748|NCT02759185|54748560|FG004|Stage 1|Withdrawal by Subject|0|||
28094749|NCT02759185|54748561|FG005|Stage 1|Withdrawal by Subject|0|||
28094750|NCT02759185|54748562|FG006|Stage 1|Withdrawal by Subject|0|||
28094751|NCT02759185|54748556|FG000|Stage 2|Adverse Event|0|||
28094752|NCT02759185|54748557|FG001|Stage 2|Adverse Event|0|||
28094753|NCT02759185|54748558|FG002|Stage 2|Adverse Event|0|||
28094754|NCT02759185|54748559|FG003|Stage 2|Adverse Event|0|||
28094755|NCT02759185|54748560|FG004|Stage 2|Adverse Event|1|||
28094756|NCT02759185|54748561|FG005|Stage 2|Adverse Event|2|||
28094757|NCT02759185|54748562|FG006|Stage 2|Adverse Event|0|||
28094758|NCT02759185|54748556|FG000|Stage 2|Withdrawal by Subject|0|||
28170156|NCT02832037|54841666|FG003|Overall Study|Withdrawal by Subject|4|||
28094759|NCT02759185|54748557|FG001|Stage 2|Withdrawal by Subject|0|||
27737573|NCT04210843|54186574|FG000|First Half Treatment Period (52 Weeks)|Death|0|||
27737574|NCT04210843|54186575|FG001|First Half Treatment Period (52 Weeks)|Death|2|||
27737575|NCT04210843|54186574|FG000|First Half Treatment Period (52 Weeks)|Lack of Efficacy|0|||
27737576|NCT04210843|54186575|FG001|First Half Treatment Period (52 Weeks)|Lack of Efficacy|2|||
27737577|NCT04210843|54186574|FG000|First Half Treatment Period (52 Weeks)|Pregnancy|0|||
27737578|NCT04210843|54186575|FG001|First Half Treatment Period (52 Weeks)|Pregnancy|1|||
27737579|NCT04210843|54186574|FG000|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|71|||
27737580|NCT04210843|54186575|FG001|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|195|||
27737581|NCT04210843|54186574|FG000|Second Half Treatment Period (52 Weeks)|Subject decision|5|||
27737582|NCT04210843|54186575|FG001|Second Half Treatment Period (52 Weeks)|Subject decision|8|||
27737583|NCT04210843|54186574|FG000|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|0|||
27737584|NCT04210843|54186575|FG001|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|1|||
27737585|NCT04210843|54186574|FG000|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|45|||
27737586|NCT04210843|54186575|FG001|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|107|||
27737587|NCT04210843|54186574|FG000|Observation Period 2 (up to 52 Weeks)|Adverse Event|0|||
27737588|NCT04210843|54186575|FG001|Observation Period 2 (up to 52 Weeks)|Adverse Event|1|||
27737589|NCT04210843|54186574|FG000|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|0|||
27737590|NCT04210843|54186575|FG001|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|1|||
27737591|NCT04210843|54186574|FG000|Observation Period 2 (up to 52 Weeks)|Subject decision|0|||
27737592|NCT04210843|54186575|FG001|Observation Period 2 (up to 52 Weeks)|Subject decision|1|||
27737593|NCT04210843|54186574|FG000|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|16|||
27737594|NCT04210843|54186575|FG001|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|32|||
27737595|NCT04210843|54186574|FG000|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|4|||
27737596|NCT04210843|54186575|FG001|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|16|||
27737597|NCT04210843|54186574|FG000|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|1|||
27737598|NCT04210843|54186575|FG001|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|6|||
27737599|NCT04210843|54186574|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|0|||
27737600|NCT04210843|54186575|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|5|||
27737601|NCT04210843|54186574|FG000|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|2|||
27737602|NCT04210843|54186575|FG001|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|1|||
27737603|NCT04210843|54186574|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|0|||
27737604|NCT04210843|54186575|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|2|||
27737605|NCT04210843|54186574|FG000|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|0|||
27737606|NCT04210843|54186575|FG001|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|1|||
27737607|NCT04210843|54186574|FG000|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|0|||
27737608|NCT04210843|54186575|FG001|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|1|||
27737609|NCT03538041|54186593|FG000|12-Week Treatment Period|Adverse Event|1|||
27737610|NCT03538041|54186594|FG001|12-Week Treatment Period|Adverse Event|1|||
27737611|NCT03538041|54186593|FG000|12-Week Treatment Period|Withdrawal by Subject|0|||
27737612|NCT03538041|54186594|FG001|12-Week Treatment Period|Withdrawal by Subject|1|||
27737613|NCT03538041|54186593|FG000|Treatment Extension Period|Adverse Event|4|||
27737614|NCT03538041|54186594|FG001|Treatment Extension Period|Adverse Event|0|||
27737615|NCT03538041|54186593|FG000|Treatment Extension Period|Physician Decision|1|||
27737616|NCT03538041|54186594|FG001|Treatment Extension Period|Physician Decision|0|||
27737617|NCT03538041|54186593|FG000|Treatment Extension Period|Lack of Efficacy|1|||
27737618|NCT03538041|54186594|FG001|Treatment Extension Period|Lack of Efficacy|3|||
27737619|NCT03538041|54186593|FG000|Treatment Extension Period|Ongoing; Still Receiving Treatment|1|||
27737620|NCT03538041|54186594|FG001|Treatment Extension Period|Ongoing; Still Receiving Treatment|7|||
27737621|NCT03091192|54186609|FG000|Overall Study|Study terminated by sponsor|21|||
27737622|NCT03091192|54186610|FG001|Overall Study|Study terminated by sponsor|14|||
27737623|NCT03091192|54186609|FG000|Overall Study|Death|9|||
27737624|NCT03091192|54186610|FG001|Overall Study|Death|13|||
27737625|NCT03091192|54186609|FG000|Overall Study|Withdrawal by Subject|2|||
27737626|NCT03091192|54186610|FG001|Overall Study|Withdrawal by Subject|0|||
27737627|NCT03091192|54186609|FG000|Overall Study|Lost to Follow-up|1|||
27737628|NCT03091192|54186610|FG001|Overall Study|Lost to Follow-up|0|||
27737629|NCT02838420|54186618|FG000|Overall Study|Ongoing in Study|113|||
27737630|NCT02838420|54186619|FG001|Overall Study|Ongoing in Study|45|||
27737631|NCT02838420|54186618|FG000|Overall Study|Lost to Follow-up|1|||
27737632|NCT02838420|54186619|FG001|Overall Study|Lost to Follow-up|0|||
27737633|NCT02838420|54186618|FG000|Overall Study|Withdrawal by Subject|3|||
27737634|NCT02838420|54186619|FG001|Overall Study|Withdrawal by Subject|4|||
27737635|NCT02838420|54186618|FG000|Overall Study|Death|8|||
27737636|NCT02838420|54186619|FG001|Overall Study|Death|13|||
27737637|NCT02651675|54186628|FG000|Overall Study|Death|0|||
27737638|NCT02651675|54186629|FG001|Overall Study|Death|0|||
27737639|NCT02651675|54186630|FG002|Overall Study|Death|1|||
27737640|NCT02611960|54186640|FG000|Overall Study|Adverse Event|7|||
27856310|NCT03670953|54387479|FG001|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
27980929|NCT00610675|54638876|FG000|Overall Study|Other reason (not specified)|25|||
27737641|NCT02611960|54186641|FG001|Overall Study|Adverse Event|8|||
28170157|NCT02832037|54841667|FG004|Overall Study|Withdrawal by Subject|8|||
27737642|NCT02611960|54186640|FG000|Overall Study|Death|98|||
27737643|NCT02611960|54186641|FG001|Overall Study|Death|92|||
27737644|NCT02611960|54186640|FG000|Overall Study|Withdrawal by Subject|1|||
27737645|NCT02611960|54186641|FG001|Overall Study|Withdrawal by Subject|5|||
27737646|NCT02611960|54186640|FG000|Overall Study|Sponsor Decision|11|||
27737647|NCT02611960|54186641|FG001|Overall Study|Sponsor Decision|11|||
27737648|NCT01909453|54186653|FG000|Overall Study|Ongoing|118|||
28094760|NCT02759185|54748558|FG002|Stage 2|Withdrawal by Subject|0|||
28094761|NCT02759185|54748559|FG003|Stage 2|Withdrawal by Subject|0|||
28094762|NCT02759185|54748560|FG004|Stage 2|Withdrawal by Subject|1|||
28094763|NCT02759185|54748561|FG005|Stage 2|Withdrawal by Subject|1|||
28094764|NCT02759185|54748562|FG006|Stage 2|Withdrawal by Subject|1|||
28094765|NCT02008396|54748608|FG000|Overall Study|Protocol Violation|0|||
28094766|NCT02008396|54748609|FG001|Overall Study|Protocol Violation|1|||
28094767|NCT01844518|54748627|FG000|Overall Study|Adverse Event|7|||
28094768|NCT01844518|54748628|FG001|Overall Study|Adverse Event|1|||
28094769|NCT01844518|54748627|FG000|Overall Study|Lack of Efficacy|17|||
28094770|NCT01844518|54748628|FG001|Overall Study|Lack of Efficacy|5|||
28094771|NCT01844518|54748627|FG000|Overall Study|Participant's request to discontinue|4|||
28094772|NCT01844518|54748628|FG001|Overall Study|Participant's request to discontinue|1|||
28094773|NCT01844518|54748627|FG000|Overall Study|Poor/Non-compliance|1|||
28094774|NCT01844518|54748628|FG001|Overall Study|Poor/Non-compliance|0|||
28170158|NCT02832037|54841663|FG000|Overall Study|Adverse Event|5|||
28170159|NCT02832037|54841664|FG001|Overall Study|Adverse Event|4|||
28170160|NCT02832037|54841665|FG002|Overall Study|Adverse Event|0|||
28170161|NCT02832037|54841666|FG003|Overall Study|Adverse Event|2|||
28170162|NCT02832037|54841667|FG004|Overall Study|Adverse Event|4|||
28170163|NCT01675154|54841683|FG000|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
28170164|NCT01675154|54841684|FG001|Third Intervention Period (4 Weeks)|Withdrawal by Subject|1|||
28170165|NCT01675154|54841685|FG002|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
28170166|NCT01675154|54841686|FG003|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
28170167|NCT02744755|54841710|FG000|Study Period 1|Protocol Violation|2|||
28170168|NCT02744755|54841711|FG001|Study Period 1|Protocol Violation|1|||
28170169|NCT02744755|54841710|FG000|Study Period 1|not defined|0|||
28170170|NCT02744755|54841711|FG001|Study Period 1|not defined|1|||
28170171|NCT02744755|54841710|FG000|Study Period 1|Pregnancy|1|||
28170172|NCT02744755|54841711|FG001|Study Period 1|Pregnancy|0|||
28170173|NCT02744755|54841710|FG000|Study Period 1|Adverse Event|1|||
28170174|NCT02744755|54841711|FG001|Study Period 1|Adverse Event|1|||
28170175|NCT02744755|54841710|FG000|Study Period 1|Lost to Follow-up|1|||
28170176|NCT02744755|54841711|FG001|Study Period 1|Lost to Follow-up|1|||
28170177|NCT02744755|54841710|FG000|Study Period 1|Lack of Efficacy|1|||
28170178|NCT02744755|54841711|FG001|Study Period 1|Lack of Efficacy|0|||
28170179|NCT02744755|54841710|FG000|Study Period 1|Withdrawal by Subject|8|||
28170180|NCT02744755|54841711|FG001|Study Period 1|Withdrawal by Subject|4|||
28170181|NCT02744755|54841710|FG000|Study Period 2|Adverse Event|5|||
28170182|NCT02744755|54841711|FG001|Study Period 2|Adverse Event|0|||
28170183|NCT02744755|54841710|FG000|Study Period 2|Protocol Violation|1|||
28170184|NCT02744755|54841711|FG001|Study Period 2|Protocol Violation|0|||
28170185|NCT02744755|54841710|FG000|Study Period 2|not defined|3|||
28170186|NCT02744755|54841711|FG001|Study Period 2|not defined|2|||
27737649|NCT01909453|54186654|FG001|Overall Study|Ongoing|103|||
28170187|NCT02744755|54841710|FG000|Study Period 2|Lost to Follow-up|0|||
28170188|NCT02744755|54841711|FG001|Study Period 2|Lost to Follow-up|2|||
28170189|NCT02744755|54841710|FG000|Study Period 2|Withdrawal by Subject|2|||
28170190|NCT02744755|54841711|FG001|Study Period 2|Withdrawal by Subject|2|||
28170191|NCT02744755|54841710|FG000|Study Period 2|Lack of Efficacy|3|||
28170192|NCT02744755|54841711|FG001|Study Period 2|Lack of Efficacy|2|||
28170193|NCT01356589|54841729|FG000|Overall Study|Enrolled, but not treated|3|||
28170194|NCT01356589|54841729|FG000|Overall Study|Dose data not recorded|2|||
27737650|NCT01909453|54186655|FG002|Overall Study|Ongoing|83|||
27737651|NCT01909453|54186656|FG003|Overall Study|Ongoing|164|||
27737652|NCT01909453|54186657|FG004|Overall Study|Ongoing|50|||
28170195|NCT02830087|54841739|FG000|Overall Study|No study staff to follow-up patients|4|||
28170196|NCT02830087|54841740|FG001|Overall Study|No study staff to follow-up patients|4|||
28170197|NCT02830087|54841741|FG002|Overall Study|No study staff to follow-up patients|4|||
28170198|NCT02830087|54841742|FG003|Overall Study|No study staff to follow-up patients|3|||
28170199|NCT02830087|54841743|FG004|Overall Study|No study staff to follow-up patients|3|||
27737653|NCT01909453|54186653|FG000|Overall Study|Death|69|||
28094775|NCT01844518|54748627|FG000|Overall Study|No Longer Met Study Criteria|2|||
28094776|NCT01844518|54748628|FG001|Overall Study|No Longer Met Study Criteria|0|||
28094777|NCT01844518|54748627|FG000|Overall Study|Withdrawal by Subject|9|||
28094778|NCT01844518|54748628|FG001|Overall Study|Withdrawal by Subject|0|||
28094779|NCT01844518|54748627|FG000|Overall Study|Pregnancy|1|||
27737654|NCT01909453|54186654|FG001|Overall Study|Death|74|||
28170200|NCT02830087|54841744|FG005|Overall Study|No study staff to follow-up patients|3|||
27737655|NCT01909453|54186655|FG002|Overall Study|Death|88|||
27737656|NCT01909453|54186656|FG003|Overall Study|Death|86|||
28170201|NCT02829775|54841758|FG000|Overall Study|Death|1|||
28170202|NCT02829775|54841758|FG000|Overall Study|Withdrawal by Subject|3|||
28170203|NCT02829775|54841758|FG000|Overall Study|Disease remission|1|||
28170204|NCT01355497|54841779|FG000|Overall Study|Death|19|||
28170205|NCT01355497|54841780|FG001|Overall Study|Death|18|||
28170206|NCT01355497|54841779|FG000|Overall Study|Lost to Follow-up|3|||
27737657|NCT01909453|54186657|FG004|Overall Study|Death|29|||
27737658|NCT01909453|54186653|FG000|Overall Study|Lost to Follow-up|3|||
27737659|NCT01909453|54186654|FG001|Overall Study|Lost to Follow-up|4|||
27737660|NCT01909453|54186655|FG002|Overall Study|Lost to Follow-up|4|||
27737661|NCT01909453|54186656|FG003|Overall Study|Lost to Follow-up|3|||
27737662|NCT01909453|54186657|FG004|Overall Study|Lost to Follow-up|3|||
27737663|NCT01909453|54186653|FG000|Overall Study|Withdrawal by Subject|2|||
27737664|NCT01909453|54186654|FG001|Overall Study|Withdrawal by Subject|13|||
27737665|NCT01909453|54186655|FG002|Overall Study|Withdrawal by Subject|16|||
27737666|NCT01909453|54186656|FG003|Overall Study|Withdrawal by Subject|5|||
27737667|NCT01909453|54186657|FG004|Overall Study|Withdrawal by Subject|4|||
27737668|NCT01845597|54186675|FG000|Overall Study|Death|8|||
27737669|NCT01845597|54186675|FG000|Overall Study|Lost to Follow-up|22|||
27737670|NCT01275677|54186695|FG000|Overall Study|Not at risk for recurrence.|1|||
28170207|NCT01355497|54841780|FG001|Overall Study|Lost to Follow-up|0|||
28170208|NCT01355497|54841779|FG000|Overall Study|Protocol Violation|0|||
28170209|NCT01355497|54841780|FG001|Overall Study|Protocol Violation|1|||
28170210|NCT01355497|54841779|FG000|Overall Study|other-not provided|9|||
28170211|NCT01355497|54841780|FG001|Overall Study|other-not provided|4|||
28170212|NCT01355497|54841779|FG000|Overall Study|Withdrawal by Subject|12|||
27737671|NCT01275677|54186696|FG001|Overall Study|Not at risk for recurrence.|1|||
27737672|NCT01275677|54186695|FG000|Overall Study|No follow-up|26|||
27737673|NCT01275677|54186696|FG001|Overall Study|No follow-up|37|||
27737674|NCT01275677|54186695|FG000|Overall Study|No clinical follow up.|1|||
28170213|NCT01355497|54841780|FG001|Overall Study|Withdrawal by Subject|20|||
28170214|NCT01355497|54841779|FG000|Overall Study|noncompliance|1|||
27737675|NCT01275677|54186696|FG001|Overall Study|No clinical follow up.|4|||
27737676|NCT00713206|54186712|FG000|Overall Study|Lost to Follow-up|4|||
27737677|NCT00713206|54186713|FG001|Overall Study|Lost to Follow-up|4|||
27737678|NCT00713206|54186712|FG000|Overall Study|Death|1|||
27737679|NCT00713206|54186713|FG001|Overall Study|Death|0|||
27737680|NCT00644228|54186721|FG000|Randomization & Eligibility|Ineligible|31|||
27737681|NCT00644228|54186722|FG001|Randomization & Eligibility|Ineligible|21|||
27737682|NCT00644228|54186721|FG000|Randomization & Eligibility|Withdrew Consent prior to therapy start|1|||
27737683|NCT00644228|54186722|FG001|Randomization & Eligibility|Withdrew Consent prior to therapy start|0|||
28094780|NCT01844518|54748628|FG001|Overall Study|Pregnancy|0|||
28094781|NCT01793610|54748664|FG000|Overall Study|Withdrawal by Subject|1|||
28094782|NCT01793610|54748665|FG001|Overall Study|Withdrawal by Subject|0|||
28094783|NCT01793610|54748666|FG002|Overall Study|Withdrawal by Subject|1|||
28094784|NCT01039584|54748714|FG000|Overall Study|Withdrawal by Subject|4|||
28094785|NCT01039584|54748715|FG001|Overall Study|Withdrawal by Subject|2|||
28094786|NCT01039584|54748716|FG002|Overall Study|Withdrawal by Subject|1|||
28094787|NCT01039584|54748714|FG000|Overall Study|Protocol Violation|10|||
28094788|NCT01039584|54748715|FG001|Overall Study|Protocol Violation|4|||
28094789|NCT01039584|54748716|FG002|Overall Study|Protocol Violation|6|||
28094790|NCT01039584|54748714|FG000|Overall Study|Lost to Follow-up|5|||
28094791|NCT01039584|54748715|FG001|Overall Study|Lost to Follow-up|3|||
28094792|NCT01039584|54748716|FG002|Overall Study|Lost to Follow-up|4|||
28094793|NCT01039584|54748714|FG000|Overall Study|Negative Baseline culture for Candida|59|||
28094794|NCT01039584|54748715|FG001|Overall Study|Negative Baseline culture for Candida|59|||
28094795|NCT01039584|54748716|FG002|Overall Study|Negative Baseline culture for Candida|24|||
28094796|NCT01039584|54748714|FG000|Overall Study|Lack of Efficacy|7|||
28094797|NCT01039584|54748715|FG001|Overall Study|Lack of Efficacy|6|||
28094798|NCT01039584|54748716|FG002|Overall Study|Lack of Efficacy|10|||
28094799|NCT01039584|54748714|FG000|Overall Study|other|1|||
28094800|NCT01039584|54748715|FG001|Overall Study|other|3|||
28094801|NCT01039584|54748716|FG002|Overall Study|other|1|||
28094802|NCT01039584|54748714|FG000|Overall Study|Pap smear with significant pathology|10|||
28170215|NCT01355497|54841780|FG001|Overall Study|noncompliance|2|||
27737684|NCT00644228|54186721|FG000|Randomization & Eligibility|Invalid Consent|0|||
27737685|NCT00644228|54186722|FG001|Randomization & Eligibility|Invalid Consent|1|||
28094803|NCT01039584|54748715|FG001|Overall Study|Pap smear with significant pathology|10|||
28094804|NCT01039584|54748716|FG002|Overall Study|Pap smear with significant pathology|3|||
28170216|NCT01355497|54841779|FG000|Overall Study|progressive disease|11|||
27737686|NCT00644228|54186721|FG000|Induction Therapy|Adverse Event|22|||
27980930|NCT00888134|54638880|FG000|Treatment With Study Drug|Withdrawal by Subject|1|||
28094805|NCT01039584|54748714|FG000|Overall Study|Positive for Chlamydia or gonorrhea|7|||
28170217|NCT01355497|54841780|FG001|Overall Study|progressive disease|8|||
27737687|NCT00644228|54186722|FG001|Induction Therapy|Adverse Event|55|||
28170218|NCT01355497|54841779|FG000|Overall Study|Adverse Event|11|||
27737688|NCT00644228|54186721|FG000|Induction Therapy|Withdrawal by Subject|10|||
27737689|NCT00644228|54186722|FG001|Induction Therapy|Withdrawal by Subject|3|||
27737690|NCT00644228|54186721|FG000|Induction Therapy|Progression/Relapse|24|||
28170219|NCT01355497|54841780|FG001|Overall Study|Adverse Event|10|||
28170220|NCT01355575|54841786|FG000|Overall Study|Withdrawal by Subject|2|||
28170221|NCT02826421|54841798|FG000|Overall Study|Adverse Event|1|||
28170222|NCT02826421|54841799|FG001|Overall Study|Adverse Event|0|||
28170223|NCT02826421|54841800|FG002|Overall Study|Adverse Event|0|||
28170224|NCT02826421|54841801|FG003|Overall Study|Adverse Event|1|||
27737691|NCT00644228|54186722|FG001|Induction Therapy|Progression/Relapse|12|||
27737692|NCT00644228|54186721|FG000|Induction Therapy|Death|3|||
27737693|NCT00644228|54186722|FG001|Induction Therapy|Death|7|||
27737694|NCT00644228|54186721|FG000|Induction Therapy|Not Protocol-Specified|24|||
27737695|NCT00644228|54186722|FG001|Induction Therapy|Not Protocol-Specified|28|||
27737696|NCT00644228|54186721|FG000|Maintenance|Adverse Event|27|||
27737697|NCT00644228|54186722|FG001|Maintenance|Adverse Event|31|||
27737698|NCT00644228|54186721|FG000|Maintenance|Withdrawal by Subject|6|||
27737699|NCT00644228|54186722|FG001|Maintenance|Withdrawal by Subject|4|||
27737700|NCT00644228|54186721|FG000|Maintenance|Progression/Relapse|67|||
27737701|NCT00644228|54186722|FG001|Maintenance|Progression/Relapse|42|||
27737702|NCT00644228|54186721|FG000|Maintenance|Death|3|||
27737703|NCT00644228|54186722|FG001|Maintenance|Death|3|||
27737704|NCT00644228|54186721|FG000|Maintenance|Not Protocol-Specified|14|||
27737705|NCT00644228|54186722|FG001|Maintenance|Not Protocol-Specified|15|||
27737706|NCT00644228|54186721|FG000|Maintenance|On Treatment|26|||
27737707|NCT00644228|54186722|FG001|Maintenance|On Treatment|40|||
27737708|NCT00495131|54186730|FG000|Overall Study|Adverse Event|6|||
27737709|NCT00495131|54186731|FG001|Overall Study|Adverse Event|2|||
27737710|NCT00495131|54186730|FG000|Overall Study|Lack of Efficacy|0|||
27737711|NCT00495131|54186731|FG001|Overall Study|Lack of Efficacy|2|||
27737712|NCT00495131|54186730|FG000|Overall Study|Lost to Follow-up|0|||
27737713|NCT00495131|54186731|FG001|Overall Study|Lost to Follow-up|2|||
27737714|NCT00495131|54186730|FG000|Overall Study|Withdrawal by Subject|1|||
27737715|NCT00495131|54186731|FG001|Overall Study|Withdrawal by Subject|0|||
27737716|NCT02257372|54186737|FG000|Overall Study|Adverse Event|3|||
27737717|NCT02257372|54186738|FG001|Overall Study|Adverse Event|7|||
27737718|NCT02257372|54186737|FG000|Overall Study|Lack of Efficacy|2|||
27737719|NCT02257372|54186738|FG001|Overall Study|Lack of Efficacy|1|||
27737720|NCT02257372|54186737|FG000|Overall Study|Protocol Violation|1|||
27737721|NCT02257372|54186738|FG001|Overall Study|Protocol Violation|1|||
27833525|NCT01712399|54316280|FG000|Overall Study|Withdrawal by Subject|39|||
27833526|NCT01712399|54316280|FG000|Overall Study|Death|1|||
27980931|NCT00888134|54638880|FG000|Follow-up|being followed for long-term survival|1|||
28094806|NCT01039584|54748715|FG001|Overall Study|Positive for Chlamydia or gonorrhea|10|||
28094807|NCT01039584|54748716|FG002|Overall Study|Positive for Chlamydia or gonorrhea|8|||
28170225|NCT02826421|54841798|FG000|Overall Study|Withdrawal by Subject|1|||
28170226|NCT02826421|54841799|FG001|Overall Study|Withdrawal by Subject|3|||
28170227|NCT02826421|54841800|FG002|Overall Study|Withdrawal by Subject|1|||
28170228|NCT02826421|54841801|FG003|Overall Study|Withdrawal by Subject|1|||
28170229|NCT02826421|54841798|FG000|Overall Study|Reason not given|1|||
28170230|NCT02826421|54841799|FG001|Overall Study|Reason not given|0|||
28170231|NCT02826421|54841800|FG002|Overall Study|Reason not given|1|||
28170232|NCT02826421|54841801|FG003|Overall Study|Reason not given|0|||
28170233|NCT02825251|54841814|FG000|Overall Study|Adverse Event|0|||
28170234|NCT02825251|54841815|FG001|Overall Study|Adverse Event|1|||
28170235|NCT02825251|54841814|FG000|Overall Study|Lost to Follow-up|0|||
28170236|NCT02825251|54841815|FG001|Overall Study|Lost to Follow-up|1|||
28170237|NCT02825251|54841814|FG000|Overall Study|Withdrawal by Subject|1|||
28170238|NCT02825251|54841815|FG001|Overall Study|Withdrawal by Subject|4|||
28170239|NCT02825251|54841814|FG000|Overall Study|Unclassified|2|||
28170240|NCT02825251|54841815|FG001|Overall Study|Unclassified|0|||
27737722|NCT02257372|54186737|FG000|Overall Study|Lost to Follow-up|0|||
27737723|NCT02257372|54186738|FG001|Overall Study|Lost to Follow-up|1|||
27737724|NCT02257372|54186737|FG000|Overall Study|Withdrew consent|1|||
27737725|NCT02257372|54186738|FG001|Overall Study|Withdrew consent|0|||
27833527|NCT01712399|54316280|FG000|Overall Study|Adverse Event|11|||
28094808|NCT00920387|54748726|FG000|Stage 1|Adverse Event|1|||
28094809|NCT00920387|54748727|FG001|Stage 1|Adverse Event|0|||
28094810|NCT00920387|54748728|FG002|Stage 1|Adverse Event|0|||
28094811|NCT00679783|54748753|FG000|Overall Study|Adverse Event|0|||
28094812|NCT00679783|54748754|FG001|Overall Study|Adverse Event|0|||
28094813|NCT00679783|54748755|FG002|Overall Study|Adverse Event|0|||
28094814|NCT00679783|54748756|FG003|Overall Study|Adverse Event|3|||
28094815|NCT00679783|54748757|FG004|Overall Study|Adverse Event|0|||
27737726|NCT02256982|54186746|FG000|Overall Study|Disease Progression|0|||
27737727|NCT02256982|54186747|FG001|Overall Study|Disease Progression|1|||
27737728|NCT02736721|54186753|FG000|Overall Study|Adverse Event|8|||
28170241|NCT02824627|54841823|FG000|Overall Study|Adverse Event|1|||
28170242|NCT02824627|54841824|FG001|Overall Study|Adverse Event|2|||
28170243|NCT02824627|54841823|FG000|Overall Study|Lost to Follow-up|2|||
27737729|NCT02736721|54186753|FG000|Overall Study|Lost to Follow-up|3|||
27737730|NCT02736721|54186753|FG000|Overall Study|Other|5|||
27737731|NCT04176445|54186757|FG000|Overall Study|Adverse Event|0|||
27737732|NCT04176445|54186758|FG001|Overall Study|Adverse Event|1|||
27737733|NCT04176445|54186757|FG000|Overall Study|change plans weaning after first intervention|0|||
27737734|NCT04176445|54186758|FG001|Overall Study|change plans weaning after first intervention|1|||
27737735|NCT02738203|54186766|FG000|Overall Study|Failed IUD Insertion|2|||
27737736|NCT02738203|54186767|FG001|Overall Study|Failed IUD Insertion|2|||
27737737|NCT02738203|54186766|FG000|Overall Study|Protocol Violation|0|||
27737738|NCT02738203|54186767|FG001|Overall Study|Protocol Violation|1|||
27737739|NCT02452034|54186779|FG000|Overall Study|Adverse Event|0|||
27737740|NCT02452034|54186780|FG001|Overall Study|Adverse Event|0|||
27737741|NCT02452034|54186781|FG002|Overall Study|Adverse Event|0|||
27856311|NCT03670953|54387480|FG002|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|1|||
27856312|NCT03670953|54387481|FG003|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
27856313|NCT03670953|54387478|FG000|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
27856314|NCT03670953|54387479|FG001|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
27856315|NCT03670953|54387480|FG002|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|10|||
27856316|NCT03670953|54387481|FG003|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|11|||
27856317|NCT03670953|54387478|FG000|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
27856318|NCT03670953|54387479|FG001|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
27856319|NCT03670953|54387480|FG002|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|1|||
27980932|NCT00573157|54638887|FG000|Overall Study|Adverse Event|3|||
27980933|NCT00573157|54638888|FG001|Overall Study|Adverse Event|1|||
27980934|NCT00573157|54638887|FG000|Overall Study|Other|1|||
27980935|NCT00573157|54638888|FG001|Overall Study|Other|1|||
27980936|NCT00802737|54638897|FG000|Overall Study|Withdrawn due to Disease Progression|9|||
27980937|NCT00802737|54638898|FG001|Overall Study|Withdrawn due to Disease Progression|3|||
28094816|NCT00679783|54748758|FG005|Overall Study|Adverse Event|0|||
28094817|NCT00679783|54748759|FG006|Overall Study|Adverse Event|1|||
27856320|NCT03670953|54387481|FG003|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
27856321|NCT02519348|54387532|FG000|Overall Study|Death|31|||
27856322|NCT02519348|54387533|FG001|Overall Study|Death|74|||
27856323|NCT02519348|54387534|FG002|Overall Study|Death|47|||
27856324|NCT02519348|54387535|FG003|Overall Study|Death|54|||
27856325|NCT02519348|54387536|FG004|Overall Study|Death|63|||
27856326|NCT02519348|54387537|FG005|Overall Study|Death|18|||
27856327|NCT02519348|54387538|FG006|Overall Study|Death|2|||
27856328|NCT02519348|54387539|FG007|Overall Study|Death|5|||
27856329|NCT02519348|54387540|FG008|Overall Study|Death|5|||
27856330|NCT02519348|54387532|FG000|Overall Study|Withdrawal by Subject|4|||
27856331|NCT02519348|54387533|FG001|Overall Study|Withdrawal by Subject|7|||
27856332|NCT02519348|54387534|FG002|Overall Study|Withdrawal by Subject|4|||
27856333|NCT02519348|54387535|FG003|Overall Study|Withdrawal by Subject|3|||
27856334|NCT02519348|54387536|FG004|Overall Study|Withdrawal by Subject|3|||
27856335|NCT02519348|54387537|FG005|Overall Study|Withdrawal by Subject|2|||
27856336|NCT02519348|54387538|FG006|Overall Study|Withdrawal by Subject|0|||
27856337|NCT02519348|54387539|FG007|Overall Study|Withdrawal by Subject|0|||
27856338|NCT02519348|54387540|FG008|Overall Study|Withdrawal by Subject|1|||
27856339|NCT02519348|54387532|FG000|Overall Study|Lost to Follow-up|0|||
27856340|NCT02519348|54387533|FG001|Overall Study|Lost to Follow-up|0|||
27856341|NCT02519348|54387534|FG002|Overall Study|Lost to Follow-up|1|||
27856342|NCT02519348|54387535|FG003|Overall Study|Lost to Follow-up|0|||
27856343|NCT02519348|54387536|FG004|Overall Study|Lost to Follow-up|2|||
27980938|NCT00802737|54638899|FG002|Overall Study|Withdrawn due to Disease Progression|0|||
27980939|NCT00802737|54638897|FG000|Overall Study|Death|6|||
28094818|NCT00679783|54748753|FG000|Overall Study|Lack of Efficacy|0|||
28094819|NCT00679783|54748754|FG001|Overall Study|Lack of Efficacy|1|||
28094820|NCT00679783|54748755|FG002|Overall Study|Lack of Efficacy|0|||
28094821|NCT00679783|54748756|FG003|Overall Study|Lack of Efficacy|2|||
28094822|NCT00679783|54748757|FG004|Overall Study|Lack of Efficacy|0|||
28094823|NCT00679783|54748758|FG005|Overall Study|Lack of Efficacy|0|||
28094824|NCT00679783|54748759|FG006|Overall Study|Lack of Efficacy|0|||
28094825|NCT00679783|54748753|FG000|Overall Study|Withdrawal by Subject|0|||
28094826|NCT00679783|54748754|FG001|Overall Study|Withdrawal by Subject|0|||
27980940|NCT00802737|54638898|FG001|Overall Study|Death|5|||
27980941|NCT00802737|54638899|FG002|Overall Study|Death|1|||
27980942|NCT00802737|54638897|FG000|Overall Study|Adverse Event|1|||
28094827|NCT00679783|54748755|FG002|Overall Study|Withdrawal by Subject|1|||
27737742|NCT02452034|54186782|FG003|Overall Study|Adverse Event|0|||
27856344|NCT02519348|54387537|FG005|Overall Study|Lost to Follow-up|1|||
27856345|NCT02519348|54387538|FG006|Overall Study|Lost to Follow-up|1|||
27856346|NCT02519348|54387539|FG007|Overall Study|Lost to Follow-up|0|||
27856347|NCT02519348|54387540|FG008|Overall Study|Lost to Follow-up|0|||
27856348|NCT02519348|54387532|FG000|Overall Study|Other|0|||
27856349|NCT02519348|54387533|FG001|Overall Study|Other|3|||
27856350|NCT02519348|54387534|FG002|Overall Study|Other|0|||
27737743|NCT02452034|54186783|FG004|Overall Study|Adverse Event|0|||
27737744|NCT02452034|54186784|FG005|Overall Study|Adverse Event|1|||
27737745|NCT02452034|54186779|FG000|Overall Study|Death|0|||
27737746|NCT02452034|54186780|FG001|Overall Study|Death|0|||
27856351|NCT02519348|54387535|FG003|Overall Study|Other|0|||
28170244|NCT02824627|54841824|FG001|Overall Study|Lost to Follow-up|1|||
28170245|NCT04860505|54841830|FG000|Overall Study|Lost to Follow-up|2|||
28170246|NCT04063865|54841836|FG000|Overall Study|Physician Decision|1|||
28170247|NCT04063865|54841837|FG001|Overall Study|Physician Decision|3|||
28170248|NCT04063865|54841836|FG000|Overall Study|Study Closed Prior to Completion|4|||
28170249|NCT04063865|54841837|FG001|Overall Study|Study Closed Prior to Completion|4|||
28170250|NCT04063865|54841836|FG000|Overall Study|Withdrawal by Subject|1|||
27856352|NCT02519348|54387536|FG004|Overall Study|Other|1|||
27856353|NCT02519348|54387537|FG005|Overall Study|Other|0|||
27856354|NCT02519348|54387538|FG006|Overall Study|Other|0|||
27856355|NCT02519348|54387539|FG007|Overall Study|Other|0|||
27856356|NCT02519348|54387540|FG008|Overall Study|Other|0|||
27856357|NCT02519348|54387532|FG000|Overall Study|Ongoing at the time of data cut-off date|5|||
27856358|NCT02519348|54387533|FG001|Overall Study|Ongoing at the time of data cut-off date|20|||
28094828|NCT00679783|54748756|FG003|Overall Study|Withdrawal by Subject|1|||
28094829|NCT00679783|54748757|FG004|Overall Study|Withdrawal by Subject|0|||
28170251|NCT04063865|54841837|FG001|Overall Study|Withdrawal by Subject|1|||
28170252|NCT03994211|54841845|FG000|Core Phase|Adverse Event|0|||
28170253|NCT03994211|54841846|FG001|Core Phase|Adverse Event|1|||
28170254|NCT03994211|54841847|FG002|Core Phase|Adverse Event|0|||
28170255|NCT03994211|54841845|FG000|Extension Phase|Adverse Event|0|||
28170256|NCT03994211|54841846|FG001|Extension Phase|Adverse Event|0|||
28170257|NCT03994211|54841847|FG002|Extension Phase|Adverse Event|1|||
28170258|NCT03994211|54841845|FG000|Extension Phase|Physician Decision|0|||
28094830|NCT00679783|54748758|FG005|Overall Study|Withdrawal by Subject|0|||
28094831|NCT00679783|54748759|FG006|Overall Study|Withdrawal by Subject|0|||
28094832|NCT00679783|54748753|FG000|Overall Study|Not Captured|0|||
28094833|NCT00679783|54748754|FG001|Overall Study|Not Captured|0|||
28094834|NCT00679783|54748755|FG002|Overall Study|Not Captured|0|||
28094835|NCT00679783|54748756|FG003|Overall Study|Not Captured|5|||
28094836|NCT00679783|54748757|FG004|Overall Study|Not Captured|0|||
28094837|NCT00679783|54748758|FG005|Overall Study|Not Captured|0|||
28094838|NCT00679783|54748759|FG006|Overall Study|Not Captured|0|||
28094839|NCT00679783|54748753|FG000|Overall Study|Ongoing at data cut-off|2|||
28094840|NCT00679783|54748754|FG001|Overall Study|Ongoing at data cut-off|2|||
28094841|NCT00679783|54748755|FG002|Overall Study|Ongoing at data cut-off|0|||
28094842|NCT00679783|54748756|FG003|Overall Study|Ongoing at data cut-off|9|||
28094843|NCT00679783|54748757|FG004|Overall Study|Ongoing at data cut-off|1|||
28094844|NCT00679783|54748758|FG005|Overall Study|Ongoing at data cut-off|0|||
28094845|NCT00679783|54748759|FG006|Overall Study|Ongoing at data cut-off|0|||
28094846|NCT03896490|54748781|FG000|Overall Study|Withdrawal by Subject|1|||
28094847|NCT03896490|54748782|FG001|Overall Study|Withdrawal by Subject|1|||
28094848|NCT03617172|54748790|FG000|Overall Study|Lost to Follow-up|1|||
28094849|NCT03617172|54748791|FG001|Overall Study|Lost to Follow-up|0|||
28094850|NCT03760146|54748803|FG000|Overall Study|Adverse Event|11|||
28094851|NCT03760146|54748804|FG001|Overall Study|Adverse Event|8|||
28094852|NCT03760146|54748805|FG002|Overall Study|Adverse Event|0|||
28094853|NCT03760146|54748806|FG003|Overall Study|Adverse Event|0|||
28094854|NCT03760146|54748807|FG004|Overall Study|Adverse Event|0|||
28094855|NCT03760146|54748808|FG005|Overall Study|Adverse Event|0|||
28094856|NCT03760146|54748803|FG000|Overall Study|Death|1|||
28094857|NCT03760146|54748804|FG001|Overall Study|Death|0|||
28094858|NCT03760146|54748805|FG002|Overall Study|Death|0|||
28094859|NCT03760146|54748806|FG003|Overall Study|Death|0|||
28094860|NCT03760146|54748807|FG004|Overall Study|Death|0|||
28094861|NCT03760146|54748808|FG005|Overall Study|Death|0|||
28094862|NCT03760146|54748803|FG000|Overall Study|Lost to Follow-up|41|||
28094863|NCT03760146|54748804|FG001|Overall Study|Lost to Follow-up|28|||
27737747|NCT02452034|54186781|FG002|Overall Study|Death|0|||
27737748|NCT02452034|54186782|FG003|Overall Study|Death|0|||
28094864|NCT03760146|54748805|FG002|Overall Study|Lost to Follow-up|9|||
28094865|NCT03760146|54748806|FG003|Overall Study|Lost to Follow-up|2|||
28094866|NCT03760146|54748807|FG004|Overall Study|Lost to Follow-up|14|||
28094867|NCT03760146|54748808|FG005|Overall Study|Lost to Follow-up|8|||
28094868|NCT03760146|54748803|FG000|Overall Study|No longer met eligibility criteria|3|||
28170259|NCT03994211|54841846|FG001|Extension Phase|Physician Decision|0|||
27737749|NCT02452034|54186783|FG004|Overall Study|Death|1|||
27856359|NCT02519348|54387534|FG002|Overall Study|Ongoing at the time of data cut-off date|23|||
27856360|NCT02519348|54387535|FG003|Overall Study|Ongoing at the time of data cut-off date|12|||
28094869|NCT03760146|54748804|FG001|Overall Study|No longer met eligibility criteria|9|||
28094870|NCT03760146|54748805|FG002|Overall Study|No longer met eligibility criteria|0|||
28094871|NCT03760146|54748806|FG003|Overall Study|No longer met eligibility criteria|0|||
28170260|NCT03994211|54841847|FG002|Extension Phase|Physician Decision|1|||
28170261|NCT03994211|54841845|FG000|Extension Phase|Progressive Disease|0|||
28170262|NCT03994211|54841846|FG001|Extension Phase|Progressive Disease|0|||
28170263|NCT03994211|54841847|FG002|Extension Phase|Progressive Disease|20|||
28170264|NCT03994211|54841845|FG000|Extension Phase|Withdrawal by Subject|0|||
28170265|NCT03994211|54841846|FG001|Extension Phase|Withdrawal by Subject|0|||
28170266|NCT03994211|54841847|FG002|Extension Phase|Withdrawal by Subject|2|||
28170267|NCT03818607|54841862|FG000|Period 1 (Week 1 to Week 52)|Adverse Event|0|||
28170268|NCT03818607|54841863|FG001|Period 1 (Week 1 to Week 52)|Adverse Event|1|||
28170269|NCT03818607|54841862|FG000|Period 2 (Week 53 to Week 79)|Participant's personal needs|0|||
28170270|NCT03818607|54841863|FG001|Period 2 (Week 53 to Week 79)|Participant's personal needs|1|||
28170271|NCT03818607|54841862|FG000|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|1|||
28170272|NCT03818607|54841863|FG001|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|0|||
28170273|NCT03300817|54841901|FG000|Overall Study|Withdrawal by Subject|1|||
28170274|NCT03300817|54841901|FG000|Overall Study|Adverse Event|1|||
28170275|NCT03300817|54841901|FG000|Overall Study|Subject Found to be Ineligible|2|||
28170276|NCT03144674|54841913|FG000|Overall Study|Participants Still Ongoing in the Study|1|||
28170277|NCT03144674|54841914|FG001|Overall Study|Participants Still Ongoing in the Study|4|||
28170278|NCT03144674|54841915|FG002|Overall Study|Participants Still Ongoing in the Study|24|||
28170279|NCT03144674|54841916|FG003|Overall Study|Participants Still Ongoing in the Study|54|||
28170280|NCT03144674|54841913|FG000|Overall Study|Death|3|||
28170281|NCT03144674|54841914|FG001|Overall Study|Death|1|||
28170282|NCT03144674|54841915|FG002|Overall Study|Death|1|||
28170283|NCT03144674|54841916|FG003|Overall Study|Death|10|||
28170284|NCT03144674|54841913|FG000|Overall Study|Lost to Follow-up|0|||
28170285|NCT03144674|54841914|FG001|Overall Study|Lost to Follow-up|1|||
28170286|NCT03144674|54841915|FG002|Overall Study|Lost to Follow-up|1|||
28170287|NCT03144674|54841916|FG003|Overall Study|Lost to Follow-up|1|||
28170288|NCT03144674|54841913|FG000|Overall Study|Withdrawal by Participant|0|||
28170289|NCT03144674|54841914|FG001|Overall Study|Withdrawal by Participant|0|||
28170290|NCT03144674|54841915|FG002|Overall Study|Withdrawal by Participant|0|||
28170291|NCT03144674|54841916|FG003|Overall Study|Withdrawal by Participant|3|||
28170292|NCT03144674|54841913|FG000|Overall Study|Reason not Specified|0|||
28170293|NCT03144674|54841914|FG001|Overall Study|Reason not Specified|0|||
28170294|NCT03144674|54841915|FG002|Overall Study|Reason not Specified|2|||
28170295|NCT03144674|54841916|FG003|Overall Study|Reason not Specified|4|||
28170296|NCT02521285|54841933|FG000|Overall Study|Lost to Follow-up|1|||
28170297|NCT02521285|54841934|FG001|Overall Study|Lost to Follow-up|1|||
28170298|NCT02521285|54841933|FG000|Overall Study|Withdrawal by Subject|1|||
28170299|NCT02521285|54841934|FG001|Overall Study|Withdrawal by Subject|1|||
28170300|NCT02521285|54841933|FG000|Overall Study|Adverse Event|0|||
28170301|NCT02521285|54841934|FG001|Overall Study|Adverse Event|1|||
28170302|NCT02422615|54841942|FG000|Overall Study|Progressive disease|193|||
28170303|NCT02422615|54841943|FG001|Overall Study|Progressive disease|142|||
27737750|NCT02452034|54186784|FG005|Overall Study|Death|1|||
27737751|NCT02452034|54186779|FG000|Overall Study|Physician Decision|0|||
27737752|NCT02452034|54186780|FG001|Overall Study|Physician Decision|1|||
27737753|NCT02452034|54186781|FG002|Overall Study|Physician Decision|1|||
27737754|NCT02452034|54186782|FG003|Overall Study|Physician Decision|0|||
27737755|NCT02452034|54186783|FG004|Overall Study|Physician Decision|0|||
27737756|NCT02452034|54186784|FG005|Overall Study|Physician Decision|0|||
28094872|NCT03760146|54748807|FG004|Overall Study|No longer met eligibility criteria|1|||
28094873|NCT03760146|54748808|FG005|Overall Study|No longer met eligibility criteria|0|||
28094874|NCT03760146|54748803|FG000|Overall Study|Protocol Violation|21|||
28094875|NCT03760146|54748804|FG001|Overall Study|Protocol Violation|13|||
28094876|NCT03760146|54748805|FG002|Overall Study|Protocol Violation|1|||
28094877|NCT03760146|54748806|FG003|Overall Study|Protocol Violation|0|||
28094878|NCT03760146|54748807|FG004|Overall Study|Protocol Violation|1|||
28094879|NCT03760146|54748808|FG005|Overall Study|Protocol Violation|0|||
28094880|NCT03760146|54748803|FG000|Overall Study|Withdrawal by Subject|19|||
28094881|NCT03760146|54748804|FG001|Overall Study|Withdrawal by Subject|20|||
28094882|NCT03760146|54748805|FG002|Overall Study|Withdrawal by Subject|1|||
28094883|NCT03760146|54748806|FG003|Overall Study|Withdrawal by Subject|0|||
28094884|NCT03760146|54748807|FG004|Overall Study|Withdrawal by Subject|1|||
28170304|NCT02422615|54841942|FG000|Overall Study|Adverse Event|41|||
28170305|NCT02422615|54841943|FG001|Overall Study|Adverse Event|10|||
28170306|NCT02422615|54841942|FG000|Overall Study|Physician Decision|22|||
28170307|NCT02422615|54841943|FG001|Overall Study|Physician Decision|7|||
28170308|NCT02422615|54841942|FG000|Overall Study|Subject/guardian decision|21|||
28170309|NCT02422615|54841943|FG001|Overall Study|Subject/guardian decision|5|||
28094885|NCT03760146|54748808|FG005|Overall Study|Withdrawal by Subject|0|||
28170310|NCT02422615|54841942|FG000|Overall Study|Death|2|||
28170311|NCT02422615|54841943|FG001|Overall Study|Death|0|||
28170312|NCT02422615|54841942|FG000|Overall Study|Protocol Violation|1|||
28170313|NCT02422615|54841943|FG001|Overall Study|Protocol Violation|1|||
28170314|NCT02422615|54841942|FG000|Overall Study|Technical problems|0|||
27737757|NCT02452034|54186779|FG000|Overall Study|Protocol Violation|0|||
28170315|NCT02422615|54841943|FG001|Overall Study|Technical problems|1|||
28170316|NCT02382406|54841952|FG000|Study Treatment|Disease Progression|8|||
27737758|NCT02452034|54186780|FG001|Overall Study|Protocol Violation|0|||
27737759|NCT02452034|54186781|FG002|Overall Study|Protocol Violation|0|||
27737760|NCT02452034|54186782|FG003|Overall Study|Protocol Violation|0|||
27737761|NCT02452034|54186783|FG004|Overall Study|Protocol Violation|0|||
27737762|NCT02452034|54186784|FG005|Overall Study|Protocol Violation|1|||
27737763|NCT02452034|54186779|FG000|Overall Study|Screen Failure|1|||
28170317|NCT02382406|54841953|FG001|Study Treatment|Disease Progression|0|||
28170318|NCT02382406|54841954|FG002|Study Treatment|Disease Progression|20|||
28170319|NCT02382406|54841952|FG000|Study Treatment|AE/ Side Effects/ Complications|4|||
28170320|NCT02382406|54841953|FG001|Study Treatment|AE/ Side Effects/ Complications|0|||
28170321|NCT02382406|54841954|FG002|Study Treatment|AE/ Side Effects/ Complications|6|||
28170322|NCT02382406|54841952|FG000|Study Treatment|Patient withdrawal after therapy start|1|||
28170323|NCT02382406|54841953|FG001|Study Treatment|Patient withdrawal after therapy start|0|||
28170324|NCT02382406|54841954|FG002|Study Treatment|Patient withdrawal after therapy start|1|||
28170325|NCT02382406|54841952|FG000|Study Treatment|symptomatic deterioration|1|||
28170326|NCT02382406|54841953|FG001|Study Treatment|symptomatic deterioration|0|||
28170327|NCT02382406|54841954|FG002|Study Treatment|symptomatic deterioration|1|||
28170328|NCT02382406|54841952|FG000|Study Treatment|Death|0|||
28170329|NCT02382406|54841953|FG001|Study Treatment|Death|0|||
27737764|NCT02452034|54186780|FG001|Overall Study|Screen Failure|0|||
27737765|NCT02452034|54186781|FG002|Overall Study|Screen Failure|0|||
27737766|NCT02452034|54186782|FG003|Overall Study|Screen Failure|1|||
27737767|NCT02452034|54186783|FG004|Overall Study|Screen Failure|0|||
27737768|NCT02452034|54186784|FG005|Overall Study|Screen Failure|0|||
27737769|NCT02452034|54186779|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
27737770|NCT02452034|54186780|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
28170330|NCT02382406|54841954|FG002|Study Treatment|Death|2|||
27737771|NCT02452034|54186781|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
27737772|NCT02452034|54186782|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
27737773|NCT02452034|54186783|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
27737774|NCT02452034|54186784|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
27737775|NCT02482298|54186811|FG000|Overall Study|Withdrawal by Subject|2|||
27737776|NCT02482298|54186812|FG001|Overall Study|Withdrawal by Subject|1|||
27737777|NCT02482298|54186813|FG002|Overall Study|Withdrawal by Subject|2|||
27737778|NCT02482298|54186811|FG000|Overall Study|Did Not Fulfill Randomization Criteria|0|||
27737779|NCT02482298|54186812|FG001|Overall Study|Did Not Fulfill Randomization Criteria|1|||
27737780|NCT02482298|54186813|FG002|Overall Study|Did Not Fulfill Randomization Criteria|0|||
27737781|NCT02482298|54186811|FG000|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
27737782|NCT02482298|54186812|FG001|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
27737783|NCT02482298|54186813|FG002|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1|||
27737784|NCT02482298|54186811|FG000|Overall Study|Lost to Follow-up|0|||
27737785|NCT02482298|54186812|FG001|Overall Study|Lost to Follow-up|1|||
27737786|NCT02482298|54186813|FG002|Overall Study|Lost to Follow-up|0|||
27737787|NCT00440531|54186824|FG000|Overall Study|Adverse Event|1|||
27737788|NCT00440531|54186825|FG001|Overall Study|Adverse Event|0|||
27737789|NCT00440531|54186826|FG002|Overall Study|Adverse Event|2|||
27737790|NCT00440531|54186824|FG000|Overall Study|Withdrawal by Subject|2|||
27737791|NCT00440531|54186825|FG001|Overall Study|Withdrawal by Subject|0|||
27737792|NCT00440531|54186826|FG002|Overall Study|Withdrawal by Subject|0|||
27737793|NCT00440531|54186824|FG000|Overall Study|Protocol Violation|1|||
27737794|NCT00440531|54186825|FG001|Overall Study|Protocol Violation|2|||
27737795|NCT00440531|54186826|FG002|Overall Study|Protocol Violation|0|||
27737796|NCT00440531|54186824|FG000|Overall Study|Lost to Follow-up|4|||
27737797|NCT00440531|54186825|FG001|Overall Study|Lost to Follow-up|3|||
27737798|NCT00440531|54186826|FG002|Overall Study|Lost to Follow-up|5|||
27737799|NCT00440531|54186824|FG000|Overall Study|see pre-assignment details|2|||
27737800|NCT00440531|54186825|FG001|Overall Study|see pre-assignment details|0|||
27737801|NCT00440531|54186826|FG002|Overall Study|see pre-assignment details|0|||
28094886|NCT03760068|54748828|FG000|Overall Study|Withdrawal by Subject|7|||
28094887|NCT03760068|54748829|FG001|Overall Study|Withdrawal by Subject|8|||
28094888|NCT03760068|54748828|FG000|Overall Study|Adverse Event|1|||
28094889|NCT03760068|54748829|FG001|Overall Study|Adverse Event|2|||
28094890|NCT03760068|54748828|FG000|Overall Study|Administrative Decision by Sponsor|0|||
28094891|NCT03760068|54748829|FG001|Overall Study|Administrative Decision by Sponsor|2|||
28094892|NCT03760068|54748828|FG000|Overall Study|Physician Decision|1|||
28094893|NCT03760068|54748829|FG001|Overall Study|Physician Decision|2|||
27737802|NCT02513732|54186832|FG000|Overall Study|Lost to Follow-up|11|||
28094894|NCT03760068|54748828|FG000|Overall Study|Lost to Follow-up|4|||
28094895|NCT03760068|54748829|FG001|Overall Study|Lost to Follow-up|9|||
27737803|NCT02513732|54186832|FG000|Overall Study|Death|9|||
28170331|NCT02382406|54841952|FG000|Follow up|Death|11|||
28170332|NCT02382406|54841953|FG001|Follow up|Death|0|||
27737804|NCT02513732|54186832|FG000|Overall Study|Changing hospital|2|||
27737805|NCT00429923|54186839|FG000|Overall Study|Adverse Event|0|||
27737806|NCT00429923|54186840|FG001|Overall Study|Adverse Event|2|||
27737807|NCT00429923|54186841|FG002|Overall Study|Adverse Event|3|||
28094896|NCT03760068|54748828|FG000|Overall Study|Subject Moved Out of State|1|||
27737808|NCT00429923|54186839|FG000|Overall Study|Lack of Efficacy|4|||
27737809|NCT00429923|54186840|FG001|Overall Study|Lack of Efficacy|1|||
27737810|NCT00429923|54186841|FG002|Overall Study|Lack of Efficacy|33|||
27737811|NCT00429923|54186839|FG000|Overall Study|Lost to Follow-up|0|||
27737812|NCT00429923|54186840|FG001|Overall Study|Lost to Follow-up|0|||
27737813|NCT00429923|54186841|FG002|Overall Study|Lost to Follow-up|2|||
27737814|NCT00429923|54186839|FG000|Overall Study|Withdrew Consent|1|||
27737815|NCT00429923|54186840|FG001|Overall Study|Withdrew Consent|0|||
27737816|NCT00429923|54186841|FG002|Overall Study|Withdrew Consent|1|||
27737817|NCT00429923|54186839|FG000|Overall Study|Early Termination|0|||
27737818|NCT00429923|54186840|FG001|Overall Study|Early Termination|1|||
27737819|NCT00429923|54186841|FG002|Overall Study|Early Termination|0|||
27737820|NCT02256436|54186848|FG000|Overall Study|Adverse Event|9|||
27737821|NCT02256436|54186849|FG001|Overall Study|Adverse Event|14|||
27737822|NCT02256436|54186848|FG000|Overall Study|Death|216|||
27737823|NCT02256436|54186849|FG001|Overall Study|Death|208|||
27737824|NCT02256436|54186848|FG000|Overall Study|Lost to Follow-up|1|||
27737825|NCT02256436|54186849|FG001|Overall Study|Lost to Follow-up|2|||
27737826|NCT02256436|54186848|FG000|Overall Study|Physician Decision|1|||
27737827|NCT02256436|54186849|FG001|Overall Study|Physician Decision|0|||
27737828|NCT02256436|54186848|FG000|Overall Study|Protocol Violation|0|||
27737829|NCT02256436|54186849|FG001|Overall Study|Protocol Violation|1|||
27737830|NCT02256436|54186848|FG000|Overall Study|Withdrawal by Subject|26|||
27737831|NCT02256436|54186849|FG001|Overall Study|Withdrawal by Subject|10|||
27737832|NCT02256436|54186848|FG000|Overall Study|Transferred to Extension Study|11|||
27737833|NCT02256436|54186849|FG001|Overall Study|Transferred to Extension Study|23|||
27737834|NCT02256436|54186848|FG000|Overall Study|Did Not Continue on Extension Study|8|||
28170333|NCT02382406|54841954|FG002|Follow up|Death|19|||
28170334|NCT02382406|54841952|FG000|Follow up|Symptomatic deterioration|1|||
28170335|NCT02382406|54841953|FG001|Follow up|Symptomatic deterioration|0|||
28170336|NCT02382406|54841954|FG002|Follow up|Symptomatic deterioration|1|||
27737835|NCT02256436|54186849|FG001|Overall Study|Did Not Continue on Extension Study|12|||
27980943|NCT00802737|54638898|FG001|Overall Study|Adverse Event|0|||
27980944|NCT00802737|54638899|FG002|Overall Study|Adverse Event|0|||
27980945|NCT00802737|54638897|FG000|Overall Study|Received Prohibited Therapy|1|||
27980946|NCT00802737|54638898|FG001|Overall Study|Received Prohibited Therapy|0|||
27980947|NCT00802737|54638899|FG002|Overall Study|Received Prohibited Therapy|0|||
27980948|NCT00802737|54638897|FG000|Overall Study|Ongoing CLL-Treatment|0|||
27980949|NCT00802737|54638898|FG001|Overall Study|Ongoing CLL-Treatment|1|||
27980950|NCT00802737|54638899|FG002|Overall Study|Ongoing CLL-Treatment|0|||
27737844|NCT00326183|54186867|FG000|Overall Study|Lost to Follow-up|104|||
27737845|NCT00326183|54186868|FG001|Overall Study|Lost to Follow-up|56|||
28094897|NCT03760068|54748829|FG001|Overall Study|Subject Moved Out of State|0|||
28094898|NCT03759600|54748836|FG000|Overall Study|Ongoing at Data Cut-off|16|||
28094899|NCT03759600|54748836|FG000|Overall Study|Adverse Event|1|||
28094900|NCT03759600|54748836|FG000|Overall Study|Progressive Disease|3|||
28094901|NCT04724733|54748843|FG000|Overall Study|Lost to Follow-up|1|||
28094902|NCT04724733|54748844|FG001|Overall Study|Lost to Follow-up|1|||
28094903|NCT04724733|54748845|FG002|Overall Study|Lost to Follow-up|1|||
28170337|NCT02382406|54841952|FG000|Follow up|Patient Refused Follow-up|1|||
28170338|NCT02382406|54841953|FG001|Follow up|Patient Refused Follow-up|0|||
28170339|NCT02382406|54841954|FG002|Follow up|Patient Refused Follow-up|0|||
28170340|NCT02382406|54841952|FG000|Follow up|Study Terminated|1|||
28170341|NCT02382406|54841953|FG001|Follow up|Study Terminated|0|||
28170342|NCT02382406|54841954|FG002|Follow up|Study Terminated|8|||
28170343|NCT02382406|54841952|FG000|Follow up|Withdrawal by Subject|0|||
28170344|NCT02382406|54841953|FG001|Follow up|Withdrawal by Subject|0|||
28170345|NCT02382406|54841954|FG002|Follow up|Withdrawal by Subject|2|||
28170346|NCT02112916|54841976|FG000|Overall Study|Adverse Event|6|||
28170347|NCT02112916|54841977|FG001|Overall Study|Adverse Event|9|||
28170348|NCT02112916|54841978|FG002|Overall Study|Adverse Event|3|||
27737846|NCT00326183|54186867|FG000|Overall Study|Protocol Violation|6|||
27737847|NCT00326183|54186868|FG001|Overall Study|Protocol Violation|3|||
27737848|NCT00326183|54186867|FG000|Overall Study|Withdrawal by Subject|35|||
27737849|NCT00326183|54186868|FG001|Overall Study|Withdrawal by Subject|7|||
27737850|NCT00326183|54186867|FG000|Overall Study|Subject Moved|7|||
27980951|NCT00802737|54638897|FG000|Overall Study|Participant too Unwell|0|||
28094904|NCT04635839|54748855|FG000|Overall Study|Delivered prior to second dose of heparin|1|||
27737851|NCT00326183|54186868|FG001|Overall Study|Subject Moved|4|||
28094905|NCT04635839|54748856|FG001|Overall Study|Delivered prior to second dose of heparin|0|||
28170349|NCT02112916|54841979|FG003|Overall Study|Adverse Event|2|||
28170350|NCT02112916|54841976|FG000|Overall Study|Death|9|||
27737852|NCT00326183|54186867|FG000|Overall Study|Other|47|||
27737853|NCT00326183|54186868|FG001|Overall Study|Other|13|||
27737854|NCT00326183|54186867|FG000|Overall Study|Adverse Event|1|||
27737855|NCT00326183|54186868|FG001|Overall Study|Adverse Event|0|||
27737856|NCT02481050|54186872|FG000|Overall Study|Adverse Event|1|||
27737857|NCT02481050|54186872|FG000|Overall Study|Disease Progression|47|||
27737858|NCT02481050|54186872|FG000|Overall Study|Withdrawal by Subject|7|||
28170351|NCT02112916|54841977|FG001|Overall Study|Death|9|||
28170352|NCT02112916|54841978|FG002|Overall Study|Death|3|||
28170353|NCT02112916|54841979|FG003|Overall Study|Death|4|||
28170354|NCT02112916|54841976|FG000|Overall Study|Lost to Follow-up|1|||
28170355|NCT02112916|54841977|FG001|Overall Study|Lost to Follow-up|0|||
28170356|NCT02112916|54841978|FG002|Overall Study|Lost to Follow-up|0|||
28170357|NCT02112916|54841979|FG003|Overall Study|Lost to Follow-up|0|||
28170358|NCT02112916|54841976|FG000|Overall Study|Physician Decision|94|||
28170359|NCT02112916|54841977|FG001|Overall Study|Physician Decision|72|||
28170360|NCT02112916|54841978|FG002|Overall Study|Physician Decision|24|||
28170361|NCT02112916|54841979|FG003|Overall Study|Physician Decision|15|||
28170362|NCT02112916|54841976|FG000|Overall Study|Withdrawal by Subject|5|||
28170363|NCT02112916|54841977|FG001|Overall Study|Withdrawal by Subject|3|||
28170364|NCT02112916|54841978|FG002|Overall Study|Withdrawal by Subject|1|||
28170365|NCT02112916|54841979|FG003|Overall Study|Withdrawal by Subject|1|||
28170366|NCT02112916|54841976|FG000|Overall Study|Ineligible|4|||
28170367|NCT02112916|54841977|FG001|Overall Study|Ineligible|8|||
28170368|NCT02112916|54841978|FG002|Overall Study|Ineligible|3|||
28170369|NCT02112916|54841979|FG003|Overall Study|Ineligible|8|||
28170370|NCT02112916|54841976|FG000|Overall Study|Inevaluable|6|||
28170371|NCT02112916|54841977|FG001|Overall Study|Inevaluable|4|||
28170372|NCT02112916|54841978|FG002|Overall Study|Inevaluable|5|||
28170373|NCT02112916|54841979|FG003|Overall Study|Inevaluable|5|||
28170374|NCT02112916|54841976|FG000|Overall Study|Refusal of further protocol therapy|19|||
28170375|NCT02112916|54841977|FG001|Overall Study|Refusal of further protocol therapy|16|||
28094906|NCT04493502|54748864|FG000|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|1|||
28094907|NCT04493502|54748865|FG001|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|0|||
28094908|NCT04493502|54748864|FG000|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|3|||
28094909|NCT04493502|54748865|FG001|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|4|||
28094910|NCT04493502|54748864|FG000|Double Blind Treatment (Week 0 - 16)|Other, Relocation|0|||
28170376|NCT02112916|54841978|FG002|Overall Study|Refusal of further protocol therapy|1|||
27980952|NCT00802737|54638898|FG001|Overall Study|Participant too Unwell|2|||
28094911|NCT04493502|54748865|FG001|Double Blind Treatment (Week 0 - 16)|Other, Relocation|1|||
28094912|NCT04493502|54748864|FG000|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|0|||
28094913|NCT04493502|54748865|FG001|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|1|||
28094914|NCT04493502|54748864|FG000|Double Blind Treatment (Week 0 - 16)|Physician Decision|1|||
28094915|NCT04493502|54748865|FG001|Double Blind Treatment (Week 0 - 16)|Physician Decision|0|||
28094916|NCT04493502|54748864|FG000|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|3|||
28094917|NCT04493502|54748865|FG001|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|1|||
28094918|NCT04493502|54748864|FG000|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|2|||
28094919|NCT04493502|54748865|FG001|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|3|||
28094920|NCT04493502|54748864|FG000|Open-label Extension (Week 16 - 36)|Lost to Follow-up|1|||
28094921|NCT04493502|54748865|FG001|Open-label Extension (Week 16 - 36)|Lost to Follow-up|0|||
28094922|NCT04493502|54748864|FG000|Open-label Extension (Week 16 - 36)|Physician Decision|0|||
28094923|NCT04493502|54748865|FG001|Open-label Extension (Week 16 - 36)|Physician Decision|1|||
28094924|NCT04493502|54748864|FG000|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|3|||
28094925|NCT04493502|54748865|FG001|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|8|||
28094926|NCT04493502|54748864|FG000|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|0|||
28094927|NCT04493502|54748865|FG001|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|1|||
28094928|NCT04493502|54748864|FG000|Post-treatment Follow-up (10 Weeks)|Physician Decision|0|||
28094929|NCT04493502|54748865|FG001|Post-treatment Follow-up (10 Weeks)|Physician Decision|1|||
28094930|NCT04493502|54748864|FG000|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|2|||
28094931|NCT04493502|54748865|FG001|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|3|||
28094932|NCT04147858|54748876|FG000|Overall Study|Adverse Event|6|||
28094933|NCT04147858|54748877|FG001|Overall Study|Adverse Event|6|||
28094934|NCT04147858|54748878|FG002|Overall Study|Adverse Event|6|||
28094935|NCT04147858|54748876|FG000|Overall Study|Lack of Efficacy|3|||
28094936|NCT04147858|54748877|FG001|Overall Study|Lack of Efficacy|3|||
28094937|NCT04147858|54748878|FG002|Overall Study|Lack of Efficacy|1|||
28094938|NCT04147858|54748876|FG000|Overall Study|Lost to Follow-up|1|||
28094939|NCT04147858|54748877|FG001|Overall Study|Lost to Follow-up|6|||
28094940|NCT04147858|54748878|FG002|Overall Study|Lost to Follow-up|2|||
28094941|NCT04147858|54748876|FG000|Overall Study|Withdrawal by Subject|3|||
28094942|NCT04147858|54748877|FG001|Overall Study|Withdrawal by Subject|4|||
28094943|NCT04147858|54748878|FG002|Overall Study|Withdrawal by Subject|10|||
28170377|NCT02112916|54841979|FG003|Overall Study|Refusal of further protocol therapy|7|||
27980953|NCT00802737|54638899|FG002|Overall Study|Participant too Unwell|0|||
28170378|NCT02112916|54841976|FG000|Overall Study|Development of SMN|1|||
28170379|NCT02112916|54841977|FG001|Overall Study|Development of SMN|0|||
28170380|NCT02112916|54841978|FG002|Overall Study|Development of SMN|0|||
28170381|NCT02112916|54841979|FG003|Overall Study|Development of SMN|1|||
28170382|NCT02112916|54841976|FG000|Overall Study|Relapse/Progression|10|||
28170383|NCT02112916|54841977|FG001|Overall Study|Relapse/Progression|18|||
28170384|NCT02112916|54841978|FG002|Overall Study|Relapse/Progression|15|||
28170385|NCT02112916|54841979|FG003|Overall Study|Relapse/Progression|2|||
28170386|NCT02112916|54841976|FG000|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
28170387|NCT02112916|54841977|FG001|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
28170388|NCT02112916|54841978|FG002|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
28170389|NCT02112916|54841979|FG003|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
28094944|NCT04147858|54748876|FG000|Overall Study|Subject Noncompliance, Other|4|||
28094945|NCT04147858|54748877|FG001|Overall Study|Subject Noncompliance, Other|3|||
28094946|NCT04147858|54748878|FG002|Overall Study|Subject Noncompliance, Other|1|||
28094947|NCT04146896|54748888|FG000|Overall Study|Adverse Event|5|||
28094948|NCT04146896|54748889|FG001|Overall Study|Adverse Event|8|||
28094949|NCT04146896|54748888|FG000|Overall Study|Lack of Efficacy|3|||
28094950|NCT04146896|54748889|FG001|Overall Study|Lack of Efficacy|2|||
28094951|NCT04146896|54748888|FG000|Overall Study|Lost to Follow-up|0|||
28094952|NCT04146896|54748889|FG001|Overall Study|Lost to Follow-up|1|||
28094953|NCT04146896|54748888|FG000|Overall Study|Non-compliance|5|||
28094954|NCT04146896|54748889|FG001|Overall Study|Non-compliance|4|||
28094955|NCT04146896|54748888|FG000|Overall Study|Withdrawal by Subject|3|||
28094956|NCT04146896|54748889|FG001|Overall Study|Withdrawal by Subject|5|||
28094957|NCT04146896|54748888|FG000|Overall Study|Randomized in error|1|||
28094958|NCT04146896|54748889|FG001|Overall Study|Randomized in error|2|||
28094959|NCT04072887|54748901|FG000|Overall Study|Withdrawal by Subject|3|||
28094960|NCT04072887|54748902|FG001|Overall Study|Withdrawal by Subject|8|||
28094961|NCT04072887|54748903|FG002|Overall Study|Withdrawal by Subject|1|||
28094962|NCT04072887|54748904|FG003|Overall Study|Withdrawal by Subject|3|||
28094963|NCT04072887|54748905|FG004|Overall Study|Withdrawal by Subject|3|||
28094964|NCT04072887|54748906|FG005|Overall Study|Withdrawal by Subject|13|||
28094965|NCT04072887|54748901|FG000|Overall Study|Adverse Event|2|||
28094966|NCT04072887|54748902|FG001|Overall Study|Adverse Event|4|||
28094967|NCT04072887|54748903|FG002|Overall Study|Adverse Event|1|||
28094968|NCT04072887|54748904|FG003|Overall Study|Adverse Event|4|||
28094969|NCT04072887|54748905|FG004|Overall Study|Adverse Event|0|||
28094970|NCT04072887|54748906|FG005|Overall Study|Adverse Event|1|||
28094971|NCT04072887|54748901|FG000|Overall Study|Physician Decision|2|||
28094972|NCT04072887|54748902|FG001|Overall Study|Physician Decision|0|||
28094973|NCT04072887|54748903|FG002|Overall Study|Physician Decision|0|||
28094974|NCT04072887|54748904|FG003|Overall Study|Physician Decision|0|||
28094975|NCT04072887|54748905|FG004|Overall Study|Physician Decision|0|||
28094976|NCT04072887|54748906|FG005|Overall Study|Physician Decision|1|||
28094977|NCT04072887|54748901|FG000|Overall Study|Lost to Follow-up|1|||
28094978|NCT04072887|54748902|FG001|Overall Study|Lost to Follow-up|3|||
28094979|NCT04072887|54748903|FG002|Overall Study|Lost to Follow-up|0|||
28094980|NCT04072887|54748904|FG003|Overall Study|Lost to Follow-up|0|||
28094981|NCT04072887|54748905|FG004|Overall Study|Lost to Follow-up|0|||
28094982|NCT04072887|54748906|FG005|Overall Study|Lost to Follow-up|0|||
28094983|NCT04072887|54748901|FG000|Overall Study|Death|0|||
28094984|NCT04072887|54748902|FG001|Overall Study|Death|2|||
28094985|NCT04072887|54748903|FG002|Overall Study|Death|0|||
28094986|NCT04072887|54748904|FG003|Overall Study|Death|2|||
28094987|NCT04072887|54748905|FG004|Overall Study|Death|3|||
28094988|NCT04072887|54748906|FG005|Overall Study|Death|0|||
28094989|NCT03516812|54748999|FG000|Overall Study|Adverse Event|4|||
28170390|NCT02112916|54841976|FG000|Overall Study|Still on Therapy|44|||
28170391|NCT02112916|54841977|FG001|Overall Study|Still on Therapy|47|||
28094990|NCT03516812|54748999|FG000|Overall Study|Lack of Efficacy|2|||
28094991|NCT03122119|54749039|FG000|Overall Study|Did not meet eligibility critria|1|||
28094992|NCT02613169|54749045|FG000|Overall Study|Withdrawal by Subject|4|||
28094993|NCT02613169|54749046|FG001|Overall Study|Withdrawal by Subject|1|||
28094994|NCT02613169|54749045|FG000|Overall Study|Lost to Follow-up|0|||
28094995|NCT02613169|54749046|FG001|Overall Study|Lost to Follow-up|5|||
28094996|NCT02613169|54749045|FG000|Overall Study|HIV|0|||
28094997|NCT02613169|54749046|FG001|Overall Study|HIV|2|||
28094998|NCT02613169|54749045|FG000|Overall Study|No TB infection endpoint|14|||
28094999|NCT02613169|54749046|FG001|Overall Study|No TB infection endpoint|9|||
28095000|NCT02362464|54749052|FG000|Overall Study|Switched to alternative therapy|1|||
28095001|NCT02362464|54749052|FG000|Overall Study|Refused further treatment|1|||
28095002|NCT02362464|54749052|FG000|Overall Study|Physician Decision|4|||
28095003|NCT02352948|54749062|FG000|Overall Study|Death|47|||
27737859|NCT02481050|54186872|FG000|Overall Study|Other|3|||
28095004|NCT02352948|54749063|FG001|Overall Study|Death|48|||
28095005|NCT02352948|54749064|FG002|Overall Study|Death|114|||
28095006|NCT02352948|54749065|FG003|Overall Study|Death|74|||
28095007|NCT02352948|54749066|FG004|Overall Study|Death|77|||
28095008|NCT02352948|54749067|FG005|Overall Study|Death|44|||
28095009|NCT02352948|54749062|FG000|Overall Study|Lost to Follow-up|1|||
28095010|NCT02352948|54749063|FG001|Overall Study|Lost to Follow-up|0|||
28095011|NCT02352948|54749064|FG002|Overall Study|Lost to Follow-up|2|||
28095012|NCT02352948|54749065|FG003|Overall Study|Lost to Follow-up|1|||
28170392|NCT02112916|54841978|FG002|Overall Study|Still on Therapy|3|||
28170393|NCT02112916|54841979|FG003|Overall Study|Still on Therapy|2|||
28170394|NCT02112916|54841976|FG000|Overall Study|Identified to have Ph+ T-ALL|0|||
28170395|NCT02112916|54841977|FG001|Overall Study|Identified to have Ph+ T-ALL|1|||
28170396|NCT02112916|54841978|FG002|Overall Study|Identified to have Ph+ T-ALL|0|||
28170397|NCT02112916|54841979|FG003|Overall Study|Identified to have Ph+ T-ALL|0|||
28170398|NCT02112916|54841976|FG000|Overall Study|Identified to have Ph+ T-Lly|0|||
28170399|NCT02112916|54841977|FG001|Overall Study|Identified to have Ph+ T-Lly|0|||
28170400|NCT02112916|54841978|FG002|Overall Study|Identified to have Ph+ T-Lly|1|||
28170401|NCT02112916|54841979|FG003|Overall Study|Identified to have Ph+ T-Lly|0|||
28170402|NCT02101268|54841996|FG000|Randomized Treatment Phase|Subject Decision|8|||
28170403|NCT02101268|54841997|FG001|Randomized Treatment Phase|Subject Decision|4|||
28170404|NCT02101268|54841998|FG002|Randomized Treatment Phase|Subject Decision|0|||
28170405|NCT02101268|54841999|FG003|Randomized Treatment Phase|Subject Decision|0|||
28170406|NCT02101268|54841996|FG000|Randomized Treatment Phase|Physician Decision|4|||
28170407|NCT02101268|54841997|FG001|Randomized Treatment Phase|Physician Decision|1|||
28170408|NCT02101268|54841998|FG002|Randomized Treatment Phase|Physician Decision|0|||
28170409|NCT02101268|54841999|FG003|Randomized Treatment Phase|Physician Decision|0|||
28170410|NCT02101268|54841996|FG000|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
28170411|NCT02101268|54841997|FG001|Randomized Treatment Phase|Symptomatic Spleen Growth|1|||
28170412|NCT02101268|54841998|FG002|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
28170413|NCT02101268|54841999|FG003|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
28170414|NCT02101268|54841996|FG000|Randomized Treatment Phase|Adverse Event|6|||
28170415|NCT02101268|54841997|FG001|Randomized Treatment Phase|Adverse Event|0|||
28170416|NCT02101268|54841998|FG002|Randomized Treatment Phase|Adverse Event|0|||
28170417|NCT02101268|54841999|FG003|Randomized Treatment Phase|Adverse Event|0|||
28170418|NCT02101268|54841996|FG000|Randomized Treatment Phase|Death|5|||
28170419|NCT02101268|54841997|FG001|Randomized Treatment Phase|Death|4|||
28170420|NCT02101268|54841998|FG002|Randomized Treatment Phase|Death|0|||
28170421|NCT02101268|54841999|FG003|Randomized Treatment Phase|Death|0|||
28170422|NCT02101268|54841996|FG000|Randomized Treatment Phase|Disease Progression|4|||
28170423|NCT02101268|54841997|FG001|Randomized Treatment Phase|Disease Progression|1|||
28170424|NCT02101268|54841998|FG002|Randomized Treatment Phase|Disease Progression|0|||
28170425|NCT02101268|54841999|FG003|Randomized Treatment Phase|Disease Progression|0|||
28170426|NCT02101268|54841996|FG000|Extended Treatment Phase|Subject Decision|0|||
28170427|NCT02101268|54841997|FG001|Extended Treatment Phase|Subject Decision|0|||
28170428|NCT02101268|54841998|FG002|Extended Treatment Phase|Subject Decision|3|||
28170429|NCT02101268|54841999|FG003|Extended Treatment Phase|Subject Decision|2|||
28170430|NCT02101268|54841996|FG000|Extended Treatment Phase|Physician Decision|0|||
28170431|NCT02101268|54841997|FG001|Extended Treatment Phase|Physician Decision|0|||
28170432|NCT02101268|54841998|FG002|Extended Treatment Phase|Physician Decision|5|||
28170433|NCT02101268|54841999|FG003|Extended Treatment Phase|Physician Decision|2|||
27833528|NCT01712399|54316280|FG000|Overall Study|Study closure|345|||
27980954|NCT00588861|54638910|FG000|Pre-Operative|Patients Did Not Complete Preop Data|95|||
28095013|NCT02352948|54749066|FG004|Overall Study|Lost to Follow-up|2|||
28095014|NCT02352948|54749067|FG005|Overall Study|Lost to Follow-up|1|||
28095015|NCT02352948|54749062|FG000|Overall Study|Withdrawal by Subject|1|||
28095016|NCT02352948|54749063|FG001|Overall Study|Withdrawal by Subject|10|||
28095017|NCT02352948|54749064|FG002|Overall Study|Withdrawal by Subject|11|||
28095018|NCT02352948|54749065|FG003|Overall Study|Withdrawal by Subject|23|||
28095019|NCT02352948|54749066|FG004|Overall Study|Withdrawal by Subject|9|||
28095020|NCT02352948|54749067|FG005|Overall Study|Withdrawal by Subject|4|||
28095021|NCT02352948|54749062|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
28095022|NCT02352948|54749063|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
28095023|NCT02352948|54749064|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
28095024|NCT02352948|54749065|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
28095025|NCT02352948|54749066|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
28095026|NCT02352948|54749067|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
28095027|NCT02352948|54749062|FG000|Overall Study|Other|0|||
28095028|NCT02352948|54749063|FG001|Overall Study|Other|0|||
28095029|NCT02352948|54749064|FG002|Overall Study|Other|2|||
28095030|NCT02352948|54749065|FG003|Overall Study|Other|0|||
28095031|NCT02352948|54749066|FG004|Overall Study|Other|0|||
28095032|NCT02352948|54749067|FG005|Overall Study|Other|0|||
28095033|NCT01974765|54749087|FG000|Overall Study|Withdrawal by Subject|1|||
28095034|NCT01974765|54749087|FG000|Overall Study|Death|1|||
28095035|NCT01974765|54749087|FG000|Overall Study|Adverse Event|2|||
28095036|NCT01802281|54749093|FG000|Overall Study|Death|1|||
28170434|NCT02101268|54841996|FG000|Extended Treatment Phase|Adverse Event|0|||
27833529|NCT03225846|54316387|FG000|Overall Study|Adverse Event|0|||
28170435|NCT02101268|54841997|FG001|Extended Treatment Phase|Adverse Event|0|||
28170436|NCT02101268|54841998|FG002|Extended Treatment Phase|Adverse Event|14|||
28170437|NCT02101268|54841999|FG003|Extended Treatment Phase|Adverse Event|18|||
28170438|NCT02101268|54841996|FG000|Extended Treatment Phase|Death|0|||
27737860|NCT02511782|54186879|FG000|Overall Study|Withdrawal by Subject|1|||
28170439|NCT02101268|54841997|FG001|Extended Treatment Phase|Death|0|||
28170440|NCT02101268|54841998|FG002|Extended Treatment Phase|Death|5|||
28170441|NCT02101268|54841999|FG003|Extended Treatment Phase|Death|1|||
28170442|NCT02101268|54841996|FG000|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
28170443|NCT02101268|54841997|FG001|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
28170444|NCT02101268|54841998|FG002|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|15|||
28170445|NCT02101268|54841999|FG003|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|7|||
28170446|NCT02101268|54841996|FG000|Extended Treatment Phase|Disease Progression|0|||
28170447|NCT02101268|54841997|FG001|Extended Treatment Phase|Disease Progression|0|||
28170448|NCT02101268|54841998|FG002|Extended Treatment Phase|Disease Progression|13|||
27737861|NCT02511782|54186880|FG001|Overall Study|Withdrawal by Subject|0|||
27737862|NCT02511782|54186881|FG002|Overall Study|Withdrawal by Subject|0|||
28170449|NCT02101268|54841999|FG003|Extended Treatment Phase|Disease Progression|6|||
28170450|NCT02101268|54841996|FG000|Extended Treatment Phase|Lack of Efficacy|0|||
28170451|NCT02101268|54841997|FG001|Extended Treatment Phase|Lack of Efficacy|0|||
28170452|NCT02101268|54841998|FG002|Extended Treatment Phase|Lack of Efficacy|9|||
28170453|NCT02101268|54841999|FG003|Extended Treatment Phase|Lack of Efficacy|4|||
27980955|NCT00588861|54638911|FG001|Pre-Operative|Patients Did Not Complete Preop Data|86|||
27980956|NCT00588861|54638910|FG000|6 Months|Patients did not return for follow-up|98|||
27980957|NCT00588861|54638911|FG001|6 Months|Patients did not return for follow-up|73|||
27737863|NCT02480114|54186891|FG000|Overall Study|Not completing surveys|3|||
27737864|NCT02480114|54186892|FG001|Overall Study|Not completing surveys|2|||
27737865|NCT02480114|54186891|FG000|Overall Study|Withdrawal by Subject|2|||
27737866|NCT02480114|54186892|FG001|Overall Study|Withdrawal by Subject|4|||
27737867|NCT02480114|54186891|FG000|Overall Study|Disease progression|3|||
27737868|NCT02480114|54186892|FG001|Overall Study|Disease progression|0|||
27737869|NCT02480114|54186891|FG000|Overall Study|Improper completion of survey|1|||
27737870|NCT02480114|54186892|FG001|Overall Study|Improper completion of survey|1|||
27737871|NCT02480114|54186891|FG000|Overall Study|Not eligible|0|||
27737872|NCT02480114|54186892|FG001|Overall Study|Not eligible|1|||
27737873|NCT02479880|54186900|FG000|Overall Study|Study Terminated by Sponsor|13|||
28170454|NCT01898650|54842016|FG000|Overall Study|the subject would not lie still for imaging|1|||
27737874|NCT02479880|54186901|FG001|Overall Study|Study Terminated by Sponsor|12|||
27737875|NCT02479880|54186900|FG000|Overall Study|Pregnancy|0|||
27737876|NCT02479880|54186901|FG001|Overall Study|Pregnancy|1|||
27737877|NCT02479802|54186907|FG000|Overall Study|Lost to Follow-up|1|||
27737878|NCT02479802|54186907|FG000|Overall Study|Adverse Event|1|||
27737879|NCT02479412|54186920|FG000|Overall Study|Adverse Event|0|||
27737880|NCT02479412|54186921|FG001|Overall Study|Adverse Event|0|||
27737881|NCT02479412|54186922|FG002|Overall Study|Adverse Event|1|||
28170455|NCT01880515|54842022|FG000|Overall Study|Lost to Follow-up|3|||
28170456|NCT01880515|54842023|FG001|Overall Study|Lost to Follow-up|2|||
28170457|NCT01880515|54842022|FG000|Overall Study|Disease Progression|5|||
28170458|NCT01880515|54842023|FG001|Overall Study|Disease Progression|7|||
28170459|NCT01668719|54842033|FG000|Phase I|On treatment|1|||
28170460|NCT01668719|54842034|FG001|Phase I|On treatment|0|||
28170461|NCT01668719|54842035|FG002|Phase I|On treatment|0|||
28170462|NCT01668719|54842033|FG000|Phase I|Adverse Event|2|||
28170463|NCT01668719|54842034|FG001|Phase I|Adverse Event|0|||
27737882|NCT02479412|54186923|FG003|Overall Study|Adverse Event|0|||
27980958|NCT00588861|54638910|FG000|1 Year|Patients did not return for follow-up|89|||
27980959|NCT00588861|54638911|FG001|1 Year|Patients did not return for follow-up|82|||
27737883|NCT02479412|54186924|FG004|Overall Study|Adverse Event|0|||
27737884|NCT02479412|54186925|FG005|Overall Study|Adverse Event|0|||
27737885|NCT02479412|54186926|FG006|Overall Study|Adverse Event|0|||
27737886|NCT02479412|54186927|FG007|Overall Study|Adverse Event|0|||
27737887|NCT02479412|54186928|FG008|Overall Study|Adverse Event|0|||
27737888|NCT02479412|54186920|FG000|Overall Study|Study-specific withdrawal criteria|0|||
27737889|NCT02479412|54186921|FG001|Overall Study|Study-specific withdrawal criteria|0|||
27737890|NCT02479412|54186922|FG002|Overall Study|Study-specific withdrawal criteria|1|||
27833530|NCT03225846|54316388|FG001|Overall Study|Adverse Event|0|||
27980960|NCT00588861|54638910|FG000|2 Years|Patients did not return for follow-up|92|||
27980961|NCT00588861|54638911|FG001|2 Years|Patients did not return for follow-up|87|||
27980962|NCT00588861|54638910|FG000|4 Years|Patients did not return for follow-up|91|||
28170464|NCT01668719|54842035|FG002|Phase I|Adverse Event|0|||
27737891|NCT02479412|54186923|FG003|Overall Study|Study-specific withdrawal criteria|1|||
27737892|NCT02479412|54186924|FG004|Overall Study|Study-specific withdrawal criteria|0|||
27737893|NCT02479412|54186925|FG005|Overall Study|Study-specific withdrawal criteria|0|||
27737894|NCT02479412|54186926|FG006|Overall Study|Study-specific withdrawal criteria|0|||
27737895|NCT02479412|54186927|FG007|Overall Study|Study-specific withdrawal criteria|1|||
27737896|NCT02479412|54186928|FG008|Overall Study|Study-specific withdrawal criteria|1|||
27737897|NCT02479412|54186920|FG000|Overall Study|Randomization to wrong PK sampling group|0|||
27737898|NCT02479412|54186921|FG001|Overall Study|Randomization to wrong PK sampling group|0|||
28170465|NCT01668719|54842033|FG000|Phase I|Progression/relapse|1|||
27737899|NCT02479412|54186922|FG002|Overall Study|Randomization to wrong PK sampling group|0|||
27737900|NCT02479412|54186923|FG003|Overall Study|Randomization to wrong PK sampling group|0|||
27737901|NCT02479412|54186924|FG004|Overall Study|Randomization to wrong PK sampling group|1|||
27737902|NCT02479412|54186925|FG005|Overall Study|Randomization to wrong PK sampling group|0|||
27737903|NCT02479412|54186926|FG006|Overall Study|Randomization to wrong PK sampling group|0|||
27737904|NCT02479412|54186927|FG007|Overall Study|Randomization to wrong PK sampling group|0|||
27737905|NCT02479412|54186928|FG008|Overall Study|Randomization to wrong PK sampling group|0|||
27737906|NCT00224003|54186944|FG000|Overall Study|Adverse Event|1|||
27737907|NCT00224003|54186944|FG000|Overall Study|Protocol Violation|2|||
27737908|NCT00224003|54186944|FG000|Overall Study|Withdrawal by Subject|1|||
27737909|NCT00224003|54186944|FG000|Overall Study|unk|3|||
27737910|NCT02450552|54186950|FG000|Overall Study|Withdrawal by Subject|4|||
27737911|NCT02450552|54186951|FG001|Overall Study|Withdrawal by Subject|0|||
27737912|NCT02450552|54186952|FG002|Overall Study|Withdrawal by Subject|4|||
27737913|NCT02450552|54186950|FG000|Overall Study|Physician Decision|1|||
27737914|NCT02450552|54186951|FG001|Overall Study|Physician Decision|0|||
27737915|NCT02450552|54186952|FG002|Overall Study|Physician Decision|1|||
27737916|NCT02508428|54186962|FG000|Overall Study|Death|32|||
27833531|NCT03225846|54316389|FG002|Overall Study|Adverse Event|0|||
28095037|NCT01802281|54749094|FG001|Overall Study|Death|2|||
28095038|NCT01802281|54749093|FG000|Overall Study|Withdrawal by Subject|2|||
28095039|NCT01802281|54749094|FG001|Overall Study|Withdrawal by Subject|1|||
28095040|NCT01802281|54749093|FG000|Overall Study|Ineligible|5|||
28095041|NCT01802281|54749094|FG001|Overall Study|Ineligible|3|||
28095042|NCT01725217|54749103|FG000|Overall Study|Withdrawal by Subject|1|||
28095043|NCT01725217|54749104|FG001|Overall Study|Withdrawal by Subject|0|||
28095044|NCT01725217|54749105|FG002|Overall Study|Withdrawal by Subject|0|||
28095045|NCT01592370|54749129|FG000|Overall Study|Disease Progression|62|||
28095046|NCT01592370|54749130|FG001|Overall Study|Disease Progression|16|||
28095047|NCT01592370|54749131|FG002|Overall Study|Disease Progression|52|||
28095048|NCT01592370|54749132|FG003|Overall Study|Disease Progression|3|||
28095049|NCT01592370|54749133|FG004|Overall Study|Disease Progression|3|||
28095050|NCT01592370|54749134|FG005|Overall Study|Disease Progression|31|||
28095051|NCT01592370|54749135|FG006|Overall Study|Disease Progression|14|||
28095052|NCT01592370|54749129|FG000|Overall Study|Study Drug Toxicity|14|||
28095053|NCT01592370|54749130|FG001|Overall Study|Study Drug Toxicity|3|||
28095054|NCT01592370|54749131|FG002|Overall Study|Study Drug Toxicity|0|||
28095055|NCT01592370|54749132|FG003|Overall Study|Study Drug Toxicity|0|||
28095056|NCT01592370|54749133|FG004|Overall Study|Study Drug Toxicity|0|||
28095057|NCT01592370|54749134|FG005|Overall Study|Study Drug Toxicity|0|||
28095058|NCT01592370|54749135|FG006|Overall Study|Study Drug Toxicity|1|||
28095059|NCT01592370|54749129|FG000|Overall Study|AE unrelated to study drug|4|||
28095060|NCT01592370|54749130|FG001|Overall Study|AE unrelated to study drug|3|||
28095061|NCT01592370|54749131|FG002|Overall Study|AE unrelated to study drug|0|||
28095062|NCT01592370|54749132|FG003|Overall Study|AE unrelated to study drug|0|||
28095063|NCT01592370|54749133|FG004|Overall Study|AE unrelated to study drug|0|||
28095064|NCT01592370|54749134|FG005|Overall Study|AE unrelated to study drug|0|||
28095065|NCT01592370|54749135|FG006|Overall Study|AE unrelated to study drug|1|||
28095066|NCT01592370|54749129|FG000|Overall Study|Request to discontinue study treatment|5|||
28095067|NCT01592370|54749130|FG001|Overall Study|Request to discontinue study treatment|0|||
28095068|NCT01592370|54749131|FG002|Overall Study|Request to discontinue study treatment|2|||
28095069|NCT01592370|54749132|FG003|Overall Study|Request to discontinue study treatment|0|||
28095070|NCT01592370|54749133|FG004|Overall Study|Request to discontinue study treatment|1|||
28095071|NCT01592370|54749134|FG005|Overall Study|Request to discontinue study treatment|2|||
28095072|NCT01592370|54749135|FG006|Overall Study|Request to discontinue study treatment|0|||
28095073|NCT01592370|54749129|FG000|Overall Study|Withdrew consent|1|||
28095074|NCT01592370|54749130|FG001|Overall Study|Withdrew consent|2|||
28095075|NCT01592370|54749131|FG002|Overall Study|Withdrew consent|1|||
28095076|NCT01592370|54749132|FG003|Overall Study|Withdrew consent|1|||
28095077|NCT01592370|54749133|FG004|Overall Study|Withdrew consent|0|||
28095078|NCT01592370|54749134|FG005|Overall Study|Withdrew consent|0|||
28095079|NCT01592370|54749135|FG006|Overall Study|Withdrew consent|0|||
28095080|NCT01592370|54749129|FG000|Overall Study|Maximum clinical benefit|11|||
28095081|NCT01592370|54749130|FG001|Overall Study|Maximum clinical benefit|1|||
28095082|NCT01592370|54749131|FG002|Overall Study|Maximum clinical benefit|7|||
28095083|NCT01592370|54749132|FG003|Overall Study|Maximum clinical benefit|1|||
28095084|NCT01592370|54749133|FG004|Overall Study|Maximum clinical benefit|0|||
28095085|NCT01592370|54749134|FG005|Overall Study|Maximum clinical benefit|0|||
28095086|NCT01592370|54749135|FG006|Overall Study|Maximum clinical benefit|0|||
28095087|NCT01592370|54749129|FG000|Overall Study|No longer meets study criteria|1|||
28095088|NCT01592370|54749130|FG001|Overall Study|No longer meets study criteria|0|||
28095089|NCT01592370|54749131|FG002|Overall Study|No longer meets study criteria|0|||
27737917|NCT02508428|54186963|FG001|Overall Study|Death|33|||
27737918|NCT02508428|54186962|FG000|Overall Study|Liner revised|3|||
27737919|NCT02508428|54186963|FG001|Overall Study|Liner revised|19|||
27737920|NCT02508428|54186962|FG000|Overall Study|Incomplete follow-up|17|||
27737921|NCT02508428|54186963|FG001|Overall Study|Incomplete follow-up|15|||
27737922|NCT02448680|54186971|FG000|Overall Study|Physician Decision|1|||
27737923|NCT02448680|54186972|FG001|Overall Study|Physician Decision|1|||
27737924|NCT02448680|54186971|FG000|Overall Study|Withdrawal by Subject|0|||
27737925|NCT02448680|54186972|FG001|Overall Study|Withdrawal by Subject|2|||
28095090|NCT01592370|54749132|FG003|Overall Study|No longer meets study criteria|0|||
28095091|NCT01592370|54749133|FG004|Overall Study|No longer meets study criteria|0|||
28095092|NCT01592370|54749134|FG005|Overall Study|No longer meets study criteria|0|||
28095093|NCT01592370|54749135|FG006|Overall Study|No longer meets study criteria|0|||
27737926|NCT02448446|54186982|FG000|Overall Study|Withdrawal by Subject|1|||
27737927|NCT02448446|54186983|FG001|Overall Study|Withdrawal by Subject|0|||
27737928|NCT02447744|54186991|FG000|Overall Study|Withdrawal by Subject|3|||
27737929|NCT02447744|54186992|FG001|Overall Study|Withdrawal by Subject|1|||
27737930|NCT02447744|54186991|FG000|Overall Study|Data not collected b/c logistic reasons|3|||
27737931|NCT02447744|54186992|FG001|Overall Study|Data not collected b/c logistic reasons|0|||
27737932|NCT02478632|54187000|FG000|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4|||
27737933|NCT02478632|54187001|FG001|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5|||
27737934|NCT02478632|54187000|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2|||
27737935|NCT02478632|54187001|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3|||
27737936|NCT02478632|54187000|FG000|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5|||
27737937|NCT02478632|54187001|FG001|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1|||
27737938|NCT02478398|54187012|FG000|Overall Study|Adverse Event|20|||
27737939|NCT02478398|54187013|FG001|Overall Study|Adverse Event|5|||
27737940|NCT02478398|54187012|FG000|Overall Study|Lost to Follow-up|5|||
27737941|NCT02478398|54187013|FG001|Overall Study|Lost to Follow-up|4|||
27737942|NCT02478398|54187012|FG000|Overall Study|Non-Compliance With Study Drug|5|||
27737943|NCT02478398|54187013|FG001|Overall Study|Non-Compliance With Study Drug|1|||
27833532|NCT03225846|54316390|FG003|Overall Study|Adverse Event|0|||
27833533|NCT03225846|54316391|FG004|Overall Study|Adverse Event|0|||
27833534|NCT03225846|54316392|FG005|Overall Study|Adverse Event|0|||
27833535|NCT03225846|54316393|FG006|Overall Study|Adverse Event|6|||
27833536|NCT03225846|54316387|FG000|Overall Study|Withdrawal by Subject|0|||
27833537|NCT03225846|54316388|FG001|Overall Study|Withdrawal by Subject|1|||
28095094|NCT01592370|54749129|FG000|Overall Study|Other Reasons|6|||
28095095|NCT01592370|54749130|FG001|Overall Study|Other Reasons|0|||
28095096|NCT01592370|54749131|FG002|Overall Study|Other Reasons|10|||
28095097|NCT01592370|54749132|FG003|Overall Study|Other Reasons|0|||
28095098|NCT01592370|54749133|FG004|Overall Study|Other Reasons|0|||
28095099|NCT01592370|54749134|FG005|Overall Study|Other Reasons|1|||
28095100|NCT01592370|54749135|FG006|Overall Study|Other Reasons|0|||
28095101|NCT01344057|54749164|FG000|Overall Study|Premature Withdrawal|1|||
28095102|NCT00886782|54749171|FG000|Overall Study|Disease progression|3|||
28095103|NCT00886782|54749172|FG001|Overall Study|Disease progression|3|||
28095104|NCT00886782|54749173|FG002|Overall Study|Disease progression|3|||
28170466|NCT01668719|54842034|FG001|Phase I|Progression/relapse|0|||
27980963|NCT00588861|54638911|FG001|4 Years|Patients did not return for follow-up|103|||
27980964|NCT00588861|54638910|FG000|6 Years|Patients did not return for follow-up|104|||
28170467|NCT01668719|54842035|FG002|Phase I|Progression/relapse|0|||
28170468|NCT01668719|54842033|FG000|Phase I|not protocol specified|2|||
28170469|NCT01668719|54842034|FG001|Phase I|not protocol specified|0|||
28170470|NCT01668719|54842035|FG002|Phase I|not protocol specified|0|||
28170471|NCT01668719|54842033|FG000|Phase II|On treatment|0|||
28170472|NCT01668719|54842034|FG001|Phase II|On treatment|4|||
28170473|NCT01668719|54842035|FG002|Phase II|On treatment|3|||
28170474|NCT01668719|54842033|FG000|Phase II|Adverse Event|0|||
27737944|NCT02478398|54187012|FG000|Overall Study|Protocol Violation|3|||
27737945|NCT02478398|54187013|FG001|Overall Study|Protocol Violation|1|||
27737946|NCT02478398|54187012|FG000|Overall Study|Withdrawal By Parent/Guardian|9|||
27833538|NCT03225846|54316389|FG002|Overall Study|Withdrawal by Subject|0|||
27833539|NCT03225846|54316390|FG003|Overall Study|Withdrawal by Subject|0|||
27833540|NCT03225846|54316391|FG004|Overall Study|Withdrawal by Subject|0|||
27833541|NCT03225846|54316392|FG005|Overall Study|Withdrawal by Subject|0|||
27833542|NCT03225846|54316393|FG006|Overall Study|Withdrawal by Subject|0|||
27833543|NCT03225846|54316387|FG000|Overall Study|Death|0|||
27833544|NCT03225846|54316388|FG001|Overall Study|Death|1|||
27980965|NCT00588861|54638911|FG001|6 Years|Patients did not return for follow-up|109|||
28170475|NCT01668719|54842034|FG001|Phase II|Adverse Event|18|||
27737947|NCT02478398|54187013|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
27980966|NCT00588861|54638910|FG000|8 Years|Patients did not return for follow-up|105|||
28095105|NCT00886782|54749171|FG000|Overall Study|Study drug toxicity|0|||
28095106|NCT00886782|54749172|FG001|Overall Study|Study drug toxicity|0|||
28095107|NCT00886782|54749173|FG002|Overall Study|Study drug toxicity|1|||
28170476|NCT01668719|54842035|FG002|Phase II|Adverse Event|18|||
27737948|NCT02478398|54187012|FG000|Overall Study|Withdrawal By Participant|10|||
27737949|NCT02478398|54187013|FG001|Overall Study|Withdrawal By Participant|4|||
27833545|NCT03225846|54316389|FG002|Overall Study|Death|0|||
27737950|NCT02478164|54187020|FG000|Overall Study|Lack of Efficacy|13|||
27737951|NCT02478164|54187020|FG000|Overall Study|Adverse Event|1|||
27737952|NCT02478164|54187020|FG000|Overall Study|Withdrawal by Subject|1|||
27737953|NCT02476994|54187026|FG000|Overall Study|Based on feedback from FDA|1|||
27737954|NCT02476994|54187027|FG001|Overall Study|Based on feedback from FDA|0|||
27737955|NCT02508194|54187035|FG000|Overall Study|Death|5|||
27737956|NCT02508194|54187036|FG001|Overall Study|Death|3|||
27737957|NCT02508194|54187035|FG000|Overall Study|Lost to Follow-up|25|||
27737958|NCT02508194|54187036|FG001|Overall Study|Lost to Follow-up|18|||
27737959|NCT02508194|54187035|FG000|Overall Study|Withdrawal by Subject|20|||
27737960|NCT02508194|54187036|FG001|Overall Study|Withdrawal by Subject|18|||
27737961|NCT02508194|54187035|FG000|Overall Study|Error in Randomization|1|||
27737962|NCT02508194|54187036|FG001|Overall Study|Error in Randomization|3|||
27737963|NCT02508194|54187035|FG000|Overall Study|Principal Investigator Decision|1|||
27737964|NCT02508194|54187036|FG001|Overall Study|Principal Investigator Decision|2|||
27737965|NCT02508116|54187044|FG000|Overall Study|Lost to Follow-up|2|||
27737966|NCT02508116|54187045|FG001|Overall Study|Lost to Follow-up|3|||
27737967|NCT02508116|54187044|FG000|Overall Study|Withdrawal by Subject|3|||
27737968|NCT02508116|54187045|FG001|Overall Study|Withdrawal by Subject|2|||
27737969|NCT02508116|54187044|FG000|Overall Study|Protocol Violation|1|||
27737970|NCT02508116|54187045|FG001|Overall Study|Protocol Violation|2|||
27737971|NCT02508116|54187044|FG000|Overall Study|Physician Decision|2|||
27737972|NCT02508116|54187045|FG001|Overall Study|Physician Decision|0|||
27737973|NCT01653782|54187054|FG000|Overall Study|Withdrawal by Subject|9|||
27737974|NCT01653782|54187055|FG001|Overall Study|Withdrawal by Subject|15|||
27737975|NCT01653782|54187056|FG002|Overall Study|Withdrawal by Subject|4|||
27737976|NCT01653782|54187054|FG000|Overall Study|Lost to Follow-up|7|||
27737977|NCT01653782|54187055|FG001|Overall Study|Lost to Follow-up|3|||
27737978|NCT01653782|54187056|FG002|Overall Study|Lost to Follow-up|2|||
27737979|NCT02318329|54187074|FG000|Overall Study|Progressive Disease|2|||
27737980|NCT02318329|54187075|FG001|Overall Study|Progressive Disease|3|||
27737981|NCT02318329|54187076|FG002|Overall Study|Progressive Disease|2|||
27737982|NCT02318329|54187077|FG003|Overall Study|Progressive Disease|3|||
27737983|NCT02318329|54187078|FG004|Overall Study|Progressive Disease|3|||
27737984|NCT02318329|54187079|FG005|Overall Study|Progressive Disease|3|||
27737985|NCT02318329|54187080|FG006|Overall Study|Progressive Disease|1|||
27737986|NCT02318329|54187081|FG007|Overall Study|Progressive Disease|1|||
27737987|NCT02318329|54187082|FG008|Overall Study|Progressive Disease|5|||
27737988|NCT02318329|54187083|FG009|Overall Study|Progressive Disease|39|||
27737989|NCT02318329|54187074|FG000|Overall Study|Death|0|||
27737990|NCT02318329|54187075|FG001|Overall Study|Death|0|||
27737991|NCT02318329|54187076|FG002|Overall Study|Death|0|||
27737992|NCT02318329|54187077|FG003|Overall Study|Death|0|||
27737993|NCT02318329|54187078|FG004|Overall Study|Death|0|||
27737994|NCT02318329|54187079|FG005|Overall Study|Death|0|||
27737995|NCT02318329|54187080|FG006|Overall Study|Death|0|||
27737996|NCT02318329|54187081|FG007|Overall Study|Death|0|||
27737997|NCT02318329|54187082|FG008|Overall Study|Death|0|||
27737998|NCT02318329|54187083|FG009|Overall Study|Death|5|||
27737999|NCT02318329|54187074|FG000|Overall Study|Lost to Follow-up|0|||
27738000|NCT02318329|54187075|FG001|Overall Study|Lost to Follow-up|0|||
27738001|NCT02318329|54187076|FG002|Overall Study|Lost to Follow-up|0|||
28170477|NCT01668719|54842033|FG000|Phase II|Refusal unrelated to adverse event|0|||
28170478|NCT01668719|54842034|FG001|Phase II|Refusal unrelated to adverse event|4|||
28170479|NCT01668719|54842035|FG002|Phase II|Refusal unrelated to adverse event|1|||
28170480|NCT01668719|54842033|FG000|Phase II|Progression/relapse|0|||
28170481|NCT01668719|54842034|FG001|Phase II|Progression/relapse|13|||
28170482|NCT01668719|54842035|FG002|Phase II|Progression/relapse|17|||
28170483|NCT01668719|54842033|FG000|Phase II|Death|0|||
28170484|NCT01668719|54842034|FG001|Phase II|Death|0|||
28170485|NCT01668719|54842035|FG002|Phase II|Death|2|||
28170486|NCT01668719|54842033|FG000|Phase II|not protocol specified|0|||
28170487|NCT01668719|54842034|FG001|Phase II|not protocol specified|13|||
28170488|NCT01668719|54842035|FG002|Phase II|not protocol specified|7|||
27738002|NCT02318329|54187077|FG003|Overall Study|Lost to Follow-up|0|||
27738003|NCT02318329|54187078|FG004|Overall Study|Lost to Follow-up|0|||
27738004|NCT02318329|54187079|FG005|Overall Study|Lost to Follow-up|0|||
27738005|NCT02318329|54187080|FG006|Overall Study|Lost to Follow-up|0|||
27738006|NCT02318329|54187081|FG007|Overall Study|Lost to Follow-up|0|||
27738007|NCT02318329|54187082|FG008|Overall Study|Lost to Follow-up|0|||
27738008|NCT02318329|54187083|FG009|Overall Study|Lost to Follow-up|1|||
27738009|NCT02318329|54187074|FG000|Overall Study|Withdrawal by Subject|0|||
27738010|NCT02318329|54187075|FG001|Overall Study|Withdrawal by Subject|0|||
27738011|NCT02318329|54187076|FG002|Overall Study|Withdrawal by Subject|0|||
27738012|NCT02318329|54187077|FG003|Overall Study|Withdrawal by Subject|0|||
27738013|NCT02318329|54187078|FG004|Overall Study|Withdrawal by Subject|0|||
27738014|NCT02318329|54187079|FG005|Overall Study|Withdrawal by Subject|0|||
27738015|NCT02318329|54187080|FG006|Overall Study|Withdrawal by Subject|0|||
27738016|NCT02318329|54187081|FG007|Overall Study|Withdrawal by Subject|0|||
28170489|NCT01642901|54842047|FG000|12-month Follow-up|Withdrawal by Subject|1|||
27738017|NCT02318329|54187082|FG008|Overall Study|Withdrawal by Subject|0|||
27738018|NCT02318329|54187083|FG009|Overall Study|Withdrawal by Subject|6|||
27738019|NCT02318329|54187074|FG000|Overall Study|Other|1|||
27738020|NCT02318329|54187075|FG001|Overall Study|Other|1|||
27738021|NCT02318329|54187076|FG002|Overall Study|Other|1|||
27738022|NCT02318329|54187077|FG003|Overall Study|Other|0|||
27738023|NCT02318329|54187078|FG004|Overall Study|Other|0|||
27738024|NCT02318329|54187079|FG005|Overall Study|Other|0|||
27738025|NCT02318329|54187080|FG006|Overall Study|Other|0|||
27738026|NCT02318329|54187081|FG007|Overall Study|Other|0|||
27738027|NCT02318329|54187082|FG008|Overall Study|Other|1|||
27738028|NCT02318329|54187083|FG009|Overall Study|Other|1|||
27738029|NCT02255656|54187124|FG000|Overall Study|Adverse Event|11|||
27833546|NCT03225846|54316390|FG003|Overall Study|Death|0|||
27833547|NCT03225846|54316391|FG004|Overall Study|Death|0|||
27833548|NCT03225846|54316392|FG005|Overall Study|Death|0|||
27833549|NCT03225846|54316393|FG006|Overall Study|Death|0|||
27833550|NCT03225846|54316387|FG000|Overall Study|Patient did not wish to comply with IC/EC|0|||
27833551|NCT03225846|54316388|FG001|Overall Study|Patient did not wish to comply with IC/EC|0|||
28095108|NCT00886782|54749171|FG000|Overall Study|Adverse event unrelated to Study drug|0|||
28095109|NCT00886782|54749172|FG001|Overall Study|Adverse event unrelated to Study drug|0|||
28095110|NCT00886782|54749173|FG002|Overall Study|Adverse event unrelated to Study drug|1|||
28095111|NCT00583024|54749181|FG000|Overall Study|Lost to Follow-up|4|||
27833552|NCT03225846|54316389|FG002|Overall Study|Patient did not wish to comply with IC/EC|1|||
27738030|NCT02255656|54187124|FG000|Overall Study|Poor compliance to protocol|3|||
27833553|NCT03225846|54316390|FG003|Overall Study|Patient did not wish to comply with IC/EC|0|||
27833554|NCT03225846|54316391|FG004|Overall Study|Patient did not wish to comply with IC/EC|0|||
27833555|NCT03225846|54316392|FG005|Overall Study|Patient did not wish to comply with IC/EC|0|||
27833556|NCT03225846|54316393|FG006|Overall Study|Patient did not wish to comply with IC/EC|0|||
27833557|NCT03225846|54316387|FG000|Overall Study|Patient decision|0|||
27833558|NCT03225846|54316388|FG001|Overall Study|Patient decision|0|||
27833559|NCT03225846|54316389|FG002|Overall Study|Patient decision|0|||
27833560|NCT03225846|54316390|FG003|Overall Study|Patient decision|0|||
27833561|NCT03225846|54316391|FG004|Overall Study|Patient decision|0|||
27833562|NCT03225846|54316392|FG005|Overall Study|Patient decision|0|||
27833563|NCT03225846|54316393|FG006|Overall Study|Patient decision|1|||
27833564|NCT01712009|54316458|FG000|Overall Study|Withdrawal by Subject|24|||
27833565|NCT01712009|54316459|FG001|Overall Study|Withdrawal by Subject|15|||
27833566|NCT01712009|54316460|FG002|Overall Study|Withdrawal by Subject|8|||
27833567|NCT01712009|54316458|FG000|Overall Study|Lost to Follow-up|2|||
27833568|NCT01712009|54316459|FG001|Overall Study|Lost to Follow-up|0|||
27833569|NCT01712009|54316460|FG002|Overall Study|Lost to Follow-up|1|||
27833570|NCT01712009|54316458|FG000|Overall Study|Decision by Sponsor|12|||
27833571|NCT01712009|54316459|FG001|Overall Study|Decision by Sponsor|14|||
27833572|NCT01712009|54316460|FG002|Overall Study|Decision by Sponsor|12|||
27833573|NCT01711853|54316489|FG000|Overall Study|Not treated|3|||
27833574|NCT01708187|54316495|FG000|Overall Study|Lost to Follow-up|0|||
27833575|NCT01708187|54316496|FG001|Overall Study|Lost to Follow-up|1|||
27833576|NCT01740401|54316572|FG000|Overall Study|Progression of disease|6|||
27833577|NCT01740401|54316572|FG000|Overall Study|Adverse Event|2|||
27833578|NCT01740401|54316572|FG000|Overall Study|Did not reach primary endpoint|2|||
27833579|NCT01711619|54316593|FG000|Overall Study|Early study termination|10|||
27833580|NCT01711619|54316594|FG001|Overall Study|Early study termination|14|||
27833581|NCT01711619|54316593|FG000|Overall Study|Withdrawal by Subject|3|||
27833582|NCT01711619|54316594|FG001|Overall Study|Withdrawal by Subject|7|||
27833583|NCT01711619|54316593|FG000|Overall Study|Protocol Violation|2|||
27833584|NCT01711619|54316594|FG001|Overall Study|Protocol Violation|3|||
27833585|NCT01711619|54316593|FG000|Overall Study|Adverse Event|2|||
27833586|NCT01711619|54316594|FG001|Overall Study|Adverse Event|0|||
27833587|NCT01711619|54316593|FG000|Overall Study|Lost to Follow-up|1|||
28095112|NCT03435640|54749196|FG000|Overall Study|Withdrawal by Subject|0|||
27833588|NCT01711619|54316594|FG001|Overall Study|Lost to Follow-up|0|||
27833589|NCT01710527|54316609|FG000|Period 2: Washout Period (7 Days)|Personal reasons|0|||
27833590|NCT01710527|54316610|FG001|Period 2: Washout Period (7 Days)|Personal reasons|1|||
27833591|NCT01706939|54316618|FG000|Pre Randomization|Screen Failure|1|||
27833592|NCT01706939|54316619|FG001|Pre Randomization|Screen Failure|0|||
27833593|NCT01706939|54316620|FG002|Pre Randomization|Screen Failure|0|||
28095113|NCT03435640|54749197|FG001|Overall Study|Withdrawal by Subject|1|||
28095114|NCT03435640|54749198|FG002|Overall Study|Withdrawal by Subject|0|||
28095115|NCT03435640|54749199|FG003|Overall Study|Withdrawal by Subject|2|||
28095116|NCT03435640|54749200|FG004|Overall Study|Withdrawal by Subject|0|||
28095117|NCT03435640|54749201|FG005|Overall Study|Withdrawal by Subject|0|||
27833594|NCT01706939|54316618|FG000|Pre Randomization|Ineligible for Randomization|1|||
27738031|NCT02255656|54187124|FG000|Overall Study|Lost to Follow-up|30|||
27738032|NCT02255656|54187124|FG000|Overall Study|Due to Coronavirus Disease (Covid-19)|300|||
27738033|NCT02255656|54187124|FG000|Overall Study|Other|126|||
27738034|NCT02255500|54187137|FG000|Overall Study|Withdrawal by Subject|1|||
27738035|NCT02255500|54187138|FG001|Overall Study|Withdrawal by Subject|0|||
27738036|NCT02505542|54187144|FG000|Part A: Open-Label Period|Adverse Event|31|||
27833595|NCT01706939|54316619|FG001|Pre Randomization|Ineligible for Randomization|0|||
27833596|NCT01706939|54316620|FG002|Pre Randomization|Ineligible for Randomization|0|||
27833597|NCT01706939|54316618|FG000|Pre Randomization|Withdrawal by Subject|1|||
27833598|NCT01706939|54316619|FG001|Pre Randomization|Withdrawal by Subject|0|||
27833599|NCT01706939|54316620|FG002|Pre Randomization|Withdrawal by Subject|0|||
27833600|NCT01706939|54316618|FG000|Randomization|Insufficient QoL survey compliance|0|||
27833601|NCT01706939|54316619|FG001|Randomization|Insufficient QoL survey compliance|1|||
27833602|NCT01706939|54316620|FG002|Randomization|Insufficient QoL survey compliance|1|||
28170490|NCT01642901|54842048|FG001|12-month Follow-up|Withdrawal by Subject|0|||
28170491|NCT01488045|54842056|FG000|Overall Study|Withdrawal by Subject|6|||
28170492|NCT01488045|54842057|FG001|Overall Study|Withdrawal by Subject|11|||
28170493|NCT01488045|54842056|FG000|Overall Study|Failure to present for colonoscopy|3|||
28170494|NCT01488045|54842057|FG001|Overall Study|Failure to present for colonoscopy|6|||
28170495|NCT01488045|54842056|FG000|Overall Study|Failure to report exclusion criteria|0|||
28170496|NCT01488045|54842057|FG001|Overall Study|Failure to report exclusion criteria|1|||
28170497|NCT00946712|54842076|FG000|Overall Study|Adverse Event|118|||
27833603|NCT01706939|54316618|FG000|Randomization|Progression of disease|0|||
27833604|NCT01706939|54316619|FG001|Randomization|Progression of disease|2|||
27833605|NCT01706939|54316620|FG002|Randomization|Progression of disease|1|||
27833606|NCT01709903|54316629|FG000|Overall Study|administrative problems|2|||
27833607|NCT01709903|54316630|FG001|Overall Study|administrative problems|6|||
27833608|NCT01709903|54316629|FG000|Overall Study|Abnormal test procedure results|1|||
27833609|NCT01709903|54316630|FG001|Overall Study|Abnormal test procedure results|0|||
27833610|NCT01709903|54316629|FG000|Overall Study|In ability to use device|1|||
27833611|NCT01709903|54316630|FG001|Overall Study|In ability to use device|1|||
27833612|NCT01709903|54316629|FG000|Overall Study|no longer needed study drug|0|||
27833613|NCT01709903|54316630|FG001|Overall Study|no longer needed study drug|1|||
27833614|NCT01709903|54316629|FG000|Overall Study|Lost to Follow-up|0|||
27833615|NCT01709903|54316630|FG001|Overall Study|Lost to Follow-up|2|||
27833616|NCT01709903|54316629|FG000|Overall Study|Death|2|||
27833617|NCT01709903|54316630|FG001|Overall Study|Death|0|||
27833618|NCT01709903|54316629|FG000|Overall Study|Protocol Violation|3|||
27833619|NCT01709903|54316630|FG001|Overall Study|Protocol Violation|2|||
27833620|NCT01709903|54316629|FG000|Overall Study|Lack of Efficacy|3|||
27833621|NCT01709903|54316630|FG001|Overall Study|Lack of Efficacy|3|||
27833622|NCT01709903|54316629|FG000|Overall Study|Withdrawal by Subject|6|||
27833623|NCT01709903|54316630|FG001|Overall Study|Withdrawal by Subject|6|||
27833624|NCT01709903|54316629|FG000|Overall Study|Adverse Event|11|||
27833625|NCT01709903|54316630|FG001|Overall Study|Adverse Event|18|||
27833626|NCT04492618|54316636|FG000|Overall Study|Withdrawal by Subject|1|||
27833627|NCT01605227|54316642|FG000|Overall Study|Did not receive study treatment|2|||
27833628|NCT01605227|54316643|FG001|Overall Study|Did not receive study treatment|3|||
27833629|NCT01605227|54316642|FG000|Overall Study|Adverse Event|228|||
27833630|NCT01605227|54316643|FG001|Overall Study|Adverse Event|42|||
27833631|NCT01605227|54316642|FG000|Overall Study|Progressive Disease|132|||
27833632|NCT01605227|54316643|FG001|Overall Study|Progressive Disease|128|||
27833633|NCT01605227|54316642|FG000|Overall Study|Clinical Deterioration|227|||
27833634|NCT01605227|54316643|FG001|Overall Study|Clinical Deterioration|133|||
27833635|NCT01605227|54316642|FG000|Overall Study|Lost to Follow-up|1|||
27833636|NCT01605227|54316643|FG001|Overall Study|Lost to Follow-up|0|||
27833637|NCT01605227|54316642|FG000|Overall Study|Protocol Violation|1|||
27833638|NCT01605227|54316643|FG001|Overall Study|Protocol Violation|0|||
27856361|NCT02519348|54387536|FG004|Overall Study|Ongoing at the time of data cut-off date|15|||
27856362|NCT02519348|54387537|FG005|Overall Study|Ongoing at the time of data cut-off date|26|||
27856363|NCT02519348|54387538|FG006|Overall Study|Ongoing at the time of data cut-off date|0|||
28170498|NCT00946712|54842077|FG001|Overall Study|Adverse Event|124|||
28170499|NCT00946712|54842076|FG000|Overall Study|Disease progression|308|||
28170500|NCT00946712|54842077|FG001|Overall Study|Disease progression|404|||
28170501|NCT00946712|54842076|FG000|Overall Study|Death|21|||
28170502|NCT00946712|54842077|FG001|Overall Study|Death|22|||
28170503|NCT00946712|54842076|FG000|Overall Study|No treatment given|25|||
28170504|NCT00946712|54842077|FG001|Overall Study|No treatment given|29|||
28170505|NCT00946712|54842076|FG000|Overall Study|Other reasons|61|||
28170506|NCT00946712|54842077|FG001|Overall Study|Other reasons|73|||
28170507|NCT00946712|54842076|FG000|Overall Study|On Treatment|0|||
28170508|NCT00946712|54842077|FG001|Overall Study|On Treatment|4|||
28170509|NCT00946712|54842076|FG000|Overall Study|Ineligible|14|||
28170510|NCT00946712|54842077|FG001|Overall Study|Ineligible|6|||
27738037|NCT02505542|54187145|FG001|Part A: Open-Label Period|Adverse Event|0|||
27833639|NCT01605227|54316642|FG000|Overall Study|Physician Decision|9|||
27833640|NCT01605227|54316643|FG001|Overall Study|Physician Decision|7|||
27833641|NCT01605227|54316642|FG000|Overall Study|Withdrawal by Subject|18|||
27980967|NCT00588861|54638911|FG001|8 Years|Patients did not return for follow-up|114|||
27833642|NCT01605227|54316643|FG001|Overall Study|Withdrawal by Subject|14|||
27738038|NCT02505542|54187146|FG002|Part A: Open-Label Period|Adverse Event|0|||
27738039|NCT02505542|54187147|FG003|Part A: Open-Label Period|Adverse Event|0|||
27738040|NCT02505542|54187144|FG000|Part A: Open-Label Period|Lack of Efficacy|5|||
27738041|NCT02505542|54187145|FG001|Part A: Open-Label Period|Lack of Efficacy|0|||
27738042|NCT02505542|54187146|FG002|Part A: Open-Label Period|Lack of Efficacy|0|||
27738043|NCT02505542|54187147|FG003|Part A: Open-Label Period|Lack of Efficacy|0|||
27738044|NCT02505542|54187144|FG000|Part A: Open-Label Period|Protocol Violation|1|||
27738045|NCT02505542|54187145|FG001|Part A: Open-Label Period|Protocol Violation|0|||
27738046|NCT02505542|54187146|FG002|Part A: Open-Label Period|Protocol Violation|0|||
27738047|NCT02505542|54187147|FG003|Part A: Open-Label Period|Protocol Violation|0|||
27738048|NCT02505542|54187144|FG000|Part A: Open-Label Period|Lost to Follow-up|5|||
27738049|NCT02505542|54187145|FG001|Part A: Open-Label Period|Lost to Follow-up|0|||
27738050|NCT02505542|54187146|FG002|Part A: Open-Label Period|Lost to Follow-up|0|||
28170511|NCT00656669|54842084|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4|||
28170512|NCT00656669|54842084|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2|||
28170513|NCT00656669|54842084|FG000|AC (Cycles 6-9)|Adverse Event|1|||
28170514|NCT00656669|54842084|FG000|AC (Cycles 6-9)|Did not start segment 3|1|||
28170515|NCT00470704|54842095|FG000|Overall Study|Withdrawal by Subject|4|||
28170516|NCT00470704|54842096|FG001|Overall Study|Withdrawal by Subject|3|||
28170517|NCT00470704|54842095|FG000|Overall Study|Relapse/Progression|37|||
28170518|NCT00470704|54842096|FG001|Overall Study|Relapse/Progression|42|||
28170519|NCT00470704|54842095|FG000|Overall Study|toxicity|0|||
28170520|NCT00470704|54842096|FG001|Overall Study|toxicity|1|||
28170521|NCT01338493|54842102|FG000|Enrolled|Withdrawal by Subject|1|||
28170522|NCT01338493|54842102|FG000|Enrolled|Patient not implanted|4|||
28170523|NCT01338493|54842102|FG000|Discharge|Death|1|||
28170524|NCT01338493|54842102|FG000|Discharge|Missed visit|1|||
28170525|NCT01338493|54842102|FG000|6 Months Follow up|Lost to Follow-up|11|||
28170526|NCT01338493|54842102|FG000|6 Months Follow up|Missed visit|8|||
28170527|NCT01338493|54842102|FG000|12 Months Follow up|Lost to Follow-up|9|||
28170528|NCT01362296|54842108|FG000|Randomized Phase (RP)|PD including Death due to PD|56|||
28170529|NCT01362296|54842109|FG001|Randomized Phase (RP)|PD including Death due to PD|28|||
28170530|NCT01362296|54842110|FG002|Randomized Phase (RP)|PD including Death due to PD|0|||
28170531|NCT01362296|54842111|FG003|Randomized Phase (RP)|PD including Death due to PD|0|||
28170532|NCT01362296|54842108|FG000|Randomized Phase (RP)|Physician Decision|1|||
28170533|NCT01362296|54842109|FG001|Randomized Phase (RP)|Physician Decision|9|||
28170534|NCT01362296|54842110|FG002|Randomized Phase (RP)|Physician Decision|0|||
28170535|NCT01362296|54842111|FG003|Randomized Phase (RP)|Physician Decision|0|||
28170536|NCT01362296|54842108|FG000|Randomized Phase (RP)|Withdrawal by Subject|2|||
28170537|NCT01362296|54842109|FG001|Randomized Phase (RP)|Withdrawal by Subject|1|||
28170538|NCT01362296|54842110|FG002|Randomized Phase (RP)|Withdrawal by Subject|0|||
28170539|NCT01362296|54842111|FG003|Randomized Phase (RP)|Withdrawal by Subject|0|||
28170540|NCT01362296|54842108|FG000|Randomized Phase (RP)|Adverse Event|20|||
28170541|NCT01362296|54842109|FG001|Randomized Phase (RP)|Adverse Event|4|||
28170542|NCT01362296|54842110|FG002|Randomized Phase (RP)|Adverse Event|0|||
28170543|NCT01362296|54842111|FG003|Randomized Phase (RP)|Adverse Event|0|||
28170544|NCT01362296|54842108|FG000|Randomized Phase (RP)|Study Closed/Terminated|8|||
28170545|NCT01362296|54842109|FG001|Randomized Phase (RP)|Study Closed/Terminated|1|||
28170546|NCT01362296|54842110|FG002|Randomized Phase (RP)|Study Closed/Terminated|0|||
28170547|NCT01362296|54842111|FG003|Randomized Phase (RP)|Study Closed/Terminated|0|||
28170548|NCT01362296|54842108|FG000|Crossover Phase|PD including Death due to PD|0|||
28170549|NCT01362296|54842109|FG001|Crossover Phase|PD including Death due to PD|0|||
28170550|NCT01362296|54842110|FG002|Crossover Phase|PD including Death due to PD|16|||
28170551|NCT01362296|54842111|FG003|Crossover Phase|PD including Death due to PD|1|||
28170552|NCT01362296|54842108|FG000|Crossover Phase|Withdrawal by Subject|0|||
28170553|NCT01362296|54842109|FG001|Crossover Phase|Withdrawal by Subject|0|||
28170554|NCT01362296|54842110|FG002|Crossover Phase|Withdrawal by Subject|2|||
28170555|NCT01362296|54842111|FG003|Crossover Phase|Withdrawal by Subject|1|||
28170556|NCT01362296|54842108|FG000|Crossover Phase|Adverse Event|0|||
28170557|NCT01362296|54842109|FG001|Crossover Phase|Adverse Event|0|||
28170558|NCT01362296|54842110|FG002|Crossover Phase|Adverse Event|4|||
28170559|NCT01362296|54842111|FG003|Crossover Phase|Adverse Event|0|||
28170560|NCT01362296|54842108|FG000|Crossover Phase|Study Closed/Terminated|0|||
28170561|NCT01362296|54842109|FG001|Crossover Phase|Study Closed/Terminated|0|||
28170562|NCT01362296|54842110|FG002|Crossover Phase|Study Closed/Terminated|1|||
28170563|NCT01362296|54842111|FG003|Crossover Phase|Study Closed/Terminated|0|||
28170564|NCT01338415|54842123|FG000|Core + Extension|Adverse Event|8|||
28170565|NCT01338415|54842124|FG001|Core + Extension|Adverse Event|6|||
28170566|NCT01338415|54842125|FG002|Core + Extension|Adverse Event|0|||
28170567|NCT01338415|54842123|FG000|Core + Extension|Withdrawal by Subject|1|||
28170568|NCT01338415|54842124|FG001|Core + Extension|Withdrawal by Subject|1|||
28170569|NCT01338415|54842125|FG002|Core + Extension|Withdrawal by Subject|0|||
27738051|NCT02505542|54187147|FG003|Part A: Open-Label Period|Lost to Follow-up|0|||
27738052|NCT02505542|54187144|FG000|Part A: Open-Label Period|Withdrawal by Subject|27|||
28170570|NCT01338415|54842123|FG000|Core + Extension|Other (PAH not the main etiology of PH)|0|||
28170571|NCT01338415|54842124|FG001|Core + Extension|Other (PAH not the main etiology of PH)|2|||
27738053|NCT02505542|54187145|FG001|Part A: Open-Label Period|Withdrawal by Subject|0|||
27738054|NCT02505542|54187146|FG002|Part A: Open-Label Period|Withdrawal by Subject|0|||
27738055|NCT02505542|54187147|FG003|Part A: Open-Label Period|Withdrawal by Subject|0|||
27738056|NCT02505542|54187144|FG000|Part A: Open-Label Period|New medical history available|1|||
27738057|NCT02505542|54187145|FG001|Part A: Open-Label Period|New medical history available|0|||
27738058|NCT02505542|54187146|FG002|Part A: Open-Label Period|New medical history available|0|||
27738059|NCT02505542|54187147|FG003|Part A: Open-Label Period|New medical history available|0|||
27738060|NCT02505542|54187144|FG000|Part A: Open-Label Period|Participant did not attend week 48 visit|1|||
27738061|NCT02505542|54187145|FG001|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
27738062|NCT02505542|54187146|FG002|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
27738063|NCT02505542|54187147|FG003|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
27738064|NCT02505542|54187144|FG000|Part A: Open-Label Period|Pregnancy|2|||
27738065|NCT02505542|54187145|FG001|Part A: Open-Label Period|Pregnancy|0|||
27738066|NCT02505542|54187146|FG002|Part A: Open-Label Period|Pregnancy|0|||
27738067|NCT02505542|54187147|FG003|Part A: Open-Label Period|Pregnancy|0|||
27738068|NCT02505542|54187144|FG000|Part A: Open-Label Period|Sponsor directive|1|||
27738069|NCT02505542|54187145|FG001|Part A: Open-Label Period|Sponsor directive|0|||
27738070|NCT02505542|54187146|FG002|Part A: Open-Label Period|Sponsor directive|0|||
27738071|NCT02505542|54187147|FG003|Part A: Open-Label Period|Sponsor directive|0|||
27738072|NCT02505542|54187144|FG000|Part A: Open-Label Period|Medical monitor decision|1|||
27738073|NCT02505542|54187145|FG001|Part A: Open-Label Period|Medical monitor decision|0|||
27738074|NCT02505542|54187146|FG002|Part A: Open-Label Period|Medical monitor decision|0|||
27738075|NCT02505542|54187147|FG003|Part A: Open-Label Period|Medical monitor decision|0|||
27738076|NCT02505542|54187144|FG000|Part A: Open-Label Period|Screening failure (detected too late)|1|||
27738077|NCT02505542|54187145|FG001|Part A: Open-Label Period|Screening failure (detected too late)|0|||
27738078|NCT02505542|54187146|FG002|Part A: Open-Label Period|Screening failure (detected too late)|0|||
27738079|NCT02505542|54187147|FG003|Part A: Open-Label Period|Screening failure (detected too late)|0|||
27738080|NCT02505542|54187144|FG000|Part A: Open-Label Period|Non-compliance|1|||
27738081|NCT02505542|54187145|FG001|Part A: Open-Label Period|Non-compliance|0|||
27738082|NCT02505542|54187146|FG002|Part A: Open-Label Period|Non-compliance|0|||
27738083|NCT02505542|54187147|FG003|Part A: Open-Label Period|Non-compliance|0|||
27738084|NCT02505542|54187144|FG000|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2|||
27738085|NCT02505542|54187145|FG001|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
27738086|NCT02505542|54187146|FG002|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
27738087|NCT02505542|54187147|FG003|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
27738088|NCT02505542|54187144|FG000|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3|||
27738089|NCT02505542|54187145|FG001|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
28095118|NCT03435640|54749202|FG006|Overall Study|Withdrawal by Subject|3|||
28095119|NCT03435640|54749203|FG007|Overall Study|Withdrawal by Subject|0|||
28095120|NCT03435640|54749204|FG008|Overall Study|Withdrawal by Subject|0|||
28095121|NCT03435640|54749205|FG009|Overall Study|Withdrawal by Subject|2|||
28095122|NCT03435640|54749206|FG010|Overall Study|Withdrawal by Subject|3|||
28095123|NCT03435640|54749196|FG000|Overall Study|Lost to Follow-up|0|||
28170572|NCT01338415|54842125|FG002|Core + Extension|Other (PAH not the main etiology of PH)|0|||
28170573|NCT01338415|54842123|FG000|Core + Extension|Other (administrative reason)|1|||
28170574|NCT01338415|54842124|FG001|Core + Extension|Other (administrative reason)|0|||
28170575|NCT01338415|54842125|FG002|Core + Extension|Other (administrative reason)|0|||
28170576|NCT01338415|54842123|FG000|Exceptional Use Treatment Period|Administrative decision|0|||
28170577|NCT01338415|54842124|FG001|Exceptional Use Treatment Period|Administrative decision|0|||
28170578|NCT01338415|54842125|FG002|Exceptional Use Treatment Period|Administrative decision|1|||
28170579|NCT01338415|54842123|FG000|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
28170580|NCT01338415|54842124|FG001|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
28170581|NCT01338415|54842125|FG002|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|3|||
28170582|NCT01338415|54842123|FG000|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
28170583|NCT01338415|54842124|FG001|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
28170584|NCT01338415|54842125|FG002|Exceptional Use Treatment Period|Withdrawal by Subject|1|||
27738090|NCT02505542|54187146|FG002|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
27833643|NCT01605227|54316642|FG000|Overall Study|Sponsor Decision|2|||
27833644|NCT01605227|54316643|FG001|Overall Study|Sponsor Decision|0|||
27833645|NCT01605227|54316642|FG000|Overall Study|Started New Therapy|1|||
28095124|NCT03435640|54749197|FG001|Overall Study|Lost to Follow-up|0|||
27833646|NCT01605227|54316643|FG001|Overall Study|Started New Therapy|0|||
28095125|NCT03435640|54749198|FG002|Overall Study|Lost to Follow-up|1|||
28095126|NCT03435640|54749199|FG003|Overall Study|Lost to Follow-up|0|||
27833647|NCT01605227|54316642|FG000|Overall Study|Subject Decision|0|||
27833648|NCT01605227|54316643|FG001|Overall Study|Subject Decision|1|||
27738091|NCT02505542|54187147|FG003|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
27738092|NCT02505542|54187144|FG000|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341|||
27738093|NCT02505542|54187145|FG001|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
27738094|NCT02505542|54187146|FG002|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
27738095|NCT02505542|54187147|FG003|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
27856364|NCT02519348|54387539|FG007|Overall Study|Ongoing at the time of data cut-off date|0|||
27856365|NCT02519348|54387540|FG008|Overall Study|Ongoing at the time of data cut-off date|0|||
27856366|NCT00636818|54387561|FG000|Overall Study|Adverse Event|1|||
27856367|NCT00636818|54387561|FG000|Overall Study|Lost to Follow-up|2|||
27856368|NCT00636818|54387561|FG000|Overall Study|Entry Criteria Exclusion|3|||
28170585|NCT01338415|54842123|FG000|Exceptional Use Treatment Period|Death|0|||
28170586|NCT01338415|54842124|FG001|Exceptional Use Treatment Period|Death|0|||
28170587|NCT01338415|54842125|FG002|Exceptional Use Treatment Period|Death|1|||
28170588|NCT05258149|54842135|FG000|Period 1|Protocol Deviation|1|||
28170589|NCT05258149|54842136|FG001|Period 1|Protocol Deviation|0|||
28170590|NCT05258149|54842135|FG000|Period 1|Adverse Event|0|||
28170591|NCT05258149|54842136|FG001|Period 1|Adverse Event|1|||
27738096|NCT02505542|54187144|FG000|Part B: Double-Blind Period|Adverse Event|0|||
27738097|NCT02505542|54187145|FG001|Part B: Double-Blind Period|Adverse Event|0|||
27738098|NCT02505542|54187146|FG002|Part B: Double-Blind Period|Adverse Event|1|||
27738099|NCT02505542|54187147|FG003|Part B: Double-Blind Period|Adverse Event|3|||
27738100|NCT02505542|54187144|FG000|Part B: Double-Blind Period|Lost to Follow-up|0|||
27738101|NCT02505542|54187145|FG001|Part B: Double-Blind Period|Lost to Follow-up|0|||
27738102|NCT02505542|54187146|FG002|Part B: Double-Blind Period|Lost to Follow-up|0|||
27738103|NCT02505542|54187147|FG003|Part B: Double-Blind Period|Lost to Follow-up|1|||
27738104|NCT02505542|54187144|FG000|Part B: Double-Blind Period|Withdrawal by Subject|0|||
27738105|NCT02505542|54187145|FG001|Part B: Double-Blind Period|Withdrawal by Subject|8|||
27738106|NCT02505542|54187146|FG002|Part B: Double-Blind Period|Withdrawal by Subject|7|||
27738107|NCT02505542|54187147|FG003|Part B: Double-Blind Period|Withdrawal by Subject|2|||
27738108|NCT02505542|54187144|FG000|Part B: Double-Blind Period|Planning pregnancy|0|||
27738109|NCT02505542|54187145|FG001|Part B: Double-Blind Period|Planning pregnancy|1|||
27738110|NCT02505542|54187146|FG002|Part B: Double-Blind Period|Planning pregnancy|0|||
27738111|NCT02505542|54187147|FG003|Part B: Double-Blind Period|Planning pregnancy|0|||
27738112|NCT02505542|54187144|FG000|Part B: Double-Blind Period|Week 94 missed|0|||
27738113|NCT02505542|54187145|FG001|Part B: Double-Blind Period|Week 94 missed|0|||
27738114|NCT02505542|54187146|FG002|Part B: Double-Blind Period|Week 94 missed|1|||
27738115|NCT02505542|54187147|FG003|Part B: Double-Blind Period|Week 94 missed|0|||
27738116|NCT02505542|54187144|FG000|Part B: Double-Blind Period|Patient was moved from the country|0|||
27738117|NCT02505542|54187145|FG001|Part B: Double-Blind Period|Patient was moved from the country|0|||
27738118|NCT02505542|54187146|FG002|Part B: Double-Blind Period|Patient was moved from the country|0|||
27738119|NCT02505542|54187147|FG003|Part B: Double-Blind Period|Patient was moved from the country|1|||
27738120|NCT02505542|54187144|FG000|Part B: Double-Blind Period|Lack of Efficacy|0|||
27738121|NCT02505542|54187145|FG001|Part B: Double-Blind Period|Lack of Efficacy|1|||
27738122|NCT02505542|54187146|FG002|Part B: Double-Blind Period|Lack of Efficacy|0|||
27738123|NCT02505542|54187147|FG003|Part B: Double-Blind Period|Lack of Efficacy|0|||
27738124|NCT02505542|54187144|FG000|Part B: Double-Blind Period|Miscalculation|0|||
27738125|NCT02505542|54187145|FG001|Part B: Double-Blind Period|Miscalculation|1|||
27738126|NCT02505542|54187146|FG002|Part B: Double-Blind Period|Miscalculation|0|||
27738127|NCT02505542|54187147|FG003|Part B: Double-Blind Period|Miscalculation|0|||
27738128|NCT02505542|54187144|FG000|Part B: Double-Blind Period|Subject did not complete all visits|0|||
27738129|NCT02505542|54187145|FG001|Part B: Double-Blind Period|Subject did not complete all visits|1|||
27738130|NCT02505542|54187146|FG002|Part B: Double-Blind Period|Subject did not complete all visits|0|||
27738131|NCT02505542|54187147|FG003|Part B: Double-Blind Period|Subject did not complete all visits|0|||
27738132|NCT02475980|54187196|FG000|Overall Study|Lost to Follow-up|4|||
27738133|NCT02475980|54187196|FG000|Overall Study|Withdrawal by Subject|1|||
27833649|NCT01605227|54316642|FG000|Overall Study|Dose Held >6 weeks|0|||
27833650|NCT01605227|54316643|FG001|Overall Study|Dose Held >6 weeks|1|||
27833651|NCT01709513|54316652|FG000|Overall Study|Randomized but not treated|0|||
27833652|NCT01709513|54316653|FG001|Overall Study|Randomized but not treated|1|||
27833653|NCT01709513|54316654|FG002|Overall Study|Randomized but not treated|0|||
27833654|NCT01709513|54316652|FG000|Overall Study|Adverse Event|16|||
27833655|NCT01709513|54316653|FG001|Overall Study|Adverse Event|31|||
27833656|NCT01709513|54316654|FG002|Overall Study|Adverse Event|23|||
27833657|NCT01709513|54316652|FG000|Overall Study|Poor compliance to protocol|2|||
27738134|NCT02447432|54187202|FG000|Epoch 001|Adverse Event|1|||
27738135|NCT02447432|54187203|FG001|Epoch 001|Adverse Event|1|||
27738136|NCT02447432|54187202|FG000|Epoch 001|Withdrawal by Subject|0|||
27738137|NCT02447432|54187203|FG001|Epoch 001|Withdrawal by Subject|4|||
27738138|NCT02447432|54187202|FG000|Epoch 001|Migrated/moved from study area|3|||
27833658|NCT01709513|54316653|FG001|Overall Study|Poor compliance to protocol|0|||
27833659|NCT01709513|54316654|FG002|Overall Study|Poor compliance to protocol|0|||
27738139|NCT02447432|54187203|FG001|Epoch 001|Migrated/moved from study area|5|||
27738140|NCT02447432|54187202|FG000|Epoch 001|Lost to Follow-up|1|||
27738141|NCT02447432|54187203|FG001|Epoch 001|Lost to Follow-up|3|||
27738142|NCT02446886|54187211|FG000|Overall Study|Adverse Event|1|||
27738143|NCT02446886|54187212|FG001|Overall Study|Adverse Event|3|||
27738144|NCT02446886|54187211|FG000|Overall Study|Withdrawal by Subject|1|||
27738145|NCT02446886|54187212|FG001|Overall Study|Withdrawal by Subject|1|||
27738146|NCT03448939|54187230|FG000|Overall Study|Adverse Event|5|||
27738147|NCT03448939|54187231|FG001|Overall Study|Adverse Event|1|||
27738148|NCT03448939|54187230|FG000|Overall Study|Lost to Follow-up|6|||
27738149|NCT03448939|54187231|FG001|Overall Study|Lost to Follow-up|6|||
27738150|NCT03448939|54187230|FG000|Overall Study|Pregnancy|1|||
27738151|NCT03448939|54187231|FG001|Overall Study|Pregnancy|1|||
27738152|NCT03448939|54187230|FG000|Overall Study|Withdrawal by Subject|9|||
27738153|NCT03448939|54187231|FG001|Overall Study|Withdrawal by Subject|3|||
27738154|NCT02504294|54187249|FG000|Overall Study|Adverse Event|15|||
27738155|NCT02504294|54187250|FG001|Overall Study|Adverse Event|12|||
27738156|NCT02504294|54187249|FG000|Overall Study|Withdrawal by Subject|7|||
27738157|NCT02504294|54187250|FG001|Overall Study|Withdrawal by Subject|1|||
27738158|NCT02504294|54187249|FG000|Overall Study|Protocol Violation|27|||
27738159|NCT02504294|54187250|FG001|Overall Study|Protocol Violation|26|||
27738160|NCT02504294|54187249|FG000|Overall Study|Physician Decision|1|||
27738161|NCT02504294|54187250|FG001|Overall Study|Physician Decision|2|||
27738162|NCT02504294|54187249|FG000|Overall Study|Lost to Follow-up|6|||
27738163|NCT02504294|54187250|FG001|Overall Study|Lost to Follow-up|7|||
27738164|NCT02446418|54187258|FG000|Overall Study|Adverse Event|4|||
27738165|NCT02446418|54187259|FG001|Overall Study|Adverse Event|8|||
27738166|NCT02446418|54187258|FG000|Overall Study|Physician Decision|5|||
27738167|NCT02446418|54187259|FG001|Overall Study|Physician Decision|1|||
27738168|NCT02446418|54187258|FG000|Overall Study|Withdrawal by Subject|3|||
27738169|NCT02446418|54187259|FG001|Overall Study|Withdrawal by Subject|3|||
27738170|NCT02446418|54187258|FG000|Overall Study|Lost to Follow-up|2|||
27738171|NCT02446418|54187259|FG001|Overall Study|Lost to Follow-up|2|||
27738172|NCT02446418|54187258|FG000|Overall Study|Protocol Violation|1|||
27738173|NCT02446418|54187259|FG001|Overall Study|Protocol Violation|2|||
27738174|NCT02446418|54187258|FG000|Overall Study|Lack of Efficacy|2|||
27856369|NCT00636818|54387561|FG000|Overall Study|Protocol Violation|1|||
27856370|NCT00636818|54387561|FG000|Overall Study|Withdrawal by Subject|4|||
27856371|NCT03127137|54387567|FG000|Overall Study|Requested sedation after consent|1|||
27856372|NCT03127137|54387568|FG001|Overall Study|Requested sedation after consent|0|||
27856373|NCT03127137|54387567|FG000|Overall Study|Malfunction in electronic data collection|1|||
27856374|NCT03127137|54387568|FG001|Overall Study|Malfunction in electronic data collection|0|||
27856375|NCT03127137|54387567|FG000|Overall Study|Post procedure testing could not be obtained|0|||
27856376|NCT03127137|54387568|FG001|Overall Study|Post procedure testing could not be obtained|1|||
27856377|NCT00636506|54387576|FG000|Overall Study|Lost to Follow-up|8|||
27856378|NCT00636506|54387576|FG000|Overall Study|Explanted|1|||
27856379|NCT00636506|54387576|FG000|Overall Study|Withdrawal by Subject|6|||
27856380|NCT00636506|54387576|FG000|Overall Study|Procedure aborted|1|||
27856381|NCT00636194|54387600|FG000|Overall Study|Study related symptoms and complaints|1|||
27856382|NCT00636194|54387601|FG001|Overall Study|Study related symptoms and complaints|0|||
27856383|NCT00636194|54387600|FG000|Overall Study|Protocol Violation|2|||
27856384|NCT00636194|54387601|FG001|Overall Study|Protocol Violation|0|||
27856385|NCT00635804|54387667|FG000|Overall Study|Adverse Event|0|||
27856386|NCT00635804|54387668|FG001|Overall Study|Adverse Event|0|||
27856387|NCT00635804|54387669|FG002|Overall Study|Adverse Event|0|||
27856388|NCT00635804|54387670|FG003|Overall Study|Adverse Event|0|||
27856389|NCT00635804|54387671|FG004|Overall Study|Adverse Event|0|||
27856390|NCT00635804|54387672|FG005|Overall Study|Adverse Event|1|||
27856391|NCT00635804|54387673|FG006|Overall Study|Adverse Event|0|||
27856392|NCT00635804|54387674|FG007|Overall Study|Adverse Event|0|||
27856393|NCT00635804|54387667|FG000|Overall Study|Withdrawal by Subject|1|||
27856394|NCT00635804|54387668|FG001|Overall Study|Withdrawal by Subject|0|||
27856395|NCT00635804|54387669|FG002|Overall Study|Withdrawal by Subject|0|||
27856396|NCT00635804|54387670|FG003|Overall Study|Withdrawal by Subject|0|||
27856397|NCT00635804|54387671|FG004|Overall Study|Withdrawal by Subject|0|||
27738175|NCT02446418|54187259|FG001|Overall Study|Lack of Efficacy|0|||
27856398|NCT00635804|54387672|FG005|Overall Study|Withdrawal by Subject|0|||
27856399|NCT00635804|54387673|FG006|Overall Study|Withdrawal by Subject|0|||
27738176|NCT02446418|54187258|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
27738177|NCT02446418|54187259|FG001|Overall Study|Protocol defined stopping criteria reach|0|||
27738178|NCT02255422|54187272|FG000|Overall Study|Withdrawal by Subject|0|||
27738179|NCT02255422|54187273|FG001|Overall Study|Withdrawal by Subject|0|||
27738180|NCT02255422|54187274|FG002|Overall Study|Withdrawal by Subject|0|||
27738181|NCT02255422|54187275|FG003|Overall Study|Withdrawal by Subject|0|||
27738182|NCT02255422|54187276|FG004|Overall Study|Withdrawal by Subject|0|||
27738183|NCT02255422|54187277|FG005|Overall Study|Withdrawal by Subject|0|||
27856400|NCT00635804|54387674|FG007|Overall Study|Withdrawal by Subject|0|||
27738184|NCT02255422|54187278|FG006|Overall Study|Withdrawal by Subject|2|||
27738185|NCT02255422|54187272|FG000|Overall Study|Lost to Follow-up|0|||
27738186|NCT02255422|54187273|FG001|Overall Study|Lost to Follow-up|0|||
27738187|NCT02255422|54187274|FG002|Overall Study|Lost to Follow-up|1|||
27738188|NCT02255422|54187275|FG003|Overall Study|Lost to Follow-up|0|||
27738189|NCT02255422|54187276|FG004|Overall Study|Lost to Follow-up|0|||
27856401|NCT00635648|54387704|FG000|Overall Study|Adverse Event|12|||
27856402|NCT00635648|54387704|FG000|Overall Study|Withdrawal by Subject|9|||
27856403|NCT00635648|54387704|FG000|Overall Study|Physician Decision|4|||
27856404|NCT00635648|54387704|FG000|Overall Study|Rapid progression of baseline disease|4|||
27856405|NCT00635648|54387704|FG000|Overall Study|Use of other antifungal agent needed|1|||
27856406|NCT00635648|54387704|FG000|Overall Study|No improvement after 7-10 days treatment|4|||
27856407|NCT00635648|54387704|FG000|Overall Study|Noncompliance with protocol|1|||
27856408|NCT00635648|54387704|FG000|Overall Study|Other reason|2|||
27856409|NCT00635102|54387729|FG000|Overall Study|Withdrawal by Subject|7|||
27856410|NCT00635102|54387730|FG001|Overall Study|Withdrawal by Subject|8|||
27856411|NCT00635024|54387745|FG000|Overall Study|Adverse Event|1|||
27856412|NCT00634244|54387794|FG000|Overall Study|Never started treatment|0|||
27856413|NCT00634244|54387795|FG001|Overall Study|Never started treatment|1|||
27833660|NCT01709513|54316652|FG000|Overall Study|Other|3|||
27856414|NCT00634244|54387796|FG002|Overall Study|Never started treatment|0|||
27856415|NCT00634244|54387794|FG000|Overall Study|Death|1|||
27856416|NCT00634244|54387795|FG001|Overall Study|Death|6|||
27856417|NCT00634244|54387796|FG002|Overall Study|Death|0|||
27856418|NCT00634244|54387794|FG000|Overall Study|Adverse Event|0|||
27856419|NCT00634244|54387795|FG001|Overall Study|Adverse Event|2|||
27856420|NCT00634244|54387796|FG002|Overall Study|Adverse Event|0|||
27856421|NCT00634244|54387794|FG000|Overall Study|Withdrawal by Subject|0|||
27856422|NCT00634244|54387795|FG001|Overall Study|Withdrawal by Subject|1|||
27856423|NCT00634244|54387796|FG002|Overall Study|Withdrawal by Subject|0|||
27856424|NCT00634244|54387794|FG000|Overall Study|Physician Decision|0|||
27856425|NCT00634244|54387795|FG001|Overall Study|Physician Decision|1|||
27856426|NCT00634244|54387796|FG002|Overall Study|Physician Decision|0|||
27856427|NCT00634244|54387794|FG000|Overall Study|Disease progression/relapse|0|||
27856428|NCT00634244|54387795|FG001|Overall Study|Disease progression/relapse|1|||
27856429|NCT00634244|54387796|FG002|Overall Study|Disease progression/relapse|0|||
27856430|NCT00634244|54387794|FG000|Overall Study|Other complicating disease|0|||
27856431|NCT00634244|54387795|FG001|Overall Study|Other complicating disease|1|||
27856432|NCT00634244|54387796|FG002|Overall Study|Other complicating disease|0|||
27856433|NCT00634088|54387980|FG000|Time Period 1: Dose Level 1|Disease progression|2|||
27856434|NCT00634088|54387981|FG001|Time Period 1: Dose Level 1|Disease progression|0|||
27856435|NCT00634088|54387982|FG002|Time Period 1: Dose Level 1|Disease progression|0|||
27856436|NCT00634088|54387983|FG003|Time Period 1: Dose Level 1|Disease progression|0|||
27856437|NCT00634088|54387980|FG000|Time Period 1: Dose Level 1|Physician Decision|1|||
27856438|NCT00634088|54387981|FG001|Time Period 1: Dose Level 1|Physician Decision|0|||
27856439|NCT00634088|54387982|FG002|Time Period 1: Dose Level 1|Physician Decision|0|||
27856440|NCT00634088|54387983|FG003|Time Period 1: Dose Level 1|Physician Decision|0|||
27980968|NCT00588861|54638910|FG000|10 Years|Incomplete due to study termination|107|||
28095127|NCT03435640|54749200|FG004|Overall Study|Lost to Follow-up|0|||
28095128|NCT03435640|54749201|FG005|Overall Study|Lost to Follow-up|0|||
28095129|NCT03435640|54749202|FG006|Overall Study|Lost to Follow-up|0|||
28095130|NCT03435640|54749203|FG007|Overall Study|Lost to Follow-up|0|||
28095131|NCT03435640|54749204|FG008|Overall Study|Lost to Follow-up|0|||
28095132|NCT03435640|54749205|FG009|Overall Study|Lost to Follow-up|0|||
28095133|NCT03435640|54749206|FG010|Overall Study|Lost to Follow-up|0|||
28095134|NCT00655876|54749234|FG000|Overall Study|Protocol Violation|9|||
27738190|NCT02255422|54187277|FG005|Overall Study|Lost to Follow-up|0|||
27738191|NCT02255422|54187278|FG006|Overall Study|Lost to Follow-up|0|||
27738192|NCT02445794|54187298|FG000|Overall Study|Adverse Event|0|||
27738193|NCT02445794|54187299|FG001|Overall Study|Adverse Event|0|||
27833661|NCT01709513|54316653|FG001|Overall Study|Other|11|||
27833662|NCT01709513|54316654|FG002|Overall Study|Other|7|||
27833663|NCT01605071|54316667|FG000|Overall Study|Withdrawal by Subject|3|||
27833664|NCT01605071|54316668|FG001|Overall Study|Withdrawal by Subject|2|||
27833665|NCT02710422|54316678|FG000|Overall Study|Termination of study|9|||
27833666|NCT02710422|54316679|FG001|Overall Study|Termination of study|9|||
27833667|NCT01706159|54316689|FG000|Overall Study|Withdrawal Criteria|2|||
27833668|NCT01706159|54316690|FG001|Overall Study|Withdrawal Criteria|1|||
27833669|NCT01706159|54316689|FG000|Overall Study|Unclassified|6|||
27833670|NCT01706159|54316690|FG001|Overall Study|Unclassified|1|||
27833671|NCT01706003|54316698|FG000|Overall Study|Withdrawal by Subject|2|||
27833672|NCT01706003|54316699|FG001|Overall Study|Withdrawal by Subject|0|||
27833673|NCT01706003|54316698|FG000|Overall Study|Not scheduled|3|||
28095135|NCT00655876|54749235|FG001|Overall Study|Protocol Violation|7|||
27738194|NCT02445794|54187300|FG002|Overall Study|Adverse Event|2|||
27738195|NCT02445794|54187301|FG003|Overall Study|Adverse Event|0|||
27833674|NCT01706003|54316699|FG001|Overall Study|Not scheduled|0|||
28095136|NCT03092752|54749241|FG000|Overall Study|Aged <40 years|14209|||
27738196|NCT02475278|54187316|FG000|Overall Study|Lost to Follow-up|1|||
27738197|NCT02475278|54187316|FG000|Overall Study|Reason Not Specified|1|||
27738198|NCT02254486|54187322|FG000|Overall Study|Adverse Event|1|||
27738199|NCT02254486|54187323|FG001|Overall Study|Adverse Event|1|||
27738200|NCT02254486|54187322|FG000|Overall Study|Lack of Efficacy|1|||
27738201|NCT02254486|54187323|FG001|Overall Study|Lack of Efficacy|0|||
27856441|NCT00634088|54387980|FG000|Time Period 1: Dose Level 1|Adverse Event|3|||
27738202|NCT02254486|54187322|FG000|Overall Study|Lost to Follow-up|2|||
27738203|NCT02254486|54187323|FG001|Overall Study|Lost to Follow-up|4|||
27738204|NCT02254486|54187322|FG000|Overall Study|Protocol Violation|1|||
28170592|NCT05258149|54842135|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
28170593|NCT05258149|54842136|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
28170594|NCT05258149|54842135|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
28170595|NCT05258149|54842136|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
28170596|NCT05258149|54842135|FG000|Period 3|Subject Was Not Returning for More Than A Week|0|||
28170597|NCT05258149|54842136|FG001|Period 3|Subject Was Not Returning for More Than A Week|1|||
28170598|NCT01371643|54842144|FG000|Overall Study|Withdrawal by Subject|3|||
28170599|NCT01371643|54842145|FG001|Overall Study|Withdrawal by Subject|0|||
28170600|NCT01371565|54842151|FG000|Overall Study|Withdrawal by Subject|1|||
28170601|NCT01371565|54842151|FG000|Overall Study|Death|1|||
28170602|NCT01371565|54842151|FG000|Overall Study|Resection of neuroendocrine tumor|1|||
28170603|NCT02821819|54842159|FG000|Overall Study|Protocol Violation|1|||
27738205|NCT02254486|54187323|FG001|Overall Study|Protocol Violation|2|||
27738206|NCT02254486|54187322|FG000|Overall Study|Withdrawal by Subject|17|||
27738207|NCT02254486|54187323|FG001|Overall Study|Withdrawal by Subject|15|||
27738208|NCT02254486|54187322|FG000|Overall Study|GFR<60mL/min|16|||
27738209|NCT02254486|54187323|FG001|Overall Study|GFR<60mL/min|21|||
27738210|NCT02254486|54187322|FG000|Overall Study|Various|12|||
27738211|NCT02254486|54187323|FG001|Overall Study|Various|12|||
27738212|NCT01641640|54187329|FG000|Overall Study|Enrolled but not treated|1|||
27738213|NCT01641640|54187329|FG000|Overall Study|Efficacy failure|29|||
27738214|NCT01641640|54187329|FG000|Overall Study|Lost to Follow-up|3|||
27738215|NCT01641640|54187329|FG000|Overall Study|Withdrawal by Subject|2|||
27738216|NCT01641640|54187329|FG000|Overall Study|Adverse Event|1|||
27738217|NCT01639144|54187335|FG000|Overall Study|Withdrawal by Subject|4|||
27738218|NCT01639144|54187336|FG001|Overall Study|Withdrawal by Subject|2|||
27738219|NCT01639144|54187335|FG000|Overall Study|Physician Decision|2|||
27738220|NCT01639144|54187336|FG001|Overall Study|Physician Decision|0|||
27738221|NCT01639144|54187335|FG000|Overall Study|Met postoperative exclusion criteria|4|||
27738222|NCT01639144|54187336|FG001|Overall Study|Met postoperative exclusion criteria|3|||
27738223|NCT01601626|54187345|FG000|Overall Study|Death|1|||
27738224|NCT01601626|54187346|FG001|Overall Study|Death|1|||
27738225|NCT01601626|54187347|FG002|Overall Study|Death|1|||
27738226|NCT01601626|54187345|FG000|Overall Study|Lost to Follow-up|1|||
27738227|NCT01601626|54187346|FG001|Overall Study|Lost to Follow-up|2|||
27738228|NCT01601626|54187347|FG002|Overall Study|Lost to Follow-up|0|||
27738229|NCT01601626|54187345|FG000|Overall Study|Unable to Get to Clinic|0|||
27738230|NCT01601626|54187346|FG001|Overall Study|Unable to Get to Clinic|1|||
27738231|NCT01601626|54187347|FG002|Overall Study|Unable to Get to Clinic|0|||
27738232|NCT01601626|54187345|FG000|Overall Study|Withdrawal by Subject|0|||
27738233|NCT01601626|54187346|FG001|Overall Study|Withdrawal by Subject|1|||
27738234|NCT01601626|54187347|FG002|Overall Study|Withdrawal by Subject|1|||
27738235|NCT01601626|54187345|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
27738236|NCT01601626|54187346|FG001|Overall Study|Not Willing to Adhere to Requirements|0|||
27738237|NCT01601626|54187347|FG002|Overall Study|Not Willing to Adhere to Requirements|0|||
27738238|NCT02737501|54187357|FG000|Randomized Phase|Died|41|||
27738239|NCT02737501|54187358|FG001|Randomized Phase|Died|29|||
27738240|NCT02737501|54187359|FG002|Randomized Phase|Died|0|||
27738241|NCT02737501|54187357|FG000|Randomized Phase|Withdrawal by Subject|16|||
27738242|NCT02737501|54187358|FG001|Randomized Phase|Withdrawal by Subject|6|||
27738243|NCT02737501|54187359|FG002|Randomized Phase|Withdrawal by Subject|0|||
27738244|NCT02737501|54187357|FG000|Randomized Phase|Lost to Follow-up|0|||
27738245|NCT02737501|54187358|FG001|Randomized Phase|Lost to Follow-up|1|||
27738246|NCT02737501|54187359|FG002|Randomized Phase|Lost to Follow-up|0|||
27980969|NCT00588861|54638911|FG001|10 Years|Incomplete due to study termination|114|||
28170604|NCT03926611|54842170|FG000|Overall Study|Adverse Event|0|||
27738247|NCT02737501|54187357|FG000|Randomized Phase|Site Terminated by Sponsor|58|||
27738248|NCT02737501|54187358|FG001|Randomized Phase|Site Terminated by Sponsor|16|||
27738249|NCT02737501|54187359|FG002|Randomized Phase|Site Terminated by Sponsor|0|||
27738250|NCT02737501|54187357|FG000|Randomized Phase|Reason not Specified|1|||
27856442|NCT00634088|54387981|FG001|Time Period 1: Dose Level 1|Adverse Event|0|||
27738251|NCT02737501|54187358|FG001|Randomized Phase|Reason not Specified|1|||
27738252|NCT02737501|54187359|FG002|Randomized Phase|Reason not Specified|0|||
27738253|NCT02737501|54187357|FG000|Randomized Phase|Never Treated|1|||
27738254|NCT02737501|54187358|FG001|Randomized Phase|Never Treated|1|||
27738255|NCT02737501|54187359|FG002|Randomized Phase|Never Treated|0|||
27738256|NCT02737501|54187357|FG000|Crossover Phase|Died|0|||
27738257|NCT02737501|54187358|FG001|Crossover Phase|Died|0|||
27738258|NCT02737501|54187359|FG002|Crossover Phase|Died|22|||
27738259|NCT02737501|54187357|FG000|Crossover Phase|Withdrew Consent|0|||
27738260|NCT02737501|54187358|FG001|Crossover Phase|Withdrew Consent|0|||
27738261|NCT02737501|54187359|FG002|Crossover Phase|Withdrew Consent|9|||
27738262|NCT02737501|54187357|FG000|Crossover Phase|Physician Decision|0|||
27738263|NCT02737501|54187358|FG001|Crossover Phase|Physician Decision|0|||
27738264|NCT02737501|54187359|FG002|Crossover Phase|Physician Decision|1|||
27738265|NCT02737501|54187357|FG000|Crossover Phase|Site Terminated by Sponsor|0|||
27738266|NCT02737501|54187358|FG001|Crossover Phase|Site Terminated by Sponsor|0|||
27738267|NCT02737501|54187359|FG002|Crossover Phase|Site Terminated by Sponsor|23|||
27738268|NCT01640314|54187369|FG000|Overall Study|Protocol Violation|0|||
27738269|NCT01640314|54187370|FG001|Overall Study|Protocol Violation|1|||
27738270|NCT02740049|54187452|FG000|Overall Study|Isolated cells did not grow sufficiently|1|||
27738271|NCT01601704|54187458|FG000|Overall Study|Randomized but not dispensed study med|1|||
27738272|NCT01601704|54187459|FG001|Overall Study|Randomized but not dispensed study med|4|||
27738273|NCT04969276|54187468|FG000|Overall Study|Protocol Deviation|0|||
27738274|NCT04969276|54187469|FG001|Overall Study|Protocol Deviation|1|||
27738275|NCT04969276|54187470|FG002|Overall Study|Protocol Deviation|0|||
27738276|NCT04969276|54187468|FG000|Overall Study|Withdrawal by Subject|1|||
27738277|NCT04969276|54187469|FG001|Overall Study|Withdrawal by Subject|10|||
27738278|NCT04969276|54187470|FG002|Overall Study|Withdrawal by Subject|0|||
27738279|NCT04969276|54187468|FG000|Overall Study|Lost to Follow-up|0|||
27738280|NCT04969276|54187469|FG001|Overall Study|Lost to Follow-up|1|||
27738281|NCT04969276|54187470|FG002|Overall Study|Lost to Follow-up|0|||
27738282|NCT01601470|54187478|FG000|Period 2 - LCZ696|Physician Decision|1|||
27738283|NCT03248375|54187502|FG000|Overall Study|Lost to Follow-up|5|||
27833675|NCT01706003|54316698|FG000|Overall Study|Lost to Follow-up|6|||
27833676|NCT01706003|54316699|FG001|Overall Study|Lost to Follow-up|4|||
27833677|NCT01705691|54316707|FG000|Overall Study|Death|1|||
27833678|NCT01705691|54316708|FG001|Overall Study|Death|2|||
27833679|NCT01705691|54316707|FG000|Overall Study|Withdrawal by Subject|1|||
27833680|NCT01705691|54316708|FG001|Overall Study|Withdrawal by Subject|2|||
27856443|NCT00634088|54387982|FG002|Time Period 1: Dose Level 1|Adverse Event|0|||
27856444|NCT00634088|54387983|FG003|Time Period 1: Dose Level 1|Adverse Event|0|||
27856445|NCT00634088|54387980|FG000|Time Period 2: Dose Level 2|Adverse Event|0|||
27856446|NCT00634088|54387981|FG001|Time Period 2: Dose Level 2|Adverse Event|2|||
27856447|NCT00634088|54387982|FG002|Time Period 2: Dose Level 2|Adverse Event|0|||
27856448|NCT00634088|54387983|FG003|Time Period 2: Dose Level 2|Adverse Event|0|||
27856449|NCT00634088|54387980|FG000|Time Period 2: Dose Level 2|Progressive disease|0|||
27856450|NCT00634088|54387981|FG001|Time Period 2: Dose Level 2|Progressive disease|1|||
27856451|NCT00634088|54387982|FG002|Time Period 2: Dose Level 2|Progressive disease|0|||
27856452|NCT00634088|54387983|FG003|Time Period 2: Dose Level 2|Progressive disease|0|||
27856453|NCT00634088|54387980|FG000|Time Period 3: Dose Level 3|Progressive disease|0|||
27856454|NCT00634088|54387981|FG001|Time Period 3: Dose Level 3|Progressive disease|0|||
27856455|NCT00634088|54387982|FG002|Time Period 3: Dose Level 3|Progressive disease|1|||
27856456|NCT00634088|54387983|FG003|Time Period 3: Dose Level 3|Progressive disease|0|||
27856457|NCT00634010|54388083|FG000|Overall Study|Adverse Event|2|||
27856458|NCT00634010|54388084|FG001|Overall Study|Adverse Event|5|||
27856459|NCT00634010|54388083|FG000|Overall Study|Withdrawal by Subject|5|||
27856460|NCT00634010|54388084|FG001|Overall Study|Withdrawal by Subject|6|||
28170605|NCT03926611|54842171|FG001|Overall Study|Adverse Event|0|||
27738284|NCT01637272|54187506|FG000|Overall Study|Adverse Event|6|||
27738285|NCT01637272|54187506|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
27738286|NCT01637272|54187506|FG000|Overall Study|Withdrawal by Subject|3|||
27833681|NCT01705691|54316707|FG000|Overall Study|Lost to Follow-up|1|||
27833682|NCT01705691|54316708|FG001|Overall Study|Lost to Follow-up|1|||
27833683|NCT01705691|54316707|FG000|Overall Study|Other|0|||
27833684|NCT01705691|54316708|FG001|Overall Study|Other|1|||
27833685|NCT03766906|54316714|FG000|Overall Study|Withdrawal by Subject|6|||
27833686|NCT01705145|54316718|FG000|Part B|Adverse Event|1|||
27833687|NCT01704755|54316736|FG000|Overall Study|Adverse Event|4|||
27833688|NCT01704755|54316737|FG001|Overall Study|Adverse Event|1|||
27833689|NCT01704755|54316736|FG000|Overall Study|Lost to Follow-up|3|||
27738287|NCT01637272|54187506|FG000|Overall Study|Lost to Follow-up|2|||
27833690|NCT01704755|54316737|FG001|Overall Study|Lost to Follow-up|4|||
27833691|NCT01704755|54316736|FG000|Overall Study|Withdrew consent|1|||
27833692|NCT01704755|54316737|FG001|Overall Study|Withdrew consent|1|||
27856461|NCT00634010|54388083|FG000|Overall Study|Physician Decision|1|||
27980970|NCT00887978|54638919|FG000|Overall Study|Adverse Event|18|||
28170606|NCT03926611|54842172|FG002|Overall Study|Adverse Event|0|||
27738288|NCT01637272|54187506|FG000|Overall Study|completed core, did not enter ext. phase|4|||
27738289|NCT01637272|54187506|FG000|Overall Study|Administrative problems|1|||
27738290|NCT01637272|54187506|FG000|Overall Study|Protocol Violation|2|||
27833693|NCT01704755|54316736|FG000|Overall Study|Other (not specified)|3|||
27833694|NCT01704755|54316737|FG001|Overall Study|Other (not specified)|1|||
27738291|NCT01636960|54187525|FG000|Induction Phase|Adverse Event|2|||
27738292|NCT01636960|54187525|FG000|Maintenance Phase|Continued drug after regulatory approval|3|||
27856462|NCT00634010|54388084|FG001|Overall Study|Physician Decision|1|||
27856463|NCT00634010|54388083|FG000|Overall Study|Disease Progression|1|||
27856464|NCT00634010|54388084|FG001|Overall Study|Disease Progression|1|||
27856465|NCT00634010|54388083|FG000|Overall Study|Non-Compliant|1|||
27856466|NCT00634010|54388084|FG001|Overall Study|Non-Compliant|1|||
27856467|NCT00633932|54388097|FG000|Overall Study|Adverse Event|1|||
27856468|NCT00633932|54388098|FG001|Overall Study|Adverse Event|3|||
27856469|NCT00633932|54388099|FG002|Overall Study|Adverse Event|4|||
27856470|NCT00633932|54388097|FG000|Overall Study|Withdrawal by Subject|3|||
27856471|NCT00633932|54388098|FG001|Overall Study|Withdrawal by Subject|9|||
27856472|NCT00633932|54388099|FG002|Overall Study|Withdrawal by Subject|1|||
27856473|NCT00633932|54388097|FG000|Overall Study|Lost to Follow-up|1|||
27856474|NCT00633932|54388098|FG001|Overall Study|Lost to Follow-up|0|||
27856475|NCT00633932|54388099|FG002|Overall Study|Lost to Follow-up|2|||
27856476|NCT00633932|54388097|FG000|Overall Study|Protocol Violation|5|||
27856477|NCT00633932|54388098|FG001|Overall Study|Protocol Violation|2|||
27856478|NCT00633932|54388099|FG002|Overall Study|Protocol Violation|3|||
27856479|NCT00633932|54388097|FG000|Overall Study|Physician Decision|0|||
27856480|NCT00633932|54388098|FG001|Overall Study|Physician Decision|0|||
27833695|NCT01704755|54316736|FG000|Overall Study|Withdrew consent and personal issues|1|||
27833696|NCT01704755|54316737|FG001|Overall Study|Withdrew consent and personal issues|0|||
27833697|NCT01704599|54316743|FG000|Overall Study|Adverse Event|1|||
27833698|NCT03599518|54316775|FG000|Overall Study|Clinical progression|0|||
27856481|NCT00633932|54388099|FG002|Overall Study|Physician Decision|1|||
27856482|NCT00633932|54388097|FG000|Overall Study|Doctor's judgement|1|||
27856483|NCT00633932|54388098|FG001|Overall Study|Doctor's judgement|0|||
27856484|NCT00633932|54388099|FG002|Overall Study|Doctor's judgement|0|||
27856485|NCT00633932|54388097|FG000|Overall Study|Moved Away|1|||
27856486|NCT00633932|54388098|FG001|Overall Study|Moved Away|0|||
27856487|NCT00633932|54388099|FG002|Overall Study|Moved Away|0|||
27856488|NCT00633464|54388229|FG000|Overall Study|Never Treated (Not met study criteria)|0|||
27856489|NCT00633464|54388230|FG001|Overall Study|Never Treated (Not met study criteria)|1|||
27856490|NCT00633464|54388229|FG000|Overall Study|Never Treated (Randomized in error)|0|||
27856491|NCT00633464|54388230|FG001|Overall Study|Never Treated (Randomized in error)|1|||
27856492|NCT00633152|54388271|FG000|Overall Study|Adverse Event|1|||
27856493|NCT00633152|54388272|FG001|Overall Study|Adverse Event|0|||
27856494|NCT00633152|54388271|FG000|Overall Study|Randomized, did not receive study drug|5|||
27856495|NCT00633152|54388272|FG001|Overall Study|Randomized, did not receive study drug|2|||
28095137|NCT03092752|54749241|FG000|Overall Study|At least one claim with T2DM|61299|||
27833699|NCT03599518|54316776|FG001|Overall Study|Clinical progression|0|||
27833700|NCT03599518|54316777|FG002|Overall Study|Clinical progression|0|||
27833701|NCT03599518|54316778|FG003|Overall Study|Clinical progression|0|||
27833702|NCT03599518|54316779|FG004|Overall Study|Clinical progression|1|||
27833703|NCT03599518|54316775|FG000|Overall Study|Adverse Event|0|||
28095138|NCT03092752|54749241|FG000|Overall Study|Having no claim of study drugs|29282|||
27833704|NCT03599518|54316776|FG001|Overall Study|Adverse Event|0|||
27856496|NCT00633152|54388271|FG000|Overall Study|Withdrawal by Subject|1|||
27856497|NCT00633152|54388272|FG001|Overall Study|Withdrawal by Subject|1|||
27856498|NCT00633152|54388271|FG000|Overall Study|Lost to Follow-up|4|||
27856499|NCT00633152|54388272|FG001|Overall Study|Lost to Follow-up|1|||
27856500|NCT00633152|54388271|FG000|Overall Study|Miscellaneous Other|3|||
28095139|NCT03092752|54749241|FG000|Overall Study|Average hospital visit interval >92 days|10779|||
28095140|NCT03092752|54749241|FG000|Overall Study|<6 month history|245900|||
28095141|NCT03750552|54749264|FG000|Overall Study|Adverse Event|5|||
28095142|NCT03750552|54749265|FG001|Overall Study|Adverse Event|1|||
28095143|NCT03750552|54749264|FG000|Overall Study|Withdrawal by Subject|1|||
28095144|NCT03750552|54749265|FG001|Overall Study|Withdrawal by Subject|1|||
28095145|NCT03750552|54749264|FG000|Overall Study|Other|2|||
28095146|NCT03750552|54749265|FG001|Overall Study|Other|0|||
28095147|NCT03750240|54749272|FG000|Overall Study|Technical Difficulties|2|||
28095148|NCT03091738|54749276|FG000|Overall Study|Adverse Event|1|||
28095149|NCT03091738|54749276|FG000|Overall Study|Lost to Follow-up|1|||
28095150|NCT03193216|54749282|FG000|Overall Study|Lost to Follow-up|1|||
28095151|NCT03193216|54749283|FG001|Overall Study|Lost to Follow-up|0|||
28095152|NCT03193216|54749282|FG000|Overall Study|Withdrawal by Subject|5|||
28095153|NCT03193216|54749283|FG001|Overall Study|Withdrawal by Subject|0|||
28095154|NCT03193216|54749282|FG000|Overall Study|Physician Decision|4|||
28095155|NCT03193216|54749283|FG001|Overall Study|Physician Decision|0|||
28095156|NCT03091348|54749291|FG000|Overall Study|Lost to Follow-up|2|||
28095157|NCT03091348|54749292|FG001|Overall Study|Lost to Follow-up|1|||
27856501|NCT00633152|54388272|FG001|Overall Study|Miscellaneous Other|2|||
27856502|NCT00633074|54388291|FG000|Overall Study|Adverse Event|1|||
27856503|NCT00633074|54388292|FG001|Overall Study|Adverse Event|0|||
27856504|NCT00630344|54388479|FG000|Overall Study|Adverse Event|5|||
27856505|NCT00630344|54388479|FG000|Overall Study|Progressive Disease|19|||
28095158|NCT03751098|54749299|FG000|Overall Study|Withdrawal by Subject|0|||
27738293|NCT01636960|54187525|FG000|Maintenance Phase|Adverse Event|3|||
27738294|NCT01636960|54187525|FG000|Maintenance Phase|Progressive disease|1|||
27738295|NCT01636258|54187531|FG000|Overall Study|Lost to Follow-up|1|||
27738296|NCT01636258|54187532|FG001|Overall Study|Lost to Follow-up|0|||
27738297|NCT02504216|54187541|FG000|Overall Study|Lost to Follow-up|3|||
27738298|NCT02504216|54187542|FG001|Overall Study|Lost to Follow-up|3|||
27738299|NCT02504216|54187541|FG000|Overall Study|Withdrawal by Subject|8|||
27738300|NCT02504216|54187542|FG001|Overall Study|Withdrawal by Subject|12|||
27738301|NCT04354870|54187550|FG000|Overall Study|Lost to Follow-up|32|||
27738302|NCT04354870|54187551|FG001|Overall Study|Lost to Follow-up|12|||
27738303|NCT04354870|54187550|FG000|Overall Study|Withdrawal by Subject|10|||
27738304|NCT04354870|54187551|FG001|Overall Study|Withdrawal by Subject|16|||
27738305|NCT04354870|54187550|FG000|Overall Study|Did not complete all study visits|6|||
27738306|NCT04354870|54187551|FG001|Overall Study|Did not complete all study visits|5|||
27738307|NCT02473952|54187559|FG000|Overall Study|Adverse Event|2|||
27738308|NCT02473952|54187560|FG001|Overall Study|Adverse Event|2|||
27738309|NCT02473952|54187559|FG000|Overall Study|Withdrawal by Subject|0|||
27738310|NCT02473952|54187560|FG001|Overall Study|Withdrawal by Subject|6|||
27738311|NCT02473640|54187566|FG000|Treatment Period 1|Adverse Event|1|||
27738312|NCT01637584|54187575|FG000|Overall Study|Withdrawal by Subject|1|||
27738313|NCT01637584|54187576|FG001|Overall Study|Withdrawal by Subject|3|||
27738314|NCT03883906|54187583|FG000|Overall Study|Withdrawal by Subject|2|||
27738315|NCT03883906|54187583|FG000|Overall Study|Physician Decision|5|||
27738316|NCT03875092|54187589|FG000|Overall Study|Adverse Event|2|||
27738317|NCT03875092|54187590|FG001|Overall Study|Adverse Event|5|||
27738318|NCT03875092|54187589|FG000|Overall Study|Death|28|||
27738319|NCT03875092|54187590|FG001|Overall Study|Death|41|||
27738320|NCT03875092|54187589|FG000|Overall Study|Ongoing in Study|35|||
27738321|NCT03875092|54187590|FG001|Overall Study|Ongoing in Study|14|||
27738322|NCT02503202|54187601|FG000|Base Study: Up to Month 6|Death|1|||
27738323|NCT02503202|54187602|FG001|Base Study: Up to Month 6|Death|1|||
27833705|NCT03599518|54316777|FG002|Overall Study|Adverse Event|0|||
28170607|NCT03926611|54842173|FG003|Overall Study|Adverse Event|3|||
28170608|NCT03926611|54842174|FG004|Overall Study|Adverse Event|1|||
28170609|NCT03926611|54842175|FG005|Overall Study|Adverse Event|3|||
28170610|NCT03926611|54842176|FG006|Overall Study|Adverse Event|0|||
28170611|NCT03926611|54842170|FG000|Overall Study|Lack of Efficacy|1|||
28170612|NCT03926611|54842171|FG001|Overall Study|Lack of Efficacy|2|||
28170613|NCT03926611|54842172|FG002|Overall Study|Lack of Efficacy|0|||
28170614|NCT03926611|54842173|FG003|Overall Study|Lack of Efficacy|0|||
28170615|NCT03926611|54842174|FG004|Overall Study|Lack of Efficacy|1|||
28170616|NCT03926611|54842175|FG005|Overall Study|Lack of Efficacy|0|||
28170617|NCT03926611|54842176|FG006|Overall Study|Lack of Efficacy|1|||
28170618|NCT03926611|54842170|FG000|Overall Study|Physician Decision|0|||
28170619|NCT03926611|54842171|FG001|Overall Study|Physician Decision|0|||
28170620|NCT03926611|54842172|FG002|Overall Study|Physician Decision|0|||
28095159|NCT03751098|54749300|FG001|Overall Study|Withdrawal by Subject|1|||
28095160|NCT03751020|54749311|FG000|Overall Study|Withdrawal by Subject|2|||
28095161|NCT03751020|54749312|FG001|Overall Study|Withdrawal by Subject|0|||
28095162|NCT03751020|54749313|FG002|Overall Study|Withdrawal by Subject|0|||
28095163|NCT03751020|54749311|FG000|Overall Study|Lost to Follow-up|7|||
28095164|NCT03751020|54749312|FG001|Overall Study|Lost to Follow-up|4|||
28095165|NCT03751020|54749313|FG002|Overall Study|Lost to Follow-up|10|||
28095166|NCT03090100|54749323|FG000|Overall Study|Adverse Event|9|||
28095167|NCT03090100|54749324|FG001|Overall Study|Adverse Event|11|||
28095168|NCT03090100|54749323|FG000|Overall Study|Pregnancy|1|||
28095169|NCT03090100|54749324|FG001|Overall Study|Pregnancy|1|||
28095170|NCT03090100|54749323|FG000|Overall Study|Lack of Efficacy|2|||
28095171|NCT03090100|54749324|FG001|Overall Study|Lack of Efficacy|7|||
28095172|NCT03090100|54749323|FG000|Overall Study|Lost to Follow-up|2|||
28095173|NCT03090100|54749324|FG001|Overall Study|Lost to Follow-up|2|||
28095174|NCT03090100|54749323|FG000|Overall Study|Withdrawal by Subject|7|||
28095175|NCT03090100|54749324|FG001|Overall Study|Withdrawal by Subject|19|||
28095176|NCT03090100|54749323|FG000|Overall Study|Protocol Violation|2|||
28095177|NCT03090100|54749324|FG001|Overall Study|Protocol Violation|6|||
28095178|NCT03090100|54749323|FG000|Overall Study|Non-compliance|2|||
28095179|NCT03090100|54749324|FG001|Overall Study|Non-compliance|0|||
28095180|NCT03090100|54749323|FG000|Overall Study|Other|2|||
28095181|NCT03090100|54749324|FG001|Overall Study|Other|2|||
28095182|NCT03089944|54749330|FG000|Overall Study|Lost to Follow-up|8|||
28170621|NCT03926611|54842173|FG003|Overall Study|Physician Decision|0|||
28170622|NCT03926611|54842174|FG004|Overall Study|Physician Decision|0|||
27738324|NCT02503202|54187603|FG002|Base Study: Up to Month 6|Death|0|||
27738325|NCT02503202|54187604|FG003|Base Study: Up to Month 6|Death|0|||
27738326|NCT02503202|54187605|FG004|Base Study: Up to Month 6|Death|0|||
27738327|NCT02503202|54187601|FG000|Base Study: Up to Month 6|Lost to Follow-up|11|||
27738328|NCT02503202|54187602|FG001|Base Study: Up to Month 6|Lost to Follow-up|8|||
27738329|NCT02503202|54187603|FG002|Base Study: Up to Month 6|Lost to Follow-up|10|||
27833706|NCT03599518|54316778|FG003|Overall Study|Adverse Event|0|||
28170623|NCT03926611|54842175|FG005|Overall Study|Physician Decision|1|||
28170624|NCT03926611|54842176|FG006|Overall Study|Physician Decision|0|||
28170625|NCT03926611|54842170|FG000|Overall Study|Protocol Violation|1|||
28170626|NCT03926611|54842171|FG001|Overall Study|Protocol Violation|0|||
28170627|NCT03926611|54842172|FG002|Overall Study|Protocol Violation|0|||
28170628|NCT03926611|54842173|FG003|Overall Study|Protocol Violation|1|||
28170629|NCT03926611|54842174|FG004|Overall Study|Protocol Violation|1|||
28170630|NCT03926611|54842175|FG005|Overall Study|Protocol Violation|1|||
28170631|NCT03926611|54842176|FG006|Overall Study|Protocol Violation|1|||
28170632|NCT03926611|54842170|FG000|Overall Study|Technical problems|0|||
28170633|NCT03926611|54842171|FG001|Overall Study|Technical problems|0|||
28170634|NCT03926611|54842172|FG002|Overall Study|Technical problems|0|||
28170635|NCT03926611|54842173|FG003|Overall Study|Technical problems|0|||
28170636|NCT03926611|54842174|FG004|Overall Study|Technical problems|0|||
28170637|NCT03926611|54842175|FG005|Overall Study|Technical problems|1|||
28170638|NCT03926611|54842176|FG006|Overall Study|Technical problems|0|||
28170639|NCT03926611|54842170|FG000|Overall Study|Withdrawal by Subject|1|||
28170640|NCT03926611|54842171|FG001|Overall Study|Withdrawal by Subject|1|||
28170641|NCT03926611|54842172|FG002|Overall Study|Withdrawal by Subject|1|||
28170642|NCT03926611|54842173|FG003|Overall Study|Withdrawal by Subject|0|||
28170643|NCT03926611|54842174|FG004|Overall Study|Withdrawal by Subject|0|||
28170644|NCT03926611|54842175|FG005|Overall Study|Withdrawal by Subject|1|||
28170645|NCT03926611|54842176|FG006|Overall Study|Withdrawal by Subject|3|||
28170646|NCT03926611|54842170|FG000|Overall Study|Covid-19 pandemic|0|||
28170647|NCT03926611|54842171|FG001|Overall Study|Covid-19 pandemic|0|||
28095183|NCT03089944|54749330|FG000|Overall Study|Withdrew Consent|2|||
28095184|NCT03089944|54749330|FG000|Overall Study|Adverse Event|1|||
28095185|NCT03089944|54749330|FG000|Overall Study|Other|1|||
28095186|NCT03739866|54749353|FG000|Overall Study|Lost to Follow-up|0|||
28095187|NCT03739866|54749354|FG001|Overall Study|Lost to Follow-up|0|||
28095188|NCT03739866|54749355|FG002|Overall Study|Lost to Follow-up|0|||
28095189|NCT03739866|54749356|FG003|Overall Study|Lost to Follow-up|1|||
28095190|NCT03739866|54749357|FG004|Overall Study|Lost to Follow-up|0|||
28095191|NCT03739866|54749358|FG005|Overall Study|Lost to Follow-up|0|||
28095192|NCT03739866|54749359|FG006|Overall Study|Lost to Follow-up|0|||
28095193|NCT03739866|54749360|FG007|Overall Study|Lost to Follow-up|0|||
28095194|NCT03739866|54749353|FG000|Overall Study|Enrolled but not treated|0|||
28095195|NCT03739866|54749354|FG001|Overall Study|Enrolled but not treated|0|||
28095196|NCT03739866|54749355|FG002|Overall Study|Enrolled but not treated|1|||
28095197|NCT03739866|54749356|FG003|Overall Study|Enrolled but not treated|0|||
28095198|NCT03739866|54749357|FG004|Overall Study|Enrolled but not treated|1|||
28095199|NCT03739866|54749358|FG005|Overall Study|Enrolled but not treated|0|||
28095200|NCT03739866|54749359|FG006|Overall Study|Enrolled but not treated|0|||
28095201|NCT03739866|54749360|FG007|Overall Study|Enrolled but not treated|0|||
28095202|NCT03739242|54749384|FG000|Overall Study|Withdrawal by Subject|1|||
28095203|NCT03739242|54749385|FG001|Overall Study|Withdrawal by Subject|1|||
28095204|NCT03739242|54749384|FG000|Overall Study|Protocol Violation|0|||
28095205|NCT03739242|54749385|FG001|Overall Study|Protocol Violation|1|||
28095206|NCT02849626|54749442|FG000|Core Phase (up to 23 Weeks)|Adverse Event|11|||
28095207|NCT02849626|54749443|FG001|Core Phase (up to 23 Weeks)|Adverse Event|3|||
28095208|NCT02849626|54749444|FG002|Core Phase (up to 23 Weeks)|Adverse Event|0|||
28095209|NCT02849626|54749445|FG003|Core Phase (up to 23 Weeks)|Adverse Event|0|||
28095210|NCT02849626|54749442|FG000|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7|||
28095211|NCT02849626|54749443|FG001|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2|||
28095212|NCT02849626|54749444|FG002|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
28095213|NCT02849626|54749445|FG003|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
28095214|NCT02849626|54749442|FG000|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6|||
28095215|NCT02849626|54749443|FG001|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2|||
28095216|NCT02849626|54749444|FG002|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
28095217|NCT02849626|54749445|FG003|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
28095218|NCT02849626|54749442|FG000|Core Phase (up to 23 Weeks)|Non-specified|3|||
28095219|NCT02849626|54749443|FG001|Core Phase (up to 23 Weeks)|Non-specified|0|||
28095220|NCT02849626|54749444|FG002|Core Phase (up to 23 Weeks)|Non-specified|0|||
28170648|NCT03926611|54842172|FG002|Overall Study|Covid-19 pandemic|1|||
28170649|NCT03926611|54842173|FG003|Overall Study|Covid-19 pandemic|0|||
28170650|NCT03926611|54842174|FG004|Overall Study|Covid-19 pandemic|1|||
28095221|NCT02849626|54749445|FG003|Core Phase (up to 23 Weeks)|Non-specified|0|||
27833707|NCT03599518|54316779|FG004|Overall Study|Adverse Event|1|||
28095222|NCT02849626|54749442|FG000|Extension Phase A (up to 29 Weeks)|Adverse Event|3|||
28095223|NCT02849626|54749443|FG001|Extension Phase A (up to 29 Weeks)|Adverse Event|2|||
28095224|NCT02849626|54749444|FG002|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
28095225|NCT02849626|54749445|FG003|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
28095226|NCT02849626|54749442|FG000|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4|||
28095227|NCT02849626|54749443|FG001|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
28170651|NCT03926611|54842175|FG005|Overall Study|Covid-19 pandemic|2|||
28170652|NCT03926611|54842176|FG006|Overall Study|Covid-19 pandemic|0|||
28170653|NCT02818777|54842205|FG000|Overall Study|Adverse Event|3|||
28170654|NCT02817841|54842219|FG000|Overall Study|Lost to Follow-up|287|||
28170655|NCT02817841|54842219|FG000|Overall Study|Withdrawal by Subject|183|||
28170656|NCT02817841|54842219|FG000|Overall Study|Adverse event not related to bleeding|131|||
28170657|NCT02817841|54842219|FG000|Overall Study|Adverse event related to bleeding|51|||
28170658|NCT02817841|54842219|FG000|Overall Study|Pregnancy|32|||
28170659|NCT02817841|54842219|FG000|Overall Study|Pregnancy wish|17|||
28170660|NCT02817841|54842219|FG000|Overall Study|Other reasons|53|||
28170661|NCT02817841|54842219|FG000|Overall Study|Protocol Violation|94|||
28170662|NCT02814565|54842229|FG000|Overall Study|Lack of Efficacy|0|||
27738330|NCT02503202|54187604|FG003|Base Study: Up to Month 6|Lost to Follow-up|5|||
27738331|NCT02503202|54187605|FG004|Base Study: Up to Month 6|Lost to Follow-up|1|||
27738332|NCT02503202|54187601|FG000|Base Study: Up to Month 6|Physician Decision|0|||
28170663|NCT02814565|54842230|FG001|Overall Study|Lack of Efficacy|1|||
27738333|NCT02503202|54187602|FG001|Base Study: Up to Month 6|Physician Decision|0|||
27738334|NCT02503202|54187603|FG002|Base Study: Up to Month 6|Physician Decision|0|||
28170664|NCT02814565|54842229|FG000|Overall Study|Subject decision, caused by AE Influenza|1|||
28170665|NCT02814565|54842230|FG001|Overall Study|Subject decision, caused by AE Influenza|1|||
27738335|NCT02503202|54187604|FG003|Base Study: Up to Month 6|Physician Decision|0|||
27738336|NCT02503202|54187605|FG004|Base Study: Up to Month 6|Physician Decision|1|||
27738337|NCT02503202|54187601|FG000|Base Study: Up to Month 6|Withdrawal by Subject|6|||
27738338|NCT02503202|54187602|FG001|Base Study: Up to Month 6|Withdrawal by Subject|3|||
27738339|NCT02503202|54187603|FG002|Base Study: Up to Month 6|Withdrawal by Subject|4|||
27738340|NCT02503202|54187604|FG003|Base Study: Up to Month 6|Withdrawal by Subject|4|||
27738341|NCT02503202|54187605|FG004|Base Study: Up to Month 6|Withdrawal by Subject|1|||
27738342|NCT02503202|54187601|FG000|Base Study: Up to Month 6|Randomized not vaccinated|0|||
27738343|NCT02503202|54187602|FG001|Base Study: Up to Month 6|Randomized not vaccinated|0|||
27738344|NCT02503202|54187603|FG002|Base Study: Up to Month 6|Randomized not vaccinated|1|||
27738345|NCT02503202|54187604|FG003|Base Study: Up to Month 6|Randomized not vaccinated|2|||
27738346|NCT02503202|54187605|FG004|Base Study: Up to Month 6|Randomized not vaccinated|0|||
27738347|NCT02503202|54187601|FG000|Extension: Month 6 to 24|Protocol Violation|0|||
27738348|NCT02503202|54187602|FG001|Extension: Month 6 to 24|Protocol Violation|0|||
27738349|NCT02503202|54187603|FG002|Extension: Month 6 to 24|Protocol Violation|0|||
27738350|NCT02503202|54187604|FG003|Extension: Month 6 to 24|Protocol Violation|1|||
27738351|NCT02503202|54187605|FG004|Extension: Month 6 to 24|Protocol Violation|0|||
27738352|NCT02503202|54187601|FG000|Extension: Month 6 to 24|Death|1|||
27738353|NCT02503202|54187602|FG001|Extension: Month 6 to 24|Death|0|||
27738354|NCT02503202|54187603|FG002|Extension: Month 6 to 24|Death|0|||
27738355|NCT02503202|54187604|FG003|Extension: Month 6 to 24|Death|0|||
27738356|NCT02503202|54187605|FG004|Extension: Month 6 to 24|Death|0|||
27738357|NCT02503202|54187601|FG000|Extension: Month 6 to 24|Lost to Follow-up|4|||
27738358|NCT02503202|54187602|FG001|Extension: Month 6 to 24|Lost to Follow-up|8|||
27738359|NCT02503202|54187603|FG002|Extension: Month 6 to 24|Lost to Follow-up|6|||
27738360|NCT02503202|54187604|FG003|Extension: Month 6 to 24|Lost to Follow-up|10|||
27738361|NCT02503202|54187605|FG004|Extension: Month 6 to 24|Lost to Follow-up|1|||
28170666|NCT02650466|54842236|FG000|Overall Study|Physician Decision|1|||
28170667|NCT02650466|54842236|FG000|Overall Study|Withdrawal by Subject|5|||
28170668|NCT02650466|54842236|FG000|Overall Study|Lost to Follow-up|1|||
28170669|NCT02815735|54842242|FG000|First Intervention (4 Weeks)|Discomfort|1|||
28170670|NCT02815735|54842243|FG001|First Intervention (4 Weeks)|Discomfort|0|||
28170671|NCT02815735|54842242|FG000|First Intervention (4 Weeks)|Lost to Follow-up|1|||
28170672|NCT02815735|54842243|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
28170673|NCT02815735|54842242|FG000|First Intervention (4 Weeks)|Poor fitting characteristics|0|||
28170674|NCT02815735|54842243|FG001|First Intervention (4 Weeks)|Poor fitting characteristics|1|||
28170675|NCT02815735|54842242|FG000|Second Intervention (4 Weeks)|Protocol Violation|1|||
28170676|NCT02815735|54842243|FG001|Second Intervention (4 Weeks)|Protocol Violation|0|||
28170677|NCT02814643|54842260|FG000|Overall Study|Lost to Follow-up|0|||
28170678|NCT02814643|54842261|FG001|Overall Study|Lost to Follow-up|1|||
28170679|NCT02814643|54842260|FG000|Overall Study|Withdrawal by Subject|1|||
28170680|NCT02814643|54842261|FG001|Overall Study|Withdrawal by Subject|2|||
28170681|NCT02724111|54842269|FG000|Overall Study|Protocol Violation|2|||
28170682|NCT02724111|54842270|FG001|Overall Study|Protocol Violation|5|||
28170683|NCT02649218|54842276|FG000|Overall Study|Adverse Event|8|||
28170684|NCT02649218|54842276|FG000|Overall Study|Lack of Efficacy|8|||
27738362|NCT02503202|54187601|FG000|Extension: Month 6 to 24|Physician Decision|1|||
27738363|NCT02503202|54187602|FG001|Extension: Month 6 to 24|Physician Decision|0|||
27856506|NCT00630344|54388479|FG000|Overall Study|Physician Decision|9|||
27856507|NCT00630344|54388479|FG000|Overall Study|Withdrawal by Subject|1|||
28170685|NCT02649218|54842276|FG000|Overall Study|Pregnancy|3|||
28170686|NCT02649218|54842276|FG000|Overall Study|Protocol Violation|3|||
28170687|NCT02649218|54842276|FG000|Overall Study|Physician Decision|1|||
28170688|NCT02649218|54842276|FG000|Overall Study|Withdrawal by Subject|2|||
28170689|NCT02814175|54842283|FG000|Part 1|Adverse Event|2|||
28170690|NCT02814175|54842284|FG001|Part 1|Adverse Event|3|||
28170691|NCT02814175|54842285|FG002|Part 1|Adverse Event|0|||
28170692|NCT02814175|54842286|FG003|Part 1|Adverse Event|0|||
28170693|NCT02814175|54842287|FG004|Part 1|Adverse Event|0|||
28170694|NCT02814175|54842288|FG005|Part 1|Adverse Event|0|||
28170695|NCT02814175|54842283|FG000|Part 1|Withdrawal Consent|8|||
28170696|NCT02814175|54842284|FG001|Part 1|Withdrawal Consent|1|||
28170697|NCT02814175|54842285|FG002|Part 1|Withdrawal Consent|0|||
28170698|NCT02814175|54842286|FG003|Part 1|Withdrawal Consent|0|||
28170699|NCT02814175|54842287|FG004|Part 1|Withdrawal Consent|0|||
28095228|NCT02849626|54749444|FG002|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
28095229|NCT02849626|54749445|FG003|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
28095230|NCT02849626|54749442|FG000|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|3|||
28095231|NCT02849626|54749443|FG001|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|1|||
28095232|NCT02849626|54749444|FG002|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
28095233|NCT02849626|54749445|FG003|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
28095234|NCT02849626|54749442|FG000|Extension Phase A (up to 29 Weeks)|Non-specified|1|||
28095235|NCT02849626|54749443|FG001|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
28095236|NCT02849626|54749444|FG002|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
28095237|NCT02849626|54749445|FG003|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
28095238|NCT02849626|54749442|FG000|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
28170700|NCT02814175|54842288|FG005|Part 1|Withdrawal Consent|0|||
28170701|NCT02814175|54842283|FG000|Part 1|Lost to Follow-up|1|||
28170702|NCT02814175|54842284|FG001|Part 1|Lost to Follow-up|0|||
28170703|NCT02814175|54842285|FG002|Part 1|Lost to Follow-up|0|||
28170704|NCT02814175|54842286|FG003|Part 1|Lost to Follow-up|0|||
28170705|NCT02814175|54842287|FG004|Part 1|Lost to Follow-up|0|||
28170706|NCT02814175|54842288|FG005|Part 1|Lost to Follow-up|0|||
28170707|NCT02814175|54842283|FG000|Part 1|Lack of Efficacy|1|||
28170708|NCT02814175|54842284|FG001|Part 1|Lack of Efficacy|2|||
28170709|NCT02814175|54842285|FG002|Part 1|Lack of Efficacy|0|||
28170710|NCT02814175|54842286|FG003|Part 1|Lack of Efficacy|0|||
28170711|NCT02814175|54842287|FG004|Part 1|Lack of Efficacy|0|||
28170712|NCT02814175|54842288|FG005|Part 1|Lack of Efficacy|0|||
28170713|NCT02814175|54842283|FG000|Part 2|Adverse Event|0|||
28170714|NCT02814175|54842284|FG001|Part 2|Adverse Event|0|||
28170715|NCT02814175|54842285|FG002|Part 2|Adverse Event|0|||
28170716|NCT02814175|54842286|FG003|Part 2|Adverse Event|1|||
28170717|NCT02814175|54842287|FG004|Part 2|Adverse Event|1|||
28170718|NCT02814175|54842288|FG005|Part 2|Adverse Event|2|||
28170719|NCT02814175|54842283|FG000|Part 2|Withdrawal Consent|0|||
28170720|NCT02814175|54842284|FG001|Part 2|Withdrawal Consent|0|||
28170721|NCT02814175|54842285|FG002|Part 2|Withdrawal Consent|0|||
28170722|NCT02814175|54842286|FG003|Part 2|Withdrawal Consent|2|||
28170723|NCT02814175|54842287|FG004|Part 2|Withdrawal Consent|1|||
28170724|NCT02814175|54842288|FG005|Part 2|Withdrawal Consent|1|||
28170725|NCT02814175|54842283|FG000|Part 2|Lost to Follow-up|0|||
28170726|NCT02814175|54842284|FG001|Part 2|Lost to Follow-up|0|||
28170727|NCT02814175|54842285|FG002|Part 2|Lost to Follow-up|0|||
28170728|NCT02814175|54842286|FG003|Part 2|Lost to Follow-up|1|||
28170729|NCT02814175|54842287|FG004|Part 2|Lost to Follow-up|0|||
28170730|NCT02814175|54842288|FG005|Part 2|Lost to Follow-up|0|||
28095239|NCT02849626|54749443|FG001|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
28095240|NCT02849626|54749444|FG002|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|3|||
28095241|NCT02849626|54749445|FG003|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
28095242|NCT02849626|54749442|FG000|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
28095243|NCT02849626|54749443|FG001|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
28170731|NCT02814175|54842283|FG000|Part 2|Lack of Efficacy|0|||
28170732|NCT02814175|54842284|FG001|Part 2|Lack of Efficacy|0|||
27833708|NCT03599518|54316775|FG000|Overall Study|Progressive disease as per RECIST v1.1|5|||
27833709|NCT03599518|54316776|FG001|Overall Study|Progressive disease as per RECIST v1.1|4|||
27833710|NCT03599518|54316777|FG002|Overall Study|Progressive disease as per RECIST v1.1|5|||
27833711|NCT03599518|54316778|FG003|Overall Study|Progressive disease as per RECIST v1.1|1|||
27833712|NCT03599518|54316779|FG004|Overall Study|Progressive disease as per RECIST v1.1|2|||
28095244|NCT02849626|54749444|FG002|Extension Phase B (up to 89 Weeks)|Participant choice|1|||
28095245|NCT02849626|54749445|FG003|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
28095246|NCT02849626|54749442|FG000|Extension Phase B (up to 89 Weeks)|Other|0|||
28170733|NCT02814175|54842285|FG002|Part 2|Lack of Efficacy|0|||
28170734|NCT02814175|54842286|FG003|Part 2|Lack of Efficacy|0|||
28170735|NCT02814175|54842287|FG004|Part 2|Lack of Efficacy|0|||
28170736|NCT02814175|54842288|FG005|Part 2|Lack of Efficacy|3|||
27833713|NCT03599518|54316775|FG000|Overall Study|Participant withdrawal from study treatment|0|||
28170737|NCT01335997|54842304|FG000|Period I and II|Adverse Event|63|||
28170738|NCT01335997|54842305|FG001|Period I and II|Adverse Event|43|||
28170739|NCT01335997|54842304|FG000|Period I and II|Noncompliance with Study Drug|1|||
28170740|NCT01335997|54842305|FG001|Period I and II|Noncompliance with Study Drug|1|||
28170741|NCT01335997|54842304|FG000|Period I and II|Lost to Follow-up|3|||
28170742|NCT01335997|54842305|FG001|Period I and II|Lost to Follow-up|5|||
28170743|NCT01335997|54842304|FG000|Period I and II|Withdrawal by Subject|9|||
28170744|NCT01335997|54842305|FG001|Period I and II|Withdrawal by Subject|4|||
28170745|NCT01335997|54842304|FG000|Period I and II|Study Terminated by Sponsor|406|||
28170746|NCT01335997|54842305|FG001|Period I and II|Study Terminated by Sponsor|415|||
28170747|NCT01335997|54842304|FG000|Period I and II|Protocol Violation|9|||
28170748|NCT01335997|54842305|FG001|Period I and II|Protocol Violation|10|||
28170749|NCT01335997|54842304|FG000|Period I and II|Physician Decision|2|||
28170750|NCT01335997|54842305|FG001|Period I and II|Physician Decision|1|||
28170751|NCT01335997|54842304|FG000|Period III|Adverse Event|0|||
28170752|NCT01335997|54842305|FG001|Period III|Adverse Event|2|||
28170753|NCT01335997|54842304|FG000|Period III|Study Terminated by Sponsor|77|||
28170754|NCT01335997|54842305|FG001|Period III|Study Terminated by Sponsor|76|||
28170755|NCT01335997|54842304|FG000|Period III|Protocol Violation|0|||
28170756|NCT01335997|54842305|FG001|Period III|Protocol Violation|1|||
28170757|NCT01335997|54842304|FG000|Period III|Lost to Follow-up|1|||
28170758|NCT01335997|54842305|FG001|Period III|Lost to Follow-up|0|||
28170759|NCT02725671|54842313|FG000|Overall Study|Lost to Follow-up|1|||
28170760|NCT02446990|54842321|FG000|Overall Study|Death|485|||
28170761|NCT02446990|54842322|FG001|Overall Study|Death|458|||
28170762|NCT02446990|54842321|FG000|Overall Study|Lost to Follow-up|3|||
28170763|NCT02446990|54842322|FG001|Overall Study|Lost to Follow-up|1|||
28170764|NCT02446990|54842321|FG000|Overall Study|Physician Decision|1|||
28170765|NCT02446990|54842322|FG001|Overall Study|Physician Decision|0|||
27856508|NCT00630344|54388479|FG000|Overall Study|Intercurrent Illness|1|||
27856509|NCT00630344|54388479|FG000|Overall Study|Other|1|||
27856510|NCT02913261|54388505|FG000|Overall Study|Technical problems|0|||
27980971|NCT00887978|54638920|FG001|Overall Study|Adverse Event|5|||
27980972|NCT00887978|54638919|FG000|Overall Study|Clinical Worsening|4|||
27980973|NCT00887978|54638920|FG001|Overall Study|Clinical Worsening|4|||
27980974|NCT00887978|54638919|FG000|Overall Study|Death|2|||
27980975|NCT00887978|54638920|FG001|Overall Study|Death|3|||
27980976|NCT00887978|54638919|FG000|Overall Study|Withdrawal by Subject|1|||
27980977|NCT00887978|54638920|FG001|Overall Study|Withdrawal by Subject|2|||
27980978|NCT00887978|54638919|FG000|Overall Study|Lost to Follow-up|0|||
27980979|NCT00887978|54638920|FG001|Overall Study|Lost to Follow-up|1|||
27980980|NCT00608023|54638929|FG000|Overall Study|Withdrawal by Subject|8|||
27980981|NCT00608023|54638930|FG001|Overall Study|Withdrawal by Subject|10|||
27980982|NCT00608023|54638931|FG002|Overall Study|Withdrawal by Subject|7|||
27980983|NCT00608023|54638929|FG000|Overall Study|Adverse Event|1|||
27980984|NCT00608023|54638930|FG001|Overall Study|Adverse Event|4|||
27856511|NCT02913261|54388506|FG001|Overall Study|Technical problems|1|||
27856512|NCT02913261|54388505|FG000|Overall Study|Lack of Efficacy|32|||
27856513|NCT02913261|54388506|FG001|Overall Study|Lack of Efficacy|69|||
27856514|NCT02913261|54388505|FG000|Overall Study|Adverse Event|27|||
27856515|NCT02913261|54388506|FG001|Overall Study|Adverse Event|5|||
27856516|NCT02913261|54388505|FG000|Overall Study|Death|25|||
27856517|NCT02913261|54388506|FG001|Overall Study|Death|22|||
27856518|NCT02913261|54388505|FG000|Overall Study|Failure to meet protocol continuation criteria|13|||
27856519|NCT02913261|54388506|FG001|Overall Study|Failure to meet protocol continuation criteria|10|||
27856520|NCT02913261|54388505|FG000|Overall Study|Disease relapse|8|||
27856521|NCT02913261|54388506|FG001|Overall Study|Disease relapse|13|||
27856522|NCT02913261|54388505|FG000|Overall Study|Physician Decision|8|||
27856523|NCT02913261|54388506|FG001|Overall Study|Physician Decision|9|||
27856524|NCT02913261|54388505|FG000|Overall Study|Subject/guardian decision|4|||
27856525|NCT02913261|54388506|FG001|Overall Study|Subject/guardian decision|6|||
28095247|NCT02849626|54749443|FG001|Extension Phase B (up to 89 Weeks)|Other|0|||
28095248|NCT02849626|54749444|FG002|Extension Phase B (up to 89 Weeks)|Other|1|||
28095249|NCT02849626|54749445|FG003|Extension Phase B (up to 89 Weeks)|Other|0|||
28095250|NCT03735498|54749463|FG000|Overall Study|Withdrawal by Subject|5|||
28095251|NCT03735498|54749463|FG000|Overall Study|one participant only completed 5 of 6 sessions|1|||
28095252|NCT02659540|54749469|FG000|Overall Study|Adverse Event|3|||
28095253|NCT02659540|54749470|FG001|Overall Study|Adverse Event|2|||
27856526|NCT02913261|54388505|FG000|Overall Study|Graft loss|2|||
27980985|NCT00608023|54638931|FG002|Overall Study|Adverse Event|5|||
27980986|NCT00608023|54638929|FG000|Overall Study|Lost to Follow-up|2|||
27980987|NCT00608023|54638930|FG001|Overall Study|Lost to Follow-up|2|||
27980988|NCT00608023|54638931|FG002|Overall Study|Lost to Follow-up|1|||
27980989|NCT00608023|54638929|FG000|Overall Study|Protocol Violation|1|||
27980990|NCT00608023|54638930|FG001|Overall Study|Protocol Violation|3|||
27980991|NCT00608023|54638931|FG002|Overall Study|Protocol Violation|1|||
27980992|NCT00608023|54638929|FG000|Overall Study|Unknown reason|0|||
27980993|NCT00608023|54638930|FG001|Overall Study|Unknown reason|3|||
28095254|NCT02659540|54749469|FG000|Overall Study|Death|1|||
28095255|NCT02659540|54749470|FG001|Overall Study|Death|0|||
28095256|NCT02659540|54749469|FG000|Overall Study|Progressive disease|2|||
28170766|NCT02446990|54842321|FG000|Overall Study|Withdrawal by Subject|231|||
28170767|NCT02446990|54842322|FG001|Overall Study|Withdrawal by Subject|199|||
28170768|NCT02725515|54842330|FG000|Overall Study|Refused infusion (no study treatment)|1|||
28170769|NCT02725515|54842331|FG001|Overall Study|Refused infusion (no study treatment)|0|||
27856527|NCT02913261|54388506|FG001|Overall Study|Graft loss|0|||
28095257|NCT02659540|54749470|FG001|Overall Study|Progressive disease|6|||
27980994|NCT00608023|54638931|FG002|Overall Study|Unknown reason|0|||
27980995|NCT00802659|54638946|FG000|Overall Study|Physician Decision|0|||
27980996|NCT00802659|54638947|FG001|Overall Study|Physician Decision|1|||
27980997|NCT00802659|54638948|FG002|Overall Study|Physician Decision|0|||
27980998|NCT00802659|54638949|FG003|Overall Study|Physician Decision|0|||
27980999|NCT00607789|54638961|FG000|Overall Study|Adverse Event|3|||
27981000|NCT00607789|54638962|FG001|Overall Study|Adverse Event|0|||
27981001|NCT00607789|54638961|FG000|Overall Study|Lack of Efficacy|0|||
28095258|NCT01097746|54749476|FG000|Overall Study|Adverse Event|4|||
28095259|NCT01097746|54749476|FG000|Overall Study|taken off study before any treatment given|1|||
28170770|NCT02725515|54842330|FG000|Overall Study|Loss of Improvement per Protocol|14|||
28095260|NCT03733470|54749506|FG000|Overall Study|PI Decision|1|||
28095261|NCT03733470|54749507|FG001|Overall Study|PI Decision|1|||
28095262|NCT03732534|54749513|FG000|Overall Study|Study terminated by Sponsor|6|||
28170771|NCT02725515|54842331|FG001|Overall Study|Loss of Improvement per Protocol|25|||
28170772|NCT02725515|54842330|FG000|Overall Study|Withdrawal by Subject|2|||
28170773|NCT02725515|54842331|FG001|Overall Study|Withdrawal by Subject|1|||
28170774|NCT02725515|54842330|FG000|Overall Study|Non-Compliance With Study Drug|0|||
28170775|NCT02725515|54842331|FG001|Overall Study|Non-Compliance With Study Drug|3|||
28170776|NCT02725515|54842330|FG000|Overall Study|Lost to Follow-up|1|||
28170777|NCT02725515|54842331|FG001|Overall Study|Lost to Follow-up|1|||
28170778|NCT02725515|54842330|FG000|Overall Study|Adverse Event|7|||
28170779|NCT02725515|54842331|FG001|Overall Study|Adverse Event|2|||
28170780|NCT02725515|54842330|FG000|Overall Study|No Documented Disease Improvement|0|||
28095263|NCT03087058|54749519|FG000|Overall Study|Withdrawal by Subject|2|||
28095264|NCT03087058|54749520|FG001|Overall Study|Withdrawal by Subject|0|||
28095265|NCT03087058|54749521|FG002|Overall Study|Withdrawal by Subject|0|||
28095266|NCT03726996|54749528|FG000|Overall Study|Parent's decision|2|||
28095267|NCT03726996|54749528|FG000|Overall Study|Study early termination|2|||
28095268|NCT03882970|54749536|FG000|Overall Study|Adverse Event|5|||
28095269|NCT03882970|54749537|FG001|Overall Study|Adverse Event|7|||
28095270|NCT03882970|54749538|FG002|Overall Study|Adverse Event|3|||
28095271|NCT03882970|54749539|FG003|Overall Study|Adverse Event|1|||
28095272|NCT03882970|54749536|FG000|Overall Study|Death|1|||
28095273|NCT03882970|54749537|FG001|Overall Study|Death|2|||
28095274|NCT03882970|54749538|FG002|Overall Study|Death|1|||
28095275|NCT03882970|54749539|FG003|Overall Study|Death|1|||
28095276|NCT03882970|54749536|FG000|Overall Study|Lost to Follow-up|8|||
28095277|NCT03882970|54749537|FG001|Overall Study|Lost to Follow-up|9|||
28095278|NCT03882970|54749538|FG002|Overall Study|Lost to Follow-up|5|||
28095279|NCT03882970|54749539|FG003|Overall Study|Lost to Follow-up|5|||
28095280|NCT03882970|54749536|FG000|Overall Study|Physician Decision|0|||
28095281|NCT03882970|54749537|FG001|Overall Study|Physician Decision|2|||
28095282|NCT03882970|54749538|FG002|Overall Study|Physician Decision|2|||
28095283|NCT03882970|54749539|FG003|Overall Study|Physician Decision|2|||
28095284|NCT03882970|54749536|FG000|Overall Study|Protocol Violation|2|||
28095285|NCT03882970|54749537|FG001|Overall Study|Protocol Violation|0|||
28095286|NCT03882970|54749538|FG002|Overall Study|Protocol Violation|0|||
28170781|NCT02725515|54842331|FG001|Overall Study|No Documented Disease Improvement|1|||
28170782|NCT02725515|54842330|FG000|Overall Study|Completed Study Under Original Protocol|0|||
28095287|NCT03882970|54749539|FG003|Overall Study|Protocol Violation|0|||
28095288|NCT03882970|54749536|FG000|Overall Study|Withdrawal by Subject|8|||
28095289|NCT03882970|54749537|FG001|Overall Study|Withdrawal by Subject|17|||
28095290|NCT03882970|54749538|FG002|Overall Study|Withdrawal by Subject|7|||
28170783|NCT02725515|54842331|FG001|Overall Study|Completed Study Under Original Protocol|1|||
28170784|NCT02725515|54842330|FG000|Overall Study|Lack of Response|0|||
28170785|NCT02725515|54842331|FG001|Overall Study|Lack of Response|1|||
28170786|NCT02416180|54842337|FG000|Overall Study|Withdrawal by Subject|1|||
28170787|NCT02473510|54842343|FG000|Overall Study|Lost to Follow-up|1|||
27981002|NCT00607789|54638962|FG001|Overall Study|Lack of Efficacy|1|||
27981003|NCT00607789|54638961|FG000|Overall Study|Inadequate adherence|3|||
27981004|NCT00607789|54638962|FG001|Overall Study|Inadequate adherence|0|||
27981005|NCT00607789|54638961|FG000|Overall Study|Lost to Follow-up|0|||
27981006|NCT00607789|54638962|FG001|Overall Study|Lost to Follow-up|5|||
27981007|NCT00607789|54638961|FG000|Overall Study|Withdrawal by Subject|1|||
27981008|NCT00607789|54638962|FG001|Overall Study|Withdrawal by Subject|0|||
27981009|NCT00887822|54638970|FG000|Overall Study|Insufficient therapeutic response|53|||
28170788|NCT02473510|54842344|FG001|Overall Study|Lost to Follow-up|2|||
28170789|NCT02445586|54842350|FG000|Overall Study|Death|14|||
28095291|NCT03882970|54749539|FG003|Overall Study|Withdrawal by Subject|22|||
28170790|NCT02445586|54842350|FG000|Overall Study|Withdrawal by Subject|13|||
28170791|NCT02445586|54842350|FG000|Overall Study|Disease Progression|10|||
28170792|NCT02445586|54842350|FG000|Overall Study|Protocol Violation|1|||
28170793|NCT02445586|54842350|FG000|Overall Study|Medical Condition|1|||
27981010|NCT00887822|54638971|FG001|Overall Study|Insufficient therapeutic response|55|||
28095292|NCT03882970|54749536|FG000|Overall Study|Personal Reason|2|||
28095293|NCT03882970|54749537|FG001|Overall Study|Personal Reason|3|||
28095294|NCT03882970|54749538|FG002|Overall Study|Personal Reason|1|||
28095295|NCT03882970|54749539|FG003|Overall Study|Personal Reason|3|||
28170794|NCT01674062|54842356|FG000|Overall Study|Insufficient Therapeutic Response|56|||
28170795|NCT01674062|54842357|FG001|Overall Study|Insufficient Therapeutic Response|26|||
28170796|NCT01674062|54842356|FG000|Overall Study|Other|8|||
28170797|NCT01674062|54842357|FG001|Overall Study|Other|1|||
28170798|NCT01674062|54842356|FG000|Overall Study|Adverse Event|1|||
28170799|NCT01674062|54842357|FG001|Overall Study|Adverse Event|1|||
28170800|NCT01674062|54842356|FG000|Overall Study|Death|0|||
28170801|NCT01674062|54842357|FG001|Overall Study|Death|1|||
28170802|NCT01674062|54842356|FG000|Overall Study|Programming Error|1|||
28170803|NCT01674062|54842357|FG001|Overall Study|Programming Error|0|||
28170804|NCT02472886|54842366|FG000|Overall Study|Lack of Efficacy|0|||
28170805|NCT02472886|54842367|FG001|Overall Study|Lack of Efficacy|2|||
28170806|NCT02472886|54842368|FG002|Overall Study|Lack of Efficacy|1|||
28170807|NCT02472652|54842381|FG000|Overall Study|Lost to Follow-up|1|||
28170808|NCT02807857|54842385|FG000|Enrolled Set|Patients not suitable for follow-up.|551|||
28170809|NCT02807857|54842385|FG000|Follow-Up Set|Study Terminated By Sponsor|131|||
28170810|NCT02807857|54842385|FG000|Follow-Up Set|Withdrawal by Subject|8|||
28170811|NCT02807857|54842385|FG000|Follow-Up Set|Lost to Follow-up|7|||
28170812|NCT02807857|54842385|FG000|Follow-Up Set|Physician Decision|6|||
28170813|NCT02807857|54842385|FG000|Follow-Up Set|Adverse Event|3|||
28170814|NCT02807857|54842385|FG000|Follow-Up Set|Death|27|||
28170815|NCT02807857|54842385|FG000|Follow-Up Set|Relocation|2|||
27833714|NCT03599518|54316776|FG001|Overall Study|Participant withdrawal from study treatment|0|||
27833715|NCT03599518|54316777|FG002|Overall Study|Participant withdrawal from study treatment|1|||
27833716|NCT03599518|54316778|FG003|Overall Study|Participant withdrawal from study treatment|0|||
27833717|NCT03599518|54316779|FG004|Overall Study|Participant withdrawal from study treatment|0|||
27833718|NCT02709486|54316856|FG000|Overall Study|Adverse Event|2|||
27833719|NCT02709486|54316857|FG001|Overall Study|Adverse Event|5|||
27833720|NCT02709486|54316858|FG002|Overall Study|Adverse Event|3|||
27833721|NCT02709486|54316856|FG000|Overall Study|Death|0|||
27833722|NCT02709486|54316857|FG001|Overall Study|Death|0|||
27833723|NCT02709486|54316858|FG002|Overall Study|Death|2|||
27833724|NCT02709486|54316856|FG000|Overall Study|Insufficient clinical response|7|||
28095296|NCT03730480|54749553|FG000|Overall Study|Meter displayed a HI result which is non evaluable.|1|||
28095297|NCT03674112|54749560|FG000|Overall Study|Adverse Event|1|||
27833725|NCT02709486|54316857|FG001|Overall Study|Insufficient clinical response|3|||
27833726|NCT02709486|54316858|FG002|Overall Study|Insufficient clinical response|3|||
27833727|NCT02709486|54316856|FG000|Overall Study|Lost to Follow-up|3|||
27833728|NCT02709486|54316857|FG001|Overall Study|Lost to Follow-up|2|||
28095298|NCT03674112|54749561|FG001|Overall Study|Adverse Event|0|||
28095299|NCT03674112|54749560|FG000|Overall Study|Ongoing in the Study|79|||
28095300|NCT03674112|54749561|FG001|Overall Study|Ongoing in the Study|80|||
28095301|NCT03668808|54749587|FG000|First Intervention|Withdrawal by Subject|2|||
28095302|NCT03668808|54749588|FG001|First Intervention|Withdrawal by Subject|2|||
28095303|NCT02982954|54749600|FG000|Overall Study|Death|55|||
28095304|NCT02982954|54749601|FG001|Overall Study|Death|29|||
28095305|NCT02982954|54749602|FG002|Overall Study|Death|15|||
28095306|NCT02982954|54749603|FG003|Overall Study|Death|20|||
28095307|NCT02982954|54749600|FG000|Overall Study|Lost to Follow-up|2|||
28095308|NCT02982954|54749601|FG001|Overall Study|Lost to Follow-up|1|||
28095309|NCT02982954|54749602|FG002|Overall Study|Lost to Follow-up|0|||
28095310|NCT02982954|54749603|FG003|Overall Study|Lost to Follow-up|0|||
28095311|NCT02982954|54749600|FG000|Overall Study|Participant withdrew consent|7|||
28095312|NCT02982954|54749601|FG001|Overall Study|Participant withdrew consent|5|||
28095313|NCT02982954|54749602|FG002|Overall Study|Participant withdrew consent|1|||
28095314|NCT02982954|54749603|FG003|Overall Study|Participant withdrew consent|1|||
28095315|NCT02982954|54749600|FG000|Overall Study|Other reasons|42|||
28095316|NCT02982954|54749601|FG001|Overall Study|Other reasons|17|||
28095317|NCT02982954|54749602|FG002|Overall Study|Other reasons|12|||
28095318|NCT02982954|54749603|FG003|Overall Study|Other reasons|3|||
28095319|NCT02982954|54749600|FG000|Overall Study|Premature site closure|0|||
28095320|NCT02982954|54749601|FG001|Overall Study|Premature site closure|0|||
28095321|NCT02982954|54749602|FG002|Overall Study|Premature site closure|0|||
28095322|NCT02982954|54749603|FG003|Overall Study|Premature site closure|1|||
28095323|NCT03724968|54749615|FG000|Overall Study|Insurance issues|0|||
27833729|NCT02709486|54316858|FG002|Overall Study|Lost to Follow-up|2|||
27833730|NCT02709486|54316856|FG000|Overall Study|Other|0|||
28095324|NCT03724968|54749616|FG001|Overall Study|Insurance issues|1|||
28095325|NCT03724968|54749615|FG000|Overall Study|Study closed|0|||
27833731|NCT02709486|54316857|FG001|Overall Study|Other|2|||
27833732|NCT02709486|54316858|FG002|Overall Study|Other|3|||
27833733|NCT02709486|54316856|FG000|Overall Study|Withdrawal by Subject|32|||
27833734|NCT02709486|54316857|FG001|Overall Study|Withdrawal by Subject|22|||
28095326|NCT03724968|54749616|FG001|Overall Study|Study closed|1|||
28095327|NCT03724812|54749622|FG000|Overall Study|Missed Visit|1|||
28170816|NCT02648438|54842398|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
27833735|NCT02709486|54316858|FG002|Overall Study|Withdrawal by Subject|32|||
27833736|NCT03110770|54316875|FG000|Overall Study|Death|1|||
27833737|NCT03110770|54316876|FG001|Overall Study|Death|0|||
27738364|NCT02503202|54187603|FG002|Extension: Month 6 to 24|Physician Decision|1|||
27738365|NCT02503202|54187604|FG003|Extension: Month 6 to 24|Physician Decision|3|||
27738366|NCT02503202|54187605|FG004|Extension: Month 6 to 24|Physician Decision|0|||
27738367|NCT02503202|54187601|FG000|Extension: Month 6 to 24|Withdrawal by Subject|5|||
27738368|NCT02503202|54187602|FG001|Extension: Month 6 to 24|Withdrawal by Subject|8|||
28095328|NCT03724812|54749622|FG000|Overall Study|Death|2|||
28095329|NCT03724812|54749622|FG000|Overall Study|Withdrawal by Subject|1|||
28095330|NCT03722784|54749629|FG000|Overall Study|Withdrawal by Subject|1|||
28095331|NCT03722784|54749630|FG001|Overall Study|Withdrawal by Subject|0|||
28095332|NCT03722784|54749629|FG000|Overall Study|Physician Decision|1|||
28095333|NCT03722784|54749630|FG001|Overall Study|Physician Decision|1|||
28095334|NCT03722784|54749629|FG000|Overall Study|Protocol Violation|0|||
28095335|NCT03722784|54749630|FG001|Overall Study|Protocol Violation|1|||
28095336|NCT03722238|54749639|FG000|Overall Study|Protocol Violation|1|||
28095337|NCT03722238|54749640|FG001|Overall Study|Protocol Violation|0|||
28095338|NCT03722238|54749639|FG000|Overall Study|Physician Decision|1|||
28095339|NCT03722238|54749640|FG001|Overall Study|Physician Decision|0|||
28095340|NCT03722238|54749639|FG000|Overall Study|Death|1|||
28095341|NCT03722238|54749640|FG001|Overall Study|Death|0|||
28095342|NCT03722238|54749639|FG000|Overall Study|Lost to Follow-up|6|||
28095343|NCT03722238|54749640|FG001|Overall Study|Lost to Follow-up|0|||
28095344|NCT03722238|54749639|FG000|Overall Study|Partial missing data|44|||
28095345|NCT03722238|54749640|FG001|Overall Study|Partial missing data|1|||
28095346|NCT03722238|54749639|FG000|Overall Study|Withdrawal by Subject|2|||
28095347|NCT03722238|54749640|FG001|Overall Study|Withdrawal by Subject|0|||
28095348|NCT03722238|54749639|FG000|Overall Study|Other|4|||
28095349|NCT03722238|54749640|FG001|Overall Study|Other|0|||
28095350|NCT03722238|54749639|FG000|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|2|||
28095351|NCT03722238|54749640|FG001|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|0|||
28095352|NCT03722238|54749639|FG000|Overall Study|Did not meet risk classification group criteria|90|||
28095353|NCT03722238|54749640|FG001|Overall Study|Did not meet risk classification group criteria|0|||
28095354|NCT03722238|54749639|FG000|Overall Study|Did not sign consent|17|||
28095355|NCT03722238|54749640|FG001|Overall Study|Did not sign consent|0|||
28095356|NCT03722238|54749639|FG000|Overall Study|Other eligibility criteria not met pre-consent|22|||
28095357|NCT03722238|54749640|FG001|Overall Study|Other eligibility criteria not met pre-consent|0|||
28095358|NCT03722238|54749639|FG000|Overall Study|Not willing to purchase study medication|142|||
28095359|NCT03722238|54749640|FG001|Overall Study|Not willing to purchase study medication|0|||
28095360|NCT03722238|54749639|FG000|Overall Study|Did not qualify at re-screening and medical conditions|133|||
28095361|NCT03722238|54749640|FG001|Overall Study|Did not qualify at re-screening and medical conditions|0|||
28095362|NCT02927080|54749656|FG000|Overall Study|Withdrawal by Subject|0|||
28095363|NCT02927080|54749657|FG001|Overall Study|Withdrawal by Subject|0|||
28095364|NCT02927080|54749658|FG002|Overall Study|Withdrawal by Subject|0|||
28095365|NCT02927080|54749659|FG003|Overall Study|Withdrawal by Subject|0|||
28095366|NCT02927080|54749660|FG004|Overall Study|Withdrawal by Subject|1|||
28095367|NCT02927080|54749661|FG005|Overall Study|Withdrawal by Subject|0|||
28095368|NCT02927080|54749662|FG006|Overall Study|Withdrawal by Subject|1|||
28095369|NCT02927080|54749663|FG007|Overall Study|Withdrawal by Subject|1|||
28095370|NCT02927080|54749664|FG008|Overall Study|Withdrawal by Subject|0|||
28095371|NCT02927080|54749665|FG009|Overall Study|Withdrawal by Subject|2|||
28095372|NCT02927080|54749656|FG000|Overall Study|Willingness to comply with protocol|0|||
28095373|NCT02927080|54749657|FG001|Overall Study|Willingness to comply with protocol|0|||
28095374|NCT02927080|54749658|FG002|Overall Study|Willingness to comply with protocol|0|||
27833738|NCT03110770|54316877|FG002|Overall Study|Death|0|||
27833739|NCT03110770|54316878|FG003|Overall Study|Death|1|||
27833740|NCT03110770|54316879|FG004|Overall Study|Death|0|||
27833741|NCT03110770|54316875|FG000|Overall Study|Enrolled but did not receive product|0|||
27833742|NCT03110770|54316876|FG001|Overall Study|Enrolled but did not receive product|0|||
27833743|NCT03110770|54316877|FG002|Overall Study|Enrolled but did not receive product|0|||
27833744|NCT03110770|54316878|FG003|Overall Study|Enrolled but did not receive product|8|||
27833745|NCT03110770|54316879|FG004|Overall Study|Enrolled but did not receive product|7|||
27833746|NCT03110770|54316875|FG000|Overall Study|Lost to Follow-up|0|||
27833747|NCT03110770|54316876|FG001|Overall Study|Lost to Follow-up|0|||
27833748|NCT03110770|54316877|FG002|Overall Study|Lost to Follow-up|0|||
27738369|NCT02503202|54187603|FG002|Extension: Month 6 to 24|Withdrawal by Subject|2|||
27738370|NCT02503202|54187604|FG003|Extension: Month 6 to 24|Withdrawal by Subject|4|||
27833749|NCT03110770|54316878|FG003|Overall Study|Lost to Follow-up|53|||
28095375|NCT02927080|54749659|FG003|Overall Study|Willingness to comply with protocol|0|||
27833750|NCT03110770|54316879|FG004|Overall Study|Lost to Follow-up|45|||
28095376|NCT02927080|54749660|FG004|Overall Study|Willingness to comply with protocol|0|||
28095377|NCT02927080|54749661|FG005|Overall Study|Willingness to comply with protocol|0|||
28095378|NCT02927080|54749662|FG006|Overall Study|Willingness to comply with protocol|0|||
28095379|NCT02927080|54749663|FG007|Overall Study|Willingness to comply with protocol|0|||
27738371|NCT02503202|54187605|FG004|Extension: Month 6 to 24|Withdrawal by Subject|0|||
27738372|NCT02728102|54187620|FG000|Overall Study|Death|3|||
27738373|NCT02728102|54187621|FG001|Overall Study|Death|0|||
27833751|NCT03110770|54316875|FG000|Overall Study|Investigator Decision|0|||
27833752|NCT03110770|54316876|FG001|Overall Study|Investigator Decision|0|||
27833753|NCT03110770|54316877|FG002|Overall Study|Investigator Decision|0|||
27833754|NCT03110770|54316878|FG003|Overall Study|Investigator Decision|5|||
27738374|NCT02728102|54187622|FG002|Overall Study|Death|1|||
27738375|NCT02728102|54187620|FG000|Overall Study|Withdrawal by Subject|0|||
27738376|NCT02728102|54187621|FG001|Overall Study|Withdrawal by Subject|2|||
27738377|NCT02728102|54187622|FG002|Overall Study|Withdrawal by Subject|3|||
27738378|NCT02728102|54187620|FG000|Overall Study|Physician Decision|1|||
27738379|NCT02728102|54187621|FG001|Overall Study|Physician Decision|1|||
27738380|NCT02728102|54187622|FG002|Overall Study|Physician Decision|0|||
27738381|NCT02728102|54187620|FG000|Overall Study|Investigational study drug permanently discontinued|3|||
27738382|NCT02728102|54187621|FG001|Overall Study|Investigational study drug permanently discontinued|1|||
27833755|NCT03110770|54316879|FG004|Overall Study|Investigator Decision|3|||
27833756|NCT03110770|54316875|FG000|Overall Study|Withdrawal by Subject|0|||
27833757|NCT03110770|54316876|FG001|Overall Study|Withdrawal by Subject|0|||
27833758|NCT03110770|54316877|FG002|Overall Study|Withdrawal by Subject|0|||
27833759|NCT03110770|54316878|FG003|Overall Study|Withdrawal by Subject|24|||
27833760|NCT03110770|54316879|FG004|Overall Study|Withdrawal by Subject|24|||
27738383|NCT02728102|54187622|FG002|Overall Study|Investigational study drug permanently discontinued|0|||
27738384|NCT02728102|54187620|FG000|Overall Study|Covid|0|||
27738385|NCT02728102|54187621|FG001|Overall Study|Covid|0|||
27833761|NCT03110770|54316875|FG000|Overall Study|Moved from area|5|||
27833762|NCT03110770|54316876|FG001|Overall Study|Moved from area|0|||
27833763|NCT03110770|54316877|FG002|Overall Study|Moved from area|2|||
27833764|NCT03110770|54316878|FG003|Overall Study|Moved from area|42|||
27833765|NCT03110770|54316879|FG004|Overall Study|Moved from area|43|||
27833766|NCT03110770|54316875|FG000|Overall Study|Illness/Injury unrelated to product|0|||
28095380|NCT02927080|54749664|FG008|Overall Study|Willingness to comply with protocol|0|||
28095381|NCT02927080|54749665|FG009|Overall Study|Willingness to comply with protocol|1|||
28095382|NCT02927080|54749656|FG000|Overall Study|Study terminated by Sponsor|0|||
28170817|NCT02648438|54842399|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
28170818|NCT02648438|54842400|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
27738386|NCT02728102|54187622|FG002|Overall Study|Covid|1|||
27738387|NCT02502734|54187631|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
27738388|NCT02502734|54187632|FG001|Double-blind Treatment Period 1|Adverse Event|0|||
27738389|NCT02502734|54187631|FG000|Washout Period|Adverse Event|1|||
27738390|NCT02502734|54187632|FG001|Washout Period|Adverse Event|0|||
27738391|NCT02473250|54187640|FG000|Overall Study|Lost to Follow-up|10|||
27738392|NCT02473250|54187640|FG000|Overall Study|Physician Decision|5|||
27738393|NCT02473250|54187640|FG000|Overall Study|Did not tolerate medication washout|3|||
27738394|NCT02473250|54187640|FG000|Overall Study|Antidepressant effect of divalproex|2|||
27738395|NCT02501642|54187647|FG000|Overall Study|Lost to Follow-up|7|||
27738396|NCT02501642|54187648|FG001|Overall Study|Lost to Follow-up|11|||
27738397|NCT02706730|54187654|FG000|Overall Study|Adverse Event|3|||
27738398|NCT02706730|54187654|FG000|Overall Study|Lack of Efficacy|5|||
27738399|NCT02706730|54187654|FG000|Overall Study|Withdrawal by Subject|11|||
27738400|NCT02706730|54187654|FG000|Overall Study|Study Terminated by Sponsor|11|||
27738401|NCT02706730|54187654|FG000|Overall Study|Subject chose not to receive injection|3|||
27738402|NCT02443688|54187661|FG000|Overall Study|Adverse Event|2|||
27738403|NCT02443688|54187662|FG001|Overall Study|Adverse Event|3|||
27738404|NCT02443688|54187663|FG002|Overall Study|Adverse Event|2|||
27738405|NCT02443688|54187661|FG000|Overall Study|Lost to Follow-up|1|||
27833767|NCT03110770|54316876|FG001|Overall Study|Illness/Injury unrelated to product|0|||
28095383|NCT02927080|54749657|FG001|Overall Study|Study terminated by Sponsor|0|||
28095384|NCT02927080|54749658|FG002|Overall Study|Study terminated by Sponsor|0|||
28095385|NCT02927080|54749659|FG003|Overall Study|Study terminated by Sponsor|0|||
28095386|NCT02927080|54749660|FG004|Overall Study|Study terminated by Sponsor|0|||
28170819|NCT02648438|54842398|FG000|Overall Study|Protocol Violation|2|||
28170820|NCT02648438|54842399|FG001|Overall Study|Protocol Violation|0|||
28170821|NCT02648438|54842400|FG002|Overall Study|Protocol Violation|0|||
28170822|NCT02648438|54842398|FG000|Overall Study|Withdrawal by Subject|1|||
28170823|NCT02648438|54842399|FG001|Overall Study|Withdrawal by Subject|1|||
28170824|NCT02648438|54842400|FG002|Overall Study|Withdrawal by Subject|0|||
27738406|NCT02443688|54187662|FG001|Overall Study|Lost to Follow-up|0|||
27738407|NCT02443688|54187663|FG002|Overall Study|Lost to Follow-up|0|||
27738408|NCT02443688|54187661|FG000|Overall Study|Physician Decision|3|||
27738409|NCT02443688|54187662|FG001|Overall Study|Physician Decision|0|||
27738410|NCT02443688|54187663|FG002|Overall Study|Physician Decision|1|||
27738411|NCT02443688|54187661|FG000|Overall Study|Pregnancy|0|||
27738412|NCT02443688|54187662|FG001|Overall Study|Pregnancy|0|||
27833768|NCT03110770|54316877|FG002|Overall Study|Illness/Injury unrelated to product|0|||
27856528|NCT00635882|54388570|FG000|Overall Study|Protocol Violation|1|||
28095387|NCT02927080|54749661|FG005|Overall Study|Study terminated by Sponsor|0|||
28170825|NCT02415556|54842420|FG000|Overall Study|Adverse Event|3|||
27738413|NCT02443688|54187663|FG002|Overall Study|Pregnancy|1|||
27738414|NCT02443688|54187661|FG000|Overall Study|Withdrawal by Subject|3|||
27738415|NCT02443688|54187662|FG001|Overall Study|Withdrawal by Subject|3|||
27738416|NCT02443688|54187663|FG002|Overall Study|Withdrawal by Subject|4|||
27738417|NCT02443688|54187661|FG000|Overall Study|Non-compliance with study drug|1|||
27738418|NCT02443688|54187662|FG001|Overall Study|Non-compliance with study drug|2|||
27738419|NCT02443688|54187663|FG002|Overall Study|Non-compliance with study drug|4|||
27738420|NCT02443688|54187661|FG000|Overall Study|Sponsor Request|2|||
27738421|NCT02443688|54187662|FG001|Overall Study|Sponsor Request|1|||
27738422|NCT02443688|54187663|FG002|Overall Study|Sponsor Request|0|||
27738423|NCT02443298|54187677|FG000|Overall Study|Adverse Event|3|||
27738424|NCT02443298|54187678|FG001|Overall Study|Adverse Event|3|||
27738425|NCT02443298|54187677|FG000|Overall Study|Withdrawal by Subject|1|||
28095388|NCT02927080|54749662|FG006|Overall Study|Study terminated by Sponsor|6|||
28095389|NCT02927080|54749663|FG007|Overall Study|Study terminated by Sponsor|7|||
28095390|NCT02927080|54749664|FG008|Overall Study|Study terminated by Sponsor|2|||
28095391|NCT02927080|54749665|FG009|Overall Study|Study terminated by Sponsor|3|||
28095392|NCT02927080|54749656|FG000|Overall Study|Adverse Event|0|||
28095393|NCT02927080|54749657|FG001|Overall Study|Adverse Event|1|||
28095394|NCT02927080|54749658|FG002|Overall Study|Adverse Event|0|||
28095395|NCT02927080|54749659|FG003|Overall Study|Adverse Event|0|||
28095396|NCT02927080|54749660|FG004|Overall Study|Adverse Event|0|||
28095397|NCT02927080|54749661|FG005|Overall Study|Adverse Event|0|||
28095398|NCT02927080|54749662|FG006|Overall Study|Adverse Event|0|||
28095399|NCT02927080|54749663|FG007|Overall Study|Adverse Event|1|||
28095400|NCT02927080|54749664|FG008|Overall Study|Adverse Event|0|||
28095401|NCT02927080|54749665|FG009|Overall Study|Adverse Event|1|||
28095402|NCT02927080|54749656|FG000|Overall Study|Other|0|||
28095403|NCT02927080|54749657|FG001|Overall Study|Other|0|||
28095404|NCT02927080|54749658|FG002|Overall Study|Other|0|||
28095405|NCT02927080|54749659|FG003|Overall Study|Other|0|||
28095406|NCT02927080|54749660|FG004|Overall Study|Other|0|||
28095407|NCT02927080|54749661|FG005|Overall Study|Other|0|||
28095408|NCT02927080|54749662|FG006|Overall Study|Other|1|||
28170826|NCT02415556|54842421|FG001|Overall Study|Adverse Event|4|||
28170827|NCT02415556|54842422|FG002|Overall Study|Adverse Event|2|||
28170828|NCT02415556|54842423|FG003|Overall Study|Adverse Event|4|||
28170829|NCT02415556|54842420|FG000|Overall Study|Lost to Follow-up|4|||
28170830|NCT02415556|54842421|FG001|Overall Study|Lost to Follow-up|5|||
28170831|NCT02415556|54842422|FG002|Overall Study|Lost to Follow-up|4|||
28170832|NCT02415556|54842423|FG003|Overall Study|Lost to Follow-up|1|||
28170833|NCT02415556|54842420|FG000|Overall Study|Withdrawal by Subject|13|||
28170834|NCT02415556|54842421|FG001|Overall Study|Withdrawal by Subject|4|||
28170835|NCT02415556|54842422|FG002|Overall Study|Withdrawal by Subject|14|||
28170836|NCT02415556|54842423|FG003|Overall Study|Withdrawal by Subject|12|||
28170837|NCT02415556|54842420|FG000|Overall Study|Physician Decision|1|||
28170838|NCT02415556|54842421|FG001|Overall Study|Physician Decision|3|||
28170839|NCT02415556|54842422|FG002|Overall Study|Physician Decision|1|||
28170840|NCT02415556|54842423|FG003|Overall Study|Physician Decision|2|||
28170841|NCT02415556|54842420|FG000|Overall Study|Censored - study completion|4|||
28095409|NCT02927080|54749663|FG007|Overall Study|Other|0|||
28095410|NCT02927080|54749664|FG008|Overall Study|Other|1|||
28095411|NCT02927080|54749665|FG009|Overall Study|Other|0|||
28095412|NCT02374476|54749712|FG000|VT Induced Ablation|Screening Failures|36|||
28095413|NCT02374476|54749713|FG001|VT Induced Ablation|Screening Failures|0|||
28095414|NCT02374476|54749714|FG002|VT Induced Ablation|Screening Failures|0|||
28095415|NCT02374476|54749712|FG000|Arm Assignment|Withdrawal by Subject|0|||
28095416|NCT02374476|54749713|FG001|Arm Assignment|Withdrawal by Subject|0|||
28095417|NCT02374476|54749714|FG002|Arm Assignment|Withdrawal by Subject|1|||
28095418|NCT02918292|54749721|FG000|Study Enrollment Prior to Transplant|Death|1|||
28095419|NCT02918292|54749721|FG000|Study Follow up After Transplant|Death|6|||
28170842|NCT02415556|54842421|FG001|Overall Study|Censored - study completion|5|||
28170843|NCT02415556|54842422|FG002|Overall Study|Censored - study completion|1|||
28170844|NCT02415556|54842423|FG003|Overall Study|Censored - study completion|0|||
28170845|NCT02415556|54842420|FG000|Overall Study|Family-related issues|0|||
28170846|NCT02415556|54842421|FG001|Overall Study|Family-related issues|0|||
28170847|NCT02415556|54842422|FG002|Overall Study|Family-related issues|0|||
27738426|NCT02443298|54187678|FG001|Overall Study|Withdrawal by Subject|2|||
27738427|NCT02500706|54187687|FG000|Overall Study|Adverse Event|0|||
27738428|NCT02500706|54187688|FG001|Overall Study|Adverse Event|0|||
28095420|NCT03720210|54749725|FG000|Overall Study|Lost to Follow-up|1|||
28095421|NCT03719586|54749733|FG000|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|8|||
28095422|NCT03719586|54749734|FG001|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|7|||
28095423|NCT03719586|54749735|FG002|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|4|||
28095424|NCT03719586|54749736|FG003|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|0|||
28170848|NCT02415556|54842423|FG003|Overall Study|Family-related issues|1|||
28170849|NCT02807623|54842436|FG000|Overall Study|Lost to Follow-up|23|||
28170850|NCT02807623|54842437|FG001|Overall Study|Lost to Follow-up|18|||
28170851|NCT02807623|54842438|FG002|Overall Study|Lost to Follow-up|22|||
28170852|NCT02807623|54842436|FG000|Overall Study|Drug intolerance|0|||
28170853|NCT02807623|54842437|FG001|Overall Study|Drug intolerance|1|||
28170854|NCT02807623|54842438|FG002|Overall Study|Drug intolerance|0|||
28170855|NCT02807623|54842436|FG000|Overall Study|incomplete blood draw|0|||
28170856|NCT02807623|54842437|FG001|Overall Study|incomplete blood draw|2|||
28170857|NCT02807623|54842438|FG002|Overall Study|incomplete blood draw|1|||
28170858|NCT02805907|54842457|FG000|Overall Study|Lost to Follow-up|3|||
28170859|NCT02805907|54842458|FG001|Overall Study|Lost to Follow-up|3|||
28170860|NCT02723175|54842466|FG000|Overall Study|Lost to 1 Month Follow Up|3|||
28170861|NCT02723175|54842467|FG001|Overall Study|Lost to 1 Month Follow Up|2|||
28170862|NCT02723175|54842466|FG000|Overall Study|Lost to 3 Month Follow Up|1|||
28170863|NCT02723175|54842467|FG001|Overall Study|Lost to 3 Month Follow Up|1|||
28170864|NCT02801617|54842475|FG000|Overall Study|Protocol Violation|2|||
28170865|NCT02801617|54842476|FG001|Overall Study|Protocol Violation|6|||
28170866|NCT01334515|54842488|FG000|Overall Study|Adverse Event|1|||
28170867|NCT01334515|54842489|FG001|Overall Study|Adverse Event|6|||
27738429|NCT02500706|54187689|FG002|Overall Study|Adverse Event|1|||
27738430|NCT02500706|54187687|FG000|Overall Study|Lost to Follow-up|0|||
27738431|NCT02500706|54187688|FG001|Overall Study|Lost to Follow-up|1|||
27738432|NCT02500706|54187689|FG002|Overall Study|Lost to Follow-up|1|||
27738433|NCT02500706|54187687|FG000|Overall Study|Withdrawal by Subject|4|||
27738434|NCT02500706|54187688|FG001|Overall Study|Withdrawal by Subject|6|||
28170868|NCT01334515|54842488|FG000|Overall Study|Death|1|||
28170869|NCT01334515|54842489|FG001|Overall Study|Death|0|||
28170870|NCT01334515|54842488|FG000|Overall Study|Lack of Efficacy|8|||
27738435|NCT02500706|54187689|FG002|Overall Study|Withdrawal by Subject|4|||
27738436|NCT02500706|54187687|FG000|Overall Study|Unclassified|0|||
27738437|NCT02500706|54187688|FG001|Overall Study|Unclassified|0|||
27738438|NCT02500706|54187689|FG002|Overall Study|Unclassified|1|||
27738439|NCT02442830|54187699|FG000|Overall Study|Technical Failure|0|||
27738440|NCT02442830|54187700|FG001|Overall Study|Technical Failure|1|||
27738441|NCT02471612|54187707|FG000|Overall Study|Lost to Follow-up|2|||
27738442|NCT02500550|54187724|FG000|Overall Study|Death|7|||
27738443|NCT02499770|54187730|FG000|Overall Study|Death|17|||
27738444|NCT02499770|54187731|FG001|Overall Study|Death|56|||
27738445|NCT02499770|54187730|FG000|Overall Study|Study completion|1|||
27738446|NCT02499770|54187731|FG001|Overall Study|Study completion|10|||
27738447|NCT02499770|54187730|FG000|Overall Study|Withdrawal by Subject|0|||
27738448|NCT02499770|54187731|FG001|Overall Study|Withdrawal by Subject|7|||
27738449|NCT02499770|54187730|FG000|Overall Study|Lost to Follow-up|0|||
27738450|NCT02499770|54187731|FG001|Overall Study|Lost to Follow-up|2|||
27738451|NCT02499770|54187730|FG000|Overall Study|Subject declined further treatment|1|||
27738452|NCT02499770|54187731|FG001|Overall Study|Subject declined further treatment|0|||
27738453|NCT02499770|54187730|FG000|Overall Study|Withdrawn by PI for compassionate reason|0|||
27738454|NCT02499770|54187731|FG001|Overall Study|Withdrawn by PI for compassionate reason|1|||
27738455|NCT02499770|54187730|FG000|Overall Study|Randomized but not enrolled|0|||
27738456|NCT02499770|54187731|FG001|Overall Study|Randomized but not enrolled|1|||
27738457|NCT02442284|54187743|FG000|Overall Study|Adverse Event|1|||
27738458|NCT02442284|54187743|FG000|Overall Study|Withdrew Consent|2|||
27738459|NCT02442284|54187743|FG000|Overall Study|Lost to Follow-up|3|||
27738460|NCT02442284|54187743|FG000|Overall Study|Other|1|||
27738461|NCT02442206|54187753|FG000|Period 1|Adverse Event|1|||
27738462|NCT02442206|54187754|FG001|Period 1|Adverse Event|1|||
27738463|NCT02442206|54187753|FG000|Period 1|withdrew consent|0|||
27738464|NCT02442206|54187754|FG001|Period 1|withdrew consent|1|||
27738465|NCT02442206|54187753|FG000|Period 1|COPD exacerbation|0|||
27738466|NCT02442206|54187754|FG001|Period 1|COPD exacerbation|1|||
27738467|NCT02442206|54187753|FG000|Period 2|Adverse Event|1|||
27738468|NCT02442206|54187754|FG001|Period 2|Adverse Event|0|||
27738469|NCT02499146|54187761|FG000|Overall Study|Lost to Follow-up|1|||
27738470|NCT02499146|54187761|FG000|Overall Study|Withdrawal by Subject|1|||
28170871|NCT01334515|54842489|FG001|Overall Study|Lack of Efficacy|21|||
28170872|NCT01334515|54842488|FG000|Overall Study|Physician Decision|1|||
27738471|NCT02499146|54187761|FG000|Overall Study|Other|2|||
28170873|NCT01334515|54842489|FG001|Overall Study|Physician Decision|1|||
28170874|NCT01334515|54842488|FG000|Overall Study|Withdrawal by Subject|1|||
28170875|NCT01334515|54842489|FG001|Overall Study|Withdrawal by Subject|1|||
28170876|NCT02802319|54842497|FG000|Overall Study|Physician Decision|2|||
27738472|NCT02499146|54187761|FG000|Overall Study|Ongoing at date of cut-off|9|||
27738473|NCT02499146|54187761|FG000|Overall Study|Began other treatment/therapy|13|||
27738474|NCT03544138|54187765|FG000|Overall Study|Lost to Follow-up|29|||
27738475|NCT01634854|54187771|FG000|Overall Study|Cesarean delivery|2|||
27738476|NCT01634854|54187772|FG001|Overall Study|Cesarean delivery|7|||
27738477|NCT02469896|54187780|FG000|Overall Study|Withdrawal by Subject|2|||
27738478|NCT02469896|54187781|FG001|Overall Study|Withdrawal by Subject|0|||
28170877|NCT02802319|54842498|FG001|Overall Study|Physician Decision|1|||
27738479|NCT02441114|54187791|FG000|Washout2|Withdrawal by Subject|4|||
27738480|NCT02498678|54187797|FG000|Overall Study|interference from the surgical team|0|||
27738481|NCT02498678|54187798|FG001|Overall Study|interference from the surgical team|2|||
27738482|NCT02441036|54187809|FG000|Overall Study|No tissue resected|0|||
27738483|NCT02441036|54187810|FG001|Overall Study|No tissue resected|1|||
27738484|NCT02441036|54187811|FG002|Overall Study|No tissue resected|0|||
27738485|NCT02441036|54187812|FG003|Overall Study|No tissue resected|1|||
27738486|NCT02441036|54187813|FG004|Overall Study|No tissue resected|0|||
27738487|NCT02498444|54187828|FG000|Overall Study|Withdrawal by Subject|3|||
27738488|NCT02498444|54187829|FG001|Overall Study|Withdrawal by Subject|0|||
27738489|NCT02498444|54187828|FG000|Overall Study|Physician Decision|1|||
27738490|NCT02498444|54187829|FG001|Overall Study|Physician Decision|0|||
27738491|NCT02497976|54187837|FG000|Overall Study|Withdrawal by Subject|2|||
27738492|NCT02497976|54187838|FG001|Overall Study|Withdrawal by Subject|0|||
27738493|NCT02497976|54187837|FG000|Overall Study|Moved out of area|0|||
27738494|NCT02497976|54187838|FG001|Overall Study|Moved out of area|1|||
27738495|NCT03347188|54187846|FG000|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
28095425|NCT03353350|54749762|FG000|30-week Core Treatment Period|Protocol Violation|1|||
28095426|NCT03353350|54749763|FG001|30-week Core Treatment Period|Protocol Violation|1|||
28095427|NCT03353350|54749764|FG002|30-week Core Treatment Period|Protocol Violation|1|||
28095428|NCT03353350|54749765|FG003|30-week Core Treatment Period|Protocol Violation|0|||
28095429|NCT03353350|54749762|FG000|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
28095430|NCT03353350|54749763|FG001|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
28095431|NCT03353350|54749764|FG002|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
28095432|NCT03353350|54749765|FG003|30-week Core Treatment Period|Other: Not related to COVID-19|0|||
28095433|NCT03353350|54749762|FG000|30-week Core Treatment Period|Adverse Event|0|||
28095434|NCT03353350|54749763|FG001|30-week Core Treatment Period|Adverse Event|4|||
28095435|NCT03353350|54749764|FG002|30-week Core Treatment Period|Adverse Event|2|||
28095436|NCT03353350|54749765|FG003|30-week Core Treatment Period|Adverse Event|3|||
28095437|NCT03353350|54749762|FG000|30-week Core Treatment Period|Withdrawal by Subject|19|||
28170878|NCT02802319|54842497|FG000|Overall Study|Lost to Follow-up|0|||
28170879|NCT02802319|54842498|FG001|Overall Study|Lost to Follow-up|4|||
28170880|NCT02415400|54842508|FG000|Overall Study|Adverse Event|0|||
28170881|NCT02415400|54842509|FG001|Overall Study|Adverse Event|1|||
28170882|NCT02415400|54842510|FG002|Overall Study|Adverse Event|1|||
28170883|NCT02415400|54842511|FG003|Overall Study|Adverse Event|2|||
28170884|NCT02415400|54842508|FG000|Overall Study|Participant request to stop therapy|4|||
28170885|NCT02415400|54842509|FG001|Overall Study|Participant request to stop therapy|3|||
28170886|NCT02415400|54842510|FG002|Overall Study|Participant request to stop therapy|8|||
28170887|NCT02415400|54842511|FG003|Overall Study|Participant request to stop therapy|6|||
28170888|NCT02415400|54842508|FG000|Overall Study|Participant withdrew consent|14|||
28170889|NCT02415400|54842509|FG001|Overall Study|Participant withdrew consent|12|||
28170890|NCT02415400|54842510|FG002|Overall Study|Participant withdrew consent|30|||
28170891|NCT02415400|54842511|FG003|Overall Study|Participant withdrew consent|21|||
28170892|NCT02415400|54842508|FG000|Overall Study|Death|39|||
28170893|NCT02415400|54842509|FG001|Overall Study|Death|41|||
28170894|NCT02415400|54842510|FG002|Overall Study|Death|35|||
27738496|NCT03347188|54187847|FG001|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
27856529|NCT00635882|54388571|FG001|Overall Study|Protocol Violation|0|||
27856530|NCT00635882|54388572|FG002|Overall Study|Protocol Violation|0|||
27856531|NCT00635882|54388573|FG003|Overall Study|Protocol Violation|0|||
27856532|NCT00635882|54388574|FG004|Overall Study|Protocol Violation|0|||
27856533|NCT00635882|54388575|FG005|Overall Study|Protocol Violation|0|||
27856534|NCT00986570|54388826|FG000|Overall Study|Lost to Follow-up|6|||
27856535|NCT00986570|54388826|FG000|Overall Study|Potential bias for objective assessment|1|||
27856536|NCT00986258|54388830|FG000|Observation Period|Not eligible to be dosed|11|||
28095438|NCT03353350|54749763|FG001|30-week Core Treatment Period|Withdrawal by Subject|12|||
28095439|NCT03353350|54749764|FG002|30-week Core Treatment Period|Withdrawal by Subject|19|||
28095440|NCT03353350|54749765|FG003|30-week Core Treatment Period|Withdrawal by Subject|19|||
28095441|NCT03353350|54749762|FG000|26-week Treatment Extension Period|Protocol Violation|2|||
28095442|NCT03353350|54749763|FG001|26-week Treatment Extension Period|Protocol Violation|0|||
28095443|NCT03353350|54749764|FG002|26-week Treatment Extension Period|Protocol Violation|0|||
28095444|NCT03353350|54749765|FG003|26-week Treatment Extension Period|Protocol Violation|0|||
28095445|NCT03353350|54749762|FG000|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
28170895|NCT02415400|54842511|FG003|Overall Study|Death|42|||
28170896|NCT02415400|54842508|FG000|Overall Study|Lost to Follow-up|3|||
28170897|NCT02415400|54842509|FG001|Overall Study|Lost to Follow-up|3|||
28170898|NCT02415400|54842510|FG002|Overall Study|Lost to Follow-up|2|||
27738497|NCT03347188|54187846|FG000|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
27738498|NCT03347188|54187847|FG001|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|8|||
27738499|NCT03347188|54187846|FG000|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|7|||
27856537|NCT00986258|54388830|FG000|Titration and Optimal Dose Period|Adverse Event|15|||
28170899|NCT02415400|54842511|FG003|Overall Study|Lost to Follow-up|5|||
27738500|NCT03347188|54187847|FG001|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
27738501|NCT03347188|54187846|FG000|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
27738502|NCT03347188|54187847|FG001|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
27738503|NCT03347188|54187846|FG000|Double-blind (DB) Period (12 Weeks)|Other than specified|1|||
27738504|NCT03347188|54187847|FG001|Double-blind (DB) Period (12 Weeks)|Other than specified|2|||
27856538|NCT00986258|54388830|FG000|Titration and Optimal Dose Period|Lack of Efficacy|3|||
27856539|NCT00986258|54388830|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|3|||
27856540|NCT00986258|54388830|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
27856541|NCT00986258|54388830|FG000|Titration and Optimal Dose Period|Other|1|||
27856542|NCT00986258|54388830|FG000|Maintenance Period|Adverse Event|5|||
27856543|NCT00986258|54388830|FG000|Maintenance Period|Lack of Efficacy|2|||
27856544|NCT00986258|54388830|FG000|Maintenance Period|Withdrawal by Subject|2|||
27856545|NCT00986180|54388846|FG000|Overall Study|Adverse Event|21|||
27856546|NCT00986180|54388847|FG001|Overall Study|Adverse Event|23|||
27856547|NCT00986180|54388846|FG000|Overall Study|Lack of Efficacy|4|||
27856548|NCT00986180|54388847|FG001|Overall Study|Lack of Efficacy|3|||
27856549|NCT00986180|54388846|FG000|Overall Study|Lost to Follow-up|5|||
27856550|NCT00986180|54388847|FG001|Overall Study|Lost to Follow-up|7|||
27856551|NCT00986180|54388846|FG000|Overall Study|Physician Decision|1|||
27856552|NCT00986180|54388847|FG001|Overall Study|Physician Decision|3|||
27856553|NCT00986180|54388846|FG000|Overall Study|Protocol Violation|2|||
27856554|NCT00986180|54388847|FG001|Overall Study|Protocol Violation|0|||
27856555|NCT00986180|54388846|FG000|Overall Study|Withdrawal by Subject|1|||
27856556|NCT00986180|54388847|FG001|Overall Study|Withdrawal by Subject|9|||
27856557|NCT00986180|54388846|FG000|Overall Study|Miscellanies|10|||
27856558|NCT00986180|54388847|FG001|Overall Study|Miscellanies|11|||
27856559|NCT00986102|54389029|FG000|Overall Study|Lost to Follow-up|0|||
27856560|NCT00986102|54389030|FG001|Overall Study|Lost to Follow-up|1|||
27856561|NCT00986102|54389031|FG002|Overall Study|Lost to Follow-up|0|||
27856562|NCT00986102|54389032|FG003|Overall Study|Lost to Follow-up|1|||
27856563|NCT00986102|54389029|FG000|Overall Study|Withdrawal by Subject|1|||
27856564|NCT00986102|54389030|FG001|Overall Study|Withdrawal by Subject|1|||
27856565|NCT00986102|54389031|FG002|Overall Study|Withdrawal by Subject|0|||
27856566|NCT00986102|54389032|FG003|Overall Study|Withdrawal by Subject|0|||
27856567|NCT00985946|54389055|FG000|Overall Study|Lost to Follow-up|6|||
27856568|NCT00985946|54389055|FG000|Overall Study|Withdrawal by Subject|1|||
27856569|NCT00985790|54389070|FG000|Overall Study|Withdrawal by Subject|1|||
27856570|NCT00985790|54389071|FG001|Overall Study|Withdrawal by Subject|1|||
27856571|NCT00985790|54389070|FG000|Overall Study|Lost to Follow-up|6|||
27856572|NCT00985790|54389071|FG001|Overall Study|Lost to Follow-up|7|||
27856573|NCT00985712|54389098|FG000|Overall Study|Adverse Event|0|||
27856574|NCT00985712|54389099|FG001|Overall Study|Adverse Event|1|||
27856575|NCT00985712|54389098|FG000|Overall Study|Lost to Follow-up|2|||
27856576|NCT00985712|54389099|FG001|Overall Study|Lost to Follow-up|2|||
27856577|NCT00985712|54389098|FG000|Overall Study|Protocol Violation|0|||
27856578|NCT00985712|54389099|FG001|Overall Study|Protocol Violation|1|||
27856579|NCT00985712|54389098|FG000|Overall Study|Withdrawal by Subject|4|||
27856580|NCT00985712|54389099|FG001|Overall Study|Withdrawal by Subject|1|||
27856581|NCT00985712|54389098|FG000|Overall Study|Sponsor decision|0|||
27856582|NCT00985712|54389099|FG001|Overall Study|Sponsor decision|2|||
27856583|NCT00985166|54389206|FG000|Overall Study|Lost to Follow-up|3|||
27856584|NCT00985166|54389207|FG001|Overall Study|Lost to Follow-up|2|||
27856585|NCT00985166|54389208|FG002|Overall Study|Lost to Follow-up|2|||
27856586|NCT00985166|54389206|FG000|Overall Study|Withdrawal by Subject|3|||
27856587|NCT00985166|54389207|FG001|Overall Study|Withdrawal by Subject|2|||
27856588|NCT00985166|54389208|FG002|Overall Study|Withdrawal by Subject|0|||
27856589|NCT00985166|54389206|FG000|Overall Study|Test not done|2|||
27856590|NCT00985166|54389207|FG001|Overall Study|Test not done|0|||
27856591|NCT00985166|54389208|FG002|Overall Study|Test not done|4|||
27856592|NCT00985166|54389206|FG000|Overall Study|Other|1|||
27738505|NCT03347188|54187846|FG000|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|26|||
27856593|NCT00985166|54389207|FG001|Overall Study|Other|0|||
27856594|NCT00985166|54389208|FG002|Overall Study|Other|1|||
27856595|NCT02184195|54389370|FG000|Overall Study|Patients ongoing Study Treatment|19|||
27738506|NCT03347188|54187847|FG001|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|28|||
27856596|NCT02184195|54389371|FG001|Overall Study|Patients ongoing Study Treatment|7|||
27856597|NCT01341405|54389463|FG000|Overall Study|Adverse Event|0|||
27856598|NCT01341405|54389464|FG001|Overall Study|Adverse Event|1|||
27856599|NCT01341405|54389465|FG002|Overall Study|Adverse Event|1|||
27856600|NCT01341405|54389463|FG000|Overall Study|Withdrawal by Subject|3|||
27856601|NCT01341405|54389464|FG001|Overall Study|Withdrawal by Subject|2|||
27856602|NCT01341405|54389465|FG002|Overall Study|Withdrawal by Subject|1|||
27856603|NCT00633945|54390738|FG000|Overall Study|Physician Decision|2|||
27856604|NCT02574078|54391002|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
27856605|NCT02574078|54391003|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
27856606|NCT02574078|54391004|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
27738507|NCT03347188|54187846|FG000|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|1|||
27738508|NCT03347188|54187847|FG001|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|0|||
27738509|NCT03347188|54187846|FG000|Open-label (OL) Period (12 Weeks)|Other than specified|0|||
27738510|NCT03347188|54187847|FG001|Open-label (OL) Period (12 Weeks)|Other than specified|1|||
27738511|NCT02440568|54187857|FG000|Overall Study|Death|1|||
27738512|NCT02440568|54187858|FG001|Overall Study|Death|3|||
27738513|NCT02440568|54187859|FG002|Overall Study|Death|4|||
27738514|NCT02440568|54187860|FG003|Overall Study|Death|2|||
27738515|NCT02440568|54187857|FG000|Overall Study|Lack of Efficacy|2|||
27738516|NCT02440568|54187858|FG001|Overall Study|Lack of Efficacy|0|||
27738517|NCT02440568|54187859|FG002|Overall Study|Lack of Efficacy|1|||
27738518|NCT02440568|54187860|FG003|Overall Study|Lack of Efficacy|0|||
27738519|NCT02440568|54187857|FG000|Overall Study|Lost to Follow-up|1|||
27738520|NCT02440568|54187858|FG001|Overall Study|Lost to Follow-up|0|||
27856607|NCT02574078|54391005|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
27856608|NCT02574078|54391006|FG004|Pre-Treatment Period|Participant no longer meets study criteria|0|||
28170900|NCT02415400|54842508|FG000|Overall Study|Poor/Non-Compliance|0|||
28170901|NCT02415400|54842509|FG001|Overall Study|Poor/Non-Compliance|1|||
28170902|NCT02415400|54842510|FG002|Overall Study|Poor/Non-Compliance|3|||
28170903|NCT02415400|54842511|FG003|Overall Study|Poor/Non-Compliance|4|||
28170904|NCT02415400|54842508|FG000|Overall Study|Participant no longer meets criteria|2|||
28170905|NCT02415400|54842509|FG001|Overall Study|Participant no longer meets criteria|0|||
28170906|NCT02415400|54842510|FG002|Overall Study|Participant no longer meets criteria|0|||
27738521|NCT02440568|54187859|FG002|Overall Study|Lost to Follow-up|0|||
27738522|NCT02440568|54187860|FG003|Overall Study|Lost to Follow-up|0|||
27738523|NCT03090191|54187873|FG000|Overall Study|Adverse Event|90|||
27738524|NCT03090191|54187874|FG001|Overall Study|Adverse Event|72|||
27738525|NCT03090191|54187873|FG000|Overall Study|Death|365|||
27738526|NCT03090191|54187874|FG001|Overall Study|Death|358|||
27738527|NCT03090191|54187873|FG000|Overall Study|Lost to Follow-up|382|||
27738528|NCT03090191|54187874|FG001|Overall Study|Lost to Follow-up|394|||
27738529|NCT03090191|54187873|FG000|Overall Study|Physician Decision|77|||
27738530|NCT03090191|54187874|FG001|Overall Study|Physician Decision|66|||
27738531|NCT03090191|54187873|FG000|Overall Study|Protocol Violation|43|||
27738532|NCT03090191|54187874|FG001|Overall Study|Protocol Violation|52|||
27738533|NCT03090191|54187873|FG000|Overall Study|Withdrawal by Subject|2160|||
27738534|NCT03090191|54187874|FG001|Overall Study|Withdrawal by Subject|2133|||
27738535|NCT03090191|54187873|FG000|Overall Study|Site terminated|7|||
27738536|NCT03090191|54187874|FG001|Overall Study|Site terminated|8|||
27738537|NCT03090191|54187873|FG000|Overall Study|Other|66|||
27738538|NCT03090191|54187874|FG001|Overall Study|Other|60|||
27738539|NCT03090191|54187873|FG000|Overall Study|Withdrawn before any study vaccination|43|||
27738540|NCT03090191|54187874|FG001|Overall Study|Withdrawn before any study vaccination|52|||
27738541|NCT02439320|54187896|FG000|Overall Study|Adverse Event|0|||
27738542|NCT02439320|54187897|FG001|Overall Study|Adverse Event|2|||
27738543|NCT02439320|54187898|FG002|Overall Study|Adverse Event|0|||
27738544|NCT02439320|54187896|FG000|Overall Study|Lost to Follow-up|37|||
27738545|NCT02439320|54187897|FG001|Overall Study|Lost to Follow-up|34|||
27738546|NCT02439320|54187898|FG002|Overall Study|Lost to Follow-up|42|||
27738547|NCT02439320|54187896|FG000|Overall Study|Death|0|||
27738548|NCT02439320|54187897|FG001|Overall Study|Death|1|||
27738549|NCT02439320|54187898|FG002|Overall Study|Death|0|||
27738550|NCT02439320|54187896|FG000|Overall Study|Noncompliance with Protocol|10|||
27738551|NCT02439320|54187897|FG001|Overall Study|Noncompliance with Protocol|11|||
27833769|NCT03110770|54316878|FG003|Overall Study|Illness/Injury unrelated to product|0|||
27833770|NCT03110770|54316879|FG004|Overall Study|Illness/Injury unrelated to product|1|||
27833771|NCT00703326|54317085|FG000|Overall Study|Lost to Follow-up|47|||
28170907|NCT02415400|54842511|FG003|Overall Study|Participant no longer meets criteria|1|||
27738552|NCT02439320|54187898|FG002|Overall Study|Noncompliance with Protocol|7|||
27738553|NCT02439320|54187896|FG000|Overall Study|Pregnancy|0|||
27833772|NCT00703326|54317086|FG001|Overall Study|Lost to Follow-up|18|||
27833773|NCT00703326|54317085|FG000|Overall Study|Withdrawal by Subject|54|||
27833774|NCT00703326|54317086|FG001|Overall Study|Withdrawal by Subject|20|||
27833775|NCT00703326|54317085|FG000|Overall Study|Adverse Event|1|||
27833776|NCT00703326|54317086|FG001|Overall Study|Adverse Event|0|||
27833777|NCT04868500|54317139|FG000|Overall Study|Participants and Clinical Site Staff terminated early|3|||
27833778|NCT04868500|54317140|FG001|Overall Study|Participants and Clinical Site Staff terminated early|1|||
27833779|NCT04868500|54317139|FG000|Overall Study|Participants and Clinical Site Staff never opened App|1|||
28170908|NCT02415400|54842508|FG000|Overall Study|Participant doesn't answer phone|1|||
27738554|NCT02439320|54187897|FG001|Overall Study|Pregnancy|1|||
27738555|NCT02439320|54187898|FG002|Overall Study|Pregnancy|1|||
27738556|NCT02439320|54187896|FG000|Overall Study|Withdrawal by Subject|12|||
27738557|NCT02439320|54187897|FG001|Overall Study|Withdrawal by Subject|16|||
27738558|NCT02439320|54187898|FG002|Overall Study|Withdrawal by Subject|14|||
27738559|NCT02439320|54187896|FG000|Overall Study|Physician Decision|2|||
27738560|NCT02439320|54187897|FG001|Overall Study|Physician Decision|1|||
27738561|NCT02439320|54187898|FG002|Overall Study|Physician Decision|0|||
28170909|NCT02415400|54842509|FG001|Overall Study|Participant doesn't answer phone|0|||
28170910|NCT02415400|54842510|FG002|Overall Study|Participant doesn't answer phone|0|||
28170911|NCT02415400|54842511|FG003|Overall Study|Participant doesn't answer phone|0|||
28170912|NCT02415400|54842508|FG000|Overall Study|Participant wanted home visits|1|||
28170913|NCT02415400|54842509|FG001|Overall Study|Participant wanted home visits|0|||
28170914|NCT02415400|54842510|FG002|Overall Study|Participant wanted home visits|0|||
28170915|NCT02415400|54842511|FG003|Overall Study|Participant wanted home visits|0|||
28170916|NCT02415400|54842508|FG000|Overall Study|Randomized in error|2|||
27738562|NCT02439320|54187896|FG000|Overall Study|Sponsor Request|0|||
27856609|NCT02574078|54391007|FG005|Pre-Treatment Period|Participant no longer meets study criteria|1|||
27856610|NCT02574078|54391008|FG006|Pre-Treatment Period|Participant no longer meets study criteria|2|||
27856611|NCT02574078|54391009|FG007|Pre-Treatment Period|Participant no longer meets study criteria|0|||
27856612|NCT02574078|54391010|FG008|Pre-Treatment Period|Participant no longer meets study criteria|1|||
27856613|NCT02574078|54391011|FG009|Pre-Treatment Period|Participant no longer meets study criteria|0|||
27856614|NCT02574078|54391012|FG010|Pre-Treatment Period|Participant no longer meets study criteria|0|||
27856615|NCT02574078|54391013|FG011|Pre-Treatment Period|Participant no longer meets study criteria|0|||
27856616|NCT02574078|54391014|FG012|Pre-Treatment Period|Participant no longer meets study criteria|0|||
27856617|NCT02574078|54391002|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
27856618|NCT02574078|54391003|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
27856619|NCT02574078|54391004|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
27856620|NCT02574078|54391005|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
27856621|NCT02574078|54391006|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
27856622|NCT02574078|54391007|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
27856623|NCT02574078|54391008|FG006|Pre-Treatment Period|Participant withdrew consent|0|||
27856624|NCT02574078|54391009|FG007|Pre-Treatment Period|Participant withdrew consent|3|||
27856625|NCT02574078|54391010|FG008|Pre-Treatment Period|Participant withdrew consent|0|||
27856626|NCT02574078|54391011|FG009|Pre-Treatment Period|Participant withdrew consent|0|||
27856627|NCT02574078|54391012|FG010|Pre-Treatment Period|Participant withdrew consent|2|||
27856628|NCT02574078|54391013|FG011|Pre-Treatment Period|Participant withdrew consent|0|||
27856629|NCT02574078|54391014|FG012|Pre-Treatment Period|Participant withdrew consent|0|||
27856630|NCT02574078|54391002|FG000|Pre-Treatment Period|Other reasons|0|||
27856631|NCT02574078|54391003|FG001|Pre-Treatment Period|Other reasons|0|||
27856632|NCT02574078|54391004|FG002|Pre-Treatment Period|Other reasons|0|||
27856633|NCT02574078|54391005|FG003|Pre-Treatment Period|Other reasons|0|||
27856634|NCT02574078|54391006|FG004|Pre-Treatment Period|Other reasons|0|||
27856635|NCT02574078|54391007|FG005|Pre-Treatment Period|Other reasons|0|||
27856636|NCT02574078|54391008|FG006|Pre-Treatment Period|Other reasons|2|||
27856637|NCT02574078|54391009|FG007|Pre-Treatment Period|Other reasons|0|||
27856638|NCT02574078|54391010|FG008|Pre-Treatment Period|Other reasons|0|||
27856639|NCT02574078|54391011|FG009|Pre-Treatment Period|Other reasons|0|||
27856640|NCT02574078|54391012|FG010|Pre-Treatment Period|Other reasons|2|||
27856641|NCT02574078|54391013|FG011|Pre-Treatment Period|Other reasons|0|||
27856642|NCT02574078|54391014|FG012|Pre-Treatment Period|Other reasons|0|||
27856643|NCT02574078|54391002|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
27856644|NCT02574078|54391003|FG001|Pre-Treatment Period|Poor/non-compliance|0|||
27856645|NCT02574078|54391004|FG002|Pre-Treatment Period|Poor/non-compliance|0|||
27856646|NCT02574078|54391005|FG003|Pre-Treatment Period|Poor/non-compliance|0|||
27856647|NCT02574078|54391006|FG004|Pre-Treatment Period|Poor/non-compliance|0|||
27856648|NCT02574078|54391007|FG005|Pre-Treatment Period|Poor/non-compliance|0|||
27856649|NCT02574078|54391008|FG006|Pre-Treatment Period|Poor/non-compliance|0|||
27856650|NCT02574078|54391009|FG007|Pre-Treatment Period|Poor/non-compliance|0|||
27856651|NCT02574078|54391010|FG008|Pre-Treatment Period|Poor/non-compliance|0|||
27856652|NCT02574078|54391011|FG009|Pre-Treatment Period|Poor/non-compliance|0|||
27856653|NCT02574078|54391012|FG010|Pre-Treatment Period|Poor/non-compliance|0|||
28170917|NCT02415400|54842509|FG001|Overall Study|Randomized in error|0|||
28170918|NCT02415400|54842510|FG002|Overall Study|Randomized in error|0|||
28170919|NCT02415400|54842511|FG003|Overall Study|Randomized in error|0|||
28170920|NCT02415400|54842508|FG000|Overall Study|No study drug on site|0|||
28170921|NCT02415400|54842509|FG001|Overall Study|No study drug on site|1|||
28170922|NCT02415400|54842510|FG002|Overall Study|No study drug on site|0|||
28170923|NCT02415400|54842511|FG003|Overall Study|No study drug on site|0|||
28170924|NCT02415400|54842508|FG000|Overall Study|Stroke and stroke rehabilitation|0|||
28170925|NCT02415400|54842509|FG001|Overall Study|Stroke and stroke rehabilitation|0|||
28170926|NCT02415400|54842510|FG002|Overall Study|Stroke and stroke rehabilitation|1|||
28170927|NCT02415400|54842511|FG003|Overall Study|Stroke and stroke rehabilitation|0|||
28170928|NCT02415400|54842508|FG000|Overall Study|Coagulation values cannot be set|0|||
27738563|NCT02439320|54187897|FG001|Overall Study|Sponsor Request|2|||
28170929|NCT02415400|54842509|FG001|Overall Study|Coagulation values cannot be set|0|||
28170930|NCT02415400|54842510|FG002|Overall Study|Coagulation values cannot be set|1|||
27856654|NCT02574078|54391013|FG011|Pre-Treatment Period|Poor/non-compliance|1|||
27981011|NCT00887822|54638970|FG000|Overall Study|Adverse Event|14|||
28170931|NCT02415400|54842511|FG003|Overall Study|Coagulation values cannot be set|0|||
27738564|NCT02439320|54187898|FG002|Overall Study|Sponsor Request|1|||
27738565|NCT02439320|54187896|FG000|Overall Study|Randomization Failure|35|||
27738566|NCT02439320|54187897|FG001|Overall Study|Randomization Failure|46|||
27738567|NCT02439320|54187898|FG002|Overall Study|Randomization Failure|34|||
27738568|NCT02469038|54187914|FG000|Overall Study|Physician Decision|4|||
27738569|NCT02469038|54187915|FG001|Overall Study|Physician Decision|5|||
27738570|NCT02468648|54187921|FG000|Overall Study|Death|1|||
27738571|NCT02468414|54187927|FG000|Overall Study|Early Study Termination by Sponsor|1|||
27738572|NCT02468414|54187928|FG001|Overall Study|Early Study Termination by Sponsor|0|||
27738573|NCT02468414|54187927|FG000|Overall Study|Poor in-vitro secreting TARGTs|1|||
27738574|NCT02468414|54187928|FG001|Overall Study|Poor in-vitro secreting TARGTs|0|||
27738575|NCT02468414|54187927|FG000|Overall Study|Screen Failure|1|||
27738576|NCT02468414|54187928|FG001|Overall Study|Screen Failure|0|||
27738577|NCT02466386|54187934|FG000|Overall Study|Adverse Event|5|||
27738578|NCT02466386|54187934|FG000|Overall Study|Protocol Violation|2|||
27738579|NCT02466386|54187934|FG000|Overall Study|Withdrawal by Subject|14|||
27738580|NCT02466386|54187934|FG000|Overall Study|Lost to Follow-up|5|||
27738581|NCT02466386|54187934|FG000|Overall Study|Lack of Efficacy|8|||
27738582|NCT02466386|54187934|FG000|Overall Study|Other|10|||
27738583|NCT01633060|54187940|FG000|Randomization Phase|Protocol deviation|1|||
27738584|NCT01633060|54187941|FG001|Randomization Phase|Protocol deviation|2|||
27738585|NCT01633060|54187940|FG000|Randomization Phase|Technical problem|0|||
27738586|NCT01633060|54187941|FG001|Randomization Phase|Technical problem|1|||
27738587|NCT01633060|54187940|FG000|Treatment Phase|Adverse Event|24|||
28170932|NCT02415400|54842508|FG000|Overall Study|State regulations prevent participation|0|||
28170933|NCT02415400|54842509|FG001|Overall Study|State regulations prevent participation|0|||
27738588|NCT01633060|54187941|FG001|Treatment Phase|Adverse Event|3|||
27738589|NCT01633060|54187940|FG000|Treatment Phase|Lost to Follow-up|1|||
27738590|NCT01633060|54187941|FG001|Treatment Phase|Lost to Follow-up|0|||
27738591|NCT01633060|54187940|FG000|Treatment Phase|Physician Decision|16|||
27738592|NCT01633060|54187941|FG001|Treatment Phase|Physician Decision|7|||
27738593|NCT01633060|54187940|FG000|Treatment Phase|Progressive Disease|210|||
27738594|NCT01633060|54187941|FG001|Treatment Phase|Progressive Disease|120|||
27738595|NCT01633060|54187940|FG000|Treatment Phase|Protocol Deviation|1|||
27738596|NCT01633060|54187941|FG001|Treatment Phase|Protocol Deviation|0|||
27738597|NCT01633060|54187940|FG000|Treatment Phase|Study Terminated by sponsor|7|||
27738598|NCT01633060|54187941|FG001|Treatment Phase|Study Terminated by sponsor|3|||
27738599|NCT01633060|54187940|FG000|Treatment Phase|Subject/guardian decision|25|||
27738600|NCT01633060|54187941|FG001|Treatment Phase|Subject/guardian decision|4|||
27738601|NCT01633060|54187940|FG000|Treatment Phase|Death|4|||
27738602|NCT01633060|54187941|FG001|Treatment Phase|Death|3|||
27738603|NCT01633060|54187940|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
27738604|NCT01633060|54187941|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
27738605|NCT01633060|54187940|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1|||
27738606|NCT01633060|54187941|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0|||
27738607|NCT01633060|54187940|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10|||
27738608|NCT01633060|54187941|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1|||
28170934|NCT02415400|54842510|FG002|Overall Study|State regulations prevent participation|1|||
28170935|NCT02415400|54842511|FG003|Overall Study|State regulations prevent participation|0|||
27738609|NCT01633060|54187940|FG000|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1|||
27738610|NCT01633060|54187941|FG001|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0|||
27738611|NCT01633060|54187940|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
28170936|NCT02415400|54842508|FG000|Overall Study|Poor treatment monitoring|0|||
28170937|NCT02415400|54842509|FG001|Overall Study|Poor treatment monitoring|0|||
28170938|NCT02415400|54842510|FG002|Overall Study|Poor treatment monitoring|1|||
27738612|NCT01633060|54187941|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
27738613|NCT01633060|54187940|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|1|||
27738614|NCT01633060|54187941|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|0|||
27833780|NCT04868500|54317140|FG001|Overall Study|Participants and Clinical Site Staff never opened App|0|||
28170939|NCT02415400|54842511|FG003|Overall Study|Poor treatment monitoring|0|||
28170940|NCT02415400|54842508|FG000|Overall Study|Participant in jail|0|||
28170941|NCT02415400|54842509|FG001|Overall Study|Participant in jail|0|||
27738615|NCT01632904|54187950|FG000|Overall Study|Adverse Event|4|||
27738616|NCT01632904|54187951|FG001|Overall Study|Adverse Event|1|||
27738617|NCT01632904|54187950|FG000|Overall Study|Physician Decision|0|||
27738618|NCT01632904|54187951|FG001|Overall Study|Physician Decision|1|||
27738619|NCT01632904|54187950|FG000|Overall Study|Subject decision|3|||
27738620|NCT01632904|54187951|FG001|Overall Study|Subject decision|2|||
27738621|NCT01632904|54187950|FG000|Overall Study|Disease Progression|0|||
28170942|NCT02415400|54842510|FG002|Overall Study|Participant in jail|1|||
27738622|NCT01632904|54187951|FG001|Overall Study|Disease Progression|1|||
27738623|NCT01632904|54187950|FG000|Overall Study|Reason for discontinuation not available|0|||
27738624|NCT01632904|54187951|FG001|Overall Study|Reason for discontinuation not available|1|||
27833781|NCT04372186|54317148|FG000|Overall Study|Death|24|||
28170943|NCT02415400|54842511|FG003|Overall Study|Participant in jail|0|||
28170944|NCT02415400|54842508|FG000|Overall Study|Investigator decision|0|||
28170945|NCT02415400|54842509|FG001|Overall Study|Investigator decision|0|||
28170946|NCT02415400|54842510|FG002|Overall Study|Investigator decision|1|||
27738625|NCT03834779|54187959|FG000|Overall Study|Death|1|||
27738626|NCT03834779|54187960|FG001|Overall Study|Death|2|||
27738627|NCT03834779|54187959|FG000|Overall Study|Lost to Follow-up|6|||
27738628|NCT03834779|54187960|FG001|Overall Study|Lost to Follow-up|4|||
27856655|NCT02574078|54391014|FG012|Pre-Treatment Period|Poor/non-compliance|0|||
27856656|NCT02574078|54391002|FG000|Treatment Period|Disease progression|6|||
27856657|NCT02574078|54391003|FG001|Treatment Period|Disease progression|4|||
27856658|NCT02574078|54391004|FG002|Treatment Period|Disease progression|7|||
27856659|NCT02574078|54391005|FG003|Treatment Period|Disease progression|18|||
27856660|NCT02574078|54391006|FG004|Treatment Period|Disease progression|16|||
27856661|NCT02574078|54391007|FG005|Treatment Period|Disease progression|26|||
27856662|NCT02574078|54391008|FG006|Treatment Period|Disease progression|5|||
27856663|NCT02574078|54391009|FG007|Treatment Period|Disease progression|9|||
27856664|NCT02574078|54391010|FG008|Treatment Period|Disease progression|8|||
27856665|NCT02574078|54391011|FG009|Treatment Period|Disease progression|5|||
27856666|NCT02574078|54391012|FG010|Treatment Period|Disease progression|20|||
27856667|NCT02574078|54391013|FG011|Treatment Period|Disease progression|29|||
27856668|NCT02574078|54391014|FG012|Treatment Period|Disease progression|2|||
27856669|NCT02574078|54391002|FG000|Treatment Period|Study drug toxicity|1|||
27856670|NCT02574078|54391003|FG001|Treatment Period|Study drug toxicity|1|||
27856671|NCT02574078|54391004|FG002|Treatment Period|Study drug toxicity|0|||
27856672|NCT02574078|54391005|FG003|Treatment Period|Study drug toxicity|5|||
27856673|NCT02574078|54391006|FG004|Treatment Period|Study drug toxicity|3|||
27856674|NCT02574078|54391007|FG005|Treatment Period|Study drug toxicity|1|||
27856675|NCT02574078|54391008|FG006|Treatment Period|Study drug toxicity|2|||
27856676|NCT02574078|54391009|FG007|Treatment Period|Study drug toxicity|0|||
27856677|NCT02574078|54391010|FG008|Treatment Period|Study drug toxicity|2|||
27856678|NCT02574078|54391011|FG009|Treatment Period|Study drug toxicity|1|||
27856679|NCT02574078|54391012|FG010|Treatment Period|Study drug toxicity|16|||
27856680|NCT02574078|54391013|FG011|Treatment Period|Study drug toxicity|2|||
27856681|NCT02574078|54391014|FG012|Treatment Period|Study drug toxicity|4|||
27856682|NCT02574078|54391002|FG000|Treatment Period|Death|2|||
28095446|NCT03353350|54749763|FG001|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
28095447|NCT03353350|54749764|FG002|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
28095448|NCT03353350|54749765|FG003|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
28095449|NCT03353350|54749762|FG000|26-week Treatment Extension Period|Adverse Event|1|||
28095450|NCT03353350|54749763|FG001|26-week Treatment Extension Period|Adverse Event|0|||
28095451|NCT03353350|54749764|FG002|26-week Treatment Extension Period|Adverse Event|0|||
28095452|NCT03353350|54749765|FG003|26-week Treatment Extension Period|Adverse Event|1|||
28095453|NCT03353350|54749762|FG000|26-week Treatment Extension Period|Withdrawal by Subject|2|||
28095454|NCT03353350|54749763|FG001|26-week Treatment Extension Period|Withdrawal by Subject|3|||
28095455|NCT03353350|54749764|FG002|26-week Treatment Extension Period|Withdrawal by Subject|3|||
27738629|NCT03726437|54187969|FG000|Overall Study|Lost to Follow-up|85|||
27738630|NCT03726437|54187970|FG001|Overall Study|Lost to Follow-up|76|||
27738631|NCT02465528|54187980|FG000|Overall Study|Progressive disease|0|||
27833782|NCT04372186|54317149|FG001|Overall Study|Death|11|||
27833783|NCT04372186|54317148|FG000|Overall Study|Transferred to a different facility for care|0|||
27833784|NCT04372186|54317149|FG001|Overall Study|Transferred to a different facility for care|2|||
27833785|NCT04317040|54317179|FG000|Overall Study|Lost to Follow-up|2|||
27833786|NCT04317040|54317180|FG001|Overall Study|Lost to Follow-up|0|||
27833787|NCT04317040|54317179|FG000|Overall Study|Death|16|||
27833788|NCT04317040|54317180|FG001|Overall Study|Death|18|||
27833789|NCT04317040|54317179|FG000|Overall Study|Withdrawal by Subject|0|||
27833790|NCT04317040|54317180|FG001|Overall Study|Withdrawal by Subject|1|||
27833791|NCT04317040|54317179|FG000|Overall Study|Incomplete assessments|0|||
27833792|NCT04317040|54317180|FG001|Overall Study|Incomplete assessments|1|||
27833793|NCT00703014|54317260|FG000|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33|||
27833794|NCT00703014|54317261|FG001|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32|||
27833795|NCT00703014|54317262|FG002|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
27833796|NCT00703014|54317263|FG003|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
27856683|NCT02574078|54391003|FG001|Treatment Period|Death|0|||
28170947|NCT02415400|54842511|FG003|Overall Study|Investigator decision|1|||
28170948|NCT02415400|54842508|FG000|Overall Study|Site closure; participant won't transfer|0|||
27738632|NCT02465528|54187981|FG001|Overall Study|Progressive disease|2|||
27856684|NCT02574078|54391004|FG002|Treatment Period|Death|0|||
27856685|NCT02574078|54391005|FG003|Treatment Period|Death|0|||
27856686|NCT02574078|54391006|FG004|Treatment Period|Death|1|||
27856687|NCT02574078|54391007|FG005|Treatment Period|Death|1|||
28095456|NCT03353350|54749765|FG003|26-week Treatment Extension Period|Withdrawal by Subject|12|||
27738633|NCT02465528|54187982|FG002|Overall Study|Progressive disease|9|||
28095457|NCT03032068|54749779|FG000|Overall Study|Adverse Event|1|||
28095458|NCT02674516|54749799|FG000|Overall Study|Lost to Follow-up|3|||
28095459|NCT02674516|54749800|FG001|Overall Study|Lost to Follow-up|0|||
28095460|NCT02674516|54749799|FG000|Overall Study|Protocol Violation|0|||
28095461|NCT02674516|54749800|FG001|Overall Study|Protocol Violation|4|||
28095462|NCT02674516|54749799|FG000|Overall Study|Knowledge of study hypothesis|1|||
28095463|NCT02674516|54749800|FG001|Overall Study|Knowledge of study hypothesis|0|||
28095464|NCT02463448|54749806|FG000|Enrollment Through 6 Months|Withdrawal by Subject|3|||
28095465|NCT02463448|54749806|FG000|6 Months Through 12 Months|Lost to Follow-up|1|||
27738634|NCT02465528|54187983|FG003|Overall Study|Progressive disease|4|||
27738635|NCT02465528|54187980|FG000|Overall Study|Study terminated by sponsor|1|||
27738636|NCT02465528|54187981|FG001|Overall Study|Study terminated by sponsor|2|||
27738637|NCT02465528|54187982|FG002|Overall Study|Study terminated by sponsor|0|||
27738638|NCT02465528|54187983|FG003|Overall Study|Study terminated by sponsor|0|||
27738639|NCT02465528|54187980|FG000|Overall Study|Withdrawal by Subject|0|||
27738640|NCT02465528|54187981|FG001|Overall Study|Withdrawal by Subject|0|||
27738641|NCT02465528|54187982|FG002|Overall Study|Withdrawal by Subject|2|||
27738642|NCT02465528|54187983|FG003|Overall Study|Withdrawal by Subject|0|||
27738643|NCT02465528|54187980|FG000|Overall Study|Adverse Event|0|||
27738644|NCT02465528|54187981|FG001|Overall Study|Adverse Event|0|||
27738645|NCT02465528|54187982|FG002|Overall Study|Adverse Event|0|||
27738646|NCT02465528|54187983|FG003|Overall Study|Adverse Event|1|||
27738647|NCT02465528|54187980|FG000|Overall Study|Physician Decision|0|||
27738648|NCT02465528|54187981|FG001|Overall Study|Physician Decision|0|||
27738649|NCT02465528|54187982|FG002|Overall Study|Physician Decision|1|||
27738650|NCT02465528|54187983|FG003|Overall Study|Physician Decision|0|||
27738651|NCT02438384|54187998|FG000|Overall Study|Lost to Follow-up|8|||
27738652|NCT02438384|54187999|FG001|Overall Study|Lost to Follow-up|6|||
27738653|NCT02438384|54188000|FG002|Overall Study|Lost to Follow-up|4|||
27738654|NCT02463032|54188010|FG000|Overall Study|Lack of Efficacy|61|||
27738655|NCT02463032|54188011|FG001|Overall Study|Lack of Efficacy|50|||
27738656|NCT02463032|54188010|FG000|Overall Study|Death|8|||
27738657|NCT02463032|54188011|FG001|Overall Study|Death|8|||
27738658|NCT02463032|54188010|FG000|Overall Study|Adverse Event|2|||
27738659|NCT02463032|54188011|FG001|Overall Study|Adverse Event|6|||
27738660|NCT02496884|54188021|FG000|Overall Study|Counted twice as enrolled|2|||
27738661|NCT02496884|54188022|FG001|Overall Study|Counted twice as enrolled|0|||
27738662|NCT02496884|54188023|FG002|Overall Study|Counted twice as enrolled|0|||
27738663|NCT02496884|54188024|FG003|Overall Study|Counted twice as enrolled|0|||
27738664|NCT02496884|54188021|FG000|Overall Study|Withdrawal by Subject|0|||
27738665|NCT02496884|54188022|FG001|Overall Study|Withdrawal by Subject|3|||
27738666|NCT02496884|54188023|FG002|Overall Study|Withdrawal by Subject|0|||
28095466|NCT02463448|54749806|FG000|6 Months Through 12 Months|Withdrawal by Subject|1|||
28095467|NCT02463448|54749806|FG000|12 Months Through End of Study|Lost to Follow-up|1|||
28095468|NCT03794544|54749814|FG000|Overall Study|Withdrawal by Subject|1|||
28095469|NCT03794544|54749815|FG001|Overall Study|Withdrawal by Subject|1|||
28170949|NCT02415400|54842509|FG001|Overall Study|Site closure; participant won't transfer|0|||
28170950|NCT02415400|54842510|FG002|Overall Study|Site closure; participant won't transfer|0|||
28170951|NCT02415400|54842511|FG003|Overall Study|Site closure; participant won't transfer|1|||
28170952|NCT04194801|54842528|FG000|Part Ib/II End Of Treatment-BLU554|Adverse Event|0|||
28170953|NCT04194801|54842529|FG001|Part Ib/II End Of Treatment-BLU554|Adverse Event|2|||
28170954|NCT04194801|54842530|FG002|Part Ib/II End Of Treatment-BLU554|Adverse Event|1|||
28170955|NCT04194801|54842528|FG000|Part Ib/II End Of Treatment-BLU554|Death|0|||
28170956|NCT04194801|54842529|FG001|Part Ib/II End Of Treatment-BLU554|Death|0|||
28170957|NCT04194801|54842530|FG002|Part Ib/II End Of Treatment-BLU554|Death|1|||
28095470|NCT03794544|54749816|FG002|Overall Study|Withdrawal by Subject|0|||
28095471|NCT03794544|54749817|FG003|Overall Study|Withdrawal by Subject|0|||
28095472|NCT03794544|54749814|FG000|Overall Study|Death|0|||
28095473|NCT03794544|54749815|FG001|Overall Study|Death|0|||
28095474|NCT03794544|54749816|FG002|Overall Study|Death|0|||
28095475|NCT03794544|54749817|FG003|Overall Study|Death|1|||
28095476|NCT03794544|54749814|FG000|Overall Study|Lost to Follow-up|0|||
28170958|NCT04194801|54842528|FG000|Part Ib/II End Of Treatment-BLU554|Physician Decision|1|||
28170959|NCT04194801|54842529|FG001|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
27738667|NCT02496884|54188024|FG003|Overall Study|Withdrawal by Subject|0|||
27738668|NCT02462876|54188034|FG000|Overall Study|Death|3|||
27738669|NCT02462876|54188034|FG000|Overall Study|Lost to Follow-up|7|||
27738670|NCT02462876|54188034|FG000|Overall Study|Surgical Bypass|9|||
27738671|NCT02462876|54188034|FG000|Overall Study|Amputation Above the Metatarsals|1|||
28095477|NCT03794544|54749815|FG001|Overall Study|Lost to Follow-up|1|||
28095478|NCT03794544|54749816|FG002|Overall Study|Lost to Follow-up|1|||
28095479|NCT03794544|54749817|FG003|Overall Study|Lost to Follow-up|0|||
27738672|NCT02462876|54188034|FG000|Overall Study|36 months follow-up visit missed|1|||
27738673|NCT02462876|54188034|FG000|Overall Study|Patient did not come back since 4 months follow-up|1|||
27738674|NCT02462876|54188034|FG000|Overall Study|Patient did not come back to the vascular department|1|||
27856688|NCT02574078|54391008|FG006|Treatment Period|Death|1|||
27738675|NCT02462876|54188034|FG000|Overall Study|Patient contacted by phone but never came back for his follow-up visits|1|||
27738676|NCT02462876|54188034|FG000|Overall Study|Patient refused to come back|1|||
27738677|NCT02462876|54188034|FG000|Overall Study|Patient was contacted on Sep 2020. He is fine but refused to come back for his 36 months|1|||
27738678|NCT02462876|54188034|FG000|Overall Study|Patient cancelled the follow-up visit twice time|1|||
27738679|NCT03386721|54188053|FG000|Overall Study|Death|12|||
27738680|NCT03386721|54188054|FG001|Overall Study|Death|21|||
27738681|NCT03386721|54188055|FG002|Overall Study|Death|2|||
27738682|NCT03386721|54188056|FG003|Overall Study|Death|5|||
27738683|NCT03386721|54188057|FG004|Overall Study|Death|1|||
27738684|NCT03386721|54188058|FG005|Overall Study|Death|12|||
27738685|NCT03386721|54188059|FG006|Overall Study|Death|1|||
27738686|NCT03386721|54188060|FG007|Overall Study|Death|1|||
27738687|NCT03386721|54188061|FG008|Overall Study|Death|12|||
27738688|NCT03386721|54188062|FG009|Overall Study|Death|20|||
27738689|NCT03386721|54188063|FG010|Overall Study|Death|21|||
27738690|NCT03386721|54188064|FG011|Overall Study|Death|21|||
27738691|NCT03386721|54188065|FG012|Overall Study|Death|14|||
27738692|NCT03386721|54188066|FG013|Overall Study|Death|2|||
27738693|NCT03386721|54188067|FG014|Overall Study|Death|1|||
27738694|NCT03386721|54188053|FG000|Overall Study|Lost to Follow-up|1|||
27856689|NCT02574078|54391009|FG007|Treatment Period|Death|1|||
27856690|NCT02574078|54391010|FG008|Treatment Period|Death|7|||
27856691|NCT02574078|54391011|FG009|Treatment Period|Death|1|||
27856692|NCT02574078|54391012|FG010|Treatment Period|Death|0|||
27856693|NCT02574078|54391013|FG011|Treatment Period|Death|2|||
27856694|NCT02574078|54391014|FG012|Treatment Period|Death|1|||
27856695|NCT02574078|54391002|FG000|Treatment Period|Adverse event unrelated to drug|0|||
27856696|NCT02574078|54391003|FG001|Treatment Period|Adverse event unrelated to drug|0|||
27856697|NCT02574078|54391004|FG002|Treatment Period|Adverse event unrelated to drug|1|||
27856698|NCT02574078|54391005|FG003|Treatment Period|Adverse event unrelated to drug|0|||
27856699|NCT02574078|54391006|FG004|Treatment Period|Adverse event unrelated to drug|2|||
27856700|NCT02574078|54391007|FG005|Treatment Period|Adverse event unrelated to drug|3|||
27856701|NCT02574078|54391008|FG006|Treatment Period|Adverse event unrelated to drug|0|||
27856702|NCT02574078|54391009|FG007|Treatment Period|Adverse event unrelated to drug|0|||
27856703|NCT02574078|54391010|FG008|Treatment Period|Adverse event unrelated to drug|1|||
27856704|NCT02574078|54391011|FG009|Treatment Period|Adverse event unrelated to drug|2|||
27856705|NCT02574078|54391012|FG010|Treatment Period|Adverse event unrelated to drug|4|||
27856706|NCT02574078|54391013|FG011|Treatment Period|Adverse event unrelated to drug|1|||
27856707|NCT02574078|54391014|FG012|Treatment Period|Adverse event unrelated to drug|0|||
27856708|NCT02574078|54391002|FG000|Treatment Period|Administrative reason by Sponsor|0|||
27856709|NCT02574078|54391003|FG001|Treatment Period|Administrative reason by Sponsor|1|||
28170960|NCT04194801|54842530|FG002|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
28170961|NCT04194801|54842528|FG000|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|3|||
28170962|NCT04194801|54842529|FG001|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|4|||
28170963|NCT04194801|54842530|FG002|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|9|||
28170964|NCT04194801|54842528|FG000|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
28170965|NCT04194801|54842529|FG001|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|1|||
28170966|NCT04194801|54842530|FG002|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
28170967|NCT04194801|54842528|FG000|Part Ib/II End Of Treatment-BLU554|Other|0|||
28170968|NCT04194801|54842529|FG001|Part Ib/II End Of Treatment-BLU554|Other|0|||
28170969|NCT04194801|54842530|FG002|Part Ib/II End Of Treatment-BLU554|Other|2|||
28170970|NCT04194801|54842528|FG000|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
28170971|NCT04194801|54842529|FG001|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
28170972|NCT04194801|54842530|FG002|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|2|||
28170973|NCT04194801|54842528|FG000|Part Ib/II End Of Treatment-CS1001|Adverse Event|1|||
28170974|NCT04194801|54842529|FG001|Part Ib/II End Of Treatment-CS1001|Adverse Event|0|||
28170975|NCT04194801|54842530|FG002|Part Ib/II End Of Treatment-CS1001|Adverse Event|2|||
28170976|NCT04194801|54842528|FG000|Part Ib/II End Of Treatment-CS1001|Death|0|||
28170977|NCT04194801|54842529|FG001|Part Ib/II End Of Treatment-CS1001|Death|0|||
28170978|NCT04194801|54842530|FG002|Part Ib/II End Of Treatment-CS1001|Death|1|||
28170979|NCT04194801|54842528|FG000|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|3|||
28170980|NCT04194801|54842529|FG001|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|6|||
27738695|NCT03386721|54188054|FG001|Overall Study|Lost to Follow-up|3|||
27738696|NCT03386721|54188055|FG002|Overall Study|Lost to Follow-up|0|||
27738697|NCT03386721|54188056|FG003|Overall Study|Lost to Follow-up|0|||
27738698|NCT03386721|54188057|FG004|Overall Study|Lost to Follow-up|0|||
27738699|NCT03386721|54188058|FG005|Overall Study|Lost to Follow-up|2|||
27856710|NCT02574078|54391004|FG002|Treatment Period|Administrative reason by Sponsor|0|||
27856711|NCT02574078|54391005|FG003|Treatment Period|Administrative reason by Sponsor|0|||
27856712|NCT02574078|54391006|FG004|Treatment Period|Administrative reason by Sponsor|0|||
27856713|NCT02574078|54391007|FG005|Treatment Period|Administrative reason by Sponsor|0|||
27738700|NCT03386721|54188059|FG006|Overall Study|Lost to Follow-up|1|||
27856714|NCT02574078|54391008|FG006|Treatment Period|Administrative reason by Sponsor|1|||
27856715|NCT02574078|54391009|FG007|Treatment Period|Administrative reason by Sponsor|0|||
27856716|NCT02574078|54391010|FG008|Treatment Period|Administrative reason by Sponsor|0|||
27856717|NCT02574078|54391011|FG009|Treatment Period|Administrative reason by Sponsor|0|||
27856718|NCT02574078|54391012|FG010|Treatment Period|Administrative reason by Sponsor|0|||
27856719|NCT02574078|54391013|FG011|Treatment Period|Administrative reason by Sponsor|0|||
27856720|NCT02574078|54391014|FG012|Treatment Period|Administrative reason by Sponsor|3|||
27856721|NCT02574078|54391002|FG000|Treatment Period|Other reasons|1|||
28095480|NCT03794544|54749814|FG000|Overall Study|Other|0|||
28095481|NCT03794544|54749815|FG001|Overall Study|Other|1|||
28095482|NCT03794544|54749816|FG002|Overall Study|Other|0|||
28170981|NCT04194801|54842530|FG002|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|9|||
28170982|NCT04194801|54842528|FG000|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
28170983|NCT04194801|54842529|FG001|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|1|||
28170984|NCT04194801|54842530|FG002|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
28170985|NCT04194801|54842528|FG000|Part Ib/II End Of Treatment-CS1001|Other|0|||
28170986|NCT04194801|54842529|FG001|Part Ib/II End Of Treatment-CS1001|Other|0|||
28170987|NCT04194801|54842530|FG002|Part Ib/II End Of Treatment-CS1001|Other|1|||
27738701|NCT03386721|54188060|FG007|Overall Study|Lost to Follow-up|0|||
27738702|NCT03386721|54188061|FG008|Overall Study|Lost to Follow-up|1|||
27738703|NCT03386721|54188062|FG009|Overall Study|Lost to Follow-up|2|||
27738704|NCT03386721|54188063|FG010|Overall Study|Lost to Follow-up|1|||
27738705|NCT03386721|54188064|FG011|Overall Study|Lost to Follow-up|0|||
27738706|NCT03386721|54188065|FG012|Overall Study|Lost to Follow-up|0|||
27738707|NCT03386721|54188066|FG013|Overall Study|Lost to Follow-up|0|||
27738708|NCT03386721|54188067|FG014|Overall Study|Lost to Follow-up|0|||
27738709|NCT03386721|54188053|FG000|Overall Study|Reason not specified|3|||
27738710|NCT03386721|54188054|FG001|Overall Study|Reason not specified|0|||
27738711|NCT03386721|54188055|FG002|Overall Study|Reason not specified|0|||
27738712|NCT03386721|54188056|FG003|Overall Study|Reason not specified|0|||
27738713|NCT03386721|54188057|FG004|Overall Study|Reason not specified|0|||
27738714|NCT03386721|54188058|FG005|Overall Study|Reason not specified|3|||
27738715|NCT03386721|54188059|FG006|Overall Study|Reason not specified|1|||
27738716|NCT03386721|54188060|FG007|Overall Study|Reason not specified|0|||
27738717|NCT03386721|54188061|FG008|Overall Study|Reason not specified|0|||
27738718|NCT03386721|54188062|FG009|Overall Study|Reason not specified|1|||
27738719|NCT03386721|54188063|FG010|Overall Study|Reason not specified|2|||
27738720|NCT03386721|54188064|FG011|Overall Study|Reason not specified|6|||
27738721|NCT03386721|54188065|FG012|Overall Study|Reason not specified|1|||
27738722|NCT03386721|54188066|FG013|Overall Study|Reason not specified|0|||
27738723|NCT03386721|54188067|FG014|Overall Study|Reason not specified|0|||
27738724|NCT03386721|54188053|FG000|Overall Study|Progressive Disease|0|||
27738725|NCT03386721|54188054|FG001|Overall Study|Progressive Disease|0|||
27738726|NCT03386721|54188055|FG002|Overall Study|Progressive Disease|1|||
27738727|NCT03386721|54188056|FG003|Overall Study|Progressive Disease|0|||
27738728|NCT03386721|54188057|FG004|Overall Study|Progressive Disease|0|||
27738729|NCT03386721|54188058|FG005|Overall Study|Progressive Disease|1|||
27738730|NCT03386721|54188059|FG006|Overall Study|Progressive Disease|0|||
27738731|NCT03386721|54188060|FG007|Overall Study|Progressive Disease|0|||
27738732|NCT03386721|54188061|FG008|Overall Study|Progressive Disease|2|||
27738733|NCT03386721|54188062|FG009|Overall Study|Progressive Disease|1|||
27738734|NCT03386721|54188063|FG010|Overall Study|Progressive Disease|1|||
27856722|NCT02574078|54391003|FG001|Treatment Period|Other reasons|0|||
28095483|NCT03794544|54749817|FG003|Overall Study|Other|0|||
28095484|NCT01804270|54749829|FG000|Overall Study|Withdrawal by Subject|1|||
28095485|NCT01804270|54749830|FG001|Overall Study|Withdrawal by Subject|1|||
28095486|NCT03107026|54749839|FG000|Overall Study|Adverse Event|2|||
28095487|NCT03107026|54749840|FG001|Overall Study|Adverse Event|14|||
28095488|NCT03107026|54749841|FG002|Overall Study|Adverse Event|23|||
28095489|NCT03107026|54749839|FG000|Overall Study|Lost to Follow-up|12|||
28095490|NCT03107026|54749840|FG001|Overall Study|Lost to Follow-up|12|||
28095491|NCT03107026|54749841|FG002|Overall Study|Lost to Follow-up|13|||
28095492|NCT03107026|54749839|FG000|Overall Study|Protocol Violation|1|||
27738735|NCT03386721|54188064|FG011|Overall Study|Progressive Disease|0|||
27738736|NCT03386721|54188065|FG012|Overall Study|Progressive Disease|1|||
27738737|NCT03386721|54188066|FG013|Overall Study|Progressive Disease|0|||
27738738|NCT03386721|54188067|FG014|Overall Study|Progressive Disease|0|||
27738739|NCT03386721|54188053|FG000|Overall Study|Site Terminated by Sponsor|5|||
27738740|NCT03386721|54188054|FG001|Overall Study|Site Terminated by Sponsor|5|||
27856723|NCT02574078|54391004|FG002|Treatment Period|Other reasons|1|||
27738741|NCT03386721|54188055|FG002|Overall Study|Site Terminated by Sponsor|0|||
27738742|NCT03386721|54188056|FG003|Overall Study|Site Terminated by Sponsor|0|||
27856724|NCT02574078|54391005|FG003|Treatment Period|Other reasons|3|||
27738743|NCT03386721|54188057|FG004|Overall Study|Site Terminated by Sponsor|1|||
28095493|NCT03107026|54749840|FG001|Overall Study|Protocol Violation|2|||
28095494|NCT03107026|54749841|FG002|Overall Study|Protocol Violation|0|||
27981012|NCT00887822|54638971|FG001|Overall Study|Adverse Event|17|||
27981013|NCT00887822|54638970|FG000|Overall Study|Failure to return|11|||
27981014|NCT00887822|54638971|FG001|Overall Study|Failure to return|11|||
27981015|NCT00887822|54638970|FG000|Overall Study|Refused treatment/Did not cooperate|12|||
27981016|NCT00887822|54638971|FG001|Overall Study|Refused treatment/Did not cooperate|10|||
28095495|NCT03107026|54749839|FG000|Overall Study|Pregnancy|1|||
28095496|NCT03107026|54749840|FG001|Overall Study|Pregnancy|0|||
28170988|NCT04194801|54842528|FG000|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
28170989|NCT04194801|54842529|FG001|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
28170990|NCT04194801|54842530|FG002|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|2|||
28170991|NCT04194801|54842528|FG000|Part Ib/II End of Study|Death|2|||
28170992|NCT04194801|54842529|FG001|Part Ib/II End of Study|Death|3|||
28170993|NCT04194801|54842530|FG002|Part Ib/II End of Study|Death|3|||
28170994|NCT04194801|54842528|FG000|Part Ib/II End of Study|Lost to Follow-up|0|||
28170995|NCT04194801|54842529|FG001|Part Ib/II End of Study|Lost to Follow-up|1|||
28170996|NCT04194801|54842530|FG002|Part Ib/II End of Study|Lost to Follow-up|0|||
28170997|NCT04194801|54842528|FG000|Part Ib/II End of Study|Withdrawal by Subject|1|||
28170998|NCT04194801|54842529|FG001|Part Ib/II End of Study|Withdrawal by Subject|0|||
28170999|NCT04194801|54842530|FG002|Part Ib/II End of Study|Withdrawal by Subject|2|||
28171000|NCT04194801|54842528|FG000|Part Ib/II End of Study|Study ended by sponsor|1|||
28171001|NCT04194801|54842529|FG001|Part Ib/II End of Study|Study ended by sponsor|3|||
28171002|NCT04194801|54842530|FG002|Part Ib/II End of Study|Study ended by sponsor|8|||
28171003|NCT04194801|54842528|FG000|Part Ib/II End of Study|Ongoing treatment|0|||
28171004|NCT04194801|54842529|FG001|Part Ib/II End of Study|Ongoing treatment|0|||
28171005|NCT04194801|54842530|FG002|Part Ib/II End of Study|Ongoing treatment|2|||
28171006|NCT02802865|54842554|FG000|Overall Study|Pregnancy|1|||
28171007|NCT02802865|54842555|FG001|Overall Study|Pregnancy|1|||
28171008|NCT02802865|54842554|FG000|Overall Study|Ineliegible due to tuberculosis|0|||
28171009|NCT02802865|54842555|FG001|Overall Study|Ineliegible due to tuberculosis|1|||
28171010|NCT02414932|54842563|FG000|Overall Study|Withdrawal by Subject|2|||
28171011|NCT02414932|54842564|FG001|Overall Study|Withdrawal by Subject|3|||
28171012|NCT02414932|54842563|FG000|Overall Study|Adverse Event|1|||
28171013|NCT02414932|54842564|FG001|Overall Study|Adverse Event|0|||
28171014|NCT00704535|54842570|FG000|Overall Study|Adverse Event|2|||
28171015|NCT00704535|54842570|FG000|Overall Study|Death|2|||
28171016|NCT00704535|54842570|FG000|Overall Study|Lost to Follow-up|8|||
28171017|NCT00704535|54842570|FG000|Overall Study|Protocol Violation|10|||
28171018|NCT00704535|54842570|FG000|Overall Study|Completed status not on Case Report Form|124|||
28171019|NCT01740687|54842574|FG000|Overall Study|Lost to Follow-up|11|||
28171020|NCT01740687|54842574|FG000|Overall Study|Withdrawal by Subject|2|||
28171021|NCT01740687|54842574|FG000|Overall Study|other reason|22|||
28171022|NCT01740687|54842574|FG000|Overall Study|treatment not received|2|||
28171023|NCT02648204|54842582|FG000|Overall Study|Withdrawal by Subject|12|||
28171024|NCT02648204|54842583|FG001|Overall Study|Withdrawal by Subject|8|||
28171025|NCT02648204|54842584|FG002|Overall Study|Withdrawal by Subject|2|||
28171026|NCT02648204|54842585|FG003|Overall Study|Withdrawal by Subject|6|||
28095497|NCT03107026|54749841|FG002|Overall Study|Pregnancy|0|||
28095498|NCT03107026|54749839|FG000|Overall Study|Withdrawal by Subject|13|||
28095499|NCT03107026|54749840|FG001|Overall Study|Withdrawal by Subject|5|||
28095500|NCT03107026|54749841|FG002|Overall Study|Withdrawal by Subject|17|||
28095501|NCT03107026|54749839|FG000|Overall Study|non compliance with study visits|1|||
28095502|NCT03107026|54749840|FG001|Overall Study|non compliance with study visits|2|||
28095503|NCT03107026|54749841|FG002|Overall Study|non compliance with study visits|0|||
28171027|NCT02648204|54842582|FG000|Overall Study|Lost to Follow-up|5|||
28171028|NCT02648204|54842583|FG001|Overall Study|Lost to Follow-up|8|||
28171029|NCT02648204|54842584|FG002|Overall Study|Lost to Follow-up|4|||
28171030|NCT02648204|54842585|FG003|Overall Study|Lost to Follow-up|6|||
28171031|NCT02648204|54842582|FG000|Overall Study|Missing follow-up information|4|||
28171032|NCT02648204|54842583|FG001|Overall Study|Missing follow-up information|4|||
28171033|NCT02648204|54842584|FG002|Overall Study|Missing follow-up information|4|||
28171034|NCT02648204|54842585|FG003|Overall Study|Missing follow-up information|2|||
28171035|NCT02648204|54842582|FG000|Overall Study|Death|1|||
28171036|NCT02648204|54842583|FG001|Overall Study|Death|1|||
28171037|NCT02648204|54842584|FG002|Overall Study|Death|2|||
27738744|NCT03386721|54188058|FG005|Overall Study|Site Terminated by Sponsor|3|||
27738745|NCT03386721|54188059|FG006|Overall Study|Site Terminated by Sponsor|0|||
28095504|NCT03107026|54749839|FG000|Overall Study|non-compliance with study drug|2|||
28095505|NCT03107026|54749840|FG001|Overall Study|non-compliance with study drug|2|||
28171038|NCT02648204|54842585|FG003|Overall Study|Death|2|||
28171039|NCT02648204|54842582|FG000|Overall Study|Adverse Event|0|||
28171040|NCT02648204|54842583|FG001|Overall Study|Adverse Event|0|||
28171041|NCT02648204|54842584|FG002|Overall Study|Adverse Event|1|||
28171042|NCT02648204|54842585|FG003|Overall Study|Adverse Event|0|||
27738746|NCT03386721|54188060|FG007|Overall Study|Site Terminated by Sponsor|1|||
28171043|NCT02799745|54842597|FG000|Overall Study|Participant moved out of state|1|||
28171044|NCT02799745|54842598|FG001|Overall Study|Participant moved out of state|0|||
28171045|NCT02799745|54842597|FG000|Overall Study|Discontinued due to planned surgery|1|||
28171046|NCT02799745|54842598|FG001|Overall Study|Discontinued due to planned surgery|0|||
28171047|NCT02799745|54842597|FG000|Overall Study|Withdrawal by Subject|16|||
28171048|NCT02799745|54842598|FG001|Overall Study|Withdrawal by Subject|25|||
28171049|NCT02799745|54842597|FG000|Overall Study|Protocol Deviation|4|||
28171050|NCT02799745|54842598|FG001|Overall Study|Protocol Deviation|5|||
28171051|NCT02799745|54842597|FG000|Overall Study|Progressive Disease|28|||
28171052|NCT02799745|54842598|FG001|Overall Study|Progressive Disease|38|||
28171053|NCT02799745|54842597|FG000|Overall Study|Lost to Follow-up|3|||
28171054|NCT02799745|54842598|FG001|Overall Study|Lost to Follow-up|2|||
28171055|NCT02799745|54842597|FG000|Overall Study|Death|3|||
28171056|NCT02799745|54842598|FG001|Overall Study|Death|0|||
28171057|NCT02799745|54842597|FG000|Overall Study|Adverse Event|0|||
27856725|NCT02574078|54391006|FG004|Treatment Period|Other reasons|3|||
27856726|NCT02574078|54391007|FG005|Treatment Period|Other reasons|1|||
27856727|NCT02574078|54391008|FG006|Treatment Period|Other reasons|2|||
27856728|NCT02574078|54391009|FG007|Treatment Period|Other reasons|1|||
27856729|NCT02574078|54391010|FG008|Treatment Period|Other reasons|3|||
27856730|NCT02574078|54391011|FG009|Treatment Period|Other reasons|1|||
27856731|NCT02574078|54391012|FG010|Treatment Period|Other reasons|1|||
27856732|NCT02574078|54391013|FG011|Treatment Period|Other reasons|3|||
28171058|NCT02799745|54842598|FG001|Overall Study|Adverse Event|1|||
28171059|NCT00705159|54842608|FG000|Overall Study|Withdrawal by Subject|0|||
28171060|NCT00705159|54842609|FG001|Overall Study|Withdrawal by Subject|1|||
28171061|NCT00705159|54842610|FG002|Overall Study|Withdrawal by Subject|1|||
28171062|NCT00705159|54842611|FG003|Overall Study|Withdrawal by Subject|1|||
28171063|NCT00705159|54842608|FG000|Overall Study|Protocol Violation|0|||
28171064|NCT00705159|54842609|FG001|Overall Study|Protocol Violation|1|||
28171065|NCT00705159|54842610|FG002|Overall Study|Protocol Violation|0|||
28171066|NCT00705159|54842611|FG003|Overall Study|Protocol Violation|0|||
27738747|NCT03386721|54188061|FG008|Overall Study|Site Terminated by Sponsor|4|||
27738748|NCT03386721|54188062|FG009|Overall Study|Site Terminated by Sponsor|5|||
27981017|NCT00887822|54638970|FG000|Overall Study|Administrative/Other than specified|5|||
27981018|NCT00887822|54638971|FG001|Overall Study|Administrative/Other than specified|4|||
27981019|NCT00887822|54638970|FG000|Overall Study|Death|2|||
27981020|NCT00887822|54638971|FG001|Overall Study|Death|3|||
27981021|NCT00887822|54638970|FG000|Overall Study|Protocol Violation|0|||
27981022|NCT00887822|54638971|FG001|Overall Study|Protocol Violation|1|||
27856733|NCT02574078|54391014|FG012|Treatment Period|Other reasons|1|||
27856734|NCT02574078|54391002|FG000|Treatment Period|Participant request to stop drug|0|||
27856735|NCT02574078|54391003|FG001|Treatment Period|Participant request to stop drug|0|||
27856736|NCT02574078|54391004|FG002|Treatment Period|Participant request to stop drug|0|||
27856737|NCT02574078|54391005|FG003|Treatment Period|Participant request to stop drug|2|||
27856738|NCT02574078|54391006|FG004|Treatment Period|Participant request to stop drug|4|||
27856739|NCT02574078|54391007|FG005|Treatment Period|Participant request to stop drug|0|||
27856740|NCT02574078|54391008|FG006|Treatment Period|Participant request to stop drug|1|||
27856741|NCT02574078|54391009|FG007|Treatment Period|Participant request to stop drug|0|||
27981023|NCT00887822|54638970|FG000|Overall Study|Randomized but not treated|0|||
27981024|NCT00887822|54638971|FG001|Overall Study|Randomized but not treated|1|||
27981025|NCT00951665|54638983|FG000|Phase 1b|Adverse Event|2|||
28095506|NCT03107026|54749841|FG002|Overall Study|non-compliance with study drug|3|||
28095507|NCT03107026|54749839|FG000|Overall Study|Physician Decision|0|||
28095508|NCT03107026|54749840|FG001|Overall Study|Physician Decision|1|||
28095509|NCT03107026|54749841|FG002|Overall Study|Physician Decision|0|||
28095510|NCT03717480|54749849|FG000|Overall Study|Never received investigational product due to product viability limitations.|1|||
28095511|NCT00005044|54749855|FG000|Overall Study|Protocol Violation|37|||
28095512|NCT00005044|54749856|FG001|Overall Study|Protocol Violation|46|||
28095513|NCT00005044|54749855|FG000|Overall Study|Withdrawal by Subject|1|||
27981026|NCT00951665|54638984|FG001|Phase 1b|Adverse Event|1|||
27981027|NCT00951665|54638985|FG002|Phase 1b|Adverse Event|0|||
27981028|NCT00951665|54638986|FG003|Phase 1b|Adverse Event|1|||
27981029|NCT00951665|54638987|FG004|Phase 1b|Adverse Event|0|||
27981030|NCT00951665|54638988|FG005|Phase 1b|Adverse Event|0|||
27981031|NCT00951665|54638983|FG000|Phase 1b|Death|1|||
27981032|NCT00951665|54638984|FG001|Phase 1b|Death|0|||
27981033|NCT00951665|54638985|FG002|Phase 1b|Death|2|||
27981034|NCT00951665|54638986|FG003|Phase 1b|Death|0|||
28095514|NCT00005044|54749856|FG001|Overall Study|Withdrawal by Subject|5|||
28171067|NCT00705159|54842608|FG000|Overall Study|Adverse Event|0|||
28171068|NCT00705159|54842609|FG001|Overall Study|Adverse Event|0|||
28171069|NCT00705159|54842610|FG002|Overall Study|Adverse Event|1|||
27738749|NCT03386721|54188063|FG010|Overall Study|Site Terminated by Sponsor|3|||
27738750|NCT03386721|54188064|FG011|Overall Study|Site Terminated by Sponsor|11|||
27738751|NCT03386721|54188065|FG012|Overall Study|Site Terminated by Sponsor|6|||
27738752|NCT03386721|54188066|FG013|Overall Study|Site Terminated by Sponsor|0|||
27738753|NCT03386721|54188067|FG014|Overall Study|Site Terminated by Sponsor|0|||
27738754|NCT03386721|54188053|FG000|Overall Study|Symptomatic Deterioration|0|||
27738755|NCT03386721|54188054|FG001|Overall Study|Symptomatic Deterioration|0|||
27833797|NCT00703014|54317260|FG000|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
28095515|NCT00005044|54749855|FG000|Overall Study|No protocol treatment|0|||
27856742|NCT02574078|54391010|FG008|Treatment Period|Participant request to stop drug|3|||
27856743|NCT02574078|54391011|FG009|Treatment Period|Participant request to stop drug|2|||
27856744|NCT02574078|54391012|FG010|Treatment Period|Participant request to stop drug|2|||
27856745|NCT02574078|54391013|FG011|Treatment Period|Participant request to stop drug|4|||
27856746|NCT02574078|54391014|FG012|Treatment Period|Participant request to stop drug|1|||
27856747|NCT02574078|54391002|FG000|Treatment Period|Participant withdrew consent|0|||
27856748|NCT02574078|54391003|FG001|Treatment Period|Participant withdrew consent|0|||
27856749|NCT02574078|54391004|FG002|Treatment Period|Participant withdrew consent|0|||
27856750|NCT02574078|54391005|FG003|Treatment Period|Participant withdrew consent|0|||
27856751|NCT02574078|54391006|FG004|Treatment Period|Participant withdrew consent|1|||
27856752|NCT02574078|54391007|FG005|Treatment Period|Participant withdrew consent|1|||
27856753|NCT02574078|54391008|FG006|Treatment Period|Participant withdrew consent|0|||
27856754|NCT02574078|54391009|FG007|Treatment Period|Participant withdrew consent|1|||
27856755|NCT02574078|54391010|FG008|Treatment Period|Participant withdrew consent|0|||
27856756|NCT02574078|54391011|FG009|Treatment Period|Participant withdrew consent|2|||
27856757|NCT02574078|54391012|FG010|Treatment Period|Participant withdrew consent|1|||
27856758|NCT02574078|54391013|FG011|Treatment Period|Participant withdrew consent|4|||
27856759|NCT02574078|54391014|FG012|Treatment Period|Participant withdrew consent|1|||
27856760|NCT02574078|54391002|FG000|Treatment Period|Participant no longer meets criteria|0|||
27856761|NCT02574078|54391003|FG001|Treatment Period|Participant no longer meets criteria|0|||
27856762|NCT02574078|54391004|FG002|Treatment Period|Participant no longer meets criteria|0|||
27856763|NCT02574078|54391005|FG003|Treatment Period|Participant no longer meets criteria|0|||
27856764|NCT02574078|54391006|FG004|Treatment Period|Participant no longer meets criteria|1|||
27856765|NCT02574078|54391007|FG005|Treatment Period|Participant no longer meets criteria|0|||
27856766|NCT02574078|54391008|FG006|Treatment Period|Participant no longer meets criteria|0|||
27856767|NCT02574078|54391009|FG007|Treatment Period|Participant no longer meets criteria|0|||
27856768|NCT02574078|54391010|FG008|Treatment Period|Participant no longer meets criteria|0|||
27856769|NCT02574078|54391011|FG009|Treatment Period|Participant no longer meets criteria|1|||
27856770|NCT02574078|54391012|FG010|Treatment Period|Participant no longer meets criteria|1|||
27856771|NCT02574078|54391013|FG011|Treatment Period|Participant no longer meets criteria|1|||
27856772|NCT02574078|54391014|FG012|Treatment Period|Participant no longer meets criteria|0|||
27856773|NCT02574078|54391002|FG000|Treatment Period|Lost to Follow-up|0|||
27856774|NCT02574078|54391003|FG001|Treatment Period|Lost to Follow-up|0|||
27856775|NCT02574078|54391004|FG002|Treatment Period|Lost to Follow-up|0|||
27856776|NCT02574078|54391005|FG003|Treatment Period|Lost to Follow-up|0|||
27856777|NCT02574078|54391006|FG004|Treatment Period|Lost to Follow-up|0|||
27856778|NCT02574078|54391007|FG005|Treatment Period|Lost to Follow-up|0|||
27856779|NCT02574078|54391008|FG006|Treatment Period|Lost to Follow-up|0|||
27856780|NCT02574078|54391009|FG007|Treatment Period|Lost to Follow-up|0|||
27856781|NCT02574078|54391010|FG008|Treatment Period|Lost to Follow-up|0|||
27856782|NCT02574078|54391011|FG009|Treatment Period|Lost to Follow-up|1|||
27856783|NCT02574078|54391012|FG010|Treatment Period|Lost to Follow-up|0|||
28095516|NCT00005044|54749856|FG001|Overall Study|No protocol treatment|1|||
28095517|NCT03084796|54749868|FG000|Overall Study|Adverse Event|4|||
28095518|NCT03084796|54749869|FG001|Overall Study|Adverse Event|5|||
28095519|NCT03084796|54749870|FG002|Overall Study|Adverse Event|6|||
28095520|NCT03084796|54749871|FG003|Overall Study|Adverse Event|2|||
28095521|NCT03084796|54749872|FG004|Overall Study|Adverse Event|3|||
28095522|NCT03084796|54749873|FG005|Overall Study|Adverse Event|5|||
28095523|NCT03084796|54749868|FG000|Overall Study|Withdrawal by Subject|3|||
28095524|NCT03084796|54749869|FG001|Overall Study|Withdrawal by Subject|5|||
28095525|NCT03084796|54749870|FG002|Overall Study|Withdrawal by Subject|2|||
28095526|NCT03084796|54749871|FG003|Overall Study|Withdrawal by Subject|1|||
28095527|NCT03084796|54749872|FG004|Overall Study|Withdrawal by Subject|3|||
28095528|NCT03084796|54749873|FG005|Overall Study|Withdrawal by Subject|0|||
27833798|NCT00703014|54317261|FG001|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
27833799|NCT00703014|54317262|FG002|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47|||
27833800|NCT00703014|54317263|FG003|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42|||
27833801|NCT03915496|54317315|FG000|Overall Study|Adverse Event|2|||
27833802|NCT03915496|54317316|FG001|Overall Study|Adverse Event|1|||
27833803|NCT03915496|54317317|FG002|Overall Study|Adverse Event|2|||
27833804|NCT02709330|54317334|FG000|Overall Study|Death|5|||
27856784|NCT02574078|54391013|FG011|Treatment Period|Lost to Follow-up|1|||
28095529|NCT03084796|54749868|FG000|Overall Study|Protocol Violation|0|||
28095530|NCT03084796|54749869|FG001|Overall Study|Protocol Violation|0|||
27856785|NCT02574078|54391014|FG012|Treatment Period|Lost to Follow-up|0|||
28095531|NCT03084796|54749870|FG002|Overall Study|Protocol Violation|1|||
27833805|NCT02709330|54317335|FG001|Overall Study|Death|0|||
27833806|NCT02709330|54317334|FG000|Overall Study|Lost to Follow-up|2|||
28095532|NCT03084796|54749871|FG003|Overall Study|Protocol Violation|0|||
28095533|NCT03084796|54749872|FG004|Overall Study|Protocol Violation|1|||
28171070|NCT00705159|54842611|FG003|Overall Study|Adverse Event|0|||
28171071|NCT00705159|54842608|FG000|Overall Study|Lost to Follow-up|0|||
28171072|NCT00705159|54842609|FG001|Overall Study|Lost to Follow-up|0|||
28171073|NCT00705159|54842610|FG002|Overall Study|Lost to Follow-up|3|||
28171074|NCT00705159|54842611|FG003|Overall Study|Lost to Follow-up|2|||
28171075|NCT00705159|54842608|FG000|Overall Study|Screen Failure|0|||
28171076|NCT00705159|54842609|FG001|Overall Study|Screen Failure|0|||
28171077|NCT00705159|54842610|FG002|Overall Study|Screen Failure|0|||
28171078|NCT00705159|54842611|FG003|Overall Study|Screen Failure|1|||
28171079|NCT01673984|54842623|FG000|Overall Study|Adverse Event|1|||
28171080|NCT01673984|54842624|FG001|Overall Study|Adverse Event|0|||
28171081|NCT01673984|54842623|FG000|Overall Study|Study termination|9|||
28171082|NCT01673984|54842624|FG001|Overall Study|Study termination|6|||
28171083|NCT02332928|54842643|FG000|Overall Study|Withdrawal by Subject|0|||
28171084|NCT02332928|54842644|FG001|Overall Study|Withdrawal by Subject|2|||
28171085|NCT02332928|54842643|FG000|Overall Study|Cronavirus disease (COVID-19) Precautions|1|||
28171086|NCT02332928|54842644|FG001|Overall Study|Cronavirus disease (COVID-19) Precautions|0|||
28171087|NCT02647658|54842652|FG000|Overall Study|Consent refusal|15|||
28171088|NCT02647658|54842653|FG001|Overall Study|Consent refusal|24|||
28171089|NCT00703677|54842659|FG000|Overall Study|Dropout-withdrawal not related to drug|3|||
28171090|NCT00703911|54842667|FG000|Overall Study|Death|1|||
28171091|NCT00703911|54842667|FG000|Overall Study|Physician Decision|6|||
28171092|NCT00703911|54842667|FG000|Overall Study|Lost to Follow-up|1|||
28171093|NCT00703911|54842667|FG000|Overall Study|Withdrawal by Subject|2|||
28171094|NCT02055547|54842671|FG000|Overall Study|Protocol Violation|0|||
28171095|NCT02055547|54842672|FG001|Overall Study|Protocol Violation|0|||
28171096|NCT02055547|54842673|FG002|Overall Study|Protocol Violation|1|||
28171097|NCT02055547|54842674|FG003|Overall Study|Protocol Violation|0|||
28171098|NCT02055547|54842675|FG004|Overall Study|Protocol Violation|0|||
27738756|NCT03386721|54188055|FG002|Overall Study|Symptomatic Deterioration|0|||
27738757|NCT03386721|54188056|FG003|Overall Study|Symptomatic Deterioration|0|||
27738758|NCT03386721|54188057|FG004|Overall Study|Symptomatic Deterioration|0|||
27738759|NCT03386721|54188058|FG005|Overall Study|Symptomatic Deterioration|0|||
27738760|NCT03386721|54188059|FG006|Overall Study|Symptomatic Deterioration|0|||
27738761|NCT03386721|54188060|FG007|Overall Study|Symptomatic Deterioration|0|||
27738762|NCT03386721|54188061|FG008|Overall Study|Symptomatic Deterioration|1|||
27738763|NCT03386721|54188062|FG009|Overall Study|Symptomatic Deterioration|0|||
27738764|NCT03386721|54188063|FG010|Overall Study|Symptomatic Deterioration|0|||
27738765|NCT03386721|54188064|FG011|Overall Study|Symptomatic Deterioration|1|||
27856786|NCT02574078|54391002|FG000|Treatment Period|Maximum clinical benefit|0|||
27856787|NCT02574078|54391003|FG001|Treatment Period|Maximum clinical benefit|0|||
27856788|NCT02574078|54391004|FG002|Treatment Period|Maximum clinical benefit|0|||
27856789|NCT02574078|54391005|FG003|Treatment Period|Maximum clinical benefit|0|||
28095534|NCT03084796|54749873|FG005|Overall Study|Protocol Violation|1|||
28095535|NCT03084796|54749868|FG000|Overall Study|Lack of Efficacy|0|||
28095536|NCT03084796|54749869|FG001|Overall Study|Lack of Efficacy|0|||
28095537|NCT03084796|54749870|FG002|Overall Study|Lack of Efficacy|1|||
28095538|NCT03084796|54749871|FG003|Overall Study|Lack of Efficacy|0|||
28095539|NCT03084796|54749872|FG004|Overall Study|Lack of Efficacy|1|||
28095540|NCT03084796|54749873|FG005|Overall Study|Lack of Efficacy|0|||
28095541|NCT03084796|54749868|FG000|Overall Study|Lost to Follow-up|0|||
28095542|NCT03084796|54749869|FG001|Overall Study|Lost to Follow-up|0|||
28095543|NCT03084796|54749870|FG002|Overall Study|Lost to Follow-up|1|||
28095544|NCT03084796|54749871|FG003|Overall Study|Lost to Follow-up|1|||
28095545|NCT03084796|54749872|FG004|Overall Study|Lost to Follow-up|3|||
28095546|NCT03084796|54749873|FG005|Overall Study|Lost to Follow-up|1|||
28095547|NCT03084796|54749868|FG000|Overall Study|Randomization error|0|||
28095548|NCT03084796|54749869|FG001|Overall Study|Randomization error|0|||
28095549|NCT03084796|54749870|FG002|Overall Study|Randomization error|1|||
28095550|NCT03084796|54749871|FG003|Overall Study|Randomization error|0|||
28095551|NCT03084796|54749872|FG004|Overall Study|Randomization error|0|||
28095552|NCT03084796|54749873|FG005|Overall Study|Randomization error|0|||
28095553|NCT03717012|54749889|FG000|Overall Study|Due to trial termination|1|||
28095554|NCT03717012|54749890|FG001|Overall Study|Due to trial termination|2|||
28095555|NCT03717012|54749889|FG000|Overall Study|Protocol Violation|0|||
28171099|NCT02055547|54842676|FG005|Overall Study|Protocol Violation|0|||
28171100|NCT02055547|54842677|FG006|Overall Study|Protocol Violation|1|||
27738766|NCT03386721|54188065|FG012|Overall Study|Symptomatic Deterioration|0|||
28095556|NCT03717012|54749890|FG001|Overall Study|Protocol Violation|2|||
28095557|NCT03717012|54749889|FG000|Overall Study|Adverse Event|0|||
28095558|NCT03717012|54749890|FG001|Overall Study|Adverse Event|1|||
28095559|NCT03717012|54749889|FG000|Overall Study|Lung transplant|0|||
28171101|NCT02055547|54842678|FG007|Overall Study|Protocol Violation|0|||
28171102|NCT02055547|54842679|FG008|Overall Study|Protocol Violation|0|||
28171103|NCT02055547|54842680|FG009|Overall Study|Protocol Violation|0|||
28171104|NCT02055547|54842681|FG010|Overall Study|Protocol Violation|0|||
28095560|NCT03717012|54749890|FG001|Overall Study|Lung transplant|1|||
27833807|NCT02709330|54317335|FG001|Overall Study|Lost to Follow-up|0|||
27833808|NCT02709330|54317334|FG000|Overall Study|Physician Decision|2|||
27833809|NCT02709330|54317335|FG001|Overall Study|Physician Decision|0|||
27833810|NCT02709330|54317334|FG000|Overall Study|Withdrawal by Subject|4|||
27833811|NCT02709330|54317335|FG001|Overall Study|Withdrawal by Subject|0|||
27833812|NCT02709096|54317343|FG000|Overall Study|non-compliance|1|||
27833813|NCT02709096|54317344|FG001|Overall Study|non-compliance|1|||
27856790|NCT02574078|54391006|FG004|Treatment Period|Maximum clinical benefit|0|||
27856791|NCT02574078|54391007|FG005|Treatment Period|Maximum clinical benefit|0|||
27856792|NCT02574078|54391008|FG006|Treatment Period|Maximum clinical benefit|0|||
27856793|NCT02574078|54391009|FG007|Treatment Period|Maximum clinical benefit|0|||
27856794|NCT02574078|54391010|FG008|Treatment Period|Maximum clinical benefit|0|||
27856795|NCT02574078|54391011|FG009|Treatment Period|Maximum clinical benefit|1|||
27856796|NCT02574078|54391012|FG010|Treatment Period|Maximum clinical benefit|0|||
27856797|NCT02574078|54391013|FG011|Treatment Period|Maximum clinical benefit|0|||
27856798|NCT02574078|54391014|FG012|Treatment Period|Maximum clinical benefit|0|||
27856799|NCT02565810|54391132|FG000|Overall Study|Withdrawal by Subject|1|||
27856800|NCT02561832|54391297|FG000|Overall Study|Withdrawal by Subject|1|||
27856801|NCT02561832|54391298|FG001|Overall Study|Withdrawal by Subject|1|||
27856802|NCT02561832|54391297|FG000|Overall Study|Adverse Event|3|||
27856803|NCT02561832|54391298|FG001|Overall Study|Adverse Event|0|||
27856804|NCT02561832|54391297|FG000|Overall Study|Disease progression|3|||
27856805|NCT02561832|54391298|FG001|Overall Study|Disease progression|3|||
27856806|NCT00985088|54392946|FG000|Overall Study|Serious Adverse Event|1|||
27856807|NCT00985088|54392947|FG001|Overall Study|Serious Adverse Event|1|||
27856808|NCT00985088|54392948|FG002|Overall Study|Serious Adverse Event|0|||
27856809|NCT00985088|54392949|FG003|Overall Study|Serious Adverse Event|0|||
27856810|NCT00985088|54392950|FG004|Overall Study|Serious Adverse Event|0|||
27856811|NCT00985088|54392951|FG005|Overall Study|Serious Adverse Event|0|||
27856812|NCT00985088|54392952|FG006|Overall Study|Serious Adverse Event|0|||
27856813|NCT00985088|54392953|FG007|Overall Study|Serious Adverse Event|1|||
27856814|NCT00985088|54392946|FG000|Overall Study|Adverse Event|0|||
27856815|NCT00985088|54392947|FG001|Overall Study|Adverse Event|0|||
27856816|NCT00985088|54392948|FG002|Overall Study|Adverse Event|1|||
27856817|NCT00985088|54392949|FG003|Overall Study|Adverse Event|0|||
27856818|NCT00985088|54392950|FG004|Overall Study|Adverse Event|0|||
27856819|NCT00985088|54392951|FG005|Overall Study|Adverse Event|0|||
27856820|NCT00985088|54392952|FG006|Overall Study|Adverse Event|0|||
27856821|NCT00985088|54392953|FG007|Overall Study|Adverse Event|0|||
27856822|NCT00985088|54392946|FG000|Overall Study|Withdrawal by Subject|4|||
27856823|NCT00985088|54392947|FG001|Overall Study|Withdrawal by Subject|0|||
27856824|NCT00985088|54392948|FG002|Overall Study|Withdrawal by Subject|0|||
27856825|NCT00985088|54392949|FG003|Overall Study|Withdrawal by Subject|1|||
27856826|NCT00985088|54392950|FG004|Overall Study|Withdrawal by Subject|3|||
27856827|NCT00985088|54392951|FG005|Overall Study|Withdrawal by Subject|2|||
28095561|NCT03078556|54749903|FG000|Treatment Period 1 (4 Days)|Adverse Event|0|||
28095562|NCT03078556|54749904|FG001|Treatment Period 1 (4 Days)|Adverse Event|1|||
28095563|NCT03078556|54749905|FG002|Treatment Period 1 (4 Days)|Adverse Event|0|||
28095564|NCT03078556|54749906|FG003|Treatment Period 1 (4 Days)|Adverse Event|0|||
28095565|NCT03078556|54749903|FG000|Washout Period 1 (7 Days)|Lost to Follow-up|2|||
28095566|NCT03078556|54749904|FG001|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
28095567|NCT03078556|54749905|FG002|Washout Period 1 (7 Days)|Lost to Follow-up|1|||
27833814|NCT01372410|54317350|FG000|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
27833815|NCT01372410|54317351|FG001|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
27833816|NCT01372410|54317352|FG002|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
27833817|NCT01372410|54317353|FG003|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
27833818|NCT01372410|54317354|FG004|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
27833819|NCT01372410|54317355|FG005|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
27833820|NCT01372410|54317356|FG006|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
27833821|NCT01372410|54317357|FG007|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
27833822|NCT01372410|54317350|FG000|Treatment Period 1 (7 Days)|Adverse Event|0|||
27833823|NCT01372410|54317351|FG001|Treatment Period 1 (7 Days)|Adverse Event|1|||
27856828|NCT00985088|54392952|FG006|Overall Study|Withdrawal by Subject|1|||
27856829|NCT00985088|54392953|FG007|Overall Study|Withdrawal by Subject|2|||
27856830|NCT00985088|54392946|FG000|Overall Study|Migrated/moved from study area|0|||
27856831|NCT00985088|54392947|FG001|Overall Study|Migrated/moved from study area|0|||
28095568|NCT03078556|54749906|FG003|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
28095569|NCT03078556|54749903|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
27856832|NCT00985088|54392948|FG002|Overall Study|Migrated/moved from study area|1|||
27856833|NCT00985088|54392949|FG003|Overall Study|Migrated/moved from study area|0|||
27856834|NCT00985088|54392950|FG004|Overall Study|Migrated/moved from study area|0|||
27856835|NCT00985088|54392951|FG005|Overall Study|Migrated/moved from study area|0|||
27833824|NCT01372410|54317352|FG002|Treatment Period 1 (7 Days)|Adverse Event|0|||
27833825|NCT01372410|54317353|FG003|Treatment Period 1 (7 Days)|Adverse Event|0|||
27833826|NCT01372410|54317354|FG004|Treatment Period 1 (7 Days)|Adverse Event|0|||
27738767|NCT03386721|54188066|FG013|Overall Study|Symptomatic Deterioration|0|||
27738768|NCT03386721|54188067|FG014|Overall Study|Symptomatic Deterioration|0|||
27738769|NCT03386721|54188053|FG000|Overall Study|Withdrawal by Subject|1|||
27738770|NCT03386721|54188054|FG001|Overall Study|Withdrawal by Subject|2|||
27738771|NCT03386721|54188055|FG002|Overall Study|Withdrawal by Subject|0|||
27738772|NCT03386721|54188056|FG003|Overall Study|Withdrawal by Subject|0|||
27738773|NCT03386721|54188057|FG004|Overall Study|Withdrawal by Subject|0|||
27738774|NCT03386721|54188058|FG005|Overall Study|Withdrawal by Subject|0|||
27738775|NCT03386721|54188059|FG006|Overall Study|Withdrawal by Subject|0|||
27738776|NCT03386721|54188060|FG007|Overall Study|Withdrawal by Subject|0|||
27738777|NCT03386721|54188061|FG008|Overall Study|Withdrawal by Subject|2|||
27738778|NCT03386721|54188062|FG009|Overall Study|Withdrawal by Subject|1|||
27738779|NCT03386721|54188063|FG010|Overall Study|Withdrawal by Subject|3|||
27738780|NCT03386721|54188064|FG011|Overall Study|Withdrawal by Subject|2|||
27738781|NCT03386721|54188065|FG012|Overall Study|Withdrawal by Subject|3|||
27738782|NCT03386721|54188066|FG013|Overall Study|Withdrawal by Subject|0|||
27738783|NCT03386721|54188067|FG014|Overall Study|Withdrawal by Subject|0|||
27738784|NCT02462720|54188099|FG000|Part 2|Withdrawal by Subject|1|||
27738785|NCT02462720|54188100|FG001|Part 2|Withdrawal by Subject|0|||
27738786|NCT02462720|54188099|FG000|Part 2|Protocol Violation|0|||
27738787|NCT02462720|54188100|FG001|Part 2|Protocol Violation|1|||
27738788|NCT02246218|54188110|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
27833827|NCT01372410|54317355|FG005|Treatment Period 1 (7 Days)|Adverse Event|0|||
27981035|NCT00951665|54638987|FG004|Phase 1b|Death|0|||
28095570|NCT03078556|54749904|FG001|Washout Period 1 (7 Days)|Adverse Event|1|||
28095571|NCT03078556|54749905|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
28095572|NCT03078556|54749906|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
28095573|NCT03078556|54749903|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
28095574|NCT03078556|54749904|FG001|Washout Period 1 (7 Days)|Physician Decision|1|||
28095575|NCT03078556|54749905|FG002|Washout Period 1 (7 Days)|Physician Decision|0|||
28095576|NCT03078556|54749906|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
28095577|NCT03714672|54749935|FG000|Overall Study|Adverse Event|0|||
28095578|NCT03714672|54749936|FG001|Overall Study|Adverse Event|0|||
28171105|NCT02055547|54842682|FG011|Overall Study|Protocol Violation|0|||
27738789|NCT02246218|54188111|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
27738790|NCT02246218|54188110|FG000|Overall Study|Stopping Rule: Liver Transplant|2|||
27738791|NCT02246218|54188111|FG001|Overall Study|Stopping Rule: Liver Transplant|4|||
27738792|NCT02246218|54188110|FG000|Overall Study|Adverse Event|1|||
27738793|NCT02246218|54188111|FG001|Overall Study|Adverse Event|1|||
27833828|NCT01372410|54317356|FG006|Treatment Period 1 (7 Days)|Adverse Event|1|||
27833829|NCT01372410|54317357|FG007|Treatment Period 1 (7 Days)|Adverse Event|0|||
27833830|NCT01372410|54317350|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
27833831|NCT01372410|54317351|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
27833832|NCT01372410|54317352|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
27833833|NCT01372410|54317353|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
27833834|NCT01372410|54317354|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
27833835|NCT01372410|54317355|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
27833836|NCT01372410|54317356|FG006|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
27833837|NCT01372410|54317357|FG007|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
27833838|NCT01372410|54317350|FG000|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
27833839|NCT01372410|54317351|FG001|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
27833840|NCT01372410|54317352|FG002|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
27833841|NCT01372410|54317353|FG003|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
27833842|NCT01372410|54317354|FG004|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
27833843|NCT01372410|54317355|FG005|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
27833844|NCT01372410|54317356|FG006|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1|||
27833845|NCT01372410|54317357|FG007|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
27833846|NCT01372410|54317350|FG000|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
27833847|NCT01372410|54317351|FG001|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
27833848|NCT01372410|54317352|FG002|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
27833849|NCT01372410|54317353|FG003|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
27833850|NCT01372410|54317354|FG004|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
27833851|NCT01372410|54317355|FG005|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
27833852|NCT01372410|54317356|FG006|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
27833853|NCT01372410|54317357|FG007|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
27833854|NCT01372410|54317350|FG000|Washout Period 2 (10-14 Days)|Adverse Event|0|||
27833855|NCT01372410|54317351|FG001|Washout Period 2 (10-14 Days)|Adverse Event|0|||
27833856|NCT01372410|54317352|FG002|Washout Period 2 (10-14 Days)|Adverse Event|0|||
27981036|NCT00951665|54638988|FG005|Phase 1b|Death|0|||
28095579|NCT03714672|54749937|FG002|Overall Study|Adverse Event|3|||
28095580|NCT03714672|54749938|FG003|Overall Study|Adverse Event|0|||
27738794|NCT02246218|54188110|FG000|Overall Study|Lost to Follow-up|1|||
28171106|NCT02055547|54842683|FG012|Overall Study|Protocol Violation|0|||
28171107|NCT02055547|54842684|FG013|Overall Study|Protocol Violation|0|||
28171108|NCT02055547|54842685|FG014|Overall Study|Protocol Violation|0|||
28171109|NCT02055547|54842686|FG015|Overall Study|Protocol Violation|0|||
28171110|NCT02055547|54842687|FG016|Overall Study|Protocol Violation|0|||
28171111|NCT02055547|54842688|FG017|Overall Study|Protocol Violation|0|||
28171112|NCT02055547|54842689|FG018|Overall Study|Protocol Violation|0|||
28171113|NCT02055547|54842671|FG000|Overall Study|Physician Decision|0|||
27833857|NCT01372410|54317353|FG003|Washout Period 2 (10-14 Days)|Adverse Event|0|||
27833858|NCT01372410|54317354|FG004|Washout Period 2 (10-14 Days)|Adverse Event|1|||
27833859|NCT01372410|54317355|FG005|Washout Period 2 (10-14 Days)|Adverse Event|0|||
27833860|NCT01372410|54317356|FG006|Washout Period 2 (10-14 Days)|Adverse Event|0|||
27833861|NCT01372410|54317357|FG007|Washout Period 2 (10-14 Days)|Adverse Event|0|||
27833862|NCT01372410|54317350|FG000|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
27833863|NCT01372410|54317351|FG001|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
27833864|NCT01372410|54317352|FG002|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
27833865|NCT01372410|54317353|FG003|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
27833866|NCT01372410|54317354|FG004|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
27833867|NCT01372410|54317355|FG005|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
27833868|NCT01372410|54317356|FG006|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
27833869|NCT01372410|54317357|FG007|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
27833870|NCT01372410|54317350|FG000|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
27833871|NCT01372410|54317351|FG001|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
27833872|NCT01372410|54317352|FG002|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
27833873|NCT01372410|54317353|FG003|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
27833874|NCT01372410|54317354|FG004|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
27833875|NCT01372410|54317355|FG005|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
27833876|NCT01372410|54317356|FG006|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
27833877|NCT01372410|54317357|FG007|Washout Period 2 (10-14 Days)|Lack of Efficacy|1|||
27833878|NCT01372410|54317350|FG000|Treatment Period 3 (7 Days)|Adverse Event|0|||
27833879|NCT01372410|54317351|FG001|Treatment Period 3 (7 Days)|Adverse Event|0|||
27833880|NCT01372410|54317352|FG002|Treatment Period 3 (7 Days)|Adverse Event|1|||
27833881|NCT01372410|54317353|FG003|Treatment Period 3 (7 Days)|Adverse Event|0|||
27833882|NCT01372410|54317354|FG004|Treatment Period 3 (7 Days)|Adverse Event|0|||
27833883|NCT01372410|54317355|FG005|Treatment Period 3 (7 Days)|Adverse Event|0|||
27833884|NCT01372410|54317356|FG006|Treatment Period 3 (7 Days)|Adverse Event|0|||
27833885|NCT01372410|54317357|FG007|Treatment Period 3 (7 Days)|Adverse Event|0|||
27833886|NCT01372410|54317350|FG000|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
27833887|NCT01372410|54317351|FG001|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
27833888|NCT01372410|54317352|FG002|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
27833889|NCT01372410|54317353|FG003|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
27833890|NCT01372410|54317354|FG004|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
27833891|NCT01372410|54317355|FG005|Treatment Period 3 (7 Days)|Protocol Deviation|1|||
27833892|NCT01372410|54317356|FG006|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
27833893|NCT01372410|54317357|FG007|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
27833894|NCT04624672|54317378|FG000|Overall Study|Early Study Closure|2|||
27833895|NCT04624672|54317379|FG001|Overall Study|Early Study Closure|1|||
27981037|NCT00951665|54638983|FG000|Phase 1b|Physician Decision|4|||
27981038|NCT00951665|54638984|FG001|Phase 1b|Physician Decision|0|||
27981039|NCT00951665|54638985|FG002|Phase 1b|Physician Decision|1|||
27981040|NCT00951665|54638986|FG003|Phase 1b|Physician Decision|0|||
27981041|NCT00951665|54638987|FG004|Phase 1b|Physician Decision|0|||
27981042|NCT00951665|54638988|FG005|Phase 1b|Physician Decision|0|||
27981043|NCT00951665|54638983|FG000|Phase 1b|Withdrawal by Subject|0|||
27981044|NCT00951665|54638984|FG001|Phase 1b|Withdrawal by Subject|1|||
27981045|NCT00951665|54638985|FG002|Phase 1b|Withdrawal by Subject|0|||
27981046|NCT00951665|54638986|FG003|Phase 1b|Withdrawal by Subject|0|||
27981047|NCT00951665|54638987|FG004|Phase 1b|Withdrawal by Subject|0|||
27981048|NCT00951665|54638988|FG005|Phase 1b|Withdrawal by Subject|0|||
27981049|NCT00951665|54638983|FG000|Phase 1b|Disease Progression|13|||
27981050|NCT00951665|54638984|FG001|Phase 1b|Disease Progression|2|||
27833910|NCT01704287|54317415|FG000|Initial Treatment Period|Death|139|||
27833911|NCT01704287|54317416|FG001|Initial Treatment Period|Death|129|||
27833912|NCT01704287|54317417|FG002|Initial Treatment Period|Death|71|||
27833913|NCT01704287|54317418|FG003|Initial Treatment Period|Death|0|||
27833914|NCT01704287|54317419|FG004|Initial Treatment Period|Death|0|||
27833915|NCT01704287|54317415|FG000|Initial Treatment Period|Withdrawal by Subject|3|||
27833916|NCT01704287|54317416|FG001|Initial Treatment Period|Withdrawal by Subject|2|||
27833917|NCT01704287|54317417|FG002|Initial Treatment Period|Withdrawal by Subject|4|||
28171114|NCT02055547|54842672|FG001|Overall Study|Physician Decision|1|||
28171115|NCT02055547|54842673|FG002|Overall Study|Physician Decision|1|||
28171116|NCT02055547|54842674|FG003|Overall Study|Physician Decision|0|||
27833918|NCT01704287|54317418|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
27981051|NCT00951665|54638985|FG002|Phase 1b|Disease Progression|14|||
27856836|NCT00985088|54392952|FG006|Overall Study|Migrated/moved from study area|0|||
27856837|NCT00985088|54392953|FG007|Overall Study|Migrated/moved from study area|1|||
27856838|NCT00985088|54392946|FG000|Overall Study|Lost to Follow-up|6|||
27856839|NCT00985088|54392947|FG001|Overall Study|Lost to Follow-up|1|||
27856840|NCT00985088|54392948|FG002|Overall Study|Lost to Follow-up|2|||
27856841|NCT00985088|54392949|FG003|Overall Study|Lost to Follow-up|6|||
27856842|NCT00985088|54392950|FG004|Overall Study|Lost to Follow-up|6|||
27856843|NCT00985088|54392951|FG005|Overall Study|Lost to Follow-up|5|||
27856844|NCT00985088|54392952|FG006|Overall Study|Lost to Follow-up|3|||
27856845|NCT00985088|54392953|FG007|Overall Study|Lost to Follow-up|2|||
27856846|NCT00984542|54392999|FG000|Overall Study|disease progression|19|||
27856847|NCT00984542|54392999|FG000|Overall Study|toxicity|7|||
27856848|NCT00984542|54392999|FG000|Overall Study|Death|7|||
27856849|NCT00984542|54392999|FG000|Overall Study|complicating disease|3|||
27856850|NCT00984542|54392999|FG000|Overall Study|Withdrawal by Subject|3|||
27856851|NCT00984542|54392999|FG000|Overall Study|clinical deterioration|2|||
27856852|NCT00983918|54393008|FG000|Overall Study|conversion to open cholecystectomy|0|||
27856853|NCT00983918|54393009|FG001|Overall Study|conversion to open cholecystectomy|2|||
27856854|NCT00983918|54393010|FG002|Overall Study|conversion to open cholecystectomy|2|||
27856855|NCT00983918|54393011|FG003|Overall Study|conversion to open cholecystectomy|2|||
27856856|NCT00983528|54393021|FG000|Overall Study|Death|4|||
27856857|NCT00983528|54393021|FG000|Overall Study|Lost to Follow-up|1|||
27856858|NCT00983528|54393021|FG000|Overall Study|Study Terminated|1|||
27856859|NCT00983372|54393025|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
27856860|NCT00983372|54393025|FG000|Diltiazem ER Alone|missed diltiazem dose|2|||
27856861|NCT00983372|54393025|FG000|Diltiazem ER Alone|Adverse Event|1|||
27856862|NCT00983294|54393057|FG000|14 Day Washout Period|Withdrawal by Subject|2|||
27856863|NCT00983294|54393057|FG000|Colchicine With Azithromycin|Adverse Event|1|||
27856864|NCT00982280|54393073|FG000|Observation Period|Not eligible to be dosed|19|||
27856865|NCT00982280|54393073|FG000|Titration and Optimal Dose Period|Adverse Event|5|||
27833919|NCT01704287|54317419|FG004|Initial Treatment Period|Withdrawal by Subject|0|||
27833920|NCT01704287|54317415|FG000|Initial Treatment Period|Lost to Follow-up|5|||
27833921|NCT01704287|54317416|FG001|Initial Treatment Period|Lost to Follow-up|3|||
27833922|NCT01704287|54317417|FG002|Initial Treatment Period|Lost to Follow-up|0|||
27833923|NCT01704287|54317418|FG003|Initial Treatment Period|Lost to Follow-up|0|||
27833924|NCT01704287|54317419|FG004|Initial Treatment Period|Lost to Follow-up|0|||
27856866|NCT00982280|54393073|FG000|Titration and Optimal Dose Period|Lack of Efficacy|2|||
27856867|NCT00982280|54393073|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|1|||
27856868|NCT00982280|54393073|FG000|Maintenance Period|Adverse Event|1|||
27856869|NCT00981578|54393091|FG000|Overall Study|Death|1|||
27856870|NCT00981578|54393091|FG000|Overall Study|Withdrawal by Subject|2|||
27856871|NCT00980798|54393114|FG000|Overall Study|Adverse Event|7|||
27856872|NCT00980798|54393115|FG001|Overall Study|Adverse Event|36|||
27856873|NCT00980798|54393114|FG000|Overall Study|Lack of Efficacy|16|||
27856874|NCT00980798|54393115|FG001|Overall Study|Lack of Efficacy|5|||
27856875|NCT00980798|54393114|FG000|Overall Study|Lost to Follow-up|0|||
27856876|NCT00980798|54393115|FG001|Overall Study|Lost to Follow-up|1|||
27856877|NCT00980798|54393114|FG000|Overall Study|Physician Decision|2|||
27856878|NCT00980798|54393115|FG001|Overall Study|Physician Decision|1|||
27856879|NCT00980798|54393114|FG000|Overall Study|Withdrawal by Subject|8|||
27856880|NCT00980798|54393115|FG001|Overall Study|Withdrawal by Subject|11|||
27856881|NCT00980798|54393114|FG000|Overall Study|Other|0|||
27856882|NCT00980798|54393115|FG001|Overall Study|Other|1|||
27856883|NCT00980330|54393260|FG000|Overall Study|Adverse Event|0|||
27856884|NCT00980330|54393261|FG001|Overall Study|Adverse Event|0|||
27856885|NCT00980330|54393262|FG002|Overall Study|Adverse Event|0|||
27856886|NCT00980330|54393263|FG003|Overall Study|Adverse Event|1|||
27856887|NCT00980330|54393264|FG004|Overall Study|Adverse Event|0|||
27856888|NCT00980330|54393265|FG005|Overall Study|Adverse Event|0|||
27856889|NCT00980330|54393266|FG006|Overall Study|Adverse Event|0|||
27856890|NCT00980330|54393260|FG000|Overall Study|Lost to Follow-up|1|||
27856891|NCT00980330|54393261|FG001|Overall Study|Lost to Follow-up|1|||
27833925|NCT01704287|54317415|FG000|Initial Treatment Period|Switched to Pembrolizumab|0|||
27833926|NCT01704287|54317416|FG001|Initial Treatment Period|Switched to Pembrolizumab|0|||
27833927|NCT01704287|54317417|FG002|Initial Treatment Period|Switched to Pembrolizumab|98|||
27833928|NCT01704287|54317418|FG003|Initial Treatment Period|Switched to Pembrolizumab|0|||
27856892|NCT00980330|54393262|FG002|Overall Study|Lost to Follow-up|4|||
27856893|NCT00980330|54393263|FG003|Overall Study|Lost to Follow-up|2|||
27856894|NCT00980330|54393264|FG004|Overall Study|Lost to Follow-up|1|||
27856895|NCT00980330|54393265|FG005|Overall Study|Lost to Follow-up|1|||
27856896|NCT00980330|54393266|FG006|Overall Study|Lost to Follow-up|2|||
27856897|NCT00980330|54393260|FG000|Overall Study|Withdrawal by Subject|2|||
27856898|NCT00980330|54393261|FG001|Overall Study|Withdrawal by Subject|4|||
27856899|NCT00980330|54393262|FG002|Overall Study|Withdrawal by Subject|4|||
27856900|NCT00980330|54393263|FG003|Overall Study|Withdrawal by Subject|1|||
27856901|NCT00980330|54393264|FG004|Overall Study|Withdrawal by Subject|3|||
27981052|NCT00951665|54638986|FG003|Phase 1b|Disease Progression|0|||
27833929|NCT01704287|54317419|FG004|Initial Treatment Period|Switched to Pembrolizumab|0|||
27833930|NCT01704287|54317415|FG000|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
27833931|NCT01704287|54317416|FG001|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
27833932|NCT01704287|54317417|FG002|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
27833933|NCT01704287|54317418|FG003|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2|||
27981053|NCT00951665|54638987|FG004|Phase 1b|Disease Progression|0|||
27981054|NCT00951665|54638988|FG005|Phase 1b|Disease Progression|0|||
28171117|NCT02055547|54842675|FG004|Overall Study|Physician Decision|1|||
28171118|NCT02055547|54842676|FG005|Overall Study|Physician Decision|0|||
28171119|NCT02055547|54842677|FG006|Overall Study|Physician Decision|0|||
28171120|NCT02055547|54842678|FG007|Overall Study|Physician Decision|0|||
28171121|NCT02055547|54842679|FG008|Overall Study|Physician Decision|0|||
28171122|NCT02055547|54842680|FG009|Overall Study|Physician Decision|1|||
28171123|NCT02055547|54842681|FG010|Overall Study|Physician Decision|1|||
28171124|NCT02055547|54842682|FG011|Overall Study|Physician Decision|0|||
28095581|NCT03714672|54749935|FG000|Overall Study|Physician Decision|0|||
28095582|NCT03714672|54749936|FG001|Overall Study|Physician Decision|1|||
28095583|NCT03714672|54749937|FG002|Overall Study|Physician Decision|0|||
28095584|NCT03714672|54749938|FG003|Overall Study|Physician Decision|0|||
28171125|NCT02055547|54842683|FG012|Overall Study|Physician Decision|0|||
28171126|NCT02055547|54842684|FG013|Overall Study|Physician Decision|0|||
28171127|NCT02055547|54842685|FG014|Overall Study|Physician Decision|0|||
28171128|NCT02055547|54842686|FG015|Overall Study|Physician Decision|0|||
28171129|NCT02055547|54842687|FG016|Overall Study|Physician Decision|0|||
28171130|NCT02055547|54842688|FG017|Overall Study|Physician Decision|0|||
28171131|NCT02055547|54842689|FG018|Overall Study|Physician Decision|0|||
28171132|NCT02055547|54842671|FG000|Overall Study|Adverse Event|0|||
28171133|NCT02055547|54842672|FG001|Overall Study|Adverse Event|0|||
28171134|NCT02055547|54842673|FG002|Overall Study|Adverse Event|0|||
28171135|NCT02055547|54842674|FG003|Overall Study|Adverse Event|0|||
28171136|NCT02055547|54842675|FG004|Overall Study|Adverse Event|0|||
28171137|NCT02055547|54842676|FG005|Overall Study|Adverse Event|0|||
28171138|NCT02055547|54842677|FG006|Overall Study|Adverse Event|1|||
28171139|NCT02055547|54842678|FG007|Overall Study|Adverse Event|0|||
28171140|NCT02055547|54842679|FG008|Overall Study|Adverse Event|1|||
28171141|NCT02055547|54842680|FG009|Overall Study|Adverse Event|0|||
28171142|NCT02055547|54842681|FG010|Overall Study|Adverse Event|0|||
28171143|NCT02055547|54842682|FG011|Overall Study|Adverse Event|0|||
28171144|NCT02055547|54842683|FG012|Overall Study|Adverse Event|0|||
28171145|NCT02055547|54842684|FG013|Overall Study|Adverse Event|0|||
28171146|NCT02055547|54842685|FG014|Overall Study|Adverse Event|0|||
28171147|NCT02055547|54842686|FG015|Overall Study|Adverse Event|0|||
28171148|NCT02055547|54842687|FG016|Overall Study|Adverse Event|0|||
27738795|NCT02246218|54188111|FG001|Overall Study|Lost to Follow-up|0|||
27738796|NCT02244580|54188117|FG000|Overall Study|No cancer tissues available|241|||
27738797|NCT02244424|54188127|FG000|Overall Study|Lost to Follow-up|20|||
27738798|NCT02244424|54188128|FG001|Overall Study|Lost to Follow-up|10|||
27738799|NCT00159783|54188137|FG000|Overall Study|Adverse Event|5|||
27738800|NCT00159783|54188138|FG001|Overall Study|Adverse Event|7|||
27738801|NCT00159783|54188139|FG002|Overall Study|Adverse Event|9|||
27738802|NCT00159783|54188137|FG000|Overall Study|Lack of Efficacy|1|||
27738803|NCT00159783|54188138|FG001|Overall Study|Lack of Efficacy|2|||
27738804|NCT00159783|54188139|FG002|Overall Study|Lack of Efficacy|3|||
27738805|NCT00159783|54188137|FG000|Overall Study|Withdrawal by Subject|7|||
27738806|NCT00159783|54188138|FG001|Overall Study|Withdrawal by Subject|11|||
27738807|NCT00159783|54188139|FG002|Overall Study|Withdrawal by Subject|12|||
27738808|NCT00159783|54188137|FG000|Overall Study|Lost to Follow-up|6|||
27738809|NCT00159783|54188138|FG001|Overall Study|Lost to Follow-up|5|||
28095585|NCT03714672|54749935|FG000|Overall Study|Other Reason|1|||
28095586|NCT03714672|54749936|FG001|Overall Study|Other Reason|2|||
28171149|NCT02055547|54842688|FG017|Overall Study|Adverse Event|0|||
28171150|NCT02055547|54842689|FG018|Overall Study|Adverse Event|0|||
28171151|NCT02055547|54842671|FG000|Overall Study|Withdrawal by Subject|0|||
28171152|NCT02055547|54842672|FG001|Overall Study|Withdrawal by Subject|0|||
28095587|NCT03714672|54749937|FG002|Overall Study|Other Reason|1|||
28095588|NCT03714672|54749938|FG003|Overall Study|Other Reason|1|||
28095589|NCT03714672|54749935|FG000|Overall Study|Lost to Follow-up|1|||
28095590|NCT03714672|54749936|FG001|Overall Study|Lost to Follow-up|1|||
28171153|NCT02055547|54842673|FG002|Overall Study|Withdrawal by Subject|0|||
28171154|NCT02055547|54842674|FG003|Overall Study|Withdrawal by Subject|0|||
27738810|NCT00159783|54188139|FG002|Overall Study|Lost to Follow-up|11|||
27738811|NCT00159783|54188137|FG000|Overall Study|Other|0|||
27738812|NCT00159783|54188138|FG001|Overall Study|Other|2|||
28095591|NCT03714672|54749937|FG002|Overall Study|Lost to Follow-up|0|||
28171155|NCT02055547|54842675|FG004|Overall Study|Withdrawal by Subject|0|||
28171156|NCT02055547|54842676|FG005|Overall Study|Withdrawal by Subject|1|||
27738813|NCT00159783|54188139|FG002|Overall Study|Other|4|||
27738814|NCT00646204|54188150|FG000|Overall Study|Adverse Event|3|||
28171157|NCT02055547|54842677|FG006|Overall Study|Withdrawal by Subject|0|||
27833934|NCT01704287|54317419|FG004|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1|||
27833935|NCT01704287|54317415|FG000|Switch to Pembrolizumab Treatment Period|Death|0|||
27833936|NCT01704287|54317416|FG001|Switch to Pembrolizumab Treatment Period|Death|0|||
27833937|NCT01704287|54317417|FG002|Switch to Pembrolizumab Treatment Period|Death|0|||
27833938|NCT01704287|54317418|FG003|Switch to Pembrolizumab Treatment Period|Death|35|||
27833939|NCT01704287|54317419|FG004|Switch to Pembrolizumab Treatment Period|Death|37|||
27833940|NCT01704287|54317415|FG000|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
27833941|NCT01704287|54317416|FG001|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
27833942|NCT01704287|54317417|FG002|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
27833943|NCT01704287|54317418|FG003|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1|||
27833944|NCT01704287|54317419|FG004|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
27833945|NCT01682837|54317447|FG000|Baseline|Withdrawal by Subject|5|||
27833946|NCT01703819|54317484|FG000|Overall Study|Adverse Event|0|||
27833947|NCT01703819|54317485|FG001|Overall Study|Adverse Event|1|||
27833948|NCT01703819|54317484|FG000|Overall Study|Withdrawal by Subject|0|||
27833949|NCT01703819|54317485|FG001|Overall Study|Withdrawal by Subject|1|||
27833950|NCT01682759|54317497|FG000|Overall Study|Death|2|||
27833951|NCT01682759|54317498|FG001|Overall Study|Death|1|||
27833952|NCT01682759|54317497|FG000|Overall Study|Lost to Follow-up|10|||
27833953|NCT01682759|54317498|FG001|Overall Study|Lost to Follow-up|13|||
27833954|NCT01682759|54317497|FG000|Overall Study|Physician Decision|1|||
27833955|NCT01682759|54317498|FG001|Overall Study|Physician Decision|1|||
27833956|NCT01682759|54317497|FG000|Overall Study|Withdrawal by Subject|56|||
27856902|NCT00980330|54393265|FG005|Overall Study|Withdrawal by Subject|2|||
27856903|NCT00980330|54393266|FG006|Overall Study|Withdrawal by Subject|5|||
27856904|NCT00980330|54393260|FG000|Overall Study|(not specified)|2|||
27856905|NCT00980330|54393261|FG001|Overall Study|(not specified)|0|||
27856906|NCT00980330|54393262|FG002|Overall Study|(not specified)|0|||
27856907|NCT00980330|54393263|FG003|Overall Study|(not specified)|1|||
27833957|NCT01682759|54317498|FG001|Overall Study|Withdrawal by Subject|55|||
27833958|NCT01682681|54317508|FG000|Overall Study|Lack of Efficacy|62|||
27833959|NCT01682681|54317508|FG000|Overall Study|Withdrawal by Subject|1|||
27833960|NCT01682681|54317508|FG000|Overall Study|Moved to other hospital|10|||
27856908|NCT00980330|54393264|FG004|Overall Study|(not specified)|1|||
27856909|NCT00980330|54393265|FG005|Overall Study|(not specified)|1|||
27856910|NCT00980330|54393266|FG006|Overall Study|(not specified)|0|||
27856911|NCT00980174|54393310|FG000|Overall Study|Withdrawal by Subject|1|||
27856912|NCT00980174|54393311|FG001|Overall Study|Withdrawal by Subject|4|||
27856913|NCT00980174|54393310|FG000|Overall Study|Adverse Event|0|||
27856914|NCT00980174|54393311|FG001|Overall Study|Adverse Event|3|||
27856915|NCT00980174|54393310|FG000|Overall Study|Ineligibility determined|2|||
27856916|NCT00980174|54393311|FG001|Overall Study|Ineligibility determined|1|||
27856917|NCT00980174|54393310|FG000|Overall Study|Death|1|||
27856918|NCT00980174|54393311|FG001|Overall Study|Death|1|||
27856919|NCT00980174|54393310|FG000|Overall Study|Other|0|||
27833961|NCT01682681|54317508|FG000|Overall Study|Lost to Follow-up|174|||
27833962|NCT01682681|54317508|FG000|Overall Study|Adverse Event|46|||
27856920|NCT00980174|54393311|FG001|Overall Study|Other|1|||
27856921|NCT00980018|54393339|FG000|Overall Study|Adverse Event|8|||
27856922|NCT00980018|54393339|FG000|Overall Study|Patient withdrew consent|3|||
27856923|NCT00980018|54393339|FG000|Overall Study|Lost to Follow-up|1|||
27856924|NCT00981656|54393360|FG000|Overall Study|Protocol Violation|1|||
27856925|NCT00981656|54393360|FG000|Overall Study|Did not start protocol treatment|2|||
27856926|NCT00988052|54393366|FG000|Overall Study|Missing|1|||
27856927|NCT00988052|54393367|FG001|Overall Study|Missing|0|||
27856928|NCT00988052|54393366|FG000|Overall Study|Teva requested subject withdrawal|3|||
27856929|NCT00988052|54393367|FG001|Overall Study|Teva requested subject withdrawal|1|||
27856930|NCT00988052|54393366|FG000|Overall Study|Death|1|||
27856931|NCT00988052|54393367|FG001|Overall Study|Death|3|||
28095592|NCT03714672|54749938|FG003|Overall Study|Lost to Follow-up|0|||
28095593|NCT03083470|54749954|FG000|Overall Study|Lost to Follow-up|0|||
27833963|NCT01682681|54317508|FG000|Overall Study|tapering of topiramate|5|||
27856932|NCT00988052|54393366|FG000|Overall Study|Protocol Violation|6|||
27856933|NCT00988052|54393367|FG001|Overall Study|Protocol Violation|5|||
27856934|NCT00988052|54393366|FG000|Overall Study|Pregnancy|6|||
27856935|NCT00988052|54393367|FG001|Overall Study|Pregnancy|6|||
28095594|NCT03083470|54749955|FG001|Overall Study|Lost to Follow-up|0|||
28095595|NCT03083470|54749956|FG002|Overall Study|Lost to Follow-up|0|||
27833964|NCT01682681|54317508|FG000|Overall Study|Other|21|||
27833965|NCT01682681|54317508|FG000|Overall Study|Low compliance|13|||
27856936|NCT00988052|54393366|FG000|Overall Study|Lack of Efficacy|8|||
27856937|NCT00988052|54393367|FG001|Overall Study|Lack of Efficacy|7|||
27856938|NCT00988052|54393366|FG000|Overall Study|Lost to Follow-up|6|||
27856939|NCT00988052|54393367|FG001|Overall Study|Lost to Follow-up|11|||
28095596|NCT03083470|54749957|FG003|Overall Study|Lost to Follow-up|0|||
28095597|NCT03083470|54749958|FG004|Overall Study|Lost to Follow-up|1|||
27833966|NCT01682603|54317512|FG000|Overall Study|Lost to Follow-up|3|||
27856940|NCT00988052|54393366|FG000|Overall Study|Physician Decision|27|||
27833967|NCT01682213|54317528|FG000|Overall Study|Withdrawal by Subject|2|||
27833968|NCT01703741|54317537|FG000|Overall Study|Withdrawal by Subject|6|||
27833969|NCT01703741|54317537|FG000|Overall Study|Adverse Event|2|||
27833970|NCT01703741|54317537|FG000|Overall Study|Physician Decision|2|||
27833971|NCT01703741|54317537|FG000|Overall Study|Protocol Violation|1|||
27833972|NCT01703741|54317537|FG000|Overall Study|Lost to Follow-up|3|||
27833973|NCT01703741|54317537|FG000|Overall Study|Subject did not want to continue|2|||
27833974|NCT01703741|54317537|FG000|Overall Study|Subject cannot comply with study visits|1|||
27833975|NCT01703741|54317537|FG000|Overall Study|Subject started testosterone injections|1|||
27833976|NCT01681511|54317543|FG000|Overall Study|No Treatment Received|1|||
27833977|NCT01681511|54317544|FG001|Overall Study|No Treatment Received|3|||
27833978|NCT01681511|54317543|FG000|Overall Study|Failed Inclusion/Exclusion|3|||
27833979|NCT01681511|54317544|FG001|Overall Study|Failed Inclusion/Exclusion|0|||
27856941|NCT00988052|54393367|FG001|Overall Study|Physician Decision|28|||
27856942|NCT00988052|54393366|FG000|Overall Study|Adverse Event|35|||
27856943|NCT00988052|54393367|FG001|Overall Study|Adverse Event|28|||
27856944|NCT00988052|54393366|FG000|Overall Study|Withdrawal by Subject|90|||
27856945|NCT00988052|54393367|FG001|Overall Study|Withdrawal by Subject|91|||
27856946|NCT00988052|54393366|FG000|Overall Study|Study terminated by sponsor|240|||
27856947|NCT00988052|54393367|FG001|Overall Study|Study terminated by sponsor|236|||
27856948|NCT02569710|54393468|FG000|Overall Study|Adverse Event|1|||
27856949|NCT02569710|54393469|FG001|Overall Study|Adverse Event|0|||
27856950|NCT02569710|54393470|FG002|Overall Study|Adverse Event|0|||
27856951|NCT02569710|54393471|FG003|Overall Study|Adverse Event|0|||
27856952|NCT02569710|54393472|FG004|Overall Study|Adverse Event|0|||
27856953|NCT02569710|54393473|FG005|Overall Study|Adverse Event|0|||
27856954|NCT02569710|54393474|FG006|Overall Study|Adverse Event|0|||
27856955|NCT02569710|54393475|FG007|Overall Study|Adverse Event|0|||
27856956|NCT02569710|54393476|FG008|Overall Study|Adverse Event|0|||
27856957|NCT02569710|54393477|FG009|Overall Study|Adverse Event|0|||
27856958|NCT02569710|54393468|FG000|Overall Study|Lost to Follow-up|0|||
27856959|NCT02569710|54393469|FG001|Overall Study|Lost to Follow-up|0|||
27856960|NCT02569710|54393470|FG002|Overall Study|Lost to Follow-up|0|||
27856961|NCT02569710|54393471|FG003|Overall Study|Lost to Follow-up|0|||
27856962|NCT02569710|54393472|FG004|Overall Study|Lost to Follow-up|0|||
28095598|NCT03083470|54749954|FG000|Overall Study|Withdrawal by Subject|0|||
28095599|NCT03083470|54749955|FG001|Overall Study|Withdrawal by Subject|0|||
28095600|NCT03083470|54749956|FG002|Overall Study|Withdrawal by Subject|0|||
28095601|NCT03083470|54749957|FG003|Overall Study|Withdrawal by Subject|0|||
28095602|NCT03083470|54749958|FG004|Overall Study|Withdrawal by Subject|1|||
28095603|NCT05405244|54749970|FG000|Washout (2 Weeks)|Lost to Follow-up|0|||
28095604|NCT05405244|54749971|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
28095605|NCT05405244|54749970|FG000|Washout (2 Weeks)|Adverse Event|2|||
28095606|NCT05405244|54749971|FG001|Washout (2 Weeks)|Adverse Event|0|||
28095607|NCT05405244|54749970|FG000|Washout (2 Weeks)|Withdrawal by Subject|2|||
28095608|NCT05405244|54749971|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
28095609|NCT03074500|54749984|FG000|Overall Study|Lost to Follow-up|1|||
28095610|NCT03074500|54749985|FG001|Overall Study|Lost to Follow-up|0|||
28095611|NCT03074500|54749986|FG002|Overall Study|Lost to Follow-up|0|||
28095612|NCT03074500|54749984|FG000|Overall Study|Lack of Efficacy|0|||
28095613|NCT03074500|54749985|FG001|Overall Study|Lack of Efficacy|1|||
28095614|NCT03074500|54749986|FG002|Overall Study|Lack of Efficacy|0|||
28095615|NCT03074500|54749984|FG000|Overall Study|Adverse Event|0|||
28095616|NCT03074500|54749985|FG001|Overall Study|Adverse Event|0|||
28095617|NCT03074500|54749986|FG002|Overall Study|Adverse Event|1|||
28095618|NCT03715530|54749999|FG000|Overall Study|Lost to Follow-up|3|||
28095619|NCT03715530|54750000|FG001|Overall Study|Lost to Follow-up|1|||
28095620|NCT03715530|54750001|FG002|Overall Study|Lost to Follow-up|2|||
28095621|NCT03077698|54750011|FG000|Progestin Monotherapy|Stable Disease|8|||
28095622|NCT03077698|54750012|FG001|Progestin Monotherapy|Stable Disease|0|||
28095623|NCT03077698|54750011|FG000|Progestin Monotherapy|Adverse Event|1|||
28095624|NCT03077698|54750012|FG001|Progestin Monotherapy|Adverse Event|0|||
28095625|NCT03077698|54750011|FG000|Progestin Monotherapy|Death|1|||
28095626|NCT03077698|54750012|FG001|Progestin Monotherapy|Death|0|||
28095627|NCT03077698|54750011|FG000|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|0|||
28095628|NCT03077698|54750012|FG001|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|2|||
28095629|NCT03077698|54750011|FG000|Sodium Cridanimod & Progestin Therapy|Disease Progression|6|||
27833980|NCT01681511|54317543|FG000|Overall Study|No Baseline Dips Stick & Urine Culture|3|||
27833981|NCT01681511|54317544|FG001|Overall Study|No Baseline Dips Stick & Urine Culture|6|||
27856963|NCT02569710|54393473|FG005|Overall Study|Lost to Follow-up|0|||
27856964|NCT02569710|54393474|FG006|Overall Study|Lost to Follow-up|1|||
28095630|NCT03077698|54750012|FG001|Sodium Cridanimod & Progestin Therapy|Disease Progression|5|||
28095631|NCT03077698|54750011|FG000|Sodium Cridanimod & Progestin Therapy|Adverse Event|0|||
27833982|NCT01681511|54317543|FG000|Overall Study|No Daily Urine Sample Collected|0|||
27856965|NCT02569710|54393475|FG007|Overall Study|Lost to Follow-up|0|||
27856966|NCT02569710|54393476|FG008|Overall Study|Lost to Follow-up|1|||
28095632|NCT03077698|54750012|FG001|Sodium Cridanimod & Progestin Therapy|Adverse Event|2|||
28095633|NCT03077698|54750011|FG000|Safety Follow Up|Withdrawal by Subject|2|||
28095634|NCT03077698|54750012|FG001|Safety Follow Up|Withdrawal by Subject|1|||
28095635|NCT03077698|54750011|FG000|Safety Follow Up|Transfer of care to hospice|1|||
28095636|NCT03077698|54750012|FG001|Safety Follow Up|Transfer of care to hospice|0|||
28095637|NCT03079102|54750030|FG000|Overall Study|Physician Decision|0|||
28095638|NCT03079102|54750031|FG001|Overall Study|Physician Decision|1|||
28095639|NCT02434354|54750037|FG000|Overall Study|screen fail|3|||
28095640|NCT03076996|54750041|FG000|Overall Study|Withdrawal by Subject|2|||
28095641|NCT03076996|54750041|FG000|Overall Study|Lost to Follow-up|3|||
28095642|NCT03076996|54750041|FG000|Overall Study|Literacy precluded participation|1|||
28095643|NCT03078868|54750045|FG000|Overall Study|Physician Decision|3|||
28095644|NCT04524598|54750053|FG000|Phase I - Feasibility|Lost to Follow-up|2|||
28095645|NCT04524598|54750054|FG001|Phase I - Feasibility|Lost to Follow-up|4|||
28095646|NCT04524598|54750055|FG002|Phase I - Feasibility|Lost to Follow-up|0|||
28095647|NCT04524598|54750056|FG003|Phase I - Feasibility|Lost to Follow-up|0|||
28095648|NCT04524598|54750057|FG004|Phase I - Feasibility|Lost to Follow-up|0|||
28095649|NCT04524598|54750053|FG000|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|2|||
28095650|NCT04524598|54750054|FG001|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|1|||
28095651|NCT04524598|54750055|FG002|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
28095652|NCT04524598|54750056|FG003|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
28095653|NCT04524598|54750057|FG004|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
28095654|NCT04524598|54750053|FG000|Phase II - Outcomes|Lost to Follow-up|0|||
28095655|NCT04524598|54750054|FG001|Phase II - Outcomes|Lost to Follow-up|0|||
28095656|NCT04524598|54750055|FG002|Phase II - Outcomes|Lost to Follow-up|16|||
28095657|NCT04524598|54750056|FG003|Phase II - Outcomes|Lost to Follow-up|8|||
28095658|NCT04524598|54750057|FG004|Phase II - Outcomes|Lost to Follow-up|0|||
28095659|NCT04524598|54750053|FG000|Phase II - Outcomes|Withdrawal by Subject|0|||
28095660|NCT04524598|54750054|FG001|Phase II - Outcomes|Withdrawal by Subject|0|||
28095661|NCT04524598|54750055|FG002|Phase II - Outcomes|Withdrawal by Subject|2|||
28095662|NCT04524598|54750056|FG003|Phase II - Outcomes|Withdrawal by Subject|0|||
28095663|NCT04524598|54750057|FG004|Phase II - Outcomes|Withdrawal by Subject|0|||
28095664|NCT04524598|54750053|FG000|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
28095665|NCT04524598|54750054|FG001|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
28095666|NCT04524598|54750055|FG002|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|8|||
28095667|NCT04524598|54750056|FG003|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|5|||
28095668|NCT04524598|54750057|FG004|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
28095669|NCT04524598|54750053|FG000|Phase II - Control Extension|Lost to Follow-up|0|||
28095670|NCT04524598|54750054|FG001|Phase II - Control Extension|Lost to Follow-up|0|||
28095671|NCT04524598|54750055|FG002|Phase II - Control Extension|Lost to Follow-up|0|||
28095672|NCT04524598|54750056|FG003|Phase II - Control Extension|Lost to Follow-up|0|||
28095673|NCT04524598|54750057|FG004|Phase II - Control Extension|Lost to Follow-up|6|||
28095674|NCT04524598|54750053|FG000|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
28095675|NCT04524598|54750054|FG001|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
28095676|NCT04524598|54750055|FG002|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
28095677|NCT04524598|54750056|FG003|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
28095678|NCT04524598|54750057|FG004|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|6|||
28095679|NCT03075904|54750071|FG000|Overall Study|Physician Decision|3|||
28095680|NCT03075904|54750071|FG000|Overall Study|Need for Medication not Permitted|1|||
28095681|NCT03073798|54750075|FG000|Overall Study|Adverse Event|1|||
28171158|NCT02055547|54842678|FG007|Overall Study|Withdrawal by Subject|0|||
28171159|NCT02055547|54842679|FG008|Overall Study|Withdrawal by Subject|1|||
28171160|NCT02055547|54842680|FG009|Overall Study|Withdrawal by Subject|0|||
28171161|NCT02055547|54842681|FG010|Overall Study|Withdrawal by Subject|0|||
28171162|NCT02055547|54842682|FG011|Overall Study|Withdrawal by Subject|0|||
28171163|NCT02055547|54842683|FG012|Overall Study|Withdrawal by Subject|0|||
28171164|NCT02055547|54842684|FG013|Overall Study|Withdrawal by Subject|1|||
28171165|NCT02055547|54842685|FG014|Overall Study|Withdrawal by Subject|0|||
28171166|NCT02055547|54842686|FG015|Overall Study|Withdrawal by Subject|1|||
28171167|NCT02055547|54842687|FG016|Overall Study|Withdrawal by Subject|0|||
28171168|NCT02055547|54842688|FG017|Overall Study|Withdrawal by Subject|0|||
28171169|NCT02055547|54842689|FG018|Overall Study|Withdrawal by Subject|0|||
28171170|NCT02055547|54842671|FG000|Overall Study|Lost to Follow-up|0|||
28171171|NCT02055547|54842672|FG001|Overall Study|Lost to Follow-up|0|||
28171172|NCT02055547|54842673|FG002|Overall Study|Lost to Follow-up|1|||
28171173|NCT02055547|54842674|FG003|Overall Study|Lost to Follow-up|0|||
28171174|NCT02055547|54842675|FG004|Overall Study|Lost to Follow-up|0|||
28171175|NCT02055547|54842676|FG005|Overall Study|Lost to Follow-up|0|||
28171176|NCT02055547|54842677|FG006|Overall Study|Lost to Follow-up|0|||
28171177|NCT02055547|54842678|FG007|Overall Study|Lost to Follow-up|0|||
28171178|NCT02055547|54842679|FG008|Overall Study|Lost to Follow-up|0|||
28171179|NCT02055547|54842680|FG009|Overall Study|Lost to Follow-up|0|||
28171180|NCT02055547|54842681|FG010|Overall Study|Lost to Follow-up|0|||
28171181|NCT02055547|54842682|FG011|Overall Study|Lost to Follow-up|0|||
28171182|NCT02055547|54842683|FG012|Overall Study|Lost to Follow-up|0|||
28171183|NCT02055547|54842684|FG013|Overall Study|Lost to Follow-up|0|||
28171184|NCT02055547|54842685|FG014|Overall Study|Lost to Follow-up|0|||
28171185|NCT02055547|54842686|FG015|Overall Study|Lost to Follow-up|0|||
28171186|NCT02055547|54842687|FG016|Overall Study|Lost to Follow-up|0|||
28171187|NCT02055547|54842688|FG017|Overall Study|Lost to Follow-up|0|||
28171188|NCT02055547|54842689|FG018|Overall Study|Lost to Follow-up|0|||
28171189|NCT02414854|54842727|FG000|Overall Study|Adverse Event|9|||
28171190|NCT02414854|54842728|FG001|Overall Study|Adverse Event|7|||
27738815|NCT00646204|54188151|FG001|Overall Study|Adverse Event|0|||
27738816|NCT00646204|54188150|FG000|Overall Study|Withdrawal by Subject|1|||
28095682|NCT03073798|54750075|FG000|Overall Study|Withdrawal by Subject|1|||
28095683|NCT03075826|54750080|FG000|Overall Study|Withdrawal by Subject|1|||
28095684|NCT03075826|54750080|FG000|Overall Study|Received less than 3 cycles of study drug|5|||
28095685|NCT02865850|54750095|FG000|Overall Study|Death|15|||
28095686|NCT02865850|54750096|FG001|Overall Study|Death|19|||
28095687|NCT02865850|54750095|FG000|Overall Study|Withdrawal by Subject|3|||
27738817|NCT00646204|54188151|FG001|Overall Study|Withdrawal by Subject|0|||
27738818|NCT02936323|54188168|FG000|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
28095688|NCT02865850|54750096|FG001|Overall Study|Withdrawal by Subject|2|||
28095689|NCT02865850|54750095|FG000|Overall Study|Lost to Follow-up|3|||
28095690|NCT02865850|54750096|FG001|Overall Study|Lost to Follow-up|2|||
28095691|NCT03711162|54750105|FG000|Overall Study|Adverse Event|5|||
27833983|NCT01681511|54317544|FG001|Overall Study|No Daily Urine Sample Collected|1|||
28095692|NCT03711162|54750106|FG001|Overall Study|Adverse Event|2|||
28095693|NCT03711162|54750107|FG002|Overall Study|Adverse Event|4|||
28095694|NCT03711162|54750105|FG000|Overall Study|Death|11|||
28095695|NCT03711162|54750106|FG001|Overall Study|Death|7|||
28095696|NCT03711162|54750107|FG002|Overall Study|Death|8|||
28095697|NCT03711162|54750105|FG000|Overall Study|Lost to Follow-up|1|||
28095698|NCT03711162|54750106|FG001|Overall Study|Lost to Follow-up|0|||
28095699|NCT03711162|54750107|FG002|Overall Study|Lost to Follow-up|1|||
28095700|NCT03711162|54750105|FG000|Overall Study|Study Terminated by Sponsor|139|||
28095701|NCT03711162|54750106|FG001|Overall Study|Study Terminated by Sponsor|152|||
28095702|NCT03711162|54750107|FG002|Overall Study|Study Terminated by Sponsor|146|||
28095703|NCT03711162|54750105|FG000|Overall Study|Withdrawal by Subject|17|||
28095704|NCT03711162|54750106|FG001|Overall Study|Withdrawal by Subject|10|||
28095705|NCT03711162|54750107|FG002|Overall Study|Withdrawal by Subject|10|||
28095706|NCT03711162|54750105|FG000|Overall Study|Miscellaneous|1|||
28095707|NCT03711162|54750106|FG001|Overall Study|Miscellaneous|2|||
28095708|NCT03711162|54750107|FG002|Overall Study|Miscellaneous|2|||
28095709|NCT03711162|54750105|FG000|Overall Study|Not Treated|1|||
28095710|NCT03711162|54750106|FG001|Overall Study|Not Treated|0|||
28095711|NCT03711162|54750107|FG002|Overall Study|Not Treated|1|||
28095712|NCT03711162|54750105|FG000|Overall Study|Physician Decision|0|||
28095713|NCT03711162|54750106|FG001|Overall Study|Physician Decision|2|||
28095714|NCT03711162|54750107|FG002|Overall Study|Physician Decision|0|||
28095715|NCT03711162|54750105|FG000|Overall Study|Lack of Efficacy|0|||
28095716|NCT03711162|54750106|FG001|Overall Study|Lack of Efficacy|0|||
28095717|NCT03711162|54750107|FG002|Overall Study|Lack of Efficacy|2|||
28095718|NCT03711162|54750105|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
28095719|NCT03711162|54750106|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
28095720|NCT03711162|54750107|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
28095721|NCT03072160|54750123|FG000|Overall Study|Adverse Event|3|||
28095722|NCT03072160|54750124|FG001|Overall Study|Adverse Event|1|||
28095723|NCT03072160|54750123|FG000|Overall Study|Refused further treatment|6|||
28095724|NCT03072160|54750124|FG001|Overall Study|Refused further treatment|1|||
28095725|NCT03072160|54750123|FG000|Overall Study|Physician Decision|1|||
28095726|NCT03072160|54750124|FG001|Overall Study|Physician Decision|0|||
28095727|NCT03072160|54750123|FG000|Overall Study|Disease progression on study|1|||
28095728|NCT03072160|54750124|FG001|Overall Study|Disease progression on study|1|||
28171191|NCT02414854|54842729|FG002|Overall Study|Adverse Event|1|||
28095729|NCT03072160|54750123|FG000|Overall Study|No contact|0|||
28171192|NCT02414854|54842730|FG003|Overall Study|Adverse Event|12|||
28171193|NCT02414854|54842727|FG000|Overall Study|Poor compliance to protocol|1|||
28171194|NCT02414854|54842728|FG001|Overall Study|Poor compliance to protocol|1|||
27833984|NCT01681511|54317543|FG000|Overall Study|No post-catheter sample collected|11|||
28095730|NCT03072160|54750124|FG001|Overall Study|No contact|1|||
28095731|NCT00407602|54750162|FG000|Overall Study|Death - unrelated to device|1|||
28095732|NCT00407602|54750162|FG000|Overall Study|Device explanted|5|||
28095733|NCT00407602|54750162|FG000|Overall Study|Withdrawal by Subject|1|||
28095734|NCT03057496|54750169|FG000|Overall Study|Withdrawal by Subject|8|||
28095735|NCT03057496|54750169|FG000|Overall Study|Lost to Follow-up|5|||
28171195|NCT02414854|54842729|FG002|Overall Study|Poor compliance to protocol|2|||
28095736|NCT03057496|54750169|FG000|Overall Study|Did not use device during home trial|3|||
28095737|NCT03057496|54750169|FG000|Overall Study|Device failure|2|||
28095738|NCT03708744|54750179|FG000|Overall Study|Withdrawal by Subject|0|||
28095739|NCT03708744|54750180|FG001|Overall Study|Withdrawal by Subject|0|||
28095740|NCT03708744|54750181|FG002|Overall Study|Withdrawal by Subject|1|||
28095741|NCT03708744|54750182|FG003|Overall Study|Withdrawal by Subject|0|||
28095742|NCT02574286|54750196|FG000|Overall Study|Adverse Event|3|||
28095743|NCT02574286|54750196|FG000|Overall Study|Withdrawal by Subject|2|||
28095744|NCT02083354|54750204|FG000|Overall Study|Withdrawal by Subject|9|||
28095745|NCT02083354|54750204|FG000|Overall Study|Lost to Follow-up|1|||
28095746|NCT02083354|54750204|FG000|Overall Study|Adverse Event|3|||
28095747|NCT02083354|54750204|FG000|Overall Study|Disease progression|46|||
28095748|NCT02083354|54750204|FG000|Overall Study|Study closed/terminated|5|||
28095749|NCT04230486|54750208|FG000|Overall Study|Screen Failure|1|||
28095750|NCT01399918|54750214|FG000|Overall Study|Not eligible and not enrolled in the study|2|||
28095751|NCT00112840|54750221|FG000|Overall Study|Physician Decision|1|||
28095752|NCT00112840|54750222|FG001|Overall Study|Physician Decision|0|||
28095753|NCT00112840|54750223|FG002|Overall Study|Physician Decision|0|||
28095754|NCT00112840|54750221|FG000|Overall Study|Withdrawal by Subject|1|||
28095755|NCT00112840|54750222|FG001|Overall Study|Withdrawal by Subject|0|||
28095756|NCT00112840|54750223|FG002|Overall Study|Withdrawal by Subject|1|||
28095757|NCT00112840|54750221|FG000|Overall Study|Protocol Violation|0|||
28095758|NCT00112840|54750222|FG001|Overall Study|Protocol Violation|0|||
28095759|NCT00112840|54750223|FG002|Overall Study|Protocol Violation|5|||
28095760|NCT02197572|54750236|FG000|Overall Study|Progressive Disease|28|||
28095761|NCT02197572|54750236|FG000|Overall Study|Withdrawal by Subject|9|||
28095762|NCT02197572|54750236|FG000|Overall Study|Adverse Event|3|||
28095763|NCT02197572|54750236|FG000|Overall Study|Reason Not Specified|4|||
28095764|NCT03176784|54750244|FG000|Overall Study|Lost to Follow-up|77|||
28095765|NCT03176784|54750245|FG001|Overall Study|Lost to Follow-up|79|||
28095766|NCT03176784|54750246|FG002|Overall Study|Lost to Follow-up|79|||
28095767|NCT03176784|54750247|FG003|Overall Study|Lost to Follow-up|49|||
28095768|NCT03176784|54750244|FG000|Overall Study|Withdrawal by Subject|28|||
28095769|NCT03176784|54750245|FG001|Overall Study|Withdrawal by Subject|34|||
28095770|NCT03176784|54750246|FG002|Overall Study|Withdrawal by Subject|34|||
28095771|NCT03176784|54750247|FG003|Overall Study|Withdrawal by Subject|21|||
28095772|NCT03049852|54750260|FG000|Overall Study|Lost to Follow-up|0|||
28095773|NCT03049852|54750261|FG001|Overall Study|Lost to Follow-up|1|||
28095774|NCT03049852|54750262|FG002|Overall Study|Lost to Follow-up|0|||
28095775|NCT05091528|54750274|FG000|Overall Study|Study Termination by Sponsor|0|||
28095776|NCT05091528|54750275|FG001|Overall Study|Study Termination by Sponsor|1|||
28095777|NCT05091528|54750276|FG002|Overall Study|Study Termination by Sponsor|0|||
28095778|NCT05091528|54750277|FG003|Overall Study|Study Termination by Sponsor|1|||
28095779|NCT01317160|54750287|FG000|Overall Study|Incorrect inclusion|1|||
28095780|NCT01317160|54750288|FG001|Overall Study|Incorrect inclusion|1|||
28095781|NCT01317160|54750287|FG000|Overall Study|Lost to Follow-up|3|||
28095782|NCT01317160|54750288|FG001|Overall Study|Lost to Follow-up|3|||
28095783|NCT01317160|54750287|FG000|Overall Study|Withdrawal by Subject|0|||
28171196|NCT02414854|54842730|FG003|Overall Study|Poor compliance to protocol|2|||
28171197|NCT02414854|54842727|FG000|Overall Study|Other than specified above|12|||
28171198|NCT02414854|54842728|FG001|Overall Study|Other than specified above|37|||
28171199|NCT02414854|54842729|FG002|Overall Study|Other than specified above|17|||
28171200|NCT02414854|54842730|FG003|Overall Study|Other than specified above|37|||
28171201|NCT03332498|54842743|FG000|Overall Study|Severe illness prior to Day 1 of treatment|0|||
28171202|NCT03332498|54842744|FG001|Overall Study|Severe illness prior to Day 1 of treatment|0|||
28171203|NCT03332498|54842745|FG002|Overall Study|Severe illness prior to Day 1 of treatment|2|||
28171204|NCT01334125|54842754|FG000|Overall Study|Lost to Follow-up|3|||
28171205|NCT01334125|54842755|FG001|Overall Study|Lost to Follow-up|3|||
28171206|NCT02414152|54842762|FG000|Overall Study|Withdrawal by Subject|1|||
28171207|NCT02414152|54842762|FG000|Overall Study|Lack of Efficacy|1|||
28171208|NCT02413996|54842768|FG000|Overall Study|not comfortable with the intervention|9|||
28171209|NCT02413996|54842769|FG001|Overall Study|not comfortable with the intervention|2|||
28171210|NCT01333501|54842777|FG000|Overall Study|Adverse Event|3|||
28171211|NCT01333501|54842778|FG001|Overall Study|Adverse Event|1|||
28171212|NCT01333501|54842777|FG000|Overall Study|Abnormal laboratory value|2|||
28095784|NCT01317160|54750288|FG001|Overall Study|Withdrawal by Subject|2|||
28095785|NCT01317004|54750309|FG000|Overall Study|Withdrawal by Subject|1|||
28095786|NCT01317004|54750310|FG001|Overall Study|Withdrawal by Subject|4|||
28095787|NCT01317004|54750309|FG000|Overall Study|Protocol Violation|0|||
28095788|NCT01317004|54750310|FG001|Overall Study|Protocol Violation|2|||
28095789|NCT01317004|54750309|FG000|Overall Study|Adverse Event|3|||
28095790|NCT01317004|54750310|FG001|Overall Study|Adverse Event|3|||
28171213|NCT01333501|54842778|FG001|Overall Study|Abnormal laboratory value|1|||
28095791|NCT01343056|54750320|FG000|Overall Study|Lost to Follow-up|7|||
28095792|NCT01343056|54750321|FG001|Overall Study|Lost to Follow-up|5|||
28095793|NCT01343056|54750322|FG002|Overall Study|Lost to Follow-up|3|||
28095794|NCT01343056|54750323|FG003|Overall Study|Lost to Follow-up|9|||
28171214|NCT01333501|54842777|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
28171215|NCT01333501|54842778|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
28171216|NCT01333501|54842777|FG000|Overall Study|Withdrawn consent|3|||
28171217|NCT01333501|54842778|FG001|Overall Study|Withdrawn consent|12|||
27856967|NCT02569710|54393477|FG009|Overall Study|Lost to Follow-up|0|||
27856968|NCT02569710|54393468|FG000|Overall Study|Virologic failure|0|||
27856969|NCT02569710|54393469|FG001|Overall Study|Virologic failure|0|||
27856970|NCT02569710|54393470|FG002|Overall Study|Virologic failure|0|||
27856971|NCT02569710|54393471|FG003|Overall Study|Virologic failure|0|||
27856972|NCT02569710|54393472|FG004|Overall Study|Virologic failure|1|||
27856973|NCT02569710|54393473|FG005|Overall Study|Virologic failure|0|||
27856974|NCT02569710|54393474|FG006|Overall Study|Virologic failure|1|||
27856975|NCT02569710|54393475|FG007|Overall Study|Virologic failure|0|||
27856976|NCT02569710|54393476|FG008|Overall Study|Virologic failure|0|||
27856977|NCT02569710|54393477|FG009|Overall Study|Virologic failure|0|||
27856978|NCT02569710|54393468|FG000|Overall Study|Withdrawal by Subject|0|||
27856979|NCT02569710|54393469|FG001|Overall Study|Withdrawal by Subject|0|||
27856980|NCT02569710|54393470|FG002|Overall Study|Withdrawal by Subject|0|||
27856981|NCT02569710|54393471|FG003|Overall Study|Withdrawal by Subject|0|||
27856982|NCT02569710|54393472|FG004|Overall Study|Withdrawal by Subject|0|||
27856983|NCT02569710|54393473|FG005|Overall Study|Withdrawal by Subject|1|||
27856984|NCT02569710|54393474|FG006|Overall Study|Withdrawal by Subject|0|||
27856985|NCT02569710|54393475|FG007|Overall Study|Withdrawal by Subject|0|||
27856986|NCT02569710|54393476|FG008|Overall Study|Withdrawal by Subject|0|||
27856987|NCT02569710|54393477|FG009|Overall Study|Withdrawal by Subject|0|||
27856988|NCT02569476|54393579|FG000|Overall Study|Roll over to Long-Term Extension Study|73|||
27856989|NCT02569476|54393579|FG000|Overall Study|Death|33|||
27856990|NCT02569476|54393579|FG000|Overall Study|Withdrawal by Subject|9|||
27856991|NCT02569476|54393579|FG000|Overall Study|Progressive disease at study withdrawal and death by end of study|1|||
27856992|NCT02569476|54393579|FG000|Overall Study|Palliative care|1|||
27856993|NCT02569476|54393579|FG000|Overall Study|Transitioned to Long Term Follow Up Study|1|||
27856994|NCT02569476|54393579|FG000|Overall Study|Transitioned to Long Term Extension Study|1|||
28095795|NCT01316692|54750337|FG000|Overall Study|Adverse Event|5|||
28095796|NCT01316692|54750337|FG000|Overall Study|Disease Progression|7|||
28095797|NCT01316380|54750344|FG000|Overall Study|Adverse Event|0|||
28095798|NCT01316380|54750345|FG001|Overall Study|Adverse Event|2|||
28095799|NCT01316380|54750346|FG002|Overall Study|Adverse Event|1|||
28095800|NCT01316380|54750344|FG000|Overall Study|Protocol Violation|0|||
28095801|NCT01316380|54750345|FG001|Overall Study|Protocol Violation|0|||
28095802|NCT01316380|54750346|FG002|Overall Study|Protocol Violation|1|||
28095803|NCT01316380|54750344|FG000|Overall Study|Withdrawal by Subject|1|||
28095804|NCT01316380|54750345|FG001|Overall Study|Withdrawal by Subject|2|||
28095805|NCT01316380|54750346|FG002|Overall Study|Withdrawal by Subject|0|||
28095806|NCT01316380|54750344|FG000|Overall Study|Other|0|||
28095807|NCT01316380|54750345|FG001|Overall Study|Other|1|||
28095808|NCT01316380|54750346|FG002|Overall Study|Other|1|||
28095809|NCT01316380|54750344|FG000|Overall Study|Not treated|1|||
28095810|NCT01316380|54750345|FG001|Overall Study|Not treated|0|||
28095811|NCT01316380|54750346|FG002|Overall Study|Not treated|0|||
28095812|NCT01316224|54750354|FG000|Overall Study|Protocol Violation|3|||
28095813|NCT01316224|54750354|FG000|Overall Study|Adverse Event|3|||
28095814|NCT01316224|54750354|FG000|Overall Study|Lack of Efficacy|1|||
28095815|NCT01316224|54750354|FG000|Overall Study|Withdrawal by Subject|1|||
28095816|NCT01316224|54750354|FG000|Overall Study|Adverse Event With Treatment Failure|1|||
28095817|NCT01316224|54750354|FG000|Overall Study|Other|1|||
28095818|NCT04315298|54750377|FG000|Overall Study|Withdrawal by Subject|0|||
28095819|NCT04315298|54750378|FG001|Overall Study|Withdrawal by Subject|0|||
28095820|NCT04315298|54750379|FG002|Overall Study|Withdrawal by Subject|0|||
28095821|NCT04315298|54750380|FG003|Overall Study|Withdrawal by Subject|2|||
28095822|NCT04315298|54750381|FG004|Overall Study|Withdrawal by Subject|2|||
28095823|NCT04315298|54750382|FG005|Overall Study|Withdrawal by Subject|2|||
28095824|NCT04315298|54750383|FG006|Overall Study|Withdrawal by Subject|0|||
28095825|NCT04315298|54750384|FG007|Overall Study|Withdrawal by Subject|1|||
28095826|NCT04315298|54750385|FG008|Overall Study|Withdrawal by Subject|1|||
28095827|NCT04315298|54750386|FG009|Overall Study|Withdrawal by Subject|1|||
28095828|NCT04315298|54750387|FG010|Overall Study|Withdrawal by Subject|0|||
28095829|NCT04315298|54750388|FG011|Overall Study|Withdrawal by Subject|0|||
28095830|NCT04315298|54750389|FG012|Overall Study|Withdrawal by Subject|0|||
28095831|NCT04315298|54750390|FG013|Overall Study|Withdrawal by Subject|0|||
28095832|NCT04315298|54750391|FG014|Overall Study|Withdrawal by Subject|0|||
28095833|NCT04315298|54750392|FG015|Overall Study|Withdrawal by Subject|0|||
28095834|NCT04315298|54750393|FG016|Overall Study|Withdrawal by Subject|0|||
28095835|NCT04315298|54750394|FG017|Overall Study|Withdrawal by Subject|0|||
28095836|NCT04315298|54750395|FG018|Overall Study|Withdrawal by Subject|0|||
28095837|NCT04315298|54750377|FG000|Overall Study|Physician Decision|0|||
28095838|NCT04315298|54750378|FG001|Overall Study|Physician Decision|0|||
28095839|NCT04315298|54750379|FG002|Overall Study|Physician Decision|0|||
28171218|NCT01362140|54842786|FG000|Overall Study|Noncompliance|1|||
27738819|NCT02936323|54188169|FG001|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
27856995|NCT02565576|54393651|FG000|Overall Study|abnormal lab value|2|||
27856996|NCT02565576|54393652|FG001|Overall Study|abnormal lab value|0|||
27856997|NCT02565576|54393651|FG000|Overall Study|subject / guardian decision|1|||
27856998|NCT02565576|54393652|FG001|Overall Study|subject / guardian decision|3|||
27856999|NCT02565576|54393651|FG000|Overall Study|Lost to Follow-up|1|||
27857000|NCT02565576|54393652|FG001|Overall Study|Lost to Follow-up|0|||
27857001|NCT02565576|54393651|FG000|Overall Study|Death|0|||
27857002|NCT02565576|54393652|FG001|Overall Study|Death|2|||
27857003|NCT02565576|54393651|FG000|Overall Study|Adverse Event|1|||
27857004|NCT02565576|54393652|FG001|Overall Study|Adverse Event|0|||
27857005|NCT02569398|54393683|FG000|Overall Study|Adverse Event|0|||
27857006|NCT02569398|54393684|FG001|Overall Study|Adverse Event|1|||
27857007|NCT02569398|54393685|FG002|Overall Study|Adverse Event|6|||
27857008|NCT02569398|54393683|FG000|Overall Study|Withdrawal by Subject|43|||
27857009|NCT02569398|54393684|FG001|Overall Study|Withdrawal by Subject|43|||
27857010|NCT02569398|54393685|FG002|Overall Study|Withdrawal by Subject|30|||
27857011|NCT02569398|54393683|FG000|Overall Study|Study terminated by sponsor|130|||
27857012|NCT02569398|54393684|FG001|Overall Study|Study terminated by sponsor|131|||
27857013|NCT02569398|54393685|FG002|Overall Study|Study terminated by sponsor|134|||
27857014|NCT02569398|54393683|FG000|Overall Study|Other|12|||
27857015|NCT02569398|54393684|FG001|Overall Study|Other|14|||
27857016|NCT02569398|54393685|FG002|Overall Study|Other|13|||
27857017|NCT02569242|54393729|FG000|Overall Study|Death|1|||
27857018|NCT02569242|54393730|FG001|Overall Study|Death|0|||
27857019|NCT02569242|54393729|FG000|Overall Study|Withdrawal by Subject|0|||
27857020|NCT02569242|54393730|FG001|Overall Study|Withdrawal by Subject|1|||
27857021|NCT01663740|54393798|FG000|Overall Study|Lost to Follow-up|1|||
27857022|NCT01663740|54393799|FG001|Overall Study|Lost to Follow-up|4|||
27857023|NCT01663740|54393798|FG000|Overall Study|Other|9|||
27857024|NCT01663740|54393799|FG001|Overall Study|Other|2|||
27857025|NCT01663740|54393798|FG000|Overall Study|Inclusion/Exclusion not met|1|||
27857026|NCT01663740|54393799|FG001|Overall Study|Inclusion/Exclusion not met|0|||
27857027|NCT01663740|54393798|FG000|Overall Study|Death|0|||
27857028|NCT01663740|54393799|FG001|Overall Study|Death|1|||
27857029|NCT01663740|54393798|FG000|Overall Study|Withdrawal by Subject|2|||
27857030|NCT01663740|54393799|FG001|Overall Study|Withdrawal by Subject|1|||
27857031|NCT01663740|54393798|FG000|Overall Study|No end of study status|3|||
27857032|NCT01663740|54393799|FG001|Overall Study|No end of study status|0|||
27857033|NCT01663506|54393915|FG000|Overall Study|Lack of Efficacy|3|||
27857034|NCT01663506|54393915|FG000|Overall Study|Consent Withdrawal by Subject|1|||
27857035|NCT01663506|54393915|FG000|Overall Study|Lost to Follow-up|1|||
27857036|NCT01663506|54393915|FG000|Overall Study|Adverse Event|1|||
27857037|NCT01663506|54393915|FG000|Overall Study|Switched to Subcutaneous Tocilizumab|2|||
27857038|NCT02568384|54393919|FG000|Overall Study|Mobile devices incompatible with App|2|||
27857039|NCT02965976|54394015|FG000|Overall Study|Withdrawal by Subject|2|||
27857040|NCT02965976|54394016|FG001|Overall Study|Withdrawal by Subject|0|||
27857041|NCT04125680|54394034|FG000|Overall Study|Lost to Follow-up|15|||
27857042|NCT02565186|54394058|FG000|Overall Study|Adverse Event|113|||
27857043|NCT02565186|54394059|FG001|Overall Study|Adverse Event|148|||
27857044|NCT02565186|54394058|FG000|Overall Study|Lost to Follow-up|102|||
27857045|NCT02565186|54394059|FG001|Overall Study|Lost to Follow-up|93|||
27857046|NCT02565186|54394058|FG000|Overall Study|Non-Compliance|57|||
27857047|NCT02565186|54394059|FG001|Overall Study|Non-Compliance|55|||
27857048|NCT02565186|54394058|FG000|Overall Study|Withdrawal by Subject|229|||
27857049|NCT02565186|54394059|FG001|Overall Study|Withdrawal by Subject|214|||
27857050|NCT02565186|54394058|FG000|Overall Study|Physician Decision|18|||
27833985|NCT01681511|54317544|FG001|Overall Study|No post-catheter sample collected|4|||
27833986|NCT02175004|54317552|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
27833987|NCT02175004|54317553|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|14|||
27833988|NCT02175004|54317552|FG000|Overall Study|Investigator Judgment|1|||
27833989|NCT02175004|54317553|FG001|Overall Study|Investigator Judgment|4|||
27833990|NCT02175004|54317552|FG000|Overall Study|Voluntary Withdrawal|6|||
27833991|NCT02175004|54317553|FG001|Overall Study|Voluntary Withdrawal|19|||
27833992|NCT02175004|54317552|FG000|Overall Study|Liver Transplant|1|||
27833993|NCT02175004|54317553|FG001|Overall Study|Liver Transplant|0|||
27833994|NCT02175004|54317552|FG000|Overall Study|Disease Progression|1|||
27833995|NCT02175004|54317553|FG001|Overall Study|Disease Progression|0|||
27833996|NCT02175004|54317552|FG000|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|27|||
27833997|NCT02175004|54317553|FG001|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|39|||
27857051|NCT02565186|54394059|FG001|Overall Study|Physician Decision|16|||
27857052|NCT02565186|54394058|FG000|Overall Study|Sponsor Request|5|||
27857053|NCT02565186|54394059|FG001|Overall Study|Sponsor Request|9|||
27857054|NCT02565186|54394058|FG000|Overall Study|Missing|1|||
27857055|NCT02565186|54394059|FG001|Overall Study|Missing|0|||
27857056|NCT02565186|54394058|FG000|Overall Study|Did Not Receive Study Drug|55|||
28171219|NCT01362140|54842787|FG001|Overall Study|Noncompliance|0|||
28171220|NCT01362140|54842786|FG000|Overall Study|Adverse Event|2|||
28171221|NCT01362140|54842787|FG001|Overall Study|Adverse Event|2|||
28171222|NCT01362140|54842786|FG000|Overall Study|Withdrawal by Subject|3|||
28171223|NCT01362140|54842787|FG001|Overall Study|Withdrawal by Subject|3|||
28171224|NCT01362140|54842786|FG000|Overall Study|Administrative Decision|0|||
28095840|NCT04315298|54750380|FG003|Overall Study|Physician Decision|0|||
28095841|NCT04315298|54750381|FG004|Overall Study|Physician Decision|1|||
28095842|NCT04315298|54750382|FG005|Overall Study|Physician Decision|0|||
27738820|NCT02936323|54188170|FG002|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
27738821|NCT02936323|54188171|FG003|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
28095843|NCT04315298|54750383|FG006|Overall Study|Physician Decision|0|||
28095844|NCT04315298|54750384|FG007|Overall Study|Physician Decision|0|||
28095845|NCT04315298|54750385|FG008|Overall Study|Physician Decision|0|||
28095846|NCT04315298|54750386|FG009|Overall Study|Physician Decision|0|||
28095847|NCT04315298|54750387|FG010|Overall Study|Physician Decision|0|||
28095848|NCT04315298|54750388|FG011|Overall Study|Physician Decision|0|||
28095849|NCT04315298|54750389|FG012|Overall Study|Physician Decision|0|||
28095850|NCT04315298|54750390|FG013|Overall Study|Physician Decision|0|||
28095851|NCT04315298|54750391|FG014|Overall Study|Physician Decision|0|||
28095852|NCT04315298|54750392|FG015|Overall Study|Physician Decision|0|||
28095853|NCT04315298|54750393|FG016|Overall Study|Physician Decision|0|||
28095854|NCT04315298|54750394|FG017|Overall Study|Physician Decision|0|||
28171225|NCT01362140|54842787|FG001|Overall Study|Administrative Decision|1|||
28171226|NCT01362140|54842786|FG000|Overall Study|Death|2|||
28171227|NCT01362140|54842787|FG001|Overall Study|Death|1|||
28171228|NCT01362140|54842786|FG000|Overall Study|Other|1|||
28171229|NCT01362140|54842787|FG001|Overall Study|Other|1|||
28171230|NCT01362140|54842786|FG000|Overall Study|Protocol-specified Criteria|1|||
28171231|NCT01362140|54842787|FG001|Overall Study|Protocol-specified Criteria|2|||
28171232|NCT01362140|54842786|FG000|Overall Study|Discontinued Without Receiving Treatment|0|||
28171233|NCT01362140|54842787|FG001|Overall Study|Discontinued Without Receiving Treatment|1|||
28171234|NCT01333189|54842795|FG000|Overall Study|Time constraints|1|||
28171235|NCT01333189|54842796|FG001|Overall Study|Time constraints|0|||
27833998|NCT01681433|54317561|FG000|Overall Study|Lack of Efficacy|23|||
27833999|NCT01681433|54317562|FG001|Overall Study|Lack of Efficacy|23|||
27834000|NCT01681433|54317561|FG000|Overall Study|Withdrawal by Subject|5|||
27834001|NCT01681433|54317562|FG001|Overall Study|Withdrawal by Subject|5|||
27834002|NCT01681433|54317561|FG000|Overall Study|Protocol Violation|2|||
27834003|NCT01681433|54317562|FG001|Overall Study|Protocol Violation|0|||
27834004|NCT01681433|54317561|FG000|Overall Study|Adverse Event|2|||
27834005|NCT01681433|54317562|FG001|Overall Study|Adverse Event|4|||
27834006|NCT01681433|54317561|FG000|Overall Study|Lost to Follow-up|0|||
27834007|NCT01681433|54317562|FG001|Overall Study|Lost to Follow-up|1|||
27834008|NCT01681277|54317573|FG000|Overall Study|Adverse Event|1|||
27834009|NCT01681277|54317574|FG001|Overall Study|Adverse Event|0|||
27834010|NCT01681277|54317575|FG002|Overall Study|Adverse Event|0|||
27834011|NCT01681277|54317576|FG003|Overall Study|Adverse Event|0|||
27834012|NCT01681277|54317577|FG004|Overall Study|Adverse Event|0|||
28095855|NCT04315298|54750395|FG018|Overall Study|Physician Decision|0|||
28095856|NCT04315298|54750377|FG000|Overall Study|Lost to Follow-up|5|||
28095857|NCT04315298|54750378|FG001|Overall Study|Lost to Follow-up|10|||
28095858|NCT04315298|54750379|FG002|Overall Study|Lost to Follow-up|6|||
28171236|NCT01333189|54842795|FG000|Overall Study|Adverse Event|1|||
28171237|NCT01333189|54842796|FG001|Overall Study|Adverse Event|0|||
27738822|NCT02936323|54188172|FG004|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
27738823|NCT02936323|54188173|FG005|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
27738824|NCT02936323|54188174|FG006|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
27738825|NCT02936323|54188175|FG007|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
27738826|NCT02936323|54188176|FG008|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
27738827|NCT02936323|54188177|FG009|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
27738828|NCT02936323|54188168|FG000|Phase 1 Dose Escalation|Death|2|||
27738829|NCT02936323|54188169|FG001|Phase 1 Dose Escalation|Death|1|||
27738830|NCT02936323|54188170|FG002|Phase 1 Dose Escalation|Death|3|||
27738831|NCT02936323|54188171|FG003|Phase 1 Dose Escalation|Death|1|||
27738832|NCT02936323|54188172|FG004|Phase 1 Dose Escalation|Death|2|||
27738833|NCT02936323|54188173|FG005|Phase 1 Dose Escalation|Death|3|||
27738834|NCT02936323|54188174|FG006|Phase 1 Dose Escalation|Death|3|||
27738835|NCT02936323|54188175|FG007|Phase 1 Dose Escalation|Death|0|||
27738836|NCT02936323|54188176|FG008|Phase 1 Dose Escalation|Death|0|||
27738837|NCT02936323|54188177|FG009|Phase 1 Dose Escalation|Death|0|||
27834013|NCT01703117|54317595|FG000|Overall Study|Adverse Event|4|||
27834014|NCT01703117|54317596|FG001|Overall Study|Adverse Event|3|||
27834015|NCT01703117|54317595|FG000|Overall Study|Withdrawal by Subject|0|||
27834016|NCT01703117|54317596|FG001|Overall Study|Withdrawal by Subject|1|||
28095859|NCT04315298|54750380|FG003|Overall Study|Lost to Follow-up|8|||
28171238|NCT01333189|54842795|FG000|Overall Study|Transportation difficulties|0|||
28171239|NCT01333189|54842796|FG001|Overall Study|Transportation difficulties|1|||
27834017|NCT01702961|54317604|FG000|Overall Study|Additional treatment|3|||
27857057|NCT02565186|54394059|FG001|Overall Study|Did Not Receive Study Drug|86|||
27857058|NCT02568072|54394065|FG000|Overall Study|Unavailable for appointment|23|||
27857059|NCT02568072|54394065|FG000|Overall Study|Unable to contact|3|||
27857060|NCT02568072|54394065|FG000|Overall Study|Diagnosis of Long QT Syndrome|1|||
27857061|NCT02568072|54394065|FG000|Overall Study|Withdrawal by Subject|1|||
27857062|NCT02568072|54394065|FG000|Overall Study|Sustained injury, marathon not run|24|||
27857063|NCT02565108|54394072|FG000|Overall Study|Adverse Event|1|||
27857064|NCT02565108|54394073|FG001|Overall Study|Adverse Event|0|||
27857065|NCT02565108|54394072|FG000|Overall Study|Withdrew Consent|1|||
27857066|NCT02565108|54394073|FG001|Overall Study|Withdrew Consent|0|||
27857067|NCT02564952|54394079|FG000|Overall Study|Adverse Event|6|||
27857068|NCT02564952|54394079|FG000|Overall Study|Lost to Follow-up|1|||
27857069|NCT02564952|54394079|FG000|Overall Study|Participant Withdrawn by Investigator|1|||
27857070|NCT02564952|54394079|FG000|Overall Study|Withdrawal by Subject|1|||
27857071|NCT02564952|54394079|FG000|Overall Study|Low Efficacy|1|||
27857072|NCT02564952|54394079|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
27857073|NCT02566902|54394085|FG000|Overall Study|Protocol Violation|2|||
27857074|NCT02566902|54394086|FG001|Overall Study|Protocol Violation|1|||
27857075|NCT02564796|54394094|FG000|Overall Study|Physician Decision|2|||
27857076|NCT02564796|54394095|FG001|Overall Study|Physician Decision|2|||
27857077|NCT02564718|54394103|FG000|Overall Study|Withdrew from treatment|0|||
27857078|NCT02564718|54394104|FG001|Overall Study|Withdrew from treatment|1|||
27857079|NCT01453946|54394110|FG000|Overall Study|Did not receive drug for the taper phase|1|||
27857080|NCT01453946|54394110|FG000|Overall Study|Protocol Violation|2|||
27857081|NCT01453946|54394110|FG000|Overall Study|Lack of Efficacy|3|||
27857082|NCT01453946|54394110|FG000|Overall Study|Adverse Event|3|||
27857083|NCT02563548|54394232|FG000|Dose Escalation (Up to 46 Weeks)|Adverse Event|2|||
27857084|NCT02563548|54394233|FG001|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
27834018|NCT01702961|54317604|FG000|Overall Study|Progressive disease|5|||
27834019|NCT01702961|54317604|FG000|Overall Study|Relapse|20|||
27834020|NCT01702961|54317604|FG000|Overall Study|Death|6|||
27834021|NCT01702961|54317604|FG000|Overall Study|Lost to Follow-up|2|||
27834022|NCT01702961|54317604|FG000|Overall Study|Ongoing|11|||
27834023|NCT01593917|54317608|FG000|Overall Study|Death|67|||
27834024|NCT01593917|54317608|FG000|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60|||
27834025|NCT01593917|54317608|FG000|Overall Study|Withdrawal by Subject|23|||
27834026|NCT01593917|54317608|FG000|Overall Study|Lost to Follow-up|12|||
27834027|NCT01593917|54317608|FG000|Overall Study|Protocol Violation|5|||
27834028|NCT01593917|54317608|FG000|Overall Study|Physician Decision|3|||
27834029|NCT01593761|54317612|FG000|Overall Study|Lost to Follow-up|1|||
27834030|NCT01593761|54317612|FG000|Overall Study|culture negative for MRSA at baseline|5|||
27834031|NCT01593761|54317612|FG000|Overall Study|positive for hepatitis C virus|1|||
27834032|NCT01593761|54317612|FG000|Overall Study|secondary cellulitis|1|||
27834033|NCT02706834|54317633|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
27834034|NCT02706834|54317634|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
27834035|NCT02706834|54317635|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
27834036|NCT02706834|54317636|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
27834037|NCT02706834|54317637|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
27834038|NCT02706834|54317638|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
27834039|NCT02706834|54317639|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
27834040|NCT02706834|54317640|FG007|Overall Study|Pretreatment Event/Adverse Event|0|||
27834041|NCT02706834|54317641|FG008|Overall Study|Pretreatment Event/Adverse Event|0|||
27834042|NCT02706834|54317642|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
27834043|NCT02706834|54317643|FG010|Overall Study|Pretreatment Event/Adverse Event|1|||
27834044|NCT02706834|54317633|FG000|Overall Study|Lost to Follow-up|0|||
27834045|NCT02706834|54317634|FG001|Overall Study|Lost to Follow-up|0|||
27834046|NCT02706834|54317635|FG002|Overall Study|Lost to Follow-up|1|||
27834047|NCT02706834|54317636|FG003|Overall Study|Lost to Follow-up|0|||
27834048|NCT02706834|54317637|FG004|Overall Study|Lost to Follow-up|0|||
27834049|NCT02706834|54317638|FG005|Overall Study|Lost to Follow-up|0|||
27834050|NCT02706834|54317639|FG006|Overall Study|Lost to Follow-up|0|||
27834051|NCT02706834|54317640|FG007|Overall Study|Lost to Follow-up|0|||
27857085|NCT02563548|54394234|FG002|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
27981055|NCT00951665|54638983|FG000|Phase 1b|Protocol Violation|2|||
27981056|NCT00951665|54638984|FG001|Phase 1b|Protocol Violation|0|||
27834052|NCT02706834|54317641|FG008|Overall Study|Lost to Follow-up|0|||
27834053|NCT02706834|54317642|FG009|Overall Study|Lost to Follow-up|0|||
27834054|NCT02706834|54317643|FG010|Overall Study|Lost to Follow-up|0|||
27834055|NCT02706834|54317633|FG000|Overall Study|Voluntary Withdrawal|1|||
27834056|NCT02706834|54317634|FG001|Overall Study|Voluntary Withdrawal|0|||
27834057|NCT02706834|54317635|FG002|Overall Study|Voluntary Withdrawal|0|||
27857086|NCT02563548|54394235|FG003|Dose Escalation (Up to 46 Weeks)|Adverse Event|1|||
27857087|NCT02563548|54394236|FG004|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
27857088|NCT02563548|54394237|FG005|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
27857089|NCT02563548|54394232|FG000|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1|||
27857090|NCT02563548|54394233|FG001|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
27857091|NCT02563548|54394234|FG002|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
27857092|NCT02563548|54394235|FG003|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
27857093|NCT02563548|54394236|FG004|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
27857094|NCT02563548|54394237|FG005|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
27857095|NCT02563548|54394232|FG000|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
27857096|NCT02563548|54394233|FG001|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
27857097|NCT02563548|54394234|FG002|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3|||
27857098|NCT02563548|54394235|FG003|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
27857099|NCT02563548|54394236|FG004|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
27857100|NCT02563548|54394237|FG005|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
27857101|NCT02563548|54394232|FG000|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
27857102|NCT02563548|54394233|FG001|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
27857103|NCT02563548|54394234|FG002|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2|||
27857104|NCT02563548|54394235|FG003|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1|||
27857105|NCT02563548|54394236|FG004|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
27857106|NCT02563548|54394237|FG005|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
27857107|NCT02563548|54394232|FG000|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
27857108|NCT02563548|54394233|FG001|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
27857109|NCT02563548|54394234|FG002|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
27857110|NCT02563548|54394235|FG003|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
27857111|NCT02563548|54394236|FG004|Dose Expansion (Up to 60 Weeks)|Adverse Event|1|||
27857112|NCT02563548|54394237|FG005|Dose Expansion (Up to 60 Weeks)|Adverse Event|8|||
27857113|NCT02563548|54394232|FG000|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
27857114|NCT02563548|54394233|FG001|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
27857115|NCT02563548|54394234|FG002|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
27857116|NCT02563548|54394235|FG003|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
27857117|NCT02563548|54394236|FG004|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15|||
27857118|NCT02563548|54394237|FG005|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3|||
27857119|NCT02563548|54394232|FG000|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
27857120|NCT02563548|54394233|FG001|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
27857121|NCT02563548|54394234|FG002|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
27857122|NCT02563548|54394235|FG003|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
27857123|NCT02563548|54394236|FG004|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6|||
27857124|NCT02563548|54394237|FG005|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
27857125|NCT02563548|54394232|FG000|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
27857126|NCT02563548|54394233|FG001|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
27857127|NCT02563548|54394234|FG002|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
27857128|NCT02563548|54394235|FG003|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
27857129|NCT02563548|54394236|FG004|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2|||
27857130|NCT02563548|54394237|FG005|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1|||
27857131|NCT02563548|54394232|FG000|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
27857132|NCT02563548|54394233|FG001|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
27857133|NCT02563548|54394234|FG002|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
27857134|NCT02563548|54394235|FG003|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
27857135|NCT02563548|54394236|FG004|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
27857136|NCT02563548|54394237|FG005|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2|||
27857137|NCT02563548|54394232|FG000|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
27857138|NCT02563548|54394233|FG001|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
27857139|NCT02563548|54394234|FG002|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
27857140|NCT02563548|54394235|FG003|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
27857141|NCT02563548|54394236|FG004|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
27857142|NCT02563548|54394237|FG005|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2|||
27857143|NCT02563548|54394232|FG000|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
27857144|NCT02563548|54394233|FG001|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
27857145|NCT02563548|54394234|FG002|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
27857146|NCT02563548|54394235|FG003|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
27981057|NCT00951665|54638985|FG002|Phase 1b|Protocol Violation|0|||
27834058|NCT02706834|54317636|FG003|Overall Study|Voluntary Withdrawal|0|||
27834059|NCT02706834|54317637|FG004|Overall Study|Voluntary Withdrawal|0|||
27834060|NCT02706834|54317638|FG005|Overall Study|Voluntary Withdrawal|0|||
27834061|NCT02706834|54317639|FG006|Overall Study|Voluntary Withdrawal|0|||
27834062|NCT02706834|54317640|FG007|Overall Study|Voluntary Withdrawal|0|||
27834063|NCT02706834|54317641|FG008|Overall Study|Voluntary Withdrawal|0|||
27834064|NCT02706834|54317642|FG009|Overall Study|Voluntary Withdrawal|1|||
27834065|NCT02706834|54317643|FG010|Overall Study|Voluntary Withdrawal|0|||
27834066|NCT02706834|54317633|FG000|Overall Study|Other Reason Not Specified|1|||
27857147|NCT02563548|54394236|FG004|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
27857148|NCT02563548|54394237|FG005|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1|||
27857149|NCT02563548|54394232|FG000|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
27857150|NCT02563548|54394233|FG001|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
27857151|NCT02563548|54394234|FG002|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
27857152|NCT02563548|54394235|FG003|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
27857153|NCT02563548|54394236|FG004|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1|||
27857154|NCT02563548|54394237|FG005|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
27857155|NCT02559570|54394318|FG000|Overall Study|Adverse Event|0|||
27857156|NCT02559570|54394319|FG001|Overall Study|Adverse Event|2|||
27857157|NCT02559570|54394320|FG002|Overall Study|Adverse Event|0|||
27857158|NCT02559570|54394321|FG003|Overall Study|Adverse Event|1|||
27857159|NCT02559570|54394322|FG004|Overall Study|Adverse Event|0|||
27857160|NCT02559570|54394318|FG000|Overall Study|Withdrawal of Consent|0|||
27857161|NCT02559570|54394319|FG001|Overall Study|Withdrawal of Consent|0|||
27857162|NCT02559570|54394320|FG002|Overall Study|Withdrawal of Consent|1|||
27857163|NCT02559570|54394321|FG003|Overall Study|Withdrawal of Consent|2|||
27857164|NCT02559570|54394322|FG004|Overall Study|Withdrawal of Consent|1|||
27857165|NCT02559570|54394318|FG000|Overall Study|Lost to Follow-up|1|||
27857166|NCT02559570|54394319|FG001|Overall Study|Lost to Follow-up|0|||
27857167|NCT02559570|54394320|FG002|Overall Study|Lost to Follow-up|0|||
27857168|NCT02559570|54394321|FG003|Overall Study|Lost to Follow-up|0|||
27857169|NCT02559570|54394322|FG004|Overall Study|Lost to Follow-up|0|||
27857170|NCT02559570|54394318|FG000|Overall Study|Protocol Violation|1|||
27857171|NCT02559570|54394319|FG001|Overall Study|Protocol Violation|0|||
27857172|NCT02559570|54394320|FG002|Overall Study|Protocol Violation|0|||
27857173|NCT02559570|54394321|FG003|Overall Study|Protocol Violation|0|||
27857174|NCT02559570|54394322|FG004|Overall Study|Protocol Violation|1|||
27857175|NCT02559570|54394318|FG000|Overall Study|Other Miscellaneous Reasons|0|||
27857176|NCT02559570|54394319|FG001|Overall Study|Other Miscellaneous Reasons|0|||
27857177|NCT02559570|54394320|FG002|Overall Study|Other Miscellaneous Reasons|1|||
27857178|NCT02559570|54394321|FG003|Overall Study|Other Miscellaneous Reasons|0|||
27857179|NCT02559570|54394322|FG004|Overall Study|Other Miscellaneous Reasons|0|||
27857180|NCT02559414|54394677|FG000|Overall Study|Lost to Follow-up|0|||
27857181|NCT02559414|54394678|FG001|Overall Study|Lost to Follow-up|1|||
27857182|NCT02559414|54394679|FG002|Overall Study|Lost to Follow-up|0|||
27857183|NCT02559414|54394677|FG000|Overall Study|Withdrawal by Subject|1|||
27857184|NCT02559414|54394678|FG001|Overall Study|Withdrawal by Subject|0|||
27857185|NCT02559414|54394679|FG002|Overall Study|Withdrawal by Subject|1|||
27857186|NCT02559414|54394677|FG000|Overall Study|Other|0|||
27857187|NCT02559414|54394678|FG001|Overall Study|Other|1|||
27857188|NCT02559414|54394679|FG002|Overall Study|Other|1|||
27857189|NCT02558790|54394754|FG000|Overall Study|Lost to Follow-up|2|||
27857190|NCT02558790|54394754|FG000|Overall Study|Physician Decision|1|||
27857191|NCT02558790|54394754|FG000|Overall Study|Withdrawal by Subject|1|||
27857192|NCT02558790|54394754|FG000|Overall Study|Screen Fail|3|||
27857193|NCT02556138|54394780|FG000|Overall Study|Withdrawal by Subject|1|||
27857194|NCT02558400|54394863|FG000|Overall Study|Adverse Event|47|||
27857195|NCT02558400|54394864|FG001|Overall Study|Adverse Event|53|||
27857196|NCT02558400|54394865|FG002|Overall Study|Adverse Event|4|||
27857197|NCT02558400|54394863|FG000|Overall Study|Withdrawal by Subject|13|||
27857198|NCT02558400|54394864|FG001|Overall Study|Withdrawal by Subject|9|||
27857199|NCT02558400|54394865|FG002|Overall Study|Withdrawal by Subject|8|||
27857200|NCT02558400|54394863|FG000|Overall Study|Non-Compliant|0|||
27857201|NCT02558400|54394864|FG001|Overall Study|Non-Compliant|1|||
27857202|NCT02558400|54394865|FG002|Overall Study|Non-Compliant|3|||
27857203|NCT02558400|54394863|FG000|Overall Study|Lost to Follow-up|5|||
27857204|NCT02558400|54394864|FG001|Overall Study|Lost to Follow-up|5|||
27857205|NCT02558400|54394865|FG002|Overall Study|Lost to Follow-up|4|||
27857206|NCT02558400|54394863|FG000|Overall Study|Lack of Efficacy|0|||
27857207|NCT02558400|54394864|FG001|Overall Study|Lack of Efficacy|13|||
27857208|NCT02558400|54394865|FG002|Overall Study|Lack of Efficacy|1|||
27857209|NCT02558400|54394863|FG000|Overall Study|Disallowed Concurrent Medication|6|||
27857210|NCT02558400|54394864|FG001|Overall Study|Disallowed Concurrent Medication|7|||
27981058|NCT00951665|54638986|FG003|Phase 1b|Protocol Violation|0|||
28095860|NCT04315298|54750381|FG004|Overall Study|Lost to Follow-up|12|||
28095861|NCT04315298|54750382|FG005|Overall Study|Lost to Follow-up|13|||
27857211|NCT02558400|54394865|FG002|Overall Study|Disallowed Concurrent Medication|5|||
28095862|NCT04315298|54750383|FG006|Overall Study|Lost to Follow-up|9|||
28095863|NCT04315298|54750384|FG007|Overall Study|Lost to Follow-up|16|||
27857212|NCT02558400|54394863|FG000|Overall Study|Physician Decision|2|||
27857213|NCT02558400|54394864|FG001|Overall Study|Physician Decision|2|||
27857214|NCT02558400|54394865|FG002|Overall Study|Physician Decision|0|||
27857215|NCT02558400|54394863|FG000|Overall Study|Protocol Violation|6|||
27981059|NCT00951665|54638987|FG004|Phase 1b|Protocol Violation|0|||
28095864|NCT04315298|54750385|FG008|Overall Study|Lost to Follow-up|14|||
27857216|NCT02558400|54394864|FG001|Overall Study|Protocol Violation|3|||
27857217|NCT02558400|54394865|FG002|Overall Study|Protocol Violation|8|||
27857218|NCT02558400|54394863|FG000|Overall Study|Death|0|||
27857219|NCT02558400|54394864|FG001|Overall Study|Death|1|||
27857220|NCT02558400|54394865|FG002|Overall Study|Death|0|||
27857221|NCT02558400|54394863|FG000|Overall Study|Ineligible for the study|0|||
27857222|NCT02558400|54394864|FG001|Overall Study|Ineligible for the study|2|||
27857223|NCT02558400|54394865|FG002|Overall Study|Ineligible for the study|0|||
27857224|NCT01662648|54394997|FG000|Overall Study|Death|1|||
27857225|NCT01662648|54394998|FG001|Overall Study|Death|3|||
27857226|NCT01662648|54394997|FG000|Overall Study|Adverse Event|40|||
27857227|NCT01662648|54394998|FG001|Overall Study|Adverse Event|37|||
27857228|NCT01662648|54394997|FG000|Overall Study|Lack of Efficacy|17|||
27857229|NCT01662648|54394998|FG001|Overall Study|Lack of Efficacy|16|||
27857230|NCT01662648|54394997|FG000|Overall Study|Participant ineligible to continue trial|1|||
27857231|NCT01662648|54394998|FG001|Overall Study|Participant ineligible to continue trial|1|||
27857232|NCT01662648|54394997|FG000|Overall Study|Lost to Follow-up|24|||
27857233|NCT01662648|54394998|FG001|Overall Study|Lost to Follow-up|36|||
27857234|NCT01662648|54394997|FG000|Overall Study|Withdrawal by Subject|36|||
27857235|NCT01662648|54394998|FG001|Overall Study|Withdrawal by Subject|53|||
27857236|NCT01662648|54394997|FG000|Overall Study|Participant non-compliant|16|||
27857237|NCT01662648|54394998|FG001|Overall Study|Participant non-compliant|20|||
27857238|NCT01662648|54394997|FG000|Overall Study|Other|8|||
27857239|NCT01662648|54394998|FG001|Overall Study|Other|11|||
27857240|NCT01662648|54394997|FG000|Overall Study|Adverse event and lack of efficacy (LOE)|3|||
27857241|NCT01662648|54394998|FG001|Overall Study|Adverse event and lack of efficacy (LOE)|0|||
27857242|NCT01662648|54394997|FG000|Overall Study|LOE and other reason unspecified|1|||
27857243|NCT01662648|54394998|FG001|Overall Study|LOE and other reason unspecified|0|||
27857244|NCT01662648|54394997|FG000|Overall Study|LOE and Participant non-compliant|0|||
27857245|NCT01662648|54394998|FG001|Overall Study|LOE and Participant non-compliant|1|||
27857246|NCT02556918|54395063|FG000|Overall Study|Protocol Violation|5|||
27857247|NCT02556918|54395064|FG001|Overall Study|Protocol Violation|6|||
27857248|NCT02556918|54395063|FG000|Overall Study|Withdrawal by Subject|4|||
27857249|NCT02556918|54395064|FG001|Overall Study|Withdrawal by Subject|4|||
27857250|NCT01662492|54395180|FG000|Overall Study|Other miscellaneous reasons.|1|||
27857251|NCT01662492|54395181|FG001|Overall Study|Other miscellaneous reasons.|0|||
27857252|NCT01662492|54395182|FG002|Overall Study|Other miscellaneous reasons.|1|||
27857253|NCT01662492|54395180|FG000|Overall Study|Withdrawal by Subject|0|||
27857254|NCT01662492|54395181|FG001|Overall Study|Withdrawal by Subject|0|||
27857255|NCT01662492|54395182|FG002|Overall Study|Withdrawal by Subject|1|||
27857256|NCT01662492|54395180|FG000|Overall Study|Protocol Violation|1|||
27857257|NCT01662492|54395181|FG001|Overall Study|Protocol Violation|0|||
27857258|NCT01662492|54395182|FG002|Overall Study|Protocol Violation|0|||
27857259|NCT01662492|54395180|FG000|Overall Study|Lost to Follow-up|0|||
27857260|NCT01662492|54395181|FG001|Overall Study|Lost to Follow-up|0|||
27857261|NCT01662492|54395182|FG002|Overall Study|Lost to Follow-up|2|||
27857262|NCT01662492|54395180|FG000|Overall Study|Lack of Efficacy|1|||
27857263|NCT01662492|54395181|FG001|Overall Study|Lack of Efficacy|1|||
27857264|NCT01662492|54395182|FG002|Overall Study|Lack of Efficacy|2|||
27857265|NCT02552238|54395352|FG000|Overall Study|Withdrawal by Subject|2|||
27857266|NCT02552238|54395352|FG000|Overall Study|Adverse Event|2|||
27857267|NCT01662102|54395570|FG000|Overall Study|Sponsor's decision|1|||
27857268|NCT01662102|54395571|FG001|Overall Study|Sponsor's decision|0|||
27857269|NCT02554656|54395611|FG000|Overall Study|Protocol Violation|3|||
27857270|NCT03414684|54395771|FG000|First-course Treatment|Complete response|0|||
27857271|NCT03414684|54395772|FG001|First-course Treatment|Complete response|1|||
28095865|NCT04315298|54750386|FG009|Overall Study|Lost to Follow-up|0|||
27857272|NCT03414684|54395771|FG000|First-course Treatment|Intercurrent illness|1|||
27857273|NCT03414684|54395772|FG001|First-course Treatment|Intercurrent illness|0|||
27857274|NCT03414684|54395771|FG000|First-course Treatment|Progressive Disease|31|||
27857275|NCT03414684|54395772|FG001|First-course Treatment|Progressive Disease|32|||
27857276|NCT03414684|54395771|FG000|First-course Treatment|Adverse Event|1|||
27857277|NCT03414684|54395772|FG001|First-course Treatment|Adverse Event|2|||
27857278|NCT03414684|54395771|FG000|First-course Treatment|Physician Decision|0|||
27857279|NCT03414684|54395772|FG001|First-course Treatment|Physician Decision|1|||
27857280|NCT03414684|54395771|FG000|First-course Treatment|Withdrawal by Subject|0|||
27857281|NCT03414684|54395772|FG001|First-course Treatment|Withdrawal by Subject|1|||
27857282|NCT03414684|54395771|FG000|First-course Treatment|"Patient proceeded with chest wall excision"|1|||
27857283|NCT03414684|54395772|FG001|First-course Treatment|"Patient proceeded with chest wall excision"|0|||
27857284|NCT03414684|54395771|FG000|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|0|||
27857285|NCT03414684|54395772|FG001|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|1|||
27857286|NCT03414684|54395771|FG000|First-course Treatment|Still on treatment|3|||
27857287|NCT03414684|54395772|FG001|First-course Treatment|Still on treatment|0|||
27857288|NCT03414684|54395771|FG000|First-course Treatment|Never started protocol therapy|2|||
27857289|NCT03414684|54395772|FG001|First-course Treatment|Never started protocol therapy|1|||
28095866|NCT04315298|54750387|FG010|Overall Study|Lost to Follow-up|2|||
27857290|NCT03414684|54395771|FG000|Crossover Treatment|Progressive disease|0|||
27857291|NCT03414684|54395772|FG001|Crossover Treatment|Progressive disease|12|||
27857292|NCT03414684|54395771|FG000|Crossover Treatment|Adverse Event|0|||
27857293|NCT03414684|54395772|FG001|Crossover Treatment|Adverse Event|3|||
27857294|NCT03414684|54395771|FG000|Crossover Treatment|Physician Decision|0|||
27857295|NCT03414684|54395772|FG001|Crossover Treatment|Physician Decision|1|||
27857296|NCT03414684|54395771|FG000|Crossover Treatment|Still on treatment|0|||
27857297|NCT03414684|54395772|FG001|Crossover Treatment|Still on treatment|2|||
27857298|NCT02551692|54395851|FG000|Overall Study|Lost to Follow-up|0|||
27857299|NCT02551692|54395852|FG001|Overall Study|Lost to Follow-up|1|||
27857300|NCT02551692|54395853|FG002|Overall Study|Lost to Follow-up|4|||
27738838|NCT02936323|54188168|FG000|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
27738839|NCT02936323|54188169|FG001|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
27738840|NCT02936323|54188170|FG002|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
27738841|NCT02936323|54188171|FG003|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
27738842|NCT02936323|54188172|FG004|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
27738843|NCT02936323|54188173|FG005|Phase 1 Dose Escalation|Study Discontinued at Site|1|||
27738844|NCT02936323|54188174|FG006|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
27834067|NCT02706834|54317634|FG001|Overall Study|Other Reason Not Specified|0|||
27834068|NCT02706834|54317635|FG002|Overall Study|Other Reason Not Specified|0|||
27834069|NCT02706834|54317636|FG003|Overall Study|Other Reason Not Specified|0|||
27834070|NCT02706834|54317637|FG004|Overall Study|Other Reason Not Specified|1|||
27834071|NCT02706834|54317638|FG005|Overall Study|Other Reason Not Specified|0|||
27834072|NCT02706834|54317639|FG006|Overall Study|Other Reason Not Specified|0|||
27834073|NCT02706834|54317640|FG007|Overall Study|Other Reason Not Specified|0|||
27834074|NCT02706834|54317641|FG008|Overall Study|Other Reason Not Specified|0|||
27834075|NCT02706834|54317642|FG009|Overall Study|Other Reason Not Specified|0|||
27834076|NCT02706834|54317643|FG010|Overall Study|Other Reason Not Specified|0|||
27834077|NCT01702025|54317692|FG000|Overall Study|Equipment failure|1|||
27834078|NCT01702025|54317693|FG001|Overall Study|Equipment failure|0|||
27834079|NCT01702025|54317694|FG002|Overall Study|Equipment failure|0|||
27834080|NCT01702025|54317695|FG003|Overall Study|Equipment failure|0|||
27834081|NCT01702025|54317692|FG000|Overall Study|Adverse Event|1|||
27834082|NCT01702025|54317693|FG001|Overall Study|Adverse Event|1|||
27834083|NCT01702025|54317694|FG002|Overall Study|Adverse Event|1|||
27834084|NCT01702025|54317695|FG003|Overall Study|Adverse Event|0|||
27834085|NCT01592747|54317712|FG000|Overall Study|Loss of Therapeutic Response|107|||
27834086|NCT01592747|54317713|FG001|Overall Study|Loss of Therapeutic Response|108|||
27834087|NCT01592747|54317714|FG002|Overall Study|Loss of Therapeutic Response|100|||
27834088|NCT01592747|54317712|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
27834089|NCT01592747|54317713|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
27834090|NCT01592747|54317714|FG002|Overall Study|Inclusion/Exclusion criteria not met|1|||
27834091|NCT01592747|54317712|FG000|Overall Study|Adverse Event|1|||
27834092|NCT01592747|54317713|FG001|Overall Study|Adverse Event|0|||
27834093|NCT01592747|54317714|FG002|Overall Study|Adverse Event|0|||
27834094|NCT01592747|54317712|FG000|Overall Study|Protocol Violation|4|||
27834095|NCT01592747|54317713|FG001|Overall Study|Protocol Violation|0|||
27834096|NCT01592747|54317714|FG002|Overall Study|Protocol Violation|4|||
27834097|NCT01592747|54317712|FG000|Overall Study|Lack of Efficacy|0|||
27834098|NCT01592747|54317713|FG001|Overall Study|Lack of Efficacy|1|||
27834099|NCT01592747|54317714|FG002|Overall Study|Lack of Efficacy|0|||
27834100|NCT01592747|54317712|FG000|Overall Study|Withdrawal by Subject|2|||
27834101|NCT01592747|54317713|FG001|Overall Study|Withdrawal by Subject|0|||
27834102|NCT01592747|54317714|FG002|Overall Study|Withdrawal by Subject|2|||
27834103|NCT01592747|54317712|FG000|Overall Study|Lost to Follow-up|1|||
27834104|NCT01592747|54317713|FG001|Overall Study|Lost to Follow-up|0|||
27834105|NCT01592747|54317714|FG002|Overall Study|Lost to Follow-up|1|||
27834106|NCT01592747|54317712|FG000|Overall Study|Other Reasons|1|||
27834107|NCT01592747|54317713|FG001|Overall Study|Other Reasons|1|||
27834108|NCT01592747|54317714|FG002|Overall Study|Other Reasons|0|||
27834109|NCT02051608|54317727|FG000|Part 1: Double Blind Treatment|Death|3|||
27834110|NCT02051608|54317728|FG001|Part 1: Double Blind Treatment|Death|3|||
27834111|NCT02051608|54317729|FG002|Part 1: Double Blind Treatment|Death|0|||
27834112|NCT02051608|54317730|FG003|Part 1: Double Blind Treatment|Death|0|||
27834113|NCT02051608|54317727|FG000|Part 1: Double Blind Treatment|Adverse Event|2|||
27834114|NCT02051608|54317728|FG001|Part 1: Double Blind Treatment|Adverse Event|8|||
27857301|NCT02551692|54395851|FG000|Overall Study|Withdrawal by Subject|1|||
27857302|NCT02551692|54395852|FG001|Overall Study|Withdrawal by Subject|0|||
27834115|NCT02051608|54317729|FG002|Part 1: Double Blind Treatment|Adverse Event|0|||
27834116|NCT02051608|54317730|FG003|Part 1: Double Blind Treatment|Adverse Event|0|||
27834117|NCT02051608|54317727|FG000|Part 1: Double Blind Treatment|Withdrawal by Subject|42|||
27857303|NCT02551692|54395853|FG002|Overall Study|Withdrawal by Subject|1|||
27857304|NCT02553330|54395940|FG000|Overall Study|Study Terminated by Sponsor|2|||
27857305|NCT02553330|54395941|FG001|Overall Study|Study Terminated by Sponsor|13|||
27857306|NCT02553330|54395942|FG002|Overall Study|Study Terminated by Sponsor|12|||
27857307|NCT02553330|54395940|FG000|Overall Study|Withdrawal by Subject|3|||
27857308|NCT02553330|54395941|FG001|Overall Study|Withdrawal by Subject|19|||
27857309|NCT02553330|54395942|FG002|Overall Study|Withdrawal by Subject|21|||
27857310|NCT02553330|54395940|FG000|Overall Study|Other|0|||
27857311|NCT02553330|54395941|FG001|Overall Study|Other|1|||
27857312|NCT02553330|54395942|FG002|Overall Study|Other|0|||
27857313|NCT02553330|54395940|FG000|Overall Study|Non compliance to study treatment|0|||
27857314|NCT02553330|54395941|FG001|Overall Study|Non compliance to study treatment|1|||
27857315|NCT02553330|54395942|FG002|Overall Study|Non compliance to study treatment|0|||
27857316|NCT02553330|54395940|FG000|Overall Study|Adverse Event|0|||
27857317|NCT02553330|54395941|FG001|Overall Study|Adverse Event|1|||
27857318|NCT02553330|54395942|FG002|Overall Study|Adverse Event|0|||
27857319|NCT02553330|54395940|FG000|Overall Study|Lost to Follow-up|0|||
27857320|NCT02553330|54395941|FG001|Overall Study|Lost to Follow-up|4|||
27857321|NCT02553330|54395942|FG002|Overall Study|Lost to Follow-up|4|||
27857322|NCT02550288|54395984|FG000|Overall Study|Adverse Event|0|||
27857323|NCT02550288|54395985|FG001|Overall Study|Adverse Event|1|||
27857324|NCT02550288|54395986|FG002|Overall Study|Adverse Event|0|||
27857325|NCT02550288|54395987|FG003|Overall Study|Adverse Event|0|||
27857326|NCT02550288|54395988|FG004|Overall Study|Adverse Event|0|||
27857327|NCT02550288|54395984|FG000|Overall Study|Physician Decision|0|||
27857328|NCT02550288|54395985|FG001|Overall Study|Physician Decision|0|||
27857329|NCT02550288|54395986|FG002|Overall Study|Physician Decision|0|||
27857330|NCT02550288|54395987|FG003|Overall Study|Physician Decision|1|||
27857331|NCT02550288|54395988|FG004|Overall Study|Physician Decision|0|||
27857332|NCT02550288|54395984|FG000|Overall Study|Protocol Violation|2|||
27857333|NCT02550288|54395985|FG001|Overall Study|Protocol Violation|2|||
27857334|NCT02550288|54395986|FG002|Overall Study|Protocol Violation|1|||
27857335|NCT02550288|54395987|FG003|Overall Study|Protocol Violation|0|||
27857336|NCT02550288|54395988|FG004|Overall Study|Protocol Violation|3|||
27857337|NCT02550288|54395984|FG000|Overall Study|Participant moved|0|||
27857338|NCT02550288|54395985|FG001|Overall Study|Participant moved|0|||
27857339|NCT02550288|54395986|FG002|Overall Study|Participant moved|0|||
27857340|NCT02550288|54395987|FG003|Overall Study|Participant moved|1|||
27857341|NCT02550288|54395988|FG004|Overall Study|Participant moved|0|||
27857342|NCT02550288|54395984|FG000|Overall Study|Withdrawal by Subject|0|||
27857343|NCT02550288|54395985|FG001|Overall Study|Withdrawal by Subject|0|||
27857344|NCT02550288|54395986|FG002|Overall Study|Withdrawal by Subject|0|||
27857345|NCT02550288|54395987|FG003|Overall Study|Withdrawal by Subject|1|||
27857346|NCT02550288|54395988|FG004|Overall Study|Withdrawal by Subject|0|||
27857347|NCT01662336|54396053|FG000|Overall Study|Adverse Event|1|||
27857348|NCT01662336|54396053|FG000|Overall Study|No longer on LPV/r|30|||
27857349|NCT01662336|54396053|FG000|Overall Study|Other|29|||
27857350|NCT01662336|54396053|FG000|Overall Study|Withdrawal by Subject|6|||
27857351|NCT02549352|54396072|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
27857352|NCT02549352|54396073|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
27857353|NCT02549352|54396072|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
27857354|NCT02549352|54396073|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
27857355|NCT02549352|54396072|FG000|3-day Treatment and 8-week Follow-up|Other|0|||
27857356|NCT02549352|54396073|FG001|3-day Treatment and 8-week Follow-up|Other|2|||
27857357|NCT02549352|54396072|FG000|12-month Follow-up|Withdrawal by Subject|4|||
27857358|NCT02549352|54396073|FG001|12-month Follow-up|Withdrawal by Subject|5|||
27857359|NCT02549352|54396072|FG000|12-month Follow-up|Lost to Follow-up|3|||
27857360|NCT02549352|54396073|FG001|12-month Follow-up|Lost to Follow-up|2|||
27857361|NCT02549352|54396072|FG000|12-month Follow-up|Death|0|||
27857362|NCT02549352|54396073|FG001|12-month Follow-up|Death|1|||
28171240|NCT01333189|54842795|FG000|Overall Study|Moved from region|0|||
27857363|NCT02549352|54396072|FG000|12-month Follow-up|Protocol Violation|0|||
27857364|NCT02549352|54396073|FG001|12-month Follow-up|Protocol Violation|1|||
27857365|NCT02549352|54396072|FG000|12-month Follow-up|Other|1|||
27857366|NCT02549352|54396073|FG001|12-month Follow-up|Other|3|||
27857367|NCT02554890|54396250|FG000|Double-blind|Adverse Event|45|||
27857368|NCT02554890|54396251|FG001|Double-blind|Adverse Event|51|||
27857369|NCT02554890|54396250|FG000|Double-blind|Death|6|||
27857370|NCT02554890|54396251|FG001|Double-blind|Death|4|||
27857371|NCT02554890|54396250|FG000|Double-blind|Protocol Violation|1|||
27857372|NCT02554890|54396251|FG001|Double-blind|Protocol Violation|1|||
27857373|NCT02554890|54396250|FG000|Double-blind|Physician Decision|4|||
27857374|NCT02554890|54396251|FG001|Double-blind|Physician Decision|3|||
27857375|NCT02554890|54396250|FG000|Double-blind|Subject/Guardian decision|21|||
27857376|NCT02554890|54396251|FG001|Double-blind|Subject/Guardian decision|16|||
27857377|NCT02554890|54396250|FG000|Double-blind|Lost to Follow-up|7|||
27857378|NCT02554890|54396251|FG001|Double-blind|Lost to Follow-up|5|||
27857379|NCT02554890|54396250|FG000|Double-blind|Technical problems|1|||
27857380|NCT02554890|54396251|FG001|Double-blind|Technical problems|0|||
27857381|NCT02554890|54396250|FG000|Double-blind|Withdrawal by Subject|5|||
27857382|NCT02554890|54396251|FG001|Double-blind|Withdrawal by Subject|6|||
27857383|NCT02554890|54396250|FG000|Double-blind|Noncompliance with study treatment|6|||
27857384|NCT02554890|54396251|FG001|Double-blind|Noncompliance with study treatment|5|||
27857385|NCT02554890|54396250|FG000|Open-label|Adverse Event|0|||
27857386|NCT02554890|54396251|FG001|Open-label|Adverse Event|30|||
27857387|NCT02554890|54396250|FG000|Open-label|Death|0|||
27857388|NCT02554890|54396251|FG001|Open-label|Death|1|||
27857389|NCT02554890|54396250|FG000|Open-label|Physician Decision|0|||
27857390|NCT02554890|54396251|FG001|Open-label|Physician Decision|1|||
27857391|NCT02554890|54396250|FG000|Open-label|Subject/Guardian decision|0|||
27857392|NCT02554890|54396251|FG001|Open-label|Subject/Guardian decision|11|||
27857393|NCT02554890|54396250|FG000|Open-label|Lost to Follow-up|0|||
27857394|NCT02554890|54396251|FG001|Open-label|Lost to Follow-up|7|||
27857395|NCT02554890|54396250|FG000|Open-label|Technical problems|0|||
27857396|NCT02554890|54396251|FG001|Open-label|Technical problems|1|||
27857397|NCT02554890|54396250|FG000|Open-label|Withdrawal by Subject|0|||
27857398|NCT02554890|54396251|FG001|Open-label|Withdrawal by Subject|1|||
27857399|NCT02552316|54396268|FG000|Overall Study|Withdrawal by Subject|1|||
27857400|NCT02552316|54396268|FG000|Overall Study|Withdrawal due to non-compliance|1|||
27857401|NCT02543346|54396316|FG000|Second Priming Visit|Withdrawal by Subject|0|||
27857402|NCT02543346|54396317|FG001|Second Priming Visit|Withdrawal by Subject|2|||
27857403|NCT02543346|54396318|FG002|Second Priming Visit|Withdrawal by Subject|2|||
27857404|NCT02543346|54396319|FG003|Second Priming Visit|Withdrawal by Subject|2|||
27857405|NCT02543346|54396316|FG000|Second Priming Visit|Adverse Event|1|||
27857406|NCT02543346|54396317|FG001|Second Priming Visit|Adverse Event|0|||
27857407|NCT02543346|54396318|FG002|Second Priming Visit|Adverse Event|0|||
27857408|NCT02543346|54396319|FG003|Second Priming Visit|Adverse Event|0|||
27857409|NCT02549196|54396333|FG000|Overall Study|Protocol Violation|0|||
27857410|NCT02549196|54396334|FG001|Overall Study|Protocol Violation|0|||
27857411|NCT02549196|54396335|FG002|Overall Study|Protocol Violation|0|||
27857412|NCT02549196|54396336|FG003|Overall Study|Protocol Violation|1|||
27857413|NCT02549196|54396333|FG000|Overall Study|Withdrawal by Subject|1|||
27857414|NCT02549196|54396334|FG001|Overall Study|Withdrawal by Subject|0|||
27857415|NCT02549196|54396335|FG002|Overall Study|Withdrawal by Subject|1|||
27857416|NCT02549196|54396336|FG003|Overall Study|Withdrawal by Subject|0|||
27857417|NCT02904954|54396348|FG000|Neoadjuvant (Preoperative) to Surgery|Death|1|||
27857418|NCT02904954|54396349|FG001|Neoadjuvant (Preoperative) to Surgery|Death|1|||
27857419|NCT02904954|54396348|FG000|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|1|||
27857420|NCT02904954|54396349|FG001|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|0|||
27857421|NCT02904954|54396348|FG000|Neoadjuvant (Preoperative) to Surgery|Disease progression|2|||
27857422|NCT02904954|54396349|FG001|Neoadjuvant (Preoperative) to Surgery|Disease progression|3|||
27857423|NCT02904954|54396348|FG000|Adjuvant Durvalumab|Recurrence|2|||
27981060|NCT00951665|54638988|FG005|Phase 1b|Protocol Violation|0|||
27981061|NCT00951665|54638983|FG000|Phase 2a|Adverse Event|0|||
27981062|NCT00951665|54638984|FG001|Phase 2a|Adverse Event|0|||
27981063|NCT00951665|54638985|FG002|Phase 2a|Adverse Event|0|||
27981064|NCT00951665|54638986|FG003|Phase 2a|Adverse Event|0|||
27981065|NCT00951665|54638987|FG004|Phase 2a|Adverse Event|2|||
27981066|NCT00951665|54638988|FG005|Phase 2a|Adverse Event|0|||
27981067|NCT00951665|54638983|FG000|Phase 2a|Death|0|||
27981068|NCT00951665|54638984|FG001|Phase 2a|Death|0|||
27981069|NCT00951665|54638985|FG002|Phase 2a|Death|0|||
27981070|NCT00951665|54638986|FG003|Phase 2a|Death|0|||
27981071|NCT00951665|54638987|FG004|Phase 2a|Death|1|||
27981072|NCT00951665|54638988|FG005|Phase 2a|Death|1|||
27981073|NCT00951665|54638983|FG000|Phase 2a|Lost to Follow-up|0|||
27981074|NCT00951665|54638984|FG001|Phase 2a|Lost to Follow-up|0|||
27981075|NCT00951665|54638985|FG002|Phase 2a|Lost to Follow-up|0|||
27981076|NCT00951665|54638986|FG003|Phase 2a|Lost to Follow-up|0|||
27738845|NCT02936323|54188175|FG007|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
27738846|NCT02936323|54188176|FG008|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
27738847|NCT02936323|54188177|FG009|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
27857424|NCT02904954|54396349|FG001|Adjuvant Durvalumab|Recurrence|0|||
27857425|NCT02904954|54396348|FG000|Adjuvant Durvalumab|Adverse Event|2|||
27857426|NCT02904954|54396349|FG001|Adjuvant Durvalumab|Adverse Event|6|||
27857427|NCT02904954|54396348|FG000|Adjuvant Durvalumab|Participant wishes|12|||
27857428|NCT02904954|54396349|FG001|Adjuvant Durvalumab|Participant wishes|7|||
27857429|NCT02904954|54396348|FG000|Adjuvant Durvalumab|Physician Decision|2|||
27857430|NCT02904954|54396349|FG001|Adjuvant Durvalumab|Physician Decision|1|||
27857431|NCT02904954|54396348|FG000|Adjuvant Durvalumab|Slow recovery after chemotherapy|1|||
27857432|NCT02904954|54396349|FG001|Adjuvant Durvalumab|Slow recovery after chemotherapy|0|||
27857433|NCT02904954|54396348|FG000|Adjuvant Durvalumab|Death|0|||
27857434|NCT02904954|54396349|FG001|Adjuvant Durvalumab|Death|1|||
27981077|NCT00951665|54638987|FG004|Phase 2a|Lost to Follow-up|1|||
27981078|NCT00951665|54638988|FG005|Phase 2a|Lost to Follow-up|0|||
27981079|NCT00951665|54638983|FG000|Phase 2a|Physician Decision|0|||
27981080|NCT00951665|54638984|FG001|Phase 2a|Physician Decision|0|||
27981081|NCT00951665|54638985|FG002|Phase 2a|Physician Decision|0|||
27981082|NCT00951665|54638986|FG003|Phase 2a|Physician Decision|0|||
27981083|NCT00951665|54638987|FG004|Phase 2a|Physician Decision|0|||
27857435|NCT02904954|54396348|FG000|Adjuvant Durvalumab|Prostate cancer|1|||
27857436|NCT02904954|54396349|FG001|Adjuvant Durvalumab|Prostate cancer|0|||
27857437|NCT02548962|54396465|FG000|Overall Study|Withdrawal by Subject|1|||
27857438|NCT02548962|54396466|FG001|Overall Study|Withdrawal by Subject|0|||
27857439|NCT02548650|54396493|FG000|Triple Therapy|Adverse Event|1|||
27857440|NCT02548650|54396494|FG001|Triple Therapy|Adverse Event|0|||
27857441|NCT02548650|54396493|FG000|Triple Therapy|Withdrawal by Subject|0|||
27857442|NCT02548650|54396494|FG001|Triple Therapy|Withdrawal by Subject|4|||
27857443|NCT02548650|54396493|FG000|Double Therapy|Adverse Event|1|||
27857444|NCT02548650|54396494|FG001|Double Therapy|Adverse Event|1|||
27857445|NCT02548650|54396493|FG000|Double Therapy|Withdrawal by Subject|0|||
27857446|NCT02548650|54396494|FG001|Double Therapy|Withdrawal by Subject|1|||
27857447|NCT02535000|54396589|FG000|Overall Study|Cancellation of surgery.|1|||
27857448|NCT02535000|54396590|FG001|Overall Study|Cancellation of surgery.|2|||
27857449|NCT03110562|54396719|FG000|Overall Study|Withdrawal by Subject|37|||
27857450|NCT03110562|54396720|FG001|Overall Study|Withdrawal by Subject|35|||
27857451|NCT03110562|54396719|FG000|Overall Study|Death|47|||
27857452|NCT03110562|54396720|FG001|Overall Study|Death|61|||
27857453|NCT03110562|54396719|FG000|Overall Study|Lost to Follow-up|7|||
27857454|NCT03110562|54396720|FG001|Overall Study|Lost to Follow-up|6|||
27857455|NCT03110562|54396719|FG000|Overall Study|Other|2|||
27857456|NCT03110562|54396720|FG001|Overall Study|Other|1|||
27857457|NCT03110562|54396719|FG000|Overall Study|Randomized but never treated|0|||
27857458|NCT03110562|54396720|FG001|Overall Study|Randomized but never treated|3|||
27857459|NCT03110562|54396719|FG000|Overall Study|Ongoing|102|||
27857460|NCT03110562|54396720|FG001|Overall Study|Ongoing|101|||
27857461|NCT02546856|54396763|FG000|4 Months Evaluation|Death|2|||
27857462|NCT02546856|54396764|FG001|4 Months Evaluation|Death|3|||
27857463|NCT02546856|54396763|FG000|4 Months Evaluation|Withdrawal by Subject|2|||
27857464|NCT02546856|54396764|FG001|4 Months Evaluation|Withdrawal by Subject|3|||
27857465|NCT02546856|54396763|FG000|4 Months Evaluation|Lost to Follow-up|3|||
27857466|NCT02546856|54396764|FG001|4 Months Evaluation|Lost to Follow-up|3|||
27857467|NCT02546856|54396763|FG000|4 Months Evaluation|Physician Decision|3|||
27857468|NCT02546856|54396764|FG001|4 Months Evaluation|Physician Decision|0|||
27857469|NCT02546856|54396763|FG000|4 Months Evaluation|Working or living abroad|5|||
27857470|NCT02546856|54396764|FG001|4 Months Evaluation|Working or living abroad|1|||
27857471|NCT02546856|54396763|FG000|4 Months Evaluation|reasons not due to titration|4|||
27857472|NCT02546856|54396764|FG001|4 Months Evaluation|reasons not due to titration|1|||
27857473|NCT02546856|54396763|FG000|4 Months Evaluation|HF Unit not active in summer|1|||
27857474|NCT02546856|54396764|FG001|4 Months Evaluation|HF Unit not active in summer|0|||
27857475|NCT02546856|54396763|FG000|6 Months Evaluation|Death|1|||
27857476|NCT02546856|54396764|FG001|6 Months Evaluation|Death|1|||
27857477|NCT02546856|54396763|FG000|6 Months Evaluation|Lost to Follow-up|1|||
27857478|NCT02546856|54396764|FG001|6 Months Evaluation|Lost to Follow-up|1|||
27857479|NCT02546856|54396763|FG000|6 Months Evaluation|Working or living abroad|6|||
27857480|NCT02546856|54396764|FG001|6 Months Evaluation|Working or living abroad|4|||
27857481|NCT02546856|54396763|FG000|6 Months Evaluation|reasons not due to titration|0|||
27857482|NCT02546856|54396764|FG001|6 Months Evaluation|reasons not due to titration|1|||
27981084|NCT00951665|54638988|FG005|Phase 2a|Physician Decision|1|||
28171241|NCT01333189|54842796|FG001|Overall Study|Moved from region|1|||
28171242|NCT01333111|54842805|FG000|Overall Study|patient undergoing major surgery|0|||
28171243|NCT01333111|54842806|FG001|Overall Study|patient undergoing major surgery|2|||
28171244|NCT01333111|54842807|FG002|Overall Study|patient undergoing major surgery|0|||
28171245|NCT01333111|54842805|FG000|Overall Study|personal reasons|0|||
27981085|NCT00951665|54638983|FG000|Phase 2a|Withdrawal by Subject|0|||
27857483|NCT02696616|54396889|FG000|Overall Study|Adverse Event|0|||
27857484|NCT02696616|54396890|FG001|Overall Study|Adverse Event|1|||
27857485|NCT02696616|54396891|FG002|Overall Study|Adverse Event|0|||
27857486|NCT02696616|54396892|FG003|Overall Study|Adverse Event|0|||
27857487|NCT02696616|54396893|FG004|Overall Study|Adverse Event|0|||
27857488|NCT02696616|54396894|FG005|Overall Study|Adverse Event|0|||
27857489|NCT02696616|54396895|FG006|Overall Study|Adverse Event|0|||
27857490|NCT01661790|54396946|FG000|Overall Study|Lost to Follow-up|0|||
27857491|NCT01661790|54396947|FG001|Overall Study|Lost to Follow-up|2|||
27857492|NCT02546544|54396967|FG000|Overall Study|Disease Progression|14|||
27857493|NCT02546544|54396967|FG000|Overall Study|Adverse Event|1|||
27857494|NCT02546544|54396967|FG000|Overall Study|Withdrawal by Subject|1|||
27857495|NCT05593211|54397262|FG000|Overall Study|Withdrawal by Subject|1|||
27857496|NCT02533674|54397601|FG000|Dose Level I|Progressive disease|1|||
27857497|NCT02533674|54397602|FG001|Dose Level I|Progressive disease|0|||
27857498|NCT02533674|54397603|FG002|Dose Level I|Progressive disease|0|||
27857499|NCT02533674|54397604|FG003|Dose Level I|Progressive disease|0|||
27857500|NCT02533674|54397605|FG004|Dose Level I|Progressive disease|0|||
27857501|NCT02533674|54397606|FG005|Dose Level I|Progressive disease|0|||
27857502|NCT02533674|54397607|FG006|Dose Level I|Progressive disease|0|||
27857503|NCT02533674|54397608|FG007|Dose Level I|Progressive disease|0|||
27981086|NCT00951665|54638984|FG001|Phase 2a|Withdrawal by Subject|0|||
28171246|NCT01333111|54842806|FG001|Overall Study|personal reasons|0|||
27981087|NCT00951665|54638985|FG002|Phase 2a|Withdrawal by Subject|0|||
28171247|NCT01333111|54842807|FG002|Overall Study|personal reasons|1|||
27857504|NCT02533674|54397601|FG000|Dose Level I|Withdrawal by Subject|1|||
27857505|NCT02533674|54397602|FG001|Dose Level I|Withdrawal by Subject|0|||
27857506|NCT02533674|54397603|FG002|Dose Level I|Withdrawal by Subject|0|||
27857507|NCT02533674|54397604|FG003|Dose Level I|Withdrawal by Subject|0|||
27857508|NCT02533674|54397605|FG004|Dose Level I|Withdrawal by Subject|0|||
27857509|NCT02533674|54397606|FG005|Dose Level I|Withdrawal by Subject|0|||
27857510|NCT02533674|54397607|FG006|Dose Level I|Withdrawal by Subject|0|||
27981088|NCT00951665|54638986|FG003|Phase 2a|Withdrawal by Subject|0|||
27981089|NCT00951665|54638987|FG004|Phase 2a|Withdrawal by Subject|2|||
28171248|NCT01333111|54842805|FG000|Overall Study|unclassified|1|||
27834118|NCT02051608|54317728|FG001|Part 1: Double Blind Treatment|Withdrawal by Subject|29|||
27834119|NCT02051608|54317729|FG002|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
27834120|NCT02051608|54317730|FG003|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
27834121|NCT02051608|54317727|FG000|Part 1: Double Blind Treatment|Physician Decision|2|||
27834122|NCT02051608|54317728|FG001|Part 1: Double Blind Treatment|Physician Decision|4|||
27834123|NCT02051608|54317729|FG002|Part 1: Double Blind Treatment|Physician Decision|0|||
27834124|NCT02051608|54317730|FG003|Part 1: Double Blind Treatment|Physician Decision|0|||
27834125|NCT02051608|54317727|FG000|Part 1: Double Blind Treatment|Lost to Follow-up|1|||
27834126|NCT02051608|54317728|FG001|Part 1: Double Blind Treatment|Lost to Follow-up|2|||
27834127|NCT02051608|54317729|FG002|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
27834128|NCT02051608|54317730|FG003|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
27834129|NCT02051608|54317727|FG000|Part 1: Double Blind Treatment|Protocol Violation|0|||
27834130|NCT02051608|54317728|FG001|Part 1: Double Blind Treatment|Protocol Violation|1|||
27834131|NCT02051608|54317729|FG002|Part 1: Double Blind Treatment|Protocol Violation|0|||
27834132|NCT02051608|54317730|FG003|Part 1: Double Blind Treatment|Protocol Violation|0|||
27834133|NCT02051608|54317727|FG000|Part 1: Double Blind Treatment|Non-Compliance|2|||
27834134|NCT02051608|54317728|FG001|Part 1: Double Blind Treatment|Non-Compliance|4|||
27834135|NCT02051608|54317729|FG002|Part 1: Double Blind Treatment|Non-Compliance|0|||
27834136|NCT02051608|54317730|FG003|Part 1: Double Blind Treatment|Non-Compliance|0|||
27834137|NCT02051608|54317727|FG000|Part 1: Double Blind Treatment|Other|6|||
27834138|NCT02051608|54317728|FG001|Part 1: Double Blind Treatment|Other|3|||
27834139|NCT02051608|54317729|FG002|Part 1: Double Blind Treatment|Other|0|||
27834140|NCT02051608|54317730|FG003|Part 1: Double Blind Treatment|Other|0|||
27834141|NCT02051608|54317727|FG000|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|3|||
27834142|NCT02051608|54317728|FG001|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|2|||
27834143|NCT02051608|54317729|FG002|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
27834144|NCT02051608|54317730|FG003|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
27834145|NCT02051608|54317727|FG000|Part 2: Open-label Extension|Adverse Event|0|||
27834146|NCT02051608|54317728|FG001|Part 2: Open-label Extension|Adverse Event|0|||
27834147|NCT02051608|54317729|FG002|Part 2: Open-label Extension|Adverse Event|6|||
27834148|NCT02051608|54317730|FG003|Part 2: Open-label Extension|Adverse Event|8|||
27834149|NCT02051608|54317727|FG000|Part 2: Open-label Extension|Death|0|||
27834150|NCT02051608|54317728|FG001|Part 2: Open-label Extension|Death|0|||
27834151|NCT02051608|54317729|FG002|Part 2: Open-label Extension|Death|7|||
27834152|NCT02051608|54317730|FG003|Part 2: Open-label Extension|Death|4|||
27834153|NCT02051608|54317727|FG000|Part 2: Open-label Extension|Lost to Follow-up|0|||
27834154|NCT02051608|54317728|FG001|Part 2: Open-label Extension|Lost to Follow-up|0|||
27834155|NCT02051608|54317729|FG002|Part 2: Open-label Extension|Lost to Follow-up|0|||
27834156|NCT02051608|54317730|FG003|Part 2: Open-label Extension|Lost to Follow-up|1|||
27834157|NCT02051608|54317727|FG000|Part 2: Open-label Extension|Non-Compliance|0|||
27834158|NCT02051608|54317728|FG001|Part 2: Open-label Extension|Non-Compliance|0|||
27834159|NCT02051608|54317729|FG002|Part 2: Open-label Extension|Non-Compliance|1|||
27834160|NCT02051608|54317730|FG003|Part 2: Open-label Extension|Non-Compliance|1|||
27834161|NCT02051608|54317727|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
27834162|NCT02051608|54317728|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
27834163|NCT02051608|54317729|FG002|Part 2: Open-label Extension|Withdrawal by Subject|39|||
27834164|NCT02051608|54317730|FG003|Part 2: Open-label Extension|Withdrawal by Subject|32|||
27834165|NCT02051608|54317727|FG000|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
27834166|NCT02051608|54317728|FG001|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
27834167|NCT02051608|54317729|FG002|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
27834168|NCT02051608|54317730|FG003|Part 2: Open-label Extension|Study Terminated By Sponsor|1|||
27834169|NCT02051608|54317727|FG000|Part 2: Open-label Extension|Physician Decision|0|||
27834170|NCT02051608|54317728|FG001|Part 2: Open-label Extension|Physician Decision|0|||
27834171|NCT02051608|54317729|FG002|Part 2: Open-label Extension|Physician Decision|8|||
27834172|NCT02051608|54317730|FG003|Part 2: Open-label Extension|Physician Decision|5|||
27834173|NCT02051608|54317727|FG000|Part 2: Open-label Extension|Other|0|||
27834174|NCT02051608|54317728|FG001|Part 2: Open-label Extension|Other|0|||
27834175|NCT02051608|54317729|FG002|Part 2: Open-label Extension|Other|9|||
27834176|NCT02051608|54317730|FG003|Part 2: Open-label Extension|Other|9|||
27857511|NCT02533674|54397608|FG007|Dose Level I|Withdrawal by Subject|0|||
27857512|NCT02533674|54397601|FG000|Dose Level I|Physician Decision|1|||
27857513|NCT02533674|54397602|FG001|Dose Level I|Physician Decision|0|||
27857514|NCT02533674|54397603|FG002|Dose Level I|Physician Decision|0|||
27857515|NCT02533674|54397604|FG003|Dose Level I|Physician Decision|0|||
27857516|NCT02533674|54397605|FG004|Dose Level I|Physician Decision|0|||
27857517|NCT02533674|54397606|FG005|Dose Level I|Physician Decision|0|||
27857518|NCT02533674|54397607|FG006|Dose Level I|Physician Decision|0|||
27857519|NCT02533674|54397608|FG007|Dose Level I|Physician Decision|0|||
27857520|NCT02533674|54397601|FG000|Dose Level I|Death|1|||
27857521|NCT02533674|54397602|FG001|Dose Level I|Death|0|||
27857522|NCT02533674|54397603|FG002|Dose Level I|Death|0|||
27857523|NCT02533674|54397604|FG003|Dose Level I|Death|0|||
27857524|NCT02533674|54397605|FG004|Dose Level I|Death|0|||
27857525|NCT02533674|54397606|FG005|Dose Level I|Death|0|||
27857526|NCT02533674|54397607|FG006|Dose Level I|Death|0|||
27857527|NCT02533674|54397608|FG007|Dose Level I|Death|0|||
27857528|NCT02533674|54397601|FG000|Dose Level I|Never Treated|1|||
27857529|NCT02533674|54397602|FG001|Dose Level I|Never Treated|0|||
27857530|NCT02533674|54397603|FG002|Dose Level I|Never Treated|0|||
27857531|NCT02533674|54397604|FG003|Dose Level I|Never Treated|0|||
27857532|NCT02533674|54397605|FG004|Dose Level I|Never Treated|0|||
27857533|NCT02533674|54397606|FG005|Dose Level I|Never Treated|0|||
27857534|NCT02533674|54397607|FG006|Dose Level I|Never Treated|0|||
27857535|NCT02533674|54397608|FG007|Dose Level I|Never Treated|0|||
27857536|NCT02533674|54397601|FG000|Dose Level II|Progressive disease|0|||
27857537|NCT02533674|54397602|FG001|Dose Level II|Progressive disease|3|||
27857538|NCT02533674|54397603|FG002|Dose Level II|Progressive disease|0|||
27857539|NCT02533674|54397604|FG003|Dose Level II|Progressive disease|0|||
27857540|NCT02533674|54397605|FG004|Dose Level II|Progressive disease|0|||
27857541|NCT02533674|54397606|FG005|Dose Level II|Progressive disease|0|||
27857542|NCT02533674|54397607|FG006|Dose Level II|Progressive disease|0|||
27857543|NCT02533674|54397608|FG007|Dose Level II|Progressive disease|0|||
27857544|NCT02533674|54397601|FG000|Dose Level II|Withdrawal by Subject|0|||
27857545|NCT02533674|54397602|FG001|Dose Level II|Withdrawal by Subject|1|||
27857546|NCT02533674|54397603|FG002|Dose Level II|Withdrawal by Subject|0|||
27857547|NCT02533674|54397604|FG003|Dose Level II|Withdrawal by Subject|0|||
27857548|NCT02533674|54397605|FG004|Dose Level II|Withdrawal by Subject|0|||
27857549|NCT02533674|54397606|FG005|Dose Level II|Withdrawal by Subject|0|||
27857550|NCT02533674|54397607|FG006|Dose Level II|Withdrawal by Subject|0|||
27857551|NCT02533674|54397608|FG007|Dose Level II|Withdrawal by Subject|0|||
27857552|NCT02533674|54397601|FG000|Dose Level II|Treatment-related AE|0|||
27857553|NCT02533674|54397602|FG001|Dose Level II|Treatment-related AE|1|||
27857554|NCT02533674|54397603|FG002|Dose Level II|Treatment-related AE|0|||
27857555|NCT02533674|54397604|FG003|Dose Level II|Treatment-related AE|0|||
27857556|NCT02533674|54397605|FG004|Dose Level II|Treatment-related AE|0|||
27857557|NCT02533674|54397606|FG005|Dose Level II|Treatment-related AE|0|||
27857558|NCT02533674|54397607|FG006|Dose Level II|Treatment-related AE|0|||
27857559|NCT02533674|54397608|FG007|Dose Level II|Treatment-related AE|0|||
27857560|NCT02533674|54397601|FG000|Dose Level II|Physician Decision|0|||
27857561|NCT02533674|54397602|FG001|Dose Level II|Physician Decision|1|||
27857562|NCT02533674|54397603|FG002|Dose Level II|Physician Decision|0|||
27857563|NCT02533674|54397604|FG003|Dose Level II|Physician Decision|0|||
27857564|NCT02533674|54397605|FG004|Dose Level II|Physician Decision|0|||
27857565|NCT02533674|54397606|FG005|Dose Level II|Physician Decision|0|||
27857566|NCT02533674|54397607|FG006|Dose Level II|Physician Decision|0|||
27857567|NCT02533674|54397608|FG007|Dose Level II|Physician Decision|0|||
27857568|NCT02533674|54397601|FG000|Dose Level II|Non-treatment-related AE|0|||
27857569|NCT02533674|54397602|FG001|Dose Level II|Non-treatment-related AE|1|||
27857570|NCT02533674|54397603|FG002|Dose Level II|Non-treatment-related AE|0|||
27857571|NCT02533674|54397604|FG003|Dose Level II|Non-treatment-related AE|0|||
27857572|NCT02533674|54397605|FG004|Dose Level II|Non-treatment-related AE|0|||
27857573|NCT02533674|54397606|FG005|Dose Level II|Non-treatment-related AE|0|||
27857574|NCT02533674|54397607|FG006|Dose Level II|Non-treatment-related AE|0|||
27857575|NCT02533674|54397608|FG007|Dose Level II|Non-treatment-related AE|0|||
27857576|NCT02533674|54397601|FG000|Dose Level III|Progressive disease|0|||
27857577|NCT02533674|54397602|FG001|Dose Level III|Progressive disease|0|||
27857578|NCT02533674|54397603|FG002|Dose Level III|Progressive disease|2|||
27857579|NCT02533674|54397604|FG003|Dose Level III|Progressive disease|0|||
27857580|NCT02533674|54397605|FG004|Dose Level III|Progressive disease|0|||
27857581|NCT02533674|54397606|FG005|Dose Level III|Progressive disease|0|||
27857582|NCT02533674|54397607|FG006|Dose Level III|Progressive disease|0|||
27857583|NCT02533674|54397608|FG007|Dose Level III|Progressive disease|0|||
27857584|NCT02533674|54397601|FG000|Dose Level III|Withdrawal by Subject|0|||
27857585|NCT02533674|54397602|FG001|Dose Level III|Withdrawal by Subject|0|||
27857586|NCT02533674|54397603|FG002|Dose Level III|Withdrawal by Subject|1|||
27857587|NCT02533674|54397604|FG003|Dose Level III|Withdrawal by Subject|0|||
27857588|NCT02533674|54397605|FG004|Dose Level III|Withdrawal by Subject|0|||
27857589|NCT02533674|54397606|FG005|Dose Level III|Withdrawal by Subject|0|||
27857590|NCT02533674|54397607|FG006|Dose Level III|Withdrawal by Subject|0|||
27857591|NCT02533674|54397608|FG007|Dose Level III|Withdrawal by Subject|0|||
27857592|NCT02533674|54397601|FG000|Dose Level III|Treatment-related AE|0|||
27857593|NCT02533674|54397602|FG001|Dose Level III|Treatment-related AE|0|||
27857594|NCT02533674|54397603|FG002|Dose Level III|Treatment-related AE|1|||
27857595|NCT02533674|54397604|FG003|Dose Level III|Treatment-related AE|0|||
27857596|NCT02533674|54397605|FG004|Dose Level III|Treatment-related AE|0|||
27857597|NCT02533674|54397606|FG005|Dose Level III|Treatment-related AE|0|||
27857598|NCT02533674|54397607|FG006|Dose Level III|Treatment-related AE|0|||
27857599|NCT02533674|54397608|FG007|Dose Level III|Treatment-related AE|0|||
27857600|NCT02533674|54397601|FG000|Dose Level IV|Progressive disease|0|||
27857601|NCT02533674|54397602|FG001|Dose Level IV|Progressive disease|0|||
27857602|NCT02533674|54397603|FG002|Dose Level IV|Progressive disease|0|||
27857603|NCT02533674|54397604|FG003|Dose Level IV|Progressive disease|3|||
27857604|NCT02533674|54397605|FG004|Dose Level IV|Progressive disease|0|||
27857605|NCT02533674|54397606|FG005|Dose Level IV|Progressive disease|0|||
27857606|NCT02533674|54397607|FG006|Dose Level IV|Progressive disease|0|||
27857607|NCT02533674|54397608|FG007|Dose Level IV|Progressive disease|0|||
27857608|NCT02533674|54397601|FG000|Dose Level IV|Withdrawal by Subject|0|||
27857609|NCT02533674|54397602|FG001|Dose Level IV|Withdrawal by Subject|0|||
27857610|NCT02533674|54397603|FG002|Dose Level IV|Withdrawal by Subject|0|||
27857611|NCT02533674|54397604|FG003|Dose Level IV|Withdrawal by Subject|1|||
27857612|NCT02533674|54397605|FG004|Dose Level IV|Withdrawal by Subject|0|||
27857613|NCT02533674|54397606|FG005|Dose Level IV|Withdrawal by Subject|0|||
27857614|NCT02533674|54397607|FG006|Dose Level IV|Withdrawal by Subject|0|||
27857615|NCT02533674|54397608|FG007|Dose Level IV|Withdrawal by Subject|0|||
27857616|NCT02533674|54397601|FG000|Dose Level IV|Physician Decision|0|||
27857617|NCT02533674|54397602|FG001|Dose Level IV|Physician Decision|0|||
27857618|NCT02533674|54397603|FG002|Dose Level IV|Physician Decision|0|||
27857619|NCT02533674|54397604|FG003|Dose Level IV|Physician Decision|1|||
27857620|NCT02533674|54397605|FG004|Dose Level IV|Physician Decision|0|||
27857621|NCT02533674|54397606|FG005|Dose Level IV|Physician Decision|0|||
27857622|NCT02533674|54397607|FG006|Dose Level IV|Physician Decision|0|||
27857623|NCT02533674|54397608|FG007|Dose Level IV|Physician Decision|0|||
27857624|NCT02533674|54397601|FG000|Dose Level V|Progressive disease|0|||
27857625|NCT02533674|54397602|FG001|Dose Level V|Progressive disease|0|||
27857626|NCT02533674|54397603|FG002|Dose Level V|Progressive disease|0|||
27857627|NCT02533674|54397604|FG003|Dose Level V|Progressive disease|0|||
27857628|NCT02533674|54397605|FG004|Dose Level V|Progressive disease|3|||
27857629|NCT02533674|54397606|FG005|Dose Level V|Progressive disease|0|||
27857630|NCT02533674|54397607|FG006|Dose Level V|Progressive disease|0|||
27857631|NCT02533674|54397608|FG007|Dose Level V|Progressive disease|0|||
27857632|NCT02533674|54397601|FG000|Dose Level V|Withdrawal by Subject|0|||
27857633|NCT02533674|54397602|FG001|Dose Level V|Withdrawal by Subject|0|||
27857634|NCT02533674|54397603|FG002|Dose Level V|Withdrawal by Subject|0|||
27857635|NCT02533674|54397604|FG003|Dose Level V|Withdrawal by Subject|0|||
27857636|NCT02533674|54397605|FG004|Dose Level V|Withdrawal by Subject|1|||
27857637|NCT02533674|54397606|FG005|Dose Level V|Withdrawal by Subject|0|||
27857638|NCT02533674|54397607|FG006|Dose Level V|Withdrawal by Subject|0|||
27857639|NCT02533674|54397608|FG007|Dose Level V|Withdrawal by Subject|0|||
27857640|NCT02533674|54397601|FG000|Dose Level V|Physician Decision|0|||
27857641|NCT02533674|54397602|FG001|Dose Level V|Physician Decision|0|||
27857642|NCT02533674|54397603|FG002|Dose Level V|Physician Decision|0|||
27857643|NCT02533674|54397604|FG003|Dose Level V|Physician Decision|0|||
27857644|NCT02533674|54397605|FG004|Dose Level V|Physician Decision|1|||
27857645|NCT02533674|54397606|FG005|Dose Level V|Physician Decision|0|||
27857646|NCT02533674|54397607|FG006|Dose Level V|Physician Decision|0|||
27857647|NCT02533674|54397608|FG007|Dose Level V|Physician Decision|0|||
27857648|NCT02533674|54397601|FG000|Dose Level VI|Progressive disease|0|||
27857649|NCT02533674|54397602|FG001|Dose Level VI|Progressive disease|0|||
27857650|NCT02533674|54397603|FG002|Dose Level VI|Progressive disease|0|||
27857651|NCT02533674|54397604|FG003|Dose Level VI|Progressive disease|0|||
27857652|NCT02533674|54397605|FG004|Dose Level VI|Progressive disease|0|||
27857653|NCT02533674|54397606|FG005|Dose Level VI|Progressive disease|7|||
28095867|NCT04315298|54750388|FG011|Overall Study|Lost to Follow-up|1|||
28095868|NCT04315298|54750389|FG012|Overall Study|Lost to Follow-up|0|||
27857654|NCT02533674|54397607|FG006|Dose Level VI|Progressive disease|0|||
27857655|NCT02533674|54397608|FG007|Dose Level VI|Progressive disease|0|||
27857656|NCT02533674|54397601|FG000|Dose Level VI|Withdrawal by Subject|0|||
27857657|NCT02533674|54397602|FG001|Dose Level VI|Withdrawal by Subject|0|||
27857658|NCT02533674|54397603|FG002|Dose Level VI|Withdrawal by Subject|0|||
27857659|NCT02533674|54397604|FG003|Dose Level VI|Withdrawal by Subject|0|||
27857660|NCT02533674|54397605|FG004|Dose Level VI|Withdrawal by Subject|0|||
27857661|NCT02533674|54397606|FG005|Dose Level VI|Withdrawal by Subject|1|||
27857662|NCT02533674|54397607|FG006|Dose Level VI|Withdrawal by Subject|0|||
27857663|NCT02533674|54397608|FG007|Dose Level VI|Withdrawal by Subject|0|||
27857664|NCT02533674|54397601|FG000|Dose Level VI|Treatment-related AE|0|||
27857665|NCT02533674|54397602|FG001|Dose Level VI|Treatment-related AE|0|||
27857666|NCT02533674|54397603|FG002|Dose Level VI|Treatment-related AE|0|||
27857667|NCT02533674|54397604|FG003|Dose Level VI|Treatment-related AE|0|||
27857668|NCT02533674|54397605|FG004|Dose Level VI|Treatment-related AE|0|||
27857669|NCT02533674|54397606|FG005|Dose Level VI|Treatment-related AE|1|||
27857670|NCT02533674|54397607|FG006|Dose Level VI|Treatment-related AE|0|||
27857671|NCT02533674|54397608|FG007|Dose Level VI|Treatment-related AE|0|||
27857672|NCT02533674|54397601|FG000|Dose Level VII|Progressive disease|0|||
27857673|NCT02533674|54397602|FG001|Dose Level VII|Progressive disease|0|||
27857674|NCT02533674|54397603|FG002|Dose Level VII|Progressive disease|0|||
27857675|NCT02533674|54397604|FG003|Dose Level VII|Progressive disease|0|||
27857676|NCT02533674|54397605|FG004|Dose Level VII|Progressive disease|0|||
27857677|NCT02533674|54397606|FG005|Dose Level VII|Progressive disease|0|||
27857678|NCT02533674|54397607|FG006|Dose Level VII|Progressive disease|10|||
27857679|NCT02533674|54397608|FG007|Dose Level VII|Progressive disease|0|||
27857680|NCT02533674|54397601|FG000|Dose Level VII|Withdrawal by Subject|0|||
27857681|NCT02533674|54397602|FG001|Dose Level VII|Withdrawal by Subject|0|||
27857682|NCT02533674|54397603|FG002|Dose Level VII|Withdrawal by Subject|0|||
27857683|NCT02533674|54397604|FG003|Dose Level VII|Withdrawal by Subject|0|||
27857684|NCT02533674|54397605|FG004|Dose Level VII|Withdrawal by Subject|0|||
27857685|NCT02533674|54397606|FG005|Dose Level VII|Withdrawal by Subject|0|||
27857686|NCT02533674|54397607|FG006|Dose Level VII|Withdrawal by Subject|3|||
27857687|NCT02533674|54397608|FG007|Dose Level VII|Withdrawal by Subject|0|||
27857688|NCT02533674|54397601|FG000|Dose Level VII|Treatment-related AE|0|||
27857689|NCT02533674|54397602|FG001|Dose Level VII|Treatment-related AE|0|||
27857690|NCT02533674|54397603|FG002|Dose Level VII|Treatment-related AE|0|||
27857691|NCT02533674|54397604|FG003|Dose Level VII|Treatment-related AE|0|||
27857692|NCT02533674|54397605|FG004|Dose Level VII|Treatment-related AE|0|||
27857693|NCT02533674|54397606|FG005|Dose Level VII|Treatment-related AE|0|||
27857694|NCT02533674|54397607|FG006|Dose Level VII|Treatment-related AE|1|||
27857695|NCT02533674|54397608|FG007|Dose Level VII|Treatment-related AE|0|||
27857696|NCT02533674|54397601|FG000|Dose Level VII|Death|0|||
27857697|NCT02533674|54397602|FG001|Dose Level VII|Death|0|||
27857698|NCT02533674|54397603|FG002|Dose Level VII|Death|0|||
27857699|NCT02533674|54397604|FG003|Dose Level VII|Death|0|||
27857700|NCT02533674|54397605|FG004|Dose Level VII|Death|0|||
27857701|NCT02533674|54397606|FG005|Dose Level VII|Death|0|||
27857702|NCT02533674|54397607|FG006|Dose Level VII|Death|2|||
27857703|NCT02533674|54397608|FG007|Dose Level VII|Death|0|||
27857704|NCT02533674|54397601|FG000|Dose Level VIII|Progressive disease|0|||
27857705|NCT02533674|54397602|FG001|Dose Level VIII|Progressive disease|0|||
27857706|NCT02533674|54397603|FG002|Dose Level VIII|Progressive disease|0|||
27857707|NCT02533674|54397604|FG003|Dose Level VIII|Progressive disease|0|||
27857708|NCT02533674|54397605|FG004|Dose Level VIII|Progressive disease|0|||
27857709|NCT02533674|54397606|FG005|Dose Level VIII|Progressive disease|0|||
27857710|NCT02533674|54397607|FG006|Dose Level VIII|Progressive disease|0|||
27857711|NCT02533674|54397608|FG007|Dose Level VIII|Progressive disease|3|||
27857712|NCT02533674|54397601|FG000|Dose Level VIII|Withdrawal by Subject|0|||
27857713|NCT02533674|54397602|FG001|Dose Level VIII|Withdrawal by Subject|0|||
27857714|NCT02533674|54397603|FG002|Dose Level VIII|Withdrawal by Subject|0|||
27857715|NCT02533674|54397604|FG003|Dose Level VIII|Withdrawal by Subject|0|||
27857716|NCT02533674|54397605|FG004|Dose Level VIII|Withdrawal by Subject|0|||
27857717|NCT02533674|54397606|FG005|Dose Level VIII|Withdrawal by Subject|0|||
27857718|NCT02533674|54397607|FG006|Dose Level VIII|Withdrawal by Subject|0|||
27857719|NCT02533674|54397608|FG007|Dose Level VIII|Withdrawal by Subject|1|||
27857720|NCT02533674|54397601|FG000|Dose Level VIII|Treatment-related AE|0|||
27857721|NCT02533674|54397602|FG001|Dose Level VIII|Treatment-related AE|0|||
27857722|NCT02533674|54397603|FG002|Dose Level VIII|Treatment-related AE|0|||
27857723|NCT02533674|54397604|FG003|Dose Level VIII|Treatment-related AE|0|||
28095869|NCT04315298|54750390|FG013|Overall Study|Lost to Follow-up|0|||
28095870|NCT04315298|54750391|FG014|Overall Study|Lost to Follow-up|0|||
27857724|NCT02533674|54397605|FG004|Dose Level VIII|Treatment-related AE|0|||
27857725|NCT02533674|54397606|FG005|Dose Level VIII|Treatment-related AE|0|||
27857726|NCT02533674|54397607|FG006|Dose Level VIII|Treatment-related AE|0|||
27857727|NCT02533674|54397608|FG007|Dose Level VIII|Treatment-related AE|1|||
27857728|NCT02533674|54397601|FG000|Dose Level VIII|Never treated|0|||
27857729|NCT02533674|54397602|FG001|Dose Level VIII|Never treated|0|||
27857730|NCT02533674|54397603|FG002|Dose Level VIII|Never treated|0|||
27857731|NCT02533674|54397604|FG003|Dose Level VIII|Never treated|0|||
27857732|NCT02533674|54397605|FG004|Dose Level VIII|Never treated|0|||
27857733|NCT02533674|54397606|FG005|Dose Level VIII|Never treated|0|||
27857734|NCT02533674|54397607|FG006|Dose Level VIII|Never treated|0|||
27857735|NCT02533674|54397608|FG007|Dose Level VIII|Never treated|1|||
28095871|NCT04315298|54750392|FG015|Overall Study|Lost to Follow-up|2|||
27857736|NCT02540850|54397629|FG000|Overall Study|Lost to Follow-up|69|||
27857737|NCT02540850|54397630|FG001|Overall Study|Lost to Follow-up|66|||
27857738|NCT02540850|54397631|FG002|Overall Study|Lost to Follow-up|34|||
28095872|NCT04315298|54750393|FG016|Overall Study|Lost to Follow-up|0|||
28095873|NCT04315298|54750394|FG017|Overall Study|Lost to Follow-up|0|||
27857739|NCT01662024|54397639|FG000|Overall Study|Pregnancy|2|||
27857740|NCT01662024|54397639|FG000|Overall Study|Withdrawal by Subject|3|||
27857741|NCT02544750|54397721|FG000|Overall Study|Physician Decision|3|||
27857742|NCT02544750|54397722|FG001|Overall Study|Physician Decision|1|||
27857743|NCT02544750|54397721|FG000|Overall Study|Other reasons|69|||
27857744|NCT02544750|54397722|FG001|Overall Study|Other reasons|39|||
27857745|NCT02544750|54397721|FG000|Overall Study|Met withdrawal criteria|2|||
27857746|NCT02544750|54397722|FG001|Overall Study|Met withdrawal criteria|2|||
27857747|NCT02544750|54397721|FG000|Overall Study|Transition To Commercial Product|1|||
27857748|NCT02544750|54397722|FG001|Overall Study|Transition To Commercial Product|0|||
27857749|NCT02544750|54397721|FG000|Overall Study|Withdrawal by Parent/Guardian|8|||
27857750|NCT02544750|54397722|FG001|Overall Study|Withdrawal by Parent/Guardian|7|||
27857751|NCT02544750|54397721|FG000|Overall Study|Adverse Event|8|||
27857752|NCT02544750|54397722|FG001|Overall Study|Adverse Event|10|||
27857753|NCT02544750|54397721|FG000|Overall Study|Withdrawal by Subject|10|||
27857754|NCT02544750|54397722|FG001|Overall Study|Withdrawal by Subject|4|||
27857755|NCT02544750|54397721|FG000|Overall Study|Lost to Follow-up|1|||
27857756|NCT02544750|54397722|FG001|Overall Study|Lost to Follow-up|0|||
27857757|NCT02540538|54397768|FG000|Overall Study|Pregnancy|0|||
27857758|NCT02540538|54397769|FG001|Overall Study|Pregnancy|1|||
27857759|NCT02540538|54397770|FG002|Overall Study|Pregnancy|0|||
27857760|NCT04697056|54397803|FG000|Overall Study|Termination of the participant participation by the Investigator or Sponsor|4|||
27857761|NCT04697056|54397804|FG001|Overall Study|Termination of the participant participation by the Investigator or Sponsor|1|||
27857762|NCT02181738|54397928|FG000|Overall Study|Death|1|||
27857763|NCT02181738|54397929|FG001|Overall Study|Death|1|||
27857764|NCT02181738|54397930|FG002|Overall Study|Death|6|||
27857765|NCT02181738|54397931|FG003|Overall Study|Death|1|||
27857766|NCT02181738|54397928|FG000|Overall Study|Subject Withdrew Consent|1|||
27857767|NCT02181738|54397929|FG001|Overall Study|Subject Withdrew Consent|3|||
27857768|NCT02181738|54397930|FG002|Overall Study|Subject Withdrew Consent|2|||
27857769|NCT02181738|54397931|FG003|Overall Study|Subject Withdrew Consent|1|||
27857770|NCT02181738|54397928|FG000|Overall Study|Lost to Follow-up|0|||
27857771|NCT02181738|54397929|FG001|Overall Study|Lost to Follow-up|4|||
27857772|NCT02181738|54397930|FG002|Overall Study|Lost to Follow-up|2|||
27857773|NCT02181738|54397931|FG003|Overall Study|Lost to Follow-up|0|||
27857774|NCT02181738|54397928|FG000|Overall Study|Patient Return to Home Country|0|||
27857775|NCT02181738|54397929|FG001|Overall Study|Patient Return to Home Country|1|||
27857776|NCT02181738|54397930|FG002|Overall Study|Patient Return to Home Country|0|||
27857777|NCT02181738|54397931|FG003|Overall Study|Patient Return to Home Country|0|||
27857778|NCT03493282|54397962|FG000|Primary Double-blind Study (180 Days)|Adverse Event|2|||
27857779|NCT03493282|54397963|FG001|Primary Double-blind Study (180 Days)|Adverse Event|2|||
27857780|NCT03493282|54397964|FG002|Primary Double-blind Study (180 Days)|Adverse Event|1|||
27857781|NCT03493282|54397962|FG000|Primary Double-blind Study (180 Days)|Subject Moved|1|||
27857782|NCT03493282|54397963|FG001|Primary Double-blind Study (180 Days)|Subject Moved|0|||
27857783|NCT03493282|54397964|FG002|Primary Double-blind Study (180 Days)|Subject Moved|0|||
27857784|NCT02532972|54397978|FG000|Overall Study|Withdrawal by Subject|1|||
27857785|NCT03187834|54398031|FG000|Overall Study|Lost to Follow-up|0|||
27857786|NCT03187834|54398032|FG001|Overall Study|Lost to Follow-up|1|||
27857787|NCT03187834|54398033|FG002|Overall Study|Lost to Follow-up|2|||
27857788|NCT03187834|54398034|FG003|Overall Study|Lost to Follow-up|2|||
27857789|NCT03187834|54398031|FG000|Overall Study|Had invalid anthropometric measurements|5|||
27857790|NCT03187834|54398032|FG001|Overall Study|Had invalid anthropometric measurements|3|||
27857791|NCT03187834|54398033|FG002|Overall Study|Had invalid anthropometric measurements|4|||
27857792|NCT03187834|54398034|FG003|Overall Study|Had invalid anthropometric measurements|2|||
27857793|NCT03713944|54398187|FG000|Study Treatment|Patient non-compliance|1|||
27857794|NCT03713944|54398187|FG000|Study Treatment|Alternative Cancer Therapy|3|||
27857795|NCT03713944|54398187|FG000|Study Treatment|Disease Progression|18|||
27857796|NCT03713944|54398187|FG000|Study Treatment|AE/Side Effects/Complications|2|||
27857797|NCT03713944|54398187|FG000|Study Treatment|Death|2|||
27857798|NCT03713944|54398187|FG000|Study Treatment|Withdrawal by Subject|1|||
27857799|NCT03713944|54398187|FG000|Study Treatment|Subject decided to come off study due to hip replacement|1|||
27857800|NCT03713944|54398187|FG000|Study Treatment|Symptomatic Deterioration|2|||
28171249|NCT01333111|54842806|FG001|Overall Study|unclassified|0|||
28171250|NCT01333111|54842807|FG002|Overall Study|unclassified|0|||
28171251|NCT01333111|54842805|FG000|Overall Study|withdrawal criteria|0|||
28171252|NCT01333111|54842806|FG001|Overall Study|withdrawal criteria|1|||
27857801|NCT03713944|54398187|FG000|Follow up|Withdrawal by Subject|2|||
27857802|NCT03713944|54398187|FG000|Follow up|Death|11|||
27857803|NCT03713944|54398187|FG000|Follow up|Study Terminated|3|||
27857804|NCT01572662|54398265|FG000|Overall Study|Withdrawal by Subject|1|||
27981090|NCT00951665|54638988|FG005|Phase 2a|Withdrawal by Subject|0|||
27981091|NCT00951665|54638983|FG000|Phase 2a|Disease Progression|0|||
27981092|NCT00951665|54638984|FG001|Phase 2a|Disease Progression|0|||
27981093|NCT00951665|54638985|FG002|Phase 2a|Disease Progression|0|||
27981094|NCT00951665|54638986|FG003|Phase 2a|Disease Progression|0|||
27857805|NCT01572662|54398266|FG001|Overall Study|Withdrawal by Subject|0|||
27857806|NCT01572662|54398265|FG000|Overall Study|Physician Decision|0|||
27857807|NCT01572662|54398266|FG001|Overall Study|Physician Decision|1|||
27857808|NCT02325154|54398296|FG000|Overall Study|Physician Decision|1|||
27857809|NCT00493870|54398423|FG000|Overall Study|Lost to Follow-up|12|||
27857810|NCT00493870|54398424|FG001|Overall Study|Lost to Follow-up|15|||
27857811|NCT04439344|54398709|FG000|Overall Study|Never started threapy|3|||
27857812|NCT04439344|54398709|FG000|Overall Study|Ineligible|3|||
27857813|NCT04439344|54398709|FG000|Overall Study|Adverse Event|13|||
27857814|NCT04439344|54398709|FG000|Overall Study|Death|2|||
27857815|NCT04439344|54398709|FG000|Overall Study|Disease progression|29|||
27857816|NCT04439344|54398709|FG000|Overall Study|Withdrawal by Subject|2|||
27857817|NCT04439344|54398709|FG000|Overall Study|Alternative therapy|1|||
27857818|NCT04439279|54398713|FG000|Overall Study|Adverse Event|7|||
27857819|NCT04439279|54398713|FG000|Overall Study|Death|4|||
27857820|NCT04439279|54398713|FG000|Overall Study|Disease progression|17|||
27857821|NCT04439279|54398713|FG000|Overall Study|Complicating disease|3|||
27857822|NCT04439279|54398713|FG000|Overall Study|Withdrawal by Subject|2|||
27857823|NCT04439279|54398713|FG000|Overall Study|Ineligible|1|||
27857824|NCT04439279|54398713|FG000|Overall Study|Treatment still ongoing|1|||
27857825|NCT04439175|54398717|FG000|Overall Study|Never started treatment|4|||
27857826|NCT04439175|54398717|FG000|Overall Study|Ineligible|5|||
27857827|NCT04439175|54398717|FG000|Overall Study|Adverse Event|6|||
27857828|NCT04439175|54398717|FG000|Overall Study|Death|4|||
27857829|NCT04439175|54398717|FG000|Overall Study|Disease progression|44|||
27857830|NCT04439175|54398717|FG000|Overall Study|Withdrawal by Subject|4|||
27857831|NCT04439175|54398717|FG000|Overall Study|Alternative Therapy|1|||
27857832|NCT04439175|54398717|FG000|Overall Study|Other|2|||
27857833|NCT03951753|54398737|FG000|Overall Study|Adverse Event|1|||
27857834|NCT03951753|54398738|FG001|Overall Study|Adverse Event|0|||
27857835|NCT03951753|54398739|FG002|Overall Study|Adverse Event|3|||
27857836|NCT03951753|54398737|FG000|Overall Study|Withdrawal by Subject|3|||
27857837|NCT03951753|54398738|FG001|Overall Study|Withdrawal by Subject|1|||
27857838|NCT03951753|54398739|FG002|Overall Study|Withdrawal by Subject|0|||
27857839|NCT03951753|54398737|FG000|Overall Study|Lost to Follow-up|0|||
27857840|NCT03951753|54398738|FG001|Overall Study|Lost to Follow-up|0|||
27857841|NCT03951753|54398739|FG002|Overall Study|Lost to Follow-up|1|||
27857842|NCT03941964|54398749|FG000|Overall Study|Adverse Event|1|||
27857843|NCT03941964|54398750|FG001|Overall Study|Adverse Event|8|||
27857844|NCT03941964|54398749|FG000|Overall Study|Progressive disease|7|||
27857845|NCT03941964|54398750|FG001|Overall Study|Progressive disease|3|||
27857846|NCT03941964|54398749|FG000|Overall Study|Lack of Efficacy|0|||
27857847|NCT03941964|54398750|FG001|Overall Study|Lack of Efficacy|1|||
27857848|NCT03941964|54398749|FG000|Overall Study|Death|3|||
27857849|NCT03941964|54398750|FG001|Overall Study|Death|1|||
27857850|NCT03941964|54398749|FG000|Overall Study|Withdrew consent|1|||
27857851|NCT03941964|54398750|FG001|Overall Study|Withdrew consent|3|||
27857852|NCT03941964|54398749|FG000|Overall Study|Physician Decision|9|||
27857853|NCT03941964|54398750|FG001|Overall Study|Physician Decision|2|||
27857854|NCT03941964|54398749|FG000|Overall Study|Other, not specified|2|||
27857855|NCT03941964|54398750|FG001|Overall Study|Other, not specified|1|||
27857856|NCT03837509|54398780|FG000|Phase 1|Death|5|||
27857857|NCT03837509|54398781|FG001|Phase 1|Death|2|||
27857858|NCT03837509|54398782|FG002|Phase 1|Death|0|||
27857859|NCT03837509|54398783|FG003|Phase 1|Death|0|||
27857860|NCT03837509|54398784|FG004|Phase 1|Death|0|||
27857861|NCT03837509|54398780|FG000|Phase 2|Death|0|||
27857862|NCT03837509|54398781|FG001|Phase 2|Death|0|||
27857863|NCT03837509|54398782|FG002|Phase 2|Death|0|||
27857864|NCT03837509|54398783|FG003|Phase 2|Death|1|||
27857865|NCT03837509|54398784|FG004|Phase 2|Death|1|||
27857866|NCT03822117|54398804|FG000|Overall Study|Death|18|||
27857867|NCT03822117|54398805|FG001|Overall Study|Death|17|||
27857868|NCT03822117|54398806|FG002|Overall Study|Death|12|||
27857869|NCT03822117|54398807|FG003|Overall Study|Death|4|||
27857870|NCT03822117|54398804|FG000|Overall Study|Lost to Follow-up|1|||
27857871|NCT03822117|54398805|FG001|Overall Study|Lost to Follow-up|2|||
27857872|NCT03822117|54398806|FG002|Overall Study|Lost to Follow-up|3|||
27981095|NCT00951665|54638987|FG004|Phase 2a|Disease Progression|6|||
27981096|NCT00951665|54638988|FG005|Phase 2a|Disease Progression|5|||
27981097|NCT00801099|54639022|FG000|Overall Study|Lost to Follow-up|101|||
27857873|NCT03822117|54398807|FG003|Overall Study|Lost to Follow-up|0|||
27857874|NCT03822117|54398804|FG000|Overall Study|Study Terminated by Sponsor|25|||
27857875|NCT03822117|54398805|FG001|Overall Study|Study Terminated by Sponsor|11|||
27857876|NCT03822117|54398806|FG002|Overall Study|Study Terminated by Sponsor|6|||
27981098|NCT00887744|54639026|FG000|Overall Study|Adverse Event|3|||
27857877|NCT03822117|54398807|FG003|Overall Study|Study Terminated by Sponsor|0|||
27857878|NCT03822117|54398804|FG000|Overall Study|Withdrawal by Subject|4|||
27857879|NCT03822117|54398805|FG001|Overall Study|Withdrawal by Subject|0|||
27857880|NCT03822117|54398806|FG002|Overall Study|Withdrawal by Subject|3|||
27857881|NCT03822117|54398807|FG003|Overall Study|Withdrawal by Subject|0|||
27857882|NCT03822117|54398804|FG000|Overall Study|Disease Progression|1|||
27857883|NCT03822117|54398805|FG001|Overall Study|Disease Progression|2|||
27857884|NCT03822117|54398806|FG002|Overall Study|Disease Progression|1|||
27857885|NCT03822117|54398807|FG003|Overall Study|Disease Progression|0|||
27857886|NCT03822117|54398804|FG000|Overall Study|Never Returned to Hospital|0|||
27857887|NCT03822117|54398805|FG001|Overall Study|Never Returned to Hospital|0|||
27857888|NCT03822117|54398806|FG002|Overall Study|Never Returned to Hospital|1|||
27857889|NCT03822117|54398807|FG003|Overall Study|Never Returned to Hospital|0|||
27857890|NCT03497897|54398821|FG000|Overall Study|Adverse Event|1|||
27857891|NCT03497897|54398822|FG001|Overall Study|Adverse Event|1|||
27857892|NCT03497897|54398823|FG002|Overall Study|Adverse Event|1|||
27857893|NCT03497897|54398821|FG000|Overall Study|Lost to Follow-up|2|||
27857894|NCT03497897|54398822|FG001|Overall Study|Lost to Follow-up|0|||
27857895|NCT03497897|54398823|FG002|Overall Study|Lost to Follow-up|2|||
27857896|NCT03497897|54398821|FG000|Overall Study|Physician Decision|1|||
27857897|NCT03497897|54398822|FG001|Overall Study|Physician Decision|0|||
27857898|NCT03497897|54398823|FG002|Overall Study|Physician Decision|0|||
27857899|NCT03497897|54398821|FG000|Overall Study|Subject/Guardian Decision|2|||
27857900|NCT03497897|54398822|FG001|Overall Study|Subject/Guardian Decision|1|||
27857901|NCT03497897|54398823|FG002|Overall Study|Subject/Guardian Decision|3|||
28171253|NCT01333111|54842807|FG002|Overall Study|withdrawal criteria|0|||
28171254|NCT01333111|54842805|FG000|Overall Study|Non-compliance|1|||
28171255|NCT01333111|54842806|FG001|Overall Study|Non-compliance|0|||
28171256|NCT01333111|54842807|FG002|Overall Study|Non-compliance|0|||
28171257|NCT01333111|54842805|FG000|Overall Study|Ineffective therapy|0|||
28171258|NCT01333111|54842806|FG001|Overall Study|Ineffective therapy|0|||
28171259|NCT01333111|54842807|FG002|Overall Study|Ineffective therapy|1|||
28171260|NCT00702507|54842815|FG000|Initial Treatment Phase|Adverse Event|2|||
28171261|NCT00702507|54842815|FG000|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3|||
28171262|NCT00702507|54842815|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
28171263|NCT00702507|54842815|FG000|Initial Treatment Phase|Negative Candida Culture|34|||
28171264|NCT00702507|54842815|FG000|Follow-up Phase|Participant's Caretaker Withdrew Consent|1|||
28171265|NCT00702507|54842815|FG000|Follow-up Phase|Protocol Violation|2|||
28171266|NCT00702507|54842815|FG000|Follow-up Phase|Lost to Follow-up|23|||
28171267|NCT00702507|54842815|FG000|Follow-up Phase|Late Enrollment|1|||
28171268|NCT01673594|54842831|FG000|Overall Study|Adverse Event|3|||
28171269|NCT01673594|54842832|FG001|Overall Study|Adverse Event|1|||
28171270|NCT01673594|54842831|FG000|Overall Study|Lost to Follow-up|1|||
28171271|NCT01673594|54842832|FG001|Overall Study|Lost to Follow-up|0|||
28171272|NCT01673594|54842831|FG000|Overall Study|Physician Decision|2|||
28171273|NCT01673594|54842832|FG001|Overall Study|Physician Decision|4|||
28171274|NCT01673594|54842831|FG000|Overall Study|Withdrawal by Subject|0|||
28171275|NCT01673594|54842832|FG001|Overall Study|Withdrawal by Subject|1|||
28171276|NCT02721147|54842841|FG000|Overall Study|Lost to Follow-up|2|||
28171277|NCT02721147|54842842|FG001|Overall Study|Lost to Follow-up|0|||
28171278|NCT02721147|54842843|FG002|Overall Study|Lost to Follow-up|0|||
28171279|NCT02720757|54842851|FG000|Overall Study|Other reason|5|||
28171280|NCT02720757|54842851|FG000|Overall Study|Loss of contact|4|||
28171281|NCT02720757|54842851|FG000|Overall Study|Informed consent withdrawal|1|||
28171282|NCT02720757|54842851|FG000|Overall Study|Patients wish to withdraw|2|||
27857902|NCT03428217|54398834|FG000|Overall Study|Death|89|||
27857903|NCT03428217|54398835|FG001|Overall Study|Death|93|||
27857904|NCT03428217|54398834|FG000|Overall Study|Withdrawal by Subject|8|||
27857905|NCT03428217|54398835|FG001|Overall Study|Withdrawal by Subject|7|||
27857906|NCT03428217|54398834|FG000|Overall Study|Lost to Follow-up|1|||
27857907|NCT03428217|54398835|FG001|Overall Study|Lost to Follow-up|3|||
27857908|NCT03428217|54398834|FG000|Overall Study|Study terminated by sponsor|124|||
27857909|NCT03428217|54398835|FG001|Overall Study|Study terminated by sponsor|118|||
27857910|NCT03428217|54398834|FG000|Overall Study|Other, Not Specified|1|||
27857911|NCT03428217|54398835|FG001|Overall Study|Other, Not Specified|0|||
27857912|NCT03189719|54398845|FG000|Overall Study|Death|260|||
27738848|NCT02936323|54188168|FG000|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
27857913|NCT03189719|54398846|FG001|Overall Study|Death|308|||
27857914|NCT03189719|54398845|FG000|Overall Study|Withdrawal by Subject|5|||
27857915|NCT03189719|54398846|FG001|Overall Study|Withdrawal by Subject|3|||
27981099|NCT00887744|54639026|FG000|Overall Study|Death|1|||
28171283|NCT02720757|54842851|FG000|Overall Study|Missing|3|||
28171284|NCT02720757|54842851|FG000|Overall Study|General exclusion|3|||
28171285|NCT02646566|54842881|FG000|Overall Study|Lost to Follow-up|5|||
28171286|NCT02646566|54842882|FG001|Overall Study|Lost to Follow-up|4|||
27738849|NCT02936323|54188169|FG001|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
27857916|NCT03189719|54398845|FG000|Overall Study|Ongoing in Study|108|||
27857917|NCT03189719|54398846|FG001|Overall Study|Ongoing in Study|65|||
27857918|NCT02969525|54398857|FG000|Double-Blind Period|Adverse Event|0|||
27857919|NCT02969525|54398858|FG001|Double-Blind Period|Adverse Event|0|||
27857920|NCT02969525|54398859|FG002|Double-Blind Period|Adverse Event|1|||
27857921|NCT02969525|54398860|FG003|Double-Blind Period|Adverse Event|1|||
28171287|NCT02646566|54842883|FG002|Overall Study|Lost to Follow-up|5|||
28171288|NCT02646566|54842881|FG000|Overall Study|Treatment failure|1|||
28171289|NCT02646566|54842882|FG001|Overall Study|Treatment failure|0|||
27857922|NCT02969525|54398861|FG004|Double-Blind Period|Adverse Event|0|||
27857923|NCT02969525|54398862|FG005|Double-Blind Period|Adverse Event|0|||
27857924|NCT02969525|54398863|FG006|Double-Blind Period|Adverse Event|0|||
27857925|NCT02969525|54398864|FG007|Double-Blind Period|Adverse Event|0|||
27857926|NCT02969525|54398865|FG008|Double-Blind Period|Adverse Event|0|||
27857927|NCT02969525|54398866|FG009|Double-Blind Period|Adverse Event|0|||
27857928|NCT02969525|54398867|FG010|Double-Blind Period|Adverse Event|0|||
27857929|NCT02969525|54398868|FG011|Double-Blind Period|Adverse Event|0|||
27857930|NCT02969525|54398857|FG000|Double-Blind Period|LOW EGFR|0|||
27857931|NCT02969525|54398858|FG001|Double-Blind Period|LOW EGFR|0|||
27857932|NCT02969525|54398859|FG002|Double-Blind Period|LOW EGFR|0|||
27857933|NCT02969525|54398860|FG003|Double-Blind Period|LOW EGFR|1|||
27857934|NCT02969525|54398861|FG004|Double-Blind Period|LOW EGFR|0|||
27857935|NCT02969525|54398862|FG005|Double-Blind Period|LOW EGFR|0|||
27857936|NCT02969525|54398863|FG006|Double-Blind Period|LOW EGFR|0|||
27857937|NCT02969525|54398864|FG007|Double-Blind Period|LOW EGFR|0|||
27857938|NCT02969525|54398865|FG008|Double-Blind Period|LOW EGFR|0|||
27857939|NCT02969525|54398866|FG009|Double-Blind Period|LOW EGFR|0|||
27857940|NCT02969525|54398867|FG010|Double-Blind Period|LOW EGFR|0|||
27857941|NCT02969525|54398868|FG011|Double-Blind Period|LOW EGFR|0|||
27857942|NCT02969525|54398857|FG000|Double-Blind Period|Study medication discontinued prior Wk12|2|||
27857943|NCT02969525|54398858|FG001|Double-Blind Period|Study medication discontinued prior Wk12|0|||
27857944|NCT02969525|54398859|FG002|Double-Blind Period|Study medication discontinued prior Wk12|0|||
27857945|NCT02969525|54398860|FG003|Double-Blind Period|Study medication discontinued prior Wk12|2|||
27857946|NCT02969525|54398861|FG004|Double-Blind Period|Study medication discontinued prior Wk12|0|||
27857947|NCT02969525|54398862|FG005|Double-Blind Period|Study medication discontinued prior Wk12|0|||
27857948|NCT02969525|54398863|FG006|Double-Blind Period|Study medication discontinued prior Wk12|0|||
27857949|NCT02969525|54398864|FG007|Double-Blind Period|Study medication discontinued prior Wk12|0|||
27857950|NCT02969525|54398865|FG008|Double-Blind Period|Study medication discontinued prior Wk12|0|||
27857951|NCT02969525|54398866|FG009|Double-Blind Period|Study medication discontinued prior Wk12|0|||
27857952|NCT02969525|54398867|FG010|Double-Blind Period|Study medication discontinued prior Wk12|0|||
27857953|NCT02969525|54398868|FG011|Double-Blind Period|Study medication discontinued prior Wk12|0|||
27857954|NCT02969525|54398857|FG000|Dose-Blind Period|Adverse Event|0|||
27857955|NCT02969525|54398858|FG001|Dose-Blind Period|Adverse Event|0|||
27857956|NCT02969525|54398859|FG002|Dose-Blind Period|Adverse Event|0|||
28171290|NCT02646566|54842883|FG002|Overall Study|Treatment failure|0|||
28171291|NCT02720523|54842899|FG000|Period 1: Placebo-controlled Period|Adverse Event|0|||
28171292|NCT02720523|54842900|FG001|Period 1: Placebo-controlled Period|Adverse Event|0|||
28171293|NCT02720523|54842901|FG002|Period 1: Placebo-controlled Period|Adverse Event|1|||
28171294|NCT02720523|54842902|FG003|Period 1: Placebo-controlled Period|Adverse Event|5|||
28171295|NCT02720523|54842903|FG004|Period 1: Placebo-controlled Period|Adverse Event|0|||
28171296|NCT02720523|54842904|FG005|Period 1: Placebo-controlled Period|Adverse Event|0|||
28171297|NCT02720523|54842905|FG006|Period 1: Placebo-controlled Period|Adverse Event|0|||
28171298|NCT02720523|54842899|FG000|Period 1: Placebo-controlled Period|Withdrawal by Subject|1|||
28171299|NCT02720523|54842900|FG001|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
28171300|NCT02720523|54842901|FG002|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
28171301|NCT02720523|54842902|FG003|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
28171302|NCT02720523|54842903|FG004|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
28171303|NCT02720523|54842904|FG005|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
28171304|NCT02720523|54842905|FG006|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
28171305|NCT02720523|54842899|FG000|Period 1: Placebo-controlled Period|Lack of Efficacy|1|||
28171306|NCT02720523|54842900|FG001|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
27857957|NCT02969525|54398860|FG003|Dose-Blind Period|Adverse Event|0|||
27857958|NCT02969525|54398861|FG004|Dose-Blind Period|Adverse Event|0|||
27857959|NCT02969525|54398862|FG005|Dose-Blind Period|Adverse Event|0|||
27857960|NCT02969525|54398863|FG006|Dose-Blind Period|Adverse Event|0|||
27857961|NCT02969525|54398864|FG007|Dose-Blind Period|Adverse Event|0|||
27981100|NCT00887744|54639026|FG000|Overall Study|Lost to Follow-up|3|||
28095874|NCT04315298|54750395|FG018|Overall Study|Lost to Follow-up|0|||
28095875|NCT04315298|54750377|FG000|Overall Study|Death|24|||
28095876|NCT04315298|54750378|FG001|Overall Study|Death|60|||
28095877|NCT04315298|54750379|FG002|Overall Study|Death|49|||
28095878|NCT04315298|54750380|FG003|Overall Study|Death|59|||
28095879|NCT04315298|54750381|FG004|Overall Study|Death|70|||
28095880|NCT04315298|54750382|FG005|Overall Study|Death|114|||
28095881|NCT04315298|54750383|FG006|Overall Study|Death|9|||
28095882|NCT04315298|54750384|FG007|Overall Study|Death|12|||
28095883|NCT04315298|54750385|FG008|Overall Study|Death|21|||
28095884|NCT04315298|54750386|FG009|Overall Study|Death|16|||
28171307|NCT02720523|54842901|FG002|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
27857962|NCT02969525|54398865|FG008|Dose-Blind Period|Adverse Event|0|||
27857963|NCT02969525|54398866|FG009|Dose-Blind Period|Adverse Event|1|||
27857964|NCT02969525|54398867|FG010|Dose-Blind Period|Adverse Event|1|||
28095885|NCT04315298|54750387|FG010|Overall Study|Death|40|||
27857965|NCT02969525|54398868|FG011|Dose-Blind Period|Adverse Event|1|||
27857966|NCT02969525|54398857|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
27857967|NCT02969525|54398858|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
27857968|NCT02969525|54398859|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
27857969|NCT02969525|54398860|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
27857970|NCT02969525|54398861|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
27857971|NCT02969525|54398862|FG005|Dose-Blind Period|Withdrawal by Subject|0|||
27857972|NCT02969525|54398863|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
27857973|NCT02969525|54398864|FG007|Dose-Blind Period|Withdrawal by Subject|0|||
27857974|NCT02969525|54398865|FG008|Dose-Blind Period|Withdrawal by Subject|1|||
27857975|NCT02969525|54398866|FG009|Dose-Blind Period|Withdrawal by Subject|2|||
27857976|NCT02969525|54398867|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
27857977|NCT02969525|54398868|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
27857978|NCT02969525|54398857|FG000|Dose-Blind Period|Non-cooperating patient|0|||
27857979|NCT02969525|54398858|FG001|Dose-Blind Period|Non-cooperating patient|0|||
27857980|NCT02969525|54398859|FG002|Dose-Blind Period|Non-cooperating patient|0|||
27857981|NCT02969525|54398860|FG003|Dose-Blind Period|Non-cooperating patient|0|||
27857982|NCT02969525|54398861|FG004|Dose-Blind Period|Non-cooperating patient|0|||
27857983|NCT02969525|54398862|FG005|Dose-Blind Period|Non-cooperating patient|0|||
27857984|NCT02969525|54398863|FG006|Dose-Blind Period|Non-cooperating patient|0|||
27857985|NCT02969525|54398864|FG007|Dose-Blind Period|Non-cooperating patient|0|||
27857986|NCT02969525|54398865|FG008|Dose-Blind Period|Non-cooperating patient|0|||
27857987|NCT02969525|54398866|FG009|Dose-Blind Period|Non-cooperating patient|0|||
27857988|NCT02969525|54398867|FG010|Dose-Blind Period|Non-cooperating patient|0|||
27857989|NCT02969525|54398868|FG011|Dose-Blind Period|Non-cooperating patient|1|||
27857990|NCT02969525|54398857|FG000|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
27857991|NCT02969525|54398858|FG001|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
27857992|NCT02969525|54398859|FG002|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
27857993|NCT02969525|54398860|FG003|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
27857994|NCT02969525|54398861|FG004|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
27857995|NCT02969525|54398862|FG005|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
27857996|NCT02969525|54398863|FG006|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
27857997|NCT02969525|54398864|FG007|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
27857998|NCT02969525|54398865|FG008|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
27857999|NCT02969525|54398866|FG009|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
27858000|NCT02969525|54398867|FG010|Dose-Blind Period|Withdrew before Safety Follow-up visit|1|||
27858001|NCT02969525|54398868|FG011|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
27858002|NCT04232215|54398899|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
27858003|NCT04232215|54398900|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
27858004|NCT02399813|54398915|FG000|Overall Study|Progressive Disease-Radiographic|2|||
27858005|NCT02399813|54398915|FG000|Overall Study|Death|20|||
27858006|NCT02399813|54398915|FG000|Overall Study|Withdrawal by Subject|3|||
27858007|NCT02399813|54398915|FG000|Overall Study|Initiating a Non-Study Cancer Treatment|4|||
27858008|NCT02399813|54398915|FG000|Overall Study|Lost to Follow-up|2|||
27858009|NCT02399813|54398915|FG000|Overall Study|Other than specified|5|||
27858010|NCT02291055|54398924|FG000|Overall Study|Death|2|||
27858011|NCT02291055|54398925|FG001|Overall Study|Death|2|||
27858012|NCT02291055|54398926|FG002|Overall Study|Death|5|||
27858013|NCT02291055|54398927|FG003|Overall Study|Death|8|||
27858014|NCT02291055|54398928|FG004|Overall Study|Death|12|||
27858015|NCT02291055|54398924|FG000|Overall Study|Lost to Follow-up|0|||
27858016|NCT02291055|54398925|FG001|Overall Study|Lost to Follow-up|0|||
27858017|NCT02291055|54398926|FG002|Overall Study|Lost to Follow-up|0|||
27858018|NCT02291055|54398927|FG003|Overall Study|Lost to Follow-up|1|||
27858019|NCT02291055|54398928|FG004|Overall Study|Lost to Follow-up|2|||
27858020|NCT02291055|54398924|FG000|Overall Study|Withdrawal by Subject|3|||
27858021|NCT02291055|54398925|FG001|Overall Study|Withdrawal by Subject|1|||
27858022|NCT02291055|54398926|FG002|Overall Study|Withdrawal by Subject|1|||
27858023|NCT02291055|54398927|FG003|Overall Study|Withdrawal by Subject|5|||
27858024|NCT02291055|54398928|FG004|Overall Study|Withdrawal by Subject|10|||
27834177|NCT02705586|54317743|FG000|Overall Study|Health Issues|2|||
27834178|NCT02705586|54317743|FG000|Overall Study|Transportation Difficulties|5|||
27834179|NCT02705586|54317743|FG000|Overall Study|Vacation/Planned Absence|1|||
27834180|NCT01592045|54317749|FG000|Overall Study|Disease Progression|1|||
27834181|NCT01592045|54317750|FG001|Overall Study|Disease Progression|1|||
27834182|NCT01592045|54317749|FG000|Overall Study|Adverse Event|1|||
27834183|NCT01592045|54317750|FG001|Overall Study|Adverse Event|1|||
27834184|NCT01592045|54317749|FG000|Overall Study|Withdrawal by Subject|1|||
27858025|NCT02291055|54398924|FG000|Overall Study|Progressive Disease|0|||
27858026|NCT02291055|54398925|FG001|Overall Study|Progressive Disease|0|||
27858027|NCT02291055|54398926|FG002|Overall Study|Progressive Disease|1|||
27858028|NCT02291055|54398927|FG003|Overall Study|Progressive Disease|4|||
27858029|NCT02291055|54398928|FG004|Overall Study|Progressive Disease|2|||
27981101|NCT00887744|54639026|FG000|Overall Study|Withdrawal by Subject|18|||
27834185|NCT01592045|54317750|FG001|Overall Study|Withdrawal by Subject|0|||
27858030|NCT02291055|54398924|FG000|Overall Study|Study Terminated by Sponsor|0|||
27858031|NCT02291055|54398925|FG001|Overall Study|Study Terminated by Sponsor|0|||
27858032|NCT02291055|54398926|FG002|Overall Study|Study Terminated by Sponsor|0|||
27858033|NCT02291055|54398927|FG003|Overall Study|Study Terminated by Sponsor|5|||
27858034|NCT02291055|54398928|FG004|Overall Study|Study Terminated by Sponsor|1|||
27858035|NCT02291055|54398924|FG000|Overall Study|Other|0|||
27858036|NCT02291055|54398925|FG001|Overall Study|Other|2|||
27858037|NCT02291055|54398926|FG002|Overall Study|Other|1|||
27858038|NCT02291055|54398927|FG003|Overall Study|Other|4|||
27858039|NCT02291055|54398928|FG004|Overall Study|Other|0|||
27858040|NCT00723697|54398944|FG000|Overall Study|Physician questionnaires not received|2|||
27858041|NCT00723697|54398944|FG000|Overall Study|Missing Informed Consent Form|10|||
27858042|NCT00723697|54398944|FG000|Overall Study|Other exclusion criteria applied|6|||
27858043|NCT00684073|54398951|FG000|Selection|Selection/non-selection criteria|3|||
27858044|NCT00684073|54398951|FG000|Selection|Death|1|||
27858045|NCT00684073|54398951|FG000|Selection|noncompliance|1|||
27858046|NCT00684073|54398951|FG000|Selection|Lost to Follow-up|1|||
27858047|NCT00684073|54398951|FG000|Selection|request of the sponsor|1|||
27858048|NCT00684073|54398951|FG000|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1|||
27858049|NCT02539368|54400900|FG000|Overall Study|Death|4|||
27858050|NCT02539368|54400901|FG001|Overall Study|Death|2|||
27858051|NCT02539368|54400902|FG002|Overall Study|Death|1|||
27858052|NCT02539368|54400903|FG003|Overall Study|Death|0|||
27858053|NCT02539368|54400904|FG004|Overall Study|Death|0|||
27858054|NCT02539368|54400900|FG000|Overall Study|Withdrawal by Subject|44|||
27858055|NCT02539368|54400901|FG001|Overall Study|Withdrawal by Subject|35|||
27858056|NCT02539368|54400902|FG002|Overall Study|Withdrawal by Subject|9|||
27858057|NCT02539368|54400903|FG003|Overall Study|Withdrawal by Subject|1|||
27858058|NCT02539368|54400904|FG004|Overall Study|Withdrawal by Subject|3|||
27858059|NCT02539368|54400900|FG000|Overall Study|Physician Decision|49|||
27858060|NCT02539368|54400901|FG001|Overall Study|Physician Decision|15|||
27858061|NCT02539368|54400902|FG002|Overall Study|Physician Decision|7|||
27858062|NCT02539368|54400903|FG003|Overall Study|Physician Decision|0|||
27858063|NCT02539368|54400904|FG004|Overall Study|Physician Decision|2|||
27858064|NCT02539368|54400900|FG000|Overall Study|Lost to Follow-up|96|||
27858065|NCT02539368|54400901|FG001|Overall Study|Lost to Follow-up|21|||
27858066|NCT02539368|54400902|FG002|Overall Study|Lost to Follow-up|16|||
27858067|NCT02539368|54400903|FG003|Overall Study|Lost to Follow-up|4|||
27858068|NCT02539368|54400904|FG004|Overall Study|Lost to Follow-up|3|||
27858069|NCT02539368|54400900|FG000|Overall Study|Adverse Event|44|||
27858070|NCT02539368|54400901|FG001|Overall Study|Adverse Event|5|||
27858071|NCT02539368|54400902|FG002|Overall Study|Adverse Event|9|||
27858072|NCT02539368|54400903|FG003|Overall Study|Adverse Event|0|||
27858073|NCT02539368|54400904|FG004|Overall Study|Adverse Event|3|||
27858074|NCT02539368|54400900|FG000|Overall Study|Participant Non-compliant|13|||
27858075|NCT02539368|54400901|FG001|Overall Study|Participant Non-compliant|2|||
27858076|NCT02539368|54400902|FG002|Overall Study|Participant Non-compliant|1|||
27858077|NCT02539368|54400903|FG003|Overall Study|Participant Non-compliant|1|||
27858078|NCT02539368|54400904|FG004|Overall Study|Participant Non-compliant|0|||
27858079|NCT02539368|54400900|FG000|Overall Study|Other|145|||
27858080|NCT02539368|54400901|FG001|Overall Study|Other|18|||
27858081|NCT02539368|54400902|FG002|Overall Study|Other|24|||
27858082|NCT02539368|54400903|FG003|Overall Study|Other|1|||
27858083|NCT02539368|54400904|FG004|Overall Study|Other|3|||
27858084|NCT02539368|54400900|FG000|Overall Study|Missing|10|||
27858085|NCT02539368|54400901|FG001|Overall Study|Missing|3|||
27858086|NCT02539368|54400902|FG002|Overall Study|Missing|0|||
27858087|NCT02539368|54400903|FG003|Overall Study|Missing|0|||
27858088|NCT02539368|54400904|FG004|Overall Study|Missing|0|||
27858089|NCT02539134|54401057|FG000|Overall Study|Lost to Follow-up|1|||
27858090|NCT02539134|54401058|FG001|Overall Study|Lost to Follow-up|0|||
27858091|NCT02539134|54401059|FG002|Overall Study|Lost to Follow-up|0|||
27858092|NCT02539134|54401060|FG003|Overall Study|Lost to Follow-up|0|||
27858093|NCT02539134|54401061|FG004|Overall Study|Lost to Follow-up|0|||
27858094|NCT02539134|54401062|FG005|Overall Study|Lost to Follow-up|0|||
27858095|NCT02538900|54401166|FG000|Overall Study|Death|2|||
27858096|NCT02538900|54401167|FG001|Overall Study|Death|2|||
27858097|NCT02538900|54401168|FG002|Overall Study|Death|2|||
27858098|NCT02538900|54401166|FG000|Overall Study|Withdrawal by Subject|18|||
27858099|NCT02538900|54401167|FG001|Overall Study|Withdrawal by Subject|16|||
27858100|NCT02538900|54401168|FG002|Overall Study|Withdrawal by Subject|15|||
27858101|NCT01986348|54401657|FG000|Overall Study|Death|8|||
27858102|NCT01986348|54401658|FG001|Overall Study|Death|22|||
27858103|NCT01986348|54401659|FG002|Overall Study|Death|10|||
27858104|NCT01986348|54401660|FG003|Overall Study|Death|21|||
27858105|NCT01986348|54401657|FG000|Overall Study|Lost to Follow-up|0|||
27858106|NCT01986348|54401658|FG001|Overall Study|Lost to Follow-up|0|||
27858107|NCT01986348|54401659|FG002|Overall Study|Lost to Follow-up|0|||
27858108|NCT01986348|54401660|FG003|Overall Study|Lost to Follow-up|2|||
27858109|NCT01986348|54401657|FG000|Overall Study|Physician Decision|0|||
27858110|NCT01986348|54401658|FG001|Overall Study|Physician Decision|0|||
27858111|NCT01986348|54401659|FG002|Overall Study|Physician Decision|0|||
27858112|NCT01986348|54401660|FG003|Overall Study|Physician Decision|1|||
27858113|NCT01986348|54401657|FG000|Overall Study|Progressive Disease|0|||
27858114|NCT01986348|54401658|FG001|Overall Study|Progressive Disease|0|||
27858115|NCT01986348|54401659|FG002|Overall Study|Progressive Disease|2|||
27858116|NCT01986348|54401660|FG003|Overall Study|Progressive Disease|0|||
27858117|NCT01986348|54401657|FG000|Overall Study|Withdrawal by Participant|0|||
27858118|NCT01986348|54401658|FG001|Overall Study|Withdrawal by Participant|1|||
27858119|NCT01986348|54401659|FG002|Overall Study|Withdrawal by Participant|2|||
27858120|NCT01986348|54401660|FG003|Overall Study|Withdrawal by Participant|1|||
27858121|NCT01986348|54401657|FG000|Overall Study|Study Terminated by Sponsor|0|||
27858122|NCT01986348|54401658|FG001|Overall Study|Study Terminated by Sponsor|0|||
27858123|NCT01986348|54401659|FG002|Overall Study|Study Terminated by Sponsor|0|||
27858124|NCT01986348|54401660|FG003|Overall Study|Study Terminated by Sponsor|3|||
27858125|NCT01986348|54401657|FG000|Overall Study|Other-unspecified|0|||
27858126|NCT01986348|54401658|FG001|Overall Study|Other-unspecified|1|||
27858127|NCT01986348|54401659|FG002|Overall Study|Other-unspecified|0|||
27858128|NCT01986348|54401660|FG003|Overall Study|Other-unspecified|2|||
27858129|NCT02543892|54402238|FG000|Received Vaccination 2|Withdrawal by Subject|1|||
27858130|NCT02543892|54402239|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
27858131|NCT02543892|54402240|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
27858132|NCT02543892|54402241|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
27858133|NCT02543892|54402242|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
27858134|NCT02543892|54402243|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
27858135|NCT02543892|54402244|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
27858136|NCT02543892|54402245|FG007|Received Vaccination 2|Withdrawal by Subject|1|||
27858137|NCT02543892|54402238|FG000|Received Vaccination 2|Physician Decision|0|||
27858138|NCT02543892|54402239|FG001|Received Vaccination 2|Physician Decision|0|||
27858139|NCT02543892|54402240|FG002|Received Vaccination 2|Physician Decision|0|||
27858140|NCT02543892|54402241|FG003|Received Vaccination 2|Physician Decision|0|||
27858141|NCT02543892|54402242|FG004|Received Vaccination 2|Physician Decision|0|||
27858142|NCT02543892|54402243|FG005|Received Vaccination 2|Physician Decision|1|||
27858143|NCT02543892|54402244|FG006|Received Vaccination 2|Physician Decision|0|||
27858144|NCT02543892|54402245|FG007|Received Vaccination 2|Physician Decision|0|||
27858145|NCT02543892|54402238|FG000|Received Vaccination 2|Adverse Event|0|||
27738850|NCT02936323|54188170|FG002|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
27738851|NCT02936323|54188171|FG003|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
27738852|NCT02936323|54188172|FG004|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
27738853|NCT02936323|54188173|FG005|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
27858146|NCT02543892|54402239|FG001|Received Vaccination 2|Adverse Event|1|||
27858147|NCT02543892|54402240|FG002|Received Vaccination 2|Adverse Event|0|||
27858148|NCT02543892|54402241|FG003|Received Vaccination 2|Adverse Event|0|||
27858149|NCT02543892|54402242|FG004|Received Vaccination 2|Adverse Event|0|||
27858150|NCT02543892|54402243|FG005|Received Vaccination 2|Adverse Event|0|||
27858151|NCT02543892|54402244|FG006|Received Vaccination 2|Adverse Event|0|||
27858152|NCT02543892|54402245|FG007|Received Vaccination 2|Adverse Event|0|||
27858153|NCT02543892|54402238|FG000|Had Immunology Data|Withdrawal by Subject|0|||
27858154|NCT02543892|54402239|FG001|Had Immunology Data|Withdrawal by Subject|0|||
27858155|NCT02543892|54402240|FG002|Had Immunology Data|Withdrawal by Subject|0|||
27858156|NCT02543892|54402241|FG003|Had Immunology Data|Withdrawal by Subject|0|||
27858157|NCT02543892|54402242|FG004|Had Immunology Data|Withdrawal by Subject|0|||
27858158|NCT02543892|54402243|FG005|Had Immunology Data|Withdrawal by Subject|0|||
27858159|NCT02543892|54402244|FG006|Had Immunology Data|Withdrawal by Subject|1|||
27858160|NCT02543892|54402245|FG007|Had Immunology Data|Withdrawal by Subject|0|||
27858161|NCT02543658|54402326|FG000|Overall Study|Lack of Efficacy|0|||
27858162|NCT02543658|54402327|FG001|Overall Study|Lack of Efficacy|4|||
27858163|NCT01607892|54403082|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
27858164|NCT01607892|54403083|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
27858165|NCT01607892|54403084|FG002|Overall Study|Need of treatment not allowed per protocol|0|||
27858166|NCT01607892|54403085|FG003|Overall Study|Need of treatment not allowed per protocol|1|||
27858167|NCT01607892|54403086|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
27858168|NCT01607892|54403082|FG000|Overall Study|Death|4|||
27858169|NCT01607892|54403083|FG001|Overall Study|Death|2|||
27858170|NCT01607892|54403084|FG002|Overall Study|Death|8|||
28095886|NCT04315298|54750388|FG011|Overall Study|Death|40|||
27858171|NCT01607892|54403085|FG003|Overall Study|Death|10|||
27858172|NCT01607892|54403086|FG004|Overall Study|Death|3|||
27858173|NCT01607892|54403082|FG000|Overall Study|Investigator discretion|2|||
27858174|NCT01607892|54403083|FG001|Overall Study|Investigator discretion|4|||
27858175|NCT01607892|54403084|FG002|Overall Study|Investigator discretion|4|||
28095887|NCT04315298|54750389|FG012|Overall Study|Death|3|||
28095888|NCT04315298|54750390|FG013|Overall Study|Death|4|||
27858176|NCT01607892|54403085|FG003|Overall Study|Investigator discretion|8|||
27858177|NCT01607892|54403086|FG004|Overall Study|Investigator discretion|0|||
27858178|NCT01607892|54403082|FG000|Overall Study|Other treatments became available|1|||
27858179|NCT01607892|54403083|FG001|Overall Study|Other treatments became available|1|||
27858180|NCT01607892|54403084|FG002|Overall Study|Other treatments became available|0|||
27858181|NCT01607892|54403085|FG003|Overall Study|Other treatments became available|0|||
27858182|NCT01607892|54403086|FG004|Overall Study|Other treatments became available|2|||
27858183|NCT01607892|54403082|FG000|Overall Study|Intercurrent illness|1|||
27858184|NCT01607892|54403083|FG001|Overall Study|Intercurrent illness|0|||
27858185|NCT01607892|54403084|FG002|Overall Study|Intercurrent illness|0|||
27858186|NCT01607892|54403085|FG003|Overall Study|Intercurrent illness|3|||
27858187|NCT01607892|54403086|FG004|Overall Study|Intercurrent illness|0|||
27858188|NCT01607892|54403082|FG000|Overall Study|Non-Compliance with study procedures|0|||
27858189|NCT01607892|54403083|FG001|Overall Study|Non-Compliance with study procedures|0|||
27858190|NCT01607892|54403084|FG002|Overall Study|Non-Compliance with study procedures|1|||
27858191|NCT01607892|54403085|FG003|Overall Study|Non-Compliance with study procedures|0|||
27858192|NCT01607892|54403086|FG004|Overall Study|Non-Compliance with study procedures|0|||
27858193|NCT01607892|54403082|FG000|Overall Study|Consent withdrawn by participant|9|||
27858194|NCT01607892|54403083|FG001|Overall Study|Consent withdrawn by participant|4|||
27858195|NCT01607892|54403084|FG002|Overall Study|Consent withdrawn by participant|24|||
27858196|NCT01607892|54403085|FG003|Overall Study|Consent withdrawn by participant|14|||
27858197|NCT01607892|54403086|FG004|Overall Study|Consent withdrawn by participant|4|||
27858198|NCT01607892|54403082|FG000|Overall Study|Disease progression|38|||
27858199|NCT01607892|54403083|FG001|Overall Study|Disease progression|13|||
27858200|NCT01607892|54403084|FG002|Overall Study|Disease progression|37|||
27858201|NCT01607892|54403085|FG003|Overall Study|Disease progression|57|||
27858202|NCT01607892|54403086|FG004|Overall Study|Disease progression|9|||
27858203|NCT01607892|54403082|FG000|Overall Study|Incidence or severity of Adverse events|3|||
27858204|NCT01607892|54403083|FG001|Overall Study|Incidence or severity of Adverse events|3|||
27858205|NCT01607892|54403084|FG002|Overall Study|Incidence or severity of Adverse events|7|||
27858206|NCT01607892|54403085|FG003|Overall Study|Incidence or severity of Adverse events|2|||
27858207|NCT01607892|54403086|FG004|Overall Study|Incidence or severity of Adverse events|6|||
27858208|NCT02530242|54403132|FG000|Overall Study|excluded due to asthma and oxcarbazepine|0|||
27858209|NCT02530242|54403133|FG001|Overall Study|excluded due to asthma and oxcarbazepine|1|||
27858210|NCT02537574|54403157|FG000|Overall Study|Adverse Event|1|||
27858211|NCT02537574|54403158|FG001|Overall Study|Adverse Event|3|||
27858212|NCT02537574|54403159|FG002|Overall Study|Adverse Event|2|||
27858213|NCT02537574|54403157|FG000|Overall Study|Lost to Follow-up|40|||
27858214|NCT02537574|54403158|FG001|Overall Study|Lost to Follow-up|51|||
27858215|NCT02537574|54403159|FG002|Overall Study|Lost to Follow-up|55|||
27858216|NCT02537574|54403157|FG000|Overall Study|Noncompliance with study drug|0|||
27858217|NCT02537574|54403158|FG001|Overall Study|Noncompliance with study drug|1|||
27858218|NCT02537574|54403159|FG002|Overall Study|Noncompliance with study drug|1|||
27858219|NCT02537574|54403157|FG000|Overall Study|Physician Decision|2|||
27858220|NCT02537574|54403158|FG001|Overall Study|Physician Decision|0|||
27858221|NCT02537574|54403159|FG002|Overall Study|Physician Decision|0|||
27858222|NCT02537574|54403157|FG000|Overall Study|Protocol Violation|4|||
27858223|NCT02537574|54403158|FG001|Overall Study|Protocol Violation|2|||
27858224|NCT02537574|54403159|FG002|Overall Study|Protocol Violation|3|||
27858225|NCT02537574|54403157|FG000|Overall Study|Withdrawal by Subject|37|||
27858226|NCT02537574|54403158|FG001|Overall Study|Withdrawal by Subject|27|||
27858227|NCT02537574|54403159|FG002|Overall Study|Withdrawal by Subject|29|||
27858228|NCT02537574|54403157|FG000|Overall Study|Lack of Efficacy|14|||
27858229|NCT02537574|54403158|FG001|Overall Study|Lack of Efficacy|16|||
27858230|NCT02537574|54403159|FG002|Overall Study|Lack of Efficacy|15|||
27858231|NCT02537574|54403157|FG000|Overall Study|Duplicate Patient|1|||
27858232|NCT02537574|54403158|FG001|Overall Study|Duplicate Patient|0|||
27858233|NCT02537574|54403159|FG002|Overall Study|Duplicate Patient|0|||
27858234|NCT02537574|54403157|FG000|Overall Study|Patient not Stable|0|||
27858235|NCT02537574|54403158|FG001|Overall Study|Patient not Stable|1|||
27858236|NCT02537574|54403159|FG002|Overall Study|Patient not Stable|0|||
27834186|NCT01592045|54317749|FG000|Overall Study|Moved out of country|2|||
27834187|NCT01592045|54317750|FG001|Overall Study|Moved out of country|0|||
27834188|NCT01591499|54317758|FG000|Baseline Visit|Withdrawal by Subject|0|||
27834189|NCT01591499|54317759|FG001|Baseline Visit|Withdrawal by Subject|2|||
27834190|NCT01591499|54317760|FG002|Baseline Visit|Withdrawal by Subject|0|||
27834191|NCT01591499|54317761|FG003|Baseline Visit|Withdrawal by Subject|2|||
27834192|NCT01591499|54317758|FG000|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
27834193|NCT01591499|54317759|FG001|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
27834194|NCT01591499|54317760|FG002|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
27858237|NCT02537574|54403157|FG000|Overall Study|Incarceration|0|||
27858238|NCT02537574|54403158|FG001|Overall Study|Incarceration|1|||
28095889|NCT04315298|54750391|FG014|Overall Study|Death|6|||
28095890|NCT04315298|54750392|FG015|Overall Study|Death|4|||
27834195|NCT01591499|54317761|FG003|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
27858239|NCT02537574|54403159|FG002|Overall Study|Incarceration|0|||
27858240|NCT02537574|54403157|FG000|Overall Study|Failed Naloxone Challenge|0|||
27858241|NCT02537574|54403158|FG001|Overall Study|Failed Naloxone Challenge|1|||
27858242|NCT02537574|54403159|FG002|Overall Study|Failed Naloxone Challenge|0|||
27858243|NCT02537574|54403157|FG000|Overall Study|Transportation Issues|0|||
27858244|NCT02537574|54403158|FG001|Overall Study|Transportation Issues|0|||
27858245|NCT02537574|54403159|FG002|Overall Study|Transportation Issues|1|||
27858246|NCT02537574|54403157|FG000|Overall Study|Subject did not want last Vivitrol Injec|0|||
27858247|NCT02537574|54403158|FG001|Overall Study|Subject did not want last Vivitrol Injec|0|||
27858248|NCT02537574|54403159|FG002|Overall Study|Subject did not want last Vivitrol Injec|1|||
27858249|NCT02537574|54403157|FG000|Overall Study|Noncompliance with Protocol|0|||
27858250|NCT02537574|54403158|FG001|Overall Study|Noncompliance with Protocol|0|||
27858251|NCT02537574|54403159|FG002|Overall Study|Noncompliance with Protocol|1|||
27858252|NCT02531802|54403824|FG000|Received Vaccination 2|Medication interfering with study taken|0|||
27858253|NCT02531802|54403825|FG001|Received Vaccination 2|Medication interfering with study taken|0|||
27858254|NCT02531802|54403826|FG002|Received Vaccination 2|Medication interfering with study taken|1|||
27858255|NCT02531802|54403827|FG003|Received Vaccination 2|Medication interfering with study taken|0|||
27858256|NCT02531802|54403828|FG004|Received Vaccination 2|Medication interfering with study taken|0|||
27858257|NCT02531802|54403829|FG005|Received Vaccination 2|Medication interfering with study taken|0|||
27858258|NCT02531802|54403830|FG006|Received Vaccination 2|Medication interfering with study taken|0|||
27858259|NCT02531802|54403831|FG007|Received Vaccination 2|Medication interfering with study taken|0|||
27858260|NCT02531802|54403832|FG008|Received Vaccination 2|Medication interfering with study taken|0|||
27858261|NCT02531802|54403833|FG009|Received Vaccination 2|Medication interfering with study taken|1|||
27858262|NCT02531802|54403834|FG010|Received Vaccination 2|Medication interfering with study taken|1|||
27858263|NCT02531802|54403835|FG011|Received Vaccination 2|Medication interfering with study taken|0|||
27858264|NCT02531802|54403836|FG012|Received Vaccination 2|Medication interfering with study taken|1|||
27858265|NCT02531802|54403837|FG013|Received Vaccination 2|Medication interfering with study taken|0|||
27858266|NCT02531802|54403838|FG014|Received Vaccination 2|Medication interfering with study taken|0|||
27858267|NCT02531802|54403839|FG015|Received Vaccination 2|Medication interfering with study taken|0|||
27858268|NCT02531802|54403840|FG016|Received Vaccination 2|Medication interfering with study taken|0|||
27858269|NCT02531802|54403841|FG017|Received Vaccination 2|Medication interfering with study taken|0|||
27858270|NCT02531802|54403842|FG018|Received Vaccination 2|Medication interfering with study taken|1|||
27858271|NCT02531802|54403843|FG019|Received Vaccination 2|Medication interfering with study taken|0|||
27858272|NCT02531802|54403844|FG020|Received Vaccination 2|Medication interfering with study taken|0|||
27858273|NCT02531802|54403824|FG000|Received Vaccination 2|Physician Decision|0|||
27858274|NCT02531802|54403825|FG001|Received Vaccination 2|Physician Decision|0|||
27858275|NCT02531802|54403826|FG002|Received Vaccination 2|Physician Decision|0|||
27858276|NCT02531802|54403827|FG003|Received Vaccination 2|Physician Decision|0|||
27981102|NCT00887744|54639026|FG000|Overall Study|Various reasons|9|||
27981103|NCT00951509|54639030|FG000|Overall Study|Withdrawal by Subject|2|||
27981104|NCT00610441|54639042|FG000|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
27981105|NCT00610441|54639043|FG001|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
27981106|NCT00610441|54639044|FG002|Treatment Period 1 - 3 Weeks|Adverse Event|4|||
27981107|NCT00610441|54639045|FG003|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
27981108|NCT00610441|54639042|FG000|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
27981109|NCT00610441|54639043|FG001|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
27981110|NCT00610441|54639044|FG002|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1|||
27981111|NCT00610441|54639045|FG003|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
27981112|NCT00610441|54639042|FG000|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
27981113|NCT00610441|54639043|FG001|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
27981114|NCT00610441|54639044|FG002|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
27981115|NCT00610441|54639045|FG003|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0|||
27981116|NCT00610441|54639042|FG000|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
27981117|NCT00610441|54639043|FG001|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0|||
27981118|NCT00610441|54639044|FG002|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
27981119|NCT00610441|54639045|FG003|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
27981120|NCT00610441|54639042|FG000|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
27981121|NCT00610441|54639043|FG001|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
27981122|NCT00610441|54639044|FG002|Placebo Washout Period - 2 Weeks|Adverse Event|2|||
27981123|NCT00610441|54639045|FG003|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
27981124|NCT00610441|54639042|FG000|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
27981125|NCT00610441|54639043|FG001|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1|||
27981126|NCT00610441|54639044|FG002|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
27981127|NCT00610441|54639045|FG003|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
27981128|NCT00610441|54639042|FG000|Treatment Period 2 - 3 Weeks|Other|1|||
27981129|NCT00610441|54639043|FG001|Treatment Period 2 - 3 Weeks|Other|1|||
27981130|NCT00610441|54639044|FG002|Treatment Period 2 - 3 Weeks|Other|0|||
27981131|NCT00610441|54639045|FG003|Treatment Period 2 - 3 Weeks|Other|1|||
27981132|NCT00610441|54639042|FG000|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
27981133|NCT00610441|54639043|FG001|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
27858277|NCT02531802|54403828|FG004|Received Vaccination 2|Physician Decision|0|||
27858278|NCT02531802|54403829|FG005|Received Vaccination 2|Physician Decision|1|||
27858279|NCT02531802|54403830|FG006|Received Vaccination 2|Physician Decision|0|||
27858280|NCT02531802|54403831|FG007|Received Vaccination 2|Physician Decision|0|||
27858281|NCT02531802|54403832|FG008|Received Vaccination 2|Physician Decision|0|||
27858282|NCT02531802|54403833|FG009|Received Vaccination 2|Physician Decision|2|||
27858283|NCT02531802|54403834|FG010|Received Vaccination 2|Physician Decision|0|||
27858284|NCT02531802|54403835|FG011|Received Vaccination 2|Physician Decision|0|||
27858285|NCT02531802|54403836|FG012|Received Vaccination 2|Physician Decision|0|||
27858286|NCT02531802|54403837|FG013|Received Vaccination 2|Physician Decision|1|||
27858287|NCT02531802|54403838|FG014|Received Vaccination 2|Physician Decision|0|||
27858288|NCT02531802|54403839|FG015|Received Vaccination 2|Physician Decision|0|||
27858289|NCT02531802|54403840|FG016|Received Vaccination 2|Physician Decision|0|||
27858290|NCT02531802|54403841|FG017|Received Vaccination 2|Physician Decision|1|||
27858291|NCT02531802|54403842|FG018|Received Vaccination 2|Physician Decision|0|||
27858292|NCT02531802|54403843|FG019|Received Vaccination 2|Physician Decision|0|||
27858293|NCT02531802|54403844|FG020|Received Vaccination 2|Physician Decision|0|||
27858294|NCT02531802|54403824|FG000|Received Vaccination 2|Adverse Event|0|||
27858295|NCT02531802|54403825|FG001|Received Vaccination 2|Adverse Event|0|||
27858296|NCT02531802|54403826|FG002|Received Vaccination 2|Adverse Event|0|||
27858297|NCT02531802|54403827|FG003|Received Vaccination 2|Adverse Event|0|||
27858298|NCT02531802|54403828|FG004|Received Vaccination 2|Adverse Event|0|||
27858299|NCT02531802|54403829|FG005|Received Vaccination 2|Adverse Event|2|||
27858300|NCT02531802|54403830|FG006|Received Vaccination 2|Adverse Event|0|||
27858301|NCT02531802|54403831|FG007|Received Vaccination 2|Adverse Event|0|||
27858302|NCT02531802|54403832|FG008|Received Vaccination 2|Adverse Event|0|||
27858303|NCT02531802|54403833|FG009|Received Vaccination 2|Adverse Event|0|||
27858304|NCT02531802|54403834|FG010|Received Vaccination 2|Adverse Event|0|||
27858305|NCT02531802|54403835|FG011|Received Vaccination 2|Adverse Event|0|||
27858306|NCT02531802|54403836|FG012|Received Vaccination 2|Adverse Event|0|||
27858307|NCT02531802|54403837|FG013|Received Vaccination 2|Adverse Event|0|||
27858308|NCT02531802|54403838|FG014|Received Vaccination 2|Adverse Event|0|||
27858309|NCT02531802|54403839|FG015|Received Vaccination 2|Adverse Event|0|||
27858310|NCT02531802|54403840|FG016|Received Vaccination 2|Adverse Event|0|||
27858311|NCT02531802|54403841|FG017|Received Vaccination 2|Adverse Event|2|||
27858312|NCT02531802|54403842|FG018|Received Vaccination 2|Adverse Event|1|||
27858313|NCT02531802|54403843|FG019|Received Vaccination 2|Adverse Event|0|||
27858314|NCT02531802|54403844|FG020|Received Vaccination 2|Adverse Event|1|||
27858315|NCT02531802|54403824|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
27858316|NCT02531802|54403825|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
27858317|NCT02531802|54403826|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
27858318|NCT02531802|54403827|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
27858319|NCT02531802|54403828|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
27858320|NCT02531802|54403829|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
27858321|NCT02531802|54403830|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
27858322|NCT02531802|54403831|FG007|Received Vaccination 2|Withdrawal by Subject|0|||
27858323|NCT02531802|54403832|FG008|Received Vaccination 2|Withdrawal by Subject|0|||
27858324|NCT02531802|54403833|FG009|Received Vaccination 2|Withdrawal by Subject|0|||
27858325|NCT02531802|54403834|FG010|Received Vaccination 2|Withdrawal by Subject|1|||
27858326|NCT02531802|54403835|FG011|Received Vaccination 2|Withdrawal by Subject|0|||
27858327|NCT02531802|54403836|FG012|Received Vaccination 2|Withdrawal by Subject|1|||
27858328|NCT02531802|54403837|FG013|Received Vaccination 2|Withdrawal by Subject|1|||
27858329|NCT02531802|54403838|FG014|Received Vaccination 2|Withdrawal by Subject|1|||
27858330|NCT02531802|54403839|FG015|Received Vaccination 2|Withdrawal by Subject|0|||
27858331|NCT02531802|54403840|FG016|Received Vaccination 2|Withdrawal by Subject|0|||
27858332|NCT02531802|54403841|FG017|Received Vaccination 2|Withdrawal by Subject|1|||
27858333|NCT02531802|54403842|FG018|Received Vaccination 2|Withdrawal by Subject|1|||
27858334|NCT02531802|54403843|FG019|Received Vaccination 2|Withdrawal by Subject|1|||
27858335|NCT02531802|54403844|FG020|Received Vaccination 2|Withdrawal by Subject|0|||
27858336|NCT01602666|54403947|FG000|Induction Chemotherapy|Death|2|||
27858337|NCT01602666|54403948|FG001|Induction Chemotherapy|Death|1|||
27858338|NCT01602666|54403947|FG000|Induction Chemotherapy|Lack of Efficacy|16|||
27858339|NCT01602666|54403948|FG001|Induction Chemotherapy|Lack of Efficacy|7|||
27858340|NCT01602666|54403947|FG000|Induction Chemotherapy|Physician Decision|12|||
27858341|NCT01602666|54403948|FG001|Induction Chemotherapy|Physician Decision|5|||
27858342|NCT01602666|54403947|FG000|Induction Chemotherapy|Withdrawal by Subject|0|||
27858343|NCT01602666|54403948|FG001|Induction Chemotherapy|Withdrawal by Subject|2|||
27858344|NCT01602666|54403947|FG000|Induction Chemotherapy|Refusal of further protocol therapy|5|||
27858345|NCT01602666|54403948|FG001|Induction Chemotherapy|Refusal of further protocol therapy|6|||
27858346|NCT01602666|54403947|FG000|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2|||
27858347|NCT01602666|54403948|FG001|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3|||
27858348|NCT01602666|54403947|FG000|Radiation Therapy on Protocol|Lost to Follow-up|4|||
27858349|NCT01602666|54403948|FG001|Radiation Therapy on Protocol|Lost to Follow-up|5|||
27858350|NCT01602666|54403947|FG000|Radiation Therapy on Protocol|Withdrawal by Subject|2|||
27858351|NCT01602666|54403948|FG001|Radiation Therapy on Protocol|Withdrawal by Subject|3|||
27858352|NCT01602666|54403947|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4|||
27858353|NCT01602666|54403948|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0|||
27858354|NCT01602666|54403947|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0|||
27858355|NCT01602666|54403948|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14|||
27858356|NCT01602666|54403947|FG000|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0|||
27858357|NCT01602666|54403948|FG001|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9|||
27858358|NCT02531646|54403959|FG000|Overall Study|equip. image processing issue|5|||
27858359|NCT02531646|54403960|FG001|Overall Study|equip. image processing issue|1|||
27858360|NCT02531646|54403961|FG002|Overall Study|equip. image processing issue|0|||
27858361|NCT02536404|54404026|FG000|Overall Study|Adverse Event|5|||
27858362|NCT02536404|54404027|FG001|Overall Study|Adverse Event|0|||
27858363|NCT02536404|54404026|FG000|Overall Study|Withdrawal by Subject|4|||
27858364|NCT02536404|54404027|FG001|Overall Study|Withdrawal by Subject|1|||
27858365|NCT02536404|54404026|FG000|Overall Study|Physician Decision|10|||
27858366|NCT02536404|54404027|FG001|Overall Study|Physician Decision|0|||
27858367|NCT02536404|54404026|FG000|Overall Study|Sponsor decision|1|||
27858368|NCT02536404|54404027|FG001|Overall Study|Sponsor decision|0|||
27858369|NCT01659996|54404987|FG000|Overall Study|Protocol Violation|3|||
27858370|NCT01659996|54404988|FG001|Overall Study|Protocol Violation|3|||
27858371|NCT01659996|54404989|FG002|Overall Study|Protocol Violation|3|||
27858372|NCT01659996|54404987|FG000|Overall Study|Lost to Follow-up|1|||
27858373|NCT01659996|54404988|FG001|Overall Study|Lost to Follow-up|3|||
27858374|NCT01659996|54404989|FG002|Overall Study|Lost to Follow-up|2|||
27858375|NCT01659996|54404987|FG000|Overall Study|Adverse Event|0|||
27858376|NCT01659996|54404988|FG001|Overall Study|Adverse Event|0|||
27858377|NCT01659996|54404989|FG002|Overall Study|Adverse Event|1|||
27858378|NCT01659996|54404987|FG000|Overall Study|Withdrawal by Subject|4|||
27858379|NCT01659996|54404988|FG001|Overall Study|Withdrawal by Subject|1|||
27858380|NCT01659996|54404989|FG002|Overall Study|Withdrawal by Subject|5|||
27858381|NCT02525874|54405353|FG000|Overall Study|Other|1|||
27858382|NCT02525874|54405353|FG000|Overall Study|Investigator Decision|1|||
27858383|NCT02525874|54405353|FG000|Overall Study|Consent withdrawn|22|||
27858384|NCT02525874|54405353|FG000|Overall Study|Non-compliance with study drug|3|||
27858385|NCT02525874|54405353|FG000|Overall Study|Adverse Event|17|||
27858386|NCT02525874|54405353|FG000|Overall Study|Lost to Follow-up|7|||
27858387|NCT02525874|54405353|FG000|Overall Study|Disease progression, defined by protocol|2|||
27858388|NCT02525874|54405353|FG000|Overall Study|Disease relapse|4|||
27858389|NCT02525874|54405353|FG000|Overall Study|Alternative Treatment for MS|2|||
27858390|NCT02525874|54405353|FG000|Overall Study|New lesions in Brain|1|||
27858391|NCT02528214|54405363|FG000|Overall Study|Protocol Violation|0|||
27858392|NCT02528214|54405364|FG001|Overall Study|Protocol Violation|1|||
27858393|NCT02528214|54405363|FG000|Overall Study|Adverse Event|0|||
27858394|NCT02528214|54405364|FG001|Overall Study|Adverse Event|1|||
27858395|NCT02528214|54405363|FG000|Overall Study|Other than specified above|0|||
27858396|NCT02528214|54405364|FG001|Overall Study|Other than specified above|1|||
27858397|NCT05348681|54405408|FG000|Overall Study|Study terminated by Sponsor|8|||
27858398|NCT05348681|54405409|FG001|Overall Study|Study terminated by Sponsor|3|||
27858399|NCT05348681|54405408|FG000|Overall Study|Withdrawal by Subject|1|||
27858400|NCT05348681|54405409|FG001|Overall Study|Withdrawal by Subject|1|||
27858401|NCT05348681|54405408|FG000|Overall Study|Lost to Follow-up|1|||
27858402|NCT05348681|54405409|FG001|Overall Study|Lost to Follow-up|1|||
27858403|NCT05348681|54405408|FG000|Overall Study|Adverse Event|1|||
27858404|NCT05348681|54405409|FG001|Overall Study|Adverse Event|0|||
27858405|NCT05348681|54405408|FG000|Overall Study|Other|2|||
27858406|NCT05348681|54405409|FG001|Overall Study|Other|1|||
27858407|NCT04423757|54405435|FG000|Overall Study|Adverse Event|2|||
27858408|NCT04423757|54405436|FG001|Overall Study|Adverse Event|0|||
27858409|NCT04423757|54405435|FG000|Overall Study|Not treated|1|||
27858410|NCT04423757|54405436|FG001|Overall Study|Not treated|1|||
27858411|NCT04379713|54405444|FG000|Overall Study|Adverse Event|2|||
28095891|NCT04315298|54750393|FG016|Overall Study|Death|3|||
27858412|NCT04379713|54405445|FG001|Overall Study|Adverse Event|0|||
27858413|NCT04379713|54405444|FG000|Overall Study|Physician Decision|2|||
27858414|NCT04379713|54405445|FG001|Overall Study|Physician Decision|1|||
27858415|NCT04379713|54405444|FG000|Overall Study|Protocol Violation|11|||
28095892|NCT04315298|54750394|FG017|Overall Study|Death|1|||
28095893|NCT04315298|54750395|FG018|Overall Study|Death|0|||
27858416|NCT04379713|54405445|FG001|Overall Study|Protocol Violation|6|||
27858417|NCT04379713|54405444|FG000|Overall Study|No longer met eligibility criteria|14|||
27858418|NCT04379713|54405445|FG001|Overall Study|No longer met eligibility criteria|11|||
27858419|NCT04379713|54405444|FG000|Overall Study|Withdrawal by parent/guardian|36|||
27858420|NCT04379713|54405445|FG001|Overall Study|Withdrawal by parent/guardian|15|||
27858421|NCT04379713|54405444|FG000|Overall Study|Lost to Follow-up|31|||
27858422|NCT04379713|54405445|FG001|Overall Study|Lost to Follow-up|21|||
27858423|NCT04085328|54405453|FG000|Overall Study|Witihdrew Consent|16|||
27858424|NCT04085328|54405454|FG001|Overall Study|Witihdrew Consent|16|||
27858425|NCT04085328|54405453|FG000|Overall Study|Adverse Event|8|||
27858426|NCT04085328|54405454|FG001|Overall Study|Adverse Event|7|||
27858427|NCT04085328|54405453|FG000|Overall Study|Lost to Follow-up|7|||
27858428|NCT04085328|54405454|FG001|Overall Study|Lost to Follow-up|2|||
27858429|NCT04085328|54405453|FG000|Overall Study|Physician Decision|0|||
27858430|NCT04085328|54405454|FG001|Overall Study|Physician Decision|1|||
27858431|NCT04085328|54405453|FG000|Overall Study|Pregnancy|0|||
27858432|NCT04085328|54405454|FG001|Overall Study|Pregnancy|1|||
27858433|NCT04085328|54405453|FG000|Overall Study|Reasons Related to COVID-19|5|||
27858434|NCT04085328|54405454|FG001|Overall Study|Reasons Related to COVID-19|8|||
27858435|NCT04085328|54405453|FG000|Overall Study|Did not meet inclusion criteria|1|||
27858436|NCT04085328|54405454|FG001|Overall Study|Did not meet inclusion criteria|1|||
27858437|NCT04085328|54405453|FG000|Overall Study|Early termination|1|||
27858438|NCT04085328|54405454|FG001|Overall Study|Early termination|0|||
27858439|NCT03789110|54405467|FG000|Overall Study|Adverse Event|2|||
27858440|NCT03789110|54405467|FG000|Overall Study|Physician Decision|1|||
27858441|NCT03789110|54405467|FG000|Overall Study|Withdrawal by Subject|2|||
27858442|NCT03789110|54405467|FG000|Overall Study|Lack of Efficacy|22|||
27858443|NCT03789110|54405467|FG000|Overall Study|still on treatment|3|||
27858444|NCT03309878|54405493|FG000|Overall Study|Adverse Event|1|||
27858445|NCT03309878|54405494|FG001|Overall Study|Adverse Event|0|||
27858446|NCT03309878|54405495|FG002|Overall Study|Adverse Event|0|||
27858447|NCT03309878|54405496|FG003|Overall Study|Adverse Event|0|||
27858448|NCT03309878|54405493|FG000|Overall Study|Did not maintain eligibility|2|||
27858449|NCT03309878|54405494|FG001|Overall Study|Did not maintain eligibility|1|||
27858450|NCT03309878|54405495|FG002|Overall Study|Did not maintain eligibility|0|||
28171308|NCT02720523|54842902|FG003|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
28171309|NCT02720523|54842903|FG004|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
28171310|NCT02720523|54842904|FG005|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
28171311|NCT02720523|54842905|FG006|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
27858451|NCT03309878|54405496|FG003|Overall Study|Did not maintain eligibility|0|||
27858452|NCT03309878|54405493|FG000|Overall Study|Withdrawal by Subject|0|||
27858453|NCT03309878|54405494|FG001|Overall Study|Withdrawal by Subject|1|||
27858454|NCT03309878|54405495|FG002|Overall Study|Withdrawal by Subject|0|||
27858455|NCT03309878|54405496|FG003|Overall Study|Withdrawal by Subject|0|||
27858456|NCT03074474|54405506|FG000|Overall Study|Lost to Follow-up|10|||
27858457|NCT03074474|54405506|FG000|Overall Study|Withdrawal by Subject|10|||
27858458|NCT03074474|54405506|FG000|Overall Study|Death|4|||
27858459|NCT03074474|54405506|FG000|Overall Study|1 exited due to recurrence and 2 exited due to mesh removal.|3|||
27858460|NCT03043313|54405514|FG000|Overall Study|Withdrawal by Subject|4|||
27858461|NCT03043313|54405515|FG001|Overall Study|Withdrawal by Subject|1|||
27858462|NCT03043313|54405516|FG002|Overall Study|Withdrawal by Subject|1|||
27858463|NCT03043313|54405514|FG000|Overall Study|Lost to Follow-up|1|||
27858464|NCT03043313|54405515|FG001|Overall Study|Lost to Follow-up|0|||
27858465|NCT03043313|54405516|FG002|Overall Study|Lost to Follow-up|0|||
27858466|NCT03043313|54405514|FG000|Overall Study|Death|26|||
27858467|NCT03043313|54405515|FG001|Overall Study|Death|13|||
27858468|NCT03043313|54405516|FG002|Overall Study|Death|8|||
27858469|NCT03043313|54405514|FG000|Overall Study|On Treatment|7|||
27858470|NCT03043313|54405515|FG001|Overall Study|On Treatment|12|||
27858471|NCT03043313|54405516|FG002|Overall Study|On Treatment|11|||
27858472|NCT03043313|54405514|FG000|Overall Study|In follow up|7|||
27858473|NCT03043313|54405515|FG001|Overall Study|In follow up|15|||
27858474|NCT03043313|54405516|FG002|Overall Study|In follow up|11|||
27858475|NCT02744391|54405527|FG000|Overall Study|Lost to Follow-up|9|||
27858476|NCT02744391|54405527|FG000|Overall Study|Physician Decision|2|||
27858477|NCT02744391|54405527|FG000|Overall Study|Withdrawal by Subject|3|||
27858478|NCT02462837|54405533|FG000|Overall Study|pt developed hives|1|||
27858479|NCT02462837|54405534|FG001|Overall Study|pt developed hives|0|||
27981134|NCT00610441|54639044|FG002|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
27981135|NCT00610441|54639045|FG003|Treatment Period 2 - 3 Weeks|Adverse Event|1|||
27981136|NCT00610441|54639042|FG000|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1|||
27858480|NCT02462837|54405533|FG000|Overall Study|Withdrawal by Subject|1|||
27858481|NCT02462837|54405534|FG001|Overall Study|Withdrawal by Subject|0|||
27858482|NCT02346201|54405542|FG000|Overall Study|Adverse Event|3|||
27858483|NCT02346201|54405543|FG001|Overall Study|Adverse Event|2|||
27858484|NCT02346201|54405542|FG000|Overall Study|Lost to Follow-up|1|||
27858485|NCT02346201|54405543|FG001|Overall Study|Lost to Follow-up|0|||
27858486|NCT02346201|54405542|FG000|Overall Study|Withdrawal by Subject|6|||
27858487|NCT02346201|54405543|FG001|Overall Study|Withdrawal by Subject|3|||
27858488|NCT02346201|54405542|FG000|Overall Study|Unavailable for future follow-up|0|||
27858489|NCT02346201|54405543|FG001|Overall Study|Unavailable for future follow-up|1|||
27858490|NCT02346201|54405542|FG000|Overall Study|Physician Decision|0|||
27858491|NCT02346201|54405543|FG001|Overall Study|Physician Decision|1|||
27981137|NCT00610441|54639043|FG001|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
27858492|NCT02346201|54405542|FG000|Overall Study|Missed final visit|0|||
27858493|NCT02346201|54405543|FG001|Overall Study|Missed final visit|2|||
27858494|NCT01866930|54405563|FG000|Treatment Period|Other|1|||
27858495|NCT01866930|54405564|FG001|Treatment Period|Other|0|||
27858496|NCT01866930|54405563|FG000|Treatment Period|Death|0|||
27858497|NCT01866930|54405564|FG001|Treatment Period|Death|2|||
27858498|NCT01866930|54405563|FG000|Treatment Period|Poor/non compliance|0|||
27858499|NCT01866930|54405564|FG001|Treatment Period|Poor/non compliance|2|||
27858500|NCT01866930|54405563|FG000|Treatment Period|No longer meets study criteria|0|||
27858501|NCT01866930|54405564|FG001|Treatment Period|No longer meets study criteria|1|||
27858502|NCT01866930|54405563|FG000|Treatment Period|Withdrawal by Subject|2|||
27858503|NCT01866930|54405564|FG001|Treatment Period|Withdrawal by Subject|8|||
27858504|NCT01866930|54405563|FG000|Treatment Period|Lack of Efficacy|1|||
27858505|NCT01866930|54405564|FG001|Treatment Period|Lack of Efficacy|9|||
27858506|NCT01866930|54405563|FG000|Treatment Period|Adverse Event|4|||
27858507|NCT01866930|54405564|FG001|Treatment Period|Adverse Event|12|||
27858508|NCT01866930|54405563|FG000|Treatment Period|Lost to Follow-up|1|||
27858509|NCT01866930|54405564|FG001|Treatment Period|Lost to Follow-up|1|||
27858510|NCT01866930|54405563|FG000|Follow-up Period|Lost to Follow-up|1|||
27858511|NCT01866930|54405564|FG001|Follow-up Period|Lost to Follow-up|1|||
27858512|NCT01866930|54405563|FG000|Follow-up Period|Other|1|||
27858513|NCT01866930|54405564|FG001|Follow-up Period|Other|5|||
27858514|NCT01866930|54405563|FG000|Follow-up Period|No longer required per protocol|1|||
27858515|NCT01866930|54405564|FG001|Follow-up Period|No longer required per protocol|0|||
27858516|NCT01866930|54405563|FG000|Follow-up Period|Withdrawal by Subject|3|||
27858517|NCT01866930|54405564|FG001|Follow-up Period|Withdrawal by Subject|3|||
27858518|NCT01621568|54405572|FG000|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|1|||
27858519|NCT01621568|54405573|FG001|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|0|||
27858520|NCT01621568|54405572|FG000|Week 5-6 No Treatment|Death|1|||
27858521|NCT01621568|54405573|FG001|Week 5-6 No Treatment|Death|0|||
27858522|NCT00813293|54405602|FG000|Overall Study|Intercurrent illness|1|||
27858523|NCT00813293|54405603|FG001|Overall Study|Intercurrent illness|0|||
27858524|NCT00813293|54405602|FG000|Overall Study|Adverse Event|0|||
27858525|NCT00813293|54405603|FG001|Overall Study|Adverse Event|1|||
27858526|NCT00777036|54405612|FG000|On Treatment|Reason Not Specified|4|||
27858527|NCT00777036|54405613|FG001|On Treatment|Reason Not Specified|7|||
27858528|NCT00777036|54405614|FG002|On Treatment|Reason Not Specified|12|||
27858529|NCT00777036|54405612|FG000|On Treatment|Failure to Meet Study Criteria|0|||
27858530|NCT00777036|54405613|FG001|On Treatment|Failure to Meet Study Criteria|1|||
27858531|NCT00777036|54405614|FG002|On Treatment|Failure to Meet Study Criteria|0|||
27858532|NCT00777036|54405612|FG000|On Treatment|Non-compliance with Study Drug|1|||
27858533|NCT00777036|54405613|FG001|On Treatment|Non-compliance with Study Drug|0|||
27858534|NCT00777036|54405614|FG002|On Treatment|Non-compliance with Study Drug|0|||
27858535|NCT00777036|54405612|FG000|On Treatment|Maximum Clinical Benefit|2|||
27858536|NCT00777036|54405613|FG001|On Treatment|Maximum Clinical Benefit|0|||
27858537|NCT00777036|54405614|FG002|On Treatment|Maximum Clinical Benefit|1|||
27858538|NCT00777036|54405612|FG000|On Treatment|Withdrawal by Subject|3|||
27858539|NCT00777036|54405613|FG001|On Treatment|Withdrawal by Subject|2|||
27858540|NCT00777036|54405614|FG002|On Treatment|Withdrawal by Subject|3|||
27858541|NCT00777036|54405612|FG000|On Treatment|Death|0|||
27858542|NCT00777036|54405613|FG001|On Treatment|Death|2|||
27858543|NCT00777036|54405614|FG002|On Treatment|Death|0|||
27858544|NCT00777036|54405612|FG000|On Treatment|Study Drug Toxicity|0|||
27858545|NCT00777036|54405613|FG001|On Treatment|Study Drug Toxicity|0|||
27858546|NCT00777036|54405614|FG002|On Treatment|Study Drug Toxicity|1|||
27858547|NCT00777036|54405612|FG000|On Treatment|Progressive Disease|5|||
27858548|NCT00777036|54405613|FG001|On Treatment|Progressive Disease|4|||
27858549|NCT00777036|54405614|FG002|On Treatment|Progressive Disease|6|||
27858550|NCT00777036|54405612|FG000|Follow-Up|Lost to Follow-up|1|||
27858551|NCT00777036|54405613|FG001|Follow-Up|Lost to Follow-up|0|||
27858552|NCT00777036|54405614|FG002|Follow-Up|Lost to Follow-up|0|||
27858553|NCT00777036|54405612|FG000|Follow-Up|Reason Not Specified|2|||
27858554|NCT00777036|54405613|FG001|Follow-Up|Reason Not Specified|0|||
27858555|NCT00777036|54405614|FG002|Follow-Up|Reason Not Specified|0|||
27858556|NCT00777036|54405612|FG000|Follow-Up|Withdrawal by Subject|1|||
27858557|NCT00777036|54405613|FG001|Follow-Up|Withdrawal by Subject|0|||
27858558|NCT00777036|54405614|FG002|Follow-Up|Withdrawal by Subject|4|||
27858559|NCT00777036|54405612|FG000|Follow-Up|Death|1|||
27858560|NCT00777036|54405613|FG001|Follow-Up|Death|8|||
27858561|NCT00777036|54405614|FG002|Follow-Up|Death|0|||
27858562|NCT00481091|54405639|FG000|Overall Study|Withdrawal by Subject|0|||
27858563|NCT00481091|54405640|FG001|Overall Study|Withdrawal by Subject|1|||
27858564|NCT00481091|54405641|FG002|Overall Study|Withdrawal by Subject|1|||
27858565|NCT00481091|54405642|FG003|Overall Study|Withdrawal by Subject|0|||
27858566|NCT00481091|54405643|FG004|Overall Study|Withdrawal by Subject|0|||
27858567|NCT00481091|54405644|FG005|Overall Study|Withdrawal by Subject|0|||
27858568|NCT00481091|54405645|FG006|Overall Study|Withdrawal by Subject|0|||
27858569|NCT00481091|54405646|FG007|Overall Study|Withdrawal by Subject|0|||
27858570|NCT00481091|54405647|FG008|Overall Study|Withdrawal by Subject|1|||
27858571|NCT00481091|54405648|FG009|Overall Study|Withdrawal by Subject|6|||
27858572|NCT00481091|54405639|FG000|Overall Study|Other, Not Specified|0|||
27858573|NCT00481091|54405640|FG001|Overall Study|Other, Not Specified|1|||
27858574|NCT00481091|54405641|FG002|Overall Study|Other, Not Specified|1|||
27858575|NCT00481091|54405642|FG003|Overall Study|Other, Not Specified|0|||
27858576|NCT00481091|54405643|FG004|Overall Study|Other, Not Specified|0|||
27858577|NCT00481091|54405644|FG005|Overall Study|Other, Not Specified|1|||
27858578|NCT00481091|54405645|FG006|Overall Study|Other, Not Specified|0|||
27858579|NCT00481091|54405646|FG007|Overall Study|Other, Not Specified|0|||
27858580|NCT00481091|54405647|FG008|Overall Study|Other, Not Specified|0|||
27858581|NCT00481091|54405648|FG009|Overall Study|Other, Not Specified|4|||
27858582|NCT00481091|54405639|FG000|Overall Study|Adverse Event|1|||
27858583|NCT00481091|54405640|FG001|Overall Study|Adverse Event|2|||
27858584|NCT00481091|54405641|FG002|Overall Study|Adverse Event|0|||
27858585|NCT00481091|54405642|FG003|Overall Study|Adverse Event|1|||
27858586|NCT00481091|54405643|FG004|Overall Study|Adverse Event|1|||
27858587|NCT00481091|54405644|FG005|Overall Study|Adverse Event|1|||
27858588|NCT00481091|54405645|FG006|Overall Study|Adverse Event|2|||
27858589|NCT00481091|54405646|FG007|Overall Study|Adverse Event|1|||
27858590|NCT00481091|54405647|FG008|Overall Study|Adverse Event|1|||
27858591|NCT00481091|54405648|FG009|Overall Study|Adverse Event|6|||
27858592|NCT00481091|54405639|FG000|Overall Study|Progressive disease clinical|0|||
27858593|NCT00481091|54405640|FG001|Overall Study|Progressive disease clinical|0|||
27858594|NCT00481091|54405641|FG002|Overall Study|Progressive disease clinical|0|||
27858595|NCT00481091|54405642|FG003|Overall Study|Progressive disease clinical|0|||
27858596|NCT00481091|54405643|FG004|Overall Study|Progressive disease clinical|0|||
27858597|NCT00481091|54405644|FG005|Overall Study|Progressive disease clinical|0|||
27858598|NCT00481091|54405645|FG006|Overall Study|Progressive disease clinical|0|||
27858599|NCT00481091|54405646|FG007|Overall Study|Progressive disease clinical|0|||
27858600|NCT00481091|54405647|FG008|Overall Study|Progressive disease clinical|1|||
27858601|NCT00481091|54405648|FG009|Overall Study|Progressive disease clinical|7|||
27858602|NCT00481091|54405639|FG000|Overall Study|Progressive disease clinical National Cancer Institute|1|||
27858603|NCT00481091|54405640|FG001|Overall Study|Progressive disease clinical National Cancer Institute|1|||
27858604|NCT00481091|54405641|FG002|Overall Study|Progressive disease clinical National Cancer Institute|0|||
27858605|NCT00481091|54405642|FG003|Overall Study|Progressive disease clinical National Cancer Institute|0|||
27858606|NCT00481091|54405643|FG004|Overall Study|Progressive disease clinical National Cancer Institute|0|||
27858607|NCT00481091|54405644|FG005|Overall Study|Progressive disease clinical National Cancer Institute|1|||
27858608|NCT00481091|54405645|FG006|Overall Study|Progressive disease clinical National Cancer Institute|0|||
27858609|NCT00481091|54405646|FG007|Overall Study|Progressive disease clinical National Cancer Institute|0|||
27858610|NCT00481091|54405647|FG008|Overall Study|Progressive disease clinical National Cancer Institute|0|||
27858611|NCT00481091|54405648|FG009|Overall Study|Progressive disease clinical National Cancer Institute|0|||
27858612|NCT00481091|54405639|FG000|Overall Study|Progressive disease other|1|||
27858613|NCT00481091|54405640|FG001|Overall Study|Progressive disease other|1|||
27858614|NCT00481091|54405641|FG002|Overall Study|Progressive disease other|0|||
27858615|NCT00481091|54405642|FG003|Overall Study|Progressive disease other|1|||
27858616|NCT00481091|54405643|FG004|Overall Study|Progressive disease other|1|||
27834196|NCT01591499|54317758|FG000|Second Intervention (up to 24 Days)|Lost to Follow-up|4|||
27834197|NCT01591499|54317759|FG001|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
27834198|NCT01591499|54317760|FG002|Second Intervention (up to 24 Days)|Lost to Follow-up|1|||
27834199|NCT01591499|54317761|FG003|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
27834200|NCT01981720|54317785|FG000|Overall Study|Adverse Event|1|||
27834201|NCT01981720|54317785|FG000|Overall Study|Withdrawal by Subject|3|||
27834202|NCT01981720|54317785|FG000|Overall Study|Pregnancy|1|||
27834203|NCT01590797|54317795|FG000|Overall Study|Adverse Event|4|||
27834204|NCT01590797|54317796|FG001|Overall Study|Adverse Event|3|||
27834205|NCT01590797|54317795|FG000|Overall Study|Lack of Efficacy|0|||
27834206|NCT01590797|54317796|FG001|Overall Study|Lack of Efficacy|2|||
27834207|NCT01590797|54317795|FG000|Overall Study|Lost to Follow-up|0|||
27834208|NCT01590797|54317796|FG001|Overall Study|Lost to Follow-up|1|||
27834209|NCT01590797|54317795|FG000|Overall Study|Protocol Violation|4|||
27834210|NCT01590797|54317796|FG001|Overall Study|Protocol Violation|1|||
27834211|NCT01590797|54317795|FG000|Overall Study|Withdrawal by Subject|7|||
27858617|NCT00481091|54405644|FG005|Overall Study|Progressive disease other|1|||
27858618|NCT00481091|54405645|FG006|Overall Study|Progressive disease other|0|||
27858619|NCT00481091|54405646|FG007|Overall Study|Progressive disease other|2|||
27858620|NCT00481091|54405647|FG008|Overall Study|Progressive disease other|0|||
27834212|NCT01590797|54317796|FG001|Overall Study|Withdrawal by Subject|5|||
27834213|NCT01590797|54317795|FG000|Overall Study|Other Protocol Specified Criteria|2|||
27834214|NCT01590797|54317796|FG001|Overall Study|Other Protocol Specified Criteria|4|||
27858621|NCT00481091|54405648|FG009|Overall Study|Progressive disease other|0|||
27858622|NCT00481091|54405639|FG000|Overall Study|No reason given|0|||
27858623|NCT00481091|54405640|FG001|Overall Study|No reason given|0|||
27858624|NCT00481091|54405641|FG002|Overall Study|No reason given|1|||
27858625|NCT00481091|54405642|FG003|Overall Study|No reason given|1|||
27858626|NCT00481091|54405643|FG004|Overall Study|No reason given|1|||
27858627|NCT00481091|54405644|FG005|Overall Study|No reason given|0|||
27858628|NCT00481091|54405645|FG006|Overall Study|No reason given|1|||
27858629|NCT00481091|54405646|FG007|Overall Study|No reason given|1|||
27858630|NCT00481091|54405647|FG008|Overall Study|No reason given|1|||
27858631|NCT00481091|54405648|FG009|Overall Study|No reason given|4|||
27858632|NCT00003641|54405679|FG000|Overall Study|Withdrawal by Subject|0|||
27858633|NCT00003641|54405680|FG001|Overall Study|Withdrawal by Subject|100|||
27858634|NCT00003641|54405679|FG000|Overall Study|Adverse Event|0|||
27858635|NCT00003641|54405680|FG001|Overall Study|Adverse Event|38|||
27858636|NCT00003641|54405679|FG000|Overall Study|Disease progression|0|||
27858637|NCT00003641|54405680|FG001|Overall Study|Disease progression|2|||
27858638|NCT00003641|54405679|FG000|Overall Study|Unknown/missing|0|||
27858639|NCT00003641|54405680|FG001|Overall Study|Unknown/missing|22|||
27858640|NCT00003641|54405679|FG000|Overall Study|Should not receive interferon therapy|2|||
27858641|NCT00003641|54405680|FG001|Overall Study|Should not receive interferon therapy|0|||
27858642|NCT00003641|54405679|FG000|Overall Study|Never started interferon|567|||
27858643|NCT00003641|54405680|FG001|Overall Study|Never started interferon|12|||
27858644|NCT02524158|54405710|FG000|12-weeks Assessment|Withdrawal by Subject|1|||
27858645|NCT02524158|54405711|FG001|12-weeks Assessment|Withdrawal by Subject|1|||
27858646|NCT02524158|54405710|FG000|12-weeks Assessment|Lost to Follow-up|18|||
27858647|NCT02524158|54405711|FG001|12-weeks Assessment|Lost to Follow-up|12|||
27858648|NCT02524158|54405710|FG000|6-month Assessment|Withdrawal by Subject|1|||
27858649|NCT02524158|54405711|FG001|6-month Assessment|Withdrawal by Subject|1|||
27858650|NCT02524158|54405710|FG000|6-month Assessment|Lost to Follow-up|21|||
27858651|NCT02524158|54405711|FG001|6-month Assessment|Lost to Follow-up|20|||
27858652|NCT02525094|54405731|FG000|Overall Study|Lost to Follow-up|2|||
27858653|NCT02525094|54405732|FG001|Overall Study|Lost to Follow-up|1|||
27858654|NCT02525094|54405731|FG000|Overall Study|Withdrawal by Subject|5|||
27858655|NCT02525094|54405732|FG001|Overall Study|Withdrawal by Subject|6|||
27858656|NCT02525094|54405731|FG000|Overall Study|Not Treated|1|||
27858657|NCT02525094|54405732|FG001|Overall Study|Not Treated|1|||
27858658|NCT01657266|54405889|FG000|Overall Study|Lost to Follow-up|2|||
27858659|NCT01657266|54405890|FG001|Overall Study|Lost to Follow-up|2|||
27858660|NCT01657266|54405889|FG000|Overall Study|Adverse Event|2|||
27858661|NCT01657266|54405890|FG001|Overall Study|Adverse Event|3|||
27858662|NCT01657032|54405975|FG000|Overall Study|Lost to Follow-up|0|||
27858663|NCT01657032|54405976|FG001|Overall Study|Lost to Follow-up|7|||
27858664|NCT01657500|54406104|FG000|Overall Study|set impropperly matched|3|||
27858665|NCT01657500|54406105|FG001|Overall Study|set impropperly matched|3|||
27858666|NCT01657500|54406104|FG000|Overall Study|Lost to Follow-up|2|||
27858667|NCT01657500|54406105|FG001|Overall Study|Lost to Follow-up|2|||
27858668|NCT01658904|54406118|FG000|Overall Study|Principal Investigator discretion|2|||
27858669|NCT01658904|54406119|FG001|Overall Study|Principal Investigator discretion|0|||
27858670|NCT01658904|54406120|FG002|Overall Study|Principal Investigator discretion|0|||
27858671|NCT01658514|54406304|FG000|Overall Study|Protocol Violation|1|||
27858672|NCT01658514|54406305|FG001|Overall Study|Protocol Violation|0|||
27858673|NCT01658514|54406306|FG002|Overall Study|Protocol Violation|2|||
27858674|NCT01658436|54406327|FG000|Overall Study|Adverse Event|6|||
27858675|NCT01658436|54406328|FG001|Overall Study|Adverse Event|5|||
27858676|NCT01658436|54406327|FG000|Overall Study|Physician Decision|1|||
27858677|NCT01658436|54406328|FG001|Overall Study|Physician Decision|0|||
27858678|NCT01658436|54406327|FG000|Overall Study|Progressive disease|12|||
27858679|NCT01658436|54406328|FG001|Overall Study|Progressive disease|4|||
27858680|NCT01658436|54406327|FG000|Overall Study|Study terminated by sponsor|0|||
27858681|NCT01658436|54406328|FG001|Overall Study|Study terminated by sponsor|1|||
27858682|NCT01658436|54406327|FG000|Overall Study|Subject/guardian decision|0|||
27858683|NCT01658436|54406328|FG001|Overall Study|Subject/guardian decision|1|||
27858684|NCT01658436|54406327|FG000|Overall Study|Death|1|||
27858685|NCT01658436|54406328|FG001|Overall Study|Death|0|||
27858686|NCT01656408|54406883|FG000|Overall Study|Adverse Event|0|||
27858687|NCT01656408|54406884|FG001|Overall Study|Adverse Event|0|||
27858688|NCT01656408|54406885|FG002|Overall Study|Adverse Event|1|||
27858689|NCT01656408|54406886|FG003|Overall Study|Adverse Event|0|||
28171312|NCT02720523|54842899|FG000|Period 1: Placebo-controlled Period|Other|0|||
27858690|NCT01656408|54406887|FG004|Overall Study|Adverse Event|0|||
27858691|NCT01656408|54406888|FG005|Overall Study|Adverse Event|1|||
27858692|NCT01656408|54406889|FG006|Overall Study|Adverse Event|1|||
27858693|NCT01656408|54406890|FG007|Overall Study|Adverse Event|0|||
27858694|NCT01656408|54406891|FG008|Overall Study|Adverse Event|1|||
27858695|NCT01656408|54406892|FG009|Overall Study|Adverse Event|0|||
27858696|NCT01656408|54406883|FG000|Overall Study|Physician Decision|1|||
27858697|NCT01656408|54406884|FG001|Overall Study|Physician Decision|0|||
27858698|NCT01656408|54406885|FG002|Overall Study|Physician Decision|1|||
27858699|NCT01656408|54406886|FG003|Overall Study|Physician Decision|0|||
27858700|NCT01656408|54406887|FG004|Overall Study|Physician Decision|1|||
27858701|NCT01656408|54406888|FG005|Overall Study|Physician Decision|1|||
27858702|NCT01656408|54406889|FG006|Overall Study|Physician Decision|0|||
27858703|NCT01656408|54406890|FG007|Overall Study|Physician Decision|1|||
27858704|NCT01656408|54406891|FG008|Overall Study|Physician Decision|1|||
27858705|NCT01656408|54406892|FG009|Overall Study|Physician Decision|3|||
27858706|NCT01364298|54407335|FG000|Overall Study|Adverse Event|3|||
27858707|NCT01364298|54407336|FG001|Overall Study|Adverse Event|4|||
27858708|NCT01364298|54407335|FG000|Overall Study|Lack of adherence to treatment|1|||
27858709|NCT01364298|54407336|FG001|Overall Study|Lack of adherence to treatment|3|||
27858710|NCT01364298|54407335|FG000|Overall Study|Lack of Efficacy|1|||
27858711|NCT01364298|54407336|FG001|Overall Study|Lack of Efficacy|0|||
27858712|NCT01364298|54407335|FG000|Overall Study|Lost to Follow-up|5|||
27858713|NCT01364298|54407336|FG001|Overall Study|Lost to Follow-up|10|||
27858714|NCT01364298|54407335|FG000|Overall Study|Withdrawal by Subject|3|||
27858715|NCT01364298|54407336|FG001|Overall Study|Withdrawal by Subject|3|||
27858716|NCT01364298|54407335|FG000|Overall Study|Other|1|||
27858717|NCT01364298|54407336|FG001|Overall Study|Other|3|||
27858718|NCT01364922|54407395|FG000|Open-label (OL) Period|Adverse Event|7|||
27858719|NCT01364922|54407396|FG001|Open-label (OL) Period|Adverse Event|0|||
27858720|NCT01364922|54407397|FG002|Open-label (OL) Period|Adverse Event|0|||
27858721|NCT01364922|54407395|FG000|Open-label (OL) Period|Did Not Meet Randomization Criteria|6|||
27858722|NCT01364922|54407396|FG001|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
27858723|NCT01364922|54407397|FG002|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
27858724|NCT01364922|54407395|FG000|Open-label (OL) Period|Withdrawal by Subject|4|||
27858725|NCT01364922|54407396|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
27858726|NCT01364922|54407397|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
27858727|NCT01364922|54407395|FG000|Open-label (OL) Period|Lack of Efficacy|3|||
27858728|NCT01364922|54407396|FG001|Open-label (OL) Period|Lack of Efficacy|0|||
27858729|NCT01364922|54407397|FG002|Open-label (OL) Period|Lack of Efficacy|0|||
27858730|NCT01364922|54407395|FG000|Open-label (OL) Period|Lost to Follow-up|1|||
27858731|NCT01364922|54407396|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
27858732|NCT01364922|54407397|FG002|Open-label (OL) Period|Lost to Follow-up|0|||
27858733|NCT01364922|54407395|FG000|Open-label (OL) Period|Other, Unspecified|1|||
27858734|NCT01364922|54407396|FG001|Open-label (OL) Period|Other, Unspecified|0|||
27858735|NCT01364922|54407397|FG002|Open-label (OL) Period|Other, Unspecified|0|||
27858736|NCT01364922|54407395|FG000|Double-Blind (DB) Period|Lack of Efficacy|0|||
27858737|NCT01364922|54407396|FG001|Double-Blind (DB) Period|Lack of Efficacy|3|||
27858738|NCT01364922|54407397|FG002|Double-Blind (DB) Period|Lack of Efficacy|4|||
27858739|NCT01364922|54407395|FG000|Double-Blind (DB) Period|Subject Noncompliant|0|||
27858740|NCT01364922|54407396|FG001|Double-Blind (DB) Period|Subject Noncompliant|1|||
27858741|NCT01364922|54407397|FG002|Double-Blind (DB) Period|Subject Noncompliant|0|||
27858742|NCT01364922|54407395|FG000|Double-Blind (DB) Period|Adverse Event|0|||
27858743|NCT01364922|54407396|FG001|Double-Blind (DB) Period|Adverse Event|0|||
27858744|NCT01364922|54407397|FG002|Double-Blind (DB) Period|Adverse Event|1|||
27858745|NCT01364922|54407395|FG000|Double-Blind (DB) Period|Other, Unspecified|0|||
27858746|NCT01364922|54407396|FG001|Double-Blind (DB) Period|Other, Unspecified|1|||
27858747|NCT01364922|54407397|FG002|Double-Blind (DB) Period|Other, Unspecified|0|||
27858748|NCT02522286|54407571|FG000|Overall Study|Withdrawal by Subject|3|||
27858749|NCT02522286|54407572|FG001|Overall Study|Withdrawal by Subject|0|||
27858750|NCT02522286|54407573|FG002|Overall Study|Withdrawal by Subject|0|||
27858751|NCT02522286|54407574|FG003|Overall Study|Withdrawal by Subject|3|||
27858752|NCT02520726|54407595|FG000|Overall Study|Lost to Follow-up|3|||
27858753|NCT02520726|54407596|FG001|Overall Study|Lost to Follow-up|2|||
27858754|NCT02519712|54407619|FG000|Overall Study|Disease Relapse|1|||
27858755|NCT02519712|54407619|FG000|Overall Study|Disease Progression|1|||
27858756|NCT02519712|54407619|FG000|Overall Study|Accruals are donors|2|||
27858757|NCT02516202|54407862|FG000|Overall Study|Withdrawal by Subject|1|||
27858758|NCT02516202|54407863|FG001|Overall Study|Withdrawal by Subject|0|||
27858759|NCT02516202|54407864|FG002|Overall Study|Withdrawal by Subject|1|||
27858760|NCT02516202|54407862|FG000|Overall Study|Lost to Follow-up|1|||
27858761|NCT02516202|54407863|FG001|Overall Study|Lost to Follow-up|1|||
27858762|NCT02516202|54407864|FG002|Overall Study|Lost to Follow-up|1|||
27858763|NCT02516202|54407862|FG000|Overall Study|Stopped Follow-up|0|||
27858764|NCT02516202|54407863|FG001|Overall Study|Stopped Follow-up|0|||
27858765|NCT02516202|54407864|FG002|Overall Study|Stopped Follow-up|1|||
27858766|NCT02518620|54408070|FG000|Overall Study|Adverse Event|23|||
27858767|NCT02518620|54408071|FG001|Overall Study|Adverse Event|11|||
27981138|NCT00610441|54639044|FG002|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
27858768|NCT02518620|54408070|FG000|Overall Study|Lack of Efficacy|2|||
27858769|NCT02518620|54408071|FG001|Overall Study|Lack of Efficacy|0|||
27858770|NCT02518620|54408070|FG000|Overall Study|Non-Compliance with Study Drug|1|||
27858771|NCT02518620|54408071|FG001|Overall Study|Non-Compliance with Study Drug|0|||
27858772|NCT02518620|54408070|FG000|Overall Study|Physician Decision|1|||
27858773|NCT02518620|54408071|FG001|Overall Study|Physician Decision|1|||
27858774|NCT02518620|54408070|FG000|Overall Study|Sponsor's Decision|0|||
27858775|NCT02518620|54408071|FG001|Overall Study|Sponsor's Decision|3|||
27858776|NCT02518620|54408070|FG000|Overall Study|Lost to Follow-up|1|||
27858777|NCT02518620|54408071|FG001|Overall Study|Lost to Follow-up|1|||
27858778|NCT02518620|54408070|FG000|Overall Study|Withdrawal by Subject|17|||
27858779|NCT02518620|54408071|FG001|Overall Study|Withdrawal by Subject|9|||
27858780|NCT02518620|54408070|FG000|Overall Study|Death|1|||
27858781|NCT02518620|54408071|FG001|Overall Study|Death|0|||
27858782|NCT02518620|54408070|FG000|Overall Study|Pregnancy Wish|3|||
27858783|NCT02518620|54408071|FG001|Overall Study|Pregnancy Wish|0|||
27858784|NCT02518620|54408070|FG000|Overall Study|Pregnancy|1|||
27858785|NCT02518620|54408071|FG001|Overall Study|Pregnancy|0|||
27858786|NCT02518620|54408070|FG000|Overall Study|Relocation|2|||
27858787|NCT02518620|54408071|FG001|Overall Study|Relocation|1|||
27858788|NCT01653912|54408250|FG000|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
27858789|NCT01653912|54408251|FG001|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1|||
27858790|NCT01653912|54408252|FG002|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
27858791|NCT01653912|54408253|FG003|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
27858792|NCT01653912|54408254|FG004|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
27858793|NCT01653912|54408255|FG005|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
27858794|NCT01653912|54408250|FG000|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
27858795|NCT01653912|54408251|FG001|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
27858796|NCT01653912|54408252|FG002|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2|||
27858797|NCT01653912|54408253|FG003|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
27858798|NCT01653912|54408254|FG004|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
27858799|NCT01653912|54408255|FG005|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
27858800|NCT01653912|54408250|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
27858801|NCT01653912|54408251|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
27858802|NCT01653912|54408252|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
27858803|NCT01653912|54408253|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1|||
27858804|NCT01653912|54408254|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
27858805|NCT01653912|54408255|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
27858806|NCT01653912|54408250|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
27858807|NCT01653912|54408251|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
27858808|NCT01653912|54408252|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
27858809|NCT01653912|54408253|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1|||
27858810|NCT01653912|54408254|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
27858811|NCT01653912|54408255|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
27858812|NCT01653912|54408250|FG000|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
27858813|NCT01653912|54408251|FG001|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
27858814|NCT01653912|54408252|FG002|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
27858815|NCT01653912|54408253|FG003|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
27858816|NCT01653912|54408254|FG004|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
27858817|NCT01653912|54408255|FG005|Phase 2: GSK2110183 125 mg|Adverse Event|1|||
27858818|NCT01653912|54408250|FG000|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
27858819|NCT01653912|54408251|FG001|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
27858820|NCT01653912|54408252|FG002|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
27858821|NCT01653912|54408253|FG003|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
27858822|NCT01653912|54408254|FG004|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
27858823|NCT01653912|54408255|FG005|Phase 2: GSK2110183 125 mg|Clinical Progression|6|||
27858824|NCT01653912|54408250|FG000|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
27858825|NCT01653912|54408251|FG001|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
27858826|NCT01653912|54408252|FG002|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
27858827|NCT01653912|54408253|FG003|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
27858828|NCT01653912|54408254|FG004|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
27858829|NCT01653912|54408255|FG005|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1|||
27858830|NCT02483520|54408281|FG000|Overall Study|Lost to Follow-up|3|||
27858831|NCT02483520|54408282|FG001|Overall Study|Lost to Follow-up|4|||
27858832|NCT02483520|54408281|FG000|Overall Study|Withdrawal by Subject|4|||
27858833|NCT02483520|54408282|FG001|Overall Study|Withdrawal by Subject|14|||
27858834|NCT02483520|54408281|FG000|Overall Study|Hospitalized|2|||
27858835|NCT02483520|54408282|FG001|Overall Study|Hospitalized|3|||
27858836|NCT02483520|54408281|FG000|Overall Study|Moved to LTC|2|||
27858837|NCT02483520|54408282|FG001|Overall Study|Moved to LTC|3|||
27858838|NCT02514174|54408288|FG000|Overall Study|Patient refused to continue medication|1|||
27858839|NCT02514174|54408288|FG000|Overall Study|Adverse Event|2|||
27858840|NCT02514174|54408288|FG000|Overall Study|Study closed by sponsor|9|||
27858841|NCT02514174|54408288|FG000|Overall Study|Progressive disease|11|||
27858842|NCT02514174|54408288|FG000|Overall Study|Treatment change|1|||
27858843|NCT02514174|54408288|FG000|Overall Study|Treated off study with Afatinib.|1|||
27858844|NCT02482428|54408348|FG000|Overall Study|Lost to Follow-up|4|||
27858845|NCT02482428|54408349|FG001|Overall Study|Lost to Follow-up|9|||
27858846|NCT02482428|54408350|FG002|Overall Study|Lost to Follow-up|1|||
27981139|NCT00610441|54639045|FG003|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
27858847|NCT02482428|54408351|FG003|Overall Study|Lost to Follow-up|2|||
27858848|NCT02482428|54408352|FG004|Overall Study|Lost to Follow-up|4|||
27858849|NCT02482428|54408348|FG000|Overall Study|Physician Decision|0|||
27858850|NCT02482428|54408349|FG001|Overall Study|Physician Decision|0|||
27858851|NCT02482428|54408350|FG002|Overall Study|Physician Decision|0|||
27858852|NCT02482428|54408351|FG003|Overall Study|Physician Decision|0|||
27858853|NCT02482428|54408352|FG004|Overall Study|Physician Decision|1|||
27858854|NCT02482428|54408348|FG000|Overall Study|protocol deviation|1|||
27858855|NCT02482428|54408349|FG001|Overall Study|protocol deviation|1|||
27858856|NCT02482428|54408350|FG002|Overall Study|protocol deviation|0|||
27858857|NCT02482428|54408351|FG003|Overall Study|protocol deviation|0|||
27858858|NCT02482428|54408352|FG004|Overall Study|protocol deviation|0|||
27858859|NCT02482428|54408348|FG000|Overall Study|subject/guardian decision|4|||
27858860|NCT02482428|54408349|FG001|Overall Study|subject/guardian decision|2|||
27858861|NCT02482428|54408350|FG002|Overall Study|subject/guardian decision|0|||
27858862|NCT02482428|54408351|FG003|Overall Study|subject/guardian decision|0|||
27858863|NCT02482428|54408352|FG004|Overall Study|subject/guardian decision|2|||
27858864|NCT02480712|54408411|FG000|Overall Study|Enrolled but Never Treated|1|||
27858865|NCT02480712|54408411|FG000|Overall Study|Lost to Follow-up|5|||
27858866|NCT02480712|54408411|FG000|Overall Study|Withdrew Consent|3|||
27858867|NCT02480712|54408411|FG000|Overall Study|Death|1|||
27858868|NCT02480712|54408411|FG000|Overall Study|Lack of Efficacy|1|||
27858869|NCT02513550|54409729|FG000|Double Blind Treatment Period|Withdrawal by Subject|11|||
27858870|NCT02513550|54409730|FG001|Double Blind Treatment Period|Withdrawal by Subject|11|||
27858871|NCT02513550|54409731|FG002|Double Blind Treatment Period|Withdrawal by Subject|25|||
27858872|NCT02513550|54409732|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
27858873|NCT02513550|54409733|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
27858874|NCT02513550|54409734|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
27858875|NCT02513550|54409729|FG000|Double Blind Treatment Period|Adverse Event|5|||
27858876|NCT02513550|54409730|FG001|Double Blind Treatment Period|Adverse Event|13|||
27858877|NCT02513550|54409731|FG002|Double Blind Treatment Period|Adverse Event|17|||
27858878|NCT02513550|54409732|FG003|Double Blind Treatment Period|Adverse Event|0|||
27858879|NCT02513550|54409733|FG004|Double Blind Treatment Period|Adverse Event|1|||
27858880|NCT02513550|54409734|FG005|Double Blind Treatment Period|Adverse Event|0|||
27858881|NCT02513550|54409729|FG000|Double Blind Treatment Period|Lost to Follow-up|9|||
27858882|NCT02513550|54409730|FG001|Double Blind Treatment Period|Lost to Follow-up|7|||
27858883|NCT02513550|54409731|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
27858884|NCT02513550|54409732|FG003|Double Blind Treatment Period|Lost to Follow-up|0|||
27858885|NCT02513550|54409733|FG004|Double Blind Treatment Period|Lost to Follow-up|0|||
27858886|NCT02513550|54409734|FG005|Double Blind Treatment Period|Lost to Follow-up|1|||
27858887|NCT02513550|54409729|FG000|Double Blind Treatment Period|Lack of Efficacy|4|||
27858888|NCT02513550|54409730|FG001|Double Blind Treatment Period|Lack of Efficacy|5|||
27858889|NCT02513550|54409731|FG002|Double Blind Treatment Period|Lack of Efficacy|6|||
27858890|NCT02513550|54409732|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
27858891|NCT02513550|54409733|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
28095894|NCT04308668|54750464|FG000|Overall Study|Lost to Follow-up|32|||
27834215|NCT01590563|54317802|FG000|Overall Study|simple uterine hyperplasia - not related|1|||
27834216|NCT01701401|54317811|FG000|Overall Study|Randomized But Not Treated|3|||
27834217|NCT01701401|54317812|FG001|Overall Study|Randomized But Not Treated|1|||
27834218|NCT01701401|54317813|FG002|Overall Study|Randomized But Not Treated|0|||
27834219|NCT01701401|54317814|FG003|Overall Study|Randomized But Not Treated|1|||
27834220|NCT01701401|54317811|FG000|Overall Study|Lost to Follow-up|5|||
27834221|NCT01701401|54317812|FG001|Overall Study|Lost to Follow-up|5|||
27834222|NCT01701401|54317813|FG002|Overall Study|Lost to Follow-up|1|||
27834223|NCT01701401|54317814|FG003|Overall Study|Lost to Follow-up|3|||
27834224|NCT01701401|54317811|FG000|Overall Study|Withdrew Consent|0|||
27834225|NCT01701401|54317812|FG001|Overall Study|Withdrew Consent|3|||
27834226|NCT01701401|54317813|FG002|Overall Study|Withdrew Consent|1|||
27834227|NCT01701401|54317814|FG003|Overall Study|Withdrew Consent|2|||
27834228|NCT01701401|54317811|FG000|Overall Study|Lack of Efficacy|1|||
27834229|NCT01701401|54317812|FG001|Overall Study|Lack of Efficacy|0|||
27834230|NCT01701401|54317813|FG002|Overall Study|Lack of Efficacy|2|||
27834231|NCT01701401|54317814|FG003|Overall Study|Lack of Efficacy|0|||
27834232|NCT01701401|54317811|FG000|Overall Study|Adverse Event|1|||
27834233|NCT01701401|54317812|FG001|Overall Study|Adverse Event|0|||
27834234|NCT01701401|54317813|FG002|Overall Study|Adverse Event|0|||
27834235|NCT01701401|54317814|FG003|Overall Study|Adverse Event|0|||
27834236|NCT01701401|54317811|FG000|Overall Study|Protocol Violation|0|||
27834237|NCT01701401|54317812|FG001|Overall Study|Protocol Violation|0|||
27834238|NCT01701401|54317813|FG002|Overall Study|Protocol Violation|1|||
27834239|NCT01701401|54317814|FG003|Overall Study|Protocol Violation|0|||
27834240|NCT01701245|54317826|FG000|Overall Study|Protocol Violation|1|||
27834241|NCT01701245|54317827|FG001|Overall Study|Protocol Violation|3|||
28095895|NCT04308668|54750465|FG001|Overall Study|Lost to Follow-up|38|||
27834242|NCT01701245|54317826|FG000|Overall Study|Did not complete the open label period|11|||
27834243|NCT01701245|54317827|FG001|Overall Study|Did not complete the open label period|12|||
27858892|NCT02513550|54409734|FG005|Double Blind Treatment Period|Lack of Efficacy|0|||
27858893|NCT02513550|54409729|FG000|Double Blind Treatment Period|Protocol Violation|1|||
27858894|NCT02513550|54409730|FG001|Double Blind Treatment Period|Protocol Violation|1|||
27858895|NCT02513550|54409731|FG002|Double Blind Treatment Period|Protocol Violation|4|||
27858896|NCT02513550|54409732|FG003|Double Blind Treatment Period|Protocol Violation|0|||
27858897|NCT02513550|54409733|FG004|Double Blind Treatment Period|Protocol Violation|0|||
27858898|NCT02513550|54409734|FG005|Double Blind Treatment Period|Protocol Violation|0|||
27858899|NCT02513550|54409729|FG000|Double Blind Treatment Period|Physician Decision|2|||
27858900|NCT02513550|54409730|FG001|Double Blind Treatment Period|Physician Decision|0|||
27858901|NCT02513550|54409731|FG002|Double Blind Treatment Period|Physician Decision|4|||
27858902|NCT02513550|54409732|FG003|Double Blind Treatment Period|Physician Decision|0|||
27858903|NCT02513550|54409733|FG004|Double Blind Treatment Period|Physician Decision|0|||
27858904|NCT02513550|54409734|FG005|Double Blind Treatment Period|Physician Decision|0|||
27858905|NCT02513550|54409729|FG000|Double Blind Treatment Period|Site terminated by sponsor|1|||
27858906|NCT02513550|54409730|FG001|Double Blind Treatment Period|Site terminated by sponsor|1|||
27858907|NCT02513550|54409731|FG002|Double Blind Treatment Period|Site terminated by sponsor|3|||
27858908|NCT02513550|54409732|FG003|Double Blind Treatment Period|Site terminated by sponsor|0|||
27858909|NCT02513550|54409733|FG004|Double Blind Treatment Period|Site terminated by sponsor|0|||
27858910|NCT02513550|54409734|FG005|Double Blind Treatment Period|Site terminated by sponsor|0|||
27858911|NCT02513550|54409729|FG000|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
27858912|NCT02513550|54409730|FG001|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
27858913|NCT02513550|54409731|FG002|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1|||
27858914|NCT02513550|54409732|FG003|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
27858915|NCT02513550|54409733|FG004|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
27858916|NCT02513550|54409734|FG005|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
27858917|NCT02513550|54409729|FG000|Double Blind Treatment Period|Due to personal business|2|||
27858918|NCT02513550|54409730|FG001|Double Blind Treatment Period|Due to personal business|0|||
27858919|NCT02513550|54409731|FG002|Double Blind Treatment Period|Due to personal business|1|||
27858920|NCT02513550|54409732|FG003|Double Blind Treatment Period|Due to personal business|0|||
27858921|NCT02513550|54409733|FG004|Double Blind Treatment Period|Due to personal business|0|||
27858922|NCT02513550|54409734|FG005|Double Blind Treatment Period|Due to personal business|0|||
27858923|NCT02513550|54409729|FG000|Double Blind Treatment Period|Death|1|||
27858924|NCT02513550|54409730|FG001|Double Blind Treatment Period|Death|0|||
27858925|NCT02513550|54409731|FG002|Double Blind Treatment Period|Death|2|||
27858926|NCT02513550|54409732|FG003|Double Blind Treatment Period|Death|0|||
27858927|NCT02513550|54409733|FG004|Double Blind Treatment Period|Death|0|||
27858928|NCT02513550|54409734|FG005|Double Blind Treatment Period|Death|0|||
27858929|NCT02513550|54409729|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|12|||
27858930|NCT02513550|54409730|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|20|||
27858931|NCT02513550|54409731|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|26|||
27858932|NCT02513550|54409732|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
27858933|NCT02513550|54409733|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
27858934|NCT02513550|54409734|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
27858935|NCT02513550|54409729|FG000|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12|||
27858936|NCT02513550|54409730|FG001|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16|||
27858937|NCT02513550|54409731|FG002|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20|||
27858938|NCT02513550|54409732|FG003|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
27858939|NCT02513550|54409733|FG004|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
27858940|NCT02513550|54409734|FG005|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
27858941|NCT02513550|54409729|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|4|||
27858942|NCT02513550|54409730|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|2|||
27858943|NCT02513550|54409731|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|7|||
27858944|NCT02513550|54409732|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
27858945|NCT02513550|54409733|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
27858946|NCT02513550|54409734|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
27858947|NCT02513550|54409729|FG000|Post-Treatment Follow-up Period|Adverse Event|1|||
27858948|NCT02513550|54409730|FG001|Post-Treatment Follow-up Period|Adverse Event|1|||
27858949|NCT02513550|54409731|FG002|Post-Treatment Follow-up Period|Adverse Event|4|||
27858950|NCT02513550|54409732|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
27834244|NCT01590017|54317833|FG000|Overall Study|Adverse Event|1|||
27834245|NCT01590017|54317833|FG000|Overall Study|Withdrawal by Subject|1|||
27834246|NCT01590017|54317833|FG000|Overall Study|Lack of Efficacy|1|||
27834247|NCT01590017|54317833|FG000|Overall Study|Physician Decision|1|||
27834248|NCT01700621|54317839|FG000|Analyzed for Immunogenicity|Lost to Follow-up|7|||
27834249|NCT01700621|54317840|FG001|Analyzed for Immunogenicity|Lost to Follow-up|4|||
27834250|NCT01700621|54317839|FG000|Analyzed for Immunogenicity|Protocol Violation|5|||
27834251|NCT01700621|54317840|FG001|Analyzed for Immunogenicity|Protocol Violation|1|||
27858951|NCT02513550|54409733|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
27858952|NCT02513550|54409734|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
27858953|NCT02513550|54409729|FG000|Post-Treatment Follow-up Period|Physician Decision|2|||
27858954|NCT02513550|54409730|FG001|Post-Treatment Follow-up Period|Physician Decision|0|||
27858955|NCT02513550|54409731|FG002|Post-Treatment Follow-up Period|Physician Decision|0|||
27858956|NCT02513550|54409732|FG003|Post-Treatment Follow-up Period|Physician Decision|0|||
27858957|NCT02513550|54409733|FG004|Post-Treatment Follow-up Period|Physician Decision|0|||
27858958|NCT02513550|54409734|FG005|Post-Treatment Follow-up Period|Physician Decision|0|||
27858959|NCT02513550|54409729|FG000|Post-Treatment Follow-up Period|Death|0|||
27858960|NCT02513550|54409730|FG001|Post-Treatment Follow-up Period|Death|0|||
27858961|NCT02513550|54409731|FG002|Post-Treatment Follow-up Period|Death|1|||
27858962|NCT02513550|54409732|FG003|Post-Treatment Follow-up Period|Death|0|||
27858963|NCT02513550|54409733|FG004|Post-Treatment Follow-up Period|Death|0|||
27858964|NCT02513550|54409734|FG005|Post-Treatment Follow-up Period|Death|0|||
27858965|NCT02513550|54409729|FG000|Post-Treatment Follow-up Period|Subject move out of town|0|||
27858966|NCT02513550|54409730|FG001|Post-Treatment Follow-up Period|Subject move out of town|0|||
27858967|NCT02513550|54409731|FG002|Post-Treatment Follow-up Period|Subject move out of town|1|||
27858968|NCT02513550|54409732|FG003|Post-Treatment Follow-up Period|Subject move out of town|0|||
27858969|NCT02513550|54409733|FG004|Post-Treatment Follow-up Period|Subject move out of town|0|||
27858970|NCT02513550|54409734|FG005|Post-Treatment Follow-up Period|Subject move out of town|0|||
27858971|NCT02513550|54409729|FG000|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
27858972|NCT02513550|54409730|FG001|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
27858973|NCT02513550|54409731|FG002|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3|||
27858974|NCT02513550|54409732|FG003|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
27858975|NCT02513550|54409733|FG004|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
27858976|NCT02513550|54409734|FG005|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
27858977|NCT02513550|54409729|FG000|Post-Treatment Follow-up Period|Labor Reasons|0|||
27858978|NCT02513550|54409730|FG001|Post-Treatment Follow-up Period|Labor Reasons|0|||
27858979|NCT02513550|54409731|FG002|Post-Treatment Follow-up Period|Labor Reasons|1|||
27858980|NCT02513550|54409732|FG003|Post-Treatment Follow-up Period|Labor Reasons|0|||
27858981|NCT02513550|54409733|FG004|Post-Treatment Follow-up Period|Labor Reasons|0|||
27858982|NCT02513550|54409734|FG005|Post-Treatment Follow-up Period|Labor Reasons|0|||
27858983|NCT02513472|54410051|FG000|Overall Study|Radiological Disease Progression|45|||
27858984|NCT02513472|54410052|FG001|Overall Study|Radiological Disease Progression|57|||
27858985|NCT02513472|54410051|FG000|Overall Study|Clinical Disease Progression|5|||
27858986|NCT02513472|54410052|FG001|Overall Study|Clinical Disease Progression|13|||
27858987|NCT02513472|54410051|FG000|Overall Study|Adverse Event|8|||
27858988|NCT02513472|54410052|FG001|Overall Study|Adverse Event|11|||
27858989|NCT02513472|54410051|FG000|Overall Study|Withdrawal by Subject|0|||
27858990|NCT02513472|54410052|FG001|Overall Study|Withdrawal by Subject|4|||
27858991|NCT02513472|54410051|FG000|Overall Study|Subject Choice|2|||
27858992|NCT02513472|54410052|FG001|Overall Study|Subject Choice|7|||
27858993|NCT02513472|54410051|FG000|Overall Study|Treatment Completed as per Protocol|3|||
27858994|NCT02513472|54410052|FG001|Overall Study|Treatment Completed as per Protocol|3|||
27858995|NCT02513472|54410051|FG000|Overall Study|Other|3|||
27858996|NCT02513472|54410052|FG001|Overall Study|Other|6|||
27858997|NCT04490395|54410281|FG000|Overall Study|Lost to Follow-up|0|||
27858998|NCT04490395|54410282|FG001|Overall Study|Lost to Follow-up|1|||
27858999|NCT03843541|54410725|FG000|Overall Study|Adverse Event|4|||
27859000|NCT03843541|54410726|FG001|Overall Study|Adverse Event|2|||
27859001|NCT03843541|54410727|FG002|Overall Study|Adverse Event|3|||
27859002|NCT03843541|54410725|FG000|Overall Study|Death|1|||
27859003|NCT03843541|54410726|FG001|Overall Study|Death|0|||
27859004|NCT03843541|54410727|FG002|Overall Study|Death|0|||
27859005|NCT03843541|54410725|FG000|Overall Study|Lack of adherence to study medication|0|||
27859006|NCT03843541|54410726|FG001|Overall Study|Lack of adherence to study medication|0|||
27859007|NCT03843541|54410727|FG002|Overall Study|Lack of adherence to study medication|1|||
27859008|NCT03843541|54410725|FG000|Overall Study|Physician Decision|1|||
27859009|NCT03843541|54410726|FG001|Overall Study|Physician Decision|2|||
27859010|NCT03843541|54410727|FG002|Overall Study|Physician Decision|2|||
27859011|NCT03843541|54410725|FG000|Overall Study|Study subject withdrawal by parent or guardian|1|||
27859012|NCT03843541|54410726|FG001|Overall Study|Study subject withdrawal by parent or guardian|0|||
27859013|NCT03843541|54410727|FG002|Overall Study|Study subject withdrawal by parent or guardian|0|||
27859014|NCT03843541|54410725|FG000|Overall Study|Withdrawal by Subject|6|||
27859015|NCT03843541|54410726|FG001|Overall Study|Withdrawal by Subject|9|||
27859016|NCT03843541|54410727|FG002|Overall Study|Withdrawal by Subject|7|||
27859017|NCT03843541|54410725|FG000|Overall Study|Administration of rescue mucolytic|0|||
27859018|NCT03843541|54410726|FG001|Overall Study|Administration of rescue mucolytic|0|||
27859019|NCT03843541|54410727|FG002|Overall Study|Administration of rescue mucolytic|1|||
27859020|NCT03843541|54410725|FG000|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|2|||
27859021|NCT03843541|54410726|FG001|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|3|||
27859022|NCT03843541|54410727|FG002|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|0|||
27859023|NCT02992418|54411990|FG000|Overall Study|Withdrawal by Subject|11|||
27859024|NCT02992418|54411991|FG001|Overall Study|Withdrawal by Subject|12|||
27859025|NCT02992418|54411990|FG000|Overall Study|Non-compliance with the protocol|308|||
27859026|NCT02992418|54411991|FG001|Overall Study|Non-compliance with the protocol|308|||
27859027|NCT02992418|54411990|FG000|Overall Study|Lost to Follow-up|27|||
27859028|NCT02992418|54411991|FG001|Overall Study|Lost to Follow-up|22|||
27859029|NCT01276106|54412233|FG000|Overall Study|Adverse Event|3|||
27859030|NCT01276106|54412234|FG001|Overall Study|Adverse Event|3|||
27859031|NCT01276106|54412235|FG002|Overall Study|Adverse Event|11|||
27859032|NCT01276106|54412236|FG003|Overall Study|Adverse Event|3|||
27859033|NCT01276106|54412233|FG000|Overall Study|Withdrawal by Subject|6|||
27859034|NCT01276106|54412234|FG001|Overall Study|Withdrawal by Subject|3|||
27859035|NCT01276106|54412235|FG002|Overall Study|Withdrawal by Subject|1|||
27859036|NCT01276106|54412236|FG003|Overall Study|Withdrawal by Subject|6|||
27859037|NCT01276106|54412233|FG000|Overall Study|Lack of Efficacy|0|||
27859038|NCT01276106|54412234|FG001|Overall Study|Lack of Efficacy|1|||
27859039|NCT01276106|54412235|FG002|Overall Study|Lack of Efficacy|0|||
27859040|NCT01276106|54412236|FG003|Overall Study|Lack of Efficacy|1|||
27859041|NCT01276106|54412233|FG000|Overall Study|Lost to Follow-up|2|||
27859042|NCT01276106|54412234|FG001|Overall Study|Lost to Follow-up|1|||
27859043|NCT01276106|54412235|FG002|Overall Study|Lost to Follow-up|1|||
27859044|NCT01276106|54412236|FG003|Overall Study|Lost to Follow-up|0|||
27859045|NCT01276106|54412233|FG000|Overall Study|Physician Decision|0|||
27859046|NCT01276106|54412234|FG001|Overall Study|Physician Decision|0|||
27859047|NCT01276106|54412235|FG002|Overall Study|Physician Decision|1|||
27859048|NCT01276106|54412236|FG003|Overall Study|Physician Decision|1|||
27859049|NCT01276106|54412233|FG000|Overall Study|Protocol Violation|1|||
27859050|NCT01276106|54412234|FG001|Overall Study|Protocol Violation|1|||
27859051|NCT01276106|54412235|FG002|Overall Study|Protocol Violation|0|||
27859052|NCT01276106|54412236|FG003|Overall Study|Protocol Violation|2|||
27859053|NCT01276106|54412233|FG000|Overall Study|Insufficient therapeutic effects|0|||
27859054|NCT01276106|54412234|FG001|Overall Study|Insufficient therapeutic effects|0|||
27859055|NCT01276106|54412235|FG002|Overall Study|Insufficient therapeutic effects|2|||
27859056|NCT01276106|54412236|FG003|Overall Study|Insufficient therapeutic effects|0|||
27859057|NCT01275170|54412254|FG000|Part 1: Period 1|Equipment malfunction before study drug|1|||
27859058|NCT01275170|54412255|FG001|Part 1: Period 1|Equipment malfunction before study drug|0|||
27859059|NCT01275170|54412256|FG002|Part 1: Period 1|Equipment malfunction before study drug|0|||
27859060|NCT01275170|54412257|FG003|Part 1: Period 1|Equipment malfunction before study drug|0|||
27859061|NCT01275170|54412258|FG004|Part 1: Period 1|Equipment malfunction before study drug|0|||
27981140|NCT00799617|54639059|FG000|Main Testosterone Trial|Randomized in error|1|||
27981141|NCT00799617|54639060|FG001|Main Testosterone Trial|Randomized in error|1|||
27981142|NCT00799617|54639059|FG000|Main Testosterone Trial|Lost to Follow-up|18|||
27981143|NCT00799617|54639060|FG001|Main Testosterone Trial|Lost to Follow-up|20|||
27981144|NCT00799617|54639059|FG000|Sexual Funtion Trial|Lost to Follow-up|12|||
27981145|NCT00799617|54639060|FG001|Sexual Funtion Trial|Lost to Follow-up|14|||
27981146|NCT00799617|54639059|FG000|Sexual Funtion Trial|No Baseline Data|4|||
27981147|NCT00799617|54639060|FG001|Sexual Funtion Trial|No Baseline Data|7|||
27981148|NCT00799617|54639059|FG000|Physical Function Trial|Lost to Follow-up|6|||
27981149|NCT00799617|54639060|FG001|Physical Function Trial|Lost to Follow-up|11|||
27981150|NCT00799617|54639059|FG000|Vitality Trial|Lost to Follow-up|7|||
27981151|NCT00799617|54639060|FG001|Vitality Trial|Lost to Follow-up|22|||
27981152|NCT00799617|54639059|FG000|Cardiovascular Trial|Month 12 scan not available|15|||
27981153|NCT00799617|54639060|FG001|Cardiovascular Trial|Month 12 scan not available|15|||
27981154|NCT00799617|54639059|FG000|Cardiovascular Trial|Baseline scan not analyzable|0|||
27981155|NCT00799617|54639060|FG001|Cardiovascular Trial|Baseline scan not analyzable|2|||
27981156|NCT00799617|54639059|FG000|Bone Trial|Month 12 scan not available|6|||
27981157|NCT00799617|54639060|FG001|Bone Trial|Month 12 scan not available|16|||
27981158|NCT00799617|54639059|FG000|Cognitive Function Trial|Lost to Follow-up|0|||
27981159|NCT00799617|54639060|FG001|Cognitive Function Trial|Lost to Follow-up|1|||
27981160|NCT00799617|54639059|FG000|Anemia Trial|Withdrawal by Subject|3|||
27981161|NCT00799617|54639060|FG001|Anemia Trial|Withdrawal by Subject|3|||
27981162|NCT00607087|54639069|FG000|Overall Study|Withdrawal by Subject|9|||
28095896|NCT04308668|54750464|FG000|Overall Study|Withdrawal by Subject|4|||
27738854|NCT02936323|54188174|FG006|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
27738855|NCT02936323|54188175|FG007|Phase 2a Dose Expansion|Informed Consent Withdrawn|11|||
27859062|NCT01275170|54412259|FG005|Part 1: Period 1|Equipment malfunction before study drug|0|||
27859063|NCT01275170|54412260|FG006|Part 1: Period 1|Equipment malfunction before study drug|0|||
27859064|NCT01275170|54412261|FG007|Part 1: Period 1|Equipment malfunction before study drug|0|||
27859065|NCT01273064|54412308|FG000|Overall Study|Adverse Event|5|||
27981163|NCT00607087|54639070|FG001|Overall Study|Withdrawal by Subject|4|||
27981164|NCT00607087|54639071|FG002|Overall Study|Withdrawal by Subject|4|||
27859066|NCT01273064|54412309|FG001|Overall Study|Adverse Event|1|||
27859067|NCT01273064|54412310|FG002|Overall Study|Adverse Event|3|||
27859068|NCT01273064|54412311|FG003|Overall Study|Adverse Event|2|||
27859069|NCT01273064|54412312|FG004|Overall Study|Adverse Event|1|||
27859070|NCT01273064|54412308|FG000|Overall Study|Withdrawal by Subject|4|||
27859071|NCT01273064|54412309|FG001|Overall Study|Withdrawal by Subject|2|||
27859072|NCT01273064|54412310|FG002|Overall Study|Withdrawal by Subject|2|||
27859073|NCT01273064|54412311|FG003|Overall Study|Withdrawal by Subject|2|||
27859074|NCT01273064|54412312|FG004|Overall Study|Withdrawal by Subject|0|||
27859075|NCT01273064|54412308|FG000|Overall Study|Study Termination|13|||
27859076|NCT01273064|54412309|FG001|Overall Study|Study Termination|27|||
27859077|NCT01273064|54412310|FG002|Overall Study|Study Termination|26|||
27859078|NCT01273064|54412311|FG003|Overall Study|Study Termination|16|||
27859079|NCT01273064|54412312|FG004|Overall Study|Study Termination|8|||
27859080|NCT01273064|54412308|FG000|Overall Study|Lost to Follow-up|1|||
27859081|NCT01273064|54412309|FG001|Overall Study|Lost to Follow-up|0|||
27859082|NCT01273064|54412310|FG002|Overall Study|Lost to Follow-up|0|||
27859083|NCT01273064|54412311|FG003|Overall Study|Lost to Follow-up|0|||
27859084|NCT01273064|54412312|FG004|Overall Study|Lost to Follow-up|0|||
27859085|NCT01273064|54412308|FG000|Overall Study|Physician Decision|0|||
27859086|NCT01273064|54412309|FG001|Overall Study|Physician Decision|0|||
27859087|NCT01273064|54412310|FG002|Overall Study|Physician Decision|0|||
27859088|NCT01273064|54412311|FG003|Overall Study|Physician Decision|0|||
27859089|NCT01273064|54412312|FG004|Overall Study|Physician Decision|1|||
27859090|NCT01272908|54412324|FG000|Initial Treatment Period|Adverse Event|1|||
27859091|NCT01272908|54412324|FG000|Initial Treatment Period|Lack of Efficacy|5|||
27859092|NCT01272908|54412324|FG000|Initial Treatment Period|Protocol Violation|1|||
27859093|NCT01272908|54412324|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
27859094|NCT01272908|54412324|FG000|Re-Treatment Period|Adverse Event|2|||
27859095|NCT01272908|54412324|FG000|Re-Treatment Period|Lack of Efficacy|3|||
27859096|NCT01272908|54412324|FG000|Re-Treatment Period|Withdrawal by Subject|1|||
27859097|NCT01271504|54412334|FG000|Overall Study|Death|7|||
27859098|NCT01271504|54412335|FG001|Overall Study|Death|6|||
27859099|NCT01271504|54412336|FG002|Overall Study|Death|32|||
27859100|NCT01271504|54412337|FG003|Overall Study|Death|32|||
27859101|NCT01271504|54412334|FG000|Overall Study|Lost to Follow-up|0|||
27859102|NCT01271504|54412335|FG001|Overall Study|Lost to Follow-up|1|||
27859103|NCT01271504|54412336|FG002|Overall Study|Lost to Follow-up|3|||
27859104|NCT01271504|54412337|FG003|Overall Study|Lost to Follow-up|1|||
27859105|NCT01271504|54412334|FG000|Overall Study|Protocol Violation|0|||
27859106|NCT01271504|54412335|FG001|Overall Study|Protocol Violation|0|||
27859107|NCT01271504|54412336|FG002|Overall Study|Protocol Violation|0|||
27859108|NCT01271504|54412337|FG003|Overall Study|Protocol Violation|2|||
27859109|NCT01271504|54412334|FG000|Overall Study|Administrative Reasons|0|||
27859110|NCT01271504|54412335|FG001|Overall Study|Administrative Reasons|0|||
27859111|NCT01271504|54412336|FG002|Overall Study|Administrative Reasons|6|||
27859112|NCT01271504|54412337|FG003|Overall Study|Administrative Reasons|5|||
27859113|NCT01271504|54412334|FG000|Overall Study|Withdrawal by Subject|0|||
27859114|NCT01271504|54412335|FG001|Overall Study|Withdrawal by Subject|0|||
27859115|NCT01271504|54412336|FG002|Overall Study|Withdrawal by Subject|1|||
27859116|NCT01271504|54412337|FG003|Overall Study|Withdrawal by Subject|3|||
27859117|NCT01271504|54412334|FG000|Overall Study|Other|0|||
27859118|NCT01271504|54412335|FG001|Overall Study|Other|1|||
27859119|NCT01271504|54412336|FG002|Overall Study|Other|2|||
27859120|NCT01271504|54412337|FG003|Overall Study|Other|0|||
27859121|NCT01270958|54412380|FG000|Overall Study|Lost to Follow-up|2|||
27859122|NCT01270958|54412380|FG000|Overall Study|Did not meet inclusion criteria for age|2|||
27859123|NCT01270880|54412384|FG000|Overall Study|Never rec'd treatment, but registered.|1|||
27859124|NCT01270802|54412390|FG000|Overall Study|Withdrawal by Subject|1|||
27859125|NCT01270802|54412391|FG001|Overall Study|Withdrawal by Subject|0|||
27859126|NCT01270802|54412390|FG000|Overall Study|Adverse Event|1|||
27859127|NCT01270802|54412391|FG001|Overall Study|Adverse Event|0|||
27859128|NCT01270802|54412390|FG000|Overall Study|Lost to Follow-up|0|||
27859129|NCT01270802|54412391|FG001|Overall Study|Lost to Follow-up|1|||
27859130|NCT01270256|54412400|FG000|Overall Study|Withdrawal by Subject|1|||
27859131|NCT01270256|54412401|FG001|Overall Study|Withdrawal by Subject|0|||
27859132|NCT01279616|54412471|FG000|Overall Study|donor could not be located|5|||
27859133|NCT01279616|54412471|FG000|Overall Study|no signs of sickle cell disease|2|||
27981165|NCT00607087|54639069|FG000|Overall Study|Adverse Event|3|||
27859134|NCT01279070|54412482|FG000|Overall Study|Withdrawal by Subject|2|||
27859135|NCT01279070|54412483|FG001|Overall Study|Withdrawal by Subject|3|||
27981166|NCT00607087|54639070|FG001|Overall Study|Adverse Event|2|||
27859136|NCT01279070|54412482|FG000|Overall Study|Acute exacerbation|3|||
27859137|NCT01279070|54412483|FG001|Overall Study|Acute exacerbation|1|||
27859138|NCT01277744|54412493|FG000|Overall Study|Physician Decision|2|||
27859139|NCT01277822|54412499|FG000|Overall Study|Adverse Event|2|||
27859140|NCT01277822|54412500|FG001|Overall Study|Adverse Event|1|||
27981167|NCT00607087|54639071|FG002|Overall Study|Adverse Event|3|||
27859141|NCT01277822|54412499|FG000|Overall Study|Withdrawal by Subject|6|||
27859142|NCT01277822|54412500|FG001|Overall Study|Withdrawal by Subject|7|||
27859143|NCT01277822|54412499|FG000|Overall Study|Physician Decision|1|||
27859144|NCT01277822|54412500|FG001|Overall Study|Physician Decision|1|||
27859145|NCT01277822|54412499|FG000|Overall Study|Protocol Violation|1|||
27859146|NCT01277822|54412500|FG001|Overall Study|Protocol Violation|0|||
27859147|NCT01277822|54412499|FG000|Overall Study|Lost to Follow-up|2|||
27859148|NCT01277822|54412500|FG001|Overall Study|Lost to Follow-up|1|||
27859149|NCT01277822|54412499|FG000|Overall Study|Contraindicated medication used|2|||
27859150|NCT01277822|54412500|FG001|Overall Study|Contraindicated medication used|1|||
27859151|NCT01277822|54412499|FG000|Overall Study|Participant moved|1|||
27859152|NCT01277822|54412500|FG001|Overall Study|Participant moved|0|||
27859153|NCT01277666|54412509|FG000|Overall Study|Adverse Event|26|||
27859154|NCT01277666|54412510|FG001|Overall Study|Adverse Event|25|||
27859155|NCT01277666|54412511|FG002|Overall Study|Adverse Event|20|||
27859156|NCT01277666|54412509|FG000|Overall Study|Lack of Efficacy|8|||
27859157|NCT01277666|54412510|FG001|Overall Study|Lack of Efficacy|20|||
27859158|NCT01277666|54412511|FG002|Overall Study|Lack of Efficacy|12|||
27859159|NCT01277666|54412509|FG000|Overall Study|Protocol Violation|2|||
27859160|NCT01277666|54412510|FG001|Overall Study|Protocol Violation|3|||
27859161|NCT01277666|54412511|FG002|Overall Study|Protocol Violation|2|||
27859162|NCT01277666|54412509|FG000|Overall Study|Protocol Defined Stopping criteria|1|||
27859163|NCT01277666|54412510|FG001|Overall Study|Protocol Defined Stopping criteria|2|||
27859164|NCT01277666|54412511|FG002|Overall Study|Protocol Defined Stopping criteria|6|||
27859165|NCT01277666|54412509|FG000|Overall Study|Lost to Follow-up|1|||
27859166|NCT01277666|54412510|FG001|Overall Study|Lost to Follow-up|1|||
27859167|NCT01277666|54412511|FG002|Overall Study|Lost to Follow-up|2|||
27859168|NCT01277666|54412509|FG000|Overall Study|Withdrawal by Subject|7|||
27859169|NCT01277666|54412510|FG001|Overall Study|Withdrawal by Subject|8|||
27859170|NCT01277666|54412511|FG002|Overall Study|Withdrawal by Subject|6|||
27859171|NCT01277666|54412509|FG000|Overall Study|Death|0|||
27859172|NCT01277666|54412510|FG001|Overall Study|Death|0|||
27859173|NCT01277666|54412511|FG002|Overall Study|Death|1|||
27981168|NCT00607087|54639069|FG000|Overall Study|Other reason|1|||
27981169|NCT00607087|54639070|FG001|Overall Study|Other reason|5|||
27981170|NCT00607087|54639071|FG002|Overall Study|Other reason|2|||
27981171|NCT00607087|54639069|FG000|Overall Study|Poor compliance to protocol|1|||
27981172|NCT00607087|54639070|FG001|Overall Study|Poor compliance to protocol|0|||
27981173|NCT00607087|54639071|FG002|Overall Study|Poor compliance to protocol|1|||
27981174|NCT00607087|54639069|FG000|Overall Study|Lost to Follow-up|1|||
27981175|NCT00607087|54639070|FG001|Overall Study|Lost to Follow-up|0|||
27981176|NCT00607087|54639071|FG002|Overall Study|Lost to Follow-up|0|||
27981177|NCT00607087|54639069|FG000|Period 1|Withdrawal by Subject|7|||
27981178|NCT00607087|54639070|FG001|Period 1|Withdrawal by Subject|2|||
27981179|NCT00607087|54639071|FG002|Period 1|Withdrawal by Subject|3|||
27981180|NCT00607087|54639069|FG000|Period 1|Adverse Event|3|||
27981181|NCT00607087|54639070|FG001|Period 1|Adverse Event|0|||
27981182|NCT00607087|54639071|FG002|Period 1|Adverse Event|0|||
27981183|NCT00607087|54639069|FG000|Period 1|Poor compliance to protocol|1|||
27981184|NCT00607087|54639070|FG001|Period 1|Poor compliance to protocol|0|||
27981185|NCT00607087|54639071|FG002|Period 1|Poor compliance to protocol|0|||
27981186|NCT00607087|54639069|FG000|Period 1|Lost to Follow-up|1|||
27981187|NCT00607087|54639070|FG001|Period 1|Lost to Follow-up|0|||
27981188|NCT00607087|54639071|FG002|Period 1|Lost to Follow-up|0|||
27981189|NCT00607087|54639069|FG000|Period 1|Other reason|0|||
27981190|NCT00607087|54639070|FG001|Period 1|Other reason|4|||
27981191|NCT00607087|54639071|FG002|Period 1|Other reason|2|||
27981192|NCT00607087|54639069|FG000|Period 2|Withdrawal by Subject|0|||
27981193|NCT00607087|54639070|FG001|Period 2|Withdrawal by Subject|1|||
27738856|NCT02936323|54188176|FG008|Phase 2a Dose Expansion|Informed Consent Withdrawn|4|||
27738857|NCT02936323|54188177|FG009|Phase 2a Dose Expansion|Informed Consent Withdrawn|2|||
27738858|NCT02936323|54188168|FG000|Phase 2a Dose Expansion|Physician Decision|0|||
27859174|NCT00249002|54412519|FG000|Overall Study|Adverse Event|2|||
27859175|NCT00249002|54412519|FG000|Overall Study|Study cancellation|3|||
27859176|NCT00249002|54412519|FG000|Overall Study|Other|2|||
27859177|NCT01277042|54412525|FG000|Overall Study|Adverse Event|4|||
27859178|NCT01277042|54412526|FG001|Overall Study|Adverse Event|3|||
27859179|NCT01277042|54412525|FG000|Overall Study|Lost to Follow-up|2|||
27859180|NCT01277042|54412526|FG001|Overall Study|Lost to Follow-up|2|||
27859181|NCT01277042|54412525|FG000|Overall Study|Withdrawal by Subject|2|||
27859182|NCT01277042|54412526|FG001|Overall Study|Withdrawal by Subject|0|||
27981194|NCT00607087|54639071|FG002|Period 2|Withdrawal by Subject|1|||
27981195|NCT00607087|54639069|FG000|Period 2|Other reason|1|||
27981196|NCT00607087|54639070|FG001|Period 2|Other reason|1|||
27981197|NCT00607087|54639071|FG002|Period 2|Other reason|0|||
27981198|NCT00607087|54639069|FG000|Period 2|Adverse Event|0|||
27981199|NCT00607087|54639070|FG001|Period 2|Adverse Event|1|||
27981200|NCT00607087|54639071|FG002|Period 2|Adverse Event|3|||
27981201|NCT00607087|54639069|FG000|Period 2|Poor compliance to protocol|0|||
27859183|NCT00246740|54412566|FG000|Initial Enrollment|Death|1|||
27981202|NCT00607087|54639070|FG001|Period 2|Poor compliance to protocol|0|||
27859184|NCT00246740|54412567|FG001|Initial Enrollment|Death|0|||
27859185|NCT00246740|54412566|FG000|Initial Enrollment|Additional surgery scheduled|0|||
27859186|NCT00246740|54412567|FG001|Initial Enrollment|Additional surgery scheduled|2|||
27859187|NCT00246740|54412566|FG000|Initial Enrollment|Surgery schedule change|4|||
27859188|NCT00246740|54412567|FG001|Initial Enrollment|Surgery schedule change|4|||
27859189|NCT00246740|54412566|FG000|Initial Enrollment|Other|1|||
27859190|NCT00246740|54412567|FG001|Initial Enrollment|Other|2|||
27859191|NCT00245102|54412612|FG000|Overall Study|Not Treated|1|||
27859192|NCT00245102|54412613|FG001|Overall Study|Not Treated|0|||
27859193|NCT00245102|54412614|FG002|Overall Study|Not Treated|1|||
27859194|NCT00245102|54412615|FG003|Overall Study|Not Treated|0|||
27859195|NCT00245102|54412616|FG004|Overall Study|Not Treated|0|||
27859196|NCT00245102|54412617|FG005|Overall Study|Not Treated|0|||
27859197|NCT00245102|54412612|FG000|Overall Study|Protocol Violation|1|||
27859198|NCT00245102|54412613|FG001|Overall Study|Protocol Violation|0|||
27834252|NCT01700621|54317839|FG000|Analyzed for Immunogenicity|Baseline measles measure high|1|||
27834253|NCT01700621|54317840|FG001|Analyzed for Immunogenicity|Baseline measles measure high|2|||
27834254|NCT01589237|54317851|FG000|Part A (52 Weeks)|Subject/guardian decision|2|||
27834255|NCT01589237|54317852|FG001|Part A (52 Weeks)|Subject/guardian decision|3|||
27834256|NCT01589237|54317853|FG002|Part A (52 Weeks)|Subject/guardian decision|2|||
27834257|NCT01589237|54317854|FG003|Part A (52 Weeks)|Subject/guardian decision|0|||
27834258|NCT01589237|54317851|FG000|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
27834259|NCT01589237|54317852|FG001|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1|||
27834260|NCT01589237|54317853|FG002|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
27834261|NCT01589237|54317854|FG003|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
27834262|NCT01589237|54317851|FG000|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
27834263|NCT01589237|54317852|FG001|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
27834264|NCT01589237|54317853|FG002|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4|||
27834265|NCT01589237|54317854|FG003|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3|||
27834266|NCT01589237|54317851|FG000|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
27834267|NCT01589237|54317852|FG001|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
27834268|NCT01589237|54317853|FG002|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
27834269|NCT01589237|54317854|FG003|Part B (Planned for 78 Week-terminated)|Physician Decision|1|||
27834270|NCT01700387|54317870|FG000|Overall Study|Withdrawal by Subject|1|||
27834271|NCT01700387|54317871|FG001|Overall Study|Withdrawal by Subject|2|||
27834272|NCT01700387|54317870|FG000|Overall Study|Adverse Event|1|||
27834273|NCT01700387|54317871|FG001|Overall Study|Adverse Event|1|||
27834274|NCT01700387|54317870|FG000|Overall Study|Lost to Follow-up|2|||
27834275|NCT01700387|54317871|FG001|Overall Study|Lost to Follow-up|1|||
27834276|NCT01699685|54317883|FG000|Period 1|Adverse Event|1|||
27834277|NCT01699685|54317884|FG001|Period 1|Adverse Event|1|||
27834278|NCT01699685|54317883|FG000|Period 1|Medical or ethical, noncompliance|2|||
27834279|NCT01699685|54317884|FG001|Period 1|Medical or ethical, noncompliance|0|||
27834280|NCT01699685|54317883|FG000|Period 1|Other|0|||
27834281|NCT01699685|54317884|FG001|Period 1|Other|1|||
27834282|NCT01699685|54317883|FG000|Period 1|Patient request|0|||
27834283|NCT01699685|54317884|FG001|Period 1|Patient request|1|||
27834284|NCT01699685|54317883|FG000|Period 2|Lost to Follow-up|1|||
27834285|NCT01699685|54317884|FG001|Period 2|Lost to Follow-up|0|||
27834286|NCT01587989|54317892|FG000|12-Week Open-Label Run-In Period|Physician Decision|7|||
27834287|NCT01587989|54317893|FG001|12-Week Open-Label Run-In Period|Physician Decision|0|||
27834288|NCT01587989|54317894|FG002|12-Week Open-Label Run-In Period|Physician Decision|0|||
27834289|NCT01587989|54317892|FG000|12-Week Open-Label Run-In Period|Withdrawal by Subject|1|||
27834290|NCT01587989|54317893|FG001|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
27834291|NCT01587989|54317894|FG002|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
27834292|NCT01587989|54317892|FG000|12-Week Open-Label Run-In Period|No EULAR Response|4|||
27834293|NCT01587989|54317893|FG001|12-Week Open-Label Run-In Period|No EULAR Response|0|||
27834294|NCT01587989|54317894|FG002|12-Week Open-Label Run-In Period|No EULAR Response|0|||
27834295|NCT01587989|54317892|FG000|Randomized Study Treatment|Withdrawal by Subject|0|||
27834296|NCT01587989|54317893|FG001|Randomized Study Treatment|Withdrawal by Subject|1|||
27834297|NCT01587989|54317894|FG002|Randomized Study Treatment|Withdrawal by Subject|0|||
27834298|NCT01587989|54317892|FG000|Randomized Study Treatment|Screening failure|0|||
27859199|NCT00245102|54412614|FG002|Overall Study|Protocol Violation|0|||
27981203|NCT00607087|54639071|FG002|Period 2|Poor compliance to protocol|1|||
27834299|NCT01587989|54317893|FG001|Randomized Study Treatment|Screening failure|1|||
27834300|NCT01587989|54317894|FG002|Randomized Study Treatment|Screening failure|0|||
27834301|NCT01587989|54317892|FG000|Randomized Study Treatment|Physician Decision|0|||
27859200|NCT00245102|54412615|FG003|Overall Study|Protocol Violation|0|||
27859201|NCT00245102|54412616|FG004|Overall Study|Protocol Violation|0|||
27859202|NCT00245102|54412617|FG005|Overall Study|Protocol Violation|0|||
27859203|NCT00245102|54412612|FG000|Overall Study|Death|0|||
27859204|NCT00245102|54412613|FG001|Overall Study|Death|0|||
27859205|NCT00245102|54412614|FG002|Overall Study|Death|0|||
27859206|NCT00245102|54412615|FG003|Overall Study|Death|1|||
27859207|NCT00245102|54412616|FG004|Overall Study|Death|0|||
27859208|NCT00245102|54412617|FG005|Overall Study|Death|0|||
27859209|NCT00245102|54412612|FG000|Overall Study|Adverse Event|4|||
27859210|NCT00245102|54412613|FG001|Overall Study|Adverse Event|2|||
27859211|NCT00245102|54412614|FG002|Overall Study|Adverse Event|5|||
27859212|NCT00245102|54412615|FG003|Overall Study|Adverse Event|1|||
27859213|NCT00245102|54412616|FG004|Overall Study|Adverse Event|0|||
27859214|NCT00245102|54412617|FG005|Overall Study|Adverse Event|2|||
27859215|NCT00245102|54412612|FG000|Overall Study|Decline in performance|0|||
27859216|NCT00245102|54412613|FG001|Overall Study|Decline in performance|2|||
27859217|NCT00245102|54412614|FG002|Overall Study|Decline in performance|0|||
27859218|NCT00245102|54412615|FG003|Overall Study|Decline in performance|1|||
27859219|NCT00245102|54412616|FG004|Overall Study|Decline in performance|0|||
27859220|NCT00245102|54412617|FG005|Overall Study|Decline in performance|2|||
27859221|NCT00245102|54412612|FG000|Overall Study|Participant needed surgery|0|||
27859222|NCT00245102|54412613|FG001|Overall Study|Participant needed surgery|0|||
27859223|NCT00245102|54412614|FG002|Overall Study|Participant needed surgery|1|||
27859224|NCT00245102|54412615|FG003|Overall Study|Participant needed surgery|0|||
27859225|NCT00245102|54412616|FG004|Overall Study|Participant needed surgery|0|||
27859226|NCT00245102|54412617|FG005|Overall Study|Participant needed surgery|0|||
27859227|NCT00245102|54412612|FG000|Overall Study|Clinical progression|1|||
27859228|NCT00245102|54412613|FG001|Overall Study|Clinical progression|0|||
27859229|NCT00245102|54412614|FG002|Overall Study|Clinical progression|0|||
27859230|NCT00245102|54412615|FG003|Overall Study|Clinical progression|0|||
27859231|NCT00245102|54412616|FG004|Overall Study|Clinical progression|0|||
27859232|NCT00245102|54412617|FG005|Overall Study|Clinical progression|0|||
27859233|NCT00244712|54412662|FG000|Overall Study|Adverse Event|20|||
27859234|NCT00244712|54412663|FG001|Overall Study|Adverse Event|21|||
27859235|NCT00244712|54412662|FG000|Overall Study|Protocol-Defined Virologic Failure|8|||
27859236|NCT00244712|54412663|FG001|Overall Study|Protocol-Defined Virologic Failure|6|||
27859237|NCT00244712|54412662|FG000|Overall Study|Lack of Compliance|10|||
27859238|NCT00244712|54412663|FG001|Overall Study|Lack of Compliance|11|||
27859239|NCT00244712|54412662|FG000|Overall Study|Lost to Follow-up|45|||
27859240|NCT00244712|54412663|FG001|Overall Study|Lost to Follow-up|52|||
27859241|NCT00244712|54412662|FG000|Overall Study|Withdrawal by Subject|13|||
27859242|NCT00244712|54412663|FG001|Overall Study|Withdrawal by Subject|23|||
27859243|NCT00244712|54412662|FG000|Overall Study|Protocol Violation, disease progression|13|||
27859244|NCT00244712|54412663|FG001|Overall Study|Protocol Violation, disease progression|11|||
27859245|NCT00243932|54412681|FG000|Stage 1: Dose Selection|Lost to Follow-up|2|||
27859246|NCT00243932|54412682|FG001|Stage 1: Dose Selection|Lost to Follow-up|0|||
27859247|NCT00243932|54412683|FG002|Stage 1: Dose Selection|Lost to Follow-up|0|||
27859248|NCT00243386|54412691|FG000|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1|||
27859249|NCT00243386|54412692|FG001|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
27859250|NCT00243386|54412693|FG002|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
27859251|NCT00243386|54412691|FG000|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1|||
27859252|NCT00243386|54412692|FG001|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
27834302|NCT01587989|54317893|FG001|Randomized Study Treatment|Physician Decision|0|||
27834303|NCT01587989|54317894|FG002|Randomized Study Treatment|Physician Decision|1|||
27834304|NCT01697969|54317900|FG000|Overall Study|Did not meet inc/exc criteria|3|||
27834305|NCT01586819|54317907|FG000|Overall Study|Withdrawal by Subject|1|||
27834306|NCT01586819|54317908|FG001|Overall Study|Withdrawal by Subject|0|||
27834307|NCT01697579|54317919|FG000|Base Study-Cycle 1|Adverse Event|1|||
27834308|NCT01697579|54317920|FG001|Base Study-Cycle 1|Adverse Event|0|||
27834309|NCT01697579|54317921|FG002|Base Study-Cycle 1|Adverse Event|0|||
27834310|NCT01697579|54317922|FG003|Base Study-Cycle 1|Adverse Event|0|||
27834311|NCT01697579|54317923|FG004|Base Study-Cycle 1|Adverse Event|0|||
27834312|NCT01697579|54317924|FG005|Base Study-Cycle 1|Adverse Event|0|||
27834313|NCT01697579|54317925|FG006|Base Study-Cycle 1|Adverse Event|0|||
27834314|NCT01697579|54317919|FG000|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1|||
27834315|NCT01697579|54317920|FG001|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
27834316|NCT01697579|54317921|FG002|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
27834317|NCT01697579|54317922|FG003|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
27834318|NCT01697579|54317923|FG004|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
27834319|NCT01697579|54317924|FG005|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
27834320|NCT01697579|54317925|FG006|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
27859253|NCT00243386|54412693|FG002|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
27859254|NCT00243386|54412691|FG000|On-Demand Regimen (Study Part 1)|Screen Failures|2|||
27859255|NCT00243386|54412692|FG001|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
27859256|NCT00243386|54412693|FG002|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
27859257|NCT00243386|54412691|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1|||
27859258|NCT00243386|54412692|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
27859259|NCT00243386|54412693|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
27859260|NCT00243386|54412691|FG000|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1|||
27859261|NCT00243386|54412692|FG001|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
27859262|NCT00243386|54412693|FG002|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
27859263|NCT00243386|54412691|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1|||
27859264|NCT00243386|54412692|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
27859265|NCT00243386|54412693|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
27859266|NCT00243386|54412691|FG000|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
27859267|NCT00243386|54412692|FG001|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2|||
27859268|NCT00243386|54412693|FG002|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
27859269|NCT00243386|54412691|FG000|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
27859270|NCT00243386|54412692|FG001|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1|||
27859271|NCT00243386|54412693|FG002|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
27859272|NCT00243230|54412752|FG000|Double-Blind Period|Adverse Event|0|||
27859273|NCT00243230|54412753|FG001|Double-Blind Period|Adverse Event|2|||
27859274|NCT00243230|54412754|FG002|Double-Blind Period|Adverse Event|2|||
27859275|NCT00243230|54412755|FG003|Double-Blind Period|Adverse Event|0|||
27859276|NCT00243230|54412752|FG000|Double-Blind Period|Withdrawal by Subject|1|||
27859277|NCT00243230|54412753|FG001|Double-Blind Period|Withdrawal by Subject|0|||
27859278|NCT00243230|54412754|FG002|Double-Blind Period|Withdrawal by Subject|0|||
27859279|NCT00243230|54412755|FG003|Double-Blind Period|Withdrawal by Subject|0|||
27859280|NCT00243230|54412752|FG000|Double-Blind Period|Protocol Violation|0|||
27859281|NCT00243230|54412753|FG001|Double-Blind Period|Protocol Violation|0|||
27859282|NCT00243230|54412754|FG002|Double-Blind Period|Protocol Violation|1|||
27859283|NCT00243230|54412755|FG003|Double-Blind Period|Protocol Violation|0|||
27859284|NCT00243230|54412752|FG000|Double-Blind Period|Randomized but Not Treated|0|||
27859285|NCT00243230|54412753|FG001|Double-Blind Period|Randomized but Not Treated|0|||
27859286|NCT00243230|54412754|FG002|Double-Blind Period|Randomized but Not Treated|2|||
27859287|NCT00243230|54412755|FG003|Double-Blind Period|Randomized but Not Treated|0|||
27859288|NCT00243230|54412752|FG000|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|5|||
27859289|NCT00243230|54412753|FG001|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|3|||
27859290|NCT00243230|54412754|FG002|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|14|||
27859291|NCT00243230|54412755|FG003|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|0|||
27859292|NCT00243230|54412752|FG000|Open Label Period|Adverse Event|0|||
27859293|NCT00243230|54412753|FG001|Open Label Period|Adverse Event|0|||
27859294|NCT00243230|54412754|FG002|Open Label Period|Adverse Event|0|||
27859295|NCT00243230|54412755|FG003|Open Label Period|Adverse Event|2|||
27859296|NCT00243230|54412752|FG000|Open Label Period|Treatment Failure - Virologic Failure|0|||
27859297|NCT00243230|54412753|FG001|Open Label Period|Treatment Failure - Virologic Failure|0|||
27859298|NCT00243230|54412754|FG002|Open Label Period|Treatment Failure - Virologic Failure|0|||
27859299|NCT00243230|54412755|FG003|Open Label Period|Treatment Failure - Virologic Failure|13|||
27859300|NCT00243230|54412752|FG000|Open Label Period|Progressive Disease (AIDS-Event)|0|||
27859301|NCT00243230|54412753|FG001|Open Label Period|Progressive Disease (AIDS-Event)|0|||
27859302|NCT00243230|54412754|FG002|Open Label Period|Progressive Disease (AIDS-Event)|0|||
27859303|NCT00243230|54412755|FG003|Open Label Period|Progressive Disease (AIDS-Event)|1|||
27859304|NCT00243230|54412752|FG000|Open Label Period|Lost to Follow-up|0|||
27859305|NCT00243230|54412753|FG001|Open Label Period|Lost to Follow-up|0|||
27859306|NCT00243230|54412754|FG002|Open Label Period|Lost to Follow-up|0|||
27859307|NCT00243230|54412755|FG003|Open Label Period|Lost to Follow-up|2|||
27859308|NCT00243230|54412752|FG000|Open Label Period|Withdrawal by Subject|0|||
27859309|NCT00243230|54412753|FG001|Open Label Period|Withdrawal by Subject|0|||
27859310|NCT00243230|54412754|FG002|Open Label Period|Withdrawal by Subject|0|||
27859311|NCT00243230|54412755|FG003|Open Label Period|Withdrawal by Subject|2|||
27859312|NCT00243230|54412752|FG000|Open Label Period|Protocol Violation|0|||
27859313|NCT00243230|54412753|FG001|Open Label Period|Protocol Violation|0|||
27859314|NCT00243230|54412754|FG002|Open Label Period|Protocol Violation|0|||
27859315|NCT00243230|54412755|FG003|Open Label Period|Protocol Violation|2|||
27859316|NCT00243230|54412752|FG000|Open Label Period|Administrative Reason|0|||
27859317|NCT00243230|54412753|FG001|Open Label Period|Administrative Reason|0|||
27859318|NCT00243230|54412754|FG002|Open Label Period|Administrative Reason|0|||
27859319|NCT00243230|54412755|FG003|Open Label Period|Administrative Reason|63|||
27859320|NCT00243074|54412765|FG000|Overall Study|Ineligible|6|||
27859321|NCT00243074|54412765|FG000|Overall Study|Adverse Event|6|||
27859322|NCT00243074|54412765|FG000|Overall Study|Withdrawal by Subject|2|||
27859323|NCT00243074|54412765|FG000|Overall Study|Lack of Efficacy|36|||
27859324|NCT00243074|54412765|FG000|Overall Study|Death|2|||
27859325|NCT00243074|54412765|FG000|Overall Study|not protocol specified|1|||
27859326|NCT00243074|54412765|FG000|Overall Study|Did not receive any treatment|1|||
27859327|NCT00241358|54412773|FG000|Overall Study|Determined to be not ineligible|0|||
27859328|NCT00241358|54412774|FG001|Overall Study|Determined to be not ineligible|1|||
27859329|NCT00241358|54412775|FG002|Overall Study|Determined to be not ineligible|1|||
27859330|NCT00241280|54412784|FG000|Overall Study|Adverse Event|2|||
27859331|NCT00241280|54412785|FG001|Overall Study|Adverse Event|6|||
27859332|NCT00241280|54412784|FG000|Overall Study|Discomfort|11|||
27859333|NCT00241280|54412785|FG001|Overall Study|Discomfort|16|||
27859334|NCT00241280|54412784|FG000|Overall Study|Pregnancy|1|||
27859335|NCT00241280|54412785|FG001|Overall Study|Pregnancy|5|||
27859336|NCT00241280|54412784|FG000|Overall Study|Lost to Follow-up|5|||
27859337|NCT00241280|54412785|FG001|Overall Study|Lost to Follow-up|8|||
27859338|NCT00241280|54412784|FG000|Overall Study|Withdrawal by Subject|7|||
27859339|NCT00241280|54412785|FG001|Overall Study|Withdrawal by Subject|4|||
27859340|NCT00241280|54412784|FG000|Overall Study|Protocol Violation|4|||
27859341|NCT00241280|54412785|FG001|Overall Study|Protocol Violation|10|||
27859342|NCT00241280|54412784|FG000|Overall Study|Relocation|4|||
27859343|NCT00241280|54412785|FG001|Overall Study|Relocation|4|||
27859344|NCT00241280|54412784|FG000|Overall Study|Unsatisfactory Physiological Response|1|||
27859345|NCT00241280|54412785|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
27859346|NCT00241280|54412784|FG000|Overall Study|Unsatisfactory Visual Response|1|||
27859347|NCT00241280|54412785|FG001|Overall Study|Unsatisfactory Visual Response|1|||
27859348|NCT00241280|54412784|FG000|Overall Study|Diabetic|1|||
27859349|NCT00241280|54412785|FG001|Overall Study|Diabetic|0|||
27859350|NCT00241280|54412784|FG000|Overall Study|Subject Ineligible/Dispensed|9|||
27859351|NCT00241280|54412785|FG001|Overall Study|Subject Ineligible/Dispensed|6|||
27859352|NCT00241280|54412784|FG000|Overall Study|Dispensed incorrect test article|1|||
27859353|NCT00241280|54412785|FG001|Overall Study|Dispensed incorrect test article|2|||
27859354|NCT00241280|54412784|FG000|Overall Study|Unacceptable Fit|0|||
27859355|NCT00241280|54412785|FG001|Overall Study|Unacceptable Fit|1|||
27859356|NCT00241280|54412784|FG000|Overall Study|Scheduling Conflict|0|||
27859357|NCT00241280|54412785|FG001|Overall Study|Scheduling Conflict|2|||
27859358|NCT00241280|54412784|FG000|Overall Study|History of Ocular Surgery|0|||
27859359|NCT00241280|54412785|FG001|Overall Study|History of Ocular Surgery|1|||
27859360|NCT00241280|54412784|FG000|Overall Study|Coating on Lens|1|||
27859361|NCT00241280|54412785|FG001|Overall Study|Coating on Lens|0|||
27859362|NCT00241280|54412784|FG000|Overall Study|Excessive Dryness|0|||
27859363|NCT00241280|54412785|FG001|Overall Study|Excessive Dryness|1|||
27859364|NCT04278872|54413362|FG000|Overall Study|Adverse Event|1|||
27859365|NCT04278872|54413363|FG001|Overall Study|Adverse Event|0|||
27859366|NCT04278872|54413362|FG000|Overall Study|Protocol Violation|0|||
27859367|NCT04278872|54413363|FG001|Overall Study|Protocol Violation|1|||
27859368|NCT04278872|54413362|FG000|Overall Study|Study Termination|2|||
27859369|NCT04278872|54413363|FG001|Overall Study|Study Termination|0|||
27859370|NCT02513160|54415852|FG000|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33|||
27859371|NCT02513160|54415853|FG001|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
27859372|NCT02513160|54415854|FG002|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
27859373|NCT02513160|54415855|FG003|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
27859374|NCT02513160|54415852|FG000|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214|||
27859375|NCT02513160|54415853|FG001|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
27859376|NCT02513160|54415854|FG002|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
27859377|NCT02513160|54415855|FG003|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
27859378|NCT02513160|54415852|FG000|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6|||
27859379|NCT02513160|54415853|FG001|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
27859380|NCT02513160|54415854|FG002|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
27859381|NCT02513160|54415855|FG003|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
27859382|NCT02513160|54415852|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|4|||
27859383|NCT02513160|54415853|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
27859384|NCT02513160|54415854|FG002|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
27859385|NCT02513160|54415855|FG003|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
27859386|NCT02513160|54415852|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20|||
27859387|NCT02513160|54415853|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
27859388|NCT02513160|54415854|FG002|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
27859389|NCT02513160|54415855|FG003|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
27859390|NCT02513160|54415852|FG000|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1|||
27859391|NCT02513160|54415853|FG001|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
27859392|NCT02513160|54415854|FG002|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
27859393|NCT02513160|54415855|FG003|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
27859394|NCT02513160|54415852|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10|||
27859395|NCT02513160|54415853|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
27859396|NCT02513160|54415854|FG002|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
28095897|NCT04308668|54750465|FG001|Overall Study|Withdrawal by Subject|4|||
27859397|NCT02513160|54415855|FG003|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
27859398|NCT02513160|54415852|FG000|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
27859399|NCT02513160|54415853|FG001|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
27981204|NCT00607087|54639069|FG000|Period 3|Withdrawal by Subject|2|||
27981205|NCT00607087|54639070|FG001|Period 3|Withdrawal by Subject|1|||
27859400|NCT02513160|54415854|FG002|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0|||
27859401|NCT02513160|54415855|FG003|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1|||
27859402|NCT02513160|54415852|FG000|Treatment Period (Day 0 to Week 6)|Noncompliance|1|||
27859403|NCT02513160|54415853|FG001|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
27859404|NCT02513160|54415854|FG002|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
27859405|NCT02513160|54415855|FG003|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
27859406|NCT02513160|54415852|FG000|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2|||
27859407|NCT02513160|54415853|FG001|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
27859408|NCT02513160|54415854|FG002|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
27859409|NCT02513160|54415855|FG003|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
27859410|NCT02513160|54415852|FG000|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1|||
27859411|NCT02513160|54415853|FG001|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
27859412|NCT02513160|54415854|FG002|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
27859413|NCT02513160|54415855|FG003|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
27859414|NCT02513160|54415852|FG000|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
27859415|NCT02513160|54415853|FG001|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1|||
27859416|NCT02513160|54415854|FG002|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
27859417|NCT02513160|54415855|FG003|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
27859418|NCT02480010|54415890|FG000|Overall Study|Adverse Event|3|||
27859419|NCT02480010|54415891|FG001|Overall Study|Adverse Event|1|||
27859420|NCT02480010|54415890|FG000|Overall Study|Death|1|||
27859421|NCT02480010|54415891|FG001|Overall Study|Death|0|||
27859422|NCT02480010|54415890|FG000|Overall Study|Insufficient therapeutic response|31|||
27859423|NCT02480010|54415891|FG001|Overall Study|Insufficient therapeutic response|29|||
27859424|NCT02480010|54415890|FG000|Overall Study|Refused Treatment|0|||
27859425|NCT02480010|54415891|FG001|Overall Study|Refused Treatment|3|||
27859426|NCT02512302|54415919|FG000|Period 1|Adverse Event|0|||
27859427|NCT02512302|54415920|FG001|Period 1|Adverse Event|1|||
27859428|NCT02512302|54415921|FG002|Period 1|Adverse Event|0|||
27859429|NCT02512302|54415922|FG003|Period 1|Adverse Event|0|||
27859430|NCT02512302|54415923|FG004|Period 1|Adverse Event|0|||
28095898|NCT04451330|54750473|FG000|Overall Study|Adverse Event|1|||
27834321|NCT01697579|54317919|FG000|Base Study-Cycle 1|Protocol Violation|0|||
27834322|NCT01697579|54317920|FG001|Base Study-Cycle 1|Protocol Violation|0|||
27834323|NCT01697579|54317921|FG002|Base Study-Cycle 1|Protocol Violation|0|||
27834324|NCT01697579|54317922|FG003|Base Study-Cycle 1|Protocol Violation|0|||
27834325|NCT01697579|54317923|FG004|Base Study-Cycle 1|Protocol Violation|3|||
27834326|NCT01697579|54317924|FG005|Base Study-Cycle 1|Protocol Violation|0|||
27834327|NCT01697579|54317925|FG006|Base Study-Cycle 1|Protocol Violation|0|||
27834328|NCT01697579|54317919|FG000|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
27834329|NCT01697579|54317920|FG001|Base Study-Cycle 1|Consent Withdrawn by Participant|1|||
27834330|NCT01697579|54317921|FG002|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
27834331|NCT01697579|54317922|FG003|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
27834332|NCT01697579|54317923|FG004|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
27834333|NCT01697579|54317924|FG005|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
27834334|NCT01697579|54317925|FG006|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
27834335|NCT01697579|54317919|FG000|Base Study-Cycle 1|Technical Problems|0|||
27834336|NCT01697579|54317920|FG001|Base Study-Cycle 1|Technical Problems|0|||
27834337|NCT01697579|54317921|FG002|Base Study-Cycle 1|Technical Problems|1|||
27834338|NCT01697579|54317922|FG003|Base Study-Cycle 1|Technical Problems|1|||
27834339|NCT01697579|54317923|FG004|Base Study-Cycle 1|Technical Problems|0|||
27834340|NCT01697579|54317924|FG005|Base Study-Cycle 1|Technical Problems|0|||
27834341|NCT01697579|54317925|FG006|Base Study-Cycle 1|Technical Problems|0|||
27834342|NCT01697579|54317919|FG000|Optional Extension-Cycles 2-6|Death|0|||
27834343|NCT01697579|54317920|FG001|Optional Extension-Cycles 2-6|Death|0|||
27834344|NCT01697579|54317921|FG002|Optional Extension-Cycles 2-6|Death|0|||
27834345|NCT01697579|54317922|FG003|Optional Extension-Cycles 2-6|Death|0|||
27834346|NCT01697579|54317923|FG004|Optional Extension-Cycles 2-6|Death|0|||
27834347|NCT01697579|54317924|FG005|Optional Extension-Cycles 2-6|Death|0|||
27834348|NCT01697579|54317925|FG006|Optional Extension-Cycles 2-6|Death|2|||
27834349|NCT01697579|54317919|FG000|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
27834350|NCT01697579|54317920|FG001|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
27834351|NCT01697579|54317921|FG002|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
27834352|NCT01697579|54317922|FG003|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
27834353|NCT01697579|54317923|FG004|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
27834354|NCT01697579|54317924|FG005|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1|||
28095899|NCT04451330|54750474|FG001|Overall Study|Adverse Event|2|||
28095900|NCT04451330|54750473|FG000|Overall Study|Lost to Follow-up|5|||
27834355|NCT01697579|54317925|FG006|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5|||
27859431|NCT02512302|54415924|FG005|Period 1|Adverse Event|0|||
27859432|NCT02512302|54415925|FG006|Period 1|Adverse Event|0|||
27859433|NCT02512302|54415926|FG007|Period 1|Adverse Event|0|||
27859434|NCT02512302|54415927|FG008|Period 1|Adverse Event|0|||
27859435|NCT02512302|54415928|FG009|Period 1|Adverse Event|0|||
27859436|NCT02512302|54415919|FG000|Period 2|Adverse Event|0|||
27859437|NCT02512302|54415920|FG001|Period 2|Adverse Event|0|||
27859438|NCT02512302|54415921|FG002|Period 2|Adverse Event|0|||
27859439|NCT02512302|54415922|FG003|Period 2|Adverse Event|0|||
27859440|NCT02512302|54415923|FG004|Period 2|Adverse Event|0|||
27859441|NCT02512302|54415924|FG005|Period 2|Adverse Event|0|||
27859442|NCT02512302|54415925|FG006|Period 2|Adverse Event|0|||
27859443|NCT02512302|54415926|FG007|Period 2|Adverse Event|0|||
27859444|NCT02512302|54415927|FG008|Period 2|Adverse Event|0|||
27859445|NCT02512302|54415928|FG009|Period 2|Adverse Event|1|||
27859446|NCT02512302|54415919|FG000|Period 3|Lost to Follow-up|0|||
27859447|NCT02512302|54415920|FG001|Period 3|Lost to Follow-up|0|||
27859448|NCT02512302|54415921|FG002|Period 3|Lost to Follow-up|1|||
27859449|NCT02512302|54415922|FG003|Period 3|Lost to Follow-up|0|||
27859450|NCT02512302|54415923|FG004|Period 3|Lost to Follow-up|0|||
27859451|NCT02512302|54415924|FG005|Period 3|Lost to Follow-up|0|||
27859452|NCT02512302|54415925|FG006|Period 3|Lost to Follow-up|0|||
27859453|NCT02512302|54415926|FG007|Period 3|Lost to Follow-up|0|||
27859454|NCT02512302|54415927|FG008|Period 3|Lost to Follow-up|0|||
27859455|NCT02512302|54415928|FG009|Period 3|Lost to Follow-up|0|||
27859456|NCT02512302|54415919|FG000|Period 4|Adverse Event|0|||
27859457|NCT02512302|54415920|FG001|Period 4|Adverse Event|0|||
27859458|NCT02512302|54415921|FG002|Period 4|Adverse Event|0|||
27859459|NCT02512302|54415922|FG003|Period 4|Adverse Event|0|||
27859460|NCT02512302|54415923|FG004|Period 4|Adverse Event|0|||
27859461|NCT02512302|54415924|FG005|Period 4|Adverse Event|0|||
27859462|NCT02512302|54415925|FG006|Period 4|Adverse Event|1|||
27859463|NCT02512302|54415926|FG007|Period 4|Adverse Event|0|||
27859464|NCT02512302|54415927|FG008|Period 4|Adverse Event|0|||
27859465|NCT02512302|54415928|FG009|Period 4|Adverse Event|0|||
27859466|NCT02512068|54416036|FG000|Overall Study|Pretreatment Event/Adverse Event|8|||
27859467|NCT02512068|54416037|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
27859468|NCT02512068|54416036|FG000|Overall Study|Major Protocol Deviation|1|||
27859469|NCT02512068|54416037|FG001|Overall Study|Major Protocol Deviation|0|||
27859470|NCT02512068|54416036|FG000|Overall Study|Voluntary Withdrawal|0|||
27859471|NCT02512068|54416037|FG001|Overall Study|Voluntary Withdrawal|1|||
27859472|NCT02512068|54416036|FG000|Overall Study|Lack of Efficacy|0|||
27859473|NCT02512068|54416037|FG001|Overall Study|Lack of Efficacy|1|||
27859474|NCT02512068|54416036|FG000|Overall Study|Reason Not Specified|3|||
27859475|NCT02512068|54416037|FG001|Overall Study|Reason Not Specified|5|||
27859476|NCT02511678|54416052|FG000|Overall Study|Withdrawal by Subject|2|||
27859477|NCT02511678|54416052|FG000|Overall Study|Lost to Follow-up|4|||
27859478|NCT02511678|54416052|FG000|Overall Study|Death|19|||
27859479|NCT02511678|54416052|FG000|Overall Study|Adverse Event|1|||
27859480|NCT02511678|54416052|FG000|Overall Study|Targeted Therapy to Index Tumor Required|5|||
27859481|NCT02511678|54416052|FG000|Overall Study|Oncologist Cancelled Study Cryoablation|1|||
27859482|NCT02511678|54416052|FG000|Overall Study|Required Radiofrequency Ablation|1|||
27859483|NCT02511678|54416052|FG000|Overall Study|Biopsy was Negative|1|||
27859484|NCT02511678|54416052|FG000|Overall Study|Protocol Violation|1|||
27859485|NCT02511678|54416052|FG000|Overall Study|Received Radiation Treatment|1|||
27859486|NCT02518464|54416079|FG000|Overall Study|Adverse Event|2|||
27859487|NCT02510820|54416083|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
27859488|NCT02510820|54416084|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
27859489|NCT02510820|54416083|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
27859490|NCT02510820|54416084|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
27859491|NCT02510664|54416094|FG000|Overall Study|Transferred Care|9|||
27859492|NCT02510664|54416095|FG001|Overall Study|Transferred Care|9|||
27859493|NCT02510664|54416096|FG002|Overall Study|Transferred Care|0|||
27859494|NCT02510664|54416094|FG000|Overall Study|Provider Retired/No Time to Reschedule|10|||
27859495|NCT02510664|54416095|FG001|Overall Study|Provider Retired/No Time to Reschedule|10|||
27738859|NCT02936323|54188169|FG001|Phase 2a Dose Expansion|Physician Decision|0|||
27738860|NCT02936323|54188170|FG002|Phase 2a Dose Expansion|Physician Decision|0|||
27859496|NCT02510664|54416096|FG002|Overall Study|Provider Retired/No Time to Reschedule|0|||
27859497|NCT02510664|54416094|FG000|Overall Study|Time Constraints|1|||
27859498|NCT02510664|54416095|FG001|Overall Study|Time Constraints|1|||
27859499|NCT02510664|54416096|FG002|Overall Study|Time Constraints|0|||
27859500|NCT01363986|54416127|FG000|Overall Study|Disease progression|1|||
27859501|NCT02478372|54416161|FG000|Overall Study|Protocol Violation|12|||
27859502|NCT02478372|54416162|FG001|Overall Study|Protocol Violation|8|||
27859503|NCT02478372|54416161|FG000|Overall Study|Lost to Follow-up|1|||
27859504|NCT02478372|54416162|FG001|Overall Study|Lost to Follow-up|4|||
27859505|NCT02478372|54416161|FG000|Overall Study|Death|0|||
27859506|NCT02478372|54416162|FG001|Overall Study|Death|2|||
27859507|NCT01654536|54416174|FG000|Overall Study|Lost to Follow-up|5|||
27859508|NCT01654536|54416175|FG001|Overall Study|Lost to Follow-up|5|||
27859509|NCT01654536|54416174|FG000|Overall Study|Physician Decision|12|||
27859510|NCT01654536|54416175|FG001|Overall Study|Physician Decision|8|||
27981206|NCT00607087|54639071|FG002|Period 3|Withdrawal by Subject|0|||
27981207|NCT00607087|54639069|FG000|Period 3|Adverse Event|0|||
27981208|NCT00607087|54639070|FG001|Period 3|Adverse Event|1|||
27981209|NCT00607087|54639071|FG002|Period 3|Adverse Event|0|||
27981210|NCT00610363|54639081|FG000|Overall Study|Non-compliance with protocol|0|||
27981211|NCT00610363|54639082|FG001|Overall Study|Non-compliance with protocol|1|||
27981212|NCT00610363|54639081|FG000|Overall Study|Adverse Event|3|||
27981213|NCT00610363|54639082|FG001|Overall Study|Adverse Event|1|||
27981214|NCT00610363|54639081|FG000|Overall Study|Lack of Efficacy|2|||
27981215|NCT00610363|54639082|FG001|Overall Study|Lack of Efficacy|0|||
27981216|NCT00610363|54639081|FG000|Overall Study|Lost to Follow-up|4|||
27981217|NCT00610363|54639082|FG001|Overall Study|Lost to Follow-up|0|||
27981218|NCT00610363|54639081|FG000|Overall Study|Withdrawal by Subject|1|||
27738861|NCT02936323|54188171|FG003|Phase 2a Dose Expansion|Physician Decision|0|||
27981219|NCT00610363|54639082|FG001|Overall Study|Withdrawal by Subject|0|||
27981220|NCT00610363|54639081|FG000|Overall Study|Other than specified above|1|||
27981221|NCT00610363|54639082|FG001|Overall Study|Other than specified above|1|||
27981222|NCT00887588|54639091|FG000|Core Period|Death|1|||
27981223|NCT00887588|54639092|FG001|Core Period|Death|1|||
27981224|NCT00887588|54639091|FG000|Core Period|Lost to Follow-up|3|||
27981225|NCT00887588|54639092|FG001|Core Period|Lost to Follow-up|1|||
27981226|NCT00887588|54639091|FG000|Core Period|Withdrawal by Subject|6|||
27981227|NCT00887588|54639092|FG001|Core Period|Withdrawal by Subject|8|||
27981228|NCT00887588|54639091|FG000|Core Period|Adverse Event|9|||
27981229|NCT00887588|54639092|FG001|Core Period|Adverse Event|11|||
28095901|NCT04451330|54750474|FG001|Overall Study|Lost to Follow-up|0|||
28095902|NCT04451330|54750473|FG000|Overall Study|Withdrawal by Subject|3|||
28095903|NCT04451330|54750474|FG001|Overall Study|Withdrawal by Subject|1|||
28095904|NCT04451330|54750473|FG000|Overall Study|Withdrawal by parent/guardian|1|||
28095905|NCT04451330|54750474|FG001|Overall Study|Withdrawal by parent/guardian|0|||
28095906|NCT04451330|54750473|FG000|Overall Study|Other than specified|0|||
28095907|NCT04451330|54750474|FG001|Overall Study|Other than specified|1|||
28095908|NCT02493426|54750480|FG000|Overall Study|Withdrawal by Subject|0|||
28095909|NCT02493426|54750481|FG001|Overall Study|Withdrawal by Subject|1|||
28095910|NCT04448756|54750490|FG000|Overall Study|Adverse Event|0|||
28095911|NCT04448756|54750491|FG001|Overall Study|Adverse Event|1|||
28095912|NCT04448756|54750492|FG002|Overall Study|Adverse Event|0|||
28095913|NCT04448756|54750490|FG000|Overall Study|Participant unable to attend Day 60 visit|1|||
28095914|NCT04448756|54750491|FG001|Overall Study|Participant unable to attend Day 60 visit|0|||
28095915|NCT04448756|54750492|FG002|Overall Study|Participant unable to attend Day 60 visit|0|||
28095916|NCT04448756|54750490|FG000|Overall Study|Withdrawal by Subject|0|||
28095917|NCT04448756|54750491|FG001|Overall Study|Withdrawal by Subject|3|||
28095918|NCT04448756|54750492|FG002|Overall Study|Withdrawal by Subject|1|||
28095919|NCT04448756|54750490|FG000|Overall Study|Death|2|||
28095920|NCT04448756|54750491|FG001|Overall Study|Death|1|||
28095921|NCT04448756|54750492|FG002|Overall Study|Death|0|||
28095922|NCT04274192|54750502|FG000|Overall Study|Protocol Violation|1|||
28095923|NCT04274192|54750503|FG001|Overall Study|Protocol Violation|0|||
28095924|NCT04387136|54750513|FG000|Overall Study|Protocol Deviation by SOC staff|1|||
28095925|NCT04387136|54750514|FG001|Overall Study|Protocol Deviation by SOC staff|2|||
28095926|NCT04252586|54750520|FG000|Overall Study|Withdrawal by parent/guardian|3|||
28095927|NCT04252586|54750520|FG000|Overall Study|Adverse Event|1|||
28095928|NCT04252586|54750520|FG000|Overall Study|Death|2|||
28095929|NCT04252586|54750520|FG000|Overall Study|Study terminated by sponsor|4|||
28095930|NCT04252586|54750520|FG000|Overall Study|Sponsor request|10|||
28095931|NCT04252586|54750520|FG000|Overall Study|Did not complete treatment period|1|||
28095932|NCT04247828|54750525|FG000|Overall Study|covid-19 mandated patient recruitment restrictions|9|||
28095933|NCT04507776|54750529|FG000|Overall Study|Participants did not meet the entrance criteria|201|||
28095934|NCT04386902|54750538|FG000|Overall Study|Withdrawal by Subject|5|||
27738862|NCT02936323|54188172|FG004|Phase 2a Dose Expansion|Physician Decision|0|||
27834356|NCT01697579|54317919|FG000|Optional Extension-Cycles 2-6|Physician Decision|0|||
27834357|NCT01697579|54317920|FG001|Optional Extension-Cycles 2-6|Physician Decision|0|||
27834358|NCT01697579|54317921|FG002|Optional Extension-Cycles 2-6|Physician Decision|0|||
27834359|NCT01697579|54317922|FG003|Optional Extension-Cycles 2-6|Physician Decision|0|||
27834360|NCT01697579|54317923|FG004|Optional Extension-Cycles 2-6|Physician Decision|0|||
27834361|NCT01697579|54317924|FG005|Optional Extension-Cycles 2-6|Physician Decision|7|||
27834362|NCT01697579|54317925|FG006|Optional Extension-Cycles 2-6|Physician Decision|11|||
27834363|NCT01697579|54317919|FG000|Optional Extension-Cycles 2-6|Protocol Violation|0|||
27859511|NCT01654536|54416174|FG000|Overall Study|Withdrawal by Subject|27|||
27981230|NCT00887588|54639091|FG000|Extension Period|Adverse Event|4|||
27981231|NCT00887588|54639092|FG001|Extension Period|Adverse Event|4|||
27981232|NCT00887588|54639091|FG000|Extension Period|Death|0|||
27834364|NCT01697579|54317920|FG001|Optional Extension-Cycles 2-6|Protocol Violation|0|||
27981233|NCT00887588|54639092|FG001|Extension Period|Death|1|||
27981234|NCT00887588|54639091|FG000|Extension Period|Protocol deviation|1|||
27981235|NCT00887588|54639092|FG001|Extension Period|Protocol deviation|0|||
27834365|NCT01697579|54317921|FG002|Optional Extension-Cycles 2-6|Protocol Violation|0|||
27834366|NCT01697579|54317922|FG003|Optional Extension-Cycles 2-6|Protocol Violation|0|||
27859512|NCT01654536|54416175|FG001|Overall Study|Withdrawal by Subject|25|||
27859513|NCT01654380|54416184|FG000|Part B, Period 1|Physician Decision|0|||
27859514|NCT01654380|54416185|FG001|Part B, Period 1|Physician Decision|0|||
27859515|NCT01654380|54416186|FG002|Part B, Period 1|Physician Decision|1|||
27859516|NCT01654380|54416187|FG003|Part B, Period 1|Physician Decision|0|||
27859517|NCT02477670|54416206|FG000|Stage 1|Adverse Event|2|||
27859518|NCT02477670|54416207|FG001|Stage 1|Adverse Event|7|||
27859519|NCT02477670|54416208|FG002|Stage 1|Adverse Event|0|||
27859520|NCT02477670|54416209|FG003|Stage 1|Adverse Event|0|||
27859521|NCT02477670|54416210|FG004|Stage 1|Adverse Event|0|||
27859522|NCT02477670|54416211|FG005|Stage 1|Adverse Event|0|||
27859523|NCT02477670|54416212|FG006|Stage 1|Adverse Event|0|||
27859524|NCT02477670|54416206|FG000|Stage 1|Lost to Follow-up|0|||
27859525|NCT02477670|54416207|FG001|Stage 1|Lost to Follow-up|2|||
27859526|NCT02477670|54416208|FG002|Stage 1|Lost to Follow-up|0|||
27859527|NCT02477670|54416209|FG003|Stage 1|Lost to Follow-up|0|||
27859528|NCT02477670|54416210|FG004|Stage 1|Lost to Follow-up|0|||
27859529|NCT02477670|54416211|FG005|Stage 1|Lost to Follow-up|0|||
27859530|NCT02477670|54416212|FG006|Stage 1|Lost to Follow-up|0|||
27859531|NCT02477670|54416206|FG000|Stage 1|Withdrawal by Subject|1|||
27859532|NCT02477670|54416207|FG001|Stage 1|Withdrawal by Subject|2|||
27859533|NCT02477670|54416208|FG002|Stage 1|Withdrawal by Subject|0|||
27859534|NCT02477670|54416209|FG003|Stage 1|Withdrawal by Subject|0|||
27859535|NCT02477670|54416210|FG004|Stage 1|Withdrawal by Subject|0|||
27859536|NCT02477670|54416211|FG005|Stage 1|Withdrawal by Subject|0|||
27859537|NCT02477670|54416212|FG006|Stage 1|Withdrawal by Subject|0|||
27859538|NCT02477670|54416206|FG000|Stage 1|Non-compliance with Study Drug|1|||
27859539|NCT02477670|54416207|FG001|Stage 1|Non-compliance with Study Drug|2|||
27859540|NCT02477670|54416208|FG002|Stage 1|Non-compliance with Study Drug|0|||
27859541|NCT02477670|54416209|FG003|Stage 1|Non-compliance with Study Drug|0|||
27859542|NCT02477670|54416210|FG004|Stage 1|Non-compliance with Study Drug|0|||
27859543|NCT02477670|54416211|FG005|Stage 1|Non-compliance with Study Drug|0|||
27859544|NCT02477670|54416212|FG006|Stage 1|Non-compliance with Study Drug|0|||
27859545|NCT02477670|54416206|FG000|Stage 2|Adverse Event|0|||
27859546|NCT02477670|54416207|FG001|Stage 2|Adverse Event|0|||
27859547|NCT02477670|54416208|FG002|Stage 2|Adverse Event|1|||
27859548|NCT02477670|54416209|FG003|Stage 2|Adverse Event|0|||
27859549|NCT02477670|54416210|FG004|Stage 2|Adverse Event|0|||
27859550|NCT02477670|54416211|FG005|Stage 2|Adverse Event|0|||
27859551|NCT02477670|54416212|FG006|Stage 2|Adverse Event|0|||
27859552|NCT02477670|54416206|FG000|Stage 2|Antipsychotic Medication Changed|0|||
27859553|NCT02477670|54416207|FG001|Stage 2|Antipsychotic Medication Changed|0|||
27859554|NCT02477670|54416208|FG002|Stage 2|Antipsychotic Medication Changed|1|||
27859555|NCT02477670|54416209|FG003|Stage 2|Antipsychotic Medication Changed|0|||
27859556|NCT02477670|54416210|FG004|Stage 2|Antipsychotic Medication Changed|0|||
27859557|NCT02477670|54416211|FG005|Stage 2|Antipsychotic Medication Changed|0|||
27859558|NCT02477670|54416212|FG006|Stage 2|Antipsychotic Medication Changed|0|||
28171313|NCT02720523|54842900|FG001|Period 1: Placebo-controlled Period|Other|0|||
28171314|NCT02720523|54842901|FG002|Period 1: Placebo-controlled Period|Other|1|||
28171315|NCT02720523|54842902|FG003|Period 1: Placebo-controlled Period|Other|1|||
27834367|NCT01697579|54317923|FG004|Optional Extension-Cycles 2-6|Protocol Violation|0|||
27834368|NCT01697579|54317924|FG005|Optional Extension-Cycles 2-6|Protocol Violation|0|||
27834369|NCT01697579|54317925|FG006|Optional Extension-Cycles 2-6|Protocol Violation|4|||
27834370|NCT01697579|54317919|FG000|Optional Extension-Cycles 2-6|Excluded Medication|0|||
27834371|NCT01697579|54317920|FG001|Optional Extension-Cycles 2-6|Excluded Medication|0|||
27834372|NCT01697579|54317921|FG002|Optional Extension-Cycles 2-6|Excluded Medication|0|||
27834373|NCT01697579|54317922|FG003|Optional Extension-Cycles 2-6|Excluded Medication|0|||
27834374|NCT01697579|54317923|FG004|Optional Extension-Cycles 2-6|Excluded Medication|0|||
27834375|NCT01697579|54317924|FG005|Optional Extension-Cycles 2-6|Excluded Medication|1|||
27834376|NCT01697579|54317925|FG006|Optional Extension-Cycles 2-6|Excluded Medication|2|||
27834377|NCT01697579|54317919|FG000|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
27834378|NCT01697579|54317920|FG001|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
27834379|NCT01697579|54317921|FG002|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
27859559|NCT02477670|54416206|FG000|Stage 2|Withdrawal by Subject|0|||
28171316|NCT02720523|54842903|FG004|Period 1: Placebo-controlled Period|Other|0|||
28171317|NCT02720523|54842904|FG005|Period 1: Placebo-controlled Period|Other|0|||
27834380|NCT01697579|54317922|FG003|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
27859560|NCT02477670|54416207|FG001|Stage 2|Withdrawal by Subject|0|||
27859561|NCT02477670|54416208|FG002|Stage 2|Withdrawal by Subject|0|||
27859562|NCT02477670|54416209|FG003|Stage 2|Withdrawal by Subject|1|||
27859563|NCT02477670|54416210|FG004|Stage 2|Withdrawal by Subject|0|||
27859564|NCT02477670|54416211|FG005|Stage 2|Withdrawal by Subject|0|||
27859565|NCT02477670|54416212|FG006|Stage 2|Withdrawal by Subject|0|||
27859566|NCT02509026|54416223|FG000|Induction Period (24 Weeks)|Adverse Event|5|||
27859567|NCT02509026|54416223|FG000|Induction Period (24 Weeks)|Eligibility Criteria|5|||
27859568|NCT02509026|54416223|FG000|Induction Period (24 Weeks)|Lack of Efficacy|6|||
27859569|NCT02509026|54416223|FG000|Induction Period (24 Weeks)|Lost to Follow-up|1|||
27859570|NCT02509026|54416223|FG000|Induction Period (24 Weeks)|Other|2|||
27859571|NCT02509026|54416223|FG000|Induction Period (24 Weeks)|Protocol Violation|1|||
27859572|NCT02509026|54416223|FG000|Induction Period (24 Weeks)|Withdrawal by Subject|1|||
27859573|NCT02509026|54416223|FG000|Induction Period (24 Weeks)|Enrolled but not treated|1|||
27859574|NCT02509026|54416223|FG000|Withdrawal Period (40 Weeks)|Protocol Violation|2|||
27859575|NCT02509026|54416223|FG000|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5|||
27859576|NCT02509026|54416223|FG000|Retreatment Period (12 Weeks)|Lost to Follow-up|1|||
27859577|NCT02509026|54416223|FG000|Retreatment Period (12 Weeks)|Withdrawal by Subject|2|||
27859578|NCT02509026|54416223|FG000|Retreatment Period (12 Weeks)|Enrolled but not treated|1|||
27859579|NCT02476968|54416606|FG000|Overall Study|Other|0|||
27859580|NCT02476968|54416607|FG001|Overall Study|Other|2|||
27859581|NCT02476968|54416608|FG002|Overall Study|Other|0|||
28095935|NCT04386902|54750538|FG000|Overall Study|Technical problems in the recording|5|||
28095936|NCT04232540|54750544|FG000|Overall Study|Lost to Follow-up|1|||
28095937|NCT04232540|54750545|FG001|Overall Study|Lost to Follow-up|0|||
28095938|NCT04504032|54750553|FG000|Overall Study|Adverse Event|1|||
28095939|NCT04504032|54750554|FG001|Overall Study|Adverse Event|2|||
28095940|NCT04504032|54750553|FG000|Overall Study|Lost to Follow-up|6|||
27859582|NCT02476968|54416606|FG000|Overall Study|Lost to Follow-up|10|||
27859583|NCT02476968|54416607|FG001|Overall Study|Lost to Follow-up|0|||
27859584|NCT02476968|54416608|FG002|Overall Study|Lost to Follow-up|1|||
27859585|NCT02476968|54416606|FG000|Overall Study|Death|48|||
27859586|NCT02476968|54416607|FG001|Overall Study|Death|8|||
27859587|NCT02476968|54416608|FG002|Overall Study|Death|1|||
27859588|NCT02476968|54416606|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
27859589|NCT02476968|54416607|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
27859590|NCT02476968|54416608|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
27859591|NCT02476968|54416606|FG000|Overall Study|Patient decision|37|||
27859592|NCT02476968|54416607|FG001|Overall Study|Patient decision|8|||
27859593|NCT02476968|54416608|FG002|Overall Study|Patient decision|0|||
27859594|NCT02476578|54416629|FG000|Overall Study|Died before Email was sent (<9.11.2015)|35|||
27859595|NCT02476578|54416630|FG001|Overall Study|Died before Email was sent (<9.11.2015)|43|||
27859596|NCT02476578|54416629|FG000|Overall Study|Lost to Follow-up|6|||
27859597|NCT02476578|54416630|FG001|Overall Study|Lost to Follow-up|13|||
27859598|NCT02504892|54416648|FG000|Overall Study|Adverse event-pneumonitis|2|||
27859599|NCT02504502|54416654|FG000|Routine Care vs. Enhanced Report|Lost to Follow-up|4|||
27859600|NCT02504502|54416655|FG001|Routine Care vs. Enhanced Report|Lost to Follow-up|7|||
27859601|NCT02504502|54416654|FG000|Crossover to Enhanced Report|Lost to Follow-up|5|||
27859602|NCT02504502|54416655|FG001|Crossover to Enhanced Report|Lost to Follow-up|0|||
27859603|NCT04184622|54416678|FG000|Overall Study|Adverse Event|7|||
27859604|NCT04184622|54416679|FG001|Overall Study|Adverse Event|7|||
27859605|NCT04184622|54416680|FG002|Overall Study|Adverse Event|11|||
27859606|NCT04184622|54416681|FG003|Overall Study|Adverse Event|8|||
27859607|NCT04184622|54416678|FG000|Overall Study|Death|4|||
27859608|NCT04184622|54416679|FG001|Overall Study|Death|4|||
27859609|NCT04184622|54416680|FG002|Overall Study|Death|2|||
27859610|NCT04184622|54416681|FG003|Overall Study|Death|1|||
27859611|NCT04184622|54416678|FG000|Overall Study|Lost to Follow-up|41|||
27834381|NCT01697579|54317923|FG004|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
27834382|NCT01697579|54317924|FG005|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1|||
27834383|NCT01697579|54317925|FG006|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
27834384|NCT01697579|54317919|FG000|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
27834385|NCT01697579|54317920|FG001|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
27834386|NCT01697579|54317921|FG002|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
27834387|NCT01697579|54317922|FG003|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
27834388|NCT01697579|54317923|FG004|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
27834389|NCT01697579|54317924|FG005|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15|||
27834390|NCT01697579|54317925|FG006|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24|||
27834391|NCT01697579|54317919|FG000|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
27834392|NCT01697579|54317920|FG001|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
27859612|NCT04184622|54416679|FG001|Overall Study|Lost to Follow-up|19|||
27859613|NCT04184622|54416680|FG002|Overall Study|Lost to Follow-up|20|||
27859614|NCT04184622|54416681|FG003|Overall Study|Lost to Follow-up|15|||
27859615|NCT04184622|54416678|FG000|Overall Study|Missing Weight at Week 72|1|||
27981236|NCT00887588|54639091|FG000|Extension Period|Lost to Follow-up|1|||
28095941|NCT04504032|54750554|FG001|Overall Study|Lost to Follow-up|9|||
27859616|NCT04184622|54416679|FG001|Overall Study|Missing Weight at Week 72|0|||
27859617|NCT04184622|54416680|FG002|Overall Study|Missing Weight at Week 72|1|||
27859618|NCT04184622|54416681|FG003|Overall Study|Missing Weight at Week 72|0|||
27859619|NCT04184622|54416678|FG000|Overall Study|Other - as reported by the investigator|22|||
28095942|NCT04504032|54750553|FG000|Overall Study|Protocol Violation|2|||
27859620|NCT04184622|54416679|FG001|Overall Study|Other - as reported by the investigator|7|||
27859621|NCT04184622|54416680|FG002|Overall Study|Other - as reported by the investigator|5|||
27859622|NCT04184622|54416681|FG003|Overall Study|Other - as reported by the investigator|12|||
27859623|NCT04184622|54416678|FG000|Overall Study|Physician Decision|0|||
27859624|NCT04184622|54416679|FG001|Overall Study|Physician Decision|0|||
27859625|NCT04184622|54416680|FG002|Overall Study|Physician Decision|3|||
27859626|NCT04184622|54416681|FG003|Overall Study|Physician Decision|1|||
27859627|NCT04184622|54416678|FG000|Overall Study|Pregnancy|4|||
27859628|NCT04184622|54416679|FG001|Overall Study|Pregnancy|4|||
27859629|NCT04184622|54416680|FG002|Overall Study|Pregnancy|3|||
27859630|NCT04184622|54416681|FG003|Overall Study|Pregnancy|5|||
27859631|NCT04184622|54416678|FG000|Overall Study|Protocol Deviation|1|||
27859632|NCT04184622|54416679|FG001|Overall Study|Protocol Deviation|0|||
27859633|NCT04184622|54416680|FG002|Overall Study|Protocol Deviation|0|||
27859634|NCT04184622|54416681|FG003|Overall Study|Protocol Deviation|0|||
27859635|NCT04184622|54416678|FG000|Overall Study|Withdrawal by Subject|68|||
27859636|NCT04184622|54416679|FG001|Overall Study|Withdrawal by Subject|28|||
27859637|NCT04184622|54416680|FG002|Overall Study|Withdrawal by Subject|29|||
27859638|NCT04184622|54416681|FG003|Overall Study|Withdrawal by Subject|22|||
27859639|NCT03772717|54416714|FG000|Overall Study|Withdrawal by Subject|2|||
27859640|NCT03770403|54416718|FG000|Overall Study|Adverse Event|8|||
27859641|NCT03770403|54416718|FG000|Overall Study|Death|5|||
27859642|NCT03770403|54416718|FG000|Overall Study|Physician Decision|1|||
27859643|NCT03770403|54416718|FG000|Overall Study|Sponsor decision|1|||
27859644|NCT03770403|54416718|FG000|Overall Study|Study terminated by Sponsor|1|||
27859645|NCT03770403|54416718|FG000|Overall Study|Withdrawal by Subject|13|||
27859646|NCT03770403|54416718|FG000|Overall Study|Other|88|||
27859647|NCT03740100|54416722|FG000|Overall Study|Adverse Event|1|||
27859648|NCT03740100|54416722|FG000|Overall Study|Death|1|||
27859649|NCT03536884|54416728|FG000|Initial Treatment Period Week 0-16|Adverse Event|8|||
27859650|NCT03536884|54416729|FG001|Initial Treatment Period Week 0-16|Adverse Event|6|||
27859651|NCT03536884|54416730|FG002|Initial Treatment Period Week 0-16|Adverse Event|0|||
27859652|NCT03536884|54416731|FG003|Initial Treatment Period Week 0-16|Adverse Event|0|||
27859653|NCT03536884|54416732|FG004|Initial Treatment Period Week 0-16|Adverse Event|0|||
27859654|NCT03536884|54416728|FG000|Initial Treatment Period Week 0-16|Lost to Follow-up|0|||
27859655|NCT03536884|54416729|FG001|Initial Treatment Period Week 0-16|Lost to Follow-up|3|||
27859656|NCT03536884|54416730|FG002|Initial Treatment Period Week 0-16|Lost to Follow-up|0|||
27859657|NCT03536884|54416731|FG003|Initial Treatment Period Week 0-16|Lost to Follow-up|0|||
27859658|NCT03536884|54416732|FG004|Initial Treatment Period Week 0-16|Lost to Follow-up|0|||
27859659|NCT03536884|54416728|FG000|Initial Treatment Period Week 0-16|Withdrawal by Subject|3|||
27859660|NCT03536884|54416729|FG001|Initial Treatment Period Week 0-16|Withdrawal by Subject|4|||
27859661|NCT03536884|54416730|FG002|Initial Treatment Period Week 0-16|Withdrawal by Subject|0|||
27859662|NCT03536884|54416731|FG003|Initial Treatment Period Week 0-16|Withdrawal by Subject|0|||
27859663|NCT03536884|54416732|FG004|Initial Treatment Period Week 0-16|Withdrawal by Subject|0|||
27859664|NCT03536884|54416728|FG000|Initial Treatment Period Week 0-16|Unblinding was reason for dropout|0|||
27859665|NCT03536884|54416729|FG001|Initial Treatment Period Week 0-16|Unblinding was reason for dropout|1|||
27859666|NCT03536884|54416730|FG002|Initial Treatment Period Week 0-16|Unblinding was reason for dropout|0|||
27859667|NCT03536884|54416731|FG003|Initial Treatment Period Week 0-16|Unblinding was reason for dropout|0|||
27859668|NCT03536884|54416732|FG004|Initial Treatment Period Week 0-16|Unblinding was reason for dropout|0|||
27859669|NCT03536884|54416728|FG000|Initial Treatment Period Week 0-16|Withdrawn by Investigator for abnormal lab values|0|||
27859670|NCT03536884|54416729|FG001|Initial Treatment Period Week 0-16|Withdrawn by Investigator for abnormal lab values|1|||
27859671|NCT03536884|54416730|FG002|Initial Treatment Period Week 0-16|Withdrawn by Investigator for abnormal lab values|0|||
27859672|NCT03536884|54416731|FG003|Initial Treatment Period Week 0-16|Withdrawn by Investigator for abnormal lab values|0|||
27859673|NCT03536884|54416732|FG004|Initial Treatment Period Week 0-16|Withdrawn by Investigator for abnormal lab values|0|||
27859674|NCT03536884|54416728|FG000|Initial Treatment Period Week 0-16|Unable to attend visits|0|||
27859675|NCT03536884|54416729|FG001|Initial Treatment Period Week 0-16|Unable to attend visits|1|||
27859676|NCT03536884|54416730|FG002|Initial Treatment Period Week 0-16|Unable to attend visits|0|||
27859677|NCT03536884|54416731|FG003|Initial Treatment Period Week 0-16|Unable to attend visits|0|||
27859678|NCT03536884|54416732|FG004|Initial Treatment Period Week 0-16|Unable to attend visits|0|||
27859679|NCT03536884|54416728|FG000|Maintenance Treatment Period Week 16-48|Death|0|||
27859680|NCT03536884|54416729|FG001|Maintenance Treatment Period Week 16-48|Death|0|||
27859681|NCT03536884|54416730|FG002|Maintenance Treatment Period Week 16-48|Death|1|||
27859682|NCT03536884|54416731|FG003|Maintenance Treatment Period Week 16-48|Death|0|||
27859683|NCT03536884|54416732|FG004|Maintenance Treatment Period Week 16-48|Death|1|||
27859684|NCT03536884|54416728|FG000|Maintenance Treatment Period Week 16-48|Adverse Event|0|||
27859685|NCT03536884|54416729|FG001|Maintenance Treatment Period Week 16-48|Adverse Event|0|||
27859686|NCT03536884|54416730|FG002|Maintenance Treatment Period Week 16-48|Adverse Event|1|||
27859687|NCT03536884|54416731|FG003|Maintenance Treatment Period Week 16-48|Adverse Event|3|||
27859688|NCT03536884|54416732|FG004|Maintenance Treatment Period Week 16-48|Adverse Event|3|||
27859689|NCT03536884|54416728|FG000|Maintenance Treatment Period Week 16-48|Lack of Efficacy|0|||
27859690|NCT03536884|54416729|FG001|Maintenance Treatment Period Week 16-48|Lack of Efficacy|0|||
27859691|NCT03536884|54416730|FG002|Maintenance Treatment Period Week 16-48|Lack of Efficacy|0|||
27859692|NCT03536884|54416731|FG003|Maintenance Treatment Period Week 16-48|Lack of Efficacy|1|||
27859693|NCT03536884|54416732|FG004|Maintenance Treatment Period Week 16-48|Lack of Efficacy|4|||
27859694|NCT03536884|54416728|FG000|Maintenance Treatment Period Week 16-48|Lost to Follow-up|0|||
27859695|NCT03536884|54416729|FG001|Maintenance Treatment Period Week 16-48|Lost to Follow-up|0|||
27859696|NCT03536884|54416730|FG002|Maintenance Treatment Period Week 16-48|Lost to Follow-up|1|||
27859697|NCT03536884|54416731|FG003|Maintenance Treatment Period Week 16-48|Lost to Follow-up|2|||
27859698|NCT03536884|54416732|FG004|Maintenance Treatment Period Week 16-48|Lost to Follow-up|8|||
27859699|NCT03536884|54416728|FG000|Maintenance Treatment Period Week 16-48|Withdrawal by Subject|0|||
27859700|NCT03536884|54416729|FG001|Maintenance Treatment Period Week 16-48|Withdrawal by Subject|0|||
27859701|NCT03536884|54416730|FG002|Maintenance Treatment Period Week 16-48|Withdrawal by Subject|7|||
27859702|NCT03536884|54416731|FG003|Maintenance Treatment Period Week 16-48|Withdrawal by Subject|3|||
27859703|NCT03536884|54416732|FG004|Maintenance Treatment Period Week 16-48|Withdrawal by Subject|12|||
27859704|NCT03536884|54416728|FG000|Maintenance Treatment Period Week 16-48|Unable to come back for study visits|0|||
27859705|NCT03536884|54416729|FG001|Maintenance Treatment Period Week 16-48|Unable to come back for study visits|0|||
27859706|NCT03536884|54416730|FG002|Maintenance Treatment Period Week 16-48|Unable to come back for study visits|0|||
27859707|NCT03536884|54416731|FG003|Maintenance Treatment Period Week 16-48|Unable to come back for study visits|0|||
27859708|NCT03536884|54416732|FG004|Maintenance Treatment Period Week 16-48|Unable to come back for study visits|1|||
27859709|NCT03499795|54416747|FG000|Overall Study|Adverse Event|1|||
27859710|NCT03499795|54416747|FG000|Overall Study|Lost to Follow-up|1|||
27859711|NCT03456700|54416764|FG000|Overall Study|Withdrawal by Subject|1|||
27859712|NCT03401450|54416770|FG000|Overall Study|Lost to Follow-up|4|||
27859713|NCT03401450|54416771|FG001|Overall Study|Lost to Follow-up|6|||
27859714|NCT03401450|54416770|FG000|Overall Study|Anesthesia plan changed|2|||
27859715|NCT03401450|54416771|FG001|Overall Study|Anesthesia plan changed|2|||
27859716|NCT03401450|54416770|FG000|Overall Study|Did not complete medication diary|4|||
27859717|NCT03401450|54416771|FG001|Overall Study|Did not complete medication diary|2|||
27859718|NCT03401450|54416770|FG000|Overall Study|post surgery medication change|2|||
27859719|NCT03401450|54416771|FG001|Overall Study|post surgery medication change|1|||
27859720|NCT03401450|54416770|FG000|Overall Study|Cancelled surgery|0|||
27859721|NCT03401450|54416771|FG001|Overall Study|Cancelled surgery|2|||
27859722|NCT03326063|54416779|FG000|Overall Study|COVID pandemic: subject recalled to her country|1|||
27859723|NCT03326063|54416780|FG001|Overall Study|COVID pandemic: subject recalled to her country|0|||
27859724|NCT03155997|54416801|FG000|Overall Study|Withdrawal by Subject|119|||
27859725|NCT03155997|54416802|FG001|Overall Study|Withdrawal by Subject|134|||
27859726|NCT03155997|54416801|FG000|Overall Study|Lost to Follow-up|12|||
27859727|NCT03155997|54416802|FG001|Overall Study|Lost to Follow-up|13|||
27859728|NCT03155997|54416801|FG000|Overall Study|Missing disposition data|0|||
27859729|NCT03155997|54416802|FG001|Overall Study|Missing disposition data|1|||
27859730|NCT03155997|54416801|FG000|Overall Study|On study treatment|2027|||
27859731|NCT03155997|54416802|FG001|Overall Study|On study treatment|2074|||
27859732|NCT02764762|54416819|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
27859733|NCT02764762|54416819|FG000|Overall Study|Lost to Follow-up|4|||
27859734|NCT02764762|54416819|FG000|Overall Study|Voluntary Withdrawal|8|||
27859735|NCT02764762|54416819|FG000|Overall Study|Site Termination|1|||
27859736|NCT02764762|54416819|FG000|Overall Study|Lack of Efficacy|16|||
27859737|NCT02764762|54416819|FG000|Overall Study|Reason not Specified|1|||
27859738|NCT02340962|54416829|FG000|Overall Study|Lost to Follow-up|1|||
27859739|NCT02340962|54416830|FG001|Overall Study|Lost to Follow-up|0|||
27859740|NCT02335268|54416840|FG000|Overall Study|Physician Decision|5|||
27859741|NCT02335268|54416841|FG001|Overall Study|Physician Decision|1|||
27859742|NCT02335268|54416840|FG000|Overall Study|Lack of Efficacy|2|||
27859743|NCT02335268|54416841|FG001|Overall Study|Lack of Efficacy|1|||
27859744|NCT02335268|54416840|FG000|Overall Study|Adverse Event|5|||
27859745|NCT02335268|54416841|FG001|Overall Study|Adverse Event|2|||
27981237|NCT00887588|54639092|FG001|Extension Period|Lost to Follow-up|0|||
27981238|NCT00945893|54639100|FG000|Overall Study|Lost to Follow-up|2|||
27981239|NCT00945893|54639101|FG001|Overall Study|Lost to Follow-up|8|||
27981240|NCT00945893|54639100|FG000|Overall Study|Withdrawal of consent|1|||
27981241|NCT00945893|54639101|FG001|Overall Study|Withdrawal of consent|2|||
27981242|NCT00799383|54639113|FG000|Overall Study|Protocol Violation|1|||
28095943|NCT04504032|54750554|FG001|Overall Study|Protocol Violation|0|||
28095944|NCT04504032|54750553|FG000|Overall Study|Study terminated by sponsor|1|||
27859746|NCT02335268|54416840|FG000|Overall Study|increase blasts|2|||
27859747|NCT02335268|54416841|FG001|Overall Study|increase blasts|0|||
27859748|NCT02335268|54416840|FG000|Overall Study|Withdrawal by Subject|3|||
27859749|NCT02335268|54416841|FG001|Overall Study|Withdrawal by Subject|2|||
27981243|NCT00799383|54639114|FG001|Overall Study|Protocol Violation|1|||
27981244|NCT00799383|54639113|FG000|Overall Study|Adverse Event|0|||
28095945|NCT04504032|54750554|FG001|Overall Study|Study terminated by sponsor|2|||
27859750|NCT02272634|54416859|FG000|Overall Study|Adverse Event|1|||
27859751|NCT02272634|54416860|FG001|Overall Study|Adverse Event|0|||
27859752|NCT02272634|54416861|FG002|Overall Study|Adverse Event|0|||
27859753|NCT02272634|54416859|FG000|Overall Study|Protocol Violation|0|||
27859754|NCT02272634|54416860|FG001|Overall Study|Protocol Violation|0|||
27859755|NCT02272634|54416861|FG002|Overall Study|Protocol Violation|1|||
27859756|NCT02272634|54416859|FG000|Overall Study|Withdrawal by Subject|0|||
27859757|NCT02272634|54416860|FG001|Overall Study|Withdrawal by Subject|1|||
27859758|NCT02272634|54416861|FG002|Overall Study|Withdrawal by Subject|0|||
27859759|NCT00788125|54416872|FG000|Overall Study|Death|6|||
27859760|NCT00676715|54416880|FG000|Overall Study|Withdrawal by Subject|7|||
27859761|NCT00676715|54416881|FG001|Overall Study|Withdrawal by Subject|9|||
27859762|NCT00676715|54416882|FG002|Overall Study|Withdrawal by Subject|10|||
27859763|NCT00676715|54416883|FG003|Overall Study|Withdrawal by Subject|10|||
27859764|NCT00676715|54416880|FG000|Overall Study|Other|2|||
27859765|NCT00676715|54416881|FG001|Overall Study|Other|6|||
27859766|NCT00676715|54416882|FG002|Overall Study|Other|4|||
27859767|NCT00676715|54416883|FG003|Overall Study|Other|3|||
27859768|NCT00676715|54416880|FG000|Overall Study|Lost to Follow-up|1|||
27859769|NCT00676715|54416881|FG001|Overall Study|Lost to Follow-up|1|||
27859770|NCT00676715|54416882|FG002|Overall Study|Lost to Follow-up|7|||
27859771|NCT00676715|54416883|FG003|Overall Study|Lost to Follow-up|3|||
27859772|NCT00676715|54416880|FG000|Overall Study|Death|1|||
27859773|NCT00676715|54416881|FG001|Overall Study|Death|1|||
27859774|NCT00676715|54416882|FG002|Overall Study|Death|1|||
27859775|NCT00676715|54416883|FG003|Overall Study|Death|0|||
27859776|NCT00676715|54416880|FG000|Overall Study|Adverse Event|0|||
27859777|NCT00676715|54416881|FG001|Overall Study|Adverse Event|1|||
27859778|NCT00676715|54416882|FG002|Overall Study|Adverse Event|2|||
27859779|NCT00676715|54416883|FG003|Overall Study|Adverse Event|0|||
27859780|NCT00676715|54416880|FG000|Overall Study|Participants Ongoing|29|||
27859781|NCT00676715|54416881|FG001|Overall Study|Participants Ongoing|29|||
27859782|NCT00676715|54416882|FG002|Overall Study|Participants Ongoing|17|||
27859783|NCT00676715|54416883|FG003|Overall Study|Participants Ongoing|24|||
27859784|NCT02504424|54416902|FG000|Overall Study|Withdrawal by Subject|2|||
27859785|NCT02548832|54417232|FG000|Overall Study|Lost to Follow-up|2|||
27859786|NCT02548832|54417233|FG001|Overall Study|Lost to Follow-up|2|||
27859787|NCT02548832|54417234|FG002|Overall Study|Lost to Follow-up|2|||
27859788|NCT02504268|54417494|FG000|Overall Study|Adverse Event|18|||
27859789|NCT02504268|54417495|FG001|Overall Study|Adverse Event|8|||
27859790|NCT02504268|54417496|FG002|Overall Study|Adverse Event|14|||
27859791|NCT02504268|54417497|FG003|Overall Study|Adverse Event|0|||
27859792|NCT02504268|54417498|FG004|Overall Study|Adverse Event|0|||
27859793|NCT02504268|54417499|FG005|Overall Study|Adverse Event|0|||
27859794|NCT02504268|54417500|FG006|Overall Study|Adverse Event|0|||
27859795|NCT02504268|54417501|FG007|Overall Study|Adverse Event|0|||
27859796|NCT02504268|54417502|FG008|Overall Study|Adverse Event|0|||
27859797|NCT02504268|54417494|FG000|Overall Study|Withdrawal of Consent|11|||
27859798|NCT02504268|54417495|FG001|Overall Study|Withdrawal of Consent|10|||
27859799|NCT02504268|54417496|FG002|Overall Study|Withdrawal of Consent|3|||
27859800|NCT02504268|54417497|FG003|Overall Study|Withdrawal of Consent|0|||
27859801|NCT02504268|54417498|FG004|Overall Study|Withdrawal of Consent|0|||
27859802|NCT02504268|54417499|FG005|Overall Study|Withdrawal of Consent|0|||
27859803|NCT02504268|54417500|FG006|Overall Study|Withdrawal of Consent|0|||
27859804|NCT02504268|54417501|FG007|Overall Study|Withdrawal of Consent|0|||
27859805|NCT02504268|54417502|FG008|Overall Study|Withdrawal of Consent|0|||
27859806|NCT02504268|54417494|FG000|Overall Study|Pregnancy|2|||
27859807|NCT02504268|54417495|FG001|Overall Study|Pregnancy|0|||
27859808|NCT02504268|54417496|FG002|Overall Study|Pregnancy|0|||
27859809|NCT02504268|54417497|FG003|Overall Study|Pregnancy|0|||
27981245|NCT00799383|54639114|FG001|Overall Study|Adverse Event|1|||
27859810|NCT02504268|54417498|FG004|Overall Study|Pregnancy|0|||
27859811|NCT02504268|54417499|FG005|Overall Study|Pregnancy|0|||
27859812|NCT02504268|54417500|FG006|Overall Study|Pregnancy|0|||
27859813|NCT02504268|54417501|FG007|Overall Study|Pregnancy|0|||
27859814|NCT02504268|54417502|FG008|Overall Study|Pregnancy|0|||
27859815|NCT02504268|54417494|FG000|Overall Study|Lost to Follow-up|3|||
27859816|NCT02504268|54417495|FG001|Overall Study|Lost to Follow-up|6|||
27981246|NCT00799383|54639113|FG000|Overall Study|Lost to Follow-up|1|||
27981247|NCT00799383|54639114|FG001|Overall Study|Lost to Follow-up|2|||
27981248|NCT00799383|54639113|FG000|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
27981249|NCT00799383|54639114|FG001|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
27859817|NCT02504268|54417496|FG002|Overall Study|Lost to Follow-up|4|||
27859818|NCT02504268|54417497|FG003|Overall Study|Lost to Follow-up|0|||
27859819|NCT02504268|54417498|FG004|Overall Study|Lost to Follow-up|0|||
27859820|NCT02504268|54417499|FG005|Overall Study|Lost to Follow-up|0|||
27859821|NCT02504268|54417500|FG006|Overall Study|Lost to Follow-up|0|||
27859822|NCT02504268|54417501|FG007|Overall Study|Lost to Follow-up|0|||
27859823|NCT02504268|54417502|FG008|Overall Study|Lost to Follow-up|0|||
27859824|NCT02504268|54417494|FG000|Overall Study|Death|1|||
27859825|NCT02504268|54417495|FG001|Overall Study|Death|1|||
27859826|NCT02504268|54417496|FG002|Overall Study|Death|0|||
27859827|NCT02504268|54417497|FG003|Overall Study|Death|0|||
27859828|NCT02504268|54417498|FG004|Overall Study|Death|0|||
27859829|NCT02504268|54417499|FG005|Overall Study|Death|0|||
27859830|NCT02504268|54417500|FG006|Overall Study|Death|0|||
27859831|NCT02504268|54417501|FG007|Overall Study|Death|0|||
27859832|NCT02504268|54417502|FG008|Overall Study|Death|0|||
27859833|NCT02504268|54417494|FG000|Overall Study|Subject Request to Discontinue|11|||
27859834|NCT02504268|54417495|FG001|Overall Study|Subject Request to Discontinue|3|||
27859835|NCT02504268|54417496|FG002|Overall Study|Subject Request to Discontinue|6|||
27859836|NCT02504268|54417497|FG003|Overall Study|Subject Request to Discontinue|0|||
27859837|NCT02504268|54417498|FG004|Overall Study|Subject Request to Discontinue|0|||
27859838|NCT02504268|54417499|FG005|Overall Study|Subject Request to Discontinue|0|||
27859839|NCT02504268|54417500|FG006|Overall Study|Subject Request to Discontinue|0|||
27859840|NCT02504268|54417501|FG007|Overall Study|Subject Request to Discontinue|0|||
27859841|NCT02504268|54417502|FG008|Overall Study|Subject Request to Discontinue|0|||
27859842|NCT02504268|54417494|FG000|Overall Study|No Longer Meets Study Criteria|2|||
27859843|NCT02504268|54417495|FG001|Overall Study|No Longer Meets Study Criteria|3|||
27859844|NCT02504268|54417496|FG002|Overall Study|No Longer Meets Study Criteria|0|||
27859845|NCT02504268|54417497|FG003|Overall Study|No Longer Meets Study Criteria|0|||
27859846|NCT02504268|54417498|FG004|Overall Study|No Longer Meets Study Criteria|0|||
27859847|NCT02504268|54417499|FG005|Overall Study|No Longer Meets Study Criteria|0|||
27859848|NCT02504268|54417500|FG006|Overall Study|No Longer Meets Study Criteria|0|||
27859849|NCT02504268|54417501|FG007|Overall Study|No Longer Meets Study Criteria|0|||
27859850|NCT02504268|54417502|FG008|Overall Study|No Longer Meets Study Criteria|0|||
27859851|NCT02504268|54417494|FG000|Overall Study|Lack of Efficacy|11|||
27859852|NCT02504268|54417495|FG001|Overall Study|Lack of Efficacy|35|||
27859853|NCT02504268|54417496|FG002|Overall Study|Lack of Efficacy|9|||
27859854|NCT02504268|54417497|FG003|Overall Study|Lack of Efficacy|0|||
27859855|NCT02504268|54417498|FG004|Overall Study|Lack of Efficacy|0|||
27859856|NCT02504268|54417499|FG005|Overall Study|Lack of Efficacy|0|||
27859857|NCT02504268|54417500|FG006|Overall Study|Lack of Efficacy|0|||
27859858|NCT02504268|54417501|FG007|Overall Study|Lack of Efficacy|0|||
27859859|NCT02504268|54417502|FG008|Overall Study|Lack of Efficacy|0|||
27859860|NCT02504268|54417494|FG000|Overall Study|Poor/Non-Compliance|3|||
27859861|NCT02504268|54417495|FG001|Overall Study|Poor/Non-Compliance|2|||
27859862|NCT02504268|54417496|FG002|Overall Study|Poor/Non-Compliance|3|||
27859863|NCT02504268|54417497|FG003|Overall Study|Poor/Non-Compliance|0|||
27859864|NCT02504268|54417498|FG004|Overall Study|Poor/Non-Compliance|0|||
27859865|NCT02504268|54417499|FG005|Overall Study|Poor/Non-Compliance|0|||
27859866|NCT02504268|54417500|FG006|Overall Study|Poor/Non-Compliance|0|||
27859867|NCT02504268|54417501|FG007|Overall Study|Poor/Non-Compliance|0|||
27859868|NCT02504268|54417502|FG008|Overall Study|Poor/Non-Compliance|0|||
27859869|NCT02504268|54417494|FG000|Overall Study|Not Disclosed|1|||
27859870|NCT02504268|54417495|FG001|Overall Study|Not Disclosed|0|||
27859871|NCT02504268|54417496|FG002|Overall Study|Not Disclosed|2|||
27859872|NCT02504268|54417497|FG003|Overall Study|Not Disclosed|0|||
27859873|NCT02504268|54417498|FG004|Overall Study|Not Disclosed|0|||
27859874|NCT02504268|54417499|FG005|Overall Study|Not Disclosed|0|||
27859875|NCT02504268|54417500|FG006|Overall Study|Not Disclosed|0|||
27859876|NCT02504268|54417501|FG007|Overall Study|Not Disclosed|0|||
27859877|NCT02504268|54417502|FG008|Overall Study|Not Disclosed|0|||
27859878|NCT01654302|54417546|FG000|Second Intervention (Day 7)|Lost to Follow-up|1|||
27859879|NCT01654302|54417547|FG001|Second Intervention (Day 7)|Lost to Follow-up|1|||
27859880|NCT02476422|54417563|FG000|Overall Study|Subject/guardian decision|0|||
27859881|NCT02476422|54417564|FG001|Overall Study|Subject/guardian decision|1|||
27859882|NCT02475954|54417576|FG000|Overall Study|Withdrawal by Subject|2|||
27859883|NCT02475954|54417577|FG001|Overall Study|Withdrawal by Subject|2|||
27859884|NCT02475954|54417576|FG000|Overall Study|Lost to Follow-up|11|||
27859885|NCT02475954|54417577|FG001|Overall Study|Lost to Follow-up|9|||
27859886|NCT02475954|54417576|FG000|Overall Study|Death|1|||
28095946|NCT04504032|54750553|FG000|Overall Study|Withdrawal by Subject|9|||
28095947|NCT04504032|54750554|FG001|Overall Study|Withdrawal by Subject|11|||
28095948|NCT04504032|54750553|FG000|Overall Study|Disease progression prior to dosing|15|||
28095949|NCT04504032|54750554|FG001|Overall Study|Disease progression prior to dosing|3|||
27859887|NCT02475954|54417577|FG001|Overall Study|Death|1|||
27859888|NCT02475564|54417604|FG000|Overall Study|Withdrawal by Subject|1|||
27859889|NCT02475564|54417605|FG001|Overall Study|Withdrawal by Subject|0|||
27859890|NCT02475564|54417604|FG000|Overall Study|Lost to Follow-up|2|||
27859891|NCT02475564|54417605|FG001|Overall Study|Lost to Follow-up|1|||
27859892|NCT02475564|54417604|FG000|Overall Study|Intense Menstrual bleeding|1|||
27859893|NCT02475564|54417605|FG001|Overall Study|Intense Menstrual bleeding|0|||
27859894|NCT02503332|54417893|FG000|Overall Study|Adverse Event|17|||
27859895|NCT02503332|54417894|FG001|Overall Study|Adverse Event|5|||
27859896|NCT02503332|54417895|FG002|Overall Study|Adverse Event|3|||
27859897|NCT02503332|54417896|FG003|Overall Study|Adverse Event|1|||
27859898|NCT02503332|54417893|FG000|Overall Study|Investigator's Decision|5|||
28095950|NCT04504032|54750553|FG000|Overall Study|Drug supply issues|1|||
27859899|NCT02503332|54417894|FG001|Overall Study|Investigator's Decision|1|||
27859900|NCT02503332|54417895|FG002|Overall Study|Investigator's Decision|0|||
27859901|NCT02503332|54417896|FG003|Overall Study|Investigator's Decision|0|||
27859902|NCT02503332|54417893|FG000|Overall Study|Sponsor's Decision|1|||
27859903|NCT02503332|54417894|FG001|Overall Study|Sponsor's Decision|0|||
27859904|NCT02503332|54417895|FG002|Overall Study|Sponsor's Decision|0|||
27859905|NCT02503332|54417896|FG003|Overall Study|Sponsor's Decision|1|||
27859906|NCT02503332|54417893|FG000|Overall Study|Subject Request|6|||
27859907|NCT02503332|54417894|FG001|Overall Study|Subject Request|5|||
27859908|NCT02503332|54417895|FG002|Overall Study|Subject Request|2|||
27859909|NCT02503332|54417896|FG003|Overall Study|Subject Request|1|||
27859910|NCT02503332|54417893|FG000|Overall Study|Death|0|||
27859911|NCT02503332|54417894|FG001|Overall Study|Death|2|||
27859912|NCT02503332|54417895|FG002|Overall Study|Death|2|||
27859913|NCT02503332|54417896|FG003|Overall Study|Death|0|||
27859914|NCT02503332|54417893|FG000|Overall Study|Other|5|||
27859915|NCT02503332|54417894|FG001|Overall Study|Other|6|||
27859916|NCT02503332|54417895|FG002|Overall Study|Other|1|||
27859917|NCT02503332|54417896|FG003|Overall Study|Other|1|||
27859918|NCT02502864|54417914|FG000|Overall Study|Withdrawal by Subject|1|||
27859919|NCT02474082|54417948|FG000|Overall Study|Adverse Event|2|||
27859920|NCT02474082|54417949|FG001|Overall Study|Adverse Event|32|||
27859921|NCT02474082|54417948|FG000|Overall Study|Withdrawal of informed consent|1|||
27859922|NCT02474082|54417949|FG001|Overall Study|Withdrawal of informed consent|11|||
27859923|NCT02474082|54417948|FG000|Overall Study|Lost to Follow-up|2|||
27859924|NCT02474082|54417949|FG001|Overall Study|Lost to Follow-up|2|||
27859925|NCT02474082|54417948|FG000|Overall Study|Dose tapering not achieved|0|||
27859926|NCT02474082|54417949|FG001|Overall Study|Dose tapering not achieved|4|||
27859927|NCT02474082|54417948|FG000|Overall Study|Participant/guardian decision|1|||
27859928|NCT02474082|54417949|FG001|Overall Study|Participant/guardian decision|2|||
27859929|NCT02474082|54417948|FG000|Overall Study|Non-compliance with study treatment|0|||
27859930|NCT02474082|54417949|FG001|Overall Study|Non-compliance with study treatment|2|||
27859931|NCT02474082|54417948|FG000|Overall Study|Protocol deviation|0|||
27859932|NCT02474082|54417949|FG001|Overall Study|Protocol deviation|1|||
27859933|NCT02501928|54418059|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
27859934|NCT02501928|54418060|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
27859935|NCT02501928|54418061|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
27859936|NCT02501928|54418062|FG003|Overall Study|Withdrawal By Parent/Guardian|0|||
27859937|NCT02501928|54418063|FG004|Overall Study|Withdrawal By Parent/Guardian|1|||
27859938|NCT02501928|54418064|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
27859939|NCT02473614|54418128|FG000|First Intervention (3 Weeks)|Job duties/lack of transportation|1|||
27859940|NCT02473614|54418129|FG001|First Intervention (3 Weeks)|Job duties/lack of transportation|0|||
27859941|NCT02500758|54418151|FG000|First Intervention (2 Minutes)|Withdrawal by Subject|0|||
27859942|NCT02500758|54418152|FG001|First Intervention (2 Minutes)|Withdrawal by Subject|1|||
27859943|NCT02500758|54418151|FG000|Washout (1 Week)|Lost to Follow-up|2|||
27859944|NCT02500758|54418152|FG001|Washout (1 Week)|Lost to Follow-up|2|||
27859945|NCT02500758|54418151|FG000|Second Intervention (2 Minutes)|Withdrawal by Subject|2|||
27859946|NCT02500758|54418152|FG001|Second Intervention (2 Minutes)|Withdrawal by Subject|0|||
27859947|NCT02500758|54418151|FG000|Second Intervention (2 Minutes)|Lost to Follow-up|0|||
27859948|NCT02500758|54418152|FG001|Second Intervention (2 Minutes)|Lost to Follow-up|1|||
27859949|NCT02500758|54418151|FG000|Second Intervention (2 Minutes)|Protocol Violation|1|||
27859950|NCT02500758|54418152|FG001|Second Intervention (2 Minutes)|Protocol Violation|1|||
27859951|NCT02500056|54418166|FG000|Overall Study|Lost to Follow-up|3|||
27859952|NCT02500056|54418167|FG001|Overall Study|Lost to Follow-up|7|||
27859953|NCT02500056|54418166|FG000|Overall Study|Recurrence|1|||
27859954|NCT02500056|54418167|FG001|Overall Study|Recurrence|0|||
27859955|NCT02500056|54418166|FG000|Overall Study|Death|3|||
27859956|NCT02500056|54418167|FG001|Overall Study|Death|1|||
27859957|NCT02472756|54418216|FG000|Induction (Approximately 6 Months)|Adverse Event|1|||
27859958|NCT02472756|54418216|FG000|Induction (Approximately 6 Months)|Enrolled But Not Treated|1|||
27859959|NCT02472756|54418216|FG000|Maintenance (Approximately 2 Years)|Lack of Drug|7|||
27859960|NCT02472756|54418216|FG000|Maintenance (Approximately 2 Years)|Progression Disease|2|||
27859961|NCT02472756|54418216|FG000|Maintenance (Approximately 2 Years)|Adverse Event|1|||
27859962|NCT02498652|54418226|FG000|Overall Study|Protocol Violation|0|||
27859963|NCT02498652|54418227|FG001|Overall Study|Protocol Violation|1|||
27859964|NCT03213158|54418251|FG000|Overall Study|Withdrawal by Subject|1|||
27859965|NCT03213158|54418251|FG000|Overall Study|Physician Decision|2|||
27859966|NCT02498418|54418258|FG000|Overall Study|Lack of Efficacy|0|||
27859967|NCT02498418|54418259|FG001|Overall Study|Lack of Efficacy|0|||
27859968|NCT02498418|54418260|FG002|Overall Study|Lack of Efficacy|1|||
27859969|NCT02498418|54418258|FG000|Overall Study|Withdrawal by Subject|2|||
27859970|NCT02498418|54418259|FG001|Overall Study|Withdrawal by Subject|0|||
27859971|NCT02498418|54418260|FG002|Overall Study|Withdrawal by Subject|3|||
27859972|NCT02498418|54418258|FG000|Overall Study|Lost to Follow-up|0|||
27859973|NCT02498418|54418259|FG001|Overall Study|Lost to Follow-up|1|||
27859974|NCT02498418|54418260|FG002|Overall Study|Lost to Follow-up|1|||
27859975|NCT02498418|54418258|FG000|Overall Study|Participant taken prohibited medication|0|||
27859976|NCT02498418|54418259|FG001|Overall Study|Participant taken prohibited medication|1|||
27859977|NCT02498418|54418260|FG002|Overall Study|Participant taken prohibited medication|1|||
27859978|NCT02472366|54418278|FG000|Overall Study|Lost to Follow-up|1|||
27859979|NCT02472366|54418279|FG001|Overall Study|Lost to Follow-up|0|||
27859980|NCT03219164|54418287|FG000|Overall Study|Study Terminated by Sponsor|16|||
27859981|NCT03219164|54418288|FG001|Overall Study|Study Terminated by Sponsor|12|||
27859982|NCT03219164|54418287|FG000|Overall Study|Withdrew Consent by Parent/Guardian|5|||
27859983|NCT03219164|54418288|FG001|Overall Study|Withdrew Consent by Parent/Guardian|4|||
27859984|NCT03219164|54418287|FG000|Overall Study|Lost to Follow-up|1|||
27859985|NCT03219164|54418288|FG001|Overall Study|Lost to Follow-up|1|||
27859986|NCT03219164|54418287|FG000|Overall Study|Adverse Event|1|||
27859987|NCT03219164|54418288|FG001|Overall Study|Adverse Event|0|||
27859988|NCT03219164|54418287|FG000|Overall Study|Non-Compliance with Study Drug|1|||
27859989|NCT03219164|54418288|FG001|Overall Study|Non-Compliance with Study Drug|0|||
27859990|NCT03219164|54418287|FG000|Overall Study|Protocol Violation|0|||
27859991|NCT03219164|54418288|FG001|Overall Study|Protocol Violation|1|||
27859992|NCT03219164|54418287|FG000|Overall Study|Withdrew Assent|1|||
27859993|NCT03219164|54418288|FG001|Overall Study|Withdrew Assent|0|||
27859994|NCT02471586|54418306|FG000|Overall Study|Lost to Follow-up|3|||
27859995|NCT02471586|54418307|FG001|Overall Study|Lost to Follow-up|8|||
27859996|NCT02471586|54418308|FG002|Overall Study|Lost to Follow-up|4|||
27859997|NCT02471586|54418306|FG000|Overall Study|Death|2|||
27859998|NCT02471586|54418307|FG001|Overall Study|Death|2|||
27859999|NCT02471586|54418308|FG002|Overall Study|Death|0|||
27860000|NCT02470806|54418459|FG000|Overall Study|Lost to Follow-up|1|||
27860001|NCT02470806|54418460|FG001|Overall Study|Lost to Follow-up|1|||
27860002|NCT02470806|54418459|FG000|Overall Study|Adverse Event|5|||
27860003|NCT02470806|54418460|FG001|Overall Study|Adverse Event|2|||
27860004|NCT02470806|54418459|FG000|Overall Study|Protocol Violation|4|||
27981250|NCT00799383|54639113|FG000|Overall Study|Withdrawal by Subject|0|||
27981251|NCT00799383|54639114|FG001|Overall Study|Withdrawal by Subject|1|||
27834393|NCT01697579|54317921|FG002|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
27834394|NCT01697579|54317922|FG003|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
27834395|NCT01697579|54317923|FG004|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
27834396|NCT01697579|54317924|FG005|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4|||
27834397|NCT01697579|54317925|FG006|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11|||
27834398|NCT01697579|54317919|FG000|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
27834399|NCT01697579|54317920|FG001|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
27834400|NCT01697579|54317921|FG002|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
27834401|NCT01697579|54317922|FG003|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
27834402|NCT01697579|54317923|FG004|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
27834403|NCT01697579|54317924|FG005|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
27834404|NCT01697579|54317925|FG006|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2|||
27834405|NCT01697579|54317919|FG000|Optional Extension-Cycles 2-6|Technical Problems|0|||
27834406|NCT01697579|54317920|FG001|Optional Extension-Cycles 2-6|Technical Problems|0|||
27834407|NCT01697579|54317921|FG002|Optional Extension-Cycles 2-6|Technical Problems|0|||
27834408|NCT01697579|54317922|FG003|Optional Extension-Cycles 2-6|Technical Problems|0|||
27834409|NCT01697579|54317923|FG004|Optional Extension-Cycles 2-6|Technical Problems|0|||
27834410|NCT01697579|54317924|FG005|Optional Extension-Cycles 2-6|Technical Problems|0|||
27834411|NCT01697579|54317925|FG006|Optional Extension-Cycles 2-6|Technical Problems|1|||
27834412|NCT01697579|54317919|FG000|Optional Extension-Cycles 2-6|Participant Moved|0|||
27834413|NCT01697579|54317920|FG001|Optional Extension-Cycles 2-6|Participant Moved|0|||
27834414|NCT01697579|54317921|FG002|Optional Extension-Cycles 2-6|Participant Moved|0|||
27834415|NCT01697579|54317922|FG003|Optional Extension-Cycles 2-6|Participant Moved|0|||
27834416|NCT01697579|54317923|FG004|Optional Extension-Cycles 2-6|Participant Moved|0|||
27834417|NCT01697579|54317924|FG005|Optional Extension-Cycles 2-6|Participant Moved|0|||
27834418|NCT01697579|54317925|FG006|Optional Extension-Cycles 2-6|Participant Moved|2|||
27834419|NCT01697579|54317919|FG000|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
27834420|NCT01697579|54317920|FG001|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
27834421|NCT01697579|54317921|FG002|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
27834422|NCT01697579|54317922|FG003|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
27834423|NCT01697579|54317923|FG004|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
27834424|NCT01697579|54317924|FG005|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6|||
27860005|NCT02470806|54418460|FG001|Overall Study|Protocol Violation|11|||
27860006|NCT02470806|54418459|FG000|Overall Study|Physician Decision|0|||
27860007|NCT02470806|54418460|FG001|Overall Study|Physician Decision|3|||
27860008|NCT02470806|54418459|FG000|Overall Study|Withdrawal by Subject|3|||
27860009|NCT02470806|54418460|FG001|Overall Study|Withdrawal by Subject|10|||
27860010|NCT02470806|54418459|FG000|Overall Study|Lack of Efficacy|5|||
27860011|NCT02470806|54418460|FG001|Overall Study|Lack of Efficacy|15|||
27860012|NCT01363908|54418502|FG000|Chronic Dosing (CD) Phase|Adverse Event|1|||
27860013|NCT01363908|54418503|FG001|Chronic Dosing (CD) Phase|Adverse Event|1|||
27860014|NCT01363908|54418502|FG000|Chronic Dosing (CD) Phase|Patient decision|0|||
27860015|NCT01363908|54418503|FG001|Chronic Dosing (CD) Phase|Patient decision|1|||
27860016|NCT01363908|54418502|FG000|Chronic Dosing (CD) Phase|Physician Decision|0|||
27860017|NCT01363908|54418503|FG001|Chronic Dosing (CD) Phase|Physician Decision|1|||
27860018|NCT01363908|54418502|FG000|Chronic Dosing (CD) Phase|Early study termination|9|||
27860019|NCT01363908|54418503|FG001|Chronic Dosing (CD) Phase|Early study termination|3|||
27860020|NCT02497404|54418541|FG000|Overall Study|Adverse Event|1|||
27860021|NCT02496702|54418574|FG000|Overall Study|Lost to Follow-up|8|||
27860022|NCT02496702|54418575|FG001|Overall Study|Lost to Follow-up|6|||
27860023|NCT02496702|54418574|FG000|Overall Study|Only partially tested|0|||
27860024|NCT02496702|54418575|FG001|Overall Study|Only partially tested|2|||
27860025|NCT02469246|54418651|FG000|Double-Blind Phase|Randomized and Never Treated|5|||
27860026|NCT02469246|54418652|FG001|Double-Blind Phase|Randomized and Never Treated|6|||
27860027|NCT02469246|54418651|FG000|Double-Blind Phase|Adverse Event|12|||
27860028|NCT02469246|54418652|FG001|Double-Blind Phase|Adverse Event|9|||
27860029|NCT02469246|54418651|FG000|Double-Blind Phase|Death|2|||
27860030|NCT02469246|54418652|FG001|Double-Blind Phase|Death|0|||
27860031|NCT02469246|54418651|FG000|Double-Blind Phase|Lack of Efficacy|2|||
27860032|NCT02469246|54418652|FG001|Double-Blind Phase|Lack of Efficacy|1|||
27860033|NCT02469246|54418651|FG000|Double-Blind Phase|Investigator's Discretion|8|||
27860034|NCT02469246|54418652|FG001|Double-Blind Phase|Investigator's Discretion|8|||
27860035|NCT02469246|54418651|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
27860036|NCT02469246|54418652|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
27860037|NCT02469246|54418651|FG000|Double-Blind Phase|Protocol Violation|1|||
27860038|NCT02469246|54418652|FG001|Double-Blind Phase|Protocol Violation|1|||
27860039|NCT02469246|54418651|FG000|Double-Blind Phase|Withdrew Consent|25|||
27860040|NCT02469246|54418652|FG001|Double-Blind Phase|Withdrew Consent|25|||
27860041|NCT02469246|54418651|FG000|Double-Blind Phase|Lost to Follow-up|9|||
27860042|NCT02469246|54418652|FG001|Double-Blind Phase|Lost to Follow-up|5|||
27860043|NCT02469168|54418671|FG000|Overall Study|Trial closed|1|||
27860044|NCT02469168|54418672|FG001|Overall Study|Trial closed|0|||
27860045|NCT02469090|54418680|FG000|Period 1: Dose Titration Phase|Adverse Event|12|||
27860046|NCT02469090|54418681|FG001|Period 1: Dose Titration Phase|Adverse Event|0|||
27860047|NCT02469090|54418682|FG002|Period 1: Dose Titration Phase|Adverse Event|0|||
27860048|NCT02469090|54418680|FG000|Period 1: Dose Titration Phase|Withdrawal by Subject|8|||
27860049|NCT02469090|54418681|FG001|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
27860050|NCT02469090|54418682|FG002|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
27860051|NCT02469090|54418680|FG000|Period 1: Dose Titration Phase|Lost to Follow-up|1|||
27860052|NCT02469090|54418681|FG001|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
27860053|NCT02469090|54418682|FG002|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
27860054|NCT02469090|54418680|FG000|Period 1: Dose Titration Phase|Lack of Efficacy|11|||
27860055|NCT02469090|54418681|FG001|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
27860056|NCT02469090|54418682|FG002|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
27860057|NCT02469090|54418680|FG000|Period 2: Maintenance Treatment Phase|Adverse Event|0|||
27860058|NCT02469090|54418681|FG001|Period 2: Maintenance Treatment Phase|Adverse Event|5|||
27860059|NCT02469090|54418682|FG002|Period 2: Maintenance Treatment Phase|Adverse Event|15|||
27860060|NCT02469090|54418680|FG000|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0|||
27860061|NCT02469090|54418681|FG001|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3|||
27860062|NCT02469090|54418682|FG002|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4|||
27860063|NCT02469090|54418680|FG000|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
27860064|NCT02469090|54418681|FG001|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1|||
27860065|NCT02469090|54418682|FG002|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
27860066|NCT02469090|54418680|FG000|Period 2: Maintenance Treatment Phase|Death|0|||
27860067|NCT02469090|54418681|FG001|Period 2: Maintenance Treatment Phase|Death|0|||
27860068|NCT02469090|54418682|FG002|Period 2: Maintenance Treatment Phase|Death|1|||
27981252|NCT00610207|54639120|FG000|Overall Study|Lost to Follow-up|3|||
28095951|NCT04504032|54750554|FG001|Overall Study|Drug supply issues|1|||
28095952|NCT04504032|54750553|FG000|Overall Study|Progressed to moderate/severe COVID-19|1|||
28095953|NCT04504032|54750554|FG001|Overall Study|Progressed to moderate/severe COVID-19|0|||
28095954|NCT04439240|54750560|FG000|Overall Study|Ineligible|2|||
28095955|NCT04439240|54750560|FG000|Overall Study|Never started treatment|2|||
28095956|NCT04439240|54750560|FG000|Overall Study|Adverse Event|12|||
27860069|NCT02496000|54418692|FG000|Overall Study|Withdrawal by Subject|1|||
27860070|NCT02496000|54418693|FG001|Overall Study|Withdrawal by Subject|2|||
27860071|NCT02496000|54418694|FG002|Overall Study|Withdrawal by Subject|0|||
28095957|NCT04439240|54750560|FG000|Overall Study|Death|2|||
28095958|NCT04439240|54750560|FG000|Overall Study|Disease progression|25|||
27860072|NCT02496000|54418692|FG000|Overall Study|Lost to Follow-up|1|||
27860073|NCT02496000|54418693|FG001|Overall Study|Lost to Follow-up|0|||
28095959|NCT04439240|54750560|FG000|Overall Study|Other diseases|2|||
28095960|NCT04439240|54750560|FG000|Overall Study|Withdrawal by Subject|3|||
28095961|NCT04439240|54750560|FG000|Overall Study|Clinical concerns for progression and increasing tumor marker|1|||
28095962|NCT04439240|54750560|FG000|Overall Study|Symptomatic decline|1|||
28095963|NCT04439240|54750560|FG000|Overall Study|Pogression of the lymphadenopathy|1|||
28095964|NCT04439240|54750560|FG000|Overall Study|Clinical progression|1|||
28095965|NCT04605588|54750566|FG000|Overall Study|Withdrawal by Subject|1|||
28095966|NCT04605588|54750567|FG001|Overall Study|Withdrawal by Subject|0|||
28095967|NCT04885296|54750573|FG000|Period 1|Covid-19 Related|1|||
28095968|NCT04885296|54750574|FG001|Period 1|Covid-19 Related|0|||
28095969|NCT04885296|54750573|FG000|Period 1|Adverse Event|0|||
28095970|NCT04885296|54750574|FG001|Period 1|Adverse Event|1|||
28095971|NCT04885296|54750573|FG000|Period 1|Withdrawal by Subject|1|||
27860074|NCT02496000|54418694|FG002|Overall Study|Lost to Follow-up|1|||
27860075|NCT02496000|54418692|FG000|Overall Study|Protocol Violation|0|||
27981253|NCT00798759|54639126|FG000|Overall Study|Adverse Event|3|||
27981254|NCT00798759|54639127|FG001|Overall Study|Adverse Event|3|||
27981255|NCT00798759|54639126|FG000|Overall Study|Lost to Follow-up|1|||
27981256|NCT00798759|54639127|FG001|Overall Study|Lost to Follow-up|1|||
27981257|NCT00798759|54639126|FG000|Overall Study|Protocol Violation|4|||
27981258|NCT00798759|54639127|FG001|Overall Study|Protocol Violation|8|||
27981259|NCT00798759|54639126|FG000|Overall Study|Other|0|||
27981260|NCT00798759|54639127|FG001|Overall Study|Other|1|||
27981261|NCT00887432|54639135|FG000|Overall Study|Start Excluded Therapy|3|||
27981262|NCT00887432|54639136|FG001|Overall Study|Start Excluded Therapy|0|||
27981263|NCT00887432|54639135|FG000|Overall Study|Did not complete treatment|6|||
27860076|NCT02496000|54418693|FG001|Overall Study|Protocol Violation|0|||
27860077|NCT02496000|54418694|FG002|Overall Study|Protocol Violation|1|||
27860078|NCT02496000|54418692|FG000|Overall Study|Non-compliance or lack of cooperation|0|||
27860079|NCT02496000|54418693|FG001|Overall Study|Non-compliance or lack of cooperation|2|||
27860080|NCT02496000|54418694|FG002|Overall Study|Non-compliance or lack of cooperation|0|||
27860081|NCT02496000|54418692|FG000|Overall Study|undetermined|0|||
27860082|NCT02496000|54418693|FG001|Overall Study|undetermined|1|||
27860083|NCT02496000|54418694|FG002|Overall Study|undetermined|0|||
27860084|NCT02468934|54418703|FG000|Overall Study|Withdrawal by Subject|4|||
27860085|NCT02468934|54418703|FG000|Overall Study|Screen Failure|3|||
27860086|NCT02517528|54418709|FG000|Overall Study|Withdrawal by Subject|1|||
27860087|NCT02495844|54418715|FG000|Overall Study|Lack of Efficacy|1|||
27860088|NCT02495844|54418716|FG001|Overall Study|Lack of Efficacy|2|||
27860089|NCT02495844|54418715|FG000|Overall Study|AE, non-fatal|0|||
27860090|NCT02495844|54418716|FG001|Overall Study|AE, non-fatal|1|||
27860091|NCT02495844|54418715|FG000|Overall Study|Hepatitis Positivity|0|||
27860092|NCT02495844|54418716|FG001|Overall Study|Hepatitis Positivity|1|||
27860093|NCT02468778|54418727|FG000|Overall Study|Death|2|||
27860094|NCT02468778|54418728|FG001|Overall Study|Death|1|||
27860095|NCT02468778|54418729|FG002|Overall Study|Death|0|||
27860096|NCT02468778|54418727|FG000|Overall Study|Lost to Follow-up|1|||
27860097|NCT02468778|54418728|FG001|Overall Study|Lost to Follow-up|2|||
27860098|NCT02468778|54418729|FG002|Overall Study|Lost to Follow-up|2|||
27860099|NCT02468778|54418727|FG000|Overall Study|Withdrawal by Subject|0|||
27860100|NCT02468778|54418728|FG001|Overall Study|Withdrawal by Subject|1|||
27860101|NCT02468778|54418729|FG002|Overall Study|Withdrawal by Subject|1|||
27860102|NCT01727336|54418743|FG000|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
27860103|NCT01727336|54418744|FG001|Part 1 Dalantercept Dose Escalation|Adverse Event|1|||
27860104|NCT01727336|54418745|FG002|Part 1 Dalantercept Dose Escalation|Adverse Event|5|||
27860105|NCT01727336|54418746|FG003|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
27860106|NCT01727336|54418747|FG004|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
27860107|NCT01727336|54418748|FG005|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
27860108|NCT01727336|54418743|FG000|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
27860109|NCT01727336|54418744|FG001|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|1|||
27860110|NCT01727336|54418745|FG002|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
27860111|NCT01727336|54418746|FG003|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
27860112|NCT01727336|54418747|FG004|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
28095972|NCT04885296|54750574|FG001|Period 1|Withdrawal by Subject|1|||
28095973|NCT04885296|54750573|FG000|Period 1|Test Article No Longer Available|1|||
28095974|NCT04885296|54750574|FG001|Period 1|Test Article No Longer Available|0|||
27860113|NCT01727336|54418748|FG005|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
27860114|NCT01727336|54418743|FG000|Part 2 Blinded|Death|0|||
27860115|NCT01727336|54418744|FG001|Part 2 Blinded|Death|0|||
27860116|NCT01727336|54418745|FG002|Part 2 Blinded|Death|0|||
27860117|NCT01727336|54418746|FG003|Part 2 Blinded|Death|0|||
27860118|NCT01727336|54418747|FG004|Part 2 Blinded|Death|20|||
27860119|NCT01727336|54418748|FG005|Part 2 Blinded|Death|16|||
27860120|NCT01727336|54418743|FG000|Part 2 Blinded|Lack of Efficacy|0|||
27860121|NCT01727336|54418744|FG001|Part 2 Blinded|Lack of Efficacy|0|||
27981264|NCT00887432|54639136|FG001|Overall Study|Did not complete treatment|8|||
27981265|NCT00887432|54639135|FG000|Overall Study|Protocol Violation|2|||
27981266|NCT00887432|54639136|FG001|Overall Study|Protocol Violation|3|||
28095975|NCT04885296|54750573|FG000|Period 1|Dispensed Study lens in Error|1|||
27860122|NCT01727336|54418745|FG002|Part 2 Blinded|Lack of Efficacy|0|||
27860123|NCT01727336|54418746|FG003|Part 2 Blinded|Lack of Efficacy|0|||
27860124|NCT01727336|54418747|FG004|Part 2 Blinded|Lack of Efficacy|42|||
27860125|NCT01727336|54418748|FG005|Part 2 Blinded|Lack of Efficacy|44|||
27860126|NCT01727336|54418743|FG000|Part 2 Blinded|Lost to Follow-up|0|||
27860127|NCT01727336|54418744|FG001|Part 2 Blinded|Lost to Follow-up|0|||
27860128|NCT01727336|54418745|FG002|Part 2 Blinded|Lost to Follow-up|0|||
27860129|NCT01727336|54418746|FG003|Part 2 Blinded|Lost to Follow-up|0|||
27860130|NCT01727336|54418747|FG004|Part 2 Blinded|Lost to Follow-up|0|||
27860131|NCT01727336|54418748|FG005|Part 2 Blinded|Lost to Follow-up|1|||
27860132|NCT01727336|54418743|FG000|Part 2 Blinded|Withdrawal by Subject|0|||
27860133|NCT01727336|54418744|FG001|Part 2 Blinded|Withdrawal by Subject|0|||
27860134|NCT01727336|54418745|FG002|Part 2 Blinded|Withdrawal by Subject|0|||
27860135|NCT01727336|54418746|FG003|Part 2 Blinded|Withdrawal by Subject|0|||
27860136|NCT01727336|54418747|FG004|Part 2 Blinded|Withdrawal by Subject|0|||
27860137|NCT01727336|54418748|FG005|Part 2 Blinded|Withdrawal by Subject|4|||
27860138|NCT01727336|54418743|FG000|Part 2 Blinded|use of prohibited medications|0|||
27860139|NCT01727336|54418744|FG001|Part 2 Blinded|use of prohibited medications|0|||
27860140|NCT01727336|54418745|FG002|Part 2 Blinded|use of prohibited medications|0|||
27860141|NCT01727336|54418746|FG003|Part 2 Blinded|use of prohibited medications|0|||
27860142|NCT01727336|54418747|FG004|Part 2 Blinded|use of prohibited medications|1|||
27860143|NCT01727336|54418748|FG005|Part 2 Blinded|use of prohibited medications|3|||
27860144|NCT02466516|54418782|FG000|Overall Study|Adverse Event|1|||
27860145|NCT02466516|54418783|FG001|Overall Study|Adverse Event|1|||
27860146|NCT02466516|54418784|FG002|Overall Study|Adverse Event|0|||
27860147|NCT02466516|54418785|FG003|Overall Study|Adverse Event|0|||
27860148|NCT02466516|54418786|FG004|Overall Study|Adverse Event|0|||
27860149|NCT02466516|54418782|FG000|Overall Study|Withdrew Consent|1|||
27860150|NCT02466516|54418783|FG001|Overall Study|Withdrew Consent|0|||
27860151|NCT02466516|54418784|FG002|Overall Study|Withdrew Consent|0|||
27860152|NCT02466516|54418785|FG003|Overall Study|Withdrew Consent|0|||
27860153|NCT02466516|54418786|FG004|Overall Study|Withdrew Consent|0|||
27860154|NCT02466516|54418782|FG000|Overall Study|Lost to Follow-up|2|||
27860155|NCT02466516|54418783|FG001|Overall Study|Lost to Follow-up|0|||
27860156|NCT02466516|54418784|FG002|Overall Study|Lost to Follow-up|1|||
27860157|NCT02466516|54418785|FG003|Overall Study|Lost to Follow-up|0|||
27860158|NCT02466516|54418786|FG004|Overall Study|Lost to Follow-up|0|||
27860159|NCT01725152|54418800|FG000|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|3|||
27860160|NCT01725152|54418801|FG001|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|0|||
27860161|NCT01725152|54418800|FG000|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|1|||
27860162|NCT01725152|54418801|FG001|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|0|||
27860163|NCT01725152|54418800|FG000|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
27860164|NCT01725152|54418801|FG001|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
27860165|NCT01725152|54418800|FG000|Treatment Period 2 (Week 8 to Week 14)|Other|0|||
27860166|NCT01725152|54418801|FG001|Treatment Period 2 (Week 8 to Week 14)|Other|2|||
27860167|NCT01049984|54418817|FG000|Overall Study|Withdrawal by Subject|1|||
27860168|NCT01049984|54418818|FG001|Overall Study|Withdrawal by Subject|5|||
27860169|NCT01049984|54418817|FG000|Overall Study|Protocol Violation|3|||
27860170|NCT01049984|54418818|FG001|Overall Study|Protocol Violation|4|||
28095976|NCT04885296|54750574|FG001|Period 1|Dispensed Study lens in Error|0|||
27738863|NCT02936323|54188173|FG005|Phase 2a Dose Expansion|Physician Decision|0|||
27738864|NCT02936323|54188174|FG006|Phase 2a Dose Expansion|Physician Decision|0|||
27738865|NCT02936323|54188175|FG007|Phase 2a Dose Expansion|Physician Decision|0|||
27738866|NCT02936323|54188176|FG008|Phase 2a Dose Expansion|Physician Decision|0|||
27738867|NCT02936323|54188177|FG009|Phase 2a Dose Expansion|Physician Decision|1|||
27738868|NCT02936323|54188168|FG000|Phase 2a Dose Expansion|Lost to Follow-up|0|||
27738869|NCT02936323|54188169|FG001|Phase 2a Dose Expansion|Lost to Follow-up|0|||
27738870|NCT02936323|54188170|FG002|Phase 2a Dose Expansion|Lost to Follow-up|0|||
27860171|NCT01049984|54418817|FG000|Overall Study|Lost to Follow-up|2|||
27860172|NCT01049984|54418818|FG001|Overall Study|Lost to Follow-up|1|||
27738871|NCT02936323|54188171|FG003|Phase 2a Dose Expansion|Lost to Follow-up|0|||
27738872|NCT02936323|54188172|FG004|Phase 2a Dose Expansion|Lost to Follow-up|0|||
27834425|NCT01697579|54317925|FG006|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4|||
27834426|NCT01697579|54317919|FG000|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
27834427|NCT01697579|54317920|FG001|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
27834428|NCT01697579|54317921|FG002|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
27834429|NCT01697579|54317922|FG003|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
27834430|NCT01697579|54317923|FG004|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
27834431|NCT01697579|54317924|FG005|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
27860173|NCT01049984|54418817|FG000|Overall Study|Adverse Event|13|||
27860174|NCT01049984|54418818|FG001|Overall Study|Adverse Event|7|||
27860175|NCT01049984|54418817|FG000|Overall Study|Treatment failure|0|||
27860176|NCT01049984|54418818|FG001|Overall Study|Treatment failure|2|||
27860177|NCT01049360|54418824|FG000|Period 1|Adverse Event|0|||
27860178|NCT01049360|54418825|FG001|Period 1|Adverse Event|1|||
27860179|NCT01049360|54418826|FG002|Period 1|Adverse Event|0|||
27860180|NCT01049360|54418827|FG003|Period 1|Adverse Event|1|||
27860181|NCT01049360|54418828|FG004|Period 1|Adverse Event|0|||
27860182|NCT01049360|54418829|FG005|Period 1|Adverse Event|0|||
27860183|NCT01049360|54418830|FG006|Period 1|Adverse Event|0|||
27860184|NCT01049360|54418831|FG007|Period 1|Adverse Event|1|||
27860185|NCT01049360|54418832|FG008|Period 1|Adverse Event|0|||
27860186|NCT01049360|54418833|FG009|Period 1|Adverse Event|0|||
27860187|NCT01049360|54418834|FG010|Period 1|Adverse Event|0|||
27860188|NCT01049360|54418835|FG011|Period 1|Adverse Event|0|||
27860189|NCT01049360|54418836|FG012|Period 1|Adverse Event|1|||
27860190|NCT01049360|54418837|FG013|Period 1|Adverse Event|1|||
27860191|NCT01049360|54418838|FG014|Period 1|Adverse Event|0|||
27860192|NCT01049360|54418839|FG015|Period 1|Adverse Event|0|||
27860193|NCT01049360|54418840|FG016|Period 1|Adverse Event|1|||
27860194|NCT01049360|54418841|FG017|Period 1|Adverse Event|0|||
27860195|NCT01049360|54418842|FG018|Period 1|Adverse Event|1|||
27860196|NCT01049360|54418843|FG019|Period 1|Adverse Event|0|||
27860197|NCT01049360|54418824|FG000|Period 1|Did not meet inc/exc criteria|0|||
27860198|NCT01049360|54418825|FG001|Period 1|Did not meet inc/exc criteria|0|||
27860199|NCT01049360|54418826|FG002|Period 1|Did not meet inc/exc criteria|0|||
27860200|NCT01049360|54418827|FG003|Period 1|Did not meet inc/exc criteria|0|||
27860201|NCT01049360|54418828|FG004|Period 1|Did not meet inc/exc criteria|0|||
27860202|NCT01049360|54418829|FG005|Period 1|Did not meet inc/exc criteria|0|||
27860203|NCT01049360|54418830|FG006|Period 1|Did not meet inc/exc criteria|0|||
27860204|NCT01049360|54418831|FG007|Period 1|Did not meet inc/exc criteria|1|||
27860205|NCT01049360|54418832|FG008|Period 1|Did not meet inc/exc criteria|1|||
27860206|NCT01049360|54418833|FG009|Period 1|Did not meet inc/exc criteria|0|||
27860207|NCT01049360|54418834|FG010|Period 1|Did not meet inc/exc criteria|0|||
27860208|NCT01049360|54418835|FG011|Period 1|Did not meet inc/exc criteria|0|||
27860209|NCT01049360|54418836|FG012|Period 1|Did not meet inc/exc criteria|0|||
27860210|NCT01049360|54418837|FG013|Period 1|Did not meet inc/exc criteria|0|||
27860211|NCT01049360|54418838|FG014|Period 1|Did not meet inc/exc criteria|0|||
27860212|NCT01049360|54418839|FG015|Period 1|Did not meet inc/exc criteria|0|||
27860213|NCT01049360|54418840|FG016|Period 1|Did not meet inc/exc criteria|0|||
27860214|NCT01049360|54418841|FG017|Period 1|Did not meet inc/exc criteria|0|||
27860215|NCT01049360|54418842|FG018|Period 1|Did not meet inc/exc criteria|0|||
27860216|NCT01049360|54418843|FG019|Period 1|Did not meet inc/exc criteria|0|||
27860217|NCT01049360|54418824|FG000|Period 1|Withdrawal by Subject|0|||
27860218|NCT01049360|54418825|FG001|Period 1|Withdrawal by Subject|0|||
27860219|NCT01049360|54418826|FG002|Period 1|Withdrawal by Subject|0|||
27860220|NCT01049360|54418827|FG003|Period 1|Withdrawal by Subject|0|||
27860221|NCT01049360|54418828|FG004|Period 1|Withdrawal by Subject|0|||
27860222|NCT01049360|54418829|FG005|Period 1|Withdrawal by Subject|0|||
27860223|NCT01049360|54418830|FG006|Period 1|Withdrawal by Subject|0|||
27860224|NCT01049360|54418831|FG007|Period 1|Withdrawal by Subject|0|||
27860225|NCT01049360|54418832|FG008|Period 1|Withdrawal by Subject|1|||
27860226|NCT01049360|54418833|FG009|Period 1|Withdrawal by Subject|0|||
27860227|NCT01049360|54418834|FG010|Period 1|Withdrawal by Subject|1|||
27860228|NCT01049360|54418835|FG011|Period 1|Withdrawal by Subject|0|||
27860229|NCT01049360|54418836|FG012|Period 1|Withdrawal by Subject|1|||
27860230|NCT01049360|54418837|FG013|Period 1|Withdrawal by Subject|0|||
27860231|NCT01049360|54418838|FG014|Period 1|Withdrawal by Subject|0|||
27860232|NCT01049360|54418839|FG015|Period 1|Withdrawal by Subject|0|||
27860233|NCT01049360|54418840|FG016|Period 1|Withdrawal by Subject|0|||
27860234|NCT01049360|54418841|FG017|Period 1|Withdrawal by Subject|0|||
27860235|NCT01049360|54418842|FG018|Period 1|Withdrawal by Subject|0|||
27860236|NCT01049360|54418843|FG019|Period 1|Withdrawal by Subject|0|||
27860237|NCT01049360|54418824|FG000|Period 2|Protocol Violation|0|||
27860238|NCT01049360|54418825|FG001|Period 2|Protocol Violation|0|||
27860239|NCT01049360|54418826|FG002|Period 2|Protocol Violation|0|||
27860240|NCT01049360|54418827|FG003|Period 2|Protocol Violation|1|||
27860241|NCT01049360|54418828|FG004|Period 2|Protocol Violation|0|||
27860242|NCT01049360|54418829|FG005|Period 2|Protocol Violation|0|||
27860243|NCT01049360|54418830|FG006|Period 2|Protocol Violation|0|||
27860244|NCT01049360|54418831|FG007|Period 2|Protocol Violation|0|||
27981267|NCT00887432|54639135|FG000|Overall Study|Withdrawal by Subject|3|||
27981268|NCT00887432|54639136|FG001|Overall Study|Withdrawal by Subject|2|||
27981269|NCT00887432|54639135|FG000|Overall Study|Lost to Follow-up|1|||
27860245|NCT01049360|54418832|FG008|Period 2|Protocol Violation|0|||
27860246|NCT01049360|54418833|FG009|Period 2|Protocol Violation|0|||
27860247|NCT01049360|54418834|FG010|Period 2|Protocol Violation|0|||
27981270|NCT00887432|54639136|FG001|Overall Study|Lost to Follow-up|0|||
27860248|NCT01049360|54418835|FG011|Period 2|Protocol Violation|0|||
27860249|NCT01049360|54418836|FG012|Period 2|Protocol Violation|0|||
27860250|NCT01049360|54418837|FG013|Period 2|Protocol Violation|0|||
27860251|NCT01049360|54418838|FG014|Period 2|Protocol Violation|1|||
27860252|NCT01049360|54418839|FG015|Period 2|Protocol Violation|1|||
27860253|NCT01049360|54418840|FG016|Period 2|Protocol Violation|0|||
27860254|NCT01049360|54418841|FG017|Period 2|Protocol Violation|0|||
27860255|NCT01049360|54418842|FG018|Period 2|Protocol Violation|0|||
27860256|NCT01049360|54418843|FG019|Period 2|Protocol Violation|0|||
27860257|NCT01049360|54418824|FG000|Period 2|Adverse Event|0|||
27860258|NCT01049360|54418825|FG001|Period 2|Adverse Event|1|||
27860259|NCT01049360|54418826|FG002|Period 2|Adverse Event|0|||
27860260|NCT01049360|54418827|FG003|Period 2|Adverse Event|0|||
27860261|NCT01049360|54418828|FG004|Period 2|Adverse Event|0|||
27860262|NCT01049360|54418829|FG005|Period 2|Adverse Event|0|||
27860263|NCT01049360|54418830|FG006|Period 2|Adverse Event|0|||
27860264|NCT01049360|54418831|FG007|Period 2|Adverse Event|0|||
27860265|NCT01049360|54418832|FG008|Period 2|Adverse Event|1|||
27860266|NCT01049360|54418833|FG009|Period 2|Adverse Event|0|||
27860267|NCT01049360|54418834|FG010|Period 2|Adverse Event|0|||
27860268|NCT01049360|54418835|FG011|Period 2|Adverse Event|0|||
27860269|NCT01049360|54418836|FG012|Period 2|Adverse Event|0|||
27860270|NCT01049360|54418837|FG013|Period 2|Adverse Event|0|||
27860271|NCT01049360|54418838|FG014|Period 2|Adverse Event|0|||
27860272|NCT01049360|54418839|FG015|Period 2|Adverse Event|0|||
27860273|NCT01049360|54418840|FG016|Period 2|Adverse Event|0|||
27860274|NCT01049360|54418841|FG017|Period 2|Adverse Event|0|||
27860275|NCT01049360|54418842|FG018|Period 2|Adverse Event|0|||
27860276|NCT01049360|54418843|FG019|Period 2|Adverse Event|1|||
27860277|NCT01049360|54418824|FG000|Period 2|Withdrawal by Subject|0|||
27860278|NCT01049360|54418825|FG001|Period 2|Withdrawal by Subject|0|||
27860279|NCT01049360|54418826|FG002|Period 2|Withdrawal by Subject|0|||
27860280|NCT01049360|54418827|FG003|Period 2|Withdrawal by Subject|1|||
27860281|NCT01049360|54418828|FG004|Period 2|Withdrawal by Subject|0|||
27860282|NCT01049360|54418829|FG005|Period 2|Withdrawal by Subject|0|||
27860283|NCT01049360|54418830|FG006|Period 2|Withdrawal by Subject|0|||
27860284|NCT01049360|54418831|FG007|Period 2|Withdrawal by Subject|0|||
27860285|NCT01049360|54418832|FG008|Period 2|Withdrawal by Subject|0|||
27860286|NCT01049360|54418833|FG009|Period 2|Withdrawal by Subject|0|||
27860287|NCT01049360|54418834|FG010|Period 2|Withdrawal by Subject|0|||
27860288|NCT01049360|54418835|FG011|Period 2|Withdrawal by Subject|0|||
27860289|NCT01049360|54418836|FG012|Period 2|Withdrawal by Subject|0|||
27860290|NCT01049360|54418837|FG013|Period 2|Withdrawal by Subject|0|||
27860291|NCT01049360|54418838|FG014|Period 2|Withdrawal by Subject|1|||
27860292|NCT01049360|54418839|FG015|Period 2|Withdrawal by Subject|0|||
27860293|NCT01049360|54418840|FG016|Period 2|Withdrawal by Subject|0|||
27860294|NCT01049360|54418841|FG017|Period 2|Withdrawal by Subject|0|||
27860295|NCT01049360|54418842|FG018|Period 2|Withdrawal by Subject|0|||
27860296|NCT01049360|54418843|FG019|Period 2|Withdrawal by Subject|1|||
27860297|NCT01049360|54418824|FG000|Period 2|Lack of Efficacy|0|||
27860298|NCT01049360|54418825|FG001|Period 2|Lack of Efficacy|0|||
27860299|NCT01049360|54418826|FG002|Period 2|Lack of Efficacy|0|||
27860300|NCT01049360|54418827|FG003|Period 2|Lack of Efficacy|0|||
27860301|NCT01049360|54418828|FG004|Period 2|Lack of Efficacy|0|||
27860302|NCT01049360|54418829|FG005|Period 2|Lack of Efficacy|1|||
27860303|NCT01049360|54418830|FG006|Period 2|Lack of Efficacy|0|||
27860304|NCT01049360|54418831|FG007|Period 2|Lack of Efficacy|0|||
27860305|NCT01049360|54418832|FG008|Period 2|Lack of Efficacy|0|||
27860306|NCT01049360|54418833|FG009|Period 2|Lack of Efficacy|0|||
27860307|NCT01049360|54418834|FG010|Period 2|Lack of Efficacy|0|||
27860308|NCT01049360|54418835|FG011|Period 2|Lack of Efficacy|0|||
27860309|NCT01049360|54418836|FG012|Period 2|Lack of Efficacy|0|||
27860310|NCT01049360|54418837|FG013|Period 2|Lack of Efficacy|0|||
27860311|NCT01049360|54418838|FG014|Period 2|Lack of Efficacy|0|||
27860312|NCT01049360|54418839|FG015|Period 2|Lack of Efficacy|0|||
27860313|NCT01049360|54418840|FG016|Period 2|Lack of Efficacy|0|||
27860314|NCT01049360|54418841|FG017|Period 2|Lack of Efficacy|0|||
27981271|NCT00887432|54639135|FG000|Overall Study|No reason provided|0|||
27981272|NCT00887432|54639136|FG001|Overall Study|No reason provided|1|||
28095977|NCT04885296|54750573|FG000|Period 1|Lost to Follow-up|1|||
27860315|NCT01049360|54418842|FG018|Period 2|Lack of Efficacy|0|||
27860316|NCT01049360|54418843|FG019|Period 2|Lack of Efficacy|0|||
27860317|NCT01049360|54418824|FG000|Period 4|Protocol Violation|0|||
27860318|NCT01049360|54418825|FG001|Period 4|Protocol Violation|0|||
27860319|NCT01049360|54418826|FG002|Period 4|Protocol Violation|0|||
27860320|NCT01049360|54418827|FG003|Period 4|Protocol Violation|0|||
27860321|NCT01049360|54418828|FG004|Period 4|Protocol Violation|0|||
27860322|NCT01049360|54418829|FG005|Period 4|Protocol Violation|0|||
27860323|NCT01049360|54418830|FG006|Period 4|Protocol Violation|0|||
27860324|NCT01049360|54418831|FG007|Period 4|Protocol Violation|0|||
27860325|NCT01049360|54418832|FG008|Period 4|Protocol Violation|0|||
27860326|NCT01049360|54418833|FG009|Period 4|Protocol Violation|0|||
27860327|NCT01049360|54418834|FG010|Period 4|Protocol Violation|0|||
27860328|NCT01049360|54418835|FG011|Period 4|Protocol Violation|0|||
27860329|NCT01049360|54418836|FG012|Period 4|Protocol Violation|0|||
27860330|NCT01049360|54418837|FG013|Period 4|Protocol Violation|0|||
27860331|NCT01049360|54418838|FG014|Period 4|Protocol Violation|0|||
27860332|NCT01049360|54418839|FG015|Period 4|Protocol Violation|0|||
27860333|NCT01049360|54418840|FG016|Period 4|Protocol Violation|0|||
27860334|NCT01049360|54418841|FG017|Period 4|Protocol Violation|1|||
27860335|NCT01049360|54418842|FG018|Period 4|Protocol Violation|0|||
27860336|NCT01049360|54418843|FG019|Period 4|Protocol Violation|0|||
27860337|NCT01049360|54418824|FG000|Period 4|Withdrawal by Subject|0|||
27860338|NCT01049360|54418825|FG001|Period 4|Withdrawal by Subject|0|||
27860339|NCT01049360|54418826|FG002|Period 4|Withdrawal by Subject|0|||
27860340|NCT01049360|54418827|FG003|Period 4|Withdrawal by Subject|1|||
27860341|NCT01049360|54418828|FG004|Period 4|Withdrawal by Subject|0|||
27860342|NCT01049360|54418829|FG005|Period 4|Withdrawal by Subject|0|||
27860343|NCT01049360|54418830|FG006|Period 4|Withdrawal by Subject|0|||
27860344|NCT01049360|54418831|FG007|Period 4|Withdrawal by Subject|0|||
27860345|NCT01049360|54418832|FG008|Period 4|Withdrawal by Subject|0|||
27860346|NCT01049360|54418833|FG009|Period 4|Withdrawal by Subject|0|||
27860347|NCT01049360|54418834|FG010|Period 4|Withdrawal by Subject|0|||
27860348|NCT01049360|54418835|FG011|Period 4|Withdrawal by Subject|0|||
27860349|NCT01049360|54418836|FG012|Period 4|Withdrawal by Subject|0|||
27860350|NCT01049360|54418837|FG013|Period 4|Withdrawal by Subject|0|||
27860351|NCT01049360|54418838|FG014|Period 4|Withdrawal by Subject|0|||
27860352|NCT01049360|54418839|FG015|Period 4|Withdrawal by Subject|0|||
27860353|NCT01049360|54418840|FG016|Period 4|Withdrawal by Subject|0|||
27860354|NCT01049360|54418841|FG017|Period 4|Withdrawal by Subject|0|||
27981273|NCT00951275|54639142|FG000|Overall Study|Administrative Reason|1|||
27981274|NCT00951275|54639142|FG000|Overall Study|Adverse Event|7|||
27981275|NCT00951275|54639142|FG000|Overall Study|Withdrawal by Subject|4|||
27981276|NCT00951275|54639142|FG000|Overall Study|Protocol Violation|1|||
27981277|NCT00798603|54639146|FG000|Overall Study|Still on treatment as of 11/6/2012|1|||
27981278|NCT00798603|54639146|FG000|Overall Study|Withdrawal by Subject|10|||
28095978|NCT04885296|54750574|FG001|Period 1|Lost to Follow-up|0|||
28095979|NCT04885296|54750573|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
28095980|NCT04885296|54750574|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
28095981|NCT04602000|54750585|FG000|Overall Study|Withdrawal by Subject|3|||
28095982|NCT04602000|54750586|FG001|Overall Study|Withdrawal by Subject|6|||
28095983|NCT04602000|54750587|FG002|Overall Study|Withdrawal by Subject|3|||
28095984|NCT04602000|54750588|FG003|Overall Study|Withdrawal by Subject|27|||
28095985|NCT04602000|54750589|FG004|Overall Study|Withdrawal by Subject|39|||
28095986|NCT04602000|54750585|FG000|Overall Study|Physician Decision|1|||
28095987|NCT04602000|54750586|FG001|Overall Study|Physician Decision|0|||
28095988|NCT04602000|54750587|FG002|Overall Study|Physician Decision|0|||
28095989|NCT04602000|54750588|FG003|Overall Study|Physician Decision|2|||
28095990|NCT04602000|54750589|FG004|Overall Study|Physician Decision|2|||
28095991|NCT04602000|54750585|FG000|Overall Study|Death|0|||
28095992|NCT04602000|54750586|FG001|Overall Study|Death|1|||
28095993|NCT04602000|54750587|FG002|Overall Study|Death|0|||
28095994|NCT04602000|54750588|FG003|Overall Study|Death|1|||
28095995|NCT04602000|54750589|FG004|Overall Study|Death|2|||
28095996|NCT04602000|54750585|FG000|Overall Study|Lost to Follow-up|0|||
28095997|NCT04602000|54750586|FG001|Overall Study|Lost to Follow-up|0|||
27860355|NCT01049360|54418842|FG018|Period 4|Withdrawal by Subject|0|||
27860356|NCT01049360|54418843|FG019|Period 4|Withdrawal by Subject|0|||
27860357|NCT02494596|54418855|FG000|Overall Study|Insufficient Therapeutic Response|3|||
27860358|NCT02494596|54418856|FG001|Overall Study|Insufficient Therapeutic Response|3|||
27981279|NCT00798603|54639146|FG000|Overall Study|Adverse Event|22|||
27981280|NCT00798603|54639146|FG000|Overall Study|Physician Decision|1|||
27860359|NCT02494596|54418857|FG002|Overall Study|Insufficient Therapeutic Response|1|||
27860360|NCT02494596|54418855|FG000|Overall Study|Adverse Event|0|||
27860361|NCT02494596|54418856|FG001|Overall Study|Adverse Event|1|||
27860362|NCT02494596|54418857|FG002|Overall Study|Adverse Event|0|||
27860363|NCT02494596|54418855|FG000|Overall Study|Refused Treatment|0|||
27860364|NCT02494596|54418856|FG001|Overall Study|Refused Treatment|1|||
27860365|NCT02494596|54418857|FG002|Overall Study|Refused Treatment|0|||
27860366|NCT02494206|54418876|FG000|Overall Study|Adverse Event|1|||
27860367|NCT02494206|54418876|FG000|Overall Study|Disease Progression|1|||
27981281|NCT00798603|54639146|FG000|Overall Study|Lack of insurance coverage|1|||
27981282|NCT00887354|54639152|FG000|Treatment Phase (Week 0 to Week 26)|Death|0|||
27981283|NCT00887354|54639153|FG001|Treatment Phase (Week 0 to Week 26)|Death|1|||
28095998|NCT04602000|54750587|FG002|Overall Study|Lost to Follow-up|0|||
28095999|NCT04602000|54750588|FG003|Overall Study|Lost to Follow-up|3|||
28096000|NCT04602000|54750589|FG004|Overall Study|Lost to Follow-up|4|||
28096001|NCT04602000|54750585|FG000|Overall Study|Other|4|||
27860368|NCT01048502|54418893|FG000|Overall Study|Lost to Follow-up|2|||
28096002|NCT04602000|54750586|FG001|Overall Study|Other|1|||
28096003|NCT04602000|54750587|FG002|Overall Study|Other|2|||
28096004|NCT04602000|54750588|FG003|Overall Study|Other|5|||
27860369|NCT01048502|54418894|FG001|Overall Study|Lost to Follow-up|0|||
27860370|NCT01048502|54418895|FG002|Overall Study|Lost to Follow-up|0|||
27860371|NCT01048502|54418896|FG003|Overall Study|Lost to Follow-up|0|||
27860372|NCT01048502|54418893|FG000|Overall Study|Adverse Event|1|||
27981284|NCT00887354|54639152|FG000|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
27981285|NCT00887354|54639153|FG001|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
28096005|NCT04602000|54750589|FG004|Overall Study|Other|4|||
27860373|NCT01048502|54418894|FG001|Overall Study|Adverse Event|0|||
27860374|NCT01048502|54418895|FG002|Overall Study|Adverse Event|0|||
27860375|NCT01048502|54418896|FG003|Overall Study|Adverse Event|0|||
27860376|NCT01048502|54418893|FG000|Overall Study|Withdrawal by Subject|1|||
27860377|NCT01048502|54418894|FG001|Overall Study|Withdrawal by Subject|4|||
27860378|NCT01048502|54418895|FG002|Overall Study|Withdrawal by Subject|5|||
27860379|NCT01048502|54418896|FG003|Overall Study|Withdrawal by Subject|3|||
27860380|NCT01048502|54418893|FG000|Overall Study|Physician Decision|0|||
27860381|NCT01048502|54418894|FG001|Overall Study|Physician Decision|3|||
27860382|NCT01048502|54418895|FG002|Overall Study|Physician Decision|0|||
27860383|NCT01048502|54418896|FG003|Overall Study|Physician Decision|1|||
27860384|NCT02465034|54418909|FG000|Overall Study|Withdrawal by Subject|1|||
27860385|NCT02465034|54418910|FG001|Overall Study|Withdrawal by Subject|1|||
27860386|NCT02465034|54418909|FG000|Overall Study|Screen fail|2|||
27860387|NCT02465034|54418910|FG001|Overall Study|Screen fail|0|||
27860388|NCT02465034|54418909|FG000|Overall Study|Could not be scheduled for study visit|0|||
27860389|NCT02465034|54418910|FG001|Overall Study|Could not be scheduled for study visit|5|||
27860390|NCT02516982|54418937|FG000|Overall Study|Called in to antenatal appointment|32|||
27860391|NCT02516982|54418938|FG001|Overall Study|Called in to antenatal appointment|35|||
27860392|NCT02516982|54418939|FG002|Overall Study|Called in to antenatal appointment|0|||
27860393|NCT02516982|54418940|FG003|Overall Study|Called in to antenatal appointment|0|||
27860394|NCT02516982|54418937|FG000|Overall Study|Withdrawal by Subject|0|||
27860395|NCT02516982|54418938|FG001|Overall Study|Withdrawal by Subject|0|||
27860396|NCT02516982|54418939|FG002|Overall Study|Withdrawal by Subject|1|||
27860397|NCT02516982|54418940|FG003|Overall Study|Withdrawal by Subject|2|||
27860398|NCT02516982|54418937|FG000|Overall Study|Protocol Violation|0|||
27860399|NCT02516982|54418938|FG001|Overall Study|Protocol Violation|0|||
27860400|NCT02516982|54418939|FG002|Overall Study|Protocol Violation|1|||
27860401|NCT02516982|54418940|FG003|Overall Study|Protocol Violation|1|||
27860402|NCT02516982|54418937|FG000|Overall Study|Did not install the app|0|||
27860403|NCT02516982|54418938|FG001|Overall Study|Did not install the app|0|||
27860404|NCT02516982|54418939|FG002|Overall Study|Did not install the app|46|||
27860405|NCT02516982|54418940|FG003|Overall Study|Did not install the app|47|||
27860406|NCT02464410|54418985|FG000|Overall Study|Death|3|||
27860407|NCT02464410|54418986|FG001|Overall Study|Death|4|||
27860408|NCT02464410|54418985|FG000|Overall Study|Lost to Follow-up|7|||
27860409|NCT02464410|54418986|FG001|Overall Study|Lost to Follow-up|9|||
27860410|NCT02464410|54418985|FG000|Overall Study|Withdrawal by Subject|12|||
27860411|NCT02464410|54418986|FG001|Overall Study|Withdrawal by Subject|3|||
27860412|NCT01047332|54418994|FG000|Overall Study|SEMS Obstruction|11|||
27860413|NCT01047332|54418995|FG001|Overall Study|SEMS Obstruction|20|||
27860414|NCT01047332|54418994|FG000|Overall Study|Died Unobstructed|38|||
27860415|NCT01047332|54418995|FG001|Overall Study|Died Unobstructed|41|||
27860416|NCT01047332|54418994|FG000|Overall Study|Lost to Follow-up|8|||
27860417|NCT01047332|54418995|FG001|Overall Study|Lost to Follow-up|3|||
27860418|NCT01046396|54419001|FG000|Overall Study|Withdrawal by Subject|5|||
27860419|NCT01046084|54419027|FG000|Third Washout of 7 Days|Withdrawal by Subject|2|||
27860420|NCT01046084|54419028|FG001|Third Washout of 7 Days|Withdrawal by Subject|0|||
27860421|NCT01045694|54419047|FG000|Overall Study|Withdrawal by Subject|2|||
27860422|NCT01044290|54419107|FG000|Follow-up 1|Death|3|||
27860423|NCT01044290|54419108|FG001|Follow-up 1|Death|3|||
27860424|NCT01044290|54419109|FG002|Follow-up 1|Death|1|||
27860425|NCT01044290|54419107|FG000|Follow-up 1|Withdrawal by Subject|2|||
27860426|NCT01044290|54419108|FG001|Follow-up 1|Withdrawal by Subject|2|||
27860427|NCT01044290|54419109|FG002|Follow-up 1|Withdrawal by Subject|0|||
27860428|NCT01044290|54419107|FG000|Follow-Up 2|Death|0|||
27860429|NCT01044290|54419108|FG001|Follow-Up 2|Death|1|||
27860430|NCT01044290|54419109|FG002|Follow-Up 2|Death|1|||
27860431|NCT01044290|54419107|FG000|Follow-Up 2|Withdrawal by Subject|0|||
27860432|NCT01044290|54419108|FG001|Follow-Up 2|Withdrawal by Subject|1|||
27860433|NCT01044290|54419109|FG002|Follow-Up 2|Withdrawal by Subject|1|||
27860434|NCT01041638|54419190|FG000|Overall Study|Adverse Event|4|||
27860435|NCT01041638|54419190|FG000|Overall Study|Death|1|||
27860436|NCT01041638|54419190|FG000|Overall Study|Lack of Efficacy|7|||
27860437|NCT01041638|54419190|FG000|Overall Study|Physician Decision|4|||
27860438|NCT01041638|54419190|FG000|Overall Study|Withdrawal by Subject|11|||
27860439|NCT01045460|54419214|FG000|Overall Study|Physician Decision|3|||
27860440|NCT01045460|54419215|FG001|Overall Study|Physician Decision|2|||
27860441|NCT01045460|54419214|FG000|Overall Study|Lost to Follow-up|0|||
27860442|NCT01045460|54419215|FG001|Overall Study|Lost to Follow-up|1|||
27860443|NCT01045460|54419214|FG000|Overall Study|Lack of Efficacy|3|||
27860444|NCT01045460|54419215|FG001|Overall Study|Lack of Efficacy|0|||
27860445|NCT05014919|54419226|FG000|Open-Label (12 Weeks)|Adverse Event|1|||
27860446|NCT05014919|54419227|FG001|Open-Label (12 Weeks)|Adverse Event|0|||
27860447|NCT05014919|54419228|FG002|Open-Label (12 Weeks)|Adverse Event|0|||
27860448|NCT05014919|54419226|FG000|Open-Label (12 Weeks)|Lack of Efficacy|1|||
27860449|NCT05014919|54419227|FG001|Open-Label (12 Weeks)|Lack of Efficacy|0|||
27860450|NCT05014919|54419228|FG002|Open-Label (12 Weeks)|Lack of Efficacy|0|||
27860451|NCT05014919|54419226|FG000|Open-Label (12 Weeks)|Withdrawal by Subject|2|||
27860452|NCT05014919|54419227|FG001|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
27860453|NCT05014919|54419228|FG002|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
27860454|NCT05014919|54419226|FG000|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|15|||
27860455|NCT05014919|54419227|FG001|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
27860456|NCT05014919|54419228|FG002|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
27860457|NCT05014919|54419226|FG000|Open-Label (12 Weeks)|Sponsor Decision|4|||
27860458|NCT05014919|54419227|FG001|Open-Label (12 Weeks)|Sponsor Decision|0|||
27860459|NCT05014919|54419228|FG002|Open-Label (12 Weeks)|Sponsor Decision|0|||
27860460|NCT05014919|54419226|FG000|Open-Label (12 Weeks)|Study Terminated by Sponsor|5|||
27860461|NCT05014919|54419227|FG001|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
27860462|NCT05014919|54419228|FG002|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
27860463|NCT05014919|54419226|FG000|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
27860464|NCT05014919|54419227|FG001|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
27860465|NCT05014919|54419228|FG002|Double-Blind (26 Weeks)|Study Terminated by Sponsor|1|||
27860466|NCT05014919|54419226|FG000|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
27860467|NCT05014919|54419227|FG001|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
27860468|NCT05014919|54419228|FG002|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
27860469|NCT03409796|54419271|FG000|Overall Study|Adverse Event|2|||
27860470|NCT03409796|54419272|FG001|Overall Study|Adverse Event|0|||
27860471|NCT03409796|54419271|FG000|Overall Study|Other|0|||
27860472|NCT03409796|54419272|FG001|Overall Study|Other|1|||
27860473|NCT02462928|54419281|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
27860474|NCT02462928|54419282|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
27860475|NCT02462928|54419283|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|2|||
27860476|NCT02462928|54419281|FG000|Overall Study|Adverse Event|47|||
27860477|NCT02462928|54419282|FG001|Overall Study|Adverse Event|51|||
27860478|NCT02462928|54419283|FG002|Overall Study|Adverse Event|25|||
27860479|NCT02462928|54419281|FG000|Overall Study|Lack of Efficacy|3|||
27860480|NCT02462928|54419282|FG001|Overall Study|Lack of Efficacy|8|||
27860481|NCT02462928|54419283|FG002|Overall Study|Lack of Efficacy|3|||
27860482|NCT02462928|54419281|FG000|Overall Study|Lost to Follow-up|4|||
27860483|NCT02462928|54419282|FG001|Overall Study|Lost to Follow-up|4|||
27860484|NCT02462928|54419283|FG002|Overall Study|Lost to Follow-up|1|||
27860485|NCT02462928|54419281|FG000|Overall Study|Withdrawal by Patient|31|||
27860486|NCT02462928|54419282|FG001|Overall Study|Withdrawal by Patient|21|||
27860487|NCT02462928|54419283|FG002|Overall Study|Withdrawal by Patient|21|||
27860488|NCT02462928|54419281|FG000|Overall Study|Protocol Violation|0|||
27860489|NCT02462928|54419282|FG001|Overall Study|Protocol Violation|1|||
27860490|NCT02462928|54419283|FG002|Overall Study|Protocol Violation|0|||
27860491|NCT02462928|54419281|FG000|Overall Study|Reason not Specified|4|||
27860492|NCT02462928|54419282|FG001|Overall Study|Reason not Specified|6|||
27860493|NCT02462928|54419283|FG002|Overall Study|Reason not Specified|5|||
27860494|NCT00019604|54419300|FG000|Overall Study|Death|1|||
27860495|NCT00019604|54419300|FG000|Overall Study|Progressive disease|23|||
27860496|NCT00019604|54419300|FG000|Overall Study|Refused treatment|1|||
27860497|NCT00019604|54419300|FG000|Overall Study|Carcinoid tumor, not treatable|1|||
27860498|NCT00019604|54419300|FG000|Overall Study|Going to have liver transplant|1|||
27860499|NCT00019604|54419300|FG000|Overall Study|Move to a different study|1|||
27860500|NCT00019604|54419300|FG000|Overall Study|Non compliant on systemic CH|1|||
27860501|NCT00019604|54419300|FG000|Overall Study|Non compliant|1|||
27860502|NCT00019604|54419300|FG000|Overall Study|Resectable disease|1|||
27860503|NCT00019604|54419300|FG000|Overall Study|Started new chemo regimen|1|||
27860504|NCT00019604|54419300|FG000|Overall Study|Pt going to immunotherapy study|1|||
27860505|NCT00019604|54419300|FG000|Overall Study|Too much disease|1|||
27860506|NCT00019604|54419300|FG000|Overall Study|Unable to evaluate|1|||
27860507|NCT00019604|54419300|FG000|Overall Study|Details for other not available|4|||
27860508|NCT02492958|54419316|FG000|Overall Study|Withdrawal by Subject|0|||
27860509|NCT02492958|54419317|FG001|Overall Study|Withdrawal by Subject|0|||
27860510|NCT02492958|54419318|FG002|Overall Study|Withdrawal by Subject|1|||
27860511|NCT02492958|54419319|FG003|Overall Study|Withdrawal by Subject|0|||
27738873|NCT02936323|54188173|FG005|Phase 2a Dose Expansion|Lost to Follow-up|0|||
27860512|NCT02492958|54419316|FG000|Overall Study|Adverse Event|1|||
27860513|NCT02492958|54419317|FG001|Overall Study|Adverse Event|0|||
27860514|NCT02492958|54419318|FG002|Overall Study|Adverse Event|1|||
28096006|NCT04602000|54750585|FG000|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
28096007|NCT04602000|54750586|FG001|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
28096008|NCT04602000|54750587|FG002|Overall Study|Completed Treatment Period but not entered into Follow-up Period|1|||
28096009|NCT04602000|54750588|FG003|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
28096010|NCT04602000|54750589|FG004|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
28096011|NCT03041116|54750605|FG000|Double-blind|Death|0|||
28096012|NCT03041116|54750606|FG001|Double-blind|Death|2|||
28096013|NCT03041116|54750605|FG000|Double-blind|Withdrawal by Subject|0|||
28096014|NCT03041116|54750606|FG001|Double-blind|Withdrawal by Subject|4|||
27860515|NCT02492958|54419319|FG003|Overall Study|Adverse Event|0|||
27860516|NCT02492880|54419329|FG000|Overall Study|Lost to Follow-up|1|||
27860517|NCT02492880|54419329|FG000|Overall Study|Protocol Violation|1|||
27860518|NCT02516592|54419335|FG000|Overall Study|Patient withdrew consent|5|||
27860519|NCT02516592|54419336|FG001|Overall Study|Patient withdrew consent|2|||
27860520|NCT02516592|54419335|FG000|Overall Study|Protocol deviation|4|||
27860521|NCT02516592|54419336|FG001|Overall Study|Protocol deviation|4|||
27860522|NCT02516592|54419335|FG000|Overall Study|Lost to Follow-up|2|||
27860523|NCT02516592|54419336|FG001|Overall Study|Lost to Follow-up|3|||
27860524|NCT02516592|54419335|FG000|Overall Study|Patient/guardian decision|2|||
27860525|NCT02516592|54419336|FG001|Overall Study|Patient/guardian decision|1|||
27860526|NCT02516592|54419335|FG000|Overall Study|Adverse Event|1|||
27860527|NCT02516592|54419336|FG001|Overall Study|Adverse Event|2|||
27860528|NCT02516592|54419335|FG000|Overall Study|Abnormal test procedure result|1|||
27860529|NCT02516592|54419336|FG001|Overall Study|Abnormal test procedure result|0|||
27860530|NCT02516592|54419335|FG000|Overall Study|Death|1|||
27860531|NCT02516592|54419336|FG001|Overall Study|Death|1|||
27860532|NCT02492100|54419364|FG000|Overall Study|Death|1|||
27860533|NCT02461758|54419387|FG000|Overall Study|Lost to Follow-up|0|||
27860534|NCT02461758|54419388|FG001|Overall Study|Lost to Follow-up|1|||
27860535|NCT02461758|54419389|FG002|Overall Study|Lost to Follow-up|1|||
27860536|NCT02461758|54419390|FG003|Overall Study|Lost to Follow-up|0|||
27860537|NCT02461290|54419412|FG000|Overall Study|Withdrawn for Inadequate Clinical Stage|7|||
27860538|NCT02461290|54419412|FG000|Overall Study|Lost to Follow-up|3|||
27860539|NCT02461134|54419416|FG000|Overall Study|Adverse Event|1|||
27860540|NCT02460978|54419445|FG000|Overall Study|Adverse Event|17|||
27860541|NCT02460978|54419446|FG001|Overall Study|Adverse Event|11|||
27860542|NCT02460978|54419447|FG002|Overall Study|Adverse Event|11|||
27860543|NCT02460978|54419445|FG000|Overall Study|Withdrawal by Subject|5|||
27860544|NCT02460978|54419446|FG001|Overall Study|Withdrawal by Subject|5|||
27860545|NCT02460978|54419447|FG002|Overall Study|Withdrawal by Subject|14|||
27860546|NCT02460978|54419445|FG000|Overall Study|Lost to Follow-up|2|||
27860547|NCT02460978|54419446|FG001|Overall Study|Lost to Follow-up|3|||
27860548|NCT02460978|54419447|FG002|Overall Study|Lost to Follow-up|1|||
27860549|NCT02460978|54419445|FG000|Overall Study|Protocol Violation|1|||
27860550|NCT02460978|54419446|FG001|Overall Study|Protocol Violation|1|||
27860551|NCT02460978|54419447|FG002|Overall Study|Protocol Violation|1|||
27860552|NCT02460978|54419445|FG000|Overall Study|Discontinued due to DKA/hypoglycemia|2|||
27860553|NCT02460978|54419446|FG001|Overall Study|Discontinued due to DKA/hypoglycemia|5|||
27860554|NCT02460978|54419447|FG002|Overall Study|Discontinued due to DKA/hypoglycemia|4|||
27860555|NCT02460978|54419445|FG000|Overall Study|Pregnancy|0|||
27860556|NCT02460978|54419446|FG001|Overall Study|Pregnancy|0|||
27860557|NCT02460978|54419447|FG002|Overall Study|Pregnancy|2|||
27860558|NCT02489448|54419462|FG000|Overall Study|Death|3|||
27860559|NCT02489448|54419462|FG000|Overall Study|Withdrawal by Subject|2|||
27860560|NCT02488980|54419483|FG000|Overall Study|Protocol Violation|2|||
27860561|NCT02488980|54419484|FG001|Overall Study|Protocol Violation|2|||
27860562|NCT02488980|54419485|FG002|Overall Study|Protocol Violation|2|||
27860563|NCT02460822|54419497|FG000|Overall Study|Withdrawal by Subject|1|||
27860564|NCT02488824|54419503|FG000|Overall Study|Adverse Event|1|||
27860565|NCT02488824|54419504|FG001|Overall Study|Adverse Event|1|||
27860566|NCT02308241|54419607|FG000|Overall Study|Withdrawal by Subject|3|||
27860567|NCT02460198|54419646|FG000|Overall Study|Adverse Event|1|||
27860568|NCT02460198|54419647|FG001|Overall Study|Adverse Event|3|||
27860569|NCT02460198|54419646|FG000|Overall Study|Death|36|||
27860570|NCT02460198|54419647|FG001|Overall Study|Death|28|||
27860571|NCT02460198|54419646|FG000|Overall Study|Lost to Follow-up|1|||
27860572|NCT02460198|54419647|FG001|Overall Study|Lost to Follow-up|1|||
27860573|NCT02460198|54419646|FG000|Overall Study|Transferred to Extension Study|15|||
27860574|NCT02460198|54419647|FG001|Overall Study|Transferred to Extension Study|15|||
27860575|NCT02460198|54419646|FG000|Overall Study|Withdrawal by Subject|2|||
27860576|NCT02460198|54419647|FG001|Overall Study|Withdrawal by Subject|4|||
27860577|NCT02460198|54419646|FG000|Overall Study|Site Terminated By Sponsor|0|||
27860578|NCT02460198|54419647|FG001|Overall Study|Site Terminated By Sponsor|1|||
27860579|NCT02460198|54419646|FG000|Overall Study|Did Not Continue on Extension Study|6|||
27860580|NCT02460198|54419647|FG001|Overall Study|Did Not Continue on Extension Study|11|||
27860581|NCT02487810|54419667|FG000|Overall Study|Withdrawal by Subject|1|||
27860582|NCT02487810|54419668|FG001|Overall Study|Withdrawal by Subject|0|||
27860583|NCT02452320|54419676|FG000|Overall Study|Adverse Event|0|||
28096015|NCT03041116|54750605|FG000|Open-label|Death|1|||
27860584|NCT02452320|54419677|FG001|Overall Study|Adverse Event|1|||
27860585|NCT02459964|54419686|FG000|Overall Study|Withdrawal by Subject|0|||
27860586|NCT02459964|54419687|FG001|Overall Study|Withdrawal by Subject|0|||
27860587|NCT02459964|54419688|FG002|Overall Study|Withdrawal by Subject|1|||
27860588|NCT02459964|54419686|FG000|Overall Study|Abnormal EKG changes|0|||
27738874|NCT02936323|54188174|FG006|Phase 2a Dose Expansion|Lost to Follow-up|0|||
27860589|NCT02459964|54419687|FG001|Overall Study|Abnormal EKG changes|0|||
28096016|NCT03041116|54750606|FG001|Open-label|Death|0|||
27860590|NCT02459964|54419688|FG002|Overall Study|Abnormal EKG changes|1|||
27860591|NCT02451930|54419765|FG000|Overall Study|Death|0|||
27860592|NCT02451930|54419766|FG001|Overall Study|Death|15|||
27860593|NCT02451930|54419765|FG000|Overall Study|Lost to Follow-up|0|||
27860594|NCT02451930|54419766|FG001|Overall Study|Lost to Follow-up|3|||
27860595|NCT02451930|54419765|FG000|Overall Study|Sponsor Decision|2|||
27860596|NCT02451930|54419766|FG001|Overall Study|Sponsor Decision|10|||
27860597|NCT02451930|54419765|FG000|Overall Study|Withdrawal by Subject|0|||
28096017|NCT03041116|54750605|FG000|Open-label|Termination of the study by Sponsor|39|||
28096018|NCT03041116|54750606|FG001|Open-label|Termination of the study by Sponsor|37|||
28096019|NCT03041116|54750605|FG000|Open-label|Withdrawal by Subject|1|||
28096020|NCT03041116|54750606|FG001|Open-label|Withdrawal by Subject|0|||
28096021|NCT04860258|54750623|FG000|Overall Study|Withdrawal by Subject|0|||
28096022|NCT04860258|54750624|FG001|Overall Study|Withdrawal by Subject|0|||
28096023|NCT04860258|54750625|FG002|Overall Study|Withdrawal by Subject|4|||
28096024|NCT04860258|54750626|FG003|Overall Study|Withdrawal by Subject|1|||
28096025|NCT04860258|54750627|FG004|Overall Study|Withdrawal by Subject|4|||
28096026|NCT04860258|54750628|FG005|Overall Study|Withdrawal by Subject|1|||
28096027|NCT04860258|54750629|FG006|Overall Study|Withdrawal by Subject|0|||
28096028|NCT03041038|54750647|FG000|Overall Study|Withdrawal by Subject|4|||
28096029|NCT03041038|54750648|FG001|Overall Study|Withdrawal by Subject|0|||
28096030|NCT03041038|54750647|FG000|Overall Study|Lost to Follow-up|1|||
27860598|NCT02451930|54419766|FG001|Overall Study|Withdrawal by Subject|1|||
27860599|NCT02451930|54419765|FG000|Overall Study|Other|0|||
27860600|NCT02451930|54419766|FG001|Overall Study|Other|1|||
27860601|NCT02451696|54419802|FG000|Overall Study|Surgery postponed|1|||
27860602|NCT02451696|54419803|FG001|Overall Study|Surgery postponed|0|||
27860603|NCT02459418|54419826|FG000|Overall Study|Exclusion Criteria|4|||
27860604|NCT02459418|54419827|FG001|Overall Study|Exclusion Criteria|0|||
27860605|NCT02459418|54419826|FG000|Overall Study|Protocol Violation|0|||
27860606|NCT02459418|54419827|FG001|Overall Study|Protocol Violation|2|||
27860607|NCT02459418|54419826|FG000|Overall Study|Physician Decision|0|||
27860608|NCT02459418|54419827|FG001|Overall Study|Physician Decision|2|||
27860609|NCT02459418|54419826|FG000|Overall Study|Endometrial thickness of >5 mm|1|||
27860610|NCT02459418|54419827|FG001|Overall Study|Endometrial thickness of >5 mm|0|||
27860611|NCT02459418|54419826|FG000|Overall Study|Adverse Event|0|||
27860612|NCT02459418|54419827|FG001|Overall Study|Adverse Event|1|||
27860613|NCT02459418|54419826|FG000|Overall Study|Withdrawal by Subject|1|||
27860614|NCT02459418|54419827|FG001|Overall Study|Withdrawal by Subject|1|||
27860615|NCT02459418|54419826|FG000|Overall Study|Elevated Creatine Kinase|1|||
27860616|NCT02459418|54419827|FG001|Overall Study|Elevated Creatine Kinase|0|||
27860617|NCT02459418|54419826|FG000|Overall Study|Abnormal Transvaginal Ultrasound|1|||
27860618|NCT02459418|54419827|FG001|Overall Study|Abnormal Transvaginal Ultrasound|0|||
27860619|NCT02487498|54419857|FG000|Period: Period 1|Adverse Event|2|||
27860620|NCT02487498|54419858|FG001|Period: Period 1|Adverse Event|4|||
27860621|NCT02487498|54419857|FG000|Period: Period 1|Subject/guardian decision|2|||
27860622|NCT02487498|54419858|FG001|Period: Period 1|Subject/guardian decision|4|||
27860623|NCT02487498|54419857|FG000|Period: Period 1|Lost to Follow-up|0|||
27860624|NCT02487498|54419858|FG001|Period: Period 1|Lost to Follow-up|2|||
27860625|NCT02487498|54419857|FG000|Period: Period 1|Lack of Efficacy|1|||
27860626|NCT02487498|54419858|FG001|Period: Period 1|Lack of Efficacy|0|||
27860627|NCT02487498|54419857|FG000|Period: Period 1|Physician Decision|0|||
27860628|NCT02487498|54419858|FG001|Period: Period 1|Physician Decision|1|||
27860629|NCT02487498|54419857|FG000|Period: Period 1|Protocol deviation|1|||
27860630|NCT02487498|54419858|FG001|Period: Period 1|Protocol deviation|0|||
28171318|NCT02720523|54842905|FG006|Period 1: Placebo-controlled Period|Other|0|||
27738875|NCT02936323|54188175|FG007|Phase 2a Dose Expansion|Lost to Follow-up|2|||
27860631|NCT02487498|54419857|FG000|Period: Washout|Subject/guardian decision|0|||
27860632|NCT02487498|54419858|FG001|Period: Washout|Subject/guardian decision|5|||
27860633|NCT02487498|54419857|FG000|Period: Washout|Lack of Efficacy|1|||
27860634|NCT02487498|54419858|FG001|Period: Washout|Lack of Efficacy|1|||
27860635|NCT02487498|54419857|FG000|Period: Washout|Physician Decision|1|||
27860636|NCT02487498|54419858|FG001|Period: Washout|Physician Decision|0|||
27860637|NCT02487498|54419857|FG000|Period: Washout|Non-compliance with study treatment|0|||
27860638|NCT02487498|54419858|FG001|Period: Washout|Non-compliance with study treatment|1|||
27860639|NCT02487498|54419857|FG000|Period: Period 2|Adverse Event|2|||
27860640|NCT02487498|54419858|FG001|Period: Period 2|Adverse Event|2|||
28096031|NCT03041038|54750648|FG001|Overall Study|Lost to Follow-up|1|||
28096032|NCT03041038|54750647|FG000|Overall Study|Protocol Violation|1|||
28096033|NCT03041038|54750648|FG001|Overall Study|Protocol Violation|1|||
27860641|NCT02487498|54419857|FG000|Period: Period 2|Subject/guardian decision|2|||
27860642|NCT02487498|54419858|FG001|Period: Period 2|Subject/guardian decision|1|||
27860643|NCT02487498|54419857|FG000|Period: Period 2|Lost to Follow-up|1|||
27860644|NCT02487498|54419858|FG001|Period: Period 2|Lost to Follow-up|1|||
27860645|NCT02487498|54419857|FG000|Period: Period 2|Death|0|||
28096034|NCT04382066|54750659|FG000|Overall Study|Adverse Event|1|||
28096035|NCT04382066|54750660|FG001|Overall Study|Adverse Event|0|||
27860646|NCT02487498|54419858|FG001|Period: Period 2|Death|1|||
27860647|NCT02487498|54419857|FG000|Period: Period 2|Physician Decision|1|||
27860648|NCT02487498|54419858|FG001|Period: Period 2|Physician Decision|0|||
27860649|NCT02487108|54419869|FG000|Overall Study|Adverse Event|1|||
27860650|NCT02487108|54419870|FG001|Overall Study|Adverse Event|6|||
27860651|NCT02487108|54419871|FG002|Overall Study|Adverse Event|12|||
27860652|NCT02487108|54419872|FG003|Overall Study|Adverse Event|6|||
27860653|NCT02487108|54419869|FG000|Overall Study|Withdrawal by Subject|8|||
27860654|NCT02487108|54419870|FG001|Overall Study|Withdrawal by Subject|5|||
27860655|NCT02487108|54419871|FG002|Overall Study|Withdrawal by Subject|5|||
27860656|NCT02487108|54419872|FG003|Overall Study|Withdrawal by Subject|0|||
27860657|NCT02487108|54419869|FG000|Overall Study|Non-compliance to study medication|3|||
27860658|NCT02487108|54419870|FG001|Overall Study|Non-compliance to study medication|2|||
27860659|NCT02487108|54419871|FG002|Overall Study|Non-compliance to study medication|5|||
27860660|NCT02487108|54419872|FG003|Overall Study|Non-compliance to study medication|4|||
27860661|NCT02487108|54419869|FG000|Overall Study|Protocol Violation|1|||
27860662|NCT02487108|54419870|FG001|Overall Study|Protocol Violation|1|||
27860663|NCT02487108|54419871|FG002|Overall Study|Protocol Violation|2|||
27860664|NCT02487108|54419872|FG003|Overall Study|Protocol Violation|0|||
27860665|NCT02487108|54419869|FG000|Overall Study|Non-compliance to study procedures|0|||
27860666|NCT02487108|54419870|FG001|Overall Study|Non-compliance to study procedures|0|||
27860667|NCT02487108|54419871|FG002|Overall Study|Non-compliance to study procedures|0|||
27860668|NCT02487108|54419872|FG003|Overall Study|Non-compliance to study procedures|1|||
27860669|NCT02487108|54419869|FG000|Overall Study|Other than specified|3|||
27860670|NCT02487108|54419870|FG001|Overall Study|Other than specified|2|||
27860671|NCT02487108|54419871|FG002|Overall Study|Other than specified|2|||
27860672|NCT02487108|54419872|FG003|Overall Study|Other than specified|0|||
27860673|NCT02487030|54419889|FG000|Overall Study|Lack of Efficacy|2|||
27860674|NCT02487030|54419890|FG001|Overall Study|Lack of Efficacy|4|||
27860675|NCT02487030|54419891|FG002|Overall Study|Lack of Efficacy|1|||
27860676|NCT02487030|54419892|FG003|Overall Study|Lack of Efficacy|0|||
27860677|NCT02487030|54419893|FG004|Overall Study|Lack of Efficacy|1|||
27860678|NCT02487030|54419894|FG005|Overall Study|Lack of Efficacy|0|||
27860679|NCT02487030|54419895|FG006|Overall Study|Lack of Efficacy|0|||
27860680|NCT02487030|54419889|FG000|Overall Study|Lost to Follow-up|0|||
27860681|NCT02487030|54419890|FG001|Overall Study|Lost to Follow-up|0|||
27860682|NCT02487030|54419891|FG002|Overall Study|Lost to Follow-up|1|||
27860683|NCT02487030|54419892|FG003|Overall Study|Lost to Follow-up|1|||
27860684|NCT02487030|54419893|FG004|Overall Study|Lost to Follow-up|0|||
27860685|NCT02487030|54419894|FG005|Overall Study|Lost to Follow-up|1|||
27860686|NCT02487030|54419895|FG006|Overall Study|Lost to Follow-up|0|||
27860687|NCT02487030|54419889|FG000|Overall Study|Adverse Event|0|||
27860688|NCT02487030|54419890|FG001|Overall Study|Adverse Event|0|||
27860689|NCT02487030|54419891|FG002|Overall Study|Adverse Event|0|||
27860690|NCT02487030|54419892|FG003|Overall Study|Adverse Event|1|||
28096036|NCT04382066|54750661|FG002|Overall Study|Adverse Event|0|||
28096037|NCT04382066|54750659|FG000|Overall Study|Death|1|||
28096038|NCT04382066|54750660|FG001|Overall Study|Death|0|||
28096039|NCT04382066|54750661|FG002|Overall Study|Death|1|||
28096040|NCT04435184|54750677|FG000|Overall Study|follow-up blood draws missing|3|||
28096041|NCT04435184|54750678|FG001|Overall Study|follow-up blood draws missing|5|||
28096042|NCT04432376|54750687|FG000|Double-blind Treatment Period|Adverse Event|2|||
28096043|NCT04432376|54750688|FG001|Double-blind Treatment Period|Adverse Event|6|||
28171319|NCT02720523|54842899|FG000|Period 2: Long-term Extension Period|Ongoing|0|||
28171320|NCT02720523|54842900|FG001|Period 2: Long-term Extension Period|Ongoing|0|||
27738876|NCT02936323|54188176|FG008|Phase 2a Dose Expansion|Lost to Follow-up|1|||
27738877|NCT02936323|54188177|FG009|Phase 2a Dose Expansion|Lost to Follow-up|0|||
27738878|NCT02936323|54188168|FG000|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
27738879|NCT02936323|54188169|FG001|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
27738880|NCT02936323|54188170|FG002|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
27738881|NCT02936323|54188171|FG003|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
27738882|NCT02936323|54188172|FG004|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
27834432|NCT01697579|54317925|FG006|Optional Extension-Cycles 2-6|Lost to Follow-up|1|||
27834433|NCT01586195|54317953|FG000|Overall Study|Death|11|||
27834434|NCT01586195|54317953|FG000|Overall Study|Withdrawal of Consent|5|||
27834435|NCT01586195|54317953|FG000|Overall Study|Started new anti-melanoma therapy|1|||
27834436|NCT01586195|54317953|FG000|Overall Study|Reason not specified|9|||
27834437|NCT01585961|54317957|FG000|Overall Study|Death|6|||
27834438|NCT01585961|54317957|FG000|Overall Study|Physician Decision|1|||
27834439|NCT01585961|54317957|FG000|Overall Study|Decision to use non-study catheter|1|||
27834440|NCT01585961|54317957|FG000|Overall Study|Withdrawal by Subject|1|||
27834441|NCT01585961|54317957|FG000|Overall Study|Lost to Follow-up|23|||
27860691|NCT02487030|54419893|FG004|Overall Study|Adverse Event|0|||
27860692|NCT02487030|54419894|FG005|Overall Study|Adverse Event|0|||
27860693|NCT02487030|54419895|FG006|Overall Study|Adverse Event|0|||
27860694|NCT02487030|54419889|FG000|Overall Study|Death|0|||
28096044|NCT04432376|54750689|FG002|Double-blind Treatment Period|Adverse Event|0|||
27860695|NCT02487030|54419890|FG001|Overall Study|Death|0|||
27860696|NCT02487030|54419891|FG002|Overall Study|Death|0|||
27860697|NCT02487030|54419892|FG003|Overall Study|Death|0|||
27860698|NCT02487030|54419893|FG004|Overall Study|Death|1|||
27860699|NCT02487030|54419894|FG005|Overall Study|Death|0|||
27860700|NCT02487030|54419895|FG006|Overall Study|Death|0|||
27860701|NCT02486952|54419912|FG000|Overall Study|Not Started Induction Therapy|3|||
27860702|NCT02486952|54419912|FG000|Overall Study|Adverse Event|1|||
27860703|NCT02486952|54419912|FG000|Overall Study|Death|15|||
27860704|NCT02486952|54419912|FG000|Overall Study|Lack of Efficacy|3|||
27860705|NCT02486952|54419912|FG000|Overall Study|Lost to Follow-up|26|||
27860706|NCT02486952|54419912|FG000|Overall Study|Other|2|||
27860707|NCT02486796|54419918|FG000|Overall Study|Withdrawal by Subject|1|||
27860708|NCT02486796|54419919|FG001|Overall Study|Withdrawal by Subject|1|||
27860709|NCT02486796|54419918|FG000|Overall Study|Physician Decision|1|||
27860710|NCT02486796|54419919|FG001|Overall Study|Physician Decision|0|||
27860711|NCT02459262|54419936|FG000|Overall Study|Withdrawal by Subject|0|||
27860712|NCT02459262|54419937|FG001|Overall Study|Withdrawal by Subject|0|||
27860713|NCT02459262|54419938|FG002|Overall Study|Withdrawal by Subject|0|||
27860714|NCT02459262|54419939|FG003|Overall Study|Withdrawal by Subject|0|||
27860715|NCT02459262|54419940|FG004|Overall Study|Withdrawal by Subject|0|||
27860716|NCT02459262|54419941|FG005|Overall Study|Withdrawal by Subject|0|||
27860717|NCT02459262|54419942|FG006|Overall Study|Withdrawal by Subject|0|||
27860718|NCT02459262|54419943|FG007|Overall Study|Withdrawal by Subject|0|||
27860719|NCT02459262|54419944|FG008|Overall Study|Withdrawal by Subject|0|||
27860720|NCT02459262|54419945|FG009|Overall Study|Withdrawal by Subject|1|||
27860721|NCT02459262|54419946|FG010|Overall Study|Withdrawal by Subject|0|||
27860722|NCT02450526|54420030|FG000|DB Period (Cycle 1)|Adverse Event|0|||
27860723|NCT02450526|54420031|FG001|DB Period (Cycle 1)|Adverse Event|0|||
27860724|NCT02450526|54420032|FG002|DB Period (Cycle 1)|Adverse Event|2|||
27860725|NCT02450526|54420033|FG003|DB Period (Cycle 1)|Adverse Event|0|||
27860726|NCT02450526|54420034|FG004|DB Period (Cycle 1)|Adverse Event|0|||
27860727|NCT02450526|54420030|FG000|DB Period (Cycle 1)|Withdrawal by Subject|28|||
27860728|NCT02450526|54420031|FG001|DB Period (Cycle 1)|Withdrawal by Subject|3|||
27860729|NCT02450526|54420032|FG002|DB Period (Cycle 1)|Withdrawal by Subject|8|||
27860730|NCT02450526|54420033|FG003|DB Period (Cycle 1)|Withdrawal by Subject|1|||
27860731|NCT02450526|54420034|FG004|DB Period (Cycle 1)|Withdrawal by Subject|0|||
27860732|NCT02450526|54420030|FG000|DB Period (Cycle 1)|Lost to Follow-up|1|||
27860733|NCT02450526|54420031|FG001|DB Period (Cycle 1)|Lost to Follow-up|0|||
27860734|NCT02450526|54420032|FG002|DB Period (Cycle 1)|Lost to Follow-up|0|||
27860735|NCT02450526|54420033|FG003|DB Period (Cycle 1)|Lost to Follow-up|0|||
27860736|NCT02450526|54420034|FG004|DB Period (Cycle 1)|Lost to Follow-up|0|||
27860737|NCT02450526|54420030|FG000|DB Period (Cycle 1)|Protocol Violation|2|||
27860738|NCT02450526|54420031|FG001|DB Period (Cycle 1)|Protocol Violation|0|||
27860739|NCT02450526|54420032|FG002|DB Period (Cycle 1)|Protocol Violation|0|||
27860740|NCT02450526|54420033|FG003|DB Period (Cycle 1)|Protocol Violation|1|||
27860741|NCT02450526|54420034|FG004|DB Period (Cycle 1)|Protocol Violation|0|||
27860742|NCT02450526|54420030|FG000|OL Period (Cycles 2-5)|Adverse Event|0|||
27860743|NCT02450526|54420031|FG001|OL Period (Cycles 2-5)|Adverse Event|0|||
27860744|NCT02450526|54420032|FG002|OL Period (Cycles 2-5)|Adverse Event|0|||
27860745|NCT02450526|54420033|FG003|OL Period (Cycles 2-5)|Adverse Event|0|||
27860746|NCT02450526|54420034|FG004|OL Period (Cycles 2-5)|Adverse Event|2|||
27860747|NCT02450526|54420030|FG000|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
27860748|NCT02450526|54420031|FG001|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
27860749|NCT02450526|54420032|FG002|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
27860750|NCT02450526|54420033|FG003|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
27860751|NCT02450526|54420034|FG004|OL Period (Cycles 2-5)|Withdrawal by Subject|31|||
27860752|NCT02450526|54420030|FG000|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
27860753|NCT02450526|54420031|FG001|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
27860754|NCT02450526|54420032|FG002|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
27860755|NCT02450526|54420033|FG003|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
27860756|NCT02450526|54420034|FG004|OL Period (Cycles 2-5)|Lack of Efficacy|1|||
27981286|NCT00887354|54639152|FG000|Treatment Phase (Week 0 to Week 26)|Physician Decision|2|||
27860757|NCT02450526|54420030|FG000|OL Period (Cycles 2-5)|Protocol Violation|0|||
27860758|NCT02450526|54420031|FG001|OL Period (Cycles 2-5)|Protocol Violation|0|||
27860759|NCT02450526|54420032|FG002|OL Period (Cycles 2-5)|Protocol Violation|0|||
27860760|NCT02450526|54420033|FG003|OL Period (Cycles 2-5)|Protocol Violation|0|||
27860761|NCT02450526|54420034|FG004|OL Period (Cycles 2-5)|Protocol Violation|7|||
27860762|NCT02458638|54420101|FG000|Overall Study|Death|309|||
27860763|NCT02458638|54420101|FG000|Overall Study|End of Cohort/End of Study|67|||
27860764|NCT02458638|54420101|FG000|Overall Study|Lost to Follow-up|31|||
27860765|NCT02458638|54420101|FG000|Overall Study|Other Reasons|4|||
27860766|NCT02458638|54420101|FG000|Overall Study|Physician Decision|1|||
27860767|NCT02458638|54420101|FG000|Overall Study|Withdrawal by Subject|47|||
27860768|NCT02458092|54420239|FG000|Overall Study|Withdrawal by Subject|1|||
27981287|NCT00887354|54639153|FG001|Treatment Phase (Week 0 to Week 26)|Physician Decision|1|||
27860769|NCT02458092|54420240|FG001|Overall Study|Withdrawal by Subject|0|||
27860770|NCT02449902|54420263|FG000|Overall Study|Adverse Event|0|||
27860771|NCT02449902|54420264|FG001|Overall Study|Adverse Event|1|||
27860772|NCT02449902|54420263|FG000|Overall Study|Withdrawal by Subject|0|||
27860773|NCT02449902|54420264|FG001|Overall Study|Withdrawal by Subject|1|||
27860774|NCT02449044|54420272|FG000|Overall Study|Lost to Follow-up|2|||
27860775|NCT02449044|54420272|FG000|Overall Study|Withdrawal by Subject|13|||
27860776|NCT02449044|54420272|FG000|Overall Study|Adverse Event|30|||
27860777|NCT02449044|54420272|FG000|Overall Study|Met Withdrawal Criteria|7|||
27860778|NCT02449044|54420272|FG000|Overall Study|Physician Decision|9|||
27860779|NCT02449044|54420272|FG000|Overall Study|Sponsor Discontinued Trial|3|||
27860780|NCT02448810|54421152|FG000|Overall Study|Adverse Event|0|||
27860781|NCT02448810|54421153|FG001|Overall Study|Adverse Event|0|||
27860782|NCT02448810|54421154|FG002|Overall Study|Adverse Event|1|||
27860783|NCT02448810|54421155|FG003|Overall Study|Adverse Event|0|||
27860784|NCT02448810|54421156|FG004|Overall Study|Adverse Event|0|||
27860785|NCT02448810|54421157|FG005|Overall Study|Adverse Event|0|||
27860786|NCT02448810|54421158|FG006|Overall Study|Adverse Event|0|||
27860787|NCT02448810|54421159|FG007|Overall Study|Adverse Event|0|||
27860788|NCT02448810|54421152|FG000|Overall Study|Withdrawal by Subject|0|||
27860789|NCT02448810|54421153|FG001|Overall Study|Withdrawal by Subject|0|||
27860790|NCT02448810|54421154|FG002|Overall Study|Withdrawal by Subject|1|||
27860791|NCT02448810|54421155|FG003|Overall Study|Withdrawal by Subject|0|||
27860792|NCT02448810|54421156|FG004|Overall Study|Withdrawal by Subject|3|||
27860793|NCT02448810|54421157|FG005|Overall Study|Withdrawal by Subject|5|||
27860794|NCT02448810|54421158|FG006|Overall Study|Withdrawal by Subject|0|||
27860795|NCT02448810|54421159|FG007|Overall Study|Withdrawal by Subject|2|||
27860796|NCT02448810|54421152|FG000|Overall Study|Other (study terminated by sponsor)|0|||
27860797|NCT02448810|54421153|FG001|Overall Study|Other (study terminated by sponsor)|0|||
27860798|NCT02448810|54421154|FG002|Overall Study|Other (study terminated by sponsor)|0|||
27860799|NCT02448810|54421155|FG003|Overall Study|Other (study terminated by sponsor)|0|||
27860800|NCT02448810|54421156|FG004|Overall Study|Other (study terminated by sponsor)|4|||
27860801|NCT02448810|54421157|FG005|Overall Study|Other (study terminated by sponsor)|2|||
27860802|NCT02448810|54421158|FG006|Overall Study|Other (study terminated by sponsor)|2|||
27860803|NCT02448810|54421159|FG007|Overall Study|Other (study terminated by sponsor)|1|||
27860804|NCT02448810|54421152|FG000|Overall Study|Death|1|||
27860805|NCT02448810|54421153|FG001|Overall Study|Death|0|||
27860806|NCT02448810|54421154|FG002|Overall Study|Death|1|||
27860807|NCT02448810|54421155|FG003|Overall Study|Death|0|||
27860808|NCT02448810|54421156|FG004|Overall Study|Death|1|||
27860809|NCT02448810|54421157|FG005|Overall Study|Death|0|||
27860810|NCT02448810|54421158|FG006|Overall Study|Death|0|||
27860811|NCT02448810|54421159|FG007|Overall Study|Death|0|||
27860812|NCT02448810|54421152|FG000|Overall Study|Other (Progressive disease)|2|||
27860813|NCT02448810|54421153|FG001|Overall Study|Other (Progressive disease)|2|||
27860814|NCT02448810|54421154|FG002|Overall Study|Other (Progressive disease)|0|||
27860815|NCT02448810|54421155|FG003|Overall Study|Other (Progressive disease)|3|||
27860816|NCT02448810|54421156|FG004|Overall Study|Other (Progressive disease)|23|||
27860817|NCT02448810|54421157|FG005|Overall Study|Other (Progressive disease)|9|||
27860818|NCT02448810|54421158|FG006|Overall Study|Other (Progressive disease)|14|||
27860819|NCT02448810|54421159|FG007|Overall Study|Other (Progressive disease)|5|||
27860820|NCT02448810|54421152|FG000|Overall Study|Lost to Follow-up|0|||
27860821|NCT02448810|54421153|FG001|Overall Study|Lost to Follow-up|1|||
27860822|NCT02448810|54421154|FG002|Overall Study|Lost to Follow-up|0|||
27860823|NCT02448810|54421155|FG003|Overall Study|Lost to Follow-up|0|||
27860824|NCT02448810|54421156|FG004|Overall Study|Lost to Follow-up|0|||
27860825|NCT02448810|54421157|FG005|Overall Study|Lost to Follow-up|0|||
27860826|NCT02448810|54421158|FG006|Overall Study|Lost to Follow-up|0|||
27860827|NCT02448810|54421159|FG007|Overall Study|Lost to Follow-up|0|||
27860828|NCT02448810|54421152|FG000|Overall Study|Other (unspecified)|0|||
27860829|NCT02448810|54421153|FG001|Overall Study|Other (unspecified)|0|||
27860830|NCT02448810|54421154|FG002|Overall Study|Other (unspecified)|0|||
27860831|NCT02448810|54421155|FG003|Overall Study|Other (unspecified)|0|||
27860832|NCT02448810|54421156|FG004|Overall Study|Other (unspecified)|0|||
27860833|NCT02448810|54421157|FG005|Overall Study|Other (unspecified)|0|||
27860834|NCT02448810|54421158|FG006|Overall Study|Other (unspecified)|2|||
27860835|NCT02448810|54421159|FG007|Overall Study|Other (unspecified)|0|||
27860836|NCT02457546|54421232|FG000|Overall Study|Other reasons|4|||
27860837|NCT02457546|54421233|FG001|Overall Study|Other reasons|1|||
27860838|NCT02457546|54421232|FG000|Overall Study|Refused to complete study/procedures|1|||
27860839|NCT02457546|54421233|FG001|Overall Study|Refused to complete study/procedures|1|||
27860840|NCT02457546|54421232|FG000|Overall Study|Lost to Follow-up|4|||
27860841|NCT02457546|54421233|FG001|Overall Study|Lost to Follow-up|1|||
27860842|NCT02457546|54421232|FG000|Overall Study|Adverse Event|0|||
27860843|NCT02457546|54421233|FG001|Overall Study|Adverse Event|1|||
27860844|NCT02447952|54421254|FG000|Overall Study|Adverse Event|2|||
27860845|NCT02447952|54421254|FG000|Overall Study|Physician Decision|1|||
27860846|NCT02447952|54421254|FG000|Overall Study|Withdrawal by Subject|4|||
27860847|NCT02447718|54421288|FG000|Overall Study|Lost to Follow-up|8|||
27860848|NCT02447718|54421289|FG001|Overall Study|Lost to Follow-up|0|||
27860849|NCT02447718|54421288|FG000|Overall Study|Withdrawal by Subject|3|||
27860850|NCT02447718|54421289|FG001|Overall Study|Withdrawal by Subject|0|||
27860851|NCT02447718|54421288|FG000|Overall Study|Screen Failure|1|||
27860852|NCT02447718|54421289|FG001|Overall Study|Screen Failure|0|||
27860853|NCT02486406|54421466|FG000|Overall Study|Withdrew consent|1|||
27860854|NCT02486406|54421467|FG001|Overall Study|Withdrew consent|0|||
27860855|NCT02486406|54421468|FG002|Overall Study|Withdrew consent|0|||
27860856|NCT02486406|54421469|FG003|Overall Study|Withdrew consent|1|||
27860857|NCT02486406|54421466|FG000|Overall Study|Lost to Follow-up|1|||
27860858|NCT02486406|54421467|FG001|Overall Study|Lost to Follow-up|3|||
27860859|NCT02486406|54421468|FG002|Overall Study|Lost to Follow-up|1|||
27860860|NCT02486406|54421469|FG003|Overall Study|Lost to Follow-up|3|||
27860861|NCT02486406|54421466|FG000|Overall Study|Other, not specified|0|||
27860862|NCT02486406|54421467|FG001|Overall Study|Other, not specified|0|||
27860863|NCT02486406|54421468|FG002|Overall Study|Other, not specified|1|||
27860864|NCT02486406|54421469|FG003|Overall Study|Other, not specified|0|||
27860865|NCT02485704|54421541|FG000|Overall Study|Lost to Follow-up|4|||
27860866|NCT02485704|54421542|FG001|Overall Study|Lost to Follow-up|5|||
27860867|NCT02485704|54421541|FG000|Overall Study|Withdrawal by Subject|0|||
27860868|NCT02485704|54421542|FG001|Overall Study|Withdrawal by Subject|3|||
27860869|NCT02485704|54421541|FG000|Overall Study|Did Not Meet Inclusion Criteria #2|1|||
27860870|NCT02485704|54421542|FG001|Overall Study|Did Not Meet Inclusion Criteria #2|0|||
27860871|NCT02485158|54421552|FG000|Overall Study|Withdrawal by Subject|3|||
27860872|NCT02485158|54421552|FG000|Overall Study|expected drug side effect|1|||
27860873|NCT02455518|54421571|FG000|Overall Study|Protocol Violation|0|||
27860874|NCT02455518|54421572|FG001|Overall Study|Protocol Violation|1|||
27860875|NCT02455518|54421573|FG002|Overall Study|Protocol Violation|1|||
27860876|NCT02455518|54421574|FG003|Overall Study|Protocol Violation|3|||
27860877|NCT02873195|54421722|FG000|Overall Study|Ineligible|5|||
27860878|NCT02873195|54421723|FG001|Overall Study|Ineligible|0|||
27860879|NCT02435849|54421758|FG000|Overall Study|Enrolled but not infused|18|||
27860880|NCT02435849|54421758|FG000|Overall Study|Death|16|||
27860881|NCT02435849|54421758|FG000|Overall Study|Lack of Efficacy|9|||
27860882|NCT02435849|54421758|FG000|Overall Study|New therapy for study indication|7|||
27860883|NCT02435849|54421758|FG000|Overall Study|Subject/guardian decision|2|||
27860884|NCT02435849|54421758|FG000|Overall Study|Study follow-up ongoing|45|||
27860885|NCT02240069|54421805|FG000|Overall Study|Withdrawal by Subject|5|||
27860886|NCT02240069|54421806|FG001|Overall Study|Withdrawal by Subject|5|||
27860887|NCT02240069|54421807|FG002|Overall Study|Withdrawal by Subject|2|||
27860888|NCT02484690|54421893|FG000|Overall Study|Adverse Event|1|||
27860889|NCT02484690|54421894|FG001|Overall Study|Adverse Event|3|||
27860890|NCT02484690|54421895|FG002|Overall Study|Adverse Event|0|||
27860891|NCT02484690|54421896|FG003|Overall Study|Adverse Event|0|||
27860892|NCT02484690|54421897|FG004|Overall Study|Adverse Event|5|||
27860893|NCT02484690|54421893|FG000|Overall Study|Death|0|||
27860894|NCT02484690|54421894|FG001|Overall Study|Death|0|||
27860895|NCT02484690|54421895|FG002|Overall Study|Death|0|||
27860896|NCT02484690|54421896|FG003|Overall Study|Death|0|||
27860897|NCT02484690|54421897|FG004|Overall Study|Death|1|||
27860898|NCT02484690|54421893|FG000|Overall Study|Withdrawal by Subject|1|||
27860899|NCT02484690|54421894|FG001|Overall Study|Withdrawal by Subject|3|||
27860900|NCT02484690|54421895|FG002|Overall Study|Withdrawal by Subject|1|||
27860901|NCT02484690|54421896|FG003|Overall Study|Withdrawal by Subject|2|||
27860902|NCT02484690|54421897|FG004|Overall Study|Withdrawal by Subject|0|||
27860903|NCT02484690|54421893|FG000|Overall Study|Physician Decision|2|||
27860904|NCT02484690|54421894|FG001|Overall Study|Physician Decision|0|||
27860905|NCT02484690|54421895|FG002|Overall Study|Physician Decision|1|||
27860906|NCT02484690|54421896|FG003|Overall Study|Physician Decision|0|||
27860907|NCT02484690|54421897|FG004|Overall Study|Physician Decision|0|||
27860908|NCT02484690|54421893|FG000|Overall Study|Lost to Follow-up|0|||
27860909|NCT02484690|54421894|FG001|Overall Study|Lost to Follow-up|0|||
27860910|NCT02484690|54421895|FG002|Overall Study|Lost to Follow-up|1|||
27860911|NCT02484690|54421896|FG003|Overall Study|Lost to Follow-up|0|||
27860912|NCT02484690|54421897|FG004|Overall Study|Lost to Follow-up|0|||
27860913|NCT01654224|54421921|FG000|Overall Study|Lost to Follow-up|2|||
27860914|NCT01654224|54421922|FG001|Overall Study|Lost to Follow-up|2|||
27860915|NCT01654224|54421921|FG000|Overall Study|Did not receive allocation|1|||
27860916|NCT01654224|54421922|FG001|Overall Study|Did not receive allocation|8|||
27860917|NCT01654224|54421921|FG000|Overall Study|Insufficient blood sample|3|||
27860918|NCT01654224|54421922|FG001|Overall Study|Insufficient blood sample|2|||
27860919|NCT02447328|54421928|FG000|Overall Study|Withdrawal by Subject|1|||
27860920|NCT02447250|54421932|FG000|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1|||
27860921|NCT02447250|54421932|FG000|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1|||
27860922|NCT02447250|54421932|FG000|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4|||
27860923|NCT02447172|54422036|FG000|Overall Study|Adverse Event|11|||
27981288|NCT00887354|54639152|FG000|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14|||
27860924|NCT02447172|54422037|FG001|Overall Study|Adverse Event|8|||
27860925|NCT02447172|54422038|FG002|Overall Study|Adverse Event|7|||
27860926|NCT02447172|54422036|FG000|Overall Study|Death|3|||
27860927|NCT02447172|54422037|FG001|Overall Study|Death|1|||
27860928|NCT02447172|54422038|FG002|Overall Study|Death|0|||
27860929|NCT02447172|54422036|FG000|Overall Study|Protocol Violation|2|||
27860930|NCT02447172|54422037|FG001|Overall Study|Protocol Violation|1|||
27860931|NCT02447172|54422038|FG002|Overall Study|Protocol Violation|2|||
27860932|NCT02447172|54422036|FG000|Overall Study|Lost to Follow-up|7|||
27860933|NCT02447172|54422037|FG001|Overall Study|Lost to Follow-up|4|||
27860934|NCT02447172|54422038|FG002|Overall Study|Lost to Follow-up|4|||
27860935|NCT02447172|54422036|FG000|Overall Study|Withdrawal by Subject|5|||
27860936|NCT02447172|54422037|FG001|Overall Study|Withdrawal by Subject|1|||
27860937|NCT02447172|54422038|FG002|Overall Study|Withdrawal by Subject|3|||
27860938|NCT02447172|54422036|FG000|Overall Study|protocol specific treatment unrelated|3|||
27860939|NCT02447172|54422037|FG001|Overall Study|protocol specific treatment unrelated|0|||
27860940|NCT02447172|54422038|FG002|Overall Study|protocol specific treatment unrelated|2|||
27860941|NCT02455050|54422071|FG000|Treatment Period 1|Lost to Follow-up|1|||
27860942|NCT02455050|54422072|FG001|Treatment Period 1|Lost to Follow-up|1|||
27860943|NCT02455050|54422073|FG002|Treatment Period 1|Lost to Follow-up|1|||
27860944|NCT02455050|54422074|FG003|Treatment Period 1|Lost to Follow-up|2|||
27860945|NCT02455050|54422071|FG000|Treatment Period 2|Lost to Follow-up|1|||
27860946|NCT02455050|54422072|FG001|Treatment Period 2|Lost to Follow-up|0|||
27860947|NCT02455050|54422073|FG002|Treatment Period 2|Lost to Follow-up|2|||
27860948|NCT02455050|54422074|FG003|Treatment Period 2|Lost to Follow-up|1|||
27860949|NCT02418468|54422114|FG000|Overall Study|Adverse Event|1|||
27860950|NCT02418468|54422115|FG001|Overall Study|Adverse Event|0|||
27860951|NCT02418468|54422114|FG000|Overall Study|Withdrawal of informed consent|1|||
27860952|NCT02418468|54422115|FG001|Overall Study|Withdrawal of informed consent|1|||
27860953|NCT02418000|54422246|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2|||
27860954|NCT02418000|54422247|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
27860955|NCT02418000|54422248|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
27860956|NCT02418000|54422249|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
27860957|NCT02418000|54422250|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
27860958|NCT02418000|54422246|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4|||
27860959|NCT02418000|54422247|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
27860960|NCT02418000|54422248|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
27860961|NCT02418000|54422249|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
27860962|NCT02418000|54422250|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
27860963|NCT02418000|54422246|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1|||
27860964|NCT02418000|54422247|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
27860965|NCT02418000|54422248|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
27860966|NCT02418000|54422249|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
27860967|NCT02418000|54422250|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
27860968|NCT02418000|54422246|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
27860969|NCT02418000|54422247|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1|||
27860970|NCT02418000|54422248|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
27860971|NCT02418000|54422249|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
27860972|NCT02418000|54422250|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
27860973|NCT02418000|54422246|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
27860974|NCT02418000|54422247|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9|||
27860975|NCT02418000|54422248|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
27860976|NCT02418000|54422249|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
27860977|NCT02418000|54422250|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
27860978|NCT02418000|54422246|FG000|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
27860979|NCT02418000|54422247|FG001|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
27860980|NCT02418000|54422248|FG002|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
27860981|NCT02418000|54422249|FG003|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
27860982|NCT02418000|54422250|FG004|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
27860983|NCT02418000|54422246|FG000|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
27860984|NCT02418000|54422247|FG001|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
27860985|NCT02418000|54422248|FG002|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
27860986|NCT02418000|54422249|FG003|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
27860987|NCT02418000|54422250|FG004|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
27738883|NCT02936323|54188173|FG005|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
27860988|NCT02418000|54422246|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
27860989|NCT02418000|54422247|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
27860990|NCT02418000|54422248|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
27860991|NCT02418000|54422249|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
27860992|NCT02418000|54422250|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1|||
27860993|NCT02418000|54422246|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
27860994|NCT02418000|54422247|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
27860995|NCT02418000|54422248|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
27860996|NCT02418000|54422249|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
27860997|NCT02418000|54422250|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
27860998|NCT02417064|54422354|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|1|||
27860999|NCT02417064|54422355|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|7|||
27861000|NCT02417064|54422356|FG002|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
27861001|NCT02417064|54422354|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
27861002|NCT02417064|54422355|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
27861003|NCT02417064|54422356|FG002|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0|||
27861004|NCT02417064|54422354|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
27861005|NCT02417064|54422355|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
27861006|NCT02417064|54422356|FG002|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
27861007|NCT02417064|54422354|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2|||
27861008|NCT02417064|54422355|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
27861009|NCT02417064|54422356|FG002|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
27861010|NCT02417064|54422354|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
27861011|NCT02417064|54422355|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5|||
27861012|NCT02417064|54422356|FG002|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
27861013|NCT02417064|54422354|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
27861014|NCT02417064|54422355|FG001|Double-blind Induction Phase (4 Weeks)|Other|4|||
27861015|NCT02417064|54422356|FG002|Double-blind Induction Phase (4 Weeks)|Other|2|||
27861016|NCT02417064|54422354|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|0|||
27861017|NCT02417064|54422355|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|2|||
27861018|NCT02417064|54422356|FG002|Follow-up Phase (24 Weeks)|Lost to Follow-up|1|||
27861019|NCT02417064|54422354|FG000|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
27861020|NCT02417064|54422355|FG001|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
27861021|NCT02417064|54422356|FG002|Follow-up Phase (24 Weeks)|Protocol Violation|1|||
27861022|NCT02417064|54422354|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
27861023|NCT02417064|54422355|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9|||
27861024|NCT02417064|54422356|FG002|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2|||
27861025|NCT02417064|54422354|FG000|Follow-up Phase (24 Weeks)|PI Decision|34|||
27861026|NCT02417064|54422355|FG001|Follow-up Phase (24 Weeks)|PI Decision|29|||
27861027|NCT02417064|54422356|FG002|Follow-up Phase (24 Weeks)|PI Decision|44|||
27861028|NCT02417064|54422354|FG000|Follow-up Phase (24 Weeks)|Other|2|||
27861029|NCT02417064|54422355|FG001|Follow-up Phase (24 Weeks)|Other|2|||
27861030|NCT02417064|54422356|FG002|Follow-up Phase (24 Weeks)|Other|3|||
27861031|NCT01653132|54422371|FG000|First Intervention|Protocol Violation|1|||
27861032|NCT01653132|54422372|FG001|First Intervention|Protocol Violation|0|||
27861033|NCT02453334|54422397|FG000|Overall Study|Death|15|||
27861034|NCT02453334|54422398|FG001|Overall Study|Death|13|||
27861035|NCT02453334|54422397|FG000|Overall Study|Adverse Event|2|||
27861036|NCT02453334|54422398|FG001|Overall Study|Adverse Event|1|||
27861037|NCT02453334|54422397|FG000|Overall Study|Lost to Follow-up|5|||
27861038|NCT02453334|54422398|FG001|Overall Study|Lost to Follow-up|9|||
27861039|NCT02453334|54422397|FG000|Overall Study|Physician Decision|1|||
27861040|NCT02453334|54422398|FG001|Overall Study|Physician Decision|0|||
27861041|NCT02453334|54422397|FG000|Overall Study|Withdrawal by Subject|17|||
27861042|NCT02453334|54422398|FG001|Overall Study|Withdrawal by Subject|13|||
27861043|NCT02453334|54422397|FG000|Overall Study|Other reason|1|||
27861044|NCT02453334|54422398|FG001|Overall Study|Other reason|4|||
27981289|NCT00887354|54639153|FG001|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8|||
27981290|NCT00887354|54639152|FG000|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
27981291|NCT00887354|54639153|FG001|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
27981292|NCT00887354|54639152|FG000|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2|||
27981293|NCT00887354|54639153|FG001|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1|||
27981294|NCT00887354|54639152|FG000|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
27981295|NCT00887354|54639153|FG001|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
28096045|NCT04432376|54750687|FG000|Double-blind Treatment Period|Lost to Follow-up|2|||
27834442|NCT01585961|54317957|FG000|Overall Study|Ablation cancelled for slow-heal wound|1|||
27834443|NCT01697501|54317961|FG000|Overall Study|Protocol Violation|2|||
27834444|NCT01697345|54317974|FG000|Overall Study|Withdrawal by Subject|1|||
27834445|NCT01697267|54318043|FG000|Overall Study|Death|3|||
27834446|NCT01697267|54318044|FG001|Overall Study|Death|1|||
27834447|NCT01697267|54318043|FG000|Overall Study|Withdrawal by Subject|5|||
27834448|NCT01697267|54318044|FG001|Overall Study|Withdrawal by Subject|5|||
27834449|NCT01697267|54318043|FG000|Overall Study|Adverse Event|2|||
27834450|NCT01697267|54318044|FG001|Overall Study|Adverse Event|1|||
27861045|NCT02443740|54422484|FG000|Intervention Period 1 (3 Days)|Adverse Event|0|||
27834451|NCT01697267|54318043|FG000|Overall Study|Lost to Follow-up|2|||
27861046|NCT02443740|54422485|FG001|Intervention Period 1 (3 Days)|Adverse Event|0|||
27861047|NCT02443740|54422486|FG002|Intervention Period 1 (3 Days)|Adverse Event|0|||
27861048|NCT02443740|54422487|FG003|Intervention Period 1 (3 Days)|Adverse Event|0|||
27861049|NCT02443740|54422488|FG004|Intervention Period 1 (3 Days)|Adverse Event|0|||
27861050|NCT02443740|54422489|FG005|Intervention Period 1 (3 Days)|Adverse Event|1|||
27861051|NCT02443740|54422490|FG006|Intervention Period 1 (3 Days)|Adverse Event|0|||
27861052|NCT02443740|54422491|FG007|Intervention Period 1 (3 Days)|Adverse Event|0|||
27861053|NCT02443740|54422492|FG008|Intervention Period 1 (3 Days)|Adverse Event|0|||
27861054|NCT02443740|54422493|FG009|Intervention Period 1 (3 Days)|Adverse Event|0|||
27861055|NCT02443740|54422494|FG010|Intervention Period 1 (3 Days)|Adverse Event|0|||
27861056|NCT02443740|54422484|FG000|Intervention Period 1 (3 Days)|Protocol Violation|1|||
27861057|NCT02443740|54422485|FG001|Intervention Period 1 (3 Days)|Protocol Violation|0|||
27861058|NCT02443740|54422486|FG002|Intervention Period 1 (3 Days)|Protocol Violation|0|||
27861059|NCT02443740|54422487|FG003|Intervention Period 1 (3 Days)|Protocol Violation|0|||
27861060|NCT02443740|54422488|FG004|Intervention Period 1 (3 Days)|Protocol Violation|0|||
27861061|NCT02443740|54422489|FG005|Intervention Period 1 (3 Days)|Protocol Violation|0|||
27861062|NCT02443740|54422490|FG006|Intervention Period 1 (3 Days)|Protocol Violation|1|||
27861063|NCT02443740|54422491|FG007|Intervention Period 1 (3 Days)|Protocol Violation|0|||
27861064|NCT02443740|54422492|FG008|Intervention Period 1 (3 Days)|Protocol Violation|0|||
27861065|NCT02443740|54422493|FG009|Intervention Period 1 (3 Days)|Protocol Violation|0|||
27861066|NCT02443740|54422494|FG010|Intervention Period 1 (3 Days)|Protocol Violation|0|||
27861067|NCT02443740|54422484|FG000|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
27861068|NCT02443740|54422485|FG001|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
27861069|NCT02443740|54422486|FG002|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
27861070|NCT02443740|54422487|FG003|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
27861071|NCT02443740|54422488|FG004|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
27861072|NCT02443740|54422489|FG005|Intervention Period 1 (3 Days)|Withdrawal by Subject|1|||
27861073|NCT02443740|54422490|FG006|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
27861074|NCT02443740|54422491|FG007|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
27861075|NCT02443740|54422492|FG008|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
27861076|NCT02443740|54422493|FG009|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
27861077|NCT02443740|54422494|FG010|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
27861078|NCT02416908|54422725|FG000|Dose Escalation Phase|Adverse Event|0|||
27861079|NCT02416908|54422726|FG001|Dose Escalation Phase|Adverse Event|0|||
27861080|NCT02416908|54422727|FG002|Dose Escalation Phase|Adverse Event|3|||
27861081|NCT02416908|54422728|FG003|Dose Escalation Phase|Adverse Event|0|||
27861082|NCT02416908|54422725|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
27861083|NCT02416908|54422726|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
27861084|NCT02416908|54422727|FG002|Dose Escalation Phase|Withdrawal by Subject|1|||
27861085|NCT02416908|54422728|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
27861086|NCT02453256|54422818|FG000|Double Blind Period|Death|1|||
27861087|NCT02453256|54422819|FG001|Double Blind Period|Death|1|||
27861088|NCT02453256|54422818|FG000|Double Blind Period|Adverse Event|3|||
27861089|NCT02453256|54422819|FG001|Double Blind Period|Adverse Event|2|||
27861090|NCT02453256|54422818|FG000|Double Blind Period|Withdrawal by Subject|9|||
27861091|NCT02453256|54422819|FG001|Double Blind Period|Withdrawal by Subject|5|||
27861092|NCT02453256|54422818|FG000|Double Blind Period|Other|0|||
27861093|NCT02453256|54422819|FG001|Double Blind Period|Other|1|||
27861094|NCT02453256|54422818|FG000|Open Label Period|Adverse Event|1|||
27861095|NCT02453256|54422819|FG001|Open Label Period|Adverse Event|3|||
27861096|NCT02453256|54422818|FG000|Open Label Period|Death|0|||
27861097|NCT02453256|54422819|FG001|Open Label Period|Death|1|||
27861098|NCT02453256|54422818|FG000|Open Label Period|Lost to Follow-up|1|||
27861099|NCT02453256|54422819|FG001|Open Label Period|Lost to Follow-up|0|||
27861100|NCT02453256|54422818|FG000|Open Label Period|Other|0|||
27861101|NCT02453256|54422819|FG001|Open Label Period|Other|2|||
27861102|NCT02453256|54422818|FG000|Open Label Period|Withdrawal by Subject|5|||
27861103|NCT02453256|54422819|FG001|Open Label Period|Withdrawal by Subject|1|||
27861104|NCT02442804|54422834|FG000|Overall Study|Withdrawal by Subject|0|||
27861105|NCT02442804|54422835|FG001|Overall Study|Withdrawal by Subject|1|||
27834452|NCT01697267|54318044|FG001|Overall Study|Lost to Follow-up|4|||
27834453|NCT01697267|54318043|FG000|Overall Study|Physician Decision|2|||
27834454|NCT01697267|54318044|FG001|Overall Study|Physician Decision|4|||
27834455|NCT01696955|54318106|FG000|Main Study|Protocol Violation|1|||
27834456|NCT01696955|54318107|FG001|Main Study|Protocol Violation|0|||
27834457|NCT01696955|54318106|FG000|Main Study|Withdrawal by Subject|1|||
27834458|NCT01696955|54318107|FG001|Main Study|Withdrawal by Subject|1|||
27834459|NCT02702388|54318131|FG000|Overall Study|Disease Progression|18|||
27834460|NCT02702388|54318132|FG001|Overall Study|Disease Progression|25|||
27834461|NCT02702388|54318131|FG000|Overall Study|Withdrawal by Subject|9|||
27834462|NCT02702388|54318132|FG001|Overall Study|Withdrawal by Subject|7|||
27861106|NCT02442804|54422834|FG000|Overall Study|Adverse Event|1|||
27861107|NCT02442804|54422835|FG001|Overall Study|Adverse Event|0|||
27861108|NCT02414958|54422924|FG000|Overall Study|Adverse Event|6|||
27861109|NCT02414958|54422925|FG001|Overall Study|Adverse Event|6|||
27861110|NCT02414958|54422926|FG002|Overall Study|Adverse Event|3|||
27861111|NCT02414958|54422924|FG000|Overall Study|Protocol Violation|10|||
27861112|NCT02414958|54422925|FG001|Overall Study|Protocol Violation|3|||
27861113|NCT02414958|54422926|FG002|Overall Study|Protocol Violation|1|||
27861114|NCT02414958|54422924|FG000|Overall Study|Lost to Follow-up|7|||
27861115|NCT02414958|54422925|FG001|Overall Study|Lost to Follow-up|4|||
27861116|NCT02414958|54422926|FG002|Overall Study|Lost to Follow-up|0|||
27861117|NCT02414958|54422924|FG000|Overall Study|Withdrawal by Subject|5|||
27861118|NCT02414958|54422925|FG001|Overall Study|Withdrawal by Subject|3|||
27861119|NCT02414958|54422926|FG002|Overall Study|Withdrawal by Subject|5|||
27861120|NCT02414958|54422924|FG000|Overall Study|Other than specified|4|||
27861121|NCT02414958|54422925|FG001|Overall Study|Other than specified|4|||
27861122|NCT02414958|54422926|FG002|Overall Study|Other than specified|5|||
27861123|NCT02452476|54422999|FG000|Overall Study|Death|4|||
27861124|NCT02452476|54423000|FG001|Overall Study|Death|7|||
27861125|NCT02452476|54422999|FG000|Overall Study|Lost to Follow-up|1|||
27861126|NCT02452476|54423000|FG001|Overall Study|Lost to Follow-up|1|||
27861127|NCT02452476|54422999|FG000|Overall Study|Physician Decision|1|||
27861128|NCT02452476|54423000|FG001|Overall Study|Physician Decision|1|||
27861129|NCT02452476|54422999|FG000|Overall Study|Not treated|5|||
27861130|NCT02452476|54423000|FG001|Overall Study|Not treated|1|||
27861131|NCT02442336|54423015|FG000|Overall Study|6 patients assisted with the intervention development only.|6|||
27861132|NCT02442336|54423015|FG000|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19|||
27861133|NCT02442336|54423015|FG000|Overall Study|Lost to Follow-up|11|||
27861134|NCT02452398|54423019|FG000|Overall Study|Adverse Event|1|||
27861135|NCT02452398|54423019|FG000|Overall Study|Lost to Follow-up|28|||
27861136|NCT02452398|54423019|FG000|Overall Study|Physician Decision|2|||
27861137|NCT02452398|54423019|FG000|Overall Study|Withdrawal by Subject|6|||
27861138|NCT02452398|54423019|FG000|Overall Study|Moved away|4|||
27861139|NCT02413398|54423025|FG000|Overall Study|Lost to Follow-up|2|||
27861140|NCT02413398|54423026|FG001|Overall Study|Lost to Follow-up|4|||
27861141|NCT02413398|54423025|FG000|Overall Study|Withdrawal by Subject|1|||
27861142|NCT02413398|54423026|FG001|Overall Study|Withdrawal by Subject|1|||
27861143|NCT02413398|54423025|FG000|Overall Study|Other Eligibility criteria|1|||
27861144|NCT02413398|54423026|FG001|Overall Study|Other Eligibility criteria|2|||
27861145|NCT02441946|54423035|FG000|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
27861146|NCT02441946|54423036|FG001|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
27861147|NCT02441946|54423037|FG002|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0|||
27861148|NCT02441946|54423035|FG000|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1|||
27861149|NCT02441946|54423036|FG001|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
27861150|NCT02441946|54423037|FG002|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
27861151|NCT02441946|54423035|FG000|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
27861152|NCT02441946|54423036|FG001|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3|||
27861153|NCT02441946|54423037|FG002|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
27861154|NCT02441946|54423035|FG000|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
27861155|NCT02441946|54423036|FG001|Cycle 1 Period 1 (2 Weeks)|Never Treated|1|||
27861156|NCT02441946|54423037|FG002|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
27861157|NCT02441946|54423035|FG000|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15|||
27861158|NCT02441946|54423036|FG001|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
27861159|NCT02441946|54423037|FG002|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
27861160|NCT02441946|54423035|FG000|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1|||
27861161|NCT02441946|54423036|FG001|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
27861162|NCT02441946|54423037|FG002|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
27861163|NCT02441946|54423035|FG000|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1|||
27861164|NCT02441946|54423036|FG001|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
27861165|NCT02441946|54423037|FG002|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
27861166|NCT02441946|54423035|FG000|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1|||
27861167|NCT02441946|54423036|FG001|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
27861168|NCT02441946|54423037|FG002|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
27861169|NCT02441946|54423035|FG000|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9|||
27861170|NCT02441946|54423036|FG001|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
27861171|NCT02441946|54423037|FG002|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
27861172|NCT02441946|54423035|FG000|Extension Period (8 Weeks)|Adverse Event|1|||
27861173|NCT02441946|54423036|FG001|Extension Period (8 Weeks)|Adverse Event|0|||
27861174|NCT02441946|54423037|FG002|Extension Period (8 Weeks)|Adverse Event|0|||
27981296|NCT00887354|54639152|FG000|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1|||
27981297|NCT00887354|54639153|FG001|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2|||
27981298|NCT00887354|54639152|FG000|Treatment Phase (Week 0 to Week 26)|No efficacy data|20|||
27981299|NCT00887354|54639153|FG001|Treatment Phase (Week 0 to Week 26)|No efficacy data|25|||
27981300|NCT00887354|54639152|FG000|Treatment Phase (Week 0 to Week 26)|Not Treated|5|||
27981301|NCT00887354|54639153|FG001|Treatment Phase (Week 0 to Week 26)|Not Treated|3|||
27981302|NCT00887354|54639152|FG000|Open Label Phase (Week 26 to Week 78)|Death|0|||
27861175|NCT02441946|54423035|FG000|Extension Period (8 Weeks)|Withdrawal by Subject|1|||
27861176|NCT02441946|54423036|FG001|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
27861177|NCT02441946|54423037|FG002|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
27861178|NCT02387580|54423071|FG000|Overall Study|Withdrawal by Subject|0|||
27861179|NCT02387580|54423072|FG001|Overall Study|Withdrawal by Subject|0|||
27861180|NCT02387580|54423073|FG002|Overall Study|Withdrawal by Subject|0|||
27861181|NCT02387580|54423074|FG003|Overall Study|Withdrawal by Subject|1|||
27861182|NCT02387580|54423075|FG004|Overall Study|Withdrawal by Subject|0|||
27861183|NCT02387580|54423076|FG005|Overall Study|Withdrawal by Subject|0|||
27861184|NCT02440854|54423092|FG000|Overall Study|Relocation of patient|1|||
27861185|NCT02440854|54423092|FG000|Overall Study|Death|6|||
27861186|NCT02440854|54423092|FG000|Overall Study|Lost to Follow-up|10|||
27861187|NCT02440854|54423092|FG000|Overall Study|Afatinib discontinuation|46|||
27861188|NCT02440854|54423092|FG000|Overall Study|stopped study at earlier timepoint|14|||
27861189|NCT02440854|54423092|FG000|Overall Study|Study medication not received|1|||
27861190|NCT02440854|54423092|FG000|Overall Study|Violation of inclusion criteria|2|||
27861191|NCT02412852|54423147|FG000|Overall Study|Withdrawal by Subject|0|||
27861192|NCT02412852|54423148|FG001|Overall Study|Withdrawal by Subject|1|||
27861193|NCT02412852|54423149|FG002|Overall Study|Withdrawal by Subject|0|||
27861194|NCT02412852|54423150|FG003|Overall Study|Withdrawal by Subject|0|||
27861195|NCT02412852|54423147|FG000|Overall Study|Physician Decision|0|||
27861196|NCT02412852|54423148|FG001|Overall Study|Physician Decision|0|||
27861197|NCT02412852|54423149|FG002|Overall Study|Physician Decision|0|||
27861198|NCT02412852|54423150|FG003|Overall Study|Physician Decision|1|||
27861199|NCT02386098|54423206|FG000|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30|||
27861200|NCT02386098|54423207|FG001|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29|||
27861201|NCT02386098|54423208|FG002|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
27861202|NCT02386098|54423209|FG003|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
27861203|NCT02386098|54423210|FG004|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
27861204|NCT02386098|54423206|FG000|Stage 1 (96 Weeks)|Adverse Event|2|||
27861205|NCT02386098|54423207|FG001|Stage 1 (96 Weeks)|Adverse Event|1|||
27861206|NCT02386098|54423208|FG002|Stage 1 (96 Weeks)|Adverse Event|0|||
27861207|NCT02386098|54423209|FG003|Stage 1 (96 Weeks)|Adverse Event|0|||
27861208|NCT02386098|54423210|FG004|Stage 1 (96 Weeks)|Adverse Event|0|||
27861209|NCT02386098|54423206|FG000|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
27861210|NCT02386098|54423207|FG001|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
27861211|NCT02386098|54423208|FG002|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
27861212|NCT02386098|54423209|FG003|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
27861213|NCT02386098|54423210|FG004|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
27861214|NCT02386098|54423206|FG000|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
27861215|NCT02386098|54423207|FG001|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2|||
27861216|NCT02386098|54423208|FG002|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
27861217|NCT02386098|54423209|FG003|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
27861218|NCT02386098|54423210|FG004|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
27861219|NCT02386098|54423206|FG000|Stage 1 (96 Weeks)|Withdrawal by Subject|3|||
27861220|NCT02386098|54423207|FG001|Stage 1 (96 Weeks)|Withdrawal by Subject|1|||
27861221|NCT02386098|54423208|FG002|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
27861222|NCT02386098|54423209|FG003|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
27861223|NCT02386098|54423210|FG004|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
27861224|NCT02386098|54423206|FG000|Stage 1 (96 Weeks)|Other|1|||
27861225|NCT02386098|54423207|FG001|Stage 1 (96 Weeks)|Other|0|||
27861226|NCT02386098|54423208|FG002|Stage 1 (96 Weeks)|Other|0|||
27861227|NCT02386098|54423209|FG003|Stage 1 (96 Weeks)|Other|0|||
27981303|NCT00887354|54639153|FG001|Open Label Phase (Week 26 to Week 78)|Death|2|||
27981304|NCT00887354|54639152|FG000|Open Label Phase (Week 26 to Week 78)|Physician Decision|0|||
27981305|NCT00887354|54639153|FG001|Open Label Phase (Week 26 to Week 78)|Physician Decision|1|||
27981306|NCT00887354|54639152|FG000|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1|||
27981307|NCT00887354|54639153|FG001|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2|||
27981308|NCT00887354|54639152|FG000|Open Label Phase (Week 26 to Week 78)|Adverse Event|1|||
27981309|NCT00887354|54639153|FG001|Open Label Phase (Week 26 to Week 78)|Adverse Event|0|||
27981310|NCT00887354|54639152|FG000|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
27981311|NCT00887354|54639153|FG001|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
27981312|NCT00951041|54639162|FG000|Overall Study|Withdrawal by Subject|1|||
27981313|NCT00951041|54639163|FG001|Overall Study|Withdrawal by Subject|1|||
27981314|NCT00951041|54639162|FG000|Overall Study|Lost to Follow-up|1|||
27981315|NCT00951041|54639163|FG001|Overall Study|Lost to Follow-up|0|||
27861228|NCT02386098|54423210|FG004|Stage 1 (96 Weeks)|Other|0|||
27861229|NCT02386098|54423206|FG000|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5|||
27861230|NCT02386098|54423207|FG001|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8|||
27861231|NCT02386098|54423208|FG002|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
27981316|NCT00951041|54639162|FG000|Overall Study|Other|3|||
27981317|NCT00951041|54639163|FG001|Overall Study|Other|0|||
27861232|NCT02386098|54423209|FG003|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
27861233|NCT02386098|54423210|FG004|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
27861234|NCT02412618|54423253|FG000|Overall Study|Withdrawal by Subject|1|||
27861235|NCT02412618|54423254|FG001|Overall Study|Withdrawal by Subject|1|||
27861236|NCT02412618|54423253|FG000|Overall Study|Expulsion|1|||
27861237|NCT02412618|54423254|FG001|Overall Study|Expulsion|1|||
27861238|NCT00585195|54423451|FG000|Overall Study|Adverse Event|0|||
27861239|NCT00585195|54423452|FG001|Overall Study|Adverse Event|0|||
27861240|NCT00585195|54423453|FG002|Overall Study|Adverse Event|0|||
27861241|NCT00585195|54423454|FG003|Overall Study|Adverse Event|0|||
27861242|NCT00585195|54423455|FG004|Overall Study|Adverse Event|2|||
27861243|NCT00585195|54423456|FG005|Overall Study|Adverse Event|1|||
27861244|NCT00585195|54423457|FG006|Overall Study|Adverse Event|0|||
27861245|NCT00585195|54423458|FG007|Overall Study|Adverse Event|1|||
27861246|NCT00585195|54423459|FG008|Overall Study|Adverse Event|0|||
27861247|NCT00585195|54423460|FG009|Overall Study|Adverse Event|0|||
27861248|NCT00585195|54423461|FG010|Overall Study|Adverse Event|3|||
27861249|NCT00585195|54423462|FG011|Overall Study|Adverse Event|0|||
27861250|NCT00585195|54423463|FG012|Overall Study|Adverse Event|8|||
27861251|NCT00585195|54423464|FG013|Overall Study|Adverse Event|6|||
27861252|NCT00585195|54423465|FG014|Overall Study|Adverse Event|4|||
27861253|NCT00585195|54423466|FG015|Overall Study|Adverse Event|1|||
27861254|NCT00585195|54423467|FG016|Overall Study|Adverse Event|14|||
27861255|NCT00585195|54423468|FG017|Overall Study|Adverse Event|9|||
27861256|NCT00585195|54423469|FG018|Overall Study|Adverse Event|2|||
27861257|NCT00585195|54423470|FG019|Overall Study|Adverse Event|3|||
27861258|NCT00585195|54423471|FG020|Overall Study|Adverse Event|1|||
27861259|NCT00585195|54423451|FG000|Overall Study|Progressive Disease|2|||
27861260|NCT00585195|54423452|FG001|Overall Study|Progressive Disease|2|||
27861261|NCT00585195|54423453|FG002|Overall Study|Progressive Disease|5|||
27861262|NCT00585195|54423454|FG003|Overall Study|Progressive Disease|4|||
27861263|NCT00585195|54423455|FG004|Overall Study|Progressive Disease|6|||
27861264|NCT00585195|54423456|FG005|Overall Study|Progressive Disease|4|||
27861265|NCT00585195|54423457|FG006|Overall Study|Progressive Disease|6|||
27861266|NCT00585195|54423458|FG007|Overall Study|Progressive Disease|3|||
27861267|NCT00585195|54423459|FG008|Overall Study|Progressive Disease|0|||
27861268|NCT00585195|54423460|FG009|Overall Study|Progressive Disease|5|||
27861269|NCT00585195|54423461|FG010|Overall Study|Progressive Disease|2|||
27861270|NCT00585195|54423462|FG011|Overall Study|Progressive Disease|25|||
27861271|NCT00585195|54423463|FG012|Overall Study|Progressive Disease|29|||
27861272|NCT00585195|54423464|FG013|Overall Study|Progressive Disease|26|||
27861273|NCT00585195|54423465|FG014|Overall Study|Progressive Disease|21|||
27861274|NCT00585195|54423466|FG015|Overall Study|Progressive Disease|12|||
27861275|NCT00585195|54423467|FG016|Overall Study|Progressive Disease|94|||
27861276|NCT00585195|54423468|FG017|Overall Study|Progressive Disease|42|||
27861277|NCT00585195|54423469|FG018|Overall Study|Progressive Disease|4|||
27861278|NCT00585195|54423470|FG019|Overall Study|Progressive Disease|9|||
27861279|NCT00585195|54423471|FG020|Overall Study|Progressive Disease|8|||
27861280|NCT00585195|54423451|FG000|Overall Study|Withdrawal by Subject|1|||
27861281|NCT00585195|54423452|FG001|Overall Study|Withdrawal by Subject|1|||
27861282|NCT00585195|54423453|FG002|Overall Study|Withdrawal by Subject|2|||
27861283|NCT00585195|54423454|FG003|Overall Study|Withdrawal by Subject|2|||
27861284|NCT00585195|54423455|FG004|Overall Study|Withdrawal by Subject|0|||
27861285|NCT00585195|54423456|FG005|Overall Study|Withdrawal by Subject|0|||
27861286|NCT00585195|54423457|FG006|Overall Study|Withdrawal by Subject|0|||
27861287|NCT00585195|54423458|FG007|Overall Study|Withdrawal by Subject|1|||
27861288|NCT00585195|54423459|FG008|Overall Study|Withdrawal by Subject|0|||
27861289|NCT00585195|54423460|FG009|Overall Study|Withdrawal by Subject|0|||
27861290|NCT00585195|54423461|FG010|Overall Study|Withdrawal by Subject|3|||
27861291|NCT00585195|54423462|FG011|Overall Study|Withdrawal by Subject|8|||
27861292|NCT00585195|54423463|FG012|Overall Study|Withdrawal by Subject|15|||
27861293|NCT00585195|54423464|FG013|Overall Study|Withdrawal by Subject|0|||
27861294|NCT00585195|54423465|FG014|Overall Study|Withdrawal by Subject|3|||
27861295|NCT00585195|54423466|FG015|Overall Study|Withdrawal by Subject|0|||
27861296|NCT00585195|54423467|FG016|Overall Study|Withdrawal by Subject|7|||
27861297|NCT00585195|54423468|FG017|Overall Study|Withdrawal by Subject|1|||
27861298|NCT00585195|54423469|FG018|Overall Study|Withdrawal by Subject|2|||
27861299|NCT00585195|54423470|FG019|Overall Study|Withdrawal by Subject|2|||
27861300|NCT00585195|54423471|FG020|Overall Study|Withdrawal by Subject|0|||
27861301|NCT00585195|54423451|FG000|Overall Study|Other|0|||
27861302|NCT00585195|54423452|FG001|Overall Study|Other|1|||
27861303|NCT00585195|54423453|FG002|Overall Study|Other|1|||
27861304|NCT00585195|54423454|FG003|Overall Study|Other|1|||
27861305|NCT00585195|54423455|FG004|Overall Study|Other|0|||
27861306|NCT00585195|54423456|FG005|Overall Study|Other|1|||
27861307|NCT00585195|54423457|FG006|Overall Study|Other|0|||
27861308|NCT00585195|54423458|FG007|Overall Study|Other|0|||
27861309|NCT00585195|54423459|FG008|Overall Study|Other|2|||
27861310|NCT00585195|54423460|FG009|Overall Study|Other|1|||
27861311|NCT00585195|54423461|FG010|Overall Study|Other|0|||
27861312|NCT00585195|54423462|FG011|Overall Study|Other|19|||
27861313|NCT00585195|54423463|FG012|Overall Study|Other|24|||
27861314|NCT00585195|54423464|FG013|Overall Study|Other|7|||
27861315|NCT00585195|54423465|FG014|Overall Study|Other|11|||
27861316|NCT00585195|54423466|FG015|Overall Study|Other|3|||
27861317|NCT00585195|54423467|FG016|Overall Study|Other|28|||
27861318|NCT00585195|54423468|FG017|Overall Study|Other|12|||
27861319|NCT00585195|54423469|FG018|Overall Study|Other|10|||
27861320|NCT00585195|54423470|FG019|Overall Study|Other|4|||
27861321|NCT00585195|54423471|FG020|Overall Study|Other|2|||
27861322|NCT00585195|54423451|FG000|Overall Study|Randomized not treated|0|||
27861323|NCT00585195|54423452|FG001|Overall Study|Randomized not treated|0|||
27861324|NCT00585195|54423453|FG002|Overall Study|Randomized not treated|1|||
27861325|NCT00585195|54423454|FG003|Overall Study|Randomized not treated|0|||
27861326|NCT00585195|54423455|FG004|Overall Study|Randomized not treated|1|||
27861327|NCT00585195|54423456|FG005|Overall Study|Randomized not treated|0|||
27861328|NCT00585195|54423457|FG006|Overall Study|Randomized not treated|1|||
27861329|NCT00585195|54423458|FG007|Overall Study|Randomized not treated|0|||
27861330|NCT00585195|54423459|FG008|Overall Study|Randomized not treated|0|||
27861331|NCT00585195|54423460|FG009|Overall Study|Randomized not treated|0|||
27861332|NCT00585195|54423461|FG010|Overall Study|Randomized not treated|2|||
27861333|NCT00585195|54423462|FG011|Overall Study|Randomized not treated|0|||
27861334|NCT00585195|54423463|FG012|Overall Study|Randomized not treated|0|||
27861335|NCT00585195|54423464|FG013|Overall Study|Randomized not treated|0|||
27861336|NCT00585195|54423465|FG014|Overall Study|Randomized not treated|0|||
27861337|NCT00585195|54423466|FG015|Overall Study|Randomized not treated|1|||
27861338|NCT00585195|54423467|FG016|Overall Study|Randomized not treated|0|||
27861339|NCT00585195|54423468|FG017|Overall Study|Randomized not treated|1|||
27861340|NCT00585195|54423469|FG018|Overall Study|Randomized not treated|3|||
27861341|NCT00585195|54423470|FG019|Overall Study|Randomized not treated|0|||
27861342|NCT00585195|54423471|FG020|Overall Study|Randomized not treated|2|||
27861343|NCT00585195|54423451|FG000|Overall Study|Death|0|||
27861344|NCT00585195|54423452|FG001|Overall Study|Death|0|||
27861345|NCT00585195|54423453|FG002|Overall Study|Death|0|||
27861346|NCT00585195|54423454|FG003|Overall Study|Death|0|||
27861347|NCT00585195|54423455|FG004|Overall Study|Death|0|||
27861348|NCT00585195|54423456|FG005|Overall Study|Death|0|||
27861349|NCT00585195|54423457|FG006|Overall Study|Death|0|||
27861350|NCT00585195|54423458|FG007|Overall Study|Death|0|||
27861351|NCT00585195|54423459|FG008|Overall Study|Death|1|||
27861352|NCT00585195|54423460|FG009|Overall Study|Death|0|||
27861353|NCT00585195|54423461|FG010|Overall Study|Death|1|||
27861354|NCT00585195|54423462|FG011|Overall Study|Death|1|||
27861355|NCT00585195|54423463|FG012|Overall Study|Death|7|||
27861356|NCT00585195|54423464|FG013|Overall Study|Death|2|||
27861357|NCT00585195|54423465|FG014|Overall Study|Death|8|||
27861358|NCT00585195|54423466|FG015|Overall Study|Death|2|||
27861359|NCT00585195|54423467|FG016|Overall Study|Death|11|||
27861360|NCT00585195|54423468|FG017|Overall Study|Death|0|||
27861361|NCT00585195|54423469|FG018|Overall Study|Death|0|||
27861362|NCT00585195|54423470|FG019|Overall Study|Death|0|||
27861363|NCT00585195|54423471|FG020|Overall Study|Death|1|||
27861364|NCT00585195|54423451|FG000|Overall Study|Lost to Follow-up|0|||
27861365|NCT00585195|54423452|FG001|Overall Study|Lost to Follow-up|0|||
27861366|NCT00585195|54423453|FG002|Overall Study|Lost to Follow-up|0|||
27861367|NCT00585195|54423454|FG003|Overall Study|Lost to Follow-up|0|||
27861368|NCT00585195|54423455|FG004|Overall Study|Lost to Follow-up|0|||
27861369|NCT00585195|54423456|FG005|Overall Study|Lost to Follow-up|0|||
27861370|NCT00585195|54423457|FG006|Overall Study|Lost to Follow-up|0|||
27861371|NCT00585195|54423458|FG007|Overall Study|Lost to Follow-up|0|||
27861372|NCT00585195|54423459|FG008|Overall Study|Lost to Follow-up|0|||
27861373|NCT00585195|54423460|FG009|Overall Study|Lost to Follow-up|0|||
27861374|NCT00585195|54423461|FG010|Overall Study|Lost to Follow-up|0|||
27861375|NCT00585195|54423462|FG011|Overall Study|Lost to Follow-up|0|||
27861376|NCT00585195|54423463|FG012|Overall Study|Lost to Follow-up|1|||
27861377|NCT00585195|54423464|FG013|Overall Study|Lost to Follow-up|0|||
27861378|NCT00585195|54423465|FG014|Overall Study|Lost to Follow-up|0|||
27861379|NCT00585195|54423466|FG015|Overall Study|Lost to Follow-up|0|||
27981318|NCT02763462|54639170|FG000|Overall Study|Protocol Violation|6|||
27981319|NCT00610129|54639184|FG000|Overall Study|Not treated since patients ineligible|3|||
27981320|NCT00945815|54639188|FG000|Overall Study|Death|3|||
27861380|NCT00585195|54423467|FG016|Overall Study|Lost to Follow-up|0|||
27861381|NCT00585195|54423468|FG017|Overall Study|Lost to Follow-up|2|||
27861382|NCT00585195|54423469|FG018|Overall Study|Lost to Follow-up|0|||
27861383|NCT00585195|54423470|FG019|Overall Study|Lost to Follow-up|0|||
27861384|NCT00585195|54423471|FG020|Overall Study|Lost to Follow-up|0|||
27861385|NCT00585195|54423451|FG000|Overall Study|Site Terminated by Sponsor|0|||
27861386|NCT00585195|54423452|FG001|Overall Study|Site Terminated by Sponsor|0|||
27861387|NCT00585195|54423453|FG002|Overall Study|Site Terminated by Sponsor|0|||
27861388|NCT00585195|54423454|FG003|Overall Study|Site Terminated by Sponsor|0|||
27981321|NCT00945815|54639188|FG000|Overall Study|Not protocol specified|1|||
27981322|NCT00945815|54639188|FG000|Overall Study|Ineligible|3|||
27738884|NCT02936323|54188174|FG006|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
27738885|NCT02936323|54188175|FG007|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
27738886|NCT02936323|54188176|FG008|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
27738887|NCT02936323|54188177|FG009|Phase 2a Dose Expansion|Change(s) to patient's condition|1|||
27738888|NCT02936323|54188168|FG000|Phase 2a Dose Expansion|Death|0|||
27738889|NCT02936323|54188169|FG001|Phase 2a Dose Expansion|Death|0|||
27738890|NCT02936323|54188170|FG002|Phase 2a Dose Expansion|Death|0|||
27738891|NCT02936323|54188171|FG003|Phase 2a Dose Expansion|Death|0|||
27738892|NCT02936323|54188172|FG004|Phase 2a Dose Expansion|Death|0|||
27738893|NCT02936323|54188173|FG005|Phase 2a Dose Expansion|Death|0|||
27834463|NCT02702388|54318131|FG000|Overall Study|Adverse Event|11|||
27834464|NCT02702388|54318132|FG001|Overall Study|Adverse Event|15|||
27834465|NCT02702388|54318131|FG000|Overall Study|Other|2|||
27834466|NCT02702388|54318132|FG001|Overall Study|Other|4|||
27834467|NCT01696877|54318158|FG000|Overall Study|Adverse Event|0|||
27834468|NCT01696877|54318159|FG001|Overall Study|Adverse Event|1|||
27834469|NCT02703636|54318355|FG000|Overall Study|Adverse Event|14|||
27834470|NCT02703636|54318355|FG000|Overall Study|Study stopped by sponsor|1|||
27834471|NCT02703636|54318355|FG000|Overall Study|Withdrawal by Subject|1|||
27834472|NCT02703324|54318583|FG000|Period Two|Withdrawal by Subject|0|||
27834473|NCT02703324|54318584|FG001|Period Two|Withdrawal by Subject|0|||
27834474|NCT02703324|54318585|FG002|Period Two|Withdrawal by Subject|1|||
27834475|NCT02703324|54318586|FG003|Period Two|Withdrawal by Subject|0|||
27834476|NCT02703324|54318587|FG004|Period Two|Withdrawal by Subject|0|||
27834477|NCT02703324|54318588|FG005|Period Two|Withdrawal by Subject|0|||
27834478|NCT02701764|54318599|FG000|Overall Study|Lost to Follow-up|0|||
27834479|NCT02701764|54318600|FG001|Overall Study|Lost to Follow-up|1|||
27834480|NCT01696643|54318781|FG000|Overall Study|Adverse Event|15|||
27834481|NCT01696643|54318782|FG001|Overall Study|Adverse Event|7|||
27834482|NCT01696643|54318781|FG000|Overall Study|Death|1|||
27834483|NCT01696643|54318782|FG001|Overall Study|Death|2|||
27834484|NCT01696643|54318781|FG000|Overall Study|Lack of Efficacy|3|||
27834485|NCT01696643|54318782|FG001|Overall Study|Lack of Efficacy|0|||
27834486|NCT01696643|54318781|FG000|Overall Study|Lost to Follow-up|67|||
27834487|NCT01696643|54318782|FG001|Overall Study|Lost to Follow-up|67|||
27834488|NCT01696643|54318781|FG000|Overall Study|Physician Decision|3|||
27834489|NCT01696643|54318782|FG001|Overall Study|Physician Decision|2|||
27834490|NCT01696643|54318781|FG000|Overall Study|Pregnancy|0|||
27834491|NCT01696643|54318782|FG001|Overall Study|Pregnancy|1|||
27834492|NCT01696643|54318781|FG000|Overall Study|Protocol Violation|7|||
27834493|NCT01696643|54318782|FG001|Overall Study|Protocol Violation|7|||
27834494|NCT01696643|54318781|FG000|Overall Study|Study Terminated by Sponsor|286|||
27834495|NCT01696643|54318782|FG001|Overall Study|Study Terminated by Sponsor|294|||
27834496|NCT01696643|54318781|FG000|Overall Study|Withdrawal by Subject|142|||
27834497|NCT01696643|54318782|FG001|Overall Study|Withdrawal by Subject|149|||
27834498|NCT01696643|54318781|FG000|Overall Study|Participant on Restricted Bed Rest|1|||
27834499|NCT01696643|54318782|FG001|Overall Study|Participant on Restricted Bed Rest|0|||
27834500|NCT01696643|54318781|FG000|Overall Study|Site Error|2|||
27834501|NCT01696643|54318782|FG001|Overall Study|Site Error|1|||
27834502|NCT01696643|54318781|FG000|Overall Study|Participant Incarcerated|0|||
27834503|NCT01696643|54318782|FG001|Overall Study|Participant Incarcerated|1|||
27834504|NCT01696643|54318781|FG000|Overall Study|Medical Monitor Decision|0|||
27834505|NCT01696643|54318782|FG001|Overall Study|Medical Monitor Decision|2|||
27834506|NCT01696643|54318781|FG000|Overall Study|Participant Did Not Receive Study Drug|2|||
27834507|NCT01696643|54318782|FG001|Overall Study|Participant Did Not Receive Study Drug|2|||
27834508|NCT01695317|54318794|FG000|Period 1 in the Cross-over Design|Withdrawal by Subject|2|||
27834509|NCT01695317|54318795|FG001|Period 1 in the Cross-over Design|Withdrawal by Subject|1|||
27834510|NCT01695317|54318794|FG000|Cross-over to Period 2|Withdrawal by Subject|4|||
27834511|NCT01695317|54318795|FG001|Cross-over to Period 2|Withdrawal by Subject|34|||
27834512|NCT02701296|54318851|FG000|Overall Study|Incomplete Data|0|||
27834513|NCT02701296|54318852|FG001|Overall Study|Incomplete Data|2|||
27834514|NCT01582451|54318869|FG000|Overall Study|Adverse Event|1|||
27834515|NCT01582451|54318870|FG001|Overall Study|Adverse Event|3|||
27834516|NCT01582451|54318869|FG000|Overall Study|Death|3|||
27834517|NCT01582451|54318870|FG001|Overall Study|Death|3|||
27834518|NCT01582451|54318869|FG000|Overall Study|Lost to Follow-up|0|||
27834519|NCT01582451|54318870|FG001|Overall Study|Lost to Follow-up|2|||
27834520|NCT01582451|54318869|FG000|Overall Study|Protocol Violation|11|||
27834521|NCT01582451|54318870|FG001|Overall Study|Protocol Violation|3|||
27834522|NCT01582451|54318869|FG000|Overall Study|Withdrawal by Subject|13|||
27834523|NCT01582451|54318870|FG001|Overall Study|Withdrawal by Subject|9|||
27834524|NCT01582451|54318869|FG000|Overall Study|Physician Decision|3|||
27834525|NCT01582451|54318870|FG001|Overall Study|Physician Decision|0|||
27834526|NCT01582451|54318869|FG000|Overall Study|Sponsor Decision|1|||
27834527|NCT01582451|54318870|FG001|Overall Study|Sponsor Decision|0|||
27834528|NCT02700984|54318954|FG000|Overall Study|Death|2|||
27834529|NCT02700984|54318955|FG001|Overall Study|Death|1|||
27861389|NCT00585195|54423455|FG004|Overall Study|Site Terminated by Sponsor|0|||
27861390|NCT00585195|54423456|FG005|Overall Study|Site Terminated by Sponsor|0|||
27861391|NCT00585195|54423457|FG006|Overall Study|Site Terminated by Sponsor|0|||
27861392|NCT00585195|54423458|FG007|Overall Study|Site Terminated by Sponsor|0|||
27861393|NCT00585195|54423459|FG008|Overall Study|Site Terminated by Sponsor|0|||
27861394|NCT00585195|54423460|FG009|Overall Study|Site Terminated by Sponsor|0|||
27861395|NCT00585195|54423461|FG010|Overall Study|Site Terminated by Sponsor|0|||
27861396|NCT00585195|54423462|FG011|Overall Study|Site Terminated by Sponsor|0|||
27861397|NCT00585195|54423463|FG012|Overall Study|Site Terminated by Sponsor|1|||
27861398|NCT00585195|54423464|FG013|Overall Study|Site Terminated by Sponsor|0|||
27861399|NCT00585195|54423465|FG014|Overall Study|Site Terminated by Sponsor|0|||
27861400|NCT00585195|54423466|FG015|Overall Study|Site Terminated by Sponsor|0|||
27861401|NCT00585195|54423467|FG016|Overall Study|Site Terminated by Sponsor|0|||
27861402|NCT00585195|54423468|FG017|Overall Study|Site Terminated by Sponsor|0|||
27861403|NCT00585195|54423469|FG018|Overall Study|Site Terminated by Sponsor|0|||
27861404|NCT00585195|54423470|FG019|Overall Study|Site Terminated by Sponsor|0|||
27861405|NCT00585195|54423471|FG020|Overall Study|Site Terminated by Sponsor|0|||
27861406|NCT00585195|54423451|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
27861407|NCT00585195|54423452|FG001|Overall Study|Withdrawn Due to Pregnancy|0|||
27861408|NCT00585195|54423453|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
27861409|NCT00585195|54423454|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
27861410|NCT00585195|54423455|FG004|Overall Study|Withdrawn Due to Pregnancy|0|||
27861411|NCT00585195|54423456|FG005|Overall Study|Withdrawn Due to Pregnancy|0|||
27861412|NCT00585195|54423457|FG006|Overall Study|Withdrawn Due to Pregnancy|0|||
27861413|NCT00585195|54423458|FG007|Overall Study|Withdrawn Due to Pregnancy|0|||
27861414|NCT00585195|54423459|FG008|Overall Study|Withdrawn Due to Pregnancy|0|||
27861415|NCT00585195|54423460|FG009|Overall Study|Withdrawn Due to Pregnancy|0|||
27861416|NCT00585195|54423461|FG010|Overall Study|Withdrawn Due to Pregnancy|0|||
27861417|NCT00585195|54423462|FG011|Overall Study|Withdrawn Due to Pregnancy|0|||
27861418|NCT00585195|54423463|FG012|Overall Study|Withdrawn Due to Pregnancy|0|||
27861419|NCT00585195|54423464|FG013|Overall Study|Withdrawn Due to Pregnancy|0|||
27861420|NCT00585195|54423465|FG014|Overall Study|Withdrawn Due to Pregnancy|1|||
27861421|NCT00585195|54423466|FG015|Overall Study|Withdrawn Due to Pregnancy|0|||
27861422|NCT00585195|54423467|FG016|Overall Study|Withdrawn Due to Pregnancy|0|||
27861423|NCT00585195|54423468|FG017|Overall Study|Withdrawn Due to Pregnancy|0|||
27861424|NCT00585195|54423469|FG018|Overall Study|Withdrawn Due to Pregnancy|0|||
27861425|NCT00585195|54423470|FG019|Overall Study|Withdrawn Due to Pregnancy|0|||
27861426|NCT00585195|54423471|FG020|Overall Study|Withdrawn Due to Pregnancy|0|||
27861427|NCT02439216|54423643|FG000|PartA(7 Day Open-Label Treatment Period)|Screen failure|1|||
27861428|NCT02439216|54423644|FG001|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
27861429|NCT02439216|54423645|FG002|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
27861430|NCT02439216|54423646|FG003|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
27861431|NCT02439216|54423647|FG004|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
27861432|NCT02439216|54423648|FG005|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
27861433|NCT02439216|54423649|FG006|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
27861434|NCT02439216|54423650|FG007|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
27861435|NCT02439216|54423651|FG008|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
27861436|NCT02439216|54423643|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
27861437|NCT02439216|54423644|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
27861438|NCT02439216|54423645|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
27861439|NCT02439216|54423646|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
27861440|NCT02439216|54423647|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
27861441|NCT02439216|54423648|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
27861442|NCT02439216|54423649|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
27861443|NCT02439216|54423650|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|1|||
27861444|NCT02439216|54423651|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
27861445|NCT02439216|54423643|FG000|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
27861446|NCT02439216|54423644|FG001|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
27861447|NCT02439216|54423645|FG002|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
27861448|NCT02439216|54423646|FG003|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
27861449|NCT02439216|54423647|FG004|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
27861450|NCT02439216|54423648|FG005|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
27861451|NCT02439216|54423649|FG006|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
27981323|NCT00945815|54639188|FG000|Overall Study|Did not begin protocol therapy|1|||
28096046|NCT04432376|54750688|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
27861452|NCT02439216|54423650|FG007|Part C (138-week, Open-label Treatment)|Lost to Follow-up|1|||
27861453|NCT02439216|54423651|FG008|Part C (138-week, Open-label Treatment)|Lost to Follow-up|2|||
27861454|NCT02439216|54423643|FG000|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
27861455|NCT02439216|54423644|FG001|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
27981324|NCT00606307|54639192|FG000|Overall Study|Adverse Event|2|||
27861456|NCT02439216|54423645|FG002|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
27861457|NCT02439216|54423646|FG003|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
27861458|NCT02439216|54423647|FG004|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
27861459|NCT02439216|54423648|FG005|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
27861460|NCT02439216|54423649|FG006|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
27861461|NCT02439216|54423650|FG007|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
27861462|NCT02439216|54423651|FG008|Part C (138-week, Open-label Treatment)|Progressive disease|3|||
27861463|NCT02439216|54423643|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
27861464|NCT02439216|54423644|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
27861465|NCT02439216|54423645|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
27861466|NCT02439216|54423646|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
27861467|NCT02439216|54423647|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
27861468|NCT02439216|54423648|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
27861469|NCT02439216|54423649|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
27861470|NCT02439216|54423650|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|5|||
27738894|NCT02936323|54188174|FG006|Phase 2a Dose Expansion|Death|0|||
27738895|NCT02936323|54188175|FG007|Phase 2a Dose Expansion|Death|4|||
27738896|NCT02936323|54188176|FG008|Phase 2a Dose Expansion|Death|8|||
27738897|NCT02936323|54188177|FG009|Phase 2a Dose Expansion|Death|10|||
27738898|NCT02243176|54188211|FG000|Overall Study|Other reason|1|||
27738899|NCT02243176|54188212|FG001|Overall Study|Other reason|2|||
27738900|NCT02243176|54188211|FG000|Overall Study|protocol specified withdrawal critera|1|||
27861471|NCT02439216|54423651|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|6|||
27861472|NCT02439138|54423679|FG000|Overall Study|Adverse Event|1|||
27861473|NCT02439138|54423679|FG000|Overall Study|PI decision to terminate the study|2|||
27861474|NCT02438826|54424055|FG000|Double-Blind Treatment Phase|Adverse Event|1|||
27861475|NCT02438826|54424056|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
27861476|NCT02438826|54424057|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
27861477|NCT02438826|54424058|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
27861478|NCT02438826|54424055|FG000|Double-Blind Treatment Phase|Lack of Efficacy|1|||
27861479|NCT02438826|54424056|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
27861480|NCT02438826|54424057|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
27861481|NCT02438826|54424058|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
27861482|NCT02438826|54424055|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
27861483|NCT02438826|54424056|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
27861484|NCT02438826|54424057|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
27861485|NCT02438826|54424058|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
27861486|NCT02438826|54424055|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
27861487|NCT02438826|54424056|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
27861488|NCT02438826|54424057|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
27861489|NCT02438826|54424058|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
27861490|NCT02438826|54424055|FG000|Double-Blind Treatment Phase|Screen Failure|2|||
27861491|NCT02438826|54424056|FG001|Double-Blind Treatment Phase|Screen Failure|0|||
27861492|NCT02438826|54424057|FG002|Double-Blind Treatment Phase|Screen Failure|0|||
27861493|NCT02438826|54424058|FG003|Double-Blind Treatment Phase|Screen Failure|0|||
27861494|NCT02438826|54424055|FG000|Open-Label Treatment Phase|Adverse Event|11|||
27861495|NCT02438826|54424056|FG001|Open-Label Treatment Phase|Adverse Event|6|||
27861496|NCT02438826|54424057|FG002|Open-Label Treatment Phase|Adverse Event|0|||
27861497|NCT02438826|54424058|FG003|Open-Label Treatment Phase|Adverse Event|0|||
27861498|NCT02438826|54424055|FG000|Open-Label Treatment Phase|Lack of Efficacy|27|||
27861499|NCT02438826|54424056|FG001|Open-Label Treatment Phase|Lack of Efficacy|18|||
27861500|NCT02438826|54424057|FG002|Open-Label Treatment Phase|Lack of Efficacy|0|||
27861501|NCT02438826|54424058|FG003|Open-Label Treatment Phase|Lack of Efficacy|0|||
27861502|NCT02438826|54424055|FG000|Open-Label Treatment Phase|Lost to Follow-up|0|||
27981325|NCT00606307|54639192|FG000|Overall Study|Withdrawal by Subject|2|||
27981326|NCT00606307|54639192|FG000|Overall Study|Disease progression|6|||
27981327|NCT00606307|54639192|FG000|Overall Study|QTc prolongation|1|||
27981328|NCT00798369|54639202|FG000|Overall Study|Subject withdrew consent|0|||
27861503|NCT02438826|54424056|FG001|Open-Label Treatment Phase|Lost to Follow-up|2|||
27861504|NCT02438826|54424057|FG002|Open-Label Treatment Phase|Lost to Follow-up|0|||
27861505|NCT02438826|54424058|FG003|Open-Label Treatment Phase|Lost to Follow-up|0|||
27861506|NCT02438826|54424055|FG000|Open-Label Treatment Phase|Withdrawal by Subject|6|||
27861507|NCT02438826|54424056|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
27861508|NCT02438826|54424057|FG002|Open-Label Treatment Phase|Withdrawal by Subject|0|||
27861509|NCT02438826|54424058|FG003|Open-Label Treatment Phase|Withdrawal by Subject|0|||
27738901|NCT02243176|54188212|FG001|Overall Study|protocol specified withdrawal critera|3|||
27981329|NCT00798369|54639203|FG001|Overall Study|Subject withdrew consent|0|||
27738902|NCT02243176|54188211|FG000|Overall Study|Protocol Violation|2|||
27861510|NCT02438826|54424055|FG000|Post-Treatment Phase|Adverse Event|3|||
27861511|NCT02438826|54424056|FG001|Post-Treatment Phase|Adverse Event|0|||
27861512|NCT02438826|54424057|FG002|Post-Treatment Phase|Adverse Event|0|||
27861513|NCT02438826|54424058|FG003|Post-Treatment Phase|Adverse Event|0|||
27861514|NCT02438826|54424055|FG000|Post-Treatment Phase|Lack of Efficacy|4|||
27861515|NCT02438826|54424056|FG001|Post-Treatment Phase|Lack of Efficacy|0|||
27861516|NCT02438826|54424057|FG002|Post-Treatment Phase|Lack of Efficacy|0|||
27861517|NCT02438826|54424058|FG003|Post-Treatment Phase|Lack of Efficacy|0|||
27861518|NCT02438826|54424055|FG000|Post-Treatment Phase|Physician Decision|1|||
27861519|NCT02438826|54424056|FG001|Post-Treatment Phase|Physician Decision|0|||
27861520|NCT02438826|54424057|FG002|Post-Treatment Phase|Physician Decision|0|||
27861521|NCT02438826|54424058|FG003|Post-Treatment Phase|Physician Decision|0|||
27861522|NCT02438826|54424055|FG000|Post-Treatment Phase|Withdrawal by Subject|1|||
27861523|NCT02438826|54424056|FG001|Post-Treatment Phase|Withdrawal by Subject|1|||
27861524|NCT02438826|54424057|FG002|Post-Treatment Phase|Withdrawal by Subject|0|||
27861525|NCT02438826|54424058|FG003|Post-Treatment Phase|Withdrawal by Subject|0|||
27861526|NCT02438280|54424075|FG000|Overall Study|Physician Decision|1|||
27861527|NCT02438280|54424076|FG001|Overall Study|Physician Decision|0|||
27861528|NCT02385708|54424094|FG000|Overall Study|Withdrawal by Subject|0|||
27861529|NCT02385708|54424095|FG001|Overall Study|Withdrawal by Subject|2|||
27861530|NCT02385708|54424094|FG000|Overall Study|Withdrawn - surgery canceled|2|||
27861531|NCT02385708|54424095|FG001|Overall Study|Withdrawn - surgery canceled|5|||
27861532|NCT02385708|54424094|FG000|Overall Study|Investigator decision|5|||
27861533|NCT02385708|54424095|FG001|Overall Study|Investigator decision|7|||
27861534|NCT02385708|54424094|FG000|Overall Study|Protocol Violation|1|||
27861535|NCT02385708|54424095|FG001|Overall Study|Protocol Violation|1|||
27861536|NCT02385084|54424834|FG000|Period 2|Protocol Violation|0|||
27861537|NCT02385084|54424835|FG001|Period 2|Protocol Violation|0|||
27861538|NCT02385084|54424836|FG002|Period 2|Protocol Violation|1|||
27861539|NCT02385084|54424837|FG003|Period 2|Protocol Violation|0|||
27861540|NCT02385084|54424838|FG004|Period 2|Protocol Violation|0|||
27861541|NCT02385084|54424839|FG005|Period 2|Protocol Violation|0|||
27861542|NCT02411292|54424848|FG000|Overall Study|Discharged before 3rd enoxaparin dose|16|||
27861543|NCT02411292|54424848|FG000|Overall Study|Death|2|||
27861544|NCT02411292|54424848|FG000|Overall Study|Lost to Follow-up|3|||
27861545|NCT02384850|54424911|FG000|Overall Study|Withdrawal by Subject|2|||
27861546|NCT02384850|54424912|FG001|Overall Study|Withdrawal by Subject|2|||
27861547|NCT02437890|54425134|FG000|Overall Study|Non-compliance to study drug|0|||
27861548|NCT02437890|54425135|FG001|Overall Study|Non-compliance to study drug|1|||
27861549|NCT02437890|54425136|FG002|Overall Study|Non-compliance to study drug|0|||
27861550|NCT02437890|54425137|FG003|Overall Study|Non-compliance to study drug|0|||
27861551|NCT02437890|54425138|FG004|Overall Study|Non-compliance to study drug|1|||
27861552|NCT02437890|54425134|FG000|Overall Study|Sponsor's decision|1|||
27861553|NCT02437890|54425135|FG001|Overall Study|Sponsor's decision|1|||
27861554|NCT02437890|54425136|FG002|Overall Study|Sponsor's decision|4|||
27861555|NCT02437890|54425137|FG003|Overall Study|Sponsor's decision|0|||
27861556|NCT02437890|54425138|FG004|Overall Study|Sponsor's decision|2|||
27861557|NCT02437890|54425134|FG000|Overall Study|Physician Decision|0|||
27861558|NCT02437890|54425135|FG001|Overall Study|Physician Decision|0|||
27861559|NCT02437890|54425136|FG002|Overall Study|Physician Decision|0|||
27861560|NCT02437890|54425137|FG003|Overall Study|Physician Decision|1|||
27861561|NCT02437890|54425138|FG004|Overall Study|Physician Decision|0|||
27861562|NCT02437890|54425134|FG000|Overall Study|Unable to attend visit(s)|1|||
27861563|NCT02437890|54425135|FG001|Overall Study|Unable to attend visit(s)|0|||
27861564|NCT02437890|54425136|FG002|Overall Study|Unable to attend visit(s)|0|||
27861565|NCT02437890|54425137|FG003|Overall Study|Unable to attend visit(s)|0|||
27861566|NCT02437890|54425138|FG004|Overall Study|Unable to attend visit(s)|0|||
27861567|NCT02437890|54425134|FG000|Overall Study|Lack of Efficacy|1|||
27861568|NCT02437890|54425135|FG001|Overall Study|Lack of Efficacy|3|||
27981330|NCT00798369|54639204|FG002|Overall Study|Subject withdrew consent|1|||
27981331|NCT00798369|54639205|FG003|Overall Study|Subject withdrew consent|1|||
27861569|NCT02437890|54425136|FG002|Overall Study|Lack of Efficacy|0|||
27861570|NCT02437890|54425137|FG003|Overall Study|Lack of Efficacy|3|||
27861571|NCT02437890|54425138|FG004|Overall Study|Lack of Efficacy|1|||
27861572|NCT02437890|54425134|FG000|Overall Study|Adverse Event|4|||
27861573|NCT02437890|54425135|FG001|Overall Study|Adverse Event|9|||
27861574|NCT02437890|54425136|FG002|Overall Study|Adverse Event|5|||
27861575|NCT02437890|54425137|FG003|Overall Study|Adverse Event|11|||
27861576|NCT02437890|54425138|FG004|Overall Study|Adverse Event|7|||
27861577|NCT02437890|54425134|FG000|Overall Study|Withdrawal by Subject|1|||
27861578|NCT02437890|54425135|FG001|Overall Study|Withdrawal by Subject|2|||
27861579|NCT02437890|54425136|FG002|Overall Study|Withdrawal by Subject|6|||
27861580|NCT02437890|54425137|FG003|Overall Study|Withdrawal by Subject|5|||
27981332|NCT00798369|54639206|FG004|Overall Study|Subject withdrew consent|0|||
27861581|NCT02437890|54425138|FG004|Overall Study|Withdrawal by Subject|5|||
27861582|NCT02437890|54425134|FG000|Overall Study|Death|0|||
27861583|NCT02437890|54425135|FG001|Overall Study|Death|0|||
27861584|NCT02437890|54425136|FG002|Overall Study|Death|0|||
27861585|NCT02437890|54425137|FG003|Overall Study|Death|2|||
27861586|NCT02437890|54425138|FG004|Overall Study|Death|0|||
27861587|NCT02384538|54425199|FG000|Overall Study|Adverse Event|1|||
27861588|NCT02384538|54425200|FG001|Overall Study|Adverse Event|4|||
27861589|NCT02384538|54425199|FG000|Overall Study|Lack of Efficacy|4|||
27861590|NCT02384538|54425200|FG001|Overall Study|Lack of Efficacy|4|||
27861591|NCT02384538|54425199|FG000|Overall Study|Withdrew Consent|0|||
27861592|NCT02384538|54425200|FG001|Overall Study|Withdrew Consent|4|||
27861593|NCT02384538|54425199|FG000|Overall Study|Other|1|||
27861594|NCT02384538|54425200|FG001|Overall Study|Other|3|||
27861595|NCT02410824|54425224|FG000|First Intervention (One Week)|Headache|0|||
27861596|NCT02410824|54425225|FG001|First Intervention (One Week)|Headache|1|||
27861597|NCT02384460|54425255|FG000|Overall Study|Protocol Violation|0|||
27861598|NCT02384460|54425256|FG001|Overall Study|Protocol Violation|1|||
27861599|NCT02384460|54425255|FG000|Overall Study|Returned to previous therapeutic regimen|0|||
27861600|NCT02384460|54425256|FG001|Overall Study|Returned to previous therapeutic regimen|1|||
27861601|NCT02384460|54425255|FG000|Overall Study|Adverse Event|5|||
27861602|NCT02384460|54425256|FG001|Overall Study|Adverse Event|2|||
27861603|NCT02384460|54425255|FG000|Overall Study|Withdrawal by Subject|0|||
27861604|NCT02384460|54425256|FG001|Overall Study|Withdrawal by Subject|3|||
27861605|NCT02384460|54425255|FG000|Overall Study|Elective medical treatment|1|||
27861606|NCT02384460|54425256|FG001|Overall Study|Elective medical treatment|0|||
27861607|NCT02384460|54425255|FG000|Overall Study|Non-compliance|1|||
27861608|NCT02384460|54425256|FG001|Overall Study|Non-compliance|0|||
27861609|NCT02384382|54425279|FG000|Overall Study|Transitioned to study-NCT02960022|5|||
27861610|NCT02384382|54425279|FG000|Overall Study|Death|1|||
27861611|NCT02384382|54425279|FG000|Overall Study|Adverse Event|1|||
27861612|NCT02384382|54425279|FG000|Overall Study|Disease progression|16|||
27861613|NCT02437188|54425299|FG000|Overall Study|Randomized but did not receive surgery|4|||
27861614|NCT02437188|54425300|FG001|Overall Study|Randomized but did not receive surgery|8|||
27861615|NCT02437188|54425299|FG000|Overall Study|Adverse Event|0|||
27861616|NCT02437188|54425300|FG001|Overall Study|Adverse Event|1|||
27861617|NCT02383758|54425322|FG000|Overall Study|Withdrawal by Subject|0|||
27861618|NCT02383758|54425323|FG001|Overall Study|Withdrawal by Subject|2|||
27861619|NCT02410278|54425373|FG000|Run-in Period|Adverse Event|5|||
27861620|NCT02410278|54425374|FG001|Run-in Period|Adverse Event|0|||
27861621|NCT02410278|54425375|FG002|Run-in Period|Adverse Event|0|||
27861622|NCT02410278|54425373|FG000|Run-in Period|GSRS Threshold Not Met|30|||
27861623|NCT02410278|54425374|FG001|Run-in Period|GSRS Threshold Not Met|0|||
27861624|NCT02410278|54425375|FG002|Run-in Period|GSRS Threshold Not Met|0|||
27861625|NCT02410278|54425373|FG000|Run-in Period|Lost to Follow-up|1|||
27834530|NCT02700984|54318954|FG000|Overall Study|Lost to Follow-up|2|||
27834531|NCT02700984|54318955|FG001|Overall Study|Lost to Follow-up|1|||
27834532|NCT02700984|54318954|FG000|Overall Study|Physician Decision|0|||
27834533|NCT02700984|54318955|FG001|Overall Study|Physician Decision|1|||
27834534|NCT02700984|54318954|FG000|Overall Study|Withdrawal by Subject|8|||
27834535|NCT02700984|54318955|FG001|Overall Study|Withdrawal by Subject|9|||
27834536|NCT02700984|54318954|FG000|Overall Study|Reason not specified|3|||
27834537|NCT02700984|54318955|FG001|Overall Study|Reason not specified|2|||
27834538|NCT02696850|54319029|FG000|Overall Study|Withdrawal by Subject|3|||
27834539|NCT02696850|54319030|FG001|Overall Study|Withdrawal by Subject|3|||
27834540|NCT02696850|54319029|FG000|Overall Study|Lost to Follow-up|8|||
27834541|NCT02696850|54319030|FG001|Overall Study|Lost to Follow-up|5|||
27834542|NCT02698410|54319193|FG000|Overall Study|Adverse Event|2|||
27834543|NCT02698410|54319193|FG000|Overall Study|Withdrawal by Subject|1|||
27861626|NCT02410278|54425374|FG001|Run-in Period|Lost to Follow-up|0|||
27861627|NCT02410278|54425375|FG002|Run-in Period|Lost to Follow-up|0|||
27861628|NCT02410278|54425373|FG000|Run-in Period|Withdrawal by Subject|1|||
27861629|NCT02410278|54425374|FG001|Run-in Period|Withdrawal by Subject|0|||
27861630|NCT02410278|54425375|FG002|Run-in Period|Withdrawal by Subject|0|||
27861631|NCT02410278|54425373|FG000|Run-in Period|Pregnancy|1|||
27861632|NCT02410278|54425374|FG001|Run-in Period|Pregnancy|0|||
27861633|NCT02410278|54425375|FG002|Run-in Period|Pregnancy|0|||
27861634|NCT02410278|54425373|FG000|Study Treatment Period|Adverse Event|0|||
27861635|NCT02410278|54425374|FG001|Study Treatment Period|Adverse Event|6|||
27861636|NCT02410278|54425375|FG002|Study Treatment Period|Adverse Event|3|||
27861637|NCT02410278|54425373|FG000|Study Treatment Period|Physician Decision|0|||
27861638|NCT02410278|54425374|FG001|Study Treatment Period|Physician Decision|0|||
27861639|NCT02410278|54425375|FG002|Study Treatment Period|Physician Decision|1|||
27861640|NCT02410278|54425373|FG000|Study Treatment Period|Withdrawal by Subject|0|||
27861641|NCT02410278|54425374|FG001|Study Treatment Period|Withdrawal by Subject|1|||
27861642|NCT02410278|54425375|FG002|Study Treatment Period|Withdrawal by Subject|0|||
27861643|NCT02410278|54425373|FG000|Study Treatment Period|Other|0|||
27861644|NCT02410278|54425374|FG001|Study Treatment Period|Other|3|||
27834544|NCT02698410|54319193|FG000|Overall Study|Other|1|||
27834545|NCT02699892|54319197|FG000|Overall Study|Other|36|||
27834546|NCT02698176|54319204|FG000|Overall Study|Progressive disease|4|||
27861645|NCT02410278|54425375|FG002|Study Treatment Period|Other|0|||
27861646|NCT02410278|54425373|FG000|Study Treatment Period|GSRS Threshold Not Met|0|||
27861647|NCT02410278|54425374|FG001|Study Treatment Period|GSRS Threshold Not Met|1|||
27861648|NCT02410278|54425375|FG002|Study Treatment Period|GSRS Threshold Not Met|0|||
27861649|NCT02410200|54425408|FG000|Overall Study|Adverse Event|2|||
27861650|NCT02383056|54425427|FG000|Overall Study|Adverse Event|1|||
27861651|NCT02383056|54425428|FG001|Overall Study|Adverse Event|0|||
27861652|NCT02383056|54425427|FG000|Overall Study|Lost to Follow-up|0|||
27861653|NCT02383056|54425428|FG001|Overall Study|Lost to Follow-up|2|||
27861654|NCT02409732|54425434|FG000|Overall Study|Withdrawal by Subject|4|||
27861655|NCT02409732|54425434|FG000|Overall Study|Lost to Follow-up|2|||
27861656|NCT01650636|54425445|FG000|Washout up to 5 Months|Withdrawal by Subject|4|||
27861657|NCT01650636|54425446|FG001|Washout up to 5 Months|Withdrawal by Subject|8|||
27861658|NCT01650636|54425445|FG000|Washout up to 5 Months|Physician Decision|2|||
27861659|NCT01650636|54425446|FG001|Washout up to 5 Months|Physician Decision|2|||
27861660|NCT01650636|54425445|FG000|Washout up to 5 Months|Death|1|||
27861661|NCT01650636|54425446|FG001|Washout up to 5 Months|Death|0|||
27861662|NCT01650636|54425445|FG000|Washout up to 5 Months|Lost to Follow-up|2|||
27861663|NCT01650636|54425446|FG001|Washout up to 5 Months|Lost to Follow-up|8|||
27861664|NCT01650636|54425445|FG000|Washout up to 9 Months|Withdrawal by Subject|4|||
27861665|NCT01650636|54425446|FG001|Washout up to 9 Months|Withdrawal by Subject|2|||
27861666|NCT01650636|54425445|FG000|Washout up to 9 Months|Lost to Follow-up|2|||
27861667|NCT01650636|54425446|FG001|Washout up to 9 Months|Lost to Follow-up|1|||
27861668|NCT02436876|54425456|FG000|Overall Study|Lost to Follow-up|0|||
27861669|NCT02436876|54425457|FG001|Overall Study|Lost to Follow-up|1|||
27861670|NCT02436876|54425458|FG002|Overall Study|Lost to Follow-up|1|||
27861671|NCT02436876|54425459|FG003|Overall Study|Lost to Follow-up|1|||
27861672|NCT02436876|54425456|FG000|Overall Study|Withdrawal by Subject|1|||
27861673|NCT02436876|54425457|FG001|Overall Study|Withdrawal by Subject|0|||
27861674|NCT02436876|54425458|FG002|Overall Study|Withdrawal by Subject|0|||
27861675|NCT02436876|54425459|FG003|Overall Study|Withdrawal by Subject|1|||
27861676|NCT02436876|54425456|FG000|Overall Study|Physician Decision|0|||
27981333|NCT00798369|54639207|FG005|Overall Study|Subject withdrew consent|2|||
27981334|NCT00798369|54639202|FG000|Overall Study|Lost to Follow-up|1|||
27981335|NCT00798369|54639203|FG001|Overall Study|Lost to Follow-up|1|||
27981336|NCT00798369|54639204|FG002|Overall Study|Lost to Follow-up|1|||
27981337|NCT00798369|54639205|FG003|Overall Study|Lost to Follow-up|0|||
27981338|NCT00798369|54639206|FG004|Overall Study|Lost to Follow-up|1|||
27981339|NCT00798369|54639207|FG005|Overall Study|Lost to Follow-up|0|||
27981340|NCT00798369|54639202|FG000|Overall Study|Adminstrative problems|0|||
27981341|NCT00798369|54639203|FG001|Overall Study|Adminstrative problems|0|||
27981342|NCT00798369|54639204|FG002|Overall Study|Adminstrative problems|0|||
27981343|NCT00798369|54639205|FG003|Overall Study|Adminstrative problems|0|||
27981344|NCT00798369|54639206|FG004|Overall Study|Adminstrative problems|0|||
27981345|NCT00798369|54639207|FG005|Overall Study|Adminstrative problems|1|||
27981346|NCT00950963|54639224|FG000|Overall Study|Lost to Follow-up|29|||
27981347|NCT00950963|54639225|FG001|Overall Study|Lost to Follow-up|24|||
27981348|NCT00608959|54639233|FG000|Part 1|Did not meet eligibility criteria|1|||
27981349|NCT00945659|54639246|FG000|Overall Study|Lost to Follow-up|7|||
27981350|NCT00945659|54639247|FG001|Overall Study|Lost to Follow-up|20|||
27981351|NCT00945659|54639248|FG002|Overall Study|Lost to Follow-up|17|||
27981352|NCT00798135|54639256|FG000|Overall Study|Disease progression, relapse|11|||
27981353|NCT00798135|54639256|FG000|Overall Study|Disease progression, refractory|1|||
27981354|NCT00798135|54639256|FG000|Overall Study|Physician Decision|1|||
27981355|NCT00941603|54639266|FG000|Overall Study|Adverse Event|10|||
27981356|NCT00941603|54639267|FG001|Overall Study|Adverse Event|15|||
27981357|NCT00941603|54639268|FG002|Overall Study|Adverse Event|5|||
27981358|NCT00941603|54639269|FG003|Overall Study|Adverse Event|1|||
27981359|NCT00941603|54639270|FG004|Overall Study|Adverse Event|4|||
27981360|NCT00941603|54639271|FG005|Overall Study|Adverse Event|0|||
27981361|NCT00941603|54639266|FG000|Overall Study|Lost to Follow-up|0|||
28096047|NCT04432376|54750689|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
28096048|NCT04432376|54750687|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
28096049|NCT04432376|54750688|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
27861677|NCT02436876|54425457|FG001|Overall Study|Physician Decision|2|||
27861678|NCT02436876|54425458|FG002|Overall Study|Physician Decision|1|||
27861679|NCT02436876|54425459|FG003|Overall Study|Physician Decision|0|||
27861680|NCT02436876|54425456|FG000|Overall Study|Inadequate amount of study drug available for randomization|0|||
27861681|NCT02436876|54425457|FG001|Overall Study|Inadequate amount of study drug available for randomization|1|||
27981362|NCT00941603|54639267|FG001|Overall Study|Lost to Follow-up|0|||
27981363|NCT00941603|54639268|FG002|Overall Study|Lost to Follow-up|0|||
27981364|NCT00941603|54639269|FG003|Overall Study|Lost to Follow-up|1|||
27981365|NCT00941603|54639270|FG004|Overall Study|Lost to Follow-up|0|||
27981366|NCT00941603|54639271|FG005|Overall Study|Lost to Follow-up|2|||
27981367|NCT00941603|54639266|FG000|Overall Study|Withdrawal by Subject|0|||
27981368|NCT00941603|54639267|FG001|Overall Study|Withdrawal by Subject|0|||
27861682|NCT02436876|54425458|FG002|Overall Study|Inadequate amount of study drug available for randomization|0|||
27861683|NCT02436876|54425459|FG003|Overall Study|Inadequate amount of study drug available for randomization|0|||
27861684|NCT02382276|54425488|FG000|Overall Study|Withdrawal by Subject|4|||
27861685|NCT02382276|54425489|FG001|Overall Study|Withdrawal by Subject|8|||
27861686|NCT02382276|54425490|FG002|Overall Study|Withdrawal by Subject|5|||
27861687|NCT02382276|54425488|FG000|Overall Study|Adverse Event|7|||
27861688|NCT02382276|54425489|FG001|Overall Study|Adverse Event|2|||
27861689|NCT02382276|54425490|FG002|Overall Study|Adverse Event|32|||
27861690|NCT02382276|54425488|FG000|Overall Study|Physician Decision|0|||
27861691|NCT02382276|54425489|FG001|Overall Study|Physician Decision|0|||
27861692|NCT02382276|54425490|FG002|Overall Study|Physician Decision|2|||
27861693|NCT02436408|54425531|FG000|Overall Study|Death|1|||
27861694|NCT02436330|54425554|FG000|Cohort 1|Lost to Follow-up|5|||
27861695|NCT02436330|54425555|FG001|Cohort 1|Lost to Follow-up|2|||
27861696|NCT02436330|54425554|FG000|Cohort 1|Withdrawal by Subject|0|||
27861697|NCT02436330|54425555|FG001|Cohort 1|Withdrawal by Subject|1|||
27861698|NCT02436330|54425554|FG000|Cohort 2|Lost to Follow-up|2|||
27861699|NCT02436330|54425555|FG001|Cohort 2|Lost to Follow-up|0|||
27861700|NCT02436330|54425554|FG000|Cohort 2|Withdrawal by Subject|2|||
27861701|NCT02436330|54425555|FG001|Cohort 2|Withdrawal by Subject|3|||
27861702|NCT02436330|54425554|FG000|Cohort 3|Lost to Follow-up|1|||
27861703|NCT02436330|54425555|FG001|Cohort 3|Lost to Follow-up|0|||
27861704|NCT02436330|54425554|FG000|Cohort 3|Withdrawal by Subject|4|||
27861705|NCT02436330|54425555|FG001|Cohort 3|Withdrawal by Subject|0|||
27981369|NCT00941603|54639268|FG002|Overall Study|Withdrawal by Subject|0|||
27981370|NCT00941603|54639269|FG003|Overall Study|Withdrawal by Subject|2|||
27981371|NCT00941603|54639270|FG004|Overall Study|Withdrawal by Subject|0|||
27981372|NCT00941603|54639271|FG005|Overall Study|Withdrawal by Subject|1|||
27981373|NCT00941603|54639266|FG000|Overall Study|Protocol Violation|0|||
27981374|NCT00941603|54639267|FG001|Overall Study|Protocol Violation|1|||
27981375|NCT00941603|54639268|FG002|Overall Study|Protocol Violation|0|||
27981376|NCT00941603|54639269|FG003|Overall Study|Protocol Violation|0|||
27981377|NCT00941603|54639270|FG004|Overall Study|Protocol Violation|0|||
27981378|NCT00941603|54639271|FG005|Overall Study|Protocol Violation|0|||
27981379|NCT00941603|54639266|FG000|Overall Study|Did not meet protocol eligibility|1|||
27981380|NCT00941603|54639267|FG001|Overall Study|Did not meet protocol eligibility|0|||
27981381|NCT00941603|54639268|FG002|Overall Study|Did not meet protocol eligibility|0|||
27981382|NCT00941603|54639269|FG003|Overall Study|Did not meet protocol eligibility|0|||
27981383|NCT00941603|54639270|FG004|Overall Study|Did not meet protocol eligibility|0|||
27981384|NCT00941603|54639271|FG005|Overall Study|Did not meet protocol eligibility|0|||
27981385|NCT00797823|54639288|FG000|First Period (Initial Randomization)|Physician Decision|1|||
27981386|NCT00797823|54639289|FG001|First Period (Initial Randomization)|Physician Decision|0|||
27981387|NCT00797823|54639290|FG002|First Period (Initial Randomization)|Physician Decision|0|||
27981388|NCT00797667|54639300|FG000|Overall Study|Lack of Efficacy|0|||
27981389|NCT00797667|54639301|FG001|Overall Study|Lack of Efficacy|1|||
27981390|NCT00797667|54639302|FG002|Overall Study|Lack of Efficacy|0|||
27981391|NCT00797667|54639300|FG000|Overall Study|Lost to Follow-up|8|||
27981392|NCT00797667|54639301|FG001|Overall Study|Lost to Follow-up|12|||
27981393|NCT00797667|54639302|FG002|Overall Study|Lost to Follow-up|2|||
27981394|NCT00797667|54639300|FG000|Overall Study|Physician Decision|3|||
27981395|NCT00797667|54639301|FG001|Overall Study|Physician Decision|1|||
27981396|NCT00797667|54639302|FG002|Overall Study|Physician Decision|0|||
27981397|NCT00797667|54639300|FG000|Overall Study|Pregnancy|2|||
27981398|NCT00797667|54639301|FG001|Overall Study|Pregnancy|0|||
27981399|NCT00797667|54639302|FG002|Overall Study|Pregnancy|0|||
27981400|NCT00797667|54639300|FG000|Overall Study|Protocol Violation|2|||
27981401|NCT00797667|54639301|FG001|Overall Study|Protocol Violation|7|||
27981402|NCT00797667|54639302|FG002|Overall Study|Protocol Violation|0|||
27981403|NCT00797667|54639300|FG000|Overall Study|Study Terminated by Sponsor|217|||
27981404|NCT00797667|54639301|FG001|Overall Study|Study Terminated by Sponsor|216|||
27981405|NCT00797667|54639302|FG002|Overall Study|Study Terminated by Sponsor|115|||
27981406|NCT00797667|54639300|FG000|Overall Study|Withdrawal by Subject|9|||
27981407|NCT00797667|54639301|FG001|Overall Study|Withdrawal by Subject|14|||
27981408|NCT00797667|54639302|FG002|Overall Study|Withdrawal by Subject|2|||
27981409|NCT00797667|54639300|FG000|Overall Study|Adverse Event|19|||
27981410|NCT00797667|54639301|FG001|Overall Study|Adverse Event|8|||
27981411|NCT00797667|54639302|FG002|Overall Study|Adverse Event|8|||
27981412|NCT00950807|54639310|FG000|Treatment Period 1|Lack of Efficacy|1|||
27981413|NCT00950807|54639311|FG001|Treatment Period 1|Lack of Efficacy|0|||
27981414|NCT00950807|54639312|FG002|Treatment Period 1|Lack of Efficacy|0|||
27981415|NCT00950807|54639313|FG003|Treatment Period 1|Lack of Efficacy|0|||
27981416|NCT00950807|54639314|FG004|Treatment Period 1|Lack of Efficacy|0|||
27861706|NCT02436330|54425554|FG000|Cohort 4|Lost to Follow-up|1|||
27861707|NCT02436330|54425555|FG001|Cohort 4|Lost to Follow-up|0|||
27981417|NCT00950807|54639315|FG005|Treatment Period 1|Lack of Efficacy|1|||
27861708|NCT02436330|54425554|FG000|Cohort 4|Withdrawal by Subject|1|||
27861709|NCT02436330|54425555|FG001|Cohort 4|Withdrawal by Subject|0|||
27861710|NCT02436330|54425554|FG000|Cohort 5|Lost to Follow-up|3|||
27861711|NCT02436330|54425555|FG001|Cohort 5|Lost to Follow-up|2|||
27861712|NCT02436330|54425554|FG000|Cohort 5|Withdrawal by Subject|3|||
27861713|NCT02436330|54425555|FG001|Cohort 5|Withdrawal by Subject|2|||
27861714|NCT02436330|54425554|FG000|Cohort 6|Lost to Follow-up|2|||
27861715|NCT02436330|54425555|FG001|Cohort 6|Lost to Follow-up|0|||
27861716|NCT02436330|54425554|FG000|Cohort 6|Withdrawal by Subject|1|||
27861717|NCT02436330|54425555|FG001|Cohort 6|Withdrawal by Subject|1|||
27861718|NCT01650558|54425592|FG000|Overall Study|Migration out of study area|61|||
27861719|NCT01650558|54425593|FG001|Overall Study|Migration out of study area|71|||
27861720|NCT01650558|54425594|FG002|Overall Study|Migration out of study area|56|||
27861721|NCT01650558|54425592|FG000|Overall Study|Lost to Follow-up|10|||
27861722|NCT01650558|54425593|FG001|Overall Study|Lost to Follow-up|13|||
27861723|NCT01650558|54425594|FG002|Overall Study|Lost to Follow-up|6|||
27861724|NCT01650558|54425592|FG000|Overall Study|Death|10|||
27861725|NCT01650558|54425593|FG001|Overall Study|Death|6|||
27861726|NCT01650558|54425594|FG002|Overall Study|Death|8|||
27861727|NCT01650558|54425592|FG000|Overall Study|Withdrawal by Subject|1|||
27861728|NCT01650558|54425593|FG001|Overall Study|Withdrawal by Subject|1|||
27861729|NCT01650558|54425594|FG002|Overall Study|Withdrawal by Subject|3|||
27861730|NCT01650558|54425592|FG000|Overall Study|Non-compliant participant|1|||
27861731|NCT01650558|54425593|FG001|Overall Study|Non-compliant participant|0|||
27861732|NCT01650558|54425594|FG002|Overall Study|Non-compliant participant|2|||
27861733|NCT01650558|54425592|FG000|Overall Study|Physician Decision|0|||
27861734|NCT01650558|54425593|FG001|Overall Study|Physician Decision|1|||
27861735|NCT01650558|54425594|FG002|Overall Study|Physician Decision|0|||
27861736|NCT02408484|54425633|FG000|Overall Study|Withdrawal by Subject|3|||
27861737|NCT02408484|54425633|FG000|Overall Study|Not treated during study period|1|||
27861738|NCT02380248|54425661|FG000|Overall Study|Lost to Follow-up|11|||
27861739|NCT02380248|54425661|FG000|Overall Study|Withdrawal by Subject|3|||
27861740|NCT02408016|54425708|FG000|Overall Study|Death|6|||
27861741|NCT02408016|54425709|FG001|Overall Study|Death|1|||
27861742|NCT02408016|54425710|FG002|Overall Study|Death|0|||
27861743|NCT02408016|54425708|FG000|Overall Study|Physician Decision|0|||
27861744|NCT02408016|54425709|FG001|Overall Study|Physician Decision|2|||
27861745|NCT02408016|54425710|FG002|Overall Study|Physician Decision|0|||
27861746|NCT02407704|54425774|FG000|Overall Study|Lost to Follow-up|0|||
27861747|NCT02407704|54425775|FG001|Overall Study|Lost to Follow-up|0|||
27861748|NCT02407704|54425776|FG002|Overall Study|Lost to Follow-up|0|||
27861749|NCT02407704|54425777|FG003|Overall Study|Lost to Follow-up|2|||
27861750|NCT02407704|54425774|FG000|Overall Study|Protocol Violation|0|||
27861751|NCT02407704|54425775|FG001|Overall Study|Protocol Violation|0|||
27861752|NCT02407704|54425776|FG002|Overall Study|Protocol Violation|0|||
27861753|NCT02407704|54425777|FG003|Overall Study|Protocol Violation|1|||
27861754|NCT02407704|54425774|FG000|Overall Study|Withdrawal by Subject|0|||
27861755|NCT02407704|54425775|FG001|Overall Study|Withdrawal by Subject|0|||
27861756|NCT02407704|54425776|FG002|Overall Study|Withdrawal by Subject|1|||
27861757|NCT02407704|54425777|FG003|Overall Study|Withdrawal by Subject|0|||
27861758|NCT02406612|54425798|FG000|Overall Study|Screening Failure|3|||
27861759|NCT02406612|54425799|FG001|Overall Study|Screening Failure|0|||
27861760|NCT02406612|54425798|FG000|Overall Study|Intra-procedural Exclusion|1|||
27861761|NCT02406612|54425799|FG001|Overall Study|Intra-procedural Exclusion|3|||
27861762|NCT02406612|54425798|FG000|Overall Study|Guidewire Failure|0|||
27861763|NCT02406612|54425799|FG001|Overall Study|Guidewire Failure|1|||
27861764|NCT02405442|54425943|FG000|Double-Blind Phase (up to Week 8)|Adverse Event|0|||
27861765|NCT02405442|54425944|FG001|Double-Blind Phase (up to Week 8)|Adverse Event|2|||
27861766|NCT02405442|54425945|FG002|Double-Blind Phase (up to Week 8)|Adverse Event|4|||
27861767|NCT02405442|54425946|FG003|Double-Blind Phase (up to Week 8)|Adverse Event|1|||
27861768|NCT02405442|54425943|FG000|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
27861769|NCT02405442|54425944|FG001|Double-Blind Phase (up to Week 8)|Withdrew Consent|1|||
27861770|NCT02405442|54425945|FG002|Double-Blind Phase (up to Week 8)|Withdrew Consent|2|||
27861771|NCT02405442|54425946|FG003|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
27738903|NCT02243176|54188212|FG001|Overall Study|Protocol Violation|1|||
27738904|NCT02243176|54188211|FG000|Overall Study|Withdrawal by Subject|8|||
27861772|NCT02405442|54425943|FG000|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
27861773|NCT02405442|54425944|FG001|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
27861774|NCT02405442|54425945|FG002|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
27861775|NCT02405442|54425946|FG003|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
27738905|NCT02243176|54188212|FG001|Overall Study|Withdrawal by Subject|7|||
27861776|NCT02405442|54425943|FG000|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
27861777|NCT02405442|54425944|FG001|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1|||
27738906|NCT02243176|54188211|FG000|Overall Study|Adverse Event|2|||
27861778|NCT02405442|54425945|FG002|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
27861779|NCT02405442|54425946|FG003|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
28096050|NCT04432376|54750689|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
27861780|NCT02405442|54425943|FG000|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27|||
27861781|NCT02405442|54425944|FG001|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
27861782|NCT02405442|54425945|FG002|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
27861783|NCT02405442|54425946|FG003|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13|||
27861784|NCT02405442|54425943|FG000|Open-Label Phase (up to Week 52)|Investigator's Discretion|14|||
27861785|NCT02405442|54425944|FG001|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
27861786|NCT02405442|54425945|FG002|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
27861787|NCT02405442|54425946|FG003|Open-Label Phase (up to Week 52)|Investigator's Discretion|2|||
27861788|NCT02405442|54425943|FG000|Open-Label Phase (up to Week 52)|Adverse Event|6|||
27861789|NCT02405442|54425944|FG001|Open-Label Phase (up to Week 52)|Adverse Event|1|||
27861790|NCT02405442|54425945|FG002|Open-Label Phase (up to Week 52)|Adverse Event|2|||
27861791|NCT02405442|54425946|FG003|Open-Label Phase (up to Week 52)|Adverse Event|6|||
27861792|NCT02405442|54425943|FG000|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0|||
27861793|NCT02405442|54425944|FG001|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1|||
27861794|NCT02405442|54425945|FG002|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3|||
27861795|NCT02405442|54425946|FG003|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2|||
27861796|NCT02405442|54425943|FG000|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
27861797|NCT02405442|54425944|FG001|Open-Label Phase (up to Week 52)|Withdrew Consent|2|||
27861798|NCT02405442|54425945|FG002|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
27861799|NCT02405442|54425946|FG003|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
27861800|NCT02405442|54425943|FG000|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
27861801|NCT02405442|54425944|FG001|Open-Label Phase (up to Week 52)|Lack of Efficacy|1|||
27861802|NCT02405442|54425945|FG002|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
27861803|NCT02405442|54425946|FG003|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
27861804|NCT02405442|54425943|FG000|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
27861805|NCT02405442|54425944|FG001|Open-Label Phase (up to Week 52)|Lost to Follow-up|1|||
27861806|NCT02405442|54425945|FG002|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
27861807|NCT02405442|54425946|FG003|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
27861808|NCT02405442|54425943|FG000|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
27861809|NCT02405442|54425944|FG001|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1|||
27861810|NCT02405442|54425945|FG002|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
27861811|NCT02405442|54425946|FG003|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
27861812|NCT02405442|54425943|FG000|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
27861813|NCT02405442|54425944|FG001|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1|||
27861814|NCT02405442|54425945|FG002|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
27861815|NCT02405442|54425946|FG003|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
27861816|NCT02405442|54425943|FG000|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1|||
27861817|NCT02405442|54425944|FG001|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
27861818|NCT02405442|54425945|FG002|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
27861819|NCT02405442|54425946|FG003|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
27861820|NCT02404350|54426062|FG000|Overall Study|Adverse Event|2|||
27861821|NCT02404350|54426063|FG001|Overall Study|Adverse Event|2|||
27861822|NCT02404350|54426064|FG002|Overall Study|Adverse Event|3|||
27861823|NCT02404350|54426065|FG003|Overall Study|Adverse Event|9|||
27861824|NCT02404350|54426062|FG000|Overall Study|Lack of Efficacy|3|||
27861825|NCT02404350|54426063|FG001|Overall Study|Lack of Efficacy|1|||
27861826|NCT02404350|54426064|FG002|Overall Study|Lack of Efficacy|0|||
27861827|NCT02404350|54426065|FG003|Overall Study|Lack of Efficacy|3|||
27861828|NCT02404350|54426062|FG000|Overall Study|Lost to Follow-up|2|||
27861829|NCT02404350|54426063|FG001|Overall Study|Lost to Follow-up|0|||
27861830|NCT02404350|54426064|FG002|Overall Study|Lost to Follow-up|0|||
27861831|NCT02404350|54426065|FG003|Overall Study|Lost to Follow-up|1|||
27861832|NCT02404350|54426062|FG000|Overall Study|Physician Decision|1|||
27861833|NCT02404350|54426063|FG001|Overall Study|Physician Decision|0|||
27861834|NCT02404350|54426064|FG002|Overall Study|Physician Decision|0|||
27861835|NCT02404350|54426065|FG003|Overall Study|Physician Decision|2|||
27861836|NCT02404350|54426062|FG000|Overall Study|Pregnancy|0|||
27861837|NCT02404350|54426063|FG001|Overall Study|Pregnancy|0|||
27861838|NCT02404350|54426064|FG002|Overall Study|Pregnancy|0|||
27861839|NCT02404350|54426065|FG003|Overall Study|Pregnancy|1|||
27861840|NCT02404350|54426062|FG000|Overall Study|Withdrawal by Subject|7|||
27861841|NCT02404350|54426063|FG001|Overall Study|Withdrawal by Subject|3|||
27861842|NCT02404350|54426064|FG002|Overall Study|Withdrawal by Subject|3|||
27861843|NCT02404350|54426065|FG003|Overall Study|Withdrawal by Subject|19|||
27861844|NCT02404350|54426062|FG000|Overall Study|Due to Non-compliance with treatment|0|||
27861845|NCT02404350|54426063|FG001|Overall Study|Due to Non-compliance with treatment|0|||
27861846|NCT02404350|54426064|FG002|Overall Study|Due to Non-compliance with treatment|0|||
27981418|NCT00950807|54639316|FG006|Treatment Period 1|Lack of Efficacy|0|||
27981419|NCT00950807|54639317|FG007|Treatment Period 1|Lack of Efficacy|0|||
27861847|NCT02404350|54426065|FG003|Overall Study|Due to Non-compliance with treatment|1|||
27861848|NCT02404350|54426062|FG000|Overall Study|Due to Technical problems|0|||
27861849|NCT02404350|54426063|FG001|Overall Study|Due to Technical problems|0|||
27861850|NCT02404350|54426064|FG002|Overall Study|Due to Technical problems|0|||
27861851|NCT02404350|54426065|FG003|Overall Study|Due to Technical problems|1|||
27861852|NCT02434770|54426364|FG000|Week 1 to Week 18|Lost to Follow-up|0|||
27861853|NCT02434770|54426365|FG001|Week 1 to Week 18|Lost to Follow-up|0|||
27861854|NCT02434770|54426366|FG002|Week 1 to Week 18|Lost to Follow-up|2|||
27861855|NCT02434770|54426364|FG000|Week 1 to Week 18|Withdrawal by Subject|6|||
27861856|NCT02434770|54426365|FG001|Week 1 to Week 18|Withdrawal by Subject|12|||
27861857|NCT02434770|54426366|FG002|Week 1 to Week 18|Withdrawal by Subject|5|||
27861858|NCT02434770|54426364|FG000|Week 1 to Week 18|Received Non-study Polio Vaccine|8|||
27861859|NCT02434770|54426365|FG001|Week 1 to Week 18|Received Non-study Polio Vaccine|10|||
27861860|NCT02434770|54426366|FG002|Week 1 to Week 18|Received Non-study Polio Vaccine|9|||
27861861|NCT02434770|54426364|FG000|Week 1 to Week 18|Relocated Out of Study Area|0|||
27861862|NCT02434770|54426365|FG001|Week 1 to Week 18|Relocated Out of Study Area|0|||
27861863|NCT02434770|54426366|FG002|Week 1 to Week 18|Relocated Out of Study Area|1|||
27861864|NCT02434770|54426364|FG000|Week 1 to Week 18|Death|1|||
27861865|NCT02434770|54426365|FG001|Week 1 to Week 18|Death|0|||
27861866|NCT02434770|54426366|FG002|Week 1 to Week 18|Death|0|||
27861867|NCT02434770|54426364|FG000|Week 18 to Week|Lost to Follow-up|2|||
27861868|NCT02434770|54426365|FG001|Week 18 to Week|Lost to Follow-up|2|||
27861869|NCT02434770|54426366|FG002|Week 18 to Week|Lost to Follow-up|1|||
27861870|NCT02434770|54426364|FG000|Week 18 to Week|Withdrawal by Subject|0|||
27861871|NCT02434770|54426365|FG001|Week 18 to Week|Withdrawal by Subject|0|||
27861872|NCT02434770|54426366|FG002|Week 18 to Week|Withdrawal by Subject|2|||
27861873|NCT02434770|54426364|FG000|Week 18 to Week|Received Non-study Polio Vaccine|6|||
27861874|NCT02434770|54426365|FG001|Week 18 to Week|Received Non-study Polio Vaccine|6|||
27861875|NCT02434770|54426366|FG002|Week 18 to Week|Received Non-study Polio Vaccine|3|||
27861876|NCT02433834|54426397|FG000|Overall Study|Protocol-specified criteria|7|||
27861877|NCT02433834|54426397|FG000|Overall Study|Protocol Violation|3|||
27981420|NCT00950807|54639318|FG008|Treatment Period 1|Lack of Efficacy|0|||
27981421|NCT00950807|54639319|FG009|Treatment Period 1|Lack of Efficacy|0|||
27981422|NCT00950807|54639310|FG000|Treatment Period 1|Protocol Violation|1|||
27981423|NCT00950807|54639311|FG001|Treatment Period 1|Protocol Violation|0|||
27981424|NCT00950807|54639312|FG002|Treatment Period 1|Protocol Violation|0|||
27981425|NCT00950807|54639313|FG003|Treatment Period 1|Protocol Violation|0|||
27981426|NCT00950807|54639314|FG004|Treatment Period 1|Protocol Violation|0|||
27981427|NCT00950807|54639315|FG005|Treatment Period 1|Protocol Violation|0|||
27981428|NCT00950807|54639316|FG006|Treatment Period 1|Protocol Violation|0|||
27981429|NCT00950807|54639317|FG007|Treatment Period 1|Protocol Violation|0|||
27981430|NCT00950807|54639318|FG008|Treatment Period 1|Protocol Violation|0|||
27981431|NCT00950807|54639319|FG009|Treatment Period 1|Protocol Violation|0|||
27981432|NCT00950807|54639310|FG000|Treatment Period 1|Lost to Follow-up|0|||
27981433|NCT00950807|54639311|FG001|Treatment Period 1|Lost to Follow-up|0|||
27981434|NCT00950807|54639312|FG002|Treatment Period 1|Lost to Follow-up|1|||
27981435|NCT00950807|54639313|FG003|Treatment Period 1|Lost to Follow-up|0|||
27981436|NCT00950807|54639314|FG004|Treatment Period 1|Lost to Follow-up|0|||
27981437|NCT00950807|54639315|FG005|Treatment Period 1|Lost to Follow-up|0|||
27981438|NCT00950807|54639316|FG006|Treatment Period 1|Lost to Follow-up|0|||
27981439|NCT00950807|54639317|FG007|Treatment Period 1|Lost to Follow-up|0|||
27981440|NCT00950807|54639318|FG008|Treatment Period 1|Lost to Follow-up|0|||
27981441|NCT00950807|54639319|FG009|Treatment Period 1|Lost to Follow-up|0|||
27981442|NCT00950807|54639310|FG000|Treatment Period 1|Withdrawal by Subject|1|||
27981443|NCT00950807|54639311|FG001|Treatment Period 1|Withdrawal by Subject|0|||
27981444|NCT00950807|54639312|FG002|Treatment Period 1|Withdrawal by Subject|0|||
27981445|NCT00950807|54639313|FG003|Treatment Period 1|Withdrawal by Subject|0|||
27981446|NCT00950807|54639314|FG004|Treatment Period 1|Withdrawal by Subject|1|||
27981447|NCT00950807|54639315|FG005|Treatment Period 1|Withdrawal by Subject|0|||
27981448|NCT00950807|54639316|FG006|Treatment Period 1|Withdrawal by Subject|0|||
27981449|NCT00950807|54639317|FG007|Treatment Period 1|Withdrawal by Subject|0|||
27981450|NCT00950807|54639318|FG008|Treatment Period 1|Withdrawal by Subject|1|||
27981451|NCT00950807|54639319|FG009|Treatment Period 1|Withdrawal by Subject|0|||
27981452|NCT00950807|54639310|FG000|Treatment Period 1|Adverse Event|0|||
27981453|NCT00950807|54639311|FG001|Treatment Period 1|Adverse Event|0|||
27981454|NCT00950807|54639312|FG002|Treatment Period 1|Adverse Event|0|||
27981455|NCT00950807|54639313|FG003|Treatment Period 1|Adverse Event|0|||
27981456|NCT00950807|54639314|FG004|Treatment Period 1|Adverse Event|0|||
27981457|NCT00950807|54639315|FG005|Treatment Period 1|Adverse Event|1|||
27981458|NCT00950807|54639316|FG006|Treatment Period 1|Adverse Event|0|||
27981459|NCT00950807|54639317|FG007|Treatment Period 1|Adverse Event|0|||
27861878|NCT02433834|54426397|FG000|Overall Study|Lost to Follow-up|6|||
27861879|NCT02433834|54426397|FG000|Overall Study|Withdrawal by Subject|14|||
27861880|NCT02433834|54426397|FG000|Overall Study|Adverse Event|6|||
27861881|NCT02433834|54426397|FG000|Overall Study|Physician Decision|1|||
27861882|NCT02433678|54426441|FG000|Overall Study|Lost to Follow-up|1|||
27861883|NCT02433678|54426442|FG001|Overall Study|Lost to Follow-up|2|||
27861884|NCT02433288|54426455|FG000|Overall Study|Severe non-compliance to protocol|13|||
27861885|NCT02433288|54426456|FG001|Overall Study|Severe non-compliance to protocol|7|||
27861886|NCT02433288|54426455|FG000|Overall Study|Eligibility criteria not fullfilled|7|||
27861887|NCT02433288|54426456|FG001|Overall Study|Eligibility criteria not fullfilled|3|||
27861888|NCT02433288|54426455|FG000|Overall Study|Withdrawal by Subject|101|||
27861889|NCT02433288|54426456|FG001|Overall Study|Withdrawal by Subject|99|||
27861890|NCT02433288|54426455|FG000|Overall Study|Lost to Follow-up|2|||
27861891|NCT02433288|54426456|FG001|Overall Study|Lost to Follow-up|14|||
27861892|NCT02433288|54426455|FG000|Overall Study|Death|0|||
27861893|NCT02433288|54426456|FG001|Overall Study|Death|3|||
27861894|NCT02433210|54426476|FG000|Overall Study|Physician Decision|1|||
27861895|NCT02433210|54426477|FG001|Overall Study|Physician Decision|0|||
27861896|NCT02433210|54426478|FG002|Overall Study|Physician Decision|0|||
27861897|NCT02432040|54426613|FG000|Overall Study|Lack of Efficacy|3|||
27981460|NCT00950807|54639318|FG008|Treatment Period 1|Adverse Event|0|||
27981461|NCT00950807|54639319|FG009|Treatment Period 1|Adverse Event|0|||
27981462|NCT00950807|54639310|FG000|Washout Period 1|Lack of Efficacy|0|||
27981463|NCT00950807|54639311|FG001|Washout Period 1|Lack of Efficacy|0|||
27981464|NCT00950807|54639312|FG002|Washout Period 1|Lack of Efficacy|0|||
27981465|NCT00950807|54639313|FG003|Washout Period 1|Lack of Efficacy|0|||
27981466|NCT00950807|54639314|FG004|Washout Period 1|Lack of Efficacy|0|||
27981467|NCT00950807|54639315|FG005|Washout Period 1|Lack of Efficacy|0|||
27981468|NCT00950807|54639316|FG006|Washout Period 1|Lack of Efficacy|1|||
27981469|NCT00950807|54639317|FG007|Washout Period 1|Lack of Efficacy|0|||
27981470|NCT00950807|54639318|FG008|Washout Period 1|Lack of Efficacy|0|||
27981471|NCT00950807|54639319|FG009|Washout Period 1|Lack of Efficacy|0|||
27981472|NCT00950807|54639310|FG000|Washout Period 1|Withdrawal by Subject|0|||
27981473|NCT00950807|54639311|FG001|Washout Period 1|Withdrawal by Subject|0|||
27981474|NCT00950807|54639312|FG002|Washout Period 1|Withdrawal by Subject|0|||
27981475|NCT00950807|54639313|FG003|Washout Period 1|Withdrawal by Subject|0|||
27981476|NCT00950807|54639314|FG004|Washout Period 1|Withdrawal by Subject|0|||
27981477|NCT00950807|54639315|FG005|Washout Period 1|Withdrawal by Subject|0|||
27981478|NCT00950807|54639316|FG006|Washout Period 1|Withdrawal by Subject|0|||
27981479|NCT00950807|54639317|FG007|Washout Period 1|Withdrawal by Subject|0|||
27981480|NCT00950807|54639318|FG008|Washout Period 1|Withdrawal by Subject|1|||
27981481|NCT00950807|54639319|FG009|Washout Period 1|Withdrawal by Subject|0|||
27981482|NCT00950807|54639310|FG000|Washout Period 1|Protocol-defined Stopping Criteria|3|||
27981483|NCT00950807|54639311|FG001|Washout Period 1|Protocol-defined Stopping Criteria|0|||
27981484|NCT00950807|54639312|FG002|Washout Period 1|Protocol-defined Stopping Criteria|0|||
27981485|NCT00950807|54639313|FG003|Washout Period 1|Protocol-defined Stopping Criteria|0|||
27981486|NCT00950807|54639314|FG004|Washout Period 1|Protocol-defined Stopping Criteria|0|||
27981487|NCT00950807|54639315|FG005|Washout Period 1|Protocol-defined Stopping Criteria|0|||
27981488|NCT00950807|54639316|FG006|Washout Period 1|Protocol-defined Stopping Criteria|1|||
27981489|NCT00950807|54639317|FG007|Washout Period 1|Protocol-defined Stopping Criteria|1|||
27981490|NCT00950807|54639318|FG008|Washout Period 1|Protocol-defined Stopping Criteria|0|||
27981491|NCT00950807|54639319|FG009|Washout Period 1|Protocol-defined Stopping Criteria|0|||
27981492|NCT00950807|54639310|FG000|Washout Period 1|Adverse Event|2|||
27981493|NCT00950807|54639311|FG001|Washout Period 1|Adverse Event|0|||
27981494|NCT00950807|54639312|FG002|Washout Period 1|Adverse Event|0|||
27981495|NCT00950807|54639313|FG003|Washout Period 1|Adverse Event|1|||
27981496|NCT00950807|54639314|FG004|Washout Period 1|Adverse Event|1|||
27834547|NCT02698176|54319205|FG001|Overall Study|Progressive disease|3|||
27834548|NCT02698176|54319206|FG002|Overall Study|Progressive disease|1|||
27834549|NCT02698176|54319207|FG003|Overall Study|Progressive disease|0|||
27834550|NCT02698176|54319204|FG000|Overall Study|Adverse Event|2|||
27834551|NCT02698176|54319205|FG001|Overall Study|Adverse Event|0|||
27834552|NCT02698176|54319206|FG002|Overall Study|Adverse Event|0|||
27834553|NCT02698176|54319207|FG003|Overall Study|Adverse Event|0|||
27834554|NCT02698176|54319204|FG000|Overall Study|Clinical progression|3|||
27834555|NCT02698176|54319205|FG001|Overall Study|Clinical progression|0|||
27834556|NCT02698176|54319206|FG002|Overall Study|Clinical progression|0|||
27834557|NCT02698176|54319207|FG003|Overall Study|Clinical progression|0|||
27834558|NCT02693418|54319223|FG000|Overall Study|Lost to Follow-up|1|||
27861898|NCT02432040|54426614|FG001|Overall Study|Lack of Efficacy|0|||
27861899|NCT02432040|54426613|FG000|Overall Study|Lost to Follow-up|4|||
27861900|NCT02432040|54426614|FG001|Overall Study|Lost to Follow-up|5|||
27861901|NCT02432040|54426613|FG000|Overall Study|Physician Decision|1|||
27861902|NCT02432040|54426614|FG001|Overall Study|Physician Decision|1|||
27981497|NCT00950807|54639315|FG005|Washout Period 1|Adverse Event|0|||
27981498|NCT00950807|54639316|FG006|Washout Period 1|Adverse Event|0|||
27981499|NCT00950807|54639317|FG007|Washout Period 1|Adverse Event|0|||
27981500|NCT00950807|54639318|FG008|Washout Period 1|Adverse Event|0|||
27981501|NCT00950807|54639319|FG009|Washout Period 1|Adverse Event|0|||
27834559|NCT02693418|54319224|FG001|Overall Study|Lost to Follow-up|2|||
27834560|NCT02693418|54319225|FG002|Overall Study|Lost to Follow-up|0|||
27834561|NCT02693418|54319226|FG003|Overall Study|Lost to Follow-up|0|||
27861903|NCT04418076|54426660|FG000|Overall Study|Death|1|||
27861904|NCT04418076|54426661|FG001|Overall Study|Death|0|||
27861905|NCT04418076|54426662|FG002|Overall Study|Death|0|||
27861906|NCT04418076|54426663|FG003|Overall Study|Death|0|||
27861907|NCT04418076|54426660|FG000|Overall Study|Lost to Follow-up|2|||
27861908|NCT04418076|54426661|FG001|Overall Study|Lost to Follow-up|5|||
27861909|NCT04418076|54426662|FG002|Overall Study|Lost to Follow-up|1|||
27861910|NCT04418076|54426663|FG003|Overall Study|Lost to Follow-up|2|||
27861911|NCT04418076|54426660|FG000|Overall Study|Withdrawal by Subject|1|||
27861912|NCT04418076|54426661|FG001|Overall Study|Withdrawal by Subject|0|||
27861913|NCT04418076|54426662|FG002|Overall Study|Withdrawal by Subject|1|||
27861914|NCT04418076|54426663|FG003|Overall Study|Withdrawal by Subject|1|||
27861915|NCT04418076|54426660|FG000|Overall Study|Dropped out after receiving pillbox and phone|2|||
27861916|NCT04418076|54426661|FG001|Overall Study|Dropped out after receiving pillbox and phone|0|||
27861917|NCT04418076|54426662|FG002|Overall Study|Dropped out after receiving pillbox and phone|2|||
27861918|NCT04418076|54426663|FG003|Overall Study|Dropped out after receiving pillbox and phone|3|||
27861919|NCT04165824|54426673|FG000|Overall Study|Adverse Event|23|||
27861920|NCT04165824|54426673|FG000|Overall Study|Physician Decision|1|||
27861921|NCT04165824|54426673|FG000|Overall Study|Withdrawal by Subject|17|||
27861922|NCT04165824|54426673|FG000|Overall Study|Other|5|||
27861923|NCT03809039|54426686|FG000|Part 1|Withdrawal by Subject|1|||
27861924|NCT03809039|54426687|FG001|Part 1|Withdrawal by Subject|0|||
27861925|NCT03809039|54426688|FG002|Part 1|Withdrawal by Subject|0|||
27861926|NCT03809039|54426689|FG003|Part 1|Withdrawal by Subject|1|||
27861927|NCT03809039|54426690|FG004|Part 1|Withdrawal by Subject|0|||
27861928|NCT03809039|54426691|FG005|Part 1|Withdrawal by Subject|0|||
27861929|NCT03809039|54426692|FG006|Part 1|Withdrawal by Subject|0|||
27861930|NCT03809039|54426693|FG007|Part 1|Withdrawal by Subject|0|||
27861931|NCT03809039|54426694|FG008|Part 1|Withdrawal by Subject|0|||
27861932|NCT03809039|54426686|FG000|Part 3|Withdrawn by study termination|0|||
27861933|NCT03809039|54426687|FG001|Part 3|Withdrawn by study termination|0|||
27861934|NCT03809039|54426688|FG002|Part 3|Withdrawn by study termination|0|||
27861935|NCT03809039|54426689|FG003|Part 3|Withdrawn by study termination|0|||
27861936|NCT03809039|54426690|FG004|Part 3|Withdrawn by study termination|0|||
27861937|NCT03809039|54426691|FG005|Part 3|Withdrawn by study termination|0|||
27861938|NCT03809039|54426692|FG006|Part 3|Withdrawn by study termination|0|||
27861939|NCT03809039|54426693|FG007|Part 3|Withdrawn by study termination|2|||
27861940|NCT03809039|54426694|FG008|Part 3|Withdrawn by study termination|6|||
27861941|NCT03541200|54426762|FG000|Overall Study|Adverse Event|19|||
27861942|NCT03541200|54426762|FG000|Overall Study|Death|1|||
27861943|NCT03541200|54426762|FG000|Overall Study|Lost to Follow-up|10|||
27861944|NCT03541200|54426762|FG000|Overall Study|Physician Decision|1|||
27861945|NCT03541200|54426762|FG000|Overall Study|Protocol Violation|51|||
27861946|NCT03541200|54426762|FG000|Overall Study|Withdrawal by Subject|23|||
27861947|NCT03541200|54426762|FG000|Overall Study|other|8|||
27861948|NCT03520036|54426769|FG000|Overall Study|Adverse Event|1|||
27861949|NCT03520036|54426770|FG001|Overall Study|Adverse Event|2|||
27861950|NCT03520036|54426771|FG002|Overall Study|Adverse Event|0|||
27861951|NCT03520036|54426769|FG000|Overall Study|Protocol Violation|1|||
27861952|NCT03520036|54426770|FG001|Overall Study|Protocol Violation|0|||
27861953|NCT03520036|54426771|FG002|Overall Study|Protocol Violation|0|||
27861954|NCT03520036|54426769|FG000|Overall Study|Withdrawal by Subject|0|||
27861955|NCT03520036|54426770|FG001|Overall Study|Withdrawal by Subject|1|||
27861956|NCT03520036|54426771|FG002|Overall Study|Withdrawal by Subject|4|||
27861957|NCT03520036|54426769|FG000|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
27861958|NCT03520036|54426770|FG001|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|1|||
27861959|NCT03520036|54426771|FG002|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
27861960|NCT03505710|54426782|FG000|Overall Study|Progressive Disease|22|||
27861961|NCT03505710|54426783|FG001|Overall Study|Progressive Disease|9|||
27861962|NCT03505710|54426784|FG002|Overall Study|Progressive Disease|34|||
27861963|NCT03505710|54426782|FG000|Overall Study|Clinical Progression|6|||
27861964|NCT03505710|54426783|FG001|Overall Study|Clinical Progression|6|||
27861965|NCT03505710|54426784|FG002|Overall Study|Clinical Progression|3|||
27861966|NCT03505710|54426782|FG000|Overall Study|Adverse Event|12|||
27861967|NCT03505710|54426783|FG001|Overall Study|Adverse Event|5|||
27861968|NCT03505710|54426784|FG002|Overall Study|Adverse Event|27|||
27861969|NCT03505710|54426782|FG000|Overall Study|Withdrawal by Subject|1|||
27861970|NCT03505710|54426783|FG001|Overall Study|Withdrawal by Subject|3|||
27861971|NCT03505710|54426784|FG002|Overall Study|Withdrawal by Subject|3|||
27861972|NCT03505710|54426782|FG000|Overall Study|Physician Decision|1|||
27861973|NCT03505710|54426783|FG001|Overall Study|Physician Decision|0|||
27861974|NCT03505710|54426784|FG002|Overall Study|Physician Decision|2|||
27861975|NCT03505710|54426782|FG000|Overall Study|Death|4|||
27861976|NCT03505710|54426783|FG001|Overall Study|Death|3|||
27861977|NCT03505710|54426784|FG002|Overall Study|Death|6|||
27861978|NCT03505710|54426782|FG000|Overall Study|Other Reasons|1|||
27861979|NCT03505710|54426783|FG001|Overall Study|Other Reasons|1|||
27861980|NCT03505710|54426784|FG002|Overall Study|Other Reasons|1|||
27861981|NCT03459729|54426792|FG000|Overall Study|Physician Decision|2|||
27981502|NCT00950807|54639310|FG000|Treatment Period 2|Lack of Efficacy|1|||
27981503|NCT00950807|54639311|FG001|Treatment Period 2|Lack of Efficacy|0|||
27981504|NCT00950807|54639312|FG002|Treatment Period 2|Lack of Efficacy|0|||
27981505|NCT00950807|54639313|FG003|Treatment Period 2|Lack of Efficacy|0|||
27981506|NCT00950807|54639314|FG004|Treatment Period 2|Lack of Efficacy|0|||
27981507|NCT00950807|54639315|FG005|Treatment Period 2|Lack of Efficacy|0|||
27981508|NCT00950807|54639316|FG006|Treatment Period 2|Lack of Efficacy|0|||
27981509|NCT00950807|54639317|FG007|Treatment Period 2|Lack of Efficacy|0|||
27981510|NCT00950807|54639318|FG008|Treatment Period 2|Lack of Efficacy|0|||
27981511|NCT00950807|54639319|FG009|Treatment Period 2|Lack of Efficacy|0|||
27981512|NCT00950807|54639310|FG000|Treatment Period 2|Withdrawal by Subject|0|||
27861982|NCT03291067|54426800|FG000|Overall Study|Adverse Event|0|||
27861983|NCT03291067|54426801|FG001|Overall Study|Adverse Event|2|||
27861984|NCT03291067|54426802|FG002|Overall Study|Adverse Event|17|||
27861985|NCT03291067|54426803|FG003|Overall Study|Adverse Event|3|||
27861986|NCT03291067|54426800|FG000|Overall Study|Lost to Follow-up|2|||
27861987|NCT03291067|54426801|FG001|Overall Study|Lost to Follow-up|1|||
27861988|NCT03291067|54426802|FG002|Overall Study|Lost to Follow-up|0|||
27861989|NCT03291067|54426803|FG003|Overall Study|Lost to Follow-up|1|||
27861990|NCT03291067|54426800|FG000|Overall Study|Physician Decision|0|||
27861991|NCT03291067|54426801|FG001|Overall Study|Physician Decision|0|||
27861992|NCT03291067|54426802|FG002|Overall Study|Physician Decision|1|||
27861993|NCT03291067|54426803|FG003|Overall Study|Physician Decision|0|||
27861994|NCT03291067|54426800|FG000|Overall Study|Protocol Violation|5|||
27861995|NCT03291067|54426801|FG001|Overall Study|Protocol Violation|3|||
27861996|NCT03291067|54426802|FG002|Overall Study|Protocol Violation|4|||
27861997|NCT03291067|54426803|FG003|Overall Study|Protocol Violation|2|||
27861998|NCT03291067|54426800|FG000|Overall Study|Withdrawal by Subject|3|||
27861999|NCT03291067|54426801|FG001|Overall Study|Withdrawal by Subject|4|||
27862000|NCT03291067|54426802|FG002|Overall Study|Withdrawal by Subject|7|||
27862001|NCT03291067|54426803|FG003|Overall Study|Withdrawal by Subject|5|||
27862002|NCT03291067|54426800|FG000|Overall Study|Other|0|||
27862003|NCT03291067|54426801|FG001|Overall Study|Other|4|||
27862004|NCT03291067|54426802|FG002|Overall Study|Other|4|||
27862005|NCT03291067|54426803|FG003|Overall Study|Other|6|||
27862006|NCT03035409|54426813|FG000|Overall Study|Adverse Event|5|||
27862007|NCT03035409|54426813|FG000|Overall Study|Death|2|||
27862008|NCT03035409|54426813|FG000|Overall Study|Withdrawal by Subject|2|||
27862009|NCT03035409|54426813|FG000|Overall Study|Non compliance|4|||
27862010|NCT03035409|54426813|FG000|Overall Study|Patient was jittery|1|||
27862011|NCT03035409|54426813|FG000|Overall Study|Did not like Questionnaire|1|||
27862012|NCT03035409|54426813|FG000|Overall Study|Aspartate Aminotransferase increased|1|||
27862013|NCT03035409|54426813|FG000|Overall Study|Did not like taking drugs|1|||
27862014|NCT02847598|54426825|FG000|Overall Study|Adverse Event|0|||
27862015|NCT02847598|54426826|FG001|Overall Study|Adverse Event|0|||
27862016|NCT02847598|54426827|FG002|Overall Study|Adverse Event|0|||
27862017|NCT02847598|54426828|FG003|Overall Study|Adverse Event|0|||
27862018|NCT02847598|54426829|FG004|Overall Study|Adverse Event|0|||
27862019|NCT02847598|54426830|FG005|Overall Study|Adverse Event|0|||
27862020|NCT02847598|54426831|FG006|Overall Study|Adverse Event|0|||
27862021|NCT02847598|54426832|FG007|Overall Study|Adverse Event|1|||
27862022|NCT02847598|54426825|FG000|Overall Study|Consent withdrawn|2|||
27862023|NCT02847598|54426826|FG001|Overall Study|Consent withdrawn|0|||
27862024|NCT02847598|54426827|FG002|Overall Study|Consent withdrawn|0|||
27862025|NCT02847598|54426828|FG003|Overall Study|Consent withdrawn|4|||
27862026|NCT02847598|54426829|FG004|Overall Study|Consent withdrawn|3|||
27862027|NCT02847598|54426830|FG005|Overall Study|Consent withdrawn|2|||
27862028|NCT02847598|54426831|FG006|Overall Study|Consent withdrawn|1|||
27862029|NCT02847598|54426832|FG007|Overall Study|Consent withdrawn|3|||
27862030|NCT02847598|54426825|FG000|Overall Study|Death|3|||
27862031|NCT02847598|54426826|FG001|Overall Study|Death|0|||
27862032|NCT02847598|54426827|FG002|Overall Study|Death|0|||
27862033|NCT02847598|54426828|FG003|Overall Study|Death|0|||
27862034|NCT02847598|54426829|FG004|Overall Study|Death|0|||
27981513|NCT00950807|54639311|FG001|Treatment Period 2|Withdrawal by Subject|0|||
27981514|NCT00950807|54639312|FG002|Treatment Period 2|Withdrawal by Subject|0|||
27981515|NCT00950807|54639313|FG003|Treatment Period 2|Withdrawal by Subject|0|||
27862035|NCT02847598|54426830|FG005|Overall Study|Death|0|||
27862036|NCT02847598|54426831|FG006|Overall Study|Death|0|||
27862037|NCT02847598|54426832|FG007|Overall Study|Death|0|||
27862038|NCT02847598|54426825|FG000|Overall Study|Lost to Follow-up|0|||
27862039|NCT02847598|54426826|FG001|Overall Study|Lost to Follow-up|0|||
27862040|NCT02847598|54426827|FG002|Overall Study|Lost to Follow-up|0|||
27862041|NCT02847598|54426828|FG003|Overall Study|Lost to Follow-up|0|||
27862042|NCT02847598|54426829|FG004|Overall Study|Lost to Follow-up|0|||
27862043|NCT02847598|54426830|FG005|Overall Study|Lost to Follow-up|1|||
27862044|NCT02847598|54426831|FG006|Overall Study|Lost to Follow-up|1|||
27862045|NCT02847598|54426832|FG007|Overall Study|Lost to Follow-up|0|||
27862046|NCT02841280|54426858|FG000|Overall Study|Adverse Event|2|||
27862047|NCT02841280|54426859|FG001|Overall Study|Adverse Event|1|||
27862048|NCT02841280|54426858|FG000|Overall Study|Death|1|||
27862049|NCT02841280|54426859|FG001|Overall Study|Death|0|||
27862050|NCT02841280|54426858|FG000|Overall Study|Lost to Follow-up|2|||
27862051|NCT02841280|54426859|FG001|Overall Study|Lost to Follow-up|2|||
27862052|NCT02841280|54426858|FG000|Overall Study|Withdrawal by Subject|7|||
27862053|NCT02841280|54426859|FG001|Overall Study|Withdrawal by Subject|3|||
27862054|NCT02841280|54426858|FG000|Overall Study|Stop Point: BP above threshold|2|||
27862055|NCT02841280|54426859|FG001|Overall Study|Stop Point: BP above threshold|0|||
27862056|NCT02576574|54426872|FG000|Overall Study|still ongoing|65|||
27862057|NCT02576574|54426873|FG001|Overall Study|still ongoing|66|||
27862058|NCT02576574|54426874|FG002|Overall Study|still ongoing|73|||
27862059|NCT02576574|54426872|FG000|Overall Study|Randomized, not treated|5|||
27862060|NCT02576574|54426873|FG001|Overall Study|Randomized, not treated|4|||
27862061|NCT02576574|54426874|FG002|Overall Study|Randomized, not treated|26|||
27862062|NCT02550652|54426886|FG000|Overall Study|Death|1|||
27862063|NCT02550652|54426887|FG001|Overall Study|Death|4|||
27862064|NCT02550652|54426886|FG000|Overall Study|Lack of Efficacy|1|||
27862065|NCT02550652|54426887|FG001|Overall Study|Lack of Efficacy|0|||
27862066|NCT02550652|54426886|FG000|Overall Study|Withdrawal by Subject|3|||
27862067|NCT02550652|54426887|FG001|Overall Study|Withdrawal by Subject|7|||
27862068|NCT02550652|54426886|FG000|Overall Study|Post Trial Access|1|||
27862069|NCT02550652|54426887|FG001|Overall Study|Post Trial Access|0|||
27862070|NCT02550652|54426886|FG000|Overall Study|Lost to Follow-up|1|||
27862071|NCT02550652|54426887|FG001|Overall Study|Lost to Follow-up|3|||
27862072|NCT02550652|54426886|FG000|Overall Study|Physician Decision|0|||
27862073|NCT02550652|54426887|FG001|Overall Study|Physician Decision|2|||
27862074|NCT02550652|54426886|FG000|Overall Study|Ongoing in safety/B-cell follow-up period|14|||
27862075|NCT02550652|54426887|FG001|Overall Study|Ongoing in safety/B-cell follow-up period|5|||
27862076|NCT02345330|54426897|FG000|Overall Study|Death|1|||
27862077|NCT02345330|54426897|FG000|Overall Study|Progressive Disease|2|||
27862078|NCT01513343|54426912|FG000|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|8|||
27862079|NCT01513343|54426913|FG001|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|0|||
27862080|NCT01513343|54426912|FG000|Post Data Collection|Dropped/withdrew from study|7|||
27862081|NCT01513343|54426913|FG001|Post Data Collection|Dropped/withdrew from study|1|||
27862082|NCT01513343|54426912|FG000|Post Data Collection|Lost to Follow-up|10|||
27862083|NCT01513343|54426913|FG001|Post Data Collection|Lost to Follow-up|23|||
27862084|NCT01513343|54426912|FG000|6-month Follow-up|Lost to Follow-up|28|||
27862085|NCT01513343|54426913|FG001|6-month Follow-up|Lost to Follow-up|17|||
27862086|NCT01513343|54426912|FG000|12-month Follow-up|Lost to Follow-up|10|||
27862087|NCT01513343|54426913|FG001|12-month Follow-up|Lost to Follow-up|3|||
27862088|NCT01440816|54426940|FG000|Overall Study|Disease Progression|0|||
27862089|NCT01440816|54426941|FG001|Overall Study|Disease Progression|9|||
27862090|NCT01440816|54426940|FG000|Overall Study|To Be Seen By Local Oncologist|1|||
27862091|NCT01440816|54426941|FG001|Overall Study|To Be Seen By Local Oncologist|2|||
27862092|NCT01348919|54426952|FG000|Overall Study|Adverse Event|3|||
27862093|NCT01348919|54426953|FG001|Overall Study|Adverse Event|1|||
27862094|NCT01348919|54426954|FG002|Overall Study|Adverse Event|0|||
27862095|NCT01348919|54426952|FG000|Overall Study|Withdrawal by Subject|0|||
27862096|NCT01348919|54426953|FG001|Overall Study|Withdrawal by Subject|1|||
27862097|NCT01348919|54426954|FG002|Overall Study|Withdrawal by Subject|0|||
27862098|NCT01348919|54426952|FG000|Overall Study|Disease progression|0|||
27862099|NCT01348919|54426953|FG001|Overall Study|Disease progression|1|||
27862100|NCT01348919|54426954|FG002|Overall Study|Disease progression|1|||
27862101|NCT00966381|54426966|FG000|Overall Study|Withdrawal by Subject|2|||
27862102|NCT00966381|54426967|FG001|Overall Study|Withdrawal by Subject|2|||
27862103|NCT02431806|54426979|FG000|Double-blind Treatment Period|Did not Receive Treatment|1|||
27862104|NCT02431806|54426980|FG001|Double-blind Treatment Period|Did not Receive Treatment|2|||
27862105|NCT02431806|54426981|FG002|Double-blind Treatment Period|Did not Receive Treatment|1|||
27862106|NCT02431806|54426982|FG003|Double-blind Treatment Period|Did not Receive Treatment|1|||
27862107|NCT02431806|54426979|FG000|Double-blind Treatment Period|Adverse Event|4|||
27862108|NCT02431806|54426980|FG001|Double-blind Treatment Period|Adverse Event|7|||
27862109|NCT02431806|54426981|FG002|Double-blind Treatment Period|Adverse Event|11|||
27862110|NCT02431806|54426982|FG003|Double-blind Treatment Period|Adverse Event|7|||
27862111|NCT02431806|54426979|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
27862112|NCT02431806|54426980|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
27862113|NCT02431806|54426981|FG002|Double-blind Treatment Period|Lack of Efficacy|2|||
27862114|NCT02431806|54426982|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
27862115|NCT02431806|54426979|FG000|Double-blind Treatment Period|Withdrawal of Consent|10|||
27862116|NCT02431806|54426980|FG001|Double-blind Treatment Period|Withdrawal of Consent|7|||
27862117|NCT02431806|54426981|FG002|Double-blind Treatment Period|Withdrawal of Consent|5|||
27862118|NCT02431806|54426982|FG003|Double-blind Treatment Period|Withdrawal of Consent|5|||
27862119|NCT02431806|54426979|FG000|Double-blind Treatment Period|Lost to Follow-up|7|||
27862120|NCT02431806|54426980|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
27862121|NCT02431806|54426981|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
27862122|NCT02431806|54426982|FG003|Double-blind Treatment Period|Lost to Follow-up|8|||
27862123|NCT02431806|54426979|FG000|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
27862124|NCT02431806|54426980|FG001|Double-blind Treatment Period|Investigational Product Non-compliance|0|||
27862125|NCT02431806|54426981|FG002|Double-blind Treatment Period|Investigational Product Non-compliance|3|||
27862126|NCT02431806|54426982|FG003|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
27862127|NCT02431806|54426979|FG000|Double-blind Treatment Period|Reason Not Specified|0|||
27862128|NCT02431806|54426980|FG001|Double-blind Treatment Period|Reason Not Specified|1|||
27862129|NCT02431806|54426981|FG002|Double-blind Treatment Period|Reason Not Specified|5|||
27862130|NCT02431806|54426982|FG003|Double-blind Treatment Period|Reason Not Specified|2|||
27862131|NCT01650246|54427023|FG000|Overall Study|Adverse Event|23|||
27862132|NCT01650246|54427023|FG000|Overall Study|Protocol Violation|5|||
27862133|NCT01650246|54427023|FG000|Overall Study|Sponsor terminated study|53|||
27862134|NCT01650246|54427023|FG000|Overall Study|Lost to Follow-up|5|||
27862135|NCT01650246|54427023|FG000|Overall Study|Withdrawal by Subject|26|||
27862136|NCT01650246|54427023|FG000|Overall Study|Death|1|||
27862137|NCT01650246|54427023|FG000|Overall Study|Lack of Efficacy|30|||
27862138|NCT01652664|54427042|FG000|Overall Study|Treatment Failure|5|||
27862139|NCT01652664|54427043|FG001|Overall Study|Treatment Failure|1|||
27862140|NCT01652664|54427042|FG000|Overall Study|Inadequate IOP control|1|||
27862141|NCT01652664|54427043|FG001|Overall Study|Inadequate IOP control|0|||
27862142|NCT02379390|54427083|FG000|Overall Study|Adverse Event|1|||
27862143|NCT02379390|54427084|FG001|Overall Study|Adverse Event|1|||
27862144|NCT02379390|54427083|FG000|Overall Study|Investigator's decision|1|||
27862145|NCT02379390|54427084|FG001|Overall Study|Investigator's decision|0|||
27862146|NCT02379390|54427083|FG000|Overall Study|Study Termination|0|||
27862147|NCT02379390|54427084|FG001|Overall Study|Study Termination|1|||
27981516|NCT00950807|54639314|FG004|Treatment Period 2|Withdrawal by Subject|0|||
27981517|NCT00950807|54639315|FG005|Treatment Period 2|Withdrawal by Subject|0|||
27981518|NCT00950807|54639316|FG006|Treatment Period 2|Withdrawal by Subject|1|||
27981519|NCT00950807|54639317|FG007|Treatment Period 2|Withdrawal by Subject|2|||
27981520|NCT00950807|54639318|FG008|Treatment Period 2|Withdrawal by Subject|0|||
27981521|NCT00950807|54639319|FG009|Treatment Period 2|Withdrawal by Subject|0|||
27981522|NCT00950807|54639310|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
27981523|NCT00950807|54639311|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
27981524|NCT00950807|54639312|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
27981525|NCT00950807|54639313|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
27981526|NCT00950807|54639314|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
27981527|NCT00950807|54639315|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
27981528|NCT00950807|54639316|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
27981529|NCT00950807|54639317|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
27981530|NCT00950807|54639318|FG008|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
27981531|NCT00950807|54639319|FG009|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
27981532|NCT00950807|54639310|FG000|Treatment Period 2|Adverse Event|0|||
27981533|NCT00950807|54639311|FG001|Treatment Period 2|Adverse Event|1|||
27981534|NCT00950807|54639312|FG002|Treatment Period 2|Adverse Event|0|||
27981535|NCT00950807|54639313|FG003|Treatment Period 2|Adverse Event|1|||
27981536|NCT00950807|54639314|FG004|Treatment Period 2|Adverse Event|0|||
27981537|NCT00950807|54639315|FG005|Treatment Period 2|Adverse Event|1|||
27981538|NCT00950807|54639316|FG006|Treatment Period 2|Adverse Event|0|||
27981539|NCT00950807|54639317|FG007|Treatment Period 2|Adverse Event|1|||
27981540|NCT00950807|54639318|FG008|Treatment Period 2|Adverse Event|0|||
27981541|NCT00950807|54639319|FG009|Treatment Period 2|Adverse Event|0|||
27981542|NCT00950807|54639310|FG000|Washout Period 2|Lack of Efficacy|1|||
27981543|NCT00950807|54639311|FG001|Washout Period 2|Lack of Efficacy|0|||
27981544|NCT00950807|54639312|FG002|Washout Period 2|Lack of Efficacy|0|||
27981545|NCT00950807|54639313|FG003|Washout Period 2|Lack of Efficacy|0|||
27981546|NCT00950807|54639314|FG004|Washout Period 2|Lack of Efficacy|0|||
27981547|NCT00950807|54639315|FG005|Washout Period 2|Lack of Efficacy|0|||
27981548|NCT00950807|54639316|FG006|Washout Period 2|Lack of Efficacy|0|||
27738907|NCT02243176|54188212|FG001|Overall Study|Adverse Event|2|||
27834562|NCT02693418|54319227|FG004|Overall Study|Lost to Follow-up|0|||
27834563|NCT02693418|54319223|FG000|Overall Study|Menses during study period|0|||
27834564|NCT02693418|54319224|FG001|Overall Study|Menses during study period|0|||
27834565|NCT02693418|54319225|FG002|Overall Study|Menses during study period|2|||
27834566|NCT02693418|54319226|FG003|Overall Study|Menses during study period|0|||
27834567|NCT02693418|54319227|FG004|Overall Study|Menses during study period|0|||
27834568|NCT02693106|54319260|FG000|Overall Study|No time|3|||
27834569|NCT02546986|54319272|FG000|Treatment Period|Progressive Disease|20|||
27834570|NCT02546986|54319273|FG001|Treatment Period|Progressive Disease|22|||
27862148|NCT02379078|54427095|FG000|Overall Study|Lost to Follow-up|33|||
27834571|NCT02546986|54319272|FG000|Treatment Period|Adverse Event|14|||
27834572|NCT02546986|54319273|FG001|Treatment Period|Adverse Event|6|||
27862149|NCT02379078|54427096|FG001|Overall Study|Lost to Follow-up|30|||
27862150|NCT02379078|54427095|FG000|Overall Study|Withdrawal by Subject|6|||
27862151|NCT02379078|54427096|FG001|Overall Study|Withdrawal by Subject|5|||
27862152|NCT01714739|54427189|FG000|Overall Study|Disease progression|3|||
27862153|NCT01714739|54427190|FG001|Overall Study|Disease progression|5|||
27862154|NCT01714739|54427191|FG002|Overall Study|Disease progression|5|||
27862155|NCT01714739|54427192|FG003|Overall Study|Disease progression|204|||
27862156|NCT01714739|54427193|FG004|Overall Study|Disease progression|1|||
27862157|NCT01714739|54427194|FG005|Overall Study|Disease progression|3|||
27862158|NCT01714739|54427195|FG006|Overall Study|Disease progression|5|||
27862159|NCT01714739|54427189|FG000|Overall Study|Study drug toxicity|1|||
27862160|NCT01714739|54427190|FG001|Overall Study|Study drug toxicity|1|||
27862161|NCT01714739|54427191|FG002|Overall Study|Study drug toxicity|1|||
27862162|NCT01714739|54427192|FG003|Overall Study|Study drug toxicity|15|||
27862163|NCT01714739|54427193|FG004|Overall Study|Study drug toxicity|0|||
27862164|NCT01714739|54427194|FG005|Overall Study|Study drug toxicity|0|||
27981549|NCT00950807|54639317|FG007|Washout Period 2|Lack of Efficacy|0|||
27981550|NCT00950807|54639318|FG008|Washout Period 2|Lack of Efficacy|0|||
27981551|NCT00950807|54639319|FG009|Washout Period 2|Lack of Efficacy|0|||
27981552|NCT00950807|54639310|FG000|Washout Period 2|Protocol-defined Stopping Criteria|0|||
27981553|NCT00950807|54639311|FG001|Washout Period 2|Protocol-defined Stopping Criteria|1|||
27981554|NCT00950807|54639312|FG002|Washout Period 2|Protocol-defined Stopping Criteria|0|||
27981555|NCT00950807|54639313|FG003|Washout Period 2|Protocol-defined Stopping Criteria|0|||
27981556|NCT00950807|54639314|FG004|Washout Period 2|Protocol-defined Stopping Criteria|1|||
27981557|NCT00950807|54639315|FG005|Washout Period 2|Protocol-defined Stopping Criteria|0|||
27981558|NCT00950807|54639316|FG006|Washout Period 2|Protocol-defined Stopping Criteria|1|||
27981559|NCT00950807|54639317|FG007|Washout Period 2|Protocol-defined Stopping Criteria|1|||
27981560|NCT00950807|54639318|FG008|Washout Period 2|Protocol-defined Stopping Criteria|0|||
27981561|NCT00950807|54639319|FG009|Washout Period 2|Protocol-defined Stopping Criteria|0|||
27981562|NCT00950807|54639310|FG000|Washout Period 2|Adverse Event|3|||
27981563|NCT00950807|54639311|FG001|Washout Period 2|Adverse Event|0|||
27981564|NCT00950807|54639312|FG002|Washout Period 2|Adverse Event|0|||
27981565|NCT00950807|54639313|FG003|Washout Period 2|Adverse Event|1|||
27981566|NCT00950807|54639314|FG004|Washout Period 2|Adverse Event|0|||
27981567|NCT00950807|54639315|FG005|Washout Period 2|Adverse Event|0|||
27981568|NCT00950807|54639316|FG006|Washout Period 2|Adverse Event|0|||
27981569|NCT00950807|54639317|FG007|Washout Period 2|Adverse Event|0|||
27981570|NCT00950807|54639318|FG008|Washout Period 2|Adverse Event|0|||
27981571|NCT00950807|54639319|FG009|Washout Period 2|Adverse Event|0|||
27981572|NCT00950807|54639310|FG000|Treatment Period 3|Withdrawal by Subject|0|||
27981573|NCT00950807|54639311|FG001|Treatment Period 3|Withdrawal by Subject|0|||
27981574|NCT00950807|54639312|FG002|Treatment Period 3|Withdrawal by Subject|0|||
27981575|NCT00950807|54639313|FG003|Treatment Period 3|Withdrawal by Subject|0|||
27981576|NCT00950807|54639314|FG004|Treatment Period 3|Withdrawal by Subject|0|||
27981577|NCT00950807|54639315|FG005|Treatment Period 3|Withdrawal by Subject|0|||
27981578|NCT00950807|54639316|FG006|Treatment Period 3|Withdrawal by Subject|0|||
27981579|NCT00950807|54639317|FG007|Treatment Period 3|Withdrawal by Subject|0|||
27981580|NCT00950807|54639318|FG008|Treatment Period 3|Withdrawal by Subject|0|||
27981581|NCT00950807|54639319|FG009|Treatment Period 3|Withdrawal by Subject|1|||
27981582|NCT00950807|54639310|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
27981583|NCT00950807|54639311|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
27981584|NCT00950807|54639312|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
27981585|NCT00950807|54639313|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
27981586|NCT00950807|54639314|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
27981587|NCT00950807|54639315|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
27981588|NCT00950807|54639316|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
27981589|NCT00950807|54639317|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
28096051|NCT04432376|54750687|FG000|Double-blind Treatment Period|Protocol Violation|0|||
28096052|NCT04432376|54750688|FG001|Double-blind Treatment Period|Protocol Violation|1|||
28096053|NCT04432376|54750689|FG002|Double-blind Treatment Period|Protocol Violation|0|||
28096054|NCT04432376|54750687|FG000|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
28096055|NCT04432376|54750688|FG001|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|1|||
28096056|NCT04432376|54750689|FG002|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
28096057|NCT03693404|54750698|FG000|Overall Study|Withdrawal by Subject|1|||
28096058|NCT03693404|54750699|FG001|Overall Study|Withdrawal by Subject|0|||
27738908|NCT00002663|54188223|FG000|Overall Study|Death|4|||
27738909|NCT00002663|54188224|FG001|Overall Study|Death|1|||
27738910|NCT00002663|54188225|FG002|Overall Study|Death|1|||
27862165|NCT01714739|54427195|FG006|Overall Study|Study drug toxicity|5|||
27862166|NCT01714739|54427189|FG000|Overall Study|Death|0|||
27862167|NCT01714739|54427190|FG001|Overall Study|Death|0|||
27862168|NCT01714739|54427191|FG002|Overall Study|Death|0|||
27981590|NCT00950807|54639318|FG008|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
27981591|NCT00950807|54639319|FG009|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
28096059|NCT03693404|54750698|FG000|Overall Study|Lost to Follow-up|0|||
28096060|NCT03693404|54750699|FG001|Overall Study|Lost to Follow-up|5|||
28096061|NCT03693404|54750698|FG000|Overall Study|Excluded from Analysis|0|||
28096062|NCT03693404|54750699|FG001|Overall Study|Excluded from Analysis|1|||
28096063|NCT03696108|54750707|FG000|Overall Study|Physician Decision|1|||
28096064|NCT03696108|54750708|FG001|Overall Study|Physician Decision|0|||
27738911|NCT00002663|54188226|FG003|Overall Study|Death|0|||
27738912|NCT00002663|54188227|FG004|Overall Study|Death|0|||
27862169|NCT01714739|54427192|FG003|Overall Study|Death|1|||
27862170|NCT01714739|54427193|FG004|Overall Study|Death|0|||
27862171|NCT01714739|54427194|FG005|Overall Study|Death|0|||
27862172|NCT01714739|54427195|FG006|Overall Study|Death|0|||
27862173|NCT01714739|54427189|FG000|Overall Study|Adverse Event unrelated to drug|0|||
27862174|NCT01714739|54427190|FG001|Overall Study|Adverse Event unrelated to drug|0|||
27862175|NCT01714739|54427191|FG002|Overall Study|Adverse Event unrelated to drug|3|||
27862176|NCT01714739|54427192|FG003|Overall Study|Adverse Event unrelated to drug|21|||
27862177|NCT01714739|54427193|FG004|Overall Study|Adverse Event unrelated to drug|0|||
27862178|NCT01714739|54427194|FG005|Overall Study|Adverse Event unrelated to drug|0|||
27862179|NCT01714739|54427195|FG006|Overall Study|Adverse Event unrelated to drug|0|||
27862180|NCT01714739|54427189|FG000|Overall Study|Participant request to stop therapy|0|||
27862181|NCT01714739|54427190|FG001|Overall Study|Participant request to stop therapy|1|||
27862182|NCT01714739|54427191|FG002|Overall Study|Participant request to stop therapy|0|||
27862183|NCT01714739|54427192|FG003|Overall Study|Participant request to stop therapy|6|||
27862184|NCT01714739|54427193|FG004|Overall Study|Participant request to stop therapy|0|||
27862185|NCT01714739|54427194|FG005|Overall Study|Participant request to stop therapy|0|||
27862186|NCT01714739|54427195|FG006|Overall Study|Participant request to stop therapy|0|||
27862187|NCT01714739|54427189|FG000|Overall Study|Participant withdrew consent|0|||
27862188|NCT01714739|54427190|FG001|Overall Study|Participant withdrew consent|1|||
27862189|NCT01714739|54427191|FG002|Overall Study|Participant withdrew consent|0|||
27862190|NCT01714739|54427192|FG003|Overall Study|Participant withdrew consent|8|||
27862191|NCT01714739|54427193|FG004|Overall Study|Participant withdrew consent|0|||
27862192|NCT01714739|54427194|FG005|Overall Study|Participant withdrew consent|0|||
27862193|NCT01714739|54427195|FG006|Overall Study|Participant withdrew consent|0|||
27862194|NCT01714739|54427189|FG000|Overall Study|Lost to Follow-up|0|||
27862195|NCT01714739|54427190|FG001|Overall Study|Lost to Follow-up|0|||
27862196|NCT01714739|54427191|FG002|Overall Study|Lost to Follow-up|0|||
27862197|NCT01714739|54427192|FG003|Overall Study|Lost to Follow-up|1|||
27862198|NCT01714739|54427193|FG004|Overall Study|Lost to Follow-up|0|||
27862199|NCT01714739|54427194|FG005|Overall Study|Lost to Follow-up|0|||
27862200|NCT01714739|54427195|FG006|Overall Study|Lost to Follow-up|0|||
28096065|NCT03696108|54750707|FG000|Overall Study|Withdrawal by Subject|3|||
28096066|NCT03696108|54750708|FG001|Overall Study|Withdrawal by Subject|6|||
28096067|NCT04218110|54750718|FG000|Overall Study|Withdrawal by Subject|0|||
27738913|NCT00002663|54188228|FG005|Overall Study|Death|13|||
27738914|NCT00002663|54188229|FG006|Overall Study|Death|0|||
27738915|NCT00002663|54188230|FG007|Overall Study|Death|1|||
27738916|NCT00002663|54188231|FG008|Overall Study|Death|1|||
27834573|NCT02546986|54319272|FG000|Treatment Period|Symptomatic Deterioration|4|||
27834574|NCT02546986|54319273|FG001|Treatment Period|Symptomatic Deterioration|3|||
27834575|NCT02546986|54319272|FG000|Treatment Period|Death|3|||
27834576|NCT02546986|54319273|FG001|Treatment Period|Death|4|||
27834577|NCT02546986|54319272|FG000|Treatment Period|Physician Decision|1|||
27834578|NCT02546986|54319273|FG001|Treatment Period|Physician Decision|2|||
27834579|NCT02546986|54319272|FG000|Treatment Period|Protocol Violation|1|||
27834580|NCT02546986|54319273|FG001|Treatment Period|Protocol Violation|0|||
27834581|NCT02546986|54319272|FG000|Treatment Period|Withdrawal by Subject|1|||
27834582|NCT02546986|54319273|FG001|Treatment Period|Withdrawal by Subject|1|||
27834583|NCT02546986|54319272|FG000|Treatment Period|Non-compliance with Study Drug|0|||
27834584|NCT02546986|54319273|FG001|Treatment Period|Non-compliance with Study Drug|1|||
27834585|NCT02546986|54319272|FG000|Treatment Period|Study Terminated by Sponsor|0|||
27834586|NCT02546986|54319273|FG001|Treatment Period|Study Terminated by Sponsor|1|||
27834587|NCT02546986|54319272|FG000|Treatment Period|Miscellaneous|7|||
27834588|NCT02546986|54319273|FG001|Treatment Period|Miscellaneous|9|||
27834589|NCT02546986|54319272|FG000|Survival Follow-Up Phase|Missing Status|3|||
27834590|NCT02546986|54319273|FG001|Survival Follow-Up Phase|Missing Status|5|||
27834591|NCT02546986|54319272|FG000|Survival Follow-Up Phase|Death|18|||
27834592|NCT02546986|54319273|FG001|Survival Follow-Up Phase|Death|12|||
27834593|NCT02546986|54319272|FG000|Survival Follow-Up Phase|Alive|13|||
27834594|NCT02546986|54319273|FG001|Survival Follow-Up Phase|Alive|16|||
27834595|NCT02546986|54319272|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
27738917|NCT00002663|54188232|FG009|Overall Study|Death|1|||
27834596|NCT02546986|54319273|FG001|Survival Follow-Up Phase|Lost to Follow-up|2|||
27834597|NCT02689206|54319284|FG000|Overall Study|Adverse Event|0|||
27834598|NCT02689206|54319285|FG001|Overall Study|Adverse Event|0|||
27834599|NCT02689206|54319286|FG002|Overall Study|Adverse Event|1|||
27834600|NCT02689206|54319287|FG003|Overall Study|Adverse Event|0|||
27862201|NCT01714739|54427189|FG000|Overall Study|Maximum clinical benefit|0|||
27862202|NCT01714739|54427190|FG001|Overall Study|Maximum clinical benefit|1|||
27862203|NCT01714739|54427191|FG002|Overall Study|Maximum clinical benefit|1|||
27862204|NCT01714739|54427192|FG003|Overall Study|Maximum clinical benefit|3|||
27862205|NCT01714739|54427193|FG004|Overall Study|Maximum clinical benefit|0|||
27862206|NCT01714739|54427194|FG005|Overall Study|Maximum clinical benefit|0|||
27862207|NCT01714739|54427195|FG006|Overall Study|Maximum clinical benefit|0|||
27862208|NCT01714739|54427189|FG000|Overall Study|Poor/non-comliance|0|||
27862209|NCT01714739|54427190|FG001|Overall Study|Poor/non-comliance|1|||
27862210|NCT01714739|54427191|FG002|Overall Study|Poor/non-comliance|0|||
27862211|NCT01714739|54427192|FG003|Overall Study|Poor/non-comliance|1|||
27862212|NCT01714739|54427193|FG004|Overall Study|Poor/non-comliance|0|||
27862213|NCT01714739|54427194|FG005|Overall Study|Poor/non-comliance|0|||
27862214|NCT01714739|54427195|FG006|Overall Study|Poor/non-comliance|0|||
27862215|NCT01714739|54427189|FG000|Overall Study|No longer meets study criteria|0|||
27862216|NCT01714739|54427190|FG001|Overall Study|No longer meets study criteria|0|||
27862217|NCT01714739|54427191|FG002|Overall Study|No longer meets study criteria|0|||
27862218|NCT01714739|54427192|FG003|Overall Study|No longer meets study criteria|1|||
27862219|NCT01714739|54427193|FG004|Overall Study|No longer meets study criteria|0|||
27862220|NCT01714739|54427194|FG005|Overall Study|No longer meets study criteria|0|||
27862221|NCT01714739|54427195|FG006|Overall Study|No longer meets study criteria|0|||
27862222|NCT01714739|54427189|FG000|Overall Study|Other reason|0|||
27862223|NCT01714739|54427190|FG001|Overall Study|Other reason|0|||
27862224|NCT01714739|54427191|FG002|Overall Study|Other reason|0|||
27862225|NCT01714739|54427192|FG003|Overall Study|Other reason|3|||
27862226|NCT01714739|54427193|FG004|Overall Study|Other reason|1|||
27862227|NCT01714739|54427194|FG005|Overall Study|Other reason|0|||
27862228|NCT01714739|54427195|FG006|Overall Study|Other reason|0|||
27862229|NCT00609791|54427263|FG000|Overall Study|Subject was deemed ineligible after starting study procedures|1|||
27862230|NCT03823287|54429199|FG000|Overall Study|Withdrawal by Subject|25|||
27862231|NCT03823287|54429200|FG001|Overall Study|Withdrawal by Subject|17|||
27862232|NCT03823287|54429199|FG000|Overall Study|Death|13|||
27862233|NCT03823287|54429200|FG001|Overall Study|Death|7|||
27862234|NCT03823287|54429199|FG000|Overall Study|Lost to Follow-up|7|||
27862235|NCT03823287|54429200|FG001|Overall Study|Lost to Follow-up|8|||
27862236|NCT03823287|54429199|FG000|Overall Study|Adverse Event|6|||
27862237|NCT03823287|54429200|FG001|Overall Study|Adverse Event|8|||
27862238|NCT03823287|54429199|FG000|Overall Study|Physician Decision|5|||
27862239|NCT03823287|54429200|FG001|Overall Study|Physician Decision|2|||
27862240|NCT03823287|54429199|FG000|Overall Study|Lack of Efficacy|2|||
27862241|NCT03823287|54429200|FG001|Overall Study|Lack of Efficacy|0|||
27862242|NCT03823287|54429199|FG000|Overall Study|Other|2|||
27862243|NCT03823287|54429200|FG001|Overall Study|Other|4|||
27862244|NCT03707925|54429361|FG000|Overall Study|Inevaluable|1|||
27862245|NCT03461757|54429421|FG000|Overall Study|Adverse Event|1|||
27862246|NCT03461757|54429422|FG001|Overall Study|Adverse Event|0|||
27862247|NCT03461757|54429421|FG000|Overall Study|Lost to Follow-up|13|||
27862248|NCT03461757|54429422|FG001|Overall Study|Lost to Follow-up|7|||
27862249|NCT03461757|54429421|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|28|||
27862250|NCT03461757|54429422|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|25|||
27862251|NCT03461757|54429421|FG000|Overall Study|Non-compliance with study treatment|0|||
27862252|NCT03461757|54429422|FG001|Overall Study|Non-compliance with study treatment|1|||
27862253|NCT03461757|54429421|FG000|Overall Study|Pregnancy|2|||
27862254|NCT03461757|54429422|FG001|Overall Study|Pregnancy|0|||
27862255|NCT03461757|54429421|FG000|Overall Study|Protocol Violation|1|||
27862256|NCT03461757|54429422|FG001|Overall Study|Protocol Violation|1|||
27862257|NCT03461757|54429421|FG000|Overall Study|Withdrawal by Subject|7|||
27862258|NCT03461757|54429422|FG001|Overall Study|Withdrawal by Subject|7|||
27862259|NCT03461757|54429421|FG000|Overall Study|Other Reasons|1|||
27862260|NCT03461757|54429422|FG001|Overall Study|Other Reasons|4|||
27862261|NCT03235479|54429910|FG000|Overall Study|Lost to Follow-up|8|||
27862262|NCT03235479|54429911|FG001|Overall Study|Lost to Follow-up|11|||
27862263|NCT03235479|54429910|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|23|||
27862264|NCT03235479|54429911|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|17|||
27862265|NCT03235479|54429910|FG000|Overall Study|Pregnancy|1|||
27862266|NCT03235479|54429911|FG001|Overall Study|Pregnancy|0|||
27862267|NCT03235479|54429910|FG000|Overall Study|Protocol Deviation|1|||
27862268|NCT03235479|54429911|FG001|Overall Study|Protocol Deviation|3|||
27862269|NCT03235479|54429910|FG000|Overall Study|Technical Problems|3|||
27862270|NCT03235479|54429911|FG001|Overall Study|Technical Problems|2|||
27862271|NCT03235479|54429910|FG000|Overall Study|Withdrawal by Subject|2|||
27862272|NCT03235479|54429911|FG001|Overall Study|Withdrawal by Subject|2|||
28096068|NCT04218110|54750719|FG001|Overall Study|Withdrawal by Subject|0|||
27862273|NCT03235479|54429910|FG000|Overall Study|Other Reasons|3|||
27862274|NCT03235479|54429911|FG001|Overall Study|Other Reasons|5|||
27862275|NCT03193437|54429967|FG000|Overall Study|Adverse Event|4|||
27862276|NCT03193437|54429967|FG000|Overall Study|Withdrawal by Subject|2|||
27862277|NCT03193437|54429967|FG000|Overall Study|Disease Progression|2|||
27862278|NCT02906787|54430020|FG000|Overall Study|Withdrawal by Subject|12|||
27862279|NCT02906787|54430021|FG001|Overall Study|Withdrawal by Subject|10|||
27862280|NCT02906787|54430020|FG000|Overall Study|Missed|24|||
27862281|NCT02906787|54430021|FG001|Overall Study|Missed|22|||
27862282|NCT02107443|54430615|FG000|Overall Study|Death|42|||
27862283|NCT02107443|54430616|FG001|Overall Study|Death|30|||
27862284|NCT02107443|54430615|FG000|Overall Study|Study Protocol Violation|3|||
27862285|NCT02107443|54430616|FG001|Overall Study|Study Protocol Violation|1|||
27862286|NCT02107443|54430615|FG000|Overall Study|Registered but Not Eligible|0|||
27862287|NCT02107443|54430616|FG001|Overall Study|Registered but Not Eligible|1|||
27862288|NCT02107443|54430615|FG000|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
27862289|NCT02107443|54430616|FG001|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
27862290|NCT02107443|54430615|FG000|Overall Study|Withdrawal: Disliked Study Procedures|1|||
27862291|NCT02107443|54430616|FG001|Overall Study|Withdrawal: Disliked Study Procedures|2|||
27862292|NCT02107443|54430615|FG000|Overall Study|Withdrawal: Changed Mind|2|||
27862293|NCT02107443|54430616|FG001|Overall Study|Withdrawal: Changed Mind|0|||
27862294|NCT02107443|54430615|FG000|Overall Study|Withdrawal: Changed MD/Facility|1|||
27862295|NCT02107443|54430616|FG001|Overall Study|Withdrawal: Changed MD/Facility|3|||
27862296|NCT02107443|54430615|FG000|Overall Study|Withdrawal: Too Many Forms|3|||
27862297|NCT02107443|54430616|FG001|Overall Study|Withdrawal: Too Many Forms|1|||
27862298|NCT02107443|54430615|FG000|Overall Study|Withdrawal: Too Time Consuming|3|||
27862299|NCT02107443|54430616|FG001|Overall Study|Withdrawal: Too Time Consuming|6|||
27862300|NCT02107443|54430615|FG000|Overall Study|Withdrawal: Feeling Overwhelmed|2|||
27862301|NCT02107443|54430616|FG001|Overall Study|Withdrawal: Feeling Overwhelmed|1|||
27862302|NCT02107443|54430615|FG000|Overall Study|Withdrawal: Other Medical|9|||
27862303|NCT02107443|54430616|FG001|Overall Study|Withdrawal: Other Medical|5|||
27862304|NCT02107443|54430615|FG000|Overall Study|Withdrawal: Disease Progression|4|||
27862305|NCT02107443|54430616|FG001|Overall Study|Withdrawal: Disease Progression|2|||
27862306|NCT02107443|54430615|FG000|Overall Study|Withdrawal: Personal Issues|0|||
27862307|NCT02107443|54430616|FG001|Overall Study|Withdrawal: Personal Issues|3|||
27862308|NCT00559949|54431533|FG000|Overall Study|Progressive Disease during cycle 1|1|||
27862309|NCT00559949|54431533|FG000|Overall Study|Adverse Event|1|||
27862310|NCT00559949|54431533|FG000|Overall Study|Withdrawal by Subject|4|||
27862311|NCT00559949|54431533|FG000|Overall Study|No disease evaluation per protocol|1|||
27862312|NCT00559637|54431585|FG000|Overall Study|Adverse Event|22|||
27862313|NCT00559637|54431585|FG000|Overall Study|Withdrawal by Subject|4|||
27862314|NCT00559637|54431585|FG000|Overall Study|Protocol Violation|6|||
27862315|NCT00559637|54431585|FG000|Overall Study|Withdrawal criteria fulfilled|4|||
27862316|NCT00559637|54431585|FG000|Overall Study|Failure to return|6|||
27862317|NCT00559637|54431585|FG000|Overall Study|Insufficient response|3|||
27862318|NCT00559637|54431585|FG000|Overall Study|Started requiring dialysis after month 7|2|||
27862319|NCT00559637|54431585|FG000|Overall Study|Suspected lung cancer|1|||
27862320|NCT00559637|54431585|FG000|Overall Study|Participation in another study|1|||
27862321|NCT00559637|54431585|FG000|Overall Study|Delayed administration of C.E.R.A|1|||
27862322|NCT00559637|54431585|FG000|Overall Study|Change of center|1|||
27862323|NCT00559637|54431585|FG000|Overall Study|Change of home|1|||
27862324|NCT00559637|54431585|FG000|Overall Study|Inclusion or exclusion criteria violated|2|||
27862325|NCT02578641|54431658|FG000|Overall Study|Adverse Event|5|||
27862326|NCT02578641|54431659|FG001|Overall Study|Adverse Event|15|||
27862327|NCT02578641|54431658|FG000|Overall Study|Death|16|||
27862328|NCT02578641|54431659|FG001|Overall Study|Death|8|||
27862329|NCT02578641|54431658|FG000|Overall Study|Lost to Follow-up|0|||
27862330|NCT02578641|54431659|FG001|Overall Study|Lost to Follow-up|1|||
27862331|NCT02578641|54431658|FG000|Overall Study|Withdrawal by Subject|14|||
27862332|NCT02578641|54431659|FG001|Overall Study|Withdrawal by Subject|7|||
27862333|NCT02578641|54431658|FG000|Overall Study|Progressive Disease|69|||
27862334|NCT02578641|54431659|FG001|Overall Study|Progressive Disease|21|||
27862335|NCT02578641|54431658|FG000|Overall Study|No Study Drug|2|||
27862336|NCT02578641|54431659|FG001|Overall Study|No Study Drug|0|||
27862337|NCT02578641|54431658|FG000|Overall Study|Randomized by Mistake with Study Treatment|0|||
27862338|NCT02578641|54431659|FG001|Overall Study|Randomized by Mistake with Study Treatment|1|||
27862339|NCT02578641|54431658|FG000|Overall Study|Non-compliance with Study Schedule|1|||
27862340|NCT02578641|54431659|FG001|Overall Study|Non-compliance with Study Schedule|0|||
27862341|NCT02578641|54431658|FG000|Overall Study|Other|1|||
27862342|NCT02578641|54431659|FG001|Overall Study|Other|10|||
27862343|NCT02578641|54431658|FG000|Overall Study|Not treated|1|||
27862344|NCT02578641|54431659|FG001|Overall Study|Not treated|4|||
27862345|NCT02431260|54431687|FG000|Overall Study|Subject Decision|0|||
27862346|NCT02431260|54431688|FG001|Overall Study|Subject Decision|1|||
27862347|NCT02431260|54431689|FG002|Overall Study|Subject Decision|1|||
27862348|NCT02431260|54431690|FG003|Overall Study|Subject Decision|0|||
27862349|NCT02431260|54431691|FG004|Overall Study|Subject Decision|0|||
27862350|NCT02431260|54431692|FG005|Overall Study|Subject Decision|0|||
27862351|NCT02431260|54431693|FG006|Overall Study|Subject Decision|0|||
28096069|NCT04218110|54750720|FG002|Overall Study|Withdrawal by Subject|0|||
27862352|NCT02431260|54431694|FG007|Overall Study|Subject Decision|0|||
27862353|NCT02431260|54431695|FG008|Overall Study|Subject Decision|1|||
27862354|NCT02431260|54431696|FG009|Overall Study|Subject Decision|1|||
27862355|NCT02431260|54431697|FG010|Overall Study|Subject Decision|0|||
27862356|NCT02431260|54431698|FG011|Overall Study|Subject Decision|1|||
27862357|NCT02431260|54431699|FG012|Overall Study|Subject Decision|0|||
27862358|NCT02431260|54431700|FG013|Overall Study|Subject Decision|0|||
27862359|NCT02431260|54431687|FG000|Overall Study|Death|4|||
27862360|NCT02431260|54431688|FG001|Overall Study|Death|4|||
27862361|NCT02431260|54431689|FG002|Overall Study|Death|3|||
27862362|NCT02431260|54431690|FG003|Overall Study|Death|4|||
27862363|NCT02431260|54431691|FG004|Overall Study|Death|2|||
27862364|NCT02431260|54431692|FG005|Overall Study|Death|2|||
27862365|NCT02431260|54431693|FG006|Overall Study|Death|3|||
27862366|NCT02431260|54431694|FG007|Overall Study|Death|1|||
27862367|NCT02431260|54431695|FG008|Overall Study|Death|6|||
27862368|NCT02431260|54431696|FG009|Overall Study|Death|6|||
27862369|NCT02431260|54431697|FG010|Overall Study|Death|3|||
27862370|NCT02431260|54431698|FG011|Overall Study|Death|2|||
27862371|NCT02431260|54431699|FG012|Overall Study|Death|5|||
27862372|NCT02431260|54431700|FG013|Overall Study|Death|1|||
27862373|NCT02431260|54431687|FG000|Overall Study|Lost to Follow-up|0|||
27862374|NCT02431260|54431688|FG001|Overall Study|Lost to Follow-up|0|||
27862375|NCT02431260|54431689|FG002|Overall Study|Lost to Follow-up|0|||
27862376|NCT02431260|54431690|FG003|Overall Study|Lost to Follow-up|0|||
27862377|NCT02431260|54431691|FG004|Overall Study|Lost to Follow-up|0|||
27862378|NCT02431260|54431692|FG005|Overall Study|Lost to Follow-up|1|||
27862379|NCT02431260|54431693|FG006|Overall Study|Lost to Follow-up|0|||
27862380|NCT02431260|54431694|FG007|Overall Study|Lost to Follow-up|0|||
27862381|NCT02431260|54431695|FG008|Overall Study|Lost to Follow-up|0|||
27862382|NCT02431260|54431696|FG009|Overall Study|Lost to Follow-up|0|||
27862383|NCT02431260|54431697|FG010|Overall Study|Lost to Follow-up|0|||
27862384|NCT02431260|54431698|FG011|Overall Study|Lost to Follow-up|0|||
27862385|NCT02431260|54431699|FG012|Overall Study|Lost to Follow-up|0|||
27862386|NCT02431260|54431700|FG013|Overall Study|Lost to Follow-up|0|||
27862387|NCT02431260|54431687|FG000|Overall Study|Study Terminated by the Sponsor|0|||
27862388|NCT02431260|54431688|FG001|Overall Study|Study Terminated by the Sponsor|0|||
27862389|NCT02431260|54431689|FG002|Overall Study|Study Terminated by the Sponsor|2|||
27862390|NCT02431260|54431690|FG003|Overall Study|Study Terminated by the Sponsor|1|||
27862391|NCT02431260|54431691|FG004|Overall Study|Study Terminated by the Sponsor|1|||
27862392|NCT02431260|54431692|FG005|Overall Study|Study Terminated by the Sponsor|0|||
27862393|NCT02431260|54431693|FG006|Overall Study|Study Terminated by the Sponsor|1|||
27862394|NCT02431260|54431694|FG007|Overall Study|Study Terminated by the Sponsor|2|||
27862395|NCT02431260|54431695|FG008|Overall Study|Study Terminated by the Sponsor|1|||
27862396|NCT02431260|54431696|FG009|Overall Study|Study Terminated by the Sponsor|1|||
27862397|NCT02431260|54431697|FG010|Overall Study|Study Terminated by the Sponsor|1|||
27862398|NCT02431260|54431698|FG011|Overall Study|Study Terminated by the Sponsor|0|||
27862399|NCT02431260|54431699|FG012|Overall Study|Study Terminated by the Sponsor|4|||
27862400|NCT02431260|54431700|FG013|Overall Study|Study Terminated by the Sponsor|0|||
27862401|NCT02431260|54431687|FG000|Overall Study|Physician Decision|0|||
27862402|NCT02431260|54431688|FG001|Overall Study|Physician Decision|0|||
27862403|NCT02431260|54431689|FG002|Overall Study|Physician Decision|0|||
27862404|NCT02431260|54431690|FG003|Overall Study|Physician Decision|0|||
27862405|NCT02431260|54431691|FG004|Overall Study|Physician Decision|0|||
27862406|NCT02431260|54431692|FG005|Overall Study|Physician Decision|1|||
27981592|NCT00950807|54639310|FG000|Treatment Period 3|Adverse Event|0|||
27981593|NCT00950807|54639311|FG001|Treatment Period 3|Adverse Event|0|||
27738918|NCT00002663|54188223|FG000|Overall Study|Lost to Follow-up|3|||
27738919|NCT00002663|54188224|FG001|Overall Study|Lost to Follow-up|0|||
27738920|NCT00002663|54188225|FG002|Overall Study|Lost to Follow-up|0|||
27738921|NCT00002663|54188226|FG003|Overall Study|Lost to Follow-up|1|||
27738922|NCT00002663|54188227|FG004|Overall Study|Lost to Follow-up|0|||
27738923|NCT00002663|54188228|FG005|Overall Study|Lost to Follow-up|1|||
27738924|NCT00002663|54188229|FG006|Overall Study|Lost to Follow-up|0|||
27862407|NCT02431260|54431693|FG006|Overall Study|Physician Decision|0|||
27862408|NCT02431260|54431694|FG007|Overall Study|Physician Decision|0|||
27862409|NCT02431260|54431695|FG008|Overall Study|Physician Decision|0|||
27862410|NCT02431260|54431696|FG009|Overall Study|Physician Decision|0|||
27862411|NCT02431260|54431697|FG010|Overall Study|Physician Decision|0|||
27862412|NCT02431260|54431698|FG011|Overall Study|Physician Decision|0|||
27862413|NCT02431260|54431699|FG012|Overall Study|Physician Decision|0|||
27862414|NCT02431260|54431700|FG013|Overall Study|Physician Decision|0|||
27862415|NCT02431260|54431687|FG000|Overall Study|Other Unspecified|0|||
27862416|NCT02431260|54431688|FG001|Overall Study|Other Unspecified|0|||
27862417|NCT02431260|54431689|FG002|Overall Study|Other Unspecified|0|||
27862418|NCT02431260|54431690|FG003|Overall Study|Other Unspecified|0|||
27862419|NCT02431260|54431691|FG004|Overall Study|Other Unspecified|0|||
27862420|NCT02431260|54431692|FG005|Overall Study|Other Unspecified|0|||
27738925|NCT00002663|54188230|FG007|Overall Study|Lost to Follow-up|0|||
27862421|NCT02431260|54431693|FG006|Overall Study|Other Unspecified|0|||
27981594|NCT00950807|54639312|FG002|Treatment Period 3|Adverse Event|0|||
27862422|NCT02431260|54431694|FG007|Overall Study|Other Unspecified|0|||
27862423|NCT02431260|54431695|FG008|Overall Study|Other Unspecified|0|||
27862424|NCT02431260|54431696|FG009|Overall Study|Other Unspecified|0|||
27862425|NCT02431260|54431697|FG010|Overall Study|Other Unspecified|0|||
27862426|NCT02431260|54431698|FG011|Overall Study|Other Unspecified|1|||
27862427|NCT02431260|54431699|FG012|Overall Study|Other Unspecified|1|||
27862428|NCT02431260|54431700|FG013|Overall Study|Other Unspecified|0|||
27925605|NCT01231659|54582143|FG000|Overall Study|Patient refused to complete study visit|1|||
27925606|NCT01231659|54582143|FG000|Overall Study|Other protocol defined criteria|12|||
27925607|NCT01054222|54582147|FG000|Overall Study|Lack of Efficacy|1|||
27925608|NCT01054222|54582147|FG000|Overall Study|Lost to Follow-up|4|||
27925609|NCT01054222|54582147|FG000|Overall Study|Withdrawal by Subject|6|||
27925610|NCT01052428|54582153|FG000|Overall Study|Death|1|||
27925611|NCT01052428|54582154|FG001|Overall Study|Death|0|||
27925612|NCT01052428|54582153|FG000|Overall Study|Withdrawal by Subject|0|||
27925613|NCT01052428|54582154|FG001|Overall Study|Withdrawal by Subject|1|||
27925614|NCT01052272|54582164|FG000|Overall Study|Death|0|||
27925615|NCT01052272|54582165|FG001|Overall Study|Death|0|||
27925616|NCT01052272|54582166|FG002|Overall Study|Death|1|||
27925617|NCT01052272|54582167|FG003|Overall Study|Death|1|||
27925618|NCT01052272|54582164|FG000|Overall Study|Physician Decision|0|||
27925619|NCT01052272|54582165|FG001|Overall Study|Physician Decision|1|||
27925620|NCT01052272|54582166|FG002|Overall Study|Physician Decision|0|||
27925621|NCT01052272|54582167|FG003|Overall Study|Physician Decision|0|||
27925622|NCT01052272|54582164|FG000|Overall Study|patient refuses follow-up|5|||
27925623|NCT01052272|54582165|FG001|Overall Study|patient refuses follow-up|4|||
27925624|NCT01052272|54582166|FG002|Overall Study|patient refuses follow-up|2|||
27925625|NCT01052272|54582167|FG003|Overall Study|patient refuses follow-up|4|||
27925626|NCT01052272|54582164|FG000|Overall Study|Withdrawal by Subject|0|||
27925627|NCT01052272|54582165|FG001|Overall Study|Withdrawal by Subject|2|||
27925628|NCT01052272|54582166|FG002|Overall Study|Withdrawal by Subject|3|||
27925629|NCT01052272|54582167|FG003|Overall Study|Withdrawal by Subject|2|||
27925630|NCT01052272|54582164|FG000|Overall Study|placed in long-term care|0|||
27925631|NCT01052272|54582165|FG001|Overall Study|placed in long-term care|0|||
27925632|NCT01052272|54582166|FG002|Overall Study|placed in long-term care|1|||
27925633|NCT01052272|54582167|FG003|Overall Study|placed in long-term care|0|||
27925634|NCT01052272|54582164|FG000|Overall Study|decline in health|0|||
27925635|NCT01052272|54582165|FG001|Overall Study|decline in health|0|||
27925636|NCT01052272|54582166|FG002|Overall Study|decline in health|1|||
27925637|NCT01052272|54582167|FG003|Overall Study|decline in health|0|||
27925638|NCT01257204|54582180|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
27925639|NCT01257204|54582181|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
27925640|NCT01257204|54582182|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|3|||
27925641|NCT01257204|54582180|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
27925642|NCT01257204|54582181|FG001|Treatment Period (up to Week 24)|Adverse Event|1|||
27925643|NCT01257204|54582182|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
27925644|NCT01257204|54582180|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
27925645|NCT01257204|54582181|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|0|||
27925646|NCT01257204|54582182|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
27925647|NCT01257204|54582180|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
27925648|NCT01257204|54582181|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
27925649|NCT01257204|54582182|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
27925650|NCT01257204|54582180|FG000|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
27925651|NCT01257204|54582181|FG001|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
27925652|NCT01257204|54582182|FG002|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1|||
27925653|NCT01257204|54582180|FG000|Treatment Period (up to Week 24)|Participant's request to discontinue|1|||
27925654|NCT01257204|54582181|FG001|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
27925655|NCT01257204|54582182|FG002|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
27925656|NCT01257204|54582180|FG000|Follow-up Period (up to Week 48)|Withdrawal by Subject|0|||
27925657|NCT01257204|54582181|FG001|Follow-up Period (up to Week 48)|Withdrawal by Subject|2|||
27925658|NCT01257204|54582182|FG002|Follow-up Period (up to Week 48)|Withdrawal by Subject|1|||
27925659|NCT01257204|54582180|FG000|Follow-up Period (up to Week 48)|Lost to Follow-up|1|||
27925660|NCT01257204|54582181|FG001|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
27925661|NCT01257204|54582182|FG002|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
27925662|NCT01257204|54582180|FG000|Follow-up Period (up to Week 48)|Other|0|||
27925663|NCT01257204|54582181|FG001|Follow-up Period (up to Week 48)|Other|0|||
27925664|NCT01257204|54582182|FG002|Follow-up Period (up to Week 48)|Other|5|||
27925665|NCT01231581|54582204|FG000|Overall Study|Lost to Follow-up|2|||
27925666|NCT01231581|54582205|FG001|Overall Study|Lost to Follow-up|2|||
27925667|NCT01231581|54582204|FG000|Overall Study|Withdrawal by Subject|6|||
27925668|NCT01231581|54582205|FG001|Overall Study|Withdrawal by Subject|9|||
27925669|NCT01231581|54582204|FG000|Overall Study|Study Closed/Terminated|6|||
27925670|NCT01231581|54582205|FG001|Overall Study|Study Closed/Terminated|5|||
27862429|NCT02430870|54431895|FG000|Part 2|Voluntary Withdrawal|0|||
27862430|NCT02430870|54431896|FG001|Part 2|Voluntary Withdrawal|0|||
27862431|NCT02430870|54431897|FG002|Part 2|Voluntary Withdrawal|0|||
27862432|NCT02430870|54431898|FG003|Part 2|Voluntary Withdrawal|0|||
27862433|NCT02430870|54431899|FG004|Part 2|Voluntary Withdrawal|0|||
27862434|NCT02430870|54431900|FG005|Part 2|Voluntary Withdrawal|0|||
27862435|NCT02430870|54431901|FG006|Part 2|Voluntary Withdrawal|1|||
27862436|NCT02430870|54431902|FG007|Part 2|Voluntary Withdrawal|0|||
27862437|NCT02430870|54431895|FG000|Part 2|Other Reason Not Specified|0|||
27862438|NCT02430870|54431896|FG001|Part 2|Other Reason Not Specified|0|||
27862439|NCT02430870|54431897|FG002|Part 2|Other Reason Not Specified|0|||
27862440|NCT02430870|54431898|FG003|Part 2|Other Reason Not Specified|0|||
27862441|NCT02430870|54431899|FG004|Part 2|Other Reason Not Specified|0|||
27862442|NCT02430870|54431900|FG005|Part 2|Other Reason Not Specified|0|||
27862443|NCT02430870|54431901|FG006|Part 2|Other Reason Not Specified|0|||
27862444|NCT02430870|54431902|FG007|Part 2|Other Reason Not Specified|1|||
27862445|NCT02429934|54431968|FG000|Overall Study|Withdrawal by Subject|0|||
27862446|NCT02429934|54431969|FG001|Overall Study|Withdrawal by Subject|2|||
27862447|NCT02429934|54431968|FG000|Overall Study|Adverse Event|2|||
27862448|NCT02429934|54431969|FG001|Overall Study|Adverse Event|0|||
27862449|NCT02429934|54431968|FG000|Overall Study|Lost to Follow-up|1|||
27862450|NCT02429934|54431969|FG001|Overall Study|Lost to Follow-up|1|||
27862451|NCT02429934|54431968|FG000|Overall Study|Physician Decision|1|||
27862452|NCT02429934|54431969|FG001|Overall Study|Physician Decision|0|||
27862453|NCT02429856|54431983|FG000|Overall Study|Death|12|||
27862454|NCT02429856|54431984|FG001|Overall Study|Death|13|||
27862455|NCT02429856|54431983|FG000|Overall Study|Lost to Follow-up|6|||
27862456|NCT02429856|54431984|FG001|Overall Study|Lost to Follow-up|5|||
27862457|NCT02429856|54431983|FG000|Overall Study|Withdrawal by Subject|1|||
27862458|NCT02429856|54431984|FG001|Overall Study|Withdrawal by Subject|1|||
27862459|NCT02429778|54431994|FG000|Overall Study|Lost to Follow-up|2|||
27862460|NCT02429778|54431995|FG001|Overall Study|Lost to Follow-up|0|||
27862461|NCT02429778|54431994|FG000|Overall Study|Withdrawal by Subject|5|||
27862462|NCT02429778|54431995|FG001|Overall Study|Withdrawal by Subject|0|||
27862463|NCT02403180|54432003|FG000|Pre-Treatment Period|Withdrawal by subject prior to treatment|0|||
27862464|NCT02403180|54432004|FG001|Pre-Treatment Period|Withdrawal by subject prior to treatment|1|||
27862465|NCT02403180|54432003|FG000|Period 2 (5 Days)|Withdrawal by Subject|0|||
27862466|NCT02403180|54432004|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
27862467|NCT00558467|54432038|FG000|Overall Study|Adverse Event|1|||
27862468|NCT00558467|54432039|FG001|Overall Study|Adverse Event|2|||
27862469|NCT00558467|54432038|FG000|Overall Study|Lack of Efficacy|0|||
27862470|NCT00558467|54432039|FG001|Overall Study|Lack of Efficacy|1|||
27862471|NCT00558467|54432038|FG000|Overall Study|Patient moving out of state|0|||
27862472|NCT00558467|54432039|FG001|Overall Study|Patient moving out of state|1|||
27862473|NCT02402166|54432045|FG000|Overall Study|Adverse Event|2|||
27862474|NCT02402166|54432045|FG000|Overall Study|Withdrawal by Subject|2|||
27981595|NCT00950807|54639313|FG003|Treatment Period 3|Adverse Event|0|||
27981596|NCT00950807|54639314|FG004|Treatment Period 3|Adverse Event|0|||
27981597|NCT00950807|54639315|FG005|Treatment Period 3|Adverse Event|0|||
27981598|NCT00950807|54639316|FG006|Treatment Period 3|Adverse Event|1|||
27981599|NCT00950807|54639317|FG007|Treatment Period 3|Adverse Event|0|||
27981600|NCT00950807|54639318|FG008|Treatment Period 3|Adverse Event|0|||
27981601|NCT00950807|54639319|FG009|Treatment Period 3|Adverse Event|0|||
27981602|NCT00797511|54639341|FG000|Overall Study|Withdrawal by Subject|1|||
27981603|NCT00608881|54639348|FG000|Overall Study|Death|22|||
27981604|NCT00608881|54639349|FG001|Overall Study|Death|13|||
27981605|NCT00608881|54639348|FG000|Overall Study|Adverse Event|5|||
27981606|NCT00608881|54639349|FG001|Overall Study|Adverse Event|3|||
27981607|NCT00608881|54639348|FG000|Overall Study|Lost to Follow-up|28|||
27981608|NCT00608881|54639349|FG001|Overall Study|Lost to Follow-up|14|||
27981609|NCT00608881|54639348|FG000|Overall Study|Withdrawal by Subject|18|||
27981610|NCT00608881|54639349|FG001|Overall Study|Withdrawal by Subject|29|||
27981611|NCT00608881|54639348|FG000|Overall Study|Physician Decision|5|||
27981612|NCT00608881|54639349|FG001|Overall Study|Physician Decision|5|||
27981613|NCT00608881|54639348|FG000|Overall Study|Institutionalized|1|||
27862475|NCT02402166|54432045|FG000|Overall Study|Lost to Follow-up|1|||
27862476|NCT02378220|54432065|FG000|Overall Study|Death|6|||
27862477|NCT02378220|54432066|FG001|Overall Study|Death|1|||
27862478|NCT04226495|54432075|FG000|Overall Study|Withdrawal by Subject|3|||
27862479|NCT04226495|54432076|FG001|Overall Study|Withdrawal by Subject|3|||
27862480|NCT04226495|54432075|FG000|Overall Study|PI discretion|2|||
27862481|NCT04226495|54432076|FG001|Overall Study|PI discretion|4|||
27981614|NCT00608881|54639349|FG001|Overall Study|Institutionalized|2|||
27981615|NCT00945191|54639355|FG000|Overall Study|Did not achieve a complete response|18|||
27862482|NCT02401308|54432084|FG000|Overall Study|Study was terminated by the PI due to lack of enrollment.|0|||
27862483|NCT02401308|54432085|FG001|Overall Study|Study was terminated by the PI due to lack of enrollment.|1|||
27981616|NCT00945191|54639355|FG000|Overall Study|Participant relocated to another state|1|||
27981617|NCT00945191|54639355|FG000|Overall Study|Disease progression|3|||
27862484|NCT02401230|54432094|FG000|Overall Study|Adverse Event|3|||
27862485|NCT02401230|54432095|FG001|Overall Study|Adverse Event|2|||
27862486|NCT02401230|54432096|FG002|Overall Study|Adverse Event|0|||
27862487|NCT02401230|54432094|FG000|Overall Study|Withdrawal by Subject|2|||
27862488|NCT02401230|54432095|FG001|Overall Study|Withdrawal by Subject|1|||
27862489|NCT02401230|54432096|FG002|Overall Study|Withdrawal by Subject|1|||
27862490|NCT02401230|54432094|FG000|Overall Study|Lost to Follow-up|1|||
27862491|NCT02401230|54432095|FG001|Overall Study|Lost to Follow-up|3|||
27862492|NCT02401230|54432096|FG002|Overall Study|Lost to Follow-up|3|||
27862493|NCT02429310|54432137|FG000|Overall Study|Lost to Follow-up|1|||
27862494|NCT02429310|54432138|FG001|Overall Study|Lost to Follow-up|2|||
27862495|NCT02429310|54432137|FG000|Overall Study|Protocol Violation|1|||
27862496|NCT02429310|54432138|FG001|Overall Study|Protocol Violation|1|||
27862497|NCT02428608|54432164|FG000|Overall Study|Pregnancy|2|||
27862498|NCT02428608|54432164|FG000|Overall Study|Lost to Follow-up|37|||
27862499|NCT02428608|54432164|FG000|Overall Study|Withdrawal by Subject|2|||
27862500|NCT02428608|54432164|FG000|Overall Study|scheduling conflicts|15|||
27862501|NCT02428608|54432164|FG000|Overall Study|moved away|10|||
27981618|NCT00945191|54639355|FG000|Overall Study|Serious adverse event or adverse event|1|||
27981619|NCT00945191|54639355|FG000|Overall Study|Investigator's discretion|1|||
27981620|NCT00606931|54639359|FG000|Overall Study|Withdrawal by Subject|3|||
27981621|NCT00792909|54639366|FG000|Overall Study|Withdrawal by Subject|0|||
27981622|NCT00792909|54639367|FG001|Overall Study|Withdrawal by Subject|1|||
27981623|NCT00792909|54639368|FG002|Overall Study|Withdrawal by Subject|0|||
27981624|NCT00944645|54639379|FG000|Period 2|Adverse Event|1|||
27981625|NCT00944645|54639380|FG001|Period 2|Adverse Event|0|||
27981626|NCT00944645|54639379|FG000|Period 2|Lost to Follow-up|0|||
27981627|NCT00944645|54639380|FG001|Period 2|Lost to Follow-up|3|||
27981628|NCT00944645|54639379|FG000|Period 2|Withdrawal by Subject|7|||
27981629|NCT00944645|54639380|FG001|Period 2|Withdrawal by Subject|6|||
27981630|NCT00606229|54639386|FG000|Overall Study|Adverse Event|11|||
27981631|NCT00606229|54639386|FG000|Overall Study|Lack of Efficacy|1|||
27981632|NCT00606229|54639386|FG000|Overall Study|Withdrawal by Subject|4|||
27981633|NCT00606229|54639386|FG000|Overall Study|does not meet inclusion criterion 1-3|4|||
27981634|NCT00606229|54639386|FG000|Overall Study|change of residence or other commitments|2|||
27981635|NCT00950651|54639392|FG000|Overall Study|Adverse Event|17|||
27981636|NCT00950651|54639393|FG001|Overall Study|Adverse Event|20|||
27981637|NCT00950651|54639392|FG000|Overall Study|Death|1|||
27981638|NCT00950651|54639393|FG001|Overall Study|Death|0|||
27981639|NCT00950651|54639392|FG000|Overall Study|Lack of Efficacy|2|||
27981640|NCT00950651|54639393|FG001|Overall Study|Lack of Efficacy|2|||
27981641|NCT00950651|54639392|FG000|Overall Study|Protocol Violation|3|||
27981642|NCT00950651|54639393|FG001|Overall Study|Protocol Violation|4|||
27981643|NCT00950651|54639392|FG000|Overall Study|Withdrawal by Subject|8|||
27981644|NCT00950651|54639393|FG001|Overall Study|Withdrawal by Subject|9|||
27981645|NCT00605293|54639401|FG000|Overall Study|Death|2|||
27981646|NCT00605293|54639402|FG001|Overall Study|Death|1|||
27981647|NCT00605293|54639401|FG000|Overall Study|Insufficient Therapeutic Response|2|||
27981648|NCT00605293|54639402|FG001|Overall Study|Insufficient Therapeutic Response|0|||
27981649|NCT00605293|54639401|FG000|Overall Study|Adverse Event|1|||
27981650|NCT00605293|54639402|FG001|Overall Study|Adverse Event|0|||
27981651|NCT00605293|54639401|FG000|Overall Study|Holidays Dialysis Out|1|||
27981652|NCT00605293|54639402|FG001|Overall Study|Holidays Dialysis Out|0|||
27981653|NCT00605293|54639401|FG000|Overall Study|Blood Transfusion|7|||
27981654|NCT00605293|54639402|FG001|Overall Study|Blood Transfusion|1|||
27981655|NCT00605293|54639401|FG000|Overall Study|Renal Transplantation|3|||
27981656|NCT00605293|54639402|FG001|Overall Study|Renal Transplantation|1|||
27981657|NCT00605293|54639401|FG000|Overall Study|Incorrect Epoetin Beta Administration|1|||
27981658|NCT00605293|54639402|FG001|Overall Study|Incorrect Epoetin Beta Administration|0|||
27981659|NCT00605293|54639401|FG000|Overall Study|Dialysis Out of Centre for 3 Months|0|||
27981660|NCT00605293|54639402|FG001|Overall Study|Dialysis Out of Centre for 3 Months|1|||
27981661|NCT00605293|54639401|FG000|Overall Study|Principal Investigator Decision|0|||
27981662|NCT00605293|54639402|FG001|Overall Study|Principal Investigator Decision|1|||
27981663|NCT00572533|54639410|FG000|Overall Study|Death|4|||
27981664|NCT00572533|54639411|FG001|Overall Study|Death|1|||
27981665|NCT00572533|54639410|FG000|Overall Study|Received Kidney Transplant|2|||
27981666|NCT00572533|54639411|FG001|Overall Study|Received Kidney Transplant|1|||
27981667|NCT00572533|54639410|FG000|Overall Study|Social Issues|1|||
27981668|NCT00572533|54639411|FG001|Overall Study|Social Issues|0|||
27862502|NCT02428608|54432164|FG000|Overall Study|Death|1|||
27862503|NCT02428608|54432164|FG000|Overall Study|various|16|||
27862504|NCT02428296|54432184|FG000|Overall Study|Adverse Event|7|||
27862505|NCT02428296|54432184|FG000|Overall Study|Withdrawal by Subject|2|||
27981669|NCT00572533|54639410|FG000|Overall Study|Transfer out of Facility|0|||
27981670|NCT00572533|54639411|FG001|Overall Study|Transfer out of Facility|1|||
27981671|NCT00949715|54639419|FG000|Overall Study|Physician Decision|1|||
27862506|NCT02427984|54432198|FG000|Overall Study|Lost to Follow-up|13|||
27981672|NCT00949715|54639420|FG001|Overall Study|Physician Decision|0|||
27981673|NCT00949715|54639419|FG000|Overall Study|Lost to Follow-up|1|||
27981674|NCT00949715|54639420|FG001|Overall Study|Lost to Follow-up|0|||
27981675|NCT00949715|54639419|FG000|Overall Study|Missing 24 month LVEF measurement|2|||
27981676|NCT00949715|54639420|FG001|Overall Study|Missing 24 month LVEF measurement|0|||
27981677|NCT00791661|54639428|FG000|7 Day Wash-out|Adverse Event|0|||
27981678|NCT00791661|54639429|FG001|7 Day Wash-out|Adverse Event|0|||
27981679|NCT00791661|54639430|FG002|7 Day Wash-out|Adverse Event|1|||
27981680|NCT00791661|54639428|FG000|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
27981681|NCT00791661|54639429|FG001|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
27981682|NCT00791661|54639430|FG002|7 Day Wash-out|Abnormal Clinical Laboratory Test|1|||
27981683|NCT00943787|54639454|FG000|Overall Study|Physician Decision|4|||
27981684|NCT00943787|54639454|FG000|Overall Study|Withdrawal by Subject|3|||
27981685|NCT00949325|54639458|FG000|Overall Study|Adverse Event|0|||
27981686|NCT00949325|54639459|FG001|Overall Study|Adverse Event|2|||
27981687|NCT00949325|54639460|FG002|Overall Study|Adverse Event|0|||
27981688|NCT00943319|54639476|FG000|Overall Study|Death|1|||
27981689|NCT00790647|54639480|FG000|Overall Study|Adverse Event|1|||
27981690|NCT00790569|54639489|FG000|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
27981691|NCT00790569|54639490|FG001|End of Treatment (6 Month Interview)|Lost to Follow-up|8|||
27981692|NCT00790569|54639491|FG002|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
28096070|NCT04218110|54750721|FG003|Overall Study|Withdrawal by Subject|1|||
28096071|NCT04214600|54750733|FG000|Overall Study|Lost to Follow-up|9|||
28096072|NCT04214600|54750734|FG001|Overall Study|Lost to Follow-up|14|||
28096073|NCT04210310|54750743|FG000|Overall Study|Lost to Follow-up|32|||
28096074|NCT04210310|54750744|FG001|Overall Study|Lost to Follow-up|1|||
28096075|NCT04209530|54750752|FG000|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|4|||
28171321|NCT02720523|54842901|FG002|Period 2: Long-term Extension Period|Ongoing|0|||
28171322|NCT02720523|54842902|FG003|Period 2: Long-term Extension Period|Ongoing|0|||
28096076|NCT04209530|54750753|FG001|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|2|||
28096077|NCT04209530|54750752|FG000|Overall Study|Withdrawal by Subject|0|||
28096078|NCT04209530|54750753|FG001|Overall Study|Withdrawal by Subject|1|||
28096079|NCT04349098|54750761|FG000|Overall Study|Death|16|||
28171323|NCT02720523|54842903|FG004|Period 2: Long-term Extension Period|Ongoing|57|||
28171324|NCT02720523|54842904|FG005|Period 2: Long-term Extension Period|Ongoing|54|||
27738926|NCT00002663|54188231|FG008|Overall Study|Lost to Follow-up|0|||
27738927|NCT00002663|54188232|FG009|Overall Study|Lost to Follow-up|0|||
27738928|NCT00002663|54188223|FG000|Overall Study|Other|0|||
27738929|NCT00002663|54188224|FG001|Overall Study|Other|1|||
27738930|NCT00002663|54188225|FG002|Overall Study|Other|0|||
27738931|NCT00002663|54188226|FG003|Overall Study|Other|0|||
27738932|NCT00002663|54188227|FG004|Overall Study|Other|0|||
27738933|NCT00002663|54188228|FG005|Overall Study|Other|1|||
27738934|NCT00002663|54188229|FG006|Overall Study|Other|1|||
27738935|NCT00002663|54188230|FG007|Overall Study|Other|0|||
27738936|NCT00002663|54188231|FG008|Overall Study|Other|0|||
27738937|NCT00002663|54188232|FG009|Overall Study|Other|0|||
27738938|NCT00002663|54188223|FG000|Overall Study|Physician Decision|0|||
27738939|NCT00002663|54188224|FG001|Overall Study|Physician Decision|0|||
27738940|NCT00002663|54188225|FG002|Overall Study|Physician Decision|0|||
27738941|NCT00002663|54188226|FG003|Overall Study|Physician Decision|0|||
27738942|NCT00002663|54188227|FG004|Overall Study|Physician Decision|1|||
27738943|NCT00002663|54188228|FG005|Overall Study|Physician Decision|0|||
27738944|NCT00002663|54188229|FG006|Overall Study|Physician Decision|0|||
27738945|NCT00002663|54188230|FG007|Overall Study|Physician Decision|0|||
27981693|NCT00790569|54639489|FG000|End of Treatment (6 Month Interview)|Death|0|||
27981694|NCT00790569|54639490|FG001|End of Treatment (6 Month Interview)|Death|2|||
27981695|NCT00790569|54639491|FG002|End of Treatment (6 Month Interview)|Death|1|||
27981696|NCT00790569|54639489|FG000|End of Treatment (6 Month Interview)|Hospitalized|2|||
27981697|NCT00790569|54639490|FG001|End of Treatment (6 Month Interview)|Hospitalized|0|||
27981698|NCT00790569|54639491|FG002|End of Treatment (6 Month Interview)|Hospitalized|0|||
28096080|NCT04349098|54750762|FG001|Overall Study|Death|8|||
28171325|NCT02720523|54842905|FG006|Period 2: Long-term Extension Period|Ongoing|45|||
28171326|NCT02720523|54842899|FG000|Period 2: Long-term Extension Period|Adverse Event|0|||
28171327|NCT02720523|54842900|FG001|Period 2: Long-term Extension Period|Adverse Event|0|||
28171328|NCT02720523|54842901|FG002|Period 2: Long-term Extension Period|Adverse Event|0|||
28171329|NCT02720523|54842902|FG003|Period 2: Long-term Extension Period|Adverse Event|0|||
28171330|NCT02720523|54842903|FG004|Period 2: Long-term Extension Period|Adverse Event|4|||
28171331|NCT02720523|54842904|FG005|Period 2: Long-term Extension Period|Adverse Event|7|||
27738946|NCT00002663|54188231|FG008|Overall Study|Physician Decision|1|||
27738947|NCT00002663|54188232|FG009|Overall Study|Physician Decision|1|||
27738948|NCT00002663|54188223|FG000|Overall Study|Adverse Event|0|||
27738949|NCT00002663|54188224|FG001|Overall Study|Adverse Event|0|||
27738950|NCT00002663|54188225|FG002|Overall Study|Adverse Event|0|||
27738951|NCT00002663|54188226|FG003|Overall Study|Adverse Event|1|||
27738952|NCT00002663|54188227|FG004|Overall Study|Adverse Event|0|||
27981699|NCT00790569|54639489|FG000|End of Treatment (6 Month Interview)|Residential Treatment|0|||
27981700|NCT00790569|54639490|FG001|End of Treatment (6 Month Interview)|Residential Treatment|0|||
27981701|NCT00790569|54639491|FG002|End of Treatment (6 Month Interview)|Residential Treatment|2|||
27981702|NCT00790569|54639489|FG000|End of Treatment (6 Month Interview)|Incarcerated|0|||
27981703|NCT00790569|54639490|FG001|End of Treatment (6 Month Interview)|Incarcerated|0|||
27981704|NCT00790569|54639491|FG002|End of Treatment (6 Month Interview)|Incarcerated|3|||
27981705|NCT00790569|54639489|FG000|End of Study (12 Month Interview)|Lost to Follow-up|66|||
27981706|NCT00790569|54639490|FG001|End of Study (12 Month Interview)|Lost to Follow-up|19|||
27981707|NCT00790569|54639491|FG002|End of Study (12 Month Interview)|Lost to Follow-up|50|||
27981708|NCT00939029|54639501|FG000|Overall Study|Withdrawal by Subject|3|||
27981709|NCT00939029|54639502|FG001|Overall Study|Withdrawal by Subject|7|||
27981710|NCT00939029|54639501|FG000|Overall Study|Lost to Follow-up|3|||
27981711|NCT00939029|54639502|FG001|Overall Study|Lost to Follow-up|4|||
27981712|NCT00939029|54639501|FG000|Overall Study|Adverse Event|0|||
27981713|NCT00939029|54639502|FG001|Overall Study|Adverse Event|1|||
27981714|NCT00587847|54639508|FG000|Overall Study|Lack of Efficacy|5|||
27981715|NCT00587847|54639508|FG000|Overall Study|Adverse Event|2|||
27981716|NCT00784563|54639516|FG000|Years 1 & 2|Withdrawal by Subject|3|||
27981717|NCT00784563|54639517|FG001|Years 1 & 2|Withdrawal by Subject|2|||
27981718|NCT00784563|54639518|FG002|Years 1 & 2|Withdrawal by Subject|0|||
27981719|NCT00784563|54639516|FG000|Years 1 & 2|Adverse Event|0|||
27981720|NCT00784563|54639517|FG001|Years 1 & 2|Adverse Event|3|||
27981721|NCT00784563|54639518|FG002|Years 1 & 2|Adverse Event|0|||
27981722|NCT00784563|54639516|FG000|Year 3|Withdrawal by Subject|0|||
27981723|NCT00784563|54639517|FG001|Year 3|Withdrawal by Subject|0|||
27981724|NCT00784563|54639518|FG002|Year 3|Withdrawal by Subject|2|||
27981725|NCT00784563|54639516|FG000|Year 3|Adverse Event|0|||
27981726|NCT00784563|54639517|FG001|Year 3|Adverse Event|0|||
27981727|NCT00784563|54639518|FG002|Year 3|Adverse Event|1|||
27981728|NCT00938717|54639526|FG000|Overall Study|Adverse Event|10|||
27981729|NCT00938717|54639527|FG001|Overall Study|Adverse Event|41|||
27981730|NCT00938717|54639526|FG000|Overall Study|Protocol Violation|11|||
27981731|NCT00938717|54639527|FG001|Overall Study|Protocol Violation|8|||
27981732|NCT00938717|54639526|FG000|Overall Study|Withdrawal by Subject|26|||
27981733|NCT00938717|54639527|FG001|Overall Study|Withdrawal by Subject|24|||
27981734|NCT00938717|54639526|FG000|Overall Study|Lost to Follow-up|13|||
27981735|NCT00938717|54639527|FG001|Overall Study|Lost to Follow-up|18|||
27981736|NCT00938717|54639526|FG000|Overall Study|Lack of Efficacy|33|||
27981737|NCT00938717|54639527|FG001|Overall Study|Lack of Efficacy|15|||
27981738|NCT00938717|54639526|FG000|Overall Study|Other reason|5|||
27981739|NCT00938717|54639527|FG001|Overall Study|Other reason|2|||
27981740|NCT00587223|54639533|FG000|Overall Study|Adverse Event|1|||
27981741|NCT00938639|54639542|FG000|Overall Study|Moved away from study area|0|||
27981742|NCT00938639|54639543|FG001|Overall Study|Moved away from study area|1|||
27981743|NCT00938639|54639542|FG000|Overall Study|Lost to Follow-up|1|||
27981744|NCT00938639|54639543|FG001|Overall Study|Lost to Follow-up|2|||
27981745|NCT00938639|54639542|FG000|Overall Study|Family issues|1|||
27981746|NCT00938639|54639543|FG001|Overall Study|Family issues|1|||
27981747|NCT00938639|54639542|FG000|Overall Study|Participant noncompliance|1|||
27981748|NCT00938639|54639543|FG001|Overall Study|Participant noncompliance|0|||
27981749|NCT00783705|54639555|FG000|Overall Study|Adverse Event|2|||
27981750|NCT00783705|54639556|FG001|Overall Study|Adverse Event|0|||
27981751|NCT00783705|54639555|FG000|Overall Study|Withdrawal by Subject|3|||
27981752|NCT00783705|54639556|FG001|Overall Study|Withdrawal by Subject|2|||
27981753|NCT00783705|54639555|FG000|Overall Study|Lost to Follow-up|1|||
27981754|NCT00783705|54639556|FG001|Overall Study|Lost to Follow-up|3|||
27981755|NCT00604669|54639562|FG000|Overall Study|lack of information in chart|7|||
27981756|NCT00938327|54639566|FG000|Overall Study|Adverse Event|2|||
27981757|NCT00938327|54639566|FG000|Overall Study|Protocol Violation|1|||
27981758|NCT00938327|54639566|FG000|Overall Study|Withdrawal by Subject|4|||
27738953|NCT00002663|54188228|FG005|Overall Study|Adverse Event|0|||
27738954|NCT00002663|54188229|FG006|Overall Study|Adverse Event|0|||
27834601|NCT02689206|54319288|FG004|Overall Study|Adverse Event|2|||
27834602|NCT02689206|54319284|FG000|Overall Study|Protocol Violation|1|||
27834603|NCT02689206|54319285|FG001|Overall Study|Protocol Violation|0|||
27834604|NCT02689206|54319286|FG002|Overall Study|Protocol Violation|0|||
27834605|NCT02689206|54319287|FG003|Overall Study|Protocol Violation|1|||
27834606|NCT02689206|54319288|FG004|Overall Study|Protocol Violation|2|||
27834607|NCT02689206|54319284|FG000|Overall Study|Other: Reached stopping criteria|0|||
27834608|NCT02689206|54319285|FG001|Overall Study|Other: Reached stopping criteria|1|||
27981759|NCT00938327|54639566|FG000|Overall Study|Lost to Follow-up|37|||
27981760|NCT00938327|54639566|FG000|Overall Study|2nd dose received outside of the study|7|||
27981761|NCT00938327|54639566|FG000|Overall Study|Vaccine not received as out of stock|9|||
27738955|NCT00002663|54188230|FG007|Overall Study|Adverse Event|1|||
27738956|NCT00002663|54188231|FG008|Overall Study|Adverse Event|0|||
27834609|NCT02689206|54319286|FG002|Overall Study|Other: Reached stopping criteria|2|||
27834610|NCT02689206|54319287|FG003|Overall Study|Other: Reached stopping criteria|3|||
27862507|NCT02427984|54432199|FG001|Overall Study|Lost to Follow-up|5|||
27862508|NCT02427984|54432200|FG002|Overall Study|Lost to Follow-up|18|||
27862509|NCT00556673|54432418|FG000|Overall Study|Protocol deviation|3|||
27862510|NCT00556673|54432419|FG001|Overall Study|Protocol deviation|2|||
27862511|NCT02402322|54432443|FG000|Pretreatment|Withdrawal by Subject|3|||
27862512|NCT02402322|54432444|FG001|Pretreatment|Withdrawal by Subject|1|||
27862513|NCT02402322|54432445|FG002|Pretreatment|Withdrawal by Subject|1|||
27862514|NCT02402322|54432443|FG000|Follow-up|Withdrawal by Subject|6|||
27862515|NCT02402322|54432444|FG001|Follow-up|Withdrawal by Subject|3|||
27862516|NCT02402322|54432445|FG002|Follow-up|Withdrawal by Subject|24|||
27862517|NCT00555425|54432561|FG000|Overall Study|Missed Medication > 1 wk|34|||
27862518|NCT00555425|54432562|FG001|Overall Study|Missed Medication > 1 wk|15|||
27862519|NCT00555425|54432561|FG000|Overall Study|Missed 3 physician management visits|1|||
27862520|NCT00555425|54432562|FG001|Overall Study|Missed 3 physician management visits|0|||
27862521|NCT00555425|54432561|FG000|Overall Study|Met criteria for protective transfer|16|||
27862522|NCT00555425|54432562|FG001|Overall Study|Met criteria for protective transfer|3|||
27862523|NCT00555425|54432561|FG000|Overall Study|Became pregnant and transferred care|0|||
27862524|NCT00555425|54432562|FG001|Overall Study|Became pregnant and transferred care|1|||
27862525|NCT00554099|54432743|FG000|Treatment Period (12 Weeks)|Adverse Event|3|||
27862526|NCT00554099|54432744|FG001|Treatment Period (12 Weeks)|Adverse Event|5|||
27862527|NCT00554099|54432745|FG002|Treatment Period (12 Weeks)|Adverse Event|1|||
27862528|NCT00554099|54432743|FG000|Treatment Period (12 Weeks)|Physician Decision|3|||
27862529|NCT00554099|54432744|FG001|Treatment Period (12 Weeks)|Physician Decision|0|||
27862530|NCT00554099|54432745|FG002|Treatment Period (12 Weeks)|Physician Decision|0|||
27862531|NCT00554099|54432743|FG000|Treatment Period (12 Weeks)|Lost to Follow-up|1|||
27862532|NCT00554099|54432744|FG001|Treatment Period (12 Weeks)|Lost to Follow-up|0|||
27862533|NCT00554099|54432745|FG002|Treatment Period (12 Weeks)|Lost to Follow-up|2|||
27862534|NCT00554099|54432743|FG000|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1|||
27862535|NCT00554099|54432744|FG001|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2|||
27862536|NCT00554099|54432745|FG002|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0|||
27862537|NCT00554099|54432743|FG000|Treatment Period (12 Weeks)|Protocol Violation|0|||
27862538|NCT00554099|54432744|FG001|Treatment Period (12 Weeks)|Protocol Violation|0|||
27862539|NCT00554099|54432745|FG002|Treatment Period (12 Weeks)|Protocol Violation|2|||
27862540|NCT00554099|54432743|FG000|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
27862541|NCT00554099|54432744|FG001|Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
27862542|NCT00554099|54432745|FG002|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
27862543|NCT00554099|54432743|FG000|Non-Treatment Phase (9 Months)|Lost to Follow-up|1|||
27862544|NCT00554099|54432744|FG001|Non-Treatment Phase (9 Months)|Lost to Follow-up|2|||
27862545|NCT00554099|54432745|FG002|Non-Treatment Phase (9 Months)|Lost to Follow-up|0|||
27862546|NCT00554099|54432743|FG000|Non-Treatment Phase (9 Months)|Relapse|2|||
27862547|NCT00554099|54432744|FG001|Non-Treatment Phase (9 Months)|Relapse|1|||
27862548|NCT00554099|54432745|FG002|Non-Treatment Phase (9 Months)|Relapse|1|||
27862549|NCT00554099|54432743|FG000|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4|||
27862550|NCT00554099|54432744|FG001|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
27862551|NCT00554099|54432745|FG002|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
27862552|NCT02377362|54432779|FG000|Part A Second Treatment|Protocol Violation|0|||
27862553|NCT02377362|54432780|FG001|Part A Second Treatment|Protocol Violation|0|||
27862554|NCT02377362|54432781|FG002|Part A Second Treatment|Protocol Violation|0|||
27862555|NCT02377362|54432782|FG003|Part A Second Treatment|Protocol Violation|0|||
27862556|NCT02377362|54432783|FG004|Part A Second Treatment|Protocol Violation|1|||
27862557|NCT02377362|54432784|FG005|Part A Second Treatment|Protocol Violation|0|||
27862558|NCT02377362|54432785|FG006|Part A Second Treatment|Protocol Violation|0|||
27862559|NCT02377362|54432786|FG007|Part A Second Treatment|Protocol Violation|0|||
27862560|NCT02377362|54432787|FG008|Part A Second Treatment|Protocol Violation|0|||
27862561|NCT02377362|54432788|FG009|Part A Second Treatment|Protocol Violation|0|||
27862562|NCT02377362|54432789|FG010|Part A Second Treatment|Protocol Violation|0|||
27862563|NCT02377362|54432790|FG011|Part A Second Treatment|Protocol Violation|0|||
27862564|NCT02377362|54432791|FG012|Part A Second Treatment|Protocol Violation|0|||
27862565|NCT02377362|54432779|FG000|Part A Third Treatment|Highest dose level 1200 not used|0|||
27862566|NCT02377362|54432780|FG001|Part A Third Treatment|Highest dose level 1200 not used|0|||
27862567|NCT02377362|54432781|FG002|Part A Third Treatment|Highest dose level 1200 not used|0|||
27862568|NCT02377362|54432782|FG003|Part A Third Treatment|Highest dose level 1200 not used|4|||
27862569|NCT02377362|54432783|FG004|Part A Third Treatment|Highest dose level 1200 not used|3|||
27862570|NCT02377362|54432784|FG005|Part A Third Treatment|Highest dose level 1200 not used|4|||
27862571|NCT02377362|54432785|FG006|Part A Third Treatment|Highest dose level 1200 not used|0|||
27862572|NCT02377362|54432786|FG007|Part A Third Treatment|Highest dose level 1200 not used|0|||
27862573|NCT02377362|54432787|FG008|Part A Third Treatment|Highest dose level 1200 not used|0|||
27862574|NCT02377362|54432788|FG009|Part A Third Treatment|Highest dose level 1200 not used|0|||
27862575|NCT02377362|54432789|FG010|Part A Third Treatment|Highest dose level 1200 not used|0|||
27862576|NCT02377362|54432790|FG011|Part A Third Treatment|Highest dose level 1200 not used|0|||
27862577|NCT02377362|54432791|FG012|Part A Third Treatment|Highest dose level 1200 not used|0|||
27862578|NCT02377362|54432779|FG000|Part B Overall|Protocol Violation|0|||
27862579|NCT02377362|54432780|FG001|Part B Overall|Protocol Violation|0|||
27862580|NCT02377362|54432781|FG002|Part B Overall|Protocol Violation|0|||
27862581|NCT02377362|54432782|FG003|Part B Overall|Protocol Violation|0|||
27862582|NCT02377362|54432783|FG004|Part B Overall|Protocol Violation|0|||
27862583|NCT02377362|54432784|FG005|Part B Overall|Protocol Violation|0|||
27862584|NCT02377362|54432785|FG006|Part B Overall|Protocol Violation|0|||
27862585|NCT02377362|54432786|FG007|Part B Overall|Protocol Violation|0|||
27862586|NCT02377362|54432787|FG008|Part B Overall|Protocol Violation|0|||
27862587|NCT02377362|54432788|FG009|Part B Overall|Protocol Violation|1|||
27862588|NCT02377362|54432789|FG010|Part B Overall|Protocol Violation|0|||
27862589|NCT02377362|54432790|FG011|Part B Overall|Protocol Violation|0|||
27862590|NCT02377362|54432791|FG012|Part B Overall|Protocol Violation|0|||
27862591|NCT02377362|54432779|FG000|Part B Overall|Adverse Event|0|||
27862592|NCT02377362|54432780|FG001|Part B Overall|Adverse Event|0|||
27862593|NCT02377362|54432781|FG002|Part B Overall|Adverse Event|0|||
27862594|NCT02377362|54432782|FG003|Part B Overall|Adverse Event|0|||
27862595|NCT02377362|54432783|FG004|Part B Overall|Adverse Event|0|||
27862596|NCT02377362|54432784|FG005|Part B Overall|Adverse Event|0|||
27862597|NCT02377362|54432785|FG006|Part B Overall|Adverse Event|1|||
27862598|NCT02377362|54432786|FG007|Part B Overall|Adverse Event|1|||
27862599|NCT02377362|54432787|FG008|Part B Overall|Adverse Event|0|||
27862600|NCT02377362|54432788|FG009|Part B Overall|Adverse Event|0|||
27862601|NCT02377362|54432789|FG010|Part B Overall|Adverse Event|0|||
27862602|NCT02377362|54432790|FG011|Part B Overall|Adverse Event|0|||
27862603|NCT02377362|54432791|FG012|Part B Overall|Adverse Event|0|||
27862604|NCT02377362|54432779|FG000|Part B Overall|Withdrawal by Subject|0|||
27862605|NCT02377362|54432780|FG001|Part B Overall|Withdrawal by Subject|0|||
27862606|NCT02377362|54432781|FG002|Part B Overall|Withdrawal by Subject|0|||
27862607|NCT02377362|54432782|FG003|Part B Overall|Withdrawal by Subject|0|||
27862608|NCT02377362|54432783|FG004|Part B Overall|Withdrawal by Subject|0|||
27862609|NCT02377362|54432784|FG005|Part B Overall|Withdrawal by Subject|0|||
27862610|NCT02377362|54432785|FG006|Part B Overall|Withdrawal by Subject|1|||
27862611|NCT02377362|54432786|FG007|Part B Overall|Withdrawal by Subject|0|||
27862612|NCT02377362|54432787|FG008|Part B Overall|Withdrawal by Subject|0|||
27862613|NCT02377362|54432788|FG009|Part B Overall|Withdrawal by Subject|0|||
27862614|NCT02377362|54432789|FG010|Part B Overall|Withdrawal by Subject|0|||
27862615|NCT02377362|54432790|FG011|Part B Overall|Withdrawal by Subject|1|||
27862616|NCT02377362|54432791|FG012|Part B Overall|Withdrawal by Subject|0|||
27862617|NCT00553631|54432831|FG000|Overall Study|Withdrawal by Subject|0|||
27862618|NCT00553631|54432832|FG001|Overall Study|Withdrawal by Subject|1|||
27862619|NCT00553631|54432831|FG000|Overall Study|Lost to Follow-up|1|||
27862620|NCT00553631|54432832|FG001|Overall Study|Lost to Follow-up|0|||
27862621|NCT00553319|54432850|FG000|Overall Study|Lost to Follow-up|10|||
27862622|NCT00553319|54432851|FG001|Overall Study|Lost to Follow-up|9|||
27862623|NCT00553319|54432852|FG002|Overall Study|Lost to Follow-up|5|||
27862624|NCT00553319|54432850|FG000|Overall Study|wanted treatment elsewhere|2|||
27862625|NCT00553319|54432851|FG001|Overall Study|wanted treatment elsewhere|1|||
27862626|NCT00553319|54432852|FG002|Overall Study|wanted treatment elsewhere|1|||
27862627|NCT00553319|54432850|FG000|Overall Study|non-compliance|0|||
27862628|NCT00553319|54432851|FG001|Overall Study|non-compliance|0|||
27862629|NCT00553319|54432852|FG002|Overall Study|non-compliance|2|||
27862630|NCT00553319|54432850|FG000|Overall Study|incarceration|1|||
27862631|NCT00553319|54432851|FG001|Overall Study|incarceration|0|||
27862632|NCT00553319|54432852|FG002|Overall Study|incarceration|0|||
27862633|NCT00553319|54432850|FG000|Overall Study|moved|1|||
27862634|NCT00553319|54432851|FG001|Overall Study|moved|0|||
27862635|NCT00553319|54432852|FG002|Overall Study|moved|1|||
27862636|NCT01649856|54433038|FG000|Overall Study|Withdrawal by Subject|14|||
27862637|NCT01649856|54433039|FG001|Overall Study|Withdrawal by Subject|14|||
27862638|NCT01649856|54433038|FG000|Overall Study|Protocol Violation|4|||
27862639|NCT01649856|54433039|FG001|Overall Study|Protocol Violation|4|||
27862640|NCT01649856|54433038|FG000|Overall Study|Treatment Failure|1|||
27862641|NCT01649856|54433039|FG001|Overall Study|Treatment Failure|1|||
27981762|NCT00887198|54639572|FG000|Randomized Period|Ongoing|42|||
27981763|NCT00887198|54639573|FG001|Randomized Period|Ongoing|0|||
28096081|NCT04349098|54750761|FG000|Overall Study|Lost to Follow-up|11|||
27738957|NCT00002663|54188232|FG009|Overall Study|Adverse Event|0|||
27738958|NCT02240680|54188243|FG000|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
27862642|NCT01649856|54433038|FG000|Overall Study|Death|69|||
27862643|NCT01649856|54433039|FG001|Overall Study|Death|34|||
27862644|NCT01649856|54433038|FG000|Overall Study|Stable or Progressed Disease|5|||
27862645|NCT01649856|54433039|FG001|Overall Study|Stable or Progressed Disease|3|||
27862646|NCT01649856|54433038|FG000|Overall Study|Lost to Follow-up|20|||
27862647|NCT01649856|54433039|FG001|Overall Study|Lost to Follow-up|16|||
27862648|NCT01649856|54433038|FG000|Overall Study|Lack of Compliance|6|||
27862649|NCT01649856|54433039|FG001|Overall Study|Lack of Compliance|1|||
27862650|NCT01649856|54433038|FG000|Overall Study|Other|20|||
27981764|NCT00887198|54639574|FG002|Randomized Period|Ongoing|0|||
27862651|NCT01649856|54433039|FG001|Overall Study|Other|5|||
27862652|NCT02375724|54433060|FG000|Overall Study|Lack of Efficacy|1|||
27862653|NCT02375724|54433061|FG001|Overall Study|Lack of Efficacy|1|||
27862654|NCT02375724|54433060|FG000|Overall Study|Withdrawal by Subject|1|||
27862655|NCT02375724|54433061|FG001|Overall Study|Withdrawal by Subject|1|||
27862656|NCT02375724|54433060|FG000|Overall Study|Lost to Follow-up|1|||
27862657|NCT02375724|54433061|FG001|Overall Study|Lost to Follow-up|0|||
27862658|NCT02375724|54433060|FG000|Overall Study|Protocol Violation|1|||
27862659|NCT02375724|54433061|FG001|Overall Study|Protocol Violation|0|||
27862660|NCT02375724|54433060|FG000|Overall Study|Adverse Event|2|||
27862661|NCT02375724|54433061|FG001|Overall Study|Adverse Event|4|||
27862662|NCT02398188|54433069|FG000|Overall Study|Adverse Event|2|||
27862663|NCT02398188|54433070|FG001|Overall Study|Adverse Event|3|||
27862664|NCT02398188|54433069|FG000|Overall Study|Lost to Follow-up|5|||
27862665|NCT02398188|54433070|FG001|Overall Study|Lost to Follow-up|0|||
27862666|NCT02398188|54433069|FG000|Overall Study|Non-compliance|4|||
27862667|NCT02398188|54433070|FG001|Overall Study|Non-compliance|4|||
27862668|NCT02398188|54433069|FG000|Overall Study|Protocol Violation|6|||
27862669|NCT02398188|54433070|FG001|Overall Study|Protocol Violation|10|||
27862670|NCT02398188|54433069|FG000|Overall Study|Sponsor Decision|2|||
27862671|NCT02398188|54433070|FG001|Overall Study|Sponsor Decision|1|||
27862672|NCT02398188|54433069|FG000|Overall Study|Pregnancy|1|||
27862673|NCT02398188|54433070|FG001|Overall Study|Pregnancy|0|||
27862674|NCT02398188|54433069|FG000|Overall Study|Withdrawal by Subject|7|||
27862675|NCT02398188|54433070|FG001|Overall Study|Withdrawal by Subject|16|||
27862676|NCT02426580|54433078|FG000|Overall Study|Death|2|||
27862677|NCT02426580|54433079|FG001|Overall Study|Death|2|||
27862678|NCT02426580|54433078|FG000|Overall Study|Lost to Follow-up|0|||
27862679|NCT02426580|54433079|FG001|Overall Study|Lost to Follow-up|9|||
27862680|NCT02426580|54433078|FG000|Overall Study|transfer to hemodialysis|5|||
27862681|NCT02426580|54433079|FG001|Overall Study|transfer to hemodialysis|5|||
27862682|NCT02426580|54433078|FG000|Overall Study|Kidney transplant|3|||
27862683|NCT02426580|54433079|FG001|Overall Study|Kidney transplant|0|||
27862684|NCT02426580|54433078|FG000|Overall Study|Allergic to egg white|1|||
27862685|NCT02426580|54433079|FG001|Overall Study|Allergic to egg white|0|||
27862686|NCT01651260|54433085|FG000|Overall Study|unable to apply product|3|||
27862687|NCT02425098|54433105|FG000|Overall Study|Lost to Follow-up|7|||
27862688|NCT02425098|54433106|FG001|Overall Study|Lost to Follow-up|7|||
27862689|NCT02425098|54433105|FG000|Overall Study|Withdrawal by Subject|4|||
27862690|NCT02425098|54433106|FG001|Overall Study|Withdrawal by Subject|8|||
27862691|NCT02425098|54433105|FG000|Overall Study|Pregnancy|2|||
27862692|NCT02425098|54433106|FG001|Overall Study|Pregnancy|0|||
27862693|NCT02425098|54433105|FG000|Overall Study|Reason not Specified|0|||
27862694|NCT02425098|54433106|FG001|Overall Study|Reason not Specified|1|||
27862695|NCT02424630|54433114|FG000|Overall Study|No rotator cuff tear|1|||
27862696|NCT02424630|54433115|FG001|Overall Study|No rotator cuff tear|2|||
27862697|NCT02424630|54433114|FG000|Overall Study|Open procedure|0|||
27862698|NCT02424630|54433115|FG001|Overall Study|Open procedure|1|||
27862699|NCT02397408|54433121|FG000|Overall Study|Physician Decision|4|||
27862700|NCT02397408|54433121|FG000|Overall Study|Surgery not completed within protocol timeframe|2|||
27862701|NCT02397096|54433127|FG000|Day 1 to Week 24|Adverse Event|7|||
27862702|NCT02397096|54433128|FG001|Day 1 to Week 24|Adverse Event|1|||
27862703|NCT02397096|54433127|FG000|Day 1 to Week 24|Death|1|||
27862704|NCT02397096|54433128|FG001|Day 1 to Week 24|Death|0|||
27862705|NCT02397096|54433127|FG000|Day 1 to Week 24|Lack of Efficacy|0|||
27862706|NCT02397096|54433128|FG001|Day 1 to Week 24|Lack of Efficacy|1|||
27862707|NCT02397096|54433127|FG000|Day 1 to Week 24|Lost to Follow-up|3|||
27862708|NCT02397096|54433128|FG001|Day 1 to Week 24|Lost to Follow-up|4|||
27862709|NCT02397096|54433127|FG000|Day 1 to Week 24|Physician Decision|2|||
27862710|NCT02397096|54433128|FG001|Day 1 to Week 24|Physician Decision|3|||
27862711|NCT02397096|54433127|FG000|Day 1 to Week 24|Protocol Violation|1|||
27862712|NCT02397096|54433128|FG001|Day 1 to Week 24|Protocol Violation|4|||
27862713|NCT02397096|54433127|FG000|Day 1 to Week 24|Withdrawal by Subject|6|||
27862714|NCT02397096|54433128|FG001|Day 1 to Week 24|Withdrawal by Subject|1|||
27862715|NCT02397096|54433127|FG000|Week 24 to Week 48|Adverse Event|6|||
27862716|NCT02397096|54433128|FG001|Week 24 to Week 48|Adverse Event|2|||
27862717|NCT02397096|54433127|FG000|Week 24 to Week 48|Lack of Efficacy|5|||
27862718|NCT02397096|54433128|FG001|Week 24 to Week 48|Lack of Efficacy|1|||
27862719|NCT02397096|54433127|FG000|Week 24 to Week 48|Non-Compliance With Study Drug|0|||
27862720|NCT02397096|54433128|FG001|Week 24 to Week 48|Non-Compliance With Study Drug|1|||
27862721|NCT02397096|54433127|FG000|Week 24 to Week 48|Physician Decision|2|||
27862722|NCT02397096|54433128|FG001|Week 24 to Week 48|Physician Decision|1|||
27862723|NCT02397096|54433127|FG000|Week 24 to Week 48|Withdrawal by Subject|5|||
27862724|NCT02397096|54433128|FG001|Week 24 to Week 48|Withdrawal by Subject|2|||
27862725|NCT02397096|54433127|FG000|Week 24 to Week 48|Lost to Follow-up|2|||
27862726|NCT02397096|54433128|FG001|Week 24 to Week 48|Lost to Follow-up|0|||
27862727|NCT02397096|54433127|FG000|Study Extensions|Ongoing|399|||
27862728|NCT02397096|54433128|FG001|Study Extensions|Ongoing|202|||
27862729|NCT02372058|54433138|FG000|Overall Study|Withdrawal by Subject|3|||
27862730|NCT02396316|54433146|FG000|Overall Study|Physician Decision|1|||
27862731|NCT02396316|54433147|FG001|Overall Study|Physician Decision|0|||
27862732|NCT02396316|54433146|FG000|Overall Study|Progressive disease|6|||
27862733|NCT02396316|54433147|FG001|Overall Study|Progressive disease|3|||
27862734|NCT02396316|54433146|FG000|Overall Study|Protocol Violation|0|||
27862735|NCT02396316|54433147|FG001|Overall Study|Protocol Violation|1|||
27862736|NCT02396316|54433146|FG000|Overall Study|Treatment unblinded|0|||
27862737|NCT02396316|54433147|FG001|Overall Study|Treatment unblinded|1|||
27862738|NCT02395536|54433157|FG000|Overall Study|Lost to Follow-up|4|||
27862739|NCT02395536|54433158|FG001|Overall Study|Lost to Follow-up|4|||
27862740|NCT02395536|54433157|FG000|Overall Study|Death|2|||
27862741|NCT02395536|54433158|FG001|Overall Study|Death|0|||
27862742|NCT02395536|54433157|FG000|Overall Study|Physician Decision|4|||
27862743|NCT02395536|54433158|FG001|Overall Study|Physician Decision|6|||
27862744|NCT02395536|54433157|FG000|Overall Study|Withdrawal by Subject|9|||
27862745|NCT02395536|54433158|FG001|Overall Study|Withdrawal by Subject|17|||
27862746|NCT02395536|54433157|FG000|Overall Study|Inclusion/Excusion Criteria Violation|1|||
27862747|NCT02395536|54433158|FG001|Overall Study|Inclusion/Excusion Criteria Violation|2|||
27862748|NCT02395536|54433157|FG000|Overall Study|Insurance issue|0|||
27862749|NCT02395536|54433158|FG001|Overall Study|Insurance issue|1|||
27862750|NCT00552929|54433174|FG000|Overall Study|Lost to Follow-up|0|||
27862751|NCT00552929|54433175|FG001|Overall Study|Lost to Follow-up|0|||
27862752|NCT00552929|54433176|FG002|Overall Study|Lost to Follow-up|0|||
27862753|NCT00552929|54433177|FG003|Overall Study|Lost to Follow-up|0|||
27862754|NCT00552929|54433178|FG004|Overall Study|Lost to Follow-up|0|||
27862755|NCT00552929|54433179|FG005|Overall Study|Lost to Follow-up|0|||
27862756|NCT00552929|54433180|FG006|Overall Study|Lost to Follow-up|0|||
27862757|NCT00552929|54433181|FG007|Overall Study|Lost to Follow-up|0|||
27862758|NCT00552929|54433182|FG008|Overall Study|Lost to Follow-up|1|||
27862759|NCT00552929|54433183|FG009|Overall Study|Lost to Follow-up|0|||
27862760|NCT00552929|54433174|FG000|Overall Study|Not Eligible|0|||
27862761|NCT00552929|54433175|FG001|Overall Study|Not Eligible|0|||
27862762|NCT00552929|54433176|FG002|Overall Study|Not Eligible|0|||
27862763|NCT00552929|54433177|FG003|Overall Study|Not Eligible|0|||
27862764|NCT00552929|54433178|FG004|Overall Study|Not Eligible|0|||
27862765|NCT00552929|54433179|FG005|Overall Study|Not Eligible|1|||
27862766|NCT00552929|54433180|FG006|Overall Study|Not Eligible|0|||
27862767|NCT00552929|54433181|FG007|Overall Study|Not Eligible|0|||
27862768|NCT00552929|54433182|FG008|Overall Study|Not Eligible|0|||
27862769|NCT00552929|54433183|FG009|Overall Study|Not Eligible|0|||
27862770|NCT02395302|54433205|FG000|Overall Study|Screen Failure|3|||
27862771|NCT02395302|54433205|FG000|Overall Study|Run In Failure|7|||
27862772|NCT02395302|54433205|FG000|Overall Study|Withdrawal by Subject|2|||
27862773|NCT02395302|54433205|FG000|Overall Study|Physician Decision|2|||
27862774|NCT02371980|54433239|FG000|Open-label Period|Pretreatment Event/Adverse Event|63|||
27862775|NCT02371980|54433240|FG001|Open-label Period|Pretreatment Event/Adverse Event|0|||
27862776|NCT02371980|54433241|FG002|Open-label Period|Pretreatment Event/Adverse Event|0|||
27862777|NCT02371980|54433242|FG003|Open-label Period|Pretreatment Event/Adverse Event|0|||
27862778|NCT02371980|54433243|FG004|Open-label Period|Pretreatment Event/Adverse Event|0|||
27862779|NCT02371980|54433239|FG000|Open-label Period|Significant Protocol Deviation|19|||
27862780|NCT02371980|54433240|FG001|Open-label Period|Significant Protocol Deviation|0|||
27862781|NCT02371980|54433241|FG002|Open-label Period|Significant Protocol Deviation|0|||
27862782|NCT02371980|54433242|FG003|Open-label Period|Significant Protocol Deviation|0|||
27862783|NCT02371980|54433243|FG004|Open-label Period|Significant Protocol Deviation|0|||
27862784|NCT02371980|54433239|FG000|Open-label Period|Noncompliance with Study Drug|10|||
27862785|NCT02371980|54433240|FG001|Open-label Period|Noncompliance with Study Drug|0|||
27862786|NCT02371980|54433241|FG002|Open-label Period|Noncompliance with Study Drug|0|||
27862787|NCT02371980|54433242|FG003|Open-label Period|Noncompliance with Study Drug|0|||
27862788|NCT02371980|54433243|FG004|Open-label Period|Noncompliance with Study Drug|0|||
27862789|NCT02371980|54433239|FG000|Open-label Period|Lost to Follow-up|55|||
27862790|NCT02371980|54433240|FG001|Open-label Period|Lost to Follow-up|0|||
27862791|NCT02371980|54433241|FG002|Open-label Period|Lost to Follow-up|0|||
27862792|NCT02371980|54433242|FG003|Open-label Period|Lost to Follow-up|0|||
27862793|NCT02371980|54433243|FG004|Open-label Period|Lost to Follow-up|0|||
27862794|NCT02371980|54433239|FG000|Open-label Period|Voluntary Withdrawal|91|||
27862795|NCT02371980|54433240|FG001|Open-label Period|Voluntary Withdrawal|0|||
27862796|NCT02371980|54433241|FG002|Open-label Period|Voluntary Withdrawal|0|||
27862797|NCT02371980|54433242|FG003|Open-label Period|Voluntary Withdrawal|0|||
27862798|NCT02371980|54433243|FG004|Open-label Period|Voluntary Withdrawal|0|||
27862799|NCT02371980|54433239|FG000|Open-label Period|Pregnancy|1|||
27981765|NCT00887198|54639572|FG000|Randomized Period|Adverse Event|50|||
27981766|NCT00887198|54639573|FG001|Randomized Period|Adverse Event|33|||
27862800|NCT02371980|54433240|FG001|Open-label Period|Pregnancy|0|||
27862801|NCT02371980|54433241|FG002|Open-label Period|Pregnancy|0|||
27862802|NCT02371980|54433242|FG003|Open-label Period|Pregnancy|0|||
27862803|NCT02371980|54433243|FG004|Open-label Period|Pregnancy|0|||
27862804|NCT02371980|54433239|FG000|Open-label Period|Lack of Efficacy|116|||
27862805|NCT02371980|54433240|FG001|Open-label Period|Lack of Efficacy|0|||
27862806|NCT02371980|54433241|FG002|Open-label Period|Lack of Efficacy|0|||
27862807|NCT02371980|54433242|FG003|Open-label Period|Lack of Efficacy|0|||
27862808|NCT02371980|54433243|FG004|Open-label Period|Lack of Efficacy|0|||
27862809|NCT02371980|54433239|FG000|Open-label Period|Did not Meet Randomization Criteria|162|||
27862810|NCT02371980|54433240|FG001|Open-label Period|Did not Meet Randomization Criteria|0|||
27862811|NCT02371980|54433241|FG002|Open-label Period|Did not Meet Randomization Criteria|0|||
27862812|NCT02371980|54433242|FG003|Open-label Period|Did not Meet Randomization Criteria|0|||
27862813|NCT02371980|54433243|FG004|Open-label Period|Did not Meet Randomization Criteria|0|||
27862814|NCT02371980|54433239|FG000|Open-label Period|Reason not Specified|9|||
27862815|NCT02371980|54433240|FG001|Open-label Period|Reason not Specified|0|||
27862816|NCT02371980|54433241|FG002|Open-label Period|Reason not Specified|0|||
27862817|NCT02371980|54433242|FG003|Open-label Period|Reason not Specified|0|||
27862818|NCT02371980|54433243|FG004|Open-label Period|Reason not Specified|0|||
27862819|NCT02371980|54433239|FG000|Double-blind Period|Pretreatment Event/Adverse Event|0|||
27862820|NCT02371980|54433240|FG001|Double-blind Period|Pretreatment Event/Adverse Event|4|||
27862821|NCT02371980|54433241|FG002|Double-blind Period|Pretreatment Event/Adverse Event|3|||
27862822|NCT02371980|54433242|FG003|Double-blind Period|Pretreatment Event/Adverse Event|2|||
27862823|NCT02371980|54433243|FG004|Double-blind Period|Pretreatment Event/Adverse Event|9|||
27862824|NCT02371980|54433239|FG000|Double-blind Period|Significant Protocol Deviation|0|||
27862825|NCT02371980|54433240|FG001|Double-blind Period|Significant Protocol Deviation|2|||
27862826|NCT02371980|54433241|FG002|Double-blind Period|Significant Protocol Deviation|7|||
27862827|NCT02371980|54433242|FG003|Double-blind Period|Significant Protocol Deviation|3|||
27862828|NCT02371980|54433243|FG004|Double-blind Period|Significant Protocol Deviation|3|||
27862829|NCT02371980|54433239|FG000|Double-blind Period|Noncompliance with Study Drug|0|||
27862830|NCT02371980|54433240|FG001|Double-blind Period|Noncompliance with Study Drug|1|||
27862831|NCT02371980|54433241|FG002|Double-blind Period|Noncompliance with Study Drug|2|||
27862832|NCT02371980|54433242|FG003|Double-blind Period|Noncompliance with Study Drug|2|||
27862833|NCT02371980|54433243|FG004|Double-blind Period|Noncompliance with Study Drug|3|||
27862834|NCT02371980|54433239|FG000|Double-blind Period|Lost to Follow-up|0|||
27862835|NCT02371980|54433240|FG001|Double-blind Period|Lost to Follow-up|8|||
27862836|NCT02371980|54433241|FG002|Double-blind Period|Lost to Follow-up|8|||
27862837|NCT02371980|54433242|FG003|Double-blind Period|Lost to Follow-up|6|||
27862838|NCT02371980|54433243|FG004|Double-blind Period|Lost to Follow-up|5|||
27862839|NCT02371980|54433239|FG000|Double-blind Period|Voluntary Withdrawal|0|||
27862840|NCT02371980|54433240|FG001|Double-blind Period|Voluntary Withdrawal|12|||
27862841|NCT02371980|54433241|FG002|Double-blind Period|Voluntary Withdrawal|8|||
27862842|NCT02371980|54433242|FG003|Double-blind Period|Voluntary Withdrawal|9|||
27862843|NCT02371980|54433243|FG004|Double-blind Period|Voluntary Withdrawal|11|||
27862844|NCT02371980|54433239|FG000|Double-blind Period|Relapse|0|||
27862845|NCT02371980|54433240|FG001|Double-blind Period|Relapse|50|||
27862846|NCT02371980|54433241|FG002|Double-blind Period|Relapse|25|||
27862847|NCT02371980|54433242|FG003|Double-blind Period|Relapse|25|||
27862848|NCT02371980|54433243|FG004|Double-blind Period|Relapse|26|||
27862849|NCT02371980|54433239|FG000|Double-blind Period|Reason not Specified|0|||
27862850|NCT02371980|54433240|FG001|Double-blind Period|Reason not Specified|3|||
27862851|NCT02371980|54433241|FG002|Double-blind Period|Reason not Specified|3|||
27862852|NCT02371980|54433242|FG003|Double-blind Period|Reason not Specified|2|||
27862853|NCT02371980|54433243|FG004|Double-blind Period|Reason not Specified|1|||
27862854|NCT02371980|54433239|FG000|Double-blind Period|Missing|0|||
27862855|NCT02371980|54433240|FG001|Double-blind Period|Missing|1|||
27862856|NCT02371980|54433241|FG002|Double-blind Period|Missing|0|||
27862857|NCT02371980|54433242|FG003|Double-blind Period|Missing|0|||
27862858|NCT02371980|54433243|FG004|Double-blind Period|Missing|0|||
27834611|NCT02689206|54319288|FG004|Overall Study|Other: Reached stopping criteria|4|||
27834612|NCT02689206|54319284|FG000|Overall Study|Physician Decision|1|||
27862859|NCT02371746|54433383|FG000|Overall Study|Consent withdrawn|0|||
27862860|NCT02371746|54433384|FG001|Overall Study|Consent withdrawn|0|||
27862861|NCT02371746|54433385|FG002|Overall Study|Consent withdrawn|0|||
27862862|NCT02371746|54433386|FG003|Overall Study|Consent withdrawn|0|||
27862863|NCT02371746|54433387|FG004|Overall Study|Consent withdrawn|0|||
27862864|NCT02371746|54433388|FG005|Overall Study|Consent withdrawn|0|||
27862865|NCT02371746|54433389|FG006|Overall Study|Consent withdrawn|1|||
27862866|NCT02421666|54433437|FG000|6-month Follow-up|Lost to Follow-up|8|||
27862867|NCT02421666|54433438|FG001|6-month Follow-up|Lost to Follow-up|7|||
27834613|NCT02689206|54319285|FG001|Overall Study|Physician Decision|0|||
27834614|NCT02689206|54319286|FG002|Overall Study|Physician Decision|0|||
27834615|NCT02689206|54319287|FG003|Overall Study|Physician Decision|0|||
27834616|NCT02689206|54319288|FG004|Overall Study|Physician Decision|0|||
27834617|NCT02689206|54319284|FG000|Overall Study|Withdrawal by Subject|1|||
27834618|NCT02689206|54319285|FG001|Overall Study|Withdrawal by Subject|0|||
27834619|NCT02689206|54319286|FG002|Overall Study|Withdrawal by Subject|1|||
27834620|NCT02689206|54319287|FG003|Overall Study|Withdrawal by Subject|0|||
27834621|NCT02689206|54319288|FG004|Overall Study|Withdrawal by Subject|0|||
27862868|NCT02421666|54433437|FG000|6-month Follow-up|Withdrawal by Subject|5|||
27862869|NCT02421666|54433438|FG001|6-month Follow-up|Withdrawal by Subject|6|||
27862870|NCT02421666|54433437|FG000|12-month Follow-up|Lost to Follow-up|5|||
27862871|NCT02421666|54433438|FG001|12-month Follow-up|Lost to Follow-up|5|||
27862872|NCT02421666|54433437|FG000|12-month Follow-up|Withdrawal by Subject|6|||
27862873|NCT02421666|54433438|FG001|12-month Follow-up|Withdrawal by Subject|11|||
27862874|NCT02394756|54433448|FG000|Period 1|Lens Discomfort|0|||
27862875|NCT02394756|54433449|FG001|Period 1|Lens Discomfort|0|||
27862876|NCT02394756|54433450|FG002|Period 1|Lens Discomfort|0|||
27862877|NCT02394756|54433451|FG003|Period 1|Lens Discomfort|0|||
27862878|NCT02394756|54433452|FG004|Period 1|Lens Discomfort|0|||
27862879|NCT02394756|54433453|FG005|Period 1|Lens Discomfort|1|||
27862880|NCT02394756|54433448|FG000|Period 1|Withdrawal by Subject|0|||
27862881|NCT02394756|54433449|FG001|Period 1|Withdrawal by Subject|1|||
27862882|NCT02394756|54433450|FG002|Period 1|Withdrawal by Subject|1|||
27862883|NCT02394756|54433451|FG003|Period 1|Withdrawal by Subject|1|||
27862884|NCT02394756|54433452|FG004|Period 1|Withdrawal by Subject|0|||
27862885|NCT02394756|54433453|FG005|Period 1|Withdrawal by Subject|0|||
28096082|NCT04349098|54750762|FG001|Overall Study|Lost to Follow-up|8|||
28096083|NCT04349098|54750761|FG000|Overall Study|Withdrawal by Subject|8|||
28096084|NCT04349098|54750762|FG001|Overall Study|Withdrawal by Subject|5|||
28096085|NCT04349098|54750761|FG000|Overall Study|Other|3|||
28171332|NCT02720523|54842905|FG006|Period 2: Long-term Extension Period|Adverse Event|11|||
27862886|NCT02394756|54433448|FG000|Period 2|Unsatisfactory Visual Response|0|||
27862887|NCT02394756|54433449|FG001|Period 2|Unsatisfactory Visual Response|0|||
27862888|NCT02394756|54433450|FG002|Period 2|Unsatisfactory Visual Response|0|||
27862889|NCT02394756|54433451|FG003|Period 2|Unsatisfactory Visual Response|0|||
27862890|NCT02394756|54433452|FG004|Period 2|Unsatisfactory Visual Response|1|||
27862891|NCT02394756|54433453|FG005|Period 2|Unsatisfactory Visual Response|0|||
27862892|NCT02370888|54433474|FG000|Overall Study|disease progression|2|||
27862893|NCT02370888|54433474|FG000|Overall Study|did not meet chimerism criteria|6|||
27862894|NCT02394600|54433498|FG000|Overall Study|Adverse Event|3|||
27862895|NCT02394600|54433499|FG001|Overall Study|Adverse Event|0|||
27862896|NCT02394600|54433498|FG000|Overall Study|Lost to Follow-up|0|||
27862897|NCT02394600|54433499|FG001|Overall Study|Lost to Follow-up|1|||
27862898|NCT02394600|54433498|FG000|Overall Study|Withdrawal by Subject|0|||
27862899|NCT02394600|54433499|FG001|Overall Study|Withdrawal by Subject|1|||
27862900|NCT02394600|54433498|FG000|Overall Study|Protocol Violation|1|||
27862901|NCT02394600|54433499|FG001|Overall Study|Protocol Violation|0|||
28171333|NCT02720523|54842899|FG000|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
28171334|NCT02720523|54842900|FG001|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
28171335|NCT02720523|54842901|FG002|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
28171336|NCT02720523|54842902|FG003|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
27862902|NCT04685499|54433515|FG000|Overall Study|Study Terminated Early|1|||
27862903|NCT02421588|54433591|FG000|Overall Study|Non-treatment-related AE|8|||
27862904|NCT02421588|54433592|FG001|Overall Study|Non-treatment-related AE|8|||
27862905|NCT02421588|54433591|FG000|Overall Study|Progressive disease|152|||
27862906|NCT02421588|54433592|FG001|Overall Study|Progressive disease|135|||
27981767|NCT00887198|54639574|FG002|Randomized Period|Adverse Event|0|||
27981768|NCT00887198|54639572|FG000|Randomized Period|Lost to Follow-up|1|||
28096086|NCT04349098|54750762|FG001|Overall Study|Other|5|||
28096087|NCT04208750|54750770|FG000|Overall Study|Lost to Follow-up|16|||
28096088|NCT04208750|54750771|FG001|Overall Study|Lost to Follow-up|15|||
28096089|NCT04381988|54750779|FG000|Overall Study|The study was terminated|4|||
28096090|NCT04381988|54750780|FG001|Overall Study|The study was terminated|0|||
28096091|NCT04333498|54750788|FG000|Overall Study|Lost to Follow-up|1|||
28096092|NCT04333498|54750789|FG001|Overall Study|Lost to Follow-up|0|||
28096093|NCT04333498|54750788|FG000|Overall Study|Lost to Follow-up|0|||
28096094|NCT04333498|54750789|FG001|Overall Study|Lost to Follow-up|1|||
28096095|NCT03355664|54750797|FG000|Overall Study|Adverse Event|1|||
28096096|NCT03355664|54750798|FG001|Overall Study|Adverse Event|2|||
28096097|NCT03355664|54750797|FG000|Overall Study|Lost to Follow-up|11|||
28096098|NCT03355664|54750798|FG001|Overall Study|Lost to Follow-up|7|||
28096099|NCT03355664|54750797|FG000|Overall Study|Protocol Violation|1|||
28171337|NCT02720523|54842903|FG004|Period 2: Long-term Extension Period|Withdrawal by Subject|2|||
27738959|NCT02240680|54188244|FG001|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
27862907|NCT02421588|54433591|FG000|Overall Study|Death|11|||
28096100|NCT03355664|54750798|FG001|Overall Study|Protocol Violation|2|||
28096101|NCT03355664|54750797|FG000|Overall Study|Withdrawal by Subject|2|||
27738960|NCT02240680|54188245|FG002|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
27862908|NCT02421588|54433592|FG001|Overall Study|Death|3|||
27862909|NCT02421588|54433591|FG000|Overall Study|Physician Decision|8|||
27862910|NCT02421588|54433592|FG001|Overall Study|Physician Decision|17|||
27862911|NCT02421588|54433591|FG000|Overall Study|Other reason not specified|3|||
27862912|NCT02421588|54433592|FG001|Overall Study|Other reason not specified|1|||
27862913|NCT02421588|54433591|FG000|Overall Study|Symptomatic deterioration|13|||
27862914|NCT02421588|54433592|FG001|Overall Study|Symptomatic deterioration|19|||
27862915|NCT02421588|54433591|FG000|Overall Study|Treatment-related AE|10|||
27862916|NCT02421588|54433592|FG001|Overall Study|Treatment-related AE|14|||
27862917|NCT02421588|54433591|FG000|Overall Study|Withdrawal by Subject|14|||
27862918|NCT02421588|54433592|FG001|Overall Study|Withdrawal by Subject|16|||
27862919|NCT02421588|54433591|FG000|Overall Study|Not treated|2|||
27862920|NCT02421588|54433592|FG001|Overall Study|Not treated|8|||
27862921|NCT02421510|54433601|FG000|Overall Study|Other|4|||
27862922|NCT02421510|54433602|FG001|Overall Study|Other|2|||
27862923|NCT02421510|54433603|FG002|Overall Study|Other|3|||
27862924|NCT02421510|54433601|FG000|Overall Study|Protocol Violation|1|||
27862925|NCT02421510|54433602|FG001|Overall Study|Protocol Violation|2|||
27862926|NCT02421510|54433603|FG002|Overall Study|Protocol Violation|0|||
27862927|NCT02421510|54433601|FG000|Overall Study|Death|1|||
27862928|NCT02421510|54433602|FG001|Overall Study|Death|0|||
27862929|NCT02421510|54433603|FG002|Overall Study|Death|0|||
27862930|NCT02421510|54433601|FG000|Overall Study|Noncompliance with study drug|1|||
27862931|NCT02421510|54433602|FG001|Overall Study|Noncompliance with study drug|0|||
27862932|NCT02421510|54433603|FG002|Overall Study|Noncompliance with study drug|0|||
27862933|NCT02421510|54433601|FG000|Overall Study|Physician Decision|1|||
27862934|NCT02421510|54433602|FG001|Overall Study|Physician Decision|1|||
27862935|NCT02421510|54433603|FG002|Overall Study|Physician Decision|3|||
27862936|NCT02421510|54433601|FG000|Overall Study|Adverse Event|9|||
27862937|NCT02421510|54433602|FG001|Overall Study|Adverse Event|10|||
27862938|NCT02421510|54433603|FG002|Overall Study|Adverse Event|18|||
27862939|NCT02421510|54433601|FG000|Overall Study|Pregnancy|1|||
27862940|NCT02421510|54433602|FG001|Overall Study|Pregnancy|1|||
27862941|NCT02421510|54433603|FG002|Overall Study|Pregnancy|0|||
27862942|NCT02421510|54433601|FG000|Overall Study|Withdrawal by Subject|14|||
27862943|NCT02421510|54433602|FG001|Overall Study|Withdrawal by Subject|18|||
27862944|NCT02421510|54433603|FG002|Overall Study|Withdrawal by Subject|12|||
27862945|NCT02421510|54433601|FG000|Overall Study|Lost to Follow-up|1|||
27862946|NCT02421510|54433602|FG001|Overall Study|Lost to Follow-up|1|||
27862947|NCT02421510|54433603|FG002|Overall Study|Lost to Follow-up|0|||
27862948|NCT00552617|54433621|FG000|Overall Study|Not Treated|0|||
27862949|NCT00552617|54433622|FG001|Overall Study|Not Treated|0|||
27862950|NCT00552617|54433623|FG002|Overall Study|Not Treated|1|||
27862951|NCT00552617|54433624|FG003|Overall Study|Not Treated|0|||
27862952|NCT00552617|54433625|FG004|Overall Study|Not Treated|0|||
27862953|NCT00552617|54433626|FG005|Overall Study|Not Treated|0|||
27862954|NCT00552617|54433627|FG006|Overall Study|Not Treated|0|||
27862955|NCT00552617|54433628|FG007|Overall Study|Not Treated|0|||
27862956|NCT00552617|54433629|FG008|Overall Study|Not Treated|0|||
27862957|NCT00552617|54433630|FG009|Overall Study|Not Treated|1|||
27862958|NCT00552617|54433621|FG000|Overall Study|Lost to Follow-up|0|||
27862959|NCT00552617|54433622|FG001|Overall Study|Lost to Follow-up|0|||
27862960|NCT00552617|54433623|FG002|Overall Study|Lost to Follow-up|0|||
27862961|NCT00552617|54433624|FG003|Overall Study|Lost to Follow-up|1|||
27862962|NCT00552617|54433625|FG004|Overall Study|Lost to Follow-up|0|||
27862963|NCT00552617|54433626|FG005|Overall Study|Lost to Follow-up|2|||
27862964|NCT00552617|54433627|FG006|Overall Study|Lost to Follow-up|0|||
27862965|NCT00552617|54433628|FG007|Overall Study|Lost to Follow-up|0|||
27862966|NCT00552617|54433629|FG008|Overall Study|Lost to Follow-up|2|||
27862967|NCT00552617|54433630|FG009|Overall Study|Lost to Follow-up|0|||
27862968|NCT02421120|54433652|FG000|Overall Study|Adverse Event|1|||
27862969|NCT02420262|54433658|FG000|Overall Study|Adverse Event|1|||
27862970|NCT02420262|54433659|FG001|Overall Study|Adverse Event|0|||
27862971|NCT02420262|54433658|FG000|Overall Study|Withdrawal by Subject|1|||
27862972|NCT02420262|54433659|FG001|Overall Study|Withdrawal by Subject|4|||
28096102|NCT03355664|54750798|FG001|Overall Study|Withdrawal by Subject|1|||
28096103|NCT04170686|54750806|FG000|Screening|Physician Decision|12|||
27834622|NCT01695239|54319308|FG000|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
27834623|NCT01695239|54319309|FG001|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
27834624|NCT01695239|54319310|FG002|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3|||
27834625|NCT01695239|54319311|FG003|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4|||
27834626|NCT01695239|54319312|FG004|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
27834627|NCT01695239|54319313|FG005|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
27862973|NCT02420262|54433658|FG000|Overall Study|Unclassified|0|||
27862974|NCT02420262|54433659|FG001|Overall Study|Unclassified|1|||
27862975|NCT00552305|54433665|FG000|Overall Study|Adverse Event|43|||
27862976|NCT00552305|54433665|FG000|Overall Study|Lack of Efficacy|120|||
27862977|NCT00552305|54433665|FG000|Overall Study|Lost to Follow-up|4|||
27862978|NCT00552305|54433665|FG000|Overall Study|Protocol Violation|3|||
27862979|NCT00552305|54433665|FG000|Overall Study|Withdrawal by Subject|44|||
27862980|NCT00552305|54433665|FG000|Overall Study|Lack of efficacy/withdrew consent|1|||
27862981|NCT00552305|54433665|FG000|Overall Study|Lack of efficacy (LoE)/adverse event|3|||
27862982|NCT00552305|54433665|FG000|Overall Study|Adverse event (AE)/withdrew (WD) consent|2|||
27862983|NCT00552305|54433665|FG000|Overall Study|Unsatisfactory compliance|11|||
27862984|NCT00552305|54433665|FG000|Overall Study|Poor compliance/lost to follow-up|1|||
27862985|NCT00552305|54433665|FG000|Overall Study|AE/Other: prohibited drug required|1|||
27862986|NCT00552305|54433665|FG000|Overall Study|LoE/WD consent/Other: cannot make visits|1|||
27862987|NCT00552305|54433665|FG000|Overall Study|Other: Site closed|4|||
27862988|NCT00552305|54433665|FG000|Overall Study|Other: Personal problems|1|||
27862989|NCT00552305|54433665|FG000|Overall Study|Other: Unable to attend visits|1|||
27862990|NCT00552305|54433665|FG000|Overall Study|Other: Subject underwent surgery|4|||
27862991|NCT00552305|54433665|FG000|Overall Study|Other: Subject became pregnant|1|||
27862992|NCT00552305|54433665|FG000|Overall Study|Other: Health problems, not drug related|1|||
27862993|NCT00552305|54433665|FG000|Overall Study|Other: Subject moved from area|2|||
27862994|NCT00552305|54433665|FG000|Overall Study|Other: Subject incarcerated|1|||
27862995|NCT00552305|54433665|FG000|Overall Study|Other: Subject went to rehab|1|||
27862996|NCT00552071|54433691|FG000|Overall Study|Adverse Event|1|||
27862997|NCT00552071|54433692|FG001|Overall Study|Adverse Event|0|||
27862998|NCT00552071|54433691|FG000|Overall Study|Lack of Efficacy|1|||
27862999|NCT00552071|54433692|FG001|Overall Study|Lack of Efficacy|0|||
27863000|NCT00552071|54433691|FG000|Overall Study|Physician Decision|1|||
27863001|NCT00552071|54433692|FG001|Overall Study|Physician Decision|0|||
27863002|NCT00552071|54433691|FG000|Overall Study|Pregnancy|1|||
28171338|NCT02720523|54842904|FG005|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
27834628|NCT01695239|54319314|FG006|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
27834629|NCT01695239|54319315|FG007|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
27834630|NCT01695239|54319316|FG008|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
27834631|NCT01695239|54319317|FG009|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
27834632|NCT01695239|54319318|FG010|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
27834633|NCT01695239|54319319|FG011|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
27834634|NCT01695239|54319320|FG012|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
27834635|NCT01695239|54319321|FG013|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
27834636|NCT01695239|54319308|FG000|Double-Blind (DB) Treatment Period|Adverse Event|2|||
27834637|NCT01695239|54319309|FG001|Double-Blind (DB) Treatment Period|Adverse Event|2|||
27834638|NCT01695239|54319310|FG002|Double-Blind (DB) Treatment Period|Adverse Event|2|||
27834639|NCT01695239|54319311|FG003|Double-Blind (DB) Treatment Period|Adverse Event|3|||
27834640|NCT01695239|54319312|FG004|Double-Blind (DB) Treatment Period|Adverse Event|0|||
27834641|NCT01695239|54319313|FG005|Double-Blind (DB) Treatment Period|Adverse Event|0|||
27834642|NCT01695239|54319314|FG006|Double-Blind (DB) Treatment Period|Adverse Event|0|||
27834643|NCT01695239|54319315|FG007|Double-Blind (DB) Treatment Period|Adverse Event|0|||
27834644|NCT01695239|54319316|FG008|Double-Blind (DB) Treatment Period|Adverse Event|0|||
27834645|NCT01695239|54319317|FG009|Double-Blind (DB) Treatment Period|Adverse Event|0|||
27834646|NCT01695239|54319318|FG010|Double-Blind (DB) Treatment Period|Adverse Event|0|||
27834647|NCT01695239|54319319|FG011|Double-Blind (DB) Treatment Period|Adverse Event|0|||
27834648|NCT01695239|54319320|FG012|Double-Blind (DB) Treatment Period|Adverse Event|0|||
27834649|NCT01695239|54319321|FG013|Double-Blind (DB) Treatment Period|Adverse Event|0|||
27834650|NCT01695239|54319308|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|4|||
27834651|NCT01695239|54319309|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
27834652|NCT01695239|54319310|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
27834653|NCT01695239|54319311|FG003|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
27834654|NCT01695239|54319312|FG004|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
27834655|NCT01695239|54319313|FG005|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
27834656|NCT01695239|54319314|FG006|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
27834657|NCT01695239|54319315|FG007|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
27834658|NCT01695239|54319316|FG008|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
27834659|NCT01695239|54319317|FG009|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
27834660|NCT01695239|54319318|FG010|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
27834661|NCT01695239|54319319|FG011|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
27834662|NCT01695239|54319320|FG012|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
27834663|NCT01695239|54319321|FG013|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
27834664|NCT01695239|54319308|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
27834665|NCT01695239|54319309|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
27834666|NCT01695239|54319310|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
27834667|NCT01695239|54319311|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
27834668|NCT01695239|54319312|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
27834669|NCT01695239|54319313|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
27834670|NCT01695239|54319314|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
27834671|NCT01695239|54319315|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
27834672|NCT01695239|54319316|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
27834673|NCT01695239|54319317|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
27834674|NCT01695239|54319318|FG010|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
27834675|NCT01695239|54319319|FG011|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
28171339|NCT02720523|54842905|FG006|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
28171340|NCT02720523|54842899|FG000|Period 2: Long-term Extension Period|Other|0|||
27863003|NCT00552071|54433692|FG001|Overall Study|Pregnancy|0|||
27863004|NCT00552071|54433691|FG000|Overall Study|Death|0|||
27863005|NCT00552071|54433692|FG001|Overall Study|Death|1|||
27863006|NCT00552071|54433691|FG000|Overall Study|Withdrawal by Subject|0|||
27863007|NCT00552071|54433692|FG001|Overall Study|Withdrawal by Subject|1|||
27863008|NCT00551525|54433700|FG000|Overall Study|Protocol Violation|5|||
27863009|NCT02370498|54433727|FG000|Overall Study|Adverse Event|10|||
27863010|NCT02370498|54433728|FG001|Overall Study|Adverse Event|8|||
27863011|NCT02370498|54433727|FG000|Overall Study|Death|263|||
27863012|NCT02370498|54433728|FG001|Overall Study|Death|265|||
27863013|NCT02370498|54433727|FG000|Overall Study|Protocol Violation|1|||
27863014|NCT02370498|54433728|FG001|Overall Study|Protocol Violation|2|||
27863015|NCT02370498|54433727|FG000|Overall Study|Withdrawal by Subject|7|||
27863016|NCT02370498|54433728|FG001|Overall Study|Withdrawal by Subject|12|||
27863017|NCT02370498|54433727|FG000|Overall Study|Sponsor's decision|15|||
27863018|NCT02370498|54433728|FG001|Overall Study|Sponsor's decision|9|||
27863019|NCT02347332|54433753|FG000|Overall Study|Not treated|5|||
27863020|NCT02347332|54433754|FG001|Overall Study|Not treated|2|||
27863021|NCT02347332|54433753|FG000|Overall Study|Progressive disease|141|||
27863022|NCT02347332|54433754|FG001|Overall Study|Progressive disease|159|||
27863023|NCT02347332|54433753|FG000|Overall Study|Adverse Event|50|||
27863024|NCT02347332|54433754|FG001|Overall Study|Adverse Event|41|||
27863025|NCT02347332|54433753|FG000|Overall Study|Death (Unknown, Various reasons)|6|||
27863026|NCT02347332|54433754|FG001|Overall Study|Death (Unknown, Various reasons)|6|||
27863027|NCT02347332|54433753|FG000|Overall Study|Protocol Violation|1|||
27863028|NCT02347332|54433754|FG001|Overall Study|Protocol Violation|1|||
27863029|NCT02347332|54433753|FG000|Overall Study|Lost to Follow-up|2|||
27863030|NCT02347332|54433754|FG001|Overall Study|Lost to Follow-up|1|||
27863031|NCT02347332|54433753|FG000|Overall Study|Physician Decision|4|||
27863032|NCT02347332|54433754|FG001|Overall Study|Physician Decision|3|||
27863033|NCT02347332|54433753|FG000|Overall Study|Withdrawal by Subject|20|||
27863034|NCT02347332|54433754|FG001|Overall Study|Withdrawal by Subject|14|||
27863035|NCT02347332|54433753|FG000|Overall Study|Protocol requirement|1|||
27863036|NCT02347332|54433754|FG001|Overall Study|Protocol requirement|1|||
27863037|NCT02347332|54433753|FG000|Overall Study|Switch Post-Trial program|0|||
27863038|NCT02347332|54433754|FG001|Overall Study|Switch Post-Trial program|1|||
27834676|NCT01695239|54319320|FG012|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
27863039|NCT02347176|54433777|FG000|Overall Study|Lost to Follow-up|2|||
27981769|NCT00887198|54639573|FG001|Randomized Period|Lost to Follow-up|0|||
27981770|NCT00887198|54639574|FG002|Randomized Period|Lost to Follow-up|0|||
27981771|NCT00887198|54639572|FG000|Randomized Period|Cross-over to AA (under amendment 3)|0|||
27981772|NCT00887198|54639573|FG001|Randomized Period|Cross-over to AA (under amendment 3)|51|||
27981773|NCT00887198|54639574|FG002|Randomized Period|Cross-over to AA (under amendment 3)|0|||
27981774|NCT00887198|54639572|FG000|Randomized Period|Withdrawal by Subject|41|||
27981775|NCT00887198|54639573|FG001|Randomized Period|Withdrawal by Subject|56|||
27981776|NCT00887198|54639574|FG002|Randomized Period|Withdrawal by Subject|0|||
27981777|NCT00887198|54639572|FG000|Randomized Period|Progressive disease|366|||
27981778|NCT00887198|54639573|FG001|Randomized Period|Progressive disease|370|||
27981779|NCT00887198|54639574|FG002|Randomized Period|Progressive disease|0|||
27981780|NCT00887198|54639572|FG000|Randomized Period|Other|42|||
28096104|NCT04170686|54750807|FG001|Screening|Physician Decision|13|||
27834677|NCT01695239|54319321|FG013|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
27834678|NCT01695239|54319308|FG000|Double-Blind (DB) Treatment Period|Sponsor Decision|3|||
27834679|NCT01695239|54319309|FG001|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
27834680|NCT01695239|54319310|FG002|Double-Blind (DB) Treatment Period|Sponsor Decision|1|||
27834681|NCT01695239|54319311|FG003|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
27834682|NCT01695239|54319312|FG004|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
27834683|NCT01695239|54319313|FG005|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
27834684|NCT01695239|54319314|FG006|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
27834685|NCT01695239|54319315|FG007|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
27834686|NCT01695239|54319316|FG008|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
27834687|NCT01695239|54319317|FG009|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
27834688|NCT01695239|54319318|FG010|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
27834689|NCT01695239|54319319|FG011|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
27834690|NCT01695239|54319320|FG012|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
27863040|NCT02347176|54433778|FG001|Overall Study|Lost to Follow-up|3|||
27863041|NCT02347176|54433779|FG002|Overall Study|Lost to Follow-up|1|||
28096105|NCT04170686|54750806|FG000|Randomization and Treatment|Lost to Follow-up|26|||
28171341|NCT02720523|54842900|FG001|Period 2: Long-term Extension Period|Other|0|||
27863042|NCT02347176|54433780|FG003|Overall Study|Lost to Follow-up|1|||
27863043|NCT02347176|54433777|FG000|Overall Study|Withdrawal by Subject|9|||
27863044|NCT02347176|54433778|FG001|Overall Study|Withdrawal by Subject|5|||
27863045|NCT02347176|54433779|FG002|Overall Study|Withdrawal by Subject|5|||
27863046|NCT02347176|54433780|FG003|Overall Study|Withdrawal by Subject|3|||
27863047|NCT02347176|54433777|FG000|Overall Study|Other|1|||
27863048|NCT02347176|54433778|FG001|Overall Study|Other|2|||
27863049|NCT02347176|54433779|FG002|Overall Study|Other|2|||
27863050|NCT02347176|54433780|FG003|Overall Study|Other|0|||
27863051|NCT02370420|54433792|FG000|Overall Study|Physician Decision|3|||
27863052|NCT02370420|54433793|FG001|Overall Study|Physician Decision|3|||
27863053|NCT02370420|54433792|FG000|Overall Study|Lost to Follow-up|11|||
27863054|NCT02370420|54433793|FG001|Overall Study|Lost to Follow-up|9|||
27863055|NCT02347098|54433815|FG000|Overall Study|Death|1|||
27863056|NCT02347098|54433816|FG001|Overall Study|Death|0|||
27863057|NCT02347098|54433815|FG000|Overall Study|Withdrawal by Subject|1|||
27863058|NCT02347098|54433816|FG001|Overall Study|Withdrawal by Subject|0|||
27863059|NCT02347098|54433815|FG000|Overall Study|Lost to Follow-up|2|||
27863060|NCT02347098|54433816|FG001|Overall Study|Lost to Follow-up|2|||
27863061|NCT02347098|54433815|FG000|Overall Study|Refuse Follow-up Visit|1|||
27863062|NCT02347098|54433816|FG001|Overall Study|Refuse Follow-up Visit|5|||
27863063|NCT02347098|54433815|FG000|Overall Study|no visit due to illness|2|||
27863064|NCT02347098|54433816|FG001|Overall Study|no visit due to illness|1|||
27863065|NCT02346708|54433833|FG000|Overall Study|Adverse Event|2|||
27863066|NCT02346708|54433834|FG001|Overall Study|Adverse Event|0|||
27863067|NCT02346708|54433833|FG000|Overall Study|Protocol Violation|0|||
27863068|NCT02346708|54433834|FG001|Overall Study|Protocol Violation|1|||
27863069|NCT02346240|54434324|FG000|Initial Period (Baseline to Week 16)|Adverse Event|0|||
27863070|NCT02346240|54434325|FG001|Initial Period (Baseline to Week 16)|Adverse Event|4|||
27863071|NCT02346240|54434326|FG002|Initial Period (Baseline to Week 16)|Adverse Event|1|||
27863072|NCT02346240|54434327|FG003|Initial Period (Baseline to Week 16)|Adverse Event|1|||
27863073|NCT02346240|54434328|FG004|Initial Period (Baseline to Week 16)|Adverse Event|0|||
27834691|NCT01695239|54319321|FG013|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
27834692|NCT01695239|54319308|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
27834693|NCT01695239|54319309|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
27834694|NCT01695239|54319310|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
27834695|NCT01695239|54319311|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
27834696|NCT01695239|54319312|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
27834697|NCT01695239|54319313|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
27834698|NCT01695239|54319314|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
27834699|NCT01695239|54319315|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
27834700|NCT01695239|54319316|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
27834701|NCT01695239|54319317|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
27834702|NCT01695239|54319318|FG010|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
27834703|NCT01695239|54319319|FG011|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
27834704|NCT01695239|54319320|FG012|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
27834705|NCT01695239|54319321|FG013|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
27834706|NCT01695239|54319308|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|1|||
27834707|NCT01695239|54319309|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
27834708|NCT01695239|54319310|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
27834709|NCT01695239|54319311|FG003|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
27834710|NCT01695239|54319312|FG004|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
27834711|NCT01695239|54319313|FG005|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
27834712|NCT01695239|54319314|FG006|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
27834713|NCT01695239|54319315|FG007|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
27834714|NCT01695239|54319316|FG008|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
27834715|NCT01695239|54319317|FG009|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
27834716|NCT01695239|54319318|FG010|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
27834717|NCT01695239|54319319|FG011|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
27834718|NCT01695239|54319320|FG012|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
27834719|NCT01695239|54319321|FG013|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
27834720|NCT01695239|54319308|FG000|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
27834721|NCT01695239|54319309|FG001|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
27834722|NCT01695239|54319310|FG002|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
27834723|NCT01695239|54319311|FG003|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
27834724|NCT01695239|54319312|FG004|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
27834725|NCT01695239|54319313|FG005|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
27834726|NCT01695239|54319314|FG006|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
27834727|NCT01695239|54319315|FG007|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9|||
27834728|NCT01695239|54319316|FG008|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
27834729|NCT01695239|54319317|FG009|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
27863074|NCT02346240|54434329|FG005|Initial Period (Baseline to Week 16)|Adverse Event|0|||
27863075|NCT02346240|54434330|FG006|Initial Period (Baseline to Week 16)|Adverse Event|0|||
27863076|NCT02346240|54434331|FG007|Initial Period (Baseline to Week 16)|Adverse Event|0|||
27863077|NCT02346240|54434332|FG008|Initial Period (Baseline to Week 16)|Adverse Event|0|||
27863078|NCT02346240|54434333|FG009|Initial Period (Baseline to Week 16)|Adverse Event|0|||
27863079|NCT02346240|54434334|FG010|Initial Period (Baseline to Week 16)|Adverse Event|0|||
27863080|NCT02346240|54434335|FG011|Initial Period (Baseline to Week 16)|Adverse Event|0|||
27863081|NCT02346240|54434336|FG012|Initial Period (Baseline to Week 16)|Adverse Event|0|||
27863082|NCT02346240|54434337|FG013|Initial Period (Baseline to Week 16)|Adverse Event|0|||
27863083|NCT02346240|54434338|FG014|Initial Period (Baseline to Week 16)|Adverse Event|0|||
27863084|NCT02346240|54434339|FG015|Initial Period (Baseline to Week 16)|Adverse Event|0|||
27863085|NCT02346240|54434340|FG016|Initial Period (Baseline to Week 16)|Adverse Event|0|||
27863086|NCT02346240|54434341|FG017|Initial Period (Baseline to Week 16)|Adverse Event|0|||
27863087|NCT02346240|54434342|FG018|Initial Period (Baseline to Week 16)|Adverse Event|0|||
27863088|NCT02346240|54434343|FG019|Initial Period (Baseline to Week 16)|Adverse Event|0|||
27863089|NCT02346240|54434344|FG020|Initial Period (Baseline to Week 16)|Adverse Event|0|||
27863090|NCT02346240|54434345|FG021|Initial Period (Baseline to Week 16)|Adverse Event|0|||
27863091|NCT02346240|54434346|FG022|Initial Period (Baseline to Week 16)|Adverse Event|0|||
27863092|NCT02346240|54434347|FG023|Initial Period (Baseline to Week 16)|Adverse Event|0|||
27863093|NCT02346240|54434324|FG000|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
27863094|NCT02346240|54434325|FG001|Initial Period (Baseline to Week 16)|Lack of Efficacy|1|||
27863095|NCT02346240|54434326|FG002|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
27863096|NCT02346240|54434327|FG003|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
27863097|NCT02346240|54434328|FG004|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
27863098|NCT02346240|54434329|FG005|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
27863099|NCT02346240|54434330|FG006|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
27863100|NCT02346240|54434331|FG007|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
27863101|NCT02346240|54434332|FG008|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
27863102|NCT02346240|54434333|FG009|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
27863103|NCT02346240|54434334|FG010|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
27863104|NCT02346240|54434335|FG011|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
27863105|NCT02346240|54434336|FG012|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
27863106|NCT02346240|54434337|FG013|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
27863107|NCT02346240|54434338|FG014|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
27863108|NCT02346240|54434339|FG015|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
27863109|NCT02346240|54434340|FG016|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
27863110|NCT02346240|54434341|FG017|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
27863111|NCT02346240|54434342|FG018|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
27863112|NCT02346240|54434343|FG019|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
27863113|NCT02346240|54434344|FG020|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
27863114|NCT02346240|54434345|FG021|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
27863115|NCT02346240|54434346|FG022|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
27863116|NCT02346240|54434347|FG023|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
27863117|NCT02346240|54434324|FG000|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
27863118|NCT02346240|54434325|FG001|Initial Period (Baseline to Week 16)|Protocol Violation|1|||
27863119|NCT02346240|54434326|FG002|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
27863120|NCT02346240|54434327|FG003|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
27863121|NCT02346240|54434328|FG004|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
27863122|NCT02346240|54434329|FG005|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
27863123|NCT02346240|54434330|FG006|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
27863124|NCT02346240|54434331|FG007|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
27863125|NCT02346240|54434332|FG008|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
27863126|NCT02346240|54434333|FG009|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
27863127|NCT02346240|54434334|FG010|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
27863128|NCT02346240|54434335|FG011|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
27863129|NCT02346240|54434336|FG012|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
27863130|NCT02346240|54434337|FG013|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
27863131|NCT02346240|54434338|FG014|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
27863132|NCT02346240|54434339|FG015|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
27863133|NCT02346240|54434340|FG016|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
27863134|NCT02346240|54434341|FG017|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
27863135|NCT02346240|54434342|FG018|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
27863136|NCT02346240|54434343|FG019|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
27863137|NCT02346240|54434344|FG020|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
27863138|NCT02346240|54434345|FG021|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
27863139|NCT02346240|54434346|FG022|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
27863140|NCT02346240|54434347|FG023|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
27863141|NCT02346240|54434324|FG000|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
27863142|NCT02346240|54434325|FG001|Initial Period (Baseline to Week 16)|Lost to Follow-up|2|||
27863143|NCT02346240|54434326|FG002|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
27925671|NCT01231581|54582204|FG000|Overall Study|Death|65|||
27863144|NCT02346240|54434327|FG003|Initial Period (Baseline to Week 16)|Lost to Follow-up|3|||
27863145|NCT02346240|54434328|FG004|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
27863146|NCT02346240|54434329|FG005|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
27863147|NCT02346240|54434330|FG006|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
27863148|NCT02346240|54434331|FG007|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
27863149|NCT02346240|54434332|FG008|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
27863150|NCT02346240|54434333|FG009|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
27863151|NCT02346240|54434334|FG010|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
27863152|NCT02346240|54434335|FG011|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
27863153|NCT02346240|54434336|FG012|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
27863154|NCT02346240|54434337|FG013|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
27863155|NCT02346240|54434338|FG014|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
27863156|NCT02346240|54434339|FG015|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
27863157|NCT02346240|54434340|FG016|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
27863158|NCT02346240|54434341|FG017|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
27863159|NCT02346240|54434342|FG018|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
27863160|NCT02346240|54434343|FG019|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
27863161|NCT02346240|54434344|FG020|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
27863162|NCT02346240|54434345|FG021|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
27863163|NCT02346240|54434346|FG022|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
27863164|NCT02346240|54434347|FG023|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
27863165|NCT02346240|54434324|FG000|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1|||
27863166|NCT02346240|54434325|FG001|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
27863167|NCT02346240|54434326|FG002|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3|||
27863168|NCT02346240|54434327|FG003|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
27863169|NCT02346240|54434328|FG004|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
27863170|NCT02346240|54434329|FG005|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
27863171|NCT02346240|54434330|FG006|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
27863172|NCT02346240|54434331|FG007|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
27863173|NCT02346240|54434332|FG008|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
27863174|NCT02346240|54434333|FG009|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
27863175|NCT02346240|54434334|FG010|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
27863176|NCT02346240|54434335|FG011|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
27863177|NCT02346240|54434336|FG012|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
27863178|NCT02346240|54434337|FG013|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
27863179|NCT02346240|54434338|FG014|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
27863180|NCT02346240|54434339|FG015|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
27863181|NCT02346240|54434340|FG016|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
27863182|NCT02346240|54434341|FG017|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
27863183|NCT02346240|54434342|FG018|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
27863184|NCT02346240|54434343|FG019|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
27863185|NCT02346240|54434344|FG020|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
27863186|NCT02346240|54434345|FG021|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
27863187|NCT02346240|54434346|FG022|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
27863188|NCT02346240|54434347|FG023|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
27863189|NCT02346240|54434324|FG000|Initial Period (Baseline to Week 16)|Non-compliance|0|||
27863190|NCT02346240|54434325|FG001|Initial Period (Baseline to Week 16)|Non-compliance|1|||
27863191|NCT02346240|54434326|FG002|Initial Period (Baseline to Week 16)|Non-compliance|0|||
27863192|NCT02346240|54434327|FG003|Initial Period (Baseline to Week 16)|Non-compliance|1|||
27863193|NCT02346240|54434328|FG004|Initial Period (Baseline to Week 16)|Non-compliance|0|||
27863194|NCT02346240|54434329|FG005|Initial Period (Baseline to Week 16)|Non-compliance|0|||
27863195|NCT02346240|54434330|FG006|Initial Period (Baseline to Week 16)|Non-compliance|0|||
27863196|NCT02346240|54434331|FG007|Initial Period (Baseline to Week 16)|Non-compliance|0|||
27863197|NCT02346240|54434332|FG008|Initial Period (Baseline to Week 16)|Non-compliance|0|||
27863198|NCT02346240|54434333|FG009|Initial Period (Baseline to Week 16)|Non-compliance|0|||
27863199|NCT02346240|54434334|FG010|Initial Period (Baseline to Week 16)|Non-compliance|0|||
27863200|NCT02346240|54434335|FG011|Initial Period (Baseline to Week 16)|Non-compliance|0|||
27925672|NCT01231581|54582205|FG001|Overall Study|Death|64|||
27925673|NCT01231581|54582204|FG000|Overall Study|Ongoing|1|||
27925674|NCT01231581|54582205|FG001|Overall Study|Ongoing|0|||
27925675|NCT01050634|54582211|FG000|Overall Study|Enrolled, but Not Treated|56|||
27925676|NCT01050634|54582211|FG000|Overall Study|Death|2|||
27738961|NCT02240680|54188246|FG003|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
27925677|NCT01050634|54582211|FG000|Overall Study|Adverse Event|42|||
27925678|NCT01050634|54582211|FG000|Overall Study|Lost to Follow-up|2|||
27863201|NCT02346240|54434336|FG012|Initial Period (Baseline to Week 16)|Non-compliance|0|||
27863202|NCT02346240|54434337|FG013|Initial Period (Baseline to Week 16)|Non-compliance|0|||
27863203|NCT02346240|54434338|FG014|Initial Period (Baseline to Week 16)|Non-compliance|0|||
27863204|NCT02346240|54434339|FG015|Initial Period (Baseline to Week 16)|Non-compliance|0|||
27863205|NCT02346240|54434340|FG016|Initial Period (Baseline to Week 16)|Non-compliance|0|||
27863206|NCT02346240|54434341|FG017|Initial Period (Baseline to Week 16)|Non-compliance|0|||
27863207|NCT02346240|54434342|FG018|Initial Period (Baseline to Week 16)|Non-compliance|0|||
27863208|NCT02346240|54434343|FG019|Initial Period (Baseline to Week 16)|Non-compliance|0|||
27863209|NCT02346240|54434344|FG020|Initial Period (Baseline to Week 16)|Non-compliance|0|||
27863210|NCT02346240|54434345|FG021|Initial Period (Baseline to Week 16)|Non-compliance|0|||
27863211|NCT02346240|54434346|FG022|Initial Period (Baseline to Week 16)|Non-compliance|0|||
27863212|NCT02346240|54434347|FG023|Initial Period (Baseline to Week 16)|Non-compliance|0|||
27863213|NCT02346240|54434324|FG000|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
27863214|NCT02346240|54434325|FG001|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
27863215|NCT02346240|54434326|FG002|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1|||
27863216|NCT02346240|54434327|FG003|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
27863217|NCT02346240|54434328|FG004|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
27863218|NCT02346240|54434329|FG005|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
27863219|NCT02346240|54434330|FG006|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
27863220|NCT02346240|54434331|FG007|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
27863221|NCT02346240|54434332|FG008|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
27863222|NCT02346240|54434333|FG009|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
27863223|NCT02346240|54434334|FG010|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
27863224|NCT02346240|54434335|FG011|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
27863225|NCT02346240|54434336|FG012|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
27863226|NCT02346240|54434337|FG013|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
27863227|NCT02346240|54434338|FG014|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
27863228|NCT02346240|54434339|FG015|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
27863229|NCT02346240|54434340|FG016|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
27863230|NCT02346240|54434341|FG017|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
27863231|NCT02346240|54434342|FG018|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
27863232|NCT02346240|54434343|FG019|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
27863233|NCT02346240|54434344|FG020|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
27863234|NCT02346240|54434345|FG021|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
27863235|NCT02346240|54434346|FG022|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
27863236|NCT02346240|54434347|FG023|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
27863237|NCT02346240|54434324|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27863238|NCT02346240|54434325|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27863239|NCT02346240|54434326|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27863240|NCT02346240|54434327|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27863241|NCT02346240|54434328|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27863242|NCT02346240|54434329|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27863243|NCT02346240|54434330|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27863244|NCT02346240|54434331|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
27863245|NCT02346240|54434332|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
27863246|NCT02346240|54434333|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27863247|NCT02346240|54434334|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27863248|NCT02346240|54434335|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27863249|NCT02346240|54434336|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27863250|NCT02346240|54434337|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
27863251|NCT02346240|54434338|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
27863252|NCT02346240|54434339|FG015|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
27863253|NCT02346240|54434340|FG016|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
27863254|NCT02346240|54434341|FG017|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27863255|NCT02346240|54434342|FG018|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27863256|NCT02346240|54434343|FG019|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27863257|NCT02346240|54434344|FG020|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27863258|NCT02346240|54434345|FG021|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27863259|NCT02346240|54434346|FG022|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27863260|NCT02346240|54434347|FG023|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27863261|NCT02346240|54434324|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27863262|NCT02346240|54434325|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27863263|NCT02346240|54434326|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
28171342|NCT02720523|54842901|FG002|Period 2: Long-term Extension Period|Other|0|||
27863264|NCT02346240|54434327|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27863265|NCT02346240|54434328|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27863266|NCT02346240|54434329|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27863267|NCT02346240|54434330|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27863268|NCT02346240|54434331|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27863269|NCT02346240|54434332|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27863270|NCT02346240|54434333|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27863271|NCT02346240|54434334|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27863272|NCT02346240|54434335|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27863273|NCT02346240|54434336|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27863274|NCT02346240|54434337|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
27863275|NCT02346240|54434338|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27863276|NCT02346240|54434339|FG015|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3|||
27863277|NCT02346240|54434340|FG016|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27863278|NCT02346240|54434341|FG017|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27863279|NCT02346240|54434342|FG018|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27863280|NCT02346240|54434343|FG019|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27863281|NCT02346240|54434344|FG020|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27863282|NCT02346240|54434345|FG021|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27863283|NCT02346240|54434346|FG022|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27863284|NCT02346240|54434347|FG023|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27863285|NCT02346240|54434324|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27863286|NCT02346240|54434325|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27863287|NCT02346240|54434326|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27863288|NCT02346240|54434327|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27863289|NCT02346240|54434328|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27863290|NCT02346240|54434329|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27863291|NCT02346240|54434330|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27863292|NCT02346240|54434331|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27863293|NCT02346240|54434332|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27863294|NCT02346240|54434333|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27863295|NCT02346240|54434334|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27863296|NCT02346240|54434335|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27863297|NCT02346240|54434336|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27863298|NCT02346240|54434337|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27863299|NCT02346240|54434338|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
27863300|NCT02346240|54434339|FG015|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27863301|NCT02346240|54434340|FG016|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27863302|NCT02346240|54434341|FG017|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27863303|NCT02346240|54434342|FG018|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27863304|NCT02346240|54434343|FG019|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27863305|NCT02346240|54434344|FG020|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27863306|NCT02346240|54434345|FG021|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27863307|NCT02346240|54434346|FG022|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27863308|NCT02346240|54434347|FG023|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27863309|NCT02346240|54434324|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27863310|NCT02346240|54434325|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27863311|NCT02346240|54434326|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27863312|NCT02346240|54434327|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27863313|NCT02346240|54434328|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27863314|NCT02346240|54434329|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
27863315|NCT02346240|54434330|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
27863316|NCT02346240|54434331|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
27863317|NCT02346240|54434332|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
27863318|NCT02346240|54434333|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27863319|NCT02346240|54434334|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
27863320|NCT02346240|54434335|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
27863321|NCT02346240|54434336|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27863322|NCT02346240|54434337|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
27863323|NCT02346240|54434338|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5|||
27863324|NCT02346240|54434339|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
27863325|NCT02346240|54434340|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
27925679|NCT01050634|54582211|FG000|Overall Study|Other|21|||
27981781|NCT00887198|54639573|FG001|Randomized Period|Other|30|||
28171343|NCT02720523|54842902|FG003|Period 2: Long-term Extension Period|Other|0|||
27863326|NCT02346240|54434341|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27863327|NCT02346240|54434342|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27863328|NCT02346240|54434343|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27863329|NCT02346240|54434344|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27863330|NCT02346240|54434345|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27863331|NCT02346240|54434346|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27863332|NCT02346240|54434347|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27863333|NCT02346240|54434324|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
27863334|NCT02346240|54434325|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
27863335|NCT02346240|54434326|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
27863336|NCT02346240|54434327|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
27863337|NCT02346240|54434328|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
27863338|NCT02346240|54434329|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
27863339|NCT02346240|54434330|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
27863340|NCT02346240|54434331|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
27863341|NCT02346240|54434332|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
27863342|NCT02346240|54434333|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
27863343|NCT02346240|54434334|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
27863344|NCT02346240|54434335|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
27863345|NCT02346240|54434336|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
27863346|NCT02346240|54434337|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
27863347|NCT02346240|54434338|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
27863348|NCT02346240|54434339|FG015|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8|||
27863349|NCT02346240|54434340|FG016|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4|||
27863350|NCT02346240|54434341|FG017|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
27863351|NCT02346240|54434342|FG018|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
27863352|NCT02346240|54434343|FG019|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
27863353|NCT02346240|54434344|FG020|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
27863354|NCT02346240|54434345|FG021|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
27863355|NCT02346240|54434346|FG022|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
27863356|NCT02346240|54434347|FG023|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
27863357|NCT02346240|54434324|FG000|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
27863358|NCT02346240|54434325|FG001|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
27863359|NCT02346240|54434326|FG002|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
27863360|NCT02346240|54434327|FG003|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
27863361|NCT02346240|54434328|FG004|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
27863362|NCT02346240|54434329|FG005|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
27863363|NCT02346240|54434330|FG006|Maintenance Period (Week 16 to Week 48)|Moved out of state|1|||
27863364|NCT02346240|54434331|FG007|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
27863365|NCT02346240|54434332|FG008|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
27863366|NCT02346240|54434333|FG009|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
27863367|NCT02346240|54434334|FG010|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
27863368|NCT02346240|54434335|FG011|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
27863369|NCT02346240|54434336|FG012|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
27863370|NCT02346240|54434337|FG013|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
27863371|NCT02346240|54434338|FG014|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
27863372|NCT02346240|54434339|FG015|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
27863373|NCT02346240|54434340|FG016|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
27863374|NCT02346240|54434341|FG017|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
27863375|NCT02346240|54434342|FG018|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
27863376|NCT02346240|54434343|FG019|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
27863377|NCT02346240|54434344|FG020|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
27863378|NCT02346240|54434345|FG021|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
27863379|NCT02346240|54434346|FG022|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
27863380|NCT02346240|54434347|FG023|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
27863381|NCT02346240|54434324|FG000|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
27863382|NCT02346240|54434325|FG001|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
27981782|NCT00887198|54639574|FG002|Randomized Period|Other|0|||
27981783|NCT00887198|54639572|FG000|Randomized Period|Randomized, Not treated|4|||
27981784|NCT00887198|54639573|FG001|Randomized Period|Randomized, Not treated|2|||
28096106|NCT04170686|54750807|FG001|Randomization and Treatment|Lost to Follow-up|15|||
28171344|NCT02720523|54842903|FG004|Period 2: Long-term Extension Period|Other|2|||
27863383|NCT02346240|54434326|FG002|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
27863384|NCT02346240|54434327|FG003|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
27863385|NCT02346240|54434328|FG004|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
27863386|NCT02346240|54434329|FG005|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
27863387|NCT02346240|54434330|FG006|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
27863388|NCT02346240|54434331|FG007|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
27863389|NCT02346240|54434332|FG008|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
27863390|NCT02346240|54434333|FG009|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
27863391|NCT02346240|54434334|FG010|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
27863392|NCT02346240|54434335|FG011|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
27863393|NCT02346240|54434336|FG012|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
27863394|NCT02346240|54434337|FG013|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
27863395|NCT02346240|54434338|FG014|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
27863396|NCT02346240|54434339|FG015|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
27863397|NCT02346240|54434340|FG016|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
27863398|NCT02346240|54434341|FG017|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
27863399|NCT02346240|54434342|FG018|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
27863400|NCT02346240|54434343|FG019|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
27863401|NCT02346240|54434344|FG020|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
27863402|NCT02346240|54434345|FG021|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
27863403|NCT02346240|54434346|FG022|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
27863404|NCT02346240|54434347|FG023|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
27863405|NCT02346240|54434324|FG000|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
27863406|NCT02346240|54434325|FG001|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
27863407|NCT02346240|54434326|FG002|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
27863408|NCT02346240|54434327|FG003|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
27863409|NCT02346240|54434328|FG004|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
27863410|NCT02346240|54434329|FG005|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
27863411|NCT02346240|54434330|FG006|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
27863412|NCT02346240|54434331|FG007|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
27863413|NCT02346240|54434332|FG008|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
27863414|NCT02346240|54434333|FG009|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1|||
27863415|NCT02346240|54434334|FG010|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
27863416|NCT02346240|54434335|FG011|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
27863417|NCT02346240|54434336|FG012|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
27863418|NCT02346240|54434337|FG013|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
27863419|NCT02346240|54434338|FG014|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
27863420|NCT02346240|54434339|FG015|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
27863421|NCT02346240|54434340|FG016|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
27863422|NCT02346240|54434341|FG017|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
27863423|NCT02346240|54434342|FG018|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
27863424|NCT02346240|54434343|FG019|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
27863425|NCT02346240|54434344|FG020|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
27863426|NCT02346240|54434345|FG021|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
27863427|NCT02346240|54434346|FG022|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
27863428|NCT02346240|54434347|FG023|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
27863429|NCT02346240|54434324|FG000|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
27863430|NCT02346240|54434325|FG001|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
27863431|NCT02346240|54434326|FG002|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
27863432|NCT02346240|54434327|FG003|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
27863433|NCT02346240|54434328|FG004|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
27863434|NCT02346240|54434329|FG005|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
27863435|NCT02346240|54434330|FG006|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
27863436|NCT02346240|54434331|FG007|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
27981785|NCT00887198|54639574|FG002|Randomized Period|Randomized, Not treated|0|||
27981786|NCT00887198|54639572|FG000|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
27863437|NCT02346240|54434332|FG008|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
27863438|NCT02346240|54434333|FG009|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
27863439|NCT02346240|54434334|FG010|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1|||
27863440|NCT02346240|54434335|FG011|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
27863441|NCT02346240|54434336|FG012|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
27863442|NCT02346240|54434337|FG013|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
27863443|NCT02346240|54434338|FG014|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
27863444|NCT02346240|54434339|FG015|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
27863445|NCT02346240|54434340|FG016|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
27863446|NCT02346240|54434341|FG017|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
27863447|NCT02346240|54434342|FG018|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
27863448|NCT02346240|54434343|FG019|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
27863449|NCT02346240|54434344|FG020|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
27863450|NCT02346240|54434345|FG021|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
27863451|NCT02346240|54434346|FG022|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
27863452|NCT02346240|54434347|FG023|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
27863453|NCT02346240|54434324|FG000|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
27863454|NCT02346240|54434325|FG001|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
27863455|NCT02346240|54434326|FG002|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
27863456|NCT02346240|54434327|FG003|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
27863457|NCT02346240|54434328|FG004|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
27863458|NCT02346240|54434329|FG005|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
27863459|NCT02346240|54434330|FG006|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
27863460|NCT02346240|54434331|FG007|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
27863461|NCT02346240|54434332|FG008|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
27863462|NCT02346240|54434333|FG009|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
27863463|NCT02346240|54434334|FG010|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
27863464|NCT02346240|54434335|FG011|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
27863465|NCT02346240|54434336|FG012|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
27863466|NCT02346240|54434337|FG013|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
27863467|NCT02346240|54434338|FG014|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1|||
27863468|NCT02346240|54434339|FG015|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
27863469|NCT02346240|54434340|FG016|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
27863470|NCT02346240|54434341|FG017|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
27863471|NCT02346240|54434342|FG018|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
27863472|NCT02346240|54434343|FG019|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
27863473|NCT02346240|54434344|FG020|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
27863474|NCT02346240|54434345|FG021|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
27863475|NCT02346240|54434346|FG022|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
27863476|NCT02346240|54434347|FG023|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
27863477|NCT02346240|54434324|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
27863478|NCT02346240|54434325|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
27863479|NCT02346240|54434326|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
27863480|NCT02346240|54434327|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
27863481|NCT02346240|54434328|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
27863482|NCT02346240|54434329|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
27863483|NCT02346240|54434330|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
27863484|NCT02346240|54434331|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
27863485|NCT02346240|54434332|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
27863486|NCT02346240|54434333|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
27863487|NCT02346240|54434334|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
27863488|NCT02346240|54434335|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
27863489|NCT02346240|54434336|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
27863490|NCT02346240|54434337|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
27863491|NCT02346240|54434338|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1|||
27863492|NCT02346240|54434339|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
27863493|NCT02346240|54434340|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
27863494|NCT02346240|54434341|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
28096107|NCT03695094|54750815|FG000|Overall Study|Adverse Event|1|||
27863495|NCT02346240|54434342|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
27863496|NCT02346240|54434343|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
27863497|NCT02346240|54434344|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
27863498|NCT02346240|54434345|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
27863499|NCT02346240|54434346|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
27863500|NCT02346240|54434347|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
27863501|NCT02346240|54434324|FG000|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
27863502|NCT02346240|54434325|FG001|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
27863503|NCT02346240|54434326|FG002|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
27863504|NCT02346240|54434327|FG003|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
27863505|NCT02346240|54434328|FG004|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
27863506|NCT02346240|54434329|FG005|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
27863507|NCT02346240|54434330|FG006|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
27863508|NCT02346240|54434331|FG007|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
27863509|NCT02346240|54434332|FG008|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
27863510|NCT02346240|54434333|FG009|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
27863511|NCT02346240|54434334|FG010|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
27863512|NCT02346240|54434335|FG011|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
27863513|NCT02346240|54434336|FG012|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
27863514|NCT02346240|54434337|FG013|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
27863515|NCT02346240|54434338|FG014|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1|||
27863516|NCT02346240|54434339|FG015|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
27863517|NCT02346240|54434340|FG016|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
27863518|NCT02346240|54434341|FG017|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
27863519|NCT02346240|54434342|FG018|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
27863520|NCT02346240|54434343|FG019|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
27863521|NCT02346240|54434344|FG020|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
27863522|NCT02346240|54434345|FG021|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
27863523|NCT02346240|54434346|FG022|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
27863524|NCT02346240|54434347|FG023|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
27863525|NCT02346240|54434324|FG000|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
27863526|NCT02346240|54434325|FG001|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
27863527|NCT02346240|54434326|FG002|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
27863528|NCT02346240|54434327|FG003|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
27863529|NCT02346240|54434328|FG004|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
27863530|NCT02346240|54434329|FG005|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
27863531|NCT02346240|54434330|FG006|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
27863532|NCT02346240|54434331|FG007|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
27863533|NCT02346240|54434332|FG008|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
27863534|NCT02346240|54434333|FG009|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
27863535|NCT02346240|54434334|FG010|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
27863536|NCT02346240|54434335|FG011|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
27863537|NCT02346240|54434336|FG012|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
27863538|NCT02346240|54434337|FG013|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
27863539|NCT02346240|54434338|FG014|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
27863540|NCT02346240|54434339|FG015|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
27863541|NCT02346240|54434340|FG016|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
27863542|NCT02346240|54434341|FG017|Open-Label Period (Week 48 to Week 144)|Adverse Event|1|||
27863543|NCT02346240|54434342|FG018|Open-Label Period (Week 48 to Week 144)|Adverse Event|6|||
27863544|NCT02346240|54434343|FG019|Open-Label Period (Week 48 to Week 144)|Adverse Event|2|||
27863545|NCT02346240|54434344|FG020|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
27863546|NCT02346240|54434345|FG021|Open-Label Period (Week 48 to Week 144)|Adverse Event|13|||
27863547|NCT02346240|54434346|FG022|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
27863548|NCT02346240|54434347|FG023|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
27863549|NCT02346240|54434324|FG000|Open-Label Period (Week 48 to Week 144)|Death|0|||
27863550|NCT02346240|54434325|FG001|Open-Label Period (Week 48 to Week 144)|Death|0|||
27863551|NCT02346240|54434326|FG002|Open-Label Period (Week 48 to Week 144)|Death|0|||
27863552|NCT02346240|54434327|FG003|Open-Label Period (Week 48 to Week 144)|Death|0|||
27863553|NCT02346240|54434328|FG004|Open-Label Period (Week 48 to Week 144)|Death|0|||
27863554|NCT02346240|54434329|FG005|Open-Label Period (Week 48 to Week 144)|Death|0|||
27863555|NCT02346240|54434330|FG006|Open-Label Period (Week 48 to Week 144)|Death|0|||
27863556|NCT02346240|54434331|FG007|Open-Label Period (Week 48 to Week 144)|Death|0|||
27863557|NCT02346240|54434332|FG008|Open-Label Period (Week 48 to Week 144)|Death|0|||
27863558|NCT02346240|54434333|FG009|Open-Label Period (Week 48 to Week 144)|Death|0|||
27863559|NCT02346240|54434334|FG010|Open-Label Period (Week 48 to Week 144)|Death|0|||
27863560|NCT02346240|54434335|FG011|Open-Label Period (Week 48 to Week 144)|Death|0|||
27863561|NCT02346240|54434336|FG012|Open-Label Period (Week 48 to Week 144)|Death|0|||
27863562|NCT02346240|54434337|FG013|Open-Label Period (Week 48 to Week 144)|Death|0|||
27863563|NCT02346240|54434338|FG014|Open-Label Period (Week 48 to Week 144)|Death|0|||
27863564|NCT02346240|54434339|FG015|Open-Label Period (Week 48 to Week 144)|Death|0|||
27863565|NCT02346240|54434340|FG016|Open-Label Period (Week 48 to Week 144)|Death|0|||
27863566|NCT02346240|54434341|FG017|Open-Label Period (Week 48 to Week 144)|Death|0|||
27863567|NCT02346240|54434342|FG018|Open-Label Period (Week 48 to Week 144)|Death|1|||
27863568|NCT02346240|54434343|FG019|Open-Label Period (Week 48 to Week 144)|Death|1|||
27863569|NCT02346240|54434344|FG020|Open-Label Period (Week 48 to Week 144)|Death|0|||
27863570|NCT02346240|54434345|FG021|Open-Label Period (Week 48 to Week 144)|Death|1|||
27863571|NCT02346240|54434346|FG022|Open-Label Period (Week 48 to Week 144)|Death|0|||
27834730|NCT01695239|54319318|FG010|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
27834731|NCT01695239|54319319|FG011|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
27834732|NCT01695239|54319320|FG012|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
27834733|NCT01695239|54319321|FG013|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
27834734|NCT01695239|54319308|FG000|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
27834735|NCT01695239|54319309|FG001|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
27834736|NCT01695239|54319310|FG002|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
27834737|NCT01695239|54319311|FG003|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
27834738|NCT01695239|54319312|FG004|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
27834739|NCT01695239|54319313|FG005|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
27834740|NCT01695239|54319314|FG006|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
27834741|NCT01695239|54319315|FG007|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1|||
27834742|NCT01695239|54319316|FG008|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
27834743|NCT01695239|54319317|FG009|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
27834744|NCT01695239|54319318|FG010|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
27834745|NCT01695239|54319319|FG011|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
27834746|NCT01695239|54319320|FG012|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
27834747|NCT01695239|54319321|FG013|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
27834748|NCT01695239|54319308|FG000|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
27834749|NCT01695239|54319309|FG001|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
27834750|NCT01695239|54319310|FG002|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
27834751|NCT01695239|54319311|FG003|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
27834752|NCT01695239|54319312|FG004|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
27834753|NCT01695239|54319313|FG005|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
27834754|NCT01695239|54319314|FG006|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
27834755|NCT01695239|54319315|FG007|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1|||
27834756|NCT01695239|54319316|FG008|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
27834757|NCT01695239|54319317|FG009|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
27834758|NCT01695239|54319318|FG010|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
27834759|NCT01695239|54319319|FG011|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
27834760|NCT01695239|54319320|FG012|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
27834761|NCT01695239|54319321|FG013|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
27834762|NCT01695239|54319308|FG000|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
27834763|NCT01695239|54319309|FG001|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
27834764|NCT01695239|54319310|FG002|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
27834765|NCT01695239|54319311|FG003|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
27834766|NCT01695239|54319312|FG004|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
27834767|NCT01695239|54319313|FG005|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
27834768|NCT01695239|54319314|FG006|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
27834769|NCT01695239|54319315|FG007|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
27834770|NCT01695239|54319316|FG008|Extension Long-Term Extension Periods|Lack of Efficacy|37|||
27834771|NCT01695239|54319317|FG009|Extension Long-Term Extension Periods|Lack of Efficacy|31|||
27834772|NCT01695239|54319318|FG010|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
27834773|NCT01695239|54319319|FG011|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
27834774|NCT01695239|54319320|FG012|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
27834775|NCT01695239|54319321|FG013|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
27834776|NCT01695239|54319308|FG000|Extension Long-Term Extension Periods|Adverse Event|0|||
27863572|NCT02346240|54434347|FG023|Open-Label Period (Week 48 to Week 144)|Death|0|||
27863573|NCT02346240|54434324|FG000|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27863574|NCT02346240|54434325|FG001|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27863575|NCT02346240|54434326|FG002|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27863576|NCT02346240|54434327|FG003|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27863577|NCT02346240|54434328|FG004|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27863578|NCT02346240|54434329|FG005|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27863579|NCT02346240|54434330|FG006|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27863580|NCT02346240|54434331|FG007|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27863581|NCT02346240|54434332|FG008|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27863582|NCT02346240|54434333|FG009|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27863583|NCT02346240|54434334|FG010|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27863584|NCT02346240|54434335|FG011|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27863585|NCT02346240|54434336|FG012|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27863586|NCT02346240|54434337|FG013|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27863587|NCT02346240|54434338|FG014|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27863588|NCT02346240|54434339|FG015|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27863589|NCT02346240|54434340|FG016|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27863590|NCT02346240|54434341|FG017|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27863591|NCT02346240|54434342|FG018|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
27863592|NCT02346240|54434343|FG019|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27863593|NCT02346240|54434344|FG020|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27863594|NCT02346240|54434345|FG021|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
27863595|NCT02346240|54434346|FG022|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27863596|NCT02346240|54434347|FG023|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27863597|NCT02346240|54434324|FG000|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
27863598|NCT02346240|54434325|FG001|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
27863599|NCT02346240|54434326|FG002|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
27863600|NCT02346240|54434327|FG003|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
27863601|NCT02346240|54434328|FG004|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
27863602|NCT02346240|54434329|FG005|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
27863603|NCT02346240|54434330|FG006|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
27863604|NCT02346240|54434331|FG007|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
27863605|NCT02346240|54434332|FG008|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
27863606|NCT02346240|54434333|FG009|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
27863607|NCT02346240|54434334|FG010|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
27863608|NCT02346240|54434335|FG011|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
27863609|NCT02346240|54434336|FG012|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
27863610|NCT02346240|54434337|FG013|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
27863611|NCT02346240|54434338|FG014|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
28171345|NCT02720523|54842904|FG005|Period 2: Long-term Extension Period|Other|0|||
28171346|NCT02720523|54842905|FG006|Period 2: Long-term Extension Period|Other|3|||
28171347|NCT02646332|54842920|FG000|Overall Study|Lost to Follow-up|0|||
28171348|NCT02646332|54842921|FG001|Overall Study|Lost to Follow-up|3|||
28171349|NCT02471716|54842932|FG000|Overall Study|Withdrawal by Subject|0|||
28171350|NCT02471716|54842933|FG001|Overall Study|Withdrawal by Subject|1|||
28171351|NCT02471716|54842934|FG002|Overall Study|Withdrawal by Subject|0|||
28171352|NCT02471716|54842935|FG003|Overall Study|Withdrawal by Subject|2|||
27863612|NCT02346240|54434339|FG015|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
27863613|NCT02346240|54434340|FG016|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
27863614|NCT02346240|54434341|FG017|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
27863615|NCT02346240|54434342|FG018|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
27863616|NCT02346240|54434343|FG019|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
27863617|NCT02346240|54434344|FG020|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
27863618|NCT02346240|54434345|FG021|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1|||
27981787|NCT00887198|54639573|FG001|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
27981788|NCT00887198|54639574|FG002|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8|||
28096108|NCT03695094|54750816|FG001|Overall Study|Adverse Event|1|||
28096109|NCT03695094|54750815|FG000|Overall Study|Withdrawal by Subject|1|||
28096110|NCT03695094|54750816|FG001|Overall Study|Withdrawal by Subject|0|||
28096111|NCT04497948|54750824|FG000|Overall Study|Death|2|||
28096112|NCT04495374|54750834|FG000|Overall Study|Protocol Violation|2|||
28096113|NCT04495374|54750835|FG001|Overall Study|Protocol Violation|1|||
28096114|NCT04794270|54750841|FG000|Period 1|Non Compliance|1|||
28096115|NCT04794270|54750842|FG001|Period 1|Non Compliance|0|||
28096116|NCT04794270|54750841|FG000|Period 1|Adverse Event|1|||
28096117|NCT04794270|54750842|FG001|Period 1|Adverse Event|0|||
28096118|NCT04794270|54750841|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
28171353|NCT02471716|54842936|FG004|Overall Study|Withdrawal by Subject|5|||
28171354|NCT02471716|54842932|FG000|Overall Study|Study Terminiated by sponsor|0|||
27863619|NCT02346240|54434346|FG022|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
27863620|NCT02346240|54434347|FG023|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
27863621|NCT02346240|54434324|FG000|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27863622|NCT02346240|54434325|FG001|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27863623|NCT02346240|54434326|FG002|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27863624|NCT02346240|54434327|FG003|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27863625|NCT02346240|54434328|FG004|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27863626|NCT02346240|54434329|FG005|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27863627|NCT02346240|54434330|FG006|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27863628|NCT02346240|54434331|FG007|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27863629|NCT02346240|54434332|FG008|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27863630|NCT02346240|54434333|FG009|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27863631|NCT02346240|54434334|FG010|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27863632|NCT02346240|54434335|FG011|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27863633|NCT02346240|54434336|FG012|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27863634|NCT02346240|54434337|FG013|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27863635|NCT02346240|54434338|FG014|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27863636|NCT02346240|54434339|FG015|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27863637|NCT02346240|54434340|FG016|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27863638|NCT02346240|54434341|FG017|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
27863639|NCT02346240|54434342|FG018|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
27863640|NCT02346240|54434343|FG019|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
27863641|NCT02346240|54434344|FG020|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27863642|NCT02346240|54434345|FG021|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
27863643|NCT02346240|54434346|FG022|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
27863644|NCT02346240|54434347|FG023|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
27863645|NCT02346240|54434324|FG000|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27863646|NCT02346240|54434325|FG001|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27863647|NCT02346240|54434326|FG002|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27863648|NCT02346240|54434327|FG003|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27863649|NCT02346240|54434328|FG004|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27863650|NCT02346240|54434329|FG005|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27863651|NCT02346240|54434330|FG006|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27863652|NCT02346240|54434331|FG007|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27863653|NCT02346240|54434332|FG008|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27863654|NCT02346240|54434333|FG009|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27863655|NCT02346240|54434334|FG010|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27863656|NCT02346240|54434335|FG011|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27863657|NCT02346240|54434336|FG012|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27863658|NCT02346240|54434337|FG013|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27863659|NCT02346240|54434338|FG014|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27863660|NCT02346240|54434339|FG015|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27863661|NCT02346240|54434340|FG016|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27863662|NCT02346240|54434341|FG017|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27863663|NCT02346240|54434342|FG018|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
27863664|NCT02346240|54434343|FG019|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
27863665|NCT02346240|54434344|FG020|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27863666|NCT02346240|54434345|FG021|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10|||
27863667|NCT02346240|54434346|FG022|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
27863668|NCT02346240|54434347|FG023|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
27863669|NCT02346240|54434324|FG000|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
27863670|NCT02346240|54434325|FG001|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
27863671|NCT02346240|54434326|FG002|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
27863672|NCT02346240|54434327|FG003|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
27863673|NCT02346240|54434328|FG004|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
27863674|NCT02346240|54434329|FG005|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
27863675|NCT02346240|54434330|FG006|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
27863676|NCT02346240|54434331|FG007|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
27863677|NCT02346240|54434332|FG008|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
27863678|NCT02346240|54434333|FG009|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
28096119|NCT04794270|54750842|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
28096120|NCT04567186|54750848|FG000|Period 1|COVID-19 related|1|||
28096121|NCT04567186|54750849|FG001|Period 1|COVID-19 related|0|||
27738962|NCT02240680|54188243|FG000|Overall Study (Up to 24 Weeks)|Protocol Violation|4|||
27863679|NCT02346240|54434334|FG010|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
27863680|NCT02346240|54434335|FG011|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
27863681|NCT02346240|54434336|FG012|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
27863682|NCT02346240|54434337|FG013|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
27863683|NCT02346240|54434338|FG014|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
27863684|NCT02346240|54434339|FG015|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
27863685|NCT02346240|54434340|FG016|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
27863686|NCT02346240|54434341|FG017|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
27863687|NCT02346240|54434342|FG018|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
27863688|NCT02346240|54434343|FG019|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
27863689|NCT02346240|54434344|FG020|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
27863690|NCT02346240|54434345|FG021|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4|||
27863691|NCT02346240|54434346|FG022|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
27863692|NCT02346240|54434347|FG023|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3|||
27863693|NCT02346240|54434324|FG000|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
27863694|NCT02346240|54434325|FG001|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
27863695|NCT02346240|54434326|FG002|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
27863696|NCT02346240|54434327|FG003|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
27863697|NCT02346240|54434328|FG004|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
27863698|NCT02346240|54434329|FG005|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
27863699|NCT02346240|54434330|FG006|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
27863700|NCT02346240|54434331|FG007|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
27863701|NCT02346240|54434332|FG008|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
27863702|NCT02346240|54434333|FG009|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
27863703|NCT02346240|54434334|FG010|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
27863704|NCT02346240|54434335|FG011|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
27863705|NCT02346240|54434336|FG012|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
27863706|NCT02346240|54434337|FG013|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
27863707|NCT02346240|54434338|FG014|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
27863708|NCT02346240|54434339|FG015|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
27863709|NCT02346240|54434340|FG016|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
27863710|NCT02346240|54434341|FG017|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
27863711|NCT02346240|54434342|FG018|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1|||
27863712|NCT02346240|54434343|FG019|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
27863713|NCT02346240|54434344|FG020|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
27863714|NCT02346240|54434345|FG021|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
27863715|NCT02346240|54434346|FG022|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
27863716|NCT02346240|54434347|FG023|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
27863717|NCT02392104|54434398|FG000|Overall Study|discontinuation of warfarin|3|||
27863718|NCT02392104|54434398|FG000|Overall Study|bleeding event|1|||
27863719|NCT02392104|54434398|FG000|Overall Study|transferred care to another doctor|2|||
27863720|NCT02392104|54434398|FG000|Overall Study|INR goal range changed|1|||
27863721|NCT02392104|54434398|FG000|Overall Study|admitted to skilled nursing facility|3|||
27863722|NCT02392104|54434398|FG000|Overall Study|INRs drawn by visiting nurse services|1|||
27863723|NCT02391948|54434416|FG000|6-month Assessment|Death|0|||
27863724|NCT02391948|54434417|FG001|6-month Assessment|Death|0|||
27863725|NCT02391948|54434418|FG002|6-month Assessment|Death|0|||
27863726|NCT02391948|54434419|FG003|6-month Assessment|Death|0|||
27863727|NCT02391948|54434420|FG004|6-month Assessment|Death|1|||
27863728|NCT02391948|54434416|FG000|6-month Assessment|Withdrawal by Subject|0|||
27863729|NCT02391948|54434417|FG001|6-month Assessment|Withdrawal by Subject|0|||
27863730|NCT02391948|54434418|FG002|6-month Assessment|Withdrawal by Subject|1|||
27863731|NCT02391948|54434419|FG003|6-month Assessment|Withdrawal by Subject|2|||
27863732|NCT02391948|54434420|FG004|6-month Assessment|Withdrawal by Subject|0|||
27863733|NCT02391948|54434416|FG000|6-month Assessment|Lost to Follow-up|4|||
27863734|NCT02391948|54434417|FG001|6-month Assessment|Lost to Follow-up|5|||
27863735|NCT02391948|54434418|FG002|6-month Assessment|Lost to Follow-up|2|||
27863736|NCT02391948|54434419|FG003|6-month Assessment|Lost to Follow-up|3|||
27863737|NCT02391948|54434420|FG004|6-month Assessment|Lost to Follow-up|1|||
27863738|NCT02391948|54434416|FG000|6-month Assessment|Medical issue/illness|1|||
27863739|NCT02391948|54434417|FG001|6-month Assessment|Medical issue/illness|1|||
27863740|NCT02391948|54434418|FG002|6-month Assessment|Medical issue/illness|0|||
27863741|NCT02391948|54434419|FG003|6-month Assessment|Medical issue/illness|0|||
27863742|NCT02391948|54434420|FG004|6-month Assessment|Medical issue/illness|0|||
27738963|NCT02240680|54188244|FG001|Overall Study (Up to 24 Weeks)|Protocol Violation|1|||
27863743|NCT02391948|54434416|FG000|6-month Assessment|Not able to schedule visit in timeframe|6|||
27863744|NCT02391948|54434417|FG001|6-month Assessment|Not able to schedule visit in timeframe|8|||
27863745|NCT02391948|54434418|FG002|6-month Assessment|Not able to schedule visit in timeframe|4|||
27863746|NCT02391948|54434419|FG003|6-month Assessment|Not able to schedule visit in timeframe|5|||
27863747|NCT02391948|54434420|FG004|6-month Assessment|Not able to schedule visit in timeframe|0|||
27863748|NCT02391948|54434416|FG000|6-month Assessment|In 2-visit study (6-month N/A)|68|||
27863749|NCT02391948|54434417|FG001|6-month Assessment|In 2-visit study (6-month N/A)|42|||
27863750|NCT02391948|54434418|FG002|6-month Assessment|In 2-visit study (6-month N/A)|24|||
27863751|NCT02391948|54434419|FG003|6-month Assessment|In 2-visit study (6-month N/A)|35|||
27863752|NCT02391948|54434420|FG004|6-month Assessment|In 2-visit study (6-month N/A)|24|||
27863753|NCT02391948|54434416|FG000|12-month Assessment|Death|0|||
27863754|NCT02391948|54434417|FG001|12-month Assessment|Death|0|||
27863755|NCT02391948|54434418|FG002|12-month Assessment|Death|0|||
27863756|NCT02391948|54434419|FG003|12-month Assessment|Death|1|||
27863757|NCT02391948|54434420|FG004|12-month Assessment|Death|0|||
27863758|NCT02391948|54434416|FG000|12-month Assessment|Withdrawal by Subject|1|||
27863759|NCT02391948|54434417|FG001|12-month Assessment|Withdrawal by Subject|0|||
27863760|NCT02391948|54434418|FG002|12-month Assessment|Withdrawal by Subject|0|||
27863761|NCT02391948|54434419|FG003|12-month Assessment|Withdrawal by Subject|1|||
27863762|NCT02391948|54434420|FG004|12-month Assessment|Withdrawal by Subject|0|||
27863763|NCT02391948|54434416|FG000|12-month Assessment|Lost to Follow-up|5|||
27863764|NCT02391948|54434417|FG001|12-month Assessment|Lost to Follow-up|4|||
27863765|NCT02391948|54434418|FG002|12-month Assessment|Lost to Follow-up|4|||
27863766|NCT02391948|54434419|FG003|12-month Assessment|Lost to Follow-up|4|||
27863767|NCT02391948|54434420|FG004|12-month Assessment|Lost to Follow-up|5|||
27863768|NCT02391948|54434416|FG000|12-month Assessment|Medical issue/illness|0|||
27863769|NCT02391948|54434417|FG001|12-month Assessment|Medical issue/illness|1|||
27863770|NCT02391948|54434418|FG002|12-month Assessment|Medical issue/illness|0|||
27863771|NCT02391948|54434419|FG003|12-month Assessment|Medical issue/illness|1|||
27863772|NCT02391948|54434420|FG004|12-month Assessment|Medical issue/illness|0|||
27863773|NCT02391948|54434416|FG000|12-month Assessment|Not able to schedule visit in timeframe|2|||
27863774|NCT02391948|54434417|FG001|12-month Assessment|Not able to schedule visit in timeframe|4|||
27863775|NCT02391948|54434418|FG002|12-month Assessment|Not able to schedule visit in timeframe|0|||
27863776|NCT02391948|54434419|FG003|12-month Assessment|Not able to schedule visit in timeframe|2|||
27863777|NCT02391948|54434420|FG004|12-month Assessment|Not able to schedule visit in timeframe|1|||
27863778|NCT02391948|54434416|FG000|18-month Assessment|Death|0|||
27863779|NCT02391948|54434417|FG001|18-month Assessment|Death|0|||
27863780|NCT02391948|54434418|FG002|18-month Assessment|Death|0|||
27863781|NCT02391948|54434419|FG003|18-month Assessment|Death|1|||
27863782|NCT02391948|54434420|FG004|18-month Assessment|Death|1|||
27863783|NCT02391948|54434416|FG000|18-month Assessment|Withdrawal by Subject|1|||
27863784|NCT02391948|54434417|FG001|18-month Assessment|Withdrawal by Subject|0|||
27863785|NCT02391948|54434418|FG002|18-month Assessment|Withdrawal by Subject|0|||
27863786|NCT02391948|54434419|FG003|18-month Assessment|Withdrawal by Subject|1|||
27863787|NCT02391948|54434420|FG004|18-month Assessment|Withdrawal by Subject|0|||
27863788|NCT02391948|54434416|FG000|18-month Assessment|Lost to Follow-up|2|||
27863789|NCT02391948|54434417|FG001|18-month Assessment|Lost to Follow-up|6|||
27863790|NCT02391948|54434418|FG002|18-month Assessment|Lost to Follow-up|2|||
27863791|NCT02391948|54434419|FG003|18-month Assessment|Lost to Follow-up|2|||
27863792|NCT02391948|54434420|FG004|18-month Assessment|Lost to Follow-up|3|||
27863793|NCT02391948|54434416|FG000|18-month Assessment|Not able to schedule visit in timeframe|3|||
27863794|NCT02391948|54434417|FG001|18-month Assessment|Not able to schedule visit in timeframe|3|||
27863795|NCT02391948|54434418|FG002|18-month Assessment|Not able to schedule visit in timeframe|2|||
27863796|NCT02391948|54434419|FG003|18-month Assessment|Not able to schedule visit in timeframe|1|||
27863797|NCT02391948|54434420|FG004|18-month Assessment|Not able to schedule visit in timeframe|4|||
27863798|NCT02391948|54434416|FG000|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66|||
27863799|NCT02391948|54434417|FG001|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41|||
27863800|NCT02391948|54434418|FG002|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
27863801|NCT02391948|54434419|FG003|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31|||
27863802|NCT02391948|54434420|FG004|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
27863803|NCT02391948|54434416|FG000|24-month Assessment|Death|0|||
27863804|NCT02391948|54434417|FG001|24-month Assessment|Death|0|||
27863805|NCT02391948|54434418|FG002|24-month Assessment|Death|0|||
27863806|NCT02391948|54434419|FG003|24-month Assessment|Death|0|||
27863807|NCT02391948|54434420|FG004|24-month Assessment|Death|1|||
27863808|NCT02391948|54434416|FG000|24-month Assessment|Withdrawal by Subject|1|||
27863809|NCT02391948|54434417|FG001|24-month Assessment|Withdrawal by Subject|1|||
27863810|NCT02391948|54434418|FG002|24-month Assessment|Withdrawal by Subject|0|||
27863811|NCT02391948|54434419|FG003|24-month Assessment|Withdrawal by Subject|0|||
27863812|NCT02391948|54434420|FG004|24-month Assessment|Withdrawal by Subject|1|||
27863813|NCT02391948|54434416|FG000|24-month Assessment|Lost to Follow-up|5|||
27863814|NCT02391948|54434417|FG001|24-month Assessment|Lost to Follow-up|4|||
27863815|NCT02391948|54434418|FG002|24-month Assessment|Lost to Follow-up|0|||
27863816|NCT02391948|54434419|FG003|24-month Assessment|Lost to Follow-up|0|||
27863817|NCT02391948|54434420|FG004|24-month Assessment|Lost to Follow-up|0|||
27863818|NCT02391948|54434416|FG000|24-month Assessment|Medical issue/illness|0|||
27863819|NCT02391948|54434417|FG001|24-month Assessment|Medical issue/illness|0|||
27863820|NCT02391948|54434418|FG002|24-month Assessment|Medical issue/illness|1|||
27863821|NCT02391948|54434419|FG003|24-month Assessment|Medical issue/illness|0|||
27863822|NCT02391948|54434420|FG004|24-month Assessment|Medical issue/illness|0|||
27863823|NCT02391948|54434416|FG000|24-month Assessment|Not able to schedule visit in timeframe|8|||
27863824|NCT02391948|54434417|FG001|24-month Assessment|Not able to schedule visit in timeframe|5|||
27863825|NCT02391948|54434418|FG002|24-month Assessment|Not able to schedule visit in timeframe|2|||
27863826|NCT02391948|54434419|FG003|24-month Assessment|Not able to schedule visit in timeframe|9|||
27863827|NCT02391948|54434420|FG004|24-month Assessment|Not able to schedule visit in timeframe|8|||
27863828|NCT02369874|54434663|FG000|Overall Study|Lost to Follow-up|2|||
27863829|NCT02369874|54434664|FG001|Overall Study|Lost to Follow-up|2|||
27863830|NCT02369874|54434665|FG002|Overall Study|Lost to Follow-up|2|||
27863831|NCT02369874|54434663|FG000|Overall Study|Withdrawal by Subject|7|||
27863832|NCT02369874|54434664|FG001|Overall Study|Withdrawal by Subject|9|||
27863833|NCT02369874|54434665|FG002|Overall Study|Withdrawal by Subject|27|||
27863834|NCT02369874|54434663|FG000|Overall Study|Miscellaneous|1|||
27863835|NCT02369874|54434664|FG001|Overall Study|Miscellaneous|1|||
27863836|NCT02369874|54434665|FG002|Overall Study|Miscellaneous|0|||
27863837|NCT02369874|54434663|FG000|Overall Study|On Treatment/Off Study|34|||
27863838|NCT02369874|54434664|FG001|Overall Study|On Treatment/Off Study|45|||
27863839|NCT02369874|54434665|FG002|Overall Study|On Treatment/Off Study|32|||
27863840|NCT02368314|54434817|FG000|Overall Study|Withdrawal by Subject|2|||
27863841|NCT02368314|54434818|FG001|Overall Study|Withdrawal by Subject|1|||
27863842|NCT02368314|54434817|FG000|Overall Study|Adverse Event|1|||
27863843|NCT02368314|54434818|FG001|Overall Study|Adverse Event|2|||
27863844|NCT02366910|54434828|FG000|Overall Study|Withdrawal by Subject|2|||
27863845|NCT02366910|54434828|FG000|Overall Study|Screen Failure|3|||
27863846|NCT01649232|54434846|FG000|Overall Study|Physician Decision|2|||
27863847|NCT01649232|54434847|FG001|Overall Study|Physician Decision|0|||
27863848|NCT02345226|54435147|FG000|Double-Blind Phase|Adverse Event|5|||
27863849|NCT02345226|54435148|FG001|Double-Blind Phase|Adverse Event|6|||
27863850|NCT02345226|54435147|FG000|Double-Blind Phase|Death|3|||
27863851|NCT02345226|54435148|FG001|Double-Blind Phase|Death|0|||
27863852|NCT02345226|54435147|FG000|Double-Blind Phase|Pregnancy|0|||
27863853|NCT02345226|54435148|FG001|Double-Blind Phase|Pregnancy|1|||
27863854|NCT02345226|54435147|FG000|Double-Blind Phase|Lack of Efficacy|1|||
27863855|NCT02345226|54435148|FG001|Double-Blind Phase|Lack of Efficacy|0|||
27863856|NCT02345226|54435147|FG000|Double-Blind Phase|Investigator's Discretion|4|||
27863857|NCT02345226|54435148|FG001|Double-Blind Phase|Investigator's Discretion|3|||
27863858|NCT02345226|54435147|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
27863859|NCT02345226|54435148|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
27981789|NCT00887198|54639572|FG000|Cross Over (Placebo to AA)|Ongoing|0|||
27981790|NCT00887198|54639573|FG001|Cross Over (Placebo to AA)|Ongoing|0|||
27981791|NCT00887198|54639574|FG002|Cross Over (Placebo to AA)|Ongoing|35|||
27981792|NCT00887198|54639572|FG000|Cross Over (Placebo to AA)|Adverse Event|0|||
27981793|NCT00887198|54639573|FG001|Cross Over (Placebo to AA)|Adverse Event|0|||
27981794|NCT00887198|54639574|FG002|Cross Over (Placebo to AA)|Adverse Event|9|||
27981795|NCT00887198|54639572|FG000|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
27981796|NCT00887198|54639573|FG001|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
27981797|NCT00887198|54639574|FG002|Cross Over (Placebo to AA)|Withdrawal by Subject|2|||
27981798|NCT00887198|54639572|FG000|Cross Over (Placebo to AA)|Progressive disease|0|||
27981799|NCT00887198|54639573|FG001|Cross Over (Placebo to AA)|Progressive disease|0|||
27981800|NCT00887198|54639574|FG002|Cross Over (Placebo to AA)|Progressive disease|20|||
27981801|NCT00887198|54639572|FG000|Cross Over (Placebo to AA)|Other|0|||
27981802|NCT00887198|54639573|FG001|Cross Over (Placebo to AA)|Other|0|||
27981803|NCT00887198|54639574|FG002|Cross Over (Placebo to AA)|Other|19|||
27981804|NCT00782067|54639582|FG000|Overall Study|Adverse Event|35|||
27981805|NCT00782067|54639582|FG000|Overall Study|Subject withdrew consent|11|||
27981806|NCT00782067|54639582|FG000|Overall Study|Lost to Follow-up|2|||
27981807|NCT00782067|54639582|FG000|Overall Study|Administrative problems|14|||
27981808|NCT00782067|54639582|FG000|Overall Study|Death|9|||
27981809|NCT00782067|54639582|FG000|Overall Study|Disease progression|43|||
27981810|NCT00782067|54639582|FG000|Overall Study|Protocol deviation|2|||
27981811|NCT00886340|54639588|FG000|Overall Study|Withdrawal by Subject|0|||
27981812|NCT00886340|54639589|FG001|Overall Study|Withdrawal by Subject|7|||
27863860|NCT02345226|54435147|FG000|Double-Blind Phase|Withdrew Consent|41|||
27863861|NCT02345226|54435148|FG001|Double-Blind Phase|Withdrew Consent|39|||
27863862|NCT02345226|54435147|FG000|Double-Blind Phase|Lost to Follow-up|12|||
27863863|NCT02345226|54435148|FG001|Double-Blind Phase|Lost to Follow-up|16|||
27863864|NCT02345226|54435147|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
27863865|NCT02345226|54435148|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
27863866|NCT02345226|54435147|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
27863867|NCT02345226|54435148|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
27863868|NCT00551369|54435719|FG000|Overall Study|Protocol Violation|5|||
27863869|NCT00551369|54435719|FG000|Overall Study|Withdrawal by Subject|1|||
27863870|NCT00551369|54435719|FG000|Overall Study|Not treated per protocol and re|1|||
27863871|NCT00551291|54435732|FG000|Overall Study|Physician Decision|1|||
27863872|NCT00551213|54435838|FG000|Overall Study|Adverse Event|6|||
27863873|NCT00551213|54435839|FG001|Overall Study|Adverse Event|3|||
27863874|NCT00551213|54435838|FG000|Overall Study|Progressive Disease|41|||
27863875|NCT00551213|54435839|FG001|Overall Study|Progressive Disease|12|||
27863876|NCT00551213|54435838|FG000|Overall Study|Withdrawal by Subject|2|||
27863877|NCT00551213|54435839|FG001|Overall Study|Withdrawal by Subject|0|||
27863878|NCT00551213|54435838|FG000|Overall Study|Not Treated|1|||
27863879|NCT00551213|54435839|FG001|Overall Study|Not Treated|2|||
27863880|NCT00550043|54435976|FG000|Overall Study|Adverse Event|0|||
27863881|NCT00550043|54435977|FG001|Overall Study|Adverse Event|0|||
27863882|NCT00550043|54435978|FG002|Overall Study|Adverse Event|0|||
27863883|NCT00550043|54435979|FG003|Overall Study|Adverse Event|1|||
27863884|NCT00550043|54435980|FG004|Overall Study|Adverse Event|1|||
27863885|NCT00550043|54435976|FG000|Overall Study|Subject Withdrew Consent|0|||
27863886|NCT00550043|54435977|FG001|Overall Study|Subject Withdrew Consent|2|||
27834777|NCT01695239|54319309|FG001|Extension Long-Term Extension Periods|Adverse Event|0|||
27834778|NCT01695239|54319310|FG002|Extension Long-Term Extension Periods|Adverse Event|0|||
27834779|NCT01695239|54319311|FG003|Extension Long-Term Extension Periods|Adverse Event|0|||
27834780|NCT01695239|54319312|FG004|Extension Long-Term Extension Periods|Adverse Event|0|||
27834781|NCT01695239|54319313|FG005|Extension Long-Term Extension Periods|Adverse Event|0|||
27834782|NCT01695239|54319314|FG006|Extension Long-Term Extension Periods|Adverse Event|0|||
27834783|NCT01695239|54319315|FG007|Extension Long-Term Extension Periods|Adverse Event|0|||
27834784|NCT01695239|54319316|FG008|Extension Long-Term Extension Periods|Adverse Event|15|||
27863887|NCT00550043|54435978|FG002|Overall Study|Subject Withdrew Consent|1|||
27863888|NCT00550043|54435979|FG003|Overall Study|Subject Withdrew Consent|0|||
27863889|NCT00550043|54435980|FG004|Overall Study|Subject Withdrew Consent|0|||
27863890|NCT00550043|54435976|FG000|Overall Study|Other Reasons- Unspecified|0|||
27863891|NCT00550043|54435977|FG001|Overall Study|Other Reasons- Unspecified|1|||
27863892|NCT00550043|54435978|FG002|Overall Study|Other Reasons- Unspecified|0|||
27863893|NCT00550043|54435979|FG003|Overall Study|Other Reasons- Unspecified|1|||
27863894|NCT00550043|54435980|FG004|Overall Study|Other Reasons- Unspecified|0|||
27863895|NCT03188822|54436708|FG000|Overall Study|Subjects chose not to attend the SOC 12 month follow up visit|6|||
27863896|NCT03188822|54436708|FG000|Overall Study|Clinic was closed due to COVID-19 for 12 month follow up visit|1|||
27863897|NCT04976777|54436851|FG000|Overall Study|COVID-19 Infection|1|||
27863898|NCT04976777|54436852|FG001|Overall Study|COVID-19 Infection|0|||
27863899|NCT00555971|54437026|FG000|Overall Study|Adverse Event|1|||
27863900|NCT00555971|54437027|FG001|Overall Study|Adverse Event|1|||
27863901|NCT02343120|54437903|FG000|Part 1: Dose Escalation|Sponsor decision|1|||
27863902|NCT02343120|54437904|FG001|Part 1: Dose Escalation|Sponsor decision|2|||
27863903|NCT02343120|54437905|FG002|Part 1: Dose Escalation|Sponsor decision|3|||
27863904|NCT02343120|54437906|FG003|Part 1: Dose Escalation|Sponsor decision|2|||
27863905|NCT02343120|54437907|FG004|Part 1: Dose Escalation|Sponsor decision|0|||
27863906|NCT02343120|54437903|FG000|Part 1: Dose Escalation|Death|1|||
27863907|NCT02343120|54437904|FG001|Part 1: Dose Escalation|Death|2|||
27863908|NCT02343120|54437905|FG002|Part 1: Dose Escalation|Death|2|||
27863909|NCT02343120|54437906|FG003|Part 1: Dose Escalation|Death|2|||
27863910|NCT02343120|54437907|FG004|Part 1: Dose Escalation|Death|1|||
27863911|NCT02343120|54437903|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
27863912|NCT02343120|54437904|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
27863913|NCT02343120|54437905|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
27863914|NCT02343120|54437906|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
27863915|NCT02343120|54437907|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
27863916|NCT02343120|54437903|FG000|Part 2: Expansion|Sponsor decision|0|||
27863917|NCT02343120|54437904|FG001|Part 2: Expansion|Sponsor decision|0|||
27863918|NCT02343120|54437905|FG002|Part 2: Expansion|Sponsor decision|0|||
27863919|NCT02343120|54437906|FG003|Part 2: Expansion|Sponsor decision|165|||
27834785|NCT01695239|54319317|FG009|Extension Long-Term Extension Periods|Adverse Event|21|||
27834786|NCT01695239|54319318|FG010|Extension Long-Term Extension Periods|Adverse Event|0|||
27834787|NCT01695239|54319319|FG011|Extension Long-Term Extension Periods|Adverse Event|0|||
27834788|NCT01695239|54319320|FG012|Extension Long-Term Extension Periods|Adverse Event|0|||
27863920|NCT02343120|54437907|FG004|Part 2: Expansion|Sponsor decision|67|||
27863921|NCT02343120|54437903|FG000|Part 2: Expansion|Death|0|||
27863922|NCT02343120|54437904|FG001|Part 2: Expansion|Death|0|||
27863923|NCT02343120|54437905|FG002|Part 2: Expansion|Death|0|||
27863924|NCT02343120|54437906|FG003|Part 2: Expansion|Death|74|||
27863925|NCT02343120|54437907|FG004|Part 2: Expansion|Death|17|||
27863926|NCT02343120|54437903|FG000|Part 2: Expansion|Withdrawal by Subject|0|||
27863927|NCT02343120|54437904|FG001|Part 2: Expansion|Withdrawal by Subject|0|||
27863928|NCT02343120|54437905|FG002|Part 2: Expansion|Withdrawal by Subject|0|||
27863929|NCT02343120|54437906|FG003|Part 2: Expansion|Withdrawal by Subject|28|||
27863930|NCT02343120|54437907|FG004|Part 2: Expansion|Withdrawal by Subject|2|||
27863931|NCT02343120|54437903|FG000|Part 2: Expansion|Lost to Follow-up|0|||
27863932|NCT02343120|54437904|FG001|Part 2: Expansion|Lost to Follow-up|0|||
27863933|NCT02343120|54437905|FG002|Part 2: Expansion|Lost to Follow-up|0|||
27863934|NCT02343120|54437906|FG003|Part 2: Expansion|Lost to Follow-up|5|||
27863935|NCT02343120|54437907|FG004|Part 2: Expansion|Lost to Follow-up|2|||
27863936|NCT02343120|54437903|FG000|Part 2: Expansion|Other|0|||
27863937|NCT02343120|54437904|FG001|Part 2: Expansion|Other|0|||
27863938|NCT02343120|54437905|FG002|Part 2: Expansion|Other|0|||
27863939|NCT02343120|54437906|FG003|Part 2: Expansion|Other|1|||
27863940|NCT02343120|54437907|FG004|Part 2: Expansion|Other|5|||
27863941|NCT02343120|54437903|FG000|Part 2: Expansion|Adverse Event|0|||
27863942|NCT02343120|54437904|FG001|Part 2: Expansion|Adverse Event|0|||
27863943|NCT02343120|54437905|FG002|Part 2: Expansion|Adverse Event|0|||
27863944|NCT02343120|54437906|FG003|Part 2: Expansion|Adverse Event|1|||
27863945|NCT02343120|54437907|FG004|Part 2: Expansion|Adverse Event|1|||
27863946|NCT02342886|54438164|FG000|Overall Study|Treatment non-compliance|1|||
27863947|NCT02342886|54438165|FG001|Overall Study|Treatment non-compliance|0|||
27863948|NCT02342886|54438166|FG002|Overall Study|Treatment non-compliance|0|||
27863949|NCT02342886|54438167|FG003|Overall Study|Treatment non-compliance|1|||
27863950|NCT02342886|54438168|FG004|Overall Study|Treatment non-compliance|0|||
27863951|NCT02342886|54438164|FG000|Overall Study|Late exclusion: rifampicin resistance|1|||
27863952|NCT02342886|54438165|FG001|Overall Study|Late exclusion: rifampicin resistance|0|||
27863953|NCT02342886|54438166|FG002|Overall Study|Late exclusion: rifampicin resistance|0|||
27863954|NCT02342886|54438167|FG003|Overall Study|Late exclusion: rifampicin resistance|0|||
27863955|NCT02342886|54438168|FG004|Overall Study|Late exclusion: rifampicin resistance|0|||
27863956|NCT02342886|54438164|FG000|Overall Study|Adverse event/specific toxicity|4|||
27863957|NCT02342886|54438165|FG001|Overall Study|Adverse event/specific toxicity|3|||
27863958|NCT02342886|54438166|FG002|Overall Study|Adverse event/specific toxicity|11|||
27863959|NCT02342886|54438167|FG003|Overall Study|Adverse event/specific toxicity|2|||
27863960|NCT02342886|54438168|FG004|Overall Study|Adverse event/specific toxicity|1|||
27863961|NCT02342886|54438164|FG000|Overall Study|Lost to Follow-up|1|||
27863962|NCT02342886|54438165|FG001|Overall Study|Lost to Follow-up|0|||
27863963|NCT02342886|54438166|FG002|Overall Study|Lost to Follow-up|0|||
27863964|NCT02342886|54438167|FG003|Overall Study|Lost to Follow-up|0|||
27863965|NCT02342886|54438168|FG004|Overall Study|Lost to Follow-up|0|||
27863966|NCT02342886|54438164|FG000|Overall Study|Death|1|||
27863967|NCT02342886|54438165|FG001|Overall Study|Death|2|||
27863968|NCT02342886|54438166|FG002|Overall Study|Death|1|||
27863969|NCT02342886|54438167|FG003|Overall Study|Death|0|||
27863970|NCT02342886|54438168|FG004|Overall Study|Death|1|||
27863971|NCT02342886|54438164|FG000|Overall Study|Withdrawal by Subject|0|||
27863972|NCT02342886|54438165|FG001|Overall Study|Withdrawal by Subject|1|||
27863973|NCT02342886|54438166|FG002|Overall Study|Withdrawal by Subject|0|||
27863974|NCT02342886|54438167|FG003|Overall Study|Withdrawal by Subject|1|||
27863975|NCT02342886|54438168|FG004|Overall Study|Withdrawal by Subject|0|||
27863976|NCT02342886|54438164|FG000|Overall Study|Investigator/sponsor decision|0|||
27863977|NCT02342886|54438165|FG001|Overall Study|Investigator/sponsor decision|2|||
27863978|NCT02342886|54438166|FG002|Overall Study|Investigator/sponsor decision|0|||
27863979|NCT02342886|54438167|FG003|Overall Study|Investigator/sponsor decision|3|||
27863980|NCT02342886|54438168|FG004|Overall Study|Investigator/sponsor decision|1|||
27863981|NCT02342886|54438164|FG000|Overall Study|Pregnancy|0|||
27863982|NCT02342886|54438165|FG001|Overall Study|Pregnancy|0|||
27863983|NCT02342886|54438166|FG002|Overall Study|Pregnancy|2|||
27863984|NCT02342886|54438167|FG003|Overall Study|Pregnancy|0|||
27863985|NCT02342886|54438168|FG004|Overall Study|Pregnancy|0|||
27863986|NCT02342886|54438164|FG000|Overall Study|Late exclusion: pyrazinamide resistance|0|||
27863987|NCT02342886|54438165|FG001|Overall Study|Late exclusion: pyrazinamide resistance|0|||
27863988|NCT02342886|54438166|FG002|Overall Study|Late exclusion: pyrazinamide resistance|1|||
27863989|NCT02342886|54438167|FG003|Overall Study|Late exclusion: pyrazinamide resistance|0|||
27863990|NCT02342886|54438168|FG004|Overall Study|Late exclusion: pyrazinamide resistance|0|||
27863991|NCT02342886|54438164|FG000|Overall Study|Protocol Violation|0|||
27863992|NCT02342886|54438165|FG001|Overall Study|Protocol Violation|0|||
27863993|NCT02342886|54438166|FG002|Overall Study|Protocol Violation|0|||
27863994|NCT02342886|54438167|FG003|Overall Study|Protocol Violation|2|||
27863995|NCT02342886|54438168|FG004|Overall Study|Protocol Violation|0|||
27863996|NCT02390076|54438204|FG000|Overall Study|Lost to Follow-up|2|||
27863997|NCT02390076|54438205|FG001|Overall Study|Lost to Follow-up|1|||
27863998|NCT02390076|54438206|FG002|Overall Study|Lost to Follow-up|4|||
27863999|NCT02389998|54438225|FG000|Overall Study|car accident|1|||
27864000|NCT02389998|54438226|FG001|Overall Study|car accident|0|||
27864001|NCT02389764|54438252|FG000|Overall Study|Lack of Efficacy|9|||
27864002|NCT02366130|54438323|FG000|Overall Study|Withdrawal by Subject|3|||
27864003|NCT02366130|54438323|FG000|Overall Study|Ineligible|6|||
27864004|NCT02389452|54438385|FG000|Overall Study|Lost to Follow-up|13|||
27864005|NCT02389452|54438385|FG000|Overall Study|Adverse Event|1|||
27864006|NCT02389452|54438385|FG000|Overall Study|Withdrawal by Subject|5|||
27864007|NCT02389452|54438385|FG000|Overall Study|Enrolled but Not Eligible for Study|6|||
27864008|NCT02365584|54438423|FG000|Overall Study|Adverse Event|2|||
27864009|NCT02365584|54438424|FG001|Overall Study|Adverse Event|2|||
27864010|NCT02365584|54438423|FG000|Overall Study|Withdrawal by Subject|1|||
27864011|NCT02365584|54438424|FG001|Overall Study|Withdrawal by Subject|0|||
27864012|NCT02365584|54438423|FG000|Overall Study|Disease Progression|9|||
27864013|NCT02365584|54438424|FG001|Overall Study|Disease Progression|12|||
27864014|NCT02342418|54438436|FG000|Overall Study|Adverse Event|0|||
27864015|NCT02342418|54438437|FG001|Overall Study|Adverse Event|1|||
27864016|NCT02365506|54438478|FG000|Overall Study|Investigator's Discretion|0|||
27864017|NCT02365506|54438479|FG001|Overall Study|Investigator's Discretion|0|||
27864018|NCT02365506|54438480|FG002|Overall Study|Investigator's Discretion|1|||
27864019|NCT02312934|54438517|FG000|Overall Study|Lost to Follow-up|1|||
27864020|NCT02312934|54438518|FG001|Overall Study|Lost to Follow-up|0|||
27864021|NCT02312934|54438517|FG000|Overall Study|Physician Decision|1|||
28096122|NCT04567186|54750848|FG000|Period 1|Protocol Violation|0|||
28096123|NCT04567186|54750849|FG001|Period 1|Protocol Violation|1|||
27864022|NCT02312934|54438518|FG001|Overall Study|Physician Decision|0|||
27864023|NCT02341482|54438552|FG000|Overall Study|Adverse Event|1|||
27864024|NCT02312856|54438592|FG000|Overall Study|Death|1|||
27864025|NCT02312856|54438592|FG000|Overall Study|Lost to Follow-up|3|||
27864026|NCT01602120|54439057|FG000|Overall Study|Adverse Event|3|||
27864027|NCT01602120|54439058|FG001|Overall Study|Adverse Event|6|||
27864028|NCT01602120|54439059|FG002|Overall Study|Adverse Event|0|||
27864029|NCT01602120|54439060|FG003|Overall Study|Adverse Event|2|||
27864030|NCT01602120|54439057|FG000|Overall Study|Death|0|||
27864031|NCT01602120|54439058|FG001|Overall Study|Death|4|||
27864032|NCT01602120|54439059|FG002|Overall Study|Death|0|||
27864033|NCT01602120|54439060|FG003|Overall Study|Death|0|||
27864034|NCT01602120|54439057|FG000|Overall Study|Lost to Follow-up|0|||
27864035|NCT01602120|54439058|FG001|Overall Study|Lost to Follow-up|1|||
27864036|NCT01602120|54439059|FG002|Overall Study|Lost to Follow-up|0|||
27864037|NCT01602120|54439060|FG003|Overall Study|Lost to Follow-up|1|||
27864038|NCT01602120|54439057|FG000|Overall Study|Protocol Violation|1|||
27864039|NCT01602120|54439058|FG001|Overall Study|Protocol Violation|1|||
27864040|NCT01602120|54439059|FG002|Overall Study|Protocol Violation|0|||
27864041|NCT01602120|54439060|FG003|Overall Study|Protocol Violation|0|||
27864042|NCT01602120|54439057|FG000|Overall Study|Non-compliance|0|||
27864043|NCT01602120|54439058|FG001|Overall Study|Non-compliance|3|||
27864044|NCT01602120|54439059|FG002|Overall Study|Non-compliance|0|||
27981813|NCT00605215|54639598|FG000|Overall Study|Death|0|||
28096124|NCT04567186|54750848|FG000|Period 1|Adverse Event|0|||
28096125|NCT04567186|54750849|FG001|Period 1|Adverse Event|2|||
28096126|NCT04567186|54750848|FG000|Period 2|COVID-19 Related|0|||
28096127|NCT04567186|54750849|FG001|Period 2|COVID-19 Related|1|||
28096128|NCT04567186|54750848|FG000|Period 2|Protocol Violation|0|||
28096129|NCT04567186|54750849|FG001|Period 2|Protocol Violation|1|||
28096130|NCT04567186|54750848|FG000|Period 2|Lost to Follow-up|0|||
28096131|NCT04567186|54750849|FG001|Period 2|Lost to Follow-up|1|||
28096132|NCT04567186|54750848|FG000|Period 3|Subject no longer meets eligibilty criteria|1|||
28096133|NCT04567186|54750849|FG001|Period 3|Subject no longer meets eligibilty criteria|0|||
28096134|NCT04168190|54750860|FG000|Overall Study|Lost to Follow-up|0|||
27834789|NCT01695239|54319321|FG013|Extension Long-Term Extension Periods|Adverse Event|0|||
27834790|NCT01695239|54319308|FG000|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
27834791|NCT01695239|54319309|FG001|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
27834792|NCT01695239|54319310|FG002|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
27834793|NCT01695239|54319311|FG003|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
27834794|NCT01695239|54319312|FG004|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
27834795|NCT01695239|54319313|FG005|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
27834796|NCT01695239|54319314|FG006|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
27834797|NCT01695239|54319315|FG007|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
27834798|NCT01695239|54319316|FG008|Extension Long-Term Extension Periods|Withdrawal by Subject|6|||
27834799|NCT01695239|54319317|FG009|Extension Long-Term Extension Periods|Withdrawal by Subject|7|||
27834800|NCT01695239|54319318|FG010|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
27834801|NCT01695239|54319319|FG011|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
27834802|NCT01695239|54319320|FG012|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
27864045|NCT01602120|54439060|FG003|Overall Study|Non-compliance|1|||
27864046|NCT01602120|54439057|FG000|Overall Study|Withdrawal by Subject|8|||
27981814|NCT00605215|54639599|FG001|Overall Study|Death|0|||
27864047|NCT01602120|54439058|FG001|Overall Study|Withdrawal by Subject|17|||
27864048|NCT01602120|54439059|FG002|Overall Study|Withdrawal by Subject|0|||
27864049|NCT01602120|54439060|FG003|Overall Study|Withdrawal by Subject|3|||
27864050|NCT01602120|54439057|FG000|Overall Study|Study Terminated by Sponsor|12|||
27864051|NCT01602120|54439058|FG001|Overall Study|Study Terminated by Sponsor|24|||
27864052|NCT01602120|54439059|FG002|Overall Study|Study Terminated by Sponsor|17|||
27864053|NCT01602120|54439060|FG003|Overall Study|Study Terminated by Sponsor|44|||
27864054|NCT01602120|54439057|FG000|Overall Study|Physician Decision|2|||
27864055|NCT01602120|54439058|FG001|Overall Study|Physician Decision|3|||
27864056|NCT01602120|54439059|FG002|Overall Study|Physician Decision|0|||
27864057|NCT01602120|54439060|FG003|Overall Study|Physician Decision|0|||
27864058|NCT01602120|54439057|FG000|Overall Study|Unspecified Reason|3|||
27864059|NCT01602120|54439058|FG001|Overall Study|Unspecified Reason|1|||
27864060|NCT01602120|54439059|FG002|Overall Study|Unspecified Reason|0|||
27864061|NCT01602120|54439060|FG003|Overall Study|Unspecified Reason|2|||
27864062|NCT04543955|54439867|FG000|Overall Study|Company cancelled study|1|||
27864063|NCT04543955|54439868|FG001|Overall Study|Company cancelled study|0|||
27864064|NCT02049515|54439936|FG000|Overall Study|Adverse Event|46|||
27864065|NCT02049515|54439937|FG001|Overall Study|Adverse Event|2|||
27864066|NCT02049515|54439936|FG000|Overall Study|Protocol-specified Disease Progression|23|||
27864067|NCT02049515|54439937|FG001|Overall Study|Protocol-specified Disease Progression|2|||
27864068|NCT02049515|54439936|FG000|Overall Study|Death|6|||
27864069|NCT02049515|54439937|FG001|Overall Study|Death|0|||
27864070|NCT02049515|54439936|FG000|Overall Study|Physician Decision|5|||
27864071|NCT02049515|54439937|FG001|Overall Study|Physician Decision|1|||
27864072|NCT02049515|54439936|FG000|Overall Study|Withdrawal by Subject|3|||
27864073|NCT02049515|54439937|FG001|Overall Study|Withdrawal by Subject|0|||
27864074|NCT02049515|54439936|FG000|Overall Study|Termination of the Study by Sponsor|2|||
27864075|NCT02049515|54439937|FG001|Overall Study|Termination of the Study by Sponsor|0|||
27864076|NCT02049515|54439936|FG000|Overall Study|Protocol Violation|1|||
27864077|NCT02049515|54439937|FG001|Overall Study|Protocol Violation|1|||
27864078|NCT02049515|54439936|FG000|Overall Study|Clinical Deterioration|1|||
27864079|NCT02049515|54439937|FG001|Overall Study|Clinical Deterioration|0|||
27864080|NCT02049515|54439936|FG000|Overall Study|Need Treatment for Metastatic Melanoma|1|||
27864081|NCT02049515|54439937|FG001|Overall Study|Need Treatment for Metastatic Melanoma|0|||
27864082|NCT02049515|54439936|FG000|Overall Study|Treatment Interruption >42 Days|1|||
27864083|NCT02049515|54439937|FG001|Overall Study|Treatment Interruption >42 Days|0|||
27864084|NCT02049515|54439936|FG000|Overall Study|Suspected and Unconfirmed Disease Progression|1|||
27864085|NCT02049515|54439937|FG001|Overall Study|Suspected and Unconfirmed Disease Progression|0|||
27864086|NCT04436744|54440427|FG000|Overall Study|Adverse Event|1|||
27864087|NCT04436744|54440428|FG001|Overall Study|Adverse Event|1|||
27864088|NCT04436744|54440427|FG000|Overall Study|Death|1|||
27864089|NCT04436744|54440428|FG001|Overall Study|Death|0|||
27864090|NCT04436744|54440427|FG000|Overall Study|Lost to Follow-up|0|||
27864091|NCT04436744|54440428|FG001|Overall Study|Lost to Follow-up|2|||
27864092|NCT04436744|54440427|FG000|Overall Study|Physician Decision|0|||
27864093|NCT04436744|54440428|FG001|Overall Study|Physician Decision|1|||
27864094|NCT04436744|54440427|FG000|Overall Study|Progressive Disease|0|||
27864095|NCT04436744|54440428|FG001|Overall Study|Progressive Disease|4|||
27864096|NCT04436744|54440427|FG000|Overall Study|Protocol Deviation|1|||
27864097|NCT04436744|54440428|FG001|Overall Study|Protocol Deviation|1|||
27864098|NCT04436744|54440427|FG000|Overall Study|Withdrawal by Subject|1|||
27864099|NCT04436744|54440428|FG001|Overall Study|Withdrawal by Subject|2|||
27864100|NCT04359758|54440468|FG000|Overall Study|Lost to Follow-up|0|||
27864101|NCT04359758|54440469|FG001|Overall Study|Lost to Follow-up|2|||
27864102|NCT04359758|54440468|FG000|Overall Study|Protocol Violation|3|||
27864103|NCT04359758|54440469|FG001|Overall Study|Protocol Violation|0|||
27864104|NCT02243306|54440584|FG000|Overall Study|Adverse Event|0|||
27864105|NCT02243306|54440585|FG001|Overall Study|Adverse Event|1|||
27864106|NCT02243306|54440584|FG000|Overall Study|Other: Reached stopping criteria|0|||
27864107|NCT02243306|54440585|FG001|Overall Study|Other: Reached stopping criteria|1|||
27864108|NCT02243306|54440584|FG000|Overall Study|Physician Decision|0|||
27864109|NCT02243306|54440585|FG001|Overall Study|Physician Decision|1|||
27864110|NCT03214679|54440741|FG000|Overall Study|Lost to Follow-up|12|||
27864111|NCT03214679|54440742|FG001|Overall Study|Lost to Follow-up|14|||
27864112|NCT03214679|54440741|FG000|Overall Study|not eligible|2|||
27864113|NCT03214679|54440742|FG001|Overall Study|not eligible|0|||
27864114|NCT01602380|54441089|FG000|Overall Study|Death|63|||
27864115|NCT01602380|54441090|FG001|Overall Study|Death|68|||
27864116|NCT01602380|54441089|FG000|Overall Study|Withdrawal by Subject|22|||
27864117|NCT01602380|54441090|FG001|Overall Study|Withdrawal by Subject|29|||
27864118|NCT01602380|54441089|FG000|Overall Study|Lost to Follow-up|6|||
27864119|NCT01602380|54441090|FG001|Overall Study|Lost to Follow-up|1|||
27864120|NCT01602380|54441089|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
27864121|NCT01602380|54441090|FG001|Overall Study|Eligibility criteria not fulfilled|3|||
27864122|NCT01349465|54442046|FG000|Overall Study|Adverse Event|1|||
27864123|NCT01349465|54442047|FG001|Overall Study|Adverse Event|0|||
27864124|NCT01349465|54442046|FG000|Overall Study|Death|3|||
27864125|NCT01349465|54442047|FG001|Overall Study|Death|0|||
27864126|NCT01349465|54442046|FG000|Overall Study|Lost to Follow-up|10|||
27864127|NCT01349465|54442047|FG001|Overall Study|Lost to Follow-up|1|||
27864128|NCT01349465|54442046|FG000|Overall Study|Withdrawal by Subject|4|||
27864129|NCT01349465|54442047|FG001|Overall Study|Withdrawal by Subject|2|||
27864130|NCT01349465|54442046|FG000|Overall Study|Subject Ineligible To Continue The Trial|0|||
27864131|NCT01349465|54442047|FG001|Overall Study|Subject Ineligible To Continue The Trial|19|||
27864132|NCT01648764|54443166|FG000|Overall Study|Progressive Disease|0|||
27864133|NCT01648764|54443167|FG001|Overall Study|Progressive Disease|1|||
27864134|NCT01648764|54443168|FG002|Overall Study|Progressive Disease|0|||
27864135|NCT01648764|54443169|FG003|Overall Study|Progressive Disease|0|||
27864136|NCT01648764|54443170|FG004|Overall Study|Progressive Disease|0|||
27864137|NCT01648764|54443171|FG005|Overall Study|Progressive Disease|1|||
27864138|NCT01648764|54443172|FG006|Overall Study|Progressive Disease|1|||
27864139|NCT01648764|54443173|FG007|Overall Study|Progressive Disease|0|||
27864140|NCT01648764|54443174|FG008|Overall Study|Progressive Disease|0|||
27864141|NCT01648764|54443175|FG009|Overall Study|Progressive Disease|2|||
27864142|NCT01648764|54443176|FG010|Overall Study|Progressive Disease|0|||
27864143|NCT01648764|54443177|FG011|Overall Study|Progressive Disease|1|||
27864144|NCT01648764|54443178|FG012|Overall Study|Progressive Disease|2|||
27864145|NCT01648764|54443179|FG013|Overall Study|Progressive Disease|1|||
27864146|NCT01648764|54443166|FG000|Overall Study|Adverse Event|0|||
27834803|NCT01695239|54319321|FG013|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
27834804|NCT01695239|54319308|FG000|Extension Long-Term Extension Periods|Physician Decision|0|||
27864147|NCT01648764|54443167|FG001|Overall Study|Adverse Event|0|||
27864148|NCT01648764|54443168|FG002|Overall Study|Adverse Event|0|||
27864149|NCT01648764|54443169|FG003|Overall Study|Adverse Event|0|||
27864150|NCT01648764|54443170|FG004|Overall Study|Adverse Event|0|||
27864151|NCT01648764|54443171|FG005|Overall Study|Adverse Event|1|||
27864152|NCT01648764|54443172|FG006|Overall Study|Adverse Event|0|||
27864153|NCT01648764|54443173|FG007|Overall Study|Adverse Event|0|||
27864154|NCT01648764|54443174|FG008|Overall Study|Adverse Event|0|||
27864155|NCT01648764|54443175|FG009|Overall Study|Adverse Event|1|||
27864156|NCT01648764|54443176|FG010|Overall Study|Adverse Event|0|||
27864157|NCT01648764|54443177|FG011|Overall Study|Adverse Event|3|||
27864158|NCT01648764|54443178|FG012|Overall Study|Adverse Event|1|||
27864159|NCT01648764|54443179|FG013|Overall Study|Adverse Event|1|||
27864160|NCT01648764|54443166|FG000|Overall Study|Death|0|||
27864161|NCT01648764|54443167|FG001|Overall Study|Death|0|||
27864162|NCT01648764|54443168|FG002|Overall Study|Death|0|||
27864163|NCT01648764|54443169|FG003|Overall Study|Death|0|||
27864164|NCT01648764|54443170|FG004|Overall Study|Death|0|||
27864165|NCT01648764|54443171|FG005|Overall Study|Death|0|||
27864166|NCT01648764|54443172|FG006|Overall Study|Death|1|||
27864167|NCT01648764|54443173|FG007|Overall Study|Death|0|||
27864168|NCT01648764|54443174|FG008|Overall Study|Death|0|||
27864169|NCT01648764|54443175|FG009|Overall Study|Death|0|||
27864170|NCT01648764|54443176|FG010|Overall Study|Death|0|||
27864171|NCT01648764|54443177|FG011|Overall Study|Death|0|||
27864172|NCT01648764|54443178|FG012|Overall Study|Death|0|||
27981815|NCT00605215|54639600|FG002|Overall Study|Death|1|||
27981816|NCT00605215|54639598|FG000|Overall Study|Adverse Event|19|||
27981817|NCT00605215|54639599|FG001|Overall Study|Adverse Event|21|||
27981818|NCT00605215|54639600|FG002|Overall Study|Adverse Event|26|||
27981819|NCT00605215|54639598|FG000|Overall Study|Refusal to sign the re-consent form|8|||
27981820|NCT00605215|54639599|FG001|Overall Study|Refusal to sign the re-consent form|3|||
27981821|NCT00605215|54639600|FG002|Overall Study|Refusal to sign the re-consent form|3|||
27981822|NCT00605215|54639598|FG000|Overall Study|Withdrawal by Subject|39|||
27834805|NCT01695239|54319309|FG001|Extension Long-Term Extension Periods|Physician Decision|0|||
27834806|NCT01695239|54319310|FG002|Extension Long-Term Extension Periods|Physician Decision|0|||
27834807|NCT01695239|54319311|FG003|Extension Long-Term Extension Periods|Physician Decision|0|||
27834808|NCT01695239|54319312|FG004|Extension Long-Term Extension Periods|Physician Decision|0|||
27834809|NCT01695239|54319313|FG005|Extension Long-Term Extension Periods|Physician Decision|0|||
27834810|NCT01695239|54319314|FG006|Extension Long-Term Extension Periods|Physician Decision|0|||
27834811|NCT01695239|54319315|FG007|Extension Long-Term Extension Periods|Physician Decision|0|||
27834812|NCT01695239|54319316|FG008|Extension Long-Term Extension Periods|Physician Decision|3|||
27834813|NCT01695239|54319317|FG009|Extension Long-Term Extension Periods|Physician Decision|0|||
27834814|NCT01695239|54319318|FG010|Extension Long-Term Extension Periods|Physician Decision|0|||
27834815|NCT01695239|54319319|FG011|Extension Long-Term Extension Periods|Physician Decision|0|||
27834816|NCT01695239|54319320|FG012|Extension Long-Term Extension Periods|Physician Decision|0|||
27834817|NCT01695239|54319321|FG013|Extension Long-Term Extension Periods|Physician Decision|0|||
27864173|NCT01648764|54443179|FG013|Overall Study|Death|1|||
27864174|NCT01648764|54443166|FG000|Overall Study|Withdrawal by Subject|0|||
27864175|NCT01648764|54443167|FG001|Overall Study|Withdrawal by Subject|0|||
27864176|NCT01648764|54443168|FG002|Overall Study|Withdrawal by Subject|0|||
27864177|NCT01648764|54443169|FG003|Overall Study|Withdrawal by Subject|0|||
27981823|NCT00605215|54639599|FG001|Overall Study|Withdrawal by Subject|37|||
27981824|NCT00605215|54639600|FG002|Overall Study|Withdrawal by Subject|27|||
27864178|NCT01648764|54443170|FG004|Overall Study|Withdrawal by Subject|0|||
27834818|NCT01695239|54319308|FG000|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
27864179|NCT01648764|54443171|FG005|Overall Study|Withdrawal by Subject|0|||
27864180|NCT01648764|54443172|FG006|Overall Study|Withdrawal by Subject|2|||
27864181|NCT01648764|54443173|FG007|Overall Study|Withdrawal by Subject|0|||
27864182|NCT01648764|54443174|FG008|Overall Study|Withdrawal by Subject|0|||
27864183|NCT01648764|54443175|FG009|Overall Study|Withdrawal by Subject|0|||
27864184|NCT01648764|54443176|FG010|Overall Study|Withdrawal by Subject|0|||
27864185|NCT01648764|54443177|FG011|Overall Study|Withdrawal by Subject|0|||
27864186|NCT01648764|54443178|FG012|Overall Study|Withdrawal by Subject|1|||
27864187|NCT01648764|54443179|FG013|Overall Study|Withdrawal by Subject|0|||
27864188|NCT01648764|54443166|FG000|Overall Study|Investigator Decision|0|||
27864189|NCT01648764|54443167|FG001|Overall Study|Investigator Decision|0|||
27864190|NCT01648764|54443168|FG002|Overall Study|Investigator Decision|0|||
27864191|NCT01648764|54443169|FG003|Overall Study|Investigator Decision|0|||
27864192|NCT01648764|54443170|FG004|Overall Study|Investigator Decision|0|||
27864193|NCT01648764|54443171|FG005|Overall Study|Investigator Decision|0|||
27864194|NCT01648764|54443172|FG006|Overall Study|Investigator Decision|1|||
27864195|NCT01648764|54443173|FG007|Overall Study|Investigator Decision|0|||
27864196|NCT01648764|54443174|FG008|Overall Study|Investigator Decision|0|||
27864197|NCT01648764|54443175|FG009|Overall Study|Investigator Decision|0|||
27864198|NCT01648764|54443176|FG010|Overall Study|Investigator Decision|0|||
27864199|NCT01648764|54443177|FG011|Overall Study|Investigator Decision|1|||
27864200|NCT01648764|54443178|FG012|Overall Study|Investigator Decision|0|||
27864201|NCT01648764|54443179|FG013|Overall Study|Investigator Decision|0|||
27864202|NCT02364336|54443215|FG000|Overall Study|Adverse Event|0|||
27864203|NCT02364336|54443216|FG001|Overall Study|Adverse Event|1|||
27864204|NCT02810951|54443447|FG000|Overall Study|Adverse Event|1|||
27864205|NCT02310906|54443543|FG000|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
27864206|NCT02310906|54443544|FG001|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
27864207|NCT02310906|54443545|FG002|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
27864208|NCT02310906|54443546|FG003|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2|||
27864209|NCT02310906|54443543|FG000|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
27864210|NCT02310906|54443544|FG001|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
27864211|NCT02310906|54443545|FG002|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2|||
27864212|NCT02310906|54443546|FG003|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4|||
27864213|NCT02310906|54443543|FG000|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
27864214|NCT02310906|54443544|FG001|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
27864215|NCT02310906|54443545|FG002|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
27864216|NCT02310906|54443546|FG003|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1|||
27864217|NCT02310906|54443543|FG000|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
27864218|NCT02310906|54443544|FG001|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
27864219|NCT02310906|54443545|FG002|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
27864220|NCT02310906|54443546|FG003|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1|||
27864221|NCT02340780|54443587|FG000|Overall Study|Ineligible|1|||
27864222|NCT02340078|54443600|FG000|Overall Study|Protocol Violation|1|||
27864223|NCT02340000|54443616|FG000|Time Period 1|Withdrawal by Subject|6|||
27864224|NCT02340000|54443617|FG001|Time Period 1|Withdrawal by Subject|8|||
27864225|NCT02340000|54443616|FG000|Time Period 1|Lost to Follow-up|6|||
27864226|NCT02340000|54443617|FG001|Time Period 1|Lost to Follow-up|7|||
27864227|NCT02340000|54443616|FG000|Time Period 2|Withdrawal by Subject|9|||
27864228|NCT02340000|54443617|FG001|Time Period 2|Withdrawal by Subject|7|||
27864229|NCT02340000|54443616|FG000|Time Period 2|Lost to Follow-up|10|||
27864230|NCT02340000|54443617|FG001|Time Period 2|Lost to Follow-up|8|||
27864231|NCT02364180|54443648|FG000|Overall Study|Screen Fail|1|||
27864232|NCT02310750|54444297|FG000|HP Period 1|Lost to Follow-up|0|||
27864233|NCT02310750|54444298|FG001|HP Period 1|Lost to Follow-up|0|||
27864234|NCT02310750|54444299|FG002|HP Period 1|Lost to Follow-up|0|||
27864235|NCT02310750|54444300|FG003|HP Period 1|Lost to Follow-up|0|||
27864236|NCT02310750|54444301|FG004|HP Period 1|Lost to Follow-up|0|||
27864237|NCT02310750|54444302|FG005|HP Period 1|Lost to Follow-up|0|||
27864238|NCT02310750|54444303|FG006|HP Period 1|Lost to Follow-up|1|||
27864239|NCT02310750|54444304|FG007|HP Period 1|Lost to Follow-up|0|||
27864240|NCT02310750|54444305|FG008|HP Period 1|Lost to Follow-up|0|||
27864241|NCT02310750|54444306|FG009|HP Period 1|Lost to Follow-up|0|||
27864242|NCT02310750|54444307|FG010|HP Period 1|Lost to Follow-up|0|||
27864243|NCT02310750|54444308|FG011|HP Period 1|Lost to Follow-up|0|||
27864244|NCT02310750|54444309|FG012|HP Period 1|Lost to Follow-up|0|||
27864245|NCT02310750|54444310|FG013|HP Period 1|Lost to Follow-up|0|||
27864246|NCT02310750|54444311|FG014|HP Period 1|Lost to Follow-up|0|||
27864247|NCT02310750|54444312|FG015|HP Period 1|Lost to Follow-up|0|||
27864248|NCT02310750|54444297|FG000|HP Period 1|Withdrawal by Subject|1|||
27864249|NCT02310750|54444298|FG001|HP Period 1|Withdrawal by Subject|0|||
27864250|NCT02310750|54444299|FG002|HP Period 1|Withdrawal by Subject|0|||
27864251|NCT02310750|54444300|FG003|HP Period 1|Withdrawal by Subject|1|||
27864252|NCT02310750|54444301|FG004|HP Period 1|Withdrawal by Subject|0|||
27864253|NCT02310750|54444302|FG005|HP Period 1|Withdrawal by Subject|0|||
27864254|NCT02310750|54444303|FG006|HP Period 1|Withdrawal by Subject|0|||
27864255|NCT02310750|54444304|FG007|HP Period 1|Withdrawal by Subject|0|||
27864256|NCT02310750|54444305|FG008|HP Period 1|Withdrawal by Subject|0|||
27864257|NCT02310750|54444306|FG009|HP Period 1|Withdrawal by Subject|0|||
27864258|NCT02310750|54444307|FG010|HP Period 1|Withdrawal by Subject|0|||
27864259|NCT02310750|54444308|FG011|HP Period 1|Withdrawal by Subject|0|||
27864260|NCT02310750|54444309|FG012|HP Period 1|Withdrawal by Subject|0|||
27864261|NCT02310750|54444310|FG013|HP Period 1|Withdrawal by Subject|0|||
27864262|NCT02310750|54444311|FG014|HP Period 1|Withdrawal by Subject|0|||
27864263|NCT02310750|54444312|FG015|HP Period 1|Withdrawal by Subject|0|||
27864264|NCT02310750|54444297|FG000|HP Washout 1|Lost to Follow-up|0|||
27864265|NCT02310750|54444298|FG001|HP Washout 1|Lost to Follow-up|0|||
27864266|NCT02310750|54444299|FG002|HP Washout 1|Lost to Follow-up|1|||
27864267|NCT02310750|54444300|FG003|HP Washout 1|Lost to Follow-up|1|||
27864268|NCT02310750|54444301|FG004|HP Washout 1|Lost to Follow-up|2|||
27864269|NCT02310750|54444302|FG005|HP Washout 1|Lost to Follow-up|2|||
27864270|NCT02310750|54444303|FG006|HP Washout 1|Lost to Follow-up|3|||
27864271|NCT02310750|54444304|FG007|HP Washout 1|Lost to Follow-up|0|||
27864272|NCT02310750|54444305|FG008|HP Washout 1|Lost to Follow-up|0|||
27864273|NCT02310750|54444306|FG009|HP Washout 1|Lost to Follow-up|0|||
27864274|NCT02310750|54444307|FG010|HP Washout 1|Lost to Follow-up|0|||
27864275|NCT02310750|54444308|FG011|HP Washout 1|Lost to Follow-up|0|||
27864276|NCT02310750|54444309|FG012|HP Washout 1|Lost to Follow-up|0|||
27864277|NCT02310750|54444310|FG013|HP Washout 1|Lost to Follow-up|0|||
27864278|NCT02310750|54444311|FG014|HP Washout 1|Lost to Follow-up|0|||
27864279|NCT02310750|54444312|FG015|HP Washout 1|Lost to Follow-up|0|||
27864280|NCT02310750|54444297|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
27864281|NCT02310750|54444298|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
27864282|NCT02310750|54444299|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
27864283|NCT02310750|54444300|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
27864284|NCT02310750|54444301|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
27864285|NCT02310750|54444302|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2|||
28096135|NCT04168190|54750861|FG001|Overall Study|Lost to Follow-up|1|||
28171355|NCT02471716|54842933|FG001|Overall Study|Study Terminiated by sponsor|0|||
28171356|NCT02471716|54842934|FG002|Overall Study|Study Terminiated by sponsor|0|||
28171357|NCT02471716|54842935|FG003|Overall Study|Study Terminiated by sponsor|1|||
28171358|NCT02471716|54842936|FG004|Overall Study|Study Terminiated by sponsor|0|||
28171359|NCT02471716|54842932|FG000|Overall Study|Lost to Follow-up|0|||
28171360|NCT02471716|54842933|FG001|Overall Study|Lost to Follow-up|0|||
28171361|NCT02471716|54842934|FG002|Overall Study|Lost to Follow-up|0|||
28171362|NCT02471716|54842935|FG003|Overall Study|Lost to Follow-up|3|||
27864286|NCT02310750|54444303|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
27864287|NCT02310750|54444304|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
27864288|NCT02310750|54444305|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6|||
27864289|NCT02310750|54444306|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
27864290|NCT02310750|54444307|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
27864291|NCT02310750|54444308|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
27864292|NCT02310750|54444309|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
28096136|NCT04168190|54750862|FG002|Overall Study|Lost to Follow-up|0|||
28096137|NCT04168190|54750863|FG003|Overall Study|Lost to Follow-up|7|||
28096138|NCT04168190|54750864|FG004|Overall Study|Lost to Follow-up|5|||
28096139|NCT04168190|54750860|FG000|Overall Study|Withdrawal by Subject|1|||
28096140|NCT04168190|54750861|FG001|Overall Study|Withdrawal by Subject|0|||
28096141|NCT04168190|54750862|FG002|Overall Study|Withdrawal by Subject|0|||
28096142|NCT04168190|54750863|FG003|Overall Study|Withdrawal by Subject|2|||
28096143|NCT04168190|54750864|FG004|Overall Study|Withdrawal by Subject|4|||
28096144|NCT04168190|54750860|FG000|Overall Study|Death|0|||
28096145|NCT04168190|54750861|FG001|Overall Study|Death|0|||
28096146|NCT04168190|54750862|FG002|Overall Study|Death|0|||
28096147|NCT04168190|54750863|FG003|Overall Study|Death|1|||
28096148|NCT04168190|54750864|FG004|Overall Study|Death|0|||
28096149|NCT04476108|54750878|FG000|Overall Study|Adverse Event|4|||
28096150|NCT04476108|54750879|FG001|Overall Study|Adverse Event|1|||
28096151|NCT04476108|54750878|FG000|Overall Study|Lost to Follow-up|1|||
28096152|NCT04476108|54750879|FG001|Overall Study|Lost to Follow-up|0|||
28096153|NCT04476108|54750878|FG000|Overall Study|Inadvertent Enrollment|1|||
28096154|NCT04476108|54750879|FG001|Overall Study|Inadvertent Enrollment|0|||
28096155|NCT04476108|54750878|FG000|Overall Study|Protocol Violation|1|||
28096156|NCT04476108|54750879|FG001|Overall Study|Protocol Violation|1|||
28096157|NCT04476108|54750878|FG000|Overall Study|Withdrawal by Subject|1|||
28096158|NCT04476108|54750879|FG001|Overall Study|Withdrawal by Subject|1|||
28096159|NCT03529942|54750885|FG000|Overall Study|Withdrawal by Subject|13|||
28096160|NCT03529942|54750885|FG000|Overall Study|Physician Decision|1|||
28096161|NCT03529942|54750885|FG000|Overall Study|Lost to Follow-up|7|||
28096162|NCT03529942|54750885|FG000|Overall Study|Needle inserted but no drug administered|1|||
28096163|NCT03529942|54750885|FG000|Overall Study|Personal reasons|1|||
28096164|NCT04732338|54750894|FG000|Overall Study|Lost to Follow-up|3|||
28096165|NCT04732338|54750895|FG001|Overall Study|Lost to Follow-up|3|||
28096166|NCT04194008|54750901|FG000|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19|||
28096167|NCT04194008|54750901|FG000|Baseline (Run-in) Phase|Withdrawal by Subject|6|||
27981825|NCT00605215|54639598|FG000|Overall Study|Request of Primary Care Physician or Investigator|6|||
27981826|NCT00605215|54639599|FG001|Overall Study|Request of Primary Care Physician or Investigator|4|||
27981827|NCT00605215|54639600|FG002|Overall Study|Request of Primary Care Physician or Investigator|4|||
27981828|NCT00605215|54639598|FG000|Overall Study|Protocol Violation|3|||
27981829|NCT00605215|54639599|FG001|Overall Study|Protocol Violation|4|||
27981830|NCT00605215|54639600|FG002|Overall Study|Protocol Violation|1|||
27981831|NCT00605215|54639598|FG000|Overall Study|Pregnancy|8|||
27981832|NCT00605215|54639599|FG001|Overall Study|Pregnancy|5|||
27981833|NCT00605215|54639600|FG002|Overall Study|Pregnancy|4|||
27981834|NCT00605215|54639598|FG000|Overall Study|Lost to Follow-up|8|||
27981835|NCT00605215|54639599|FG001|Overall Study|Lost to Follow-up|5|||
27981836|NCT00605215|54639600|FG002|Overall Study|Lost to Follow-up|2|||
27981837|NCT00605215|54639598|FG000|Overall Study|Other than specified|0|||
27981838|NCT00605215|54639599|FG001|Overall Study|Other than specified|2|||
27981839|NCT00605215|54639600|FG002|Overall Study|Other than specified|1|||
27981840|NCT00604279|54639610|FG000|Overall Study|Lack of Efficacy|22|||
27981841|NCT00604279|54639611|FG001|Overall Study|Lack of Efficacy|9|||
27981842|NCT00604279|54639610|FG000|Overall Study|Lost to Follow-up|9|||
27981843|NCT00604279|54639611|FG001|Overall Study|Lost to Follow-up|14|||
27981844|NCT00604279|54639610|FG000|Overall Study|Pregnancy|2|||
27981845|NCT00604279|54639611|FG001|Overall Study|Pregnancy|0|||
27981846|NCT00604279|54639610|FG000|Overall Study|Protocol Violation|3|||
27981847|NCT00604279|54639611|FG001|Overall Study|Protocol Violation|1|||
27981848|NCT00604279|54639610|FG000|Overall Study|Withdrawal by Subject|16|||
27981849|NCT00604279|54639611|FG001|Overall Study|Withdrawal by Subject|5|||
27981850|NCT00604279|54639610|FG000|Overall Study|Adverse Event|4|||
27981851|NCT00604279|54639611|FG001|Overall Study|Adverse Event|5|||
27981852|NCT00604279|54639610|FG000|Overall Study|Other|8|||
27981853|NCT00604279|54639611|FG001|Overall Study|Other|4|||
27981854|NCT00938015|54639617|FG000|Overall Study|Death|2|||
27981855|NCT00938015|54639617|FG000|Overall Study|Lost to Follow-up|32|||
27981856|NCT00938015|54639617|FG000|Overall Study|Adverse Event|32|||
27981857|NCT00938015|54639617|FG000|Overall Study|Non-responder|52|||
27981858|NCT00938015|54639617|FG000|Overall Study|Reason not related to Etanercept|29|||
27981859|NCT00781911|54639623|FG000|Overall Study|Adverse Event|4|||
27981860|NCT00781911|54639624|FG001|Overall Study|Adverse Event|4|||
27981861|NCT00781911|54639623|FG000|Overall Study|Withdrawal by Subject|1|||
27981862|NCT00781911|54639624|FG001|Overall Study|Withdrawal by Subject|2|||
27981863|NCT00781911|54639623|FG000|Overall Study|Physician Decision|0|||
27981864|NCT00781911|54639624|FG001|Overall Study|Physician Decision|2|||
27981865|NCT00781911|54639623|FG000|Overall Study|Sponsor Decision|1|||
27981866|NCT00781911|54639624|FG001|Overall Study|Sponsor Decision|0|||
27981867|NCT00605917|54639632|FG000|Overall Study|Protocol Violation|79|||
27981868|NCT00781599|54639669|FG000|Overall Study|Lost to Follow-up|7|||
27981869|NCT00781599|54639670|FG001|Overall Study|Lost to Follow-up|4|||
27981870|NCT00605839|54639688|FG000|Overall Study|Protocol Violation|1|||
27981871|NCT00605839|54639689|FG001|Overall Study|Protocol Violation|0|||
27981872|NCT00605839|54639690|FG002|Overall Study|Protocol Violation|0|||
27981873|NCT00781365|54639700|FG000|Overall Study|Withdrawal by Subject|13|||
27981874|NCT00781365|54639701|FG001|Overall Study|Withdrawal by Subject|8|||
27981875|NCT00781365|54639700|FG000|Overall Study|Did Not Attend Visit|20|||
27981876|NCT00781365|54639701|FG001|Overall Study|Did Not Attend Visit|28|||
28096168|NCT04194008|54750901|FG000|Baseline (Run-in) Phase|Lost to Follow-up|2|||
28096169|NCT04194008|54750901|FG000|Treatment Phase With Nerivio|Withdrawal by Subject|3|||
28096170|NCT04194008|54750901|FG000|Treatment Phase With Nerivio|Missing data|4|||
28096171|NCT04194008|54750901|FG000|Treatment Phase With Nerivio|Lost to Follow-up|1|||
28096172|NCT04189952|54750914|FG000|Follow-up Period|Death|1|||
28096173|NCT04189952|54750914|FG000|Follow-up Period|Withdrawal by Subject|1|||
28096174|NCT04716426|54750920|FG000|Overall Study|Vaccination|1|||
28096175|NCT04716426|54750921|FG001|Overall Study|Vaccination|1|||
28096176|NCT04716426|54750920|FG000|Overall Study|Contamination|1|||
27981877|NCT00781365|54639700|FG000|Overall Study|Language barrier|1|||
27981878|NCT00781365|54639701|FG001|Overall Study|Language barrier|0|||
27981879|NCT00937547|54639710|FG000|Overall Study|misdiagnosis|1|||
27981880|NCT00937547|54639711|FG001|Overall Study|misdiagnosis|6|||
27981881|NCT00937547|54639712|FG002|Overall Study|misdiagnosis|7|||
27981882|NCT00780975|54639720|FG000|Overall Study|Progressive disease|3|||
27981883|NCT00780975|54639720|FG000|Overall Study|Toxicity|5|||
27981884|NCT00780273|54639724|FG000|Overall Study|Death|1|||
27981885|NCT00780273|54639724|FG000|Overall Study|Lost to Follow-up|1|||
27981886|NCT00779259|54639729|FG000|Quinine Alone|Adverse Event|2|||
27981887|NCT00779025|54639747|FG000|Overall Study|Withdrawal by Subject|1|||
28096177|NCT04716426|54750921|FG001|Overall Study|Contamination|0|||
27981888|NCT00936065|54639755|FG000|Overall Study|Adverse Event|1|||
27981889|NCT00936065|54639756|FG001|Overall Study|Adverse Event|0|||
27981890|NCT00936065|54639757|FG002|Overall Study|Adverse Event|1|||
27981891|NCT00936065|54639755|FG000|Overall Study|Lack of Efficacy|1|||
27981892|NCT00936065|54639756|FG001|Overall Study|Lack of Efficacy|0|||
27981893|NCT00936065|54639757|FG002|Overall Study|Lack of Efficacy|1|||
28096178|NCT03694548|54750929|FG000|Part A Survey|Protocol Violation|3|||
27864293|NCT02310750|54444310|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
27864294|NCT02310750|54444311|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
27864295|NCT02310750|54444312|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
27864296|NCT02310750|54444297|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
27864297|NCT02310750|54444298|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
27864298|NCT02310750|54444299|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
27864299|NCT02310750|54444300|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
27864300|NCT02310750|54444301|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
27864301|NCT02310750|54444302|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
27864302|NCT02310750|54444303|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
27864303|NCT02310750|54444304|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
27864304|NCT02310750|54444305|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
27864305|NCT02310750|54444306|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1|||
27864306|NCT02310750|54444307|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
27864307|NCT02310750|54444308|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
27864308|NCT02310750|54444309|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
27864309|NCT02310750|54444310|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
27864310|NCT02310750|54444311|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
27864311|NCT02310750|54444312|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
27864312|NCT02310750|54444297|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
27864313|NCT02310750|54444298|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
27864314|NCT02310750|54444299|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
27864315|NCT02310750|54444300|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
27864316|NCT02310750|54444301|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
27864317|NCT02310750|54444302|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
27864318|NCT02310750|54444303|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
27864319|NCT02310750|54444304|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
27864320|NCT02310750|54444305|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
27864321|NCT02310750|54444306|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
27864322|NCT02310750|54444307|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
27864323|NCT02310750|54444308|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
27864324|NCT02310750|54444309|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
27864325|NCT02310750|54444310|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
27864326|NCT02310750|54444311|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
27864327|NCT02310750|54444312|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
27864328|NCT02310750|54444297|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
27864329|NCT02310750|54444298|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
27864330|NCT02310750|54444299|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
27864331|NCT02310750|54444300|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
27864332|NCT02310750|54444301|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
27864333|NCT02310750|54444302|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
27864334|NCT02310750|54444303|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
27864335|NCT02310750|54444304|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
27864336|NCT02310750|54444305|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
27864337|NCT02310750|54444306|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
27864338|NCT02310750|54444307|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
28096179|NCT03694548|54750930|FG001|Part A Survey|Protocol Violation|3|||
28096180|NCT03694548|54750931|FG002|Part A Survey|Protocol Violation|0|||
28096181|NCT03694548|54750929|FG000|Part B Yoga Program|Protocol Violation|0|||
28096182|NCT03694548|54750930|FG001|Part B Yoga Program|Protocol Violation|0|||
28096183|NCT03694548|54750931|FG002|Part B Yoga Program|Protocol Violation|3|||
28096184|NCT03694548|54750929|FG000|Part B Yoga Program|Did not attend intervention|0|||
28096185|NCT03694548|54750930|FG001|Part B Yoga Program|Did not attend intervention|0|||
28096186|NCT03694548|54750931|FG002|Part B Yoga Program|Did not attend intervention|8|||
28096187|NCT04166630|54750943|FG000|Overall Study|Withdrawal by Subject|0|||
28096188|NCT04166630|54750944|FG001|Overall Study|Withdrawal by Subject|1|||
28096189|NCT04164758|54750953|FG000|Overall Study|COVID-19 withdrawal of consent|1|||
28096190|NCT04164758|54750954|FG001|Overall Study|COVID-19 withdrawal of consent|0|||
28096191|NCT04164758|54750955|FG002|Overall Study|COVID-19 withdrawal of consent|0|||
28096192|NCT04164758|54750953|FG000|Overall Study|Adverse Event|0|||
27834819|NCT01695239|54319309|FG001|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
27834820|NCT01695239|54319310|FG002|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
27834821|NCT01695239|54319311|FG003|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
27834822|NCT01695239|54319312|FG004|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
27834823|NCT01695239|54319313|FG005|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
27834824|NCT01695239|54319314|FG006|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
27834825|NCT01695239|54319315|FG007|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
27864339|NCT02310750|54444308|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
27864340|NCT02310750|54444309|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
27864341|NCT02310750|54444310|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
27864342|NCT02310750|54444311|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
27864343|NCT02310750|54444312|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
27864344|NCT02310750|54444297|FG000|HP Washout 2|Lost to Follow-up|0|||
27864345|NCT02310750|54444298|FG001|HP Washout 2|Lost to Follow-up|0|||
27864346|NCT02310750|54444299|FG002|HP Washout 2|Lost to Follow-up|0|||
27864347|NCT02310750|54444300|FG003|HP Washout 2|Lost to Follow-up|0|||
27864348|NCT02310750|54444301|FG004|HP Washout 2|Lost to Follow-up|1|||
27864349|NCT02310750|54444302|FG005|HP Washout 2|Lost to Follow-up|0|||
27864350|NCT02310750|54444303|FG006|HP Washout 2|Lost to Follow-up|7|||
27864351|NCT02310750|54444304|FG007|HP Washout 2|Lost to Follow-up|0|||
27864352|NCT02310750|54444305|FG008|HP Washout 2|Lost to Follow-up|0|||
27864353|NCT02310750|54444306|FG009|HP Washout 2|Lost to Follow-up|0|||
27864354|NCT02310750|54444307|FG010|HP Washout 2|Lost to Follow-up|0|||
27864355|NCT02310750|54444308|FG011|HP Washout 2|Lost to Follow-up|0|||
27864356|NCT02310750|54444309|FG012|HP Washout 2|Lost to Follow-up|0|||
27864357|NCT02310750|54444310|FG013|HP Washout 2|Lost to Follow-up|0|||
27864358|NCT02310750|54444311|FG014|HP Washout 2|Lost to Follow-up|0|||
27864359|NCT02310750|54444312|FG015|HP Washout 2|Lost to Follow-up|0|||
27864360|NCT02310672|54444417|FG000|Overall Study|Death|1|||
27864361|NCT02310672|54444417|FG000|Overall Study|Lost to Follow-up|1|||
27864362|NCT02310672|54444417|FG000|Overall Study|Withdrawal by Subject|1|||
27864363|NCT02310672|54444417|FG000|Overall Study|Sponsor's decision|12|||
27864364|NCT02363946|54444563|FG000|Overall Study|Lost to Follow-up|0|||
27864365|NCT02363946|54444564|FG001|Overall Study|Lost to Follow-up|0|||
27864366|NCT02363946|54444565|FG002|Overall Study|Lost to Follow-up|0|||
27864367|NCT02363946|54444566|FG003|Overall Study|Lost to Follow-up|0|||
27864368|NCT02363946|54444567|FG004|Overall Study|Lost to Follow-up|0|||
27864369|NCT02363946|54444568|FG005|Overall Study|Lost to Follow-up|0|||
27864370|NCT02363946|54444569|FG006|Overall Study|Lost to Follow-up|0|||
27864371|NCT02363946|54444570|FG007|Overall Study|Lost to Follow-up|1|||
27864372|NCT02363946|54444571|FG008|Overall Study|Lost to Follow-up|0|||
27864373|NCT02363946|54444572|FG009|Overall Study|Lost to Follow-up|0|||
27864374|NCT02363946|54444573|FG010|Overall Study|Lost to Follow-up|0|||
27864375|NCT02363946|54444574|FG011|Overall Study|Lost to Follow-up|0|||
27864376|NCT02363946|54444575|FG012|Overall Study|Lost to Follow-up|0|||
27864377|NCT02363478|54444603|FG000|Overall Study|Lost to Follow-up|4|||
27864378|NCT02363478|54444603|FG000|Overall Study|Adverse Event|4|||
27864379|NCT02310126|54444610|FG000|Period 1 (15 Minutes)|Lost to Follow-up|0|||
27864380|NCT02310126|54444611|FG001|Period 1 (15 Minutes)|Lost to Follow-up|1|||
27864381|NCT02310126|54444610|FG000|Period 1 (15 Minutes)|Protocol Violation|0|||
27864382|NCT02310126|54444611|FG001|Period 1 (15 Minutes)|Protocol Violation|1|||
27864383|NCT02338362|54444619|FG000|Overall Study|Withdrawal by Subject|1|||
27864384|NCT02338362|54444620|FG001|Overall Study|Withdrawal by Subject|1|||
27864385|NCT02363322|54444628|FG000|Overall Study|Lost to Follow-up|1|||
27864386|NCT02363322|54444629|FG001|Overall Study|Lost to Follow-up|0|||
27864387|NCT02361762|54444637|FG000|Overall Study|Withdrawal by Subject|0|||
27864388|NCT02361762|54444638|FG001|Overall Study|Withdrawal by Subject|1|||
27864389|NCT02361762|54444637|FG000|Overall Study|Lost to Follow-up|0|||
27864390|NCT02361762|54444638|FG001|Overall Study|Lost to Follow-up|1|||
27864391|NCT02337738|54444647|FG000|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
27864392|NCT02337738|54444648|FG001|Overall Study|Major Protocol Deviation (Pre-Treatment)|1|||
27864393|NCT02337738|54444649|FG002|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
27864394|NCT02337738|54444647|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
27864395|NCT02337738|54444648|FG001|Overall Study|Pretreatment Event/Adverse Event|18|||
27864396|NCT02337738|54444649|FG002|Overall Study|Pretreatment Event/Adverse Event|21|||
27864397|NCT02337738|54444647|FG000|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
27864398|NCT02337738|54444648|FG001|Overall Study|Major Protocol Deviation (in-Treatment)|1|||
27864399|NCT02337738|54444649|FG002|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
27864400|NCT02337738|54444647|FG000|Overall Study|Voluntary Withdrawal|10|||
27864401|NCT02337738|54444648|FG001|Overall Study|Voluntary Withdrawal|5|||
27864402|NCT02337738|54444649|FG002|Overall Study|Voluntary Withdrawal|2|||
27864403|NCT02337738|54444647|FG000|Overall Study|Lack of Efficacy|2|||
27864404|NCT02337738|54444648|FG001|Overall Study|Lack of Efficacy|4|||
27864405|NCT02337738|54444649|FG002|Overall Study|Lack of Efficacy|0|||
27864406|NCT02337738|54444647|FG000|Overall Study|Investigator's Judgment|1|||
27981894|NCT00936065|54639755|FG000|Overall Study|Lost to Follow-up|1|||
27864407|NCT02337738|54444648|FG001|Overall Study|Investigator's Judgment|1|||
27981895|NCT00936065|54639756|FG001|Overall Study|Lost to Follow-up|0|||
27981896|NCT00936065|54639757|FG002|Overall Study|Lost to Follow-up|0|||
27981897|NCT00936065|54639755|FG000|Overall Study|Protocol Violation|1|||
27981898|NCT00936065|54639756|FG001|Overall Study|Protocol Violation|2|||
27864408|NCT02337738|54444649|FG002|Overall Study|Investigator's Judgment|3|||
27864409|NCT02309112|54444660|FG000|Overall Study|Withdrawal by Subject|1|||
27981899|NCT00936065|54639757|FG002|Overall Study|Protocol Violation|1|||
27864410|NCT02309112|54444661|FG001|Overall Study|Withdrawal by Subject|0|||
27864411|NCT02309112|54444662|FG002|Overall Study|Withdrawal by Subject|1|||
27864412|NCT02309112|54444660|FG000|Overall Study|Lost to Follow-up|0|||
27864413|NCT02309112|54444661|FG001|Overall Study|Lost to Follow-up|1|||
27864414|NCT02309112|54444662|FG002|Overall Study|Lost to Follow-up|0|||
27864415|NCT02361216|54444674|FG000|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0|||
27864416|NCT02361216|54444675|FG001|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1|||
27864417|NCT02361216|54444674|FG000|3 Day Treatment and 8 Week Follow/up|Adverse Event|1|||
27864418|NCT02361216|54444675|FG001|3 Day Treatment and 8 Week Follow/up|Adverse Event|2|||
27864419|NCT02361216|54444674|FG000|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1|||
27864420|NCT02361216|54444675|FG001|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0|||
27864421|NCT02361216|54444674|FG000|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6|||
27864422|NCT02361216|54444675|FG001|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11|||
27864423|NCT02361216|54444674|FG000|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
27864424|NCT02361216|54444675|FG001|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
27864425|NCT02361216|54444674|FG000|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0|||
27864426|NCT02361216|54444675|FG001|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2|||
27864427|NCT00559988|54445108|FG000|Overall Study|Death|147|||
27864428|NCT00559988|54445109|FG001|Overall Study|Death|140|||
27864429|NCT00559988|54445108|FG000|Overall Study|Withdrawal by Subject|152|||
27864430|NCT00559988|54445109|FG001|Overall Study|Withdrawal by Subject|139|||
27864431|NCT00559988|54445108|FG000|Overall Study|Lost to Follow-up|42|||
27864432|NCT00559988|54445109|FG001|Overall Study|Lost to Follow-up|56|||
27864433|NCT00559988|54445108|FG000|Overall Study|ICD device explanted|10|||
27864434|NCT00559988|54445109|FG001|Overall Study|ICD device explanted|17|||
27864435|NCT00559754|54445171|FG000|Overall Study|Disease progression|1|||
27864436|NCT00559754|54445171|FG000|Overall Study|Adverse Event|5|||
27864437|NCT00559754|54445171|FG000|Overall Study|Protocol Violation|1|||
27864438|NCT00559754|54445171|FG000|Overall Study|Investigator criteria|2|||
27864439|NCT00559754|54445171|FG000|Overall Study|Withdrawal by Subject|2|||
27864440|NCT00559364|54445285|FG000|Overall Study|Inclusion/exclusion criteria failure|1|||
27864441|NCT00559364|54445286|FG001|Overall Study|Inclusion/exclusion criteria failure|0|||
27864442|NCT02308020|54445349|FG000|Overall Study|Lost to Follow-up|1|||
27864443|NCT02308020|54445350|FG001|Overall Study|Lost to Follow-up|7|||
27864444|NCT02308020|54445351|FG002|Overall Study|Lost to Follow-up|0|||
27864445|NCT02308020|54445352|FG003|Overall Study|Lost to Follow-up|0|||
27864446|NCT02308020|54445353|FG004|Overall Study|Lost to Follow-up|1|||
27864447|NCT02308020|54445354|FG005|Overall Study|Lost to Follow-up|2|||
27864448|NCT02308020|54445349|FG000|Overall Study|Sponsor Decision|0|||
27864449|NCT02308020|54445350|FG001|Overall Study|Sponsor Decision|8|||
27864450|NCT02308020|54445351|FG002|Overall Study|Sponsor Decision|0|||
27864451|NCT02308020|54445352|FG003|Overall Study|Sponsor Decision|2|||
27864452|NCT02308020|54445353|FG004|Overall Study|Sponsor Decision|2|||
27864453|NCT02308020|54445354|FG005|Overall Study|Sponsor Decision|1|||
27864454|NCT02308020|54445349|FG000|Overall Study|Withdrawal by Subject|3|||
27864455|NCT02308020|54445350|FG001|Overall Study|Withdrawal by Subject|5|||
27864456|NCT02308020|54445351|FG002|Overall Study|Withdrawal by Subject|3|||
27864457|NCT02308020|54445352|FG003|Overall Study|Withdrawal by Subject|2|||
27864458|NCT02308020|54445353|FG004|Overall Study|Withdrawal by Subject|1|||
27864459|NCT02308020|54445354|FG005|Overall Study|Withdrawal by Subject|2|||
27864460|NCT02359890|54445374|FG000|Overall Study|Not meeting eligibility|4|||
27864461|NCT02359890|54445374|FG000|Overall Study|Never treated with study catheter|6|||
27864462|NCT02306850|54445378|FG000|Overall Study|Lack of Efficacy|2|||
27864463|NCT02306694|54445383|FG000|Overall Study|Withdrawal by Subject|3|||
27864464|NCT02306694|54445383|FG000|Overall Study|Lost to Follow-up|1|||
27864465|NCT01648140|54445395|FG000|Overall Study|Physician Decision|1|||
27864466|NCT01648140|54445396|FG001|Overall Study|Physician Decision|0|||
27864467|NCT01648140|54445397|FG002|Overall Study|Physician Decision|0|||
27864468|NCT01648140|54445398|FG003|Overall Study|Physician Decision|0|||
27864469|NCT01648140|54445395|FG000|Overall Study|Lack of Efficacy|4|||
27864470|NCT01648140|54445396|FG001|Overall Study|Lack of Efficacy|7|||
27864471|NCT01648140|54445397|FG002|Overall Study|Lack of Efficacy|1|||
27864472|NCT01648140|54445398|FG003|Overall Study|Lack of Efficacy|0|||
27864473|NCT01648140|54445395|FG000|Overall Study|Adverse Event|3|||
27864474|NCT01648140|54445396|FG001|Overall Study|Adverse Event|1|||
27864475|NCT01648140|54445397|FG002|Overall Study|Adverse Event|2|||
27864476|NCT01648140|54445398|FG003|Overall Study|Adverse Event|0|||
27864477|NCT01648140|54445395|FG000|Overall Study|Withdrawal by Subject|2|||
27864478|NCT01648140|54445396|FG001|Overall Study|Withdrawal by Subject|3|||
27864479|NCT01648140|54445397|FG002|Overall Study|Withdrawal by Subject|3|||
27864480|NCT01648140|54445398|FG003|Overall Study|Withdrawal by Subject|2|||
27864481|NCT01648140|54445395|FG000|Overall Study|Lost to Follow-up|2|||
27864482|NCT01648140|54445396|FG001|Overall Study|Lost to Follow-up|1|||
27864483|NCT01648140|54445397|FG002|Overall Study|Lost to Follow-up|2|||
27864484|NCT01648140|54445398|FG003|Overall Study|Lost to Follow-up|0|||
27864485|NCT02336178|54445417|FG000|Overall Study|Lost to Follow-up|1|||
27864486|NCT02336178|54445417|FG000|Overall Study|Protocol Violation|1|||
27864487|NCT02336178|54445417|FG000|Overall Study|Withdrawal by Subject|1|||
27981900|NCT00936065|54639755|FG000|Overall Study|Withdrawal by Subject|0|||
27981901|NCT00936065|54639756|FG001|Overall Study|Withdrawal by Subject|2|||
27981902|NCT00936065|54639757|FG002|Overall Study|Withdrawal by Subject|4|||
27981903|NCT04441788|54639768|FG000|Overall Study|Voluntary Withdrawl|0|||
27981904|NCT04441788|54639769|FG001|Overall Study|Voluntary Withdrawl|1|||
27981905|NCT04441788|54639770|FG002|Overall Study|Voluntary Withdrawl|0|||
27981906|NCT04441788|54639768|FG000|Overall Study|Ineligibility|1|||
27981907|NCT04441788|54639769|FG001|Overall Study|Ineligibility|0|||
27981908|NCT04441788|54639770|FG002|Overall Study|Ineligibility|0|||
27981909|NCT04441788|54639768|FG000|Overall Study|Adverse Event|0|||
27981910|NCT04441788|54639769|FG001|Overall Study|Adverse Event|0|||
27981911|NCT04441788|54639770|FG002|Overall Study|Adverse Event|4|||
27981912|NCT04441788|54639768|FG000|Overall Study|Study Terminated by Sponsor|16|||
27981913|NCT04441788|54639769|FG001|Overall Study|Study Terminated by Sponsor|16|||
27981914|NCT04441788|54639770|FG002|Overall Study|Study Terminated by Sponsor|12|||
27981915|NCT00604825|54639786|FG000|Overall Study|Adverse Event|2|||
27981916|NCT00604825|54639787|FG001|Overall Study|Adverse Event|6|||
27981917|NCT00604825|54639788|FG002|Overall Study|Adverse Event|7|||
27981918|NCT00604825|54639789|FG003|Overall Study|Adverse Event|4|||
27981919|NCT00604825|54639786|FG000|Overall Study|Lost to Follow-up|0|||
27981920|NCT00604825|54639787|FG001|Overall Study|Lost to Follow-up|3|||
27981921|NCT00604825|54639788|FG002|Overall Study|Lost to Follow-up|1|||
27981922|NCT00604825|54639789|FG003|Overall Study|Lost to Follow-up|0|||
27981923|NCT00604825|54639786|FG000|Overall Study|Protocol Violation|0|||
27981924|NCT00604825|54639787|FG001|Overall Study|Protocol Violation|1|||
27981925|NCT00604825|54639788|FG002|Overall Study|Protocol Violation|0|||
28096193|NCT04164758|54750954|FG001|Overall Study|Adverse Event|1|||
28096194|NCT04164758|54750955|FG002|Overall Study|Adverse Event|0|||
27864488|NCT02336178|54445417|FG000|Overall Study|Other|1|||
27864489|NCT02357940|54445431|FG000|Overall Study|Adverse Event|0|||
27864490|NCT02357940|54445432|FG001|Overall Study|Adverse Event|1|||
27864491|NCT02357940|54445431|FG000|Overall Study|Investigator's judgement|0|||
27864492|NCT02357940|54445432|FG001|Overall Study|Investigator's judgement|1|||
27864493|NCT02335242|54445440|FG000|Randomized Phase (20 Weeks)|Withdrawal by Subject|1|||
27864494|NCT02335242|54445441|FG001|Randomized Phase (20 Weeks)|Withdrawal by Subject|0|||
27864495|NCT02335242|54445440|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
27864496|NCT02335242|54445441|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
27864497|NCT02335242|54445440|FG000|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
27864498|NCT02335242|54445441|FG001|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
27864499|NCT02334384|54445453|FG000|Overall Study|Lost to Follow-up|1|||
27864500|NCT02334384|54445454|FG001|Overall Study|Lost to Follow-up|1|||
27864501|NCT02334306|54445462|FG000|Double-blind Period|Adverse Event|0|||
27864502|NCT02334306|54445463|FG001|Double-blind Period|Adverse Event|1|||
27864503|NCT02334306|54445462|FG000|Double-blind Period|Withdrawal by Subject|1|||
27864504|NCT02334306|54445463|FG001|Double-blind Period|Withdrawal by Subject|1|||
27864505|NCT02305758|54445472|FG000|Overall Study|Death|27|||
27864506|NCT02305758|54445473|FG001|Overall Study|Death|27|||
27864507|NCT02305758|54445472|FG000|Overall Study|Withdrew consent|9|||
27864508|NCT02305758|54445473|FG001|Overall Study|Withdrew consent|2|||
27864509|NCT02305758|54445472|FG000|Overall Study|Lost to Follow-up|6|||
27864510|NCT02305758|54445473|FG001|Overall Study|Lost to Follow-up|1|||
27864511|NCT02305758|54445472|FG000|Overall Study|Study Terminated by Sponsor|21|||
27864512|NCT02305758|54445473|FG001|Overall Study|Study Terminated by Sponsor|34|||
27864513|NCT02305758|54445472|FG000|Overall Study|Other, not specified|2|||
27864514|NCT02305758|54445473|FG001|Overall Study|Other, not specified|1|||
27864515|NCT02305446|54445479|FG000|Overall Study|Adverse Event|1|||
27981926|NCT00604825|54639789|FG003|Overall Study|Protocol Violation|0|||
27981927|NCT00604825|54639786|FG000|Overall Study|Withdrawal by Subject|4|||
27981928|NCT00604825|54639787|FG001|Overall Study|Withdrawal by Subject|3|||
27981929|NCT00604825|54639788|FG002|Overall Study|Withdrawal by Subject|5|||
27981930|NCT00604825|54639789|FG003|Overall Study|Withdrawal by Subject|5|||
27981931|NCT00604825|54639786|FG000|Overall Study|Lack of Efficacy|3|||
27864516|NCT02303574|54445616|FG000|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
27864517|NCT02303574|54445617|FG001|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
27864518|NCT02303574|54445618|FG002|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1|||
27864519|NCT02303574|54445619|FG003|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
27864520|NCT02303574|54445620|FG004|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
27981932|NCT00604825|54639787|FG001|Overall Study|Lack of Efficacy|2|||
27864521|NCT02303574|54445621|FG005|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
27981933|NCT00604825|54639788|FG002|Overall Study|Lack of Efficacy|1|||
27981934|NCT00604825|54639789|FG003|Overall Study|Lack of Efficacy|0|||
27981935|NCT00604825|54639786|FG000|Overall Study|Did not meet eligibility criteria|0|||
27981936|NCT00604825|54639787|FG001|Overall Study|Did not meet eligibility criteria|0|||
27981937|NCT00604825|54639788|FG002|Overall Study|Did not meet eligibility criteria|2|||
27981938|NCT00604825|54639789|FG003|Overall Study|Did not meet eligibility criteria|0|||
27864522|NCT02303574|54445622|FG006|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
27864523|NCT02303574|54445623|FG007|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
27864524|NCT02303574|54445624|FG008|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
27864525|NCT02303574|54445625|FG009|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
27864526|NCT02303574|54445616|FG000|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
27864527|NCT02303574|54445617|FG001|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
27864528|NCT02303574|54445618|FG002|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
27864529|NCT02303574|54445619|FG003|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
27864530|NCT02303574|54445620|FG004|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
27864531|NCT02303574|54445621|FG005|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
27864532|NCT02303574|54445622|FG006|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
27864533|NCT02303574|54445623|FG007|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1|||
27864534|NCT02303574|54445624|FG008|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
27864535|NCT02303574|54445625|FG009|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
27864536|NCT02354976|54445661|FG000|Overall Study|Other - reason not specified|1|||
27864537|NCT02354976|54445662|FG001|Overall Study|Other - reason not specified|0|||
27864538|NCT02354976|54445663|FG002|Overall Study|Other - reason not specified|1|||
27864539|NCT02354976|54445661|FG000|Overall Study|Study-specifc withdrawal criteria|0|||
27864540|NCT02354976|54445662|FG001|Overall Study|Study-specifc withdrawal criteria|1|||
27864541|NCT02354976|54445663|FG002|Overall Study|Study-specifc withdrawal criteria|0|||
27864542|NCT02354976|54445661|FG000|Overall Study|Adverse Event|1|||
27864543|NCT02354976|54445662|FG001|Overall Study|Adverse Event|0|||
27864544|NCT02354976|54445663|FG002|Overall Study|Adverse Event|2|||
27864545|NCT02303262|54445671|FG000|Overall Study|Withdrawal by Subject|2|||
27864546|NCT00558896|54445682|FG000|Overall Study|Adverse Event|1|||
27864547|NCT00558896|54445683|FG001|Overall Study|Adverse Event|1|||
27864548|NCT00558896|54445684|FG002|Overall Study|Adverse Event|1|||
27864549|NCT00558896|54445685|FG003|Overall Study|Adverse Event|3|||
27864550|NCT00558896|54445686|FG004|Overall Study|Adverse Event|4|||
27864551|NCT00558896|54445687|FG005|Overall Study|Adverse Event|10|||
27864552|NCT00558896|54445688|FG006|Overall Study|Adverse Event|3|||
27864553|NCT00558896|54445682|FG000|Overall Study|Death|3|||
27864554|NCT00558896|54445683|FG001|Overall Study|Death|0|||
27864555|NCT00558896|54445684|FG002|Overall Study|Death|2|||
27864556|NCT00558896|54445685|FG003|Overall Study|Death|3|||
27864557|NCT00558896|54445686|FG004|Overall Study|Death|2|||
27864558|NCT00558896|54445687|FG005|Overall Study|Death|2|||
27864559|NCT00558896|54445688|FG006|Overall Study|Death|6|||
27864560|NCT00558896|54445682|FG000|Overall Study|Withdrawal by Subject|2|||
27864561|NCT00558896|54445683|FG001|Overall Study|Withdrawal by Subject|1|||
27864562|NCT00558896|54445684|FG002|Overall Study|Withdrawal by Subject|1|||
27864563|NCT00558896|54445685|FG003|Overall Study|Withdrawal by Subject|1|||
27864564|NCT00558896|54445686|FG004|Overall Study|Withdrawal by Subject|1|||
27864565|NCT00558896|54445687|FG005|Overall Study|Withdrawal by Subject|5|||
27864566|NCT00558896|54445688|FG006|Overall Study|Withdrawal by Subject|5|||
27864567|NCT00558896|54445682|FG000|Overall Study|Alternative Treatment|2|||
27864568|NCT00558896|54445683|FG001|Overall Study|Alternative Treatment|2|||
27864569|NCT00558896|54445684|FG002|Overall Study|Alternative Treatment|0|||
27864570|NCT00558896|54445685|FG003|Overall Study|Alternative Treatment|2|||
27864571|NCT00558896|54445686|FG004|Overall Study|Alternative Treatment|6|||
27864572|NCT00558896|54445687|FG005|Overall Study|Alternative Treatment|7|||
27864573|NCT00558896|54445688|FG006|Overall Study|Alternative Treatment|1|||
27864574|NCT00558896|54445682|FG000|Overall Study|Physician discretion|3|||
27864575|NCT00558896|54445683|FG001|Overall Study|Physician discretion|2|||
27864576|NCT00558896|54445684|FG002|Overall Study|Physician discretion|1|||
27864577|NCT00558896|54445685|FG003|Overall Study|Physician discretion|2|||
27864578|NCT00558896|54445686|FG004|Overall Study|Physician discretion|1|||
27864579|NCT00558896|54445687|FG005|Overall Study|Physician discretion|3|||
27864580|NCT00558896|54445688|FG006|Overall Study|Physician discretion|3|||
28171363|NCT02471716|54842936|FG004|Overall Study|Lost to Follow-up|2|||
28171364|NCT02471716|54842932|FG000|Overall Study|Death|0|||
27738964|NCT02240680|54188245|FG002|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
27738965|NCT02240680|54188246|FG003|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
27864581|NCT00558896|54445682|FG000|Overall Study|Continues on treatment|10|||
27864582|NCT00558896|54445683|FG001|Overall Study|Continues on treatment|1|||
27864583|NCT00558896|54445684|FG002|Overall Study|Continues on treatment|0|||
27864584|NCT00558896|54445685|FG003|Overall Study|Continues on treatment|1|||
27864585|NCT00558896|54445686|FG004|Overall Study|Continues on treatment|9|||
27864586|NCT00558896|54445687|FG005|Overall Study|Continues on treatment|25|||
27864587|NCT00558896|54445688|FG006|Overall Study|Continues on treatment|6|||
27864588|NCT00558428|54445822|FG000|Overall Study|Adverse Event|6|||
27864589|NCT00558428|54445823|FG001|Overall Study|Adverse Event|22|||
27864590|NCT00558428|54445824|FG002|Overall Study|Adverse Event|3|||
27864591|NCT00558428|54445825|FG003|Overall Study|Adverse Event|4|||
27864592|NCT00558428|54445822|FG000|Overall Study|Lost to Follow-up|0|||
27864593|NCT00558428|54445823|FG001|Overall Study|Lost to Follow-up|1|||
27864594|NCT00558428|54445824|FG002|Overall Study|Lost to Follow-up|0|||
27864595|NCT00558428|54445825|FG003|Overall Study|Lost to Follow-up|0|||
27864596|NCT00558428|54445822|FG000|Overall Study|Lack of Efficacy|0|||
27864597|NCT00558428|54445823|FG001|Overall Study|Lack of Efficacy|0|||
27864598|NCT00558428|54445824|FG002|Overall Study|Lack of Efficacy|1|||
27864599|NCT00558428|54445825|FG003|Overall Study|Lack of Efficacy|2|||
27864600|NCT00558428|54445822|FG000|Overall Study|Non compliant with protocol|1|||
27864601|NCT00558428|54445823|FG001|Overall Study|Non compliant with protocol|0|||
27864602|NCT00558428|54445824|FG002|Overall Study|Non compliant with protocol|0|||
27864603|NCT00558428|54445825|FG003|Overall Study|Non compliant with protocol|3|||
27864604|NCT00558428|54445822|FG000|Overall Study|Consent withdrawn|2|||
27864605|NCT00558428|54445823|FG001|Overall Study|Consent withdrawn|1|||
27864606|NCT00558428|54445824|FG002|Overall Study|Consent withdrawn|0|||
27864607|NCT00558428|54445825|FG003|Overall Study|Consent withdrawn|1|||
27864608|NCT00558428|54445822|FG000|Overall Study|Other|3|||
27864609|NCT00558428|54445823|FG001|Overall Study|Other|0|||
27864610|NCT00558428|54445824|FG002|Overall Study|Other|0|||
27864611|NCT00558428|54445825|FG003|Overall Study|Other|1|||
27864612|NCT00558272|54445864|FG000|Overall Study|Adverse Event|10|||
27864613|NCT00558272|54445865|FG001|Overall Study|Adverse Event|0|||
27864614|NCT00558272|54445864|FG000|Overall Study|Death|1|||
27864615|NCT00558272|54445865|FG001|Overall Study|Death|0|||
27864616|NCT00558272|54445864|FG000|Overall Study|Dev. of study specific discon. criteria|1|||
27864617|NCT00558272|54445865|FG001|Overall Study|Dev. of study specific discon. criteria|0|||
27864618|NCT00558272|54445864|FG000|Overall Study|AZ study team decision|0|||
27864619|NCT00558272|54445865|FG001|Overall Study|AZ study team decision|1|||
27864620|NCT00558272|54445864|FG000|Overall Study|Incorrectly enrolled|1|||
27864621|NCT00558272|54445865|FG001|Overall Study|Incorrectly enrolled|0|||
27864622|NCT00558272|54445864|FG000|Overall Study|Withdrawal by Subject|0|||
27864623|NCT00558272|54445865|FG001|Overall Study|Withdrawal by Subject|1|||
27864624|NCT00557492|54446015|FG000|Overall Study|Change in health insurance|1|||
27864625|NCT02354586|54446118|FG000|Overall Study|Death|230|||
27864626|NCT02354586|54446118|FG000|Overall Study|Withdrawal by Subject|59|||
27864627|NCT02354586|54446118|FG000|Overall Study|Lost to Follow-up|11|||
27864628|NCT02354586|54446118|FG000|Overall Study|Sponsor decision|51|||
27864629|NCT02354586|54446118|FG000|Overall Study|Site closure|2|||
27864630|NCT02354586|54446118|FG000|Overall Study|Intercurrent illness|1|||
27864631|NCT02354586|54446118|FG000|Overall Study|Protocol Violation|3|||
27864632|NCT02354586|54446118|FG000|Overall Study|Physician Decision|13|||
27864633|NCT02354586|54446118|FG000|Overall Study|Lack of Efficacy|86|||
27981939|NCT00604825|54639786|FG000|Overall Study|Physician Decision|0|||
27981940|NCT00604825|54639787|FG001|Overall Study|Physician Decision|0|||
27981941|NCT00604825|54639788|FG002|Overall Study|Physician Decision|0|||
27981942|NCT00604825|54639789|FG003|Overall Study|Physician Decision|1|||
27981943|NCT00604825|54639786|FG000|Overall Study|Exclusion criterion met|0|||
27981944|NCT00604825|54639787|FG001|Overall Study|Exclusion criterion met|0|||
27981945|NCT00604825|54639788|FG002|Overall Study|Exclusion criterion met|0|||
27981946|NCT00604825|54639789|FG003|Overall Study|Exclusion criterion met|1|||
27981947|NCT00937391|54639801|FG000|Stage 2|Withdrawal by Subject|1|||
27981948|NCT00937157|54639818|FG000|Overall Study|Pregnancy|1|||
27981949|NCT00937157|54639818|FG000|Overall Study|Lost to Follow-up|3|||
27981950|NCT00777153|54639825|FG000|Overall Study|Lost to Follow-up|1|||
27981951|NCT00777153|54639826|FG001|Overall Study|Lost to Follow-up|1|||
27981952|NCT00777153|54639827|FG002|Overall Study|Lost to Follow-up|0|||
27981953|NCT00777153|54639825|FG000|Overall Study|Death|85|||
27981954|NCT00777153|54639826|FG001|Overall Study|Death|73|||
27981955|NCT00777153|54639827|FG002|Overall Study|Death|33|||
27981956|NCT00777153|54639825|FG000|Overall Study|Withdrawal by Subject|3|||
27981957|NCT00777153|54639826|FG001|Overall Study|Withdrawal by Subject|4|||
27981958|NCT00777153|54639827|FG002|Overall Study|Withdrawal by Subject|3|||
27981959|NCT00777153|54639825|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
27981960|NCT00777153|54639826|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|5|||
27981961|NCT00777153|54639827|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
27981962|NCT00567541|54639841|FG000|Overall Study|Adverse Event|0|||
27981963|NCT00567541|54639842|FG001|Overall Study|Adverse Event|1|||
27981964|NCT00776997|54639848|FG000|Overall Study|Adverse Event|2|||
27981965|NCT00940823|54639854|FG000|Overall Study|Death|8|||
27981966|NCT00940823|54639855|FG001|Overall Study|Death|12|||
27864634|NCT02354586|54446118|FG000|Overall Study|Adverse Event|7|||
27864635|NCT02332824|54446143|FG000|Overall Study|Pretreatment Event/Adverse Event|4|||
27981967|NCT00940823|54639854|FG000|Overall Study|Lost to Follow-up|27|||
27981968|NCT00940823|54639855|FG001|Overall Study|Lost to Follow-up|20|||
27864636|NCT02332824|54446144|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
27864637|NCT02332824|54446145|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
27864638|NCT02332824|54446146|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
27864639|NCT02332824|54446147|FG004|Overall Study|Pretreatment Event/Adverse Event|4|||
27864640|NCT02332824|54446148|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
27864641|NCT02332824|54446143|FG000|Overall Study|Voluntary Withdrawal|1|||
27864642|NCT02332824|54446144|FG001|Overall Study|Voluntary Withdrawal|0|||
27864643|NCT02332824|54446145|FG002|Overall Study|Voluntary Withdrawal|0|||
27864644|NCT02332824|54446146|FG003|Overall Study|Voluntary Withdrawal|0|||
27864645|NCT02332824|54446147|FG004|Overall Study|Voluntary Withdrawal|0|||
27864646|NCT02332824|54446148|FG005|Overall Study|Voluntary Withdrawal|0|||
27864647|NCT02332824|54446143|FG000|Overall Study|Inconvenient schedule|1|||
27864648|NCT02332824|54446144|FG001|Overall Study|Inconvenient schedule|1|||
27864649|NCT02332824|54446145|FG002|Overall Study|Inconvenient schedule|0|||
27864650|NCT02332824|54446146|FG003|Overall Study|Inconvenient schedule|0|||
27864651|NCT02332824|54446147|FG004|Overall Study|Inconvenient schedule|0|||
27864652|NCT02332824|54446148|FG005|Overall Study|Inconvenient schedule|0|||
27864653|NCT02332824|54446143|FG000|Overall Study|Transfer|0|||
27864654|NCT02332824|54446144|FG001|Overall Study|Transfer|0|||
27864655|NCT02332824|54446145|FG002|Overall Study|Transfer|1|||
27864656|NCT02332824|54446146|FG003|Overall Study|Transfer|1|||
27864657|NCT02332824|54446147|FG004|Overall Study|Transfer|0|||
27864658|NCT02332824|54446148|FG005|Overall Study|Transfer|0|||
27981969|NCT00936611|54639863|FG000|Overall Study|Progressive Disease|3|||
27981970|NCT00936611|54639863|FG000|Overall Study|New Systemic Therapy|22|||
27981971|NCT00936611|54639863|FG000|Overall Study|Lost to Follow-up|1|||
27981972|NCT00936611|54639863|FG000|Overall Study|Withdrawal by Subject|2|||
27981973|NCT00936611|54639863|FG000|Overall Study|Still on Follow-up|1|||
27981974|NCT00936611|54639863|FG000|Overall Study|Still on Active Therapy|7|||
27981975|NCT00936611|54639863|FG000|Overall Study|Ineligible for Study Drug|3|||
27981976|NCT00936221|54639886|FG000|Overall Study|Withdrawal by Subject|1|||
27981977|NCT00936221|54639887|FG001|Overall Study|Withdrawal by Subject|1|||
27981978|NCT00776919|54639897|FG000|Overall Study|Withdrawal by Subject|16|||
27981979|NCT00776919|54639898|FG001|Overall Study|Withdrawal by Subject|14|||
27981980|NCT00776919|54639899|FG002|Overall Study|Withdrawal by Subject|15|||
27981981|NCT00776919|54639900|FG003|Overall Study|Withdrawal by Subject|26|||
27981982|NCT00776919|54639897|FG000|Overall Study|Lost to Follow-up|8|||
27981983|NCT00776919|54639898|FG001|Overall Study|Lost to Follow-up|12|||
27981984|NCT00776919|54639899|FG002|Overall Study|Lost to Follow-up|11|||
27981985|NCT00776919|54639900|FG003|Overall Study|Lost to Follow-up|8|||
27981986|NCT00776919|54639897|FG000|Overall Study|Adverse Event|1|||
27981987|NCT00776919|54639898|FG001|Overall Study|Adverse Event|0|||
27981988|NCT00776919|54639899|FG002|Overall Study|Adverse Event|2|||
27981989|NCT00776919|54639900|FG003|Overall Study|Adverse Event|2|||
27981990|NCT00776919|54639897|FG000|Overall Study|Protocol Violation|1|||
27981991|NCT00776919|54639898|FG001|Overall Study|Protocol Violation|2|||
27981992|NCT00776919|54639899|FG002|Overall Study|Protocol Violation|0|||
27981993|NCT00776919|54639900|FG003|Overall Study|Protocol Violation|1|||
27981994|NCT00776919|54639897|FG000|Overall Study|Other: Lack of Efficacy/Lost Medication|1|||
27981995|NCT00776919|54639898|FG001|Overall Study|Other: Lack of Efficacy/Lost Medication|5|||
27981996|NCT00776919|54639899|FG002|Overall Study|Other: Lack of Efficacy/Lost Medication|4|||
27981997|NCT00776919|54639900|FG003|Overall Study|Other: Lack of Efficacy/Lost Medication|2|||
27981998|NCT00775983|54639927|FG000|Overall Study|Protocol Violation|1|||
27981999|NCT00775983|54639928|FG001|Overall Study|Protocol Violation|2|||
27982000|NCT00775593|54639934|FG000|Overall Study|Unmet eligibility criteria|6|||
27982001|NCT00775593|54639934|FG000|Overall Study|Death|1|||
27982002|NCT00939809|54639938|FG000|Overall Study|Adverse Event|2|||
27982003|NCT00939809|54639938|FG000|Overall Study|Death|1|||
27982004|NCT00934661|54639944|FG000|Overall Study|Failure of Combined/Spinal Epidural|1|||
27982005|NCT00934661|54639945|FG001|Overall Study|Failure of Combined/Spinal Epidural|0|||
27982006|NCT00775437|54639951|FG000|Overall Study|Loss of efficacy|2|||
27982007|NCT00775437|54639951|FG000|Overall Study|Withdrawal by Subject|3|||
27982008|NCT00775437|54639951|FG000|Overall Study|Lost to Follow-up|1|||
27982009|NCT00775203|54639957|FG000|Overall Study|Adverse Event|25|||
27982010|NCT00775203|54639958|FG001|Overall Study|Adverse Event|6|||
27982011|NCT00775203|54639957|FG000|Overall Study|Lack of Efficacy|8|||
27982012|NCT00775203|54639958|FG001|Overall Study|Lack of Efficacy|9|||
27982013|NCT00775203|54639957|FG000|Overall Study|Withdrawal by Subject|11|||
27982014|NCT00775203|54639958|FG001|Overall Study|Withdrawal by Subject|9|||
27982015|NCT00775203|54639957|FG000|Overall Study|Lost to Follow-up|11|||
27864659|NCT00556712|54446295|FG000|Overall Study|Adverse Event|7|||
27864660|NCT00556712|54446296|FG001|Overall Study|Adverse Event|19|||
27864661|NCT00556712|54446295|FG000|Overall Study|Death|5|||
27864662|NCT00556712|54446296|FG001|Overall Study|Death|10|||
27864663|NCT00556712|54446295|FG000|Overall Study|Progressive Disease|383|||
27982016|NCT00775203|54639958|FG001|Overall Study|Lost to Follow-up|15|||
27982017|NCT00775203|54639957|FG000|Overall Study|Administrative reason|2|||
27982018|NCT00775203|54639958|FG001|Overall Study|Administrative reason|0|||
27982019|NCT00775203|54639957|FG000|Overall Study|Noncompliance|4|||
27982020|NCT00775203|54639958|FG001|Overall Study|Noncompliance|2|||
27982021|NCT00775203|54639957|FG000|Overall Study|Protocol Violation|0|||
27864664|NCT00556712|54446296|FG001|Overall Study|Progressive Disease|320|||
27864665|NCT00556712|54446295|FG000|Overall Study|Protocol Violation|3|||
27982022|NCT00775203|54639958|FG001|Overall Study|Protocol Violation|1|||
27982023|NCT00775203|54639957|FG000|Overall Study|Entered other study|1|||
27982024|NCT00775203|54639958|FG001|Overall Study|Entered other study|0|||
27982025|NCT00775203|54639957|FG000|Overall Study|Physician Decision|0|||
27982026|NCT00775203|54639958|FG001|Overall Study|Physician Decision|1|||
27982027|NCT00568321|54639967|FG000|Overall Study|Adverse Event|1|||
27982028|NCT00568321|54639968|FG001|Overall Study|Adverse Event|0|||
27982029|NCT00568321|54639969|FG002|Overall Study|Adverse Event|0|||
27982030|NCT00568321|54639967|FG000|Overall Study|Lack of Efficacy|8|||
27982031|NCT00568321|54639968|FG001|Overall Study|Lack of Efficacy|5|||
27982032|NCT00568321|54639969|FG002|Overall Study|Lack of Efficacy|6|||
27982033|NCT00568321|54639967|FG000|Overall Study|Lost to Follow-up|0|||
27982034|NCT00568321|54639968|FG001|Overall Study|Lost to Follow-up|0|||
27982035|NCT00568321|54639969|FG002|Overall Study|Lost to Follow-up|1|||
27982036|NCT00568321|54639967|FG000|Overall Study|Withdrawal by Subject|2|||
27982037|NCT00568321|54639968|FG001|Overall Study|Withdrawal by Subject|0|||
27982038|NCT00568321|54639969|FG002|Overall Study|Withdrawal by Subject|0|||
27982039|NCT00568321|54639967|FG000|Overall Study|Protocol Violation|0|||
27982040|NCT00568321|54639968|FG001|Overall Study|Protocol Violation|0|||
27982041|NCT00568321|54639969|FG002|Overall Study|Protocol Violation|1|||
27982042|NCT00568321|54639967|FG000|Overall Study|Randomized, not treated|2|||
27982043|NCT00568321|54639968|FG001|Overall Study|Randomized, not treated|0|||
27982044|NCT00568321|54639969|FG002|Overall Study|Randomized, not treated|1|||
27982045|NCT00774345|54639981|FG000|Pre-treatment|Other reasons|2|||
27982046|NCT00774345|54639982|FG001|Pre-treatment|Other reasons|0|||
27982047|NCT00774345|54639981|FG000|Treatment|Adverse Event|61|||
27982048|NCT00774345|54639982|FG001|Treatment|Adverse Event|15|||
27982049|NCT00774345|54639981|FG000|Treatment|Progressive Disease without histologic transformation|51|||
27982050|NCT00774345|54639982|FG001|Treatment|Progressive Disease without histologic transformation|111|||
27982051|NCT00774345|54639981|FG000|Treatment|Progressive Disease with histologic transformation|4|||
27982052|NCT00774345|54639982|FG001|Treatment|Progressive Disease with histologic transformation|2|||
27982053|NCT00774345|54639981|FG000|Treatment|Withdrawal by Subject|5|||
27982054|NCT00774345|54639982|FG001|Treatment|Withdrawal by Subject|2|||
27982055|NCT00774345|54639981|FG000|Treatment|Lost to Follow-up|1|||
28096195|NCT04178720|54750965|FG000|Overall Study|Withdrawal by Subject|2|||
28096196|NCT04178720|54750966|FG001|Overall Study|Withdrawal by Subject|0|||
28096197|NCT04178720|54750965|FG000|Overall Study|Relocation|0|||
28096198|NCT04178720|54750966|FG001|Overall Study|Relocation|1|||
28096199|NCT04177862|54750977|FG000|Overall Study|Protocol Violation|2|||
27864666|NCT00556712|54446296|FG001|Overall Study|Protocol Violation|2|||
27982056|NCT00774345|54639982|FG001|Treatment|Lost to Follow-up|1|||
27982057|NCT00774345|54639981|FG000|Treatment|Death|4|||
27982058|NCT00774345|54639982|FG001|Treatment|Death|0|||
27982059|NCT00774345|54639981|FG000|Treatment|Other Reasons|32|||
27982060|NCT00774345|54639982|FG001|Treatment|Other Reasons|26|||
27982061|NCT00773253|54639994|FG000|First Intervention (Week 0-24)|Frontalis Test Negative|0|||
27982062|NCT00773253|54639995|FG001|First Intervention (Week 0-24)|Frontalis Test Negative|1|||
27982063|NCT00773175|54640005|FG000|Overall Study|Adverse Event|2|||
27982064|NCT00773175|54640006|FG001|Overall Study|Adverse Event|0|||
27982065|NCT00773175|54640005|FG000|Overall Study|Consent Withdrawn|0|||
27982066|NCT00773175|54640006|FG001|Overall Study|Consent Withdrawn|2|||
27982067|NCT00566527|54640020|FG000|Overall Study|Reason not provided|3|||
27982068|NCT00566527|54640021|FG001|Overall Study|Reason not provided|11|||
27982069|NCT00566527|54640022|FG002|Overall Study|Reason not provided|10|||
27982070|NCT00566527|54640020|FG000|Overall Study|Adverse Event|2|||
27982071|NCT00566527|54640021|FG001|Overall Study|Adverse Event|0|||
27982072|NCT00566527|54640022|FG002|Overall Study|Adverse Event|1|||
27982073|NCT00566527|54640020|FG000|Overall Study|Physician Decision|3|||
27982074|NCT00566527|54640021|FG001|Overall Study|Physician Decision|8|||
27982075|NCT00566527|54640022|FG002|Overall Study|Physician Decision|20|||
27982076|NCT00566527|54640020|FG000|Overall Study|Lost to Follow-up|3|||
28096200|NCT04177862|54750978|FG001|Overall Study|Protocol Violation|7|||
28096201|NCT04173572|54750987|FG000|Overall Study|Withdrawal by Subject|1|||
28096202|NCT04173572|54750988|FG001|Overall Study|Withdrawal by Subject|5|||
27982077|NCT00566527|54640021|FG001|Overall Study|Lost to Follow-up|4|||
27982078|NCT00566527|54640022|FG002|Overall Study|Lost to Follow-up|4|||
27982079|NCT00566527|54640020|FG000|Overall Study|Withdrawal by Subject|6|||
27982080|NCT00566527|54640021|FG001|Overall Study|Withdrawal by Subject|43|||
27982081|NCT00566527|54640022|FG002|Overall Study|Withdrawal by Subject|43|||
27982082|NCT00773097|54640032|FG000|Overall Study|Withdrawal by Subject|1|||
27982083|NCT00773097|54640032|FG000|Overall Study|Physician Decision|6|||
27982084|NCT00933335|54640038|FG000|Overall Study|Lost to Follow-up|1|||
27982085|NCT00933335|54640039|FG001|Overall Study|Lost to Follow-up|3|||
27982086|NCT00933335|54640038|FG000|Overall Study|Withdrawal by Subject|0|||
27982087|NCT00933335|54640039|FG001|Overall Study|Withdrawal by Subject|1|||
27982088|NCT00933335|54640038|FG000|Overall Study|Progressive Disease|0|||
27982089|NCT00933335|54640039|FG001|Overall Study|Progressive Disease|11|||
28096203|NCT04173572|54750987|FG000|Overall Study|Lost to Follow-up|3|||
27864667|NCT00556712|54446295|FG000|Overall Study|Refused Treatment|17|||
27864668|NCT00556712|54446296|FG001|Overall Study|Refused Treatment|16|||
27864669|NCT00556712|54446295|FG000|Overall Study|Failure to Return|2|||
27864670|NCT00556712|54446296|FG001|Overall Study|Failure to Return|3|||
27864671|NCT00556712|54446295|FG000|Overall Study|Other|2|||
27864672|NCT00556712|54446296|FG001|Overall Study|Other|2|||
27864673|NCT00556712|54446295|FG000|Overall Study|Ongoing at Data Cutoff|32|||
27864674|NCT00556712|54446296|FG001|Overall Study|Ongoing at Data Cutoff|66|||
27864675|NCT00556322|54446370|FG000|Overall Study|Insufficient therapeutic response|158|||
27864676|NCT00556322|54446371|FG001|Overall Study|Insufficient therapeutic response|168|||
27864677|NCT00556322|54446370|FG000|Overall Study|Adverse Event|7|||
27864678|NCT00556322|54446371|FG001|Overall Study|Adverse Event|4|||
27864679|NCT00556322|54446370|FG000|Overall Study|Other|4|||
27864680|NCT00556322|54446371|FG001|Overall Study|Other|1|||
27864681|NCT00556322|54446370|FG000|Overall Study|Lost to Follow-up|5|||
27864682|NCT00556322|54446371|FG001|Overall Study|Lost to Follow-up|3|||
27864683|NCT00556322|54446370|FG000|Overall Study|Withdrawal by Subject|19|||
27864684|NCT00556322|54446371|FG001|Overall Study|Withdrawal by Subject|7|||
27864685|NCT00556322|54446370|FG000|Overall Study|Protocol Violation|5|||
27864686|NCT00556322|54446371|FG001|Overall Study|Protocol Violation|1|||
27864687|NCT00556322|54446370|FG000|Overall Study|Ongoing at data cutoff|3|||
27864688|NCT00556322|54446371|FG001|Overall Study|Ongoing at data cutoff|5|||
27864689|NCT00556322|54446370|FG000|Overall Study|Death|20|||
27864690|NCT00556322|54446371|FG001|Overall Study|Death|14|||
27864691|NCT00556166|54446389|FG000|Overall Study|Withdrawal by Subject|1|||
27864692|NCT02332590|54446549|FG000|DB Period (up to 24 Weeks)|Adverse Event|15|||
27864693|NCT02332590|54446550|FG001|DB Period (up to 24 Weeks)|Adverse Event|11|||
27864694|NCT02332590|54446549|FG000|DB Period (up to 24 Weeks)|Lack of Efficacy|4|||
27864695|NCT02332590|54446550|FG001|DB Period (up to 24 Weeks)|Lack of Efficacy|2|||
27864696|NCT02332590|54446549|FG000|DB Period (up to 24 Weeks)|Poor compliance to protocol|3|||
27864697|NCT02332590|54446550|FG001|DB Period (up to 24 Weeks)|Poor compliance to protocol|1|||
27864698|NCT02332590|54446549|FG000|DB Period (up to 24 Weeks)|Randomized but not treated|1|||
27864699|NCT02332590|54446550|FG001|DB Period (up to 24 Weeks)|Randomized but not treated|0|||
27864700|NCT02332590|54446549|FG000|DB Period (up to 24 Weeks)|Other than specified above|6|||
27864701|NCT02332590|54446550|FG001|DB Period (up to 24 Weeks)|Other than specified above|5|||
27864702|NCT02332590|54446549|FG000|OLE Period (Week 24 up to Week 300)|Adverse Event|20|||
27864703|NCT02332590|54446550|FG001|OLE Period (Week 24 up to Week 300)|Adverse Event|23|||
27864704|NCT02332590|54446549|FG000|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|2|||
27864705|NCT02332590|54446550|FG001|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|6|||
27864706|NCT02332590|54446549|FG000|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|5|||
27864707|NCT02332590|54446550|FG001|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|1|||
27864708|NCT02332590|54446549|FG000|OLE Period (Week 24 up to Week 300)|Other Unspecified|20|||
27864709|NCT02332590|54446550|FG001|OLE Period (Week 24 up to Week 300)|Other Unspecified|15|||
27864710|NCT00554840|54446621|FG000|Overall Study|Physician Decision|0|||
27864711|NCT00554840|54446622|FG001|Overall Study|Physician Decision|1|||
27864712|NCT02302716|54446647|FG000|Overall Study|Adverse Event|1|||
27864713|NCT02302716|54446648|FG001|Overall Study|Adverse Event|1|||
27864714|NCT02302716|54446647|FG000|Overall Study|Death|0|||
27864715|NCT02302716|54446648|FG001|Overall Study|Death|1|||
27864716|NCT02302716|54446647|FG000|Overall Study|Lack of Efficacy|0|||
27864717|NCT02302716|54446648|FG001|Overall Study|Lack of Efficacy|1|||
27864718|NCT02302716|54446647|FG000|Overall Study|Lost to Follow-up|2|||
27864719|NCT02302716|54446648|FG001|Overall Study|Lost to Follow-up|4|||
27864720|NCT02302716|54446647|FG000|Overall Study|Physician Decision|3|||
27864721|NCT02302716|54446648|FG001|Overall Study|Physician Decision|4|||
27864722|NCT02302716|54446647|FG000|Overall Study|Withdrawal by Subject|13|||
27864723|NCT02302716|54446648|FG001|Overall Study|Withdrawal by Subject|7|||
27864724|NCT02302716|54446647|FG000|Overall Study|Protocol Violation|0|||
27864725|NCT02302716|54446648|FG001|Overall Study|Protocol Violation|1|||
27864726|NCT00554606|54446677|FG000|Overall Study|Adverse Event|3|||
27864727|NCT00554606|54446677|FG000|Overall Study|Abnormal laboratory values|1|||
27864728|NCT00554606|54446677|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
27864729|NCT00554606|54446677|FG000|Overall Study|Subject withdrew consent|2|||
27864730|NCT00554606|54446677|FG000|Overall Study|Lost to Follow-up|2|||
27864731|NCT00554606|54446677|FG000|Overall Study|Administrative problems|60|||
27864732|NCT00554606|54446677|FG000|Overall Study|Death|1|||
27864733|NCT00554606|54446677|FG000|Overall Study|Protocol deviation|2|||
27864734|NCT02354508|54446713|FG000|Period 1: Core Phase|Adverse Event|1|||
27864735|NCT02354508|54446714|FG001|Period 1: Core Phase|Adverse Event|1|||
27864736|NCT02354508|54446715|FG002|Period 1: Core Phase|Adverse Event|2|||
27864737|NCT02354508|54446713|FG000|Period 1: Core Phase|Unsatisfactory therapeutic effect|1|||
27864738|NCT02354508|54446714|FG001|Period 1: Core Phase|Unsatisfactory therapeutic effect|0|||
27864739|NCT02354508|54446715|FG002|Period 1: Core Phase|Unsatisfactory therapeutic effect|2|||
27864740|NCT02354508|54446713|FG000|Period 1: Core Phase|Withdrawal by Subject|0|||
28096204|NCT04173572|54750988|FG001|Overall Study|Lost to Follow-up|1|||
28096205|NCT04157738|54750996|FG000|Overall Study|Moved out of state|0|||
28096206|NCT04157738|54750997|FG001|Overall Study|Moved out of state|2|||
27834826|NCT01695239|54319316|FG008|Extension Long-Term Extension Periods|Lost to Follow-up|2|||
27834827|NCT01695239|54319317|FG009|Extension Long-Term Extension Periods|Lost to Follow-up|1|||
27834828|NCT01695239|54319318|FG010|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
27834829|NCT01695239|54319319|FG011|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
27834830|NCT01695239|54319320|FG012|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
27834831|NCT01695239|54319321|FG013|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
27834832|NCT01695239|54319308|FG000|Extension Long-Term Extension Periods|Sponsor Decision|0|||
27834833|NCT01695239|54319309|FG001|Extension Long-Term Extension Periods|Sponsor Decision|0|||
27834834|NCT01695239|54319310|FG002|Extension Long-Term Extension Periods|Sponsor Decision|0|||
27834835|NCT01695239|54319311|FG003|Extension Long-Term Extension Periods|Sponsor Decision|0|||
27834836|NCT01695239|54319312|FG004|Extension Long-Term Extension Periods|Sponsor Decision|0|||
27834837|NCT01695239|54319313|FG005|Extension Long-Term Extension Periods|Sponsor Decision|0|||
27834838|NCT01695239|54319314|FG006|Extension Long-Term Extension Periods|Sponsor Decision|0|||
27834839|NCT01695239|54319315|FG007|Extension Long-Term Extension Periods|Sponsor Decision|0|||
27834840|NCT01695239|54319316|FG008|Extension Long-Term Extension Periods|Sponsor Decision|2|||
27834841|NCT01695239|54319317|FG009|Extension Long-Term Extension Periods|Sponsor Decision|1|||
27834842|NCT01695239|54319318|FG010|Extension Long-Term Extension Periods|Sponsor Decision|0|||
27834843|NCT01695239|54319319|FG011|Extension Long-Term Extension Periods|Sponsor Decision|0|||
27834844|NCT01695239|54319320|FG012|Extension Long-Term Extension Periods|Sponsor Decision|0|||
27834845|NCT01695239|54319321|FG013|Extension Long-Term Extension Periods|Sponsor Decision|0|||
27834846|NCT01695239|54319308|FG000|Extension Long-Term Extension Periods|Death|0|||
27834847|NCT01695239|54319309|FG001|Extension Long-Term Extension Periods|Death|0|||
27834848|NCT01695239|54319310|FG002|Extension Long-Term Extension Periods|Death|0|||
27834849|NCT01695239|54319311|FG003|Extension Long-Term Extension Periods|Death|0|||
27834850|NCT01695239|54319312|FG004|Extension Long-Term Extension Periods|Death|0|||
27834851|NCT01695239|54319313|FG005|Extension Long-Term Extension Periods|Death|0|||
27834852|NCT01695239|54319314|FG006|Extension Long-Term Extension Periods|Death|0|||
27834853|NCT01695239|54319315|FG007|Extension Long-Term Extension Periods|Death|0|||
27834854|NCT01695239|54319316|FG008|Extension Long-Term Extension Periods|Death|1|||
27834855|NCT01695239|54319317|FG009|Extension Long-Term Extension Periods|Death|0|||
27834856|NCT01695239|54319318|FG010|Extension Long-Term Extension Periods|Death|0|||
27834857|NCT01695239|54319319|FG011|Extension Long-Term Extension Periods|Death|0|||
27834858|NCT01695239|54319320|FG012|Extension Long-Term Extension Periods|Death|0|||
27834859|NCT01695239|54319321|FG013|Extension Long-Term Extension Periods|Death|0|||
27834860|NCT01695239|54319308|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
27834861|NCT01695239|54319309|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
27834862|NCT01695239|54319310|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
27834863|NCT01695239|54319311|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
27834864|NCT01695239|54319312|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
27834865|NCT01695239|54319313|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
27834866|NCT01695239|54319314|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
27834867|NCT01695239|54319315|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
27834868|NCT01695239|54319316|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
27834869|NCT01695239|54319317|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
27834870|NCT01695239|54319318|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
27834871|NCT01695239|54319319|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
27834872|NCT01695239|54319320|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
27834873|NCT01695239|54319321|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
27834874|NCT01695239|54319308|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
27834875|NCT01695239|54319309|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
27834876|NCT01695239|54319310|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
27834877|NCT01695239|54319311|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
27834878|NCT01695239|54319312|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
27834879|NCT01695239|54319313|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
27834880|NCT01695239|54319314|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
27834881|NCT01695239|54319315|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
27834882|NCT01695239|54319316|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
27834883|NCT01695239|54319317|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
27834884|NCT01695239|54319318|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
28096207|NCT04157738|54750996|FG000|Overall Study|Did not show up to the Follow-up appointment|1|||
28096208|NCT04157738|54750997|FG001|Overall Study|Did not show up to the Follow-up appointment|0|||
28096209|NCT04156646|54751005|FG000|Treatment Period 3 (6 Days)|Withdrawal by Subject|0|||
28096210|NCT04156646|54751006|FG001|Treatment Period 3 (6 Days)|Withdrawal by Subject|1|||
27834885|NCT01695239|54319319|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
27834886|NCT01695239|54319320|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
27834887|NCT01695239|54319321|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
27834888|NCT01695239|54319308|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
27864741|NCT02354508|54446714|FG001|Period 1: Core Phase|Withdrawal by Subject|1|||
27864742|NCT02354508|54446715|FG002|Period 1: Core Phase|Withdrawal by Subject|2|||
27864743|NCT02354508|54446713|FG000|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1|||
27864744|NCT02354508|54446714|FG001|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3|||
27864745|NCT02354508|54446715|FG002|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2|||
27864746|NCT02354508|54446713|FG000|Period 2: Extension Phase|Withdrawal by Subject|0|||
27864747|NCT02354508|54446714|FG001|Period 2: Extension Phase|Withdrawal by Subject|1|||
27864748|NCT02354508|54446715|FG002|Period 2: Extension Phase|Withdrawal by Subject|0|||
27864749|NCT02354508|54446713|FG000|Period 2: Extension Phase|Physician Decision|5|||
27864750|NCT02354508|54446714|FG001|Period 2: Extension Phase|Physician Decision|0|||
27864751|NCT02354508|54446715|FG002|Period 2: Extension Phase|Physician Decision|1|||
27864752|NCT02354508|54446713|FG000|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1|||
27864753|NCT02354508|54446714|FG001|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
27864754|NCT02354508|54446715|FG002|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
27864755|NCT02354508|54446713|FG000|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
27864756|NCT02354508|54446714|FG001|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1|||
27864757|NCT02354508|54446715|FG002|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
27864758|NCT02354508|54446713|FG000|Period 3: Post-treatment Follow up Phase|Physician Decision|3|||
27864759|NCT02354508|54446714|FG001|Period 3: Post-treatment Follow up Phase|Physician Decision|0|||
28096211|NCT04676412|54751017|FG000|Overall Study|Death|17|||
27834889|NCT01695239|54319309|FG001|Post-Treatment Follow-Up Period|Physician Decision|0|||
27834890|NCT01695239|54319310|FG002|Post-Treatment Follow-Up Period|Physician Decision|0|||
27834891|NCT01695239|54319311|FG003|Post-Treatment Follow-Up Period|Physician Decision|0|||
27834892|NCT01695239|54319312|FG004|Post-Treatment Follow-Up Period|Physician Decision|0|||
27834893|NCT01695239|54319313|FG005|Post-Treatment Follow-Up Period|Physician Decision|0|||
27834894|NCT01695239|54319314|FG006|Post-Treatment Follow-Up Period|Physician Decision|0|||
27834895|NCT01695239|54319315|FG007|Post-Treatment Follow-Up Period|Physician Decision|0|||
27834896|NCT01695239|54319316|FG008|Post-Treatment Follow-Up Period|Physician Decision|0|||
27834897|NCT01695239|54319317|FG009|Post-Treatment Follow-Up Period|Physician Decision|0|||
27834898|NCT01695239|54319318|FG010|Post-Treatment Follow-Up Period|Physician Decision|0|||
27834899|NCT01695239|54319319|FG011|Post-Treatment Follow-Up Period|Physician Decision|0|||
27834900|NCT01695239|54319320|FG012|Post-Treatment Follow-Up Period|Physician Decision|2|||
27834901|NCT01695239|54319321|FG013|Post-Treatment Follow-Up Period|Physician Decision|0|||
27834902|NCT01695239|54319308|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
27834903|NCT01695239|54319309|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
27834904|NCT01695239|54319310|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
27834905|NCT01695239|54319311|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
27834906|NCT01695239|54319312|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
27834907|NCT01695239|54319313|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
27834908|NCT01695239|54319314|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
27834909|NCT01695239|54319315|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
27834910|NCT01695239|54319316|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
27834911|NCT01695239|54319317|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
27834912|NCT01695239|54319318|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
27834913|NCT01695239|54319319|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
27834914|NCT01695239|54319320|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
27834915|NCT01695239|54319321|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
27834916|NCT02163694|54319345|FG000|Overall Study|Adverse event- related to progression|3|||
27834917|NCT02163694|54319346|FG001|Overall Study|Adverse event- related to progression|8|||
27834918|NCT02163694|54319345|FG000|Overall Study|Adverse event- not related to progression|7|||
27834919|NCT02163694|54319346|FG001|Overall Study|Adverse event- not related to progression|17|||
27834920|NCT02163694|54319345|FG000|Overall Study|Withdrew consent|8|||
27834921|NCT02163694|54319346|FG001|Overall Study|Withdrew consent|21|||
27834922|NCT02163694|54319345|FG000|Overall Study|Lost to Follow-up|1|||
27834923|NCT02163694|54319346|FG001|Overall Study|Lost to Follow-up|2|||
27834924|NCT02163694|54319345|FG000|Overall Study|Progressive disease per protocol|122|||
27834925|NCT02163694|54319346|FG001|Overall Study|Progressive disease per protocol|197|||
27834926|NCT02163694|54319345|FG000|Overall Study|Other, not specified|13|||
27834927|NCT02163694|54319346|FG001|Overall Study|Other, not specified|22|||
27834928|NCT01694849|54319380|FG000|Treatment Period (Visit 2 to Visit 8)|Adverse Event|6|||
27834929|NCT01694849|54319381|FG001|Treatment Period (Visit 2 to Visit 8)|Adverse Event|7|||
27834930|NCT01694849|54319382|FG002|Treatment Period (Visit 2 to Visit 8)|Adverse Event|4|||
27834931|NCT01694849|54319380|FG000|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|1|||
27982090|NCT00933335|54640038|FG000|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0|||
28096212|NCT04676412|54751018|FG001|Overall Study|Death|23|||
27834932|NCT01694849|54319381|FG001|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|3|||
27864760|NCT02354508|54446715|FG002|Period 3: Post-treatment Follow up Phase|Physician Decision|1|||
27864761|NCT00554216|54446767|FG000|Overall Study|Lost to Follow-up|92|||
27864762|NCT00554216|54446768|FG001|Overall Study|Lost to Follow-up|31|||
27864763|NCT00554216|54446769|FG002|Overall Study|Lost to Follow-up|63|||
27864764|NCT00554216|54446767|FG000|Overall Study|Adverse Event|16|||
27864765|NCT00554216|54446768|FG001|Overall Study|Adverse Event|16|||
27864766|NCT00554216|54446769|FG002|Overall Study|Adverse Event|36|||
27864767|NCT00554216|54446767|FG000|Overall Study|Withdrawal by Subject|92|||
27864768|NCT00554216|54446768|FG001|Overall Study|Withdrawal by Subject|31|||
27864769|NCT00554216|54446769|FG002|Overall Study|Withdrawal by Subject|43|||
27864770|NCT00554216|54446767|FG000|Overall Study|Non compliance|10|||
27864771|NCT00554216|54446768|FG001|Overall Study|Non compliance|4|||
27864772|NCT00554216|54446769|FG002|Overall Study|Non compliance|5|||
27864773|NCT00554216|54446767|FG000|Overall Study|Pregnancy|2|||
27864774|NCT00554216|54446768|FG001|Overall Study|Pregnancy|1|||
27864775|NCT00554216|54446769|FG002|Overall Study|Pregnancy|14|||
27864776|NCT00554216|54446767|FG000|Overall Study|Restricted med|3|||
27864777|NCT00554216|54446768|FG001|Overall Study|Restricted med|1|||
27864778|NCT00554216|54446769|FG002|Overall Study|Restricted med|1|||
27864779|NCT00554216|54446767|FG000|Overall Study|Other|12|||
27864780|NCT00554216|54446768|FG001|Overall Study|Other|7|||
27864781|NCT00554216|54446769|FG002|Overall Study|Other|10|||
27864782|NCT00554216|54446767|FG000|Overall Study|Lack of Efficacy|15|||
27864783|NCT00554216|54446768|FG001|Overall Study|Lack of Efficacy|3|||
27864784|NCT00554216|54446769|FG002|Overall Study|Lack of Efficacy|0|||
27864785|NCT02353572|54446794|FG000|Overall Study|Withdrawal by Subject|1|||
27864786|NCT02353572|54446794|FG000|Overall Study|Study terminated|2|||
27864787|NCT00552578|54446806|FG000|Overall Study|Lost to Follow-up|1|||
27864788|NCT00552578|54446807|FG001|Overall Study|Lost to Follow-up|1|||
27864789|NCT02301936|54446815|FG000|Overall Study|Lost to Follow-up|1|||
27864790|NCT02301936|54446816|FG001|Overall Study|Lost to Follow-up|0|||
27864791|NCT00552344|54446855|FG000|Overall Study|Lack of Efficacy|55|||
27864792|NCT00552344|54446855|FG000|Overall Study|Loss of efficacy|75|||
27864793|NCT00552344|54446855|FG000|Overall Study|Lost to Follow-up|8|||
27864794|NCT00552344|54446855|FG000|Overall Study|Withdrawal by Subject|48|||
27864795|NCT00552344|54446855|FG000|Overall Study|SAE, non-fatal|6|||
27864796|NCT00552344|54446855|FG000|Overall Study|AE, non-serious non-fatal|38|||
27864797|NCT00552344|54446855|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62|||
27864798|NCT00552344|54446855|FG000|Overall Study|SAE, fatal + AE, non-serious non-fatal|1|||
27864799|NCT00552344|54446855|FG000|Overall Study|Other Reason|22|||
27864800|NCT00553514|54446892|FG000|Overall Study|Protocol deviation|0|||
27864801|NCT00553514|54446893|FG001|Overall Study|Protocol deviation|0|||
27864802|NCT00553514|54446894|FG002|Overall Study|Protocol deviation|0|||
27864803|NCT00553514|54446895|FG003|Overall Study|Protocol deviation|1|||
27864804|NCT00553514|54446896|FG004|Overall Study|Protocol deviation|0|||
27864805|NCT00553514|54446892|FG000|Overall Study|Lack of ovarian response|4|||
27864806|NCT00553514|54446893|FG001|Overall Study|Lack of ovarian response|5|||
27864807|NCT00553514|54446894|FG002|Overall Study|Lack of ovarian response|5|||
27864808|NCT00553514|54446895|FG003|Overall Study|Lack of ovarian response|5|||
27864809|NCT00553514|54446896|FG004|Overall Study|Lack of ovarian response|6|||
27864810|NCT00553514|54446892|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
27864811|NCT00553514|54446893|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
27864812|NCT00553514|54446894|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
27864813|NCT00553514|54446895|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
27864814|NCT00553514|54446896|FG004|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
27864815|NCT00553514|54446892|FG000|Overall Study|Risk of multiple pregnancy|0|||
27864816|NCT00553514|54446893|FG001|Overall Study|Risk of multiple pregnancy|2|||
27864817|NCT00553514|54446894|FG002|Overall Study|Risk of multiple pregnancy|0|||
27864818|NCT00553514|54446895|FG003|Overall Study|Risk of multiple pregnancy|1|||
27864819|NCT00553514|54446896|FG004|Overall Study|Risk of multiple pregnancy|0|||
27864820|NCT00553514|54446892|FG000|Overall Study|Other|1|||
27864821|NCT00553514|54446893|FG001|Overall Study|Other|1|||
27864822|NCT00553514|54446894|FG002|Overall Study|Other|0|||
27864823|NCT00553514|54446895|FG003|Overall Study|Other|0|||
27982091|NCT00933335|54640039|FG001|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1|||
27982092|NCT00933335|54640038|FG000|Overall Study|Co-morbid Illness|1|||
28171365|NCT02471716|54842933|FG001|Overall Study|Death|0|||
27864824|NCT00553514|54446896|FG004|Overall Study|Other|1|||
27864825|NCT00553436|54446920|FG000|Overall Study|Conversion to another procedure|1|||
27864826|NCT00553202|54446951|FG000|Overall Study|Death|16|||
27864827|NCT00553202|54446951|FG000|Overall Study|Lost to Follow-up|1|||
27864828|NCT00553202|54446951|FG000|Overall Study|Physician Decision|28|||
27864829|NCT00553202|54446951|FG000|Overall Study|Withdrawal by Subject|1|||
27864830|NCT00553202|54446951|FG000|Overall Study|No donor identified|16|||
27864831|NCT00553202|54446951|FG000|Overall Study|Fails to meet organ function|6|||
27864832|NCT00552188|54446975|FG000|Overall Study|Adverse Event|0|||
27864833|NCT00552188|54446976|FG001|Overall Study|Adverse Event|2|||
27864834|NCT00552188|54446975|FG000|Overall Study|Lost to Follow-up|2|||
27864835|NCT00552188|54446976|FG001|Overall Study|Lost to Follow-up|1|||
27864836|NCT00552188|54446975|FG000|Overall Study|Withdrawal of consent|0|||
27864837|NCT00552188|54446976|FG001|Overall Study|Withdrawal of consent|1|||
27864838|NCT00552188|54446975|FG000|Overall Study|Subject returned to home country|0|||
27864839|NCT00552188|54446976|FG001|Overall Study|Subject returned to home country|1|||
27864840|NCT00552110|54446996|FG000|Overall Study|Serious or Life-Threatening AE|0|||
27864841|NCT00552110|54446997|FG001|Overall Study|Serious or Life-Threatening AE|0|||
27864842|NCT00552110|54446998|FG002|Overall Study|Serious or Life-Threatening AE|1|||
27864843|NCT00552110|54446999|FG003|Overall Study|Serious or Life-Threatening AE|0|||
27864844|NCT00552110|54447000|FG004|Overall Study|Serious or Life-Threatening AE|0|||
27864845|NCT00552110|54446996|FG000|Overall Study|Lack of Efficacy|1|||
27864846|NCT00552110|54446997|FG001|Overall Study|Lack of Efficacy|0|||
27864847|NCT00552110|54446998|FG002|Overall Study|Lack of Efficacy|0|||
27864848|NCT00552110|54446999|FG003|Overall Study|Lack of Efficacy|1|||
27864849|NCT00552110|54447000|FG004|Overall Study|Lack of Efficacy|4|||
27864850|NCT00552110|54446996|FG000|Overall Study|Withdrawal by Subject|0|||
27864851|NCT00552110|54446997|FG001|Overall Study|Withdrawal by Subject|2|||
27864852|NCT00552110|54446998|FG002|Overall Study|Withdrawal by Subject|0|||
27864853|NCT00552110|54446999|FG003|Overall Study|Withdrawal by Subject|3|||
27864854|NCT00552110|54447000|FG004|Overall Study|Withdrawal by Subject|2|||
27864855|NCT00552110|54446996|FG000|Overall Study|Lost to Follow-up|0|||
27864856|NCT00552110|54446997|FG001|Overall Study|Lost to Follow-up|0|||
27864857|NCT00552110|54446998|FG002|Overall Study|Lost to Follow-up|0|||
27864858|NCT00552110|54446999|FG003|Overall Study|Lost to Follow-up|1|||
27864859|NCT00552110|54447000|FG004|Overall Study|Lost to Follow-up|1|||
27864860|NCT00552110|54446996|FG000|Overall Study|Failed to Comply With Study Requirements|1|||
27864861|NCT00552110|54446997|FG001|Overall Study|Failed to Comply With Study Requirements|1|||
27864862|NCT00552110|54446998|FG002|Overall Study|Failed to Comply With Study Requirements|1|||
27864863|NCT00552110|54446999|FG003|Overall Study|Failed to Comply With Study Requirements|0|||
27864864|NCT00552110|54447000|FG004|Overall Study|Failed to Comply With Study Requirements|1|||
27864865|NCT00552110|54446996|FG000|Overall Study|Withdrawn per Sponsor|0|||
27864866|NCT00552110|54446997|FG001|Overall Study|Withdrawn per Sponsor|1|||
27864867|NCT00552110|54446998|FG002|Overall Study|Withdrawn per Sponsor|0|||
27864868|NCT00552110|54446999|FG003|Overall Study|Withdrawn per Sponsor|0|||
27864869|NCT00552110|54447000|FG004|Overall Study|Withdrawn per Sponsor|1|||
27864870|NCT00552110|54446996|FG000|Overall Study|Use of Prohibited Medication|1|||
27864871|NCT00552110|54446997|FG001|Overall Study|Use of Prohibited Medication|1|||
27864872|NCT00552110|54446998|FG002|Overall Study|Use of Prohibited Medication|0|||
27864873|NCT00552110|54446999|FG003|Overall Study|Use of Prohibited Medication|0|||
27864874|NCT00552110|54447000|FG004|Overall Study|Use of Prohibited Medication|0|||
27864875|NCT00552110|54446996|FG000|Overall Study|Delay of Study due to Relabeling|0|||
27864876|NCT00552110|54446997|FG001|Overall Study|Delay of Study due to Relabeling|0|||
27864877|NCT00552110|54446998|FG002|Overall Study|Delay of Study due to Relabeling|0|||
27864878|NCT00552110|54446999|FG003|Overall Study|Delay of Study due to Relabeling|1|||
27864879|NCT00552110|54447000|FG004|Overall Study|Delay of Study due to Relabeling|0|||
27864880|NCT00552110|54446996|FG000|Overall Study|Increased Blood Pressure at Visit 2|0|||
27864881|NCT00552110|54446997|FG001|Overall Study|Increased Blood Pressure at Visit 2|0|||
27864882|NCT00552110|54446998|FG002|Overall Study|Increased Blood Pressure at Visit 2|0|||
27864883|NCT00552110|54446999|FG003|Overall Study|Increased Blood Pressure at Visit 2|1|||
27864884|NCT00552110|54447000|FG004|Overall Study|Increased Blood Pressure at Visit 2|0|||
27864885|NCT00552110|54446996|FG000|Overall Study|Nonserious Adverse Event (AE)|1|||
27864886|NCT00552110|54446997|FG001|Overall Study|Nonserious Adverse Event (AE)|0|||
27864887|NCT00552110|54446998|FG002|Overall Study|Nonserious Adverse Event (AE)|0|||
27864888|NCT00552110|54446999|FG003|Overall Study|Nonserious Adverse Event (AE)|1|||
27864889|NCT00552110|54447000|FG004|Overall Study|Nonserious Adverse Event (AE)|0|||
27864890|NCT02301624|54447023|FG000|Blind Induction Phase|Withdrawal by Subject|1|||
27864891|NCT02301624|54447024|FG001|Blind Induction Phase|Withdrawal by Subject|0|||
27864892|NCT02301624|54447023|FG000|Open-label Maintenance Phase|Withdrawal by Subject|4|||
27864893|NCT02301624|54447024|FG001|Open-label Maintenance Phase|Withdrawal by Subject|8|||
27864894|NCT02301624|54447023|FG000|Open-label Maintenance Phase|Adverse Event|2|||
27864895|NCT02301624|54447024|FG001|Open-label Maintenance Phase|Adverse Event|5|||
27864896|NCT02301624|54447023|FG000|Open-label Maintenance Phase|Physician Decision|3|||
27864897|NCT02301624|54447024|FG001|Open-label Maintenance Phase|Physician Decision|3|||
27864898|NCT02301624|54447023|FG000|Open-label Maintenance Phase|Death|2|||
27864899|NCT02301624|54447024|FG001|Open-label Maintenance Phase|Death|1|||
27864900|NCT02301624|54447023|FG000|Open-label Maintenance Phase|Participant felt no change in condition|1|||
27982093|NCT00933335|54640039|FG001|Overall Study|Co-morbid Illness|0|||
27864901|NCT02301624|54447024|FG001|Open-label Maintenance Phase|Participant felt no change in condition|0|||
27864902|NCT02301546|54447065|FG000|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7|||
27864903|NCT02301546|54447066|FG001|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8|||
27864904|NCT02301546|54447065|FG000|Short-term Effectiveness (~13 Weeks)|non-compliant|10|||
27864905|NCT02301546|54447066|FG001|Short-term Effectiveness (~13 Weeks)|non-compliant|7|||
27864906|NCT02301546|54447065|FG000|Short-term Effectiveness (~13 Weeks)|screen fail|1|||
27864907|NCT02301546|54447066|FG001|Short-term Effectiveness (~13 Weeks)|screen fail|0|||
27864908|NCT02301546|54447065|FG000|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
27864909|NCT02301546|54447066|FG001|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
27864910|NCT02301546|54447065|FG000|Long Term Effectiveness (~1 Year)|Death|2|||
27864911|NCT02301546|54447066|FG001|Long Term Effectiveness (~1 Year)|Death|0|||
27864912|NCT02301546|54447065|FG000|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6|||
27864913|NCT02301546|54447066|FG001|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2|||
27864914|NCT02301546|54447065|FG000|Long Term Effectiveness (~1 Year)|moved away|1|||
27864915|NCT02301546|54447066|FG001|Long Term Effectiveness (~1 Year)|moved away|2|||
27864916|NCT02351934|54447090|FG000|Allocation|POD weight<pre-op weight|3|||
27864917|NCT02351934|54447091|FG001|Allocation|POD weight<pre-op weight|0|||
27864918|NCT02351934|54447090|FG000|Allocation|Hypotension preventing administration|2|||
27864919|NCT02351934|54447091|FG001|Allocation|Hypotension preventing administration|0|||
27864920|NCT02351934|54447090|FG000|Allocation|Acute Kidney Injury on Post Op Day 1|1|||
27864921|NCT02351934|54447091|FG001|Allocation|Acute Kidney Injury on Post Op Day 1|0|||
27864922|NCT02351934|54447090|FG000|Follow-Up|POD weight<pre-op weight|3|||
27864923|NCT02351934|54447091|FG001|Follow-Up|POD weight<pre-op weight|0|||
27864924|NCT02351934|54447090|FG000|Follow-Up|Acute Kidney Injury|1|||
27864925|NCT02351934|54447091|FG001|Follow-Up|Acute Kidney Injury|0|||
27864926|NCT02351934|54447090|FG000|Follow-Up|Early dismissal|3|||
27864927|NCT02351934|54447091|FG001|Follow-Up|Early dismissal|0|||
27864928|NCT02351934|54447090|FG000|Follow-Up|Hypotension|3|||
27864929|NCT02351934|54447091|FG001|Follow-Up|Hypotension|0|||
27864930|NCT02351934|54447090|FG000|Follow-Up|No documentation|2|||
27864931|NCT02351934|54447091|FG001|Follow-Up|No documentation|0|||
27864932|NCT02351934|54447090|FG000|Follow-Up|1 ERAS Component Noncompliant|0|||
27864933|NCT02351934|54447091|FG001|Follow-Up|1 ERAS Component Noncompliant|6|||
27864934|NCT02351934|54447090|FG000|Follow-Up|2 ERAS Components Noncompliant|0|||
27864935|NCT02351934|54447091|FG001|Follow-Up|2 ERAS Components Noncompliant|4|||
27864936|NCT02351856|54447131|FG000|Overall Study|Adverse Event|2|||
27864937|NCT02351856|54447131|FG000|Overall Study|Physician Decision|5|||
27864938|NCT02351856|54447131|FG000|Overall Study|Study terminated by sponsor|1|||
27864939|NCT02349360|54447171|FG000|Overall Study|Withdrawal by Subject|0|||
27864940|NCT02349360|54447172|FG001|Overall Study|Withdrawal by Subject|1|||
27864941|NCT00551642|54447197|FG000|Treatment Period|Protocol Deviation|6|||
27864942|NCT00551642|54447198|FG001|Treatment Period|Protocol Deviation|11|||
27864943|NCT00551642|54447197|FG000|Treatment Period|Delivery device failure|1|||
27864944|NCT00551642|54447198|FG001|Treatment Period|Delivery device failure|3|||
27864945|NCT00551642|54447197|FG000|Treatment Period|Physician Decision|0|||
27864946|NCT00551642|54447198|FG001|Treatment Period|Physician Decision|1|||
27864947|NCT00551642|54447197|FG000|Treatment Period|Death|33|||
27864948|NCT00551642|54447198|FG001|Treatment Period|Death|31|||
27864949|NCT00551642|54447197|FG000|Treatment Period|Inclusion/Exclusion criteria|4|||
27864950|NCT00551642|54447198|FG001|Treatment Period|Inclusion/Exclusion criteria|4|||
27864951|NCT00551642|54447197|FG000|Treatment Period|Adverse Event|15|||
27864952|NCT00551642|54447198|FG001|Treatment Period|Adverse Event|12|||
27864953|NCT00551642|54447197|FG000|Treatment Period|Withdrawal by Subject|2|||
27864954|NCT00551642|54447198|FG001|Treatment Period|Withdrawal by Subject|1|||
27864955|NCT00550550|54447292|FG000|Overall Study|Adverse Event|13|||
27864956|NCT00550550|54447293|FG001|Overall Study|Adverse Event|5|||
27864957|NCT00550550|54447292|FG000|Overall Study|Treatment Failure|0|||
27864958|NCT00550550|54447293|FG001|Overall Study|Treatment Failure|1|||
27864959|NCT00550550|54447292|FG000|Overall Study|Lost to Follow-up|4|||
27864960|NCT00550550|54447293|FG001|Overall Study|Lost to Follow-up|0|||
27864961|NCT00550550|54447292|FG000|Overall Study|Withdrawal by Subject|10|||
27864962|NCT00550550|54447293|FG001|Overall Study|Withdrawal by Subject|8|||
27864963|NCT00550550|54447292|FG000|Overall Study|Protocol Violation|5|||
27864964|NCT00550550|54447293|FG001|Overall Study|Protocol Violation|14|||
27864965|NCT00550550|54447292|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
27864966|NCT00550550|54447293|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
27864967|NCT00550550|54447292|FG000|Overall Study|Randomized But Not Treated|1|||
27864968|NCT00550550|54447293|FG001|Overall Study|Randomized But Not Treated|0|||
27864969|NCT02301156|54447344|FG000|Overall Study|Adverse Event|13|||
27864970|NCT02301156|54447345|FG001|Overall Study|Adverse Event|14|||
27864971|NCT02301156|54447344|FG000|Overall Study|Death|1|||
27864972|NCT02301156|54447345|FG001|Overall Study|Death|5|||
27864973|NCT02301156|54447344|FG000|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
27864974|NCT02301156|54447345|FG001|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
27864975|NCT02301156|54447344|FG000|Overall Study|Site Terminated by Sponsor at the End of Study|27|||
27864976|NCT02301156|54447345|FG001|Overall Study|Site Terminated by Sponsor at the End of Study|16|||
27864977|NCT02301156|54447344|FG000|Overall Study|Withdrawal of Consent by Subject|4|||
27864978|NCT02301156|54447345|FG001|Overall Study|Withdrawal of Consent by Subject|12|||
27864979|NCT02301156|54447344|FG000|Overall Study|Reason not Specified|6|||
27864980|NCT02301156|54447345|FG001|Overall Study|Reason not Specified|3|||
27864981|NCT02301390|54447426|FG000|Overall Study|Withdrawal by Subject|3|||
27864982|NCT02301390|54447427|FG001|Overall Study|Withdrawal by Subject|5|||
27864983|NCT02301390|54447426|FG000|Overall Study|Protocol Violation|1|||
27864984|NCT02301390|54447427|FG001|Overall Study|Protocol Violation|0|||
27864985|NCT02301390|54447426|FG000|Overall Study|Physician Decision|1|||
27864986|NCT02301390|54447427|FG001|Overall Study|Physician Decision|0|||
27864987|NCT02301390|54447426|FG000|Overall Study|Lost to Follow-up|0|||
27864988|NCT02301390|54447427|FG001|Overall Study|Lost to Follow-up|1|||
27864989|NCT02301390|54447426|FG000|Overall Study|Death|2|||
27864990|NCT02301390|54447427|FG001|Overall Study|Death|2|||
27864991|NCT02301390|54447426|FG000|Overall Study|Procedure not completed|0|||
27864992|NCT02301390|54447427|FG001|Overall Study|Procedure not completed|4|||
27864993|NCT02301390|54447426|FG000|Overall Study|Missed multiple visits|1|||
27864994|NCT02301390|54447427|FG001|Overall Study|Missed multiple visits|1|||
27864995|NCT02301390|54447426|FG000|Overall Study|study terminated|2|||
27864996|NCT02301390|54447427|FG001|Overall Study|study terminated|0|||
27864997|NCT02300610|54447544|FG000|Overall Study|Withdrawal by Subject|1|||
27864998|NCT02300610|54447545|FG001|Overall Study|Withdrawal by Subject|0|||
27864999|NCT02300610|54447546|FG002|Overall Study|Withdrawal by Subject|1|||
27865000|NCT02300298|54447591|FG000|Disposition for Nintedanib|Progressive disease|10|||
27865001|NCT02300298|54447592|FG001|Disposition for Nintedanib|Progressive disease|0|||
27865002|NCT02300298|54447591|FG000|Disposition for Docetaxel|Progressive disease|0|||
27865003|NCT02300298|54447592|FG001|Disposition for Docetaxel|Progressive disease|6|||
27865004|NCT02300298|54447591|FG000|Disposition for Docetaxel|other adverse event|0|||
27865005|NCT02300298|54447592|FG001|Disposition for Docetaxel|other adverse event|4|||
27865006|NCT02300220|54447598|FG000|Overall Study|Lost to Follow-up|1|||
27865007|NCT02300220|54447599|FG001|Overall Study|Lost to Follow-up|2|||
27865008|NCT02300220|54447598|FG000|Overall Study|Death|1|||
27865009|NCT02300220|54447599|FG001|Overall Study|Death|1|||
27865010|NCT02300220|54447598|FG000|Overall Study|Adverse Event|1|||
27865011|NCT02300220|54447599|FG001|Overall Study|Adverse Event|1|||
27865012|NCT02300220|54447598|FG000|Overall Study|Protocol Violation|1|||
27865013|NCT02300220|54447599|FG001|Overall Study|Protocol Violation|0|||
27865014|NCT02300220|54447598|FG000|Overall Study|Withdrawal by Subject|0|||
27865015|NCT02300220|54447599|FG001|Overall Study|Withdrawal by Subject|2|||
27865016|NCT02300220|54447598|FG000|Overall Study|Did not tolerate IMP|0|||
27865017|NCT02300220|54447599|FG001|Overall Study|Did not tolerate IMP|1|||
27865018|NCT02327130|54447623|FG000|Overall Study|Discharged in less than 5 days|5|||
27865019|NCT02327130|54447623|FG000|Overall Study|Physician Decision|2|||
27865020|NCT02327130|54447623|FG000|Overall Study|Unable to provide breath sample|1|||
27865021|NCT02327130|54447623|FG000|Overall Study|Incorrectly place ventilator adaptor|1|||
27865022|NCT02327130|54447623|FG000|Overall Study|Met exclusion criteria|3|||
27865023|NCT02326272|54447678|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
27865024|NCT02326272|54447679|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|3|||
27865025|NCT02326272|54447680|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
27865026|NCT02326272|54447681|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
27865027|NCT02326272|54447682|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
27865028|NCT02326272|54447683|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
27865029|NCT02326272|54447684|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
27865030|NCT02326272|54447685|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
27865031|NCT02326272|54447686|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
27865032|NCT02326272|54447687|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
27865033|NCT02326272|54447688|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
27865034|NCT02326272|54447689|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
28096213|NCT04676412|54751017|FG000|Overall Study|Withdrawal by Subject|0|||
28096214|NCT04676412|54751018|FG001|Overall Study|Withdrawal by Subject|2|||
27738966|NCT02240680|54188243|FG000|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1|||
27834933|NCT01694849|54319382|FG002|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|7|||
27834934|NCT01694849|54319380|FG000|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
27834935|NCT01694849|54319381|FG001|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
27834936|NCT01694849|54319382|FG002|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|1|||
27834937|NCT01694849|54319380|FG000|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
27834938|NCT01694849|54319381|FG001|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|0|||
27834939|NCT01694849|54319382|FG002|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
27834940|NCT01694849|54319380|FG000|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
27865035|NCT02326272|54447690|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
27865036|NCT02326272|54447691|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
27865037|NCT02326272|54447692|FG014|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
27865038|NCT02326272|54447678|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
27865039|NCT02326272|54447679|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2|||
27865040|NCT02326272|54447680|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
27865041|NCT02326272|54447681|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
27865042|NCT02326272|54447682|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
27865043|NCT02326272|54447683|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
27865044|NCT02326272|54447684|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
27865045|NCT02326272|54447685|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
27865046|NCT02326272|54447686|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
27865047|NCT02326272|54447687|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
27865048|NCT02326272|54447688|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
27865049|NCT02326272|54447689|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
27865050|NCT02326272|54447690|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
27865051|NCT02326272|54447691|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
27865052|NCT02326272|54447692|FG014|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
27865053|NCT02326272|54447678|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
27865054|NCT02326272|54447679|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
27865055|NCT02326272|54447680|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
27865056|NCT02326272|54447681|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
27865057|NCT02326272|54447682|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
27865058|NCT02326272|54447683|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
27865059|NCT02326272|54447684|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
27865060|NCT02326272|54447685|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
27865061|NCT02326272|54447686|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
27865062|NCT02326272|54447687|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
27865063|NCT02326272|54447688|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
27865064|NCT02326272|54447689|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
27865065|NCT02326272|54447690|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
27865066|NCT02326272|54447691|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
27865067|NCT02326272|54447692|FG014|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
27865068|NCT02326272|54447678|FG000|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
27865069|NCT02326272|54447679|FG001|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
27865070|NCT02326272|54447680|FG002|Initial Period (Week 0 to Week 16)|Moved from the study area|1|||
27865071|NCT02326272|54447681|FG003|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
27865072|NCT02326272|54447682|FG004|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
27865073|NCT02326272|54447683|FG005|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
27865074|NCT02326272|54447684|FG006|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
27865075|NCT02326272|54447685|FG007|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
27865076|NCT02326272|54447686|FG008|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
27865077|NCT02326272|54447687|FG009|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
27865078|NCT02326272|54447688|FG010|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
27865079|NCT02326272|54447689|FG011|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
27865080|NCT02326272|54447690|FG012|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
27865081|NCT02326272|54447691|FG013|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
27865082|NCT02326272|54447692|FG014|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
27865083|NCT02326272|54447678|FG000|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
27865084|NCT02326272|54447679|FG001|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
27865085|NCT02326272|54447680|FG002|Initial Period (Week 0 to Week 16)|Missed two doses|1|||
27834941|NCT01694849|54319381|FG001|Treatment Period (Visit 2 to Visit 8)|Non-compliance|0|||
27834942|NCT01694849|54319382|FG002|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
27834943|NCT01694849|54319380|FG000|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
27865086|NCT02326272|54447681|FG003|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
27865087|NCT02326272|54447682|FG004|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
27865088|NCT02326272|54447683|FG005|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
27865089|NCT02326272|54447684|FG006|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
27865090|NCT02326272|54447685|FG007|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
27865091|NCT02326272|54447686|FG008|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
27865092|NCT02326272|54447687|FG009|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
27865093|NCT02326272|54447688|FG010|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
27865094|NCT02326272|54447689|FG011|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
27982094|NCT00772941|54640051|FG000|Overall Study|CRFs not available|195|||
27982095|NCT00772941|54640051|FG000|Overall Study|Study not completed|16|||
27982096|NCT00772941|54640051|FG000|Overall Study|Missed Visits|374|||
28171366|NCT02471716|54842934|FG002|Overall Study|Death|0|||
27834944|NCT01694849|54319381|FG001|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|1|||
27834945|NCT01694849|54319382|FG002|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
27834946|NCT01694849|54319380|FG000|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
27834947|NCT01694849|54319381|FG001|Follow-up Period (to Visit 9)|Withdrawal by Subject|1|||
27865095|NCT02326272|54447690|FG012|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
27865096|NCT02326272|54447691|FG013|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
27865097|NCT02326272|54447692|FG014|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
27865098|NCT02326272|54447678|FG000|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
27865099|NCT02326272|54447679|FG001|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
27865100|NCT02326272|54447680|FG002|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1|||
27865101|NCT02326272|54447681|FG003|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
27865102|NCT02326272|54447682|FG004|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
27865103|NCT02326272|54447683|FG005|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
27865104|NCT02326272|54447684|FG006|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
27865105|NCT02326272|54447685|FG007|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
27865106|NCT02326272|54447686|FG008|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
27865107|NCT02326272|54447687|FG009|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
27865108|NCT02326272|54447688|FG010|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
27865109|NCT02326272|54447689|FG011|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
27865110|NCT02326272|54447690|FG012|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
27865111|NCT02326272|54447691|FG013|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
27865112|NCT02326272|54447692|FG014|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
27865113|NCT02326272|54447678|FG000|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
27865114|NCT02326272|54447679|FG001|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
27865115|NCT02326272|54447680|FG002|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1|||
27865116|NCT02326272|54447681|FG003|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
27865117|NCT02326272|54447682|FG004|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
27865118|NCT02326272|54447683|FG005|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
27865119|NCT02326272|54447684|FG006|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
27865120|NCT02326272|54447685|FG007|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
27865121|NCT02326272|54447686|FG008|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
27865122|NCT02326272|54447687|FG009|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
27865123|NCT02326272|54447688|FG010|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
27865124|NCT02326272|54447689|FG011|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
27865125|NCT02326272|54447690|FG012|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
27865126|NCT02326272|54447691|FG013|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
27865127|NCT02326272|54447692|FG014|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
27865128|NCT02326272|54447678|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27865129|NCT02326272|54447679|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27865130|NCT02326272|54447680|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27865131|NCT02326272|54447681|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27865132|NCT02326272|54447682|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
27865133|NCT02326272|54447683|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|3|||
27865134|NCT02326272|54447684|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
27865135|NCT02326272|54447685|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
27865136|NCT02326272|54447686|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
27865137|NCT02326272|54447687|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27865138|NCT02326272|54447688|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27865139|NCT02326272|54447689|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27865140|NCT02326272|54447690|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27865141|NCT02326272|54447691|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27865142|NCT02326272|54447692|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27865143|NCT02326272|54447678|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27865144|NCT02326272|54447679|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27865145|NCT02326272|54447680|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27865146|NCT02326272|54447681|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27865147|NCT02326272|54447682|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27865148|NCT02326272|54447683|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2|||
27865149|NCT02326272|54447684|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
27865150|NCT02326272|54447685|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27865151|NCT02326272|54447686|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
27865152|NCT02326272|54447687|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
27982097|NCT00772941|54640051|FG000|Overall Study|Poor Compliance|7|||
27738967|NCT02240680|54188244|FG001|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
27865153|NCT02326272|54447688|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27865154|NCT02326272|54447689|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27865155|NCT02326272|54447690|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27865156|NCT02326272|54447691|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27865157|NCT02326272|54447692|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27865158|NCT02326272|54447678|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27865159|NCT02326272|54447679|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27865160|NCT02326272|54447680|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27865161|NCT02326272|54447681|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27865162|NCT02326272|54447682|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27865163|NCT02326272|54447683|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
27865164|NCT02326272|54447684|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27865165|NCT02326272|54447685|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
27865166|NCT02326272|54447686|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27865167|NCT02326272|54447687|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27865168|NCT02326272|54447688|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27865169|NCT02326272|54447689|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27865170|NCT02326272|54447690|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27865171|NCT02326272|54447691|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27865172|NCT02326272|54447692|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27865173|NCT02326272|54447678|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27865174|NCT02326272|54447679|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27865175|NCT02326272|54447680|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27865176|NCT02326272|54447681|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
27865177|NCT02326272|54447682|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27865178|NCT02326272|54447683|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
27865179|NCT02326272|54447684|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
27865180|NCT02326272|54447685|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
27865181|NCT02326272|54447686|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27865182|NCT02326272|54447687|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
27865183|NCT02326272|54447688|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27865184|NCT02326272|54447689|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27865185|NCT02326272|54447690|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27865186|NCT02326272|54447691|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27865187|NCT02326272|54447692|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27865188|NCT02326272|54447678|FG000|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
27865189|NCT02326272|54447679|FG001|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
27865190|NCT02326272|54447680|FG002|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
27865191|NCT02326272|54447681|FG003|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
27865192|NCT02326272|54447682|FG004|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
27865193|NCT02326272|54447683|FG005|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
27865194|NCT02326272|54447684|FG006|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
27865195|NCT02326272|54447685|FG007|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1|||
27865196|NCT02326272|54447686|FG008|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
27865197|NCT02326272|54447687|FG009|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
27865198|NCT02326272|54447688|FG010|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
27865199|NCT02326272|54447689|FG011|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
27865200|NCT02326272|54447690|FG012|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
27865201|NCT02326272|54447691|FG013|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
27865202|NCT02326272|54447692|FG014|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
27865203|NCT02326272|54447678|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
27865204|NCT02326272|54447679|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
27865205|NCT02326272|54447680|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
27865206|NCT02326272|54447681|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
27865207|NCT02326272|54447682|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
27865208|NCT02326272|54447683|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
27865209|NCT02326272|54447684|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
27865210|NCT02326272|54447685|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
27865211|NCT02326272|54447686|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
27865212|NCT02326272|54447687|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
27865213|NCT02326272|54447688|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
27982098|NCT00772941|54640051|FG000|Overall Study|GPSP Violation|90|||
27982099|NCT00772707|54640078|FG000|Overall Study|Withdrawn|3|||
27982100|NCT00772629|54640084|FG000|Overall Study|Subject was not vaccinated|1|||
27865214|NCT02326272|54447689|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
27865215|NCT02326272|54447690|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
27865216|NCT02326272|54447691|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
27865217|NCT02326272|54447692|FG014|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
27865218|NCT02326272|54447678|FG000|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
27865219|NCT02326272|54447679|FG001|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
27865220|NCT02326272|54447680|FG002|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
27865221|NCT02326272|54447681|FG003|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
27865222|NCT02326272|54447682|FG004|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
27865223|NCT02326272|54447683|FG005|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
27865224|NCT02326272|54447684|FG006|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
27865225|NCT02326272|54447685|FG007|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
27865226|NCT02326272|54447686|FG008|Maintenance Period (Week 16 to Week 48)|Non-compliance|1|||
27865227|NCT02326272|54447687|FG009|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
27982101|NCT00772629|54640085|FG001|Overall Study|Subject was not vaccinated|0|||
27982102|NCT00939341|54640091|FG000|Overall Study|Adverse Event|15|||
27982103|NCT00939341|54640091|FG000|Overall Study|Pregnancy|1|||
27982104|NCT00939341|54640091|FG000|Overall Study|Lost to Follow-up|23|||
27982105|NCT00939341|54640091|FG000|Overall Study|Withdrawal by Subject|13|||
27982106|NCT00939341|54640091|FG000|Overall Study|Protocol Violation|6|||
27982107|NCT00939341|54640091|FG000|Overall Study|Incorrect enrolment|8|||
27982108|NCT04292470|54640120|FG000|Overall Study|Withdrawal by Subject|0|||
27982109|NCT04292470|54640121|FG001|Overall Study|Withdrawal by Subject|1|||
27982110|NCT04217590|54640129|FG000|Overall Study|Other|1|||
27982111|NCT04217590|54640130|FG001|Overall Study|Other|1|||
27982112|NCT04217590|54640129|FG000|Overall Study|Withdrawal by Subject|3|||
27982113|NCT04217590|54640130|FG001|Overall Study|Withdrawal by Subject|1|||
27982114|NCT04217590|54640129|FG000|Overall Study|Death|0|||
27982115|NCT04217590|54640130|FG001|Overall Study|Death|1|||
27982116|NCT03963232|54640138|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
27982117|NCT03963232|54640139|FG001|Double-Blind Treatment Phase|Adverse Event|6|||
27982118|NCT03963232|54640138|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
27982119|NCT03963232|54640139|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
27982120|NCT03963232|54640138|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
27982121|NCT03963232|54640139|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
27982122|NCT03963232|54640138|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
27982123|NCT03963232|54640139|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
27982124|NCT03963232|54640138|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
27982125|NCT03963232|54640139|FG001|Double-Blind Treatment Phase|Physician Decision|3|||
27982126|NCT03963232|54640138|FG000|Open-Label Treatment Phase|Adverse Event|1|||
27982127|NCT03963232|54640139|FG001|Open-Label Treatment Phase|Adverse Event|2|||
27982128|NCT03963232|54640138|FG000|Open-Label Treatment Phase|Protocol Violation|0|||
27982129|NCT03963232|54640139|FG001|Open-Label Treatment Phase|Protocol Violation|2|||
27982130|NCT03963232|54640138|FG000|Open-Label Treatment Phase|Withdrawal by Subject|5|||
27982131|NCT03963232|54640139|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
27982132|NCT03963232|54640138|FG000|Open-Label Treatment Phase|Pregnancy|1|||
27982133|NCT03963232|54640139|FG001|Open-Label Treatment Phase|Pregnancy|0|||
27982134|NCT03963232|54640138|FG000|Follow-up Phase|Withdrawal by Subject|7|||
27982135|NCT03963232|54640139|FG001|Follow-up Phase|Withdrawal by Subject|5|||
28171367|NCT02471716|54842935|FG003|Overall Study|Death|1|||
27834948|NCT01694849|54319382|FG002|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
27834949|NCT01694849|54319380|FG000|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
27834950|NCT01694849|54319381|FG001|Follow-up Period (to Visit 9)|Lost to Follow-up|2|||
27834951|NCT01694849|54319382|FG002|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
27834952|NCT01694771|54319431|FG000|Overall Study|Adverse Event|18|||
27834953|NCT01694771|54319432|FG001|Overall Study|Adverse Event|16|||
27834954|NCT01694771|54319431|FG000|Overall Study|Lack of Efficacy|1|||
27834955|NCT01694771|54319432|FG001|Overall Study|Lack of Efficacy|0|||
27834956|NCT01694771|54319431|FG000|Overall Study|Non compliance protocol|7|||
27834957|NCT01694771|54319432|FG001|Overall Study|Non compliance protocol|6|||
27834958|NCT01694771|54319431|FG000|Overall Study|Lost to Follow-up|2|||
27834959|NCT01694771|54319432|FG001|Overall Study|Lost to Follow-up|3|||
27865228|NCT02326272|54447688|FG010|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
27982136|NCT03963232|54640138|FG000|Follow-up Phase|Protocol Violation|0|||
27982137|NCT03963232|54640139|FG001|Follow-up Phase|Protocol Violation|2|||
27982138|NCT03963232|54640138|FG000|Follow-up Phase|Adverse Event|0|||
27982139|NCT03963232|54640139|FG001|Follow-up Phase|Adverse Event|1|||
27982140|NCT03963232|54640138|FG000|Follow-up Phase|Lost to Follow-up|0|||
27982141|NCT03963232|54640139|FG001|Follow-up Phase|Lost to Follow-up|1|||
28171368|NCT02471716|54842936|FG004|Overall Study|Death|0|||
27982142|NCT03856593|54640163|FG000|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|15|||
27834960|NCT01694771|54319431|FG000|Overall Study|Consent withdrawn|7|||
27834961|NCT01694771|54319432|FG001|Overall Study|Consent withdrawn|9|||
27865229|NCT02326272|54447689|FG011|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
27865230|NCT02326272|54447690|FG012|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
27865231|NCT02326272|54447691|FG013|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
27865232|NCT02326272|54447692|FG014|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
27865233|NCT02326272|54447678|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
27865234|NCT02326272|54447679|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
27865235|NCT02326272|54447680|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
27865236|NCT02326272|54447681|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
27865237|NCT02326272|54447682|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
27865238|NCT02326272|54447683|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
27865239|NCT02326272|54447684|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
27865240|NCT02326272|54447685|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
27865241|NCT02326272|54447686|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
27865242|NCT02326272|54447687|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
27865243|NCT02326272|54447688|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
27865244|NCT02326272|54447689|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
27865245|NCT02326272|54447690|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
27865246|NCT02326272|54447691|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
27865247|NCT02326272|54447692|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
27865248|NCT02326272|54447678|FG000|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
27865249|NCT02326272|54447679|FG001|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
27865250|NCT02326272|54447680|FG002|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
27865251|NCT02326272|54447681|FG003|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
27865252|NCT02326272|54447682|FG004|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
28096215|NCT04676412|54751017|FG000|Overall Study|Participants ongoing|32|||
28096216|NCT04676412|54751018|FG001|Overall Study|Participants ongoing|33|||
28096217|NCT04150250|54751026|FG000|Overall Study|Lost to Follow-up|0|||
28096218|NCT04150250|54751027|FG001|Overall Study|Lost to Follow-up|2|||
28096219|NCT04537806|54751035|FG000|Overall Study|Randomized but not treated|1|||
28096220|NCT04537806|54751036|FG001|Overall Study|Randomized but not treated|0|||
28096221|NCT04537806|54751035|FG000|Overall Study|Adverse Event|1|||
28096222|NCT04537806|54751036|FG001|Overall Study|Adverse Event|1|||
28096223|NCT04015232|54751044|FG000|Overall Study|Withdrawal by Subject|7|||
28096224|NCT04015232|54751045|FG001|Overall Study|Withdrawal by Subject|4|||
28096225|NCT04015232|54751044|FG000|Overall Study|Protocol Violation|1|||
28096226|NCT04015232|54751045|FG001|Overall Study|Protocol Violation|0|||
28096227|NCT04015232|54751044|FG000|Overall Study|Medical Grounds|3|||
27738968|NCT02240680|54188245|FG002|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
27834962|NCT01694771|54319431|FG000|Overall Study|Other reasons|5|||
27834963|NCT01694771|54319432|FG001|Overall Study|Other reasons|6|||
27834964|NCT01582061|54319461|FG000|Overall Study|Lack of Efficacy|3|||
27834965|NCT01582061|54319462|FG001|Overall Study|Lack of Efficacy|23|||
27834966|NCT01582061|54319461|FG000|Overall Study|Adverse Event|12|||
27834967|NCT01582061|54319462|FG001|Overall Study|Adverse Event|8|||
27834968|NCT01582061|54319461|FG000|Overall Study|Withdrawal by Subject|10|||
27834969|NCT01582061|54319462|FG001|Overall Study|Withdrawal by Subject|4|||
27834970|NCT01582061|54319461|FG000|Overall Study|Abnormal laboratory value(s)|1|||
27834971|NCT01582061|54319462|FG001|Overall Study|Abnormal laboratory value(s)|0|||
27834972|NCT01582061|54319461|FG000|Overall Study|Death|0|||
27834973|NCT01582061|54319462|FG001|Overall Study|Death|1|||
27834974|NCT01582061|54319461|FG000|Overall Study|condition no longer requires study drug|1|||
27834975|NCT01582061|54319462|FG001|Overall Study|condition no longer requires study drug|0|||
27834976|NCT01582061|54319461|FG000|Overall Study|Lost to Follow-up|1|||
27834977|NCT01582061|54319462|FG001|Overall Study|Lost to Follow-up|0|||
27834978|NCT01693523|54319481|FG000|Overall Study|Adverse Event|2|||
27834979|NCT01693523|54319482|FG001|Overall Study|Adverse Event|1|||
27834980|NCT01693523|54319483|FG002|Overall Study|Adverse Event|0|||
27834981|NCT01693523|54319481|FG000|Overall Study|Death|0|||
27834982|NCT01693523|54319482|FG001|Overall Study|Death|1|||
27834983|NCT01693523|54319483|FG002|Overall Study|Death|1|||
27834984|NCT01693523|54319481|FG000|Overall Study|Lost to Follow-up|0|||
27834985|NCT01693523|54319482|FG001|Overall Study|Lost to Follow-up|0|||
27834986|NCT01693523|54319483|FG002|Overall Study|Lost to Follow-up|4|||
27834987|NCT01693523|54319481|FG000|Overall Study|Physician Decision|0|||
27834988|NCT01693523|54319482|FG001|Overall Study|Physician Decision|0|||
27834989|NCT01693523|54319483|FG002|Overall Study|Physician Decision|1|||
27834990|NCT01693523|54319481|FG000|Overall Study|Withdrawal by Subject|1|||
27834991|NCT01693523|54319482|FG001|Overall Study|Withdrawal by Subject|2|||
27834992|NCT01693523|54319483|FG002|Overall Study|Withdrawal by Subject|2|||
27834993|NCT01693523|54319481|FG000|Overall Study|Lack of compliance study medication|1|||
27865253|NCT02326272|54447683|FG005|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1|||
27865254|NCT02326272|54447684|FG006|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
27865255|NCT02326272|54447685|FG007|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
27865256|NCT02326272|54447686|FG008|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
27865257|NCT02326272|54447687|FG009|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
27865258|NCT02326272|54447688|FG010|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
27865259|NCT02326272|54447689|FG011|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
27865260|NCT02326272|54447690|FG012|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
27865261|NCT02326272|54447691|FG013|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
27865262|NCT02326272|54447692|FG014|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
27865263|NCT02326272|54447678|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
27865264|NCT02326272|54447679|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
27865265|NCT02326272|54447680|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
27865266|NCT02326272|54447681|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
27865267|NCT02326272|54447682|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
27865268|NCT02326272|54447683|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
27865269|NCT02326272|54447684|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1|||
27865270|NCT02326272|54447685|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
27865271|NCT02326272|54447686|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
27865272|NCT02326272|54447687|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
27865273|NCT02326272|54447688|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
27865274|NCT02326272|54447689|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
27865275|NCT02326272|54447690|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
27865276|NCT02326272|54447691|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
27865277|NCT02326272|54447692|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
27865278|NCT02326272|54447678|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
27865279|NCT02326272|54447679|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
27865280|NCT02326272|54447680|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
27865281|NCT02326272|54447681|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
27865282|NCT02326272|54447682|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
27865283|NCT02326272|54447683|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
27865284|NCT02326272|54447684|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
27865285|NCT02326272|54447685|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
27865286|NCT02326272|54447686|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
27865287|NCT02326272|54447687|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
27865288|NCT02326272|54447688|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
27865289|NCT02326272|54447689|FG011|Open-label Period (Week 48 to Week 144)|Death|0|||
27865290|NCT02326272|54447690|FG012|Open-label Period (Week 48 to Week 144)|Death|1|||
27865291|NCT02326272|54447691|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
27865292|NCT02326272|54447692|FG014|Open-label Period (Week 48 to Week 144)|Death|0|||
28171369|NCT02471716|54842932|FG000|Overall Study|Other|0|||
27834994|NCT01693523|54319482|FG001|Overall Study|Lack of compliance study medication|2|||
27834995|NCT01693523|54319483|FG002|Overall Study|Lack of compliance study medication|0|||
27834996|NCT01693523|54319481|FG000|Overall Study|Chemotherapy was held|1|||
27834997|NCT01693523|54319482|FG001|Overall Study|Chemotherapy was held|2|||
27834998|NCT01693523|54319483|FG002|Overall Study|Chemotherapy was held|0|||
27834999|NCT01581593|54319499|FG000|Overall Study|Withdrawal by Subject|1|||
27835000|NCT01581281|54319510|FG000|Overall Study|Early Study Closure|15|||
27835001|NCT01581281|54319511|FG001|Overall Study|Early Study Closure|6|||
27835002|NCT01581281|54319512|FG002|Overall Study|Early Study Closure|12|||
27835003|NCT02692716|54319523|FG000|Overall Study|Lost to Follow-up|2|||
27835004|NCT02692716|54319524|FG001|Overall Study|Lost to Follow-up|5|||
27835005|NCT02692716|54319523|FG000|Overall Study|Withdrawal by Subject|3|||
27835006|NCT02692716|54319524|FG001|Overall Study|Withdrawal by Subject|1|||
27835007|NCT01580969|54319533|FG000|Overall Study|Physician Decision|3|||
27835008|NCT01580969|54319534|FG001|Overall Study|Physician Decision|0|||
27835009|NCT01580969|54319535|FG002|Overall Study|Physician Decision|0|||
27835010|NCT01693367|54319545|FG000|Overall Study|Withdrawal by Subject|1|||
27835011|NCT01693367|54319546|FG001|Overall Study|Withdrawal by Subject|1|||
27835012|NCT01693367|54319545|FG000|Overall Study|Physician Decision|0|||
27835013|NCT01693367|54319546|FG001|Overall Study|Physician Decision|1|||
27738969|NCT02240680|54188246|FG003|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
27738970|NCT02240680|54188243|FG000|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3|||
27835014|NCT02696226|54319556|FG000|Overall Study|Study terminated - lack of enrollment|1|||
27835015|NCT02696226|54319557|FG001|Overall Study|Study terminated - lack of enrollment|0|||
27835016|NCT02696226|54319558|FG002|Overall Study|Study terminated - lack of enrollment|2|||
27865293|NCT02326272|54447678|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
27865294|NCT02326272|54447679|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
27865295|NCT02326272|54447680|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
27865296|NCT02326272|54447681|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
27865297|NCT02326272|54447682|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
27865298|NCT02326272|54447683|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
27865299|NCT02326272|54447684|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
27865300|NCT02326272|54447685|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
27865301|NCT02326272|54447686|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
27865302|NCT02326272|54447687|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
27865303|NCT02326272|54447688|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
27865304|NCT02326272|54447689|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|8|||
27865305|NCT02326272|54447690|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
27865306|NCT02326272|54447691|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
27865307|NCT02326272|54447692|FG014|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
27865308|NCT02326272|54447678|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27865309|NCT02326272|54447679|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27865310|NCT02326272|54447680|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27865311|NCT02326272|54447681|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27865312|NCT02326272|54447682|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27865313|NCT02326272|54447683|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27865314|NCT02326272|54447684|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27865315|NCT02326272|54447685|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27865316|NCT02326272|54447686|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27865317|NCT02326272|54447687|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27865318|NCT02326272|54447688|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
27865319|NCT02326272|54447689|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27865320|NCT02326272|54447690|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
27865321|NCT02326272|54447691|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27865322|NCT02326272|54447692|FG014|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27865323|NCT02326272|54447678|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
27865324|NCT02326272|54447679|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
27865325|NCT02326272|54447680|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
27865326|NCT02326272|54447681|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
27865327|NCT02326272|54447682|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
27865328|NCT02326272|54447683|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
27865329|NCT02326272|54447684|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
27865330|NCT02326272|54447685|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
27865331|NCT02326272|54447686|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
27865332|NCT02326272|54447687|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
27865333|NCT02326272|54447688|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
27865334|NCT02326272|54447689|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|1|||
27865335|NCT02326272|54447690|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
27865336|NCT02326272|54447691|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
27865337|NCT02326272|54447692|FG014|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
27865338|NCT02326272|54447678|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27865339|NCT02326272|54447679|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27865340|NCT02326272|54447680|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27865341|NCT02326272|54447681|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27865342|NCT02326272|54447682|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27865343|NCT02326272|54447683|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27865344|NCT02326272|54447684|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27865345|NCT02326272|54447685|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27865346|NCT02326272|54447686|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27865347|NCT02326272|54447687|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
28096228|NCT04015232|54751045|FG001|Overall Study|Medical Grounds|3|||
27835017|NCT02696226|54319559|FG003|Overall Study|Study terminated - lack of enrollment|0|||
27835018|NCT01692275|54319575|FG000|Overall Study|Lost to Follow-up|57|||
27835019|NCT01692275|54319576|FG001|Overall Study|Lost to Follow-up|48|||
27835020|NCT01692275|54319575|FG000|Overall Study|Withdrawal by Subject|9|||
27835021|NCT01692275|54319576|FG001|Overall Study|Withdrawal by Subject|11|||
27835022|NCT02692560|54319596|FG000|Overall Study|Withdrawal by Subject|0|||
27835023|NCT02692560|54319597|FG001|Overall Study|Withdrawal by Subject|6|||
28171370|NCT02471716|54842933|FG001|Overall Study|Other|0|||
27835024|NCT02688192|54319605|FG000|Overall Study|Lost to Follow-up|11|||
27835025|NCT02688192|54319606|FG001|Overall Study|Lost to Follow-up|5|||
27865348|NCT02326272|54447688|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
27865349|NCT02326272|54447689|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27865350|NCT02326272|54447690|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
27865351|NCT02326272|54447691|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27865352|NCT02326272|54447692|FG014|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
27865353|NCT02326272|54447678|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27865354|NCT02326272|54447679|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27865355|NCT02326272|54447680|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27865356|NCT02326272|54447681|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27865357|NCT02326272|54447682|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27865358|NCT02326272|54447683|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27865359|NCT02326272|54447684|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27865360|NCT02326272|54447685|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27865361|NCT02326272|54447686|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27865362|NCT02326272|54447687|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27865363|NCT02326272|54447688|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27865364|NCT02326272|54447689|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
27865365|NCT02326272|54447690|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27865366|NCT02326272|54447691|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27865367|NCT02326272|54447692|FG014|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
27865368|NCT02326272|54447678|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
27865369|NCT02326272|54447679|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
27865370|NCT02326272|54447680|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
27865371|NCT02326272|54447681|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
27865372|NCT02326272|54447682|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
27865373|NCT02326272|54447683|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
27865374|NCT02326272|54447684|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
27865375|NCT02326272|54447685|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
27865376|NCT02326272|54447686|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
27865377|NCT02326272|54447687|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
27865378|NCT02326272|54447688|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
27865379|NCT02326272|54447689|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1|||
27865380|NCT02326272|54447690|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
27865381|NCT02326272|54447691|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
27865382|NCT02326272|54447692|FG014|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
27865383|NCT02326272|54447678|FG000|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
27865384|NCT02326272|54447679|FG001|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
27865385|NCT02326272|54447680|FG002|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
27865386|NCT02326272|54447681|FG003|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
27865387|NCT02326272|54447682|FG004|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
27865388|NCT02326272|54447683|FG005|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
27865389|NCT02326272|54447684|FG006|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
27865390|NCT02326272|54447685|FG007|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
27865391|NCT02326272|54447686|FG008|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
27865392|NCT02326272|54447687|FG009|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
27865393|NCT02326272|54447688|FG010|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
27865394|NCT02326272|54447689|FG011|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1|||
27865395|NCT02326272|54447690|FG012|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
27865396|NCT02326272|54447691|FG013|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
27865397|NCT02326272|54447692|FG014|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
27865398|NCT02326272|54447678|FG000|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
27865399|NCT02326272|54447679|FG001|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
27865400|NCT02326272|54447680|FG002|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
27865401|NCT02326272|54447681|FG003|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
27865402|NCT02326272|54447682|FG004|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
27865403|NCT02326272|54447683|FG005|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
27865404|NCT02326272|54447684|FG006|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
27865405|NCT02326272|54447685|FG007|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
27865406|NCT02326272|54447686|FG008|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
27865407|NCT02326272|54447687|FG009|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
27865408|NCT02326272|54447688|FG010|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
27865409|NCT02326272|54447689|FG011|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
27865410|NCT02326272|54447690|FG012|Open-label Period (Week 48 to Week 144)|Pregnancy|1|||
27865411|NCT02326272|54447691|FG013|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
28171371|NCT02471716|54842934|FG002|Overall Study|Other|0|||
28171372|NCT02471716|54842935|FG003|Overall Study|Other|8|||
27835026|NCT02688192|54319605|FG000|Overall Study|Physician Decision|1|||
27835027|NCT02688192|54319606|FG001|Overall Study|Physician Decision|0|||
27835028|NCT01579565|54319615|FG000|Randomized|Adverse Event|1|||
27835029|NCT01579565|54319616|FG001|Randomized|Adverse Event|3|||
27835030|NCT01579565|54319615|FG000|Randomized|Withdrawal by Subject|3|||
27835031|NCT01579565|54319616|FG001|Randomized|Withdrawal by Subject|0|||
27835032|NCT01579565|54319615|FG000|Randomized|inadequate preoperative pupil dilation|0|||
27835033|NCT01579565|54319616|FG001|Randomized|inadequate preoperative pupil dilation|1|||
27835034|NCT01579565|54319615|FG000|Randomized|prohibited preoperative eating|1|||
27835035|NCT01579565|54319616|FG001|Randomized|prohibited preoperative eating|0|||
27835036|NCT01579565|54319615|FG000|Randomized|prohibited preoperative medication|0|||
27835037|NCT01579565|54319616|FG001|Randomized|prohibited preoperative medication|1|||
27835038|NCT01579565|54319615|FG000|Treated|Physician Decision|0|||
27835039|NCT01579565|54319616|FG001|Treated|Physician Decision|1|||
27835040|NCT01579565|54319615|FG000|Treated|Lost to Follow-up|2|||
27835041|NCT01579565|54319616|FG001|Treated|Lost to Follow-up|1|||
27835042|NCT01579565|54319615|FG000|Treated|declined to return for final visit|0|||
27835043|NCT01579565|54319616|FG001|Treated|declined to return for final visit|1|||
27835044|NCT01578785|54319626|FG000|Overall Study|Withdrawal by Subject|0|||
27835045|NCT01578785|54319627|FG001|Overall Study|Withdrawal by Subject|1|||
27835046|NCT01578785|54319626|FG000|Overall Study|Study terminated by sponsor|59|||
27835047|NCT01578785|54319627|FG001|Overall Study|Study terminated by sponsor|118|||
27835048|NCT02692482|54319635|FG000|Overall Study|Death|2|||
27835049|NCT02692482|54319636|FG001|Overall Study|Death|2|||
27835050|NCT02692482|54319635|FG000|Overall Study|Withdrawal by Subject|1|||
27835051|NCT02692482|54319636|FG001|Overall Study|Withdrawal by Subject|2|||
27835052|NCT01578551|54319645|FG000|Overall Study|Adverse Event|1|||
27835053|NCT01578551|54319646|FG001|Overall Study|Adverse Event|0|||
27835054|NCT01692197|54319653|FG000|Overall Study|Failed Screening|3|||
27835055|NCT01692119|54319660|FG000|Overall Study|Protocol Violation|3|||
27835056|NCT01692119|54319661|FG001|Overall Study|Protocol Violation|1|||
27835057|NCT01692119|54319660|FG000|Overall Study|Intervention: pts. did not present to participating pharmacy|17|||
27835058|NCT01692119|54319661|FG001|Overall Study|Intervention: pts. did not present to participating pharmacy|0|||
27835059|NCT01691885|54319667|FG000|Treatment Period 1(7-14 Days)|Adverse Event|1|||
27835060|NCT01691885|54319668|FG001|Treatment Period 1(7-14 Days)|Adverse Event|1|||
27835061|NCT01691885|54319667|FG000|Washout Period (7-9 Days)|Adverse Event|0|||
27835062|NCT01691885|54319668|FG001|Washout Period (7-9 Days)|Adverse Event|1|||
27835063|NCT01587703|54319701|FG000|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1|||
27835064|NCT01587703|54319702|FG001|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
27835065|NCT01587703|54319703|FG002|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
27835066|NCT01587703|54319704|FG003|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
27835067|NCT01587703|54319705|FG004|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
27835068|NCT01587703|54319706|FG005|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
27835069|NCT01587703|54319707|FG006|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
27835070|NCT01587703|54319708|FG007|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
27835071|NCT01587703|54319709|FG008|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
27835072|NCT01587703|54319710|FG009|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
27835073|NCT01587703|54319711|FG010|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
27835074|NCT01587703|54319712|FG011|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
27835075|NCT01587703|54319713|FG012|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
27835076|NCT01587703|54319714|FG013|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
27835077|NCT01587703|54319715|FG014|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
27835078|NCT01587703|54319716|FG015|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
27835079|NCT01587703|54319717|FG016|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
27835080|NCT01587703|54319718|FG017|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
27835081|NCT01587703|54319719|FG018|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
27835082|NCT01587703|54319701|FG000|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
27835083|NCT01587703|54319702|FG001|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
27835084|NCT01587703|54319703|FG002|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
27835085|NCT01587703|54319704|FG003|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
27835086|NCT01587703|54319705|FG004|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
27835087|NCT01587703|54319706|FG005|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1|||
27835088|NCT01587703|54319707|FG006|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
27835089|NCT01587703|54319708|FG007|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2|||
27835090|NCT01587703|54319709|FG008|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
27835091|NCT01587703|54319710|FG009|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
27835092|NCT01587703|54319711|FG010|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
27865412|NCT02326272|54447692|FG014|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
27865413|NCT02325414|54447729|FG000|Overall Study|Withdrawal by Subject|3|||
27865414|NCT02325414|54447730|FG001|Overall Study|Withdrawal by Subject|1|||
27865415|NCT02325414|54447729|FG000|Overall Study|Lost to Follow-up|5|||
27865416|NCT02325414|54447730|FG001|Overall Study|Lost to Follow-up|5|||
27865417|NCT02349048|54447748|FG000|Overall Study|Withdrawal by Subject|4|||
27865418|NCT02349048|54447749|FG001|Overall Study|Withdrawal by Subject|0|||
27865419|NCT02349048|54447748|FG000|Overall Study|Lost to Follow-up|1|||
27865420|NCT02349048|54447749|FG001|Overall Study|Lost to Follow-up|0|||
27865421|NCT02299206|54447796|FG000|Overall Study|Lost to Follow-up|1|||
27865422|NCT02299206|54447796|FG000|Overall Study|Withdrawal by Subject|1|||
27865423|NCT02298192|54447815|FG000|Overall Study|Unclassified|3|||
27865424|NCT02298192|54447816|FG001|Overall Study|Unclassified|2|||
27865425|NCT02298192|54447815|FG000|Overall Study|Withdrawal criteria|2|||
27865426|NCT02298192|54447816|FG001|Overall Study|Withdrawal criteria|0|||
27865427|NCT02298192|54447815|FG000|Overall Study|Withdrawal by Subject|6|||
27865428|NCT02298192|54447816|FG001|Overall Study|Withdrawal by Subject|1|||
27865429|NCT02298192|54447815|FG000|Overall Study|Lost to Follow-up|2|||
27865430|NCT02298192|54447816|FG001|Overall Study|Lost to Follow-up|1|||
27865431|NCT02298192|54447815|FG000|Overall Study|Adverse Event|6|||
27865432|NCT02298192|54447816|FG001|Overall Study|Adverse Event|2|||
27865433|NCT02280408|54447942|FG000|Overall Study|Lost to Follow-up|0|||
27865434|NCT02280408|54447943|FG001|Overall Study|Lost to Follow-up|2|||
27865435|NCT02280408|54447944|FG002|Overall Study|Lost to Follow-up|0|||
27865436|NCT02280408|54447945|FG003|Overall Study|Lost to Follow-up|0|||
27865437|NCT02296476|54448021|FG000|Overall Study|Disease Progression|6|||
27865438|NCT02296476|54448022|FG001|Overall Study|Disease Progression|4|||
27865439|NCT02296476|54448023|FG002|Overall Study|Disease Progression|2|||
27865440|NCT00552032|54448064|FG000|Overall Study|Withdrawal by Subject|2|||
27865441|NCT00552032|54448065|FG001|Overall Study|Withdrawal by Subject|2|||
27865442|NCT00552032|54448064|FG000|Overall Study|Protocol Violation|7|||
27865443|NCT00552032|54448065|FG001|Overall Study|Protocol Violation|12|||
27865444|NCT00552032|54448064|FG000|Overall Study|Lost to Follow-up|8|||
27865445|NCT00552032|54448065|FG001|Overall Study|Lost to Follow-up|5|||
27865446|NCT02988817|54448825|FG000|Overall Study|Withdrawal by Subject|1|||
27865447|NCT02988817|54448826|FG001|Overall Study|Withdrawal by Subject|0|||
27865448|NCT02988817|54448827|FG002|Overall Study|Withdrawal by Subject|0|||
27865449|NCT02988817|54448828|FG003|Overall Study|Withdrawal by Subject|1|||
27865450|NCT02988817|54448829|FG004|Overall Study|Withdrawal by Subject|3|||
27865451|NCT02988817|54448830|FG005|Overall Study|Withdrawal by Subject|1|||
27865452|NCT02988817|54448831|FG006|Overall Study|Withdrawal by Subject|2|||
27865453|NCT02988817|54448832|FG007|Overall Study|Withdrawal by Subject|1|||
27865454|NCT02988817|54448833|FG008|Overall Study|Withdrawal by Subject|1|||
27865455|NCT02988817|54448834|FG009|Overall Study|Withdrawal by Subject|1|||
27865456|NCT02988817|54448835|FG010|Overall Study|Withdrawal by Subject|1|||
27865457|NCT02988817|54448836|FG011|Overall Study|Withdrawal by Subject|12|||
27865458|NCT02988817|54448837|FG012|Overall Study|Withdrawal by Subject|6|||
27865459|NCT02988817|54448838|FG013|Overall Study|Withdrawal by Subject|6|||
27865460|NCT02988817|54448839|FG014|Overall Study|Withdrawal by Subject|4|||
27865461|NCT02988817|54448840|FG015|Overall Study|Withdrawal by Subject|5|||
27865462|NCT02988817|54448841|FG016|Overall Study|Withdrawal by Subject|4|||
27865463|NCT02988817|54448842|FG017|Overall Study|Withdrawal by Subject|11|||
27865464|NCT02988817|54448843|FG018|Overall Study|Withdrawal by Subject|4|||
27865465|NCT02988817|54448844|FG019|Overall Study|Withdrawal by Subject|2|||
27865466|NCT02988817|54448825|FG000|Overall Study|Death|0|||
27865467|NCT02988817|54448826|FG001|Overall Study|Death|1|||
27865468|NCT02988817|54448827|FG002|Overall Study|Death|3|||
27982143|NCT03856593|54640164|FG001|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|16|||
27865469|NCT02988817|54448828|FG003|Overall Study|Death|1|||
27865470|NCT02988817|54448829|FG004|Overall Study|Death|6|||
27865471|NCT02988817|54448830|FG005|Overall Study|Death|10|||
27865472|NCT02988817|54448831|FG006|Overall Study|Death|1|||
27865473|NCT02988817|54448832|FG007|Overall Study|Death|2|||
27865474|NCT02988817|54448833|FG008|Overall Study|Death|1|||
27865475|NCT02988817|54448834|FG009|Overall Study|Death|5|||
27865476|NCT02988817|54448835|FG010|Overall Study|Death|1|||
27865477|NCT02988817|54448836|FG011|Overall Study|Death|8|||
27865478|NCT02988817|54448837|FG012|Overall Study|Death|9|||
27865479|NCT02988817|54448838|FG013|Overall Study|Death|17|||
27865480|NCT02988817|54448839|FG014|Overall Study|Death|18|||
27865481|NCT02988817|54448840|FG015|Overall Study|Death|30|||
27865482|NCT02988817|54448841|FG016|Overall Study|Death|17|||
27865483|NCT02988817|54448842|FG017|Overall Study|Death|38|||
27865484|NCT02988817|54448843|FG018|Overall Study|Death|14|||
27865485|NCT02988817|54448844|FG019|Overall Study|Death|16|||
27865486|NCT02988817|54448825|FG000|Overall Study|Other|0|||
27865487|NCT02988817|54448826|FG001|Overall Study|Other|0|||
27865488|NCT02988817|54448827|FG002|Overall Study|Other|0|||
27865489|NCT02988817|54448828|FG003|Overall Study|Other|1|||
27865490|NCT02988817|54448829|FG004|Overall Study|Other|1|||
27865491|NCT02988817|54448830|FG005|Overall Study|Other|0|||
27865492|NCT02988817|54448831|FG006|Overall Study|Other|0|||
27865493|NCT02988817|54448832|FG007|Overall Study|Other|0|||
27865494|NCT02988817|54448833|FG008|Overall Study|Other|0|||
27865495|NCT02988817|54448834|FG009|Overall Study|Other|0|||
27865496|NCT02988817|54448835|FG010|Overall Study|Other|0|||
27865497|NCT02988817|54448836|FG011|Overall Study|Other|0|||
27865498|NCT02988817|54448837|FG012|Overall Study|Other|0|||
27865499|NCT02988817|54448838|FG013|Overall Study|Other|0|||
27865500|NCT02988817|54448839|FG014|Overall Study|Other|0|||
27865501|NCT02988817|54448840|FG015|Overall Study|Other|1|||
27865502|NCT02988817|54448841|FG016|Overall Study|Other|0|||
27865503|NCT02988817|54448842|FG017|Overall Study|Other|0|||
27865504|NCT02988817|54448843|FG018|Overall Study|Other|0|||
27865505|NCT02988817|54448844|FG019|Overall Study|Other|0|||
27865506|NCT02988817|54448825|FG000|Overall Study|Lost to Follow-up|0|||
27865507|NCT02988817|54448826|FG001|Overall Study|Lost to Follow-up|0|||
27865508|NCT02988817|54448827|FG002|Overall Study|Lost to Follow-up|0|||
27865509|NCT02988817|54448828|FG003|Overall Study|Lost to Follow-up|0|||
27865510|NCT02988817|54448829|FG004|Overall Study|Lost to Follow-up|0|||
27865511|NCT02988817|54448830|FG005|Overall Study|Lost to Follow-up|0|||
27865512|NCT02988817|54448831|FG006|Overall Study|Lost to Follow-up|0|||
27865513|NCT02988817|54448832|FG007|Overall Study|Lost to Follow-up|0|||
27865514|NCT02988817|54448833|FG008|Overall Study|Lost to Follow-up|1|||
27865515|NCT02988817|54448834|FG009|Overall Study|Lost to Follow-up|0|||
27865516|NCT02988817|54448835|FG010|Overall Study|Lost to Follow-up|1|||
27865517|NCT02988817|54448836|FG011|Overall Study|Lost to Follow-up|1|||
27865518|NCT02988817|54448837|FG012|Overall Study|Lost to Follow-up|0|||
27865519|NCT02988817|54448838|FG013|Overall Study|Lost to Follow-up|0|||
27865520|NCT02988817|54448839|FG014|Overall Study|Lost to Follow-up|1|||
27865521|NCT02988817|54448840|FG015|Overall Study|Lost to Follow-up|1|||
27865522|NCT02988817|54448841|FG016|Overall Study|Lost to Follow-up|2|||
27865523|NCT02988817|54448842|FG017|Overall Study|Lost to Follow-up|3|||
27865524|NCT02988817|54448843|FG018|Overall Study|Lost to Follow-up|0|||
27865525|NCT02988817|54448844|FG019|Overall Study|Lost to Follow-up|0|||
27865526|NCT02988817|54448825|FG000|Overall Study|Sponsor decision|0|||
27865527|NCT02988817|54448826|FG001|Overall Study|Sponsor decision|0|||
27865528|NCT02988817|54448827|FG002|Overall Study|Sponsor decision|0|||
27865529|NCT02988817|54448828|FG003|Overall Study|Sponsor decision|0|||
27865530|NCT02988817|54448829|FG004|Overall Study|Sponsor decision|0|||
27865531|NCT02988817|54448830|FG005|Overall Study|Sponsor decision|0|||
27865532|NCT02988817|54448831|FG006|Overall Study|Sponsor decision|0|||
27865533|NCT02988817|54448832|FG007|Overall Study|Sponsor decision|0|||
27865534|NCT02988817|54448833|FG008|Overall Study|Sponsor decision|0|||
27865535|NCT02988817|54448834|FG009|Overall Study|Sponsor decision|0|||
27865536|NCT02988817|54448835|FG010|Overall Study|Sponsor decision|0|||
27865537|NCT02988817|54448836|FG011|Overall Study|Sponsor decision|1|||
27865538|NCT02988817|54448837|FG012|Overall Study|Sponsor decision|1|||
27865539|NCT02988817|54448838|FG013|Overall Study|Sponsor decision|2|||
27865540|NCT02988817|54448839|FG014|Overall Study|Sponsor decision|2|||
27865541|NCT02988817|54448840|FG015|Overall Study|Sponsor decision|6|||
27865542|NCT02988817|54448841|FG016|Overall Study|Sponsor decision|2|||
27865543|NCT02988817|54448842|FG017|Overall Study|Sponsor decision|3|||
27865544|NCT02988817|54448843|FG018|Overall Study|Sponsor decision|2|||
27865545|NCT02988817|54448844|FG019|Overall Study|Sponsor decision|7|||
27865546|NCT02988817|54448825|FG000|Overall Study|Physician Decision|0|||
27865547|NCT02988817|54448826|FG001|Overall Study|Physician Decision|0|||
27865548|NCT02988817|54448827|FG002|Overall Study|Physician Decision|0|||
27865549|NCT02988817|54448828|FG003|Overall Study|Physician Decision|0|||
27865550|NCT02988817|54448829|FG004|Overall Study|Physician Decision|0|||
27865551|NCT02988817|54448830|FG005|Overall Study|Physician Decision|0|||
27865552|NCT02988817|54448831|FG006|Overall Study|Physician Decision|0|||
27865553|NCT02988817|54448832|FG007|Overall Study|Physician Decision|0|||
27865554|NCT02988817|54448833|FG008|Overall Study|Physician Decision|0|||
27865555|NCT02988817|54448834|FG009|Overall Study|Physician Decision|0|||
27865556|NCT02988817|54448835|FG010|Overall Study|Physician Decision|0|||
27865557|NCT02988817|54448836|FG011|Overall Study|Physician Decision|0|||
27865558|NCT02988817|54448837|FG012|Overall Study|Physician Decision|0|||
27865559|NCT02988817|54448838|FG013|Overall Study|Physician Decision|0|||
27865560|NCT02988817|54448839|FG014|Overall Study|Physician Decision|0|||
27865561|NCT02988817|54448840|FG015|Overall Study|Physician Decision|1|||
27865562|NCT02988817|54448841|FG016|Overall Study|Physician Decision|0|||
27865563|NCT02988817|54448842|FG017|Overall Study|Physician Decision|0|||
27865564|NCT02988817|54448843|FG018|Overall Study|Physician Decision|1|||
27865565|NCT02988817|54448844|FG019|Overall Study|Physician Decision|1|||
27865566|NCT03312530|54448968|FG000|Overall Study|Death|5|||
27865567|NCT03312530|54448969|FG001|Overall Study|Death|5|||
27865568|NCT03312530|54448970|FG002|Overall Study|Death|4|||
27865569|NCT03312530|54448971|FG003|Overall Study|Death|10|||
27865570|NCT03312530|54448972|FG004|Overall Study|Death|8|||
27865571|NCT03312530|54448968|FG000|Overall Study|Lost to Follow-up|0|||
27865572|NCT03312530|54448969|FG001|Overall Study|Lost to Follow-up|0|||
27865573|NCT03312530|54448970|FG002|Overall Study|Lost to Follow-up|0|||
27865574|NCT03312530|54448971|FG003|Overall Study|Lost to Follow-up|1|||
27865575|NCT03312530|54448972|FG004|Overall Study|Lost to Follow-up|0|||
27865576|NCT03312530|54448968|FG000|Overall Study|Participant in another sponsor study.|0|||
27865577|NCT03312530|54448969|FG001|Overall Study|Participant in another sponsor study.|0|||
27865578|NCT03312530|54448970|FG002|Overall Study|Participant in another sponsor study.|0|||
27865579|NCT03312530|54448971|FG003|Overall Study|Participant in another sponsor study.|1|||
27865580|NCT03312530|54448972|FG004|Overall Study|Participant in another sponsor study.|0|||
27865581|NCT03312530|54448968|FG000|Overall Study|Study terminated by sponsor|1|||
27865582|NCT03312530|54448969|FG001|Overall Study|Study terminated by sponsor|0|||
27865583|NCT03312530|54448970|FG002|Overall Study|Study terminated by sponsor|2|||
27865584|NCT03312530|54448971|FG003|Overall Study|Study terminated by sponsor|3|||
27865585|NCT03312530|54448972|FG004|Overall Study|Study terminated by sponsor|7|||
27865586|NCT03312530|54448968|FG000|Overall Study|Withdrawal by Subject|0|||
27865587|NCT03312530|54448969|FG001|Overall Study|Withdrawal by Subject|1|||
27865588|NCT03312530|54448970|FG002|Overall Study|Withdrawal by Subject|0|||
27865589|NCT03312530|54448971|FG003|Overall Study|Withdrawal by Subject|0|||
27865590|NCT03312530|54448972|FG004|Overall Study|Withdrawal by Subject|0|||
27865591|NCT03312530|54448968|FG000|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
27865592|NCT03312530|54448969|FG001|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
27865593|NCT03312530|54448970|FG002|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
27865594|NCT03312530|54448971|FG003|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|1|||
27865595|NCT03312530|54448972|FG004|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
27865596|NCT02296320|54449103|FG000|Overall Study|Withdrawal by Subject|4|||
27865597|NCT02296320|54449104|FG001|Overall Study|Withdrawal by Subject|0|||
27865598|NCT02296320|54449105|FG002|Overall Study|Withdrawal by Subject|2|||
27865599|NCT02296320|54449103|FG000|Overall Study|Death|24|||
27738971|NCT02240680|54188244|FG001|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1|||
27738972|NCT02240680|54188245|FG002|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
27865600|NCT02296320|54449104|FG001|Overall Study|Death|3|||
27865601|NCT02296320|54449105|FG002|Overall Study|Death|27|||
27865602|NCT02296320|54449103|FG000|Overall Study|Lost to Follow-up|5|||
27865603|NCT02296320|54449104|FG001|Overall Study|Lost to Follow-up|2|||
27865604|NCT02296320|54449105|FG002|Overall Study|Lost to Follow-up|7|||
27865605|NCT02296320|54449103|FG000|Overall Study|Not treated|2|||
27865606|NCT02296320|54449104|FG001|Overall Study|Not treated|0|||
27865607|NCT02296320|54449105|FG002|Overall Study|Not treated|0|||
27865608|NCT02296320|54449103|FG000|Overall Study|Not - specified|0|||
27865609|NCT02296320|54449104|FG001|Overall Study|Not - specified|0|||
27865610|NCT02296320|54449105|FG002|Overall Study|Not - specified|1|||
27865611|NCT02296242|54449144|FG000|Overall Study|Death|1|||
27982144|NCT03785925|54640172|FG000|Overall Study|Withdrawal by Subject|15|||
27982145|NCT03785925|54640172|FG000|Overall Study|Lost to Follow-up|1|||
27982146|NCT03427411|54640183|FG000|Overall Study|Screen failure - platelets too low|0|||
27982147|NCT03427411|54640184|FG001|Overall Study|Screen failure - platelets too low|1|||
27982148|NCT03330106|54640192|FG000|Part A|Withdrawal by Subject|1|||
27982149|NCT03330106|54640193|FG001|Part A|Withdrawal by Subject|1|||
27982150|NCT03330106|54640194|FG002|Part A|Withdrawal by Subject|0|||
27982151|NCT03330106|54640195|FG003|Part A|Withdrawal by Subject|0|||
27982152|NCT03330106|54640192|FG000|Part A|Death|2|||
27982153|NCT03330106|54640193|FG001|Part A|Death|1|||
27982154|NCT03330106|54640194|FG002|Part A|Death|0|||
27982155|NCT03330106|54640195|FG003|Part A|Death|0|||
27982156|NCT03330106|54640192|FG000|Part A|Adverse Event|0|||
27982157|NCT03330106|54640193|FG001|Part A|Adverse Event|1|||
27982158|NCT03330106|54640194|FG002|Part A|Adverse Event|0|||
27982159|NCT03330106|54640195|FG003|Part A|Adverse Event|0|||
27982160|NCT03330106|54640192|FG000|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
27982161|NCT03330106|54640193|FG001|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|1|||
27982162|NCT03330106|54640194|FG002|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
27982163|NCT03330106|54640195|FG003|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
27982164|NCT03330106|54640192|FG000|Part A|Worsening Creatinine Clearance and Thrombocytopenia|1|||
28096229|NCT04533204|54751057|FG000|Overall Study|Unable to understand training instructions|1|||
27982165|NCT03330106|54640193|FG001|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
28096230|NCT04533204|54751058|FG001|Overall Study|Unable to understand training instructions|1|||
28096231|NCT04465422|54751066|FG000|Overall Study|Lost to Follow-up|0|||
27865612|NCT02296242|54449145|FG001|Overall Study|Death|1|||
27865613|NCT02296242|54449146|FG002|Overall Study|Death|1|||
27865614|NCT02296242|54449147|FG003|Overall Study|Death|1|||
27865615|NCT02296242|54449148|FG004|Overall Study|Death|1|||
27865616|NCT02296242|54449144|FG000|Overall Study|Withdrawal by Subject|0|||
27865617|NCT02296242|54449145|FG001|Overall Study|Withdrawal by Subject|0|||
27865618|NCT02296242|54449146|FG002|Overall Study|Withdrawal by Subject|1|||
27865619|NCT02296242|54449147|FG003|Overall Study|Withdrawal by Subject|1|||
27865620|NCT02296242|54449148|FG004|Overall Study|Withdrawal by Subject|3|||
27865621|NCT02296242|54449144|FG000|Overall Study|Disease Progression|1|||
27865622|NCT02296242|54449145|FG001|Overall Study|Disease Progression|3|||
27865623|NCT02296242|54449146|FG002|Overall Study|Disease Progression|2|||
27865624|NCT02296242|54449147|FG003|Overall Study|Disease Progression|8|||
27865625|NCT02296242|54449148|FG004|Overall Study|Disease Progression|11|||
27865626|NCT02296242|54449144|FG000|Overall Study|Unacceptable Toxicity|0|||
27865627|NCT02296242|54449145|FG001|Overall Study|Unacceptable Toxicity|0|||
27865628|NCT02296242|54449146|FG002|Overall Study|Unacceptable Toxicity|0|||
27865629|NCT02296242|54449147|FG003|Overall Study|Unacceptable Toxicity|0|||
27865630|NCT02296242|54449148|FG004|Overall Study|Unacceptable Toxicity|1|||
27865631|NCT02296242|54449144|FG000|Overall Study|Patient Condition Changed|0|||
27865632|NCT02296242|54449145|FG001|Overall Study|Patient Condition Changed|0|||
27865633|NCT02296242|54449146|FG002|Overall Study|Patient Condition Changed|2|||
27865634|NCT02296242|54449147|FG003|Overall Study|Patient Condition Changed|0|||
27865635|NCT02296242|54449148|FG004|Overall Study|Patient Condition Changed|1|||
27865636|NCT02296242|54449144|FG000|Overall Study|At Least 3 Drug Interruptions|0|||
27865637|NCT02296242|54449145|FG001|Overall Study|At Least 3 Drug Interruptions|0|||
27865638|NCT02296242|54449146|FG002|Overall Study|At Least 3 Drug Interruptions|1|||
27865639|NCT02296242|54449147|FG003|Overall Study|At Least 3 Drug Interruptions|1|||
27865640|NCT02296242|54449148|FG004|Overall Study|At Least 3 Drug Interruptions|1|||
27865641|NCT02296242|54449144|FG000|Overall Study|Lost to Follow-up|1|||
27865642|NCT02296242|54449145|FG001|Overall Study|Lost to Follow-up|0|||
27865643|NCT02296242|54449146|FG002|Overall Study|Lost to Follow-up|0|||
28096232|NCT04465422|54751067|FG001|Overall Study|Lost to Follow-up|2|||
28096233|NCT04014062|54751077|FG000|Period I: Dosing|Medical Grounds|4|||
28096234|NCT04014062|54751078|FG001|Period I: Dosing|Medical Grounds|5|||
28096235|NCT04014062|54751077|FG000|Period I: Dosing|Withdrawal by Subject|3|||
28096236|NCT04014062|54751078|FG001|Period I: Dosing|Withdrawal by Subject|1|||
28096237|NCT04531098|54751092|FG000|Stage I|Adverse Event|0|||
28096238|NCT04531098|54751093|FG001|Stage I|Adverse Event|0|||
28096239|NCT04531098|54751094|FG002|Stage I|Adverse Event|3|||
28096240|NCT04531098|54751092|FG000|Stage I|Protocol Violation|0|||
28096241|NCT04531098|54751093|FG001|Stage I|Protocol Violation|0|||
28096242|NCT04531098|54751094|FG002|Stage I|Protocol Violation|5|||
28096243|NCT04531098|54751092|FG000|Stage I|Withdrawal by Subject|0|||
28096244|NCT04531098|54751093|FG001|Stage I|Withdrawal by Subject|5|||
28096245|NCT04531098|54751094|FG002|Stage I|Withdrawal by Subject|10|||
28096246|NCT04531098|54751092|FG000|Stage II|Adverse Event|1|||
28096247|NCT04531098|54751093|FG001|Stage II|Adverse Event|2|||
27865644|NCT02296242|54449147|FG003|Overall Study|Lost to Follow-up|0|||
27865645|NCT02296242|54449148|FG004|Overall Study|Lost to Follow-up|0|||
27865646|NCT02296242|54449144|FG000|Overall Study|Need for Hydroxyurea|2|||
27865647|NCT02296242|54449145|FG001|Overall Study|Need for Hydroxyurea|0|||
27865648|NCT02296242|54449146|FG002|Overall Study|Need for Hydroxyurea|0|||
27865649|NCT02296242|54449147|FG003|Overall Study|Need for Hydroxyurea|0|||
27865650|NCT02296242|54449148|FG004|Overall Study|Need for Hydroxyurea|0|||
27865651|NCT02296242|54449144|FG000|Overall Study|Screened for Other Protocol|0|||
27865652|NCT02296242|54449145|FG001|Overall Study|Screened for Other Protocol|1|||
27865653|NCT02296242|54449146|FG002|Overall Study|Screened for Other Protocol|0|||
27865654|NCT02296242|54449147|FG003|Overall Study|Screened for Other Protocol|0|||
27865655|NCT02296242|54449148|FG004|Overall Study|Screened for Other Protocol|0|||
27865656|NCT02296242|54449144|FG000|Overall Study|Physician Decision|0|||
27865657|NCT02296242|54449145|FG001|Overall Study|Physician Decision|1|||
27865658|NCT02296242|54449146|FG002|Overall Study|Physician Decision|0|||
27865659|NCT02296242|54449147|FG003|Overall Study|Physician Decision|1|||
27865660|NCT02296242|54449148|FG004|Overall Study|Physician Decision|0|||
27865661|NCT02296242|54449144|FG000|Overall Study|Alternative Treatment|0|||
27865662|NCT02296242|54449145|FG001|Overall Study|Alternative Treatment|0|||
27865663|NCT02296242|54449146|FG002|Overall Study|Alternative Treatment|0|||
27865664|NCT02296242|54449147|FG003|Overall Study|Alternative Treatment|1|||
27865665|NCT02296242|54449148|FG004|Overall Study|Alternative Treatment|0|||
27865666|NCT02296242|54449144|FG000|Overall Study|Adverse Event|0|||
27865667|NCT02296242|54449145|FG001|Overall Study|Adverse Event|0|||
27865668|NCT02296242|54449146|FG002|Overall Study|Adverse Event|0|||
27865669|NCT02296242|54449147|FG003|Overall Study|Adverse Event|1|||
27865670|NCT02296242|54449148|FG004|Overall Study|Adverse Event|0|||
27865671|NCT02296242|54449144|FG000|Overall Study|Lack of Efficacy|0|||
27865672|NCT02296242|54449145|FG001|Overall Study|Lack of Efficacy|0|||
27865673|NCT02296242|54449146|FG002|Overall Study|Lack of Efficacy|0|||
27865674|NCT02296242|54449147|FG003|Overall Study|Lack of Efficacy|0|||
27865675|NCT02296242|54449148|FG004|Overall Study|Lack of Efficacy|3|||
27865676|NCT02295774|54449168|FG000|Overall Study|Physician Decision|1|||
27865677|NCT02295774|54449168|FG000|Overall Study|Withdrawal by Subject|2|||
28096248|NCT04531098|54751094|FG002|Stage II|Adverse Event|0|||
28096249|NCT04531098|54751092|FG000|Stage II|Protocol Violation|1|||
28096250|NCT04531098|54751093|FG001|Stage II|Protocol Violation|2|||
27865678|NCT02294682|54449183|FG000|Overall Study|Could not swallow pills|1|||
27865679|NCT02294682|54449184|FG001|Overall Study|Could not swallow pills|0|||
27865680|NCT02294604|54449193|FG000|Overall Study|Did not provide samples for culture|0|||
27865681|NCT02294604|54449194|FG001|Overall Study|Did not provide samples for culture|1|||
27865682|NCT02294604|54449195|FG002|Overall Study|Did not provide samples for culture|0|||
27865683|NCT02294604|54449193|FG000|Overall Study|Culture contamination|1|||
27865684|NCT02294604|54449194|FG001|Overall Study|Culture contamination|2|||
27865685|NCT02294604|54449195|FG002|Overall Study|Culture contamination|0|||
27865686|NCT01645176|54449214|FG000|Overall Study|Lack of Efficacy|4|||
27865687|NCT01645176|54449214|FG000|Overall Study|did not complete final MRI|1|||
27865688|NCT02322216|54449229|FG000|Overall Study|Adverse Event|1|||
27865689|NCT02322216|54449230|FG001|Overall Study|Adverse Event|0|||
27865690|NCT02322216|54449229|FG000|Overall Study|Withdrawal by Subject|1|||
27865691|NCT02322216|54449230|FG001|Overall Study|Withdrawal by Subject|4|||
27865692|NCT01647516|54449271|FG000|Induction Period (IP)|Physician Decision|2|||
27865693|NCT01647516|54449272|FG001|Induction Period (IP)|Physician Decision|0|||
27865694|NCT01647516|54449273|FG002|Induction Period (IP)|Physician Decision|0|||
27865695|NCT01647516|54449274|FG003|Induction Period (IP)|Physician Decision|0|||
27865696|NCT01647516|54449275|FG004|Induction Period (IP)|Physician Decision|0|||
27865697|NCT01647516|54449276|FG005|Induction Period (IP)|Physician Decision|0|||
27865698|NCT01647516|54449271|FG000|Induction Period (IP)|Adverse Event|1|||
27865699|NCT01647516|54449272|FG001|Induction Period (IP)|Adverse Event|2|||
27865700|NCT01647516|54449273|FG002|Induction Period (IP)|Adverse Event|0|||
27865701|NCT01647516|54449274|FG003|Induction Period (IP)|Adverse Event|0|||
27865702|NCT01647516|54449275|FG004|Induction Period (IP)|Adverse Event|0|||
27865703|NCT01647516|54449276|FG005|Induction Period (IP)|Adverse Event|0|||
27865704|NCT01647516|54449271|FG000|Induction Period (IP)|Withdrawal by Subject|1|||
27865705|NCT01647516|54449272|FG001|Induction Period (IP)|Withdrawal by Subject|0|||
27865706|NCT01647516|54449273|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
27865707|NCT01647516|54449274|FG003|Induction Period (IP)|Withdrawal by Subject|0|||
27865708|NCT01647516|54449275|FG004|Induction Period (IP)|Withdrawal by Subject|0|||
27865709|NCT01647516|54449276|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
27865710|NCT01647516|54449271|FG000|Induction Period (IP)|Participant Choice|0|||
27865711|NCT01647516|54449272|FG001|Induction Period (IP)|Participant Choice|0|||
27865712|NCT01647516|54449273|FG002|Induction Period (IP)|Participant Choice|1|||
27865713|NCT01647516|54449274|FG003|Induction Period (IP)|Participant Choice|0|||
27865714|NCT01647516|54449275|FG004|Induction Period (IP)|Participant Choice|0|||
27865715|NCT01647516|54449276|FG005|Induction Period (IP)|Participant Choice|0|||
27865716|NCT01647516|54449271|FG000|Induction Period (IP)|Lack of Efficacy|1|||
27865717|NCT01647516|54449272|FG001|Induction Period (IP)|Lack of Efficacy|0|||
27865718|NCT01647516|54449273|FG002|Induction Period (IP)|Lack of Efficacy|0|||
27865719|NCT01647516|54449274|FG003|Induction Period (IP)|Lack of Efficacy|0|||
27865720|NCT01647516|54449275|FG004|Induction Period (IP)|Lack of Efficacy|0|||
27865721|NCT01647516|54449276|FG005|Induction Period (IP)|Lack of Efficacy|0|||
27865722|NCT01647516|54449271|FG000|Induction Period (IP)|No study drug received|1|||
27865723|NCT01647516|54449272|FG001|Induction Period (IP)|No study drug received|1|||
27865724|NCT01647516|54449273|FG002|Induction Period (IP)|No study drug received|0|||
27865725|NCT01647516|54449274|FG003|Induction Period (IP)|No study drug received|0|||
27865726|NCT01647516|54449275|FG004|Induction Period (IP)|No study drug received|0|||
27865727|NCT01647516|54449276|FG005|Induction Period (IP)|No study drug received|0|||
27865728|NCT01647516|54449271|FG000|Maintenance Period (MP)|Adverse Event|2|||
27865729|NCT01647516|54449272|FG001|Maintenance Period (MP)|Adverse Event|1|||
27982166|NCT03330106|54640194|FG002|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
27982167|NCT03330106|54640195|FG003|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
28096251|NCT04531098|54751094|FG002|Stage II|Protocol Violation|0|||
28096252|NCT04531098|54751092|FG000|Stage II|Withdrawal by Subject|3|||
28096253|NCT04531098|54751093|FG001|Stage II|Withdrawal by Subject|1|||
28096254|NCT04531098|54751094|FG002|Stage II|Withdrawal by Subject|0|||
28096255|NCT04531098|54751092|FG000|Stage II|Moved from study area|8|||
28096256|NCT04531098|54751093|FG001|Stage II|Moved from study area|5|||
28096257|NCT04531098|54751094|FG002|Stage II|Moved from study area|0|||
28096258|NCT04144166|54751102|FG000|Overall Study|Discharged before study start|1|||
27865730|NCT01647516|54449273|FG002|Maintenance Period (MP)|Adverse Event|0|||
27865731|NCT01647516|54449274|FG003|Maintenance Period (MP)|Adverse Event|0|||
27865732|NCT01647516|54449275|FG004|Maintenance Period (MP)|Adverse Event|0|||
27865733|NCT01647516|54449276|FG005|Maintenance Period (MP)|Adverse Event|0|||
28096259|NCT04144166|54751102|FG000|Overall Study|Pregnancy|1|||
28096260|NCT04144166|54751102|FG000|Overall Study|Nail polish could not be removed from finger|1|||
27865734|NCT01647516|54449271|FG000|Maintenance Period (MP)|Non-compliance|1|||
27865735|NCT01647516|54449272|FG001|Maintenance Period (MP)|Non-compliance|0|||
27865736|NCT01647516|54449273|FG002|Maintenance Period (MP)|Non-compliance|0|||
27865737|NCT01647516|54449274|FG003|Maintenance Period (MP)|Non-compliance|0|||
27865738|NCT01647516|54449275|FG004|Maintenance Period (MP)|Non-compliance|0|||
27865739|NCT01647516|54449276|FG005|Maintenance Period (MP)|Non-compliance|0|||
27865740|NCT01647516|54449271|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
27865741|NCT01647516|54449272|FG001|Maintenance Period (MP)|Withdrawal by Subject|1|||
27865742|NCT01647516|54449273|FG002|Maintenance Period (MP)|Withdrawal by Subject|1|||
27865743|NCT01647516|54449274|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
27865744|NCT01647516|54449275|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
27865745|NCT01647516|54449276|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
27865746|NCT01647516|54449271|FG000|Maintenance Period (MP)|Lack of Efficacy|1|||
27865747|NCT01647516|54449272|FG001|Maintenance Period (MP)|Lack of Efficacy|4|||
27865748|NCT01647516|54449273|FG002|Maintenance Period (MP)|Lack of Efficacy|1|||
27865749|NCT01647516|54449274|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
27865750|NCT01647516|54449275|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
27865751|NCT01647516|54449276|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
27865752|NCT01647516|54449271|FG000|Open-Label Period|Adverse Event|0|||
27865753|NCT01647516|54449272|FG001|Open-Label Period|Adverse Event|0|||
27865754|NCT01647516|54449273|FG002|Open-Label Period|Adverse Event|0|||
27865755|NCT01647516|54449274|FG003|Open-Label Period|Adverse Event|5|||
27865756|NCT01647516|54449275|FG004|Open-Label Period|Adverse Event|6|||
27865757|NCT01647516|54449276|FG005|Open-Label Period|Adverse Event|3|||
27865758|NCT01647516|54449271|FG000|Open-Label Period|Pregnancy|0|||
27865759|NCT01647516|54449272|FG001|Open-Label Period|Pregnancy|0|||
27865760|NCT01647516|54449273|FG002|Open-Label Period|Pregnancy|0|||
27865761|NCT01647516|54449274|FG003|Open-Label Period|Pregnancy|0|||
27865762|NCT01647516|54449275|FG004|Open-Label Period|Pregnancy|0|||
27865763|NCT01647516|54449276|FG005|Open-Label Period|Pregnancy|1|||
27865764|NCT01647516|54449271|FG000|Open-Label Period|Non-compliance|0|||
27865765|NCT01647516|54449272|FG001|Open-Label Period|Non-compliance|0|||
27865766|NCT01647516|54449273|FG002|Open-Label Period|Non-compliance|0|||
27865767|NCT01647516|54449274|FG003|Open-Label Period|Non-compliance|1|||
27865768|NCT01647516|54449275|FG004|Open-Label Period|Non-compliance|0|||
27865769|NCT01647516|54449276|FG005|Open-Label Period|Non-compliance|1|||
27865770|NCT01647516|54449271|FG000|Open-Label Period|Physician Decision|0|||
27865771|NCT01647516|54449272|FG001|Open-Label Period|Physician Decision|0|||
27865772|NCT01647516|54449273|FG002|Open-Label Period|Physician Decision|0|||
27865773|NCT01647516|54449274|FG003|Open-Label Period|Physician Decision|1|||
27865774|NCT01647516|54449275|FG004|Open-Label Period|Physician Decision|1|||
27865775|NCT01647516|54449276|FG005|Open-Label Period|Physician Decision|0|||
27865776|NCT01647516|54449271|FG000|Open-Label Period|Withdrawal by Subject|0|||
27865777|NCT01647516|54449272|FG001|Open-Label Period|Withdrawal by Subject|0|||
27865778|NCT01647516|54449273|FG002|Open-Label Period|Withdrawal by Subject|0|||
27865779|NCT01647516|54449274|FG003|Open-Label Period|Withdrawal by Subject|9|||
27865780|NCT01647516|54449275|FG004|Open-Label Period|Withdrawal by Subject|11|||
27865781|NCT01647516|54449276|FG005|Open-Label Period|Withdrawal by Subject|6|||
27865782|NCT01647516|54449271|FG000|Open-Label Period|Lost to Follow-up|0|||
27865783|NCT01647516|54449272|FG001|Open-Label Period|Lost to Follow-up|0|||
27865784|NCT01647516|54449273|FG002|Open-Label Period|Lost to Follow-up|0|||
27865785|NCT01647516|54449274|FG003|Open-Label Period|Lost to Follow-up|1|||
27865786|NCT01647516|54449275|FG004|Open-Label Period|Lost to Follow-up|0|||
27865787|NCT01647516|54449276|FG005|Open-Label Period|Lost to Follow-up|1|||
27865788|NCT01647516|54449271|FG000|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
27865789|NCT01647516|54449272|FG001|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
27865790|NCT01647516|54449273|FG002|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
27865791|NCT01647516|54449274|FG003|Open-Label Period|Sponsor Termination; moved to 3102 study|18|||
27865792|NCT01647516|54449275|FG004|Open-Label Period|Sponsor Termination; moved to 3102 study|13|||
27865793|NCT01647516|54449276|FG005|Open-Label Period|Sponsor Termination; moved to 3102 study|23|||
27865794|NCT01647516|54449271|FG000|Open-Label Period|Lack of Efficacy|0|||
27865795|NCT01647516|54449272|FG001|Open-Label Period|Lack of Efficacy|0|||
27865796|NCT01647516|54449273|FG002|Open-Label Period|Lack of Efficacy|0|||
27865797|NCT01647516|54449274|FG003|Open-Label Period|Lack of Efficacy|7|||
27865798|NCT01647516|54449275|FG004|Open-Label Period|Lack of Efficacy|9|||
27865799|NCT01647516|54449276|FG005|Open-Label Period|Lack of Efficacy|10|||
27865800|NCT01647516|54449271|FG000|Open-Label Period|Participant Choice to Stop Study Drug|0|||
27865801|NCT01647516|54449272|FG001|Open-Label Period|Participant Choice to Stop Study Drug|0|||
27865802|NCT01647516|54449273|FG002|Open-Label Period|Participant Choice to Stop Study Drug|0|||
27865803|NCT01647516|54449274|FG003|Open-Label Period|Participant Choice to Stop Study Drug|7|||
27865804|NCT01647516|54449275|FG004|Open-Label Period|Participant Choice to Stop Study Drug|9|||
27865805|NCT01647516|54449276|FG005|Open-Label Period|Participant Choice to Stop Study Drug|10|||
27865806|NCT01647516|54449271|FG000|Open-Label Period|No completion / discontinuation visit|0|||
28171373|NCT02471716|54842936|FG004|Overall Study|Other|9|||
28171374|NCT01370863|54842952|FG000|Overall Study|Adverse Event|1|||
27865807|NCT01647516|54449272|FG001|Open-Label Period|No completion / discontinuation visit|0|||
27865808|NCT01647516|54449273|FG002|Open-Label Period|No completion / discontinuation visit|0|||
27865809|NCT01647516|54449274|FG003|Open-Label Period|No completion / discontinuation visit|0|||
27865810|NCT01647516|54449275|FG004|Open-Label Period|No completion / discontinuation visit|2|||
27865811|NCT01647516|54449276|FG005|Open-Label Period|No completion / discontinuation visit|1|||
27865812|NCT01647282|54449293|FG000|Overall Study|Physician Decision|7|||
27865813|NCT01647282|54449294|FG001|Overall Study|Physician Decision|5|||
27865814|NCT02321436|54449302|FG000|Overall Study|Withdrawal by Subject|1|||
27865815|NCT02321436|54449303|FG001|Overall Study|Withdrawal by Subject|0|||
27865816|NCT02321436|54449302|FG000|Overall Study|Lost to Follow-up|0|||
27865817|NCT02321436|54449303|FG001|Overall Study|Lost to Follow-up|1|||
27865818|NCT02319642|54449312|FG000|Overall Study|Adverse Event|2|||
27865819|NCT02319642|54449313|FG001|Overall Study|Adverse Event|4|||
27865820|NCT02319642|54449312|FG000|Overall Study|Lack of Efficacy|1|||
27865821|NCT02319642|54449313|FG001|Overall Study|Lack of Efficacy|1|||
27865822|NCT02319642|54449312|FG000|Overall Study|Withdrawal by Subject|1|||
27865823|NCT02319642|54449313|FG001|Overall Study|Withdrawal by Subject|1|||
27865824|NCT02280096|54449323|FG000|Overall Study|Pregnancy|1|||
27865825|NCT02280096|54449324|FG001|Overall Study|Pregnancy|0|||
27865826|NCT02280096|54449323|FG000|Overall Study|Functional neurological disorder|1|||
27865827|NCT02280096|54449324|FG001|Overall Study|Functional neurological disorder|0|||
27865828|NCT02280096|54449323|FG000|Overall Study|Lack of attachment|0|||
27865829|NCT02280096|54449324|FG001|Overall Study|Lack of attachment|1|||
27865830|NCT02279862|54449341|FG000|Overall Study|Study drug toxicity|3|||
27865831|NCT02279862|54449342|FG001|Overall Study|Study drug toxicity|6|||
27865832|NCT02279862|54449341|FG000|Overall Study|No longer meets criteria|0|||
27865833|NCT02279862|54449342|FG001|Overall Study|No longer meets criteria|1|||
27865834|NCT02279862|54449341|FG000|Overall Study|Administrative reason by sponsor|0|||
27865835|NCT02279862|54449342|FG001|Overall Study|Administrative reason by sponsor|1|||
27865836|NCT02279862|54449341|FG000|Overall Study|Disease progression|5|||
27865837|NCT02279862|54449342|FG001|Overall Study|Disease progression|2|||
27865838|NCT02279862|54449341|FG000|Overall Study|Study closed by sponsor|16|||
27865839|NCT02279862|54449342|FG001|Overall Study|Study closed by sponsor|13|||
27865840|NCT02279862|54449341|FG000|Overall Study|Other|1|||
27865841|NCT02279862|54449342|FG001|Overall Study|Other|2|||
27865842|NCT02279862|54449341|FG000|Overall Study|Withdrawal by Subject|1|||
27865843|NCT02279862|54449342|FG001|Overall Study|Withdrawal by Subject|0|||
27865844|NCT02318940|54449350|FG000|Overall Study|lost the record|1|||
27865845|NCT02318940|54449351|FG001|Overall Study|lost the record|0|||
27865846|NCT02294058|54449360|FG000|Overall Study|Adverse Event|16|||
27865847|NCT02294058|54449361|FG001|Overall Study|Adverse Event|7|||
27865848|NCT02294058|54449362|FG002|Overall Study|Adverse Event|13|||
27865849|NCT02294058|54449360|FG000|Overall Study|Lack of Efficacy|3|||
27865850|NCT02294058|54449361|FG001|Overall Study|Lack of Efficacy|3|||
27865851|NCT02294058|54449362|FG002|Overall Study|Lack of Efficacy|0|||
27865852|NCT02294058|54449360|FG000|Overall Study|Lost to Follow-up|1|||
27865853|NCT02294058|54449361|FG001|Overall Study|Lost to Follow-up|0|||
27865854|NCT02294058|54449362|FG002|Overall Study|Lost to Follow-up|2|||
27865855|NCT02294058|54449360|FG000|Overall Study|Withdrawal by Subject|10|||
27865856|NCT02294058|54449361|FG001|Overall Study|Withdrawal by Subject|14|||
27865857|NCT02294058|54449362|FG002|Overall Study|Withdrawal by Subject|13|||
27865858|NCT02294058|54449360|FG000|Overall Study|Physician Decision|2|||
27865859|NCT02294058|54449361|FG001|Overall Study|Physician Decision|1|||
27865860|NCT02294058|54449362|FG002|Overall Study|Physician Decision|0|||
27865861|NCT02294058|54449360|FG000|Overall Study|Miscellaneous|4|||
27865862|NCT02294058|54449361|FG001|Overall Study|Miscellaneous|1|||
27865863|NCT02294058|54449362|FG002|Overall Study|Miscellaneous|1|||
27865864|NCT05065619|54449373|FG000|Overall Study|Lost to Follow-up|1|||
27982168|NCT03330106|54640192|FG000|Part A|Progressive Disease|0|||
27865865|NCT05065619|54449374|FG001|Overall Study|Lost to Follow-up|0|||
27865866|NCT05065619|54449373|FG000|Overall Study|Withdrawal by Subject|1|||
27865867|NCT05065619|54449374|FG001|Overall Study|Withdrawal by Subject|0|||
27865868|NCT02293902|54449383|FG000|Double-Blind Period (Up to Week 24)|Adverse Event|5|||
27865869|NCT02293902|54449384|FG001|Double-Blind Period (Up to Week 24)|Adverse Event|6|||
27865870|NCT02293902|54449385|FG002|Double-Blind Period (Up to Week 24)|Adverse Event|8|||
27865871|NCT02293902|54449386|FG003|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
27865872|NCT02293902|54449387|FG004|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
27865873|NCT02293902|54449383|FG000|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5|||
27865874|NCT02293902|54449384|FG001|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1|||
27865875|NCT02293902|54449385|FG002|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2|||
27865876|NCT02293902|54449386|FG003|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
27865877|NCT02293902|54449387|FG004|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
27865878|NCT02293902|54449383|FG000|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1|||
27865879|NCT02293902|54449384|FG001|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
27865880|NCT02293902|54449385|FG002|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
27865881|NCT02293902|54449386|FG003|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
27865882|NCT02293902|54449387|FG004|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
27865883|NCT02293902|54449383|FG000|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0|||
27865884|NCT02293902|54449384|FG001|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7|||
27865885|NCT02293902|54449385|FG002|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
27865886|NCT02293902|54449386|FG003|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
27865887|NCT02293902|54449387|FG004|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6|||
27865888|NCT02293902|54449383|FG000|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
27865889|NCT02293902|54449384|FG001|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
27865890|NCT02293902|54449385|FG002|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
27865891|NCT02293902|54449386|FG003|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
27865892|NCT02293902|54449387|FG004|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
27865893|NCT02278614|54449407|FG000|Overall Study|Withdrawal by Subject|3|||
27865894|NCT02278614|54449408|FG001|Overall Study|Withdrawal by Subject|5|||
27865895|NCT02278614|54449407|FG000|Overall Study|Adverse Event|1|||
27865896|NCT02278614|54449408|FG001|Overall Study|Adverse Event|0|||
27865897|NCT02278614|54449407|FG000|Overall Study|left eye was not eligible|1|||
27865898|NCT02278614|54449408|FG001|Overall Study|left eye was not eligible|0|||
27865899|NCT02318706|54449418|FG000|Double-blind Phase|Adverse Event|7|||
27865900|NCT02318706|54449419|FG001|Double-blind Phase|Adverse Event|4|||
27865901|NCT02318706|54449420|FG002|Double-blind Phase|Adverse Event|3|||
27865902|NCT02318706|54449421|FG003|Double-blind Phase|Adverse Event|10|||
27865903|NCT02318706|54449422|FG004|Double-blind Phase|Adverse Event|0|||
27865904|NCT02318706|54449418|FG000|Double-blind Phase|Lost to Follow-up|1|||
27865905|NCT02318706|54449419|FG001|Double-blind Phase|Lost to Follow-up|0|||
27865906|NCT02318706|54449420|FG002|Double-blind Phase|Lost to Follow-up|0|||
27865907|NCT02318706|54449421|FG003|Double-blind Phase|Lost to Follow-up|0|||
27865908|NCT02318706|54449422|FG004|Double-blind Phase|Lost to Follow-up|0|||
27865909|NCT02318706|54449418|FG000|Double-blind Phase|Protocol Violation|4|||
27865910|NCT02318706|54449419|FG001|Double-blind Phase|Protocol Violation|2|||
27865911|NCT02318706|54449420|FG002|Double-blind Phase|Protocol Violation|4|||
27865912|NCT02318706|54449421|FG003|Double-blind Phase|Protocol Violation|3|||
27865913|NCT02318706|54449422|FG004|Double-blind Phase|Protocol Violation|0|||
27865914|NCT02318706|54449418|FG000|Double-blind Phase|Withdrawal by Subject|9|||
27865915|NCT02318706|54449419|FG001|Double-blind Phase|Withdrawal by Subject|5|||
27865916|NCT02318706|54449420|FG002|Double-blind Phase|Withdrawal by Subject|7|||
27865917|NCT02318706|54449421|FG003|Double-blind Phase|Withdrawal by Subject|10|||
27865918|NCT02318706|54449422|FG004|Double-blind Phase|Withdrawal by Subject|0|||
27865919|NCT02318706|54449418|FG000|Double-blind Phase|Other|4|||
27865920|NCT02318706|54449419|FG001|Double-blind Phase|Other|1|||
27865921|NCT02318706|54449420|FG002|Double-blind Phase|Other|2|||
27865922|NCT02318706|54449421|FG003|Double-blind Phase|Other|1|||
27865923|NCT02318706|54449422|FG004|Double-blind Phase|Other|0|||
27865924|NCT02318706|54449418|FG000|Double-blind Phase|Death|0|||
27865925|NCT02318706|54449419|FG001|Double-blind Phase|Death|0|||
27865926|NCT02318706|54449420|FG002|Double-blind Phase|Death|2|||
27865927|NCT02318706|54449421|FG003|Double-blind Phase|Death|0|||
27865928|NCT02318706|54449422|FG004|Double-blind Phase|Death|0|||
27865929|NCT02318706|54449418|FG000|Open-label Extension Phase|Adverse Event|0|||
27865930|NCT02318706|54449419|FG001|Open-label Extension Phase|Adverse Event|0|||
27865931|NCT02318706|54449420|FG002|Open-label Extension Phase|Adverse Event|0|||
27865932|NCT02318706|54449421|FG003|Open-label Extension Phase|Adverse Event|0|||
27865933|NCT02318706|54449422|FG004|Open-label Extension Phase|Adverse Event|21|||
27865934|NCT02318706|54449418|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
27865935|NCT02318706|54449419|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
27865936|NCT02318706|54449420|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
27865937|NCT02318706|54449421|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
27865938|NCT02318706|54449422|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
27865939|NCT02318706|54449418|FG000|Open-label Extension Phase|Death|0|||
27865940|NCT02318706|54449419|FG001|Open-label Extension Phase|Death|0|||
27865941|NCT02318706|54449420|FG002|Open-label Extension Phase|Death|0|||
27865942|NCT02318706|54449421|FG003|Open-label Extension Phase|Death|0|||
27865943|NCT02318706|54449422|FG004|Open-label Extension Phase|Death|1|||
27865944|NCT02318706|54449418|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
27865945|NCT02318706|54449419|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
27865946|NCT02318706|54449420|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
27865947|NCT02318706|54449421|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
27865948|NCT02318706|54449422|FG004|Open-label Extension Phase|Withdrawal by Subject|19|||
27865949|NCT04747275|54449464|FG000|Overall Study|Study terminated|0|||
27865950|NCT04747275|54449465|FG001|Overall Study|Study terminated|1|||
27865951|NCT04583280|54449473|FG000|Overall Study|Consent withdrawn by parent/caregiver|0|||
27865952|NCT04583280|54449474|FG001|Overall Study|Consent withdrawn by parent/caregiver|1|||
27865953|NCT04489940|54449493|FG000|Overall Study|Other|2|||
27865954|NCT04489940|54449493|FG000|Overall Study|Withdrawal by Subject|2|||
27865955|NCT04489940|54449493|FG000|Overall Study|Death|5|||
28171375|NCT01370863|54842953|FG001|Overall Study|Adverse Event|1|||
27865956|NCT04489940|54449493|FG000|Overall Study|Lost to Follow-up|1|||
27865957|NCT04365257|54449499|FG000|Overall Study|Physician Decision|1|||
28171376|NCT01370863|54842952|FG000|Overall Study|Did not want second pH/MII monitoring|1|||
28171377|NCT01370863|54842953|FG001|Overall Study|Did not want second pH/MII monitoring|1|||
27865958|NCT04365257|54449500|FG001|Overall Study|Physician Decision|0|||
27865959|NCT04365257|54449499|FG000|Overall Study|Patient Noncompliance|1|||
27865960|NCT04365257|54449500|FG001|Overall Study|Patient Noncompliance|0|||
27865961|NCT04365257|54449499|FG000|Overall Study|Withdrawal by Subject|0|||
27865962|NCT04365257|54449500|FG001|Overall Study|Withdrawal by Subject|1|||
27865963|NCT03395223|54449532|FG000|Overall Study|Lost to Follow-up|3|||
27865964|NCT03395223|54449532|FG000|Overall Study|Other|1|||
27865965|NCT02937818|54449564|FG000|Overall Study|Participants decision|1|||
27865966|NCT02937818|54449565|FG001|Overall Study|Participants decision|0|||
27865967|NCT02937818|54449566|FG002|Overall Study|Participants decision|1|||
27865968|NCT02937818|54449567|FG003|Overall Study|Participants decision|1|||
27865969|NCT02937818|54449564|FG000|Overall Study|Adverse Event|2|||
27865970|NCT02937818|54449565|FG001|Overall Study|Adverse Event|4|||
27865971|NCT02937818|54449566|FG002|Overall Study|Adverse Event|1|||
27865972|NCT02937818|54449567|FG003|Overall Study|Adverse Event|1|||
27865973|NCT02937818|54449564|FG000|Overall Study|Disease progression|17|||
27865974|NCT02937818|54449565|FG001|Overall Study|Disease progression|14|||
27865975|NCT02937818|54449566|FG002|Overall Study|Disease progression|7|||
27865976|NCT02937818|54449567|FG003|Overall Study|Disease progression|18|||
27865977|NCT02937818|54449564|FG000|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|1|||
27865978|NCT02937818|54449565|FG001|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|2|||
27865979|NCT02937818|54449566|FG002|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|0|||
27865980|NCT02937818|54449567|FG003|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|0|||
27865981|NCT02937818|54449564|FG000|Overall Study|Condition under investigation worsened|0|||
27865982|NCT02937818|54449565|FG001|Overall Study|Condition under investigation worsened|0|||
27865983|NCT02937818|54449566|FG002|Overall Study|Condition under investigation worsened|1|||
27865984|NCT02937818|54449567|FG003|Overall Study|Condition under investigation worsened|0|||
27865985|NCT02937818|54449564|FG000|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|0|||
27865986|NCT02937818|54449565|FG001|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|0|||
27865987|NCT02937818|54449566|FG002|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|0|||
27865988|NCT02937818|54449567|FG003|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|1|||
27865989|NCT02864940|54449582|FG000|Overall Study|Never took part in intervention or control arm activities or completed post assessments|13|||
27865990|NCT02864940|54449583|FG001|Overall Study|Never took part in intervention or control arm activities or completed post assessments|11|||
27865991|NCT02756611|54449602|FG000|Overall Study|Death|70|||
27865992|NCT02756611|54449602|FG000|Overall Study|Withdrawal by Subject|2|||
27865993|NCT02756611|54449602|FG000|Overall Study|Lost to Follow-up|3|||
27865994|NCT02756611|54449602|FG000|Overall Study|Transitioned to Long-term Extension Study M19-388 (NCT03844048)|49|||
27865995|NCT02756611|54449602|FG000|Overall Study|Other|10|||
27865996|NCT02624518|54449606|FG000|Overall Study|Physician Decision|1|||
27865997|NCT02287623|54449612|FG000|Overall Study|Protocol Violation|0|||
27865998|NCT02287623|54449613|FG001|Overall Study|Protocol Violation|1|||
27865999|NCT01794520|54449635|FG000|Overall Study|Adverse events- related to progression|0|||
27866000|NCT01794520|54449636|FG001|Overall Study|Adverse events- related to progression|0|||
27866001|NCT01794520|54449637|FG002|Overall Study|Adverse events- related to progression|1|||
27866002|NCT01794520|54449638|FG003|Overall Study|Adverse events- related to progression|2|||
27866003|NCT01794520|54449639|FG004|Overall Study|Adverse events- related to progression|0|||
27866004|NCT01794520|54449640|FG005|Overall Study|Adverse events- related to progression|1|||
27866005|NCT01794520|54449641|FG006|Overall Study|Adverse events- related to progression|0|||
27866006|NCT01794520|54449635|FG000|Overall Study|Adverse event- not related to progression|1|||
27866007|NCT01794520|54449636|FG001|Overall Study|Adverse event- not related to progression|1|||
27866008|NCT01794520|54449637|FG002|Overall Study|Adverse event- not related to progression|0|||
27866009|NCT01794520|54449638|FG003|Overall Study|Adverse event- not related to progression|0|||
27866010|NCT01794520|54449639|FG004|Overall Study|Adverse event- not related to progression|2|||
28096261|NCT04142450|54751111|FG000|Overall Study|Screen Failure|1|||
28096262|NCT04142450|54751111|FG000|Overall Study|Lost to Follow-up|1|||
28096263|NCT04529850|54751115|FG000|Overall Study|Death|2|||
28096264|NCT04529850|54751115|FG000|Overall Study|Physician Decision|1|||
28096265|NCT04529850|54751115|FG000|Overall Study|Withdrawal by Subject|2|||
27835093|NCT01587703|54319712|FG011|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
27835094|NCT01587703|54319713|FG012|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
27835095|NCT01587703|54319714|FG013|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
27835096|NCT01587703|54319715|FG014|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
27835097|NCT01587703|54319716|FG015|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
27835098|NCT01587703|54319717|FG016|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
27835099|NCT01587703|54319718|FG017|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
27835100|NCT01587703|54319719|FG018|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
27835101|NCT01587703|54319701|FG000|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
27835102|NCT01587703|54319702|FG001|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
27835103|NCT01587703|54319703|FG002|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
27866011|NCT01794520|54449640|FG005|Overall Study|Adverse event- not related to progression|0|||
27866012|NCT01794520|54449641|FG006|Overall Study|Adverse event- not related to progression|0|||
27866013|NCT01794520|54449635|FG000|Overall Study|Progressive disease|5|||
27866014|NCT01794520|54449636|FG001|Overall Study|Progressive disease|6|||
27866015|NCT01794520|54449637|FG002|Overall Study|Progressive disease|2|||
27866016|NCT01794520|54449638|FG003|Overall Study|Progressive disease|5|||
27866017|NCT01794520|54449639|FG004|Overall Study|Progressive disease|27|||
27866018|NCT01794520|54449640|FG005|Overall Study|Progressive disease|18|||
27866019|NCT01794520|54449641|FG006|Overall Study|Progressive disease|0|||
27866020|NCT01794520|54449635|FG000|Overall Study|Withdrew consent|0|||
27866021|NCT01794520|54449636|FG001|Overall Study|Withdrew consent|0|||
27866022|NCT01794520|54449637|FG002|Overall Study|Withdrew consent|1|||
27866023|NCT01794520|54449638|FG003|Overall Study|Withdrew consent|1|||
27866024|NCT01794520|54449639|FG004|Overall Study|Withdrew consent|0|||
27866025|NCT01794520|54449640|FG005|Overall Study|Withdrew consent|0|||
27866026|NCT01794520|54449641|FG006|Overall Study|Withdrew consent|0|||
27866027|NCT01794520|54449635|FG000|Overall Study|Lost to Follow-up|0|||
27866028|NCT01794520|54449636|FG001|Overall Study|Lost to Follow-up|0|||
27866029|NCT01794520|54449637|FG002|Overall Study|Lost to Follow-up|0|||
27866030|NCT01794520|54449638|FG003|Overall Study|Lost to Follow-up|0|||
27866031|NCT01794520|54449639|FG004|Overall Study|Lost to Follow-up|1|||
27866032|NCT01794520|54449640|FG005|Overall Study|Lost to Follow-up|0|||
27866033|NCT01794520|54449641|FG006|Overall Study|Lost to Follow-up|0|||
27866034|NCT01794520|54449635|FG000|Overall Study|Toxicity|0|||
27866035|NCT01794520|54449636|FG001|Overall Study|Toxicity|2|||
27866036|NCT01794520|54449637|FG002|Overall Study|Toxicity|0|||
27866037|NCT01794520|54449638|FG003|Overall Study|Toxicity|0|||
27866038|NCT01794520|54449639|FG004|Overall Study|Toxicity|0|||
27866039|NCT01794520|54449640|FG005|Overall Study|Toxicity|0|||
27866040|NCT01794520|54449641|FG006|Overall Study|Toxicity|0|||
27866041|NCT01794520|54449635|FG000|Overall Study|Study terminated by sponsor|0|||
27866042|NCT01794520|54449636|FG001|Overall Study|Study terminated by sponsor|0|||
27866043|NCT01794520|54449637|FG002|Overall Study|Study terminated by sponsor|1|||
27866044|NCT01794520|54449638|FG003|Overall Study|Study terminated by sponsor|0|||
27866045|NCT01794520|54449639|FG004|Overall Study|Study terminated by sponsor|1|||
27866046|NCT01794520|54449640|FG005|Overall Study|Study terminated by sponsor|0|||
27866047|NCT01794520|54449641|FG006|Overall Study|Study terminated by sponsor|7|||
27866048|NCT01794520|54449635|FG000|Overall Study|Death|0|||
27866049|NCT01794520|54449636|FG001|Overall Study|Death|0|||
27866050|NCT01794520|54449637|FG002|Overall Study|Death|0|||
27866051|NCT01794520|54449638|FG003|Overall Study|Death|0|||
27866052|NCT01794520|54449639|FG004|Overall Study|Death|1|||
27866053|NCT01794520|54449640|FG005|Overall Study|Death|0|||
27866054|NCT01794520|54449641|FG006|Overall Study|Death|22|||
27866055|NCT01794520|54449635|FG000|Overall Study|Other, not specified|0|||
27866056|NCT01794520|54449636|FG001|Overall Study|Other, not specified|0|||
27866057|NCT01794520|54449637|FG002|Overall Study|Other, not specified|1|||
27866058|NCT01794520|54449638|FG003|Overall Study|Other, not specified|1|||
27866059|NCT01794520|54449639|FG004|Overall Study|Other, not specified|4|||
27866060|NCT01794520|54449640|FG005|Overall Study|Other, not specified|1|||
27866061|NCT01794520|54449641|FG006|Overall Study|Other, not specified|2|||
27866062|NCT01774019|54449664|FG000|Overall Study|No longer meets protocol criteria|2|||
27866063|NCT01774019|54449665|FG001|Overall Study|No longer meets protocol criteria|0|||
27835104|NCT01587703|54319704|FG003|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
27835105|NCT01587703|54319705|FG004|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
27835106|NCT01587703|54319706|FG005|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
27835107|NCT01587703|54319707|FG006|Part1 QD(Median Exposure of 1.38months)|Site closed|2|||
27835108|NCT01587703|54319708|FG007|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
27835109|NCT01587703|54319709|FG008|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
27835110|NCT01587703|54319710|FG009|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
27835111|NCT01587703|54319711|FG010|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
27835112|NCT01587703|54319712|FG011|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
27835113|NCT01587703|54319713|FG012|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
27835114|NCT01587703|54319714|FG013|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
27835115|NCT01587703|54319715|FG014|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
27866064|NCT01774019|54449664|FG000|Overall Study|Withdrawal by Subject|1|||
27866065|NCT01774019|54449665|FG001|Overall Study|Withdrawal by Subject|0|||
27866066|NCT01774019|54449664|FG000|Overall Study|Surgery delayed > 120 days|1|||
27866067|NCT01774019|54449665|FG001|Overall Study|Surgery delayed > 120 days|0|||
27866068|NCT01774019|54449664|FG000|Overall Study|Patient refused surgery|1|||
27866069|NCT01774019|54449665|FG001|Overall Study|Patient refused surgery|1|||
27866070|NCT01774019|54449664|FG000|Overall Study|Unable to implant study device|1|||
27866071|NCT01774019|54449665|FG001|Overall Study|Unable to implant study device|0|||
27866072|NCT01774019|54449664|FG000|Overall Study|Lost to Follow-up|0|||
27866073|NCT01774019|54449665|FG001|Overall Study|Lost to Follow-up|3|||
27835116|NCT01587703|54319716|FG015|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
27866074|NCT03251924|54450041|FG000|Overall Study|Disease Progression|6|||
27866075|NCT03251924|54450042|FG001|Overall Study|Disease Progression|6|||
27866076|NCT03251924|54450043|FG002|Overall Study|Disease Progression|7|||
27866077|NCT03251924|54450044|FG003|Overall Study|Disease Progression|8|||
27866078|NCT03251924|54450045|FG004|Overall Study|Disease Progression|8|||
27866079|NCT03251924|54450046|FG005|Overall Study|Disease Progression|7|||
27866080|NCT03251924|54450047|FG006|Overall Study|Disease Progression|6|||
27866081|NCT03251924|54450048|FG007|Overall Study|Disease Progression|10|||
27866082|NCT03251924|54450049|FG008|Overall Study|Disease Progression|6|||
28096266|NCT04225676|54751119|FG000|Overall Study|Physician Decision|1|||
27866083|NCT03251924|54450041|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
27866084|NCT03251924|54450042|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
27866085|NCT03251924|54450043|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
27866086|NCT03251924|54450044|FG003|Overall Study|Adverse Event unrelated to study drug|1|||
27866087|NCT03251924|54450045|FG004|Overall Study|Adverse Event unrelated to study drug|0|||
27866088|NCT03251924|54450046|FG005|Overall Study|Adverse Event unrelated to study drug|1|||
27866089|NCT03251924|54450047|FG006|Overall Study|Adverse Event unrelated to study drug|1|||
27866090|NCT03251924|54450048|FG007|Overall Study|Adverse Event unrelated to study drug|0|||
27866091|NCT03251924|54450049|FG008|Overall Study|Adverse Event unrelated to study drug|0|||
27866092|NCT03251924|54450041|FG000|Overall Study|Death|0|||
27866093|NCT03251924|54450042|FG001|Overall Study|Death|1|||
27866094|NCT03251924|54450043|FG002|Overall Study|Death|0|||
27866095|NCT03251924|54450044|FG003|Overall Study|Death|1|||
27866096|NCT03251924|54450045|FG004|Overall Study|Death|1|||
27866097|NCT03251924|54450046|FG005|Overall Study|Death|1|||
27866098|NCT03251924|54450047|FG006|Overall Study|Death|0|||
27866099|NCT03251924|54450048|FG007|Overall Study|Death|0|||
27866100|NCT03251924|54450049|FG008|Overall Study|Death|0|||
27866101|NCT03251924|54450041|FG000|Overall Study|Study Drug Toxicity|0|||
27982169|NCT03330106|54640193|FG001|Part A|Progressive Disease|1|||
27982170|NCT03330106|54640194|FG002|Part A|Progressive Disease|0|||
27982171|NCT03330106|54640195|FG003|Part A|Progressive Disease|0|||
27982172|NCT03330106|54640192|FG000|Part B|Lost to Follow-up|0|||
27982173|NCT03330106|54640193|FG001|Part B|Lost to Follow-up|0|||
27982174|NCT03330106|54640194|FG002|Part B|Lost to Follow-up|0|||
27982175|NCT03330106|54640195|FG003|Part B|Lost to Follow-up|1|||
27982176|NCT03330106|54640192|FG000|Part B|Withdrawal by Subject|0|||
27982177|NCT03330106|54640193|FG001|Part B|Withdrawal by Subject|0|||
27982178|NCT03330106|54640194|FG002|Part B|Withdrawal by Subject|4|||
27982179|NCT03330106|54640195|FG003|Part B|Withdrawal by Subject|0|||
27982180|NCT03330106|54640192|FG000|Part B|Death|0|||
27982181|NCT03330106|54640193|FG001|Part B|Death|0|||
27982182|NCT03330106|54640194|FG002|Part B|Death|2|||
27982183|NCT03330106|54640195|FG003|Part B|Death|0|||
27982184|NCT03330106|54640192|FG000|Part B|Clinical Progression|0|||
27982185|NCT03330106|54640193|FG001|Part B|Clinical Progression|0|||
27982186|NCT03330106|54640194|FG002|Part B|Clinical Progression|1|||
27982187|NCT03330106|54640195|FG003|Part B|Clinical Progression|1|||
27982188|NCT03330106|54640192|FG000|Part B|Symptomatic Deterioration|0|||
27982189|NCT03330106|54640193|FG001|Part B|Symptomatic Deterioration|0|||
27982190|NCT03330106|54640194|FG002|Part B|Symptomatic Deterioration|0|||
27982191|NCT03330106|54640195|FG003|Part B|Symptomatic Deterioration|1|||
27982192|NCT03330106|54640192|FG000|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
27982193|NCT03330106|54640193|FG001|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
27835117|NCT01587703|54319717|FG016|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
27835118|NCT01587703|54319718|FG017|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
27835119|NCT01587703|54319719|FG018|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
27835120|NCT01587703|54319701|FG000|Part1 QD(Median Exposure of 1.38months)|Death|2|||
27835121|NCT01587703|54319702|FG001|Part1 QD(Median Exposure of 1.38months)|Death|4|||
27835122|NCT01587703|54319703|FG002|Part1 QD(Median Exposure of 1.38months)|Death|1|||
27835123|NCT01587703|54319704|FG003|Part1 QD(Median Exposure of 1.38months)|Death|3|||
27835124|NCT01587703|54319705|FG004|Part1 QD(Median Exposure of 1.38months)|Death|4|||
27835125|NCT01587703|54319706|FG005|Part1 QD(Median Exposure of 1.38months)|Death|7|||
27866102|NCT03251924|54450042|FG001|Overall Study|Study Drug Toxicity|0|||
27866103|NCT03251924|54450043|FG002|Overall Study|Study Drug Toxicity|0|||
27866104|NCT03251924|54450044|FG003|Overall Study|Study Drug Toxicity|1|||
27866105|NCT03251924|54450045|FG004|Overall Study|Study Drug Toxicity|0|||
27982194|NCT03330106|54640194|FG002|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
27982195|NCT03330106|54640195|FG003|Part B|Symptomatic Deterioration, Participant Placed on Hospice|1|||
28096267|NCT04225676|54751119|FG000|Overall Study|Lack of Efficacy|1|||
27982196|NCT03330106|54640192|FG000|Part B|Progressive Disease|0|||
27982197|NCT03330106|54640193|FG001|Part B|Progressive Disease|0|||
27982198|NCT03330106|54640194|FG002|Part B|Progressive Disease|11|||
27866106|NCT03251924|54450046|FG005|Overall Study|Study Drug Toxicity|0|||
27866107|NCT03251924|54450047|FG006|Overall Study|Study Drug Toxicity|0|||
27866108|NCT03251924|54450048|FG007|Overall Study|Study Drug Toxicity|0|||
27982199|NCT03330106|54640195|FG003|Part B|Progressive Disease|4|||
28096268|NCT04225676|54751119|FG000|Overall Study|Study terminated by sponsor|3|||
27866109|NCT03251924|54450049|FG008|Overall Study|Study Drug Toxicity|1|||
27866110|NCT03251924|54450041|FG000|Overall Study|Other Reasons|0|||
27866111|NCT03251924|54450042|FG001|Overall Study|Other Reasons|0|||
27866112|NCT03251924|54450043|FG002|Overall Study|Other Reasons|0|||
27866113|NCT03251924|54450044|FG003|Overall Study|Other Reasons|0|||
27866114|NCT03251924|54450045|FG004|Overall Study|Other Reasons|0|||
27866115|NCT03251924|54450046|FG005|Overall Study|Other Reasons|0|||
27866116|NCT03251924|54450047|FG006|Overall Study|Other Reasons|0|||
27866117|NCT03251924|54450048|FG007|Overall Study|Other Reasons|0|||
27866118|NCT03251924|54450049|FG008|Overall Study|Other Reasons|1|||
27866119|NCT03251924|54450041|FG000|Overall Study|Participant request to discontinue study treatment|0|||
27866120|NCT03251924|54450042|FG001|Overall Study|Participant request to discontinue study treatment|0|||
27866121|NCT03251924|54450043|FG002|Overall Study|Participant request to discontinue study treatment|0|||
27866122|NCT03251924|54450044|FG003|Overall Study|Participant request to discontinue study treatment|0|||
27866123|NCT03251924|54450045|FG004|Overall Study|Participant request to discontinue study treatment|0|||
27866124|NCT03251924|54450046|FG005|Overall Study|Participant request to discontinue study treatment|0|||
27866125|NCT03251924|54450047|FG006|Overall Study|Participant request to discontinue study treatment|0|||
27866126|NCT03251924|54450048|FG007|Overall Study|Participant request to discontinue study treatment|1|||
27866127|NCT03251924|54450049|FG008|Overall Study|Participant request to discontinue study treatment|0|||
27866128|NCT01350141|54450245|FG000|Overall Study|Lost to Follow-up|1|||
27866129|NCT01350141|54450246|FG001|Overall Study|Lost to Follow-up|0|||
27866130|NCT01350141|54450247|FG002|Overall Study|Lost to Follow-up|1|||
27866131|NCT01350141|54450245|FG000|Overall Study|Withdrawal by Subject|1|||
27866132|NCT01350141|54450246|FG001|Overall Study|Withdrawal by Subject|0|||
27866133|NCT01350141|54450247|FG002|Overall Study|Withdrawal by Subject|0|||
27866134|NCT01350141|54450245|FG000|Overall Study|Randomized but not treated|1|||
27866135|NCT01350141|54450246|FG001|Overall Study|Randomized but not treated|0|||
27866136|NCT01350141|54450247|FG002|Overall Study|Randomized but not treated|0|||
27866137|NCT05045625|54450786|FG000|Overall Study|Lost to Follow-up|3|||
27866138|NCT04830969|54451168|FG000|Overall Study|Withdrawal by Subject|6|||
27866139|NCT04830969|54451169|FG001|Overall Study|Withdrawal by Subject|2|||
27866140|NCT04830969|54451168|FG000|Overall Study|Protocol Violation|3|||
27866141|NCT04830969|54451169|FG001|Overall Study|Protocol Violation|9|||
27866142|NCT04830969|54451168|FG000|Overall Study|Lost to Follow-up|4|||
27866143|NCT04830969|54451169|FG001|Overall Study|Lost to Follow-up|4|||
27866144|NCT02384993|54451480|FG000|Overall Study|Adverse Event|0|||
27866145|NCT02384993|54451481|FG001|Overall Study|Adverse Event|1|||
27866146|NCT01352117|54451529|FG000|Overall Study|Death|15|||
27866147|NCT01352117|54451530|FG001|Overall Study|Death|16|||
27866148|NCT01352117|54451529|FG000|Overall Study|Withdrawal by Subject|1|||
27866149|NCT01352117|54451530|FG001|Overall Study|Withdrawal by Subject|0|||
27866150|NCT01352117|54451529|FG000|Overall Study|Lost to Follow-up|2|||
27866151|NCT01352117|54451530|FG001|Overall Study|Lost to Follow-up|7|||
27866152|NCT01352117|54451529|FG000|Overall Study|Non-adherent to study requirements|1|||
27866153|NCT01352117|54451530|FG001|Overall Study|Non-adherent to study requirements|1|||
27866154|NCT01352117|54451529|FG000|Overall Study|Did not initiate study treatment|1|||
27866155|NCT01352117|54451530|FG001|Overall Study|Did not initiate study treatment|0|||
27866156|NCT01352117|54451529|FG000|Overall Study|Ineligible (no KS diagnosis)|1|||
27866157|NCT01352117|54451530|FG001|Overall Study|Ineligible (no KS diagnosis)|0|||
27866158|NCT03578237|54451601|FG000|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|14|||
27866159|NCT03578237|54451602|FG001|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|16|||
27866160|NCT04173507|54451681|FG000|Overall Study|On Treatment|3|||
27866161|NCT04173507|54451681|FG000|Overall Study|Adverse Event|3|||
27866162|NCT04173507|54451681|FG000|Overall Study|Progression/Relapse|34|||
27866163|NCT04173507|54451681|FG000|Overall Study|Death|2|||
27866164|NCT02220725|54451689|FG000|Overall Study|Lost to Follow-up|0|||
27866165|NCT02220725|54451690|FG001|Overall Study|Lost to Follow-up|0|||
27866166|NCT02220725|54451691|FG002|Overall Study|Lost to Follow-up|0|||
27866167|NCT02220725|54451692|FG003|Overall Study|Lost to Follow-up|1|||
27866168|NCT02220725|54451689|FG000|Overall Study|Withdrawal by Subject|0|||
27866169|NCT02220725|54451690|FG001|Overall Study|Withdrawal by Subject|0|||
27866170|NCT02220725|54451691|FG002|Overall Study|Withdrawal by Subject|0|||
27866171|NCT02220725|54451692|FG003|Overall Study|Withdrawal by Subject|1|||
27866172|NCT02259517|54451738|FG000|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
27866173|NCT02259517|54451739|FG001|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
27866174|NCT02259517|54451740|FG002|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|6|||
27866175|NCT02259517|54451738|FG000|Overall Study|Withdrawal by Subject|0|||
27866176|NCT02259517|54451739|FG001|Overall Study|Withdrawal by Subject|0|||
27866177|NCT02259517|54451740|FG002|Overall Study|Withdrawal by Subject|3|||
27866178|NCT02277990|54451783|FG000|Overall Study|Death|170|||
27866179|NCT02277990|54451784|FG001|Overall Study|Death|188|||
27866180|NCT02277990|54451783|FG000|Overall Study|Withdrawal by Subject|64|||
27866181|NCT02277990|54451784|FG001|Overall Study|Withdrawal by Subject|53|||
27866182|NCT02277990|54451783|FG000|Overall Study|Physician Decision|40|||
27866183|NCT02277990|54451784|FG001|Overall Study|Physician Decision|34|||
27866184|NCT02277990|54451783|FG000|Overall Study|Lost to Follow-up|66|||
27866185|NCT02277990|54451784|FG001|Overall Study|Lost to Follow-up|69|||
27866186|NCT02277990|54451783|FG000|Overall Study|Had other reason|26|||
27866187|NCT02277990|54451784|FG001|Overall Study|Had other reason|32|||
27866188|NCT02317614|54451806|FG000|Overall Study|Lost to Follow-up|1|||
27866189|NCT02317614|54451807|FG001|Overall Study|Lost to Follow-up|1|||
27866190|NCT02317614|54451806|FG000|Overall Study|Withdrawal by Subject|1|||
27866191|NCT02317614|54451807|FG001|Overall Study|Withdrawal by Subject|0|||
27866192|NCT02317614|54451806|FG000|Overall Study|Death|1|||
27866193|NCT02317614|54451807|FG001|Overall Study|Death|1|||
27866194|NCT02276040|54451820|FG000|Overall Study|Physician Decision|15|||
27866195|NCT02315664|54451826|FG000|Overall Study|Lost to Follow-up|1|||
27866196|NCT02315664|54451827|FG001|Overall Study|Lost to Follow-up|1|||
27866197|NCT02315664|54451826|FG000|Overall Study|Withdrawal by Subject|0|||
27866198|NCT02315664|54451827|FG001|Overall Study|Withdrawal by Subject|3|||
27866199|NCT02314728|54451855|FG000|Overall Study|Protocol Violation|1|||
27866200|NCT02314728|54451856|FG001|Overall Study|Protocol Violation|0|||
27866201|NCT02314728|54451855|FG000|Overall Study|Lost to Follow-up|0|||
27866202|NCT02314728|54451856|FG001|Overall Study|Lost to Follow-up|1|||
27866203|NCT02275338|54451875|FG000|Overall Study|Adverse Event|15|||
27866204|NCT02275338|54451875|FG000|Overall Study|Lack of Efficacy|3|||
27866205|NCT02275338|54451875|FG000|Overall Study|Withdrawal by Subject|4|||
27866206|NCT02275338|54451875|FG000|Overall Study|Disease progression (death)|1|||
27866207|NCT02275338|54451875|FG000|Overall Study|Ineligible to start Phase 2|4|||
27866208|NCT02275338|54451875|FG000|Overall Study|Reason not specified|5|||
27866209|NCT02275338|54451875|FG000|Overall Study|Does not meet entry criteria|1|||
27866210|NCT02313558|54451882|FG000|Overall Study|Withdrawal by Subject|2|||
27866211|NCT02313558|54451883|FG001|Overall Study|Withdrawal by Subject|0|||
27866212|NCT02313558|54451882|FG000|Overall Study|Lost to Follow-up|4|||
27866213|NCT02313558|54451883|FG001|Overall Study|Lost to Follow-up|4|||
27866214|NCT01646268|54451911|FG000|Overall Study|Adverse Event|6|||
27866215|NCT01646268|54451912|FG001|Overall Study|Adverse Event|7|||
27866216|NCT01646268|54451911|FG000|Overall Study|Lack of Efficacy|1|||
27866217|NCT01646268|54451912|FG001|Overall Study|Lack of Efficacy|3|||
27866218|NCT01646268|54451911|FG000|Overall Study|Protocol Violation|0|||
27866219|NCT01646268|54451912|FG001|Overall Study|Protocol Violation|1|||
27866220|NCT01646268|54451911|FG000|Overall Study|Withdrawal by Subject|2|||
27866221|NCT01646268|54451912|FG001|Overall Study|Withdrawal by Subject|5|||
27866222|NCT01646268|54451911|FG000|Overall Study|Other|2|||
27866223|NCT01646268|54451912|FG001|Overall Study|Other|0|||
27866224|NCT02275026|54451918|FG000|Overall Study|Ineligible after cognitive baseline testing|11|||
27866225|NCT02275026|54451918|FG000|Overall Study|Withdrawal by Subject|4|||
27866226|NCT02275026|54451918|FG000|Overall Study|Ineligible due to medical history|13|||
27866227|NCT02275026|54451918|FG000|Overall Study|MRI malfunction precluded testing|1|||
27866228|NCT02275026|54451918|FG000|Overall Study|Ineligible after MRI findings|1|||
27866229|NCT02275026|54451918|FG000|Overall Study|Lost to Follow-up|2|||
27866230|NCT02275026|54451918|FG000|Overall Study|Scanner failure|1|||
27866231|NCT02711852|54451985|FG000|Overall Study|Death|5|||
27866232|NCT02711852|54451985|FG000|Overall Study|Lost to Follow-up|1|||
27866233|NCT02711852|54451985|FG000|Overall Study|Completed follow-up|3|||
27866234|NCT02711852|54451985|FG000|Overall Study|Withdrawal by Subject|1|||
27866235|NCT04579250|54452025|FG000|Overall Study|Withdrawal by Subject|1|||
27866236|NCT04579250|54452026|FG001|Overall Study|Withdrawal by Subject|1|||
27866237|NCT04579250|54452027|FG002|Overall Study|Withdrawal by Subject|0|||
27866238|NCT04579250|54452025|FG000|Overall Study|Lost to Follow-up|1|||
27866239|NCT04579250|54452026|FG001|Overall Study|Lost to Follow-up|1|||
27866240|NCT04579250|54452027|FG002|Overall Study|Lost to Follow-up|0|||
27866241|NCT04579250|54452025|FG000|Overall Study|Moved from area|0|||
27866242|NCT04579250|54452026|FG001|Overall Study|Moved from area|1|||
27866243|NCT04579250|54452027|FG002|Overall Study|Moved from area|2|||
27866244|NCT03175367|54452054|FG000|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
27866245|NCT03175367|54452055|FG001|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
27866246|NCT03175367|54452056|FG002|Double-blind Treatment Period (DBTP)|Protocol Violation|1|||
27866247|NCT03175367|54452057|FG003|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
27866248|NCT03175367|54452058|FG004|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
27866249|NCT03175367|54452059|FG005|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
27866250|NCT03175367|54452060|FG006|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
28171378|NCT01370863|54842952|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
27866251|NCT03175367|54452054|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
27866252|NCT03175367|54452055|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
27866253|NCT03175367|54452056|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
27866254|NCT03175367|54452057|FG003|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
27866255|NCT03175367|54452058|FG004|Double-blind Treatment Period (DBTP)|Adverse Event|1|||
27866256|NCT03175367|54452059|FG005|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
27866257|NCT03175367|54452060|FG006|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
27866258|NCT03175367|54452054|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
27866259|NCT03175367|54452055|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
27866260|NCT03175367|54452056|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
27866261|NCT03175367|54452057|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
27866262|NCT03175367|54452058|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
27866263|NCT03175367|54452059|FG005|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
27866264|NCT03175367|54452060|FG006|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
27866265|NCT03175367|54452054|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
27866266|NCT03175367|54452055|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|5|||
27866267|NCT03175367|54452056|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|8|||
27866268|NCT03175367|54452057|FG003|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
27866269|NCT03175367|54452058|FG004|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
27866270|NCT03175367|54452059|FG005|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
27866271|NCT03175367|54452060|FG006|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
27866272|NCT03175367|54452054|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
27866273|NCT03175367|54452055|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
27866274|NCT03175367|54452056|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
27866275|NCT03175367|54452057|FG003|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
27866276|NCT03175367|54452058|FG004|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
27866277|NCT03175367|54452059|FG005|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
27866278|NCT03175367|54452060|FG006|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
27866279|NCT03175367|54452054|FG000|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
27866280|NCT03175367|54452055|FG001|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
27866281|NCT03175367|54452056|FG002|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
27866282|NCT03175367|54452057|FG003|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
27866283|NCT03175367|54452058|FG004|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
27866284|NCT03175367|54452059|FG005|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
27866285|NCT03175367|54452060|FG006|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|1|||
27866286|NCT03175367|54452054|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
27866287|NCT03175367|54452055|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
27866288|NCT03175367|54452056|FG002|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
27866289|NCT03175367|54452057|FG003|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
27866290|NCT03175367|54452058|FG004|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
27866291|NCT03175367|54452059|FG005|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|2|||
27866292|NCT03175367|54452060|FG006|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
27866293|NCT03174275|54452117|FG000|Overall Study (Until End of Surgery)|Adverse Event|4|||
27866294|NCT03174275|54452117|FG000|Overall Study (Until End of Surgery)|Withdrawal by Subject|9|||
27866295|NCT03174275|54452117|FG000|Overall Study (Until End of Surgery)|Lack of Efficacy|1|||
27866296|NCT03174275|54452117|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|6|||
27866297|NCT03174275|54452117|FG000|Adjuvant Chemotherapy|Progression|1|||
27866298|NCT03174275|54452117|FG000|Adjuvant Chemotherapy|Adverse Event|1|||
27866299|NCT03174275|54452117|FG000|Adjuvant Durvalumab|Withdrawal by Subject|6|||
27866300|NCT03174275|54452117|FG000|Adjuvant Durvalumab|Progression|1|||
27866301|NCT03174275|54452117|FG000|Adjuvant Durvalumab|Adverse Event|3|||
27866302|NCT03174275|54452117|FG000|Adjuvant Radiotherapy|Withdrawal by Subject|5|||
27866303|NCT03174275|54452117|FG000|Adjuvant Radiotherapy|Progression|1|||
27866304|NCT03174275|54452117|FG000|Adjuvant Radiotherapy|Adverse Event|1|||
27866305|NCT03990363|54452218|FG000|Overall Study|Withdrawal by Subject|10|||
27866306|NCT03990363|54452219|FG001|Overall Study|Withdrawal by Subject|9|||
27866307|NCT03990363|54452220|FG002|Overall Study|Withdrawal by Subject|18|||
27866308|NCT03990363|54452221|FG003|Overall Study|Withdrawal by Subject|11|||
27866309|NCT03990363|54452222|FG004|Overall Study|Withdrawal by Subject|9|||
27866310|NCT03990363|54452218|FG000|Overall Study|Physician Decision|1|||
27866311|NCT03990363|54452219|FG001|Overall Study|Physician Decision|0|||
27866312|NCT03990363|54452220|FG002|Overall Study|Physician Decision|0|||
27866313|NCT03990363|54452221|FG003|Overall Study|Physician Decision|0|||
27866314|NCT03990363|54452222|FG004|Overall Study|Physician Decision|0|||
27866315|NCT03990363|54452218|FG000|Overall Study|Adverse Event|1|||
27866316|NCT03990363|54452219|FG001|Overall Study|Adverse Event|3|||
27866317|NCT03990363|54452220|FG002|Overall Study|Adverse Event|2|||
27866318|NCT03990363|54452221|FG003|Overall Study|Adverse Event|2|||
27866319|NCT03990363|54452222|FG004|Overall Study|Adverse Event|0|||
27866320|NCT03990363|54452218|FG000|Overall Study|Death|14|||
27866321|NCT03990363|54452219|FG001|Overall Study|Death|8|||
27866322|NCT03990363|54452220|FG002|Overall Study|Death|14|||
27866323|NCT03990363|54452221|FG003|Overall Study|Death|10|||
27866324|NCT03990363|54452222|FG004|Overall Study|Death|11|||
27866325|NCT03990363|54452218|FG000|Overall Study|Failure to meet randomization criteria|0|||
27866326|NCT03990363|54452219|FG001|Overall Study|Failure to meet randomization criteria|1|||
27866327|NCT03990363|54452220|FG002|Overall Study|Failure to meet randomization criteria|1|||
27866328|NCT03990363|54452221|FG003|Overall Study|Failure to meet randomization criteria|0|||
27866329|NCT03990363|54452222|FG004|Overall Study|Failure to meet randomization criteria|0|||
27866330|NCT03990363|54452218|FG000|Overall Study|Lost to Follow-up|0|||
27866331|NCT03990363|54452219|FG001|Overall Study|Lost to Follow-up|0|||
27866332|NCT03990363|54452220|FG002|Overall Study|Lost to Follow-up|0|||
27866333|NCT03990363|54452221|FG003|Overall Study|Lost to Follow-up|1|||
27866334|NCT03990363|54452222|FG004|Overall Study|Lost to Follow-up|2|||
27866335|NCT03990363|54452218|FG000|Overall Study|Non-compliance with study drug|2|||
27866336|NCT03990363|54452219|FG001|Overall Study|Non-compliance with study drug|1|||
27866337|NCT03990363|54452220|FG002|Overall Study|Non-compliance with study drug|2|||
27866338|NCT03990363|54452221|FG003|Overall Study|Non-compliance with study drug|0|||
27866339|NCT03990363|54452222|FG004|Overall Study|Non-compliance with study drug|0|||
27866340|NCT03990363|54452218|FG000|Overall Study|Study terminated by sponsor|0|||
27866341|NCT03990363|54452219|FG001|Overall Study|Study terminated by sponsor|1|||
27866342|NCT03990363|54452220|FG002|Overall Study|Study terminated by sponsor|0|||
27866343|NCT03990363|54452221|FG003|Overall Study|Study terminated by sponsor|0|||
27866344|NCT03990363|54452222|FG004|Overall Study|Study terminated by sponsor|0|||
27866345|NCT03990363|54452218|FG000|Overall Study|Site terminated by sponsor|2|||
27866346|NCT03990363|54452219|FG001|Overall Study|Site terminated by sponsor|1|||
27866347|NCT03990363|54452220|FG002|Overall Study|Site terminated by sponsor|2|||
27866348|NCT03990363|54452221|FG003|Overall Study|Site terminated by sponsor|0|||
27866349|NCT03990363|54452222|FG004|Overall Study|Site terminated by sponsor|2|||
27866350|NCT03990363|54452218|FG000|Overall Study|Not categorized|5|||
27866351|NCT03990363|54452219|FG001|Overall Study|Not categorized|5|||
27866352|NCT03990363|54452220|FG002|Overall Study|Not categorized|3|||
27866353|NCT03990363|54452221|FG003|Overall Study|Not categorized|2|||
27866354|NCT03990363|54452222|FG004|Overall Study|Not categorized|2|||
27866355|NCT04661839|54452292|FG000|Overall Study|Not Treated|0|||
27866356|NCT04661839|54452293|FG001|Overall Study|Not Treated|0|||
27866357|NCT04661839|54452294|FG002|Overall Study|Not Treated|1|||
27866358|NCT04661839|54452295|FG003|Overall Study|Not Treated|0|||
27866359|NCT04661839|54452292|FG000|Overall Study|Lost to Follow-up|1|||
27866360|NCT04661839|54452293|FG001|Overall Study|Lost to Follow-up|0|||
27866361|NCT04661839|54452294|FG002|Overall Study|Lost to Follow-up|0|||
27866362|NCT04661839|54452295|FG003|Overall Study|Lost to Follow-up|1|||
27866363|NCT02240485|54452396|FG000|3 Months Post-admission|Lost to Follow-up|1|||
27866364|NCT02240485|54452397|FG001|3 Months Post-admission|Lost to Follow-up|5|||
27866365|NCT02240485|54452396|FG000|3 Months Post-admission|Withdrawal by Subject|2|||
27866366|NCT02240485|54452397|FG001|3 Months Post-admission|Withdrawal by Subject|1|||
27866367|NCT02240485|54452396|FG000|9 Months Post-admission|Lost to Follow-up|3|||
27866368|NCT02240485|54452397|FG001|9 Months Post-admission|Lost to Follow-up|1|||
27866369|NCT02240485|54452396|FG000|9 Months Post-admission|Withdrawal by Subject|0|||
27866370|NCT02240485|54452397|FG001|9 Months Post-admission|Withdrawal by Subject|3|||
27866371|NCT02240485|54452396|FG000|18 Months Post-admission|Lost to Follow-up|1|||
27866372|NCT02240485|54452397|FG001|18 Months Post-admission|Lost to Follow-up|1|||
27866373|NCT02240485|54452396|FG000|18 Months Post-admission|Withdrawal by Subject|2|||
27866374|NCT02240485|54452397|FG001|18 Months Post-admission|Withdrawal by Subject|4|||
27866375|NCT04149535|54452420|FG000|Overall Study|Death|11|||
27866376|NCT04149535|54452421|FG001|Overall Study|Death|7|||
27866377|NCT04149535|54452420|FG000|Overall Study|Physician Decision|10|||
27866378|NCT04149535|54452421|FG001|Overall Study|Physician Decision|4|||
27866379|NCT04149535|54452420|FG000|Overall Study|Withdrawal by Subject|6|||
27866380|NCT04149535|54452421|FG001|Overall Study|Withdrawal by Subject|7|||
27866381|NCT04149535|54452420|FG000|Overall Study|Not described|2|||
27866382|NCT04149535|54452421|FG001|Overall Study|Not described|0|||
27866383|NCT02210559|54452439|FG000|Overall Study|Progressive Disease|3|||
27866384|NCT02210559|54452440|FG001|Overall Study|Progressive Disease|2|||
28096269|NCT04142216|54751127|FG000|Overall Study|Hospitalization|0|||
28096270|NCT04142216|54751128|FG001|Overall Study|Hospitalization|2|||
28096271|NCT04142216|54751127|FG000|Overall Study|Death|3|||
28096272|NCT04142216|54751128|FG001|Overall Study|Death|1|||
27835126|NCT01587703|54319707|FG006|Part1 QD(Median Exposure of 1.38months)|Death|30|||
27835127|NCT01587703|54319708|FG007|Part1 QD(Median Exposure of 1.38months)|Death|7|||
27835128|NCT01587703|54319709|FG008|Part1 QD(Median Exposure of 1.38months)|Death|0|||
27835129|NCT01587703|54319710|FG009|Part1 QD(Median Exposure of 1.38months)|Death|0|||
27835130|NCT01587703|54319711|FG010|Part1 QD(Median Exposure of 1.38months)|Death|0|||
27835131|NCT01587703|54319712|FG011|Part1 QD(Median Exposure of 1.38months)|Death|0|||
27835132|NCT01587703|54319713|FG012|Part1 QD(Median Exposure of 1.38months)|Death|0|||
27835133|NCT01587703|54319714|FG013|Part1 QD(Median Exposure of 1.38months)|Death|0|||
27835134|NCT01587703|54319715|FG014|Part1 QD(Median Exposure of 1.38months)|Death|0|||
27835135|NCT01587703|54319716|FG015|Part1 QD(Median Exposure of 1.38months)|Death|0|||
27835136|NCT01587703|54319717|FG016|Part1 QD(Median Exposure of 1.38months)|Death|0|||
27835137|NCT01587703|54319718|FG017|Part1 QD(Median Exposure of 1.38months)|Death|0|||
27835138|NCT01587703|54319719|FG018|Part1 QD(Median Exposure of 1.38months)|Death|0|||
27835139|NCT01587703|54319701|FG000|Part1 BID(Median Exposure of 1.41months)|Death|0|||
28096273|NCT04142216|54751127|FG000|Overall Study|Referral to another hemodialysis unit|3|||
27866385|NCT02210559|54452439|FG000|Overall Study|Adverse Event|2|||
27866386|NCT02210559|54452440|FG001|Overall Study|Adverse Event|2|||
27866387|NCT02210559|54452439|FG000|Overall Study|Physician Decision|1|||
27866388|NCT02210559|54452440|FG001|Overall Study|Physician Decision|0|||
27866389|NCT02210559|54452439|FG000|Overall Study|Withdrawal by Subject|0|||
27866390|NCT02210559|54452440|FG001|Overall Study|Withdrawal by Subject|1|||
27866391|NCT02210559|54452439|FG000|Overall Study|Other than specified|0|||
27866392|NCT02210559|54452440|FG001|Overall Study|Other than specified|1|||
27866393|NCT02073279|54452597|FG000|Double-blind Period|Adverse Event|1|||
27866394|NCT02073279|54452598|FG001|Double-blind Period|Adverse Event|1|||
27866395|NCT02073279|54452597|FG000|Double-blind Period|Switched to another treatment|1|||
27866396|NCT02073279|54452598|FG001|Double-blind Period|Switched to another treatment|2|||
27866397|NCT02073279|54452597|FG000|Double-blind Period|Protocol Violation|0|||
27866398|NCT02073279|54452598|FG001|Double-blind Period|Protocol Violation|1|||
27866399|NCT02073279|54452597|FG000|Double-blind Period|Refused Treatment/Did Not Cooperate|0|||
27866400|NCT02073279|54452598|FG001|Double-blind Period|Refused Treatment/Did Not Cooperate|1|||
27866401|NCT02073279|54452597|FG000|Double-blind Period|Withdrawal by Subject|2|||
27866402|NCT02073279|54452598|FG001|Double-blind Period|Withdrawal by Subject|2|||
27866403|NCT02073279|54452597|FG000|Open-label Extension Period|Adverse Event|1|||
27866404|NCT02073279|54452598|FG001|Open-label Extension Period|Adverse Event|0|||
27866405|NCT02073279|54452597|FG000|Open-label Extension Period|Lack of Efficacy|1|||
27866406|NCT02073279|54452598|FG001|Open-label Extension Period|Lack of Efficacy|0|||
27866407|NCT02073279|54452597|FG000|Open-label Extension Period|Lost to Follow-up|0|||
27866408|NCT02073279|54452598|FG001|Open-label Extension Period|Lost to Follow-up|4|||
27866409|NCT02073279|54452597|FG000|Open-label Extension Period|Switched to another treatment|1|||
27866410|NCT02073279|54452598|FG001|Open-label Extension Period|Switched to another treatment|4|||
27866411|NCT02073279|54452597|FG000|Open-label Extension Period|Protocol Violation|0|||
27866412|NCT02073279|54452598|FG001|Open-label Extension Period|Protocol Violation|1|||
27866413|NCT02073279|54452597|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
27866414|NCT02073279|54452598|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
27866415|NCT02073279|54452597|FG000|Open-label Extension Period|Withdrawal by Subject|4|||
27866416|NCT02073279|54452598|FG001|Open-label Extension Period|Withdrawal by Subject|5|||
27866417|NCT01673867|54452854|FG000|Randomization|Adverse event unrelated to study drug|1|||
27866418|NCT01673867|54452855|FG001|Randomization|Adverse event unrelated to study drug|0|||
27866419|NCT01673867|54452854|FG000|Randomization|Participant request to discontinue study treatment|0|||
27866420|NCT01673867|54452855|FG001|Randomization|Participant request to discontinue study treatment|4|||
27866421|NCT01673867|54452854|FG000|Randomization|Withdrawal by participant|0|||
27866422|NCT01673867|54452855|FG001|Randomization|Withdrawal by participant|12|||
27866423|NCT01673867|54452854|FG000|Randomization|Lost to Follow-up|0|||
27866424|NCT01673867|54452855|FG001|Randomization|Lost to Follow-up|1|||
27866425|NCT01673867|54452854|FG000|Randomization|Participant no longer meets study criteria|4|||
27866426|NCT01673867|54452855|FG001|Randomization|Participant no longer meets study criteria|5|||
27866427|NCT01673867|54452854|FG000|Treatment|Disease Progression|208|||
27866428|NCT01673867|54452855|FG001|Treatment|Disease Progression|178|||
27866429|NCT01673867|54452854|FG000|Treatment|Study Drug Toxicity|23|||
27866430|NCT01673867|54452855|FG001|Treatment|Study Drug Toxicity|43|||
27866431|NCT01673867|54452854|FG000|Treatment|Death|2|||
27866432|NCT01673867|54452855|FG001|Treatment|Death|3|||
27866433|NCT01673867|54452854|FG000|Treatment|Adverse event unrelated to study drug|23|||
27866434|NCT01673867|54452855|FG001|Treatment|Adverse event unrelated to study drug|10|||
27866435|NCT01673867|54452854|FG000|Treatment|Participant request to discontinue study treatment|7|||
27866436|NCT01673867|54452855|FG001|Treatment|Participant request to discontinue study treatment|17|||
27866437|NCT01673867|54452854|FG000|Treatment|Withdrawal by participant|5|||
27866438|NCT01673867|54452855|FG001|Treatment|Withdrawal by participant|5|||
27866439|NCT01673867|54452854|FG000|Treatment|Maximum clinical benefit|1|||
27866440|NCT01673867|54452855|FG001|Treatment|Maximum clinical benefit|10|||
27866441|NCT01673867|54452854|FG000|Treatment|Participant no longer meets study criteria|2|||
27866442|NCT01673867|54452855|FG001|Treatment|Participant no longer meets study criteria|0|||
27866443|NCT01673867|54452854|FG000|Treatment|Administrative reason by sponsor|3|||
27866444|NCT01673867|54452855|FG001|Treatment|Administrative reason by sponsor|0|||
27866445|NCT01673867|54452854|FG000|Treatment|Other reason|11|||
27866446|NCT01673867|54452855|FG001|Treatment|Other reason|2|||
27866447|NCT02041533|54452951|FG000|Pre-Treatment Period|Disease Progression|1|||
27866448|NCT02041533|54452952|FG001|Pre-Treatment Period|Disease Progression|1|||
27866449|NCT02041533|54452951|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
27866450|NCT02041533|54452952|FG001|Pre-Treatment Period|Participant Withdrew Consent|5|||
27866451|NCT02041533|54452951|FG000|Pre-Treatment Period|Participant no Longer Meets Study Criteria|3|||
27866452|NCT02041533|54452952|FG001|Pre-Treatment Period|Participant no Longer Meets Study Criteria|1|||
27866453|NCT02041533|54452951|FG000|Treatment Period|Disease progression|189|||
27866454|NCT02041533|54452952|FG001|Treatment Period|Disease progression|146|||
27866455|NCT02041533|54452951|FG000|Treatment Period|Study drug toxicity|30|||
27866456|NCT02041533|54452952|FG001|Treatment Period|Study drug toxicity|34|||
27866457|NCT02041533|54452951|FG000|Treatment Period|Death|1|||
27866458|NCT02041533|54452952|FG001|Treatment Period|Death|0|||
27866459|NCT02041533|54452951|FG000|Treatment Period|Adverse event unrelated to study drug|22|||
27866460|NCT02041533|54452952|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
27866461|NCT02041533|54452951|FG000|Treatment Period|Participant request to discontinue study treatment|12|||
27866462|NCT02041533|54452952|FG001|Treatment Period|Participant request to discontinue study treatment|9|||
27866463|NCT02041533|54452951|FG000|Treatment Period|Participant withdrew consent|2|||
27866464|NCT02041533|54452952|FG001|Treatment Period|Participant withdrew consent|2|||
27866465|NCT02041533|54452951|FG000|Treatment Period|Maximum clinical benefit|0|||
27866466|NCT02041533|54452952|FG001|Treatment Period|Maximum clinical benefit|18|||
27866467|NCT02041533|54452951|FG000|Treatment Period|Poor/Non-compliance|1|||
27982200|NCT03164564|54640207|FG000|Overall Study|Death|3|||
27982201|NCT03164564|54640208|FG001|Overall Study|Death|0|||
27982202|NCT03164564|54640207|FG000|Overall Study|Withdrawal by Subject|20|||
27982203|NCT03164564|54640208|FG001|Overall Study|Withdrawal by Subject|15|||
27982204|NCT03164564|54640207|FG000|Overall Study|Lost to Follow-up|2|||
27982205|NCT03164564|54640208|FG001|Overall Study|Lost to Follow-up|0|||
27982206|NCT03164564|54640207|FG000|Overall Study|Physician Decision|0|||
27982207|NCT03164564|54640208|FG001|Overall Study|Physician Decision|1|||
27982208|NCT03164564|54640207|FG000|Overall Study|Adverse Event|0|||
27982209|NCT03164564|54640208|FG001|Overall Study|Adverse Event|1|||
27982210|NCT03164564|54640207|FG000|Overall Study|Ongoing|1586|||
27982211|NCT03164564|54640208|FG001|Overall Study|Ongoing|1586|||
27982212|NCT02821754|54640228|FG000|Overall Study|Procedure not required prior to amendment change|13|||
27982213|NCT02821754|54640229|FG001|Overall Study|Procedure not required prior to amendment change|11|||
27982214|NCT02821754|54640230|FG002|Overall Study|Procedure not required prior to amendment change|0|||
27982215|NCT02821754|54640228|FG000|Overall Study|Participant's Clinical status|2|||
27982216|NCT02821754|54640229|FG001|Overall Study|Participant's Clinical status|0|||
27982217|NCT02821754|54640230|FG002|Overall Study|Participant's Clinical status|0|||
27982218|NCT02821754|54640228|FG000|Overall Study|Participant removed for noncompliance|1|||
27982219|NCT02821754|54640229|FG001|Overall Study|Participant removed for noncompliance|0|||
27982220|NCT02821754|54640230|FG002|Overall Study|Participant removed for noncompliance|0|||
27982221|NCT02821754|54640228|FG000|Overall Study|Drug not available.|0|||
27982222|NCT02821754|54640229|FG001|Overall Study|Drug not available.|0|||
27982223|NCT02821754|54640230|FG002|Overall Study|Drug not available.|1|||
27982224|NCT02821754|54640228|FG000|Overall Study|Participant declined to participate (before treatment started.)|0|||
27982225|NCT02821754|54640229|FG001|Overall Study|Participant declined to participate (before treatment started.)|1|||
27982226|NCT02821754|54640230|FG002|Overall Study|Participant declined to participate (before treatment started.)|1|||
27982227|NCT02742246|54640239|FG000|Overall Study|Never initiated treatment|5|||
28096274|NCT04142216|54751128|FG001|Overall Study|Referral to another hemodialysis unit|2|||
28096275|NCT04142216|54751127|FG000|Overall Study|Use of clove|0|||
28096276|NCT04142216|54751128|FG001|Overall Study|Use of clove|1|||
28096277|NCT04140890|54751136|FG000|Overall Study|Withdrawal by Subject|0|||
28096278|NCT04140890|54751137|FG001|Overall Study|Withdrawal by Subject|1|||
28096279|NCT03700320|54751148|FG000|Overall Study|Adverse Event|5|||
28096280|NCT03700320|54751149|FG001|Overall Study|Adverse Event|31|||
28096281|NCT03700320|54751148|FG000|Overall Study|Lack of Efficacy|2|||
28096282|NCT03700320|54751149|FG001|Overall Study|Lack of Efficacy|5|||
28096283|NCT03700320|54751148|FG000|Overall Study|Withdrawal by Subject|29|||
28096284|NCT03700320|54751149|FG001|Overall Study|Withdrawal by Subject|75|||
28096285|NCT03700320|54751148|FG000|Overall Study|Lost to Follow-up|16|||
28096286|NCT03700320|54751149|FG001|Overall Study|Lost to Follow-up|23|||
28096287|NCT03700320|54751148|FG000|Overall Study|Pregnancy|2|||
28096288|NCT03700320|54751149|FG001|Overall Study|Pregnancy|4|||
28096289|NCT03700320|54751148|FG000|Overall Study|Protocol Deviation|7|||
28096290|NCT03700320|54751149|FG001|Overall Study|Protocol Deviation|31|||
28096291|NCT03700320|54751148|FG000|Overall Study|Non-compliance with Study Drug|1|||
27982228|NCT02742246|54640240|FG001|Overall Study|Never initiated treatment|3|||
27982229|NCT02742246|54640241|FG002|Overall Study|Never initiated treatment|1|||
27982230|NCT02742246|54640239|FG000|Overall Study|dropped out during treatment|14|||
27982231|NCT02742246|54640240|FG001|Overall Study|dropped out during treatment|14|||
27982232|NCT02742246|54640241|FG002|Overall Study|dropped out during treatment|11|||
28096292|NCT03700320|54751149|FG001|Overall Study|Non-compliance with Study Drug|3|||
28096293|NCT03700320|54751148|FG000|Overall Study|Reason not Specified|0|||
28096294|NCT03700320|54751149|FG001|Overall Study|Reason not Specified|1|||
28096295|NCT04139018|54751157|FG000|Overall Study|Screen fail|1|||
28096296|NCT04139018|54751158|FG001|Overall Study|Screen fail|0|||
28096297|NCT04139018|54751157|FG000|Overall Study|Withdrawal by Subject|2|||
28096298|NCT04139018|54751158|FG001|Overall Study|Withdrawal by Subject|0|||
28096299|NCT04139018|54751157|FG000|Overall Study|Lost to Follow-up|0|||
28096300|NCT04139018|54751158|FG001|Overall Study|Lost to Follow-up|1|||
28096301|NCT04456686|54751166|FG000|Overall Study|Adverse Event|2|||
27866468|NCT02041533|54452952|FG001|Treatment Period|Poor/Non-compliance|0|||
28096302|NCT04456686|54751167|FG001|Overall Study|Adverse Event|1|||
27866469|NCT02041533|54452951|FG000|Treatment Period|Administrative reason by sponsor|1|||
27866470|NCT02041533|54452952|FG001|Treatment Period|Administrative reason by sponsor|0|||
27866471|NCT02041533|54452951|FG000|Treatment Period|Other reasons|9|||
27866472|NCT02041533|54452952|FG001|Treatment Period|Other reasons|2|||
27866473|NCT02041533|54452951|FG000|Treatment Period|Not Reported|0|||
27866474|NCT02041533|54452952|FG001|Treatment Period|Not Reported|1|||
27866475|NCT02907203|54452959|FG000|Overall Study|Death|1|||
27866476|NCT02907203|54452959|FG000|Overall Study|Lost to Follow-up|3|||
27866477|NCT02907203|54452959|FG000|Overall Study|Withdrawal by Subject|3|||
27866478|NCT02907203|54452959|FG000|Overall Study|Surgical bypass|1|||
27866479|NCT00559585|54454121|FG000|Double Blind ST Period Main Study|Adverse Event|17|||
27866480|NCT00559585|54454122|FG001|Double Blind ST Period Main Study|Adverse Event|25|||
27866481|NCT00559585|54454121|FG000|Double Blind ST Period Main Study|Withdrawal by Subject|11|||
27866482|NCT00559585|54454122|FG001|Double Blind ST Period Main Study|Withdrawal by Subject|5|||
27866483|NCT00559585|54454121|FG000|Double Blind ST Period Main Study|Lost to Follow-up|0|||
27866484|NCT00559585|54454122|FG001|Double Blind ST Period Main Study|Lost to Follow-up|6|||
27866485|NCT00559585|54454121|FG000|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1|||
27866486|NCT00559585|54454122|FG001|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0|||
27866487|NCT00559585|54454121|FG000|Double Blind ST Period Main Study|Death|1|||
27866488|NCT00559585|54454122|FG001|Double Blind ST Period Main Study|Death|1|||
27866489|NCT00559585|54454121|FG000|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2|||
27866490|NCT00559585|54454122|FG001|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1|||
27866491|NCT00559585|54454121|FG000|Double Blind ST Period Main Study|Lack of Efficacy|6|||
27866492|NCT00559585|54454122|FG001|Double Blind ST Period Main Study|Lack of Efficacy|1|||
27866493|NCT00559585|54454121|FG000|Double Blind ST Period Main Study|Poor/Non-Compliance|3|||
27866494|NCT00559585|54454122|FG001|Double Blind ST Period Main Study|Poor/Non-Compliance|0|||
27866495|NCT00559585|54454121|FG000|Double Blind ST Period Main Study|Missed Doses|0|||
27866496|NCT00559585|54454122|FG001|Double Blind ST Period Main Study|Missed Doses|1|||
27866497|NCT00559585|54454121|FG000|Double Blind ST Period Main Study|Incomplete Breast Exam|0|||
27866498|NCT00559585|54454122|FG001|Double Blind ST Period Main Study|Incomplete Breast Exam|1|||
27866499|NCT00559585|54454121|FG000|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0|||
27866500|NCT00559585|54454122|FG001|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1|||
27866501|NCT00559585|54454121|FG000|Double Blind ST Period Main Study|Early Discontinuation|0|||
27866502|NCT00559585|54454122|FG001|Double Blind ST Period Main Study|Early Discontinuation|1|||
27866503|NCT00559585|54454121|FG000|Double Blind ST Period Main Study|Participant Weight Gain|1|||
27866504|NCT00559585|54454122|FG001|Double Blind ST Period Main Study|Participant Weight Gain|0|||
27866505|NCT00559585|54454121|FG000|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0|||
27866506|NCT00559585|54454122|FG001|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1|||
27866507|NCT00559585|54454121|FG000|Double Blind ST Period Main Study|Investigator Decision|0|||
27866508|NCT00559585|54454122|FG001|Double Blind ST Period Main Study|Investigator Decision|1|||
27866509|NCT00559585|54454121|FG000|Double Blind ST Period Main Study|Ongoing Infection Risk|1|||
27866510|NCT00559585|54454122|FG001|Double Blind ST Period Main Study|Ongoing Infection Risk|0|||
27866511|NCT00559585|54454121|FG000|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
27866512|NCT00559585|54454122|FG001|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
27866513|NCT00559585|54454121|FG000|Open Label LT Period Main + Sub-Study|Adverse Event|100|||
27866514|NCT00559585|54454122|FG001|Open Label LT Period Main + Sub-Study|Adverse Event|0|||
27866515|NCT00559585|54454121|FG000|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81|||
27866516|NCT00559585|54454122|FG001|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0|||
27866517|NCT00559585|54454121|FG000|Open Label LT Period Main + Sub-Study|Pregnancy|16|||
27866518|NCT00559585|54454122|FG001|Open Label LT Period Main + Sub-Study|Pregnancy|0|||
27866519|NCT00559585|54454121|FG000|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32|||
27866520|NCT00559585|54454122|FG001|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0|||
27866521|NCT00559585|54454121|FG000|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9|||
27866522|NCT00559585|54454122|FG001|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0|||
27866523|NCT00559585|54454121|FG000|Open Label LT Period Main + Sub-Study|Death|20|||
27982233|NCT02742246|54640239|FG000|Overall Study|Death|1|||
27982234|NCT02742246|54640240|FG001|Overall Study|Death|0|||
27982235|NCT02742246|54640241|FG002|Overall Study|Death|0|||
28096303|NCT04456686|54751166|FG000|Overall Study|Lack of Efficacy|3|||
28096304|NCT04456686|54751167|FG001|Overall Study|Lack of Efficacy|1|||
27866524|NCT00559585|54454122|FG001|Open Label LT Period Main + Sub-Study|Death|0|||
27866525|NCT00559585|54454121|FG000|Open Label LT Period Main + Sub-Study|No longer met criteria|1|||
27866526|NCT00559585|54454122|FG001|Open Label LT Period Main + Sub-Study|No longer met criteria|0|||
27866527|NCT00559585|54454121|FG000|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89|||
27866528|NCT00559585|54454122|FG001|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0|||
27982236|NCT02708108|54640251|FG000|Overall Study|Death|1|||
28096305|NCT04456686|54751166|FG000|Overall Study|Withdrew consent|3|||
28096306|NCT04456686|54751167|FG001|Overall Study|Withdrew consent|1|||
28096307|NCT04456686|54751166|FG000|Overall Study|Physician Decision|2|||
27866529|NCT00559585|54454121|FG000|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8|||
27866530|NCT00559585|54454122|FG001|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0|||
27866531|NCT00559585|54454121|FG000|Open Label LT Period Main + Sub-Study|non-specified|71|||
27866532|NCT00559585|54454122|FG001|Open Label LT Period Main + Sub-Study|non-specified|0|||
27866533|NCT00559585|54454121|FG000|Open Label LT Period Main + Sub-Study|no end of study status page|1|||
27866534|NCT00559585|54454122|FG001|Open Label LT Period Main + Sub-Study|no end of study status page|0|||
27866535|NCT00559507|54454162|FG000|Overall Study|Not treated, patient ineligible|3|||
27866536|NCT00559273|54454430|FG000|Correction Period (20 Weeks)|Death|3|||
27866537|NCT00559273|54454431|FG001|Correction Period (20 Weeks)|Death|4|||
27866538|NCT00559273|54454430|FG000|Correction Period (20 Weeks)|Adverse Event|2|||
27866539|NCT00559273|54454431|FG001|Correction Period (20 Weeks)|Adverse Event|1|||
27866540|NCT00559273|54454430|FG000|Correction Period (20 Weeks)|Withdrawal by Subject|2|||
27866541|NCT00559273|54454431|FG001|Correction Period (20 Weeks)|Withdrawal by Subject|6|||
27866542|NCT00559273|54454430|FG000|Correction Period (20 Weeks)|Participant treated by another center|0|||
27866543|NCT00559273|54454431|FG001|Correction Period (20 Weeks)|Participant treated by another center|1|||
27866544|NCT00559273|54454430|FG000|Correction Period (20 Weeks)|Did not received study treatment|2|||
27866545|NCT00559273|54454431|FG001|Correction Period (20 Weeks)|Did not received study treatment|0|||
27866546|NCT00559273|54454430|FG000|Evaluation Period (8 Weeks)|Death|1|||
27866547|NCT00559273|54454431|FG001|Evaluation Period (8 Weeks)|Death|3|||
27866548|NCT00559273|54454430|FG000|Evaluation Period (8 Weeks)|Adverse Event|0|||
27866549|NCT00559273|54454431|FG001|Evaluation Period (8 Weeks)|Adverse Event|1|||
27866550|NCT00559273|54454430|FG000|Evaluation Period (8 Weeks)|Withdrawal by Subject|2|||
27866551|NCT00559273|54454431|FG001|Evaluation Period (8 Weeks)|Withdrawal by Subject|0|||
27866552|NCT00559273|54454430|FG000|Evaluation Period (8 Weeks)|Physician Decision|0|||
27866553|NCT00559273|54454431|FG001|Evaluation Period (8 Weeks)|Physician Decision|1|||
27866554|NCT00558259|54454486|FG000|Overall Study|Adverse Event|50|||
27866555|NCT00558259|54454487|FG001|Overall Study|Adverse Event|81|||
27866556|NCT00558259|54454486|FG000|Overall Study|Protocol Violation|9|||
27866557|NCT00558259|54454487|FG001|Overall Study|Protocol Violation|5|||
27866558|NCT00558259|54454486|FG000|Overall Study|Withdrawal by Subject|12|||
27866559|NCT00558259|54454487|FG001|Overall Study|Withdrawal by Subject|13|||
27835140|NCT01587703|54319702|FG001|Part1 BID(Median Exposure of 1.41months)|Death|0|||
27835141|NCT01587703|54319703|FG002|Part1 BID(Median Exposure of 1.41months)|Death|0|||
27835142|NCT01587703|54319704|FG003|Part1 BID(Median Exposure of 1.41months)|Death|0|||
27835143|NCT01587703|54319705|FG004|Part1 BID(Median Exposure of 1.41months)|Death|0|||
27835144|NCT01587703|54319706|FG005|Part1 BID(Median Exposure of 1.41months)|Death|0|||
27835145|NCT01587703|54319707|FG006|Part1 BID(Median Exposure of 1.41months)|Death|0|||
27835146|NCT01587703|54319708|FG007|Part1 BID(Median Exposure of 1.41months)|Death|0|||
27835147|NCT01587703|54319709|FG008|Part1 BID(Median Exposure of 1.41months)|Death|1|||
27835148|NCT01587703|54319710|FG009|Part1 BID(Median Exposure of 1.41months)|Death|9|||
27866560|NCT00558103|54454634|FG000|Randomized Treatment Phase|Lost to Follow-up|2|||
27866561|NCT00558103|54454635|FG001|Randomized Treatment Phase|Lost to Follow-up|2|||
27866562|NCT00558103|54454636|FG002|Randomized Treatment Phase|Lost to Follow-up|2|||
27866563|NCT00558103|54454637|FG003|Randomized Treatment Phase|Lost to Follow-up|1|||
27866564|NCT00558103|54454638|FG004|Randomized Treatment Phase|Lost to Follow-up|3|||
27866565|NCT00558103|54454639|FG005|Randomized Treatment Phase|Lost to Follow-up|0|||
27866566|NCT00558103|54454634|FG000|Randomized Treatment Phase|Withdrawal by Subject|2|||
27866567|NCT00558103|54454635|FG001|Randomized Treatment Phase|Withdrawal by Subject|2|||
27866568|NCT00558103|54454636|FG002|Randomized Treatment Phase|Withdrawal by Subject|0|||
27866569|NCT00558103|54454637|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
27866570|NCT00558103|54454638|FG004|Randomized Treatment Phase|Withdrawal by Subject|1|||
27866571|NCT00558103|54454639|FG005|Randomized Treatment Phase|Withdrawal by Subject|0|||
27866572|NCT00558103|54454634|FG000|Randomized Treatment Phase|Disease Progression|1|||
27866573|NCT00558103|54454635|FG001|Randomized Treatment Phase|Disease Progression|0|||
27866574|NCT00558103|54454636|FG002|Randomized Treatment Phase|Disease Progression|1|||
27866575|NCT00558103|54454637|FG003|Randomized Treatment Phase|Disease Progression|0|||
27866576|NCT00558103|54454638|FG004|Randomized Treatment Phase|Disease Progression|0|||
27866577|NCT00558103|54454639|FG005|Randomized Treatment Phase|Disease Progression|0|||
27866578|NCT00558103|54454634|FG000|Randomized Treatment Phase|Adverse Event|0|||
27866579|NCT00558103|54454635|FG001|Randomized Treatment Phase|Adverse Event|0|||
28096308|NCT04456686|54751167|FG001|Overall Study|Physician Decision|2|||
27835149|NCT01587703|54319711|FG010|Part1 BID(Median Exposure of 1.41months)|Death|3|||
27866580|NCT00558103|54454636|FG002|Randomized Treatment Phase|Adverse Event|0|||
27866581|NCT00558103|54454637|FG003|Randomized Treatment Phase|Adverse Event|1|||
27866582|NCT00558103|54454638|FG004|Randomized Treatment Phase|Adverse Event|1|||
27866583|NCT00558103|54454639|FG005|Randomized Treatment Phase|Adverse Event|0|||
27866584|NCT00558103|54454634|FG000|Monotherapy Extension Phase|Protocol Violation|0|||
27866585|NCT00558103|54454635|FG001|Monotherapy Extension Phase|Protocol Violation|0|||
28096309|NCT04456686|54751166|FG000|Overall Study|Withdrawal by Subject|5|||
27835150|NCT01587703|54319712|FG011|Part1 BID(Median Exposure of 1.41months)|Death|0|||
27866586|NCT00558103|54454636|FG002|Monotherapy Extension Phase|Protocol Violation|0|||
27866587|NCT00558103|54454637|FG003|Monotherapy Extension Phase|Protocol Violation|0|||
27866588|NCT00558103|54454638|FG004|Monotherapy Extension Phase|Protocol Violation|0|||
27866589|NCT00558103|54454639|FG005|Monotherapy Extension Phase|Protocol Violation|1|||
27866590|NCT00558103|54454634|FG000|Monotherapy Extension Phase|Disease Progression|0|||
27866591|NCT00558103|54454635|FG001|Monotherapy Extension Phase|Disease Progression|0|||
27866592|NCT00558103|54454636|FG002|Monotherapy Extension Phase|Disease Progression|0|||
27866593|NCT00558103|54454637|FG003|Monotherapy Extension Phase|Disease Progression|0|||
27866594|NCT00558103|54454638|FG004|Monotherapy Extension Phase|Disease Progression|0|||
27866595|NCT00558103|54454639|FG005|Monotherapy Extension Phase|Disease Progression|8|||
27866596|NCT00558025|54454676|FG000|Overall Study|Adverse Event|1|||
27866597|NCT00558025|54454677|FG001|Overall Study|Adverse Event|1|||
27866598|NCT00558025|54454676|FG000|Overall Study|Withdrawal by Subject|2|||
27866599|NCT00558025|54454677|FG001|Overall Study|Withdrawal by Subject|2|||
27866600|NCT00558025|54454676|FG000|Overall Study|Protocol Violation|1|||
27866601|NCT00558025|54454677|FG001|Overall Study|Protocol Violation|0|||
27866602|NCT00557323|54454730|FG000|Overall Study|Death|3|||
27866603|NCT00557323|54454730|FG000|Overall Study|Withdrawal by Subject|2|||
27866604|NCT00557323|54454730|FG000|Overall Study|Administrative change|2|||
27866605|NCT00557245|54454764|FG000|Overall Study|Lost to Follow-up|7|||
27866606|NCT00557245|54454765|FG001|Overall Study|Lost to Follow-up|8|||
27866607|NCT00557245|54454766|FG002|Overall Study|Lost to Follow-up|10|||
27866608|NCT00557245|54454764|FG000|Overall Study|Ineligible|5|||
27866609|NCT00557245|54454765|FG001|Overall Study|Ineligible|4|||
27866610|NCT00557245|54454766|FG002|Overall Study|Ineligible|2|||
27866611|NCT00556075|54454827|FG000|Overall Study|Lost to Follow-up|3|||
27866612|NCT00556075|54454828|FG001|Overall Study|Lost to Follow-up|0|||
27866613|NCT00556075|54454829|FG002|Overall Study|Lost to Follow-up|3|||
27866614|NCT00556075|54454827|FG000|Overall Study|Withdrawal by Subject|3|||
27866615|NCT00556075|54454828|FG001|Overall Study|Withdrawal by Subject|3|||
27866616|NCT00556075|54454829|FG002|Overall Study|Withdrawal by Subject|0|||
27866617|NCT00556075|54454827|FG000|Overall Study|Protocol Violation|1|||
27866618|NCT00556075|54454828|FG001|Overall Study|Protocol Violation|1|||
27866619|NCT00556075|54454829|FG002|Overall Study|Protocol Violation|3|||
27866620|NCT00556075|54454827|FG000|Overall Study|Not eligible|1|||
27866621|NCT00556075|54454828|FG001|Overall Study|Not eligible|1|||
27866622|NCT00556075|54454829|FG002|Overall Study|Not eligible|2|||
27866623|NCT00556075|54454827|FG000|Overall Study|Adverse Event|1|||
27866624|NCT00556075|54454828|FG001|Overall Study|Adverse Event|2|||
27866625|NCT00556075|54454829|FG002|Overall Study|Adverse Event|0|||
27866626|NCT00556075|54454827|FG000|Overall Study|Personal issues|4|||
27866627|NCT00556075|54454828|FG001|Overall Study|Personal issues|1|||
27866628|NCT00556075|54454829|FG002|Overall Study|Personal issues|0|||
27866629|NCT00556075|54454827|FG000|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
27866630|NCT00556075|54454828|FG001|Overall Study|Endometrial stripe not viewed on 2 tvu|1|||
27866631|NCT00556075|54454829|FG002|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
27866632|NCT02289690|54454860|FG000|Overall Study|Adverse Event Related to Progression|0|||
27866633|NCT02289690|54454861|FG001|Overall Study|Adverse Event Related to Progression|1|||
27866634|NCT02289690|54454862|FG002|Overall Study|Adverse Event Related to Progression|1|||
27866635|NCT02289690|54454863|FG003|Overall Study|Adverse Event Related to Progression|0|||
27866636|NCT02289690|54454864|FG004|Overall Study|Adverse Event Related to Progression|1|||
27866637|NCT02289690|54454865|FG005|Overall Study|Adverse Event Related to Progression|0|||
27866638|NCT02289690|54454866|FG006|Overall Study|Adverse Event Related to Progression|1|||
27866639|NCT02289690|54454867|FG007|Overall Study|Adverse Event Related to Progression|0|||
27866640|NCT02289690|54454868|FG008|Overall Study|Adverse Event Related to Progression|0|||
27866641|NCT02289690|54454869|FG009|Overall Study|Adverse Event Related to Progression|0|||
27866642|NCT02289690|54454860|FG000|Overall Study|Withdrawal by Subject|1|||
27866643|NCT02289690|54454861|FG001|Overall Study|Withdrawal by Subject|0|||
27866644|NCT02289690|54454862|FG002|Overall Study|Withdrawal by Subject|0|||
27866645|NCT02289690|54454863|FG003|Overall Study|Withdrawal by Subject|0|||
27866646|NCT02289690|54454864|FG004|Overall Study|Withdrawal by Subject|1|||
27866647|NCT02289690|54454865|FG005|Overall Study|Withdrawal by Subject|1|||
27866648|NCT02289690|54454866|FG006|Overall Study|Withdrawal by Subject|0|||
27866649|NCT02289690|54454867|FG007|Overall Study|Withdrawal by Subject|0|||
27866650|NCT02289690|54454868|FG008|Overall Study|Withdrawal by Subject|4|||
27866651|NCT02289690|54454869|FG009|Overall Study|Withdrawal by Subject|2|||
27866652|NCT02289690|54454860|FG000|Overall Study|Progressive Disease, Per Protocol|3|||
27866653|NCT02289690|54454861|FG001|Overall Study|Progressive Disease, Per Protocol|2|||
27866654|NCT02289690|54454862|FG002|Overall Study|Progressive Disease, Per Protocol|3|||
27866655|NCT02289690|54454863|FG003|Overall Study|Progressive Disease, Per Protocol|2|||
27866656|NCT02289690|54454864|FG004|Overall Study|Progressive Disease, Per Protocol|5|||
27866657|NCT02289690|54454865|FG005|Overall Study|Progressive Disease, Per Protocol|13|||
27866658|NCT02289690|54454866|FG006|Overall Study|Progressive Disease, Per Protocol|2|||
28096310|NCT04456686|54751167|FG001|Overall Study|Withdrawal by Subject|1|||
27866659|NCT02289690|54454867|FG007|Overall Study|Progressive Disease, Per Protocol|0|||
27866660|NCT02289690|54454868|FG008|Overall Study|Progressive Disease, Per Protocol|0|||
27866661|NCT02289690|54454869|FG009|Overall Study|Progressive Disease, Per Protocol|0|||
27866662|NCT02289690|54454860|FG000|Overall Study|Lost to Follow-up|0|||
27866663|NCT02289690|54454861|FG001|Overall Study|Lost to Follow-up|0|||
27866664|NCT02289690|54454862|FG002|Overall Study|Lost to Follow-up|0|||
27866665|NCT02289690|54454863|FG003|Overall Study|Lost to Follow-up|0|||
27866666|NCT02289690|54454864|FG004|Overall Study|Lost to Follow-up|0|||
27866667|NCT02289690|54454865|FG005|Overall Study|Lost to Follow-up|0|||
27866668|NCT02289690|54454866|FG006|Overall Study|Lost to Follow-up|0|||
27866669|NCT02289690|54454867|FG007|Overall Study|Lost to Follow-up|1|||
27866670|NCT02289690|54454868|FG008|Overall Study|Lost to Follow-up|0|||
27866671|NCT02289690|54454869|FG009|Overall Study|Lost to Follow-up|2|||
27866672|NCT02289690|54454860|FG000|Overall Study|Death|0|||
27866673|NCT02289690|54454861|FG001|Overall Study|Death|0|||
27866674|NCT02289690|54454862|FG002|Overall Study|Death|0|||
27866675|NCT02289690|54454863|FG003|Overall Study|Death|0|||
27866676|NCT02289690|54454864|FG004|Overall Study|Death|0|||
27866677|NCT02289690|54454865|FG005|Overall Study|Death|0|||
27866678|NCT02289690|54454866|FG006|Overall Study|Death|0|||
27866679|NCT02289690|54454867|FG007|Overall Study|Death|49|||
27866680|NCT02289690|54454868|FG008|Overall Study|Death|45|||
27866681|NCT02289690|54454869|FG009|Overall Study|Death|41|||
27866682|NCT02289690|54454860|FG000|Overall Study|Sponsor Discontinued Study|0|||
27866683|NCT02289690|54454861|FG001|Overall Study|Sponsor Discontinued Study|0|||
27866684|NCT02289690|54454862|FG002|Overall Study|Sponsor Discontinued Study|0|||
27866685|NCT02289690|54454863|FG003|Overall Study|Sponsor Discontinued Study|0|||
27866686|NCT02289690|54454864|FG004|Overall Study|Sponsor Discontinued Study|0|||
27866687|NCT02289690|54454865|FG005|Overall Study|Sponsor Discontinued Study|0|||
27866688|NCT02289690|54454866|FG006|Overall Study|Sponsor Discontinued Study|0|||
27866689|NCT02289690|54454867|FG007|Overall Study|Sponsor Discontinued Study|9|||
27866690|NCT02289690|54454868|FG008|Overall Study|Sponsor Discontinued Study|7|||
27866691|NCT02289690|54454869|FG009|Overall Study|Sponsor Discontinued Study|15|||
27866692|NCT02289690|54454860|FG000|Overall Study|Other|0|||
27866693|NCT02289690|54454861|FG001|Overall Study|Other|0|||
27866694|NCT02289690|54454862|FG002|Overall Study|Other|0|||
27866695|NCT02289690|54454863|FG003|Overall Study|Other|1|||
27866696|NCT02289690|54454864|FG004|Overall Study|Other|1|||
27866697|NCT02289690|54454865|FG005|Overall Study|Other|0|||
27866698|NCT02289690|54454866|FG006|Overall Study|Other|1|||
27866699|NCT02289690|54454867|FG007|Overall Study|Other|2|||
27866700|NCT02289690|54454868|FG008|Overall Study|Other|3|||
27866701|NCT02289690|54454869|FG009|Overall Study|Other|1|||
27866702|NCT02289456|54454972|FG000|Induction Period|Death|2|||
27866703|NCT02289456|54454972|FG000|Induction Period|Adverse Event|11|||
27866704|NCT02289456|54454972|FG000|Induction Period|Progressive Disease (PD)|4|||
27866705|NCT02289456|54454972|FG000|Induction Period|Symptomatic Deterioration|4|||
27866706|NCT02289456|54454972|FG000|Induction Period|Withdrawal by Subject|2|||
27866707|NCT02289456|54454972|FG000|Induction Period|Miscellaneous|1|||
27866708|NCT02289456|54454972|FG000|Monotherapy Period|Death|1|||
27866709|NCT02289456|54454972|FG000|Monotherapy Period|Adverse Event|1|||
27866710|NCT02289456|54454972|FG000|Monotherapy Period|Progressive Disease (PD)|8|||
27866711|NCT02289456|54454972|FG000|Monotherapy Period|Symptomatic Deterioration|1|||
27866712|NCT02289456|54454972|FG000|Monotherapy Period|Withdrawal by Subject|2|||
27866713|NCT02289456|54454972|FG000|Monotherapy Period|Study Terminated by Sponsor|2|||
27866714|NCT02289456|54454972|FG000|Monotherapy Period|Miscellaneous|1|||
27866715|NCT02274948|54455021|FG000|Overall Study|Lost to Follow-up|28|||
27866716|NCT02274948|54455022|FG001|Overall Study|Lost to Follow-up|25|||
27866717|NCT02274948|54455021|FG000|Overall Study|Withdrawal by Subject|64|||
27866718|NCT02274948|54455022|FG001|Overall Study|Withdrawal by Subject|58|||
27866719|NCT02274948|54455021|FG000|Overall Study|Stopped on family Practitioner advice|2|||
28096311|NCT04456686|54751166|FG000|Overall Study|Protocol Violation|0|||
27835151|NCT01587703|54319713|FG012|Part1 BID(Median Exposure of 1.41months)|Death|0|||
27866720|NCT02274948|54455022|FG001|Overall Study|Stopped on family Practitioner advice|5|||
27866721|NCT02274948|54455021|FG000|Overall Study|Left the area|4|||
28096312|NCT04456686|54751167|FG001|Overall Study|Protocol Violation|1|||
27835152|NCT01587703|54319714|FG013|Part1 BID(Median Exposure of 1.41months)|Death|0|||
27835153|NCT01587703|54319715|FG014|Part1 BID(Median Exposure of 1.41months)|Death|0|||
27835154|NCT01587703|54319716|FG015|Part1 BID(Median Exposure of 1.41months)|Death|0|||
27835155|NCT01587703|54319717|FG016|Part1 BID(Median Exposure of 1.41months)|Death|0|||
27835156|NCT01587703|54319718|FG017|Part1 BID(Median Exposure of 1.41months)|Death|0|||
27835157|NCT01587703|54319719|FG018|Part1 BID(Median Exposure of 1.41months)|Death|0|||
27835158|NCT01587703|54319701|FG000|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
27866722|NCT02274948|54455022|FG001|Overall Study|Left the area|3|||
27866723|NCT02274792|54455038|FG000|Overall Study|Withdrawal by Subject|13|||
27866724|NCT02274792|54455038|FG000|Overall Study|Lost to Follow-up|8|||
27866725|NCT02274792|54455038|FG000|Overall Study|Protocol Specified Criteria|2|||
27866726|NCT02274792|54455038|FG000|Overall Study|Sponsor Decision|2|||
27866727|NCT02274558|54455068|FG000|Overall Study|Adverse Event|2|||
27866728|NCT02274558|54455069|FG001|Overall Study|Adverse Event|4|||
27866729|NCT02274558|54455070|FG002|Overall Study|Adverse Event|2|||
27866730|NCT02274558|54455068|FG000|Overall Study|Non-compliance|2|||
27866731|NCT02274558|54455069|FG001|Overall Study|Non-compliance|1|||
27866732|NCT02274558|54455070|FG002|Overall Study|Non-compliance|0|||
27866733|NCT02274558|54455068|FG000|Overall Study|Withdrawal by Subject|1|||
27866734|NCT02274558|54455069|FG001|Overall Study|Withdrawal by Subject|5|||
27866735|NCT02274558|54455070|FG002|Overall Study|Withdrawal by Subject|4|||
27866736|NCT02274558|54455068|FG000|Overall Study|Death|0|||
27866737|NCT02274558|54455069|FG001|Overall Study|Death|0|||
27866738|NCT02274558|54455070|FG002|Overall Study|Death|1|||
27866739|NCT02274558|54455068|FG000|Overall Study|Lost to Follow-up|2|||
27866740|NCT02274558|54455069|FG001|Overall Study|Lost to Follow-up|1|||
27866741|NCT02274558|54455070|FG002|Overall Study|Lost to Follow-up|1|||
27866742|NCT02274558|54455068|FG000|Overall Study|Physician Decision|0|||
27866743|NCT02274558|54455069|FG001|Overall Study|Physician Decision|2|||
27866744|NCT02274558|54455070|FG002|Overall Study|Physician Decision|1|||
27866745|NCT02287896|54455087|FG000|Second Injection Visit|Withdrawal by Subject|0|||
27866746|NCT02287896|54455088|FG001|Second Injection Visit|Withdrawal by Subject|1|||
27866747|NCT00553501|54455146|FG000|Overall Study|Adverse Event|2|||
27866748|NCT00553501|54455146|FG000|Overall Study|Death|1|||
27866749|NCT00553501|54455146|FG000|Overall Study|Progression|1|||
27866750|NCT02287584|54455174|FG000|the Double-blind Phase|Adverse Event|17|||
27866751|NCT02287584|54455175|FG001|the Double-blind Phase|Adverse Event|17|||
27866752|NCT02287584|54455176|FG002|the Double-blind Phase|Adverse Event|12|||
27866753|NCT02287584|54455177|FG003|the Double-blind Phase|Adverse Event|0|||
27866754|NCT02287584|54455178|FG004|the Double-blind Phase|Adverse Event|0|||
27866755|NCT02287584|54455179|FG005|the Double-blind Phase|Adverse Event|0|||
27866756|NCT02287584|54455174|FG000|the Double-blind Phase|Lack of Efficacy|18|||
27866757|NCT02287584|54455175|FG001|the Double-blind Phase|Lack of Efficacy|8|||
27866758|NCT02287584|54455176|FG002|the Double-blind Phase|Lack of Efficacy|8|||
27866759|NCT02287584|54455177|FG003|the Double-blind Phase|Lack of Efficacy|0|||
27866760|NCT02287584|54455178|FG004|the Double-blind Phase|Lack of Efficacy|0|||
27866761|NCT02287584|54455179|FG005|the Double-blind Phase|Lack of Efficacy|0|||
27835159|NCT01587703|54319702|FG001|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
27835160|NCT01587703|54319703|FG002|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
27835161|NCT01587703|54319704|FG003|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
27835162|NCT01587703|54319705|FG004|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
27835163|NCT01587703|54319706|FG005|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
27835164|NCT01587703|54319707|FG006|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
27835165|NCT01587703|54319708|FG007|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
27835166|NCT01587703|54319709|FG008|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
27835167|NCT01587703|54319710|FG009|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
27835168|NCT01587703|54319711|FG010|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
27835169|NCT01587703|54319712|FG011|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
27835170|NCT01587703|54319713|FG012|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
27835171|NCT01587703|54319714|FG013|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
27835172|NCT01587703|54319715|FG014|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
27835173|NCT01587703|54319716|FG015|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
27835174|NCT01587703|54319717|FG016|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
27835175|NCT01587703|54319718|FG017|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
27835176|NCT01587703|54319719|FG018|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
27835177|NCT01587703|54319701|FG000|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
27835178|NCT01587703|54319702|FG001|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
27835179|NCT01587703|54319703|FG002|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
27835180|NCT01587703|54319704|FG003|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
27835181|NCT01587703|54319705|FG004|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
27835182|NCT01587703|54319706|FG005|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
27835183|NCT01587703|54319707|FG006|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
27835184|NCT01587703|54319708|FG007|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
27835185|NCT01587703|54319709|FG008|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
27835186|NCT01587703|54319710|FG009|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
27835187|NCT01587703|54319711|FG010|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
27866762|NCT02287584|54455174|FG000|the Double-blind Phase|Lost to Follow-up|0|||
27866763|NCT02287584|54455175|FG001|the Double-blind Phase|Lost to Follow-up|1|||
27866764|NCT02287584|54455176|FG002|the Double-blind Phase|Lost to Follow-up|1|||
27866765|NCT02287584|54455177|FG003|the Double-blind Phase|Lost to Follow-up|0|||
27866766|NCT02287584|54455178|FG004|the Double-blind Phase|Lost to Follow-up|0|||
27866767|NCT02287584|54455179|FG005|the Double-blind Phase|Lost to Follow-up|0|||
27866768|NCT02287584|54455174|FG000|the Double-blind Phase|Withdrawal by Subject|17|||
27866769|NCT02287584|54455175|FG001|the Double-blind Phase|Withdrawal by Subject|17|||
27866770|NCT02287584|54455176|FG002|the Double-blind Phase|Withdrawal by Subject|11|||
27866771|NCT02287584|54455177|FG003|the Double-blind Phase|Withdrawal by Subject|0|||
27866772|NCT02287584|54455178|FG004|the Double-blind Phase|Withdrawal by Subject|0|||
27866773|NCT02287584|54455179|FG005|the Double-blind Phase|Withdrawal by Subject|0|||
27866774|NCT02287584|54455174|FG000|the Double-blind Phase|Pregnancy|0|||
27866775|NCT02287584|54455175|FG001|the Double-blind Phase|Pregnancy|1|||
27866776|NCT02287584|54455176|FG002|the Double-blind Phase|Pregnancy|0|||
27866777|NCT02287584|54455177|FG003|the Double-blind Phase|Pregnancy|0|||
27866778|NCT02287584|54455178|FG004|the Double-blind Phase|Pregnancy|0|||
27866779|NCT02287584|54455179|FG005|the Double-blind Phase|Pregnancy|0|||
27866780|NCT02287584|54455174|FG000|the Double-blind Phase|Protocol Violation|0|||
27866781|NCT02287584|54455175|FG001|the Double-blind Phase|Protocol Violation|3|||
27866782|NCT02287584|54455176|FG002|the Double-blind Phase|Protocol Violation|0|||
27866783|NCT02287584|54455177|FG003|the Double-blind Phase|Protocol Violation|0|||
27866784|NCT02287584|54455178|FG004|the Double-blind Phase|Protocol Violation|0|||
27866785|NCT02287584|54455179|FG005|the Double-blind Phase|Protocol Violation|0|||
27866786|NCT02287584|54455174|FG000|the Double-blind Phase|other reasons|0|||
27866787|NCT02287584|54455175|FG001|the Double-blind Phase|other reasons|0|||
27866788|NCT02287584|54455176|FG002|the Double-blind Phase|other reasons|1|||
27866789|NCT02287584|54455177|FG003|the Double-blind Phase|other reasons|0|||
27866790|NCT02287584|54455178|FG004|the Double-blind Phase|other reasons|0|||
27866791|NCT02287584|54455179|FG005|the Double-blind Phase|other reasons|0|||
27866792|NCT02287584|54455174|FG000|the Open-label Phase|Did not receive drug|0|||
27866793|NCT02287584|54455175|FG001|the Open-label Phase|Did not receive drug|0|||
27866794|NCT02287584|54455176|FG002|the Open-label Phase|Did not receive drug|0|||
27866795|NCT02287584|54455177|FG003|the Open-label Phase|Did not receive drug|7|||
27866796|NCT02287584|54455178|FG004|the Open-label Phase|Did not receive drug|6|||
27866797|NCT02287584|54455179|FG005|the Open-label Phase|Did not receive drug|4|||
27866798|NCT02287584|54455174|FG000|the Open-label Phase|Adverse Event|0|||
27866799|NCT02287584|54455175|FG001|the Open-label Phase|Adverse Event|0|||
27866800|NCT02287584|54455176|FG002|the Open-label Phase|Adverse Event|0|||
27866801|NCT02287584|54455177|FG003|the Open-label Phase|Adverse Event|15|||
27866802|NCT02287584|54455178|FG004|the Open-label Phase|Adverse Event|12|||
27866803|NCT02287584|54455179|FG005|the Open-label Phase|Adverse Event|16|||
27866804|NCT02287584|54455174|FG000|the Open-label Phase|Lack of Efficacy|0|||
27866805|NCT02287584|54455175|FG001|the Open-label Phase|Lack of Efficacy|0|||
27866806|NCT02287584|54455176|FG002|the Open-label Phase|Lack of Efficacy|0|||
27866807|NCT02287584|54455177|FG003|the Open-label Phase|Lack of Efficacy|8|||
27866808|NCT02287584|54455178|FG004|the Open-label Phase|Lack of Efficacy|3|||
27866809|NCT02287584|54455179|FG005|the Open-label Phase|Lack of Efficacy|7|||
27866810|NCT02287584|54455174|FG000|the Open-label Phase|Lost to Follow-up|0|||
27866811|NCT02287584|54455175|FG001|the Open-label Phase|Lost to Follow-up|0|||
27866812|NCT02287584|54455176|FG002|the Open-label Phase|Lost to Follow-up|0|||
27866813|NCT02287584|54455177|FG003|the Open-label Phase|Lost to Follow-up|4|||
27866814|NCT02287584|54455178|FG004|the Open-label Phase|Lost to Follow-up|1|||
27866815|NCT02287584|54455179|FG005|the Open-label Phase|Lost to Follow-up|2|||
27866816|NCT02287584|54455174|FG000|the Open-label Phase|Withdrawal by Subject|0|||
27866817|NCT02287584|54455175|FG001|the Open-label Phase|Withdrawal by Subject|0|||
27866818|NCT02287584|54455176|FG002|the Open-label Phase|Withdrawal by Subject|0|||
27866819|NCT02287584|54455177|FG003|the Open-label Phase|Withdrawal by Subject|18|||
27866820|NCT02287584|54455178|FG004|the Open-label Phase|Withdrawal by Subject|29|||
27866821|NCT02287584|54455179|FG005|the Open-label Phase|Withdrawal by Subject|21|||
27866822|NCT02287584|54455174|FG000|the Open-label Phase|non-compliance|0|||
27866823|NCT02287584|54455175|FG001|the Open-label Phase|non-compliance|0|||
27866824|NCT02287584|54455176|FG002|the Open-label Phase|non-compliance|0|||
27866825|NCT02287584|54455177|FG003|the Open-label Phase|non-compliance|2|||
27866826|NCT02287584|54455178|FG004|the Open-label Phase|non-compliance|5|||
27866827|NCT02287584|54455179|FG005|the Open-label Phase|non-compliance|1|||
27866828|NCT02287584|54455174|FG000|the Open-label Phase|other reasons|0|||
27866829|NCT02287584|54455175|FG001|the Open-label Phase|other reasons|0|||
27866830|NCT02287584|54455176|FG002|the Open-label Phase|other reasons|0|||
27866831|NCT02287584|54455177|FG003|the Open-label Phase|other reasons|3|||
27866832|NCT02287584|54455178|FG004|the Open-label Phase|other reasons|6|||
27835188|NCT01587703|54319712|FG011|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
27835189|NCT01587703|54319713|FG012|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
27835190|NCT01587703|54319714|FG013|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
27835191|NCT01587703|54319715|FG014|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
27835192|NCT01587703|54319716|FG015|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
27835193|NCT01587703|54319717|FG016|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
27835194|NCT01587703|54319718|FG017|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
27835195|NCT01587703|54319719|FG018|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
27835196|NCT01587703|54319701|FG000|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
27835197|NCT01587703|54319702|FG001|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
27866833|NCT02287584|54455179|FG005|the Open-label Phase|other reasons|6|||
27866834|NCT00553267|54455212|FG000|Overall Study|Adverse Event|8|||
27866835|NCT00553267|54455213|FG001|Overall Study|Adverse Event|10|||
27866836|NCT00553267|54455214|FG002|Overall Study|Adverse Event|5|||
27866837|NCT00553267|54455212|FG000|Overall Study|Non compliant with protocol|3|||
27866838|NCT00553267|54455213|FG001|Overall Study|Non compliant with protocol|3|||
27866839|NCT00553267|54455214|FG002|Overall Study|Non compliant with protocol|2|||
27866840|NCT00553267|54455212|FG000|Overall Study|Lost to Follow-up|0|||
27866841|NCT00553267|54455213|FG001|Overall Study|Lost to Follow-up|0|||
27866842|NCT00553267|54455214|FG002|Overall Study|Lost to Follow-up|1|||
27866843|NCT00553267|54455212|FG000|Overall Study|Consent withdrawn|2|||
27866844|NCT00553267|54455213|FG001|Overall Study|Consent withdrawn|3|||
27866845|NCT00553267|54455214|FG002|Overall Study|Consent withdrawn|1|||
27866846|NCT00553267|54455212|FG000|Overall Study|Specified category|1|||
27866847|NCT00553267|54455213|FG001|Overall Study|Specified category|2|||
27866848|NCT00553267|54455214|FG002|Overall Study|Specified category|1|||
27866849|NCT02271984|54455228|FG000|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
27866850|NCT02271984|54455229|FG001|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
27866851|NCT02271984|54455230|FG002|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
27866852|NCT02271984|54455231|FG003|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
27866853|NCT02271984|54455232|FG004|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
27866854|NCT02271984|54455233|FG005|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
27866855|NCT02271984|54455234|FG006|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
27866856|NCT02271984|54455235|FG007|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
27866857|NCT02271984|54455236|FG008|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
27866858|NCT02271984|54455237|FG009|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
27866859|NCT02271984|54455238|FG010|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
27866860|NCT02271984|54455239|FG011|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
27866861|NCT02287038|54455290|FG000|Overall Study|Stopped attending appointments|3|||
27866862|NCT02287038|54455291|FG001|Overall Study|Stopped attending appointments|2|||
27866863|NCT02287038|54455290|FG000|Overall Study|Anxiety after starting medication|0|||
27866864|NCT02287038|54455291|FG001|Overall Study|Anxiety after starting medication|1|||
27866865|NCT02287038|54455290|FG000|Overall Study|Nausea after starting medication|1|||
27866866|NCT02287038|54455291|FG001|Overall Study|Nausea after starting medication|0|||
27866867|NCT02287038|54455290|FG000|Overall Study|Abnormal ECG after starting medication|1|||
27866868|NCT02287038|54455291|FG001|Overall Study|Abnormal ECG after starting medication|0|||
27866869|NCT02286960|54455301|FG000|Overall Study|Lost to Follow-up|3|||
27866870|NCT02286960|54455302|FG001|Overall Study|Lost to Follow-up|3|||
27866871|NCT02286102|54455319|FG000|Overall Study|Screen Failure|1|||
27835198|NCT01587703|54319703|FG002|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
27866872|NCT02286102|54455320|FG001|Overall Study|Screen Failure|1|||
27866873|NCT02285166|54455326|FG000|Overall Study|Case Report Forms Uncollected|564|||
27866874|NCT02285166|54455326|FG000|Overall Study|Protocol Deviation|402|||
27866875|NCT00555061|54455389|FG000|Overall Study|Adverse Event|3|||
27866876|NCT00555061|54455389|FG000|Overall Study|Protocol Violation|1|||
27866877|NCT00555061|54455389|FG000|Overall Study|Lost to Follow-up|2|||
27866878|NCT00555061|54455389|FG000|Overall Study|Withdrawal by Subject|2|||
27866879|NCT00555061|54455389|FG000|Overall Study|Participant enrolled, but never treated|1|||
27866880|NCT01642212|54455407|FG000|Single-blind Baseline|Did Not Meet Eligibility Criteria|26|||
27866881|NCT01642212|54455408|FG001|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
27866882|NCT01642212|54455409|FG002|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
27866883|NCT01642212|54455410|FG003|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
27866884|NCT01642212|54455411|FG004|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
27982237|NCT02708108|54640252|FG001|Overall Study|Death|2|||
27835199|NCT01587703|54319704|FG003|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
27835200|NCT01587703|54319705|FG004|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
27835201|NCT01587703|54319706|FG005|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
27835202|NCT01587703|54319707|FG006|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
27835203|NCT01587703|54319708|FG007|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
27835204|NCT01587703|54319709|FG008|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1|||
27835205|NCT01587703|54319710|FG009|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
27835206|NCT01587703|54319711|FG010|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
27835207|NCT01587703|54319712|FG011|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
27835208|NCT01587703|54319713|FG012|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
27835209|NCT01587703|54319714|FG013|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
27835210|NCT01587703|54319715|FG014|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
27835211|NCT01587703|54319716|FG015|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
27835212|NCT01587703|54319717|FG016|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
27835213|NCT01587703|54319718|FG017|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
27835214|NCT01587703|54319719|FG018|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
27866885|NCT01642212|54455407|FG000|Double-blind Treatment|Other|0|||
27866886|NCT01642212|54455408|FG001|Double-blind Treatment|Other|2|||
27866887|NCT01642212|54455409|FG002|Double-blind Treatment|Other|1|||
27866888|NCT01642212|54455410|FG003|Double-blind Treatment|Other|0|||
27866889|NCT01642212|54455411|FG004|Double-blind Treatment|Other|0|||
27866890|NCT01642212|54455407|FG000|Double-blind Treatment|Non-compliance|0|||
27866891|NCT01642212|54455408|FG001|Double-blind Treatment|Non-compliance|1|||
27866892|NCT01642212|54455409|FG002|Double-blind Treatment|Non-compliance|0|||
27866893|NCT01642212|54455410|FG003|Double-blind Treatment|Non-compliance|0|||
27866894|NCT01642212|54455411|FG004|Double-blind Treatment|Non-compliance|0|||
27866895|NCT01642212|54455407|FG000|Double-blind Treatment|Adverse Event|0|||
27866896|NCT01642212|54455408|FG001|Double-blind Treatment|Adverse Event|0|||
27866897|NCT01642212|54455409|FG002|Double-blind Treatment|Adverse Event|1|||
27866898|NCT01642212|54455410|FG003|Double-blind Treatment|Adverse Event|0|||
27866899|NCT01642212|54455411|FG004|Double-blind Treatment|Adverse Event|0|||
27866900|NCT01642212|54455407|FG000|Open-label Extension|Adverse Event|0|||
27866901|NCT01642212|54455408|FG001|Open-label Extension|Adverse Event|0|||
27866902|NCT01642212|54455409|FG002|Open-label Extension|Adverse Event|0|||
27866903|NCT01642212|54455410|FG003|Open-label Extension|Adverse Event|3|||
27866904|NCT01642212|54455411|FG004|Open-label Extension|Adverse Event|0|||
27866905|NCT01642212|54455407|FG000|Open-label Extension|Sponsor Decision|0|||
27866906|NCT01642212|54455408|FG001|Open-label Extension|Sponsor Decision|0|||
27866907|NCT01642212|54455409|FG002|Open-label Extension|Sponsor Decision|0|||
27866908|NCT01642212|54455410|FG003|Open-label Extension|Sponsor Decision|7|||
27866909|NCT01642212|54455411|FG004|Open-label Extension|Sponsor Decision|4|||
27866910|NCT01642212|54455407|FG000|Open-label Extension|Consent Withdrawn|0|||
27866911|NCT01642212|54455408|FG001|Open-label Extension|Consent Withdrawn|0|||
27866912|NCT01642212|54455409|FG002|Open-label Extension|Consent Withdrawn|0|||
27866913|NCT01642212|54455410|FG003|Open-label Extension|Consent Withdrawn|0|||
27866914|NCT01642212|54455411|FG004|Open-label Extension|Consent Withdrawn|2|||
27866915|NCT01642212|54455407|FG000|Open-label Extension|Lost to Follow-up|0|||
27866916|NCT01642212|54455408|FG001|Open-label Extension|Lost to Follow-up|0|||
27866917|NCT01642212|54455409|FG002|Open-label Extension|Lost to Follow-up|0|||
27866918|NCT01642212|54455410|FG003|Open-label Extension|Lost to Follow-up|0|||
27866919|NCT01642212|54455411|FG004|Open-label Extension|Lost to Follow-up|1|||
27866920|NCT01642212|54455407|FG000|Open-label Extension|Other|0|||
27866921|NCT01642212|54455408|FG001|Open-label Extension|Other|0|||
27866922|NCT01642212|54455409|FG002|Open-label Extension|Other|0|||
27866923|NCT01642212|54455410|FG003|Open-label Extension|Other|0|||
27866924|NCT01642212|54455411|FG004|Open-label Extension|Other|1|||
27866925|NCT00552175|54455436|FG000|Overall Study|Lack of Efficacy|2|||
27866926|NCT00552175|54455437|FG001|Overall Study|Lack of Efficacy|0|||
27866927|NCT00552175|54455438|FG002|Overall Study|Lack of Efficacy|1|||
27866928|NCT00552175|54455436|FG000|Overall Study|Adverse Event|9|||
27866929|NCT00552175|54455437|FG001|Overall Study|Adverse Event|9|||
27866930|NCT00552175|54455438|FG002|Overall Study|Adverse Event|10|||
27866931|NCT00552175|54455436|FG000|Overall Study|Withdrawal by Subject|2|||
27866932|NCT00552175|54455437|FG001|Overall Study|Withdrawal by Subject|2|||
27866933|NCT00552175|54455438|FG002|Overall Study|Withdrawal by Subject|1|||
27866934|NCT00552175|54455436|FG000|Overall Study|Lost to Follow-up|0|||
27866935|NCT00552175|54455437|FG001|Overall Study|Lost to Follow-up|0|||
27866936|NCT00552175|54455438|FG002|Overall Study|Lost to Follow-up|1|||
27866937|NCT00552175|54455436|FG000|Overall Study|Entry Criteria Not Met|1|||
27866938|NCT00552175|54455437|FG001|Overall Study|Entry Criteria Not Met|1|||
27866939|NCT00552175|54455438|FG002|Overall Study|Entry Criteria Not Met|0|||
27866940|NCT00552175|54455436|FG000|Overall Study|Reason Not Specified|3|||
27866941|NCT00552175|54455437|FG001|Overall Study|Reason Not Specified|1|||
27866942|NCT00552175|54455438|FG002|Overall Study|Reason Not Specified|1|||
27866943|NCT01644474|54455449|FG000|Overall Study|Poor compliance to protocol|1|||
27866944|NCT01644474|54455450|FG001|Overall Study|Poor compliance to protocol|0|||
27866945|NCT01644474|54455449|FG000|Overall Study|Consent withdrawn by participant|0|||
27866946|NCT01644474|54455450|FG001|Overall Study|Consent withdrawn by participant|1|||
27866947|NCT01644474|54455449|FG000|Overall Study|Participant moved|0|||
27866948|NCT01644474|54455450|FG001|Overall Study|Participant moved|1|||
27866949|NCT01644474|54455449|FG000|Overall Study|Adverse Event|4|||
27866950|NCT01644474|54455450|FG001|Overall Study|Adverse Event|5|||
27866951|NCT01644474|54455449|FG000|Overall Study|Site scheduling error|1|||
27866952|NCT01644474|54455450|FG001|Overall Study|Site scheduling error|1|||
27866953|NCT01644474|54455449|FG000|Overall Study|Protocol Violation|1|||
27866954|NCT01644474|54455450|FG001|Overall Study|Protocol Violation|0|||
27866955|NCT02285010|54455485|FG000|Overall Study|not abdominal hysterectomy|2|||
27866956|NCT02285010|54455486|FG001|Overall Study|not abdominal hysterectomy|0|||
28096313|NCT04527978|54751175|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
27866957|NCT02285010|54455485|FG000|Overall Study|Not spinal anesthesia|3|||
27866958|NCT02285010|54455486|FG001|Overall Study|Not spinal anesthesia|1|||
27866959|NCT00551161|54455530|FG000|Overall Study|Withdrawal by Subject|1|||
27866960|NCT00550771|54455566|FG000|Overall Study|Adverse Event|11|||
27866961|NCT00550771|54455567|FG001|Overall Study|Adverse Event|3|||
27866962|NCT00550771|54455566|FG000|Overall Study|Discontinued for study-related reasons|0|||
27866963|NCT00550771|54455567|FG001|Overall Study|Discontinued for study-related reasons|1|||
27866964|NCT00550771|54455566|FG000|Overall Study|Physician Decision|2|||
27866965|NCT00550771|54455567|FG001|Overall Study|Physician Decision|0|||
27866966|NCT00550771|54455566|FG000|Overall Study|Withdrawal by Subject|0|||
27866967|NCT00550771|54455567|FG001|Overall Study|Withdrawal by Subject|1|||
27866968|NCT00550771|54455566|FG000|Overall Study|Protocol Violation|4|||
27866969|NCT00550771|54455567|FG001|Overall Study|Protocol Violation|5|||
27866970|NCT00550537|54455600|FG000|Overall Study|Death|18|||
27866971|NCT00550537|54455600|FG000|Overall Study|Adverse Event|20|||
27866972|NCT00550537|54455600|FG000|Overall Study|Disease progression before|46|||
27866973|NCT00550537|54455600|FG000|Overall Study|Withdrawal by Subject|7|||
27866974|NCT00550537|54455600|FG000|Overall Study|Change in treatment plan|4|||
27866975|NCT00550537|54455600|FG000|Overall Study|Other complicating ilness|3|||
27866976|NCT00550537|54455600|FG000|Overall Study|Declining performance status|2|||
27866977|NCT00550537|54455600|FG000|Overall Study|Treated closer to home|4|||
27866978|NCT00550147|54455618|FG000|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4|||
27866979|NCT00550147|54455618|FG000|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2|||
27866980|NCT00550147|54455618|FG000|Quetiapine Addition Treatment Period|Adverse Event|3|||
27866981|NCT00550147|54455618|FG000|Quetiapine Addition Treatment Period|Noncompliance|2|||
27866982|NCT00550147|54455618|FG000|Quetiapine Addition Treatment Period|Moved out of state|1|||
27866983|NCT00550459|54455829|FG000|Overall Study|Adverse Event|0|||
27866984|NCT00550459|54455830|FG001|Overall Study|Adverse Event|2|||
28171379|NCT01370863|54842953|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
28171380|NCT02444182|54842961|FG000|Overall Study|non-compliance|2|||
28171381|NCT02444182|54842962|FG001|Overall Study|non-compliance|1|||
28171382|NCT02444182|54842961|FG000|Overall Study|Lost to Follow-up|0|||
27738973|NCT02240680|54188246|FG003|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
27866985|NCT00550459|54455829|FG000|Overall Study|Withdrawal by Subject|1|||
27866986|NCT00550459|54455830|FG001|Overall Study|Withdrawal by Subject|1|||
27866987|NCT01643928|54456129|FG000|Overall Study|Lost to Follow-up|1|||
27866988|NCT01643928|54456130|FG001|Overall Study|Lost to Follow-up|0|||
27866989|NCT01643928|54456131|FG002|Overall Study|Lost to Follow-up|2|||
27866990|NCT01643928|54456132|FG003|Overall Study|Lost to Follow-up|0|||
27866991|NCT01643928|54456133|FG004|Overall Study|Lost to Follow-up|0|||
27866992|NCT01643928|54456129|FG000|Overall Study|Withdrawal by Subject|2|||
27866993|NCT01643928|54456130|FG001|Overall Study|Withdrawal by Subject|0|||
27866994|NCT01643928|54456131|FG002|Overall Study|Withdrawal by Subject|0|||
27866995|NCT01643928|54456132|FG003|Overall Study|Withdrawal by Subject|1|||
27866996|NCT01643928|54456133|FG004|Overall Study|Withdrawal by Subject|0|||
27866997|NCT01643928|54456129|FG000|Overall Study|Pregnancy|0|||
27866998|NCT01643928|54456130|FG001|Overall Study|Pregnancy|0|||
27866999|NCT01643928|54456131|FG002|Overall Study|Pregnancy|0|||
27867000|NCT01643928|54456132|FG003|Overall Study|Pregnancy|1|||
27867001|NCT01643928|54456133|FG004|Overall Study|Pregnancy|0|||
27867002|NCT01643928|54456129|FG000|Overall Study|Other|5|||
27867003|NCT01643928|54456130|FG001|Overall Study|Other|1|||
27867004|NCT01643928|54456131|FG002|Overall Study|Other|1|||
27867005|NCT01643928|54456132|FG003|Overall Study|Other|0|||
27867006|NCT01643928|54456133|FG004|Overall Study|Other|0|||
27867007|NCT01643928|54456129|FG000|Overall Study|Adverse Event|2|||
27867008|NCT01643928|54456130|FG001|Overall Study|Adverse Event|1|||
27867009|NCT01643928|54456131|FG002|Overall Study|Adverse Event|0|||
27867010|NCT01643928|54456132|FG003|Overall Study|Adverse Event|1|||
27867011|NCT01643928|54456133|FG004|Overall Study|Adverse Event|2|||
27867012|NCT03237845|54456344|FG000|Overall Study|Adverse Event|0|||
27867013|NCT03237845|54456345|FG001|Overall Study|Adverse Event|1|||
27867014|NCT03237845|54456344|FG000|Overall Study|Lost to Follow-up|13|||
27867015|NCT03237845|54456345|FG001|Overall Study|Lost to Follow-up|10|||
27867016|NCT03237845|54456344|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|26|||
27867017|NCT03237845|54456345|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|31|||
27738974|NCT02240680|54188243|FG000|Overall Study (Up to 24 Weeks)|Other than specified|1|||
27738975|NCT02240680|54188244|FG001|Overall Study (Up to 24 Weeks)|Other than specified|0|||
27867018|NCT03237845|54456344|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
27867019|NCT03237845|54456345|FG001|Overall Study|Non-Compliance With Study Treatment|1|||
27867020|NCT03237845|54456344|FG000|Overall Study|Physician Decision|1|||
27867021|NCT03237845|54456345|FG001|Overall Study|Physician Decision|2|||
27867022|NCT03237845|54456344|FG000|Overall Study|Pregnancy|1|||
27867023|NCT03237845|54456345|FG001|Overall Study|Pregnancy|0|||
27867024|NCT03237845|54456344|FG000|Overall Study|Protocol Deviation|0|||
27867025|NCT03237845|54456345|FG001|Overall Study|Protocol Deviation|1|||
27867026|NCT03237845|54456344|FG000|Overall Study|Technical Problems|8|||
27867027|NCT03237845|54456345|FG001|Overall Study|Technical Problems|1|||
27867028|NCT03237845|54456344|FG000|Overall Study|Withdrawal by Subject|3|||
27867029|NCT03237845|54456345|FG001|Overall Study|Withdrawal by Subject|3|||
28171383|NCT02444182|54842962|FG001|Overall Study|Lost to Follow-up|4|||
27867030|NCT03237845|54456344|FG000|Overall Study|Other Reasons|4|||
27867031|NCT03237845|54456345|FG001|Overall Study|Other Reasons|0|||
27867032|NCT01643850|54456432|FG000|Overall Study|Withdrawal by Subject|0|||
27867033|NCT01643850|54456433|FG001|Overall Study|Withdrawal by Subject|0|||
27867034|NCT01643850|54456434|FG002|Overall Study|Withdrawal by Subject|0|||
27867035|NCT01643850|54456435|FG003|Overall Study|Withdrawal by Subject|0|||
27867036|NCT01643850|54456436|FG004|Overall Study|Withdrawal by Subject|1|||
27867037|NCT01643850|54456437|FG005|Overall Study|Withdrawal by Subject|0|||
27867038|NCT01643850|54456438|FG006|Overall Study|Withdrawal by Subject|0|||
27867039|NCT01643850|54456439|FG007|Overall Study|Withdrawal by Subject|0|||
27867040|NCT01643850|54456440|FG008|Overall Study|Withdrawal by Subject|0|||
27867041|NCT01643850|54456432|FG000|Overall Study|Lost to Follow-up|0|||
27867042|NCT01643850|54456433|FG001|Overall Study|Lost to Follow-up|0|||
27867043|NCT01643850|54456434|FG002|Overall Study|Lost to Follow-up|0|||
27867044|NCT01643850|54456435|FG003|Overall Study|Lost to Follow-up|0|||
27867045|NCT01643850|54456436|FG004|Overall Study|Lost to Follow-up|0|||
27867046|NCT01643850|54456437|FG005|Overall Study|Lost to Follow-up|0|||
27867047|NCT01643850|54456438|FG006|Overall Study|Lost to Follow-up|1|||
27867048|NCT01643850|54456439|FG007|Overall Study|Lost to Follow-up|0|||
27867049|NCT01643850|54456440|FG008|Overall Study|Lost to Follow-up|1|||
27867050|NCT01643850|54456432|FG000|Overall Study|Adverse Event|0|||
27867051|NCT01643850|54456433|FG001|Overall Study|Adverse Event|0|||
27867052|NCT01643850|54456434|FG002|Overall Study|Adverse Event|0|||
27867053|NCT01643850|54456435|FG003|Overall Study|Adverse Event|0|||
27867054|NCT01643850|54456436|FG004|Overall Study|Adverse Event|1|||
27867055|NCT01643850|54456437|FG005|Overall Study|Adverse Event|0|||
27867056|NCT01643850|54456438|FG006|Overall Study|Adverse Event|0|||
27867057|NCT01643850|54456439|FG007|Overall Study|Adverse Event|0|||
27867058|NCT01643850|54456440|FG008|Overall Study|Adverse Event|0|||
27867059|NCT01643850|54456432|FG000|Overall Study|Administrative Problems|0|||
27867060|NCT01643850|54456433|FG001|Overall Study|Administrative Problems|0|||
27867061|NCT01643850|54456434|FG002|Overall Study|Administrative Problems|1|||
27867062|NCT01643850|54456435|FG003|Overall Study|Administrative Problems|0|||
27867063|NCT01643850|54456436|FG004|Overall Study|Administrative Problems|1|||
27867064|NCT01643850|54456437|FG005|Overall Study|Administrative Problems|0|||
27867065|NCT01643850|54456438|FG006|Overall Study|Administrative Problems|0|||
27867066|NCT01643850|54456439|FG007|Overall Study|Administrative Problems|0|||
27867067|NCT01643850|54456440|FG008|Overall Study|Administrative Problems|0|||
27867068|NCT02271594|54456508|FG000|Overall Study|Study closed; recruiting failure|19|||
27867069|NCT02271594|54456509|FG001|Overall Study|Study closed; recruiting failure|12|||
27867070|NCT02535923|54456528|FG000|Overall Study|Lost to Follow-up|5|||
27867071|NCT02535923|54456529|FG001|Overall Study|Lost to Follow-up|5|||
27867072|NCT02535923|54456528|FG000|Overall Study|Withdrawal by Subject|4|||
27867073|NCT02535923|54456529|FG001|Overall Study|Withdrawal by Subject|3|||
27867074|NCT02270736|54456538|FG000|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
27867075|NCT02270736|54456539|FG001|Main Period (MP) (up to 16 Weeks)|Adverse Event|1|||
27867076|NCT02270736|54456540|FG002|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
27867077|NCT02270736|54456541|FG003|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
27867078|NCT02270736|54456542|FG004|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
27867079|NCT02270736|54456538|FG000|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2|||
27867080|NCT02270736|54456539|FG001|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
27867081|NCT02270736|54456540|FG002|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1|||
27867082|NCT02270736|54456541|FG003|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
27867083|NCT02270736|54456542|FG004|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
27867084|NCT02270736|54456538|FG000|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
27867085|NCT02270736|54456539|FG001|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1|||
27867086|NCT02270736|54456540|FG002|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
27867087|NCT02270736|54456541|FG003|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
28171384|NCT02471404|54842971|FG000|Overall Study|Adverse Event|7|||
28171385|NCT02471404|54842972|FG001|Overall Study|Adverse Event|1|||
27867088|NCT02270736|54456542|FG004|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
27867089|NCT02270736|54456538|FG000|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
27867090|NCT02270736|54456539|FG001|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
27867091|NCT02270736|54456540|FG002|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1|||
27867092|NCT02270736|54456541|FG003|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
27867093|NCT02270736|54456542|FG004|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
27867094|NCT02270736|54456538|FG000|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
27867095|NCT02270736|54456539|FG001|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
27867096|NCT02270736|54456540|FG002|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
27867097|NCT02270736|54456541|FG003|OLEX Period (up to 48 Weeks)|Physician Decision|1|||
27867098|NCT02270736|54456542|FG004|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
27867099|NCT02270736|54456538|FG000|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
27867100|NCT02270736|54456539|FG001|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
28171386|NCT02471404|54842973|FG002|Overall Study|Adverse Event|2|||
27867101|NCT02270736|54456540|FG002|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
27867102|NCT02270736|54456541|FG003|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2|||
27867103|NCT02270736|54456542|FG004|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
27867104|NCT02270736|54456538|FG000|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
27867105|NCT02270736|54456539|FG001|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
27867106|NCT02270736|54456540|FG002|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
27867107|NCT02270736|54456541|FG003|OLEX Period (up to 48 Weeks)|Adverse Event|4|||
27867108|NCT02270736|54456542|FG004|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
27867109|NCT02270736|54456538|FG000|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
27867110|NCT02270736|54456539|FG001|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
27867111|NCT02270736|54456540|FG002|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
27867112|NCT02270736|54456541|FG003|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16|||
27867113|NCT02270736|54456542|FG004|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
27867114|NCT02270736|54456538|FG000|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
27867115|NCT02270736|54456539|FG001|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
27867116|NCT02270736|54456540|FG002|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
27867117|NCT02270736|54456541|FG003|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2|||
27867118|NCT02270736|54456542|FG004|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
27867119|NCT02269098|54456557|FG000|Overall Study|Lost to Follow-up|14|||
27867120|NCT02269098|54456558|FG001|Overall Study|Lost to Follow-up|9|||
27867121|NCT02283762|54456702|FG000|Main Treatment Phase (MT)|Adverse Event|9|||
27867122|NCT02283762|54456703|FG001|Main Treatment Phase (MT)|Adverse Event|9|||
27867123|NCT02283762|54456702|FG000|Main Treatment Phase (MT)|Lack of Efficacy|1|||
27867124|NCT02283762|54456703|FG001|Main Treatment Phase (MT)|Lack of Efficacy|0|||
27867125|NCT02283762|54456702|FG000|Main Treatment Phase (MT)|Physician Decision|1|||
27867126|NCT02283762|54456703|FG001|Main Treatment Phase (MT)|Physician Decision|1|||
27867127|NCT02283762|54456702|FG000|Main Treatment Phase (MT)|Pregnancy|0|||
27867128|NCT02283762|54456703|FG001|Main Treatment Phase (MT)|Pregnancy|1|||
28096314|NCT04527978|54751176|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
28096315|NCT04136444|54751187|FG000|Overall Study|Sponsor request due to undisclosed concomitant medication|0|||
27835215|NCT01587703|54319701|FG000|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
27835216|NCT01587703|54319702|FG001|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
27835217|NCT01587703|54319703|FG002|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
27835218|NCT01587703|54319704|FG003|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
27835219|NCT01587703|54319705|FG004|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
27835220|NCT01587703|54319706|FG005|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
27835221|NCT01587703|54319707|FG006|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
27835222|NCT01587703|54319708|FG007|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
27835223|NCT01587703|54319709|FG008|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
27835224|NCT01587703|54319710|FG009|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
27835225|NCT01587703|54319711|FG010|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
27835226|NCT01587703|54319712|FG011|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
27835227|NCT01587703|54319713|FG012|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
27835228|NCT01587703|54319714|FG013|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
27835229|NCT01587703|54319715|FG014|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
27835230|NCT01587703|54319716|FG015|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
27835231|NCT01587703|54319717|FG016|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
27835232|NCT01587703|54319718|FG017|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
27835233|NCT01587703|54319719|FG018|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1|||
27835234|NCT01587703|54319701|FG000|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
27835235|NCT01587703|54319702|FG001|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
27835236|NCT01587703|54319703|FG002|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
27835237|NCT01587703|54319704|FG003|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
27835238|NCT01587703|54319705|FG004|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
27835239|NCT01587703|54319706|FG005|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
27835240|NCT01587703|54319707|FG006|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
27835241|NCT01587703|54319708|FG007|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
27835242|NCT01587703|54319709|FG008|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
27835243|NCT01587703|54319710|FG009|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
27835244|NCT01587703|54319711|FG010|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
27835245|NCT01587703|54319712|FG011|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
27867129|NCT02283762|54456702|FG000|Main Treatment Phase (MT)|Withdrawal by Subject|7|||
27867130|NCT02283762|54456703|FG001|Main Treatment Phase (MT)|Withdrawal by Subject|4|||
28096316|NCT04136444|54751188|FG001|Overall Study|Sponsor request due to undisclosed concomitant medication|1|||
28096317|NCT04425252|54751202|FG000|Overall Study|Withdrawal by Subject|2|||
27835246|NCT01587703|54319713|FG012|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
27835247|NCT01587703|54319714|FG013|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
27867131|NCT02283762|54456702|FG000|Long-term Extension Phase (LTE)|Adverse Event|2|||
27867132|NCT02283762|54456703|FG001|Long-term Extension Phase (LTE)|Adverse Event|6|||
27867133|NCT02283762|54456702|FG000|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
27867134|NCT02283762|54456703|FG001|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
27867135|NCT02283762|54456702|FG000|Long-term Extension Phase (LTE)|Study terminated at site|1|||
27867136|NCT02283762|54456703|FG001|Long-term Extension Phase (LTE)|Study terminated at site|0|||
27867137|NCT02283762|54456702|FG000|Long-term Extension Phase (LTE)|Withdrawal by Subject|4|||
27867138|NCT02283762|54456703|FG001|Long-term Extension Phase (LTE)|Withdrawal by Subject|3|||
27867139|NCT02283762|54456702|FG000|Long-term Extension Phase (LTE)|Protocol Violation|1|||
27867140|NCT02283762|54456703|FG001|Long-term Extension Phase (LTE)|Protocol Violation|1|||
27867141|NCT02283762|54456702|FG000|Long-term Extension Phase (LTE)|Lost to Follow-up|0|||
27867142|NCT02283762|54456703|FG001|Long-term Extension Phase (LTE)|Lost to Follow-up|1|||
27867143|NCT02283762|54456702|FG000|Long-term Extension Phase (LTE)|Physician Decision|1|||
27867144|NCT02283762|54456703|FG001|Long-term Extension Phase (LTE)|Physician Decision|2|||
27867145|NCT02283294|54456803|FG000|Overall Study|Lost to Follow-up|1|||
27867146|NCT02283294|54456804|FG001|Overall Study|Lost to Follow-up|1|||
27867147|NCT02283294|54456803|FG000|Overall Study|Withdrawal by Subject|1|||
27867148|NCT02283294|54456804|FG001|Overall Study|Withdrawal by Subject|6|||
27867149|NCT02283294|54456803|FG000|Overall Study|Protocol Violation|1|||
27867150|NCT02283294|54456804|FG001|Overall Study|Protocol Violation|0|||
27867151|NCT02283294|54456803|FG000|Overall Study|Thrombus on transesophageal echocardiogram|0|||
27867152|NCT02283294|54456804|FG001|Overall Study|Thrombus on transesophageal echocardiogram|1|||
27867153|NCT02282982|54456820|FG000|Overall Study|Lost to Follow-up|15|||
27867154|NCT02282982|54456820|FG000|Overall Study|Withdrew consent|2|||
27867155|NCT02282982|54456820|FG000|Overall Study|Death|4|||
27867156|NCT02282982|54456820|FG000|Overall Study|Lack of product|156|||
27867157|NCT02282982|54456820|FG000|Overall Study|Palivizumab is ended|11|||
27867158|NCT02282982|54456820|FG000|Overall Study|Other, not specified|18|||
27867159|NCT02268864|54456862|FG000|Overall Study|Withdrawal by Subject|2|||
27867160|NCT02268864|54456863|FG001|Overall Study|Withdrawal by Subject|0|||
27867161|NCT02268864|54456864|FG002|Overall Study|Withdrawal by Subject|0|||
27867162|NCT02268864|54456862|FG000|Overall Study|Death|0|||
27867163|NCT02268864|54456863|FG001|Overall Study|Death|1|||
27867164|NCT02268864|54456864|FG002|Overall Study|Death|0|||
27867165|NCT02268786|54456893|FG000|Overall Study|No Euploid Embryos available|42|||
27867166|NCT02268786|54456894|FG001|Overall Study|No Euploid Embryos available|0|||
27867167|NCT02268786|54456893|FG000|Overall Study|Withdrawal by Subject|7|||
27867168|NCT02268786|54456894|FG001|Overall Study|Withdrawal by Subject|14|||
27867169|NCT02268786|54456893|FG000|Overall Study|Thaw Failure|6|||
27867170|NCT02268786|54456894|FG001|Overall Study|Thaw Failure|4|||
27867171|NCT02268786|54456893|FG000|Overall Study|Protocol Violation|1|||
27867172|NCT02268786|54456894|FG001|Overall Study|Protocol Violation|0|||
27867173|NCT02268396|54456909|FG000|Overall Study|Adverse Event|3|||
27867174|NCT02268396|54456909|FG000|Overall Study|Administrative|2|||
27867175|NCT02268396|54456909|FG000|Overall Study|Withdrawal by Subject|1|||
27867176|NCT02268396|54456909|FG000|Overall Study|Lost to Follow-up|2|||
27867177|NCT02268396|54456909|FG000|Overall Study|Protocol-Specified Criteria|2|||
27867178|NCT02268396|54456909|FG000|Overall Study|2 Subjects no Day 29 Assessment|2|||
27867179|NCT02268084|54456915|FG000|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|0|||
27867180|NCT02268084|54456916|FG001|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|3|||
27867181|NCT02268084|54456915|FG000|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|9|||
27867182|NCT02268084|54456916|FG001|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|4|||
27867183|NCT01643772|54456945|FG000|Overall Study|Protocol Violation|0|||
27867184|NCT01643772|54456946|FG001|Overall Study|Protocol Violation|0|||
27867185|NCT01643772|54456947|FG002|Overall Study|Protocol Violation|0|||
27867186|NCT01643772|54456948|FG003|Overall Study|Protocol Violation|1|||
27867187|NCT01643772|54456945|FG000|Overall Study|Adverse Event|0|||
27867188|NCT01643772|54456946|FG001|Overall Study|Adverse Event|0|||
27867189|NCT01643772|54456947|FG002|Overall Study|Adverse Event|0|||
27867190|NCT01643772|54456948|FG003|Overall Study|Adverse Event|1|||
27867191|NCT02265744|54457051|FG000|Overall Study|Poor/Non-compliance|1|||
27867192|NCT02265744|54457052|FG001|Overall Study|Poor/Non-compliance|1|||
27867193|NCT02265744|54457053|FG002|Overall Study|Poor/Non-compliance|0|||
27867194|NCT02265744|54457054|FG003|Overall Study|Poor/Non-compliance|0|||
27867195|NCT02265744|54457055|FG004|Overall Study|Poor/Non-compliance|2|||
27867196|NCT02265744|54457051|FG000|Overall Study|Lost to Follow-up|0|||
27867197|NCT02265744|54457052|FG001|Overall Study|Lost to Follow-up|0|||
27867198|NCT02265744|54457053|FG002|Overall Study|Lost to Follow-up|0|||
27867199|NCT02265744|54457054|FG003|Overall Study|Lost to Follow-up|1|||
27867200|NCT02265744|54457055|FG004|Overall Study|Lost to Follow-up|0|||
27867201|NCT02265744|54457051|FG000|Overall Study|Death|0|||
27867202|NCT02265744|54457052|FG001|Overall Study|Death|0|||
27867203|NCT02265744|54457053|FG002|Overall Study|Death|0|||
28096318|NCT04425252|54751203|FG001|Overall Study|Withdrawal by Subject|1|||
27867204|NCT02265744|54457054|FG003|Overall Study|Death|2|||
27867205|NCT02265744|54457055|FG004|Overall Study|Death|0|||
27867206|NCT02265744|54457051|FG000|Overall Study|Withdrawal by Subject|2|||
27867207|NCT02265744|54457052|FG001|Overall Study|Withdrawal by Subject|0|||
27867208|NCT02265744|54457053|FG002|Overall Study|Withdrawal by Subject|0|||
27867209|NCT02265744|54457054|FG003|Overall Study|Withdrawal by Subject|2|||
27867210|NCT02265744|54457055|FG004|Overall Study|Withdrawal by Subject|0|||
27867211|NCT02265744|54457051|FG000|Overall Study|Participant request to discontinue|2|||
27867212|NCT02265744|54457052|FG001|Overall Study|Participant request to discontinue|2|||
27867213|NCT02265744|54457053|FG002|Overall Study|Participant request to discontinue|2|||
27867214|NCT02265744|54457054|FG003|Overall Study|Participant request to discontinue|0|||
27867215|NCT02265744|54457055|FG004|Overall Study|Participant request to discontinue|0|||
27867216|NCT02265744|54457051|FG000|Overall Study|Adverse Event|8|||
27867217|NCT02265744|54457052|FG001|Overall Study|Adverse Event|4|||
27867218|NCT02265744|54457053|FG002|Overall Study|Adverse Event|9|||
27867219|NCT02265744|54457054|FG003|Overall Study|Adverse Event|8|||
27867220|NCT02265744|54457055|FG004|Overall Study|Adverse Event|2|||
27867221|NCT02265744|54457051|FG000|Overall Study|Lack of Efficacy|2|||
27867222|NCT02265744|54457052|FG001|Overall Study|Lack of Efficacy|4|||
27867223|NCT02265744|54457053|FG002|Overall Study|Lack of Efficacy|3|||
27867224|NCT02265744|54457054|FG003|Overall Study|Lack of Efficacy|4|||
27867225|NCT02265744|54457055|FG004|Overall Study|Lack of Efficacy|5|||
27867226|NCT02265744|54457051|FG000|Overall Study|Reason not provided by Investigator|1|||
27867227|NCT02265744|54457052|FG001|Overall Study|Reason not provided by Investigator|0|||
27867228|NCT02265744|54457053|FG002|Overall Study|Reason not provided by Investigator|0|||
27867229|NCT02265744|54457054|FG003|Overall Study|Reason not provided by Investigator|2|||
27867230|NCT02265744|54457055|FG004|Overall Study|Reason not provided by Investigator|0|||
27867231|NCT02265744|54457051|FG000|Overall Study|Administrative reason by sponsor|3|||
27867232|NCT02265744|54457052|FG001|Overall Study|Administrative reason by sponsor|2|||
27867233|NCT02265744|54457053|FG002|Overall Study|Administrative reason by sponsor|2|||
27867234|NCT02265744|54457054|FG003|Overall Study|Administrative reason by sponsor|3|||
27867235|NCT02265744|54457055|FG004|Overall Study|Administrative reason by sponsor|3|||
27867236|NCT02265744|54457051|FG000|Overall Study|Subject no longer meets study criteria|0|||
27867237|NCT02265744|54457052|FG001|Overall Study|Subject no longer meets study criteria|0|||
27867238|NCT02265744|54457053|FG002|Overall Study|Subject no longer meets study criteria|0|||
27867239|NCT02265744|54457054|FG003|Overall Study|Subject no longer meets study criteria|0|||
27867240|NCT02265744|54457055|FG004|Overall Study|Subject no longer meets study criteria|1|||
27867241|NCT02265744|54457051|FG000|Overall Study|Pregnancy|1|||
27867242|NCT02265744|54457052|FG001|Overall Study|Pregnancy|2|||
27867243|NCT02265744|54457053|FG002|Overall Study|Pregnancy|1|||
27867244|NCT02265744|54457054|FG003|Overall Study|Pregnancy|1|||
27867245|NCT02265744|54457055|FG004|Overall Study|Pregnancy|0|||
27867246|NCT00085735|54457084|FG000|Overall Study|Adverse Event|1|||
27867247|NCT00085735|54457085|FG001|Overall Study|Adverse Event|0|||
27867248|NCT00085735|54457086|FG002|Overall Study|Adverse Event|0|||
27867249|NCT00085735|54457087|FG003|Overall Study|Adverse Event|0|||
27867250|NCT00085735|54457088|FG004|Overall Study|Adverse Event|0|||
27867251|NCT00085735|54457089|FG005|Overall Study|Adverse Event|0|||
27867252|NCT00085735|54457084|FG000|Overall Study|Lack of Efficacy|2|||
27867253|NCT00085735|54457085|FG001|Overall Study|Lack of Efficacy|4|||
27867254|NCT00085735|54457086|FG002|Overall Study|Lack of Efficacy|6|||
27867255|NCT00085735|54457087|FG003|Overall Study|Lack of Efficacy|3|||
27867256|NCT00085735|54457088|FG004|Overall Study|Lack of Efficacy|4|||
27867257|NCT00085735|54457089|FG005|Overall Study|Lack of Efficacy|3|||
27867258|NCT00085735|54457084|FG000|Overall Study|Lost to Follow-up|0|||
27867259|NCT00085735|54457085|FG001|Overall Study|Lost to Follow-up|1|||
27867260|NCT00085735|54457086|FG002|Overall Study|Lost to Follow-up|0|||
27867261|NCT00085735|54457087|FG003|Overall Study|Lost to Follow-up|0|||
27867262|NCT00085735|54457088|FG004|Overall Study|Lost to Follow-up|1|||
27867263|NCT00085735|54457089|FG005|Overall Study|Lost to Follow-up|0|||
27867264|NCT00085735|54457084|FG000|Overall Study|Physician Decision|2|||
27867265|NCT00085735|54457085|FG001|Overall Study|Physician Decision|3|||
27867266|NCT00085735|54457086|FG002|Overall Study|Physician Decision|2|||
27867267|NCT00085735|54457087|FG003|Overall Study|Physician Decision|3|||
27867268|NCT00085735|54457088|FG004|Overall Study|Physician Decision|11|||
27867269|NCT00085735|54457089|FG005|Overall Study|Physician Decision|8|||
27867270|NCT00085735|54457084|FG000|Overall Study|Protocol Violation|1|||
27867271|NCT00085735|54457085|FG001|Overall Study|Protocol Violation|0|||
27867272|NCT00085735|54457086|FG002|Overall Study|Protocol Violation|0|||
27867273|NCT00085735|54457087|FG003|Overall Study|Protocol Violation|0|||
27867274|NCT00085735|54457088|FG004|Overall Study|Protocol Violation|0|||
27867275|NCT00085735|54457089|FG005|Overall Study|Protocol Violation|0|||
27982238|NCT02708108|54640251|FG000|Overall Study|Regimen change|1|||
27982239|NCT02708108|54640252|FG001|Overall Study|Regimen change|0|||
27867276|NCT00085735|54457084|FG000|Overall Study|Withdrawal by Subject|1|||
27867277|NCT00085735|54457085|FG001|Overall Study|Withdrawal by Subject|0|||
27867278|NCT00085735|54457086|FG002|Overall Study|Withdrawal by Subject|4|||
28096319|NCT04425252|54751202|FG000|Overall Study|Lost to Follow-up|1|||
27867279|NCT00085735|54457087|FG003|Overall Study|Withdrawal by Subject|5|||
27867280|NCT00085735|54457088|FG004|Overall Study|Withdrawal by Subject|7|||
27867281|NCT00085735|54457089|FG005|Overall Study|Withdrawal by Subject|8|||
27867282|NCT00085735|54457084|FG000|Overall Study|Patient ineligible|1|||
27867283|NCT00085735|54457085|FG001|Overall Study|Patient ineligible|0|||
27867284|NCT00085735|54457086|FG002|Overall Study|Patient ineligible|3|||
27867285|NCT00085735|54457087|FG003|Overall Study|Patient ineligible|7|||
27867286|NCT00085735|54457088|FG004|Overall Study|Patient ineligible|17|||
27867287|NCT00085735|54457089|FG005|Overall Study|Patient ineligible|8|||
27867288|NCT00085735|54457084|FG000|Overall Study|Excess residual disease|2|||
27867289|NCT00085735|54457085|FG001|Overall Study|Excess residual disease|2|||
27867290|NCT00085735|54457086|FG002|Overall Study|Excess residual disease|1|||
27867291|NCT00085735|54457087|FG003|Overall Study|Excess residual disease|1|||
27867292|NCT00085735|54457088|FG004|Overall Study|Excess residual disease|1|||
27867293|NCT00085735|54457089|FG005|Overall Study|Excess residual disease|4|||
27867294|NCT00085735|54457084|FG000|Overall Study|Reason not documented|1|||
27867295|NCT00085735|54457085|FG001|Overall Study|Reason not documented|0|||
27867296|NCT00085735|54457086|FG002|Overall Study|Reason not documented|1|||
27867297|NCT00085735|54457087|FG003|Overall Study|Reason not documented|0|||
27867298|NCT00085735|54457088|FG004|Overall Study|Reason not documented|1|||
27867299|NCT00085735|54457089|FG005|Overall Study|Reason not documented|0|||
27867300|NCT00085735|54457084|FG000|Overall Study|Pt transferred to inst w/out study open|1|||
27867301|NCT00085735|54457085|FG001|Overall Study|Pt transferred to inst w/out study open|0|||
27867302|NCT00085735|54457086|FG002|Overall Study|Pt transferred to inst w/out study open|0|||
27867303|NCT00085735|54457087|FG003|Overall Study|Pt transferred to inst w/out study open|0|||
27867304|NCT00085735|54457088|FG004|Overall Study|Pt transferred to inst w/out study open|0|||
27867305|NCT00085735|54457089|FG005|Overall Study|Pt transferred to inst w/out study open|0|||
27867306|NCT04537793|54457391|FG000|Part B (24 Weeks)|Adverse Event|0|||
27867307|NCT04537793|54457392|FG001|Part B (24 Weeks)|Adverse Event|1|||
27867308|NCT01938001|54458654|FG000|Pre-Treatment|Adverse Event unrelated to Study Drug|1|||
27867309|NCT01938001|54458655|FG001|Pre-Treatment|Adverse Event unrelated to Study Drug|0|||
27867310|NCT01938001|54458654|FG000|Pre-Treatment|Death|1|||
27867311|NCT01938001|54458655|FG001|Pre-Treatment|Death|0|||
27867312|NCT01938001|54458654|FG000|Treatment|Death|2|||
27867313|NCT01938001|54458655|FG001|Treatment|Death|0|||
27867314|NCT01938001|54458654|FG000|Treatment|Adverse Event|14|||
27867315|NCT01938001|54458655|FG001|Treatment|Adverse Event|8|||
27867316|NCT01938001|54458654|FG000|Treatment|Progressive Disease|21|||
27867317|NCT01938001|54458655|FG001|Treatment|Progressive Disease|54|||
27867318|NCT01938001|54458654|FG000|Treatment|Withdrawal by Subject|13|||
27867319|NCT01938001|54458655|FG001|Treatment|Withdrawal by Subject|7|||
27867320|NCT01938001|54458654|FG000|Treatment|Other reasons|2|||
27867321|NCT01938001|54458655|FG001|Treatment|Other reasons|1|||
27867322|NCT01066663|54458828|FG000|Overall Study|Adverse Event|0|||
27867323|NCT01066663|54458829|FG001|Overall Study|Adverse Event|0|||
27867324|NCT01066663|54458830|FG002|Overall Study|Adverse Event|1|||
27867325|NCT03930745|54461063|FG000|Overall Study|Lost to Follow-up|10|||
27867326|NCT03930745|54461064|FG001|Overall Study|Lost to Follow-up|5|||
27867327|NCT03930745|54461063|FG000|Overall Study|Withdrawal by Subject|1|||
27867328|NCT03930745|54461064|FG001|Overall Study|Withdrawal by Subject|2|||
27867329|NCT03930745|54461063|FG000|Overall Study|Protocol Violation|2|||
27867330|NCT03930745|54461064|FG001|Overall Study|Protocol Violation|2|||
27867331|NCT03930745|54461063|FG000|Overall Study|COVID-19 Shelter in Place Order|3|||
27867332|NCT03930745|54461064|FG001|Overall Study|COVID-19 Shelter in Place Order|5|||
27867333|NCT03930745|54461063|FG000|Overall Study|Adverse Event|0|||
27867334|NCT03930745|54461064|FG001|Overall Study|Adverse Event|1|||
27867335|NCT03930745|54461063|FG000|Overall Study|Pregnancy|0|||
27867336|NCT03930745|54461064|FG001|Overall Study|Pregnancy|1|||
27867337|NCT04473326|54463809|FG000|Overall Study|Death|0|||
27867338|NCT04473326|54463810|FG001|Overall Study|Death|1|||
27867339|NCT04473326|54463809|FG000|Overall Study|Withdrawal by Subject|1|||
27867340|NCT04473326|54463810|FG001|Overall Study|Withdrawal by Subject|2|||
28171387|NCT02471404|54842971|FG000|Overall Study|Developed Study Withdrawal Criteria|4|||
27867341|NCT03838484|54464392|FG000|Overall Study|Lost to Follow-up|0|||
27867342|NCT03838484|54464393|FG001|Overall Study|Lost to Follow-up|1|||
27867343|NCT03838484|54464394|FG002|Overall Study|Lost to Follow-up|0|||
27867344|NCT03838484|54464395|FG003|Overall Study|Lost to Follow-up|0|||
27867345|NCT01349192|54464627|FG000|Overall Study|Protocol Violation|0|||
27867346|NCT01349192|54464628|FG001|Overall Study|Protocol Violation|1|||
27867347|NCT01349192|54464627|FG000|Overall Study|Withdrawal by Subject|0|||
27867348|NCT01349192|54464628|FG001|Overall Study|Withdrawal by Subject|2|||
27867349|NCT01349192|54464627|FG000|Overall Study|Lost to Follow-up|1|||
27867350|NCT01349192|54464628|FG001|Overall Study|Lost to Follow-up|3|||
27867351|NCT01349192|54464627|FG000|Overall Study|Failure to adhere to Protocol|2|||
27867352|NCT01349192|54464628|FG001|Overall Study|Failure to adhere to Protocol|0|||
27867353|NCT01721876|54464983|FG000|Overall Study|Not treated|1|||
27867354|NCT01721876|54464984|FG001|Overall Study|Not treated|4|||
27867355|NCT01721876|54464983|FG000|Overall Study|Disease progression / relapse|123|||
27867356|NCT01721876|54464984|FG001|Overall Study|Disease progression / relapse|156|||
27867357|NCT01721876|54464983|FG000|Overall Study|Death|6|||
27867358|NCT01721876|54464984|FG001|Overall Study|Death|13|||
27867359|NCT01721876|54464983|FG000|Overall Study|Adverse Event|41|||
27867360|NCT01721876|54464984|FG001|Overall Study|Adverse Event|165|||
27867361|NCT01721876|54464983|FG000|Overall Study|Protocol Violation|2|||
27867362|NCT01721876|54464984|FG001|Overall Study|Protocol Violation|1|||
27867363|NCT01721876|54464983|FG000|Overall Study|Withdrawal by Subject|15|||
27867364|NCT01721876|54464984|FG001|Overall Study|Withdrawal by Subject|38|||
27867365|NCT01721876|54464983|FG000|Overall Study|Reason not listed|34|||
27867366|NCT01721876|54464984|FG001|Overall Study|Reason not listed|63|||
27867367|NCT01721876|54464983|FG000|Overall Study|Sponsor terminated trial|0|||
27867368|NCT01721876|54464984|FG001|Overall Study|Sponsor terminated trial|4|||
27867369|NCT02265510|54465219|FG000|Overall Study|Withdrawal by Subject|1|||
27867370|NCT02265510|54465220|FG001|Overall Study|Withdrawal by Subject|1|||
27867371|NCT02265510|54465221|FG002|Overall Study|Withdrawal by Subject|2|||
27867372|NCT02265510|54465222|FG003|Overall Study|Withdrawal by Subject|1|||
27867373|NCT02265510|54465223|FG004|Overall Study|Withdrawal by Subject|0|||
27867374|NCT02265510|54465224|FG005|Overall Study|Withdrawal by Subject|2|||
27867375|NCT02265510|54465225|FG006|Overall Study|Withdrawal by Subject|0|||
27867376|NCT02265510|54465226|FG007|Overall Study|Withdrawal by Subject|2|||
27867377|NCT02265510|54465227|FG008|Overall Study|Withdrawal by Subject|0|||
27867378|NCT02265510|54465228|FG009|Overall Study|Withdrawal by Subject|0|||
27867379|NCT02265510|54465229|FG010|Overall Study|Withdrawal by Subject|0|||
27867380|NCT02265510|54465230|FG011|Overall Study|Withdrawal by Subject|0|||
27867381|NCT02265510|54465231|FG012|Overall Study|Withdrawal by Subject|1|||
27867382|NCT02265510|54465232|FG013|Overall Study|Withdrawal by Subject|0|||
27867383|NCT02265510|54465219|FG000|Overall Study|Disease Progression|0|||
27867384|NCT02265510|54465220|FG001|Overall Study|Disease Progression|1|||
27867385|NCT02265510|54465221|FG002|Overall Study|Disease Progression|2|||
27867386|NCT02265510|54465222|FG003|Overall Study|Disease Progression|1|||
27867387|NCT02265510|54465223|FG004|Overall Study|Disease Progression|1|||
27867388|NCT02265510|54465224|FG005|Overall Study|Disease Progression|0|||
27867389|NCT02265510|54465225|FG006|Overall Study|Disease Progression|0|||
27867390|NCT02265510|54465226|FG007|Overall Study|Disease Progression|0|||
27867391|NCT02265510|54465227|FG008|Overall Study|Disease Progression|0|||
27867392|NCT02265510|54465228|FG009|Overall Study|Disease Progression|0|||
27867393|NCT02265510|54465229|FG010|Overall Study|Disease Progression|0|||
27867394|NCT02265510|54465230|FG011|Overall Study|Disease Progression|0|||
27867395|NCT02265510|54465231|FG012|Overall Study|Disease Progression|0|||
27867396|NCT02265510|54465232|FG013|Overall Study|Disease Progression|0|||
27867397|NCT02265510|54465219|FG000|Overall Study|Death|2|||
27867398|NCT02265510|54465220|FG001|Overall Study|Death|0|||
27867399|NCT02265510|54465221|FG002|Overall Study|Death|2|||
27867400|NCT02265510|54465222|FG003|Overall Study|Death|2|||
27867401|NCT02265510|54465223|FG004|Overall Study|Death|1|||
27867402|NCT02265510|54465224|FG005|Overall Study|Death|3|||
27867403|NCT02265510|54465225|FG006|Overall Study|Death|2|||
27867404|NCT02265510|54465226|FG007|Overall Study|Death|1|||
27867405|NCT02265510|54465227|FG008|Overall Study|Death|3|||
27867406|NCT02265510|54465228|FG009|Overall Study|Death|3|||
27867407|NCT02265510|54465229|FG010|Overall Study|Death|4|||
27867408|NCT02265510|54465230|FG011|Overall Study|Death|12|||
27867409|NCT02265510|54465231|FG012|Overall Study|Death|7|||
27867410|NCT02265510|54465232|FG013|Overall Study|Death|6|||
27867411|NCT02265510|54465219|FG000|Overall Study|Lost to Follow-up|0|||
27867412|NCT02265510|54465220|FG001|Overall Study|Lost to Follow-up|0|||
27867413|NCT02265510|54465221|FG002|Overall Study|Lost to Follow-up|0|||
27867414|NCT02265510|54465222|FG003|Overall Study|Lost to Follow-up|0|||
27867415|NCT02265510|54465223|FG004|Overall Study|Lost to Follow-up|1|||
27867416|NCT02265510|54465224|FG005|Overall Study|Lost to Follow-up|0|||
27867417|NCT02265510|54465225|FG006|Overall Study|Lost to Follow-up|0|||
27867418|NCT02265510|54465226|FG007|Overall Study|Lost to Follow-up|0|||
27867419|NCT02265510|54465227|FG008|Overall Study|Lost to Follow-up|0|||
27867420|NCT02265510|54465228|FG009|Overall Study|Lost to Follow-up|2|||
27867421|NCT02265510|54465229|FG010|Overall Study|Lost to Follow-up|0|||
27867422|NCT02265510|54465230|FG011|Overall Study|Lost to Follow-up|0|||
27867423|NCT02265510|54465231|FG012|Overall Study|Lost to Follow-up|0|||
27867424|NCT02265510|54465232|FG013|Overall Study|Lost to Follow-up|2|||
27867425|NCT02265510|54465219|FG000|Overall Study|Other|0|||
28096320|NCT04425252|54751203|FG001|Overall Study|Lost to Follow-up|0|||
27867426|NCT02265510|54465220|FG001|Overall Study|Other|1|||
27867427|NCT02265510|54465221|FG002|Overall Study|Other|0|||
27867428|NCT02265510|54465222|FG003|Overall Study|Other|0|||
27867429|NCT02265510|54465223|FG004|Overall Study|Other|0|||
27867430|NCT02265510|54465224|FG005|Overall Study|Other|0|||
27867431|NCT02265510|54465225|FG006|Overall Study|Other|0|||
27867432|NCT02265510|54465226|FG007|Overall Study|Other|0|||
27867433|NCT02265510|54465227|FG008|Overall Study|Other|0|||
27867434|NCT02265510|54465228|FG009|Overall Study|Other|0|||
27867435|NCT02265510|54465229|FG010|Overall Study|Other|0|||
27867436|NCT02265510|54465230|FG011|Overall Study|Other|0|||
27867437|NCT02265510|54465231|FG012|Overall Study|Other|0|||
27867438|NCT02265510|54465232|FG013|Overall Study|Other|0|||
27835248|NCT01587703|54319715|FG014|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
27835249|NCT01587703|54319716|FG015|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
27835250|NCT01587703|54319717|FG016|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
27835251|NCT01587703|54319718|FG017|Substudy-P4,Maximum Exposure of 5.5month|Death|5|||
27835252|NCT01587703|54319719|FG018|Substudy-P4,Maximum Exposure of 5.5month|Death|4|||
27835253|NCT01587703|54319701|FG000|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
27835254|NCT01587703|54319702|FG001|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
27835255|NCT01587703|54319703|FG002|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
27835256|NCT01587703|54319704|FG003|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
27835257|NCT01587703|54319705|FG004|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
27835258|NCT01587703|54319706|FG005|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
27835259|NCT01587703|54319707|FG006|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
27835260|NCT01587703|54319708|FG007|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
27835261|NCT01587703|54319709|FG008|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
27835262|NCT01587703|54319710|FG009|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
27835263|NCT01587703|54319711|FG010|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
27835264|NCT01587703|54319712|FG011|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
27835265|NCT01587703|54319713|FG012|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
27835266|NCT01587703|54319714|FG013|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
27835267|NCT01587703|54319715|FG014|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
27835268|NCT01587703|54319716|FG015|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1|||
27835269|NCT01587703|54319717|FG016|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
27835270|NCT01587703|54319718|FG017|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
27835271|NCT01587703|54319719|FG018|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
27835272|NCT01587703|54319701|FG000|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
27835273|NCT01587703|54319702|FG001|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
27835274|NCT01587703|54319703|FG002|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
27835275|NCT01587703|54319704|FG003|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
27835276|NCT01587703|54319705|FG004|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
27835277|NCT01587703|54319706|FG005|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
27835278|NCT01587703|54319707|FG006|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
27835279|NCT01587703|54319708|FG007|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
27835280|NCT01587703|54319709|FG008|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
27835281|NCT01587703|54319710|FG009|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
27835282|NCT01587703|54319711|FG010|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
27835283|NCT01587703|54319712|FG011|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1|||
27835284|NCT01587703|54319713|FG012|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
27835285|NCT01587703|54319714|FG013|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
27835286|NCT01587703|54319715|FG014|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2|||
27835287|NCT01587703|54319716|FG015|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
27835288|NCT01587703|54319717|FG016|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
27835289|NCT01587703|54319718|FG017|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
27835290|NCT01587703|54319719|FG018|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
27835291|NCT01587703|54319701|FG000|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
27835292|NCT01587703|54319702|FG001|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
27835293|NCT01587703|54319703|FG002|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
27835294|NCT01587703|54319704|FG003|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
27835295|NCT01587703|54319705|FG004|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
27835296|NCT01587703|54319706|FG005|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
27835297|NCT01587703|54319707|FG006|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
27835298|NCT01587703|54319708|FG007|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
27835299|NCT01587703|54319709|FG008|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
27835300|NCT01587703|54319710|FG009|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
27835301|NCT01587703|54319711|FG010|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
27835302|NCT01587703|54319712|FG011|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
27835303|NCT01587703|54319713|FG012|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
27835304|NCT01587703|54319714|FG013|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
27835305|NCT01587703|54319715|FG014|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
27835306|NCT01587703|54319716|FG015|Part2(Median Exposure of 1.41 Months)|Site closed|3|||
27835307|NCT01587703|54319717|FG016|Part2(Median Exposure of 1.41 Months)|Site closed|8|||
27867439|NCT02265510|54465219|FG000|Overall Study|Study Terminated by Sponsor|0|||
27867440|NCT02265510|54465220|FG001|Overall Study|Study Terminated by Sponsor|0|||
27867441|NCT02265510|54465221|FG002|Overall Study|Study Terminated by Sponsor|0|||
27867442|NCT02265510|54465222|FG003|Overall Study|Study Terminated by Sponsor|0|||
27867443|NCT02265510|54465223|FG004|Overall Study|Study Terminated by Sponsor|0|||
27867444|NCT02265510|54465224|FG005|Overall Study|Study Terminated by Sponsor|1|||
27867445|NCT02265510|54465225|FG006|Overall Study|Study Terminated by Sponsor|1|||
27867446|NCT02265510|54465226|FG007|Overall Study|Study Terminated by Sponsor|1|||
27867447|NCT02265510|54465227|FG008|Overall Study|Study Terminated by Sponsor|1|||
27867448|NCT02265510|54465228|FG009|Overall Study|Study Terminated by Sponsor|2|||
27867449|NCT02265510|54465229|FG010|Overall Study|Study Terminated by Sponsor|1|||
27867450|NCT02265510|54465230|FG011|Overall Study|Study Terminated by Sponsor|4|||
27867451|NCT02265510|54465231|FG012|Overall Study|Study Terminated by Sponsor|1|||
27867452|NCT02265510|54465232|FG013|Overall Study|Study Terminated by Sponsor|2|||
27867453|NCT01238211|54465333|FG000|Overall Study|Continues active treatment|31|||
27867454|NCT01238211|54465333|FG000|Overall Study|Adverse Event|7|||
27867455|NCT01238211|54465333|FG000|Overall Study|Death|4|||
27867456|NCT01238211|54465333|FG000|Overall Study|Relapse/Progression|2|||
27867457|NCT01238211|54465333|FG000|Overall Study|Withdrawal by Subject|7|||
27867458|NCT01238211|54465333|FG000|Overall Study|Non-protocol treatment|4|||
27867459|NCT01238211|54465333|FG000|Overall Study|Investigator/Patient Decision|3|||
27867460|NCT02264574|54465509|FG000|Overall Study|Death|21|||
27867461|NCT02264574|54465510|FG001|Overall Study|Death|21|||
27867462|NCT02264574|54465509|FG000|Overall Study|Withdrawal by Subject|8|||
27867463|NCT02264574|54465510|FG001|Overall Study|Withdrawal by Subject|6|||
27867464|NCT02264574|54465509|FG000|Overall Study|Other, Not Specified|0|||
27867465|NCT02264574|54465510|FG001|Overall Study|Other, Not Specified|3|||
27867466|NCT01641900|54465550|FG000|Overall Study|Withdrawal by Subject|2|||
27867467|NCT01641900|54465551|FG001|Overall Study|Withdrawal by Subject|2|||
27867468|NCT01640808|54465624|FG000|Overall Study|Unable to continue dynamic CT|14|||
27867469|NCT01640808|54465625|FG001|Overall Study|Unable to continue dynamic CT|4|||
27867470|NCT01640808|54465624|FG000|Overall Study|Withdrawal by Subject|12|||
27867471|NCT01640808|54465625|FG001|Overall Study|Withdrawal by Subject|4|||
27867472|NCT01640808|54465624|FG000|Overall Study|Lost to Follow-up|4|||
27867473|NCT01640808|54465625|FG001|Overall Study|Lost to Follow-up|0|||
27867474|NCT01640808|54465624|FG000|Overall Study|Start an antiviral therapy using IFN|3|||
27867475|NCT01640808|54465625|FG001|Overall Study|Start an antiviral therapy using IFN|0|||
27867476|NCT01640808|54465624|FG000|Overall Study|Administration of anticancer drugs|2|||
27867477|NCT01640808|54465625|FG001|Overall Study|Administration of anticancer drugs|1|||
27867478|NCT01640808|54465624|FG000|Overall Study|Physician Decision|19|||
27867479|NCT01640808|54465625|FG001|Overall Study|Physician Decision|5|||
27867480|NCT01640808|54465624|FG000|Overall Study|Randomized but not treated|4|||
27867481|NCT01640808|54465625|FG001|Overall Study|Randomized but not treated|2|||
27867482|NCT02263326|54465646|FG000|Overall Study|Lost to Follow-up|1|||
27867483|NCT02263326|54465647|FG001|Overall Study|Lost to Follow-up|1|||
27867484|NCT02260986|54465758|FG000|Overall Study|Adverse Event|24|||
27867485|NCT02260986|54465759|FG001|Overall Study|Adverse Event|0|||
27867486|NCT02260986|54465760|FG002|Overall Study|Adverse Event|11|||
27867487|NCT02260986|54465758|FG000|Overall Study|Lack of Efficacy|27|||
27867488|NCT02260986|54465759|FG001|Overall Study|Lack of Efficacy|3|||
27867489|NCT02260986|54465760|FG002|Overall Study|Lack of Efficacy|0|||
27867490|NCT02260986|54465758|FG000|Overall Study|Protocol Violation|14|||
27867491|NCT02260986|54465759|FG001|Overall Study|Protocol Violation|5|||
27867492|NCT02260986|54465760|FG002|Overall Study|Protocol Violation|16|||
27867493|NCT02260986|54465758|FG000|Overall Study|Car accident|0|||
27867494|NCT02260986|54465759|FG001|Overall Study|Car accident|0|||
27867495|NCT02260986|54465760|FG002|Overall Study|Car accident|1|||
27867496|NCT02260986|54465758|FG000|Overall Study|Withdrawal by Subject|17|||
27867497|NCT02260986|54465759|FG001|Overall Study|Withdrawal by Subject|4|||
27867498|NCT02260986|54465760|FG002|Overall Study|Withdrawal by Subject|9|||
27867499|NCT02260986|54465758|FG000|Overall Study|Incorrect randomization|0|||
27867500|NCT02260986|54465759|FG001|Overall Study|Incorrect randomization|1|||
27867501|NCT02260986|54465760|FG002|Overall Study|Incorrect randomization|0|||
27867502|NCT02260986|54465758|FG000|Overall Study|Lack of investigation product supply|2|||
27867503|NCT02260986|54465759|FG001|Overall Study|Lack of investigation product supply|0|||
27867504|NCT02260986|54465760|FG002|Overall Study|Lack of investigation product supply|1|||
27867505|NCT02260986|54465758|FG000|Overall Study|Lost to Follow-up|4|||
27867506|NCT02260986|54465759|FG001|Overall Study|Lost to Follow-up|0|||
27867507|NCT02260986|54465760|FG002|Overall Study|Lost to Follow-up|3|||
27867508|NCT02260986|54465758|FG000|Overall Study|Pregnancy|2|||
27867509|NCT02260986|54465759|FG001|Overall Study|Pregnancy|0|||
27867510|NCT02260986|54465760|FG002|Overall Study|Pregnancy|0|||
27867511|NCT02259582|54465776|FG000|Overall Study|Physician Decision|0|||
27867512|NCT02259582|54465777|FG001|Overall Study|Physician Decision|1|||
27867513|NCT02259582|54465778|FG002|Overall Study|Physician Decision|0|||
27867514|NCT02259582|54465776|FG000|Overall Study|Death|0|||
27867515|NCT02259582|54465777|FG001|Overall Study|Death|0|||
27867516|NCT02259582|54465778|FG002|Overall Study|Death|1|||
27982240|NCT02708108|54640251|FG000|Overall Study|No MRD and no imaging available|0|||
27867517|NCT02259582|54465776|FG000|Overall Study|Adverse Event|1|||
27867518|NCT02259582|54465777|FG001|Overall Study|Adverse Event|0|||
27867519|NCT02259582|54465778|FG002|Overall Study|Adverse Event|1|||
27867520|NCT02259582|54465776|FG000|Overall Study|Withdrawal by Subject|0|||
27867521|NCT02259582|54465777|FG001|Overall Study|Withdrawal by Subject|0|||
27867522|NCT02259582|54465778|FG002|Overall Study|Withdrawal by Subject|1|||
27867523|NCT02259582|54465776|FG000|Overall Study|Disease progression|14|||
27867524|NCT02259582|54465777|FG001|Overall Study|Disease progression|15|||
27867525|NCT02259582|54465778|FG002|Overall Study|Disease progression|17|||
27867526|NCT02259582|54465776|FG000|Overall Study|Lack of Subject Adherence to Protocol|1|||
27867527|NCT02259582|54465777|FG001|Overall Study|Lack of Subject Adherence to Protocol|1|||
27867528|NCT02259582|54465778|FG002|Overall Study|Lack of Subject Adherence to Protocol|1|||
27867529|NCT03238651|54465791|FG000|Overall Study|Other|0|||
27867530|NCT03238651|54465792|FG001|Overall Study|Other|0|||
27867531|NCT03238651|54465793|FG002|Overall Study|Other|0|||
27867532|NCT03238651|54465794|FG003|Overall Study|Other|0|||
27867533|NCT03238651|54465795|FG004|Overall Study|Other|1|||
27867534|NCT03238651|54465791|FG000|Overall Study|Progressive Disease|2|||
27867535|NCT03238651|54465792|FG001|Overall Study|Progressive Disease|2|||
27982241|NCT02708108|54640252|FG001|Overall Study|No MRD and no imaging available|1|||
27982242|NCT02619682|54640259|FG000|Overall Study|Withdrawal by Subject|3|||
27982243|NCT02619682|54640259|FG000|Overall Study|Lack of Efficacy|8|||
27982244|NCT02619682|54640259|FG000|Overall Study|new secondary cancer|1|||
27982245|NCT02619682|54640259|FG000|Overall Study|post surgery complications|2|||
27982246|NCT02617589|54640265|FG000|Randomization|Request to Discontinue Study Treatment|1|||
27982247|NCT02617589|54640266|FG001|Randomization|Request to Discontinue Study Treatment|3|||
27982248|NCT02617589|54640265|FG000|Randomization|Participant Withdrew Consent|1|||
27982249|NCT02617589|54640266|FG001|Randomization|Participant Withdrew Consent|2|||
27982250|NCT02617589|54640265|FG000|Treatment|Other Reasons|3|||
27982251|NCT02617589|54640266|FG001|Treatment|Other Reasons|3|||
27982252|NCT02617589|54640265|FG000|Treatment|Poor/Non Compliance|1|||
27982253|NCT02617589|54640266|FG001|Treatment|Poor/Non Compliance|1|||
27982254|NCT02617589|54640265|FG000|Treatment|Maximum Clinical Benefit|0|||
27982255|NCT02617589|54640266|FG001|Treatment|Maximum Clinical Benefit|2|||
27982256|NCT02617589|54640265|FG000|Treatment|Participant Withdrew Consent|2|||
27982257|NCT02617589|54640266|FG001|Treatment|Participant Withdrew Consent|6|||
27982258|NCT02617589|54640265|FG000|Treatment|Participant Request to Discontinue|12|||
27982259|NCT02617589|54640266|FG001|Treatment|Participant Request to Discontinue|21|||
27982260|NCT02617589|54640265|FG000|Treatment|Adverse Event Unrelated to Study Drug|16|||
27982261|NCT02617589|54640266|FG001|Treatment|Adverse Event Unrelated to Study Drug|9|||
27982262|NCT02617589|54640265|FG000|Treatment|Death|1|||
27982263|NCT02617589|54640266|FG001|Treatment|Death|1|||
27982264|NCT02617589|54640265|FG000|Treatment|Study Drug Toxicity|27|||
27982265|NCT02617589|54640266|FG001|Treatment|Study Drug Toxicity|20|||
27982266|NCT02617589|54640265|FG000|Treatment|Disease Progression|216|||
27738976|NCT02240680|54188245|FG002|Overall Study (Up to 24 Weeks)|Other than specified|0|||
27738977|NCT02240680|54188246|FG003|Overall Study (Up to 24 Weeks)|Other than specified|0|||
27738978|NCT02240680|54188243|FG000|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
27738979|NCT02240680|54188244|FG001|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
27738980|NCT02240680|54188245|FG002|Japanese Patients (Up to 52 Weeks)|Adverse Event|6|||
27738981|NCT02240680|54188246|FG003|Japanese Patients (Up to 52 Weeks)|Adverse Event|7|||
27835308|NCT01587703|54319718|FG017|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
27982267|NCT02617589|54640266|FG001|Treatment|Disease Progression|136|||
27982268|NCT02471807|54640272|FG000|Overall Study|Death|14|||
27982269|NCT02471807|54640272|FG000|Overall Study|Withdrawal by Subject|2|||
27982270|NCT02471807|54640272|FG000|Overall Study|Explant|5|||
28096321|NCT04425252|54751202|FG000|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
28096322|NCT04425252|54751203|FG001|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
27835309|NCT01587703|54319719|FG018|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
27835310|NCT01587703|54319701|FG000|Part2(Median Exposure of 1.41 Months)|Death|0|||
27835311|NCT01587703|54319702|FG001|Part2(Median Exposure of 1.41 Months)|Death|0|||
27835312|NCT01587703|54319703|FG002|Part2(Median Exposure of 1.41 Months)|Death|0|||
27835313|NCT01587703|54319704|FG003|Part2(Median Exposure of 1.41 Months)|Death|0|||
27867536|NCT03238651|54465793|FG002|Overall Study|Progressive Disease|2|||
27867537|NCT03238651|54465794|FG003|Overall Study|Progressive Disease|2|||
27867538|NCT03238651|54465795|FG004|Overall Study|Progressive Disease|0|||
27982271|NCT02471807|54640272|FG000|Overall Study|Lost to Follow-up|1|||
28096323|NCT03696576|54751214|FG000|Overall Study|Soreness of throat after therapy|1|||
28096324|NCT03696576|54751215|FG001|Overall Study|Soreness of throat after therapy|1|||
28096325|NCT03696576|54751214|FG000|Overall Study|Lost to Follow-up|2|||
27835314|NCT01587703|54319705|FG004|Part2(Median Exposure of 1.41 Months)|Death|0|||
27835315|NCT01587703|54319706|FG005|Part2(Median Exposure of 1.41 Months)|Death|0|||
27867539|NCT03238651|54465791|FG000|Overall Study|Withdrawal by Subject|0|||
27982272|NCT02364557|54640278|FG000|Overall Study|Protocol Violation|3|||
27982273|NCT02364557|54640279|FG001|Overall Study|Protocol Violation|1|||
27982274|NCT02337829|54640315|FG000|Overall Study|Death|0|||
27982275|NCT02337829|54640316|FG001|Overall Study|Death|1|||
27982276|NCT02337829|54640317|FG002|Overall Study|Death|0|||
27867540|NCT03238651|54465792|FG001|Overall Study|Withdrawal by Subject|1|||
27867541|NCT03238651|54465793|FG002|Overall Study|Withdrawal by Subject|0|||
27867542|NCT03238651|54465794|FG003|Overall Study|Withdrawal by Subject|1|||
27867543|NCT03238651|54465795|FG004|Overall Study|Withdrawal by Subject|0|||
27867544|NCT03238651|54465791|FG000|Overall Study|Adverse Event|1|||
27867545|NCT03238651|54465792|FG001|Overall Study|Adverse Event|3|||
27867546|NCT03238651|54465793|FG002|Overall Study|Adverse Event|2|||
27867547|NCT03238651|54465794|FG003|Overall Study|Adverse Event|0|||
27867548|NCT03238651|54465795|FG004|Overall Study|Adverse Event|0|||
27867549|NCT05490771|54465819|FG000|Overall Study|Disease progression|18|||
27867550|NCT05490771|54465819|FG000|Overall Study|Adverse Event|3|||
27867551|NCT05490771|54465819|FG000|Overall Study|Other complicating disease|1|||
27867552|NCT05490771|54465819|FG000|Overall Study|Withdrawal by Subject|3|||
27867553|NCT05490771|54465819|FG000|Overall Study|Physician Decision|1|||
27867554|NCT05490771|54465819|FG000|Overall Study|Still on treatment|2|||
27867555|NCT05490771|54465819|FG000|Overall Study|Never start protocol therapy|5|||
27867556|NCT05490771|54465819|FG000|Overall Study|Ineligible|2|||
27867557|NCT05346055|54465823|FG000|Overall Study|Withdrawal by Subject|1|||
27867558|NCT05346055|54465823|FG000|Overall Study|Protocol Violation|1|||
27867559|NCT05346055|54465823|FG000|Overall Study|Therapist decision|1|||
27867560|NCT05211739|54465833|FG000|First Wear Period (Approx 30 Days)|Adverse Event|0|||
27867561|NCT05211739|54465834|FG001|First Wear Period (Approx 30 Days)|Adverse Event|1|||
27867562|NCT05211739|54465833|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|1|||
27867563|NCT05211739|54465834|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|0|||
27867564|NCT05211739|54465833|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
27867565|NCT05211739|54465834|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
27867566|NCT05211739|54465833|FG000|Second Wear Period (Approx 30 Days)|Adverse Event|1|||
27867567|NCT05211739|54465834|FG001|Second Wear Period (Approx 30 Days)|Adverse Event|0|||
27867568|NCT05085405|54465862|FG000|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
27867569|NCT05085405|54465863|FG001|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
27867570|NCT05085405|54465864|FG002|Overall Study|Patient closed to the anticoagulation clinic monitoring service|1|||
27867571|NCT05085405|54465865|FG003|Overall Study|Patient closed to the anticoagulation clinic monitoring service|2|||
27867572|NCT05085405|54465866|FG004|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
27867573|NCT05085405|54465867|FG005|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
27867574|NCT05085405|54465862|FG000|Overall Study|Patient started PPI prior to intervention delivery.|0|||
27867575|NCT05085405|54465863|FG001|Overall Study|Patient started PPI prior to intervention delivery.|0|||
27867576|NCT05085405|54465864|FG002|Overall Study|Patient started PPI prior to intervention delivery.|0|||
27867577|NCT05085405|54465865|FG003|Overall Study|Patient started PPI prior to intervention delivery.|1|||
27867578|NCT05085405|54465866|FG004|Overall Study|Patient started PPI prior to intervention delivery.|0|||
27867579|NCT05085405|54465867|FG005|Overall Study|Patient started PPI prior to intervention delivery.|0|||
27867580|NCT04932941|54465879|FG000|Overall Study|Lost to Follow-up|3|||
27867581|NCT04932941|54465880|FG001|Overall Study|Lost to Follow-up|1|||
27867582|NCT04932941|54465879|FG000|Overall Study|Withdrawal by Subject|7|||
27867583|NCT04932941|54465880|FG001|Overall Study|Withdrawal by Subject|4|||
27867584|NCT04932941|54465879|FG000|Overall Study|Other|4|||
27867585|NCT04932941|54465880|FG001|Overall Study|Other|2|||
27867586|NCT04677504|54465927|FG000|Overall Study|Death|31|||
27867587|NCT04677504|54465928|FG001|Overall Study|Death|24|||
27867588|NCT04677504|54465927|FG000|Overall Study|Progressive Disease|1|||
27867589|NCT04677504|54465928|FG001|Overall Study|Progressive Disease|0|||
27867590|NCT04677504|54465927|FG000|Overall Study|Symptomatic Deterioration|1|||
27867591|NCT04677504|54465928|FG001|Overall Study|Symptomatic Deterioration|0|||
27867592|NCT04677504|54465927|FG000|Overall Study|Withdrawal by Subject|2|||
27867593|NCT04677504|54465928|FG001|Overall Study|Withdrawal by Subject|5|||
27867594|NCT04677504|54465927|FG000|Overall Study|Ongoing in study|48|||
27867595|NCT04677504|54465928|FG001|Overall Study|Ongoing in study|50|||
27867596|NCT04662073|54465951|FG000|Overall Study|Withdrawal by Subject|1|||
27867597|NCT04662073|54465952|FG001|Overall Study|Withdrawal by Subject|0|||
27867598|NCT04656418|54465960|FG000|Overall Study|Withdrawal by Subject|1|||
27867599|NCT04656418|54465961|FG001|Overall Study|Withdrawal by Subject|3|||
27867600|NCT04622306|54465968|FG000|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
27867601|NCT04622306|54465969|FG001|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
27867602|NCT04622306|54465970|FG002|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
27867603|NCT04622306|54465971|FG003|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
27867604|NCT04622306|54465972|FG004|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
27867605|NCT04622306|54465973|FG005|Couples Used First Assigned Condom Set|Withdrawal by Subject|5|||
27867606|NCT04622306|54465968|FG000|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
27867607|NCT04622306|54465969|FG001|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
27867608|NCT04622306|54465970|FG002|Couples Used Third Assigned Condom Set|Withdrawal by Subject|2|||
27867609|NCT04622306|54465971|FG003|Couples Used Third Assigned Condom Set|Withdrawal by Subject|3|||
27738982|NCT02240680|54188243|FG000|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
27835316|NCT01587703|54319707|FG006|Part2(Median Exposure of 1.41 Months)|Death|0|||
27835317|NCT01587703|54319708|FG007|Part2(Median Exposure of 1.41 Months)|Death|0|||
27835318|NCT01587703|54319709|FG008|Part2(Median Exposure of 1.41 Months)|Death|0|||
27835319|NCT01587703|54319710|FG009|Part2(Median Exposure of 1.41 Months)|Death|0|||
27835320|NCT01587703|54319711|FG010|Part2(Median Exposure of 1.41 Months)|Death|0|||
27835321|NCT01587703|54319712|FG011|Part2(Median Exposure of 1.41 Months)|Death|8|||
27835322|NCT01587703|54319713|FG012|Part2(Median Exposure of 1.41 Months)|Death|12|||
27835323|NCT01587703|54319714|FG013|Part2(Median Exposure of 1.41 Months)|Death|21|||
27835324|NCT01587703|54319715|FG014|Part2(Median Exposure of 1.41 Months)|Death|16|||
27835325|NCT01587703|54319716|FG015|Part2(Median Exposure of 1.41 Months)|Death|17|||
27835326|NCT01587703|54319717|FG016|Part2(Median Exposure of 1.41 Months)|Death|5|||
27835327|NCT01587703|54319718|FG017|Part2(Median Exposure of 1.41 Months)|Death|0|||
27835328|NCT01587703|54319719|FG018|Part2(Median Exposure of 1.41 Months)|Death|0|||
27835329|NCT01587703|54319701|FG000|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
27835330|NCT01587703|54319702|FG001|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
27835331|NCT01587703|54319703|FG002|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
27835332|NCT01587703|54319704|FG003|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
27835333|NCT01587703|54319705|FG004|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
27835334|NCT01587703|54319706|FG005|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
27835335|NCT01587703|54319707|FG006|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
27835336|NCT01587703|54319708|FG007|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
27835337|NCT01587703|54319709|FG008|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
27835338|NCT01587703|54319710|FG009|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
27835339|NCT01587703|54319711|FG010|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
27835340|NCT01587703|54319712|FG011|Part2(Median Exposure of 1.41 Months)|Physician Decision|1|||
27835341|NCT01587703|54319713|FG012|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
27835342|NCT01587703|54319714|FG013|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
27835343|NCT01587703|54319715|FG014|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
27835344|NCT01587703|54319716|FG015|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
27835345|NCT01587703|54319717|FG016|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
27835346|NCT01587703|54319718|FG017|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
27835347|NCT01587703|54319719|FG018|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
27835348|NCT01577381|54319782|FG000|Overall Study|Discontinued|2|||
27835349|NCT01577381|54319783|FG001|Overall Study|Discontinued|1|||
27835350|NCT01577381|54319784|FG002|Overall Study|Discontinued|2|||
27835351|NCT01577381|54319785|FG003|Overall Study|Discontinued|2|||
27835352|NCT01577381|54319782|FG000|Overall Study|Ongoing at Date of Cut-Off|0|||
27835353|NCT01577381|54319783|FG001|Overall Study|Ongoing at Date of Cut-Off|2|||
27835354|NCT01577381|54319784|FG002|Overall Study|Ongoing at Date of Cut-Off|1|||
27835355|NCT01577381|54319785|FG003|Overall Study|Ongoing at Date of Cut-Off|0|||
27835356|NCT02686164|54319795|FG000|Overall Study|Adverse Event|1|||
27835357|NCT02686164|54319795|FG000|Overall Study|Withdrawal of consent|1|||
27835358|NCT02686164|54319795|FG000|Overall Study|Clinical progression|1|||
27835359|NCT01691105|54319816|FG000|1 Month Follow-up|Lost to Follow-up|41|||
27835360|NCT01691105|54319817|FG001|1 Month Follow-up|Lost to Follow-up|38|||
27835361|NCT01691105|54319816|FG000|1 Month Follow-up|Death|2|||
27835362|NCT01691105|54319817|FG001|1 Month Follow-up|Death|3|||
27835363|NCT01691105|54319816|FG000|6 Month Follow-up|Lost to Follow-up|39|||
27835364|NCT01691105|54319817|FG001|6 Month Follow-up|Lost to Follow-up|58|||
27835365|NCT01691105|54319816|FG000|6 Month Follow-up|Death|13|||
27835366|NCT01691105|54319817|FG001|6 Month Follow-up|Death|13|||
27835367|NCT01691105|54319816|FG000|12 Month Follow-up|Lost to Follow-up|50|||
27835368|NCT01691105|54319817|FG001|12 Month Follow-up|Lost to Follow-up|71|||
27835369|NCT01691105|54319816|FG000|12 Month Follow-up|Death|22|||
27835370|NCT01691105|54319817|FG001|12 Month Follow-up|Death|30|||
27835371|NCT01691105|54319816|FG000|12 Month Biochemical Verification|Death|22|||
27835372|NCT01691105|54319817|FG001|12 Month Biochemical Verification|Death|30|||
27835373|NCT01691105|54319816|FG000|12 Month Biochemical Verification|Lost to Follow-up|50|||
27835374|NCT01691105|54319817|FG001|12 Month Biochemical Verification|Lost to Follow-up|71|||
27835375|NCT01691105|54319816|FG000|12 Month Biochemical Verification|subject did not self-report abstinence|352|||
27835376|NCT01691105|54319817|FG001|12 Month Biochemical Verification|subject did not self-report abstinence|401|||
27982277|NCT02337829|54640318|FG003|Overall Study|Death|0|||
27738983|NCT02240680|54188244|FG001|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
27738984|NCT02240680|54188245|FG002|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1|||
27835377|NCT02685072|54319825|FG000|Treatment Period|Lost to Follow-up|12|||
27835378|NCT02685072|54319826|FG001|Treatment Period|Lost to Follow-up|6|||
27835379|NCT02685072|54319825|FG000|Treatment Period|Withdrawal by Subject|1|||
27835380|NCT02685072|54319826|FG001|Treatment Period|Withdrawal by Subject|3|||
27835381|NCT02685072|54319825|FG000|1-Month Follow-Up|Withdrawal by Subject|1|||
27835382|NCT02685072|54319826|FG001|1-Month Follow-Up|Withdrawal by Subject|0|||
28096326|NCT03696576|54751215|FG001|Overall Study|Lost to Follow-up|4|||
27867610|NCT04622306|54465972|FG004|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
27867611|NCT04622306|54465973|FG005|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
27867612|NCT04614246|54465987|FG000|Overall Study|Adverse Event|0|||
27867613|NCT04614246|54465988|FG001|Overall Study|Adverse Event|1|||
27867614|NCT04614246|54465989|FG002|Overall Study|Adverse Event|1|||
27867615|NCT04614246|54465990|FG003|Overall Study|Adverse Event|2|||
27867616|NCT04614246|54465991|FG004|Overall Study|Adverse Event|1|||
27867617|NCT04614246|54465987|FG000|Overall Study|Lost to Follow-up|0|||
27867618|NCT04614246|54465988|FG001|Overall Study|Lost to Follow-up|1|||
27867619|NCT04614246|54465989|FG002|Overall Study|Lost to Follow-up|0|||
27867620|NCT04614246|54465990|FG003|Overall Study|Lost to Follow-up|1|||
27867621|NCT04614246|54465991|FG004|Overall Study|Lost to Follow-up|3|||
27867622|NCT04614246|54465987|FG000|Overall Study|Other reason|0|||
27867623|NCT04614246|54465988|FG001|Overall Study|Other reason|1|||
27867624|NCT04614246|54465989|FG002|Overall Study|Other reason|2|||
27867625|NCT04614246|54465990|FG003|Overall Study|Other reason|0|||
27867626|NCT04614246|54465991|FG004|Overall Study|Other reason|0|||
27867627|NCT04614246|54465987|FG000|Overall Study|Withdrawal by Subject|4|||
27867628|NCT04614246|54465988|FG001|Overall Study|Withdrawal by Subject|2|||
27867629|NCT04614246|54465989|FG002|Overall Study|Withdrawal by Subject|4|||
27867630|NCT04614246|54465990|FG003|Overall Study|Withdrawal by Subject|3|||
27867631|NCT04614246|54465991|FG004|Overall Study|Withdrawal by Subject|4|||
27867632|NCT04614246|54465987|FG000|Overall Study|Physician Decision|0|||
27867633|NCT04614246|54465988|FG001|Overall Study|Physician Decision|2|||
27867634|NCT04614246|54465989|FG002|Overall Study|Physician Decision|1|||
27867635|NCT04614246|54465990|FG003|Overall Study|Physician Decision|0|||
27867636|NCT04614246|54465991|FG004|Overall Study|Physician Decision|0|||
27867637|NCT04614246|54465987|FG000|Overall Study|Study terminated by sponsor|10|||
27867638|NCT04614246|54465988|FG001|Overall Study|Study terminated by sponsor|15|||
27867639|NCT04614246|54465989|FG002|Overall Study|Study terminated by sponsor|12|||
27867640|NCT04614246|54465990|FG003|Overall Study|Study terminated by sponsor|13|||
27867641|NCT04614246|54465991|FG004|Overall Study|Study terminated by sponsor|9|||
27867642|NCT04614246|54465987|FG000|Overall Study|Pregnancy|2|||
27867643|NCT04614246|54465988|FG001|Overall Study|Pregnancy|0|||
27867644|NCT04614246|54465989|FG002|Overall Study|Pregnancy|1|||
27867645|NCT04614246|54465990|FG003|Overall Study|Pregnancy|0|||
27867646|NCT04614246|54465991|FG004|Overall Study|Pregnancy|0|||
27867647|NCT04601103|54466006|FG000|Overall Study|Needed crown & cleaning|0|||
27867648|NCT04601103|54466007|FG001|Overall Study|Needed crown & cleaning|0|||
27867649|NCT04601103|54466008|FG002|Overall Study|Needed crown & cleaning|1|||
27867650|NCT04601103|54466006|FG000|Overall Study|study was terminated|18|||
27867651|NCT04601103|54466007|FG001|Overall Study|study was terminated|18|||
27867652|NCT04601103|54466008|FG002|Overall Study|study was terminated|16|||
27867653|NCT04575597|54466022|FG000|Overall Study|Death|0|||
27867654|NCT04575597|54466023|FG001|Overall Study|Death|0|||
27867655|NCT04575597|54466024|FG002|Overall Study|Death|0|||
27867656|NCT04575597|54466025|FG003|Overall Study|Death|1|||
27867657|NCT04575597|54466026|FG004|Overall Study|Death|3|||
27867658|NCT04575597|54466027|FG005|Overall Study|Death|14|||
27867659|NCT04575597|54466022|FG000|Overall Study|Lost to Follow-up|2|||
27867660|NCT04575597|54466023|FG001|Overall Study|Lost to Follow-up|1|||
27867661|NCT04575597|54466024|FG002|Overall Study|Lost to Follow-up|1|||
27867662|NCT04575597|54466025|FG003|Overall Study|Lost to Follow-up|2|||
27867663|NCT04575597|54466026|FG004|Overall Study|Lost to Follow-up|10|||
27867664|NCT04575597|54466027|FG005|Overall Study|Lost to Follow-up|8|||
27867665|NCT04575597|54466022|FG000|Overall Study|Withdrawal by Subject|2|||
27867666|NCT04575597|54466023|FG001|Overall Study|Withdrawal by Subject|2|||
27867667|NCT04575597|54466024|FG002|Overall Study|Withdrawal by Subject|4|||
27867668|NCT04575597|54466025|FG003|Overall Study|Withdrawal by Subject|2|||
27867669|NCT04575597|54466026|FG004|Overall Study|Withdrawal by Subject|25|||
27867670|NCT04575597|54466027|FG005|Overall Study|Withdrawal by Subject|28|||
27867671|NCT04575597|54466022|FG000|Overall Study|Not Recorded|0|||
27867672|NCT04575597|54466023|FG001|Overall Study|Not Recorded|0|||
27867673|NCT04575597|54466024|FG002|Overall Study|Not Recorded|0|||
27867674|NCT04575597|54466025|FG003|Overall Study|Not Recorded|0|||
27867675|NCT04575597|54466026|FG004|Overall Study|Not Recorded|0|||
27867676|NCT04575597|54466027|FG005|Overall Study|Not Recorded|2|||
27867677|NCT04575597|54466022|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
27867678|NCT04575597|54466023|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
27867679|NCT04575597|54466024|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
27867680|NCT04575597|54466025|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
27867681|NCT04575597|54466026|FG004|Overall Study|Randomized By Mistake Without Study Treatment|3|||
27867682|NCT04575597|54466027|FG005|Overall Study|Randomized By Mistake Without Study Treatment|2|||
27867683|NCT04546724|54466049|FG000|Overall Study|Withdrawal by Subject|145|||
27867684|NCT04546724|54466050|FG001|Overall Study|Withdrawal by Subject|41|||
27867685|NCT04546724|54466049|FG000|Overall Study|Adverse Event|1|||
27867686|NCT04546724|54466050|FG001|Overall Study|Adverse Event|1|||
27867687|NCT04546724|54466049|FG000|Overall Study|Lost to Follow-up|186|||
27867688|NCT04546724|54466050|FG001|Overall Study|Lost to Follow-up|63|||
27867689|NCT04546724|54466049|FG000|Overall Study|Physician Decision|8|||
27867690|NCT04546724|54466050|FG001|Overall Study|Physician Decision|2|||
27867691|NCT04546724|54466049|FG000|Overall Study|Death|2|||
27867692|NCT04546724|54466050|FG001|Overall Study|Death|1|||
27867693|NCT04546724|54466049|FG000|Overall Study|subject has been out of town|1|||
27867694|NCT04546724|54466050|FG001|Overall Study|subject has been out of town|0|||
27867695|NCT04546724|54466049|FG000|Overall Study|subject is incarcerated|2|||
27867696|NCT04546724|54466050|FG001|Overall Study|subject is incarcerated|0|||
27867697|NCT04546724|54466049|FG000|Overall Study|subject is relocating|12|||
27867698|NCT04546724|54466050|FG001|Overall Study|subject is relocating|4|||
27867699|NCT04546724|54466049|FG000|Overall Study|Subject in another study|1|||
27867700|NCT04546724|54466050|FG001|Overall Study|Subject in another study|1|||
27867701|NCT04514510|54466062|FG000|Overall Study|Lost to Follow-up|0|||
27867702|NCT04514510|54466063|FG001|Overall Study|Lost to Follow-up|1|||
27867703|NCT04514510|54466062|FG000|Overall Study|Randomized but did not receive Isoquercetin|1|||
27867704|NCT04514510|54466063|FG001|Overall Study|Randomized but did not receive Isoquercetin|0|||
27867705|NCT04439136|54466075|FG000|Overall Study|Ineligible|1|||
27867706|NCT04439136|54466075|FG000|Overall Study|Never Started Treatment|2|||
27867707|NCT04439136|54466075|FG000|Overall Study|Adverse Event|4|||
27867708|NCT04439136|54466075|FG000|Overall Study|Death|3|||
27867709|NCT04439136|54466075|FG000|Overall Study|Disease Progression|27|||
27867710|NCT04439136|54466075|FG000|Overall Study|Alternative Therapy|1|||
27867711|NCT04439136|54466075|FG000|Overall Study|Increased Tumor Burden|1|||
27867712|NCT04439136|54466075|FG000|Overall Study|Symptomatic Detrioration|1|||
27867713|NCT04439123|54466079|FG000|Overall Study|Adverse Event|11|||
27867714|NCT04439123|54466079|FG000|Overall Study|Death|1|||
27867715|NCT04439123|54466079|FG000|Overall Study|Disease progression|19|||
27867716|NCT04439123|54466079|FG000|Overall Study|Withdrawal by Subject|2|||
27867717|NCT04439123|54466079|FG000|Overall Study|Still on treatment|2|||
27867718|NCT04439110|54466083|FG000|Overall Study|Ineligible|2|||
27867719|NCT04439110|54466083|FG000|Overall Study|Adverse Event|4|||
27867720|NCT04439110|54466083|FG000|Overall Study|Death|2|||
27867721|NCT04439110|54466083|FG000|Overall Study|Disease proression|25|||
27867722|NCT04439110|54466083|FG000|Overall Study|Withdrawal by Subject|1|||
27867723|NCT04439110|54466083|FG000|Overall Study|Alternative therapy|1|||
27867724|NCT04439110|54466083|FG000|Overall Study|Other complicating disease|1|||
27867725|NCT04439110|54466083|FG000|Overall Study|Personal reasons|1|||
27867726|NCT04439110|54466083|FG000|Overall Study|Still on treatment|1|||
27867727|NCT04391842|54466087|FG000|Overall Study|Withdrawal by Subject|2|||
27867728|NCT04327024|54466110|FG000|Overall Study|Death|1|||
27867729|NCT04327024|54466111|FG001|Overall Study|Death|2|||
27867730|NCT04327024|54466112|FG002|Overall Study|Death|1|||
27867731|NCT04327024|54466110|FG000|Overall Study|Non-compliance with study drug|0|||
27867732|NCT04327024|54466111|FG001|Overall Study|Non-compliance with study drug|1|||
27867733|NCT04327024|54466112|FG002|Overall Study|Non-compliance with study drug|0|||
27867734|NCT04327024|54466110|FG000|Overall Study|Withdrawal by Subject|1|||
27867735|NCT04327024|54466111|FG001|Overall Study|Withdrawal by Subject|1|||
27867736|NCT04327024|54466112|FG002|Overall Study|Withdrawal by Subject|2|||
27867737|NCT04322149|54466125|FG000|Overall Study|Adverse Event|1|||
27867738|NCT04322149|54466126|FG001|Overall Study|Adverse Event|1|||
27867739|NCT04322149|54466127|FG002|Overall Study|Adverse Event|0|||
27867740|NCT04322149|54466128|FG003|Overall Study|Adverse Event|0|||
27867741|NCT04322149|54466125|FG000|Overall Study|Withdrawal by Subject|0|||
27867742|NCT04322149|54466126|FG001|Overall Study|Withdrawal by Subject|0|||
27867743|NCT04322149|54466127|FG002|Overall Study|Withdrawal by Subject|0|||
27867744|NCT04322149|54466128|FG003|Overall Study|Withdrawal by Subject|2|||
27867745|NCT04322149|54466125|FG000|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
27867746|NCT04322149|54466126|FG001|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|1|||
27867747|NCT04322149|54466127|FG002|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
27867748|NCT04322149|54466128|FG003|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
27867749|NCT04294459|54466149|FG000|Overall Study|Adverse Event|0|||
27867750|NCT04294459|54466150|FG001|Overall Study|Adverse Event|1|||
27867751|NCT04226742|54466159|FG000|Overall Study|Lost to Follow-up|16|||
27867752|NCT04226742|54466160|FG001|Overall Study|Lost to Follow-up|13|||
27867753|NCT04226742|54466159|FG000|Overall Study|Withdrawal by Subject|5|||
28096327|NCT04003610|54751224|FG000|Overall Study|Lost to Follow-up|0|||
27867754|NCT04226742|54466160|FG001|Overall Study|Withdrawal by Subject|3|||
27867755|NCT04194528|54466166|FG000|Overall Study|Adverse Event|1|||
27867756|NCT04146012|54466198|FG000|Overall Study|Study Terminated|30|||
27867757|NCT04146012|54466199|FG001|Overall Study|Study Terminated|15|||
27867758|NCT04085458|54466205|FG000|Overall Study|Other|1|||
27867759|NCT04085458|54466205|FG000|Overall Study|Withdrawal by Subject|2|||
27867760|NCT04085458|54466205|FG000|Overall Study|Adverse Event|2|||
27867761|NCT04033159|54466211|FG000|Washout Period|Physician Decision|0|||
28096328|NCT04003610|54751225|FG001|Overall Study|Lost to Follow-up|1|||
27867762|NCT04033159|54466212|FG001|Washout Period|Physician Decision|1|||
27867763|NCT04033159|54466213|FG002|Washout Period|Physician Decision|0|||
27867764|NCT04033159|54466211|FG000|Washout Period|Study terminated by Sponsor|0|||
27867765|NCT04033159|54466212|FG001|Washout Period|Study terminated by Sponsor|7|||
27867766|NCT04033159|54466213|FG002|Washout Period|Study terminated by Sponsor|0|||
27867767|NCT04033159|54466211|FG000|Multiple Ascending Dose Period|Study terminated by Sponsor|6|||
27867768|NCT04033159|54466212|FG001|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
27867769|NCT04033159|54466213|FG002|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
27867770|NCT03969888|54466229|FG000|Overall Study|Never Received Study Drug|0|||
27867771|NCT03969888|54466230|FG001|Overall Study|Never Received Study Drug|0|||
27867772|NCT03969888|54466231|FG002|Overall Study|Never Received Study Drug|1|||
27867773|NCT03969888|54466232|FG003|Overall Study|Never Received Study Drug|0|||
27867774|NCT03969888|54466233|FG004|Overall Study|Never Received Study Drug|0|||
27867775|NCT03969888|54466234|FG005|Overall Study|Never Received Study Drug|0|||
27867776|NCT03969888|54466235|FG006|Overall Study|Never Received Study Drug|1|||
27867777|NCT03969888|54466236|FG007|Overall Study|Never Received Study Drug|0|||
27867778|NCT03969888|54466229|FG000|Overall Study|Reason Not Specified|0|||
27867779|NCT03969888|54466230|FG001|Overall Study|Reason Not Specified|0|||
27867780|NCT03969888|54466231|FG002|Overall Study|Reason Not Specified|0|||
27867781|NCT03969888|54466232|FG003|Overall Study|Reason Not Specified|0|||
27867782|NCT03969888|54466233|FG004|Overall Study|Reason Not Specified|0|||
27867783|NCT03969888|54466234|FG005|Overall Study|Reason Not Specified|0|||
27867784|NCT03969888|54466235|FG006|Overall Study|Reason Not Specified|0|||
27867785|NCT03969888|54466236|FG007|Overall Study|Reason Not Specified|1|||
27867786|NCT03952559|54466260|FG000|Double Blind Treatment Period|Adverse Event|0|||
27867787|NCT03952559|54466261|FG001|Double Blind Treatment Period|Adverse Event|2|||
27867788|NCT03952559|54466262|FG002|Double Blind Treatment Period|Adverse Event|1|||
27867789|NCT03952559|54466263|FG003|Double Blind Treatment Period|Adverse Event|0|||
27867790|NCT03952559|54466264|FG004|Double Blind Treatment Period|Adverse Event|1|||
27867791|NCT03952559|54466260|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
27867792|NCT03952559|54466261|FG001|Double Blind Treatment Period|Lack of Efficacy|4|||
27867793|NCT03952559|54466262|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
27867794|NCT03952559|54466263|FG003|Double Blind Treatment Period|Lack of Efficacy|1|||
27867795|NCT03952559|54466264|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
27867796|NCT03952559|54466260|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
27867797|NCT03952559|54466261|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
27867798|NCT03952559|54466262|FG002|Double Blind Treatment Period|Withdrawal by Subject|2|||
27867799|NCT03952559|54466263|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
27867800|NCT03952559|54466264|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
27867801|NCT03952559|54466260|FG000|Double Blind Treatment Period|Inadvertently randomized|0|||
27867802|NCT03952559|54466261|FG001|Double Blind Treatment Period|Inadvertently randomized|0|||
27867803|NCT03952559|54466262|FG002|Double Blind Treatment Period|Inadvertently randomized|1|||
27867804|NCT03952559|54466263|FG003|Double Blind Treatment Period|Inadvertently randomized|0|||
27867805|NCT03952559|54466264|FG004|Double Blind Treatment Period|Inadvertently randomized|0|||
27867806|NCT03945175|54466300|FG000|Overall Study|Did not meet inclusion criteria|31|||
27867807|NCT03945175|54466300|FG000|Overall Study|Withdrew consent|2|||
27867808|NCT03945175|54466300|FG000|Overall Study|Responded to Placebo Treatment and was not Allocated to Mydayis|1|||
27867809|NCT03945175|54466300|FG000|Overall Study|Early termination during Mydayis treatment|1|||
27867810|NCT03942406|54466311|FG000|Overall Study|Lost to Follow-up|4|||
27867811|NCT03942406|54466312|FG001|Overall Study|Lost to Follow-up|5|||
27867812|NCT03942406|54466313|FG002|Overall Study|Lost to Follow-up|3|||
27867813|NCT03942406|54466314|FG003|Overall Study|Lost to Follow-up|7|||
27867814|NCT03942406|54466315|FG004|Overall Study|Lost to Follow-up|1|||
27867815|NCT03942406|54466316|FG005|Overall Study|Lost to Follow-up|0|||
27867816|NCT03942406|54466317|FG006|Overall Study|Lost to Follow-up|0|||
27867817|NCT03942406|54466311|FG000|Overall Study|Withdrawal by Subject|3|||
27867818|NCT03942406|54466312|FG001|Overall Study|Withdrawal by Subject|1|||
27867819|NCT03942406|54466313|FG002|Overall Study|Withdrawal by Subject|1|||
27867820|NCT03942406|54466314|FG003|Overall Study|Withdrawal by Subject|3|||
27867821|NCT03942406|54466315|FG004|Overall Study|Withdrawal by Subject|0|||
27867822|NCT03942406|54466316|FG005|Overall Study|Withdrawal by Subject|0|||
27867823|NCT03942406|54466317|FG006|Overall Study|Withdrawal by Subject|0|||
27867824|NCT03942406|54466311|FG000|Overall Study|Other: early termination, telemedicine visits|4|||
28096329|NCT04003610|54751226|FG002|Overall Study|Lost to Follow-up|0|||
27867825|NCT03942406|54466312|FG001|Overall Study|Other: early termination, telemedicine visits|1|||
27867826|NCT03942406|54466313|FG002|Overall Study|Other: early termination, telemedicine visits|1|||
27867827|NCT03942406|54466314|FG003|Overall Study|Other: early termination, telemedicine visits|0|||
27867828|NCT03942406|54466315|FG004|Overall Study|Other: early termination, telemedicine visits|1|||
28096330|NCT04003610|54751224|FG000|Overall Study|Death|0|||
28096331|NCT04003610|54751225|FG001|Overall Study|Death|0|||
27867829|NCT03942406|54466316|FG005|Overall Study|Other: early termination, telemedicine visits|1|||
27867830|NCT03942406|54466317|FG006|Overall Study|Other: early termination, telemedicine visits|0|||
27867831|NCT03909100|54466351|FG000|Overall Study|Protocol Deviation|2|||
27867832|NCT03909100|54466351|FG000|Overall Study|Technical Problems|4|||
27867833|NCT03909100|54466351|FG000|Overall Study|Withdrawal by Subject|4|||
27867834|NCT03909100|54466351|FG000|Overall Study|Lost to Follow-up|1|||
27867835|NCT03909100|54466351|FG000|Overall Study|Reason not Specified|4|||
27867836|NCT03896295|54466373|FG000|Overall Study|Adverse Event|0|||
27867837|NCT03896295|54466374|FG001|Overall Study|Adverse Event|1|||
27867838|NCT03896295|54466373|FG000|Overall Study|COVID-19|7|||
27867839|NCT03896295|54466374|FG001|Overall Study|COVID-19|29|||
27867840|NCT03734666|54466424|FG000|Overall Study|Other|7|||
27867841|NCT03734666|54466425|FG001|Overall Study|Other|4|||
27867842|NCT03734666|54466424|FG000|Overall Study|Lost to Follow-up|12|||
27867843|NCT03734666|54466425|FG001|Overall Study|Lost to Follow-up|12|||
27867844|NCT03635489|54466438|FG000|Overall Study|Death|6|||
27867845|NCT03635489|54466439|FG001|Overall Study|Death|3|||
27867846|NCT03635489|54466438|FG000|Overall Study|Lost to Follow-up|0|||
27867847|NCT03635489|54466439|FG001|Overall Study|Lost to Follow-up|1|||
27867848|NCT03635489|54466438|FG000|Overall Study|Withdrawal by Subject|1|||
27867849|NCT03635489|54466439|FG001|Overall Study|Withdrawal by Subject|2|||
27867850|NCT03633617|54466450|FG000|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|1|||
27867851|NCT03633617|54466451|FG001|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|3|||
27867852|NCT03633617|54466452|FG002|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
27867853|NCT03633617|54466453|FG003|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
27867854|NCT03633617|54466454|FG004|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
27867855|NCT03633617|54466455|FG005|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
27867856|NCT03633617|54466456|FG006|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
27867857|NCT03633617|54466457|FG007|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
27867858|NCT03633617|54466458|FG008|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
27867859|NCT03633617|54466459|FG009|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
27867860|NCT03633617|54466460|FG010|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
27867861|NCT03633617|54466450|FG000|Part A|Unconfirmed early termination visit|1|||
27867862|NCT03633617|54466451|FG001|Part A|Unconfirmed early termination visit|0|||
27867863|NCT03633617|54466452|FG002|Part A|Unconfirmed early termination visit|0|||
27867864|NCT03633617|54466453|FG003|Part A|Unconfirmed early termination visit|0|||
27867865|NCT03633617|54466454|FG004|Part A|Unconfirmed early termination visit|0|||
27867866|NCT03633617|54466455|FG005|Part A|Unconfirmed early termination visit|0|||
27867867|NCT03633617|54466456|FG006|Part A|Unconfirmed early termination visit|0|||
27867868|NCT03633617|54466457|FG007|Part A|Unconfirmed early termination visit|0|||
27867869|NCT03633617|54466458|FG008|Part A|Unconfirmed early termination visit|0|||
27867870|NCT03633617|54466459|FG009|Part A|Unconfirmed early termination visit|0|||
27867871|NCT03633617|54466460|FG010|Part A|Unconfirmed early termination visit|0|||
27867872|NCT03633617|54466450|FG000|Part A|Adverse Event|0|||
27867873|NCT03633617|54466451|FG001|Part A|Adverse Event|1|||
27867874|NCT03633617|54466452|FG002|Part A|Adverse Event|0|||
27867875|NCT03633617|54466453|FG003|Part A|Adverse Event|0|||
27867876|NCT03633617|54466454|FG004|Part A|Adverse Event|0|||
27867877|NCT03633617|54466455|FG005|Part A|Adverse Event|0|||
27867878|NCT03633617|54466456|FG006|Part A|Adverse Event|0|||
27867879|NCT03633617|54466457|FG007|Part A|Adverse Event|0|||
27867880|NCT03633617|54466458|FG008|Part A|Adverse Event|0|||
27867881|NCT03633617|54466459|FG009|Part A|Adverse Event|0|||
27867882|NCT03633617|54466460|FG010|Part A|Adverse Event|0|||
27867883|NCT03633617|54466450|FG000|Part A|Pregnancy|1|||
27867884|NCT03633617|54466451|FG001|Part A|Pregnancy|0|||
27867885|NCT03633617|54466452|FG002|Part A|Pregnancy|0|||
27867886|NCT03633617|54466453|FG003|Part A|Pregnancy|0|||
27867887|NCT03633617|54466454|FG004|Part A|Pregnancy|0|||
27867888|NCT03633617|54466455|FG005|Part A|Pregnancy|0|||
27867889|NCT03633617|54466456|FG006|Part A|Pregnancy|0|||
27867890|NCT03633617|54466457|FG007|Part A|Pregnancy|0|||
27867891|NCT03633617|54466458|FG008|Part A|Pregnancy|0|||
27867892|NCT03633617|54466459|FG009|Part A|Pregnancy|0|||
27982278|NCT02337829|54640315|FG000|Overall Study|Study terminated by sponsor|12|||
27867893|NCT03633617|54466460|FG010|Part A|Pregnancy|0|||
27867894|NCT03633617|54466450|FG000|Part A|Withdrawal by Subject|0|||
27867895|NCT03633617|54466451|FG001|Part A|Withdrawal by Subject|1|||
27867896|NCT03633617|54466452|FG002|Part A|Withdrawal by Subject|0|||
27867897|NCT03633617|54466453|FG003|Part A|Withdrawal by Subject|0|||
27867898|NCT03633617|54466454|FG004|Part A|Withdrawal by Subject|0|||
27867899|NCT03633617|54466455|FG005|Part A|Withdrawal by Subject|0|||
27867900|NCT03633617|54466456|FG006|Part A|Withdrawal by Subject|0|||
28171388|NCT02471404|54842972|FG001|Overall Study|Developed Study Withdrawal Criteria|1|||
27867901|NCT03633617|54466457|FG007|Part A|Withdrawal by Subject|0|||
27867902|NCT03633617|54466458|FG008|Part A|Withdrawal by Subject|0|||
27867903|NCT03633617|54466459|FG009|Part A|Withdrawal by Subject|0|||
27867904|NCT03633617|54466460|FG010|Part A|Withdrawal by Subject|0|||
27867905|NCT03633617|54466450|FG000|Part B|Adverse Event|0|||
27867906|NCT03633617|54466451|FG001|Part B|Adverse Event|0|||
27867907|NCT03633617|54466452|FG002|Part B|Adverse Event|2|||
27867908|NCT03633617|54466453|FG003|Part B|Adverse Event|2|||
27867909|NCT03633617|54466454|FG004|Part B|Adverse Event|1|||
27867910|NCT03633617|54466455|FG005|Part B|Adverse Event|0|||
27867911|NCT03633617|54466456|FG006|Part B|Adverse Event|0|||
27867912|NCT03633617|54466457|FG007|Part B|Adverse Event|0|||
27867913|NCT03633617|54466458|FG008|Part B|Adverse Event|0|||
27867914|NCT03633617|54466459|FG009|Part B|Adverse Event|0|||
27867915|NCT03633617|54466460|FG010|Part B|Adverse Event|0|||
27867916|NCT03633617|54466450|FG000|Part B|Withdrawal by Subject|0|||
27867917|NCT03633617|54466451|FG001|Part B|Withdrawal by Subject|0|||
27867918|NCT03633617|54466452|FG002|Part B|Withdrawal by Subject|1|||
27867919|NCT03633617|54466453|FG003|Part B|Withdrawal by Subject|0|||
27867920|NCT03633617|54466454|FG004|Part B|Withdrawal by Subject|2|||
27867921|NCT03633617|54466455|FG005|Part B|Withdrawal by Subject|0|||
27867922|NCT03633617|54466456|FG006|Part B|Withdrawal by Subject|0|||
27867923|NCT03633617|54466457|FG007|Part B|Withdrawal by Subject|0|||
27867924|NCT03633617|54466458|FG008|Part B|Withdrawal by Subject|0|||
27867925|NCT03633617|54466459|FG009|Part B|Withdrawal by Subject|0|||
27867926|NCT03633617|54466460|FG010|Part B|Withdrawal by Subject|0|||
27867927|NCT03633617|54466450|FG000|Part B|Lost to Follow-up|0|||
27867928|NCT03633617|54466451|FG001|Part B|Lost to Follow-up|0|||
27867929|NCT03633617|54466452|FG002|Part B|Lost to Follow-up|0|||
27867930|NCT03633617|54466453|FG003|Part B|Lost to Follow-up|0|||
27867931|NCT03633617|54466454|FG004|Part B|Lost to Follow-up|1|||
27867932|NCT03633617|54466455|FG005|Part B|Lost to Follow-up|0|||
27867933|NCT03633617|54466456|FG006|Part B|Lost to Follow-up|0|||
27867934|NCT03633617|54466457|FG007|Part B|Lost to Follow-up|0|||
27867935|NCT03633617|54466458|FG008|Part B|Lost to Follow-up|0|||
27867936|NCT03633617|54466459|FG009|Part B|Lost to Follow-up|0|||
27867937|NCT03633617|54466460|FG010|Part B|Lost to Follow-up|0|||
27867938|NCT03633617|54466450|FG000|Part B|Physician Decision|0|||
27867939|NCT03633617|54466451|FG001|Part B|Physician Decision|0|||
27867940|NCT03633617|54466452|FG002|Part B|Physician Decision|0|||
27867941|NCT03633617|54466453|FG003|Part B|Physician Decision|0|||
27867942|NCT03633617|54466454|FG004|Part B|Physician Decision|1|||
27867943|NCT03633617|54466455|FG005|Part B|Physician Decision|0|||
27867944|NCT03633617|54466456|FG006|Part B|Physician Decision|0|||
27867945|NCT03633617|54466457|FG007|Part B|Physician Decision|0|||
27867946|NCT03633617|54466458|FG008|Part B|Physician Decision|0|||
27867947|NCT03633617|54466459|FG009|Part B|Physician Decision|0|||
27867948|NCT03633617|54466460|FG010|Part B|Physician Decision|0|||
27867949|NCT03633617|54466450|FG000|Part B|COVID-19 Restrictions|0|||
27867950|NCT03633617|54466451|FG001|Part B|COVID-19 Restrictions|0|||
27867951|NCT03633617|54466452|FG002|Part B|COVID-19 Restrictions|1|||
27867952|NCT03633617|54466453|FG003|Part B|COVID-19 Restrictions|0|||
27867953|NCT03633617|54466454|FG004|Part B|COVID-19 Restrictions|0|||
27867954|NCT03633617|54466455|FG005|Part B|COVID-19 Restrictions|0|||
27867955|NCT03633617|54466456|FG006|Part B|COVID-19 Restrictions|0|||
27867956|NCT03633617|54466457|FG007|Part B|COVID-19 Restrictions|0|||
27867957|NCT03633617|54466458|FG008|Part B|COVID-19 Restrictions|0|||
27867958|NCT03633617|54466459|FG009|Part B|COVID-19 Restrictions|0|||
27867959|NCT03633617|54466460|FG010|Part B|COVID-19 Restrictions|0|||
27867960|NCT03633617|54466450|FG000|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
27867961|NCT03633617|54466451|FG001|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
27867962|NCT03633617|54466452|FG002|Part B|Subject randomized, but did not receive study drug; did not qualify for study|1|||
27867963|NCT03633617|54466453|FG003|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
27867964|NCT03633617|54466454|FG004|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
27867965|NCT03633617|54466455|FG005|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
27867966|NCT03633617|54466456|FG006|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
27867967|NCT03633617|54466457|FG007|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
27867968|NCT03633617|54466458|FG008|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
27867969|NCT03633617|54466459|FG009|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
28171389|NCT02471404|54842973|FG002|Overall Study|Developed Study Withdrawal Criteria|2|||
27867970|NCT03633617|54466460|FG010|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
27867971|NCT03633617|54466450|FG000|Part C (& Follow-up)|Adverse Event|0|||
27867972|NCT03633617|54466451|FG001|Part C (& Follow-up)|Adverse Event|0|||
27867973|NCT03633617|54466452|FG002|Part C (& Follow-up)|Adverse Event|0|||
27867974|NCT03633617|54466453|FG003|Part C (& Follow-up)|Adverse Event|0|||
28096332|NCT04003610|54751226|FG002|Overall Study|Death|3|||
28096333|NCT04003610|54751224|FG000|Overall Study|Study Terminated by Sponsor|0|||
27867975|NCT03633617|54466454|FG004|Part C (& Follow-up)|Adverse Event|0|||
27867976|NCT03633617|54466455|FG005|Part C (& Follow-up)|Adverse Event|1|||
27867977|NCT03633617|54466456|FG006|Part C (& Follow-up)|Adverse Event|0|||
27867978|NCT03633617|54466457|FG007|Part C (& Follow-up)|Adverse Event|1|||
27867979|NCT03633617|54466458|FG008|Part C (& Follow-up)|Adverse Event|0|||
27867980|NCT03633617|54466459|FG009|Part C (& Follow-up)|Adverse Event|0|||
27867981|NCT03633617|54466460|FG010|Part C (& Follow-up)|Adverse Event|0|||
27867982|NCT03633617|54466450|FG000|Part C (& Follow-up)|Pregnancy|0|||
27867983|NCT03633617|54466451|FG001|Part C (& Follow-up)|Pregnancy|0|||
27867984|NCT03633617|54466452|FG002|Part C (& Follow-up)|Pregnancy|0|||
27867985|NCT03633617|54466453|FG003|Part C (& Follow-up)|Pregnancy|0|||
27867986|NCT03633617|54466454|FG004|Part C (& Follow-up)|Pregnancy|0|||
27867987|NCT03633617|54466455|FG005|Part C (& Follow-up)|Pregnancy|0|||
27867988|NCT03633617|54466456|FG006|Part C (& Follow-up)|Pregnancy|0|||
27867989|NCT03633617|54466457|FG007|Part C (& Follow-up)|Pregnancy|0|||
27867990|NCT03633617|54466458|FG008|Part C (& Follow-up)|Pregnancy|0|||
27867991|NCT03633617|54466459|FG009|Part C (& Follow-up)|Pregnancy|1|||
27867992|NCT03633617|54466460|FG010|Part C (& Follow-up)|Pregnancy|0|||
27867993|NCT03633617|54466450|FG000|Part C (& Follow-up)|Withdrawal by Subject|0|||
27867994|NCT03633617|54466451|FG001|Part C (& Follow-up)|Withdrawal by Subject|0|||
27867995|NCT03633617|54466452|FG002|Part C (& Follow-up)|Withdrawal by Subject|0|||
27867996|NCT03633617|54466453|FG003|Part C (& Follow-up)|Withdrawal by Subject|0|||
27867997|NCT03633617|54466454|FG004|Part C (& Follow-up)|Withdrawal by Subject|0|||
27867998|NCT03633617|54466455|FG005|Part C (& Follow-up)|Withdrawal by Subject|2|||
27867999|NCT03633617|54466456|FG006|Part C (& Follow-up)|Withdrawal by Subject|2|||
27868000|NCT03633617|54466457|FG007|Part C (& Follow-up)|Withdrawal by Subject|0|||
27868001|NCT03633617|54466458|FG008|Part C (& Follow-up)|Withdrawal by Subject|1|||
27868002|NCT03633617|54466459|FG009|Part C (& Follow-up)|Withdrawal by Subject|1|||
27868003|NCT03633617|54466460|FG010|Part C (& Follow-up)|Withdrawal by Subject|6|||
27868004|NCT03633617|54466450|FG000|Part C (& Follow-up)|Lost to Follow-up|0|||
27868005|NCT03633617|54466451|FG001|Part C (& Follow-up)|Lost to Follow-up|0|||
27868006|NCT03633617|54466452|FG002|Part C (& Follow-up)|Lost to Follow-up|0|||
27868007|NCT03633617|54466453|FG003|Part C (& Follow-up)|Lost to Follow-up|0|||
27868008|NCT03633617|54466454|FG004|Part C (& Follow-up)|Lost to Follow-up|0|||
27868009|NCT03633617|54466455|FG005|Part C (& Follow-up)|Lost to Follow-up|3|||
27868010|NCT03633617|54466456|FG006|Part C (& Follow-up)|Lost to Follow-up|3|||
27868011|NCT03633617|54466457|FG007|Part C (& Follow-up)|Lost to Follow-up|1|||
27868012|NCT03633617|54466458|FG008|Part C (& Follow-up)|Lost to Follow-up|0|||
27868013|NCT03633617|54466459|FG009|Part C (& Follow-up)|Lost to Follow-up|7|||
27868014|NCT03633617|54466460|FG010|Part C (& Follow-up)|Lost to Follow-up|2|||
27868015|NCT03633617|54466450|FG000|Part C (& Follow-up)|Physician Decision|0|||
27868016|NCT03633617|54466451|FG001|Part C (& Follow-up)|Physician Decision|0|||
27868017|NCT03633617|54466452|FG002|Part C (& Follow-up)|Physician Decision|0|||
27868018|NCT03633617|54466453|FG003|Part C (& Follow-up)|Physician Decision|0|||
27868019|NCT03633617|54466454|FG004|Part C (& Follow-up)|Physician Decision|0|||
27868020|NCT03633617|54466455|FG005|Part C (& Follow-up)|Physician Decision|0|||
27868021|NCT03633617|54466456|FG006|Part C (& Follow-up)|Physician Decision|0|||
27868022|NCT03633617|54466457|FG007|Part C (& Follow-up)|Physician Decision|1|||
27868023|NCT03633617|54466458|FG008|Part C (& Follow-up)|Physician Decision|0|||
27868024|NCT03633617|54466459|FG009|Part C (& Follow-up)|Physician Decision|0|||
27868025|NCT03633617|54466460|FG010|Part C (& Follow-up)|Physician Decision|1|||
27868026|NCT03633617|54466450|FG000|Part C (& Follow-up)|COVID-19 related|0|||
27868027|NCT03633617|54466451|FG001|Part C (& Follow-up)|COVID-19 related|0|||
27868028|NCT03633617|54466452|FG002|Part C (& Follow-up)|COVID-19 related|0|||
27868029|NCT03633617|54466453|FG003|Part C (& Follow-up)|COVID-19 related|0|||
27868030|NCT03633617|54466454|FG004|Part C (& Follow-up)|COVID-19 related|0|||
27868031|NCT03633617|54466455|FG005|Part C (& Follow-up)|COVID-19 related|1|||
27868032|NCT03633617|54466456|FG006|Part C (& Follow-up)|COVID-19 related|0|||
27868033|NCT03633617|54466457|FG007|Part C (& Follow-up)|COVID-19 related|0|||
27868034|NCT03633617|54466458|FG008|Part C (& Follow-up)|COVID-19 related|0|||
27868035|NCT03633617|54466459|FG009|Part C (& Follow-up)|COVID-19 related|0|||
27868036|NCT03633617|54466460|FG010|Part C (& Follow-up)|COVID-19 related|0|||
27868037|NCT03633617|54466450|FG000|Part C (& Follow-up)|Protocol Violation|0|||
28096334|NCT04003610|54751225|FG001|Overall Study|Study Terminated by Sponsor|0|||
28096335|NCT04003610|54751226|FG002|Overall Study|Study Terminated by Sponsor|3|||
28096336|NCT03999554|54751240|FG000|Overall Study|Lost to Follow-up|4|||
28096337|NCT03999554|54751241|FG001|Overall Study|Lost to Follow-up|5|||
28096338|NCT03999554|54751242|FG002|Overall Study|Lost to Follow-up|4|||
28096339|NCT03999554|54751243|FG003|Overall Study|Lost to Follow-up|5|||
28096340|NCT03999554|54751244|FG004|Overall Study|Lost to Follow-up|8|||
27868038|NCT03633617|54466451|FG001|Part C (& Follow-up)|Protocol Violation|0|||
27868039|NCT03633617|54466452|FG002|Part C (& Follow-up)|Protocol Violation|0|||
27868040|NCT03633617|54466453|FG003|Part C (& Follow-up)|Protocol Violation|0|||
27868041|NCT03633617|54466454|FG004|Part C (& Follow-up)|Protocol Violation|0|||
27868042|NCT03633617|54466455|FG005|Part C (& Follow-up)|Protocol Violation|0|||
27868043|NCT03633617|54466456|FG006|Part C (& Follow-up)|Protocol Violation|0|||
28096341|NCT03999554|54751240|FG000|Overall Study|Protocol Violation|0|||
27868044|NCT03633617|54466457|FG007|Part C (& Follow-up)|Protocol Violation|0|||
27868045|NCT03633617|54466458|FG008|Part C (& Follow-up)|Protocol Violation|0|||
28096342|NCT03999554|54751241|FG001|Overall Study|Protocol Violation|0|||
27868046|NCT03633617|54466459|FG009|Part C (& Follow-up)|Protocol Violation|3|||
27868047|NCT03633617|54466460|FG010|Part C (& Follow-up)|Protocol Violation|1|||
27868048|NCT03633617|54466450|FG000|Part C (& Follow-up)|Lack of Efficacy|0|||
27868049|NCT03633617|54466451|FG001|Part C (& Follow-up)|Lack of Efficacy|0|||
27868050|NCT03633617|54466452|FG002|Part C (& Follow-up)|Lack of Efficacy|0|||
27868051|NCT03633617|54466453|FG003|Part C (& Follow-up)|Lack of Efficacy|0|||
27868052|NCT03633617|54466454|FG004|Part C (& Follow-up)|Lack of Efficacy|0|||
27868053|NCT03633617|54466455|FG005|Part C (& Follow-up)|Lack of Efficacy|0|||
27868054|NCT03633617|54466456|FG006|Part C (& Follow-up)|Lack of Efficacy|0|||
27868055|NCT03633617|54466457|FG007|Part C (& Follow-up)|Lack of Efficacy|1|||
27868056|NCT03633617|54466458|FG008|Part C (& Follow-up)|Lack of Efficacy|0|||
27868057|NCT03633617|54466459|FG009|Part C (& Follow-up)|Lack of Efficacy|0|||
27868058|NCT03633617|54466460|FG010|Part C (& Follow-up)|Lack of Efficacy|0|||
27868059|NCT03631784|54466490|FG000|Overall Study|Death|48|||
27868060|NCT03631784|54466491|FG001|Overall Study|Death|28|||
27868061|NCT03631784|54466490|FG000|Overall Study|Lost to Follow-up|1|||
27868062|NCT03631784|54466491|FG001|Overall Study|Lost to Follow-up|0|||
27868063|NCT03631784|54466490|FG000|Overall Study|Withdrawal by Subject|0|||
27868064|NCT03631784|54466491|FG001|Overall Study|Withdrawal by Subject|3|||
27868065|NCT03631784|54466490|FG000|Overall Study|Participants Ongoing|63|||
27868066|NCT03631784|54466491|FG001|Overall Study|Participants Ongoing|71|||
27868067|NCT03617705|54466497|FG000|Overall Study|Withdrawal by Subject|2|||
27868068|NCT03617705|54466497|FG000|Overall Study|lost contact after screening due to covid pandemic|6|||
27868069|NCT03617705|54466497|FG000|Overall Study|withdrawal by study team due to non-compliance|1|||
27868070|NCT03607422|54466507|FG000|Overall Study|Adverse Event|7|||
27868071|NCT03607422|54466508|FG001|Overall Study|Adverse Event|3|||
27868072|NCT03607422|54466509|FG002|Overall Study|Adverse Event|2|||
27868073|NCT03607422|54466510|FG003|Overall Study|Adverse Event|0|||
27868074|NCT03607422|54466511|FG004|Overall Study|Adverse Event|2|||
27868075|NCT03607422|54466512|FG005|Overall Study|Adverse Event|0|||
27868076|NCT03607422|54466507|FG000|Overall Study|Withdrawal by Subject|11|||
27868077|NCT03607422|54466508|FG001|Overall Study|Withdrawal by Subject|3|||
27868078|NCT03607422|54466509|FG002|Overall Study|Withdrawal by Subject|6|||
27868079|NCT03607422|54466510|FG003|Overall Study|Withdrawal by Subject|2|||
27868080|NCT03607422|54466511|FG004|Overall Study|Withdrawal by Subject|0|||
27868081|NCT03607422|54466512|FG005|Overall Study|Withdrawal by Subject|0|||
27868082|NCT03607422|54466507|FG000|Overall Study|Lost to Follow-up|0|||
27868083|NCT03607422|54466508|FG001|Overall Study|Lost to Follow-up|0|||
27868084|NCT03607422|54466509|FG002|Overall Study|Lost to Follow-up|1|||
27868085|NCT03607422|54466510|FG003|Overall Study|Lost to Follow-up|0|||
27868086|NCT03607422|54466511|FG004|Overall Study|Lost to Follow-up|0|||
27868087|NCT03607422|54466512|FG005|Overall Study|Lost to Follow-up|0|||
27868088|NCT03607422|54466507|FG000|Overall Study|Other|12|||
27868089|NCT03607422|54466508|FG001|Overall Study|Other|4|||
27868090|NCT03607422|54466509|FG002|Overall Study|Other|1|||
27868091|NCT03607422|54466510|FG003|Overall Study|Other|2|||
27868092|NCT03607422|54466511|FG004|Overall Study|Other|0|||
27868093|NCT03607422|54466512|FG005|Overall Study|Other|2|||
27868094|NCT03607422|54466507|FG000|Overall Study|Ongoing at Time of Analysis|8|||
27868095|NCT03607422|54466508|FG001|Overall Study|Ongoing at Time of Analysis|0|||
27868096|NCT03607422|54466509|FG002|Overall Study|Ongoing at Time of Analysis|2|||
27868097|NCT03607422|54466510|FG003|Overall Study|Ongoing at Time of Analysis|1|||
27868098|NCT03607422|54466511|FG004|Overall Study|Ongoing at Time of Analysis|1|||
27868099|NCT03607422|54466512|FG005|Overall Study|Ongoing at Time of Analysis|1|||
27868100|NCT03568318|54466550|FG000|Overall Study|Adverse Event|3|||
27868101|NCT03568318|54466551|FG001|Overall Study|Adverse Event|1|||
27868102|NCT03568318|54466552|FG002|Overall Study|Adverse Event|1|||
27868103|NCT03568318|54466553|FG003|Overall Study|Adverse Event|0|||
27868104|NCT03568318|54466554|FG004|Overall Study|Adverse Event|1|||
27868105|NCT03568318|54466555|FG005|Overall Study|Adverse Event|0|||
27868106|NCT03568318|54466550|FG000|Overall Study|Withdrawal by Subject|6|||
27868107|NCT03568318|54466551|FG001|Overall Study|Withdrawal by Subject|5|||
27868108|NCT03568318|54466552|FG002|Overall Study|Withdrawal by Subject|2|||
27868109|NCT03568318|54466553|FG003|Overall Study|Withdrawal by Subject|1|||
28096343|NCT03999554|54751242|FG002|Overall Study|Protocol Violation|5|||
27982279|NCT02337829|54640316|FG001|Overall Study|Study terminated by sponsor|10|||
28096344|NCT03999554|54751243|FG003|Overall Study|Protocol Violation|0|||
28096345|NCT03999554|54751244|FG004|Overall Study|Protocol Violation|0|||
28096346|NCT03999554|54751240|FG000|Overall Study|Pregnancy|0|||
27868110|NCT03568318|54466554|FG004|Overall Study|Withdrawal by Subject|0|||
27868111|NCT03568318|54466555|FG005|Overall Study|Withdrawal by Subject|0|||
27868112|NCT03568318|54466550|FG000|Overall Study|Lost to Follow-up|3|||
27868113|NCT03568318|54466551|FG001|Overall Study|Lost to Follow-up|2|||
27868114|NCT03568318|54466552|FG002|Overall Study|Lost to Follow-up|2|||
27868115|NCT03568318|54466553|FG003|Overall Study|Lost to Follow-up|2|||
27868116|NCT03568318|54466554|FG004|Overall Study|Lost to Follow-up|1|||
27868117|NCT03568318|54466555|FG005|Overall Study|Lost to Follow-up|0|||
27868118|NCT03568318|54466550|FG000|Overall Study|Other|3|||
27868119|NCT03568318|54466551|FG001|Overall Study|Other|1|||
27868120|NCT03568318|54466552|FG002|Overall Study|Other|3|||
27868121|NCT03568318|54466553|FG003|Overall Study|Other|0|||
27868122|NCT03568318|54466554|FG004|Overall Study|Other|0|||
27868123|NCT03568318|54466555|FG005|Overall Study|Other|0|||
27868124|NCT03568318|54466550|FG000|Overall Study|Ongoing at Time of Analysis|5|||
27868125|NCT03568318|54466551|FG001|Overall Study|Ongoing at Time of Analysis|3|||
27868126|NCT03568318|54466552|FG002|Overall Study|Ongoing at Time of Analysis|2|||
27868127|NCT03568318|54466553|FG003|Overall Study|Ongoing at Time of Analysis|1|||
27868128|NCT03568318|54466554|FG004|Overall Study|Ongoing at Time of Analysis|0|||
27868129|NCT03568318|54466555|FG005|Overall Study|Ongoing at Time of Analysis|0|||
27868130|NCT03550794|54466571|FG000|Overall Study|No longer met inclusion criteria|1|||
27868131|NCT03550794|54466572|FG001|Overall Study|No longer met inclusion criteria|2|||
27868132|NCT03550794|54466571|FG000|Overall Study|Goals of care changed|1|||
27868133|NCT03550794|54466572|FG001|Overall Study|Goals of care changed|0|||
27868134|NCT03550794|54466571|FG000|Overall Study|Withdrawal by Subject|2|||
27868135|NCT03550794|54466572|FG001|Overall Study|Withdrawal by Subject|0|||
27868136|NCT03550794|54466571|FG000|Overall Study|Death|0|||
27868137|NCT03550794|54466572|FG001|Overall Study|Death|1|||
27868138|NCT03459846|54466597|FG000|Overall Study|Death|52|||
27868139|NCT03459846|54466598|FG001|Overall Study|Death|46|||
27868140|NCT03459846|54466597|FG000|Overall Study|Study terminated by sponsor|24|||
27868141|NCT03459846|54466598|FG001|Overall Study|Study terminated by sponsor|28|||
27868142|NCT03459846|54466597|FG000|Overall Study|Withdrawal by Subject|2|||
27868143|NCT03459846|54466598|FG001|Overall Study|Withdrawal by Subject|2|||
27868144|NCT03427125|54466624|FG000|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
27868145|NCT03427125|54466625|FG001|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|995|||
27868146|NCT03427125|54466626|FG002|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
27868147|NCT03341273|54466641|FG000|Overall Study|Lost to Follow-up|7|||
27868148|NCT03341273|54466642|FG001|Overall Study|Lost to Follow-up|7|||
27868149|NCT03341273|54466641|FG000|Overall Study|Withdrawal by Subject|4|||
27868150|NCT03341273|54466642|FG001|Overall Study|Withdrawal by Subject|2|||
27868151|NCT03341273|54466641|FG000|Overall Study|Physician Decision|1|||
27868152|NCT03341273|54466642|FG001|Overall Study|Physician Decision|0|||
27868153|NCT03341273|54466641|FG000|Overall Study|Protocol Violation|0|||
27868154|NCT03341273|54466642|FG001|Overall Study|Protocol Violation|1|||
27868155|NCT03341273|54466641|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
27868156|NCT03341273|54466642|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
27868157|NCT03341273|54466641|FG000|Overall Study|Became ineligible after enrollment|1|||
27868158|NCT03341273|54466642|FG001|Overall Study|Became ineligible after enrollment|0|||
27868159|NCT03341273|54466641|FG000|Overall Study|Not Eligible at Enrollment|0|||
27868160|NCT03341273|54466642|FG001|Overall Study|Not Eligible at Enrollment|1|||
27868161|NCT03341273|54466641|FG000|Overall Study|Participant incarcerated|1|||
27868162|NCT03341273|54466642|FG001|Overall Study|Participant incarcerated|0|||
27868163|NCT03307785|54466659|FG000|Part A: Up to 28.5 Months|Disease progression|2|||
27868164|NCT03307785|54466660|FG001|Part A: Up to 28.5 Months|Disease progression|0|||
27868165|NCT03307785|54466661|FG002|Part A: Up to 28.5 Months|Disease progression|0|||
27868166|NCT03307785|54466662|FG003|Part A: Up to 28.5 Months|Disease progression|0|||
27868167|NCT03307785|54466663|FG004|Part A: Up to 28.5 Months|Disease progression|0|||
27868168|NCT03307785|54466664|FG005|Part A: Up to 28.5 Months|Disease progression|0|||
27868169|NCT03307785|54466665|FG006|Part A: Up to 28.5 Months|Disease progression|0|||
27868170|NCT03307785|54466666|FG007|Part A: Up to 28.5 Months|Disease progression|0|||
27868171|NCT03307785|54466667|FG008|Part A: Up to 28.5 Months|Disease progression|0|||
27868172|NCT03307785|54466668|FG009|Part A: Up to 28.5 Months|Disease progression|0|||
27868173|NCT03307785|54466669|FG010|Part A: Up to 28.5 Months|Disease progression|0|||
27868174|NCT03307785|54466659|FG000|Part A: Up to 28.5 Months|Withdrawal by Subject|7|||
27868175|NCT03307785|54466660|FG001|Part A: Up to 28.5 Months|Withdrawal by Subject|1|||
27868176|NCT03307785|54466661|FG002|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
27868177|NCT03307785|54466662|FG003|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
27868178|NCT03307785|54466663|FG004|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
27868179|NCT03307785|54466664|FG005|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
27868180|NCT03307785|54466665|FG006|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
27868181|NCT03307785|54466666|FG007|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
27868182|NCT03307785|54466667|FG008|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
27868183|NCT03307785|54466668|FG009|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
27868184|NCT03307785|54466669|FG010|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
27868185|NCT03307785|54466659|FG000|Part A: Up to 28.5 Months|Death|4|||
27868186|NCT03307785|54466660|FG001|Part A: Up to 28.5 Months|Death|4|||
27868187|NCT03307785|54466661|FG002|Part A: Up to 28.5 Months|Death|0|||
27868188|NCT03307785|54466662|FG003|Part A: Up to 28.5 Months|Death|0|||
27868189|NCT03307785|54466663|FG004|Part A: Up to 28.5 Months|Death|0|||
27868190|NCT03307785|54466664|FG005|Part A: Up to 28.5 Months|Death|0|||
27868191|NCT03307785|54466665|FG006|Part A: Up to 28.5 Months|Death|0|||
27868192|NCT03307785|54466666|FG007|Part A: Up to 28.5 Months|Death|0|||
27868193|NCT03307785|54466667|FG008|Part A: Up to 28.5 Months|Death|0|||
27868194|NCT03307785|54466668|FG009|Part A: Up to 28.5 Months|Death|0|||
27868195|NCT03307785|54466669|FG010|Part A: Up to 28.5 Months|Death|0|||
27868196|NCT03307785|54466659|FG000|Part A: Up to 28.5 Months|Physician Decision|3|||
27868197|NCT03307785|54466660|FG001|Part A: Up to 28.5 Months|Physician Decision|1|||
27868198|NCT03307785|54466661|FG002|Part A: Up to 28.5 Months|Physician Decision|0|||
27868199|NCT03307785|54466662|FG003|Part A: Up to 28.5 Months|Physician Decision|0|||
27868200|NCT03307785|54466663|FG004|Part A: Up to 28.5 Months|Physician Decision|0|||
27868201|NCT03307785|54466664|FG005|Part A: Up to 28.5 Months|Physician Decision|0|||
27868202|NCT03307785|54466665|FG006|Part A: Up to 28.5 Months|Physician Decision|0|||
27868203|NCT03307785|54466666|FG007|Part A: Up to 28.5 Months|Physician Decision|0|||
27868204|NCT03307785|54466667|FG008|Part A: Up to 28.5 Months|Physician Decision|0|||
27868205|NCT03307785|54466668|FG009|Part A: Up to 28.5 Months|Physician Decision|0|||
27868206|NCT03307785|54466669|FG010|Part A: Up to 28.5 Months|Physician Decision|0|||
27868207|NCT03307785|54466659|FG000|Part B: Up to 28.5 Months|Disease progression|0|||
27868208|NCT03307785|54466660|FG001|Part B: Up to 28.5 Months|Disease progression|0|||
27868209|NCT03307785|54466661|FG002|Part B: Up to 28.5 Months|Disease progression|1|||
27868210|NCT03307785|54466662|FG003|Part B: Up to 28.5 Months|Disease progression|0|||
27868211|NCT03307785|54466663|FG004|Part B: Up to 28.5 Months|Disease progression|0|||
27868212|NCT03307785|54466664|FG005|Part B: Up to 28.5 Months|Disease progression|0|||
27868213|NCT03307785|54466665|FG006|Part B: Up to 28.5 Months|Disease progression|0|||
27868214|NCT03307785|54466666|FG007|Part B: Up to 28.5 Months|Disease progression|0|||
27868215|NCT03307785|54466667|FG008|Part B: Up to 28.5 Months|Disease progression|0|||
27868216|NCT03307785|54466668|FG009|Part B: Up to 28.5 Months|Disease progression|0|||
27868217|NCT03307785|54466669|FG010|Part B: Up to 28.5 Months|Disease progression|0|||
27868218|NCT03307785|54466659|FG000|Part B: Up to 28.5 Months|Physician Decision|0|||
27868219|NCT03307785|54466660|FG001|Part B: Up to 28.5 Months|Physician Decision|0|||
27868220|NCT03307785|54466661|FG002|Part B: Up to 28.5 Months|Physician Decision|1|||
27868221|NCT03307785|54466662|FG003|Part B: Up to 28.5 Months|Physician Decision|0|||
27868222|NCT03307785|54466663|FG004|Part B: Up to 28.5 Months|Physician Decision|0|||
27868223|NCT03307785|54466664|FG005|Part B: Up to 28.5 Months|Physician Decision|0|||
27868224|NCT03307785|54466665|FG006|Part B: Up to 28.5 Months|Physician Decision|0|||
27868225|NCT03307785|54466666|FG007|Part B: Up to 28.5 Months|Physician Decision|0|||
27868226|NCT03307785|54466667|FG008|Part B: Up to 28.5 Months|Physician Decision|0|||
27868227|NCT03307785|54466668|FG009|Part B: Up to 28.5 Months|Physician Decision|0|||
27868228|NCT03307785|54466669|FG010|Part B: Up to 28.5 Months|Physician Decision|0|||
27868229|NCT03307785|54466659|FG000|Part B: Up to 28.5 Months|Death|0|||
27868230|NCT03307785|54466660|FG001|Part B: Up to 28.5 Months|Death|0|||
27868231|NCT03307785|54466661|FG002|Part B: Up to 28.5 Months|Death|7|||
27868232|NCT03307785|54466662|FG003|Part B: Up to 28.5 Months|Death|0|||
27868233|NCT03307785|54466663|FG004|Part B: Up to 28.5 Months|Death|0|||
27868234|NCT03307785|54466664|FG005|Part B: Up to 28.5 Months|Death|0|||
27868235|NCT03307785|54466665|FG006|Part B: Up to 28.5 Months|Death|0|||
27868236|NCT03307785|54466666|FG007|Part B: Up to 28.5 Months|Death|0|||
27868237|NCT03307785|54466667|FG008|Part B: Up to 28.5 Months|Death|0|||
27868238|NCT03307785|54466668|FG009|Part B: Up to 28.5 Months|Death|0|||
27868239|NCT03307785|54466669|FG010|Part B: Up to 28.5 Months|Death|0|||
27868240|NCT03307785|54466659|FG000|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
27868241|NCT03307785|54466660|FG001|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
27868242|NCT03307785|54466661|FG002|Part B: Up to 28.5 Months|Withdrawal by Subject|1|||
27868243|NCT03307785|54466662|FG003|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
27868244|NCT03307785|54466663|FG004|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
27868245|NCT03307785|54466664|FG005|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
27868246|NCT03307785|54466665|FG006|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
27868247|NCT03307785|54466666|FG007|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
27868248|NCT03307785|54466667|FG008|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
27868249|NCT03307785|54466668|FG009|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
27868250|NCT03307785|54466669|FG010|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
27868251|NCT03307785|54466659|FG000|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
27868252|NCT03307785|54466660|FG001|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
27868253|NCT03307785|54466661|FG002|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|4|||
27868254|NCT03307785|54466662|FG003|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
27868255|NCT03307785|54466663|FG004|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
27868256|NCT03307785|54466664|FG005|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
27868257|NCT03307785|54466665|FG006|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
27868258|NCT03307785|54466666|FG007|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
27982280|NCT02337829|54640317|FG002|Overall Study|Study terminated by sponsor|5|||
27868259|NCT03307785|54466667|FG008|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
27868260|NCT03307785|54466668|FG009|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
27868261|NCT03307785|54466669|FG010|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
28096347|NCT03999554|54751241|FG001|Overall Study|Pregnancy|0|||
27868262|NCT03307785|54466659|FG000|Part C: Up to 22.5 Months|Disease progression|0|||
27868263|NCT03307785|54466660|FG001|Part C: Up to 22.5 Months|Disease progression|0|||
27868264|NCT03307785|54466661|FG002|Part C: Up to 22.5 Months|Disease progression|0|||
27868265|NCT03307785|54466662|FG003|Part C: Up to 22.5 Months|Disease progression|0|||
27868266|NCT03307785|54466663|FG004|Part C: Up to 22.5 Months|Disease progression|1|||
27868267|NCT03307785|54466664|FG005|Part C: Up to 22.5 Months|Disease progression|0|||
27868268|NCT03307785|54466665|FG006|Part C: Up to 22.5 Months|Disease progression|0|||
27868269|NCT03307785|54466666|FG007|Part C: Up to 22.5 Months|Disease progression|0|||
27868270|NCT03307785|54466667|FG008|Part C: Up to 22.5 Months|Disease progression|0|||
27868271|NCT03307785|54466668|FG009|Part C: Up to 22.5 Months|Disease progression|0|||
27868272|NCT03307785|54466669|FG010|Part C: Up to 22.5 Months|Disease progression|0|||
27868273|NCT03307785|54466659|FG000|Part C: Up to 22.5 Months|Physician Decision|0|||
27868274|NCT03307785|54466660|FG001|Part C: Up to 22.5 Months|Physician Decision|0|||
27868275|NCT03307785|54466661|FG002|Part C: Up to 22.5 Months|Physician Decision|0|||
27868276|NCT03307785|54466662|FG003|Part C: Up to 22.5 Months|Physician Decision|3|||
27868277|NCT03307785|54466663|FG004|Part C: Up to 22.5 Months|Physician Decision|1|||
27868278|NCT03307785|54466664|FG005|Part C: Up to 22.5 Months|Physician Decision|0|||
27868279|NCT03307785|54466665|FG006|Part C: Up to 22.5 Months|Physician Decision|0|||
27868280|NCT03307785|54466666|FG007|Part C: Up to 22.5 Months|Physician Decision|0|||
27868281|NCT03307785|54466667|FG008|Part C: Up to 22.5 Months|Physician Decision|0|||
27868282|NCT03307785|54466668|FG009|Part C: Up to 22.5 Months|Physician Decision|0|||
27868283|NCT03307785|54466669|FG010|Part C: Up to 22.5 Months|Physician Decision|0|||
27868284|NCT03307785|54466659|FG000|Part C: Up to 22.5 Months|Death|0|||
27868285|NCT03307785|54466660|FG001|Part C: Up to 22.5 Months|Death|0|||
27868286|NCT03307785|54466661|FG002|Part C: Up to 22.5 Months|Death|0|||
27868287|NCT03307785|54466662|FG003|Part C: Up to 22.5 Months|Death|1|||
27868288|NCT03307785|54466663|FG004|Part C: Up to 22.5 Months|Death|4|||
27868289|NCT03307785|54466664|FG005|Part C: Up to 22.5 Months|Death|0|||
27868290|NCT03307785|54466665|FG006|Part C: Up to 22.5 Months|Death|0|||
27868291|NCT03307785|54466666|FG007|Part C: Up to 22.5 Months|Death|0|||
27868292|NCT03307785|54466667|FG008|Part C: Up to 22.5 Months|Death|0|||
27868293|NCT03307785|54466668|FG009|Part C: Up to 22.5 Months|Death|0|||
27868294|NCT03307785|54466669|FG010|Part C: Up to 22.5 Months|Death|0|||
27868295|NCT03307785|54466659|FG000|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
27868296|NCT03307785|54466660|FG001|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
27868297|NCT03307785|54466661|FG002|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
27868298|NCT03307785|54466662|FG003|Part C: Up to 22.5 Months|Withdrawal by Subject|1|||
27868299|NCT03307785|54466663|FG004|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
27868300|NCT03307785|54466664|FG005|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
27868301|NCT03307785|54466665|FG006|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
27868302|NCT03307785|54466666|FG007|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
27868303|NCT03307785|54466667|FG008|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
27868304|NCT03307785|54466668|FG009|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
27868305|NCT03307785|54466669|FG010|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
27868306|NCT03307785|54466659|FG000|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
27868307|NCT03307785|54466660|FG001|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
27868308|NCT03307785|54466661|FG002|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
27868309|NCT03307785|54466662|FG003|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|1|||
27868310|NCT03307785|54466663|FG004|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|1|||
27868311|NCT03307785|54466664|FG005|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
27868312|NCT03307785|54466665|FG006|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
27868313|NCT03307785|54466666|FG007|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
27835383|NCT02695524|54319896|FG000|Overall Study|Lost to Follow-up|3|||
27835384|NCT02695524|54319897|FG001|Overall Study|Lost to Follow-up|2|||
27835385|NCT02695524|54319896|FG000|Overall Study|Death|0|||
27835386|NCT02695524|54319897|FG001|Overall Study|Death|1|||
27835387|NCT01576367|54319903|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
27835388|NCT01576367|54319903|FG000|Overall Study|Moved to commercial use after 6 months|1|||
27835389|NCT01689857|54319914|FG000|Overall Study|Lost to Follow-up|5|||
27835390|NCT01689857|54319915|FG001|Overall Study|Lost to Follow-up|2|||
27835391|NCT01587079|54319930|FG000|Overall Study|Protocol-specified criteria|9|||
27835392|NCT01587079|54319930|FG000|Overall Study|Protocol Violation|5|||
27835393|NCT01587079|54319930|FG000|Overall Study|Lost to Follow-up|2|||
27868314|NCT03307785|54466667|FG008|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
27868315|NCT03307785|54466668|FG009|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
27868316|NCT03307785|54466669|FG010|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
27868317|NCT03307785|54466659|FG000|Part D: Up to 9.5 Months|Physician Decision|0|||
27868318|NCT03307785|54466660|FG001|Part D: Up to 9.5 Months|Physician Decision|0|||
27868319|NCT03307785|54466661|FG002|Part D: Up to 9.5 Months|Physician Decision|0|||
27868320|NCT03307785|54466662|FG003|Part D: Up to 9.5 Months|Physician Decision|0|||
27868321|NCT03307785|54466663|FG004|Part D: Up to 9.5 Months|Physician Decision|0|||
27868322|NCT03307785|54466664|FG005|Part D: Up to 9.5 Months|Physician Decision|1|||
27868323|NCT03307785|54466665|FG006|Part D: Up to 9.5 Months|Physician Decision|0|||
27868324|NCT03307785|54466666|FG007|Part D: Up to 9.5 Months|Physician Decision|0|||
27868325|NCT03307785|54466667|FG008|Part D: Up to 9.5 Months|Physician Decision|0|||
27868326|NCT03307785|54466668|FG009|Part D: Up to 9.5 Months|Physician Decision|0|||
27868327|NCT03307785|54466669|FG010|Part D: Up to 9.5 Months|Physician Decision|0|||
27868328|NCT03307785|54466659|FG000|Part D: Up to 9.5 Months|Death|0|||
27868329|NCT03307785|54466660|FG001|Part D: Up to 9.5 Months|Death|0|||
27868330|NCT03307785|54466661|FG002|Part D: Up to 9.5 Months|Death|0|||
27868331|NCT03307785|54466662|FG003|Part D: Up to 9.5 Months|Death|0|||
27868332|NCT03307785|54466663|FG004|Part D: Up to 9.5 Months|Death|0|||
27868333|NCT03307785|54466664|FG005|Part D: Up to 9.5 Months|Death|1|||
27868334|NCT03307785|54466665|FG006|Part D: Up to 9.5 Months|Death|0|||
27868335|NCT03307785|54466666|FG007|Part D: Up to 9.5 Months|Death|0|||
27868336|NCT03307785|54466667|FG008|Part D: Up to 9.5 Months|Death|0|||
27868337|NCT03307785|54466668|FG009|Part D: Up to 9.5 Months|Death|0|||
27868338|NCT03307785|54466669|FG010|Part D: Up to 9.5 Months|Death|0|||
27868339|NCT03307785|54466659|FG000|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
27868340|NCT03307785|54466660|FG001|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
27868341|NCT03307785|54466661|FG002|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
27868342|NCT03307785|54466662|FG003|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
27868343|NCT03307785|54466663|FG004|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
27868344|NCT03307785|54466664|FG005|Part D: Up to 9.5 Months|Withdrawal by Subject|1|||
27868345|NCT03307785|54466665|FG006|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
27868346|NCT03307785|54466666|FG007|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
27868347|NCT03307785|54466667|FG008|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
27868348|NCT03307785|54466668|FG009|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
27868349|NCT03307785|54466669|FG010|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
27868350|NCT03307785|54466659|FG000|Part E: Up to 4.4 Months|Death|0|||
27868351|NCT03307785|54466660|FG001|Part E: Up to 4.4 Months|Death|0|||
27868352|NCT03307785|54466661|FG002|Part E: Up to 4.4 Months|Death|0|||
27868353|NCT03307785|54466662|FG003|Part E: Up to 4.4 Months|Death|0|||
27868354|NCT03307785|54466663|FG004|Part E: Up to 4.4 Months|Death|0|||
27868355|NCT03307785|54466664|FG005|Part E: Up to 4.4 Months|Death|0|||
27868356|NCT03307785|54466665|FG006|Part E: Up to 4.4 Months|Death|1|||
27868357|NCT03307785|54466666|FG007|Part E: Up to 4.4 Months|Death|0|||
27868358|NCT03307785|54466667|FG008|Part E: Up to 4.4 Months|Death|0|||
27868359|NCT03307785|54466668|FG009|Part E: Up to 4.4 Months|Death|0|||
27868360|NCT03307785|54466669|FG010|Part E: Up to 4.4 Months|Death|0|||
27868361|NCT03307785|54466659|FG000|Part E: Up to 4.4 Months|Physician Decision|0|||
27868362|NCT03307785|54466660|FG001|Part E: Up to 4.4 Months|Physician Decision|0|||
27868363|NCT03307785|54466661|FG002|Part E: Up to 4.4 Months|Physician Decision|0|||
27868364|NCT03307785|54466662|FG003|Part E: Up to 4.4 Months|Physician Decision|0|||
27868365|NCT03307785|54466663|FG004|Part E: Up to 4.4 Months|Physician Decision|0|||
27868366|NCT03307785|54466664|FG005|Part E: Up to 4.4 Months|Physician Decision|0|||
27868367|NCT03307785|54466665|FG006|Part E: Up to 4.4 Months|Physician Decision|1|||
27868368|NCT03307785|54466666|FG007|Part E: Up to 4.4 Months|Physician Decision|0|||
27868369|NCT03307785|54466667|FG008|Part E: Up to 4.4 Months|Physician Decision|0|||
27868370|NCT03307785|54466668|FG009|Part E: Up to 4.4 Months|Physician Decision|0|||
27868371|NCT03307785|54466669|FG010|Part E: Up to 4.4 Months|Physician Decision|0|||
27868372|NCT03307785|54466659|FG000|Part F: Up to 3.5 Months|Physician Decision|0|||
27868373|NCT03307785|54466660|FG001|Part F: Up to 3.5 Months|Physician Decision|0|||
27868374|NCT03307785|54466661|FG002|Part F: Up to 3.5 Months|Physician Decision|0|||
27868375|NCT03307785|54466662|FG003|Part F: Up to 3.5 Months|Physician Decision|0|||
28171390|NCT02471404|54842971|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
28171391|NCT02471404|54842972|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
28171392|NCT02471404|54842973|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
27835394|NCT01587079|54319930|FG000|Overall Study|Physician Decision|2|||
27868376|NCT03307785|54466663|FG004|Part F: Up to 3.5 Months|Physician Decision|0|||
27868377|NCT03307785|54466664|FG005|Part F: Up to 3.5 Months|Physician Decision|0|||
27868378|NCT03307785|54466665|FG006|Part F: Up to 3.5 Months|Physician Decision|0|||
27868379|NCT03307785|54466666|FG007|Part F: Up to 3.5 Months|Physician Decision|1|||
27868380|NCT03307785|54466667|FG008|Part F: Up to 3.5 Months|Physician Decision|0|||
27868381|NCT03307785|54466668|FG009|Part F: Up to 3.5 Months|Physician Decision|0|||
27868382|NCT03307785|54466669|FG010|Part F: Up to 3.5 Months|Physician Decision|0|||
27868383|NCT03284710|54466694|FG000|Overall Study|Withdrawal by Subject|1|||
27835395|NCT01587079|54319930|FG000|Overall Study|Withdrawal by Subject|7|||
27835396|NCT01587079|54319930|FG000|Overall Study|Adverse Event|14|||
27835397|NCT01587001|54319983|FG000|Overall Study|Lost to Follow-up|2|||
27835398|NCT01587001|54319984|FG001|Overall Study|Lost to Follow-up|0|||
27835399|NCT01587001|54319983|FG000|Overall Study|Insufficient samples to complete testing|4|||
27868384|NCT03284710|54466695|FG001|Overall Study|Withdrawal by Subject|0|||
27835400|NCT01587001|54319984|FG001|Overall Study|Insufficient samples to complete testing|1|||
27868385|NCT03284710|54466696|FG002|Overall Study|Withdrawal by Subject|1|||
27868386|NCT03284710|54466697|FG003|Overall Study|Withdrawal by Subject|6|||
27868387|NCT03284710|54466694|FG000|Overall Study|Lost to Follow-up|3|||
27868388|NCT03284710|54466695|FG001|Overall Study|Lost to Follow-up|3|||
27868389|NCT03284710|54466696|FG002|Overall Study|Lost to Follow-up|1|||
27868390|NCT03284710|54466697|FG003|Overall Study|Lost to Follow-up|0|||
27868391|NCT03284710|54466694|FG000|Overall Study|Physician Decision|1|||
27868392|NCT03284710|54466695|FG001|Overall Study|Physician Decision|0|||
27868393|NCT03284710|54466696|FG002|Overall Study|Physician Decision|0|||
27868394|NCT03284710|54466697|FG003|Overall Study|Physician Decision|0|||
27868395|NCT03284710|54466694|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
27868396|NCT03284710|54466695|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
27868397|NCT03284710|54466696|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
27868398|NCT03284710|54466697|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
27868399|NCT03284710|54466694|FG000|Overall Study|HIV Infection|0|||
27868400|NCT03284710|54466695|FG001|Overall Study|HIV Infection|2|||
27868401|NCT03284710|54466696|FG002|Overall Study|HIV Infection|2|||
27868402|NCT03284710|54466697|FG003|Overall Study|HIV Infection|1|||
27868403|NCT03248167|54466716|FG000|Overall Study|Withdrawal by Subject|2|||
27868404|NCT03248167|54466717|FG001|Overall Study|Withdrawal by Subject|2|||
27868405|NCT03248167|54466716|FG000|Overall Study|Physician Decision|0|||
27868406|NCT03248167|54466717|FG001|Overall Study|Physician Decision|1|||
27868407|NCT03248167|54466716|FG000|Overall Study|Institution Mandated COVID-19 Research Pause|2|||
27868408|NCT03248167|54466717|FG001|Overall Study|Institution Mandated COVID-19 Research Pause|1|||
27868409|NCT03248167|54466716|FG000|Overall Study|Lost to Follow-up|1|||
27868410|NCT03248167|54466717|FG001|Overall Study|Lost to Follow-up|0|||
27868411|NCT03220737|54466731|FG000|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
27868412|NCT03220737|54466732|FG001|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
27868413|NCT03220737|54466733|FG002|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
27868414|NCT03220737|54466734|FG003|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
27868415|NCT03220737|54466735|FG004|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
27868416|NCT03220737|54466736|FG005|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
27868417|NCT03220737|54466737|FG006|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
27868418|NCT03220737|54466731|FG000|Main Study (Day 1 - 181)|Lost to Follow-up|2|||
27868419|NCT03220737|54466732|FG001|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
27868420|NCT03220737|54466733|FG002|Main Study (Day 1 - 181)|Lost to Follow-up|6|||
27868421|NCT03220737|54466734|FG003|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
27868422|NCT03220737|54466735|FG004|Main Study (Day 1 - 181)|Lost to Follow-up|13|||
27868423|NCT03220737|54466736|FG005|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
27868424|NCT03220737|54466737|FG006|Main Study (Day 1 - 181)|Lost to Follow-up|0|||
27868425|NCT03220737|54466731|FG000|Main Study (Day 1 - 181)|Protocol Violation|0|||
27868426|NCT03220737|54466732|FG001|Main Study (Day 1 - 181)|Protocol Violation|0|||
27868427|NCT03220737|54466733|FG002|Main Study (Day 1 - 181)|Protocol Violation|1|||
27868428|NCT03220737|54466734|FG003|Main Study (Day 1 - 181)|Protocol Violation|1|||
27868429|NCT03220737|54466735|FG004|Main Study (Day 1 - 181)|Protocol Violation|3|||
27868430|NCT03220737|54466736|FG005|Main Study (Day 1 - 181)|Protocol Violation|0|||
27868431|NCT03220737|54466737|FG006|Main Study (Day 1 - 181)|Protocol Violation|1|||
27868432|NCT03220737|54466731|FG000|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
27868433|NCT03220737|54466732|FG001|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
27868434|NCT03220737|54466733|FG002|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1|||
27868435|NCT03220737|54466734|FG003|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
27868436|NCT03220737|54466735|FG004|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
27868437|NCT03220737|54466736|FG005|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
27868438|NCT03220737|54466737|FG006|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
27868439|NCT03220737|54466731|FG000|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
27868440|NCT03220737|54466732|FG001|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
27868441|NCT03220737|54466733|FG002|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
27868442|NCT03220737|54466734|FG003|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
27868443|NCT03220737|54466735|FG004|Placebo Crossover (Day 181-365)|Lost to Follow-up|2|||
27868444|NCT03220737|54466736|FG005|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
27868445|NCT03220737|54466737|FG006|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
27868446|NCT03220737|54466731|FG000|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1|||
27868447|NCT03220737|54466732|FG001|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
27868448|NCT03220737|54466733|FG002|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
27868449|NCT03220737|54466734|FG003|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
27868450|NCT03220737|54466735|FG004|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
27868451|NCT03220737|54466736|FG005|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
27868452|NCT03220737|54466737|FG006|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
27868453|NCT03220737|54466731|FG000|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9|||
27868454|NCT03220737|54466732|FG001|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
27868455|NCT03220737|54466733|FG002|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
27868456|NCT03220737|54466734|FG003|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
27868457|NCT03220737|54466735|FG004|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
27868458|NCT03220737|54466736|FG005|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
27868459|NCT03220737|54466737|FG006|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
27868460|NCT03220737|54466731|FG000|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1|||
27868461|NCT03220737|54466732|FG001|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
27868462|NCT03220737|54466733|FG002|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
27868463|NCT03220737|54466734|FG003|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
27868464|NCT03220737|54466735|FG004|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
27868465|NCT03220737|54466736|FG005|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
27868466|NCT03220737|54466737|FG006|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
27868467|NCT03198728|54466761|FG000|Overall Study|Adverse Event|10|||
27868468|NCT03198728|54466762|FG001|Overall Study|Adverse Event|5|||
27868469|NCT03198728|54466761|FG000|Overall Study|Lost to Follow-up|21|||
27868470|NCT03198728|54466762|FG001|Overall Study|Lost to Follow-up|7|||
27868471|NCT03198728|54466761|FG000|Overall Study|Physician Decision|7|||
27868472|NCT03198728|54466762|FG001|Overall Study|Physician Decision|2|||
27868473|NCT03198728|54466761|FG000|Overall Study|Withdrawal by Subject|14|||
27868474|NCT03198728|54466762|FG001|Overall Study|Withdrawal by Subject|10|||
27868475|NCT03144804|54466794|FG000|Overall Study|4 participants had disease progression within 1 month of study treatment and were deemed unevaluable|4|||
27868476|NCT03142334|54466800|FG000|Overall Study|Death|18|||
27868477|NCT03142334|54466801|FG001|Overall Study|Death|33|||
27868478|NCT03142334|54466800|FG000|Overall Study|Withdrawal by Subject|15|||
27868479|NCT03142334|54466801|FG001|Overall Study|Withdrawal by Subject|11|||
27868480|NCT03142334|54466800|FG000|Overall Study|Ongoing on trial follow up|463|||
27868481|NCT03142334|54466801|FG001|Overall Study|Ongoing on trial follow up|454|||
27868482|NCT03126539|54466809|FG000|Overall Study|Lost to Follow-up|1|||
27868483|NCT03126539|54466810|FG001|Overall Study|Lost to Follow-up|1|||
27868484|NCT03126539|54466811|FG002|Overall Study|Lost to Follow-up|1|||
27868485|NCT03126539|54466812|FG003|Overall Study|Lost to Follow-up|0|||
27868486|NCT03126539|54466813|FG004|Overall Study|Lost to Follow-up|0|||
27868487|NCT03123250|54466826|FG000|60 Months Follow Up|Withdrawal by Subject|2|||
27868488|NCT03099096|54466830|FG000|Overall Study|Adverse Event|1|||
27868489|NCT03099096|54466830|FG000|Overall Study|Physician Decision|1|||
27868490|NCT03096782|54466834|FG000|Overall Study|Death|1|||
27868491|NCT03096782|54466834|FG000|Overall Study|Participant Relapsed|1|||
27868492|NCT03064126|54466842|FG000|Overall Study|Death|6|||
27868493|NCT03064126|54466843|FG001|Overall Study|Death|2|||
27868494|NCT03064126|54466844|FG002|Overall Study|Death|2|||
27868495|NCT03064126|54466845|FG003|Overall Study|Death|1|||
27868496|NCT03064126|54466842|FG000|Overall Study|Investigator Discretion|1|||
27868497|NCT03064126|54466843|FG001|Overall Study|Investigator Discretion|0|||
27868498|NCT03064126|54466844|FG002|Overall Study|Investigator Discretion|0|||
27868499|NCT03064126|54466845|FG003|Overall Study|Investigator Discretion|0|||
27982281|NCT02337829|54640318|FG003|Overall Study|Study terminated by sponsor|6|||
27982282|NCT02337829|54640315|FG000|Overall Study|discontinued for other reasons|6|||
27982283|NCT02337829|54640316|FG001|Overall Study|discontinued for other reasons|3|||
28171393|NCT02471404|54842971|FG000|Overall Study|Lost to Follow-up|1|||
28171394|NCT02471404|54842972|FG001|Overall Study|Lost to Follow-up|1|||
27835401|NCT01568047|54320014|FG000|Overall Study|Ineligibility|1|||
27835402|NCT01568047|54320015|FG001|Overall Study|Ineligibility|0|||
27835403|NCT01568047|54320016|FG002|Overall Study|Ineligibility|0|||
27835404|NCT01568047|54320017|FG003|Overall Study|Ineligibility|0|||
27835405|NCT01568047|54320014|FG000|Overall Study|Withdrawal by Subject|0|||
27835406|NCT01568047|54320015|FG001|Overall Study|Withdrawal by Subject|1|||
27835407|NCT01568047|54320016|FG002|Overall Study|Withdrawal by Subject|0|||
27835408|NCT01568047|54320017|FG003|Overall Study|Withdrawal by Subject|0|||
27835409|NCT01568047|54320014|FG000|Overall Study|Adverse Event|0|||
27835410|NCT01568047|54320015|FG001|Overall Study|Adverse Event|0|||
27835411|NCT01568047|54320016|FG002|Overall Study|Adverse Event|1|||
27835412|NCT01568047|54320017|FG003|Overall Study|Adverse Event|1|||
27835413|NCT01688999|54320030|FG000|Overall Study|Withdrawal by Subject|5|||
27835414|NCT01688999|54320031|FG001|Overall Study|Withdrawal by Subject|1|||
27835415|NCT01688999|54320032|FG002|Overall Study|Withdrawal by Subject|1|||
27835416|NCT01688999|54320030|FG000|Overall Study|Adverse Event|2|||
27835417|NCT01688999|54320031|FG001|Overall Study|Adverse Event|0|||
27835418|NCT01688999|54320032|FG002|Overall Study|Adverse Event|2|||
27835419|NCT01688999|54320030|FG000|Overall Study|Ineligible/Not treated|1|||
27835420|NCT01688999|54320031|FG001|Overall Study|Ineligible/Not treated|0|||
27835421|NCT01688999|54320032|FG002|Overall Study|Ineligible/Not treated|0|||
27835422|NCT01541917|54320056|FG000|Overall Study|Lost to Follow-up|2|||
27835423|NCT01541917|54320057|FG001|Overall Study|Lost to Follow-up|2|||
27835424|NCT01541917|54320056|FG000|Overall Study|Withdrawal by Subject|13|||
27835425|NCT01541917|54320057|FG001|Overall Study|Withdrawal by Subject|7|||
27835426|NCT01688921|54320077|FG000|Overall Study|Lost to Follow-up|7|||
27835427|NCT01688921|54320078|FG001|Overall Study|Lost to Follow-up|13|||
27868500|NCT03064126|54466842|FG000|Overall Study|Withdrawal by Subject|7|||
27868501|NCT03064126|54466843|FG001|Overall Study|Withdrawal by Subject|4|||
27868502|NCT03064126|54466844|FG002|Overall Study|Withdrawal by Subject|0|||
27868503|NCT03064126|54466845|FG003|Overall Study|Withdrawal by Subject|0|||
27868504|NCT03064126|54466842|FG000|Overall Study|Subject moved|1|||
27868505|NCT03064126|54466843|FG001|Overall Study|Subject moved|0|||
27868506|NCT03064126|54466844|FG002|Overall Study|Subject moved|0|||
27868507|NCT03064126|54466845|FG003|Overall Study|Subject moved|0|||
27868508|NCT03064126|54466842|FG000|Overall Study|Protocol Violation|11|||
27868509|NCT03064126|54466843|FG001|Overall Study|Protocol Violation|1|||
27868510|NCT03064126|54466844|FG002|Overall Study|Protocol Violation|1|||
27868511|NCT03064126|54466845|FG003|Overall Study|Protocol Violation|0|||
27868512|NCT03043664|54466856|FG000|Overall Study|Lost to Follow-up|1|||
27868513|NCT03041467|54466862|FG000|Overall Study|Death|40|||
27868514|NCT03041467|54466863|FG001|Overall Study|Death|36|||
27868515|NCT03041467|54466862|FG000|Overall Study|Withdrawal by Subject|36|||
27868516|NCT03041467|54466863|FG001|Overall Study|Withdrawal by Subject|37|||
27868517|NCT03041467|54466862|FG000|Overall Study|Lost to Follow-up|6|||
27868518|NCT03041467|54466863|FG001|Overall Study|Lost to Follow-up|7|||
27868519|NCT03041467|54466862|FG000|Overall Study|Declined consent for study extension|21|||
27868520|NCT03041467|54466863|FG001|Overall Study|Declined consent for study extension|33|||
27868521|NCT03041467|54466862|FG000|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|4|||
27868522|NCT03041467|54466863|FG001|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|2|||
27868523|NCT03041467|54466862|FG000|Overall Study|48 Month visit not completed|9|||
27868524|NCT03041467|54466863|FG001|Overall Study|48 Month visit not completed|4|||
27868525|NCT03019406|54466875|FG000|ETP: Ongoing From Week 26|Ongoing|6|||
27868526|NCT03019406|54466876|FG001|ETP: Ongoing From Week 26|Ongoing|5|||
27868527|NCT03019406|54466877|FG002|ETP: Ongoing From Week 26|Ongoing|5|||
27868528|NCT03019406|54466878|FG003|ETP: Ongoing From Week 26|Ongoing|3|||
27868529|NCT02972593|54466893|FG000|Overall Study|Lost to Follow-up|19|||
27868530|NCT02972593|54466894|FG001|Overall Study|Lost to Follow-up|15|||
27868531|NCT02972593|54466893|FG000|Overall Study|Protocol Violation|1|||
27868532|NCT02972593|54466894|FG001|Overall Study|Protocol Violation|0|||
27868533|NCT02949700|54466906|FG000|Phase I|Withdrawal by Subject|1|||
27868534|NCT02949700|54466907|FG001|Phase I|Withdrawal by Subject|1|||
27868535|NCT02949700|54466908|FG002|Phase I|Withdrawal by Subject|0|||
27868536|NCT02949700|54466909|FG003|Phase I|Withdrawal by Subject|0|||
27868537|NCT02949700|54466906|FG000|Phase I|Protocol Violation|1|||
27868538|NCT02949700|54466907|FG001|Phase I|Protocol Violation|0|||
27868539|NCT02949700|54466908|FG002|Phase I|Protocol Violation|0|||
27868540|NCT02949700|54466909|FG003|Phase I|Protocol Violation|0|||
27868541|NCT02949700|54466906|FG000|Phase II|Withdrawal by Subject|0|||
27982284|NCT02337829|54640317|FG002|Overall Study|discontinued for other reasons|1|||
27982285|NCT02337829|54640318|FG003|Overall Study|discontinued for other reasons|4|||
27982286|NCT02257528|54640330|FG000|Overall Study|Never received study treatment|1|||
27982287|NCT01899326|54640341|FG000|Overall Study|Withdrawal by Subject|1|||
27982288|NCT01899326|54640341|FG000|Overall Study|Adverse Event|2|||
27982289|NCT01899326|54640341|FG000|Overall Study|Disease Relapse (patient with previously undiagnosed relapsing disease)|1|||
27982290|NCT01856192|54640348|FG000|Overall Study|Adverse Event|12|||
27982291|NCT01856192|54640349|FG001|Overall Study|Adverse Event|4|||
27982292|NCT01856192|54640348|FG000|Overall Study|Alternative therapy|0|||
27982293|NCT01856192|54640349|FG001|Overall Study|Alternative therapy|3|||
27738985|NCT02240680|54188246|FG003|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
27738986|NCT02240680|54188243|FG000|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
27835428|NCT01688921|54320077|FG000|Overall Study|Physician Decision|6|||
27835429|NCT01688921|54320078|FG001|Overall Study|Physician Decision|1|||
27835430|NCT01688921|54320077|FG000|Overall Study|Protocol Violation|0|||
27835431|NCT01688921|54320078|FG001|Overall Study|Protocol Violation|1|||
27982294|NCT01856192|54640348|FG000|Overall Study|Death|3|||
27835432|NCT01688921|54320077|FG000|Overall Study|informed consent|3|||
27835433|NCT01688921|54320078|FG001|Overall Study|informed consent|0|||
27835434|NCT01541371|54320100|FG000|Overall Study|Withdrawal by Subject|14|||
27835435|NCT01541371|54320100|FG000|Overall Study|Lost to Follow-up|21|||
27835436|NCT01541371|54320100|FG000|Overall Study|Adverse Event|15|||
27835437|NCT01541371|54320100|FG000|Overall Study|Lack of Efficacy|12|||
27835438|NCT01541371|54320100|FG000|Overall Study|Protocol Violation|6|||
27835439|NCT01541371|54320100|FG000|Overall Study|Study medication non-compliance|3|||
27835440|NCT01541371|54320100|FG000|Overall Study|Other|6|||
27835441|NCT01687673|54320133|FG000|Overall Study|Physician Decision|1|||
27835442|NCT01687595|54320213|FG000|Overall Study|Withdrawal by Subject|8|||
27835443|NCT01687595|54320214|FG001|Overall Study|Withdrawal by Subject|0|||
27868542|NCT02949700|54466907|FG001|Phase II|Withdrawal by Subject|0|||
27868543|NCT02949700|54466908|FG002|Phase II|Withdrawal by Subject|0|||
27868544|NCT02949700|54466909|FG003|Phase II|Withdrawal by Subject|2|||
27868545|NCT02949700|54466906|FG000|Phase II|Protocol Violation|0|||
27738987|NCT02240680|54188244|FG001|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
27738988|NCT02240680|54188245|FG002|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1|||
27738989|NCT02240680|54188246|FG003|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
27738990|NCT02240368|54188257|FG000|Overall Study|Surgery lasted less then 20 minutes|1|||
27738991|NCT02240368|54188258|FG001|Overall Study|Surgery lasted less then 20 minutes|0|||
27738992|NCT02240368|54188259|FG002|Overall Study|Surgery lasted less then 20 minutes|0|||
27868546|NCT02949700|54466907|FG001|Phase II|Protocol Violation|0|||
27868547|NCT02949700|54466908|FG002|Phase II|Protocol Violation|1|||
27868548|NCT02949700|54466909|FG003|Phase II|Protocol Violation|3|||
27868549|NCT02947087|54466920|FG000|Overall Study|Withdrawal by Subject|3|||
27868550|NCT02947087|54466921|FG001|Overall Study|Withdrawal by Subject|2|||
27868551|NCT02879448|54466929|FG000|Overall Study|No implant attempt|17|||
27868552|NCT02879448|54466930|FG001|Overall Study|No implant attempt|28|||
27868553|NCT02879448|54466929|FG000|Overall Study|Withdrawal by Subject|20|||
27868554|NCT02879448|54466930|FG001|Overall Study|Withdrawal by Subject|46|||
27868555|NCT02879448|54466929|FG000|Overall Study|Death|63|||
27868556|NCT02879448|54466930|FG001|Overall Study|Death|85|||
27868557|NCT02879448|54466929|FG000|Overall Study|Lost to Follow-up|3|||
27868558|NCT02879448|54466930|FG001|Overall Study|Lost to Follow-up|4|||
27868559|NCT02879448|54466929|FG000|Overall Study|Missing visit|34|||
27868560|NCT02879448|54466930|FG001|Overall Study|Missing visit|39|||
27868561|NCT02879448|54466929|FG000|Overall Study|Pending evaluation|1|||
27868562|NCT02879448|54466930|FG001|Overall Study|Pending evaluation|0|||
27868563|NCT02868216|54466938|FG000|Overall Study|Death|0|||
27868564|NCT02868216|54466939|FG001|Overall Study|Death|1|||
27868565|NCT02868216|54466938|FG000|Overall Study|coronary artery bypass|1|||
27868566|NCT02868216|54466939|FG001|Overall Study|coronary artery bypass|0|||
27868567|NCT02868216|54466938|FG000|Overall Study|Withdrawal by Subject|7|||
27868568|NCT02868216|54466939|FG001|Overall Study|Withdrawal by Subject|5|||
27868569|NCT02841995|54466948|FG000|Overall Study|Disease progression|5|||
27868570|NCT02841995|54466949|FG001|Overall Study|Disease progression|11|||
27868571|NCT02841995|54466950|FG002|Overall Study|Disease progression|8|||
27868572|NCT02841995|54466948|FG000|Overall Study|Withdrawal by Subject|2|||
27868573|NCT02841995|54466949|FG001|Overall Study|Withdrawal by Subject|4|||
27868574|NCT02841995|54466950|FG002|Overall Study|Withdrawal by Subject|4|||
27868575|NCT02841995|54466948|FG000|Overall Study|Adverse Event|2|||
27868576|NCT02841995|54466949|FG001|Overall Study|Adverse Event|0|||
27868577|NCT02841995|54466950|FG002|Overall Study|Adverse Event|1|||
27868578|NCT02841995|54466948|FG000|Overall Study|Investigator decision|2|||
27868579|NCT02841995|54466949|FG001|Overall Study|Investigator decision|0|||
27868580|NCT02841995|54466950|FG002|Overall Study|Investigator decision|1|||
27868581|NCT02841995|54466948|FG000|Overall Study|Death|0|||
27868582|NCT02841995|54466949|FG001|Overall Study|Death|0|||
27868583|NCT02841995|54466950|FG002|Overall Study|Death|2|||
27868584|NCT02841995|54466948|FG000|Overall Study|Noncompliance to protocol|1|||
27868585|NCT02841995|54466949|FG001|Overall Study|Noncompliance to protocol|0|||
27868586|NCT02841995|54466950|FG002|Overall Study|Noncompliance to protocol|0|||
27868587|NCT02841995|54466948|FG000|Overall Study|Sponsor decision|1|||
27868588|NCT02841995|54466949|FG001|Overall Study|Sponsor decision|0|||
27868589|NCT02841995|54466950|FG002|Overall Study|Sponsor decision|0|||
27868590|NCT02841995|54466948|FG000|Overall Study|Other|4|||
27868591|NCT02841995|54466949|FG001|Overall Study|Other|1|||
27868592|NCT02841995|54466950|FG002|Overall Study|Other|5|||
27868593|NCT02702414|54466969|FG000|Overall Study|Death|77|||
27868594|NCT02702414|54466970|FG001|Overall Study|Death|34|||
27868595|NCT02702414|54466969|FG000|Overall Study|Lost to Follow-up|0|||
27868596|NCT02702414|54466970|FG001|Overall Study|Lost to Follow-up|1|||
27868597|NCT02702414|54466969|FG000|Overall Study|Withdrawal by Subject|0|||
27982295|NCT01856192|54640349|FG001|Overall Study|Death|5|||
27982296|NCT01856192|54640348|FG000|Overall Study|Lack of Efficacy|0|||
27868598|NCT02702414|54466970|FG001|Overall Study|Withdrawal by Subject|1|||
27868599|NCT02702414|54466969|FG000|Overall Study|Participants Ongoing in Study|27|||
27868600|NCT02702414|54466970|FG001|Overall Study|Participants Ongoing in Study|15|||
27868601|NCT02702414|54466969|FG000|Overall Study|Not Treated|1|||
27868602|NCT02702414|54466970|FG001|Overall Study|Not Treated|0|||
27982297|NCT01856192|54640349|FG001|Overall Study|Lack of Efficacy|5|||
27738993|NCT02240368|54188257|FG000|Overall Study|Entropy failed to detect more than 50%|0|||
27868603|NCT02667587|54466980|FG000|Pre-Treatment|Not reported|1|||
27868604|NCT02667587|54466981|FG001|Pre-Treatment|Not reported|0|||
27868605|NCT02667587|54466980|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
27868606|NCT02667587|54466981|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
27868607|NCT02667587|54466980|FG000|Pre-Treatment|Participant withdrew consent|0|||
27868608|NCT02667587|54466981|FG001|Pre-Treatment|Participant withdrew consent|1|||
27868609|NCT02667587|54466980|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
27868610|NCT02667587|54466981|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
27868611|NCT02667587|54466980|FG000|End of Treatment|Other reasons|11|||
27868612|NCT02667587|54466981|FG001|End of Treatment|Other reasons|8|||
27982298|NCT01856192|54640348|FG000|Overall Study|Withdrawal by Subject|1|||
27982299|NCT01856192|54640349|FG001|Overall Study|Withdrawal by Subject|1|||
27982300|NCT01856192|54640348|FG000|Overall Study|Other diseases|1|||
27982301|NCT01856192|54640349|FG001|Overall Study|Other diseases|0|||
27835444|NCT01687595|54320213|FG000|Overall Study|Lost to Follow-up|3|||
27868613|NCT02667587|54466980|FG000|End of Treatment|Participant no Longer Meets Study Criteria|1|||
27868614|NCT02667587|54466981|FG001|End of Treatment|Participant no Longer Meets Study Criteria|2|||
27868615|NCT02667587|54466980|FG000|End of Treatment|Poor/Non-Compliance|0|||
27868616|NCT02667587|54466981|FG001|End of Treatment|Poor/Non-Compliance|1|||
27868617|NCT02667587|54466980|FG000|End of Treatment|Maximum Clinical Benefit|3|||
27868618|NCT02667587|54466981|FG001|End of Treatment|Maximum Clinical Benefit|3|||
27868619|NCT02667587|54466980|FG000|End of Treatment|Participant Withdrew Consent|5|||
27868620|NCT02667587|54466981|FG001|End of Treatment|Participant Withdrew Consent|6|||
27868621|NCT02667587|54466980|FG000|End of Treatment|Participants Request to Discontinue Study Treatment|25|||
27868622|NCT02667587|54466981|FG001|End of Treatment|Participants Request to Discontinue Study Treatment|26|||
27868623|NCT02667587|54466980|FG000|End of Treatment|Adverse Event Unrelated to Study Drug|19|||
27868624|NCT02667587|54466981|FG001|End of Treatment|Adverse Event Unrelated to Study Drug|20|||
27868625|NCT02667587|54466980|FG000|End of Treatment|Death|2|||
27868626|NCT02667587|54466981|FG001|End of Treatment|Death|1|||
27868627|NCT02667587|54466980|FG000|End of Treatment|Study Drug Toxicity|74|||
27868628|NCT02667587|54466981|FG001|End of Treatment|Study Drug Toxicity|18|||
27868629|NCT02667587|54466980|FG000|End of Treatment|Disease progression|177|||
27868630|NCT02667587|54466981|FG001|End of Treatment|Disease progression|222|||
27868631|NCT02667587|54466980|FG000|End of Treatment|Lost to Follow-up|1|||
27868632|NCT02667587|54466981|FG001|End of Treatment|Lost to Follow-up|3|||
27868633|NCT02643966|54466987|FG000|First Screening Round|ineligible|1|||
27868634|NCT02643966|54466987|FG000|First Screening Round|excluded from analysis|2|||
27868635|NCT02643966|54466987|FG000|First Screening Round|Lost to Follow-up|56|||
27868636|NCT02643966|54466987|FG000|First Screening Round|Withdrawal by Subject|28|||
27868637|NCT02643966|54466987|FG000|First Screening Round|Death|1|||
27868638|NCT02643966|54466987|FG000|Between First and Second Screening|Lost to Follow-up|65|||
27868639|NCT02643966|54466987|FG000|Between First and Second Screening|Withdrawal by Subject|82|||
27868640|NCT02643966|54466987|FG000|Between First and Second Screening|women who skipped year 2 exam|11|||
27868641|NCT02643966|54466987|FG000|Second Screening Round|Withdrawal by Subject|20|||
27868642|NCT02643966|54466987|FG000|Second Screening Round|Lost to Follow-up|57|||
27868643|NCT02643966|54466987|FG000|Second Screening Round|Physician Decision|2|||
27868644|NCT02643966|54466987|FG000|Second Screening Round|Death|4|||
27868645|NCT02643966|54466987|FG000|Between Second and Third Screening|Lost to Follow-up|75|||
27868646|NCT02643966|54466987|FG000|Between Second and Third Screening|Death|1|||
27868647|NCT02643966|54466987|FG000|Between Second and Third Screening|Withdrawal by Subject|181|||
27868648|NCT02643966|54466987|FG000|Third Screening Round|PI excluded|2|||
27868649|NCT02643966|54466987|FG000|Third Screening Round|Lost to Follow-up|241|||
27868650|NCT02632409|54467001|FG000|Randomized|AE unrelated to study Drug|0|||
27868651|NCT02632409|54467002|FG001|Randomized|AE unrelated to study Drug|1|||
27868652|NCT02632409|54467001|FG000|Randomized|Participant withdrew consent|2|||
27868653|NCT02632409|54467002|FG001|Randomized|Participant withdrew consent|1|||
27868654|NCT02632409|54467001|FG000|Randomized|No Longer meets study criteria|5|||
27868655|NCT02632409|54467002|FG001|Randomized|No Longer meets study criteria|0|||
27868656|NCT02632409|54467001|FG000|Randomized|other reasons|1|||
27868657|NCT02632409|54467002|FG001|Randomized|other reasons|0|||
27868658|NCT02632409|54467001|FG000|Treatment Period|Ongoing Treatment|20|||
27868659|NCT02632409|54467002|FG001|Treatment Period|Ongoing Treatment|21|||
27868660|NCT02632409|54467001|FG000|Treatment Period|Disease Recurrence|147|||
27868661|NCT02632409|54467002|FG001|Treatment Period|Disease Recurrence|90|||
27868662|NCT02632409|54467001|FG000|Treatment Period|Study Drug Toxicity|8|||
27868663|NCT02632409|54467002|FG001|Treatment Period|Study Drug Toxicity|49|||
27868664|NCT02632409|54467001|FG000|Treatment Period|Death|1|||
27868665|NCT02632409|54467002|FG001|Treatment Period|Death|0|||
27868666|NCT02632409|54467001|FG000|Treatment Period|AE unrelated to study drug|15|||
27868667|NCT02632409|54467002|FG001|Treatment Period|AE unrelated to study drug|16|||
27868668|NCT02632409|54467001|FG000|Treatment Period|Request to discontinue treatment|4|||
27868669|NCT02632409|54467002|FG001|Treatment Period|Request to discontinue treatment|19|||
27868670|NCT02632409|54467001|FG000|Treatment Period|Participant withdrew consent|7|||
27868671|NCT02632409|54467002|FG001|Treatment Period|Participant withdrew consent|5|||
27868672|NCT02632409|54467001|FG000|Treatment Period|Lost to Follow-up|0|||
28096348|NCT03999554|54751242|FG002|Overall Study|Pregnancy|1|||
27835445|NCT01687595|54320214|FG001|Overall Study|Lost to Follow-up|1|||
27835446|NCT01687595|54320213|FG000|Overall Study|Investigator's decision|1|||
27835447|NCT01687595|54320214|FG001|Overall Study|Investigator's decision|0|||
27835448|NCT01687595|54320213|FG000|Overall Study|Sponsor's decision|1|||
27835449|NCT01687595|54320214|FG001|Overall Study|Sponsor's decision|0|||
27835450|NCT01687595|54320213|FG000|Overall Study|Noncompliance|1|||
27835451|NCT01687595|54320214|FG001|Overall Study|Noncompliance|2|||
27835452|NCT01687595|54320213|FG000|Overall Study|Other than specified|56|||
27835453|NCT01687595|54320214|FG001|Overall Study|Other than specified|7|||
27868673|NCT02632409|54467002|FG001|Treatment Period|Lost to Follow-up|1|||
27868674|NCT02632409|54467001|FG000|Treatment Period|Maximum clinical benefit|1|||
27868675|NCT02632409|54467002|FG001|Treatment Period|Maximum clinical benefit|0|||
27868676|NCT02632409|54467001|FG000|Treatment Period|No longer meets study criteria|3|||
27868677|NCT02632409|54467002|FG001|Treatment Period|No longer meets study criteria|0|||
27868678|NCT02632409|54467001|FG000|Treatment Period|Administrative Reason by sponsor|0|||
27868679|NCT02632409|54467002|FG001|Treatment Period|Administrative Reason by sponsor|1|||
27868680|NCT02632409|54467001|FG000|Treatment Period|Other Reasons|10|||
27868681|NCT02632409|54467002|FG001|Treatment Period|Other Reasons|6|||
27868682|NCT02554383|54467025|FG000|Overall Study|Ineligible|3|||
27868683|NCT02554383|54467026|FG001|Overall Study|Ineligible|2|||
27868684|NCT02554383|54467025|FG000|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|8|||
27868685|NCT02554383|54467026|FG001|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|6|||
27868686|NCT02554383|54467025|FG000|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|0|||
27868687|NCT02554383|54467026|FG001|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|2|||
27868688|NCT02554383|54467025|FG000|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|12|||
27868689|NCT02554383|54467026|FG001|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|9|||
27868690|NCT02522871|54467034|FG000|Overall Study|Protocol Violation|1|||
27868691|NCT02522871|54467035|FG001|Overall Study|Protocol Violation|4|||
27868692|NCT02522871|54467034|FG000|Overall Study|Treated without randomization|1|||
27868693|NCT02522871|54467035|FG001|Overall Study|Treated without randomization|0|||
27868694|NCT02522871|54467034|FG000|Overall Study|Death|9|||
27868695|NCT02522871|54467035|FG001|Overall Study|Death|9|||
27868696|NCT02522871|54467034|FG000|Overall Study|Died in operating room prior to transplant|0|||
27868697|NCT02522871|54467035|FG001|Overall Study|Died in operating room prior to transplant|1|||
27868698|NCT02519439|54467050|FG000|Overall Study|Study Termination|19|||
27868699|NCT02519439|54467050|FG000|Overall Study|Withdrawal by Subject|1|||
27868700|NCT02519439|54467050|FG000|Overall Study|Adverse Event|1|||
27868701|NCT02500797|54467062|FG000|Overall Study|Cancel (rapid disease progression)|0|||
27868702|NCT02500797|54467063|FG001|Overall Study|Cancel (rapid disease progression)|0|||
27868703|NCT02500797|54467064|FG002|Overall Study|Cancel (rapid disease progression)|0|||
27868704|NCT02500797|54467065|FG003|Overall Study|Cancel (rapid disease progression)|0|||
27868705|NCT02500797|54467066|FG004|Overall Study|Cancel (rapid disease progression)|1|||
27868706|NCT02500797|54467067|FG005|Overall Study|Cancel (rapid disease progression)|1|||
27868707|NCT02500797|54467068|FG006|Overall Study|Cancel (rapid disease progression)|0|||
27868708|NCT02500797|54467069|FG007|Overall Study|Cancel (rapid disease progression)|0|||
27868709|NCT02500797|54467062|FG000|Overall Study|Withdrawal by Subject|1|||
27868710|NCT02500797|54467063|FG001|Overall Study|Withdrawal by Subject|0|||
27868711|NCT02500797|54467064|FG002|Overall Study|Withdrawal by Subject|0|||
27868712|NCT02500797|54467065|FG003|Overall Study|Withdrawal by Subject|0|||
27868713|NCT02500797|54467066|FG004|Overall Study|Withdrawal by Subject|0|||
27868714|NCT02500797|54467067|FG005|Overall Study|Withdrawal by Subject|0|||
27868715|NCT02500797|54467068|FG006|Overall Study|Withdrawal by Subject|0|||
27868716|NCT02500797|54467069|FG007|Overall Study|Withdrawal by Subject|0|||
27868717|NCT02147184|54467100|FG000|Overall Study|Lost to Follow-up|28|||
27868718|NCT02147184|54467101|FG001|Overall Study|Lost to Follow-up|15|||
27868719|NCT02147184|54467100|FG000|Overall Study|Study Burden|11|||
27868720|NCT02147184|54467101|FG001|Overall Study|Study Burden|7|||
27868721|NCT02147184|54467100|FG000|Overall Study|Pregnancy|6|||
27868722|NCT02147184|54467101|FG001|Overall Study|Pregnancy|0|||
27868723|NCT02147184|54467100|FG000|Overall Study|Moved out of state|3|||
27868724|NCT02147184|54467101|FG001|Overall Study|Moved out of state|3|||
27868725|NCT02147184|54467100|FG000|Overall Study|Physician Decision|0|||
27868726|NCT02147184|54467101|FG001|Overall Study|Physician Decision|2|||
27868727|NCT02147184|54467100|FG000|Overall Study|Other|1|||
27868728|NCT02147184|54467101|FG001|Overall Study|Other|0|||
27868729|NCT02101021|54467112|FG000|Overall Study|Death|4|||
27868730|NCT02101021|54467113|FG001|Overall Study|Death|3|||
27982302|NCT01856192|54640348|FG000|Overall Study|Never started treatment|7|||
27982303|NCT01856192|54640349|FG001|Overall Study|Never started treatment|5|||
27982304|NCT01856192|54640348|FG000|Overall Study|Path ineligible|20|||
27982305|NCT01856192|54640349|FG001|Overall Study|Path ineligible|34|||
27982306|NCT01856192|54640348|FG000|Overall Study|Non-path ineligible|2|||
27868731|NCT02101021|54467114|FG002|Overall Study|Death|6|||
27982307|NCT01856192|54640349|FG001|Overall Study|Non-path ineligible|2|||
27868732|NCT02101021|54467115|FG003|Overall Study|Death|0|||
27868733|NCT02101021|54467116|FG004|Overall Study|Death|3|||
27868734|NCT02101021|54467112|FG000|Overall Study|Withdrew Consent from study|1|||
27868735|NCT02101021|54467113|FG001|Overall Study|Withdrew Consent from study|1|||
27868736|NCT02101021|54467114|FG002|Overall Study|Withdrew Consent from study|0|||
27982308|NCT01856192|54640348|FG000|Overall Study|Physician Decision|1|||
27868737|NCT02101021|54467115|FG003|Overall Study|Withdrew Consent from study|2|||
27868738|NCT02101021|54467116|FG004|Overall Study|Withdrew Consent from study|0|||
27868739|NCT02101021|54467112|FG000|Overall Study|Lost to Follow-up|1|||
27868740|NCT02101021|54467113|FG001|Overall Study|Lost to Follow-up|0|||
27982309|NCT01856192|54640349|FG001|Overall Study|Physician Decision|1|||
28096349|NCT03999554|54751243|FG003|Overall Study|Pregnancy|0|||
28096350|NCT03999554|54751244|FG004|Overall Study|Pregnancy|0|||
28096351|NCT03999554|54751240|FG000|Overall Study|Withdrawal by Subject|2|||
28096352|NCT03999554|54751241|FG001|Overall Study|Withdrawal by Subject|2|||
27835454|NCT01687283|54320222|FG000|Overall Study|Adverse Event|11|||
27835455|NCT01687283|54320223|FG001|Overall Study|Adverse Event|4|||
27835456|NCT01687283|54320222|FG000|Overall Study|Lack of Efficacy|3|||
27835457|NCT01687283|54320223|FG001|Overall Study|Lack of Efficacy|1|||
27835458|NCT01687283|54320222|FG000|Overall Study|Protocol Violation|1|||
27835459|NCT01687283|54320223|FG001|Overall Study|Protocol Violation|3|||
27835460|NCT01687283|54320222|FG000|Overall Study|protocol defined stopping criteria|8|||
27835461|NCT01687283|54320223|FG001|Overall Study|protocol defined stopping criteria|10|||
27835462|NCT01687283|54320222|FG000|Overall Study|Lost to Follow-up|1|||
27835463|NCT01687283|54320223|FG001|Overall Study|Lost to Follow-up|1|||
27835464|NCT01687283|54320222|FG000|Overall Study|Investigator discretion|2|||
27835465|NCT01687283|54320223|FG001|Overall Study|Investigator discretion|0|||
27835466|NCT01687283|54320222|FG000|Overall Study|Withdrawal by Subject|9|||
27835467|NCT01687283|54320223|FG001|Overall Study|Withdrawal by Subject|8|||
27835468|NCT02684370|54320232|FG000|Part A|Adverse Event|2|||
27835469|NCT02684370|54320233|FG001|Part A|Adverse Event|0|||
27835470|NCT02684370|54320234|FG002|Part A|Adverse Event|1|||
27835471|NCT02684370|54320235|FG003|Part A|Adverse Event|0|||
27835472|NCT02684370|54320236|FG004|Part A|Adverse Event|0|||
27835473|NCT02684370|54320237|FG005|Part A|Adverse Event|0|||
27835474|NCT02684370|54320232|FG000|Part A|Lost to Follow-up|1|||
27835475|NCT02684370|54320233|FG001|Part A|Lost to Follow-up|1|||
27835476|NCT02684370|54320234|FG002|Part A|Lost to Follow-up|0|||
27835477|NCT02684370|54320235|FG003|Part A|Lost to Follow-up|0|||
27835478|NCT02684370|54320236|FG004|Part A|Lost to Follow-up|0|||
27835479|NCT02684370|54320237|FG005|Part A|Lost to Follow-up|0|||
27835480|NCT02684370|54320232|FG000|Part A|Subject Withdrawal|1|||
27835481|NCT02684370|54320233|FG001|Part A|Subject Withdrawal|0|||
27835482|NCT02684370|54320234|FG002|Part A|Subject Withdrawal|3|||
27835483|NCT02684370|54320235|FG003|Part A|Subject Withdrawal|0|||
27835484|NCT02684370|54320236|FG004|Part A|Subject Withdrawal|0|||
27835485|NCT02684370|54320237|FG005|Part A|Subject Withdrawal|0|||
27835486|NCT02684370|54320232|FG000|Part A|Other|0|||
27835487|NCT02684370|54320233|FG001|Part A|Other|0|||
27835488|NCT02684370|54320234|FG002|Part A|Other|1|||
27835489|NCT02684370|54320235|FG003|Part A|Other|0|||
27835490|NCT02684370|54320236|FG004|Part A|Other|0|||
27835491|NCT02684370|54320237|FG005|Part A|Other|0|||
27835492|NCT02684370|54320232|FG000|Part B|Adverse Event|0|||
27835493|NCT02684370|54320233|FG001|Part B|Adverse Event|0|||
27835494|NCT02684370|54320234|FG002|Part B|Adverse Event|0|||
27835495|NCT02684370|54320235|FG003|Part B|Adverse Event|0|||
27835496|NCT02684370|54320236|FG004|Part B|Adverse Event|2|||
27835497|NCT02684370|54320237|FG005|Part B|Adverse Event|1|||
27835498|NCT02684370|54320232|FG000|Part B|Lost to Follow-up|0|||
27835499|NCT02684370|54320233|FG001|Part B|Lost to Follow-up|0|||
27835500|NCT02684370|54320234|FG002|Part B|Lost to Follow-up|0|||
27835501|NCT02684370|54320235|FG003|Part B|Lost to Follow-up|1|||
27835502|NCT02684370|54320236|FG004|Part B|Lost to Follow-up|2|||
27835503|NCT02684370|54320237|FG005|Part B|Lost to Follow-up|5|||
27835504|NCT02684370|54320232|FG000|Part B|Subject Withdrawal|0|||
27835505|NCT02684370|54320233|FG001|Part B|Subject Withdrawal|0|||
27835506|NCT02684370|54320234|FG002|Part B|Subject Withdrawal|0|||
27835507|NCT02684370|54320235|FG003|Part B|Subject Withdrawal|1|||
27835508|NCT02684370|54320236|FG004|Part B|Subject Withdrawal|1|||
27835509|NCT02684370|54320237|FG005|Part B|Subject Withdrawal|2|||
27835510|NCT01686581|54320264|FG000|Overall Study|Side-effects or Health Problems|15|||
27835511|NCT01686581|54320264|FG000|Overall Study|Lack of Efficacy|90|||
27835512|NCT01686581|54320264|FG000|Overall Study|Participant Concerned about Risks|6|||
27835513|NCT01686581|54320264|FG000|Overall Study|Thinks Injections Too Painful|8|||
27835514|NCT01686581|54320264|FG000|Overall Study|Thinks Injections Take Too Much Time|2|||
27835515|NCT01686581|54320264|FG000|Overall Study|Trying to get Pregnant or Nursing|2|||
27835516|NCT01686581|54320264|FG000|Overall Study|Thinks it is Inconvenient|17|||
27835517|NCT01686581|54320264|FG000|Overall Study|Other Miscellaneous Reasons|36|||
27835518|NCT01686581|54320264|FG000|Overall Study|Reason Missing|1|||
27835519|NCT02691936|54320282|FG000|Overall Study|Withdrawal by Subject|2|||
27835520|NCT02691936|54320283|FG001|Overall Study|Withdrawal by Subject|5|||
27835521|NCT01685801|54320330|FG000|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
27835522|NCT01685801|54320331|FG001|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
27835523|NCT01685801|54320332|FG002|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
27835524|NCT01685801|54320333|FG003|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1|||
27835525|NCT01685801|54320330|FG000|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
27835526|NCT01685801|54320331|FG001|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
27835527|NCT01685801|54320332|FG002|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
27868741|NCT02101021|54467114|FG002|Overall Study|Lost to Follow-up|0|||
27868742|NCT02101021|54467115|FG003|Overall Study|Lost to Follow-up|0|||
27868743|NCT02101021|54467116|FG004|Overall Study|Lost to Follow-up|0|||
27868744|NCT02101021|54467112|FG000|Overall Study|Study Terminated by Sponsor|1|||
27868745|NCT02101021|54467113|FG001|Overall Study|Study Terminated by Sponsor|0|||
27868746|NCT02101021|54467114|FG002|Overall Study|Study Terminated by Sponsor|1|||
27868747|NCT02101021|54467115|FG003|Overall Study|Study Terminated by Sponsor|1|||
27868748|NCT02101021|54467116|FG004|Overall Study|Study Terminated by Sponsor|1|||
27868749|NCT02031536|54467141|FG000|Overall Study|ineligible|1|||
27868750|NCT02031536|54467142|FG001|Overall Study|ineligible|0|||
27868751|NCT02028455|54467156|FG000|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
27868752|NCT02028455|54467157|FG001|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
27868753|NCT02028455|54467158|FG002|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
27868754|NCT02028455|54467159|FG003|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
27868755|NCT02028455|54467160|FG004|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
27868756|NCT02028455|54467161|FG005|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
27868757|NCT02028455|54467162|FG006|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|4|||
27868758|NCT02028455|54467163|FG007|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|17|||
27868759|NCT02028455|54467156|FG000|Treatment(T Cell Infusion) and Follow up|Death|4|||
27868760|NCT02028455|54467157|FG001|Treatment(T Cell Infusion) and Follow up|Death|9|||
27868761|NCT02028455|54467158|FG002|Treatment(T Cell Infusion) and Follow up|Death|3|||
27868762|NCT02028455|54467159|FG003|Treatment(T Cell Infusion) and Follow up|Death|5|||
27868763|NCT02028455|54467160|FG004|Treatment(T Cell Infusion) and Follow up|Death|3|||
27868764|NCT02028455|54467161|FG005|Treatment(T Cell Infusion) and Follow up|Death|2|||
27868765|NCT02028455|54467162|FG006|Treatment(T Cell Infusion) and Follow up|Death|0|||
27868766|NCT02028455|54467163|FG007|Treatment(T Cell Infusion) and Follow up|Death|40|||
27868767|NCT02028455|54467156|FG000|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
27868768|NCT02028455|54467157|FG001|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
27868769|NCT02028455|54467158|FG002|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
27868770|NCT02028455|54467159|FG003|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
27868771|NCT02028455|54467160|FG004|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
27868772|NCT02028455|54467161|FG005|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|1|||
27868773|NCT02028455|54467162|FG006|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
27868774|NCT02028455|54467163|FG007|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|2|||
27868775|NCT02028455|54467156|FG000|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
27868776|NCT02028455|54467157|FG001|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
27868777|NCT02028455|54467158|FG002|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|4|||
27868778|NCT02028455|54467159|FG003|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
27868779|NCT02028455|54467160|FG004|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
27868780|NCT02028455|54467161|FG005|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
27868781|NCT02028455|54467162|FG006|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
27868782|NCT02028455|54467163|FG007|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|61|||
27868783|NCT02019641|54467187|FG000|10-Week Follow up|Withdrawal by investigator|2|||
27868784|NCT02019641|54467188|FG001|10-Week Follow up|Withdrawal by investigator|0|||
27868785|NCT02019641|54467189|FG002|10-Week Follow up|Withdrawal by investigator|0|||
27868786|NCT02019641|54467187|FG000|10-Week Follow up|Withdrawal by Subject|1|||
27868787|NCT02019641|54467188|FG001|10-Week Follow up|Withdrawal by Subject|1|||
27868788|NCT02019641|54467189|FG002|10-Week Follow up|Withdrawal by Subject|0|||
27868789|NCT02019641|54467187|FG000|20-Week Follow up|Withdrawal by investigator|0|||
27868790|NCT02019641|54467188|FG001|20-Week Follow up|Withdrawal by investigator|0|||
27868791|NCT02019641|54467189|FG002|20-Week Follow up|Withdrawal by investigator|1|||
27868792|NCT01964430|54467198|FG000|Pre-Treatment (Randomization) Period|Protocol Deviation|0|||
27868793|NCT01964430|54467199|FG001|Pre-Treatment (Randomization) Period|Protocol Deviation|2|||
27868794|NCT01964430|54467198|FG000|Pre-Treatment (Randomization) Period|Withdrawal by Subject|2|||
27868795|NCT01964430|54467199|FG001|Pre-Treatment (Randomization) Period|Withdrawal by Subject|9|||
27868796|NCT01964430|54467198|FG000|Pre-Treatment (Randomization) Period|Adverse Event|1|||
27868797|NCT01964430|54467199|FG001|Pre-Treatment (Randomization) Period|Adverse Event|0|||
27868798|NCT01964430|54467198|FG000|Treatment Period|Adverse Event|71|||
27868799|NCT01964430|54467199|FG001|Treatment Period|Adverse Event|37|||
27868800|NCT01964430|54467198|FG000|Treatment Period|Withdrawal by Subject|36|||
27868801|NCT01964430|54467199|FG001|Treatment Period|Withdrawal by Subject|27|||
27868802|NCT01964430|54467198|FG000|Treatment Period|Death|1|||
27738994|NCT02240368|54188258|FG001|Overall Study|Entropy failed to detect more than 50%|0|||
27868803|NCT01964430|54467199|FG001|Treatment Period|Death|3|||
27868804|NCT01964430|54467198|FG000|Treatment Period|Protocol Deviation|0|||
27868805|NCT01964430|54467199|FG001|Treatment Period|Protocol Deviation|1|||
27868806|NCT01964430|54467198|FG000|Treatment Period|Physician Decision|5|||
27868807|NCT01964430|54467199|FG001|Treatment Period|Physician Decision|4|||
27868808|NCT01964430|54467198|FG000|Treatment Period|Disease Relapse|28|||
27868809|NCT01964430|54467199|FG001|Treatment Period|Disease Relapse|38|||
27868810|NCT01964430|54467198|FG000|Treatment Period|Other reasons|1|||
27868811|NCT01964430|54467199|FG001|Treatment Period|Other reasons|3|||
27868812|NCT01928394|54467228|FG000|Treatment Period|Disease progression|17|||
27868813|NCT01928394|54467229|FG001|Treatment Period|Disease progression|2|||
27868814|NCT01928394|54467230|FG002|Treatment Period|Disease progression|12|||
27868815|NCT01928394|54467231|FG003|Treatment Period|Disease progression|48|||
27868816|NCT01928394|54467232|FG004|Treatment Period|Disease progression|3|||
27868817|NCT01928394|54467233|FG005|Treatment Period|Disease progression|25|||
27868818|NCT01928394|54467234|FG006|Treatment Period|Disease progression|38|||
27868819|NCT01928394|54467235|FG007|Treatment Period|Disease progression|16|||
27868820|NCT01928394|54467236|FG008|Treatment Period|Disease progression|3|||
27868821|NCT01928394|54467237|FG009|Treatment Period|Disease progression|11|||
27868822|NCT01928394|54467238|FG010|Treatment Period|Disease progression|22|||
27868823|NCT01928394|54467239|FG011|Treatment Period|Disease progression|73|||
27868824|NCT01928394|54467240|FG012|Treatment Period|Disease progression|38|||
27868825|NCT01928394|54467241|FG013|Treatment Period|Disease progression|118|||
27868826|NCT01928394|54467242|FG014|Treatment Period|Disease progression|59|||
27868827|NCT01928394|54467243|FG015|Treatment Period|Disease progression|1|||
27868828|NCT01928394|54467244|FG016|Treatment Period|Disease progression|43|||
27868829|NCT01928394|54467245|FG017|Treatment Period|Disease progression|56|||
27868830|NCT01928394|54467246|FG018|Treatment Period|Disease progression|50|||
27868831|NCT01928394|54467247|FG019|Treatment Period|Disease progression|71|||
27868832|NCT01928394|54467248|FG020|Treatment Period|Disease progression|30|||
27868833|NCT01928394|54467249|FG021|Treatment Period|Disease progression|31|||
27868834|NCT01928394|54467250|FG022|Treatment Period|Disease progression|31|||
27868835|NCT01928394|54467228|FG000|Treatment Period|Study drug toxicity|1|||
27868836|NCT01928394|54467229|FG001|Treatment Period|Study drug toxicity|1|||
27868837|NCT01928394|54467230|FG002|Treatment Period|Study drug toxicity|3|||
27868838|NCT01928394|54467231|FG003|Treatment Period|Study drug toxicity|3|||
27868839|NCT01928394|54467232|FG004|Treatment Period|Study drug toxicity|0|||
27868840|NCT01928394|54467233|FG005|Treatment Period|Study drug toxicity|9|||
27868841|NCT01928394|54467234|FG006|Treatment Period|Study drug toxicity|7|||
27868842|NCT01928394|54467235|FG007|Treatment Period|Study drug toxicity|1|||
27868843|NCT01928394|54467236|FG008|Treatment Period|Study drug toxicity|0|||
27868844|NCT01928394|54467237|FG009|Treatment Period|Study drug toxicity|5|||
27868845|NCT01928394|54467238|FG010|Treatment Period|Study drug toxicity|2|||
27868846|NCT01928394|54467239|FG011|Treatment Period|Study drug toxicity|3|||
27868847|NCT01928394|54467240|FG012|Treatment Period|Study drug toxicity|7|||
27868848|NCT01928394|54467241|FG013|Treatment Period|Study drug toxicity|5|||
27868849|NCT01928394|54467242|FG014|Treatment Period|Study drug toxicity|12|||
27868850|NCT01928394|54467243|FG015|Treatment Period|Study drug toxicity|0|||
27868851|NCT01928394|54467244|FG016|Treatment Period|Study drug toxicity|3|||
27868852|NCT01928394|54467245|FG017|Treatment Period|Study drug toxicity|3|||
27868853|NCT01928394|54467246|FG018|Treatment Period|Study drug toxicity|12|||
27868854|NCT01928394|54467247|FG019|Treatment Period|Study drug toxicity|15|||
27868855|NCT01928394|54467248|FG020|Treatment Period|Study drug toxicity|4|||
27868856|NCT01928394|54467249|FG021|Treatment Period|Study drug toxicity|7|||
27868857|NCT01928394|54467250|FG022|Treatment Period|Study drug toxicity|4|||
27868858|NCT01928394|54467228|FG000|Treatment Period|AE unrelated to study drug|0|||
27868859|NCT01928394|54467229|FG001|Treatment Period|AE unrelated to study drug|0|||
27868860|NCT01928394|54467230|FG002|Treatment Period|AE unrelated to study drug|2|||
27868861|NCT01928394|54467231|FG003|Treatment Period|AE unrelated to study drug|3|||
27868862|NCT01928394|54467232|FG004|Treatment Period|AE unrelated to study drug|0|||
27868863|NCT01928394|54467233|FG005|Treatment Period|AE unrelated to study drug|5|||
27868864|NCT01928394|54467234|FG006|Treatment Period|AE unrelated to study drug|1|||
27868865|NCT01928394|54467235|FG007|Treatment Period|AE unrelated to study drug|0|||
27868866|NCT01928394|54467236|FG008|Treatment Period|AE unrelated to study drug|0|||
27982310|NCT01856192|54640348|FG000|Overall Study|Suspicion of progressive disease|1|||
27982311|NCT01856192|54640349|FG001|Overall Study|Suspicion of progressive disease|0|||
27982312|NCT01856192|54640348|FG000|Overall Study|Non-compliance|1|||
28171395|NCT02471404|54842973|FG002|Overall Study|Lost to Follow-up|3|||
27868867|NCT01928394|54467237|FG009|Treatment Period|AE unrelated to study drug|2|||
27868868|NCT01928394|54467238|FG010|Treatment Period|AE unrelated to study drug|0|||
27868869|NCT01928394|54467239|FG011|Treatment Period|AE unrelated to study drug|12|||
27868870|NCT01928394|54467240|FG012|Treatment Period|AE unrelated to study drug|6|||
27868871|NCT01928394|54467241|FG013|Treatment Period|AE unrelated to study drug|13|||
27868872|NCT01928394|54467242|FG014|Treatment Period|AE unrelated to study drug|6|||
27868873|NCT01928394|54467243|FG015|Treatment Period|AE unrelated to study drug|1|||
27868874|NCT01928394|54467244|FG016|Treatment Period|AE unrelated to study drug|1|||
27868875|NCT01928394|54467245|FG017|Treatment Period|AE unrelated to study drug|6|||
27868876|NCT01928394|54467246|FG018|Treatment Period|AE unrelated to study drug|3|||
27868877|NCT01928394|54467247|FG019|Treatment Period|AE unrelated to study drug|5|||
27868878|NCT01928394|54467248|FG020|Treatment Period|AE unrelated to study drug|1|||
27868879|NCT01928394|54467249|FG021|Treatment Period|AE unrelated to study drug|1|||
27868880|NCT01928394|54467250|FG022|Treatment Period|AE unrelated to study drug|0|||
27868881|NCT01928394|54467228|FG000|Treatment Period|Participant request to stop therapy|0|||
27868882|NCT01928394|54467229|FG001|Treatment Period|Participant request to stop therapy|0|||
27868883|NCT01928394|54467230|FG002|Treatment Period|Participant request to stop therapy|0|||
27868884|NCT01928394|54467231|FG003|Treatment Period|Participant request to stop therapy|0|||
27868885|NCT01928394|54467232|FG004|Treatment Period|Participant request to stop therapy|0|||
27868886|NCT01928394|54467233|FG005|Treatment Period|Participant request to stop therapy|3|||
27868887|NCT01928394|54467234|FG006|Treatment Period|Participant request to stop therapy|3|||
27868888|NCT01928394|54467235|FG007|Treatment Period|Participant request to stop therapy|0|||
27868889|NCT01928394|54467236|FG008|Treatment Period|Participant request to stop therapy|0|||
27868890|NCT01928394|54467237|FG009|Treatment Period|Participant request to stop therapy|0|||
27868891|NCT01928394|54467238|FG010|Treatment Period|Participant request to stop therapy|3|||
27868892|NCT01928394|54467239|FG011|Treatment Period|Participant request to stop therapy|2|||
27868893|NCT01928394|54467240|FG012|Treatment Period|Participant request to stop therapy|1|||
27868894|NCT01928394|54467241|FG013|Treatment Period|Participant request to stop therapy|2|||
27868895|NCT01928394|54467242|FG014|Treatment Period|Participant request to stop therapy|4|||
27868896|NCT01928394|54467243|FG015|Treatment Period|Participant request to stop therapy|0|||
27868897|NCT01928394|54467244|FG016|Treatment Period|Participant request to stop therapy|1|||
27868898|NCT01928394|54467245|FG017|Treatment Period|Participant request to stop therapy|3|||
27868899|NCT01928394|54467246|FG018|Treatment Period|Participant request to stop therapy|1|||
27868900|NCT01928394|54467247|FG019|Treatment Period|Participant request to stop therapy|1|||
27868901|NCT01928394|54467248|FG020|Treatment Period|Participant request to stop therapy|3|||
27868902|NCT01928394|54467249|FG021|Treatment Period|Participant request to stop therapy|1|||
27868903|NCT01928394|54467250|FG022|Treatment Period|Participant request to stop therapy|3|||
27868904|NCT01928394|54467228|FG000|Treatment Period|Participant withdrew consent|0|||
27868905|NCT01928394|54467229|FG001|Treatment Period|Participant withdrew consent|0|||
27868906|NCT01928394|54467230|FG002|Treatment Period|Participant withdrew consent|1|||
27868907|NCT01928394|54467231|FG003|Treatment Period|Participant withdrew consent|1|||
27868908|NCT01928394|54467232|FG004|Treatment Period|Participant withdrew consent|0|||
27868909|NCT01928394|54467233|FG005|Treatment Period|Participant withdrew consent|1|||
27868910|NCT01928394|54467234|FG006|Treatment Period|Participant withdrew consent|0|||
27868911|NCT01928394|54467235|FG007|Treatment Period|Participant withdrew consent|1|||
27868912|NCT01928394|54467236|FG008|Treatment Period|Participant withdrew consent|0|||
27868913|NCT01928394|54467237|FG009|Treatment Period|Participant withdrew consent|0|||
27868914|NCT01928394|54467238|FG010|Treatment Period|Participant withdrew consent|1|||
27868915|NCT01928394|54467239|FG011|Treatment Period|Participant withdrew consent|1|||
27868916|NCT01928394|54467240|FG012|Treatment Period|Participant withdrew consent|1|||
27868917|NCT01928394|54467241|FG013|Treatment Period|Participant withdrew consent|0|||
27868918|NCT01928394|54467242|FG014|Treatment Period|Participant withdrew consent|2|||
27868919|NCT01928394|54467243|FG015|Treatment Period|Participant withdrew consent|0|||
27868920|NCT01928394|54467244|FG016|Treatment Period|Participant withdrew consent|2|||
27868921|NCT01928394|54467245|FG017|Treatment Period|Participant withdrew consent|1|||
27868922|NCT01928394|54467246|FG018|Treatment Period|Participant withdrew consent|1|||
27868923|NCT01928394|54467247|FG019|Treatment Period|Participant withdrew consent|1|||
27868924|NCT01928394|54467248|FG020|Treatment Period|Participant withdrew consent|0|||
27868925|NCT01928394|54467249|FG021|Treatment Period|Participant withdrew consent|2|||
27868926|NCT01928394|54467250|FG022|Treatment Period|Participant withdrew consent|0|||
27868927|NCT01928394|54467228|FG000|Treatment Period|Poor/non-compliance|0|||
27868928|NCT01928394|54467229|FG001|Treatment Period|Poor/non-compliance|0|||
27868929|NCT01928394|54467230|FG002|Treatment Period|Poor/non-compliance|0|||
27868930|NCT01928394|54467231|FG003|Treatment Period|Poor/non-compliance|1|||
27868931|NCT01928394|54467232|FG004|Treatment Period|Poor/non-compliance|0|||
27868932|NCT01928394|54467233|FG005|Treatment Period|Poor/non-compliance|0|||
27868933|NCT01928394|54467234|FG006|Treatment Period|Poor/non-compliance|0|||
27868934|NCT01928394|54467235|FG007|Treatment Period|Poor/non-compliance|0|||
27868935|NCT01928394|54467236|FG008|Treatment Period|Poor/non-compliance|0|||
27868936|NCT01928394|54467237|FG009|Treatment Period|Poor/non-compliance|0|||
27868937|NCT01928394|54467238|FG010|Treatment Period|Poor/non-compliance|0|||
27868938|NCT01928394|54467239|FG011|Treatment Period|Poor/non-compliance|0|||
27868939|NCT01928394|54467240|FG012|Treatment Period|Poor/non-compliance|1|||
27868940|NCT01928394|54467241|FG013|Treatment Period|Poor/non-compliance|0|||
27868941|NCT01928394|54467242|FG014|Treatment Period|Poor/non-compliance|1|||
27868942|NCT01928394|54467243|FG015|Treatment Period|Poor/non-compliance|0|||
27868943|NCT01928394|54467244|FG016|Treatment Period|Poor/non-compliance|0|||
27868944|NCT01928394|54467245|FG017|Treatment Period|Poor/non-compliance|1|||
27868945|NCT01928394|54467246|FG018|Treatment Period|Poor/non-compliance|0|||
27868946|NCT01928394|54467247|FG019|Treatment Period|Poor/non-compliance|1|||
27868947|NCT01928394|54467248|FG020|Treatment Period|Poor/non-compliance|0|||
27868948|NCT01928394|54467249|FG021|Treatment Period|Poor/non-compliance|0|||
27868949|NCT01928394|54467250|FG022|Treatment Period|Poor/non-compliance|0|||
27868950|NCT01928394|54467228|FG000|Treatment Period|other reason|0|||
27868951|NCT01928394|54467229|FG001|Treatment Period|other reason|0|||
27868952|NCT01928394|54467230|FG002|Treatment Period|other reason|0|||
27868953|NCT01928394|54467231|FG003|Treatment Period|other reason|0|||
27868954|NCT01928394|54467232|FG004|Treatment Period|other reason|0|||
27868955|NCT01928394|54467233|FG005|Treatment Period|other reason|0|||
27868956|NCT01928394|54467234|FG006|Treatment Period|other reason|0|||
27868957|NCT01928394|54467235|FG007|Treatment Period|other reason|0|||
27868958|NCT01928394|54467236|FG008|Treatment Period|other reason|0|||
27868959|NCT01928394|54467237|FG009|Treatment Period|other reason|0|||
27868960|NCT01928394|54467238|FG010|Treatment Period|other reason|1|||
27868961|NCT01928394|54467239|FG011|Treatment Period|other reason|1|||
27868962|NCT01928394|54467240|FG012|Treatment Period|other reason|1|||
27868963|NCT01928394|54467241|FG013|Treatment Period|other reason|0|||
27868964|NCT01928394|54467242|FG014|Treatment Period|other reason|1|||
27868965|NCT01928394|54467243|FG015|Treatment Period|other reason|0|||
27868966|NCT01928394|54467244|FG016|Treatment Period|other reason|0|||
27868967|NCT01928394|54467245|FG017|Treatment Period|other reason|0|||
27868968|NCT01928394|54467246|FG018|Treatment Period|other reason|2|||
27868969|NCT01928394|54467247|FG019|Treatment Period|other reason|2|||
27868970|NCT01928394|54467248|FG020|Treatment Period|other reason|0|||
27868971|NCT01928394|54467249|FG021|Treatment Period|other reason|0|||
27868972|NCT01928394|54467250|FG022|Treatment Period|other reason|0|||
27868973|NCT01928394|54467228|FG000|Treatment Period|Maximum clinical benefit|0|||
27868974|NCT01928394|54467229|FG001|Treatment Period|Maximum clinical benefit|0|||
27868975|NCT01928394|54467230|FG002|Treatment Period|Maximum clinical benefit|0|||
27868976|NCT01928394|54467231|FG003|Treatment Period|Maximum clinical benefit|0|||
27868977|NCT01928394|54467232|FG004|Treatment Period|Maximum clinical benefit|0|||
27868978|NCT01928394|54467233|FG005|Treatment Period|Maximum clinical benefit|0|||
27868979|NCT01928394|54467234|FG006|Treatment Period|Maximum clinical benefit|0|||
27868980|NCT01928394|54467235|FG007|Treatment Period|Maximum clinical benefit|0|||
27868981|NCT01928394|54467236|FG008|Treatment Period|Maximum clinical benefit|0|||
27868982|NCT01928394|54467237|FG009|Treatment Period|Maximum clinical benefit|0|||
27868983|NCT01928394|54467238|FG010|Treatment Period|Maximum clinical benefit|1|||
27868984|NCT01928394|54467239|FG011|Treatment Period|Maximum clinical benefit|1|||
27868985|NCT01928394|54467240|FG012|Treatment Period|Maximum clinical benefit|0|||
27868986|NCT01928394|54467241|FG013|Treatment Period|Maximum clinical benefit|0|||
27868987|NCT01928394|54467242|FG014|Treatment Period|Maximum clinical benefit|1|||
27868988|NCT01928394|54467243|FG015|Treatment Period|Maximum clinical benefit|0|||
27868989|NCT01928394|54467244|FG016|Treatment Period|Maximum clinical benefit|0|||
27868990|NCT01928394|54467245|FG017|Treatment Period|Maximum clinical benefit|1|||
27868991|NCT01928394|54467246|FG018|Treatment Period|Maximum clinical benefit|1|||
27868992|NCT01928394|54467247|FG019|Treatment Period|Maximum clinical benefit|0|||
27868993|NCT01928394|54467248|FG020|Treatment Period|Maximum clinical benefit|2|||
27868994|NCT01928394|54467249|FG021|Treatment Period|Maximum clinical benefit|0|||
27868995|NCT01928394|54467250|FG022|Treatment Period|Maximum clinical benefit|0|||
27868996|NCT01928394|54467228|FG000|Treatment Period|Lost to Follow-up|0|||
27868997|NCT01928394|54467229|FG001|Treatment Period|Lost to Follow-up|0|||
27868998|NCT01928394|54467230|FG002|Treatment Period|Lost to Follow-up|0|||
27868999|NCT01928394|54467231|FG003|Treatment Period|Lost to Follow-up|0|||
27869000|NCT01928394|54467232|FG004|Treatment Period|Lost to Follow-up|0|||
27869001|NCT01928394|54467233|FG005|Treatment Period|Lost to Follow-up|0|||
27869002|NCT01928394|54467234|FG006|Treatment Period|Lost to Follow-up|0|||
27869003|NCT01928394|54467235|FG007|Treatment Period|Lost to Follow-up|0|||
27869004|NCT01928394|54467236|FG008|Treatment Period|Lost to Follow-up|0|||
27869005|NCT01928394|54467237|FG009|Treatment Period|Lost to Follow-up|0|||
27869006|NCT01928394|54467238|FG010|Treatment Period|Lost to Follow-up|0|||
27869007|NCT01928394|54467239|FG011|Treatment Period|Lost to Follow-up|0|||
27869008|NCT01928394|54467240|FG012|Treatment Period|Lost to Follow-up|0|||
27869009|NCT01928394|54467241|FG013|Treatment Period|Lost to Follow-up|0|||
27869010|NCT01928394|54467242|FG014|Treatment Period|Lost to Follow-up|0|||
27869011|NCT01928394|54467243|FG015|Treatment Period|Lost to Follow-up|0|||
27869012|NCT01928394|54467244|FG016|Treatment Period|Lost to Follow-up|0|||
27869013|NCT01928394|54467245|FG017|Treatment Period|Lost to Follow-up|0|||
27869014|NCT01928394|54467246|FG018|Treatment Period|Lost to Follow-up|0|||
27869015|NCT01928394|54467247|FG019|Treatment Period|Lost to Follow-up|0|||
27869016|NCT01928394|54467248|FG020|Treatment Period|Lost to Follow-up|0|||
27869017|NCT01928394|54467249|FG021|Treatment Period|Lost to Follow-up|0|||
27869018|NCT01928394|54467250|FG022|Treatment Period|Lost to Follow-up|1|||
27869019|NCT01928394|54467228|FG000|Treatment Period|Death|0|||
27869020|NCT01928394|54467229|FG001|Treatment Period|Death|0|||
27869021|NCT01928394|54467230|FG002|Treatment Period|Death|0|||
27869022|NCT01928394|54467231|FG003|Treatment Period|Death|0|||
27869023|NCT01928394|54467232|FG004|Treatment Period|Death|0|||
27869024|NCT01928394|54467233|FG005|Treatment Period|Death|0|||
27869025|NCT01928394|54467234|FG006|Treatment Period|Death|0|||
27869026|NCT01928394|54467235|FG007|Treatment Period|Death|0|||
27869027|NCT01928394|54467236|FG008|Treatment Period|Death|0|||
27869028|NCT01928394|54467237|FG009|Treatment Period|Death|0|||
27869029|NCT01928394|54467238|FG010|Treatment Period|Death|0|||
27869030|NCT01928394|54467239|FG011|Treatment Period|Death|0|||
27869031|NCT01928394|54467240|FG012|Treatment Period|Death|0|||
27869032|NCT01928394|54467241|FG013|Treatment Period|Death|1|||
27869033|NCT01928394|54467242|FG014|Treatment Period|Death|2|||
27869034|NCT01928394|54467243|FG015|Treatment Period|Death|0|||
27869035|NCT01928394|54467244|FG016|Treatment Period|Death|0|||
27869036|NCT01928394|54467245|FG017|Treatment Period|Death|0|||
27869037|NCT01928394|54467246|FG018|Treatment Period|Death|0|||
27869038|NCT01928394|54467247|FG019|Treatment Period|Death|0|||
27869039|NCT01928394|54467248|FG020|Treatment Period|Death|0|||
27869040|NCT01928394|54467249|FG021|Treatment Period|Death|0|||
27869041|NCT01928394|54467250|FG022|Treatment Period|Death|0|||
27869042|NCT01928394|54467228|FG000|Follow-up Period|Participant withdrew consent|3|||
27869043|NCT01928394|54467229|FG001|Follow-up Period|Participant withdrew consent|0|||
27869044|NCT01928394|54467230|FG002|Follow-up Period|Participant withdrew consent|1|||
27869045|NCT01928394|54467231|FG003|Follow-up Period|Participant withdrew consent|4|||
27869046|NCT01928394|54467232|FG004|Follow-up Period|Participant withdrew consent|0|||
27869047|NCT01928394|54467233|FG005|Follow-up Period|Participant withdrew consent|2|||
27869048|NCT01928394|54467234|FG006|Follow-up Period|Participant withdrew consent|5|||
27869049|NCT01928394|54467235|FG007|Follow-up Period|Participant withdrew consent|1|||
27869050|NCT01928394|54467236|FG008|Follow-up Period|Participant withdrew consent|0|||
27869051|NCT01928394|54467237|FG009|Follow-up Period|Participant withdrew consent|0|||
27869052|NCT01928394|54467238|FG010|Follow-up Period|Participant withdrew consent|5|||
27869053|NCT01928394|54467239|FG011|Follow-up Period|Participant withdrew consent|8|||
27869054|NCT01928394|54467240|FG012|Follow-up Period|Participant withdrew consent|2|||
27869055|NCT01928394|54467241|FG013|Follow-up Period|Participant withdrew consent|12|||
27869056|NCT01928394|54467242|FG014|Follow-up Period|Participant withdrew consent|7|||
27869057|NCT01928394|54467243|FG015|Follow-up Period|Participant withdrew consent|0|||
27869058|NCT01928394|54467244|FG016|Follow-up Period|Participant withdrew consent|5|||
27869059|NCT01928394|54467245|FG017|Follow-up Period|Participant withdrew consent|3|||
27869060|NCT01928394|54467246|FG018|Follow-up Period|Participant withdrew consent|2|||
27869061|NCT01928394|54467247|FG019|Follow-up Period|Participant withdrew consent|7|||
27869062|NCT01928394|54467248|FG020|Follow-up Period|Participant withdrew consent|4|||
27869063|NCT01928394|54467249|FG021|Follow-up Period|Participant withdrew consent|6|||
27869064|NCT01928394|54467250|FG022|Follow-up Period|Participant withdrew consent|2|||
27869065|NCT01928394|54467228|FG000|Follow-up Period|Death|0|||
27869066|NCT01928394|54467229|FG001|Follow-up Period|Death|0|||
27869067|NCT01928394|54467230|FG002|Follow-up Period|Death|2|||
27869068|NCT01928394|54467231|FG003|Follow-up Period|Death|6|||
27869069|NCT01928394|54467232|FG004|Follow-up Period|Death|0|||
27869070|NCT01928394|54467233|FG005|Follow-up Period|Death|6|||
27869071|NCT01928394|54467234|FG006|Follow-up Period|Death|6|||
27869072|NCT01928394|54467235|FG007|Follow-up Period|Death|2|||
27869073|NCT01928394|54467236|FG008|Follow-up Period|Death|1|||
27869074|NCT01928394|54467237|FG009|Follow-up Period|Death|2|||
27869075|NCT01928394|54467238|FG010|Follow-up Period|Death|4|||
27869076|NCT01928394|54467239|FG011|Follow-up Period|Death|12|||
27869077|NCT01928394|54467240|FG012|Follow-up Period|Death|11|||
27869078|NCT01928394|54467241|FG013|Follow-up Period|Death|25|||
27869079|NCT01928394|54467242|FG014|Follow-up Period|Death|18|||
27869080|NCT01928394|54467243|FG015|Follow-up Period|Death|0|||
27869081|NCT01928394|54467244|FG016|Follow-up Period|Death|6|||
27869082|NCT01928394|54467245|FG017|Follow-up Period|Death|5|||
27869083|NCT01928394|54467246|FG018|Follow-up Period|Death|13|||
27869084|NCT01928394|54467247|FG019|Follow-up Period|Death|13|||
27869085|NCT01928394|54467248|FG020|Follow-up Period|Death|5|||
27869086|NCT01928394|54467249|FG021|Follow-up Period|Death|3|||
27869087|NCT01928394|54467250|FG022|Follow-up Period|Death|2|||
27869088|NCT01928394|54467228|FG000|Follow-up Period|other reason|0|||
27869089|NCT01928394|54467229|FG001|Follow-up Period|other reason|0|||
27869090|NCT01928394|54467230|FG002|Follow-up Period|other reason|0|||
27869091|NCT01928394|54467231|FG003|Follow-up Period|other reason|0|||
27869092|NCT01928394|54467232|FG004|Follow-up Period|other reason|0|||
27869093|NCT01928394|54467233|FG005|Follow-up Period|other reason|0|||
27869094|NCT01928394|54467234|FG006|Follow-up Period|other reason|1|||
27869095|NCT01928394|54467235|FG007|Follow-up Period|other reason|3|||
27869096|NCT01928394|54467236|FG008|Follow-up Period|other reason|0|||
27869097|NCT01928394|54467237|FG009|Follow-up Period|other reason|0|||
27869098|NCT01928394|54467238|FG010|Follow-up Period|other reason|2|||
27869099|NCT01928394|54467239|FG011|Follow-up Period|other reason|1|||
27869100|NCT01928394|54467240|FG012|Follow-up Period|other reason|0|||
27869101|NCT01928394|54467241|FG013|Follow-up Period|other reason|1|||
27869102|NCT01928394|54467242|FG014|Follow-up Period|other reason|4|||
27869103|NCT01928394|54467243|FG015|Follow-up Period|other reason|0|||
27869104|NCT01928394|54467244|FG016|Follow-up Period|other reason|2|||
27869105|NCT01928394|54467245|FG017|Follow-up Period|other reason|0|||
27869106|NCT01928394|54467246|FG018|Follow-up Period|other reason|1|||
27869107|NCT01928394|54467247|FG019|Follow-up Period|other reason|1|||
27869108|NCT01928394|54467248|FG020|Follow-up Period|other reason|0|||
27869109|NCT01928394|54467249|FG021|Follow-up Period|other reason|0|||
27869110|NCT01928394|54467250|FG022|Follow-up Period|other reason|1|||
27869111|NCT01928394|54467228|FG000|Follow-up Period|Lost to Follow-up|0|||
27869112|NCT01928394|54467229|FG001|Follow-up Period|Lost to Follow-up|0|||
27869113|NCT01928394|54467230|FG002|Follow-up Period|Lost to Follow-up|0|||
27869114|NCT01928394|54467231|FG003|Follow-up Period|Lost to Follow-up|0|||
27869115|NCT01928394|54467232|FG004|Follow-up Period|Lost to Follow-up|0|||
27869116|NCT01928394|54467233|FG005|Follow-up Period|Lost to Follow-up|0|||
27869117|NCT01928394|54467234|FG006|Follow-up Period|Lost to Follow-up|0|||
27869118|NCT01928394|54467235|FG007|Follow-up Period|Lost to Follow-up|0|||
27869119|NCT01928394|54467236|FG008|Follow-up Period|Lost to Follow-up|0|||
27869120|NCT01928394|54467237|FG009|Follow-up Period|Lost to Follow-up|0|||
27869121|NCT01928394|54467238|FG010|Follow-up Period|Lost to Follow-up|0|||
27869122|NCT01928394|54467239|FG011|Follow-up Period|Lost to Follow-up|1|||
27869123|NCT01928394|54467240|FG012|Follow-up Period|Lost to Follow-up|1|||
27869124|NCT01928394|54467241|FG013|Follow-up Period|Lost to Follow-up|0|||
27869125|NCT01928394|54467242|FG014|Follow-up Period|Lost to Follow-up|1|||
27869126|NCT01928394|54467243|FG015|Follow-up Period|Lost to Follow-up|0|||
27869127|NCT01928394|54467244|FG016|Follow-up Period|Lost to Follow-up|1|||
27869128|NCT01928394|54467245|FG017|Follow-up Period|Lost to Follow-up|0|||
27869129|NCT01928394|54467246|FG018|Follow-up Period|Lost to Follow-up|0|||
27869130|NCT01928394|54467247|FG019|Follow-up Period|Lost to Follow-up|0|||
27869131|NCT01928394|54467248|FG020|Follow-up Period|Lost to Follow-up|0|||
27869132|NCT01928394|54467249|FG021|Follow-up Period|Lost to Follow-up|0|||
27869133|NCT01928394|54467250|FG022|Follow-up Period|Lost to Follow-up|1|||
27869134|NCT01898494|54467302|FG000|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
27869135|NCT01898494|54467303|FG001|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
27869136|NCT01898494|54467304|FG002|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
27869137|NCT01898494|54467305|FG003|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
27869138|NCT01898494|54467306|FG004|Step 1 (Arm S - Transoral Surgery)|Physician Decision|2|||
27869139|NCT01898494|54467302|FG000|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
27869140|NCT01898494|54467303|FG001|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
27869141|NCT01898494|54467304|FG002|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
27869142|NCT01898494|54467305|FG003|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
27869143|NCT01898494|54467306|FG004|Step 1 (Arm S - Transoral Surgery)|Adverse Event|1|||
28171396|NCT02471404|54842971|FG000|Overall Study|Protocol Violation|1|||
28171397|NCT02471404|54842972|FG001|Overall Study|Protocol Violation|0|||
28171398|NCT02471404|54842973|FG002|Overall Study|Protocol Violation|0|||
28171399|NCT02471404|54842971|FG000|Overall Study|Withdrawal by Subject|8|||
28171400|NCT02471404|54842972|FG001|Overall Study|Withdrawal by Subject|4|||
28171401|NCT02471404|54842973|FG002|Overall Study|Withdrawal by Subject|5|||
28171402|NCT02471404|54842971|FG000|Overall Study|Other reasons not specified|10|||
28171403|NCT02471404|54842972|FG001|Overall Study|Other reasons not specified|7|||
28171404|NCT02471404|54842973|FG002|Overall Study|Other reasons not specified|12|||
27869144|NCT01898494|54467302|FG000|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
27869145|NCT01898494|54467303|FG001|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
27869146|NCT01898494|54467304|FG002|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
27869147|NCT01898494|54467305|FG003|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
27869148|NCT01898494|54467306|FG004|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|7|||
27869149|NCT01898494|54467302|FG000|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
27869150|NCT01898494|54467303|FG001|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
27869151|NCT01898494|54467304|FG002|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
27869152|NCT01898494|54467305|FG003|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
27869153|NCT01898494|54467306|FG004|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|9|||
27869154|NCT01898494|54467302|FG000|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
27869155|NCT01898494|54467303|FG001|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
27869156|NCT01898494|54467304|FG002|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
27869157|NCT01898494|54467305|FG003|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
27869158|NCT01898494|54467306|FG004|Step 1 (Arm S - Transoral Surgery)|Disease progression|2|||
27869159|NCT01898494|54467302|FG000|Step 1 (Arm S - Transoral Surgery)|Death|0|||
27869160|NCT01898494|54467303|FG001|Step 1 (Arm S - Transoral Surgery)|Death|0|||
27869161|NCT01898494|54467304|FG002|Step 1 (Arm S - Transoral Surgery)|Death|0|||
27869162|NCT01898494|54467305|FG003|Step 1 (Arm S - Transoral Surgery)|Death|0|||
27869163|NCT01898494|54467306|FG004|Step 1 (Arm S - Transoral Surgery)|Death|1|||
27869164|NCT01898494|54467302|FG000|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
27982313|NCT01856192|54640349|FG001|Overall Study|Non-compliance|0|||
28171405|NCT02471014|54842983|FG000|Overall Study|Lost to Follow-up|2|||
28171406|NCT02471014|54842984|FG001|Overall Study|Lost to Follow-up|2|||
28171407|NCT02413372|54842993|FG000|Treatment|Lost to Follow-up|0|||
27869165|NCT01898494|54467303|FG001|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
27869166|NCT01898494|54467304|FG002|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
27869167|NCT01898494|54467305|FG003|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
27738995|NCT02240368|54188259|FG002|Overall Study|Entropy failed to detect more than 50%|1|||
27869168|NCT01898494|54467306|FG004|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|1|||
27869169|NCT01898494|54467302|FG000|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
27869170|NCT01898494|54467303|FG001|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
27869171|NCT01898494|54467304|FG002|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
27869172|NCT01898494|54467305|FG003|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
27869173|NCT01898494|54467306|FG004|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|1|||
27869174|NCT01898494|54467302|FG000|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
27869175|NCT01898494|54467303|FG001|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
27869176|NCT01898494|54467304|FG002|Step 2 (Adjuvant Treatment)|Adverse Event|2|||
27869177|NCT01898494|54467305|FG003|Step 2 (Adjuvant Treatment)|Adverse Event|3|||
27869178|NCT01898494|54467306|FG004|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
27869179|NCT01898494|54467302|FG000|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
27869180|NCT01898494|54467303|FG001|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
27869181|NCT01898494|54467304|FG002|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|6|||
27869182|NCT01898494|54467305|FG003|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|3|||
27869183|NCT01898494|54467306|FG004|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
27869184|NCT01898494|54467302|FG000|Step 2 (Adjuvant Treatment)|Death|0|||
27869185|NCT01898494|54467303|FG001|Step 2 (Adjuvant Treatment)|Death|0|||
28096353|NCT03999554|54751242|FG002|Overall Study|Withdrawal by Subject|2|||
28096354|NCT03999554|54751243|FG003|Overall Study|Withdrawal by Subject|1|||
27738996|NCT02239978|54188269|FG000|Overall Study|Withdrawal by Subject|2|||
27738997|NCT02239978|54188270|FG001|Overall Study|Withdrawal by Subject|0|||
27869186|NCT01898494|54467304|FG002|Step 2 (Adjuvant Treatment)|Death|0|||
27869187|NCT01898494|54467305|FG003|Step 2 (Adjuvant Treatment)|Death|1|||
27869188|NCT01898494|54467306|FG004|Step 2 (Adjuvant Treatment)|Death|0|||
27869189|NCT01898494|54467302|FG000|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
27869190|NCT01898494|54467303|FG001|Step 2 (Adjuvant Treatment)|Physician Decision|1|||
27869191|NCT01898494|54467304|FG002|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
27869192|NCT01898494|54467305|FG003|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
27869193|NCT01898494|54467306|FG004|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
27869194|NCT01898494|54467302|FG000|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
27869195|NCT01898494|54467303|FG001|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
27869196|NCT01898494|54467304|FG002|Step 2 (Adjuvant Treatment)|Alternative therapy|1|||
27869197|NCT01898494|54467305|FG003|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
27869198|NCT01898494|54467306|FG004|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
27869199|NCT01898494|54467302|FG000|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
27869200|NCT01898494|54467303|FG001|Step 2 (Adjuvant Treatment)|Never started treatment|6|||
27869201|NCT01898494|54467304|FG002|Step 2 (Adjuvant Treatment)|Never started treatment|5|||
27869202|NCT01898494|54467305|FG003|Step 2 (Adjuvant Treatment)|Never started treatment|4|||
27869203|NCT01898494|54467306|FG004|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
27869204|NCT01863043|54467324|FG000|Overall Study|Death|6|||
27869205|NCT01863043|54467325|FG001|Overall Study|Death|1|||
27869206|NCT01863043|54467324|FG000|Overall Study|Withdrawal by Subject|0|||
27869207|NCT01863043|54467325|FG001|Overall Study|Withdrawal by Subject|2|||
27869208|NCT01863043|54467324|FG000|Overall Study|Adverse Event|7|||
27869209|NCT01863043|54467325|FG001|Overall Study|Adverse Event|8|||
27869210|NCT01863043|54467324|FG000|Overall Study|exclusion criteria found after enrollment|0|||
27869211|NCT01863043|54467325|FG001|Overall Study|exclusion criteria found after enrollment|1|||
27869212|NCT01841359|54467331|FG000|Overall Study|Underwent reversal of Roux-en-Y gastric bypass (RYGB)|2|||
27869213|NCT01841359|54467331|FG000|Overall Study|Concommitant medical issues|2|||
27869214|NCT01841359|54467331|FG000|Overall Study|Adverse Event|3|||
27869215|NCT01841359|54467331|FG000|Overall Study|Did not receive study drug at visit 4 prior to mixed meal testing|1|||
27869216|NCT01824875|54467340|FG000|Overall Study|Disease progression|22|||
27869217|NCT01824875|54467341|FG001|Overall Study|Disease progression|15|||
27869218|NCT01824875|54467340|FG000|Overall Study|Withdrawal by Subject|5|||
27869219|NCT01824875|54467341|FG001|Overall Study|Withdrawal by Subject|4|||
27869220|NCT01824875|54467340|FG000|Overall Study|Adverse Event|4|||
27869221|NCT01824875|54467341|FG001|Overall Study|Adverse Event|10|||
27869222|NCT01824875|54467340|FG000|Overall Study|Alternative therapy|3|||
27869223|NCT01824875|54467341|FG001|Overall Study|Alternative therapy|0|||
27869224|NCT01824875|54467340|FG000|Overall Study|Complicating disease|1|||
27869225|NCT01824875|54467341|FG001|Overall Study|Complicating disease|0|||
27869226|NCT01824875|54467340|FG000|Overall Study|Physician Decision|0|||
27869227|NCT01824875|54467341|FG001|Overall Study|Physician Decision|1|||
27869228|NCT01824875|54467340|FG000|Overall Study|Non-compliance|1|||
27869229|NCT01824875|54467341|FG001|Overall Study|Non-compliance|1|||
28096355|NCT03999554|54751244|FG004|Overall Study|Withdrawal by Subject|1|||
27738998|NCT02239510|54188280|FG000|Overall Study|Lost to Follow-up|2|||
27869230|NCT01824875|54467340|FG000|Overall Study|Treatment ended early due to mis-interpretation of protocol|1|||
27869231|NCT01824875|54467341|FG001|Overall Study|Treatment ended early due to mis-interpretation of protocol|0|||
27869232|NCT01824875|54467340|FG000|Overall Study|Administrative issues|0|||
27869233|NCT01824875|54467341|FG001|Overall Study|Administrative issues|2|||
27869234|NCT01824875|54467340|FG000|Overall Study|Ineligible or never started treatment|9|||
27869235|NCT01824875|54467341|FG001|Overall Study|Ineligible or never started treatment|5|||
27869236|NCT01824875|54467340|FG000|Overall Study|Other|0|||
27869237|NCT01824875|54467341|FG001|Overall Study|Other|2|||
27869238|NCT01660451|54467363|FG000|Overall Study|Protocol Violation|0|||
27869239|NCT01660451|54467364|FG001|Overall Study|Protocol Violation|1|||
27869240|NCT01660451|54467365|FG002|Overall Study|Protocol Violation|1|||
27869241|NCT01660451|54467363|FG000|Overall Study|Adverse Event (AE) without Clinical PD|11|||
27869242|NCT01660451|54467364|FG001|Overall Study|Adverse Event (AE) without Clinical PD|8|||
27869243|NCT01660451|54467365|FG002|Overall Study|Adverse Event (AE) without Clinical PD|26|||
27869244|NCT01660451|54467363|FG000|Overall Study|AE with Clinical PD|1|||
27869245|NCT01660451|54467364|FG001|Overall Study|AE with Clinical PD|3|||
27869246|NCT01660451|54467365|FG002|Overall Study|AE with Clinical PD|9|||
27869247|NCT01660451|54467363|FG000|Overall Study|Sponsor Decision|0|||
27869248|NCT01660451|54467364|FG001|Overall Study|Sponsor Decision|0|||
27869249|NCT01660451|54467365|FG002|Overall Study|Sponsor Decision|1|||
27869250|NCT01660451|54467363|FG000|Overall Study|Protocol Deviation|0|||
27869251|NCT01660451|54467364|FG001|Overall Study|Protocol Deviation|0|||
27869252|NCT01660451|54467365|FG002|Overall Study|Protocol Deviation|1|||
27869253|NCT01660451|54467363|FG000|Overall Study|Physician Decision|1|||
27869254|NCT01660451|54467364|FG001|Overall Study|Physician Decision|2|||
27869255|NCT01660451|54467365|FG002|Overall Study|Physician Decision|5|||
27869256|NCT01660451|54467363|FG000|Overall Study|Withdrawal by Subject|1|||
27869257|NCT01660451|54467364|FG001|Overall Study|Withdrawal by Subject|0|||
27869258|NCT01660451|54467365|FG002|Overall Study|Withdrawal by Subject|16|||
27869259|NCT01660451|54467363|FG000|Overall Study|Ongoing with treatment|3|||
27869260|NCT01660451|54467364|FG001|Overall Study|Ongoing with treatment|3|||
27869261|NCT01660451|54467365|FG002|Overall Study|Ongoing with treatment|46|||
27869262|NCT01390584|54467384|FG000|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
27869263|NCT01390584|54467385|FG001|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
27869264|NCT01390584|54467386|FG002|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1|||
27869265|NCT01385176|54467397|FG000|Randomization Phase|Death|1|||
27869266|NCT01385176|54467398|FG001|Randomization Phase|Death|2|||
27869267|NCT01385176|54467397|FG000|6-18 Month All VNS Active|Death|1|||
27869268|NCT01385176|54467398|FG001|6-18 Month All VNS Active|Death|2|||
27869269|NCT01385176|54467397|FG000|6-18 Month All VNS Active|Physician Decision|0|||
27869270|NCT01385176|54467398|FG001|6-18 Month All VNS Active|Physician Decision|1|||
27869271|NCT01385176|54467397|FG000|6-18 Month All VNS Active|Withdrawal by Subject|2|||
27869272|NCT01385176|54467398|FG001|6-18 Month All VNS Active|Withdrawal by Subject|0|||
27869273|NCT01385176|54467397|FG000|6-18 Month All VNS Active|Heart Transplant|1|||
27869274|NCT01385176|54467398|FG001|6-18 Month All VNS Active|Heart Transplant|0|||
27869275|NCT01251965|54467412|FG000|Overall Study|Participant/physician decision|1|||
27869276|NCT01251965|54467413|FG001|Overall Study|Participant/physician decision|2|||
27869277|NCT01251965|54467414|FG002|Overall Study|Participant/physician decision|0|||
27869278|NCT01251965|54467412|FG000|Overall Study|Death|0|||
27869279|NCT01251965|54467413|FG001|Overall Study|Death|0|||
27869280|NCT01251965|54467414|FG002|Overall Study|Death|11|||
27869281|NCT01242800|54467425|FG000|Overall Study|Patient refusal|0|||
27869282|NCT01242800|54467426|FG001|Overall Study|Patient refusal|10|||
28096356|NCT03999554|54751240|FG000|Overall Study|failure to comply with protocol requirements|0|||
27869283|NCT01242800|54467425|FG000|Overall Study|Physician Decision|0|||
27869284|NCT01242800|54467426|FG001|Overall Study|Physician Decision|1|||
27869285|NCT01242800|54467425|FG000|Overall Study|Disease progression|0|||
27869286|NCT01242800|54467426|FG001|Overall Study|Disease progression|3|||
27869287|NCT01242800|54467425|FG000|Overall Study|Lack of insurance coverage for surgery|0|||
28096357|NCT03999554|54751241|FG001|Overall Study|failure to comply with protocol requirements|0|||
28096358|NCT03999554|54751242|FG002|Overall Study|failure to comply with protocol requirements|0|||
28096359|NCT03999554|54751243|FG003|Overall Study|failure to comply with protocol requirements|1|||
27738999|NCT02239510|54188281|FG001|Overall Study|Lost to Follow-up|1|||
27739000|NCT02462486|54188290|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
27869288|NCT01242800|54467426|FG001|Overall Study|Lack of insurance coverage for surgery|1|||
27869289|NCT01242800|54467425|FG000|Overall Study|Reasons not reported|0|||
27869290|NCT01242800|54467426|FG001|Overall Study|Reasons not reported|4|||
27869291|NCT01216683|54467435|FG000|Induction|Never started treatment|0|||
27869292|NCT01216683|54467436|FG001|Induction|Never started treatment|6|||
27869293|NCT01216683|54467437|FG002|Induction|Never started treatment|3|||
27869294|NCT01216683|54467435|FG000|Induction|Lack of Efficacy|4|||
27869295|NCT01216683|54467436|FG001|Induction|Lack of Efficacy|3|||
27869296|NCT01216683|54467437|FG002|Induction|Lack of Efficacy|7|||
27869297|NCT01216683|54467435|FG000|Induction|Adverse Event|0|||
27869298|NCT01216683|54467436|FG001|Induction|Adverse Event|5|||
27869299|NCT01216683|54467437|FG002|Induction|Adverse Event|5|||
27869300|NCT01216683|54467435|FG000|Induction|Death|0|||
27869301|NCT01216683|54467436|FG001|Induction|Death|0|||
27869302|NCT01216683|54467437|FG002|Induction|Death|2|||
27869303|NCT01216683|54467435|FG000|Induction|Withdrawal by Subject|0|||
27869304|NCT01216683|54467436|FG001|Induction|Withdrawal by Subject|4|||
27869305|NCT01216683|54467437|FG002|Induction|Withdrawal by Subject|2|||
27869306|NCT01216683|54467435|FG000|Induction|Other disease|0|||
27869307|NCT01216683|54467436|FG001|Induction|Other disease|1|||
27869308|NCT01216683|54467437|FG002|Induction|Other disease|2|||
27869309|NCT01216683|54467435|FG000|Continuation|Lack of Efficacy|3|||
27869310|NCT01216683|54467436|FG001|Continuation|Lack of Efficacy|2|||
27869311|NCT01216683|54467437|FG002|Continuation|Lack of Efficacy|7|||
27869312|NCT01216683|54467435|FG000|Continuation|Adverse Event|5|||
27869313|NCT01216683|54467436|FG001|Continuation|Adverse Event|3|||
27869314|NCT01216683|54467437|FG002|Continuation|Adverse Event|16|||
27869315|NCT01216683|54467435|FG000|Continuation|Death|1|||
27869316|NCT01216683|54467436|FG001|Continuation|Death|0|||
27869317|NCT01216683|54467437|FG002|Continuation|Death|2|||
27869318|NCT01216683|54467435|FG000|Continuation|Withdrawal by Subject|4|||
27869319|NCT01216683|54467436|FG001|Continuation|Withdrawal by Subject|5|||
27869320|NCT01216683|54467437|FG002|Continuation|Withdrawal by Subject|9|||
27869321|NCT01216683|54467435|FG000|Continuation|Other diseases|0|||
27869322|NCT01216683|54467436|FG001|Continuation|Other diseases|2|||
27869323|NCT01216683|54467437|FG002|Continuation|Other diseases|1|||
27869324|NCT01216683|54467435|FG000|Continuation|Physician Decision|1|||
27869325|NCT01216683|54467436|FG001|Continuation|Physician Decision|0|||
27869326|NCT01216683|54467437|FG002|Continuation|Physician Decision|1|||
27869327|NCT01216683|54467435|FG000|Continuation|Non-compliance|1|||
27869328|NCT01216683|54467436|FG001|Continuation|Non-compliance|0|||
27869329|NCT01216683|54467437|FG002|Continuation|Non-compliance|1|||
27869330|NCT01216683|54467435|FG000|Continuation|Insurance change|0|||
27869331|NCT01216683|54467436|FG001|Continuation|Insurance change|1|||
28096360|NCT03999554|54751244|FG004|Overall Study|failure to comply with protocol requirements|0|||
27869332|NCT01216683|54467437|FG002|Continuation|Insurance change|0|||
27869333|NCT01216683|54467435|FG000|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
27869334|NCT01216683|54467436|FG001|Continuation|Mistakenly stayed on treatment for longer than expected|1|||
27869335|NCT01216683|54467437|FG002|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
27869336|NCT01216683|54467435|FG000|Continuation|Not reported|0|||
27869337|NCT01216683|54467436|FG001|Continuation|Not reported|0|||
27869338|NCT01216683|54467437|FG002|Continuation|Not reported|1|||
27869339|NCT01216683|54467435|FG000|Continuation|Never started treatment|0|||
27869340|NCT01216683|54467436|FG001|Continuation|Never started treatment|1|||
27869341|NCT01216683|54467437|FG002|Continuation|Never started treatment|5|||
27869342|NCT01145495|54467458|FG000|Overall Study|Adverse Event|6|||
27869343|NCT01145495|54467458|FG000|Overall Study|Withdrawal by Subject|6|||
27869344|NCT01145495|54467458|FG000|Overall Study|Disease progression after respone|2|||
27869345|NCT01124695|54467464|FG000|Overall Study|Disease progression|77|||
27869346|NCT01124695|54467464|FG000|Overall Study|Adverse Event|11|||
27869347|NCT01124695|54467464|FG000|Overall Study|Death|1|||
27869348|NCT01124695|54467464|FG000|Overall Study|Withdrawal by Subject|7|||
27869349|NCT01124695|54467464|FG000|Overall Study|Physician Decision|3|||
27869350|NCT01124695|54467464|FG000|Overall Study|Alternative therapy|9|||
27869351|NCT01124695|54467464|FG000|Overall Study|No documentation that patient went off treatment|4|||
27869352|NCT01124695|54467464|FG000|Overall Study|Ineligible|9|||
27869353|NCT01124695|54467464|FG000|Overall Study|Ineligible and never start treatment|2|||
27869354|NCT01084083|54467475|FG000|Overall Study|Adverse Event|5|||
27869355|NCT01084083|54467475|FG000|Overall Study|Death|1|||
27869356|NCT01084083|54467475|FG000|Overall Study|Withdrawal by Subject|2|||
27869357|NCT01084083|54467475|FG000|Overall Study|Complicating disease|1|||
27869358|NCT01084083|54467475|FG000|Overall Study|Other|2|||
27869359|NCT01084083|54467475|FG000|Overall Study|Never started assigned therapy|1|||
27869360|NCT01079780|54467483|FG000|Overall Study|Disease progression|43|||
27869361|NCT01079780|54467484|FG001|Overall Study|Disease progression|7|||
27869362|NCT01079780|54467485|FG002|Overall Study|Disease progression|31|||
27869363|NCT01079780|54467483|FG000|Overall Study|Adverse Event|13|||
27869364|NCT01079780|54467484|FG001|Overall Study|Adverse Event|5|||
27869365|NCT01079780|54467485|FG002|Overall Study|Adverse Event|7|||
28096361|NCT04129346|54751259|FG000|Overall Study|Death|1|||
28096362|NCT04129346|54751260|FG001|Overall Study|Death|0|||
28096363|NCT04526574|54751268|FG000|Overall Study|Protocol Violation|3|||
27869366|NCT01079780|54467483|FG000|Overall Study|Death|2|||
27869367|NCT01079780|54467484|FG001|Overall Study|Death|0|||
27869368|NCT01079780|54467485|FG002|Overall Study|Death|2|||
27869369|NCT01079780|54467483|FG000|Overall Study|Withdrawal by Subject|6|||
27869370|NCT01079780|54467484|FG001|Overall Study|Withdrawal by Subject|4|||
27869371|NCT01079780|54467485|FG002|Overall Study|Withdrawal by Subject|4|||
27869372|NCT01079780|54467483|FG000|Overall Study|Alternative therapy|2|||
27869373|NCT01079780|54467484|FG001|Overall Study|Alternative therapy|0|||
27869374|NCT01079780|54467485|FG002|Overall Study|Alternative therapy|2|||
27869375|NCT01079780|54467483|FG000|Overall Study|Physician Decision|1|||
27869376|NCT01079780|54467484|FG001|Overall Study|Physician Decision|0|||
27869377|NCT01079780|54467485|FG002|Overall Study|Physician Decision|1|||
27869378|NCT01079780|54467483|FG000|Overall Study|Error made in lesion measurement|1|||
27869379|NCT01079780|54467484|FG001|Overall Study|Error made in lesion measurement|0|||
27869380|NCT01079780|54467485|FG002|Overall Study|Error made in lesion measurement|0|||
27869381|NCT01079780|54467483|FG000|Overall Study|Patient had surgery|1|||
27869382|NCT01079780|54467484|FG001|Overall Study|Patient had surgery|0|||
27869383|NCT01079780|54467485|FG002|Overall Study|Patient had surgery|0|||
27869384|NCT01079780|54467483|FG000|Overall Study|Treatment cycle delay|0|||
27869385|NCT01079780|54467484|FG001|Overall Study|Treatment cycle delay|0|||
27869386|NCT01079780|54467485|FG002|Overall Study|Treatment cycle delay|1|||
27869387|NCT01079780|54467483|FG000|Overall Study|Never started treatment|1|||
27869388|NCT01079780|54467484|FG001|Overall Study|Never started treatment|0|||
27869389|NCT01079780|54467485|FG002|Overall Study|Never started treatment|2|||
27869390|NCT01013961|54467495|FG000|Overall Study|Adverse Event|2|||
27869391|NCT01013961|54467496|FG001|Overall Study|Adverse Event|2|||
27869392|NCT01013961|54467495|FG000|Overall Study|Withdrawal by Subject|1|||
27869393|NCT01013961|54467496|FG001|Overall Study|Withdrawal by Subject|0|||
27869394|NCT01013961|54467495|FG000|Overall Study|Physician Decision|0|||
27869395|NCT01013961|54467496|FG001|Overall Study|Physician Decision|1|||
27869396|NCT00834093|54467511|FG000|Overall Study|Progressive Disease|3|||
27869397|NCT00834093|54467511|FG000|Overall Study|Withdrawal by subject or MD Decision|5|||
27869398|NCT00606294|54467517|FG000|Overall Study|Withdrawal by Subject|36|||
27869399|NCT00606294|54467518|FG001|Overall Study|Withdrawal by Subject|0|||
27869400|NCT00583596|54467524|FG000|Overall Study|Lost to Follow-up|110|||
27869401|NCT00583596|54467524|FG000|Overall Study|Excluded due to Hurricane Katrina|30|||
27869402|NCT00583596|54467524|FG000|Overall Study|Death|2|||
27869403|NCT00583596|54467524|FG000|Overall Study|Withdrawal by Subject|6|||
27869404|NCT00583596|54467524|FG000|Overall Study|Lost to Follow-up|94|||
27869405|NCT00583596|54467524|FG000|Overall Study|Data not complete|1|||
27869406|NCT00583596|54467524|FG000|Overall Study|Not consented|15|||
27869407|NCT00583596|54467524|FG000|Overall Study|Outside f-up window|26|||
27869408|NCT00316888|54467535|FG000|Overall Study|Adverse Event|4|||
27869409|NCT00316888|54467536|FG001|Overall Study|Adverse Event|5|||
27869410|NCT00316888|54467535|FG000|Overall Study|Withdrawal by Subject|2|||
27869411|NCT00316888|54467536|FG001|Overall Study|Withdrawal by Subject|2|||
27869412|NCT00316888|54467535|FG000|Overall Study|Not start protocol therapy|0|||
27869413|NCT00316888|54467536|FG001|Overall Study|Not start protocol therapy|1|||
27869414|NCT00274924|54467545|FG000|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4|||
27869415|NCT00274924|54467546|FG001|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14|||
27869416|NCT00274924|54467547|FG002|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1|||
27869417|NCT00274924|54467545|FG000|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
27869418|NCT00274924|54467546|FG001|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
27869419|NCT00274924|54467547|FG002|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1|||
27869420|NCT00274924|54467545|FG000|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
27869421|NCT00274924|54467546|FG001|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
27869422|NCT00274924|54467547|FG002|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1|||
27869423|NCT00274924|54467545|FG000|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
27869424|NCT00274924|54467546|FG001|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
27869425|NCT00274924|54467547|FG002|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1|||
27869426|NCT00274924|54467545|FG000|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
27869427|NCT00274924|54467546|FG001|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
27869428|NCT00274924|54467547|FG002|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1|||
27869429|NCT00274924|54467545|FG000|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
27869430|NCT00274924|54467546|FG001|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
27869431|NCT00274924|54467547|FG002|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1|||
27869432|NCT00274924|54467545|FG000|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4|||
27869433|NCT00274924|54467546|FG001|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15|||
27869434|NCT00274924|54467547|FG002|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0|||
27869435|NCT00274924|54467545|FG000|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1|||
27869436|NCT00274924|54467546|FG001|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
27739001|NCT02462486|54188291|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
27869437|NCT00274924|54467547|FG002|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
27869438|NCT00274924|54467545|FG000|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1|||
27869439|NCT00274924|54467546|FG001|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
27869440|NCT00274924|54467547|FG002|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
27869441|NCT00274924|54467545|FG000|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1|||
27869442|NCT00274924|54467546|FG001|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
27869443|NCT00274924|54467547|FG002|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
27869444|NCT00274924|54467545|FG000|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
27869445|NCT00274924|54467546|FG001|Step 2 (Tx Based on Mid-treatment PET)|Death|1|||
27869446|NCT00274924|54467547|FG002|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
27869447|NCT00274924|54467545|FG000|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
27869448|NCT00274924|54467546|FG001|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1|||
27869449|NCT00274924|54467547|FG002|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
27869450|NCT00274924|54467545|FG000|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
27869451|NCT00274924|54467546|FG001|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1|||
27869452|NCT00274924|54467547|FG002|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
27869453|NCT00104884|54467554|FG000|Overall Study|Disease progression|4|||
27869454|NCT00096174|54467558|FG000|Overall Study|Lack of Efficacy|9|||
27869455|NCT00096174|54467558|FG000|Overall Study|Adverse Event|15|||
27869456|NCT00096174|54467558|FG000|Overall Study|Death|6|||
27869457|NCT00096174|54467558|FG000|Overall Study|Withdrawal by Subject|15|||
27869458|NCT00096174|54467558|FG000|Overall Study|Not started protocol therapy|3|||
27869459|NCT00096174|54467558|FG000|Overall Study|Ineligible|6|||
27869460|NCT00096174|54467558|FG000|Overall Study|other reason|8|||
27869461|NCT00080938|54467562|FG000|Overall Study|Adverse Event|3|||
27869462|NCT00080938|54467562|FG000|Overall Study|Withdrawal by Subject|6|||
27869463|NCT00080938|54467562|FG000|Overall Study|Death|2|||
27869464|NCT00080938|54467562|FG000|Overall Study|Lack of Efficacy|7|||
27869465|NCT00080938|54467562|FG000|Overall Study|other disease|1|||
27869466|NCT00080938|54467562|FG000|Overall Study|Not started protocol therapy|1|||
27869467|NCT00080938|54467562|FG000|Overall Study|Ineligible|4|||
27982314|NCT01572480|54640355|FG000|Participants Enrolled|Withdrawal by Subject|1|||
27982315|NCT01572480|54640355|FG000|Drug Administration|Discontinued drug/Off Study|1|||
27982316|NCT01572480|54640355|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events and withdrew consent|1|||
27982317|NCT01572480|54640355|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events|2|||
27982318|NCT01126190|54640362|FG000|Double-Blind Phase|Death|0|||
27982319|NCT01126190|54640363|FG001|Double-Blind Phase|Death|1|||
27982320|NCT01126190|54640364|FG002|Double-Blind Phase|Death|0|||
27982321|NCT01126190|54640362|FG000|Double-Blind Phase|Adverse Event|1|||
27982322|NCT01126190|54640363|FG001|Double-Blind Phase|Adverse Event|2|||
27982323|NCT01126190|54640364|FG002|Double-Blind Phase|Adverse Event|0|||
27982324|NCT01126190|54640362|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
27982325|NCT01126190|54640363|FG001|Double-Blind Phase|Withdrawal by Subject|5|||
27982326|NCT01126190|54640364|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
27982327|NCT01126190|54640362|FG000|Double-Blind Phase|Request of Investigator|1|||
27982328|NCT01126190|54640363|FG001|Double-Blind Phase|Request of Investigator|0|||
27982329|NCT01126190|54640364|FG002|Double-Blind Phase|Request of Investigator|0|||
27982330|NCT01126190|54640362|FG000|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
27982331|NCT01126190|54640363|FG001|Double-Blind Phase|Treatment Failure/Disease Progression|4|||
27982332|NCT01126190|54640364|FG002|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
27982333|NCT01126190|54640362|FG000|Double-Blind Phase|Non-compliance|1|||
27982334|NCT01126190|54640363|FG001|Double-Blind Phase|Non-compliance|0|||
27982335|NCT01126190|54640364|FG002|Double-Blind Phase|Non-compliance|0|||
27982336|NCT01126190|54640362|FG000|Double-Blind Phase|Lost to Follow-up|1|||
27982337|NCT01126190|54640363|FG001|Double-Blind Phase|Lost to Follow-up|3|||
27982338|NCT01126190|54640364|FG002|Double-Blind Phase|Lost to Follow-up|0|||
27982339|NCT01126190|54640362|FG000|Open-Label Phase|Death|0|||
27982340|NCT01126190|54640363|FG001|Open-Label Phase|Death|0|||
27982341|NCT01126190|54640364|FG002|Open-Label Phase|Death|1|||
27982342|NCT01126190|54640362|FG000|Open-Label Phase|Adverse Event|0|||
27982343|NCT01126190|54640363|FG001|Open-Label Phase|Adverse Event|0|||
27982344|NCT01126190|54640364|FG002|Open-Label Phase|Adverse Event|4|||
27982345|NCT01126190|54640362|FG000|Open-Label Phase|Withdrawal by Subject|0|||
27982346|NCT01126190|54640363|FG001|Open-Label Phase|Withdrawal by Subject|0|||
27982347|NCT01126190|54640364|FG002|Open-Label Phase|Withdrawal by Subject|6|||
27982348|NCT00939185|54640397|FG000|Overall Study|Adverse Event|3|||
27982349|NCT00939185|54640397|FG000|Overall Study|Lack of Efficacy|1|||
27982350|NCT00939185|54640397|FG000|Overall Study|Lost to Follow-up|6|||
27982351|NCT00939185|54640397|FG000|Overall Study|Other|3|||
27982352|NCT00939185|54640397|FG000|Overall Study|Withdrawal by Subject|2|||
27982353|NCT00939185|54640397|FG000|Overall Study|Randomized But Did Not Receive Treatment|10|||
27982354|NCT03977155|54640404|FG000|Overall Study|Adverse Event|3|||
27982355|NCT03977155|54640405|FG001|Overall Study|Adverse Event|0|||
27982356|NCT03977155|54640406|FG002|Overall Study|Adverse Event|0|||
27982357|NCT03977155|54640404|FG000|Overall Study|Lost to Follow-up|0|||
28171408|NCT02413372|54842994|FG001|Treatment|Lost to Follow-up|2|||
27869468|NCT00078949|54467570|FG000|Overall Study|No treated|4|||
27982358|NCT03977155|54640405|FG001|Overall Study|Lost to Follow-up|1|||
27982359|NCT03977155|54640406|FG002|Overall Study|Lost to Follow-up|0|||
27982360|NCT03977155|54640404|FG000|Overall Study|Withdrawal by Subject|1|||
27982361|NCT03977155|54640405|FG001|Overall Study|Withdrawal by Subject|1|||
27982362|NCT03977155|54640406|FG002|Overall Study|Withdrawal by Subject|2|||
27982363|NCT03977155|54640404|FG000|Overall Study|Participant was unable to come in for the Visit|1|||
27982364|NCT03977155|54640405|FG001|Overall Study|Participant was unable to come in for the Visit|0|||
27869469|NCT00078949|54467571|FG001|Overall Study|No treated|5|||
27869470|NCT00078949|54467572|FG002|Overall Study|No treated|3|||
27869471|NCT00078949|54467573|FG003|Overall Study|No treated|3|||
27869472|NCT00074282|54467585|FG000|Step 1|Adverse Event|32|||
27869473|NCT00074282|54467586|FG001|Step 1|Adverse Event|0|||
27869474|NCT00074282|54467587|FG002|Step 1|Adverse Event|0|||
27869475|NCT00074282|54467585|FG000|Step 1|Death|6|||
27869476|NCT00074282|54467586|FG001|Step 1|Death|0|||
27869477|NCT00074282|54467587|FG002|Step 1|Death|0|||
27869478|NCT00074282|54467585|FG000|Step 1|Withdrawal by Subject|7|||
27869479|NCT00074282|54467586|FG001|Step 1|Withdrawal by Subject|0|||
27869480|NCT00074282|54467587|FG002|Step 1|Withdrawal by Subject|0|||
27869481|NCT00074282|54467585|FG000|Step 1|Disease progression|2|||
27869482|NCT00074282|54467586|FG001|Step 1|Disease progression|0|||
27869483|NCT00074282|54467587|FG002|Step 1|Disease progression|0|||
27869484|NCT00074282|54467585|FG000|Step 1|Alternative therapy|2|||
27869485|NCT00074282|54467586|FG001|Step 1|Alternative therapy|0|||
27869486|NCT00074282|54467587|FG002|Step 1|Alternative therapy|0|||
27869487|NCT00074282|54467585|FG000|Step 1|Other complicating disease|2|||
27869488|NCT00074282|54467586|FG001|Step 1|Other complicating disease|0|||
27869489|NCT00074282|54467587|FG002|Step 1|Other complicating disease|0|||
27869490|NCT00074282|54467585|FG000|Step 1|Physician Decision|1|||
27869491|NCT00074282|54467586|FG001|Step 1|Physician Decision|0|||
27869492|NCT00074282|54467587|FG002|Step 1|Physician Decision|0|||
27869493|NCT00074282|54467585|FG000|Step 1|Ineligible|4|||
27869494|NCT00074282|54467586|FG001|Step 1|Ineligible|0|||
27869495|NCT00074282|54467587|FG002|Step 1|Ineligible|0|||
27869496|NCT00074282|54467585|FG000|Step 1|Never started treatment|2|||
27869497|NCT00074282|54467586|FG001|Step 1|Never started treatment|0|||
27869498|NCT00074282|54467587|FG002|Step 1|Never started treatment|0|||
27869499|NCT00074282|54467585|FG000|Step 2|Adverse Event|0|||
27869500|NCT00074282|54467586|FG001|Step 2|Adverse Event|2|||
27869501|NCT00074282|54467587|FG002|Step 2|Adverse Event|12|||
27869502|NCT00074282|54467585|FG000|Step 2|Disease progression|0|||
27869503|NCT00074282|54467586|FG001|Step 2|Disease progression|0|||
27869504|NCT00074282|54467587|FG002|Step 2|Disease progression|5|||
27869505|NCT00074282|54467585|FG000|Step 2|Death|0|||
27869506|NCT00074282|54467586|FG001|Step 2|Death|0|||
27869507|NCT00074282|54467587|FG002|Step 2|Death|3|||
27869508|NCT00074282|54467585|FG000|Step 2|Withdrawal by Subject|0|||
27869509|NCT00074282|54467586|FG001|Step 2|Withdrawal by Subject|0|||
27869510|NCT00074282|54467587|FG002|Step 2|Withdrawal by Subject|2|||
27869511|NCT00074282|54467585|FG000|Step 2|Physician Decision|0|||
27869512|NCT00074282|54467586|FG001|Step 2|Physician Decision|0|||
27869513|NCT00074282|54467587|FG002|Step 2|Physician Decision|1|||
27869514|NCT00074282|54467585|FG000|Step 2|Ineligible|0|||
27869515|NCT00074282|54467586|FG001|Step 2|Ineligible|0|||
27869516|NCT00074282|54467587|FG002|Step 2|Ineligible|1|||
27869517|NCT00071981|54467599|FG000|Overall Study|Lack of Efficacy|37|||
27869518|NCT00071981|54467600|FG001|Overall Study|Lack of Efficacy|29|||
27869519|NCT00071981|54467601|FG002|Overall Study|Lack of Efficacy|30|||
27869520|NCT00071981|54467602|FG003|Overall Study|Lack of Efficacy|43|||
27869521|NCT00071981|54467599|FG000|Overall Study|Adverse Event|4|||
27869522|NCT00071981|54467600|FG001|Overall Study|Adverse Event|4|||
27869523|NCT00071981|54467601|FG002|Overall Study|Adverse Event|3|||
27869524|NCT00071981|54467602|FG003|Overall Study|Adverse Event|1|||
27869525|NCT00071981|54467599|FG000|Overall Study|Death|0|||
27869526|NCT00071981|54467600|FG001|Overall Study|Death|0|||
27869527|NCT00071981|54467601|FG002|Overall Study|Death|1|||
27869528|NCT00071981|54467602|FG003|Overall Study|Death|1|||
27869529|NCT00071981|54467599|FG000|Overall Study|Withdrawal by Subject|3|||
27869530|NCT00071981|54467600|FG001|Overall Study|Withdrawal by Subject|1|||
27869531|NCT00071981|54467601|FG002|Overall Study|Withdrawal by Subject|0|||
28096364|NCT04526574|54751269|FG001|Overall Study|Protocol Violation|1|||
28096365|NCT04526574|54751268|FG000|Overall Study|Withdrawal by Subject|12|||
28096366|NCT04526574|54751269|FG001|Overall Study|Withdrawal by Subject|9|||
27869532|NCT00071981|54467602|FG003|Overall Study|Withdrawal by Subject|0|||
27869533|NCT00071981|54467599|FG000|Overall Study|No protocol therapy|2|||
27869534|NCT00071981|54467600|FG001|Overall Study|No protocol therapy|5|||
27869535|NCT00071981|54467601|FG002|Overall Study|No protocol therapy|1|||
27869536|NCT00071981|54467602|FG003|Overall Study|No protocol therapy|0|||
27869537|NCT00071981|54467599|FG000|Overall Study|others (not specified in the study)|0|||
27869538|NCT00071981|54467600|FG001|Overall Study|others (not specified in the study)|2|||
28096367|NCT04526574|54751268|FG000|Overall Study|Other|1|||
27869539|NCT00071981|54467601|FG002|Overall Study|others (not specified in the study)|2|||
27869540|NCT00071981|54467602|FG003|Overall Study|others (not specified in the study)|0|||
27869541|NCT00070291|54467612|FG000|Step 1|Withdrawal by Subject|1|||
28096368|NCT04526574|54751269|FG001|Overall Study|Other|2|||
27869542|NCT00070291|54467612|FG000|Step 1|Adverse Event|1|||
27869543|NCT00070291|54467612|FG000|Step 2|Adverse Event|1|||
27869544|NCT00064350|54467619|FG000|Induction Treatment|Disease Progression|5|||
27869545|NCT00064350|54467620|FG001|Induction Treatment|Disease Progression|1|||
27869546|NCT00064350|54467621|FG002|Induction Treatment|Disease Progression|110|||
27869547|NCT00064350|54467619|FG000|Induction Treatment|Adverse Event|0|||
27869548|NCT00064350|54467620|FG001|Induction Treatment|Adverse Event|2|||
27869549|NCT00064350|54467621|FG002|Induction Treatment|Adverse Event|49|||
27869550|NCT00064350|54467619|FG000|Induction Treatment|Death|0|||
27869551|NCT00064350|54467620|FG001|Induction Treatment|Death|0|||
27869552|NCT00064350|54467621|FG002|Induction Treatment|Death|9|||
27869553|NCT00064350|54467619|FG000|Induction Treatment|Withdrawal by Subject|0|||
27869554|NCT00064350|54467620|FG001|Induction Treatment|Withdrawal by Subject|0|||
27869555|NCT00064350|54467621|FG002|Induction Treatment|Withdrawal by Subject|21|||
27869556|NCT00064350|54467619|FG000|Induction Treatment|Ineligible or never started treatment|3|||
27869557|NCT00064350|54467620|FG001|Induction Treatment|Ineligible or never started treatment|6|||
27869558|NCT00064350|54467621|FG002|Induction Treatment|Ineligible or never started treatment|34|||
27869559|NCT00064350|54467619|FG000|Induction Treatment|Other|0|||
27869560|NCT00064350|54467620|FG001|Induction Treatment|Other|0|||
27869561|NCT00064350|54467621|FG002|Induction Treatment|Other|13|||
27869562|NCT00064350|54467619|FG000|Randomization|Adverse Event|8|||
27869563|NCT00064350|54467620|FG001|Randomization|Adverse Event|3|||
27869564|NCT00064350|54467621|FG002|Randomization|Adverse Event|0|||
27869565|NCT00064350|54467619|FG000|Randomization|Death|3|||
27869566|NCT00064350|54467620|FG001|Randomization|Death|0|||
27869567|NCT00064350|54467621|FG002|Randomization|Death|0|||
27869568|NCT00064350|54467619|FG000|Randomization|Withdrawal by Subject|1|||
27869569|NCT00064350|54467620|FG001|Randomization|Withdrawal by Subject|0|||
27869570|NCT00064350|54467621|FG002|Randomization|Withdrawal by Subject|0|||
27869571|NCT00064350|54467619|FG000|Randomization|Ineligible or never started treatment|9|||
27869572|NCT00064350|54467620|FG001|Randomization|Ineligible or never started treatment|15|||
27869573|NCT00064350|54467621|FG002|Randomization|Ineligible or never started treatment|0|||
27869574|NCT00064350|54467619|FG000|Randomization|Other|5|||
27869575|NCT00064350|54467620|FG001|Randomization|Other|0|||
27869576|NCT00064350|54467621|FG002|Randomization|Other|0|||
27869577|NCT00064350|54467619|FG000|Cross-Over|Adverse Event|0|||
27869578|NCT00064350|54467620|FG001|Cross-Over|Adverse Event|1|||
27869579|NCT00064350|54467621|FG002|Cross-Over|Adverse Event|0|||
27869580|NCT00064350|54467619|FG000|Cross-Over|Death|1|||
27869581|NCT00064350|54467620|FG001|Cross-Over|Death|3|||
27869582|NCT00064350|54467621|FG002|Cross-Over|Death|0|||
27869583|NCT00064350|54467619|FG000|Cross-Over|Withdrawal by Subject|2|||
27869584|NCT00064350|54467620|FG001|Cross-Over|Withdrawal by Subject|2|||
27869585|NCT00064350|54467621|FG002|Cross-Over|Withdrawal by Subject|0|||
27869586|NCT00064350|54467619|FG000|Cross-Over|Ineligible or never started treatment|3|||
27869587|NCT00064350|54467620|FG001|Cross-Over|Ineligible or never started treatment|6|||
27869588|NCT00064350|54467621|FG002|Cross-Over|Ineligible or never started treatment|0|||
27869589|NCT00064350|54467619|FG000|Cross-Over|Other|0|||
27869590|NCT00064350|54467620|FG001|Cross-Over|Other|2|||
27869591|NCT00064350|54467621|FG002|Cross-Over|Other|0|||
27869592|NCT00063986|54467630|FG000|Overall Study|Withdrawal by Subject|1|||
27869593|NCT00063986|54467630|FG000|Overall Study|Ineligible|1|||
27869594|NCT00063986|54467630|FG000|Overall Study|Intra-operatively ineligible|4|||
27869595|NCT00057954|54467638|FG000|Overall Study|Death|1|||
27869596|NCT00057954|54467638|FG000|Overall Study|Disease progression|1|||
27869597|NCT00049530|54467642|FG000|Overall Study|Lack of Efficacy|25|||
27869598|NCT00049530|54467642|FG000|Overall Study|Adverse Event|2|||
27869599|NCT00049530|54467642|FG000|Overall Study|Death|1|||
27869600|NCT00049530|54467642|FG000|Overall Study|symptomatic deterioration|1|||
27869601|NCT00049530|54467642|FG000|Overall Study|ineligible|3|||
27869602|NCT00045305|54467646|FG000|Overall Study|Lack of Efficacy|6|||
27869603|NCT00045305|54467646|FG000|Overall Study|Adverse Event|3|||
27869604|NCT00045305|54467646|FG000|Overall Study|Death|3|||
27869605|NCT00045305|54467646|FG000|Overall Study|site error|2|||
27869606|NCT00033657|54467652|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|1|||
27869607|NCT00033657|54467653|FG001|Neoadjuvant Chemotherapy|Lack of Efficacy|2|||
27869608|NCT00033657|54467652|FG000|Neoadjuvant Chemotherapy|Adverse Event|0|||
27869609|NCT00033657|54467653|FG001|Neoadjuvant Chemotherapy|Adverse Event|2|||
27869610|NCT00033657|54467652|FG000|Neoadjuvant Chemotherapy|Death|1|||
27869611|NCT00033657|54467653|FG001|Neoadjuvant Chemotherapy|Death|1|||
27869612|NCT00033657|54467652|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
27869613|NCT00033657|54467653|FG001|Neoadjuvant Chemotherapy|Withdrawal by Subject|0|||
27869614|NCT00033657|54467652|FG000|Neoadjuvant Chemotherapy|other complicating disease|0|||
27869615|NCT00033657|54467653|FG001|Neoadjuvant Chemotherapy|other complicating disease|1|||
27869616|NCT00033657|54467652|FG000|Neoadjuvant Chemotherapy|Ineligible|8|||
27869617|NCT00033657|54467653|FG001|Neoadjuvant Chemotherapy|Ineligible|4|||
27869618|NCT00033657|54467652|FG000|Neoadjuvant Chemotherapy|Not started protocol therapy|3|||
27869619|NCT00033657|54467653|FG001|Neoadjuvant Chemotherapy|Not started protocol therapy|1|||
27869620|NCT00033657|54467652|FG000|Surgical Resection|not complete resection|0|||
27869621|NCT00033657|54467653|FG001|Surgical Resection|not complete resection|3|||
27869622|NCT00033657|54467652|FG000|Adjuvant Chemotherapy|Lack of Efficacy|3|||
27869623|NCT00033657|54467653|FG001|Adjuvant Chemotherapy|Lack of Efficacy|1|||
27869624|NCT00033657|54467652|FG000|Adjuvant Chemotherapy|Adverse Event|7|||
27869625|NCT00033657|54467653|FG001|Adjuvant Chemotherapy|Adverse Event|10|||
27869626|NCT00033657|54467652|FG000|Adjuvant Chemotherapy|Death|2|||
27869627|NCT00033657|54467653|FG001|Adjuvant Chemotherapy|Death|1|||
27869628|NCT00033657|54467652|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|5|||
27869629|NCT00033657|54467653|FG001|Adjuvant Chemotherapy|Withdrawal by Subject|3|||
27869630|NCT00033657|54467652|FG000|Adjuvant Chemotherapy|alternative therapy|1|||
27869631|NCT00033657|54467653|FG001|Adjuvant Chemotherapy|alternative therapy|0|||
27869632|NCT00033657|54467652|FG000|Adjuvant Chemotherapy|Other|0|||
27869633|NCT00033657|54467653|FG001|Adjuvant Chemotherapy|Other|2|||
27869634|NCT00003389|54467663|FG000|Overall Study|Disease progression|6|||
27869635|NCT00003389|54467664|FG001|Overall Study|Disease progression|1|||
27869636|NCT00003389|54467663|FG000|Overall Study|Adverse Event|13|||
27869637|NCT00003389|54467664|FG001|Overall Study|Adverse Event|2|||
27869638|NCT00003389|54467663|FG000|Overall Study|Death|0|||
27869639|NCT00003389|54467664|FG001|Overall Study|Death|3|||
27869640|NCT00003389|54467663|FG000|Overall Study|Withdrawal by Subject|12|||
27869641|NCT00003389|54467664|FG001|Overall Study|Withdrawal by Subject|5|||
27869642|NCT00003389|54467663|FG000|Overall Study|Alternative therapy|2|||
27869643|NCT00003389|54467664|FG001|Overall Study|Alternative therapy|1|||
27869644|NCT00003389|54467663|FG000|Overall Study|Complicating disease|1|||
27869645|NCT00003389|54467664|FG001|Overall Study|Complicating disease|0|||
27869646|NCT00003389|54467663|FG000|Overall Study|Off-treatment reason missing|31|||
27869647|NCT00003389|54467664|FG001|Overall Study|Off-treatment reason missing|21|||
27869648|NCT00003389|54467663|FG000|Overall Study|Ineligible|33|||
27869649|NCT00003389|54467664|FG001|Overall Study|Ineligible|27|||
27869650|NCT00003138|54467672|FG000|Step 1|Reasons off treatment not documented|60|||
27869651|NCT00003138|54467673|FG001|Step 1|Reasons off treatment not documented|57|||
27869652|NCT00003138|54467672|FG000|Step 1|Never started treatment|1|||
27869653|NCT00003138|54467673|FG001|Step 1|Never started treatment|0|||
27869654|NCT00003138|54467672|FG000|Step 2 (Cross Over)|Reasons off treatment not documented|26|||
27869655|NCT00003138|54467673|FG001|Step 2 (Cross Over)|Reasons off treatment not documented|0|||
27869656|NCT00003138|54467672|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12|||
27869657|NCT00003138|54467673|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19|||
27869658|NCT00003138|54467672|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0|||
27869659|NCT00003138|54467673|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1|||
27869660|NCT00003138|54467672|FG000|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6|||
27869661|NCT00003138|54467673|FG001|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7|||
27869662|NCT00002525|54467684|FG000|Overall Study|Adverse Event|36|||
27869663|NCT00002525|54467685|FG001|Overall Study|Adverse Event|0|||
27869664|NCT00002525|54467684|FG000|Overall Study|Death|5|||
27869665|NCT00002525|54467685|FG001|Overall Study|Death|0|||
27869666|NCT00002525|54467684|FG000|Overall Study|Withdrawal by Subject|11|||
27869667|NCT00002525|54467685|FG001|Overall Study|Withdrawal by Subject|0|||
27869668|NCT00002525|54467684|FG000|Overall Study|Start non-protocol therapy|1|||
27869669|NCT00002525|54467685|FG001|Overall Study|Start non-protocol therapy|0|||
27869670|NCT00002525|54467684|FG000|Overall Study|Other complicating disease|1|||
27869671|NCT00002525|54467685|FG001|Overall Study|Other complicating disease|0|||
27869672|NCT00002525|54467684|FG000|Overall Study|Duke's A, B1, D disease|92|||
27869673|NCT00002525|54467685|FG001|Overall Study|Duke's A, B1, D disease|0|||
27869674|NCT00002525|54467684|FG000|Overall Study|Error|6|||
27869675|NCT00002525|54467685|FG001|Overall Study|Error|0|||
27869676|NCT00002525|54467684|FG000|Overall Study|Other|26|||
27869677|NCT00002525|54467685|FG001|Overall Study|Other|0|||
27869678|NCT00002525|54467684|FG000|Overall Study|Never start protocol therapy|8|||
27869679|NCT00002525|54467685|FG001|Overall Study|Never start protocol therapy|0|||
27869680|NCT02259348|54467693|FG000|Overall Study|Donors|6|||
27869681|NCT02259348|54467693|FG000|Overall Study|Death|4|||
27869682|NCT02259114|54467954|FG000|Overall Study|Progressive Disease|14|||
27869683|NCT02259114|54467955|FG001|Overall Study|Progressive Disease|2|||
27869684|NCT02259114|54467956|FG002|Overall Study|Progressive Disease|10|||
27869685|NCT02259114|54467957|FG003|Overall Study|Progressive Disease|2|||
27869686|NCT02259114|54467958|FG004|Overall Study|Progressive Disease|5|||
27869687|NCT02259114|54467954|FG000|Overall Study|Adverse Event|2|||
28171409|NCT02413372|54842995|FG002|Treatment|Lost to Follow-up|1|||
27869688|NCT02259114|54467955|FG001|Overall Study|Adverse Event|1|||
27869689|NCT02259114|54467956|FG002|Overall Study|Adverse Event|0|||
27869690|NCT02259114|54467957|FG003|Overall Study|Adverse Event|0|||
27869691|NCT02259114|54467958|FG004|Overall Study|Adverse Event|1|||
27869692|NCT02259114|54467954|FG000|Overall Study|Death|3|||
27869693|NCT02259114|54467955|FG001|Overall Study|Death|0|||
27869694|NCT02259114|54467956|FG002|Overall Study|Death|1|||
27869695|NCT02259114|54467957|FG003|Overall Study|Death|0|||
27869696|NCT02259114|54467958|FG004|Overall Study|Death|0|||
27869697|NCT02259114|54467954|FG000|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
27869698|NCT02259114|54467955|FG001|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
27869699|NCT02259114|54467956|FG002|Overall Study|Treatment Delay >2 wks: Adverse Event|1|||
27869700|NCT02259114|54467957|FG003|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
27869701|NCT02259114|54467958|FG004|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
27869702|NCT02259114|54467954|FG000|Overall Study|Withdrawal by Subject|0|||
27869703|NCT02259114|54467955|FG001|Overall Study|Withdrawal by Subject|0|||
27869704|NCT02259114|54467956|FG002|Overall Study|Withdrawal by Subject|1|||
27869705|NCT02259114|54467957|FG003|Overall Study|Withdrawal by Subject|1|||
27869706|NCT02259114|54467958|FG004|Overall Study|Withdrawal by Subject|0|||
27869707|NCT02259114|54467954|FG000|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
27869708|NCT02259114|54467955|FG001|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
27869709|NCT02259114|54467956|FG002|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
27869710|NCT02259114|54467957|FG003|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
27869711|NCT02259114|54467958|FG004|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
27869712|NCT02259114|54467954|FG000|Overall Study|Not Treated|1|||
27869713|NCT02259114|54467955|FG001|Overall Study|Not Treated|0|||
27869714|NCT02259114|54467956|FG002|Overall Study|Not Treated|0|||
27869715|NCT02259114|54467957|FG003|Overall Study|Not Treated|0|||
27869716|NCT02259114|54467958|FG004|Overall Study|Not Treated|0|||
27869717|NCT02258334|54468013|FG000|Overall Study|Adverse Event|1|||
27869718|NCT02258334|54468014|FG001|Overall Study|Adverse Event|0|||
27869719|NCT02258334|54468015|FG002|Overall Study|Adverse Event|0|||
27869720|NCT02258334|54468016|FG003|Overall Study|Adverse Event|0|||
27869721|NCT04960202|54468053|FG000|Overall Study|Other|12|||
27869722|NCT04960202|54468054|FG001|Overall Study|Other|10|||
27869723|NCT04960202|54468053|FG000|Overall Study|Withdrawal by Subject|43|||
27869724|NCT04960202|54468054|FG001|Overall Study|Withdrawal by Subject|45|||
27869725|NCT04960202|54468053|FG000|Overall Study|Lost to Follow-up|20|||
27869726|NCT04960202|54468054|FG001|Overall Study|Lost to Follow-up|17|||
27869727|NCT04960202|54468053|FG000|Overall Study|Death|0|||
27869728|NCT04960202|54468054|FG001|Overall Study|Death|15|||
27869729|NCT02257632|54468124|FG000|Overall Study|Withdrawal by Subject|0|||
27869730|NCT02257632|54468125|FG001|Overall Study|Withdrawal by Subject|1|||
27869731|NCT02257632|54468124|FG000|Overall Study|Adverse Event|1|||
27869732|NCT02257632|54468125|FG001|Overall Study|Adverse Event|2|||
27869733|NCT01642914|54468159|FG000|Overall Study|Adverse Event|11|||
27869734|NCT01642914|54468160|FG001|Overall Study|Adverse Event|7|||
27869735|NCT01642914|54468161|FG002|Overall Study|Adverse Event|15|||
27869736|NCT01642914|54468159|FG000|Overall Study|Lack of Efficacy|9|||
27869737|NCT01642914|54468160|FG001|Overall Study|Lack of Efficacy|4|||
27869738|NCT01642914|54468161|FG002|Overall Study|Lack of Efficacy|2|||
27869739|NCT01642914|54468159|FG000|Overall Study|Protocol Violation|15|||
27869740|NCT01642914|54468160|FG001|Overall Study|Protocol Violation|13|||
27869741|NCT01642914|54468161|FG002|Overall Study|Protocol Violation|6|||
27869742|NCT01642914|54468159|FG000|Overall Study|Withdrawal by Subject|5|||
27869743|NCT01642914|54468160|FG001|Overall Study|Withdrawal by Subject|5|||
27869744|NCT01642914|54468161|FG002|Overall Study|Withdrawal by Subject|10|||
27869745|NCT01642914|54468159|FG000|Overall Study|Lost to Follow-up|5|||
27869746|NCT01642914|54468160|FG001|Overall Study|Lost to Follow-up|3|||
27869747|NCT01642914|54468161|FG002|Overall Study|Lost to Follow-up|7|||
27869748|NCT01642914|54468159|FG000|Overall Study|Other Reason|1|||
27869749|NCT01642914|54468160|FG001|Overall Study|Other Reason|0|||
27869750|NCT01642914|54468161|FG002|Overall Study|Other Reason|0|||
27869751|NCT01642602|54468220|FG000|Overall Study|Adverse Event|2|||
27869752|NCT02256540|54468286|FG000|Overall Study|Withdrawal by Subject|0|||
27869753|NCT02256540|54468287|FG001|Overall Study|Withdrawal by Subject|1|||
27869754|NCT02256540|54468288|FG002|Overall Study|Withdrawal by Subject|1|||
27869755|NCT02256540|54468286|FG000|Overall Study|Back pain preventing exercise|0|||
27869756|NCT02256540|54468287|FG001|Overall Study|Back pain preventing exercise|0|||
27869757|NCT02256540|54468288|FG002|Overall Study|Back pain preventing exercise|1|||
27869758|NCT01640184|54468312|FG000|Overall Study|Death|1|||
27869759|NCT01640184|54468313|FG001|Overall Study|Death|0|||
27869760|NCT01640184|54468314|FG002|Overall Study|Death|0|||
27869761|NCT01640184|54468312|FG000|Overall Study|Lost to Follow-up|4|||
27869762|NCT01640184|54468313|FG001|Overall Study|Lost to Follow-up|1|||
27869763|NCT01640184|54468314|FG002|Overall Study|Lost to Follow-up|0|||
27869764|NCT01640184|54468312|FG000|Overall Study|Physician Decision|3|||
27869765|NCT01640184|54468313|FG001|Overall Study|Physician Decision|0|||
27869766|NCT01640184|54468314|FG002|Overall Study|Physician Decision|0|||
27869767|NCT01640184|54468312|FG000|Overall Study|Withdrawal by Subject|0|||
27869768|NCT01640184|54468313|FG001|Overall Study|Withdrawal by Subject|1|||
27869769|NCT01640184|54468314|FG002|Overall Study|Withdrawal by Subject|1|||
27869770|NCT01640184|54468312|FG000|Overall Study|Protocol Violation|0|||
27869771|NCT01640184|54468313|FG001|Overall Study|Protocol Violation|0|||
27869772|NCT01640184|54468314|FG002|Overall Study|Protocol Violation|1|||
27869773|NCT02256384|54468334|FG000|Overall Study|Withdrawal by Subject|12|||
27869774|NCT02256384|54468334|FG000|Overall Study|Equipment not capturing data|2|||
27869775|NCT02255760|54468377|FG000|Overall Study|Lost to Follow-up|0|||
27869776|NCT02255760|54468378|FG001|Overall Study|Lost to Follow-up|1|||
27869777|NCT02255760|54468379|FG002|Overall Study|Lost to Follow-up|0|||
27869778|NCT02255760|54468380|FG003|Overall Study|Lost to Follow-up|0|||
27869779|NCT02255760|54468381|FG004|Overall Study|Lost to Follow-up|0|||
27869780|NCT01641822|54468477|FG000|Run-in Phase|Noncompliance with study drug|1|||
27869781|NCT01641822|54468478|FG001|Run-in Phase|Noncompliance with study drug|0|||
27869782|NCT01641822|54468479|FG002|Run-in Phase|Noncompliance with study drug|0|||
27869783|NCT01641822|54468477|FG000|Run-in Phase|Adverse Event|3|||
27869784|NCT01641822|54468478|FG001|Run-in Phase|Adverse Event|0|||
27869785|NCT01641822|54468479|FG002|Run-in Phase|Adverse Event|0|||
27869786|NCT01641822|54468477|FG000|Run-in Phase|Withdrew consent|1|||
27869787|NCT01641822|54468478|FG001|Run-in Phase|Withdrew consent|0|||
27869788|NCT01641822|54468479|FG002|Run-in Phase|Withdrew consent|0|||
27869789|NCT01641822|54468477|FG000|Run-in Phase|Protocol-specified criteria for withdraw|9|||
27869790|NCT01641822|54468478|FG001|Run-in Phase|Protocol-specified criteria for withdraw|0|||
27869791|NCT01641822|54468479|FG002|Run-in Phase|Protocol-specified criteria for withdraw|0|||
27869792|NCT01641822|54468477|FG000|Comparative Phase|Noncompliance with study drug|0|||
27869793|NCT01641822|54468478|FG001|Comparative Phase|Noncompliance with study drug|1|||
27869794|NCT01641822|54468479|FG002|Comparative Phase|Noncompliance with study drug|0|||
27869795|NCT01641822|54468477|FG000|Comparative Phase|Investigator's discretion|0|||
27869796|NCT01641822|54468478|FG001|Comparative Phase|Investigator's discretion|0|||
27869797|NCT01641822|54468479|FG002|Comparative Phase|Investigator's discretion|1|||
27869798|NCT01641822|54468477|FG000|Comparative Phase|Pregnancy|0|||
27869799|NCT01641822|54468478|FG001|Comparative Phase|Pregnancy|0|||
27869800|NCT01641822|54468479|FG002|Comparative Phase|Pregnancy|1|||
27869801|NCT01641822|54468477|FG000|Comparative Phase|Adverse event, serious fatal|0|||
27869802|NCT01641822|54468478|FG001|Comparative Phase|Adverse event, serious fatal|1|||
27869803|NCT01641822|54468479|FG002|Comparative Phase|Adverse event, serious fatal|0|||
27869804|NCT01641822|54468477|FG000|Comparative Phase|Withdrew consent|0|||
27869805|NCT01641822|54468478|FG001|Comparative Phase|Withdrew consent|3|||
27869806|NCT01641822|54468479|FG002|Comparative Phase|Withdrew consent|7|||
27869807|NCT01641822|54468477|FG000|Comparative Phase|Protocol-specified criteria for withdraw|0|||
27869808|NCT01641822|54468478|FG001|Comparative Phase|Protocol-specified criteria for withdraw|1|||
27869809|NCT01641822|54468479|FG002|Comparative Phase|Protocol-specified criteria for withdraw|1|||
27869810|NCT01641198|54468559|FG000|After 12 Months of Function|Lost to Follow-up|3|||
27869811|NCT01641198|54468560|FG001|After 12 Months of Function|Lost to Follow-up|2|||
27869812|NCT01641198|54468561|FG002|After 12 Months of Function|Lost to Follow-up|2|||
27869813|NCT01641198|54468559|FG000|After 12 Months of Function|Protocol Violation|1|||
27869814|NCT01641198|54468560|FG001|After 12 Months of Function|Protocol Violation|0|||
27869815|NCT01641198|54468561|FG002|After 12 Months of Function|Protocol Violation|0|||
27869816|NCT01641198|54468559|FG000|After 12 Months of Function|Adverse Event|0|||
27869817|NCT01641198|54468560|FG001|After 12 Months of Function|Adverse Event|1|||
27869818|NCT01641198|54468561|FG002|After 12 Months of Function|Adverse Event|0|||
27869819|NCT01641198|54468559|FG000|After 24 Months of Function|Lost to Follow-up|4|||
27869820|NCT01641198|54468560|FG001|After 24 Months of Function|Lost to Follow-up|9|||
27869821|NCT01641198|54468561|FG002|After 24 Months of Function|Lost to Follow-up|6|||
27869822|NCT01641198|54468559|FG000|At 15-20 Years of Function|Lost to Follow-up|5|||
27869823|NCT01641198|54468560|FG001|At 15-20 Years of Function|Lost to Follow-up|1|||
27869824|NCT01641198|54468561|FG002|At 15-20 Years of Function|Lost to Follow-up|1|||
27869825|NCT01641198|54468559|FG000|At 15-20 Years of Function|Death|1|||
27869826|NCT01641198|54468560|FG001|At 15-20 Years of Function|Death|0|||
27869827|NCT01641198|54468561|FG002|At 15-20 Years of Function|Death|1|||
27869828|NCT01639560|54468646|FG000|Overall Study|Withdrawal by Subject|9|||
27869829|NCT01639560|54468647|FG001|Overall Study|Withdrawal by Subject|14|||
27869830|NCT01639560|54468646|FG000|Overall Study|Lack of Efficacy|1|||
27869831|NCT01639560|54468647|FG001|Overall Study|Lack of Efficacy|2|||
27869832|NCT01639560|54468646|FG000|Overall Study|Lost to Follow-up|9|||
27869833|NCT01639560|54468647|FG001|Overall Study|Lost to Follow-up|11|||
27869834|NCT01639560|54468646|FG000|Overall Study|Adverse Event|0|||
27869835|NCT01639560|54468647|FG001|Overall Study|Adverse Event|2|||
27869836|NCT01601652|54468669|FG000|Overall Study|Death|1|||
27869837|NCT03952130|54468707|FG000|Overall Study|Adverse Event|0|||
27869838|NCT03952130|54468708|FG001|Overall Study|Adverse Event|1|||
27869839|NCT03952130|54468707|FG000|Overall Study|Lost to Follow-up|1|||
27869840|NCT03952130|54468708|FG001|Overall Study|Lost to Follow-up|0|||
27869841|NCT03952130|54468707|FG000|Overall Study|Withdrawal by Subject|1|||
27869842|NCT03952130|54468708|FG001|Overall Study|Withdrawal by Subject|5|||
27869843|NCT01640964|54468752|FG000|Overall Study|Lost to Follow-up|0|||
27869844|NCT01640964|54468753|FG001|Overall Study|Lost to Follow-up|0|||
27869845|NCT01640964|54468754|FG002|Overall Study|Lost to Follow-up|1|||
27869846|NCT01640964|54468752|FG000|Overall Study|Protocol Deviation|1|||
27869847|NCT01640964|54468753|FG001|Overall Study|Protocol Deviation|1|||
27869848|NCT01640964|54468754|FG002|Overall Study|Protocol Deviation|2|||
28171410|NCT02413372|54842993|FG000|Treatment|Withdrawal by Subject|1|||
27869849|NCT01638390|54468874|FG000|Overall Study|screening failures|21|||
27869850|NCT01600716|54468905|FG000|Overall Study|Other Reasons|3|||
27869851|NCT01600716|54468906|FG001|Overall Study|Other Reasons|1|||
27869852|NCT01600716|54468905|FG000|Overall Study|Personal Reasons|0|||
27869853|NCT01600716|54468906|FG001|Overall Study|Personal Reasons|2|||
28171411|NCT02413372|54842994|FG001|Treatment|Withdrawal by Subject|0|||
27869854|NCT01600716|54468905|FG000|Overall Study|Lost to Follow-up|0|||
27869855|NCT01600716|54468906|FG001|Overall Study|Lost to Follow-up|2|||
27869856|NCT01600716|54468905|FG000|Overall Study|Pregnancy|1|||
27869857|NCT01600716|54468906|FG001|Overall Study|Pregnancy|0|||
27869858|NCT01600716|54468905|FG000|Overall Study|Lack of Efficacy|2|||
27869859|NCT01600716|54468906|FG001|Overall Study|Lack of Efficacy|1|||
27869860|NCT01600716|54468905|FG000|Overall Study|Adverse Event|1|||
27869861|NCT01600716|54468906|FG001|Overall Study|Adverse Event|1|||
27869862|NCT01600326|54469022|FG000|Overall Study|Lost to Follow-up|1|||
27869863|NCT01600326|54469023|FG001|Overall Study|Lost to Follow-up|1|||
27869864|NCT01637142|54469159|FG000|Washout Period (at Least 3 Days)|Physician Decision|1|||
27869865|NCT01636986|54469177|FG000|Overall Study|Withdrawal by Subject|0|||
27869866|NCT01636986|54469178|FG001|Overall Study|Withdrawal by Subject|1|||
27869867|NCT01636986|54469177|FG000|Overall Study|Corneal Staining|0|||
27869868|NCT01636986|54469178|FG001|Overall Study|Corneal Staining|1|||
27869869|NCT01601496|54469264|FG000|Overall Study|Physician Decision|1|||
27869870|NCT01601496|54469264|FG000|Overall Study|Withdrawal by Subject|1|||
27869871|NCT01601496|54469264|FG000|Overall Study|Lost to Follow-up|6|||
27869872|NCT01601496|54469264|FG000|Overall Study|Death|4|||
27869873|NCT01601496|54469264|FG000|Overall Study|Other: patient refusal to continue|3|||
27869874|NCT03211832|54469270|FG000|Overall Study|No longer with agency|32|||
27869875|NCT03211832|54469271|FG001|Overall Study|No longer with agency|49|||
27869876|NCT03211832|54469272|FG002|Overall Study|No longer with agency|30|||
27869877|NCT03211832|54469270|FG000|Overall Study|Declined survey|3|||
27869878|NCT03211832|54469271|FG001|Overall Study|Declined survey|3|||
27869879|NCT03211832|54469272|FG002|Overall Study|Declined survey|2|||
27869880|NCT03211832|54469270|FG000|Overall Study|Not available during data collection|1|||
27869881|NCT03211832|54469271|FG001|Overall Study|Not available during data collection|0|||
27869882|NCT03211832|54469272|FG002|Overall Study|Not available during data collection|2|||
27869883|NCT04887948|54469281|FG000|Overall Study|Death|1|||
27869884|NCT04887948|54469282|FG001|Overall Study|Death|0|||
27869885|NCT04887948|54469283|FG002|Overall Study|Death|0|||
27869886|NCT04887948|54469281|FG000|Overall Study|Lost to Follow-up|1|||
27869887|NCT04887948|54469282|FG001|Overall Study|Lost to Follow-up|0|||
27869888|NCT04887948|54469283|FG002|Overall Study|Lost to Follow-up|3|||
27869889|NCT04887948|54469281|FG000|Overall Study|Physician Decision|0|||
27869890|NCT04887948|54469282|FG001|Overall Study|Physician Decision|4|||
27869891|NCT04887948|54469283|FG002|Overall Study|Physician Decision|1|||
27869892|NCT04887948|54469281|FG000|Overall Study|Protocol Violation|1|||
27869893|NCT04887948|54469282|FG001|Overall Study|Protocol Violation|1|||
27869894|NCT04887948|54469283|FG002|Overall Study|Protocol Violation|0|||
27869895|NCT04887948|54469281|FG000|Overall Study|Withdrawal by Subject|0|||
27869896|NCT04887948|54469282|FG001|Overall Study|Withdrawal by Subject|6|||
27869897|NCT04887948|54469283|FG002|Overall Study|Withdrawal by Subject|1|||
27869898|NCT04887948|54469281|FG000|Overall Study|No longer met eligibility criteria|1|||
27869899|NCT04887948|54469282|FG001|Overall Study|No longer met eligibility criteria|2|||
27869900|NCT04887948|54469283|FG002|Overall Study|No longer met eligibility criteria|1|||
27869901|NCT04887948|54469281|FG000|Overall Study|Other|2|||
27869902|NCT04887948|54469282|FG001|Overall Study|Other|1|||
27869903|NCT04887948|54469283|FG002|Overall Study|Other|1|||
27869904|NCT01638000|54469421|FG000|Overall Study|Randomized but Never Received Drug|7|||
27869905|NCT01638000|54469422|FG001|Overall Study|Randomized but Never Received Drug|10|||
27869906|NCT01638000|54469421|FG000|Overall Study|Adverse Event|14|||
27869907|NCT01638000|54469422|FG001|Overall Study|Adverse Event|16|||
27869908|NCT01638000|54469421|FG000|Overall Study|Lack of Efficacy|5|||
27869909|NCT01638000|54469422|FG001|Overall Study|Lack of Efficacy|6|||
27869910|NCT01638000|54469421|FG000|Overall Study|Protocol Violation|11|||
27869911|NCT01638000|54469422|FG001|Overall Study|Protocol Violation|13|||
27869912|NCT01638000|54469421|FG000|Overall Study|Withdrawal by Subject|21|||
27869913|NCT01638000|54469422|FG001|Overall Study|Withdrawal by Subject|24|||
27869914|NCT01638000|54469421|FG000|Overall Study|Miscellaneous|2|||
27869915|NCT01638000|54469422|FG001|Overall Study|Miscellaneous|2|||
27869916|NCT01637922|54469481|FG000|Overall Study|Adverse Event|0|||
27869917|NCT01637922|54469482|FG001|Overall Study|Adverse Event|1|||
27869918|NCT01637922|54469481|FG000|Overall Study|Protocol Violation|0|||
27869919|NCT01637922|54469482|FG001|Overall Study|Protocol Violation|1|||
27869920|NCT01637922|54469481|FG000|Overall Study|Withdrawal by Subject|0|||
27869921|NCT01637922|54469482|FG001|Overall Study|Withdrawal by Subject|3|||
27869922|NCT01637922|54469481|FG000|Overall Study|Lost to Follow-up|2|||
27869923|NCT01637922|54469482|FG001|Overall Study|Lost to Follow-up|0|||
27869924|NCT01920932|54469631|FG000|Overall Study|Death|1|||
27869925|NCT01920932|54469631|FG000|Overall Study|Withdrawal of consent|1|||
27869926|NCT03496662|54469708|FG000|Overall Study|Adverse Event|1|||
27869927|NCT03496662|54469709|FG001|Overall Study|Adverse Event|0|||
27869928|NCT03496662|54469710|FG002|Overall Study|Adverse Event|1|||
27869929|NCT03496662|54469708|FG000|Overall Study|Physician Decision|1|||
27869930|NCT03496662|54469709|FG001|Overall Study|Physician Decision|0|||
27869931|NCT03496662|54469710|FG002|Overall Study|Physician Decision|3|||
27869932|NCT03496662|54469708|FG000|Overall Study|Withdrawal by Subject|0|||
27869933|NCT03496662|54469709|FG001|Overall Study|Withdrawal by Subject|0|||
27869934|NCT03496662|54469710|FG002|Overall Study|Withdrawal by Subject|2|||
27869935|NCT03496662|54469708|FG000|Overall Study|Death|0|||
27869936|NCT03496662|54469709|FG001|Overall Study|Death|0|||
27869937|NCT03496662|54469710|FG002|Overall Study|Death|2|||
27869938|NCT03496662|54469708|FG000|Overall Study|Noncompliance|0|||
27869939|NCT03496662|54469709|FG001|Overall Study|Noncompliance|0|||
27869940|NCT03496662|54469710|FG002|Overall Study|Noncompliance|1|||
27869941|NCT01638546|54469720|FG000|Overall Study|Adverse Event|1|||
27869942|NCT01638546|54469721|FG001|Overall Study|Adverse Event|3|||
27869943|NCT01000051|54469731|FG000|Overall Study|Withdrawal by Subject|1|||
27869944|NCT01000051|54469732|FG001|Overall Study|Withdrawal by Subject|1|||
27869945|NCT01000051|54469731|FG000|Overall Study|Disease Progression|1|||
27869946|NCT01000051|54469732|FG001|Overall Study|Disease Progression|0|||
27869947|NCT01000051|54469731|FG000|Overall Study|Serious noncompliance|1|||
27869948|NCT01000051|54469732|FG001|Overall Study|Serious noncompliance|0|||
27869949|NCT03172494|54469750|FG000|Overall Study|Adverse Event|5|||
27869950|NCT03172494|54469751|FG001|Overall Study|Adverse Event|1|||
27869951|NCT03172494|54469752|FG002|Overall Study|Adverse Event|15|||
27869952|NCT03172494|54469750|FG000|Overall Study|Protocol Violation|3|||
27869953|NCT03172494|54469751|FG001|Overall Study|Protocol Violation|2|||
27869954|NCT03172494|54469752|FG002|Overall Study|Protocol Violation|1|||
27869955|NCT03172494|54469750|FG000|Overall Study|Lack of Efficacy|0|||
27869956|NCT03172494|54469751|FG001|Overall Study|Lack of Efficacy|0|||
27869957|NCT03172494|54469752|FG002|Overall Study|Lack of Efficacy|4|||
27869958|NCT03172494|54469750|FG000|Overall Study|Pregnancy|0|||
27869959|NCT03172494|54469751|FG001|Overall Study|Pregnancy|1|||
27869960|NCT03172494|54469752|FG002|Overall Study|Pregnancy|0|||
27869961|NCT03172494|54469750|FG000|Overall Study|Withdrawal by Subject|10|||
27869962|NCT03172494|54469751|FG001|Overall Study|Withdrawal by Subject|8|||
27869963|NCT03172494|54469752|FG002|Overall Study|Withdrawal by Subject|8|||
27869964|NCT03172494|54469750|FG000|Overall Study|Severe hypoglycaemic episode|0|||
27869965|NCT03172494|54469751|FG001|Overall Study|Severe hypoglycaemic episode|0|||
27869966|NCT03172494|54469752|FG002|Overall Study|Severe hypoglycaemic episode|1|||
27869967|NCT03172494|54469750|FG000|Overall Study|Non-compliance towards treatment|2|||
27869968|NCT03172494|54469751|FG001|Overall Study|Non-compliance towards treatment|0|||
27869969|NCT03172494|54469752|FG002|Overall Study|Non-compliance towards treatment|0|||
27869970|NCT01636362|54469853|FG000|Overall Study|Physician Decision|6|||
27869971|NCT01636362|54469853|FG000|Overall Study|Subject healed, not returning|1|||
27869972|NCT01636362|54469853|FG000|Overall Study|Withdrawal by Subject|1|||
27869973|NCT02797184|54469882|FG000|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
27869974|NCT02797184|54469883|FG001|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
27869975|NCT03042468|54469925|FG000|Overall Study|Death|0|||
27869976|NCT03042468|54469926|FG001|Overall Study|Death|1|||
27869977|NCT03042468|54469927|FG002|Overall Study|Death|1|||
27869978|NCT03042468|54469928|FG003|Overall Study|Death|0|||
27869979|NCT03042468|54469929|FG004|Overall Study|Death|0|||
27869980|NCT03042468|54469930|FG005|Overall Study|Death|0|||
27869981|NCT03042468|54469925|FG000|Overall Study|Withdrawal by Subject|0|||
27869982|NCT03042468|54469926|FG001|Overall Study|Withdrawal by Subject|0|||
27869983|NCT03042468|54469927|FG002|Overall Study|Withdrawal by Subject|0|||
27869984|NCT03042468|54469928|FG003|Overall Study|Withdrawal by Subject|0|||
27869985|NCT03042468|54469929|FG004|Overall Study|Withdrawal by Subject|0|||
27869986|NCT03042468|54469930|FG005|Overall Study|Withdrawal by Subject|1|||
27869987|NCT03042468|54469925|FG000|Overall Study|Lost to Follow-up|0|||
27869988|NCT03042468|54469926|FG001|Overall Study|Lost to Follow-up|0|||
27869989|NCT03042468|54469927|FG002|Overall Study|Lost to Follow-up|0|||
27869990|NCT03042468|54469928|FG003|Overall Study|Lost to Follow-up|0|||
27869991|NCT03042468|54469929|FG004|Overall Study|Lost to Follow-up|1|||
27869992|NCT03042468|54469930|FG005|Overall Study|Lost to Follow-up|1|||
27869993|NCT01634178|54469948|FG000|Treatment Period 1|Adverse Event|0|||
27869994|NCT01634178|54469949|FG001|Treatment Period 1|Adverse Event|1|||
27869995|NCT01634178|54469948|FG000|Treatment Period 2|Adverse Event|1|||
27869996|NCT01634178|54469949|FG001|Treatment Period 2|Adverse Event|0|||
27869997|NCT02412306|54469991|FG000|Overall Study|Lost to Follow-up|0|||
27869998|NCT02412306|54469992|FG001|Overall Study|Lost to Follow-up|1|||
27869999|NCT02412306|54469993|FG002|Overall Study|Lost to Follow-up|0|||
28171412|NCT02413372|54842995|FG002|Treatment|Withdrawal by Subject|0|||
27870000|NCT02412306|54469994|FG003|Overall Study|Lost to Follow-up|0|||
27870001|NCT02412306|54469995|FG004|Overall Study|Lost to Follow-up|0|||
27870002|NCT02412306|54469991|FG000|Overall Study|Withdrawal by Subject|0|||
27870003|NCT02412306|54469992|FG001|Overall Study|Withdrawal by Subject|0|||
27870004|NCT02412306|54469993|FG002|Overall Study|Withdrawal by Subject|1|||
27870005|NCT02412306|54469994|FG003|Overall Study|Withdrawal by Subject|0|||
27870006|NCT02412306|54469995|FG004|Overall Study|Withdrawal by Subject|0|||
27870007|NCT02412306|54469991|FG000|Overall Study|Death|5|||
27870008|NCT02412306|54469992|FG001|Overall Study|Death|7|||
27870009|NCT02412306|54469993|FG002|Overall Study|Death|15|||
27870010|NCT02412306|54469994|FG003|Overall Study|Death|0|||
27870011|NCT02412306|54469995|FG004|Overall Study|Death|2|||
27870012|NCT04285723|54470018|FG000|Overall Study|Subject decision|1|||
27870013|NCT04285723|54470019|FG001|Overall Study|Subject decision|2|||
27870014|NCT04285723|54470018|FG000|Overall Study|Physician Decision|1|||
27870015|NCT04285723|54470019|FG001|Overall Study|Physician Decision|0|||
28171413|NCT02413372|54842993|FG000|Follow-up|Lost to Follow-up|1|||
28171414|NCT02413372|54842994|FG001|Follow-up|Lost to Follow-up|1|||
28171415|NCT02413372|54842995|FG002|Follow-up|Lost to Follow-up|0|||
28171416|NCT02413372|54842993|FG000|Follow-up|Subject Withdrew Consent|1|||
28171417|NCT02413372|54842994|FG001|Follow-up|Subject Withdrew Consent|0|||
28171418|NCT02413372|54842995|FG002|Follow-up|Subject Withdrew Consent|1|||
28171419|NCT02413372|54842993|FG000|Follow-up|Subject unable to return for visit|0|||
28171420|NCT02413372|54842994|FG001|Follow-up|Subject unable to return for visit|0|||
28171421|NCT02413372|54842995|FG002|Follow-up|Subject unable to return for visit|1|||
28171422|NCT02413294|54843003|FG000|Overall Study|Withdrawal by Subject|1|||
28171423|NCT02719353|54843016|FG000|First Intervention|Physician Decision|0|||
28171424|NCT02719353|54843017|FG001|First Intervention|Physician Decision|1|||
28171425|NCT01362062|54843026|FG000|Overall Study|Adverse Event|1|||
28171426|NCT01362062|54843027|FG001|Overall Study|Adverse Event|0|||
27870016|NCT04285723|54470018|FG000|Overall Study|No efficiency|1|||
27870017|NCT04285723|54470019|FG001|Overall Study|No efficiency|0|||
27870018|NCT01352221|54470033|FG000|Double-blind Phase|Adverse Event|6|||
27870019|NCT01352221|54470034|FG001|Double-blind Phase|Adverse Event|4|||
27870020|NCT01352221|54470035|FG002|Double-blind Phase|Adverse Event|0|||
27870021|NCT01352221|54470036|FG003|Double-blind Phase|Adverse Event|0|||
27870022|NCT01352221|54470033|FG000|Double-blind Phase|Withdrawal by Subject|3|||
27870023|NCT01352221|54470034|FG001|Double-blind Phase|Withdrawal by Subject|5|||
27870024|NCT01352221|54470035|FG002|Double-blind Phase|Withdrawal by Subject|0|||
27870025|NCT01352221|54470036|FG003|Double-blind Phase|Withdrawal by Subject|0|||
27870026|NCT01352221|54470033|FG000|Double-blind Phase|Lost to Follow-up|0|||
27870027|NCT01352221|54470034|FG001|Double-blind Phase|Lost to Follow-up|1|||
27870028|NCT01352221|54470035|FG002|Double-blind Phase|Lost to Follow-up|0|||
27870029|NCT01352221|54470036|FG003|Double-blind Phase|Lost to Follow-up|0|||
27870030|NCT01352221|54470033|FG000|Double-blind Phase|Protocol Violation|0|||
27870031|NCT01352221|54470034|FG001|Double-blind Phase|Protocol Violation|1|||
27870032|NCT01352221|54470035|FG002|Double-blind Phase|Protocol Violation|0|||
27870033|NCT01352221|54470036|FG003|Double-blind Phase|Protocol Violation|0|||
27870034|NCT01352221|54470033|FG000|Open-label Phase|Physician Decision|0|||
27870035|NCT01352221|54470034|FG001|Open-label Phase|Physician Decision|0|||
27870036|NCT01352221|54470035|FG002|Open-label Phase|Physician Decision|2|||
27870037|NCT01352221|54470036|FG003|Open-label Phase|Physician Decision|1|||
27870038|NCT01352221|54470033|FG000|Open-label Phase|Pregnancy|0|||
27870039|NCT01352221|54470034|FG001|Open-label Phase|Pregnancy|0|||
27870040|NCT01352221|54470035|FG002|Open-label Phase|Pregnancy|1|||
27870041|NCT01352221|54470036|FG003|Open-label Phase|Pregnancy|0|||
27870042|NCT01352221|54470033|FG000|Open-label Phase|Adverse Event|0|||
27870043|NCT01352221|54470034|FG001|Open-label Phase|Adverse Event|0|||
27870044|NCT01352221|54470035|FG002|Open-label Phase|Adverse Event|8|||
27870045|NCT01352221|54470036|FG003|Open-label Phase|Adverse Event|4|||
27870046|NCT01352221|54470033|FG000|Open-label Phase|Withdrawal by Subject|0|||
27870047|NCT01352221|54470034|FG001|Open-label Phase|Withdrawal by Subject|0|||
27870048|NCT01352221|54470035|FG002|Open-label Phase|Withdrawal by Subject|1|||
27870049|NCT01352221|54470036|FG003|Open-label Phase|Withdrawal by Subject|6|||
27870050|NCT01352221|54470033|FG000|Open-label Phase|Worsening of IBD|0|||
27870051|NCT01352221|54470034|FG001|Open-label Phase|Worsening of IBD|0|||
27870052|NCT01352221|54470035|FG002|Open-label Phase|Worsening of IBD|1|||
27870053|NCT01352221|54470036|FG003|Open-label Phase|Worsening of IBD|0|||
27870054|NCT01634100|54470062|FG000|Overall Study|Withdrawal by Subject|1|||
27870055|NCT01634100|54470063|FG001|Overall Study|Withdrawal by Subject|0|||
27982365|NCT03977155|54640406|FG002|Overall Study|Participant was unable to come in for the Visit|0|||
27870056|NCT01634100|54470064|FG002|Overall Study|Withdrawal by Subject|1|||
27870057|NCT01634100|54470065|FG003|Overall Study|Withdrawal by Subject|0|||
27870058|NCT01634100|54470066|FG004|Overall Study|Withdrawal by Subject|0|||
27870059|NCT01634100|54470067|FG005|Overall Study|Withdrawal by Subject|0|||
27870060|NCT03662659|54470077|FG000|Pre-treatment|Participant no longer met study criteria|1|||
27870061|NCT03662659|54470078|FG001|Pre-treatment|Participant no longer met study criteria|1|||
27870062|NCT03662659|54470077|FG000|Pre-treatment|Other reasons|1|||
27870063|NCT03662659|54470078|FG001|Pre-treatment|Other reasons|0|||
27870064|NCT03662659|54470077|FG000|Treatment|Completed Treatment|0|||
27870065|NCT03662659|54470078|FG001|Treatment|Completed Treatment|3|||
27870066|NCT03662659|54470077|FG000|Treatment|Disease Progression|69|||
27870067|NCT03662659|54470078|FG001|Treatment|Disease Progression|78|||
27870068|NCT03662659|54470077|FG000|Treatment|Study Drug Toxicity|18|||
27870069|NCT03662659|54470078|FG001|Treatment|Study Drug Toxicity|8|||
27870070|NCT03662659|54470077|FG000|Treatment|Death|12|||
27870071|NCT03662659|54470078|FG001|Treatment|Death|7|||
27870072|NCT03662659|54470077|FG000|Treatment|Adverse Event unrelated to Study Drug|7|||
27870073|NCT03662659|54470078|FG001|Treatment|Adverse Event unrelated to Study Drug|4|||
27870074|NCT03662659|54470077|FG000|Treatment|Withdrawal by Subject|1|||
27870075|NCT03662659|54470078|FG001|Treatment|Withdrawal by Subject|1|||
27870076|NCT03662659|54470077|FG000|Treatment|Poor/Non-compliance|1|||
27870077|NCT03662659|54470078|FG001|Treatment|Poor/Non-compliance|0|||
27870078|NCT03662659|54470077|FG000|Treatment|Participant no longer meets study criteria|1|||
27870079|NCT03662659|54470078|FG001|Treatment|Participant no longer meets study criteria|0|||
27870080|NCT03662659|54470077|FG000|Treatment|Other reasons|6|||
27870081|NCT03662659|54470078|FG001|Treatment|Other reasons|5|||
27870082|NCT01633944|54470086|FG000|Open-label Titration Phase|Adverse Event|109|||
27870083|NCT01633944|54470087|FG001|Open-label Titration Phase|Adverse Event|0|||
27870084|NCT01633944|54470088|FG002|Open-label Titration Phase|Adverse Event|0|||
27870085|NCT01633944|54470086|FG000|Open-label Titration Phase|Lack of Efficacy|33|||
27870086|NCT01633944|54470087|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
27870087|NCT01633944|54470088|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
27870088|NCT01633944|54470086|FG000|Open-label Titration Phase|Withdrawal by Subject|34|||
27870089|NCT01633944|54470087|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
27870090|NCT01633944|54470088|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
27870091|NCT01633944|54470086|FG000|Open-label Titration Phase|Protocol Violation|24|||
27870092|NCT01633944|54470087|FG001|Open-label Titration Phase|Protocol Violation|0|||
27870093|NCT01633944|54470088|FG002|Open-label Titration Phase|Protocol Violation|0|||
27870094|NCT01633944|54470086|FG000|Open-label Titration Phase|Lost to Follow-up|22|||
27870095|NCT01633944|54470087|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
27870096|NCT01633944|54470088|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
27870097|NCT01633944|54470086|FG000|Open-label Titration Phase|Other|68|||
27870098|NCT01633944|54470087|FG001|Open-label Titration Phase|Other|0|||
27870099|NCT01633944|54470088|FG002|Open-label Titration Phase|Other|0|||
27870100|NCT01633944|54470086|FG000|Double-blind Treatment Phase|Adverse Event|0|||
27870101|NCT01633944|54470087|FG001|Double-blind Treatment Phase|Adverse Event|13|||
27870102|NCT01633944|54470088|FG002|Double-blind Treatment Phase|Adverse Event|7|||
27870103|NCT01633944|54470086|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
27870104|NCT01633944|54470087|FG001|Double-blind Treatment Phase|Lack of Efficacy|8|||
27870105|NCT01633944|54470088|FG002|Double-blind Treatment Phase|Lack of Efficacy|23|||
27870106|NCT01633944|54470086|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
27870107|NCT01633944|54470087|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
27870108|NCT01633944|54470088|FG002|Double-blind Treatment Phase|Withdrawal by Subject|8|||
27870109|NCT01633944|54470086|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
27870110|NCT01633944|54470087|FG001|Double-blind Treatment Phase|Protocol Violation|7|||
27870111|NCT01633944|54470088|FG002|Double-blind Treatment Phase|Protocol Violation|10|||
28171427|NCT01362062|54843026|FG000|Overall Study|Lost to Follow-up|11|||
28171428|NCT01362062|54843027|FG001|Overall Study|Lost to Follow-up|0|||
27870112|NCT01633944|54470086|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
27870113|NCT01633944|54470087|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
27870114|NCT01633944|54470088|FG002|Double-blind Treatment Phase|Lost to Follow-up|9|||
27870115|NCT01633944|54470086|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
27870116|NCT01633944|54470087|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3|||
27870117|NCT01633944|54470088|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
27870118|NCT01633944|54470086|FG000|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
27870119|NCT01633944|54470087|FG001|Double-blind Treatment Phase|Not exposed to DB study medication|1|||
27870120|NCT01633944|54470088|FG002|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
27870121|NCT01633944|54470086|FG000|Double-blind Treatment Phase|Other|0|||
27870122|NCT01633944|54470087|FG001|Double-blind Treatment Phase|Other|7|||
27870123|NCT01633944|54470088|FG002|Double-blind Treatment Phase|Other|0|||
27870124|NCT01633788|54470133|FG000|Overall Study|Adverse Event|1|||
27870125|NCT01633788|54470134|FG001|Overall Study|Adverse Event|3|||
27870126|NCT01633788|54470135|FG002|Overall Study|Adverse Event|3|||
27870127|NCT01633788|54470136|FG003|Overall Study|Adverse Event|3|||
27870128|NCT01633788|54470133|FG000|Overall Study|Lost to Follow-up|2|||
27870129|NCT01633788|54470134|FG001|Overall Study|Lost to Follow-up|2|||
27870130|NCT01633788|54470135|FG002|Overall Study|Lost to Follow-up|2|||
27870131|NCT01633788|54470136|FG003|Overall Study|Lost to Follow-up|0|||
27870132|NCT01633788|54470133|FG000|Overall Study|Personal Reasons|3|||
27870133|NCT01633788|54470134|FG001|Overall Study|Personal Reasons|1|||
27870134|NCT01633788|54470135|FG002|Overall Study|Personal Reasons|1|||
27870135|NCT01633788|54470136|FG003|Overall Study|Personal Reasons|3|||
27870136|NCT01633788|54470133|FG000|Overall Study|Protocol Violation|1|||
27870137|NCT01633788|54470134|FG001|Overall Study|Protocol Violation|0|||
27870138|NCT01633788|54470135|FG002|Overall Study|Protocol Violation|1|||
27870139|NCT01633788|54470136|FG003|Overall Study|Protocol Violation|0|||
27870140|NCT01633788|54470133|FG000|Overall Study|Other Reasons|0|||
28171429|NCT01362062|54843026|FG000|Overall Study|Withdrawal by Subject|2|||
27870141|NCT01633788|54470134|FG001|Overall Study|Other Reasons|2|||
27870142|NCT01633788|54470135|FG002|Overall Study|Other Reasons|3|||
28171430|NCT01362062|54843027|FG001|Overall Study|Withdrawal by Subject|0|||
27870143|NCT01633788|54470136|FG003|Overall Study|Other Reasons|7|||
27870144|NCT04154943|54470146|FG000|Overall Study|Study Ongoing|68|||
27870145|NCT04154943|54470146|FG000|Overall Study|Lost to Follow-up|1|||
27870146|NCT04154943|54470146|FG000|Overall Study|Decision by the Investigator|1|||
27870147|NCT04154943|54470146|FG000|Overall Study|Death|5|||
27870148|NCT04154943|54470146|FG000|Overall Study|Withdrawal by Subject|4|||
27870149|NCT03476239|54470167|FG000|Overall Study|Withdrawal by Subject|10|||
27870150|NCT03476239|54470167|FG000|Overall Study|Death|80|||
27870151|NCT03476239|54470167|FG000|Overall Study|Lost to Follow-up|8|||
27870152|NCT03468985|54470175|FG000|Overall Study|Adverse Event|0|||
27870153|NCT03468985|54470176|FG001|Overall Study|Adverse Event|2|||
27870154|NCT03468985|54470177|FG002|Overall Study|Adverse Event|0|||
27870155|NCT03468985|54470178|FG003|Overall Study|Adverse Event|0|||
27870156|NCT03468985|54470175|FG000|Overall Study|Withdrawal by Subject|0|||
27870157|NCT03468985|54470176|FG001|Overall Study|Withdrawal by Subject|0|||
27870158|NCT03468985|54470177|FG002|Overall Study|Withdrawal by Subject|0|||
27870159|NCT03468985|54470178|FG003|Overall Study|Withdrawal by Subject|1|||
27870160|NCT02678312|54470193|FG000|Part 1 Open Label Epoch- Period 1|Adverse Event|1|||
27870161|NCT02678312|54470194|FG001|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
27870162|NCT02678312|54470195|FG002|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
27870163|NCT02678312|54470196|FG003|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
27870164|NCT02678312|54470197|FG004|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
27870165|NCT02678312|54470193|FG000|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|1|||
27870166|NCT02678312|54470194|FG001|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
27870167|NCT02678312|54470195|FG002|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
27870168|NCT02678312|54470196|FG003|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
27870169|NCT02678312|54470197|FG004|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
27870170|NCT02678312|54470193|FG000|Part 1 Open Label Epoch- Period 1|Physician Decision|1|||
27870171|NCT02678312|54470194|FG001|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
27870172|NCT02678312|54470195|FG002|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
27870173|NCT02678312|54470196|FG003|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
27870174|NCT02678312|54470197|FG004|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
27870175|NCT02678312|54470193|FG000|Part 2 Double Blind Epoch|Adverse Event|0|||
27870176|NCT02678312|54470194|FG001|Part 2 Double Blind Epoch|Adverse Event|0|||
27870177|NCT02678312|54470195|FG002|Part 2 Double Blind Epoch|Adverse Event|0|||
27870178|NCT02678312|54470196|FG003|Part 2 Double Blind Epoch|Adverse Event|1|||
27870179|NCT02678312|54470197|FG004|Part 2 Double Blind Epoch|Adverse Event|2|||
27870180|NCT02678312|54470193|FG000|Part 2 Double Blind Epoch|Death|0|||
27870181|NCT02678312|54470194|FG001|Part 2 Double Blind Epoch|Death|0|||
27870182|NCT02678312|54470195|FG002|Part 2 Double Blind Epoch|Death|0|||
27870183|NCT02678312|54470196|FG003|Part 2 Double Blind Epoch|Death|8|||
27870184|NCT02678312|54470197|FG004|Part 2 Double Blind Epoch|Death|12|||
27870185|NCT02678312|54470193|FG000|Part 2 Double Blind Epoch|Technical Problems|0|||
27870186|NCT02678312|54470194|FG001|Part 2 Double Blind Epoch|Technical Problems|0|||
27870187|NCT02678312|54470195|FG002|Part 2 Double Blind Epoch|Technical Problems|0|||
27870188|NCT02678312|54470196|FG003|Part 2 Double Blind Epoch|Technical Problems|4|||
27870189|NCT02678312|54470197|FG004|Part 2 Double Blind Epoch|Technical Problems|2|||
27870190|NCT02678312|54470193|FG000|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
27870191|NCT02678312|54470194|FG001|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
27870192|NCT02678312|54470195|FG002|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
27870193|NCT02678312|54470196|FG003|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
27870194|NCT02678312|54470197|FG004|Part 2 Double Blind Epoch|Lost to Follow-up|2|||
27870195|NCT02678312|54470193|FG000|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
27870196|NCT02678312|54470194|FG001|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
27870197|NCT02678312|54470195|FG002|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
27870198|NCT02678312|54470196|FG003|Part 2 Double Blind Epoch|Subject/guardian Decision|5|||
27870199|NCT02678312|54470197|FG004|Part 2 Double Blind Epoch|Subject/guardian Decision|6|||
27870200|NCT02256631|54470444|FG000|Overall Study|Lost to Follow-up|1|||
27870201|NCT02256631|54470445|FG001|Overall Study|Lost to Follow-up|1|||
27870202|NCT02256631|54470446|FG002|Overall Study|Lost to Follow-up|0|||
27870203|NCT02256631|54470447|FG003|Overall Study|Lost to Follow-up|2|||
27870204|NCT02256631|54470448|FG004|Overall Study|Lost to Follow-up|0|||
27870205|NCT02256631|54470449|FG005|Overall Study|Lost to Follow-up|4|||
27870206|NCT02256631|54470450|FG006|Overall Study|Lost to Follow-up|1|||
27870207|NCT02256631|54470444|FG000|Overall Study|Withdrawal by Subject|0|||
27870208|NCT02256631|54470445|FG001|Overall Study|Withdrawal by Subject|0|||
27870209|NCT02256631|54470446|FG002|Overall Study|Withdrawal by Subject|0|||
27870210|NCT02256631|54470447|FG003|Overall Study|Withdrawal by Subject|1|||
27870211|NCT02256631|54470448|FG004|Overall Study|Withdrawal by Subject|1|||
27870212|NCT02256631|54470449|FG005|Overall Study|Withdrawal by Subject|0|||
27870213|NCT02256631|54470450|FG006|Overall Study|Withdrawal by Subject|1|||
27870214|NCT02256631|54470444|FG000|Overall Study|Unable to get to clinic|0|||
27870215|NCT02256631|54470445|FG001|Overall Study|Unable to get to clinic|2|||
27870216|NCT02256631|54470446|FG002|Overall Study|Unable to get to clinic|0|||
27870217|NCT02256631|54470447|FG003|Overall Study|Unable to get to clinic|1|||
27870218|NCT02256631|54470448|FG004|Overall Study|Unable to get to clinic|0|||
27870219|NCT02256631|54470449|FG005|Overall Study|Unable to get to clinic|1|||
27870220|NCT02256631|54470450|FG006|Overall Study|Unable to get to clinic|2|||
27870221|NCT02163733|54470548|FG000|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
27870222|NCT02163733|54470549|FG001|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
27870223|NCT02163733|54470550|FG002|Part B: Day 15 to End Part B (AZD9291)|Death|5|||
27870224|NCT02163733|54470548|FG000|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
27870225|NCT02163733|54470549|FG001|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
27870226|NCT02163733|54470550|FG002|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19|||
27870227|NCT02279745|54470580|FG000|Overall Study|Adverse Event|7|||
27870228|NCT02279745|54470580|FG000|Overall Study|Death|6|||
27870229|NCT02279745|54470580|FG000|Overall Study|Clinical Worsening as Defined by Protocol|2|||
27870230|NCT02279745|54470580|FG000|Overall Study|Withdrawal by Subject|2|||
27870231|NCT02279745|54470580|FG000|Overall Study|Pregnancy|1|||
27870232|NCT02279745|54470580|FG000|Overall Study|Study Non-compliance|1|||
27870233|NCT02279745|54470580|FG000|Overall Study|Did Not Transition to Study ROR-PH-303|1|||
27870234|NCT01761877|54470619|FG000|Overall Study|Adverse Event|7|||
27870235|NCT01761877|54470620|FG001|Overall Study|Adverse Event|0|||
27870236|NCT01761877|54470619|FG000|Overall Study|Withdrawal by Subject|6|||
27870237|NCT01761877|54470620|FG001|Overall Study|Withdrawal by Subject|4|||
27870238|NCT01761877|54470619|FG000|Overall Study|Stopped taking AI Aromatase Inhibitor|1|||
27870239|NCT01761877|54470620|FG001|Overall Study|Stopped taking AI Aromatase Inhibitor|5|||
27870240|NCT01761877|54470619|FG000|Overall Study|Death|0|||
27870241|NCT01761877|54470620|FG001|Overall Study|Death|1|||
27870242|NCT01761877|54470619|FG000|Overall Study|MRI intolerant|1|||
27870243|NCT01761877|54470620|FG001|Overall Study|MRI intolerant|6|||
27870244|NCT03093259|54470874|FG000|Overall Study|Adverse Event|1|||
27870245|NCT03093259|54470875|FG001|Overall Study|Adverse Event|0|||
27870246|NCT03093259|54470874|FG000|Overall Study|Withdrawal by Subject|1|||
27870247|NCT03093259|54470875|FG001|Overall Study|Withdrawal by Subject|0|||
27870248|NCT02997865|54471167|FG000|Overall Study|Death|2|||
27870249|NCT02997865|54471168|FG001|Overall Study|Death|1|||
27870250|NCT02997865|54471167|FG000|Overall Study|Lost to Follow-up|6|||
27870251|NCT02997865|54471168|FG001|Overall Study|Lost to Follow-up|3|||
27870252|NCT02997865|54471167|FG000|Overall Study|Withdrawal by Subject|5|||
27870253|NCT02997865|54471168|FG001|Overall Study|Withdrawal by Subject|0|||
27870254|NCT04936334|54472395|FG000|Overall Study|Metastatic disease found on PSMA-PET, surgery cancelled|1|||
27870255|NCT01575834|54472403|FG000|Overall Study|Withdrawal by Subject|352|||
27870256|NCT01575834|54472404|FG001|Overall Study|Withdrawal by Subject|390|||
27870257|NCT01575834|54472403|FG000|Overall Study|Death|81|||
27870258|NCT01575834|54472404|FG001|Overall Study|Death|74|||
27870259|NCT01575834|54472403|FG000|Overall Study|Other|70|||
27870260|NCT01575834|54472404|FG001|Overall Study|Other|70|||
27870261|NCT01575834|54472403|FG000|Overall Study|Adverse Event|63|||
27870262|NCT01575834|54472404|FG001|Overall Study|Adverse Event|61|||
27870263|NCT01575834|54472403|FG000|Overall Study|Lost to Follow-up|55|||
27870264|NCT01575834|54472404|FG001|Overall Study|Lost to Follow-up|68|||
27870265|NCT01575834|54472403|FG000|Overall Study|Noncompliance|52|||
27870266|NCT01575834|54472404|FG001|Overall Study|Noncompliance|27|||
27870267|NCT01575834|54472403|FG000|Overall Study|Administrative decision|15|||
27870268|NCT01575834|54472404|FG001|Overall Study|Administrative decision|33|||
27870269|NCT01575834|54472403|FG000|Overall Study|Ineligibility Determined|5|||
27870270|NCT01575834|54472404|FG001|Overall Study|Ineligibility Determined|8|||
27870271|NCT01575834|54472403|FG000|Overall Study|Protocol Deviation|4|||
27870272|NCT01575834|54472404|FG001|Overall Study|Protocol Deviation|3|||
27870273|NCT01575834|54472403|FG000|Overall Study|Requirement for Alternative Therapy|2|||
27870274|NCT01575834|54472404|FG001|Overall Study|Requirement for Alternative Therapy|4|||
27870275|NCT02253654|54472516|FG000|Overall Study|Withdrawal by Subject|12|||
27870276|NCT02253654|54472517|FG001|Overall Study|Withdrawal by Subject|4|||
27870277|NCT02253654|54472516|FG000|Overall Study|Decision by Sponsor|1|||
27870278|NCT02253654|54472517|FG001|Overall Study|Decision by Sponsor|1|||
27870279|NCT02253654|54472516|FG000|Overall Study|Lost to Follow-up|2|||
27870280|NCT02253654|54472517|FG001|Overall Study|Lost to Follow-up|5|||
27870281|NCT02253654|54472516|FG000|Overall Study|Death|4|||
27870282|NCT02253654|54472517|FG001|Overall Study|Death|7|||
27870283|NCT02253654|54472516|FG000|Overall Study|Did Not Receive Study Treatment|4|||
27870284|NCT02253654|54472517|FG001|Overall Study|Did Not Receive Study Treatment|1|||
27870285|NCT02252406|54472525|FG000|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2|||
27870286|NCT02252406|54472526|FG001|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3|||
28096369|NCT04526574|54751268|FG000|Overall Study|Adverse Event|1|||
27870287|NCT02252406|54472525|FG000|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1|||
27870288|NCT02252406|54472526|FG001|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0|||
27739002|NCT02462486|54188292|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|3|||
27870289|NCT02252406|54472525|FG000|Starting Dose Ranolazine 500 mg BID|Adverse Event|1|||
27870290|NCT02252406|54472526|FG001|Starting Dose Ranolazine 500 mg BID|Adverse Event|0|||
27870291|NCT02252406|54472525|FG000|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
27870292|NCT02252406|54472526|FG001|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
27870293|NCT02252406|54472525|FG000|Titrated to Ranolazine 1000mg BID|Adverse Event|2|||
27870294|NCT02252406|54472526|FG001|Titrated to Ranolazine 1000mg BID|Adverse Event|0|||
27870295|NCT02246478|54472536|FG000|Multiple-dose Phase|Protocol Violation|1|||
27870296|NCT02246478|54472537|FG001|Multiple-dose Phase|Protocol Violation|0|||
27870297|NCT02246478|54472538|FG002|Multiple-dose Phase|Protocol Violation|0|||
27870298|NCT02246478|54472539|FG003|Multiple-dose Phase|Protocol Violation|1|||
27870299|NCT02252016|54472558|FG000|Overall Study|Lost to Follow-up|2|||
27870300|NCT02252016|54472559|FG001|Overall Study|Lost to Follow-up|1|||
27870301|NCT02252016|54472558|FG000|Overall Study|Physician Decision|1|||
27870302|NCT02252016|54472559|FG001|Overall Study|Physician Decision|0|||
27870303|NCT02252016|54472558|FG000|Overall Study|Withdrawal by Subject|0|||
27870304|NCT02252016|54472559|FG001|Overall Study|Withdrawal by Subject|2|||
27870305|NCT02249832|54472565|FG000|Overall Study|Withdrawal by Subject|3|||
27870306|NCT02249832|54472565|FG000|Overall Study|Lost to Follow-up|10|||
27870307|NCT02248974|54472576|FG000|1-Day Follow-Up|Lost to Follow-up|4|||
27870308|NCT02248974|54472577|FG001|1-Day Follow-Up|Lost to Follow-up|0|||
27870309|NCT02248974|54472576|FG000|1-Day Follow-Up|Withdrawal by Subject|5|||
27870310|NCT02248974|54472577|FG001|1-Day Follow-Up|Withdrawal by Subject|0|||
27870311|NCT02248974|54472576|FG000|1-Day Follow-Up|Enrolled in another study|1|||
27870312|NCT02248974|54472577|FG001|1-Day Follow-Up|Enrolled in another study|0|||
27870313|NCT02248974|54472576|FG000|1-Week Follow-Up|Became ineligible for LVAD|4|||
27870314|NCT02248974|54472577|FG001|1-Week Follow-Up|Became ineligible for LVAD|1|||
27870315|NCT02248974|54472576|FG000|1-Week Follow-Up|Enrolled in another study|1|||
27870316|NCT02248974|54472577|FG001|1-Week Follow-Up|Enrolled in another study|1|||
27870317|NCT02248974|54472576|FG000|1-Week Follow-Up|Transferred to another facility|1|||
27870318|NCT02248974|54472577|FG001|1-Week Follow-Up|Transferred to another facility|0|||
27870319|NCT02248974|54472576|FG000|1-Week Follow-Up|Cognitive Difficulty|1|||
27870320|NCT02248974|54472577|FG001|1-Week Follow-Up|Cognitive Difficulty|0|||
27870321|NCT02248974|54472576|FG000|1-Week Follow-Up|Death|1|||
27870322|NCT02248974|54472577|FG001|1-Week Follow-Up|Death|1|||
27870323|NCT02248974|54472576|FG000|1-Week Follow-Up|Excluded because of age|0|||
27870324|NCT02248974|54472577|FG001|1-Week Follow-Up|Excluded because of age|1|||
27870325|NCT02248974|54472576|FG000|1-Week Follow-Up|Noncompliant with terms of participation|0|||
27870326|NCT02248974|54472577|FG001|1-Week Follow-Up|Noncompliant with terms of participation|1|||
27870327|NCT02248974|54472576|FG000|1-Week Follow-Up|Timing: implanted before survey|0|||
27870328|NCT02248974|54472577|FG001|1-Week Follow-Up|Timing: implanted before survey|2|||
27870329|NCT02248974|54472576|FG000|1-Week Follow-Up|Withdrawal by Subject|0|||
27870330|NCT02248974|54472577|FG001|1-Week Follow-Up|Withdrawal by Subject|2|||
27870331|NCT02248974|54472576|FG000|1-Week Follow-Up|Lost to Follow-up|0|||
27870332|NCT02248974|54472577|FG001|1-Week Follow-Up|Lost to Follow-up|8|||
27870333|NCT02248974|54472576|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
27870334|NCT02248974|54472577|FG001|1-Month Follow-Up|Lost to Follow-up|3|||
27870335|NCT02246166|54472585|FG000|Overall Study|Protocol Violation|1|||
27870336|NCT02246166|54472586|FG001|Overall Study|Protocol Violation|0|||
27870337|NCT02706847|54472595|FG000|Period 1: Day 1 to Week 12|Adverse Event|2|||
27870338|NCT02706847|54472596|FG001|Period 1: Day 1 to Week 12|Adverse Event|2|||
27870339|NCT02706847|54472597|FG002|Period 1: Day 1 to Week 12|Adverse Event|1|||
27870340|NCT02706847|54472598|FG003|Period 1: Day 1 to Week 12|Adverse Event|12|||
27870341|NCT02706847|54472595|FG000|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
27870342|NCT02706847|54472596|FG001|Period 1: Day 1 to Week 12|Withdrawal by Subject|1|||
27870343|NCT02706847|54472597|FG002|Period 1: Day 1 to Week 12|Withdrawal by Subject|4|||
27870344|NCT02706847|54472598|FG003|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
27870345|NCT02706847|54472595|FG000|Period 1: Day 1 to Week 12|Lost to Follow-up|2|||
27870346|NCT02706847|54472596|FG001|Period 1: Day 1 to Week 12|Lost to Follow-up|1|||
27870347|NCT02706847|54472597|FG002|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
27870348|NCT02706847|54472598|FG003|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
27870349|NCT02706847|54472595|FG000|Period 1: Day 1 to Week 12|Other|4|||
27870350|NCT02706847|54472596|FG001|Period 1: Day 1 to Week 12|Other|4|||
27870351|NCT02706847|54472597|FG002|Period 1: Day 1 to Week 12|Other|2|||
27870352|NCT02706847|54472598|FG003|Period 1: Day 1 to Week 12|Other|2|||
27870353|NCT02706847|54472595|FG000|Period 1: Day 1 to Week 12|Randomized in Error|0|||
27870354|NCT02706847|54472596|FG001|Period 1: Day 1 to Week 12|Randomized in Error|0|||
27870355|NCT02706847|54472597|FG002|Period 1: Day 1 to Week 12|Randomized in Error|1|||
27870356|NCT02706847|54472598|FG003|Period 1: Day 1 to Week 12|Randomized in Error|0|||
27870357|NCT02706847|54472595|FG000|Period 1: Week 12 to Week 24|Adverse Event|1|||
27870358|NCT02706847|54472596|FG001|Period 1: Week 12 to Week 24|Adverse Event|2|||
27870359|NCT02706847|54472597|FG002|Period 1: Week 12 to Week 24|Adverse Event|2|||
27870360|NCT02706847|54472598|FG003|Period 1: Week 12 to Week 24|Adverse Event|5|||
27870361|NCT02706847|54472595|FG000|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
27870362|NCT02706847|54472596|FG001|Period 1: Week 12 to Week 24|Withdrawal by Subject|0|||
27870363|NCT02706847|54472597|FG002|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
27982366|NCT00930059|54640431|FG000|Overall Study|Death|1|||
27870364|NCT02706847|54472598|FG003|Period 1: Week 12 to Week 24|Withdrawal by Subject|4|||
27870365|NCT02706847|54472595|FG000|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
27870366|NCT02706847|54472596|FG001|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
27870367|NCT02706847|54472597|FG002|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
27870368|NCT02706847|54472598|FG003|Period 1: Week 12 to Week 24|Lost to Follow-up|1|||
27870369|NCT02706847|54472595|FG000|Period 1: Week 12 to Week 24|Other|1|||
27870370|NCT02706847|54472596|FG001|Period 1: Week 12 to Week 24|Other|0|||
27870371|NCT02706847|54472597|FG002|Period 1: Week 12 to Week 24|Other|1|||
27870372|NCT02706847|54472598|FG003|Period 1: Week 12 to Week 24|Other|4|||
27870373|NCT02706847|54472595|FG000|Period 2: Week 24 to Week 260|Adverse Event|11|||
27870374|NCT02706847|54472596|FG001|Period 2: Week 24 to Week 260|Adverse Event|9|||
27870375|NCT02706847|54472597|FG002|Period 2: Week 24 to Week 260|Adverse Event|21|||
27870376|NCT02706847|54472598|FG003|Period 2: Week 24 to Week 260|Adverse Event|11|||
27870377|NCT02706847|54472595|FG000|Period 2: Week 24 to Week 260|Withdrawal by Subject|11|||
27870378|NCT02706847|54472596|FG001|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
27870379|NCT02706847|54472597|FG002|Period 2: Week 24 to Week 260|Withdrawal by Subject|17|||
27870380|NCT02706847|54472598|FG003|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
27870381|NCT02706847|54472595|FG000|Period 2: Week 24 to Week 260|Lost to Follow-up|1|||
27870382|NCT02706847|54472596|FG001|Period 2: Week 24 to Week 260|Lost to Follow-up|5|||
27870383|NCT02706847|54472597|FG002|Period 2: Week 24 to Week 260|Lost to Follow-up|9|||
27870384|NCT02706847|54472598|FG003|Period 2: Week 24 to Week 260|Lost to Follow-up|6|||
27870385|NCT02706847|54472595|FG000|Period 2: Week 24 to Week 260|Lack of Efficacy|5|||
27870386|NCT02706847|54472596|FG001|Period 2: Week 24 to Week 260|Lack of Efficacy|3|||
27870387|NCT02706847|54472597|FG002|Period 2: Week 24 to Week 260|Lack of Efficacy|9|||
27870388|NCT02706847|54472598|FG003|Period 2: Week 24 to Week 260|Lack of Efficacy|8|||
27870389|NCT02706847|54472595|FG000|Period 2: Week 24 to Week 260|Other|8|||
27870390|NCT02706847|54472596|FG001|Period 2: Week 24 to Week 260|Other|5|||
27870391|NCT02706847|54472597|FG002|Period 2: Week 24 to Week 260|Other|15|||
27870392|NCT02706847|54472598|FG003|Period 2: Week 24 to Week 260|Other|15|||
27870393|NCT02245620|54472611|FG000|Overall Study|Physician Decision|1|||
27870394|NCT02245620|54472612|FG001|Overall Study|Physician Decision|1|||
27870395|NCT02244996|54472620|FG000|Overall Study|Lack of Efficacy|2|||
27870396|NCT02244996|54472621|FG001|Overall Study|Lack of Efficacy|6|||
27870397|NCT02243280|54472656|FG000|Treated|Adverse Event|1|||
27870398|NCT02243280|54472657|FG001|Treated|Adverse Event|0|||
27870399|NCT02243280|54472658|FG002|Treated|Adverse Event|0|||
27870400|NCT02243280|54472659|FG003|Treated|Adverse Event|0|||
27870401|NCT02243280|54472660|FG004|Treated|Adverse Event|0|||
27870402|NCT02243280|54472661|FG005|Treated|Adverse Event|0|||
27870403|NCT02243280|54472662|FG006|Treated|Adverse Event|0|||
27870404|NCT02243280|54472663|FG007|Treated|Adverse Event|0|||
27870405|NCT02243280|54472664|FG008|Treated|Adverse Event|0|||
27870406|NCT02243280|54472665|FG009|Treated|Adverse Event|0|||
28096370|NCT04526574|54751269|FG001|Overall Study|Adverse Event|1|||
28096371|NCT04526574|54751268|FG000|Overall Study|Death|2|||
27870407|NCT02243280|54472666|FG010|Treated|Adverse Event|1|||
27870408|NCT02243280|54472656|FG000|Treated|Lost to Follow-up|0|||
27870409|NCT02243280|54472657|FG001|Treated|Lost to Follow-up|0|||
27870410|NCT02243280|54472658|FG002|Treated|Lost to Follow-up|0|||
27870411|NCT02243280|54472659|FG003|Treated|Lost to Follow-up|0|||
27870412|NCT02243280|54472660|FG004|Treated|Lost to Follow-up|0|||
27870413|NCT02243280|54472661|FG005|Treated|Lost to Follow-up|0|||
27870414|NCT02243280|54472662|FG006|Treated|Lost to Follow-up|0|||
27870415|NCT02243280|54472663|FG007|Treated|Lost to Follow-up|0|||
27870416|NCT02243280|54472664|FG008|Treated|Lost to Follow-up|1|||
27870417|NCT02243280|54472665|FG009|Treated|Lost to Follow-up|0|||
27870418|NCT02243280|54472666|FG010|Treated|Lost to Follow-up|2|||
27870419|NCT02248818|54472724|FG000|Screening|Protocol Violation|0|||
27870420|NCT02248818|54472725|FG001|Screening|Protocol Violation|0|||
27870421|NCT02248818|54472726|FG002|Screening|Protocol Violation|0|||
28096372|NCT04526574|54751269|FG001|Overall Study|Death|3|||
28096373|NCT04526574|54751268|FG000|Overall Study|Lost to Follow-up|9|||
27870422|NCT02248818|54472727|FG003|Screening|Protocol Violation|0|||
27870423|NCT02248818|54472728|FG004|Screening|Protocol Violation|0|||
27870424|NCT02248818|54472729|FG005|Screening|Protocol Violation|0|||
27870425|NCT02248818|54472730|FG006|Screening|Protocol Violation|0|||
27870426|NCT02248818|54472731|FG007|Screening|Protocol Violation|0|||
27739003|NCT02462486|54188290|FG000|Overall Study|Adverse Event|53|||
27870427|NCT02248818|54472732|FG008|Screening|Protocol Violation|7|||
27870428|NCT02248818|54472724|FG000|Screening|Study fully enrolled|0|||
27870429|NCT02248818|54472725|FG001|Screening|Study fully enrolled|0|||
28096374|NCT04526574|54751269|FG001|Overall Study|Lost to Follow-up|9|||
27870430|NCT02248818|54472726|FG002|Screening|Study fully enrolled|0|||
27870431|NCT02248818|54472727|FG003|Screening|Study fully enrolled|0|||
27870432|NCT02248818|54472728|FG004|Screening|Study fully enrolled|0|||
27870433|NCT02248818|54472729|FG005|Screening|Study fully enrolled|0|||
27870434|NCT02248818|54472730|FG006|Screening|Study fully enrolled|0|||
27870435|NCT02248818|54472731|FG007|Screening|Study fully enrolled|0|||
27870436|NCT02248818|54472732|FG008|Screening|Study fully enrolled|14|||
27870437|NCT02248818|54472724|FG000|Screening|Physician Decision|0|||
27870438|NCT02248818|54472725|FG001|Screening|Physician Decision|0|||
27870439|NCT02248818|54472726|FG002|Screening|Physician Decision|0|||
27870440|NCT02248818|54472727|FG003|Screening|Physician Decision|0|||
27870441|NCT02248818|54472728|FG004|Screening|Physician Decision|0|||
27870442|NCT02248818|54472729|FG005|Screening|Physician Decision|0|||
27870443|NCT02248818|54472730|FG006|Screening|Physician Decision|0|||
27870444|NCT02248818|54472731|FG007|Screening|Physician Decision|0|||
27870445|NCT02248818|54472732|FG008|Screening|Physician Decision|73|||
27870446|NCT02248818|54472724|FG000|Screening|Withdrawal by Subject|0|||
27870447|NCT02248818|54472725|FG001|Screening|Withdrawal by Subject|0|||
27870448|NCT02248818|54472726|FG002|Screening|Withdrawal by Subject|0|||
27870449|NCT02248818|54472727|FG003|Screening|Withdrawal by Subject|0|||
27870450|NCT02248818|54472728|FG004|Screening|Withdrawal by Subject|0|||
27870451|NCT02248818|54472729|FG005|Screening|Withdrawal by Subject|0|||
27870452|NCT02248818|54472730|FG006|Screening|Withdrawal by Subject|0|||
27870453|NCT02248818|54472731|FG007|Screening|Withdrawal by Subject|0|||
27870454|NCT02248818|54472732|FG008|Screening|Withdrawal by Subject|6|||
27870455|NCT02248818|54472724|FG000|Screening|Lost to Follow-up|0|||
27870456|NCT02248818|54472725|FG001|Screening|Lost to Follow-up|0|||
27870457|NCT02248818|54472726|FG002|Screening|Lost to Follow-up|0|||
27870458|NCT02248818|54472727|FG003|Screening|Lost to Follow-up|0|||
27870459|NCT02248818|54472728|FG004|Screening|Lost to Follow-up|0|||
27870460|NCT02248818|54472729|FG005|Screening|Lost to Follow-up|0|||
27870461|NCT02248818|54472730|FG006|Screening|Lost to Follow-up|0|||
27870462|NCT02248818|54472731|FG007|Screening|Lost to Follow-up|0|||
27870463|NCT02248818|54472732|FG008|Screening|Lost to Follow-up|7|||
27870464|NCT02248818|54472724|FG000|Randomised Study|Administrative - randomization error|0|||
27870465|NCT02248818|54472725|FG001|Randomised Study|Administrative - randomization error|0|||
27870466|NCT02248818|54472726|FG002|Randomised Study|Administrative - randomization error|0|||
27870467|NCT02248818|54472727|FG003|Randomised Study|Administrative - randomization error|0|||
27870468|NCT02248818|54472728|FG004|Randomised Study|Administrative - randomization error|0|||
27870469|NCT02248818|54472729|FG005|Randomised Study|Administrative - randomization error|8|||
27870470|NCT02248818|54472730|FG006|Randomised Study|Administrative - randomization error|0|||
27870471|NCT02248818|54472731|FG007|Randomised Study|Administrative - randomization error|0|||
27870472|NCT02248818|54472732|FG008|Randomised Study|Administrative - randomization error|0|||
27870473|NCT02247960|54472761|FG000|Patient Consent and Randomization|Physician Decision|2|||
27870474|NCT02247960|54472762|FG001|Patient Consent and Randomization|Physician Decision|2|||
27870475|NCT02247960|54472761|FG000|Patient Consent and Randomization|Withdrawal by Subject|0|||
27870476|NCT02247960|54472762|FG001|Patient Consent and Randomization|Withdrawal by Subject|4|||
27870477|NCT02247960|54472761|FG000|Catheter Removed|Lost to Follow-up|7|||
27870478|NCT02247960|54472762|FG001|Catheter Removed|Lost to Follow-up|10|||
27870479|NCT02247804|54472851|FG000|Treatment Period 1|Adverse Event|9|||
27870480|NCT02247804|54472852|FG001|Treatment Period 1|Adverse Event|2|||
27870481|NCT02247804|54472853|FG002|Treatment Period 1|Adverse Event|0|||
27870482|NCT02247804|54472851|FG000|Treatment Period 1|Lack of Efficacy|0|||
27870483|NCT02247804|54472852|FG001|Treatment Period 1|Lack of Efficacy|0|||
27870484|NCT02247804|54472853|FG002|Treatment Period 1|Lack of Efficacy|2|||
27870485|NCT02247804|54472851|FG000|Treatment Period 1|Lost to Follow-up|1|||
27870486|NCT02247804|54472852|FG001|Treatment Period 1|Lost to Follow-up|0|||
27870487|NCT02247804|54472853|FG002|Treatment Period 1|Lost to Follow-up|2|||
27870488|NCT02247804|54472851|FG000|Treatment Period 1|Personal Reasons|7|||
27870489|NCT02247804|54472852|FG001|Treatment Period 1|Personal Reasons|1|||
27870490|NCT02247804|54472853|FG002|Treatment Period 1|Personal Reasons|2|||
27870491|NCT02247804|54472851|FG000|Treatment Period 1|Protocol Deviation|0|||
27870492|NCT02247804|54472852|FG001|Treatment Period 1|Protocol Deviation|0|||
27870493|NCT02247804|54472853|FG002|Treatment Period 1|Protocol Deviation|1|||
27870494|NCT02247804|54472851|FG000|Treatment Period 1|Randomized but not Treated|5|||
28096375|NCT04526574|54751268|FG000|Overall Study|No longer meets eligibility criteria|8|||
28096376|NCT04526574|54751269|FG001|Overall Study|No longer meets eligibility criteria|8|||
27870495|NCT02247804|54472852|FG001|Treatment Period 1|Randomized but not Treated|1|||
27870496|NCT02247804|54472853|FG002|Treatment Period 1|Randomized but not Treated|1|||
27870497|NCT02247804|54472851|FG000|Treatment Period 2|Adverse Event|6|||
27870498|NCT02247804|54472852|FG001|Treatment Period 2|Adverse Event|3|||
27870499|NCT02247804|54472853|FG002|Treatment Period 2|Adverse Event|3|||
27870500|NCT02247804|54472851|FG000|Treatment Period 2|Lack of Efficacy|0|||
27870501|NCT02247804|54472852|FG001|Treatment Period 2|Lack of Efficacy|0|||
27870502|NCT02247804|54472853|FG002|Treatment Period 2|Lack of Efficacy|1|||
27870503|NCT02247804|54472851|FG000|Treatment Period 2|Lost to Follow-up|0|||
27870504|NCT02247804|54472852|FG001|Treatment Period 2|Lost to Follow-up|1|||
27870505|NCT02247804|54472853|FG002|Treatment Period 2|Lost to Follow-up|1|||
27870506|NCT02247804|54472851|FG000|Treatment Period 2|Personal Reasons|2|||
27870507|NCT02247804|54472852|FG001|Treatment Period 2|Personal Reasons|1|||
27870508|NCT02247804|54472853|FG002|Treatment Period 2|Personal Reasons|1|||
27870509|NCT02247804|54472851|FG000|Treatment Period 2|Reason not Specified|0|||
27870510|NCT02247804|54472852|FG001|Treatment Period 2|Reason not Specified|0|||
27870511|NCT02247804|54472853|FG002|Treatment Period 2|Reason not Specified|2|||
27870512|NCT02247804|54472851|FG000|Treatment Period 3|Adverse Event|4|||
27870513|NCT02247804|54472852|FG001|Treatment Period 3|Adverse Event|3|||
27870514|NCT02247804|54472853|FG002|Treatment Period 3|Adverse Event|3|||
27870515|NCT02247804|54472851|FG000|Treatment Period 3|Lack of Efficacy|0|||
27870516|NCT02247804|54472852|FG001|Treatment Period 3|Lack of Efficacy|1|||
27870517|NCT02247804|54472853|FG002|Treatment Period 3|Lack of Efficacy|0|||
27870518|NCT02247804|54472851|FG000|Treatment Period 3|Lost to Follow-up|1|||
27870519|NCT02247804|54472852|FG001|Treatment Period 3|Lost to Follow-up|2|||
27870520|NCT02247804|54472853|FG002|Treatment Period 3|Lost to Follow-up|2|||
27870521|NCT02247804|54472851|FG000|Treatment Period 3|Personal Reasons|4|||
27870522|NCT02247804|54472852|FG001|Treatment Period 3|Personal Reasons|3|||
27870523|NCT02247804|54472853|FG002|Treatment Period 3|Personal Reasons|2|||
27870524|NCT02247804|54472851|FG000|Treatment Period 3|Reason not Specified|2|||
27870525|NCT02247804|54472852|FG001|Treatment Period 3|Reason not Specified|1|||
27870526|NCT02247804|54472853|FG002|Treatment Period 3|Reason not Specified|3|||
27870527|NCT02243202|54472878|FG000|Overall Study|Adverse Event|5|||
27870528|NCT02243202|54472879|FG001|Overall Study|Adverse Event|6|||
27870529|NCT02243202|54472880|FG002|Overall Study|Adverse Event|10|||
27870530|NCT02243202|54472881|FG003|Overall Study|Adverse Event|4|||
27870531|NCT02243202|54472878|FG000|Overall Study|Lost to Follow-up|9|||
27870532|NCT02243202|54472879|FG001|Overall Study|Lost to Follow-up|9|||
27870533|NCT02243202|54472880|FG002|Overall Study|Lost to Follow-up|14|||
27870534|NCT02243202|54472881|FG003|Overall Study|Lost to Follow-up|11|||
27870535|NCT02243202|54472878|FG000|Overall Study|Protocol Violation|3|||
27870536|NCT02243202|54472879|FG001|Overall Study|Protocol Violation|1|||
27870537|NCT02243202|54472880|FG002|Overall Study|Protocol Violation|2|||
27870538|NCT02243202|54472881|FG003|Overall Study|Protocol Violation|1|||
27870539|NCT02243202|54472878|FG000|Overall Study|Withdrawal by Subject|7|||
27870540|NCT02243202|54472879|FG001|Overall Study|Withdrawal by Subject|6|||
27870541|NCT02243202|54472880|FG002|Overall Study|Withdrawal by Subject|4|||
27870542|NCT02243202|54472881|FG003|Overall Study|Withdrawal by Subject|4|||
27870543|NCT02243202|54472878|FG000|Overall Study|Other|1|||
27870544|NCT02243202|54472879|FG001|Overall Study|Other|3|||
27870545|NCT02243202|54472880|FG002|Overall Study|Other|1|||
27870546|NCT02243202|54472881|FG003|Overall Study|Other|2|||
27870547|NCT02243202|54472878|FG000|Overall Study|Randomized but not received treatment|0|||
27870548|NCT02243202|54472879|FG001|Overall Study|Randomized but not received treatment|0|||
27870549|NCT02243202|54472880|FG002|Overall Study|Randomized but not received treatment|0|||
27870550|NCT02243202|54472881|FG003|Overall Study|Randomized but not received treatment|1|||
27870551|NCT02243046|54472894|FG000|Overall Study|Lost to Follow-up|1|||
27870552|NCT02243046|54472895|FG001|Overall Study|Lost to Follow-up|1|||
27870553|NCT02243046|54472896|FG002|Overall Study|Lost to Follow-up|4|||
27870554|NCT02207946|54472906|FG000|Overall Study|Lost to Follow-up|1|||
27870555|NCT02207946|54472907|FG001|Overall Study|Lost to Follow-up|0|||
27870556|NCT02207946|54472906|FG000|Overall Study|Adverse Event|0|||
27870557|NCT02207946|54472907|FG001|Overall Study|Adverse Event|1|||
27870558|NCT03976076|54472914|FG000|Overall Study|Withdrawal by Subject|2|||
27870559|NCT03551210|54473113|FG000|Overall Study|Adverse Event|5|||
27870560|NCT03551210|54473114|FG001|Overall Study|Adverse Event|6|||
27870561|NCT03551210|54473113|FG000|Overall Study|Withdrawal by Subject|1|||
27870562|NCT03551210|54473114|FG001|Overall Study|Withdrawal by Subject|7|||
27870563|NCT03551210|54473113|FG000|Overall Study|Needed in other antibiotic treatment|2|||
27870564|NCT03551210|54473114|FG001|Overall Study|Needed in other antibiotic treatment|5|||
27870565|NCT03551210|54473113|FG000|Overall Study|Lost to Follow-up|1|||
27870566|NCT03551210|54473114|FG001|Overall Study|Lost to Follow-up|1|||
27870567|NCT03551210|54473113|FG000|Overall Study|Absence of visit 4 and 5|1|||
27982367|NCT00930059|54640432|FG001|Overall Study|Death|0|||
27982368|NCT00930059|54640431|FG000|Overall Study|Did not meet entrance criteria|1|||
27870568|NCT03551210|54473114|FG001|Overall Study|Absence of visit 4 and 5|0|||
27870569|NCT03551210|54473113|FG000|Overall Study|No drug for dispensing|0|||
27870570|NCT03551210|54473114|FG001|Overall Study|No drug for dispensing|1|||
27870571|NCT02207634|54473251|FG000|Overall Study|Withdrawal by Subject|21|||
27870572|NCT02207634|54473252|FG001|Overall Study|Withdrawal by Subject|31|||
27870573|NCT02207634|54473251|FG000|Overall Study|Lost to Follow-up|1|||
27870574|NCT02207634|54473252|FG001|Overall Study|Lost to Follow-up|0|||
27870575|NCT03452228|54473295|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
27870576|NCT03452228|54473296|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
27870577|NCT03452228|54473297|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
27870578|NCT03452228|54473295|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
27870579|NCT03452228|54473296|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
27870580|NCT03452228|54473297|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
27982369|NCT00930059|54640432|FG001|Overall Study|Did not meet entrance criteria|1|||
27870581|NCT03452228|54473295|FG000|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|1|||
27870582|NCT03452228|54473296|FG001|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
27870583|NCT03452228|54473297|FG002|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
27870584|NCT03452228|54473295|FG000|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
27870585|NCT03452228|54473296|FG001|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
27870586|NCT03452228|54473297|FG002|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
27870587|NCT02207556|54473360|FG000|Overall Study|Physician Decision|1|||
27870588|NCT02207556|54473361|FG001|Overall Study|Physician Decision|0|||
27870589|NCT02207556|54473360|FG000|Overall Study|Withdrawal by Subject|1|||
27870590|NCT02207556|54473361|FG001|Overall Study|Withdrawal by Subject|0|||
27870591|NCT02207556|54473360|FG000|Overall Study|Death|0|||
27870592|NCT02207556|54473361|FG001|Overall Study|Death|5|||
27870593|NCT03732638|54473376|FG000|DBT Phase (Weeks 1 to 12)|Adverse Event|5|||
27870594|NCT03732638|54473377|FG001|DBT Phase (Weeks 1 to 12)|Adverse Event|2|||
27870595|NCT03732638|54473376|FG000|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|8|||
27870596|NCT03732638|54473377|FG001|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|13|||
27870597|NCT03732638|54473376|FG000|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
27870598|NCT03732638|54473377|FG001|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
27870599|NCT03732638|54473376|FG000|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|19|||
27870600|NCT03732638|54473377|FG001|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|12|||
27870601|NCT03732638|54473376|FG000|DBT Phase (Weeks 1 to 12)|Non-compliance|6|||
27870602|NCT03732638|54473377|FG001|DBT Phase (Weeks 1 to 12)|Non-compliance|5|||
27870603|NCT03732638|54473376|FG000|DBT Phase (Weeks 1 to 12)|Physician Decision|0|||
27870604|NCT03732638|54473377|FG001|DBT Phase (Weeks 1 to 12)|Physician Decision|1|||
27870605|NCT03732638|54473376|FG000|DBT Phase (Weeks 1 to 12)|Protocol deviation|4|||
27870606|NCT03732638|54473377|FG001|DBT Phase (Weeks 1 to 12)|Protocol deviation|5|||
27870607|NCT03732638|54473376|FG000|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|11|||
27870608|NCT03732638|54473377|FG001|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|22|||
27870609|NCT03732638|54473376|FG000|OLE Phase (Weeks 13 to 64)|Adverse Event|10|||
27870610|NCT03732638|54473377|FG001|OLE Phase (Weeks 13 to 64)|Adverse Event|9|||
27870611|NCT03732638|54473376|FG000|OLE Phase (Weeks 13 to 64)|Death|1|||
27870612|NCT03732638|54473377|FG001|OLE Phase (Weeks 13 to 64)|Death|1|||
27870613|NCT03732638|54473376|FG000|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|2|||
27870614|NCT03732638|54473377|FG001|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|0|||
27870615|NCT03732638|54473376|FG000|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
27870616|NCT03732638|54473377|FG001|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
27870617|NCT03732638|54473376|FG000|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|19|||
27870618|NCT03732638|54473377|FG001|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|13|||
27870619|NCT03732638|54473376|FG000|OLE Phase (Weeks 13 to 64)|Non-compliance|15|||
27870620|NCT03732638|54473377|FG001|OLE Phase (Weeks 13 to 64)|Non-compliance|14|||
27870621|NCT03732638|54473376|FG000|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
27870622|NCT03732638|54473377|FG001|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
27870623|NCT03732638|54473376|FG000|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
27870624|NCT03732638|54473377|FG001|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
27870625|NCT03732638|54473376|FG000|OLE Phase (Weeks 13 to 64)|Protocol deviation|2|||
27870626|NCT03732638|54473377|FG001|OLE Phase (Weeks 13 to 64)|Protocol deviation|3|||
27870627|NCT03732638|54473376|FG000|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|1|||
27870628|NCT03732638|54473377|FG001|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|0|||
27870629|NCT03732638|54473376|FG000|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|29|||
27870630|NCT03732638|54473377|FG001|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|28|||
27870631|NCT03732638|54473376|FG000|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
27870632|NCT03732638|54473377|FG001|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
27870633|NCT03732638|54473376|FG000|Follow-up Phase (up to 72 Weeks)|Not reported|49|||
27870634|NCT03732638|54473377|FG001|Follow-up Phase (up to 72 Weeks)|Not reported|48|||
27870635|NCT03732638|54473376|FG000|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|10|||
27870636|NCT03732638|54473377|FG001|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|6|||
27870637|NCT03732638|54473376|FG000|Follow-up Phase (up to 72 Weeks)|Non-compliance|2|||
27870638|NCT03732638|54473377|FG001|Follow-up Phase (up to 72 Weeks)|Non-compliance|1|||
27870639|NCT03732638|54473376|FG000|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|4|||
27870640|NCT03732638|54473377|FG001|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|7|||
27870641|NCT03266588|54473416|FG000|Observational Period|Screen Failure: Eligibility Criteria|439|||
27870642|NCT03266588|54473417|FG001|Observational Period|Screen Failure: Eligibility Criteria|228|||
27870643|NCT03266588|54473418|FG002|Observational Period|Screen Failure: Eligibility Criteria|140|||
27870644|NCT03266588|54473416|FG000|Observational Period|Withdrawal by Subject|44|||
27870645|NCT03266588|54473417|FG001|Observational Period|Withdrawal by Subject|22|||
27982370|NCT00930059|54640431|FG000|Overall Study|Withdrawal by Subject|3|||
27982371|NCT00930059|54640432|FG001|Overall Study|Withdrawal by Subject|4|||
27870646|NCT03266588|54473418|FG002|Observational Period|Withdrawal by Subject|13|||
27982372|NCT00930059|54640431|FG000|Overall Study|Other|1|||
27982373|NCT00930059|54640432|FG001|Overall Study|Other|0|||
27739004|NCT02462486|54188291|FG001|Overall Study|Adverse Event|48|||
27870647|NCT03266588|54473416|FG000|Observational Period|Non-compliance|18|||
27870648|NCT03266588|54473417|FG001|Observational Period|Non-compliance|12|||
27870649|NCT03266588|54473418|FG002|Observational Period|Non-compliance|10|||
27870650|NCT03266588|54473416|FG000|Observational Period|Lost to Follow-up|8|||
27870651|NCT03266588|54473417|FG001|Observational Period|Lost to Follow-up|12|||
27870652|NCT03266588|54473418|FG002|Observational Period|Lost to Follow-up|4|||
27870653|NCT03266588|54473416|FG000|Observational Period|Eligibility Failure- Baseline Lab Values|3|||
27870654|NCT03266588|54473417|FG001|Observational Period|Eligibility Failure- Baseline Lab Values|1|||
27870655|NCT03266588|54473418|FG002|Observational Period|Eligibility Failure- Baseline Lab Values|0|||
27870656|NCT03266588|54473416|FG000|Observational Period|Protocol Deviation|1|||
27870657|NCT03266588|54473417|FG001|Observational Period|Protocol Deviation|0|||
27870658|NCT03266588|54473418|FG002|Observational Period|Protocol Deviation|0|||
27870659|NCT03266588|54473416|FG000|Observational Period|Other Reasons|3|||
27870660|NCT03266588|54473417|FG001|Observational Period|Other Reasons|0|||
27870661|NCT03266588|54473418|FG002|Observational Period|Other Reasons|1|||
27870662|NCT03266588|54473416|FG000|Long-term Treatment Period|Adverse Event|33|||
28096377|NCT03993392|54751279|FG000|Overall Study|Withdrawal by Subject|3|||
28096378|NCT03993392|54751279|FG000|Overall Study|Lost to Follow-up|2|||
28096379|NCT03993392|54751279|FG000|Overall Study|Did not meet Day 1 check-in criteria|1|||
28096380|NCT04422990|54751286|FG000|Overall Study|Withdrawal by Subject|0|||
28096381|NCT04422990|54751287|FG001|Overall Study|Withdrawal by Subject|1|||
28096382|NCT04422990|54751286|FG000|Overall Study|Travel|3|||
28096383|NCT04422990|54751287|FG001|Overall Study|Travel|0|||
27870663|NCT03266588|54473417|FG001|Long-term Treatment Period|Adverse Event|17|||
27870664|NCT03266588|54473418|FG002|Long-term Treatment Period|Adverse Event|8|||
27870665|NCT03266588|54473416|FG000|Long-term Treatment Period|Lack of Efficacy|41|||
27870666|NCT03266588|54473417|FG001|Long-term Treatment Period|Lack of Efficacy|31|||
27870667|NCT03266588|54473418|FG002|Long-term Treatment Period|Lack of Efficacy|5|||
27870668|NCT03266588|54473416|FG000|Long-term Treatment Period|Lost to Follow-up|39|||
27870669|NCT03266588|54473417|FG001|Long-term Treatment Period|Lost to Follow-up|37|||
27870670|NCT03266588|54473418|FG002|Long-term Treatment Period|Lost to Follow-up|8|||
27870671|NCT03266588|54473416|FG000|Long-term Treatment Period|Non-Compliance|126|||
27870672|NCT03266588|54473417|FG001|Long-term Treatment Period|Non-Compliance|57|||
27870673|NCT03266588|54473418|FG002|Long-term Treatment Period|Non-Compliance|7|||
27870674|NCT03266588|54473416|FG000|Long-term Treatment Period|Pregnancy|11|||
27870675|NCT03266588|54473417|FG001|Long-term Treatment Period|Pregnancy|5|||
27870676|NCT03266588|54473418|FG002|Long-term Treatment Period|Pregnancy|0|||
27870677|NCT03266588|54473416|FG000|Long-term Treatment Period|Protocol Deviation|17|||
27870678|NCT03266588|54473417|FG001|Long-term Treatment Period|Protocol Deviation|10|||
27870679|NCT03266588|54473418|FG002|Long-term Treatment Period|Protocol Deviation|4|||
27870680|NCT03266588|54473416|FG000|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33|||
27870681|NCT03266588|54473417|FG001|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
27870682|NCT03266588|54473418|FG002|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
27870683|NCT03266588|54473416|FG000|Long-term Treatment Period|Withdrawal by Subject|100|||
27870684|NCT03266588|54473417|FG001|Long-term Treatment Period|Withdrawal by Subject|63|||
27870685|NCT03266588|54473418|FG002|Long-term Treatment Period|Withdrawal by Subject|16|||
27870686|NCT03266588|54473416|FG000|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1|||
27870687|NCT03266588|54473417|FG001|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2|||
27870688|NCT03266588|54473418|FG002|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0|||
27870689|NCT03266588|54473416|FG000|Long-term Treatment Period|Other Reasons|5|||
27870690|NCT03266588|54473417|FG001|Long-term Treatment Period|Other Reasons|0|||
27870691|NCT03266588|54473418|FG002|Long-term Treatment Period|Other Reasons|0|||
27870692|NCT03266588|54473416|FG000|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
27870693|NCT03266588|54473417|FG001|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1|||
27870694|NCT03266588|54473418|FG002|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
27870695|NCT03238196|54473482|FG000|Overall Study|Adverse Event|3|||
27870696|NCT03238196|54473483|FG001|Overall Study|Adverse Event|0|||
27870697|NCT03238196|54473484|FG002|Overall Study|Adverse Event|2|||
27870698|NCT03238196|54473485|FG003|Overall Study|Adverse Event|2|||
27870699|NCT03238196|54473482|FG000|Overall Study|Withdrawal by Subject|4|||
27870700|NCT03238196|54473483|FG001|Overall Study|Withdrawal by Subject|1|||
27870701|NCT03238196|54473484|FG002|Overall Study|Withdrawal by Subject|1|||
27870702|NCT03238196|54473485|FG003|Overall Study|Withdrawal by Subject|0|||
27870703|NCT03238196|54473482|FG000|Overall Study|Disease progression|14|||
27870704|NCT03238196|54473483|FG001|Overall Study|Disease progression|2|||
27870705|NCT03238196|54473484|FG002|Overall Study|Disease progression|3|||
27870706|NCT03238196|54473485|FG003|Overall Study|Disease progression|2|||
27870707|NCT03238196|54473482|FG000|Overall Study|Still on treatment|1|||
27870708|NCT03238196|54473483|FG001|Overall Study|Still on treatment|0|||
27982374|NCT00930059|54640431|FG000|Overall Study|1 site terminated by sponsor|1|||
27739005|NCT02462486|54188292|FG002|Overall Study|Adverse Event|21|||
28096384|NCT04377308|54751298|FG000|Overall Study|Withdrawal by Subject|0|||
28171431|NCT01362062|54843026|FG000|Overall Study|Non-compliant participant|2|||
27870709|NCT03238196|54473484|FG002|Overall Study|Still on treatment|0|||
27870710|NCT03238196|54473485|FG003|Overall Study|Still on treatment|0|||
27870711|NCT03019640|54473504|FG000|Overall Study|Screen Failures|4|||
27870712|NCT03019640|54473504|FG000|Overall Study|Adverse Event|3|||
27870713|NCT03019640|54473504|FG000|Overall Study|Participant Relapsed|1|||
27870714|NCT02240706|54473572|FG000|Overall Study|Lack of Efficacy|2|||
27870715|NCT02240706|54473573|FG001|Overall Study|Lack of Efficacy|2|||
27870716|NCT02240706|54473574|FG002|Overall Study|Lack of Efficacy|2|||
27870717|NCT02240706|54473575|FG003|Overall Study|Lack of Efficacy|2|||
27870718|NCT02240706|54473576|FG004|Overall Study|Lack of Efficacy|5|||
27870719|NCT02240706|54473577|FG005|Overall Study|Lack of Efficacy|0|||
27870720|NCT02240706|54473578|FG006|Overall Study|Lack of Efficacy|0|||
27870721|NCT02240706|54473572|FG000|Overall Study|Adverse Event|1|||
27870722|NCT02240706|54473573|FG001|Overall Study|Adverse Event|0|||
27870723|NCT02240706|54473574|FG002|Overall Study|Adverse Event|1|||
27870724|NCT02240706|54473575|FG003|Overall Study|Adverse Event|0|||
27870725|NCT02240706|54473576|FG004|Overall Study|Adverse Event|2|||
27870726|NCT02240706|54473577|FG005|Overall Study|Adverse Event|0|||
27870727|NCT02240706|54473578|FG006|Overall Study|Adverse Event|0|||
27870728|NCT02240706|54473572|FG000|Overall Study|Progressive disease|0|||
27870729|NCT02240706|54473573|FG001|Overall Study|Progressive disease|0|||
27870730|NCT02240706|54473574|FG002|Overall Study|Progressive disease|0|||
27870731|NCT02240706|54473575|FG003|Overall Study|Progressive disease|0|||
27870732|NCT02240706|54473576|FG004|Overall Study|Progressive disease|1|||
27870733|NCT02240706|54473577|FG005|Overall Study|Progressive disease|0|||
27870734|NCT02240706|54473578|FG006|Overall Study|Progressive disease|0|||
27870735|NCT02240706|54473572|FG000|Overall Study|Dose limiting toxicity|0|||
27870736|NCT02240706|54473573|FG001|Overall Study|Dose limiting toxicity|0|||
27870737|NCT02240706|54473574|FG002|Overall Study|Dose limiting toxicity|0|||
27870738|NCT02240706|54473575|FG003|Overall Study|Dose limiting toxicity|0|||
27870739|NCT02240706|54473576|FG004|Overall Study|Dose limiting toxicity|1|||
27870740|NCT02240706|54473577|FG005|Overall Study|Dose limiting toxicity|0|||
27870741|NCT02240706|54473578|FG006|Overall Study|Dose limiting toxicity|0|||
27870742|NCT02240706|54473572|FG000|Overall Study|Refused to continue taking medication|0|||
27870743|NCT02240706|54473573|FG001|Overall Study|Refused to continue taking medication|1|||
27870744|NCT02240706|54473574|FG002|Overall Study|Refused to continue taking medication|3|||
27870745|NCT02240706|54473575|FG003|Overall Study|Refused to continue taking medication|1|||
27870746|NCT02240706|54473576|FG004|Overall Study|Refused to continue taking medication|2|||
27870747|NCT02240706|54473577|FG005|Overall Study|Refused to continue taking medication|0|||
27870748|NCT02240706|54473578|FG006|Overall Study|Refused to continue taking medication|0|||
27870749|NCT02240706|54473572|FG000|Overall Study|Insurance billing concerns|0|||
27870750|NCT02240706|54473573|FG001|Overall Study|Insurance billing concerns|0|||
27870751|NCT02240706|54473574|FG002|Overall Study|Insurance billing concerns|0|||
27870752|NCT02240706|54473575|FG003|Overall Study|Insurance billing concerns|1|||
27870753|NCT02240706|54473576|FG004|Overall Study|Insurance billing concerns|0|||
27870754|NCT02240706|54473577|FG005|Overall Study|Insurance billing concerns|0|||
27870755|NCT02240706|54473578|FG006|Overall Study|Insurance billing concerns|0|||
27870756|NCT01600092|54473603|FG000|Overall Study|Adverse Event|2|||
27870757|NCT01600092|54473604|FG001|Overall Study|Adverse Event|0|||
27870758|NCT01600092|54473603|FG000|Overall Study|Lost to Follow-up|4|||
27870759|NCT01600092|54473604|FG001|Overall Study|Lost to Follow-up|6|||
27870760|NCT01600092|54473603|FG000|Overall Study|Withdrawal by parent/guardian|8|||
27870761|NCT01600092|54473604|FG001|Overall Study|Withdrawal by parent/guardian|6|||
27870762|NCT01600092|54473603|FG000|Overall Study|Physician Decision|1|||
27870763|NCT01600092|54473604|FG001|Overall Study|Physician Decision|1|||
27870764|NCT01600092|54473603|FG000|Overall Study|Randomized but not vaccinated|3|||
27870765|NCT01600092|54473604|FG001|Overall Study|Randomized but not vaccinated|3|||
27870766|NCT02240628|54473616|FG000|Overall Study|Physician Decision|6|||
27870767|NCT02240628|54473617|FG001|Overall Study|Physician Decision|5|||
27870768|NCT02207400|54473639|FG000|Overall Study|Adverse Event|1|||
27870769|NCT02207400|54473640|FG001|Overall Study|Adverse Event|1|||
27870770|NCT02207400|54473639|FG000|Overall Study|Lost to Follow-up|6|||
27870771|NCT02207400|54473640|FG001|Overall Study|Lost to Follow-up|7|||
27870772|NCT02207400|54473639|FG000|Overall Study|Protocol Violation|1|||
27870773|NCT02207400|54473640|FG001|Overall Study|Protocol Violation|1|||
27870774|NCT02207400|54473639|FG000|Overall Study|Withdrawal by Subject|8|||
27870775|NCT02207400|54473640|FG001|Overall Study|Withdrawal by Subject|4|||
27870776|NCT02207400|54473639|FG000|Overall Study|Positive Urine Pregnancy Test|0|||
27870777|NCT02207400|54473640|FG001|Overall Study|Positive Urine Pregnancy Test|1|||
27870778|NCT02207244|54474012|FG000|Placebo Controlled Period: Week 0-16|Adverse Event|2|||
27870779|NCT02207244|54474013|FG001|Placebo Controlled Period: Week 0-16|Adverse Event|9|||
27870780|NCT02207244|54474014|FG002|Placebo Controlled Period: Week 0-16|Adverse Event|4|||
27870781|NCT02207244|54474015|FG003|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
27870782|NCT02207244|54474016|FG004|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
27870783|NCT02207244|54474017|FG005|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
27870784|NCT02207244|54474018|FG006|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
27870785|NCT02207244|54474019|FG007|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
27870786|NCT02207244|54474020|FG008|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
27870787|NCT02207244|54474021|FG009|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
27870788|NCT02207244|54474022|FG010|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
27870789|NCT02207244|54474012|FG000|Placebo Controlled Period: Week 0-16|Lack of Efficacy|4|||
27870790|NCT02207244|54474013|FG001|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
27870791|NCT02207244|54474014|FG002|Placebo Controlled Period: Week 0-16|Lack of Efficacy|2|||
27870792|NCT02207244|54474015|FG003|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
27870793|NCT02207244|54474016|FG004|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
27870794|NCT02207244|54474017|FG005|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
27870795|NCT02207244|54474018|FG006|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
27870796|NCT02207244|54474019|FG007|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
27870797|NCT02207244|54474020|FG008|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
27870798|NCT02207244|54474021|FG009|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
27870799|NCT02207244|54474022|FG010|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
27870800|NCT02207244|54474012|FG000|Placebo Controlled Period: Week 0-16|Lost to Follow-up|1|||
27870801|NCT02207244|54474013|FG001|Placebo Controlled Period: Week 0-16|Lost to Follow-up|3|||
27870802|NCT02207244|54474014|FG002|Placebo Controlled Period: Week 0-16|Lost to Follow-up|2|||
27870803|NCT02207244|54474015|FG003|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
27870804|NCT02207244|54474016|FG004|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
27870805|NCT02207244|54474017|FG005|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
27870806|NCT02207244|54474018|FG006|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
27870807|NCT02207244|54474019|FG007|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
27870808|NCT02207244|54474020|FG008|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
27870809|NCT02207244|54474021|FG009|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
27870810|NCT02207244|54474022|FG010|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
27870811|NCT02207244|54474012|FG000|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|7|||
27870812|NCT02207244|54474013|FG001|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|1|||
27870813|NCT02207244|54474014|FG002|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
27870814|NCT02207244|54474015|FG003|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
27870815|NCT02207244|54474016|FG004|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
27870816|NCT02207244|54474017|FG005|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
27870817|NCT02207244|54474018|FG006|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
27870818|NCT02207244|54474019|FG007|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
27870819|NCT02207244|54474020|FG008|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
27870820|NCT02207244|54474021|FG009|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
27870821|NCT02207244|54474022|FG010|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
27870822|NCT02207244|54474012|FG000|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
27870823|NCT02207244|54474013|FG001|Placebo Controlled Period: Week 0-16|Protocol Violation|3|||
27870824|NCT02207244|54474014|FG002|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
27870825|NCT02207244|54474015|FG003|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
27870826|NCT02207244|54474016|FG004|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
27870827|NCT02207244|54474017|FG005|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
27870828|NCT02207244|54474018|FG006|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
27870829|NCT02207244|54474019|FG007|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
27870830|NCT02207244|54474020|FG008|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
27870831|NCT02207244|54474021|FG009|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
27870832|NCT02207244|54474022|FG010|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
27870833|NCT02207244|54474012|FG000|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
27870834|NCT02207244|54474013|FG001|Placebo Controlled Period: Week 0-16|Noncompliance|1|||
27870835|NCT02207244|54474014|FG002|Placebo Controlled Period: Week 0-16|Noncompliance|2|||
27870836|NCT02207244|54474015|FG003|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
27870837|NCT02207244|54474016|FG004|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
27870838|NCT02207244|54474017|FG005|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
27870839|NCT02207244|54474018|FG006|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
27870840|NCT02207244|54474019|FG007|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
27870841|NCT02207244|54474020|FG008|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
27870842|NCT02207244|54474021|FG009|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
27870843|NCT02207244|54474022|FG010|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
27870844|NCT02207244|54474012|FG000|Placebo Controlled Period: Week 0-16|OTHER|0|||
27870845|NCT02207244|54474013|FG001|Placebo Controlled Period: Week 0-16|OTHER|1|||
27870846|NCT02207244|54474014|FG002|Placebo Controlled Period: Week 0-16|OTHER|0|||
27870847|NCT02207244|54474015|FG003|Placebo Controlled Period: Week 0-16|OTHER|0|||
27870848|NCT02207244|54474016|FG004|Placebo Controlled Period: Week 0-16|OTHER|0|||
27870849|NCT02207244|54474017|FG005|Placebo Controlled Period: Week 0-16|OTHER|0|||
27870850|NCT02207244|54474018|FG006|Placebo Controlled Period: Week 0-16|OTHER|0|||
27870851|NCT02207244|54474019|FG007|Placebo Controlled Period: Week 0-16|OTHER|0|||
27870852|NCT02207244|54474020|FG008|Placebo Controlled Period: Week 0-16|OTHER|0|||
27870853|NCT02207244|54474021|FG009|Placebo Controlled Period: Week 0-16|OTHER|0|||
27870854|NCT02207244|54474022|FG010|Placebo Controlled Period: Week 0-16|OTHER|0|||
27870855|NCT02207244|54474012|FG000|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
27870856|NCT02207244|54474013|FG001|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
27870857|NCT02207244|54474014|FG002|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
27870858|NCT02207244|54474015|FG003|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
27870859|NCT02207244|54474016|FG004|Placebo Crossover and ACP: Week 16-28|Adverse Event|3|||
27870860|NCT02207244|54474017|FG005|Placebo Crossover and ACP: Week 16-28|Adverse Event|2|||
27870861|NCT02207244|54474018|FG006|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
27870862|NCT02207244|54474019|FG007|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
27870863|NCT02207244|54474020|FG008|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
27870864|NCT02207244|54474021|FG009|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
27982375|NCT00930059|54640432|FG001|Overall Study|1 site terminated by sponsor|1|||
27982376|NCT00930059|54640431|FG000|Overall Study|Adverse Event|1|||
27982377|NCT00930059|54640432|FG001|Overall Study|Adverse Event|6|||
27982378|NCT00772005|54640451|FG000|Overall Study|Adverse Event|9|||
27982379|NCT00772005|54640452|FG001|Overall Study|Adverse Event|14|||
27982380|NCT00772005|54640453|FG002|Overall Study|Adverse Event|10|||
27982381|NCT00772005|54640454|FG003|Overall Study|Adverse Event|13|||
27982382|NCT00772005|54640451|FG000|Overall Study|Lack of Efficacy|0|||
27982383|NCT00772005|54640452|FG001|Overall Study|Lack of Efficacy|1|||
27982384|NCT00772005|54640453|FG002|Overall Study|Lack of Efficacy|0|||
27982385|NCT00772005|54640454|FG003|Overall Study|Lack of Efficacy|0|||
27982386|NCT00772005|54640451|FG000|Overall Study|Withdrawal by Subject|3|||
27982387|NCT00772005|54640452|FG001|Overall Study|Withdrawal by Subject|7|||
27982388|NCT00772005|54640453|FG002|Overall Study|Withdrawal by Subject|10|||
27982389|NCT00772005|54640454|FG003|Overall Study|Withdrawal by Subject|2|||
27982390|NCT00772005|54640451|FG000|Overall Study|Protocol Violation|2|||
27870865|NCT02207244|54474022|FG010|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
27982391|NCT00772005|54640452|FG001|Overall Study|Protocol Violation|4|||
27982392|NCT00772005|54640453|FG002|Overall Study|Protocol Violation|1|||
27982393|NCT00772005|54640454|FG003|Overall Study|Protocol Violation|6|||
27982394|NCT00772005|54640451|FG000|Overall Study|Lost to Follow-up|7|||
27982395|NCT00772005|54640452|FG001|Overall Study|Lost to Follow-up|3|||
27982396|NCT00772005|54640453|FG002|Overall Study|Lost to Follow-up|6|||
27982397|NCT00772005|54640454|FG003|Overall Study|Lost to Follow-up|3|||
27982398|NCT00772005|54640451|FG000|Overall Study|Non-compliance with study procedures|1|||
27982399|NCT00772005|54640452|FG001|Overall Study|Non-compliance with study procedures|1|||
27982400|NCT00772005|54640453|FG002|Overall Study|Non-compliance with study procedures|0|||
27982401|NCT00772005|54640454|FG003|Overall Study|Non-compliance with study procedures|1|||
27982402|NCT00772005|54640451|FG000|Overall Study|Non-compliance with drug administration|3|||
27982403|NCT00772005|54640452|FG001|Overall Study|Non-compliance with drug administration|0|||
27982404|NCT00772005|54640453|FG002|Overall Study|Non-compliance with drug administration|1|||
27982405|NCT00772005|54640454|FG003|Overall Study|Non-compliance with drug administration|1|||
27982406|NCT00939107|54640466|FG000|Overall Study|Lost to Follow-up|14|||
27870866|NCT02207244|54474012|FG000|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
27870867|NCT02207244|54474013|FG001|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
27870868|NCT02207244|54474014|FG002|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
27870869|NCT02207244|54474015|FG003|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
27870870|NCT02207244|54474016|FG004|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
27870871|NCT02207244|54474017|FG005|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|2|||
27870872|NCT02207244|54474018|FG006|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
27870873|NCT02207244|54474019|FG007|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
27870874|NCT02207244|54474020|FG008|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
27870875|NCT02207244|54474021|FG009|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
27870876|NCT02207244|54474022|FG010|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
27870877|NCT02207244|54474012|FG000|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
27870878|NCT02207244|54474013|FG001|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
27870879|NCT02207244|54474014|FG002|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
27870880|NCT02207244|54474015|FG003|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|1|||
27982407|NCT00939107|54640467|FG001|Overall Study|Lost to Follow-up|12|||
27982408|NCT00927485|54640475|FG000|Overall Study|Adverse Event|4|||
27982409|NCT00927485|54640476|FG001|Overall Study|Adverse Event|2|||
27982410|NCT00927485|54640475|FG000|Overall Study|noncompliance, prophylactic surgery, inc|2|||
27739006|NCT02462486|54188290|FG000|Overall Study|Lack of Efficacy|6|||
27982411|NCT00927485|54640476|FG001|Overall Study|noncompliance, prophylactic surgery, inc|2|||
27982412|NCT00927251|54640482|FG000|Overall Study|Patients not implanted with 4296 lead|8|||
27982413|NCT00927095|54640489|FG000|Overall Study|Adverse Event|3|||
27870881|NCT02207244|54474016|FG004|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
27870882|NCT02207244|54474017|FG005|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
27870883|NCT02207244|54474018|FG006|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
27870884|NCT02207244|54474019|FG007|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
27870885|NCT02207244|54474020|FG008|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
27870886|NCT02207244|54474021|FG009|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
27870887|NCT02207244|54474022|FG010|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
27870888|NCT02207244|54474012|FG000|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
27870889|NCT02207244|54474013|FG001|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
27870890|NCT02207244|54474014|FG002|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
27870891|NCT02207244|54474015|FG003|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
27870892|NCT02207244|54474016|FG004|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
27870893|NCT02207244|54474017|FG005|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|2|||
27870894|NCT02207244|54474018|FG006|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
27870895|NCT02207244|54474019|FG007|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
27870896|NCT02207244|54474020|FG008|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
27870897|NCT02207244|54474021|FG009|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
27870898|NCT02207244|54474022|FG010|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
27870899|NCT02207244|54474012|FG000|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
27870900|NCT02207244|54474013|FG001|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
27870901|NCT02207244|54474014|FG002|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
27870902|NCT02207244|54474015|FG003|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
27870903|NCT02207244|54474016|FG004|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
27870904|NCT02207244|54474017|FG005|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
27870905|NCT02207244|54474018|FG006|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
27870906|NCT02207244|54474019|FG007|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
27870907|NCT02207244|54474020|FG008|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
27870908|NCT02207244|54474021|FG009|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
27870909|NCT02207244|54474022|FG010|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
27870910|NCT02207244|54474012|FG000|Placebo Crossover and ACP: Week 16-28|Other|0|||
27870911|NCT02207244|54474013|FG001|Placebo Crossover and ACP: Week 16-28|Other|0|||
27870912|NCT02207244|54474014|FG002|Placebo Crossover and ACP: Week 16-28|Other|0|||
27870913|NCT02207244|54474015|FG003|Placebo Crossover and ACP: Week 16-28|Other|1|||
27870914|NCT02207244|54474016|FG004|Placebo Crossover and ACP: Week 16-28|Other|0|||
27870915|NCT02207244|54474017|FG005|Placebo Crossover and ACP: Week 16-28|Other|0|||
27870916|NCT02207244|54474018|FG006|Placebo Crossover and ACP: Week 16-28|Other|0|||
27870917|NCT02207244|54474019|FG007|Placebo Crossover and ACP: Week 16-28|Other|0|||
27870918|NCT02207244|54474020|FG008|Placebo Crossover and ACP: Week 16-28|Other|0|||
27870919|NCT02207244|54474021|FG009|Placebo Crossover and ACP: Week 16-28|Other|0|||
27870920|NCT02207244|54474022|FG010|Placebo Crossover and ACP: Week 16-28|Other|0|||
27870921|NCT02207244|54474012|FG000|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
27870922|NCT02207244|54474013|FG001|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
27870923|NCT02207244|54474014|FG002|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
27870924|NCT02207244|54474015|FG003|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
27870925|NCT02207244|54474016|FG004|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
27870926|NCT02207244|54474017|FG005|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
27870927|NCT02207244|54474018|FG006|Withdrawal and Re-treatment: Week 28-72|Adverse Event|1|||
27870928|NCT02207244|54474019|FG007|Withdrawal and Re-treatment: Week 28-72|Adverse Event|5|||
27870929|NCT02207244|54474020|FG008|Withdrawal and Re-treatment: Week 28-72|Adverse Event|3|||
27870930|NCT02207244|54474021|FG009|Withdrawal and Re-treatment: Week 28-72|Adverse Event|2|||
27870931|NCT02207244|54474022|FG010|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
27870932|NCT02207244|54474012|FG000|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
27870933|NCT02207244|54474013|FG001|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
27870934|NCT02207244|54474014|FG002|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
27870935|NCT02207244|54474015|FG003|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
27870936|NCT02207244|54474016|FG004|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
27870937|NCT02207244|54474017|FG005|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
27870938|NCT02207244|54474018|FG006|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
27870939|NCT02207244|54474019|FG007|Withdrawal and Re-treatment: Week 28-72|Pregnancy|2|||
27870940|NCT02207244|54474020|FG008|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
27870941|NCT02207244|54474021|FG009|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
27870942|NCT02207244|54474022|FG010|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
27870943|NCT02207244|54474012|FG000|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
27870944|NCT02207244|54474013|FG001|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
27870945|NCT02207244|54474014|FG002|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
27870946|NCT02207244|54474015|FG003|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
27870947|NCT02207244|54474016|FG004|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
27870948|NCT02207244|54474017|FG005|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
27870949|NCT02207244|54474018|FG006|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|1|||
27870950|NCT02207244|54474019|FG007|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|3|||
27870951|NCT02207244|54474020|FG008|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
27870952|NCT02207244|54474021|FG009|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
27870953|NCT02207244|54474022|FG010|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
27870954|NCT02207244|54474012|FG000|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
27870955|NCT02207244|54474013|FG001|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
27870956|NCT02207244|54474014|FG002|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
27870957|NCT02207244|54474015|FG003|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
27870958|NCT02207244|54474016|FG004|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
27870959|NCT02207244|54474017|FG005|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
27870960|NCT02207244|54474018|FG006|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
27870961|NCT02207244|54474019|FG007|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|7|||
27870962|NCT02207244|54474020|FG008|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
27870963|NCT02207244|54474021|FG009|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
27870964|NCT02207244|54474022|FG010|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
27870965|NCT02207244|54474012|FG000|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
27870966|NCT02207244|54474013|FG001|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
27870967|NCT02207244|54474014|FG002|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
27870968|NCT02207244|54474015|FG003|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
27870969|NCT02207244|54474016|FG004|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
27870970|NCT02207244|54474017|FG005|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
27870971|NCT02207244|54474018|FG006|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
27870972|NCT02207244|54474019|FG007|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|7|||
27870973|NCT02207244|54474020|FG008|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
27870974|NCT02207244|54474021|FG009|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
27870975|NCT02207244|54474022|FG010|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
27870976|NCT02207244|54474012|FG000|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
27870977|NCT02207244|54474013|FG001|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
27870978|NCT02207244|54474014|FG002|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
27870979|NCT02207244|54474015|FG003|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
27870980|NCT02207244|54474016|FG004|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
27870981|NCT02207244|54474017|FG005|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
27870982|NCT02207244|54474018|FG006|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
27870983|NCT02207244|54474019|FG007|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
27870984|NCT02207244|54474020|FG008|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
27870985|NCT02207244|54474021|FG009|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
27870986|NCT02207244|54474022|FG010|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
27870987|NCT02207244|54474012|FG000|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
27870988|NCT02207244|54474013|FG001|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
27870989|NCT02207244|54474014|FG002|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
27870990|NCT02207244|54474015|FG003|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
27870991|NCT02207244|54474016|FG004|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
27870992|NCT02207244|54474017|FG005|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
27870993|NCT02207244|54474018|FG006|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
27870994|NCT02207244|54474019|FG007|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
27870995|NCT02207244|54474020|FG008|Withdrawal and Re-treatment: Week 28-72|Noncompliance|1|||
27870996|NCT02207244|54474021|FG009|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
27870997|NCT02207244|54474022|FG010|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
27870998|NCT02207244|54474012|FG000|Withdrawal and Re-treatment: Week 28-72|Other|0|||
27870999|NCT02207244|54474013|FG001|Withdrawal and Re-treatment: Week 28-72|Other|0|||
27871000|NCT02207244|54474014|FG002|Withdrawal and Re-treatment: Week 28-72|Other|0|||
27871001|NCT02207244|54474015|FG003|Withdrawal and Re-treatment: Week 28-72|Other|0|||
27871002|NCT02207244|54474016|FG004|Withdrawal and Re-treatment: Week 28-72|Other|0|||
27871003|NCT02207244|54474017|FG005|Withdrawal and Re-treatment: Week 28-72|Other|0|||
27871004|NCT02207244|54474018|FG006|Withdrawal and Re-treatment: Week 28-72|Other|0|||
27871005|NCT02207244|54474019|FG007|Withdrawal and Re-treatment: Week 28-72|Other|2|||
27871006|NCT02207244|54474020|FG008|Withdrawal and Re-treatment: Week 28-72|Other|0|||
27871007|NCT02207244|54474021|FG009|Withdrawal and Re-treatment: Week 28-72|Other|0|||
27871008|NCT02207244|54474022|FG010|Withdrawal and Re-treatment: Week 28-72|Other|0|||
27871009|NCT02207244|54474012|FG000|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
27871010|NCT02207244|54474013|FG001|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
27871011|NCT02207244|54474014|FG002|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
27871012|NCT02207244|54474015|FG003|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
27871013|NCT02207244|54474016|FG004|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
27871014|NCT02207244|54474017|FG005|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
27871015|NCT02207244|54474018|FG006|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|8|||
27871016|NCT02207244|54474019|FG007|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
27871017|NCT02207244|54474020|FG008|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
27871018|NCT02207244|54474021|FG009|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
27871019|NCT02207244|54474022|FG010|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
27871020|NCT02207244|54474012|FG000|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
27871021|NCT02207244|54474013|FG001|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
27871022|NCT02207244|54474014|FG002|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
27871023|NCT02207244|54474015|FG003|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
27871024|NCT02207244|54474016|FG004|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
27871025|NCT02207244|54474017|FG005|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
27871026|NCT02207244|54474018|FG006|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
27871027|NCT02207244|54474019|FG007|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
27871028|NCT02207244|54474020|FG008|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|10|||
27871029|NCT02207244|54474021|FG009|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
27871030|NCT02207244|54474022|FG010|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|30|||
27871031|NCT02207244|54474012|FG000|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
27871032|NCT02207244|54474013|FG001|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
27871033|NCT02207244|54474014|FG002|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
27871034|NCT02207244|54474015|FG003|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
27871035|NCT02207244|54474016|FG004|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
27871036|NCT02207244|54474017|FG005|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
27871037|NCT02207244|54474018|FG006|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
27871038|NCT02207244|54474019|FG007|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
27871039|NCT02207244|54474020|FG008|Open-label Guselkumab: Week 72-264|Lack of Efficacy|2|||
27871040|NCT02207244|54474021|FG009|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
27871041|NCT02207244|54474022|FG010|Open-label Guselkumab: Week 72-264|Lack of Efficacy|3|||
27871042|NCT02207244|54474012|FG000|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
27871043|NCT02207244|54474013|FG001|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
27871044|NCT02207244|54474014|FG002|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
27871045|NCT02207244|54474015|FG003|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
27871046|NCT02207244|54474016|FG004|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
27871047|NCT02207244|54474017|FG005|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
27871048|NCT02207244|54474018|FG006|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
27871049|NCT02207244|54474019|FG007|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
27871050|NCT02207244|54474020|FG008|Open-label Guselkumab: Week 72-264|Lost to Follow-up|5|||
27871051|NCT02207244|54474021|FG009|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
27871052|NCT02207244|54474022|FG010|Open-label Guselkumab: Week 72-264|Lost to Follow-up|26|||
27871053|NCT02207244|54474012|FG000|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
27871054|NCT02207244|54474013|FG001|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
27871055|NCT02207244|54474014|FG002|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
27871056|NCT02207244|54474015|FG003|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
27871057|NCT02207244|54474016|FG004|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
27871058|NCT02207244|54474017|FG005|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
27871059|NCT02207244|54474018|FG006|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
27871060|NCT02207244|54474019|FG007|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
27871061|NCT02207244|54474020|FG008|Open-label Guselkumab: Week 72-264|Adverse Event|12|||
27871062|NCT02207244|54474021|FG009|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
27871063|NCT02207244|54474022|FG010|Open-label Guselkumab: Week 72-264|Adverse Event|21|||
27871064|NCT02207244|54474012|FG000|Open-label Guselkumab: Week 72-264|Death|0|||
27871065|NCT02207244|54474013|FG001|Open-label Guselkumab: Week 72-264|Death|0|||
27871066|NCT02207244|54474014|FG002|Open-label Guselkumab: Week 72-264|Death|0|||
27871067|NCT02207244|54474015|FG003|Open-label Guselkumab: Week 72-264|Death|0|||
27871068|NCT02207244|54474016|FG004|Open-label Guselkumab: Week 72-264|Death|0|||
27871069|NCT02207244|54474017|FG005|Open-label Guselkumab: Week 72-264|Death|0|||
27871070|NCT02207244|54474018|FG006|Open-label Guselkumab: Week 72-264|Death|0|||
27871071|NCT02207244|54474019|FG007|Open-label Guselkumab: Week 72-264|Death|0|||
27871072|NCT02207244|54474020|FG008|Open-label Guselkumab: Week 72-264|Death|1|||
27871073|NCT02207244|54474021|FG009|Open-label Guselkumab: Week 72-264|Death|0|||
27871074|NCT02207244|54474022|FG010|Open-label Guselkumab: Week 72-264|Death|1|||
28171432|NCT01362062|54843027|FG001|Overall Study|Non-compliant participant|0|||
27871075|NCT02207244|54474012|FG000|Open-label Guselkumab: Week 72-264|Other|0|||
27871076|NCT02207244|54474013|FG001|Open-label Guselkumab: Week 72-264|Other|0|||
27871077|NCT02207244|54474014|FG002|Open-label Guselkumab: Week 72-264|Other|0|||
27871078|NCT02207244|54474015|FG003|Open-label Guselkumab: Week 72-264|Other|0|||
27871079|NCT02207244|54474016|FG004|Open-label Guselkumab: Week 72-264|Other|0|||
27871080|NCT02207244|54474017|FG005|Open-label Guselkumab: Week 72-264|Other|0|||
27871081|NCT02207244|54474018|FG006|Open-label Guselkumab: Week 72-264|Other|0|||
27871082|NCT02207244|54474019|FG007|Open-label Guselkumab: Week 72-264|Other|0|||
27871083|NCT02207244|54474020|FG008|Open-label Guselkumab: Week 72-264|Other|8|||
27871084|NCT02207244|54474021|FG009|Open-label Guselkumab: Week 72-264|Other|0|||
27871085|NCT02207244|54474022|FG010|Open-label Guselkumab: Week 72-264|Other|19|||
27871086|NCT02207244|54474012|FG000|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
27871087|NCT02207244|54474013|FG001|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
27871088|NCT02207244|54474014|FG002|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
27871089|NCT02207244|54474015|FG003|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
27871090|NCT02207244|54474016|FG004|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
27871091|NCT02207244|54474017|FG005|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
27871092|NCT02207244|54474018|FG006|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
27871093|NCT02207244|54474019|FG007|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
27871094|NCT02207244|54474020|FG008|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
27871095|NCT02207244|54474021|FG009|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
27871096|NCT02207244|54474022|FG010|Open-label Guselkumab: Week 72-264|Pregnancy|2|||
27871097|NCT02207088|54474075|FG000|Overall Study|Adverse Event|2|||
27871098|NCT02206620|54474090|FG000|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
27871099|NCT02206620|54474091|FG001|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
27871100|NCT02206620|54474090|FG000|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
27871101|NCT02206620|54474091|FG001|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2|||
27871102|NCT02239926|54474105|FG000|Overall Study|Withdrawal by Subject|0|||
27871103|NCT02239926|54474106|FG001|Overall Study|Withdrawal by Subject|1|||
27871104|NCT02239692|54474114|FG000|Overall Study|Incomplete colonoscopy|1|||
27871105|NCT02239692|54474115|FG001|Overall Study|Incomplete colonoscopy|2|||
27871106|NCT02239692|54474114|FG000|Overall Study|Adverse Event|0|||
27871107|NCT02239692|54474115|FG001|Overall Study|Adverse Event|1|||
27871108|NCT02239692|54474114|FG000|Overall Study|Physician Decision|0|||
27871109|NCT02239692|54474115|FG001|Overall Study|Physician Decision|1|||
27871110|NCT02239692|54474114|FG000|Overall Study|Lost to Follow-up|1|||
27871111|NCT02239692|54474115|FG001|Overall Study|Lost to Follow-up|4|||
27871112|NCT02239692|54474114|FG000|Overall Study|Withdrawal by Subject|3|||
27871113|NCT02239692|54474115|FG001|Overall Study|Withdrawal by Subject|5|||
27871114|NCT02239692|54474114|FG000|Overall Study|Other reason|1|||
27871115|NCT02239692|54474115|FG001|Overall Study|Other reason|0|||
27871116|NCT02206152|54474143|FG000|Pre-Randomization|Withdrawal by Subject|2|||
27871117|NCT02204982|54474151|FG000|Overall Study|Patient ineligible-medical monitor|1|||
27871118|NCT02204982|54474152|FG001|Overall Study|Patient ineligible-medical monitor|0|||
27871119|NCT02204982|54474151|FG000|Overall Study|Withdrawal by Subject|1|||
27871120|NCT02204982|54474152|FG001|Overall Study|Withdrawal by Subject|0|||
27871121|NCT02204982|54474151|FG000|Overall Study|Adverse Event|1|||
27982414|NCT00927095|54640490|FG001|Overall Study|Adverse Event|1|||
27982415|NCT00927095|54640491|FG002|Overall Study|Adverse Event|0|||
27982416|NCT00927095|54640489|FG000|Overall Study|Withdrawal by Subject|2|||
27739007|NCT02462486|54188291|FG001|Overall Study|Lack of Efficacy|12|||
27739008|NCT02462486|54188292|FG002|Overall Study|Lack of Efficacy|3|||
27739009|NCT02462486|54188290|FG000|Overall Study|Lost to Follow-up|3|||
27739010|NCT02462486|54188291|FG001|Overall Study|Lost to Follow-up|4|||
27739011|NCT02462486|54188292|FG002|Overall Study|Lost to Follow-up|2|||
27739012|NCT02462486|54188290|FG000|Overall Study|Withdrawal by Subject|25|||
27739013|NCT02462486|54188291|FG001|Overall Study|Withdrawal by Subject|22|||
27739014|NCT02462486|54188292|FG002|Overall Study|Withdrawal by Subject|19|||
27739015|NCT02462486|54188290|FG000|Overall Study|Protocol Violation|3|||
27739016|NCT02462486|54188291|FG001|Overall Study|Protocol Violation|1|||
27739017|NCT02462486|54188292|FG002|Overall Study|Protocol Violation|1|||
27739018|NCT02462486|54188290|FG000|Overall Study|Reason not Specified|3|||
27739019|NCT02462486|54188291|FG001|Overall Study|Reason not Specified|4|||
27739020|NCT02462486|54188292|FG002|Overall Study|Reason not Specified|3|||
27739021|NCT02495948|54188300|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
27739022|NCT02495948|54188301|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
27739023|NCT02495948|54188300|FG000|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
27739024|NCT02495948|54188301|FG001|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
27739025|NCT02461628|54188310|FG000|Overall Study|Refused to complete survey|4|||
27871122|NCT02204982|54474152|FG001|Overall Study|Adverse Event|0|||
27871123|NCT02204982|54474151|FG000|Overall Study|Adverse Event and Investigator decision|1|||
27871124|NCT02204982|54474152|FG001|Overall Study|Adverse Event and Investigator decision|0|||
27871125|NCT02204982|54474151|FG000|Overall Study|Physician Decision|0|||
27871126|NCT02204982|54474152|FG001|Overall Study|Physician Decision|2|||
27739026|NCT02461628|54188311|FG001|Overall Study|Refused to complete survey|7|||
27739027|NCT02429791|54188319|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|6|||
27739028|NCT02429791|54188320|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|2|||
27739029|NCT02429791|54188319|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
27739030|NCT02429791|54188320|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|2|||
27739031|NCT02429791|54188319|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
27739032|NCT02429791|54188320|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
27739033|NCT02429791|54188319|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
27739034|NCT02429791|54188320|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2|||
27739035|NCT02429791|54188319|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|1|||
27871127|NCT02204982|54474151|FG000|Overall Study|Protocol-Specified Disease Progression|0|||
27871128|NCT02204982|54474152|FG001|Overall Study|Protocol-Specified Disease Progression|4|||
27871129|NCT02204982|54474151|FG000|Overall Study|Termination of Study bySponsor|0|||
27871130|NCT02204982|54474152|FG001|Overall Study|Termination of Study bySponsor|1|||
27871131|NCT02239536|54474160|FG000|Overall Study|Non-neoplastic polyp|23|||
27871132|NCT02239536|54474161|FG001|Overall Study|Non-neoplastic polyp|17|||
27871133|NCT02239224|54474171|FG000|Overall Study|Administrative|0|||
27871134|NCT02239224|54474172|FG001|Overall Study|Administrative|0|||
27871135|NCT02239224|54474173|FG002|Overall Study|Administrative|3|||
27982417|NCT00927095|54640490|FG001|Overall Study|Withdrawal by Subject|1|||
27982418|NCT00927095|54640491|FG002|Overall Study|Withdrawal by Subject|1|||
27982419|NCT00927095|54640489|FG000|Overall Study|Physician Decision|1|||
27982420|NCT00927095|54640490|FG001|Overall Study|Physician Decision|2|||
27982421|NCT00927095|54640491|FG002|Overall Study|Physician Decision|1|||
27982422|NCT00932165|54640499|FG000|Overall Study|Lost to Follow-up|1|||
27982423|NCT04888494|54640506|FG000|Overall Study|Lost to Follow-up|2|||
27982424|NCT04888494|54640507|FG001|Overall Study|Lost to Follow-up|3|||
27982425|NCT04888494|54640506|FG000|Overall Study|We dropped the participant due to safety concerns for the staff.|1|||
27982426|NCT04888494|54640507|FG001|Overall Study|We dropped the participant due to safety concerns for the staff.|0|||
27982427|NCT04761822|54640567|FG000|Overall Study|Adverse Event|3|||
27982428|NCT04761822|54640568|FG001|Overall Study|Adverse Event|1|||
27982429|NCT04761822|54640569|FG002|Overall Study|Adverse Event|1|||
27982430|NCT04761822|54640570|FG003|Overall Study|Adverse Event|3|||
27982431|NCT04761822|54640567|FG000|Overall Study|Lost to Follow-up|1|||
27982432|NCT04761822|54640568|FG001|Overall Study|Lost to Follow-up|0|||
27982433|NCT04761822|54640569|FG002|Overall Study|Lost to Follow-up|2|||
28096385|NCT04377308|54751299|FG001|Overall Study|Withdrawal by Subject|1|||
28096386|NCT04447404|54751307|FG000|Overall Study|Death|2|||
28096387|NCT04447404|54751308|FG001|Overall Study|Death|0|||
27871136|NCT02239224|54474174|FG003|Overall Study|Administrative|1|||
27871137|NCT01600014|54474184|FG000|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24|||
27871138|NCT01600014|54474185|FG001|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0|||
27871139|NCT01600014|54474184|FG000|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203|||
27871140|NCT01600014|54474185|FG001|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0|||
27871141|NCT01600014|54474184|FG000|1. Cycle & Observation Period D1 to W52|Adverse Event|6|||
27871142|NCT01600014|54474185|FG001|1. Cycle & Observation Period D1 to W52|Adverse Event|0|||
27871143|NCT01600014|54474184|FG000|1. Cycle & Observation Period D1 to W52|Other|27|||
27871144|NCT01600014|54474185|FG001|1. Cycle & Observation Period D1 to W52|Other|0|||
27871145|NCT01600014|54474184|FG000|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14|||
27871146|NCT01600014|54474185|FG001|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0|||
27871147|NCT01600014|54474184|FG000|1. Cycle & Observation Period D1 to W52|Protocol Violation|6|||
27871148|NCT01600014|54474185|FG001|1. Cycle & Observation Period D1 to W52|Protocol Violation|0|||
27871149|NCT01600014|54474184|FG000|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8|||
27871150|NCT01600014|54474185|FG001|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0|||
27871151|NCT01600014|54474184|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1|||
27871152|NCT01600014|54474185|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2|||
27871153|NCT01600014|54474184|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1|||
27871154|NCT01600014|54474185|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3|||
27871155|NCT01600014|54474184|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2|||
27871156|NCT01600014|54474185|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1|||
27871157|NCT01600014|54474184|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1|||
27871158|NCT01600014|54474185|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0|||
27871159|NCT01600014|54474184|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5|||
27982434|NCT04761822|54640570|FG003|Overall Study|Lost to Follow-up|3|||
27982435|NCT04761822|54640567|FG000|Overall Study|Physician Decision|0|||
27982436|NCT04761822|54640568|FG001|Overall Study|Physician Decision|1|||
27739036|NCT02429791|54188320|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|4|||
27982437|NCT04761822|54640569|FG002|Overall Study|Physician Decision|0|||
27982438|NCT04761822|54640570|FG003|Overall Study|Physician Decision|0|||
28096388|NCT03988166|54751314|FG000|Overall Study|Lost to Follow-up|2|||
28096389|NCT03988166|54751314|FG000|Overall Study|Death|1|||
27871160|NCT01600014|54474185|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0|||
27871161|NCT01600014|54474184|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
27871162|NCT01600014|54474185|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
27871163|NCT01600014|54474184|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1|||
27871164|NCT01600014|54474185|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3|||
27871165|NCT01600014|54474184|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1|||
27871166|NCT01600014|54474185|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0|||
27871167|NCT01600014|54474184|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1|||
27871168|NCT01600014|54474185|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0|||
27871169|NCT01600014|54474184|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1|||
27871170|NCT01600014|54474185|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0|||
27871171|NCT02237196|54474207|FG000|Overall Study|Adverse Event|0|||
27871172|NCT02237196|54474208|FG001|Overall Study|Adverse Event|1|||
27871173|NCT02237196|54474209|FG002|Overall Study|Adverse Event|1|||
27871174|NCT02237196|54474210|FG003|Overall Study|Adverse Event|0|||
27871175|NCT02237196|54474207|FG000|Overall Study|Lost to Follow-up|4|||
27871176|NCT02237196|54474208|FG001|Overall Study|Lost to Follow-up|2|||
27871177|NCT02237196|54474209|FG002|Overall Study|Lost to Follow-up|4|||
27871178|NCT02237196|54474210|FG003|Overall Study|Lost to Follow-up|6|||
27871179|NCT02237196|54474207|FG000|Overall Study|Physician Decision|2|||
27871180|NCT02237196|54474208|FG001|Overall Study|Physician Decision|0|||
27871181|NCT02237196|54474209|FG002|Overall Study|Physician Decision|0|||
27871182|NCT02237196|54474210|FG003|Overall Study|Physician Decision|1|||
27871183|NCT02237196|54474207|FG000|Overall Study|Pregnancy|0|||
27871184|NCT02237196|54474208|FG001|Overall Study|Pregnancy|0|||
27871185|NCT02237196|54474209|FG002|Overall Study|Pregnancy|1|||
27871186|NCT02237196|54474210|FG003|Overall Study|Pregnancy|1|||
27871187|NCT02237196|54474207|FG000|Overall Study|Withdrawal by Subject|1|||
27871188|NCT02237196|54474208|FG001|Overall Study|Withdrawal by Subject|1|||
27871189|NCT02237196|54474209|FG002|Overall Study|Withdrawal by Subject|4|||
27871190|NCT02237196|54474210|FG003|Overall Study|Withdrawal by Subject|1|||
27871191|NCT02237196|54474207|FG000|Overall Study|Site Error|1|||
27871192|NCT02237196|54474208|FG001|Overall Study|Site Error|2|||
27871193|NCT02237196|54474209|FG002|Overall Study|Site Error|0|||
27871194|NCT02237196|54474210|FG003|Overall Study|Site Error|2|||
27871195|NCT02237118|54474226|FG000|Overall Study|Protocol Violation|0|||
27871196|NCT02237118|54474227|FG001|Overall Study|Protocol Violation|1|||
27871197|NCT02237118|54474226|FG000|Overall Study|consent withdrawn|1|||
27871198|NCT02237118|54474227|FG001|Overall Study|consent withdrawn|0|||
27871199|NCT02234622|54474243|FG000|Overall Study|Withdrawal by Subject|16|||
27871200|NCT02234622|54474244|FG001|Overall Study|Withdrawal by Subject|22|||
27871201|NCT02234622|54474243|FG000|Overall Study|Lost to Follow-up|27|||
27871202|NCT02234622|54474244|FG001|Overall Study|Lost to Follow-up|14|||
27871203|NCT03250273|54474254|FG000|Overall Study|Disease Progression|2|||
27871204|NCT03250273|54474255|FG001|Overall Study|Disease Progression|11|||
27871205|NCT03250273|54474254|FG000|Overall Study|Death|0|||
27871206|NCT03250273|54474255|FG001|Overall Study|Death|1|||
27871207|NCT02203032|54474261|FG000|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2|||
27871208|NCT02203032|54474262|FG001|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
27871209|NCT02203032|54474263|FG002|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
27871210|NCT02203032|54474264|FG003|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
27871211|NCT02203032|54474261|FG000|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1|||
27871212|NCT02203032|54474262|FG001|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
27871213|NCT02203032|54474263|FG002|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
27871214|NCT02203032|54474264|FG003|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
27871215|NCT02203032|54474261|FG000|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3|||
27871216|NCT02203032|54474262|FG001|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
27871217|NCT02203032|54474263|FG002|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
27871218|NCT02203032|54474264|FG003|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
27871219|NCT02203032|54474261|FG000|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6|||
27871220|NCT02203032|54474262|FG001|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
27871221|NCT02203032|54474263|FG002|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
27871222|NCT02203032|54474264|FG003|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
27871223|NCT02203032|54474261|FG000|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4|||
27871224|NCT02203032|54474262|FG001|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
27871225|NCT02203032|54474263|FG002|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
27871226|NCT02203032|54474264|FG003|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
27871227|NCT02203032|54474261|FG000|Open Label Run-in (Week 0 to Week 16)|Other|2|||
27871228|NCT02203032|54474262|FG001|Open Label Run-in (Week 0 to Week 16)|Other|0|||
27871229|NCT02203032|54474263|FG002|Open Label Run-in (Week 0 to Week 16)|Other|0|||
27871230|NCT02203032|54474264|FG003|Open Label Run-in (Week 0 to Week 16)|Other|0|||
28096390|NCT03988088|54751323|FG000|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
27871231|NCT02203032|54474261|FG000|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1|||
27871232|NCT02203032|54474262|FG001|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
27871233|NCT02203032|54474263|FG002|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
27871234|NCT02203032|54474264|FG003|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
27871235|NCT02203032|54474261|FG000|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0|||
27871236|NCT02203032|54474262|FG001|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2|||
27871237|NCT02203032|54474263|FG002|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3|||
27871238|NCT02203032|54474264|FG003|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8|||
27871239|NCT02203032|54474261|FG000|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0|||
27871240|NCT02203032|54474262|FG001|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8|||
27871241|NCT02203032|54474263|FG002|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19|||
27871242|NCT02203032|54474264|FG003|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20|||
27871243|NCT02203032|54474261|FG000|Blinded Phase (Week 16 to Week 44)|Other|0|||
27871244|NCT02203032|54474262|FG001|Blinded Phase (Week 16 to Week 44)|Other|4|||
28171433|NCT01362062|54843026|FG000|Overall Study|Detected with Spondylo-arthritis|1|||
28171434|NCT01362062|54843027|FG001|Overall Study|Detected with Spondylo-arthritis|0|||
27871245|NCT02203032|54474263|FG002|Blinded Phase (Week 16 to Week 44)|Other|1|||
27871246|NCT02203032|54474264|FG003|Blinded Phase (Week 16 to Week 44)|Other|15|||
27871247|NCT02203032|54474261|FG000|Blinded Phase (Week 16 to Week 44)|Death|0|||
27871248|NCT02203032|54474262|FG001|Blinded Phase (Week 16 to Week 44)|Death|0|||
27871249|NCT02203032|54474263|FG002|Blinded Phase (Week 16 to Week 44)|Death|0|||
27871250|NCT02203032|54474264|FG003|Blinded Phase (Week 16 to Week 44)|Death|1|||
27871251|NCT02203032|54474261|FG000|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0|||
27871252|NCT02203032|54474262|FG001|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1|||
27871253|NCT02203032|54474263|FG002|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3|||
27871254|NCT02203032|54474264|FG003|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2|||
27871255|NCT02169414|54474276|FG000|Overall Study|Withdrawal by Subject|1|||
27871256|NCT02169414|54474277|FG001|Overall Study|Withdrawal by Subject|0|||
27871257|NCT02169414|54474278|FG002|Overall Study|Withdrawal by Subject|0|||
27871258|NCT02169414|54474279|FG003|Overall Study|Withdrawal by Subject|0|||
27871259|NCT02169414|54474276|FG000|Overall Study|Adverse Event|0|||
27871260|NCT02169414|54474277|FG001|Overall Study|Adverse Event|1|||
27871261|NCT02169414|54474278|FG002|Overall Study|Adverse Event|0|||
27871262|NCT02169414|54474279|FG003|Overall Study|Adverse Event|0|||
27871263|NCT03213457|54474296|FG000|Overall Study|Not Treated|1|||
27871264|NCT03213457|54474297|FG001|Overall Study|Not Treated|1|||
27871265|NCT03213457|54474298|FG002|Overall Study|Not Treated|0|||
27871266|NCT03213457|54474296|FG000|Overall Study|Adverse Event|16|||
27871267|NCT03213457|54474297|FG001|Overall Study|Adverse Event|9|||
27871268|NCT03213457|54474298|FG002|Overall Study|Adverse Event|41|||
27871269|NCT03213457|54474296|FG000|Overall Study|Non-Compliance With Study Drug|1|||
27871270|NCT03213457|54474297|FG001|Overall Study|Non-Compliance With Study Drug|2|||
27871271|NCT03213457|54474298|FG002|Overall Study|Non-Compliance With Study Drug|7|||
27871272|NCT03213457|54474296|FG000|Overall Study|Non-Compliance Other, Not Specified|0|||
27871273|NCT03213457|54474297|FG001|Overall Study|Non-Compliance Other, Not Specified|1|||
28171435|NCT01362062|54843026|FG000|Overall Study|Had significant improvement|9|||
27871274|NCT03213457|54474298|FG002|Overall Study|Non-Compliance Other, Not Specified|5|||
27871275|NCT03213457|54474296|FG000|Overall Study|Withdrawal by Subject|18|||
27871276|NCT03213457|54474297|FG001|Overall Study|Withdrawal by Subject|7|||
27871277|NCT03213457|54474298|FG002|Overall Study|Withdrawal by Subject|35|||
27871278|NCT03213457|54474296|FG000|Overall Study|Lost to Follow-up|12|||
27871279|NCT03213457|54474297|FG001|Overall Study|Lost to Follow-up|12|||
27871280|NCT03213457|54474298|FG002|Overall Study|Lost to Follow-up|33|||
27871281|NCT03213457|54474296|FG000|Overall Study|Pregnancy|11|||
27871282|NCT03213457|54474297|FG001|Overall Study|Pregnancy|0|||
27871283|NCT03213457|54474298|FG002|Overall Study|Pregnancy|7|||
27871284|NCT03213457|54474296|FG000|Overall Study|Protocol Violation|1|||
27871285|NCT03213457|54474297|FG001|Overall Study|Protocol Violation|1|||
27871286|NCT03213457|54474298|FG002|Overall Study|Protocol Violation|6|||
27871287|NCT03213457|54474296|FG000|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|4|||
27871288|NCT03213457|54474297|FG001|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|0|||
27871289|NCT03213457|54474298|FG002|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|2|||
27871290|NCT03213457|54474296|FG000|Overall Study|Dual Energy X-Ray Absorptiometry Finding|1|||
27871291|NCT03213457|54474297|FG001|Overall Study|Dual Energy X-Ray Absorptiometry Finding|1|||
27871292|NCT03213457|54474298|FG002|Overall Study|Dual Energy X-Ray Absorptiometry Finding|3|||
27871293|NCT03213457|54474296|FG000|Overall Study|Lack of Efficacy|12|||
27871294|NCT03213457|54474297|FG001|Overall Study|Lack of Efficacy|2|||
27871295|NCT03213457|54474298|FG002|Overall Study|Lack of Efficacy|9|||
27871296|NCT03213457|54474296|FG000|Overall Study|Other, Not Specified|11|||
27871297|NCT03213457|54474297|FG001|Overall Study|Other, Not Specified|3|||
27871298|NCT03213457|54474298|FG002|Overall Study|Other, Not Specified|26|||
28171436|NCT01362062|54843027|FG001|Overall Study|Had significant improvement|0|||
27871299|NCT02201940|54474308|FG000|Overall Study|Randomized/Enrolled but Never Treated|1|||
27871300|NCT02201940|54474309|FG001|Overall Study|Randomized/Enrolled but Never Treated|0|||
27871301|NCT02201940|54474308|FG000|Overall Study|Lack of Efficacy|2|||
27871302|NCT02201940|54474309|FG001|Overall Study|Lack of Efficacy|113|||
27871303|NCT02201940|54474308|FG000|Overall Study|Lost to Follow-up|5|||
27871304|NCT02201940|54474309|FG001|Overall Study|Lost to Follow-up|0|||
27871305|NCT02201940|54474308|FG000|Overall Study|Withdrew Consent|2|||
27871306|NCT02201940|54474309|FG001|Overall Study|Withdrew Consent|1|||
27871307|NCT02201940|54474308|FG000|Overall Study|Investigator's Discretion|1|||
27871308|NCT02201940|54474309|FG001|Overall Study|Investigator's Discretion|1|||
27871309|NCT02201940|54474308|FG000|Overall Study|Death|1|||
27871310|NCT02201940|54474309|FG001|Overall Study|Death|0|||
27871311|NCT02201940|54474308|FG000|Overall Study|Adverse Event|0|||
27871312|NCT02201940|54474309|FG001|Overall Study|Adverse Event|1|||
27871313|NCT02232984|54474315|FG000|Overall Study|Withdrawal by Subject|5|||
27871314|NCT02232984|54474315|FG000|Overall Study|Death|1|||
27871315|NCT02232984|54474315|FG000|Overall Study|Investigator withdrawal|10|||
27871316|NCT02232984|54474315|FG000|Overall Study|Device implant unsuccessful|53|||
27871317|NCT02232984|54474315|FG000|Overall Study|not disclosed by site|7|||
27871318|NCT02232984|54474315|FG000|Overall Study|Protocol Violation|1|||
27871319|NCT02169336|54474325|FG000|Overall Study|Lack of Efficacy|1|||
27871320|NCT02169336|54474326|FG001|Overall Study|Lack of Efficacy|1|||
27871321|NCT02169336|54474327|FG002|Overall Study|Lack of Efficacy|0|||
27871322|NCT02169336|54474325|FG000|Overall Study|Adverse Event|2|||
27871323|NCT02169336|54474326|FG001|Overall Study|Adverse Event|3|||
27871324|NCT02169336|54474327|FG002|Overall Study|Adverse Event|1|||
27871325|NCT02169336|54474325|FG000|Overall Study|Withdrawal by Subject|1|||
27871326|NCT02169336|54474326|FG001|Overall Study|Withdrawal by Subject|0|||
27871327|NCT02169336|54474327|FG002|Overall Study|Withdrawal by Subject|0|||
27871328|NCT02169336|54474325|FG000|Overall Study|Physician Decision|0|||
27871329|NCT02169336|54474326|FG001|Overall Study|Physician Decision|0|||
27871330|NCT02169336|54474327|FG002|Overall Study|Physician Decision|1|||
27871331|NCT02169336|54474325|FG000|Overall Study|Subject declined to continue dosing|0|||
27871332|NCT02169336|54474326|FG001|Overall Study|Subject declined to continue dosing|0|||
27871333|NCT02169336|54474327|FG002|Overall Study|Subject declined to continue dosing|1|||
27871334|NCT02609828|54474343|FG000|Overall Study|Adverse Event|8|||
27871335|NCT02609828|54474344|FG001|Overall Study|Adverse Event|1|||
27871336|NCT02609828|54474345|FG002|Overall Study|Adverse Event|0|||
27871337|NCT02609828|54474346|FG003|Overall Study|Adverse Event|6|||
27871338|NCT02609828|54474343|FG000|Overall Study|Death|15|||
27871339|NCT02609828|54474344|FG001|Overall Study|Death|1|||
27871340|NCT02609828|54474345|FG002|Overall Study|Death|1|||
27871341|NCT02609828|54474346|FG003|Overall Study|Death|19|||
27871342|NCT02609828|54474343|FG000|Overall Study|Insufficient clinical response|2|||
27871343|NCT02609828|54474344|FG001|Overall Study|Insufficient clinical response|1|||
27871344|NCT02609828|54474345|FG002|Overall Study|Insufficient clinical response|0|||
27871345|NCT02609828|54474346|FG003|Overall Study|Insufficient clinical response|0|||
27871346|NCT02609828|54474343|FG000|Overall Study|Lost to Follow-up|0|||
27871347|NCT02609828|54474344|FG001|Overall Study|Lost to Follow-up|0|||
27871348|NCT02609828|54474345|FG002|Overall Study|Lost to Follow-up|0|||
27871349|NCT02609828|54474346|FG003|Overall Study|Lost to Follow-up|1|||
27871350|NCT02609828|54474343|FG000|Overall Study|Protocol Violation|2|||
27871351|NCT02609828|54474344|FG001|Overall Study|Protocol Violation|0|||
27871352|NCT02609828|54474345|FG002|Overall Study|Protocol Violation|0|||
27871353|NCT02609828|54474346|FG003|Overall Study|Protocol Violation|1|||
27871354|NCT02609828|54474343|FG000|Overall Study|Withdrawal by Subject|12|||
27871355|NCT02609828|54474344|FG001|Overall Study|Withdrawal by Subject|1|||
27871356|NCT02609828|54474345|FG002|Overall Study|Withdrawal by Subject|0|||
27871357|NCT02609828|54474346|FG003|Overall Study|Withdrawal by Subject|10|||
27871358|NCT02609828|54474343|FG000|Overall Study|Other|3|||
27871359|NCT02609828|54474344|FG001|Overall Study|Other|0|||
27871360|NCT02609828|54474345|FG002|Overall Study|Other|0|||
28096391|NCT03988088|54751324|FG001|Single-Dose Pharmacokinetic Study|Adverse Event|1|||
27871361|NCT02609828|54474346|FG003|Overall Study|Other|6|||
27871362|NCT02609828|54474343|FG000|Overall Study|Randomized but not treated|1|||
27871363|NCT02609828|54474344|FG001|Overall Study|Randomized but not treated|0|||
27871364|NCT02609828|54474345|FG002|Overall Study|Randomized but not treated|0|||
27871365|NCT02609828|54474346|FG003|Overall Study|Randomized but not treated|0|||
27871366|NCT01632306|54474362|FG000|Overall Study|Protocol Violation|1|||
27871367|NCT01632306|54474363|FG001|Overall Study|Protocol Violation|0|||
27871368|NCT01632306|54474364|FG002|Overall Study|Protocol Violation|0|||
27871369|NCT02201784|54474372|FG000|Overall Study|Failure to achieve adequate block|2|||
27871370|NCT02201784|54474373|FG001|Overall Study|Failure to achieve adequate block|0|||
27871371|NCT02201472|54474379|FG000|Overall Study|Lack of Efficacy|2|||
27871372|NCT02168946|54474424|FG000|Overall Study|Adverse Event|8|||
27871373|NCT02168946|54474425|FG001|Overall Study|Adverse Event|5|||
27871374|NCT02168946|54474424|FG000|Overall Study|Lost to Follow-up|3|||
27871375|NCT02168946|54474425|FG001|Overall Study|Lost to Follow-up|0|||
27871376|NCT02168946|54474424|FG000|Overall Study|Subject unable to come back for visits|1|||
27871377|NCT02168946|54474425|FG001|Overall Study|Subject unable to come back for visits|0|||
27871378|NCT02168478|54474446|FG000|Overall Study|Withdrawal by Subject|1|||
27871379|NCT02168478|54474446|FG000|Overall Study|Did Not Consent to Participation|2|||
27871380|NCT02168478|54474446|FG000|Overall Study|Did Not Meet Exclusionary Criteria|1|||
27871381|NCT02200614|54475623|FG000|Double Blind Treatment|Adverse Event|86|||
27871382|NCT02200614|54475624|FG001|Double Blind Treatment|Adverse Event|48|||
27871383|NCT02200614|54475623|FG000|Double Blind Treatment|Confirmed metastasis|120|||
27871384|NCT02200614|54475624|FG001|Double Blind Treatment|Confirmed metastasis|140|||
27871385|NCT02200614|54475623|FG000|Double Blind Treatment|Judgment of the investigator|59|||
27871386|NCT02200614|54475624|FG001|Double Blind Treatment|Judgment of the investigator|99|||
27871387|NCT02200614|54475623|FG000|Double Blind Treatment|Metastasis by local reading|1|||
27871388|NCT02200614|54475624|FG001|Double Blind Treatment|Metastasis by local reading|3|||
27871389|NCT02200614|54475623|FG000|Double Blind Treatment|Other reason|6|||
27871390|NCT02200614|54475624|FG001|Double Blind Treatment|Other reason|2|||
27871391|NCT02200614|54475623|FG000|Double Blind Treatment|Personal reason|77|||
27871392|NCT02200614|54475624|FG001|Double Blind Treatment|Personal reason|85|||
27871393|NCT02200614|54475623|FG000|Double Blind Treatment|Protocol deviation|14|||
27871394|NCT02200614|54475624|FG001|Double Blind Treatment|Protocol deviation|7|||
27871395|NCT02200614|54475623|FG000|Double Blind Treatment|Not treated|1|||
27871396|NCT02200614|54475624|FG001|Double Blind Treatment|Not treated|0|||
27871397|NCT02200614|54475623|FG000|Open Label|Adverse Event|41|||
27871398|NCT02200614|54475624|FG001|Open Label|Adverse Event|11|||
27871399|NCT02200614|54475623|FG000|Open Label|Confirmed metastasis|1|||
27871400|NCT02200614|54475624|FG001|Open Label|Confirmed metastasis|0|||
27871401|NCT02200614|54475623|FG000|Open Label|Judgment of the investigator|29|||
27871402|NCT02200614|54475624|FG001|Open Label|Judgment of the investigator|2|||
27871403|NCT02200614|54475623|FG000|Open Label|Metastasis by local reading|138|||
27871404|NCT02200614|54475624|FG001|Open Label|Metastasis by local reading|27|||
27871405|NCT02200614|54475623|FG000|Open Label|Other reason|22|||
27871406|NCT02200614|54475624|FG001|Open Label|Other reason|4|||
27871407|NCT02200614|54475623|FG000|Open Label|Personal reason|60|||
27871408|NCT02200614|54475624|FG001|Open Label|Personal reason|8|||
27871409|NCT02200614|54475623|FG000|Open Label|Protocol deviation|3|||
27871410|NCT02200614|54475624|FG001|Open Label|Protocol deviation|2|||
27871411|NCT02200614|54475623|FG000|Open Label|Missing|2|||
27871412|NCT02200614|54475624|FG001|Open Label|Missing|2|||
27871413|NCT02231892|54475635|FG000|Overall Study|Lost to Follow-up|1|||
27871414|NCT02231892|54475636|FG001|Overall Study|Lost to Follow-up|0|||
27871415|NCT02231892|54475637|FG002|Overall Study|Lost to Follow-up|3|||
27871416|NCT02231892|54475635|FG000|Overall Study|Withdrawal by Subject|4|||
27871417|NCT02231892|54475636|FG001|Overall Study|Withdrawal by Subject|3|||
27871418|NCT02231892|54475637|FG002|Overall Study|Withdrawal by Subject|15|||
27871419|NCT02231892|54475635|FG000|Overall Study|Physician Decision|0|||
27871420|NCT02231892|54475636|FG001|Overall Study|Physician Decision|2|||
27871421|NCT02231892|54475637|FG002|Overall Study|Physician Decision|4|||
27871422|NCT02231892|54475635|FG000|Overall Study|Motor activity when stimulating ante ACC|4|||
27871423|NCT02231892|54475636|FG001|Overall Study|Motor activity when stimulating ante ACC|7|||
27871424|NCT02231892|54475637|FG002|Overall Study|Motor activity when stimulating ante ACC|12|||
27871425|NCT02231892|54475635|FG000|Overall Study|Participant motor threshold was >83%|0|||
27871426|NCT02231892|54475636|FG001|Overall Study|Participant motor threshold was >83%|0|||
27871427|NCT02231892|54475637|FG002|Overall Study|Participant motor threshold was >83%|9|||
27871428|NCT02231892|54475635|FG000|Overall Study|Could not find motor threshold|2|||
27871429|NCT02231892|54475636|FG001|Overall Study|Could not find motor threshold|0|||
27871430|NCT02231892|54475637|FG002|Overall Study|Could not find motor threshold|1|||
27871431|NCT02231892|54475635|FG000|Overall Study|Could not find reliable motor hotspot|0|||
27871432|NCT02231892|54475636|FG001|Overall Study|Could not find reliable motor hotspot|0|||
27871433|NCT02231892|54475637|FG002|Overall Study|Could not find reliable motor hotspot|1|||
27871434|NCT02231580|54475653|FG000|Overall Study|Adverse Event|5|||
27871435|NCT02231580|54475654|FG001|Overall Study|Adverse Event|0|||
27871436|NCT02166606|54475662|FG000|Overall Study|Adverse Event|3|||
27871437|NCT02166606|54475662|FG000|Overall Study|Death|31|||
27871438|NCT02166606|54475662|FG000|Overall Study|Protocol Violation|7|||
27871439|NCT02166606|54475662|FG000|Overall Study|Lost to Follow-up|30|||
27871440|NCT02166606|54475662|FG000|Overall Study|Withdrawal by Subject|1|||
27871441|NCT02166606|54475662|FG000|Overall Study|Physician Decision|1|||
27871442|NCT02166606|54475662|FG000|Overall Study|Device upgrade|1|||
27871443|NCT02166606|54475662|FG000|Overall Study|Enrolled after End of Enrollment|4|||
27871444|NCT02230956|54475669|FG000|Overall Study|Adverse Event|1|||
27871445|NCT02230956|54475670|FG001|Overall Study|Adverse Event|1|||
28171437|NCT01361594|54843034|FG000|Overall Study|Withdrawal by Subject|1|||
27871446|NCT02230956|54475671|FG002|Overall Study|Adverse Event|0|||
27871447|NCT02230956|54475669|FG000|Overall Study|Lack of Efficacy|1|||
27871448|NCT02230956|54475670|FG001|Overall Study|Lack of Efficacy|1|||
27871449|NCT02230956|54475671|FG002|Overall Study|Lack of Efficacy|1|||
27871450|NCT02230956|54475669|FG000|Overall Study|Lost to Follow-up|1|||
27871451|NCT02230956|54475670|FG001|Overall Study|Lost to Follow-up|1|||
27871452|NCT02230956|54475671|FG002|Overall Study|Lost to Follow-up|2|||
27871453|NCT02230956|54475669|FG000|Overall Study|Personal Reasons|2|||
27871454|NCT02230956|54475670|FG001|Overall Study|Personal Reasons|1|||
27871455|NCT02230956|54475671|FG002|Overall Study|Personal Reasons|1|||
27871456|NCT02230956|54475669|FG000|Overall Study|Protocol Violation|0|||
27871457|NCT02230956|54475670|FG001|Overall Study|Protocol Violation|1|||
27871458|NCT02230956|54475671|FG002|Overall Study|Protocol Violation|1|||
27871459|NCT02230956|54475669|FG000|Overall Study|Other Miscellaneous Reason|0|||
27871460|NCT02230956|54475670|FG001|Overall Study|Other Miscellaneous Reason|1|||
27871461|NCT02230956|54475671|FG002|Overall Study|Other Miscellaneous Reason|2|||
27871462|NCT02230410|54475679|FG000|Overall Study|Screen Failure|3|||
27871463|NCT02230332|54475685|FG000|Overall Study|Adverse Event|2|||
27871464|NCT02230332|54475686|FG001|Overall Study|Adverse Event|1|||
27871465|NCT02230332|54475685|FG000|Overall Study|Lost to Follow-up|1|||
27871466|NCT02230332|54475686|FG001|Overall Study|Lost to Follow-up|0|||
27871467|NCT02230332|54475685|FG000|Overall Study|Protocol Violation|1|||
27871468|NCT02230332|54475686|FG001|Overall Study|Protocol Violation|0|||
27982439|NCT04761822|54640567|FG000|Overall Study|Withdrawal by Subject|3|||
27982440|NCT04761822|54640568|FG001|Overall Study|Withdrawal by Subject|8|||
27982441|NCT04761822|54640569|FG002|Overall Study|Withdrawal by Subject|1|||
27982442|NCT04761822|54640570|FG003|Overall Study|Withdrawal by Subject|11|||
27982443|NCT04761822|54640567|FG000|Overall Study|Previously rec'd COVID-19 vaccine|1|||
27982444|NCT04761822|54640568|FG001|Overall Study|Previously rec'd COVID-19 vaccine|0|||
27982445|NCT04761822|54640569|FG002|Overall Study|Previously rec'd COVID-19 vaccine|0|||
27982446|NCT04761822|54640570|FG003|Overall Study|Previously rec'd COVID-19 vaccine|0|||
27982447|NCT04761822|54640567|FG000|Overall Study|Participant requested unblinding|0|||
27982448|NCT04761822|54640568|FG001|Overall Study|Participant requested unblinding|0|||
27739037|NCT02429791|54188319|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3|||
27739038|NCT02429791|54188320|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
27739039|NCT02429791|54188319|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11|||
27739040|NCT02429791|54188320|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12|||
27739041|NCT02429791|54188319|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
27982449|NCT04761822|54640569|FG002|Overall Study|Participant requested unblinding|0|||
27982450|NCT04761822|54640570|FG003|Overall Study|Participant requested unblinding|1|||
27982451|NCT04573972|54640599|FG000|Overall Study|Dyad partner did not join study or did not walk >0 steps|32|||
27982452|NCT04573972|54640600|FG001|Overall Study|Dyad partner did not join study or did not walk >0 steps|14|||
27982453|NCT04476043|54640621|FG000|Overall Study|Withdrawal by Subject|1|||
27982454|NCT04476043|54640622|FG001|Overall Study|Withdrawal by Subject|3|||
27982455|NCT04476043|54640623|FG002|Overall Study|Withdrawal by Subject|4|||
27982456|NCT04476043|54640624|FG003|Overall Study|Withdrawal by Subject|1|||
27982457|NCT04476043|54640621|FG000|Overall Study|Lost to Follow-up|1|||
27982458|NCT04476043|54640622|FG001|Overall Study|Lost to Follow-up|1|||
27982459|NCT04476043|54640623|FG002|Overall Study|Lost to Follow-up|2|||
27982460|NCT04476043|54640624|FG003|Overall Study|Lost to Follow-up|1|||
27982461|NCT04476043|54640621|FG000|Overall Study|Adverse Event|2|||
27982462|NCT04476043|54640622|FG001|Overall Study|Adverse Event|0|||
27982463|NCT04476043|54640623|FG002|Overall Study|Adverse Event|1|||
27982464|NCT04476043|54640624|FG003|Overall Study|Adverse Event|0|||
27982465|NCT04476043|54640621|FG000|Overall Study|Protocol Violation|0|||
27982466|NCT04476043|54640622|FG001|Overall Study|Protocol Violation|1|||
27982467|NCT04476043|54640623|FG002|Overall Study|Protocol Violation|0|||
27982468|NCT04476043|54640624|FG003|Overall Study|Protocol Violation|0|||
27982469|NCT04391309|54640645|FG000|Overall Study|Death|1|||
27982470|NCT04391309|54640646|FG001|Overall Study|Death|1|||
27982471|NCT04391309|54640645|FG000|Overall Study|Lost to Follow-up|3|||
27982472|NCT04391309|54640646|FG001|Overall Study|Lost to Follow-up|2|||
27982473|NCT04391309|54640645|FG000|Overall Study|Withdrawal by Subject|2|||
27739042|NCT02429791|54188320|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4|||
27871469|NCT02230254|54475692|FG000|Overall Study|Lost to Follow-up|3|||
27871470|NCT02198664|54475698|FG000|Overall Study|Adverse Event|2|||
27871471|NCT02198664|54475699|FG001|Overall Study|Adverse Event|0|||
27871472|NCT02198664|54475698|FG000|Overall Study|Withdrawal by Subject|11|||
27871473|NCT02198664|54475699|FG001|Overall Study|Withdrawal by Subject|8|||
27982474|NCT04391309|54640646|FG001|Overall Study|Withdrawal by Subject|2|||
27982475|NCT04202965|54640674|FG000|Overall Study|Adverse Event|3|||
27982476|NCT04202965|54640674|FG000|Overall Study|Did not meet inclusion criteria|1|||
27982477|NCT04056624|54640682|FG000|Overall Study|Withdrawal by Subject|0|||
27982478|NCT04056624|54640683|FG001|Overall Study|Withdrawal by Subject|0|||
27871474|NCT02198664|54475698|FG000|Overall Study|Failure to tolerate|2|||
27871475|NCT02198664|54475699|FG001|Overall Study|Failure to tolerate|0|||
27871476|NCT02198664|54475698|FG000|Overall Study|Not stated|1|||
27871477|NCT02198664|54475699|FG001|Overall Study|Not stated|0|||
27982479|NCT04056624|54640684|FG002|Overall Study|Withdrawal by Subject|1|||
27982480|NCT04056624|54640682|FG000|Overall Study|Protocol Violation|1|||
27982481|NCT04056624|54640683|FG001|Overall Study|Protocol Violation|2|||
27982482|NCT04056624|54640684|FG002|Overall Study|Protocol Violation|0|||
27982483|NCT03870763|54640704|FG000|Overall Study|Study terminated by sponsor|0|||
27982484|NCT03870763|54640705|FG001|Overall Study|Study terminated by sponsor|2|||
27982485|NCT03870763|54640706|FG002|Overall Study|Study terminated by sponsor|0|||
27982486|NCT03870763|54640704|FG000|Overall Study|Withdrawal by Subject|0|||
27982487|NCT03870763|54640705|FG001|Overall Study|Withdrawal by Subject|1|||
27982488|NCT03870763|54640706|FG002|Overall Study|Withdrawal by Subject|0|||
27982489|NCT03870763|54640704|FG000|Overall Study|Worsening of multiple sclerosis attack|0|||
27982490|NCT03870763|54640705|FG001|Overall Study|Worsening of multiple sclerosis attack|0|||
27982491|NCT03870763|54640706|FG002|Overall Study|Worsening of multiple sclerosis attack|1|||
27982492|NCT03647501|54640716|FG000|Overall Study|Lost to Follow-up|1|||
27982493|NCT03647501|54640717|FG001|Overall Study|Lost to Follow-up|1|||
27982494|NCT03647501|54640716|FG000|Overall Study|Withdrawal by Subject|0|||
27982495|NCT03647501|54640717|FG001|Overall Study|Withdrawal by Subject|1|||
27982496|NCT03587142|54640749|FG000|Overall Study|Lost to Follow-up|5|||
27982497|NCT03587142|54640750|FG001|Overall Study|Lost to Follow-up|3|||
27982498|NCT03587142|54640749|FG000|Overall Study|Did not complete the f4 visit|3|||
27982499|NCT03587142|54640750|FG001|Overall Study|Did not complete the f4 visit|7|||
27982500|NCT03493854|54640758|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3|||
27982501|NCT03493854|54640759|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5|||
27982502|NCT03493854|54640758|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
27982503|NCT03493854|54640759|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
27982504|NCT03493854|54640758|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0|||
27982505|NCT03493854|54640759|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1|||
27982506|NCT03493854|54640758|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1|||
27982507|NCT03493854|54640759|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2|||
27982508|NCT03493854|54640758|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
27982509|NCT03493854|54640759|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
27982510|NCT03493854|54640758|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
27982511|NCT03493854|54640759|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|2|||
27982512|NCT03493854|54640758|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
27982513|NCT03493854|54640759|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|0|||
27982514|NCT03493854|54640758|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Ongoing Adjuvant Treatment|229|||
27982515|NCT03493854|54640759|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Ongoing Adjuvant Treatment|228|||
27982516|NCT03493854|54640758|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|2|||
27982517|NCT03493854|54640759|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|2|||
27982518|NCT03493854|54640758|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0|||
27982519|NCT03493854|54640759|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|1|||
27982520|NCT03493854|54640758|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|3|||
27982521|NCT03493854|54640759|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0|||
27982522|NCT03493854|54640758|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Protocol Violation|1|||
27982523|NCT03493854|54640759|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Protocol Violation|0|||
27982524|NCT03493854|54640758|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
27982525|NCT03493854|54640759|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|0|||
27982526|NCT03493854|54640758|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Other|5|||
27982527|NCT03493854|54640759|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Other|3|||
27982528|NCT03493854|54640758|FG000|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|1|||
27982529|NCT03493854|54640759|FG001|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|1|||
27982530|NCT03493854|54640758|FG000|Treatment-Free Follow-Up (up to 3 Years)|Ongoing in Follow-Up|18|||
27982531|NCT03493854|54640759|FG001|Treatment-Free Follow-Up (up to 3 Years)|Ongoing in Follow-Up|16|||
27982532|NCT03188705|54640765|FG000|Clopidogrel Treatment|Withdrawal by Subject|1|||
27982533|NCT03188705|54640765|FG000|Clopidogrel Plus Aspirin Treatment|Withdrawal by Subject|1|||
27982534|NCT03072238|54640772|FG000|Overall Study|Withdrawal by Subject|30|||
27982535|NCT03072238|54640773|FG001|Overall Study|Withdrawal by Subject|51|||
27871478|NCT02165826|54475710|FG000|Main Treatment Period|Pre-treatment Event/Adverse Event|44|||
27871479|NCT02165826|54475711|FG001|Main Treatment Period|Pre-treatment Event/Adverse Event|57|||
27871480|NCT02165826|54475712|FG002|Main Treatment Period|Pre-treatment Event/Adverse Event|68|||
27871481|NCT02165826|54475710|FG000|Main Treatment Period|Major/Significant Protocol Deviation|0|||
27871482|NCT02165826|54475711|FG001|Main Treatment Period|Major/Significant Protocol Deviation|1|||
27871483|NCT02165826|54475712|FG002|Main Treatment Period|Major/Significant Protocol Deviation|3|||
27871484|NCT02165826|54475710|FG000|Main Treatment Period|Lost to Follow-up|4|||
27871485|NCT02165826|54475711|FG001|Main Treatment Period|Lost to Follow-up|2|||
27871486|NCT02165826|54475712|FG002|Main Treatment Period|Lost to Follow-up|1|||
27982536|NCT03072238|54640772|FG000|Overall Study|Lost to Follow-up|7|||
27982537|NCT03072238|54640773|FG001|Overall Study|Lost to Follow-up|4|||
27982538|NCT03072238|54640772|FG000|Overall Study|Physician Decision|1|||
27982539|NCT03072238|54640773|FG001|Overall Study|Physician Decision|3|||
27982540|NCT03072238|54640772|FG000|Overall Study|Death|139|||
27871487|NCT02165826|54475710|FG000|Main Treatment Period|Voluntary Withdrawal|23|||
27871488|NCT02165826|54475711|FG001|Main Treatment Period|Voluntary Withdrawal|23|||
27871489|NCT02165826|54475712|FG002|Main Treatment Period|Voluntary Withdrawal|21|||
27871490|NCT02165826|54475710|FG000|Main Treatment Period|Lack of Efficacy|2|||
27871491|NCT02165826|54475711|FG001|Main Treatment Period|Lack of Efficacy|0|||
27871492|NCT02165826|54475712|FG002|Main Treatment Period|Lack of Efficacy|0|||
27871493|NCT02165826|54475710|FG000|Main Treatment Period|Reason Not Specified|8|||
27871494|NCT02165826|54475711|FG001|Main Treatment Period|Reason Not Specified|5|||
27871495|NCT02165826|54475712|FG002|Main Treatment Period|Reason Not Specified|16|||
27871496|NCT02165826|54475710|FG000|Main Treatment Period|Did Not Receive Study Drug|0|||
27871497|NCT02165826|54475711|FG001|Main Treatment Period|Did Not Receive Study Drug|2|||
27871498|NCT02165826|54475712|FG002|Main Treatment Period|Did Not Receive Study Drug|0|||
27871499|NCT02165826|54475710|FG000|Down-Titration Period|Pre-treatment Event/Adverse Event|4|||
27871500|NCT02165826|54475711|FG001|Down-Titration Period|Pre-treatment Event/Adverse Event|10|||
27871501|NCT02165826|54475712|FG002|Down-Titration Period|Pre-treatment Event/Adverse Event|3|||
27871502|NCT02165826|54475710|FG000|Down-Titration Period|Voluntary Withdrawal|2|||
27871503|NCT02165826|54475711|FG001|Down-Titration Period|Voluntary Withdrawal|1|||
27871504|NCT02165826|54475712|FG002|Down-Titration Period|Voluntary Withdrawal|2|||
27871505|NCT02165826|54475710|FG000|Down-Titration Period|Reason Not Specified|1|||
27871506|NCT02165826|54475711|FG001|Down-Titration Period|Reason Not Specified|0|||
27871507|NCT02165826|54475712|FG002|Down-Titration Period|Reason Not Specified|2|||
27871508|NCT02198040|54475749|FG000|Overall Study|Work reasons|0|||
27871509|NCT02198040|54475750|FG001|Overall Study|Work reasons|1|||
27871510|NCT02198040|54475751|FG002|Overall Study|Work reasons|0|||
27871511|NCT02198040|54475749|FG000|Overall Study|Withdrawal by Subject|0|||
27871512|NCT02198040|54475750|FG001|Overall Study|Withdrawal by Subject|0|||
27871513|NCT02198040|54475751|FG002|Overall Study|Withdrawal by Subject|1|||
27871514|NCT02197806|54475765|FG000|Overall Study|Adverse Event|0|||
27871515|NCT02197806|54475766|FG001|Overall Study|Adverse Event|1|||
27871516|NCT02197806|54475767|FG002|Overall Study|Adverse Event|0|||
27871517|NCT02197806|54475768|FG003|Overall Study|Adverse Event|1|||
27871518|NCT02229864|54475815|FG000|Overall Study|Death|2|||
27871519|NCT02229864|54475815|FG000|Overall Study|Lost to Follow-up|1|||
27871520|NCT02229552|54475819|FG000|Baseline|Withdrawal by Subject|6|||
27871521|NCT02229552|54475819|FG000|1-year Follow up|Withdrawal by Subject|7|||
27871522|NCT02229552|54475819|FG000|1-year Follow up|Lost to Follow-up|18|||
27871523|NCT02229552|54475819|FG000|2-Year Follow up|Withdrawal by Subject|9|||
27871524|NCT02229552|54475819|FG000|2-Year Follow up|Lost to Follow-up|17|||
27871525|NCT02229396|54475826|FG000|Overall Study|Adverse Event|6|||
27871526|NCT02229396|54475827|FG001|Overall Study|Adverse Event|12|||
27871527|NCT02229396|54475828|FG002|Overall Study|Adverse Event|12|||
27871528|NCT02229396|54475826|FG000|Overall Study|Death|2|||
27871529|NCT02229396|54475827|FG001|Overall Study|Death|3|||
27871530|NCT02229396|54475828|FG002|Overall Study|Death|1|||
27871531|NCT02229396|54475826|FG000|Overall Study|Lost to Follow-up|14|||
27871532|NCT02229396|54475827|FG001|Overall Study|Lost to Follow-up|14|||
27871533|NCT02229396|54475828|FG002|Overall Study|Lost to Follow-up|21|||
27871534|NCT02229396|54475826|FG000|Overall Study|Protocol Violation|2|||
27871535|NCT02229396|54475827|FG001|Overall Study|Protocol Violation|1|||
28096392|NCT03988088|54751325|FG002|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
27871536|NCT02229396|54475828|FG002|Overall Study|Protocol Violation|0|||
27871537|NCT02229396|54475826|FG000|Overall Study|Patient Incorrectly Randomized|0|||
27871538|NCT02229396|54475827|FG001|Overall Study|Patient Incorrectly Randomized|0|||
27871539|NCT02229396|54475828|FG002|Overall Study|Patient Incorrectly Randomized|1|||
27871540|NCT02229396|54475826|FG000|Overall Study|Other|10|||
27871541|NCT02229396|54475827|FG001|Overall Study|Other|18|||
27871542|NCT02229396|54475828|FG002|Overall Study|Other|15|||
27871543|NCT02229396|54475826|FG000|Overall Study|Withdrawal by Subject|42|||
27871544|NCT02229396|54475827|FG001|Overall Study|Withdrawal by Subject|28|||
27871545|NCT02229396|54475828|FG002|Overall Study|Withdrawal by Subject|41|||
27871546|NCT02229396|54475826|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
27871547|NCT02229396|54475827|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
27871548|NCT02229396|54475828|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
27871549|NCT02229396|54475826|FG000|Overall Study|Withdrew; No Record on Termination Page|2|||
27871550|NCT02229396|54475827|FG001|Overall Study|Withdrew; No Record on Termination Page|0|||
27871551|NCT02229396|54475828|FG002|Overall Study|Withdrew; No Record on Termination Page|1|||
27871552|NCT02197416|54475843|FG000|Overall Study|Other reasons|0|||
27871553|NCT02197416|54475844|FG001|Overall Study|Other reasons|2|||
28096393|NCT03988088|54751326|FG003|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
28096394|NCT03988088|54751323|FG000|Open-Label Addendum|Lost to Follow-up|0|||
28096395|NCT03988088|54751324|FG001|Open-Label Addendum|Lost to Follow-up|0|||
27871554|NCT02197416|54475845|FG002|Overall Study|Other reasons|5|||
27871555|NCT02197416|54475843|FG000|Overall Study|Withdrawal by Subject|0|||
27871556|NCT02197416|54475844|FG001|Overall Study|Withdrawal by Subject|2|||
27871557|NCT02197416|54475845|FG002|Overall Study|Withdrawal by Subject|1|||
27871558|NCT02197416|54475843|FG000|Overall Study|Protocol Violation|1|||
27871559|NCT02197416|54475844|FG001|Overall Study|Protocol Violation|0|||
27871560|NCT02197416|54475845|FG002|Overall Study|Protocol Violation|1|||
27871561|NCT02197416|54475843|FG000|Overall Study|Adverse Event|0|||
27871562|NCT02197416|54475844|FG001|Overall Study|Adverse Event|0|||
27871563|NCT02197416|54475845|FG002|Overall Study|Adverse Event|1|||
27871564|NCT02165202|54475853|FG000|Oral Phase|Refused further participation|5|||
27871565|NCT02165202|54475854|FG001|Oral Phase|Refused further participation|1|||
27871566|NCT02165202|54475853|FG000|Oral Phase|Study product Related Toxicity|1|||
27871567|NCT02165202|54475854|FG001|Oral Phase|Study product Related Toxicity|0|||
27871568|NCT02165202|54475853|FG000|Oral Phase|Unable to contact Participant|1|||
27871569|NCT02165202|54475854|FG001|Oral Phase|Unable to contact Participant|1|||
27871570|NCT02165202|54475853|FG000|Oral Phase|Clinical reasons|1|||
27871571|NCT02165202|54475854|FG001|Oral Phase|Clinical reasons|0|||
27871572|NCT02165202|54475853|FG000|Oral Phase|QTcF>500 ms or increase of>60 ms|1|||
27871573|NCT02165202|54475854|FG001|Oral Phase|QTcF>500 ms or increase of>60 ms|0|||
27871574|NCT02165202|54475853|FG000|Oral Phase|CMC advised termination|1|||
27871575|NCT02165202|54475854|FG001|Oral Phase|CMC advised termination|0|||
27871576|NCT02165202|54475853|FG000|Oral Phase|Relocated, no follow-up planned|1|||
27871577|NCT02165202|54475854|FG001|Oral Phase|Relocated, no follow-up planned|0|||
27871578|NCT02165202|54475853|FG000|Oral Phase|Abnormal EKG|0|||
27871579|NCT02165202|54475854|FG001|Oral Phase|Abnormal EKG|1|||
27871580|NCT02165202|54475853|FG000|Injection Phase|Abnormal Lab Value|5|||
27871581|NCT02165202|54475854|FG001|Injection Phase|Abnormal Lab Value|1|||
27871582|NCT02165202|54475853|FG000|Injection Phase|Reactive HIV or HIV Suspected|0|||
27871583|NCT02165202|54475854|FG001|Injection Phase|Reactive HIV or HIV Suspected|2|||
27871584|NCT02165202|54475853|FG000|Injection Phase|Unable to attend within Visit Window|1|||
27871585|NCT02165202|54475854|FG001|Injection Phase|Unable to attend within Visit Window|0|||
27871586|NCT02165202|54475853|FG000|Injection Phase|QTcF>500 ms or increase of>60 ms|0|||
27871587|NCT02165202|54475854|FG001|Injection Phase|QTcF>500 ms or increase of>60 ms|1|||
27871588|NCT02165202|54475853|FG000|Injection Phase|End of Study|2|||
27871589|NCT02165202|54475854|FG001|Injection Phase|End of Study|1|||
27871590|NCT02165202|54475853|FG000|Injection Phase|Study Product related Toxicity|1|||
27871591|NCT02165202|54475854|FG001|Injection Phase|Study Product related Toxicity|0|||
27871592|NCT02165202|54475853|FG000|Injection Phase|No longer interested|0|||
27871593|NCT02165202|54475854|FG001|Injection Phase|No longer interested|1|||
27871594|NCT02165202|54475853|FG000|Injection Phase|Participant unwilling to comply|1|||
27871595|NCT02165202|54475854|FG001|Injection Phase|Participant unwilling to comply|0|||
27871596|NCT01628874|54475862|FG000|Overall Study|Physician Decision|1|||
27871597|NCT01628874|54475863|FG001|Overall Study|Physician Decision|1|||
27871598|NCT01628874|54475862|FG000|Overall Study|Age >4 months|4|||
27871599|NCT01628874|54475863|FG001|Overall Study|Age >4 months|2|||
27871600|NCT02196714|54475888|FG000|Overall Study|Protocol Violation|0|||
27871601|NCT02196714|54475889|FG001|Overall Study|Protocol Violation|0|||
27871602|NCT02196714|54475890|FG002|Overall Study|Protocol Violation|1|||
27871603|NCT02196714|54475891|FG003|Overall Study|Protocol Violation|0|||
27871604|NCT02196558|54475915|FG000|Treatment Phase (12 Weeks)|Adverse Event|0|||
27982541|NCT03072238|54640773|FG001|Overall Study|Death|121|||
27982542|NCT03072238|54640772|FG000|Overall Study|Other|0|||
27982543|NCT03072238|54640773|FG001|Overall Study|Other|1|||
27982544|NCT03072238|54640772|FG000|Overall Study|Ongoing on study|377|||
27982545|NCT03072238|54640773|FG001|Overall Study|Ongoing on study|367|||
27982546|NCT03032484|54640780|FG000|Overall Study Cycle 1 (C1)|Withdrawal by Subject|1|||
27982547|NCT03032484|54640781|FG001|Overall Study Cycle 1 (C1)|Withdrawal by Subject|0|||
27982548|NCT03032484|54640780|FG000|Start of Second Cycle (C2)|Withdrawal by Subject|1|||
27982549|NCT03032484|54640781|FG001|Start of Second Cycle (C2)|Withdrawal by Subject|0|||
27982550|NCT02975349|54640790|FG000|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
27982551|NCT02975349|54640791|FG001|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
27982552|NCT02975349|54640792|FG002|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
27982553|NCT02975349|54640793|FG003|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
27982554|NCT02975349|54640794|FG004|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
27982555|NCT02975349|54640795|FG005|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
27982556|NCT02975349|54640790|FG000|Active Treatment Period (24 Weeks)|Lost to Follow-up|1|||
27982557|NCT02975349|54640791|FG001|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
27982558|NCT02975349|54640792|FG002|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
27871605|NCT02196558|54475916|FG001|Treatment Phase (12 Weeks)|Adverse Event|2|||
27871606|NCT02196558|54475917|FG002|Treatment Phase (12 Weeks)|Adverse Event|0|||
27982559|NCT02975349|54640793|FG003|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
27982560|NCT02975349|54640794|FG004|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
27982561|NCT02975349|54640795|FG005|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
27982562|NCT02975349|54640790|FG000|Active Treatment Period (24 Weeks)|Adverse Event|4|||
27982563|NCT02975349|54640791|FG001|Active Treatment Period (24 Weeks)|Adverse Event|0|||
27871607|NCT02196558|54475915|FG000|Treatment Phase (12 Weeks)|Participant Choice|0|||
27871608|NCT02196558|54475916|FG001|Treatment Phase (12 Weeks)|Participant Choice|1|||
27871609|NCT02196558|54475917|FG002|Treatment Phase (12 Weeks)|Participant Choice|1|||
27871610|NCT02196558|54475915|FG000|Treatment Phase (12 Weeks)|Progression of Disease|0|||
27871611|NCT02196558|54475916|FG001|Treatment Phase (12 Weeks)|Progression of Disease|0|||
27871612|NCT02196558|54475917|FG002|Treatment Phase (12 Weeks)|Progression of Disease|1|||
27871613|NCT02196558|54475915|FG000|Extension Phase (40 Weeks)|Adverse Event|1|||
27871614|NCT02196558|54475916|FG001|Extension Phase (40 Weeks)|Adverse Event|2|||
27871615|NCT02196558|54475917|FG002|Extension Phase (40 Weeks)|Adverse Event|0|||
27871616|NCT02196558|54475915|FG000|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
27871617|NCT02196558|54475916|FG001|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
27871618|NCT02196558|54475917|FG002|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
27871619|NCT02196324|54475938|FG000|Overall Study|Withdrawal by Subject|8|||
27871620|NCT02196324|54475939|FG001|Overall Study|Withdrawal by Subject|4|||
27871621|NCT02196324|54475938|FG000|Overall Study|Adverse Event or Serious Adverse Event|6|||
27871622|NCT02196324|54475939|FG001|Overall Study|Adverse Event or Serious Adverse Event|3|||
27871623|NCT02196324|54475938|FG000|Overall Study|Occurrence of an Exclusion Criterion|0|||
27871624|NCT02196324|54475939|FG001|Overall Study|Occurrence of an Exclusion Criterion|1|||
27871625|NCT02196324|54475938|FG000|Overall Study|Other|1|||
27871626|NCT02196324|54475939|FG001|Overall Study|Other|0|||
27871627|NCT02195700|54475947|FG000|Overall Study|Protocol Violation|0|||
27871628|NCT02195700|54475948|FG001|Overall Study|Protocol Violation|2|||
27871629|NCT02195700|54475947|FG000|Overall Study|Noncompliance|1|||
27871630|NCT02195700|54475948|FG001|Overall Study|Noncompliance|0|||
27871631|NCT02195700|54475947|FG000|Overall Study|Adverse Event|1|||
27871632|NCT02195700|54475948|FG001|Overall Study|Adverse Event|2|||
27871633|NCT02195700|54475947|FG000|Overall Study|Withdrawal by Subject|3|||
27871634|NCT02195700|54475948|FG001|Overall Study|Withdrawal by Subject|2|||
27871635|NCT02195700|54475947|FG000|Overall Study|Lost to Follow-up|1|||
27871636|NCT02195700|54475948|FG001|Overall Study|Lost to Follow-up|1|||
27871637|NCT02228460|54475963|FG000|Overall Study|Adverse Event|1|||
27871638|NCT02228460|54475963|FG000|Overall Study|Lost to Follow-up|1|||
27871639|NCT02227446|54475979|FG000|Overall Study|not eligible post randomization|18|||
27871640|NCT02227446|54475980|FG001|Overall Study|not eligible post randomization|29|||
27871641|NCT02227446|54475979|FG000|Overall Study|Withdrawal by Subject|4|||
27871642|NCT02227446|54475980|FG001|Overall Study|Withdrawal by Subject|5|||
27871643|NCT02227368|54475988|FG000|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0|||
27871644|NCT02227368|54475989|FG001|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4|||
27871645|NCT02227368|54475988|FG000|Overall Study|Lost to Follow-up|1|||
27871646|NCT02227368|54475989|FG001|Overall Study|Lost to Follow-up|0|||
27871647|NCT02227368|54475988|FG000|Overall Study|Adverse Event|1|||
27871648|NCT02227368|54475989|FG001|Overall Study|Adverse Event|0|||
27871649|NCT02162862|54475998|FG000|Overall Study|Lost to Follow-up|0|||
27871650|NCT02162862|54475999|FG001|Overall Study|Lost to Follow-up|11|||
27871651|NCT02162862|54476000|FG002|Overall Study|Lost to Follow-up|0|||
27871652|NCT02162862|54475998|FG000|Overall Study|Subject did not feel the med was needed|0|||
27871653|NCT02162862|54475999|FG001|Overall Study|Subject did not feel the med was needed|0|||
27871654|NCT02162862|54476000|FG002|Overall Study|Subject did not feel the med was needed|4|||
27871655|NCT02226198|54476038|FG000|Lead-in Phase|Protocol Violation|1|||
27871656|NCT02226198|54476039|FG001|Lead-in Phase|Protocol Violation|0|||
27871657|NCT02226198|54476040|FG002|Lead-in Phase|Protocol Violation|0|||
27871658|NCT02226198|54476038|FG000|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
27871659|NCT02226198|54476039|FG001|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1|||
27871660|NCT02226198|54476040|FG002|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
27871661|NCT02226120|54476211|FG000|Overall Study|Adverse Event|60|||
27871662|NCT02226120|54476211|FG000|Overall Study|Death|172|||
27871663|NCT02226120|54476211|FG000|Overall Study|Study terminated by sponsor|1|||
27871664|NCT02226120|54476211|FG000|Overall Study|Technical problems|4|||
27982564|NCT02975349|54640792|FG002|Active Treatment Period (24 Weeks)|Adverse Event|1|||
27982565|NCT02975349|54640793|FG003|Active Treatment Period (24 Weeks)|Adverse Event|2|||
27982566|NCT02975349|54640794|FG004|Active Treatment Period (24 Weeks)|Adverse Event|6|||
27982567|NCT02975349|54640795|FG005|Active Treatment Period (24 Weeks)|Adverse Event|2|||
27982568|NCT02975349|54640790|FG000|Active Treatment Period (24 Weeks)|Un-specified|0|||
27982569|NCT02975349|54640791|FG001|Active Treatment Period (24 Weeks)|Un-specified|0|||
27982570|NCT02975349|54640792|FG002|Active Treatment Period (24 Weeks)|Un-specified|1|||
27982571|NCT02975349|54640793|FG003|Active Treatment Period (24 Weeks)|Un-specified|0|||
27982572|NCT02975349|54640794|FG004|Active Treatment Period (24 Weeks)|Un-specified|0|||
27982573|NCT02975349|54640795|FG005|Active Treatment Period (24 Weeks)|Un-specified|0|||
27982574|NCT02975349|54640790|FG000|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
28171438|NCT01361594|54843035|FG001|Overall Study|Withdrawal by Subject|2|||
27871665|NCT02226120|54476211|FG000|Overall Study|Lost to Follow-up|13|||
27871666|NCT02226120|54476211|FG000|Overall Study|Physician Decision|21|||
27871667|NCT02226120|54476211|FG000|Overall Study|Withdrawal by parent/guardian|36|||
27871668|NCT02226120|54476211|FG000|Overall Study|Non-compliance with study drug|10|||
27871669|NCT02226120|54476211|FG000|Overall Study|Protocol deviation|1|||
27871670|NCT02226120|54476211|FG000|Overall Study|missing treatment disposition pages|2|||
27871671|NCT02194998|54476389|FG000|On-HCV Treatment|Did not pick up study medication|0|||
27871672|NCT02194998|54476390|FG001|On-HCV Treatment|Did not pick up study medication|1|||
27871673|NCT02194998|54476391|FG002|On-HCV Treatment|Did not pick up study medication|0|||
27871674|NCT02194998|54476392|FG003|On-HCV Treatment|Did not pick up study medication|0|||
27871675|NCT02194998|54476389|FG000|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
27871676|NCT02194998|54476390|FG001|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
27871677|NCT02194998|54476391|FG002|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
27871678|NCT02194998|54476392|FG003|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
27871679|NCT02194062|54476405|FG000|Overall Study|Lost to Follow-up|2|||
27871680|NCT02194062|54476406|FG001|Overall Study|Lost to Follow-up|2|||
27871681|NCT02194062|54476407|FG002|Overall Study|Lost to Follow-up|5|||
27871682|NCT02193828|54476428|FG000|Overall Study|Withdrawal by Subject|0|||
27871683|NCT02193828|54476429|FG001|Overall Study|Withdrawal by Subject|0|||
27871684|NCT02193828|54476430|FG002|Overall Study|Withdrawal by Subject|1|||
27871685|NCT02193828|54476431|FG003|Overall Study|Withdrawal by Subject|1|||
27871686|NCT02192970|54476452|FG000|Overall Study|Lost to Follow-up|6|||
27871687|NCT02192970|54476453|FG001|Overall Study|Lost to Follow-up|0|||
27871688|NCT02192190|54476637|FG000|Overall Study|Adverse Event|1|||
27871689|NCT02192190|54476638|FG001|Overall Study|Adverse Event|1|||
27871690|NCT02192190|54476639|FG002|Overall Study|Adverse Event|0|||
27871691|NCT02192190|54476640|FG003|Overall Study|Adverse Event|0|||
27871692|NCT02192190|54476641|FG004|Overall Study|Adverse Event|0|||
27871693|NCT02192190|54476642|FG005|Overall Study|Adverse Event|0|||
27871694|NCT02192190|54476637|FG000|Overall Study|Lost to Follow-up|3|||
27871695|NCT02192190|54476638|FG001|Overall Study|Lost to Follow-up|3|||
27871696|NCT02192190|54476639|FG002|Overall Study|Lost to Follow-up|2|||
27871697|NCT02192190|54476640|FG003|Overall Study|Lost to Follow-up|1|||
27871698|NCT02192190|54476641|FG004|Overall Study|Lost to Follow-up|4|||
27871699|NCT02192190|54476642|FG005|Overall Study|Lost to Follow-up|3|||
27871700|NCT02192190|54476637|FG000|Overall Study|Physician Decision|2|||
27871701|NCT02192190|54476638|FG001|Overall Study|Physician Decision|0|||
27871702|NCT02192190|54476639|FG002|Overall Study|Physician Decision|0|||
27871703|NCT02192190|54476640|FG003|Overall Study|Physician Decision|0|||
27871704|NCT02192190|54476641|FG004|Overall Study|Physician Decision|0|||
27871705|NCT02192190|54476642|FG005|Overall Study|Physician Decision|0|||
27871706|NCT02192190|54476637|FG000|Overall Study|Terminated by Sponsor|43|||
27871707|NCT02192190|54476638|FG001|Overall Study|Terminated by Sponsor|23|||
27871708|NCT02192190|54476639|FG002|Overall Study|Terminated by Sponsor|20|||
27871709|NCT02192190|54476640|FG003|Overall Study|Terminated by Sponsor|23|||
27871710|NCT02192190|54476641|FG004|Overall Study|Terminated by Sponsor|21|||
27871711|NCT02192190|54476642|FG005|Overall Study|Terminated by Sponsor|23|||
27871712|NCT02192190|54476637|FG000|Overall Study|Withdrawal by Subject|4|||
27871713|NCT02192190|54476638|FG001|Overall Study|Withdrawal by Subject|1|||
27871714|NCT02192190|54476639|FG002|Overall Study|Withdrawal by Subject|2|||
27871715|NCT02192190|54476640|FG003|Overall Study|Withdrawal by Subject|1|||
27871716|NCT02192190|54476641|FG004|Overall Study|Withdrawal by Subject|5|||
27871717|NCT02192190|54476642|FG005|Overall Study|Withdrawal by Subject|3|||
27871718|NCT02192190|54476637|FG000|Overall Study|Could not Keep Visit Schedule|1|||
27871719|NCT02192190|54476638|FG001|Overall Study|Could not Keep Visit Schedule|0|||
27871720|NCT02192190|54476639|FG002|Overall Study|Could not Keep Visit Schedule|0|||
27871721|NCT02192190|54476640|FG003|Overall Study|Could not Keep Visit Schedule|0|||
27871722|NCT02192190|54476641|FG004|Overall Study|Could not Keep Visit Schedule|0|||
27871723|NCT02192190|54476642|FG005|Overall Study|Could not Keep Visit Schedule|0|||
27871724|NCT02192190|54476637|FG000|Overall Study|Positive Drug Screen|0|||
27871725|NCT02192190|54476638|FG001|Overall Study|Positive Drug Screen|0|||
27871726|NCT02192190|54476639|FG002|Overall Study|Positive Drug Screen|0|||
27871727|NCT02192190|54476640|FG003|Overall Study|Positive Drug Screen|1|||
27871728|NCT02192190|54476641|FG004|Overall Study|Positive Drug Screen|0|||
27871729|NCT02192190|54476642|FG005|Overall Study|Positive Drug Screen|0|||
27871730|NCT02192190|54476637|FG000|Overall Study|Inadequate Pain Relief|0|||
27871731|NCT02192190|54476638|FG001|Overall Study|Inadequate Pain Relief|1|||
27871732|NCT02192190|54476639|FG002|Overall Study|Inadequate Pain Relief|1|||
27871733|NCT02192190|54476640|FG003|Overall Study|Inadequate Pain Relief|0|||
27871734|NCT02192190|54476641|FG004|Overall Study|Inadequate Pain Relief|0|||
27871735|NCT02192190|54476642|FG005|Overall Study|Inadequate Pain Relief|0|||
27871736|NCT02224638|54476670|FG000|Overall Study|Adverse Event|1|||
27871737|NCT02224638|54476671|FG001|Overall Study|Adverse Event|1|||
27871738|NCT02224560|54476686|FG000|Overall Study|Protocol Deviation|1|||
27871739|NCT02224560|54476687|FG001|Overall Study|Protocol Deviation|0|||
27871740|NCT02224560|54476688|FG002|Overall Study|Protocol Deviation|0|||
27871741|NCT02224560|54476686|FG000|Overall Study|Withdrawal by Subject|2|||
27871742|NCT02224560|54476687|FG001|Overall Study|Withdrawal by Subject|0|||
27871743|NCT02224560|54476688|FG002|Overall Study|Withdrawal by Subject|1|||
27871744|NCT02224560|54476686|FG000|Overall Study|Met Withdrawal Criteria|1|||
28171439|NCT02642432|54843041|FG000|Overall Study|Adverse Event|2|||
27739043|NCT02429791|54188319|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4|||
27739044|NCT02429791|54188320|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
27739045|NCT02429791|54188319|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0|||
27739046|NCT02429791|54188320|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1|||
27739047|NCT02429791|54188319|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
27739048|NCT02429791|54188320|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
27739049|NCT02429791|54188319|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7|||
27739050|NCT02429791|54188320|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5|||
27739051|NCT02461160|54188346|FG000|Overall Study|Lost to Follow-up|0|||
27739052|NCT02461160|54188347|FG001|Overall Study|Lost to Follow-up|0|||
27739053|NCT02461160|54188348|FG002|Overall Study|Lost to Follow-up|0|||
27739054|NCT02461160|54188349|FG003|Overall Study|Lost to Follow-up|0|||
27739055|NCT02461160|54188350|FG004|Overall Study|Lost to Follow-up|0|||
27739056|NCT02461160|54188351|FG005|Overall Study|Lost to Follow-up|0|||
27739057|NCT02461160|54188352|FG006|Overall Study|Lost to Follow-up|0|||
27739058|NCT02461160|54188353|FG007|Overall Study|Lost to Follow-up|1|||
27739059|NCT02461160|54188354|FG008|Overall Study|Lost to Follow-up|0|||
27739060|NCT02461160|54188355|FG009|Overall Study|Lost to Follow-up|0|||
27739061|NCT02461160|54188356|FG010|Overall Study|Lost to Follow-up|0|||
27739062|NCT02461160|54188357|FG011|Overall Study|Lost to Follow-up|0|||
27739063|NCT02461160|54188358|FG012|Overall Study|Lost to Follow-up|0|||
27871745|NCT02224560|54476687|FG001|Overall Study|Met Withdrawal Criteria|0|||
27871746|NCT02224560|54476688|FG002|Overall Study|Met Withdrawal Criteria|0|||
27871747|NCT02224560|54476686|FG000|Overall Study|Adverse Event|4|||
27871748|NCT02224560|54476687|FG001|Overall Study|Adverse Event|1|||
27871749|NCT02224560|54476688|FG002|Overall Study|Adverse Event|1|||
27871750|NCT02224560|54476686|FG000|Overall Study|Withdrawn by Investigator|1|||
27871751|NCT02224560|54476687|FG001|Overall Study|Withdrawn by Investigator|1|||
27871752|NCT02224560|54476688|FG002|Overall Study|Withdrawn by Investigator|0|||
27871753|NCT02161458|54476700|FG000|Overall Study|Withdrawal by Subject|0|||
27871754|NCT02161458|54476701|FG001|Overall Study|Withdrawal by Subject|4|||
27871755|NCT02161458|54476702|FG002|Overall Study|Withdrawal by Subject|4|||
27871756|NCT02161458|54476703|FG003|Overall Study|Withdrawal by Subject|0|||
27871757|NCT02161458|54476700|FG000|Overall Study|Lost to Follow-up|0|||
27871758|NCT02161458|54476701|FG001|Overall Study|Lost to Follow-up|2|||
27871759|NCT02161458|54476702|FG002|Overall Study|Lost to Follow-up|1|||
27871760|NCT02161458|54476703|FG003|Overall Study|Lost to Follow-up|0|||
27871761|NCT02223858|54476715|FG000|Overall Study|Death|1|||
27871762|NCT02223858|54476716|FG001|Overall Study|Death|1|||
27871763|NCT02223858|54476715|FG000|Overall Study|Lost to Follow-up|6|||
27871764|NCT02223858|54476716|FG001|Overall Study|Lost to Follow-up|11|||
27871765|NCT02223858|54476715|FG000|Overall Study|Withdrawal by Subject|8|||
27871766|NCT02223858|54476716|FG001|Overall Study|Withdrawal by Subject|5|||
27871767|NCT02223858|54476715|FG000|Overall Study|Refused|9|||
27871768|NCT02223858|54476716|FG001|Overall Study|Refused|9|||
27871769|NCT02223390|54476724|FG000|Overall Study|Lost to Follow-up|9|||
27871770|NCT02223390|54476725|FG001|Overall Study|Lost to Follow-up|4|||
27871771|NCT04914000|54478628|FG000|Overall Study|Lost to Follow-up|8|||
27871772|NCT04914000|54478628|FG000|Overall Study|Withdrawal by Subject|1|||
27871773|NCT04530825|54478645|FG000|Overall Study|No longer eligible on the day of baseline visit|0|||
27871774|NCT04530825|54478646|FG001|Overall Study|No longer eligible on the day of baseline visit|1|||
27871775|NCT04530825|54478647|FG002|Overall Study|No longer eligible on the day of baseline visit|0|||
27871776|NCT04530825|54478648|FG003|Overall Study|No longer eligible on the day of baseline visit|1|||
27871777|NCT04530825|54478645|FG000|Overall Study|Did not complete follow-up|3|||
27871778|NCT04530825|54478646|FG001|Overall Study|Did not complete follow-up|0|||
27871779|NCT04530825|54478647|FG002|Overall Study|Did not complete follow-up|0|||
27871780|NCT04530825|54478648|FG003|Overall Study|Did not complete follow-up|0|||
27871781|NCT04169373|54478662|FG000|Week 1 to Week 14|Adverse Event|1|||
27871782|NCT04169373|54478663|FG001|Week 1 to Week 14|Adverse Event|0|||
27871783|NCT04169373|54478664|FG002|Week 1 to Week 14|Adverse Event|1|||
27871784|NCT04169373|54478665|FG003|Week 1 to Week 14|Adverse Event|2|||
27871785|NCT04169373|54478662|FG000|Week 1 to Week 14|Withdrawal by Subject|2|||
27871786|NCT04169373|54478663|FG001|Week 1 to Week 14|Withdrawal by Subject|0|||
27871787|NCT04169373|54478664|FG002|Week 1 to Week 14|Withdrawal by Subject|5|||
27739064|NCT01653704|54188409|FG000|Overall Study|Technical failure during recording|1|||
27739065|NCT01653704|54188410|FG001|Overall Study|Technical failure during recording|1|||
27871788|NCT04169373|54478665|FG003|Week 1 to Week 14|Withdrawal by Subject|6|||
27871789|NCT04169373|54478662|FG000|Week 1 to Week 14|Lost to Follow-up|1|||
27739066|NCT01653704|54188409|FG000|Overall Study|Performance not reflective of training|1|||
27871790|NCT04169373|54478663|FG001|Week 1 to Week 14|Lost to Follow-up|1|||
27871791|NCT04169373|54478664|FG002|Week 1 to Week 14|Lost to Follow-up|0|||
27739067|NCT01653704|54188410|FG001|Overall Study|Performance not reflective of training|0|||
27871792|NCT04169373|54478665|FG003|Week 1 to Week 14|Lost to Follow-up|1|||
27739068|NCT02495168|54188419|FG000|Overall Study|Other than Specified|18|||
27871793|NCT04169373|54478662|FG000|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
27871794|NCT04169373|54478663|FG001|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|1|||
27871795|NCT04169373|54478664|FG002|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
27871796|NCT04169373|54478665|FG003|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
27871797|NCT04169373|54478662|FG000|Week 1 to Week 14|Other|1|||
27871798|NCT04169373|54478663|FG001|Week 1 to Week 14|Other|3|||
27871799|NCT04169373|54478664|FG002|Week 1 to Week 14|Other|3|||
27871800|NCT04169373|54478665|FG003|Week 1 to Week 14|Other|5|||
27871801|NCT04169373|54478662|FG000|Week 14 to Week 52|Adverse Event|1|||
27871802|NCT04169373|54478663|FG001|Week 14 to Week 52|Adverse Event|0|||
27871803|NCT04169373|54478664|FG002|Week 14 to Week 52|Adverse Event|0|||
27871804|NCT04169373|54478665|FG003|Week 14 to Week 52|Adverse Event|1|||
27871805|NCT04169373|54478662|FG000|Week 14 to Week 52|Withdrawal by Subject|4|||
27871806|NCT04169373|54478663|FG001|Week 14 to Week 52|Withdrawal by Subject|5|||
27871807|NCT04169373|54478664|FG002|Week 14 to Week 52|Withdrawal by Subject|7|||
27871808|NCT04169373|54478665|FG003|Week 14 to Week 52|Withdrawal by Subject|2|||
27871809|NCT04169373|54478662|FG000|Week 14 to Week 52|Lost to Follow-up|2|||
27871810|NCT04169373|54478663|FG001|Week 14 to Week 52|Lost to Follow-up|1|||
27871811|NCT04169373|54478664|FG002|Week 14 to Week 52|Lost to Follow-up|0|||
27871812|NCT04169373|54478665|FG003|Week 14 to Week 52|Lost to Follow-up|1|||
27871813|NCT04169373|54478662|FG000|Week 14 to Week 52|COVID-19 Logistical Restrictions|1|||
27871814|NCT04169373|54478663|FG001|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
27871815|NCT04169373|54478664|FG002|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
27871816|NCT04169373|54478665|FG003|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
27871817|NCT04169373|54478662|FG000|Week 14 to Week 52|Other|4|||
27871818|NCT04169373|54478663|FG001|Week 14 to Week 52|Other|5|||
27871819|NCT04169373|54478664|FG002|Week 14 to Week 52|Other|4|||
27871820|NCT04169373|54478665|FG003|Week 14 to Week 52|Other|5|||
27871821|NCT04169373|54478662|FG000|Week 14 to Week 52|Ongoing|0|||
27871822|NCT04169373|54478663|FG001|Week 14 to Week 52|Ongoing|1|||
27871823|NCT04169373|54478664|FG002|Week 14 to Week 52|Ongoing|0|||
27871824|NCT04169373|54478665|FG003|Week 14 to Week 52|Ongoing|0|||
27871825|NCT04154930|54478680|FG000|Overall Study|Withdrawal by Subject|15|||
27871826|NCT04154930|54478681|FG001|Overall Study|Withdrawal by Subject|6|||
27871827|NCT04154930|54478680|FG000|Overall Study|Withdrew consent- Covid-19 related|2|||
27871828|NCT04154930|54478681|FG001|Overall Study|Withdrew consent- Covid-19 related|1|||
27871829|NCT04154930|54478680|FG000|Overall Study|Lost to Follow-up|14|||
27871830|NCT04154930|54478681|FG001|Overall Study|Lost to Follow-up|6|||
27871831|NCT04154930|54478680|FG000|Overall Study|Other|6|||
27871832|NCT04154930|54478681|FG001|Overall Study|Other|0|||
27871833|NCT04124471|54478687|FG000|Overall Study|screen failure|1|||
27871834|NCT04093024|54478693|FG000|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
27871835|NCT04093024|54478694|FG001|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
27871836|NCT04093024|54478693|FG000|Double-blind Period|Discontinued treatment due to adverse event|0|||
27871837|NCT04093024|54478694|FG001|Double-blind Period|Discontinued treatment due to adverse event|2|||
27871838|NCT04093024|54478693|FG000|Double-blind Period|Discontinued treatment due to other reason|0|||
27871839|NCT04093024|54478694|FG001|Double-blind Period|Discontinued treatment due to other reason|1|||
27871840|NCT04093024|54478693|FG000|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|0|||
27871841|NCT04093024|54478694|FG001|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|1|||
27871842|NCT03971474|54478730|FG000|Overall Study|Adverse Event|11|||
27871843|NCT03971474|54478731|FG001|Overall Study|Adverse Event|7|||
27871844|NCT03971474|54478730|FG000|Overall Study|Refusal unrelated to adverse event|5|||
27871845|NCT03971474|54478731|FG001|Overall Study|Refusal unrelated to adverse event|1|||
27871846|NCT03971474|54478730|FG000|Overall Study|Progression/relapse|40|||
27871847|NCT03971474|54478731|FG001|Overall Study|Progression/relapse|47|||
27871848|NCT03971474|54478730|FG000|Overall Study|Death|6|||
27871849|NCT03971474|54478731|FG001|Overall Study|Death|3|||
27871850|NCT03971474|54478730|FG000|Overall Study|Other - not protocol specified|5|||
27871851|NCT03971474|54478731|FG001|Overall Study|Other - not protocol specified|4|||
27871852|NCT03971474|54478730|FG000|Overall Study|On treatment|0|||
27871853|NCT03971474|54478731|FG001|Overall Study|On treatment|7|||
27871854|NCT03633929|54478738|FG000|Overall Study|Lost to Follow-up|1|||
27871855|NCT03633929|54478738|FG000|Overall Study|Did not login to software. Did not participate|3|||
27871856|NCT03625687|54478742|FG000|Overall Study|Death|1|||
27871857|NCT02869633|54478765|FG000|Overall Study|Death|2|||
27871858|NCT02869633|54478766|FG001|Overall Study|Death|1|||
27871859|NCT02869633|54478765|FG000|Overall Study|Patient refused follow-up|1|||
27871860|NCT02869633|54478766|FG001|Overall Study|Patient refused follow-up|0|||
27871861|NCT02869633|54478765|FG000|Overall Study|Provider discretion|1|||
28171440|NCT02642432|54843041|FG000|Overall Study|Withdrew Consent|1|||
27871862|NCT02869633|54478766|FG001|Overall Study|Provider discretion|0|||
27871863|NCT02869633|54478765|FG000|Overall Study|Investigator decision|1|||
27871864|NCT02869633|54478766|FG001|Overall Study|Investigator decision|0|||
27871865|NCT02869633|54478765|FG000|Overall Study|Lost to Follow-up|0|||
27871866|NCT02869633|54478766|FG001|Overall Study|Lost to Follow-up|1|||
27871867|NCT02869633|54478765|FG000|Overall Study|Not eligible|6|||
27871868|NCT02869633|54478766|FG001|Overall Study|Not eligible|1|||
27871869|NCT02869633|54478765|FG000|Overall Study|Protocol-defined follow-up period completed|2|||
27871870|NCT02869633|54478766|FG001|Overall Study|Protocol-defined follow-up period completed|1|||
27871871|NCT02869633|54478765|FG000|Overall Study|Withdrawal by Subject|0|||
27871872|NCT02869633|54478766|FG001|Overall Study|Withdrawal by Subject|1|||
27871873|NCT02785952|54478776|FG000|Overall Study|Adverse Event|31|||
27871874|NCT02785952|54478777|FG001|Overall Study|Adverse Event|19|||
27871875|NCT02785952|54478776|FG000|Overall Study|Refusal unrelated to adverse events|10|||
27871876|NCT02785952|54478777|FG001|Overall Study|Refusal unrelated to adverse events|5|||
27871877|NCT02785952|54478776|FG000|Overall Study|Disease progression/relapse|61|||
27871878|NCT02785952|54478777|FG001|Overall Study|Disease progression/relapse|89|||
27871879|NCT02785952|54478776|FG000|Overall Study|Death|11|||
27871880|NCT02785952|54478777|FG001|Overall Study|Death|7|||
27871881|NCT02785952|54478776|FG000|Overall Study|Other- not protocol specified|6|||
27871882|NCT02785952|54478777|FG001|Overall Study|Other- not protocol specified|4|||
27871883|NCT02785952|54478776|FG000|Overall Study|On protocol treatment|6|||
27871884|NCT02785952|54478777|FG001|Overall Study|On protocol treatment|3|||
27871885|NCT02674685|54478785|FG000|Overall Study|Withdrawal by Subject|4|||
27871886|NCT02654236|54478792|FG000|Overall Study|Withdrawal by Subject|0|||
27871887|NCT02654236|54478793|FG001|Overall Study|Withdrawal by Subject|0|||
27871888|NCT02654236|54478794|FG002|Overall Study|Withdrawal by Subject|2|||
27871889|NCT02372136|54478804|FG000|Overall Study|Death|3|||
27871890|NCT02372136|54478805|FG001|Overall Study|Death|1|||
27871891|NCT02194829|54478815|FG000|Overall Study|Adverse Event|2|||
27871892|NCT02194829|54478816|FG001|Overall Study|Adverse Event|2|||
27871893|NCT02194829|54478815|FG000|Overall Study|Death|0|||
27871894|NCT02194829|54478816|FG001|Overall Study|Death|1|||
27871895|NCT02194829|54478815|FG000|Overall Study|Disease progression|0|||
27871896|NCT02194829|54478816|FG001|Overall Study|Disease progression|1|||
27871897|NCT02194829|54478815|FG000|Overall Study|Withdrawal by Subject|0|||
27871898|NCT02194829|54478816|FG001|Overall Study|Withdrawal by Subject|1|||
27871899|NCT02194829|54478815|FG000|Overall Study|Never started protocol therapy|0|||
27871900|NCT02194829|54478816|FG001|Overall Study|Never started protocol therapy|1|||
27871901|NCT02087046|54478823|FG000|Overall Study|Adverse Event|4|||
27871902|NCT02087046|54478823|FG000|Overall Study|Death|1|||
27871903|NCT02087046|54478823|FG000|Overall Study|Lost to Follow-up|3|||
27871904|NCT02087046|54478823|FG000|Overall Study|Withdrawal by Subject|2|||
27871905|NCT02087046|54478823|FG000|Overall Study|Physician Decision|1|||
27871906|NCT01390038|54478832|FG000|Overall Study|Death|1|||
27871907|NCT01390038|54478832|FG000|Overall Study|Lost to Follow-up|1|||
27871908|NCT01390038|54478832|FG000|Overall Study|Withdrawal by Subject|4|||
27871909|NCT01390038|54478832|FG000|Overall Study|Simpliciti System Removal|2|||
27871910|NCT00621192|54478850|FG000|Overall Study|Withdrawal by Subject|0|||
27871911|NCT00621192|54478851|FG001|Overall Study|Withdrawal by Subject|0|||
27871912|NCT00621192|54478852|FG002|Overall Study|Withdrawal by Subject|2|||
27871913|NCT00621192|54478853|FG003|Overall Study|Withdrawal by Subject|0|||
27871914|NCT00621192|54478850|FG000|Overall Study|Physician Decision|1|||
27871915|NCT00621192|54478851|FG001|Overall Study|Physician Decision|3|||
27871916|NCT00621192|54478852|FG002|Overall Study|Physician Decision|0|||
27871917|NCT00621192|54478853|FG003|Overall Study|Physician Decision|0|||
27871918|NCT00621192|54478850|FG000|Overall Study|Protocol Violation|1|||
27871919|NCT00621192|54478851|FG001|Overall Study|Protocol Violation|0|||
27871920|NCT00621192|54478852|FG002|Overall Study|Protocol Violation|0|||
27871921|NCT00621192|54478853|FG003|Overall Study|Protocol Violation|1|||
27871922|NCT00621192|54478850|FG000|Overall Study|Adverse Event|0|||
27871923|NCT00621192|54478851|FG001|Overall Study|Adverse Event|1|||
27871924|NCT00621192|54478852|FG002|Overall Study|Adverse Event|0|||
27871925|NCT00621192|54478853|FG003|Overall Study|Adverse Event|1|||
27871926|NCT00621192|54478850|FG000|Overall Study|Death|2|||
27871927|NCT00621192|54478851|FG001|Overall Study|Death|5|||
27871928|NCT00621192|54478852|FG002|Overall Study|Death|0|||
27871929|NCT00621192|54478853|FG003|Overall Study|Death|0|||
27871930|NCT00621192|54478850|FG000|Overall Study|Final Assessments not Completed|0|||
27871931|NCT00621192|54478851|FG001|Overall Study|Final Assessments not Completed|0|||
27871932|NCT00621192|54478852|FG002|Overall Study|Final Assessments not Completed|3|||
27871933|NCT00621192|54478853|FG003|Overall Study|Final Assessments not Completed|1|||
27871934|NCT00364286|54478863|FG000|Overall Study|Withdrawal by Subject|1|||
27871935|NCT00364286|54478863|FG000|Overall Study|Adverse Event|2|||
27871936|NCT00278200|54478869|FG000|Overall Study|Death|1|||
27871937|NCT00278200|54478870|FG001|Overall Study|Death|3|||
28171441|NCT02642432|54843041|FG000|Overall Study|Lost to Follow-up|2|||
27871938|NCT00278200|54478869|FG000|Overall Study|Physician Decision|0|||
27871939|NCT00278200|54478870|FG001|Overall Study|Physician Decision|1|||
27871940|NCT00255346|54478881|FG000|Overall Study|Adverse Event|1|||
27871941|NCT00255346|54478882|FG001|Overall Study|Adverse Event|0|||
27871942|NCT00255346|54478883|FG002|Overall Study|Adverse Event|0|||
27871943|NCT00255346|54478884|FG003|Overall Study|Adverse Event|0|||
27871944|NCT00255346|54478885|FG004|Overall Study|Adverse Event|0|||
27871945|NCT02222922|54481045|FG000|Overall Study|Death|0|||
27871946|NCT02222922|54481046|FG001|Overall Study|Death|0|||
27871947|NCT02222922|54481047|FG002|Overall Study|Death|0|||
27871948|NCT02222922|54481048|FG003|Overall Study|Death|0|||
27871949|NCT02222922|54481049|FG004|Overall Study|Death|13|||
27871950|NCT02222922|54481050|FG005|Overall Study|Death|0|||
27871951|NCT02222922|54481051|FG006|Overall Study|Death|0|||
27871952|NCT02222922|54481052|FG007|Overall Study|Death|0|||
27871953|NCT02222922|54481053|FG008|Overall Study|Death|2|||
27871954|NCT02222922|54481045|FG000|Overall Study|Lost to Follow-up|0|||
27871955|NCT02222922|54481046|FG001|Overall Study|Lost to Follow-up|0|||
27871956|NCT02222922|54481047|FG002|Overall Study|Lost to Follow-up|1|||
27871957|NCT02222922|54481048|FG003|Overall Study|Lost to Follow-up|0|||
27871958|NCT02222922|54481049|FG004|Overall Study|Lost to Follow-up|9|||
27871959|NCT02222922|54481050|FG005|Overall Study|Lost to Follow-up|1|||
27871960|NCT02222922|54481051|FG006|Overall Study|Lost to Follow-up|0|||
27871961|NCT02222922|54481052|FG007|Overall Study|Lost to Follow-up|0|||
27871962|NCT02222922|54481053|FG008|Overall Study|Lost to Follow-up|0|||
27871963|NCT02222922|54481045|FG000|Overall Study|Other|0|||
27871964|NCT02222922|54481046|FG001|Overall Study|Other|0|||
27871965|NCT02222922|54481047|FG002|Overall Study|Other|0|||
27871966|NCT02222922|54481048|FG003|Overall Study|Other|2|||
27871967|NCT02222922|54481049|FG004|Overall Study|Other|10|||
27871968|NCT02222922|54481050|FG005|Overall Study|Other|2|||
27871969|NCT02222922|54481051|FG006|Overall Study|Other|2|||
27871970|NCT02222922|54481052|FG007|Overall Study|Other|4|||
27871971|NCT02222922|54481053|FG008|Overall Study|Other|1|||
27871972|NCT02222922|54481045|FG000|Overall Study|Participant refused further follow-up|1|||
27871973|NCT02222922|54481046|FG001|Overall Study|Participant refused further follow-up|0|||
27871974|NCT02222922|54481047|FG002|Overall Study|Participant refused further follow-up|0|||
27871975|NCT02222922|54481048|FG003|Overall Study|Participant refused further follow-up|1|||
27871976|NCT02222922|54481049|FG004|Overall Study|Participant refused further follow-up|6|||
27871977|NCT02222922|54481050|FG005|Overall Study|Participant refused further follow-up|0|||
27871978|NCT02222922|54481051|FG006|Overall Study|Participant refused further follow-up|0|||
27871979|NCT02222922|54481052|FG007|Overall Study|Participant refused further follow-up|0|||
27871980|NCT02222922|54481053|FG008|Overall Study|Participant refused further follow-up|3|||
27871981|NCT02161146|54481105|FG000|Overall Study|Adverse Event|1|||
27871982|NCT02161146|54481106|FG001|Overall Study|Adverse Event|1|||
27871983|NCT02161146|54481107|FG002|Overall Study|Adverse Event|0|||
27871984|NCT02161146|54481108|FG003|Overall Study|Adverse Event|1|||
27871985|NCT02161146|54481109|FG004|Overall Study|Adverse Event|0|||
27871986|NCT02161146|54481105|FG000|Overall Study|Lost to Follow-up|0|||
27871987|NCT02161146|54481106|FG001|Overall Study|Lost to Follow-up|1|||
27871988|NCT02161146|54481107|FG002|Overall Study|Lost to Follow-up|0|||
27871989|NCT02161146|54481108|FG003|Overall Study|Lost to Follow-up|0|||
27871990|NCT02161146|54481109|FG004|Overall Study|Lost to Follow-up|0|||
27871991|NCT02161146|54481105|FG000|Overall Study|Personal Reasons|0|||
27871992|NCT02161146|54481106|FG001|Overall Study|Personal Reasons|1|||
27871993|NCT02161146|54481107|FG002|Overall Study|Personal Reasons|0|||
27871994|NCT02161146|54481108|FG003|Overall Study|Personal Reasons|2|||
27871995|NCT02161146|54481109|FG004|Overall Study|Personal Reasons|1|||
27871996|NCT02161146|54481105|FG000|Overall Study|Other Miscellaneous Reasons|0|||
27871997|NCT02161146|54481106|FG001|Overall Study|Other Miscellaneous Reasons|1|||
27871998|NCT02161146|54481107|FG002|Overall Study|Other Miscellaneous Reasons|0|||
27871999|NCT02161146|54481108|FG003|Overall Study|Other Miscellaneous Reasons|0|||
27872000|NCT02161146|54481109|FG004|Overall Study|Other Miscellaneous Reasons|0|||
27872001|NCT02222688|54481344|FG000|Overall Study|Withdrawal by Subject|0|||
27872002|NCT02222688|54481345|FG001|Overall Study|Withdrawal by Subject|0|||
27872003|NCT02222688|54481346|FG002|Overall Study|Withdrawal by Subject|0|||
27872004|NCT02222688|54481347|FG003|Overall Study|Withdrawal by Subject|2|||
27872005|NCT02222688|54481348|FG004|Overall Study|Withdrawal by Subject|1|||
27872006|NCT02222688|54481349|FG005|Overall Study|Withdrawal by Subject|0|||
27872007|NCT02222688|54481350|FG006|Overall Study|Withdrawal by Subject|1|||
27872008|NCT02222688|54481344|FG000|Overall Study|Disease progression|1|||
27872009|NCT02222688|54481345|FG001|Overall Study|Disease progression|0|||
27872010|NCT02222688|54481346|FG002|Overall Study|Disease progression|0|||
27872011|NCT02222688|54481347|FG003|Overall Study|Disease progression|0|||
27872012|NCT02222688|54481348|FG004|Overall Study|Disease progression|0|||
27872013|NCT02222688|54481349|FG005|Overall Study|Disease progression|0|||
27872014|NCT02222688|54481350|FG006|Overall Study|Disease progression|0|||
27872015|NCT02159352|54481402|FG000|Overall Study|Adverse Event|3|||
27872016|NCT02159352|54481403|FG001|Overall Study|Adverse Event|1|||
27872017|NCT02159352|54481402|FG000|Overall Study|Withdrawal by Subject|0|||
27982575|NCT02975349|54640791|FG001|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
27982576|NCT02975349|54640792|FG002|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
27872018|NCT02159352|54481403|FG001|Overall Study|Withdrawal by Subject|1|||
27872019|NCT02187744|54481440|FG000|Study|Participant refused further follow-up|1|||
27872020|NCT02187744|54481441|FG001|Study|Participant refused further follow-up|0|||
27872021|NCT02187744|54481440|FG000|Study|Other|2|||
27872022|NCT02187744|54481441|FG001|Study|Other|1|||
27872023|NCT02187744|54481440|FG000|Study|Lost to Follow-up|0|||
27872024|NCT02187744|54481441|FG001|Study|Lost to Follow-up|2|||
27872025|NCT02187744|54481440|FG000|Study|Related adverse event, not serious|0|||
27872026|NCT02187744|54481441|FG001|Study|Related adverse event, not serious|2|||
27872027|NCT02187744|54481440|FG000|Study|Death|1|||
27872028|NCT02187744|54481441|FG001|Study|Death|0|||
27872029|NCT02187744|54481440|FG000|Study|Related adverse event, serious non-fatal|0|||
27872030|NCT02187744|54481441|FG001|Study|Related adverse event, serious non-fatal|1|||
27872031|NCT02187744|54481440|FG000|Treatment|Death|1|||
27872032|NCT02187744|54481441|FG001|Treatment|Death|0|||
27872033|NCT02187744|54481440|FG000|Treatment|Related adverse event, serious non-fatal|0|||
27872034|NCT02187744|54481441|FG001|Treatment|Related adverse event, serious non-fatal|1|||
27872035|NCT02187744|54481440|FG000|Treatment|Related adverse event, not serious|0|||
27872036|NCT02187744|54481441|FG001|Treatment|Related adverse event, not serious|2|||
27872037|NCT02187744|54481440|FG000|Treatment|Lost to Follow-up|0|||
27872038|NCT02187744|54481441|FG001|Treatment|Lost to Follow-up|1|||
27872039|NCT02187744|54481440|FG000|Treatment|Other|2|||
27872040|NCT02187744|54481441|FG001|Treatment|Other|0|||
27872041|NCT02187744|54481440|FG000|Treatment|Participant refused continued treatment|1|||
27872042|NCT02187744|54481441|FG001|Treatment|Participant refused continued treatment|1|||
27872043|NCT02186652|54481603|FG000|Overall Study|Lost to Follow-up|2|||
27872044|NCT02186652|54481604|FG001|Overall Study|Lost to Follow-up|0|||
27872045|NCT02185794|54481640|FG000|Overall Study|Enrolled but Never Dosed|1|||
27872046|NCT02185794|54481641|FG001|Overall Study|Enrolled but Never Dosed|6|||
27872047|NCT02185794|54481642|FG002|Overall Study|Enrolled but Never Dosed|3|||
27872048|NCT02185794|54481643|FG003|Overall Study|Enrolled but Never Dosed|1|||
27872049|NCT02185794|54481644|FG004|Overall Study|Enrolled but Never Dosed|1|||
27872050|NCT02185794|54481645|FG005|Overall Study|Enrolled but Never Dosed|0|||
27872051|NCT02185794|54481640|FG000|Overall Study|Investigator's Discretion|1|||
27872052|NCT02185794|54481641|FG001|Overall Study|Investigator's Discretion|0|||
27872053|NCT02185794|54481642|FG002|Overall Study|Investigator's Discretion|1|||
27872054|NCT02185794|54481643|FG003|Overall Study|Investigator's Discretion|2|||
28171442|NCT02642432|54843041|FG000|Overall Study|Other|3|||
28171443|NCT02640482|54843047|FG000|Overall Study|Lost to Follow-up|3|||
28171444|NCT02640482|54843048|FG001|Overall Study|Lost to Follow-up|0|||
28171445|NCT02719743|54843059|FG000|Overall Study|Consent withdrawal|0|||
27872055|NCT02185794|54481644|FG004|Overall Study|Investigator's Discretion|2|||
27872056|NCT02185794|54481645|FG005|Overall Study|Investigator's Discretion|15|||
27872057|NCT02185794|54481640|FG000|Overall Study|Withdrew Consent|2|||
27872058|NCT02185794|54481641|FG001|Overall Study|Withdrew Consent|5|||
27872059|NCT02185794|54481642|FG002|Overall Study|Withdrew Consent|10|||
27872060|NCT02185794|54481643|FG003|Overall Study|Withdrew Consent|2|||
27872061|NCT02185794|54481644|FG004|Overall Study|Withdrew Consent|0|||
27872062|NCT02185794|54481645|FG005|Overall Study|Withdrew Consent|0|||
27872063|NCT02185794|54481640|FG000|Overall Study|Lost to Follow-up|1|||
27872064|NCT02185794|54481641|FG001|Overall Study|Lost to Follow-up|2|||
27872065|NCT02185794|54481642|FG002|Overall Study|Lost to Follow-up|2|||
27872066|NCT02185794|54481643|FG003|Overall Study|Lost to Follow-up|3|||
27872067|NCT02185794|54481644|FG004|Overall Study|Lost to Follow-up|0|||
27872068|NCT02185794|54481645|FG005|Overall Study|Lost to Follow-up|1|||
27872069|NCT02221674|54481676|FG000|Overall Study|Lost to Follow-up|1|||
27872070|NCT02221674|54481677|FG001|Overall Study|Lost to Follow-up|0|||
27872071|NCT02221674|54481678|FG002|Overall Study|Lost to Follow-up|0|||
27872072|NCT02221284|54481693|FG000|Overall Study|Case Report Forms Uncollected|56|||
27872073|NCT02221284|54481693|FG000|Overall Study|Protocol Deviation|5|||
27872074|NCT02187042|54481854|FG000|Overall Study|Death|1|||
27872075|NCT02187042|54481855|FG001|Overall Study|Death|1|||
27872076|NCT02187042|54481854|FG000|Overall Study|Toxicity|6|||
27872077|NCT02187042|54481855|FG001|Overall Study|Toxicity|5|||
27872078|NCT02187042|54481854|FG000|Overall Study|Participant choice|1|||
27872079|NCT02187042|54481855|FG001|Overall Study|Participant choice|0|||
27872080|NCT02187042|54481854|FG000|Overall Study|Doctor choice|1|||
27872081|NCT02187042|54481855|FG001|Overall Study|Doctor choice|0|||
27872082|NCT02187042|54481854|FG000|Overall Study|Progressive disease|4|||
27872083|NCT02187042|54481855|FG001|Overall Study|Progressive disease|8|||
27872084|NCT02220894|54482029|FG000|Overall Study|Adverse Event|118|||
27872085|NCT02220894|54482030|FG001|Overall Study|Adverse Event|70|||
27872086|NCT02220894|54482029|FG000|Overall Study|Death|252|||
27872087|NCT02220894|54482030|FG001|Overall Study|Death|368|||
27872088|NCT02220894|54482029|FG000|Overall Study|Lost to Follow-up|0|||
27872089|NCT02220894|54482030|FG001|Overall Study|Lost to Follow-up|2|||
27872090|NCT02220894|54482029|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
27872091|NCT02220894|54482030|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
27872092|NCT02220894|54482029|FG000|Overall Study|Withdrawal by Subject|2|||
27872093|NCT02220894|54482030|FG001|Overall Study|Withdrawal by Subject|13|||
27872094|NCT02220894|54482029|FG000|Overall Study|Ongoing in Study|265|||
27872095|NCT02220894|54482030|FG001|Overall Study|Ongoing in Study|183|||
27872096|NCT02219334|54482047|FG000|Overall Study|Withdrawal by Subject|1|||
27872097|NCT02219334|54482048|FG001|Overall Study|Withdrawal by Subject|0|||
27872098|NCT02219334|54482047|FG000|Overall Study|Protocol Violation|7|||
27872099|NCT02219334|54482048|FG001|Overall Study|Protocol Violation|3|||
27872100|NCT02159040|54482066|FG000|Overall Study|Death|1|||
27872101|NCT02218008|54482091|FG000|Stage 1 (S1)|Adverse Event|6|||
27872102|NCT02218008|54482092|FG001|Stage 1 (S1)|Adverse Event|5|||
27872103|NCT02218008|54482093|FG002|Stage 1 (S1)|Adverse Event|11|||
27872104|NCT02218008|54482094|FG003|Stage 1 (S1)|Adverse Event|0|||
27872105|NCT02218008|54482095|FG004|Stage 1 (S1)|Adverse Event|0|||
27872106|NCT02218008|54482096|FG005|Stage 1 (S1)|Adverse Event|0|||
27872107|NCT02218008|54482091|FG000|Stage 1 (S1)|Withdrawal by Subject|6|||
27872108|NCT02218008|54482092|FG001|Stage 1 (S1)|Withdrawal by Subject|1|||
27872109|NCT02218008|54482093|FG002|Stage 1 (S1)|Withdrawal by Subject|1|||
27872110|NCT02218008|54482094|FG003|Stage 1 (S1)|Withdrawal by Subject|0|||
27872111|NCT02218008|54482095|FG004|Stage 1 (S1)|Withdrawal by Subject|0|||
27872112|NCT02218008|54482096|FG005|Stage 1 (S1)|Withdrawal by Subject|0|||
27872113|NCT02218008|54482091|FG000|Stage 1 (S1)|Lack of Efficacy|3|||
27872114|NCT02218008|54482092|FG001|Stage 1 (S1)|Lack of Efficacy|0|||
27872115|NCT02218008|54482093|FG002|Stage 1 (S1)|Lack of Efficacy|0|||
27872116|NCT02218008|54482094|FG003|Stage 1 (S1)|Lack of Efficacy|0|||
27872117|NCT02218008|54482095|FG004|Stage 1 (S1)|Lack of Efficacy|0|||
27872118|NCT02218008|54482096|FG005|Stage 1 (S1)|Lack of Efficacy|0|||
27872119|NCT02218008|54482091|FG000|Stage 1 (S1)|Lost to Follow-up|3|||
27872120|NCT02218008|54482092|FG001|Stage 1 (S1)|Lost to Follow-up|0|||
27872121|NCT02218008|54482093|FG002|Stage 1 (S1)|Lost to Follow-up|1|||
27872122|NCT02218008|54482094|FG003|Stage 1 (S1)|Lost to Follow-up|0|||
27872123|NCT02218008|54482095|FG004|Stage 1 (S1)|Lost to Follow-up|0|||
27872124|NCT02218008|54482096|FG005|Stage 1 (S1)|Lost to Follow-up|0|||
27872125|NCT02218008|54482091|FG000|Stage 1 (S1)|Non-compliance with Study Drug|2|||
27872126|NCT02218008|54482092|FG001|Stage 1 (S1)|Non-compliance with Study Drug|1|||
27872127|NCT02218008|54482093|FG002|Stage 1 (S1)|Non-compliance with Study Drug|0|||
27872128|NCT02218008|54482094|FG003|Stage 1 (S1)|Non-compliance with Study Drug|0|||
27872129|NCT02218008|54482095|FG004|Stage 1 (S1)|Non-compliance with Study Drug|0|||
27872130|NCT02218008|54482096|FG005|Stage 1 (S1)|Non-compliance with Study Drug|0|||
27872131|NCT02218008|54482091|FG000|Stage 1 (S1)|Non-compliance; drug use|1|||
27872132|NCT02218008|54482092|FG001|Stage 1 (S1)|Non-compliance; drug use|0|||
27872133|NCT02218008|54482093|FG002|Stage 1 (S1)|Non-compliance; drug use|0|||
27872134|NCT02218008|54482094|FG003|Stage 1 (S1)|Non-compliance; drug use|0|||
27872135|NCT02218008|54482095|FG004|Stage 1 (S1)|Non-compliance; drug use|0|||
27872136|NCT02218008|54482096|FG005|Stage 1 (S1)|Non-compliance; drug use|0|||
27872137|NCT02218008|54482091|FG000|Stage 1 (S1)|Pregnancy|0|||
27872138|NCT02218008|54482092|FG001|Stage 1 (S1)|Pregnancy|0|||
27872139|NCT02218008|54482093|FG002|Stage 1 (S1)|Pregnancy|1|||
27872140|NCT02218008|54482094|FG003|Stage 1 (S1)|Pregnancy|0|||
27872141|NCT02218008|54482095|FG004|Stage 1 (S1)|Pregnancy|0|||
27872142|NCT02218008|54482096|FG005|Stage 1 (S1)|Pregnancy|0|||
27872143|NCT02218008|54482091|FG000|Stage 1 (S1)|Protocol Violation|0|||
27872144|NCT02218008|54482092|FG001|Stage 1 (S1)|Protocol Violation|0|||
27872145|NCT02218008|54482093|FG002|Stage 1 (S1)|Protocol Violation|1|||
27872146|NCT02218008|54482094|FG003|Stage 1 (S1)|Protocol Violation|0|||
27872147|NCT02218008|54482095|FG004|Stage 1 (S1)|Protocol Violation|0|||
27872148|NCT02218008|54482096|FG005|Stage 1 (S1)|Protocol Violation|0|||
27872149|NCT02218008|54482091|FG000|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1|||
27872150|NCT02218008|54482092|FG001|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
27872151|NCT02218008|54482093|FG002|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
27872152|NCT02218008|54482094|FG003|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
27872153|NCT02218008|54482095|FG004|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
27872154|NCT02218008|54482096|FG005|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
27872155|NCT02218008|54482091|FG000|Stage 2 (S2)|Adverse Event|0|||
27872156|NCT02218008|54482092|FG001|Stage 2 (S2)|Adverse Event|0|||
27872157|NCT02218008|54482093|FG002|Stage 2 (S2)|Adverse Event|0|||
27872158|NCT02218008|54482094|FG003|Stage 2 (S2)|Adverse Event|2|||
27872159|NCT02218008|54482095|FG004|Stage 2 (S2)|Adverse Event|3|||
27872160|NCT02218008|54482096|FG005|Stage 2 (S2)|Adverse Event|3|||
27872161|NCT02218008|54482091|FG000|Stage 2 (S2)|Withdrawal by Subject|0|||
27872162|NCT02218008|54482092|FG001|Stage 2 (S2)|Withdrawal by Subject|0|||
27872163|NCT02218008|54482093|FG002|Stage 2 (S2)|Withdrawal by Subject|0|||
28171446|NCT02719743|54843060|FG001|Overall Study|Consent withdrawal|2|||
27872164|NCT02218008|54482094|FG003|Stage 2 (S2)|Withdrawal by Subject|1|||
27872165|NCT02218008|54482095|FG004|Stage 2 (S2)|Withdrawal by Subject|1|||
27872166|NCT02218008|54482096|FG005|Stage 2 (S2)|Withdrawal by Subject|0|||
27872167|NCT02218008|54482091|FG000|Stage 2 (S2)|Lack of Efficacy|0|||
27872168|NCT02218008|54482092|FG001|Stage 2 (S2)|Lack of Efficacy|0|||
27872169|NCT02218008|54482093|FG002|Stage 2 (S2)|Lack of Efficacy|0|||
27872170|NCT02218008|54482094|FG003|Stage 2 (S2)|Lack of Efficacy|0|||
27872171|NCT02218008|54482095|FG004|Stage 2 (S2)|Lack of Efficacy|0|||
27872172|NCT02218008|54482096|FG005|Stage 2 (S2)|Lack of Efficacy|2|||
27872173|NCT02218008|54482091|FG000|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
27872174|NCT02218008|54482092|FG001|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
27872175|NCT02218008|54482093|FG002|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
27872176|NCT02218008|54482094|FG003|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1|||
27872177|NCT02218008|54482095|FG004|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
27872178|NCT02218008|54482096|FG005|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
27872179|NCT02218008|54482091|FG000|Stage 2 (S2)|Lost to Follow-up|0|||
27872180|NCT02218008|54482092|FG001|Stage 2 (S2)|Lost to Follow-up|0|||
27872181|NCT02218008|54482093|FG002|Stage 2 (S2)|Lost to Follow-up|0|||
27872182|NCT02218008|54482094|FG003|Stage 2 (S2)|Lost to Follow-up|0|||
27872183|NCT02218008|54482095|FG004|Stage 2 (S2)|Lost to Follow-up|0|||
27872184|NCT02218008|54482096|FG005|Stage 2 (S2)|Lost to Follow-up|1|||
27872185|NCT01632150|54482193|FG000|Overall Study|Disease progression|27|||
27872186|NCT01632150|54482193|FG000|Overall Study|Study drug toxicity|1|||
27872187|NCT01632150|54482193|FG000|Overall Study|Unrelated adverse event|7|||
27872188|NCT01632150|54482193|FG000|Overall Study|Withdrawal by Subject|2|||
27872189|NCT01632150|54482193|FG000|Overall Study|Patient underwent autologous transplant|1|||
27872190|NCT01632150|54482193|FG000|Overall Study|Moved to compassionate program|2|||
27872191|NCT02185014|54482218|FG000|Overall Study|Adverse Event|18|||
27872192|NCT02185014|54482218|FG000|Overall Study|Withdrew Consent|8|||
27872193|NCT02185014|54482218|FG000|Overall Study|Lost to Follow-up|4|||
27872194|NCT02185014|54482218|FG000|Overall Study|Lack of Efficacy|14|||
27872195|NCT02185014|54482218|FG000|Overall Study|Requires Alternative/Prohibited Therapy|5|||
27872196|NCT02185014|54482218|FG000|Overall Study|Subject Noncompliance|1|||
27872197|NCT02185014|54482218|FG000|Overall Study|Other|4|||
27872198|NCT02184156|54482268|FG000|Phase 2 20 Week Efficacy|Protocol Violation|0|||
27982577|NCT02975349|54640793|FG003|Blinded Extension Period (24 Weeks)|Adverse Event|2|||
27982578|NCT02975349|54640794|FG004|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
27982579|NCT02975349|54640795|FG005|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
27982580|NCT02975349|54640790|FG000|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
27982581|NCT02975349|54640791|FG001|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5|||
27982582|NCT02975349|54640792|FG002|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2|||
27982583|NCT02975349|54640793|FG003|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
27982584|NCT02975349|54640794|FG004|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
27982585|NCT02975349|54640795|FG005|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
27982586|NCT02975349|54640790|FG000|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
27982587|NCT02975349|54640791|FG001|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
27982588|NCT02975349|54640792|FG002|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1|||
27982589|NCT02975349|54640793|FG003|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
27982590|NCT02975349|54640794|FG004|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
27982591|NCT02975349|54640795|FG005|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
27982592|NCT02975349|54640790|FG000|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
27982593|NCT02975349|54640791|FG001|Blinded Extension Period (24 Weeks)|Progressive Disease|1|||
27982594|NCT02975349|54640792|FG002|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
27982595|NCT02975349|54640793|FG003|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
27982596|NCT02975349|54640794|FG004|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
27982597|NCT02975349|54640795|FG005|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
27982598|NCT02975349|54640790|FG000|Blinded Extension Period (24 Weeks)|Un-specified|0|||
27982599|NCT02975349|54640791|FG001|Blinded Extension Period (24 Weeks)|Un-specified|0|||
27982600|NCT02975349|54640792|FG002|Blinded Extension Period (24 Weeks)|Un-specified|0|||
27982601|NCT02975349|54640793|FG003|Blinded Extension Period (24 Weeks)|Un-specified|1|||
27982602|NCT02975349|54640794|FG004|Blinded Extension Period (24 Weeks)|Un-specified|0|||
27982603|NCT02975349|54640795|FG005|Blinded Extension Period (24 Weeks)|Un-specified|0|||
27982604|NCT02520141|54640866|FG000|Overall Study|Rapid decline clinically and thus unable to enroll|1|||
27982605|NCT02513394|54640874|FG000|Overall Study|Withdrawal by Subject|11|||
27739069|NCT02495168|54188420|FG001|Overall Study|Other than Specified|22|||
27739070|NCT02495168|54188421|FG002|Overall Study|Other than Specified|5|||
27739071|NCT02495168|54188419|FG000|Overall Study|Did not Complete Final Visit On Time|4|||
27872199|NCT02184156|54482269|FG001|Phase 2 20 Week Efficacy|Protocol Violation|1|||
27872200|NCT02184156|54482268|FG000|Phase 2 20 Week Efficacy|Withdrawal by Subject|1|||
27872201|NCT02184156|54482269|FG001|Phase 2 20 Week Efficacy|Withdrawal by Subject|0|||
27872202|NCT02158884|54482292|FG000|Baseline Assessment|Missed performance assessment|3|||
27872203|NCT02158884|54482292|FG000|Baseline Assessment|Missed SMFA|1|||
27872204|NCT02158884|54482292|FG000|Intervention: IDEO and PT Program|Did not complete PT intervention|6|||
27872205|NCT02158884|54482292|FG000|Post Intervention (~4 Weeks)|Did not complete performance assessment|10|||
27872206|NCT02158884|54482292|FG000|6 Month Assessment|Missed SMFA|20|||
27872207|NCT02158884|54482292|FG000|12 Month Assessment|Missed SMFA|17|||
27872208|NCT02158806|54482335|FG000|Overall Study|Death|2|||
27872209|NCT02158806|54482336|FG001|Overall Study|Death|0|||
27872210|NCT02158806|54482335|FG000|Overall Study|Withdrawal by Subject|2|||
27982606|NCT02513394|54640875|FG001|Overall Study|Withdrawal by Subject|23|||
27982607|NCT02513394|54640874|FG000|Overall Study|Ineligible|1|||
27982608|NCT02513394|54640875|FG001|Overall Study|Ineligible|0|||
27872211|NCT02158806|54482336|FG001|Overall Study|Withdrawal by Subject|0|||
27872212|NCT02158806|54482335|FG000|Overall Study|Lost to Follow-up|0|||
27872213|NCT02158806|54482336|FG001|Overall Study|Lost to Follow-up|3|||
27872214|NCT02158806|54482335|FG000|Overall Study|Moved out of area|0|||
27872215|NCT02158806|54482336|FG001|Overall Study|Moved out of area|1|||
27872216|NCT02158806|54482335|FG000|Overall Study|Transferred to palliative care|0|||
27872217|NCT02158806|54482336|FG001|Overall Study|Transferred to palliative care|1|||
27872218|NCT02158728|54482367|FG000|Overall Study|no procedure according to CIP done|3|||
27872219|NCT02158728|54482367|FG000|Overall Study|no qualified dataset|24|||
27872220|NCT02157948|54482412|FG000|Overall Study|Withdrawal by Subject|4|||
27872221|NCT02157948|54482413|FG001|Overall Study|Withdrawal by Subject|5|||
27872222|NCT02157948|54482412|FG000|Overall Study|Lost to Follow-up|3|||
27872223|NCT02157948|54482413|FG001|Overall Study|Lost to Follow-up|2|||
27872224|NCT02157948|54482412|FG000|Overall Study|Protocol Specified Criteria|2|||
27872225|NCT02157948|54482413|FG001|Overall Study|Protocol Specified Criteria|1|||
27872226|NCT02157948|54482412|FG000|Overall Study|Decision by Sponsor|0|||
27872227|NCT02157948|54482413|FG001|Overall Study|Decision by Sponsor|1|||
27872228|NCT02182830|54482454|FG000|Overall Study|Not Treated|1|||
27872229|NCT02182830|54482455|FG001|Overall Study|Not Treated|1|||
27872230|NCT02182830|54482454|FG000|Overall Study|Trial stopped, reason missing|3|||
27872231|NCT02182830|54482455|FG001|Overall Study|Trial stopped, reason missing|3|||
27872232|NCT02182830|54482454|FG000|Overall Study|Consent withdrawn|8|||
27872233|NCT02182830|54482455|FG001|Overall Study|Consent withdrawn|8|||
27872234|NCT02182830|54482454|FG000|Overall Study|Lost to Follow-up|3|||
27872235|NCT02182830|54482455|FG001|Overall Study|Lost to Follow-up|3|||
27872236|NCT02182440|54483029|FG000|Overall Study|Adverse Event|0|||
27872237|NCT02182440|54483030|FG001|Overall Study|Adverse Event|1|||
27872238|NCT02182440|54483031|FG002|Overall Study|Adverse Event|0|||
27872239|NCT02182440|54483032|FG003|Overall Study|Adverse Event|0|||
27872240|NCT02182440|54483029|FG000|Overall Study|Death|31|||
27872241|NCT02182440|54483030|FG001|Overall Study|Death|8|||
27872242|NCT02182440|54483031|FG002|Overall Study|Death|5|||
27872243|NCT02182440|54483032|FG003|Overall Study|Death|16|||
27872244|NCT02182440|54483029|FG000|Overall Study|Protocol Violation|0|||
27872245|NCT02182440|54483030|FG001|Overall Study|Protocol Violation|1|||
27872246|NCT02182440|54483031|FG002|Overall Study|Protocol Violation|0|||
27872247|NCT02182440|54483032|FG003|Overall Study|Protocol Violation|0|||
27872248|NCT02182440|54483029|FG000|Overall Study|Physician Decision|1|||
27872249|NCT02182440|54483030|FG001|Overall Study|Physician Decision|0|||
27872250|NCT02182440|54483031|FG002|Overall Study|Physician Decision|0|||
27872251|NCT02182440|54483032|FG003|Overall Study|Physician Decision|0|||
27872252|NCT02182440|54483029|FG000|Overall Study|Withdrawal by Subject|1|||
27872253|NCT02182440|54483030|FG001|Overall Study|Withdrawal by Subject|1|||
27872254|NCT02182440|54483031|FG002|Overall Study|Withdrawal by Subject|3|||
27872255|NCT02182440|54483032|FG003|Overall Study|Withdrawal by Subject|4|||
27872256|NCT02182440|54483029|FG000|Overall Study|different, e.g adm other hospital|12|||
27872257|NCT02182440|54483030|FG001|Overall Study|different, e.g adm other hospital|3|||
27872258|NCT02182440|54483031|FG002|Overall Study|different, e.g adm other hospital|3|||
27872259|NCT02182440|54483032|FG003|Overall Study|different, e.g adm other hospital|10|||
27872260|NCT02181816|54483074|FG000|Overall Study|Case Report Forms Uncollected|38|||
27872261|NCT02181816|54483074|FG000|Overall Study|Protocol Deviation|21|||
27872262|NCT02156466|54483230|FG000|Overall Study|Adverse Event|0|||
27872263|NCT02156466|54483231|FG001|Overall Study|Adverse Event|0|||
27872264|NCT02156466|54483232|FG002|Overall Study|Adverse Event|1|||
27872265|NCT02156466|54483233|FG003|Overall Study|Adverse Event|1|||
27872266|NCT02156466|54483234|FG004|Overall Study|Adverse Event|0|||
27872267|NCT02156466|54483230|FG000|Overall Study|Quantiferon Positivity|0|||
27872268|NCT02156466|54483231|FG001|Overall Study|Quantiferon Positivity|0|||
27872269|NCT02156466|54483232|FG002|Overall Study|Quantiferon Positivity|0|||
27872270|NCT02156466|54483233|FG003|Overall Study|Quantiferon Positivity|1|||
27872271|NCT02156466|54483234|FG004|Overall Study|Quantiferon Positivity|0|||
27872272|NCT02216526|54483273|FG000|Overall Study|Adverse Event|1|||
27872273|NCT02216526|54483274|FG001|Overall Study|Adverse Event|1|||
27872274|NCT02216526|54483275|FG002|Overall Study|Adverse Event|0|||
27872275|NCT02216526|54483273|FG000|Overall Study|Death|0|||
27872276|NCT02216526|54483274|FG001|Overall Study|Death|1|||
27872277|NCT02216526|54483275|FG002|Overall Study|Death|3|||
27872278|NCT02216526|54483273|FG000|Overall Study|Protocol Violation|2|||
27872279|NCT02216526|54483274|FG001|Overall Study|Protocol Violation|0|||
27872280|NCT02216526|54483275|FG002|Overall Study|Protocol Violation|2|||
27872281|NCT02216526|54483273|FG000|Overall Study|Hospitalization|2|||
27872282|NCT02216526|54483274|FG001|Overall Study|Hospitalization|1|||
27872283|NCT02216526|54483275|FG002|Overall Study|Hospitalization|3|||
27872284|NCT02216214|54483315|FG000|Overall Study|Randomized Never Received Study Drug|1|||
27872285|NCT02216214|54483316|FG001|Overall Study|Randomized Never Received Study Drug|0|||
27872286|NCT02216214|54483315|FG000|Overall Study|Adverse Event|10|||
27872287|NCT02216214|54483316|FG001|Overall Study|Adverse Event|8|||
27872288|NCT02216214|54483315|FG000|Overall Study|Lack of Efficacy|2|||
27872289|NCT02216214|54483316|FG001|Overall Study|Lack of Efficacy|2|||
27872290|NCT02216214|54483315|FG000|Overall Study|Lost to Follow-up|3|||
27872291|NCT02216214|54483316|FG001|Overall Study|Lost to Follow-up|2|||
27872292|NCT02216214|54483315|FG000|Overall Study|Protocol Violation|4|||
27872293|NCT02216214|54483316|FG001|Overall Study|Protocol Violation|2|||
27872294|NCT02216214|54483315|FG000|Overall Study|Withdrawal by Subject|22|||
27872295|NCT02216214|54483316|FG001|Overall Study|Withdrawal by Subject|20|||
27872296|NCT02216214|54483315|FG000|Overall Study|Study Terminated By Sponsor|0|||
27872297|NCT02216214|54483316|FG001|Overall Study|Study Terminated By Sponsor|1|||
27872298|NCT02216214|54483315|FG000|Overall Study|Miscellaneous|1|||
27872299|NCT02216214|54483316|FG001|Overall Study|Miscellaneous|1|||
27872300|NCT02214186|54483347|FG000|Overall Study|Lost to Follow-up|1|||
27872301|NCT02214186|54483348|FG001|Overall Study|Lost to Follow-up|1|||
27872302|NCT02214186|54483347|FG000|Overall Study|Protocol Violation|1|||
27872303|NCT02214186|54483348|FG001|Overall Study|Protocol Violation|1|||
27872304|NCT02181504|54483404|FG000|Overall Study|Adverse Event|1|||
27872305|NCT02181504|54483405|FG001|Overall Study|Adverse Event|1|||
27872306|NCT02181504|54483406|FG002|Overall Study|Adverse Event|1|||
27872307|NCT02179398|54483436|FG000|Overall Study|Lack of obligatory data|3|||
27872308|NCT02179398|54483437|FG001|Overall Study|Lack of obligatory data|3|||
27872309|NCT02179398|54483436|FG000|Overall Study|Lost to Follow-up|0|||
27872310|NCT02179398|54483437|FG001|Overall Study|Lost to Follow-up|1|||
27872311|NCT02156076|54483451|FG000|Treatment Period|no longer meets study criteria|0|||
27872312|NCT02156076|54483452|FG001|Treatment Period|no longer meets study criteria|0|||
27872313|NCT02156076|54483453|FG002|Treatment Period|no longer meets study criteria|1|||
27872314|NCT02156076|54483454|FG003|Treatment Period|no longer meets study criteria|0|||
27872315|NCT02156076|54483451|FG000|Treatment Period|Poor/non-compliance|0|||
27872316|NCT02156076|54483452|FG001|Treatment Period|Poor/non-compliance|1|||
27872317|NCT02156076|54483453|FG002|Treatment Period|Poor/non-compliance|0|||
27872318|NCT02156076|54483454|FG003|Treatment Period|Poor/non-compliance|0|||
27872319|NCT02156076|54483451|FG000|Treatment Period|Lost to Follow-up|0|||
27872320|NCT02156076|54483452|FG001|Treatment Period|Lost to Follow-up|0|||
27872321|NCT02156076|54483453|FG002|Treatment Period|Lost to Follow-up|0|||
27872322|NCT02156076|54483454|FG003|Treatment Period|Lost to Follow-up|1|||
27872323|NCT02156076|54483451|FG000|Treatment Period|Withdrawal by Subject|0|||
27872324|NCT02156076|54483452|FG001|Treatment Period|Withdrawal by Subject|0|||
27872325|NCT02156076|54483453|FG002|Treatment Period|Withdrawal by Subject|1|||
27872326|NCT02156076|54483454|FG003|Treatment Period|Withdrawal by Subject|0|||
27872327|NCT02156076|54483451|FG000|Treatment Period|Subject request to discontinue treatment|0|||
27872328|NCT02156076|54483452|FG001|Treatment Period|Subject request to discontinue treatment|1|||
27872329|NCT02156076|54483453|FG002|Treatment Period|Subject request to discontinue treatment|0|||
27872330|NCT02156076|54483454|FG003|Treatment Period|Subject request to discontinue treatment|0|||
27872331|NCT02156076|54483451|FG000|Treatment Period|Adverse Event|0|||
27872332|NCT02156076|54483452|FG001|Treatment Period|Adverse Event|0|||
27872333|NCT02156076|54483453|FG002|Treatment Period|Adverse Event|0|||
27872334|NCT02156076|54483454|FG003|Treatment Period|Adverse Event|1|||
27872335|NCT02156076|54483451|FG000|Follow-up Period|Withdrawal by Subject|1|||
27872336|NCT02156076|54483452|FG001|Follow-up Period|Withdrawal by Subject|0|||
27872337|NCT02156076|54483453|FG002|Follow-up Period|Withdrawal by Subject|0|||
27872338|NCT02156076|54483454|FG003|Follow-up Period|Withdrawal by Subject|0|||
27872339|NCT02213094|54483466|FG000|Overall Study|Adverse Event|1|||
27872340|NCT02213094|54483467|FG001|Overall Study|Adverse Event|0|||
27872341|NCT02155608|54483475|FG000|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0|||
27872342|NCT02155608|54483476|FG001|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1|||
27872343|NCT02155608|54483475|FG000|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
27872344|NCT02155608|54483476|FG001|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
27872345|NCT01629966|54483491|FG000|Overall Study|Pregnancy|0|||
27872346|NCT01629966|54483492|FG001|Overall Study|Pregnancy|1|||
27872347|NCT01629966|54483493|FG002|Overall Study|Pregnancy|0|||
27872348|NCT01629966|54483491|FG000|Overall Study|Lost to Follow-up|10|||
27872349|NCT01629966|54483492|FG001|Overall Study|Lost to Follow-up|13|||
27872350|NCT01629966|54483493|FG002|Overall Study|Lost to Follow-up|9|||
27872351|NCT01629966|54483491|FG000|Overall Study|Withdrawal by Subject|8|||
27872352|NCT01629966|54483492|FG001|Overall Study|Withdrawal by Subject|9|||
27872353|NCT01629966|54483493|FG002|Overall Study|Withdrawal by Subject|16|||
27872354|NCT01629966|54483491|FG000|Overall Study|Protocol Violation|7|||
27872355|NCT01629966|54483492|FG001|Overall Study|Protocol Violation|9|||
27872356|NCT01629966|54483493|FG002|Overall Study|Protocol Violation|7|||
28171447|NCT02719743|54843061|FG002|Overall Study|Consent withdrawal|0|||
27872357|NCT01629966|54483491|FG000|Overall Study|Lack of Efficacy|5|||
28171448|NCT02719743|54843062|FG003|Overall Study|Consent withdrawal|1|||
27872358|NCT01629966|54483492|FG001|Overall Study|Lack of Efficacy|2|||
27872359|NCT01629966|54483493|FG002|Overall Study|Lack of Efficacy|4|||
27872360|NCT01629966|54483491|FG000|Overall Study|Adverse Event|11|||
27872361|NCT01629966|54483492|FG001|Overall Study|Adverse Event|18|||
27872362|NCT01629966|54483493|FG002|Overall Study|Adverse Event|30|||
27982609|NCT02329847|54640887|FG000|Overall Study|Death|4|||
28171449|NCT02719743|54843063|FG004|Overall Study|Consent withdrawal|0|||
27872363|NCT02177838|54483533|FG000|Overall Study|Withdrawal by Subject|1|||
27872364|NCT02177838|54483533|FG000|Overall Study|Physician Decision|1|||
27872365|NCT02177838|54483533|FG000|Overall Study|Death|1|||
27872366|NCT02177136|54483630|FG000|DB Phase|Withdrawal by Subject|2|||
27872367|NCT02177136|54483631|FG001|DB Phase|Withdrawal by Subject|0|||
27872368|NCT02177136|54483632|FG002|DB Phase|Withdrawal by Subject|0|||
27872369|NCT02177136|54483633|FG003|DB Phase|Withdrawal by Subject|0|||
27872370|NCT02177136|54483630|FG000|DB Phase|Discontinued Due to Pruritus|1|||
27872371|NCT02177136|54483631|FG001|DB Phase|Discontinued Due to Pruritus|3|||
27872372|NCT02177136|54483632|FG002|DB Phase|Discontinued Due to Pruritus|0|||
27872373|NCT02177136|54483633|FG003|DB Phase|Discontinued Due to Pruritus|0|||
27872374|NCT02177136|54483630|FG000|DB Phase|Adverse Event|3|||
27872375|NCT02177136|54483631|FG001|DB Phase|Adverse Event|2|||
27872376|NCT02177136|54483632|FG002|DB Phase|Adverse Event|3|||
27872377|NCT02177136|54483633|FG003|DB Phase|Adverse Event|0|||
27872378|NCT02177136|54483630|FG000|DB Phase|Protocol Violation|0|||
27872379|NCT02177136|54483631|FG001|DB Phase|Protocol Violation|0|||
27872380|NCT02177136|54483632|FG002|DB Phase|Protocol Violation|1|||
27872381|NCT02177136|54483633|FG003|DB Phase|Protocol Violation|0|||
27872382|NCT02177136|54483630|FG000|DB Phase|Withdrew Consent Prior to Dosing|1|||
27872383|NCT02177136|54483631|FG001|DB Phase|Withdrew Consent Prior to Dosing|0|||
27872384|NCT02177136|54483632|FG002|DB Phase|Withdrew Consent Prior to Dosing|0|||
27872385|NCT02177136|54483633|FG003|DB Phase|Withdrew Consent Prior to Dosing|0|||
27872386|NCT02177136|54483630|FG000|LTSE Phase|Withdrawal by Subject|0|||
27872387|NCT02177136|54483631|FG001|LTSE Phase|Withdrawal by Subject|0|||
27872388|NCT02177136|54483632|FG002|LTSE Phase|Withdrawal by Subject|0|||
27872389|NCT02177136|54483633|FG003|LTSE Phase|Withdrawal by Subject|6|||
27872390|NCT02177136|54483630|FG000|LTSE Phase|Adverse Event|0|||
27872391|NCT02177136|54483631|FG001|LTSE Phase|Adverse Event|0|||
27872392|NCT02177136|54483632|FG002|LTSE Phase|Adverse Event|0|||
27872393|NCT02177136|54483633|FG003|LTSE Phase|Adverse Event|10|||
27872394|NCT02177136|54483630|FG000|LTSE Phase|Discontinued Due to Pruritus|0|||
27872395|NCT02177136|54483631|FG001|LTSE Phase|Discontinued Due to Pruritus|0|||
27872396|NCT02177136|54483632|FG002|LTSE Phase|Discontinued Due to Pruritus|0|||
27872397|NCT02177136|54483633|FG003|LTSE Phase|Discontinued Due to Pruritus|4|||
27872398|NCT02177136|54483630|FG000|LTSE Phase|Physician Decision|0|||
27872399|NCT02177136|54483631|FG001|LTSE Phase|Physician Decision|0|||
27872400|NCT02177136|54483632|FG002|LTSE Phase|Physician Decision|0|||
27872401|NCT02177136|54483633|FG003|LTSE Phase|Physician Decision|2|||
27872402|NCT02177136|54483630|FG000|LTSE Phase|Lost to Follow-up|0|||
27872403|NCT02177136|54483631|FG001|LTSE Phase|Lost to Follow-up|0|||
27872404|NCT02177136|54483632|FG002|LTSE Phase|Lost to Follow-up|0|||
27872405|NCT02177136|54483633|FG003|LTSE Phase|Lost to Follow-up|1|||
27872406|NCT02177136|54483630|FG000|LTSE Phase|Participant Moved|0|||
27872407|NCT02177136|54483631|FG001|LTSE Phase|Participant Moved|0|||
27872408|NCT02177136|54483632|FG002|LTSE Phase|Participant Moved|0|||
27872409|NCT02177136|54483633|FG003|LTSE Phase|Participant Moved|1|||
27872410|NCT02176356|54483661|FG000|Overall Study|Screen Failure|14|||
27872411|NCT02176356|54483661|FG000|Overall Study|Lost to Follow-up|4|||
27872412|NCT02176356|54483661|FG000|Overall Study|Personal Reasons|3|||
27872413|NCT02176356|54483661|FG000|Overall Study|Other Miscellaneous Reasons|2|||
27872414|NCT02210208|54483671|FG000|Period A (Graft Site)|Withdrawal by Subject|1|||
27872415|NCT02210208|54483671|FG000|Period A (Graft Site)|Physician decided not to graft at OR|1|||
27872416|NCT02210208|54483671|FG000|Period B (Donor Site)|7 subjects healed at or before Day 14|7|||
27872417|NCT02209506|54483691|FG000|Overall Study|Withdrawal by Subject|0|||
27872418|NCT02209506|54483692|FG001|Overall Study|Withdrawal by Subject|0|||
27872419|NCT02209506|54483693|FG002|Overall Study|Withdrawal by Subject|0|||
27872420|NCT02209506|54483694|FG003|Overall Study|Withdrawal by Subject|0|||
27872421|NCT02209506|54483695|FG004|Overall Study|Withdrawal by Subject|1|||
27872422|NCT02153736|54483712|FG000|Overall Study|Lost to Follow-up|1|||
27872423|NCT02153736|54483713|FG001|Overall Study|Lost to Follow-up|0|||
27872424|NCT02153736|54483712|FG000|Overall Study|Medical status change made ineligible|1|||
27872425|NCT02153736|54483713|FG001|Overall Study|Medical status change made ineligible|0|||
27872426|NCT02153736|54483712|FG000|Overall Study|Death|0|||
27872427|NCT02153736|54483713|FG001|Overall Study|Death|1|||
27872428|NCT02153736|54483712|FG000|Overall Study|Withdrawal by Subject|0|||
27872429|NCT02153736|54483713|FG001|Overall Study|Withdrawal by Subject|1|||
27872430|NCT02175966|54483721|FG000|Follow-up Period|Lack of Efficacy|10|||
27872431|NCT02175966|54483722|FG001|Follow-up Period|Lack of Efficacy|6|||
27872432|NCT02153346|54483728|FG000|Overall Study|Lost to Follow-up|11|||
27872433|NCT02174562|54483735|FG000|Overall Study|Withdrawal by Subject|7|||
27872434|NCT02174562|54483736|FG001|Overall Study|Withdrawal by Subject|2|||
27872435|NCT02174562|54483735|FG000|Overall Study|Death|2|||
27872436|NCT02174562|54483736|FG001|Overall Study|Death|0|||
27872437|NCT02174562|54483735|FG000|Overall Study|Lost to Follow-up|0|||
27872438|NCT02174562|54483736|FG001|Overall Study|Lost to Follow-up|3|||
27872439|NCT02136576|54483745|FG000|Overall Study|Lost to Follow-up|2|||
27872440|NCT02136576|54483746|FG001|Overall Study|Lost to Follow-up|0|||
27872441|NCT02136576|54483747|FG002|Overall Study|Lost to Follow-up|0|||
27872442|NCT02153112|54484004|FG000|Overall Study|Adverse Event|0|||
27872443|NCT02153112|54484005|FG001|Overall Study|Adverse Event|0|||
27872444|NCT02153112|54484006|FG002|Overall Study|Adverse Event|1|||
27872445|NCT02153112|54484007|FG003|Overall Study|Adverse Event|0|||
27872446|NCT02153112|54484008|FG004|Overall Study|Adverse Event|0|||
27872447|NCT02153112|54484009|FG005|Overall Study|Adverse Event|0|||
27872448|NCT02153112|54484010|FG006|Overall Study|Adverse Event|0|||
27872449|NCT02153112|54484011|FG007|Overall Study|Adverse Event|0|||
27872450|NCT02153112|54484012|FG008|Overall Study|Adverse Event|0|||
27872451|NCT02153112|54484013|FG009|Overall Study|Adverse Event|0|||
27872452|NCT02153112|54484004|FG000|Overall Study|Lost to Follow-up|1|||
27872453|NCT02153112|54484005|FG001|Overall Study|Lost to Follow-up|1|||
27872454|NCT02153112|54484006|FG002|Overall Study|Lost to Follow-up|0|||
27872455|NCT02153112|54484007|FG003|Overall Study|Lost to Follow-up|0|||
27872456|NCT02153112|54484008|FG004|Overall Study|Lost to Follow-up|2|||
27872457|NCT02153112|54484009|FG005|Overall Study|Lost to Follow-up|1|||
27872458|NCT02153112|54484010|FG006|Overall Study|Lost to Follow-up|1|||
27872459|NCT02153112|54484011|FG007|Overall Study|Lost to Follow-up|0|||
27872460|NCT02153112|54484012|FG008|Overall Study|Lost to Follow-up|1|||
27872461|NCT02153112|54484013|FG009|Overall Study|Lost to Follow-up|1|||
27872462|NCT02153112|54484004|FG000|Overall Study|Withdrawal by Subject|3|||
27872463|NCT02153112|54484005|FG001|Overall Study|Withdrawal by Subject|1|||
27872464|NCT02153112|54484006|FG002|Overall Study|Withdrawal by Subject|2|||
27872465|NCT02153112|54484007|FG003|Overall Study|Withdrawal by Subject|2|||
27872466|NCT02153112|54484008|FG004|Overall Study|Withdrawal by Subject|1|||
27872467|NCT02153112|54484009|FG005|Overall Study|Withdrawal by Subject|1|||
27872468|NCT02153112|54484010|FG006|Overall Study|Withdrawal by Subject|7|||
27872469|NCT02153112|54484011|FG007|Overall Study|Withdrawal by Subject|2|||
27872470|NCT02153112|54484012|FG008|Overall Study|Withdrawal by Subject|13|||
27872471|NCT02153112|54484013|FG009|Overall Study|Withdrawal by Subject|12|||
27872472|NCT02153112|54484004|FG000|Overall Study|Reason not Specified|0|||
27872473|NCT02153112|54484005|FG001|Overall Study|Reason not Specified|0|||
27872474|NCT02153112|54484006|FG002|Overall Study|Reason not Specified|0|||
27872475|NCT02153112|54484007|FG003|Overall Study|Reason not Specified|0|||
27872476|NCT02153112|54484008|FG004|Overall Study|Reason not Specified|0|||
27872477|NCT02153112|54484009|FG005|Overall Study|Reason not Specified|0|||
27872478|NCT02153112|54484010|FG006|Overall Study|Reason not Specified|0|||
27872479|NCT02153112|54484011|FG007|Overall Study|Reason not Specified|0|||
27872480|NCT02153112|54484012|FG008|Overall Study|Reason not Specified|1|||
27872481|NCT02153112|54484013|FG009|Overall Study|Reason not Specified|1|||
27872482|NCT02133924|54484063|FG000|Overall Study|Death|38|||
27872483|NCT02133924|54484063|FG000|Overall Study|Physician Decision|1|||
27872484|NCT02133924|54484063|FG000|Overall Study|Withdrawal by Subject|3|||
27872485|NCT02173704|54484154|FG000|Overall Study|Adverse Event|1|||
27872486|NCT02173704|54484155|FG001|Overall Study|Adverse Event|0|||
27872487|NCT02173704|54484154|FG000|Overall Study|Lost to Follow-up|1|||
27872488|NCT02173704|54484155|FG001|Overall Study|Lost to Follow-up|0|||
27872489|NCT02173704|54484154|FG000|Overall Study|Other|1|||
27872490|NCT02173704|54484155|FG001|Overall Study|Other|0|||
27872491|NCT02173704|54484154|FG000|Overall Study|Protocol Violation|1|||
27872492|NCT02173704|54484155|FG001|Overall Study|Protocol Violation|0|||
27872493|NCT02173704|54484154|FG000|Overall Study|Withdrawal by Subject|9|||
27872494|NCT02173704|54484155|FG001|Overall Study|Withdrawal by Subject|4|||
27872495|NCT02173548|54484176|FG000|Overall Study|Lost to Follow-up|0|||
27872496|NCT02173548|54484177|FG001|Overall Study|Lost to Follow-up|2|||
27872497|NCT02173548|54484176|FG000|Overall Study|Withdrawal by Subject|1|||
27872498|NCT02173548|54484177|FG001|Overall Study|Withdrawal by Subject|0|||
27872499|NCT02173158|54484193|FG000|Efficacy Phase|Adverse Event|1|||
27872500|NCT02152566|54484215|FG000|Overall Study|Lost to Follow-up|1|||
27872501|NCT02152566|54484215|FG000|Overall Study|Withdrawal by Subject|2|||
27872502|NCT02171130|54484244|FG000|Overall Study|Death|1|||
27872503|NCT02171130|54484244|FG000|Overall Study|Discontinued; Clinical Material Issue|16|||
27872504|NCT02171130|54484244|FG000|Overall Study|Discontinued; Site Termination|5|||
27872505|NCT02171130|54484244|FG000|Overall Study|Withdrawal by Subject|3|||
27872506|NCT02171130|54484244|FG000|Overall Study|Physician Decision|1|||
27872507|NCT02171130|54484244|FG000|Overall Study|Lost to Follow-up|1|||
27872508|NCT02171130|54484244|FG000|Overall Study|Met Exclusion Criteria|1|||
27872509|NCT03603314|54490156|FG000|Overall Study|Lost to Follow-up|0|||
27872510|NCT03603314|54490157|FG001|Overall Study|Lost to Follow-up|3|||
27872511|NCT03603314|54490158|FG002|Overall Study|Lost to Follow-up|0|||
27872512|NCT03603314|54490156|FG000|Overall Study|Protocol Violation|0|||
27872513|NCT03603314|54490157|FG001|Overall Study|Protocol Violation|1|||
27872514|NCT03603314|54490158|FG002|Overall Study|Protocol Violation|0|||
27872515|NCT03603314|54490156|FG000|Overall Study|Adverse Event|2|||
27872516|NCT03603314|54490157|FG001|Overall Study|Adverse Event|0|||
27872517|NCT03603314|54490158|FG002|Overall Study|Adverse Event|0|||
27872518|NCT03603314|54490156|FG000|Overall Study|Physician Decision|1|||
27872519|NCT03603314|54490157|FG001|Overall Study|Physician Decision|1|||
27872520|NCT03603314|54490158|FG002|Overall Study|Physician Decision|0|||
27872521|NCT03603314|54490156|FG000|Overall Study|Withdrawal by Subject|4|||
27872522|NCT03603314|54490157|FG001|Overall Study|Withdrawal by Subject|5|||
27872523|NCT03603314|54490158|FG002|Overall Study|Withdrawal by Subject|3|||
27872524|NCT03603314|54490156|FG000|Overall Study|Other|0|||
27872525|NCT03603314|54490157|FG001|Overall Study|Other|1|||
27872526|NCT03603314|54490158|FG002|Overall Study|Other|0|||
27872527|NCT04302350|54490173|FG000|Overall Study|Physician Decision|1|||
27872528|NCT04302350|54490174|FG001|Overall Study|Physician Decision|1|||
27872529|NCT04302350|54490175|FG002|Overall Study|Physician Decision|2|||
27872530|NCT04302350|54490173|FG000|Overall Study|Lack of Efficacy|1|||
27872531|NCT04302350|54490174|FG001|Overall Study|Lack of Efficacy|1|||
27872532|NCT04302350|54490175|FG002|Overall Study|Lack of Efficacy|4|||
27872533|NCT04302350|54490173|FG000|Overall Study|Adverse Event|0|||
27872534|NCT04302350|54490174|FG001|Overall Study|Adverse Event|1|||
27872535|NCT04302350|54490175|FG002|Overall Study|Adverse Event|2|||
27872536|NCT02335424|54490197|FG000|Overall Study|Withdrawal by Subject|19|||
27872537|NCT02335424|54490197|FG000|Overall Study|Adverse Event|25|||
27872538|NCT02335424|54490197|FG000|Overall Study|Death|273|||
27872539|NCT02335424|54490197|FG000|Overall Study|Lost to Follow-up|3|||
27872540|NCT02335424|54490197|FG000|Overall Study|Physician Decision|13|||
27872541|NCT02335424|54490197|FG000|Overall Study|Participation in study terminated by Sponsor|39|||
27872542|NCT02335424|54490197|FG000|Overall Study|Protocol Violation|1|||
27872543|NCT02335424|54490197|FG000|Overall Study|Screen failure|1|||
27872544|NCT03805412|54490204|FG000|Overall Study|Lost to Follow-up|0|||
27872545|NCT03805412|54490205|FG001|Overall Study|Lost to Follow-up|1|||
27872546|NCT04791319|54490225|FG000|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|4|||
27872547|NCT04791319|54490226|FG001|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|2|||
27872548|NCT04791319|54490227|FG002|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|9|||
27872549|NCT04791319|54490228|FG003|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|3|||
27872550|NCT04791319|54490229|FG004|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
27872551|NCT04791319|54490230|FG005|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
27872552|NCT04791319|54490231|FG006|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
27872553|NCT04791319|54490232|FG007|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
27872554|NCT04791319|54490233|FG008|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
27872555|NCT04791319|54490234|FG009|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
27872556|NCT04791319|54490235|FG010|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
27872557|NCT04791319|54490225|FG000|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
27872558|NCT04791319|54490226|FG001|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
27872559|NCT04791319|54490227|FG002|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|2|||
27872560|NCT04791319|54490228|FG003|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
27872561|NCT04791319|54490229|FG004|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
27872562|NCT04791319|54490230|FG005|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
27872563|NCT04791319|54490231|FG006|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
27872564|NCT04791319|54490232|FG007|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
27872565|NCT04791319|54490233|FG008|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
27872566|NCT04791319|54490234|FG009|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
27872567|NCT04791319|54490235|FG010|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
27872568|NCT04791319|54490225|FG000|Placebo Controlled Period (Week 0-15)|Trial termination|2|||
27872569|NCT04791319|54490226|FG001|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
27872570|NCT04791319|54490227|FG002|Placebo Controlled Period (Week 0-15)|Trial termination|5|||
27872571|NCT04791319|54490228|FG003|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
27872572|NCT04791319|54490229|FG004|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
27872573|NCT04791319|54490230|FG005|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
27872574|NCT04791319|54490231|FG006|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
27872575|NCT04791319|54490232|FG007|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
27872576|NCT04791319|54490233|FG008|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
27872577|NCT04791319|54490234|FG009|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
27872578|NCT04791319|54490235|FG010|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
27872579|NCT04791319|54490225|FG000|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|7|||
27872580|NCT04791319|54490226|FG001|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|6|||
27872581|NCT04791319|54490227|FG002|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|21|||
27872582|NCT04791319|54490228|FG003|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|19|||
27872583|NCT04791319|54490229|FG004|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
27872584|NCT04791319|54490230|FG005|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
27872585|NCT04791319|54490231|FG006|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
27872586|NCT04791319|54490232|FG007|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
27872587|NCT04791319|54490233|FG008|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
27872588|NCT04791319|54490234|FG009|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
27872589|NCT04791319|54490235|FG010|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
27872590|NCT04791319|54490225|FG000|Placebo Controlled Period (Week 0-15)|Not treated|0|||
27872591|NCT04791319|54490226|FG001|Placebo Controlled Period (Week 0-15)|Not treated|0|||
27872592|NCT04791319|54490227|FG002|Placebo Controlled Period (Week 0-15)|Not treated|0|||
27872593|NCT04791319|54490228|FG003|Placebo Controlled Period (Week 0-15)|Not treated|1|||
27872594|NCT04791319|54490229|FG004|Placebo Controlled Period (Week 0-15)|Not treated|0|||
27872595|NCT04791319|54490230|FG005|Placebo Controlled Period (Week 0-15)|Not treated|0|||
27872596|NCT04791319|54490231|FG006|Placebo Controlled Period (Week 0-15)|Not treated|0|||
27982610|NCT02329847|54640888|FG001|Overall Study|Death|4|||
27982611|NCT02329847|54640889|FG002|Overall Study|Death|22|||
27982612|NCT02329847|54640890|FG003|Overall Study|Death|12|||
27982613|NCT02329847|54640891|FG004|Overall Study|Death|20|||
27982614|NCT02329847|54640892|FG005|Overall Study|Death|13|||
27982615|NCT02329847|54640887|FG000|Overall Study|Lost to Follow-up|0|||
27982616|NCT02329847|54640888|FG001|Overall Study|Lost to Follow-up|0|||
27982617|NCT02329847|54640889|FG002|Overall Study|Lost to Follow-up|2|||
27982618|NCT02329847|54640890|FG003|Overall Study|Lost to Follow-up|3|||
27982619|NCT02329847|54640891|FG004|Overall Study|Lost to Follow-up|0|||
27982620|NCT02329847|54640892|FG005|Overall Study|Lost to Follow-up|1|||
27982621|NCT02329847|54640887|FG000|Overall Study|Physician Decision|0|||
27982622|NCT02329847|54640888|FG001|Overall Study|Physician Decision|0|||
27982623|NCT02329847|54640889|FG002|Overall Study|Physician Decision|0|||
27982624|NCT02329847|54640890|FG003|Overall Study|Physician Decision|0|||
27982625|NCT02329847|54640891|FG004|Overall Study|Physician Decision|1|||
27982626|NCT02329847|54640892|FG005|Overall Study|Physician Decision|0|||
27982627|NCT02329847|54640887|FG000|Overall Study|Withdrawal by Subject|2|||
27982628|NCT02329847|54640888|FG001|Overall Study|Withdrawal by Subject|1|||
27982629|NCT02329847|54640889|FG002|Overall Study|Withdrawal by Subject|5|||
27982630|NCT02329847|54640890|FG003|Overall Study|Withdrawal by Subject|7|||
27982631|NCT02329847|54640891|FG004|Overall Study|Withdrawal by Subject|8|||
27872597|NCT04791319|54490232|FG007|Placebo Controlled Period (Week 0-15)|Not treated|0|||
27872598|NCT04791319|54490233|FG008|Placebo Controlled Period (Week 0-15)|Not treated|0|||
27982632|NCT02329847|54640892|FG005|Overall Study|Withdrawal by Subject|3|||
27982633|NCT02329847|54640887|FG000|Overall Study|Other|1|||
27982634|NCT02329847|54640888|FG001|Overall Study|Other|2|||
27982635|NCT02329847|54640889|FG002|Overall Study|Other|6|||
27982636|NCT02329847|54640890|FG003|Overall Study|Other|13|||
27982637|NCT02329847|54640891|FG004|Overall Study|Other|10|||
27982638|NCT02329847|54640892|FG005|Overall Study|Other|3|||
27982639|NCT02314624|54640913|FG000|Overall Study|No participating patient|16|||
27982640|NCT02314624|54640914|FG001|Overall Study|No participating patient|13|||
27982641|NCT02314624|54640913|FG000|Overall Study|Participant withdrew|7|||
27982642|NCT02314624|54640914|FG001|Overall Study|Participant withdrew|2|||
27982643|NCT02314624|54640913|FG000|Overall Study|Lost to Follow-up|2|||
27982644|NCT02314624|54640914|FG001|Overall Study|Lost to Follow-up|5|||
27982645|NCT02314624|54640913|FG000|Overall Study|Dropped/Excluded by PI|6|||
27982646|NCT02314624|54640914|FG001|Overall Study|Dropped/Excluded by PI|6|||
27982647|NCT02017717|54640939|FG000|Before Treatment Period|Adverse Event unrelated to study drug|0|||
27982648|NCT02017717|54640940|FG001|Before Treatment Period|Adverse Event unrelated to study drug|0|||
27982649|NCT02017717|54640941|FG002|Before Treatment Period|Adverse Event unrelated to study drug|0|||
27982650|NCT02017717|54640942|FG003|Before Treatment Period|Adverse Event unrelated to study drug|1|||
27982651|NCT02017717|54640943|FG004|Before Treatment Period|Adverse Event unrelated to study drug|0|||
27982652|NCT02017717|54640944|FG005|Before Treatment Period|Adverse Event unrelated to study drug|0|||
27982653|NCT02017717|54640945|FG006|Before Treatment Period|Adverse Event unrelated to study drug|0|||
27982654|NCT02017717|54640946|FG007|Before Treatment Period|Adverse Event unrelated to study drug|0|||
27982655|NCT02017717|54640947|FG008|Before Treatment Period|Adverse Event unrelated to study drug|0|||
27982656|NCT02017717|54640939|FG000|Before Treatment Period|Participant request to stop therapy|0|||
27982657|NCT02017717|54640940|FG001|Before Treatment Period|Participant request to stop therapy|0|||
27982658|NCT02017717|54640941|FG002|Before Treatment Period|Participant request to stop therapy|0|||
27982659|NCT02017717|54640942|FG003|Before Treatment Period|Participant request to stop therapy|0|||
27982660|NCT02017717|54640943|FG004|Before Treatment Period|Participant request to stop therapy|5|||
27982661|NCT02017717|54640944|FG005|Before Treatment Period|Participant request to stop therapy|0|||
27982662|NCT02017717|54640945|FG006|Before Treatment Period|Participant request to stop therapy|0|||
27982663|NCT02017717|54640946|FG007|Before Treatment Period|Participant request to stop therapy|0|||
27982664|NCT02017717|54640947|FG008|Before Treatment Period|Participant request to stop therapy|0|||
27982665|NCT02017717|54640939|FG000|Before Treatment Period|Participant withdrew consent|0|||
27982666|NCT02017717|54640940|FG001|Before Treatment Period|Participant withdrew consent|0|||
27982667|NCT02017717|54640941|FG002|Before Treatment Period|Participant withdrew consent|0|||
27982668|NCT02017717|54640942|FG003|Before Treatment Period|Participant withdrew consent|0|||
27982669|NCT02017717|54640943|FG004|Before Treatment Period|Participant withdrew consent|11|||
27872599|NCT04791319|54490234|FG009|Placebo Controlled Period (Week 0-15)|Not treated|0|||
27872600|NCT04791319|54490235|FG010|Placebo Controlled Period (Week 0-15)|Not treated|0|||
27872601|NCT04791319|54490225|FG000|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
27872602|NCT04791319|54490226|FG001|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
27872603|NCT04791319|54490227|FG002|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
27872604|NCT04791319|54490228|FG003|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
27872605|NCT04791319|54490229|FG004|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
27872606|NCT04791319|54490230|FG005|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
27872607|NCT04791319|54490231|FG006|Active Treatment Period (Week 16-31)|Withdrawal by Subject|1|||
27872608|NCT04791319|54490232|FG007|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
27872609|NCT04791319|54490233|FG008|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
27872610|NCT04791319|54490234|FG009|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
27872611|NCT04791319|54490235|FG010|Active Treatment Period (Week 16-31)|Withdrawal by Subject|3|||
27872612|NCT04791319|54490225|FG000|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
27872613|NCT04791319|54490226|FG001|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
27872614|NCT04791319|54490227|FG002|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
27872615|NCT04791319|54490228|FG003|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
27872616|NCT04791319|54490229|FG004|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
27872617|NCT04791319|54490230|FG005|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
27872618|NCT04791319|54490231|FG006|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
27872619|NCT04791319|54490232|FG007|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
27872620|NCT04791319|54490233|FG008|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
27872621|NCT04791319|54490234|FG009|Active Treatment Period (Week 16-31)|Lost to Follow-up|1|||
27872622|NCT04791319|54490235|FG010|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
27872623|NCT04791319|54490225|FG000|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
27872624|NCT04791319|54490226|FG001|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
27872625|NCT04791319|54490227|FG002|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
27872626|NCT04791319|54490228|FG003|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
27872627|NCT04791319|54490229|FG004|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|4|||
27872628|NCT04791319|54490230|FG005|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|5|||
27872629|NCT04791319|54490231|FG006|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
27872630|NCT04791319|54490232|FG007|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
27872631|NCT04791319|54490233|FG008|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|1|||
27872632|NCT04791319|54490234|FG009|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|9|||
27872633|NCT04791319|54490235|FG010|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
27872634|NCT04791319|54490225|FG000|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
27872635|NCT04791319|54490226|FG001|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
27872636|NCT04791319|54490227|FG002|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
27872637|NCT04791319|54490228|FG003|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
27872638|NCT04791319|54490229|FG004|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|12|||
27872639|NCT04791319|54490230|FG005|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|8|||
27872640|NCT04791319|54490231|FG006|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|16|||
27872641|NCT04791319|54490232|FG007|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|2|||
27872642|NCT04791319|54490233|FG008|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|3|||
27872643|NCT04791319|54490234|FG009|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|11|||
27872644|NCT04791319|54490235|FG010|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|4|||
27872645|NCT03472495|54490292|FG000|Overall Study|Treatment no longer indicated|1|||
27872646|NCT03472495|54490293|FG001|Overall Study|Treatment no longer indicated|2|||
27872647|NCT03472495|54490292|FG000|Overall Study|Physician Decision|0|||
27872648|NCT03472495|54490293|FG001|Overall Study|Physician Decision|2|||
27872649|NCT03234907|54490301|FG000|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
27872650|NCT03234907|54490302|FG001|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
27872651|NCT03234907|54490303|FG002|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
27872652|NCT03234907|54490304|FG003|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
27872653|NCT03234907|54490305|FG004|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
27872654|NCT03234907|54490306|FG005|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
27872655|NCT03234907|54490301|FG000|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|6|||
27872656|NCT03234907|54490302|FG001|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|4|||
27872657|NCT03234907|54490303|FG002|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
27872658|NCT03234907|54490304|FG003|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
27872659|NCT03234907|54490305|FG004|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
27872660|NCT03234907|54490306|FG005|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
27872661|NCT03234907|54490301|FG000|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|2|||
27872662|NCT03234907|54490302|FG001|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
27872663|NCT03234907|54490303|FG002|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
27872664|NCT03234907|54490304|FG003|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
27872665|NCT03234907|54490305|FG004|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
27872666|NCT03234907|54490306|FG005|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
27872667|NCT03234907|54490301|FG000|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
27872668|NCT03234907|54490302|FG001|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
27872669|NCT03234907|54490303|FG002|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
27872670|NCT03234907|54490304|FG003|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
27872671|NCT03234907|54490305|FG004|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
27872672|NCT03234907|54490306|FG005|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
27872673|NCT03234907|54490301|FG000|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
27872674|NCT03234907|54490302|FG001|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
27872675|NCT03234907|54490303|FG002|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
27872676|NCT03234907|54490304|FG003|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|4|||
27872677|NCT03234907|54490305|FG004|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|3|||
27872678|NCT03234907|54490306|FG005|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|7|||
27872679|NCT03234907|54490301|FG000|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
27872680|NCT03234907|54490302|FG001|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
27872681|NCT03234907|54490303|FG002|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|1|||
27872682|NCT03234907|54490304|FG003|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
27872683|NCT03234907|54490305|FG004|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
27872684|NCT03234907|54490306|FG005|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|4|||
27872685|NCT03234907|54490301|FG000|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
27872686|NCT03234907|54490302|FG001|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
27872687|NCT03234907|54490303|FG002|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
27872688|NCT03234907|54490304|FG003|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
27872689|NCT03234907|54490305|FG004|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
27872690|NCT03234907|54490306|FG005|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|10|||
27872691|NCT03818581|54490320|FG000|Overall Study|Adverse Event|1|||
27872692|NCT03818581|54490321|FG001|Overall Study|Adverse Event|0|||
27872693|NCT03818581|54490322|FG002|Overall Study|Adverse Event|0|||
27872694|NCT03818581|54490323|FG003|Overall Study|Adverse Event|0|||
27872695|NCT03818581|54490324|FG004|Overall Study|Adverse Event|0|||
27872696|NCT03818581|54490320|FG000|Overall Study|Covid-19|2|||
27872697|NCT03818581|54490321|FG001|Overall Study|Covid-19|0|||
27872698|NCT03818581|54490322|FG002|Overall Study|Covid-19|0|||
27872699|NCT03818581|54490323|FG003|Overall Study|Covid-19|0|||
27872700|NCT03818581|54490324|FG004|Overall Study|Covid-19|1|||
27872701|NCT03818581|54490320|FG000|Overall Study|Withdrawal by Subject|0|||
27872702|NCT03818581|54490321|FG001|Overall Study|Withdrawal by Subject|0|||
27872703|NCT03818581|54490322|FG002|Overall Study|Withdrawal by Subject|0|||
27872704|NCT03818581|54490323|FG003|Overall Study|Withdrawal by Subject|0|||
27872705|NCT03818581|54490324|FG004|Overall Study|Withdrawal by Subject|1|||
27872706|NCT03818581|54490320|FG000|Overall Study|No longer met study criteria|1|||
27872707|NCT03818581|54490321|FG001|Overall Study|No longer met study criteria|0|||
27872708|NCT03818581|54490322|FG002|Overall Study|No longer met study criteria|0|||
27872709|NCT03818581|54490323|FG003|Overall Study|No longer met study criteria|0|||
27872710|NCT03818581|54490324|FG004|Overall Study|No longer met study criteria|2|||
27872711|NCT03736447|54490338|FG000|Overall Study|Adverse Event|5|||
27872712|NCT03736447|54490339|FG001|Overall Study|Adverse Event|1|||
27872713|NCT03736447|54490338|FG000|Overall Study|Withdrawal by Subject|5|||
27872714|NCT03736447|54490339|FG001|Overall Study|Withdrawal by Subject|1|||
27872715|NCT03736447|54490338|FG000|Overall Study|Lost to Follow-up|1|||
27872716|NCT03736447|54490339|FG001|Overall Study|Lost to Follow-up|0|||
27872717|NCT03736447|54490338|FG000|Overall Study|Physician Decision|1|||
27872718|NCT03736447|54490339|FG001|Overall Study|Physician Decision|0|||
27872719|NCT03736447|54490338|FG000|Overall Study|Continued commitment to study treatment|3|||
27872720|NCT03736447|54490339|FG001|Overall Study|Continued commitment to study treatment|0|||
27872721|NCT03736447|54490338|FG000|Overall Study|Taste aversion to study product|0|||
27872722|NCT03736447|54490339|FG001|Overall Study|Taste aversion to study product|1|||
27872723|NCT02132754|54490388|FG000|Overall Study|Adverse Event|0|||
27872724|NCT02132754|54490389|FG001|Overall Study|Adverse Event|0|||
27872725|NCT02132754|54490390|FG002|Overall Study|Adverse Event|0|||
27982670|NCT02017717|54640944|FG005|Before Treatment Period|Participant withdrew consent|0|||
27982671|NCT02017717|54640945|FG006|Before Treatment Period|Participant withdrew consent|0|||
27982672|NCT02017717|54640946|FG007|Before Treatment Period|Participant withdrew consent|0|||
27739072|NCT02495168|54188420|FG001|Overall Study|Did not Complete Final Visit On Time|3|||
27872726|NCT02132754|54490391|FG003|Overall Study|Adverse Event|0|||
27872727|NCT02132754|54490392|FG004|Overall Study|Adverse Event|0|||
27872728|NCT02132754|54490393|FG005|Overall Study|Adverse Event|0|||
27872729|NCT02132754|54490394|FG006|Overall Study|Adverse Event|0|||
27872730|NCT02132754|54490395|FG007|Overall Study|Adverse Event|0|||
27872731|NCT02132754|54490396|FG008|Overall Study|Adverse Event|0|||
27872732|NCT02132754|54490397|FG009|Overall Study|Adverse Event|0|||
27872733|NCT02132754|54490398|FG010|Overall Study|Adverse Event|0|||
27872734|NCT02132754|54490399|FG011|Overall Study|Adverse Event|0|||
27872735|NCT02132754|54490400|FG012|Overall Study|Adverse Event|0|||
28171450|NCT02719743|54843059|FG000|Overall Study|Migrated/moved from study area|0|||
28171451|NCT02719743|54843060|FG001|Overall Study|Migrated/moved from study area|0|||
28171452|NCT02719743|54843061|FG002|Overall Study|Migrated/moved from study area|0|||
28171453|NCT02719743|54843062|FG003|Overall Study|Migrated/moved from study area|0|||
28171454|NCT02719743|54843063|FG004|Overall Study|Migrated/moved from study area|2|||
28171455|NCT02719743|54843059|FG000|Overall Study|Lost to Follow-up|1|||
28171456|NCT02719743|54843060|FG001|Overall Study|Lost to Follow-up|1|||
28171457|NCT02719743|54843061|FG002|Overall Study|Lost to Follow-up|0|||
28171458|NCT02719743|54843062|FG003|Overall Study|Lost to Follow-up|0|||
28171459|NCT02719743|54843063|FG004|Overall Study|Lost to Follow-up|0|||
28171460|NCT02641730|54843078|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
28171461|NCT02641730|54843079|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
28171462|NCT02641730|54843080|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
28171463|NCT02641730|54843081|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
28171464|NCT02641730|54843082|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
28171465|NCT02641730|54843078|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
28171466|NCT02641730|54843079|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
28171467|NCT02641730|54843080|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
28171468|NCT02641730|54843081|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|5|||
28171469|NCT02641730|54843082|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|4|||
28171470|NCT02641730|54843078|FG000|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
28171471|NCT02641730|54843079|FG001|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
28171472|NCT02641730|54843080|FG002|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
28171473|NCT02641730|54843081|FG003|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
28171474|NCT02641730|54843082|FG004|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
28171475|NCT02641730|54843078|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
28171476|NCT02641730|54843079|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
28171477|NCT02641730|54843080|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
28171478|NCT02641730|54843081|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
28171479|NCT02641730|54843082|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
28171480|NCT02641730|54843078|FG000|After Controlled Period (Week 16 - 52)|Other|0|||
28171481|NCT02641730|54843079|FG001|After Controlled Period (Week 16 - 52)|Other|1|||
28171482|NCT02641730|54843080|FG002|After Controlled Period (Week 16 - 52)|Other|1|||
28171483|NCT02641730|54843081|FG003|After Controlled Period (Week 16 - 52)|Other|0|||
28171484|NCT02641730|54843082|FG004|After Controlled Period (Week 16 - 52)|Other|1|||
28171485|NCT02641730|54843078|FG000|Observational Period (Week 60 - Week 84)|Other|0|||
28171486|NCT02641730|54843079|FG001|Observational Period (Week 60 - Week 84)|Other|0|||
28171487|NCT02641730|54843080|FG002|Observational Period (Week 60 - Week 84)|Other|0|||
28171488|NCT02641730|54843081|FG003|Observational Period (Week 60 - Week 84)|Other|0|||
28171489|NCT02641730|54843082|FG004|Observational Period (Week 60 - Week 84)|Other|1|||
28171490|NCT02797171|54843102|FG000|Overall Study|Lost to Follow-up|2|||
28171491|NCT02797171|54843103|FG001|Overall Study|Lost to Follow-up|0|||
28171492|NCT02797171|54843104|FG002|Overall Study|Lost to Follow-up|2|||
28171493|NCT02797171|54843105|FG003|Overall Study|Lost to Follow-up|1|||
28171494|NCT02797171|54843106|FG004|Overall Study|Lost to Follow-up|2|||
28171495|NCT02797171|54843107|FG005|Overall Study|Lost to Follow-up|0|||
28171496|NCT02797171|54843102|FG000|Overall Study|Withdrawal by Subject|1|||
28171497|NCT02797171|54843103|FG001|Overall Study|Withdrawal by Subject|1|||
28171498|NCT02797171|54843104|FG002|Overall Study|Withdrawal by Subject|0|||
28171499|NCT02797171|54843105|FG003|Overall Study|Withdrawal by Subject|0|||
28171500|NCT02797171|54843106|FG004|Overall Study|Withdrawal by Subject|0|||
28171501|NCT02797171|54843107|FG005|Overall Study|Withdrawal by Subject|0|||
28171502|NCT02797171|54843102|FG000|Overall Study|Protocol Violation|1|||
28171503|NCT02797171|54843103|FG001|Overall Study|Protocol Violation|0|||
27739073|NCT02495168|54188421|FG002|Overall Study|Did not Complete Final Visit On Time|2|||
27872736|NCT02132754|54490401|FG013|Overall Study|Adverse Event|0|||
28171504|NCT02797171|54843104|FG002|Overall Study|Protocol Violation|0|||
28171505|NCT02797171|54843105|FG003|Overall Study|Protocol Violation|0|||
28171506|NCT02797171|54843106|FG004|Overall Study|Protocol Violation|0|||
28171507|NCT02797171|54843107|FG005|Overall Study|Protocol Violation|0|||
28171508|NCT02797171|54843102|FG000|Overall Study|Participant unable to adhere|0|||
27872737|NCT02132754|54490402|FG014|Overall Study|Adverse Event|0|||
27872738|NCT02132754|54490403|FG015|Overall Study|Adverse Event|0|||
28171509|NCT02797171|54843103|FG001|Overall Study|Participant unable to adhere|1|||
28171510|NCT02797171|54843104|FG002|Overall Study|Participant unable to adhere|0|||
28171511|NCT02797171|54843105|FG003|Overall Study|Participant unable to adhere|0|||
28171512|NCT02797171|54843106|FG004|Overall Study|Participant unable to adhere|0|||
28171513|NCT02797171|54843107|FG005|Overall Study|Participant unable to adhere|0|||
28171514|NCT02797171|54843102|FG000|Overall Study|Not Randomized|0|||
28171515|NCT02797171|54843103|FG001|Overall Study|Not Randomized|0|||
28171516|NCT02797171|54843104|FG002|Overall Study|Not Randomized|0|||
28171517|NCT02797171|54843105|FG003|Overall Study|Not Randomized|0|||
28171518|NCT02797171|54843106|FG004|Overall Study|Not Randomized|0|||
28171519|NCT02797171|54843107|FG005|Overall Study|Not Randomized|1|||
28171520|NCT02797951|54843121|FG000|Overall Study|Adverse Event|4|||
28171521|NCT02797951|54843121|FG000|Overall Study|Death|1|||
28171522|NCT02797951|54843121|FG000|Overall Study|Lack of Efficacy|19|||
28171523|NCT02797951|54843121|FG000|Overall Study|Lost to Follow-up|4|||
28171524|NCT02797951|54843121|FG000|Overall Study|Physician Decision|6|||
28171525|NCT02797951|54843121|FG000|Overall Study|Withdrawal by Subject|15|||
28171526|NCT00701805|54843129|FG000|Overall Study|Withdrawal by Subject|3|||
28171527|NCT00701805|54843130|FG001|Overall Study|Withdrawal by Subject|1|||
28171528|NCT00701805|54843131|FG002|Overall Study|Withdrawal by Subject|4|||
28171529|NCT00701805|54843132|FG003|Overall Study|Withdrawal by Subject|3|||
28171530|NCT00701805|54843129|FG000|Overall Study|Adverse Event|0|||
28171531|NCT00701805|54843130|FG001|Overall Study|Adverse Event|1|||
28171532|NCT00701805|54843131|FG002|Overall Study|Adverse Event|1|||
28171533|NCT00701805|54843132|FG003|Overall Study|Adverse Event|0|||
28171534|NCT00701805|54843129|FG000|Overall Study|Missed 7 consecutive doses|0|||
28171535|NCT00701805|54843130|FG001|Overall Study|Missed 7 consecutive doses|1|||
28171536|NCT00701805|54843131|FG002|Overall Study|Missed 7 consecutive doses|0|||
28171537|NCT00701805|54843132|FG003|Overall Study|Missed 7 consecutive doses|0|||
28171538|NCT00701805|54843129|FG000|Overall Study|Admitted to hospital for 2 weeks|0|||
28171539|NCT00701805|54843130|FG001|Overall Study|Admitted to hospital for 2 weeks|0|||
28171540|NCT00701805|54843131|FG002|Overall Study|Admitted to hospital for 2 weeks|1|||
28171541|NCT00701805|54843132|FG003|Overall Study|Admitted to hospital for 2 weeks|0|||
28171542|NCT00701805|54843129|FG000|Overall Study|Physician decision, change of therapy|0|||
28171543|NCT00701805|54843130|FG001|Overall Study|Physician decision, change of therapy|0|||
28171544|NCT00701805|54843131|FG002|Overall Study|Physician decision, change of therapy|0|||
28171545|NCT00701805|54843132|FG003|Overall Study|Physician decision, change of therapy|1|||
28171546|NCT00701805|54843129|FG000|Overall Study|Difficult to travel to dialysis site|0|||
28171547|NCT00701805|54843130|FG001|Overall Study|Difficult to travel to dialysis site|0|||
28171548|NCT00701805|54843131|FG002|Overall Study|Difficult to travel to dialysis site|1|||
28171549|NCT00701805|54843132|FG003|Overall Study|Difficult to travel to dialysis site|0|||
28171550|NCT00701805|54843129|FG000|Overall Study|Resumption criteria were not met|0|||
28171551|NCT00701805|54843130|FG001|Overall Study|Resumption criteria were not met|1|||
28171552|NCT00701805|54843131|FG002|Overall Study|Resumption criteria were not met|0|||
28171553|NCT00701805|54843132|FG003|Overall Study|Resumption criteria were not met|0|||
28171554|NCT02715765|54843145|FG000|Overall Study|Study Termination|3|||
28171555|NCT02715765|54843146|FG001|Overall Study|Study Termination|0|||
28171556|NCT02715765|54843147|FG002|Overall Study|Study Termination|0|||
28171557|NCT04542291|54843155|FG000|Overall Study|Adverse Event|1|||
28171558|NCT04542291|54843155|FG000|Overall Study|Physician Decision|2|||
28171559|NCT02795767|54843162|FG000|Overall Study|Received Commercial Emicizumab|1|||
27872739|NCT02132754|54490404|FG016|Overall Study|Adverse Event|0|||
27872740|NCT02132754|54490405|FG017|Overall Study|Adverse Event|1|||
27872741|NCT02132754|54490406|FG018|Overall Study|Adverse Event|0|||
27872742|NCT02132754|54490407|FG019|Overall Study|Adverse Event|0|||
27872743|NCT02132754|54490408|FG020|Overall Study|Adverse Event|0|||
27872744|NCT02132754|54490409|FG021|Overall Study|Adverse Event|0|||
27872745|NCT02132754|54490410|FG022|Overall Study|Adverse Event|0|||
27872746|NCT02132754|54490411|FG023|Overall Study|Adverse Event|0|||
27872747|NCT02132754|54490412|FG024|Overall Study|Adverse Event|0|||
27872748|NCT02132754|54490413|FG025|Overall Study|Adverse Event|1|||
27872749|NCT02132754|54490414|FG026|Overall Study|Adverse Event|1|||
27872750|NCT02132754|54490415|FG027|Overall Study|Adverse Event|0|||
27872751|NCT02132754|54490416|FG028|Overall Study|Adverse Event|0|||
27872752|NCT02132754|54490417|FG029|Overall Study|Adverse Event|0|||
27982673|NCT02017717|54640947|FG008|Before Treatment Period|Participant withdrew consent|2|||
27872753|NCT02132754|54490418|FG030|Overall Study|Adverse Event|1|||
27872754|NCT02132754|54490419|FG031|Overall Study|Adverse Event|0|||
27872755|NCT02132754|54490420|FG032|Overall Study|Adverse Event|1|||
27872756|NCT02132754|54490421|FG033|Overall Study|Adverse Event|1|||
28171560|NCT02795767|54843163|FG001|Overall Study|Received Commercial Emicizumab|0|||
28171561|NCT02795767|54843164|FG002|Overall Study|Received Commercial Emicizumab|0|||
28171562|NCT02639559|54843178|FG000|Overall Study|Mobilization failure|0|||
27872757|NCT02132754|54490388|FG000|Overall Study|Clinical Progression|0|||
27872758|NCT02132754|54490389|FG001|Overall Study|Clinical Progression|0|||
27872759|NCT02132754|54490390|FG002|Overall Study|Clinical Progression|0|||
27872760|NCT02132754|54490391|FG003|Overall Study|Clinical Progression|0|||
27872761|NCT02132754|54490392|FG004|Overall Study|Clinical Progression|0|||
27872762|NCT02132754|54490393|FG005|Overall Study|Clinical Progression|0|||
27872763|NCT02132754|54490394|FG006|Overall Study|Clinical Progression|0|||
27872764|NCT02132754|54490395|FG007|Overall Study|Clinical Progression|0|||
27872765|NCT02132754|54490396|FG008|Overall Study|Clinical Progression|0|||
27872766|NCT02132754|54490397|FG009|Overall Study|Clinical Progression|1|||
27872767|NCT02132754|54490398|FG010|Overall Study|Clinical Progression|0|||
27872768|NCT02132754|54490399|FG011|Overall Study|Clinical Progression|0|||
27872769|NCT02132754|54490400|FG012|Overall Study|Clinical Progression|0|||
27872770|NCT02132754|54490401|FG013|Overall Study|Clinical Progression|0|||
27872771|NCT02132754|54490402|FG014|Overall Study|Clinical Progression|0|||
27872772|NCT02132754|54490403|FG015|Overall Study|Clinical Progression|0|||
27872773|NCT02132754|54490404|FG016|Overall Study|Clinical Progression|1|||
27872774|NCT02132754|54490405|FG017|Overall Study|Clinical Progression|1|||
27872775|NCT02132754|54490406|FG018|Overall Study|Clinical Progression|0|||
27872776|NCT02132754|54490407|FG019|Overall Study|Clinical Progression|1|||
27872777|NCT02132754|54490408|FG020|Overall Study|Clinical Progression|0|||
27872778|NCT02132754|54490409|FG021|Overall Study|Clinical Progression|0|||
27872779|NCT02132754|54490410|FG022|Overall Study|Clinical Progression|1|||
27872780|NCT02132754|54490411|FG023|Overall Study|Clinical Progression|0|||
27872781|NCT02132754|54490412|FG024|Overall Study|Clinical Progression|1|||
27872782|NCT02132754|54490413|FG025|Overall Study|Clinical Progression|1|||
27872783|NCT02132754|54490414|FG026|Overall Study|Clinical Progression|0|||
27872784|NCT02132754|54490415|FG027|Overall Study|Clinical Progression|1|||
27872785|NCT02132754|54490416|FG028|Overall Study|Clinical Progression|1|||
27872786|NCT02132754|54490417|FG029|Overall Study|Clinical Progression|0|||
27872787|NCT02132754|54490418|FG030|Overall Study|Clinical Progression|1|||
27872788|NCT02132754|54490419|FG031|Overall Study|Clinical Progression|0|||
27872789|NCT02132754|54490420|FG032|Overall Study|Clinical Progression|0|||
27872790|NCT02132754|54490421|FG033|Overall Study|Clinical Progression|2|||
27872791|NCT02132754|54490388|FG000|Overall Study|Death|0|||
27872792|NCT02132754|54490389|FG001|Overall Study|Death|0|||
27872793|NCT02132754|54490390|FG002|Overall Study|Death|0|||
27872794|NCT02132754|54490391|FG003|Overall Study|Death|0|||
27872795|NCT02132754|54490392|FG004|Overall Study|Death|0|||
27872796|NCT02132754|54490393|FG005|Overall Study|Death|0|||
27872797|NCT02132754|54490394|FG006|Overall Study|Death|0|||
27872798|NCT02132754|54490395|FG007|Overall Study|Death|0|||
27872799|NCT02132754|54490396|FG008|Overall Study|Death|0|||
27872800|NCT02132754|54490397|FG009|Overall Study|Death|0|||
27872801|NCT02132754|54490398|FG010|Overall Study|Death|0|||
27872802|NCT02132754|54490399|FG011|Overall Study|Death|0|||
27872803|NCT02132754|54490400|FG012|Overall Study|Death|0|||
27872804|NCT02132754|54490401|FG013|Overall Study|Death|0|||
27872805|NCT02132754|54490402|FG014|Overall Study|Death|0|||
27872806|NCT02132754|54490403|FG015|Overall Study|Death|1|||
27872807|NCT02132754|54490404|FG016|Overall Study|Death|0|||
27872808|NCT02132754|54490405|FG017|Overall Study|Death|0|||
27872809|NCT02132754|54490406|FG018|Overall Study|Death|0|||
27872810|NCT02132754|54490407|FG019|Overall Study|Death|1|||
27872811|NCT02132754|54490408|FG020|Overall Study|Death|0|||
27872812|NCT02132754|54490409|FG021|Overall Study|Death|1|||
27872813|NCT02132754|54490410|FG022|Overall Study|Death|0|||
27872814|NCT02132754|54490411|FG023|Overall Study|Death|0|||
27872815|NCT02132754|54490412|FG024|Overall Study|Death|0|||
27872816|NCT02132754|54490413|FG025|Overall Study|Death|0|||
27872817|NCT02132754|54490414|FG026|Overall Study|Death|1|||
27872818|NCT02132754|54490415|FG027|Overall Study|Death|0|||
27872819|NCT02132754|54490416|FG028|Overall Study|Death|0|||
27872820|NCT02132754|54490417|FG029|Overall Study|Death|0|||
27872821|NCT02132754|54490418|FG030|Overall Study|Death|0|||
27872822|NCT02132754|54490419|FG031|Overall Study|Death|0|||
27872823|NCT02132754|54490420|FG032|Overall Study|Death|0|||
27982674|NCT02017717|54640939|FG000|Before Treatment Period|Lost to Follow-up|0|||
27872824|NCT02132754|54490421|FG033|Overall Study|Death|2|||
27872825|NCT02132754|54490388|FG000|Overall Study|Excluded Medication|0|||
27872826|NCT02132754|54490389|FG001|Overall Study|Excluded Medication|0|||
27872827|NCT02132754|54490390|FG002|Overall Study|Excluded Medication|0|||
27872828|NCT02132754|54490391|FG003|Overall Study|Excluded Medication|0|||
27872829|NCT02132754|54490392|FG004|Overall Study|Excluded Medication|0|||
27872830|NCT02132754|54490393|FG005|Overall Study|Excluded Medication|0|||
27872831|NCT02132754|54490394|FG006|Overall Study|Excluded Medication|0|||
27872832|NCT02132754|54490395|FG007|Overall Study|Excluded Medication|0|||
27872833|NCT02132754|54490396|FG008|Overall Study|Excluded Medication|0|||
27872834|NCT02132754|54490397|FG009|Overall Study|Excluded Medication|0|||
27872835|NCT02132754|54490398|FG010|Overall Study|Excluded Medication|0|||
27872836|NCT02132754|54490399|FG011|Overall Study|Excluded Medication|0|||
27872837|NCT02132754|54490400|FG012|Overall Study|Excluded Medication|0|||
27872838|NCT02132754|54490401|FG013|Overall Study|Excluded Medication|0|||
27872839|NCT02132754|54490402|FG014|Overall Study|Excluded Medication|0|||
27872840|NCT02132754|54490403|FG015|Overall Study|Excluded Medication|0|||
27872841|NCT02132754|54490404|FG016|Overall Study|Excluded Medication|0|||
27872842|NCT02132754|54490405|FG017|Overall Study|Excluded Medication|0|||
27872843|NCT02132754|54490406|FG018|Overall Study|Excluded Medication|0|||
27872844|NCT02132754|54490407|FG019|Overall Study|Excluded Medication|0|||
27872845|NCT02132754|54490408|FG020|Overall Study|Excluded Medication|1|||
27872846|NCT02132754|54490409|FG021|Overall Study|Excluded Medication|0|||
27872847|NCT02132754|54490410|FG022|Overall Study|Excluded Medication|0|||
27872848|NCT02132754|54490411|FG023|Overall Study|Excluded Medication|0|||
27872849|NCT02132754|54490412|FG024|Overall Study|Excluded Medication|0|||
27872850|NCT02132754|54490413|FG025|Overall Study|Excluded Medication|0|||
27872851|NCT02132754|54490414|FG026|Overall Study|Excluded Medication|0|||
27872852|NCT02132754|54490415|FG027|Overall Study|Excluded Medication|0|||
27872853|NCT02132754|54490416|FG028|Overall Study|Excluded Medication|0|||
27872854|NCT02132754|54490417|FG029|Overall Study|Excluded Medication|0|||
27872855|NCT02132754|54490418|FG030|Overall Study|Excluded Medication|0|||
27872856|NCT02132754|54490419|FG031|Overall Study|Excluded Medication|0|||
27872857|NCT02132754|54490420|FG032|Overall Study|Excluded Medication|0|||
27872858|NCT02132754|54490421|FG033|Overall Study|Excluded Medication|1|||
27872859|NCT02132754|54490388|FG000|Overall Study|Physician Decision|0|||
27872860|NCT02132754|54490389|FG001|Overall Study|Physician Decision|0|||
27872861|NCT02132754|54490390|FG002|Overall Study|Physician Decision|0|||
27872862|NCT02132754|54490391|FG003|Overall Study|Physician Decision|0|||
27872863|NCT02132754|54490392|FG004|Overall Study|Physician Decision|0|||
27872864|NCT02132754|54490393|FG005|Overall Study|Physician Decision|0|||
27872865|NCT02132754|54490394|FG006|Overall Study|Physician Decision|0|||
27872866|NCT02132754|54490395|FG007|Overall Study|Physician Decision|0|||
27872867|NCT02132754|54490396|FG008|Overall Study|Physician Decision|0|||
27872868|NCT02132754|54490397|FG009|Overall Study|Physician Decision|1|||
27872869|NCT02132754|54490398|FG010|Overall Study|Physician Decision|0|||
27872870|NCT02132754|54490399|FG011|Overall Study|Physician Decision|1|||
27872871|NCT02132754|54490400|FG012|Overall Study|Physician Decision|1|||
27872872|NCT02132754|54490401|FG013|Overall Study|Physician Decision|0|||
27872873|NCT02132754|54490402|FG014|Overall Study|Physician Decision|0|||
27872874|NCT02132754|54490403|FG015|Overall Study|Physician Decision|1|||
27872875|NCT02132754|54490404|FG016|Overall Study|Physician Decision|0|||
27872876|NCT02132754|54490405|FG017|Overall Study|Physician Decision|0|||
27872877|NCT02132754|54490406|FG018|Overall Study|Physician Decision|0|||
27872878|NCT02132754|54490407|FG019|Overall Study|Physician Decision|0|||
27872879|NCT02132754|54490408|FG020|Overall Study|Physician Decision|0|||
27872880|NCT02132754|54490409|FG021|Overall Study|Physician Decision|0|||
27872881|NCT02132754|54490410|FG022|Overall Study|Physician Decision|0|||
27872882|NCT02132754|54490411|FG023|Overall Study|Physician Decision|0|||
27872883|NCT02132754|54490412|FG024|Overall Study|Physician Decision|1|||
27872884|NCT02132754|54490413|FG025|Overall Study|Physician Decision|0|||
27872885|NCT02132754|54490414|FG026|Overall Study|Physician Decision|0|||
27872886|NCT02132754|54490415|FG027|Overall Study|Physician Decision|0|||
27872887|NCT02132754|54490416|FG028|Overall Study|Physician Decision|0|||
27872888|NCT02132754|54490417|FG029|Overall Study|Physician Decision|0|||
27872889|NCT02132754|54490418|FG030|Overall Study|Physician Decision|0|||
27872890|NCT02132754|54490419|FG031|Overall Study|Physician Decision|1|||
27872891|NCT02132754|54490420|FG032|Overall Study|Physician Decision|0|||
27872892|NCT02132754|54490421|FG033|Overall Study|Physician Decision|3|||
27872893|NCT02132754|54490388|FG000|Overall Study|Progressive Disease|1|||
27872894|NCT02132754|54490389|FG001|Overall Study|Progressive Disease|1|||
27872895|NCT02132754|54490390|FG002|Overall Study|Progressive Disease|1|||
27872896|NCT02132754|54490391|FG003|Overall Study|Progressive Disease|1|||
27872897|NCT02132754|54490392|FG004|Overall Study|Progressive Disease|1|||
27872898|NCT02132754|54490393|FG005|Overall Study|Progressive Disease|1|||
27872899|NCT02132754|54490394|FG006|Overall Study|Progressive Disease|1|||
27872900|NCT02132754|54490395|FG007|Overall Study|Progressive Disease|1|||
27872901|NCT02132754|54490396|FG008|Overall Study|Progressive Disease|1|||
27872902|NCT02132754|54490397|FG009|Overall Study|Progressive Disease|3|||
27872903|NCT02132754|54490398|FG010|Overall Study|Progressive Disease|3|||
27872904|NCT02132754|54490399|FG011|Overall Study|Progressive Disease|2|||
27872905|NCT02132754|54490400|FG012|Overall Study|Progressive Disease|2|||
27872906|NCT02132754|54490401|FG013|Overall Study|Progressive Disease|3|||
27872907|NCT02132754|54490402|FG014|Overall Study|Progressive Disease|2|||
27872908|NCT02132754|54490403|FG015|Overall Study|Progressive Disease|1|||
27872909|NCT02132754|54490404|FG016|Overall Study|Progressive Disease|2|||
27872910|NCT02132754|54490405|FG017|Overall Study|Progressive Disease|1|||
27872911|NCT02132754|54490406|FG018|Overall Study|Progressive Disease|3|||
27872912|NCT02132754|54490407|FG019|Overall Study|Progressive Disease|1|||
27872913|NCT02132754|54490408|FG020|Overall Study|Progressive Disease|1|||
27872914|NCT02132754|54490409|FG021|Overall Study|Progressive Disease|3|||
27872915|NCT02132754|54490410|FG022|Overall Study|Progressive Disease|2|||
27872916|NCT02132754|54490411|FG023|Overall Study|Progressive Disease|3|||
27872917|NCT02132754|54490412|FG024|Overall Study|Progressive Disease|0|||
27872918|NCT02132754|54490413|FG025|Overall Study|Progressive Disease|1|||
27872919|NCT02132754|54490414|FG026|Overall Study|Progressive Disease|2|||
27872920|NCT02132754|54490415|FG027|Overall Study|Progressive Disease|1|||
27872921|NCT02132754|54490416|FG028|Overall Study|Progressive Disease|2|||
27872922|NCT02132754|54490417|FG029|Overall Study|Progressive Disease|3|||
27872923|NCT02132754|54490418|FG030|Overall Study|Progressive Disease|1|||
27872924|NCT02132754|54490419|FG031|Overall Study|Progressive Disease|1|||
27872925|NCT02132754|54490420|FG032|Overall Study|Progressive Disease|3|||
27872926|NCT02132754|54490421|FG033|Overall Study|Progressive Disease|6|||
27872927|NCT02132754|54490388|FG000|Overall Study|Screen Failure|0|||
27872928|NCT02132754|54490389|FG001|Overall Study|Screen Failure|0|||
27872929|NCT02132754|54490390|FG002|Overall Study|Screen Failure|0|||
27872930|NCT02132754|54490391|FG003|Overall Study|Screen Failure|0|||
27872931|NCT02132754|54490392|FG004|Overall Study|Screen Failure|0|||
27872932|NCT02132754|54490393|FG005|Overall Study|Screen Failure|0|||
27872933|NCT02132754|54490394|FG006|Overall Study|Screen Failure|0|||
27872934|NCT02132754|54490395|FG007|Overall Study|Screen Failure|0|||
27872935|NCT02132754|54490396|FG008|Overall Study|Screen Failure|0|||
27872936|NCT02132754|54490397|FG009|Overall Study|Screen Failure|0|||
27872937|NCT02132754|54490398|FG010|Overall Study|Screen Failure|0|||
27872938|NCT02132754|54490399|FG011|Overall Study|Screen Failure|0|||
27872939|NCT02132754|54490400|FG012|Overall Study|Screen Failure|0|||
27872940|NCT02132754|54490401|FG013|Overall Study|Screen Failure|0|||
27872941|NCT02132754|54490402|FG014|Overall Study|Screen Failure|0|||
27872942|NCT02132754|54490403|FG015|Overall Study|Screen Failure|0|||
27872943|NCT02132754|54490404|FG016|Overall Study|Screen Failure|0|||
27872944|NCT02132754|54490405|FG017|Overall Study|Screen Failure|0|||
27872945|NCT02132754|54490406|FG018|Overall Study|Screen Failure|0|||
27872946|NCT02132754|54490407|FG019|Overall Study|Screen Failure|1|||
27872947|NCT02132754|54490408|FG020|Overall Study|Screen Failure|0|||
27872948|NCT02132754|54490409|FG021|Overall Study|Screen Failure|1|||
27872949|NCT02132754|54490410|FG022|Overall Study|Screen Failure|0|||
27872950|NCT02132754|54490411|FG023|Overall Study|Screen Failure|0|||
27872951|NCT02132754|54490412|FG024|Overall Study|Screen Failure|0|||
27872952|NCT02132754|54490413|FG025|Overall Study|Screen Failure|0|||
27872953|NCT02132754|54490414|FG026|Overall Study|Screen Failure|0|||
27872954|NCT02132754|54490415|FG027|Overall Study|Screen Failure|0|||
27872955|NCT02132754|54490416|FG028|Overall Study|Screen Failure|0|||
27872956|NCT02132754|54490417|FG029|Overall Study|Screen Failure|0|||
27872957|NCT02132754|54490418|FG030|Overall Study|Screen Failure|0|||
27872958|NCT02132754|54490419|FG031|Overall Study|Screen Failure|0|||
27872959|NCT02132754|54490420|FG032|Overall Study|Screen Failure|0|||
27872960|NCT02132754|54490421|FG033|Overall Study|Screen Failure|0|||
27872961|NCT02132754|54490388|FG000|Overall Study|Transferred to Extension Study|0|||
27872962|NCT02132754|54490389|FG001|Overall Study|Transferred to Extension Study|0|||
27872963|NCT02132754|54490390|FG002|Overall Study|Transferred to Extension Study|0|||
27872964|NCT02132754|54490391|FG003|Overall Study|Transferred to Extension Study|0|||
27872965|NCT02132754|54490392|FG004|Overall Study|Transferred to Extension Study|0|||
27872966|NCT02132754|54490393|FG005|Overall Study|Transferred to Extension Study|0|||
27872967|NCT02132754|54490394|FG006|Overall Study|Transferred to Extension Study|0|||
27872968|NCT02132754|54490395|FG007|Overall Study|Transferred to Extension Study|0|||
27872969|NCT02132754|54490396|FG008|Overall Study|Transferred to Extension Study|0|||
27872970|NCT02132754|54490397|FG009|Overall Study|Transferred to Extension Study|0|||
27872971|NCT02132754|54490398|FG010|Overall Study|Transferred to Extension Study|0|||
27872972|NCT02132754|54490399|FG011|Overall Study|Transferred to Extension Study|0|||
27872973|NCT02132754|54490400|FG012|Overall Study|Transferred to Extension Study|0|||
27872974|NCT02132754|54490401|FG013|Overall Study|Transferred to Extension Study|0|||
27872975|NCT02132754|54490402|FG014|Overall Study|Transferred to Extension Study|0|||
27872976|NCT02132754|54490403|FG015|Overall Study|Transferred to Extension Study|0|||
27872977|NCT02132754|54490404|FG016|Overall Study|Transferred to Extension Study|0|||
27872978|NCT02132754|54490405|FG017|Overall Study|Transferred to Extension Study|0|||
27872979|NCT02132754|54490406|FG018|Overall Study|Transferred to Extension Study|0|||
27872980|NCT02132754|54490407|FG019|Overall Study|Transferred to Extension Study|0|||
27872981|NCT02132754|54490408|FG020|Overall Study|Transferred to Extension Study|0|||
27872982|NCT02132754|54490409|FG021|Overall Study|Transferred to Extension Study|0|||
27872983|NCT02132754|54490410|FG022|Overall Study|Transferred to Extension Study|0|||
27872984|NCT02132754|54490411|FG023|Overall Study|Transferred to Extension Study|0|||
27872985|NCT02132754|54490412|FG024|Overall Study|Transferred to Extension Study|0|||
27872986|NCT02132754|54490413|FG025|Overall Study|Transferred to Extension Study|0|||
27872987|NCT02132754|54490414|FG026|Overall Study|Transferred to Extension Study|0|||
27872988|NCT02132754|54490415|FG027|Overall Study|Transferred to Extension Study|0|||
27872989|NCT02132754|54490416|FG028|Overall Study|Transferred to Extension Study|0|||
27872990|NCT02132754|54490417|FG029|Overall Study|Transferred to Extension Study|0|||
27872991|NCT02132754|54490418|FG030|Overall Study|Transferred to Extension Study|0|||
27872992|NCT02132754|54490419|FG031|Overall Study|Transferred to Extension Study|0|||
27872993|NCT02132754|54490420|FG032|Overall Study|Transferred to Extension Study|0|||
27872994|NCT02132754|54490421|FG033|Overall Study|Transferred to Extension Study|6|||
27872995|NCT02132754|54490388|FG000|Overall Study|Withdrawal by Subject|0|||
27872996|NCT02132754|54490389|FG001|Overall Study|Withdrawal by Subject|0|||
27872997|NCT02132754|54490390|FG002|Overall Study|Withdrawal by Subject|0|||
27872998|NCT02132754|54490391|FG003|Overall Study|Withdrawal by Subject|0|||
27872999|NCT02132754|54490392|FG004|Overall Study|Withdrawal by Subject|0|||
27873000|NCT02132754|54490393|FG005|Overall Study|Withdrawal by Subject|0|||
27873001|NCT02132754|54490394|FG006|Overall Study|Withdrawal by Subject|0|||
27873002|NCT02132754|54490395|FG007|Overall Study|Withdrawal by Subject|0|||
27873003|NCT02132754|54490396|FG008|Overall Study|Withdrawal by Subject|0|||
27873004|NCT02132754|54490397|FG009|Overall Study|Withdrawal by Subject|1|||
27873005|NCT02132754|54490398|FG010|Overall Study|Withdrawal by Subject|0|||
27873006|NCT02132754|54490399|FG011|Overall Study|Withdrawal by Subject|0|||
27873007|NCT02132754|54490400|FG012|Overall Study|Withdrawal by Subject|1|||
27873008|NCT02132754|54490401|FG013|Overall Study|Withdrawal by Subject|0|||
27873009|NCT02132754|54490402|FG014|Overall Study|Withdrawal by Subject|1|||
27873010|NCT02132754|54490403|FG015|Overall Study|Withdrawal by Subject|2|||
27873011|NCT02132754|54490404|FG016|Overall Study|Withdrawal by Subject|1|||
27873012|NCT02132754|54490405|FG017|Overall Study|Withdrawal by Subject|0|||
27873013|NCT02132754|54490406|FG018|Overall Study|Withdrawal by Subject|0|||
27873014|NCT02132754|54490407|FG019|Overall Study|Withdrawal by Subject|0|||
27873015|NCT02132754|54490408|FG020|Overall Study|Withdrawal by Subject|1|||
27873016|NCT02132754|54490409|FG021|Overall Study|Withdrawal by Subject|0|||
27873017|NCT02132754|54490410|FG022|Overall Study|Withdrawal by Subject|0|||
27873018|NCT02132754|54490411|FG023|Overall Study|Withdrawal by Subject|0|||
27873019|NCT02132754|54490412|FG024|Overall Study|Withdrawal by Subject|1|||
27873020|NCT02132754|54490413|FG025|Overall Study|Withdrawal by Subject|0|||
27873021|NCT02132754|54490414|FG026|Overall Study|Withdrawal by Subject|0|||
27873022|NCT02132754|54490415|FG027|Overall Study|Withdrawal by Subject|1|||
27873023|NCT02132754|54490416|FG028|Overall Study|Withdrawal by Subject|0|||
27873024|NCT02132754|54490417|FG029|Overall Study|Withdrawal by Subject|0|||
27873025|NCT02132754|54490418|FG030|Overall Study|Withdrawal by Subject|0|||
27873026|NCT02132754|54490419|FG031|Overall Study|Withdrawal by Subject|1|||
27873027|NCT02132754|54490420|FG032|Overall Study|Withdrawal by Subject|0|||
27873028|NCT02132754|54490421|FG033|Overall Study|Withdrawal by Subject|2|||
27873029|NCT02151786|54490531|FG000|Overall Study|Unavailability of Case Report Form|26|||
27873030|NCT02151786|54490531|FG000|Overall Study|Outside the Contract Period|1|||
27873031|NCT02151786|54490531|FG000|Overall Study|Randomized, not Treated|1|||
27873032|NCT02151786|54490531|FG000|Overall Study|Unavailability of Information|8|||
27873033|NCT02132130|54490539|FG000|Overall Study|Lost to Follow-up|0|||
27873034|NCT02132130|54490540|FG001|Overall Study|Lost to Follow-up|2|||
27873035|NCT02132130|54490541|FG002|Overall Study|Lost to Follow-up|0|||
27873036|NCT02132130|54490542|FG003|Overall Study|Lost to Follow-up|0|||
27873037|NCT02132130|54490539|FG000|Overall Study|Withdrawal by Subject|0|||
27873038|NCT02132130|54490540|FG001|Overall Study|Withdrawal by Subject|0|||
27873039|NCT02132130|54490541|FG002|Overall Study|Withdrawal by Subject|0|||
27873040|NCT02132130|54490542|FG003|Overall Study|Withdrawal by Subject|1|||
27873041|NCT02131662|54490561|FG000|Overall Study|Protocol Violation|1|||
27873042|NCT02131662|54490562|FG001|Overall Study|Protocol Violation|0|||
27873043|NCT02131662|54490563|FG002|Overall Study|Protocol Violation|0|||
27873044|NCT02131662|54490564|FG003|Overall Study|Protocol Violation|0|||
27873045|NCT02131662|54490565|FG004|Overall Study|Protocol Violation|0|||
27873046|NCT02131662|54490561|FG000|Overall Study|Other|2|||
27873047|NCT02131662|54490562|FG001|Overall Study|Other|4|||
27873048|NCT02131662|54490563|FG002|Overall Study|Other|3|||
27873049|NCT02131662|54490564|FG003|Overall Study|Other|3|||
27873050|NCT02131662|54490565|FG004|Overall Study|Other|4|||
27873051|NCT02131662|54490561|FG000|Overall Study|Adverse Event|0|||
27873052|NCT02131662|54490562|FG001|Overall Study|Adverse Event|1|||
27873053|NCT02131662|54490563|FG002|Overall Study|Adverse Event|1|||
27873054|NCT02131662|54490564|FG003|Overall Study|Adverse Event|1|||
27873055|NCT02131662|54490565|FG004|Overall Study|Adverse Event|3|||
27873056|NCT02131662|54490561|FG000|Overall Study|Pregnancy|0|||
28171563|NCT02639559|54843179|FG001|Overall Study|Mobilization failure|3|||
28171564|NCT02639559|54843178|FG000|Overall Study|Issues with vascular acess|1|||
28171565|NCT02639559|54843179|FG001|Overall Study|Issues with vascular acess|0|||
27873057|NCT02131662|54490562|FG001|Overall Study|Pregnancy|1|||
27873058|NCT02131662|54490563|FG002|Overall Study|Pregnancy|0|||
27873059|NCT02131662|54490564|FG003|Overall Study|Pregnancy|1|||
27873060|NCT02131662|54490565|FG004|Overall Study|Pregnancy|0|||
27873061|NCT02131662|54490561|FG000|Overall Study|Wish for pregnancy|0|||
27873062|NCT02131662|54490562|FG001|Overall Study|Wish for pregnancy|0|||
27873063|NCT02131662|54490563|FG002|Overall Study|Wish for pregnancy|0|||
27873064|NCT02131662|54490564|FG003|Overall Study|Wish for pregnancy|0|||
27873065|NCT02131662|54490565|FG004|Overall Study|Wish for pregnancy|1|||
27873066|NCT02131662|54490561|FG000|Overall Study|Lack of Efficacy|1|||
27873067|NCT02131662|54490562|FG001|Overall Study|Lack of Efficacy|0|||
27873068|NCT02131662|54490563|FG002|Overall Study|Lack of Efficacy|0|||
27873069|NCT02131662|54490564|FG003|Overall Study|Lack of Efficacy|0|||
27873070|NCT02131662|54490565|FG004|Overall Study|Lack of Efficacy|1|||
27873071|NCT02131662|54490561|FG000|Overall Study|Withdrawal by Subject|1|||
27873072|NCT02131662|54490562|FG001|Overall Study|Withdrawal by Subject|5|||
27873073|NCT02131662|54490563|FG002|Overall Study|Withdrawal by Subject|1|||
27873074|NCT02131662|54490564|FG003|Overall Study|Withdrawal by Subject|5|||
27873075|NCT02131662|54490565|FG004|Overall Study|Withdrawal by Subject|6|||
27873076|NCT02131662|54490561|FG000|Overall Study|Lost to Follow-up|1|||
27873077|NCT02131662|54490562|FG001|Overall Study|Lost to Follow-up|3|||
27873078|NCT02131662|54490563|FG002|Overall Study|Lost to Follow-up|0|||
27873079|NCT02131662|54490564|FG003|Overall Study|Lost to Follow-up|9|||
27873080|NCT02131662|54490565|FG004|Overall Study|Lost to Follow-up|0|||
27873081|NCT02131662|54490561|FG000|Overall Study|Not treated|2|||
27873082|NCT02131662|54490562|FG001|Overall Study|Not treated|0|||
27873083|NCT02131662|54490563|FG002|Overall Study|Not treated|2|||
27873084|NCT02131662|54490564|FG003|Overall Study|Not treated|2|||
27873085|NCT02131662|54490565|FG004|Overall Study|Not treated|3|||
27873086|NCT02106156|54490584|FG000|Overall Study|Patient Died|19|||
27873087|NCT02106156|54490585|FG001|Overall Study|Patient Died|0|||
27873088|NCT02106156|54490586|FG002|Overall Study|Patient Died|0|||
27873089|NCT02106156|54490584|FG000|Overall Study|Lack of Tolerability|305|||
27873090|NCT02106156|54490585|FG001|Overall Study|Lack of Tolerability|3|||
27873091|NCT02106156|54490586|FG002|Overall Study|Lack of Tolerability|0|||
27873092|NCT02106156|54490584|FG000|Overall Study|Lack of Virological Response|1044|||
27873093|NCT02106156|54490585|FG001|Overall Study|Lack of Virological Response|8|||
27873094|NCT02106156|54490586|FG002|Overall Study|Lack of Virological Response|0|||
27873095|NCT02106156|54490584|FG000|Overall Study|Concomitant Disease|74|||
27873096|NCT02106156|54490585|FG001|Overall Study|Concomitant Disease|2|||
27873097|NCT02106156|54490586|FG002|Overall Study|Concomitant Disease|0|||
27873098|NCT02106156|54490584|FG000|Overall Study|Lack of Compliance|211|||
27873099|NCT02106156|54490585|FG001|Overall Study|Lack of Compliance|7|||
27873100|NCT02106156|54490586|FG002|Overall Study|Lack of Compliance|0|||
27873101|NCT02106156|54490584|FG000|Overall Study|Patients Request|307|||
27873102|NCT02106156|54490585|FG001|Overall Study|Patients Request|9|||
27873103|NCT02106156|54490586|FG002|Overall Study|Patients Request|0|||
27873104|NCT02106156|54490584|FG000|Overall Study|Lost to Follow-up|451|||
27873105|NCT02106156|54490585|FG001|Overall Study|Lost to Follow-up|8|||
27873106|NCT02106156|54490586|FG002|Overall Study|Lost to Follow-up|0|||
27873107|NCT02106156|54490584|FG000|Overall Study|Unplanned Event|82|||
27873108|NCT02106156|54490585|FG001|Overall Study|Unplanned Event|2|||
27873109|NCT02106156|54490586|FG002|Overall Study|Unplanned Event|0|||
27873110|NCT02106156|54490584|FG000|Overall Study|Change of Laboratory Parameter|10|||
27873111|NCT02106156|54490585|FG001|Overall Study|Change of Laboratory Parameter|0|||
27873112|NCT02106156|54490586|FG002|Overall Study|Change of Laboratory Parameter|0|||
27873113|NCT02106156|54490584|FG000|Overall Study|Hospitalization/Surgical Intervention|6|||
27982675|NCT02017717|54640940|FG001|Before Treatment Period|Lost to Follow-up|0|||
27873114|NCT02106156|54490585|FG001|Overall Study|Hospitalization/Surgical Intervention|0|||
27873115|NCT02106156|54490586|FG002|Overall Study|Hospitalization/Surgical Intervention|0|||
27873116|NCT02106156|54490584|FG000|Overall Study|Relocation/Change of Physician|40|||
27873117|NCT02106156|54490585|FG001|Overall Study|Relocation/Change of Physician|1|||
27873118|NCT02106156|54490586|FG002|Overall Study|Relocation/Change of Physician|0|||
27873119|NCT01598610|54490593|FG000|Overall Study|Adverse Event|1|||
27873120|NCT01625988|54490599|FG000|Overall Study|Lost to Follow-up|5|||
27873121|NCT01625988|54490600|FG001|Overall Study|Lost to Follow-up|6|||
27873122|NCT01625988|54490599|FG000|Overall Study|Withdrawal by Subject|8|||
27873123|NCT01625988|54490600|FG001|Overall Study|Withdrawal by Subject|3|||
28171566|NCT02796391|54843200|FG000|Overall Study|Lost to Follow-up|2|||
28171567|NCT02796391|54843201|FG001|Overall Study|Lost to Follow-up|2|||
28171568|NCT02796391|54843202|FG002|Overall Study|Lost to Follow-up|13|||
28171569|NCT02796391|54843203|FG003|Overall Study|Lost to Follow-up|8|||
28171570|NCT02796391|54843204|FG004|Overall Study|Lost to Follow-up|14|||
28171571|NCT02796391|54843205|FG005|Overall Study|Lost to Follow-up|13|||
28171572|NCT02796391|54843200|FG000|Overall Study|COVID|0|||
28171573|NCT02796391|54843201|FG001|Overall Study|COVID|0|||
28171574|NCT02796391|54843202|FG002|Overall Study|COVID|5|||
28171575|NCT02796391|54843203|FG003|Overall Study|COVID|5|||
28171576|NCT02796391|54843204|FG004|Overall Study|COVID|2|||
28171577|NCT02796391|54843205|FG005|Overall Study|COVID|4|||
28171578|NCT02796391|54843200|FG000|Overall Study|Participant did not like study cigarettes|0|||
27873124|NCT01625988|54490599|FG000|Overall Study|Adverse Event|0|||
27873125|NCT01625988|54490600|FG001|Overall Study|Adverse Event|1|||
27873126|NCT01625988|54490599|FG000|Overall Study|Lack of Efficacy|0|||
27873127|NCT01625988|54490600|FG001|Overall Study|Lack of Efficacy|1|||
27873128|NCT01625988|54490599|FG000|Overall Study|Randomized Inappropriately|1|||
27873129|NCT01625988|54490600|FG001|Overall Study|Randomized Inappropriately|0|||
27873130|NCT01625988|54490599|FG000|Overall Study|Protocol Violation|0|||
27873131|NCT01625988|54490600|FG001|Overall Study|Protocol Violation|2|||
27873132|NCT02131272|54490611|FG000|Overall Study|Withdrawal by parent|0|||
27873133|NCT02131272|54490612|FG001|Overall Study|Withdrawal by parent|1|||
28171579|NCT02796391|54843201|FG001|Overall Study|Participant did not like study cigarettes|0|||
27873134|NCT02131272|54490611|FG000|Overall Study|Withdrawal by Subject|0|||
27873135|NCT02131272|54490612|FG001|Overall Study|Withdrawal by Subject|1|||
27873136|NCT02131272|54490611|FG000|Overall Study|Withdrawal Criteria|1|||
27873137|NCT02131272|54490612|FG001|Overall Study|Withdrawal Criteria|0|||
27873138|NCT02130882|54490620|FG000|Overall Study|Withdrawal by Subject|0|||
27873139|NCT02130882|54490621|FG001|Overall Study|Withdrawal by Subject|1|||
27873140|NCT02130570|54490629|FG000|Overall Study|Death|3|||
27873141|NCT02130570|54490630|FG001|Overall Study|Death|5|||
27873142|NCT02130570|54490629|FG000|Overall Study|Withdrawal by Subject|6|||
27873143|NCT02130570|54490630|FG001|Overall Study|Withdrawal by Subject|3|||
27873144|NCT02130570|54490629|FG000|Overall Study|Part of practice that discontinued study|0|||
27873145|NCT02130570|54490630|FG001|Overall Study|Part of practice that discontinued study|5|||
27873146|NCT02149836|54490637|FG000|Overall Study|Withdrawal by Subject|1|||
27873147|NCT02130024|54490643|FG000|Overall Study|Adverse Event|10|||
27873148|NCT02130024|54490644|FG001|Overall Study|Adverse Event|11|||
27873149|NCT02130024|54490643|FG000|Overall Study|Death|2|||
27873150|NCT02130024|54490644|FG001|Overall Study|Death|2|||
27873151|NCT02130024|54490643|FG000|Overall Study|Lost to Follow-up|1|||
27873152|NCT02130024|54490644|FG001|Overall Study|Lost to Follow-up|1|||
27873153|NCT02130024|54490643|FG000|Overall Study|Physician Decision|1|||
27873154|NCT02130024|54490644|FG001|Overall Study|Physician Decision|3|||
27873155|NCT02130024|54490643|FG000|Overall Study|Protocol Deviation|4|||
27873156|NCT02130024|54490644|FG001|Overall Study|Protocol Deviation|0|||
27873157|NCT02130024|54490643|FG000|Overall Study|Site Administration Problems|1|||
27873158|NCT02130024|54490644|FG001|Overall Study|Site Administration Problems|0|||
27873159|NCT02130024|54490643|FG000|Overall Study|Subject Withdrew Consent|6|||
27873160|NCT02130024|54490644|FG001|Overall Study|Subject Withdrew Consent|14|||
27873161|NCT02105688|54490652|FG000|Part A: Double-Blind|Adverse Event|1|||
27873162|NCT02105688|54490653|FG001|Part A: Double-Blind|Adverse Event|0|||
27873163|NCT02105688|54490652|FG000|Part A: Double-Blind|Death|0|||
27873164|NCT02105688|54490653|FG001|Part A: Double-Blind|Death|1|||
27873165|NCT02105688|54490652|FG000|Part A: Double-Blind|Lost to Follow-up|15|||
27873166|NCT02105688|54490653|FG001|Part A: Double-Blind|Lost to Follow-up|11|||
27873167|NCT02105688|54490652|FG000|Part A: Double-Blind|Physician Decision|0|||
27873168|NCT02105688|54490653|FG001|Part A: Double-Blind|Physician Decision|1|||
27873169|NCT02105688|54490652|FG000|Part A: Double-Blind|Status Unknown|0|||
27873170|NCT02105688|54490653|FG001|Part A: Double-Blind|Status Unknown|2|||
27873171|NCT02105688|54490652|FG000|Part A: Double-Blind|Withdrawal by Subject|4|||
27873172|NCT02105688|54490653|FG001|Part A: Double-Blind|Withdrawal by Subject|2|||
27873173|NCT02105688|54490652|FG000|Part B: Observational Follow-up|Death|2|||
27873174|NCT02105688|54490653|FG001|Part B: Observational Follow-up|Death|1|||
27873175|NCT02105688|54490652|FG000|Part B: Observational Follow-up|Lost to Follow-up|23|||
27873176|NCT02105688|54490653|FG001|Part B: Observational Follow-up|Lost to Follow-up|15|||
27873177|NCT02105688|54490652|FG000|Part B: Observational Follow-up|Withdrawal by Subject|9|||
27873178|NCT02105688|54490653|FG001|Part B: Observational Follow-up|Withdrawal by Subject|3|||
27873179|NCT02105688|54490652|FG000|Part B: Observational Follow-up|Physician Decision|3|||
27873180|NCT02105688|54490653|FG001|Part B: Observational Follow-up|Physician Decision|1|||
27873181|NCT02105454|54490660|FG000|Overall Study|Withdrawal by Subject|1|||
27873182|NCT01625910|54490666|FG000|Overall Study|Lost to Follow-up|3|||
27873183|NCT01625910|54490667|FG001|Overall Study|Lost to Follow-up|4|||
27873184|NCT02104752|54490677|FG000|Overall Study|Withdrawal by Subject|1|||
27873185|NCT02104752|54490678|FG001|Overall Study|Withdrawal by Subject|0|||
27873186|NCT02104752|54490677|FG000|Overall Study|Weight gain; unrelated anxiety|0|||
27873187|NCT02104752|54490678|FG001|Overall Study|Weight gain; unrelated anxiety|2|||
27873188|NCT02102724|54490686|FG000|Overall Study|Lost to Follow-up|1|||
27873189|NCT02102724|54490687|FG001|Overall Study|Lost to Follow-up|0|||
27873190|NCT02102724|54490686|FG000|Overall Study|surgery for brain aneurysm|1|||
27873191|NCT02102724|54490687|FG001|Overall Study|surgery for brain aneurysm|1|||
27873192|NCT02102490|54490693|FG000|Overall Study|Death|6|||
27873193|NCT02102490|54490693|FG000|Overall Study|Lost to Follow-up|1|||
27873194|NCT02101554|54490700|FG000|Overall Study|Protocol Violation|0|||
27873195|NCT02101554|54490701|FG001|Overall Study|Protocol Violation|1|||
27873196|NCT02101554|54490702|FG002|Overall Study|Protocol Violation|0|||
27873197|NCT02101554|54490700|FG000|Overall Study|Insufficient Clinical Response|0|||
27873198|NCT02101554|54490701|FG001|Overall Study|Insufficient Clinical Response|2|||
27873199|NCT02101554|54490702|FG002|Overall Study|Insufficient Clinical Response|0|||
27873200|NCT02101554|54490700|FG000|Overall Study|Adverse Event|2|||
27873201|NCT02101554|54490701|FG001|Overall Study|Adverse Event|1|||
27873202|NCT02101554|54490702|FG002|Overall Study|Adverse Event|1|||
27873203|NCT02101554|54490700|FG000|Overall Study|Lost to Follow-up|0|||
27873204|NCT02101554|54490701|FG001|Overall Study|Lost to Follow-up|1|||
27873205|NCT02101554|54490702|FG002|Overall Study|Lost to Follow-up|0|||
27873206|NCT02101554|54490700|FG000|Overall Study|Withdrawl by Parents/Guardians|1|||
27873207|NCT02101554|54490701|FG001|Overall Study|Withdrawl by Parents/Guardians|0|||
27873208|NCT02101554|54490702|FG002|Overall Study|Withdrawl by Parents/Guardians|0|||
27873209|NCT02128932|54490713|FG000|Overall Study|Withdrawal by Subject|11|||
27873210|NCT02128932|54490714|FG001|Overall Study|Withdrawal by Subject|7|||
27873211|NCT02128932|54490715|FG002|Overall Study|Withdrawal by Subject|8|||
27873212|NCT02128932|54490713|FG000|Overall Study|Death|2|||
27873213|NCT02128932|54490714|FG001|Overall Study|Death|0|||
27873214|NCT02128932|54490715|FG002|Overall Study|Death|2|||
27873215|NCT02128932|54490713|FG000|Overall Study|Lost to Follow-up|2|||
27873216|NCT02128932|54490714|FG001|Overall Study|Lost to Follow-up|1|||
27873217|NCT02128932|54490715|FG002|Overall Study|Lost to Follow-up|1|||
27873218|NCT02128932|54490713|FG000|Overall Study|No reason for withdrawal|12|||
27873219|NCT02128932|54490714|FG001|Overall Study|No reason for withdrawal|11|||
27873220|NCT02128932|54490715|FG002|Overall Study|No reason for withdrawal|7|||
27873221|NCT02128542|54490725|FG000|Overall Study|Lost to Follow-up|3|||
27873222|NCT02128542|54490726|FG001|Overall Study|Lost to Follow-up|0|||
27873223|NCT02128542|54490725|FG000|Overall Study|Withdrew Consent|1|||
27873224|NCT02128542|54490726|FG001|Overall Study|Withdrew Consent|0|||
27873225|NCT02127372|54490736|FG000|Overall Study|Withdrawal by Subject|1|||
27873226|NCT02127372|54490737|FG001|Overall Study|Withdrawal by Subject|0|||
27873227|NCT02126826|54490751|FG000|Overall Study|Withdrawal by Subject|0|||
27873228|NCT02126826|54490752|FG001|Overall Study|Withdrawal by Subject|0|||
27873229|NCT02126826|54490753|FG002|Overall Study|Withdrawal by Subject|0|||
27873230|NCT02126826|54490754|FG003|Overall Study|Withdrawal by Subject|1|||
27873231|NCT02126826|54490755|FG004|Overall Study|Withdrawal by Subject|0|||
27873232|NCT02126826|54490756|FG005|Overall Study|Withdrawal by Subject|0|||
27873233|NCT02126826|54490757|FG006|Overall Study|Withdrawal by Subject|0|||
27873234|NCT02126670|54490782|FG000|Overall Study|Withdrawal by Subject|1|||
27873235|NCT02126670|54490783|FG001|Overall Study|Withdrawal by Subject|0|||
27873236|NCT02126670|54490784|FG002|Overall Study|Withdrawal by Subject|0|||
27873237|NCT02126670|54490785|FG003|Overall Study|Withdrawal by Subject|1|||
27873238|NCT02125734|54490797|FG000|Period 2|Adverse Event|0|||
27873239|NCT02125734|54490798|FG001|Period 2|Adverse Event|1|||
27873240|NCT02124798|54490804|FG000|Overall Study|Adverse Event|3|||
27873241|NCT02124798|54490804|FG000|Overall Study|Lost to Follow-up|1|||
27873242|NCT02146326|54490812|FG000|Overall Study|Lost to Follow-up|3|||
27873243|NCT02146326|54490813|FG001|Overall Study|Lost to Follow-up|3|||
27873244|NCT02146326|54490814|FG002|Overall Study|Lost to Follow-up|11|||
27873245|NCT02146326|54490815|FG003|Overall Study|Lost to Follow-up|19|||
27873246|NCT02146326|54490812|FG000|Overall Study|Withdrawal by Subject|2|||
27873247|NCT02146326|54490813|FG001|Overall Study|Withdrawal by Subject|1|||
27873248|NCT02146326|54490814|FG002|Overall Study|Withdrawal by Subject|15|||
27873249|NCT02146326|54490815|FG003|Overall Study|Withdrawal by Subject|11|||
27873250|NCT02146326|54490812|FG000|Overall Study|Separated from mental health center|23|||
27873251|NCT02146326|54490813|FG001|Overall Study|Separated from mental health center|33|||
27873252|NCT02146326|54490814|FG002|Overall Study|Separated from mental health center|0|||
27873253|NCT02146326|54490815|FG003|Overall Study|Separated from mental health center|0|||
27873254|NCT02146326|54490812|FG000|Overall Study|Incarcerated|0|||
27873255|NCT02146326|54490813|FG001|Overall Study|Incarcerated|0|||
27873256|NCT02146326|54490814|FG002|Overall Study|Incarcerated|3|||
27873257|NCT02146326|54490815|FG003|Overall Study|Incarcerated|8|||
27873258|NCT02146326|54490812|FG000|Overall Study|Death|0|||
27873259|NCT02146326|54490813|FG001|Overall Study|Death|0|||
27873260|NCT02146326|54490814|FG002|Overall Study|Death|4|||
27873261|NCT02146326|54490815|FG003|Overall Study|Death|4|||
27873262|NCT02146326|54490812|FG000|Overall Study|Unable to complete interview|0|||
27873263|NCT02146326|54490813|FG001|Overall Study|Unable to complete interview|0|||
27873264|NCT02146326|54490814|FG002|Overall Study|Unable to complete interview|10|||
27873265|NCT02146326|54490815|FG003|Overall Study|Unable to complete interview|6|||
27873266|NCT02146248|54490831|FG000|Overall Study|Withdrawal by Subject|2|||
27873267|NCT02145468|54490841|FG000|Overall Study|Withdrawal by Subject|5|||
27873268|NCT02145468|54490842|FG001|Overall Study|Withdrawal by Subject|8|||
27873269|NCT02124564|54490848|FG000|Treatment Period|Adverse Event|2|||
27873270|NCT02124564|54490848|FG000|Treatment Period|Lack of Efficacy|3|||
27873271|NCT02124564|54490848|FG000|Treatment Period|Withdrawal by Subject|2|||
27873272|NCT02145390|54490853|FG000|Overall Study|Withdrawal by Subject|1|||
28171580|NCT02796391|54843202|FG002|Overall Study|Participant did not like study cigarettes|3|||
28171581|NCT02796391|54843203|FG003|Overall Study|Participant did not like study cigarettes|0|||
27739074|NCT02495168|54188419|FG000|Overall Study|Physician Decision|1|||
27739075|NCT02495168|54188420|FG001|Overall Study|Physician Decision|1|||
27873273|NCT02100696|54490863|FG000|Induction Phase|Adverse Event|0|||
27873274|NCT02100696|54490864|FG001|Induction Phase|Adverse Event|0|||
27873275|NCT02100696|54490865|FG002|Induction Phase|Adverse Event|1|||
27873276|NCT02100696|54490866|FG003|Induction Phase|Adverse Event|0|||
27873277|NCT02100696|54490867|FG004|Induction Phase|Adverse Event|0|||
27873278|NCT02100696|54490868|FG005|Induction Phase|Adverse Event|0|||
27873279|NCT02100696|54490863|FG000|Induction Phase|Lost to Follow-up|1|||
27873280|NCT02100696|54490864|FG001|Induction Phase|Lost to Follow-up|0|||
27873281|NCT02100696|54490865|FG002|Induction Phase|Lost to Follow-up|1|||
27873282|NCT02100696|54490866|FG003|Induction Phase|Lost to Follow-up|0|||
27873283|NCT02100696|54490867|FG004|Induction Phase|Lost to Follow-up|0|||
27873284|NCT02100696|54490868|FG005|Induction Phase|Lost to Follow-up|0|||
27873285|NCT02100696|54490863|FG000|Induction Phase|Protocol Violation|0|||
27873286|NCT02100696|54490864|FG001|Induction Phase|Protocol Violation|1|||
27873287|NCT02100696|54490865|FG002|Induction Phase|Protocol Violation|1|||
27873288|NCT02100696|54490866|FG003|Induction Phase|Protocol Violation|0|||
27873289|NCT02100696|54490867|FG004|Induction Phase|Protocol Violation|0|||
27873290|NCT02100696|54490868|FG005|Induction Phase|Protocol Violation|0|||
27873291|NCT02100696|54490863|FG000|Induction Phase|Withdrawal by Subject|8|||
27873292|NCT02100696|54490864|FG001|Induction Phase|Withdrawal by Subject|2|||
27873293|NCT02100696|54490865|FG002|Induction Phase|Withdrawal by Subject|13|||
27873294|NCT02100696|54490866|FG003|Induction Phase|Withdrawal by Subject|0|||
27873295|NCT02100696|54490867|FG004|Induction Phase|Withdrawal by Subject|0|||
27873296|NCT02100696|54490868|FG005|Induction Phase|Withdrawal by Subject|0|||
27873297|NCT02100696|54490863|FG000|Induction Phase|Physician Decision|1|||
27873298|NCT02100696|54490864|FG001|Induction Phase|Physician Decision|0|||
27873299|NCT02100696|54490865|FG002|Induction Phase|Physician Decision|2|||
27873300|NCT02100696|54490866|FG003|Induction Phase|Physician Decision|0|||
27873301|NCT02100696|54490867|FG004|Induction Phase|Physician Decision|0|||
27873302|NCT02100696|54490868|FG005|Induction Phase|Physician Decision|0|||
27873303|NCT02100696|54490863|FG000|Induction Phase|Multiple Reasons|5|||
27873304|NCT02100696|54490864|FG001|Induction Phase|Multiple Reasons|2|||
27873305|NCT02100696|54490865|FG002|Induction Phase|Multiple Reasons|8|||
27873306|NCT02100696|54490866|FG003|Induction Phase|Multiple Reasons|0|||
27873307|NCT02100696|54490867|FG004|Induction Phase|Multiple Reasons|0|||
27873308|NCT02100696|54490868|FG005|Induction Phase|Multiple Reasons|0|||
27873309|NCT02100696|54490863|FG000|Maintenance Phase|Adverse Event|0|||
27873310|NCT02100696|54490864|FG001|Maintenance Phase|Adverse Event|0|||
27873311|NCT02100696|54490865|FG002|Maintenance Phase|Adverse Event|0|||
27873312|NCT02100696|54490866|FG003|Maintenance Phase|Adverse Event|0|||
27873313|NCT02100696|54490867|FG004|Maintenance Phase|Adverse Event|0|||
27873314|NCT02100696|54490868|FG005|Maintenance Phase|Adverse Event|2|||
27873315|NCT02100696|54490863|FG000|Maintenance Phase|Lost to Follow-up|0|||
27873316|NCT02100696|54490864|FG001|Maintenance Phase|Lost to Follow-up|0|||
27873317|NCT02100696|54490865|FG002|Maintenance Phase|Lost to Follow-up|0|||
27873318|NCT02100696|54490866|FG003|Maintenance Phase|Lost to Follow-up|0|||
27873319|NCT02100696|54490867|FG004|Maintenance Phase|Lost to Follow-up|1|||
27873320|NCT02100696|54490868|FG005|Maintenance Phase|Lost to Follow-up|0|||
27873321|NCT02100696|54490863|FG000|Maintenance Phase|Protocol Violation|0|||
27873322|NCT02100696|54490864|FG001|Maintenance Phase|Protocol Violation|0|||
27873323|NCT02100696|54490865|FG002|Maintenance Phase|Protocol Violation|0|||
27873324|NCT02100696|54490866|FG003|Maintenance Phase|Protocol Violation|0|||
27873325|NCT02100696|54490867|FG004|Maintenance Phase|Protocol Violation|1|||
27873326|NCT02100696|54490868|FG005|Maintenance Phase|Protocol Violation|0|||
27873327|NCT02100696|54490863|FG000|Maintenance Phase|Withdrawal by Subject|0|||
27873328|NCT02100696|54490864|FG001|Maintenance Phase|Withdrawal by Subject|0|||
27873329|NCT02100696|54490865|FG002|Maintenance Phase|Withdrawal by Subject|0|||
27873330|NCT02100696|54490866|FG003|Maintenance Phase|Withdrawal by Subject|1|||
27873331|NCT02100696|54490867|FG004|Maintenance Phase|Withdrawal by Subject|4|||
27873332|NCT02100696|54490868|FG005|Maintenance Phase|Withdrawal by Subject|2|||
27873333|NCT02100696|54490863|FG000|Maintenance Phase|Physician Decision|0|||
27873334|NCT02100696|54490864|FG001|Maintenance Phase|Physician Decision|0|||
27873335|NCT02100696|54490865|FG002|Maintenance Phase|Physician Decision|0|||
27873336|NCT02100696|54490866|FG003|Maintenance Phase|Physician Decision|0|||
27873337|NCT02100696|54490867|FG004|Maintenance Phase|Physician Decision|1|||
27873338|NCT02100696|54490868|FG005|Maintenance Phase|Physician Decision|0|||
27873339|NCT02100696|54490863|FG000|Maintenance Phase|Multiple Reasons|0|||
27873340|NCT02100696|54490864|FG001|Maintenance Phase|Multiple Reasons|0|||
27873341|NCT02100696|54490865|FG002|Maintenance Phase|Multiple Reasons|0|||
27873342|NCT02100696|54490866|FG003|Maintenance Phase|Multiple Reasons|0|||
27873343|NCT02100696|54490867|FG004|Maintenance Phase|Multiple Reasons|2|||
27873344|NCT02100696|54490868|FG005|Maintenance Phase|Multiple Reasons|1|||
27873345|NCT02145156|54490892|FG000|Overall Study|No match to vaccination records|60|||
27873346|NCT02145156|54490893|FG001|Overall Study|No match to vaccination records|52|||
27873347|NCT02145156|54490894|FG002|Overall Study|No match to vaccination records|41|||
27873348|NCT02123472|54490902|FG000|Period 2 (7 Days)|Withdrawal by Subject|0|||
27873349|NCT02123472|54490903|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
27873350|NCT02145078|54490909|FG000|Overall Study|Death|1|||
27873351|NCT02145078|54490909|FG000|Overall Study|Reason not given|3|||
27873352|NCT02144610|54490915|FG000|Overall Study|Physician Decision|1|||
27873353|NCT02144610|54490916|FG001|Overall Study|Physician Decision|0|||
27873354|NCT02144610|54490915|FG000|Overall Study|Withdrawal by Subject|1|||
27873355|NCT02144610|54490916|FG001|Overall Study|Withdrawal by Subject|5|||
27873356|NCT02144610|54490915|FG000|Overall Study|Death|2|||
27873357|NCT02144610|54490916|FG001|Overall Study|Death|2|||
27873358|NCT02144610|54490915|FG000|Overall Study|Study Discontinuation by Sponsor|19|||
27873359|NCT02144610|54490916|FG001|Overall Study|Study Discontinuation by Sponsor|14|||
27873360|NCT02144610|54490915|FG000|Overall Study|Other|0|||
27873361|NCT02144610|54490916|FG001|Overall Study|Other|1|||
27873362|NCT02100228|54490924|FG000|Overall Study|Other|19|||
27873363|NCT02100228|54490925|FG001|Overall Study|Other|19|||
27873364|NCT02100228|54490924|FG000|Overall Study|Administrative reason|0|||
27873365|NCT02100228|54490925|FG001|Overall Study|Administrative reason|1|||
27873366|NCT02100228|54490924|FG000|Overall Study|Inclusion/Exclusion criteria not met|12|||
27982676|NCT02017717|54640941|FG002|Before Treatment Period|Lost to Follow-up|0|||
27982677|NCT02017717|54640942|FG003|Before Treatment Period|Lost to Follow-up|0|||
27982678|NCT02017717|54640943|FG004|Before Treatment Period|Lost to Follow-up|1|||
27982679|NCT02017717|54640944|FG005|Before Treatment Period|Lost to Follow-up|0|||
27982680|NCT02017717|54640945|FG006|Before Treatment Period|Lost to Follow-up|0|||
27982681|NCT02017717|54640946|FG007|Before Treatment Period|Lost to Follow-up|0|||
27873367|NCT02100228|54490925|FG001|Overall Study|Inclusion/Exclusion criteria not met|16|||
27982682|NCT02017717|54640947|FG008|Before Treatment Period|Lost to Follow-up|0|||
27982683|NCT02017717|54640939|FG000|Before Treatment Period|Participant no longer met criteria|0|||
27982684|NCT02017717|54640940|FG001|Before Treatment Period|Participant no longer met criteria|0|||
27982685|NCT02017717|54640941|FG002|Before Treatment Period|Participant no longer met criteria|0|||
27982686|NCT02017717|54640942|FG003|Before Treatment Period|Participant no longer met criteria|1|||
27982687|NCT02017717|54640943|FG004|Before Treatment Period|Participant no longer met criteria|2|||
27982688|NCT02017717|54640944|FG005|Before Treatment Period|Participant no longer met criteria|0|||
27982689|NCT02017717|54640945|FG006|Before Treatment Period|Participant no longer met criteria|0|||
27982690|NCT02017717|54640946|FG007|Before Treatment Period|Participant no longer met criteria|1|||
27982691|NCT02017717|54640947|FG008|Before Treatment Period|Participant no longer met criteria|0|||
27982692|NCT02017717|54640939|FG000|Before Treatment Period|other reason|0|||
27982693|NCT02017717|54640940|FG001|Before Treatment Period|other reason|0|||
27982694|NCT02017717|54640941|FG002|Before Treatment Period|other reason|0|||
27982695|NCT02017717|54640942|FG003|Before Treatment Period|other reason|0|||
27982696|NCT02017717|54640943|FG004|Before Treatment Period|other reason|1|||
27982697|NCT02017717|54640944|FG005|Before Treatment Period|other reason|0|||
27982698|NCT02017717|54640945|FG006|Before Treatment Period|other reason|0|||
27982699|NCT02017717|54640946|FG007|Before Treatment Period|other reason|0|||
27982700|NCT02017717|54640947|FG008|Before Treatment Period|other reason|0|||
27982701|NCT02017717|54640939|FG000|Treatment Period|Disease progression|7|||
27982702|NCT02017717|54640940|FG001|Treatment Period|Disease progression|9|||
27982703|NCT02017717|54640941|FG002|Treatment Period|Disease progression|12|||
27982704|NCT02017717|54640942|FG003|Treatment Period|Disease progression|165|||
27982705|NCT02017717|54640943|FG004|Treatment Period|Disease progression|134|||
27982706|NCT02017717|54640944|FG005|Treatment Period|Disease progression|20|||
27982707|NCT02017717|54640945|FG006|Treatment Period|Disease progression|26|||
27982708|NCT02017717|54640946|FG007|Treatment Period|Disease progression|17|||
27982709|NCT02017717|54640947|FG008|Treatment Period|Disease progression|22|||
27982710|NCT02017717|54640939|FG000|Treatment Period|Study drug toxicity|3|||
27982711|NCT02017717|54640940|FG001|Treatment Period|Study drug toxicity|0|||
27982712|NCT02017717|54640941|FG002|Treatment Period|Study drug toxicity|1|||
27982713|NCT02017717|54640942|FG003|Treatment Period|Study drug toxicity|7|||
27982714|NCT02017717|54640943|FG004|Treatment Period|Study drug toxicity|11|||
27982715|NCT02017717|54640944|FG005|Treatment Period|Study drug toxicity|4|||
27982716|NCT02017717|54640945|FG006|Treatment Period|Study drug toxicity|4|||
27982717|NCT02017717|54640946|FG007|Treatment Period|Study drug toxicity|5|||
27982718|NCT02017717|54640947|FG008|Treatment Period|Study drug toxicity|3|||
27982719|NCT02017717|54640939|FG000|Treatment Period|Death|0|||
27982720|NCT02017717|54640940|FG001|Treatment Period|Death|0|||
27982721|NCT02017717|54640941|FG002|Treatment Period|Death|1|||
27982722|NCT02017717|54640942|FG003|Treatment Period|Death|0|||
27982723|NCT02017717|54640943|FG004|Treatment Period|Death|0|||
27982724|NCT02017717|54640944|FG005|Treatment Period|Death|0|||
27982725|NCT02017717|54640945|FG006|Treatment Period|Death|0|||
27982726|NCT02017717|54640946|FG007|Treatment Period|Death|1|||
27982727|NCT02017717|54640947|FG008|Treatment Period|Death|0|||
27982728|NCT02017717|54640939|FG000|Treatment Period|Adverse event unrelated to study drug|0|||
27982729|NCT02017717|54640940|FG001|Treatment Period|Adverse event unrelated to study drug|0|||
27982730|NCT02017717|54640941|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
27982731|NCT02017717|54640942|FG003|Treatment Period|Adverse event unrelated to study drug|4|||
27982732|NCT02017717|54640943|FG004|Treatment Period|Adverse event unrelated to study drug|5|||
27982733|NCT02017717|54640944|FG005|Treatment Period|Adverse event unrelated to study drug|0|||
27982734|NCT02017717|54640945|FG006|Treatment Period|Adverse event unrelated to study drug|0|||
27982735|NCT02017717|54640946|FG007|Treatment Period|Adverse event unrelated to study drug|0|||
27982736|NCT02017717|54640947|FG008|Treatment Period|Adverse event unrelated to study drug|1|||
27982737|NCT02017717|54640939|FG000|Treatment Period|Participant request to stop therapy|0|||
27982738|NCT02017717|54640940|FG001|Treatment Period|Participant request to stop therapy|0|||
27739076|NCT02495168|54188421|FG002|Overall Study|Physician Decision|0|||
27873368|NCT02100228|54490924|FG000|Overall Study|Non-compliance|0|||
27873369|NCT02100228|54490925|FG001|Overall Study|Non-compliance|3|||
27873370|NCT02100228|54490924|FG000|Overall Study|Lost to Follow-up|0|||
27873371|NCT02100228|54490925|FG001|Overall Study|Lost to Follow-up|1|||
27873372|NCT02100228|54490924|FG000|Overall Study|Withdrawal by Subject|27|||
27873373|NCT02100228|54490925|FG001|Overall Study|Withdrawal by Subject|37|||
27873374|NCT02100228|54490924|FG000|Overall Study|Adverse Event|16|||
27873375|NCT02100228|54490925|FG001|Overall Study|Adverse Event|12|||
27873376|NCT02100228|54490924|FG000|Overall Study|Death|1|||
27873377|NCT02100228|54490925|FG001|Overall Study|Death|1|||
27873378|NCT02099838|54490933|FG000|Overall Study|Death|1|||
27873379|NCT02099838|54490934|FG001|Overall Study|Death|0|||
27873380|NCT02099838|54490933|FG000|Overall Study|Lost to Follow-up|3|||
27873381|NCT02099838|54490934|FG001|Overall Study|Lost to Follow-up|1|||
27873382|NCT02099838|54490933|FG000|Overall Study|Withdrawal by Subject|0|||
27873383|NCT02099838|54490934|FG001|Overall Study|Withdrawal by Subject|1|||
27873384|NCT02144220|54490940|FG000|Overall Study|technology incompatibility|9|||
27873385|NCT02144220|54490940|FG000|Overall Study|Lack of Efficacy|4|||
27873386|NCT02144220|54490940|FG000|Overall Study|Physician Decision|3|||
27873387|NCT02144220|54490940|FG000|Overall Study|Withdrawal by Subject|2|||
27873388|NCT02144220|54490940|FG000|Overall Study|Protocol Violation|1|||
27873389|NCT02099682|54490944|FG000|Overall Study|Data Not Available|51|||
27873390|NCT02099682|54490944|FG000|Overall Study|Lost to Follow-up|31|||
27873391|NCT02099682|54490944|FG000|Overall Study|Other|29|||
27873392|NCT02142894|54490948|FG000|Overall Study|Protocol Violation|8|||
27873393|NCT02098746|54490952|FG000|Overall Study|Changes of Investigator|2|||
27873394|NCT02098746|54490952|FG000|Overall Study|Other Miscellaneous Reasons|1|||
27873395|NCT02098746|54490952|FG000|Overall Study|Enrolled 15 Days After the First Dose|1|||
27873396|NCT02098746|54490952|FG000|Overall Study|Data Not Available After Treatment|1|||
27873397|NCT02122770|54490960|FG000|Part A: Drug-drug Interaction 2|Adverse Event|3|||
27873398|NCT02122770|54490961|FG001|Part A: Drug-drug Interaction 2|Adverse Event|0|||
27873399|NCT02122770|54490962|FG002|Part A: Drug-drug Interaction 2|Adverse Event|1|||
27873400|NCT02122770|54490963|FG003|Part A: Drug-drug Interaction 2|Adverse Event|2|||
27873401|NCT02122770|54490964|FG004|Part A: Drug-drug Interaction 2|Adverse Event|0|||
27873402|NCT02122770|54490965|FG005|Part A: Drug-drug Interaction 2|Adverse Event|0|||
27873403|NCT02122770|54490960|FG000|Part A: Drug-drug Interaction 2|Other|0|||
27873404|NCT02122770|54490961|FG001|Part A: Drug-drug Interaction 2|Other|0|||
27873405|NCT02122770|54490962|FG002|Part A: Drug-drug Interaction 2|Other|1|||
27873406|NCT02122770|54490963|FG003|Part A: Drug-drug Interaction 2|Other|0|||
27873407|NCT02122770|54490964|FG004|Part A: Drug-drug Interaction 2|Other|0|||
27873408|NCT02122770|54490965|FG005|Part A: Drug-drug Interaction 2|Other|0|||
27873409|NCT02122770|54490960|FG000|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
27873410|NCT02122770|54490961|FG001|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1|||
27873411|NCT02122770|54490962|FG002|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
27873412|NCT02122770|54490963|FG003|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
27873413|NCT02122770|54490964|FG004|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
27873414|NCT02122770|54490965|FG005|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
27873415|NCT02122770|54490960|FG000|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
27873416|NCT02122770|54490961|FG001|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5|||
27873417|NCT02122770|54490962|FG002|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
27873418|NCT02122770|54490963|FG003|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
27873419|NCT02122770|54490964|FG004|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
27873420|NCT02122770|54490965|FG005|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
27873421|NCT02122770|54490960|FG000|Part B: Standard of Care|Adverse Event|0|||
27873422|NCT02122770|54490961|FG001|Part B: Standard of Care|Adverse Event|0|||
27873423|NCT02122770|54490962|FG002|Part B: Standard of Care|Adverse Event|0|||
27873424|NCT02122770|54490963|FG003|Part B: Standard of Care|Adverse Event|0|||
27873425|NCT02122770|54490964|FG004|Part B: Standard of Care|Adverse Event|4|||
27873426|NCT02122770|54490965|FG005|Part B: Standard of Care|Adverse Event|1|||
27873427|NCT02122770|54490960|FG000|Part B: Standard of Care|Other|0|||
27873428|NCT02122770|54490961|FG001|Part B: Standard of Care|Other|0|||
27873429|NCT02122770|54490962|FG002|Part B: Standard of Care|Other|0|||
27873430|NCT02122770|54490963|FG003|Part B: Standard of Care|Other|0|||
27873431|NCT02122770|54490964|FG004|Part B: Standard of Care|Other|0|||
27873432|NCT02122770|54490965|FG005|Part B: Standard of Care|Other|2|||
27873433|NCT02122770|54490960|FG000|Part B: Standard of Care|Withdrawal by Subject|0|||
27873434|NCT02122770|54490961|FG001|Part B: Standard of Care|Withdrawal by Subject|0|||
27873435|NCT02122770|54490962|FG002|Part B: Standard of Care|Withdrawal by Subject|0|||
27873436|NCT02122770|54490963|FG003|Part B: Standard of Care|Withdrawal by Subject|0|||
27873437|NCT02122770|54490964|FG004|Part B: Standard of Care|Withdrawal by Subject|4|||
27873438|NCT02122770|54490965|FG005|Part B: Standard of Care|Withdrawal by Subject|2|||
27873439|NCT02122770|54490960|FG000|Part B: Standard of Care|Symptomatic Deterioration|0|||
27873440|NCT02122770|54490961|FG001|Part B: Standard of Care|Symptomatic Deterioration|0|||
27873441|NCT02122770|54490962|FG002|Part B: Standard of Care|Symptomatic Deterioration|0|||
27873442|NCT02122770|54490963|FG003|Part B: Standard of Care|Symptomatic Deterioration|0|||
27873443|NCT02122770|54490964|FG004|Part B: Standard of Care|Symptomatic Deterioration|5|||
27873444|NCT02122770|54490965|FG005|Part B: Standard of Care|Symptomatic Deterioration|0|||
27873445|NCT02122770|54490960|FG000|Part B: Standard of Care|Progressive Disease|0|||
27873446|NCT02122770|54490961|FG001|Part B: Standard of Care|Progressive Disease|0|||
27873447|NCT02122770|54490962|FG002|Part B: Standard of Care|Progressive Disease|0|||
27873448|NCT02122770|54490963|FG003|Part B: Standard of Care|Progressive Disease|0|||
27873449|NCT02122770|54490964|FG004|Part B: Standard of Care|Progressive Disease|10|||
27873450|NCT02122770|54490965|FG005|Part B: Standard of Care|Progressive Disease|8|||
27873451|NCT02122380|54490990|FG000|First Intervention (30 Days)|Adverse Event|1|||
27873452|NCT02122380|54490991|FG001|First Intervention (30 Days)|Adverse Event|0|||
27873453|NCT02122380|54490990|FG000|First Intervention (30 Days)|Physician Decision|0|||
27873454|NCT02122380|54490991|FG001|First Intervention (30 Days)|Physician Decision|1|||
27873455|NCT02122380|54490990|FG000|Washout (8 Weeks)|Lost to Follow-up|1|||
27873456|NCT02122380|54490991|FG001|Washout (8 Weeks)|Lost to Follow-up|0|||
27873457|NCT02122380|54490990|FG000|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0|||
27873458|NCT02122380|54490991|FG001|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2|||
27873459|NCT02122380|54490990|FG000|Second Intervention (30 Days)|2 did not complete all of inpatient day|0|||
27873460|NCT02122380|54490991|FG001|Second Intervention (30 Days)|2 did not complete all of inpatient day|2|||
27873461|NCT02122146|54491006|FG000|Part 1: Dose Escalation|Death|0|||
27873462|NCT02122146|54491007|FG001|Part 1: Dose Escalation|Death|1|||
27873463|NCT02122146|54491008|FG002|Part 1: Dose Escalation|Death|1|||
27873464|NCT02122146|54491009|FG003|Part 1: Dose Escalation|Death|0|||
27873465|NCT02122146|54491010|FG004|Part 1: Dose Escalation|Death|0|||
27873466|NCT02122146|54491011|FG005|Part 1: Dose Escalation|Death|0|||
27873467|NCT02122146|54491012|FG006|Part 1: Dose Escalation|Death|0|||
27873468|NCT02122146|54491013|FG007|Part 1: Dose Escalation|Death|0|||
27873469|NCT02122146|54491006|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
27873470|NCT02122146|54491007|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
27873471|NCT02122146|54491008|FG002|Part 1: Dose Escalation|Lost to Follow-up|1|||
27873472|NCT02122146|54491009|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
27873473|NCT02122146|54491010|FG004|Part 1: Dose Escalation|Lost to Follow-up|1|||
27873474|NCT02122146|54491011|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
27873475|NCT02122146|54491012|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
27873476|NCT02122146|54491013|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
27873477|NCT02122146|54491006|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
27873478|NCT02122146|54491007|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
27873479|NCT02122146|54491008|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
27873480|NCT02122146|54491009|FG003|Part 1: Dose Escalation|Withdrawal by Subject|1|||
27873481|NCT02122146|54491010|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
27873482|NCT02122146|54491011|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
27873483|NCT02122146|54491012|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
27873484|NCT02122146|54491013|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
27873485|NCT02122146|54491006|FG000|Part 1: Dose Escalation|Other|1|||
27873486|NCT02122146|54491007|FG001|Part 1: Dose Escalation|Other|0|||
27873487|NCT02122146|54491008|FG002|Part 1: Dose Escalation|Other|0|||
27873488|NCT02122146|54491009|FG003|Part 1: Dose Escalation|Other|0|||
27873489|NCT02122146|54491010|FG004|Part 1: Dose Escalation|Other|0|||
27873490|NCT02122146|54491011|FG005|Part 1: Dose Escalation|Other|1|||
27873491|NCT02122146|54491012|FG006|Part 1: Dose Escalation|Other|1|||
27873492|NCT02122146|54491013|FG007|Part 1: Dose Escalation|Other|2|||
27873493|NCT02121834|54491039|FG000|Overall Study|Protocol Violation|0|||
27873494|NCT02121834|54491040|FG001|Overall Study|Protocol Violation|1|||
27873495|NCT02121834|54491041|FG002|Overall Study|Protocol Violation|0|||
27873496|NCT02121834|54491042|FG003|Overall Study|Protocol Violation|0|||
27873497|NCT02121834|54491043|FG004|Overall Study|Protocol Violation|0|||
27873498|NCT02121834|54491044|FG005|Overall Study|Protocol Violation|0|||
27873499|NCT02121834|54491045|FG006|Overall Study|Protocol Violation|0|||
27873500|NCT02121834|54491039|FG000|Overall Study|Withdrawal by Subject|0|||
27873501|NCT02121834|54491040|FG001|Overall Study|Withdrawal by Subject|1|||
27873502|NCT02121834|54491041|FG002|Overall Study|Withdrawal by Subject|1|||
27873503|NCT02121834|54491042|FG003|Overall Study|Withdrawal by Subject|0|||
27873504|NCT02121834|54491043|FG004|Overall Study|Withdrawal by Subject|0|||
27873505|NCT02121834|54491044|FG005|Overall Study|Withdrawal by Subject|0|||
27873506|NCT02121834|54491045|FG006|Overall Study|Withdrawal by Subject|0|||
27873507|NCT02121834|54491039|FG000|Overall Study|Lost to Follow-up|0|||
27873508|NCT02121834|54491040|FG001|Overall Study|Lost to Follow-up|0|||
27873509|NCT02121834|54491041|FG002|Overall Study|Lost to Follow-up|1|||
27873510|NCT02121834|54491042|FG003|Overall Study|Lost to Follow-up|0|||
27982739|NCT02017717|54640941|FG002|Treatment Period|Participant request to stop therapy|3|||
27873511|NCT02121834|54491043|FG004|Overall Study|Lost to Follow-up|0|||
27873512|NCT02121834|54491044|FG005|Overall Study|Lost to Follow-up|0|||
27873513|NCT02121834|54491045|FG006|Overall Study|Lost to Follow-up|0|||
27873514|NCT02121756|54491073|FG000|Overall Study|Adverse Event|3|||
27873515|NCT02121756|54491074|FG001|Overall Study|Adverse Event|0|||
27873516|NCT02121756|54491073|FG000|Overall Study|Protocol Violation|1|||
27873517|NCT02121756|54491074|FG001|Overall Study|Protocol Violation|1|||
27873518|NCT02121756|54491073|FG000|Overall Study|Physician Decision|2|||
27873519|NCT02121756|54491074|FG001|Overall Study|Physician Decision|1|||
27873520|NCT02142504|54491086|FG000|Overall Study|Protocol Violation|2|||
27873521|NCT02142504|54491087|FG001|Overall Study|Protocol Violation|1|||
27873522|NCT02142504|54491088|FG002|Overall Study|Protocol Violation|2|||
27873523|NCT02142504|54491086|FG000|Overall Study|Adverse Event|2|||
27873524|NCT02142504|54491087|FG001|Overall Study|Adverse Event|3|||
27873525|NCT02142504|54491088|FG002|Overall Study|Adverse Event|4|||
27873526|NCT02142504|54491086|FG000|Overall Study|Lost to Follow-up|12|||
27873527|NCT02142504|54491087|FG001|Overall Study|Lost to Follow-up|19|||
27873528|NCT02142504|54491088|FG002|Overall Study|Lost to Follow-up|17|||
27873529|NCT02142504|54491086|FG000|Overall Study|Withdrawal by Subject|7|||
27873530|NCT02142504|54491087|FG001|Overall Study|Withdrawal by Subject|9|||
27873531|NCT02142504|54491088|FG002|Overall Study|Withdrawal by Subject|11|||
27873532|NCT02142504|54491086|FG000|Overall Study|Pregnancy|4|||
27873533|NCT02142504|54491087|FG001|Overall Study|Pregnancy|4|||
27873534|NCT02142504|54491088|FG002|Overall Study|Pregnancy|2|||
27873535|NCT02142504|54491086|FG000|Overall Study|Physician Decision|0|||
27873536|NCT02142504|54491087|FG001|Overall Study|Physician Decision|1|||
27873537|NCT02142504|54491088|FG002|Overall Study|Physician Decision|3|||
27873538|NCT02142504|54491086|FG000|Overall Study|Reason Not Specified|4|||
27873539|NCT02142504|54491087|FG001|Overall Study|Reason Not Specified|5|||
27873540|NCT02142504|54491088|FG002|Overall Study|Reason Not Specified|4|||
27873541|NCT02121522|54491096|FG000|Overall Study|Adverse Event|1|||
27873542|NCT02121210|54491102|FG000|Overall Study|Adverse Event|5|||
27873543|NCT02121210|54491103|FG001|Overall Study|Adverse Event|7|||
27873544|NCT02121210|54491102|FG000|Overall Study|Lack of Efficacy|2|||
27873545|NCT02121210|54491103|FG001|Overall Study|Lack of Efficacy|0|||
27873546|NCT02121210|54491102|FG000|Overall Study|Other than specified above|0|||
27873547|NCT02121210|54491103|FG001|Overall Study|Other than specified above|2|||
27873548|NCT02141490|54491112|FG000|Overall Study|Screening failures|4|||
27873549|NCT02141490|54491113|FG001|Overall Study|Screening failures|0|||
27873550|NCT02141490|54491114|FG002|Overall Study|Screening failures|0|||
27873551|NCT02097108|54491124|FG000|Overall Study|Adverse Event|1|||
27873552|NCT02097108|54491124|FG000|Overall Study|patient was abroad for 6 months|1|||
27873553|NCT02097030|54491130|FG000|First Intervention (3 Days)|Lost to Follow-up|1|||
27873554|NCT02097030|54491131|FG001|First Intervention (3 Days)|Lost to Follow-up|0|||
27873555|NCT02097030|54491130|FG000|First Intervention (3 Days)|Visual Acuity|0|||
27873556|NCT02097030|54491131|FG001|First Intervention (3 Days)|Visual Acuity|1|||
27873557|NCT02096952|54491141|FG000|Overall Study|Adverse Event|1|||
27873558|NCT02120898|54491148|FG000|Overall Study|Withdrawal by Subject|4|||
27873559|NCT02120898|54491149|FG001|Overall Study|Withdrawal by Subject|2|||
27873560|NCT02120898|54491150|FG002|Overall Study|Withdrawal by Subject|2|||
27873561|NCT02120898|54491148|FG000|Overall Study|Non-compliance with study drug|3|||
27873562|NCT02120898|54491149|FG001|Overall Study|Non-compliance with study drug|0|||
27873563|NCT02120898|54491150|FG002|Overall Study|Non-compliance with study drug|0|||
27873564|NCT02120898|54491148|FG000|Overall Study|Adverse Event|1|||
27873565|NCT02120898|54491149|FG001|Overall Study|Adverse Event|2|||
27873566|NCT02120898|54491150|FG002|Overall Study|Adverse Event|1|||
27873567|NCT02120898|54491148|FG000|Overall Study|Protocol Violation|1|||
27873568|NCT02120898|54491149|FG001|Overall Study|Protocol Violation|2|||
27873569|NCT02120898|54491150|FG002|Overall Study|Protocol Violation|0|||
27873570|NCT02120898|54491148|FG000|Overall Study|Lost to Follow-up|0|||
27873571|NCT02120898|54491149|FG001|Overall Study|Lost to Follow-up|0|||
27873572|NCT02120898|54491150|FG002|Overall Study|Lost to Follow-up|1|||
27873573|NCT02120664|54491163|FG000|Overall Study|Withdrawal by Subject|0|||
27873574|NCT02120664|54491164|FG001|Overall Study|Withdrawal by Subject|0|||
27873575|NCT02120664|54491165|FG002|Overall Study|Withdrawal by Subject|0|||
27873576|NCT02120664|54491166|FG003|Overall Study|Withdrawal by Subject|1|||
27873577|NCT02120664|54491167|FG004|Overall Study|Withdrawal by Subject|0|||
27873578|NCT01627860|54491182|FG000|Overall Study|Adverse Event|9|||
27873579|NCT01627860|54491183|FG001|Overall Study|Adverse Event|4|||
27873580|NCT01627860|54491182|FG000|Overall Study|Withdrawal by Subject|2|||
27873581|NCT01627860|54491183|FG001|Overall Study|Withdrawal by Subject|1|||
27873582|NCT01627860|54491182|FG000|Overall Study|Seizure frequency doubled|0|||
27873583|NCT01627860|54491183|FG001|Overall Study|Seizure frequency doubled|1|||
27873584|NCT01627860|54491182|FG000|Overall Study|Protocol Violation|1|||
27873585|NCT01627860|54491183|FG001|Overall Study|Protocol Violation|0|||
27873586|NCT01627782|54491193|FG000|Overall Study|Adverse Event|1|||
27873587|NCT01627782|54491194|FG001|Overall Study|Adverse Event|2|||
27873588|NCT01627782|54491195|FG002|Overall Study|Adverse Event|0|||
27873589|NCT01627782|54491196|FG003|Overall Study|Adverse Event|1|||
27873590|NCT01627782|54491193|FG000|Overall Study|Lack of Efficacy|11|||
27873591|NCT01627782|54491194|FG001|Overall Study|Lack of Efficacy|1|||
27873592|NCT01627782|54491195|FG002|Overall Study|Lack of Efficacy|15|||
27873593|NCT01627782|54491196|FG003|Overall Study|Lack of Efficacy|2|||
27873594|NCT01627782|54491193|FG000|Overall Study|Protocol Violation|1|||
27873595|NCT01627782|54491194|FG001|Overall Study|Protocol Violation|0|||
27873596|NCT01627782|54491195|FG002|Overall Study|Protocol Violation|0|||
27873597|NCT01627782|54491196|FG003|Overall Study|Protocol Violation|0|||
27873598|NCT01627782|54491193|FG000|Overall Study|Withdrawal by Subject|2|||
27873599|NCT01627782|54491194|FG001|Overall Study|Withdrawal by Subject|1|||
27873600|NCT01627782|54491195|FG002|Overall Study|Withdrawal by Subject|0|||
27873601|NCT01627782|54491196|FG003|Overall Study|Withdrawal by Subject|0|||
27873602|NCT01627782|54491193|FG000|Overall Study|Other|0|||
27873603|NCT01627782|54491194|FG001|Overall Study|Other|2|||
27873604|NCT01627782|54491195|FG002|Overall Study|Other|0|||
27873605|NCT01627782|54491196|FG003|Overall Study|Other|3|||
27873606|NCT01627782|54491193|FG000|Overall Study|Randomized But Not Treated|1|||
27873607|NCT01627782|54491194|FG001|Overall Study|Randomized But Not Treated|0|||
27873608|NCT01627782|54491195|FG002|Overall Study|Randomized But Not Treated|0|||
27873609|NCT01627782|54491196|FG003|Overall Study|Randomized But Not Treated|0|||
27873610|NCT01598532|54491208|FG000|Overall Study|Lost to Follow-up|3|||
27873611|NCT01598532|54491208|FG000|Overall Study|Did not meet inclusion criteria|8|||
27873612|NCT02119650|54491217|FG000|Overall Study|Adverse Event|3|||
27873613|NCT02119650|54491218|FG001|Overall Study|Adverse Event|4|||
27873614|NCT02119650|54491217|FG000|Overall Study|Subject decision|2|||
27873615|NCT02119650|54491218|FG001|Overall Study|Subject decision|3|||
27873616|NCT02119650|54491217|FG000|Overall Study|Disease progression|11|||
27873617|NCT02119650|54491218|FG001|Overall Study|Disease progression|14|||
27873618|NCT02119650|54491217|FG000|Overall Study|Death|5|||
27873619|NCT02119650|54491218|FG001|Overall Study|Death|1|||
27873620|NCT02119650|54491217|FG000|Overall Study|Noncompliance with study treatment|1|||
27873621|NCT02119650|54491218|FG001|Overall Study|Noncompliance with study treatment|1|||
27873622|NCT02119650|54491217|FG000|Overall Study|Study terminated by the sponsor|1|||
27873623|NCT02119650|54491218|FG001|Overall Study|Study terminated by the sponsor|0|||
27873624|NCT02119650|54491217|FG000|Overall Study|Physician Decision|0|||
27873625|NCT02119650|54491218|FG001|Overall Study|Physician Decision|2|||
27873626|NCT02119650|54491217|FG000|Overall Study|Multiple reasons for termination|2|||
27873627|NCT02119650|54491218|FG001|Overall Study|Multiple reasons for termination|1|||
27873628|NCT02119416|54491227|FG000|Overall Study|Protocol Violation|1|||
27873629|NCT02119416|54491228|FG001|Overall Study|Protocol Violation|1|||
27873630|NCT02119416|54491229|FG002|Overall Study|Protocol Violation|1|||
27873631|NCT02119416|54491227|FG000|Overall Study|wrong pubertal stage|1|||
27873632|NCT02119416|54491228|FG001|Overall Study|wrong pubertal stage|0|||
27873633|NCT02119416|54491229|FG002|Overall Study|wrong pubertal stage|1|||
27873634|NCT02140164|54491240|FG000|Overall Study|Cystoid Macular Edema (CME) resolved|2|||
27873635|NCT02119260|54491251|FG000|Overall Study|Adverse Event|1|||
27873636|NCT02119260|54491252|FG001|Overall Study|Adverse Event|0|||
27873637|NCT02119260|54491253|FG002|Overall Study|Adverse Event|0|||
27873638|NCT02119260|54491254|FG003|Overall Study|Adverse Event|0|||
27873639|NCT02119260|54491255|FG004|Overall Study|Adverse Event|0|||
27873640|NCT02119260|54491256|FG005|Overall Study|Adverse Event|0|||
27873641|NCT02119260|54491257|FG006|Overall Study|Adverse Event|0|||
27873642|NCT02119260|54491251|FG000|Overall Study|Withdrew consent|0|||
27873643|NCT02119260|54491252|FG001|Overall Study|Withdrew consent|1|||
27873644|NCT02119260|54491253|FG002|Overall Study|Withdrew consent|1|||
27873645|NCT02119260|54491254|FG003|Overall Study|Withdrew consent|0|||
27873646|NCT02119260|54491255|FG004|Overall Study|Withdrew consent|0|||
27873647|NCT02119260|54491256|FG005|Overall Study|Withdrew consent|0|||
27873648|NCT02119260|54491257|FG006|Overall Study|Withdrew consent|0|||
27873649|NCT02119104|54491282|FG000|Overall Study|Protocol Violation|16|||
27873650|NCT02119026|54491288|FG000|1st-line Treatment|Adverse Event|9|||
27873651|NCT02119026|54491289|FG001|1st-line Treatment|Adverse Event|14|||
27873652|NCT02119026|54491288|FG000|1st-line Treatment|Physician Decision|3|||
27873653|NCT02119026|54491289|FG001|1st-line Treatment|Physician Decision|8|||
27873654|NCT02119026|54491288|FG000|1st-line Treatment|Withdrawal by Subject|4|||
27873655|NCT02119026|54491289|FG001|1st-line Treatment|Withdrawal by Subject|10|||
27873656|NCT02119026|54491288|FG000|1st-line Treatment|Patient condition or compliance|6|||
27873657|NCT02119026|54491289|FG001|1st-line Treatment|Patient condition or compliance|4|||
27982740|NCT02017717|54640942|FG003|Treatment Period|Participant request to stop therapy|4|||
27982741|NCT02017717|54640943|FG004|Treatment Period|Participant request to stop therapy|7|||
27982742|NCT02017717|54640944|FG005|Treatment Period|Participant request to stop therapy|5|||
27982743|NCT02017717|54640945|FG006|Treatment Period|Participant request to stop therapy|0|||
27739077|NCT02495168|54188419|FG000|Overall Study|Lost to Follow-up|10|||
27873658|NCT02119026|54491288|FG000|1st-line Treatment|Surgery of metastases|2|||
27873659|NCT02119026|54491289|FG001|1st-line Treatment|Surgery of metastases|1|||
27873660|NCT02119026|54491288|FG000|1st-line Treatment|Death|2|||
27873661|NCT02119026|54491289|FG001|1st-line Treatment|Death|1|||
27873662|NCT02119026|54491288|FG000|2nd-line Treatment|Lost to Follow-up|2|||
27873663|NCT02119026|54491289|FG001|2nd-line Treatment|Lost to Follow-up|0|||
27873664|NCT02119026|54491288|FG000|2nd-line Treatment|Withdrawal by Subject|3|||
27873665|NCT02119026|54491289|FG001|2nd-line Treatment|Withdrawal by Subject|1|||
27873666|NCT02119026|54491288|FG000|2nd-line Treatment|Adverse Event|4|||
27873667|NCT02119026|54491289|FG001|2nd-line Treatment|Adverse Event|1|||
27873668|NCT02095158|54491295|FG000|Overall Study|Adverse Event|14|||
27873669|NCT02095158|54491295|FG000|Overall Study|Lack of Efficacy|3|||
27873670|NCT02095158|54491295|FG000|Overall Study|Pregnancy|1|||
27873671|NCT02095158|54491295|FG000|Overall Study|Lost to Follow-up|20|||
27873672|NCT02095158|54491295|FG000|Overall Study|Personal Reasons|35|||
27873673|NCT02095158|54491295|FG000|Overall Study|Protocol Violation|1|||
27873674|NCT02095158|54491295|FG000|Overall Study|Other Miscellaneous Reasons|1|||
27873675|NCT02094612|54491301|FG000|Overall Study|Lost to Follow-up|47|||
27873676|NCT02094612|54491302|FG001|Overall Study|Lost to Follow-up|47|||
27873677|NCT02094612|54491301|FG000|Overall Study|Never started ADHD medication|32|||
27873678|NCT02094612|54491302|FG001|Overall Study|Never started ADHD medication|23|||
27873679|NCT02139306|54491310|FG000|Overall Study|Withdrawal by Subject|4|||
27873680|NCT02139306|54491311|FG001|Overall Study|Withdrawal by Subject|6|||
27873681|NCT02139306|54491310|FG000|Overall Study|Adverse Event|3|||
27873682|NCT02139306|54491311|FG001|Overall Study|Adverse Event|4|||
27873683|NCT02139306|54491310|FG000|Overall Study|Physician Decision|0|||
27873684|NCT02139306|54491311|FG001|Overall Study|Physician Decision|1|||
27873685|NCT02139306|54491310|FG000|Overall Study|Other Unspecified|2|||
27873686|NCT02139306|54491311|FG001|Overall Study|Other Unspecified|3|||
27982744|NCT02017717|54640946|FG007|Treatment Period|Participant request to stop therapy|2|||
27982745|NCT02017717|54640947|FG008|Treatment Period|Participant request to stop therapy|1|||
27982746|NCT02017717|54640939|FG000|Treatment Period|Participant withdrew consent|0|||
27982747|NCT02017717|54640940|FG001|Treatment Period|Participant withdrew consent|0|||
27982748|NCT02017717|54640941|FG002|Treatment Period|Participant withdrew consent|1|||
27982749|NCT02017717|54640942|FG003|Treatment Period|Participant withdrew consent|1|||
27982750|NCT02017717|54640943|FG004|Treatment Period|Participant withdrew consent|4|||
27982751|NCT02017717|54640944|FG005|Treatment Period|Participant withdrew consent|0|||
27982752|NCT02017717|54640945|FG006|Treatment Period|Participant withdrew consent|0|||
27982753|NCT02017717|54640946|FG007|Treatment Period|Participant withdrew consent|2|||
27873687|NCT02139306|54491310|FG000|Overall Study|Protocol Violation|4|||
27873688|NCT02139306|54491311|FG001|Overall Study|Protocol Violation|0|||
27873689|NCT02094300|54491318|FG000|Overall Study|Death|7|||
27873690|NCT02094300|54491318|FG000|Overall Study|Lost to Follow-up|10|||
27873691|NCT02094300|54491318|FG000|Overall Study|Still be eligible for follow-up|3|||
27873692|NCT02118792|54491324|FG000|Overall Study|Withdrawal by Subject|6|||
27873693|NCT02118792|54491325|FG001|Overall Study|Withdrawal by Subject|3|||
27873694|NCT02118792|54491324|FG000|Overall Study|Lost to Follow-up|4|||
27873695|NCT02118792|54491325|FG001|Overall Study|Lost to Follow-up|4|||
27873696|NCT02118792|54491324|FG000|Overall Study|Adverse Event|5|||
27873697|NCT02118792|54491325|FG001|Overall Study|Adverse Event|4|||
27873698|NCT02118792|54491324|FG000|Overall Study|Withdrawal by parent/guardian|14|||
27873699|NCT02118792|54491325|FG001|Overall Study|Withdrawal by parent/guardian|20|||
27873700|NCT02118792|54491324|FG000|Overall Study|Other|1|||
27873701|NCT02118792|54491325|FG001|Overall Study|Other|6|||
27873702|NCT02118792|54491324|FG000|Overall Study|Randomised but not treated|1|||
27873703|NCT02118792|54491325|FG001|Overall Study|Randomised but not treated|0|||
27873704|NCT02118714|54491333|FG000|Overall Study|Lost to Follow-up|2|||
27873705|NCT02118714|54491333|FG000|Overall Study|Protocol Violation|1|||
27873706|NCT02138916|54491340|FG000|Overall Study|eg., meds change, lack of efficacy, etc.|6|||
27873707|NCT02138916|54491341|FG001|Overall Study|eg., meds change, lack of efficacy, etc.|9|||
27873708|NCT02138916|54491342|FG002|Overall Study|eg., meds change, lack of efficacy, etc.|7|||
27873709|NCT02138916|54491340|FG000|Overall Study|Death|14|||
27873710|NCT02138916|54491341|FG001|Overall Study|Death|11|||
27873711|NCT02138916|54491342|FG002|Overall Study|Death|12|||
27873712|NCT02138916|54491340|FG000|Overall Study|Withdrawal by Subject|27|||
27873713|NCT02138916|54491341|FG001|Overall Study|Withdrawal by Subject|31|||
27873714|NCT02138916|54491342|FG002|Overall Study|Withdrawal by Subject|32|||
27873715|NCT02138916|54491340|FG000|Overall Study|Study specific withdrawal criteria|0|||
27873716|NCT02138916|54491341|FG001|Overall Study|Study specific withdrawal criteria|0|||
27873717|NCT02138916|54491342|FG002|Overall Study|Study specific withdrawal criteria|1|||
27873718|NCT02138916|54491340|FG000|Overall Study|incorrect enrolment|1|||
27982754|NCT02017717|54640947|FG008|Treatment Period|Participant withdrew consent|0|||
27982755|NCT02017717|54640939|FG000|Treatment Period|Participant no longer met criteria|0|||
27982756|NCT02017717|54640940|FG001|Treatment Period|Participant no longer met criteria|0|||
27982757|NCT02017717|54640941|FG002|Treatment Period|Participant no longer met criteria|0|||
27982758|NCT02017717|54640942|FG003|Treatment Period|Participant no longer met criteria|0|||
27873719|NCT02138916|54491341|FG001|Overall Study|incorrect enrolment|1|||
27873720|NCT02138916|54491342|FG002|Overall Study|incorrect enrolment|0|||
27873721|NCT02138916|54491340|FG000|Overall Study|Severe non-compliance|1|||
27873722|NCT02138916|54491341|FG001|Overall Study|Severe non-compliance|2|||
27873723|NCT02138916|54491342|FG002|Overall Study|Severe non-compliance|1|||
27873724|NCT02138916|54491340|FG000|Overall Study|Lost to Follow-up|4|||
27873725|NCT02138916|54491341|FG001|Overall Study|Lost to Follow-up|2|||
27873726|NCT02138916|54491342|FG002|Overall Study|Lost to Follow-up|3|||
27873727|NCT02138916|54491340|FG000|Overall Study|Adverse Event|4|||
27873728|NCT02138916|54491341|FG001|Overall Study|Adverse Event|4|||
27873729|NCT02138916|54491342|FG002|Overall Study|Adverse Event|3|||
27873730|NCT02118012|54491352|FG000|Overall Study|Adverse Event|0|||
27873731|NCT02118012|54491353|FG001|Overall Study|Adverse Event|1|||
27873732|NCT02118012|54491352|FG000|Overall Study|Physician Decision|0|||
27873733|NCT02118012|54491353|FG001|Overall Study|Physician Decision|1|||
27873734|NCT02093520|54491361|FG000|Overall Study|Not treated|6|||
27873735|NCT02093520|54491362|FG001|Overall Study|Not treated|22|||
27873736|NCT02138838|54491370|FG000|Overall Study|Study Closure|7|||
27873737|NCT02138838|54491371|FG001|Overall Study|Study Closure|6|||
27873738|NCT02138838|54491370|FG000|Overall Study|Withdrawal by Subject|1|||
27873739|NCT02138838|54491371|FG001|Overall Study|Withdrawal by Subject|5|||
27873740|NCT02138214|54491380|FG000|Overall Study|Withdrawal by Subject|0|||
27873741|NCT02138214|54491381|FG001|Overall Study|Withdrawal by Subject|1|||
27873742|NCT02138214|54491382|FG002|Overall Study|Withdrawal by Subject|0|||
27873743|NCT02138214|54491380|FG000|Overall Study|Lost to Follow-up|0|||
27873744|NCT02138214|54491381|FG001|Overall Study|Lost to Follow-up|2|||
27873745|NCT02138214|54491382|FG002|Overall Study|Lost to Follow-up|4|||
27873746|NCT02138214|54491380|FG000|Overall Study|Screen Failure|0|||
27873747|NCT02138214|54491381|FG001|Overall Study|Screen Failure|1|||
27873748|NCT02138214|54491382|FG002|Overall Study|Screen Failure|0|||
27873749|NCT02092662|54491391|FG000|Overall Study|Lost to Follow-up|13|||
27873750|NCT02092662|54491392|FG001|Overall Study|Lost to Follow-up|0|||
27873751|NCT02092350|54491401|FG000|Overall Study|Adverse Event|0|||
27873752|NCT02092350|54491402|FG001|Overall Study|Adverse Event|3|||
27873753|NCT02092350|54491401|FG000|Overall Study|Death|2|||
27873754|NCT02092350|54491402|FG001|Overall Study|Death|5|||
27873755|NCT02092350|54491401|FG000|Overall Study|Lost to Follow-up|3|||
27873756|NCT02092350|54491402|FG001|Overall Study|Lost to Follow-up|1|||
27873757|NCT02092350|54491401|FG000|Overall Study|Protocol Violation|1|||
27873758|NCT02092350|54491402|FG001|Overall Study|Protocol Violation|0|||
27873759|NCT02092350|54491401|FG000|Overall Study|Physician Decision|1|||
27873760|NCT02092350|54491402|FG001|Overall Study|Physician Decision|1|||
27873761|NCT02092350|54491401|FG000|Overall Study|Screen Failure|1|||
27873762|NCT02092350|54491402|FG001|Overall Study|Screen Failure|0|||
27873763|NCT02092350|54491401|FG000|Overall Study|Withdrawal by Subject|2|||
27873764|NCT02092350|54491402|FG001|Overall Study|Withdrawal by Subject|2|||
27873765|NCT02117544|54491410|FG000|Period 1|Lost to follow-up (prior to treatment)|2|||
27873766|NCT02117544|54491411|FG001|Period 1|Lost to follow-up (prior to treatment)|0|||
27873767|NCT02138136|54491418|FG000|Overall Study|Protocol Violation|4|||
27873768|NCT02138136|54491418|FG000|Overall Study|Physician Decision|7|||
27873769|NCT02138136|54491418|FG000|Overall Study|Lack of Efficacy|35|||
27873770|NCT02138136|54491418|FG000|Overall Study|Pregnancy|2|||
27873771|NCT02138136|54491418|FG000|Overall Study|Adverse Event|18|||
27873772|NCT02138136|54491418|FG000|Overall Study|Withdrawal by Subject|36|||
27873773|NCT02138136|54491418|FG000|Overall Study|Lost to Follow-up|32|||
27873774|NCT02138136|54491418|FG000|Overall Study|Withdrawn by Sponsor|5|||
27873775|NCT01626690|54491425|FG000|Overall Study|Protocol Violation|1|||
27873776|NCT01626690|54491426|FG001|Overall Study|Protocol Violation|0|||
27873777|NCT01626690|54491425|FG000|Overall Study|Adverse Event|1|||
27873778|NCT01626690|54491426|FG001|Overall Study|Adverse Event|0|||
27873779|NCT01626456|54491436|FG000|Overall Study|Withdrawal by Subject|21|||
27873780|NCT01626456|54491437|FG001|Overall Study|Withdrawal by Subject|46|||
27873781|NCT01626456|54491436|FG000|Overall Study|Adverse Event|2|||
27873782|NCT01626456|54491437|FG001|Overall Study|Adverse Event|27|||
27873783|NCT01626456|54491436|FG000|Overall Study|Lost to Follow-up|2|||
27873784|NCT01626456|54491437|FG001|Overall Study|Lost to Follow-up|27|||
27873785|NCT01626456|54491436|FG000|Overall Study|Lack of Efficacy|6|||
27873786|NCT01626456|54491437|FG001|Overall Study|Lack of Efficacy|7|||
27873787|NCT01626456|54491436|FG000|Overall Study|Physician Decision|1|||
27873788|NCT01626456|54491437|FG001|Overall Study|Physician Decision|4|||
27873789|NCT01626456|54491436|FG000|Overall Study|Protocol Violation|1|||
27873790|NCT01626456|54491437|FG001|Overall Study|Protocol Violation|1|||
27873791|NCT01626456|54491436|FG000|Overall Study|Site Closure|2|||
27873792|NCT01626456|54491437|FG001|Overall Study|Site Closure|3|||
27873793|NCT01626456|54491436|FG000|Overall Study|Incarceration|0|||
27873794|NCT01626456|54491437|FG001|Overall Study|Incarceration|2|||
27873795|NCT02116608|54491455|FG000|Overall Study|Lost to Follow-up|0|||
27873796|NCT02116608|54491456|FG001|Overall Study|Lost to Follow-up|0|||
27739078|NCT02495168|54188420|FG001|Overall Study|Lost to Follow-up|6|||
27873797|NCT02116608|54491457|FG002|Overall Study|Lost to Follow-up|1|||
27873798|NCT02116608|54491455|FG000|Overall Study|Physician Decision|0|||
27982759|NCT02017717|54640943|FG004|Treatment Period|Participant no longer met criteria|1|||
27873799|NCT02116608|54491456|FG001|Overall Study|Physician Decision|1|||
27873800|NCT02116608|54491457|FG002|Overall Study|Physician Decision|0|||
27873801|NCT02116608|54491455|FG000|Overall Study|Death|0|||
27873802|NCT02116608|54491456|FG001|Overall Study|Death|1|||
27873803|NCT02116608|54491457|FG002|Overall Study|Death|0|||
27873804|NCT02092116|54491467|FG000|Overall Study|Withdrawal by Subject|0|||
27873805|NCT02092116|54491468|FG001|Overall Study|Withdrawal by Subject|3|||
27873806|NCT02092116|54491467|FG000|Overall Study|Adverse Event|0|||
27873807|NCT02092116|54491468|FG001|Overall Study|Adverse Event|1|||
27873808|NCT02091726|54491474|FG000|Overall Study|Lost to Follow-up|6|||
27873809|NCT02091414|54491478|FG000|Overall Study|Withdrawal by Subject|2|||
27873810|NCT02091414|54491478|FG000|Overall Study|Death|2|||
27873811|NCT02116530|54491484|FG000|Overall Study|Withdrawal by Subject|1|||
27873812|NCT02116530|54491485|FG001|Overall Study|Withdrawal by Subject|2|||
27873813|NCT02116530|54491484|FG000|Overall Study|Adverse Event|4|||
27873814|NCT02116530|54491485|FG001|Overall Study|Adverse Event|0|||
27873815|NCT02116530|54491484|FG000|Overall Study|Physician Decision|1|||
27873816|NCT02116530|54491485|FG001|Overall Study|Physician Decision|0|||
27873817|NCT02116530|54491484|FG000|Overall Study|Lost to Follow-up|1|||
27873818|NCT02116530|54491485|FG001|Overall Study|Lost to Follow-up|0|||
27873819|NCT02116530|54491484|FG000|Overall Study|Other Medical Problems|2|||
27873820|NCT02116530|54491485|FG001|Overall Study|Other Medical Problems|2|||
27873821|NCT02072226|54491493|FG000|Overall Study|Lost to Follow-up|11|||
27873822|NCT02072226|54491494|FG001|Overall Study|Lost to Follow-up|7|||
27873823|NCT02072226|54491493|FG000|Overall Study|Patient Non-compliance|2|||
27873824|NCT02072226|54491494|FG001|Overall Study|Patient Non-compliance|3|||
27873825|NCT02072226|54491493|FG000|Overall Study|Death|1|||
27873826|NCT02072226|54491494|FG001|Overall Study|Death|0|||
27873827|NCT02072226|54491493|FG000|Overall Study|Patient Withdrawal of Consent|1|||
27873828|NCT02072226|54491494|FG001|Overall Study|Patient Withdrawal of Consent|0|||
27873829|NCT02090634|54491502|FG000|Overall Study|Lost to Follow-up|0|||
27873830|NCT02090634|54491503|FG001|Overall Study|Lost to Follow-up|1|||
27873831|NCT02090634|54491502|FG000|Overall Study|Death|0|||
27873832|NCT02090634|54491503|FG001|Overall Study|Death|1|||
27873833|NCT02090634|54491502|FG000|Overall Study|Protocol Violation|3|||
27873834|NCT02090634|54491503|FG001|Overall Study|Protocol Violation|1|||
28171582|NCT02796391|54843204|FG004|Overall Study|Participant did not like study cigarettes|0|||
28171583|NCT02796391|54843205|FG005|Overall Study|Participant did not like study cigarettes|0|||
28171584|NCT02796391|54843200|FG000|Overall Study|Withdrawal by Subject|1|||
28171585|NCT02796391|54843201|FG001|Overall Study|Withdrawal by Subject|1|||
28171586|NCT02796391|54843202|FG002|Overall Study|Withdrawal by Subject|4|||
28171587|NCT02796391|54843203|FG003|Overall Study|Withdrawal by Subject|3|||
28171588|NCT02796391|54843204|FG004|Overall Study|Withdrawal by Subject|4|||
28171589|NCT02796391|54843205|FG005|Overall Study|Withdrawal by Subject|3|||
28171590|NCT02796391|54843200|FG000|Overall Study|Adverse Event|0|||
28171591|NCT02796391|54843201|FG001|Overall Study|Adverse Event|0|||
28171592|NCT02796391|54843202|FG002|Overall Study|Adverse Event|0|||
28171593|NCT02796391|54843203|FG003|Overall Study|Adverse Event|1|||
28171594|NCT02796391|54843204|FG004|Overall Study|Adverse Event|0|||
28171595|NCT02796391|54843205|FG005|Overall Study|Adverse Event|0|||
28171596|NCT02796391|54843200|FG000|Overall Study|Protocol Violation|0|||
28171597|NCT02796391|54843201|FG001|Overall Study|Protocol Violation|0|||
27873835|NCT02090634|54491502|FG000|Overall Study|Adverse Event|2|||
27873836|NCT02090634|54491503|FG001|Overall Study|Adverse Event|0|||
27873837|NCT02114892|54491511|FG000|Overall Study|Lost to Follow-up|1|||
27873838|NCT02114892|54491512|FG001|Overall Study|Lost to Follow-up|2|||
27873839|NCT02070978|54491521|FG000|Overall Study|Adverse Event|6|||
27873840|NCT02070978|54491522|FG001|Overall Study|Adverse Event|2|||
27873841|NCT02070978|54491523|FG002|Overall Study|Adverse Event|0|||
27873842|NCT02070978|54491521|FG000|Overall Study|Lost to Follow-up|1|||
27873843|NCT02070978|54491522|FG001|Overall Study|Lost to Follow-up|3|||
27873844|NCT02070978|54491523|FG002|Overall Study|Lost to Follow-up|4|||
27873845|NCT02070978|54491521|FG000|Overall Study|Withdrawal by Subject|3|||
27873846|NCT02070978|54491522|FG001|Overall Study|Withdrawal by Subject|5|||
27873847|NCT02070978|54491523|FG002|Overall Study|Withdrawal by Subject|3|||
27873848|NCT02070978|54491521|FG000|Overall Study|Protocol Violation|1|||
27873849|NCT02070978|54491522|FG001|Overall Study|Protocol Violation|0|||
27873850|NCT02070978|54491523|FG002|Overall Study|Protocol Violation|3|||
27873851|NCT02070978|54491521|FG000|Overall Study|Lack of Efficacy|0|||
27873852|NCT02070978|54491522|FG001|Overall Study|Lack of Efficacy|1|||
27873853|NCT02070978|54491523|FG002|Overall Study|Lack of Efficacy|0|||
27873854|NCT02070978|54491521|FG000|Overall Study|Death|0|||
27873855|NCT02070978|54491522|FG001|Overall Study|Death|0|||
27873856|NCT02070978|54491523|FG002|Overall Study|Death|2|||
27873857|NCT02070978|54491521|FG000|Overall Study|Un-specified|3|||
27873858|NCT02070978|54491522|FG001|Overall Study|Un-specified|2|||
27982760|NCT02017717|54640944|FG005|Treatment Period|Participant no longer met criteria|0|||
27982761|NCT02017717|54640945|FG006|Treatment Period|Participant no longer met criteria|0|||
27873859|NCT02070978|54491523|FG002|Overall Study|Un-specified|2|||
27873860|NCT02070978|54491521|FG000|Overall Study|Terminated by Sponsor|33|||
27873861|NCT02070978|54491522|FG001|Overall Study|Terminated by Sponsor|40|||
28171598|NCT02796391|54843202|FG002|Overall Study|Protocol Violation|0|||
28171599|NCT02796391|54843203|FG003|Overall Study|Protocol Violation|1|||
28171600|NCT02796391|54843204|FG004|Overall Study|Protocol Violation|0|||
27873862|NCT02070978|54491523|FG002|Overall Study|Terminated by Sponsor|39|||
27873863|NCT02114268|54491537|FG000|Overall Study|Lost to Follow-up|4|||
27873864|NCT02114268|54491538|FG001|Overall Study|Lost to Follow-up|1|||
27873865|NCT02114268|54491539|FG002|Overall Study|Lost to Follow-up|1|||
27873866|NCT02114268|54491540|FG003|Overall Study|Lost to Follow-up|0|||
27873867|NCT02114268|54491541|FG004|Overall Study|Lost to Follow-up|0|||
27873868|NCT02114268|54491542|FG005|Overall Study|Lost to Follow-up|2|||
27873869|NCT02114268|54491537|FG000|Overall Study|Withdrawal by Subject|1|||
27873870|NCT02114268|54491538|FG001|Overall Study|Withdrawal by Subject|0|||
27873871|NCT02114268|54491539|FG002|Overall Study|Withdrawal by Subject|0|||
27873872|NCT02114268|54491540|FG003|Overall Study|Withdrawal by Subject|0|||
27873873|NCT02114268|54491541|FG004|Overall Study|Withdrawal by Subject|0|||
27873874|NCT02114268|54491542|FG005|Overall Study|Withdrawal by Subject|1|||
27873875|NCT02114268|54491537|FG000|Overall Study|Withdrawn by site due to noncompliance|1|||
27873876|NCT02114268|54491538|FG001|Overall Study|Withdrawn by site due to noncompliance|0|||
27873877|NCT02114268|54491539|FG002|Overall Study|Withdrawn by site due to noncompliance|0|||
27873878|NCT02114268|54491540|FG003|Overall Study|Withdrawn by site due to noncompliance|0|||
27873879|NCT02114268|54491541|FG004|Overall Study|Withdrawn by site due to noncompliance|0|||
27873880|NCT02114268|54491542|FG005|Overall Study|Withdrawn by site due to noncompliance|0|||
27873881|NCT02089230|54491564|FG000|Overall Study|Death|0|||
27873882|NCT02089230|54491565|FG001|Overall Study|Death|0|||
27873883|NCT02089230|54491566|FG002|Overall Study|Death|2|||
27873884|NCT02089230|54491564|FG000|Overall Study|Seeking Alternative Therapy|0|||
27873885|NCT02089230|54491565|FG001|Overall Study|Seeking Alternative Therapy|0|||
27873886|NCT02089230|54491566|FG002|Overall Study|Seeking Alternative Therapy|4|||
27873887|NCT02070744|54491578|FG000|PC Phase (12 Weeks)|Randomized, but not treated|0|||
27873888|NCT02070744|54491579|FG001|PC Phase (12 Weeks)|Randomized, but not treated|0|||
27873889|NCT02070744|54491580|FG002|PC Phase (12 Weeks)|Randomized, but not treated|0|||
27873890|NCT02070744|54491581|FG003|PC Phase (12 Weeks)|Randomized, but not treated|1|||
27982762|NCT02017717|54640946|FG007|Treatment Period|Participant no longer met criteria|0|||
27982763|NCT02017717|54640947|FG008|Treatment Period|Participant no longer met criteria|0|||
27982764|NCT02017717|54640939|FG000|Treatment Period|other reasons|0|||
28171601|NCT02796391|54843205|FG005|Overall Study|Protocol Violation|0|||
27873891|NCT02070744|54491582|FG004|PC Phase (12 Weeks)|Randomized, but not treated|0|||
27873892|NCT02070744|54491578|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
27873893|NCT02070744|54491579|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
27873894|NCT02070744|54491580|FG002|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
27873895|NCT02070744|54491581|FG003|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
27873896|NCT02070744|54491582|FG004|OLE Phase (48 Weeks)|Withdrawal by Subject|2|||
27873897|NCT02070744|54491578|FG000|OLE Phase (48 Weeks)|Other|0|||
27873898|NCT02070744|54491579|FG001|OLE Phase (48 Weeks)|Other|0|||
27873899|NCT02070744|54491580|FG002|OLE Phase (48 Weeks)|Other|0|||
27873900|NCT02070744|54491581|FG003|OLE Phase (48 Weeks)|Other|0|||
27873901|NCT02070744|54491582|FG004|OLE Phase (48 Weeks)|Other|1|||
27873902|NCT02113956|54491599|FG000|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5|||
27873903|NCT02113956|54491600|FG001|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1|||
27873904|NCT02113956|54491599|FG000|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4|||
27873905|NCT02113956|54491600|FG001|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3|||
27873906|NCT02113956|54491599|FG000|3 Month Post-intervention|Lost to Follow-up|4|||
27873907|NCT02113956|54491600|FG001|3 Month Post-intervention|Lost to Follow-up|2|||
27873908|NCT02070588|54491609|FG000|Overall Study|Withdrawal by Subject|29|||
27873909|NCT02070588|54491610|FG001|Overall Study|Withdrawal by Subject|1|||
27873910|NCT02070588|54491611|FG002|Overall Study|Withdrawal by Subject|0|||
27873911|NCT02070588|54491609|FG000|Overall Study|Writhdrawal due to early termination|9|||
27873912|NCT02070588|54491610|FG001|Overall Study|Writhdrawal due to early termination|0|||
27873913|NCT02070588|54491611|FG002|Overall Study|Writhdrawal due to early termination|0|||
27873914|NCT02070588|54491609|FG000|Overall Study|Adverse Event|1|||
27873915|NCT02070588|54491610|FG001|Overall Study|Adverse Event|0|||
27873916|NCT02070588|54491611|FG002|Overall Study|Adverse Event|0|||
27873917|NCT02111850|54491630|FG000|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
27873918|NCT02111850|54491631|FG001|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
27873919|NCT02111850|54491632|FG002|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
27873920|NCT02111850|54491633|FG003|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
27873921|NCT02111850|54491634|FG004|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|1|||
27873922|NCT02111850|54491635|FG005|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
27873923|NCT02111850|54491636|FG006|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
27873924|NCT02111850|54491637|FG007|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
27873925|NCT02111850|54491638|FG008|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
27873926|NCT02111850|54491639|FG009|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
28171602|NCT01370317|54843221|FG000|Overall Study|Participant withdrew consent|1|||
27873927|NCT02111850|54491640|FG010|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
27873928|NCT02087904|54491670|FG000|Overall Study|Did Not Receive Study Drug|0|||
27873929|NCT02087904|54491671|FG001|Overall Study|Did Not Receive Study Drug|0|||
27873930|NCT02087904|54491672|FG002|Overall Study|Did Not Receive Study Drug|2|||
27873931|NCT02087904|54491673|FG003|Overall Study|Did Not Receive Study Drug|1|||
27873932|NCT02087904|54491670|FG000|Overall Study|Adverse Event|8|||
27873933|NCT02087904|54491671|FG001|Overall Study|Adverse Event|4|||
27873934|NCT02087904|54491672|FG002|Overall Study|Adverse Event|4|||
27873935|NCT02087904|54491673|FG003|Overall Study|Adverse Event|12|||
27873936|NCT02087904|54491670|FG000|Overall Study|Lack of Efficacy|3|||
27873937|NCT02087904|54491671|FG001|Overall Study|Lack of Efficacy|6|||
27873938|NCT02087904|54491672|FG002|Overall Study|Lack of Efficacy|3|||
27873939|NCT02087904|54491673|FG003|Overall Study|Lack of Efficacy|2|||
27873940|NCT02087904|54491670|FG000|Overall Study|Other|6|||
27873941|NCT02087904|54491671|FG001|Overall Study|Other|2|||
27873942|NCT02087904|54491672|FG002|Overall Study|Other|4|||
27873943|NCT02087904|54491673|FG003|Overall Study|Other|4|||
27873944|NCT02087904|54491670|FG000|Overall Study|Withdrawal by Subject|8|||
27873945|NCT02087904|54491671|FG001|Overall Study|Withdrawal by Subject|3|||
27873946|NCT02087904|54491672|FG002|Overall Study|Withdrawal by Subject|7|||
27873947|NCT02087904|54491673|FG003|Overall Study|Withdrawal by Subject|4|||
27873948|NCT02087904|54491670|FG000|Overall Study|Lost to Follow-up|0|||
27873949|NCT02087904|54491671|FG001|Overall Study|Lost to Follow-up|4|||
27873950|NCT02087904|54491672|FG002|Overall Study|Lost to Follow-up|2|||
27873951|NCT02087904|54491673|FG003|Overall Study|Lost to Follow-up|2|||
27873952|NCT02087670|54491685|FG000|Overall Study|Withdrawal by Subject|3|||
27873953|NCT02087670|54491686|FG001|Overall Study|Withdrawal by Subject|2|||
27873954|NCT02086968|54491694|FG000|Overall Study|Adverse Event|1|||
27873955|NCT02086968|54491695|FG001|Overall Study|Adverse Event|5|||
27873956|NCT02086968|54491694|FG000|Overall Study|Lost to Follow-up|2|||
27873957|NCT02086968|54491695|FG001|Overall Study|Lost to Follow-up|3|||
27873958|NCT02086968|54491694|FG000|Overall Study|Study drug received outside protocol|0|||
27873959|NCT02086968|54491695|FG001|Overall Study|Study drug received outside protocol|1|||
27873960|NCT02086968|54491694|FG000|Overall Study|Physician Decision|4|||
27873961|NCT02086968|54491695|FG001|Overall Study|Physician Decision|0|||
27873962|NCT02086968|54491694|FG000|Overall Study|Withdrawal by Subject|1|||
27873963|NCT02086968|54491695|FG001|Overall Study|Withdrawal by Subject|4|||
27873964|NCT02086110|54491703|FG000|Overall Study|Withdrawal by Subject|1|||
27873965|NCT02086110|54491704|FG001|Overall Study|Withdrawal by Subject|1|||
27873966|NCT02085252|54491713|FG000|Overall Study|Withdrawal of Consent|1|||
27873967|NCT02085252|54491714|FG001|Overall Study|Withdrawal of Consent|0|||
27873968|NCT02085252|54491713|FG000|Overall Study|Adverse Event|0|||
27873969|NCT02085252|54491714|FG001|Overall Study|Adverse Event|1|||
27873970|NCT02085252|54491713|FG000|Overall Study|Discontinuation Due to Patient Decision|0|||
27835528|NCT01685801|54320333|FG003|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
27835529|NCT01353222|54320352|FG000|Overall Study|Death|30|||
27835530|NCT01353222|54320353|FG001|Overall Study|Death|30|||
27835531|NCT01353222|54320352|FG000|Overall Study|Withdrawal by Subject|8|||
27835532|NCT01353222|54320353|FG001|Overall Study|Withdrawal by Subject|5|||
27835533|NCT01353222|54320352|FG000|Overall Study|Study Terminated|31|||
27835534|NCT01353222|54320353|FG001|Overall Study|Study Terminated|37|||
27835535|NCT01353222|54320352|FG000|Overall Study|Site closed research department|1|||
27835536|NCT01353222|54320353|FG001|Overall Study|Site closed research department|0|||
27835537|NCT01684943|54320383|FG000|Overall Study|Inadequate Venous Access|3|||
27835538|NCT01684943|54320384|FG001|Overall Study|Inadequate Venous Access|0|||
27835539|NCT01684943|54320385|FG002|Overall Study|Inadequate Venous Access|0|||
27835540|NCT01684943|54320383|FG000|Overall Study|Principal Investigator Determination|1|||
27835541|NCT01684943|54320384|FG001|Overall Study|Principal Investigator Determination|0|||
27835542|NCT01684943|54320385|FG002|Overall Study|Principal Investigator Determination|0|||
27835543|NCT01684943|54320383|FG000|Overall Study|Excluded from Analysis|1|||
27835544|NCT01684943|54320384|FG001|Overall Study|Excluded from Analysis|1|||
27835545|NCT01684943|54320385|FG002|Overall Study|Excluded from Analysis|1|||
27835546|NCT01684943|54320383|FG000|Overall Study|Lost to Follow-up|3|||
27835547|NCT01684943|54320384|FG001|Overall Study|Lost to Follow-up|0|||
27835548|NCT01684943|54320385|FG002|Overall Study|Lost to Follow-up|0|||
27835549|NCT01684943|54320383|FG000|Overall Study|Planning Pregnancy|1|||
27835550|NCT01684943|54320384|FG001|Overall Study|Planning Pregnancy|0|||
27835551|NCT01684943|54320385|FG002|Overall Study|Planning Pregnancy|0|||
27835552|NCT01683383|54320400|FG000|Overall Study|Infant was not transported|1|||
27835553|NCT01683383|54320401|FG001|Overall Study|Infant was not transported|0|||
27835554|NCT02694744|54320409|FG000|Overall Study|Adverse Event|2|||
27835555|NCT02694744|54320410|FG001|Overall Study|Adverse Event|1|||
27835556|NCT02694744|54320409|FG000|Overall Study|Withdrawal by Subject|2|||
27835557|NCT02694744|54320410|FG001|Overall Study|Withdrawal by Subject|1|||
27835558|NCT02694744|54320409|FG000|Overall Study|Physician Decision|1|||
27835559|NCT02694744|54320410|FG001|Overall Study|Physician Decision|2|||
27835560|NCT02694744|54320409|FG000|Overall Study|Lost to Follow-up|1|||
27835561|NCT02694744|54320410|FG001|Overall Study|Lost to Follow-up|0|||
27835562|NCT02694744|54320409|FG000|Overall Study|Taking potassium supplement: exclusion 6|0|||
27873971|NCT02085252|54491714|FG001|Overall Study|Discontinuation Due to Patient Decision|1|||
27873972|NCT02085252|54491713|FG000|Overall Study|Reason Not Specified|0|||
27873973|NCT02085252|54491714|FG001|Overall Study|Reason Not Specified|1|||
27873974|NCT02085252|54491713|FG000|Overall Study|Reason Unknown|0|||
27873975|NCT02085252|54491714|FG001|Overall Study|Reason Unknown|1|||
27873976|NCT02084238|54491720|FG000|Overall Study|Lost to Follow-up|2|||
27873977|NCT02084082|54491733|FG000|Washout Period 1 (35 Days)|Adverse Event|0|||
27873978|NCT02084082|54491734|FG001|Washout Period 1 (35 Days)|Adverse Event|0|||
27873979|NCT02084082|54491735|FG002|Washout Period 1 (35 Days)|Adverse Event|1|||
27873980|NCT02084082|54491736|FG003|Washout Period 1 (35 Days)|Adverse Event|1|||
27873981|NCT02084082|54491733|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
27873982|NCT02084082|54491734|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
27873983|NCT02084082|54491735|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
27873984|NCT02084082|54491736|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
27873985|NCT02083926|54491748|FG000|Overall Study|Withdrawal by Subject|1|||
27873986|NCT02083926|54491749|FG001|Overall Study|Withdrawal by Subject|0|||
27873987|NCT02083380|54491759|FG000|Overall Study|Lack of Efficacy|68|||
27873988|NCT02083380|54491760|FG001|Overall Study|Lack of Efficacy|79|||
27873989|NCT02083380|54491761|FG002|Overall Study|Lack of Efficacy|64|||
27873990|NCT02083380|54491759|FG000|Overall Study|Withdrawal by Subject|9|||
27873991|NCT02083380|54491760|FG001|Overall Study|Withdrawal by Subject|3|||
27873992|NCT02083380|54491761|FG002|Overall Study|Withdrawal by Subject|7|||
27873993|NCT02083380|54491759|FG000|Overall Study|Physician Decision|1|||
27873994|NCT02083380|54491760|FG001|Overall Study|Physician Decision|6|||
27873995|NCT02083380|54491761|FG002|Overall Study|Physician Decision|3|||
27873996|NCT02083380|54491759|FG000|Overall Study|Adverse Event|0|||
27873997|NCT02083380|54491760|FG001|Overall Study|Adverse Event|0|||
27873998|NCT02083380|54491761|FG002|Overall Study|Adverse Event|1|||
27873999|NCT02083380|54491759|FG000|Overall Study|Lost to Follow-up|5|||
27874000|NCT02083380|54491760|FG001|Overall Study|Lost to Follow-up|3|||
27874001|NCT02083380|54491761|FG002|Overall Study|Lost to Follow-up|3|||
27874002|NCT02083380|54491759|FG000|Overall Study|Other|8|||
27874003|NCT02083380|54491760|FG001|Overall Study|Other|4|||
27874004|NCT02083380|54491761|FG002|Overall Study|Other|6|||
27874005|NCT02109744|54491776|FG000|Overall Study|Death|1|||
27874006|NCT02109744|54491777|FG001|Overall Study|Death|1|||
27874007|NCT02109744|54491776|FG000|Overall Study|no marrow exam|1|||
27874008|NCT02109744|54491777|FG001|Overall Study|no marrow exam|0|||
27874009|NCT02109432|54491783|FG000|Overall Study|Withdrawal by Subject|1|||
27874010|NCT02109042|54491787|FG000|Overall Study|Sponsor Decision|15|||
27874011|NCT02066922|54491792|FG000|Overall Study|Adverse Event|1|||
27874012|NCT02108262|54491803|FG000|Overall Study|Non-compliance|0|||
27874013|NCT02108262|54491804|FG001|Overall Study|Non-compliance|2|||
27874014|NCT02108262|54491805|FG002|Overall Study|Non-compliance|1|||
27874015|NCT02108262|54491806|FG003|Overall Study|Non-compliance|1|||
27874016|NCT02108262|54491803|FG000|Overall Study|Randomized by error/screen failure|0|||
27874017|NCT02108262|54491804|FG001|Overall Study|Randomized by error/screen failure|0|||
27874018|NCT02108262|54491805|FG002|Overall Study|Randomized by error/screen failure|1|||
28171603|NCT01370317|54843222|FG001|Overall Study|Participant withdrew consent|0|||
28171604|NCT01370317|54843221|FG000|Overall Study|Protocol deviation|0|||
27835563|NCT02694744|54320410|FG001|Overall Study|Taking potassium supplement: exclusion 6|1|||
27835564|NCT01683071|54320424|FG000|Part 1|Lack of Efficacy|1|||
27835565|NCT01683071|54320425|FG001|Part 1|Lack of Efficacy|0|||
27835566|NCT01683071|54320426|FG002|Part 1|Lack of Efficacy|0|||
27835567|NCT01683071|54320427|FG003|Part 1|Lack of Efficacy|3|||
27835568|NCT01683071|54320428|FG004|Part 1|Lack of Efficacy|0|||
27835569|NCT01683071|54320429|FG005|Part 1|Lack of Efficacy|0|||
27835570|NCT01683071|54320424|FG000|Part 1|Withdrawal by Subject|1|||
27835571|NCT01683071|54320425|FG001|Part 1|Withdrawal by Subject|2|||
27835572|NCT01683071|54320426|FG002|Part 1|Withdrawal by Subject|2|||
27835573|NCT01683071|54320427|FG003|Part 1|Withdrawal by Subject|1|||
27835574|NCT01683071|54320428|FG004|Part 1|Withdrawal by Subject|0|||
27835575|NCT01683071|54320429|FG005|Part 1|Withdrawal by Subject|0|||
27835576|NCT01683071|54320424|FG000|Part 1|Surgery Cancelled|1|||
27835577|NCT01683071|54320425|FG001|Part 1|Surgery Cancelled|0|||
27835578|NCT01683071|54320426|FG002|Part 1|Surgery Cancelled|0|||
27835579|NCT01683071|54320427|FG003|Part 1|Surgery Cancelled|0|||
27874019|NCT02108262|54491806|FG003|Overall Study|Randomized by error/screen failure|0|||
27874020|NCT02108262|54491803|FG000|Overall Study|Distance to center|0|||
27874021|NCT02108262|54491804|FG001|Overall Study|Distance to center|1|||
27874022|NCT02108262|54491805|FG002|Overall Study|Distance to center|1|||
27874023|NCT02108262|54491806|FG003|Overall Study|Distance to center|0|||
27874024|NCT02108262|54491803|FG000|Overall Study|Adverse Event|0|||
27874025|NCT02108262|54491804|FG001|Overall Study|Adverse Event|11|||
27874026|NCT02108262|54491805|FG002|Overall Study|Adverse Event|6|||
27874027|NCT02108262|54491806|FG003|Overall Study|Adverse Event|12|||
27874028|NCT02108262|54491803|FG000|Overall Study|Death|0|||
28171605|NCT01370317|54843222|FG001|Overall Study|Protocol deviation|1|||
27835580|NCT01683071|54320428|FG004|Part 1|Surgery Cancelled|0|||
27835581|NCT01683071|54320429|FG005|Part 1|Surgery Cancelled|0|||
27874029|NCT02108262|54491804|FG001|Overall Study|Death|2|||
27874030|NCT02108262|54491805|FG002|Overall Study|Death|2|||
27874031|NCT02108262|54491806|FG003|Overall Study|Death|1|||
27874032|NCT02108262|54491803|FG000|Overall Study|Lost to Follow-up|0|||
27874033|NCT02108262|54491804|FG001|Overall Study|Lost to Follow-up|0|||
27874034|NCT02108262|54491805|FG002|Overall Study|Lost to Follow-up|1|||
27874035|NCT02108262|54491806|FG003|Overall Study|Lost to Follow-up|0|||
27874036|NCT02108262|54491803|FG000|Overall Study|Physician Decision|0|||
27874037|NCT02108262|54491804|FG001|Overall Study|Physician Decision|0|||
27874038|NCT02108262|54491805|FG002|Overall Study|Physician Decision|2|||
27874039|NCT02108262|54491806|FG003|Overall Study|Physician Decision|0|||
27874040|NCT02108262|54491803|FG000|Overall Study|Withdrawal by Subject|0|||
27874041|NCT02108262|54491804|FG001|Overall Study|Withdrawal by Subject|7|||
27874042|NCT02108262|54491805|FG002|Overall Study|Withdrawal by Subject|3|||
27874043|NCT02108262|54491806|FG003|Overall Study|Withdrawal by Subject|4|||
27874044|NCT02108262|54491803|FG000|Overall Study|Due to key hepatic values|0|||
27874045|NCT02108262|54491804|FG001|Overall Study|Due to key hepatic values|1|||
27874046|NCT02108262|54491805|FG002|Overall Study|Due to key hepatic values|0|||
27874047|NCT02108262|54491806|FG003|Overall Study|Due to key hepatic values|0|||
27874048|NCT02108262|54491803|FG000|Overall Study|Unable to contact patient|0|||
27982765|NCT02017717|54640940|FG001|Treatment Period|other reasons|0|||
27982766|NCT02017717|54640941|FG002|Treatment Period|other reasons|0|||
28096396|NCT03988088|54751325|FG002|Open-Label Addendum|Lost to Follow-up|1|||
27874049|NCT02108262|54491804|FG001|Overall Study|Unable to contact patient|3|||
27874050|NCT02108262|54491805|FG002|Overall Study|Unable to contact patient|1|||
27874051|NCT02108262|54491806|FG003|Overall Study|Unable to contact patient|2|||
27874052|NCT02108262|54491803|FG000|Overall Study|Patient unable to come to site/attend visit|0|||
27874053|NCT02108262|54491804|FG001|Overall Study|Patient unable to come to site/attend visit|6|||
27874054|NCT02108262|54491805|FG002|Overall Study|Patient unable to come to site/attend visit|11|||
27874055|NCT02108262|54491806|FG003|Overall Study|Patient unable to come to site/attend visit|6|||
27874056|NCT02108262|54491803|FG000|Overall Study|Patient did not want another infusion|0|||
27874057|NCT02108262|54491804|FG001|Overall Study|Patient did not want another infusion|3|||
27874058|NCT02108262|54491805|FG002|Overall Study|Patient did not want another infusion|3|||
27874059|NCT02108262|54491806|FG003|Overall Study|Patient did not want another infusion|2|||
27874060|NCT02108262|54491803|FG000|Overall Study|Vacation|0|||
27874061|NCT02108262|54491804|FG001|Overall Study|Vacation|1|||
27874062|NCT02108262|54491805|FG002|Overall Study|Vacation|0|||
27874063|NCT02108262|54491806|FG003|Overall Study|Vacation|0|||
27874064|NCT02108262|54491803|FG000|Overall Study|Patient decision|0|||
27874065|NCT02108262|54491804|FG001|Overall Study|Patient decision|7|||
27874066|NCT02108262|54491805|FG002|Overall Study|Patient decision|9|||
27874067|NCT02108262|54491806|FG003|Overall Study|Patient decision|14|||
27874068|NCT02108262|54491803|FG000|Overall Study|Missed IV due to pharmacy error|0|||
27874069|NCT02108262|54491804|FG001|Overall Study|Missed IV due to pharmacy error|0|||
27874070|NCT02108262|54491805|FG002|Overall Study|Missed IV due to pharmacy error|1|||
27874071|NCT02108262|54491806|FG003|Overall Study|Missed IV due to pharmacy error|0|||
27874072|NCT02107482|54491815|FG000|Overall Study|inconveinence|2|||
27874073|NCT02107482|54491815|FG000|Overall Study|Lost to Follow-up|1|||
27874074|NCT02107482|54491815|FG000|Overall Study|Lack of Efficacy|1|||
27874075|NCT02066298|54491825|FG000|Overall Study|Lost to Follow-up|3|||
27874076|NCT02066298|54491826|FG001|Overall Study|Lost to Follow-up|2|||
27874077|NCT02066298|54491827|FG002|Overall Study|Lost to Follow-up|3|||
27874078|NCT02066298|54491828|FG003|Overall Study|Lost to Follow-up|2|||
27874079|NCT02066298|54491829|FG004|Overall Study|Lost to Follow-up|3|||
27874080|NCT02066298|54491830|FG005|Overall Study|Lost to Follow-up|4|||
27874081|NCT02066298|54491825|FG000|Overall Study|Withdrawal by Subject|6|||
27874082|NCT02066298|54491826|FG001|Overall Study|Withdrawal by Subject|6|||
27982767|NCT02017717|54640942|FG003|Treatment Period|other reasons|0|||
27982768|NCT02017717|54640943|FG004|Treatment Period|other reasons|1|||
27982769|NCT02017717|54640944|FG005|Treatment Period|other reasons|0|||
28096397|NCT03988088|54751326|FG003|Open-Label Addendum|Lost to Follow-up|0|||
28096398|NCT03987932|54751337|FG000|Overall Study|Lost to Follow-up|2|||
28096399|NCT03987932|54751338|FG001|Overall Study|Lost to Follow-up|1|||
27874083|NCT02066298|54491827|FG002|Overall Study|Withdrawal by Subject|6|||
27874084|NCT02066298|54491828|FG003|Overall Study|Withdrawal by Subject|4|||
27874085|NCT02066298|54491829|FG004|Overall Study|Withdrawal by Subject|5|||
27874086|NCT02066298|54491830|FG005|Overall Study|Withdrawal by Subject|8|||
27874087|NCT02066298|54491825|FG000|Overall Study|Physician Decision|0|||
27874088|NCT02066298|54491826|FG001|Overall Study|Physician Decision|0|||
27874089|NCT02066298|54491827|FG002|Overall Study|Physician Decision|1|||
27874090|NCT02066298|54491828|FG003|Overall Study|Physician Decision|0|||
27874091|NCT02066298|54491829|FG004|Overall Study|Physician Decision|1|||
27874092|NCT02066298|54491830|FG005|Overall Study|Physician Decision|0|||
28096400|NCT03987932|54751339|FG002|Overall Study|Lost to Follow-up|1|||
27739079|NCT02495168|54188421|FG002|Overall Study|Lost to Follow-up|1|||
27874093|NCT02082912|54491844|FG000|Overall Study|Physician Decision|0|||
27874094|NCT02082912|54491845|FG001|Overall Study|Physician Decision|1|||
27982770|NCT02017717|54640945|FG006|Treatment Period|other reasons|0|||
27874095|NCT02082522|54491853|FG000|Overall Study|Sponsor termination|5|||
27874096|NCT02082522|54491854|FG001|Overall Study|Sponsor termination|3|||
27874097|NCT02082522|54491853|FG000|Overall Study|Withdrawal by Subject|2|||
27874098|NCT02082522|54491854|FG001|Overall Study|Withdrawal by Subject|4|||
27874099|NCT02082522|54491853|FG000|Overall Study|Death|1|||
27874100|NCT02082522|54491854|FG001|Overall Study|Death|0|||
27874101|NCT02082522|54491853|FG000|Overall Study|Lost to Follow-up|1|||
27874102|NCT02082522|54491854|FG001|Overall Study|Lost to Follow-up|0|||
27874103|NCT02082522|54491853|FG000|Overall Study|Physician Decision|3|||
27874104|NCT02082522|54491854|FG001|Overall Study|Physician Decision|1|||
27874105|NCT02082522|54491853|FG000|Overall Study|Disease progression|2|||
27874106|NCT02082522|54491854|FG001|Overall Study|Disease progression|2|||
27874107|NCT02082522|54491853|FG000|Overall Study|Chemotherapy change|1|||
27874108|NCT02082522|54491854|FG001|Overall Study|Chemotherapy change|3|||
27874109|NCT02082210|54491866|FG000|Overall Study|Death|0|||
27874110|NCT02082210|54491867|FG001|Overall Study|Death|0|||
27874111|NCT02082210|54491868|FG002|Overall Study|Death|1|||
27874112|NCT02082210|54491869|FG003|Overall Study|Death|1|||
27874113|NCT02082210|54491870|FG004|Overall Study|Death|1|||
27874114|NCT02082210|54491871|FG005|Overall Study|Death|0|||
27874115|NCT02082210|54491866|FG000|Overall Study|Withdrawal by Subject|0|||
27874116|NCT02082210|54491867|FG001|Overall Study|Withdrawal by Subject|0|||
27874117|NCT02082210|54491868|FG002|Overall Study|Withdrawal by Subject|0|||
27874118|NCT02082210|54491869|FG003|Overall Study|Withdrawal by Subject|1|||
27874119|NCT02082210|54491870|FG004|Overall Study|Withdrawal by Subject|2|||
27874120|NCT02082210|54491871|FG005|Overall Study|Withdrawal by Subject|2|||
27874121|NCT02082210|54491866|FG000|Overall Study|Clinical Progression|0|||
27874122|NCT02082210|54491867|FG001|Overall Study|Clinical Progression|0|||
27874123|NCT02082210|54491868|FG002|Overall Study|Clinical Progression|0|||
27874124|NCT02082210|54491869|FG003|Overall Study|Clinical Progression|1|||
27874125|NCT02082210|54491870|FG004|Overall Study|Clinical Progression|0|||
27874126|NCT02082210|54491871|FG005|Overall Study|Clinical Progression|0|||
27874127|NCT02082210|54491866|FG000|Overall Study|No Post-Baseline Tumor Assesment|0|||
27874128|NCT02082210|54491867|FG001|Overall Study|No Post-Baseline Tumor Assesment|0|||
27874129|NCT02082210|54491868|FG002|Overall Study|No Post-Baseline Tumor Assesment|1|||
27874130|NCT02082210|54491869|FG003|Overall Study|No Post-Baseline Tumor Assesment|2|||
27874131|NCT02082210|54491870|FG004|Overall Study|No Post-Baseline Tumor Assesment|0|||
27874132|NCT02082210|54491871|FG005|Overall Study|No Post-Baseline Tumor Assesment|0|||
27874133|NCT02082210|54491866|FG000|Overall Study|Physician Decision|0|||
27874134|NCT02082210|54491867|FG001|Overall Study|Physician Decision|0|||
27874135|NCT02082210|54491868|FG002|Overall Study|Physician Decision|1|||
27874136|NCT02082210|54491869|FG003|Overall Study|Physician Decision|1|||
27874137|NCT02082210|54491870|FG004|Overall Study|Physician Decision|0|||
27874138|NCT02082210|54491871|FG005|Overall Study|Physician Decision|0|||
27874139|NCT02107092|54491897|FG000|Overall Study|Miscellaneous|3|||
27874140|NCT02107092|54491897|FG000|Overall Study|Subject compliance|3|||
27874141|NCT02107092|54491897|FG000|Overall Study|Hypo-or hyperkalemia|2|||
27874142|NCT02107092|54491897|FG000|Overall Study|Met ECG withdrawal criteria|3|||
27874143|NCT02107092|54491897|FG000|Overall Study|Physician Decision|3|||
27874144|NCT02107092|54491897|FG000|Overall Study|Lost to Follow-up|2|||
27874145|NCT02107092|54491897|FG000|Overall Study|Withdrawal by Subject|9|||
27874146|NCT02107092|54491897|FG000|Overall Study|Adverse Event|7|||
27874147|NCT02107092|54491897|FG000|Overall Study|Expected progression of CKD|12|||
27874148|NCT02107014|54491901|FG000|Overall Study|Withdrew before drug: moving interstate|1|||
27874149|NCT01624974|54491907|FG000|Period III of Treatment (4 Weeks)|Lack of Efficacy|0|||
27874150|NCT01624974|54491908|FG001|Period III of Treatment (4 Weeks)|Lack of Efficacy|2|||
27874151|NCT01624974|54491907|FG000|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1|||
27874152|NCT01624974|54491908|FG001|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2|||
27874153|NCT01624974|54491907|FG000|Period III of Treatment (4 Weeks)|Physician Decision|5|||
27874154|NCT01624974|54491908|FG001|Period III of Treatment (4 Weeks)|Physician Decision|3|||
27874155|NCT01624974|54491907|FG000|Period III of Treatment (4 Weeks)|Protocol Violation|1|||
27874156|NCT01624974|54491908|FG001|Period III of Treatment (4 Weeks)|Protocol Violation|0|||
27874157|NCT01624974|54491907|FG000|Period III of Treatment (4 Weeks)|Adverse Event|0|||
28096401|NCT03987932|54751337|FG000|Overall Study|Non-study related elective surgery|0|||
27739080|NCT02495168|54188419|FG000|Overall Study|Withdrawal by Subject|1|||
27874158|NCT01624974|54491908|FG001|Period III of Treatment (4 Weeks)|Adverse Event|1|||
27874159|NCT01624974|54491907|FG000|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
27874160|NCT01624974|54491908|FG001|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
27874161|NCT01624974|54491907|FG000|Period IV Washout (4 Weeks)|Withdrawal by Subject|0|||
27874162|NCT01624974|54491908|FG001|Period IV Washout (4 Weeks)|Withdrawal by Subject|1|||
27874163|NCT01624974|54491907|FG000|Period IV Washout (4 Weeks)|Adverse Event|2|||
27874164|NCT01624974|54491908|FG001|Period IV Washout (4 Weeks)|Adverse Event|0|||
27874165|NCT01624974|54491907|FG000|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0|||
27874166|NCT01624974|54491908|FG001|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1|||
27874167|NCT01624974|54491907|FG000|Period V of Treatment (4 Weeks)|Lack of Efficacy|1|||
27874168|NCT01624974|54491908|FG001|Period V of Treatment (4 Weeks)|Lack of Efficacy|0|||
27874169|NCT01624974|54491907|FG000|Period V of Treatment (4 Weeks)|Physician Decision|3|||
27874170|NCT01624974|54491908|FG001|Period V of Treatment (4 Weeks)|Physician Decision|0|||
27874171|NCT01624974|54491907|FG000|Period V of Treatment (4 Weeks)|Adverse Event|1|||
27874172|NCT01624974|54491908|FG001|Period V of Treatment (4 Weeks)|Adverse Event|0|||
27874173|NCT02065518|54491919|FG000|Overall Study|Lost to Follow-up|3|||
27874174|NCT02065518|54491920|FG001|Overall Study|Lost to Follow-up|4|||
27874175|NCT02065518|54491921|FG002|Overall Study|Lost to Follow-up|0|||
27874176|NCT02065518|54491922|FG003|Overall Study|Lost to Follow-up|3|||
27874177|NCT02065518|54491919|FG000|Overall Study|Withdrawal by Subject|3|||
27874178|NCT02065518|54491920|FG001|Overall Study|Withdrawal by Subject|4|||
27874179|NCT02065518|54491921|FG002|Overall Study|Withdrawal by Subject|9|||
27874180|NCT02065518|54491922|FG003|Overall Study|Withdrawal by Subject|2|||
27874181|NCT01624662|54491936|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
27874182|NCT01624662|54491937|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
27874183|NCT01624662|54491938|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
27874184|NCT01624662|54491939|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0|||
27874185|NCT01624662|54491936|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5|||
27874186|NCT01624662|54491937|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1|||
27874187|NCT01624662|54491938|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
27874188|NCT01624662|54491939|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
27874189|NCT01624662|54491936|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
27874190|NCT01624662|54491937|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
27874191|NCT01624662|54491938|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
27874192|NCT01624662|54491939|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
27874193|NCT01624662|54491936|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
27874194|NCT01624662|54491937|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
27874195|NCT01624662|54491938|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
27874196|NCT01624662|54491939|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
27874197|NCT01624662|54491936|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
27874198|NCT01624662|54491937|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
27874199|NCT01624662|54491938|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
27874200|NCT01624662|54491939|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
27874201|NCT01624662|54491936|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
27874202|NCT01624662|54491937|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
27874203|NCT01624662|54491938|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
27874204|NCT01624662|54491939|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
27874205|NCT01624662|54491936|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
27874206|NCT01624662|54491937|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
27874207|NCT01624662|54491938|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
27874208|NCT01624662|54491939|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
27874209|NCT01624506|54491962|FG000|Overall Study|Lost to Follow-up|29|||
27874210|NCT01624506|54491963|FG001|Overall Study|Lost to Follow-up|15|||
27874211|NCT01624506|54491962|FG000|Overall Study|Withdrawal by Subject|9|||
27874212|NCT01624506|54491963|FG001|Overall Study|Withdrawal by Subject|2|||
27874213|NCT01624506|54491962|FG000|Overall Study|Death|1|||
27874214|NCT01624506|54491963|FG001|Overall Study|Death|0|||
27874215|NCT01624506|54491962|FG000|Overall Study|LINX explants|23|||
27874216|NCT01624506|54491963|FG001|Overall Study|LINX explants|0|||
27874217|NCT01624506|54491962|FG000|Overall Study|Adverse Event|3|||
27874218|NCT01624506|54491963|FG001|Overall Study|Adverse Event|0|||
27874219|NCT02106390|54491972|FG000|Overall Study|Withdrawal by Subject|15|||
27874220|NCT02106390|54491973|FG001|Overall Study|Withdrawal by Subject|16|||
27874221|NCT02106390|54491974|FG002|Overall Study|Withdrawal by Subject|15|||
27874222|NCT02106390|54491972|FG000|Overall Study|Lost to Follow-up|25|||
27874223|NCT02106390|54491973|FG001|Overall Study|Lost to Follow-up|20|||
27874224|NCT02106390|54491974|FG002|Overall Study|Lost to Follow-up|13|||
27874225|NCT02106390|54491972|FG000|Overall Study|Other: Administrative Reason|8|||
27874226|NCT02106390|54491973|FG001|Overall Study|Other: Administrative Reason|5|||
27874227|NCT02106390|54491974|FG002|Overall Study|Other: Administrative Reason|12|||
27874228|NCT02106390|54491972|FG000|Overall Study|Other: Unspecified|1|||
27874229|NCT02106390|54491973|FG001|Overall Study|Other: Unspecified|4|||
27874230|NCT02106390|54491974|FG002|Overall Study|Other: Unspecified|2|||
27874231|NCT02106390|54491972|FG000|Overall Study|Adverse Event|0|||
27874232|NCT02106390|54491973|FG001|Overall Study|Adverse Event|2|||
27874233|NCT02106390|54491974|FG002|Overall Study|Adverse Event|1|||
27874234|NCT02106390|54491972|FG000|Overall Study|Protocol Violation|0|||
27874235|NCT02106390|54491973|FG001|Overall Study|Protocol Violation|1|||
27874236|NCT02106390|54491974|FG002|Overall Study|Protocol Violation|0|||
27874237|NCT02064894|54491988|FG000|Overall Study|Withdrawal by Subject|43|||
27874238|NCT02064894|54491989|FG001|Overall Study|Withdrawal by Subject|102|||
27874239|NCT02064894|54491990|FG002|Overall Study|Withdrawal by Subject|115|||
27874240|NCT02081586|54492002|FG000|Overall Study|Lost to Follow-up|0|||
27874241|NCT02081586|54492003|FG001|Overall Study|Lost to Follow-up|1|||
27874242|NCT02081586|54492004|FG002|Overall Study|Lost to Follow-up|0|||
27874243|NCT02081586|54492005|FG003|Overall Study|Lost to Follow-up|1|||
27874244|NCT02081586|54492002|FG000|Overall Study|Head injury not related to study|0|||
27874245|NCT02081586|54492003|FG001|Overall Study|Head injury not related to study|0|||
27874246|NCT02081586|54492004|FG002|Overall Study|Head injury not related to study|1|||
27874247|NCT02081586|54492005|FG003|Overall Study|Head injury not related to study|0|||
27874248|NCT02081196|54492017|FG000|Overall Study|Lost to Follow-up|1|||
27874249|NCT02064816|54492025|FG000|Overall Study|Adverse Event|3|||
27874250|NCT02064816|54492026|FG001|Overall Study|Adverse Event|2|||
27874251|NCT02064816|54492025|FG000|Overall Study|Withdrawal by Subject|2|||
27874252|NCT02064816|54492026|FG001|Overall Study|Withdrawal by Subject|1|||
27874253|NCT02064816|54492025|FG000|Overall Study|Lost to Follow-up|2|||
27874254|NCT02064816|54492026|FG001|Overall Study|Lost to Follow-up|1|||
27874255|NCT02064816|54492025|FG000|Overall Study|Therapeutic failure|0|||
27874256|NCT02064816|54492026|FG001|Overall Study|Therapeutic failure|1|||
27874257|NCT02064816|54492025|FG000|Overall Study|Other|1|||
27874258|NCT02064816|54492026|FG001|Overall Study|Other|3|||
27874259|NCT02080260|54492032|FG000|Overall Study|Death|18|||
27874260|NCT02080260|54492032|FG000|Overall Study|Withdrawal by Subject|1|||
27874261|NCT01624194|54492038|FG000|Overall Study|Lost to Follow-up|1|||
27874262|NCT01624194|54492039|FG001|Overall Study|Lost to Follow-up|0|||
27874263|NCT01624194|54492038|FG000|Overall Study|Withdrawal by Subject|1|||
27874264|NCT01624194|54492039|FG001|Overall Study|Withdrawal by Subject|0|||
27874265|NCT02079636|54492061|FG000|Overall Study|Death|2|||
27874266|NCT02079636|54492062|FG001|Overall Study|Death|1|||
27874267|NCT02079636|54492063|FG002|Overall Study|Death|0|||
27874268|NCT02079636|54492064|FG003|Overall Study|Death|5|||
27874269|NCT02079636|54492065|FG004|Overall Study|Death|1|||
27874270|NCT02079636|54492066|FG005|Overall Study|Death|2|||
27874271|NCT02079636|54492067|FG006|Overall Study|Death|1|||
27874272|NCT02079636|54492068|FG007|Overall Study|Death|0|||
27874273|NCT02079636|54492069|FG008|Overall Study|Death|0|||
27874274|NCT02079636|54492070|FG009|Overall Study|Death|0|||
27874275|NCT02079636|54492071|FG010|Overall Study|Death|0|||
27874276|NCT02079636|54492072|FG011|Overall Study|Death|1|||
27874277|NCT02079636|54492073|FG012|Overall Study|Death|1|||
27874278|NCT02079636|54492074|FG013|Overall Study|Death|0|||
27874279|NCT02079636|54492075|FG014|Overall Study|Death|2|||
27874280|NCT02079636|54492061|FG000|Overall Study|Adverse Event|1|||
27874281|NCT02079636|54492062|FG001|Overall Study|Adverse Event|1|||
27874282|NCT02079636|54492063|FG002|Overall Study|Adverse Event|0|||
27874283|NCT02079636|54492064|FG003|Overall Study|Adverse Event|1|||
27874284|NCT02079636|54492065|FG004|Overall Study|Adverse Event|1|||
27874285|NCT02079636|54492066|FG005|Overall Study|Adverse Event|2|||
27874286|NCT02079636|54492067|FG006|Overall Study|Adverse Event|0|||
27874287|NCT02079636|54492068|FG007|Overall Study|Adverse Event|0|||
27874288|NCT02079636|54492069|FG008|Overall Study|Adverse Event|0|||
27874289|NCT02079636|54492070|FG009|Overall Study|Adverse Event|0|||
27874290|NCT02079636|54492071|FG010|Overall Study|Adverse Event|0|||
27874291|NCT02079636|54492072|FG011|Overall Study|Adverse Event|0|||
27874292|NCT02079636|54492073|FG012|Overall Study|Adverse Event|0|||
27874293|NCT02079636|54492074|FG013|Overall Study|Adverse Event|0|||
27874294|NCT02079636|54492075|FG014|Overall Study|Adverse Event|0|||
27874295|NCT02079636|54492061|FG000|Overall Study|Progressive disease|0|||
27874296|NCT02079636|54492062|FG001|Overall Study|Progressive disease|0|||
27874297|NCT02079636|54492063|FG002|Overall Study|Progressive disease|0|||
27874298|NCT02079636|54492064|FG003|Overall Study|Progressive disease|2|||
27874299|NCT02079636|54492065|FG004|Overall Study|Progressive disease|0|||
27874300|NCT02079636|54492066|FG005|Overall Study|Progressive disease|0|||
27874301|NCT02079636|54492067|FG006|Overall Study|Progressive disease|0|||
27874302|NCT02079636|54492068|FG007|Overall Study|Progressive disease|0|||
27874303|NCT02079636|54492069|FG008|Overall Study|Progressive disease|0|||
27874304|NCT02079636|54492070|FG009|Overall Study|Progressive disease|0|||
27874305|NCT02079636|54492071|FG010|Overall Study|Progressive disease|0|||
27874306|NCT02079636|54492072|FG011|Overall Study|Progressive disease|0|||
28096402|NCT03987932|54751338|FG001|Overall Study|Non-study related elective surgery|0|||
28096403|NCT03987932|54751339|FG002|Overall Study|Non-study related elective surgery|1|||
28096404|NCT03987620|54751349|FG000|Overall Study|Lack of Efficacy or Use of antifungal therapy|43|||
27874307|NCT02079636|54492073|FG012|Overall Study|Progressive disease|1|||
27874308|NCT02079636|54492074|FG013|Overall Study|Progressive disease|0|||
27874309|NCT02079636|54492075|FG014|Overall Study|Progressive disease|0|||
27874310|NCT02079636|54492061|FG000|Overall Study|Withdrawal by Subject|0|||
27874311|NCT02079636|54492062|FG001|Overall Study|Withdrawal by Subject|0|||
27874312|NCT02079636|54492063|FG002|Overall Study|Withdrawal by Subject|0|||
27874313|NCT02079636|54492064|FG003|Overall Study|Withdrawal by Subject|4|||
27874314|NCT02079636|54492065|FG004|Overall Study|Withdrawal by Subject|0|||
27874315|NCT02079636|54492066|FG005|Overall Study|Withdrawal by Subject|1|||
27874316|NCT02079636|54492067|FG006|Overall Study|Withdrawal by Subject|0|||
27874317|NCT02079636|54492068|FG007|Overall Study|Withdrawal by Subject|0|||
27874318|NCT02079636|54492069|FG008|Overall Study|Withdrawal by Subject|0|||
27874319|NCT02079636|54492070|FG009|Overall Study|Withdrawal by Subject|2|||
27874320|NCT02079636|54492071|FG010|Overall Study|Withdrawal by Subject|1|||
27874321|NCT02079636|54492072|FG011|Overall Study|Withdrawal by Subject|1|||
27874322|NCT02079636|54492073|FG012|Overall Study|Withdrawal by Subject|1|||
27874323|NCT02079636|54492074|FG013|Overall Study|Withdrawal by Subject|0|||
27874324|NCT02079636|54492075|FG014|Overall Study|Withdrawal by Subject|2|||
27874325|NCT02079636|54492061|FG000|Overall Study|Physician Decision|0|||
27874326|NCT02079636|54492062|FG001|Overall Study|Physician Decision|0|||
27874327|NCT02079636|54492063|FG002|Overall Study|Physician Decision|0|||
27874328|NCT02079636|54492064|FG003|Overall Study|Physician Decision|0|||
27874329|NCT02079636|54492065|FG004|Overall Study|Physician Decision|0|||
27874330|NCT02079636|54492066|FG005|Overall Study|Physician Decision|1|||
27874331|NCT02079636|54492067|FG006|Overall Study|Physician Decision|0|||
27874332|NCT02079636|54492068|FG007|Overall Study|Physician Decision|0|||
27874333|NCT02079636|54492069|FG008|Overall Study|Physician Decision|0|||
27874334|NCT02079636|54492070|FG009|Overall Study|Physician Decision|1|||
27874335|NCT02079636|54492071|FG010|Overall Study|Physician Decision|1|||
27874336|NCT02079636|54492072|FG011|Overall Study|Physician Decision|0|||
27874337|NCT02079636|54492073|FG012|Overall Study|Physician Decision|0|||
27874338|NCT02079636|54492074|FG013|Overall Study|Physician Decision|0|||
27874339|NCT02079636|54492075|FG014|Overall Study|Physician Decision|1|||
27874340|NCT02079636|54492061|FG000|Overall Study|Lost to Follow-up|0|||
27874341|NCT02079636|54492062|FG001|Overall Study|Lost to Follow-up|0|||
27874342|NCT02079636|54492063|FG002|Overall Study|Lost to Follow-up|0|||
27874343|NCT02079636|54492064|FG003|Overall Study|Lost to Follow-up|0|||
27874344|NCT02079636|54492065|FG004|Overall Study|Lost to Follow-up|0|||
27874345|NCT02079636|54492066|FG005|Overall Study|Lost to Follow-up|0|||
27874346|NCT02079636|54492067|FG006|Overall Study|Lost to Follow-up|0|||
27874347|NCT02079636|54492068|FG007|Overall Study|Lost to Follow-up|1|||
27874348|NCT02079636|54492069|FG008|Overall Study|Lost to Follow-up|0|||
27874349|NCT02079636|54492070|FG009|Overall Study|Lost to Follow-up|0|||
27874350|NCT02079636|54492071|FG010|Overall Study|Lost to Follow-up|0|||
27874351|NCT02079636|54492072|FG011|Overall Study|Lost to Follow-up|0|||
27874352|NCT02079636|54492073|FG012|Overall Study|Lost to Follow-up|0|||
27874353|NCT02079636|54492074|FG013|Overall Study|Lost to Follow-up|0|||
27874354|NCT02079636|54492075|FG014|Overall Study|Lost to Follow-up|0|||
27874355|NCT02079246|54492139|FG000|OLEX|Withdrawal before treatment|1|||
27874356|NCT02079246|54492140|FG001|OLEX|Withdrawal before treatment|0|||
27874357|NCT02079246|54492139|FG000|OLEX|Death|11|||
27874358|NCT02079246|54492140|FG001|OLEX|Death|0|||
27874359|NCT02079246|54492139|FG000|OLEX|Adverse Event|66|||
27874360|NCT02079246|54492140|FG001|OLEX|Adverse Event|0|||
27874361|NCT02079246|54492139|FG000|OLEX|Withdrawal by Subject|60|||
27874362|NCT02079246|54492140|FG001|OLEX|Withdrawal by Subject|0|||
27874363|NCT02079246|54492139|FG000|OLEX|Lost to Follow-up|6|||
27874364|NCT02079246|54492140|FG001|OLEX|Lost to Follow-up|0|||
27874365|NCT02079246|54492139|FG000|OLEX|Protocol Violation|6|||
27874366|NCT02079246|54492140|FG001|OLEX|Protocol Violation|0|||
27874367|NCT02079246|54492139|FG000|OLEX|Lack of Efficacy|3|||
27874368|NCT02079246|54492140|FG001|OLEX|Lack of Efficacy|0|||
27874369|NCT02079246|54492139|FG000|OLEX|Results of the lead-in studies|58|||
27874370|NCT02079246|54492140|FG001|OLEX|Results of the lead-in studies|0|||
27874371|NCT02079246|54492139|FG000|OLEX|Other: Disallowed medication|8|||
27874372|NCT02079246|54492140|FG001|OLEX|Other: Disallowed medication|0|||
27874373|NCT02079246|54492139|FG000|OLEX|Other: Insufficient compliance|2|||
27874374|NCT02079246|54492140|FG001|OLEX|Other: Insufficient compliance|0|||
27874375|NCT02079246|54492139|FG000|OLEX|Other: Caregiver unavailable|3|||
27874376|NCT02079246|54492140|FG001|OLEX|Other: Caregiver unavailable|0|||
27874377|NCT02079246|54492139|FG000|OLEX|Other: Coordinator decision|1|||
27874378|NCT02079246|54492140|FG001|OLEX|Other: Coordinator decision|0|||
27874379|NCT02079246|54492139|FG000|OLEX|Other: Worsening of condition|1|||
27874380|NCT02079246|54492140|FG001|OLEX|Other: Worsening of condition|0|||
27874381|NCT02079246|54492139|FG000|OLEX|Other: Moved to nursing home|1|||
27874382|NCT02079246|54492140|FG001|OLEX|Other: Moved to nursing home|0|||
27874383|NCT02079246|54492139|FG000|OLEX|Other: Withdrawal of caregiver consent|1|||
27874384|NCT02079246|54492140|FG001|OLEX|Other: Withdrawal of caregiver consent|0|||
27874385|NCT02079246|54492139|FG000|OLEX-MEM|Adverse Event|0|||
27874386|NCT02079246|54492140|FG001|OLEX-MEM|Adverse Event|6|||
27874387|NCT02079246|54492139|FG000|OLEX-MEM|Withdrawal by Subject|0|||
27874388|NCT02079246|54492140|FG001|OLEX-MEM|Withdrawal by Subject|7|||
27874389|NCT02079246|54492139|FG000|OLEX-MEM|Protocol Violation|0|||
27874390|NCT02079246|54492140|FG001|OLEX-MEM|Protocol Violation|2|||
27874391|NCT02079246|54492139|FG000|OLEX-MEM|Lost to Follow-up|0|||
27874392|NCT02079246|54492140|FG001|OLEX-MEM|Lost to Follow-up|1|||
27874393|NCT02079246|54492139|FG000|OLEX-MEM|Other: Moved to nursing home|0|||
27874394|NCT02079246|54492140|FG001|OLEX-MEM|Other: Moved to nursing home|3|||
27874395|NCT02077374|54492151|FG000|Overall Study|Withdrawal by Subject|0|||
27982771|NCT02017717|54640946|FG007|Treatment Period|other reasons|1|||
27874396|NCT02077374|54492152|FG001|Overall Study|Withdrawal by Subject|1|||
27874397|NCT02077374|54492151|FG000|Overall Study|Protocol Violation|0|||
27874398|NCT02077374|54492152|FG001|Overall Study|Protocol Violation|1|||
27874399|NCT02077140|54492166|FG000|Overall Study|Lost to Follow-up|4|||
27874400|NCT02077140|54492167|FG001|Overall Study|Lost to Follow-up|1|||
27874401|NCT02077140|54492168|FG002|Overall Study|Lost to Follow-up|2|||
28171606|NCT01370083|54843230|FG000|Overall Study|Lost to Follow-up|2|||
28171607|NCT01370083|54843231|FG001|Overall Study|Lost to Follow-up|0|||
27739081|NCT02495168|54188420|FG001|Overall Study|Withdrawal by Subject|4|||
27739082|NCT02495168|54188421|FG002|Overall Study|Withdrawal by Subject|2|||
27739083|NCT02495168|54188419|FG000|Overall Study|Protocol Violation|0|||
27739084|NCT02495168|54188420|FG001|Overall Study|Protocol Violation|10|||
27739085|NCT02495168|54188421|FG002|Overall Study|Protocol Violation|1|||
27739086|NCT02495168|54188419|FG000|Overall Study|Adverse Event|4|||
27739087|NCT02495168|54188420|FG001|Overall Study|Adverse Event|8|||
27739088|NCT02495168|54188421|FG002|Overall Study|Adverse Event|3|||
27739089|NCT02495168|54188419|FG000|Overall Study|Lack of Efficacy|0|||
27739090|NCT02495168|54188420|FG001|Overall Study|Lack of Efficacy|0|||
27739091|NCT02495168|54188421|FG002|Overall Study|Lack of Efficacy|3|||
27739092|NCT02494778|54188429|FG000|Overall Study|Death|3|||
27739093|NCT02494778|54188429|FG000|Overall Study|Other|173|||
27739094|NCT02494778|54188429|FG000|Overall Study|Lack of Efficacy|4|||
27739095|NCT02494778|54188429|FG000|Overall Study|Adverse Event|18|||
27739096|NCT02494778|54188429|FG000|Overall Study|Withdrawal by Subject|20|||
27739097|NCT02494778|54188429|FG000|Overall Study|Lost to Follow-up|2|||
27739098|NCT02494778|54188429|FG000|Overall Study|Noncompliant with study drug admin.|1|||
27739099|NCT02493764|54188435|FG000|Overall Study|Adverse Event|2|||
27739100|NCT02493764|54188436|FG001|Overall Study|Adverse Event|2|||
27739101|NCT02493764|54188435|FG000|Overall Study|Death|44|||
27739102|NCT02493764|54188436|FG001|Overall Study|Death|58|||
27739103|NCT02493764|54188435|FG000|Overall Study|Lost to Follow-up|2|||
27739104|NCT02493764|54188436|FG001|Overall Study|Lost to Follow-up|1|||
27739105|NCT02493764|54188435|FG000|Overall Study|Protocol Violation|6|||
27739106|NCT02493764|54188436|FG001|Overall Study|Protocol Violation|7|||
27739107|NCT02493764|54188435|FG000|Overall Study|Physician Decision|1|||
27739108|NCT02493764|54188436|FG001|Overall Study|Physician Decision|1|||
27739109|NCT02493764|54188435|FG000|Overall Study|Participant moved|17|||
27739110|NCT02493764|54188436|FG001|Overall Study|Participant moved|5|||
27739111|NCT02493764|54188435|FG000|Overall Study|Withdrawal parent/guardian|0|||
27739112|NCT02493764|54188436|FG001|Overall Study|Withdrawal parent/guardian|1|||
27739113|NCT02493764|54188435|FG000|Overall Study|Withdrawal by Subject|11|||
27739114|NCT02493764|54188436|FG001|Overall Study|Withdrawal by Subject|7|||
27739115|NCT02460380|54188444|FG000|Overall Study|Withdrawal by Subject|10|||
27739116|NCT02460380|54188445|FG001|Overall Study|Withdrawal by Subject|5|||
27739117|NCT02493062|54188452|FG000|Overall Study|Physician Decision|12|||
27739118|NCT02492984|54188458|FG000|Overall Study|Adverse Event|1|||
27739119|NCT02492984|54188459|FG001|Overall Study|Adverse Event|0|||
27739120|NCT02492984|54188458|FG000|Overall Study|Protocol Violation|1|||
27739121|NCT02492984|54188459|FG001|Overall Study|Protocol Violation|0|||
27739122|NCT02492984|54188458|FG000|Overall Study|Withdrawal by Subject|1|||
27739123|NCT02492984|54188459|FG001|Overall Study|Withdrawal by Subject|0|||
27739124|NCT01680159|54188472|FG000|Screening Period|Not meet criteria for dose-up period|7|||
27739125|NCT01680159|54188472|FG000|Increased Dose Period|Adverse Event|6|||
27739126|NCT01680159|54188472|FG000|Increased Dose Period|Withdrawal by Subject|2|||
27739127|NCT02491892|54188494|FG000|Overall Study|Adverse Event|1|||
27739128|NCT02491892|54188495|FG001|Overall Study|Adverse Event|1|||
27739129|NCT02491892|54188494|FG000|Overall Study|Death|1|||
27874402|NCT02077140|54492169|FG003|Overall Study|Lost to Follow-up|2|||
28171608|NCT01370083|54843230|FG000|Overall Study|Adverse Event|0|||
28171609|NCT01370083|54843231|FG001|Overall Study|Adverse Event|1|||
28171610|NCT03350815|54843237|FG000|Period 1|Adverse Event|10|||
28171611|NCT03350815|54843238|FG001|Period 1|Adverse Event|0|||
28171612|NCT03350815|54843239|FG002|Period 1|Adverse Event|0|||
28171613|NCT03350815|54843240|FG003|Period 1|Adverse Event|0|||
28171614|NCT03350815|54843237|FG000|Period 1|Technical problems|1|||
28171615|NCT03350815|54843238|FG001|Period 1|Technical problems|0|||
28171616|NCT03350815|54843239|FG002|Period 1|Technical problems|0|||
28171617|NCT03350815|54843240|FG003|Period 1|Technical problems|0|||
27739130|NCT02491892|54188495|FG001|Overall Study|Death|1|||
27739131|NCT02491892|54188494|FG000|Overall Study|Lack of Efficacy|37|||
27739132|NCT02491892|54188495|FG001|Overall Study|Lack of Efficacy|36|||
27739133|NCT02491892|54188494|FG000|Overall Study|Refused Treatment|1|||
27739134|NCT02491892|54188495|FG001|Overall Study|Refused Treatment|0|||
27739135|NCT02491892|54188494|FG000|Overall Study|Lost to Follow-up|1|||
27739136|NCT02491892|54188495|FG001|Overall Study|Lost to Follow-up|0|||
28171618|NCT03350815|54843237|FG000|Period 1|Lost to Follow-up|3|||
27739137|NCT02436356|54188511|FG000|Overall Study|Excluded by MRI Screening|0|||
27739138|NCT02436356|54188512|FG001|Overall Study|Excluded by MRI Screening|0|||
27739139|NCT02436356|54188513|FG002|Overall Study|Excluded by MRI Screening|2|||
27874403|NCT02077140|54492170|FG004|Overall Study|Lost to Follow-up|3|||
27739140|NCT02436356|54188511|FG000|Overall Study|Lost to Follow-up|0|||
27739141|NCT02436356|54188512|FG001|Overall Study|Lost to Follow-up|1|||
27739142|NCT02436356|54188513|FG002|Overall Study|Lost to Follow-up|0|||
27739143|NCT02436356|54188511|FG000|Overall Study|Surgical Approach (Dorsal not volar)|1|||
27739144|NCT02436356|54188512|FG001|Overall Study|Surgical Approach (Dorsal not volar)|0|||
27739145|NCT02436356|54188513|FG002|Overall Study|Surgical Approach (Dorsal not volar)|0|||
27739146|NCT02436356|54188511|FG000|Overall Study|Excluded due to other medical conditions|3|||
27739147|NCT02436356|54188512|FG001|Overall Study|Excluded due to other medical conditions|0|||
27739148|NCT02436356|54188513|FG002|Overall Study|Excluded due to other medical conditions|0|||
27739149|NCT02436356|54188511|FG000|Overall Study|Withdrawal by Subject|1|||
27739150|NCT02436356|54188512|FG001|Overall Study|Withdrawal by Subject|0|||
27739151|NCT02436356|54188513|FG002|Overall Study|Withdrawal by Subject|0|||
27739152|NCT02436200|54188526|FG000|Overall Study|Significant outlier|1|||
27739153|NCT01679613|54188530|FG000|Overall Study|other than stated above|0|||
27739154|NCT01679613|54188531|FG001|Overall Study|other than stated above|1|||
27739155|NCT01679613|54188532|FG002|Overall Study|other than stated above|2|||
27739156|NCT01679613|54188533|FG003|Overall Study|other than stated above|2|||
27739157|NCT02489630|54188542|FG000|Overall Study|Oversedation|1|||
27739158|NCT02489630|54188543|FG001|Overall Study|Oversedation|1|||
27739159|NCT02489630|54188542|FG000|Overall Study|Time to med. admin. > protocol limit|1|||
27739160|NCT02489630|54188543|FG001|Overall Study|Time to med. admin. > protocol limit|1|||
27739161|NCT02739347|54188551|FG000|Overall Study|Adverse Event|3|||
27739162|NCT02739347|54188552|FG001|Overall Study|Adverse Event|0|||
27739163|NCT02739347|54188551|FG000|Overall Study|Protocol Violation|0|||
27739164|NCT02739347|54188552|FG001|Overall Study|Protocol Violation|1|||
27739165|NCT02739347|54188551|FG000|Overall Study|Lost to Follow-up|0|||
27739166|NCT02739347|54188552|FG001|Overall Study|Lost to Follow-up|2|||
27739167|NCT02435966|54188561|FG000|Overall Study|Withdrawal by Subject|0|||
27739168|NCT02435966|54188562|FG001|Overall Study|Withdrawal by Subject|1|||
27739169|NCT02435966|54188563|FG002|Overall Study|Withdrawal by Subject|0|||
27739170|NCT01679301|54188571|FG000|Screening Period|screen failure|3|||
27739171|NCT01679301|54188572|FG001|Screening Period|screen failure|0|||
27739172|NCT01679301|54188573|FG002|Screening Period|screen failure|0|||
27739173|NCT01678911|54188579|FG000|Second Intervention|Lost to Follow-up|2|||
27739174|NCT01678911|54188580|FG001|Second Intervention|Lost to Follow-up|0|||
27739175|NCT02487446|54188586|FG000|Period 1|Physician Decision|0|||
27739176|NCT02487446|54188587|FG001|Period 1|Physician Decision|1|||
27739177|NCT02487446|54188586|FG000|Period 1|Lack of Efficacy|1|||
27739178|NCT02487446|54188587|FG001|Period 1|Lack of Efficacy|0|||
27739179|NCT02487446|54188586|FG000|Period 1|Protocol deviation|3|||
27739180|NCT02487446|54188587|FG001|Period 1|Protocol deviation|2|||
27739181|NCT02487446|54188586|FG000|Period 1|Lost to Follow-up|2|||
27739182|NCT02487446|54188587|FG001|Period 1|Lost to Follow-up|0|||
27739183|NCT02487446|54188586|FG000|Period 1|Withdrawal by Subject|2|||
27739184|NCT02487446|54188587|FG001|Period 1|Withdrawal by Subject|0|||
27739185|NCT02487446|54188586|FG000|Period 1|Adverse Event|5|||
27739186|NCT02487446|54188587|FG001|Period 1|Adverse Event|5|||
27739187|NCT02487446|54188586|FG000|Washout|Lost to Follow-up|0|||
27739188|NCT02487446|54188587|FG001|Washout|Lost to Follow-up|2|||
28096405|NCT03987620|54751350|FG001|Overall Study|Lack of Efficacy or Use of antifungal therapy|41|||
28096406|NCT03987620|54751349|FG000|Overall Study|Adverse Event|3|||
28096407|NCT03987620|54751350|FG001|Overall Study|Adverse Event|0|||
27739189|NCT02487446|54188586|FG000|Washout|Withdrawal by Subject|1|||
27739190|NCT02487446|54188587|FG001|Washout|Withdrawal by Subject|4|||
27739191|NCT02487446|54188586|FG000|Washout|Adverse Event|2|||
27739192|NCT02487446|54188587|FG001|Washout|Adverse Event|2|||
27739193|NCT02487446|54188586|FG000|Period 2|Protocol deviation|0|||
27739194|NCT02487446|54188587|FG001|Period 2|Protocol deviation|1|||
27739195|NCT02487446|54188586|FG000|Period 2|Lost to Follow-up|1|||
27739196|NCT02487446|54188587|FG001|Period 2|Lost to Follow-up|1|||
27739197|NCT02487446|54188586|FG000|Period 2|Withdrawal by Subject|1|||
27739198|NCT02487446|54188587|FG001|Period 2|Withdrawal by Subject|1|||
27739199|NCT02487446|54188586|FG000|Period 2|Adverse Event|6|||
27982772|NCT02017717|54640947|FG008|Treatment Period|other reasons|1|||
28096408|NCT03987620|54751349|FG000|Overall Study|Lost to Follow-up|1|||
27739200|NCT02487446|54188587|FG001|Period 2|Adverse Event|2|||
27739201|NCT02739269|54188596|FG000|Overall Study|Protocol Violation|5|||
27739202|NCT02739269|54188597|FG001|Overall Study|Protocol Violation|0|||
27739203|NCT02739269|54188596|FG000|Overall Study|Cycle cancellation|2|||
27739204|NCT02739269|54188597|FG001|Overall Study|Cycle cancellation|2|||
27739205|NCT02739269|54188596|FG000|Overall Study|Withdrawal by Subject|0|||
27739206|NCT02739269|54188597|FG001|Overall Study|Withdrawal by Subject|2|||
27739207|NCT03318523|54188607|FG000|PC Period: Up to Year 1|Adverse Event|1|||
27739208|NCT03318523|54188608|FG001|PC Period: Up to Year 1|Adverse Event|0|||
27739209|NCT03318523|54188609|FG002|PC Period: Up to Year 1|Adverse Event|2|||
27739210|NCT03318523|54188610|FG003|PC Period: Up to Year 1|Adverse Event|0|||
27739211|NCT03318523|54188611|FG004|PC Period: Up to Year 1|Adverse Event|0|||
28096409|NCT03987620|54751350|FG001|Overall Study|Lost to Follow-up|2|||
27739212|NCT03318523|54188612|FG005|PC Period: Up to Year 1|Adverse Event|0|||
27739213|NCT03318523|54188613|FG006|PC Period: Up to Year 1|Adverse Event|0|||
27739214|NCT03318523|54188614|FG007|PC Period: Up to Year 1|Adverse Event|0|||
27739215|NCT03318523|54188615|FG008|PC Period: Up to Year 1|Adverse Event|0|||
27739216|NCT03318523|54188616|FG009|PC Period: Up to Year 1|Adverse Event|0|||
27739217|NCT03318523|54188607|FG000|PC Period: Up to Year 1|Consent Withdrawn|3|||
27739218|NCT03318523|54188608|FG001|PC Period: Up to Year 1|Consent Withdrawn|2|||
27739219|NCT03318523|54188609|FG002|PC Period: Up to Year 1|Consent Withdrawn|0|||
27739220|NCT03318523|54188610|FG003|PC Period: Up to Year 1|Consent Withdrawn|4|||
27739221|NCT03318523|54188611|FG004|PC Period: Up to Year 1|Consent Withdrawn|0|||
27739222|NCT03318523|54188612|FG005|PC Period: Up to Year 1|Consent Withdrawn|0|||
27874404|NCT02077140|54492166|FG000|Overall Study|Withdrawal by Subject|0|||
27874405|NCT02077140|54492167|FG001|Overall Study|Withdrawal by Subject|1|||
27874406|NCT02077140|54492168|FG002|Overall Study|Withdrawal by Subject|0|||
27874407|NCT02077140|54492169|FG003|Overall Study|Withdrawal by Subject|2|||
27874408|NCT02077140|54492170|FG004|Overall Study|Withdrawal by Subject|2|||
27739223|NCT03318523|54188613|FG006|PC Period: Up to Year 1|Consent Withdrawn|0|||
27739224|NCT03318523|54188614|FG007|PC Period: Up to Year 1|Consent Withdrawn|0|||
27739225|NCT03318523|54188615|FG008|PC Period: Up to Year 1|Consent Withdrawn|0|||
27874409|NCT02047110|54492189|FG000|DB Treatment Period up to Week 24|Adverse Event|1|||
27874410|NCT02047110|54492190|FG001|DB Treatment Period up to Week 24|Adverse Event|0|||
27874411|NCT02047110|54492191|FG002|DB Treatment Period up to Week 24|Adverse Event|0|||
27874412|NCT02047110|54492192|FG003|DB Treatment Period up to Week 24|Adverse Event|0|||
27874413|NCT02047110|54492189|FG000|DB Treatment Period up to Week 24|Lost to Follow-up|1|||
27874414|NCT02047110|54492190|FG001|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
27874415|NCT02047110|54492191|FG002|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
27874416|NCT02047110|54492192|FG003|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
27874417|NCT02047110|54492189|FG000|DB Treatment Period up to Week 24|Protocol Violation|1|||
27874418|NCT02047110|54492190|FG001|DB Treatment Period up to Week 24|Protocol Violation|0|||
27874419|NCT02047110|54492191|FG002|DB Treatment Period up to Week 24|Protocol Violation|0|||
27874420|NCT02047110|54492192|FG003|DB Treatment Period up to Week 24|Protocol Violation|0|||
27874421|NCT02047110|54492189|FG000|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
27874422|NCT02047110|54492190|FG001|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
27874423|NCT02047110|54492191|FG002|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
27874424|NCT02047110|54492192|FG003|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
27874425|NCT02047110|54492189|FG000|DB Treatment Period up to Week 24|Other than specified|1|||
27874426|NCT02047110|54492190|FG001|DB Treatment Period up to Week 24|Other than specified|2|||
27874427|NCT02047110|54492191|FG002|DB Treatment Period up to Week 24|Other than specified|3|||
27874428|NCT02047110|54492192|FG003|DB Treatment Period up to Week 24|Other than specified|1|||
27874429|NCT02047110|54492189|FG000|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
27874430|NCT02047110|54492190|FG001|DB (Week 12 up to Week 24)|Withdrawal by Subject|1|||
27874431|NCT02047110|54492191|FG002|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
27874432|NCT02047110|54492192|FG003|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
27874433|NCT02047110|54492189|FG000|DB (Week 12 up to Week 24)|Other than specified|0|||
27874434|NCT02047110|54492190|FG001|DB (Week 12 up to Week 24)|Other than specified|1|||
27874435|NCT02047110|54492191|FG002|DB (Week 12 up to Week 24)|Other than specified|1|||
27874436|NCT02047110|54492192|FG003|DB (Week 12 up to Week 24)|Other than specified|0|||
27874437|NCT02047110|54492189|FG000|Escape Treatment Period|Withdrawal by Subject|1|||
27874438|NCT02047110|54492190|FG001|Escape Treatment Period|Withdrawal by Subject|2|||
27874439|NCT02047110|54492191|FG002|Escape Treatment Period|Withdrawal by Subject|1|||
27874440|NCT02047110|54492192|FG003|Escape Treatment Period|Withdrawal by Subject|1|||
27874441|NCT02047110|54492189|FG000|Escape Treatment Period|Adverse Event|1|||
27739226|NCT03318523|54188616|FG009|PC Period: Up to Year 1|Consent Withdrawn|0|||
27874442|NCT02047110|54492190|FG001|Escape Treatment Period|Adverse Event|2|||
27874443|NCT02047110|54492191|FG002|Escape Treatment Period|Adverse Event|2|||
27874444|NCT02047110|54492192|FG003|Escape Treatment Period|Adverse Event|0|||
27874445|NCT02047110|54492189|FG000|Escape Treatment Period|Other than specified|1|||
27874446|NCT02047110|54492190|FG001|Escape Treatment Period|Other than specified|2|||
27874447|NCT02047110|54492191|FG002|Escape Treatment Period|Other than specified|0|||
27874448|NCT02047110|54492192|FG003|Escape Treatment Period|Other than specified|1|||
27739227|NCT03318523|54188607|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
27739228|NCT03318523|54188608|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
27739229|NCT03318523|54188609|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
27739230|NCT03318523|54188610|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
27874449|NCT02047110|54492189|FG000|OLE Treatment Period|Other than specified|0|||
27874450|NCT02047110|54492190|FG001|OLE Treatment Period|Other than specified|0|||
27874451|NCT02047110|54492191|FG002|OLE Treatment Period|Other than specified|1|||
27874452|NCT02047110|54492192|FG003|OLE Treatment Period|Other than specified|0|||
27874453|NCT02046564|54492211|FG000|Overall Study|Adverse Event|6|||
27874454|NCT02046564|54492212|FG001|Overall Study|Adverse Event|3|||
27739231|NCT03318523|54188611|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
27874455|NCT02046564|54492211|FG000|Overall Study|Physician Decision|0|||
27874456|NCT02046564|54492212|FG001|Overall Study|Physician Decision|1|||
27874457|NCT02046564|54492211|FG000|Overall Study|Protocol Violation|3|||
27874458|NCT02046564|54492212|FG001|Overall Study|Protocol Violation|1|||
27874459|NCT02046564|54492211|FG000|Overall Study|Withdrawal by Subject|4|||
27874460|NCT02046564|54492212|FG001|Overall Study|Withdrawal by Subject|10|||
27874461|NCT02046564|54492211|FG000|Overall Study|Subject met withdrawal criteria|2|||
27874462|NCT02046564|54492212|FG001|Overall Study|Subject met withdrawal criteria|5|||
27874463|NCT02046174|54492218|FG000|Overall Study|Too many adhesions to receive implant (at time of surgery).|1|||
27874464|NCT02046174|54492219|FG001|Overall Study|Too many adhesions to receive implant (at time of surgery).|0|||
27874465|NCT02045862|54492307|FG000|Overall Study|Death|0|||
27874466|NCT02045862|54492308|FG001|Overall Study|Death|0|||
27874467|NCT02045862|54492309|FG002|Overall Study|Death|1|||
27874468|NCT02045862|54492307|FG000|Overall Study|Miscellaneous|5|||
27874469|NCT02045862|54492308|FG001|Overall Study|Miscellaneous|0|||
27874470|NCT02045862|54492309|FG002|Overall Study|Miscellaneous|8|||
27874471|NCT02045862|54492307|FG000|Overall Study|Withdrawal by Patient|18|||
27874472|NCT02045862|54492308|FG001|Overall Study|Withdrawal by Patient|27|||
27874473|NCT02045862|54492309|FG002|Overall Study|Withdrawal by Patient|57|||
27874474|NCT02045862|54492307|FG000|Overall Study|Protocol Violation|0|||
27874475|NCT02045862|54492308|FG001|Overall Study|Protocol Violation|0|||
27874476|NCT02045862|54492309|FG002|Overall Study|Protocol Violation|6|||
27874477|NCT02045862|54492307|FG000|Overall Study|Lack of Efficacy|8|||
27874478|NCT02045862|54492308|FG001|Overall Study|Lack of Efficacy|4|||
27874479|NCT02045862|54492309|FG002|Overall Study|Lack of Efficacy|13|||
27874480|NCT02045862|54492307|FG000|Overall Study|Randomized but not Received Study Drug|0|||
27874481|NCT02045862|54492308|FG001|Overall Study|Randomized but not Received Study Drug|2|||
27874482|NCT02045862|54492309|FG002|Overall Study|Randomized but not Received Study Drug|8|||
27874483|NCT02045862|54492307|FG000|Overall Study|Adverse Event|7|||
27874484|NCT02045862|54492308|FG001|Overall Study|Adverse Event|5|||
27874485|NCT02045862|54492309|FG002|Overall Study|Adverse Event|27|||
27874486|NCT02045862|54492307|FG000|Overall Study|Lost to Follow-up|1|||
27874487|NCT02045862|54492308|FG001|Overall Study|Lost to Follow-up|2|||
27874488|NCT02045862|54492309|FG002|Overall Study|Lost to Follow-up|6|||
27874489|NCT02075658|54492319|FG000|Overall Study|Physician Decision|2|||
27874490|NCT02075658|54492320|FG001|Overall Study|Physician Decision|2|||
27874491|NCT02063880|54492328|FG000|Overall Study|Death|21|||
27874492|NCT02063880|54492329|FG001|Overall Study|Death|18|||
27874493|NCT02063880|54492328|FG000|Overall Study|Lost to Follow-up|7|||
27874494|NCT02063880|54492329|FG001|Overall Study|Lost to Follow-up|7|||
27874495|NCT02063880|54492328|FG000|Overall Study|Ineligible|0|||
27874496|NCT02063880|54492329|FG001|Overall Study|Ineligible|2|||
27874497|NCT02044848|54492337|FG000|Overall Study|Administrative Problems|2|||
27874498|NCT02044848|54492338|FG001|Overall Study|Administrative Problems|3|||
27874499|NCT02044458|54492346|FG000|Overall Study|Protocol Violation|3|||
27874500|NCT02044458|54492347|FG001|Overall Study|Protocol Violation|8|||
27874501|NCT02044302|54492355|FG000|Overall Study|study terminated|2|||
27874502|NCT02044302|54492356|FG001|Overall Study|study terminated|0|||
27874503|NCT02062944|54492360|FG000|Overall Study|Lost to Follow-up|1|||
27874504|NCT02062944|54492360|FG000|Overall Study|New hemotological disorder identified|1|||
27874505|NCT02062944|54492360|FG000|Overall Study|Uncontrolled Hypertension|1|||
27874506|NCT02062944|54492360|FG000|Overall Study|underwent pre-weaning biospsy and excluded for mild subclinical ACR|3|||
27874507|NCT02062632|54492365|FG000|Overall Study|No treatment data|1|||
27874508|NCT02062398|54492369|FG000|Overall Study|Implant removal|1|||
27874509|NCT02061540|54492373|FG000|Overall Study|Adverse Event|2|||
27874510|NCT02061540|54492373|FG000|Overall Study|Withdrawal by Subject|2|||
27874511|NCT02043366|54492388|FG000|Overall Study|Lost to Follow-up|2|||
27874512|NCT02043366|54492389|FG001|Overall Study|Lost to Follow-up|2|||
27874513|NCT02043366|54492390|FG002|Overall Study|Lost to Follow-up|2|||
28171619|NCT03350815|54843238|FG001|Period 1|Lost to Follow-up|0|||
27874514|NCT02043366|54492391|FG003|Overall Study|Lost to Follow-up|2|||
27874515|NCT02043366|54492392|FG004|Overall Study|Lost to Follow-up|2|||
27874516|NCT02043366|54492393|FG005|Overall Study|Lost to Follow-up|2|||
27874517|NCT02060370|54492409|FG000|Overall Study|Physician Decision|1|||
27874518|NCT01622088|54492413|FG000|Overall Study|Adverse Event|20|||
27874519|NCT01622088|54492413|FG000|Overall Study|Lost to Follow-up|1|||
27874520|NCT01622088|54492413|FG000|Overall Study|Withdrawal by Subject|20|||
27874521|NCT01622088|54492413|FG000|Overall Study|Investigator Decision|1|||
27874522|NCT01622088|54492413|FG000|Overall Study|Death|53|||
27874523|NCT01622088|54492413|FG000|Overall Study|STUDY TERMINATED EARLY BY SPONSOR|521|||
27874524|NCT01621542|54492424|FG000|Overall Study|Adverse Event|0|||
27874525|NCT01621542|54492425|FG001|Overall Study|Adverse Event|0|||
27874526|NCT01621542|54492426|FG002|Overall Study|Adverse Event|1|||
27874527|NCT01621542|54492427|FG003|Overall Study|Adverse Event|3|||
27874528|NCT01621542|54492428|FG004|Overall Study|Adverse Event|0|||
27874529|NCT01621542|54492429|FG005|Overall Study|Adverse Event|0|||
27874530|NCT01621542|54492424|FG000|Overall Study|Death|0|||
27874531|NCT01621542|54492425|FG001|Overall Study|Death|1|||
27874532|NCT01621542|54492426|FG002|Overall Study|Death|0|||
27874533|NCT01621542|54492427|FG003|Overall Study|Death|0|||
27874534|NCT01621542|54492428|FG004|Overall Study|Death|0|||
27874535|NCT01621542|54492429|FG005|Overall Study|Death|0|||
27874536|NCT01621542|54492424|FG000|Overall Study|Physician Decision|1|||
27874537|NCT01621542|54492425|FG001|Overall Study|Physician Decision|0|||
27874538|NCT01621542|54492426|FG002|Overall Study|Physician Decision|1|||
27874539|NCT01621542|54492427|FG003|Overall Study|Physician Decision|13|||
27874540|NCT01621542|54492428|FG004|Overall Study|Physician Decision|3|||
27874541|NCT01621542|54492429|FG005|Overall Study|Physician Decision|1|||
27874542|NCT01621542|54492424|FG000|Overall Study|Withdrawal by Subject|2|||
27874543|NCT01621542|54492425|FG001|Overall Study|Withdrawal by Subject|0|||
27874544|NCT01621542|54492426|FG002|Overall Study|Withdrawal by Subject|1|||
27874545|NCT01621542|54492427|FG003|Overall Study|Withdrawal by Subject|3|||
27874546|NCT01621542|54492428|FG004|Overall Study|Withdrawal by Subject|3|||
27874547|NCT01621542|54492429|FG005|Overall Study|Withdrawal by Subject|3|||
27874548|NCT01621542|54492424|FG000|Overall Study|progression/treatment failure|2|||
27874549|NCT01621542|54492425|FG001|Overall Study|progression/treatment failure|4|||
27874550|NCT01621542|54492426|FG002|Overall Study|progression/treatment failure|3|||
27874551|NCT01621542|54492427|FG003|Overall Study|progression/treatment failure|7|||
27874552|NCT01621542|54492428|FG004|Overall Study|progression/treatment failure|3|||
27874553|NCT01621542|54492429|FG005|Overall Study|progression/treatment failure|5|||
27874554|NCT01621542|54492424|FG000|Overall Study|Protocol Violation|0|||
27874555|NCT01621542|54492425|FG001|Overall Study|Protocol Violation|0|||
27874556|NCT01621542|54492426|FG002|Overall Study|Protocol Violation|0|||
27874557|NCT01621542|54492427|FG003|Overall Study|Protocol Violation|1|||
27874558|NCT01621542|54492428|FG004|Overall Study|Protocol Violation|0|||
27874559|NCT01621542|54492429|FG005|Overall Study|Protocol Violation|0|||
27874560|NCT01621542|54492424|FG000|Overall Study|study stopped by sponsor|0|||
27874561|NCT01621542|54492425|FG001|Overall Study|study stopped by sponsor|0|||
27874562|NCT01621542|54492426|FG002|Overall Study|study stopped by sponsor|0|||
27874563|NCT01621542|54492427|FG003|Overall Study|study stopped by sponsor|1|||
27874564|NCT01621542|54492428|FG004|Overall Study|study stopped by sponsor|0|||
27874565|NCT01621542|54492429|FG005|Overall Study|study stopped by sponsor|0|||
27874566|NCT02021292|54492445|FG000|Overall Study|Physician Decision|0|||
27874567|NCT02021292|54492446|FG001|Overall Study|Physician Decision|1|||
27874568|NCT02021292|54492445|FG000|Overall Study|Lost to Follow-up|0|||
27874569|NCT02021292|54492446|FG001|Overall Study|Lost to Follow-up|1|||
27874570|NCT02021292|54492445|FG000|Overall Study|Death|0|||
27874571|NCT02021292|54492446|FG001|Overall Study|Death|1|||
27874572|NCT02059980|54492456|FG000|Overall Study|Lost to Follow-up|2|||
27874573|NCT02059980|54492457|FG001|Overall Study|Lost to Follow-up|1|||
27874574|NCT02043132|54492465|FG000|Overall Study|Lost to Follow-up|1|||
27874575|NCT02043132|54492466|FG001|Overall Study|Lost to Follow-up|1|||
27874576|NCT02043132|54492465|FG000|Overall Study|screen failures|4|||
27982773|NCT02017717|54640939|FG000|Treatment Period|Maximum clinical benefit|0|||
27982774|NCT02017717|54640940|FG001|Treatment Period|Maximum clinical benefit|0|||
28171620|NCT03350815|54843239|FG002|Period 1|Lost to Follow-up|0|||
27739232|NCT03318523|54188612|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
27739233|NCT03318523|54188613|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
27739234|NCT03318523|54188614|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
27739235|NCT03318523|54188615|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
27739236|NCT03318523|54188616|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|2|||
27739237|NCT03318523|54188607|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
27739238|NCT03318523|54188608|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
27739239|NCT03318523|54188609|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
27739240|NCT03318523|54188610|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
27739241|NCT03318523|54188611|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
27739242|NCT03318523|54188612|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
27739243|NCT03318523|54188613|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
27739244|NCT03318523|54188614|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
27739245|NCT03318523|54188615|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|3|||
27739246|NCT03318523|54188616|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|2|||
27739247|NCT03318523|54188607|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
27739248|NCT03318523|54188608|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
27874577|NCT02043132|54492466|FG001|Overall Study|screen failures|8|||
27874578|NCT02059434|54492481|FG000|Washout Between Periods 1 and 2|Physician Decision|0|||
27874579|NCT02059434|54492482|FG001|Washout Between Periods 1 and 2|Physician Decision|0|||
27874580|NCT02059434|54492483|FG002|Washout Between Periods 1 and 2|Physician Decision|0|||
27874581|NCT02059434|54492484|FG003|Washout Between Periods 1 and 2|Physician Decision|0|||
27874582|NCT02059434|54492485|FG004|Washout Between Periods 1 and 2|Physician Decision|0|||
27874583|NCT02059434|54492486|FG005|Washout Between Periods 1 and 2|Physician Decision|0|||
27874584|NCT02059434|54492487|FG006|Washout Between Periods 1 and 2|Physician Decision|0|||
27874585|NCT02059434|54492488|FG007|Washout Between Periods 1 and 2|Physician Decision|1|||
27874586|NCT02059434|54492489|FG008|Washout Between Periods 1 and 2|Physician Decision|0|||
27874587|NCT02059434|54492481|FG000|Washout Between Periods 4 and 5|Adverse Event|0|||
27874588|NCT02059434|54492482|FG001|Washout Between Periods 4 and 5|Adverse Event|0|||
27874589|NCT02059434|54492483|FG002|Washout Between Periods 4 and 5|Adverse Event|0|||
27874590|NCT02059434|54492484|FG003|Washout Between Periods 4 and 5|Adverse Event|0|||
27874591|NCT02059434|54492485|FG004|Washout Between Periods 4 and 5|Adverse Event|0|||
27874592|NCT02059434|54492486|FG005|Washout Between Periods 4 and 5|Adverse Event|0|||
27874593|NCT02059434|54492487|FG006|Washout Between Periods 4 and 5|Adverse Event|0|||
27874594|NCT02059434|54492488|FG007|Washout Between Periods 4 and 5|Adverse Event|0|||
27874595|NCT02059434|54492489|FG008|Washout Between Periods 4 and 5|Adverse Event|1|||
27874596|NCT02059434|54492481|FG000|Washout Between Periods 6 and 7|Physician Decision|0|||
27874597|NCT02059434|54492482|FG001|Washout Between Periods 6 and 7|Physician Decision|0|||
27874598|NCT02059434|54492483|FG002|Washout Between Periods 6 and 7|Physician Decision|0|||
27874599|NCT02059434|54492484|FG003|Washout Between Periods 6 and 7|Physician Decision|0|||
27874600|NCT02059434|54492485|FG004|Washout Between Periods 6 and 7|Physician Decision|0|||
27874601|NCT02059434|54492486|FG005|Washout Between Periods 6 and 7|Physician Decision|0|||
27874602|NCT02059434|54492487|FG006|Washout Between Periods 6 and 7|Physician Decision|0|||
27874603|NCT02059434|54492488|FG007|Washout Between Periods 6 and 7|Physician Decision|0|||
27874604|NCT02059434|54492489|FG008|Washout Between Periods 6 and 7|Physician Decision|1|||
27874605|NCT02059434|54492481|FG000|Washout Between Periods 7 and 8|Adverse Event|0|||
27874606|NCT02059434|54492482|FG001|Washout Between Periods 7 and 8|Adverse Event|0|||
27874607|NCT02059434|54492483|FG002|Washout Between Periods 7 and 8|Adverse Event|0|||
27874608|NCT02059434|54492484|FG003|Washout Between Periods 7 and 8|Adverse Event|0|||
27874609|NCT02059434|54492485|FG004|Washout Between Periods 7 and 8|Adverse Event|0|||
27874610|NCT02059434|54492486|FG005|Washout Between Periods 7 and 8|Adverse Event|0|||
27874611|NCT02059434|54492487|FG006|Washout Between Periods 7 and 8|Adverse Event|0|||
27874612|NCT02059434|54492488|FG007|Washout Between Periods 7 and 8|Adverse Event|0|||
27874613|NCT02059434|54492489|FG008|Washout Between Periods 7 and 8|Adverse Event|1|||
27874614|NCT02059434|54492481|FG000|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
27874615|NCT02059434|54492482|FG001|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
27874616|NCT02059434|54492483|FG002|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
27874617|NCT02059434|54492484|FG003|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
27874618|NCT02059434|54492485|FG004|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
27874619|NCT02059434|54492486|FG005|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
27874620|NCT02059434|54492487|FG006|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
27874621|NCT02059434|54492488|FG007|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
27874622|NCT02059434|54492489|FG008|Washout Between Periods 7 and 8|Withdrawal by Subject|1|||
27874623|NCT02059278|54492519|FG000|Overall Study|Adverse Event|1|||
27874624|NCT02059278|54492520|FG001|Overall Study|Adverse Event|1|||
27874625|NCT02059278|54492519|FG000|Overall Study|Lost to Follow-up|1|||
27874626|NCT02059278|54492520|FG001|Overall Study|Lost to Follow-up|0|||
27874627|NCT02059278|54492519|FG000|Overall Study|Withdrawal by Subject|0|||
27874628|NCT02059278|54492520|FG001|Overall Study|Withdrawal by Subject|3|||
27874629|NCT02059278|54492519|FG000|Overall Study|Ran out of IP and decided to discontinue|1|||
27874630|NCT02059278|54492520|FG001|Overall Study|Ran out of IP and decided to discontinue|0|||
27874631|NCT02020512|54492526|FG000|Overall Study|Adverse Event|1|||
27874632|NCT02020512|54492526|FG000|Overall Study|Lost to Follow-up|3|||
27874633|NCT02020512|54492526|FG000|Overall Study|Protocol Violation|4|||
27874634|NCT02041962|54492532|FG000|Overall Study|Lost Aetna Coverage|43|||
27874635|NCT02041962|54492533|FG001|Overall Study|Lost Aetna Coverage|40|||
27874636|NCT02041962|54492532|FG000|Overall Study|Death|1|||
27874637|NCT02041962|54492533|FG001|Overall Study|Death|1|||
27874638|NCT02041962|54492532|FG000|Overall Study|Lost to Follow-up|37|||
27874639|NCT02041962|54492533|FG001|Overall Study|Lost to Follow-up|32|||
27874640|NCT02041962|54492532|FG000|Overall Study|Withdrawal by Subject|0|||
27874641|NCT02041962|54492533|FG001|Overall Study|Withdrawal by Subject|11|||
27874642|NCT02041494|54492541|FG000|Overall Study|Death|1|||
27874643|NCT02041494|54492542|FG001|Overall Study|Death|3|||
27874644|NCT02041494|54492541|FG000|Overall Study|Lost to Follow-up|2|||
27874645|NCT02041494|54492542|FG001|Overall Study|Lost to Follow-up|6|||
27874646|NCT02041494|54492541|FG000|Overall Study|study terminated|16|||
27874647|NCT02041494|54492542|FG001|Overall Study|study terminated|11|||
27874648|NCT02041104|54492573|FG000|Overall Study|Lost to Follow-up|1|||
27874649|NCT02041104|54492574|FG001|Overall Study|Lost to Follow-up|4|||
27874650|NCT02041104|54492573|FG000|Overall Study|discomfort during OGTT|0|||
27874651|NCT02041104|54492574|FG001|Overall Study|discomfort during OGTT|3|||
27874652|NCT02019420|54492584|FG000|Overall Study|Did not receive study drug|2|||
27874653|NCT02019420|54492585|FG001|Overall Study|Did not receive study drug|2|||
27874654|NCT02019420|54492584|FG000|Overall Study|Withdrawal by Subject|1|||
28096410|NCT03987620|54751349|FG000|Overall Study|Physician Decision|0|||
28096411|NCT03987620|54751350|FG001|Overall Study|Physician Decision|1|||
28096412|NCT03987620|54751349|FG000|Overall Study|Pregnancy|1|||
27874655|NCT02019420|54492585|FG001|Overall Study|Withdrawal by Subject|3|||
27874656|NCT02019420|54492584|FG000|Overall Study|At request of sponsor or investigator|0|||
27874657|NCT02019420|54492585|FG001|Overall Study|At request of sponsor or investigator|1|||
27874658|NCT02019420|54492584|FG000|Overall Study|Death|104|||
27874659|NCT02019420|54492585|FG001|Overall Study|Death|99|||
27874660|NCT02019420|54492584|FG000|Overall Study|Transferred to other care facility|1|||
27874661|NCT02019420|54492585|FG001|Overall Study|Transferred to other care facility|1|||
27874662|NCT02019264|54492593|FG000|Overall Study|Not treated|6|||
27874663|NCT02019264|54492594|FG001|Overall Study|Not treated|4|||
27874664|NCT02019264|54492593|FG000|Overall Study|Lost to Follow-up|50|||
27874665|NCT02019264|54492594|FG001|Overall Study|Lost to Follow-up|47|||
27874666|NCT02019264|54492593|FG000|Overall Study|Withdrawal by Subject|142|||
27874667|NCT02019264|54492594|FG001|Overall Study|Withdrawal by Subject|117|||
27874668|NCT02019264|54492593|FG000|Overall Study|Administrative reason|36|||
27874669|NCT02019264|54492594|FG001|Overall Study|Administrative reason|28|||
27874670|NCT02019264|54492593|FG000|Overall Study|Missing|14|||
27874671|NCT02019264|54492594|FG001|Overall Study|Missing|11|||
27874672|NCT02019108|54492602|FG000|Overall Study|Lost to Follow-up|5|||
27874673|NCT02019108|54492603|FG001|Overall Study|Lost to Follow-up|7|||
27874674|NCT02018562|54492611|FG000|Overall Study|Withdrawal by Subject|2|||
27874675|NCT02018562|54492612|FG001|Overall Study|Withdrawal by Subject|0|||
27874676|NCT02018562|54492611|FG000|Overall Study|Discharged prior to study completion|1|||
27874677|NCT02018562|54492612|FG001|Overall Study|Discharged prior to study completion|0|||
27874678|NCT02058966|54492618|FG000|Open-Label Methamphetamine|Adverse Event|1|||
27874679|NCT02058966|54492618|FG000|First Intervention|Withdrawal by Subject|1|||
27874680|NCT02017860|54492630|FG000|Overall Study|Adverse Event|1|||
27874681|NCT02017860|54492630|FG000|Overall Study|Withdrawal by Subject|1|||
27874682|NCT02040870|54492634|FG000|Overall Study|Completed treatment phase|6|||
27874683|NCT02040870|54492634|FG000|Overall Study|Adverse Event|7|||
27874684|NCT02040870|54492634|FG000|Overall Study|Progressive disease|58|||
27874685|NCT02040870|54492634|FG000|Overall Study|Physician Decision|6|||
27874686|NCT02040870|54492634|FG000|Overall Study|Subject/guardian decision|10|||
27874687|NCT02040870|54492634|FG000|Overall Study|Lost to Follow-up|3|||
27874688|NCT02040870|54492634|FG000|Overall Study|Death|13|||
27874689|NCT02016690|54492638|FG000|Overall Study|Excluded from SAS: Enrollment violation|2|||
27874690|NCT02016690|54492638|FG000|Overall Study|Excluded from SAS: Duplication|2|||
27874691|NCT02016690|54492638|FG000|Overall Study|Excluded from SAS: Early treatment|2|||
27874692|NCT02016690|54492638|FG000|Overall Study|Excluded from SAS: Ineligible for study|2|||
27874693|NCT02016690|54492638|FG000|Overall Study|Did not meet inclusion criteria|13|||
27874694|NCT02016690|54492638|FG000|Overall Study|Hospitalized for RSV at study start|3|||
27874695|NCT02016300|54492644|FG000|Overall Study|Lost to Follow-up|0|||
27874696|NCT02016300|54492645|FG001|Overall Study|Lost to Follow-up|3|||
27874697|NCT02040090|54492653|FG000|Overall Study|Adverse Event|2|||
27874698|NCT02040090|54492654|FG001|Overall Study|Adverse Event|0|||
27874699|NCT02040090|54492653|FG000|Overall Study|Physician Decision|1|||
27874700|NCT02040090|54492654|FG001|Overall Study|Physician Decision|0|||
27874701|NCT02040090|54492653|FG000|Overall Study|Withdrawal by Subject|0|||
27874702|NCT02040090|54492654|FG001|Overall Study|Withdrawal by Subject|1|||
27874703|NCT02040090|54492653|FG000|Overall Study|Lost to Follow-up|0|||
27874704|NCT02040090|54492654|FG001|Overall Study|Lost to Follow-up|1|||
27874705|NCT02058498|54492660|FG000|Overall Study|Withdrawal by Subject|4|||
27874706|NCT02039778|54492664|FG000|Overall Study|Death|2|||
27874707|NCT02039778|54492664|FG000|Overall Study|Withdrawal by Subject|1|||
27874708|NCT02039778|54492664|FG000|Overall Study|Never started the protocol treatment|1|||
27874709|NCT02015754|54492668|FG000|Overall Study|Disease progression|5|||
27874710|NCT02015754|54492668|FG000|Overall Study|Change in treatment modality|5|||
27874711|NCT02015754|54492668|FG000|Overall Study|Lost to Follow-up|1|||
27874712|NCT02015676|54492675|FG000|Overall Study|Adverse Event|2|||
27874713|NCT02015676|54492676|FG001|Overall Study|Adverse Event|18|||
27874714|NCT02015676|54492677|FG002|Overall Study|Adverse Event|0|||
27874715|NCT02015676|54492675|FG000|Overall Study|Lack of Efficacy|2|||
27874716|NCT02015676|54492676|FG001|Overall Study|Lack of Efficacy|4|||
27874717|NCT02015676|54492677|FG002|Overall Study|Lack of Efficacy|0|||
27874718|NCT02015676|54492675|FG000|Overall Study|Protocol Violation|1|||
27874719|NCT02015676|54492676|FG001|Overall Study|Protocol Violation|0|||
27874720|NCT02015676|54492677|FG002|Overall Study|Protocol Violation|0|||
27874721|NCT02015676|54492675|FG000|Overall Study|Withdrawal by Subject|1|||
27874722|NCT02015676|54492676|FG001|Overall Study|Withdrawal by Subject|7|||
27874723|NCT02015676|54492677|FG002|Overall Study|Withdrawal by Subject|1|||
27874724|NCT02015676|54492675|FG000|Overall Study|Administrative reasons|0|||
27874725|NCT02015676|54492676|FG001|Overall Study|Administrative reasons|3|||
27874726|NCT02015676|54492677|FG002|Overall Study|Administrative reasons|1|||
27874727|NCT02015676|54492675|FG000|Overall Study|Death|0|||
27874728|NCT02015676|54492676|FG001|Overall Study|Death|1|||
27874729|NCT02015676|54492677|FG002|Overall Study|Death|0|||
27874730|NCT02015676|54492675|FG000|Overall Study|Disease progression|3|||
27874731|NCT02015676|54492676|FG001|Overall Study|Disease progression|1|||
27874732|NCT02015676|54492677|FG002|Overall Study|Disease progression|1|||
27874733|NCT02015520|54492685|FG000|Overall Study|Lack of Efficacy|1|||
27874734|NCT02015520|54492686|FG001|Overall Study|Lack of Efficacy|0|||
27874735|NCT02015520|54492687|FG002|Overall Study|Lack of Efficacy|3|||
27874736|NCT02015520|54492688|FG003|Overall Study|Lack of Efficacy|2|||
27874737|NCT02015520|54492685|FG000|Overall Study|Adverse Event|0|||
27874738|NCT02015520|54492686|FG001|Overall Study|Adverse Event|0|||
27874739|NCT02015520|54492687|FG002|Overall Study|Adverse Event|0|||
27874740|NCT02015520|54492688|FG003|Overall Study|Adverse Event|1|||
27874741|NCT02015520|54492685|FG000|Overall Study|Withdrawal by Subject|2|||
27874742|NCT02015520|54492686|FG001|Overall Study|Withdrawal by Subject|2|||
27874743|NCT02015520|54492687|FG002|Overall Study|Withdrawal by Subject|1|||
27874744|NCT02015520|54492688|FG003|Overall Study|Withdrawal by Subject|0|||
27874745|NCT02015520|54492685|FG000|Overall Study|Death|1|||
27874746|NCT02015520|54492686|FG001|Overall Study|Death|0|||
27874747|NCT02015520|54492687|FG002|Overall Study|Death|0|||
27874748|NCT02015520|54492688|FG003|Overall Study|Death|0|||
27874749|NCT02015520|54492685|FG000|Overall Study|Lost to Follow-up|0|||
27874750|NCT02015520|54492686|FG001|Overall Study|Lost to Follow-up|0|||
27874751|NCT02015520|54492687|FG002|Overall Study|Lost to Follow-up|1|||
27874752|NCT02015520|54492688|FG003|Overall Study|Lost to Follow-up|0|||
27874753|NCT02015520|54492685|FG000|Overall Study|Subject Request to Discontinue Study Treatment|1|||
27874754|NCT02015520|54492686|FG001|Overall Study|Subject Request to Discontinue Study Treatment|1|||
27874755|NCT02015520|54492687|FG002|Overall Study|Subject Request to Discontinue Study Treatment|2|||
27874756|NCT02015520|54492688|FG003|Overall Study|Subject Request to Discontinue Study Treatment|1|||
27874757|NCT02015520|54492685|FG000|Overall Study|Subject no Longer Meets Study Criteria|0|||
27874758|NCT02015520|54492686|FG001|Overall Study|Subject no Longer Meets Study Criteria|1|||
27874759|NCT02015520|54492687|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
27874760|NCT02015520|54492688|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
27874761|NCT02058108|54492700|FG000|Overall Study|Abnormal Laboratory Values|0|||
27874762|NCT02058108|54492701|FG001|Overall Study|Abnormal Laboratory Values|1|||
27874763|NCT02058108|54492700|FG000|Overall Study|Unsatisfactory therapeutic effect|37|||
27874764|NCT02058108|54492701|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
27874765|NCT02058108|54492700|FG000|Overall Study|No longer requires study drug|0|||
27874766|NCT02058108|54492701|FG001|Overall Study|No longer requires study drug|1|||
27874767|NCT02058108|54492700|FG000|Overall Study|Withdrawal by Subject|1|||
27874768|NCT02058108|54492701|FG001|Overall Study|Withdrawal by Subject|0|||
27874769|NCT02058108|54492700|FG000|Overall Study|Administrative problems|3|||
27874770|NCT02058108|54492701|FG001|Overall Study|Administrative problems|3|||
27874771|NCT02058108|54492700|FG000|Overall Study|Protocol Violation|0|||
27874772|NCT02058108|54492701|FG001|Overall Study|Protocol Violation|1|||
27874773|NCT02057874|54492709|FG000|Overall Study|participant did not return for scan|1|||
27874774|NCT02038920|54492716|FG000|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3|||
27874775|NCT02038920|54492717|FG001|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11|||
27874776|NCT02038920|54492718|FG002|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
27874777|NCT02038920|54492719|FG003|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
27874778|NCT02038920|54492720|FG004|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
27874779|NCT02038920|54492721|FG005|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
27874780|NCT02038920|54492716|FG000|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2|||
27874781|NCT02038920|54492717|FG001|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
27874782|NCT02038920|54492718|FG002|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
27874783|NCT02038920|54492719|FG003|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
27874784|NCT02038920|54492720|FG004|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
27874785|NCT02038920|54492721|FG005|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
27874786|NCT02038920|54492716|FG000|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
27874787|NCT02038920|54492717|FG001|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
27874788|NCT02038920|54492718|FG002|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
27874789|NCT02038920|54492719|FG003|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
27874790|NCT02038920|54492720|FG004|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
27874791|NCT02038920|54492721|FG005|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
27874792|NCT02038920|54492716|FG000|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
27874793|NCT02038920|54492717|FG001|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
27874794|NCT02038920|54492718|FG002|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
27874795|NCT02038920|54492719|FG003|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4|||
27874796|NCT02038920|54492720|FG004|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
27874797|NCT02038920|54492721|FG005|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
27874798|NCT02038920|54492716|FG000|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
27874799|NCT02038920|54492717|FG001|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
27874800|NCT02038920|54492718|FG002|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1|||
27874801|NCT02038920|54492719|FG003|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
27874802|NCT02038920|54492720|FG004|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
27874803|NCT02038920|54492721|FG005|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
27874804|NCT02038920|54492716|FG000|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
27874805|NCT02038920|54492717|FG001|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
27874806|NCT02038920|54492718|FG002|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2|||
27874807|NCT02038920|54492719|FG003|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4|||
27874808|NCT02038920|54492720|FG004|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10|||
27874809|NCT02038920|54492721|FG005|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
27874810|NCT02038920|54492716|FG000|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
27874811|NCT02038920|54492717|FG001|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
27874812|NCT02038920|54492718|FG002|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
27874813|NCT02038920|54492719|FG003|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
27874814|NCT02038920|54492720|FG004|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
27874815|NCT02038920|54492721|FG005|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43|||
27874816|NCT02038920|54492716|FG000|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
27874817|NCT02038920|54492717|FG001|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
27874818|NCT02038920|54492718|FG002|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
27874819|NCT02038920|54492719|FG003|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
27874820|NCT02038920|54492720|FG004|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
27874821|NCT02038920|54492721|FG005|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1|||
27874822|NCT02038920|54492716|FG000|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
27874823|NCT02038920|54492717|FG001|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
27874824|NCT02038920|54492718|FG002|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
27874825|NCT02038920|54492719|FG003|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
27874826|NCT02038920|54492720|FG004|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
27874827|NCT02038920|54492721|FG005|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7|||
27874828|NCT02038920|54492716|FG000|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
27874829|NCT02038920|54492717|FG001|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
27874830|NCT02038920|54492718|FG002|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
27874831|NCT02038920|54492719|FG003|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
27874832|NCT02038920|54492720|FG004|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
27874833|NCT02038920|54492721|FG005|Open Label Cohort (Week 10 to 154)|Pregnancy|1|||
27874834|NCT02038920|54492716|FG000|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
27874835|NCT02038920|54492717|FG001|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
27874836|NCT02038920|54492718|FG002|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
27874837|NCT02038920|54492719|FG003|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
27874838|NCT02038920|54492720|FG004|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
27874839|NCT02038920|54492721|FG005|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23|||
27874840|NCT02038920|54492716|FG000|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
27874841|NCT02038920|54492717|FG001|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
27874842|NCT02038920|54492718|FG002|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
27874843|NCT02038920|54492719|FG003|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
27874844|NCT02038920|54492720|FG004|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
27874845|NCT02038920|54492721|FG005|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2|||
27874846|NCT02038764|54492743|FG000|Overall Study|Adverse Event|0|||
27874847|NCT02038764|54492744|FG001|Overall Study|Adverse Event|0|||
27874848|NCT02038764|54492745|FG002|Overall Study|Adverse Event|1|||
27874849|NCT02038764|54492746|FG003|Overall Study|Adverse Event|0|||
27874850|NCT02038764|54492747|FG004|Overall Study|Adverse Event|0|||
27874851|NCT02038764|54492743|FG000|Overall Study|Lost to Follow-up|0|||
27874852|NCT02038764|54492744|FG001|Overall Study|Lost to Follow-up|1|||
27874853|NCT02038764|54492745|FG002|Overall Study|Lost to Follow-up|0|||
27874854|NCT02038764|54492746|FG003|Overall Study|Lost to Follow-up|0|||
27874855|NCT02038764|54492747|FG004|Overall Study|Lost to Follow-up|0|||
27874856|NCT02038764|54492743|FG000|Overall Study|Withdrawal by Subject|0|||
27874857|NCT02038764|54492744|FG001|Overall Study|Withdrawal by Subject|0|||
27874858|NCT02038764|54492745|FG002|Overall Study|Withdrawal by Subject|0|||
27874859|NCT02038764|54492746|FG003|Overall Study|Withdrawal by Subject|0|||
27874860|NCT02038764|54492747|FG004|Overall Study|Withdrawal by Subject|1|||
27874861|NCT02038764|54492743|FG000|Overall Study|Other|1|||
27874862|NCT02038764|54492744|FG001|Overall Study|Other|0|||
27874863|NCT02038764|54492745|FG002|Overall Study|Other|1|||
27874864|NCT02038764|54492746|FG003|Overall Study|Other|0|||
27874865|NCT02038764|54492747|FG004|Overall Study|Other|0|||
27874866|NCT02057718|54492765|FG000|Completed Study Treatment Through Wk. 72|Progressive disease|0|||
27874867|NCT02057718|54492766|FG001|Completed Study Treatment Through Wk. 72|Progressive disease|2|||
28096413|NCT03987620|54751350|FG001|Overall Study|Pregnancy|0|||
28096414|NCT03987620|54751349|FG000|Overall Study|Withdrawal by Subject|7|||
27874868|NCT02057718|54492765|FG000|Completed Study Treatment Through Wk. 72|Physician Decision|1|||
28096415|NCT03987620|54751350|FG001|Overall Study|Withdrawal by Subject|1|||
27874869|NCT02057718|54492766|FG001|Completed Study Treatment Through Wk. 72|Physician Decision|0|||
27874870|NCT02057718|54492765|FG000|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|0|||
27874871|NCT02057718|54492766|FG001|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|1|||
27874872|NCT02057718|54492765|FG000|Completed Study Treatment Through Wk. 72|Adverse Event|0|||
27874873|NCT02057718|54492766|FG001|Completed Study Treatment Through Wk. 72|Adverse Event|3|||
27874874|NCT02057718|54492765|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
27874875|NCT02057718|54492766|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
27874876|NCT02057718|54492765|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|0|||
27874877|NCT02057718|54492766|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|1|||
27874878|NCT02057718|54492765|FG000|Completed Study Treatment Through Wk. 72|Liver Transplant|0|||
27874879|NCT02057718|54492766|FG001|Completed Study Treatment Through Wk. 72|Liver Transplant|1|||
27874880|NCT02057718|54492765|FG000|Optional Follow-up Treatment Period|Did not consent to protocol amendment|1|||
27874881|NCT02057718|54492766|FG001|Optional Follow-up Treatment Period|Did not consent to protocol amendment|3|||
27874882|NCT02057718|54492765|FG000|Optional Follow-up Treatment Period|Progressive disease|0|||
27874883|NCT02057718|54492766|FG001|Optional Follow-up Treatment Period|Progressive disease|1|||
27874884|NCT02057718|54492765|FG000|Optional Follow-up Treatment Period|Adverse Event|1|||
27874885|NCT02057718|54492766|FG001|Optional Follow-up Treatment Period|Adverse Event|2|||
27874886|NCT02057718|54492765|FG000|Optional Follow-up Treatment Period|Liver Transplant|0|||
27874887|NCT02057718|54492766|FG001|Optional Follow-up Treatment Period|Liver Transplant|2|||
27874888|NCT01622868|54492774|FG000|Overall Study|Protocol Violation|7|||
27874889|NCT01622868|54492775|FG001|Overall Study|Protocol Violation|0|||
27874890|NCT02014740|54492783|FG000|Overall Study|Lost to Follow-up|4|||
27874891|NCT02014740|54492784|FG001|Overall Study|Lost to Follow-up|4|||
27874892|NCT02014740|54492783|FG000|Overall Study|Withdrawal by Subject|2|||
27874893|NCT02014740|54492784|FG001|Overall Study|Withdrawal by Subject|1|||
27874894|NCT02014584|54492792|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
27874895|NCT02014584|54492793|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
27874896|NCT02014584|54492794|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
27874897|NCT02014584|54492795|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
27874898|NCT02014584|54492796|FG004|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
27874899|NCT02014584|54492797|FG005|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
27874900|NCT02014584|54492792|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2|||
27874901|NCT02014584|54492793|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5|||
27874902|NCT02014584|54492794|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
27874903|NCT02014584|54492795|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
27874904|NCT02014584|54492796|FG004|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
27874905|NCT02014584|54492797|FG005|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
27874906|NCT02014584|54492792|FG000|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
27874907|NCT02014584|54492793|FG001|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
27874908|NCT02014584|54492794|FG002|Open-Label Period (24 Weeks)|Lost to Follow-up|2|||
27874909|NCT02014584|54492795|FG003|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
27874910|NCT02014584|54492796|FG004|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
27874911|NCT02014584|54492797|FG005|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
27874912|NCT02014584|54492792|FG000|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
27874913|NCT02014584|54492793|FG001|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
27874914|NCT02014584|54492794|FG002|Open-Label Period (24 Weeks)|Withdrawal by Subject|3|||
27874915|NCT02014584|54492795|FG003|Open-Label Period (24 Weeks)|Withdrawal by Subject|1|||
27874916|NCT02014584|54492796|FG004|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
27874917|NCT02014584|54492797|FG005|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
27874918|NCT02014584|54492792|FG000|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
27874919|NCT02014584|54492793|FG001|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
27874920|NCT02014584|54492794|FG002|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
27874921|NCT02014584|54492795|FG003|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
27874922|NCT02014584|54492796|FG004|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1|||
27874923|NCT02014584|54492797|FG005|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
27874924|NCT02014272|54492809|FG000|Intervention Period 1|Withdrawal by Subject|1|||
27874925|NCT02014272|54492810|FG001|Intervention Period 1|Withdrawal by Subject|0|||
27874926|NCT02014272|54492809|FG000|Intervention Period 1|Adverse Event|0|||
27874927|NCT02014272|54492810|FG001|Intervention Period 1|Adverse Event|1|||
27874928|NCT02037984|54492824|FG000|Overall Study|Lack of Efficacy|0|||
27874929|NCT02037984|54492825|FG001|Overall Study|Lack of Efficacy|0|||
28096416|NCT03987620|54751349|FG000|Overall Study|Other|2|||
28096417|NCT03987620|54751350|FG001|Overall Study|Other|5|||
28096418|NCT04376060|54751356|FG000|Overall Study|Physician Decision|1|||
28096419|NCT04413552|54751370|FG000|Overall Study|Adverse Event|0|||
28096420|NCT04413552|54751371|FG001|Overall Study|Adverse Event|0|||
28096421|NCT04413552|54751372|FG002|Overall Study|Adverse Event|0|||
28096422|NCT04413552|54751373|FG003|Overall Study|Adverse Event|0|||
27835582|NCT01683071|54320424|FG000|Part 1|Did not receive study drug|1|||
27835583|NCT01683071|54320425|FG001|Part 1|Did not receive study drug|0|||
27835584|NCT01683071|54320426|FG002|Part 1|Did not receive study drug|0|||
27835585|NCT01683071|54320427|FG003|Part 1|Did not receive study drug|1|||
27835586|NCT01683071|54320428|FG004|Part 1|Did not receive study drug|0|||
27835587|NCT01683071|54320429|FG005|Part 1|Did not receive study drug|0|||
27835588|NCT01683071|54320424|FG000|Part 1|Early termination; met exclusion criteria|0|||
27835589|NCT01683071|54320425|FG001|Part 1|Early termination; met exclusion criteria|2|||
27835590|NCT01683071|54320426|FG002|Part 1|Early termination; met exclusion criteria|1|||
27835591|NCT01683071|54320427|FG003|Part 1|Early termination; met exclusion criteria|0|||
27835592|NCT01683071|54320428|FG004|Part 1|Early termination; met exclusion criteria|0|||
27835593|NCT01683071|54320429|FG005|Part 1|Early termination; met exclusion criteria|0|||
27835594|NCT01683071|54320424|FG000|Part 2|Lack of Efficacy|0|||
27835595|NCT01683071|54320425|FG001|Part 2|Lack of Efficacy|0|||
27835596|NCT01683071|54320426|FG002|Part 2|Lack of Efficacy|0|||
27835597|NCT01683071|54320427|FG003|Part 2|Lack of Efficacy|0|||
27835598|NCT01683071|54320428|FG004|Part 2|Lack of Efficacy|3|||
27835599|NCT01683071|54320429|FG005|Part 2|Lack of Efficacy|4|||
27835600|NCT01683071|54320424|FG000|Part 2|Lost to Follow-up|0|||
27835601|NCT01683071|54320425|FG001|Part 2|Lost to Follow-up|0|||
27835602|NCT01683071|54320426|FG002|Part 2|Lost to Follow-up|0|||
27835603|NCT01683071|54320427|FG003|Part 2|Lost to Follow-up|0|||
27835604|NCT01683071|54320428|FG004|Part 2|Lost to Follow-up|2|||
27835605|NCT01683071|54320429|FG005|Part 2|Lost to Follow-up|0|||
27835606|NCT01683071|54320424|FG000|Part 2|Withdrawal by Subject|0|||
27835607|NCT01683071|54320425|FG001|Part 2|Withdrawal by Subject|0|||
27835608|NCT01683071|54320426|FG002|Part 2|Withdrawal by Subject|0|||
27835609|NCT01683071|54320427|FG003|Part 2|Withdrawal by Subject|0|||
27835610|NCT01683071|54320428|FG004|Part 2|Withdrawal by Subject|3|||
27835611|NCT01683071|54320429|FG005|Part 2|Withdrawal by Subject|3|||
27835612|NCT01683071|54320424|FG000|Part 2|Surgery cancelled|0|||
27835613|NCT01683071|54320425|FG001|Part 2|Surgery cancelled|0|||
27835614|NCT01683071|54320426|FG002|Part 2|Surgery cancelled|0|||
27835615|NCT01683071|54320427|FG003|Part 2|Surgery cancelled|0|||
27835616|NCT01683071|54320428|FG004|Part 2|Surgery cancelled|4|||
27835617|NCT01683071|54320429|FG005|Part 2|Surgery cancelled|2|||
27835618|NCT01683071|54320424|FG000|Part 2|Did not receive study drug|0|||
27835619|NCT01683071|54320425|FG001|Part 2|Did not receive study drug|0|||
27835620|NCT01683071|54320426|FG002|Part 2|Did not receive study drug|0|||
27835621|NCT01683071|54320427|FG003|Part 2|Did not receive study drug|0|||
27835622|NCT01683071|54320428|FG004|Part 2|Did not receive study drug|2|||
27835623|NCT01683071|54320429|FG005|Part 2|Did not receive study drug|1|||
27835624|NCT01683071|54320424|FG000|Part 2|Met exclusion criterion|0|||
27835625|NCT01683071|54320425|FG001|Part 2|Met exclusion criterion|0|||
27835626|NCT01683071|54320426|FG002|Part 2|Met exclusion criterion|0|||
27835627|NCT01683071|54320427|FG003|Part 2|Met exclusion criterion|0|||
27835628|NCT01683071|54320428|FG004|Part 2|Met exclusion criterion|1|||
27835629|NCT01683071|54320429|FG005|Part 2|Met exclusion criterion|1|||
27835630|NCT01683071|54320424|FG000|Part 2|Protocol deviation|0|||
27835631|NCT01683071|54320425|FG001|Part 2|Protocol deviation|0|||
27835632|NCT01683071|54320426|FG002|Part 2|Protocol deviation|0|||
27835633|NCT01683071|54320427|FG003|Part 2|Protocol deviation|0|||
27835634|NCT01683071|54320428|FG004|Part 2|Protocol deviation|1|||
27835635|NCT01683071|54320429|FG005|Part 2|Protocol deviation|2|||
27835636|NCT01683071|54320424|FG000|Part 2|Withdrawal by investigator decision|0|||
27835637|NCT01683071|54320425|FG001|Part 2|Withdrawal by investigator decision|0|||
27835638|NCT01683071|54320426|FG002|Part 2|Withdrawal by investigator decision|0|||
27835639|NCT01683071|54320427|FG003|Part 2|Withdrawal by investigator decision|0|||
27835640|NCT01683071|54320428|FG004|Part 2|Withdrawal by investigator decision|1|||
27835641|NCT01683071|54320429|FG005|Part 2|Withdrawal by investigator decision|2|||
27835642|NCT01567865|54320453|FG000|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0|||
27835643|NCT01567865|54320454|FG001|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1|||
27835644|NCT01567865|54320455|FG002|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3|||
27835645|NCT01567865|54320456|FG003|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2|||
27835646|NCT01567865|54320453|FG000|Evaluated for Immunogenicity|Missing blood sample|17|||
27835647|NCT01567865|54320454|FG001|Evaluated for Immunogenicity|Missing blood sample|24|||
27835648|NCT01567865|54320455|FG002|Evaluated for Immunogenicity|Missing blood sample|16|||
27835649|NCT01567865|54320456|FG003|Evaluated for Immunogenicity|Missing blood sample|28|||
27835650|NCT01567163|54320467|FG000|Overall Study|Progressive Disease|2|||
27835651|NCT01567163|54320467|FG000|Overall Study|Lost to Follow-up|2|||
27835652|NCT01567085|54320476|FG000|Overall Study|Death|6|||
27835653|NCT01567085|54320476|FG000|Overall Study|Adverse Event|6|||
27835654|NCT01567085|54320476|FG000|Overall Study|Lost to Follow-up|3|||
27835655|NCT01567085|54320476|FG000|Overall Study|Graft loss|2|||
27835656|NCT01567085|54320476|FG000|Overall Study|Renal transplantectomy|1|||
27835657|NCT01567085|54320476|FG000|Overall Study|Returned to chronic dialysis|1|||
27874930|NCT02037984|54492826|FG002|Overall Study|Lack of Efficacy|3|||
27874931|NCT02037984|54492827|FG003|Overall Study|Lack of Efficacy|10|||
27874932|NCT02037984|54492828|FG004|Overall Study|Lack of Efficacy|2|||
27874933|NCT02037984|54492829|FG005|Overall Study|Lack of Efficacy|2|||
27874934|NCT02037984|54492830|FG006|Overall Study|Lack of Efficacy|4|||
27874935|NCT02037984|54492831|FG007|Overall Study|Lack of Efficacy|3|||
27874936|NCT02037984|54492824|FG000|Overall Study|Lost to Follow-up|1|||
27874937|NCT02037984|54492825|FG001|Overall Study|Lost to Follow-up|0|||
27874938|NCT02037984|54492826|FG002|Overall Study|Lost to Follow-up|3|||
27874939|NCT02037984|54492827|FG003|Overall Study|Lost to Follow-up|5|||
27874940|NCT02037984|54492828|FG004|Overall Study|Lost to Follow-up|2|||
27874941|NCT02037984|54492829|FG005|Overall Study|Lost to Follow-up|2|||
27874942|NCT02037984|54492830|FG006|Overall Study|Lost to Follow-up|2|||
27874943|NCT02037984|54492831|FG007|Overall Study|Lost to Follow-up|4|||
27874944|NCT02037984|54492824|FG000|Overall Study|Physician Decision|0|||
27874945|NCT02037984|54492825|FG001|Overall Study|Physician Decision|0|||
27874946|NCT02037984|54492826|FG002|Overall Study|Physician Decision|0|||
27874947|NCT02037984|54492827|FG003|Overall Study|Physician Decision|0|||
27874948|NCT02037984|54492828|FG004|Overall Study|Physician Decision|0|||
27874949|NCT02037984|54492829|FG005|Overall Study|Physician Decision|0|||
27874950|NCT02037984|54492830|FG006|Overall Study|Physician Decision|1|||
27874951|NCT02037984|54492831|FG007|Overall Study|Physician Decision|0|||
27874952|NCT02037984|54492824|FG000|Overall Study|Protocol Violation|0|||
27874953|NCT02037984|54492825|FG001|Overall Study|Protocol Violation|0|||
27874954|NCT02037984|54492826|FG002|Overall Study|Protocol Violation|0|||
27874955|NCT02037984|54492827|FG003|Overall Study|Protocol Violation|0|||
27874956|NCT02037984|54492828|FG004|Overall Study|Protocol Violation|0|||
27874957|NCT02037984|54492829|FG005|Overall Study|Protocol Violation|1|||
27874958|NCT02037984|54492830|FG006|Overall Study|Protocol Violation|2|||
27874959|NCT02037984|54492831|FG007|Overall Study|Protocol Violation|0|||
27874960|NCT02037984|54492824|FG000|Overall Study|Technical Problems|0|||
27874961|NCT02037984|54492825|FG001|Overall Study|Technical Problems|0|||
27874962|NCT02037984|54492826|FG002|Overall Study|Technical Problems|3|||
27874963|NCT02037984|54492827|FG003|Overall Study|Technical Problems|3|||
27874964|NCT02037984|54492828|FG004|Overall Study|Technical Problems|2|||
27874965|NCT02037984|54492829|FG005|Overall Study|Technical Problems|3|||
27874966|NCT02037984|54492830|FG006|Overall Study|Technical Problems|4|||
27874967|NCT02037984|54492831|FG007|Overall Study|Technical Problems|2|||
27874968|NCT02037984|54492824|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
27874969|NCT02037984|54492825|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
27874970|NCT02037984|54492826|FG002|Overall Study|Withdrawal by Parent/Guardian|3|||
27874971|NCT02037984|54492827|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
27874972|NCT02037984|54492828|FG004|Overall Study|Withdrawal by Parent/Guardian|5|||
27874973|NCT02037984|54492829|FG005|Overall Study|Withdrawal by Parent/Guardian|1|||
27874974|NCT02037984|54492830|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
27874975|NCT02037984|54492831|FG007|Overall Study|Withdrawal by Parent/Guardian|2|||
27874976|NCT02037984|54492824|FG000|Overall Study|Withdrawal by Subject|0|||
27874977|NCT02037984|54492825|FG001|Overall Study|Withdrawal by Subject|0|||
27874978|NCT02037984|54492826|FG002|Overall Study|Withdrawal by Subject|0|||
27874979|NCT02037984|54492827|FG003|Overall Study|Withdrawal by Subject|1|||
27874980|NCT02037984|54492828|FG004|Overall Study|Withdrawal by Subject|1|||
27874981|NCT02037984|54492829|FG005|Overall Study|Withdrawal by Subject|3|||
27874982|NCT02037984|54492830|FG006|Overall Study|Withdrawal by Subject|0|||
27874983|NCT02037984|54492831|FG007|Overall Study|Withdrawal by Subject|1|||
27874984|NCT02057406|54492862|FG000|Overall Study|Physician Decision|0|||
27874985|NCT02057406|54492863|FG001|Overall Study|Physician Decision|0|||
27874986|NCT02057406|54492864|FG002|Overall Study|Physician Decision|2|||
28096423|NCT04413552|54751374|FG004|Overall Study|Adverse Event|0|||
28096424|NCT04413552|54751375|FG005|Overall Study|Adverse Event|0|||
27874987|NCT02057406|54492862|FG000|Overall Study|Withdrawal by Subject|0|||
27874988|NCT02057406|54492863|FG001|Overall Study|Withdrawal by Subject|2|||
27874989|NCT02057406|54492864|FG002|Overall Study|Withdrawal by Subject|0|||
27874990|NCT02057406|54492862|FG000|Overall Study|Lost to Follow-up|0|||
27874991|NCT02057406|54492863|FG001|Overall Study|Lost to Follow-up|0|||
27874992|NCT02057406|54492864|FG002|Overall Study|Lost to Follow-up|1|||
27874993|NCT02057406|54492862|FG000|Overall Study|Death|1|||
27874994|NCT02057406|54492863|FG001|Overall Study|Death|0|||
28096425|NCT04413552|54751376|FG006|Overall Study|Adverse Event|1|||
28096426|NCT04413552|54751377|FG007|Overall Study|Adverse Event|0|||
27874995|NCT02057406|54492864|FG002|Overall Study|Death|0|||
27874996|NCT02057406|54492862|FG000|Overall Study|Protocol Violation|0|||
27874997|NCT02057406|54492863|FG001|Overall Study|Protocol Violation|1|||
27874998|NCT02057406|54492864|FG002|Overall Study|Protocol Violation|0|||
27874999|NCT02057406|54492862|FG000|Overall Study|Patient transportation issues|0|||
27875000|NCT02057406|54492863|FG001|Overall Study|Patient transportation issues|0|||
27875001|NCT02057406|54492864|FG002|Overall Study|Patient transportation issues|1|||
27875002|NCT02036580|54492875|FG000|Overall Study|Withdrawal by Subject|0|||
28096427|NCT04413552|54751378|FG008|Overall Study|Adverse Event|0|||
28096428|NCT04413552|54751379|FG009|Overall Study|Adverse Event|0|||
27875003|NCT02036580|54492876|FG001|Overall Study|Withdrawal by Subject|1|||
27875004|NCT02036580|54492877|FG002|Overall Study|Withdrawal by Subject|0|||
27875005|NCT02036580|54492875|FG000|Overall Study|Adverse Event|1|||
27875006|NCT02036580|54492876|FG001|Overall Study|Adverse Event|0|||
27875007|NCT02036580|54492877|FG002|Overall Study|Adverse Event|0|||
27875008|NCT02014116|54492894|FG000|Overall Study|Progressive Disease|3|||
27875009|NCT02014116|54492895|FG001|Overall Study|Progressive Disease|4|||
27875010|NCT02014116|54492896|FG002|Overall Study|Progressive Disease|2|||
27875011|NCT02014116|54492897|FG003|Overall Study|Progressive Disease|6|||
27875012|NCT02014116|54492898|FG004|Overall Study|Progressive Disease|1|||
27875013|NCT02014116|54492899|FG005|Overall Study|Progressive Disease|13|||
27875014|NCT02014116|54492900|FG006|Overall Study|Progressive Disease|1|||
27875015|NCT02014116|54492901|FG007|Overall Study|Progressive Disease|3|||
27875016|NCT02014116|54492902|FG008|Overall Study|Progressive Disease|7|||
27875017|NCT02014116|54492894|FG000|Overall Study|Adverse Event|0|||
27875018|NCT02014116|54492895|FG001|Overall Study|Adverse Event|0|||
27875019|NCT02014116|54492896|FG002|Overall Study|Adverse Event|0|||
27875020|NCT02014116|54492897|FG003|Overall Study|Adverse Event|0|||
27875021|NCT02014116|54492898|FG004|Overall Study|Adverse Event|1|||
27875022|NCT02014116|54492899|FG005|Overall Study|Adverse Event|0|||
27875023|NCT02014116|54492900|FG006|Overall Study|Adverse Event|0|||
27875024|NCT02014116|54492901|FG007|Overall Study|Adverse Event|1|||
27875025|NCT02014116|54492902|FG008|Overall Study|Adverse Event|0|||
27875026|NCT02014116|54492894|FG000|Overall Study|Lost to Follow-up|0|||
27875027|NCT02014116|54492895|FG001|Overall Study|Lost to Follow-up|0|||
27875028|NCT02014116|54492896|FG002|Overall Study|Lost to Follow-up|0|||
27875029|NCT02014116|54492897|FG003|Overall Study|Lost to Follow-up|0|||
27875030|NCT02014116|54492898|FG004|Overall Study|Lost to Follow-up|0|||
27875031|NCT02014116|54492899|FG005|Overall Study|Lost to Follow-up|1|||
27875032|NCT02014116|54492900|FG006|Overall Study|Lost to Follow-up|0|||
27875033|NCT02014116|54492901|FG007|Overall Study|Lost to Follow-up|0|||
27875034|NCT02014116|54492902|FG008|Overall Study|Lost to Follow-up|1|||
27875035|NCT02014116|54492894|FG000|Overall Study|Death|0|||
27875036|NCT02014116|54492895|FG001|Overall Study|Death|0|||
27875037|NCT02014116|54492896|FG002|Overall Study|Death|0|||
27875038|NCT02014116|54492897|FG003|Overall Study|Death|0|||
27875039|NCT02014116|54492898|FG004|Overall Study|Death|0|||
27875040|NCT02014116|54492899|FG005|Overall Study|Death|0|||
27875041|NCT02014116|54492900|FG006|Overall Study|Death|0|||
27875042|NCT02014116|54492901|FG007|Overall Study|Death|1|||
27875043|NCT02014116|54492902|FG008|Overall Study|Death|1|||
27875044|NCT02014116|54492894|FG000|Overall Study|Withdrawal by Subject|0|||
27875045|NCT02014116|54492895|FG001|Overall Study|Withdrawal by Subject|0|||
27875046|NCT02014116|54492896|FG002|Overall Study|Withdrawal by Subject|1|||
27875047|NCT02014116|54492897|FG003|Overall Study|Withdrawal by Subject|1|||
27875048|NCT02014116|54492898|FG004|Overall Study|Withdrawal by Subject|0|||
27875049|NCT02014116|54492899|FG005|Overall Study|Withdrawal by Subject|1|||
27875050|NCT02014116|54492900|FG006|Overall Study|Withdrawal by Subject|0|||
27875051|NCT02014116|54492901|FG007|Overall Study|Withdrawal by Subject|0|||
27875052|NCT02014116|54492902|FG008|Overall Study|Withdrawal by Subject|0|||
27875053|NCT02014116|54492894|FG000|Overall Study|Withdrawal Caregiver Decision|0|||
27875054|NCT02014116|54492895|FG001|Overall Study|Withdrawal Caregiver Decision|0|||
27875055|NCT02014116|54492896|FG002|Overall Study|Withdrawal Caregiver Decision|0|||
27875056|NCT02014116|54492897|FG003|Overall Study|Withdrawal Caregiver Decision|0|||
27875057|NCT02014116|54492898|FG004|Overall Study|Withdrawal Caregiver Decision|0|||
27875058|NCT02014116|54492899|FG005|Overall Study|Withdrawal Caregiver Decision|1|||
27875059|NCT02014116|54492900|FG006|Overall Study|Withdrawal Caregiver Decision|0|||
27875060|NCT02014116|54492901|FG007|Overall Study|Withdrawal Caregiver Decision|0|||
27875061|NCT02014116|54492902|FG008|Overall Study|Withdrawal Caregiver Decision|0|||
27875062|NCT02014116|54492894|FG000|Overall Study|Physician Decision|0|||
27875063|NCT02014116|54492895|FG001|Overall Study|Physician Decision|0|||
27875064|NCT02014116|54492896|FG002|Overall Study|Physician Decision|0|||
27875065|NCT02014116|54492897|FG003|Overall Study|Physician Decision|0|||
27875066|NCT02014116|54492898|FG004|Overall Study|Physician Decision|0|||
27875067|NCT02014116|54492899|FG005|Overall Study|Physician Decision|0|||
27875068|NCT02014116|54492900|FG006|Overall Study|Physician Decision|0|||
27875069|NCT02014116|54492901|FG007|Overall Study|Physician Decision|0|||
27875070|NCT02014116|54492902|FG008|Overall Study|Physician Decision|1|||
27875071|NCT02057250|54492929|FG000|AID Assessment Phase|Adverse Event|3|||
27875072|NCT02057250|54492930|FG001|AID Assessment Phase|Adverse Event|2|||
27875073|NCT02057250|54492931|FG002|AID Assessment Phase|Adverse Event|6|||
27875074|NCT02057250|54492932|FG003|AID Assessment Phase|Adverse Event|1|||
27875075|NCT02057250|54492933|FG004|AID Assessment Phase|Adverse Event|0|||
27875076|NCT02057250|54492929|FG000|AID Assessment Phase|Other than specified above|1|||
27875077|NCT02057250|54492930|FG001|AID Assessment Phase|Other than specified above|1|||
27875078|NCT02057250|54492931|FG002|AID Assessment Phase|Other than specified above|1|||
27875079|NCT02057250|54492932|FG003|AID Assessment Phase|Other than specified above|1|||
27875080|NCT02057250|54492933|FG004|AID Assessment Phase|Other than specified above|0|||
27875081|NCT02057250|54492929|FG000|Extension Phase|Adverse Event|0|||
27875082|NCT02057250|54492930|FG001|Extension Phase|Adverse Event|0|||
27875083|NCT02057250|54492931|FG002|Extension Phase|Adverse Event|0|||
27875084|NCT02057250|54492932|FG003|Extension Phase|Adverse Event|0|||
27875085|NCT02057250|54492933|FG004|Extension Phase|Adverse Event|15|||
27875086|NCT02057250|54492929|FG000|Extension Phase|Lack of Efficacy|0|||
27875087|NCT02057250|54492930|FG001|Extension Phase|Lack of Efficacy|0|||
27875088|NCT02057250|54492931|FG002|Extension Phase|Lack of Efficacy|0|||
27875089|NCT02057250|54492932|FG003|Extension Phase|Lack of Efficacy|0|||
27875090|NCT02057250|54492933|FG004|Extension Phase|Lack of Efficacy|10|||
27875091|NCT02057250|54492929|FG000|Extension Phase|Entered in this period but not treated|0|||
27875092|NCT02057250|54492930|FG001|Extension Phase|Entered in this period but not treated|0|||
27875093|NCT02057250|54492931|FG002|Extension Phase|Entered in this period but not treated|0|||
27875094|NCT02057250|54492932|FG003|Extension Phase|Entered in this period but not treated|0|||
27875095|NCT02057250|54492933|FG004|Extension Phase|Entered in this period but not treated|4|||
27875096|NCT02057250|54492929|FG000|Extension Phase|Other than specified above|0|||
27875097|NCT02057250|54492930|FG001|Extension Phase|Other than specified above|0|||
27875098|NCT02057250|54492931|FG002|Extension Phase|Other than specified above|0|||
27875099|NCT02057250|54492932|FG003|Extension Phase|Other than specified above|0|||
27875100|NCT02057250|54492933|FG004|Extension Phase|Other than specified above|7|||
27875101|NCT02036502|54492953|FG000|Part 1:Dose Determination/Escalation|Death|3|||
27875102|NCT02036502|54492954|FG001|Part 1:Dose Determination/Escalation|Death|2|||
27875103|NCT02036502|54492955|FG002|Part 1:Dose Determination/Escalation|Death|0|||
27875104|NCT02036502|54492956|FG003|Part 1:Dose Determination/Escalation|Death|0|||
27875105|NCT02036502|54492957|FG004|Part 1:Dose Determination/Escalation|Death|0|||
27875106|NCT02036502|54492958|FG005|Part 1:Dose Determination/Escalation|Death|0|||
27875107|NCT02036502|54492959|FG006|Part 1:Dose Determination/Escalation|Death|0|||
27875108|NCT02036502|54492960|FG007|Part 1:Dose Determination/Escalation|Death|0|||
27875109|NCT02036502|54492953|FG000|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|3|||
27875110|NCT02036502|54492954|FG001|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
27875111|NCT02036502|54492955|FG002|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
27875112|NCT02036502|54492956|FG003|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
27875113|NCT02036502|54492957|FG004|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
27875114|NCT02036502|54492958|FG005|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
27875115|NCT02036502|54492959|FG006|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
27875116|NCT02036502|54492960|FG007|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
27875117|NCT02036502|54492953|FG000|Part 1:Dose Determination/Escalation|Adverse Event|0|||
27875118|NCT02036502|54492954|FG001|Part 1:Dose Determination/Escalation|Adverse Event|1|||
27875119|NCT02036502|54492955|FG002|Part 1:Dose Determination/Escalation|Adverse Event|0|||
27875120|NCT02036502|54492956|FG003|Part 1:Dose Determination/Escalation|Adverse Event|0|||
27875121|NCT02036502|54492957|FG004|Part 1:Dose Determination/Escalation|Adverse Event|0|||
27875122|NCT02036502|54492958|FG005|Part 1:Dose Determination/Escalation|Adverse Event|0|||
27875123|NCT02036502|54492959|FG006|Part 1:Dose Determination/Escalation|Adverse Event|0|||
27875124|NCT02036502|54492960|FG007|Part 1:Dose Determination/Escalation|Adverse Event|0|||
27875125|NCT02036502|54492953|FG000|Part 1:Dose Determination/Escalation|Not treated|0|||
27875126|NCT02036502|54492954|FG001|Part 1:Dose Determination/Escalation|Not treated|1|||
27875127|NCT02036502|54492955|FG002|Part 1:Dose Determination/Escalation|Not treated|0|||
27875128|NCT02036502|54492956|FG003|Part 1:Dose Determination/Escalation|Not treated|0|||
27875129|NCT02036502|54492957|FG004|Part 1:Dose Determination/Escalation|Not treated|0|||
27875130|NCT02036502|54492958|FG005|Part 1:Dose Determination/Escalation|Not treated|0|||
27875131|NCT02036502|54492959|FG006|Part 1:Dose Determination/Escalation|Not treated|0|||
27875132|NCT02036502|54492960|FG007|Part 1:Dose Determination/Escalation|Not treated|0|||
27875133|NCT02036502|54492953|FG000|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
27875134|NCT02036502|54492954|FG001|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
27875135|NCT02036502|54492955|FG002|Part 2:Dose Confirmation|Study Terminated by Sponsor|2|||
27875136|NCT02036502|54492956|FG003|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
27875137|NCT02036502|54492957|FG004|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
27875138|NCT02036502|54492958|FG005|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
27875139|NCT02036502|54492959|FG006|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
27875140|NCT02036502|54492960|FG007|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
27875141|NCT02036502|54492953|FG000|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
27875142|NCT02036502|54492954|FG001|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
27875143|NCT02036502|54492955|FG002|Part 2:Dose Confirmation|Withdrawal by Subject|3|||
27875144|NCT02036502|54492956|FG003|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
27875145|NCT02036502|54492957|FG004|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
27875146|NCT02036502|54492958|FG005|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
27875147|NCT02036502|54492959|FG006|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
27875148|NCT02036502|54492960|FG007|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
28171621|NCT03350815|54843240|FG003|Period 1|Lost to Follow-up|0|||
27875149|NCT02036502|54492953|FG000|Part 2:Dose Confirmation|Death|0|||
27875150|NCT02036502|54492954|FG001|Part 2:Dose Confirmation|Death|0|||
27875151|NCT02036502|54492955|FG002|Part 2:Dose Confirmation|Death|1|||
27875152|NCT02036502|54492956|FG003|Part 2:Dose Confirmation|Death|0|||
27875153|NCT02036502|54492957|FG004|Part 2:Dose Confirmation|Death|0|||
27875154|NCT02036502|54492958|FG005|Part 2:Dose Confirmation|Death|0|||
27875155|NCT02036502|54492959|FG006|Part 2:Dose Confirmation|Death|0|||
27875156|NCT02036502|54492960|FG007|Part 2:Dose Confirmation|Death|0|||
27875157|NCT02036502|54492953|FG000|Part 2:Dose Confirmation|Not treated|0|||
27875158|NCT02036502|54492954|FG001|Part 2:Dose Confirmation|Not treated|0|||
27875159|NCT02036502|54492955|FG002|Part 2:Dose Confirmation|Not treated|0|||
27875160|NCT02036502|54492956|FG003|Part 2:Dose Confirmation|Not treated|1|||
27875161|NCT02036502|54492957|FG004|Part 2:Dose Confirmation|Not treated|0|||
27875162|NCT02036502|54492958|FG005|Part 2:Dose Confirmation|Not treated|0|||
27875163|NCT02036502|54492959|FG006|Part 2:Dose Confirmation|Not treated|0|||
27875164|NCT02036502|54492960|FG007|Part 2:Dose Confirmation|Not treated|0|||
27875165|NCT02036502|54492953|FG000|Part 3:Dose Expansion|Adverse Event|0|||
27875166|NCT02036502|54492954|FG001|Part 3:Dose Expansion|Adverse Event|0|||
27875167|NCT02036502|54492955|FG002|Part 3:Dose Expansion|Adverse Event|0|||
27875168|NCT02036502|54492956|FG003|Part 3:Dose Expansion|Adverse Event|0|||
27875169|NCT02036502|54492957|FG004|Part 3:Dose Expansion|Adverse Event|0|||
27875170|NCT02036502|54492958|FG005|Part 3:Dose Expansion|Adverse Event|4|||
27875171|NCT02036502|54492959|FG006|Part 3:Dose Expansion|Adverse Event|0|||
27875172|NCT02036502|54492960|FG007|Part 3:Dose Expansion|Adverse Event|2|||
27875173|NCT02036502|54492953|FG000|Part 3:Dose Expansion|Death|0|||
27875174|NCT02036502|54492954|FG001|Part 3:Dose Expansion|Death|0|||
27875175|NCT02036502|54492955|FG002|Part 3:Dose Expansion|Death|0|||
27875176|NCT02036502|54492956|FG003|Part 3:Dose Expansion|Death|0|||
27875177|NCT02036502|54492957|FG004|Part 3:Dose Expansion|Death|0|||
27875178|NCT02036502|54492958|FG005|Part 3:Dose Expansion|Death|24|||
27875179|NCT02036502|54492959|FG006|Part 3:Dose Expansion|Death|0|||
27875180|NCT02036502|54492960|FG007|Part 3:Dose Expansion|Death|3|||
27875181|NCT02036502|54492953|FG000|Part 3:Dose Expansion|Lost to Follow-up|0|||
27875182|NCT02036502|54492954|FG001|Part 3:Dose Expansion|Lost to Follow-up|0|||
27875183|NCT02036502|54492955|FG002|Part 3:Dose Expansion|Lost to Follow-up|0|||
27875184|NCT02036502|54492956|FG003|Part 3:Dose Expansion|Lost to Follow-up|0|||
27875185|NCT02036502|54492957|FG004|Part 3:Dose Expansion|Lost to Follow-up|0|||
27875186|NCT02036502|54492958|FG005|Part 3:Dose Expansion|Lost to Follow-up|0|||
27875187|NCT02036502|54492959|FG006|Part 3:Dose Expansion|Lost to Follow-up|0|||
27875188|NCT02036502|54492960|FG007|Part 3:Dose Expansion|Lost to Follow-up|1|||
27875189|NCT02036502|54492953|FG000|Part 3:Dose Expansion|Physician Decision|0|||
27875190|NCT02036502|54492954|FG001|Part 3:Dose Expansion|Physician Decision|0|||
27875191|NCT02036502|54492955|FG002|Part 3:Dose Expansion|Physician Decision|0|||
27875192|NCT02036502|54492956|FG003|Part 3:Dose Expansion|Physician Decision|0|||
27875193|NCT02036502|54492957|FG004|Part 3:Dose Expansion|Physician Decision|0|||
27875194|NCT02036502|54492958|FG005|Part 3:Dose Expansion|Physician Decision|1|||
27875195|NCT02036502|54492959|FG006|Part 3:Dose Expansion|Physician Decision|0|||
27875196|NCT02036502|54492960|FG007|Part 3:Dose Expansion|Physician Decision|0|||
27875197|NCT02036502|54492953|FG000|Part 3:Dose Expansion|Progressive Disease|0|||
27875198|NCT02036502|54492954|FG001|Part 3:Dose Expansion|Progressive Disease|0|||
27875199|NCT02036502|54492955|FG002|Part 3:Dose Expansion|Progressive Disease|0|||
27875200|NCT02036502|54492956|FG003|Part 3:Dose Expansion|Progressive Disease|0|||
27875201|NCT02036502|54492957|FG004|Part 3:Dose Expansion|Progressive Disease|0|||
27875202|NCT02036502|54492958|FG005|Part 3:Dose Expansion|Progressive Disease|1|||
27875203|NCT02036502|54492959|FG006|Part 3:Dose Expansion|Progressive Disease|0|||
27875204|NCT02036502|54492960|FG007|Part 3:Dose Expansion|Progressive Disease|0|||
27875205|NCT02036502|54492953|FG000|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
27875206|NCT02036502|54492954|FG001|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
27875207|NCT02036502|54492955|FG002|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
27875208|NCT02036502|54492956|FG003|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
27875209|NCT02036502|54492957|FG004|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
27875210|NCT02036502|54492958|FG005|Part 3:Dose Expansion|Study Terminated by Sponsor|11|||
27875211|NCT02036502|54492959|FG006|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
27875212|NCT02036502|54492960|FG007|Part 3:Dose Expansion|Study Terminated by Sponsor|2|||
27875213|NCT02036502|54492953|FG000|Part 3:Dose Expansion|Withdrawal by Subject|0|||
27875214|NCT02036502|54492954|FG001|Part 3:Dose Expansion|Withdrawal by Subject|0|||
27875215|NCT02036502|54492955|FG002|Part 3:Dose Expansion|Withdrawal by Subject|0|||
27875216|NCT02036502|54492956|FG003|Part 3:Dose Expansion|Withdrawal by Subject|0|||
27875217|NCT02036502|54492957|FG004|Part 3:Dose Expansion|Withdrawal by Subject|0|||
27875218|NCT02036502|54492958|FG005|Part 3:Dose Expansion|Withdrawal by Subject|4|||
27875219|NCT02036502|54492959|FG006|Part 3:Dose Expansion|Withdrawal by Subject|1|||
27875220|NCT02036502|54492960|FG007|Part 3:Dose Expansion|Withdrawal by Subject|2|||
27875221|NCT02036502|54492953|FG000|Part 3:Dose Expansion|Not Treated|0|||
27875222|NCT02036502|54492954|FG001|Part 3:Dose Expansion|Not Treated|0|||
27739249|NCT03318523|54188609|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
27875223|NCT02036502|54492955|FG002|Part 3:Dose Expansion|Not Treated|0|||
27982775|NCT02017717|54640941|FG002|Treatment Period|Maximum clinical benefit|0|||
27982776|NCT02017717|54640942|FG003|Treatment Period|Maximum clinical benefit|0|||
27982777|NCT02017717|54640943|FG004|Treatment Period|Maximum clinical benefit|1|||
27739250|NCT03318523|54188610|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
27875224|NCT02036502|54492956|FG003|Part 3:Dose Expansion|Not Treated|0|||
27875225|NCT02036502|54492957|FG004|Part 3:Dose Expansion|Not Treated|0|||
27875226|NCT02036502|54492958|FG005|Part 3:Dose Expansion|Not Treated|2|||
27875227|NCT02036502|54492959|FG006|Part 3:Dose Expansion|Not Treated|0|||
27875228|NCT02036502|54492960|FG007|Part 3:Dose Expansion|Not Treated|0|||
27875229|NCT02056626|54492984|FG000|Overall Study|patient did not follow directions|3|||
27875230|NCT02056626|54492985|FG001|Overall Study|patient did not follow directions|1|||
27875231|NCT02056626|54492986|FG002|Overall Study|patient did not follow directions|0|||
27875232|NCT02056626|54492987|FG003|Overall Study|patient did not follow directions|0|||
27875233|NCT02035332|54492997|FG000|Overall Study|Procedure Aborted due to Uterine Width|1|||
27875234|NCT02056392|54493007|FG000|Overall Study|Lost to Follow-up|0|||
27875235|NCT02056392|54493008|FG001|Overall Study|Lost to Follow-up|1|||
27875236|NCT02056392|54493009|FG002|Overall Study|Lost to Follow-up|2|||
27875237|NCT02056392|54493010|FG003|Overall Study|Lost to Follow-up|0|||
27875238|NCT02056392|54493011|FG004|Overall Study|Lost to Follow-up|0|||
27875239|NCT02056392|54493012|FG005|Overall Study|Lost to Follow-up|0|||
27875240|NCT02056392|54493007|FG000|Overall Study|Protocol Violation|1|||
27875241|NCT02056392|54493008|FG001|Overall Study|Protocol Violation|0|||
27875242|NCT02056392|54493009|FG002|Overall Study|Protocol Violation|1|||
27875243|NCT02056392|54493010|FG003|Overall Study|Protocol Violation|0|||
27875244|NCT02056392|54493011|FG004|Overall Study|Protocol Violation|0|||
27875245|NCT02056392|54493012|FG005|Overall Study|Protocol Violation|0|||
27875246|NCT02056392|54493007|FG000|Overall Study|Withdrawal by Subject|1|||
27875247|NCT02056392|54493008|FG001|Overall Study|Withdrawal by Subject|0|||
27875248|NCT02056392|54493009|FG002|Overall Study|Withdrawal by Subject|0|||
27875249|NCT02056392|54493010|FG003|Overall Study|Withdrawal by Subject|0|||
27875250|NCT02056392|54493011|FG004|Overall Study|Withdrawal by Subject|1|||
27875251|NCT02056392|54493012|FG005|Overall Study|Withdrawal by Subject|0|||
27875252|NCT02034708|54493022|FG000|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2|||
27875253|NCT02034708|54493023|FG001|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5|||
27875254|NCT02034708|54493022|FG000|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1|||
27875255|NCT02034708|54493023|FG001|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0|||
27875256|NCT02034708|54493022|FG000|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
27875257|NCT02034708|54493023|FG001|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
27875258|NCT02034708|54493022|FG000|Wash-out (From 2 Days up to 14 Days)|other reason|3|||
27875259|NCT02034708|54493023|FG001|Wash-out (From 2 Days up to 14 Days)|other reason|2|||
27875260|NCT02034552|54493037|FG000|Overall Study|Never treated|3|||
27875261|NCT02034552|54493038|FG001|Overall Study|Never treated|2|||
27875262|NCT02034552|54493039|FG002|Overall Study|Never treated|0|||
27875263|NCT02034552|54493037|FG000|Overall Study|Radiological progression|3|||
27875264|NCT02034552|54493038|FG001|Overall Study|Radiological progression|5|||
27875265|NCT02034552|54493039|FG002|Overall Study|Radiological progression|4|||
27875266|NCT02034552|54493037|FG000|Overall Study|AE not assoc. with disease progression|1|||
27875267|NCT02034552|54493038|FG001|Overall Study|AE not assoc. with disease progression|4|||
27875268|NCT02034552|54493039|FG002|Overall Study|AE not assoc. with disease progression|2|||
27875269|NCT02034552|54493037|FG000|Overall Study|AE associated with disease progression|0|||
27875270|NCT02034552|54493038|FG001|Overall Study|AE associated with disease progression|1|||
27875271|NCT02034552|54493039|FG002|Overall Study|AE associated with disease progression|0|||
27875272|NCT02034552|54493037|FG000|Overall Study|Withdrawal by Subject|2|||
27875273|NCT02034552|54493038|FG001|Overall Study|Withdrawal by Subject|1|||
27875274|NCT02034552|54493039|FG002|Overall Study|Withdrawal by Subject|1|||
27875275|NCT02034552|54493037|FG000|Overall Study|Non-compliance with study drug|0|||
27875276|NCT02034552|54493038|FG001|Overall Study|Non-compliance with study drug|0|||
27875277|NCT02034552|54493039|FG002|Overall Study|Non-compliance with study drug|1|||
27875278|NCT02034552|54493037|FG000|Overall Study|Clinical progression|5|||
27875279|NCT02034552|54493038|FG001|Overall Study|Clinical progression|7|||
27875280|NCT02034552|54493039|FG002|Overall Study|Clinical progression|9|||
27875281|NCT02034474|54493049|FG000|Overall Study|Adverse Event|3|||
27875282|NCT02034474|54493050|FG001|Overall Study|Adverse Event|2|||
27875283|NCT02034474|54493049|FG000|Overall Study|Withdrawal by Subject|1|||
27875284|NCT02034474|54493050|FG001|Overall Study|Withdrawal by Subject|2|||
27875285|NCT02011542|54493058|FG000|Overall Study|Physician Decision|1|||
27875286|NCT02011386|54493062|FG000|Overall Study|Non-compliance|2|||
27875287|NCT02011386|54493062|FG000|Overall Study|Lack of Efficacy|3|||
27875288|NCT02010684|54493068|FG000|Overall Study|Lost to Follow-up|8|||
27875289|NCT02010684|54493069|FG001|Overall Study|Lost to Follow-up|18|||
27875290|NCT02010684|54493068|FG000|Overall Study|Withdrawal by Subject|4|||
27982778|NCT02017717|54640944|FG005|Treatment Period|Maximum clinical benefit|0|||
27875291|NCT02010684|54493069|FG001|Overall Study|Withdrawal by Subject|5|||
27875292|NCT02034162|54493077|FG000|Double-blind|Lost to Follow-up|3|||
27875293|NCT02034162|54493078|FG001|Double-blind|Lost to Follow-up|0|||
27875294|NCT02034162|54493079|FG002|Double-blind|Lost to Follow-up|0|||
27875295|NCT02034162|54493077|FG000|Double-blind|Physician Decision|1|||
27875296|NCT02034162|54493078|FG001|Double-blind|Physician Decision|0|||
27875297|NCT02034162|54493079|FG002|Double-blind|Physician Decision|0|||
27875298|NCT02034162|54493077|FG000|Double-blind|Protocol Violation|0|||
27875299|NCT02034162|54493078|FG001|Double-blind|Protocol Violation|1|||
27875300|NCT02034162|54493079|FG002|Double-blind|Protocol Violation|0|||
27875301|NCT02034162|54493077|FG000|Double-blind|Withdrawal by Subject|5|||
27875302|NCT02034162|54493078|FG001|Double-blind|Withdrawal by Subject|7|||
27875303|NCT02034162|54493079|FG002|Double-blind|Withdrawal by Subject|0|||
27875304|NCT02034006|54493092|FG000|Overall Study|Withdrawal by Subject|7|||
27875305|NCT02034006|54493092|FG000|Overall Study|Lost to Follow-up|5|||
27875306|NCT02034006|54493092|FG000|Overall Study|Death|1|||
27875307|NCT02034006|54493092|FG000|Overall Study|Pregnancy|1|||
27875308|NCT02054910|54493101|FG000|Overall Study|Lost to Follow-up|4|||
27875309|NCT02054910|54493102|FG001|Overall Study|Lost to Follow-up|1|||
27875310|NCT02033850|54493112|FG000|Overall Study|Death|1|||
27875311|NCT02033850|54493113|FG001|Overall Study|Death|0|||
27875312|NCT02033850|54493112|FG000|Overall Study|unrelated medical reason|1|||
27875313|NCT02033850|54493113|FG001|Overall Study|unrelated medical reason|1|||
27875314|NCT02054130|54493123|FG000|Overall Study|Withdrawal by Subject|4|||
27875315|NCT02054130|54493124|FG001|Overall Study|Withdrawal by Subject|4|||
27875316|NCT02054130|54493125|FG002|Overall Study|Withdrawal by Subject|7|||
27875317|NCT02054130|54493126|FG003|Overall Study|Withdrawal by Subject|10|||
27875318|NCT02054130|54493123|FG000|Overall Study|Death|0|||
27875319|NCT02054130|54493124|FG001|Overall Study|Death|1|||
27875320|NCT02054130|54493125|FG002|Overall Study|Death|0|||
27875321|NCT02054130|54493126|FG003|Overall Study|Death|0|||
27875322|NCT02054130|54493123|FG000|Overall Study|Lost to Follow-up|0|||
27875323|NCT02054130|54493124|FG001|Overall Study|Lost to Follow-up|0|||
27875324|NCT02054130|54493125|FG002|Overall Study|Lost to Follow-up|1|||
27875325|NCT02054130|54493126|FG003|Overall Study|Lost to Follow-up|2|||
28171622|NCT03350815|54843237|FG000|Period 1|Physician Decision|1|||
28171623|NCT03350815|54843238|FG001|Period 1|Physician Decision|0|||
28171624|NCT03350815|54843239|FG002|Period 1|Physician Decision|0|||
28171625|NCT03350815|54843240|FG003|Period 1|Physician Decision|0|||
27875326|NCT02054130|54493123|FG000|Overall Study|Missed dose|4|||
27875327|NCT02054130|54493124|FG001|Overall Study|Missed dose|6|||
27875328|NCT02054130|54493125|FG002|Overall Study|Missed dose|7|||
27875329|NCT02054130|54493126|FG003|Overall Study|Missed dose|10|||
27875330|NCT02009046|54493141|FG000|Overall Study|Lost to Follow-up|256|||
27875331|NCT02009046|54493142|FG001|Overall Study|Lost to Follow-up|206|||
27875332|NCT02052960|54493158|FG000|Overall Study|Adverse Event|19|||
27875333|NCT02052960|54493159|FG001|Overall Study|Adverse Event|17|||
27875334|NCT02052960|54493158|FG000|Overall Study|Protocol Violation|4|||
27875335|NCT02052960|54493159|FG001|Overall Study|Protocol Violation|3|||
27875336|NCT02052960|54493158|FG000|Overall Study|Withdrawal by Subject|6|||
27875337|NCT02052960|54493159|FG001|Overall Study|Withdrawal by Subject|11|||
27875338|NCT02052960|54493158|FG000|Overall Study|Other|25|||
27875339|NCT02052960|54493159|FG001|Overall Study|Other|15|||
27875340|NCT02008890|54493171|FG000|Period 1|Withdrawal by Subject|7|||
27875341|NCT02008890|54493172|FG001|Period 1|Withdrawal by Subject|7|||
27875342|NCT02008890|54493173|FG002|Period 1|Withdrawal by Subject|5|||
27875343|NCT02008890|54493174|FG003|Period 1|Withdrawal by Subject|0|||
27875344|NCT02008890|54493175|FG004|Period 1|Withdrawal by Subject|0|||
27875345|NCT02008890|54493171|FG000|Period 1|Pregnancy|1|||
27875346|NCT02008890|54493172|FG001|Period 1|Pregnancy|0|||
27875347|NCT02008890|54493173|FG002|Period 1|Pregnancy|0|||
27875348|NCT02008890|54493174|FG003|Period 1|Pregnancy|0|||
27739251|NCT03318523|54188611|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
27875349|NCT02008890|54493175|FG004|Period 1|Pregnancy|0|||
27875350|NCT02008890|54493171|FG000|Period 1|Physician Decision|1|||
27875351|NCT02008890|54493172|FG001|Period 1|Physician Decision|0|||
27875352|NCT02008890|54493173|FG002|Period 1|Physician Decision|1|||
27875353|NCT02008890|54493174|FG003|Period 1|Physician Decision|0|||
27875354|NCT02008890|54493175|FG004|Period 1|Physician Decision|0|||
27875355|NCT02008890|54493171|FG000|Period 1|Adverse Event|6|||
27875356|NCT02008890|54493172|FG001|Period 1|Adverse Event|8|||
27875357|NCT02008890|54493173|FG002|Period 1|Adverse Event|6|||
28171626|NCT03350815|54843237|FG000|Period 1|Withdrawal by Subject|8|||
27875358|NCT02008890|54493174|FG003|Period 1|Adverse Event|0|||
27739252|NCT03318523|54188612|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|1|||
27875359|NCT02008890|54493175|FG004|Period 1|Adverse Event|0|||
27875360|NCT02008890|54493171|FG000|Period 2|Adverse Event|12|||
27875361|NCT02008890|54493172|FG001|Period 2|Adverse Event|7|||
27875362|NCT02008890|54493173|FG002|Period 2|Adverse Event|0|||
27875363|NCT02008890|54493174|FG003|Period 2|Adverse Event|5|||
27875364|NCT02008890|54493175|FG004|Period 2|Adverse Event|5|||
27875365|NCT02008890|54493171|FG000|Period 2|Withdrawal by Subject|11|||
27875366|NCT02008890|54493172|FG001|Period 2|Withdrawal by Subject|8|||
27875367|NCT02008890|54493173|FG002|Period 2|Withdrawal by Subject|0|||
27875368|NCT02008890|54493174|FG003|Period 2|Withdrawal by Subject|7|||
27875369|NCT02008890|54493175|FG004|Period 2|Withdrawal by Subject|2|||
27875370|NCT02008890|54493171|FG000|Period 2|Physician Decision|4|||
27875371|NCT02008890|54493172|FG001|Period 2|Physician Decision|0|||
27875372|NCT02008890|54493173|FG002|Period 2|Physician Decision|0|||
27875373|NCT02008890|54493174|FG003|Period 2|Physician Decision|2|||
27875374|NCT02008890|54493175|FG004|Period 2|Physician Decision|1|||
27875375|NCT02008890|54493171|FG000|Period 2|Lost to Follow-up|0|||
27875376|NCT02008890|54493172|FG001|Period 2|Lost to Follow-up|0|||
27875377|NCT02008890|54493173|FG002|Period 2|Lost to Follow-up|1|||
27875378|NCT02008890|54493174|FG003|Period 2|Lost to Follow-up|0|||
27875379|NCT02008890|54493175|FG004|Period 2|Lost to Follow-up|0|||
27875380|NCT02008890|54493171|FG000|Extension Period|Withdrawal by Subject|3|||
27875381|NCT02008890|54493172|FG001|Extension Period|Withdrawal by Subject|2|||
27875382|NCT02008890|54493173|FG002|Extension Period|Withdrawal by Subject|0|||
27875383|NCT02008890|54493174|FG003|Extension Period|Withdrawal by Subject|4|||
27875384|NCT02008890|54493175|FG004|Extension Period|Withdrawal by Subject|2|||
27875385|NCT02008890|54493171|FG000|Extension Period|Lost to Follow-up|1|||
27875386|NCT02008890|54493172|FG001|Extension Period|Lost to Follow-up|0|||
27875387|NCT02008890|54493173|FG002|Extension Period|Lost to Follow-up|0|||
27875388|NCT02008890|54493174|FG003|Extension Period|Lost to Follow-up|0|||
27875389|NCT02008890|54493175|FG004|Extension Period|Lost to Follow-up|0|||
27875390|NCT02008890|54493171|FG000|Extension Period|Adverse Event|1|||
27875391|NCT02008890|54493172|FG001|Extension Period|Adverse Event|3|||
27875392|NCT02008890|54493173|FG002|Extension Period|Adverse Event|0|||
27875393|NCT02008890|54493174|FG003|Extension Period|Adverse Event|0|||
27875394|NCT02008890|54493175|FG004|Extension Period|Adverse Event|2|||
27875395|NCT02052414|54493190|FG000|Overall Study|Adverse Event|12|||
27875396|NCT02052414|54493190|FG000|Overall Study|Lack of Efficacy|2|||
27875397|NCT02052414|54493190|FG000|Overall Study|Withdrawal by Subject|3|||
27875398|NCT02007954|54493195|FG000|Overall Study|Received liver transplant|3|||
27875399|NCT02007954|54493195|FG000|Overall Study|Switch in treatment modality|2|||
27875400|NCT02007954|54493195|FG000|Overall Study|Disease progression and unrelated AE|1|||
27875401|NCT02007954|54493195|FG000|Overall Study|Death|1|||
27875402|NCT02049450|54493199|FG000|Overall Study|Adverse Event|2|||
27875403|NCT02049450|54493199|FG000|Overall Study|Withdrawal by Subject|1|||
27875404|NCT02049450|54493199|FG000|Overall Study|Patients/guardian decision|1|||
27875405|NCT02031432|54493210|FG000|Overall Study|Protocol Violation|1|||
27875406|NCT02031432|54493210|FG000|Overall Study|Lack of Efficacy|5|||
27875407|NCT02031432|54493210|FG000|Overall Study|Cancer Progression|2|||
27875408|NCT02031432|54493210|FG000|Overall Study|Withdrawn as forbidden meds required|1|||
27875409|NCT02031432|54493210|FG000|Overall Study|Adverse Event|8|||
27875410|NCT02031432|54493210|FG000|Overall Study|Withdrawal by Subject|5|||
27875411|NCT02031432|54493210|FG000|Overall Study|Lost to Follow-up|1|||
27875412|NCT02031432|54493210|FG000|Overall Study|Inclusion/Exclusion criteria not met|5|||
27875413|NCT02031432|54493210|FG000|Overall Study|Death|10|||
27875414|NCT02031276|54493217|FG000|Period 1 Double-blind IV|Adverse Event|6|||
27875415|NCT02031276|54493218|FG001|Period 1 Double-blind IV|Adverse Event|5|||
27875416|NCT02031276|54493219|FG002|Period 1 Double-blind IV|Adverse Event|1|||
27875417|NCT02031276|54493217|FG000|Period 1 Double-blind IV|Other|0|||
27875418|NCT02031276|54493218|FG001|Period 1 Double-blind IV|Other|1|||
27875419|NCT02031276|54493219|FG002|Period 1 Double-blind IV|Other|0|||
27875420|NCT02031276|54493217|FG000|Period 2 Open-label Risankizumab IV|Adverse Event|1|||
27875421|NCT02031276|54493218|FG001|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
27875422|NCT02031276|54493219|FG002|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
27875423|NCT02031276|54493217|FG000|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3|||
27875424|NCT02031276|54493218|FG001|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
27875425|NCT02031276|54493219|FG002|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
27875426|NCT02031276|54493217|FG000|Period 2 Open-label Risankizumab IV|Other|0|||
27875427|NCT02031276|54493218|FG001|Period 2 Open-label Risankizumab IV|Other|2|||
27875428|NCT02031276|54493219|FG002|Period 2 Open-label Risankizumab IV|Other|1|||
27875429|NCT02031276|54493217|FG000|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
27875430|NCT02031276|54493218|FG001|Period 3 Open-label Risankizumab SC|Adverse Event|2|||
27875431|NCT02031276|54493219|FG002|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
27875432|NCT02031276|54493217|FG000|Period 3 Open-label Risankizumab SC|Protocol Violation|2|||
27875433|NCT02031276|54493218|FG001|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
27875434|NCT02031276|54493219|FG002|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
27875435|NCT02031276|54493217|FG000|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
27875436|NCT02031276|54493218|FG001|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
27875437|NCT02031276|54493219|FG002|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
27875438|NCT02031276|54493217|FG000|Period 3 Open-label Risankizumab SC|Other|0|||
27875439|NCT02031276|54493218|FG001|Period 3 Open-label Risankizumab SC|Other|0|||
27875440|NCT02031276|54493219|FG002|Period 3 Open-label Risankizumab SC|Other|1|||
27875441|NCT02007720|54493233|FG000|Overall Study|Withdrawal by Subject|9|||
27875442|NCT02007720|54493234|FG001|Overall Study|Withdrawal by Subject|11|||
27875443|NCT02007720|54493233|FG000|Overall Study|study terminated by sponsor|58|||
27875444|NCT02007720|54493234|FG001|Overall Study|study terminated by sponsor|54|||
27875445|NCT02007720|54493233|FG000|Overall Study|technical problem|4|||
27875446|NCT02007720|54493234|FG001|Overall Study|technical problem|2|||
27875447|NCT02007720|54493233|FG000|Overall Study|patient followd less than 165 days|11|||
27875448|NCT02007720|54493234|FG001|Overall Study|patient followd less than 165 days|5|||
27875449|NCT01363440|54493244|FG000|Overall Study|Adverse Event|5|||
27875450|NCT01363440|54493245|FG001|Overall Study|Adverse Event|4|||
27875451|NCT01363440|54493246|FG002|Overall Study|Adverse Event|4|||
27875452|NCT01363440|54493244|FG000|Overall Study|Death|3|||
27875453|NCT01363440|54493245|FG001|Overall Study|Death|7|||
27875454|NCT01363440|54493246|FG002|Overall Study|Death|5|||
27875455|NCT01363440|54493244|FG000|Overall Study|Withdrawal by Subject|9|||
27875456|NCT01363440|54493245|FG001|Overall Study|Withdrawal by Subject|11|||
27875457|NCT01363440|54493246|FG002|Overall Study|Withdrawal by Subject|11|||
27875458|NCT01363440|54493244|FG000|Overall Study|Lost to Follow-up|2|||
27875459|NCT01363440|54493245|FG001|Overall Study|Lost to Follow-up|4|||
27875460|NCT01363440|54493246|FG002|Overall Study|Lost to Follow-up|5|||
27875461|NCT01363440|54493244|FG000|Overall Study|Other|4|||
27875462|NCT01363440|54493245|FG001|Overall Study|Other|5|||
27875463|NCT01363440|54493246|FG002|Overall Study|Other|2|||
27875464|NCT02007252|54493259|FG000|Overall Study|Administrative problems|3|||
27875465|NCT02007252|54493260|FG001|Overall Study|Administrative problems|7|||
27875466|NCT02007252|54493259|FG000|Overall Study|Abnormal laboratory value(s)|1|||
27875467|NCT02007252|54493260|FG001|Overall Study|Abnormal laboratory value(s)|0|||
27875468|NCT02007252|54493259|FG000|Overall Study|Adverse Event|7|||
27875469|NCT02007252|54493260|FG001|Overall Study|Adverse Event|4|||
27875470|NCT02007096|54493268|FG000|Overall Study|medication not available|2|||
27875471|NCT02007096|54493269|FG001|Overall Study|medication not available|0|||
27875472|NCT02007096|54493268|FG000|Overall Study|did not inject saline|0|||
27875473|NCT02007096|54493269|FG001|Overall Study|did not inject saline|3|||
27875474|NCT02007096|54493268|FG000|Overall Study|did not follow postoperative protocol|8|||
27875475|NCT02007096|54493269|FG001|Overall Study|did not follow postoperative protocol|11|||
27875476|NCT02007096|54493268|FG000|Overall Study|converted to open surgery|1|||
27875477|NCT02007096|54493269|FG001|Overall Study|converted to open surgery|1|||
27875478|NCT02007096|54493268|FG000|Overall Study|no mesh placed|0|||
27875479|NCT02007096|54493269|FG001|Overall Study|no mesh placed|1|||
27875480|NCT02006706|54493275|FG000|Overall Study|Lost to Follow-up|1|||
27875481|NCT02049138|54493282|FG000|Overall Study|Adverse Event|46|||
27875482|NCT02049138|54493283|FG001|Overall Study|Adverse Event|25|||
27875483|NCT02049138|54493284|FG002|Overall Study|Adverse Event|1|||
27875484|NCT02049138|54493282|FG000|Overall Study|Withdrawal by Subject|57|||
27875485|NCT02049138|54493283|FG001|Overall Study|Withdrawal by Subject|21|||
27875486|NCT02049138|54493284|FG002|Overall Study|Withdrawal by Subject|5|||
27875487|NCT02049138|54493282|FG000|Overall Study|Lost to Follow-up|18|||
27875488|NCT02049138|54493283|FG001|Overall Study|Lost to Follow-up|5|||
27875489|NCT02049138|54493284|FG002|Overall Study|Lost to Follow-up|1|||
27875490|NCT02049138|54493282|FG000|Overall Study|Lack of Efficacy|10|||
27875491|NCT02049138|54493283|FG001|Overall Study|Lack of Efficacy|26|||
27875492|NCT02049138|54493284|FG002|Overall Study|Lack of Efficacy|1|||
27875493|NCT02049138|54493282|FG000|Overall Study|Non-Compliance|15|||
27875494|NCT02049138|54493283|FG001|Overall Study|Non-Compliance|6|||
27875495|NCT02049138|54493284|FG002|Overall Study|Non-Compliance|0|||
27875496|NCT02049138|54493282|FG000|Overall Study|Required Alternative / Prohibited Therapy|1|||
27875497|NCT02049138|54493283|FG001|Overall Study|Required Alternative / Prohibited Therapy|1|||
27875498|NCT02049138|54493284|FG002|Overall Study|Required Alternative / Prohibited Therapy|0|||
27875499|NCT02049138|54493282|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|1|||
27875500|NCT02049138|54493283|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
27875501|NCT02049138|54493284|FG002|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
27875502|NCT02049138|54493282|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
28096429|NCT03987074|54751410|FG000|Overall Study|Withdrew Consent|1|||
28096430|NCT03987074|54751411|FG001|Overall Study|Withdrew Consent|1|||
27875503|NCT02049138|54493283|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
27875504|NCT02049138|54493284|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
27875505|NCT02049138|54493282|FG000|Overall Study|Other|15|||
27875506|NCT02049138|54493283|FG001|Overall Study|Other|13|||
27875507|NCT02049138|54493284|FG002|Overall Study|Other|0|||
27875508|NCT02049138|54493282|FG000|Overall Study|Missing|0|||
27875509|NCT02049138|54493283|FG001|Overall Study|Missing|1|||
27875510|NCT02049138|54493284|FG002|Overall Study|Missing|0|||
27875511|NCT02048904|54493295|FG000|Overall Study|Withdrawal by Subject|7|||
27875512|NCT02048904|54493295|FG000|Overall Study|Physician Decision|70|||
27875513|NCT02006628|54493301|FG000|Overall Study|Adverse Event|1|||
27875514|NCT02006628|54493302|FG001|Overall Study|Adverse Event|1|||
27875515|NCT02006628|54493301|FG000|Overall Study|Withdrawal by Subject|2|||
27875516|NCT02006628|54493302|FG001|Overall Study|Withdrawal by Subject|1|||
27875517|NCT02048826|54493310|FG000|Overall Study|Withdrawal by Subject|1|||
27875518|NCT02048826|54493311|FG001|Overall Study|Withdrawal by Subject|0|||
27875519|NCT02006472|54493322|FG000|Period 1 (Through Week 26)|Protocol Violation|1|||
27875520|NCT02006472|54493323|FG001|Period 1 (Through Week 26)|Protocol Violation|1|||
27875521|NCT02006472|54493324|FG002|Period 1 (Through Week 26)|Protocol Violation|1|||
27875522|NCT02006472|54493325|FG003|Period 1 (Through Week 26)|Protocol Violation|1|||
27875523|NCT02006472|54493326|FG004|Period 1 (Through Week 26)|Protocol Violation|0|||
27875524|NCT02006472|54493322|FG000|Period 1 (Through Week 26)|Lack of Efficacy|0|||
27875525|NCT02006472|54493323|FG001|Period 1 (Through Week 26)|Lack of Efficacy|0|||
27875526|NCT02006472|54493324|FG002|Period 1 (Through Week 26)|Lack of Efficacy|1|||
27875527|NCT02006472|54493325|FG003|Period 1 (Through Week 26)|Lack of Efficacy|0|||
27875528|NCT02006472|54493326|FG004|Period 1 (Through Week 26)|Lack of Efficacy|0|||
27875529|NCT02006472|54493322|FG000|Period 1 (Through Week 26)|Noncompliance|2|||
27875530|NCT02006472|54493323|FG001|Period 1 (Through Week 26)|Noncompliance|1|||
27875531|NCT02006472|54493324|FG002|Period 1 (Through Week 26)|Noncompliance|1|||
27875532|NCT02006472|54493325|FG003|Period 1 (Through Week 26)|Noncompliance|0|||
27875533|NCT02006472|54493326|FG004|Period 1 (Through Week 26)|Noncompliance|0|||
27875534|NCT02006472|54493322|FG000|Period 1 (Through Week 26)|Other|1|||
27875535|NCT02006472|54493323|FG001|Period 1 (Through Week 26)|Other|5|||
27875536|NCT02006472|54493324|FG002|Period 1 (Through Week 26)|Other|0|||
27875537|NCT02006472|54493325|FG003|Period 1 (Through Week 26)|Other|2|||
27875538|NCT02006472|54493326|FG004|Period 1 (Through Week 26)|Other|3|||
27875539|NCT02006472|54493322|FG000|Period 1 (Through Week 26)|Adverse Event|5|||
27875540|NCT02006472|54493323|FG001|Period 1 (Through Week 26)|Adverse Event|6|||
27875541|NCT02006472|54493324|FG002|Period 1 (Through Week 26)|Adverse Event|11|||
27875542|NCT02006472|54493325|FG003|Period 1 (Through Week 26)|Adverse Event|11|||
27875543|NCT02006472|54493326|FG004|Period 1 (Through Week 26)|Adverse Event|14|||
27875544|NCT02006472|54493322|FG000|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
27875545|NCT02006472|54493323|FG001|Period 1 (Through Week 26)|Withdrawal by Subject|9|||
27875546|NCT02006472|54493324|FG002|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
27875547|NCT02006472|54493325|FG003|Period 1 (Through Week 26)|Withdrawal by Subject|0|||
27875548|NCT02006472|54493326|FG004|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
27875549|NCT02006472|54493322|FG000|Period 2 (Through Week 52)|Lack of Efficacy|1|||
27875550|NCT02006472|54493323|FG001|Period 2 (Through Week 52)|Lack of Efficacy|0|||
27875551|NCT02006472|54493324|FG002|Period 2 (Through Week 52)|Lack of Efficacy|0|||
27875552|NCT02006472|54493325|FG003|Period 2 (Through Week 52)|Lack of Efficacy|1|||
27875553|NCT02006472|54493326|FG004|Period 2 (Through Week 52)|Lack of Efficacy|1|||
27875554|NCT02006472|54493322|FG000|Period 2 (Through Week 52)|Noncompliance|1|||
27875555|NCT02006472|54493323|FG001|Period 2 (Through Week 52)|Noncompliance|0|||
27875556|NCT02006472|54493324|FG002|Period 2 (Through Week 52)|Noncompliance|0|||
27875557|NCT02006472|54493325|FG003|Period 2 (Through Week 52)|Noncompliance|0|||
27875558|NCT02006472|54493326|FG004|Period 2 (Through Week 52)|Noncompliance|0|||
27875559|NCT02006472|54493322|FG000|Period 2 (Through Week 52)|Adverse Event|1|||
27875560|NCT02006472|54493323|FG001|Period 2 (Through Week 52)|Adverse Event|4|||
27875561|NCT02006472|54493324|FG002|Period 2 (Through Week 52)|Adverse Event|5|||
27875562|NCT02006472|54493325|FG003|Period 2 (Through Week 52)|Adverse Event|1|||
27875563|NCT02006472|54493326|FG004|Period 2 (Through Week 52)|Adverse Event|1|||
27875564|NCT02006472|54493322|FG000|Period 2 (Through Week 52)|Other|0|||
27875565|NCT02006472|54493323|FG001|Period 2 (Through Week 52)|Other|1|||
27875566|NCT02006472|54493324|FG002|Period 2 (Through Week 52)|Other|0|||
27875567|NCT02006472|54493325|FG003|Period 2 (Through Week 52)|Other|1|||
27875568|NCT02006472|54493326|FG004|Period 2 (Through Week 52)|Other|0|||
27875569|NCT02006472|54493322|FG000|Period 2 (Through Week 52)|Not treated|0|||
27875570|NCT02006472|54493323|FG001|Period 2 (Through Week 52)|Not treated|0|||
27875571|NCT02006472|54493324|FG002|Period 2 (Through Week 52)|Not treated|2|||
27875572|NCT02006472|54493325|FG003|Period 2 (Through Week 52)|Not treated|0|||
27875573|NCT02006472|54493326|FG004|Period 2 (Through Week 52)|Not treated|0|||
27875574|NCT02006472|54493322|FG000|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
27875575|NCT02006472|54493323|FG001|Period 2 (Through Week 52)|Withdrawal by Subject|1|||
27875576|NCT02006472|54493324|FG002|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
27875577|NCT02006472|54493325|FG003|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
27875578|NCT02006472|54493326|FG004|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
27875579|NCT02006472|54493322|FG000|Period 2 (Through Week 52)|Sponsor decision|0|||
27875580|NCT02006472|54493323|FG001|Period 2 (Through Week 52)|Sponsor decision|0|||
27875581|NCT02006472|54493324|FG002|Period 2 (Through Week 52)|Sponsor decision|1|||
27875582|NCT02006472|54493325|FG003|Period 2 (Through Week 52)|Sponsor decision|0|||
27875583|NCT02006472|54493326|FG004|Period 2 (Through Week 52)|Sponsor decision|0|||
27875584|NCT02005692|54493343|FG000|Overall Study|Protocol Violation|1|||
27875585|NCT02005692|54493343|FG000|Overall Study|Withdrawal by Subject|1|||
27875586|NCT02005692|54493343|FG000|Overall Study|Discharged earlier than anticipated|5|||
27875587|NCT02029638|54493351|FG000|Overall Study|Death|0|||
27875588|NCT02029638|54493352|FG001|Overall Study|Death|0|||
27875589|NCT02029638|54493353|FG002|Overall Study|Death|1|||
27875590|NCT02029638|54493351|FG000|Overall Study|Decision by Study Sponsor or Regulatory|2|||
27875591|NCT02029638|54493352|FG001|Overall Study|Decision by Study Sponsor or Regulatory|0|||
27875592|NCT02029638|54493353|FG002|Overall Study|Decision by Study Sponsor or Regulatory|0|||
27875593|NCT02047734|54493364|FG000|Overall Study|Adverse Event|18|||
27875594|NCT02047734|54493365|FG001|Overall Study|Adverse Event|13|||
27875595|NCT02047734|54493366|FG002|Overall Study|Adverse Event|13|||
27875596|NCT02047734|54493364|FG000|Overall Study|Lack of Efficacy|4|||
27875597|NCT02047734|54493365|FG001|Overall Study|Lack of Efficacy|5|||
27875598|NCT02047734|54493366|FG002|Overall Study|Lack of Efficacy|1|||
27875599|NCT02047734|54493364|FG000|Overall Study|Protocol Violation|3|||
27875600|NCT02047734|54493365|FG001|Overall Study|Protocol Violation|1|||
27875601|NCT02047734|54493366|FG002|Overall Study|Protocol Violation|1|||
27875602|NCT02047734|54493364|FG000|Overall Study|Lost to Follow-up|1|||
27875603|NCT02047734|54493365|FG001|Overall Study|Lost to Follow-up|4|||
27875604|NCT02047734|54493366|FG002|Overall Study|Lost to Follow-up|0|||
27875605|NCT02047734|54493364|FG000|Overall Study|Death|0|||
27875606|NCT02047734|54493365|FG001|Overall Study|Death|1|||
27875607|NCT02047734|54493366|FG002|Overall Study|Death|0|||
27875608|NCT02047734|54493364|FG000|Overall Study|Withdrawal by Subject|30|||
27875609|NCT02047734|54493365|FG001|Overall Study|Withdrawal by Subject|31|||
27875610|NCT02047734|54493366|FG002|Overall Study|Withdrawal by Subject|19|||
27875611|NCT02047734|54493364|FG000|Overall Study|Physician Decision|7|||
27875612|NCT02047734|54493365|FG001|Overall Study|Physician Decision|6|||
27875613|NCT02047734|54493366|FG002|Overall Study|Physician Decision|5|||
27875614|NCT02047734|54493364|FG000|Overall Study|Miscellaneous|2|||
27875615|NCT02047734|54493365|FG001|Overall Study|Miscellaneous|4|||
27875616|NCT02047734|54493366|FG002|Overall Study|Miscellaneous|6|||
27875617|NCT02047734|54493364|FG000|Overall Study|Did Not Receive Study Drug|2|||
27875618|NCT02047734|54493365|FG001|Overall Study|Did Not Receive Study Drug|4|||
27875619|NCT02047734|54493366|FG002|Overall Study|Did Not Receive Study Drug|1|||
27875620|NCT02053350|54493374|FG000|Overall Study|Withdrawal by Subject|1|||
27875621|NCT02053350|54493374|FG000|Overall Study|Adverse Event|4|||
27875622|NCT01994850|54493378|FG000|Overall Study|Physician Decision|1|||
27875623|NCT01994850|54493378|FG000|Overall Study|Withdrawal by Subject|1|||
27875624|NCT02027844|54493385|FG000|Overall Study|Withdrawal by Subject|3|||
27875625|NCT02027844|54493386|FG001|Overall Study|Withdrawal by Subject|2|||
27875626|NCT02027844|54493387|FG002|Overall Study|Withdrawal by Subject|1|||
27875627|NCT02027844|54493385|FG000|Overall Study|Lost to Follow-up|0|||
27875628|NCT02027844|54493386|FG001|Overall Study|Lost to Follow-up|2|||
27875629|NCT02027844|54493387|FG002|Overall Study|Lost to Follow-up|1|||
27875630|NCT02027844|54493385|FG000|Overall Study|Protocol Violation|0|||
27875631|NCT02027844|54493386|FG001|Overall Study|Protocol Violation|2|||
27875632|NCT02027844|54493387|FG002|Overall Study|Protocol Violation|0|||
27875633|NCT02027844|54493385|FG000|Overall Study|Incomlete data|2|||
27875634|NCT02027844|54493386|FG001|Overall Study|Incomlete data|0|||
27875635|NCT02027844|54493387|FG002|Overall Study|Incomlete data|0|||
27875636|NCT01994382|54493412|FG000|Overall Study|Informed consent withdrawn|0|||
27875637|NCT01994382|54493413|FG001|Overall Study|Informed consent withdrawn|0|||
27875638|NCT01994382|54493414|FG002|Overall Study|Informed consent withdrawn|0|||
27982779|NCT02017717|54640945|FG006|Treatment Period|Maximum clinical benefit|0|||
27982780|NCT02017717|54640946|FG007|Treatment Period|Maximum clinical benefit|0|||
27982781|NCT02017717|54640947|FG008|Treatment Period|Maximum clinical benefit|0|||
27982782|NCT01419080|54640984|FG000|Overall Study|Withdrawal by Subject|75|||
27982783|NCT01419080|54640984|FG000|Overall Study|Death|30|||
27982784|NCT01419080|54640984|FG000|Overall Study|Lost to Follow-up|23|||
27982785|NCT01419080|54640984|FG000|Overall Study|Too Ill|3|||
27982786|NCT01164228|54640992|FG000|Overall Study|Progression|24|||
27982787|NCT01164228|54640993|FG001|Overall Study|Progression|25|||
27982788|NCT01164228|54640992|FG000|Overall Study|Adverse Event|13|||
27982789|NCT01164228|54640993|FG001|Overall Study|Adverse Event|7|||
27982790|NCT01164228|54640992|FG000|Overall Study|Death|1|||
27982791|NCT01164228|54640993|FG001|Overall Study|Death|1|||
27982792|NCT01164228|54640992|FG000|Overall Study|Withdrawal by Subject|2|||
27982793|NCT01164228|54640993|FG001|Overall Study|Withdrawal by Subject|0|||
27982794|NCT01164228|54640992|FG000|Overall Study|Physician Decision|1|||
27982795|NCT01164228|54640993|FG001|Overall Study|Physician Decision|2|||
27875639|NCT01994382|54493415|FG003|Overall Study|Informed consent withdrawn|0|||
27875640|NCT01994382|54493416|FG004|Overall Study|Informed consent withdrawn|0|||
27875641|NCT01994382|54493417|FG005|Overall Study|Informed consent withdrawn|0|||
27875642|NCT01994382|54493418|FG006|Overall Study|Informed consent withdrawn|1|||
27982796|NCT01164228|54640992|FG000|Overall Study|Symptomatic deterioration|1|||
27982797|NCT01164228|54640993|FG001|Overall Study|Symptomatic deterioration|0|||
27982798|NCT01164228|54640992|FG000|Overall Study|Never started treatment|1|||
27982799|NCT01164228|54640993|FG001|Overall Study|Never started treatment|3|||
27982800|NCT01164228|54640992|FG000|Overall Study|Ineligible|1|||
27982801|NCT01164228|54640993|FG001|Overall Study|Ineligible|0|||
27875643|NCT01994382|54493419|FG007|Overall Study|Informed consent withdrawn|0|||
27875644|NCT01994382|54493420|FG008|Overall Study|Informed consent withdrawn|0|||
27982802|NCT00554515|54640999|FG000|Overall Study|Withdrawal by Subject|3|||
27982803|NCT00554515|54640999|FG000|Overall Study|Disease progression|52|||
27875645|NCT01994382|54493421|FG009|Overall Study|Informed consent withdrawn|0|||
27875646|NCT01994382|54493422|FG010|Overall Study|Informed consent withdrawn|0|||
27875647|NCT01994382|54493423|FG011|Overall Study|Informed consent withdrawn|0|||
27875648|NCT01994382|54493424|FG012|Overall Study|Informed consent withdrawn|0|||
27875649|NCT01994382|54493425|FG013|Overall Study|Informed consent withdrawn|0|||
27875650|NCT01994382|54493426|FG014|Overall Study|Informed consent withdrawn|0|||
27875651|NCT01994382|54493427|FG015|Overall Study|Informed consent withdrawn|0|||
27875652|NCT01994382|54493428|FG016|Overall Study|Informed consent withdrawn|0|||
27875653|NCT01994382|54493412|FG000|Overall Study|Progressive disease|3|||
27875654|NCT01994382|54493413|FG001|Overall Study|Progressive disease|4|||
27875655|NCT01994382|54493414|FG002|Overall Study|Progressive disease|4|||
27875656|NCT01994382|54493415|FG003|Overall Study|Progressive disease|3|||
27875657|NCT01994382|54493416|FG004|Overall Study|Progressive disease|2|||
27875658|NCT01994382|54493417|FG005|Overall Study|Progressive disease|3|||
27875659|NCT01994382|54493418|FG006|Overall Study|Progressive disease|3|||
27875660|NCT01994382|54493419|FG007|Overall Study|Progressive disease|6|||
27875661|NCT01994382|54493420|FG008|Overall Study|Progressive disease|2|||
27875662|NCT01994382|54493421|FG009|Overall Study|Progressive disease|2|||
27875663|NCT01994382|54493422|FG010|Overall Study|Progressive disease|13|||
27875664|NCT01994382|54493423|FG011|Overall Study|Progressive disease|8|||
27875665|NCT01994382|54493424|FG012|Overall Study|Progressive disease|7|||
27875666|NCT01994382|54493425|FG013|Overall Study|Progressive disease|3|||
27875667|NCT01994382|54493426|FG014|Overall Study|Progressive disease|6|||
27875668|NCT01994382|54493427|FG015|Overall Study|Progressive disease|44|||
27875669|NCT01994382|54493428|FG016|Overall Study|Progressive disease|28|||
27875670|NCT01994382|54493412|FG000|Overall Study|Physician Decision|0|||
27875671|NCT01994382|54493413|FG001|Overall Study|Physician Decision|1|||
27875672|NCT01994382|54493414|FG002|Overall Study|Physician Decision|0|||
27875673|NCT01994382|54493415|FG003|Overall Study|Physician Decision|0|||
27875674|NCT01994382|54493416|FG004|Overall Study|Physician Decision|0|||
27875675|NCT01994382|54493417|FG005|Overall Study|Physician Decision|0|||
27875676|NCT01994382|54493418|FG006|Overall Study|Physician Decision|0|||
27875677|NCT01994382|54493419|FG007|Overall Study|Physician Decision|0|||
27875678|NCT01994382|54493420|FG008|Overall Study|Physician Decision|0|||
27875679|NCT01994382|54493421|FG009|Overall Study|Physician Decision|0|||
27875680|NCT01994382|54493422|FG010|Overall Study|Physician Decision|3|||
27875681|NCT01994382|54493423|FG011|Overall Study|Physician Decision|1|||
27875682|NCT01994382|54493424|FG012|Overall Study|Physician Decision|1|||
27875683|NCT01994382|54493425|FG013|Overall Study|Physician Decision|0|||
27875684|NCT01994382|54493426|FG014|Overall Study|Physician Decision|1|||
27875685|NCT01994382|54493427|FG015|Overall Study|Physician Decision|4|||
27875686|NCT01994382|54493428|FG016|Overall Study|Physician Decision|2|||
27875687|NCT01994382|54493412|FG000|Overall Study|Death|0|||
27875688|NCT01994382|54493413|FG001|Overall Study|Death|0|||
27875689|NCT01994382|54493414|FG002|Overall Study|Death|0|||
27875690|NCT01994382|54493415|FG003|Overall Study|Death|0|||
27875691|NCT01994382|54493416|FG004|Overall Study|Death|1|||
27875692|NCT01994382|54493417|FG005|Overall Study|Death|0|||
27875693|NCT01994382|54493418|FG006|Overall Study|Death|0|||
27875694|NCT01994382|54493419|FG007|Overall Study|Death|0|||
27875695|NCT01994382|54493420|FG008|Overall Study|Death|1|||
27875696|NCT01994382|54493421|FG009|Overall Study|Death|1|||
27875697|NCT01994382|54493422|FG010|Overall Study|Death|0|||
27875698|NCT01994382|54493423|FG011|Overall Study|Death|0|||
27875699|NCT01994382|54493424|FG012|Overall Study|Death|0|||
27875700|NCT01994382|54493425|FG013|Overall Study|Death|0|||
27875701|NCT01994382|54493426|FG014|Overall Study|Death|0|||
27875702|NCT01994382|54493427|FG015|Overall Study|Death|1|||
27875703|NCT01994382|54493428|FG016|Overall Study|Death|0|||
27875704|NCT01994382|54493412|FG000|Overall Study|Adverse Event|0|||
27875705|NCT01994382|54493413|FG001|Overall Study|Adverse Event|1|||
27875706|NCT01994382|54493414|FG002|Overall Study|Adverse Event|2|||
27875707|NCT01994382|54493415|FG003|Overall Study|Adverse Event|0|||
27875708|NCT01994382|54493416|FG004|Overall Study|Adverse Event|0|||
27875709|NCT01994382|54493417|FG005|Overall Study|Adverse Event|0|||
27875710|NCT01994382|54493418|FG006|Overall Study|Adverse Event|0|||
27875711|NCT01994382|54493419|FG007|Overall Study|Adverse Event|0|||
27875712|NCT01994382|54493420|FG008|Overall Study|Adverse Event|0|||
27875713|NCT01994382|54493421|FG009|Overall Study|Adverse Event|0|||
27875714|NCT01994382|54493422|FG010|Overall Study|Adverse Event|15|||
27982804|NCT00554515|54640999|FG000|Overall Study|Physician Decision|18|||
27875715|NCT01994382|54493423|FG011|Overall Study|Adverse Event|2|||
27875716|NCT01994382|54493424|FG012|Overall Study|Adverse Event|7|||
27875717|NCT01994382|54493425|FG013|Overall Study|Adverse Event|3|||
27875718|NCT01994382|54493426|FG014|Overall Study|Adverse Event|17|||
27875719|NCT01994382|54493427|FG015|Overall Study|Adverse Event|6|||
27875720|NCT01994382|54493428|FG016|Overall Study|Adverse Event|3|||
27875721|NCT01994382|54493412|FG000|Overall Study|Other than specified|0|||
27875722|NCT01994382|54493413|FG001|Overall Study|Other than specified|0|||
27875723|NCT01994382|54493414|FG002|Overall Study|Other than specified|0|||
27875724|NCT01994382|54493415|FG003|Overall Study|Other than specified|0|||
27982805|NCT00554515|54640999|FG000|Overall Study|Withdrawal by Subject|11|||
27875725|NCT01994382|54493416|FG004|Overall Study|Other than specified|0|||
27875726|NCT01994382|54493417|FG005|Overall Study|Other than specified|0|||
27875727|NCT01994382|54493418|FG006|Overall Study|Other than specified|0|||
27875728|NCT01994382|54493419|FG007|Overall Study|Other than specified|0|||
27875729|NCT01994382|54493420|FG008|Overall Study|Other than specified|0|||
27875730|NCT01994382|54493421|FG009|Overall Study|Other than specified|0|||
27875731|NCT01994382|54493422|FG010|Overall Study|Other than specified|2|||
27875732|NCT01994382|54493423|FG011|Overall Study|Other than specified|0|||
27875733|NCT01994382|54493424|FG012|Overall Study|Other than specified|2|||
27875734|NCT01994382|54493425|FG013|Overall Study|Other than specified|0|||
27875735|NCT01994382|54493426|FG014|Overall Study|Other than specified|0|||
27875736|NCT01994382|54493427|FG015|Overall Study|Other than specified|4|||
27875737|NCT01994382|54493428|FG016|Overall Study|Other than specified|4|||
27875738|NCT01994382|54493412|FG000|Overall Study|Withdrawal by Subject|0|||
27875739|NCT01994382|54493413|FG001|Overall Study|Withdrawal by Subject|0|||
27875740|NCT01994382|54493414|FG002|Overall Study|Withdrawal by Subject|0|||
27875741|NCT01994382|54493415|FG003|Overall Study|Withdrawal by Subject|0|||
27875742|NCT01994382|54493416|FG004|Overall Study|Withdrawal by Subject|0|||
27875743|NCT01994382|54493417|FG005|Overall Study|Withdrawal by Subject|0|||
27875744|NCT01994382|54493418|FG006|Overall Study|Withdrawal by Subject|0|||
27875745|NCT01994382|54493419|FG007|Overall Study|Withdrawal by Subject|0|||
27875746|NCT01994382|54493420|FG008|Overall Study|Withdrawal by Subject|0|||
27875747|NCT01994382|54493421|FG009|Overall Study|Withdrawal by Subject|0|||
27875748|NCT01994382|54493422|FG010|Overall Study|Withdrawal by Subject|6|||
27875749|NCT01994382|54493423|FG011|Overall Study|Withdrawal by Subject|0|||
27875750|NCT01994382|54493424|FG012|Overall Study|Withdrawal by Subject|2|||
27875751|NCT01994382|54493425|FG013|Overall Study|Withdrawal by Subject|0|||
27875752|NCT01994382|54493426|FG014|Overall Study|Withdrawal by Subject|4|||
27875753|NCT01994382|54493427|FG015|Overall Study|Withdrawal by Subject|3|||
27875754|NCT01994382|54493428|FG016|Overall Study|Withdrawal by Subject|0|||
27875755|NCT01994382|54493412|FG000|Overall Study|Lost to Follow-up|0|||
27875756|NCT01994382|54493413|FG001|Overall Study|Lost to Follow-up|0|||
27875757|NCT01994382|54493414|FG002|Overall Study|Lost to Follow-up|0|||
27875758|NCT01994382|54493415|FG003|Overall Study|Lost to Follow-up|0|||
27875759|NCT01994382|54493416|FG004|Overall Study|Lost to Follow-up|0|||
27875760|NCT01994382|54493417|FG005|Overall Study|Lost to Follow-up|0|||
27875761|NCT01994382|54493418|FG006|Overall Study|Lost to Follow-up|0|||
27875762|NCT01994382|54493419|FG007|Overall Study|Lost to Follow-up|0|||
27875763|NCT01994382|54493420|FG008|Overall Study|Lost to Follow-up|0|||
27875764|NCT01994382|54493421|FG009|Overall Study|Lost to Follow-up|0|||
27875765|NCT01994382|54493422|FG010|Overall Study|Lost to Follow-up|1|||
27875766|NCT01994382|54493423|FG011|Overall Study|Lost to Follow-up|0|||
27875767|NCT01994382|54493424|FG012|Overall Study|Lost to Follow-up|0|||
27875768|NCT01994382|54493425|FG013|Overall Study|Lost to Follow-up|0|||
27875769|NCT01994382|54493426|FG014|Overall Study|Lost to Follow-up|0|||
27875770|NCT01994382|54493427|FG015|Overall Study|Lost to Follow-up|0|||
27875771|NCT01994382|54493428|FG016|Overall Study|Lost to Follow-up|0|||
27875772|NCT01994382|54493412|FG000|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
27875773|NCT01994382|54493413|FG001|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
27875774|NCT01994382|54493414|FG002|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
27875775|NCT01994382|54493415|FG003|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
27875776|NCT01994382|54493416|FG004|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
27875777|NCT01994382|54493417|FG005|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
27875778|NCT01994382|54493418|FG006|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
27875779|NCT01994382|54493419|FG007|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
27875780|NCT01994382|54493420|FG008|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
27875781|NCT01994382|54493421|FG009|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
27875782|NCT01994382|54493422|FG010|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
27875783|NCT01994382|54493423|FG011|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
27875784|NCT01994382|54493424|FG012|Overall Study|Participants rolled over into expanded access program (NCT04757259)|7|||
27875785|NCT01994382|54493425|FG013|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
27875786|NCT01994382|54493426|FG014|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
27875787|NCT01994382|54493427|FG015|Overall Study|Participants rolled over into expanded access program (NCT04757259)|3|||
27875788|NCT01994382|54493428|FG016|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
27875789|NCT01994382|54493412|FG000|Overall Study|Protocol violation/noncompliance|0|||
27875790|NCT01994382|54493413|FG001|Overall Study|Protocol violation/noncompliance|0|||
27875791|NCT01994382|54493414|FG002|Overall Study|Protocol violation/noncompliance|0|||
27875792|NCT01994382|54493415|FG003|Overall Study|Protocol violation/noncompliance|0|||
27875793|NCT01994382|54493416|FG004|Overall Study|Protocol violation/noncompliance|0|||
27875794|NCT01994382|54493417|FG005|Overall Study|Protocol violation/noncompliance|0|||
27875795|NCT01994382|54493418|FG006|Overall Study|Protocol violation/noncompliance|0|||
27875796|NCT01994382|54493419|FG007|Overall Study|Protocol violation/noncompliance|0|||
27875797|NCT01994382|54493420|FG008|Overall Study|Protocol violation/noncompliance|0|||
27875798|NCT01994382|54493421|FG009|Overall Study|Protocol violation/noncompliance|0|||
27875799|NCT01994382|54493422|FG010|Overall Study|Protocol violation/noncompliance|0|||
27875800|NCT01994382|54493423|FG011|Overall Study|Protocol violation/noncompliance|1|||
27875801|NCT01994382|54493424|FG012|Overall Study|Protocol violation/noncompliance|0|||
27875802|NCT01994382|54493425|FG013|Overall Study|Protocol violation/noncompliance|0|||
27875803|NCT01994382|54493426|FG014|Overall Study|Protocol violation/noncompliance|0|||
27875804|NCT01994382|54493427|FG015|Overall Study|Protocol violation/noncompliance|0|||
27875805|NCT01994382|54493428|FG016|Overall Study|Protocol violation/noncompliance|2|||
27875806|NCT01994382|54493412|FG000|Overall Study|Rolled over to Phase 2a|0|||
27875807|NCT01994382|54493413|FG001|Overall Study|Rolled over to Phase 2a|0|||
27875808|NCT01994382|54493414|FG002|Overall Study|Rolled over to Phase 2a|1|||
27875809|NCT01994382|54493415|FG003|Overall Study|Rolled over to Phase 2a|0|||
27875810|NCT01994382|54493416|FG004|Overall Study|Rolled over to Phase 2a|0|||
27875811|NCT01994382|54493417|FG005|Overall Study|Rolled over to Phase 2a|0|||
27875812|NCT01994382|54493418|FG006|Overall Study|Rolled over to Phase 2a|0|||
27875813|NCT01994382|54493419|FG007|Overall Study|Rolled over to Phase 2a|0|||
27875814|NCT01994382|54493420|FG008|Overall Study|Rolled over to Phase 2a|0|||
27875815|NCT01994382|54493421|FG009|Overall Study|Rolled over to Phase 2a|2|||
27875816|NCT01994382|54493422|FG010|Overall Study|Rolled over to Phase 2a|0|||
27875817|NCT01994382|54493423|FG011|Overall Study|Rolled over to Phase 2a|0|||
27875818|NCT01994382|54493424|FG012|Overall Study|Rolled over to Phase 2a|0|||
27875819|NCT01994382|54493425|FG013|Overall Study|Rolled over to Phase 2a|0|||
27875820|NCT01994382|54493426|FG014|Overall Study|Rolled over to Phase 2a|0|||
27875821|NCT01994382|54493427|FG015|Overall Study|Rolled over to Phase 2a|0|||
27875822|NCT01994382|54493428|FG016|Overall Study|Rolled over to Phase 2a|0|||
27875823|NCT02003898|54493471|FG000|Overall Study|Death|3|||
27875824|NCT02003898|54493471|FG000|Overall Study|Lost to Follow-up|12|||
27875825|NCT02003898|54493471|FG000|Overall Study|Withdrawal by Subject|52|||
27875826|NCT01994226|54493477|FG000|Overall Study|Protocol Violation|13|||
27875827|NCT01994226|54493478|FG001|Overall Study|Protocol Violation|10|||
27875828|NCT01994226|54493477|FG000|Overall Study|Early Cessation of treatment|6|||
27875829|NCT01994226|54493478|FG001|Overall Study|Early Cessation of treatment|11|||
27875830|NCT02002884|54493487|FG000|Main Period (MP)|Other|0|||
27875831|NCT02002884|54493488|FG001|Main Period (MP)|Other|3|||
27875832|NCT02002884|54493489|FG002|Main Period (MP)|Other|3|||
27875833|NCT02002884|54493490|FG003|Main Period (MP)|Other|0|||
27875834|NCT02002884|54493487|FG000|Main Period (MP)|Adverse Event|0|||
27875835|NCT02002884|54493488|FG001|Main Period (MP)|Adverse Event|1|||
27875836|NCT02002884|54493489|FG002|Main Period (MP)|Adverse Event|1|||
27875837|NCT02002884|54493490|FG003|Main Period (MP)|Adverse Event|0|||
27875838|NCT02002884|54493487|FG000|Main Period (MP)|Withdrawal by Subject|6|||
27875839|NCT02002884|54493488|FG001|Main Period (MP)|Withdrawal by Subject|2|||
27875840|NCT02002884|54493489|FG002|Main Period (MP)|Withdrawal by Subject|2|||
27875841|NCT02002884|54493490|FG003|Main Period (MP)|Withdrawal by Subject|0|||
27875842|NCT02002884|54493487|FG000|Main Period (MP)|Lost to Follow-up|0|||
27875843|NCT02002884|54493488|FG001|Main Period (MP)|Lost to Follow-up|0|||
27875844|NCT02002884|54493489|FG002|Main Period (MP)|Lost to Follow-up|2|||
27875845|NCT02002884|54493490|FG003|Main Period (MP)|Lost to Follow-up|0|||
27875846|NCT02002884|54493487|FG000|Open-Label Extension Period (OLEX)|Other|0|||
27875847|NCT02002884|54493488|FG001|Open-Label Extension Period (OLEX)|Other|0|||
27875848|NCT02002884|54493489|FG002|Open-Label Extension Period (OLEX)|Other|0|||
27875849|NCT02002884|54493490|FG003|Open-Label Extension Period (OLEX)|Other|24|||
27875850|NCT02002884|54493487|FG000|Open-Label Extension Period (OLEX)|Physician Decision|0|||
27875851|NCT02002884|54493488|FG001|Open-Label Extension Period (OLEX)|Physician Decision|0|||
27875852|NCT02002884|54493489|FG002|Open-Label Extension Period (OLEX)|Physician Decision|0|||
27875853|NCT02002884|54493490|FG003|Open-Label Extension Period (OLEX)|Physician Decision|1|||
27875854|NCT02002884|54493487|FG000|Open-Label Extension Period (OLEX)|Adverse Event|0|||
27875855|NCT02002884|54493488|FG001|Open-Label Extension Period (OLEX)|Adverse Event|0|||
27875856|NCT02002884|54493489|FG002|Open-Label Extension Period (OLEX)|Adverse Event|0|||
27875857|NCT02002884|54493490|FG003|Open-Label Extension Period (OLEX)|Adverse Event|5|||
28096431|NCT03987074|54751412|FG002|Overall Study|Withdrew Consent|0|||
27875858|NCT02002884|54493487|FG000|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
27875859|NCT02002884|54493488|FG001|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
27875860|NCT02002884|54493489|FG002|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
27875861|NCT02002884|54493490|FG003|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10|||
27875862|NCT02002884|54493487|FG000|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
27875863|NCT02002884|54493488|FG001|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
27875864|NCT02002884|54493489|FG002|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
28096432|NCT03987074|54751413|FG003|Overall Study|Withdrew Consent|2|||
28096433|NCT03987074|54751414|FG004|Overall Study|Withdrew Consent|1|||
28096434|NCT03987074|54751410|FG000|Overall Study|Adverse Event|2|||
27875865|NCT02002884|54493490|FG003|Open-Label Extension Period (OLEX)|Lost to Follow-up|10|||
27875866|NCT02002182|54493502|FG000|Overall Study|Withdraw from study|3|||
27875867|NCT02002182|54493503|FG001|Overall Study|Withdraw from study|1|||
27875868|NCT02002182|54493502|FG000|Overall Study|Health Reasons|1|||
27875869|NCT02002182|54493503|FG001|Overall Study|Health Reasons|0|||
27875870|NCT02002182|54493502|FG000|Overall Study|Death|1|||
27875871|NCT02002182|54493503|FG001|Overall Study|Death|0|||
27875872|NCT01990950|54493509|FG000|Overall Study|Death|3|||
27875873|NCT01990950|54493509|FG000|Overall Study|Lost to Follow-up|2|||
27875874|NCT01990950|54493509|FG000|Overall Study|Withdrawal by Subject|6|||
27875875|NCT02001558|54493515|FG000|Overall Study|Lost to Follow-up|8|||
27875876|NCT02001558|54493516|FG001|Overall Study|Lost to Follow-up|14|||
27875877|NCT02023866|54493522|FG000|Overall Study|Non-compliance|2|||
27875878|NCT02023866|54493522|FG000|Overall Study|Adverse Event|3|||
27875879|NCT02023866|54493522|FG000|Overall Study|Withdrawal by Subject|1|||
27875880|NCT02023242|54493528|FG000|Overall Study|Lost to Follow-up|3|||
27875881|NCT02023242|54493529|FG001|Overall Study|Lost to Follow-up|1|||
27875882|NCT02023242|54493528|FG000|Overall Study|Death|0|||
27875883|NCT02023242|54493529|FG001|Overall Study|Death|1|||
27875884|NCT01967940|54493538|FG000|Part 2|Enrolled in Part 2 and Never Treated|0|||
27875885|NCT01967940|54493539|FG001|Part 2|Enrolled in Part 2 and Never Treated|0|||
27875886|NCT01967940|54493540|FG002|Part 2|Enrolled in Part 2 and Never Treated|0|||
27875887|NCT01967940|54493541|FG003|Part 2|Enrolled in Part 2 and Never Treated|1|||
27875888|NCT01967940|54493538|FG000|Part 2|Adverse Event|0|||
27875889|NCT01967940|54493539|FG001|Part 2|Adverse Event|0|||
27875890|NCT01967940|54493540|FG002|Part 2|Adverse Event|0|||
27875891|NCT01967940|54493541|FG003|Part 2|Adverse Event|1|||
27875892|NCT01967940|54493538|FG000|Part 2|Unknown Reason|0|||
27875893|NCT01967940|54493539|FG001|Part 2|Unknown Reason|0|||
27875894|NCT01967940|54493540|FG002|Part 2|Unknown Reason|0|||
27875895|NCT01967940|54493541|FG003|Part 2|Unknown Reason|1|||
27875896|NCT01990560|54493551|FG000|Overall Study|Withdrawal by Subject|1|||
27875897|NCT01998984|54493559|FG000|Overall Study|Adverse Event|0|||
27875898|NCT01998984|54493560|FG001|Overall Study|Adverse Event|0|||
27875899|NCT01998984|54493561|FG002|Overall Study|Adverse Event|0|||
27875900|NCT01998984|54493562|FG003|Overall Study|Adverse Event|1|||
27875901|NCT01998984|54493559|FG000|Overall Study|Lost to Follow-up|0|||
27875902|NCT01998984|54493560|FG001|Overall Study|Lost to Follow-up|1|||
27875903|NCT01998984|54493561|FG002|Overall Study|Lost to Follow-up|0|||
27875904|NCT01998984|54493562|FG003|Overall Study|Lost to Follow-up|1|||
27875905|NCT01998984|54493559|FG000|Overall Study|Withdrawal by Subject|0|||
27875906|NCT01998984|54493560|FG001|Overall Study|Withdrawal by Subject|0|||
27875907|NCT01998984|54493561|FG002|Overall Study|Withdrawal by Subject|1|||
27875908|NCT01998984|54493562|FG003|Overall Study|Withdrawal by Subject|0|||
27875909|NCT01998984|54493559|FG000|Overall Study|Other|0|||
27875910|NCT01998984|54493560|FG001|Overall Study|Other|0|||
27875911|NCT01998984|54493561|FG002|Overall Study|Other|0|||
27875912|NCT01998984|54493562|FG003|Overall Study|Other|1|||
27875913|NCT01967706|54493574|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
27875914|NCT01967706|54493575|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
27875915|NCT01967706|54493576|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
27875916|NCT01967706|54493577|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
27875917|NCT01967628|54493588|FG000|Overall Study|Withdrawal by Subject|2|||
27875918|NCT01967628|54493589|FG001|Overall Study|Withdrawal by Subject|0|||
27875919|NCT01967628|54493588|FG000|Overall Study|Unable to complete bronchoscopy|4|||
27875920|NCT01967628|54493589|FG001|Overall Study|Unable to complete bronchoscopy|6|||
27875921|NCT01967628|54493588|FG000|Overall Study|Lost to Follow-up|1|||
27875922|NCT01967628|54493589|FG001|Overall Study|Lost to Follow-up|0|||
27875923|NCT01967628|54493588|FG000|Overall Study|Low protein concentration in sample|20|||
27875924|NCT01967628|54493589|FG001|Overall Study|Low protein concentration in sample|25|||
27875925|NCT01998906|54493598|FG000|Overall Study|Participants ongoing in follow-up|77|||
27875926|NCT01998906|54493599|FG001|Overall Study|Participants ongoing in follow-up|60|||
27875927|NCT01998906|54493600|FG002|Overall Study|Participants ongoing in follow-up|58|||
27875928|NCT01998906|54493598|FG000|Overall Study|Death|21|||
27875929|NCT01998906|54493599|FG001|Overall Study|Death|30|||
27875930|NCT01998906|54493600|FG002|Overall Study|Death|17|||
27875931|NCT01998906|54493598|FG000|Overall Study|Lack of Efficacy|10|||
27875932|NCT01998906|54493599|FG001|Overall Study|Lack of Efficacy|9|||
27875933|NCT01998906|54493600|FG002|Overall Study|Lack of Efficacy|8|||
27875934|NCT01998906|54493598|FG000|Overall Study|Failure to return|0|||
27875935|NCT01998906|54493599|FG001|Overall Study|Failure to return|2|||
27875936|NCT01998906|54493600|FG002|Overall Study|Failure to return|4|||
28096435|NCT03987074|54751411|FG001|Overall Study|Adverse Event|1|||
27875937|NCT01998906|54493598|FG000|Overall Study|Violation of Selection Criteria|0|||
27875938|NCT01998906|54493599|FG001|Overall Study|Violation of Selection Criteria|0|||
27875939|NCT01998906|54493600|FG002|Overall Study|Violation of Selection Criteria|1|||
27875940|NCT01998906|54493598|FG000|Overall Study|Withdrawal by Subject|1|||
27875941|NCT01998906|54493599|FG001|Overall Study|Withdrawal by Subject|4|||
27875942|NCT01998906|54493600|FG002|Overall Study|Withdrawal by Subject|3|||
27875943|NCT01998906|54493598|FG000|Overall Study|Administrative/Other|2|||
27875944|NCT01998906|54493599|FG001|Overall Study|Administrative/Other|1|||
27875945|NCT01998906|54493600|FG002|Overall Study|Administrative/Other|3|||
27875946|NCT01998906|54493598|FG000|Overall Study|Other|3|||
27875947|NCT01998906|54493599|FG001|Overall Study|Other|8|||
27875948|NCT01998906|54493600|FG002|Overall Study|Other|4|||
27982806|NCT00554515|54640999|FG000|Overall Study|Adverse Event|9|||
27982807|NCT00554515|54640999|FG000|Overall Study|Death|2|||
27982808|NCT00554515|54640999|FG000|Overall Study|Achieved Stable Disease|7|||
27982809|NCT00554515|54640999|FG000|Overall Study|Other|1|||
27982810|NCT00554515|54640999|FG000|Overall Study|Misc|15|||
27982811|NCT00049517|54641026|FG000|Induction|Disease progression|0|||
27982812|NCT00049517|54641027|FG001|Induction|Disease progression|0|||
27982813|NCT00049517|54641028|FG002|Induction|Disease progression|0|||
27982814|NCT00049517|54641029|FG003|Induction|Disease progression|0|||
27982815|NCT00049517|54641030|FG004|Induction|Disease progression|18|||
27982816|NCT00049517|54641031|FG005|Induction|Disease progression|11|||
27982817|NCT00049517|54641026|FG000|Induction|Adverse Event|0|||
27982818|NCT00049517|54641027|FG001|Induction|Adverse Event|0|||
27982819|NCT00049517|54641028|FG002|Induction|Adverse Event|0|||
27982820|NCT00049517|54641029|FG003|Induction|Adverse Event|0|||
27982821|NCT00049517|54641030|FG004|Induction|Adverse Event|5|||
27982822|NCT00049517|54641031|FG005|Induction|Adverse Event|7|||
27982823|NCT00049517|54641026|FG000|Induction|Death|0|||
27982824|NCT00049517|54641027|FG001|Induction|Death|0|||
27982825|NCT00049517|54641028|FG002|Induction|Death|0|||
27982826|NCT00049517|54641029|FG003|Induction|Death|0|||
27982827|NCT00049517|54641030|FG004|Induction|Death|9|||
27982828|NCT00049517|54641031|FG005|Induction|Death|6|||
27982829|NCT00049517|54641026|FG000|Induction|Withdrawal by Subject|0|||
27982830|NCT00049517|54641027|FG001|Induction|Withdrawal by Subject|0|||
27982831|NCT00049517|54641028|FG002|Induction|Withdrawal by Subject|0|||
27982832|NCT00049517|54641029|FG003|Induction|Withdrawal by Subject|0|||
27982833|NCT00049517|54641030|FG004|Induction|Withdrawal by Subject|1|||
27982834|NCT00049517|54641031|FG005|Induction|Withdrawal by Subject|3|||
27982835|NCT00049517|54641026|FG000|Induction|Alternative therapy|0|||
27982836|NCT00049517|54641027|FG001|Induction|Alternative therapy|0|||
27982837|NCT00049517|54641028|FG002|Induction|Alternative therapy|0|||
27982838|NCT00049517|54641029|FG003|Induction|Alternative therapy|0|||
27982839|NCT00049517|54641030|FG004|Induction|Alternative therapy|2|||
27982840|NCT00049517|54641031|FG005|Induction|Alternative therapy|2|||
27982841|NCT00049517|54641026|FG000|Induction|Other complicating disease|0|||
27982842|NCT00049517|54641027|FG001|Induction|Other complicating disease|0|||
27982843|NCT00049517|54641028|FG002|Induction|Other complicating disease|0|||
27982844|NCT00049517|54641029|FG003|Induction|Other complicating disease|0|||
27982845|NCT00049517|54641030|FG004|Induction|Other complicating disease|3|||
27982846|NCT00049517|54641031|FG005|Induction|Other complicating disease|0|||
27982847|NCT00049517|54641026|FG000|Induction|Reasons not reported|0|||
27982848|NCT00049517|54641027|FG001|Induction|Reasons not reported|0|||
27982849|NCT00049517|54641028|FG002|Induction|Reasons not reported|0|||
27982850|NCT00049517|54641029|FG003|Induction|Reasons not reported|0|||
27982851|NCT00049517|54641030|FG004|Induction|Reasons not reported|22|||
27982852|NCT00049517|54641031|FG005|Induction|Reasons not reported|25|||
27982853|NCT00049517|54641026|FG000|Conditioning/Transplant|Disease progression|14|||
27982854|NCT00049517|54641027|FG001|Conditioning/Transplant|Disease progression|6|||
27982855|NCT00049517|54641028|FG002|Conditioning/Transplant|Disease progression|10|||
27982856|NCT00049517|54641029|FG003|Conditioning/Transplant|Disease progression|6|||
27982857|NCT00049517|54641030|FG004|Conditioning/Transplant|Disease progression|0|||
27982858|NCT00049517|54641031|FG005|Conditioning/Transplant|Disease progression|0|||
27982859|NCT00049517|54641026|FG000|Conditioning/Transplant|Adverse Event|2|||
27982860|NCT00049517|54641027|FG001|Conditioning/Transplant|Adverse Event|1|||
27982861|NCT00049517|54641028|FG002|Conditioning/Transplant|Adverse Event|4|||
27982862|NCT00049517|54641029|FG003|Conditioning/Transplant|Adverse Event|8|||
27982863|NCT00049517|54641030|FG004|Conditioning/Transplant|Adverse Event|0|||
27982864|NCT00049517|54641031|FG005|Conditioning/Transplant|Adverse Event|0|||
27982865|NCT00049517|54641026|FG000|Conditioning/Transplant|Death|1|||
28096436|NCT03987074|54751412|FG002|Overall Study|Adverse Event|0|||
27982866|NCT00049517|54641027|FG001|Conditioning/Transplant|Death|0|||
27875949|NCT01967550|54493613|FG000|Overall Study|Withdrawal by Subject|1|||
27982867|NCT00049517|54641028|FG002|Conditioning/Transplant|Death|0|||
27982868|NCT00049517|54641029|FG003|Conditioning/Transplant|Death|2|||
27982869|NCT00049517|54641030|FG004|Conditioning/Transplant|Death|0|||
27982870|NCT00049517|54641031|FG005|Conditioning/Transplant|Death|0|||
27982871|NCT00049517|54641026|FG000|Conditioning/Transplant|Withdrawal by Subject|4|||
27982872|NCT00049517|54641027|FG001|Conditioning/Transplant|Withdrawal by Subject|8|||
27982873|NCT00049517|54641028|FG002|Conditioning/Transplant|Withdrawal by Subject|4|||
27982874|NCT00049517|54641029|FG003|Conditioning/Transplant|Withdrawal by Subject|7|||
27875950|NCT01967550|54493614|FG001|Overall Study|Withdrawal by Subject|0|||
27982875|NCT00049517|54641030|FG004|Conditioning/Transplant|Withdrawal by Subject|0|||
27982876|NCT00049517|54641031|FG005|Conditioning/Transplant|Withdrawal by Subject|0|||
27875951|NCT01967550|54493613|FG000|Overall Study|Adverse Event|2|||
27875952|NCT01967550|54493614|FG001|Overall Study|Adverse Event|0|||
27875953|NCT01967550|54493613|FG000|Overall Study|Protocol Violation|2|||
27875954|NCT01967550|54493614|FG001|Overall Study|Protocol Violation|1|||
27875955|NCT01967550|54493613|FG000|Overall Study|Non Compliance|0|||
27875956|NCT01967550|54493614|FG001|Overall Study|Non Compliance|1|||
27875957|NCT01989546|54493620|FG000|Overall Study|Clinical Progression|1|||
27875958|NCT01989546|54493620|FG000|Overall Study|Disease progression on study|8|||
27875959|NCT01997892|54493624|FG000|Overall Study|Physician Decision|2|||
27875960|NCT01997892|54493624|FG000|Overall Study|Lost to Follow-up|6|||
27875961|NCT01997892|54493624|FG000|Overall Study|Death|14|||
27875962|NCT01997892|54493624|FG000|Overall Study|Renal transplant|8|||
27875963|NCT01997892|54493624|FG000|Overall Study|Other|3|||
27875964|NCT01997892|54493624|FG000|Overall Study|Study completion data not recorded|35|||
27875965|NCT01989468|54493636|FG000|Overall Study|Adverse Event|10|||
27875966|NCT01989468|54493637|FG001|Overall Study|Adverse Event|15|||
27875967|NCT01989468|54493638|FG002|Overall Study|Adverse Event|4|||
27875968|NCT01989468|54493639|FG003|Overall Study|Adverse Event|5|||
27875969|NCT01989468|54493640|FG004|Overall Study|Adverse Event|4|||
27875970|NCT01989468|54493636|FG000|Overall Study|Lack of Efficacy|11|||
27875971|NCT01989468|54493637|FG001|Overall Study|Lack of Efficacy|11|||
27875972|NCT01989468|54493638|FG002|Overall Study|Lack of Efficacy|7|||
27875973|NCT01989468|54493639|FG003|Overall Study|Lack of Efficacy|4|||
27875974|NCT01989468|54493640|FG004|Overall Study|Lack of Efficacy|2|||
27875975|NCT01989468|54493636|FG000|Overall Study|Lost to Follow-up|5|||
27875976|NCT01989468|54493637|FG001|Overall Study|Lost to Follow-up|2|||
27875977|NCT01989468|54493638|FG002|Overall Study|Lost to Follow-up|0|||
27875978|NCT01989468|54493639|FG003|Overall Study|Lost to Follow-up|1|||
27875979|NCT01989468|54493640|FG004|Overall Study|Lost to Follow-up|1|||
27875980|NCT01989468|54493636|FG000|Overall Study|Physician Decision|4|||
27875981|NCT01989468|54493637|FG001|Overall Study|Physician Decision|1|||
27875982|NCT01989468|54493638|FG002|Overall Study|Physician Decision|0|||
27875983|NCT01989468|54493639|FG003|Overall Study|Physician Decision|1|||
27875984|NCT01989468|54493640|FG004|Overall Study|Physician Decision|0|||
27875985|NCT01989468|54493636|FG000|Overall Study|Pregnancy|0|||
27875986|NCT01989468|54493637|FG001|Overall Study|Pregnancy|1|||
27875987|NCT01989468|54493638|FG002|Overall Study|Pregnancy|0|||
27875988|NCT01989468|54493639|FG003|Overall Study|Pregnancy|0|||
27875989|NCT01989468|54493640|FG004|Overall Study|Pregnancy|0|||
27875990|NCT01989468|54493636|FG000|Overall Study|Technical Problems|3|||
27875991|NCT01989468|54493637|FG001|Overall Study|Technical Problems|1|||
27875992|NCT01989468|54493638|FG002|Overall Study|Technical Problems|3|||
27875993|NCT01989468|54493639|FG003|Overall Study|Technical Problems|1|||
27875994|NCT01989468|54493640|FG004|Overall Study|Technical Problems|0|||
27875995|NCT01989468|54493636|FG000|Overall Study|Subject Guardian Decision|11|||
27875996|NCT01989468|54493637|FG001|Overall Study|Subject Guardian Decision|6|||
27875997|NCT01989468|54493638|FG002|Overall Study|Subject Guardian Decision|4|||
27875998|NCT01989468|54493639|FG003|Overall Study|Subject Guardian Decision|4|||
27875999|NCT01989468|54493640|FG004|Overall Study|Subject Guardian Decision|1|||
27876000|NCT01989468|54493636|FG000|Overall Study|Death|3|||
27876001|NCT01989468|54493637|FG001|Overall Study|Death|0|||
27876002|NCT01989468|54493638|FG002|Overall Study|Death|1|||
27876003|NCT01989468|54493639|FG003|Overall Study|Death|0|||
27876004|NCT01989468|54493640|FG004|Overall Study|Death|0|||
27876005|NCT01989156|54493656|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|0|||
27876006|NCT01989156|54493657|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
27876007|NCT01989156|54493658|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|3|||
27876008|NCT01989156|54493656|FG000|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
27876009|NCT01989156|54493657|FG001|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
27876010|NCT01989156|54493658|FG002|Confinement Period (Population at Day 5)|Patient Anxiety|1|||
27876011|NCT01989156|54493656|FG000|Confinement Period (Population at Day 5)|Adverse Event|0|||
27876012|NCT01989156|54493657|FG001|Confinement Period (Population at Day 5)|Adverse Event|0|||
27876013|NCT01989156|54493658|FG002|Confinement Period (Population at Day 5)|Adverse Event|1|||
28096437|NCT03987074|54751413|FG003|Overall Study|Adverse Event|0|||
27876014|NCT01989156|54493656|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
27876015|NCT01989156|54493657|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
27876016|NCT01989156|54493658|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
27876017|NCT01989156|54493656|FG000|End of Study (Population at Day 90)|Lost to Follow-up|3|||
27876018|NCT01989156|54493657|FG001|End of Study (Population at Day 90)|Lost to Follow-up|2|||
27876019|NCT01989156|54493658|FG002|End of Study (Population at Day 90)|Lost to Follow-up|0|||
27876020|NCT01989156|54493656|FG000|End of Study (Population at Day 90)|Physician Decision|1|||
27876021|NCT01989156|54493657|FG001|End of Study (Population at Day 90)|Physician Decision|0|||
28096438|NCT03987074|54751414|FG004|Overall Study|Adverse Event|1|||
27876022|NCT01989156|54493658|FG002|End of Study (Population at Day 90)|Physician Decision|1|||
28096439|NCT03987074|54751410|FG000|Overall Study|Lost to Follow-up|0|||
28096440|NCT03987074|54751411|FG001|Overall Study|Lost to Follow-up|0|||
28096441|NCT03987074|54751412|FG002|Overall Study|Lost to Follow-up|1|||
27876023|NCT01989156|54493656|FG000|End of Study (Population at Day 90)|Moved out of state|1|||
27876024|NCT01989156|54493657|FG001|End of Study (Population at Day 90)|Moved out of state|0|||
27876025|NCT01989156|54493658|FG002|End of Study (Population at Day 90)|Moved out of state|0|||
27876026|NCT01989156|54493656|FG000|End of Study (Population at Day 90)|Employment Conflict|0|||
27876027|NCT01989156|54493657|FG001|End of Study (Population at Day 90)|Employment Conflict|1|||
27876028|NCT01989156|54493658|FG002|End of Study (Population at Day 90)|Employment Conflict|0|||
27876029|NCT01620762|54493669|FG000|Overall Study|Protocol Violation|1|||
27876030|NCT01620762|54493670|FG001|Overall Study|Protocol Violation|1|||
27876031|NCT01620762|54493671|FG002|Overall Study|Protocol Violation|1|||
27876032|NCT01620762|54493669|FG000|Overall Study|Adverse Event|9|||
27876033|NCT01620762|54493670|FG001|Overall Study|Adverse Event|5|||
27876034|NCT01620762|54493671|FG002|Overall Study|Adverse Event|2|||
27876035|NCT01620762|54493669|FG000|Overall Study|Withdrawal by Subject|23|||
27876036|NCT01620762|54493670|FG001|Overall Study|Withdrawal by Subject|26|||
27876037|NCT01620762|54493671|FG002|Overall Study|Withdrawal by Subject|27|||
27876038|NCT01620762|54493669|FG000|Overall Study|Lost to Follow-up|11|||
27876039|NCT01620762|54493670|FG001|Overall Study|Lost to Follow-up|17|||
27876040|NCT01620762|54493671|FG002|Overall Study|Lost to Follow-up|10|||
27876041|NCT01620762|54493669|FG000|Overall Study|Protocol deviation|1|||
27876042|NCT01620762|54493670|FG001|Overall Study|Protocol deviation|1|||
27876043|NCT01620762|54493671|FG002|Overall Study|Protocol deviation|6|||
27876044|NCT01620762|54493669|FG000|Overall Study|Subject deterioration|0|||
27876045|NCT01620762|54493670|FG001|Overall Study|Subject deterioration|1|||
27876046|NCT01620762|54493671|FG002|Overall Study|Subject deterioration|1|||
27876047|NCT01620762|54493669|FG000|Overall Study|Non-specified|3|||
27876048|NCT01620762|54493670|FG001|Overall Study|Non-specified|6|||
27876049|NCT01620762|54493671|FG002|Overall Study|Non-specified|5|||
27876050|NCT01620762|54493669|FG000|Overall Study|Use of prohibted therapies|0|||
27876051|NCT01620762|54493670|FG001|Overall Study|Use of prohibted therapies|1|||
27876052|NCT01620762|54493671|FG002|Overall Study|Use of prohibted therapies|1|||
27876053|NCT01966068|54493681|FG000|Overall Study|Withdrawal by Subject|57|||
27876054|NCT01966068|54493681|FG000|Overall Study|Lost to Follow-up|81|||
27876055|NCT01620528|54493689|FG000|Treatment Period|Did Not Receive Study Drug|0|||
27876056|NCT01620528|54493690|FG001|Treatment Period|Did Not Receive Study Drug|0|||
27876057|NCT01620528|54493691|FG002|Treatment Period|Did Not Receive Study Drug|1|||
27876058|NCT01620528|54493689|FG000|Treatment Period|Withdrawal by Subject|35|||
27876059|NCT01620528|54493690|FG001|Treatment Period|Withdrawal by Subject|21|||
27876060|NCT01620528|54493691|FG002|Treatment Period|Withdrawal by Subject|16|||
27876061|NCT01620528|54493689|FG000|Treatment Period|Adverse Event|17|||
27876062|NCT01620528|54493690|FG001|Treatment Period|Adverse Event|13|||
27876063|NCT01620528|54493691|FG002|Treatment Period|Adverse Event|21|||
27876064|NCT01620528|54493689|FG000|Treatment Period|Lost to Follow-up|16|||
27876065|NCT01620528|54493690|FG001|Treatment Period|Lost to Follow-up|8|||
27876066|NCT01620528|54493691|FG002|Treatment Period|Lost to Follow-up|14|||
27982877|NCT00049517|54641026|FG000|Conditioning/Transplant|Alternative therapy|4|||
27982878|NCT00049517|54641027|FG001|Conditioning/Transplant|Alternative therapy|4|||
27982879|NCT00049517|54641028|FG002|Conditioning/Transplant|Alternative therapy|2|||
27982880|NCT00049517|54641029|FG003|Conditioning/Transplant|Alternative therapy|1|||
27982881|NCT00049517|54641030|FG004|Conditioning/Transplant|Alternative therapy|1|||
27982882|NCT00049517|54641031|FG005|Conditioning/Transplant|Alternative therapy|0|||
27982883|NCT00049517|54641026|FG000|Conditioning/Transplant|Other complicating disease|2|||
27982884|NCT00049517|54641027|FG001|Conditioning/Transplant|Other complicating disease|0|||
27982885|NCT00049517|54641028|FG002|Conditioning/Transplant|Other complicating disease|0|||
27982886|NCT00049517|54641029|FG003|Conditioning/Transplant|Other complicating disease|4|||
27982887|NCT00049517|54641030|FG004|Conditioning/Transplant|Other complicating disease|0|||
27876067|NCT01620528|54493689|FG000|Treatment Period|Other|9|||
27876068|NCT01620528|54493690|FG001|Treatment Period|Other|5|||
27876069|NCT01620528|54493691|FG002|Treatment Period|Other|7|||
27876070|NCT01620528|54493689|FG000|Treatment Period|Subject Noncompliant|11|||
27876071|NCT01620528|54493690|FG001|Treatment Period|Subject Noncompliant|2|||
27876072|NCT01620528|54493691|FG002|Treatment Period|Subject Noncompliant|2|||
27876073|NCT01620528|54493689|FG000|Treatment Period|Pregnancy|7|||
27876074|NCT01620528|54493690|FG001|Treatment Period|Pregnancy|2|||
27876075|NCT01620528|54493691|FG002|Treatment Period|Pregnancy|2|||
27876076|NCT01620528|54493689|FG000|Treatment Period|Surgery/Invasive Intervention|5|||
27876077|NCT01620528|54493690|FG001|Treatment Period|Surgery/Invasive Intervention|1|||
27876078|NCT01620528|54493691|FG002|Treatment Period|Surgery/Invasive Intervention|3|||
27876079|NCT01620528|54493689|FG000|Treatment Period|Exclusionary Medication Received|0|||
27876080|NCT01620528|54493690|FG001|Treatment Period|Exclusionary Medication Received|1|||
27876081|NCT01620528|54493691|FG002|Treatment Period|Exclusionary Medication Received|0|||
27876082|NCT01620528|54493689|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
27876083|NCT01620528|54493690|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
27876084|NCT01620528|54493691|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
27876085|NCT01620528|54493689|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
27876086|NCT01620528|54493690|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
27876087|NCT01620528|54493691|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
27876088|NCT01620528|54493689|FG000|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0|||
27876089|NCT01620528|54493690|FG001|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
27876090|NCT01620528|54493691|FG002|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
27876091|NCT01620528|54493689|FG000|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8|||
27876092|NCT01620528|54493690|FG001|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3|||
27876093|NCT01620528|54493691|FG002|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4|||
27876094|NCT01620528|54493689|FG000|Post-Treatment Follow-Up Period|Other|6|||
27876095|NCT01620528|54493690|FG001|Post-Treatment Follow-Up Period|Other|4|||
27876096|NCT01620528|54493691|FG002|Post-Treatment Follow-Up Period|Other|2|||
27876097|NCT01965834|54493699|FG000|Overall Study|Lack of Efficacy|4|||
27876098|NCT01965600|54493703|FG000|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
27876099|NCT01965600|54493704|FG001|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3|||
27876100|NCT01965600|54493705|FG002|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2|||
27876101|NCT01965600|54493706|FG003|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
27876102|NCT01965600|54493703|FG000|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
27876103|NCT01965600|54493704|FG001|Washout Period of Approximately 15 Days|Withdrawal by Subject|1|||
27876104|NCT01965600|54493705|FG002|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
27876105|NCT01965600|54493706|FG003|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
27876106|NCT01965600|54493703|FG000|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1|||
27876107|NCT01965600|54493704|FG001|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
27876108|NCT01965600|54493705|FG002|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
27876109|NCT01965600|54493706|FG003|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
27876110|NCT01965600|54493703|FG000|Washout Period of Approximately 15 Days|Adverse Event|0|||
27876111|NCT01965600|54493704|FG001|Washout Period of Approximately 15 Days|Adverse Event|0|||
27876112|NCT01965600|54493705|FG002|Washout Period of Approximately 15 Days|Adverse Event|0|||
27876113|NCT01965600|54493706|FG003|Washout Period of Approximately 15 Days|Adverse Event|1|||
27876114|NCT01965600|54493703|FG000|Second Intervention|Study terminated by Sponsor|0|||
27876115|NCT01965600|54493704|FG001|Second Intervention|Study terminated by Sponsor|0|||
27876116|NCT01965600|54493705|FG002|Second Intervention|Study terminated by Sponsor|2|||
27876117|NCT01965600|54493706|FG003|Second Intervention|Study terminated by Sponsor|2|||
27876118|NCT01996332|54493714|FG000|Overall Study|Adverse Event|117|||
27876119|NCT01996332|54493714|FG000|Overall Study|Lack of Efficacy|1245|||
27876120|NCT01996332|54493714|FG000|Overall Study|Death|264|||
27876121|NCT01996332|54493714|FG000|Overall Study|Protocol Violation|9|||
27876122|NCT01996332|54493714|FG000|Overall Study|Withdrawal by Subject|71|||
27876123|NCT01996332|54493714|FG000|Overall Study|Other|20|||
27876124|NCT01996332|54493714|FG000|Overall Study|Clinical Deterioration|28|||
27876125|NCT01996332|54493714|FG000|Overall Study|Physician Decision|17|||
27876126|NCT01996332|54493714|FG000|Overall Study|Lost to Follow-up|34|||
27876127|NCT01996254|54493720|FG000|Overall Study|Change in Eligibility|0|||
27876128|NCT01996254|54493721|FG001|Overall Study|Change in Eligibility|2|||
27876129|NCT01996254|54493722|FG002|Overall Study|Change in Eligibility|0|||
27876130|NCT01996254|54493720|FG000|Overall Study|Withdrawal by Subject|0|||
27876131|NCT01996254|54493721|FG001|Overall Study|Withdrawal by Subject|3|||
27876132|NCT01996254|54493722|FG002|Overall Study|Withdrawal by Subject|4|||
27876133|NCT01996254|54493720|FG000|Overall Study|Lost to Follow-up|1|||
27876134|NCT01996254|54493721|FG001|Overall Study|Lost to Follow-up|0|||
27876135|NCT01996254|54493722|FG002|Overall Study|Lost to Follow-up|4|||
27876136|NCT01987986|54493736|FG000|Overall Study|Lost to Follow-up|1|||
27876137|NCT01987986|54493737|FG001|Overall Study|Lost to Follow-up|0|||
27876138|NCT01987986|54493738|FG002|Overall Study|Lost to Follow-up|0|||
27876139|NCT01987986|54493739|FG003|Overall Study|Lost to Follow-up|0|||
27876140|NCT01987986|54493736|FG000|Overall Study|Adverse Event|1|||
27876141|NCT01987986|54493737|FG001|Overall Study|Adverse Event|0|||
27876142|NCT01987986|54493738|FG002|Overall Study|Adverse Event|2|||
27876143|NCT01987986|54493739|FG003|Overall Study|Adverse Event|0|||
27876144|NCT01987908|54493749|FG000|Placebo Lead-in Period|Adverse Event|2|||
27876145|NCT01987908|54493750|FG001|Placebo Lead-in Period|Adverse Event|0|||
27876146|NCT01987908|54493751|FG002|Placebo Lead-in Period|Adverse Event|0|||
27876147|NCT01987908|54493749|FG000|Placebo Lead-in Period|Physician Decision|2|||
27876148|NCT01987908|54493750|FG001|Placebo Lead-in Period|Physician Decision|0|||
27876149|NCT01987908|54493751|FG002|Placebo Lead-in Period|Physician Decision|0|||
27876150|NCT01987908|54493749|FG000|Placebo Lead-in Period|Withdrawal by Subject|1|||
27876151|NCT01987908|54493750|FG001|Placebo Lead-in Period|Withdrawal by Subject|0|||
27876152|NCT01987908|54493751|FG002|Placebo Lead-in Period|Withdrawal by Subject|0|||
27876153|NCT01987908|54493749|FG000|Placebo Lead-in Period|Other: Study Termination by Sponsor|4|||
27876154|NCT01987908|54493750|FG001|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
27876155|NCT01987908|54493751|FG002|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
27876156|NCT01987908|54493749|FG000|Treatment Period|Adverse Event|0|||
27876157|NCT01987908|54493750|FG001|Treatment Period|Adverse Event|1|||
27876158|NCT01987908|54493751|FG002|Treatment Period|Adverse Event|1|||
27876159|NCT01987908|54493749|FG000|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
27876160|NCT01987908|54493750|FG001|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2|||
27876161|NCT01987908|54493751|FG002|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
27876162|NCT01987908|54493749|FG000|Post-Treatment Observation Period|Other: Bad Veins|0|||
27876163|NCT01987908|54493750|FG001|Post-Treatment Observation Period|Other: Bad Veins|1|||
27876164|NCT01987908|54493751|FG002|Post-Treatment Observation Period|Other: Bad Veins|0|||
27876165|NCT01995552|54493775|FG000|Overall Study|Protocol Violation|1|||
27876166|NCT01995552|54493775|FG000|Overall Study|Lack of Efficacy|15|||
27876167|NCT01995552|54493775|FG000|Overall Study|Death|1|||
27876168|NCT01987830|54493781|FG000|Overall Study|Never received baseline scan|1|||
27876169|NCT01987596|54493787|FG000|Overall Study|Physician Decision|1|||
27876170|NCT01987596|54493788|FG001|Overall Study|Physician Decision|0|||
27876171|NCT01987596|54493787|FG000|Overall Study|Progressive Disease; missing all period|0|||
27876172|NCT01987596|54493788|FG001|Overall Study|Progressive Disease; missing all period|1|||
27876173|NCT01964976|54493802|FG000|Overall Study|Protocol Violation|31|||
27876174|NCT01964898|54493811|FG000|Overall Study|ineligible post-randomization|1|||
27876175|NCT01964898|54493812|FG001|Overall Study|ineligible post-randomization|1|||
27876176|NCT01964898|54493811|FG000|Overall Study|did not receive the allocated interventi|2|||
27876177|NCT01964898|54493812|FG001|Overall Study|did not receive the allocated interventi|1|||
27876178|NCT01964898|54493811|FG000|Overall Study|Lost to Follow-up|3|||
27876179|NCT01964898|54493812|FG001|Overall Study|Lost to Follow-up|5|||
27876180|NCT01964898|54493811|FG000|Overall Study|Withdrawal by Subject|1|||
27876181|NCT01964898|54493812|FG001|Overall Study|Withdrawal by Subject|0|||
27876182|NCT01964352|54493822|FG000|Overall Study|Adverse Event|13|||
27876183|NCT01964352|54493823|FG001|Overall Study|Adverse Event|3|||
27876184|NCT01964352|54493824|FG002|Overall Study|Adverse Event|4|||
27876185|NCT01964352|54493825|FG003|Overall Study|Adverse Event|3|||
27876186|NCT01964352|54493822|FG000|Overall Study|Lack of Efficacy|6|||
27876187|NCT01964352|54493823|FG001|Overall Study|Lack of Efficacy|0|||
27876188|NCT01964352|54493824|FG002|Overall Study|Lack of Efficacy|0|||
27876189|NCT01964352|54493825|FG003|Overall Study|Lack of Efficacy|0|||
27876190|NCT01964352|54493822|FG000|Overall Study|Protocol Violation|2|||
27876191|NCT01964352|54493823|FG001|Overall Study|Protocol Violation|4|||
27876192|NCT01964352|54493824|FG002|Overall Study|Protocol Violation|0|||
27876193|NCT01964352|54493825|FG003|Overall Study|Protocol Violation|2|||
27876194|NCT01964352|54493822|FG000|Overall Study|Lost to Follow-up|1|||
27876195|NCT01964352|54493823|FG001|Overall Study|Lost to Follow-up|0|||
27876196|NCT01964352|54493824|FG002|Overall Study|Lost to Follow-up|0|||
27876197|NCT01964352|54493825|FG003|Overall Study|Lost to Follow-up|1|||
27876198|NCT01964352|54493822|FG000|Overall Study|Withdrawal by Subject|4|||
27876199|NCT01964352|54493823|FG001|Overall Study|Withdrawal by Subject|2|||
27876200|NCT01964352|54493824|FG002|Overall Study|Withdrawal by Subject|1|||
27876201|NCT01964352|54493825|FG003|Overall Study|Withdrawal by Subject|0|||
27876202|NCT01964352|54493822|FG000|Overall Study|Other than stated above|0|||
27876203|NCT01964352|54493823|FG001|Overall Study|Other than stated above|2|||
27876204|NCT01964352|54493824|FG002|Overall Study|Other than stated above|1|||
27876205|NCT01964352|54493825|FG003|Overall Study|Other than stated above|2|||
27876206|NCT01946412|54493835|FG000|Overall Study|Adverse Event|1|||
27876207|NCT01946412|54493835|FG000|Overall Study|Non-Compliance|1|||
27876208|NCT01946412|54493835|FG000|Overall Study|Continued with commercial Kalydeco|2|||
27876209|NCT01946412|54493835|FG000|Overall Study|Difficulty in swallowing|1|||
27876210|NCT01946178|54493841|FG000|Overall Study|Pregnancy|1|||
27876211|NCT01946178|54493841|FG000|Overall Study|Lost to Follow-up|1|||
27876212|NCT01945944|54493851|FG000|Overall Study|Adverse Event|0|||
27876213|NCT01945944|54493852|FG001|Overall Study|Adverse Event|2|||
27876214|NCT01945944|54493851|FG000|Overall Study|Physician Decision|1|||
27876215|NCT01945944|54493852|FG001|Overall Study|Physician Decision|0|||
27876216|NCT01945944|54493851|FG000|Overall Study|Withdrawal by Subject|0|||
27876217|NCT01945944|54493852|FG001|Overall Study|Withdrawal by Subject|1|||
27876218|NCT01945866|54493862|FG000|Overall Study|Eyes did not complete or were dropped|2|||
27876219|NCT01945866|54493863|FG001|Overall Study|Eyes did not complete or were dropped|0|||
27876220|NCT01986114|54493870|FG000|Overall Study|Adverse Event|59|||
27876221|NCT01986114|54493870|FG000|Overall Study|Lack of Efficacy|23|||
27739253|NCT03318523|54188613|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
27876222|NCT01986114|54493870|FG000|Overall Study|Withdrawal by Subject|58|||
27876223|NCT01986114|54493870|FG000|Overall Study|Noncompliance|3|||
27876224|NCT01986114|54493870|FG000|Overall Study|Protocol Violation|1|||
27739254|NCT03318523|54188614|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
27739255|NCT03318523|54188615|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
27876225|NCT01986114|54493870|FG000|Overall Study|Lost to Follow-up|5|||
27876226|NCT01986114|54493870|FG000|Overall Study|Other reason|7|||
27876227|NCT01945710|54493883|FG000|Overall Study|Progressive Disease|5|||
27876228|NCT01945710|54493884|FG001|Overall Study|Progressive Disease|4|||
27876229|NCT01945710|54493885|FG002|Overall Study|Progressive Disease|3|||
27876230|NCT01945710|54493886|FG003|Overall Study|Progressive Disease|2|||
27876231|NCT01945710|54493887|FG004|Overall Study|Progressive Disease|7|||
27876232|NCT01945710|54493888|FG005|Overall Study|Progressive Disease|3|||
27876233|NCT01945710|54493889|FG006|Overall Study|Progressive Disease|19|||
27876234|NCT01945710|54493883|FG000|Overall Study|Adverse Event|0|||
27876235|NCT01945710|54493884|FG001|Overall Study|Adverse Event|1|||
27876236|NCT01945710|54493885|FG002|Overall Study|Adverse Event|0|||
27876237|NCT01945710|54493886|FG003|Overall Study|Adverse Event|0|||
27876238|NCT01945710|54493887|FG004|Overall Study|Adverse Event|0|||
27876239|NCT01945710|54493888|FG005|Overall Study|Adverse Event|0|||
27876240|NCT01945710|54493889|FG006|Overall Study|Adverse Event|0|||
27876241|NCT01945710|54493883|FG000|Overall Study|Other|2|||
27876242|NCT01945710|54493884|FG001|Overall Study|Other|0|||
27876243|NCT01945710|54493885|FG002|Overall Study|Other|3|||
27876244|NCT01945710|54493886|FG003|Overall Study|Other|1|||
27876245|NCT01945710|54493887|FG004|Overall Study|Other|1|||
27876246|NCT01945710|54493888|FG005|Overall Study|Other|0|||
27876247|NCT01945710|54493889|FG006|Overall Study|Other|4|||
27876248|NCT01945710|54493883|FG000|Overall Study|Withdrawal by Subject|0|||
27876249|NCT01945710|54493884|FG001|Overall Study|Withdrawal by Subject|1|||
27876250|NCT01945710|54493885|FG002|Overall Study|Withdrawal by Subject|1|||
27876251|NCT01945710|54493886|FG003|Overall Study|Withdrawal by Subject|0|||
27876252|NCT01945710|54493887|FG004|Overall Study|Withdrawal by Subject|1|||
27982888|NCT00049517|54641031|FG005|Conditioning/Transplant|Other complicating disease|1|||
27982889|NCT00049517|54641026|FG000|Conditioning/Transplant|Reasons not reported|25|||
27982890|NCT00049517|54641027|FG001|Conditioning/Transplant|Reasons not reported|31|||
27876253|NCT01945710|54493888|FG005|Overall Study|Withdrawal by Subject|0|||
27876254|NCT01945710|54493889|FG006|Overall Study|Withdrawal by Subject|0|||
27876255|NCT01945242|54493909|FG000|Overall Study|Physician Decision|3|||
27876256|NCT01945242|54493910|FG001|Overall Study|Physician Decision|3|||
27876257|NCT01945086|54493920|FG000|Overall Study|Withdrawal by Subject|1|||
27876258|NCT01945086|54493921|FG001|Overall Study|Withdrawal by Subject|0|||
27876259|NCT01945086|54493922|FG002|Overall Study|Withdrawal by Subject|1|||
28096442|NCT03987074|54751413|FG003|Overall Study|Lost to Follow-up|1|||
28096443|NCT03987074|54751414|FG004|Overall Study|Lost to Follow-up|0|||
28096444|NCT03987074|54751410|FG000|Overall Study|Investigator's Discretion|0|||
28096445|NCT03987074|54751411|FG001|Overall Study|Investigator's Discretion|0|||
27982891|NCT00049517|54641028|FG002|Conditioning/Transplant|Reasons not reported|18|||
27982892|NCT00049517|54641029|FG003|Conditioning/Transplant|Reasons not reported|15|||
27982893|NCT00049517|54641030|FG004|Conditioning/Transplant|Reasons not reported|5|||
27982894|NCT00049517|54641031|FG005|Conditioning/Transplant|Reasons not reported|5|||
27982895|NCT00926783|54641041|FG000|Overall Study|Incomplete CFAE Procedures|3|||
27982896|NCT00926783|54641042|FG001|Overall Study|Incomplete CFAE Procedures|3|||
27982897|NCT00929669|54641048|FG000|Overall Study|elevated glucose levels|1|||
27982898|NCT00566995|54641052|FG000|Overall Study|Toxicity|4|||
27982899|NCT00566995|54641052|FG000|Overall Study|Withdrew consent|3|||
27982900|NCT00926393|54641058|FG000|Overall Study|Withdrawal by Subject|1|||
27982901|NCT00926393|54641059|FG001|Overall Study|Withdrawal by Subject|2|||
27982902|NCT00926393|54641058|FG000|Overall Study|Adverse Event|1|||
27982903|NCT00926393|54641059|FG001|Overall Study|Adverse Event|1|||
27982904|NCT00926237|54641065|FG000|Overall Study|Withdrawal by Subject|2|||
27982905|NCT00926237|54641066|FG001|Overall Study|Withdrawal by Subject|1|||
27982906|NCT00931463|54641078|FG000|Overall Study|Death|8|||
27982907|NCT00931463|54641079|FG001|Overall Study|Death|4|||
27982908|NCT00931463|54641078|FG000|Overall Study|Withdrawal by Subject|5|||
27982909|NCT00931463|54641079|FG001|Overall Study|Withdrawal by Subject|0|||
27982910|NCT00931463|54641078|FG000|Overall Study|Lost to Follow-up|4|||
27982911|NCT00931463|54641079|FG001|Overall Study|Lost to Follow-up|1|||
27982912|NCT00929201|54641085|FG000|Period 1|Withdrawal by Subject|0|||
27982913|NCT00929201|54641086|FG001|Period 1|Withdrawal by Subject|1|||
27982914|NCT00926003|54641096|FG000|Post-Training Evaluation|Withdrawal by Subject|1|||
27982915|NCT00926003|54641097|FG001|Post-Training Evaluation|Withdrawal by Subject|0|||
28096446|NCT03987074|54751412|FG002|Overall Study|Investigator's Discretion|0|||
28096447|NCT03987074|54751413|FG003|Overall Study|Investigator's Discretion|1|||
28096448|NCT03987074|54751414|FG004|Overall Study|Investigator's Discretion|0|||
27982916|NCT00926003|54641098|FG002|Post-Training Evaluation|Withdrawal by Subject|0|||
27982917|NCT00926003|54641096|FG000|Post-Training 3-month Follow-up|Lost to Follow-up|1|||
27982918|NCT00926003|54641097|FG001|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
28096449|NCT04439214|54751426|FG000|Overall Study|Adverse Event|13|||
28096450|NCT04439214|54751426|FG000|Overall Study|Disease progression|16|||
27876260|NCT01945086|54493920|FG000|Overall Study|Adverse Event|0|||
27876261|NCT01945086|54493921|FG001|Overall Study|Adverse Event|0|||
27876262|NCT01945086|54493922|FG002|Overall Study|Adverse Event|1|||
27876263|NCT01963728|54493932|FG000|Overall Study|Study terminated early|0|||
27876264|NCT01963728|54493933|FG001|Overall Study|Study terminated early|1|||
27982919|NCT00926003|54641098|FG002|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
27982920|NCT00928889|54641108|FG000|Overall Study|Lost to Follow-up|3|||
27982921|NCT00928889|54641109|FG001|Overall Study|Lost to Follow-up|1|||
27982922|NCT00928889|54641108|FG000|Overall Study|Protocol Violation|0|||
27982923|NCT00928889|54641109|FG001|Overall Study|Protocol Violation|1|||
27982924|NCT00928889|54641108|FG000|Overall Study|Adverse Event|1|||
27982925|NCT00928889|54641109|FG001|Overall Study|Adverse Event|0|||
27982926|NCT00928889|54641108|FG000|Overall Study|Other|1|||
27982927|NCT00928889|54641109|FG001|Overall Study|Other|0|||
27982928|NCT03978091|54641121|FG000|Overall Study|Lost to Follow-up|0|||
27982929|NCT03978091|54641122|FG001|Overall Study|Lost to Follow-up|0|||
27982930|NCT03978091|54641123|FG002|Overall Study|Lost to Follow-up|1|||
27982931|NCT03978091|54641124|FG003|Overall Study|Lost to Follow-up|0|||
27982932|NCT03978091|54641125|FG004|Overall Study|Lost to Follow-up|0|||
27982933|NCT03978091|54641126|FG005|Overall Study|Lost to Follow-up|0|||
27982934|NCT03978091|54641121|FG000|Overall Study|Withdrawal by Subject|0|||
27982935|NCT03978091|54641122|FG001|Overall Study|Withdrawal by Subject|0|||
27982936|NCT03978091|54641123|FG002|Overall Study|Withdrawal by Subject|0|||
27982937|NCT03978091|54641124|FG003|Overall Study|Withdrawal by Subject|1|||
27982938|NCT03978091|54641125|FG004|Overall Study|Withdrawal by Subject|1|||
27982939|NCT03978091|54641126|FG005|Overall Study|Withdrawal by Subject|0|||
27982940|NCT00564733|54641149|FG000|Overall Study|Withdrawal by Subject|4|||
27982941|NCT00564733|54641149|FG000|Overall Study|Ineligible|5|||
27876265|NCT01963260|54493949|FG000|Overall Study|Withdrawal by Subject|2|||
27876266|NCT01963260|54493950|FG001|Overall Study|Withdrawal by Subject|0|||
27876267|NCT01963260|54493951|FG002|Overall Study|Withdrawal by Subject|0|||
27876268|NCT01963260|54493952|FG003|Overall Study|Withdrawal by Subject|1|||
27876269|NCT01963260|54493953|FG004|Overall Study|Withdrawal by Subject|2|||
27876270|NCT01963260|54493954|FG005|Overall Study|Withdrawal by Subject|0|||
27876271|NCT01963260|54493955|FG006|Overall Study|Withdrawal by Subject|0|||
27876272|NCT01963260|54493956|FG007|Overall Study|Withdrawal by Subject|0|||
27876273|NCT01963260|54493957|FG008|Overall Study|Withdrawal by Subject|0|||
27876274|NCT01963260|54493958|FG009|Overall Study|Withdrawal by Subject|0|||
27876275|NCT01962948|54493991|FG000|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
27876276|NCT01962948|54493992|FG001|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
27925680|NCT01050634|54582211|FG000|Overall Study|Ongoing at Date of Cut-Off|5|||
27925681|NCT01020526|54582215|FG000|Overall Study|Withdrawal by Subject|5|||
27982942|NCT00931385|54641153|FG000|Overall Study|Adverse Event|2|||
27982943|NCT00931385|54641154|FG001|Overall Study|Adverse Event|1|||
27982944|NCT00931385|54641155|FG002|Overall Study|Adverse Event|0|||
27982945|NCT00931385|54641156|FG003|Overall Study|Adverse Event|3|||
27982946|NCT00931385|54641153|FG000|Overall Study|Protocol Violation|0|||
27982947|NCT00931385|54641154|FG001|Overall Study|Protocol Violation|0|||
27982948|NCT00931385|54641155|FG002|Overall Study|Protocol Violation|1|||
27982949|NCT00931385|54641156|FG003|Overall Study|Protocol Violation|0|||
27982950|NCT00931385|54641153|FG000|Overall Study|Withdrawal by Subject|0|||
27982951|NCT00931385|54641154|FG001|Overall Study|Withdrawal by Subject|1|||
27982952|NCT00931385|54641155|FG002|Overall Study|Withdrawal by Subject|0|||
27982953|NCT00931385|54641156|FG003|Overall Study|Withdrawal by Subject|1|||
27982954|NCT00931385|54641153|FG000|Overall Study|Lost to Follow-up|0|||
27982955|NCT00931385|54641154|FG001|Overall Study|Lost to Follow-up|0|||
27982956|NCT00931385|54641155|FG002|Overall Study|Lost to Follow-up|0|||
27982957|NCT00931385|54641156|FG003|Overall Study|Lost to Follow-up|1|||
27982958|NCT00565747|54641172|FG000|Overall Study|No embryo transfer|67|||
27982959|NCT00565747|54641173|FG001|Overall Study|No embryo transfer|73|||
27982960|NCT00563797|54641181|FG000|Overall Study|Lost to Follow-up|7|||
27982961|NCT00563797|54641182|FG001|Overall Study|Lost to Follow-up|2|||
27982962|NCT00771927|54641201|FG000|Overall Study|Adverse Event|100|||
27982963|NCT00771927|54641202|FG001|Overall Study|Adverse Event|105|||
27982964|NCT00771927|54641201|FG000|Overall Study|Lack of Efficacy|70|||
27982965|NCT00771927|54641202|FG001|Overall Study|Lack of Efficacy|42|||
27982966|NCT00771927|54641201|FG000|Overall Study|Lost to Follow-up|46|||
27982967|NCT00771927|54641202|FG001|Overall Study|Lost to Follow-up|46|||
27982968|NCT00771927|54641201|FG000|Overall Study|Withdrawal by Subject|16|||
27982969|NCT00771927|54641202|FG001|Overall Study|Withdrawal by Subject|17|||
27982970|NCT00771927|54641201|FG000|Overall Study|Other reason|23|||
27982971|NCT00771927|54641202|FG001|Overall Study|Other reason|27|||
27982972|NCT00771849|54641210|FG000|Overall Study|Lost to Follow-up|1|||
27982973|NCT00771849|54641211|FG001|Overall Study|Lost to Follow-up|2|||
27982974|NCT00771849|54641210|FG000|Overall Study|Withdrawal by Subject|1|||
27925682|NCT01020526|54582215|FG000|Overall Study|Other reasons|3|||
27925683|NCT01020526|54582215|FG000|Overall Study|Insufficient clinical response|3|||
27925684|NCT01020526|54582215|FG000|Overall Study|Lost to Follow-up|1|||
27925685|NCT01020526|54582215|FG000|Overall Study|Adverse Event|2|||
27925686|NCT01020448|54582219|FG000|Pre-assignment|Adverse Event|6|||
27925687|NCT01020448|54582219|FG000|Pre-assignment|Withdrawal by Subject|5|||
27925688|NCT01020448|54582219|FG000|Pre-assignment|Does Not Meet Entry Criteria|2|||
27925689|NCT01020448|54582219|FG000|Treatment|Adverse Event|11|||
27876277|NCT01962948|54493993|FG002|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|6|||
27876278|NCT01962948|54493994|FG003|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|0|||
27876279|NCT01985334|54494009|FG000|Overall Study|Administrative problems|1|||
27876280|NCT01985334|54494010|FG001|Overall Study|Administrative problems|1|||
27876281|NCT01985334|54494011|FG002|Overall Study|Administrative problems|0|||
27876282|NCT01985334|54494012|FG003|Overall Study|Administrative problems|2|||
27876283|NCT01985334|54494013|FG004|Overall Study|Administrative problems|0|||
27876284|NCT01985334|54494014|FG005|Overall Study|Administrative problems|1|||
27876285|NCT01985334|54494015|FG006|Overall Study|Administrative problems|1|||
27876286|NCT01985334|54494016|FG007|Overall Study|Administrative problems|3|||
27876287|NCT01985334|54494009|FG000|Overall Study|Death|1|||
27876288|NCT01985334|54494010|FG001|Overall Study|Death|0|||
27876289|NCT01985334|54494011|FG002|Overall Study|Death|0|||
27876290|NCT01985334|54494012|FG003|Overall Study|Death|3|||
27876291|NCT01985334|54494013|FG004|Overall Study|Death|0|||
27876292|NCT01985334|54494014|FG005|Overall Study|Death|0|||
27876293|NCT01985334|54494015|FG006|Overall Study|Death|1|||
27876294|NCT01985334|54494016|FG007|Overall Study|Death|2|||
27876295|NCT01985334|54494009|FG000|Overall Study|Worsening of disease|0|||
27876296|NCT01985334|54494010|FG001|Overall Study|Worsening of disease|0|||
27876297|NCT01985334|54494011|FG002|Overall Study|Worsening of disease|0|||
27876298|NCT01985334|54494012|FG003|Overall Study|Worsening of disease|1|||
27876299|NCT01985334|54494013|FG004|Overall Study|Worsening of disease|0|||
27876300|NCT01985334|54494014|FG005|Overall Study|Worsening of disease|3|||
27876301|NCT01985334|54494015|FG006|Overall Study|Worsening of disease|0|||
27876302|NCT01985334|54494016|FG007|Overall Study|Worsening of disease|1|||
27876303|NCT01985334|54494009|FG000|Overall Study|Other|2|||
27876304|NCT01985334|54494010|FG001|Overall Study|Other|9|||
27876305|NCT01985334|54494011|FG002|Overall Study|Other|7|||
27876306|NCT01985334|54494012|FG003|Overall Study|Other|17|||
27876307|NCT01985334|54494013|FG004|Overall Study|Other|4|||
27876308|NCT01985334|54494014|FG005|Overall Study|Other|8|||
27876309|NCT01985334|54494015|FG006|Overall Study|Other|4|||
27876310|NCT01985334|54494016|FG007|Overall Study|Other|7|||
27876311|NCT01985334|54494009|FG000|Overall Study|Protocol deviation|6|||
27876312|NCT01985334|54494010|FG001|Overall Study|Protocol deviation|31|||
27876313|NCT01985334|54494011|FG002|Overall Study|Protocol deviation|25|||
27876314|NCT01985334|54494012|FG003|Overall Study|Protocol deviation|84|||
27876315|NCT01985334|54494013|FG004|Overall Study|Protocol deviation|17|||
27876316|NCT01985334|54494014|FG005|Overall Study|Protocol deviation|47|||
27876317|NCT01985334|54494015|FG006|Overall Study|Protocol deviation|15|||
27876318|NCT01985334|54494016|FG007|Overall Study|Protocol deviation|42|||
27876319|NCT01985334|54494009|FG000|Overall Study|Moderate / severe COPD exacerbation|5|||
27876320|NCT01985334|54494010|FG001|Overall Study|Moderate / severe COPD exacerbation|14|||
27876321|NCT01985334|54494011|FG002|Overall Study|Moderate / severe COPD exacerbation|12|||
27876322|NCT01985334|54494012|FG003|Overall Study|Moderate / severe COPD exacerbation|40|||
27876323|NCT01985334|54494013|FG004|Overall Study|Moderate / severe COPD exacerbation|6|||
27876324|NCT01985334|54494014|FG005|Overall Study|Moderate / severe COPD exacerbation|40|||
27876325|NCT01985334|54494015|FG006|Overall Study|Moderate / severe COPD exacerbation|8|||
27876326|NCT01985334|54494016|FG007|Overall Study|Moderate / severe COPD exacerbation|19|||
27876327|NCT01985334|54494009|FG000|Overall Study|Subject withdrawal of consent|3|||
27876328|NCT01985334|54494010|FG001|Overall Study|Subject withdrawal of consent|6|||
27876329|NCT01985334|54494011|FG002|Overall Study|Subject withdrawal of consent|2|||
27876330|NCT01985334|54494012|FG003|Overall Study|Subject withdrawal of consent|28|||
27876331|NCT01985334|54494013|FG004|Overall Study|Subject withdrawal of consent|4|||
27876332|NCT01985334|54494014|FG005|Overall Study|Subject withdrawal of consent|19|||
27876333|NCT01985334|54494015|FG006|Overall Study|Subject withdrawal of consent|0|||
27876334|NCT01985334|54494016|FG007|Overall Study|Subject withdrawal of consent|20|||
27876335|NCT01985334|54494009|FG000|Overall Study|Adverse Event|0|||
27876336|NCT01985334|54494010|FG001|Overall Study|Adverse Event|8|||
27876337|NCT01985334|54494011|FG002|Overall Study|Adverse Event|2|||
27876338|NCT01985334|54494012|FG003|Overall Study|Adverse Event|26|||
27876339|NCT01985334|54494013|FG004|Overall Study|Adverse Event|3|||
27876340|NCT01985334|54494014|FG005|Overall Study|Adverse Event|18|||
27876341|NCT01985334|54494015|FG006|Overall Study|Adverse Event|3|||
27982975|NCT00771849|54641211|FG001|Overall Study|Withdrawal by Subject|1|||
27982976|NCT00771849|54641210|FG000|Overall Study|Not vaccinated|0|||
27876342|NCT01985334|54494016|FG007|Overall Study|Adverse Event|15|||
27876343|NCT01985334|54494009|FG000|Overall Study|Other|4|||
27876344|NCT01985334|54494010|FG001|Overall Study|Other|2|||
27876345|NCT01985334|54494011|FG002|Overall Study|Other|3|||
27876346|NCT01985334|54494012|FG003|Overall Study|Other|10|||
27876347|NCT01985334|54494013|FG004|Overall Study|Other|1|||
27876348|NCT01985334|54494014|FG005|Overall Study|Other|6|||
27876349|NCT01985334|54494015|FG006|Overall Study|Other|2|||
27876350|NCT01985334|54494016|FG007|Overall Study|Other|2|||
27876351|NCT01985334|54494009|FG000|Overall Study|Medication non-compliance|0|||
27982977|NCT00771849|54641211|FG001|Overall Study|Not vaccinated|1|||
27876352|NCT01985334|54494010|FG001|Overall Study|Medication non-compliance|4|||
27876353|NCT01985334|54494011|FG002|Overall Study|Medication non-compliance|1|||
27876354|NCT01985334|54494012|FG003|Overall Study|Medication non-compliance|6|||
27876355|NCT01985334|54494013|FG004|Overall Study|Medication non-compliance|2|||
27876356|NCT01985334|54494014|FG005|Overall Study|Medication non-compliance|3|||
27876357|NCT01985334|54494015|FG006|Overall Study|Medication non-compliance|1|||
27876358|NCT01985334|54494016|FG007|Overall Study|Medication non-compliance|3|||
27876359|NCT01985334|54494009|FG000|Overall Study|Use of prohibited treatment|1|||
27876360|NCT01985334|54494010|FG001|Overall Study|Use of prohibited treatment|4|||
27876361|NCT01985334|54494011|FG002|Overall Study|Use of prohibited treatment|1|||
27876362|NCT01985334|54494012|FG003|Overall Study|Use of prohibited treatment|2|||
27876363|NCT01985334|54494013|FG004|Overall Study|Use of prohibited treatment|1|||
27876364|NCT01985334|54494014|FG005|Overall Study|Use of prohibited treatment|6|||
27876365|NCT01985334|54494015|FG006|Overall Study|Use of prohibited treatment|2|||
27876366|NCT01985334|54494016|FG007|Overall Study|Use of prohibited treatment|0|||
27876367|NCT01985334|54494009|FG000|Overall Study|Investigator decision|0|||
27876368|NCT01985334|54494010|FG001|Overall Study|Investigator decision|3|||
27876369|NCT01985334|54494011|FG002|Overall Study|Investigator decision|0|||
27876370|NCT01985334|54494012|FG003|Overall Study|Investigator decision|7|||
27876371|NCT01985334|54494013|FG004|Overall Study|Investigator decision|1|||
27876372|NCT01985334|54494014|FG005|Overall Study|Investigator decision|1|||
27876373|NCT01985334|54494015|FG006|Overall Study|Investigator decision|0|||
27876374|NCT01985334|54494016|FG007|Overall Study|Investigator decision|4|||
27876375|NCT01985334|54494009|FG000|Overall Study|Lost to Follow-up|0|||
27876376|NCT01985334|54494010|FG001|Overall Study|Lost to Follow-up|2|||
27876377|NCT01985334|54494011|FG002|Overall Study|Lost to Follow-up|0|||
27876378|NCT01985334|54494012|FG003|Overall Study|Lost to Follow-up|3|||
27876379|NCT01985334|54494013|FG004|Overall Study|Lost to Follow-up|1|||
27876380|NCT01985334|54494014|FG005|Overall Study|Lost to Follow-up|4|||
27876381|NCT01985334|54494015|FG006|Overall Study|Lost to Follow-up|0|||
27876382|NCT01985334|54494016|FG007|Overall Study|Lost to Follow-up|3|||
27876383|NCT01944774|54494051|FG000|Overall Study|Withdrawal by Subject|2|||
27876384|NCT01944774|54494052|FG001|Overall Study|Withdrawal by Subject|3|||
27876385|NCT01944774|54494053|FG002|Overall Study|Withdrawal by Subject|3|||
27876386|NCT01944774|54494051|FG000|Overall Study|Adverse Event|3|||
27876387|NCT01944774|54494052|FG001|Overall Study|Adverse Event|2|||
27876388|NCT01944774|54494053|FG002|Overall Study|Adverse Event|3|||
27876389|NCT01944774|54494051|FG000|Overall Study|Lack of Efficacy|1|||
27876390|NCT01944774|54494052|FG001|Overall Study|Lack of Efficacy|2|||
27876391|NCT01944774|54494053|FG002|Overall Study|Lack of Efficacy|2|||
27876392|NCT01944774|54494051|FG000|Overall Study|Lost to Follow-up|0|||
27876393|NCT01944774|54494052|FG001|Overall Study|Lost to Follow-up|1|||
27876394|NCT01944774|54494053|FG002|Overall Study|Lost to Follow-up|0|||
27876395|NCT01944462|54494064|FG000|PPPP Educational Program|Lost to Follow-up|60|||
27876396|NCT01943292|54494072|FG000|Overall Study|Withdrawal by Subject|1|||
27876397|NCT01943292|54494073|FG001|Overall Study|Withdrawal by Subject|0|||
27876398|NCT01943292|54494074|FG002|Overall Study|Withdrawal by Subject|0|||
27876399|NCT01961544|54494082|FG000|Overall Study|Protocol Violation|1|||
27876400|NCT01961544|54494082|FG000|Overall Study|Withdrawal by Subject|7|||
27876401|NCT01961544|54494082|FG000|Overall Study|Adverse Event|1|||
27876402|NCT01961544|54494082|FG000|Overall Study|Physician Decision|2|||
27876403|NCT01961544|54494082|FG000|Overall Study|Poor Tolerance|1|||
27876404|NCT01961544|54494082|FG000|Overall Study|Aggravation of Steral Pain|1|||
27876405|NCT01942590|54494088|FG000|Overall Study|Withdrawal by Subject|0|||
27876406|NCT01942590|54494089|FG001|Overall Study|Withdrawal by Subject|1|||
27876407|NCT01942590|54494088|FG000|Overall Study|Adverse Event|1|||
27876408|NCT01942590|54494089|FG001|Overall Study|Adverse Event|0|||
27876409|NCT01984242|54494099|FG000|Overall Study|Death|52|||
27876410|NCT01984242|54494100|FG001|Overall Study|Death|50|||
27876411|NCT01984242|54494101|FG002|Overall Study|Death|52|||
27876412|NCT01984242|54494099|FG000|Overall Study|Withdrawal by Subject|5|||
27876413|NCT01984242|54494100|FG001|Overall Study|Withdrawal by Subject|3|||
27876414|NCT01984242|54494101|FG002|Overall Study|Withdrawal by Subject|10|||
27876415|NCT01984242|54494099|FG000|Overall Study|Physician Decision|0|||
27876416|NCT01984242|54494100|FG001|Overall Study|Physician Decision|0|||
27876417|NCT01984242|54494101|FG002|Overall Study|Physician Decision|1|||
27876418|NCT01984242|54494099|FG000|Overall Study|Lost to Follow-up|4|||
27876419|NCT01984242|54494100|FG001|Overall Study|Lost to Follow-up|0|||
27876420|NCT01984242|54494101|FG002|Overall Study|Lost to Follow-up|3|||
27876421|NCT01984242|54494099|FG000|Overall Study|Sponsor Decision|1|||
27876422|NCT01984242|54494100|FG001|Overall Study|Sponsor Decision|0|||
27876423|NCT01984242|54494101|FG002|Overall Study|Sponsor Decision|0|||
27876424|NCT01984242|54494099|FG000|Overall Study|Non-Compliance|1|||
27876425|NCT01984242|54494100|FG001|Overall Study|Non-Compliance|0|||
27876426|NCT01984242|54494101|FG002|Overall Study|Non-Compliance|0|||
27876427|NCT01984242|54494099|FG000|Overall Study|Study terminated by Sponsor|38|||
27876428|NCT01984242|54494100|FG001|Overall Study|Study terminated by Sponsor|50|||
27876429|NCT01984242|54494101|FG002|Overall Study|Study terminated by Sponsor|34|||
27876430|NCT01984242|54494099|FG000|Overall Study|Disease Progression|0|||
27876431|NCT01984242|54494100|FG001|Overall Study|Disease Progression|0|||
27876432|NCT01984242|54494101|FG002|Overall Study|Disease Progression|1|||
27876433|NCT01941498|54494117|FG000|Overall Study|Relocated out of state|1|||
27876434|NCT01960998|54494138|FG000|Overall Study|Lost to Follow-up|3|||
27876435|NCT01960998|54494139|FG001|Overall Study|Lost to Follow-up|7|||
27876436|NCT01960998|54494138|FG000|Overall Study|Death|0|||
27876437|NCT01960998|54494139|FG001|Overall Study|Death|1|||
27876438|NCT01960998|54494138|FG000|Overall Study|Withdrawal by Subject|8|||
27876439|NCT01960998|54494139|FG001|Overall Study|Withdrawal by Subject|2|||
27876440|NCT01960998|54494138|FG000|Overall Study|lost computer access|0|||
27876441|NCT01960998|54494139|FG001|Overall Study|lost computer access|1|||
27876442|NCT01941186|54494149|FG000|Follow-up|Lost to Follow-up|1|||
27876443|NCT01941186|54494150|FG001|Follow-up|Lost to Follow-up|0|||
27876444|NCT01960842|54494169|FG000|Overall Study|Adverse Event|1|||
27876445|NCT01960842|54494169|FG000|Overall Study|Withdrawal by Subject|2|||
27876446|NCT01984164|54494175|FG000|Overall Study|Withdrawal by Subject|4|||
27876447|NCT01984164|54494176|FG001|Overall Study|Withdrawal by Subject|3|||
27876448|NCT01984164|54494175|FG000|Overall Study|Adverse Event|5|||
27876449|NCT01984164|54494176|FG001|Overall Study|Adverse Event|19|||
27876450|NCT01984164|54494175|FG000|Overall Study|Lost to Follow-up|1|||
27876451|NCT01984164|54494176|FG001|Overall Study|Lost to Follow-up|3|||
27876452|NCT01983930|54494184|FG000|Overall Study|Withdrawal by Subject|9|||
27876453|NCT01983930|54494185|FG001|Overall Study|Withdrawal by Subject|8|||
27876454|NCT01983930|54494184|FG000|Overall Study|Adverse Event|0|||
27876455|NCT01983930|54494185|FG001|Overall Study|Adverse Event|1|||
27876456|NCT01983774|54494198|FG000|Overall Study|Lung Transplant|0|||
27876457|NCT01983774|54494199|FG001|Overall Study|Lung Transplant|1|||
27876458|NCT01983774|54494198|FG000|Overall Study|Lost to Follow-up|1|||
27876459|NCT01983774|54494199|FG001|Overall Study|Lost to Follow-up|0|||
27876460|NCT01982682|54494207|FG000|Overall Study|Physician Decision|1|||
27876461|NCT01940484|54494212|FG000|Overall Study|Withdrawal by Subject|3|||
27876462|NCT01940484|54494212|FG000|Overall Study|Underwent transplantation|4|||
27876463|NCT01940484|54494212|FG000|Overall Study|Death|2|||
27876464|NCT01940484|54494212|FG000|Overall Study|Adverse Event|1|||
27876465|NCT01939548|54494219|FG000|Overall Study|Non compliance|0|||
27876466|NCT01939548|54494220|FG001|Overall Study|Non compliance|2|||
27876467|NCT01939548|54494221|FG002|Overall Study|Non compliance|0|||
27876468|NCT01939548|54494219|FG000|Overall Study|Study Terminated by Sponsor|17|||
27876469|NCT01939548|54494220|FG001|Overall Study|Study Terminated by Sponsor|19|||
27876470|NCT01939548|54494221|FG002|Overall Study|Study Terminated by Sponsor|12|||
27876471|NCT01939548|54494219|FG000|Overall Study|Insufficient Clinical Response|1|||
27876472|NCT01939548|54494220|FG001|Overall Study|Insufficient Clinical Response|0|||
27876473|NCT01939548|54494221|FG002|Overall Study|Insufficient Clinical Response|0|||
27876474|NCT01939548|54494219|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
27876475|NCT01939548|54494220|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
27876476|NCT01939548|54494221|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
27876477|NCT01939548|54494219|FG000|Overall Study|Withdrawal by Subject|4|||
27876478|NCT01939548|54494220|FG001|Overall Study|Withdrawal by Subject|4|||
27876479|NCT01939548|54494221|FG002|Overall Study|Withdrawal by Subject|1|||
27876480|NCT01939548|54494219|FG000|Overall Study|Protocol Violation|7|||
27876481|NCT01939548|54494220|FG001|Overall Study|Protocol Violation|6|||
27876482|NCT01939548|54494221|FG002|Overall Study|Protocol Violation|5|||
27876483|NCT01939548|54494219|FG000|Overall Study|Lost to Follow-up|5|||
27876484|NCT01939548|54494220|FG001|Overall Study|Lost to Follow-up|5|||
27876485|NCT01939548|54494221|FG002|Overall Study|Lost to Follow-up|3|||
27876486|NCT01939548|54494219|FG000|Overall Study|Adverse Event|2|||
27876487|NCT01939548|54494220|FG001|Overall Study|Adverse Event|9|||
27876488|NCT01939548|54494221|FG002|Overall Study|Adverse Event|7|||
27876489|NCT01939548|54494219|FG000|Overall Study|Death|0|||
27876490|NCT01939548|54494220|FG001|Overall Study|Death|0|||
27876491|NCT01939548|54494221|FG002|Overall Study|Death|1|||
27876492|NCT01939548|54494219|FG000|Overall Study|Participant dropped|0|||
27876493|NCT01939548|54494220|FG001|Overall Study|Participant dropped|0|||
27876494|NCT01939548|54494221|FG002|Overall Study|Participant dropped|1|||
27876495|NCT01939548|54494219|FG000|Overall Study|Participant unwilling to continue|0|||
27876496|NCT01939548|54494220|FG001|Overall Study|Participant unwilling to continue|1|||
27876497|NCT01939548|54494221|FG002|Overall Study|Participant unwilling to continue|0|||
27876498|NCT01939548|54494219|FG000|Overall Study|Participant withdrew consent|0|||
27876499|NCT01939548|54494220|FG001|Overall Study|Participant withdrew consent|2|||
27876500|NCT01939548|54494221|FG002|Overall Study|Participant withdrew consent|0|||
27876501|NCT01939548|54494219|FG000|Overall Study|Did not complete follow-up|0|||
27876502|NCT01939548|54494220|FG001|Overall Study|Did not complete follow-up|1|||
27876503|NCT01939548|54494221|FG002|Overall Study|Did not complete follow-up|0|||
27876504|NCT01960296|54494231|FG000|Overall Study|Postponed surgery|1|||
27876505|NCT01960296|54494232|FG001|Overall Study|Postponed surgery|0|||
27876506|NCT01960296|54494231|FG000|Overall Study|Received different procedure|1|||
27876507|NCT01960296|54494232|FG001|Overall Study|Received different procedure|3|||
27876508|NCT01982292|54494240|FG000|Overall Study|Adverse Event|2|||
27876509|NCT01982292|54494241|FG001|Overall Study|Adverse Event|0|||
27876510|NCT01982292|54494240|FG000|Overall Study|Death|1|||
27876511|NCT01982292|54494241|FG001|Overall Study|Death|0|||
27876512|NCT01982292|54494240|FG000|Overall Study|Lost to Follow-up|2|||
27876513|NCT01982292|54494241|FG001|Overall Study|Lost to Follow-up|0|||
27876514|NCT01982292|54494240|FG000|Overall Study|Non-Compliance With Study Treatment|1|||
27876515|NCT01982292|54494241|FG001|Overall Study|Non-Compliance With Study Treatment|0|||
27876516|NCT01982292|54494240|FG000|Overall Study|Protocol Deviation|1|||
27876517|NCT01982292|54494241|FG001|Overall Study|Protocol Deviation|0|||
27876518|NCT01982292|54494240|FG000|Overall Study|Patient/Guardian Decision|3|||
27876519|NCT01982292|54494241|FG001|Overall Study|Patient/Guardian Decision|1|||
27876520|NCT01982292|54494240|FG000|Overall Study|Technical Problems|2|||
27876521|NCT01982292|54494241|FG001|Overall Study|Technical Problems|0|||
27876522|NCT01939314|54494249|FG000|Overall Study|Withdrawal by Subject|3|||
27876523|NCT01939314|54494250|FG001|Overall Study|Withdrawal by Subject|1|||
27876524|NCT01939314|54494249|FG000|Overall Study|Protocol Violation|1|||
27876525|NCT01939314|54494250|FG001|Overall Study|Protocol Violation|0|||
27876526|NCT01939314|54494249|FG000|Overall Study|Pregnancy|0|||
27876527|NCT01939314|54494250|FG001|Overall Study|Pregnancy|1|||
27876528|NCT01939314|54494249|FG000|Overall Study|Lost to Follow-up|5|||
27876529|NCT01939314|54494250|FG001|Overall Study|Lost to Follow-up|6|||
27876530|NCT01939158|54494262|FG000|Overall Study|Adverse Event|1|||
27876531|NCT01939158|54494263|FG001|Overall Study|Adverse Event|0|||
27876532|NCT01939158|54494264|FG002|Overall Study|Adverse Event|0|||
27876533|NCT01939158|54494265|FG003|Overall Study|Adverse Event|0|||
27876534|NCT01939158|54494262|FG000|Overall Study|Withdrawal by Subject|22|||
27876535|NCT01939158|54494263|FG001|Overall Study|Withdrawal by Subject|25|||
27876536|NCT01939158|54494264|FG002|Overall Study|Withdrawal by Subject|15|||
27876537|NCT01939158|54494265|FG003|Overall Study|Withdrawal by Subject|17|||
27876538|NCT01939158|54494262|FG000|Overall Study|Migrated/moved from study area|5|||
27876539|NCT01939158|54494263|FG001|Overall Study|Migrated/moved from study area|7|||
27876540|NCT01939158|54494264|FG002|Overall Study|Migrated/moved from study area|3|||
27876541|NCT01939158|54494265|FG003|Overall Study|Migrated/moved from study area|6|||
27876542|NCT01939158|54494262|FG000|Overall Study|Lost to Follow-up|18|||
27876543|NCT01939158|54494263|FG001|Overall Study|Lost to Follow-up|17|||
27876544|NCT01939158|54494264|FG002|Overall Study|Lost to Follow-up|17|||
27876545|NCT01939158|54494265|FG003|Overall Study|Lost to Follow-up|17|||
27876546|NCT01939158|54494262|FG000|Overall Study|Death|0|||
27876547|NCT01939158|54494263|FG001|Overall Study|Death|0|||
27876548|NCT01939158|54494264|FG002|Overall Study|Death|1|||
27876549|NCT01939158|54494265|FG003|Overall Study|Death|1|||
27876550|NCT01939158|54494262|FG000|Overall Study|No longer meets eligibility criteria|0|||
27876551|NCT01939158|54494263|FG001|Overall Study|No longer meets eligibility criteria|0|||
27876552|NCT01939158|54494264|FG002|Overall Study|No longer meets eligibility criteria|1|||
27876553|NCT01939158|54494265|FG003|Overall Study|No longer meets eligibility criteria|0|||
27876554|NCT01939158|54494262|FG000|Overall Study|Other|1|||
27876555|NCT01939158|54494263|FG001|Overall Study|Other|3|||
27876556|NCT01939158|54494264|FG002|Overall Study|Other|4|||
27876557|NCT01939158|54494265|FG003|Overall Study|Other|3|||
27876558|NCT01939002|54494281|FG000|Overall Study|Adverse Event|13|||
27876559|NCT01939002|54494282|FG001|Overall Study|Adverse Event|13|||
27876560|NCT01939002|54494281|FG000|Overall Study|Withdrawal by Subject|5|||
27876561|NCT01939002|54494282|FG001|Overall Study|Withdrawal by Subject|3|||
27876562|NCT01939002|54494281|FG000|Overall Study|Other|1|||
27876563|NCT01939002|54494282|FG001|Overall Study|Other|2|||
27876564|NCT01938846|54494296|FG000|Overall Study|Progressive disease|26|||
27876565|NCT01938846|54494297|FG001|Overall Study|Progressive disease|18|||
27876566|NCT01938846|54494298|FG002|Overall Study|Progressive disease|16|||
27876567|NCT01938846|54494296|FG000|Overall Study|Adverse Event|8|||
27876568|NCT01938846|54494297|FG001|Overall Study|Adverse Event|4|||
27876569|NCT01938846|54494298|FG002|Overall Study|Adverse Event|3|||
27876570|NCT01938846|54494296|FG000|Overall Study|Withdrawal by Subject|2|||
27876571|NCT01938846|54494297|FG001|Overall Study|Withdrawal by Subject|2|||
27876572|NCT01938846|54494298|FG002|Overall Study|Withdrawal by Subject|1|||
27876573|NCT01938846|54494296|FG000|Overall Study|Other than listed|5|||
27876574|NCT01938846|54494297|FG001|Overall Study|Other than listed|1|||
27876575|NCT01938846|54494298|FG002|Overall Study|Other than listed|4|||
27876576|NCT01960140|54494339|FG000|Period 2 (Days 3-18)|Adverse Event|2|||
28096451|NCT04439214|54751426|FG000|Overall Study|Death|1|||
28096452|NCT04439214|54751426|FG000|Overall Study|Withdrawal by Subject|2|||
27876577|NCT01981356|54494349|FG000|Overall Study|Lost to Follow-up|4|||
27876578|NCT01981356|54494350|FG001|Overall Study|Lost to Follow-up|1|||
27876579|NCT01981356|54494349|FG000|Overall Study|Withdrawal by Subject|1|||
27876580|NCT01981356|54494350|FG001|Overall Study|Withdrawal by Subject|1|||
27876581|NCT01981356|54494349|FG000|Overall Study|Protocol Violation|2|||
27876582|NCT01981356|54494350|FG001|Overall Study|Protocol Violation|0|||
27876583|NCT01981122|54494359|FG000|Overall Study|Withdrawal by Subject|0|||
27876584|NCT01981122|54494360|FG001|Overall Study|Withdrawal by Subject|2|||
27876585|NCT01981122|54494359|FG000|Overall Study|Protocol Violation|0|||
27876586|NCT01981122|54494360|FG001|Overall Study|Protocol Violation|1|||
27876587|NCT01981122|54494359|FG000|Overall Study|Lost to Follow-up|0|||
27876588|NCT01981122|54494360|FG001|Overall Study|Lost to Follow-up|1|||
27876589|NCT01981122|54494359|FG000|Overall Study|Investigator Or Dendreon Discretion|0|||
27876590|NCT01981122|54494360|FG001|Overall Study|Investigator Or Dendreon Discretion|1|||
27876591|NCT01981122|54494359|FG000|Overall Study|Death|14|||
27876592|NCT01981122|54494360|FG001|Overall Study|Death|15|||
27876593|NCT01959672|54494366|FG000|Overall Study|Death|1|||
27876594|NCT01980888|54494375|FG000|Overall Study|Study Terminated by Sponsor|116|||
27876595|NCT01980888|54494376|FG001|Overall Study|Study Terminated by Sponsor|122|||
27876596|NCT01980888|54494375|FG000|Overall Study|Withdrew Consent|17|||
27876597|NCT01980888|54494376|FG001|Overall Study|Withdrew Consent|6|||
27876598|NCT01980888|54494375|FG000|Overall Study|Investigator's Discretion|8|||
27876599|NCT01980888|54494376|FG001|Overall Study|Investigator's Discretion|3|||
27876600|NCT01980888|54494375|FG000|Overall Study|Non-Compliance with Study Drug|3|||
27876601|NCT01980888|54494376|FG001|Overall Study|Non-Compliance with Study Drug|2|||
27876602|NCT01937364|54494393|FG000|Overall Study|Adverse Event|2|||
27876603|NCT01937364|54494394|FG001|Overall Study|Adverse Event|1|||
27876604|NCT01979952|54494402|FG000|Overall Study|Adverse Event|4|||
27876605|NCT01979952|54494403|FG001|Overall Study|Adverse Event|5|||
27876606|NCT01979952|54494402|FG000|Overall Study|Protocol Violation|1|||
27876607|NCT01979952|54494403|FG001|Overall Study|Protocol Violation|0|||
27876608|NCT01979952|54494402|FG000|Overall Study|Withdrawal by Subject|2|||
27876609|NCT01979952|54494403|FG001|Overall Study|Withdrawal by Subject|1|||
27876610|NCT01979952|54494402|FG000|Overall Study|Other than specified above|1|||
27876611|NCT01979952|54494403|FG001|Overall Study|Other than specified above|0|||
27876612|NCT01999218|54494412|FG000|Overall Study|Hyperglycemia|18|||
27876613|NCT01999218|54494413|FG001|Overall Study|Hyperglycemia|17|||
27876614|NCT01999218|54494414|FG002|Overall Study|Hyperglycemia|17|||
27876615|NCT01999218|54494412|FG000|Overall Study|Lack of Efficacy|1|||
27876616|NCT01999218|54494413|FG001|Overall Study|Lack of Efficacy|0|||
27876617|NCT01999218|54494414|FG002|Overall Study|Lack of Efficacy|1|||
27876618|NCT01999218|54494412|FG000|Overall Study|Lost to Follow-up|22|||
27876619|NCT01999218|54494413|FG001|Overall Study|Lost to Follow-up|17|||
27876620|NCT01999218|54494414|FG002|Overall Study|Lost to Follow-up|18|||
27876621|NCT01999218|54494412|FG000|Overall Study|Non-Compliance With Study Drug|6|||
27876622|NCT01999218|54494413|FG001|Overall Study|Non-Compliance With Study Drug|4|||
27876623|NCT01999218|54494414|FG002|Overall Study|Non-Compliance With Study Drug|1|||
27876624|NCT01999218|54494412|FG000|Overall Study|Physician Decision|1|||
27876625|NCT01999218|54494413|FG001|Overall Study|Physician Decision|4|||
27876626|NCT01999218|54494414|FG002|Overall Study|Physician Decision|6|||
27876627|NCT01999218|54494412|FG000|Overall Study|Protocol Violation|4|||
27876628|NCT01999218|54494413|FG001|Overall Study|Protocol Violation|5|||
27876629|NCT01999218|54494414|FG002|Overall Study|Protocol Violation|4|||
27876630|NCT01999218|54494412|FG000|Overall Study|Screen failure|0|||
27876631|NCT01999218|54494413|FG001|Overall Study|Screen failure|1|||
27876632|NCT01999218|54494414|FG002|Overall Study|Screen failure|0|||
27876633|NCT01999218|54494412|FG000|Overall Study|Study Terminated By Sponsor|7|||
27876634|NCT01999218|54494413|FG001|Overall Study|Study Terminated By Sponsor|5|||
27876635|NCT01999218|54494414|FG002|Overall Study|Study Terminated By Sponsor|12|||
27876636|NCT01999218|54494412|FG000|Overall Study|Participant moves|2|||
27876637|NCT01999218|54494413|FG001|Overall Study|Participant moves|5|||
27876638|NCT01999218|54494414|FG002|Overall Study|Participant moves|3|||
27876639|NCT01999218|54494412|FG000|Overall Study|Withdrawal by Subject|28|||
27876640|NCT01999218|54494413|FG001|Overall Study|Withdrawal by Subject|29|||
27739256|NCT03318523|54188616|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
27739257|NCT03318523|54188607|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
27739258|NCT03318523|54188608|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
27739259|NCT03318523|54188609|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
27739260|NCT03318523|54188610|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
27739261|NCT03318523|54188611|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
27876641|NCT01999218|54494414|FG002|Overall Study|Withdrawal by Subject|34|||
27876642|NCT01999218|54494412|FG000|Overall Study|Creatinine/eGFR|0|||
27876643|NCT01999218|54494413|FG001|Overall Study|Creatinine/eGFR|0|||
27739262|NCT03318523|54188612|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
27739263|NCT03318523|54188613|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
27876644|NCT01999218|54494414|FG002|Overall Study|Creatinine/eGFR|1|||
27876645|NCT01999218|54494412|FG000|Overall Study|Death|7|||
27739264|NCT03318523|54188614|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
27876646|NCT01999218|54494413|FG001|Overall Study|Death|1|||
27876647|NCT01999218|54494414|FG002|Overall Study|Death|2|||
27876648|NCT01999218|54494412|FG000|Overall Study|Excluded Medication|1|||
27739265|NCT03318523|54188615|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
27876649|NCT01999218|54494413|FG001|Overall Study|Excluded Medication|1|||
27876650|NCT01999218|54494414|FG002|Overall Study|Excluded Medication|2|||
27876651|NCT01999218|54494412|FG000|Overall Study|Adverse Event|9|||
27876652|NCT01999218|54494413|FG001|Overall Study|Adverse Event|7|||
27876653|NCT01999218|54494414|FG002|Overall Study|Adverse Event|7|||
27876654|NCT01999218|54494412|FG000|Overall Study|Treated but excluded at 1 trial site|3|||
27876655|NCT01999218|54494413|FG001|Overall Study|Treated but excluded at 1 trial site|5|||
27876656|NCT01999218|54494414|FG002|Overall Study|Treated but excluded at 1 trial site|2|||
27876657|NCT01937130|54494426|FG000|Overall Study|Withdrawal by Subject|0|||
27876658|NCT01937130|54494427|FG001|Overall Study|Withdrawal by Subject|0|||
27876659|NCT01937130|54494428|FG002|Overall Study|Withdrawal by Subject|0|||
27876660|NCT01937130|54494429|FG003|Overall Study|Withdrawal by Subject|1|||
27876661|NCT01937130|54494426|FG000|Overall Study|Adverse Event|0|||
27876662|NCT01937130|54494427|FG001|Overall Study|Adverse Event|1|||
27876663|NCT01937130|54494428|FG002|Overall Study|Adverse Event|0|||
27876664|NCT01937130|54494429|FG003|Overall Study|Adverse Event|1|||
27876665|NCT01937130|54494426|FG000|Overall Study|Death|1|||
27876666|NCT01937130|54494427|FG001|Overall Study|Death|1|||
27876667|NCT01937130|54494428|FG002|Overall Study|Death|1|||
27876668|NCT01937130|54494429|FG003|Overall Study|Death|0|||
27876669|NCT01937130|54494426|FG000|Overall Study|Lost to Follow-up|2|||
27876670|NCT01937130|54494427|FG001|Overall Study|Lost to Follow-up|0|||
27876671|NCT01937130|54494428|FG002|Overall Study|Lost to Follow-up|2|||
27876672|NCT01937130|54494429|FG003|Overall Study|Lost to Follow-up|0|||
27876673|NCT01937130|54494426|FG000|Overall Study|Physician Decision|0|||
27876674|NCT01937130|54494427|FG001|Overall Study|Physician Decision|1|||
27876675|NCT01937130|54494428|FG002|Overall Study|Physician Decision|0|||
27876676|NCT01937130|54494429|FG003|Overall Study|Physician Decision|0|||
27876677|NCT01937130|54494426|FG000|Overall Study|Patients unable to swallow|0|||
27876678|NCT01937130|54494427|FG001|Overall Study|Patients unable to swallow|1|||
27876679|NCT01937130|54494428|FG002|Overall Study|Patients unable to swallow|0|||
27876680|NCT01937130|54494429|FG003|Overall Study|Patients unable to swallow|0|||
27876681|NCT01937130|54494426|FG000|Overall Study|Patient lost to FU due to death|2|||
27876682|NCT01937130|54494427|FG001|Overall Study|Patient lost to FU due to death|0|||
27876683|NCT01937130|54494428|FG002|Overall Study|Patient lost to FU due to death|0|||
27876684|NCT01937130|54494429|FG003|Overall Study|Patient lost to FU due to death|0|||
27876685|NCT01936974|54494441|FG000|Overall Study|Physician Decision|2|||
27876686|NCT01936974|54494442|FG001|Overall Study|Physician Decision|5|||
27876687|NCT01959516|54494448|FG000|Epoch 1|Adverse Event|4|||
27876688|NCT01959516|54494449|FG001|Epoch 1|Adverse Event|1|||
27876689|NCT01959516|54494448|FG000|Epoch 1|unsatisfactory therapeutic effect|1|||
27876690|NCT01959516|54494449|FG001|Epoch 1|unsatisfactory therapeutic effect|0|||
27876691|NCT01959516|54494448|FG000|Epoch 1|Subject withdrew consent|3|||
27876692|NCT01959516|54494449|FG001|Epoch 1|Subject withdrew consent|2|||
27876693|NCT01959516|54494448|FG000|Epoch 1|Administrative problems|1|||
27876694|NCT01959516|54494449|FG001|Epoch 1|Administrative problems|0|||
27876695|NCT01959516|54494448|FG000|Epoch 1|Use of prohibited treatment|1|||
27876696|NCT01959516|54494449|FG001|Epoch 1|Use of prohibited treatment|0|||
27876697|NCT01959516|54494448|FG000|Epoch 1|Moderate or severe COPD exacerbation|0|||
27876698|NCT01959516|54494449|FG001|Epoch 1|Moderate or severe COPD exacerbation|1|||
27876699|NCT01959516|54494448|FG000|Epoch 1|Protocol deviation|0|||
27876700|NCT01959516|54494449|FG001|Epoch 1|Protocol deviation|1|||
27876701|NCT01959516|54494448|FG000|Epoch 2|unsatisfactory therapeutic effect|1|||
27876702|NCT01959516|54494449|FG001|Epoch 2|unsatisfactory therapeutic effect|0|||
27876703|NCT01959516|54494448|FG000|Epoch 2|Subject withdrew consent|1|||
27876704|NCT01959516|54494449|FG001|Epoch 2|Subject withdrew consent|0|||
27876705|NCT01959516|54494448|FG000|Epoch 2|Moderate or severe COPD exacerbation|0|||
27876706|NCT01959516|54494449|FG001|Epoch 2|Moderate or severe COPD exacerbation|1|||
27876707|NCT01979016|54494457|FG000|Overall Study|Withdrawal by Subject|2|||
27876708|NCT01979016|54494458|FG001|Overall Study|Withdrawal by Subject|0|||
27876709|NCT01979016|54494457|FG000|Overall Study|Adverse Event|0|||
27876710|NCT01979016|54494458|FG001|Overall Study|Adverse Event|1|||
27876711|NCT01935336|54494468|FG000|Overall Study|Adverse Event|1|||
27876712|NCT01935336|54494469|FG001|Overall Study|Adverse Event|0|||
27876713|NCT01935336|54494470|FG002|Overall Study|Adverse Event|0|||
27876714|NCT01935336|54494471|FG003|Overall Study|Adverse Event|0|||
27876715|NCT01935336|54494468|FG000|Overall Study|Progressive disease|5|||
27876716|NCT01935336|54494469|FG001|Overall Study|Progressive disease|3|||
27876717|NCT01935336|54494470|FG002|Overall Study|Progressive disease|47|||
27876718|NCT01935336|54494471|FG003|Overall Study|Progressive disease|66|||
27876719|NCT01978236|54494487|FG000|Overall Study|Discontinued due to study close|2|||
27876720|NCT01977846|54494493|FG000|Total Study - Prospective|Death|0|||
27876721|NCT01977846|54494494|FG001|Total Study - Prospective|Death|1|||
27876722|NCT01977846|54494493|FG000|Total Study - Prospective|Lost to Follow-up|0|||
27876723|NCT01977846|54494494|FG001|Total Study - Prospective|Lost to Follow-up|8|||
27876724|NCT01977846|54494493|FG000|Total Study - Prospective|Withdrawal by Subject|0|||
27876725|NCT01977846|54494494|FG001|Total Study - Prospective|Withdrawal by Subject|13|||
27876726|NCT01977846|54494493|FG000|Total Study - Prospective|Not available at time of visit|0|||
27876727|NCT01977846|54494494|FG001|Total Study - Prospective|Not available at time of visit|5|||
27876728|NCT01977846|54494493|FG000|Total Study - Prospective|No show|0|||
27876729|NCT01977846|54494494|FG001|Total Study - Prospective|No show|1|||
27876730|NCT01977846|54494493|FG000|Total Study - Prospective|Protocol Violation|0|||
27876731|NCT01977846|54494494|FG001|Total Study - Prospective|Protocol Violation|1|||
27876732|NCT01934790|54494501|FG000|Treatment|Adverse Event|3|||
27876733|NCT01934790|54494501|FG000|Treatment|Clinical progression|6|||
27876734|NCT01934790|54494501|FG000|Treatment|Radiological progression|4|||
27876735|NCT01934790|54494501|FG000|Treatment|Withdrawal by Subject|2|||
27876736|NCT01934790|54494501|FG000|Treatment|Study drug never administered|1|||
27876737|NCT01934790|54494501|FG000|Active Follow up|Death|20|||
27876738|NCT01934790|54494501|FG000|Active Follow up|Physician Decision|2|||
27876739|NCT01934790|54494501|FG000|Active Follow up|Progressive disease|1|||
27876740|NCT01934790|54494501|FG000|Active Follow up|Other reason|1|||
27876741|NCT01934556|54494508|FG000|Overall Study|Withdrawal by Subject|0|||
27876742|NCT01934556|54494509|FG001|Overall Study|Withdrawal by Subject|1|||
27876743|NCT01934556|54494510|FG002|Overall Study|Withdrawal by Subject|1|||
27876744|NCT01934556|54494508|FG000|Overall Study|Lost to Follow-up|4|||
27876745|NCT01934556|54494509|FG001|Overall Study|Lost to Follow-up|10|||
27876746|NCT01934556|54494510|FG002|Overall Study|Lost to Follow-up|7|||
27876747|NCT01934556|54494508|FG000|Overall Study|Death|1|||
27876748|NCT01934556|54494509|FG001|Overall Study|Death|5|||
27876749|NCT01934556|54494510|FG002|Overall Study|Death|2|||
27876750|NCT01977690|54494520|FG000|Overall Study|Withdrawal by Subject|0|||
27876751|NCT01977690|54494521|FG001|Overall Study|Withdrawal by Subject|4|||
27876752|NCT01934010|54494596|FG000|Overall Study|Adverse Event|1|||
27876753|NCT01934010|54494597|FG001|Overall Study|Adverse Event|1|||
27876754|NCT01934010|54494598|FG002|Overall Study|Adverse Event|0|||
27876755|NCT01934010|54494596|FG000|Overall Study|Withdrawal by Subject|15|||
27876756|NCT01934010|54494597|FG001|Overall Study|Withdrawal by Subject|6|||
27876757|NCT01934010|54494598|FG002|Overall Study|Withdrawal by Subject|2|||
27876758|NCT01934010|54494596|FG000|Overall Study|Lost to Follow-up|7|||
27876759|NCT01934010|54494597|FG001|Overall Study|Lost to Follow-up|4|||
27876760|NCT01934010|54494598|FG002|Overall Study|Lost to Follow-up|0|||
27876761|NCT01620138|54494617|FG000|Overall Study|Withdrawal by Subject|3|||
27876762|NCT01620138|54494618|FG001|Overall Study|Withdrawal by Subject|0|||
27876763|NCT01620138|54494617|FG000|Overall Study|Lack of Efficacy|1|||
27876764|NCT01620138|54494618|FG001|Overall Study|Lack of Efficacy|0|||
27876765|NCT01620138|54494617|FG000|Overall Study|Adverse Event|2|||
27876766|NCT01620138|54494618|FG001|Overall Study|Adverse Event|0|||
27876767|NCT01977612|54494626|FG000|Overall Study|Lost to Follow-up|1|||
27876768|NCT01977612|54494627|FG001|Overall Study|Lost to Follow-up|1|||
27876769|NCT01932996|54494635|FG000|Overall Study|Protocol Violation|2|||
27876770|NCT01932996|54494636|FG001|Overall Study|Protocol Violation|0|||
27876771|NCT01932762|54494646|FG000|Overall Study|Withdrawal by Subject|1|||
27876772|NCT01932762|54494647|FG001|Overall Study|Withdrawal by Subject|2|||
27876773|NCT01932762|54494648|FG002|Overall Study|Withdrawal by Subject|0|||
27876774|NCT01932762|54494649|FG003|Overall Study|Withdrawal by Subject|0|||
27876775|NCT01932762|54494646|FG000|Overall Study|Lost to Follow-up|4|||
27876776|NCT01932762|54494647|FG001|Overall Study|Lost to Follow-up|0|||
27876777|NCT01932762|54494648|FG002|Overall Study|Lost to Follow-up|0|||
27876778|NCT01932762|54494649|FG003|Overall Study|Lost to Follow-up|1|||
27876779|NCT01932762|54494646|FG000|Overall Study|Physician Decision|1|||
27876780|NCT01932762|54494647|FG001|Overall Study|Physician Decision|0|||
27876781|NCT01932762|54494648|FG002|Overall Study|Physician Decision|0|||
27876782|NCT01932762|54494649|FG003|Overall Study|Physician Decision|0|||
27876783|NCT01618968|54494663|FG000|Overall Study|Adverse Event|1|||
27876784|NCT01618968|54494664|FG001|Overall Study|Adverse Event|0|||
27876785|NCT01618968|54494665|FG002|Overall Study|Adverse Event|0|||
27876786|NCT01618968|54494666|FG003|Overall Study|Adverse Event|0|||
27876787|NCT01618968|54494663|FG000|Overall Study|Death|0|||
27876788|NCT01618968|54494664|FG001|Overall Study|Death|0|||
27982978|NCT00564889|54641217|FG000|Overall Study|Death|7|||
27982979|NCT00564889|54641217|FG000|Overall Study|Adverse Event|12|||
27982980|NCT00564889|54641217|FG000|Overall Study|Alternative treatment|3|||
27982981|NCT00564889|54641217|FG000|Overall Study|Disease progression|3|||
27982982|NCT00564889|54641217|FG000|Overall Study|Other, not specified|4|||
27982983|NCT00560833|54641235|FG000|Overall Study|Adverse Event|16|||
27982984|NCT00560833|54641236|FG001|Overall Study|Adverse Event|10|||
27876789|NCT01618968|54494665|FG002|Overall Study|Death|0|||
27876790|NCT01618968|54494666|FG003|Overall Study|Death|1|||
27876791|NCT01932294|54494675|FG000|Overall Study|Death|43|||
27876792|NCT01932294|54494675|FG000|Overall Study|Lost to Follow-up|8|||
27876793|NCT01932294|54494675|FG000|Overall Study|VAD Implantation|20|||
27876794|NCT01932294|54494675|FG000|Overall Study|Heart Transplantation|16|||
27876795|NCT01932294|54494675|FG000|Overall Study|Transferred to other hospitals|12|||
27876796|NCT01931670|54494683|FG000|Treatment Period|Exclusionary Medication Received|1|||
27876797|NCT01931670|54494684|FG001|Treatment Period|Exclusionary Medication Received|1|||
27876798|NCT01931670|54494685|FG002|Treatment Period|Exclusionary Medication Received|1|||
27876799|NCT01931670|54494683|FG000|Treatment Period|Surgery/Invasive Intervention|4|||
27876800|NCT01931670|54494684|FG001|Treatment Period|Surgery/Invasive Intervention|2|||
27982985|NCT00560833|54641237|FG002|Overall Study|Adverse Event|25|||
27876801|NCT01931670|54494685|FG002|Treatment Period|Surgery/Invasive Intervention|0|||
27876802|NCT01931670|54494683|FG000|Treatment Period|Subject Noncompliant|4|||
27876803|NCT01931670|54494684|FG001|Treatment Period|Subject Noncompliant|9|||
27876804|NCT01931670|54494685|FG002|Treatment Period|Subject Noncompliant|5|||
27876805|NCT01931670|54494683|FG000|Treatment Period|Adverse Event|19|||
27876806|NCT01931670|54494684|FG001|Treatment Period|Adverse Event|8|||
27876807|NCT01931670|54494685|FG002|Treatment Period|Adverse Event|21|||
27876808|NCT01931670|54494683|FG000|Treatment Period|Lack of Efficacy|11|||
27876809|NCT01931670|54494684|FG001|Treatment Period|Lack of Efficacy|2|||
27876810|NCT01931670|54494685|FG002|Treatment Period|Lack of Efficacy|2|||
27876811|NCT01931670|54494683|FG000|Treatment Period|Pregnancy|7|||
27876812|NCT01931670|54494684|FG001|Treatment Period|Pregnancy|2|||
27876813|NCT01931670|54494685|FG002|Treatment Period|Pregnancy|0|||
27876814|NCT01931670|54494683|FG000|Treatment Period|Other|8|||
27876815|NCT01931670|54494684|FG001|Treatment Period|Other|7|||
27876816|NCT01931670|54494685|FG002|Treatment Period|Other|2|||
27876817|NCT01931670|54494683|FG000|Treatment Period|Consent Withdrawn by Subject|17|||
27876818|NCT01931670|54494684|FG001|Treatment Period|Consent Withdrawn by Subject|12|||
27876819|NCT01931670|54494685|FG002|Treatment Period|Consent Withdrawn by Subject|7|||
27876820|NCT01931670|54494683|FG000|Treatment Period|Lost to Follow-up|19|||
27876821|NCT01931670|54494684|FG001|Treatment Period|Lost to Follow-up|5|||
27876822|NCT01931670|54494685|FG002|Treatment Period|Lost to Follow-up|7|||
27876823|NCT01931670|54494683|FG000|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3|||
27876824|NCT01931670|54494684|FG001|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
27876825|NCT01931670|54494685|FG002|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
27876826|NCT01931670|54494683|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0|||
27876827|NCT01931670|54494684|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2|||
27876828|NCT01931670|54494685|FG002|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1|||
27876829|NCT01931670|54494683|FG000|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
27876830|NCT01931670|54494684|FG001|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
27876831|NCT01931670|54494685|FG002|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2|||
27876832|NCT01931670|54494683|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|6|||
27876833|NCT01931670|54494684|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
27876834|NCT01931670|54494685|FG002|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
27876835|NCT01931670|54494683|FG000|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6|||
27876836|NCT01931670|54494684|FG001|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3|||
27876837|NCT01931670|54494685|FG002|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13|||
27876838|NCT01931670|54494683|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
27876839|NCT01931670|54494684|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
27876840|NCT01931670|54494685|FG002|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2|||
27876841|NCT01977456|54494693|FG000|Overall Study|Death|5|||
27876842|NCT01957644|54494702|FG000|Overall Study|Adverse Event|4|||
27876843|NCT01957644|54494703|FG001|Overall Study|Adverse Event|2|||
27876844|NCT01957644|54494704|FG002|Overall Study|Adverse Event|0|||
27876845|NCT01957644|54494705|FG003|Overall Study|Adverse Event|0|||
27876846|NCT01957644|54494706|FG004|Overall Study|Adverse Event|1|||
27876847|NCT01957644|54494702|FG000|Overall Study|Progressive disease / relapse|0|||
27876848|NCT01957644|54494703|FG001|Overall Study|Progressive disease / relapse|1|||
27876849|NCT01957644|54494704|FG002|Overall Study|Progressive disease / relapse|0|||
27876850|NCT01957644|54494705|FG003|Overall Study|Progressive disease / relapse|1|||
27876851|NCT01957644|54494706|FG004|Overall Study|Progressive disease / relapse|0|||
27876852|NCT01957644|54494702|FG000|Overall Study|Other reason|1|||
27876853|NCT01957644|54494703|FG001|Overall Study|Other reason|2|||
27876854|NCT01957644|54494704|FG002|Overall Study|Other reason|1|||
27876855|NCT01957644|54494705|FG003|Overall Study|Other reason|1|||
27876856|NCT01957644|54494706|FG004|Overall Study|Other reason|0|||
27876857|NCT01957644|54494702|FG000|Overall Study|Withdrawal by Subject|1|||
27876858|NCT01957644|54494703|FG001|Overall Study|Withdrawal by Subject|0|||
27876859|NCT01957644|54494704|FG002|Overall Study|Withdrawal by Subject|0|||
27876860|NCT01957644|54494705|FG003|Overall Study|Withdrawal by Subject|0|||
27876861|NCT01957644|54494706|FG004|Overall Study|Withdrawal by Subject|0|||
27876862|NCT01957644|54494702|FG000|Overall Study|Protocol Violation|0|||
27876863|NCT01957644|54494703|FG001|Overall Study|Protocol Violation|1|||
27876864|NCT01957644|54494704|FG002|Overall Study|Protocol Violation|0|||
27982986|NCT00560833|54641238|FG003|Overall Study|Adverse Event|23|||
27982987|NCT00560833|54641239|FG004|Overall Study|Adverse Event|35|||
28096453|NCT04439214|54751426|FG000|Overall Study|Declining health|1|||
28096454|NCT04439214|54751426|FG000|Overall Study|Still receiving treatment at the time of the analysis|9|||
27876865|NCT01957644|54494705|FG003|Overall Study|Protocol Violation|0|||
27876866|NCT01957644|54494706|FG004|Overall Study|Protocol Violation|0|||
27876867|NCT01931202|54494723|FG000|Overall Study|Withdrawal by Subject|0|||
28096455|NCT04439214|54751426|FG000|Overall Study|Ineligible|5|||
27982988|NCT00560833|54641235|FG000|Overall Study|Lost to Follow-up|0|||
27876868|NCT01931202|54494724|FG001|Overall Study|Withdrawal by Subject|0|||
27876869|NCT01931202|54494725|FG002|Overall Study|Withdrawal by Subject|2|||
27876870|NCT01931202|54494723|FG000|Overall Study|Lost to Follow-up|0|||
27876871|NCT01931202|54494724|FG001|Overall Study|Lost to Follow-up|5|||
27876872|NCT01931202|54494725|FG002|Overall Study|Lost to Follow-up|2|||
27876873|NCT01930890|54494740|FG000|Overall Study|Study Termination|14|||
27876874|NCT01930890|54494741|FG001|Overall Study|Study Termination|28|||
27876875|NCT01930890|54494742|FG002|Overall Study|Study Termination|13|||
27876876|NCT01930890|54494743|FG003|Overall Study|Study Termination|25|||
27876877|NCT01930890|54494740|FG000|Overall Study|Death|0|||
27876878|NCT01930890|54494741|FG001|Overall Study|Death|0|||
27876879|NCT01930890|54494742|FG002|Overall Study|Death|0|||
27876880|NCT01930890|54494743|FG003|Overall Study|Death|1|||
27876881|NCT01930890|54494740|FG000|Overall Study|Investigator Decision|0|||
27876882|NCT01930890|54494741|FG001|Overall Study|Investigator Decision|1|||
27876883|NCT01930890|54494742|FG002|Overall Study|Investigator Decision|0|||
27876884|NCT01930890|54494743|FG003|Overall Study|Investigator Decision|0|||
27876885|NCT01930890|54494740|FG000|Overall Study|Consent Withdrawn|0|||
27876886|NCT01930890|54494741|FG001|Overall Study|Consent Withdrawn|3|||
27876887|NCT01930890|54494742|FG002|Overall Study|Consent Withdrawn|0|||
27876888|NCT01930890|54494743|FG003|Overall Study|Consent Withdrawn|1|||
27876889|NCT01930890|54494740|FG000|Overall Study|Adverse Event|0|||
27876890|NCT01930890|54494741|FG001|Overall Study|Adverse Event|1|||
27876891|NCT01930890|54494742|FG002|Overall Study|Adverse Event|0|||
27876892|NCT01930890|54494743|FG003|Overall Study|Adverse Event|0|||
27876893|NCT01930188|54494756|FG000|Overall Study|unclassified|4|||
27876894|NCT01930188|54494757|FG001|Overall Study|unclassified|5|||
27876895|NCT01930188|54494758|FG002|Overall Study|unclassified|3|||
27876896|NCT01930188|54494756|FG000|Overall Study|Missing follow-up information|2|||
27876897|NCT01930188|54494757|FG001|Overall Study|Missing follow-up information|2|||
27876898|NCT01930188|54494758|FG002|Overall Study|Missing follow-up information|3|||
27876899|NCT01930188|54494756|FG000|Overall Study|Lost to Follow-up|5|||
27876900|NCT01930188|54494757|FG001|Overall Study|Lost to Follow-up|2|||
27876901|NCT01930188|54494758|FG002|Overall Study|Lost to Follow-up|2|||
27876902|NCT01930188|54494756|FG000|Overall Study|Death|2|||
27876903|NCT01930188|54494757|FG001|Overall Study|Death|1|||
27876904|NCT01930188|54494758|FG002|Overall Study|Death|3|||
27876905|NCT01930188|54494756|FG000|Overall Study|Withdrawal by Subject|9|||
27876906|NCT01930188|54494757|FG001|Overall Study|Withdrawal by Subject|11|||
27876907|NCT01930188|54494758|FG002|Overall Study|Withdrawal by Subject|8|||
27876908|NCT01977222|54494767|FG000|Overall Study|Withdrawal by Subject|1|||
27876909|NCT01957488|54494771|FG000|Test Period 1 (2 Weeks)|Lost to Follow-up|2|||
27876910|NCT01957488|54494772|FG001|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
27876911|NCT01957488|54494773|FG002|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
27876912|NCT01957488|54494774|FG003|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
27876913|NCT01957488|54494775|FG004|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
27876914|NCT01957488|54494776|FG005|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
27876915|NCT01957488|54494771|FG000|Test Period 1 (2 Weeks)|Protocol Violation|1|||
27876916|NCT01957488|54494772|FG001|Test Period 1 (2 Weeks)|Protocol Violation|2|||
27876917|NCT01957488|54494773|FG002|Test Period 1 (2 Weeks)|Protocol Violation|2|||
27876918|NCT01957488|54494774|FG003|Test Period 1 (2 Weeks)|Protocol Violation|1|||
27876919|NCT01957488|54494775|FG004|Test Period 1 (2 Weeks)|Protocol Violation|0|||
27876920|NCT01957488|54494776|FG005|Test Period 1 (2 Weeks)|Protocol Violation|3|||
27876921|NCT01957488|54494771|FG000|Test Period 1 (2 Weeks)|Adverse Event|0|||
27876922|NCT01957488|54494772|FG001|Test Period 1 (2 Weeks)|Adverse Event|1|||
27876923|NCT01957488|54494773|FG002|Test Period 1 (2 Weeks)|Adverse Event|1|||
27876924|NCT01957488|54494774|FG003|Test Period 1 (2 Weeks)|Adverse Event|0|||
27876925|NCT01957488|54494775|FG004|Test Period 1 (2 Weeks)|Adverse Event|1|||
27876926|NCT01957488|54494776|FG005|Test Period 1 (2 Weeks)|Adverse Event|0|||
27876927|NCT01957488|54494771|FG000|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
27876928|NCT01957488|54494772|FG001|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
27876929|NCT01957488|54494773|FG002|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
27876930|NCT01957488|54494774|FG003|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
27876931|NCT01957488|54494775|FG004|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
27876932|NCT01957488|54494776|FG005|Test Period 1 (2 Weeks)|Withdrawal by Subject|2|||
27876933|NCT01957488|54494771|FG000|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
27876934|NCT01957488|54494772|FG001|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
27876935|NCT01957488|54494773|FG002|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
27876936|NCT01957488|54494774|FG003|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
27876937|NCT01957488|54494775|FG004|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1|||
27876938|NCT01957488|54494776|FG005|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
27876939|NCT01957488|54494771|FG000|Test Period 1 (2 Weeks)|screen failure|0|||
27876940|NCT01957488|54494772|FG001|Test Period 1 (2 Weeks)|screen failure|0|||
27876941|NCT01957488|54494773|FG002|Test Period 1 (2 Weeks)|screen failure|0|||
27876942|NCT01957488|54494774|FG003|Test Period 1 (2 Weeks)|screen failure|0|||
27876943|NCT01957488|54494775|FG004|Test Period 1 (2 Weeks)|screen failure|0|||
27876944|NCT01957488|54494776|FG005|Test Period 1 (2 Weeks)|screen failure|1|||
27876945|NCT01957488|54494771|FG000|Test Period 2 (2 Weeks)|Protocol Violation|2|||
27876946|NCT01957488|54494772|FG001|Test Period 2 (2 Weeks)|Protocol Violation|0|||
27876947|NCT01957488|54494773|FG002|Test Period 2 (2 Weeks)|Protocol Violation|1|||
27876948|NCT01957488|54494774|FG003|Test Period 2 (2 Weeks)|Protocol Violation|1|||
27876949|NCT01957488|54494775|FG004|Test Period 2 (2 Weeks)|Protocol Violation|0|||
27876950|NCT01957488|54494776|FG005|Test Period 2 (2 Weeks)|Protocol Violation|0|||
27876951|NCT01957488|54494771|FG000|Test Period 2 (2 Weeks)|Other|1|||
27876952|NCT01957488|54494772|FG001|Test Period 2 (2 Weeks)|Other|0|||
27876953|NCT01957488|54494773|FG002|Test Period 2 (2 Weeks)|Other|0|||
27876954|NCT01957488|54494774|FG003|Test Period 2 (2 Weeks)|Other|0|||
27876955|NCT01957488|54494775|FG004|Test Period 2 (2 Weeks)|Other|0|||
27876956|NCT01957488|54494776|FG005|Test Period 2 (2 Weeks)|Other|0|||
27876957|NCT01957488|54494771|FG000|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
27876958|NCT01957488|54494772|FG001|Test Period 2 (2 Weeks)|Withdrawal by Subject|1|||
27876959|NCT01957488|54494773|FG002|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
27876960|NCT01957488|54494774|FG003|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
27876961|NCT01957488|54494775|FG004|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
27876962|NCT01957488|54494776|FG005|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
27876963|NCT01957488|54494771|FG000|Test Period 2 (2 Weeks)|Adverse Event|0|||
27876964|NCT01957488|54494772|FG001|Test Period 2 (2 Weeks)|Adverse Event|0|||
27876965|NCT01957488|54494773|FG002|Test Period 2 (2 Weeks)|Adverse Event|0|||
27876966|NCT01957488|54494774|FG003|Test Period 2 (2 Weeks)|Adverse Event|0|||
27876967|NCT01957488|54494775|FG004|Test Period 2 (2 Weeks)|Adverse Event|2|||
27876968|NCT01957488|54494776|FG005|Test Period 2 (2 Weeks)|Adverse Event|0|||
27876969|NCT01957488|54494771|FG000|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
27876970|NCT01957488|54494772|FG001|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
27876971|NCT01957488|54494773|FG002|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
27876972|NCT01957488|54494774|FG003|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
27876973|NCT01957488|54494775|FG004|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
27876974|NCT01957488|54494776|FG005|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1|||
27876975|NCT01957488|54494771|FG000|Test Period 3 (2 Weeks)|Withdrawal by Subject|1|||
27876976|NCT01957488|54494772|FG001|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
27876977|NCT01957488|54494773|FG002|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
27876978|NCT01957488|54494774|FG003|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
27876979|NCT01957488|54494775|FG004|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
27876980|NCT01957488|54494776|FG005|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
27876981|NCT01957488|54494771|FG000|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
27876982|NCT01957488|54494772|FG001|Test Period 3 (2 Weeks)|Lack of Efficacy|1|||
27876983|NCT01957488|54494773|FG002|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
27876984|NCT01957488|54494774|FG003|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
27876985|NCT01957488|54494775|FG004|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
27876986|NCT01957488|54494776|FG005|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
27876987|NCT01976364|54494784|FG000|Main Study (36 Months)|Adverse Event|63|||
27876988|NCT01976364|54494785|FG001|Main Study (36 Months)|Adverse Event|0|||
27876989|NCT01976364|54494786|FG002|Main Study (36 Months)|Adverse Event|0|||
27876990|NCT01976364|54494784|FG000|Main Study (36 Months)|Withdrawn due to pregnancy|5|||
27876991|NCT01976364|54494785|FG001|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
27876992|NCT01976364|54494786|FG002|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
27876993|NCT01976364|54494784|FG000|Main Study (36 Months)|Other|13|||
27876994|NCT01976364|54494785|FG001|Main Study (36 Months)|Other|0|||
27876995|NCT01976364|54494786|FG002|Main Study (36 Months)|Other|0|||
27876996|NCT01976364|54494784|FG000|Main Study (36 Months)|No longer met eligibility criteria|2|||
27876997|NCT01976364|54494785|FG001|Main Study (36 Months)|No longer met eligibility criteria|0|||
27876998|NCT01976364|54494786|FG002|Main Study (36 Months)|No longer met eligibility criteria|0|||
27876999|NCT01976364|54494784|FG000|Main Study (36 Months)|Medication error|1|||
27877000|NCT01976364|54494785|FG001|Main Study (36 Months)|Medication error|0|||
27877001|NCT01976364|54494786|FG002|Main Study (36 Months)|Medication error|0|||
27877002|NCT01976364|54494784|FG000|Main Study (36 Months)|Lost to Follow-up|10|||
27877003|NCT01976364|54494785|FG001|Main Study (36 Months)|Lost to Follow-up|0|||
27877004|NCT01976364|54494786|FG002|Main Study (36 Months)|Lost to Follow-up|0|||
27877005|NCT01976364|54494784|FG000|Main Study (36 Months)|Lack of Efficacy|40|||
27877006|NCT01976364|54494785|FG001|Main Study (36 Months)|Lack of Efficacy|0|||
27877007|NCT01976364|54494786|FG002|Main Study (36 Months)|Lack of Efficacy|0|||
27877008|NCT01976364|54494784|FG000|Main Study (36 Months)|Protocol Violation|13|||
27877009|NCT01976364|54494785|FG001|Main Study (36 Months)|Protocol Violation|0|||
27877010|NCT01976364|54494786|FG002|Main Study (36 Months)|Protocol Violation|0|||
27877011|NCT01976364|54494784|FG000|Main Study (36 Months)|Withdrawal by Subject|69|||
27877012|NCT01976364|54494785|FG001|Main Study (36 Months)|Withdrawal by Subject|0|||
27877013|NCT01976364|54494786|FG002|Main Study (36 Months)|Withdrawal by Subject|0|||
27877014|NCT01976364|54494784|FG000|Main Study (36 Months)|Death|5|||
27877015|NCT01976364|54494785|FG001|Main Study (36 Months)|Death|0|||
27877016|NCT01976364|54494786|FG002|Main Study (36 Months)|Death|0|||
27877017|NCT01976364|54494784|FG000|Sub-study (12 Months)|Lost to Follow-up|0|||
27877018|NCT01976364|54494785|FG001|Sub-study (12 Months)|Lost to Follow-up|1|||
27877019|NCT01976364|54494786|FG002|Sub-study (12 Months)|Lost to Follow-up|0|||
27877020|NCT01976364|54494784|FG000|Sub-study (12 Months)|Withdrawal by Subject|0|||
27877021|NCT01976364|54494785|FG001|Sub-study (12 Months)|Withdrawal by Subject|0|||
27877022|NCT01976364|54494786|FG002|Sub-study (12 Months)|Withdrawal by Subject|1|||
27877023|NCT01976364|54494784|FG000|Sub-study (12 Months)|Protocol Violation|0|||
27877024|NCT01976364|54494785|FG001|Sub-study (12 Months)|Protocol Violation|1|||
27877025|NCT01976364|54494786|FG002|Sub-study (12 Months)|Protocol Violation|1|||
27877026|NCT01976364|54494784|FG000|Sub-study (12 Months)|Adverse Event|0|||
27877027|NCT01976364|54494785|FG001|Sub-study (12 Months)|Adverse Event|4|||
27877028|NCT01976364|54494786|FG002|Sub-study (12 Months)|Adverse Event|3|||
27877029|NCT01956240|54494797|FG000|Overall Study|Lost to Follow-up|6|||
27877030|NCT01956240|54494798|FG001|Overall Study|Lost to Follow-up|20|||
27877031|NCT01956240|54494797|FG000|Overall Study|Adverse Event|17|||
27877032|NCT01956240|54494798|FG001|Overall Study|Adverse Event|4|||
27877033|NCT01929876|54494804|FG000|Period 2|Non-Compliance|1|||
27877034|NCT01929408|54494808|FG000|Overall Study|received HCT as initial treatment|8|||
27877035|NCT01929018|54494814|FG000|Overall Study|Lost to Follow-up|1|||
27877036|NCT01929018|54494815|FG001|Overall Study|Lost to Follow-up|0|||
27877037|NCT01929018|54494814|FG000|Overall Study|Hospitalization|0|||
27877038|NCT01929018|54494815|FG001|Overall Study|Hospitalization|1|||
27877039|NCT01928940|54494823|FG000|Overall Study|Adverse Event|0|||
27877040|NCT01928940|54494824|FG001|Overall Study|Adverse Event|1|||
27877041|NCT01928862|54494836|FG000|Overall Study|Lost to Follow-up|1|||
27877042|NCT01928862|54494837|FG001|Overall Study|Lost to Follow-up|0|||
27877043|NCT01928862|54494838|FG002|Overall Study|Lost to Follow-up|0|||
27877044|NCT01928862|54494839|FG003|Overall Study|Lost to Follow-up|0|||
27877045|NCT01928862|54494840|FG004|Overall Study|Lost to Follow-up|1|||
27877046|NCT01954056|54494855|FG000|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1|||
27877047|NCT01954056|54494856|FG001|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0|||
27877048|NCT01953354|54494864|FG000|Overall Study|Withdrawal by Subject|0|||
27877049|NCT01953354|54494865|FG001|Overall Study|Withdrawal by Subject|1|||
27877050|NCT01953354|54494864|FG000|Overall Study|Decision of Sponsor|0|||
28171627|NCT03350815|54843238|FG001|Period 1|Withdrawal by Subject|0|||
28171628|NCT03350815|54843239|FG002|Period 1|Withdrawal by Subject|0|||
28171629|NCT03350815|54843240|FG003|Period 1|Withdrawal by Subject|0|||
28171630|NCT03350815|54843237|FG000|Period 1|Lack of Efficacy|15|||
28171631|NCT03350815|54843238|FG001|Period 1|Lack of Efficacy|0|||
28171632|NCT03350815|54843239|FG002|Period 1|Lack of Efficacy|0|||
28171633|NCT03350815|54843240|FG003|Period 1|Lack of Efficacy|0|||
28171634|NCT03350815|54843237|FG000|Period 1|Non-compliance with study treatment|2|||
28171635|NCT03350815|54843238|FG001|Period 1|Non-compliance with study treatment|0|||
28171636|NCT03350815|54843239|FG002|Period 1|Non-compliance with study treatment|0|||
28171637|NCT03350815|54843240|FG003|Period 1|Non-compliance with study treatment|0|||
28171638|NCT03350815|54843237|FG000|Period 1|Protocol Violation|3|||
28171639|NCT03350815|54843238|FG001|Period 1|Protocol Violation|0|||
27739266|NCT03318523|54188616|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|1|||
27877051|NCT01953354|54494865|FG001|Overall Study|Decision of Sponsor|1|||
27877052|NCT01953354|54494864|FG000|Overall Study|Disease Exacerbation|1|||
27877053|NCT01953354|54494865|FG001|Overall Study|Disease Exacerbation|0|||
27877054|NCT01975272|54494874|FG000|Overall Study|Excluded after protocol amendment|1|||
27877055|NCT01975272|54494875|FG001|Overall Study|Excluded after protocol amendment|1|||
27877056|NCT01975272|54494876|FG002|Overall Study|Excluded after protocol amendment|2|||
27877057|NCT01951638|54494889|FG000|Treatment Period|Protocol Violation|0|||
27877058|NCT01951638|54494890|FG001|Treatment Period|Protocol Violation|0|||
27877059|NCT01951638|54494891|FG002|Treatment Period|Protocol Violation|0|||
27877060|NCT01951638|54494892|FG003|Treatment Period|Protocol Violation|2|||
27877061|NCT01951638|54494893|FG004|Treatment Period|Protocol Violation|0|||
28096456|NCT03696342|54751432|FG000|Overall Study|Lost to Follow-up|1|||
28096457|NCT03696342|54751433|FG001|Overall Study|Lost to Follow-up|0|||
28096458|NCT04411680|54751441|FG000|Treatment Period|Adverse Event|3|||
28096459|NCT04411680|54751442|FG001|Treatment Period|Adverse Event|0|||
28096460|NCT04411680|54751441|FG000|Treatment Period|Discharged from hospital|18|||
28096461|NCT04411680|54751442|FG001|Treatment Period|Discharged from hospital|7|||
28096462|NCT04411680|54751441|FG000|Treatment Period|Missed 1 or more doses|8|||
28096463|NCT04411680|54751442|FG001|Treatment Period|Missed 1 or more doses|0|||
28096464|NCT04411680|54751441|FG000|Treatment Period|Transferred to another hospital|0|||
28096465|NCT04411680|54751442|FG001|Treatment Period|Transferred to another hospital|1|||
28096466|NCT04411680|54751441|FG000|Follow up Period|Withdrawal by Subject|2|||
28096467|NCT04411680|54751442|FG001|Follow up Period|Withdrawal by Subject|0|||
28096468|NCT04411680|54751441|FG000|Follow up Period|Lost to Follow-up|5|||
28096469|NCT04411680|54751442|FG001|Follow up Period|Lost to Follow-up|6|||
28096470|NCT04411680|54751441|FG000|Follow up Period|Death|11|||
28096471|NCT04411680|54751442|FG001|Follow up Period|Death|8|||
28171640|NCT03350815|54843239|FG002|Period 1|Protocol Violation|0|||
28171641|NCT03350815|54843240|FG003|Period 1|Protocol Violation|0|||
28171642|NCT03350815|54843237|FG000|Period 2|Adverse Event|0|||
27877062|NCT01951638|54494889|FG000|Treatment Period|Protocol-driven decision point|1|||
27877063|NCT01951638|54494890|FG001|Treatment Period|Protocol-driven decision point|3|||
27877064|NCT01951638|54494891|FG002|Treatment Period|Protocol-driven decision point|0|||
27877065|NCT01951638|54494892|FG003|Treatment Period|Protocol-driven decision point|0|||
27982989|NCT00560833|54641236|FG001|Overall Study|Lost to Follow-up|0|||
27982990|NCT00560833|54641237|FG002|Overall Study|Lost to Follow-up|1|||
27982991|NCT00560833|54641238|FG003|Overall Study|Lost to Follow-up|0|||
27982992|NCT00560833|54641239|FG004|Overall Study|Lost to Follow-up|0|||
27982993|NCT00560833|54641235|FG000|Overall Study|Lack of Efficacy|22|||
27982994|NCT00560833|54641236|FG001|Overall Study|Lack of Efficacy|9|||
27982995|NCT00560833|54641237|FG002|Overall Study|Lack of Efficacy|6|||
27982996|NCT00560833|54641238|FG003|Overall Study|Lack of Efficacy|4|||
27982997|NCT00560833|54641239|FG004|Overall Study|Lack of Efficacy|4|||
27982998|NCT00560833|54641235|FG000|Overall Study|Participant uncooperative|5|||
27982999|NCT00560833|54641236|FG001|Overall Study|Participant uncooperative|5|||
27983000|NCT00560833|54641237|FG002|Overall Study|Participant uncooperative|4|||
27983001|NCT00560833|54641238|FG003|Overall Study|Participant uncooperative|4|||
27983002|NCT00560833|54641239|FG004|Overall Study|Participant uncooperative|2|||
27983003|NCT00560833|54641235|FG000|Overall Study|Other|1|||
27983004|NCT00560833|54641236|FG001|Overall Study|Other|1|||
27983005|NCT00560833|54641237|FG002|Overall Study|Other|3|||
27983006|NCT00560833|54641238|FG003|Overall Study|Other|0|||
27983007|NCT00560833|54641239|FG004|Overall Study|Other|0|||
27983008|NCT00560833|54641235|FG000|Overall Study|Never received drug|0|||
27983009|NCT00560833|54641236|FG001|Overall Study|Never received drug|1|||
27983010|NCT00560833|54641237|FG002|Overall Study|Never received drug|0|||
27983011|NCT00560833|54641238|FG003|Overall Study|Never received drug|0|||
27983012|NCT00560833|54641239|FG004|Overall Study|Never received drug|1|||
27983013|NCT00771615|54641260|FG000|Overall Study|Withdrawal by Subject|0|||
27983014|NCT00771615|54641261|FG001|Overall Study|Withdrawal by Subject|1|||
27983015|NCT00771615|54641262|FG002|Overall Study|Withdrawal by Subject|0|||
27983016|NCT00771615|54641263|FG003|Overall Study|Withdrawal by Subject|0|||
27983017|NCT00771615|54641264|FG004|Overall Study|Withdrawal by Subject|0|||
27983018|NCT00771615|54641265|FG005|Overall Study|Withdrawal by Subject|0|||
27983019|NCT00771615|54641266|FG006|Overall Study|Withdrawal by Subject|0|||
27983020|NCT00771615|54641267|FG007|Overall Study|Withdrawal by Subject|1|||
27983021|NCT00771615|54641268|FG008|Overall Study|Withdrawal by Subject|0|||
27983022|NCT00771615|54641260|FG000|Overall Study|Lost to Follow-up|1|||
27983023|NCT00771615|54641261|FG001|Overall Study|Lost to Follow-up|1|||
27983024|NCT00771615|54641262|FG002|Overall Study|Lost to Follow-up|1|||
27983025|NCT00771615|54641263|FG003|Overall Study|Lost to Follow-up|1|||
27983026|NCT00771615|54641264|FG004|Overall Study|Lost to Follow-up|0|||
27983027|NCT00771615|54641265|FG005|Overall Study|Lost to Follow-up|1|||
27983028|NCT00771615|54641266|FG006|Overall Study|Lost to Follow-up|1|||
27983029|NCT00771615|54641267|FG007|Overall Study|Lost to Follow-up|0|||
27983030|NCT00771615|54641268|FG008|Overall Study|Lost to Follow-up|0|||
27983031|NCT02723604|54641297|FG000|Overall Study|ineligible|1|||
27983032|NCT02723604|54641297|FG000|Overall Study|never received treatment|1|||
27983033|NCT00560755|54641301|FG000|Overall Study|Protocol Violation|15|||
27983034|NCT00560755|54641301|FG000|Overall Study|Withdrawal by Subject|26|||
27983035|NCT00560755|54641301|FG000|Overall Study|Lost to Follow-up|9|||
27983036|NCT00560755|54641301|FG000|Overall Study|Adverse Event|8|||
27983037|NCT00560755|54641301|FG000|Overall Study|Physician Decision|2|||
27983038|NCT00770991|54641308|FG000|Overall Study|Physician Decision|2|||
27983039|NCT00770991|54641309|FG001|Overall Study|Physician Decision|0|||
27983040|NCT00770991|54641308|FG000|Overall Study|Withdrawal by Subject|1|||
27983041|NCT00770991|54641309|FG001|Overall Study|Withdrawal by Subject|0|||
27983042|NCT00770991|54641308|FG000|Overall Study|Adverse Event|1|||
27983043|NCT00770991|54641309|FG001|Overall Study|Adverse Event|5|||
27983044|NCT00770991|54641308|FG000|Overall Study|Pregnancy|1|||
27983045|NCT00770991|54641309|FG001|Overall Study|Pregnancy|0|||
27983046|NCT00925769|54641320|FG000|Overall Study|Major toxicity|1|||
27983047|NCT00925769|54641321|FG001|Overall Study|Major toxicity|0|||
27983048|NCT00925769|54641322|FG002|Overall Study|Major toxicity|1|||
27983049|NCT00925769|54641323|FG003|Overall Study|Major toxicity|1|||
27835658|NCT01567085|54320476|FG000|Overall Study|Terminal chronic kidney dysfunction|1|||
27835659|NCT01566773|54320480|FG000|Overall Study|Protocol specified criteria|4|||
27835660|NCT01566773|54320480|FG000|Overall Study|Protocol Violation|4|||
27835661|NCT01566773|54320480|FG000|Overall Study|Withdrawal by Subject|9|||
27835662|NCT01566773|54320480|FG000|Overall Study|Administrative reason|1|||
27835663|NCT01566773|54320480|FG000|Overall Study|Adverse Event|10|||
27835664|NCT01566773|54320480|FG000|Overall Study|Physician Decision|2|||
27835665|NCT01566149|54320502|FG000|Overall Study|Adverse Event|0|||
27835666|NCT01566149|54320503|FG001|Overall Study|Adverse Event|1|||
27835667|NCT01566149|54320502|FG000|Overall Study|Non-compliance with study medication|2|||
27835668|NCT01566149|54320503|FG001|Overall Study|Non-compliance with study medication|0|||
27877066|NCT01951638|54494893|FG004|Treatment Period|Protocol-driven decision point|0|||
27877067|NCT01951638|54494889|FG000|Treatment Period|Logistical difficulties|0|||
27877068|NCT01951638|54494890|FG001|Treatment Period|Logistical difficulties|1|||
27877069|NCT01951638|54494891|FG002|Treatment Period|Logistical difficulties|1|||
27877070|NCT01951638|54494892|FG003|Treatment Period|Logistical difficulties|0|||
27877071|NCT01951638|54494893|FG004|Treatment Period|Logistical difficulties|0|||
27877072|NCT01951638|54494889|FG000|Treatment Period|Withdrawal by Subject|9|||
27877073|NCT01951638|54494890|FG001|Treatment Period|Withdrawal by Subject|6|||
27877074|NCT01951638|54494891|FG002|Treatment Period|Withdrawal by Subject|4|||
27877075|NCT01951638|54494892|FG003|Treatment Period|Withdrawal by Subject|5|||
27877076|NCT01951638|54494893|FG004|Treatment Period|Withdrawal by Subject|4|||
27877077|NCT01951638|54494889|FG000|Treatment Period|Death|0|||
27877078|NCT01951638|54494890|FG001|Treatment Period|Death|0|||
27877079|NCT01951638|54494891|FG002|Treatment Period|Death|0|||
27877080|NCT01951638|54494892|FG003|Treatment Period|Death|3|||
27877081|NCT01951638|54494893|FG004|Treatment Period|Death|1|||
27877082|NCT01951638|54494889|FG000|Treatment Period|Adverse Event|3|||
27877083|NCT01951638|54494890|FG001|Treatment Period|Adverse Event|4|||
27877084|NCT01951638|54494891|FG002|Treatment Period|Adverse Event|8|||
27877085|NCT01951638|54494892|FG003|Treatment Period|Adverse Event|6|||
27877086|NCT01951638|54494893|FG004|Treatment Period|Adverse Event|5|||
27877087|NCT01951638|54494889|FG000|Follow-up Period|Protocol Violation|0|||
27877088|NCT01951638|54494890|FG001|Follow-up Period|Protocol Violation|0|||
27877089|NCT01951638|54494891|FG002|Follow-up Period|Protocol Violation|0|||
27877090|NCT01951638|54494892|FG003|Follow-up Period|Protocol Violation|1|||
27877091|NCT01951638|54494893|FG004|Follow-up Period|Protocol Violation|0|||
27877092|NCT01951638|54494889|FG000|Follow-up Period|Logistical difficulties|0|||
27877093|NCT01951638|54494890|FG001|Follow-up Period|Logistical difficulties|2|||
27877094|NCT01951638|54494891|FG002|Follow-up Period|Logistical difficulties|0|||
27877095|NCT01951638|54494892|FG003|Follow-up Period|Logistical difficulties|0|||
27877096|NCT01951638|54494893|FG004|Follow-up Period|Logistical difficulties|1|||
27877097|NCT01951638|54494889|FG000|Follow-up Period|Withdrawal by Subject|1|||
27877098|NCT01951638|54494890|FG001|Follow-up Period|Withdrawal by Subject|5|||
27877099|NCT01951638|54494891|FG002|Follow-up Period|Withdrawal by Subject|2|||
27877100|NCT01951638|54494892|FG003|Follow-up Period|Withdrawal by Subject|1|||
27877101|NCT01951638|54494893|FG004|Follow-up Period|Withdrawal by Subject|2|||
27877102|NCT01951638|54494889|FG000|Follow-up Period|Lost to Follow-up|0|||
27877103|NCT01951638|54494890|FG001|Follow-up Period|Lost to Follow-up|1|||
27877104|NCT01951638|54494891|FG002|Follow-up Period|Lost to Follow-up|0|||
27877105|NCT01951638|54494892|FG003|Follow-up Period|Lost to Follow-up|1|||
27877106|NCT01951638|54494893|FG004|Follow-up Period|Lost to Follow-up|0|||
27877107|NCT01951638|54494889|FG000|Follow-up Period|Death|1|||
27877108|NCT01951638|54494890|FG001|Follow-up Period|Death|0|||
27877109|NCT01951638|54494891|FG002|Follow-up Period|Death|1|||
27877110|NCT01951638|54494892|FG003|Follow-up Period|Death|4|||
27877111|NCT01951638|54494893|FG004|Follow-up Period|Death|1|||
27877112|NCT01951638|54494889|FG000|Follow-up Period|Adverse Event|0|||
27877113|NCT01951638|54494890|FG001|Follow-up Period|Adverse Event|1|||
27877114|NCT01951638|54494891|FG002|Follow-up Period|Adverse Event|2|||
27877115|NCT01951638|54494892|FG003|Follow-up Period|Adverse Event|1|||
27877116|NCT01951638|54494893|FG004|Follow-up Period|Adverse Event|1|||
27877117|NCT01928472|54494909|FG000|Overall Study|Death|0|||
27877118|NCT01928472|54494910|FG001|Overall Study|Death|0|||
27877119|NCT01928472|54494911|FG002|Overall Study|Death|1|||
27877120|NCT01928472|54494912|FG003|Overall Study|Death|0|||
27877121|NCT01928472|54494909|FG000|Overall Study|Withdrawal by Subject|4|||
27877122|NCT01928472|54494910|FG001|Overall Study|Withdrawal by Subject|4|||
27877123|NCT01928472|54494911|FG002|Overall Study|Withdrawal by Subject|1|||
27877124|NCT01928472|54494912|FG003|Overall Study|Withdrawal by Subject|2|||
27877125|NCT01928472|54494909|FG000|Overall Study|Lost to Follow-up|2|||
27877126|NCT01928472|54494910|FG001|Overall Study|Lost to Follow-up|3|||
27877127|NCT01928472|54494911|FG002|Overall Study|Lost to Follow-up|4|||
27877128|NCT01928472|54494912|FG003|Overall Study|Lost to Follow-up|0|||
27877129|NCT01928472|54494909|FG000|Overall Study|Administrative Reason|2|||
27877130|NCT01928472|54494910|FG001|Overall Study|Administrative Reason|1|||
27877131|NCT01928472|54494911|FG002|Overall Study|Administrative Reason|0|||
27877132|NCT01928472|54494912|FG003|Overall Study|Administrative Reason|0|||
27877133|NCT01928472|54494909|FG000|Overall Study|Unclassified|0|||
27877134|NCT01928472|54494910|FG001|Overall Study|Unclassified|0|||
27877135|NCT01928472|54494911|FG002|Overall Study|Unclassified|1|||
27877136|NCT01928472|54494912|FG003|Overall Study|Unclassified|0|||
27877137|NCT01351415|54496773|FG000|Overall Study|Withdrawal by Subject|15|||
27877138|NCT01351415|54496774|FG001|Overall Study|Withdrawal by Subject|17|||
27877139|NCT01351415|54496773|FG000|Overall Study|Trial termination by the Sponsor|28|||
27877140|NCT01351415|54496774|FG001|Overall Study|Trial termination by the Sponsor|19|||
27877141|NCT01351415|54496773|FG000|Overall Study|Lost to Follow-up|5|||
27877142|NCT01351415|54496774|FG001|Overall Study|Lost to Follow-up|7|||
27877143|NCT01351415|54496773|FG000|Overall Study|Death|190|||
27877144|NCT01351415|54496774|FG001|Overall Study|Death|187|||
27983050|NCT00925769|54641324|FG004|Overall Study|Major toxicity|0|||
27983051|NCT00925769|54641325|FG005|Overall Study|Major toxicity|0|||
27983052|NCT00925769|54641320|FG000|Overall Study|Disease progression|4|||
27983053|NCT00925769|54641321|FG001|Overall Study|Disease progression|5|||
27983054|NCT00925769|54641322|FG002|Overall Study|Disease progression|3|||
27983055|NCT00925769|54641323|FG003|Overall Study|Disease progression|4|||
27983056|NCT00925769|54641324|FG004|Overall Study|Disease progression|2|||
27983057|NCT00925769|54641325|FG005|Overall Study|Disease progression|3|||
27835669|NCT01566149|54320502|FG000|Overall Study|Protocol Violation|0|||
27835670|NCT01566149|54320503|FG001|Overall Study|Protocol Violation|1|||
27835671|NCT01566149|54320502|FG000|Overall Study|Withdrawal by Subject|1|||
27835672|NCT01566149|54320503|FG001|Overall Study|Withdrawal by Subject|0|||
27983058|NCT00925769|54641320|FG000|Overall Study|Death|0|||
27983059|NCT00925769|54641321|FG001|Overall Study|Death|0|||
27983060|NCT00925769|54641322|FG002|Overall Study|Death|1|||
27983061|NCT00925769|54641323|FG003|Overall Study|Death|0|||
27983062|NCT00925769|54641324|FG004|Overall Study|Death|0|||
27983063|NCT00925769|54641325|FG005|Overall Study|Death|0|||
27983064|NCT00925769|54641320|FG000|Overall Study|Physician Decision|1|||
27983065|NCT00925769|54641321|FG001|Overall Study|Physician Decision|0|||
27983066|NCT00925769|54641322|FG002|Overall Study|Physician Decision|0|||
27983067|NCT00925769|54641323|FG003|Overall Study|Physician Decision|0|||
27983068|NCT00925769|54641324|FG004|Overall Study|Physician Decision|0|||
27983069|NCT00925769|54641325|FG005|Overall Study|Physician Decision|0|||
27983070|NCT00925769|54641320|FG000|Overall Study|Missing documentation|0|||
27983071|NCT00925769|54641321|FG001|Overall Study|Missing documentation|1|||
27983072|NCT00925769|54641322|FG002|Overall Study|Missing documentation|0|||
27983073|NCT00925769|54641323|FG003|Overall Study|Missing documentation|0|||
27983074|NCT00925769|54641324|FG004|Overall Study|Missing documentation|0|||
27983075|NCT00925769|54641325|FG005|Overall Study|Missing documentation|0|||
27983076|NCT00925769|54641320|FG000|Overall Study|End of study visit not done|0|||
27983077|NCT00925769|54641321|FG001|Overall Study|End of study visit not done|0|||
27983078|NCT00925769|54641322|FG002|Overall Study|End of study visit not done|1|||
27983079|NCT00925769|54641323|FG003|Overall Study|End of study visit not done|0|||
27983080|NCT00925769|54641324|FG004|Overall Study|End of study visit not done|0|||
27983081|NCT00925769|54641325|FG005|Overall Study|End of study visit not done|0|||
27983082|NCT00925769|54641320|FG000|Overall Study|Participant is unable to swallow drug|0|||
27983083|NCT00925769|54641321|FG001|Overall Study|Participant is unable to swallow drug|0|||
27983084|NCT00925769|54641322|FG002|Overall Study|Participant is unable to swallow drug|0|||
27983085|NCT00925769|54641323|FG003|Overall Study|Participant is unable to swallow drug|1|||
27983086|NCT00925769|54641324|FG004|Overall Study|Participant is unable to swallow drug|0|||
27983087|NCT00925769|54641325|FG005|Overall Study|Participant is unable to swallow drug|0|||
27983088|NCT00925769|54641320|FG000|Overall Study|Adverse Event|0|||
27983089|NCT00925769|54641321|FG001|Overall Study|Adverse Event|0|||
27983090|NCT00925769|54641322|FG002|Overall Study|Adverse Event|0|||
27983091|NCT00925769|54641323|FG003|Overall Study|Adverse Event|0|||
27983092|NCT00925769|54641324|FG004|Overall Study|Adverse Event|1|||
27983093|NCT00925769|54641325|FG005|Overall Study|Adverse Event|0|||
27983094|NCT00770913|54641344|FG000|Overall Study|Adverse Event|1|||
27983095|NCT00770913|54641345|FG001|Overall Study|Adverse Event|3|||
27983096|NCT00770913|54641346|FG002|Overall Study|Adverse Event|6|||
27983097|NCT00770913|54641344|FG000|Overall Study|Refusal to continue participation|6|||
27983098|NCT00770913|54641345|FG001|Overall Study|Refusal to continue participation|4|||
27983099|NCT00770913|54641346|FG002|Overall Study|Refusal to continue participation|5|||
27983100|NCT00770913|54641344|FG000|Overall Study|Physician Decision|0|||
27983101|NCT00770913|54641345|FG001|Overall Study|Physician Decision|1|||
27983102|NCT00770913|54641346|FG002|Overall Study|Physician Decision|1|||
27983103|NCT00770913|54641344|FG000|Overall Study|Protocol Violation|3|||
27983104|NCT00770913|54641345|FG001|Overall Study|Protocol Violation|0|||
27983105|NCT00770913|54641346|FG002|Overall Study|Protocol Violation|1|||
27983106|NCT00770913|54641344|FG000|Overall Study|Incorrect drug was allocated|1|||
27983107|NCT00770913|54641345|FG001|Overall Study|Incorrect drug was allocated|0|||
27983108|NCT00770913|54641346|FG002|Overall Study|Incorrect drug was allocated|0|||
27983109|NCT00562861|54641356|FG000|Overall Study|Adverse Event|1|||
27983110|NCT00562861|54641357|FG001|Overall Study|Adverse Event|1|||
27983111|NCT00562861|54641356|FG000|Overall Study|Lack of Efficacy|5|||
27983112|NCT00562861|54641357|FG001|Overall Study|Lack of Efficacy|5|||
27983113|NCT00562861|54641356|FG000|Overall Study|noncompliance, moved|7|||
27983114|NCT00562861|54641357|FG001|Overall Study|noncompliance, moved|2|||
27835673|NCT01565993|54320511|FG000|Overall Study|Physician Decision|0|||
27835674|NCT01565993|54320512|FG001|Overall Study|Physician Decision|3|||
27835675|NCT01565291|54320520|FG000|Overall Study|Withdrawal by Subject|1|||
27835676|NCT01565291|54320521|FG001|Overall Study|Withdrawal by Subject|0|||
27835677|NCT02691702|54320538|FG000|Overall Study|Adverse Event|1|||
27835678|NCT02691702|54320539|FG001|Overall Study|Adverse Event|0|||
27835679|NCT02691702|54320540|FG002|Overall Study|Adverse Event|0|||
27835680|NCT02691702|54320541|FG003|Overall Study|Adverse Event|0|||
27835681|NCT02691702|54320542|FG004|Overall Study|Adverse Event|0|||
27877145|NCT01351415|54496773|FG000|Overall Study|Physician Decision|2|||
27983115|NCT00562861|54641356|FG000|Overall Study|Lost to Follow-up|7|||
27983116|NCT00562861|54641357|FG001|Overall Study|Lost to Follow-up|3|||
27983117|NCT00770679|54641363|FG000|Overall Study|Lost to Follow-up|3|||
27983118|NCT00770679|54641363|FG000|Overall Study|Follow-up LDL measurement not collected|3|||
27983119|NCT00770601|54641367|FG000|Overall Study|Withdrawal by Subject|1|||
27983120|NCT00770367|54641373|FG000|First Intervention|Withdrawal by Subject|0|||
27983121|NCT00770367|54641374|FG001|First Intervention|Withdrawal by Subject|2|||
27983122|NCT00770367|54641373|FG000|Washout Period of 4 Weeks|Withdrawal by Subject|0|||
27983123|NCT00770367|54641374|FG001|Washout Period of 4 Weeks|Withdrawal by Subject|1|||
27983124|NCT00770367|54641373|FG000|Second Intervention|Lost to Follow-up|2|||
27983125|NCT00770367|54641374|FG001|Second Intervention|Lost to Follow-up|0|||
27983126|NCT00931307|54641382|FG000|Overall Study|Lack of Efficacy|12|||
27983127|NCT00931307|54641382|FG000|Overall Study|Biomicroscopy|1|||
27983128|NCT00930761|54641388|FG000|Overall Study|3 newborns died; 1 mother quit the study|4|||
27983129|NCT00930761|54641389|FG001|Overall Study|3 newborns died; 1 mother quit the study|0|||
27983130|NCT00930761|54641388|FG000|Overall Study|less than 3 music therapy sessions|0|||
27983131|NCT00930761|54641389|FG001|Overall Study|less than 3 music therapy sessions|3|||
27983132|NCT00770289|54641395|FG000|Overall Study|Other|6|||
27983133|NCT00556933|54641408|FG000|Single vs. Divided-dose rATG Induction|Protocol Violation|2|||
27983134|NCT00556933|54641409|FG001|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
27983135|NCT00556933|54641410|FG002|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
27983136|NCT00556933|54641411|FG003|Single vs. Divided-dose rATG Induction|Protocol Violation|0|||
27983137|NCT00556933|54641408|FG000|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
27983138|NCT00556933|54641409|FG001|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
27983139|NCT00556933|54641410|FG002|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1|||
27983140|NCT00556933|54641411|FG003|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
27983141|NCT00556933|54641408|FG000|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0|||
27983142|NCT00556933|54641409|FG001|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
27983143|NCT00556933|54641410|FG002|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
27983144|NCT00556933|54641411|FG003|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
27983145|NCT00556933|54641408|FG000|Single vs. Divided-dose rATG Induction|Death|0|||
27983146|NCT00556933|54641409|FG001|Single vs. Divided-dose rATG Induction|Death|1|||
27983147|NCT00556933|54641410|FG002|Single vs. Divided-dose rATG Induction|Death|0|||
27983148|NCT00556933|54641411|FG003|Single vs. Divided-dose rATG Induction|Death|0|||
27983149|NCT00556933|54641408|FG000|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
27983150|NCT00556933|54641409|FG001|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1|||
27983151|NCT00556933|54641410|FG002|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
27983152|NCT00556933|54641411|FG003|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
27983153|NCT00556933|54641408|FG000|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
27983154|NCT00556933|54641409|FG001|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1|||
27983155|NCT00556933|54641410|FG002|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
27983156|NCT00556933|54641411|FG003|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
27983157|NCT00556933|54641408|FG000|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
27983158|NCT00556933|54641409|FG001|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
27983159|NCT00556933|54641410|FG002|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
27983160|NCT00556933|54641411|FG003|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
27739267|NCT03318523|54188607|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
27739268|NCT03318523|54188608|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
27877146|NCT01351415|54496774|FG001|Overall Study|Physician Decision|3|||
27877147|NCT01351415|54496773|FG000|Overall Study|Reason unknown|0|||
27877148|NCT01351415|54496774|FG001|Overall Study|Reason unknown|2|||
27877149|NCT01351415|54496773|FG000|Overall Study|Never Started|5|||
27877150|NCT01351415|54496774|FG001|Overall Study|Never Started|5|||
27877151|NCT04811339|54496882|FG000|Overall Study|lack of transportation not wanting to return|4|||
27877152|NCT04811339|54496883|FG001|Overall Study|lack of transportation not wanting to return|8|||
27877153|NCT04811339|54496884|FG002|Overall Study|lack of transportation not wanting to return|0|||
27877154|NCT04811339|54496882|FG000|Overall Study|Adverse Event|3|||
27983161|NCT00556933|54641408|FG000|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
27983162|NCT00556933|54641409|FG001|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
27983163|NCT00556933|54641410|FG002|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
27983164|NCT00556933|54641411|FG003|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
27983165|NCT00556933|54641408|FG000|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
27877155|NCT04811339|54496883|FG001|Overall Study|Adverse Event|0|||
27877156|NCT04811339|54496884|FG002|Overall Study|Adverse Event|0|||
27983166|NCT00556933|54641409|FG001|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
27983167|NCT00556933|54641410|FG002|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
27739269|NCT03318523|54188609|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
27877157|NCT04811339|54496882|FG000|Overall Study|Lost to Follow-up|1|||
27877158|NCT04811339|54496883|FG001|Overall Study|Lost to Follow-up|0|||
27877159|NCT04811339|54496884|FG002|Overall Study|Lost to Follow-up|0|||
27877160|NCT04811339|54496882|FG000|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|1|||
27877161|NCT04811339|54496883|FG001|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
27877162|NCT04811339|54496884|FG002|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
27877163|NCT04811339|54496882|FG000|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
27877164|NCT04811339|54496883|FG001|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|6|||
27877165|NCT04811339|54496884|FG002|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
27877166|NCT04811339|54496882|FG000|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
27877167|NCT04811339|54496883|FG001|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|4|||
27877168|NCT04811339|54496884|FG002|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
27877169|NCT04811339|54496882|FG000|Overall Study|Withdrawal by Subject|0|||
27877170|NCT04811339|54496883|FG001|Overall Study|Withdrawal by Subject|3|||
27877171|NCT04811339|54496884|FG002|Overall Study|Withdrawal by Subject|0|||
27877172|NCT04811339|54496882|FG000|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
27877173|NCT04811339|54496883|FG001|Overall Study|Transferred to ICU for non-COVID-19 related problem|1|||
27877174|NCT04811339|54496884|FG002|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
27877175|NCT04811339|54496882|FG000|Overall Study|Early on Nurse/Physician communication issue|0|||
27877176|NCT04811339|54496883|FG001|Overall Study|Early on Nurse/Physician communication issue|3|||
27877177|NCT04811339|54496884|FG002|Overall Study|Early on Nurse/Physician communication issue|0|||
27877178|NCT04652453|54496897|FG000|Overall Study|Death|8|||
27877179|NCT04652453|54496898|FG001|Overall Study|Death|2|||
27877180|NCT04652453|54496899|FG002|Overall Study|Death|0|||
27877181|NCT04652453|54496897|FG000|Overall Study|Hospice|5|||
27877182|NCT04652453|54496898|FG001|Overall Study|Hospice|5|||
27877183|NCT04652453|54496899|FG002|Overall Study|Hospice|0|||
27877184|NCT04652453|54496897|FG000|Overall Study|Withdrawal by Subject|2|||
27877185|NCT04652453|54496898|FG001|Overall Study|Withdrawal by Subject|0|||
27877186|NCT04652453|54496899|FG002|Overall Study|Withdrawal by Subject|0|||
27877187|NCT04332107|54496907|FG000|Day 3|Lost to Follow-up|23|||
27877188|NCT04332107|54496908|FG001|Day 3|Lost to Follow-up|14|||
27877189|NCT04332107|54496907|FG000|Day 3|Missing outcome data|3|||
27877190|NCT04332107|54496908|FG001|Day 3|Missing outcome data|6|||
27877191|NCT04332107|54496907|FG000|Day 14|Lost to Follow-up|13|||
27877192|NCT04332107|54496908|FG001|Day 14|Lost to Follow-up|4|||
27877193|NCT04332107|54496907|FG000|Day 14|Missing outcome data|4|||
27877194|NCT04332107|54496908|FG001|Day 14|Missing outcome data|4|||
27877195|NCT04332107|54496907|FG000|Day 21|Lost to Follow-up|10|||
27877196|NCT04332107|54496908|FG001|Day 21|Lost to Follow-up|2|||
27877197|NCT03375203|54496923|FG000|Overall Study|Protocol Violation|0|||
27877198|NCT03375203|54496924|FG001|Overall Study|Protocol Violation|0|||
27877199|NCT03375203|54496925|FG002|Overall Study|Protocol Violation|1|||
27877200|NCT03375203|54496926|FG003|Overall Study|Protocol Violation|0|||
27877201|NCT03375203|54496927|FG004|Overall Study|Protocol Violation|0|||
27877202|NCT03375203|54496923|FG000|Overall Study|Adverse Event|2|||
27877203|NCT03375203|54496924|FG001|Overall Study|Adverse Event|3|||
27877204|NCT03375203|54496925|FG002|Overall Study|Adverse Event|0|||
27877205|NCT03375203|54496926|FG003|Overall Study|Adverse Event|2|||
27877206|NCT03375203|54496927|FG004|Overall Study|Adverse Event|2|||
27877207|NCT03375203|54496923|FG000|Overall Study|Withdrawal by Subject|3|||
27877208|NCT03375203|54496924|FG001|Overall Study|Withdrawal by Subject|0|||
27877209|NCT03375203|54496925|FG002|Overall Study|Withdrawal by Subject|1|||
27877210|NCT03375203|54496926|FG003|Overall Study|Withdrawal by Subject|0|||
27877211|NCT03375203|54496927|FG004|Overall Study|Withdrawal by Subject|2|||
27877212|NCT03375203|54496923|FG000|Overall Study|Non-compliance with study drug|1|||
27877213|NCT03375203|54496924|FG001|Overall Study|Non-compliance with study drug|0|||
27877214|NCT03375203|54496925|FG002|Overall Study|Non-compliance with study drug|0|||
27877215|NCT03375203|54496926|FG003|Overall Study|Non-compliance with study drug|0|||
27877216|NCT03375203|54496927|FG004|Overall Study|Non-compliance with study drug|0|||
27877217|NCT03375203|54496923|FG000|Overall Study|Randomized, not treated.|0|||
27877218|NCT03375203|54496924|FG001|Overall Study|Randomized, not treated.|1|||
27877219|NCT03375203|54496925|FG002|Overall Study|Randomized, not treated.|0|||
27877220|NCT03375203|54496926|FG003|Overall Study|Randomized, not treated.|0|||
27877221|NCT03375203|54496927|FG004|Overall Study|Randomized, not treated.|0|||
27877222|NCT03075839|54496949|FG000|Overall Study|Lost to Follow-up|4|||
27877223|NCT02919683|54496955|FG000|Post-Surgery Follow-Up|Death|2|||
27877224|NCT02919683|54496956|FG001|Post-Surgery Follow-Up|Death|2|||
27877225|NCT02919683|54496955|FG000|Post-Surgery Follow-Up|Patient is still completing follow-ups|1|||
27877226|NCT02919683|54496956|FG001|Post-Surgery Follow-Up|Patient is still completing follow-ups|0|||
27877227|NCT01928082|54496963|FG000|Overall Study|Study terminated.|1|||
27877228|NCT01972776|54496973|FG000|Part 1|Withdrawal by Subject|0|||
27877229|NCT01972776|54496974|FG001|Part 1|Withdrawal by Subject|0|||
27877230|NCT01972776|54496975|FG002|Part 1|Withdrawal by Subject|1|||
27877231|NCT01972776|54496976|FG003|Part 1|Withdrawal by Subject|0|||
27877232|NCT01972776|54496977|FG004|Part 1|Withdrawal by Subject|0|||
27877233|NCT01972776|54496978|FG005|Part 1|Withdrawal by Subject|0|||
27877234|NCT01972776|54496973|FG000|Part 1|Adverse Event|0|||
27877235|NCT01972776|54496974|FG001|Part 1|Adverse Event|0|||
27877236|NCT01972776|54496975|FG002|Part 1|Adverse Event|1|||
27877237|NCT01972776|54496976|FG003|Part 1|Adverse Event|1|||
27877238|NCT01972776|54496977|FG004|Part 1|Adverse Event|0|||
27877239|NCT01972776|54496978|FG005|Part 1|Adverse Event|0|||
27877240|NCT01972776|54496973|FG000|Part 2|Adverse Event|0|||
27877241|NCT01972776|54496974|FG001|Part 2|Adverse Event|0|||
27877242|NCT01972776|54496975|FG002|Part 2|Adverse Event|0|||
27877243|NCT01972776|54496976|FG003|Part 2|Adverse Event|0|||
27877244|NCT01972776|54496977|FG004|Part 2|Adverse Event|3|||
27877245|NCT01972776|54496978|FG005|Part 2|Adverse Event|0|||
27877246|NCT01972776|54496973|FG000|Part 2|Administrative problems|0|||
27877247|NCT01972776|54496974|FG001|Part 2|Administrative problems|0|||
27877248|NCT01972776|54496975|FG002|Part 2|Administrative problems|0|||
27877249|NCT01972776|54496976|FG003|Part 2|Administrative problems|0|||
27877250|NCT01972776|54496977|FG004|Part 2|Administrative problems|10|||
27877251|NCT01972776|54496978|FG005|Part 2|Administrative problems|7|||
27877252|NCT03763331|54496994|FG000|Overall Study|Lost to Follow-up|1|||
27877253|NCT03763331|54496995|FG001|Overall Study|Lost to Follow-up|0|||
27877254|NCT03763331|54496994|FG000|Overall Study|Withdrawal by Subject|1|||
27877255|NCT03763331|54496995|FG001|Overall Study|Withdrawal by Subject|0|||
27877256|NCT03763331|54496994|FG000|Overall Study|Non-compliance|0|||
27877257|NCT03763331|54496995|FG001|Overall Study|Non-compliance|3|||
27877258|NCT00001259|54497022|FG000|Study 2|Adverse Event|0|||
27877259|NCT00001259|54497023|FG001|Study 2|Adverse Event|0|||
27877260|NCT00001259|54497024|FG002|Study 2|Adverse Event|0|||
27877261|NCT00001259|54497025|FG003|Study 2|Adverse Event|0|||
27877262|NCT00001259|54497026|FG004|Study 2|Adverse Event|2|||
27877263|NCT00001259|54497027|FG005|Study 2|Adverse Event|0|||
27877264|NCT00001259|54497028|FG006|Study 2|Adverse Event|0|||
27877265|NCT01926444|54497042|FG000|Overall Study|Colonoscopy not performed|0|||
27877266|NCT01926444|54497043|FG001|Overall Study|Colonoscopy not performed|0|||
27877267|NCT01926444|54497044|FG002|Overall Study|Colonoscopy not performed|4|||
27877268|NCT01926444|54497045|FG003|Overall Study|Colonoscopy not performed|2|||
27877269|NCT05003167|54497055|FG000|Overall Study|Withdrawal by Subject|1|||
27877270|NCT04988035|54497061|FG000|Overall Study|Death|19|||
27877271|NCT04988035|54497062|FG001|Overall Study|Death|13|||
27877272|NCT04988035|54497061|FG000|Overall Study|Lost to Follow-up|12|||
27877273|NCT04988035|54497062|FG001|Overall Study|Lost to Follow-up|6|||
27877274|NCT04988035|54497061|FG000|Overall Study|Protocol Violation|0|||
27877275|NCT04988035|54497062|FG001|Overall Study|Protocol Violation|1|||
27877276|NCT04988035|54497061|FG000|Overall Study|Withdrawal by Subject|2|||
27877277|NCT04988035|54497062|FG001|Overall Study|Withdrawal by Subject|4|||
27877278|NCT04988035|54497061|FG000|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
27877279|NCT04988035|54497062|FG001|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
27877280|NCT04847674|54497080|FG000|Overall Study|Withdrawal by Subject|0|||
27877281|NCT04847674|54497081|FG001|Overall Study|Withdrawal by Subject|1|||
27877282|NCT04847674|54497082|FG002|Overall Study|Withdrawal by Subject|0|||
27877283|NCT04847674|54497080|FG000|Overall Study|Lost to Follow-up|0|||
27877284|NCT04847674|54497081|FG001|Overall Study|Lost to Follow-up|0|||
27877285|NCT04847674|54497082|FG002|Overall Study|Lost to Follow-up|2|||
27877286|NCT04847674|54497080|FG000|Overall Study|Other than specified|21|||
27877287|NCT04847674|54497081|FG001|Overall Study|Other than specified|20|||
27877288|NCT04847674|54497082|FG002|Overall Study|Other than specified|20|||
27877289|NCT04649060|54497094|FG000|Arm A/Arm B Treatment|Adverse Event|0|||
27877290|NCT04649060|54497095|FG001|Arm A/Arm B Treatment|Adverse Event|3|||
27877291|NCT04649060|54497094|FG000|Arm A/Arm B Treatment|Physician Decision|1|||
27877292|NCT04649060|54497095|FG001|Arm A/Arm B Treatment|Physician Decision|1|||
27877293|NCT04649060|54497094|FG000|Arm A/Arm B Treatment|Progressive Disease|3|||
28096472|NCT04410198|54751448|FG000|Overall Study|Death|10|||
27877294|NCT04649060|54497095|FG001|Arm A/Arm B Treatment|Progressive Disease|12|||
27877295|NCT04649060|54497094|FG000|Arm A/Arm B Treatment|Study Terminated by Sponsor|17|||
27877296|NCT04649060|54497095|FG001|Arm A/Arm B Treatment|Study Terminated by Sponsor|10|||
27877297|NCT04649060|54497094|FG000|Arm A/Arm B Treatment|Patient Request|1|||
27877298|NCT04649060|54497095|FG001|Arm A/Arm B Treatment|Patient Request|0|||
27877299|NCT04649060|54497094|FG000|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|4|||
27877300|NCT04649060|54497095|FG001|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|1|||
27877301|NCT04649060|54497094|FG000|Arm A/Arm B Treatment|Other|1|||
28096473|NCT04410198|54751448|FG000|Overall Study|Withdrawal by Subject|7|||
27877302|NCT04649060|54497095|FG001|Arm A/Arm B Treatment|Other|0|||
27877303|NCT04649060|54497094|FG000|Crossover (Arm B)|Adverse Event|0|||
27877304|NCT04649060|54497095|FG001|Crossover (Arm B)|Adverse Event|1|||
27877305|NCT04649060|54497094|FG000|Crossover (Arm B)|Lost to Follow-up|0|||
27925690|NCT01020448|54582219|FG000|Treatment|Consent Withdrawn|3|||
27877306|NCT04649060|54497095|FG001|Crossover (Arm B)|Lost to Follow-up|1|||
27877307|NCT04640272|54497102|FG000|Overall Study|Subject moved out of area|1|||
27877308|NCT04511650|54497109|FG000|Overall Study|Lost to Follow-up|1|||
27877309|NCT04511650|54497110|FG001|Overall Study|Lost to Follow-up|0|||
27877310|NCT04511650|54497111|FG002|Overall Study|Lost to Follow-up|0|||
27877311|NCT04511650|54497109|FG000|Overall Study|Withdrawal by Subject|1|||
27877312|NCT04511650|54497110|FG001|Overall Study|Withdrawal by Subject|0|||
27877313|NCT04511650|54497111|FG002|Overall Study|Withdrawal by Subject|0|||
27877314|NCT04511650|54497109|FG000|Overall Study|reason not provided|0|||
27877315|NCT04511650|54497110|FG001|Overall Study|reason not provided|0|||
27877316|NCT04511650|54497111|FG002|Overall Study|reason not provided|1|||
27877317|NCT04511650|54497109|FG000|Overall Study|Death|1|||
27877318|NCT04511650|54497110|FG001|Overall Study|Death|1|||
27877319|NCT04511650|54497111|FG002|Overall Study|Death|1|||
27877320|NCT04285580|54497143|FG000|Overall Study|Protocol Violation|0|||
27877321|NCT04285580|54497144|FG001|Overall Study|Protocol Violation|1|||
27877322|NCT04200248|54497162|FG000|Overall Study|Personal reasons|0|||
27877323|NCT04200248|54497163|FG001|Overall Study|Personal reasons|0|||
27877324|NCT04200248|54497164|FG002|Overall Study|Personal reasons|1|||
27877325|NCT04200248|54497162|FG000|Overall Study|Discontinued prior to treatment|3|||
27877326|NCT04200248|54497163|FG001|Overall Study|Discontinued prior to treatment|3|||
27877327|NCT04200248|54497164|FG002|Overall Study|Discontinued prior to treatment|2|||
27877328|NCT04137887|54497174|FG000|Overall Study|Death|102|||
27877329|NCT04137887|54497175|FG001|Overall Study|Death|92|||
27877330|NCT04137887|54497174|FG000|Overall Study|Withdrawal by Subject|2|||
27877331|NCT04137887|54497175|FG001|Overall Study|Withdrawal by Subject|3|||
27877332|NCT04137887|54497174|FG000|Overall Study|Randomized but not treated|0|||
27877333|NCT04137887|54497175|FG001|Overall Study|Randomized but not treated|1|||
27877334|NCT03726879|54497194|FG000|Overall Study|Death|6|||
27877335|NCT03726879|54497195|FG001|Overall Study|Death|4|||
27877336|NCT03726879|54497194|FG000|Overall Study|Physician Decision|0|||
27877337|NCT03726879|54497195|FG001|Overall Study|Physician Decision|2|||
27877338|NCT03726879|54497194|FG000|Overall Study|Protocol Violation|0|||
27877339|NCT03726879|54497195|FG001|Overall Study|Protocol Violation|1|||
27877340|NCT03726879|54497194|FG000|Overall Study|Withdrawal by Subject|5|||
27877341|NCT03726879|54497195|FG001|Overall Study|Withdrawal by Subject|5|||
27877342|NCT03726879|54497194|FG000|Overall Study|TSH result is unstable|0|||
27877343|NCT03726879|54497195|FG001|Overall Study|TSH result is unstable|1|||
27877344|NCT03726879|54497194|FG000|Overall Study|Continuing on Study|215|||
27877345|NCT03726879|54497195|FG001|Overall Study|Continuing on Study|215|||
27877346|NCT03557008|54497220|FG000|Overall Study|Withdrawal by Subject|2|||
27877347|NCT03557008|54497221|FG001|Overall Study|Withdrawal by Subject|2|||
27877348|NCT03557008|54497220|FG000|Overall Study|Early termination from study|3|||
27877349|NCT03557008|54497221|FG001|Overall Study|Early termination from study|1|||
27877350|NCT03040999|54497229|FG000|Overall Study|Lost to Follow-up|1|||
27877351|NCT03040999|54497230|FG001|Overall Study|Lost to Follow-up|0|||
27877352|NCT03040999|54497229|FG000|Overall Study|Withdrawal by Subject|7|||
27877353|NCT03040999|54497230|FG001|Overall Study|Withdrawal by Subject|12|||
27877354|NCT03040999|54497229|FG000|Overall Study|Death|128|||
27877355|NCT03040999|54497230|FG001|Overall Study|Death|138|||
27877356|NCT03040999|54497229|FG000|Overall Study|Participants Ongoing in Trial|266|||
27877357|NCT03040999|54497230|FG001|Overall Study|Participants Ongoing in Trial|252|||
27877358|NCT02990338|54497238|FG000|Overall Study|Ongoing|30|||
27877359|NCT02990338|54497239|FG001|Overall Study|Ongoing|36|||
27877360|NCT02366728|54497255|FG000|Overall Study|Death|0|||
27877361|NCT02366728|54497256|FG001|Overall Study|Death|0|||
27877362|NCT02366728|54497257|FG002|Overall Study|Death|1|||
27877363|NCT02366728|54497255|FG000|Overall Study|Adverse Event|1|||
27877364|NCT02366728|54497256|FG001|Overall Study|Adverse Event|0|||
27877365|NCT02366728|54497257|FG002|Overall Study|Adverse Event|0|||
27877366|NCT02366728|54497255|FG000|Overall Study|Screen Failure|2|||
27877367|NCT02366728|54497256|FG001|Overall Study|Screen Failure|1|||
27877368|NCT02366728|54497257|FG002|Overall Study|Screen Failure|0|||
27877369|NCT02366728|54497255|FG000|Overall Study|Only yielded 2 vaccines|1|||
27877370|NCT02366728|54497256|FG001|Overall Study|Only yielded 2 vaccines|0|||
28171643|NCT03350815|54843238|FG001|Period 2|Adverse Event|3|||
27877371|NCT02366728|54497257|FG002|Overall Study|Only yielded 2 vaccines|0|||
27877372|NCT02355002|54497267|FG000|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|1|||
27877373|NCT02355002|54497268|FG001|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|0|||
27877374|NCT02355002|54497267|FG000|Period 1: Phase 1, Randomized-Controlled|Adverse Event|1|||
27877375|NCT02355002|54497268|FG001|Period 1: Phase 1, Randomized-Controlled|Adverse Event|0|||
27877376|NCT02355002|54497267|FG000|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
27877377|NCT02355002|54497268|FG001|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
27877378|NCT02355002|54497267|FG000|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|0|||
27877379|NCT02355002|54497268|FG001|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|1|||
27877380|NCT02355002|54497267|FG000|Period 2: Phase 2 Open-Label|Withdrawal by Subject|2|||
27877381|NCT02355002|54497268|FG001|Period 2: Phase 2 Open-Label|Withdrawal by Subject|0|||
27877382|NCT02355002|54497267|FG000|Period 2: Phase 2 Open-Label|Participant left country|1|||
27877383|NCT02355002|54497268|FG001|Period 2: Phase 2 Open-Label|Participant left country|0|||
27877384|NCT02355002|54497267|FG000|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
27877385|NCT02355002|54497268|FG001|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
27877386|NCT02246920|54497278|FG000|Overall Study|Adverse Event|3|||
27877387|NCT02246920|54497279|FG001|Overall Study|Adverse Event|1|||
27877388|NCT02246920|54497280|FG002|Overall Study|Adverse Event|1|||
27877389|NCT02246920|54497278|FG000|Overall Study|Lost to Follow-up|2|||
27877390|NCT02246920|54497279|FG001|Overall Study|Lost to Follow-up|1|||
27877391|NCT02246920|54497280|FG002|Overall Study|Lost to Follow-up|0|||
27877392|NCT02246920|54497278|FG000|Overall Study|Protocol Violation|2|||
27877393|NCT02246920|54497279|FG001|Overall Study|Protocol Violation|5|||
27877394|NCT02246920|54497280|FG002|Overall Study|Protocol Violation|1|||
27877395|NCT02246920|54497278|FG000|Overall Study|Withdrawal by Subject|0|||
27877396|NCT02246920|54497279|FG001|Overall Study|Withdrawal by Subject|0|||
27877397|NCT02246920|54497280|FG002|Overall Study|Withdrawal by Subject|1|||
27877398|NCT01832402|54497290|FG000|Overall Study|Lost to Follow-up|2|||
27877399|NCT01832402|54497291|FG001|Overall Study|Lost to Follow-up|0|||
27877400|NCT01832402|54497290|FG000|Overall Study|Withdrawal by Subject|3|||
27877401|NCT01832402|54497291|FG001|Overall Study|Withdrawal by Subject|3|||
27877402|NCT01832402|54497290|FG000|Overall Study|Declining Performance status|2|||
27877403|NCT01832402|54497291|FG001|Overall Study|Declining Performance status|1|||
27877404|NCT01661881|54497301|FG000|Overall Study|Disease Progression|1|||
27877405|NCT00667628|54497311|FG000|Overall Study|Lost to Follow-up|1|||
27877406|NCT00667628|54497312|FG001|Overall Study|Lost to Follow-up|0|||
27877407|NCT00667628|54497311|FG000|Overall Study|Death|6|||
27877408|NCT00667628|54497312|FG001|Overall Study|Death|6|||
27877409|NCT00667628|54497311|FG000|Overall Study|Investigator Considers in Best Interest|1|||
27877410|NCT00667628|54497312|FG001|Overall Study|Investigator Considers in Best Interest|0|||
27877411|NCT00667628|54497311|FG000|Overall Study|Sponsor Terminated Study|17|||
27877412|NCT00667628|54497312|FG001|Overall Study|Sponsor Terminated Study|21|||
27877413|NCT00321555|54497318|FG000|Overall Study|Developed antibodies|1|||
27877414|NCT00321555|54497318|FG000|Overall Study|Switched to alternative treatment|3|||
27877415|NCT00321555|54497318|FG000|Overall Study|Physician Decision|1|||
27877416|NCT00321555|54497318|FG000|Overall Study|Disease progression on study|1|||
27877417|NCT01597908|54497328|FG000|Randomized Phase|Death|217|||
27877418|NCT01597908|54497329|FG001|Randomized Phase|Death|238|||
27877419|NCT01597908|54497330|FG002|Randomized Phase|Death|0|||
27877420|NCT01597908|54497328|FG000|Randomized Phase|Sponsor Decision|93|||
27877421|NCT01597908|54497329|FG001|Randomized Phase|Sponsor Decision|39|||
27877422|NCT01597908|54497330|FG002|Randomized Phase|Sponsor Decision|0|||
27877423|NCT01597908|54497328|FG000|Randomized Phase|Lost to Follow-up|9|||
27877424|NCT01597908|54497329|FG001|Randomized Phase|Lost to Follow-up|16|||
27877425|NCT01597908|54497330|FG002|Randomized Phase|Lost to Follow-up|0|||
27877426|NCT01597908|54497328|FG000|Randomized Phase|Physician Decision|6|||
27877427|NCT01597908|54497329|FG001|Randomized Phase|Physician Decision|3|||
27877428|NCT01597908|54497330|FG002|Randomized Phase|Physician Decision|0|||
27877429|NCT01597908|54497328|FG000|Randomized Phase|Withdrawal by Subject|26|||
27877430|NCT01597908|54497329|FG001|Randomized Phase|Withdrawal by Subject|22|||
27877431|NCT01597908|54497330|FG002|Randomized Phase|Withdrawal by Subject|0|||
27877432|NCT01597908|54497328|FG000|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
27877433|NCT01597908|54497329|FG001|Randomized Phase|Crossover to Dabrafenib&Trametinib|34|||
27877434|NCT01597908|54497330|FG002|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
27877435|NCT01597908|54497328|FG000|Crossover Phase|Death|0|||
27877436|NCT01597908|54497329|FG001|Crossover Phase|Death|0|||
27877437|NCT01597908|54497330|FG002|Crossover Phase|Death|11|||
27877438|NCT01597908|54497328|FG000|Crossover Phase|Withdrawal by Subject|0|||
27877439|NCT01597908|54497329|FG001|Crossover Phase|Withdrawal by Subject|0|||
27877440|NCT01597908|54497330|FG002|Crossover Phase|Withdrawal by Subject|3|||
27877441|NCT01597908|54497328|FG000|Crossover Phase|Sponsor Decision|0|||
27877442|NCT01597908|54497329|FG001|Crossover Phase|Sponsor Decision|0|||
27877443|NCT01597908|54497330|FG002|Crossover Phase|Sponsor Decision|20|||
27877444|NCT01951170|54497339|FG000|Overall Study|Investigator decision|1|||
27877445|NCT01951092|54497343|FG000|Overall Study|Lost to Follow-up|10|||
27877446|NCT01951092|54497343|FG000|Overall Study|Incarceration|1|||
27877447|NCT01951092|54497343|FG000|Overall Study|Transfer of Care|1|||
27877448|NCT01949532|54497349|FG000|Overall Study|On-study at the Data Cut-off Date|3|||
27877449|NCT01949532|54497350|FG001|Overall Study|On-study at the Data Cut-off Date|3|||
27877450|NCT01949142|54497358|FG000|Overall Study|Withdrawal of consent|1|||
27877451|NCT01949142|54497359|FG001|Overall Study|Withdrawal of consent|0|||
27877452|NCT01949142|54497358|FG000|Overall Study|Lost to Follow-up|1|||
27877453|NCT01949142|54497359|FG001|Overall Study|Lost to Follow-up|1|||
27877454|NCT01949142|54497358|FG000|Overall Study|Parent changed their mind|1|||
27877455|NCT01949142|54497359|FG001|Overall Study|Parent changed their mind|0|||
27877456|NCT01948908|54497369|FG000|Overall Study|Protocol Violation|1|||
27877457|NCT01948908|54497370|FG001|Overall Study|Protocol Violation|0|||
27877458|NCT01948908|54497371|FG002|Overall Study|Protocol Violation|2|||
27877459|NCT01925274|54497382|FG000|Overall Study|Death|1|||
27877460|NCT01925274|54497383|FG001|Overall Study|Death|0|||
27877461|NCT01925274|54497384|FG002|Overall Study|Death|0|||
27877462|NCT01925274|54497382|FG000|Overall Study|Lost to Follow-up|0|||
27877463|NCT01925274|54497383|FG001|Overall Study|Lost to Follow-up|1|||
27877464|NCT01925274|54497384|FG002|Overall Study|Lost to Follow-up|0|||
27877465|NCT01925274|54497382|FG000|Overall Study|Withdrawal by Subject|1|||
27877466|NCT01925274|54497383|FG001|Overall Study|Withdrawal by Subject|2|||
27877467|NCT01925274|54497384|FG002|Overall Study|Withdrawal by Subject|0|||
27877468|NCT01925274|54497382|FG000|Overall Study|Study terminated by sponsor|4|||
27877469|NCT01925274|54497383|FG001|Overall Study|Study terminated by sponsor|0|||
27877470|NCT01925274|54497384|FG002|Overall Study|Study terminated by sponsor|0|||
27877471|NCT01925274|54497382|FG000|Overall Study|Protocol amendment|1|||
27877472|NCT01925274|54497383|FG001|Overall Study|Protocol amendment|3|||
27877473|NCT01925274|54497384|FG002|Overall Study|Protocol amendment|6|||
27877474|NCT01948830|54497396|FG000|Overall Study|Physician Decision|1|||
27877475|NCT01948830|54497397|FG001|Overall Study|Physician Decision|3|||
27877476|NCT01948830|54497396|FG000|Overall Study|Protocol deviation|1|||
27877477|NCT01948830|54497397|FG001|Overall Study|Protocol deviation|2|||
27877478|NCT01948830|54497396|FG000|Overall Study|Lost to Follow-up|5|||
27877479|NCT01948830|54497397|FG001|Overall Study|Lost to Follow-up|4|||
27877480|NCT01948830|54497396|FG000|Overall Study|Withdrawal by Subject|14|||
27877481|NCT01948830|54497397|FG001|Overall Study|Withdrawal by Subject|17|||
27877482|NCT01948830|54497396|FG000|Overall Study|Adverse Event|9|||
27877483|NCT01948830|54497397|FG001|Overall Study|Adverse Event|2|||
27877484|NCT01948830|54497396|FG000|Overall Study|Death|3|||
27877485|NCT01948830|54497397|FG001|Overall Study|Death|4|||
27877486|NCT01972464|54497405|FG000|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2|||
27877487|NCT01972464|54497406|FG001|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3|||
27877488|NCT01972464|54497405|FG000|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1|||
27877489|NCT01972464|54497406|FG001|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0|||
27877490|NCT01972464|54497405|FG000|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0|||
27877491|NCT01972464|54497406|FG001|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1|||
27877492|NCT01972464|54497405|FG000|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
27877493|NCT01972464|54497406|FG001|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
27877494|NCT01948050|54497415|FG000|Overall Study|Withdrawal by Subject|0|||
27877495|NCT01948050|54497416|FG001|Overall Study|Withdrawal by Subject|1|||
27877496|NCT01947894|54497425|FG000|Overall Study|Other|3|||
27877497|NCT01947894|54497426|FG001|Overall Study|Other|4|||
27877498|NCT01947894|54497427|FG002|Overall Study|Other|3|||
27877499|NCT01947894|54497425|FG000|Overall Study|Withdrawal by Subject|12|||
27877500|NCT01947894|54497426|FG001|Overall Study|Withdrawal by Subject|4|||
27877501|NCT01947894|54497427|FG002|Overall Study|Withdrawal by Subject|1|||
27877502|NCT01947894|54497425|FG000|Overall Study|Death|12|||
27877503|NCT01947894|54497426|FG001|Overall Study|Death|1|||
27877504|NCT01947894|54497427|FG002|Overall Study|Death|0|||
27877505|NCT01947894|54497425|FG000|Overall Study|Physician Decision|2|||
27877506|NCT01947894|54497426|FG001|Overall Study|Physician Decision|0|||
27877507|NCT01947894|54497427|FG002|Overall Study|Physician Decision|0|||
27877508|NCT01947894|54497425|FG000|Overall Study|Adverse Event|5|||
27877509|NCT01947894|54497426|FG001|Overall Study|Adverse Event|1|||
27877510|NCT01947894|54497427|FG002|Overall Study|Adverse Event|0|||
27877511|NCT01947894|54497425|FG000|Overall Study|Switched to other growth hormone brand|53|||
27877512|NCT01947894|54497426|FG001|Overall Study|Switched to other growth hormone brand|8|||
27877513|NCT01947894|54497427|FG002|Overall Study|Switched to other growth hormone brand|23|||
27877514|NCT01947582|54497435|FG000|Overall Study|Withdrawal by Subject|1|||
27877515|NCT01924806|54497441|FG000|Overall Study|Physician Decision|2|||
27877516|NCT01924806|54497442|FG001|Overall Study|Physician Decision|1|||
27877517|NCT01924182|54497450|FG000|Overall Study|Withdrawal by Subject|1|||
27877518|NCT01924182|54497451|FG001|Overall Study|Withdrawal by Subject|0|||
27877519|NCT01972308|54497459|FG000|Overall Study|Withdrawal by Subject|0|||
27877520|NCT01972308|54497460|FG001|Overall Study|Withdrawal by Subject|1|||
27877521|NCT01972308|54497459|FG000|Overall Study|Lost to Follow-up|4|||
27877522|NCT01972308|54497460|FG001|Overall Study|Lost to Follow-up|6|||
27877523|NCT01972308|54497459|FG000|Overall Study|Death|4|||
27877524|NCT01972308|54497460|FG001|Overall Study|Death|1|||
27877525|NCT01946880|54497470|FG000|Overall Study|Lost to Follow-up|1|||
27877526|NCT01946880|54497471|FG001|Overall Study|Lost to Follow-up|0|||
27877527|NCT01946880|54497470|FG000|Overall Study|Physician Decision|1|||
27877528|NCT01946880|54497471|FG001|Overall Study|Physician Decision|1|||
27877529|NCT01946880|54497470|FG000|Overall Study|Withdrawal by Subject|3|||
27877530|NCT01946880|54497471|FG001|Overall Study|Withdrawal by Subject|2|||
27877531|NCT01946880|54497470|FG000|Overall Study|Met Primary Endpoint|1|||
27877532|NCT01946880|54497471|FG001|Overall Study|Met Primary Endpoint|0|||
27877533|NCT01946880|54497470|FG000|Overall Study|Personal and Family Issues|1|||
27877534|NCT01946880|54497471|FG001|Overall Study|Personal and Family Issues|0|||
27877535|NCT01972152|54497477|FG000|First Treatment Visit|Lost to Follow-up|0|||
27877536|NCT01972152|54497478|FG001|First Treatment Visit|Lost to Follow-up|1|||
27877537|NCT01972152|54497479|FG002|First Treatment Visit|Lost to Follow-up|0|||
27877538|NCT01972152|54497480|FG003|First Treatment Visit|Lost to Follow-up|0|||
27877539|NCT01972152|54497481|FG004|First Treatment Visit|Lost to Follow-up|0|||
27877540|NCT01972152|54497482|FG005|First Treatment Visit|Lost to Follow-up|0|||
27877541|NCT01972152|54497477|FG000|Second Treatment Visit|Protocol Violation|0|||
27877542|NCT01972152|54497478|FG001|Second Treatment Visit|Protocol Violation|1|||
27877543|NCT01972152|54497479|FG002|Second Treatment Visit|Protocol Violation|0|||
27877544|NCT01972152|54497480|FG003|Second Treatment Visit|Protocol Violation|0|||
27877545|NCT01972152|54497481|FG004|Second Treatment Visit|Protocol Violation|0|||
27877546|NCT01972152|54497482|FG005|Second Treatment Visit|Protocol Violation|0|||
27877547|NCT01972074|54497496|FG000|Overall Study|Adverse Event|4|||
27877548|NCT01972074|54497497|FG001|Overall Study|Adverse Event|1|||
27877549|NCT01972074|54497498|FG002|Overall Study|Adverse Event|0|||
27877550|NCT01972074|54497496|FG000|Overall Study|Lack of Efficacy|1|||
27877551|NCT01972074|54497497|FG001|Overall Study|Lack of Efficacy|1|||
27877552|NCT01972074|54497498|FG002|Overall Study|Lack of Efficacy|0|||
27877553|NCT01972074|54497496|FG000|Overall Study|Lost to Follow-up|0|||
27877554|NCT01972074|54497497|FG001|Overall Study|Lost to Follow-up|1|||
27877555|NCT01972074|54497498|FG002|Overall Study|Lost to Follow-up|1|||
27877556|NCT01972074|54497496|FG000|Overall Study|Withdrawal by Subject|1|||
27877557|NCT01972074|54497497|FG001|Overall Study|Withdrawal by Subject|1|||
27877558|NCT01972074|54497498|FG002|Overall Study|Withdrawal by Subject|1|||
27877559|NCT01972074|54497496|FG000|Overall Study|Scanner Unavailable|0|||
27877560|NCT01972074|54497497|FG001|Overall Study|Scanner Unavailable|0|||
27877561|NCT01972074|54497498|FG002|Overall Study|Scanner Unavailable|1|||
27877562|NCT01970982|54497508|FG000|Overall Study|Withdrawal by Subject|0|||
27877563|NCT01970982|54497509|FG001|Overall Study|Withdrawal by Subject|0|||
27877564|NCT01970982|54497510|FG002|Overall Study|Withdrawal by Subject|2|||
27877565|NCT01946802|54497519|FG000|Overall Study|Death|1|||
27877566|NCT01946802|54497519|FG000|Overall Study|Withdrawal by Subject|2|||
27877567|NCT01946802|54497519|FG000|Overall Study|Combined septic shock|1|||
27877568|NCT01946802|54497519|FG000|Overall Study|Protocol Violation|1|||
27877569|NCT01618266|54497523|FG000|Overall Study|Lost to Follow-up|9|||
27877570|NCT01618266|54497523|FG000|Overall Study|Treatment satisfaction|10|||
27877571|NCT01618266|54497523|FG000|Overall Study|Other reasons|11|||
27877572|NCT01618266|54497523|FG000|Overall Study|Lack of Efficacy|23|||
27877573|NCT01618266|54497523|FG000|Overall Study|Protocol Violation|43|||
27877574|NCT01919112|54497530|FG000|Secondary Analysis-day 30|Death|1|||
27877575|NCT01919112|54497531|FG001|Secondary Analysis-day 30|Death|1|||
27877576|NCT01919112|54497532|FG002|Secondary Analysis-day 30|Death|1|||
27877577|NCT01919112|54497530|FG000|Secondary Analysis-day 30|Lost to Follow-up|1|||
27877578|NCT01919112|54497531|FG001|Secondary Analysis-day 30|Lost to Follow-up|0|||
27877579|NCT01919112|54497532|FG002|Secondary Analysis-day 30|Lost to Follow-up|0|||
27877580|NCT01918332|54497544|FG000|Overall Study|Adverse Event|0|||
27877581|NCT01918332|54497545|FG001|Overall Study|Adverse Event|0|||
27877582|NCT01918332|54497546|FG002|Overall Study|Adverse Event|0|||
27877583|NCT01918332|54497547|FG003|Overall Study|Adverse Event|1|||
27877584|NCT01918332|54497544|FG000|Overall Study|Withdrawal by Subject|2|||
27877585|NCT01918332|54497545|FG001|Overall Study|Withdrawal by Subject|3|||
27877586|NCT01918332|54497546|FG002|Overall Study|Withdrawal by Subject|2|||
27877587|NCT01918332|54497547|FG003|Overall Study|Withdrawal by Subject|3|||
27877588|NCT01918332|54497544|FG000|Overall Study|Protocol Violation|6|||
27877589|NCT01918332|54497545|FG001|Overall Study|Protocol Violation|2|||
27877590|NCT01918332|54497546|FG002|Overall Study|Protocol Violation|6|||
27877591|NCT01918332|54497547|FG003|Overall Study|Protocol Violation|3|||
27877592|NCT01918332|54497544|FG000|Overall Study|lipid result by central lab did not meet|0|||
27877593|NCT01918332|54497545|FG001|Overall Study|lipid result by central lab did not meet|0|||
27877594|NCT01918332|54497546|FG002|Overall Study|lipid result by central lab did not meet|1|||
27877595|NCT01918332|54497547|FG003|Overall Study|lipid result by central lab did not meet|0|||
27877596|NCT01922934|54497559|FG000|Eligible Patients|Death|0|||
27877597|NCT01922934|54497560|FG001|Eligible Patients|Death|7|||
27877598|NCT01922934|54497559|FG000|Eligible Patients|Physician Decision|17|||
27877599|NCT01922934|54497560|FG001|Eligible Patients|Physician Decision|0|||
27877600|NCT01922934|54497559|FG000|Eligible Patients|Did not meet inclusion criteria|36|||
27877601|NCT01922934|54497560|FG001|Eligible Patients|Did not meet inclusion criteria|81|||
27877602|NCT01922934|54497559|FG000|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169|||
27877603|NCT01922934|54497560|FG001|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0|||
27877604|NCT01922934|54497559|FG000|Visit 0 - Patient Contacted & Consented|No response or could not reach|66|||
27983168|NCT00556933|54641411|FG003|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
27877605|NCT01922934|54497560|FG001|Visit 0 - Patient Contacted & Consented|No response or could not reach|0|||
27877606|NCT01922934|54497559|FG000|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21|||
27877607|NCT01922934|54497560|FG001|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284|||
27877608|NCT01970592|54497568|FG000|Overall Study|Withdrawal by Subject|4|||
27877609|NCT01970592|54497568|FG000|Overall Study|Physician Decision|1|||
27877610|NCT01970592|54497568|FG000|Overall Study|Adverse Event|1|||
27877611|NCT01920594|54497574|FG000|Overall Study|Adverse Event|4|||
27877612|NCT01920594|54497575|FG001|Overall Study|Adverse Event|2|||
27877613|NCT01920594|54497574|FG000|Overall Study|Lost to Follow-up|1|||
27877614|NCT01920594|54497575|FG001|Overall Study|Lost to Follow-up|0|||
27877615|NCT01920594|54497574|FG000|Overall Study|Recovery|2|||
27877616|NCT01920594|54497575|FG001|Overall Study|Recovery|0|||
27877617|NCT01920594|54497574|FG000|Overall Study|Investigator discretion|0|||
27877618|NCT01920594|54497575|FG001|Overall Study|Investigator discretion|1|||
27877619|NCT01917084|54497581|FG000|Overall Study|Withdrawal by Subject|1|||
27877620|NCT01917006|54497592|FG000|Randomized-treatment Period|Lost to Follow-up|1|||
27877621|NCT01917006|54497593|FG001|Randomized-treatment Period|Lost to Follow-up|0|||
27877622|NCT01917006|54497594|FG002|Randomized-treatment Period|Lost to Follow-up|0|||
27877623|NCT01917006|54497595|FG003|Randomized-treatment Period|Lost to Follow-up|1|||
27877624|NCT01917006|54497596|FG004|Randomized-treatment Period|Lost to Follow-up|0|||
27877625|NCT01917006|54497597|FG005|Randomized-treatment Period|Lost to Follow-up|0|||
27877626|NCT01917006|54497598|FG006|Randomized-treatment Period|Lost to Follow-up|0|||
27877627|NCT01917006|54497599|FG007|Randomized-treatment Period|Lost to Follow-up|0|||
27877628|NCT01917006|54497592|FG000|Randomized-treatment Period|Personal Reasons|0|||
27877629|NCT01917006|54497593|FG001|Randomized-treatment Period|Personal Reasons|0|||
27877630|NCT01917006|54497594|FG002|Randomized-treatment Period|Personal Reasons|0|||
27877631|NCT01917006|54497595|FG003|Randomized-treatment Period|Personal Reasons|0|||
27877632|NCT01917006|54497596|FG004|Randomized-treatment Period|Personal Reasons|0|||
27877633|NCT01917006|54497597|FG005|Randomized-treatment Period|Personal Reasons|1|||
27877634|NCT01917006|54497598|FG006|Randomized-treatment Period|Personal Reasons|0|||
27877635|NCT01917006|54497599|FG007|Randomized-treatment Period|Personal Reasons|0|||
27877636|NCT01917006|54497592|FG000|Randomized-treatment Period|Protocol Violation|1|||
27877637|NCT01917006|54497593|FG001|Randomized-treatment Period|Protocol Violation|0|||
27877638|NCT01917006|54497594|FG002|Randomized-treatment Period|Protocol Violation|0|||
27877639|NCT01917006|54497595|FG003|Randomized-treatment Period|Protocol Violation|0|||
27877640|NCT01917006|54497596|FG004|Randomized-treatment Period|Protocol Violation|0|||
27877641|NCT01917006|54497597|FG005|Randomized-treatment Period|Protocol Violation|0|||
27877642|NCT01917006|54497598|FG006|Randomized-treatment Period|Protocol Violation|0|||
27877643|NCT01917006|54497599|FG007|Randomized-treatment Period|Protocol Violation|0|||
27877644|NCT01917006|54497592|FG000|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
27877645|NCT01917006|54497593|FG001|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
27877646|NCT01917006|54497594|FG002|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
27877647|NCT01917006|54497595|FG003|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
27877648|NCT01917006|54497596|FG004|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
27877649|NCT01917006|54497597|FG005|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
27877650|NCT01917006|54497598|FG006|Randomized-treatment Period|Other Miscellaneous Reasons|1|||
27877651|NCT01917006|54497599|FG007|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
27877652|NCT01917006|54497592|FG000|Open-label Period|Adverse Event|0|||
27877653|NCT01917006|54497593|FG001|Open-label Period|Adverse Event|0|||
27877654|NCT01917006|54497594|FG002|Open-label Period|Adverse Event|0|||
27877655|NCT01917006|54497595|FG003|Open-label Period|Adverse Event|0|||
27877656|NCT01917006|54497596|FG004|Open-label Period|Adverse Event|0|||
27877657|NCT01917006|54497597|FG005|Open-label Period|Adverse Event|0|||
27877658|NCT01917006|54497598|FG006|Open-label Period|Adverse Event|0|||
27877659|NCT01917006|54497599|FG007|Open-label Period|Adverse Event|1|||
27877660|NCT01917006|54497592|FG000|Open-label Period|Lost to Follow-up|0|||
27877661|NCT01917006|54497593|FG001|Open-label Period|Lost to Follow-up|0|||
27877662|NCT01917006|54497594|FG002|Open-label Period|Lost to Follow-up|0|||
27877663|NCT01917006|54497595|FG003|Open-label Period|Lost to Follow-up|0|||
27877664|NCT01917006|54497596|FG004|Open-label Period|Lost to Follow-up|0|||
27877665|NCT01917006|54497597|FG005|Open-label Period|Lost to Follow-up|0|||
27877666|NCT01917006|54497598|FG006|Open-label Period|Lost to Follow-up|0|||
27877667|NCT01917006|54497599|FG007|Open-label Period|Lost to Follow-up|1|||
27877668|NCT01916304|54497616|FG000|Overall Study|Screening failure|17|||
27877669|NCT01916226|54497624|FG000|Overall Study|Adverse Event|1|||
27877670|NCT01916226|54497625|FG001|Overall Study|Adverse Event|0|||
27877671|NCT01916226|54497626|FG002|Overall Study|Adverse Event|1|||
27877672|NCT01916226|54497627|FG003|Overall Study|Adverse Event|1|||
27877673|NCT01916226|54497624|FG000|Overall Study|Lack of Efficacy|0|||
27877674|NCT01916226|54497625|FG001|Overall Study|Lack of Efficacy|0|||
27877675|NCT01916226|54497626|FG002|Overall Study|Lack of Efficacy|2|||
28171644|NCT03350815|54843239|FG002|Period 2|Adverse Event|5|||
28171645|NCT03350815|54843240|FG003|Period 2|Adverse Event|0|||
27877676|NCT01916226|54497627|FG003|Overall Study|Lack of Efficacy|1|||
27877677|NCT01916226|54497624|FG000|Overall Study|Protocol Violation|0|||
27877678|NCT01916226|54497625|FG001|Overall Study|Protocol Violation|1|||
27877679|NCT01916226|54497626|FG002|Overall Study|Protocol Violation|0|||
28171646|NCT03350815|54843237|FG000|Period 2|Technical problem|0|||
28171647|NCT03350815|54843238|FG001|Period 2|Technical problem|1|||
28171648|NCT03350815|54843239|FG002|Period 2|Technical problem|0|||
28171649|NCT03350815|54843240|FG003|Period 2|Technical problem|0|||
28171650|NCT03350815|54843237|FG000|Period 2|Lost to Follow-up|0|||
28171651|NCT03350815|54843238|FG001|Period 2|Lost to Follow-up|3|||
28171652|NCT03350815|54843239|FG002|Period 2|Lost to Follow-up|3|||
28171653|NCT03350815|54843240|FG003|Period 2|Lost to Follow-up|0|||
28171654|NCT03350815|54843237|FG000|Period 2|Physician Decision|0|||
28171655|NCT03350815|54843238|FG001|Period 2|Physician Decision|0|||
28171656|NCT03350815|54843239|FG002|Period 2|Physician Decision|1|||
28171657|NCT03350815|54843240|FG003|Period 2|Physician Decision|0|||
28171658|NCT03350815|54843237|FG000|Period 2|Withdrawal by Subject|0|||
27739270|NCT03318523|54188610|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
27739271|NCT03318523|54188611|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|17|||
27739272|NCT03318523|54188612|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|36|||
27877680|NCT01916226|54497627|FG003|Overall Study|Protocol Violation|1|||
27877681|NCT01916226|54497624|FG000|Overall Study|Physician Decision|0|||
27877682|NCT01916226|54497625|FG001|Overall Study|Physician Decision|0|||
27877683|NCT01916226|54497626|FG002|Overall Study|Physician Decision|0|||
27877684|NCT01916226|54497627|FG003|Overall Study|Physician Decision|1|||
27877685|NCT01969500|54497640|FG000|Overall Study|Death|0|||
27877686|NCT01969500|54497641|FG001|Overall Study|Death|1|||
27877687|NCT01969500|54497640|FG000|Overall Study|extended hospitalization|1|||
27877688|NCT01969500|54497641|FG001|Overall Study|extended hospitalization|1|||
27877689|NCT01915914|54497647|FG000|Acute Phase|Withdrawal by Subject|4|||
27877690|NCT01915914|54497648|FG001|Acute Phase|Withdrawal by Subject|0|||
27877691|NCT01915914|54497649|FG002|Acute Phase|Withdrawal by Subject|0|||
27877692|NCT01915914|54497650|FG003|Acute Phase|Withdrawal by Subject|0|||
27877693|NCT01915914|54497647|FG000|Acute Phase|Lost to Follow-up|4|||
27877694|NCT01915914|54497648|FG001|Acute Phase|Lost to Follow-up|0|||
27877695|NCT01915914|54497649|FG002|Acute Phase|Lost to Follow-up|0|||
27877696|NCT01915914|54497650|FG003|Acute Phase|Lost to Follow-up|0|||
27877697|NCT01915914|54497647|FG000|Acute Phase|Physician Decision|1|||
27877698|NCT01915914|54497648|FG001|Acute Phase|Physician Decision|0|||
27877699|NCT01915914|54497649|FG002|Acute Phase|Physician Decision|0|||
27877700|NCT01915914|54497650|FG003|Acute Phase|Physician Decision|0|||
27877701|NCT01915914|54497647|FG000|Acute Phase|Accepted Other Topic Therapies|1|||
27877702|NCT01915914|54497648|FG001|Acute Phase|Accepted Other Topic Therapies|0|||
27877703|NCT01915914|54497649|FG002|Acute Phase|Accepted Other Topic Therapies|0|||
27877704|NCT01915914|54497650|FG003|Acute Phase|Accepted Other Topic Therapies|0|||
27877705|NCT01915914|54497647|FG000|Acute Phase|"Not Achieved treatment success"|1|||
27877706|NCT01915914|54497648|FG001|Acute Phase|"Not Achieved treatment success"|0|||
27877707|NCT01915914|54497649|FG002|Acute Phase|"Not Achieved treatment success"|0|||
27877708|NCT01915914|54497650|FG003|Acute Phase|"Not Achieved treatment success"|0|||
27877709|NCT01915914|54497647|FG000|Acute Phase|Missing|1|||
27877710|NCT01915914|54497648|FG001|Acute Phase|Missing|0|||
27877711|NCT01915914|54497649|FG002|Acute Phase|Missing|0|||
27877712|NCT01915914|54497650|FG003|Acute Phase|Missing|0|||
27877713|NCT01915914|54497647|FG000|Maintenance Phase|Withdrawal by Subject|0|||
27877714|NCT01915914|54497648|FG001|Maintenance Phase|Withdrawal by Subject|1|||
27877715|NCT01915914|54497649|FG002|Maintenance Phase|Withdrawal by Subject|1|||
27877716|NCT01915914|54497650|FG003|Maintenance Phase|Withdrawal by Subject|0|||
27877717|NCT01915914|54497647|FG000|Maintenance Phase|Lost to Follow-up|0|||
27877718|NCT01915914|54497648|FG001|Maintenance Phase|Lost to Follow-up|4|||
27877719|NCT01915914|54497649|FG002|Maintenance Phase|Lost to Follow-up|1|||
27877720|NCT01915914|54497650|FG003|Maintenance Phase|Lost to Follow-up|0|||
27877721|NCT01915914|54497647|FG000|Maintenance Phase|Missing|0|||
27877722|NCT01915914|54497648|FG001|Maintenance Phase|Missing|1|||
27877723|NCT01915914|54497649|FG002|Maintenance Phase|Missing|0|||
27877724|NCT01915914|54497650|FG003|Maintenance Phase|Missing|0|||
27877725|NCT01915914|54497647|FG000|Follow-up Phase|Withdrawal by Subject|0|||
27877726|NCT01915914|54497648|FG001|Follow-up Phase|Withdrawal by Subject|0|||
27877727|NCT01915914|54497649|FG002|Follow-up Phase|Withdrawal by Subject|0|||
27877728|NCT01915914|54497650|FG003|Follow-up Phase|Withdrawal by Subject|1|||
27877729|NCT01915914|54497647|FG000|Follow-up Phase|Physician Decision|0|||
27877730|NCT01915914|54497648|FG001|Follow-up Phase|Physician Decision|0|||
27877731|NCT01915914|54497649|FG002|Follow-up Phase|Physician Decision|0|||
27739273|NCT03318523|54188613|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|39|||
27877732|NCT01915914|54497650|FG003|Follow-up Phase|Physician Decision|1|||
27877733|NCT01919970|54497670|FG000|Overall Study|Withdrawal by Subject|3|||
27877734|NCT01919970|54497671|FG001|Overall Study|Withdrawal by Subject|0|||
27877735|NCT01919814|54497677|FG000|Overall Study|Adverse Event|1|||
27877736|NCT01919814|54497678|FG001|Overall Study|Adverse Event|0|||
27877737|NCT01919814|54497677|FG000|Overall Study|Protocol Violation|1|||
27877738|NCT01919814|54497678|FG001|Overall Study|Protocol Violation|0|||
27877739|NCT01919814|54497677|FG000|Overall Study|Withdrawal by Subject|1|||
28171659|NCT03350815|54843238|FG001|Period 2|Withdrawal by Subject|3|||
27877740|NCT01919814|54497678|FG001|Overall Study|Withdrawal by Subject|0|||
27877741|NCT01968954|54497686|FG000|Overall Study|Adverse Event|6|||
27877742|NCT01968954|54497687|FG001|Overall Study|Adverse Event|3|||
27877743|NCT01968954|54497686|FG000|Overall Study|Death|1|||
27877744|NCT01968954|54497687|FG001|Overall Study|Death|2|||
27877745|NCT01968954|54497686|FG000|Overall Study|Lost to Follow-up|6|||
27877746|NCT01968954|54497687|FG001|Overall Study|Lost to Follow-up|4|||
27877747|NCT01968954|54497686|FG000|Overall Study|Withdrawal by Subject|20|||
27877748|NCT01968954|54497687|FG001|Overall Study|Withdrawal by Subject|23|||
27877749|NCT01968954|54497686|FG000|Overall Study|Other|7|||
27877750|NCT01968954|54497687|FG001|Overall Study|Other|8|||
27877751|NCT01968954|54497686|FG000|Overall Study|Protocol Violation|0|||
27877752|NCT01968954|54497687|FG001|Overall Study|Protocol Violation|1|||
27877753|NCT01968954|54497686|FG000|Overall Study|Did not met inclusion criteria|0|||
27877754|NCT01968954|54497687|FG001|Overall Study|Did not met inclusion criteria|2|||
27877755|NCT01919190|54497696|FG000|Overall Study|Intra-op findings, etc.|3|||
27877756|NCT01919190|54497697|FG001|Overall Study|Intra-op findings, etc.|0|||
27877757|NCT01620060|54497704|FG000|Overall Study|Adverse Event|9|||
27877758|NCT01620060|54497704|FG000|Overall Study|Protocol Violation|1|||
27877759|NCT01620060|54497704|FG000|Overall Study|Withdrawal by Subject|1|||
27877760|NCT01620060|54497704|FG000|Overall Study|Did not comply with Study Produre|1|||
27877761|NCT01620060|54497704|FG000|Overall Study|Family emergency|1|||
27877762|NCT01620060|54497704|FG000|Overall Study|Per Sponsor Decision|2|||
27877763|NCT01914666|54497711|FG000|Treatment Period|Lack of Efficacy|0|||
27877764|NCT01914666|54497712|FG001|Treatment Period|Lack of Efficacy|0|||
27877765|NCT01914666|54497713|FG002|Treatment Period|Lack of Efficacy|2|||
27877766|NCT01914666|54497711|FG000|Treatment Period|Adverse Event|10|||
27877767|NCT01914666|54497712|FG001|Treatment Period|Adverse Event|4|||
27877768|NCT01914666|54497713|FG002|Treatment Period|Adverse Event|2|||
27877769|NCT01914666|54497711|FG000|Treatment Period|Withdrawal by Subject|3|||
27877770|NCT01914666|54497712|FG001|Treatment Period|Withdrawal by Subject|2|||
27877771|NCT01914666|54497713|FG002|Treatment Period|Withdrawal by Subject|2|||
27877772|NCT01914666|54497711|FG000|Treatment Period|Physician Decision|0|||
27877773|NCT01914666|54497712|FG001|Treatment Period|Physician Decision|0|||
27877774|NCT01914666|54497713|FG002|Treatment Period|Physician Decision|2|||
27877775|NCT01913340|54497721|FG000|Overall Study|Death|2|||
27983169|NCT00556933|54641408|FG000|CNI Withdrawal vs. Minimization|Graft loss|0|||
27983170|NCT00556933|54641409|FG001|CNI Withdrawal vs. Minimization|Graft loss|1|||
27983171|NCT00556933|54641410|FG002|CNI Withdrawal vs. Minimization|Graft loss|2|||
27983172|NCT00556933|54641411|FG003|CNI Withdrawal vs. Minimization|Graft loss|0|||
27983173|NCT00556933|54641408|FG000|CNI Withdrawal vs. Minimization|Death|0|||
27983174|NCT00556933|54641409|FG001|CNI Withdrawal vs. Minimization|Death|0|||
27983175|NCT00556933|54641410|FG002|CNI Withdrawal vs. Minimization|Death|0|||
27983176|NCT00556933|54641411|FG003|CNI Withdrawal vs. Minimization|Death|1|||
27983177|NCT00770211|54641432|FG000|Overall Study|Lost to Follow-up|1|||
27983178|NCT00770211|54641433|FG001|Overall Study|Lost to Follow-up|0|||
27983179|NCT00770211|54641432|FG000|Overall Study|Withdrawal by Subject|0|||
27983180|NCT00770211|54641433|FG001|Overall Study|Withdrawal by Subject|2|||
27983181|NCT00928187|54641442|FG000|Overall Study|Death|1|||
27983182|NCT00928187|54641443|FG001|Overall Study|Death|2|||
27983183|NCT00928187|54641444|FG002|Overall Study|Death|3|||
27983184|NCT00928187|54641442|FG000|Overall Study|Lost to Follow-up|1|||
27983185|NCT00928187|54641443|FG001|Overall Study|Lost to Follow-up|2|||
27983186|NCT00928187|54641444|FG002|Overall Study|Lost to Follow-up|1|||
27983187|NCT00928187|54641442|FG000|Overall Study|Withdrawal by Subject|0|||
27983188|NCT00928187|54641443|FG001|Overall Study|Withdrawal by Subject|1|||
27983189|NCT00928187|54641444|FG002|Overall Study|Withdrawal by Subject|1|||
27983190|NCT00928187|54641442|FG000|Overall Study|Protocol Violation|0|||
27983191|NCT00928187|54641443|FG001|Overall Study|Protocol Violation|1|||
27983192|NCT00928187|54641444|FG002|Overall Study|Protocol Violation|0|||
27983193|NCT00769119|54641454|FG000|Overall Study|Voluntary discontinuation|0|||
27983194|NCT00769119|54641455|FG001|Overall Study|Voluntary discontinuation|2|||
27983195|NCT00769119|54641454|FG000|Overall Study|Adverse Event|1|||
27983196|NCT00769119|54641455|FG001|Overall Study|Adverse Event|1|||
27983197|NCT00769119|54641454|FG000|Overall Study|Disallowed medication|1|||
27983198|NCT00769119|54641455|FG001|Overall Study|Disallowed medication|0|||
27983199|NCT00927953|54641463|FG000|Overall Study|Death|2|||
27983200|NCT00927953|54641464|FG001|Overall Study|Death|1|||
27983201|NCT00768651|54641471|FG000|Overall Study|Withdrawal by Subject|1|||
27983202|NCT00756717|54641476|FG000|Overall Study|Withdrawal by Subject|2|||
27983203|NCT03962101|54641480|FG000|Overall Study|Adverse Event|1|||
27877776|NCT01913340|54497722|FG001|Overall Study|Death|5|||
27877777|NCT01913340|54497721|FG000|Overall Study|Lost to Follow-up|1|||
27877778|NCT01913340|54497722|FG001|Overall Study|Lost to Follow-up|1|||
27877779|NCT01864200|54497730|FG000|Overall Study|Lost to Follow-up|1|||
27877780|NCT01864200|54497731|FG001|Overall Study|Lost to Follow-up|3|||
27983204|NCT03962101|54641480|FG000|Overall Study|Physician Decision|2|||
27983205|NCT03962101|54641480|FG000|Overall Study|Not related to medical events|1|||
28171660|NCT03350815|54843239|FG002|Period 2|Withdrawal by Subject|4|||
27877781|NCT01864200|54497730|FG000|Overall Study|Protocol Violation|1|||
27877782|NCT01864200|54497731|FG001|Overall Study|Protocol Violation|0|||
27877783|NCT01912872|54497741|FG000|Overall Study|Lost to Follow-up|2|||
27877784|NCT01912872|54497742|FG001|Overall Study|Lost to Follow-up|3|||
27877785|NCT01912872|54497743|FG002|Overall Study|Lost to Follow-up|5|||
27877786|NCT01912872|54497744|FG003|Overall Study|Lost to Follow-up|5|||
27877787|NCT01912872|54497741|FG000|Overall Study|Other unspecified|3|||
27877788|NCT01912872|54497742|FG001|Overall Study|Other unspecified|1|||
27877789|NCT01912872|54497743|FG002|Overall Study|Other unspecified|3|||
27877790|NCT01912872|54497744|FG003|Overall Study|Other unspecified|0|||
27877791|NCT01912872|54497741|FG000|Overall Study|Informed consent withdrawn|0|||
27877792|NCT01912872|54497742|FG001|Overall Study|Informed consent withdrawn|0|||
27877793|NCT01912872|54497743|FG002|Overall Study|Informed consent withdrawn|1|||
27877794|NCT01912872|54497744|FG003|Overall Study|Informed consent withdrawn|1|||
27877795|NCT01912872|54497741|FG000|Overall Study|Non-compliance with lab inc/exclusion|0|||
27877796|NCT01912872|54497742|FG001|Overall Study|Non-compliance with lab inc/exclusion|0|||
27877797|NCT01912872|54497743|FG002|Overall Study|Non-compliance with lab inc/exclusion|0|||
27877798|NCT01912872|54497744|FG003|Overall Study|Non-compliance with lab inc/exclusion|1|||
27877799|NCT01912872|54497741|FG000|Overall Study|Protocol Violation|0|||
27877800|NCT01912872|54497742|FG001|Overall Study|Protocol Violation|0|||
27877801|NCT01912872|54497743|FG002|Overall Study|Protocol Violation|1|||
27877802|NCT01912872|54497744|FG003|Overall Study|Protocol Violation|0|||
27877803|NCT01912872|54497741|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
27877804|NCT01912872|54497742|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
27877805|NCT01912872|54497743|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
27877806|NCT01912872|54497744|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
27877807|NCT01912872|54497741|FG000|Overall Study|Withdrawal of study medication|0|||
27877808|NCT01912872|54497742|FG001|Overall Study|Withdrawal of study medication|0|||
27877809|NCT01912872|54497743|FG002|Overall Study|Withdrawal of study medication|0|||
27877810|NCT01912872|54497744|FG003|Overall Study|Withdrawal of study medication|2|||
27877811|NCT01912872|54497741|FG000|Overall Study|Missing|0|||
27877812|NCT01912872|54497742|FG001|Overall Study|Missing|0|||
27877813|NCT01912872|54497743|FG002|Overall Study|Missing|0|||
27877814|NCT01912872|54497744|FG003|Overall Study|Missing|1|||
27877815|NCT01912404|54497757|FG000|Overall Study|Due to personal reasons|1|||
27877816|NCT01912404|54497758|FG001|Overall Study|Due to personal reasons|0|||
27877817|NCT01911780|54497766|FG000|Double-blind Period (8 Weeks)|Adverse Event|1|||
27877818|NCT01911780|54497767|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
27877819|NCT01911780|54497766|FG000|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
27877820|NCT01911780|54497767|FG001|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
27877821|NCT01911780|54497766|FG000|Double-blind Period (8 Weeks)|Personal reason|1|||
27877822|NCT01911780|54497767|FG001|Double-blind Period (8 Weeks)|Personal reason|0|||
27877823|NCT01911780|54497766|FG000|Extension Period (52 Weeks)|Adverse Event|3|||
27877824|NCT01911780|54497767|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
27877825|NCT01911780|54497766|FG000|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0|||
27877826|NCT01911780|54497767|FG001|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2|||
27877827|NCT01911780|54497766|FG000|Extension Period (52 Weeks)|Personal reason|1|||
27877828|NCT01911780|54497767|FG001|Extension Period (52 Weeks)|Personal reason|1|||
27877829|NCT01911546|54497777|FG000|Overall Study|Lost to Follow-up|1|||
27877830|NCT01911546|54497777|FG000|Overall Study|Everolimus was discontinued|5|||
27877831|NCT01910298|54497783|FG000|Overall Study|Adverse Event|1|||
27877832|NCT01910298|54497784|FG001|Overall Study|Adverse Event|0|||
27877833|NCT01910298|54497783|FG000|Overall Study|Withdrawal by Subject|2|||
27877834|NCT01910298|54497784|FG001|Overall Study|Withdrawal by Subject|7|||
27877835|NCT01910298|54497783|FG000|Overall Study|Protocol Deviation|0|||
27877836|NCT01910298|54497784|FG001|Overall Study|Protocol Deviation|5|||
27877837|NCT01910298|54497783|FG000|Overall Study|Lost to Follow-up|1|||
27877838|NCT01910298|54497784|FG001|Overall Study|Lost to Follow-up|1|||
27877839|NCT01910298|54497783|FG000|Overall Study|Study Terminated by Sponsor|1|||
27877840|NCT01910298|54497784|FG001|Overall Study|Study Terminated by Sponsor|17|||
27877841|NCT01910298|54497783|FG000|Overall Study|Other Miscellaneous Reasons|0|||
27877842|NCT01910298|54497784|FG001|Overall Study|Other Miscellaneous Reasons|2|||
27877843|NCT01909674|54497792|FG000|Overall Study|Withdrawal by Subject|5|||
27877844|NCT01909674|54497793|FG001|Overall Study|Withdrawal by Subject|2|||
27877845|NCT01908816|54497803|FG000|Overall Study|Subject's no longer requires study drug|0|||
27877846|NCT01908816|54497804|FG001|Overall Study|Subject's no longer requires study drug|0|||
27877847|NCT01908816|54497805|FG002|Overall Study|Subject's no longer requires study drug|0|||
27877848|NCT01908816|54497806|FG003|Overall Study|Subject's no longer requires study drug|1|||
27877849|NCT01908816|54497803|FG000|Overall Study|Protocol deviation|1|||
27877850|NCT01908816|54497804|FG001|Overall Study|Protocol deviation|2|||
27877851|NCT01908816|54497805|FG002|Overall Study|Protocol deviation|1|||
27877852|NCT01908816|54497806|FG003|Overall Study|Protocol deviation|1|||
27877853|NCT01908816|54497803|FG000|Overall Study|Withdrawal by Subject|0|||
28096474|NCT04410198|54751448|FG000|Overall Study|Transferred/Relocation|4|||
28096475|NCT04410198|54751448|FG000|Overall Study|Kidney Transplant|9|||
27877854|NCT01908816|54497804|FG001|Overall Study|Withdrawal by Subject|4|||
27877855|NCT01908816|54497805|FG002|Overall Study|Withdrawal by Subject|2|||
27877856|NCT01908816|54497806|FG003|Overall Study|Withdrawal by Subject|2|||
27877857|NCT01908816|54497803|FG000|Overall Study|Lost to Follow-up|3|||
27877858|NCT01908816|54497804|FG001|Overall Study|Lost to Follow-up|5|||
27877859|NCT01908816|54497805|FG002|Overall Study|Lost to Follow-up|4|||
27877860|NCT01908816|54497806|FG003|Overall Study|Lost to Follow-up|2|||
27877861|NCT01908816|54497803|FG000|Overall Study|Death|1|||
27877862|NCT01908816|54497804|FG001|Overall Study|Death|0|||
27877863|NCT01908816|54497805|FG002|Overall Study|Death|7|||
27877864|NCT01908816|54497806|FG003|Overall Study|Death|1|||
27877865|NCT01908816|54497803|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
27877866|NCT01908816|54497804|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
27877867|NCT01908816|54497805|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
27877868|NCT01908816|54497806|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
27877869|NCT01908816|54497803|FG000|Overall Study|Early termination|87|||
27877870|NCT01908816|54497804|FG001|Overall Study|Early termination|60|||
27877871|NCT01908816|54497805|FG002|Overall Study|Early termination|43|||
27877872|NCT01908816|54497806|FG003|Overall Study|Early termination|28|||
27877873|NCT01908582|54497819|FG000|Period 2|Physician Decision|1|||
27877874|NCT01908582|54497819|FG000|Period 2|Withdrawal by Subject|1|||
27877875|NCT01908426|54497828|FG000|Overall Study|Adverse Event|98|||
27877876|NCT01908426|54497829|FG001|Overall Study|Adverse Event|11|||
27877877|NCT01908426|54497828|FG000|Overall Study|Clinical Deterioration|72|||
27877878|NCT01908426|54497829|FG001|Overall Study|Clinical Deterioration|38|||
27877879|NCT01908426|54497828|FG000|Overall Study|Lack of Efficacy|3|||
27877880|NCT01908426|54497829|FG001|Overall Study|Lack of Efficacy|0|||
27877881|NCT01908426|54497828|FG000|Overall Study|Lost to Follow-up|0|||
27877882|NCT01908426|54497829|FG001|Overall Study|Lost to Follow-up|1|||
27877883|NCT01908426|54497828|FG000|Overall Study|Physician Decision|3|||
27877884|NCT01908426|54497829|FG001|Overall Study|Physician Decision|3|||
27877885|NCT01908426|54497828|FG000|Overall Study|Withdrawal by Subject|11|||
27877886|NCT01908426|54497829|FG001|Overall Study|Withdrawal by Subject|6|||
27877887|NCT01908426|54497828|FG000|Overall Study|Progressive Disease|206|||
27877888|NCT01908426|54497829|FG001|Overall Study|Progressive Disease|152|||
27877889|NCT01908426|54497828|FG000|Overall Study|Protocol Violation|1|||
27877890|NCT01908426|54497829|FG001|Overall Study|Protocol Violation|0|||
27877891|NCT01908426|54497828|FG000|Overall Study|No Study Treatment Given|3|||
27877892|NCT01908426|54497829|FG001|Overall Study|No Study Treatment Given|0|||
27877893|NCT01907100|54497839|FG000|Overall Study|PD based on modified RECIST criteria|31|||
27877894|NCT01907100|54497840|FG001|Overall Study|PD based on modified RECIST criteria|32|||
27877895|NCT01907100|54497841|FG002|Overall Study|PD based on modified RECIST criteria|95|||
27877896|NCT01907100|54497842|FG003|Overall Study|PD based on modified RECIST criteria|92|||
27877897|NCT01907100|54497839|FG000|Overall Study|Withdrawal by Subject|2|||
27877898|NCT01907100|54497840|FG001|Overall Study|Withdrawal by Subject|5|||
27877899|NCT01907100|54497841|FG002|Overall Study|Withdrawal by Subject|10|||
27877900|NCT01907100|54497842|FG003|Overall Study|Withdrawal by Subject|13|||
27877901|NCT01907100|54497839|FG000|Overall Study|Protocol Violation|0|||
27877902|NCT01907100|54497840|FG001|Overall Study|Protocol Violation|0|||
27877903|NCT01907100|54497841|FG002|Overall Study|Protocol Violation|1|||
27877904|NCT01907100|54497842|FG003|Overall Study|Protocol Violation|1|||
27877905|NCT01907100|54497839|FG000|Overall Study|Lost to Follow-up|0|||
27877906|NCT01907100|54497840|FG001|Overall Study|Lost to Follow-up|0|||
27877907|NCT01907100|54497841|FG002|Overall Study|Lost to Follow-up|0|||
27983206|NCT00923351|54641487|FG000|Overall Study|no apheresis/adequate tumor sample|0|||
27983207|NCT00923351|54641488|FG001|Overall Study|no apheresis/adequate tumor sample|0|||
27983208|NCT00923351|54641489|FG002|Overall Study|no apheresis/adequate tumor sample|12|||
27983209|NCT00755937|54641495|FG000|Recruitment|Unknown if infliximab received|164|||
27983210|NCT00755937|54641495|FG000|Observational Follow-up|Lost to Follow-up|148|||
27983211|NCT00755079|54641501|FG000|Overall Study|Lost to Follow-up|1|||
27983212|NCT00755079|54641502|FG001|Overall Study|Lost to Follow-up|3|||
27983213|NCT00755079|54641501|FG000|Overall Study|Adverse Event|0|||
27877908|NCT01907100|54497842|FG003|Overall Study|Lost to Follow-up|1|||
27877909|NCT01907100|54497839|FG000|Overall Study|Not treated|2|||
27877910|NCT01907100|54497840|FG001|Overall Study|Not treated|0|||
27877911|NCT01907100|54497841|FG002|Overall Study|Not treated|1|||
27983214|NCT00755079|54641502|FG001|Overall Study|Adverse Event|1|||
27983215|NCT00755079|54641501|FG000|Overall Study|Withdrawal by Subject|0|||
27983216|NCT00755079|54641502|FG001|Overall Study|Withdrawal by Subject|2|||
27877912|NCT01907100|54497842|FG003|Overall Study|Not treated|2|||
27877913|NCT01907100|54497839|FG000|Overall Study|Other than reasons specified|1|||
27877914|NCT01907100|54497840|FG001|Overall Study|Other than reasons specified|0|||
27877915|NCT01907100|54497841|FG002|Overall Study|Other than reasons specified|10|||
27877916|NCT01907100|54497842|FG003|Overall Study|Other than reasons specified|6|||
27877917|NCT01907100|54497839|FG000|Overall Study|Adverse event (AE)|6|||
27877918|NCT01907100|54497840|FG001|Overall Study|Adverse event (AE)|3|||
27877919|NCT01907100|54497841|FG002|Overall Study|Adverse event (AE)|22|||
28096476|NCT04410198|54751448|FG000|Overall Study|Adverse Event|4|||
27877920|NCT01907100|54497842|FG003|Overall Study|Adverse event (AE)|23|||
27877921|NCT01907100|54497839|FG000|Overall Study|Worsening/AE underlying cancer disease|0|||
27877922|NCT01907100|54497840|FG001|Overall Study|Worsening/AE underlying cancer disease|0|||
27877923|NCT01907100|54497841|FG002|Overall Study|Worsening/AE underlying cancer disease|8|||
27877924|NCT01907100|54497842|FG003|Overall Study|Worsening/AE underlying cancer disease|8|||
27877925|NCT01889862|54497850|FG000|Part 1 (Up to 13 Weeks)|Adverse Event|4|||
27877926|NCT01889862|54497851|FG001|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
27877927|NCT01889862|54497852|FG002|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
27877928|NCT01889862|54497853|FG003|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
27877929|NCT01889862|54497854|FG004|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
27877930|NCT01889862|54497850|FG000|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|2|||
27877931|NCT01889862|54497851|FG001|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
27877932|NCT01889862|54497852|FG002|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
27877933|NCT01889862|54497853|FG003|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
27877934|NCT01889862|54497854|FG004|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
27877935|NCT01889862|54497850|FG000|Part 1 (Up to 13 Weeks)|Lost to Follow-up|4|||
27877936|NCT01889862|54497851|FG001|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
27877937|NCT01889862|54497852|FG002|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
27877938|NCT01889862|54497853|FG003|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
27877939|NCT01889862|54497854|FG004|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
27877940|NCT01889862|54497850|FG000|Part 1 (Up to 13 Weeks)|Physician Decision|2|||
27877941|NCT01889862|54497851|FG001|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
27877942|NCT01889862|54497852|FG002|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
27877943|NCT01889862|54497853|FG003|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
27877944|NCT01889862|54497854|FG004|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
27877945|NCT01889862|54497850|FG000|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
27877946|NCT01889862|54497851|FG001|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
27877947|NCT01889862|54497852|FG002|Part 2 (8 Weeks)|Withdrawal by Subject|1|||
27877948|NCT01889862|54497853|FG003|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
27877949|NCT01889862|54497854|FG004|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
27877950|NCT01889862|54497850|FG000|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
27877951|NCT01889862|54497851|FG001|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
27877952|NCT01889862|54497852|FG002|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
27877953|NCT01889862|54497853|FG003|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
27877954|NCT01889862|54497854|FG004|Part 4 (Up to 274 Weeks)|Adverse Event|5|||
27877955|NCT01889862|54497850|FG000|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
27877956|NCT01889862|54497851|FG001|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
27877957|NCT01889862|54497852|FG002|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
27877958|NCT01889862|54497853|FG003|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
27983217|NCT00925301|54641510|FG000|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
27983218|NCT00925301|54641511|FG001|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2|||
27983219|NCT00925301|54641512|FG002|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
27983220|NCT00925301|54641513|FG003|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
27983221|NCT00925301|54641510|FG000|6-Month Double-blind (Stage 1)|Pregnancy|0|||
27983222|NCT00925301|54641511|FG001|6-Month Double-blind (Stage 1)|Pregnancy|1|||
27983223|NCT00925301|54641512|FG002|6-Month Double-blind (Stage 1)|Pregnancy|0|||
27983224|NCT00925301|54641513|FG003|6-Month Double-blind (Stage 1)|Pregnancy|0|||
27983225|NCT00925301|54641510|FG000|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
27983226|NCT00925301|54641511|FG001|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
27983227|NCT00925301|54641512|FG002|6-Month Open-label (Stage 2)|Withdrawal by Subject|1|||
27983228|NCT00925301|54641513|FG003|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
27983229|NCT00925301|54641510|FG000|6-Month Open-label (Stage 2)|Adverse Event|0|||
27983230|NCT00925301|54641511|FG001|6-Month Open-label (Stage 2)|Adverse Event|0|||
27983231|NCT00925301|54641512|FG002|6-Month Open-label (Stage 2)|Adverse Event|2|||
27983232|NCT00925301|54641513|FG003|6-Month Open-label (Stage 2)|Adverse Event|0|||
27983233|NCT00925301|54641510|FG000|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
28096477|NCT04410198|54751448|FG000|Overall Study|Physician Decision|2|||
27877959|NCT01889862|54497854|FG004|Part 4 (Up to 274 Weeks)|Subject withdrew consent|14|||
27877960|NCT01889862|54497850|FG000|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
27877961|NCT01889862|54497851|FG001|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
27877962|NCT01889862|54497852|FG002|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
27877963|NCT01889862|54497853|FG003|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
27877964|NCT01889862|54497854|FG004|Part 4 (Up to 274 Weeks)|Lost to Follow-up|4|||
27925691|NCT01020448|54582219|FG000|Treatment|Disease Progression|2|||
27925692|NCT01020448|54582219|FG000|Treatment|Lack of Efficacy|8|||
27925693|NCT01020448|54582219|FG000|Treatment|Lost to Follow-up|2|||
27925694|NCT01256658|54582226|FG000|Period 1|Lost to Follow-up|837|||
27925695|NCT01256658|54582227|FG001|Period 1|Lost to Follow-up|661|||
27925696|NCT01256658|54582226|FG000|Period 1|Withdrawal by Subject|35|||
27925697|NCT01256658|54582227|FG001|Period 1|Withdrawal by Subject|43|||
27925698|NCT01256658|54582226|FG000|Period 1|Death|48|||
27925699|NCT01256658|54582227|FG001|Period 1|Death|44|||
27877965|NCT01889862|54497850|FG000|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
27877966|NCT01889862|54497851|FG001|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
27877967|NCT01889862|54497852|FG002|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
27877968|NCT01889862|54497853|FG003|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
27877969|NCT01889862|54497854|FG004|Part 4 (Up to 274 Weeks)|Physician Decision|5|||
27877970|NCT01889862|54497850|FG000|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
27877971|NCT01889862|54497851|FG001|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
27877972|NCT01889862|54497852|FG002|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
27877973|NCT01889862|54497853|FG003|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
27877974|NCT01889862|54497854|FG004|Part 4 (Up to 274 Weeks)|Protocol deviations|2|||
27877975|NCT01887912|54497881|FG000|Overall Study|Serious adverse event|400|||
27877976|NCT01887912|54497882|FG001|Overall Study|Serious adverse event|198|||
27877977|NCT01887912|54497881|FG000|Overall Study|Other Adverse Event|34|||
27877978|NCT01887912|54497882|FG001|Overall Study|Other Adverse Event|15|||
27877979|NCT01887912|54497881|FG000|Overall Study|Protocol Violation|67|||
27877980|NCT01887912|54497882|FG001|Overall Study|Protocol Violation|37|||
27877981|NCT01887912|54497881|FG000|Overall Study|Lost to Follow-up|163|||
27877982|NCT01887912|54497882|FG001|Overall Study|Lost to Follow-up|74|||
27877983|NCT01887912|54497881|FG000|Overall Study|Withdrawal by Subject|606|||
27877984|NCT01887912|54497882|FG001|Overall Study|Withdrawal by Subject|349|||
27877985|NCT01887912|54497881|FG000|Overall Study|Other|122|||
27877986|NCT01887912|54497882|FG001|Overall Study|Other|58|||
27877987|NCT01887678|54497890|FG000|Overall Study|Adverse Event|4|||
27877988|NCT01887678|54497891|FG001|Overall Study|Adverse Event|6|||
27877989|NCT01887678|54497890|FG000|Overall Study|Exceeded rescue medication dosage|4|||
28171661|NCT03350815|54843240|FG003|Period 2|Withdrawal by Subject|0|||
28171662|NCT03350815|54843237|FG000|Period 2|Lack of Efficacy|0|||
28171663|NCT03350815|54843238|FG001|Period 2|Lack of Efficacy|6|||
28171664|NCT03350815|54843239|FG002|Period 2|Lack of Efficacy|2|||
28171665|NCT03350815|54843240|FG003|Period 2|Lack of Efficacy|0|||
28171666|NCT03350815|54843237|FG000|Period 2|Protocol Violation|0|||
28171667|NCT03350815|54843238|FG001|Period 2|Protocol Violation|0|||
28171668|NCT03350815|54843239|FG002|Period 2|Protocol Violation|1|||
28171669|NCT03350815|54843240|FG003|Period 2|Protocol Violation|0|||
28171670|NCT03350815|54843237|FG000|Period 2|New therapy for study indication|0|||
28171671|NCT03350815|54843238|FG001|Period 2|New therapy for study indication|0|||
28171672|NCT03350815|54843239|FG002|Period 2|New therapy for study indication|1|||
28171673|NCT03350815|54843240|FG003|Period 2|New therapy for study indication|0|||
28171674|NCT00854295|54843255|FG000|Overall Study|Death|7|||
28171675|NCT00854295|54843256|FG001|Overall Study|Death|0|||
28171676|NCT00854295|54843257|FG002|Overall Study|Death|1|||
28171677|NCT00854295|54843258|FG003|Overall Study|Death|1|||
28171678|NCT00854295|54843255|FG000|Overall Study|Adverse Event|6|||
28171679|NCT00854295|54843256|FG001|Overall Study|Adverse Event|1|||
28171680|NCT00854295|54843257|FG002|Overall Study|Adverse Event|1|||
28171681|NCT00854295|54843258|FG003|Overall Study|Adverse Event|3|||
28171682|NCT00854295|54843255|FG000|Overall Study|Lost to Follow-up|18|||
27877990|NCT01887678|54497891|FG001|Overall Study|Exceeded rescue medication dosage|5|||
27877991|NCT01887678|54497890|FG000|Overall Study|Withdrawal of consent|3|||
27877992|NCT01887678|54497891|FG001|Overall Study|Withdrawal of consent|4|||
27877993|NCT01887678|54497890|FG000|Overall Study|Lost to Follow-up|4|||
27877994|NCT01887678|54497891|FG001|Overall Study|Lost to Follow-up|2|||
27877995|NCT01887678|54497890|FG000|Overall Study|Deterioration of clinical condition|0|||
27877996|NCT01887678|54497891|FG001|Overall Study|Deterioration of clinical condition|4|||
27877997|NCT01887678|54497890|FG000|Overall Study|Lack of Efficacy|1|||
27877998|NCT01887678|54497891|FG001|Overall Study|Lack of Efficacy|2|||
27877999|NCT01887678|54497890|FG000|Overall Study|Non-compliance|0|||
27878000|NCT01887678|54497891|FG001|Overall Study|Non-compliance|3|||
27983234|NCT00925301|54641511|FG001|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
27983235|NCT00925301|54641512|FG002|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
27983236|NCT00925301|54641513|FG003|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1|||
27983237|NCT00925301|54641510|FG000|12-Month Open-label Extension (Optional)|Pregnancy|0|||
27983238|NCT00925301|54641511|FG001|12-Month Open-label Extension (Optional)|Pregnancy|0|||
27983239|NCT00925301|54641512|FG002|12-Month Open-label Extension (Optional)|Pregnancy|0|||
27983240|NCT00925301|54641513|FG003|12-Month Open-label Extension (Optional)|Pregnancy|1|||
28171683|NCT00854295|54843256|FG001|Overall Study|Lost to Follow-up|5|||
27878001|NCT01887678|54497890|FG000|Overall Study|Specified|1|||
27878002|NCT01887678|54497891|FG001|Overall Study|Specified|2|||
27878003|NCT01887600|54497899|FG000|Overall Study|Death|39|||
27878004|NCT01887600|54497900|FG001|Overall Study|Death|16|||
27878005|NCT01887600|54497899|FG000|Overall Study|Lack of Efficacy|3|||
28171684|NCT00854295|54843257|FG002|Overall Study|Lost to Follow-up|21|||
28171685|NCT00854295|54843258|FG003|Overall Study|Lost to Follow-up|21|||
28171686|NCT00854295|54843255|FG000|Overall Study|Physician Decision|10|||
28171687|NCT00854295|54843256|FG001|Overall Study|Physician Decision|0|||
28171688|NCT00854295|54843257|FG002|Overall Study|Physician Decision|0|||
28171689|NCT00854295|54843258|FG003|Overall Study|Physician Decision|0|||
27878006|NCT01887600|54497900|FG001|Overall Study|Lack of Efficacy|26|||
27878007|NCT01887600|54497899|FG000|Overall Study|Lost to Follow-up|5|||
27878008|NCT01887600|54497900|FG001|Overall Study|Lost to Follow-up|1|||
27878009|NCT01887600|54497899|FG000|Overall Study|Physician Decision|7|||
27878010|NCT01887600|54497900|FG001|Overall Study|Physician Decision|8|||
27878011|NCT01887600|54497899|FG000|Overall Study|Protocol Deviation|3|||
27878012|NCT01887600|54497900|FG001|Overall Study|Protocol Deviation|0|||
27878013|NCT01887600|54497899|FG000|Overall Study|Withdrawal by Subject|58|||
27878014|NCT01887600|54497900|FG001|Overall Study|Withdrawal by Subject|52|||
27878015|NCT01887600|54497899|FG000|Overall Study|Adverse Event|21|||
27878016|NCT01887600|54497900|FG001|Overall Study|Adverse Event|9|||
27878017|NCT01887600|54497899|FG000|Overall Study|Non-compliance with study drug|3|||
27878018|NCT01887600|54497900|FG001|Overall Study|Non-compliance with study drug|0|||
27878019|NCT01887600|54497899|FG000|Overall Study|Miscellaneous|6|||
27878020|NCT01887600|54497900|FG001|Overall Study|Miscellaneous|2|||
27878021|NCT01887600|54497899|FG000|Overall Study|Progressive Disease|1|||
27878022|NCT01887600|54497900|FG001|Overall Study|Progressive Disease|0|||
27878023|NCT01887288|54497907|FG000|Overall Study|The study was terminated and the PI has|16|||
27878024|NCT01887210|54497913|FG000|Overall Study|Withdrawal by Subject|1|||
27878025|NCT01887210|54497914|FG001|Overall Study|Withdrawal by Subject|3|||
27878026|NCT01887210|54497913|FG000|Overall Study|Lost to Follow-up|0|||
27878027|NCT01887210|54497914|FG001|Overall Study|Lost to Follow-up|1|||
27878028|NCT01885182|54497945|FG000|Overall Study|Adverse Event|11|||
27878029|NCT01885182|54497946|FG001|Overall Study|Adverse Event|13|||
27878030|NCT01885182|54497945|FG000|Overall Study|Withdrawal by Subject|13|||
27878031|NCT01885182|54497946|FG001|Overall Study|Withdrawal by Subject|6|||
27878032|NCT01885182|54497945|FG000|Overall Study|Lost to Follow-up|2|||
27878033|NCT01885182|54497946|FG001|Overall Study|Lost to Follow-up|2|||
27878034|NCT01885182|54497945|FG000|Overall Study|Lack of Efficacy|8|||
27878035|NCT01885182|54497946|FG001|Overall Study|Lack of Efficacy|1|||
27878036|NCT01885104|54497956|FG000|Overall Study|Withdrawal of Consent|1|||
27878037|NCT01885104|54497957|FG001|Overall Study|Withdrawal of Consent|0|||
27878038|NCT01885104|54497956|FG000|Overall Study|Lost to Follow-up|0|||
27878039|NCT01885104|54497957|FG001|Overall Study|Lost to Follow-up|1|||
27878040|NCT01885104|54497956|FG000|Overall Study|Physician Decision|1|||
27878041|NCT01885104|54497957|FG001|Overall Study|Physician Decision|0|||
27878042|NCT01881750|54497965|FG000|Overall Study|Changes in concomitant therapies|2|||
27878043|NCT01881750|54497966|FG001|Overall Study|Changes in concomitant therapies|3|||
27878044|NCT01881750|54497965|FG000|Overall Study|Lost to Follow-up|0|||
27878045|NCT01881750|54497966|FG001|Overall Study|Lost to Follow-up|1|||
27878046|NCT01906008|54497976|FG000|Overall Study|Lost to Follow-up|2|||
27878047|NCT01906008|54497977|FG001|Overall Study|Lost to Follow-up|0|||
27878048|NCT01906008|54497976|FG000|Overall Study|Oxaliplatin toxicity|2|||
27878049|NCT01906008|54497977|FG001|Overall Study|Oxaliplatin toxicity|0|||
27878050|NCT01906008|54497976|FG000|Overall Study|Protocol Violation|0|||
27878051|NCT01906008|54497977|FG001|Overall Study|Protocol Violation|1|||
27878052|NCT01906008|54497976|FG000|Overall Study|Withdrawal by Subject|1|||
27878053|NCT01906008|54497977|FG001|Overall Study|Withdrawal by Subject|5|||
27878054|NCT01906008|54497976|FG000|Overall Study|Did not start study med|3|||
27878055|NCT01906008|54497977|FG001|Overall Study|Did not start study med|4|||
27878056|NCT01906008|54497976|FG000|Overall Study|Oxaliplatin stops|10|||
27878057|NCT01906008|54497977|FG001|Overall Study|Oxaliplatin stops|8|||
27878058|NCT01906008|54497976|FG000|Overall Study|Hospice|1|||
27983241|NCT00925301|54641510|FG000|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
27983242|NCT00925301|54641511|FG001|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
27983243|NCT00925301|54641512|FG002|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
27983244|NCT00925301|54641513|FG003|12-Month Open-label Extension (Optional)|Lost to Follow-up|1|||
27983245|NCT00754065|54641526|FG000|Overall Study|Never received treatment|12|||
27983246|NCT00754065|54641527|FG001|Overall Study|Never received treatment|2|||
27983247|NCT00754065|54641526|FG000|Overall Study|Adverse Event|19|||
27983248|NCT00754065|54641527|FG001|Overall Study|Adverse Event|25|||
27983249|NCT00754065|54641526|FG000|Overall Study|Lost to Follow-up|7|||
27983250|NCT00754065|54641527|FG001|Overall Study|Lost to Follow-up|11|||
27878059|NCT01906008|54497977|FG001|Overall Study|Hospice|0|||
27878060|NCT01906008|54497976|FG000|Overall Study|Physician Decision|3|||
27878061|NCT01906008|54497977|FG001|Overall Study|Physician Decision|3|||
27983251|NCT00754065|54641526|FG000|Overall Study|Protocol Violation|12|||
27878062|NCT01906008|54497976|FG000|Overall Study|Lack of compliance of study med|5|||
27878063|NCT01906008|54497977|FG001|Overall Study|Lack of compliance of study med|3|||
27878064|NCT01906008|54497976|FG000|Overall Study|Adverse Event|0|||
27878065|NCT01906008|54497977|FG001|Overall Study|Adverse Event|3|||
27878066|NCT01863732|54497987|FG000|Overall Study|Adverse Event|2|||
27878067|NCT01863732|54497988|FG001|Overall Study|Adverse Event|0|||
27878068|NCT01863732|54497989|FG002|Overall Study|Adverse Event|3|||
27878069|NCT01863732|54497990|FG003|Overall Study|Adverse Event|3|||
27878070|NCT01863732|54497987|FG000|Overall Study|Lack of Efficacy|1|||
27878071|NCT01863732|54497988|FG001|Overall Study|Lack of Efficacy|0|||
27983252|NCT00754065|54641527|FG001|Overall Study|Protocol Violation|10|||
27878072|NCT01863732|54497989|FG002|Overall Study|Lack of Efficacy|2|||
27878073|NCT01863732|54497990|FG003|Overall Study|Lack of Efficacy|1|||
27878074|NCT01863732|54497987|FG000|Overall Study|Lost to Follow-up|2|||
27878075|NCT01863732|54497988|FG001|Overall Study|Lost to Follow-up|2|||
27878076|NCT01863732|54497989|FG002|Overall Study|Lost to Follow-up|1|||
27878077|NCT01863732|54497990|FG003|Overall Study|Lost to Follow-up|1|||
27878078|NCT01863732|54497987|FG000|Overall Study|Physician Decision|1|||
27878079|NCT01863732|54497988|FG001|Overall Study|Physician Decision|0|||
27878080|NCT01863732|54497989|FG002|Overall Study|Physician Decision|1|||
27878081|NCT01863732|54497990|FG003|Overall Study|Physician Decision|0|||
27878082|NCT01863732|54497987|FG000|Overall Study|Pregnancy|0|||
27878083|NCT01863732|54497988|FG001|Overall Study|Pregnancy|0|||
27878084|NCT01863732|54497989|FG002|Overall Study|Pregnancy|0|||
27878085|NCT01863732|54497990|FG003|Overall Study|Pregnancy|1|||
27878086|NCT01863732|54497987|FG000|Overall Study|Technical problems|0|||
27878087|NCT01863732|54497988|FG001|Overall Study|Technical problems|1|||
27878088|NCT01863732|54497989|FG002|Overall Study|Technical problems|1|||
27878089|NCT01863732|54497990|FG003|Overall Study|Technical problems|0|||
27878090|NCT01863732|54497987|FG000|Overall Study|Subject/guardian decision|6|||
27878091|NCT01863732|54497988|FG001|Overall Study|Subject/guardian decision|9|||
27878092|NCT01863732|54497989|FG002|Overall Study|Subject/guardian decision|3|||
27878093|NCT01863732|54497990|FG003|Overall Study|Subject/guardian decision|1|||
27878094|NCT01863732|54497987|FG000|Overall Study|Death|1|||
27878095|NCT01863732|54497988|FG001|Overall Study|Death|0|||
27878096|NCT01863732|54497989|FG002|Overall Study|Death|0|||
27878097|NCT01863732|54497990|FG003|Overall Study|Death|1|||
27878098|NCT01905540|54498003|FG000|Period 3|Other|1|||
27878099|NCT01905540|54498004|FG001|Period 3|Other|0|||
27878100|NCT01905540|54498005|FG002|Period 3|Other|1|||
27878101|NCT01905540|54498006|FG003|Period 3|Other|1|||
27878102|NCT01904760|54498018|FG000|Overall Study|Protocol Violation|1|||
27878103|NCT01904760|54498019|FG001|Overall Study|Protocol Violation|0|||
27878104|NCT01904604|54498028|FG000|Overall Study|Withdrew before receiving dosing|0|||
27878105|NCT01904604|54498029|FG001|Overall Study|Withdrew before receiving dosing|1|||
27878106|NCT01904604|54498030|FG002|Overall Study|Withdrew before receiving dosing|0|||
27878107|NCT01904604|54498028|FG000|Overall Study|Non-compliance|1|||
27878108|NCT01904604|54498029|FG001|Overall Study|Non-compliance|0|||
27878109|NCT01904604|54498030|FG002|Overall Study|Non-compliance|0|||
27878110|NCT01904604|54498028|FG000|Overall Study|Anxiety about OFC/Refused OFC|2|||
27878111|NCT01904604|54498029|FG001|Overall Study|Anxiety about OFC/Refused OFC|0|||
27878112|NCT01904604|54498030|FG002|Overall Study|Anxiety about OFC/Refused OFC|0|||
27878113|NCT01904604|54498028|FG000|Overall Study|Patch site reactions|1|||
27878114|NCT01904604|54498029|FG001|Overall Study|Patch site reactions|1|||
27878115|NCT01904604|54498030|FG002|Overall Study|Patch site reactions|0|||
27878116|NCT01904604|54498028|FG000|Overall Study|Increased syncope|0|||
27878117|NCT01904604|54498029|FG001|Overall Study|Increased syncope|1|||
27878118|NCT01904604|54498030|FG002|Overall Study|Increased syncope|0|||
27878119|NCT01904604|54498028|FG000|Overall Study|Unrelated illness|0|||
27878120|NCT01904604|54498029|FG001|Overall Study|Unrelated illness|1|||
27878121|NCT01904604|54498030|FG002|Overall Study|Unrelated illness|0|||
27878122|NCT01904604|54498028|FG000|Overall Study|Passed Week 52 OFC|1|||
27878123|NCT01904604|54498029|FG001|Overall Study|Passed Week 52 OFC|0|||
27878124|NCT01904604|54498030|FG002|Overall Study|Passed Week 52 OFC|0|||
27878125|NCT01904604|54498028|FG000|Overall Study|Withdrawal by Subject|1|||
27878126|NCT01904604|54498029|FG001|Overall Study|Withdrawal by Subject|2|||
27878127|NCT01904604|54498030|FG002|Overall Study|Withdrawal by Subject|0|||
27878128|NCT01904604|54498028|FG000|Overall Study|Participant Relocated|1|||
27878129|NCT01904604|54498029|FG001|Overall Study|Participant Relocated|1|||
27878130|NCT01904604|54498030|FG002|Overall Study|Participant Relocated|1|||
27878131|NCT01904604|54498028|FG000|Overall Study|Lost to Follow-up|0|||
27878132|NCT01904604|54498029|FG001|Overall Study|Lost to Follow-up|0|||
27878133|NCT01904604|54498030|FG002|Overall Study|Lost to Follow-up|1|||
27878134|NCT01904058|54498045|FG000|Overall Study|Adverse Event|2|||
27739274|NCT03318523|54188614|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|48|||
27878135|NCT01904058|54498046|FG001|Overall Study|Adverse Event|0|||
27878136|NCT01904058|54498047|FG002|Overall Study|Adverse Event|0|||
27878137|NCT01904058|54498048|FG003|Overall Study|Adverse Event|0|||
27878138|NCT01904058|54498045|FG000|Overall Study|Withdrawal by Subject|1|||
27878139|NCT01904058|54498046|FG001|Overall Study|Withdrawal by Subject|0|||
27878140|NCT01904058|54498047|FG002|Overall Study|Withdrawal by Subject|1|||
27878141|NCT01904058|54498048|FG003|Overall Study|Withdrawal by Subject|0|||
27878142|NCT01904058|54498045|FG000|Overall Study|Pregnancy|0|||
27878143|NCT01904058|54498046|FG001|Overall Study|Pregnancy|0|||
27878144|NCT01904058|54498047|FG002|Overall Study|Pregnancy|0|||
27878145|NCT01904058|54498048|FG003|Overall Study|Pregnancy|1|||
27878146|NCT01881126|54498066|FG000|Overall Study|Non-compliance|1|||
27878147|NCT01881126|54498067|FG001|Overall Study|Non-compliance|1|||
27878148|NCT01881126|54498066|FG000|Overall Study|Adverse Event|0|||
27878149|NCT01881126|54498067|FG001|Overall Study|Adverse Event|1|||
27878150|NCT01614600|54498073|FG000|Overall Study|Unacceptable fit|1|||
27878151|NCT01614600|54498073|FG000|Overall Study|Discomfort|1|||
27878152|NCT01614600|54498073|FG000|Overall Study|Unable to remove lens at the end of day|1|||
27878153|NCT01614600|54498073|FG000|Overall Study|Protocol deviation|1|||
27878154|NCT01880736|54498081|FG000|Overall Study|Adverse Event|0|||
27878155|NCT01880736|54498082|FG001|Overall Study|Adverse Event|0|||
27878156|NCT01880736|54498083|FG002|Overall Study|Adverse Event|0|||
27878157|NCT01880736|54498084|FG003|Overall Study|Adverse Event|1|||
27878158|NCT01880736|54498081|FG000|Overall Study|Withdrawal Criteria|1|||
27878159|NCT01880736|54498082|FG001|Overall Study|Withdrawal Criteria|2|||
27878160|NCT01880736|54498083|FG002|Overall Study|Withdrawal Criteria|1|||
27878161|NCT01880736|54498084|FG003|Overall Study|Withdrawal Criteria|5|||
27878162|NCT01880424|54498096|FG000|Overall Study|Adverse Event|7|||
27878163|NCT01880424|54498097|FG001|Overall Study|Adverse Event|6|||
27878164|NCT01880424|54498096|FG000|Overall Study|Lack of Efficacy|1|||
27878165|NCT01880424|54498097|FG001|Overall Study|Lack of Efficacy|4|||
27878166|NCT01880424|54498096|FG000|Overall Study|Lost to Follow-up|3|||
27878167|NCT01880424|54498097|FG001|Overall Study|Lost to Follow-up|2|||
27878168|NCT01880424|54498096|FG000|Overall Study|Protocol Violation|11|||
27878169|NCT01880424|54498097|FG001|Overall Study|Protocol Violation|13|||
27878170|NCT01880424|54498096|FG000|Overall Study|Withdrawal by Subject|10|||
27878171|NCT01880424|54498097|FG001|Overall Study|Withdrawal by Subject|30|||
27878172|NCT01880424|54498096|FG000|Overall Study|Other|1|||
27878173|NCT01880424|54498097|FG001|Overall Study|Other|0|||
27878174|NCT01862874|54498105|FG000|Overall Study|Randomized not treated|1|||
27878175|NCT01862874|54498106|FG001|Overall Study|Randomized not treated|0|||
27878176|NCT01862874|54498105|FG000|Overall Study|Adverse Event|0|||
27878177|NCT01862874|54498106|FG001|Overall Study|Adverse Event|3|||
27878178|NCT01862874|54498105|FG000|Overall Study|Lost to Follow-up|26|||
27878179|NCT01862874|54498106|FG001|Overall Study|Lost to Follow-up|29|||
27878180|NCT01862874|54498105|FG000|Overall Study|Physician Decision|5|||
27878181|NCT01862874|54498106|FG001|Overall Study|Physician Decision|3|||
27878182|NCT01862874|54498105|FG000|Overall Study|Withdrawn by parent/guardian|1|||
27878183|NCT01862874|54498106|FG001|Overall Study|Withdrawn by parent/guardian|1|||
27878184|NCT01862874|54498105|FG000|Overall Study|Withdrawal by Subject|46|||
27878185|NCT01862874|54498106|FG001|Overall Study|Withdrawal by Subject|40|||
27878186|NCT01862874|54498105|FG000|Overall Study|Death|0|||
27878187|NCT01862874|54498106|FG001|Overall Study|Death|1|||
27878188|NCT01879722|54498122|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
27878189|NCT01879722|54498123|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
27878190|NCT01879722|54498124|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
27878191|NCT01879722|54498125|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
27878192|NCT01879722|54498126|FG004|Overall Study|Pretreatment Event/Adverse Event|1|||
27878193|NCT01879722|54498127|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
27878194|NCT01879722|54498128|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
27878195|NCT01879722|54498129|FG007|Overall Study|Pretreatment Event/Adverse Event|1|||
27878196|NCT01879722|54498130|FG008|Overall Study|Pretreatment Event/Adverse Event|1|||
27878197|NCT01879722|54498131|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
27878198|NCT01879722|54498122|FG000|Overall Study|Voluntary Withdrawal|0|||
27878199|NCT01879722|54498123|FG001|Overall Study|Voluntary Withdrawal|0|||
27878200|NCT01879722|54498124|FG002|Overall Study|Voluntary Withdrawal|0|||
27878201|NCT01879722|54498125|FG003|Overall Study|Voluntary Withdrawal|0|||
27878202|NCT01879722|54498126|FG004|Overall Study|Voluntary Withdrawal|0|||
27878203|NCT01879722|54498127|FG005|Overall Study|Voluntary Withdrawal|0|||
27878204|NCT01879722|54498128|FG006|Overall Study|Voluntary Withdrawal|0|||
27878205|NCT01879722|54498129|FG007|Overall Study|Voluntary Withdrawal|0|||
27878206|NCT01879722|54498130|FG008|Overall Study|Voluntary Withdrawal|1|||
27878207|NCT01879722|54498131|FG009|Overall Study|Voluntary Withdrawal|0|||
27878208|NCT01879410|54498158|FG000|Overall Study|Adverse Event|9|||
27878209|NCT01879410|54498159|FG001|Overall Study|Adverse Event|14|||
27878210|NCT01879410|54498158|FG000|Overall Study|Lack of Efficacy|4|||
27878211|NCT01879410|54498159|FG001|Overall Study|Lack of Efficacy|6|||
27878212|NCT01879410|54498158|FG000|Overall Study|Protocol Violation|1|||
27878213|NCT01879410|54498159|FG001|Overall Study|Protocol Violation|7|||
27878214|NCT01879410|54498158|FG000|Overall Study|Lost to Follow-up|2|||
27739275|NCT03318523|54188615|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|94|||
27878215|NCT01879410|54498159|FG001|Overall Study|Lost to Follow-up|1|||
27878216|NCT01879410|54498158|FG000|Overall Study|Withdrawal by Subject|7|||
27878217|NCT01879410|54498159|FG001|Overall Study|Withdrawal by Subject|8|||
27878218|NCT01879410|54498158|FG000|Overall Study|Randomised in Error|1|||
27878219|NCT01879410|54498159|FG001|Overall Study|Randomised in Error|2|||
27878220|NCT01903434|54498165|FG000|Washout Period 1 (at Least 14 Days)|Adverse Event|1|||
27878221|NCT01903434|54498166|FG001|Washout Period 1 (at Least 14 Days)|Adverse Event|0|||
27878222|NCT01903434|54498165|FG000|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0|||
27878223|NCT01903434|54498166|FG001|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2|||
27878224|NCT01903356|54498172|FG000|Overall Study|Lost to Follow-up|7|||
27878225|NCT01903356|54498172|FG000|Overall Study|Violated inclusion/exclusion criteria|5|||
28171690|NCT02792959|54843269|FG000|Overall Study|Protocol Violation|1|||
28096478|NCT04410198|54751448|FG000|Overall Study|Other than specified|1|||
28096479|NCT04161144|54751454|FG000|Overall Study|Withdrawal by Subject|0|||
28096480|NCT04161144|54751455|FG001|Overall Study|Withdrawal by Subject|1|||
28096481|NCT04161144|54751454|FG000|Overall Study|Protocol Violation|1|||
28096482|NCT04161144|54751455|FG001|Overall Study|Protocol Violation|0|||
28096483|NCT03984812|54751472|FG000|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
27739276|NCT03318523|54188616|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|91|||
27878226|NCT01903356|54498172|FG000|Overall Study|Violated the dosage and administration|3|||
27878227|NCT01862796|54498179|FG000|Overall Study|Prohibited medications|0|||
27878228|NCT01862796|54498180|FG001|Overall Study|Prohibited medications|0|||
27878229|NCT01862796|54498181|FG002|Overall Study|Prohibited medications|1|||
27878230|NCT01878084|54498189|FG000|Overall Study|Physician Decision|2|||
27878231|NCT01862640|54498198|FG000|Overall Study|Adverse Event|4|||
27878232|NCT01862640|54498199|FG001|Overall Study|Adverse Event|10|||
27878233|NCT01862640|54498200|FG002|Overall Study|Adverse Event|6|||
27878234|NCT01862640|54498201|FG003|Overall Study|Adverse Event|8|||
27878235|NCT01862640|54498198|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
27878236|NCT01862640|54498199|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
27878237|NCT01862640|54498200|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
27878238|NCT01862640|54498201|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
27878239|NCT01862640|54498198|FG000|Overall Study|Participant Withdrawn by Investigator|0|||
27878240|NCT01862640|54498199|FG001|Overall Study|Participant Withdrawn by Investigator|1|||
27878241|NCT01862640|54498200|FG002|Overall Study|Participant Withdrawn by Investigator|1|||
27878242|NCT01862640|54498201|FG003|Overall Study|Participant Withdrawn by Investigator|1|||
27878243|NCT01862640|54498198|FG000|Overall Study|Withdrawal by Subject|2|||
27878244|NCT01862640|54498199|FG001|Overall Study|Withdrawal by Subject|4|||
27878245|NCT01862640|54498200|FG002|Overall Study|Withdrawal by Subject|8|||
27878246|NCT01862640|54498201|FG003|Overall Study|Withdrawal by Subject|5|||
27878247|NCT01862640|54498198|FG000|Overall Study|Protocol Deviation|0|||
27878248|NCT01862640|54498199|FG001|Overall Study|Protocol Deviation|0|||
27878249|NCT01862640|54498200|FG002|Overall Study|Protocol Deviation|1|||
27878250|NCT01862640|54498201|FG003|Overall Study|Protocol Deviation|0|||
27878251|NCT01902966|54498210|FG000|Overall Study|Death|1|||
27878252|NCT01902966|54498210|FG000|Overall Study|Physician Decision|1|||
27878253|NCT01902966|54498210|FG000|Overall Study|Withdrawal by Subject|1|||
27878254|NCT01862484|54498216|FG000|Overall Study|Lack of Efficacy|1|||
27878255|NCT01862484|54498217|FG001|Overall Study|Lack of Efficacy|1|||
27878256|NCT01862484|54498216|FG000|Overall Study|Lost to Follow-up|1|||
27878257|NCT01862484|54498217|FG001|Overall Study|Lost to Follow-up|2|||
27878258|NCT01862484|54498216|FG000|Overall Study|Protocol Violation|0|||
27878259|NCT01862484|54498217|FG001|Overall Study|Protocol Violation|2|||
27878260|NCT01862484|54498216|FG000|Overall Study|Withdrawal by Subject|0|||
27878261|NCT01862484|54498217|FG001|Overall Study|Withdrawal by Subject|3|||
27878262|NCT01902888|54498223|FG000|Overall Study|Study Terminated|3|||
27878263|NCT01862328|54498234|FG000|Overall Study|Progressive Disease|3|||
27878264|NCT01862328|54498235|FG001|Overall Study|Progressive Disease|11|||
27878265|NCT01862328|54498236|FG002|Overall Study|Progressive Disease|5|||
27878266|NCT01862328|54498237|FG003|Overall Study|Progressive Disease|6|||
27878267|NCT01862328|54498238|FG004|Overall Study|Progressive Disease|7|||
27878268|NCT01862328|54498239|FG005|Overall Study|Progressive Disease|4|||
27878269|NCT01862328|54498240|FG006|Overall Study|Progressive Disease|3|||
27878270|NCT01862328|54498234|FG000|Overall Study|Adverse Event|0|||
27878271|NCT01862328|54498235|FG001|Overall Study|Adverse Event|4|||
27878272|NCT01862328|54498236|FG002|Overall Study|Adverse Event|0|||
27878273|NCT01862328|54498237|FG003|Overall Study|Adverse Event|1|||
27878274|NCT01862328|54498238|FG004|Overall Study|Adverse Event|0|||
27878275|NCT01862328|54498239|FG005|Overall Study|Adverse Event|2|||
27878276|NCT01862328|54498240|FG006|Overall Study|Adverse Event|4|||
27878277|NCT01862328|54498234|FG000|Overall Study|Other|0|||
27878278|NCT01862328|54498235|FG001|Overall Study|Other|2|||
27878279|NCT01862328|54498236|FG002|Overall Study|Other|1|||
27878280|NCT01862328|54498237|FG003|Overall Study|Other|0|||
27878281|NCT01862328|54498238|FG004|Overall Study|Other|4|||
27878282|NCT01862328|54498239|FG005|Overall Study|Other|0|||
28096484|NCT03984812|54751473|FG001|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
27739277|NCT03318523|54188607|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
27878283|NCT01862328|54498240|FG006|Overall Study|Other|1|||
27878284|NCT01862328|54498234|FG000|Overall Study|Withdrawal by Subject|1|||
27878285|NCT01862328|54498235|FG001|Overall Study|Withdrawal by Subject|1|||
28096485|NCT03984812|54751474|FG002|Part 1 (Up to Day 28)|Withdrawal by Subject|1|||
27878286|NCT01862328|54498236|FG002|Overall Study|Withdrawal by Subject|0|||
27878287|NCT01862328|54498237|FG003|Overall Study|Withdrawal by Subject|0|||
27878288|NCT01862328|54498238|FG004|Overall Study|Withdrawal by Subject|1|||
27878289|NCT01862328|54498239|FG005|Overall Study|Withdrawal by Subject|1|||
27878290|NCT01862328|54498240|FG006|Overall Study|Withdrawal by Subject|1|||
27878291|NCT01862328|54498234|FG000|Overall Study|Symptomatic Deterioration|0|||
27878292|NCT01862328|54498235|FG001|Overall Study|Symptomatic Deterioration|0|||
27878293|NCT01862328|54498236|FG002|Overall Study|Symptomatic Deterioration|0|||
27878294|NCT01862328|54498237|FG003|Overall Study|Symptomatic Deterioration|0|||
27878295|NCT01862328|54498238|FG004|Overall Study|Symptomatic Deterioration|0|||
27878296|NCT01862328|54498239|FG005|Overall Study|Symptomatic Deterioration|0|||
27878297|NCT01862328|54498240|FG006|Overall Study|Symptomatic Deterioration|1|||
27878298|NCT01862250|54498262|FG000|Overall Study|Adverse Event|4|||
27878299|NCT01860846|54498266|FG000|Overall Study|Lost to Follow-up|33|||
27878300|NCT01901874|54498270|FG000|Screening Committee Retrospective Review|Protocol Violation|47|||
27878301|NCT01901874|54498270|FG000|30-Day MAE Evaluation|Insufficient Follow-up|1|||
27878302|NCT01901874|54498270|FG000|1-Year (365-Day) MAE Evaluation|Death|7|||
27878303|NCT01901874|54498270|FG000|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5|||
27878304|NCT01901874|54498270|FG000|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2|||
27878305|NCT01901874|54498270|FG000|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6|||
27878306|NCT01860534|54498276|FG000|ROP #1|Needed treatment for ROP|0|||
27878307|NCT01860534|54498277|FG001|ROP #1|Needed treatment for ROP|1|||
27878308|NCT01860534|54498276|FG000|ROP #2|discharged prior to ROP #2|1|||
27878309|NCT01860534|54498277|FG001|ROP #2|discharged prior to ROP #2|0|||
27878310|NCT01901328|54498287|FG000|Overall Study|Lost to Follow-up|1|||
27878311|NCT01901328|54498288|FG001|Overall Study|Lost to Follow-up|0|||
27878312|NCT01901328|54498287|FG000|Overall Study|Physician Decision|0|||
27878313|NCT01901328|54498288|FG001|Overall Study|Physician Decision|1|||
27878314|NCT01901328|54498287|FG000|Overall Study|Protocol Violation|1|||
27878315|NCT01901328|54498288|FG001|Overall Study|Protocol Violation|1|||
27878316|NCT01901328|54498287|FG000|Overall Study|Study Terminated by Sponsor|19|||
27878317|NCT01901328|54498288|FG001|Overall Study|Study Terminated by Sponsor|16|||
27878318|NCT01901328|54498287|FG000|Overall Study|Withdrawal by Subject|1|||
27878319|NCT01901328|54498288|FG001|Overall Study|Withdrawal by Subject|2|||
27878320|NCT01901328|54498287|FG000|Overall Study|Lack of Efficacy|0|||
27878321|NCT01901328|54498288|FG001|Overall Study|Lack of Efficacy|1|||
28171691|NCT01652872|54843275|FG000|Overall Study|Death|36|||
27835682|NCT02691702|54320543|FG005|Overall Study|Adverse Event|0|||
27835683|NCT02691702|54320544|FG006|Overall Study|Adverse Event|0|||
27835684|NCT02691702|54320545|FG007|Overall Study|Adverse Event|0|||
27835685|NCT02691702|54320546|FG008|Overall Study|Adverse Event|1|||
27835686|NCT02691702|54320547|FG009|Overall Study|Adverse Event|0|||
27835687|NCT02691702|54320548|FG010|Overall Study|Adverse Event|1|||
27835688|NCT02691702|54320538|FG000|Overall Study|Lost to Follow-up|0|||
27835689|NCT02691702|54320539|FG001|Overall Study|Lost to Follow-up|0|||
27835690|NCT02691702|54320540|FG002|Overall Study|Lost to Follow-up|1|||
27835691|NCT02691702|54320541|FG003|Overall Study|Lost to Follow-up|0|||
27835692|NCT02691702|54320542|FG004|Overall Study|Lost to Follow-up|0|||
27835693|NCT02691702|54320543|FG005|Overall Study|Lost to Follow-up|2|||
27835694|NCT02691702|54320544|FG006|Overall Study|Lost to Follow-up|0|||
27835695|NCT02691702|54320545|FG007|Overall Study|Lost to Follow-up|0|||
27835696|NCT02691702|54320546|FG008|Overall Study|Lost to Follow-up|0|||
27835697|NCT02691702|54320547|FG009|Overall Study|Lost to Follow-up|0|||
27835698|NCT02691702|54320548|FG010|Overall Study|Lost to Follow-up|1|||
27835699|NCT02691702|54320538|FG000|Overall Study|Withdrawal by Subject|1|||
27835700|NCT02691702|54320539|FG001|Overall Study|Withdrawal by Subject|1|||
27835701|NCT02691702|54320540|FG002|Overall Study|Withdrawal by Subject|0|||
27835702|NCT02691702|54320541|FG003|Overall Study|Withdrawal by Subject|0|||
27835703|NCT02691702|54320542|FG004|Overall Study|Withdrawal by Subject|0|||
27835704|NCT02691702|54320543|FG005|Overall Study|Withdrawal by Subject|1|||
27835705|NCT02691702|54320544|FG006|Overall Study|Withdrawal by Subject|2|||
27835706|NCT02691702|54320545|FG007|Overall Study|Withdrawal by Subject|0|||
27835707|NCT02691702|54320546|FG008|Overall Study|Withdrawal by Subject|0|||
27835708|NCT02691702|54320547|FG009|Overall Study|Withdrawal by Subject|0|||
27835709|NCT02691702|54320548|FG010|Overall Study|Withdrawal by Subject|0|||
27835710|NCT02691702|54320538|FG000|Overall Study|Other|0|||
27835711|NCT02691702|54320539|FG001|Overall Study|Other|0|||
27835712|NCT02691702|54320540|FG002|Overall Study|Other|0|||
27835713|NCT02691702|54320541|FG003|Overall Study|Other|0|||
27835714|NCT02691702|54320542|FG004|Overall Study|Other|0|||
27835715|NCT02691702|54320543|FG005|Overall Study|Other|0|||
27835716|NCT02691702|54320544|FG006|Overall Study|Other|1|||
27835717|NCT02691702|54320545|FG007|Overall Study|Other|0|||
27835718|NCT02691702|54320546|FG008|Overall Study|Other|1|||
27835719|NCT02691702|54320547|FG009|Overall Study|Other|0|||
27835720|NCT02691702|54320548|FG010|Overall Study|Other|0|||
27835721|NCT02691702|54320538|FG000|Overall Study|Protocol Violation|0|||
27835722|NCT02691702|54320539|FG001|Overall Study|Protocol Violation|0|||
27835723|NCT02691702|54320540|FG002|Overall Study|Protocol Violation|0|||
27835724|NCT02691702|54320541|FG003|Overall Study|Protocol Violation|0|||
27835725|NCT02691702|54320542|FG004|Overall Study|Protocol Violation|0|||
27835726|NCT02691702|54320543|FG005|Overall Study|Protocol Violation|0|||
27835727|NCT02691702|54320544|FG006|Overall Study|Protocol Violation|0|||
27835728|NCT02691702|54320545|FG007|Overall Study|Protocol Violation|0|||
27835729|NCT02691702|54320546|FG008|Overall Study|Protocol Violation|0|||
27878322|NCT01859988|54498301|FG000|Overall Study|Withdrawal by Subject|6|||
27878323|NCT01859988|54498302|FG001|Overall Study|Withdrawal by Subject|3|||
27878324|NCT01859988|54498303|FG002|Overall Study|Withdrawal by Subject|4|||
27878325|NCT01859988|54498304|FG003|Overall Study|Withdrawal by Subject|3|||
27878326|NCT01859988|54498305|FG004|Overall Study|Withdrawal by Subject|2|||
27878327|NCT01859988|54498306|FG005|Overall Study|Withdrawal by Subject|2|||
27878328|NCT01859988|54498301|FG000|Overall Study|Lack of Efficacy|1|||
27878329|NCT01859988|54498302|FG001|Overall Study|Lack of Efficacy|1|||
27878330|NCT01859988|54498303|FG002|Overall Study|Lack of Efficacy|5|||
27878331|NCT01859988|54498304|FG003|Overall Study|Lack of Efficacy|0|||
27878332|NCT01859988|54498305|FG004|Overall Study|Lack of Efficacy|7|||
27878333|NCT01859988|54498306|FG005|Overall Study|Lack of Efficacy|9|||
27878334|NCT01859988|54498301|FG000|Overall Study|Physician Decision|1|||
27878335|NCT01859988|54498302|FG001|Overall Study|Physician Decision|3|||
27878336|NCT01859988|54498303|FG002|Overall Study|Physician Decision|1|||
27878337|NCT01859988|54498304|FG003|Overall Study|Physician Decision|3|||
27878338|NCT01859988|54498305|FG004|Overall Study|Physician Decision|4|||
27878339|NCT01859988|54498306|FG005|Overall Study|Physician Decision|1|||
27878340|NCT01859988|54498301|FG000|Overall Study|Adverse Event|2|||
27878341|NCT01859988|54498302|FG001|Overall Study|Adverse Event|1|||
27878342|NCT01859988|54498303|FG002|Overall Study|Adverse Event|3|||
27878343|NCT01859988|54498304|FG003|Overall Study|Adverse Event|1|||
27878344|NCT01859988|54498305|FG004|Overall Study|Adverse Event|2|||
27878345|NCT01859988|54498306|FG005|Overall Study|Adverse Event|2|||
27878346|NCT01859988|54498301|FG000|Overall Study|Lost to Follow-up|1|||
27878347|NCT01859988|54498302|FG001|Overall Study|Lost to Follow-up|2|||
27878348|NCT01859988|54498303|FG002|Overall Study|Lost to Follow-up|3|||
27878349|NCT01859988|54498304|FG003|Overall Study|Lost to Follow-up|0|||
27878350|NCT01859988|54498305|FG004|Overall Study|Lost to Follow-up|3|||
27878351|NCT01859988|54498306|FG005|Overall Study|Lost to Follow-up|2|||
27878352|NCT01859988|54498301|FG000|Overall Study|Protocol Violation|0|||
27878353|NCT01859988|54498302|FG001|Overall Study|Protocol Violation|0|||
27878354|NCT01859988|54498303|FG002|Overall Study|Protocol Violation|1|||
27878355|NCT01859988|54498304|FG003|Overall Study|Protocol Violation|0|||
27878356|NCT01859988|54498305|FG004|Overall Study|Protocol Violation|0|||
27878357|NCT01859988|54498306|FG005|Overall Study|Protocol Violation|0|||
27878358|NCT01859988|54498301|FG000|Overall Study|Other than specified above|0|||
27878359|NCT01859988|54498302|FG001|Overall Study|Other than specified above|2|||
27878360|NCT01859988|54498303|FG002|Overall Study|Other than specified above|11|||
27878361|NCT01859988|54498304|FG003|Overall Study|Other than specified above|3|||
27878362|NCT01859988|54498305|FG004|Overall Study|Other than specified above|5|||
27878363|NCT01859988|54498306|FG005|Overall Study|Other than specified above|3|||
27878364|NCT01859598|54498320|FG000|Visit 2 at 3 Months|Lost to Follow-up|1742|||
27878365|NCT01876446|54498328|FG000|Overall Study|Death|0|||
27878366|NCT01876446|54498329|FG001|Overall Study|Death|1|||
27878367|NCT01876446|54498328|FG000|Overall Study|Withdrawal by Subject|1|||
27878368|NCT01876446|54498329|FG001|Overall Study|Withdrawal by Subject|2|||
27878369|NCT01876446|54498328|FG000|Overall Study|Physician Decision|1|||
27878370|NCT01876446|54498329|FG001|Overall Study|Physician Decision|3|||
27878371|NCT01900626|54498337|FG000|Overall Study|study was closed due to low enrollment|1|||
27878372|NCT01900626|54498338|FG001|Overall Study|study was closed due to low enrollment|1|||
27878373|NCT01900314|54498348|FG000|Overall Study|Lost to Follow-up|1|||
27878374|NCT01900314|54498349|FG001|Overall Study|Lost to Follow-up|0|||
27878375|NCT01900314|54498348|FG000|Overall Study|Protocol Violation|0|||
27878376|NCT01900314|54498349|FG001|Overall Study|Protocol Violation|1|||
27878377|NCT01900314|54498348|FG000|Overall Study|Withdrawal by Subject|3|||
27878378|NCT01900314|54498349|FG001|Overall Study|Withdrawal by Subject|3|||
27878379|NCT01899768|54498356|FG000|Part A|Adverse Event|2|||
27878380|NCT01899768|54498356|FG000|Part A|Withdrawal by Subject|1|||
27878381|NCT01899768|54498356|FG000|Part B|Adverse Event|1|||
27878382|NCT01899768|54498356|FG000|Part B|Withdrawal by Subject|1|||
27878383|NCT01898598|54498366|FG000|Overall Study|Adverse Event|1|||
27878384|NCT01898598|54498367|FG001|Overall Study|Adverse Event|0|||
27878385|NCT01898598|54498366|FG000|Overall Study|Withdrawal by Subject|3|||
28096486|NCT03984812|54751475|FG003|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
28096487|NCT03984812|54751476|FG004|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
27878386|NCT01898598|54498367|FG001|Overall Study|Withdrawal by Subject|0|||
27878387|NCT01898598|54498366|FG000|Overall Study|Lost to Follow-up|0|||
27878388|NCT01898598|54498367|FG001|Overall Study|Lost to Follow-up|1|||
27878389|NCT01898598|54498366|FG000|Overall Study|Other|0|||
27878390|NCT01898598|54498367|FG001|Overall Study|Other|1|||
27878391|NCT01898442|54498376|FG000|Overall Study|Hemolysis/technical problems|1|||
27878392|NCT01898442|54498377|FG001|Overall Study|Hemolysis/technical problems|2|||
27878393|NCT01898442|54498378|FG002|Overall Study|Hemolysis/technical problems|2|||
27878394|NCT01898442|54498376|FG000|Overall Study|Patient vomited pills|0|||
27878395|NCT01898442|54498377|FG001|Overall Study|Patient vomited pills|0|||
27878396|NCT01898442|54498378|FG002|Overall Study|Patient vomited pills|1|||
27878397|NCT01898286|54498386|FG000|Overall Study|Withdrawal by Subject|1|||
27878398|NCT01898286|54498386|FG000|Overall Study|Protocol Violation|1|||
27878399|NCT01898286|54498386|FG000|Overall Study|Lost to Follow-up|1|||
27878400|NCT01898208|54498393|FG000|Overall Study|Positive blood culture|17|||
27878401|NCT01898208|54498394|FG001|Overall Study|Positive blood culture|23|||
27878402|NCT01898208|54498395|FG002|Overall Study|Positive blood culture|15|||
27878403|NCT01898208|54498393|FG000|Overall Study|Death/comfort care within 24 hours|10|||
27878404|NCT01898208|54498394|FG001|Overall Study|Death/comfort care within 24 hours|9|||
27878405|NCT01898208|54498395|FG002|Overall Study|Death/comfort care within 24 hours|8|||
27878406|NCT01898208|54498393|FG000|Overall Study|Negative Gram Stain|6|||
27878407|NCT01898208|54498394|FG001|Overall Study|Negative Gram Stain|9|||
27878408|NCT01898208|54498395|FG002|Overall Study|Negative Gram Stain|6|||
27878409|NCT01898208|54498393|FG000|Overall Study|Non-Blood Specimens in Bottles|3|||
27878410|NCT01898208|54498394|FG001|Overall Study|Non-Blood Specimens in Bottles|5|||
27878411|NCT01898208|54498395|FG002|Overall Study|Non-Blood Specimens in Bottles|4|||
27878412|NCT01898208|54498393|FG000|Overall Study|System/Technical Error|1|||
27878413|NCT01898208|54498394|FG001|Overall Study|System/Technical Error|2|||
27878414|NCT01898208|54498395|FG002|Overall Study|System/Technical Error|3|||
27878415|NCT01898208|54498393|FG000|Overall Study|Lost to Follow-up|3|||
27878416|NCT01898208|54498394|FG001|Overall Study|Lost to Follow-up|1|||
27878417|NCT01898208|54498395|FG002|Overall Study|Lost to Follow-up|1|||
27878418|NCT01898130|54498403|FG000|Treatment|Withdrawal by Subject|2|||
27878419|NCT01898130|54498403|FG000|Treatment|Progressive Disease|4|||
27878420|NCT01898130|54498403|FG000|Follow up Until PD or Death|Lost to Follow-up|1|||
27878421|NCT01876368|54498409|FG000|Overall Study|Adverse Event|2|||
28096488|NCT03984812|54751477|FG005|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
27878422|NCT01876368|54498410|FG001|Overall Study|Adverse Event|5|||
27878423|NCT01876368|54498409|FG000|Overall Study|Lack of Efficacy|1|||
27878424|NCT01876368|54498410|FG001|Overall Study|Lack of Efficacy|0|||
27878425|NCT01876368|54498409|FG000|Overall Study|Lost to Follow-up|0|||
27878426|NCT01876368|54498410|FG001|Overall Study|Lost to Follow-up|1|||
27878427|NCT01876368|54498409|FG000|Overall Study|Non-compliance with study treatment|0|||
27878428|NCT01876368|54498410|FG001|Overall Study|Non-compliance with study treatment|1|||
27878429|NCT01876368|54498409|FG000|Overall Study|Physician Decision|0|||
27878430|NCT01876368|54498410|FG001|Overall Study|Physician Decision|2|||
27878431|NCT01876368|54498409|FG000|Overall Study|Protocol deviation|3|||
27878432|NCT01876368|54498410|FG001|Overall Study|Protocol deviation|3|||
27878433|NCT01876368|54498409|FG000|Overall Study|Subject/guardian decision|3|||
27878434|NCT01876368|54498410|FG001|Overall Study|Subject/guardian decision|1|||
27878435|NCT01874340|54498420|FG000|Overall Study|Study terminated by Sponsor|6|||
27878436|NCT01874340|54498421|FG001|Overall Study|Study terminated by Sponsor|8|||
27878437|NCT01874340|54498422|FG002|Overall Study|Study terminated by Sponsor|8|||
27878438|NCT01874340|54498423|FG003|Overall Study|Study terminated by Sponsor|4|||
27878439|NCT01874340|54498420|FG000|Overall Study|Withdrawal by Subject|0|||
27878440|NCT01874340|54498421|FG001|Overall Study|Withdrawal by Subject|0|||
27878441|NCT01874340|54498422|FG002|Overall Study|Withdrawal by Subject|0|||
27878442|NCT01874340|54498423|FG003|Overall Study|Withdrawal by Subject|1|||
27878443|NCT01897896|54498435|FG000|Overall Study|Death|1|||
27878444|NCT01897896|54498436|FG001|Overall Study|Death|0|||
27878445|NCT01897896|54498435|FG000|Overall Study|Adverse Event|11|||
27878446|NCT01897896|54498436|FG001|Overall Study|Adverse Event|1|||
27878447|NCT01897896|54498435|FG000|Overall Study|Lost to Follow-up|1|||
27878448|NCT01897896|54498436|FG001|Overall Study|Lost to Follow-up|0|||
27878449|NCT01897896|54498435|FG000|Overall Study|Non-compliance with study drug dosing|1|||
27878450|NCT01897896|54498436|FG001|Overall Study|Non-compliance with study drug dosing|1|||
27878451|NCT01897896|54498435|FG000|Overall Study|Withdrawal by Subject|7|||
27878452|NCT01897896|54498436|FG001|Overall Study|Withdrawal by Subject|1|||
27878453|NCT01897896|54498435|FG000|Overall Study|Require drug that interfere with study|1|||
27878454|NCT01897896|54498436|FG001|Overall Study|Require drug that interfere with study|4|||
27878455|NCT01897896|54498435|FG000|Overall Study|Protocol Violation|1|||
27878456|NCT01897896|54498436|FG001|Overall Study|Protocol Violation|1|||
27878457|NCT01897896|54498435|FG000|Overall Study|Withdrawal per Investigator's judgement|1|||
27878458|NCT01897896|54498436|FG001|Overall Study|Withdrawal per Investigator's judgement|1|||
27878459|NCT01897896|54498435|FG000|Overall Study|Caregiver can no longer participate|0|||
27878460|NCT01897896|54498436|FG001|Overall Study|Caregiver can no longer participate|2|||
27878461|NCT01897896|54498435|FG000|Overall Study|Other than specified|2|||
27878462|NCT01897896|54498436|FG001|Overall Study|Other than specified|1|||
27878463|NCT01858194|54498446|FG000|Overall Study|Total Artificial Heart Implant|0|||
27878464|NCT01858194|54498447|FG001|Overall Study|Total Artificial Heart Implant|1|||
27878465|NCT01858194|54498446|FG000|Overall Study|Lost to Follow-up|0|||
27878466|NCT01858194|54498447|FG001|Overall Study|Lost to Follow-up|1|||
27878467|NCT01873950|54498455|FG000|Period 5|Withdrawal by Subject|0|||
28096489|NCT03984812|54751478|FG006|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
27878468|NCT01873950|54498456|FG001|Period 5|Withdrawal by Subject|0|||
27878469|NCT01873950|54498457|FG002|Period 5|Withdrawal by Subject|0|||
27878470|NCT01873950|54498458|FG003|Period 5|Withdrawal by Subject|1|||
27878471|NCT01873950|54498459|FG004|Period 5|Withdrawal by Subject|0|||
27878472|NCT01857102|54498473|FG000|Period 1|No longer meets Eligibility Criteria|0|||
27878473|NCT01857102|54498474|FG001|Period 1|No longer meets Eligibility Criteria|2|||
27878474|NCT01857102|54498473|FG000|Period 1|Lost to Follow-up|0|||
27878475|NCT01857102|54498474|FG001|Period 1|Lost to Follow-up|3|||
27878476|NCT01857102|54498473|FG000|Period 1|Unsatisfactory Lens Fit|1|||
27878477|NCT01857102|54498474|FG001|Period 1|Unsatisfactory Lens Fit|0|||
27878478|NCT01857102|54498473|FG000|Period 1|Unsatisfactory Visual Response|1|||
27878479|NCT01857102|54498474|FG001|Period 1|Unsatisfactory Visual Response|0|||
27878480|NCT01857102|54498473|FG000|Period 1|Physician Decision|1|||
27878481|NCT01857102|54498474|FG001|Period 1|Physician Decision|0|||
27878482|NCT01857102|54498473|FG000|Period 2|Lens Discomfort|1|||
27878483|NCT01857102|54498474|FG001|Period 2|Lens Discomfort|0|||
27878484|NCT01857102|54498473|FG000|Period 2|Unsatisfactory Lens Fit|1|||
27878485|NCT01857102|54498474|FG001|Period 2|Unsatisfactory Lens Fit|0|||
27878486|NCT01872078|54498486|FG000|Overall Study|Adverse Event|0|||
27878487|NCT01872078|54498487|FG001|Overall Study|Adverse Event|0|||
27878488|NCT01872078|54498488|FG002|Overall Study|Adverse Event|1|||
27878489|NCT01872078|54498489|FG003|Overall Study|Adverse Event|0|||
27878490|NCT01872078|54498486|FG000|Overall Study|Dose administration non-compliance|0|||
27878491|NCT01872078|54498487|FG001|Overall Study|Dose administration non-compliance|0|||
27878492|NCT01872078|54498488|FG002|Overall Study|Dose administration non-compliance|0|||
27878493|NCT01872078|54498489|FG003|Overall Study|Dose administration non-compliance|1|||
27878494|NCT01872078|54498486|FG000|Overall Study|Protocol Violation|0|||
27878495|NCT01872078|54498487|FG001|Overall Study|Protocol Violation|0|||
27878496|NCT01872078|54498488|FG002|Overall Study|Protocol Violation|1|||
27878497|NCT01872078|54498489|FG003|Overall Study|Protocol Violation|0|||
27878498|NCT01872078|54498486|FG000|Overall Study|Withdrawal by Subject|0|||
27878499|NCT01872078|54498487|FG001|Overall Study|Withdrawal by Subject|0|||
27878500|NCT01872078|54498488|FG002|Overall Study|Withdrawal by Subject|1|||
27878501|NCT01872078|54498489|FG003|Overall Study|Withdrawal by Subject|0|||
27878502|NCT01872078|54498486|FG000|Overall Study|Patient met exclusion criterion 16.|0|||
27878503|NCT01872078|54498487|FG001|Overall Study|Patient met exclusion criterion 16.|0|||
27878504|NCT01872078|54498488|FG002|Overall Study|Patient met exclusion criterion 16.|0|||
27878505|NCT01872078|54498489|FG003|Overall Study|Patient met exclusion criterion 16.|1|||
27878506|NCT01896726|54498499|FG000|Treatment Period 2 (Days 23-31)|Adverse Event|1|||
27878507|NCT01896726|54498499|FG000|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1|||
27878508|NCT01856790|54498506|FG000|Closed Loop Control|Withdrawal by Subject|2|||
27878509|NCT01856790|54498506|FG000|Closed Loop Control + Liraglutide|Withdrawal by Subject|2|||
27878510|NCT01856322|54498520|FG000|Overall Study|off study due to lack of accrual|0|||
27878511|NCT01856322|54498521|FG001|Overall Study|off study due to lack of accrual|0|||
27878512|NCT01856322|54498522|FG002|Overall Study|off study due to lack of accrual|3|||
27878513|NCT01896102|54498529|FG000|Overall Study|Death|1|||
27878514|NCT01896102|54498529|FG000|Overall Study|Participant to receive allogenic transplant|2|||
27878515|NCT01871532|54498536|FG000|Overall Study|Withdrawal by Subject|1|||
27878516|NCT01871532|54498537|FG001|Overall Study|Withdrawal by Subject|2|||
27878517|NCT01855074|54498543|FG000|Overall Study|Adverse Event|1|||
27878518|NCT01855074|54498543|FG000|Overall Study|Lost to Follow-up|4|||
27878519|NCT01855074|54498543|FG000|Overall Study|Withdrawal by Subject|8|||
27878520|NCT01855074|54498543|FG000|Overall Study|Started but not treated|1|||
27878521|NCT01871142|54498547|FG000|Overall Study|Adverse Event|1|||
27878522|NCT01895322|54498561|FG000|Overall Study|Adverse Event|1|||
27878523|NCT01895322|54498561|FG000|Overall Study|Withdrawal by Subject|2|||
27878524|NCT01895322|54498561|FG000|Overall Study|Protocol Violation|10|||
27878525|NCT01894776|54498566|FG000|Overall Study|Withdrawal by Subject|1|||
27878526|NCT01894620|54498572|FG000|Overall Study|Withdrawal by Subject|0|||
27878527|NCT01894620|54498573|FG001|Overall Study|Withdrawal by Subject|1|||
27878528|NCT01854918|54498583|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|20|||
27878529|NCT01854918|54498584|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|49|||
27878530|NCT01854918|54498583|FG000|SOC-controlled Period (Year 1)|Decision by Sponsor|2|||
27878531|NCT01854918|54498584|FG001|SOC-controlled Period (Year 1)|Decision by Sponsor|1|||
27878532|NCT01854918|54498583|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|3|||
27878533|NCT01854918|54498584|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|8|||
27878534|NCT01854918|54498583|FG000|SOC-controlled Period (Year 1)|Death|5|||
27878535|NCT01854918|54498584|FG001|SOC-controlled Period (Year 1)|Death|5|||
27878536|NCT01854918|54498583|FG000|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78|||
27878537|NCT01854918|54498584|FG001|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117|||
27878538|NCT01854918|54498583|FG000|All-IP Period (Years 2 and 3)|Decision by Sponsor|8|||
27878539|NCT01854918|54498584|FG001|All-IP Period (Years 2 and 3)|Decision by Sponsor|11|||
27878540|NCT01854918|54498583|FG000|All-IP Period (Years 2 and 3)|Lost to Follow-up|27|||
27878541|NCT01854918|54498584|FG001|All-IP Period (Years 2 and 3)|Lost to Follow-up|51|||
27878542|NCT01854918|54498583|FG000|All-IP Period (Years 2 and 3)|Death|5|||
27878543|NCT01854918|54498584|FG001|All-IP Period (Years 2 and 3)|Death|16|||
27878544|NCT01894230|54498599|FG000|Overall Study|Lost to Follow-up|2|||
27878545|NCT01894230|54498600|FG001|Overall Study|Lost to Follow-up|2|||
27878546|NCT01894230|54498599|FG000|Overall Study|Withdrawal by Subject|4|||
27878547|NCT01894230|54498600|FG001|Overall Study|Withdrawal by Subject|4|||
27878548|NCT01894230|54498599|FG000|Overall Study|Non-adherent|0|||
27878549|NCT01894230|54498600|FG001|Overall Study|Non-adherent|1|||
27878550|NCT01894230|54498599|FG000|Overall Study|Death|1|||
27878551|NCT01894230|54498600|FG001|Overall Study|Death|0|||
27878552|NCT01894152|54498606|FG000|Overall Study|No DMR and no Stent thrombosis|151|||
27878553|NCT01854528|54498612|FG000|Overall Study|Adverse Event|0|||
27878554|NCT01854528|54498613|FG001|Overall Study|Adverse Event|4|||
27878555|NCT01854528|54498612|FG000|Overall Study|Withdrawal by Subject|0|||
27878556|NCT01854528|54498613|FG001|Overall Study|Withdrawal by Subject|2|||
27878557|NCT01854528|54498612|FG000|Overall Study|Virologic Failure|0|||
27878558|NCT01854528|54498613|FG001|Overall Study|Virologic Failure|9|||
27878559|NCT01853982|54498621|FG000|Overall Study|Withdrawal by Subject|1|||
27878560|NCT01853982|54498622|FG001|Overall Study|Withdrawal by Subject|0|||
27878561|NCT01853982|54498621|FG000|Overall Study|Death|1|||
27878562|NCT01853982|54498622|FG001|Overall Study|Death|0|||
27878563|NCT01853982|54498621|FG000|Overall Study|Lost to Follow-up|0|||
27878564|NCT01853982|54498622|FG001|Overall Study|Lost to Follow-up|1|||
27878565|NCT01853280|54498630|FG000|Overall Study|Lack of Efficacy|2|||
27878566|NCT01853280|54498631|FG001|Overall Study|Lack of Efficacy|2|||
27878567|NCT01853280|54498630|FG000|Overall Study|Lost to Follow-up|0|||
27878568|NCT01853280|54498631|FG001|Overall Study|Lost to Follow-up|1|||
27878569|NCT01853280|54498630|FG000|Overall Study|Physician Decision|0|||
27878570|NCT01853280|54498631|FG001|Overall Study|Physician Decision|1|||
27878571|NCT01853280|54498630|FG000|Overall Study|Withdrawal by Subject|0|||
27878572|NCT01853280|54498631|FG001|Overall Study|Withdrawal by Subject|1|||
27878573|NCT01853280|54498630|FG000|Overall Study|Ineligible|0|||
27878574|NCT01853280|54498631|FG001|Overall Study|Ineligible|1|||
27878575|NCT01892436|54498641|FG000|Overall Study|Withdrawal by Subject|8|||
27878576|NCT01892436|54498642|FG001|Overall Study|Withdrawal by Subject|15|||
27878577|NCT01892436|54498643|FG002|Overall Study|Withdrawal by Subject|4|||
27878578|NCT01892436|54498644|FG003|Overall Study|Withdrawal by Subject|4|||
27878579|NCT01892436|54498641|FG000|Overall Study|Death|1|||
27878580|NCT01892436|54498642|FG001|Overall Study|Death|1|||
27878581|NCT01892436|54498643|FG002|Overall Study|Death|0|||
27878582|NCT01892436|54498644|FG003|Overall Study|Death|0|||
27878583|NCT01892436|54498641|FG000|Overall Study|Physician Decision|2|||
27878584|NCT01892436|54498642|FG001|Overall Study|Physician Decision|1|||
27878585|NCT01892436|54498643|FG002|Overall Study|Physician Decision|0|||
27878586|NCT01892436|54498644|FG003|Overall Study|Physician Decision|1|||
27878587|NCT01892436|54498641|FG000|Overall Study|Pregnancy|0|||
27878588|NCT01892436|54498642|FG001|Overall Study|Pregnancy|2|||
27878589|NCT01892436|54498643|FG002|Overall Study|Pregnancy|1|||
27878590|NCT01892436|54498644|FG003|Overall Study|Pregnancy|0|||
27878591|NCT01892436|54498641|FG000|Overall Study|Technical problems|2|||
27878592|NCT01892436|54498642|FG001|Overall Study|Technical problems|1|||
27878593|NCT01892436|54498643|FG002|Overall Study|Technical problems|1|||
27878594|NCT01892436|54498644|FG003|Overall Study|Technical problems|1|||
27878595|NCT01892436|54498641|FG000|Overall Study|Lack of Efficacy|1|||
27878596|NCT01892436|54498642|FG001|Overall Study|Lack of Efficacy|2|||
27878597|NCT01892436|54498643|FG002|Overall Study|Lack of Efficacy|2|||
27878598|NCT01892436|54498644|FG003|Overall Study|Lack of Efficacy|2|||
27878599|NCT01892436|54498641|FG000|Overall Study|Lost to Follow-up|1|||
27878600|NCT01892436|54498642|FG001|Overall Study|Lost to Follow-up|1|||
27878601|NCT01892436|54498643|FG002|Overall Study|Lost to Follow-up|1|||
27878602|NCT01892436|54498644|FG003|Overall Study|Lost to Follow-up|3|||
27878603|NCT01892436|54498641|FG000|Overall Study|non-compliance with treatment|1|||
27878604|NCT01892436|54498642|FG001|Overall Study|non-compliance with treatment|0|||
27878605|NCT01892436|54498643|FG002|Overall Study|non-compliance with treatment|0|||
27878606|NCT01892436|54498644|FG003|Overall Study|non-compliance with treatment|0|||
27878607|NCT01892436|54498641|FG000|Overall Study|Adverse Event|7|||
27878608|NCT01892436|54498642|FG001|Overall Study|Adverse Event|6|||
27878609|NCT01892436|54498643|FG002|Overall Study|Adverse Event|2|||
27878610|NCT01892436|54498644|FG003|Overall Study|Adverse Event|3|||
27878611|NCT01853046|54498656|FG000|Overall Study|Withdrawal by Subject|1|||
27878612|NCT01853046|54498657|FG001|Overall Study|Withdrawal by Subject|1|||
27878613|NCT01853046|54498656|FG000|Overall Study|Adverse Event|4|||
27878614|NCT01853046|54498657|FG001|Overall Study|Adverse Event|2|||
27878615|NCT01853046|54498656|FG000|Overall Study|Disease progression|13|||
27878616|NCT01853046|54498657|FG001|Overall Study|Disease progression|3|||
27878617|NCT01891890|54498667|FG000|Overall Study|Lost to Follow-up|0|||
27878618|NCT01891890|54498668|FG001|Overall Study|Lost to Follow-up|0|||
27983253|NCT00754065|54641526|FG000|Overall Study|Withdrawal by Subject|4|||
27983254|NCT00754065|54641527|FG001|Overall Study|Withdrawal by Subject|5|||
27878619|NCT01891890|54498669|FG002|Overall Study|Lost to Follow-up|1|||
27878620|NCT01891890|54498667|FG000|Overall Study|Study ended before endpoint reached|7|||
27878621|NCT01891890|54498668|FG001|Overall Study|Study ended before endpoint reached|3|||
27878622|NCT01891890|54498669|FG002|Overall Study|Study ended before endpoint reached|6|||
27878623|NCT01852812|54498680|FG000|Overall Study|Adverse Event|0|||
27878624|NCT01852812|54498681|FG001|Overall Study|Adverse Event|0|||
27878625|NCT01852812|54498682|FG002|Overall Study|Adverse Event|1|||
27878626|NCT01852812|54498680|FG000|Overall Study|Non-compliance With Study Drug|0|||
27878627|NCT01852812|54498681|FG001|Overall Study|Non-compliance With Study Drug|1|||
27983255|NCT00754065|54641526|FG000|Overall Study|Pregnancy|6|||
27983256|NCT00754065|54641527|FG001|Overall Study|Pregnancy|0|||
27983257|NCT00754065|54641526|FG000|Overall Study|Reason not specified or unknown, etc.|21|||
27983258|NCT00754065|54641527|FG001|Overall Study|Reason not specified or unknown, etc.|27|||
27983259|NCT04138056|54641547|FG000|Primary Study|Lost to Follow-up|3|||
27983260|NCT04138056|54641548|FG001|Primary Study|Lost to Follow-up|4|||
27983261|NCT04138056|54641549|FG002|Primary Study|Lost to Follow-up|1|||
27983262|NCT04138056|54641550|FG003|Primary Study|Lost to Follow-up|1|||
27983263|NCT04138056|54641551|FG004|Primary Study|Lost to Follow-up|4|||
27983264|NCT04138056|54641547|FG000|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|3|||
27983265|NCT04138056|54641548|FG001|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|4|||
27983266|NCT04138056|54641549|FG002|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|2|||
27983267|NCT04138056|54641550|FG003|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|1|||
27983268|NCT04138056|54641551|FG004|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|0|||
27983269|NCT04138056|54641547|FG000|Extension Study|Lost to Follow-up|1|||
27983270|NCT04138056|54641548|FG001|Extension Study|Lost to Follow-up|2|||
27983271|NCT04138056|54641549|FG002|Extension Study|Lost to Follow-up|1|||
27983272|NCT04138056|54641550|FG003|Extension Study|Lost to Follow-up|0|||
27983273|NCT04138056|54641551|FG004|Extension Study|Lost to Follow-up|1|||
27983274|NCT00753675|54641597|FG000|Overall Study|other reason|11|||
27983275|NCT00753675|54641598|FG001|Overall Study|other reason|12|||
27983276|NCT00753675|54641599|FG002|Overall Study|other reason|13|||
27983277|NCT00753675|54641597|FG000|Overall Study|Death|1|||
27983278|NCT00753675|54641598|FG001|Overall Study|Death|2|||
27983279|NCT00753675|54641599|FG002|Overall Study|Death|4|||
27983280|NCT00753675|54641597|FG000|Overall Study|Adverse Event|11|||
27983281|NCT00753675|54641598|FG001|Overall Study|Adverse Event|9|||
27983282|NCT00753675|54641599|FG002|Overall Study|Adverse Event|4|||
27983283|NCT00753675|54641597|FG000|Overall Study|Objective progression of disease|35|||
27983284|NCT00753675|54641598|FG001|Overall Study|Objective progression of disease|35|||
27983285|NCT00753675|54641599|FG002|Overall Study|Objective progression of disease|35|||
27983286|NCT00753675|54641597|FG000|Overall Study|Withdrawal by Subject|0|||
27983287|NCT00753675|54641598|FG001|Overall Study|Withdrawal by Subject|1|||
27983288|NCT00753675|54641599|FG002|Overall Study|Withdrawal by Subject|0|||
27983289|NCT00753675|54641597|FG000|Overall Study|Lost to Follow-up|1|||
27983290|NCT00753675|54641598|FG001|Overall Study|Lost to Follow-up|0|||
27983291|NCT00753675|54641599|FG002|Overall Study|Lost to Follow-up|0|||
27983292|NCT00586521|54641607|FG000|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1|||
27983293|NCT00923273|54641616|FG000|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
27983294|NCT00923273|54641617|FG001|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
27983295|NCT00923273|54641618|FG002|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
27983296|NCT00923273|54641619|FG003|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1|||
27983297|NCT00923273|54641620|FG004|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
27983298|NCT00923273|54641616|FG000|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
27983299|NCT00923273|54641617|FG001|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
27983300|NCT00923273|54641618|FG002|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
27983301|NCT00923273|54641619|FG003|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6|||
27983302|NCT00923273|54641620|FG004|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
27983303|NCT00923195|54641640|FG000|Overall Study|Death|0|||
27983304|NCT00923195|54641641|FG001|Overall Study|Death|1|||
27983305|NCT00753519|54641649|FG000|Overall Study|Withdrawal by Subject|0|||
27983306|NCT00753519|54641650|FG001|Overall Study|Withdrawal by Subject|2|||
27983307|NCT00919061|54641658|FG000|Overall Study|Adverse Event|1|||
27983308|NCT00919061|54641658|FG000|Overall Study|Withdrawal by Subject|1|||
27983309|NCT00747435|54641662|FG000|Overall Study|Lost to Follow-up|2|||
27983310|NCT00747435|54641662|FG000|Overall Study|Withdrawal by Subject|3|||
27983311|NCT00747435|54641662|FG000|Overall Study|Still undergoing follow up|1|||
27983312|NCT00918749|54641669|FG000|Overall Study|Adverse Event|1|||
27983313|NCT00918749|54641670|FG001|Overall Study|Adverse Event|0|||
27878628|NCT01852812|54498682|FG002|Overall Study|Non-compliance With Study Drug|0|||
27878629|NCT01869348|54498692|FG000|Overall Study|Withdrawal by Subject|1|||
27878630|NCT01869348|54498693|FG001|Overall Study|Withdrawal by Subject|1|||
27878631|NCT01869192|54498701|FG000|Preoperative Chemotherapy to Surgery|patient choice|2|||
27983314|NCT00918749|54641671|FG002|Overall Study|Adverse Event|1|||
27983315|NCT00918749|54641669|FG000|Overall Study|Lost to Follow-up|0|||
27983316|NCT00918749|54641670|FG001|Overall Study|Lost to Follow-up|0|||
27983317|NCT00918749|54641671|FG002|Overall Study|Lost to Follow-up|1|||
27983318|NCT00918749|54641669|FG000|Overall Study|Withdrawal by Subject|5|||
27983319|NCT00918749|54641670|FG001|Overall Study|Withdrawal by Subject|3|||
27983320|NCT00918749|54641671|FG002|Overall Study|Withdrawal by Subject|5|||
27878632|NCT01869192|54498702|FG001|Preoperative Chemotherapy to Surgery|patient choice|1|||
27878633|NCT01869192|54498701|FG000|Postoperative Chemotherapy|Physician Decision|0|||
27878634|NCT01869192|54498702|FG001|Postoperative Chemotherapy|Physician Decision|2|||
27878635|NCT01868646|54498710|FG000|Overall Study|Do not meet inclusion criteria|3|||
27878636|NCT01868646|54498711|FG001|Overall Study|Do not meet inclusion criteria|5|||
27878637|NCT01852110|54498719|FG000|Overall Study|Adverse Event|12|||
27878638|NCT01852110|54498720|FG001|Overall Study|Adverse Event|5|||
27878639|NCT01852110|54498721|FG002|Overall Study|Adverse Event|0|||
27878640|NCT01852110|54498722|FG003|Overall Study|Adverse Event|0|||
27878641|NCT01852110|54498723|FG004|Overall Study|Adverse Event|0|||
27878642|NCT01852110|54498724|FG005|Overall Study|Adverse Event|0|||
27878643|NCT01852110|54498719|FG000|Overall Study|Lost to Follow-up|1|||
27878644|NCT01852110|54498720|FG001|Overall Study|Lost to Follow-up|3|||
27878645|NCT01852110|54498721|FG002|Overall Study|Lost to Follow-up|0|||
27878646|NCT01852110|54498722|FG003|Overall Study|Lost to Follow-up|0|||
27878647|NCT01852110|54498723|FG004|Overall Study|Lost to Follow-up|0|||
27878648|NCT01852110|54498724|FG005|Overall Study|Lost to Follow-up|0|||
27878649|NCT01852110|54498719|FG000|Overall Study|Non-compliance with Study Drug|2|||
27878650|NCT01852110|54498720|FG001|Overall Study|Non-compliance with Study Drug|1|||
27878651|NCT01852110|54498721|FG002|Overall Study|Non-compliance with Study Drug|0|||
27878652|NCT01852110|54498722|FG003|Overall Study|Non-compliance with Study Drug|0|||
27878653|NCT01852110|54498723|FG004|Overall Study|Non-compliance with Study Drug|0|||
27878654|NCT01852110|54498724|FG005|Overall Study|Non-compliance with Study Drug|0|||
27878655|NCT01852110|54498719|FG000|Overall Study|Physician Decision|1|||
27878656|NCT01852110|54498720|FG001|Overall Study|Physician Decision|0|||
27878657|NCT01852110|54498721|FG002|Overall Study|Physician Decision|0|||
27878658|NCT01852110|54498722|FG003|Overall Study|Physician Decision|0|||
27878659|NCT01852110|54498723|FG004|Overall Study|Physician Decision|0|||
27878660|NCT01852110|54498724|FG005|Overall Study|Physician Decision|0|||
27878661|NCT01852110|54498719|FG000|Overall Study|Protocol Violation|0|||
27878662|NCT01852110|54498720|FG001|Overall Study|Protocol Violation|1|||
27739278|NCT03318523|54188608|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
27739279|NCT03318523|54188609|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
27739280|NCT03318523|54188610|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
27739281|NCT03318523|54188611|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|1|||
27878663|NCT01852110|54498721|FG002|Overall Study|Protocol Violation|0|||
27878664|NCT01852110|54498722|FG003|Overall Study|Protocol Violation|0|||
27878665|NCT01852110|54498723|FG004|Overall Study|Protocol Violation|0|||
27878666|NCT01852110|54498724|FG005|Overall Study|Protocol Violation|0|||
27878667|NCT01852110|54498719|FG000|Overall Study|Study Terminated by Sponsor|30|||
27878668|NCT01852110|54498720|FG001|Overall Study|Study Terminated by Sponsor|32|||
27878669|NCT01852110|54498721|FG002|Overall Study|Study Terminated by Sponsor|0|||
27878670|NCT01852110|54498722|FG003|Overall Study|Study Terminated by Sponsor|0|||
27878671|NCT01852110|54498723|FG004|Overall Study|Study Terminated by Sponsor|0|||
27878672|NCT01852110|54498724|FG005|Overall Study|Study Terminated by Sponsor|0|||
27878673|NCT01852110|54498719|FG000|Overall Study|Withdrawal by Subject|4|||
27878674|NCT01852110|54498720|FG001|Overall Study|Withdrawal by Subject|4|||
27878675|NCT01852110|54498721|FG002|Overall Study|Withdrawal by Subject|0|||
27878676|NCT01852110|54498722|FG003|Overall Study|Withdrawal by Subject|0|||
27878677|NCT01852110|54498723|FG004|Overall Study|Withdrawal by Subject|0|||
27878678|NCT01852110|54498724|FG005|Overall Study|Withdrawal by Subject|0|||
27878679|NCT01851720|54498740|FG000|Overall Study|Lost to Follow-up|0|||
27878680|NCT01851720|54498741|FG001|Overall Study|Lost to Follow-up|1|||
27878681|NCT01851330|54498750|FG000|Overall Study|Lack of Efficacy|10|||
27878682|NCT01851330|54498751|FG001|Overall Study|Lack of Efficacy|9|||
27878683|NCT01851330|54498752|FG002|Overall Study|Lack of Efficacy|2|||
27878684|NCT01851330|54498750|FG000|Overall Study|Lost to Follow-up|1|||
27878685|NCT01851330|54498751|FG001|Overall Study|Lost to Follow-up|6|||
27878686|NCT01851330|54498752|FG002|Overall Study|Lost to Follow-up|9|||
27878687|NCT01851330|54498750|FG000|Overall Study|Withdrew Consent|2|||
27878688|NCT01851330|54498751|FG001|Overall Study|Withdrew Consent|1|||
27878689|NCT01851330|54498752|FG002|Overall Study|Withdrew Consent|0|||
27878690|NCT01851330|54498750|FG000|Overall Study|Investigator's Discretion|0|||
27878691|NCT01851330|54498751|FG001|Overall Study|Investigator's Discretion|0|||
27739282|NCT03318523|54188612|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
27739283|NCT03318523|54188613|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
27878692|NCT01851330|54498752|FG002|Overall Study|Investigator's Discretion|1|||
27878693|NCT01868022|54498769|FG000|Overall Study|Withdrawal by Subject|0|||
27878694|NCT01868022|54498770|FG001|Overall Study|Withdrawal by Subject|0|||
27878695|NCT01868022|54498771|FG002|Overall Study|Withdrawal by Subject|1|||
27878696|NCT01868022|54498772|FG003|Overall Study|Withdrawal by Subject|1|||
27878697|NCT01868022|54498773|FG004|Overall Study|Withdrawal by Subject|0|||
27878698|NCT01868022|54498774|FG005|Overall Study|Withdrawal by Subject|0|||
27878699|NCT01868022|54498775|FG006|Overall Study|Withdrawal by Subject|0|||
27878700|NCT01868022|54498776|FG007|Overall Study|Withdrawal by Subject|1|||
27878701|NCT01868022|54498777|FG008|Overall Study|Withdrawal by Subject|0|||
27878702|NCT01868022|54498769|FG000|Overall Study|Adverse Event|0|||
27878703|NCT01868022|54498770|FG001|Overall Study|Adverse Event|0|||
27878704|NCT01868022|54498771|FG002|Overall Study|Adverse Event|0|||
27878705|NCT01868022|54498772|FG003|Overall Study|Adverse Event|0|||
27878706|NCT01868022|54498773|FG004|Overall Study|Adverse Event|2|||
27878707|NCT01868022|54498774|FG005|Overall Study|Adverse Event|0|||
27878708|NCT01868022|54498775|FG006|Overall Study|Adverse Event|0|||
27878709|NCT01868022|54498776|FG007|Overall Study|Adverse Event|2|||
27878710|NCT01868022|54498777|FG008|Overall Study|Adverse Event|2|||
27878711|NCT01868022|54498769|FG000|Overall Study|Physician Decision|0|||
27878712|NCT01868022|54498770|FG001|Overall Study|Physician Decision|0|||
27878713|NCT01868022|54498771|FG002|Overall Study|Physician Decision|0|||
27878714|NCT01868022|54498772|FG003|Overall Study|Physician Decision|0|||
27878715|NCT01868022|54498773|FG004|Overall Study|Physician Decision|0|||
27878716|NCT01868022|54498774|FG005|Overall Study|Physician Decision|1|||
27878717|NCT01868022|54498775|FG006|Overall Study|Physician Decision|0|||
27878718|NCT01868022|54498776|FG007|Overall Study|Physician Decision|2|||
27878719|NCT01868022|54498777|FG008|Overall Study|Physician Decision|0|||
27878720|NCT01868022|54498769|FG000|Overall Study|Study closed/terminated|0|||
27878721|NCT01868022|54498770|FG001|Overall Study|Study closed/terminated|0|||
27878722|NCT01868022|54498771|FG002|Overall Study|Study closed/terminated|0|||
27878723|NCT01868022|54498772|FG003|Overall Study|Study closed/terminated|0|||
27878724|NCT01868022|54498773|FG004|Overall Study|Study closed/terminated|0|||
27878725|NCT01868022|54498774|FG005|Overall Study|Study closed/terminated|0|||
27878726|NCT01868022|54498775|FG006|Overall Study|Study closed/terminated|0|||
27878727|NCT01868022|54498776|FG007|Overall Study|Study closed/terminated|1|||
27878728|NCT01868022|54498777|FG008|Overall Study|Study closed/terminated|0|||
27878729|NCT01868022|54498769|FG000|Overall Study|Ongoing|0|||
27878730|NCT01868022|54498770|FG001|Overall Study|Ongoing|0|||
27878731|NCT01868022|54498771|FG002|Overall Study|Ongoing|0|||
27878732|NCT01868022|54498772|FG003|Overall Study|Ongoing|0|||
27878733|NCT01868022|54498773|FG004|Overall Study|Ongoing|0|||
27878734|NCT01868022|54498774|FG005|Overall Study|Ongoing|0|||
27878735|NCT01868022|54498775|FG006|Overall Study|Ongoing|0|||
27878736|NCT01868022|54498776|FG007|Overall Study|Ongoing|3|||
27878737|NCT01868022|54498777|FG008|Overall Study|Ongoing|0|||
27878738|NCT01850004|54498803|FG000|Overall Study|Poor/Non-compliance|1|||
27878739|NCT01850004|54498803|FG000|Overall Study|Participant Withdrew Consent|9|||
27878740|NCT01850004|54498803|FG000|Overall Study|Participant Request to Discontinue Treatment|2|||
27878741|NCT01850004|54498803|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
27878742|NCT01850004|54498803|FG000|Overall Study|Adverse Event Related to Study Drug|4|||
27878743|NCT01850004|54498803|FG000|Overall Study|Other Reasons|2|||
27878744|NCT01850004|54498803|FG000|Overall Study|Participant No Longer Meets Study Criteria|1|||
27878745|NCT01850004|54498803|FG000|Overall Study|Maximum Clinical Benefit|4|||
27878746|NCT01867710|54498811|FG000|Overall Study|Death|25|||
27878747|NCT01867710|54498812|FG001|Overall Study|Death|15|||
27878748|NCT01867710|54498813|FG002|Overall Study|Death|27|||
27878749|NCT01867710|54498814|FG003|Overall Study|Death|20|||
27878750|NCT01867710|54498811|FG000|Overall Study|Lost to Follow-up|3|||
27878751|NCT01867710|54498812|FG001|Overall Study|Lost to Follow-up|4|||
27878752|NCT01867710|54498813|FG002|Overall Study|Lost to Follow-up|3|||
27878753|NCT01867710|54498814|FG003|Overall Study|Lost to Follow-up|2|||
27878754|NCT01867710|54498811|FG000|Overall Study|Withdrawal of consent|2|||
27878755|NCT01867710|54498812|FG001|Overall Study|Withdrawal of consent|5|||
27878756|NCT01867710|54498813|FG002|Overall Study|Withdrawal of consent|1|||
27878757|NCT01867710|54498814|FG003|Overall Study|Withdrawal of consent|2|||
27878758|NCT01867710|54498811|FG000|Overall Study|Study Terminated by Sponsor|9|||
27878759|NCT01867710|54498812|FG001|Overall Study|Study Terminated by Sponsor|13|||
27878760|NCT01867710|54498813|FG002|Overall Study|Study Terminated by Sponsor|8|||
27878761|NCT01867710|54498814|FG003|Overall Study|Study Terminated by Sponsor|16|||
27878762|NCT01867710|54498811|FG000|Overall Study|Biochemical progression|0|||
27878763|NCT01867710|54498812|FG001|Overall Study|Biochemical progression|1|||
27878764|NCT01867710|54498813|FG002|Overall Study|Biochemical progression|0|||
27878765|NCT01867710|54498814|FG003|Overall Study|Biochemical progression|0|||
27878766|NCT01867710|54498811|FG000|Overall Study|Clinical progression|0|||
27878767|NCT01867710|54498812|FG001|Overall Study|Clinical progression|0|||
27878768|NCT01867710|54498813|FG002|Overall Study|Clinical progression|1|||
27878769|NCT01867710|54498814|FG003|Overall Study|Clinical progression|0|||
27878770|NCT01867710|54498811|FG000|Overall Study|Disease progression|1|||
27878771|NCT01867710|54498812|FG001|Overall Study|Disease progression|0|||
28171692|NCT01652872|54843276|FG001|Overall Study|Death|39|||
27878772|NCT01867710|54498813|FG002|Overall Study|Disease progression|0|||
27878773|NCT01867710|54498814|FG003|Overall Study|Disease progression|0|||
27878774|NCT01867710|54498811|FG000|Overall Study|Patient decision|0|||
27878775|NCT01867710|54498812|FG001|Overall Study|Patient decision|0|||
27878776|NCT01867710|54498813|FG002|Overall Study|Patient decision|0|||
27878777|NCT01867710|54498814|FG003|Overall Study|Patient decision|1|||
27878778|NCT01867710|54498811|FG000|Overall Study|Patient to follow subsequent treatment|0|||
27878779|NCT01867710|54498812|FG001|Overall Study|Patient to follow subsequent treatment|1|||
27878780|NCT01867710|54498813|FG002|Overall Study|Patient to follow subsequent treatment|0|||
27878781|NCT01867710|54498814|FG003|Overall Study|Patient to follow subsequent treatment|0|||
27878782|NCT01867710|54498811|FG000|Overall Study|Progressive disease|1|||
27878783|NCT01867710|54498812|FG001|Overall Study|Progressive disease|0|||
27878784|NCT01867710|54498813|FG002|Overall Study|Progressive disease|0|||
27878785|NCT01867710|54498814|FG003|Overall Study|Progressive disease|0|||
27878786|NCT01867710|54498811|FG000|Overall Study|Protocol Violation|0|||
27878787|NCT01867710|54498812|FG001|Overall Study|Protocol Violation|0|||
27878788|NCT01867710|54498813|FG002|Overall Study|Protocol Violation|0|||
27878789|NCT01867710|54498814|FG003|Overall Study|Protocol Violation|1|||
27878790|NCT01867710|54498811|FG000|Overall Study|PSA-progression|0|||
27878791|NCT01867710|54498812|FG001|Overall Study|PSA-progression|1|||
27983321|NCT00918749|54641669|FG000|Overall Study|No Study Medication Taken|1|||
27983322|NCT00918749|54641670|FG001|Overall Study|No Study Medication Taken|0|||
27983323|NCT00918749|54641671|FG002|Overall Study|No Study Medication Taken|0|||
27983324|NCT00746733|54641679|FG000|Second Intervention|Adverse Event|1|||
27983325|NCT00746733|54641680|FG001|Second Intervention|Adverse Event|0|||
27983326|NCT00746733|54641679|FG000|Third Intervention|Withdrawal by Subject|1|||
27983327|NCT00746733|54641680|FG001|Third Intervention|Withdrawal by Subject|1|||
27983328|NCT00745875|54641695|FG000|Overall Study|Continuing study treatment|4|||
27983329|NCT00745875|54641696|FG001|Overall Study|Continuing study treatment|4|||
27983330|NCT00555217|54641704|FG000|Overall Study|Withdrawal by Subject|35|||
27983331|NCT00555217|54641705|FG001|Overall Study|Withdrawal by Subject|31|||
27983332|NCT00555217|54641704|FG000|Overall Study|Lost to Follow-up|19|||
27983333|NCT00555217|54641705|FG001|Overall Study|Lost to Follow-up|20|||
27983334|NCT00555217|54641704|FG000|Overall Study|close out sites|21|||
27983335|NCT00555217|54641705|FG001|Overall Study|close out sites|17|||
27983336|NCT00745251|54641713|FG000|Overall Study|Adverse Event|1|||
27983337|NCT00745251|54641714|FG001|Overall Study|Adverse Event|2|||
27983338|NCT00745251|54641713|FG000|Overall Study|Withdrawal by Subject|1|||
27983339|NCT00745251|54641714|FG001|Overall Study|Withdrawal by Subject|1|||
27983340|NCT00745095|54641726|FG000|Overall Study|Declined to participate|1|||
27983341|NCT00745095|54641727|FG001|Overall Study|Declined to participate|0|||
27983342|NCT00745095|54641728|FG002|Overall Study|Declined to participate|0|||
27983343|NCT00745095|54641729|FG003|Overall Study|Declined to participate|0|||
27983344|NCT00745095|54641730|FG004|Overall Study|Declined to participate|92|||
27983345|NCT00745095|54641731|FG005|Overall Study|Declined to participate|95|||
27983346|NCT00745095|54641726|FG000|Overall Study|Ineligible due to GFR criteria|0|||
27983347|NCT00745095|54641727|FG001|Overall Study|Ineligible due to GFR criteria|2|||
27983348|NCT00745095|54641728|FG002|Overall Study|Ineligible due to GFR criteria|3|||
27983349|NCT00745095|54641729|FG003|Overall Study|Ineligible due to GFR criteria|3|||
27983350|NCT00745095|54641730|FG004|Overall Study|Ineligible due to GFR criteria|30|||
27983351|NCT00745095|54641731|FG005|Overall Study|Ineligible due to GFR criteria|28|||
27983352|NCT00744939|54641752|FG000|Overall Study|Withdrawal by Subject|9|||
27983353|NCT00744939|54641752|FG000|Overall Study|Protocol Violation|13|||
27983354|NCT00744939|54641752|FG000|Overall Study|Death|24|||
27983355|NCT00744939|54641752|FG000|Overall Study|distance|4|||
27983356|NCT00744939|54641752|FG000|Overall Study|Lost to Follow-up|12|||
27983357|NCT00744939|54641752|FG000|Overall Study|Medical history exclusionary|1|||
27983358|NCT00744939|54641752|FG000|Overall Study|Did not receive Magnevist|7|||
27983359|NCT00744939|54641752|FG000|Overall Study|Failed inclusion/exclusion criteria|19|||
27983360|NCT00744939|54641752|FG000|Overall Study|coma|1|||
27983361|NCT00744939|54641752|FG000|Overall Study|incorrect race|1|||
27983362|NCT00744861|54641768|FG000|Feasibility Stage 1|Withdrawal by Subject|1|||
27983363|NCT00744861|54641769|FG001|Feasibility Stage 1|Withdrawal by Subject|1|||
27983364|NCT00744861|54641770|FG002|Feasibility Stage 1|Withdrawal by Subject|0|||
27983365|NCT00744861|54641771|FG003|Feasibility Stage 1|Withdrawal by Subject|0|||
27878792|NCT01867710|54498813|FG002|Overall Study|PSA-progression|0|||
27878793|NCT01867710|54498814|FG003|Overall Study|PSA-progression|0|||
27878794|NCT01867710|54498811|FG000|Overall Study|Study medication no longer effective|0|||
27878795|NCT01867710|54498812|FG001|Overall Study|Study medication no longer effective|1|||
27878796|NCT01867710|54498813|FG002|Overall Study|Study medication no longer effective|0|||
27878797|NCT01867710|54498814|FG003|Overall Study|Study medication no longer effective|0|||
27878798|NCT01849848|54498824|FG000|Overall Study|Physician Decision|1|||
27878799|NCT01849848|54498824|FG000|Overall Study|Progression of the primary disease|3|||
27878800|NCT01849458|54498828|FG000|Overall Study|Lost to Follow-up|4|||
27878801|NCT01832766|54498832|FG000|Washout|Lost to Follow-up|0|||
27878802|NCT01832766|54498833|FG001|Washout|Lost to Follow-up|1|||
27878803|NCT01832532|54498841|FG000|Overall Study|Withdrawal by Subject|5|||
27983366|NCT00744861|54641768|FG000|Feasibility Stage 1|Pregnancy|0|||
27983367|NCT00744861|54641769|FG001|Feasibility Stage 1|Pregnancy|1|||
27983368|NCT00744861|54641770|FG002|Feasibility Stage 1|Pregnancy|0|||
27983369|NCT00744861|54641771|FG003|Feasibility Stage 1|Pregnancy|0|||
27983370|NCT00744861|54641768|FG000|Pivotal Stage 2|Adverse Event|0|||
27983371|NCT00744861|54641769|FG001|Pivotal Stage 2|Adverse Event|0|||
27983372|NCT00744861|54641770|FG002|Pivotal Stage 2|Adverse Event|6|||
27983373|NCT00744861|54641771|FG003|Pivotal Stage 2|Adverse Event|11|||
27878804|NCT01832532|54498842|FG001|Overall Study|Withdrawal by Subject|2|||
27878805|NCT01848990|54498851|FG000|Overall Study|Adverse Event|6|||
27878806|NCT01848990|54498852|FG001|Overall Study|Adverse Event|2|||
27878807|NCT01848990|54498853|FG002|Overall Study|Adverse Event|0|||
27878808|NCT01848990|54498851|FG000|Overall Study|Lost to Follow-up|6|||
27878809|NCT01848990|54498852|FG001|Overall Study|Lost to Follow-up|2|||
27878810|NCT01848990|54498853|FG002|Overall Study|Lost to Follow-up|2|||
27878811|NCT01848990|54498851|FG000|Overall Study|Protocol Violation|1|||
27878812|NCT01848990|54498852|FG001|Overall Study|Protocol Violation|1|||
27878813|NCT01848990|54498853|FG002|Overall Study|Protocol Violation|0|||
27878814|NCT01848990|54498851|FG000|Overall Study|Withdrawal by Subject|29|||
27878815|NCT01848990|54498852|FG001|Overall Study|Withdrawal by Subject|10|||
27878816|NCT01848990|54498853|FG002|Overall Study|Withdrawal by Subject|11|||
27878817|NCT01848990|54498851|FG000|Overall Study|Physician Decision|1|||
27878818|NCT01848990|54498852|FG001|Overall Study|Physician Decision|1|||
27878819|NCT01848990|54498853|FG002|Overall Study|Physician Decision|0|||
27878820|NCT01848990|54498851|FG000|Overall Study|Non Compliance|1|||
27878821|NCT01848990|54498852|FG001|Overall Study|Non Compliance|0|||
27878822|NCT01848990|54498853|FG002|Overall Study|Non Compliance|0|||
27878823|NCT01848990|54498851|FG000|Overall Study|Death|1|||
27878824|NCT01848990|54498852|FG001|Overall Study|Death|0|||
27878825|NCT01848990|54498853|FG002|Overall Study|Death|1|||
27878826|NCT01848990|54498851|FG000|Overall Study|Other|1|||
27878827|NCT01848990|54498852|FG001|Overall Study|Other|4|||
27878828|NCT01848990|54498853|FG002|Overall Study|Other|2|||
27878829|NCT01867086|54498865|FG000|Overall Study|Disease Progression|1|||
27878830|NCT01831596|54498869|FG000|Overall Study|Other|8|||
27878831|NCT01848834|54498878|FG000|Overall Study|Adverse Event|3|||
27878832|NCT01848834|54498879|FG001|Overall Study|Adverse Event|11|||
27878833|NCT01848834|54498880|FG002|Overall Study|Adverse Event|3|||
27878834|NCT01848834|54498881|FG003|Overall Study|Adverse Event|5|||
27878835|NCT01848834|54498882|FG004|Overall Study|Adverse Event|9|||
27878836|NCT01848834|54498878|FG000|Overall Study|Death|2|||
27878837|NCT01848834|54498879|FG001|Overall Study|Death|11|||
27878838|NCT01848834|54498880|FG002|Overall Study|Death|1|||
27878839|NCT01848834|54498881|FG003|Overall Study|Death|8|||
27878840|NCT01848834|54498882|FG004|Overall Study|Death|27|||
27878841|NCT01848834|54498878|FG000|Overall Study|Excluded Medication|5|||
27878842|NCT01848834|54498879|FG001|Overall Study|Excluded Medication|4|||
27878843|NCT01848834|54498880|FG002|Overall Study|Excluded Medication|3|||
27878844|NCT01848834|54498881|FG003|Overall Study|Excluded Medication|6|||
27878845|NCT01848834|54498882|FG004|Overall Study|Excluded Medication|6|||
27878846|NCT01848834|54498878|FG000|Overall Study|Lost to Follow-up|5|||
27878847|NCT01848834|54498879|FG001|Overall Study|Lost to Follow-up|5|||
27878848|NCT01848834|54498880|FG002|Overall Study|Lost to Follow-up|3|||
27878849|NCT01848834|54498881|FG003|Overall Study|Lost to Follow-up|0|||
27878850|NCT01848834|54498882|FG004|Overall Study|Lost to Follow-up|3|||
27878851|NCT01848834|54498878|FG000|Overall Study|Physician Decision|1|||
27878852|NCT01848834|54498879|FG001|Overall Study|Physician Decision|3|||
27878853|NCT01848834|54498880|FG002|Overall Study|Physician Decision|4|||
27878854|NCT01848834|54498881|FG003|Overall Study|Physician Decision|0|||
27878855|NCT01848834|54498882|FG004|Overall Study|Physician Decision|11|||
27878856|NCT01848834|54498878|FG000|Overall Study|Protocol Violation|0|||
27878857|NCT01848834|54498879|FG001|Overall Study|Protocol Violation|0|||
27878858|NCT01848834|54498880|FG002|Overall Study|Protocol Violation|0|||
27878859|NCT01848834|54498881|FG003|Overall Study|Protocol Violation|0|||
27878860|NCT01848834|54498882|FG004|Overall Study|Protocol Violation|1|||
27878861|NCT01848834|54498878|FG000|Overall Study|Sponsor Decision|1|||
27878862|NCT01848834|54498879|FG001|Overall Study|Sponsor Decision|1|||
27878863|NCT01848834|54498880|FG002|Overall Study|Sponsor Decision|0|||
27878864|NCT01848834|54498881|FG003|Overall Study|Sponsor Decision|1|||
27878865|NCT01848834|54498882|FG004|Overall Study|Sponsor Decision|1|||
27878866|NCT01848834|54498878|FG000|Overall Study|Withdrawal by Subject|2|||
27878867|NCT01848834|54498879|FG001|Overall Study|Withdrawal by Subject|13|||
27878868|NCT01848834|54498880|FG002|Overall Study|Withdrawal by Subject|10|||
27878869|NCT01848834|54498881|FG003|Overall Study|Withdrawal by Subject|6|||
27878870|NCT01848834|54498882|FG004|Overall Study|Withdrawal by Subject|36|||
27878871|NCT01867008|54498898|FG000|Overall Study|Withdrawal by Subject|1|||
27878872|NCT01848756|54498902|FG000|Overall Study|Adverse Event|1|||
27878873|NCT01848756|54498902|FG000|Overall Study|Withdrawal by Subject|1|||
27878874|NCT01848756|54498902|FG000|Overall Study|Enrolled in Error|1|||
27835730|NCT02691702|54320547|FG009|Overall Study|Protocol Violation|2|||
27878875|NCT01830972|54498909|FG000|Part II|Withdrawal by Subject|2|||
27835731|NCT02691702|54320548|FG010|Overall Study|Protocol Violation|0|||
27835732|NCT01564277|54320582|FG000|Overall Study|Protocol Violation|0|||
27835733|NCT01564277|54320583|FG001|Overall Study|Protocol Violation|1|||
27835734|NCT01564277|54320582|FG000|Overall Study|Physician Decision|1|||
27835735|NCT01564277|54320583|FG001|Overall Study|Physician Decision|0|||
27835736|NCT02679222|54320589|FG000|Overall Study|No time for project|1|||
27835737|NCT01563185|54320601|FG000|Overall Study|Withdrawal by Subject|1|||
27835738|NCT01563185|54320601|FG000|Overall Study|Non-Compliance with study drug|1|||
27878876|NCT01830972|54498910|FG001|Part II|Withdrawal by Subject|2|||
27878877|NCT01830972|54498909|FG000|Part III|Withdrawal by Subject|1|||
27878878|NCT01830972|54498910|FG001|Part III|Withdrawal by Subject|0|||
27878879|NCT01830972|54498909|FG000|Part III|Noncompliance|1|||
27878880|NCT01830972|54498910|FG001|Part III|Noncompliance|0|||
27878881|NCT01830972|54498909|FG000|Part IV|Withdrawal by Subject|2|||
27878882|NCT01830972|54498910|FG001|Part IV|Withdrawal by Subject|1|||
27878883|NCT01830972|54498909|FG000|Part IV|Non-Compliance|1|||
27878884|NCT01830972|54498910|FG001|Part IV|Non-Compliance|0|||
27878885|NCT01848288|54498926|FG000|Overall Study|Death|1|||
27878886|NCT01848288|54498926|FG000|Overall Study|Protocol Violation|1|||
27878887|NCT01848288|54498926|FG000|Overall Study|Withdrawal by Subject|1|||
27878888|NCT01848210|54498933|FG000|Overall Study|Informed Consent Form Withdrawal|28|||
27878889|NCT01848210|54498934|FG001|Overall Study|Informed Consent Form Withdrawal|24|||
27878890|NCT01848210|54498933|FG000|Overall Study|Lost to Follow-up|24|||
27878891|NCT01848210|54498934|FG001|Overall Study|Lost to Follow-up|12|||
27878892|NCT01848210|54498933|FG000|Overall Study|Protocol Violation|3|||
27878893|NCT01848210|54498934|FG001|Overall Study|Protocol Violation|5|||
27878894|NCT01848210|54498933|FG000|Overall Study|Use of Forbidden Drugs|9|||
27878895|NCT01848210|54498934|FG001|Overall Study|Use of Forbidden Drugs|10|||
27878896|NCT01848210|54498933|FG000|Overall Study|Impedition Condition|5|||
27878897|NCT01848210|54498934|FG001|Overall Study|Impedition Condition|9|||
27878898|NCT01848210|54498933|FG000|Overall Study|Adverse Event|7|||
27878899|NCT01848210|54498934|FG001|Overall Study|Adverse Event|9|||
27878900|NCT01848210|54498933|FG000|Overall Study|Discontinuation Criterion|5|||
27878901|NCT01848210|54498934|FG001|Overall Study|Discontinuation Criterion|7|||
27878902|NCT01848210|54498933|FG000|Overall Study|Hypesensitivity|1|||
27878903|NCT01848210|54498934|FG001|Overall Study|Hypesensitivity|0|||
27878904|NCT01848210|54498933|FG000|Overall Study|Hepatic Function Alteration|4|||
27878905|NCT01848210|54498934|FG001|Overall Study|Hepatic Function Alteration|0|||
27878906|NCT01848210|54498933|FG000|Overall Study|Chronic Venous Insufficiency Course|1|||
27878907|NCT01848210|54498934|FG001|Overall Study|Chronic Venous Insufficiency Course|2|||
27878908|NCT01848210|54498933|FG000|Overall Study|Administrative|1|||
27878909|NCT01848210|54498934|FG001|Overall Study|Administrative|0|||
27878910|NCT01830816|54498943|FG000|Overall Study|Progressive Disease|12|||
27878911|NCT01830816|54498944|FG001|Overall Study|Progressive Disease|7|||
27878912|NCT01830816|54498945|FG002|Overall Study|Progressive Disease|7|||
27878913|NCT01830816|54498943|FG000|Overall Study|Adverse Event|3|||
27878914|NCT01830816|54498944|FG001|Overall Study|Adverse Event|4|||
27878915|NCT01830816|54498945|FG002|Overall Study|Adverse Event|0|||
27878916|NCT01830816|54498943|FG000|Overall Study|Study Terminated by Sponsor|1|||
27878917|NCT01830816|54498944|FG001|Overall Study|Study Terminated by Sponsor|1|||
27878918|NCT01830816|54498945|FG002|Overall Study|Study Terminated by Sponsor|0|||
27878919|NCT01830816|54498943|FG000|Overall Study|Withdrawal by Subject|1|||
27878920|NCT01830816|54498944|FG001|Overall Study|Withdrawal by Subject|1|||
27878921|NCT01830816|54498945|FG002|Overall Study|Withdrawal by Subject|0|||
27878922|NCT01830816|54498943|FG000|Overall Study|Lost to Follow-up|0|||
27878923|NCT01830816|54498944|FG001|Overall Study|Lost to Follow-up|1|||
27878924|NCT01830816|54498945|FG002|Overall Study|Lost to Follow-up|0|||
27878925|NCT01830816|54498943|FG000|Overall Study|Symptomatic Deterioration|1|||
27878926|NCT01830816|54498944|FG001|Overall Study|Symptomatic Deterioration|0|||
27878927|NCT01830816|54498945|FG002|Overall Study|Symptomatic Deterioration|0|||
27878928|NCT01830816|54498943|FG000|Overall Study|Reason not Specified|2|||
27878929|NCT01830816|54498944|FG001|Overall Study|Reason not Specified|0|||
27878930|NCT01830816|54498945|FG002|Overall Study|Reason not Specified|0|||
27878931|NCT01846416|54498959|FG000|Treatment Phase|Death|2|||
27878932|NCT01846416|54498960|FG001|Treatment Phase|Death|9|||
27878933|NCT01846416|54498961|FG002|Treatment Phase|Death|1|||
27878934|NCT01846416|54498959|FG000|Treatment Phase|Withdrawal by Subject|2|||
27878935|NCT01846416|54498960|FG001|Treatment Phase|Withdrawal by Subject|4|||
27878936|NCT01846416|54498961|FG002|Treatment Phase|Withdrawal by Subject|2|||
27878937|NCT01846416|54498959|FG000|Treatment Phase|Other|1|||
27878938|NCT01846416|54498960|FG001|Treatment Phase|Other|5|||
27878939|NCT01846416|54498961|FG002|Treatment Phase|Other|1|||
27878940|NCT01846416|54498959|FG000|Treatment Phase|Physician Decision|1|||
27878941|NCT01846416|54498960|FG001|Treatment Phase|Physician Decision|2|||
27878942|NCT01846416|54498961|FG002|Treatment Phase|Physician Decision|0|||
27878943|NCT01846416|54498959|FG000|Treatment Phase|Adverse Event|3|||
27878944|NCT01846416|54498960|FG001|Treatment Phase|Adverse Event|4|||
27878945|NCT01846416|54498961|FG002|Treatment Phase|Adverse Event|0|||
27878946|NCT01846416|54498959|FG000|Treatment Phase|Non-compliance|0|||
27878947|NCT01846416|54498960|FG001|Treatment Phase|Non-compliance|2|||
27878948|NCT01846416|54498961|FG002|Treatment Phase|Non-compliance|0|||
27878949|NCT01846416|54498959|FG000|Treatment Phase|Study Terminated by Sponsor|1|||
27878950|NCT01846416|54498960|FG001|Treatment Phase|Study Terminated by Sponsor|4|||
27878951|NCT01846416|54498961|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
27878952|NCT01846416|54498959|FG000|Treatment Phase|Progressive Disease|21|||
27878953|NCT01846416|54498960|FG001|Treatment Phase|Progressive Disease|63|||
27878954|NCT01846416|54498961|FG002|Treatment Phase|Progressive Disease|9|||
27878955|NCT01846416|54498959|FG000|Survival Follow-up|Death|21|||
27878956|NCT01846416|54498960|FG001|Survival Follow-up|Death|62|||
27878957|NCT01846416|54498961|FG002|Survival Follow-up|Death|9|||
27878958|NCT01846416|54498959|FG000|Survival Follow-up|Lost to Follow-up|0|||
27878959|NCT01846416|54498960|FG001|Survival Follow-up|Lost to Follow-up|2|||
27878960|NCT01846416|54498961|FG002|Survival Follow-up|Lost to Follow-up|2|||
27878961|NCT01846416|54498959|FG000|Survival Follow-up|Withdrawal by Subject|2|||
27878962|NCT01846416|54498960|FG001|Survival Follow-up|Withdrawal by Subject|7|||
27878963|NCT01846416|54498961|FG002|Survival Follow-up|Withdrawal by Subject|0|||
27878964|NCT01846416|54498959|FG000|Survival Follow-up|Study Terminated by Sponsor|2|||
27878965|NCT01846416|54498960|FG001|Survival Follow-up|Study Terminated by Sponsor|8|||
27878966|NCT01846416|54498961|FG002|Survival Follow-up|Study Terminated by Sponsor|0|||
27878967|NCT01846416|54498959|FG000|Survival Follow-up|Other|3|||
27878968|NCT01846416|54498960|FG001|Survival Follow-up|Other|1|||
27878969|NCT01846416|54498961|FG002|Survival Follow-up|Other|1|||
27878970|NCT01865448|54498972|FG000|Overall Study|Adverse Event|1|||
27878971|NCT01865448|54498973|FG001|Overall Study|Adverse Event|1|||
27878972|NCT01865448|54498972|FG000|Overall Study|Pregnancy|0|||
27878973|NCT01865448|54498973|FG001|Overall Study|Pregnancy|1|||
27878974|NCT01865448|54498972|FG000|Overall Study|dropout unrelated to study|1|||
27878975|NCT01865448|54498973|FG001|Overall Study|dropout unrelated to study|1|||
27878976|NCT01804140|54498980|FG000|Overall Study|No sampling or biopsy procedures done|114|||
27878977|NCT01846104|54498984|FG000|Overall Study|Withdrawal by Subject|1|||
27878978|NCT01803282|54499000|FG000|Overall Study|Progressive Disease|4|||
27878979|NCT01803282|54499001|FG001|Overall Study|Progressive Disease|3|||
27878980|NCT01803282|54499002|FG002|Overall Study|Progressive Disease|6|||
27878981|NCT01803282|54499003|FG003|Overall Study|Progressive Disease|22|||
27878982|NCT01803282|54499004|FG004|Overall Study|Progressive Disease|5|||
27878983|NCT01803282|54499005|FG005|Overall Study|Progressive Disease|8|||
27878984|NCT01803282|54499006|FG006|Overall Study|Progressive Disease|23|||
27878985|NCT01803282|54499007|FG007|Overall Study|Progressive Disease|24|||
27878986|NCT01803282|54499008|FG008|Overall Study|Progressive Disease|3|||
27878987|NCT01803282|54499009|FG009|Overall Study|Progressive Disease|29|||
27878988|NCT01803282|54499010|FG010|Overall Study|Progressive Disease|6|||
27878989|NCT01803282|54499011|FG011|Overall Study|Progressive Disease|11|||
27878990|NCT01803282|54499000|FG000|Overall Study|Death|0|||
27878991|NCT01803282|54499001|FG001|Overall Study|Death|0|||
27878992|NCT01803282|54499002|FG002|Overall Study|Death|0|||
27878993|NCT01803282|54499003|FG003|Overall Study|Death|0|||
27878994|NCT01803282|54499004|FG004|Overall Study|Death|2|||
27878995|NCT01803282|54499005|FG005|Overall Study|Death|1|||
27878996|NCT01803282|54499006|FG006|Overall Study|Death|1|||
27878997|NCT01803282|54499007|FG007|Overall Study|Death|5|||
27878998|NCT01803282|54499008|FG008|Overall Study|Death|1|||
27878999|NCT01803282|54499009|FG009|Overall Study|Death|1|||
27879000|NCT01803282|54499010|FG010|Overall Study|Death|0|||
27879001|NCT01803282|54499011|FG011|Overall Study|Death|0|||
27879002|NCT01803282|54499000|FG000|Overall Study|Withdrew Consent|0|||
27879003|NCT01803282|54499001|FG001|Overall Study|Withdrew Consent|0|||
27879004|NCT01803282|54499002|FG002|Overall Study|Withdrew Consent|0|||
27879005|NCT01803282|54499003|FG003|Overall Study|Withdrew Consent|6|||
27879006|NCT01803282|54499004|FG004|Overall Study|Withdrew Consent|1|||
27879007|NCT01803282|54499005|FG005|Overall Study|Withdrew Consent|0|||
27879008|NCT01803282|54499006|FG006|Overall Study|Withdrew Consent|8|||
27879009|NCT01803282|54499007|FG007|Overall Study|Withdrew Consent|3|||
27879010|NCT01803282|54499008|FG008|Overall Study|Withdrew Consent|1|||
27879011|NCT01803282|54499009|FG009|Overall Study|Withdrew Consent|5|||
27879012|NCT01803282|54499010|FG010|Overall Study|Withdrew Consent|0|||
27879013|NCT01803282|54499011|FG011|Overall Study|Withdrew Consent|1|||
27879014|NCT01803282|54499000|FG000|Overall Study|Investigator's Discretion|0|||
27739284|NCT03318523|54188614|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|2|||
27739285|NCT03318523|54188615|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|3|||
27739286|NCT03318523|54188616|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
27739287|NCT01678209|54188643|FG000|Overall Study|could not scan twice|1|||
27739288|NCT01678209|54188644|FG001|Overall Study|could not scan twice|1|||
27879015|NCT01803282|54499001|FG001|Overall Study|Investigator's Discretion|0|||
27879016|NCT01803282|54499002|FG002|Overall Study|Investigator's Discretion|0|||
27879017|NCT01803282|54499003|FG003|Overall Study|Investigator's Discretion|7|||
27879018|NCT01803282|54499004|FG004|Overall Study|Investigator's Discretion|2|||
27879019|NCT01803282|54499005|FG005|Overall Study|Investigator's Discretion|1|||
27879020|NCT01803282|54499006|FG006|Overall Study|Investigator's Discretion|7|||
27879021|NCT01803282|54499007|FG007|Overall Study|Investigator's Discretion|10|||
27879022|NCT01803282|54499008|FG008|Overall Study|Investigator's Discretion|6|||
27739289|NCT01678209|54188645|FG002|Overall Study|could not scan twice|1|||
27879023|NCT01803282|54499009|FG009|Overall Study|Investigator's Discretion|7|||
27879024|NCT01803282|54499010|FG010|Overall Study|Investigator's Discretion|1|||
27879025|NCT01803282|54499011|FG011|Overall Study|Investigator's Discretion|0|||
27879026|NCT01803282|54499000|FG000|Overall Study|Adverse Event|0|||
27879027|NCT01803282|54499001|FG001|Overall Study|Adverse Event|0|||
27879028|NCT01803282|54499002|FG002|Overall Study|Adverse Event|0|||
27879029|NCT01803282|54499003|FG003|Overall Study|Adverse Event|0|||
27879030|NCT01803282|54499004|FG004|Overall Study|Adverse Event|0|||
27879031|NCT01803282|54499005|FG005|Overall Study|Adverse Event|0|||
27879032|NCT01803282|54499006|FG006|Overall Study|Adverse Event|1|||
27879033|NCT01803282|54499007|FG007|Overall Study|Adverse Event|2|||
27879034|NCT01803282|54499008|FG008|Overall Study|Adverse Event|0|||
27879035|NCT01803282|54499009|FG009|Overall Study|Adverse Event|1|||
27879036|NCT01803282|54499010|FG010|Overall Study|Adverse Event|0|||
27879037|NCT01803282|54499011|FG011|Overall Study|Adverse Event|3|||
27879038|NCT01803282|54499000|FG000|Overall Study|Non-Compliance with Study Drug|0|||
27879039|NCT01803282|54499001|FG001|Overall Study|Non-Compliance with Study Drug|0|||
27879040|NCT01803282|54499002|FG002|Overall Study|Non-Compliance with Study Drug|0|||
27879041|NCT01803282|54499003|FG003|Overall Study|Non-Compliance with Study Drug|1|||
27879042|NCT01803282|54499004|FG004|Overall Study|Non-Compliance with Study Drug|0|||
27879043|NCT01803282|54499005|FG005|Overall Study|Non-Compliance with Study Drug|0|||
27879044|NCT01803282|54499006|FG006|Overall Study|Non-Compliance with Study Drug|0|||
27879045|NCT01803282|54499007|FG007|Overall Study|Non-Compliance with Study Drug|0|||
27879046|NCT01803282|54499008|FG008|Overall Study|Non-Compliance with Study Drug|0|||
27879047|NCT01803282|54499009|FG009|Overall Study|Non-Compliance with Study Drug|0|||
27879048|NCT01803282|54499010|FG010|Overall Study|Non-Compliance with Study Drug|0|||
27879049|NCT01803282|54499011|FG011|Overall Study|Non-Compliance with Study Drug|0|||
27879050|NCT01803282|54499000|FG000|Overall Study|Unknown Reason|0|||
27879051|NCT01803282|54499001|FG001|Overall Study|Unknown Reason|0|||
27879052|NCT01803282|54499002|FG002|Overall Study|Unknown Reason|0|||
27879053|NCT01803282|54499003|FG003|Overall Study|Unknown Reason|0|||
27879054|NCT01803282|54499004|FG004|Overall Study|Unknown Reason|0|||
27879055|NCT01803282|54499005|FG005|Overall Study|Unknown Reason|0|||
27879056|NCT01803282|54499006|FG006|Overall Study|Unknown Reason|0|||
27879057|NCT01803282|54499007|FG007|Overall Study|Unknown Reason|1|||
27879058|NCT01803282|54499008|FG008|Overall Study|Unknown Reason|0|||
27879059|NCT01803282|54499009|FG009|Overall Study|Unknown Reason|0|||
27879060|NCT01803282|54499010|FG010|Overall Study|Unknown Reason|0|||
27879061|NCT01803282|54499011|FG011|Overall Study|Unknown Reason|0|||
27879062|NCT01803282|54499000|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
27879063|NCT01803282|54499001|FG001|Overall Study|Specified Criteria for Withdrawal|0|||
27879064|NCT01803282|54499002|FG002|Overall Study|Specified Criteria for Withdrawal|0|||
27879065|NCT01803282|54499003|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
27879066|NCT01803282|54499004|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
27879067|NCT01803282|54499005|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
27879068|NCT01803282|54499006|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
27879069|NCT01803282|54499007|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
27879070|NCT01803282|54499008|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
27879071|NCT01803282|54499009|FG009|Overall Study|Specified Criteria for Withdrawal|1|||
27879072|NCT01803282|54499010|FG010|Overall Study|Specified Criteria for Withdrawal|1|||
27879073|NCT01803282|54499011|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
27879074|NCT01803282|54499000|FG000|Overall Study|Enrolled but Never Treated|0|||
27879075|NCT01803282|54499001|FG001|Overall Study|Enrolled but Never Treated|0|||
27879076|NCT01803282|54499002|FG002|Overall Study|Enrolled but Never Treated|0|||
27879077|NCT01803282|54499003|FG003|Overall Study|Enrolled but Never Treated|0|||
27879078|NCT01803282|54499004|FG004|Overall Study|Enrolled but Never Treated|1|||
27879079|NCT01803282|54499005|FG005|Overall Study|Enrolled but Never Treated|0|||
27879080|NCT01803282|54499006|FG006|Overall Study|Enrolled but Never Treated|1|||
27879081|NCT01803282|54499007|FG007|Overall Study|Enrolled but Never Treated|1|||
27879082|NCT01803282|54499008|FG008|Overall Study|Enrolled but Never Treated|0|||
27879083|NCT01803282|54499009|FG009|Overall Study|Enrolled but Never Treated|1|||
27879084|NCT01803282|54499010|FG010|Overall Study|Enrolled but Never Treated|0|||
27879085|NCT01803282|54499011|FG011|Overall Study|Enrolled but Never Treated|0|||
27879086|NCT01844778|54499040|FG000|Overall Study|Protocol deviation|0|||
27879087|NCT01844778|54499041|FG001|Overall Study|Protocol deviation|1|||
27879088|NCT01844778|54499042|FG002|Overall Study|Protocol deviation|2|||
27879089|NCT01844778|54499040|FG000|Overall Study|Withdrawal by Subject|2|||
27879090|NCT01844778|54499041|FG001|Overall Study|Withdrawal by Subject|0|||
27879091|NCT01844778|54499042|FG002|Overall Study|Withdrawal by Subject|0|||
27879092|NCT01844778|54499040|FG000|Overall Study|Adverse Event|0|||
27879093|NCT01844778|54499041|FG001|Overall Study|Adverse Event|2|||
27879094|NCT01844778|54499042|FG002|Overall Study|Adverse Event|2|||
27879095|NCT01802580|54499056|FG000|Overall Study|Physician Decision|1|||
27879096|NCT01802580|54499057|FG001|Overall Study|Physician Decision|0|||
27879097|NCT01802580|54499056|FG000|Overall Study|Protocol Violation|2|||
27879098|NCT01802580|54499057|FG001|Overall Study|Protocol Violation|0|||
27879099|NCT01802580|54499056|FG000|Overall Study|Withdrawal by Subject|5|||
27879100|NCT01802580|54499057|FG001|Overall Study|Withdrawal by Subject|6|||
27879101|NCT01802580|54499056|FG000|Overall Study|Other|1|||
27879102|NCT01802580|54499057|FG001|Overall Study|Other|3|||
27879103|NCT01802580|54499056|FG000|Overall Study|Lack of Efficacy|0|||
27879104|NCT01802580|54499057|FG001|Overall Study|Lack of Efficacy|2|||
27879105|NCT01611090|54499065|FG000|Randomized Period|Lost to Follow-up|8|||
27879106|NCT01611090|54499066|FG001|Randomized Period|Lost to Follow-up|3|||
27879107|NCT01611090|54499067|FG002|Randomized Period|Lost to Follow-up|0|||
27879108|NCT01611090|54499065|FG000|Randomized Period|Withdrawal by Subject|22|||
27879109|NCT01611090|54499066|FG001|Randomized Period|Withdrawal by Subject|26|||
27879110|NCT01611090|54499067|FG002|Randomized Period|Withdrawal by Subject|0|||
27879111|NCT01611090|54499065|FG000|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
27879112|NCT01611090|54499066|FG001|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
27879113|NCT01611090|54499067|FG002|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4|||
27879114|NCT01611090|54499065|FG000|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
27879115|NCT01611090|54499066|FG001|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
27879116|NCT01611090|54499067|FG002|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1|||
27879117|NCT01844700|54499076|FG000|Overall Study|Lack of Efficacy|1|||
27879118|NCT01844700|54499077|FG001|Overall Study|Lack of Efficacy|0|||
27879119|NCT01844700|54499076|FG000|Overall Study|refused medication switch|1|||
27879120|NCT01844700|54499077|FG001|Overall Study|refused medication switch|0|||
27879121|NCT01844700|54499076|FG000|Overall Study|Withdrawal by Subject|1|||
27879122|NCT01844700|54499077|FG001|Overall Study|Withdrawal by Subject|0|||
27879123|NCT01844700|54499076|FG000|Overall Study|stopped taking meds|0|||
27879124|NCT01844700|54499077|FG001|Overall Study|stopped taking meds|1|||
27879125|NCT01827384|54499097|FG000|Overall Study|Switched to alternative treatment|0|||
27879126|NCT01827384|54499098|FG001|Overall Study|Switched to alternative treatment|0|||
27879127|NCT01827384|54499099|FG002|Overall Study|Switched to alternative treatment|0|||
27879128|NCT01827384|54499100|FG003|Overall Study|Switched to alternative treatment|0|||
27879129|NCT01827384|54499101|FG004|Overall Study|Switched to alternative treatment|0|||
27879130|NCT01827384|54499102|FG005|Overall Study|Switched to alternative treatment|0|||
27879131|NCT01827384|54499103|FG006|Overall Study|Switched to alternative treatment|0|||
27879132|NCT01827384|54499104|FG007|Overall Study|Switched to alternative treatment|0|||
27879133|NCT01827384|54499105|FG008|Overall Study|Switched to alternative treatment|0|||
27879134|NCT01827384|54499106|FG009|Overall Study|Switched to alternative treatment|0|||
27879135|NCT01827384|54499107|FG010|Overall Study|Switched to alternative treatment|0|||
27879136|NCT01827384|54499108|FG011|Overall Study|Switched to alternative treatment|0|||
27879137|NCT01827384|54499109|FG012|Overall Study|Switched to alternative treatment|0|||
27879138|NCT01827384|54499110|FG013|Overall Study|Switched to alternative treatment|2|||
27879139|NCT01827384|54499097|FG000|Overall Study|Disease progression before treatment|0|||
27879140|NCT01827384|54499098|FG001|Overall Study|Disease progression before treatment|0|||
27879141|NCT01827384|54499099|FG002|Overall Study|Disease progression before treatment|0|||
27879142|NCT01827384|54499100|FG003|Overall Study|Disease progression before treatment|0|||
27879143|NCT01827384|54499101|FG004|Overall Study|Disease progression before treatment|0|||
27879144|NCT01827384|54499102|FG005|Overall Study|Disease progression before treatment|0|||
27879145|NCT01827384|54499103|FG006|Overall Study|Disease progression before treatment|0|||
27879146|NCT01827384|54499104|FG007|Overall Study|Disease progression before treatment|0|||
27879147|NCT01827384|54499105|FG008|Overall Study|Disease progression before treatment|0|||
27879148|NCT01827384|54499106|FG009|Overall Study|Disease progression before treatment|0|||
27879149|NCT01827384|54499107|FG010|Overall Study|Disease progression before treatment|0|||
27879150|NCT01827384|54499108|FG011|Overall Study|Disease progression before treatment|0|||
27879151|NCT01827384|54499109|FG012|Overall Study|Disease progression before treatment|0|||
27879152|NCT01827384|54499110|FG013|Overall Study|Disease progression before treatment|4|||
27879153|NCT01827384|54499097|FG000|Overall Study|Ineligible|0|||
27879154|NCT01827384|54499098|FG001|Overall Study|Ineligible|0|||
27879155|NCT01827384|54499099|FG002|Overall Study|Ineligible|0|||
27879156|NCT01827384|54499100|FG003|Overall Study|Ineligible|0|||
27879157|NCT01827384|54499101|FG004|Overall Study|Ineligible|0|||
27879158|NCT01827384|54499102|FG005|Overall Study|Ineligible|0|||
27879159|NCT01827384|54499103|FG006|Overall Study|Ineligible|0|||
27879160|NCT01827384|54499104|FG007|Overall Study|Ineligible|0|||
27879161|NCT01827384|54499105|FG008|Overall Study|Ineligible|0|||
27879162|NCT01827384|54499106|FG009|Overall Study|Ineligible|0|||
27879163|NCT01827384|54499107|FG010|Overall Study|Ineligible|0|||
27879164|NCT01827384|54499108|FG011|Overall Study|Ineligible|0|||
27983374|NCT00744861|54641768|FG000|Pivotal Stage 2|Death|0|||
27983375|NCT00744861|54641769|FG001|Pivotal Stage 2|Death|0|||
27983376|NCT00744861|54641770|FG002|Pivotal Stage 2|Death|0|||
27983377|NCT00744861|54641771|FG003|Pivotal Stage 2|Death|1|||
27879165|NCT01827384|54499109|FG012|Overall Study|Ineligible|0|||
27879166|NCT01827384|54499110|FG013|Overall Study|Ineligible|19|||
27879167|NCT01827384|54499097|FG000|Overall Study|Participant died before treatment|0|||
27879168|NCT01827384|54499098|FG001|Overall Study|Participant died before treatment|0|||
27879169|NCT01827384|54499099|FG002|Overall Study|Participant died before treatment|0|||
27879170|NCT01827384|54499100|FG003|Overall Study|Participant died before treatment|0|||
27879171|NCT01827384|54499101|FG004|Overall Study|Participant died before treatment|0|||
27879172|NCT01827384|54499102|FG005|Overall Study|Participant died before treatment|0|||
27879173|NCT01827384|54499103|FG006|Overall Study|Participant died before treatment|0|||
27983378|NCT00744861|54641768|FG000|Pivotal Stage 2|Lost to Follow-up|0|||
27879174|NCT01827384|54499104|FG007|Overall Study|Participant died before treatment|0|||
27879175|NCT01827384|54499105|FG008|Overall Study|Participant died before treatment|0|||
27879176|NCT01827384|54499106|FG009|Overall Study|Participant died before treatment|0|||
27879177|NCT01827384|54499107|FG010|Overall Study|Participant died before treatment|0|||
27983379|NCT00744861|54641769|FG001|Pivotal Stage 2|Lost to Follow-up|0|||
27983380|NCT00744861|54641770|FG002|Pivotal Stage 2|Lost to Follow-up|13|||
27983381|NCT00744861|54641771|FG003|Pivotal Stage 2|Lost to Follow-up|14|||
27983382|NCT00744861|54641768|FG000|Pivotal Stage 2|Physician Decision|0|||
27983383|NCT00744861|54641769|FG001|Pivotal Stage 2|Physician Decision|0|||
27983384|NCT00744861|54641770|FG002|Pivotal Stage 2|Physician Decision|3|||
27983385|NCT00744861|54641771|FG003|Pivotal Stage 2|Physician Decision|1|||
27983386|NCT00744861|54641768|FG000|Pivotal Stage 2|Protocol Violation|0|||
27983387|NCT00744861|54641769|FG001|Pivotal Stage 2|Protocol Violation|0|||
27983388|NCT00744861|54641770|FG002|Pivotal Stage 2|Protocol Violation|0|||
27983389|NCT00744861|54641771|FG003|Pivotal Stage 2|Protocol Violation|1|||
27983390|NCT00744861|54641768|FG000|Pivotal Stage 2|Withdrawal by Subject|0|||
27983391|NCT00744861|54641769|FG001|Pivotal Stage 2|Withdrawal by Subject|0|||
27983392|NCT00744861|54641770|FG002|Pivotal Stage 2|Withdrawal by Subject|20|||
27983393|NCT00744861|54641771|FG003|Pivotal Stage 2|Withdrawal by Subject|14|||
27983394|NCT00744861|54641768|FG000|Pivotal Stage 2|Study Terminated by Sponsor|0|||
27983395|NCT00744861|54641769|FG001|Pivotal Stage 2|Study Terminated by Sponsor|0|||
27983396|NCT00744861|54641770|FG002|Pivotal Stage 2|Study Terminated by Sponsor|60|||
27983397|NCT00744861|54641771|FG003|Pivotal Stage 2|Study Terminated by Sponsor|63|||
27983398|NCT03969589|54641781|FG000|Overall Study|Lost to Follow-up|3|||
27983399|NCT03969589|54641782|FG001|Overall Study|Lost to Follow-up|2|||
27983400|NCT03969589|54641781|FG000|Overall Study|Declined Follow-Up|0|||
27983401|NCT03969589|54641782|FG001|Overall Study|Declined Follow-Up|1|||
27983402|NCT00744627|54641790|FG000|Overall Study|Adverse Event|6|||
27983403|NCT00744627|54641791|FG001|Overall Study|Adverse Event|9|||
27983404|NCT00744627|54641790|FG000|Overall Study|Lack of Efficacy|7|||
27983405|NCT00744627|54641791|FG001|Overall Study|Lack of Efficacy|3|||
27983406|NCT00744627|54641790|FG000|Overall Study|Noncompliance|0|||
27983407|NCT00744627|54641791|FG001|Overall Study|Noncompliance|1|||
27983408|NCT00744627|54641790|FG000|Overall Study|Protocol Deviations|0|||
27983409|NCT00744627|54641791|FG001|Overall Study|Protocol Deviations|2|||
27983410|NCT00744627|54641790|FG000|Overall Study|Voluntary Withdrawal|9|||
27983411|NCT00744627|54641791|FG001|Overall Study|Voluntary Withdrawal|6|||
27983412|NCT00744627|54641790|FG000|Overall Study|Lost to Follow-up|2|||
27983413|NCT00744627|54641791|FG001|Overall Study|Lost to Follow-up|1|||
27983414|NCT00744627|54641790|FG000|Overall Study|Other|1|||
27983415|NCT00744627|54641791|FG001|Overall Study|Other|0|||
27983416|NCT03959137|54641797|FG000|Overall Study|Protocol Violation|6|||
27983417|NCT00562627|54641804|FG000|Overall Study|Protocol Violation|1|||
27983418|NCT00562627|54641805|FG001|Overall Study|Protocol Violation|1|||
27983419|NCT00562627|54641806|FG002|Overall Study|Protocol Violation|1|||
27983420|NCT00562159|54641816|FG000|Overall Study|Adverse Event|11|||
27983421|NCT00562159|54641817|FG001|Overall Study|Adverse Event|8|||
27983422|NCT00562159|54641816|FG000|Overall Study|Lost to Follow-up|5|||
27983423|NCT00562159|54641817|FG001|Overall Study|Lost to Follow-up|4|||
27983424|NCT00562159|54641816|FG000|Overall Study|Withdrawal by Subject|9|||
27983425|NCT00562159|54641817|FG001|Overall Study|Withdrawal by Subject|8|||
27983426|NCT00562159|54641816|FG000|Overall Study|Protocol Violation|12|||
27983427|NCT00562159|54641817|FG001|Overall Study|Protocol Violation|12|||
27983428|NCT00562159|54641816|FG000|Overall Study|Did not meet protocol eligibility|1|||
27983429|NCT00562159|54641817|FG001|Overall Study|Did not meet protocol eligibility|1|||
27983430|NCT04223778|54641826|FG000|Overall Study|Ongoing|322|||
27983431|NCT04223778|54641827|FG001|Overall Study|Ongoing|326|||
27983432|NCT04223778|54641826|FG000|Overall Study|Death|0|||
27983433|NCT04223778|54641827|FG001|Overall Study|Death|1|||
27983434|NCT04223778|54641826|FG000|Overall Study|Lost to Follow-up|1|||
27983435|NCT04223778|54641827|FG001|Overall Study|Lost to Follow-up|5|||
27983436|NCT04223778|54641826|FG000|Overall Study|Physician Decision|3|||
27983437|NCT04223778|54641827|FG001|Overall Study|Physician Decision|1|||
27983438|NCT04223778|54641826|FG000|Overall Study|Withdrawal by Subject|10|||
27983439|NCT04223778|54641827|FG001|Overall Study|Withdrawal by Subject|1|||
27983440|NCT04223778|54641826|FG000|Overall Study|Lack of Efficacy|0|||
27983441|NCT04223778|54641827|FG001|Overall Study|Lack of Efficacy|2|||
27983442|NCT00921557|54641836|FG000|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2|||
27983443|NCT00921557|54641837|FG001|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
27983444|NCT00921557|54641838|FG002|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
27983445|NCT00921557|54641836|FG000|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
27983446|NCT00921557|54641837|FG001|Weeks 48-96 (on Study Treatment)|Site Closure|1|||
27983447|NCT00921557|54641838|FG002|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
27983448|NCT00921557|54641836|FG000|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
27983449|NCT00921557|54641837|FG001|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
27983450|NCT00921557|54641838|FG002|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1|||
27879178|NCT01827384|54499108|FG011|Overall Study|Participant died before treatment|0|||
27879179|NCT01827384|54499109|FG012|Overall Study|Participant died before treatment|0|||
27879180|NCT01827384|54499110|FG013|Overall Study|Participant died before treatment|5|||
27879181|NCT01827384|54499097|FG000|Overall Study|Insufficient tumor cells|0|||
27879182|NCT01827384|54499098|FG001|Overall Study|Insufficient tumor cells|0|||
27879183|NCT01827384|54499099|FG002|Overall Study|Insufficient tumor cells|0|||
27879184|NCT01827384|54499100|FG003|Overall Study|Insufficient tumor cells|0|||
27879185|NCT01827384|54499101|FG004|Overall Study|Insufficient tumor cells|0|||
27879186|NCT01827384|54499102|FG005|Overall Study|Insufficient tumor cells|0|||
27879187|NCT01827384|54499103|FG006|Overall Study|Insufficient tumor cells|0|||
27879188|NCT01827384|54499104|FG007|Overall Study|Insufficient tumor cells|0|||
27879189|NCT01827384|54499105|FG008|Overall Study|Insufficient tumor cells|0|||
27879190|NCT01827384|54499106|FG009|Overall Study|Insufficient tumor cells|0|||
27879191|NCT01827384|54499107|FG010|Overall Study|Insufficient tumor cells|0|||
27879192|NCT01827384|54499108|FG011|Overall Study|Insufficient tumor cells|0|||
27879193|NCT01827384|54499109|FG012|Overall Study|Insufficient tumor cells|0|||
27879194|NCT01827384|54499110|FG013|Overall Study|Insufficient tumor cells|13|||
27879195|NCT01827384|54499097|FG000|Overall Study|No actionable mutation|0|||
27879196|NCT01827384|54499098|FG001|Overall Study|No actionable mutation|0|||
27879197|NCT01827384|54499099|FG002|Overall Study|No actionable mutation|0|||
28171693|NCT01652872|54843275|FG000|Overall Study|Lost to Follow-up|28|||
28171694|NCT01652872|54843276|FG001|Overall Study|Lost to Follow-up|23|||
28171695|NCT01652872|54843275|FG000|Overall Study|Decision by sponsor|5|||
28171696|NCT01652872|54843276|FG001|Overall Study|Decision by sponsor|7|||
28171697|NCT01652872|54843275|FG000|Overall Study|Withdrawal by Subject|76|||
28171698|NCT01652872|54843276|FG001|Overall Study|Withdrawal by Subject|84|||
28171699|NCT04251273|54843284|FG000|Overall Study|Lost to Follow-up|331|||
28171700|NCT04251273|54843285|FG001|Overall Study|Lost to Follow-up|290|||
28171701|NCT02443402|54843293|FG000|Overall Study|Withdrawal by Subject|3|||
28171702|NCT02443402|54843294|FG001|Overall Study|Withdrawal by Subject|1|||
28171703|NCT02443402|54843293|FG000|Overall Study|Screen Failure|1|||
28171704|NCT02443402|54843294|FG001|Overall Study|Screen Failure|2|||
28171705|NCT01370005|54843303|FG000|Overall Study|Not treated|1|||
28171706|NCT01370005|54843304|FG001|Overall Study|Not treated|0|||
28171707|NCT01370005|54843305|FG002|Overall Study|Not treated|0|||
28171708|NCT01370005|54843303|FG000|Overall Study|Adverse Event|5|||
28171709|NCT01370005|54843304|FG001|Overall Study|Adverse Event|5|||
28171710|NCT01370005|54843305|FG002|Overall Study|Adverse Event|6|||
28171711|NCT01370005|54843303|FG000|Overall Study|Lack of Efficacy|1|||
28171712|NCT01370005|54843304|FG001|Overall Study|Lack of Efficacy|0|||
28171713|NCT01370005|54843305|FG002|Overall Study|Lack of Efficacy|0|||
28171714|NCT01370005|54843303|FG000|Overall Study|Non compliant with protocol|0|||
28171715|NCT01370005|54843304|FG001|Overall Study|Non compliant with protocol|1|||
28171716|NCT01370005|54843305|FG002|Overall Study|Non compliant with protocol|2|||
28171717|NCT01370005|54843303|FG000|Overall Study|Lost to Follow-up|1|||
28171718|NCT01370005|54843304|FG001|Overall Study|Lost to Follow-up|1|||
28171719|NCT01370005|54843305|FG002|Overall Study|Lost to Follow-up|1|||
28171720|NCT01370005|54843303|FG000|Overall Study|Patient refusal to continue,not due toAE|5|||
28171721|NCT01370005|54843304|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
28171722|NCT01370005|54843305|FG002|Overall Study|Patient refusal to continue,not due toAE|0|||
28171723|NCT01370005|54843303|FG000|Overall Study|Other reason not defined above|3|||
28171724|NCT01370005|54843304|FG001|Overall Study|Other reason not defined above|0|||
28171725|NCT01370005|54843305|FG002|Overall Study|Other reason not defined above|2|||
28171726|NCT02442778|54843316|FG000|Overall Study|Adverse Event|2|||
28171727|NCT02442778|54843317|FG001|Overall Study|Adverse Event|6|||
28171728|NCT02442778|54843318|FG002|Overall Study|Adverse Event|6|||
28171729|NCT02442778|54843316|FG000|Overall Study|Death|0|||
27739290|NCT01678209|54188643|FG000|Overall Study|scheduling conflicts|0|||
27879198|NCT01827384|54499100|FG003|Overall Study|No actionable mutation|0|||
27879199|NCT01827384|54499101|FG004|Overall Study|No actionable mutation|0|||
27983451|NCT00921557|54641836|FG000|Weeks 96-144 (Off Study Treatment)|Site closure|1|||
27983452|NCT00921557|54641837|FG001|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
27879200|NCT01827384|54499102|FG005|Overall Study|No actionable mutation|0|||
27879201|NCT01827384|54499103|FG006|Overall Study|No actionable mutation|0|||
27879202|NCT01827384|54499104|FG007|Overall Study|No actionable mutation|0|||
27879203|NCT01827384|54499105|FG008|Overall Study|No actionable mutation|0|||
27879204|NCT01827384|54499106|FG009|Overall Study|No actionable mutation|0|||
27879205|NCT01827384|54499107|FG010|Overall Study|No actionable mutation|0|||
27879206|NCT01827384|54499108|FG011|Overall Study|No actionable mutation|0|||
27879207|NCT01827384|54499109|FG012|Overall Study|No actionable mutation|0|||
27879208|NCT01827384|54499110|FG013|Overall Study|No actionable mutation|73|||
27879209|NCT01827384|54499097|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
27879210|NCT01827384|54499098|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
27983453|NCT00921557|54641838|FG002|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
27983454|NCT00921557|54641836|FG000|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2|||
27879211|NCT01827384|54499099|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
27879212|NCT01827384|54499100|FG003|Overall Study|Participant declined to participate (before treatment started)|0|||
27879213|NCT01827384|54499101|FG004|Overall Study|Participant declined to participate (before treatment started)|0|||
27879214|NCT01827384|54499102|FG005|Overall Study|Participant declined to participate (before treatment started)|0|||
27879215|NCT01827384|54499103|FG006|Overall Study|Participant declined to participate (before treatment started)|0|||
27879216|NCT01827384|54499104|FG007|Overall Study|Participant declined to participate (before treatment started)|0|||
27879217|NCT01827384|54499105|FG008|Overall Study|Participant declined to participate (before treatment started)|0|||
27879218|NCT01827384|54499106|FG009|Overall Study|Participant declined to participate (before treatment started)|0|||
27879219|NCT01827384|54499107|FG010|Overall Study|Participant declined to participate (before treatment started)|0|||
27879220|NCT01827384|54499108|FG011|Overall Study|Participant declined to participate (before treatment started)|0|||
27879221|NCT01827384|54499109|FG012|Overall Study|Participant declined to participate (before treatment started)|0|||
27879222|NCT01827384|54499110|FG013|Overall Study|Participant declined to participate (before treatment started)|15|||
27879223|NCT01844076|54499144|FG000|Overall Study|Adverse Event|1|||
27879224|NCT01844076|54499145|FG001|Overall Study|Adverse Event|0|||
27879225|NCT01844076|54499146|FG002|Overall Study|Adverse Event|0|||
27879226|NCT01844076|54499147|FG003|Overall Study|Adverse Event|0|||
27879227|NCT01844076|54499144|FG000|Overall Study|Withdrawal by Subject|1|||
27879228|NCT01844076|54499145|FG001|Overall Study|Withdrawal by Subject|0|||
27879229|NCT01844076|54499146|FG002|Overall Study|Withdrawal by Subject|0|||
27879230|NCT01844076|54499147|FG003|Overall Study|Withdrawal by Subject|0|||
27879231|NCT01826604|54499159|FG000|Overall Study|Lost to Follow-up|8|||
27879232|NCT01826604|54499160|FG001|Overall Study|Lost to Follow-up|9|||
27879233|NCT01843842|54499168|FG000|Overall Study|Do not meet inclusion criteria|1|||
27879234|NCT01843842|54499169|FG001|Overall Study|Do not meet inclusion criteria|1|||
27879235|NCT01826448|54499177|FG000|Overall Study|Adverse Event|1|||
27879236|NCT01826448|54499178|FG001|Overall Study|Adverse Event|3|||
27879237|NCT01826448|54499177|FG000|Overall Study|Disease progression|2|||
27879238|NCT01826448|54499178|FG001|Overall Study|Disease progression|4|||
27879239|NCT01826448|54499177|FG000|Overall Study|Withdrawal by Subject|1|||
27879240|NCT01826448|54499178|FG001|Overall Study|Withdrawal by Subject|0|||
27879241|NCT01826448|54499177|FG000|Overall Study|Physician Decision|0|||
27879242|NCT01826448|54499178|FG001|Overall Study|Physician Decision|1|||
27879243|NCT01826448|54499177|FG000|Overall Study|2 active cancers|0|||
27879244|NCT01826448|54499178|FG001|Overall Study|2 active cancers|1|||
27879245|NCT01826370|54499184|FG000|Overall Study|Protocol Violation|6|||
27879246|NCT01826370|54499184|FG000|Overall Study|Lost to Follow-up|12|||
27879247|NCT01826370|54499184|FG000|Overall Study|Other reason not defined above|2|||
27879248|NCT01826214|54499190|FG000|Overall Study|Adverse Event|7|||
27879249|NCT01826214|54499191|FG001|Overall Study|Adverse Event|6|||
27879250|NCT01826214|54499190|FG000|Overall Study|Death|3|||
27879251|NCT01826214|54499191|FG001|Overall Study|Death|1|||
27879252|NCT01826214|54499190|FG000|Overall Study|Lost to Follow-up|1|||
27879253|NCT01826214|54499191|FG001|Overall Study|Lost to Follow-up|0|||
27879254|NCT01826214|54499190|FG000|Overall Study|Physician Decision|0|||
27879255|NCT01826214|54499191|FG001|Overall Study|Physician Decision|2|||
27879256|NCT01826214|54499190|FG000|Overall Study|Progressive disease|22|||
27879257|NCT01826214|54499191|FG001|Overall Study|Progressive disease|21|||
27879258|NCT01826214|54499190|FG000|Overall Study|Study terminated by Sponsor|0|||
27879259|NCT01826214|54499191|FG001|Overall Study|Study terminated by Sponsor|1|||
27879260|NCT01826214|54499190|FG000|Overall Study|Subject/guardian decision|2|||
27879261|NCT01826214|54499191|FG001|Overall Study|Subject/guardian decision|3|||
27879262|NCT01843062|54499199|FG000|Overall Study|Protocol Violation|1|||
27879263|NCT01843062|54499200|FG001|Overall Study|Protocol Violation|0|||
27879264|NCT01843062|54499199|FG000|Overall Study|New treatment following progression|2|||
27879265|NCT01843062|54499200|FG001|Overall Study|New treatment following progression|0|||
27879266|NCT01843062|54499199|FG000|Overall Study|Pregnancy|1|||
27879267|NCT01843062|54499200|FG001|Overall Study|Pregnancy|0|||
27879268|NCT01843062|54499199|FG000|Overall Study|Adverse Event|2|||
27879269|NCT01843062|54499200|FG001|Overall Study|Adverse Event|0|||
27879270|NCT01843062|54499199|FG000|Overall Study|Incorrect randomisation|1|||
27879271|NCT01843062|54499200|FG001|Overall Study|Incorrect randomisation|0|||
27879272|NCT01843062|54499199|FG000|Overall Study|Withdrawal by Subject|12|||
27879273|NCT01843062|54499200|FG001|Overall Study|Withdrawal by Subject|3|||
27879274|NCT01843062|54499199|FG000|Overall Study|Death|1|||
27879275|NCT01843062|54499200|FG001|Overall Study|Death|2|||
27879276|NCT01843062|54499199|FG000|Overall Study|Lost to Follow-up|2|||
27879277|NCT01843062|54499200|FG001|Overall Study|Lost to Follow-up|4|||
27879278|NCT01842438|54499208|FG000|T1: Immediately After the Intervention|Withdrawal by Subject|6|||
27879279|NCT01842438|54499209|FG001|T1: Immediately After the Intervention|Withdrawal by Subject|8|||
27879280|NCT01842438|54499208|FG000|T2: 6month Follow-up|Withdrawal by Subject|4|||
27879281|NCT01842438|54499209|FG001|T2: 6month Follow-up|Withdrawal by Subject|3|||
27983455|NCT00921557|54641837|FG001|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
28171730|NCT02442778|54843317|FG001|Overall Study|Death|2|||
27879282|NCT01842438|54499208|FG000|T2: 6month Follow-up|Death|0|||
27879283|NCT01842438|54499209|FG001|T2: 6month Follow-up|Death|1|||
27879284|NCT01799226|54499221|FG000|Overall Study|Withdrawal by Subject|1|||
27879285|NCT01799226|54499222|FG001|Overall Study|Withdrawal by Subject|0|||
27879286|NCT01799226|54499221|FG000|Overall Study|Disqualified at Day 14|1|||
27879287|NCT01799226|54499222|FG001|Overall Study|Disqualified at Day 14|0|||
27879288|NCT01798992|54499232|FG000|Overall Study|Administrative withdrawal|0|||
27879289|NCT01798992|54499233|FG001|Overall Study|Administrative withdrawal|1|||
27879290|NCT01798992|54499234|FG002|Overall Study|Administrative withdrawal|0|||
27879291|NCT01798992|54499235|FG003|Overall Study|Administrative withdrawal|1|||
27879292|NCT01798992|54499232|FG000|Overall Study|Lost to Follow-up|0|||
27879293|NCT01798992|54499233|FG001|Overall Study|Lost to Follow-up|1|||
27879294|NCT01798992|54499234|FG002|Overall Study|Lost to Follow-up|1|||
27879295|NCT01798992|54499235|FG003|Overall Study|Lost to Follow-up|0|||
27879296|NCT01798992|54499232|FG000|Overall Study|Insufficient biopsy tissue|0|||
27879297|NCT01798992|54499233|FG001|Overall Study|Insufficient biopsy tissue|0|||
27879298|NCT01798992|54499234|FG002|Overall Study|Insufficient biopsy tissue|1|||
27879299|NCT01798992|54499235|FG003|Overall Study|Insufficient biopsy tissue|0|||
27879300|NCT01825200|54499246|FG000|Overall Study|Lost to Follow-up|5|||
27879301|NCT01825200|54499247|FG001|Overall Study|Lost to Follow-up|6|||
27879302|NCT01825200|54499246|FG000|Overall Study|Withdrawal by Subject|0|||
27879303|NCT01825200|54499247|FG001|Overall Study|Withdrawal by Subject|1|||
27879304|NCT01824576|54499253|FG000|Overall Study|Device deficiency|2|||
27879305|NCT01824498|54499263|FG000|Washout (8 Weeks)|Withdrawal by Subject|2|||
27879306|NCT01824498|54499264|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
27879307|NCT01824498|54499265|FG002|Washout (8 Weeks)|Withdrawal by Subject|2|||
27879308|NCT01824498|54499266|FG003|Washout (8 Weeks)|Withdrawal by Subject|1|||
27879309|NCT01824498|54499267|FG004|Washout (8 Weeks)|Withdrawal by Subject|1|||
27879310|NCT01824498|54499268|FG005|Washout (8 Weeks)|Withdrawal by Subject|0|||
27879311|NCT01798134|54499276|FG000|Overall Study|Lost to Follow-up|1|||
27879312|NCT01798134|54499276|FG000|Overall Study|Withdrawal by Subject|3|||
27879313|NCT01798134|54499276|FG000|Overall Study|Death|2|||
27879314|NCT01798134|54499276|FG000|Overall Study|Adverse Event|3|||
27879315|NCT01798134|54499276|FG000|Overall Study|Physician Decision|3|||
27879316|NCT01798134|54499276|FG000|Overall Study|Liver transplant/surgery|4|||
27879317|NCT01798056|54499282|FG000|Overall Study|Serious Adverse Event|13|||
27879318|NCT01798056|54499283|FG001|Overall Study|Serious Adverse Event|12|||
27879319|NCT01798056|54499282|FG000|Overall Study|Withdrawal by Subject|12|||
27879320|NCT01798056|54499283|FG001|Overall Study|Withdrawal by Subject|9|||
27879321|NCT01798056|54499282|FG000|Overall Study|Migrated/moved from study area|1|||
27879322|NCT01798056|54499283|FG001|Overall Study|Migrated/moved from study area|1|||
27879323|NCT01798056|54499282|FG000|Overall Study|Lost to Follow-up|1|||
27879324|NCT01798056|54499283|FG001|Overall Study|Lost to Follow-up|1|||
27879325|NCT01798056|54499282|FG000|Overall Study|Other|0|||
27879326|NCT01798056|54499283|FG001|Overall Study|Other|2|||
27879327|NCT01824342|54499293|FG000|Overall Study|Withdrawal by Subject|0|||
27879328|NCT01824342|54499294|FG001|Overall Study|Withdrawal by Subject|3|||
27879329|NCT01824342|54499293|FG000|Overall Study|Adverse Event|1|||
27879330|NCT01824342|54499294|FG001|Overall Study|Adverse Event|1|||
27879331|NCT01824342|54499293|FG000|Overall Study|Disease Progression|1|||
27879332|NCT01824342|54499294|FG001|Overall Study|Disease Progression|1|||
27879333|NCT01824342|54499293|FG000|Overall Study|Physician Decision|5|||
27879334|NCT01824342|54499294|FG001|Overall Study|Physician Decision|0|||
27879335|NCT01824342|54499293|FG000|Overall Study|Death|2|||
27879336|NCT01824342|54499294|FG001|Overall Study|Death|0|||
27879337|NCT01841970|54499300|FG000|Overall Study|Withdrawal by Subject|1|||
27879338|NCT01841970|54499300|FG000|Overall Study|Physician Decision|2|||
27879339|NCT01841970|54499300|FG000|Overall Study|Lost to Follow-up|8|||
27879340|NCT01823328|54499309|FG000|Overall Study|Withdrawal by Subject|8|||
27879341|NCT01823328|54499310|FG001|Overall Study|Withdrawal by Subject|6|||
27879342|NCT01840410|54499318|FG000|Overall Study|Physician Decision|1|||
27879343|NCT01840410|54499319|FG001|Overall Study|Physician Decision|2|||
27879344|NCT01840410|54499318|FG000|Overall Study|Pregnancy|1|||
27739291|NCT01678209|54188644|FG001|Overall Study|scheduling conflicts|0|||
27739292|NCT01678209|54188645|FG002|Overall Study|scheduling conflicts|1|||
27879345|NCT01840410|54499319|FG001|Overall Study|Pregnancy|0|||
27879346|NCT01840410|54499318|FG000|Overall Study|Protocol deviation|1|||
27879347|NCT01840410|54499319|FG001|Overall Study|Protocol deviation|0|||
27879348|NCT01840410|54499318|FG000|Overall Study|Lost to Follow-up|1|||
27879349|NCT01840410|54499319|FG001|Overall Study|Lost to Follow-up|0|||
27879350|NCT01840410|54499318|FG000|Overall Study|Withdrawal by Subject|2|||
27879351|NCT01840410|54499319|FG001|Overall Study|Withdrawal by Subject|1|||
27879352|NCT01840410|54499318|FG000|Overall Study|Adverse Event|1|||
27879353|NCT01840410|54499319|FG001|Overall Study|Adverse Event|1|||
27879354|NCT01797432|54499327|FG000|Overall Study|Lost to Follow-up|1|||
27879355|NCT01797432|54499327|FG000|Overall Study|Adverse Event|1|||
27879356|NCT01797432|54499327|FG000|Overall Study|Withdrawal by Subject|1|||
27879357|NCT01797432|54499327|FG000|Overall Study|lived too far from study site|1|||
27879358|NCT01797120|54499333|FG000|Overall Study|Disesae progression|37|||
27879359|NCT01797120|54499334|FG001|Overall Study|Disesae progression|49|||
27879360|NCT01797120|54499333|FG000|Overall Study|Adverse Event|13|||
27879361|NCT01797120|54499334|FG001|Overall Study|Adverse Event|5|||
27879362|NCT01797120|54499333|FG000|Overall Study|Withdrawal by Subject|6|||
27879363|NCT01797120|54499334|FG001|Overall Study|Withdrawal by Subject|6|||
27879364|NCT01797120|54499333|FG000|Overall Study|Symptomatic progression|2|||
27879365|NCT01797120|54499334|FG001|Overall Study|Symptomatic progression|1|||
27879366|NCT01797120|54499333|FG000|Overall Study|Non-compliance|1|||
27879367|NCT01797120|54499334|FG001|Overall Study|Non-compliance|0|||
27879368|NCT01797120|54499333|FG000|Overall Study|Physician Decision|3|||
27879369|NCT01797120|54499334|FG001|Overall Study|Physician Decision|0|||
27879370|NCT01797120|54499333|FG000|Overall Study|still on treatment|2|||
27879371|NCT01797120|54499334|FG001|Overall Study|still on treatment|4|||
27879372|NCT01797120|54499333|FG000|Overall Study|never start protocol therapy|2|||
27879373|NCT01797120|54499334|FG001|Overall Study|never start protocol therapy|0|||
27879374|NCT01796964|54499342|FG000|Overall Study|Adverse Event|1|||
27879375|NCT01796964|54499343|FG001|Overall Study|Adverse Event|1|||
27879376|NCT01796964|54499342|FG000|Overall Study|Death|1|||
27879377|NCT01796964|54499343|FG001|Overall Study|Death|0|||
27879378|NCT01796964|54499342|FG000|Overall Study|Protocol Violation|0|||
27879379|NCT01796964|54499343|FG001|Overall Study|Protocol Violation|1|||
27879380|NCT01796964|54499342|FG000|Overall Study|Withdrawal by Subject|1|||
27983456|NCT00921557|54641838|FG002|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
28171731|NCT02442778|54843318|FG002|Overall Study|Death|0|||
28171732|NCT02442778|54843316|FG000|Overall Study|Lack of Efficacy|1|||
28171733|NCT02442778|54843317|FG001|Overall Study|Lack of Efficacy|0|||
28171734|NCT02442778|54843318|FG002|Overall Study|Lack of Efficacy|0|||
27879381|NCT01796964|54499343|FG001|Overall Study|Withdrawal by Subject|1|||
27879382|NCT01838694|54499352|FG000|Overall Study|Adverse Event|0|||
27879383|NCT01838694|54499353|FG001|Overall Study|Adverse Event|1|||
27879384|NCT01795638|54499364|FG000|Overall Study|Death|0|||
27879385|NCT01795638|54499365|FG001|Overall Study|Death|3|||
27879386|NCT01795638|54499364|FG000|Overall Study|transferred to quaternary hospital|2|||
27879387|NCT01795638|54499365|FG001|Overall Study|transferred to quaternary hospital|3|||
27879388|NCT01795638|54499364|FG000|Overall Study|Protocol Violation|3|||
27879389|NCT01795638|54499365|FG001|Overall Study|Protocol Violation|0|||
27879390|NCT01795638|54499364|FG000|Overall Study|discharged from hospital|7|||
27879391|NCT01795638|54499365|FG001|Overall Study|discharged from hospital|5|||
27879392|NCT01795638|54499364|FG000|Overall Study|Withdrawal by Subject|1|||
27879393|NCT01795638|54499365|FG001|Overall Study|Withdrawal by Subject|0|||
27879394|NCT01794780|54499379|FG000|Overall Study|Adverse Event|0|||
27879395|NCT01794780|54499380|FG001|Overall Study|Adverse Event|1|||
27879396|NCT01794780|54499381|FG002|Overall Study|Adverse Event|2|||
27879397|NCT01794780|54499382|FG003|Overall Study|Adverse Event|0|||
27879398|NCT01794780|54499383|FG004|Overall Study|Adverse Event|0|||
27879399|NCT01794780|54499384|FG005|Overall Study|Adverse Event|0|||
27879400|NCT01794780|54499385|FG006|Overall Study|Adverse Event|0|||
27879401|NCT01794780|54499386|FG007|Overall Study|Adverse Event|0|||
27879402|NCT01794780|54499379|FG000|Overall Study|Death|0|||
27879403|NCT01794780|54499380|FG001|Overall Study|Death|2|||
27879404|NCT01794780|54499381|FG002|Overall Study|Death|14|||
27879405|NCT01794780|54499382|FG003|Overall Study|Death|1|||
27879406|NCT01794780|54499383|FG004|Overall Study|Death|0|||
27879407|NCT01794780|54499384|FG005|Overall Study|Death|9|||
27879408|NCT01794780|54499385|FG006|Overall Study|Death|4|||
27879409|NCT01794780|54499386|FG007|Overall Study|Death|0|||
27879410|NCT01794780|54499379|FG000|Overall Study|Lost to Follow-up|10|||
27879411|NCT01794780|54499380|FG001|Overall Study|Lost to Follow-up|64|||
27879412|NCT01794780|54499381|FG002|Overall Study|Lost to Follow-up|165|||
27879413|NCT01794780|54499382|FG003|Overall Study|Lost to Follow-up|53|||
27879414|NCT01794780|54499383|FG004|Overall Study|Lost to Follow-up|2|||
27879415|NCT01794780|54499384|FG005|Overall Study|Lost to Follow-up|99|||
27879416|NCT01794780|54499385|FG006|Overall Study|Lost to Follow-up|30|||
27879417|NCT01794780|54499386|FG007|Overall Study|Lost to Follow-up|5|||
27879418|NCT01794780|54499379|FG000|Overall Study|Withdrew informed consent|7|||
27879419|NCT01794780|54499380|FG001|Overall Study|Withdrew informed consent|17|||
27879420|NCT01794780|54499381|FG002|Overall Study|Withdrew informed consent|36|||
27879421|NCT01794780|54499382|FG003|Overall Study|Withdrew informed consent|9|||
27879422|NCT01794780|54499383|FG004|Overall Study|Withdrew informed consent|0|||
27879423|NCT01794780|54499384|FG005|Overall Study|Withdrew informed consent|48|||
27983457|NCT00550615|54641853|FG000|Overall Study|Withdrawal by Subject|0|||
27983458|NCT00550615|54641854|FG001|Overall Study|Withdrawal by Subject|0|||
27879424|NCT01794780|54499385|FG006|Overall Study|Withdrew informed consent|4|||
27879425|NCT01794780|54499386|FG007|Overall Study|Withdrew informed consent|3|||
27879426|NCT01794780|54499379|FG000|Overall Study|Other|0|||
27879427|NCT01794780|54499380|FG001|Overall Study|Other|12|||
27879428|NCT01794780|54499381|FG002|Overall Study|Other|25|||
27879429|NCT01794780|54499382|FG003|Overall Study|Other|20|||
27879430|NCT01794780|54499383|FG004|Overall Study|Other|1|||
27879431|NCT01794780|54499384|FG005|Overall Study|Other|24|||
27879432|NCT01794780|54499385|FG006|Overall Study|Other|4|||
27879433|NCT01794780|54499386|FG007|Overall Study|Other|1|||
27879434|NCT01838616|54499413|FG000|Titration Period|Adverse Event|18|||
27879435|NCT01838616|54499414|FG001|Titration Period|Adverse Event|48|||
27879436|NCT01838616|54499413|FG000|Titration Period|Lack of Efficacy|5|||
27879437|NCT01838616|54499414|FG001|Titration Period|Lack of Efficacy|12|||
27879438|NCT01838616|54499413|FG000|Titration Period|Withdrawal by Subject|5|||
27879439|NCT01838616|54499414|FG001|Titration Period|Withdrawal by Subject|5|||
27879440|NCT01838616|54499413|FG000|Titration Period|Technical problems|1|||
27879441|NCT01838616|54499414|FG001|Titration Period|Technical problems|0|||
27879442|NCT01838616|54499413|FG000|Titration Period|Other|1|||
27879443|NCT01838616|54499414|FG001|Titration Period|Other|0|||
27879444|NCT01838616|54499413|FG000|Titration Period|Protocol Violation|0|||
27879445|NCT01838616|54499414|FG001|Titration Period|Protocol Violation|1|||
27879446|NCT01838616|54499413|FG000|Continuation Period|Lack of Efficacy|3|||
27879447|NCT01838616|54499414|FG001|Continuation Period|Lack of Efficacy|5|||
27879448|NCT01838616|54499413|FG000|Continuation Period|Adverse Event|8|||
27879449|NCT01838616|54499414|FG001|Continuation Period|Adverse Event|4|||
27879450|NCT01838616|54499413|FG000|Continuation Period|Protocol Violation|2|||
27879451|NCT01838616|54499414|FG001|Continuation Period|Protocol Violation|0|||
27879452|NCT01838616|54499413|FG000|Continuation Period|Lost to Follow-up|1|||
27879453|NCT01838616|54499414|FG001|Continuation Period|Lost to Follow-up|0|||
27879454|NCT01838616|54499413|FG000|Continuation Period|Withdrawal by Subject|0|||
27879455|NCT01838616|54499414|FG001|Continuation Period|Withdrawal by Subject|4|||
27879456|NCT01838616|54499413|FG000|Continuation Period|Technical problems|0|||
27879457|NCT01838616|54499414|FG001|Continuation Period|Technical problems|1|||
27879458|NCT01838616|54499413|FG000|Pick-up Arm|Lack of Efficacy|4|||
27879459|NCT01838616|54499414|FG001|Pick-up Arm|Lack of Efficacy|0|||
27879460|NCT01838616|54499413|FG000|Pick-up Arm|Adverse Event|9|||
27879461|NCT01838616|54499414|FG001|Pick-up Arm|Adverse Event|0|||
27879462|NCT01838616|54499413|FG000|Pick-up Arm|Withdrawal by Subject|1|||
27879463|NCT01838616|54499414|FG001|Pick-up Arm|Withdrawal by Subject|0|||
27879464|NCT01838616|54499413|FG000|Pick-up Arm|Technical problems|1|||
27879465|NCT01838616|54499414|FG001|Pick-up Arm|Technical problems|0|||
27879466|NCT01611792|54499427|FG000|Initial Period: Time 0|unable to schedule 10 consecutive appts|12|||
27879467|NCT01611792|54499428|FG001|Initial Period: Time 0|unable to schedule 10 consecutive appts|9|||
27879468|NCT01611792|54499427|FG000|Followup: at 6 Months|Lost to Follow-up|6|||
27879469|NCT01611792|54499428|FG001|Followup: at 6 Months|Lost to Follow-up|13|||
27879470|NCT01820364|54499435|FG000|Part I: LGX818|Death|1|||
27879471|NCT01820364|54499436|FG001|Part I: LGX818|Death|0|||
27879472|NCT01820364|54499435|FG000|Part I: LGX818|Administrative Problems|3|||
27879473|NCT01820364|54499436|FG001|Part I: LGX818|Administrative Problems|0|||
27879474|NCT01820364|54499435|FG000|Part I: LGX818|Adverse Event|6|||
27879475|NCT01820364|54499436|FG001|Part I: LGX818|Adverse Event|0|||
27879476|NCT01820364|54499435|FG000|Part I: LGX818|Disease Progression|4|||
27879477|NCT01820364|54499436|FG001|Part I: LGX818|Disease Progression|0|||
27879478|NCT01820364|54499435|FG000|Part II: LGX818 + MEK162|Study Termination|0|||
27879479|NCT01820364|54499436|FG001|Part II: LGX818 + MEK162|Study Termination|1|||
27879480|NCT01819506|54499444|FG000|Overall Study|Physician Decision|5|||
27879481|NCT01819506|54499445|FG001|Overall Study|Physician Decision|2|||
27879482|NCT01819506|54499444|FG000|Overall Study|Withdrawal by Subject|3|||
27879483|NCT01819506|54499445|FG001|Overall Study|Withdrawal by Subject|3|||
27879484|NCT01794000|54499453|FG000|Double-Blind Phase (DBP)|Adverse Event|5|||
27879485|NCT01794000|54499454|FG001|Double-Blind Phase (DBP)|Adverse Event|2|||
27879486|NCT01794000|54499453|FG000|Double-Blind Phase (DBP)|Death|1|||
27879487|NCT01794000|54499454|FG001|Double-Blind Phase (DBP)|Death|2|||
27879488|NCT01794000|54499453|FG000|Double-Blind Phase (DBP)|Entry Criteria Not Met|2|||
27879489|NCT01794000|54499454|FG001|Double-Blind Phase (DBP)|Entry Criteria Not Met|0|||
27879490|NCT01794000|54499453|FG000|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5|||
27879491|NCT01794000|54499454|FG001|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2|||
27879492|NCT01794000|54499453|FG000|Double-Blind Phase (DBP)|Physician Decision|2|||
27879493|NCT01794000|54499454|FG001|Double-Blind Phase (DBP)|Physician Decision|0|||
27879494|NCT01794000|54499453|FG000|Double-Blind Phase (DBP)|Sponsor Decision|148|||
27879495|NCT01794000|54499454|FG001|Double-Blind Phase (DBP)|Sponsor Decision|149|||
27739293|NCT01678209|54188643|FG000|Overall Study|screen fail|16|||
27879496|NCT01794000|54499453|FG000|Double-Blind Phase (DBP)|Withdrawal by Subject|6|||
27879497|NCT01794000|54499454|FG001|Double-Blind Phase (DBP)|Withdrawal by Subject|11|||
27739294|NCT01678209|54188644|FG001|Overall Study|screen fail|17|||
27879498|NCT01794000|54499453|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|3|||
27879499|NCT01794000|54499454|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
27879500|NCT01609296|54499461|FG000|Overall Study|Death|253|||
27879501|NCT01609296|54499461|FG000|Overall Study|Withdrawal by Subject|151|||
27879502|NCT01609296|54499461|FG000|Overall Study|Lost to Follow-up|21|||
27879503|NCT01609296|54499461|FG000|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35|||
27879504|NCT01609296|54499461|FG000|Overall Study|missed visit but known to be alive|28|||
27879505|NCT01609218|54499469|FG000|Period 1|Adverse Event|3|||
27879506|NCT01609218|54499470|FG001|Period 1|Adverse Event|5|||
27879507|NCT01609218|54499469|FG000|Period 1|Sponsor Decision|0|||
27879508|NCT01609218|54499470|FG001|Period 1|Sponsor Decision|1|||
27879509|NCT01609218|54499469|FG000|Period 2|Adverse Event|1|||
27879510|NCT01609218|54499470|FG001|Period 2|Adverse Event|0|||
27879511|NCT01609062|54499478|FG000|Extension Phase|Terminated by Sponsor|14|||
27879512|NCT01609062|54499479|FG001|Extension Phase|Terminated by Sponsor|9|||
27879513|NCT01609062|54499478|FG000|Extension Phase|Discontinued drug and then was pregnant|1|||
27879514|NCT01609062|54499479|FG001|Extension Phase|Discontinued drug and then was pregnant|0|||
27879515|NCT01609062|54499478|FG000|Extension Phase|Anticipated surgery & transition to EAP|0|||
27879516|NCT01609062|54499479|FG001|Extension Phase|Anticipated surgery & transition to EAP|1|||
27879517|NCT01819272|54499492|FG000|Overall Study|Adverse Event|1|||
27879518|NCT01819272|54499493|FG001|Overall Study|Adverse Event|0|||
27879519|NCT01819272|54499494|FG002|Overall Study|Adverse Event|0|||
27879520|NCT01819272|54499495|FG003|Overall Study|Adverse Event|2|||
27879521|NCT01819272|54499496|FG004|Overall Study|Adverse Event|0|||
27879522|NCT01819272|54499497|FG005|Overall Study|Adverse Event|0|||
27879523|NCT01819272|54499492|FG000|Overall Study|Lost to Follow-up|3|||
27879524|NCT01819272|54499493|FG001|Overall Study|Lost to Follow-up|0|||
27879525|NCT01819272|54499494|FG002|Overall Study|Lost to Follow-up|1|||
27879526|NCT01819272|54499495|FG003|Overall Study|Lost to Follow-up|0|||
27879527|NCT01819272|54499496|FG004|Overall Study|Lost to Follow-up|0|||
27879528|NCT01819272|54499497|FG005|Overall Study|Lost to Follow-up|3|||
27879529|NCT01819272|54499492|FG000|Overall Study|Protocol Violation|0|||
27879530|NCT01819272|54499493|FG001|Overall Study|Protocol Violation|0|||
27879531|NCT01819272|54499494|FG002|Overall Study|Protocol Violation|0|||
27879532|NCT01819272|54499495|FG003|Overall Study|Protocol Violation|1|||
27879533|NCT01819272|54499496|FG004|Overall Study|Protocol Violation|2|||
27879534|NCT01819272|54499497|FG005|Overall Study|Protocol Violation|3|||
27879535|NCT01819272|54499492|FG000|Overall Study|Physician Decision|0|||
27879536|NCT01819272|54499493|FG001|Overall Study|Physician Decision|1|||
27879537|NCT01819272|54499494|FG002|Overall Study|Physician Decision|0|||
27879538|NCT01819272|54499495|FG003|Overall Study|Physician Decision|0|||
27879539|NCT01819272|54499496|FG004|Overall Study|Physician Decision|0|||
27879540|NCT01819272|54499497|FG005|Overall Study|Physician Decision|0|||
27879541|NCT01819272|54499492|FG000|Overall Study|Withdrawal of Consent|0|||
27879542|NCT01819272|54499493|FG001|Overall Study|Withdrawal of Consent|1|||
27879543|NCT01819272|54499494|FG002|Overall Study|Withdrawal of Consent|2|||
27879544|NCT01819272|54499495|FG003|Overall Study|Withdrawal of Consent|1|||
27879545|NCT01819272|54499496|FG004|Overall Study|Withdrawal of Consent|0|||
27879546|NCT01819272|54499497|FG005|Overall Study|Withdrawal of Consent|1|||
27879547|NCT01819272|54499492|FG000|Overall Study|Loss of Glucose Control|2|||
27879548|NCT01819272|54499493|FG001|Overall Study|Loss of Glucose Control|1|||
27879549|NCT01819272|54499494|FG002|Overall Study|Loss of Glucose Control|0|||
27879550|NCT01819272|54499495|FG003|Overall Study|Loss of Glucose Control|1|||
27879551|NCT01819272|54499496|FG004|Overall Study|Loss of Glucose Control|2|||
27879552|NCT01819272|54499497|FG005|Overall Study|Loss of Glucose Control|0|||
27879553|NCT01819194|54499511|FG000|Overall Study|Loss of study articles|2|||
27879554|NCT01611558|54499515|FG000|Induction Phase|Study drug toxicity|15|||
27879555|NCT01611558|54499515|FG000|Induction Phase|Disease progression|18|||
27879556|NCT01611558|54499515|FG000|Induction Phase|Heart arrest,urosepsis,respiratory fail|1|||
27879557|NCT01611558|54499515|FG000|Induction Phase|Adverse event unrelated to study drug|3|||
27879558|NCT01611558|54499515|FG000|Induction Phase|Death|1|||
27879559|NCT01611558|54499515|FG000|Maintenance Phase|Withdrawal by Subject|1|||
27879560|NCT01611558|54499515|FG000|Maintenance Phase|Elevated Uric acid|1|||
27879561|NCT01818726|54499522|FG000|Overall Study|Administrative reasons|5|||
27879562|NCT01818726|54499523|FG001|Overall Study|Administrative reasons|1|||
27879563|NCT01818726|54499522|FG000|Overall Study|Withdrawal by Subject|0|||
27879564|NCT01818726|54499523|FG001|Overall Study|Withdrawal by Subject|1|||
27879565|NCT01818726|54499522|FG000|Overall Study|Decision to perform 2nd course of trtmnt|1|||
27879566|NCT01818726|54499523|FG001|Overall Study|Decision to perform 2nd course of trtmnt|0|||
27879567|NCT01818336|54499529|FG000|Overall Study|Declined retest visit|0|||
27879568|NCT01818336|54499530|FG001|Overall Study|Declined retest visit|11|||
27879569|NCT01818336|54499529|FG000|Overall Study|Lost to Follow-up|0|||
27879570|NCT01818336|54499530|FG001|Overall Study|Lost to Follow-up|1|||
27879571|NCT01818258|54499538|FG000|Overall Study|Death|3|||
27879572|NCT01818258|54499539|FG001|Overall Study|Death|0|||
27879573|NCT01818258|54499538|FG000|Overall Study|Withdrawal by Subject|0|||
27879574|NCT01818258|54499539|FG001|Overall Study|Withdrawal by Subject|1|||
28171735|NCT02442778|54843316|FG000|Overall Study|Lost to Follow-up|1|||
27879575|NCT01818258|54499538|FG000|Overall Study|Lost to Follow-up|0|||
27879576|NCT01818258|54499539|FG001|Overall Study|Lost to Follow-up|1|||
27879577|NCT01818258|54499538|FG000|Overall Study|Unable to Travel to Clinic|0|||
27879578|NCT01818258|54499539|FG001|Overall Study|Unable to Travel to Clinic|1|||
27879579|NCT01817790|54499548|FG000|Overall Study|Adverse Event|0|||
27879580|NCT01817790|54499549|FG001|Overall Study|Adverse Event|2|||
27879581|NCT01817790|54499548|FG000|Overall Study|Lost to Follow-up|0|||
27879582|NCT01817790|54499549|FG001|Overall Study|Lost to Follow-up|1|||
27879583|NCT01817790|54499548|FG000|Overall Study|Protocol Violation|2|||
27879584|NCT01817790|54499549|FG001|Overall Study|Protocol Violation|1|||
27879585|NCT01817790|54499548|FG000|Overall Study|Withdrawal by Subject|1|||
27879586|NCT01817790|54499549|FG001|Overall Study|Withdrawal by Subject|3|||
27879587|NCT01817790|54499548|FG000|Overall Study|Other: Could not attend appointment|1|||
27879588|NCT01817790|54499549|FG001|Overall Study|Other: Could not attend appointment|1|||
27879589|NCT01793688|54499557|FG000|Overall Study|Protocol Violation|2|||
27879590|NCT01793142|54499561|FG000|Overall Study|Randomized not treated|7|||
27879591|NCT01792830|54499576|FG000|Overall Study|Withdrawal by Subject|22|||
27879592|NCT01792830|54499577|FG001|Overall Study|Withdrawal by Subject|0|||
27879593|NCT01792830|54499578|FG002|Overall Study|Withdrawal by Subject|0|||
27879594|NCT01792830|54499579|FG003|Overall Study|Withdrawal by Subject|2|||
27879595|NCT01792830|54499580|FG004|Overall Study|Withdrawal by Subject|1|||
27879596|NCT01792830|54499581|FG005|Overall Study|Withdrawal by Subject|1|||
27879597|NCT01792830|54499582|FG006|Overall Study|Withdrawal by Subject|1|||
27879598|NCT01792830|54499583|FG007|Overall Study|Withdrawal by Subject|1|||
27879599|NCT01792830|54499584|FG008|Overall Study|Withdrawal by Subject|7|||
27879600|NCT01792830|54499585|FG009|Overall Study|Withdrawal by Subject|0|||
27879601|NCT01792830|54499586|FG010|Overall Study|Withdrawal by Subject|2|||
27879602|NCT01792830|54499576|FG000|Overall Study|Death|3|||
27879603|NCT01792830|54499577|FG001|Overall Study|Death|0|||
27879604|NCT01792830|54499578|FG002|Overall Study|Death|0|||
27879605|NCT01792830|54499579|FG003|Overall Study|Death|1|||
27879606|NCT01792830|54499580|FG004|Overall Study|Death|0|||
27879607|NCT01792830|54499581|FG005|Overall Study|Death|0|||
27879608|NCT01792830|54499582|FG006|Overall Study|Death|1|||
27879609|NCT01792830|54499583|FG007|Overall Study|Death|0|||
27879610|NCT01792830|54499584|FG008|Overall Study|Death|1|||
27879611|NCT01792830|54499585|FG009|Overall Study|Death|0|||
27879612|NCT01792830|54499586|FG010|Overall Study|Death|1|||
27879613|NCT01792830|54499576|FG000|Overall Study|Adverse Event|0|||
27879614|NCT01792830|54499577|FG001|Overall Study|Adverse Event|0|||
27879615|NCT01792830|54499578|FG002|Overall Study|Adverse Event|0|||
27879616|NCT01792830|54499579|FG003|Overall Study|Adverse Event|0|||
27879617|NCT01792830|54499580|FG004|Overall Study|Adverse Event|0|||
27879618|NCT01792830|54499581|FG005|Overall Study|Adverse Event|0|||
27879619|NCT01792830|54499582|FG006|Overall Study|Adverse Event|0|||
27879620|NCT01792830|54499583|FG007|Overall Study|Adverse Event|0|||
27879621|NCT01792830|54499584|FG008|Overall Study|Adverse Event|1|||
27879622|NCT01792830|54499585|FG009|Overall Study|Adverse Event|0|||
27983459|NCT00550615|54641855|FG002|Overall Study|Withdrawal by Subject|2|||
27983460|NCT00550615|54641856|FG003|Overall Study|Withdrawal by Subject|3|||
27983461|NCT00550615|54641853|FG000|Overall Study|Not evaluable|0|||
27983462|NCT00550615|54641854|FG001|Overall Study|Not evaluable|0|||
27983463|NCT00550615|54641855|FG002|Overall Study|Not evaluable|2|||
27983464|NCT00550615|54641856|FG003|Overall Study|Not evaluable|7|||
27983465|NCT00744471|54641866|FG000|Overall Study|Randomized but not treated|1|||
27983466|NCT00744471|54641867|FG001|Overall Study|Randomized but not treated|1|||
27983467|NCT00744471|54641868|FG002|Overall Study|Randomized but not treated|4|||
27983468|NCT00744471|54641869|FG003|Overall Study|Randomized but not treated|0|||
27983469|NCT00744471|54641866|FG000|Overall Study|Death|0|||
27983470|NCT00744471|54641867|FG001|Overall Study|Death|0|||
27983471|NCT00744471|54641868|FG002|Overall Study|Death|0|||
27983472|NCT00744471|54641869|FG003|Overall Study|Death|1|||
27983473|NCT00744471|54641866|FG000|Overall Study|Adverse Event|6|||
27983474|NCT00744471|54641867|FG001|Overall Study|Adverse Event|7|||
27983475|NCT00744471|54641868|FG002|Overall Study|Adverse Event|5|||
27983476|NCT00744471|54641869|FG003|Overall Study|Adverse Event|9|||
27983477|NCT00744471|54641866|FG000|Overall Study|Withdrawal by Subject|9|||
27983478|NCT00744471|54641867|FG001|Overall Study|Withdrawal by Subject|9|||
27983479|NCT00744471|54641868|FG002|Overall Study|Withdrawal by Subject|15|||
27983480|NCT00744471|54641869|FG003|Overall Study|Withdrawal by Subject|12|||
27983481|NCT00744471|54641866|FG000|Overall Study|Protocol Violation|1|||
27983482|NCT00744471|54641867|FG001|Overall Study|Protocol Violation|4|||
27983483|NCT00744471|54641868|FG002|Overall Study|Protocol Violation|1|||
27983484|NCT00744471|54641869|FG003|Overall Study|Protocol Violation|2|||
27983485|NCT00744471|54641866|FG000|Overall Study|Entered extension study|41|||
27983486|NCT00744471|54641867|FG001|Overall Study|Entered extension study|84|||
27983487|NCT00744471|54641868|FG002|Overall Study|Entered extension study|100|||
28096490|NCT03984812|54751479|FG007|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
28171736|NCT02442778|54843317|FG001|Overall Study|Lost to Follow-up|1|||
27879623|NCT01792830|54499586|FG010|Overall Study|Adverse Event|0|||
27879624|NCT01792518|54499618|FG000|Overall Study|Adverse Event|3|||
27879625|NCT01792518|54499619|FG001|Overall Study|Adverse Event|4|||
27879626|NCT01792518|54499618|FG000|Overall Study|Protocol Violation|0|||
27879627|NCT01792518|54499619|FG001|Overall Study|Protocol Violation|1|||
27879628|NCT01792518|54499618|FG000|Overall Study|Lost to Follow-up|3|||
27879629|NCT01792518|54499619|FG001|Overall Study|Lost to Follow-up|1|||
27879630|NCT01792518|54499618|FG000|Overall Study|Withdrawal by Subject|2|||
27879631|NCT01792518|54499619|FG001|Overall Study|Withdrawal by Subject|0|||
27879632|NCT01792518|54499618|FG000|Overall Study|Other Reason|0|||
27879633|NCT01792518|54499619|FG001|Overall Study|Other Reason|1|||
27879634|NCT01792284|54499625|FG000|Lead-in Period|Adverse Event|15|||
27879635|NCT01792284|54499626|FG001|Lead-in Period|Adverse Event|0|||
27879636|NCT01792284|54499627|FG002|Lead-in Period|Adverse Event|0|||
27879637|NCT01792284|54499625|FG000|Lead-in Period|Lost to Follow-up|2|||
27879638|NCT01792284|54499626|FG001|Lead-in Period|Lost to Follow-up|0|||
27879639|NCT01792284|54499627|FG002|Lead-in Period|Lost to Follow-up|0|||
27879640|NCT01792284|54499625|FG000|Lead-in Period|Protocol Violation|1|||
27879641|NCT01792284|54499626|FG001|Lead-in Period|Protocol Violation|0|||
27879642|NCT01792284|54499627|FG002|Lead-in Period|Protocol Violation|0|||
27879643|NCT01792284|54499625|FG000|Lead-in Period|Withdrawal by Subject|10|||
27879644|NCT01792284|54499626|FG001|Lead-in Period|Withdrawal by Subject|0|||
27879645|NCT01792284|54499627|FG002|Lead-in Period|Withdrawal by Subject|0|||
27879646|NCT01792284|54499625|FG000|Lead-in Period|Physician Decision|1|||
27879647|NCT01792284|54499626|FG001|Lead-in Period|Physician Decision|0|||
27879648|NCT01792284|54499627|FG002|Lead-in Period|Physician Decision|0|||
27879649|NCT01792284|54499625|FG000|Lead-in Period|Protocol Required Discontinuation|1|||
27879650|NCT01792284|54499626|FG001|Lead-in Period|Protocol Required Discontinuation|0|||
27879651|NCT01792284|54499627|FG002|Lead-in Period|Protocol Required Discontinuation|0|||
27879652|NCT01792284|54499625|FG000|Randomization Period 1|Withdrawal by Subject|0|||
27879653|NCT01792284|54499626|FG001|Randomization Period 1|Withdrawal by Subject|1|||
27879654|NCT01792284|54499627|FG002|Randomization Period 1|Withdrawal by Subject|1|||
27879655|NCT01792284|54499625|FG000|Randomization Period 1|Physician Decision|0|||
27879656|NCT01792284|54499626|FG001|Randomization Period 1|Physician Decision|1|||
27879657|NCT01792284|54499627|FG002|Randomization Period 1|Physician Decision|1|||
27879658|NCT01792284|54499625|FG000|Randomization Period 1|Adverse Event|0|||
27879659|NCT01792284|54499626|FG001|Randomization Period 1|Adverse Event|0|||
27879660|NCT01792284|54499627|FG002|Randomization Period 1|Adverse Event|2|||
27879661|NCT01792284|54499625|FG000|Randomization Period 1|Lost to Follow-up|0|||
27879662|NCT01792284|54499626|FG001|Randomization Period 1|Lost to Follow-up|0|||
27879663|NCT01792284|54499627|FG002|Randomization Period 1|Lost to Follow-up|1|||
27879664|NCT01792284|54499625|FG000|Randomization Period 2|Protocol Violation|0|||
27879665|NCT01792284|54499626|FG001|Randomization Period 2|Protocol Violation|1|||
27879666|NCT01792284|54499627|FG002|Randomization Period 2|Protocol Violation|0|||
27879667|NCT01792284|54499625|FG000|Randomization Period 2|Withdrawal by Subject|0|||
27879668|NCT01792284|54499626|FG001|Randomization Period 2|Withdrawal by Subject|2|||
27879669|NCT01792284|54499627|FG002|Randomization Period 2|Withdrawal by Subject|0|||
27879670|NCT01791894|54499635|FG000|Overall Study|Adverse Event|1|||
27879671|NCT01837680|54499642|FG000|Overall Study|Lost to Follow-up|2|||
27879672|NCT01837680|54499643|FG001|Overall Study|Lost to Follow-up|2|||
27879673|NCT01837680|54499642|FG000|Overall Study|lack of insurance|0|||
27879674|NCT01837680|54499643|FG001|Overall Study|lack of insurance|2|||
27879675|NCT01837680|54499642|FG000|Overall Study|allergic reaction|6|||
27879676|NCT01837680|54499643|FG001|Overall Study|allergic reaction|0|||
27879677|NCT01837680|54499642|FG000|Overall Study|switched to oral hypoglycemic or diet|2|||
27879678|NCT01837680|54499643|FG001|Overall Study|switched to oral hypoglycemic or diet|4|||
27879679|NCT01836276|54499651|FG000|Overall Study|Lost to Follow-up|28|||
27879680|NCT01836276|54499652|FG001|Overall Study|Lost to Follow-up|51|||
27879681|NCT01790568|54499658|FG000|Overall Study|Progression prior to transplant|0|||
27879682|NCT01790568|54499659|FG001|Overall Study|Progression prior to transplant|1|||
27879683|NCT01610076|54499665|FG000|Overall Study|Technical issue with video|0|||
27879684|NCT01610076|54499666|FG001|Overall Study|Technical issue with video|1|||
27879685|NCT01610076|54499665|FG000|Overall Study|Lost to Follow-up|3|||
27879686|NCT01610076|54499666|FG001|Overall Study|Lost to Follow-up|4|||
27879687|NCT01836198|54499675|FG000|Part A, Period 2|Protocol Violation|0|||
27879688|NCT01836198|54499676|FG001|Part A, Period 2|Protocol Violation|1|||
27879689|NCT01836198|54499677|FG002|Part A, Period 2|Protocol Violation|0|||
27879690|NCT01816074|54499697|FG000|Phase 1|Time commitment issues|0|||
27879691|NCT01816074|54499698|FG001|Phase 1|Time commitment issues|0|||
27879692|NCT01816074|54499699|FG002|Phase 1|Time commitment issues|1|||
27879693|NCT01816074|54499700|FG003|Phase 1|Time commitment issues|0|||
27879694|NCT01816074|54499697|FG000|Phase 2|Time commitment Issues|0|||
27879695|NCT01816074|54499698|FG001|Phase 2|Time commitment Issues|2|||
27879696|NCT01816074|54499699|FG002|Phase 2|Time commitment Issues|0|||
28171737|NCT02442778|54843318|FG002|Overall Study|Lost to Follow-up|1|||
27879697|NCT01816074|54499700|FG003|Phase 2|Time commitment Issues|0|||
27879698|NCT01816074|54499697|FG000|Phase 2|Unsatisfied with Randomization assignmen|1|||
27879699|NCT01816074|54499698|FG001|Phase 2|Unsatisfied with Randomization assignmen|0|||
27879700|NCT01816074|54499699|FG002|Phase 2|Unsatisfied with Randomization assignmen|0|||
27879701|NCT01816074|54499700|FG003|Phase 2|Unsatisfied with Randomization assignmen|0|||
27879702|NCT01816074|54499697|FG000|Phase 2|Physician Decision|0|||
27879703|NCT01816074|54499698|FG001|Phase 2|Physician Decision|0|||
27879704|NCT01816074|54499699|FG002|Phase 2|Physician Decision|0|||
27879705|NCT01816074|54499700|FG003|Phase 2|Physician Decision|1|||
27879706|NCT01816074|54499697|FG000|Phase 2|Withdrawal by Subject|1|||
27879707|NCT01816074|54499698|FG001|Phase 2|Withdrawal by Subject|0|||
27879708|NCT01816074|54499699|FG002|Phase 2|Withdrawal by Subject|0|||
27879709|NCT01816074|54499700|FG003|Phase 2|Withdrawal by Subject|0|||
27879710|NCT01815918|54499726|FG000|Overall Study|Patient samples not analyzable|3|||
27879711|NCT01815918|54499727|FG001|Overall Study|Patient samples not analyzable|4|||
27879712|NCT01815918|54499726|FG000|Overall Study|Lack of Efficacy|15|||
27879713|NCT01815918|54499727|FG001|Overall Study|Lack of Efficacy|15|||
27879714|NCT01789476|54499739|FG000|Overall Study|Lack of Efficacy|6|||
27879715|NCT01789476|54499740|FG001|Overall Study|Lack of Efficacy|2|||
27879716|NCT01789476|54499739|FG000|Overall Study|Adverse Event|1|||
27879717|NCT01789476|54499740|FG001|Overall Study|Adverse Event|0|||
27879718|NCT01789476|54499739|FG000|Overall Study|Unable to get IV access|1|||
27879719|NCT01789476|54499740|FG001|Overall Study|Unable to get IV access|0|||
27879720|NCT01789320|54499746|FG000|Overall Study|Re-enrolled into study|1|||
27879721|NCT01789320|54499746|FG000|Overall Study|Lost to Follow-up|1|||
27879722|NCT01815840|54499752|FG000|Overall Study|Missing|1|||
27879723|NCT01815840|54499753|FG001|Overall Study|Missing|0|||
27879724|NCT01815840|54499752|FG000|Overall Study|Withdrew Consent|31|||
27879725|NCT01815840|54499753|FG001|Overall Study|Withdrew Consent|30|||
27879726|NCT01815840|54499752|FG000|Overall Study|Administrative/Other|1|||
27879727|NCT01815840|54499753|FG001|Overall Study|Administrative/Other|3|||
27879728|NCT01815840|54499752|FG000|Overall Study|Adverse Event|10|||
27879729|NCT01815840|54499753|FG001|Overall Study|Adverse Event|16|||
27879730|NCT01815840|54499752|FG000|Overall Study|Death|2|||
27879731|NCT01815840|54499753|FG001|Overall Study|Death|2|||
27879732|NCT01815840|54499752|FG000|Overall Study|Disease progression|3|||
27879733|NCT01815840|54499753|FG001|Overall Study|Disease progression|2|||
27879734|NCT01815840|54499752|FG000|Overall Study|Investigators Decision|2|||
27879735|NCT01815840|54499753|FG001|Overall Study|Investigators Decision|3|||
27879736|NCT01815840|54499752|FG000|Overall Study|Lost to Follow-up|3|||
27879737|NCT01815840|54499753|FG001|Overall Study|Lost to Follow-up|6|||
27879738|NCT01815840|54499752|FG000|Overall Study|Refused Treatment|5|||
27879739|NCT01815840|54499753|FG001|Overall Study|Refused Treatment|1|||
27879740|NCT01815840|54499752|FG000|Overall Study|Sponsor Termination Treatment|1|||
27879741|NCT01815840|54499753|FG001|Overall Study|Sponsor Termination Treatment|0|||
27879742|NCT01774110|54499759|FG000|Overall Study|Lost to Follow-up|7|||
27879743|NCT01788228|54499766|FG000|Overall Study|Migrated/moved from study area|1|||
27879744|NCT01788228|54499767|FG001|Overall Study|Migrated/moved from study area|0|||
27879745|NCT01607346|54499776|FG000|Overall Study|Adverse Event|3|||
27879746|NCT01787838|54499780|FG000|Overall Study|refused|1413|||
27879747|NCT01787760|54499787|FG000|Overall Study|Anisometropia > -1.00D in spherical equi|1|||
27879748|NCT01787760|54499788|FG001|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
27879749|NCT01787760|54499789|FG002|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
27879750|NCT01787760|54499787|FG000|Overall Study|Decompensated on left exotropia|0|||
27879751|NCT01787760|54499788|FG001|Overall Study|Decompensated on left exotropia|0|||
27879752|NCT01787760|54499789|FG002|Overall Study|Decompensated on left exotropia|1|||
27879753|NCT01787760|54499787|FG000|Overall Study|Dryness|0|||
27879754|NCT01787760|54499788|FG001|Overall Study|Dryness|1|||
27879755|NCT01787760|54499789|FG002|Overall Study|Dryness|0|||
27879756|NCT01787760|54499787|FG000|Overall Study|Relocation|1|||
27879757|NCT01787760|54499788|FG001|Overall Study|Relocation|1|||
27879758|NCT01787760|54499789|FG002|Overall Study|Relocation|0|||
27879759|NCT01787760|54499787|FG000|Overall Study|Lens discomfort|3|||
27879760|NCT01787760|54499788|FG001|Overall Study|Lens discomfort|0|||
27879761|NCT01787760|54499789|FG002|Overall Study|Lens discomfort|0|||
27879762|NCT01787760|54499787|FG000|Overall Study|Lens handling difficulty|1|||
27879763|NCT01787760|54499788|FG001|Overall Study|Lens handling difficulty|2|||
27879764|NCT01787760|54499789|FG002|Overall Study|Lens handling difficulty|0|||
27879765|NCT01787760|54499787|FG000|Overall Study|Protocol Violation|6|||
27879766|NCT01787760|54499788|FG001|Overall Study|Protocol Violation|0|||
27879767|NCT01787760|54499789|FG002|Overall Study|Protocol Violation|1|||
27879768|NCT01787760|54499787|FG000|Overall Study|Withdrawal by Subject|5|||
27879769|NCT01787760|54499788|FG001|Overall Study|Withdrawal by Subject|1|||
27879770|NCT01787760|54499789|FG002|Overall Study|Withdrawal by Subject|2|||
27879771|NCT01787760|54499787|FG000|Overall Study|Lost to Follow-up|1|||
27879772|NCT01787760|54499788|FG001|Overall Study|Lost to Follow-up|0|||
27879773|NCT01787760|54499789|FG002|Overall Study|Lost to Follow-up|1|||
27879774|NCT01787760|54499787|FG000|Overall Study|Stroke|1|||
27879775|NCT01787760|54499788|FG001|Overall Study|Stroke|0|||
27879776|NCT01787760|54499789|FG002|Overall Study|Stroke|0|||
27879777|NCT01787760|54499787|FG000|Overall Study|Unsatisfactory lens fitting performance|3|||
27879778|NCT01787760|54499788|FG001|Overall Study|Unsatisfactory lens fitting performance|6|||
27879779|NCT01787760|54499789|FG002|Overall Study|Unsatisfactory lens fitting performance|0|||
27879780|NCT01787760|54499787|FG000|Overall Study|Unsatisfactory physiological response|2|||
27879781|NCT01787760|54499788|FG001|Overall Study|Unsatisfactory physiological response|4|||
27879782|NCT01787760|54499789|FG002|Overall Study|Unsatisfactory physiological response|0|||
27879783|NCT01787760|54499787|FG000|Overall Study|Unsatisfactory visual response|1|||
27879784|NCT01787760|54499788|FG001|Overall Study|Unsatisfactory visual response|1|||
27879785|NCT01787760|54499789|FG002|Overall Study|Unsatisfactory visual response|0|||
27879786|NCT01787760|54499787|FG000|Overall Study|Near vision blur|1|||
27879787|NCT01787760|54499788|FG001|Overall Study|Near vision blur|0|||
27879788|NCT01787760|54499789|FG002|Overall Study|Near vision blur|0|||
27879789|NCT01815138|54499800|FG000|Overall Study|Withdrawal by Subject|0|||
27879790|NCT01815138|54499801|FG001|Overall Study|Withdrawal by Subject|1|||
27879791|NCT01815138|54499800|FG000|Overall Study|Physician Decision|8|||
27879792|NCT01815138|54499801|FG001|Overall Study|Physician Decision|5|||
27879793|NCT01606800|54499809|FG000|Overall Study|Adverse Event|3|||
27879794|NCT01606800|54499810|FG001|Overall Study|Adverse Event|1|||
27879795|NCT01606800|54499809|FG000|Overall Study|Participant withdrew consent|0|||
27879796|NCT01606800|54499810|FG001|Overall Study|Participant withdrew consent|1|||
27879797|NCT01606800|54499809|FG000|Overall Study|Missing completion status|2|||
27879798|NCT01606800|54499810|FG001|Overall Study|Missing completion status|0|||
27879799|NCT01772550|54499819|FG000|Overall Study|Unable to insert IV in antecubital vein|1|||
27879800|NCT01772550|54499820|FG001|Overall Study|Unable to insert IV in antecubital vein|1|||
27879801|NCT01772550|54499821|FG002|Overall Study|Unable to insert IV in antecubital vein|5|||
27879802|NCT01772550|54499819|FG000|Overall Study|Adverse Event|0|||
27879803|NCT01772550|54499820|FG001|Overall Study|Adverse Event|0|||
27879804|NCT01772550|54499821|FG002|Overall Study|Adverse Event|1|||
27879805|NCT01787292|54499829|FG000|Crossover Exercise Interventions|Withdrawal by Subject|2|||
27879806|NCT01787292|54499830|FG001|Crossover Exercise Interventions|Withdrawal by Subject|2|||
27879807|NCT01787292|54499829|FG000|Home Based Exercise Program|Withdrawal by Subject|3|||
27879808|NCT01787292|54499830|FG001|Home Based Exercise Program|Withdrawal by Subject|1|||
27879809|NCT01814748|54499843|FG000|Overall Study|Lost to Follow-up|1|||
27879810|NCT01814748|54499844|FG001|Overall Study|Lost to Follow-up|2|||
27879811|NCT01814748|54499843|FG000|Overall Study|Study site terminated by sponsor|1|||
27879812|NCT01814748|54499844|FG001|Overall Study|Study site terminated by sponsor|1|||
27879813|NCT01814748|54499843|FG000|Overall Study|Withdrawal by Subject|6|||
27879814|NCT01814748|54499844|FG001|Overall Study|Withdrawal by Subject|4|||
27879815|NCT01814670|54499850|FG000|Overall Study|Protocol Violation|12|||
27879816|NCT01814046|54499856|FG000|Drug Administration|Death due to complications of RSV|1|||
27879817|NCT01814046|54499857|FG001|Drug Administration|Death due to complications of RSV|0|||
27879818|NCT01814046|54499858|FG002|Drug Administration|Death due to complications of RSV|0|||
27879819|NCT01813890|54499868|FG000|Overall Study|Adverse Event|0|||
27879820|NCT01813890|54499869|FG001|Overall Study|Adverse Event|3|||
27879821|NCT01813890|54499870|FG002|Overall Study|Adverse Event|4|||
27879822|NCT01813890|54499868|FG000|Overall Study|Lack of Efficacy|9|||
27879823|NCT01813890|54499869|FG001|Overall Study|Lack of Efficacy|1|||
27879824|NCT01813890|54499870|FG002|Overall Study|Lack of Efficacy|2|||
27879825|NCT01772316|54499878|FG000|Overall Study|Serious adverse event|1|||
27879826|NCT01772316|54499878|FG000|Overall Study|Inform consent withdrawn|1|||
27879827|NCT01772316|54499878|FG000|Overall Study|Withdrawn by sponsor decision|5|||
27879828|NCT01813422|54499884|FG000|Overall Study|Withdrawal by Subject|14|||
27879829|NCT01813422|54499885|FG001|Overall Study|Withdrawal by Subject|8|||
27879830|NCT01813422|54499884|FG000|Overall Study|Death|2|||
27879831|NCT01813422|54499885|FG001|Overall Study|Death|3|||
27879832|NCT01813422|54499884|FG000|Overall Study|Sponsor Decision|2|||
27879833|NCT01813422|54499885|FG001|Overall Study|Sponsor Decision|1|||
27879834|NCT01813422|54499884|FG000|Overall Study|Lost to Follow-up|2|||
27879835|NCT01813422|54499885|FG001|Overall Study|Lost to Follow-up|4|||
27879836|NCT01786668|54499895|FG000|Overall Study|Adverse Event|0|||
27879837|NCT01786668|54499896|FG001|Overall Study|Adverse Event|1|||
27879838|NCT01786668|54499897|FG002|Overall Study|Adverse Event|1|||
27879839|NCT01786668|54499898|FG003|Overall Study|Adverse Event|2|||
27879840|NCT01786668|54499895|FG000|Overall Study|Withdrawal by Subject|0|||
27879841|NCT01786668|54499896|FG001|Overall Study|Withdrawal by Subject|0|||
27879842|NCT01786668|54499897|FG002|Overall Study|Withdrawal by Subject|3|||
27879843|NCT01786668|54499898|FG003|Overall Study|Withdrawal by Subject|1|||
27879844|NCT01786668|54499895|FG000|Overall Study|Pregnancy|0|||
27879845|NCT01786668|54499896|FG001|Overall Study|Pregnancy|0|||
27879846|NCT01786668|54499897|FG002|Overall Study|Pregnancy|0|||
27879847|NCT01786668|54499898|FG003|Overall Study|Pregnancy|1|||
27879848|NCT01786668|54499895|FG000|Overall Study|Lost to Follow-up|1|||
27879849|NCT01786668|54499896|FG001|Overall Study|Lost to Follow-up|0|||
27879850|NCT01786668|54499897|FG002|Overall Study|Lost to Follow-up|1|||
27879851|NCT01786668|54499898|FG003|Overall Study|Lost to Follow-up|0|||
27879852|NCT01786512|54499919|FG000|Overall Study|Lost to Follow-up|0|||
27879853|NCT01786512|54499920|FG001|Overall Study|Lost to Follow-up|0|||
27879854|NCT01786512|54499921|FG002|Overall Study|Lost to Follow-up|0|||
27879855|NCT01786512|54499922|FG003|Overall Study|Lost to Follow-up|0|||
27739295|NCT01678209|54188645|FG002|Overall Study|screen fail|16|||
27879856|NCT01786512|54499923|FG004|Overall Study|Lost to Follow-up|0|||
27879857|NCT01786512|54499924|FG005|Overall Study|Lost to Follow-up|0|||
27879858|NCT01786512|54499925|FG006|Overall Study|Lost to Follow-up|0|||
27879859|NCT01786512|54499926|FG007|Overall Study|Lost to Follow-up|0|||
27879860|NCT01786512|54499927|FG008|Overall Study|Lost to Follow-up|0|||
27879861|NCT01786512|54499928|FG009|Overall Study|Lost to Follow-up|1|||
27879862|NCT01786512|54499929|FG010|Overall Study|Lost to Follow-up|0|||
27879863|NCT01786512|54499919|FG000|Overall Study|Decision by sponsor|0|||
27879864|NCT01786512|54499920|FG001|Overall Study|Decision by sponsor|0|||
27879865|NCT01786512|54499921|FG002|Overall Study|Decision by sponsor|0|||
27879866|NCT01786512|54499922|FG003|Overall Study|Decision by sponsor|0|||
27879867|NCT01786512|54499923|FG004|Overall Study|Decision by sponsor|0|||
27879868|NCT01786512|54499924|FG005|Overall Study|Decision by sponsor|0|||
27879869|NCT01786512|54499925|FG006|Overall Study|Decision by sponsor|0|||
27879870|NCT01786512|54499926|FG007|Overall Study|Decision by sponsor|0|||
27879871|NCT01786512|54499927|FG008|Overall Study|Decision by sponsor|0|||
27879872|NCT01786512|54499928|FG009|Overall Study|Decision by sponsor|0|||
27879873|NCT01786512|54499929|FG010|Overall Study|Decision by sponsor|2|||
27879874|NCT01786512|54499919|FG000|Overall Study|Withdrawal by Subject|0|||
27879875|NCT01786512|54499920|FG001|Overall Study|Withdrawal by Subject|1|||
27879876|NCT01786512|54499921|FG002|Overall Study|Withdrawal by Subject|0|||
27879877|NCT01786512|54499922|FG003|Overall Study|Withdrawal by Subject|0|||
27879878|NCT01786512|54499923|FG004|Overall Study|Withdrawal by Subject|0|||
27879879|NCT01786512|54499924|FG005|Overall Study|Withdrawal by Subject|0|||
27879880|NCT01786512|54499925|FG006|Overall Study|Withdrawal by Subject|1|||
27879881|NCT01786512|54499926|FG007|Overall Study|Withdrawal by Subject|0|||
27879882|NCT01786512|54499927|FG008|Overall Study|Withdrawal by Subject|0|||
27879883|NCT01786512|54499928|FG009|Overall Study|Withdrawal by Subject|3|||
27879884|NCT01786512|54499929|FG010|Overall Study|Withdrawal by Subject|7|||
27879885|NCT01786512|54499919|FG000|Overall Study|Death|0|||
27879886|NCT01786512|54499920|FG001|Overall Study|Death|0|||
27879887|NCT01786512|54499921|FG002|Overall Study|Death|0|||
27879888|NCT01786512|54499922|FG003|Overall Study|Death|0|||
27879889|NCT01786512|54499923|FG004|Overall Study|Death|0|||
27879890|NCT01786512|54499924|FG005|Overall Study|Death|0|||
27879891|NCT01786512|54499925|FG006|Overall Study|Death|0|||
27879892|NCT01786512|54499926|FG007|Overall Study|Death|0|||
27879893|NCT01786512|54499927|FG008|Overall Study|Death|4|||
27879894|NCT01786512|54499928|FG009|Overall Study|Death|1|||
27879895|NCT01786512|54499929|FG010|Overall Study|Death|3|||
27879896|NCT01772160|54499961|FG000|Overall Study|Death|3|||
27879897|NCT01772160|54499961|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
27879898|NCT01772160|54499961|FG000|Overall Study|Consent withdrawal|3|||
27879899|NCT01772160|54499961|FG000|Overall Study|Migrated / moved from the study area|4|||
27879900|NCT01772160|54499961|FG000|Overall Study|Lost to Follow-up|30|||
27879901|NCT01772160|54499961|FG000|Overall Study|Other|5|||
27879902|NCT01770912|54499967|FG000|Overall Study|Lost to Follow-up|2|||
27879903|NCT01770912|54499968|FG001|Overall Study|Lost to Follow-up|0|||
27879904|NCT01811706|54499974|FG000|First Intervention ( 4 Weeks)|Adverse Event|1|||
27879905|NCT01811706|54499975|FG001|First Intervention ( 4 Weeks)|Adverse Event|0|||
27879906|NCT01811472|54499986|FG000|Overall Study|Adverse Event|1|||
27879907|NCT01811472|54499987|FG001|Overall Study|Adverse Event|0|||
27879908|NCT01811472|54499988|FG002|Overall Study|Adverse Event|4|||
27879909|NCT01811472|54499986|FG000|Overall Study|Lost to Follow-up|0|||
27879910|NCT01811472|54499987|FG001|Overall Study|Lost to Follow-up|0|||
27879911|NCT01811472|54499988|FG002|Overall Study|Lost to Follow-up|1|||
27879912|NCT01811472|54499986|FG000|Overall Study|Subject/guardian decision|1|||
27879913|NCT01811472|54499987|FG001|Overall Study|Subject/guardian decision|0|||
27879914|NCT01811472|54499988|FG002|Overall Study|Subject/guardian decision|0|||
27879915|NCT01811238|54499997|FG000|Overall Study|Withdrawal by Subject|42|||
27879916|NCT01811238|54499997|FG000|Overall Study|Adverse Event|25|||
27879917|NCT01811238|54499997|FG000|Overall Study|Protocol Violation|4|||
27879918|NCT01811238|54499997|FG000|Overall Study|Lack of Efficacy|4|||
27879919|NCT01811238|54499997|FG000|Overall Study|subject refused study medication|6|||
27879920|NCT01769508|54500002|FG000|Overall Study|Death|3|||
27879921|NCT01769508|54500002|FG000|Overall Study|Withdrawal by Subject|1|||
27879922|NCT01769508|54500002|FG000|Overall Study|Adverse Event|1|||
27879923|NCT01769508|54500002|FG000|Overall Study|Lost to Follow-up|1|||
27879924|NCT01810380|54500009|FG000|Overall Study|Randomised not treated|2|||
27879925|NCT01810380|54500010|FG001|Overall Study|Randomised not treated|1|||
27879926|NCT01810380|54500011|FG002|Overall Study|Randomised not treated|1|||
27879927|NCT01810380|54500009|FG000|Overall Study|Adverse Event|11|||
27879928|NCT01810380|54500010|FG001|Overall Study|Adverse Event|14|||
27879929|NCT01810380|54500011|FG002|Overall Study|Adverse Event|4|||
27879930|NCT01810380|54500009|FG000|Overall Study|Lack of Efficacy|24|||
27879931|NCT01810380|54500010|FG001|Overall Study|Lack of Efficacy|10|||
27879932|NCT01810380|54500011|FG002|Overall Study|Lack of Efficacy|11|||
27879933|NCT01810380|54500009|FG000|Overall Study|Protocol Violation|1|||
27879934|NCT01810380|54500010|FG001|Overall Study|Protocol Violation|0|||
27879935|NCT01810380|54500011|FG002|Overall Study|Protocol Violation|1|||
27879936|NCT01810380|54500009|FG000|Overall Study|Withdrawal by Subject|6|||
27879937|NCT01810380|54500010|FG001|Overall Study|Withdrawal by Subject|0|||
27879938|NCT01810380|54500011|FG002|Overall Study|Withdrawal by Subject|6|||
27879939|NCT01810380|54500009|FG000|Overall Study|Administrative or other reasons|11|||
27879940|NCT01810380|54500010|FG001|Overall Study|Administrative or other reasons|13|||
27879941|NCT01810380|54500011|FG002|Overall Study|Administrative or other reasons|9|||
27879942|NCT01769196|54500021|FG000|Overall Study|Adverse Event|24|||
27879943|NCT01769196|54500022|FG001|Overall Study|Adverse Event|20|||
27879944|NCT01769196|54500021|FG000|Overall Study|Death|21|||
27879945|NCT01769196|54500022|FG001|Overall Study|Death|26|||
27879946|NCT01769196|54500021|FG000|Overall Study|Investigator Discretion|7|||
27879947|NCT01769196|54500022|FG001|Overall Study|Investigator Discretion|3|||
27879948|NCT01769196|54500021|FG000|Overall Study|Lack of Efficacy|3|||
27879949|NCT01769196|54500022|FG001|Overall Study|Lack of Efficacy|2|||
27879950|NCT01769196|54500021|FG000|Overall Study|Progressive disease|11|||
27879951|NCT01769196|54500022|FG001|Overall Study|Progressive disease|6|||
27879952|NCT01769196|54500021|FG000|Overall Study|Protocol defined criteria for withdrawal|9|||
27879953|NCT01769196|54500022|FG001|Overall Study|Protocol defined criteria for withdrawal|11|||
27879954|NCT01769196|54500021|FG000|Overall Study|Protocol Violation|0|||
27879955|NCT01769196|54500022|FG001|Overall Study|Protocol Violation|3|||
27879956|NCT01769196|54500021|FG000|Overall Study|Study terminated by sponsor|160|||
27879957|NCT01769196|54500022|FG001|Overall Study|Study terminated by sponsor|161|||
27879958|NCT01769196|54500021|FG000|Overall Study|Participant never dosed with study drug|1|||
27879959|NCT01769196|54500022|FG001|Overall Study|Participant never dosed with study drug|0|||
27879960|NCT01769196|54500021|FG000|Overall Study|Withdrew consent|36|||
27879961|NCT01769196|54500022|FG001|Overall Study|Withdrew consent|40|||
27879962|NCT01810302|54500030|FG000|Overall Study|Death|1|||
27879963|NCT01810302|54500031|FG001|Overall Study|Death|0|||
27879964|NCT01810302|54500030|FG000|Overall Study|Physician Decision|0|||
27879965|NCT01810302|54500031|FG001|Overall Study|Physician Decision|1|||
27879966|NCT01783938|54500039|FG000|Overall Study|Disease Progression|18|||
27879967|NCT01783938|54500040|FG001|Overall Study|Disease Progression|41|||
27879968|NCT01783938|54500039|FG000|Overall Study|Study Drug Toxicity|27|||
27879969|NCT01783938|54500040|FG001|Overall Study|Study Drug Toxicity|14|||
27879970|NCT01783938|54500039|FG000|Overall Study|Adverse Event Unrelated to Study Drug|4|||
27879971|NCT01783938|54500040|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
27879972|NCT01783938|54500039|FG000|Overall Study|Participant Request to Discontinue Study Treatment|2|||
27879973|NCT01783938|54500040|FG001|Overall Study|Participant Request to Discontinue Study Treatment|3|||
27879974|NCT01783938|54500039|FG000|Overall Study|Participant Withdrew Consent|2|||
27879975|NCT01783938|54500040|FG001|Overall Study|Participant Withdrew Consent|0|||
27879976|NCT01783938|54500039|FG000|Overall Study|Maximum Clinical Benefit|1|||
27879977|NCT01783938|54500040|FG001|Overall Study|Maximum Clinical Benefit|0|||
27879978|NCT01783938|54500039|FG000|Overall Study|Other Reasons|3|||
27879979|NCT01783938|54500040|FG001|Overall Study|Other Reasons|1|||
27879980|NCT01768572|54500049|FG000|Overall Study|Adverse Event|7|||
27879981|NCT01768572|54500050|FG001|Overall Study|Adverse Event|8|||
27879982|NCT01768572|54500051|FG002|Overall Study|Adverse Event|4|||
27879983|NCT01768572|54500049|FG000|Overall Study|Lack of Efficacy|1|||
27879984|NCT01768572|54500050|FG001|Overall Study|Lack of Efficacy|3|||
27879985|NCT01768572|54500051|FG002|Overall Study|Lack of Efficacy|1|||
27879986|NCT01768572|54500049|FG000|Overall Study|Other, Not due to an adverse event|1|||
27879987|NCT01768572|54500050|FG001|Overall Study|Other, Not due to an adverse event|1|||
27879988|NCT01768572|54500051|FG002|Overall Study|Other, Not due to an adverse event|1|||
27879989|NCT01783548|54500061|FG000|Overall Study|Adverse Event|8|||
27879990|NCT01783548|54500062|FG001|Overall Study|Adverse Event|4|||
27879991|NCT01783548|54500061|FG000|Overall Study|Withdrawal by Subject|11|||
27879992|NCT01783548|54500062|FG001|Overall Study|Withdrawal by Subject|8|||
27879993|NCT01783548|54500061|FG000|Overall Study|Non-compliance|4|||
27879994|NCT01783548|54500062|FG001|Overall Study|Non-compliance|0|||
27879995|NCT01783548|54500061|FG000|Overall Study|Protocol Violation|2|||
27879996|NCT01783548|54500062|FG001|Overall Study|Protocol Violation|2|||
27879997|NCT01783548|54500061|FG000|Overall Study|Lost to Follow-up|8|||
27879998|NCT01783548|54500062|FG001|Overall Study|Lost to Follow-up|3|||
27879999|NCT01783548|54500061|FG000|Overall Study|Lack of Efficacy|1|||
27880000|NCT01783548|54500062|FG001|Overall Study|Lack of Efficacy|1|||
27880001|NCT01809210|54500075|FG000|Overall Study|Withdrawal by Subject|0|||
27880002|NCT01809210|54500076|FG001|Overall Study|Withdrawal by Subject|0|||
27880003|NCT01809210|54500077|FG002|Overall Study|Withdrawal by Subject|1|||
27880004|NCT01809210|54500078|FG003|Overall Study|Withdrawal by Subject|1|||
27880005|NCT01809210|54500079|FG004|Overall Study|Withdrawal by Subject|1|||
27880006|NCT01809210|54500080|FG005|Overall Study|Withdrawal by Subject|0|||
27880007|NCT01809210|54500081|FG006|Overall Study|Withdrawal by Subject|4|||
27880008|NCT01809210|54500075|FG000|Overall Study|Death|1|||
27880009|NCT01809210|54500076|FG001|Overall Study|Death|1|||
27880010|NCT01809210|54500077|FG002|Overall Study|Death|2|||
27880011|NCT01809210|54500078|FG003|Overall Study|Death|0|||
27880012|NCT01809210|54500079|FG004|Overall Study|Death|1|||
27880013|NCT01809210|54500080|FG005|Overall Study|Death|3|||
27880014|NCT01809210|54500081|FG006|Overall Study|Death|1|||
27880015|NCT01809132|54500100|FG000|Overall Study|Withdrawal by Subject|0|||
27880016|NCT01809132|54500101|FG001|Overall Study|Withdrawal by Subject|0|||
27880017|NCT01809132|54500102|FG002|Overall Study|Withdrawal by Subject|1|||
27880018|NCT01808508|54500113|FG000|Overall Study|Lost to Follow-up|1|||
27880019|NCT01808508|54500114|FG001|Overall Study|Lost to Follow-up|0|||
27880020|NCT01808508|54500115|FG002|Overall Study|Lost to Follow-up|0|||
27880021|NCT01766778|54500125|FG000|Overall Study|Adverse Event|4|||
27880022|NCT01766778|54500126|FG001|Overall Study|Adverse Event|4|||
27880023|NCT01766778|54500125|FG000|Overall Study|Withdrawal by Subject|1|||
27880024|NCT01766778|54500126|FG001|Overall Study|Withdrawal by Subject|0|||
27880025|NCT01808196|54500132|FG000|Overall Study|Lost to Follow-up|1|||
27880026|NCT01808118|54500136|FG000|Period 1|Adverse Event|15|||
27880027|NCT01808118|54500137|FG001|Period 1|Adverse Event|0|||
27880028|NCT01808118|54500138|FG002|Period 1|Adverse Event|0|||
27880029|NCT01808118|54500136|FG000|Period 1|Withdrew consent|24|||
27880030|NCT01808118|54500137|FG001|Period 1|Withdrew consent|0|||
27880031|NCT01808118|54500138|FG002|Period 1|Withdrew consent|0|||
27880032|NCT01808118|54500136|FG000|Period 1|Lost to Follow-up|9|||
27880033|NCT01808118|54500137|FG001|Period 1|Lost to Follow-up|0|||
27880034|NCT01808118|54500138|FG002|Period 1|Lost to Follow-up|0|||
27880035|NCT01808118|54500136|FG000|Period 1|Did not meet criteria for remission|303|||
27880036|NCT01808118|54500137|FG001|Period 1|Did not meet criteria for remission|0|||
27880037|NCT01808118|54500138|FG002|Period 1|Did not meet criteria for remission|0|||
27880038|NCT01808118|54500136|FG000|Period 1|Enrolled in error|7|||
27880039|NCT01808118|54500137|FG001|Period 1|Enrolled in error|0|||
27880040|NCT01808118|54500138|FG002|Period 1|Enrolled in error|0|||
27880041|NCT01808118|54500136|FG000|Period 1|Did not meet inclusion criteria|3|||
27880042|NCT01808118|54500137|FG001|Period 1|Did not meet inclusion criteria|0|||
27880043|NCT01808118|54500138|FG002|Period 1|Did not meet inclusion criteria|0|||
27880044|NCT01808118|54500136|FG000|Period 1|Non-conformance with inclusion criteria|3|||
27880045|NCT01808118|54500137|FG001|Period 1|Non-conformance with inclusion criteria|0|||
27880046|NCT01808118|54500138|FG002|Period 1|Non-conformance with inclusion criteria|0|||
27880047|NCT01808118|54500136|FG000|Period 1|Investigator decision: site closure|2|||
27880048|NCT01808118|54500137|FG001|Period 1|Investigator decision: site closure|0|||
27880049|NCT01808118|54500138|FG002|Period 1|Investigator decision: site closure|0|||
27880050|NCT01808118|54500136|FG000|Period 1|Non-compliance per sponsor|1|||
27880051|NCT01808118|54500137|FG001|Period 1|Non-compliance per sponsor|0|||
27880052|NCT01808118|54500138|FG002|Period 1|Non-compliance per sponsor|0|||
27880053|NCT01808118|54500136|FG000|Period 1|Lack of Efficacy|1|||
27880054|NCT01808118|54500137|FG001|Period 1|Lack of Efficacy|0|||
27880055|NCT01808118|54500138|FG002|Period 1|Lack of Efficacy|0|||
27880056|NCT01808118|54500136|FG000|Period 2|Adverse Event|0|||
27880057|NCT01808118|54500137|FG001|Period 2|Adverse Event|4|||
27880058|NCT01808118|54500138|FG002|Period 2|Adverse Event|0|||
27880059|NCT01808118|54500136|FG000|Period 2|Withdrew consent|0|||
27880060|NCT01808118|54500137|FG001|Period 2|Withdrew consent|7|||
27880061|NCT01808118|54500138|FG002|Period 2|Withdrew consent|6|||
27880062|NCT01808118|54500136|FG000|Period 2|Lost to Follow-up|0|||
27880063|NCT01808118|54500137|FG001|Period 2|Lost to Follow-up|0|||
27880064|NCT01808118|54500138|FG002|Period 2|Lost to Follow-up|2|||
27880065|NCT01808118|54500136|FG000|Period 2|Investigator no longer conducting trials|0|||
27880066|NCT01808118|54500137|FG001|Period 2|Investigator no longer conducting trials|1|||
27880067|NCT01808118|54500138|FG002|Period 2|Investigator no longer conducting trials|0|||
27880068|NCT01808118|54500136|FG000|Period 2|Switched to other therapy|0|||
27880069|NCT01808118|54500137|FG001|Period 2|Switched to other therapy|1|||
27880070|NCT01808118|54500138|FG002|Period 2|Switched to other therapy|0|||
27880071|NCT01807650|54500152|FG000|Overall Study|Lack of Full Wound Closure at Day 28|13|||
27880072|NCT01807650|54500152|FG000|Overall Study|Adverse Event|5|||
27880073|NCT01807650|54500152|FG000|Overall Study|Other|2|||
27880074|NCT01782690|54500193|FG000|Overall Study|Not reported|7|||
27880075|NCT01782690|54500193|FG000|Overall Study|Toxicity of gemcitabine|1|||
27880076|NCT01782690|54500193|FG000|Overall Study|Toxicity of erlotinib|1|||
27880077|NCT01782690|54500193|FG000|Overall Study|Lost to Follow-up|31|||
27880078|NCT01782690|54500193|FG000|Overall Study|Withdrawal of informed consent|2|||
27880079|NCT01782690|54500193|FG000|Overall Study|Absent rash|9|||
27880080|NCT01782690|54500193|FG000|Overall Study|Physician Decision|13|||
27880081|NCT01782690|54500193|FG000|Overall Study|Patient's wish|21|||
27880082|NCT01782690|54500193|FG000|Overall Study|Tumor progression|74|||
27880083|NCT01782690|54500193|FG000|Overall Study|Death|133|||
27880084|NCT01782690|54500193|FG000|Overall Study|Study completion unknown|7|||
27880085|NCT01782378|54500199|FG000|First Series|Lost to Follow-up|7|||
27880086|NCT01782378|54500200|FG001|First Series|Lost to Follow-up|8|||
27983488|NCT00744471|54641869|FG003|Overall Study|Entered extension study|91|||
27880087|NCT01782378|54500199|FG000|Second Series|Partial Crossover Design- no Sham 2nd|0|||
27880088|NCT01782378|54500200|FG001|Second Series|Partial Crossover Design- no Sham 2nd|25|||
27880089|NCT01782378|54500199|FG000|Second Series|Lost to Follow-up|8|||
27880090|NCT01782378|54500200|FG001|Second Series|Lost to Follow-up|7|||
27880091|NCT01782378|54500199|FG000|Second Series|Did not choose to complete S2 Optional|18|||
27880092|NCT01782378|54500200|FG001|Second Series|Did not choose to complete S2 Optional|0|||
27880093|NCT01766310|54500208|FG000|Overall Study|Lost to Follow-up|1|||
27983489|NCT00744471|54641866|FG000|Overall Study|Other|2|||
27983490|NCT00744471|54641867|FG001|Overall Study|Other|3|||
27983491|NCT00744471|54641868|FG002|Overall Study|Other|6|||
27983492|NCT00744471|54641869|FG003|Overall Study|Other|2|||
27983493|NCT00744471|54641866|FG000|Overall Study|Lack of Efficacy|83|||
27983494|NCT00744471|54641867|FG001|Overall Study|Lack of Efficacy|37|||
27983495|NCT00744471|54641868|FG002|Overall Study|Lack of Efficacy|19|||
27983496|NCT00744471|54641869|FG003|Overall Study|Lack of Efficacy|31|||
27983497|NCT00744471|54641866|FG000|Overall Study|Lost to Follow-up|0|||
27983498|NCT00744471|54641867|FG001|Overall Study|Lost to Follow-up|0|||
27983499|NCT00744471|54641868|FG002|Overall Study|Lost to Follow-up|2|||
27983500|NCT00744471|54641869|FG003|Overall Study|Lost to Follow-up|0|||
28096491|NCT03984812|54751480|FG008|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
28096492|NCT03984812|54751481|FG009|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
28096493|NCT03984812|54751482|FG010|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
27880094|NCT01766310|54500209|FG001|Overall Study|Lost to Follow-up|3|||
27983501|NCT00744237|54641882|FG000|Overall Study|Lack of Efficacy|1|||
27983502|NCT00744237|54641883|FG001|Overall Study|Lack of Efficacy|1|||
27983503|NCT00744237|54641884|FG002|Overall Study|Lack of Efficacy|0|||
27983504|NCT00744237|54641882|FG000|Overall Study|Withdrawal by Subject|9|||
27983505|NCT00744237|54641883|FG001|Overall Study|Withdrawal by Subject|5|||
27983506|NCT00744237|54641884|FG002|Overall Study|Withdrawal by Subject|3|||
27983507|NCT00744237|54641882|FG000|Overall Study|Lost to Follow-up|1|||
27983508|NCT00744237|54641883|FG001|Overall Study|Lost to Follow-up|1|||
27983509|NCT00744237|54641884|FG002|Overall Study|Lost to Follow-up|1|||
27983510|NCT00744237|54641882|FG000|Overall Study|Protocol Violation|3|||
27983511|NCT00744237|54641883|FG001|Overall Study|Protocol Violation|4|||
27983512|NCT00744237|54641884|FG002|Overall Study|Protocol Violation|3|||
27983513|NCT00744237|54641882|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
27983514|NCT00744237|54641883|FG001|Overall Study|Inclusion/Exclusion criteria not met|0|||
27983515|NCT00744237|54641884|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
27983516|NCT00744237|54641882|FG000|Overall Study|Dosing Error|1|||
27983517|NCT00744237|54641883|FG001|Overall Study|Dosing Error|0|||
27983518|NCT00744237|54641884|FG002|Overall Study|Dosing Error|1|||
27983519|NCT00744237|54641882|FG000|Overall Study|Study Drug Error|1|||
27983520|NCT00744237|54641883|FG001|Overall Study|Study Drug Error|0|||
27983521|NCT00744237|54641884|FG002|Overall Study|Study Drug Error|0|||
27983522|NCT00744237|54641882|FG000|Overall Study|Prohibited Concomitant Medication|0|||
27983523|NCT00744237|54641883|FG001|Overall Study|Prohibited Concomitant Medication|0|||
27983524|NCT00744237|54641884|FG002|Overall Study|Prohibited Concomitant Medication|1|||
27983525|NCT00744237|54641882|FG000|Overall Study|Poor Compliance|0|||
27983526|NCT00744237|54641883|FG001|Overall Study|Poor Compliance|2|||
27983527|NCT00744237|54641884|FG002|Overall Study|Poor Compliance|0|||
27983528|NCT00744237|54641882|FG000|Overall Study|Administrative. Site Closed|1|||
27983529|NCT00744237|54641883|FG001|Overall Study|Administrative. Site Closed|1|||
27983530|NCT00744237|54641884|FG002|Overall Study|Administrative. Site Closed|1|||
27983531|NCT00744237|54641882|FG000|Overall Study|Adverse Event|9|||
27983532|NCT00744237|54641883|FG001|Overall Study|Adverse Event|13|||
27983533|NCT00744237|54641884|FG002|Overall Study|Adverse Event|5|||
27983534|NCT00743145|54641892|FG000|Overall Study|Withdrawal by Subject|1|||
27983535|NCT00743145|54641892|FG000|Overall Study|Adverse Event|2|||
27983536|NCT00743145|54641892|FG000|Overall Study|Pregnancy|1|||
27983537|NCT00920855|54641909|FG000|Overall Study|Adverse Event|1|||
28096494|NCT04160988|54751509|FG000|Overall Study|poor image quality|28|||
27739296|NCT02239120|54188655|FG000|Overall Study|Death|56|||
27880095|NCT01765920|54500217|FG000|Overall Study|Incorrect inclusion ineligible patient|2|||
27880096|NCT01765920|54500218|FG001|Overall Study|Incorrect inclusion ineligible patient|5|||
27880097|NCT01765920|54500217|FG000|Overall Study|Patient code disclosure|0|||
27880098|NCT01765920|54500218|FG001|Overall Study|Patient code disclosure|1|||
27880099|NCT01782222|54500227|FG000|Overall Study|Adverse Event|4|||
27880100|NCT01782222|54500228|FG001|Overall Study|Adverse Event|5|||
27880101|NCT01782222|54500229|FG002|Overall Study|Adverse Event|3|||
27880102|NCT01782222|54500227|FG000|Overall Study|Lack of Efficacy|2|||
27880103|NCT01782222|54500228|FG001|Overall Study|Lack of Efficacy|1|||
27880104|NCT01782222|54500229|FG002|Overall Study|Lack of Efficacy|0|||
27880105|NCT01782222|54500227|FG000|Overall Study|Protocol Violation|1|||
27880106|NCT01782222|54500228|FG001|Overall Study|Protocol Violation|0|||
27880107|NCT01782222|54500229|FG002|Overall Study|Protocol Violation|0|||
27880108|NCT01782222|54500227|FG000|Overall Study|Withdrawal by Subject|1|||
27983538|NCT00920855|54641910|FG001|Overall Study|Adverse Event|1|||
27983539|NCT00920855|54641911|FG002|Overall Study|Adverse Event|4|||
27983540|NCT00920855|54641909|FG000|Overall Study|Withdrawal by Subject|2|||
27983541|NCT00920855|54641910|FG001|Overall Study|Withdrawal by Subject|1|||
27983542|NCT00920855|54641911|FG002|Overall Study|Withdrawal by Subject|6|||
27983543|NCT00920855|54641909|FG000|Overall Study|Disease progression|2|||
27983544|NCT00920855|54641910|FG001|Overall Study|Disease progression|1|||
27983545|NCT00920855|54641911|FG002|Overall Study|Disease progression|10|||
27983546|NCT00920855|54641909|FG000|Overall Study|Noncompliance to study medication|0|||
27880109|NCT01782222|54500228|FG001|Overall Study|Withdrawal by Subject|4|||
27880110|NCT01782222|54500229|FG002|Overall Study|Withdrawal by Subject|1|||
27880111|NCT01782222|54500227|FG000|Overall Study|Moved to other state|0|||
27880112|NCT01782222|54500228|FG001|Overall Study|Moved to other state|1|||
27880113|NCT01782222|54500229|FG002|Overall Study|Moved to other state|0|||
27880114|NCT01781832|54500237|FG000|Overall Study|Withdrawal by Subject|1|||
27880115|NCT01807182|54500241|FG000|Overall Study|Death|1|||
27880116|NCT01807182|54500241|FG000|Overall Study|New therapy|1|||
27880117|NCT01807182|54500241|FG000|Overall Study|Moved to hospice care|1|||
27880118|NCT01806714|54500247|FG000|Overall Study|No functioning phone number|200|||
27880119|NCT01806714|54500248|FG001|Overall Study|No functioning phone number|170|||
27880120|NCT01765764|54500257|FG000|Treatment Period|Adverse Event|1|||
27880121|NCT01765764|54500258|FG001|Treatment Period|Adverse Event|2|||
27880122|NCT01765764|54500259|FG002|Treatment Period|Adverse Event|1|||
27880123|NCT01765764|54500257|FG000|Treatment Period|Lost to Follow-up|0|||
27880124|NCT01765764|54500258|FG001|Treatment Period|Lost to Follow-up|3|||
27880125|NCT01765764|54500259|FG002|Treatment Period|Lost to Follow-up|2|||
27880126|NCT01765764|54500257|FG000|Treatment Period|Personal Reasons|1|||
27880127|NCT01765764|54500258|FG001|Treatment Period|Personal Reasons|2|||
27880128|NCT01765764|54500259|FG002|Treatment Period|Personal Reasons|1|||
27880129|NCT01765764|54500257|FG000|Treatment Period|Other Miscellaneous Reasons|1|||
27880130|NCT01765764|54500258|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
27880131|NCT01765764|54500259|FG002|Treatment Period|Other Miscellaneous Reasons|2|||
27983547|NCT00920855|54641910|FG001|Overall Study|Noncompliance to study medication|0|||
27983548|NCT00920855|54641911|FG002|Overall Study|Noncompliance to study medication|1|||
27983549|NCT00920855|54641909|FG000|Overall Study|Response plateau; started maintenance|0|||
27983550|NCT00920855|54641910|FG001|Overall Study|Response plateau; started maintenance|0|||
27983551|NCT00920855|54641911|FG002|Overall Study|Response plateau; started maintenance|1|||
27983552|NCT03738228|54641922|FG000|Overall Study|Never received study treatment|2|||
27983553|NCT03738228|54641923|FG001|Overall Study|Never received study treatment|2|||
27983554|NCT00742209|54641934|FG000|Overall Study|Adverse Event|11|||
27983555|NCT00742209|54641935|FG001|Overall Study|Adverse Event|4|||
27983556|NCT00742209|54641936|FG002|Overall Study|Adverse Event|17|||
27983557|NCT00742209|54641937|FG003|Overall Study|Adverse Event|16|||
27983558|NCT00742209|54641938|FG004|Overall Study|Adverse Event|13|||
27983559|NCT00742209|54641934|FG000|Overall Study|Participant Withdrew Consent|8|||
27983560|NCT00742209|54641935|FG001|Overall Study|Participant Withdrew Consent|4|||
27983561|NCT00742209|54641936|FG002|Overall Study|Participant Withdrew Consent|14|||
27983562|NCT00742209|54641937|FG003|Overall Study|Participant Withdrew Consent|7|||
27983563|NCT00742209|54641938|FG004|Overall Study|Participant Withdrew Consent|4|||
27983564|NCT00742209|54641934|FG000|Overall Study|Protocol Violation|6|||
27983565|NCT00742209|54641935|FG001|Overall Study|Protocol Violation|5|||
27983566|NCT00742209|54641936|FG002|Overall Study|Protocol Violation|4|||
27983567|NCT00742209|54641937|FG003|Overall Study|Protocol Violation|5|||
27983568|NCT00742209|54641938|FG004|Overall Study|Protocol Violation|3|||
27983569|NCT00742209|54641934|FG000|Overall Study|Lost to Follow-up|3|||
27983570|NCT00742209|54641935|FG001|Overall Study|Lost to Follow-up|4|||
27983571|NCT00742209|54641936|FG002|Overall Study|Lost to Follow-up|5|||
27983572|NCT00742209|54641937|FG003|Overall Study|Lost to Follow-up|5|||
27983573|NCT00742209|54641938|FG004|Overall Study|Lost to Follow-up|3|||
27983574|NCT00742209|54641934|FG000|Overall Study|Lack of Efficacy|6|||
27983575|NCT00742209|54641935|FG001|Overall Study|Lack of Efficacy|1|||
27983576|NCT00742209|54641936|FG002|Overall Study|Lack of Efficacy|1|||
27983577|NCT00742209|54641937|FG003|Overall Study|Lack of Efficacy|3|||
27983578|NCT00742209|54641938|FG004|Overall Study|Lack of Efficacy|1|||
27983579|NCT00742209|54641934|FG000|Overall Study|Investigator Discretion|0|||
27983580|NCT00742209|54641935|FG001|Overall Study|Investigator Discretion|0|||
27983581|NCT00742209|54641936|FG002|Overall Study|Investigator Discretion|5|||
27983582|NCT00742209|54641937|FG003|Overall Study|Investigator Discretion|1|||
27983583|NCT00742209|54641938|FG004|Overall Study|Investigator Discretion|1|||
27983584|NCT00741819|54641951|FG000|Overall Study|Adverse Event|3|||
27983585|NCT00741819|54641951|FG000|Overall Study|Withdrawal by Subject|3|||
27880132|NCT01806168|54500270|FG000|Overall Study|Adverse Event|1|||
27880133|NCT01806168|54500271|FG001|Overall Study|Adverse Event|0|||
27880134|NCT01806168|54500272|FG002|Overall Study|Adverse Event|0|||
27880135|NCT01806168|54500270|FG000|Overall Study|Withdrawal by Subject|0|||
27880136|NCT01806168|54500271|FG001|Overall Study|Withdrawal by Subject|1|||
27983586|NCT00741819|54641951|FG000|Overall Study|Death|1|||
27983587|NCT00741819|54641951|FG000|Overall Study|Disease progression|1|||
27983588|NCT00924443|54641957|FG000|Overall Study|Physician Decision|2|||
27983589|NCT00924443|54641957|FG000|Overall Study|Protocol Violation|1|||
27983590|NCT00924287|54641961|FG000|Overall Study|Death|1|||
27983591|NCT00923975|54641965|FG000|Overall Study|Did not meet inclusion criteria|1|||
27983592|NCT00918203|54642001|FG000|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
27983593|NCT00918203|54642002|FG001|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
27983594|NCT00918203|54642003|FG002|Treatment With or Without Olaratumab|Lost to Follow-up|0|||
27880137|NCT01806168|54500272|FG002|Overall Study|Withdrawal by Subject|2|||
27880138|NCT01806168|54500270|FG000|Overall Study|Protocol Violation|0|||
27880139|NCT01806168|54500271|FG001|Overall Study|Protocol Violation|0|||
27983595|NCT00918203|54642001|FG000|Treatment With or Without Olaratumab|Withdrawal by Subject|2|||
27983596|NCT00918203|54642002|FG001|Treatment With or Without Olaratumab|Withdrawal by Subject|8|||
27983597|NCT00918203|54642003|FG002|Treatment With or Without Olaratumab|Withdrawal by Subject|0|||
27983598|NCT00918203|54642001|FG000|Treatment With or Without Olaratumab|Other Therapy Started|2|||
27983599|NCT00918203|54642002|FG001|Treatment With or Without Olaratumab|Other Therapy Started|1|||
27983600|NCT00918203|54642003|FG002|Treatment With or Without Olaratumab|Other Therapy Started|0|||
27983601|NCT00918203|54642001|FG000|Treatment With or Without Olaratumab|Never Treated/Death|1|||
27983602|NCT00918203|54642002|FG001|Treatment With or Without Olaratumab|Never Treated/Death|0|||
27983603|NCT00918203|54642003|FG002|Treatment With or Without Olaratumab|Never Treated/Death|0|||
27983604|NCT00918281|54642015|FG000|Overall Study|Physician Decision|29|||
27983605|NCT02770716|54642024|FG000|Overall Study|Death|101|||
27983606|NCT02770716|54642025|FG001|Overall Study|Death|45|||
27983607|NCT02770716|54642024|FG000|Overall Study|Withdrawal by Subject|4|||
27983608|NCT02770716|54642025|FG001|Overall Study|Withdrawal by Subject|2|||
27983609|NCT02770716|54642024|FG000|Overall Study|Lost to Follow-up|1|||
27983610|NCT02770716|54642025|FG001|Overall Study|Lost to Follow-up|0|||
27983611|NCT02770716|54642024|FG000|Overall Study|Various reasons|6|||
27983612|NCT02770716|54642025|FG001|Overall Study|Various reasons|2|||
27983613|NCT00917579|54642031|FG000|Washout >= 2 Weeks|Adverse Event|1|||
27983614|NCT00917579|54642032|FG001|Washout >= 2 Weeks|Adverse Event|0|||
27983615|NCT00917579|54642031|FG000|Washout >= 2 Weeks|Withdrawal by Subject|1|||
27983616|NCT00917579|54642032|FG001|Washout >= 2 Weeks|Withdrawal by Subject|0|||
27983617|NCT00915551|54642040|FG000|Overall Study|Withdrawal by Subject|0|||
27983618|NCT00915551|54642041|FG001|Overall Study|Withdrawal by Subject|1|||
27983619|NCT00915473|54642049|FG000|Screening|Withdrawal by Subject|1|||
27983620|NCT00915473|54642050|FG001|Screening|Withdrawal by Subject|0|||
27983621|NCT00915473|54642049|FG000|4-week Follow Up|Lost to Follow-up|1|||
27983622|NCT00915473|54642050|FG001|4-week Follow Up|Lost to Follow-up|5|||
27983623|NCT00917501|54642058|FG000|Overall Study|Lost to Follow-up|4|||
27983624|NCT00917501|54642059|FG001|Overall Study|Lost to Follow-up|1|||
27983625|NCT00917501|54642058|FG000|Overall Study|Withdrawal by Subject|3|||
27983626|NCT00917501|54642059|FG001|Overall Study|Withdrawal by Subject|1|||
27983627|NCT00917501|54642058|FG000|Overall Study|Lack of Efficacy|1|||
27983628|NCT00917501|54642059|FG001|Overall Study|Lack of Efficacy|2|||
27983629|NCT00917501|54642058|FG000|Overall Study|trouble swollowing capsules|0|||
27983630|NCT00917501|54642059|FG001|Overall Study|trouble swollowing capsules|1|||
27983631|NCT00917267|54642078|FG000|Overall Study|Adverse Event|15|||
27983632|NCT00917267|54642079|FG001|Overall Study|Adverse Event|36|||
27983633|NCT00917267|54642078|FG000|Overall Study|Physician Decision|2|||
27983634|NCT00917267|54642079|FG001|Overall Study|Physician Decision|4|||
27983635|NCT00917267|54642078|FG000|Overall Study|Protocol Violation|9|||
27983636|NCT00917267|54642079|FG001|Overall Study|Protocol Violation|18|||
27983637|NCT00917267|54642078|FG000|Overall Study|Withdrawal by Subject|5|||
27983638|NCT00917267|54642079|FG001|Overall Study|Withdrawal by Subject|12|||
27983639|NCT00917267|54642078|FG000|Overall Study|Lost to follow up|0|||
27983640|NCT00917267|54642079|FG001|Overall Study|Lost to follow up|2|||
27983641|NCT00917267|54642078|FG000|Overall Study|Entry Criteria Not Met|1|||
27983642|NCT00917267|54642079|FG001|Overall Study|Entry Criteria Not Met|0|||
27983643|NCT00917267|54642078|FG000|Overall Study|Sponsor Decision|5|||
27983644|NCT00917267|54642079|FG001|Overall Study|Sponsor Decision|5|||
27983645|NCT00917267|54642078|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
27983646|NCT00917267|54642079|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
27983647|NCT00920699|54642092|FG000|Overall Study|Withdrawal by Subject|2|||
27983648|NCT00920699|54642093|FG001|Overall Study|Withdrawal by Subject|0|||
27983649|NCT00920699|54642094|FG002|Overall Study|Withdrawal by Subject|2|||
27983650|NCT00920699|54642092|FG000|Overall Study|no longer met eligibility|0|||
27983651|NCT00920699|54642093|FG001|Overall Study|no longer met eligibility|1|||
27880140|NCT01806168|54500272|FG002|Overall Study|Protocol Violation|1|||
27880141|NCT01804842|54500286|FG000|Overall Study|Adverse Event|1|||
27880142|NCT01804842|54500287|FG001|Overall Study|Adverse Event|1|||
27880143|NCT01804842|54500288|FG002|Overall Study|Adverse Event|0|||
27880144|NCT01804842|54500286|FG000|Overall Study|Lost to Follow-up|1|||
27880145|NCT01804842|54500287|FG001|Overall Study|Lost to Follow-up|0|||
27880146|NCT01804842|54500288|FG002|Overall Study|Lost to Follow-up|0|||
27880147|NCT01804842|54500286|FG000|Overall Study|Non-Compliance|1|||
27880148|NCT01804842|54500287|FG001|Overall Study|Non-Compliance|1|||
27983652|NCT00920699|54642094|FG002|Overall Study|no longer met eligibility|0|||
27983653|NCT00920699|54642092|FG000|Overall Study|Lost to Follow-up|0|||
27983654|NCT00920699|54642093|FG001|Overall Study|Lost to Follow-up|0|||
27983655|NCT00920699|54642094|FG002|Overall Study|Lost to Follow-up|2|||
27983656|NCT03462576|54642105|FG000|Overall Study|Protocol Violation|5|||
27983657|NCT03462576|54642106|FG001|Overall Study|Protocol Violation|11|||
27880149|NCT01804842|54500288|FG002|Overall Study|Non-Compliance|0|||
27880150|NCT01804842|54500286|FG000|Overall Study|Personal Reason|0|||
27880151|NCT01804842|54500287|FG001|Overall Study|Personal Reason|0|||
27880152|NCT01804842|54500288|FG002|Overall Study|Personal Reason|1|||
27880153|NCT01781286|54500296|FG000|Overall Study|Lost to Follow-up|0|||
27880154|NCT01781286|54500297|FG001|Overall Study|Lost to Follow-up|0|||
27880155|NCT01781286|54500298|FG002|Overall Study|Lost to Follow-up|0|||
27880156|NCT01781286|54500299|FG003|Overall Study|Lost to Follow-up|0|||
27880157|NCT01781286|54500300|FG004|Overall Study|Lost to Follow-up|0|||
27880158|NCT01781286|54500301|FG005|Overall Study|Lost to Follow-up|1|||
27880159|NCT01781286|54500296|FG000|Overall Study|Time Constraints|2|||
27880160|NCT01781286|54500297|FG001|Overall Study|Time Constraints|0|||
27880161|NCT01781286|54500298|FG002|Overall Study|Time Constraints|2|||
27880162|NCT01781286|54500299|FG003|Overall Study|Time Constraints|0|||
27880163|NCT01781286|54500300|FG004|Overall Study|Time Constraints|0|||
28096495|NCT04153188|54751530|FG000|Overall Study|Lost to Follow-up|1|||
28096496|NCT04153188|54751531|FG001|Overall Study|Lost to Follow-up|1|||
28096497|NCT04153188|54751530|FG000|Overall Study|Withdrawal by Subject|2|||
27880164|NCT01781286|54500301|FG005|Overall Study|Time Constraints|0|||
27880165|NCT01781286|54500296|FG000|Overall Study|Noncompliance|0|||
27880166|NCT01781286|54500297|FG001|Overall Study|Noncompliance|0|||
27880167|NCT01781286|54500298|FG002|Overall Study|Noncompliance|0|||
27880168|NCT01781286|54500299|FG003|Overall Study|Noncompliance|1|||
27880169|NCT01781286|54500300|FG004|Overall Study|Noncompliance|0|||
27880170|NCT01781286|54500301|FG005|Overall Study|Noncompliance|0|||
27880171|NCT01780974|54500313|FG000|Overall Study|Death|1|||
27880172|NCT01780974|54500314|FG001|Overall Study|Death|0|||
27880173|NCT01780974|54500313|FG000|Overall Study|Adverse Event|1|||
27880174|NCT01780974|54500314|FG001|Overall Study|Adverse Event|3|||
27983658|NCT03462576|54642107|FG002|Overall Study|Protocol Violation|7|||
27983659|NCT03462576|54642105|FG000|Overall Study|Device Malfunction|0|||
27983660|NCT03462576|54642106|FG001|Overall Study|Device Malfunction|0|||
27880175|NCT01780662|54500323|FG000|Overall Study|Adverse Event|1|||
27880176|NCT01780662|54500324|FG001|Overall Study|Adverse Event|0|||
27983661|NCT03462576|54642107|FG002|Overall Study|Device Malfunction|1|||
27983662|NCT00916721|54642117|FG000|Overall Study|Lost to Follow-up|0|||
27983663|NCT00916721|54642118|FG001|Overall Study|Lost to Follow-up|1|||
27983664|NCT00916721|54642117|FG000|Overall Study|Adverse Event|6|||
27983665|NCT00916721|54642118|FG001|Overall Study|Adverse Event|3|||
27983666|NCT00916721|54642117|FG000|Overall Study|Withdrawal by Subject|2|||
27983667|NCT00916721|54642118|FG001|Overall Study|Withdrawal by Subject|2|||
27983668|NCT00916721|54642117|FG000|Overall Study|Protocol Violation|2|||
27983669|NCT00916721|54642118|FG001|Overall Study|Protocol Violation|4|||
27983670|NCT00915005|54642126|FG000|Overall Study|Withdrawal by Subject|4|||
27983671|NCT00915005|54642127|FG001|Overall Study|Withdrawal by Subject|4|||
27983672|NCT00915005|54642126|FG000|Overall Study|Patient preferred protons therapy|6|||
27983673|NCT00915005|54642127|FG001|Overall Study|Patient preferred protons therapy|0|||
27983674|NCT00915005|54642126|FG000|Overall Study|Insurance denial|3|||
27983675|NCT00915005|54642127|FG001|Overall Study|Insurance denial|15|||
27983676|NCT01143246|54642135|FG000|Overall Study|Adverse Event|24|||
27983677|NCT01143246|54642136|FG001|Overall Study|Adverse Event|28|||
27983678|NCT01143246|54642135|FG000|Overall Study|Participant Withdrew Informed Consent|2|||
27983679|NCT01143246|54642136|FG001|Overall Study|Participant Withdrew Informed Consent|2|||
27983680|NCT01143246|54642135|FG000|Overall Study|Lost to Follow-up|0|||
27983681|NCT01143246|54642136|FG001|Overall Study|Lost to Follow-up|1|||
27983682|NCT01143246|54642135|FG000|Overall Study|Death|16|||
27983683|NCT01143246|54642136|FG001|Overall Study|Death|15|||
27983684|NCT01143246|54642135|FG000|Overall Study|Reason not Specified|3|||
27983685|NCT01143246|54642136|FG001|Overall Study|Reason not Specified|5|||
27983686|NCT00561925|54642150|FG000|14 Day Lead-In Period|Adverse Event|38|||
28096498|NCT04153188|54751531|FG001|Overall Study|Withdrawal by Subject|0|||
28096499|NCT04153188|54751530|FG000|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|0|||
28096500|NCT04153188|54751531|FG001|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|1|||
28096501|NCT04113746|54751539|FG000|Overall Study|Lost to Follow-up|4|||
28096502|NCT04113746|54751540|FG001|Overall Study|Lost to Follow-up|4|||
28096503|NCT03611010|54751550|FG000|Period 2: 15 Day Treatment|Inaccessible veins|1|||
28096504|NCT03611010|54751551|FG001|Period 2: 15 Day Treatment|Inaccessible veins|0|||
28096505|NCT03611010|54751552|FG002|Period 2: 15 Day Treatment|Inaccessible veins|0|||
28096506|NCT03611010|54751553|FG003|Period 2: 15 Day Treatment|Inaccessible veins|0|||
28096507|NCT04357782|54751568|FG000|Overall Study|Discharged from hospital|1|||
28096508|NCT04357782|54751569|FG001|Overall Study|Discharged from hospital|0|||
28096509|NCT04357782|54751568|FG000|Overall Study|Death|0|||
27880177|NCT01780662|54500325|FG002|Overall Study|Adverse Event|2|||
27880178|NCT01780662|54500323|FG000|Overall Study|Physician Decision|0|||
27880179|NCT01780662|54500324|FG001|Overall Study|Physician Decision|5|||
27880180|NCT01780662|54500325|FG002|Overall Study|Physician Decision|7|||
27880181|NCT01780662|54500323|FG000|Overall Study|Protocol Violation|0|||
27880182|NCT01780662|54500324|FG001|Overall Study|Protocol Violation|1|||
27880183|NCT01780662|54500325|FG002|Overall Study|Protocol Violation|0|||
27880184|NCT01780662|54500323|FG000|Overall Study|Ineligible|0|||
27880185|NCT01780662|54500324|FG001|Overall Study|Ineligible|0|||
27880186|NCT01780662|54500325|FG002|Overall Study|Ineligible|1|||
27880187|NCT01780584|54500337|FG000|Overall Study|Death|1|||
27880188|NCT01780584|54500338|FG001|Overall Study|Death|0|||
27880189|NCT01780584|54500339|FG002|Overall Study|Death|1|||
27880190|NCT01780584|54500337|FG000|Overall Study|Adverse Event|0|||
27880191|NCT01780584|54500338|FG001|Overall Study|Adverse Event|1|||
27880192|NCT01780584|54500339|FG002|Overall Study|Adverse Event|0|||
27880193|NCT01780584|54500337|FG000|Overall Study|Protocol Violation|0|||
27880194|NCT01780584|54500338|FG001|Overall Study|Protocol Violation|0|||
27880195|NCT01780584|54500339|FG002|Overall Study|Protocol Violation|1|||
27880196|NCT01780506|54500349|FG000|Double-Blind Phase|Randomized but not Treated|3|||
27880197|NCT01780506|54500350|FG001|Double-Blind Phase|Randomized but not Treated|2|||
27880198|NCT01780506|54500349|FG000|Double-Blind Phase|Adverse Event|4|||
27880199|NCT01780506|54500350|FG001|Double-Blind Phase|Adverse Event|14|||
27880200|NCT01780506|54500349|FG000|Double-Blind Phase|Death|1|||
27880201|NCT01780506|54500350|FG001|Double-Blind Phase|Death|2|||
27880202|NCT01780506|54500349|FG000|Double-Blind Phase|Pregnancy|2|||
27880203|NCT01780506|54500350|FG001|Double-Blind Phase|Pregnancy|1|||
27880204|NCT01780506|54500349|FG000|Double-Blind Phase|Lack of Efficacy|1|||
27880205|NCT01780506|54500350|FG001|Double-Blind Phase|Lack of Efficacy|1|||
27880206|NCT01780506|54500349|FG000|Double-Blind Phase|Investigator's Discretion|5|||
27880207|NCT01780506|54500350|FG001|Double-Blind Phase|Investigator's Discretion|2|||
27880208|NCT01780506|54500349|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
27880209|NCT01780506|54500350|FG001|Double-Blind Phase|Non-Compliance with Study Drug|3|||
27880210|NCT01780506|54500349|FG000|Double-Blind Phase|Protocol Violation|4|||
27880211|NCT01780506|54500350|FG001|Double-Blind Phase|Protocol Violation|3|||
27880212|NCT01780506|54500349|FG000|Double-Blind Phase|Withdrew Consent|23|||
27880213|NCT01780506|54500350|FG001|Double-Blind Phase|Withdrew Consent|24|||
27880214|NCT01780506|54500349|FG000|Double-Blind Phase|Lost to Follow-up|23|||
27880215|NCT01780506|54500350|FG001|Double-Blind Phase|Lost to Follow-up|26|||
27880216|NCT01780506|54500349|FG000|Open-Label Extension Phase|Enrolled but not Treated|0|||
27880217|NCT01780506|54500350|FG001|Open-Label Extension Phase|Enrolled but not Treated|1|||
27880218|NCT01779648|54500360|FG000|Overall Study|Protocol Violation|1|||
27880219|NCT01779648|54500361|FG001|Overall Study|Protocol Violation|0|||
27880220|NCT01762800|54500369|FG000|Overall Study|Adverse Event|8|||
27880221|NCT01762800|54500370|FG001|Overall Study|Adverse Event|13|||
27880222|NCT01762800|54500369|FG000|Overall Study|Lack of Efficacy|3|||
27880223|NCT01762800|54500370|FG001|Overall Study|Lack of Efficacy|2|||
27880224|NCT01762800|54500369|FG000|Overall Study|Study Closed/Terminated|0|||
27880225|NCT01762800|54500370|FG001|Overall Study|Study Closed/Terminated|1|||
27880226|NCT01762800|54500369|FG000|Overall Study|Physician Decision|1|||
27880227|NCT01762800|54500370|FG001|Overall Study|Physician Decision|1|||
27880228|NCT01762800|54500369|FG000|Overall Study|Withdrawal by Subject|7|||
27880229|NCT01762800|54500370|FG001|Overall Study|Withdrawal by Subject|4|||
27880230|NCT01597596|54500384|FG000|Overall Study|Study terminated by sponsor|1|||
27880231|NCT01597596|54500385|FG001|Overall Study|Study terminated by sponsor|0|||
27880232|NCT01597596|54500384|FG000|Overall Study|Physician Decision|0|||
27880233|NCT01597596|54500385|FG001|Overall Study|Physician Decision|1|||
27880234|NCT01778556|54500393|FG000|Intervention 1 (5 Days)|Protocol Violation|0|||
27880235|NCT01778556|54500394|FG001|Intervention 1 (5 Days)|Protocol Violation|1|||
27880236|NCT01778556|54500393|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
27880237|NCT01778556|54500394|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|1|||
27880238|NCT01778556|54500393|FG000|Intervention 2 (14 Days)|Protocol Violation|1|||
27880239|NCT01778556|54500394|FG001|Intervention 2 (14 Days)|Protocol Violation|0|||
27880240|NCT01778556|54500393|FG000|Long-term Follow-up|noncompliance with metreleptin|1|||
27880241|NCT01778556|54500394|FG001|Long-term Follow-up|noncompliance with metreleptin|0|||
28096510|NCT04357782|54751569|FG001|Overall Study|Death|2|||
28096511|NCT03980522|54751580|FG000|Treatment Period|Adverse Event|1|||
28096512|NCT03980522|54751581|FG001|Treatment Period|Adverse Event|0|||
28096513|NCT03980522|54751582|FG002|Treatment Period|Adverse Event|0|||
28096514|NCT03980522|54751583|FG003|Treatment Period|Adverse Event|0|||
27739297|NCT02239120|54188656|FG001|Overall Study|Death|58|||
27739298|NCT02239120|54188655|FG000|Overall Study|Lost to Follow-up|19|||
27880242|NCT01761162|54500403|FG000|Overall Study|Withdrawal by Subject|3|||
27880243|NCT01778010|54500407|FG000|Overall Study|Withdrawal by Subject|2|||
27880244|NCT01778010|54500407|FG000|Overall Study|abnormal ECG before meds|1|||
27880245|NCT01778010|54500407|FG000|Overall Study|Arrested|1|||
27880246|NCT01778010|54500407|FG000|Overall Study|rash while on placebo|1|||
27880247|NCT01777932|54500424|FG000|Overall Study|Disease progression|136|||
27880248|NCT01777932|54500424|FG000|Overall Study|Death|3|||
27880249|NCT01777932|54500424|FG000|Overall Study|Adverse Event|34|||
27880250|NCT01777932|54500424|FG000|Overall Study|Lost to Follow-up|3|||
27880251|NCT01777932|54500424|FG000|Overall Study|Investigator decision|10|||
27880252|NCT01777932|54500424|FG000|Overall Study|Reimbursement limit|9|||
27880253|NCT01777932|54500424|FG000|Overall Study|Patient refused further treatment|10|||
27880254|NCT01777854|54500428|FG000|Overall Study|Physician Decision|3|||
27880255|NCT01777854|54500429|FG001|Overall Study|Physician Decision|3|||
27880256|NCT01777776|54500437|FG000|Overall Study|Adverse Event|2|||
27880257|NCT01777776|54500438|FG001|Overall Study|Adverse Event|4|||
27880258|NCT01777776|54500439|FG002|Overall Study|Adverse Event|0|||
27880259|NCT01777776|54500440|FG003|Overall Study|Adverse Event|0|||
27880260|NCT01777776|54500437|FG000|Overall Study|Disease Progression|4|||
27880261|NCT01777776|54500438|FG001|Overall Study|Disease Progression|8|||
27880262|NCT01777776|54500439|FG002|Overall Study|Disease Progression|6|||
27880263|NCT01777776|54500440|FG003|Overall Study|Disease Progression|3|||
27880264|NCT01777776|54500437|FG000|Overall Study|Withdrawal by Subject|0|||
27880265|NCT01777776|54500438|FG001|Overall Study|Withdrawal by Subject|0|||
27880266|NCT01777776|54500439|FG002|Overall Study|Withdrawal by Subject|0|||
27880267|NCT01777776|54500440|FG003|Overall Study|Withdrawal by Subject|1|||
27880268|NCT01777620|54500461|FG000|Overall Study|Subject Withdrawal|1|||
27880269|NCT01777620|54500462|FG001|Overall Study|Subject Withdrawal|0|||
27880270|NCT01777542|54500468|FG000|Second Intervention (20 Weeks)|Adverse Event|0|||
27880271|NCT01777542|54500469|FG001|Second Intervention (20 Weeks)|Adverse Event|1|||
27880272|NCT01736124|54500478|FG000|Post-intervention Assessment|Death|2|||
27880273|NCT01736124|54500479|FG001|Post-intervention Assessment|Death|2|||
27880274|NCT01736124|54500478|FG000|Post-intervention Assessment|lost computer access|1|||
27880275|NCT01736124|54500479|FG001|Post-intervention Assessment|lost computer access|1|||
27880276|NCT01736124|54500478|FG000|Post-intervention Assessment|Moved away|3|||
27880277|NCT01736124|54500479|FG001|Post-intervention Assessment|Moved away|1|||
27880278|NCT01736124|54500478|FG000|Post-intervention Assessment|Withdrawal by Subject|11|||
27880279|NCT01736124|54500479|FG001|Post-intervention Assessment|Withdrawal by Subject|9|||
27880280|NCT01736124|54500478|FG000|Post-intervention Assessment|Illness|3|||
27880281|NCT01736124|54500479|FG001|Post-intervention Assessment|Illness|2|||
27880282|NCT01736124|54500478|FG000|Post-intervention Assessment|Lost to Follow-up|8|||
27880283|NCT01736124|54500479|FG001|Post-intervention Assessment|Lost to Follow-up|5|||
27880284|NCT01736124|54500478|FG000|Post-intervention Assessment|Temporarily away|3|||
27880285|NCT01736124|54500479|FG001|Post-intervention Assessment|Temporarily away|1|||
27880286|NCT01736124|54500478|FG000|6 Mo. Post-Intervention Assessment|Death|0|||
27880287|NCT01736124|54500479|FG001|6 Mo. Post-Intervention Assessment|Death|1|||
27880288|NCT01736124|54500478|FG000|6 Mo. Post-Intervention Assessment|Moved away|0|||
27880289|NCT01736124|54500479|FG001|6 Mo. Post-Intervention Assessment|Moved away|2|||
27880290|NCT01736124|54500478|FG000|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
27880291|NCT01736124|54500479|FG001|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
27880292|NCT01736124|54500478|FG000|6 Mo. Post-Intervention Assessment|Illness|1|||
27880293|NCT01736124|54500479|FG001|6 Mo. Post-Intervention Assessment|Illness|2|||
27880294|NCT01736124|54500478|FG000|6 Mo. Post-Intervention Assessment|Temporarily away|1|||
27880295|NCT01736124|54500479|FG001|6 Mo. Post-Intervention Assessment|Temporarily away|4|||
27880296|NCT01736124|54500478|FG000|12 Mo. Post-Intervention Assessment|Death|1|||
27880297|NCT01736124|54500479|FG001|12 Mo. Post-Intervention Assessment|Death|0|||
27880298|NCT01736124|54500478|FG000|12 Mo. Post-Intervention Assessment|Moved away|1|||
27880299|NCT01736124|54500479|FG001|12 Mo. Post-Intervention Assessment|Moved away|0|||
27880300|NCT01736124|54500478|FG000|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0|||
27880301|NCT01736124|54500479|FG001|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2|||
27880302|NCT01736124|54500478|FG000|12 Mo. Post-Intervention Assessment|End of study|10|||
27880303|NCT01736124|54500479|FG001|12 Mo. Post-Intervention Assessment|End of study|10|||
27880304|NCT01759446|54500492|FG000|Overall Study|Protocol Violation|1|||
27880305|NCT01759446|54500493|FG001|Overall Study|Protocol Violation|0|||
27880306|NCT01759446|54500494|FG002|Overall Study|Protocol Violation|1|||
27880307|NCT01759446|54500495|FG003|Overall Study|Protocol Violation|0|||
27880308|NCT01759446|54500496|FG004|Overall Study|Protocol Violation|0|||
27880309|NCT01759446|54500492|FG000|Overall Study|Withdrawal by Subject|0|||
27880310|NCT01759446|54500493|FG001|Overall Study|Withdrawal by Subject|1|||
27880311|NCT01759446|54500494|FG002|Overall Study|Withdrawal by Subject|0|||
27880312|NCT01759446|54500495|FG003|Overall Study|Withdrawal by Subject|1|||
27880313|NCT01759446|54500496|FG004|Overall Study|Withdrawal by Subject|0|||
27880314|NCT01777308|54500510|FG000|Overall Study|Withdrawal by Subject|5|||
27880315|NCT01777308|54500511|FG001|Overall Study|Withdrawal by Subject|1|||
27880316|NCT01777308|54500510|FG000|Overall Study|Migrated/moved from study area|1|||
27880317|NCT01777308|54500511|FG001|Overall Study|Migrated/moved from study area|0|||
27880318|NCT01777308|54500510|FG000|Overall Study|Lost to Follow-up|7|||
27880319|NCT01777308|54500511|FG001|Overall Study|Lost to Follow-up|2|||
27880320|NCT01777308|54500510|FG000|Overall Study|Blood draw refusal at Visit 3|1|||
27880321|NCT01777308|54500511|FG001|Overall Study|Blood draw refusal at Visit 3|0|||
27880322|NCT01759368|54500520|FG000|Overall Study|Lost to Follow-up|1|||
27880323|NCT01759368|54500521|FG001|Overall Study|Lost to Follow-up|0|||
27880324|NCT01777152|54500531|FG000|Overall Study|Withdrawal by Subject|22|||
27880325|NCT01777152|54500532|FG001|Overall Study|Withdrawal by Subject|16|||
27880326|NCT01777152|54500531|FG000|Overall Study|Lost to Follow-up|3|||
27880327|NCT01777152|54500532|FG001|Overall Study|Lost to Follow-up|5|||
27739299|NCT02239120|54188656|FG001|Overall Study|Lost to Follow-up|14|||
27880328|NCT01777152|54500531|FG000|Overall Study|Death|68|||
27880329|NCT01777152|54500532|FG001|Overall Study|Death|89|||
27880330|NCT01777152|54500531|FG000|Overall Study|Not eligible, no study drug received|1|||
27880331|NCT01777152|54500532|FG001|Overall Study|Not eligible, no study drug received|0|||
27880332|NCT01777152|54500531|FG000|Overall Study|Change of diagnosis|1|||
27880333|NCT01777152|54500532|FG001|Overall Study|Change of diagnosis|0|||
27880334|NCT01759290|54500539|FG000|Overall Study|Subjects withdrawn consent|5|||
27880335|NCT01759290|54500539|FG000|Overall Study|Physician Decision|2|||
27880336|NCT01759290|54500539|FG000|Overall Study|Death|17|||
27880337|NCT01759290|54500539|FG000|Overall Study|Lost to Follow-up|53|||
27880338|NCT01759290|54500539|FG000|Overall Study|Unknown reason|4|||
27983687|NCT00561925|54642151|FG001|14 Day Lead-In Period|Adverse Event|0|||
27983688|NCT00561925|54642152|FG002|14 Day Lead-In Period|Adverse Event|0|||
27983689|NCT00561925|54642153|FG003|14 Day Lead-In Period|Adverse Event|0|||
27983690|NCT00561925|54642154|FG004|14 Day Lead-In Period|Adverse Event|0|||
27983691|NCT00561925|54642150|FG000|14 Day Lead-In Period|In/Exclusion criteria|4|||
27983692|NCT00561925|54642151|FG001|14 Day Lead-In Period|In/Exclusion criteria|0|||
27983693|NCT00561925|54642152|FG002|14 Day Lead-In Period|In/Exclusion criteria|0|||
27983694|NCT00561925|54642153|FG003|14 Day Lead-In Period|In/Exclusion criteria|0|||
27983695|NCT00561925|54642154|FG004|14 Day Lead-In Period|In/Exclusion criteria|0|||
27983696|NCT00561925|54642150|FG000|14 Day Lead-In Period|Lost to Follow-up|4|||
27983697|NCT00561925|54642151|FG001|14 Day Lead-In Period|Lost to Follow-up|0|||
27983698|NCT00561925|54642152|FG002|14 Day Lead-In Period|Lost to Follow-up|0|||
27983699|NCT00561925|54642153|FG003|14 Day Lead-In Period|Lost to Follow-up|0|||
27983700|NCT00561925|54642154|FG004|14 Day Lead-In Period|Lost to Follow-up|0|||
27880339|NCT01758900|54500545|FG000|Overall Study|difficulty for further intubation|7|||
27880340|NCT01758900|54500546|FG001|Overall Study|difficulty for further intubation|8|||
27880341|NCT01757184|54500554|FG000|Double-blind Period|Adverse Event|1|||
27880342|NCT01757184|54500555|FG001|Double-blind Period|Adverse Event|0|||
27880343|NCT01757184|54500556|FG002|Double-blind Period|Adverse Event|0|||
27880344|NCT01757184|54500557|FG003|Double-blind Period|Adverse Event|0|||
27880345|NCT01757184|54500554|FG000|Open-label Period|Lost to Follow-up|0|||
27880346|NCT01757184|54500555|FG001|Open-label Period|Lost to Follow-up|0|||
27880347|NCT01757184|54500556|FG002|Open-label Period|Lost to Follow-up|2|||
27880348|NCT01757184|54500557|FG003|Open-label Period|Lost to Follow-up|0|||
27880349|NCT01757184|54500554|FG000|Open-label Period|Withdrawal by Subject|0|||
27880350|NCT01757184|54500555|FG001|Open-label Period|Withdrawal by Subject|0|||
27880351|NCT01757184|54500556|FG002|Open-label Period|Withdrawal by Subject|1|||
27880352|NCT01757184|54500557|FG003|Open-label Period|Withdrawal by Subject|1|||
27880353|NCT01757184|54500554|FG000|Open-label Period|Discontinued by Sponsor|0|||
27880354|NCT01757184|54500555|FG001|Open-label Period|Discontinued by Sponsor|0|||
27880355|NCT01757184|54500556|FG002|Open-label Period|Discontinued by Sponsor|1|||
27880356|NCT01757184|54500557|FG003|Open-label Period|Discontinued by Sponsor|2|||
27880357|NCT01775904|54500571|FG000|LY2886721 Capsule (Water, Fasting)|Adverse Event|1|||
27880358|NCT01775904|54500571|FG000|LY2886721 ODT (Water, Fasting)|Adverse Event|1|||
27880359|NCT01775670|54500583|FG000|Overall Study|Lost to Follow-up|1|||
27880360|NCT01775670|54500584|FG001|Overall Study|Lost to Follow-up|1|||
27880361|NCT01775124|54500592|FG000|Core Period|Disease Progression|0|||
27880362|NCT01775124|54500593|FG001|Core Period|Disease Progression|1|||
27880363|NCT01775124|54500592|FG000|Core Period|Physician Decision|1|||
27880364|NCT01775124|54500593|FG001|Core Period|Physician Decision|1|||
27880365|NCT01775124|54500592|FG000|Core Period|Death|0|||
27880366|NCT01775124|54500593|FG001|Core Period|Death|1|||
27880367|NCT01775124|54500592|FG000|Core Period|Administrative problems|1|||
27880368|NCT01775124|54500593|FG001|Core Period|Administrative problems|0|||
27880369|NCT01775124|54500592|FG000|Core Period|Withdrawal by Subject|4|||
27880370|NCT01775124|54500593|FG001|Core Period|Withdrawal by Subject|2|||
27880371|NCT01775124|54500592|FG000|Core Period|Adverse Event|5|||
27880372|NCT01775124|54500593|FG001|Core Period|Adverse Event|5|||
27880373|NCT01775124|54500592|FG000|Extension Period|Adverse Event|3|||
27880374|NCT01775124|54500593|FG001|Extension Period|Adverse Event|2|||
27880375|NCT01775124|54500592|FG000|Extension Period|Physician Decision|0|||
27880376|NCT01775124|54500593|FG001|Extension Period|Physician Decision|2|||
27880377|NCT01775124|54500592|FG000|Extension Period|Administrative problems|0|||
27880378|NCT01775124|54500593|FG001|Extension Period|Administrative problems|1|||
27983701|NCT00561925|54642150|FG000|14 Day Lead-In Period|Withdrawal by Subject|4|||
27983702|NCT00561925|54642151|FG001|14 Day Lead-In Period|Withdrawal by Subject|0|||
27983703|NCT00561925|54642152|FG002|14 Day Lead-In Period|Withdrawal by Subject|0|||
27983704|NCT00561925|54642153|FG003|14 Day Lead-In Period|Withdrawal by Subject|0|||
27983705|NCT00561925|54642154|FG004|14 Day Lead-In Period|Withdrawal by Subject|0|||
27739300|NCT01603407|54188665|FG000|Overall Study|Adverse Event|1|||
27880379|NCT01775124|54500592|FG000|Extension Period|Lost to Follow-up|0|||
27880380|NCT01775124|54500593|FG001|Extension Period|Lost to Follow-up|1|||
27880381|NCT01775124|54500592|FG000|Extension Period|Withdrawal by Subject|9|||
27880382|NCT01775124|54500593|FG001|Extension Period|Withdrawal by Subject|12|||
27880383|NCT01733316|54500600|FG000|RP103 Phase|Non-compliance|1|||
27983706|NCT00561925|54642150|FG000|14 Day Lead-In Period|Other|5|||
27880384|NCT01733316|54500600|FG000|Long Term Extension Phase|Adverse Event|1|||
27880385|NCT01733316|54500600|FG000|Long Term Extension Phase|Consent Withdrawn by Subject|2|||
27880386|NCT01733316|54500600|FG000|Long Term Extension Phase|Sponsor Decision|2|||
27880387|NCT01732926|54500613|FG000|Overall Study|Study Terminated by Sponsor|168|||
27880388|NCT01732926|54500614|FG001|Overall Study|Study Terminated by Sponsor|80|||
27880389|NCT01732926|54500613|FG000|Overall Study|Withdrawal by Subject|46|||
27880390|NCT01732926|54500614|FG001|Overall Study|Withdrawal by Subject|8|||
27880391|NCT01732926|54500613|FG000|Overall Study|Physician Decision|24|||
27880392|NCT01732926|54500614|FG001|Overall Study|Physician Decision|11|||
27880393|NCT01732926|54500613|FG000|Overall Study|Other Reason|21|||
27880394|NCT01732926|54500614|FG001|Overall Study|Other Reason|4|||
27880395|NCT01732926|54500613|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|7|||
27880396|NCT01732926|54500614|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|6|||
27880397|NCT01732926|54500613|FG000|Overall Study|Blind Broken by Subject or Study Site|1|||
27880398|NCT01732926|54500614|FG001|Overall Study|Blind Broken by Subject or Study Site|1|||
27880399|NCT01755858|54500622|FG000|Overall Study|Adverse Event|1|||
27880400|NCT01755858|54500623|FG001|Overall Study|Adverse Event|1|||
27880401|NCT01732770|54500633|FG000|Overall Study|Lost to Follow-up|2|||
27880402|NCT01732770|54500634|FG001|Overall Study|Lost to Follow-up|3|||
27880403|NCT01732770|54500633|FG000|Overall Study|Withdrawal by Subject|5|||
27880404|NCT01732770|54500634|FG001|Overall Study|Withdrawal by Subject|3|||
27880405|NCT01732770|54500633|FG000|Overall Study|Decision by Sponsor|2|||
27880406|NCT01732770|54500634|FG001|Overall Study|Decision by Sponsor|2|||
27880407|NCT01732770|54500633|FG000|Overall Study|Death|1|||
27880408|NCT01732770|54500634|FG001|Overall Study|Death|0|||
27880409|NCT01732692|54500642|FG000|Overall Study|Adverse Event|0|||
27880410|NCT01732692|54500643|FG001|Overall Study|Adverse Event|1|||
27880411|NCT01774968|54500651|FG000|Overall Study|Adverse Event|4|||
27880412|NCT01774968|54500652|FG001|Overall Study|Adverse Event|4|||
27880413|NCT01774968|54500651|FG000|Overall Study|Death|0|||
27880414|NCT01774968|54500652|FG001|Overall Study|Death|1|||
27880415|NCT01774968|54500651|FG000|Overall Study|Lost to Follow-up|1|||
27880416|NCT01774968|54500652|FG001|Overall Study|Lost to Follow-up|3|||
27880417|NCT01774968|54500651|FG000|Overall Study|Physician Decision|5|||
27880418|NCT01774968|54500652|FG001|Overall Study|Physician Decision|1|||
27880419|NCT01774968|54500651|FG000|Overall Study|Protocol Violation|14|||
27880420|NCT01774968|54500652|FG001|Overall Study|Protocol Violation|13|||
27880421|NCT01774968|54500651|FG000|Overall Study|Sponsor Decision|0|||
27880422|NCT01774968|54500652|FG001|Overall Study|Sponsor Decision|2|||
27880423|NCT01774968|54500651|FG000|Overall Study|Withdrawal by Subject|6|||
27880424|NCT01774968|54500652|FG001|Overall Study|Withdrawal by Subject|11|||
27880425|NCT01774344|54500660|FG000|Overall Study|Withdrawal by Subject|3|||
27880426|NCT01774344|54500661|FG001|Overall Study|Withdrawal by Subject|10|||
27880427|NCT01774344|54500660|FG000|Overall Study|Protocol Violation|0|||
27880428|NCT01774344|54500661|FG001|Overall Study|Protocol Violation|1|||
27880429|NCT01774344|54500660|FG000|Overall Study|Lost to Follow-up|4|||
27880430|NCT01774344|54500661|FG001|Overall Study|Lost to Follow-up|10|||
27880431|NCT01774344|54500660|FG000|Overall Study|End of survival follow-up not available|2|||
27880432|NCT01774344|54500661|FG001|Overall Study|End of survival follow-up not available|2|||
27880433|NCT01774344|54500660|FG000|Overall Study|Data collection finished|4|||
27880434|NCT01774344|54500661|FG001|Overall Study|Data collection finished|14|||
27880435|NCT01774344|54500660|FG000|Overall Study|Other|0|||
27880436|NCT01774344|54500661|FG001|Overall Study|Other|1|||
27880437|NCT01774344|54500660|FG000|Overall Study|Did not enter Survival Follow up|49|||
27880438|NCT01774344|54500661|FG001|Overall Study|Did not enter Survival Follow up|83|||
27880439|NCT01732536|54500669|FG000|Overall Study|Withdrawal by Subject|1|||
27880440|NCT01732536|54500670|FG001|Overall Study|Withdrawal by Subject|1|||
27880441|NCT01755702|54500679|FG000|Wash Out Period I|Other Reason|3|||
27880442|NCT01755702|54500679|FG000|Washout Period II|Other Reason|5|||
27880443|NCT01732458|54500693|FG000|Overall Study|Lost to Follow-up|0|||
27880444|NCT01732458|54500694|FG001|Overall Study|Lost to Follow-up|2|||
27880445|NCT01732458|54500695|FG002|Overall Study|Lost to Follow-up|0|||
27739301|NCT01603407|54188666|FG001|Overall Study|Adverse Event|1|||
27739302|NCT01603407|54188667|FG002|Overall Study|Adverse Event|1|||
27880446|NCT01732458|54500696|FG003|Overall Study|Lost to Follow-up|0|||
27880447|NCT01732458|54500693|FG000|Overall Study|Non-Compliance With Study Drug|0|||
27880448|NCT01732458|54500694|FG001|Overall Study|Non-Compliance With Study Drug|0|||
27880449|NCT01732458|54500695|FG002|Overall Study|Non-Compliance With Study Drug|1|||
27880450|NCT01732458|54500696|FG003|Overall Study|Non-Compliance With Study Drug|0|||
27880451|NCT01732458|54500693|FG000|Overall Study|Physician Decision|1|||
27880452|NCT01732458|54500694|FG001|Overall Study|Physician Decision|2|||
27880453|NCT01732458|54500695|FG002|Overall Study|Physician Decision|2|||
27880454|NCT01732458|54500696|FG003|Overall Study|Physician Decision|0|||
27880455|NCT01732458|54500693|FG000|Overall Study|Protocol Violation|2|||
27880456|NCT01732458|54500694|FG001|Overall Study|Protocol Violation|0|||
27880457|NCT01732458|54500695|FG002|Overall Study|Protocol Violation|0|||
28096515|NCT03980522|54751584|FG004|Treatment Period|Adverse Event|0|||
28096516|NCT04402866|54751602|FG000|Overall Study|Discontinued Prior to Treatment|0|||
27880458|NCT01732458|54500696|FG003|Overall Study|Protocol Violation|2|||
27880459|NCT01732458|54500693|FG000|Overall Study|Screen Failure|0|||
27880460|NCT01732458|54500694|FG001|Overall Study|Screen Failure|1|||
27880461|NCT01732458|54500695|FG002|Overall Study|Screen Failure|0|||
27880462|NCT01732458|54500696|FG003|Overall Study|Screen Failure|0|||
27880463|NCT01731990|54500720|FG000|Overall Study|Adverse Event|1|||
27880464|NCT01731990|54500721|FG001|Overall Study|Adverse Event|5|||
27880465|NCT01731990|54500720|FG000|Overall Study|Withdrawal by Subject|1|||
27880466|NCT01731990|54500721|FG001|Overall Study|Withdrawal by Subject|1|||
27880467|NCT01731990|54500720|FG000|Overall Study|Protocol deviation|1|||
27880468|NCT01731990|54500721|FG001|Overall Study|Protocol deviation|2|||
27880469|NCT01731990|54500720|FG000|Overall Study|Death|1|||
27880470|NCT01731990|54500721|FG001|Overall Study|Death|0|||
27880471|NCT01708902|54500734|FG000|Overall Study|Adverse Event|3|||
27880472|NCT01708902|54500735|FG001|Overall Study|Adverse Event|4|||
27880473|NCT01708902|54500736|FG002|Overall Study|Adverse Event|9|||
27880474|NCT01708902|54500737|FG003|Overall Study|Adverse Event|2|||
27880475|NCT01708902|54500738|FG004|Overall Study|Adverse Event|7|||
27880476|NCT01708902|54500739|FG005|Overall Study|Adverse Event|3|||
27983707|NCT00561925|54642151|FG001|14 Day Lead-In Period|Other|0|||
27983708|NCT00561925|54642152|FG002|14 Day Lead-In Period|Other|0|||
27983709|NCT00561925|54642153|FG003|14 Day Lead-In Period|Other|0|||
27983710|NCT00561925|54642154|FG004|14 Day Lead-In Period|Other|0|||
27983711|NCT00561925|54642150|FG000|144-week Double-blind, Double-dummy|Adverse Event|0|||
27983712|NCT00561925|54642151|FG001|144-week Double-blind, Double-dummy|Adverse Event|48|||
27983713|NCT00561925|54642152|FG002|144-week Double-blind, Double-dummy|Adverse Event|43|||
27983714|NCT00561925|54642153|FG003|144-week Double-blind, Double-dummy|Adverse Event|0|||
27983715|NCT00561925|54642154|FG004|144-week Double-blind, Double-dummy|Adverse Event|0|||
27983716|NCT00561925|54642150|FG000|144-week Double-blind, Double-dummy|Protocol Violation|0|||
27983717|NCT00561925|54642151|FG001|144-week Double-blind, Double-dummy|Protocol Violation|15|||
27983718|NCT00561925|54642152|FG002|144-week Double-blind, Double-dummy|Protocol Violation|9|||
27983719|NCT00561925|54642153|FG003|144-week Double-blind, Double-dummy|Protocol Violation|0|||
27983720|NCT00561925|54642154|FG004|144-week Double-blind, Double-dummy|Protocol Violation|0|||
27983721|NCT00561925|54642150|FG000|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
27983722|NCT00561925|54642151|FG001|144-week Double-blind, Double-dummy|Lost to Follow-up|15|||
27983723|NCT00561925|54642152|FG002|144-week Double-blind, Double-dummy|Lost to Follow-up|12|||
27983724|NCT00561925|54642153|FG003|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
27983725|NCT00561925|54642154|FG004|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
27983726|NCT00561925|54642150|FG000|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
27983727|NCT00561925|54642151|FG001|144-week Double-blind, Double-dummy|Withdrawal by Subject|19|||
27983728|NCT00561925|54642152|FG002|144-week Double-blind, Double-dummy|Withdrawal by Subject|7|||
27983729|NCT00561925|54642153|FG003|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
27983730|NCT00561925|54642154|FG004|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
27983731|NCT00561925|54642150|FG000|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
27983732|NCT00561925|54642151|FG001|144-week Double-blind, Double-dummy|Lack of Efficacy|36|||
27983733|NCT00561925|54642152|FG002|144-week Double-blind, Double-dummy|Lack of Efficacy|33|||
27983734|NCT00561925|54642153|FG003|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
27983735|NCT00561925|54642154|FG004|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
27983736|NCT00561925|54642150|FG000|144-week Double-blind, Double-dummy|Pregnancy|0|||
27983737|NCT00561925|54642151|FG001|144-week Double-blind, Double-dummy|Pregnancy|1|||
27983738|NCT00561925|54642152|FG002|144-week Double-blind, Double-dummy|Pregnancy|9|||
27983739|NCT00561925|54642153|FG003|144-week Double-blind, Double-dummy|Pregnancy|0|||
27983740|NCT00561925|54642154|FG004|144-week Double-blind, Double-dummy|Pregnancy|0|||
27983741|NCT00561925|54642150|FG000|144-week Double-blind, Double-dummy|Death|0|||
27983742|NCT00561925|54642151|FG001|144-week Double-blind, Double-dummy|Death|6|||
27983743|NCT00561925|54642152|FG002|144-week Double-blind, Double-dummy|Death|3|||
27983744|NCT00561925|54642153|FG003|144-week Double-blind, Double-dummy|Death|0|||
27983745|NCT00561925|54642154|FG004|144-week Double-blind, Double-dummy|Death|0|||
27983746|NCT00561925|54642150|FG000|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
27983747|NCT00561925|54642151|FG001|144-week Double-blind, Double-dummy|Not treated with study drug|2|||
28096517|NCT04402866|54751603|FG001|Overall Study|Discontinued Prior to Treatment|0|||
28096518|NCT04402866|54751604|FG002|Overall Study|Discontinued Prior to Treatment|0|||
27880477|NCT01708902|54500740|FG006|Overall Study|Adverse Event|5|||
27983748|NCT00561925|54642152|FG002|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
28096519|NCT04402866|54751605|FG003|Overall Study|Discontinued Prior to Treatment|0|||
28096520|NCT04402866|54751606|FG004|Overall Study|Discontinued Prior to Treatment|2|||
27880478|NCT01708902|54500734|FG000|Overall Study|Lack of Efficacy|3|||
27880479|NCT01708902|54500735|FG001|Overall Study|Lack of Efficacy|1|||
27880480|NCT01708902|54500736|FG002|Overall Study|Lack of Efficacy|0|||
27880481|NCT01708902|54500737|FG003|Overall Study|Lack of Efficacy|0|||
27880482|NCT01708902|54500738|FG004|Overall Study|Lack of Efficacy|0|||
27880483|NCT01708902|54500739|FG005|Overall Study|Lack of Efficacy|1|||
27880484|NCT01708902|54500740|FG006|Overall Study|Lack of Efficacy|0|||
27880485|NCT01708902|54500734|FG000|Overall Study|Non compliance with protocol|0|||
27880486|NCT01708902|54500735|FG001|Overall Study|Non compliance with protocol|2|||
27880487|NCT01708902|54500736|FG002|Overall Study|Non compliance with protocol|1|||
27880488|NCT01708902|54500737|FG003|Overall Study|Non compliance with protocol|3|||
27880489|NCT01708902|54500738|FG004|Overall Study|Non compliance with protocol|0|||
27880490|NCT01708902|54500739|FG005|Overall Study|Non compliance with protocol|0|||
27880491|NCT01708902|54500740|FG006|Overall Study|Non compliance with protocol|0|||
27880492|NCT01708902|54500734|FG000|Overall Study|Lost to Follow-up|2|||
27880493|NCT01708902|54500735|FG001|Overall Study|Lost to Follow-up|1|||
27880494|NCT01708902|54500736|FG002|Overall Study|Lost to Follow-up|2|||
27880495|NCT01708902|54500737|FG003|Overall Study|Lost to Follow-up|2|||
27880496|NCT01708902|54500738|FG004|Overall Study|Lost to Follow-up|0|||
27880497|NCT01708902|54500739|FG005|Overall Study|Lost to Follow-up|0|||
27880498|NCT01708902|54500740|FG006|Overall Study|Lost to Follow-up|1|||
27880499|NCT01708902|54500734|FG000|Overall Study|Refused to continue trial medication|8|||
27880500|NCT01708902|54500735|FG001|Overall Study|Refused to continue trial medication|0|||
27880501|NCT01708902|54500736|FG002|Overall Study|Refused to continue trial medication|4|||
27880502|NCT01708902|54500737|FG003|Overall Study|Refused to continue trial medication|2|||
27880503|NCT01708902|54500738|FG004|Overall Study|Refused to continue trial medication|8|||
27880504|NCT01708902|54500739|FG005|Overall Study|Refused to continue trial medication|1|||
27880505|NCT01708902|54500740|FG006|Overall Study|Refused to continue trial medication|1|||
27880506|NCT01708902|54500734|FG000|Overall Study|Other Reason|1|||
27880507|NCT01708902|54500735|FG001|Overall Study|Other Reason|0|||
27880508|NCT01708902|54500736|FG002|Overall Study|Other Reason|1|||
27880509|NCT01708902|54500737|FG003|Overall Study|Other Reason|1|||
27880510|NCT01708902|54500738|FG004|Overall Study|Other Reason|1|||
27880511|NCT01708902|54500739|FG005|Overall Study|Other Reason|2|||
27880512|NCT01708902|54500740|FG006|Overall Study|Other Reason|0|||
27880513|NCT01755546|54500759|FG000|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1|||
27880514|NCT01755546|54500759|FG000|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3|||
27880515|NCT01755546|54500759|FG000|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1|||
27880516|NCT01755546|54500759|FG000|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5|||
27880517|NCT01755546|54500759|FG000|Titration Phase|Adverse Event|11|||
27880518|NCT01755546|54500759|FG000|Titration Phase|Lack of Efficacy|18|||
27880519|NCT01755546|54500759|FG000|Titration Phase|Protocol Violation|9|||
27880520|NCT01755546|54500759|FG000|Titration Phase|Lost to Follow-up|2|||
27880521|NCT01755546|54500759|FG000|Titration Phase|Other and Continuing|22|||
27880522|NCT01755546|54500759|FG000|Titration Phase|Withdrawal by Subject|8|||
27880523|NCT01755546|54500759|FG000|Long Term Treatment|Adverse Event|12|||
27880524|NCT01755546|54500759|FG000|Long Term Treatment|Lack of Efficacy|6|||
27880525|NCT01755546|54500759|FG000|Long Term Treatment|Protocol Violation|10|||
27880526|NCT01755546|54500759|FG000|Long Term Treatment|Withdrawal by Subject|35|||
27880527|NCT01755546|54500759|FG000|Long Term Treatment|Lost to Follow-up|17|||
27880528|NCT01755546|54500759|FG000|Long Term Treatment|other and ongoing|41|||
27880529|NCT01755234|54500765|FG000|Overall Study|Lost to Follow-up|11|||
27880530|NCT01755234|54500766|FG001|Overall Study|Lost to Follow-up|6|||
27880531|NCT01755234|54500765|FG000|Overall Study|Change in surgical case|2|||
27880532|NCT01755234|54500766|FG001|Overall Study|Change in surgical case|1|||
27880533|NCT01755234|54500765|FG000|Overall Study|case cancelled|1|||
27880534|NCT01755234|54500766|FG001|Overall Study|case cancelled|0|||
27880535|NCT01755234|54500765|FG000|Overall Study|Withdrawal by Subject|0|||
27880536|NCT01755234|54500766|FG001|Overall Study|Withdrawal by Subject|1|||
27880537|NCT01755234|54500765|FG000|Overall Study|unblinded|1|||
27880538|NCT01755234|54500766|FG001|Overall Study|unblinded|0|||
27880539|NCT01731912|54500772|FG000|Overall Study|noncompliance|2|||
27880540|NCT01731678|54500776|FG000|Overall Study|Withdrawal by Subject|3|||
27880541|NCT01731678|54500776|FG000|Overall Study|Did not meet inclusion criteria|1|||
27880542|NCT01731678|54500776|FG000|Overall Study|RMT too high, making TMS difficult|3|||
27880543|NCT01731600|54500782|FG000|Overall Study|Adverse Event|2|||
27880544|NCT01731600|54500783|FG001|Overall Study|Adverse Event|0|||
27880545|NCT01731600|54500782|FG000|Overall Study|Withdrawal criteria|1|||
27880546|NCT01731600|54500783|FG001|Overall Study|Withdrawal criteria|0|||
27880547|NCT01731600|54500782|FG000|Overall Study|Other reasons|3|||
27880548|NCT01731600|54500783|FG001|Overall Study|Other reasons|0|||
27880549|NCT01730586|54500793|FG000|Overall Study|Progressive Disease|2|||
27880550|NCT01730586|54500793|FG000|Overall Study|Inadequate Trial|8|||
27880551|NCT01730586|54500793|FG000|Overall Study|Adverse Event|2|||
27880552|NCT01730586|54500793|FG000|Overall Study|Hospice|1|||
27880553|NCT01707030|54500801|FG000|Overall Study|Death|1|||
27880554|NCT01707030|54500802|FG001|Overall Study|Death|1|||
27880555|NCT01707030|54500801|FG000|Overall Study|Withdrawal by Subject|2|||
27880556|NCT01707030|54500802|FG001|Overall Study|Withdrawal by Subject|3|||
27880557|NCT01707030|54500801|FG000|Overall Study|Lost to Follow-up|8|||
27880558|NCT01707030|54500802|FG001|Overall Study|Lost to Follow-up|13|||
27880559|NCT01755156|54500814|FG000|Phase A (Weeks 0-24)|Adverse Event|2|||
27880560|NCT01755156|54500815|FG001|Phase A (Weeks 0-24)|Adverse Event|3|||
27880561|NCT01755156|54500814|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|1|||
27880562|NCT01755156|54500815|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|0|||
27880563|NCT01755156|54500814|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
27880564|NCT01755156|54500815|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|3|||
27880565|NCT01755156|54500814|FG000|Phase A (Weeks 0-24)|Non-compliance with study drug|1|||
27880566|NCT01755156|54500815|FG001|Phase A (Weeks 0-24)|Non-compliance with study drug|0|||
27880567|NCT01755156|54500814|FG000|Phase A (Weeks 0-24)|Physician Decision|0|||
27880568|NCT01755156|54500815|FG001|Phase A (Weeks 0-24)|Physician Decision|1|||
27880569|NCT01755156|54500814|FG000|Phase A (Weeks 0-24)|Protocol Violation|1|||
27880570|NCT01755156|54500815|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
27880571|NCT01755156|54500814|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|6|||
27880572|NCT01755156|54500815|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|13|||
27880573|NCT01755156|54500814|FG000|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0|||
27880574|NCT01755156|54500815|FG001|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2|||
27880575|NCT01755156|54500814|FG000|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
27880576|NCT01755156|54500815|FG001|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
27880577|NCT01755156|54500814|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|12|||
27880578|NCT01755156|54500815|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|5|||
27880579|NCT01755156|54500814|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|27|||
27880580|NCT01755156|54500815|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|31|||
27880581|NCT01754922|54500827|FG000|Overall Study|Adverse Event|0|||
27880582|NCT01754922|54500828|FG001|Overall Study|Adverse Event|1|||
27880583|NCT01754766|54500838|FG000|Overall Study|Personal reasons|1|||
27880584|NCT01754766|54500839|FG001|Overall Study|Personal reasons|1|||
27880585|NCT01754766|54500840|FG002|Overall Study|Personal reasons|0|||
27880586|NCT01754376|54500848|FG000|Overall Study|Adverse Event|1|||
27880587|NCT01754376|54500848|FG000|Overall Study|Lack of Efficacy|2|||
27880588|NCT01605396|54500855|FG000|Overall Study|Adverse Event|5|||
27880589|NCT01605396|54500856|FG001|Overall Study|Adverse Event|3|||
27880590|NCT01605396|54500855|FG000|Overall Study|Lost to Follow-up|1|||
27880591|NCT01605396|54500856|FG001|Overall Study|Lost to Follow-up|0|||
27880592|NCT01605396|54500855|FG000|Overall Study|Non-Compliance With Study Drug|1|||
27880593|NCT01605396|54500856|FG001|Overall Study|Non-Compliance With Study Drug|1|||
27880594|NCT01605396|54500855|FG000|Overall Study|Physician Decision|2|||
27880595|NCT01605396|54500856|FG001|Overall Study|Physician Decision|2|||
27880596|NCT01605396|54500855|FG000|Overall Study|Progressive Disease|23|||
27880597|NCT01605396|54500856|FG001|Overall Study|Progressive Disease|27|||
27880598|NCT01605396|54500855|FG000|Overall Study|Withdrawal by Subject|4|||
27880599|NCT01605396|54500856|FG001|Overall Study|Withdrawal by Subject|2|||
27880600|NCT01605396|54500855|FG000|Overall Study|Transfer Off Study|4|||
27880601|NCT01605396|54500856|FG001|Overall Study|Transfer Off Study|5|||
27880602|NCT01730118|54500869|FG000|Dose Escalation|Death on study|5|||
27880603|NCT01730118|54500870|FG001|Dose Escalation|Death on study|7|||
27880604|NCT01730118|54500871|FG002|Dose Escalation|Death on study|2|||
27880605|NCT01730118|54500872|FG003|Dose Escalation|Death on study|6|||
27880606|NCT01730118|54500873|FG004|Dose Escalation|Death on study|0|||
27880607|NCT01730118|54500874|FG005|Dose Escalation|Death on study|0|||
27880608|NCT01730118|54500875|FG006|Dose Escalation|Death on study|0|||
27880609|NCT01730118|54500869|FG000|Dose Escalation|Died before treatment|0|||
27880610|NCT01730118|54500870|FG001|Dose Escalation|Died before treatment|0|||
27880611|NCT01730118|54500871|FG002|Dose Escalation|Died before treatment|0|||
27880612|NCT01730118|54500872|FG003|Dose Escalation|Died before treatment|0|||
27880613|NCT01730118|54500873|FG004|Dose Escalation|Died before treatment|0|||
27880614|NCT01730118|54500874|FG005|Dose Escalation|Died before treatment|0|||
27880615|NCT01730118|54500875|FG006|Dose Escalation|Died before treatment|1|||
27880616|NCT01730118|54500869|FG000|Dose Escalation|Chose to start a different treatment|1|||
27880617|NCT01730118|54500870|FG001|Dose Escalation|Chose to start a different treatment|0|||
27880618|NCT01730118|54500871|FG002|Dose Escalation|Chose to start a different treatment|0|||
27880619|NCT01730118|54500872|FG003|Dose Escalation|Chose to start a different treatment|0|||
27983749|NCT00561925|54642153|FG003|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
27983750|NCT00561925|54642154|FG004|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
27880620|NCT01730118|54500873|FG004|Dose Escalation|Chose to start a different treatment|0|||
27880621|NCT01730118|54500874|FG005|Dose Escalation|Chose to start a different treatment|0|||
27880622|NCT01730118|54500875|FG006|Dose Escalation|Chose to start a different treatment|0|||
27880623|NCT01730118|54500869|FG000|Dose Escalation|Withdrawal by Subject|0|||
27880624|NCT01730118|54500870|FG001|Dose Escalation|Withdrawal by Subject|0|||
27880625|NCT01730118|54500871|FG002|Dose Escalation|Withdrawal by Subject|1|||
27880626|NCT01730118|54500872|FG003|Dose Escalation|Withdrawal by Subject|0|||
27880627|NCT01730118|54500873|FG004|Dose Escalation|Withdrawal by Subject|0|||
27880628|NCT01730118|54500874|FG005|Dose Escalation|Withdrawal by Subject|0|||
27880629|NCT01730118|54500875|FG006|Dose Escalation|Withdrawal by Subject|0|||
27880630|NCT01730118|54500869|FG000|Dose Escalation|Disease progression prior to treatment|0|||
27880631|NCT01730118|54500870|FG001|Dose Escalation|Disease progression prior to treatment|0|||
27880632|NCT01730118|54500871|FG002|Dose Escalation|Disease progression prior to treatment|0|||
27880633|NCT01730118|54500872|FG003|Dose Escalation|Disease progression prior to treatment|0|||
27880634|NCT01730118|54500873|FG004|Dose Escalation|Disease progression prior to treatment|0|||
27880635|NCT01730118|54500874|FG005|Dose Escalation|Disease progression prior to treatment|0|||
27880636|NCT01730118|54500875|FG006|Dose Escalation|Disease progression prior to treatment|1|||
27880637|NCT01730118|54500869|FG000|Dose Expansion|Death|0|||
27880638|NCT01730118|54500870|FG001|Dose Expansion|Death|0|||
27880639|NCT01730118|54500871|FG002|Dose Expansion|Death|0|||
27880640|NCT01730118|54500872|FG003|Dose Expansion|Death|0|||
27880641|NCT01730118|54500873|FG004|Dose Expansion|Death|1|||
27880642|NCT01730118|54500874|FG005|Dose Expansion|Death|0|||
27880643|NCT01730118|54500875|FG006|Dose Expansion|Death|0|||
27880644|NCT01730118|54500869|FG000|Dose Expansion|Other medical condition|0|||
27880645|NCT01730118|54500870|FG001|Dose Expansion|Other medical condition|0|||
27880646|NCT01730118|54500871|FG002|Dose Expansion|Other medical condition|0|||
27880647|NCT01730118|54500872|FG003|Dose Expansion|Other medical condition|0|||
27880648|NCT01730118|54500873|FG004|Dose Expansion|Other medical condition|1|||
27880649|NCT01730118|54500874|FG005|Dose Expansion|Other medical condition|0|||
27880650|NCT01730118|54500875|FG006|Dose Expansion|Other medical condition|0|||
27880651|NCT01730118|54500869|FG000|Dose Expansion|Withdrawal by Subject|0|||
27880652|NCT01730118|54500870|FG001|Dose Expansion|Withdrawal by Subject|0|||
27880653|NCT01730118|54500871|FG002|Dose Expansion|Withdrawal by Subject|0|||
27880654|NCT01730118|54500872|FG003|Dose Expansion|Withdrawal by Subject|0|||
27880655|NCT01730118|54500873|FG004|Dose Expansion|Withdrawal by Subject|1|||
27880656|NCT01730118|54500874|FG005|Dose Expansion|Withdrawal by Subject|0|||
27880657|NCT01730118|54500875|FG006|Dose Expansion|Withdrawal by Subject|0|||
27880658|NCT01730118|54500869|FG000|Dose Expansion|Disease progression|0|||
27880659|NCT01730118|54500870|FG001|Dose Expansion|Disease progression|0|||
27880660|NCT01730118|54500871|FG002|Dose Expansion|Disease progression|0|||
27880661|NCT01730118|54500872|FG003|Dose Expansion|Disease progression|0|||
27880662|NCT01730118|54500873|FG004|Dose Expansion|Disease progression|0|||
27880663|NCT01730118|54500874|FG005|Dose Expansion|Disease progression|1|||
27880664|NCT01730118|54500875|FG006|Dose Expansion|Disease progression|0|||
27880665|NCT01730118|54500869|FG000|Dose Expansion|Inability to return|0|||
27880666|NCT01730118|54500870|FG001|Dose Expansion|Inability to return|0|||
27880667|NCT01730118|54500871|FG002|Dose Expansion|Inability to return|0|||
27880668|NCT01730118|54500872|FG003|Dose Expansion|Inability to return|0|||
27880669|NCT01730118|54500873|FG004|Dose Expansion|Inability to return|0|||
27880670|NCT01730118|54500874|FG005|Dose Expansion|Inability to return|1|||
27880671|NCT01730118|54500875|FG006|Dose Expansion|Inability to return|0|||
27880672|NCT01730118|54500869|FG000|Dose Expansion|Physician Decision|0|||
27880673|NCT01730118|54500870|FG001|Dose Expansion|Physician Decision|0|||
27880674|NCT01730118|54500871|FG002|Dose Expansion|Physician Decision|0|||
27880675|NCT01730118|54500872|FG003|Dose Expansion|Physician Decision|0|||
27880676|NCT01730118|54500873|FG004|Dose Expansion|Physician Decision|0|||
27880677|NCT01730118|54500874|FG005|Dose Expansion|Physician Decision|1|||
27880678|NCT01730118|54500875|FG006|Dose Expansion|Physician Decision|0|||
27880679|NCT01730040|54500899|FG000|Overall Study|Randomized but not treated|0|||
27880680|NCT01730040|54500900|FG001|Overall Study|Randomized but not treated|0|||
27880681|NCT01730040|54500901|FG002|Overall Study|Randomized but not treated|0|||
27880682|NCT01730040|54500902|FG003|Overall Study|Randomized but not treated|0|||
27880683|NCT01730040|54500903|FG004|Overall Study|Randomized but not treated|0|||
27880684|NCT01730040|54500904|FG005|Overall Study|Randomized but not treated|1|||
27880685|NCT01730040|54500905|FG006|Overall Study|Randomized but not treated|0|||
27880686|NCT01730040|54500899|FG000|Overall Study|Subject moved|0|||
27880687|NCT01730040|54500900|FG001|Overall Study|Subject moved|0|||
27880688|NCT01730040|54500901|FG002|Overall Study|Subject moved|1|||
27880689|NCT01730040|54500902|FG003|Overall Study|Subject moved|0|||
27880690|NCT01730040|54500903|FG004|Overall Study|Subject moved|0|||
27880691|NCT01730040|54500904|FG005|Overall Study|Subject moved|0|||
27880692|NCT01730040|54500905|FG006|Overall Study|Subject moved|1|||
27880693|NCT01730040|54500899|FG000|Overall Study|Physician Decision|0|||
27880694|NCT01730040|54500900|FG001|Overall Study|Physician Decision|0|||
27983751|NCT00561925|54642150|FG000|144-week Double-blind, Double-dummy|Other|0|||
27983752|NCT00561925|54642151|FG001|144-week Double-blind, Double-dummy|Other|8|||
27983753|NCT00561925|54642152|FG002|144-week Double-blind, Double-dummy|Other|11|||
27880695|NCT01730040|54500901|FG002|Overall Study|Physician Decision|0|||
27880696|NCT01730040|54500902|FG003|Overall Study|Physician Decision|0|||
27880697|NCT01730040|54500903|FG004|Overall Study|Physician Decision|0|||
27880698|NCT01730040|54500904|FG005|Overall Study|Physician Decision|1|||
27880699|NCT01730040|54500905|FG006|Overall Study|Physician Decision|1|||
27880700|NCT01730040|54500899|FG000|Overall Study|Other than specified|7|||
27880701|NCT01730040|54500900|FG001|Overall Study|Other than specified|8|||
27880702|NCT01730040|54500901|FG002|Overall Study|Other than specified|5|||
27880703|NCT01730040|54500902|FG003|Overall Study|Other than specified|5|||
27880704|NCT01730040|54500903|FG004|Overall Study|Other than specified|5|||
27880705|NCT01730040|54500904|FG005|Overall Study|Other than specified|4|||
27880706|NCT01730040|54500905|FG006|Overall Study|Other than specified|4|||
27880707|NCT01730040|54500899|FG000|Overall Study|Adverse Event|4|||
27880708|NCT01730040|54500900|FG001|Overall Study|Adverse Event|3|||
27880709|NCT01730040|54500901|FG002|Overall Study|Adverse Event|5|||
27880710|NCT01730040|54500902|FG003|Overall Study|Adverse Event|3|||
27880711|NCT01730040|54500903|FG004|Overall Study|Adverse Event|1|||
27880712|NCT01730040|54500904|FG005|Overall Study|Adverse Event|1|||
27880713|NCT01730040|54500905|FG006|Overall Study|Adverse Event|2|||
27880714|NCT01730040|54500899|FG000|Overall Study|Poor compliance to protocol|2|||
27880715|NCT01730040|54500900|FG001|Overall Study|Poor compliance to protocol|4|||
27880716|NCT01730040|54500901|FG002|Overall Study|Poor compliance to protocol|0|||
27880717|NCT01730040|54500902|FG003|Overall Study|Poor compliance to protocol|0|||
27880718|NCT01730040|54500903|FG004|Overall Study|Poor compliance to protocol|0|||
27880719|NCT01730040|54500904|FG005|Overall Study|Poor compliance to protocol|0|||
27880720|NCT01730040|54500905|FG006|Overall Study|Poor compliance to protocol|1|||
27880721|NCT01706328|54500923|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140|||
27880722|NCT01706328|54500924|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
27880723|NCT01706328|54500925|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
27880724|NCT01706328|54500923|FG000|2-week Run-in Period|Withdrawal by Subject|15|||
27880725|NCT01706328|54500924|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
27880726|NCT01706328|54500925|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
27880727|NCT01706328|54500923|FG000|2-week Run-in Period|Physician Decision|4|||
27880728|NCT01706328|54500924|FG001|2-week Run-in Period|Physician Decision|0|||
27880729|NCT01706328|54500925|FG002|2-week Run-in Period|Physician Decision|0|||
27880730|NCT01706328|54500923|FG000|2-week Run-in Period|Adverse Event|4|||
27880731|NCT01706328|54500924|FG001|2-week Run-in Period|Adverse Event|0|||
27880732|NCT01706328|54500925|FG002|2-week Run-in Period|Adverse Event|0|||
27880733|NCT01706328|54500923|FG000|2-week Run-in Period|Lost to Follow-up|2|||
27880734|NCT01706328|54500924|FG001|2-week Run-in Period|Lost to Follow-up|0|||
27880735|NCT01706328|54500925|FG002|2-week Run-in Period|Lost to Follow-up|0|||
27880736|NCT01706328|54500923|FG000|12-week Double-blind Treatment Period|Adverse Event|0|||
27880737|NCT01706328|54500924|FG001|12-week Double-blind Treatment Period|Adverse Event|14|||
27880738|NCT01706328|54500925|FG002|12-week Double-blind Treatment Period|Adverse Event|16|||
27880739|NCT01706328|54500923|FG000|12-week Double-blind Treatment Period|Lack of Efficacy|0|||
27880740|NCT01706328|54500924|FG001|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
27880741|NCT01706328|54500925|FG002|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
27880742|NCT01706328|54500923|FG000|12-week Double-blind Treatment Period|Protocol Violation|0|||
27880743|NCT01706328|54500924|FG001|12-week Double-blind Treatment Period|Protocol Violation|4|||
27880744|NCT01706328|54500925|FG002|12-week Double-blind Treatment Period|Protocol Violation|2|||
27880745|NCT01706328|54500923|FG000|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0|||
27880746|NCT01706328|54500924|FG001|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11|||
27880747|NCT01706328|54500925|FG002|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9|||
27880748|NCT01706328|54500923|FG000|12-week Double-blind Treatment Period|Lost to Follow-up|0|||
27880749|NCT01706328|54500924|FG001|12-week Double-blind Treatment Period|Lost to Follow-up|3|||
27880750|NCT01706328|54500925|FG002|12-week Double-blind Treatment Period|Lost to Follow-up|1|||
27880751|NCT01706328|54500923|FG000|12-week Double-blind Treatment Period|Physician Decision|0|||
27880752|NCT01706328|54500924|FG001|12-week Double-blind Treatment Period|Physician Decision|2|||
27880753|NCT01706328|54500925|FG002|12-week Double-blind Treatment Period|Physician Decision|2|||
27880754|NCT01706328|54500923|FG000|12-week Double-blind Treatment Period|Withdrawal by Subject|0|||
27880755|NCT01706328|54500924|FG001|12-week Double-blind Treatment Period|Withdrawal by Subject|8|||
27880756|NCT01706328|54500925|FG002|12-week Double-blind Treatment Period|Withdrawal by Subject|11|||
27880757|NCT01753518|54500933|FG000|Intention-to-Treat Analysis|Missing consent form|5|||
27880758|NCT01753518|54500934|FG001|Intention-to-Treat Analysis|Missing consent form|3|||
27880759|NCT01753518|54500933|FG000|Intention-to-Treat Analysis|Multifetal gestation|2|||
27880760|NCT01753518|54500934|FG001|Intention-to-Treat Analysis|Multifetal gestation|3|||
27880761|NCT01753518|54500933|FG000|Intention-to-Treat Analysis|Body Mass Index>50|0|||
27880762|NCT01753518|54500934|FG001|Intention-to-Treat Analysis|Body Mass Index>50|1|||
27880763|NCT01753518|54500933|FG000|Postpartum Follow-up|Lost to Follow-up|22|||
27880764|NCT01753518|54500934|FG001|Postpartum Follow-up|Lost to Follow-up|15|||
27880765|NCT01706250|54500940|FG000|Overall Study|Lost to Follow-up|2|||
27880766|NCT01729728|54500952|FG000|Overall Study|Adverse Event|0|||
27880767|NCT01729728|54500953|FG001|Overall Study|Adverse Event|6|||
27880768|NCT01729728|54500954|FG002|Overall Study|Adverse Event|0|||
27983754|NCT00561925|54642153|FG003|144-week Double-blind, Double-dummy|Other|0|||
27880769|NCT01729728|54500952|FG000|Overall Study|Protocol Violation|1|||
27880770|NCT01729728|54500953|FG001|Overall Study|Protocol Violation|0|||
27880771|NCT01729728|54500954|FG002|Overall Study|Protocol Violation|1|||
27880772|NCT01729026|54501087|FG000|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
27880773|NCT01729026|54501088|FG001|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
27880774|NCT01729026|54501087|FG000|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1|||
27983755|NCT00561925|54642154|FG004|144-week Double-blind, Double-dummy|Other|0|||
27880775|NCT01729026|54501088|FG001|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2|||
27880776|NCT01728792|54501102|FG000|Overall Study|Withdrawal of Consent|1|||
27880777|NCT01728792|54501103|FG001|Overall Study|Withdrawal of Consent|1|||
27880778|NCT01728792|54501104|FG002|Overall Study|Withdrawal of Consent|0|||
27880779|NCT01728792|54501105|FG003|Overall Study|Withdrawal of Consent|1|||
27880780|NCT01728792|54501106|FG004|Overall Study|Withdrawal of Consent|0|||
27880781|NCT01728792|54501102|FG000|Overall Study|Lost to Follow-up|2|||
27880782|NCT01728792|54501103|FG001|Overall Study|Lost to Follow-up|1|||
27880783|NCT01728792|54501104|FG002|Overall Study|Lost to Follow-up|4|||
27880784|NCT01728792|54501105|FG003|Overall Study|Lost to Follow-up|2|||
27880785|NCT01728792|54501106|FG004|Overall Study|Lost to Follow-up|0|||
27880786|NCT01752036|54501118|FG000|Overall Study|Death|2|||
27880787|NCT01728324|54501126|FG000|Termination of DBV|Adverse Event|14|||
27880788|NCT01728324|54501127|FG001|Termination of DBV|Adverse Event|13|||
27880789|NCT01728324|54501128|FG002|Termination of DBV|Adverse Event|4|||
27880790|NCT01728324|54501126|FG000|Termination of DBV|Lack of Efficacy|14|||
27880791|NCT01728324|54501127|FG001|Termination of DBV|Lack of Efficacy|12|||
27880792|NCT01728324|54501128|FG002|Termination of DBV|Lack of Efficacy|8|||
27880793|NCT01728324|54501126|FG000|Termination of DBV|Withdrawal by Subject|9|||
27880794|NCT01728324|54501127|FG001|Termination of DBV|Withdrawal by Subject|6|||
27880795|NCT01728324|54501128|FG002|Termination of DBV|Withdrawal by Subject|2|||
27880796|NCT01728324|54501126|FG000|Termination of DBV|Other than stated|1|||
27880797|NCT01728324|54501127|FG001|Termination of DBV|Other than stated|3|||
27880798|NCT01728324|54501128|FG002|Termination of DBV|Other than stated|0|||
27880799|NCT01728324|54501126|FG000|Termination of DBV|Adverse Event (Placebo Period)|0|||
27880800|NCT01728324|54501127|FG001|Termination of DBV|Adverse Event (Placebo Period)|1|||
27880801|NCT01728324|54501128|FG002|Termination of DBV|Adverse Event (Placebo Period)|0|||
27880802|NCT01728324|54501126|FG000|Termination of DBV|Protocol Violation (Placebo Period)|0|||
27880803|NCT01728324|54501127|FG001|Termination of DBV|Protocol Violation (Placebo Period)|1|||
27880804|NCT01728324|54501128|FG002|Termination of DBV|Protocol Violation (Placebo Period)|0|||
27880805|NCT01728324|54501126|FG000|Termination of FDV|Adverse Event|14|||
27880806|NCT01728324|54501127|FG001|Termination of FDV|Adverse Event|13|||
27880807|NCT01728324|54501128|FG002|Termination of FDV|Adverse Event|4|||
27880808|NCT01728324|54501126|FG000|Termination of FDV|Lack of Efficacy|14|||
27880809|NCT01728324|54501127|FG001|Termination of FDV|Lack of Efficacy|12|||
27880810|NCT01728324|54501128|FG002|Termination of FDV|Lack of Efficacy|8|||
27880811|NCT01728324|54501126|FG000|Termination of FDV|Withdrawal by Subject|9|||
27880812|NCT01728324|54501127|FG001|Termination of FDV|Withdrawal by Subject|6|||
27880813|NCT01728324|54501128|FG002|Termination of FDV|Withdrawal by Subject|2|||
27880814|NCT01728324|54501126|FG000|Termination of FDV|Other than stated|1|||
27880815|NCT01728324|54501127|FG001|Termination of FDV|Other than stated|3|||
27880816|NCT01728324|54501128|FG002|Termination of FDV|Other than stated|0|||
27880817|NCT01728324|54501126|FG000|Termination of FDV|Adverse Event (Placebo Period)|0|||
27880818|NCT01728324|54501127|FG001|Termination of FDV|Adverse Event (Placebo Period)|1|||
27880819|NCT01728324|54501128|FG002|Termination of FDV|Adverse Event (Placebo Period)|0|||
27880820|NCT01728324|54501126|FG000|Termination of FDV|Protocol Violation (Placebo Period)|0|||
27880821|NCT01728324|54501127|FG001|Termination of FDV|Protocol Violation (Placebo Period)|1|||
27880822|NCT01728324|54501128|FG002|Termination of FDV|Protocol Violation (Placebo Period)|0|||
27880823|NCT01728324|54501126|FG000|Termination of RBV|Adverse Event|15|||
27880824|NCT01728324|54501127|FG001|Termination of RBV|Adverse Event|16|||
27880825|NCT01728324|54501128|FG002|Termination of RBV|Adverse Event|5|||
27880826|NCT01728324|54501126|FG000|Termination of RBV|Lack of Efficacy|14|||
27880827|NCT01728324|54501127|FG001|Termination of RBV|Lack of Efficacy|11|||
27880828|NCT01728324|54501128|FG002|Termination of RBV|Lack of Efficacy|7|||
27880829|NCT01728324|54501126|FG000|Termination of RBV|Withdrawal by Subject|9|||
27880830|NCT01728324|54501127|FG001|Termination of RBV|Withdrawal by Subject|5|||
27880831|NCT01728324|54501128|FG002|Termination of RBV|Withdrawal by Subject|2|||
27880832|NCT01728324|54501126|FG000|Termination of RBV|Other than stated|1|||
27880833|NCT01728324|54501127|FG001|Termination of RBV|Other than stated|3|||
27880834|NCT01728324|54501128|FG002|Termination of RBV|Other than stated|1|||
27880835|NCT01728324|54501126|FG000|Termination of RBV|Adverse Event (Placebo Period)|0|||
27880836|NCT01728324|54501127|FG001|Termination of RBV|Adverse Event (Placebo Period)|1|||
27880837|NCT01728324|54501128|FG002|Termination of RBV|Adverse Event (Placebo Period)|0|||
27880838|NCT01728324|54501126|FG000|Termination of RBV|Protocol Violation (Placebo Period)|0|||
27880839|NCT01728324|54501127|FG001|Termination of RBV|Protocol Violation (Placebo Period)|1|||
27880840|NCT01728324|54501128|FG002|Termination of RBV|Protocol Violation (Placebo Period)|0|||
27880841|NCT01728246|54501140|FG000|Overall Study|Participant needed rescue medication|1|||
27880842|NCT01728246|54501141|FG001|Overall Study|Participant needed rescue medication|5|||
27880843|NCT01728246|54501140|FG000|Overall Study|Protocol Violation|1|||
27880844|NCT01728246|54501141|FG001|Overall Study|Protocol Violation|0|||
27880845|NCT01728246|54501140|FG000|Overall Study|Withdrawal by Subject|2|||
27880846|NCT01728246|54501141|FG001|Overall Study|Withdrawal by Subject|3|||
27880847|NCT01728246|54501140|FG000|Overall Study|Lost to Follow-up|23|||
27880848|NCT01728246|54501141|FG001|Overall Study|Lost to Follow-up|22|||
27880849|NCT01728246|54501140|FG000|Overall Study|Lack of Efficacy|1|||
27880850|NCT01728246|54501141|FG001|Overall Study|Lack of Efficacy|1|||
27880851|NCT01728246|54501140|FG000|Overall Study|Adverse Event|8|||
27880852|NCT01728246|54501141|FG001|Overall Study|Adverse Event|5|||
27880853|NCT01705236|54501147|FG000|Overall Study|Lost to Follow-up|1|||
27880854|NCT01705236|54501147|FG000|Overall Study|Administrative problems|2|||
27880855|NCT01705236|54501147|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
27880856|NCT01705236|54501147|FG000|Overall Study|Protocol Violation|3|||
27880857|NCT01705236|54501147|FG000|Overall Study|Abnormal test procedure result(s)|4|||
27880858|NCT01705236|54501147|FG000|Overall Study|Abnormal laboratory value(s)|4|||
27880859|NCT01705236|54501147|FG000|Overall Study|Withdrawal by Subject|5|||
27880860|NCT01705236|54501147|FG000|Overall Study|Adverse Event|5|||
27880861|NCT01705080|54501154|FG000|Overall Study|Missed visit|10|||
27880862|NCT01705080|54501155|FG001|Overall Study|Missed visit|4|||
27880863|NCT01705080|54501156|FG002|Overall Study|Missed visit|1|||
27880864|NCT01705080|54501154|FG000|Overall Study|Death|4|||
27880865|NCT01705080|54501155|FG001|Overall Study|Death|4|||
27880866|NCT01705080|54501156|FG002|Overall Study|Death|6|||
27880867|NCT01705080|54501154|FG000|Overall Study|Withdrawal by Subject|61|||
27880868|NCT01705080|54501155|FG001|Overall Study|Withdrawal by Subject|44|||
27880869|NCT01705080|54501156|FG002|Overall Study|Withdrawal by Subject|9|||
27880870|NCT01704846|54501166|FG000|Treatment Period 2|Withdrawal by Subject|0|||
27880871|NCT01704846|54501167|FG001|Treatment Period 2|Withdrawal by Subject|1|||
27880872|NCT01751802|54501175|FG000|Overall Study|Adverse Event|4|||
27880873|NCT01751802|54501176|FG001|Overall Study|Adverse Event|2|||
27880874|NCT01704456|54501190|FG000|Overall Study|Lost to Follow-up|8|||
27880875|NCT01704456|54501191|FG001|Overall Study|Lost to Follow-up|14|||
27880876|NCT01703988|54501201|FG000|Overall Study|Investigator Judgment|0|||
27880877|NCT01703988|54501202|FG001|Overall Study|Investigator Judgment|0|||
27880878|NCT01703988|54501203|FG002|Overall Study|Investigator Judgment|0|||
27880879|NCT01703988|54501204|FG003|Overall Study|Investigator Judgment|1|||
27880880|NCT01703832|54501217|FG000|Overall Study|Withdrawal by Subject|1|||
27880881|NCT01703832|54501218|FG001|Overall Study|Withdrawal by Subject|0|||
27880882|NCT01703286|54501224|FG000|Period 1 Including Washout|Withdrawal by Subject|0|||
27880883|NCT01703286|54501225|FG001|Period 1 Including Washout|Withdrawal by Subject|0|||
27880884|NCT01703286|54501226|FG002|Period 1 Including Washout|Withdrawal by Subject|0|||
27880885|NCT01703286|54501227|FG003|Period 1 Including Washout|Withdrawal by Subject|1|||
27880886|NCT01703286|54501228|FG004|Period 1 Including Washout|Withdrawal by Subject|0|||
27880887|NCT01703286|54501229|FG005|Period 1 Including Washout|Withdrawal by Subject|1|||
27880888|NCT01703286|54501224|FG000|Period 2 Including Washout|Adverse Event|0|||
27880889|NCT01703286|54501225|FG001|Period 2 Including Washout|Adverse Event|0|||
27880890|NCT01703286|54501226|FG002|Period 2 Including Washout|Adverse Event|0|||
27880891|NCT01703286|54501227|FG003|Period 2 Including Washout|Adverse Event|1|||
27880892|NCT01703286|54501228|FG004|Period 2 Including Washout|Adverse Event|0|||
27880893|NCT01703286|54501229|FG005|Period 2 Including Washout|Adverse Event|0|||
27880894|NCT01703208|54501242|FG000|Overall Study|Death|61|||
27880895|NCT01703208|54501243|FG001|Overall Study|Death|48|||
27880896|NCT01703208|54501242|FG000|Overall Study|Lack of Efficacy|1|||
27880897|NCT01703208|54501243|FG001|Overall Study|Lack of Efficacy|2|||
27880898|NCT01703208|54501242|FG000|Overall Study|Lost to Follow-up|68|||
27880899|NCT01703208|54501243|FG001|Overall Study|Lost to Follow-up|62|||
27880900|NCT01703208|54501242|FG000|Overall Study|Non-Compliance with Study Drug|1|||
27880901|NCT01703208|54501243|FG001|Overall Study|Non-Compliance with Study Drug|0|||
27880902|NCT01703208|54501242|FG000|Overall Study|Excluded Medication|1|||
27880903|NCT01703208|54501243|FG001|Overall Study|Excluded Medication|2|||
27880904|NCT01703208|54501242|FG000|Overall Study|Site Discontinued Study Participation|23|||
27880905|NCT01703208|54501243|FG001|Overall Study|Site Discontinued Study Participation|27|||
27880906|NCT01703208|54501242|FG000|Overall Study|Physician Decision|11|||
27880907|NCT01703208|54501243|FG001|Overall Study|Physician Decision|13|||
27880908|NCT01703208|54501242|FG000|Overall Study|Progressive disease|2|||
27880909|NCT01703208|54501243|FG001|Overall Study|Progressive disease|2|||
27880910|NCT01703208|54501242|FG000|Overall Study|Protocol Violation|1|||
27880911|NCT01703208|54501243|FG001|Overall Study|Protocol Violation|1|||
27880912|NCT01703208|54501242|FG000|Overall Study|Study Terminated by Sponsor|1710|||
27880913|NCT01703208|54501243|FG001|Overall Study|Study Terminated by Sponsor|1716|||
28096521|NCT04402866|54751607|FG005|Overall Study|Discontinued Prior to Treatment|3|||
27880914|NCT01703208|54501242|FG000|Overall Study|Withdrawal by Subject|205|||
27880915|NCT01703208|54501243|FG001|Overall Study|Withdrawal by Subject|209|||
27880916|NCT01703208|54501242|FG000|Overall Study|Adverse Event|14|||
27880917|NCT01703208|54501243|FG001|Overall Study|Adverse Event|19|||
28096522|NCT04402866|54751602|FG000|Overall Study|Adverse Event|2|||
28171738|NCT02442778|54843316|FG000|Overall Study|Non-compliance with study drug|2|||
27880918|NCT01703208|54501242|FG000|Overall Study|Technical Problems|0|||
27880919|NCT01703208|54501243|FG001|Overall Study|Technical Problems|1|||
27880920|NCT01703208|54501242|FG000|Overall Study|Protocol Deviation|2|||
27880921|NCT01703208|54501243|FG001|Overall Study|Protocol Deviation|0|||
27880922|NCT01727700|54501252|FG000|Overall Study|Adverse Event|0|||
27880923|NCT01727700|54501253|FG001|Overall Study|Adverse Event|7|||
27880924|NCT01727700|54501254|FG002|Overall Study|Adverse Event|1|||
27880925|NCT01727700|54501252|FG000|Overall Study|Particpant withdrew consent|0|||
27880926|NCT01727700|54501253|FG001|Overall Study|Particpant withdrew consent|3|||
27880927|NCT01727700|54501254|FG002|Overall Study|Particpant withdrew consent|1|||
27880928|NCT01727700|54501252|FG000|Overall Study|Protocol Violation|2|||
27880929|NCT01727700|54501253|FG001|Overall Study|Protocol Violation|0|||
27880930|NCT01727700|54501254|FG002|Overall Study|Protocol Violation|0|||
27880931|NCT01727154|54501262|FG000|Overall Study|Death|17|||
27880932|NCT01727154|54501262|FG000|Overall Study|Withdrawal by Subject|14|||
27880933|NCT01727154|54501262|FG000|Overall Study|Subject Withdrew Consent|18|||
27880934|NCT01727154|54501262|FG000|Overall Study|Study Terminated|6|||
27880935|NCT01727154|54501262|FG000|Overall Study|No Discontinuation Documentation|4|||
27880936|NCT01725750|54501268|FG000|Overall Study|Adverse Event|1|||
27880937|NCT01725750|54501269|FG001|Overall Study|Adverse Event|0|||
27880938|NCT01725750|54501268|FG000|Overall Study|Lost to Follow-up|1|||
27880939|NCT01725750|54501269|FG001|Overall Study|Lost to Follow-up|1|||
27880940|NCT01725750|54501268|FG000|Overall Study|Withdrawal by Subject|0|||
27880941|NCT01725750|54501269|FG001|Overall Study|Withdrawal by Subject|9|||
27880942|NCT01725282|54501281|FG000|Overall Study|Adverse Event|1|||
27880943|NCT01725282|54501282|FG001|Overall Study|Adverse Event|3|||
27880944|NCT01725282|54501283|FG002|Overall Study|Adverse Event|6|||
27880945|NCT01725282|54501284|FG003|Overall Study|Adverse Event|4|||
27880946|NCT01725282|54501281|FG000|Overall Study|Exacerbation of Target Disease|1|||
27880947|NCT01725282|54501282|FG001|Overall Study|Exacerbation of Target Disease|0|||
27880948|NCT01725282|54501283|FG002|Overall Study|Exacerbation of Target Disease|0|||
27880949|NCT01725282|54501284|FG003|Overall Study|Exacerbation of Target Disease|1|||
27880950|NCT01725282|54501281|FG000|Overall Study|Met Exclusion Criteria|0|||
27880951|NCT01725282|54501282|FG001|Overall Study|Met Exclusion Criteria|0|||
27880952|NCT01725282|54501283|FG002|Overall Study|Met Exclusion Criteria|1|||
27880953|NCT01725282|54501284|FG003|Overall Study|Met Exclusion Criteria|0|||
27880954|NCT01725282|54501281|FG000|Overall Study|Study Site Withdrawal|0|||
27880955|NCT01725282|54501282|FG001|Overall Study|Study Site Withdrawal|1|||
27880956|NCT01725282|54501283|FG002|Overall Study|Study Site Withdrawal|0|||
27880957|NCT01725282|54501284|FG003|Overall Study|Study Site Withdrawal|0|||
27880958|NCT01725282|54501281|FG000|Overall Study|Withdrawal by Subject|0|||
27880959|NCT01725282|54501282|FG001|Overall Study|Withdrawal by Subject|0|||
27880960|NCT01725282|54501283|FG002|Overall Study|Withdrawal by Subject|1|||
27880961|NCT01725282|54501284|FG003|Overall Study|Withdrawal by Subject|1|||
27880962|NCT01725282|54501281|FG000|Overall Study|Lack of Efficacy|0|||
27880963|NCT01725282|54501282|FG001|Overall Study|Lack of Efficacy|1|||
27880964|NCT01725282|54501283|FG002|Overall Study|Lack of Efficacy|0|||
27880965|NCT01725282|54501284|FG003|Overall Study|Lack of Efficacy|1|||
27880966|NCT01725126|54501300|FG000|Overall Study|Protocol Violation|0|||
27880967|NCT01725126|54501301|FG001|Overall Study|Protocol Violation|1|||
27880968|NCT01725126|54501302|FG002|Overall Study|Protocol Violation|0|||
27880969|NCT01725126|54501303|FG003|Overall Study|Protocol Violation|0|||
27880970|NCT01725126|54501304|FG004|Overall Study|Protocol Violation|0|||
27880971|NCT01725126|54501305|FG005|Overall Study|Protocol Violation|0|||
27880972|NCT01725126|54501300|FG000|Overall Study|Withdrawal by Subject|0|||
27880973|NCT01725126|54501301|FG001|Overall Study|Withdrawal by Subject|0|||
27880974|NCT01725126|54501302|FG002|Overall Study|Withdrawal by Subject|0|||
27880975|NCT01725126|54501303|FG003|Overall Study|Withdrawal by Subject|1|||
27880976|NCT01725126|54501304|FG004|Overall Study|Withdrawal by Subject|0|||
27880977|NCT01725126|54501305|FG005|Overall Study|Withdrawal by Subject|0|||
27880978|NCT01751724|54501330|FG000|Overall Study|extubated bef.start assigned treatment|1|||
27880979|NCT01751724|54501331|FG001|Overall Study|extubated bef.start assigned treatment|0|||
27880980|NCT01751724|54501330|FG000|Overall Study|withdrawn by parent|0|||
27880981|NCT01751724|54501331|FG001|Overall Study|withdrawn by parent|2|||
27880982|NCT01751646|54501339|FG000|Overall Study|Lost to Follow-up|5|||
27880983|NCT01751646|54501340|FG001|Overall Study|Lost to Follow-up|1|||
27880984|NCT01751646|54501339|FG000|Overall Study|Withdrawal by Subject|0|||
27880985|NCT01751646|54501340|FG001|Overall Study|Withdrawal by Subject|4|||
27880986|NCT01751646|54501339|FG000|Overall Study|Starting hormone therapy|1|||
27880987|NCT01751646|54501340|FG001|Overall Study|Starting hormone therapy|0|||
27880988|NCT01751646|54501339|FG000|Overall Study|Missed 4 or more consecutive DOT visits|2|||
27880989|NCT01751646|54501340|FG001|Overall Study|Missed 4 or more consecutive DOT visits|3|||
27880990|NCT01751646|54501339|FG000|Overall Study|Inadvertent enrollment|1|||
27880991|NCT01751646|54501340|FG001|Overall Study|Inadvertent enrollment|1|||
28096523|NCT04402866|54751603|FG001|Overall Study|Adverse Event|1|||
28096524|NCT04402866|54751604|FG002|Overall Study|Adverse Event|0|||
27880992|NCT01751646|54501339|FG000|Overall Study|Moved out of the area|1|||
27739303|NCT01603407|54188665|FG000|Overall Study|Protocol Violation|2|||
27739304|NCT01603407|54188666|FG001|Overall Study|Protocol Violation|2|||
27880993|NCT01751646|54501340|FG001|Overall Study|Moved out of the area|5|||
27880994|NCT01751646|54501339|FG000|Overall Study|Inability to attend required visits|0|||
28096525|NCT04402866|54751605|FG003|Overall Study|Adverse Event|0|||
27880995|NCT01751646|54501340|FG001|Overall Study|Inability to attend required visits|1|||
27880996|NCT01751646|54501339|FG000|Overall Study|Off study due to multiple obligations|0|||
27880997|NCT01751646|54501340|FG001|Overall Study|Off study due to multiple obligations|1|||
27880998|NCT01751646|54501339|FG000|Overall Study|Fails to comply with study requirements|0|||
27880999|NCT01751646|54501340|FG001|Overall Study|Fails to comply with study requirements|1|||
27881000|NCT01751646|54501339|FG000|Overall Study|Childcare issues|1|||
27881001|NCT01751646|54501340|FG001|Overall Study|Childcare issues|1|||
27881002|NCT01751568|54501353|FG000|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1|||
27881003|NCT01751568|54501354|FG001|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
27881004|NCT01751568|54501355|FG002|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
27881005|NCT01751412|54501363|FG000|Overall Study|Disease Progression Before Treatment|1|||
27881006|NCT01751178|54501370|FG000|Overall Study|Adverse Event|2|||
27881007|NCT01751178|54501371|FG001|Overall Study|Adverse Event|0|||
27881008|NCT01751178|54501372|FG002|Overall Study|Adverse Event|0|||
27881009|NCT01751178|54501370|FG000|Overall Study|Other Reason (unknown)|1|||
27881010|NCT01751178|54501371|FG001|Overall Study|Other Reason (unknown)|0|||
27881011|NCT01751178|54501372|FG002|Overall Study|Other Reason (unknown)|2|||
27881012|NCT01606254|54501388|FG000|Overall Study|Withdrawal by Subject|1|||
27881013|NCT01606254|54501389|FG001|Overall Study|Withdrawal by Subject|3|||
27881014|NCT01606254|54501390|FG002|Overall Study|Withdrawal by Subject|0|||
27881015|NCT01606254|54501391|FG003|Overall Study|Withdrawal by Subject|2|||
27881016|NCT01606254|54501388|FG000|Overall Study|Adverse Event|1|||
27881017|NCT01606254|54501389|FG001|Overall Study|Adverse Event|1|||
27881018|NCT01606254|54501390|FG002|Overall Study|Adverse Event|0|||
27881019|NCT01606254|54501391|FG003|Overall Study|Adverse Event|1|||
27881020|NCT01750242|54501401|FG000|Overall Study|Unreadable Images|3|||
27881021|NCT01723254|54501414|FG000|Overall Study|Conflict with work schedule|0|||
27881022|NCT01723254|54501415|FG001|Overall Study|Conflict with work schedule|0|||
27881023|NCT01723254|54501416|FG002|Overall Study|Conflict with work schedule|0|||
27881024|NCT01723254|54501417|FG003|Overall Study|Conflict with work schedule|0|||
27881025|NCT01723254|54501418|FG004|Overall Study|Conflict with work schedule|0|||
27881026|NCT01723254|54501419|FG005|Overall Study|Conflict with work schedule|0|||
27881027|NCT01723254|54501420|FG006|Overall Study|Conflict with work schedule|0|||
27881028|NCT01723254|54501421|FG007|Overall Study|Conflict with work schedule|1|||
27881029|NCT01723254|54501414|FG000|Overall Study|Personal issues|0|||
27881030|NCT01723254|54501415|FG001|Overall Study|Personal issues|0|||
27881031|NCT01723254|54501416|FG002|Overall Study|Personal issues|0|||
27881032|NCT01723254|54501417|FG003|Overall Study|Personal issues|0|||
27881033|NCT01723254|54501418|FG004|Overall Study|Personal issues|0|||
27881034|NCT01723254|54501419|FG005|Overall Study|Personal issues|1|||
27881035|NCT01723254|54501420|FG006|Overall Study|Personal issues|0|||
27881036|NCT01723254|54501421|FG007|Overall Study|Personal issues|0|||
27881037|NCT01723254|54501414|FG000|Overall Study|No longer have time to participate|0|||
27881038|NCT01723254|54501415|FG001|Overall Study|No longer have time to participate|0|||
27881039|NCT01723254|54501416|FG002|Overall Study|No longer have time to participate|0|||
27881040|NCT01723254|54501417|FG003|Overall Study|No longer have time to participate|1|||
27881041|NCT01723254|54501418|FG004|Overall Study|No longer have time to participate|0|||
27881042|NCT01723254|54501419|FG005|Overall Study|No longer have time to participate|0|||
27881043|NCT01723254|54501420|FG006|Overall Study|No longer have time to participate|0|||
27881044|NCT01723254|54501421|FG007|Overall Study|No longer have time to participate|0|||
27881045|NCT01723254|54501414|FG000|Overall Study|Move/Left to another country/city|0|||
27881046|NCT01723254|54501415|FG001|Overall Study|Move/Left to another country/city|0|||
27881047|NCT01723254|54501416|FG002|Overall Study|Move/Left to another country/city|2|||
27881048|NCT01723254|54501417|FG003|Overall Study|Move/Left to another country/city|1|||
27881049|NCT01723254|54501418|FG004|Overall Study|Move/Left to another country/city|1|||
27881050|NCT01723254|54501419|FG005|Overall Study|Move/Left to another country/city|0|||
27881051|NCT01723254|54501420|FG006|Overall Study|Move/Left to another country/city|0|||
27881052|NCT01723254|54501421|FG007|Overall Study|Move/Left to another country/city|0|||
27881053|NCT01723254|54501414|FG000|Overall Study|Protocol Violation|0|||
27881054|NCT01723254|54501415|FG001|Overall Study|Protocol Violation|1|||
27881055|NCT01723254|54501416|FG002|Overall Study|Protocol Violation|0|||
27881056|NCT01723254|54501417|FG003|Overall Study|Protocol Violation|0|||
27881057|NCT01723254|54501418|FG004|Overall Study|Protocol Violation|0|||
27881058|NCT01723254|54501419|FG005|Overall Study|Protocol Violation|0|||
27881059|NCT01723254|54501420|FG006|Overall Study|Protocol Violation|0|||
27881060|NCT01723254|54501421|FG007|Overall Study|Protocol Violation|0|||
27881061|NCT01723254|54501414|FG000|Overall Study|Withdrawal by Subject|1|||
27881062|NCT01723254|54501415|FG001|Overall Study|Withdrawal by Subject|2|||
27881063|NCT01723254|54501416|FG002|Overall Study|Withdrawal by Subject|1|||
27881064|NCT01723254|54501417|FG003|Overall Study|Withdrawal by Subject|0|||
27881065|NCT01723254|54501418|FG004|Overall Study|Withdrawal by Subject|1|||
27881066|NCT01723254|54501419|FG005|Overall Study|Withdrawal by Subject|1|||
28171739|NCT02442778|54843317|FG001|Overall Study|Non-compliance with study drug|0|||
28171740|NCT02442778|54843318|FG002|Overall Study|Non-compliance with study drug|1|||
27881067|NCT01723254|54501420|FG006|Overall Study|Withdrawal by Subject|1|||
27881068|NCT01723254|54501421|FG007|Overall Study|Withdrawal by Subject|2|||
27881069|NCT01722162|54501441|FG000|Overall Study|Withdrawal by Subject|1|||
27881070|NCT01722162|54501442|FG001|Overall Study|Withdrawal by Subject|1|||
27881071|NCT01722162|54501441|FG000|Overall Study|Found ineligible|1|||
27881072|NCT01722162|54501442|FG001|Overall Study|Found ineligible|0|||
27881073|NCT01722162|54501441|FG000|Overall Study|Unrelated to study adverse event|2|||
27881074|NCT01722162|54501442|FG001|Overall Study|Unrelated to study adverse event|2|||
27881075|NCT01722162|54501441|FG000|Overall Study|Adverse Event|1|||
27881076|NCT01722162|54501442|FG001|Overall Study|Adverse Event|1|||
27881077|NCT01722162|54501441|FG000|Overall Study|Insurance denial post enrollment|0|||
27881078|NCT01722162|54501442|FG001|Overall Study|Insurance denial post enrollment|1|||
27881079|NCT01722162|54501441|FG000|Overall Study|Noncompliance|0|||
27881080|NCT01722162|54501442|FG001|Overall Study|Noncompliance|1|||
27881081|NCT01721772|54501450|FG000|Pre-Treatment|Participant no longer meets study criteria|3|||
27881082|NCT01721772|54501451|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
27881083|NCT01721772|54501450|FG000|Pre-Treatment|Poor/non-compliance|0|||
27881084|NCT01721772|54501451|FG001|Pre-Treatment|Poor/non-compliance|1|||
27881085|NCT01721772|54501450|FG000|Pre-Treatment|Participant withdrew consent|0|||
27881086|NCT01721772|54501451|FG001|Pre-Treatment|Participant withdrew consent|1|||
27881087|NCT01721772|54501450|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
27881088|NCT01721772|54501451|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
27881089|NCT01721772|54501450|FG000|Treatment|Disease progression|119|||
27881090|NCT01721772|54501451|FG001|Treatment|Disease progression|168|||
27881091|NCT01721772|54501450|FG000|Treatment|Study drug toxicity|19|||
27881092|NCT01721772|54501451|FG001|Treatment|Study drug toxicity|10|||
27881093|NCT01721772|54501450|FG000|Treatment|Adverse event unrelated to study drug|7|||
27881094|NCT01721772|54501451|FG001|Treatment|Adverse event unrelated to study drug|7|||
27881095|NCT01721772|54501450|FG000|Treatment|Maximum clinical benefit|16|||
27881096|NCT01721772|54501451|FG001|Treatment|Maximum clinical benefit|4|||
27881097|NCT01721772|54501450|FG000|Treatment|Other|19|||
27881098|NCT01721772|54501451|FG001|Treatment|Other|2|||
27881099|NCT01721772|54501450|FG000|Treatment|Participant withdrew consent|2|||
27881100|NCT01721772|54501451|FG001|Treatment|Participant withdrew consent|5|||
27881101|NCT01721772|54501450|FG000|Treatment|Participant request to discontinue study treatment|21|||
27881102|NCT01721772|54501451|FG001|Treatment|Participant request to discontinue study treatment|8|||
27881103|NCT01721772|54501450|FG000|Treatment|Death|1|||
27881104|NCT01721772|54501451|FG001|Treatment|Death|0|||
27881105|NCT01721772|54501450|FG000|Treatment|Not reported|1|||
27881106|NCT01721772|54501451|FG001|Treatment|Not reported|0|||
27881107|NCT01721772|54501450|FG000|Treatment|Poor/non-compliance|1|||
27881108|NCT01721772|54501451|FG001|Treatment|Poor/non-compliance|0|||
27881109|NCT01721772|54501450|FG000|Treatment|Lost to Follow-up|0|||
27881110|NCT01721772|54501451|FG001|Treatment|Lost to Follow-up|1|||
27881111|NCT01702428|54501461|FG000|Overall Study|Adverse Event|2|||
27881112|NCT01702428|54501462|FG001|Overall Study|Adverse Event|0|||
27881113|NCT01702428|54501463|FG002|Overall Study|Adverse Event|0|||
27881114|NCT01702428|54501464|FG003|Overall Study|Adverse Event|0|||
27881115|NCT01702428|54501461|FG000|Overall Study|Lost to Follow-up|33|||
27881116|NCT01702428|54501462|FG001|Overall Study|Lost to Follow-up|41|||
27881117|NCT01702428|54501463|FG002|Overall Study|Lost to Follow-up|37|||
27881118|NCT01702428|54501464|FG003|Overall Study|Lost to Follow-up|44|||
27881119|NCT01702428|54501461|FG000|Overall Study|Parents cannot assist to site|1|||
27881120|NCT01702428|54501462|FG001|Overall Study|Parents cannot assist to site|0|||
27881121|NCT01702428|54501463|FG002|Overall Study|Parents cannot assist to site|1|||
27881122|NCT01702428|54501464|FG003|Overall Study|Parents cannot assist to site|0|||
27881123|NCT01702428|54501461|FG000|Overall Study|Lost Coverage|0|||
27881124|NCT01702428|54501462|FG001|Overall Study|Lost Coverage|0|||
27881125|NCT01702428|54501463|FG002|Overall Study|Lost Coverage|0|||
27881126|NCT01702428|54501464|FG003|Overall Study|Lost Coverage|1|||
27881127|NCT01702428|54501461|FG000|Overall Study|Lost Health Plan|3|||
27881128|NCT01702428|54501462|FG001|Overall Study|Lost Health Plan|5|||
27881129|NCT01702428|54501463|FG002|Overall Study|Lost Health Plan|0|||
27881130|NCT01702428|54501464|FG003|Overall Study|Lost Health Plan|2|||
27881131|NCT01702428|54501461|FG000|Overall Study|Mother transferred care|0|||
27881132|NCT01702428|54501462|FG001|Overall Study|Mother transferred care|1|||
27881133|NCT01702428|54501463|FG002|Overall Study|Mother transferred care|0|||
27881134|NCT01702428|54501464|FG003|Overall Study|Mother transferred care|0|||
27881135|NCT01702428|54501461|FG000|Overall Study|Parents too busy|1|||
27881136|NCT01702428|54501462|FG001|Overall Study|Parents too busy|0|||
27881137|NCT01702428|54501463|FG002|Overall Study|Parents too busy|0|||
27881138|NCT01702428|54501464|FG003|Overall Study|Parents too busy|0|||
27881139|NCT01702428|54501461|FG000|Overall Study|Protocol Violation|3|||
27881140|NCT01702428|54501462|FG001|Overall Study|Protocol Violation|0|||
27881141|NCT01702428|54501463|FG002|Overall Study|Protocol Violation|1|||
27881142|NCT01702428|54501464|FG003|Overall Study|Protocol Violation|0|||
28096526|NCT04402866|54751606|FG004|Overall Study|Adverse Event|13|||
27881143|NCT01702428|54501461|FG000|Overall Study|Withdrawal by Subject|21|||
27881144|NCT01702428|54501462|FG001|Overall Study|Withdrawal by Subject|23|||
27881145|NCT01702428|54501463|FG002|Overall Study|Withdrawal by Subject|14|||
27881146|NCT01702428|54501464|FG003|Overall Study|Withdrawal by Subject|10|||
27881147|NCT01701258|54501485|FG000|Assessment and Scheduling|Found to be Ineligible|57|||
27881148|NCT01701258|54501486|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
27881149|NCT01701258|54501487|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
27881150|NCT01701258|54501488|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
27881151|NCT01701258|54501489|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
27881152|NCT01701258|54501490|FG005|Assessment and Scheduling|Found to be Ineligible|0|||
27881153|NCT01701258|54501491|FG006|Assessment and Scheduling|Found to be Ineligible|0|||
27881154|NCT01701258|54501492|FG007|Assessment and Scheduling|Found to be Ineligible|0|||
27881155|NCT01701258|54501493|FG008|Assessment and Scheduling|Found to be Ineligible|0|||
27881156|NCT01701258|54501494|FG009|Assessment and Scheduling|Found to be Ineligible|0|||
27881157|NCT01701258|54501495|FG010|Assessment and Scheduling|Found to be Ineligible|0|||
27881158|NCT01701258|54501496|FG011|Assessment and Scheduling|Found to be Ineligible|0|||
27881159|NCT01701258|54501497|FG012|Assessment and Scheduling|Found to be Ineligible|0|||
27881160|NCT01701258|54501485|FG000|Assessment and Scheduling|Lost to Follow-up|10|||
27881161|NCT01701258|54501486|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
27881162|NCT01701258|54501487|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
27881163|NCT01701258|54501488|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
27881164|NCT01701258|54501489|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
27881165|NCT01701258|54501490|FG005|Assessment and Scheduling|Lost to Follow-up|0|||
27881166|NCT01701258|54501491|FG006|Assessment and Scheduling|Lost to Follow-up|0|||
27881167|NCT01701258|54501492|FG007|Assessment and Scheduling|Lost to Follow-up|0|||
27881168|NCT01701258|54501493|FG008|Assessment and Scheduling|Lost to Follow-up|0|||
27881169|NCT01701258|54501494|FG009|Assessment and Scheduling|Lost to Follow-up|0|||
27881170|NCT01701258|54501495|FG010|Assessment and Scheduling|Lost to Follow-up|0|||
27881171|NCT01701258|54501496|FG011|Assessment and Scheduling|Lost to Follow-up|0|||
27881172|NCT01701258|54501497|FG012|Assessment and Scheduling|Lost to Follow-up|0|||
27881173|NCT01701258|54501485|FG000|Assessment and Scheduling|Withdrawal by Subject|14|||
27881174|NCT01701258|54501486|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
27881175|NCT01701258|54501487|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
27881176|NCT01701258|54501488|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
27881177|NCT01701258|54501489|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
27881178|NCT01701258|54501490|FG005|Assessment and Scheduling|Withdrawal by Subject|0|||
27881179|NCT01701258|54501491|FG006|Assessment and Scheduling|Withdrawal by Subject|0|||
27881180|NCT01701258|54501492|FG007|Assessment and Scheduling|Withdrawal by Subject|0|||
27881181|NCT01701258|54501493|FG008|Assessment and Scheduling|Withdrawal by Subject|0|||
27881182|NCT01701258|54501494|FG009|Assessment and Scheduling|Withdrawal by Subject|0|||
27881183|NCT01701258|54501495|FG010|Assessment and Scheduling|Withdrawal by Subject|0|||
27881184|NCT01701258|54501496|FG011|Assessment and Scheduling|Withdrawal by Subject|0|||
27881185|NCT01701258|54501497|FG012|Assessment and Scheduling|Withdrawal by Subject|0|||
27881186|NCT01701258|54501485|FG000|Assessment and Scheduling|Investigator Terminated|2|||
27881187|NCT01701258|54501486|FG001|Assessment and Scheduling|Investigator Terminated|0|||
27881188|NCT01701258|54501487|FG002|Assessment and Scheduling|Investigator Terminated|0|||
27881189|NCT01701258|54501488|FG003|Assessment and Scheduling|Investigator Terminated|0|||
27881190|NCT01701258|54501489|FG004|Assessment and Scheduling|Investigator Terminated|0|||
27881191|NCT01701258|54501490|FG005|Assessment and Scheduling|Investigator Terminated|0|||
27881192|NCT01701258|54501491|FG006|Assessment and Scheduling|Investigator Terminated|0|||
27881193|NCT01701258|54501492|FG007|Assessment and Scheduling|Investigator Terminated|0|||
27881194|NCT01701258|54501493|FG008|Assessment and Scheduling|Investigator Terminated|0|||
27881195|NCT01701258|54501494|FG009|Assessment and Scheduling|Investigator Terminated|0|||
27881196|NCT01701258|54501495|FG010|Assessment and Scheduling|Investigator Terminated|0|||
27881197|NCT01701258|54501496|FG011|Assessment and Scheduling|Investigator Terminated|0|||
27881198|NCT01701258|54501497|FG012|Assessment and Scheduling|Investigator Terminated|0|||
27881199|NCT01700946|54501527|FG000|Overall Study|Lost to Follow-up|1|||
27881200|NCT01700946|54501528|FG001|Overall Study|Lost to Follow-up|0|||
27881201|NCT01700946|54501527|FG000|Overall Study|Physician Decision|7|||
28171741|NCT02442778|54843316|FG000|Overall Study|Physician Decision|1|||
28171742|NCT02442778|54843317|FG001|Overall Study|Physician Decision|1|||
27881202|NCT01700946|54501528|FG001|Overall Study|Physician Decision|12|||
27881203|NCT01700946|54501527|FG000|Overall Study|Withdrawal by Subject|0|||
27881204|NCT01700946|54501528|FG001|Overall Study|Withdrawal by Subject|2|||
27881205|NCT01700946|54501527|FG000|Overall Study|Failed to achieve Complete Remission after Induction Block III|0|||
27881206|NCT01700946|54501528|FG001|Overall Study|Failed to achieve Complete Remission after Induction Block III|2|||
27881207|NCT01700946|54501527|FG000|Overall Study|Relapse|2|||
27881208|NCT01700946|54501528|FG001|Overall Study|Relapse|1|||
27881209|NCT01700946|54501527|FG000|Overall Study|Unacceptable toxicity|1|||
27881210|NCT01700946|54501528|FG001|Overall Study|Unacceptable toxicity|0|||
27881211|NCT01748994|54501540|FG000|Overall Study|Lost to Follow-up|8|||
27881212|NCT01748994|54501541|FG001|Overall Study|Lost to Follow-up|6|||
27881213|NCT01721070|54501547|FG000|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1|||
27881214|NCT01748760|54501556|FG000|Overall Study|Withdrawal by Subject|1|||
27881215|NCT01748760|54501557|FG001|Overall Study|Withdrawal by Subject|1|||
27881216|NCT01748760|54501556|FG000|Overall Study|Lost to Follow-up|5|||
27881217|NCT01748760|54501557|FG001|Overall Study|Lost to Follow-up|1|||
27881218|NCT01748292|54501565|FG000|Overall Study|Adverse Event|2|||
27881219|NCT01748292|54501566|FG001|Overall Study|Adverse Event|4|||
27881220|NCT01748292|54501565|FG000|Overall Study|Lost to Follow-up|0|||
27881221|NCT01748292|54501566|FG001|Overall Study|Lost to Follow-up|3|||
27881222|NCT01748292|54501565|FG000|Overall Study|Death|0|||
27881223|NCT01748292|54501566|FG001|Overall Study|Death|3|||
27881224|NCT01748292|54501565|FG000|Overall Study|Withdrawal by Subject|0|||
27881225|NCT01748292|54501566|FG001|Overall Study|Withdrawal by Subject|2|||
27881226|NCT01720602|54501572|FG000|Overall Study|Adverse Event|3|||
27881227|NCT01720602|54501572|FG000|Overall Study|Progressive disease on therapy|2|||
27881228|NCT01746732|54501576|FG000|Lead-In Period|Withdrawal by Subject|1|||
27881229|NCT01746732|54501577|FG001|Lead-In Period|Withdrawal by Subject|0|||
27881230|NCT01746732|54501578|FG002|Lead-In Period|Withdrawal by Subject|0|||
27881231|NCT01746732|54501576|FG000|Period 1|Physician Decision|0|||
27881232|NCT01746732|54501577|FG001|Period 1|Physician Decision|1|||
27881233|NCT01746732|54501578|FG002|Period 1|Physician Decision|0|||
27881234|NCT01746732|54501576|FG000|Period 2|Withdrawal by Subject|0|||
27881235|NCT01746732|54501577|FG001|Period 2|Withdrawal by Subject|0|||
27983756|NCT00561925|54642150|FG000|Open-Label Extension Period|Declined entry into extension period|0|||
27983757|NCT00561925|54642151|FG001|Open-Label Extension Period|Declined entry into extension period|0|||
27983758|NCT00561925|54642152|FG002|Open-Label Extension Period|Declined entry into extension period|0|||
27983759|NCT00561925|54642153|FG003|Open-Label Extension Period|Declined entry into extension period|43|||
27983760|NCT00561925|54642154|FG004|Open-Label Extension Period|Declined entry into extension period|50|||
27983761|NCT00549445|54642174|FG000|Overall Study|Sputum & Blood Samples Not Available|15|||
27983762|NCT00549445|54642175|FG001|Overall Study|Sputum & Blood Samples Not Available|17|||
27983763|NCT00601107|54642185|FG000|Overall Study|Adverse Event|0|||
27983764|NCT00601107|54642186|FG001|Overall Study|Adverse Event|1|||
27983765|NCT00601107|54642187|FG002|Overall Study|Adverse Event|3|||
27983766|NCT00601107|54642188|FG003|Overall Study|Adverse Event|0|||
27983767|NCT00601107|54642185|FG000|Overall Study|Withdrawal by Subject|5|||
27983768|NCT00601107|54642186|FG001|Overall Study|Withdrawal by Subject|4|||
27983769|NCT00601107|54642187|FG002|Overall Study|Withdrawal by Subject|7|||
27983770|NCT00601107|54642188|FG003|Overall Study|Withdrawal by Subject|4|||
27983771|NCT00601107|54642185|FG000|Overall Study|Lost to Follow-up|3|||
27983772|NCT00601107|54642186|FG001|Overall Study|Lost to Follow-up|3|||
27983773|NCT00601107|54642187|FG002|Overall Study|Lost to Follow-up|0|||
27983774|NCT00601107|54642188|FG003|Overall Study|Lost to Follow-up|3|||
27983775|NCT00601107|54642185|FG000|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
27983776|NCT00601107|54642186|FG001|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
27983777|NCT00601107|54642187|FG002|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
27983778|NCT00601107|54642188|FG003|Overall Study|Serum Calcium >11.5 milligram/deciliter|1|||
27983779|NCT00601107|54642185|FG000|Overall Study|Worsening of Psoriasis|4|||
27983780|NCT00601107|54642186|FG001|Overall Study|Worsening of Psoriasis|1|||
27983781|NCT00601107|54642187|FG002|Overall Study|Worsening of Psoriasis|1|||
27983782|NCT00601107|54642188|FG003|Overall Study|Worsening of Psoriasis|4|||
27983783|NCT00601107|54642185|FG000|Overall Study|Undefined|1|||
27983784|NCT00601107|54642186|FG001|Overall Study|Undefined|0|||
27983785|NCT00601107|54642187|FG002|Overall Study|Undefined|1|||
27983786|NCT00601107|54642188|FG003|Overall Study|Undefined|0|||
27983787|NCT00914927|54642205|FG000|Overall Study|Adverse Event|0|||
27983788|NCT00914927|54642206|FG001|Overall Study|Adverse Event|0|||
27983789|NCT00914927|54642207|FG002|Overall Study|Adverse Event|0|||
27983790|NCT00914927|54642208|FG003|Overall Study|Adverse Event|0|||
27983791|NCT00914927|54642209|FG004|Overall Study|Adverse Event|1|||
27983792|NCT00914927|54642210|FG005|Overall Study|Adverse Event|0|||
27983793|NCT00914927|54642211|FG006|Overall Study|Adverse Event|0|||
27983794|NCT00914927|54642205|FG000|Overall Study|Withdrawal by Subject|0|||
27983795|NCT00914927|54642206|FG001|Overall Study|Withdrawal by Subject|1|||
27983796|NCT00914927|54642207|FG002|Overall Study|Withdrawal by Subject|0|||
27983797|NCT00914927|54642208|FG003|Overall Study|Withdrawal by Subject|1|||
27983798|NCT00914927|54642209|FG004|Overall Study|Withdrawal by Subject|0|||
28096527|NCT04402866|54751607|FG005|Overall Study|Adverse Event|8|||
28096528|NCT04402866|54751602|FG000|Overall Study|Miscellaneous|0|||
28096529|NCT04402866|54751603|FG001|Overall Study|Miscellaneous|0|||
28096530|NCT04402866|54751604|FG002|Overall Study|Miscellaneous|1|||
28096531|NCT04402866|54751605|FG003|Overall Study|Miscellaneous|0|||
27881236|NCT01746732|54501578|FG002|Period 2|Withdrawal by Subject|2|||
27881237|NCT01746732|54501576|FG000|Period 2|Adverse Event|0|||
27881238|NCT01746732|54501577|FG001|Period 2|Adverse Event|0|||
27881239|NCT01746732|54501578|FG002|Period 2|Adverse Event|1|||
27881240|NCT01746732|54501576|FG000|Period 2|Lost to Follow-up|0|||
27881241|NCT01746732|54501577|FG001|Period 2|Lost to Follow-up|0|||
27881242|NCT01746732|54501578|FG002|Period 2|Lost to Follow-up|1|||
27881243|NCT01720524|54501588|FG000|Part A|Insufficient Clinical Response|2|||
27881244|NCT01720524|54501589|FG001|Part A|Insufficient Clinical Response|4|||
27881245|NCT01720524|54501588|FG000|Part A|Adverse Event|2|||
27881246|NCT01720524|54501589|FG001|Part A|Adverse Event|2|||
27881247|NCT01720524|54501588|FG000|Part A|Death|2|||
27881248|NCT01720524|54501589|FG001|Part A|Death|1|||
27881249|NCT01720524|54501588|FG000|Part A|Lost to Follow-up|0|||
27881250|NCT01720524|54501589|FG001|Part A|Lost to Follow-up|1|||
27881251|NCT01720524|54501588|FG000|Part A|Missed 28 day follow-up visit|1|||
27881252|NCT01720524|54501589|FG001|Part A|Missed 28 day follow-up visit|1|||
27881253|NCT01720524|54501588|FG000|Part A|Withdrawal by Subject|0|||
27881254|NCT01720524|54501589|FG001|Part A|Withdrawal by Subject|1|||
27881255|NCT01720524|54501588|FG000|Part A|Other|0|||
27881256|NCT01720524|54501589|FG001|Part A|Other|1|||
27881257|NCT01720524|54501588|FG000|Part A|Lost to Follow-up|0|||
27881258|NCT01720524|54501589|FG001|Part A|Lost to Follow-up|1|||
27881259|NCT01720524|54501588|FG000|Part B|No longer willing to participate in study|1|||
27881260|NCT01720524|54501589|FG001|Part B|No longer willing to participate in study|4|||
27881261|NCT01720524|54501588|FG000|Part B|Other|2|||
27881262|NCT01720524|54501589|FG001|Part B|Other|0|||
27881263|NCT01720524|54501588|FG000|Part B|Lost to Follow-up|2|||
27881264|NCT01720524|54501589|FG001|Part B|Lost to Follow-up|3|||
27881265|NCT01720524|54501588|FG000|Part B|Death|0|||
27881266|NCT01720524|54501589|FG001|Part B|Death|2|||
27881267|NCT01720446|54501601|FG000|Overall Study|Lost to Follow-up|12|||
27881268|NCT01720446|54501602|FG001|Overall Study|Lost to Follow-up|6|||
27881269|NCT01720446|54501603|FG002|Overall Study|Lost to Follow-up|16|||
27881270|NCT01720446|54501604|FG003|Overall Study|Lost to Follow-up|16|||
27881271|NCT01720446|54501601|FG000|Overall Study|Withdrawal by Subject|2|||
27881272|NCT01720446|54501602|FG001|Overall Study|Withdrawal by Subject|5|||
27881273|NCT01720446|54501603|FG002|Overall Study|Withdrawal by Subject|4|||
27881274|NCT01720446|54501604|FG003|Overall Study|Withdrawal by Subject|4|||
27881275|NCT01746108|54501620|FG000|Overall Study|Migrated /moved from study area|0|||
27881276|NCT01746108|54501621|FG001|Overall Study|Migrated /moved from study area|1|||
27881277|NCT01746108|54501622|FG002|Overall Study|Migrated /moved from study area|0|||
27881278|NCT01746108|54501620|FG000|Overall Study|Adverse event, non-fatal|0|||
27881279|NCT01746108|54501621|FG001|Overall Study|Adverse event, non-fatal|1|||
27881280|NCT01746108|54501622|FG002|Overall Study|Adverse event, non-fatal|0|||
27881281|NCT01746108|54501620|FG000|Overall Study|Withdrawal by Subject|0|||
27881282|NCT01746108|54501621|FG001|Overall Study|Withdrawal by Subject|1|||
27881283|NCT01746108|54501622|FG002|Overall Study|Withdrawal by Subject|0|||
27881284|NCT01746108|54501620|FG000|Overall Study|Lost to Follow-up|0|||
27881285|NCT01746108|54501621|FG001|Overall Study|Lost to Follow-up|1|||
27881286|NCT01746108|54501622|FG002|Overall Study|Lost to Follow-up|0|||
27881287|NCT01717638|54501651|FG000|Overall Study|Lost to Follow-up|0|||
27881288|NCT01717638|54501652|FG001|Overall Study|Lost to Follow-up|0|||
27881289|NCT01717638|54501653|FG002|Overall Study|Lost to Follow-up|0|||
27881290|NCT01717638|54501654|FG003|Overall Study|Lost to Follow-up|0|||
27881291|NCT01717638|54501655|FG004|Overall Study|Lost to Follow-up|0|||
27881292|NCT01717638|54501656|FG005|Overall Study|Lost to Follow-up|1|||
27881293|NCT01717638|54501657|FG006|Overall Study|Lost to Follow-up|0|||
27881294|NCT01717638|54501658|FG007|Overall Study|Lost to Follow-up|0|||
27881295|NCT01717638|54501659|FG008|Overall Study|Lost to Follow-up|0|||
27881296|NCT01717638|54501660|FG009|Overall Study|Lost to Follow-up|0|||
27881297|NCT01717638|54501661|FG010|Overall Study|Lost to Follow-up|0|||
27881298|NCT01717638|54501662|FG011|Overall Study|Lost to Follow-up|0|||
27881299|NCT01717638|54501663|FG012|Overall Study|Lost to Follow-up|0|||
27881300|NCT01717638|54501651|FG000|Overall Study|Father in hospital|0|||
27881301|NCT01717638|54501652|FG001|Overall Study|Father in hospital|0|||
28096532|NCT04402866|54751606|FG004|Overall Study|Miscellaneous|0|||
28096533|NCT04402866|54751607|FG005|Overall Study|Miscellaneous|0|||
27881302|NCT01717638|54501653|FG002|Overall Study|Father in hospital|0|||
27881303|NCT01717638|54501654|FG003|Overall Study|Father in hospital|0|||
27881304|NCT01717638|54501655|FG004|Overall Study|Father in hospital|0|||
27881305|NCT01717638|54501656|FG005|Overall Study|Father in hospital|0|||
27881306|NCT01717638|54501657|FG006|Overall Study|Father in hospital|0|||
27881307|NCT01717638|54501658|FG007|Overall Study|Father in hospital|0|||
27881308|NCT01717638|54501659|FG008|Overall Study|Father in hospital|0|||
27881309|NCT01717638|54501660|FG009|Overall Study|Father in hospital|0|||
27881310|NCT01717638|54501661|FG010|Overall Study|Father in hospital|0|||
27881311|NCT01717638|54501662|FG011|Overall Study|Father in hospital|0|||
27881312|NCT01717638|54501663|FG012|Overall Study|Father in hospital|1|||
27881313|NCT01717638|54501651|FG000|Overall Study|Withdrawal by Subject|0|||
27881314|NCT01717638|54501652|FG001|Overall Study|Withdrawal by Subject|1|||
27881315|NCT01717638|54501653|FG002|Overall Study|Withdrawal by Subject|1|||
27881316|NCT01717638|54501654|FG003|Overall Study|Withdrawal by Subject|0|||
28096534|NCT04402866|54751602|FG000|Overall Study|Lost to Follow-up|0|||
27881317|NCT01717638|54501655|FG004|Overall Study|Withdrawal by Subject|1|||
27881318|NCT01717638|54501656|FG005|Overall Study|Withdrawal by Subject|0|||
27881319|NCT01717638|54501657|FG006|Overall Study|Withdrawal by Subject|2|||
27881320|NCT01717638|54501658|FG007|Overall Study|Withdrawal by Subject|1|||
27881321|NCT01717638|54501659|FG008|Overall Study|Withdrawal by Subject|2|||
27881322|NCT01717638|54501660|FG009|Overall Study|Withdrawal by Subject|1|||
27881323|NCT01717638|54501661|FG010|Overall Study|Withdrawal by Subject|0|||
27881324|NCT01717638|54501662|FG011|Overall Study|Withdrawal by Subject|0|||
27881325|NCT01717638|54501663|FG012|Overall Study|Withdrawal by Subject|18|||
27881326|NCT01745094|54501701|FG000|Overall Study|Not Meeting the Eligibility Criteria|1|||
27881327|NCT01745094|54501702|FG001|Overall Study|Not Meeting the Eligibility Criteria|0|||
27881328|NCT01745094|54501703|FG002|Overall Study|Not Meeting the Eligibility Criteria|3|||
27881329|NCT01745094|54501704|FG003|Overall Study|Not Meeting the Eligibility Criteria|0|||
27881330|NCT01745094|54501701|FG000|Overall Study|Adverse Event|0|||
27881331|NCT01745094|54501702|FG001|Overall Study|Adverse Event|0|||
27881332|NCT01745094|54501703|FG002|Overall Study|Adverse Event|3|||
27881333|NCT01745094|54501704|FG003|Overall Study|Adverse Event|0|||
27881334|NCT01745094|54501701|FG000|Overall Study|Withdrawal by Subject|2|||
27881335|NCT01745094|54501702|FG001|Overall Study|Withdrawal by Subject|0|||
27881336|NCT01745094|54501703|FG002|Overall Study|Withdrawal by Subject|1|||
27881337|NCT01745094|54501704|FG003|Overall Study|Withdrawal by Subject|2|||
27881338|NCT01745094|54501701|FG000|Overall Study|Protocol Violation|1|||
27881339|NCT01745094|54501702|FG001|Overall Study|Protocol Violation|0|||
27881340|NCT01745094|54501703|FG002|Overall Study|Protocol Violation|3|||
27881341|NCT01745094|54501704|FG003|Overall Study|Protocol Violation|1|||
27881342|NCT01745094|54501701|FG000|Overall Study|Need Further Examinations Due to Biopsy|0|||
27881343|NCT01745094|54501702|FG001|Overall Study|Need Further Examinations Due to Biopsy|0|||
27881344|NCT01745094|54501703|FG002|Overall Study|Need Further Examinations Due to Biopsy|1|||
27881345|NCT01745094|54501704|FG003|Overall Study|Need Further Examinations Due to Biopsy|0|||
27881346|NCT01745094|54501701|FG000|Overall Study|Show no Stable Solifenacin Intake|0|||
27881347|NCT01745094|54501702|FG001|Overall Study|Show no Stable Solifenacin Intake|0|||
27881348|NCT01745094|54501703|FG002|Overall Study|Show no Stable Solifenacin Intake|1|||
27881349|NCT01745094|54501704|FG003|Overall Study|Show no Stable Solifenacin Intake|0|||
27881350|NCT01745094|54501701|FG000|Overall Study|Untenable Due to Recurrent Cystitis|1|||
27881351|NCT01745094|54501702|FG001|Overall Study|Untenable Due to Recurrent Cystitis|0|||
27881352|NCT01745094|54501703|FG002|Overall Study|Untenable Due to Recurrent Cystitis|0|||
27881353|NCT01745094|54501704|FG003|Overall Study|Untenable Due to Recurrent Cystitis|0|||
27881354|NCT01697748|54501719|FG000|Overall Study|ineligible skin incision|1|||
27881355|NCT01697748|54501720|FG001|Overall Study|ineligible skin incision|2|||
27881356|NCT01697748|54501719|FG000|Overall Study|ineligible uterine incision|4|||
27881357|NCT01697748|54501720|FG001|Overall Study|ineligible uterine incision|1|||
27881358|NCT01697748|54501719|FG000|Overall Study|Lost to Follow-up|53|||
27881359|NCT01697748|54501720|FG001|Overall Study|Lost to Follow-up|65|||
27881360|NCT01717326|54501746|FG000|Overall Study|Death|0|||
27881361|NCT01717326|54501747|FG001|Overall Study|Death|0|||
27881362|NCT01717326|54501748|FG002|Overall Study|Death|0|||
27881363|NCT01717326|54501749|FG003|Overall Study|Death|0|||
27881364|NCT01717326|54501750|FG004|Overall Study|Death|0|||
27881365|NCT01717326|54501751|FG005|Overall Study|Death|0|||
27881366|NCT01717326|54501752|FG006|Overall Study|Death|0|||
27881367|NCT01717326|54501753|FG007|Overall Study|Death|0|||
27881368|NCT01717326|54501754|FG008|Overall Study|Death|0|||
27881369|NCT01717326|54501755|FG009|Overall Study|Death|0|||
27881370|NCT01717326|54501756|FG010|Overall Study|Death|1|||
27881371|NCT01717326|54501757|FG011|Overall Study|Death|0|||
27881372|NCT01717326|54501758|FG012|Overall Study|Death|0|||
27881373|NCT01717326|54501759|FG013|Overall Study|Death|0|||
27881374|NCT01717326|54501760|FG014|Overall Study|Death|0|||
27881375|NCT01717326|54501761|FG015|Overall Study|Death|0|||
27881376|NCT01717326|54501762|FG016|Overall Study|Death|0|||
27881377|NCT01717326|54501763|FG017|Overall Study|Death|0|||
27881378|NCT01717326|54501764|FG018|Overall Study|Death|0|||
27881379|NCT01717326|54501765|FG019|Overall Study|Death|0|||
27881380|NCT01717326|54501746|FG000|Overall Study|Lost to Follow-up|3|||
27881381|NCT01717326|54501747|FG001|Overall Study|Lost to Follow-up|0|||
27881382|NCT01717326|54501748|FG002|Overall Study|Lost to Follow-up|0|||
27881383|NCT01717326|54501749|FG003|Overall Study|Lost to Follow-up|2|||
27881384|NCT01717326|54501750|FG004|Overall Study|Lost to Follow-up|1|||
27881385|NCT01717326|54501751|FG005|Overall Study|Lost to Follow-up|0|||
27881386|NCT01717326|54501752|FG006|Overall Study|Lost to Follow-up|1|||
27881387|NCT01717326|54501753|FG007|Overall Study|Lost to Follow-up|0|||
27881388|NCT01717326|54501754|FG008|Overall Study|Lost to Follow-up|0|||
27881389|NCT01717326|54501755|FG009|Overall Study|Lost to Follow-up|0|||
27881390|NCT01717326|54501756|FG010|Overall Study|Lost to Follow-up|1|||
27881391|NCT01717326|54501757|FG011|Overall Study|Lost to Follow-up|0|||
27881392|NCT01717326|54501758|FG012|Overall Study|Lost to Follow-up|0|||
27881393|NCT01717326|54501759|FG013|Overall Study|Lost to Follow-up|0|||
27881394|NCT01717326|54501760|FG014|Overall Study|Lost to Follow-up|0|||
27881395|NCT01717326|54501761|FG015|Overall Study|Lost to Follow-up|2|||
27881396|NCT01717326|54501762|FG016|Overall Study|Lost to Follow-up|1|||
27881397|NCT01717326|54501763|FG017|Overall Study|Lost to Follow-up|0|||
27881398|NCT01717326|54501764|FG018|Overall Study|Lost to Follow-up|2|||
27881399|NCT01717326|54501765|FG019|Overall Study|Lost to Follow-up|3|||
27881400|NCT01717326|54501746|FG000|Overall Study|Physician Decision|0|||
27881401|NCT01717326|54501747|FG001|Overall Study|Physician Decision|0|||
27881402|NCT01717326|54501748|FG002|Overall Study|Physician Decision|0|||
27881403|NCT01717326|54501749|FG003|Overall Study|Physician Decision|0|||
27881404|NCT01717326|54501750|FG004|Overall Study|Physician Decision|0|||
27881405|NCT01717326|54501751|FG005|Overall Study|Physician Decision|0|||
27881406|NCT01717326|54501752|FG006|Overall Study|Physician Decision|0|||
27881407|NCT01717326|54501753|FG007|Overall Study|Physician Decision|0|||
27881408|NCT01717326|54501754|FG008|Overall Study|Physician Decision|0|||
27881409|NCT01717326|54501755|FG009|Overall Study|Physician Decision|1|||
27881410|NCT01717326|54501756|FG010|Overall Study|Physician Decision|0|||
27881411|NCT01717326|54501757|FG011|Overall Study|Physician Decision|0|||
27881412|NCT01717326|54501758|FG012|Overall Study|Physician Decision|0|||
27881413|NCT01717326|54501759|FG013|Overall Study|Physician Decision|0|||
27881414|NCT01717326|54501760|FG014|Overall Study|Physician Decision|0|||
27881415|NCT01717326|54501761|FG015|Overall Study|Physician Decision|0|||
27881416|NCT01717326|54501762|FG016|Overall Study|Physician Decision|0|||
27881417|NCT01717326|54501763|FG017|Overall Study|Physician Decision|0|||
27881418|NCT01717326|54501764|FG018|Overall Study|Physician Decision|0|||
27881419|NCT01717326|54501765|FG019|Overall Study|Physician Decision|0|||
27881420|NCT01717326|54501746|FG000|Overall Study|Protocol Violation|0|||
27881421|NCT01717326|54501747|FG001|Overall Study|Protocol Violation|0|||
27881422|NCT01717326|54501748|FG002|Overall Study|Protocol Violation|0|||
27881423|NCT01717326|54501749|FG003|Overall Study|Protocol Violation|0|||
27881424|NCT01717326|54501750|FG004|Overall Study|Protocol Violation|1|||
27881425|NCT01717326|54501751|FG005|Overall Study|Protocol Violation|0|||
27881426|NCT01717326|54501752|FG006|Overall Study|Protocol Violation|0|||
27881427|NCT01717326|54501753|FG007|Overall Study|Protocol Violation|0|||
27881428|NCT01717326|54501754|FG008|Overall Study|Protocol Violation|0|||
27881429|NCT01717326|54501755|FG009|Overall Study|Protocol Violation|0|||
27881430|NCT01717326|54501756|FG010|Overall Study|Protocol Violation|0|||
27881431|NCT01717326|54501757|FG011|Overall Study|Protocol Violation|0|||
27881432|NCT01717326|54501758|FG012|Overall Study|Protocol Violation|0|||
27881433|NCT01717326|54501759|FG013|Overall Study|Protocol Violation|0|||
27881434|NCT01717326|54501760|FG014|Overall Study|Protocol Violation|0|||
27881435|NCT01717326|54501761|FG015|Overall Study|Protocol Violation|0|||
27881436|NCT01717326|54501762|FG016|Overall Study|Protocol Violation|0|||
27881437|NCT01717326|54501763|FG017|Overall Study|Protocol Violation|0|||
27881438|NCT01717326|54501764|FG018|Overall Study|Protocol Violation|0|||
27881439|NCT01717326|54501765|FG019|Overall Study|Protocol Violation|0|||
27881440|NCT01717326|54501746|FG000|Overall Study|Withdrawal by Subject|0|||
27881441|NCT01717326|54501747|FG001|Overall Study|Withdrawal by Subject|1|||
27881442|NCT01717326|54501748|FG002|Overall Study|Withdrawal by Subject|0|||
27881443|NCT01717326|54501749|FG003|Overall Study|Withdrawal by Subject|0|||
27881444|NCT01717326|54501750|FG004|Overall Study|Withdrawal by Subject|0|||
27881445|NCT01717326|54501751|FG005|Overall Study|Withdrawal by Subject|0|||
27881446|NCT01717326|54501752|FG006|Overall Study|Withdrawal by Subject|0|||
27881447|NCT01717326|54501753|FG007|Overall Study|Withdrawal by Subject|0|||
27881448|NCT01717326|54501754|FG008|Overall Study|Withdrawal by Subject|0|||
27881449|NCT01717326|54501755|FG009|Overall Study|Withdrawal by Subject|1|||
27881450|NCT01717326|54501756|FG010|Overall Study|Withdrawal by Subject|0|||
27881451|NCT01717326|54501757|FG011|Overall Study|Withdrawal by Subject|0|||
27881452|NCT01717326|54501758|FG012|Overall Study|Withdrawal by Subject|1|||
27881453|NCT01717326|54501759|FG013|Overall Study|Withdrawal by Subject|0|||
27881454|NCT01717326|54501760|FG014|Overall Study|Withdrawal by Subject|0|||
27881455|NCT01717326|54501761|FG015|Overall Study|Withdrawal by Subject|1|||
27881456|NCT01717326|54501762|FG016|Overall Study|Withdrawal by Subject|0|||
27881457|NCT01717326|54501763|FG017|Overall Study|Withdrawal by Subject|0|||
28171743|NCT02442778|54843318|FG002|Overall Study|Physician Decision|1|||
27739305|NCT01603407|54188667|FG002|Overall Study|Protocol Violation|0|||
27881458|NCT01717326|54501764|FG018|Overall Study|Withdrawal by Subject|2|||
27881459|NCT01717326|54501765|FG019|Overall Study|Withdrawal by Subject|3|||
27881460|NCT01697592|54501817|FG000|Phase A (Up to 24 Weeks)|Lost to Follow-up|1|||
27881461|NCT01697592|54501818|FG001|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
27881462|NCT01697592|54501819|FG002|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
27881463|NCT01697592|54501820|FG003|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
28171744|NCT02442778|54843316|FG000|Overall Study|Protocol Deviation|3|||
27881464|NCT01697592|54501821|FG004|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
27881465|NCT01697592|54501822|FG005|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
27881466|NCT01697592|54501823|FG006|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
27881467|NCT01697592|54501824|FG007|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
27881468|NCT01697592|54501825|FG008|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
27881469|NCT01697592|54501826|FG009|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
27881470|NCT01697592|54501817|FG000|Phase A (Up to 24 Weeks)|Physician Decision|0|||
27881471|NCT01697592|54501818|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
27881472|NCT01697592|54501819|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
27881473|NCT01697592|54501820|FG003|Phase A (Up to 24 Weeks)|Physician Decision|0|||
27881474|NCT01697592|54501821|FG004|Phase A (Up to 24 Weeks)|Physician Decision|0|||
27881475|NCT01697592|54501822|FG005|Phase A (Up to 24 Weeks)|Physician Decision|1|||
27881476|NCT01697592|54501823|FG006|Phase A (Up to 24 Weeks)|Physician Decision|0|||
27881477|NCT01697592|54501824|FG007|Phase A (Up to 24 Weeks)|Physician Decision|0|||
27881478|NCT01697592|54501825|FG008|Phase A (Up to 24 Weeks)|Physician Decision|0|||
27881479|NCT01697592|54501826|FG009|Phase A (Up to 24 Weeks)|Physician Decision|0|||
27881480|NCT01697592|54501817|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
27881481|NCT01697592|54501818|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
27881482|NCT01697592|54501819|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
27881483|NCT01697592|54501820|FG003|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
27881484|NCT01697592|54501821|FG004|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
27881485|NCT01697592|54501822|FG005|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
27881486|NCT01697592|54501823|FG006|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
27881487|NCT01697592|54501824|FG007|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
27881488|NCT01697592|54501825|FG008|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
27881489|NCT01697592|54501826|FG009|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
27881490|NCT01697592|54501817|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
27881491|NCT01697592|54501818|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
27881492|NCT01697592|54501819|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
27881493|NCT01697592|54501820|FG003|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
27881494|NCT01697592|54501821|FG004|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
27881495|NCT01697592|54501822|FG005|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
27881496|NCT01697592|54501823|FG006|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
27881497|NCT01697592|54501824|FG007|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
27881498|NCT01697592|54501825|FG008|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
27881499|NCT01697592|54501826|FG009|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
27881500|NCT01697592|54501817|FG000|Phase A (Up to 24 Weeks)|Adverse Event|0|||
27881501|NCT01697592|54501818|FG001|Phase A (Up to 24 Weeks)|Adverse Event|2|||
27881502|NCT01697592|54501819|FG002|Phase A (Up to 24 Weeks)|Adverse Event|1|||
27881503|NCT01697592|54501820|FG003|Phase A (Up to 24 Weeks)|Adverse Event|2|||
27881504|NCT01697592|54501821|FG004|Phase A (Up to 24 Weeks)|Adverse Event|0|||
27881505|NCT01697592|54501822|FG005|Phase A (Up to 24 Weeks)|Adverse Event|0|||
27881506|NCT01697592|54501823|FG006|Phase A (Up to 24 Weeks)|Adverse Event|1|||
27881507|NCT01697592|54501824|FG007|Phase A (Up to 24 Weeks)|Adverse Event|0|||
27881508|NCT01697592|54501825|FG008|Phase A (Up to 24 Weeks)|Adverse Event|0|||
27881509|NCT01697592|54501826|FG009|Phase A (Up to 24 Weeks)|Adverse Event|1|||
27881510|NCT01697592|54501817|FG000|Phase B (Week 25 to Week 52)|Physician Decision|1|||
27881511|NCT01697592|54501818|FG001|Phase B (Week 25 to Week 52)|Physician Decision|0|||
27881512|NCT01697592|54501819|FG002|Phase B (Week 25 to Week 52)|Physician Decision|0|||
27881513|NCT01697592|54501820|FG003|Phase B (Week 25 to Week 52)|Physician Decision|1|||
27881514|NCT01697592|54501821|FG004|Phase B (Week 25 to Week 52)|Physician Decision|0|||
27881515|NCT01697592|54501822|FG005|Phase B (Week 25 to Week 52)|Physician Decision|0|||
27881516|NCT01697592|54501823|FG006|Phase B (Week 25 to Week 52)|Physician Decision|0|||
27881517|NCT01697592|54501824|FG007|Phase B (Week 25 to Week 52)|Physician Decision|0|||
27881518|NCT01697592|54501825|FG008|Phase B (Week 25 to Week 52)|Physician Decision|0|||
27881519|NCT01697592|54501826|FG009|Phase B (Week 25 to Week 52)|Physician Decision|0|||
27881520|NCT01697592|54501817|FG000|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2|||
27881521|NCT01697592|54501818|FG001|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
27881522|NCT01697592|54501819|FG002|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
27881523|NCT01697592|54501820|FG003|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
27881524|NCT01697592|54501821|FG004|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
27881525|NCT01697592|54501822|FG005|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
27881526|NCT01697592|54501823|FG006|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
27881527|NCT01697592|54501824|FG007|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
27881528|NCT01697592|54501825|FG008|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
27881529|NCT01697592|54501826|FG009|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
27881530|NCT01697592|54501817|FG000|Phase B (Week 25 to Week 52)|Adverse Event|2|||
27881531|NCT01697592|54501818|FG001|Phase B (Week 25 to Week 52)|Adverse Event|1|||
27881532|NCT01697592|54501819|FG002|Phase B (Week 25 to Week 52)|Adverse Event|1|||
27881533|NCT01697592|54501820|FG003|Phase B (Week 25 to Week 52)|Adverse Event|2|||
27881534|NCT01697592|54501821|FG004|Phase B (Week 25 to Week 52)|Adverse Event|0|||
27881535|NCT01697592|54501822|FG005|Phase B (Week 25 to Week 52)|Adverse Event|1|||
27881536|NCT01697592|54501823|FG006|Phase B (Week 25 to Week 52)|Adverse Event|1|||
27881537|NCT01697592|54501824|FG007|Phase B (Week 25 to Week 52)|Adverse Event|0|||
27881538|NCT01697592|54501825|FG008|Phase B (Week 25 to Week 52)|Adverse Event|2|||
27881539|NCT01697592|54501826|FG009|Phase B (Week 25 to Week 52)|Adverse Event|0|||
27881540|NCT01744782|54501862|FG000|Overall Study|Death|1|||
27881541|NCT01744392|54501866|FG000|Overall Study|Physician Decision|1|||
27881542|NCT01604850|54501873|FG000|Overall Study|Enrolled but never treated|0|||
27881543|NCT01604850|54501874|FG001|Overall Study|Enrolled but never treated|1|||
27881544|NCT01604850|54501873|FG000|Overall Study|Efficacy Failure|50|||
27881545|NCT01604850|54501874|FG001|Overall Study|Efficacy Failure|29|||
27881546|NCT01604850|54501873|FG000|Overall Study|Lost to Follow-up|1|||
27881547|NCT01604850|54501874|FG001|Overall Study|Lost to Follow-up|0|||
27881548|NCT01604850|54501873|FG000|Overall Study|Subject withdrew consent|1|||
27881549|NCT01604850|54501874|FG001|Overall Study|Subject withdrew consent|0|||
27881550|NCT01742286|54501887|FG000|Escalation Phase|Administrative problems|1|||
27881551|NCT01742286|54501888|FG001|Escalation Phase|Administrative problems|1|||
27881552|NCT01742286|54501889|FG002|Escalation Phase|Administrative problems|0|||
27881553|NCT01742286|54501890|FG003|Escalation Phase|Administrative problems|0|||
27881554|NCT01742286|54501891|FG004|Escalation Phase|Administrative problems|0|||
27881555|NCT01742286|54501892|FG005|Escalation Phase|Administrative problems|0|||
27881556|NCT01742286|54501893|FG006|Escalation Phase|Administrative problems|2|||
27881557|NCT01742286|54501887|FG000|Escalation Phase|Adverse Event|0|||
27881558|NCT01742286|54501888|FG001|Escalation Phase|Adverse Event|1|||
27983799|NCT00914927|54642210|FG005|Overall Study|Withdrawal by Subject|0|||
27983800|NCT00914927|54642211|FG006|Overall Study|Withdrawal by Subject|0|||
27983801|NCT00914927|54642205|FG000|Overall Study|Lost to Follow-up|0|||
27983802|NCT00914927|54642206|FG001|Overall Study|Lost to Follow-up|0|||
27983803|NCT00914927|54642207|FG002|Overall Study|Lost to Follow-up|0|||
27983804|NCT00914927|54642208|FG003|Overall Study|Lost to Follow-up|1|||
27983805|NCT00914927|54642209|FG004|Overall Study|Lost to Follow-up|0|||
27983806|NCT00914927|54642210|FG005|Overall Study|Lost to Follow-up|0|||
27983807|NCT00914927|54642211|FG006|Overall Study|Lost to Follow-up|0|||
27983808|NCT00914927|54642205|FG000|Overall Study|Administrative/Other|2|||
27983809|NCT00914927|54642206|FG001|Overall Study|Administrative/Other|1|||
27983810|NCT00914927|54642207|FG002|Overall Study|Administrative/Other|0|||
27983811|NCT00914927|54642208|FG003|Overall Study|Administrative/Other|0|||
27983812|NCT00914927|54642209|FG004|Overall Study|Administrative/Other|1|||
27983813|NCT00914927|54642210|FG005|Overall Study|Administrative/Other|0|||
27983814|NCT00914927|54642211|FG006|Overall Study|Administrative/Other|0|||
27983815|NCT00914849|54642238|FG000|Overall Study|Withdrawal by Subject|1|||
27983816|NCT00914849|54642239|FG001|Overall Study|Withdrawal by Subject|0|||
27983817|NCT00914849|54642238|FG000|Overall Study|Not eligible|0|||
27983818|NCT00914849|54642239|FG001|Overall Study|Not eligible|1|||
27983819|NCT00912743|54642247|FG000|Overall Study|Adverse Event|3|||
27983820|NCT00912743|54642248|FG001|Overall Study|Adverse Event|1|||
27983821|NCT00912743|54642247|FG000|Overall Study|Lack of Efficacy|9|||
27983822|NCT00912743|54642248|FG001|Overall Study|Lack of Efficacy|18|||
27983823|NCT00912743|54642247|FG000|Overall Study|Toxicity|0|||
27983824|NCT00912743|54642248|FG001|Overall Study|Toxicity|1|||
27983825|NCT00912743|54642247|FG000|Overall Study|End of treatment form was not collected|1|||
27983826|NCT00912743|54642248|FG001|Overall Study|End of treatment form was not collected|0|||
27983827|NCT00914459|54642256|FG000|Overall Study|Protocol Violation|0|||
27983828|NCT00914459|54642257|FG001|Overall Study|Protocol Violation|1|||
27983829|NCT00914459|54642256|FG000|Overall Study|Parent/Legal guardian request|1|||
27983830|NCT00914459|54642257|FG001|Overall Study|Parent/Legal guardian request|0|||
27983831|NCT00912509|54642267|FG000|Overall Study|Lost to Follow-up|1|||
27983832|NCT00912509|54642268|FG001|Overall Study|Lost to Follow-up|0|||
27983833|NCT00912509|54642267|FG000|Overall Study|Lack of Efficacy|4|||
27983834|NCT00912509|54642268|FG001|Overall Study|Lack of Efficacy|3|||
27983835|NCT00913835|54642288|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2|||
27983836|NCT00913835|54642289|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3|||
27983837|NCT00913835|54642288|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1|||
27983838|NCT00913835|54642289|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0|||
27983839|NCT00913835|54642288|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Other|4|||
27983840|NCT00913835|54642289|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Other|3|||
27983841|NCT00913835|54642288|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
27983842|NCT00913835|54642289|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
27983843|NCT00913835|54642288|FG000|Lip Dox: Olaratumab Monotherapy|Other|0|||
27983844|NCT00913835|54642289|FG001|Lip Dox: Olaratumab Monotherapy|Other|3|||
27983845|NCT00913523|54642314|FG000|Overall Study|Withdrawal by Subject|3|||
27983846|NCT00913523|54642315|FG001|Overall Study|Withdrawal by Subject|2|||
27983847|NCT00913523|54642316|FG002|Overall Study|Withdrawal by Subject|2|||
27983848|NCT00913523|54642314|FG000|Overall Study|Lost to Follow-up|1|||
27983849|NCT00913523|54642315|FG001|Overall Study|Lost to Follow-up|1|||
27983850|NCT00913523|54642316|FG002|Overall Study|Lost to Follow-up|1|||
27983851|NCT00913523|54642314|FG000|Overall Study|Adverse Event|1|||
27983852|NCT00913523|54642315|FG001|Overall Study|Adverse Event|0|||
27983853|NCT00913523|54642316|FG002|Overall Study|Adverse Event|0|||
27881559|NCT01742286|54501889|FG002|Escalation Phase|Adverse Event|2|||
27881560|NCT01742286|54501890|FG003|Escalation Phase|Adverse Event|0|||
27881561|NCT01742286|54501891|FG004|Escalation Phase|Adverse Event|0|||
27881562|NCT01742286|54501892|FG005|Escalation Phase|Adverse Event|1|||
27881563|NCT01742286|54501893|FG006|Escalation Phase|Adverse Event|0|||
27881564|NCT01742286|54501887|FG000|Escalation Phase|Disease progression|3|||
27881565|NCT01742286|54501888|FG001|Escalation Phase|Disease progression|7|||
27881566|NCT01742286|54501889|FG002|Escalation Phase|Disease progression|4|||
27881567|NCT01742286|54501890|FG003|Escalation Phase|Disease progression|1|||
27881568|NCT01742286|54501891|FG004|Escalation Phase|Disease progression|4|||
27881569|NCT01742286|54501892|FG005|Escalation Phase|Disease progression|3|||
27881570|NCT01742286|54501893|FG006|Escalation Phase|Disease progression|2|||
27881571|NCT01742286|54501887|FG000|Escalation Phase|Death|0|||
27881572|NCT01742286|54501888|FG001|Escalation Phase|Death|0|||
27881573|NCT01742286|54501889|FG002|Escalation Phase|Death|0|||
27881574|NCT01742286|54501890|FG003|Escalation Phase|Death|0|||
27881575|NCT01742286|54501891|FG004|Escalation Phase|Death|0|||
27881576|NCT01742286|54501892|FG005|Escalation Phase|Death|1|||
27881577|NCT01742286|54501893|FG006|Escalation Phase|Death|0|||
27881578|NCT01742286|54501887|FG000|Escalation Phase|Physician Decision|0|||
27881579|NCT01742286|54501888|FG001|Escalation Phase|Physician Decision|3|||
27881580|NCT01742286|54501889|FG002|Escalation Phase|Physician Decision|0|||
27881581|NCT01742286|54501890|FG003|Escalation Phase|Physician Decision|1|||
27881582|NCT01742286|54501891|FG004|Escalation Phase|Physician Decision|0|||
27881583|NCT01742286|54501892|FG005|Escalation Phase|Physician Decision|0|||
27881584|NCT01742286|54501893|FG006|Escalation Phase|Physician Decision|2|||
27881585|NCT01742286|54501887|FG000|Escalation Phase|Subject/guardian decision|1|||
27881586|NCT01742286|54501888|FG001|Escalation Phase|Subject/guardian decision|0|||
27881587|NCT01742286|54501889|FG002|Escalation Phase|Subject/guardian decision|0|||
27881588|NCT01742286|54501890|FG003|Escalation Phase|Subject/guardian decision|0|||
27881589|NCT01742286|54501891|FG004|Escalation Phase|Subject/guardian decision|0|||
27881590|NCT01742286|54501892|FG005|Escalation Phase|Subject/guardian decision|0|||
27881591|NCT01742286|54501893|FG006|Escalation Phase|Subject/guardian decision|0|||
27881592|NCT01742286|54501887|FG000|Expansion Phase|Administrative problems|0|||
27881593|NCT01742286|54501888|FG001|Expansion Phase|Administrative problems|0|||
27881594|NCT01742286|54501889|FG002|Expansion Phase|Administrative problems|0|||
27881595|NCT01742286|54501890|FG003|Expansion Phase|Administrative problems|0|||
27881596|NCT01742286|54501891|FG004|Expansion Phase|Administrative problems|0|||
27881597|NCT01742286|54501892|FG005|Expansion Phase|Administrative problems|0|||
27881598|NCT01742286|54501893|FG006|Expansion Phase|Administrative problems|5|||
27881599|NCT01742286|54501887|FG000|Expansion Phase|Physician Decision|0|||
27881600|NCT01742286|54501888|FG001|Expansion Phase|Physician Decision|0|||
27881601|NCT01742286|54501889|FG002|Expansion Phase|Physician Decision|4|||
27881602|NCT01742286|54501890|FG003|Expansion Phase|Physician Decision|0|||
27881603|NCT01742286|54501891|FG004|Expansion Phase|Physician Decision|0|||
27881604|NCT01742286|54501892|FG005|Expansion Phase|Physician Decision|0|||
27881605|NCT01742286|54501893|FG006|Expansion Phase|Physician Decision|9|||
27881606|NCT01742286|54501887|FG000|Expansion Phase|Adverse Event|0|||
27881607|NCT01742286|54501888|FG001|Expansion Phase|Adverse Event|0|||
27881608|NCT01742286|54501889|FG002|Expansion Phase|Adverse Event|0|||
27881609|NCT01742286|54501890|FG003|Expansion Phase|Adverse Event|0|||
27881610|NCT01742286|54501891|FG004|Expansion Phase|Adverse Event|0|||
27881611|NCT01742286|54501892|FG005|Expansion Phase|Adverse Event|0|||
27881612|NCT01742286|54501893|FG006|Expansion Phase|Adverse Event|6|||
27881613|NCT01742286|54501887|FG000|Expansion Phase|Disease progression|0|||
27881614|NCT01742286|54501888|FG001|Expansion Phase|Disease progression|0|||
27881615|NCT01742286|54501889|FG002|Expansion Phase|Disease progression|3|||
27881616|NCT01742286|54501890|FG003|Expansion Phase|Disease progression|0|||
27881617|NCT01742286|54501891|FG004|Expansion Phase|Disease progression|0|||
27881618|NCT01742286|54501892|FG005|Expansion Phase|Disease progression|0|||
27881619|NCT01742286|54501893|FG006|Expansion Phase|Disease progression|15|||
27881620|NCT01742286|54501887|FG000|Expansion Phase|Withdrawal by Subject|0|||
27881621|NCT01742286|54501888|FG001|Expansion Phase|Withdrawal by Subject|0|||
27881622|NCT01742286|54501889|FG002|Expansion Phase|Withdrawal by Subject|0|||
27881623|NCT01742286|54501890|FG003|Expansion Phase|Withdrawal by Subject|0|||
27881624|NCT01742286|54501891|FG004|Expansion Phase|Withdrawal by Subject|0|||
27881625|NCT01742286|54501892|FG005|Expansion Phase|Withdrawal by Subject|0|||
27983854|NCT00913523|54642314|FG000|Overall Study|Protocol Violation|5|||
28171745|NCT02442778|54843317|FG001|Overall Study|Protocol Deviation|0|||
27881626|NCT01742286|54501893|FG006|Expansion Phase|Withdrawal by Subject|1|||
27881627|NCT01697358|54501918|FG000|Period I: Randomization to 6 Months|Withdrawal by Subject|6|||
27881628|NCT01697358|54501919|FG001|Period I: Randomization to 6 Months|Withdrawal by Subject|0|||
27881629|NCT01697358|54501918|FG000|Period I: Randomization to 6 Months|Physician Decision|4|||
27881630|NCT01697358|54501919|FG001|Period I: Randomization to 6 Months|Physician Decision|0|||
27881631|NCT01697358|54501918|FG000|Period I: Randomization to 6 Months|Adverse Event|1|||
27881632|NCT01697358|54501919|FG001|Period I: Randomization to 6 Months|Adverse Event|1|||
27881633|NCT01697358|54501918|FG000|Period I: Randomization to 6 Months|Lost to Follow-up|2|||
27881634|NCT01697358|54501919|FG001|Period I: Randomization to 6 Months|Lost to Follow-up|0|||
27881635|NCT01697358|54501918|FG000|Period II: 6-24M Long-term Follow-up|Physician Decision|3|||
27881636|NCT01697358|54501919|FG001|Period II: 6-24M Long-term Follow-up|Physician Decision|12|||
27881637|NCT01697358|54501918|FG000|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8|||
27881638|NCT01697358|54501919|FG001|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10|||
27881639|NCT01697358|54501918|FG000|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
27983855|NCT00913523|54642315|FG001|Overall Study|Protocol Violation|8|||
27983856|NCT00913523|54642316|FG002|Overall Study|Protocol Violation|8|||
27983857|NCT00913523|54642314|FG000|Overall Study|Pregnancy|1|||
27983858|NCT00913523|54642315|FG001|Overall Study|Pregnancy|3|||
27983859|NCT00913523|54642316|FG002|Overall Study|Pregnancy|0|||
27983860|NCT00913523|54642314|FG000|Overall Study|Inadequate Number of Tampons Used|7|||
27983861|NCT00913523|54642315|FG001|Overall Study|Inadequate Number of Tampons Used|2|||
27983862|NCT00913523|54642316|FG002|Overall Study|Inadequate Number of Tampons Used|3|||
27983863|NCT00912197|54642326|FG000|Overall Study|Withdrawal by Subject|3|||
27983864|NCT00912197|54642327|FG001|Overall Study|Withdrawal by Subject|3|||
27983865|NCT00910247|54642335|FG000|Overall Study|Adverse Event|15|||
27983866|NCT00910247|54642335|FG000|Overall Study|Death|2|||
27983867|NCT00910247|54642335|FG000|Overall Study|Lost to Follow-up|10|||
27983868|NCT00910247|54642335|FG000|Overall Study|Physician Decision|3|||
27983869|NCT00910247|54642335|FG000|Overall Study|Protocol Violation|10|||
27983870|NCT00910247|54642335|FG000|Overall Study|Withdrawal by Subject|25|||
27983871|NCT00910247|54642335|FG000|Overall Study|Not collected|4|||
27983872|NCT00659334|54642346|FG000|Overall Study|Screen Failure|8|||
27983873|NCT00659334|54642347|FG001|Overall Study|Screen Failure|5|||
27983874|NCT00659334|54642348|FG002|Overall Study|Screen Failure|0|||
27983875|NCT00659334|54642349|FG003|Overall Study|Screen Failure|0|||
27983876|NCT00659334|54642350|FG004|Overall Study|Screen Failure|0|||
27983877|NCT00659334|54642351|FG005|Overall Study|Screen Failure|0|||
27983878|NCT00659334|54642352|FG006|Overall Study|Screen Failure|1|||
27983879|NCT00910091|54642374|FG000|Pre-assignment|Withdrawal by Subject|0|||
27983880|NCT00910091|54642375|FG001|Pre-assignment|Withdrawal by Subject|2|||
27983881|NCT00910091|54642374|FG000|Treatment and Survival|Withdrawal by Subject|3|||
27983882|NCT00910091|54642375|FG001|Treatment and Survival|Withdrawal by Subject|4|||
27983883|NCT00910091|54642374|FG000|Treatment and Survival|Adverse Event|1|||
27983884|NCT00910091|54642375|FG001|Treatment and Survival|Adverse Event|0|||
27983885|NCT00909857|54642384|FG000|Overall Study|Withdrawal by Subject|6|||
27983886|NCT00909857|54642385|FG001|Overall Study|Withdrawal by Subject|10|||
27983887|NCT00909857|54642384|FG000|Overall Study|Adverse Event|5|||
27983888|NCT00909857|54642385|FG001|Overall Study|Adverse Event|5|||
27983889|NCT00909857|54642384|FG000|Overall Study|Lost to Follow-up|2|||
27983890|NCT00909857|54642385|FG001|Overall Study|Lost to Follow-up|5|||
27983891|NCT00909857|54642384|FG000|Overall Study|Protocol Violation|2|||
27983892|NCT00909857|54642385|FG001|Overall Study|Protocol Violation|1|||
27983893|NCT00909857|54642384|FG000|Overall Study|Pregnancy|1|||
27983894|NCT00909857|54642385|FG001|Overall Study|Pregnancy|0|||
27983895|NCT00909857|54642384|FG000|Overall Study|Other|1|||
27983896|NCT00909857|54642385|FG001|Overall Study|Other|0|||
27983897|NCT00909857|54642384|FG000|Overall Study|Did not receive study medication|19|||
27983898|NCT00909857|54642385|FG001|Overall Study|Did not receive study medication|24|||
27983899|NCT00911807|54642394|FG000|Overall Study|Adverse Event|2|||
27983900|NCT00911807|54642395|FG001|Overall Study|Adverse Event|1|||
27983901|NCT00911807|54642396|FG002|Overall Study|Adverse Event|5|||
27983902|NCT00911807|54642394|FG000|Overall Study|Death|0|||
27983903|NCT00911807|54642395|FG001|Overall Study|Death|0|||
27983904|NCT00911807|54642396|FG002|Overall Study|Death|1|||
27983905|NCT00911807|54642394|FG000|Overall Study|Protocol Violation|6|||
27983906|NCT00911807|54642395|FG001|Overall Study|Protocol Violation|4|||
27983907|NCT00911807|54642396|FG002|Overall Study|Protocol Violation|9|||
27983908|NCT00911807|54642394|FG000|Overall Study|Withdrawal by Subject|8|||
27983909|NCT00911807|54642395|FG001|Overall Study|Withdrawal by Subject|10|||
27983910|NCT00911807|54642396|FG002|Overall Study|Withdrawal by Subject|7|||
27983911|NCT00911807|54642394|FG000|Overall Study|Organizational reasons|1|||
27983912|NCT00911807|54642395|FG001|Overall Study|Organizational reasons|3|||
27983913|NCT00911807|54642396|FG002|Overall Study|Organizational reasons|1|||
27983914|NCT04287920|54642423|FG000|Overall Study|Lost to Follow-up|1|||
27881640|NCT01697358|54501919|FG001|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
28096535|NCT04402866|54751603|FG001|Overall Study|Lost to Follow-up|0|||
27881641|NCT01697358|54501918|FG000|Period II: 6-24M Long-term Follow-up|Death|1|||
27881642|NCT01697358|54501919|FG001|Period II: 6-24M Long-term Follow-up|Death|1|||
27983915|NCT04287920|54642424|FG001|Overall Study|Lost to Follow-up|1|||
27983916|NCT04287920|54642423|FG000|Overall Study|Withdrawal by Subject|0|||
27983917|NCT04287920|54642424|FG001|Overall Study|Withdrawal by Subject|3|||
27983918|NCT00909779|54642432|FG000|Overall Study|Adverse Event|53|||
27983919|NCT00909779|54642433|FG001|Overall Study|Adverse Event|55|||
27983920|NCT00909779|54642432|FG000|Overall Study|Lack of Efficacy|7|||
27983921|NCT00909779|54642433|FG001|Overall Study|Lack of Efficacy|4|||
27983922|NCT00909779|54642432|FG000|Overall Study|Lost to Follow-up|19|||
27983923|NCT00909779|54642433|FG001|Overall Study|Lost to Follow-up|15|||
28096536|NCT04402866|54751604|FG002|Overall Study|Lost to Follow-up|0|||
27881643|NCT01697358|54501918|FG000|Period II: 6-24M Long-term Follow-up|Adverse Event|0|||
27881644|NCT01697358|54501919|FG001|Period II: 6-24M Long-term Follow-up|Adverse Event|3|||
27881645|NCT01697358|54501918|FG000|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34|||
27881646|NCT01697358|54501919|FG001|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26|||
27881647|NCT01716234|54501932|FG000|Overall Study|Protocol Violation|0|||
27881648|NCT01716234|54501933|FG001|Overall Study|Protocol Violation|0|||
27881649|NCT01716234|54501934|FG002|Overall Study|Protocol Violation|0|||
27881650|NCT01716234|54501935|FG003|Overall Study|Protocol Violation|1|||
27881651|NCT01716234|54501936|FG004|Overall Study|Protocol Violation|1|||
27881652|NCT01716234|54501937|FG005|Overall Study|Protocol Violation|1|||
27881653|NCT01716234|54501938|FG006|Overall Study|Protocol Violation|0|||
27881654|NCT01716234|54501932|FG000|Overall Study|Lack of Efficacy|0|||
27881655|NCT01716234|54501933|FG001|Overall Study|Lack of Efficacy|0|||
27881656|NCT01716234|54501934|FG002|Overall Study|Lack of Efficacy|0|||
27881657|NCT01716234|54501935|FG003|Overall Study|Lack of Efficacy|1|||
27881658|NCT01716234|54501936|FG004|Overall Study|Lack of Efficacy|0|||
27881659|NCT01716234|54501937|FG005|Overall Study|Lack of Efficacy|0|||
27881660|NCT01716234|54501938|FG006|Overall Study|Lack of Efficacy|0|||
27881661|NCT01716234|54501932|FG000|Overall Study|Did not meet protocol eligibility|0|||
27881662|NCT01716234|54501933|FG001|Overall Study|Did not meet protocol eligibility|0|||
27881663|NCT01716234|54501934|FG002|Overall Study|Did not meet protocol eligibility|1|||
27881664|NCT01716234|54501935|FG003|Overall Study|Did not meet protocol eligibility|0|||
27881665|NCT01716234|54501936|FG004|Overall Study|Did not meet protocol eligibility|0|||
27881666|NCT01716234|54501937|FG005|Overall Study|Did not meet protocol eligibility|4|||
27881667|NCT01716234|54501938|FG006|Overall Study|Did not meet protocol eligibility|0|||
27881668|NCT01716234|54501932|FG000|Overall Study|Adverse Event|7|||
27881669|NCT01716234|54501933|FG001|Overall Study|Adverse Event|10|||
27881670|NCT01716234|54501934|FG002|Overall Study|Adverse Event|2|||
27881671|NCT01716234|54501935|FG003|Overall Study|Adverse Event|8|||
27881672|NCT01716234|54501936|FG004|Overall Study|Adverse Event|3|||
27881673|NCT01716234|54501937|FG005|Overall Study|Adverse Event|6|||
27881674|NCT01716234|54501938|FG006|Overall Study|Adverse Event|0|||
27881675|NCT01716234|54501932|FG000|Overall Study|Withdrawal by Subject|3|||
27881676|NCT01716234|54501933|FG001|Overall Study|Withdrawal by Subject|0|||
27881677|NCT01716234|54501934|FG002|Overall Study|Withdrawal by Subject|2|||
27881678|NCT01716234|54501935|FG003|Overall Study|Withdrawal by Subject|2|||
27881679|NCT01716234|54501936|FG004|Overall Study|Withdrawal by Subject|1|||
27881680|NCT01716234|54501937|FG005|Overall Study|Withdrawal by Subject|3|||
27881681|NCT01716234|54501938|FG006|Overall Study|Withdrawal by Subject|0|||
27881682|NCT01716156|54501957|FG000|Overall Study|Protocol Violation|1|||
27881683|NCT01716156|54501958|FG001|Overall Study|Protocol Violation|0|||
27881684|NCT01716156|54501959|FG002|Overall Study|Protocol Violation|0|||
27881685|NCT01716156|54501957|FG000|Overall Study|Withdrawal by Subject|0|||
27881686|NCT01716156|54501958|FG001|Overall Study|Withdrawal by Subject|1|||
27881687|NCT01716156|54501959|FG002|Overall Study|Withdrawal by Subject|2|||
27881688|NCT01716156|54501957|FG000|Overall Study|Lost to Follow-up|1|||
27881689|NCT01716156|54501958|FG001|Overall Study|Lost to Follow-up|0|||
27881690|NCT01716156|54501959|FG002|Overall Study|Lost to Follow-up|0|||
27881691|NCT01739790|54501973|FG000|Overall Study|Early Trial Termination|2|||
27881692|NCT01739790|54501974|FG001|Overall Study|Early Trial Termination|4|||
27881693|NCT01696032|54501984|FG000|Overall Study|Withdrawal by Subject|0|||
27881694|NCT01696032|54501985|FG001|Overall Study|Withdrawal by Subject|0|||
27881695|NCT01696032|54501986|FG002|Overall Study|Withdrawal by Subject|1|||
27881696|NCT01696032|54501987|FG003|Overall Study|Withdrawal by Subject|2|||
27881697|NCT01696032|54501984|FG000|Overall Study|Death|14|||
27881698|NCT01696032|54501985|FG001|Overall Study|Death|4|||
27881699|NCT01696032|54501986|FG002|Overall Study|Death|43|||
27881700|NCT01696032|54501987|FG003|Overall Study|Death|18|||
27881701|NCT01696032|54501984|FG000|Overall Study|Lost to Follow-up|0|||
27881702|NCT01696032|54501985|FG001|Overall Study|Lost to Follow-up|1|||
27881703|NCT01696032|54501986|FG002|Overall Study|Lost to Follow-up|0|||
27881704|NCT01696032|54501987|FG003|Overall Study|Lost to Follow-up|0|||
27881705|NCT01696032|54501984|FG000|Overall Study|Database lock|0|||
27881706|NCT01696032|54501985|FG001|Overall Study|Database lock|1|||
27881707|NCT01696032|54501986|FG002|Overall Study|Database lock|7|||
27881708|NCT01696032|54501987|FG003|Overall Study|Database lock|2|||
27881709|NCT01695954|54502003|FG000|Overall Study|Withdrawal by Subject|4|||
27881710|NCT01695954|54502004|FG001|Overall Study|Withdrawal by Subject|0|||
27881711|NCT01695954|54502003|FG000|Overall Study|Adverse Event|0|||
27881712|NCT01695954|54502004|FG001|Overall Study|Adverse Event|2|||
27881713|NCT01694706|54502012|FG000|Overall Study|Adverse Event|0|||
27881714|NCT01694706|54502013|FG001|Overall Study|Adverse Event|1|||
27881715|NCT01694706|54502014|FG002|Overall Study|Adverse Event|0|||
27881716|NCT01694706|54502012|FG000|Overall Study|other reason not defined above|1|||
27881717|NCT01694706|54502013|FG001|Overall Study|other reason not defined above|0|||
27881718|NCT01694706|54502014|FG002|Overall Study|other reason not defined above|0|||
27881719|NCT01693692|54502026|FG000|Overall Study|Withdrawal by Subject|12|||
27881720|NCT01693692|54502027|FG001|Overall Study|Withdrawal by Subject|10|||
27881721|NCT01693692|54502028|FG002|Overall Study|Withdrawal by Subject|11|||
27881722|NCT01693692|54502026|FG000|Overall Study|Adverse Event|7|||
27881723|NCT01693692|54502027|FG001|Overall Study|Adverse Event|14|||
27881724|NCT01693692|54502028|FG002|Overall Study|Adverse Event|9|||
27881725|NCT01693692|54502026|FG000|Overall Study|Physician Decision|0|||
27881726|NCT01693692|54502027|FG001|Overall Study|Physician Decision|0|||
27881727|NCT01693692|54502028|FG002|Overall Study|Physician Decision|1|||
27881728|NCT01693692|54502026|FG000|Overall Study|Protocol Violation|5|||
27881729|NCT01693692|54502027|FG001|Overall Study|Protocol Violation|4|||
27881730|NCT01693692|54502028|FG002|Overall Study|Protocol Violation|6|||
27881731|NCT01693692|54502026|FG000|Overall Study|Lost to Follow-up|2|||
27881732|NCT01693692|54502027|FG001|Overall Study|Lost to Follow-up|2|||
27881733|NCT01693692|54502028|FG002|Overall Study|Lost to Follow-up|3|||
27881734|NCT01693692|54502026|FG000|Overall Study|Other|4|||
27881735|NCT01693692|54502027|FG001|Overall Study|Other|4|||
27881736|NCT01693692|54502028|FG002|Overall Study|Other|6|||
27881737|NCT01693614|54502039|FG000|Overall Study|Adverse Event|7|||
27881738|NCT01693614|54502040|FG001|Overall Study|Adverse Event|11|||
27881739|NCT01693614|54502041|FG002|Overall Study|Adverse Event|5|||
27881740|NCT01693614|54502039|FG000|Overall Study|Disease progression|11|||
27881741|NCT01693614|54502040|FG001|Overall Study|Disease progression|8|||
27881742|NCT01693614|54502041|FG002|Overall Study|Disease progression|7|||
27881743|NCT01693614|54502039|FG000|Overall Study|Protocol Violation|5|||
27881744|NCT01693614|54502040|FG001|Overall Study|Protocol Violation|2|||
27881745|NCT01693614|54502041|FG002|Overall Study|Protocol Violation|1|||
27881746|NCT01693614|54502039|FG000|Overall Study|Death|1|||
27881747|NCT01693614|54502040|FG001|Overall Study|Death|0|||
27881748|NCT01693614|54502041|FG002|Overall Study|Death|0|||
27881749|NCT01693614|54502039|FG000|Overall Study|Physician Decision|1|||
27881750|NCT01693614|54502040|FG001|Overall Study|Physician Decision|1|||
27881751|NCT01693614|54502041|FG002|Overall Study|Physician Decision|4|||
27881752|NCT01693614|54502039|FG000|Overall Study|Withdrawal by subject/guardian|0|||
27881753|NCT01693614|54502040|FG001|Overall Study|Withdrawal by subject/guardian|0|||
27881754|NCT01693614|54502041|FG002|Overall Study|Withdrawal by subject/guardian|2|||
27881755|NCT01693614|54502039|FG000|Overall Study|Withdrawal by Subject|1|||
27881756|NCT01693614|54502040|FG001|Overall Study|Withdrawal by Subject|0|||
27983924|NCT00909779|54642432|FG000|Overall Study|Physician Decision|8|||
27983925|NCT00909779|54642433|FG001|Overall Study|Physician Decision|2|||
27983926|NCT00909779|54642432|FG000|Overall Study|Protocol Violation|2|||
27983927|NCT00909779|54642433|FG001|Overall Study|Protocol Violation|5|||
27983928|NCT00909779|54642432|FG000|Overall Study|Withdrawal by Subject|116|||
27983929|NCT00909779|54642433|FG001|Overall Study|Withdrawal by Subject|80|||
27983930|NCT00909779|54642432|FG000|Overall Study|Site Ceasing Operation|2|||
27983931|NCT00909779|54642433|FG001|Overall Study|Site Ceasing Operation|2|||
27983932|NCT00909779|54642432|FG000|Overall Study|Medical Monitor Decision|1|||
27983933|NCT00909779|54642433|FG001|Overall Study|Medical Monitor Decision|0|||
27983934|NCT00909779|54642432|FG000|Overall Study|Noncompliance|1|||
27983935|NCT00909779|54642433|FG001|Overall Study|Noncompliance|1|||
27983936|NCT00909779|54642432|FG000|Overall Study|Randomized in error|1|||
27983937|NCT00909779|54642433|FG001|Overall Study|Randomized in error|1|||
27983938|NCT00910871|54642441|FG000|Overall Study|Adverse Event|5|||
27983939|NCT00910871|54642441|FG000|Overall Study|Death|12|||
27983940|NCT00910871|54642441|FG000|Overall Study|Lost to Follow-up|8|||
27983941|NCT00910871|54642441|FG000|Overall Study|Protocol Violation|11|||
27983942|NCT00910871|54642441|FG000|Overall Study|Withdrawal by Subject|12|||
27983943|NCT00910871|54642441|FG000|Overall Study|Subject didn't meet eligibility criteria|5|||
27983944|NCT00910871|54642441|FG000|Overall Study|Undefined|1|||
27983945|NCT02631941|54642466|FG000|Overall Study|Physician Decision|0|||
27983946|NCT02631941|54642467|FG001|Overall Study|Physician Decision|1|||
27983947|NCT02631941|54642468|FG002|Overall Study|Physician Decision|0|||
27983948|NCT02631941|54642469|FG003|Overall Study|Physician Decision|0|||
27983949|NCT02631941|54642470|FG004|Overall Study|Physician Decision|0|||
27983950|NCT02631941|54642471|FG005|Overall Study|Physician Decision|0|||
27983951|NCT02631941|54642472|FG006|Overall Study|Physician Decision|0|||
27983952|NCT02631941|54642473|FG007|Overall Study|Physician Decision|0|||
27881757|NCT01693614|54502041|FG002|Overall Study|Withdrawal by Subject|5|||
27983953|NCT02631941|54642474|FG008|Overall Study|Physician Decision|0|||
27983954|NCT02631941|54642475|FG009|Overall Study|Physician Decision|0|||
27983955|NCT02631941|54642466|FG000|Overall Study|Adverse Event|0|||
27881758|NCT01715298|54502052|FG000|Overall Study|Lost to Follow-up|0|||
27881759|NCT01715298|54502053|FG001|Overall Study|Lost to Follow-up|2|||
27881760|NCT01715298|54502052|FG000|Overall Study|Patient/guardian decision|7|||
27881761|NCT01715298|54502053|FG001|Overall Study|Patient/guardian decision|9|||
27881762|NCT01713582|54502080|FG000|Overall Study|Disease progression|3|||
27881763|NCT01713582|54502081|FG001|Overall Study|Disease progression|3|||
27881764|NCT01713582|54502082|FG002|Overall Study|Disease progression|3|||
27881765|NCT01713582|54502083|FG003|Overall Study|Disease progression|2|||
27881766|NCT01713582|54502084|FG004|Overall Study|Disease progression|3|||
27983956|NCT02631941|54642467|FG001|Overall Study|Adverse Event|1|||
27881767|NCT01713582|54502085|FG005|Overall Study|Disease progression|3|||
27881768|NCT01713582|54502086|FG006|Overall Study|Disease progression|3|||
27881769|NCT01713582|54502087|FG007|Overall Study|Disease progression|3|||
27881770|NCT01713582|54502088|FG008|Overall Study|Disease progression|3|||
27881771|NCT01713582|54502089|FG009|Overall Study|Disease progression|11|||
27881772|NCT01713582|54502090|FG010|Overall Study|Disease progression|10|||
27881773|NCT01713582|54502091|FG011|Overall Study|Disease progression|5|||
27881774|NCT01713582|54502092|FG012|Overall Study|Disease progression|3|||
27881775|NCT01713582|54502093|FG013|Overall Study|Disease progression|3|||
27881776|NCT01713582|54502094|FG014|Overall Study|Disease progression|6|||
27881777|NCT01713582|54502095|FG015|Overall Study|Disease progression|6|||
27881778|NCT01713582|54502096|FG016|Overall Study|Disease progression|5|||
27881779|NCT01713582|54502097|FG017|Overall Study|Disease progression|2|||
27881780|NCT01713582|54502098|FG018|Overall Study|Disease progression|3|||
27881781|NCT01713582|54502099|FG019|Overall Study|Disease progression|5|||
27881782|NCT01713582|54502100|FG020|Overall Study|Disease progression|15|||
27881783|NCT01713582|54502080|FG000|Overall Study|Death|0|||
27881784|NCT01713582|54502081|FG001|Overall Study|Death|0|||
27881785|NCT01713582|54502082|FG002|Overall Study|Death|0|||
27881786|NCT01713582|54502083|FG003|Overall Study|Death|1|||
27881787|NCT01713582|54502084|FG004|Overall Study|Death|1|||
27881788|NCT01713582|54502085|FG005|Overall Study|Death|3|||
27881789|NCT01713582|54502086|FG006|Overall Study|Death|3|||
27881790|NCT01713582|54502087|FG007|Overall Study|Death|2|||
27881791|NCT01713582|54502088|FG008|Overall Study|Death|3|||
27881792|NCT01713582|54502089|FG009|Overall Study|Death|4|||
27881793|NCT01713582|54502090|FG010|Overall Study|Death|3|||
27881794|NCT01713582|54502091|FG011|Overall Study|Death|0|||
27881795|NCT01713582|54502092|FG012|Overall Study|Death|0|||
27881796|NCT01713582|54502093|FG013|Overall Study|Death|0|||
27881797|NCT01713582|54502094|FG014|Overall Study|Death|0|||
27881798|NCT01713582|54502095|FG015|Overall Study|Death|0|||
27881799|NCT01713582|54502096|FG016|Overall Study|Death|0|||
27881800|NCT01713582|54502097|FG017|Overall Study|Death|0|||
27881801|NCT01713582|54502098|FG018|Overall Study|Death|0|||
27881802|NCT01713582|54502099|FG019|Overall Study|Death|0|||
27881803|NCT01713582|54502100|FG020|Overall Study|Death|0|||
27881804|NCT01713582|54502080|FG000|Overall Study|Adverse event-related|0|||
27881805|NCT01713582|54502081|FG001|Overall Study|Adverse event-related|0|||
27881806|NCT01713582|54502082|FG002|Overall Study|Adverse event-related|0|||
27881807|NCT01713582|54502083|FG003|Overall Study|Adverse event-related|0|||
27881808|NCT01713582|54502084|FG004|Overall Study|Adverse event-related|0|||
27881809|NCT01713582|54502085|FG005|Overall Study|Adverse event-related|0|||
27881810|NCT01713582|54502086|FG006|Overall Study|Adverse event-related|0|||
27881811|NCT01713582|54502087|FG007|Overall Study|Adverse event-related|0|||
27881812|NCT01713582|54502088|FG008|Overall Study|Adverse event-related|0|||
27881813|NCT01713582|54502089|FG009|Overall Study|Adverse event-related|1|||
27881814|NCT01713582|54502090|FG010|Overall Study|Adverse event-related|1|||
27881815|NCT01713582|54502091|FG011|Overall Study|Adverse event-related|0|||
27881816|NCT01713582|54502092|FG012|Overall Study|Adverse event-related|0|||
27881817|NCT01713582|54502093|FG013|Overall Study|Adverse event-related|0|||
27881818|NCT01713582|54502094|FG014|Overall Study|Adverse event-related|0|||
27881819|NCT01713582|54502095|FG015|Overall Study|Adverse event-related|0|||
27881820|NCT01713582|54502096|FG016|Overall Study|Adverse event-related|0|||
27881821|NCT01713582|54502097|FG017|Overall Study|Adverse event-related|0|||
27881822|NCT01713582|54502098|FG018|Overall Study|Adverse event-related|1|||
27881823|NCT01713582|54502099|FG019|Overall Study|Adverse event-related|0|||
27881824|NCT01713582|54502100|FG020|Overall Study|Adverse event-related|0|||
27881825|NCT01713582|54502080|FG000|Overall Study|Adverse event-unrelated|0|||
27881826|NCT01713582|54502081|FG001|Overall Study|Adverse event-unrelated|0|||
27881827|NCT01713582|54502082|FG002|Overall Study|Adverse event-unrelated|0|||
27881828|NCT01713582|54502083|FG003|Overall Study|Adverse event-unrelated|0|||
27983957|NCT02631941|54642468|FG002|Overall Study|Adverse Event|0|||
27881829|NCT01713582|54502084|FG004|Overall Study|Adverse event-unrelated|0|||
27881830|NCT01713582|54502085|FG005|Overall Study|Adverse event-unrelated|1|||
27881831|NCT01713582|54502086|FG006|Overall Study|Adverse event-unrelated|1|||
27881832|NCT01713582|54502087|FG007|Overall Study|Adverse event-unrelated|1|||
27881833|NCT01713582|54502088|FG008|Overall Study|Adverse event-unrelated|0|||
27881834|NCT01713582|54502089|FG009|Overall Study|Adverse event-unrelated|0|||
27983958|NCT02631941|54642469|FG003|Overall Study|Adverse Event|0|||
27881835|NCT01713582|54502090|FG010|Overall Study|Adverse event-unrelated|0|||
27881836|NCT01713582|54502091|FG011|Overall Study|Adverse event-unrelated|0|||
27881837|NCT01713582|54502092|FG012|Overall Study|Adverse event-unrelated|0|||
27881838|NCT01713582|54502093|FG013|Overall Study|Adverse event-unrelated|1|||
27881839|NCT01713582|54502094|FG014|Overall Study|Adverse event-unrelated|1|||
27881840|NCT01713582|54502095|FG015|Overall Study|Adverse event-unrelated|0|||
27881841|NCT01713582|54502096|FG016|Overall Study|Adverse event-unrelated|0|||
27881842|NCT01713582|54502097|FG017|Overall Study|Adverse event-unrelated|0|||
27881843|NCT01713582|54502098|FG018|Overall Study|Adverse event-unrelated|0|||
27983959|NCT02631941|54642470|FG004|Overall Study|Adverse Event|0|||
27881844|NCT01713582|54502099|FG019|Overall Study|Adverse event-unrelated|0|||
27881845|NCT01713582|54502100|FG020|Overall Study|Adverse event-unrelated|0|||
27881846|NCT01713582|54502080|FG000|Overall Study|Withdrawal of consent|0|||
27881847|NCT01713582|54502081|FG001|Overall Study|Withdrawal of consent|0|||
27881848|NCT01713582|54502082|FG002|Overall Study|Withdrawal of consent|1|||
27881849|NCT01713582|54502083|FG003|Overall Study|Withdrawal of consent|0|||
27881850|NCT01713582|54502084|FG004|Overall Study|Withdrawal of consent|0|||
27881851|NCT01713582|54502085|FG005|Overall Study|Withdrawal of consent|1|||
27881852|NCT01713582|54502086|FG006|Overall Study|Withdrawal of consent|0|||
27881853|NCT01713582|54502087|FG007|Overall Study|Withdrawal of consent|0|||
27881854|NCT01713582|54502088|FG008|Overall Study|Withdrawal of consent|0|||
27881855|NCT01713582|54502089|FG009|Overall Study|Withdrawal of consent|1|||
27881856|NCT01713582|54502090|FG010|Overall Study|Withdrawal of consent|0|||
27881857|NCT01713582|54502091|FG011|Overall Study|Withdrawal of consent|0|||
27881858|NCT01713582|54502092|FG012|Overall Study|Withdrawal of consent|0|||
27881859|NCT01713582|54502093|FG013|Overall Study|Withdrawal of consent|0|||
27881860|NCT01713582|54502094|FG014|Overall Study|Withdrawal of consent|0|||
27881861|NCT01713582|54502095|FG015|Overall Study|Withdrawal of consent|0|||
27881862|NCT01713582|54502096|FG016|Overall Study|Withdrawal of consent|0|||
27881863|NCT01713582|54502097|FG017|Overall Study|Withdrawal of consent|0|||
27881864|NCT01713582|54502098|FG018|Overall Study|Withdrawal of consent|1|||
27881865|NCT01713582|54502099|FG019|Overall Study|Withdrawal of consent|0|||
27881866|NCT01713582|54502100|FG020|Overall Study|Withdrawal of consent|0|||
27881867|NCT01713582|54502080|FG000|Overall Study|Lack of Efficacy|0|||
27881868|NCT01713582|54502081|FG001|Overall Study|Lack of Efficacy|0|||
27881869|NCT01713582|54502082|FG002|Overall Study|Lack of Efficacy|0|||
27881870|NCT01713582|54502083|FG003|Overall Study|Lack of Efficacy|0|||
27881871|NCT01713582|54502084|FG004|Overall Study|Lack of Efficacy|0|||
27881872|NCT01713582|54502085|FG005|Overall Study|Lack of Efficacy|0|||
27881873|NCT01713582|54502086|FG006|Overall Study|Lack of Efficacy|0|||
27881874|NCT01713582|54502087|FG007|Overall Study|Lack of Efficacy|0|||
27881875|NCT01713582|54502088|FG008|Overall Study|Lack of Efficacy|0|||
27881876|NCT01713582|54502089|FG009|Overall Study|Lack of Efficacy|1|||
27881877|NCT01713582|54502090|FG010|Overall Study|Lack of Efficacy|2|||
27881878|NCT01713582|54502091|FG011|Overall Study|Lack of Efficacy|0|||
27881879|NCT01713582|54502092|FG012|Overall Study|Lack of Efficacy|0|||
27881880|NCT01713582|54502093|FG013|Overall Study|Lack of Efficacy|0|||
27881881|NCT01713582|54502094|FG014|Overall Study|Lack of Efficacy|0|||
27881882|NCT01713582|54502095|FG015|Overall Study|Lack of Efficacy|0|||
27881883|NCT01713582|54502096|FG016|Overall Study|Lack of Efficacy|0|||
27881884|NCT01713582|54502097|FG017|Overall Study|Lack of Efficacy|0|||
27881885|NCT01713582|54502098|FG018|Overall Study|Lack of Efficacy|0|||
27881886|NCT01713582|54502099|FG019|Overall Study|Lack of Efficacy|0|||
27881887|NCT01713582|54502100|FG020|Overall Study|Lack of Efficacy|0|||
27881888|NCT01713582|54502080|FG000|Overall Study|Withdrawal by Subject|0|||
27881889|NCT01713582|54502081|FG001|Overall Study|Withdrawal by Subject|0|||
27881890|NCT01713582|54502082|FG002|Overall Study|Withdrawal by Subject|0|||
27881891|NCT01713582|54502083|FG003|Overall Study|Withdrawal by Subject|0|||
27881892|NCT01713582|54502084|FG004|Overall Study|Withdrawal by Subject|0|||
27881893|NCT01713582|54502085|FG005|Overall Study|Withdrawal by Subject|0|||
27881894|NCT01713582|54502086|FG006|Overall Study|Withdrawal by Subject|0|||
27881895|NCT01713582|54502087|FG007|Overall Study|Withdrawal by Subject|0|||
27881896|NCT01713582|54502088|FG008|Overall Study|Withdrawal by Subject|0|||
27881897|NCT01713582|54502089|FG009|Overall Study|Withdrawal by Subject|0|||
27881898|NCT01713582|54502090|FG010|Overall Study|Withdrawal by Subject|0|||
27881899|NCT01713582|54502091|FG011|Overall Study|Withdrawal by Subject|0|||
27881900|NCT01713582|54502092|FG012|Overall Study|Withdrawal by Subject|0|||
27881901|NCT01713582|54502093|FG013|Overall Study|Withdrawal by Subject|0|||
27881902|NCT01713582|54502094|FG014|Overall Study|Withdrawal by Subject|0|||
27881903|NCT01713582|54502095|FG015|Overall Study|Withdrawal by Subject|0|||
27881904|NCT01713582|54502096|FG016|Overall Study|Withdrawal by Subject|0|||
27881905|NCT01713582|54502097|FG017|Overall Study|Withdrawal by Subject|1|||
27881906|NCT01713582|54502098|FG018|Overall Study|Withdrawal by Subject|0|||
27881907|NCT01713582|54502099|FG019|Overall Study|Withdrawal by Subject|0|||
27881908|NCT01713582|54502100|FG020|Overall Study|Withdrawal by Subject|0|||
27881909|NCT01713582|54502080|FG000|Overall Study|Stopped to receive bone marrow graft|0|||
27881910|NCT01713582|54502081|FG001|Overall Study|Stopped to receive bone marrow graft|0|||
27881911|NCT01713582|54502082|FG002|Overall Study|Stopped to receive bone marrow graft|0|||
27881912|NCT01713582|54502083|FG003|Overall Study|Stopped to receive bone marrow graft|0|||
27881913|NCT01713582|54502084|FG004|Overall Study|Stopped to receive bone marrow graft|0|||
27881914|NCT01713582|54502085|FG005|Overall Study|Stopped to receive bone marrow graft|0|||
27881915|NCT01713582|54502086|FG006|Overall Study|Stopped to receive bone marrow graft|0|||
27881916|NCT01713582|54502087|FG007|Overall Study|Stopped to receive bone marrow graft|0|||
27881917|NCT01713582|54502088|FG008|Overall Study|Stopped to receive bone marrow graft|0|||
27983960|NCT02631941|54642471|FG005|Overall Study|Adverse Event|0|||
27881918|NCT01713582|54502089|FG009|Overall Study|Stopped to receive bone marrow graft|0|||
27881919|NCT01713582|54502090|FG010|Overall Study|Stopped to receive bone marrow graft|0|||
27881920|NCT01713582|54502091|FG011|Overall Study|Stopped to receive bone marrow graft|0|||
27881921|NCT01713582|54502092|FG012|Overall Study|Stopped to receive bone marrow graft|0|||
27881922|NCT01713582|54502093|FG013|Overall Study|Stopped to receive bone marrow graft|0|||
27881923|NCT01713582|54502094|FG014|Overall Study|Stopped to receive bone marrow graft|0|||
27881924|NCT01713582|54502095|FG015|Overall Study|Stopped to receive bone marrow graft|0|||
27881925|NCT01713582|54502096|FG016|Overall Study|Stopped to receive bone marrow graft|1|||
27881926|NCT01713582|54502097|FG017|Overall Study|Stopped to receive bone marrow graft|0|||
27881927|NCT01713582|54502098|FG018|Overall Study|Stopped to receive bone marrow graft|0|||
27881928|NCT01713582|54502099|FG019|Overall Study|Stopped to receive bone marrow graft|0|||
27881929|NCT01713582|54502100|FG020|Overall Study|Stopped to receive bone marrow graft|0|||
27881930|NCT01713582|54502080|FG000|Overall Study|Disease progression and adverse event|0|||
27881931|NCT01713582|54502081|FG001|Overall Study|Disease progression and adverse event|0|||
27881932|NCT01713582|54502082|FG002|Overall Study|Disease progression and adverse event|0|||
27881933|NCT01713582|54502083|FG003|Overall Study|Disease progression and adverse event|0|||
27881934|NCT01713582|54502084|FG004|Overall Study|Disease progression and adverse event|0|||
27881935|NCT01713582|54502085|FG005|Overall Study|Disease progression and adverse event|0|||
27881936|NCT01713582|54502086|FG006|Overall Study|Disease progression and adverse event|0|||
27881937|NCT01713582|54502087|FG007|Overall Study|Disease progression and adverse event|0|||
27881938|NCT01713582|54502088|FG008|Overall Study|Disease progression and adverse event|0|||
27881939|NCT01713582|54502089|FG009|Overall Study|Disease progression and adverse event|0|||
27881940|NCT01713582|54502090|FG010|Overall Study|Disease progression and adverse event|0|||
27881941|NCT01713582|54502091|FG011|Overall Study|Disease progression and adverse event|0|||
27881942|NCT01713582|54502092|FG012|Overall Study|Disease progression and adverse event|0|||
27881943|NCT01713582|54502093|FG013|Overall Study|Disease progression and adverse event|0|||
27881944|NCT01713582|54502094|FG014|Overall Study|Disease progression and adverse event|0|||
27881945|NCT01713582|54502095|FG015|Overall Study|Disease progression and adverse event|0|||
27881946|NCT01713582|54502096|FG016|Overall Study|Disease progression and adverse event|1|||
27881947|NCT01713582|54502097|FG017|Overall Study|Disease progression and adverse event|0|||
27881948|NCT01713582|54502098|FG018|Overall Study|Disease progression and adverse event|0|||
27881949|NCT01713582|54502099|FG019|Overall Study|Disease progression and adverse event|0|||
27881950|NCT01713582|54502100|FG020|Overall Study|Disease progression and adverse event|0|||
27881951|NCT01739400|54502160|FG000|Overall Study|Physician Decision|3|||
27881952|NCT01739400|54502161|FG001|Overall Study|Physician Decision|0|||
27881953|NCT01739400|54502160|FG000|Overall Study|Lost to Follow-up|2|||
27881954|NCT01739400|54502161|FG001|Overall Study|Lost to Follow-up|0|||
27881955|NCT01739400|54502160|FG000|Overall Study|Death|5|||
27881956|NCT01739400|54502161|FG001|Overall Study|Death|2|||
27881957|NCT01739400|54502160|FG000|Overall Study|Withdrawal by Subject|7|||
27881958|NCT01739400|54502161|FG001|Overall Study|Withdrawal by Subject|7|||
27881959|NCT01713348|54502170|FG000|Overall Study|Withdrawal by Subject|3|||
27881960|NCT01713348|54502171|FG001|Overall Study|Withdrawal by Subject|2|||
27881961|NCT01713348|54502172|FG002|Overall Study|Withdrawal by Subject|2|||
27881962|NCT01713348|54502173|FG003|Overall Study|Withdrawal by Subject|0|||
27881963|NCT01713348|54502170|FG000|Overall Study|Lost to Follow-up|1|||
27881964|NCT01713348|54502171|FG001|Overall Study|Lost to Follow-up|0|||
27881965|NCT01713348|54502172|FG002|Overall Study|Lost to Follow-up|0|||
27881966|NCT01713348|54502173|FG003|Overall Study|Lost to Follow-up|0|||
27881967|NCT01737996|54502186|FG000|Overall Study|Adverse Event|0|||
27881968|NCT01737996|54502187|FG001|Overall Study|Adverse Event|1|||
27881969|NCT01737996|54502188|FG002|Overall Study|Adverse Event|1|||
27881970|NCT01737996|54502186|FG000|Overall Study|Withdrawal by Subject|0|||
27881971|NCT01737996|54502187|FG001|Overall Study|Withdrawal by Subject|0|||
27881972|NCT01737996|54502188|FG002|Overall Study|Withdrawal by Subject|1|||
27881973|NCT01713036|54502196|FG000|Overall Study|Death|1|||
27881974|NCT01712334|54502206|FG000|Treatment Period 1|Randomized in Error|0|||
27881975|NCT01712334|54502207|FG001|Treatment Period 1|Randomized in Error|2|||
27881976|NCT01712256|54502213|FG000|Overall Study|Lost to Follow-up|1|||
27881977|NCT01712178|54502219|FG000|Overall Study|Withdrew consent due to an adverse event|1|||
27881978|NCT01712178|54502220|FG001|Overall Study|Withdrew consent due to an adverse event|1|||
27881979|NCT01712178|54502219|FG000|Overall Study|Serious adverse event/withdrew consent|0|||
27881980|NCT01712178|54502220|FG001|Overall Study|Serious adverse event/withdrew consent|1|||
27881981|NCT01712178|54502219|FG000|Overall Study|Lost to Follow-up|0|||
27881982|NCT01712178|54502220|FG001|Overall Study|Lost to Follow-up|1|||
27881983|NCT01693068|54502228|FG000|Randomization Period|On-study|2|||
27881984|NCT01693068|54502229|FG001|Randomization Period|On-study|5|||
27881985|NCT01693068|54502230|FG002|Randomization Period|On-study|0|||
28096537|NCT04402866|54751605|FG003|Overall Study|Lost to Follow-up|0|||
28096538|NCT04402866|54751606|FG004|Overall Study|Lost to Follow-up|0|||
28096539|NCT04402866|54751607|FG005|Overall Study|Lost to Follow-up|1|||
28096540|NCT04402866|54751602|FG000|Overall Study|Withdrawal by Subject|0|||
27881986|NCT01693068|54502228|FG000|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
27881987|NCT01693068|54502229|FG001|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
27881988|NCT01693068|54502230|FG002|Cross-over (Dacarbazine To Pimasertib)|On-study|1|||
27881989|NCT01691898|54502244|FG000|Overall Study|Death|34|||
27881990|NCT01691898|54502245|FG001|Overall Study|Death|32|||
27881991|NCT01691898|54502246|FG002|Overall Study|Death|6|||
27881992|NCT01691898|54502247|FG003|Overall Study|Death|3|||
27881993|NCT01691898|54502248|FG004|Overall Study|Death|8|||
27881994|NCT01691898|54502249|FG005|Overall Study|Death|31|||
27881995|NCT01691898|54502244|FG000|Overall Study|Adverse Event|0|||
27881996|NCT01691898|54502245|FG001|Overall Study|Adverse Event|1|||
27881997|NCT01691898|54502246|FG002|Overall Study|Adverse Event|0|||
27881998|NCT01691898|54502247|FG003|Overall Study|Adverse Event|1|||
27881999|NCT01691898|54502248|FG004|Overall Study|Adverse Event|1|||
27882000|NCT01691898|54502249|FG005|Overall Study|Adverse Event|0|||
27882001|NCT01691898|54502244|FG000|Overall Study|Progression of Disease|1|||
27882002|NCT01691898|54502245|FG001|Overall Study|Progression of Disease|2|||
27882003|NCT01691898|54502246|FG002|Overall Study|Progression of Disease|1|||
27882004|NCT01691898|54502247|FG003|Overall Study|Progression of Disease|0|||
27882005|NCT01691898|54502248|FG004|Overall Study|Progression of Disease|0|||
27882006|NCT01691898|54502249|FG005|Overall Study|Progression of Disease|1|||
27882007|NCT01691898|54502244|FG000|Overall Study|Lost to Follow-up|3|||
27882008|NCT01691898|54502245|FG001|Overall Study|Lost to Follow-up|1|||
27882009|NCT01691898|54502246|FG002|Overall Study|Lost to Follow-up|0|||
27882010|NCT01691898|54502247|FG003|Overall Study|Lost to Follow-up|0|||
27882011|NCT01691898|54502248|FG004|Overall Study|Lost to Follow-up|1|||
27882012|NCT01691898|54502249|FG005|Overall Study|Lost to Follow-up|0|||
27882013|NCT01691898|54502244|FG000|Overall Study|Withdrawal by Subject|9|||
27882014|NCT01691898|54502245|FG001|Overall Study|Withdrawal by Subject|8|||
27882015|NCT01691898|54502246|FG002|Overall Study|Withdrawal by Subject|2|||
27882016|NCT01691898|54502247|FG003|Overall Study|Withdrawal by Subject|1|||
27882017|NCT01691898|54502248|FG004|Overall Study|Withdrawal by Subject|3|||
27882018|NCT01691898|54502249|FG005|Overall Study|Withdrawal by Subject|3|||
27882019|NCT01691898|54502244|FG000|Overall Study|Non-Compliance|0|||
27882020|NCT01691898|54502245|FG001|Overall Study|Non-Compliance|0|||
27882021|NCT01691898|54502246|FG002|Overall Study|Non-Compliance|0|||
27882022|NCT01691898|54502247|FG003|Overall Study|Non-Compliance|0|||
27882023|NCT01691898|54502248|FG004|Overall Study|Non-Compliance|1|||
27882024|NCT01691898|54502249|FG005|Overall Study|Non-Compliance|0|||
27882025|NCT01737840|54502283|FG000|Overall Study|Diagnosed with an other pathology|2|||
27882026|NCT01737840|54502284|FG001|Overall Study|Diagnosed with an other pathology|2|||
27882027|NCT01691820|54502294|FG000|Overall Study|Consent withdrawal (not due to an AE)|9|||
27882028|NCT01691820|54502295|FG001|Overall Study|Consent withdrawal (not due to an AE)|15|||
27882029|NCT01691820|54502294|FG000|Overall Study|Migrated/moved from study area|7|||
27882030|NCT01691820|54502295|FG001|Overall Study|Migrated/moved from study area|4|||
27882031|NCT01691820|54502294|FG000|Overall Study|Lost to Follow-up|6|||
27882032|NCT01691820|54502295|FG001|Overall Study|Lost to Follow-up|17|||
27882033|NCT01691820|54502294|FG000|Overall Study|Other (unspecified)|4|||
27882034|NCT01691820|54502295|FG001|Overall Study|Other (unspecified)|1|||
27882035|NCT01711866|54502305|FG000|Overall Study|Noncompliant|3|||
27882036|NCT01711866|54502305|FG000|Overall Study|Withdrawal by Subject|3|||
27882037|NCT01711866|54502305|FG000|Overall Study|Adverse Event|2|||
27882038|NCT01737762|54502311|FG000|Overall Study|Adverse Event|2|||
27882039|NCT01737762|54502312|FG001|Overall Study|Adverse Event|2|||
27882040|NCT01737762|54502311|FG000|Overall Study|Lost to Follow-up|1|||
27882041|NCT01737762|54502312|FG001|Overall Study|Lost to Follow-up|0|||
27882042|NCT01737762|54502311|FG000|Overall Study|Withdrawal by Subject|2|||
27882043|NCT01737762|54502312|FG001|Overall Study|Withdrawal by Subject|2|||
27882044|NCT01737762|54502311|FG000|Overall Study|Progressive disease|1|||
27882045|NCT01737762|54502312|FG001|Overall Study|Progressive disease|2|||
27882046|NCT01737762|54502311|FG000|Overall Study|Physician Decision|1|||
27882047|NCT01737762|54502312|FG001|Overall Study|Physician Decision|1|||
27882048|NCT01737762|54502311|FG000|Overall Study|Moved from area|2|||
27983961|NCT02631941|54642472|FG006|Overall Study|Adverse Event|0|||
27983962|NCT02631941|54642473|FG007|Overall Study|Adverse Event|0|||
27983963|NCT02631941|54642474|FG008|Overall Study|Adverse Event|0|||
27983964|NCT02631941|54642475|FG009|Overall Study|Adverse Event|0|||
27882049|NCT01737762|54502312|FG001|Overall Study|Moved from area|1|||
27882050|NCT01737762|54502311|FG000|Overall Study|Trial termination|11|||
27882051|NCT01737762|54502312|FG001|Overall Study|Trial termination|9|||
27882052|NCT01691508|54502320|FG000|Overall Study|Adverse Event|3|||
27882053|NCT01691508|54502321|FG001|Overall Study|Adverse Event|3|||
27882054|NCT01691508|54502320|FG000|Overall Study|Withdrawal by Subject|1|||
27882055|NCT01691508|54502321|FG001|Overall Study|Withdrawal by Subject|0|||
27882056|NCT01682460|54502327|FG000|Overall Study|Withdrawal by Subject|2|||
27882057|NCT01682460|54502327|FG000|Overall Study|Did not meet inclusion criteria|2|||
27882058|NCT01691430|54502333|FG000|Overall Study|Death|17|||
27882059|NCT01691430|54502334|FG001|Overall Study|Death|16|||
27983965|NCT02631941|54642466|FG000|Overall Study|Withdrawal by Subject|0|||
27882060|NCT01691430|54502333|FG000|Overall Study|Withdrawal by Subject|5|||
27882061|NCT01691430|54502334|FG001|Overall Study|Withdrawal by Subject|1|||
27882062|NCT01691430|54502333|FG000|Overall Study|Lost to Follow-up|0|||
27882063|NCT01691430|54502334|FG001|Overall Study|Lost to Follow-up|3|||
27882064|NCT01709838|54502340|FG000|Overall Study|Withdrawal by Subject|21|||
27882065|NCT01709838|54502340|FG000|Overall Study|Lost to Follow-up|16|||
27882066|NCT01709838|54502340|FG000|Overall Study|Pregnancy|10|||
27882067|NCT01709838|54502340|FG000|Overall Study|Subject/guardian decision|8|||
27882068|NCT01709838|54502340|FG000|Overall Study|Adverse Event|4|||
27882069|NCT01709838|54502340|FG000|Overall Study|Physician Decision|4|||
27882070|NCT01709838|54502340|FG000|Overall Study|Death|3|||
27882071|NCT01709838|54502340|FG000|Overall Study|Protocol Violation|1|||
27882072|NCT01682226|54502346|FG000|Overall Study|Participants were pediatric subjects and not adults subjects|3|||
27882073|NCT01682226|54502346|FG000|Overall Study|Participants did not receive treatment|2|||
27882074|NCT01682226|54502346|FG000|Overall Study|Participants received a transplant under a different protocol|1|||
27882075|NCT01688466|54502352|FG000|Overall Study|Withdrawal by Subject|2|||
27882076|NCT01688466|54502353|FG001|Overall Study|Withdrawal by Subject|1|||
27882077|NCT01688466|54502352|FG000|Overall Study|Death|0|||
27882078|NCT01688466|54502353|FG001|Overall Study|Death|1|||
27882079|NCT01688466|54502352|FG000|Overall Study|Adverse Event|0|||
27882080|NCT01688466|54502353|FG001|Overall Study|Adverse Event|4|||
27882081|NCT01688466|54502352|FG000|Overall Study|Not evaluable|0|||
27882082|NCT01688466|54502353|FG001|Overall Study|Not evaluable|1|||
27882083|NCT01682148|54502361|FG000|Overall Study|Withdrawal by Subject|2|||
27882084|NCT01682148|54502362|FG001|Overall Study|Withdrawal by Subject|0|||
27882085|NCT01682148|54502361|FG000|Overall Study|Lost to Follow-up|1|||
27882086|NCT01682148|54502362|FG001|Overall Study|Lost to Follow-up|2|||
27882087|NCT01682148|54502361|FG000|Overall Study|Protocol Violation|1|||
27882088|NCT01682148|54502362|FG001|Overall Study|Protocol Violation|1|||
27882089|NCT01681992|54502376|FG000|Overall Study|Adverse Event|3|||
27882090|NCT01681992|54502377|FG001|Overall Study|Adverse Event|2|||
27882091|NCT01681992|54502378|FG002|Overall Study|Adverse Event|3|||
27882092|NCT01681992|54502376|FG000|Overall Study|Lost to Follow-up|36|||
27882093|NCT01681992|54502377|FG001|Overall Study|Lost to Follow-up|38|||
27882094|NCT01681992|54502378|FG002|Overall Study|Lost to Follow-up|53|||
27882095|NCT01681992|54502376|FG000|Overall Study|As Per Sponsor Decision|0|||
27882096|NCT01681992|54502377|FG001|Overall Study|As Per Sponsor Decision|0|||
27882097|NCT01681992|54502378|FG002|Overall Study|As Per Sponsor Decision|1|||
27882098|NCT01681992|54502376|FG000|Overall Study|Protocol Violation|0|||
27882099|NCT01681992|54502377|FG001|Overall Study|Protocol Violation|0|||
27882100|NCT01681992|54502378|FG002|Overall Study|Protocol Violation|1|||
27882101|NCT01681992|54502376|FG000|Overall Study|Withdrawal by Subject|27|||
27882102|NCT01681992|54502377|FG001|Overall Study|Withdrawal by Subject|30|||
27882103|NCT01681992|54502378|FG002|Overall Study|Withdrawal by Subject|25|||
27882104|NCT01687998|54502388|FG000|Overall Study|Withdrawal by Subject|49|||
27882105|NCT01687998|54502389|FG001|Overall Study|Withdrawal by Subject|51|||
27882106|NCT01687998|54502388|FG000|Overall Study|Known to be Alive at Study End|54|||
27882107|NCT01687998|54502389|FG001|Overall Study|Known to be Alive at Study End|62|||
27882108|NCT01687998|54502388|FG000|Overall Study|Lost to Follow-up|9|||
27882109|NCT01687998|54502389|FG001|Overall Study|Lost to Follow-up|7|||
27882110|NCT01681836|54502395|FG000|Second Intervention|Withdrawal by Subject|0|||
27882111|NCT01681836|54502396|FG001|Second Intervention|Withdrawal by Subject|1|||
27882112|NCT01681368|54502402|FG000|Overall Study|Refused further treatment|1|||
27882113|NCT01681368|54502402|FG000|Overall Study|Refused further follow up|1|||
27882114|NCT01681212|54502406|FG000|Overall Study|No longer met study criteria|5|||
27882115|NCT01681212|54502406|FG000|Overall Study|Administrative reason by sponsor|1|||
27882116|NCT01687296|54502412|FG000|Overall Study|Lack of Efficacy|1|||
27882117|NCT01687296|54502413|FG001|Overall Study|Lack of Efficacy|1|||
27882118|NCT01687296|54502412|FG000|Overall Study|Protocol Violation|0|||
27882119|NCT01687296|54502413|FG001|Overall Study|Protocol Violation|1|||
27882120|NCT01687296|54502412|FG000|Overall Study|Withdrawal by Subject|6|||
27882121|NCT01687296|54502413|FG001|Overall Study|Withdrawal by Subject|3|||
27882122|NCT01568892|54502434|FG000|Open-label Phase|Adverse Event|2|||
27882123|NCT01568892|54502435|FG001|Open-label Phase|Adverse Event|0|||
27882124|NCT01568892|54502434|FG000|Open-label Phase|Lack of Efficacy|4|||
27882125|NCT01568892|54502435|FG001|Open-label Phase|Lack of Efficacy|2|||
27882126|NCT01568892|54502434|FG000|Open-label Phase|Lost to Follow-up|0|||
27882127|NCT01568892|54502435|FG001|Open-label Phase|Lost to Follow-up|1|||
27882128|NCT01568112|54502446|FG000|Overall Study|Randomized But Not Treated|0|||
27882129|NCT01568112|54502447|FG001|Overall Study|Randomized But Not Treated|1|||
27882130|NCT01568112|54502448|FG002|Overall Study|Randomized But Not Treated|0|||
27882131|NCT01568112|54502449|FG003|Overall Study|Randomized But Not Treated|0|||
27882132|NCT01568112|54502446|FG000|Overall Study|Withdrew due to Adverse Event|2|||
28171746|NCT02442778|54843318|FG002|Overall Study|Protocol Deviation|1|||
27882133|NCT01568112|54502447|FG001|Overall Study|Withdrew due to Adverse Event|4|||
27882134|NCT01568112|54502448|FG002|Overall Study|Withdrew due to Adverse Event|6|||
27882135|NCT01568112|54502449|FG003|Overall Study|Withdrew due to Adverse Event|3|||
27882136|NCT01568112|54502446|FG000|Overall Study|Lost to Follow-up|0|||
27882137|NCT01568112|54502447|FG001|Overall Study|Lost to Follow-up|0|||
27882138|NCT01568112|54502448|FG002|Overall Study|Lost to Follow-up|0|||
27882139|NCT01568112|54502449|FG003|Overall Study|Lost to Follow-up|1|||
27882140|NCT01568112|54502446|FG000|Overall Study|Withdrawal by Subject|2|||
27882141|NCT01568112|54502447|FG001|Overall Study|Withdrawal by Subject|3|||
27882142|NCT01568112|54502448|FG002|Overall Study|Withdrawal by Subject|0|||
27882143|NCT01568112|54502449|FG003|Overall Study|Withdrawal by Subject|7|||
27882144|NCT01568112|54502446|FG000|Overall Study|Withdrawal by Physician|1|||
27882145|NCT01568112|54502447|FG001|Overall Study|Withdrawal by Physician|0|||
27882146|NCT01568112|54502448|FG002|Overall Study|Withdrawal by Physician|1|||
27882147|NCT01568112|54502449|FG003|Overall Study|Withdrawal by Physician|1|||
27882148|NCT01568034|54502460|FG000|Overall Study|Withdrawal by Subject|1|||
27882149|NCT01568034|54502461|FG001|Overall Study|Withdrawal by Subject|0|||
27882150|NCT01568034|54502462|FG002|Overall Study|Withdrawal by Subject|0|||
27882151|NCT01568034|54502463|FG003|Overall Study|Withdrawal by Subject|0|||
27882152|NCT01687218|54502479|FG000|Overall Study|Withdrawal by Subject|2|||
27882153|NCT01687218|54502480|FG001|Overall Study|Withdrawal by Subject|3|||
27882154|NCT01687218|54502481|FG002|Overall Study|Withdrawal by Subject|0|||
27882155|NCT01687218|54502482|FG003|Overall Study|Withdrawal by Subject|1|||
27882156|NCT01687218|54502483|FG004|Overall Study|Withdrawal by Subject|1|||
27882157|NCT01687218|54502484|FG005|Overall Study|Withdrawal by Subject|0|||
27882158|NCT01687218|54502479|FG000|Overall Study|Relocated, no follow-up planned|1|||
27882159|NCT01687218|54502480|FG001|Overall Study|Relocated, no follow-up planned|0|||
27882160|NCT01687218|54502481|FG002|Overall Study|Relocated, no follow-up planned|1|||
27882161|NCT01687218|54502482|FG003|Overall Study|Relocated, no follow-up planned|1|||
27882162|NCT01687218|54502483|FG004|Overall Study|Relocated, no follow-up planned|0|||
27882163|NCT01687218|54502484|FG005|Overall Study|Relocated, no follow-up planned|0|||
27882164|NCT01686828|54502496|FG000|Overall Study|Physician Decision|1|||
27882165|NCT01686828|54502497|FG001|Overall Study|Physician Decision|0|||
27882166|NCT01686828|54502498|FG002|Overall Study|Physician Decision|0|||
27882167|NCT01686828|54502499|FG003|Overall Study|Physician Decision|0|||
27882168|NCT01686828|54502496|FG000|Overall Study|New Job|0|||
27882169|NCT01686828|54502497|FG001|Overall Study|New Job|1|||
27882170|NCT01686828|54502498|FG002|Overall Study|New Job|0|||
27882171|NCT01686828|54502499|FG003|Overall Study|New Job|0|||
27882172|NCT01686828|54502496|FG000|Overall Study|Weight Loss|0|||
27882173|NCT01686828|54502497|FG001|Overall Study|Weight Loss|0|||
27882174|NCT01686828|54502498|FG002|Overall Study|Weight Loss|1|||
27882175|NCT01686828|54502499|FG003|Overall Study|Weight Loss|0|||
27882176|NCT01686438|54502516|FG000|Overall Study|Lost to Follow-up|8|||
27882177|NCT01686438|54502517|FG001|Overall Study|Lost to Follow-up|9|||
27882178|NCT01686438|54502518|FG002|Overall Study|Lost to Follow-up|10|||
27882179|NCT01686438|54502516|FG000|Overall Study|Adverse Event|0|||
27882180|NCT01686438|54502517|FG001|Overall Study|Adverse Event|0|||
27882181|NCT01686438|54502518|FG002|Overall Study|Adverse Event|1|||
27882182|NCT01686438|54502516|FG000|Overall Study|Protocol Violation|0|||
27882183|NCT01686438|54502517|FG001|Overall Study|Protocol Violation|0|||
27882184|NCT01686438|54502518|FG002|Overall Study|Protocol Violation|1|||
27882185|NCT01686438|54502516|FG000|Overall Study|Withdrawal by Subject|0|||
27882186|NCT01686438|54502517|FG001|Overall Study|Withdrawal by Subject|0|||
27882187|NCT01686438|54502518|FG002|Overall Study|Withdrawal by Subject|1|||
27882188|NCT01593696|54502532|FG000|Dose Escalation|Progressive Disease|2|||
27882189|NCT01593696|54502533|FG001|Dose Escalation|Progressive Disease|0|||
27882190|NCT01593696|54502534|FG002|Dose Escalation|Progressive Disease|0|||
27882191|NCT01593696|54502535|FG003|Dose Escalation|Progressive Disease|0|||
27882192|NCT01593696|54502532|FG000|Dose Expansion|Fungal infection|0|||
27882193|NCT01593696|54502533|FG001|Dose Expansion|Fungal infection|0|||
27882194|NCT01593696|54502534|FG002|Dose Expansion|Fungal infection|1|||
27882195|NCT01593696|54502535|FG003|Dose Expansion|Fungal infection|0|||
27882196|NCT01592760|54502548|FG000|24-hour Follow-Up|Lost to Follow-up|4|||
27882197|NCT01592760|54502549|FG001|24-hour Follow-Up|Lost to Follow-up|3|||
27882198|NCT01592760|54502550|FG002|24-hour Follow-Up|Lost to Follow-up|2|||
27882199|NCT01696188|54502563|FG000|Overall Study|Protocol Violation|1|||
27882200|NCT01696188|54502564|FG001|Overall Study|Protocol Violation|1|||
27983966|NCT02631941|54642467|FG001|Overall Study|Withdrawal by Subject|0|||
27882201|NCT01603602|54502573|FG000|Overall Study|Adverse Event|1|||
27882202|NCT01603602|54502574|FG001|Overall Study|Adverse Event|0|||
27882203|NCT01603602|54502575|FG002|Overall Study|Adverse Event|0|||
27882204|NCT01603602|54502573|FG000|Overall Study|Personal Reasons|1|||
27882205|NCT01603602|54502574|FG001|Overall Study|Personal Reasons|0|||
27983967|NCT02631941|54642468|FG002|Overall Study|Withdrawal by Subject|0|||
27882206|NCT01603602|54502575|FG002|Overall Study|Personal Reasons|1|||
27882207|NCT01684878|54502587|FG000|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
27882208|NCT01684878|54502588|FG001|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
27882209|NCT01684878|54502589|FG002|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
27882210|NCT01684878|54502590|FG003|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
27882211|NCT01684878|54502587|FG000|Part 1: Safety Run in Phase|Death|15|||
27882212|NCT01684878|54502588|FG001|Part 1: Safety Run in Phase|Death|20|||
27882213|NCT01684878|54502589|FG002|Part 1: Safety Run in Phase|Death|0|||
27882214|NCT01684878|54502590|FG003|Part 1: Safety Run in Phase|Death|0|||
27882215|NCT01684878|54502587|FG000|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
27882216|NCT01684878|54502588|FG001|Part 1: Safety Run in Phase|Lost to Follow-up|2|||
27882217|NCT01684878|54502589|FG002|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
27882218|NCT01684878|54502590|FG003|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
27882219|NCT01684878|54502587|FG000|Part 2: Randomized Phase|Participant withdrew consent|0|||
27882220|NCT01684878|54502588|FG001|Part 2: Randomized Phase|Participant withdrew consent|0|||
27882221|NCT01684878|54502589|FG002|Part 2: Randomized Phase|Participant withdrew consent|1|||
27882222|NCT01684878|54502590|FG003|Part 2: Randomized Phase|Participant withdrew consent|2|||
27983968|NCT02631941|54642469|FG003|Overall Study|Withdrawal by Subject|0|||
27983969|NCT02631941|54642470|FG004|Overall Study|Withdrawal by Subject|1|||
27983970|NCT02631941|54642471|FG005|Overall Study|Withdrawal by Subject|0|||
27983971|NCT02631941|54642472|FG006|Overall Study|Withdrawal by Subject|0|||
27983972|NCT02631941|54642473|FG007|Overall Study|Withdrawal by Subject|1|||
27983973|NCT02631941|54642474|FG008|Overall Study|Withdrawal by Subject|0|||
27983974|NCT02631941|54642475|FG009|Overall Study|Withdrawal by Subject|0|||
27983975|NCT02631941|54642466|FG000|Overall Study|Lost to Follow-up|0|||
27882223|NCT01684878|54502587|FG000|Part 2: Randomized Phase|Lost to Follow-up|0|||
27882224|NCT01684878|54502588|FG001|Part 2: Randomized Phase|Lost to Follow-up|0|||
27882225|NCT01684878|54502589|FG002|Part 2: Randomized Phase|Lost to Follow-up|2|||
27882226|NCT01684878|54502590|FG003|Part 2: Randomized Phase|Lost to Follow-up|0|||
27882227|NCT01684878|54502587|FG000|Part 2: Randomized Phase|Death|0|||
27882228|NCT01684878|54502588|FG001|Part 2: Randomized Phase|Death|0|||
27882229|NCT01684878|54502589|FG002|Part 2: Randomized Phase|Death|62|||
27882230|NCT01684878|54502590|FG003|Part 2: Randomized Phase|Death|68|||
27882231|NCT01684878|54502587|FG000|Part 2: Randomized Phase|Alive at data-cut|0|||
27882232|NCT01684878|54502588|FG001|Part 2: Randomized Phase|Alive at data-cut|0|||
27882233|NCT01684878|54502589|FG002|Part 2: Randomized Phase|Alive at data-cut|13|||
27882234|NCT01684878|54502590|FG003|Part 2: Randomized Phase|Alive at data-cut|7|||
27882235|NCT01684878|54502587|FG000|Part 2: Randomized Phase|Participant noncompliance|0|||
27882236|NCT01684878|54502588|FG001|Part 2: Randomized Phase|Participant noncompliance|0|||
27882237|NCT01684878|54502589|FG002|Part 2: Randomized Phase|Participant noncompliance|0|||
27882238|NCT01684878|54502590|FG003|Part 2: Randomized Phase|Participant noncompliance|1|||
27882239|NCT01684722|54502604|FG000|Overall Study|Lost to Follow-up|78|||
27882240|NCT01684722|54502605|FG001|Overall Study|Lost to Follow-up|56|||
27882241|NCT01684722|54502606|FG002|Overall Study|Lost to Follow-up|75|||
27882242|NCT01684722|54502607|FG003|Overall Study|Lost to Follow-up|89|||
27882243|NCT01684722|54502604|FG000|Overall Study|Death|19|||
27882244|NCT01684722|54502605|FG001|Overall Study|Death|21|||
27882245|NCT01684722|54502606|FG002|Overall Study|Death|19|||
27882246|NCT01684722|54502607|FG003|Overall Study|Death|21|||
27882247|NCT01592292|54502624|FG000|Overall Study|Follow-up loss|3|||
27882248|NCT01592292|54502625|FG001|Overall Study|Follow-up loss|3|||
27882249|NCT01592292|54502626|FG002|Overall Study|Follow-up loss|1|||
27882250|NCT01592292|54502627|FG003|Overall Study|Follow-up loss|0|||
27882251|NCT01592292|54502624|FG000|Overall Study|Withdrew consent|2|||
27882252|NCT01592292|54502625|FG001|Overall Study|Withdrew consent|1|||
27882253|NCT01592292|54502626|FG002|Overall Study|Withdrew consent|0|||
27882254|NCT01592292|54502627|FG003|Overall Study|Withdrew consent|0|||
27882255|NCT01592292|54502624|FG000|Overall Study|Other|1|||
27882256|NCT01592292|54502625|FG001|Overall Study|Other|1|||
27882257|NCT01592292|54502626|FG002|Overall Study|Other|2|||
27882258|NCT01592292|54502627|FG003|Overall Study|Other|1|||
27882259|NCT01590888|54502636|FG000|Overall Study|Adverse Event|3|||
27882260|NCT01590888|54502637|FG001|Overall Study|Adverse Event|0|||
27882261|NCT01590888|54502638|FG002|Overall Study|Adverse Event|1|||
27882262|NCT01590888|54502636|FG000|Overall Study|Lost to Follow-up|1|||
27882263|NCT01590888|54502637|FG001|Overall Study|Lost to Follow-up|0|||
27882264|NCT01590888|54502638|FG002|Overall Study|Lost to Follow-up|0|||
27882265|NCT01565928|54502646|FG000|Overall Study|Adverse Event|3|||
27882266|NCT01565928|54502646|FG000|Overall Study|Other|3|||
27882267|NCT01565928|54502646|FG000|Overall Study|Progressive Disease|13|||
27882268|NCT01565928|54502646|FG000|Overall Study|Withdrawal by Subject|1|||
27882269|NCT01565928|54502646|FG000|Overall Study|Death|2|||
27882270|NCT01565850|54502655|FG000|Overall Study|Adverse Event|0|||
27882271|NCT01565850|54502656|FG001|Overall Study|Adverse Event|1|||
27882272|NCT01565850|54502655|FG000|Overall Study|Lost to Follow-up|12|||
27882273|NCT01565850|54502656|FG001|Overall Study|Lost to Follow-up|4|||
27882274|NCT01565850|54502655|FG000|Overall Study|Investigator's Discretion|2|||
27882275|NCT01565850|54502656|FG001|Overall Study|Investigator's Discretion|1|||
27882276|NCT01565850|54502655|FG000|Overall Study|Participant noncompliance|2|||
27882277|NCT01565850|54502656|FG001|Overall Study|Participant noncompliance|0|||
27983976|NCT02631941|54642467|FG001|Overall Study|Lost to Follow-up|0|||
27983977|NCT02631941|54642468|FG002|Overall Study|Lost to Follow-up|0|||
27882278|NCT01565850|54502655|FG000|Overall Study|Withdrew Consent|4|||
27882279|NCT01565850|54502656|FG001|Overall Study|Withdrew Consent|2|||
27882280|NCT01565694|54502662|FG000|Dose-Titration Period|Adverse Event|4|||
27882281|NCT01565694|54502662|FG000|Dose-Titration Period|Protocol Violation|10|||
27882282|NCT01565694|54502662|FG000|Fixed-Dose Assessment Period|Withdrawal by Subject|4|||
27882283|NCT01543152|54502671|FG000|Overall Study|Withdrawal by Subject|0|||
27882284|NCT01543152|54502672|FG001|Overall Study|Withdrawal by Subject|2|||
27882285|NCT01543152|54502673|FG002|Overall Study|Withdrawal by Subject|0|||
27882286|NCT01543152|54502674|FG003|Overall Study|Withdrawal by Subject|0|||
27882287|NCT01543152|54502675|FG004|Overall Study|Withdrawal by Subject|0|||
27882288|NCT01590810|54502692|FG000|Overall Study|Physician Decision|0|||
27882289|NCT01590810|54502693|FG001|Overall Study|Physician Decision|1|||
27882290|NCT01590810|54502694|FG002|Overall Study|Physician Decision|1|||
27882291|NCT01590810|54502695|FG003|Overall Study|Physician Decision|0|||
27882292|NCT01590810|54502696|FG004|Overall Study|Physician Decision|0|||
27882293|NCT01542528|54502731|FG000|Overall Study|Lost to Follow-up|2|||
27882294|NCT01542528|54502732|FG001|Overall Study|Lost to Follow-up|1|||
27882295|NCT01542528|54502731|FG000|Overall Study|Physician Decision|1|||
27882296|NCT01542528|54502732|FG001|Overall Study|Physician Decision|0|||
27882297|NCT01542528|54502731|FG000|Overall Study|Withdrawal by Subject|9|||
27882298|NCT01542528|54502732|FG001|Overall Study|Withdrawal by Subject|6|||
27882299|NCT01565148|54502742|FG000|Overall Study|Withdrawal by Subject|1|||
27882300|NCT01565148|54502743|FG001|Overall Study|Withdrawal by Subject|1|||
27882301|NCT01565148|54502744|FG002|Overall Study|Withdrawal by Subject|1|||
27882302|NCT01565148|54502745|FG003|Overall Study|Withdrawal by Subject|2|||
27882303|NCT01565148|54502742|FG000|Overall Study|Lost to Follow-up|4|||
27882304|NCT01565148|54502743|FG001|Overall Study|Lost to Follow-up|4|||
27882305|NCT01565148|54502744|FG002|Overall Study|Lost to Follow-up|0|||
27882306|NCT01565148|54502745|FG003|Overall Study|Lost to Follow-up|3|||
27882307|NCT01565148|54502742|FG000|Overall Study|Rescue Therapy|8|||
27882308|NCT01565148|54502743|FG001|Overall Study|Rescue Therapy|5|||
27882309|NCT01565148|54502744|FG002|Overall Study|Rescue Therapy|5|||
27882310|NCT01565148|54502745|FG003|Overall Study|Rescue Therapy|8|||
27882311|NCT01565148|54502742|FG000|Overall Study|Death|0|||
27882312|NCT01565148|54502743|FG001|Overall Study|Death|0|||
27882313|NCT01565148|54502744|FG002|Overall Study|Death|1|||
27882314|NCT01565148|54502745|FG003|Overall Study|Death|0|||
27882315|NCT01565148|54502742|FG000|Overall Study|Physician Decision|2|||
27882316|NCT01565148|54502743|FG001|Overall Study|Physician Decision|5|||
27882317|NCT01565148|54502744|FG002|Overall Study|Physician Decision|0|||
27882318|NCT01565148|54502745|FG003|Overall Study|Physician Decision|0|||
27882319|NCT01564758|54502759|FG000|Overall Study|Death|8|||
27882320|NCT01564758|54502759|FG000|Overall Study|Adverse Event|3|||
27882321|NCT01564758|54502759|FG000|Overall Study|Other|3|||
27882322|NCT01541826|54502766|FG000|Overall Study|Lost to Follow-up|2|||
27882323|NCT01541826|54502767|FG001|Overall Study|Lost to Follow-up|3|||
27882324|NCT01541826|54502768|FG002|Overall Study|Lost to Follow-up|0|||
27882325|NCT01541826|54502766|FG000|Overall Study|Withdrawal by Subject|2|||
27882326|NCT01541826|54502767|FG001|Overall Study|Withdrawal by Subject|0|||
27882327|NCT01541826|54502768|FG002|Overall Study|Withdrawal by Subject|0|||
27882328|NCT01541748|54502776|FG000|Overall Study|Lost to Follow-up|17|||
27882329|NCT01541748|54502776|FG000|Overall Study|Moved out of state|1|||
27882330|NCT01541748|54502776|FG000|Overall Study|Withdrawal by Subject|7|||
27882331|NCT01541748|54502776|FG000|Overall Study|Screen failure|5|||
27882332|NCT01541748|54502776|FG000|Overall Study|Did not receive study device|1|||
27882333|NCT01589094|54502789|FG000|Overall Study|Did not receive treatment|2|||
27882334|NCT01563978|54502795|FG000|Overall Study|Physician Decision|1|||
27882335|NCT01563978|54502796|FG001|Overall Study|Physician Decision|0|||
27882336|NCT01563978|54502795|FG000|Overall Study|Lost to Follow-up|1|||
27882337|NCT01563978|54502796|FG001|Overall Study|Lost to Follow-up|0|||
27882338|NCT01563978|54502795|FG000|Overall Study|Dev. of study specific discont. criteria|1|||
27882339|NCT01563978|54502796|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
27882340|NCT01563978|54502795|FG000|Overall Study|Adverse Event|1|||
27882341|NCT01563978|54502796|FG001|Overall Study|Adverse Event|2|||
27882342|NCT01563354|54502805|FG000|Core Phase|Adverse Event|5|||
27882343|NCT01563354|54502806|FG001|Core Phase|Adverse Event|15|||
27882344|NCT01563354|54502807|FG002|Core Phase|Adverse Event|13|||
27882345|NCT01563354|54502805|FG000|Core Phase|Withdrawal by Subject|1|||
27882346|NCT01563354|54502806|FG001|Core Phase|Withdrawal by Subject|0|||
27882347|NCT01563354|54502807|FG002|Core Phase|Withdrawal by Subject|3|||
27882348|NCT01563354|54502805|FG000|Core Phase|Lost to Follow-up|1|||
27882349|NCT01563354|54502806|FG001|Core Phase|Lost to Follow-up|0|||
27882350|NCT01563354|54502807|FG002|Core Phase|Lost to Follow-up|0|||
27882351|NCT01563354|54502805|FG000|Core Phase|Death|1|||
27882352|NCT01563354|54502806|FG001|Core Phase|Death|5|||
27882353|NCT01563354|54502807|FG002|Core Phase|Death|2|||
27882354|NCT01563354|54502805|FG000|Core Phase|Diseasse progression|18|||
27882355|NCT01563354|54502806|FG001|Core Phase|Diseasse progression|7|||
27882356|NCT01563354|54502807|FG002|Core Phase|Diseasse progression|8|||
27882357|NCT01563354|54502805|FG000|Core Phase|Protocol deviation|2|||
27882358|NCT01563354|54502806|FG001|Core Phase|Protocol deviation|0|||
27882359|NCT01563354|54502807|FG002|Core Phase|Protocol deviation|0|||
27882360|NCT01563354|54502805|FG000|Core Phase|PI decision - did not enter extension|0|||
27882361|NCT01563354|54502806|FG001|Core Phase|PI decision - did not enter extension|1|||
27882362|NCT01563354|54502807|FG002|Core Phase|PI decision - did not enter extension|0|||
27882363|NCT01563354|54502805|FG000|Core Phase|Worsening of clinical condition - did not enter extension|1|||
27882364|NCT01563354|54502806|FG001|Core Phase|Worsening of clinical condition - did not enter extension|0|||
27882365|NCT01563354|54502807|FG002|Core Phase|Worsening of clinical condition - did not enter extension|0|||
27882366|NCT01563354|54502805|FG000|Extension Phase|Adverse Event|0|||
27882367|NCT01563354|54502806|FG001|Extension Phase|Adverse Event|3|||
27882368|NCT01563354|54502807|FG002|Extension Phase|Adverse Event|2|||
27882369|NCT01563354|54502805|FG000|Extension Phase|Withdrawal by Subject|0|||
27882370|NCT01563354|54502806|FG001|Extension Phase|Withdrawal by Subject|1|||
27882371|NCT01563354|54502807|FG002|Extension Phase|Withdrawal by Subject|0|||
27882372|NCT01563354|54502805|FG000|Extension Phase|Administration problems|3|||
27882373|NCT01563354|54502806|FG001|Extension Phase|Administration problems|2|||
27882374|NCT01563354|54502807|FG002|Extension Phase|Administration problems|3|||
27882375|NCT01563354|54502805|FG000|Extension Phase|Disease progression|9|||
27882376|NCT01563354|54502806|FG001|Extension Phase|Disease progression|8|||
27882377|NCT01563354|54502807|FG002|Extension Phase|Disease progression|10|||
27882378|NCT01588548|54502821|FG000|Overall Study|Withdrawal by Subject|0|||
27882379|NCT01588548|54502822|FG001|Overall Study|Withdrawal by Subject|1|||
27882380|NCT01588548|54502823|FG002|Overall Study|Withdrawal by Subject|1|||
27882381|NCT01588548|54502824|FG003|Overall Study|Withdrawal by Subject|1|||
27882382|NCT01588548|54502825|FG004|Overall Study|Withdrawal by Subject|2|||
27882383|NCT01588548|54502826|FG005|Overall Study|Withdrawal by Subject|3|||
27882384|NCT01588548|54502821|FG000|Overall Study|Adverse Event|0|||
27882385|NCT01588548|54502822|FG001|Overall Study|Adverse Event|0|||
27882386|NCT01588548|54502823|FG002|Overall Study|Adverse Event|1|||
27882387|NCT01588548|54502824|FG003|Overall Study|Adverse Event|2|||
27882388|NCT01588548|54502825|FG004|Overall Study|Adverse Event|1|||
27882389|NCT01588548|54502826|FG005|Overall Study|Adverse Event|0|||
27882390|NCT01588548|54502821|FG000|Overall Study|Condition Under Investigation Worsened|3|||
27882391|NCT01588548|54502822|FG001|Overall Study|Condition Under Investigation Worsened|6|||
27882392|NCT01588548|54502823|FG002|Overall Study|Condition Under Investigation Worsened|4|||
27882393|NCT01588548|54502824|FG003|Overall Study|Condition Under Investigation Worsened|4|||
27882394|NCT01588548|54502825|FG004|Overall Study|Condition Under Investigation Worsened|3|||
27882395|NCT01588548|54502826|FG005|Overall Study|Condition Under Investigation Worsened|3|||
27882396|NCT01587924|54502844|FG000|Overall Study|Adverse Event|0|||
27882397|NCT01587924|54502845|FG001|Overall Study|Adverse Event|2|||
27882398|NCT01587924|54502846|FG002|Overall Study|Adverse Event|0|||
27882399|NCT01587924|54502847|FG003|Overall Study|Adverse Event|0|||
27882400|NCT01587924|54502844|FG000|Overall Study|Protocol Violation|2|||
27882401|NCT01587924|54502845|FG001|Overall Study|Protocol Violation|1|||
27882402|NCT01587924|54502846|FG002|Overall Study|Protocol Violation|2|||
27882403|NCT01587924|54502847|FG003|Overall Study|Protocol Violation|1|||
27882404|NCT01587924|54502844|FG000|Overall Study|Met Hemoglobin stopping criteria|2|||
27882405|NCT01587924|54502845|FG001|Overall Study|Met Hemoglobin stopping criteria|0|||
27882406|NCT01587924|54502846|FG002|Overall Study|Met Hemoglobin stopping criteria|1|||
27882407|NCT01587924|54502847|FG003|Overall Study|Met Hemoglobin stopping criteria|0|||
27882408|NCT01587924|54502844|FG000|Overall Study|Withdrawal by Subject|0|||
27882409|NCT01587924|54502845|FG001|Overall Study|Withdrawal by Subject|1|||
27882410|NCT01587924|54502846|FG002|Overall Study|Withdrawal by Subject|1|||
27882411|NCT01587924|54502847|FG003|Overall Study|Withdrawal by Subject|0|||
27882412|NCT01539642|54502859|FG000|Overall Study|Lack of Efficacy|20|||
27882413|NCT01539642|54502860|FG001|Overall Study|Lack of Efficacy|18|||
27882414|NCT01539642|54502859|FG000|Overall Study|Patient ready for early discharge|8|||
27882415|NCT01539642|54502860|FG001|Overall Study|Patient ready for early discharge|7|||
27882416|NCT01539642|54502859|FG000|Overall Study|Adverse Event|6|||
28171747|NCT02442778|54843316|FG000|Overall Study|Study participant withdrawal by parent or guardian|3|||
27882417|NCT01539642|54502860|FG001|Overall Study|Adverse Event|4|||
27882418|NCT01539642|54502859|FG000|Overall Study|Withdrawal by Subject|2|||
27882419|NCT01539642|54502860|FG001|Overall Study|Withdrawal by Subject|2|||
27882420|NCT01586364|54502866|FG000|Overall Study|Withdrawal by Subject|40|||
27882421|NCT01586364|54502866|FG000|Overall Study|Adverse Event|37|||
27882422|NCT01586364|54502866|FG000|Overall Study|Lost to Follow-up|17|||
27882423|NCT01586364|54502866|FG000|Overall Study|Protocol Violation|16|||
27882424|NCT01586364|54502866|FG000|Overall Study|Lack of Efficacy|1|||
27882425|NCT01586364|54502866|FG000|Overall Study|Other-Did not feel better post-treatment|1|||
27882426|NCT01586364|54502866|FG000|Overall Study|Other-Subject wasn't getting much relief|1|||
27882427|NCT01586364|54502866|FG000|Overall Study|Other-Site closure due to PI illness|1|||
27882428|NCT01586364|54502866|FG000|Overall Study|Other-PI discretion, site closing|2|||
27882429|NCT01586364|54502866|FG000|Overall Study|Other-Not specified|1|||
27882430|NCT01538628|54502872|FG000|Overall Study|Withdrawal by Subject|1|||
27882431|NCT01538628|54502873|FG001|Overall Study|Withdrawal by Subject|1|||
27882432|NCT01538628|54502872|FG000|Overall Study|Lost to Follow-up|0|||
27882433|NCT01538628|54502873|FG001|Overall Study|Lost to Follow-up|1|||
27882434|NCT01538472|54502880|FG000|Overall Study|Disease Progression|3|||
27882435|NCT01538472|54502880|FG000|Overall Study|Death|1|||
27882436|NCT01562028|54502886|FG000|Overall Study|Withdrawal by Subject|1|||
27882437|NCT01562028|54502887|FG001|Overall Study|Withdrawal by Subject|1|||
27882438|NCT01562028|54502886|FG000|Overall Study|Lost to Follow-up|2|||
27882439|NCT01562028|54502887|FG001|Overall Study|Lost to Follow-up|1|||
27882440|NCT01585584|54502893|FG000|Overall Study|Lack of Efficacy|1|||
27882441|NCT01585584|54502893|FG000|Overall Study|Withdrawal by Subject|1|||
27882442|NCT01585584|54502893|FG000|Overall Study|Physician Decision|2|||
27882443|NCT01561560|54502897|FG000|First Two Weeks of Wear|Time/job conflict|0|||
27882444|NCT01561560|54502898|FG001|First Two Weeks of Wear|Time/job conflict|1|||
27882445|NCT01561560|54502897|FG000|First Two Weeks of Wear|Adverse Event|0|||
27882446|NCT01561560|54502898|FG001|First Two Weeks of Wear|Adverse Event|1|||
27882447|NCT01561560|54502897|FG000|Second Two Weeks of Wear|Adverse Event|0|||
27882448|NCT01561560|54502898|FG001|Second Two Weeks of Wear|Adverse Event|1|||
27882449|NCT01537068|54502906|FG000|Overall Study|Lost to Follow-up|2|||
27882450|NCT01537068|54502907|FG001|Overall Study|Lost to Follow-up|1|||
27882451|NCT01537068|54502906|FG000|Overall Study|Adverse Event|0|||
27882452|NCT01537068|54502907|FG001|Overall Study|Adverse Event|1|||
27882453|NCT01537068|54502906|FG000|Overall Study|Withdrawal by Subject|1|||
27882454|NCT01537068|54502907|FG001|Overall Study|Withdrawal by Subject|1|||
27882455|NCT01537068|54502906|FG000|Overall Study|Lack of Efficacy|1|||
27882456|NCT01537068|54502907|FG001|Overall Study|Lack of Efficacy|0|||
27882457|NCT01585428|54502915|FG000|Overall Study|Death during treatment|1|||
27882458|NCT01585428|54502916|FG001|Overall Study|Death during treatment|0|||
27882459|NCT01585272|54502923|FG000|Overall Study|Adverse Event|22|||
27882460|NCT01585272|54502923|FG000|Overall Study|Protocol Violation|7|||
27882461|NCT01585272|54502923|FG000|Overall Study|Withdrawal by Subject|10|||
27882462|NCT01585194|54502927|FG000|Overall Study|Withdrawal by Subject|1|||
27882463|NCT01585194|54502927|FG000|Overall Study|Physician Decision|2|||
27882464|NCT01585194|54502927|FG000|Overall Study|Lack of insurance|1|||
27882465|NCT01560780|54502933|FG000|Overall Study|Death|2|||
27882466|NCT01560780|54502934|FG001|Overall Study|Death|1|||
27882467|NCT01560780|54502933|FG000|Overall Study|Patient Preference|11|||
27882468|NCT01560780|54502934|FG001|Overall Study|Patient Preference|11|||
27882469|NCT01585038|54502942|FG000|Overall Study|Adverse Event|2|||
27882470|NCT01585038|54502943|FG001|Overall Study|Adverse Event|2|||
27882471|NCT01560234|54502957|FG000|Overall Study|Lost to Follow-up|3|||
27882472|NCT01560234|54502958|FG001|Overall Study|Lost to Follow-up|0|||
27882473|NCT01560234|54502959|FG002|Overall Study|Lost to Follow-up|1|||
27882474|NCT01560234|54502960|FG003|Overall Study|Lost to Follow-up|0|||
27882475|NCT01560234|54502961|FG004|Overall Study|Lost to Follow-up|0|||
27882476|NCT01560234|54502962|FG005|Overall Study|Lost to Follow-up|2|||
27882477|NCT01560234|54502963|FG006|Overall Study|Lost to Follow-up|0|||
27882478|NCT01560234|54502964|FG007|Overall Study|Lost to Follow-up|2|||
27882479|NCT01559844|54502982|FG000|Overall Study|Consent Withdrawn|7|||
27882480|NCT01559844|54502982|FG000|Overall Study|Death|5|||
27882481|NCT01559844|54502982|FG000|Overall Study|Efficacy Failure|10|||
27882482|NCT01559844|54502982|FG000|Overall Study|No Longer A Transplant Candidate|3|||
27882483|NCT01584648|54502988|FG000|Overall Study|Death|136|||
27882484|NCT01584648|54502989|FG001|Overall Study|Death|146|||
27882485|NCT01584648|54502988|FG000|Overall Study|Lost to Follow-up|9|||
27882486|NCT01584648|54502989|FG001|Overall Study|Lost to Follow-up|9|||
27882487|NCT01584648|54502988|FG000|Overall Study|Investigator discretion|3|||
27882488|NCT01584648|54502989|FG001|Overall Study|Investigator discretion|2|||
27882489|NCT01584648|54502988|FG000|Overall Study|Withdrew consent|13|||
27882490|NCT01584648|54502989|FG001|Overall Study|Withdrew consent|4|||
27882491|NCT01584648|54502988|FG000|Overall Study|Study closed/terminated|50|||
27882492|NCT01584648|54502989|FG001|Overall Study|Study closed/terminated|23|||
27882493|NCT01584648|54502988|FG000|Overall Study|Crossover to Dabrafenib + Trametinib|0|||
27882494|NCT01584648|54502989|FG001|Overall Study|Crossover to Dabrafenib + Trametinib|28|||
27882495|NCT01559454|54503000|FG000|Overall Study|Lost to Follow-up|3|||
27882496|NCT01559454|54503001|FG001|Overall Study|Lost to Follow-up|2|||
27882497|NCT01559454|54503000|FG000|Overall Study|Withdrawal by Subject|0|||
27882498|NCT01559454|54503001|FG001|Overall Study|Withdrawal by Subject|1|||
27882499|NCT01559454|54503000|FG000|Overall Study|Physician Decision|0|||
27882500|NCT01559454|54503001|FG001|Overall Study|Physician Decision|1|||
27882501|NCT01559454|54503000|FG000|Overall Study|Protocol Violation|0|||
27882502|NCT01559454|54503001|FG001|Overall Study|Protocol Violation|1|||
27882503|NCT01559454|54503000|FG000|Overall Study|Lack of Efficacy|0|||
27882504|NCT01559454|54503001|FG001|Overall Study|Lack of Efficacy|1|||
27882505|NCT01584024|54503007|FG000|Overall Study|Lost to Follow-up|10|||
27882506|NCT01584024|54503007|FG000|Overall Study|Withdrawal by Subject|3|||
27882507|NCT01583166|54503014|FG000|Overall Study|Withdrawal by Subject|4|||
27882508|NCT01583166|54503015|FG001|Overall Study|Withdrawal by Subject|6|||
27882509|NCT01535274|54503023|FG000|Overall Study|Determined to be ineligible|0|||
27882510|NCT01535274|54503024|FG001|Overall Study|Determined to be ineligible|1|||
27882511|NCT01535274|54503023|FG000|Overall Study|Misallocated to propofol intervention|0|||
27882512|NCT01535274|54503024|FG001|Overall Study|Misallocated to propofol intervention|1|||
27882513|NCT01558752|54503034|FG000|Overall Study|Physician Decision|2|||
27882514|NCT01558752|54503035|FG001|Overall Study|Physician Decision|0|||
27882515|NCT01582854|54503043|FG000|Overall Study|Death|8|||
27882516|NCT01582854|54503044|FG001|Overall Study|Death|5|||
27882517|NCT01582854|54503043|FG000|Overall Study|Adverse Event|2|||
27882518|NCT01582854|54503044|FG001|Overall Study|Adverse Event|3|||
27882519|NCT01582854|54503043|FG000|Overall Study|Withdrawal by Participant|8|||
27882520|NCT01582854|54503044|FG001|Overall Study|Withdrawal by Participant|11|||
27882521|NCT01582854|54503043|FG000|Overall Study|Lost to Follow-up|1|||
27882522|NCT01582854|54503044|FG001|Overall Study|Lost to Follow-up|2|||
27882523|NCT01582854|54503043|FG000|Overall Study|Physician Decision|0|||
27882524|NCT01582854|54503044|FG001|Overall Study|Physician Decision|1|||
27882525|NCT01582854|54503043|FG000|Overall Study|Recurrent Stroke|13|||
27882526|NCT01582854|54503044|FG001|Overall Study|Recurrent Stroke|8|||
27882527|NCT01582854|54503043|FG000|Overall Study|Disallowed Concomitant Medication|3|||
27882528|NCT01582854|54503044|FG001|Overall Study|Disallowed Concomitant Medication|2|||
27882529|NCT01582854|54503043|FG000|Overall Study|Carotid or Neurosurgery|0|||
27882530|NCT01582854|54503044|FG001|Overall Study|Carotid or Neurosurgery|1|||
27882531|NCT01582854|54503043|FG000|Overall Study|General Anaesthesia|0|||
27882532|NCT01582854|54503044|FG001|Overall Study|General Anaesthesia|1|||
27882533|NCT01582854|54503043|FG000|Overall Study|Other Miscellaneous Reason|1|||
27882534|NCT01582854|54503044|FG001|Overall Study|Other Miscellaneous Reason|0|||
27882535|NCT01582308|54503050|FG000|Period 1|Withdrawal by Subject|0|||
27882536|NCT01582308|54503051|FG001|Period 1|Withdrawal by Subject|0|||
27882537|NCT01582308|54503052|FG002|Period 1|Withdrawal by Subject|0|||
27882538|NCT01582308|54503053|FG003|Period 1|Withdrawal by Subject|0|||
27882539|NCT01582308|54503054|FG004|Period 1|Withdrawal by Subject|0|||
27882540|NCT01582308|54503055|FG005|Period 1|Withdrawal by Subject|0|||
27882541|NCT01582308|54503056|FG006|Period 1|Withdrawal by Subject|1|||
27882542|NCT01582308|54503057|FG007|Period 1|Withdrawal by Subject|0|||
27882543|NCT01582308|54503058|FG008|Period 1|Withdrawal by Subject|0|||
27882544|NCT01582308|54503059|FG009|Period 1|Withdrawal by Subject|0|||
27882545|NCT01582308|54503050|FG000|10-day Washout Following Period 1|Physician Decision|0|||
27882546|NCT01582308|54503051|FG001|10-day Washout Following Period 1|Physician Decision|0|||
27882547|NCT01582308|54503052|FG002|10-day Washout Following Period 1|Physician Decision|0|||
27882548|NCT01582308|54503053|FG003|10-day Washout Following Period 1|Physician Decision|0|||
27882549|NCT01582308|54503054|FG004|10-day Washout Following Period 1|Physician Decision|1|||
27882550|NCT01582308|54503055|FG005|10-day Washout Following Period 1|Physician Decision|0|||
27882551|NCT01582308|54503056|FG006|10-day Washout Following Period 1|Physician Decision|0|||
27882552|NCT01582308|54503057|FG007|10-day Washout Following Period 1|Physician Decision|0|||
27882553|NCT01582308|54503058|FG008|10-day Washout Following Period 1|Physician Decision|0|||
27882554|NCT01582308|54503059|FG009|10-day Washout Following Period 1|Physician Decision|0|||
27882555|NCT01582308|54503050|FG000|Period 4|Physician Decision|1|||
27882556|NCT01582308|54503051|FG001|Period 4|Physician Decision|0|||
27882557|NCT01582308|54503052|FG002|Period 4|Physician Decision|0|||
27882558|NCT01582308|54503053|FG003|Period 4|Physician Decision|0|||
27882559|NCT01582308|54503054|FG004|Period 4|Physician Decision|0|||
27882560|NCT01582308|54503055|FG005|Period 4|Physician Decision|1|||
27882561|NCT01582308|54503056|FG006|Period 4|Physician Decision|0|||
27882562|NCT01582308|54503057|FG007|Period 4|Physician Decision|0|||
27882563|NCT01582308|54503058|FG008|Period 4|Physician Decision|0|||
27882564|NCT01582308|54503059|FG009|Period 4|Physician Decision|1|||
27882565|NCT01558674|54503074|FG000|Part 1|Study Terminated by Sponsor|10|||
27882566|NCT01558674|54503075|FG001|Part 1|Study Terminated by Sponsor|0|||
27882567|NCT01558674|54503074|FG000|Part 1|Withdrawal by Subject|1|||
27882568|NCT01558674|54503075|FG001|Part 1|Withdrawal by Subject|0|||
27882569|NCT01558596|54503096|FG000|Overall Study|Withdrawal by Subject|1|||
27882570|NCT01558596|54503097|FG001|Overall Study|Withdrawal by Subject|0|||
27882571|NCT01558596|54503096|FG000|Overall Study|surgery elsewhere or cancelled|1|||
27882572|NCT01558596|54503097|FG001|Overall Study|surgery elsewhere or cancelled|1|||
27882573|NCT01558596|54503096|FG000|Overall Study|Protocol Violation|1|||
27882574|NCT01558596|54503097|FG001|Overall Study|Protocol Violation|0|||
27882575|NCT01535040|54503105|FG000|Overall Study|Physician Decision|0|||
27882576|NCT01535040|54503106|FG001|Overall Study|Physician Decision|1|||
27882577|NCT01535040|54503105|FG000|Overall Study|Withdrawal by Subject|13|||
27882578|NCT01535040|54503106|FG001|Overall Study|Withdrawal by Subject|10|||
27882579|NCT01535040|54503105|FG000|Overall Study|Never Started|9|||
27882580|NCT01535040|54503106|FG001|Overall Study|Never Started|4|||
27882581|NCT01535040|54503105|FG000|Overall Study|Toxicity|7|||
27983978|NCT02631941|54642469|FG003|Overall Study|Lost to Follow-up|0|||
27882582|NCT01535040|54503106|FG001|Overall Study|Toxicity|5|||
27882583|NCT01535040|54503105|FG000|Overall Study|Multiple Reasons|1|||
27882584|NCT01535040|54503106|FG001|Overall Study|Multiple Reasons|1|||
27983979|NCT02631941|54642470|FG004|Overall Study|Lost to Follow-up|0|||
27882585|NCT01534962|54503116|FG000|Overall Study|Randomized but did not start treatment|2|||
27882586|NCT01534962|54503117|FG001|Overall Study|Randomized but did not start treatment|0|||
27882587|NCT01534962|54503118|FG002|Overall Study|Randomized but did not start treatment|0|||
27882588|NCT01534962|54503119|FG003|Overall Study|Randomized but did not start treatment|1|||
27882589|NCT01534962|54503116|FG000|Overall Study|Discontinued at AF recurrence|35|||
27882590|NCT01534962|54503117|FG001|Overall Study|Discontinued at AF recurrence|26|||
27882591|NCT01534962|54503118|FG002|Overall Study|Discontinued at AF recurrence|24|||
27882592|NCT01534962|54503119|FG003|Overall Study|Discontinued at AF recurrence|31|||
27882593|NCT01582152|54503131|FG000|Overall Study|Disease Progression|4|||
27882594|NCT01582152|54503132|FG001|Overall Study|Disease Progression|5|||
27882595|NCT01582152|54503131|FG000|Overall Study|Adverse Event|2|||
27882596|NCT01582152|54503132|FG001|Overall Study|Adverse Event|1|||
27882597|NCT01581684|54503148|FG000|Overall Study|Other reason not defined|0|||
27882598|NCT01581684|54503149|FG001|Overall Study|Other reason not defined|0|||
27882599|NCT01581684|54503150|FG002|Overall Study|Other reason not defined|0|||
27882600|NCT01581684|54503151|FG003|Overall Study|Other reason not defined|0|||
27882601|NCT01581684|54503152|FG004|Overall Study|Other reason not defined|0|||
27882602|NCT01581684|54503153|FG005|Overall Study|Other reason not defined|0|||
27882603|NCT01581684|54503154|FG006|Overall Study|Other reason not defined|0|||
27882604|NCT01581684|54503155|FG007|Overall Study|Other reason not defined|0|||
27882605|NCT01581684|54503156|FG008|Overall Study|Other reason not defined|1|||
27882606|NCT01581684|54503157|FG009|Overall Study|Other reason not defined|0|||
27882607|NCT01557582|54503190|FG000|Overall Study|Protocol Violation|4|||
27882608|NCT01557582|54503190|FG000|Overall Study|Operator error|2|||
27882609|NCT01557504|54503196|FG000|Overall Study|Physician Decision|1|||
27882610|NCT01557504|54503197|FG001|Overall Study|Physician Decision|0|||
27882611|NCT01557348|54503211|FG000|Overall Study|Adverse Event|6|||
27882612|NCT01557348|54503212|FG001|Overall Study|Adverse Event|16|||
27882613|NCT01557348|54503211|FG000|Overall Study|Infusion reaction event|5|||
27882614|NCT01557348|54503212|FG001|Overall Study|Infusion reaction event|5|||
27882615|NCT01557348|54503211|FG000|Overall Study|Death|7|||
27882616|NCT01557348|54503212|FG001|Overall Study|Death|4|||
27882617|NCT01557348|54503211|FG000|Overall Study|Insufficient Therapeutic Response|13|||
27882618|NCT01557348|54503212|FG001|Overall Study|Insufficient Therapeutic Response|28|||
27882619|NCT01557348|54503211|FG000|Overall Study|Withdrawal by Subject|5|||
27882620|NCT01557348|54503212|FG001|Overall Study|Withdrawal by Subject|4|||
27882621|NCT01557348|54503211|FG000|Overall Study|Lost to Follow-up|26|||
27882622|NCT01557348|54503212|FG001|Overall Study|Lost to Follow-up|22|||
27882623|NCT01557348|54503211|FG000|Overall Study|Administrative|18|||
27882624|NCT01557348|54503212|FG001|Overall Study|Administrative|11|||
27882625|NCT01580670|54503219|FG000|Maintenance Period (Week 14 to 54)|Adverse Event|1|||
27882626|NCT01580670|54503219|FG000|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1|||
27882627|NCT01534260|54503225|FG000|Overall Study|Adverse Event|1|||
27882628|NCT01534260|54503226|FG001|Overall Study|Adverse Event|8|||
27882629|NCT01534260|54503225|FG000|Overall Study|Death|2|||
27882630|NCT01534260|54503226|FG001|Overall Study|Death|0|||
27882631|NCT01534260|54503225|FG000|Overall Study|Lack of Efficacy|1|||
27882632|NCT01534260|54503226|FG001|Overall Study|Lack of Efficacy|1|||
27882633|NCT01534260|54503225|FG000|Overall Study|Withdrawal by Subject|1|||
27882634|NCT01534260|54503226|FG001|Overall Study|Withdrawal by Subject|3|||
27882635|NCT01534260|54503225|FG000|Overall Study|Disease Progression|8|||
27882636|NCT01534260|54503226|FG001|Overall Study|Disease Progression|6|||
27882637|NCT01534260|54503225|FG000|Overall Study|Physician Decision|3|||
27882638|NCT01534260|54503226|FG001|Overall Study|Physician Decision|1|||
27983980|NCT02631941|54642471|FG005|Overall Study|Lost to Follow-up|0|||
27983981|NCT02631941|54642472|FG006|Overall Study|Lost to Follow-up|0|||
27983982|NCT02631941|54642473|FG007|Overall Study|Lost to Follow-up|0|||
27983983|NCT02631941|54642474|FG008|Overall Study|Lost to Follow-up|1|||
27983984|NCT02631941|54642475|FG009|Overall Study|Lost to Follow-up|0|||
27983985|NCT00908375|54642487|FG000|Overall Study|Withdrawal by Subject|2|||
27983986|NCT00908375|54642488|FG001|Overall Study|Withdrawal by Subject|4|||
27983987|NCT00908375|54642487|FG000|Overall Study|Lost to Follow-up|8|||
27983988|NCT00908375|54642488|FG001|Overall Study|Lost to Follow-up|6|||
27983989|NCT00909389|54642494|FG000|Overall Study|Adverse Event|6|||
27983990|NCT00909389|54642494|FG000|Overall Study|Death|4|||
28171748|NCT02442778|54843317|FG001|Overall Study|Study participant withdrawal by parent or guardian|12|||
27882639|NCT01534260|54503225|FG000|Overall Study|No treatment, per protocol|0|||
27882640|NCT01534260|54503226|FG001|Overall Study|No treatment, per protocol|1|||
27882641|NCT01534182|54503234|FG000|Overall Study|Administrative problems|1|||
27983991|NCT00909389|54642494|FG000|Overall Study|Poor Compliance|16|||
27882642|NCT01534182|54503235|FG001|Overall Study|Administrative problems|0|||
27882643|NCT01534182|54503234|FG000|Overall Study|Withdrawal by Subject|4|||
27882644|NCT01534182|54503235|FG001|Overall Study|Withdrawal by Subject|7|||
27882645|NCT01534182|54503234|FG000|Overall Study|Adverse Event|7|||
27983992|NCT00909389|54642494|FG000|Overall Study|Lost to Follow-up|4|||
27882646|NCT01534182|54503235|FG001|Overall Study|Adverse Event|3|||
27983993|NCT00909389|54642494|FG000|Overall Study|No Information|103|||
27882647|NCT01579812|54503242|FG000|Overall Study|Ineligible after treatment start|40|||
27882648|NCT01579812|54503242|FG000|Overall Study|Patient choice|3|||
27882649|NCT01579812|54503242|FG000|Overall Study|Noncompliance|3|||
27882650|NCT01579812|54503242|FG000|Overall Study|Withdrawal by Subject|6|||
27882651|NCT01533714|54503255|FG000|Overall Study|Adverse Event|0|||
27882652|NCT01533714|54503256|FG001|Overall Study|Adverse Event|1|||
27882653|NCT01533714|54503257|FG002|Overall Study|Adverse Event|2|||
27882654|NCT01533714|54503258|FG003|Overall Study|Adverse Event|2|||
27882655|NCT01533714|54503259|FG004|Overall Study|Adverse Event|2|||
27882656|NCT01533714|54503260|FG005|Overall Study|Adverse Event|1|||
27882657|NCT01533714|54503255|FG000|Overall Study|Lack of Efficacy|0|||
27882658|NCT01533714|54503256|FG001|Overall Study|Lack of Efficacy|0|||
27882659|NCT01533714|54503257|FG002|Overall Study|Lack of Efficacy|0|||
27882660|NCT01533714|54503258|FG003|Overall Study|Lack of Efficacy|0|||
27882661|NCT01533714|54503259|FG004|Overall Study|Lack of Efficacy|0|||
27882662|NCT01533714|54503260|FG005|Overall Study|Lack of Efficacy|1|||
27882663|NCT01533714|54503255|FG000|Overall Study|Withdrawal by Subject|0|||
27882664|NCT01533714|54503256|FG001|Overall Study|Withdrawal by Subject|1|||
27882665|NCT01533714|54503257|FG002|Overall Study|Withdrawal by Subject|0|||
27882666|NCT01533714|54503258|FG003|Overall Study|Withdrawal by Subject|1|||
27882667|NCT01533714|54503259|FG004|Overall Study|Withdrawal by Subject|1|||
27882668|NCT01533714|54503260|FG005|Overall Study|Withdrawal by Subject|0|||
27882669|NCT01533714|54503255|FG000|Overall Study|Exclusion criteria|0|||
27882670|NCT01533714|54503256|FG001|Overall Study|Exclusion criteria|1|||
27882671|NCT01533714|54503257|FG002|Overall Study|Exclusion criteria|0|||
27882672|NCT01533714|54503258|FG003|Overall Study|Exclusion criteria|0|||
27882673|NCT01533714|54503259|FG004|Overall Study|Exclusion criteria|0|||
27882674|NCT01533714|54503260|FG005|Overall Study|Exclusion criteria|0|||
27882675|NCT01533714|54503255|FG000|Overall Study|Positive for purified protein derivative|0|||
27882676|NCT01533714|54503256|FG001|Overall Study|Positive for purified protein derivative|0|||
27882677|NCT01533714|54503257|FG002|Overall Study|Positive for purified protein derivative|1|||
27882678|NCT01533714|54503258|FG003|Overall Study|Positive for purified protein derivative|0|||
27882679|NCT01533714|54503259|FG004|Overall Study|Positive for purified protein derivative|1|||
27882680|NCT01533714|54503260|FG005|Overall Study|Positive for purified protein derivative|0|||
27882681|NCT01533714|54503255|FG000|Overall Study|Withdrawal criteria|0|||
27882682|NCT01533714|54503256|FG001|Overall Study|Withdrawal criteria|0|||
27882683|NCT01533714|54503257|FG002|Overall Study|Withdrawal criteria|1|||
27882684|NCT01533714|54503258|FG003|Overall Study|Withdrawal criteria|0|||
27882685|NCT01533714|54503259|FG004|Overall Study|Withdrawal criteria|3|||
27882686|NCT01533714|54503260|FG005|Overall Study|Withdrawal criteria|1|||
27882687|NCT01533714|54503255|FG000|Overall Study|Ineligibility reason|0|||
27882688|NCT01533714|54503256|FG001|Overall Study|Ineligibility reason|0|||
27882689|NCT01533714|54503257|FG002|Overall Study|Ineligibility reason|0|||
27882690|NCT01533714|54503258|FG003|Overall Study|Ineligibility reason|1|||
27882691|NCT01533714|54503259|FG004|Overall Study|Ineligibility reason|0|||
27882692|NCT01533714|54503260|FG005|Overall Study|Ineligibility reason|0|||
27882693|NCT01533246|54503274|FG000|Overall Study|Adverse Event|1|||
27882694|NCT01533246|54503274|FG000|Overall Study|Withdrawal by Subject|1|||
27882695|NCT01579578|54503280|FG000|Overall Study|Death|4|||
27882696|NCT01579578|54503281|FG001|Overall Study|Death|1|||
27882697|NCT01579578|54503280|FG000|Overall Study|Lost to Follow-up|1|||
27882698|NCT01579578|54503281|FG001|Overall Study|Lost to Follow-up|1|||
27882699|NCT01579578|54503280|FG000|Overall Study|Withdrawal by Subject|2|||
27882700|NCT01579578|54503281|FG001|Overall Study|Withdrawal by Subject|1|||
27882701|NCT01579578|54503280|FG000|Overall Study|Eligibility criteria|3|||
27882702|NCT01579578|54503281|FG001|Overall Study|Eligibility criteria|9|||
27882703|NCT01579578|54503280|FG000|Overall Study|Ongoing|3|||
27882704|NCT01579578|54503281|FG001|Overall Study|Ongoing|0|||
27882705|NCT01578486|54503287|FG000|Overall Study|Physician Decision|3|||
27882706|NCT01578486|54503287|FG000|Overall Study|Withdrawal by Subject|2|||
27882707|NCT01532934|54503293|FG000|Overall Study|Lost to Follow-up|11|||
27882708|NCT01532934|54503294|FG001|Overall Study|Lost to Follow-up|11|||
27882709|NCT01532934|54503293|FG000|Overall Study|In controlled environment|3|||
27882710|NCT01532934|54503294|FG001|Overall Study|In controlled environment|2|||
27882711|NCT01532388|54503304|FG000|3-month Follow-up|Lost to Follow-up|68|||
27882712|NCT01532388|54503305|FG001|3-month Follow-up|Lost to Follow-up|68|||
27882713|NCT01532388|54503304|FG000|6-month Follow-up|Lost to Follow-up|74|||
27882714|NCT01532388|54503305|FG001|6-month Follow-up|Lost to Follow-up|66|||
27882715|NCT01532388|54503304|FG000|12-month Follow-up|Lost to Follow-up|69|||
27882716|NCT01532388|54503305|FG001|12-month Follow-up|Lost to Follow-up|67|||
27882717|NCT01555164|54503313|FG000|Overall Study|Adverse Event|5|||
27882718|NCT01555164|54503314|FG001|Overall Study|Adverse Event|7|||
27882719|NCT01555164|54503313|FG000|Overall Study|Hyperglycemia|0|||
27882720|NCT01555164|54503314|FG001|Overall Study|Hyperglycemia|1|||
27882721|NCT01555164|54503313|FG000|Overall Study|Investigator's Discretion|2|||
27882722|NCT01555164|54503314|FG001|Overall Study|Investigator's Discretion|2|||
27882723|NCT01555164|54503313|FG000|Overall Study|Lost to Follow-up|4|||
27882724|NCT01555164|54503314|FG001|Overall Study|Lost to Follow-up|3|||
27882725|NCT01555164|54503313|FG000|Overall Study|Protocol Violation|9|||
27882726|NCT01555164|54503314|FG001|Overall Study|Protocol Violation|5|||
27882727|NCT01555164|54503313|FG000|Overall Study|Subject Non-compliance|14|||
27882728|NCT01555164|54503314|FG001|Overall Study|Subject Non-compliance|6|||
27882729|NCT01555164|54503313|FG000|Overall Study|Subject Withdrew Consent|6|||
27882730|NCT01555164|54503314|FG001|Overall Study|Subject Withdrew Consent|11|||
27882731|NCT01578330|54503320|FG000|Overall Study|Adverse Event|2|||
27882732|NCT01578330|54503320|FG000|Overall Study|Protocol Violation|5|||
27882733|NCT01577160|54503324|FG000|Overall Study|Adverse Event|9|||
27882734|NCT01577160|54503324|FG000|Overall Study|Lack of Efficacy|15|||
27882735|NCT01577160|54503324|FG000|Overall Study|Lost to Follow-up|40|||
27882736|NCT01577160|54503324|FG000|Overall Study|Withdrawal by Subject|18|||
27882737|NCT01577160|54503324|FG000|Overall Study|Subject Uncooperative|7|||
27882738|NCT01577160|54503324|FG000|Overall Study|Other|9|||
27882739|NCT01554618|54503330|FG000|Randomized Through Start of Treatment|Adverse Event|1|||
27882740|NCT01554618|54503331|FG001|Randomized Through Start of Treatment|Adverse Event|0|||
27882741|NCT01554618|54503330|FG000|Controlled Assessment Period|Lost to Follow-up|2|||
27882742|NCT01554618|54503331|FG001|Controlled Assessment Period|Lost to Follow-up|1|||
27882743|NCT01554618|54503330|FG000|Controlled Assessment Period|Withdrawal by Subject|6|||
27882744|NCT01554618|54503331|FG001|Controlled Assessment Period|Withdrawal by Subject|0|||
27882745|NCT01554618|54503330|FG000|Open-Label Extension Period|Withdrawal by Subject|2|||
27882746|NCT01554618|54503331|FG001|Open-Label Extension Period|Withdrawal by Subject|3|||
27882747|NCT01554618|54503330|FG000|Open-Label Extension Period|Physician Decision|0|||
27882748|NCT01554618|54503331|FG001|Open-Label Extension Period|Physician Decision|1|||
27882749|NCT01554618|54503330|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
27882750|NCT01554618|54503331|FG001|Open-Label Extension Period|Lost to Follow-up|1|||
27882751|NCT01531998|54503341|FG000|Overall Study|Withdrawal by Subject|3|||
27882752|NCT01576146|54503345|FG000|Extension Period 1|Adverse Event|2|||
27882753|NCT01576146|54503345|FG000|Extension Period 1|Death|2|||
27882754|NCT01576146|54503345|FG000|Extension Period 1|Physician Decision|2|||
27882755|NCT01576146|54503345|FG000|Extension Period 1|Withdrawal by Subject|1|||
27882756|NCT01576146|54503345|FG000|Extension Period 1|Lost to Follow-up|1|||
27882757|NCT01576146|54503345|FG000|Extension Period 1|Parathyroidectomy|1|||
27882758|NCT01576146|54503345|FG000|Extension Period 1|Renal Transplant|1|||
27882759|NCT01576146|54503345|FG000|Extension Period 2|Sponsor Decision|13|||
27882760|NCT01576146|54503345|FG000|Extension Period 2|Death|1|||
27882761|NCT01576146|54503345|FG000|Extension Period 2|Adverse Event|1|||
27882762|NCT01576146|54503345|FG000|Extension Period 2|Renal Transplant|1|||
27882763|NCT01576146|54503345|FG000|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1|||
27882764|NCT01553916|54503349|FG000|Overall Study|Withdrawal by Subject|2|||
27882765|NCT01553916|54503349|FG000|Overall Study|Pre-treatment MRI metastatic disease|1|||
27882766|NCT01553136|54503355|FG000|Overall Study|Adverse Event|3|||
27882767|NCT01553136|54503356|FG001|Overall Study|Adverse Event|2|||
27882768|NCT01553136|54503355|FG000|Overall Study|Withdrawal by Subject|2|||
27882769|NCT01553136|54503356|FG001|Overall Study|Withdrawal by Subject|3|||
27882770|NCT01553136|54503355|FG000|Overall Study|Lost to Follow-up|4|||
27882771|NCT01553136|54503356|FG001|Overall Study|Lost to Follow-up|10|||
27882772|NCT01553136|54503355|FG000|Overall Study|Physician Decision|2|||
27882773|NCT01553136|54503356|FG001|Overall Study|Physician Decision|3|||
27882774|NCT01553136|54503355|FG000|Overall Study|Scheduling Difficulties|5|||
27882775|NCT01553136|54503356|FG001|Overall Study|Scheduling Difficulties|4|||
27882776|NCT01552902|54503365|FG000|Overall Study|Adverse Event|1|||
27882777|NCT01552902|54503366|FG001|Overall Study|Adverse Event|15|||
27882778|NCT01552902|54503367|FG002|Overall Study|Adverse Event|14|||
27882779|NCT01552902|54503365|FG000|Overall Study|Protocol Violation|3|||
27882780|NCT01552902|54503366|FG001|Overall Study|Protocol Violation|3|||
27882781|NCT01552902|54503367|FG002|Overall Study|Protocol Violation|3|||
27882782|NCT01552902|54503365|FG000|Overall Study|Lack of Efficacy|4|||
27882783|NCT01552902|54503366|FG001|Overall Study|Lack of Efficacy|3|||
27882784|NCT01552902|54503367|FG002|Overall Study|Lack of Efficacy|1|||
27882785|NCT01552902|54503365|FG000|Overall Study|Withdrawal by Subject|1|||
27882786|NCT01552902|54503366|FG001|Overall Study|Withdrawal by Subject|9|||
27882787|NCT01552902|54503367|FG002|Overall Study|Withdrawal by Subject|6|||
27882788|NCT01552902|54503365|FG000|Overall Study|Lost to Follow-up|1|||
27882789|NCT01552902|54503366|FG001|Overall Study|Lost to Follow-up|3|||
27882790|NCT01552902|54503367|FG002|Overall Study|Lost to Follow-up|6|||
27882791|NCT01552902|54503365|FG000|Overall Study|Other|3|||
27882792|NCT01552902|54503366|FG001|Overall Study|Other|4|||
27882793|NCT01552902|54503367|FG002|Overall Study|Other|3|||
27882794|NCT01529346|54503393|FG000|Overall Study|Lost to Follow-up|2|||
27882795|NCT01529346|54503394|FG001|Overall Study|Lost to Follow-up|0|||
27882796|NCT01529346|54503395|FG002|Overall Study|Lost to Follow-up|1|||
27882797|NCT01529346|54503396|FG003|Overall Study|Lost to Follow-up|0|||
27882798|NCT01529346|54503397|FG004|Overall Study|Lost to Follow-up|0|||
27882799|NCT01529346|54503393|FG000|Overall Study|Other|0|||
27882800|NCT01529346|54503394|FG001|Overall Study|Other|1|||
28096541|NCT04402866|54751603|FG001|Overall Study|Withdrawal by Subject|0|||
27882801|NCT01529346|54503395|FG002|Overall Study|Other|1|||
27882802|NCT01529346|54503396|FG003|Overall Study|Other|0|||
27882803|NCT01529346|54503397|FG004|Overall Study|Other|0|||
27882804|NCT01529268|54503421|FG000|Overall Study|Lost to Follow-up|9|||
27882805|NCT01529268|54503422|FG001|Overall Study|Lost to Follow-up|3|||
27882806|NCT01529268|54503421|FG000|Overall Study|Moved|3|||
27882807|NCT01529268|54503422|FG001|Overall Study|Moved|0|||
27882808|NCT01529112|54503430|FG000|Overall Study|Adverse Event|2|||
27882809|NCT01529112|54503431|FG001|Overall Study|Adverse Event|0|||
27882810|NCT01529112|54503430|FG000|Overall Study|Death|59|||
27882811|NCT01529112|54503431|FG001|Overall Study|Death|38|||
27882812|NCT01529112|54503430|FG000|Overall Study|Protocol Violation|1|||
27882813|NCT01529112|54503431|FG001|Overall Study|Protocol Violation|0|||
27882814|NCT01529112|54503430|FG000|Overall Study|Withdrawal by Subject|7|||
27882815|NCT01529112|54503431|FG001|Overall Study|Withdrawal by Subject|3|||
27882816|NCT01551420|54503439|FG000|In-laboratory (Part A)|Lost to Follow-up|2|||
27882817|NCT01551420|54503440|FG001|In-laboratory (Part A)|Lost to Follow-up|1|||
27882818|NCT01551420|54503439|FG000|In-laboratory (Part A)|Withdrawal by Subject|2|||
27882819|NCT01551420|54503440|FG001|In-laboratory (Part A)|Withdrawal by Subject|0|||
27882820|NCT01551420|54503439|FG000|In-laboratory (Part A)|Scheduling conflict|2|||
27882821|NCT01551420|54503440|FG001|In-laboratory (Part A)|Scheduling conflict|1|||
27882822|NCT01551420|54503439|FG000|Screened for Part B Eligibility|Declined participation|8|||
27882823|NCT01551420|54503440|FG001|Screened for Part B Eligibility|Declined participation|1|||
27882824|NCT01551420|54503439|FG000|Screened for Part B Eligibility|Deemed ineligible by staff|1|||
27882825|NCT01551420|54503440|FG001|Screened for Part B Eligibility|Deemed ineligible by staff|2|||
27882826|NCT01551420|54503439|FG000|Home Use (Part B)|Withdrawal by Subject|6|||
27882827|NCT01551420|54503440|FG001|Home Use (Part B)|Withdrawal by Subject|0|||
27882828|NCT01551420|54503439|FG000|Home Use (Part B)|Withdrawal by staff|0|||
27882829|NCT01551420|54503440|FG001|Home Use (Part B)|Withdrawal by staff|1|||
27882830|NCT01575054|54503448|FG000|Overall Study|Other Reasons|5|||
27882831|NCT01575054|54503449|FG001|Overall Study|Other Reasons|3|||
27882832|NCT01575054|54503448|FG000|Overall Study|Protocol Violation|2|||
27882833|NCT01575054|54503449|FG001|Overall Study|Protocol Violation|1|||
27882834|NCT01575054|54503448|FG000|Overall Study|Personal Reasons|10|||
27882835|NCT01575054|54503449|FG001|Overall Study|Personal Reasons|11|||
27882836|NCT01575054|54503448|FG000|Overall Study|Lost to Follow-up|3|||
27882837|NCT01575054|54503449|FG001|Overall Study|Lost to Follow-up|3|||
27882838|NCT01575054|54503448|FG000|Overall Study|Adverse Event|9|||
27882839|NCT01575054|54503449|FG001|Overall Study|Adverse Event|8|||
27882840|NCT01528254|54503457|FG000|Overall Study|Administrative problems|96|||
27882841|NCT01528254|54503458|FG001|Overall Study|Administrative problems|94|||
27882842|NCT01528254|54503457|FG000|Overall Study|Adverse Event|28|||
27882843|NCT01528254|54503458|FG001|Overall Study|Adverse Event|44|||
27882844|NCT01528254|54503457|FG000|Overall Study|Lost to Follow-up|17|||
27882845|NCT01528254|54503458|FG001|Overall Study|Lost to Follow-up|24|||
27882846|NCT01528254|54503457|FG000|Overall Study|Death|13|||
27882847|NCT01528254|54503458|FG001|Overall Study|Death|9|||
27882848|NCT01528254|54503457|FG000|Overall Study|Protocol deviation|9|||
27882849|NCT01528254|54503458|FG001|Overall Study|Protocol deviation|19|||
27882850|NCT01528254|54503457|FG000|Overall Study|New therapy for study indication|8|||
27882851|NCT01528254|54503458|FG001|Overall Study|New therapy for study indication|6|||
27882852|NCT01528254|54503457|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
27882853|NCT01528254|54503458|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
27882854|NCT01528254|54503457|FG000|Overall Study|Withdrawal by Subject|5|||
27882855|NCT01528254|54503458|FG001|Overall Study|Withdrawal by Subject|4|||
27882856|NCT01528254|54503457|FG000|Overall Study|Abnormal laboratory value(s)|3|||
27882857|NCT01528254|54503458|FG001|Overall Study|Abnormal laboratory value(s)|7|||
27882858|NCT01528254|54503457|FG000|Overall Study|Abnormal test procedure result(s)|1|||
27882859|NCT01528254|54503458|FG001|Overall Study|Abnormal test procedure result(s)|0|||
27882860|NCT01528254|54503457|FG000|Overall Study|No longer requires study drug|1|||
27882861|NCT01528254|54503458|FG001|Overall Study|No longer requires study drug|1|||
27882862|NCT01574352|54503467|FG000|Overall Study|Withdrawal by Subject|6|||
27882863|NCT01574352|54503468|FG001|Overall Study|Withdrawal by Subject|13|||
27882864|NCT01574352|54503467|FG000|Overall Study|Injury in non-camp related sport|1|||
27882865|NCT01574352|54503468|FG001|Overall Study|Injury in non-camp related sport|0|||
27882866|NCT01527006|54503476|FG000|Core Study|Adverse Event|0|||
27882867|NCT01527006|54503477|FG001|Core Study|Adverse Event|2|||
27882868|NCT01527006|54503476|FG000|Core Study|Lost to Follow-up|0|||
27882869|NCT01527006|54503477|FG001|Core Study|Lost to Follow-up|1|||
27882870|NCT01527006|54503476|FG000|Core Study|Subject Choice|1|||
27882871|NCT01527006|54503477|FG001|Core Study|Subject Choice|0|||
27882872|NCT01527006|54503476|FG000|Core Study|Inadequate Therapeutic Effect|1|||
27882873|NCT01527006|54503477|FG001|Core Study|Inadequate Therapeutic Effect|0|||
27882874|NCT01527006|54503476|FG000|Core Study|Withdrawal by Subject|0|||
27882875|NCT01527006|54503477|FG001|Core Study|Withdrawal by Subject|1|||
27882876|NCT01527006|54503476|FG000|Core Study|Other|0|||
27882877|NCT01527006|54503477|FG001|Core Study|Other|2|||
27882878|NCT01527006|54503476|FG000|Extension Phase|Adverse Event|4|||
27882879|NCT01527006|54503477|FG001|Extension Phase|Adverse Event|2|||
27882880|NCT01527006|54503476|FG000|Extension Phase|Lost to Follow-up|0|||
27882881|NCT01527006|54503477|FG001|Extension Phase|Lost to Follow-up|1|||
27882882|NCT01527006|54503476|FG000|Extension Phase|Subject Choice|1|||
27882883|NCT01527006|54503477|FG001|Extension Phase|Subject Choice|1|||
27882884|NCT01527006|54503476|FG000|Extension Phase|Inadequate therapeutic effect|1|||
27882885|NCT01527006|54503477|FG001|Extension Phase|Inadequate therapeutic effect|1|||
27882886|NCT01527006|54503476|FG000|Extension Phase|Other|0|||
27882887|NCT01527006|54503477|FG001|Extension Phase|Other|3|||
27882888|NCT01526928|54503495|FG000|Overall Study|Progressive Disease|35|||
27882889|NCT01526928|54503496|FG001|Overall Study|Progressive Disease|17|||
27882890|NCT01526928|54503497|FG002|Overall Study|Progressive Disease|150|||
27882891|NCT01526928|54503498|FG003|Overall Study|Progressive Disease|182|||
27882892|NCT01526928|54503499|FG004|Overall Study|Progressive Disease|76|||
27882893|NCT01526928|54503500|FG005|Overall Study|Progressive Disease|4|||
27882894|NCT01526928|54503495|FG000|Overall Study|Adverse Event|2|||
27882895|NCT01526928|54503496|FG001|Overall Study|Adverse Event|1|||
27882896|NCT01526928|54503497|FG002|Overall Study|Adverse Event|29|||
27882897|NCT01526928|54503498|FG003|Overall Study|Adverse Event|40|||
27882898|NCT01526928|54503499|FG004|Overall Study|Adverse Event|13|||
27882899|NCT01526928|54503500|FG005|Overall Study|Adverse Event|2|||
27882900|NCT01526928|54503495|FG000|Overall Study|Death|0|||
27882901|NCT01526928|54503496|FG001|Overall Study|Death|0|||
27882902|NCT01526928|54503497|FG002|Overall Study|Death|3|||
27882903|NCT01526928|54503498|FG003|Overall Study|Death|0|||
27882904|NCT01526928|54503499|FG004|Overall Study|Death|0|||
27882905|NCT01526928|54503500|FG005|Overall Study|Death|0|||
27882906|NCT01526928|54503495|FG000|Overall Study|Withdrawal by Subject|1|||
27882907|NCT01526928|54503496|FG001|Overall Study|Withdrawal by Subject|0|||
27882908|NCT01526928|54503497|FG002|Overall Study|Withdrawal by Subject|13|||
27882909|NCT01526928|54503498|FG003|Overall Study|Withdrawal by Subject|11|||
27882910|NCT01526928|54503499|FG004|Overall Study|Withdrawal by Subject|3|||
27882911|NCT01526928|54503500|FG005|Overall Study|Withdrawal by Subject|0|||
27882912|NCT01526928|54503495|FG000|Overall Study|Physician Decision|0|||
27882913|NCT01526928|54503496|FG001|Overall Study|Physician Decision|0|||
27882914|NCT01526928|54503497|FG002|Overall Study|Physician Decision|2|||
27882915|NCT01526928|54503498|FG003|Overall Study|Physician Decision|5|||
27882916|NCT01526928|54503499|FG004|Overall Study|Physician Decision|0|||
27882917|NCT01526928|54503500|FG005|Overall Study|Physician Decision|0|||
27882918|NCT01526928|54503495|FG000|Overall Study|Other Reason|0|||
27882919|NCT01526928|54503496|FG001|Overall Study|Other Reason|1|||
27882920|NCT01526928|54503497|FG002|Overall Study|Other Reason|11|||
27882921|NCT01526928|54503498|FG003|Overall Study|Other Reason|4|||
27882922|NCT01526928|54503499|FG004|Overall Study|Other Reason|1|||
27882923|NCT01526928|54503500|FG005|Overall Study|Other Reason|0|||
27882924|NCT01526928|54503495|FG000|Overall Study|Lost to Follow-up|0|||
27882925|NCT01526928|54503496|FG001|Overall Study|Lost to Follow-up|0|||
27882926|NCT01526928|54503497|FG002|Overall Study|Lost to Follow-up|0|||
27882927|NCT01526928|54503498|FG003|Overall Study|Lost to Follow-up|1|||
27882928|NCT01526928|54503499|FG004|Overall Study|Lost to Follow-up|0|||
27882929|NCT01526928|54503500|FG005|Overall Study|Lost to Follow-up|0|||
27882930|NCT01526928|54503495|FG000|Overall Study|Protocol Deviation|0|||
27882931|NCT01526928|54503496|FG001|Overall Study|Protocol Deviation|0|||
27882932|NCT01526928|54503497|FG002|Overall Study|Protocol Deviation|0|||
27882933|NCT01526928|54503498|FG003|Overall Study|Protocol Deviation|2|||
27882934|NCT01526928|54503499|FG004|Overall Study|Protocol Deviation|0|||
27882935|NCT01526928|54503500|FG005|Overall Study|Protocol Deviation|0|||
27882936|NCT01526928|54503495|FG000|Overall Study|Missing|0|||
27882937|NCT01526928|54503496|FG001|Overall Study|Missing|0|||
27882938|NCT01526928|54503497|FG002|Overall Study|Missing|1|||
27882939|NCT01526928|54503498|FG003|Overall Study|Missing|0|||
27882940|NCT01526928|54503499|FG004|Overall Study|Missing|2|||
27882941|NCT01526928|54503500|FG005|Overall Study|Missing|0|||
27882942|NCT01549860|54503558|FG000|Overall Study|Withdrawal by Subject|1|||
27882943|NCT01549860|54503559|FG001|Overall Study|Withdrawal by Subject|0|||
27882944|NCT01549860|54503558|FG000|Overall Study|Physician Decision|1|||
27882945|NCT01549860|54503559|FG001|Overall Study|Physician Decision|1|||
27882946|NCT01549392|54503567|FG000|Overall Study|Withdrawal by Subject|1|||
27882947|NCT01549392|54503568|FG001|Overall Study|Withdrawal by Subject|0|||
27882948|NCT01526148|54503576|FG000|Overall Study|Adverse Event|6|||
27882949|NCT01526148|54503577|FG001|Overall Study|Adverse Event|5|||
27882950|NCT01526148|54503576|FG000|Overall Study|Lost to Follow-up|3|||
27882951|NCT01526148|54503577|FG001|Overall Study|Lost to Follow-up|6|||
27882952|NCT01526148|54503576|FG000|Overall Study|Withdrawal by Subject|2|||
27882953|NCT01526148|54503577|FG001|Overall Study|Withdrawal by Subject|0|||
27882954|NCT01526148|54503576|FG000|Overall Study|Unstable Medical Condition|1|||
27882955|NCT01526148|54503577|FG001|Overall Study|Unstable Medical Condition|0|||
27882956|NCT01526148|54503576|FG000|Overall Study|Unable to discontinue concomitant med|1|||
27882957|NCT01526148|54503577|FG001|Overall Study|Unable to discontinue concomitant med|0|||
27882958|NCT01526148|54503576|FG000|Overall Study|Moved out of state|1|||
27882959|NCT01526148|54503577|FG001|Overall Study|Moved out of state|0|||
27882960|NCT01526148|54503576|FG000|Overall Study|Incarcerated|0|||
27882961|NCT01526148|54503577|FG001|Overall Study|Incarcerated|2|||
27882962|NCT01572948|54503585|FG000|Overall Study|Lost to Follow-up|1|||
27882963|NCT01572948|54503586|FG001|Overall Study|Lost to Follow-up|0|||
27882964|NCT01572948|54503585|FG000|Overall Study|unable to contact|0|||
27882965|NCT01572948|54503586|FG001|Overall Study|unable to contact|1|||
27882966|NCT01525602|54503604|FG000|Overall Study|Adverse Event|1|||
27882967|NCT01525602|54503605|FG001|Overall Study|Adverse Event|0|||
27882968|NCT01525602|54503606|FG002|Overall Study|Adverse Event|1|||
27882969|NCT01525602|54503607|FG003|Overall Study|Adverse Event|1|||
27882970|NCT01525602|54503608|FG004|Overall Study|Adverse Event|3|||
27882971|NCT01525602|54503609|FG005|Overall Study|Adverse Event|3|||
27882972|NCT01525602|54503610|FG006|Overall Study|Adverse Event|0|||
27882973|NCT01525602|54503611|FG007|Overall Study|Adverse Event|1|||
27882974|NCT01525602|54503604|FG000|Overall Study|Disease progression|6|||
27882975|NCT01525602|54503605|FG001|Overall Study|Disease progression|3|||
27882976|NCT01525602|54503606|FG002|Overall Study|Disease progression|2|||
27882977|NCT01525602|54503607|FG003|Overall Study|Disease progression|5|||
27882978|NCT01525602|54503608|FG004|Overall Study|Disease progression|22|||
27882979|NCT01525602|54503609|FG005|Overall Study|Disease progression|2|||
27882980|NCT01525602|54503610|FG006|Overall Study|Disease progression|3|||
27882981|NCT01525602|54503611|FG007|Overall Study|Disease progression|3|||
27882982|NCT01525602|54503604|FG000|Overall Study|Clinical progression|2|||
27882983|NCT01525602|54503605|FG001|Overall Study|Clinical progression|0|||
27882984|NCT01525602|54503606|FG002|Overall Study|Clinical progression|0|||
27882985|NCT01525602|54503607|FG003|Overall Study|Clinical progression|0|||
27882986|NCT01525602|54503608|FG004|Overall Study|Clinical progression|0|||
27882987|NCT01525602|54503609|FG005|Overall Study|Clinical progression|0|||
27882988|NCT01525602|54503610|FG006|Overall Study|Clinical progression|1|||
27882989|NCT01525602|54503611|FG007|Overall Study|Clinical progression|1|||
27882990|NCT01525602|54503604|FG000|Overall Study|Non-compliance|0|||
27882991|NCT01525602|54503605|FG001|Overall Study|Non-compliance|0|||
27882992|NCT01525602|54503606|FG002|Overall Study|Non-compliance|0|||
27882993|NCT01525602|54503607|FG003|Overall Study|Non-compliance|0|||
27882994|NCT01525602|54503608|FG004|Overall Study|Non-compliance|1|||
27882995|NCT01525602|54503609|FG005|Overall Study|Non-compliance|0|||
27882996|NCT01525602|54503610|FG006|Overall Study|Non-compliance|0|||
27882997|NCT01525602|54503611|FG007|Overall Study|Non-compliance|0|||
27882998|NCT01525602|54503604|FG000|Overall Study|Withdrawal by Subject|0|||
27882999|NCT01525602|54503605|FG001|Overall Study|Withdrawal by Subject|0|||
27883000|NCT01525602|54503606|FG002|Overall Study|Withdrawal by Subject|0|||
27883001|NCT01525602|54503607|FG003|Overall Study|Withdrawal by Subject|0|||
27883002|NCT01525602|54503608|FG004|Overall Study|Withdrawal by Subject|3|||
27883003|NCT01525602|54503609|FG005|Overall Study|Withdrawal by Subject|1|||
27883004|NCT01525602|54503610|FG006|Overall Study|Withdrawal by Subject|0|||
27883005|NCT01525602|54503611|FG007|Overall Study|Withdrawal by Subject|1|||
27883006|NCT01525602|54503604|FG000|Overall Study|Physician Decision|0|||
27883007|NCT01525602|54503605|FG001|Overall Study|Physician Decision|0|||
27883008|NCT01525602|54503606|FG002|Overall Study|Physician Decision|0|||
27883009|NCT01525602|54503607|FG003|Overall Study|Physician Decision|0|||
27883010|NCT01525602|54503608|FG004|Overall Study|Physician Decision|3|||
27883011|NCT01525602|54503609|FG005|Overall Study|Physician Decision|0|||
27883012|NCT01525602|54503610|FG006|Overall Study|Physician Decision|1|||
27883013|NCT01525602|54503611|FG007|Overall Study|Physician Decision|0|||
27883014|NCT01525602|54503604|FG000|Overall Study|Death|0|||
27883015|NCT01525602|54503605|FG001|Overall Study|Death|0|||
27883016|NCT01525602|54503606|FG002|Overall Study|Death|0|||
27883017|NCT01525602|54503607|FG003|Overall Study|Death|0|||
27883018|NCT01525602|54503608|FG004|Overall Study|Death|1|||
27883019|NCT01525602|54503609|FG005|Overall Study|Death|1|||
27883020|NCT01525602|54503610|FG006|Overall Study|Death|0|||
27883021|NCT01525602|54503611|FG007|Overall Study|Death|0|||
27883022|NCT01525602|54503604|FG000|Overall Study|Unqualified based on biopsy; not dosed|0|||
27883023|NCT01525602|54503605|FG001|Overall Study|Unqualified based on biopsy; not dosed|0|||
27883024|NCT01525602|54503606|FG002|Overall Study|Unqualified based on biopsy; not dosed|0|||
27883025|NCT01525602|54503607|FG003|Overall Study|Unqualified based on biopsy; not dosed|0|||
27883026|NCT01525602|54503608|FG004|Overall Study|Unqualified based on biopsy; not dosed|0|||
27883027|NCT01525602|54503609|FG005|Overall Study|Unqualified based on biopsy; not dosed|0|||
27883028|NCT01525602|54503610|FG006|Overall Study|Unqualified based on biopsy; not dosed|1|||
27883029|NCT01525602|54503611|FG007|Overall Study|Unqualified based on biopsy; not dosed|1|||
27883030|NCT01549002|54503638|FG000|Overall Study|Excessive pain|0|||
27883031|NCT01549002|54503639|FG001|Overall Study|Excessive pain|2|||
27883032|NCT01549002|54503638|FG000|Overall Study|Moderate sedation required|0|||
27883033|NCT01549002|54503639|FG001|Overall Study|Moderate sedation required|2|||
27883034|NCT01548768|54503649|FG000|Overall Study|Withdrawal by Subject|0|||
27883035|NCT01548768|54503650|FG001|Overall Study|Withdrawal by Subject|2|||
27883036|NCT01548768|54503651|FG002|Overall Study|Withdrawal by Subject|1|||
27883037|NCT01548768|54503652|FG003|Overall Study|Withdrawal by Subject|0|||
27883038|NCT01548768|54503649|FG000|Overall Study|Physician Decision|1|||
27883039|NCT01548768|54503650|FG001|Overall Study|Physician Decision|0|||
27883040|NCT01548768|54503651|FG002|Overall Study|Physician Decision|0|||
27883041|NCT01548768|54503652|FG003|Overall Study|Physician Decision|0|||
27883042|NCT01548768|54503649|FG000|Overall Study|Adverse Event|0|||
27883043|NCT01548768|54503650|FG001|Overall Study|Adverse Event|0|||
27883044|NCT01548768|54503651|FG002|Overall Study|Adverse Event|0|||
27883045|NCT01548768|54503652|FG003|Overall Study|Adverse Event|1|||
27883046|NCT01548768|54503649|FG000|Overall Study|Non-Compliance|0|||
27883047|NCT01548768|54503650|FG001|Overall Study|Non-Compliance|0|||
27883048|NCT01548768|54503651|FG002|Overall Study|Non-Compliance|0|||
27883049|NCT01548768|54503652|FG003|Overall Study|Non-Compliance|3|||
27883050|NCT01572792|54503669|FG000|Lead-in Study|Lost to Follow-up|5|||
27883051|NCT01572792|54503670|FG001|Lead-in Study|Lost to Follow-up|9|||
27883052|NCT01572792|54503671|FG002|Lead-in Study|Lost to Follow-up|4|||
27883053|NCT01572792|54503672|FG003|Lead-in Study|Lost to Follow-up|2|||
27883054|NCT01572792|54503673|FG004|Lead-in Study|Lost to Follow-up|4|||
27883055|NCT01572792|54503669|FG000|Lead-in Study|Withdrawal by Subject|22|||
27883056|NCT01572792|54503670|FG001|Lead-in Study|Withdrawal by Subject|11|||
27883057|NCT01572792|54503671|FG002|Lead-in Study|Withdrawal by Subject|12|||
27883058|NCT01572792|54503672|FG003|Lead-in Study|Withdrawal by Subject|24|||
27883059|NCT01572792|54503673|FG004|Lead-in Study|Withdrawal by Subject|11|||
27883060|NCT01572792|54503669|FG000|Lead-in Study|Protocol Violation|19|||
27883061|NCT01572792|54503670|FG001|Lead-in Study|Protocol Violation|10|||
27883062|NCT01572792|54503671|FG002|Lead-in Study|Protocol Violation|12|||
27883063|NCT01572792|54503672|FG003|Lead-in Study|Protocol Violation|13|||
27883064|NCT01572792|54503673|FG004|Lead-in Study|Protocol Violation|21|||
27883065|NCT01572792|54503669|FG000|Lead-in Study|Lack of Efficacy|20|||
27883066|NCT01572792|54503670|FG001|Lead-in Study|Lack of Efficacy|5|||
27883067|NCT01572792|54503671|FG002|Lead-in Study|Lack of Efficacy|4|||
27883068|NCT01572792|54503672|FG003|Lead-in Study|Lack of Efficacy|8|||
27883069|NCT01572792|54503673|FG004|Lead-in Study|Lack of Efficacy|10|||
27883070|NCT01572792|54503669|FG000|Lead-in Study|Adverse Event|21|||
27883071|NCT01572792|54503670|FG001|Lead-in Study|Adverse Event|21|||
27883072|NCT01572792|54503671|FG002|Lead-in Study|Adverse Event|22|||
27883073|NCT01572792|54503672|FG003|Lead-in Study|Adverse Event|16|||
27883074|NCT01572792|54503673|FG004|Lead-in Study|Adverse Event|14|||
27883075|NCT01572792|54503669|FG000|Lead-in Study|Site termination/COPD exacerbation/other|14|||
27883076|NCT01572792|54503670|FG001|Lead-in Study|Site termination/COPD exacerbation/other|10|||
27883077|NCT01572792|54503671|FG002|Lead-in Study|Site termination/COPD exacerbation/other|8|||
27883078|NCT01572792|54503672|FG003|Lead-in Study|Site termination/COPD exacerbation/other|9|||
27883079|NCT01572792|54503673|FG004|Lead-in Study|Site termination/COPD exacerbation/other|9|||
27883080|NCT01572792|54503669|FG000|Extension Study|Lost to Follow-up|6|||
27883081|NCT01572792|54503670|FG001|Extension Study|Lost to Follow-up|2|||
27883082|NCT01572792|54503671|FG002|Extension Study|Lost to Follow-up|0|||
27883083|NCT01572792|54503672|FG003|Extension Study|Lost to Follow-up|3|||
27883084|NCT01572792|54503673|FG004|Extension Study|Lost to Follow-up|3|||
27883085|NCT01572792|54503669|FG000|Extension Study|Withdrawal by Subject|7|||
27883086|NCT01572792|54503670|FG001|Extension Study|Withdrawal by Subject|6|||
27883087|NCT01572792|54503671|FG002|Extension Study|Withdrawal by Subject|11|||
27883088|NCT01572792|54503672|FG003|Extension Study|Withdrawal by Subject|8|||
27883089|NCT01572792|54503673|FG004|Extension Study|Withdrawal by Subject|14|||
27883090|NCT01572792|54503669|FG000|Extension Study|Protocol Violation|0|||
27883091|NCT01572792|54503670|FG001|Extension Study|Protocol Violation|4|||
27883092|NCT01572792|54503671|FG002|Extension Study|Protocol Violation|3|||
27883093|NCT01572792|54503672|FG003|Extension Study|Protocol Violation|4|||
27883094|NCT01572792|54503673|FG004|Extension Study|Protocol Violation|3|||
27883095|NCT01572792|54503669|FG000|Extension Study|Lack of Efficacy|2|||
27883096|NCT01572792|54503670|FG001|Extension Study|Lack of Efficacy|3|||
27883097|NCT01572792|54503671|FG002|Extension Study|Lack of Efficacy|3|||
27883098|NCT01572792|54503672|FG003|Extension Study|Lack of Efficacy|2|||
27883099|NCT01572792|54503673|FG004|Extension Study|Lack of Efficacy|2|||
27883100|NCT01572792|54503669|FG000|Extension Study|Adverse Event|7|||
27883101|NCT01572792|54503670|FG001|Extension Study|Adverse Event|6|||
27883102|NCT01572792|54503671|FG002|Extension Study|Adverse Event|5|||
27883103|NCT01572792|54503672|FG003|Extension Study|Adverse Event|6|||
27883104|NCT01572792|54503673|FG004|Extension Study|Adverse Event|4|||
27883105|NCT01572792|54503669|FG000|Extension Study|Site termination/COPD exacerbation/other|3|||
27883106|NCT01572792|54503670|FG001|Extension Study|Site termination/COPD exacerbation/other|8|||
27883107|NCT01572792|54503671|FG002|Extension Study|Site termination/COPD exacerbation/other|4|||
27883108|NCT01572792|54503672|FG003|Extension Study|Site termination/COPD exacerbation/other|6|||
27983994|NCT00910715|54642501|FG000|Overall Study|Lost to Follow-up|22|||
27883109|NCT01572792|54503673|FG004|Extension Study|Site termination/COPD exacerbation/other|6|||
27883110|NCT01547598|54503688|FG000|Overall Study|Withdrew consent|1|||
27883111|NCT01547598|54503689|FG001|Overall Study|Withdrew consent|1|||
27883112|NCT01547598|54503688|FG000|Overall Study|Lost to Follow-up|1|||
27983995|NCT00910715|54642502|FG001|Overall Study|Lost to Follow-up|26|||
27883113|NCT01547598|54503689|FG001|Overall Study|Lost to Follow-up|1|||
27883114|NCT01547598|54503688|FG000|Overall Study|Adverse Event|1|||
27883115|NCT01547598|54503689|FG001|Overall Study|Adverse Event|1|||
27983996|NCT00910715|54642503|FG002|Overall Study|Lost to Follow-up|0|||
27983997|NCT00600483|54642583|FG000|Overall Study|Lost to Follow-up|26|||
27983998|NCT00600483|54642584|FG001|Overall Study|Lost to Follow-up|47|||
27983999|NCT00600483|54642583|FG000|Overall Study|Randomized but not treated|10|||
27984000|NCT00600483|54642584|FG001|Overall Study|Randomized but not treated|0|||
27984001|NCT00600171|54642596|FG000|Overall Study|Adverse Event|0|||
27984002|NCT00600171|54642597|FG001|Overall Study|Adverse Event|1|||
27984003|NCT00600171|54642598|FG002|Overall Study|Adverse Event|0|||
27984004|NCT00600171|54642599|FG003|Overall Study|Adverse Event|0|||
27984005|NCT00600171|54642600|FG004|Overall Study|Adverse Event|1|||
27984006|NCT00600171|54642601|FG005|Overall Study|Adverse Event|0|||
27984007|NCT00600171|54642596|FG000|Overall Study|Lack of Efficacy|9|||
27984008|NCT00600171|54642597|FG001|Overall Study|Lack of Efficacy|12|||
27984009|NCT00600171|54642598|FG002|Overall Study|Lack of Efficacy|3|||
27984010|NCT00600171|54642599|FG003|Overall Study|Lack of Efficacy|5|||
27984011|NCT00600171|54642600|FG004|Overall Study|Lack of Efficacy|4|||
27984012|NCT00600171|54642601|FG005|Overall Study|Lack of Efficacy|0|||
27984013|NCT00600171|54642596|FG000|Overall Study|Protocol Violation|1|||
27984014|NCT00600171|54642597|FG001|Overall Study|Protocol Violation|2|||
27984015|NCT00600171|54642598|FG002|Overall Study|Protocol Violation|0|||
27984016|NCT00600171|54642599|FG003|Overall Study|Protocol Violation|1|||
27984017|NCT00600171|54642600|FG004|Overall Study|Protocol Violation|0|||
27984018|NCT00600171|54642601|FG005|Overall Study|Protocol Violation|0|||
27984019|NCT00600171|54642596|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
27984020|NCT00600171|54642597|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
27984021|NCT00600171|54642598|FG002|Overall Study|Met Protocol-defined Stopping Criteria|7|||
27984022|NCT00600171|54642599|FG003|Overall Study|Met Protocol-defined Stopping Criteria|3|||
27984023|NCT00600171|54642600|FG004|Overall Study|Met Protocol-defined Stopping Criteria|2|||
27984024|NCT00600171|54642601|FG005|Overall Study|Met Protocol-defined Stopping Criteria|2|||
27984025|NCT00600171|54642596|FG000|Overall Study|Withdrawal by Subject|3|||
27984026|NCT00600171|54642597|FG001|Overall Study|Withdrawal by Subject|0|||
27984027|NCT00600171|54642598|FG002|Overall Study|Withdrawal by Subject|0|||
27984028|NCT00600171|54642599|FG003|Overall Study|Withdrawal by Subject|1|||
27984029|NCT00600171|54642600|FG004|Overall Study|Withdrawal by Subject|1|||
27984030|NCT00600171|54642601|FG005|Overall Study|Withdrawal by Subject|1|||
27984031|NCT00600171|54642596|FG000|Overall Study|Physician Decision|0|||
27984032|NCT00600171|54642597|FG001|Overall Study|Physician Decision|1|||
27984033|NCT00600171|54642598|FG002|Overall Study|Physician Decision|0|||
27984034|NCT00600171|54642599|FG003|Overall Study|Physician Decision|1|||
27984035|NCT00600171|54642600|FG004|Overall Study|Physician Decision|0|||
27984036|NCT00600171|54642601|FG005|Overall Study|Physician Decision|2|||
27984037|NCT00600171|54642596|FG000|Overall Study|Lost to Follow-up|0|||
27984038|NCT00600171|54642597|FG001|Overall Study|Lost to Follow-up|0|||
27984039|NCT00600171|54642598|FG002|Overall Study|Lost to Follow-up|0|||
27984040|NCT00600171|54642599|FG003|Overall Study|Lost to Follow-up|1|||
27984041|NCT00600171|54642600|FG004|Overall Study|Lost to Follow-up|0|||
27984042|NCT00600171|54642601|FG005|Overall Study|Lost to Follow-up|0|||
27984043|NCT04035668|54642620|FG000|Overall Study|Adverse Event|3|||
27984044|NCT04035668|54642621|FG001|Overall Study|Adverse Event|4|||
27984045|NCT04035668|54642622|FG002|Overall Study|Adverse Event|2|||
27984046|NCT04035668|54642620|FG000|Overall Study|Lost to Follow-up|0|||
27984047|NCT04035668|54642621|FG001|Overall Study|Lost to Follow-up|1|||
27984048|NCT04035668|54642622|FG002|Overall Study|Lost to Follow-up|0|||
27984049|NCT04035668|54642620|FG000|Overall Study|Physician Decision|2|||
27984050|NCT04035668|54642621|FG001|Overall Study|Physician Decision|1|||
27984051|NCT04035668|54642622|FG002|Overall Study|Physician Decision|1|||
27984052|NCT04035668|54642620|FG000|Overall Study|Subject Decision|2|||
27984053|NCT04035668|54642621|FG001|Overall Study|Subject Decision|2|||
27984054|NCT04035668|54642622|FG002|Overall Study|Subject Decision|0|||
27984055|NCT00885495|54642642|FG000|Overall Study|Adverse Event|1|||
27984056|NCT00885495|54642643|FG001|Overall Study|Adverse Event|2|||
27984057|NCT00885495|54642642|FG000|Overall Study|Protocol Violation|0|||
27984058|NCT00885495|54642643|FG001|Overall Study|Protocol Violation|1|||
27984059|NCT00885495|54642642|FG000|Overall Study|Withdrawal by Subject|1|||
27984060|NCT00885495|54642643|FG001|Overall Study|Withdrawal by Subject|0|||
27984061|NCT00885105|54642656|FG000|Overall Study|Withdrawal by Subject|0|||
27984062|NCT00885105|54642657|FG001|Overall Study|Withdrawal by Subject|8|||
27984063|NCT00885105|54642656|FG000|Overall Study|Adverse Event|1|||
27984064|NCT00885105|54642657|FG001|Overall Study|Adverse Event|0|||
27984065|NCT00885105|54642656|FG000|Overall Study|Protocol Violation|0|||
27984066|NCT00885105|54642657|FG001|Overall Study|Protocol Violation|2|||
27984067|NCT03945188|54642665|FG000|Overall Study|Protocol Violation|1|||
27984068|NCT03945188|54642666|FG001|Overall Study|Protocol Violation|0|||
27984069|NCT03945188|54642665|FG000|Overall Study|Disease worsening|79|||
27984070|NCT03945188|54642666|FG001|Overall Study|Disease worsening|73|||
27984071|NCT03945188|54642665|FG000|Overall Study|Physician Decision|2|||
27883116|NCT01547598|54503688|FG000|Overall Study|Protocol Violation|1|||
27883117|NCT01547598|54503689|FG001|Overall Study|Protocol Violation|1|||
27883118|NCT01547598|54503688|FG000|Overall Study|Other Miscellaneous Reasons|2|||
27883119|NCT01547598|54503689|FG001|Overall Study|Other Miscellaneous Reasons|1|||
27883120|NCT01547286|54503696|FG000|Overall Study|Did not meet all eligibility criteria|1|||
27883121|NCT01547286|54503696|FG000|Overall Study|Physician Decision|1|||
27883122|NCT01547130|54503703|FG000|Overall Study|Lost to Follow-up|9|||
27883123|NCT01547130|54503704|FG001|Overall Study|Lost to Follow-up|5|||
27883124|NCT01524978|54503729|FG000|Overall Study|Other|16|||
27883125|NCT01524978|54503730|FG001|Overall Study|Other|2|||
27883126|NCT01524978|54503731|FG002|Overall Study|Other|1|||
27883127|NCT01524978|54503732|FG003|Overall Study|Other|2|||
27883128|NCT01524978|54503733|FG004|Overall Study|Other|1|||
27883129|NCT01524978|54503734|FG005|Overall Study|Other|3|||
27883130|NCT01524978|54503735|FG006|Overall Study|Other|17|||
27883131|NCT01524978|54503736|FG007|Overall Study|Other|1|||
27883132|NCT01524978|54503737|FG008|Overall Study|Other|2|||
27883133|NCT01524978|54503738|FG009|Overall Study|Other|2|||
27883134|NCT01524978|54503739|FG010|Overall Study|Other|5|||
27883135|NCT01524978|54503729|FG000|Overall Study|Withdrawal by Subject|12|||
27883136|NCT01524978|54503730|FG001|Overall Study|Withdrawal by Subject|0|||
27883137|NCT01524978|54503731|FG002|Overall Study|Withdrawal by Subject|1|||
27883138|NCT01524978|54503732|FG003|Overall Study|Withdrawal by Subject|1|||
27883139|NCT01524978|54503733|FG004|Overall Study|Withdrawal by Subject|3|||
27883140|NCT01524978|54503734|FG005|Overall Study|Withdrawal by Subject|1|||
27883141|NCT01524978|54503735|FG006|Overall Study|Withdrawal by Subject|6|||
27883142|NCT01524978|54503736|FG007|Overall Study|Withdrawal by Subject|2|||
27883143|NCT01524978|54503737|FG008|Overall Study|Withdrawal by Subject|4|||
27883144|NCT01524978|54503738|FG009|Overall Study|Withdrawal by Subject|0|||
27883145|NCT01524978|54503739|FG010|Overall Study|Withdrawal by Subject|5|||
27883146|NCT01524978|54503729|FG000|Overall Study|Lost to Follow-up|0|||
27883147|NCT01524978|54503730|FG001|Overall Study|Lost to Follow-up|0|||
27883148|NCT01524978|54503731|FG002|Overall Study|Lost to Follow-up|3|||
27883149|NCT01524978|54503732|FG003|Overall Study|Lost to Follow-up|0|||
27883150|NCT01524978|54503733|FG004|Overall Study|Lost to Follow-up|1|||
27883151|NCT01524978|54503734|FG005|Overall Study|Lost to Follow-up|1|||
27883152|NCT01524978|54503735|FG006|Overall Study|Lost to Follow-up|2|||
27883153|NCT01524978|54503736|FG007|Overall Study|Lost to Follow-up|0|||
27883154|NCT01524978|54503737|FG008|Overall Study|Lost to Follow-up|1|||
27883155|NCT01524978|54503738|FG009|Overall Study|Lost to Follow-up|1|||
27883156|NCT01524978|54503739|FG010|Overall Study|Lost to Follow-up|1|||
27883157|NCT01524978|54503729|FG000|Overall Study|Death|34|||
27883158|NCT01524978|54503730|FG001|Overall Study|Death|2|||
27883159|NCT01524978|54503731|FG002|Overall Study|Death|5|||
27883160|NCT01524978|54503732|FG003|Overall Study|Death|24|||
27883161|NCT01524978|54503733|FG004|Overall Study|Death|4|||
27883162|NCT01524978|54503734|FG005|Overall Study|Death|4|||
27883163|NCT01524978|54503735|FG006|Overall Study|Death|1|||
27883164|NCT01524978|54503736|FG007|Overall Study|Death|9|||
27883165|NCT01524978|54503737|FG008|Overall Study|Death|5|||
27883166|NCT01524978|54503738|FG009|Overall Study|Death|6|||
27883167|NCT01524978|54503739|FG010|Overall Study|Death|17|||
27883168|NCT01524900|54503759|FG000|Overall Study|Lost to Follow-up|3|||
27883169|NCT01524900|54503760|FG001|Overall Study|Lost to Follow-up|12|||
27883170|NCT01524900|54503761|FG002|Overall Study|Lost to Follow-up|1|||
27883171|NCT01524900|54503762|FG003|Overall Study|Lost to Follow-up|0|||
27883172|NCT01524900|54503763|FG004|Overall Study|Lost to Follow-up|0|||
27883173|NCT01524900|54503759|FG000|Overall Study|Other reason than stated above|1|||
27883174|NCT01524900|54503760|FG001|Overall Study|Other reason than stated above|1|||
27883175|NCT01524900|54503761|FG002|Overall Study|Other reason than stated above|0|||
27883176|NCT01524900|54503762|FG003|Overall Study|Other reason than stated above|0|||
27883177|NCT01524900|54503763|FG004|Overall Study|Other reason than stated above|0|||
27883178|NCT01524900|54503759|FG000|Overall Study|No reason documented|2|||
27883179|NCT01524900|54503760|FG001|Overall Study|No reason documented|1|||
27883180|NCT01524900|54503761|FG002|Overall Study|No reason documented|0|||
27883181|NCT01524900|54503762|FG003|Overall Study|No reason documented|1|||
27883182|NCT01524900|54503763|FG004|Overall Study|No reason documented|0|||
27883183|NCT01524198|54503778|FG000|Overall Study|Protocol Violation|8|||
27883184|NCT01524198|54503779|FG001|Overall Study|Protocol Violation|6|||
27883185|NCT01524198|54503778|FG000|Overall Study|Withdrawal by Subject|15|||
28171749|NCT02442778|54843318|FG002|Overall Study|Study participant withdrawal by parent or guardian|2|||
28171750|NCT02442778|54843316|FG000|Overall Study|Withdrawal by Subject|4|||
27883186|NCT01524198|54503779|FG001|Overall Study|Withdrawal by Subject|10|||
27883187|NCT01523886|54503787|FG000|Overall Study|surgery cancelled|0|||
27883188|NCT01523886|54503788|FG001|Overall Study|surgery cancelled|1|||
27883189|NCT01546038|54503800|FG000|Overall Study|Death|15|||
27984072|NCT03945188|54642666|FG001|Overall Study|Physician Decision|2|||
27883190|NCT01546038|54503801|FG001|Overall Study|Death|6|||
27883191|NCT01546038|54503802|FG002|Overall Study|Death|4|||
27883192|NCT01546038|54503803|FG003|Overall Study|Death|2|||
27883193|NCT01546038|54503804|FG004|Overall Study|Death|9|||
27883194|NCT01546038|54503805|FG005|Overall Study|Death|3|||
27883195|NCT01546038|54503806|FG006|Overall Study|Death|46|||
27883196|NCT01546038|54503807|FG007|Overall Study|Death|76|||
27883197|NCT01546038|54503808|FG008|Overall Study|Death|39|||
27883198|NCT01546038|54503800|FG000|Overall Study|Lost to Follow-up|0|||
27883199|NCT01546038|54503801|FG001|Overall Study|Lost to Follow-up|0|||
27883200|NCT01546038|54503802|FG002|Overall Study|Lost to Follow-up|0|||
27883201|NCT01546038|54503803|FG003|Overall Study|Lost to Follow-up|0|||
27883202|NCT01546038|54503804|FG004|Overall Study|Lost to Follow-up|1|||
27883203|NCT01546038|54503805|FG005|Overall Study|Lost to Follow-up|0|||
27883204|NCT01546038|54503806|FG006|Overall Study|Lost to Follow-up|2|||
27883205|NCT01546038|54503807|FG007|Overall Study|Lost to Follow-up|1|||
27883206|NCT01546038|54503808|FG008|Overall Study|Lost to Follow-up|0|||
27883207|NCT01546038|54503800|FG000|Overall Study|Withdrawal by Subject|1|||
27883208|NCT01546038|54503801|FG001|Overall Study|Withdrawal by Subject|0|||
27883209|NCT01546038|54503802|FG002|Overall Study|Withdrawal by Subject|0|||
27883210|NCT01546038|54503803|FG003|Overall Study|Withdrawal by Subject|1|||
27883211|NCT01546038|54503804|FG004|Overall Study|Withdrawal by Subject|0|||
27883212|NCT01546038|54503805|FG005|Overall Study|Withdrawal by Subject|1|||
27883213|NCT01546038|54503806|FG006|Overall Study|Withdrawal by Subject|3|||
27883214|NCT01546038|54503807|FG007|Overall Study|Withdrawal by Subject|3|||
27883215|NCT01546038|54503808|FG008|Overall Study|Withdrawal by Subject|1|||
27883216|NCT01546038|54503800|FG000|Overall Study|: Randomized, not treated|0|||
27883217|NCT01546038|54503801|FG001|Overall Study|: Randomized, not treated|0|||
27883218|NCT01546038|54503802|FG002|Overall Study|: Randomized, not treated|0|||
27883219|NCT01546038|54503803|FG003|Overall Study|: Randomized, not treated|0|||
27984073|NCT03945188|54642665|FG000|Overall Study|Lack of Efficacy|7|||
27984074|NCT03945188|54642666|FG001|Overall Study|Lack of Efficacy|4|||
27984075|NCT03945188|54642665|FG000|Overall Study|Pregnancy|2|||
27984076|NCT03945188|54642666|FG001|Overall Study|Pregnancy|0|||
27984077|NCT03945188|54642665|FG000|Overall Study|Withdrawal by participant or parent/guardian|24|||
27984078|NCT03945188|54642666|FG001|Overall Study|Withdrawal by participant or parent/guardian|10|||
27984079|NCT03945188|54642665|FG000|Overall Study|Adverse Event|10|||
27984080|NCT03945188|54642666|FG001|Overall Study|Adverse Event|5|||
27984081|NCT03945188|54642665|FG000|Overall Study|Other|2|||
27984082|NCT03945188|54642666|FG001|Overall Study|Other|2|||
27984083|NCT03945188|54642665|FG000|Overall Study|Lost to Follow-up|1|||
27984084|NCT03945188|54642666|FG001|Overall Study|Lost to Follow-up|2|||
27984085|NCT00884949|54642672|FG000|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1|||
27984086|NCT00884949|54642672|FG000|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1|||
27984087|NCT00884793|54642685|FG000|Overall Study|Withdrawal by Subject|1|||
27984088|NCT00884325|54642691|FG000|Overall Study|Lost to Follow-up|1|||
27984089|NCT00884325|54642692|FG001|Overall Study|Lost to Follow-up|2|||
27984090|NCT00884325|54642691|FG000|Overall Study|Lack of Efficacy|0|||
27984091|NCT00884325|54642692|FG001|Overall Study|Lack of Efficacy|1|||
27984092|NCT00884325|54642691|FG000|Overall Study|Withdrawal by Subject|1|||
27984093|NCT00884325|54642692|FG001|Overall Study|Withdrawal by Subject|1|||
27984094|NCT00884325|54642691|FG000|Overall Study|Not provided|1|||
27984095|NCT00884325|54642692|FG001|Overall Study|Not provided|0|||
27984096|NCT00883779|54642700|FG000|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
27984097|NCT00883779|54642701|FG001|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
27984098|NCT00883779|54642700|FG000|Primary Study Treatment Phase|Disease progression|75|||
27984099|NCT00883779|54642701|FG001|Primary Study Treatment Phase|Disease progression|59|||
27984100|NCT00883779|54642700|FG000|Primary Study Treatment Phase|Adverse Event|16|||
27984101|NCT00883779|54642701|FG001|Primary Study Treatment Phase|Adverse Event|16|||
27984102|NCT00883779|54642700|FG000|Primary Study Treatment Phase|Death|2|||
27984103|NCT00883779|54642701|FG001|Primary Study Treatment Phase|Death|3|||
27984104|NCT00883779|54642700|FG000|Primary Study Treatment Phase|Refused Treatment|5|||
27984105|NCT00883779|54642701|FG001|Primary Study Treatment Phase|Refused Treatment|4|||
27984106|NCT00883779|54642700|FG000|Primary Study Treatment Phase|Other|3|||
27984107|NCT00883779|54642701|FG001|Primary Study Treatment Phase|Other|0|||
27984108|NCT00883779|54642700|FG000|Post-Study Treatment Phase|Adverse Event|2|||
27984109|NCT00883779|54642701|FG001|Post-Study Treatment Phase|Adverse Event|3|||
27984110|NCT00883779|54642700|FG000|Post-Study Treatment Phase|Death|1|||
27984111|NCT00883779|54642701|FG001|Post-Study Treatment Phase|Death|3|||
27883220|NCT01546038|54503804|FG004|Overall Study|: Randomized, not treated|0|||
27883221|NCT01546038|54503805|FG005|Overall Study|: Randomized, not treated|0|||
27883222|NCT01546038|54503806|FG006|Overall Study|: Randomized, not treated|2|||
27883223|NCT01546038|54503807|FG007|Overall Study|: Randomized, not treated|4|||
27883224|NCT01546038|54503808|FG008|Overall Study|: Randomized, not treated|3|||
27984112|NCT00883779|54642700|FG000|Post-Study Treatment Phase|Protocol Violation|0|||
27984113|NCT00883779|54642701|FG001|Post-Study Treatment Phase|Protocol Violation|1|||
27883225|NCT01571232|54503860|FG000|Overall Study|Lost to Follow-up|0|||
27883226|NCT01571232|54503861|FG001|Overall Study|Lost to Follow-up|1|||
27984114|NCT00883779|54642700|FG000|Post-Study Treatment Phase|Refused Treatment|3|||
27883227|NCT01571232|54503860|FG000|Overall Study|Withdrawal by Subject|1|||
27984115|NCT00883779|54642701|FG001|Post-Study Treatment Phase|Refused Treatment|0|||
27984116|NCT00883779|54642700|FG000|Post-Study Treatment Phase|Disease progression|103|||
27984117|NCT00883779|54642701|FG001|Post-Study Treatment Phase|Disease progression|122|||
27984118|NCT00883779|54642700|FG000|Post-Study Treatment Phase|Other|3|||
27984119|NCT00883779|54642701|FG001|Post-Study Treatment Phase|Other|0|||
27984120|NCT00883779|54642700|FG000|Post-Study Treatment Phase|Ongoing in the study|0|||
27984121|NCT00883779|54642701|FG001|Post-Study Treatment Phase|Ongoing in the study|6|||
27984122|NCT00883779|54642700|FG000|Off-study Phase|Death|185|||
27984123|NCT00883779|54642701|FG001|Off-study Phase|Death|174|||
27984124|NCT00883779|54642700|FG000|Off-study Phase|Refused treatment|1|||
27984125|NCT00883779|54642701|FG001|Off-study Phase|Refused treatment|1|||
27984126|NCT00883779|54642700|FG000|Off-study Phase|Failure to return|5|||
27984127|NCT00883779|54642701|FG001|Off-study Phase|Failure to return|6|||
27984128|NCT00883779|54642700|FG000|Off-study Phase|Other|18|||
27984129|NCT00883779|54642701|FG001|Off-study Phase|Other|21|||
27984130|NCT04159701|54642709|FG000|Period 1: Treatment Period|Pregnancy|1|||
27984131|NCT04159701|54642710|FG001|Period 1: Treatment Period|Pregnancy|0|||
27984132|NCT04159701|54642709|FG000|Period 1: Treatment Period|Study Terminated by sponsor|4|||
27984133|NCT04159701|54642710|FG001|Period 1: Treatment Period|Study Terminated by sponsor|1|||
28096542|NCT04402866|54751604|FG002|Overall Study|Withdrawal by Subject|0|||
28096543|NCT04402866|54751605|FG003|Overall Study|Withdrawal by Subject|0|||
28096544|NCT04402866|54751606|FG004|Overall Study|Withdrawal by Subject|0|||
28096545|NCT04402866|54751607|FG005|Overall Study|Withdrawal by Subject|2|||
28096546|NCT04400682|54751619|FG000|Period 1|Withdrawal by Subject|1|||
27984134|NCT04159701|54642709|FG000|Period 1: Treatment Period|Withdrawal by Subject|3|||
27984135|NCT04159701|54642710|FG001|Period 1: Treatment Period|Withdrawal by Subject|0|||
27984136|NCT04159701|54642709|FG000|Washout Period|site terminated by sponsor|0|||
27984137|NCT04159701|54642710|FG001|Washout Period|site terminated by sponsor|1|||
27984138|NCT04159701|54642709|FG000|Washout Period|study terminated by sponsor|10|||
27984139|NCT04159701|54642710|FG001|Washout Period|study terminated by sponsor|3|||
27984140|NCT04159701|54642709|FG000|Washout Period|Withdrawal by Subject|1|||
27984141|NCT04159701|54642710|FG001|Washout Period|Withdrawal by Subject|0|||
27984142|NCT04159701|54642709|FG000|Washout Period|Inadvertent Enrollment|1|||
27984143|NCT04159701|54642710|FG001|Washout Period|Inadvertent Enrollment|0|||
27984144|NCT04159701|54642709|FG000|Washout Period|Miscellaneous|1|||
27984145|NCT04159701|54642710|FG001|Washout Period|Miscellaneous|0|||
27984146|NCT04159701|54642709|FG000|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|0|||
27984147|NCT04159701|54642710|FG001|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|2|||
27984148|NCT04159701|54642709|FG000|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|0|||
27984149|NCT04159701|54642710|FG001|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|1|||
27984150|NCT04159701|54642709|FG000|Post-treatment Follow-up|Study Terminated by Sponsor|6|||
27984151|NCT04159701|54642710|FG001|Post-treatment Follow-up|Study Terminated by Sponsor|3|||
27984152|NCT04159701|54642709|FG000|Post-treatment Follow-up|Withdrawal by Subject|3|||
27984153|NCT04159701|54642710|FG001|Post-treatment Follow-up|Withdrawal by Subject|0|||
27984154|NCT04159701|54642709|FG000|Post-treatment Follow-up|Inadvertent Enrollment|1|||
27984155|NCT04159701|54642710|FG001|Post-treatment Follow-up|Inadvertent Enrollment|0|||
27984156|NCT00880269|54642722|FG000|Overall Study|Protocol Violation|1|||
27984157|NCT00880269|54642723|FG001|Overall Study|Protocol Violation|0|||
27984158|NCT00880269|54642722|FG000|Overall Study|Disease Progression|13|||
27984159|NCT00880269|54642723|FG001|Overall Study|Disease Progression|11|||
27984160|NCT00880269|54642722|FG000|Overall Study|New Cancer Therapy|1|||
27984161|NCT00880269|54642723|FG001|Overall Study|New Cancer Therapy|0|||
27984162|NCT00880269|54642722|FG000|Overall Study|Death|4|||
27984163|NCT00880269|54642723|FG001|Overall Study|Death|2|||
27984164|NCT00880269|54642722|FG000|Overall Study|Lost to Follow-up|0|||
27984165|NCT00880269|54642723|FG001|Overall Study|Lost to Follow-up|1|||
27984166|NCT00880269|54642722|FG000|Overall Study|Withdrawal by Subject|3|||
27984167|NCT00880269|54642723|FG001|Overall Study|Withdrawal by Subject|4|||
27984168|NCT00880269|54642722|FG000|Overall Study|Adverse Event|10|||
27984169|NCT00880269|54642723|FG001|Overall Study|Adverse Event|9|||
28096547|NCT04400682|54751620|FG001|Period 1|Withdrawal by Subject|4|||
28096548|NCT03066778|54751628|FG000|Overall Study|Death|195|||
28096549|NCT03066778|54751629|FG001|Overall Study|Death|205|||
28096550|NCT03066778|54751628|FG000|Overall Study|Withdrawal by Subject|5|||
28096551|NCT03066778|54751629|FG001|Overall Study|Withdrawal by Subject|7|||
27883228|NCT01571232|54503861|FG001|Overall Study|Withdrawal by Subject|0|||
28096552|NCT04348656|54751638|FG000|Overall Study|Withdrawal by Subject|2|||
28096553|NCT04348656|54751639|FG001|Overall Study|Withdrawal by Subject|0|||
28096554|NCT04348656|54751638|FG000|Overall Study|Lost to Follow-up|11|||
28096555|NCT04348656|54751639|FG001|Overall Study|Lost to Follow-up|6|||
27883229|NCT01544478|54503868|FG000|Overall Study|Adverse Event|1|||
27984170|NCT00880191|54642731|FG000|Overall Study|Refused further treatment|4|||
27984171|NCT00880191|54642732|FG001|Overall Study|Refused further treatment|1|||
28096556|NCT04348500|54751654|FG000|Overall Study|Death|2|||
28096557|NCT04348500|54751655|FG001|Overall Study|Death|2|||
28096558|NCT04348500|54751654|FG000|Overall Study|Withdrawn by subject due to dementia|0|||
28096559|NCT04348500|54751655|FG001|Overall Study|Withdrawn by subject due to dementia|1|||
28096560|NCT04347954|54751664|FG000|Overall Study|Did not present to study site for allocated intervention|3|||
27984172|NCT00880191|54642731|FG000|Overall Study|Adverse Event|8|||
27984173|NCT00880191|54642732|FG001|Overall Study|Adverse Event|6|||
27984174|NCT00880191|54642731|FG000|Overall Study|Hospitalization/efficacy|1|||
27984175|NCT00880191|54642732|FG001|Overall Study|Hospitalization/efficacy|1|||
27984176|NCT00597519|54642738|FG000|Overall Study|Death|1|||
27984177|NCT00879333|54642744|FG000|Overall Study|Adverse Event|94|||
27984178|NCT00879333|54642745|FG001|Overall Study|Adverse Event|34|||
27984179|NCT00879333|54642744|FG000|Overall Study|Abnormal Laboratory Value|1|||
27984180|NCT00879333|54642745|FG001|Overall Study|Abnormal Laboratory Value|0|||
27984181|NCT00879333|54642744|FG000|Overall Study|Withdrawal by Subject|20|||
27984182|NCT00879333|54642745|FG001|Overall Study|Withdrawal by Subject|7|||
27984183|NCT00879333|54642744|FG000|Overall Study|Lost to Follow-up|2|||
27984184|NCT00879333|54642745|FG001|Overall Study|Lost to Follow-up|1|||
27984185|NCT00879333|54642744|FG000|Overall Study|Administrative Problems|2|||
27984186|NCT00879333|54642745|FG001|Overall Study|Administrative Problems|0|||
27984187|NCT00879333|54642744|FG000|Overall Study|Death|16|||
28096561|NCT04347954|54751665|FG001|Overall Study|Did not present to study site for allocated intervention|0|||
28096562|NCT04347954|54751666|FG002|Overall Study|Did not present to study site for allocated intervention|3|||
28096563|NCT04347954|54751664|FG000|Overall Study|Lost to Follow-up|0|||
28096564|NCT04347954|54751665|FG001|Overall Study|Lost to Follow-up|1|||
28096565|NCT04347954|54751666|FG002|Overall Study|Lost to Follow-up|0|||
28096566|NCT03065530|54751678|FG000|Overall Study|Lack of Efficacy|1|||
28096567|NCT03065530|54751679|FG001|Overall Study|Lack of Efficacy|1|||
28096568|NCT03065530|54751680|FG002|Overall Study|Lack of Efficacy|0|||
28096569|NCT03065530|54751681|FG003|Overall Study|Lack of Efficacy|1|||
28096570|NCT03065530|54751678|FG000|Overall Study|Protocol Violation|1|||
28096571|NCT03065530|54751679|FG001|Overall Study|Protocol Violation|0|||
28096572|NCT03065530|54751680|FG002|Overall Study|Protocol Violation|1|||
28096573|NCT03065530|54751681|FG003|Overall Study|Protocol Violation|1|||
28096574|NCT03979820|54751703|FG000|Overall Study|Protocol Violation|1|||
28096575|NCT03979820|54751704|FG001|Overall Study|Protocol Violation|0|||
28171751|NCT02442778|54843317|FG001|Overall Study|Withdrawal by Subject|4|||
28171752|NCT02442778|54843318|FG002|Overall Study|Withdrawal by Subject|3|||
28171753|NCT02442778|54843316|FG000|Overall Study|Reason not specified|1|||
28171754|NCT02442778|54843317|FG001|Overall Study|Reason not specified|4|||
28171755|NCT02442778|54843318|FG002|Overall Study|Reason not specified|0|||
28171756|NCT02412436|54843326|FG000|Overall Study|Protocol-mandated Discontinuation|7|||
28171757|NCT02412436|54843326|FG000|Overall Study|Lost to Follow-up|6|||
28171758|NCT02412436|54843326|FG000|Overall Study|Unable to get to clinic|3|||
28171759|NCT02412436|54843326|FG000|Overall Study|Death|1|||
28171760|NCT02412436|54843326|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
28171761|NCT01651000|54843332|FG000|Overall Study|Adverse Event|2|||
28171762|NCT01651000|54843333|FG001|Overall Study|Adverse Event|8|||
28171763|NCT01651000|54843332|FG000|Overall Study|Lost to Follow-up|3|||
27883230|NCT01544478|54503868|FG000|Overall Study|Death|1|||
27883231|NCT01544478|54503868|FG000|Overall Study|Lost to Follow-up|48|||
27883232|NCT01544478|54503868|FG000|Overall Study|Physician Decision|15|||
27883233|NCT01544478|54503868|FG000|Overall Study|Pregnancy|1|||
27883234|NCT01544478|54503868|FG000|Overall Study|Withdrawal by Subject|52|||
27883235|NCT01522950|54503875|FG000|Overall Study|Withdrawal by Subject|3|||
27883236|NCT01522950|54503876|FG001|Overall Study|Withdrawal by Subject|2|||
27883237|NCT01522950|54503877|FG002|Overall Study|Withdrawal by Subject|1|||
27883238|NCT01522950|54503875|FG000|Overall Study|Adverse Event|3|||
27883239|NCT01522950|54503876|FG001|Overall Study|Adverse Event|1|||
27883240|NCT01522950|54503877|FG002|Overall Study|Adverse Event|1|||
27883241|NCT01522950|54503875|FG000|Overall Study|Protocol Violation|0|||
27883242|NCT01522950|54503876|FG001|Overall Study|Protocol Violation|0|||
27883243|NCT01522950|54503877|FG002|Overall Study|Protocol Violation|2|||
27883244|NCT01522950|54503875|FG000|Overall Study|Death|0|||
27883245|NCT01522950|54503876|FG001|Overall Study|Death|1|||
27883246|NCT01522950|54503877|FG002|Overall Study|Death|1|||
27883247|NCT01522950|54503875|FG000|Overall Study|Study Medication Sensitivity|0|||
27883248|NCT01522950|54503876|FG001|Overall Study|Study Medication Sensitivity|1|||
27883249|NCT01522950|54503877|FG002|Overall Study|Study Medication Sensitivity|0|||
27883250|NCT01522404|54503887|FG000|First Intervention (up to Week 29)|Withdrawal by Subject|1|||
27883251|NCT01522404|54503888|FG001|First Intervention (up to Week 29)|Withdrawal by Subject|0|||
28171764|NCT01651000|54843333|FG001|Overall Study|Lost to Follow-up|2|||
28171765|NCT01651000|54843332|FG000|Overall Study|Protocol Violation|0|||
28171766|NCT01651000|54843333|FG001|Overall Study|Protocol Violation|3|||
27883252|NCT01522404|54503887|FG000|First Intervention (up to Week 29)|Adverse Event|1|||
27984188|NCT00879333|54642745|FG001|Overall Study|Death|5|||
27984189|NCT00879333|54642744|FG000|Overall Study|Disease Progression|292|||
27984190|NCT00879333|54642745|FG001|Overall Study|Disease Progression|169|||
27984191|NCT00879333|54642744|FG000|Overall Study|Protocol Violation|1|||
28096576|NCT03979820|54751705|FG002|Overall Study|Protocol Violation|0|||
27984192|NCT00879333|54642745|FG001|Overall Study|Protocol Violation|1|||
27984193|NCT03481556|54642757|FG000|Overall Study|Adverse Event|1|||
27984194|NCT03481556|54642758|FG001|Overall Study|Adverse Event|0|||
27984195|NCT03481556|54642759|FG002|Overall Study|Adverse Event|0|||
27984196|NCT03481556|54642760|FG003|Overall Study|Adverse Event|0|||
27984197|NCT03481556|54642757|FG000|Overall Study|Death|4|||
27984198|NCT03481556|54642758|FG001|Overall Study|Death|2|||
27984199|NCT03481556|54642759|FG002|Overall Study|Death|3|||
27984200|NCT03481556|54642760|FG003|Overall Study|Death|16|||
27984201|NCT03481556|54642757|FG000|Overall Study|Study Terminated by Sponsor|10|||
27984202|NCT03481556|54642758|FG001|Overall Study|Study Terminated by Sponsor|5|||
27984203|NCT03481556|54642759|FG002|Overall Study|Study Terminated by Sponsor|2|||
27984204|NCT03481556|54642760|FG003|Overall Study|Study Terminated by Sponsor|9|||
27984205|NCT00596427|54642778|FG000|Overall Study|Withdrawal by Subject|2|||
27984206|NCT00596427|54642779|FG001|Overall Study|Withdrawal by Subject|2|||
27984207|NCT00596427|54642778|FG000|Overall Study|Increased Fasting Triacylglycerol level|1|||
27984208|NCT00596427|54642779|FG001|Overall Study|Increased Fasting Triacylglycerol level|0|||
27984209|NCT00596427|54642778|FG000|Overall Study|Protocol Violation|1|||
27984210|NCT00596427|54642779|FG001|Overall Study|Protocol Violation|0|||
27984211|NCT02732210|54642788|FG000|Overall Study|Site Closed|0|||
27984212|NCT02732210|54642789|FG001|Overall Study|Site Closed|11|||
27984213|NCT02732210|54642788|FG000|Overall Study|Study Ended|13|||
27984214|NCT02732210|54642789|FG001|Overall Study|Study Ended|13|||
27984215|NCT02732210|54642788|FG000|Overall Study|Withdrawal by Subject|28|||
27984216|NCT02732210|54642789|FG001|Overall Study|Withdrawal by Subject|87|||
27984217|NCT02732210|54642788|FG000|Overall Study|Lost to Follow-up|5|||
27984218|NCT02732210|54642789|FG001|Overall Study|Lost to Follow-up|57|||
27984219|NCT02732210|54642788|FG000|Overall Study|Death|4|||
27984220|NCT02732210|54642789|FG001|Overall Study|Death|15|||
27984221|NCT02732210|54642788|FG000|Overall Study|Other|35|||
27984222|NCT02732210|54642789|FG001|Overall Study|Other|103|||
27984223|NCT02732210|54642788|FG000|Overall Study|Missing|0|||
27984224|NCT02732210|54642789|FG001|Overall Study|Missing|8|||
27984225|NCT00595959|54642795|FG000|Overall Study|Withdrawal by Subject|1|||
27984226|NCT00595959|54642795|FG000|Overall Study|Lost to Follow-up|1|||
27984227|NCT00436748|54642833|FG000|Overall Study|Ineligibility Determined|1|||
27984228|NCT00436748|54642834|FG001|Overall Study|Ineligibility Determined|1|||
27984229|NCT00436748|54642833|FG000|Overall Study|Adverse Event|0|||
27984230|NCT00436748|54642834|FG001|Overall Study|Adverse Event|2|||
27984231|NCT00436748|54642833|FG000|Overall Study|Consent Withdrawn|1|||
27984232|NCT00436748|54642834|FG001|Overall Study|Consent Withdrawn|4|||
27984233|NCT00436748|54642833|FG000|Overall Study|Administrative Decision|1|||
27984234|NCT00436748|54642834|FG001|Overall Study|Administrative Decision|0|||
27984235|NCT00436748|54642833|FG000|Overall Study|Lost to Follow-up|0|||
27984236|NCT00436748|54642834|FG001|Overall Study|Lost to Follow-up|1|||
27984237|NCT00436748|54642833|FG000|Overall Study|Protocol-specified Criteria|5|||
27984238|NCT00436748|54642834|FG001|Overall Study|Protocol-specified Criteria|4|||
27984239|NCT00436748|54642833|FG000|Overall Study|Other|3|||
27984240|NCT00436748|54642834|FG001|Overall Study|Other|0|||
27984241|NCT03342404|54642842|FG000|Overall Study|Withdrawal by Subject|9|||
27984242|NCT03342404|54642843|FG001|Overall Study|Withdrawal by Subject|10|||
27984243|NCT03342404|54642842|FG000|Overall Study|Lack of Efficacy|1|||
27984244|NCT03342404|54642843|FG001|Overall Study|Lack of Efficacy|17|||
27984245|NCT03342404|54642842|FG000|Overall Study|Adverse Event|3|||
27984246|NCT03342404|54642843|FG001|Overall Study|Adverse Event|4|||
27984247|NCT03342404|54642842|FG000|Overall Study|Noncompliance with study drug|1|||
27984248|NCT03342404|54642843|FG001|Overall Study|Noncompliance with study drug|0|||
27984249|NCT03342404|54642842|FG000|Overall Study|Other reasons|1|||
27984250|NCT03342404|54642843|FG001|Overall Study|Other reasons|0|||
27984251|NCT02703272|54642853|FG000|Overall Study|Death|4|||
27984252|NCT02703272|54642854|FG001|Overall Study|Death|9|||
27984253|NCT02703272|54642855|FG002|Overall Study|Death|19|||
27984254|NCT02703272|54642856|FG003|Overall Study|Death|10|||
27984255|NCT02703272|54642853|FG000|Overall Study|Withdrawal by Subject|0|||
27984256|NCT02703272|54642854|FG001|Overall Study|Withdrawal by Subject|0|||
27984257|NCT02703272|54642855|FG002|Overall Study|Withdrawal by Subject|4|||
27984258|NCT02703272|54642856|FG003|Overall Study|Withdrawal by Subject|2|||
28096577|NCT03979820|54751706|FG003|Overall Study|Protocol Violation|0|||
27984259|NCT02703272|54642853|FG000|Overall Study|Study Terminated by Sponsor|6|||
27984260|NCT02703272|54642854|FG001|Overall Study|Study Terminated by Sponsor|1|||
27984261|NCT02703272|54642855|FG002|Overall Study|Study Terminated by Sponsor|12|||
27984262|NCT02703272|54642856|FG003|Overall Study|Study Terminated by Sponsor|4|||
28096578|NCT03979820|54751703|FG000|Overall Study|Withdrawal by Subject|0|||
28096579|NCT03979820|54751704|FG001|Overall Study|Withdrawal by Subject|0|||
27984263|NCT02703272|54642853|FG000|Overall Study|Other|1|||
27984264|NCT02703272|54642854|FG001|Overall Study|Other|0|||
27984265|NCT02703272|54642855|FG002|Overall Study|Other|0|||
27984266|NCT02703272|54642856|FG003|Overall Study|Other|0|||
27984267|NCT02568215|54642896|FG000|Overall Study|Death|1|||
27984268|NCT02568215|54642897|FG001|Overall Study|Death|2|||
27984269|NCT02568215|54642898|FG002|Overall Study|Death|0|||
27984270|NCT02568215|54642896|FG000|Overall Study|Physician Decision|2|||
27984271|NCT02568215|54642897|FG001|Overall Study|Physician Decision|2|||
27984272|NCT02568215|54642898|FG002|Overall Study|Physician Decision|2|||
28096580|NCT03979820|54751705|FG002|Overall Study|Withdrawal by Subject|1|||
28096581|NCT03979820|54751706|FG003|Overall Study|Withdrawal by Subject|0|||
28096582|NCT03979820|54751703|FG000|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|5|||
28096583|NCT03979820|54751704|FG001|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
28096584|NCT03979820|54751705|FG002|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
28096585|NCT03979820|54751706|FG003|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|10|||
28171767|NCT01651000|54843332|FG000|Overall Study|Withdrawal by Subject|2|||
27739306|NCT01603407|54188665|FG000|Overall Study|Withdrawal by Subject|8|||
27739307|NCT01603407|54188666|FG001|Overall Study|Withdrawal by Subject|5|||
27739308|NCT01603407|54188667|FG002|Overall Study|Withdrawal by Subject|7|||
27739309|NCT01603407|54188665|FG000|Overall Study|Lost to Follow-up|0|||
27739310|NCT01603407|54188666|FG001|Overall Study|Lost to Follow-up|3|||
27739311|NCT01603407|54188667|FG002|Overall Study|Lost to Follow-up|2|||
27739312|NCT02235454|54188697|FG000|Overall Study|Withdrawal by Subject|2|||
27739313|NCT02235298|54188703|FG000|Overall Study|Lost to Follow-up|6|||
27739314|NCT02235298|54188704|FG001|Overall Study|Lost to Follow-up|5|||
27739315|NCT02235298|54188703|FG000|Overall Study|Adverse Event|2|||
27739316|NCT02235298|54188704|FG001|Overall Study|Adverse Event|2|||
27739317|NCT02235298|54188703|FG000|Overall Study|Withdrawal by Subject|0|||
27739318|NCT02235298|54188704|FG001|Overall Study|Withdrawal by Subject|1|||
27739319|NCT02234596|54188710|FG000|Overall Study|Participant not treated|2|||
27739320|NCT02234362|54188714|FG000|Overall Study|Not eligible after first screening visit|17|||
27739321|NCT02234362|54188714|FG000|Overall Study|Lost to Follow-up|6|||
27739322|NCT02234362|54188714|FG000|Overall Study|Withdrawal by Subject|3|||
27739323|NCT02234284|54188720|FG000|Overall Study|Death|4|||
27739324|NCT02234284|54188721|FG001|Overall Study|Death|2|||
27739325|NCT02234284|54188720|FG000|Overall Study|Withdrawal by Subject|1|||
27739326|NCT02234284|54188721|FG001|Overall Study|Withdrawal by Subject|0|||
27739327|NCT02234284|54188720|FG000|Overall Study|Lost to Follow-up|20|||
27739328|NCT02234284|54188721|FG001|Overall Study|Lost to Follow-up|7|||
27984273|NCT02568215|54642896|FG000|Overall Study|Lost to Follow-up|29|||
27984274|NCT02568215|54642897|FG001|Overall Study|Lost to Follow-up|32|||
27984275|NCT02568215|54642898|FG002|Overall Study|Lost to Follow-up|41|||
27984276|NCT02568215|54642896|FG000|Overall Study|Withdrawal by Subject|21|||
27984277|NCT02568215|54642897|FG001|Overall Study|Withdrawal by Subject|19|||
27984278|NCT02568215|54642898|FG002|Overall Study|Withdrawal by Subject|22|||
27984279|NCT02568215|54642896|FG000|Overall Study|Protocol Violation|1|||
27984280|NCT02568215|54642897|FG001|Overall Study|Protocol Violation|1|||
27739337|NCT02232880|54188902|FG000|Overall Study|study stopped prior to randomization|1|||
27739338|NCT02896855|54188908|FG000|Overall Study|Death|50|||
27739339|NCT02896855|54188909|FG001|Overall Study|Death|40|||
27739340|NCT02896855|54188908|FG000|Overall Study|Lost to Follow-up|15|||
27739341|NCT02896855|54188909|FG001|Overall Study|Lost to Follow-up|9|||
27883253|NCT01522404|54503888|FG001|First Intervention (up to Week 29)|Adverse Event|0|||
27883254|NCT01522404|54503887|FG000|Second Intervention (up to Week 58)|Withdrawal by Subject|1|||
27883255|NCT01522404|54503888|FG001|Second Intervention (up to Week 58)|Withdrawal by Subject|0|||
27883256|NCT01570686|54503904|FG000|Overall Study|Abnormal test procedure result(s)|1|||
27883257|NCT01570686|54503905|FG001|Overall Study|Abnormal test procedure result(s)|1|||
27883258|NCT01570686|54503904|FG000|Overall Study|Administrative problems|0|||
27883259|NCT01570686|54503905|FG001|Overall Study|Administrative problems|1|||
27883260|NCT01570686|54503904|FG000|Overall Study|Adverse Event|8|||
27883261|NCT01570686|54503905|FG001|Overall Study|Adverse Event|6|||
27883262|NCT01570686|54503904|FG000|Overall Study|Lost to Follow-up|4|||
27883263|NCT01570686|54503905|FG001|Overall Study|Lost to Follow-up|3|||
27883264|NCT01570686|54503904|FG000|Overall Study|Protocol Deviation|3|||
27883265|NCT01570686|54503905|FG001|Overall Study|Protocol Deviation|0|||
27883266|NCT01570686|54503904|FG000|Overall Study|Withdrawal by Subject|4|||
27984281|NCT02568215|54642898|FG002|Overall Study|Protocol Violation|0|||
27984282|NCT02568215|54642896|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|25|||
27739342|NCT02896855|54188908|FG000|Overall Study|Withdrawal by Subject|7|||
27739343|NCT02896855|54188909|FG001|Overall Study|Withdrawal by Subject|4|||
27739344|NCT02232802|54188920|FG000|Period 1|Sponsor request|1|||
27739345|NCT02232802|54188921|FG001|Period 1|Sponsor request|0|||
27739346|NCT02232802|54188920|FG000|Period 1|Adverse Event|1|||
27739347|NCT02232802|54188921|FG001|Period 1|Adverse Event|1|||
27739348|NCT02434328|54188929|FG000|Overall Study|Adverse Event|9|||
27739349|NCT02434328|54188930|FG001|Overall Study|Adverse Event|4|||
27739350|NCT02434328|54188929|FG000|Overall Study|Lack of Efficacy|0|||
27739351|NCT02434328|54188930|FG001|Overall Study|Lack of Efficacy|2|||
27739352|NCT02434328|54188929|FG000|Overall Study|Physician Decision|0|||
27883267|NCT01570686|54503905|FG001|Overall Study|Withdrawal by Subject|4|||
28096586|NCT03647488|54751723|FG000|Overall Study|Progressive disease|10|||
28096587|NCT03647488|54751724|FG001|Overall Study|Progressive disease|0|||
28096588|NCT03647488|54751725|FG002|Overall Study|Progressive disease|0|||
28096589|NCT03647488|54751723|FG000|Overall Study|Adverse Event|5|||
28096590|NCT03647488|54751724|FG001|Overall Study|Adverse Event|0|||
27984283|NCT02568215|54642897|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|23|||
27984284|NCT02568215|54642898|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
27984285|NCT02568215|54642896|FG000|Overall Study|Other|0|||
27984286|NCT02568215|54642897|FG001|Overall Study|Other|1|||
27984287|NCT02568215|54642898|FG002|Overall Study|Other|4|||
27984288|NCT00908141|54642935|FG000|Overall Study|Withdrawal by Subject|0|||
27984289|NCT00908141|54642936|FG001|Overall Study|Withdrawal by Subject|1|||
27984290|NCT00906347|54642944|FG000|Received Study Drug|8 cm prior to initiation of study drug|18|||
27984291|NCT00906347|54642945|FG001|Received Study Drug|8 cm prior to initiation of study drug|30|||
27984292|NCT00906347|54642944|FG000|Received Study Drug|Nonreassuring fetal heart rate|13|||
27984293|NCT00906347|54642945|FG001|Received Study Drug|Nonreassuring fetal heart rate|1|||
27984294|NCT00906347|54642944|FG000|Received Study Drug|Refused study drug|1|||
27984295|NCT00906347|54642945|FG001|Received Study Drug|Refused study drug|0|||
27984296|NCT00906347|54642944|FG000|Received Study Drug|Uterine tachysystole or hypertonus|8|||
27984297|NCT00906347|54642945|FG001|Received Study Drug|Uterine tachysystole or hypertonus|0|||
27984298|NCT00906035|54642954|FG000|Overall Study|Withdrawal by Subject|2|||
27984299|NCT00906035|54642955|FG001|Overall Study|Withdrawal by Subject|3|||
27984300|NCT00906035|54642956|FG002|Overall Study|Withdrawal by Subject|0|||
27984301|NCT00905489|54642964|FG000|Pharmaco-kinetic (PK) Phase|Protocol Violation|2|||
27984302|NCT00905489|54642964|FG000|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3|||
27984303|NCT00905489|54642964|FG000|Optional Extension Phase (OEP)|Adverse Event|1|||
27984304|NCT02704754|54642975|FG000|Overall Study|Lost to Follow-up|1|||
27984305|NCT02704754|54642976|FG001|Overall Study|Lost to Follow-up|1|||
27984306|NCT02704754|54642975|FG000|Overall Study|Lack of Efficacy|1|||
27984307|NCT02704754|54642976|FG001|Overall Study|Lack of Efficacy|0|||
27984308|NCT02704754|54642975|FG000|Overall Study|Withdrawal by Subject|1|||
27984309|NCT02704754|54642976|FG001|Overall Study|Withdrawal by Subject|0|||
27984310|NCT03170882|54642984|FG000|Overall Study|Death|17|||
27984311|NCT03170882|54642985|FG001|Overall Study|Death|29|||
27984312|NCT03170882|54642984|FG000|Overall Study|Lost to Follow-up|0|||
27984313|NCT03170882|54642985|FG001|Overall Study|Lost to Follow-up|1|||
27984314|NCT03170882|54642984|FG000|Overall Study|Withdrawal by Subject|4|||
27984315|NCT03170882|54642985|FG001|Overall Study|Withdrawal by Subject|7|||
27984316|NCT03170882|54642984|FG000|Overall Study|Reason not Specified|28|||
27984317|NCT03170882|54642985|FG001|Overall Study|Reason not Specified|36|||
27984318|NCT00907517|54642996|FG000|Overall Study|Progressive Disease|3|||
28096591|NCT03647488|54751725|FG002|Overall Study|Adverse Event|0|||
28171768|NCT01651000|54843333|FG001|Overall Study|Withdrawal by Subject|10|||
27984319|NCT00907517|54642997|FG001|Overall Study|Progressive Disease|3|||
27984320|NCT00907517|54642998|FG002|Overall Study|Progressive Disease|4|||
27984321|NCT00907517|54642999|FG003|Overall Study|Progressive Disease|4|||
27984322|NCT00907517|54643000|FG004|Overall Study|Progressive Disease|4|||
27984323|NCT00907517|54642996|FG000|Overall Study|Symptomatic Deterioration|0|||
27984324|NCT00907517|54642997|FG001|Overall Study|Symptomatic Deterioration|0|||
27984325|NCT00907517|54642998|FG002|Overall Study|Symptomatic Deterioration|0|||
27984326|NCT00907517|54642999|FG003|Overall Study|Symptomatic Deterioration|0|||
27984327|NCT00907517|54643000|FG004|Overall Study|Symptomatic Deterioration|1|||
27984328|NCT00905255|54643014|FG000|Overall Study|Adverse Event|7|||
27984329|NCT00905255|54643015|FG001|Overall Study|Adverse Event|5|||
27984330|NCT00905255|54643014|FG000|Overall Study|Withdrawal by Subject|5|||
27984331|NCT00905255|54643015|FG001|Overall Study|Withdrawal by Subject|4|||
27984332|NCT00905255|54643014|FG000|Overall Study|Familial and Personal Reasons|1|||
27984333|NCT00905255|54643015|FG001|Overall Study|Familial and Personal Reasons|0|||
27984334|NCT00905021|54643022|FG000|Overall Study|Adverse Event|2|||
27984335|NCT00906971|54643029|FG000|Overall Study|Withdrawal by Subject|8|||
27984336|NCT00906971|54643030|FG001|Overall Study|Withdrawal by Subject|2|||
27984337|NCT00906971|54643029|FG000|Overall Study|Lost to Follow-up|0|||
27984338|NCT00906971|54643030|FG001|Overall Study|Lost to Follow-up|1|||
27984339|NCT00903929|54643036|FG000|Overall Study|Withdrawal by Subject|0|||
27984340|NCT00903929|54643037|FG001|Overall Study|Withdrawal by Subject|0|||
27984341|NCT00903929|54643038|FG002|Overall Study|Withdrawal by Subject|1|||
27984342|NCT00903929|54643039|FG003|Overall Study|Withdrawal by Subject|2|||
27984343|NCT00903929|54643036|FG000|Overall Study|Adverse Event|0|||
27984344|NCT00903929|54643037|FG001|Overall Study|Adverse Event|0|||
28096592|NCT03647488|54751723|FG000|Overall Study|Clinical progression|2|||
28096593|NCT03647488|54751724|FG001|Overall Study|Clinical progression|0|||
28096594|NCT03647488|54751725|FG002|Overall Study|Clinical progression|0|||
28096595|NCT03647488|54751723|FG000|Overall Study|Participant refused to take investigational product|1|||
28096596|NCT03647488|54751724|FG001|Overall Study|Participant refused to take investigational product|0|||
28096597|NCT03647488|54751725|FG002|Overall Study|Participant refused to take investigational product|0|||
28096598|NCT03693950|54751733|FG000|Overall Study|Withdrawal by Subject|1|||
27984345|NCT00903929|54643038|FG002|Overall Study|Adverse Event|0|||
27984346|NCT00903929|54643039|FG003|Overall Study|Adverse Event|1|||
27984347|NCT00903695|54643046|FG000|Overall Study|medical exclusion after 1st testing|1|||
27984348|NCT00903695|54643047|FG001|Overall Study|medical exclusion after 1st testing|0|||
27984349|NCT00903695|54643046|FG000|Overall Study|lung cancer|1|||
27984350|NCT00903695|54643047|FG001|Overall Study|lung cancer|0|||
27984351|NCT00903617|54643059|FG000|Overall Study|Adverse Event|0|||
27883268|NCT01570686|54503904|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
27883269|NCT01570686|54503905|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
27883270|NCT01522248|54503913|FG000|Overall Study|Lost to Follow-up|1|||
27883271|NCT01522248|54503914|FG001|Overall Study|Lost to Follow-up|0|||
27883272|NCT01543776|54503927|FG000|Overall Study|Withdrawal by Subject|2|||
27883273|NCT01543776|54503928|FG001|Overall Study|Withdrawal by Subject|2|||
27883274|NCT01518192|54503937|FG000|Overall Study|Lost to Follow-up|29|||
27984352|NCT00903617|54643060|FG001|Overall Study|Adverse Event|1|||
27984353|NCT00903617|54643061|FG002|Overall Study|Adverse Event|1|||
27984354|NCT00903617|54643062|FG003|Overall Study|Adverse Event|0|||
27984355|NCT00903617|54643059|FG000|Overall Study|Protocol-defined stopping criteria|0|||
27984356|NCT00903617|54643060|FG001|Overall Study|Protocol-defined stopping criteria|2|||
27984357|NCT00903617|54643061|FG002|Overall Study|Protocol-defined stopping criteria|0|||
27984358|NCT00903617|54643062|FG003|Overall Study|Protocol-defined stopping criteria|0|||
27984359|NCT00903617|54643059|FG000|Overall Study|Lost to Follow-up|2|||
27984360|NCT00903617|54643060|FG001|Overall Study|Lost to Follow-up|0|||
27984361|NCT00903617|54643061|FG002|Overall Study|Lost to Follow-up|1|||
27984362|NCT00903617|54643062|FG003|Overall Study|Lost to Follow-up|1|||
27984363|NCT00903617|54643059|FG000|Overall Study|Withdrawal by Subject|1|||
27984364|NCT00903617|54643060|FG001|Overall Study|Withdrawal by Subject|2|||
27984365|NCT00903617|54643061|FG002|Overall Study|Withdrawal by Subject|3|||
27984366|NCT00903617|54643062|FG003|Overall Study|Withdrawal by Subject|0|||
27984367|NCT00903383|54643077|FG000|Overall Study|Adverse Event|1|||
27984368|NCT00903383|54643078|FG001|Overall Study|Adverse Event|2|||
27984369|NCT00903383|54643079|FG002|Overall Study|Adverse Event|3|||
27984370|NCT00903383|54643080|FG003|Overall Study|Adverse Event|1|||
27984371|NCT00903383|54643077|FG000|Overall Study|Physician Decision|1|||
27984372|NCT00903383|54643078|FG001|Overall Study|Physician Decision|2|||
27984373|NCT00903383|54643079|FG002|Overall Study|Physician Decision|0|||
27984374|NCT00903383|54643080|FG003|Overall Study|Physician Decision|0|||
27984375|NCT00903383|54643077|FG000|Overall Study|Lost to Follow-up|0|||
27984376|NCT00903383|54643078|FG001|Overall Study|Lost to Follow-up|0|||
27984377|NCT00903383|54643079|FG002|Overall Study|Lost to Follow-up|0|||
27984378|NCT00903383|54643080|FG003|Overall Study|Lost to Follow-up|1|||
27984379|NCT00903383|54643077|FG000|Overall Study|Decision of Sponsor|1|||
27984380|NCT00903383|54643078|FG001|Overall Study|Decision of Sponsor|0|||
27984381|NCT00903383|54643079|FG002|Overall Study|Decision of Sponsor|0|||
27984382|NCT00903383|54643080|FG003|Overall Study|Decision of Sponsor|0|||
27984383|NCT00903383|54643077|FG000|Overall Study|Withdrawal by Subject|4|||
27984384|NCT00903383|54643078|FG001|Overall Study|Withdrawal by Subject|1|||
27984385|NCT00903383|54643079|FG002|Overall Study|Withdrawal by Subject|0|||
27984386|NCT00903383|54643080|FG003|Overall Study|Withdrawal by Subject|2|||
27984387|NCT00903383|54643077|FG000|Overall Study|Patient Decision - Lack of Efficacy|0|||
27984388|NCT00903383|54643078|FG001|Overall Study|Patient Decision - Lack of Efficacy|1|||
27984389|NCT00903383|54643079|FG002|Overall Study|Patient Decision - Lack of Efficacy|0|||
27984390|NCT00903383|54643080|FG003|Overall Study|Patient Decision - Lack of Efficacy|0|||
27984391|NCT00903383|54643077|FG000|Overall Study|Patient Decision|0|||
27984392|NCT00903383|54643078|FG001|Overall Study|Patient Decision|0|||
27984393|NCT00903383|54643079|FG002|Overall Study|Patient Decision|0|||
27984394|NCT00903383|54643080|FG003|Overall Study|Patient Decision|1|||
27984395|NCT02314026|54643090|FG000|Overall Study|Protocol Violation|28|||
27984396|NCT01617096|54643100|FG000|Overall Study|Withdrawal by Subject|96|||
27984397|NCT01617096|54643101|FG001|Overall Study|Withdrawal by Subject|81|||
27984398|NCT01617096|54643100|FG000|Overall Study|Lost to Follow-up|37|||
27984399|NCT01617096|54643101|FG001|Overall Study|Lost to Follow-up|32|||
27984400|NCT01617096|54643100|FG000|Overall Study|Physician Decision|10|||
27984401|NCT01617096|54643101|FG001|Overall Study|Physician Decision|18|||
27984402|NCT01617096|54643100|FG000|Overall Study|Death|4|||
27984403|NCT01617096|54643101|FG001|Overall Study|Death|3|||
27984404|NCT01617096|54643100|FG000|Overall Study|Other|1|||
27984405|NCT01617096|54643101|FG001|Overall Study|Other|3|||
27984406|NCT00900731|54643130|FG000|Overall Study|Adverse Event|31|||
27984407|NCT00900731|54643131|FG001|Overall Study|Adverse Event|27|||
27984408|NCT00900731|54643130|FG000|Overall Study|Withdrawal by Subject|8|||
27984409|NCT00900731|54643131|FG001|Overall Study|Withdrawal by Subject|7|||
27984410|NCT00900731|54643130|FG000|Overall Study|Protocol Deviation|8|||
27984411|NCT00900731|54643131|FG001|Overall Study|Protocol Deviation|11|||
27984412|NCT00900731|54643130|FG000|Overall Study|Administrative Problems|5|||
27984413|NCT00900731|54643131|FG001|Overall Study|Administrative Problems|4|||
27984414|NCT00900731|54643130|FG000|Overall Study|Abnormal Test Procedure Result(s)|3|||
27984415|NCT00900731|54643131|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
27984416|NCT00900731|54643130|FG000|Overall Study|Abnormal Laboratory Value(s)|2|||
27984417|NCT00900731|54643131|FG001|Overall Study|Abnormal Laboratory Value(s)|4|||
27984418|NCT00900731|54643130|FG000|Overall Study|Lost to Follow-up|2|||
27984419|NCT00900731|54643131|FG001|Overall Study|Lost to Follow-up|3|||
27984420|NCT00900731|54643130|FG000|Overall Study|Lack of Efficacy|1|||
27984421|NCT00900731|54643131|FG001|Overall Study|Lack of Efficacy|3|||
27984422|NCT00900731|54643130|FG000|Overall Study|Death|0|||
27984423|NCT00900731|54643131|FG001|Overall Study|Death|2|||
27984424|NCT03842436|54643137|FG000|Overall Study|Lost to Follow-up|1|||
27984425|NCT00602472|54643177|FG000|Overall Study|Adverse Event|5|||
27984426|NCT00602472|54643178|FG001|Overall Study|Adverse Event|23|||
27984427|NCT00602472|54643177|FG000|Overall Study|Protocol Violation|4|||
27984428|NCT00602472|54643178|FG001|Overall Study|Protocol Violation|19|||
27984429|NCT00602472|54643177|FG000|Overall Study|Withdrawal by Subject|8|||
27984430|NCT00602472|54643178|FG001|Overall Study|Withdrawal by Subject|14|||
27984431|NCT00602472|54643177|FG000|Overall Study|Other incl. lack of efficacy|4|||
27984432|NCT00602472|54643178|FG001|Overall Study|Other incl. lack of efficacy|2|||
27984433|NCT00901901|54643213|FG000|Treatment Period|Adverse Event|120|||
27984434|NCT00901901|54643214|FG001|Treatment Period|Adverse Event|128|||
27984435|NCT00901901|54643213|FG000|Treatment Period|Withdrawal by Subject|26|||
27984436|NCT00901901|54643214|FG001|Treatment Period|Withdrawal by Subject|24|||
27984437|NCT00901901|54643213|FG000|Treatment Period|Physician Decision|2|||
27984438|NCT00901901|54643214|FG001|Treatment Period|Physician Decision|2|||
27984439|NCT00901901|54643213|FG000|Treatment Period|Lost to Follow-up|3|||
27984440|NCT00901901|54643214|FG001|Treatment Period|Lost to Follow-up|5|||
27984441|NCT00901901|54643213|FG000|Treatment Period|Noncompliance with study medication|4|||
27984442|NCT00901901|54643214|FG001|Treatment Period|Noncompliance with study medication|1|||
27984443|NCT00901901|54643213|FG000|Treatment Period|Missing|1|||
27984444|NCT00901901|54643214|FG001|Treatment Period|Missing|0|||
27984445|NCT00901901|54643213|FG000|Treatment Period|Never treated|0|||
27984446|NCT00901901|54643214|FG001|Treatment Period|Never treated|3|||
27984447|NCT00901901|54643213|FG000|Treatment Period|Protocol driven decision point|0|||
27984448|NCT00901901|54643214|FG001|Treatment Period|Protocol driven decision point|2|||
27984449|NCT00901901|54643213|FG000|Treatment Period|Study terminated by sponsor|2|||
27984450|NCT00901901|54643214|FG001|Treatment Period|Study terminated by sponsor|0|||
27984451|NCT00901901|54643213|FG000|Treatment Period|Protocol Violation|5|||
27984452|NCT00901901|54643214|FG001|Treatment Period|Protocol Violation|9|||
27984453|NCT00901901|54643213|FG000|Treatment Period|Switch to commercial drug|1|||
27984454|NCT00901901|54643214|FG001|Treatment Period|Switch to commercial drug|1|||
27984455|NCT00901901|54643213|FG000|Treatment Period|Transfer to treatment continuation study|5|||
27984456|NCT00901901|54643214|FG001|Treatment Period|Transfer to treatment continuation study|2|||
27984457|NCT00901901|54643213|FG000|Follow-up Period|Death|181|||
27984458|NCT00901901|54643214|FG001|Follow-up Period|Death|208|||
27984459|NCT00901901|54643213|FG000|Follow-up Period|Protocol driven decision point|47|||
27984460|NCT00901901|54643214|FG001|Follow-up Period|Protocol driven decision point|36|||
27984461|NCT00901901|54643213|FG000|Follow-up Period|Withdrawal by Subject|6|||
27984462|NCT00901901|54643214|FG001|Follow-up Period|Withdrawal by Subject|9|||
27984463|NCT00901901|54643213|FG000|Follow-up Period|Lost to Follow-up|12|||
27984464|NCT00901901|54643214|FG001|Follow-up Period|Lost to Follow-up|8|||
27984465|NCT00901901|54643213|FG000|Follow-up Period|Missing|94|||
27984466|NCT00901901|54643214|FG001|Follow-up Period|Missing|80|||
27984467|NCT02143778|54643222|FG000|Overall Study|Withdrawal by Subject|2|||
27984468|NCT02143778|54643222|FG000|Overall Study|Device malfunction|1|||
27984469|NCT00896363|54643266|FG000|Overall Study|Adverse Event|3|||
27984470|NCT00896363|54643267|FG001|Overall Study|Adverse Event|4|||
27984471|NCT00896363|54643268|FG002|Overall Study|Adverse Event|2|||
27984472|NCT00896363|54643266|FG000|Overall Study|Lack of Efficacy|0|||
27984473|NCT00896363|54643267|FG001|Overall Study|Lack of Efficacy|2|||
27984474|NCT00896363|54643268|FG002|Overall Study|Lack of Efficacy|1|||
27984475|NCT00896363|54643266|FG000|Overall Study|Withdrawal by Subject|3|||
27984476|NCT00896363|54643267|FG001|Overall Study|Withdrawal by Subject|5|||
27984477|NCT00896363|54643268|FG002|Overall Study|Withdrawal by Subject|5|||
27984478|NCT00900029|54643284|FG000|Overall Study|Lost to Follow-up|0|||
27984479|NCT00900029|54643285|FG001|Overall Study|Lost to Follow-up|2|||
27984480|NCT00900029|54643286|FG002|Overall Study|Lost to Follow-up|1|||
27984481|NCT00900029|54643287|FG003|Overall Study|Lost to Follow-up|4|||
27984482|NCT00900029|54643288|FG004|Overall Study|Lost to Follow-up|4|||
27984483|NCT00900029|54643284|FG000|Overall Study|Withdrawal by Subject|2|||
27984484|NCT00900029|54643285|FG001|Overall Study|Withdrawal by Subject|2|||
27984485|NCT00900029|54643286|FG002|Overall Study|Withdrawal by Subject|1|||
27984486|NCT00900029|54643287|FG003|Overall Study|Withdrawal by Subject|1|||
27984487|NCT00900029|54643288|FG004|Overall Study|Withdrawal by Subject|1|||
27984488|NCT00900029|54643284|FG000|Overall Study|Adverse Event|0|||
27984489|NCT00900029|54643285|FG001|Overall Study|Adverse Event|0|||
27984490|NCT00900029|54643286|FG002|Overall Study|Adverse Event|1|||
27984491|NCT00900029|54643287|FG003|Overall Study|Adverse Event|1|||
27984492|NCT00900029|54643288|FG004|Overall Study|Adverse Event|1|||
27984493|NCT00900029|54643284|FG000|Overall Study|Death|1|||
27984494|NCT00900029|54643285|FG001|Overall Study|Death|0|||
27984495|NCT00900029|54643286|FG002|Overall Study|Death|0|||
27984496|NCT00900029|54643287|FG003|Overall Study|Death|1|||
27984497|NCT00900029|54643288|FG004|Overall Study|Death|0|||
27984498|NCT00896051|54643306|FG000|Overall Study|Adverse Event|2|||
27984499|NCT00896051|54643307|FG001|Overall Study|Adverse Event|1|||
27984500|NCT00896051|54643306|FG000|Overall Study|Lost to Follow-up|3|||
27984501|NCT00896051|54643307|FG001|Overall Study|Lost to Follow-up|2|||
27984502|NCT00896051|54643306|FG000|Overall Study|Withdrawal by Subject|3|||
27984503|NCT00896051|54643307|FG001|Overall Study|Withdrawal by Subject|2|||
27984504|NCT00896051|54643306|FG000|Overall Study|Subject noncompliant|1|||
27984505|NCT00896051|54643307|FG001|Overall Study|Subject noncompliant|3|||
27984506|NCT00896051|54643306|FG000|Overall Study|Other|1|||
27984507|NCT00896051|54643307|FG001|Overall Study|Other|1|||
27984508|NCT00894647|54643324|FG000|Overall Study|Adverse Event|5|||
27984509|NCT00894647|54643325|FG001|Overall Study|Adverse Event|4|||
27984510|NCT00894647|54643324|FG000|Overall Study|Withdrawal by Subject|4|||
27984511|NCT00894647|54643325|FG001|Overall Study|Withdrawal by Subject|4|||
27984512|NCT00894647|54643324|FG000|Overall Study|Lost to Follow-up|0|||
27984513|NCT00894647|54643325|FG001|Overall Study|Lost to Follow-up|2|||
27984514|NCT00894647|54643324|FG000|Overall Study|Non-compliance with study procedures|0|||
27984515|NCT00894647|54643325|FG001|Overall Study|Non-compliance with study procedures|2|||
27984516|NCT00894647|54643324|FG000|Overall Study|Other, not due to AE|1|||
27984517|NCT00894647|54643325|FG001|Overall Study|Other, not due to AE|2|||
27984518|NCT00892775|54643333|FG000|Overall Study|Protocol Violation|1|||
27984519|NCT00892775|54643334|FG001|Overall Study|Protocol Violation|0|||
27984520|NCT00892775|54643333|FG000|Overall Study|Subject difficulties with blood drawing|1|||
27984521|NCT00892775|54643334|FG001|Overall Study|Subject difficulties with blood drawing|0|||
27984522|NCT00892775|54643333|FG000|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1|||
27984523|NCT00892775|54643334|FG001|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0|||
27984524|NCT00892775|54643333|FG000|Overall Study|Migrated/ moved from study area|1|||
27984525|NCT00892775|54643334|FG001|Overall Study|Migrated/ moved from study area|0|||
27984526|NCT00892775|54643333|FG000|Overall Study|Withdrawal by Subject|0|||
27984527|NCT00892775|54643334|FG001|Overall Study|Withdrawal by Subject|1|||
27984528|NCT00892775|54643333|FG000|Overall Study|Lost to Follow-up|1|||
27984529|NCT00892775|54643334|FG001|Overall Study|Lost to Follow-up|0|||
27984530|NCT00895895|54643345|FG000|Period 1|Adverse Event|7|||
27984531|NCT00895895|54643346|FG001|Period 1|Adverse Event|6|||
27984532|NCT00895895|54643347|FG002|Period 1|Adverse Event|4|||
27984533|NCT00895895|54643348|FG003|Period 1|Adverse Event|6|||
27984534|NCT00895895|54643349|FG004|Period 1|Adverse Event|7|||
27984535|NCT00895895|54643345|FG000|Period 1|Death|0|||
27984536|NCT00895895|54643346|FG001|Period 1|Death|0|||
27984537|NCT00895895|54643347|FG002|Period 1|Death|0|||
27984538|NCT00895895|54643348|FG003|Period 1|Death|0|||
27984539|NCT00895895|54643349|FG004|Period 1|Death|1|||
27984540|NCT00895895|54643345|FG000|Period 1|discontinued by sponsor|2|||
27984541|NCT00895895|54643346|FG001|Period 1|discontinued by sponsor|1|||
27984542|NCT00895895|54643347|FG002|Period 1|discontinued by sponsor|2|||
27984543|NCT00895895|54643348|FG003|Period 1|discontinued by sponsor|1|||
27984544|NCT00895895|54643349|FG004|Period 1|discontinued by sponsor|1|||
27984545|NCT00895895|54643345|FG000|Period 1|failed to return|0|||
27984546|NCT00895895|54643346|FG001|Period 1|failed to return|0|||
27883275|NCT01518192|54503938|FG001|Overall Study|Lost to Follow-up|26|||
27984547|NCT00895895|54643347|FG002|Period 1|failed to return|1|||
27984548|NCT00895895|54643348|FG003|Period 1|failed to return|0|||
27984549|NCT00895895|54643349|FG004|Period 1|failed to return|1|||
27984550|NCT00895895|54643345|FG000|Period 1|investigator request|0|||
27883276|NCT01518192|54503939|FG002|Overall Study|Lost to Follow-up|35|||
27883277|NCT01517802|54503953|FG000|Overall Study|Death|1|||
27883278|NCT01520922|54503959|FG000|Treatment Phase|Physician Decision|2|||
27883279|NCT01520922|54503960|FG001|Treatment Phase|Physician Decision|1|||
27883280|NCT01520922|54503959|FG000|Treatment Phase|Progression|0|||
27883281|NCT01520922|54503960|FG001|Treatment Phase|Progression|2|||
27883282|NCT01520922|54503959|FG000|Treatment Phase|Adverse Event|3|||
27883283|NCT01520922|54503960|FG001|Treatment Phase|Adverse Event|5|||
27883284|NCT01520922|54503959|FG000|Follow up|Lost to Follow-up|0|||
27883285|NCT01520922|54503960|FG001|Follow up|Lost to Follow-up|1|||
27984551|NCT00895895|54643346|FG001|Period 1|investigator request|1|||
27883286|NCT01520922|54503959|FG000|Survival Follow-up|Withdrawal by Subject|1|||
27984552|NCT00895895|54643347|FG002|Period 1|investigator request|0|||
27984553|NCT00895895|54643348|FG003|Period 1|investigator request|0|||
27984554|NCT00895895|54643349|FG004|Period 1|investigator request|0|||
27984555|NCT00895895|54643345|FG000|Period 1|Lost to Follow-up|2|||
27883287|NCT01520922|54503960|FG001|Survival Follow-up|Withdrawal by Subject|0|||
27984556|NCT00895895|54643346|FG001|Period 1|Lost to Follow-up|1|||
27883288|NCT01569438|54503968|FG000|Overall Study|Lack of Efficacy|1|||
27984557|NCT00895895|54643347|FG002|Period 1|Lost to Follow-up|3|||
27984558|NCT00895895|54643348|FG003|Period 1|Lost to Follow-up|2|||
27984559|NCT00895895|54643349|FG004|Period 1|Lost to Follow-up|3|||
27883289|NCT01569438|54503969|FG001|Overall Study|Lack of Efficacy|2|||
27883290|NCT01569438|54503968|FG000|Overall Study|Withdrawal by Subject|0|||
27883291|NCT01569438|54503969|FG001|Overall Study|Withdrawal by Subject|3|||
27883292|NCT01569438|54503968|FG000|Overall Study|Adverse Event|2|||
27883293|NCT01569438|54503969|FG001|Overall Study|Adverse Event|15|||
27883294|NCT01569438|54503968|FG000|Overall Study|Protocol Violation|2|||
27883295|NCT01569438|54503969|FG001|Overall Study|Protocol Violation|0|||
27883296|NCT01569438|54503968|FG000|Overall Study|Decrease of GFR greater than 30 ml/min|1|||
27883297|NCT01569438|54503969|FG001|Overall Study|Decrease of GFR greater than 30 ml/min|0|||
27883298|NCT01569438|54503968|FG000|Overall Study|Sponsor/Physician decision|1|||
27883299|NCT01569438|54503969|FG001|Overall Study|Sponsor/Physician decision|1|||
27883300|NCT01569438|54503968|FG000|Overall Study|Unable to adhere to study schedule|0|||
27883301|NCT01569438|54503969|FG001|Overall Study|Unable to adhere to study schedule|1|||
27883302|NCT01517412|54503977|FG000|Overall Study|Adverse Event|10|||
27883303|NCT01517412|54503978|FG001|Overall Study|Adverse Event|11|||
27883304|NCT01517412|54503977|FG000|Overall Study|Lack of Efficacy|10|||
27883305|NCT01517412|54503978|FG001|Overall Study|Lack of Efficacy|5|||
27883306|NCT01517412|54503977|FG000|Overall Study|Poor compliance to protocol|8|||
27883307|NCT01517412|54503978|FG001|Overall Study|Poor compliance to protocol|3|||
27883308|NCT01517412|54503977|FG000|Overall Study|Other than specified above|8|||
27883309|NCT01517412|54503978|FG001|Overall Study|Other than specified above|5|||
27883310|NCT01517178|54503984|FG000|Period 1|Adverse Event|1|||
27883311|NCT01517178|54503985|FG001|Period 1|Adverse Event|2|||
27883312|NCT01517178|54503984|FG000|Period 1|Lack of Efficacy|0|||
27883313|NCT01517178|54503985|FG001|Period 1|Lack of Efficacy|1|||
27883314|NCT01517178|54503984|FG000|Period 1|E.g. study termination|3|||
27883315|NCT01517178|54503985|FG001|Period 1|E.g. study termination|1|||
27883316|NCT01517178|54503984|FG000|Period 1|Withdrawal by Subject|0|||
27883317|NCT01517178|54503985|FG001|Period 1|Withdrawal by Subject|1|||
27883318|NCT01517178|54503984|FG000|Period 2|Adverse Event|1|||
27883319|NCT01517178|54503985|FG001|Period 2|Adverse Event|0|||
27883320|NCT01517178|54503984|FG000|Period 2|Withdrawal by Subject|3|||
27883321|NCT01517178|54503985|FG001|Period 2|Withdrawal by Subject|0|||
27883322|NCT01517178|54503984|FG000|Period 2|E.g. study termination|2|||
27883323|NCT01517178|54503985|FG001|Period 2|E.g. study termination|2|||
27883324|NCT01489956|54503993|FG000|Overall Study|Lost to Follow-up|1|||
27883325|NCT01489956|54503994|FG001|Overall Study|Lost to Follow-up|0|||
27883326|NCT01489956|54503995|FG002|Overall Study|Lost to Follow-up|0|||
27883327|NCT01489956|54503993|FG000|Overall Study|Withdrawal by Subject|0|||
27883328|NCT01489956|54503994|FG001|Overall Study|Withdrawal by Subject|0|||
27883329|NCT01489956|54503995|FG002|Overall Study|Withdrawal by Subject|1|||
27883330|NCT01516008|54504006|FG000|Overall Study|Adverse Event|0|||
27883331|NCT01516008|54504007|FG001|Overall Study|Adverse Event|2|||
27883332|NCT01516008|54504008|FG002|Overall Study|Adverse Event|7|||
27883333|NCT01516008|54504006|FG000|Overall Study|Lack of Efficacy|44|||
27883334|NCT01516008|54504007|FG001|Overall Study|Lack of Efficacy|14|||
27883335|NCT01516008|54504008|FG002|Overall Study|Lack of Efficacy|10|||
27883336|NCT01516008|54504006|FG000|Overall Study|Protocol Violation|1|||
27883337|NCT01516008|54504007|FG001|Overall Study|Protocol Violation|0|||
27883338|NCT01516008|54504008|FG002|Overall Study|Protocol Violation|0|||
27883339|NCT01516008|54504006|FG000|Overall Study|Reason not specified|0|||
27883340|NCT01516008|54504007|FG001|Overall Study|Reason not specified|0|||
27883341|NCT01516008|54504008|FG002|Overall Study|Reason not specified|1|||
27883342|NCT01489254|54504019|FG000|Double-blind Part|Adverse Event|7|||
27883343|NCT01489254|54504020|FG001|Double-blind Part|Adverse Event|2|||
27883344|NCT01489254|54504021|FG002|Double-blind Part|Adverse Event|2|||
27883345|NCT01489254|54504022|FG003|Double-blind Part|Adverse Event|0|||
27883346|NCT01489254|54504019|FG000|Double-blind Part|Pregnancy|1|||
27883347|NCT01489254|54504020|FG001|Double-blind Part|Pregnancy|3|||
27883348|NCT01489254|54504021|FG002|Double-blind Part|Pregnancy|0|||
27883349|NCT01489254|54504022|FG003|Double-blind Part|Pregnancy|0|||
27883350|NCT01489254|54504019|FG000|Double-blind Part|Withdrawal by Subject|12|||
27883351|NCT01489254|54504020|FG001|Double-blind Part|Withdrawal by Subject|20|||
27883352|NCT01489254|54504021|FG002|Double-blind Part|Withdrawal by Subject|1|||
27883353|NCT01489254|54504022|FG003|Double-blind Part|Withdrawal by Subject|0|||
27883354|NCT01489254|54504019|FG000|Double-blind Part|Lost to Follow-up|1|||
27883355|NCT01489254|54504020|FG001|Double-blind Part|Lost to Follow-up|2|||
27883356|NCT01489254|54504021|FG002|Double-blind Part|Lost to Follow-up|0|||
27883357|NCT01489254|54504022|FG003|Double-blind Part|Lost to Follow-up|0|||
27883358|NCT01489254|54504019|FG000|Double-blind Part|Other reasons for not completing study|4|||
27883359|NCT01489254|54504020|FG001|Double-blind Part|Other reasons for not completing study|6|||
27883360|NCT01489254|54504021|FG002|Double-blind Part|Other reasons for not completing study|0|||
27883361|NCT01489254|54504022|FG003|Double-blind Part|Other reasons for not completing study|0|||
28096599|NCT03693950|54751734|FG001|Overall Study|Withdrawal by Subject|0|||
28096600|NCT04110314|54751746|FG000|Overall Study|Did not meet inclusion criteria|35255|||
28096601|NCT04110314|54751747|FG001|Overall Study|Did not meet inclusion criteria|35104|||
27883362|NCT01489254|54504019|FG000|Open-label Extension Part|Adverse Event|0|||
27883363|NCT01489254|54504020|FG001|Open-label Extension Part|Adverse Event|0|||
27883364|NCT01489254|54504021|FG002|Open-label Extension Part|Adverse Event|0|||
27883365|NCT01489254|54504022|FG003|Open-label Extension Part|Adverse Event|10|||
27883366|NCT01489254|54504019|FG000|Open-label Extension Part|Pregnancy|0|||
27883367|NCT01489254|54504020|FG001|Open-label Extension Part|Pregnancy|0|||
27883368|NCT01489254|54504021|FG002|Open-label Extension Part|Pregnancy|0|||
27883369|NCT01489254|54504022|FG003|Open-label Extension Part|Pregnancy|3|||
27883370|NCT01489254|54504019|FG000|Open-label Extension Part|Withdrawal by Subject|0|||
27883371|NCT01489254|54504020|FG001|Open-label Extension Part|Withdrawal by Subject|0|||
27883372|NCT01489254|54504021|FG002|Open-label Extension Part|Withdrawal by Subject|0|||
27883373|NCT01489254|54504022|FG003|Open-label Extension Part|Withdrawal by Subject|30|||
27883374|NCT01489254|54504019|FG000|Open-label Extension Part|Protocol Violation|0|||
27883375|NCT01489254|54504020|FG001|Open-label Extension Part|Protocol Violation|0|||
27883376|NCT01489254|54504021|FG002|Open-label Extension Part|Protocol Violation|0|||
27883377|NCT01489254|54504022|FG003|Open-label Extension Part|Protocol Violation|1|||
27883378|NCT01489254|54504019|FG000|Open-label Extension Part|Lost to Follow-up|0|||
27883379|NCT01489254|54504020|FG001|Open-label Extension Part|Lost to Follow-up|0|||
27883380|NCT01489254|54504021|FG002|Open-label Extension Part|Lost to Follow-up|0|||
27883381|NCT01489254|54504022|FG003|Open-label Extension Part|Lost to Follow-up|9|||
27883382|NCT01489254|54504019|FG000|Open-label Extension Part|Other reasons for not completing study|0|||
27883383|NCT01489254|54504020|FG001|Open-label Extension Part|Other reasons for not completing study|0|||
27883384|NCT01489254|54504021|FG002|Open-label Extension Part|Other reasons for not completing study|0|||
27883385|NCT01489254|54504022|FG003|Open-label Extension Part|Other reasons for not completing study|5|||
27883386|NCT01489020|54504037|FG000|Overall Study|Withdrawal by Subject|1|||
27883387|NCT01489020|54504038|FG001|Overall Study|Withdrawal by Subject|0|||
27883388|NCT01489020|54504039|FG002|Overall Study|Withdrawal by Subject|0|||
27883389|NCT01489020|54504040|FG003|Overall Study|Withdrawal by Subject|0|||
27883390|NCT01489020|54504041|FG004|Overall Study|Withdrawal by Subject|0|||
27883391|NCT01489020|54504042|FG005|Overall Study|Withdrawal by Subject|0|||
27883392|NCT01489020|54504037|FG000|Overall Study|Adverse Event|0|||
27883393|NCT01489020|54504038|FG001|Overall Study|Adverse Event|0|||
27883394|NCT01489020|54504039|FG002|Overall Study|Adverse Event|3|||
27883395|NCT01489020|54504040|FG003|Overall Study|Adverse Event|0|||
27883396|NCT01489020|54504041|FG004|Overall Study|Adverse Event|3|||
27883397|NCT01489020|54504042|FG005|Overall Study|Adverse Event|0|||
27883398|NCT01489020|54504037|FG000|Overall Study|Concomitant disease|0|||
27883399|NCT01489020|54504038|FG001|Overall Study|Concomitant disease|0|||
27883400|NCT01489020|54504039|FG002|Overall Study|Concomitant disease|0|||
27883401|NCT01489020|54504040|FG003|Overall Study|Concomitant disease|0|||
27883402|NCT01489020|54504041|FG004|Overall Study|Concomitant disease|3|||
27883403|NCT01489020|54504042|FG005|Overall Study|Concomitant disease|0|||
27883404|NCT01514760|54504062|FG000|Overall Study|Lost to Follow-up|2|||
27883405|NCT01514682|54504068|FG000|Overall Study|Withdrawal by Subject|2|||
27883406|NCT01514682|54504069|FG001|Overall Study|Withdrawal by Subject|3|||
27883407|NCT01514682|54504068|FG000|Overall Study|Physician Decision|4|||
27883408|NCT01514682|54504069|FG001|Overall Study|Physician Decision|3|||
27883409|NCT01514448|54504077|FG000|Overall Study|Death|7|||
27883410|NCT01514448|54504078|FG001|Overall Study|Death|8|||
27883411|NCT01514448|54504077|FG000|Overall Study|Withdrawal by Subject|2|||
27883412|NCT01514448|54504078|FG001|Overall Study|Withdrawal by Subject|0|||
27883413|NCT01514448|54504077|FG000|Overall Study|Lost to Follow-up|2|||
27883414|NCT01514448|54504078|FG001|Overall Study|Lost to Follow-up|0|||
27883415|NCT01514448|54504077|FG000|Overall Study|New Cancer Therapy|1|||
27883416|NCT01514448|54504078|FG001|Overall Study|New Cancer Therapy|0|||
27883417|NCT01514370|54504087|FG000|Overall Study|Protocol Violation|2|||
27883418|NCT01514370|54504088|FG001|Overall Study|Protocol Violation|3|||
27883419|NCT01514370|54504087|FG000|Overall Study|Lost to Follow-up|0|||
27883420|NCT01514370|54504088|FG001|Overall Study|Lost to Follow-up|2|||
27883421|NCT01514370|54504087|FG000|Overall Study|Withdrawal by Subject|2|||
27883422|NCT01514370|54504088|FG001|Overall Study|Withdrawal by Subject|1|||
27883423|NCT01514370|54504087|FG000|Overall Study|Adverse Event|1|||
27883424|NCT01514370|54504088|FG001|Overall Study|Adverse Event|3|||
27883425|NCT01514370|54504087|FG000|Overall Study|Other|6|||
27883426|NCT01514370|54504088|FG001|Overall Study|Other|7|||
27883427|NCT01519674|54504098|FG000|Overall Study|Adverse Event|3|||
27883428|NCT01519674|54504099|FG001|Overall Study|Adverse Event|3|||
27883429|NCT01519674|54504100|FG002|Overall Study|Adverse Event|0|||
27883430|NCT01519674|54504098|FG000|Overall Study|Lack of Efficacy|1|||
27883431|NCT01519674|54504099|FG001|Overall Study|Lack of Efficacy|1|||
27883432|NCT01519674|54504100|FG002|Overall Study|Lack of Efficacy|1|||
27883433|NCT01519674|54504098|FG000|Overall Study|Protocol Violation|0|||
27883434|NCT01519674|54504099|FG001|Overall Study|Protocol Violation|3|||
27883435|NCT01519674|54504100|FG002|Overall Study|Protocol Violation|1|||
27883436|NCT01519674|54504098|FG000|Overall Study|Withdrawal Criteria|7|||
27883437|NCT01519674|54504099|FG001|Overall Study|Withdrawal Criteria|2|||
27883438|NCT01519674|54504100|FG002|Overall Study|Withdrawal Criteria|7|||
27883439|NCT01519674|54504098|FG000|Overall Study|Unsclassified|10|||
27883440|NCT01519674|54504099|FG001|Overall Study|Unsclassified|4|||
27883441|NCT01519674|54504100|FG002|Overall Study|Unsclassified|3|||
27883442|NCT01519518|54504110|FG000|Overall Study|Consent not available|7|||
27883443|NCT01519518|54504111|FG001|Overall Study|Consent not available|10|||
27883444|NCT01519206|54504117|FG000|Overall Study|Lost to Follow-up|3|||
27883445|NCT01519206|54504117|FG000|Overall Study|Missed Visit|2|||
27883446|NCT01518972|54504130|FG000|Overall Study|Lost to Follow-up|2|||
27883447|NCT01518972|54504131|FG001|Overall Study|Lost to Follow-up|1|||
27883448|NCT01518972|54504130|FG000|Overall Study|Withdrawal by Subject|1|||
27883449|NCT01518972|54504131|FG001|Overall Study|Withdrawal by Subject|0|||
27883450|NCT01518972|54504130|FG000|Overall Study|Moved from area|1|||
27883451|NCT01518972|54504131|FG001|Overall Study|Moved from area|0|||
27883452|NCT01518972|54504130|FG000|Overall Study|Transportation problems|1|||
27883453|NCT01518972|54504131|FG001|Overall Study|Transportation problems|0|||
27883454|NCT01518972|54504130|FG000|Overall Study|Exclusionary medical condition|1|||
27883455|NCT01518972|54504131|FG001|Overall Study|Exclusionary medical condition|0|||
27883456|NCT01518972|54504130|FG000|Overall Study|Missed safety visits|0|||
27883457|NCT01518972|54504131|FG001|Overall Study|Missed safety visits|1|||
27883458|NCT01518972|54504130|FG000|Overall Study|Exclusionary medication|0|||
27883459|NCT01518972|54504131|FG001|Overall Study|Exclusionary medication|1|||
27883460|NCT01518972|54504130|FG000|Overall Study|Declined medication starting on day 12|0|||
27883461|NCT01518972|54504131|FG001|Overall Study|Declined medication starting on day 12|1|||
27883462|NCT01514136|54504139|FG000|Test Period 1; Test A|Protocol Violation|1|||
27883463|NCT01514136|54504140|FG001|Test Period 1; Test A|Protocol Violation|0|||
27883464|NCT01514136|54504141|FG002|Test Period 1; Test A|Protocol Violation|0|||
27883465|NCT01514136|54504142|FG003|Test Period 1; Test A|Protocol Violation|0|||
27883466|NCT01514136|54504143|FG004|Test Period 1; Test A|Protocol Violation|0|||
27883467|NCT01514136|54504144|FG005|Test Period 1; Test A|Protocol Violation|0|||
27883468|NCT01514136|54504145|FG006|Test Period 1; Test A|Protocol Violation|0|||
27883469|NCT01514136|54504146|FG007|Test Period 1; Test A|Protocol Violation|0|||
27883470|NCT01514136|54504139|FG000|Test Period 1; Test A|Break from study holiday|2|||
27883471|NCT01514136|54504140|FG001|Test Period 1; Test A|Break from study holiday|0|||
27883472|NCT01514136|54504141|FG002|Test Period 1; Test A|Break from study holiday|0|||
27883473|NCT01514136|54504142|FG003|Test Period 1; Test A|Break from study holiday|0|||
27883474|NCT01514136|54504143|FG004|Test Period 1; Test A|Break from study holiday|0|||
27883475|NCT01514136|54504144|FG005|Test Period 1; Test A|Break from study holiday|0|||
27883476|NCT01514136|54504145|FG006|Test Period 1; Test A|Break from study holiday|0|||
27883477|NCT01514136|54504146|FG007|Test Period 1; Test A|Break from study holiday|0|||
27883478|NCT01514136|54504139|FG000|Test Period 1; Test B|Withdrawal by Subject|0|||
27883479|NCT01514136|54504140|FG001|Test Period 1; Test B|Withdrawal by Subject|1|||
27883480|NCT01514136|54504141|FG002|Test Period 1; Test B|Withdrawal by Subject|0|||
27883481|NCT01514136|54504142|FG003|Test Period 1; Test B|Withdrawal by Subject|0|||
27883482|NCT01514136|54504143|FG004|Test Period 1; Test B|Withdrawal by Subject|0|||
27883483|NCT01514136|54504144|FG005|Test Period 1; Test B|Withdrawal by Subject|0|||
27883484|NCT01514136|54504145|FG006|Test Period 1; Test B|Withdrawal by Subject|0|||
27883485|NCT01514136|54504146|FG007|Test Period 1; Test B|Withdrawal by Subject|0|||
27883486|NCT01514136|54504139|FG000|Test Period 1; Test D|Subject took a break due to holiday|0|||
27883487|NCT01514136|54504140|FG001|Test Period 1; Test D|Subject took a break due to holiday|0|||
27883488|NCT01514136|54504141|FG002|Test Period 1; Test D|Subject took a break due to holiday|0|||
27883489|NCT01514136|54504142|FG003|Test Period 1; Test D|Subject took a break due to holiday|2|||
27883490|NCT01514136|54504143|FG004|Test Period 1; Test D|Subject took a break due to holiday|0|||
27883491|NCT01514136|54504144|FG005|Test Period 1; Test D|Subject took a break due to holiday|0|||
27883492|NCT01514136|54504145|FG006|Test Period 1; Test D|Subject took a break due to holiday|0|||
27883493|NCT01514136|54504146|FG007|Test Period 1; Test D|Subject took a break due to holiday|0|||
27883494|NCT01514136|54504139|FG000|Test Period 2; Test A*|Adverse Event|0|||
27883495|NCT01514136|54504140|FG001|Test Period 2; Test A*|Adverse Event|0|||
27883496|NCT01514136|54504141|FG002|Test Period 2; Test A*|Adverse Event|0|||
27883497|NCT01514136|54504142|FG003|Test Period 2; Test A*|Adverse Event|0|||
27883498|NCT01514136|54504143|FG004|Test Period 2; Test A*|Adverse Event|1|||
27883499|NCT01514136|54504144|FG005|Test Period 2; Test A*|Adverse Event|0|||
27883500|NCT01514136|54504145|FG006|Test Period 2; Test A*|Adverse Event|0|||
27883501|NCT01514136|54504146|FG007|Test Period 2; Test A*|Adverse Event|0|||
27883502|NCT01514136|54504139|FG000|Test Period 2; Test A*|Holiday|0|||
27883503|NCT01514136|54504140|FG001|Test Period 2; Test A*|Holiday|0|||
27883504|NCT01514136|54504141|FG002|Test Period 2; Test A*|Holiday|0|||
27883505|NCT01514136|54504142|FG003|Test Period 2; Test A*|Holiday|0|||
27883506|NCT01514136|54504143|FG004|Test Period 2; Test A*|Holiday|1|||
27883507|NCT01514136|54504144|FG005|Test Period 2; Test A*|Holiday|0|||
27883508|NCT01514136|54504145|FG006|Test Period 2; Test A*|Holiday|0|||
27883509|NCT01514136|54504146|FG007|Test Period 2; Test A*|Holiday|0|||
27883510|NCT01514136|54504139|FG000|Test Period 2; Test B*|Withdrawal by Subject|0|||
27883511|NCT01514136|54504140|FG001|Test Period 2; Test B*|Withdrawal by Subject|0|||
27883512|NCT01514136|54504141|FG002|Test Period 2; Test B*|Withdrawal by Subject|0|||
27883513|NCT01514136|54504142|FG003|Test Period 2; Test B*|Withdrawal by Subject|0|||
27883514|NCT01514136|54504143|FG004|Test Period 2; Test B*|Withdrawal by Subject|0|||
27883515|NCT01514136|54504144|FG005|Test Period 2; Test B*|Withdrawal by Subject|2|||
27883516|NCT01514136|54504145|FG006|Test Period 2; Test B*|Withdrawal by Subject|0|||
27883517|NCT01514136|54504146|FG007|Test Period 2; Test B*|Withdrawal by Subject|0|||
27883518|NCT01514136|54504139|FG000|Test Period 2; Test C*|Withdrawal by Subject|0|||
27883519|NCT01514136|54504140|FG001|Test Period 2; Test C*|Withdrawal by Subject|0|||
27883520|NCT01514136|54504141|FG002|Test Period 2; Test C*|Withdrawal by Subject|0|||
27883521|NCT01514136|54504142|FG003|Test Period 2; Test C*|Withdrawal by Subject|0|||
27883522|NCT01514136|54504143|FG004|Test Period 2; Test C*|Withdrawal by Subject|0|||
27883523|NCT01514136|54504144|FG005|Test Period 2; Test C*|Withdrawal by Subject|0|||
27883524|NCT01514136|54504145|FG006|Test Period 2; Test C*|Withdrawal by Subject|1|||
27883525|NCT01514136|54504146|FG007|Test Period 2; Test C*|Withdrawal by Subject|0|||
27883526|NCT01514136|54504139|FG000|Test Period 2; Test C*|holiday|0|||
27883527|NCT01514136|54504140|FG001|Test Period 2; Test C*|holiday|0|||
27883528|NCT01514136|54504141|FG002|Test Period 2; Test C*|holiday|0|||
27883529|NCT01514136|54504142|FG003|Test Period 2; Test C*|holiday|0|||
27883530|NCT01514136|54504143|FG004|Test Period 2; Test C*|holiday|0|||
27883531|NCT01514136|54504144|FG005|Test Period 2; Test C*|holiday|0|||
27883532|NCT01514136|54504145|FG006|Test Period 2; Test C*|holiday|1|||
27883533|NCT01514136|54504146|FG007|Test Period 2; Test C*|holiday|0|||
27883534|NCT01514136|54504139|FG000|Test Period 2; Test C*|Protocol Violation|0|||
27883535|NCT01514136|54504140|FG001|Test Period 2; Test C*|Protocol Violation|0|||
27883536|NCT01514136|54504141|FG002|Test Period 2; Test C*|Protocol Violation|0|||
27883537|NCT01514136|54504142|FG003|Test Period 2; Test C*|Protocol Violation|0|||
27883538|NCT01514136|54504143|FG004|Test Period 2; Test C*|Protocol Violation|0|||
27883539|NCT01514136|54504144|FG005|Test Period 2; Test C*|Protocol Violation|0|||
27883540|NCT01514136|54504145|FG006|Test Period 2; Test C*|Protocol Violation|1|||
27883541|NCT01514136|54504146|FG007|Test Period 2; Test C*|Protocol Violation|0|||
27883542|NCT01513590|54504174|FG000|Overall Study|Adverse Event|2|||
27883543|NCT01513590|54504175|FG001|Overall Study|Adverse Event|3|||
27883544|NCT01513590|54504174|FG000|Overall Study|Withdrawal Criteria|3|||
27883545|NCT01513590|54504175|FG001|Overall Study|Withdrawal Criteria|0|||
27883546|NCT01513590|54504174|FG000|Overall Study|Unclassified|5|||
27883547|NCT01513590|54504175|FG001|Overall Study|Unclassified|10|||
27883548|NCT01512264|54504185|FG000|Overall Study|Lost to Follow-up|0|||
27883549|NCT01512264|54504186|FG001|Overall Study|Lost to Follow-up|0|||
27883550|NCT01512264|54504187|FG002|Overall Study|Lost to Follow-up|0|||
27883551|NCT01512264|54504188|FG003|Overall Study|Lost to Follow-up|1|||
27883552|NCT01512108|54504200|FG000|Overall Study|Adverse Event|9|||
27883553|NCT01512108|54504201|FG001|Overall Study|Adverse Event|4|||
27883554|NCT01512108|54504200|FG000|Overall Study|Protocol Violation|1|||
27883555|NCT01512108|54504201|FG001|Overall Study|Protocol Violation|2|||
27883556|NCT01512108|54504200|FG000|Overall Study|Withdrawal Criteria|1|||
27883557|NCT01512108|54504201|FG001|Overall Study|Withdrawal Criteria|0|||
27883558|NCT01512108|54504200|FG000|Overall Study|Unclassified|11|||
27883559|NCT01512108|54504201|FG001|Overall Study|Unclassified|3|||
27883560|NCT01486758|54504209|FG000|Overall Study|Lost to Follow-up|0|||
27883561|NCT01486758|54504210|FG001|Overall Study|Lost to Follow-up|1|||
27883562|NCT01463982|54504221|FG000|Overall Study|Withdrawal by Subject|0|||
27883563|NCT01463982|54504222|FG001|Overall Study|Withdrawal by Subject|1|||
27883564|NCT01463982|54504223|FG002|Overall Study|Withdrawal by Subject|1|||
27883565|NCT01463982|54504224|FG003|Overall Study|Withdrawal by Subject|0|||
27883566|NCT01463982|54504221|FG000|Overall Study|Treatment delay over 5 week|0|||
27883567|NCT01463982|54504222|FG001|Overall Study|Treatment delay over 5 week|0|||
27883568|NCT01463982|54504223|FG002|Overall Study|Treatment delay over 5 week|1|||
27883569|NCT01463982|54504224|FG003|Overall Study|Treatment delay over 5 week|0|||
27883570|NCT01486446|54504236|FG000|Overall Study|Adverse Event|1|||
27883571|NCT01486446|54504237|FG001|Overall Study|Adverse Event|0|||
27883572|NCT01485354|54504243|FG000|Overall Study|Withdrawal by Subject|5|||
27883573|NCT01510158|54504250|FG000|Overall Study|Adverse Event|7|||
27883574|NCT01510158|54504251|FG001|Overall Study|Adverse Event|8|||
27883575|NCT01510158|54504252|FG002|Overall Study|Adverse Event|5|||
27883576|NCT01510158|54504250|FG000|Overall Study|Gout flare|1|||
27883577|NCT01510158|54504251|FG001|Overall Study|Gout flare|0|||
27883578|NCT01510158|54504252|FG002|Overall Study|Gout flare|0|||
27883579|NCT01510158|54504250|FG000|Overall Study|Protocol Violation|17|||
27883580|NCT01510158|54504251|FG001|Overall Study|Protocol Violation|16|||
27883581|NCT01510158|54504252|FG002|Overall Study|Protocol Violation|24|||
27883582|NCT01510158|54504250|FG000|Overall Study|Sponsor terminated study.|2|||
28096602|NCT04110314|54751748|FG002|Overall Study|Did not meet inclusion criteria|35636|||
28096603|NCT04110314|54751749|FG003|Overall Study|Did not meet inclusion criteria|35135|||
27883583|NCT01510158|54504251|FG001|Overall Study|Sponsor terminated study.|0|||
27883584|NCT01510158|54504252|FG002|Overall Study|Sponsor terminated study.|2|||
27883585|NCT01510158|54504250|FG000|Overall Study|Lost to Follow-up|13|||
27883586|NCT01510158|54504251|FG001|Overall Study|Lost to Follow-up|16|||
27883587|NCT01510158|54504252|FG002|Overall Study|Lost to Follow-up|9|||
27883588|NCT01510158|54504250|FG000|Overall Study|Withdrawal by Subject|10|||
27883589|NCT01510158|54504251|FG001|Overall Study|Withdrawal by Subject|13|||
27883590|NCT01510158|54504252|FG002|Overall Study|Withdrawal by Subject|10|||
27883591|NCT01510158|54504250|FG000|Overall Study|Death|1|||
27883592|NCT01510158|54504251|FG001|Overall Study|Death|0|||
27883593|NCT01510158|54504252|FG002|Overall Study|Death|0|||
27883594|NCT01485120|54504269|FG000|Overall Study|Withdrawal by Subject|2|||
27883595|NCT01484496|54504276|FG000|Period 1|Protocol Violation|3|||
27883596|NCT01484496|54504277|FG001|Period 1|Protocol Violation|4|||
27883597|NCT01484496|54504278|FG002|Period 1|Protocol Violation|0|||
27883598|NCT01484496|54504279|FG003|Period 1|Protocol Violation|0|||
27883599|NCT01484496|54504276|FG000|Period 1|Physician Decision|5|||
27883600|NCT01484496|54504277|FG001|Period 1|Physician Decision|1|||
27883601|NCT01484496|54504278|FG002|Period 1|Physician Decision|0|||
27883602|NCT01484496|54504279|FG003|Period 1|Physician Decision|0|||
27883603|NCT01484496|54504276|FG000|Period 1|Lack of Efficacy|10|||
27883604|NCT01484496|54504277|FG001|Period 1|Lack of Efficacy|15|||
27883605|NCT01484496|54504278|FG002|Period 1|Lack of Efficacy|0|||
27883606|NCT01484496|54504279|FG003|Period 1|Lack of Efficacy|0|||
27883607|NCT01484496|54504276|FG000|Period 1|Adverse Event|25|||
27883608|NCT01484496|54504277|FG001|Period 1|Adverse Event|40|||
27883609|NCT01484496|54504278|FG002|Period 1|Adverse Event|0|||
27883610|NCT01484496|54504279|FG003|Period 1|Adverse Event|0|||
27883611|NCT01484496|54504276|FG000|Period 1|Withdrawal by Subject|15|||
27883612|NCT01484496|54504277|FG001|Period 1|Withdrawal by Subject|12|||
27883613|NCT01484496|54504278|FG002|Period 1|Withdrawal by Subject|0|||
27883614|NCT01484496|54504279|FG003|Period 1|Withdrawal by Subject|0|||
27883615|NCT01484496|54504276|FG000|Period 1|Lost to Follow-up|2|||
27883616|NCT01484496|54504277|FG001|Period 1|Lost to Follow-up|6|||
27883617|NCT01484496|54504278|FG002|Period 1|Lost to Follow-up|0|||
27883618|NCT01484496|54504279|FG003|Period 1|Lost to Follow-up|0|||
27883619|NCT01484496|54504276|FG000|Period 1|Positive Pregnancy|1|||
27883620|NCT01484496|54504277|FG001|Period 1|Positive Pregnancy|6|||
27883621|NCT01484496|54504278|FG002|Period 1|Positive Pregnancy|0|||
27883622|NCT01484496|54504279|FG003|Period 1|Positive Pregnancy|0|||
27883623|NCT01484496|54504276|FG000|Period 1|Treatment Failure|3|||
27883624|NCT01484496|54504277|FG001|Period 1|Treatment Failure|6|||
27883625|NCT01484496|54504278|FG002|Period 1|Treatment Failure|0|||
27883626|NCT01484496|54504279|FG003|Period 1|Treatment Failure|0|||
27883627|NCT01484496|54504276|FG000|Period 1|Lack of Compliance|2|||
27883628|NCT01484496|54504277|FG001|Period 1|Lack of Compliance|1|||
27883629|NCT01484496|54504278|FG002|Period 1|Lack of Compliance|0|||
27883630|NCT01484496|54504279|FG003|Period 1|Lack of Compliance|0|||
27883631|NCT01484496|54504276|FG000|Period 1|Unable to Visit Site|0|||
27883632|NCT01484496|54504277|FG001|Period 1|Unable to Visit Site|2|||
27883633|NCT01484496|54504278|FG002|Period 1|Unable to Visit Site|0|||
27883634|NCT01484496|54504279|FG003|Period 1|Unable to Visit Site|0|||
27883635|NCT01484496|54504276|FG000|Period 2|Lack of Efficacy|0|||
27883636|NCT01484496|54504277|FG001|Period 2|Lack of Efficacy|0|||
27883637|NCT01484496|54504278|FG002|Period 2|Lack of Efficacy|1|||
27883638|NCT01484496|54504279|FG003|Period 2|Lack of Efficacy|3|||
27883639|NCT01484496|54504276|FG000|Period 2|Adverse Event|0|||
27883640|NCT01484496|54504277|FG001|Period 2|Adverse Event|0|||
27883641|NCT01484496|54504278|FG002|Period 2|Adverse Event|5|||
27883642|NCT01484496|54504279|FG003|Period 2|Adverse Event|13|||
27883643|NCT01484496|54504276|FG000|Period 2|Other|0|||
27883644|NCT01484496|54504277|FG001|Period 2|Other|0|||
27883645|NCT01484496|54504278|FG002|Period 2|Other|9|||
27883646|NCT01484496|54504279|FG003|Period 2|Other|6|||
27883647|NCT01509846|54504292|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
27883648|NCT01509846|54504293|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
27883649|NCT01509846|54504294|FG002|Received Vaccination 2|Withdrawal by Subject|1|||
27883650|NCT01509846|54504295|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
27883651|NCT01509846|54504296|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
27883652|NCT01509846|54504292|FG000|Received Vaccination 2|Illness|0|||
27883653|NCT01509846|54504293|FG001|Received Vaccination 2|Illness|0|||
27883654|NCT01509846|54504294|FG002|Received Vaccination 2|Illness|0|||
27883655|NCT01509846|54504295|FG003|Received Vaccination 2|Illness|0|||
27883656|NCT01509846|54504296|FG004|Received Vaccination 2|Illness|1|||
27883657|NCT01509846|54504292|FG000|Received Vaccination 2|Not vaccinated per protocol|5|||
27883658|NCT01509846|54504293|FG001|Received Vaccination 2|Not vaccinated per protocol|0|||
27883659|NCT01509846|54504294|FG002|Received Vaccination 2|Not vaccinated per protocol|0|||
27883660|NCT01509846|54504295|FG003|Received Vaccination 2|Not vaccinated per protocol|0|||
27883661|NCT01509846|54504296|FG004|Received Vaccination 2|Not vaccinated per protocol|2|||
27883662|NCT01509846|54504292|FG000|Received Vaccination 3|Withdrawal by Subject|0|||
27883663|NCT01509846|54504293|FG001|Received Vaccination 3|Withdrawal by Subject|1|||
27883664|NCT01509846|54504294|FG002|Received Vaccination 3|Withdrawal by Subject|0|||
27883665|NCT01509846|54504295|FG003|Received Vaccination 3|Withdrawal by Subject|0|||
27883666|NCT01509846|54504296|FG004|Received Vaccination 3|Withdrawal by Subject|0|||
27883667|NCT01509846|54504292|FG000|Received Vaccination 3|Pregnancy|0|||
27883668|NCT01509846|54504293|FG001|Received Vaccination 3|Pregnancy|0|||
27883669|NCT01509846|54504294|FG002|Received Vaccination 3|Pregnancy|0|||
27883670|NCT01509846|54504295|FG003|Received Vaccination 3|Pregnancy|1|||
27883671|NCT01509846|54504296|FG004|Received Vaccination 3|Pregnancy|0|||
27883672|NCT01509846|54504292|FG000|Received Vaccination 3|Lost to Follow-up|0|||
27883673|NCT01509846|54504293|FG001|Received Vaccination 3|Lost to Follow-up|0|||
27883674|NCT01509846|54504294|FG002|Received Vaccination 3|Lost to Follow-up|1|||
27883675|NCT01509846|54504295|FG003|Received Vaccination 3|Lost to Follow-up|0|||
27883676|NCT01509846|54504296|FG004|Received Vaccination 3|Lost to Follow-up|0|||
27883677|NCT01462344|54504317|FG000|Overall Study|Withdrawal by Subject|245|||
27883678|NCT01462344|54504318|FG001|Overall Study|Withdrawal by Subject|226|||
27883679|NCT01462344|54504317|FG000|Overall Study|Adverse Event|24|||
27883680|NCT01462344|54504318|FG001|Overall Study|Adverse Event|23|||
27883681|NCT01462344|54504317|FG000|Overall Study|Asthma Exacerbation|34|||
27883682|NCT01462344|54504318|FG001|Overall Study|Asthma Exacerbation|35|||
27883683|NCT01462344|54504317|FG000|Overall Study|Lack of Efficacy|5|||
27883684|NCT01462344|54504318|FG001|Overall Study|Lack of Efficacy|6|||
27883685|NCT01462344|54504317|FG000|Overall Study|Protocol Violation|68|||
27883686|NCT01462344|54504318|FG001|Overall Study|Protocol Violation|53|||
27883687|NCT01462344|54504317|FG000|Overall Study|Lost to Follow-up|7|||
27883688|NCT01462344|54504318|FG001|Overall Study|Lost to Follow-up|7|||
27883689|NCT01484028|54504324|FG000|Period 1|Lost to Follow-up|0|||
27883690|NCT01484028|54504325|FG001|Period 1|Lost to Follow-up|1|||
27883691|NCT01484028|54504326|FG002|Period 1|Lost to Follow-up|0|||
27883692|NCT01484028|54504327|FG003|Period 1|Lost to Follow-up|0|||
27883693|NCT01484028|54504324|FG000|Period 1|Non-Compliance to Protocol|0|||
27883694|NCT01484028|54504325|FG001|Period 1|Non-Compliance to Protocol|1|||
27883695|NCT01484028|54504326|FG002|Period 1|Non-Compliance to Protocol|0|||
27883696|NCT01484028|54504327|FG003|Period 1|Non-Compliance to Protocol|1|||
27883697|NCT01484028|54504324|FG000|Period 1|Lens Discomfort|0|||
27883698|NCT01484028|54504325|FG001|Period 1|Lens Discomfort|1|||
27883699|NCT01484028|54504326|FG002|Period 1|Lens Discomfort|0|||
27883700|NCT01484028|54504327|FG003|Period 1|Lens Discomfort|0|||
27883701|NCT01462266|54504337|FG000|Overall Study|Adverse Event|7|||
27883702|NCT01462266|54504338|FG001|Overall Study|Adverse Event|6|||
27883703|NCT01462266|54504337|FG000|Overall Study|Death|2|||
27883704|NCT01462266|54504338|FG001|Overall Study|Death|1|||
27883705|NCT01462266|54504337|FG000|Overall Study|Lack of Efficacy|0|||
27883706|NCT01462266|54504338|FG001|Overall Study|Lack of Efficacy|2|||
27883707|NCT01462266|54504337|FG000|Overall Study|Lost to Follow-up|4|||
27883708|NCT01462266|54504338|FG001|Overall Study|Lost to Follow-up|3|||
27883709|NCT01462266|54504337|FG000|Overall Study|Non-compliance with study drug|3|||
27883710|NCT01462266|54504338|FG001|Overall Study|Non-compliance with study drug|0|||
27883711|NCT01462266|54504337|FG000|Overall Study|Creatinine and eGFR, excluded medication|8|||
27883712|NCT01462266|54504338|FG001|Overall Study|Creatinine and eGFR, excluded medication|4|||
27883713|NCT01462266|54504337|FG000|Overall Study|Physician Decision|2|||
27883714|NCT01462266|54504338|FG001|Overall Study|Physician Decision|5|||
27883715|NCT01462266|54504337|FG000|Overall Study|Protocol Violation|1|||
27883716|NCT01462266|54504338|FG001|Overall Study|Protocol Violation|3|||
27883717|NCT01462266|54504337|FG000|Overall Study|Withdrawal by Subject|7|||
27883718|NCT01462266|54504338|FG001|Overall Study|Withdrawal by Subject|2|||
27883719|NCT01462266|54504337|FG000|Overall Study|Screen failure|1|||
27883720|NCT01462266|54504338|FG001|Overall Study|Screen failure|1|||
27883721|NCT01508910|54504347|FG000|Treatment|Death|2|||
27883722|NCT01508910|54504348|FG001|Treatment|Death|3|||
27883723|NCT01508910|54504349|FG002|Treatment|Death|2|||
27883724|NCT01508910|54504350|FG003|Treatment|Death|0|||
27883725|NCT01508910|54504347|FG000|Treatment|Lost to Follow-up|0|||
27883726|NCT01508910|54504348|FG001|Treatment|Lost to Follow-up|0|||
27883727|NCT01508910|54504349|FG002|Treatment|Lost to Follow-up|2|||
27883728|NCT01508910|54504350|FG003|Treatment|Lost to Follow-up|1|||
27883729|NCT01508910|54504347|FG000|Treatment|Withdrawal by Subject|0|||
27883730|NCT01508910|54504348|FG001|Treatment|Withdrawal by Subject|1|||
27883731|NCT01508910|54504349|FG002|Treatment|Withdrawal by Subject|6|||
27883732|NCT01508910|54504350|FG003|Treatment|Withdrawal by Subject|1|||
27883733|NCT01508910|54504347|FG000|Treatment|Sponsor Decision|0|||
27883734|NCT01508910|54504348|FG001|Treatment|Sponsor Decision|0|||
27883735|NCT01508910|54504349|FG002|Treatment|Sponsor Decision|0|||
27883736|NCT01508910|54504350|FG003|Treatment|Sponsor Decision|1|||
27883737|NCT01462110|54504364|FG000|Overall Study|Adverse Event|1|||
27883738|NCT01462110|54504365|FG001|Overall Study|Adverse Event|0|||
27883739|NCT01508676|54504373|FG000|Phase I (2 Weeks)|Medication Exclusion|1|||
28171769|NCT01651000|54843332|FG000|Overall Study|Subject noncompliance|0|||
27883740|NCT01508676|54504374|FG001|Phase I (2 Weeks)|Medication Exclusion|1|||
27883741|NCT01508676|54504373|FG000|Phase I (2 Weeks)|Wrong Pain Type|1|||
27883742|NCT01508676|54504374|FG001|Phase I (2 Weeks)|Wrong Pain Type|0|||
27883743|NCT01508676|54504373|FG000|Phase I (2 Weeks)|Positive Drug Screen|0|||
27883744|NCT01508676|54504374|FG001|Phase I (2 Weeks)|Positive Drug Screen|2|||
27883745|NCT01508676|54504373|FG000|Phase II (2 Weeks)|Skin Sensitivity|0|||
27883746|NCT01508676|54504374|FG001|Phase II (2 Weeks)|Skin Sensitivity|1|||
27883747|NCT01508676|54504373|FG000|Phase II (2 Weeks)|Medication Exclusion|1|||
27883748|NCT01508676|54504374|FG001|Phase II (2 Weeks)|Medication Exclusion|0|||
27883749|NCT01508130|54504383|FG000|Overall Study|Adverse Event|81|||
27883750|NCT01508130|54504384|FG001|Overall Study|Adverse Event|28|||
27883751|NCT01508130|54504383|FG000|Overall Study|Death|3|||
27883752|NCT01508130|54504384|FG001|Overall Study|Death|1|||
27883753|NCT01508130|54504383|FG000|Overall Study|Protocol Violation|2|||
27883754|NCT01508130|54504384|FG001|Overall Study|Protocol Violation|0|||
27883755|NCT01508130|54504383|FG000|Overall Study|Lost to Follow-up|25|||
27883756|NCT01508130|54504384|FG001|Overall Study|Lost to Follow-up|2|||
27883757|NCT01508130|54504383|FG000|Overall Study|Withdrawal by Subject|3|||
27883758|NCT01508130|54504384|FG001|Overall Study|Withdrawal by Subject|3|||
27883759|NCT01508130|54504383|FG000|Overall Study|Subject's substantial non-compliance|25|||
27883760|NCT01508130|54504384|FG001|Overall Study|Subject's substantial non-compliance|9|||
27883761|NCT01508130|54504383|FG000|Overall Study|Insufficient therapeutic response|74|||
27883762|NCT01508130|54504384|FG001|Overall Study|Insufficient therapeutic response|23|||
27883763|NCT01508130|54504383|FG000|Overall Study|Administrative|14|||
27883764|NCT01508130|54504384|FG001|Overall Study|Administrative|3|||
27883765|NCT01482312|54504392|FG000|Period 1, 90 Minutes of Wear|Other|1|||
27883766|NCT01482312|54504393|FG001|Period 1, 90 Minutes of Wear|Other|0|||
27883767|NCT01482312|54504394|FG002|Period 1, 90 Minutes of Wear|Other|0|||
27883768|NCT01482312|54504392|FG000|Period 2, 90 Minutes of Wear|Other|1|||
27883769|NCT01482312|54504393|FG001|Period 2, 90 Minutes of Wear|Other|0|||
27883770|NCT01482312|54504394|FG002|Period 2, 90 Minutes of Wear|Other|0|||
27883771|NCT01461096|54504404|FG000|Overall Study|Death|3|||
27883772|NCT01461096|54504405|FG001|Overall Study|Death|6|||
27883773|NCT01461096|54504404|FG000|Overall Study|Severe debilitation, unable to continue|1|||
27883774|NCT01461096|54504405|FG001|Overall Study|Severe debilitation, unable to continue|1|||
27883775|NCT01461096|54504404|FG000|Overall Study|Subj not able to get to clinic|15|||
27883776|NCT01461096|54504405|FG001|Overall Study|Subj not able to get to clinic|13|||
27883777|NCT01461096|54504404|FG000|Overall Study|Site is closing|27|||
27883778|NCT01461096|54504405|FG001|Overall Study|Site is closing|30|||
27883779|NCT01461096|54504404|FG000|Overall Study|Withdrawal by Subject|5|||
27883780|NCT01461096|54504405|FG001|Overall Study|Withdrawal by Subject|3|||
27883781|NCT01461096|54504404|FG000|Overall Study|Subj not willing to adhere to reqs|3|||
27883782|NCT01461096|54504405|FG001|Overall Study|Subj not willing to adhere to reqs|4|||
27883783|NCT01461096|54504404|FG000|Overall Study|Lost to Follow-up|8|||
27883784|NCT01461096|54504405|FG001|Overall Study|Lost to Follow-up|4|||
27883785|NCT01507896|54504412|FG000|Overall Study|Withdrawal by Subject|1|||
27883786|NCT01507896|54504412|FG000|Overall Study|The surgery was denied by the sponsor.|1|||
27984560|NCT00895895|54643345|FG000|Period 1|Other|1|||
27984561|NCT00895895|54643346|FG001|Period 1|Other|2|||
27984562|NCT00895895|54643347|FG002|Period 1|Other|1|||
27984563|NCT00895895|54643348|FG003|Period 1|Other|1|||
27984564|NCT00895895|54643349|FG004|Period 1|Other|1|||
27984565|NCT00895895|54643345|FG000|Period 1|Protocol Violation|0|||
27984566|NCT00895895|54643346|FG001|Period 1|Protocol Violation|1|||
27984567|NCT00895895|54643347|FG002|Period 1|Protocol Violation|0|||
27984568|NCT00895895|54643348|FG003|Period 1|Protocol Violation|0|||
27984569|NCT00895895|54643349|FG004|Period 1|Protocol Violation|0|||
27984570|NCT00895895|54643345|FG000|Period 1|Withdrawal by Subject|6|||
27984571|NCT00895895|54643346|FG001|Period 1|Withdrawal by Subject|6|||
27984572|NCT00895895|54643347|FG002|Period 1|Withdrawal by Subject|8|||
27984573|NCT00895895|54643348|FG003|Period 1|Withdrawal by Subject|2|||
27984574|NCT00895895|54643349|FG004|Period 1|Withdrawal by Subject|4|||
27984575|NCT00895895|54643345|FG000|Period 1|unsatisfactory response-efficacy|2|||
27984576|NCT00895895|54643346|FG001|Period 1|unsatisfactory response-efficacy|0|||
27984577|NCT00895895|54643347|FG002|Period 1|unsatisfactory response-efficacy|0|||
27984578|NCT00895895|54643348|FG003|Period 1|unsatisfactory response-efficacy|0|||
27984579|NCT00895895|54643349|FG004|Period 1|unsatisfactory response-efficacy|0|||
27984580|NCT00895895|54643345|FG000|Period 1|randomized and not treated|1|||
27984581|NCT00895895|54643346|FG001|Period 1|randomized and not treated|3|||
27883787|NCT01507662|54504427|FG000|Overall Study|Death|26|||
27883788|NCT01507662|54504428|FG001|Overall Study|Death|18|||
27883789|NCT01507662|54504427|FG000|Overall Study|Withdrawal by Subject|290|||
27984582|NCT00895895|54643347|FG002|Period 1|randomized and not treated|1|||
27984583|NCT00895895|54643348|FG003|Period 1|randomized and not treated|1|||
27883790|NCT01507662|54504428|FG001|Overall Study|Withdrawal by Subject|287|||
27883791|NCT01507662|54504427|FG000|Overall Study|Lost to Follow-up|498|||
27883792|NCT01507662|54504428|FG001|Overall Study|Lost to Follow-up|523|||
27984584|NCT00895895|54643349|FG004|Period 1|randomized and not treated|2|||
27984585|NCT00895895|54643345|FG000|After Period 1, Prior to Period 2|Adverse Event|0|||
27984586|NCT00895895|54643346|FG001|After Period 1, Prior to Period 2|Adverse Event|0|||
27883793|NCT01507662|54504427|FG000|Overall Study|Proxy interview done|2|||
27883794|NCT01507662|54504428|FG001|Overall Study|Proxy interview done|3|||
27883795|NCT01506960|54504434|FG000|Overall Study|Did not meet angiographic criteria|47|||
27984587|NCT00895895|54643347|FG002|After Period 1, Prior to Period 2|Adverse Event|1|||
27984588|NCT00895895|54643348|FG003|After Period 1, Prior to Period 2|Adverse Event|0|||
27883796|NCT01480674|54504440|FG000|Overall Study|Death|23|||
27883797|NCT01480674|54504440|FG000|Overall Study|Lost to Follow-up|2|||
27883798|NCT01480674|54504440|FG000|Overall Study|visit not done|10|||
27883799|NCT01506882|54504446|FG000|Overall Study|Lack of Efficacy|4|||
27883800|NCT01506882|54504447|FG001|Overall Study|Lack of Efficacy|3|||
27883801|NCT01506882|54504446|FG000|Overall Study|Lost to Follow-up|1|||
27883802|NCT01506882|54504447|FG001|Overall Study|Lost to Follow-up|0|||
27883803|NCT01506882|54504446|FG000|Overall Study|Withdrawal by Subject|9|||
27883804|NCT01506882|54504447|FG001|Overall Study|Withdrawal by Subject|3|||
27883805|NCT01506882|54504446|FG000|Overall Study|SAE, non-fatal|2|||
27883806|NCT01506882|54504447|FG001|Overall Study|SAE, non-fatal|0|||
27883807|NCT01506882|54504446|FG000|Overall Study|AE, non-serious non-fatal|3|||
27883808|NCT01506882|54504447|FG001|Overall Study|AE, non-serious non-fatal|1|||
27883809|NCT01506882|54504446|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
27883810|NCT01506882|54504447|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
27883811|NCT01506882|54504446|FG000|Overall Study|Other Reason|2|||
27883812|NCT01506882|54504447|FG001|Overall Study|Other Reason|0|||
27883813|NCT01506726|54504457|FG000|Overall Study|Adverse Event|1|||
27883814|NCT01506726|54504458|FG001|Overall Study|Adverse Event|2|||
27883815|NCT01505868|54504469|FG000|Overall Study|Withdrawal by Subject|1|||
27883816|NCT01505868|54504470|FG001|Overall Study|Withdrawal by Subject|0|||
27883817|NCT01505868|54504471|FG002|Overall Study|Withdrawal by Subject|0|||
27883818|NCT01505868|54504472|FG003|Overall Study|Withdrawal by Subject|0|||
27883819|NCT01505868|54504473|FG004|Overall Study|Withdrawal by Subject|0|||
27883820|NCT01505634|54504488|FG000|Overall Study|Withdrawal by Subject|2|||
27883821|NCT01505634|54504489|FG001|Overall Study|Withdrawal by Subject|5|||
27883822|NCT01505634|54504490|FG002|Overall Study|Withdrawal by Subject|1|||
27883823|NCT01505634|54504488|FG000|Overall Study|Physician Decision|1|||
27883824|NCT01505634|54504489|FG001|Overall Study|Physician Decision|1|||
27883825|NCT01505634|54504490|FG002|Overall Study|Physician Decision|0|||
27883826|NCT01505634|54504488|FG000|Overall Study|Adverse Event|1|||
27883827|NCT01505634|54504489|FG001|Overall Study|Adverse Event|0|||
27883828|NCT01505634|54504490|FG002|Overall Study|Adverse Event|0|||
27883829|NCT01505634|54504488|FG000|Overall Study|Insufficient supply of drug at site|1|||
27883830|NCT01505634|54504489|FG001|Overall Study|Insufficient supply of drug at site|0|||
27883831|NCT01505634|54504490|FG002|Overall Study|Insufficient supply of drug at site|0|||
27883832|NCT01505634|54504488|FG000|Overall Study|Protocol Violation|2|||
27883833|NCT01505634|54504489|FG001|Overall Study|Protocol Violation|0|||
27883834|NCT01505634|54504490|FG002|Overall Study|Protocol Violation|0|||
27883835|NCT01505634|54504488|FG000|Overall Study|Lost to Follow-up|1|||
27883836|NCT01505634|54504489|FG001|Overall Study|Lost to Follow-up|4|||
27883837|NCT01505634|54504490|FG002|Overall Study|Lost to Follow-up|4|||
27883838|NCT01505634|54504488|FG000|Overall Study|Death|1|||
27883839|NCT01505634|54504489|FG001|Overall Study|Death|0|||
27883840|NCT01505634|54504490|FG002|Overall Study|Death|0|||
27883841|NCT01505634|54504488|FG000|Overall Study|In a conflict zone|0|||
27883842|NCT01505634|54504489|FG001|Overall Study|In a conflict zone|0|||
27883843|NCT01505634|54504490|FG002|Overall Study|In a conflict zone|1|||
27883844|NCT01460628|54504498|FG000|Overall Study|Adverse Event|3|||
27883845|NCT01460628|54504498|FG000|Overall Study|Withdrawal by Subject|2|||
27883846|NCT01480596|54504504|FG000|Overall Study|Adverse Event|3|||
27883847|NCT01480596|54504505|FG001|Overall Study|Adverse Event|0|||
27883848|NCT01480596|54504504|FG000|Overall Study|MG exacerbation or change in medication|2|||
27883849|NCT01480596|54504505|FG001|Overall Study|MG exacerbation or change in medication|2|||
27883850|NCT01480284|54504513|FG000|Overall Study|Withdrawal by Subject|2|||
27883851|NCT01480284|54504514|FG001|Overall Study|Withdrawal by Subject|0|||
27883852|NCT01480284|54504513|FG000|Overall Study|Adverse Event|1|||
27883853|NCT01480284|54504514|FG001|Overall Study|Adverse Event|0|||
27883854|NCT01480284|54504513|FG000|Overall Study|Study closed/terminated|3|||
27883855|NCT01480284|54504514|FG001|Overall Study|Study closed/terminated|0|||
27883856|NCT01480284|54504513|FG000|Overall Study|Lost to Follow-up|1|||
27883857|NCT01480284|54504514|FG001|Overall Study|Lost to Follow-up|0|||
27883858|NCT01480284|54504513|FG000|Overall Study|Physician Decision|1|||
27883859|NCT01480284|54504514|FG001|Overall Study|Physician Decision|0|||
27883860|NCT01459614|54504522|FG000|Overall Study|Adverse Event|1|||
27883861|NCT01459614|54504523|FG001|Overall Study|Adverse Event|0|||
27883862|NCT01459068|54504531|FG000|Overall Study|Withdrawal by Subject|8|||
27883863|NCT01459068|54504532|FG001|Overall Study|Withdrawal by Subject|18|||
27883864|NCT01459068|54504531|FG000|Overall Study|Lost to Follow-up|31|||
27883865|NCT01459068|54504532|FG001|Overall Study|Lost to Follow-up|15|||
27883866|NCT01459068|54504531|FG000|Overall Study|Death|0|||
27883867|NCT01459068|54504532|FG001|Overall Study|Death|1|||
27883868|NCT01458522|54504540|FG000|Overall Study|Withdrawal by Subject|2|||
27883869|NCT01458522|54504541|FG001|Overall Study|Withdrawal by Subject|2|||
27883870|NCT01458522|54504540|FG000|Overall Study|Physician Decision|1|||
27883871|NCT01458522|54504541|FG001|Overall Study|Physician Decision|9|||
27883872|NCT01505010|54504555|FG000|Overall Study|Protocol Violation|0|||
27883873|NCT01505010|54504556|FG001|Overall Study|Protocol Violation|1|||
27883874|NCT01505010|54504555|FG000|Overall Study|Lost to Follow-up|0|||
27883875|NCT01505010|54504556|FG001|Overall Study|Lost to Follow-up|1|||
27883876|NCT01458366|54504567|FG000|Period 1: 70mg/m^2|Physician Decision|2|||
27883877|NCT01458366|54504568|FG001|Period 1: 70mg/m^2|Physician Decision|0|||
27883878|NCT01458366|54504569|FG002|Period 1: 70mg/m^2|Physician Decision|0|||
27883879|NCT01458366|54504570|FG003|Period 1: 70mg/m^2|Physician Decision|0|||
27883880|NCT01458366|54504571|FG004|Period 1: 70mg/m^2|Physician Decision|0|||
27883881|NCT01458366|54504567|FG000|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
27883882|NCT01458366|54504568|FG001|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
27883883|NCT01458366|54504569|FG002|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
27883884|NCT01458366|54504570|FG003|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
27883885|NCT01458366|54504571|FG004|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1|||
27883886|NCT01458210|54504579|FG000|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2|||
27883887|NCT01458210|54504579|FG000|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2|||
27883888|NCT01458210|54504579|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2|||
27883889|NCT01458210|54504579|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1|||
27883890|NCT01478958|54504589|FG000|Overall Study|Withdrawal by Subject|1|||
27883891|NCT01478958|54504590|FG001|Overall Study|Withdrawal by Subject|1|||
27883892|NCT01478958|54504591|FG002|Overall Study|Withdrawal by Subject|1|||
27883893|NCT01478958|54504589|FG000|Overall Study|Weight loss|1|||
27883894|NCT01478958|54504590|FG001|Overall Study|Weight loss|0|||
27883895|NCT01478958|54504591|FG002|Overall Study|Weight loss|0|||
27883896|NCT01478958|54504589|FG000|Overall Study|Re-located|0|||
27883897|NCT01478958|54504590|FG001|Overall Study|Re-located|1|||
27883898|NCT01478958|54504591|FG002|Overall Study|Re-located|0|||
27883899|NCT01478958|54504589|FG000|Overall Study|Unable to comply|0|||
27883900|NCT01478958|54504590|FG001|Overall Study|Unable to comply|0|||
27883901|NCT01478958|54504591|FG002|Overall Study|Unable to comply|2|||
27883902|NCT01458132|54504601|FG000|Overall Study|Other|15|||
27883903|NCT01458132|54504602|FG001|Overall Study|Other|3|||
27883904|NCT01457352|54504610|FG000|Period 1|Adverse Event|2|||
27883905|NCT01457352|54504611|FG001|Period 1|Adverse Event|0|||
27883906|NCT01457352|54504610|FG000|Period 1|Withdrawal by Subject|2|||
27883907|NCT01457352|54504611|FG001|Period 1|Withdrawal by Subject|0|||
27883908|NCT01457352|54504610|FG000|Period 1|Physician Decision|2|||
27883909|NCT01457352|54504611|FG001|Period 1|Physician Decision|0|||
27883910|NCT01457352|54504610|FG000|Period 1|MS related disease progression|1|||
27883911|NCT01457352|54504611|FG001|Period 1|MS related disease progression|0|||
27883912|NCT01457352|54504610|FG000|Period 1|Withdrawn|1|||
27883913|NCT01457352|54504611|FG001|Period 1|Withdrawn|0|||
27883914|NCT01457352|54504610|FG000|Period 1|withdrew per sponsor|1|||
27883915|NCT01457352|54504611|FG001|Period 1|withdrew per sponsor|0|||
27883916|NCT01457352|54504610|FG000|Period 1|Protocol Violation|4|||
27883917|NCT01457352|54504611|FG001|Period 1|Protocol Violation|0|||
27883918|NCT01457352|54504610|FG000|Period 1|Did not meet eligibility criteria|3|||
27883919|NCT01457352|54504611|FG001|Period 1|Did not meet eligibility criteria|0|||
27883920|NCT01457352|54504610|FG000|Period 2|Withdrawal by Subject|23|||
27883921|NCT01457352|54504611|FG001|Period 2|Withdrawal by Subject|0|||
27883922|NCT01457352|54504610|FG000|Period 2|Adverse Event|22|||
27883923|NCT01457352|54504611|FG001|Period 2|Adverse Event|0|||
27883924|NCT01457352|54504610|FG000|Period 2|no analysis|10|||
27883925|NCT01457352|54504611|FG001|Period 2|no analysis|0|||
27883926|NCT01457352|54504610|FG000|Period 2|Lack of Efficacy|8|||
27883927|NCT01457352|54504611|FG001|Period 2|Lack of Efficacy|0|||
27883928|NCT01457352|54504610|FG000|Period 2|Protocol Violation|4|||
27883929|NCT01457352|54504611|FG001|Period 2|Protocol Violation|0|||
27883930|NCT01457352|54504610|FG000|Period 2|Sponsor's withdrawal|7|||
27883931|NCT01457352|54504611|FG001|Period 2|Sponsor's withdrawal|0|||
27883932|NCT01457352|54504610|FG000|Period 2|Lost to Follow-up|1|||
27883933|NCT01457352|54504611|FG001|Period 2|Lost to Follow-up|0|||
27883934|NCT01457352|54504610|FG000|Period 2|dose change|1|||
27883935|NCT01457352|54504611|FG001|Period 2|dose change|0|||
27883936|NCT01457352|54504610|FG000|Period 2|Physician Decision|1|||
27883937|NCT01457352|54504611|FG001|Period 2|Physician Decision|0|||
27883938|NCT01457352|54504610|FG000|Period 2|Did not meet eligibility criteria|3|||
27883939|NCT01457352|54504611|FG001|Period 2|Did not meet eligibility criteria|0|||
27883940|NCT01457352|54504610|FG000|Period 3|Adverse Event|1|||
27883941|NCT01457352|54504611|FG001|Period 3|Adverse Event|1|||
27883942|NCT01457352|54504610|FG000|Period 3|Withdrawal by Subject|0|||
27883943|NCT01457352|54504611|FG001|Period 3|Withdrawal by Subject|2|||
27883944|NCT01457352|54504610|FG000|Period 3|incorrect treatment|0|||
27984589|NCT00895895|54643349|FG004|After Period 1, Prior to Period 2|Adverse Event|0|||
27883945|NCT01457352|54504611|FG001|Period 3|incorrect treatment|1|||
27883946|NCT01457352|54504610|FG000|Period 3|Sponsor's withdrawal|0|||
27883947|NCT01457352|54504611|FG001|Period 3|Sponsor's withdrawal|1|||
27883948|NCT01457118|54504625|FG000|Overall Study|Adverse Event|1|||
27883949|NCT01457118|54504626|FG001|Overall Study|Adverse Event|0|||
27883950|NCT01457118|54504627|FG002|Overall Study|Adverse Event|0|||
27883951|NCT01457118|54504628|FG003|Overall Study|Adverse Event|1|||
27883952|NCT01457118|54504625|FG000|Overall Study|Clinical Progression|0|||
27883953|NCT01457118|54504626|FG001|Overall Study|Clinical Progression|1|||
27883954|NCT01457118|54504627|FG002|Overall Study|Clinical Progression|0|||
27883955|NCT01457118|54504628|FG003|Overall Study|Clinical Progression|1|||
27883956|NCT01457118|54504625|FG000|Overall Study|Physician Decision|2|||
27883957|NCT01457118|54504626|FG001|Overall Study|Physician Decision|0|||
27883958|NCT01457118|54504627|FG002|Overall Study|Physician Decision|0|||
27883959|NCT01457118|54504628|FG003|Overall Study|Physician Decision|0|||
27883960|NCT01457118|54504625|FG000|Overall Study|Progressive Disease by RECIST|12|||
27883961|NCT01457118|54504626|FG001|Overall Study|Progressive Disease by RECIST|3|||
27883962|NCT01457118|54504627|FG002|Overall Study|Progressive Disease by RECIST|1|||
27883963|NCT01457118|54504628|FG003|Overall Study|Progressive Disease by RECIST|0|||
27883964|NCT01457118|54504625|FG000|Overall Study|Withdrawal by Subject|5|||
27883965|NCT01457118|54504626|FG001|Overall Study|Withdrawal by Subject|0|||
27883966|NCT01457118|54504627|FG002|Overall Study|Withdrawal by Subject|0|||
27883967|NCT01457118|54504628|FG003|Overall Study|Withdrawal by Subject|0|||
27883968|NCT01456962|54504640|FG000|Overall Study|Lost to Follow-up|2|||
27883969|NCT01456962|54504641|FG001|Overall Study|Lost to Follow-up|1|||
27883970|NCT01501110|54504649|FG000|Overall Study|Death|0|||
27883971|NCT01501110|54504650|FG001|Overall Study|Death|1|||
27883972|NCT01500720|54504658|FG000|Overall Study|Randomized But Not Treated|1|||
27883973|NCT01500720|54504659|FG001|Overall Study|Randomized But Not Treated|1|||
27883974|NCT01500720|54504658|FG000|Overall Study|Other|4|||
27883975|NCT01500720|54504659|FG001|Overall Study|Other|8|||
27883976|NCT01500252|54504667|FG000|Overall Study|Death|4|||
27883977|NCT01500252|54504668|FG001|Overall Study|Death|2|||
27883978|NCT01500252|54504667|FG000|Overall Study|Lost to Follow-up|5|||
27883979|NCT01500252|54504668|FG001|Overall Study|Lost to Follow-up|4|||
27883980|NCT01476696|54504675|FG000|Overall Study|Sponsor decision|2|||
27883981|NCT01476696|54504676|FG001|Overall Study|Sponsor decision|1|||
27883982|NCT01476696|54504677|FG002|Overall Study|Sponsor decision|0|||
27883983|NCT01476696|54504675|FG000|Overall Study|Withdrawal by Subject|1|||
27883984|NCT01476696|54504676|FG001|Overall Study|Withdrawal by Subject|0|||
27883985|NCT01476696|54504677|FG002|Overall Study|Withdrawal by Subject|0|||
27883986|NCT01500096|54504694|FG000|Overall Study|Lost to Follow-up|1|||
27883987|NCT01500096|54504695|FG001|Overall Study|Lost to Follow-up|0|||
27883988|NCT01500096|54504696|FG002|Overall Study|Lost to Follow-up|0|||
27883989|NCT01500096|54504697|FG003|Overall Study|Lost to Follow-up|2|||
27883990|NCT01455012|54504709|FG000|Overall Study|Adverse Event|0|||
27883991|NCT01455012|54504710|FG001|Overall Study|Adverse Event|2|||
27883992|NCT01455012|54504709|FG000|Overall Study|Lack of Efficacy|6|||
27883993|NCT01455012|54504710|FG001|Overall Study|Lack of Efficacy|1|||
27883994|NCT01455012|54504709|FG000|Overall Study|Withdrawal by Subject|3|||
27883995|NCT01455012|54504710|FG001|Overall Study|Withdrawal by Subject|1|||
27883996|NCT01455012|54504709|FG000|Overall Study|Unknown reason|2|||
27883997|NCT01455012|54504710|FG001|Overall Study|Unknown reason|0|||
27883998|NCT01454778|54504716|FG000|Overall Study|Lost to Follow-up|2|||
27883999|NCT01454778|54504716|FG000|Overall Study|Death|1|||
27884000|NCT01454076|54504725|FG000|Overall Study|Other|2|||
27884001|NCT01454076|54504726|FG001|Overall Study|Other|0|||
27884002|NCT01454076|54504727|FG002|Overall Study|Other|0|||
27884003|NCT01454076|54504728|FG003|Overall Study|Other|1|||
27884004|NCT01454076|54504729|FG004|Overall Study|Other|2|||
27884005|NCT01454076|54504725|FG000|Overall Study|Withdrawal by Subject|3|||
27884006|NCT01454076|54504726|FG001|Overall Study|Withdrawal by Subject|4|||
27884007|NCT01454076|54504727|FG002|Overall Study|Withdrawal by Subject|2|||
27884008|NCT01454076|54504728|FG003|Overall Study|Withdrawal by Subject|1|||
27884009|NCT01454076|54504729|FG004|Overall Study|Withdrawal by Subject|2|||
27884010|NCT01454076|54504725|FG000|Overall Study|Adverse Event|8|||
27884011|NCT01454076|54504726|FG001|Overall Study|Adverse Event|2|||
27884012|NCT01454076|54504727|FG002|Overall Study|Adverse Event|7|||
27884013|NCT01454076|54504728|FG003|Overall Study|Adverse Event|0|||
27884014|NCT01454076|54504729|FG004|Overall Study|Adverse Event|2|||
27884015|NCT01453998|54504753|FG000|After Protocol Amendment 2.|Withdrawal by Subject|1|||
27984590|NCT00895895|54643345|FG000|After Period 1, Prior to Period 2|Other|0|||
27984591|NCT00895895|54643346|FG001|After Period 1, Prior to Period 2|Other|0|||
27984592|NCT00895895|54643347|FG002|After Period 1, Prior to Period 2|Other|1|||
27884016|NCT01453998|54504754|FG001|After Protocol Amendment 2.|Withdrawal by Subject|0|||
27884017|NCT01453998|54504755|FG002|After Protocol Amendment 2.|Withdrawal by Subject|0|||
27884018|NCT01453374|54504766|FG000|Overall Study|Adverse Event|7|||
27884019|NCT01453374|54504766|FG000|Overall Study|Lack of Efficacy|1|||
27884020|NCT01453374|54504766|FG000|Overall Study|Lost to Follow-up|3|||
27884021|NCT01453374|54504766|FG000|Overall Study|Withdrawal by Subject|5|||
27884022|NCT01453374|54504766|FG000|Overall Study|Incarcerated|2|||
27884023|NCT01453296|54504772|FG000|Treatment Period 1|Adverse Event|0|||
27884024|NCT01453296|54504773|FG001|Treatment Period 1|Adverse Event|1|||
27884025|NCT01453296|54504772|FG000|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1|||
27884026|NCT01453296|54504773|FG001|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0|||
27884027|NCT01453296|54504772|FG000|Treatment Period 2|Adverse Event|1|||
27884028|NCT01453296|54504773|FG001|Treatment Period 2|Adverse Event|0|||
27884029|NCT01453296|54504772|FG000|Treatment Period 2|Withdrawal by Subject|1|||
27884030|NCT01453296|54504773|FG001|Treatment Period 2|Withdrawal by Subject|0|||
27884031|NCT01453140|54504779|FG000|Overall Study|Adverse Event|3|||
27884032|NCT01499940|54504787|FG000|Overall Study|Study was withdrawn before completion.|9|||
27884033|NCT01499160|54504791|FG000|Overall Study|Adverse Event|1|||
27884034|NCT01499160|54504791|FG000|Overall Study|Withdrawal by Subject|1|||
27884035|NCT01498692|54504796|FG000|Overall Study|Death|4|||
27884036|NCT01498692|54504796|FG000|Overall Study|Withdrawal by Subject|1|||
27884037|NCT01498692|54504796|FG000|Overall Study|Missed 12-month visit|3|||
27884038|NCT01498068|54504802|FG000|Overall Study|Withdrawal by Subject|1|||
27884039|NCT01498068|54504803|FG001|Overall Study|Withdrawal by Subject|1|||
27884040|NCT01497366|54504811|FG000|Overall Study|Virologic failure|2|||
27884041|NCT01497366|54504812|FG001|Overall Study|Virologic failure|50|||
27884042|NCT01497366|54504811|FG000|Overall Study|Lost to Follow-up|11|||
27884043|NCT01497366|54504812|FG001|Overall Study|Lost to Follow-up|10|||
27884044|NCT01497366|54504811|FG000|Overall Study|Withdrawal by Subject|6|||
27884045|NCT01497366|54504812|FG001|Overall Study|Withdrawal by Subject|6|||
27884046|NCT01497366|54504811|FG000|Overall Study|Initiated Non-protocol HCV Treatment|7|||
27884047|NCT01497366|54504812|FG001|Overall Study|Initiated Non-protocol HCV Treatment|0|||
27884048|NCT01497366|54504811|FG000|Overall Study|Other|5|||
27884049|NCT01497366|54504812|FG001|Overall Study|Other|0|||
27884050|NCT01497366|54504811|FG000|Overall Study|Death|1|||
27884051|NCT01497366|54504812|FG001|Overall Study|Death|1|||
27884052|NCT01497366|54504811|FG000|Overall Study|Randomized but not treated|7|||
27884053|NCT01497366|54504812|FG001|Overall Study|Randomized but not treated|21|||
27884054|NCT01475838|54504821|FG000|Randomized Phase|Randomized but Not Treated|0|||
27884055|NCT01475838|54504822|FG001|Randomized Phase|Randomized but Not Treated|5|||
27884056|NCT01475838|54504821|FG000|Randomized Phase|Adverse Event|6|||
27884057|NCT01475838|54504822|FG001|Randomized Phase|Adverse Event|1|||
27884058|NCT01475838|54504821|FG000|Randomized Phase|Pregnancy|0|||
27884059|NCT01475838|54504822|FG001|Randomized Phase|Pregnancy|1|||
27884060|NCT01475838|54504821|FG000|Randomized Phase|Investigators Discretion|1|||
27884061|NCT01475838|54504822|FG001|Randomized Phase|Investigators Discretion|2|||
27884062|NCT01475838|54504821|FG000|Randomized Phase|Withdrew Consent|10|||
27884063|NCT01475838|54504822|FG001|Randomized Phase|Withdrew Consent|14|||
27884064|NCT01475838|54504821|FG000|Randomized Phase|Lost to Follow-up|3|||
27884065|NCT01475838|54504822|FG001|Randomized Phase|Lost to Follow-up|4|||
27884066|NCT01475838|54504821|FG000|Randomized Phase|Participant Noncompliance|1|||
27884067|NCT01475838|54504822|FG001|Randomized Phase|Participant Noncompliance|5|||
27884068|NCT01475838|54504821|FG000|Randomized Phase|Protocol Violation|9|||
27884069|NCT01475838|54504822|FG001|Randomized Phase|Protocol Violation|4|||
27884070|NCT01475838|54504821|FG000|Extension Phase|Participant Noncompliance|1|||
27884071|NCT01475838|54504822|FG001|Extension Phase|Participant Noncompliance|0|||
27884072|NCT01451814|54504831|FG000|Overall Study|Withdrawal by Subject|1|||
27884073|NCT01451814|54504832|FG001|Overall Study|Withdrawal by Subject|1|||
27884074|NCT01451814|54504831|FG000|Overall Study|Lost to Follow-up|5|||
27884075|NCT01451814|54504832|FG001|Overall Study|Lost to Follow-up|4|||
27884076|NCT01475370|54504841|FG000|Overall Study|Exacerbation of primary disease|2|||
27884077|NCT01475370|54504842|FG001|Overall Study|Exacerbation of primary disease|2|||
27884078|NCT01475370|54504843|FG002|Overall Study|Exacerbation of primary disease|2|||
27884079|NCT01475370|54504841|FG000|Overall Study|Study drug administration difficult|0|||
27884080|NCT01475370|54504842|FG001|Overall Study|Study drug administration difficult|1|||
27884081|NCT01475370|54504843|FG002|Overall Study|Study drug administration difficult|1|||
27884082|NCT01475370|54504841|FG000|Overall Study|Other than specified|1|||
27884083|NCT01475370|54504842|FG001|Overall Study|Other than specified|0|||
27884084|NCT01475370|54504843|FG002|Overall Study|Other than specified|0|||
27884085|NCT01496430|54504854|FG000|Overall Study|Adverse Event|0|||
27884086|NCT01496430|54504855|FG001|Overall Study|Adverse Event|0|||
27884087|NCT01496430|54504856|FG002|Overall Study|Adverse Event|1|||
27884088|NCT01496430|54504854|FG000|Overall Study|Major Protocol Deviation|0|||
27884089|NCT01496430|54504855|FG001|Overall Study|Major Protocol Deviation|0|||
27884090|NCT01496430|54504856|FG002|Overall Study|Major Protocol Deviation|1|||
27884091|NCT01496430|54504854|FG000|Overall Study|Lost to Follow-up|2|||
27884092|NCT01496430|54504855|FG001|Overall Study|Lost to Follow-up|3|||
27884093|NCT01496430|54504856|FG002|Overall Study|Lost to Follow-up|1|||
27884094|NCT01496430|54504854|FG000|Overall Study|Voluntary Withdrawal|2|||
27884095|NCT01496430|54504855|FG001|Overall Study|Voluntary Withdrawal|1|||
27884096|NCT01496430|54504856|FG002|Overall Study|Voluntary Withdrawal|6|||
27884097|NCT01496430|54504854|FG000|Overall Study|Principal Investigator Discretion|0|||
27884098|NCT01496430|54504855|FG001|Overall Study|Principal Investigator Discretion|1|||
27884099|NCT01496430|54504856|FG002|Overall Study|Principal Investigator Discretion|1|||
27884100|NCT01496430|54504854|FG000|Overall Study|Other|2|||
27884101|NCT01496430|54504855|FG001|Overall Study|Other|0|||
27884102|NCT01496430|54504856|FG002|Overall Study|Other|0|||
27884103|NCT01451424|54504868|FG000|Overall Study|Withdrawal by Subject|1|||
27884104|NCT01451424|54504869|FG001|Overall Study|Withdrawal by Subject|1|||
27884105|NCT01451424|54504870|FG002|Overall Study|Withdrawal by Subject|0|||
27884106|NCT01451424|54504871|FG003|Overall Study|Withdrawal by Subject|2|||
27884107|NCT01451424|54504868|FG000|Overall Study|Lost to Follow-up|0|||
27884108|NCT01451424|54504869|FG001|Overall Study|Lost to Follow-up|1|||
27884109|NCT01451424|54504870|FG002|Overall Study|Lost to Follow-up|0|||
27884110|NCT01451424|54504871|FG003|Overall Study|Lost to Follow-up|1|||
27884111|NCT01451424|54504868|FG000|Overall Study|Physician Decision|0|||
27884112|NCT01451424|54504869|FG001|Overall Study|Physician Decision|0|||
27884113|NCT01451424|54504870|FG002|Overall Study|Physician Decision|1|||
27884114|NCT01451424|54504871|FG003|Overall Study|Physician Decision|1|||
27884115|NCT01451424|54504868|FG000|Overall Study|Adverse Event|0|||
27884116|NCT01451424|54504869|FG001|Overall Study|Adverse Event|0|||
27884117|NCT01451424|54504870|FG002|Overall Study|Adverse Event|0|||
27884118|NCT01451424|54504871|FG003|Overall Study|Adverse Event|1|||
27884119|NCT01475214|54504889|FG000|Overall Study|Lost to Follow-up|1|||
27884120|NCT01475214|54504890|FG001|Overall Study|Lost to Follow-up|0|||
27884121|NCT01475214|54504891|FG002|Overall Study|Lost to Follow-up|1|||
27884122|NCT01475214|54504889|FG000|Overall Study|Physician Decision|2|||
27884123|NCT01475214|54504890|FG001|Overall Study|Physician Decision|0|||
27884124|NCT01475214|54504891|FG002|Overall Study|Physician Decision|0|||
27884125|NCT01475214|54504889|FG000|Overall Study|Withdrawal by Subject|2|||
27884126|NCT01475214|54504890|FG001|Overall Study|Withdrawal by Subject|4|||
27884127|NCT01475214|54504891|FG002|Overall Study|Withdrawal by Subject|1|||
27884128|NCT01496274|54504902|FG000|Overall Study|Protocol Violation|0|||
27884129|NCT01496274|54504903|FG001|Overall Study|Protocol Violation|1|||
27884130|NCT01496274|54504902|FG000|Overall Study|Adverse Event|1|||
27884131|NCT01496274|54504903|FG001|Overall Study|Adverse Event|1|||
27884132|NCT01496274|54504902|FG000|Overall Study|Withdrawal by Subject|2|||
27884133|NCT01496274|54504903|FG001|Overall Study|Withdrawal by Subject|0|||
27884134|NCT01496274|54504902|FG000|Overall Study|Lost to Follow-up|0|||
27884135|NCT01496274|54504903|FG001|Overall Study|Lost to Follow-up|3|||
27884136|NCT01475136|54504928|FG000|Overall Study|Sponsor Decision|0|||
27884137|NCT01475136|54504929|FG001|Overall Study|Sponsor Decision|1|||
27884138|NCT01475136|54504930|FG002|Overall Study|Sponsor Decision|0|||
27884139|NCT01475136|54504931|FG003|Overall Study|Sponsor Decision|0|||
27884140|NCT01475136|54504928|FG000|Overall Study|Entry Criteria Not Met|0|||
27884141|NCT01475136|54504929|FG001|Overall Study|Entry Criteria Not Met|2|||
27884142|NCT01475136|54504930|FG002|Overall Study|Entry Criteria Not Met|3|||
27884143|NCT01475136|54504931|FG003|Overall Study|Entry Criteria Not Met|1|||
27884144|NCT01475136|54504928|FG000|Overall Study|Withdrawal by Subject|0|||
27884145|NCT01475136|54504929|FG001|Overall Study|Withdrawal by Subject|0|||
27884146|NCT01475136|54504930|FG002|Overall Study|Withdrawal by Subject|0|||
27884147|NCT01475136|54504931|FG003|Overall Study|Withdrawal by Subject|2|||
27884148|NCT01475136|54504928|FG000|Overall Study|Adverse Event|1|||
27884149|NCT01475136|54504929|FG001|Overall Study|Adverse Event|0|||
27884150|NCT01475136|54504930|FG002|Overall Study|Adverse Event|0|||
27884151|NCT01475136|54504931|FG003|Overall Study|Adverse Event|1|||
27884152|NCT01475136|54504928|FG000|Overall Study|Death|0|||
27884153|NCT01475136|54504929|FG001|Overall Study|Death|0|||
27884154|NCT01475136|54504930|FG002|Overall Study|Death|0|||
27884155|NCT01475136|54504931|FG003|Overall Study|Death|1|||
27884156|NCT01474746|54504943|FG000|Overall Study|Lost to Follow-up|1|||
27884157|NCT01474746|54504944|FG001|Overall Study|Lost to Follow-up|1|||
27884158|NCT01474746|54504943|FG000|Overall Study|Withdrawal by Subject|2|||
27884159|NCT01474746|54504944|FG001|Overall Study|Withdrawal by Subject|1|||
27884160|NCT01450800|54504952|FG000|Overall Study|Protocol Violation|1|||
27884161|NCT01450800|54504953|FG001|Overall Study|Protocol Violation|3|||
27884162|NCT01474512|54504964|FG000|Induction Period|Adverse Event|6|||
27884163|NCT01474512|54504965|FG001|Induction Period|Adverse Event|10|||
27884164|NCT01474512|54504966|FG002|Induction Period|Adverse Event|10|||
27884165|NCT01474512|54504967|FG003|Induction Period|Adverse Event|0|||
27884166|NCT01474512|54504968|FG004|Induction Period|Adverse Event|0|||
27884167|NCT01474512|54504969|FG005|Induction Period|Adverse Event|0|||
27884168|NCT01474512|54504970|FG006|Induction Period|Adverse Event|0|||
27884169|NCT01474512|54504971|FG007|Induction Period|Adverse Event|0|||
27884170|NCT01474512|54504972|FG008|Induction Period|Adverse Event|0|||
27884171|NCT01474512|54504973|FG009|Induction Period|Adverse Event|0|||
27884172|NCT01474512|54504974|FG010|Induction Period|Adverse Event|0|||
27884173|NCT01474512|54504975|FG011|Induction Period|Adverse Event|0|||
27884174|NCT01474512|54504976|FG012|Induction Period|Adverse Event|0|||
27884175|NCT01474512|54504977|FG013|Induction Period|Adverse Event|0|||
27884176|NCT01474512|54504978|FG014|Induction Period|Adverse Event|0|||
27884177|NCT01474512|54504979|FG015|Induction Period|Adverse Event|0|||
27884178|NCT01474512|54504980|FG016|Induction Period|Adverse Event|0|||
27884179|NCT01474512|54504981|FG017|Induction Period|Adverse Event|0|||
27884180|NCT01474512|54504964|FG000|Induction Period|Lack of Efficacy|7|||
27884181|NCT01474512|54504965|FG001|Induction Period|Lack of Efficacy|1|||
27884182|NCT01474512|54504966|FG002|Induction Period|Lack of Efficacy|0|||
27884183|NCT01474512|54504967|FG003|Induction Period|Lack of Efficacy|0|||
27884184|NCT01474512|54504968|FG004|Induction Period|Lack of Efficacy|0|||
27884185|NCT01474512|54504969|FG005|Induction Period|Lack of Efficacy|0|||
27884186|NCT01474512|54504970|FG006|Induction Period|Lack of Efficacy|0|||
27884187|NCT01474512|54504971|FG007|Induction Period|Lack of Efficacy|0|||
27884188|NCT01474512|54504972|FG008|Induction Period|Lack of Efficacy|0|||
27884189|NCT01474512|54504973|FG009|Induction Period|Lack of Efficacy|0|||
27884190|NCT01474512|54504974|FG010|Induction Period|Lack of Efficacy|0|||
27884191|NCT01474512|54504975|FG011|Induction Period|Lack of Efficacy|0|||
27884192|NCT01474512|54504976|FG012|Induction Period|Lack of Efficacy|0|||
27884193|NCT01474512|54504977|FG013|Induction Period|Lack of Efficacy|0|||
27884194|NCT01474512|54504978|FG014|Induction Period|Lack of Efficacy|0|||
27884195|NCT01474512|54504979|FG015|Induction Period|Lack of Efficacy|0|||
27884196|NCT01474512|54504980|FG016|Induction Period|Lack of Efficacy|0|||
27884197|NCT01474512|54504981|FG017|Induction Period|Lack of Efficacy|0|||
27884198|NCT01474512|54504964|FG000|Induction Period|Withdrawal by Subject|6|||
27884199|NCT01474512|54504965|FG001|Induction Period|Withdrawal by Subject|6|||
27884200|NCT01474512|54504966|FG002|Induction Period|Withdrawal by Subject|5|||
27884201|NCT01474512|54504967|FG003|Induction Period|Withdrawal by Subject|0|||
27884202|NCT01474512|54504968|FG004|Induction Period|Withdrawal by Subject|0|||
27884203|NCT01474512|54504969|FG005|Induction Period|Withdrawal by Subject|0|||
27884204|NCT01474512|54504970|FG006|Induction Period|Withdrawal by Subject|0|||
27884205|NCT01474512|54504971|FG007|Induction Period|Withdrawal by Subject|0|||
27884206|NCT01474512|54504972|FG008|Induction Period|Withdrawal by Subject|0|||
27884207|NCT01474512|54504973|FG009|Induction Period|Withdrawal by Subject|0|||
27884208|NCT01474512|54504974|FG010|Induction Period|Withdrawal by Subject|0|||
27884209|NCT01474512|54504975|FG011|Induction Period|Withdrawal by Subject|0|||
27884210|NCT01474512|54504976|FG012|Induction Period|Withdrawal by Subject|0|||
27884211|NCT01474512|54504977|FG013|Induction Period|Withdrawal by Subject|0|||
27884212|NCT01474512|54504978|FG014|Induction Period|Withdrawal by Subject|0|||
27884213|NCT01474512|54504979|FG015|Induction Period|Withdrawal by Subject|0|||
27884214|NCT01474512|54504980|FG016|Induction Period|Withdrawal by Subject|0|||
27884215|NCT01474512|54504981|FG017|Induction Period|Withdrawal by Subject|0|||
27884216|NCT01474512|54504964|FG000|Induction Period|Protocol Violation|3|||
27884217|NCT01474512|54504965|FG001|Induction Period|Protocol Violation|6|||
27884218|NCT01474512|54504966|FG002|Induction Period|Protocol Violation|0|||
27884219|NCT01474512|54504967|FG003|Induction Period|Protocol Violation|0|||
27884220|NCT01474512|54504968|FG004|Induction Period|Protocol Violation|0|||
27884221|NCT01474512|54504969|FG005|Induction Period|Protocol Violation|0|||
27884222|NCT01474512|54504970|FG006|Induction Period|Protocol Violation|0|||
27884223|NCT01474512|54504971|FG007|Induction Period|Protocol Violation|0|||
27884224|NCT01474512|54504972|FG008|Induction Period|Protocol Violation|0|||
27884225|NCT01474512|54504973|FG009|Induction Period|Protocol Violation|0|||
27884226|NCT01474512|54504974|FG010|Induction Period|Protocol Violation|0|||
27884227|NCT01474512|54504975|FG011|Induction Period|Protocol Violation|0|||
27884228|NCT01474512|54504976|FG012|Induction Period|Protocol Violation|0|||
27884229|NCT01474512|54504977|FG013|Induction Period|Protocol Violation|0|||
27984593|NCT00895895|54643348|FG003|After Period 1, Prior to Period 2|Other|0|||
27984594|NCT00895895|54643349|FG004|After Period 1, Prior to Period 2|Other|0|||
27984595|NCT00895895|54643345|FG000|After Period 1, Prior to Period 2|Protocol Violation|0|||
27984596|NCT00895895|54643346|FG001|After Period 1, Prior to Period 2|Protocol Violation|0|||
27984597|NCT00895895|54643347|FG002|After Period 1, Prior to Period 2|Protocol Violation|0|||
27984598|NCT00895895|54643348|FG003|After Period 1, Prior to Period 2|Protocol Violation|0|||
27984599|NCT00895895|54643349|FG004|After Period 1, Prior to Period 2|Protocol Violation|1|||
27984600|NCT00895895|54643345|FG000|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
27984601|NCT00895895|54643346|FG001|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
27984602|NCT00895895|54643347|FG002|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
27984603|NCT00895895|54643348|FG003|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
27984604|NCT00895895|54643349|FG004|After Period 1, Prior to Period 2|Withdrawal by Subject|1|||
27984605|NCT00895895|54643345|FG000|Period 2|Adverse Event|3|||
27984606|NCT00895895|54643346|FG001|Period 2|Adverse Event|3|||
27984607|NCT00895895|54643347|FG002|Period 2|Adverse Event|5|||
27984608|NCT00895895|54643348|FG003|Period 2|Adverse Event|2|||
27984609|NCT00895895|54643349|FG004|Period 2|Adverse Event|5|||
27984610|NCT00895895|54643345|FG000|Period 2|Death|0|||
27984611|NCT00895895|54643346|FG001|Period 2|Death|0|||
27984612|NCT00895895|54643347|FG002|Period 2|Death|1|||
27984613|NCT00895895|54643348|FG003|Period 2|Death|0|||
27984614|NCT00895895|54643349|FG004|Period 2|Death|0|||
27884230|NCT01474512|54504978|FG014|Induction Period|Protocol Violation|0|||
27884231|NCT01474512|54504979|FG015|Induction Period|Protocol Violation|0|||
27884232|NCT01474512|54504980|FG016|Induction Period|Protocol Violation|0|||
27984615|NCT00895895|54643345|FG000|Period 2|discontinued by sponsor|44|||
27884233|NCT01474512|54504981|FG017|Induction Period|Protocol Violation|0|||
27884234|NCT01474512|54504964|FG000|Induction Period|Sponsor Decision|1|||
27884235|NCT01474512|54504965|FG001|Induction Period|Sponsor Decision|1|||
27884236|NCT01474512|54504966|FG002|Induction Period|Sponsor Decision|1|||
27884237|NCT01474512|54504967|FG003|Induction Period|Sponsor Decision|0|||
27884238|NCT01474512|54504968|FG004|Induction Period|Sponsor Decision|0|||
27884239|NCT01474512|54504969|FG005|Induction Period|Sponsor Decision|0|||
27884240|NCT01474512|54504970|FG006|Induction Period|Sponsor Decision|0|||
27884241|NCT01474512|54504971|FG007|Induction Period|Sponsor Decision|0|||
27884242|NCT01474512|54504972|FG008|Induction Period|Sponsor Decision|0|||
27884243|NCT01474512|54504973|FG009|Induction Period|Sponsor Decision|0|||
27884244|NCT01474512|54504974|FG010|Induction Period|Sponsor Decision|0|||
27884245|NCT01474512|54504975|FG011|Induction Period|Sponsor Decision|0|||
27884246|NCT01474512|54504976|FG012|Induction Period|Sponsor Decision|0|||
27884247|NCT01474512|54504977|FG013|Induction Period|Sponsor Decision|0|||
27884248|NCT01474512|54504978|FG014|Induction Period|Sponsor Decision|0|||
27884249|NCT01474512|54504979|FG015|Induction Period|Sponsor Decision|0|||
27884250|NCT01474512|54504980|FG016|Induction Period|Sponsor Decision|0|||
27884251|NCT01474512|54504981|FG017|Induction Period|Sponsor Decision|0|||
27884252|NCT01474512|54504964|FG000|Induction Period|Lost to Follow-up|1|||
27884253|NCT01474512|54504965|FG001|Induction Period|Lost to Follow-up|0|||
27884254|NCT01474512|54504966|FG002|Induction Period|Lost to Follow-up|2|||
27884255|NCT01474512|54504967|FG003|Induction Period|Lost to Follow-up|0|||
27884256|NCT01474512|54504968|FG004|Induction Period|Lost to Follow-up|0|||
27884257|NCT01474512|54504969|FG005|Induction Period|Lost to Follow-up|0|||
27884258|NCT01474512|54504970|FG006|Induction Period|Lost to Follow-up|0|||
27884259|NCT01474512|54504971|FG007|Induction Period|Lost to Follow-up|0|||
27884260|NCT01474512|54504972|FG008|Induction Period|Lost to Follow-up|0|||
27884261|NCT01474512|54504973|FG009|Induction Period|Lost to Follow-up|0|||
27884262|NCT01474512|54504974|FG010|Induction Period|Lost to Follow-up|0|||
27884263|NCT01474512|54504975|FG011|Induction Period|Lost to Follow-up|0|||
27884264|NCT01474512|54504976|FG012|Induction Period|Lost to Follow-up|0|||
27884265|NCT01474512|54504977|FG013|Induction Period|Lost to Follow-up|0|||
27884266|NCT01474512|54504978|FG014|Induction Period|Lost to Follow-up|0|||
27884267|NCT01474512|54504979|FG015|Induction Period|Lost to Follow-up|0|||
27884268|NCT01474512|54504980|FG016|Induction Period|Lost to Follow-up|0|||
27884269|NCT01474512|54504981|FG017|Induction Period|Lost to Follow-up|0|||
27884270|NCT01474512|54504964|FG000|Maintenance Period|Relapsed (sPGA ≥3)|0|||
27884271|NCT01474512|54504965|FG001|Maintenance Period|Relapsed (sPGA ≥3)|0|||
27884272|NCT01474512|54504966|FG002|Maintenance Period|Relapsed (sPGA ≥3)|0|||
27884273|NCT01474512|54504967|FG003|Maintenance Period|Relapsed (sPGA ≥3)|186|||
27884274|NCT01474512|54504968|FG004|Maintenance Period|Relapsed (sPGA ≥3)|111|||
27884275|NCT01474512|54504969|FG005|Maintenance Period|Relapsed (sPGA ≥3)|39|||
27884276|NCT01474512|54504970|FG006|Maintenance Period|Relapsed (sPGA ≥3)|9|||
27884277|NCT01474512|54504971|FG007|Maintenance Period|Relapsed (sPGA ≥3)|0|||
27884278|NCT01474512|54504972|FG008|Maintenance Period|Relapsed (sPGA ≥3)|0|||
27884279|NCT01474512|54504973|FG009|Maintenance Period|Relapsed (sPGA ≥3)|0|||
27884280|NCT01474512|54504974|FG010|Maintenance Period|Relapsed (sPGA ≥3)|0|||
27884281|NCT01474512|54504975|FG011|Maintenance Period|Relapsed (sPGA ≥3)|0|||
27884282|NCT01474512|54504976|FG012|Maintenance Period|Relapsed (sPGA ≥3)|0|||
27884283|NCT01474512|54504977|FG013|Maintenance Period|Relapsed (sPGA ≥3)|0|||
27884284|NCT01474512|54504978|FG014|Maintenance Period|Relapsed (sPGA ≥3)|0|||
27884285|NCT01474512|54504979|FG015|Maintenance Period|Relapsed (sPGA ≥3)|0|||
27884286|NCT01474512|54504980|FG016|Maintenance Period|Relapsed (sPGA ≥3)|0|||
27884287|NCT01474512|54504981|FG017|Maintenance Period|Relapsed (sPGA ≥3)|0|||
27884288|NCT01474512|54504964|FG000|Maintenance Period|Adverse Event|0|||
27884289|NCT01474512|54504965|FG001|Maintenance Period|Adverse Event|0|||
27884290|NCT01474512|54504966|FG002|Maintenance Period|Adverse Event|0|||
27884291|NCT01474512|54504967|FG003|Maintenance Period|Adverse Event|4|||
27884292|NCT01474512|54504968|FG004|Maintenance Period|Adverse Event|2|||
27884293|NCT01474512|54504969|FG005|Maintenance Period|Adverse Event|7|||
27884294|NCT01474512|54504970|FG006|Maintenance Period|Adverse Event|0|||
27884295|NCT01474512|54504971|FG007|Maintenance Period|Adverse Event|19|||
27884296|NCT01474512|54504972|FG008|Maintenance Period|Adverse Event|1|||
27884297|NCT01474512|54504973|FG009|Maintenance Period|Adverse Event|3|||
27884298|NCT01474512|54504974|FG010|Maintenance Period|Adverse Event|0|||
27884299|NCT01474512|54504975|FG011|Maintenance Period|Adverse Event|0|||
27884300|NCT01474512|54504976|FG012|Maintenance Period|Adverse Event|0|||
27984616|NCT00895895|54643346|FG001|Period 2|discontinued by sponsor|44|||
27984617|NCT00895895|54643347|FG002|Period 2|discontinued by sponsor|38|||
27884301|NCT01474512|54504977|FG013|Maintenance Period|Adverse Event|0|||
27884302|NCT01474512|54504978|FG014|Maintenance Period|Adverse Event|0|||
27884303|NCT01474512|54504979|FG015|Maintenance Period|Adverse Event|0|||
27884304|NCT01474512|54504980|FG016|Maintenance Period|Adverse Event|0|||
27984618|NCT00895895|54643348|FG003|Period 2|discontinued by sponsor|46|||
27984619|NCT00895895|54643349|FG004|Period 2|discontinued by sponsor|37|||
27884305|NCT01474512|54504981|FG017|Maintenance Period|Adverse Event|0|||
27884306|NCT01474512|54504964|FG000|Maintenance Period|Withdrawal by Subject|0|||
27884307|NCT01474512|54504965|FG001|Maintenance Period|Withdrawal by Subject|0|||
27884308|NCT01474512|54504966|FG002|Maintenance Period|Withdrawal by Subject|0|||
27884309|NCT01474512|54504967|FG003|Maintenance Period|Withdrawal by Subject|6|||
27884310|NCT01474512|54504968|FG004|Maintenance Period|Withdrawal by Subject|2|||
27884311|NCT01474512|54504969|FG005|Maintenance Period|Withdrawal by Subject|3|||
27884312|NCT01474512|54504970|FG006|Maintenance Period|Withdrawal by Subject|1|||
27884313|NCT01474512|54504971|FG007|Maintenance Period|Withdrawal by Subject|6|||
27884314|NCT01474512|54504972|FG008|Maintenance Period|Withdrawal by Subject|3|||
27884315|NCT01474512|54504973|FG009|Maintenance Period|Withdrawal by Subject|1|||
27884316|NCT01474512|54504974|FG010|Maintenance Period|Withdrawal by Subject|0|||
27884317|NCT01474512|54504975|FG011|Maintenance Period|Withdrawal by Subject|0|||
27884318|NCT01474512|54504976|FG012|Maintenance Period|Withdrawal by Subject|0|||
27884319|NCT01474512|54504977|FG013|Maintenance Period|Withdrawal by Subject|0|||
27884320|NCT01474512|54504978|FG014|Maintenance Period|Withdrawal by Subject|0|||
27884321|NCT01474512|54504979|FG015|Maintenance Period|Withdrawal by Subject|0|||
27884322|NCT01474512|54504980|FG016|Maintenance Period|Withdrawal by Subject|0|||
27884323|NCT01474512|54504981|FG017|Maintenance Period|Withdrawal by Subject|0|||
27884324|NCT01474512|54504964|FG000|Maintenance Period|Lost to Follow-up|0|||
27884325|NCT01474512|54504965|FG001|Maintenance Period|Lost to Follow-up|0|||
27884326|NCT01474512|54504966|FG002|Maintenance Period|Lost to Follow-up|0|||
27884327|NCT01474512|54504967|FG003|Maintenance Period|Lost to Follow-up|3|||
27884328|NCT01474512|54504968|FG004|Maintenance Period|Lost to Follow-up|3|||
27884329|NCT01474512|54504969|FG005|Maintenance Period|Lost to Follow-up|0|||
27884330|NCT01474512|54504970|FG006|Maintenance Period|Lost to Follow-up|0|||
27884331|NCT01474512|54504971|FG007|Maintenance Period|Lost to Follow-up|2|||
27884332|NCT01474512|54504972|FG008|Maintenance Period|Lost to Follow-up|1|||
27884333|NCT01474512|54504973|FG009|Maintenance Period|Lost to Follow-up|1|||
27884334|NCT01474512|54504974|FG010|Maintenance Period|Lost to Follow-up|0|||
27884335|NCT01474512|54504975|FG011|Maintenance Period|Lost to Follow-up|0|||
27884336|NCT01474512|54504976|FG012|Maintenance Period|Lost to Follow-up|0|||
27884337|NCT01474512|54504977|FG013|Maintenance Period|Lost to Follow-up|0|||
27884338|NCT01474512|54504978|FG014|Maintenance Period|Lost to Follow-up|0|||
27884339|NCT01474512|54504979|FG015|Maintenance Period|Lost to Follow-up|0|||
27884340|NCT01474512|54504980|FG016|Maintenance Period|Lost to Follow-up|0|||
27884341|NCT01474512|54504981|FG017|Maintenance Period|Lost to Follow-up|0|||
27884342|NCT01474512|54504964|FG000|Maintenance Period|Death|0|||
27884343|NCT01474512|54504965|FG001|Maintenance Period|Death|0|||
27884344|NCT01474512|54504966|FG002|Maintenance Period|Death|0|||
27884345|NCT01474512|54504967|FG003|Maintenance Period|Death|0|||
27884346|NCT01474512|54504968|FG004|Maintenance Period|Death|0|||
27884347|NCT01474512|54504969|FG005|Maintenance Period|Death|2|||
27884348|NCT01474512|54504970|FG006|Maintenance Period|Death|0|||
27884349|NCT01474512|54504971|FG007|Maintenance Period|Death|0|||
27884350|NCT01474512|54504972|FG008|Maintenance Period|Death|0|||
27884351|NCT01474512|54504973|FG009|Maintenance Period|Death|0|||
27884352|NCT01474512|54504974|FG010|Maintenance Period|Death|0|||
27884353|NCT01474512|54504975|FG011|Maintenance Period|Death|0|||
27884354|NCT01474512|54504976|FG012|Maintenance Period|Death|0|||
27884355|NCT01474512|54504977|FG013|Maintenance Period|Death|0|||
27884356|NCT01474512|54504978|FG014|Maintenance Period|Death|0|||
27884357|NCT01474512|54504979|FG015|Maintenance Period|Death|0|||
27884358|NCT01474512|54504980|FG016|Maintenance Period|Death|0|||
27884359|NCT01474512|54504981|FG017|Maintenance Period|Death|0|||
27884360|NCT01474512|54504964|FG000|Maintenance Period|Physician Decision|0|||
27884361|NCT01474512|54504965|FG001|Maintenance Period|Physician Decision|0|||
27884362|NCT01474512|54504966|FG002|Maintenance Period|Physician Decision|0|||
27884363|NCT01474512|54504967|FG003|Maintenance Period|Physician Decision|0|||
27884364|NCT01474512|54504968|FG004|Maintenance Period|Physician Decision|0|||
27884365|NCT01474512|54504969|FG005|Maintenance Period|Physician Decision|1|||
27884366|NCT01474512|54504970|FG006|Maintenance Period|Physician Decision|0|||
27884367|NCT01474512|54504971|FG007|Maintenance Period|Physician Decision|2|||
27884368|NCT01474512|54504972|FG008|Maintenance Period|Physician Decision|0|||
27884369|NCT01474512|54504973|FG009|Maintenance Period|Physician Decision|0|||
27884370|NCT01474512|54504974|FG010|Maintenance Period|Physician Decision|0|||
27884371|NCT01474512|54504975|FG011|Maintenance Period|Physician Decision|0|||
27884372|NCT01474512|54504976|FG012|Maintenance Period|Physician Decision|0|||
27884373|NCT01474512|54504977|FG013|Maintenance Period|Physician Decision|0|||
27884374|NCT01474512|54504978|FG014|Maintenance Period|Physician Decision|0|||
27884375|NCT01474512|54504979|FG015|Maintenance Period|Physician Decision|0|||
27884376|NCT01474512|54504980|FG016|Maintenance Period|Physician Decision|0|||
27884377|NCT01474512|54504981|FG017|Maintenance Period|Physician Decision|0|||
27884378|NCT01474512|54504964|FG000|Maintenance Period|Clinical Relapse|0|||
27884379|NCT01474512|54504965|FG001|Maintenance Period|Clinical Relapse|0|||
27884380|NCT01474512|54504966|FG002|Maintenance Period|Clinical Relapse|0|||
27884381|NCT01474512|54504967|FG003|Maintenance Period|Clinical Relapse|1|||
27884382|NCT01474512|54504968|FG004|Maintenance Period|Clinical Relapse|0|||
27884383|NCT01474512|54504969|FG005|Maintenance Period|Clinical Relapse|0|||
27884384|NCT01474512|54504970|FG006|Maintenance Period|Clinical Relapse|0|||
27884385|NCT01474512|54504971|FG007|Maintenance Period|Clinical Relapse|0|||
27884386|NCT01474512|54504972|FG008|Maintenance Period|Clinical Relapse|0|||
27884387|NCT01474512|54504973|FG009|Maintenance Period|Clinical Relapse|0|||
27884388|NCT01474512|54504974|FG010|Maintenance Period|Clinical Relapse|0|||
27884389|NCT01474512|54504975|FG011|Maintenance Period|Clinical Relapse|0|||
27884390|NCT01474512|54504976|FG012|Maintenance Period|Clinical Relapse|0|||
27884391|NCT01474512|54504977|FG013|Maintenance Period|Clinical Relapse|0|||
27884392|NCT01474512|54504978|FG014|Maintenance Period|Clinical Relapse|0|||
27884393|NCT01474512|54504979|FG015|Maintenance Period|Clinical Relapse|0|||
27884394|NCT01474512|54504980|FG016|Maintenance Period|Clinical Relapse|0|||
27884395|NCT01474512|54504981|FG017|Maintenance Period|Clinical Relapse|0|||
27884396|NCT01474512|54504964|FG000|Maintenance Period|Lack of Efficacy|0|||
27884397|NCT01474512|54504965|FG001|Maintenance Period|Lack of Efficacy|0|||
27884398|NCT01474512|54504966|FG002|Maintenance Period|Lack of Efficacy|0|||
27884399|NCT01474512|54504967|FG003|Maintenance Period|Lack of Efficacy|1|||
27884400|NCT01474512|54504968|FG004|Maintenance Period|Lack of Efficacy|0|||
27884401|NCT01474512|54504969|FG005|Maintenance Period|Lack of Efficacy|0|||
27884402|NCT01474512|54504970|FG006|Maintenance Period|Lack of Efficacy|0|||
27884403|NCT01474512|54504971|FG007|Maintenance Period|Lack of Efficacy|11|||
27884404|NCT01474512|54504972|FG008|Maintenance Period|Lack of Efficacy|11|||
27884405|NCT01474512|54504973|FG009|Maintenance Period|Lack of Efficacy|12|||
27884406|NCT01474512|54504974|FG010|Maintenance Period|Lack of Efficacy|0|||
27884407|NCT01474512|54504975|FG011|Maintenance Period|Lack of Efficacy|0|||
27884408|NCT01474512|54504976|FG012|Maintenance Period|Lack of Efficacy|0|||
27884409|NCT01474512|54504977|FG013|Maintenance Period|Lack of Efficacy|0|||
27884410|NCT01474512|54504978|FG014|Maintenance Period|Lack of Efficacy|0|||
27884411|NCT01474512|54504979|FG015|Maintenance Period|Lack of Efficacy|0|||
27884412|NCT01474512|54504980|FG016|Maintenance Period|Lack of Efficacy|0|||
27884413|NCT01474512|54504981|FG017|Maintenance Period|Lack of Efficacy|0|||
27884414|NCT01474512|54504964|FG000|Maintenance Period|Protocol Violation|0|||
27884415|NCT01474512|54504965|FG001|Maintenance Period|Protocol Violation|0|||
27884416|NCT01474512|54504966|FG002|Maintenance Period|Protocol Violation|0|||
27884417|NCT01474512|54504967|FG003|Maintenance Period|Protocol Violation|1|||
27884418|NCT01474512|54504968|FG004|Maintenance Period|Protocol Violation|0|||
27884419|NCT01474512|54504969|FG005|Maintenance Period|Protocol Violation|0|||
27884420|NCT01474512|54504970|FG006|Maintenance Period|Protocol Violation|0|||
27884421|NCT01474512|54504971|FG007|Maintenance Period|Protocol Violation|1|||
27884422|NCT01474512|54504972|FG008|Maintenance Period|Protocol Violation|0|||
27884423|NCT01474512|54504973|FG009|Maintenance Period|Protocol Violation|1|||
27884424|NCT01474512|54504974|FG010|Maintenance Period|Protocol Violation|0|||
27884425|NCT01474512|54504975|FG011|Maintenance Period|Protocol Violation|0|||
27884426|NCT01474512|54504976|FG012|Maintenance Period|Protocol Violation|0|||
27884427|NCT01474512|54504977|FG013|Maintenance Period|Protocol Violation|0|||
27884428|NCT01474512|54504978|FG014|Maintenance Period|Protocol Violation|0|||
27884429|NCT01474512|54504979|FG015|Maintenance Period|Protocol Violation|0|||
27884430|NCT01474512|54504980|FG016|Maintenance Period|Protocol Violation|0|||
27884431|NCT01474512|54504981|FG017|Maintenance Period|Protocol Violation|0|||
27884432|NCT01474512|54504964|FG000|Maintenance Period|Treated but Discontinued in Induction|0|||
27884433|NCT01474512|54504965|FG001|Maintenance Period|Treated but Discontinued in Induction|0|||
27884434|NCT01474512|54504966|FG002|Maintenance Period|Treated but Discontinued in Induction|0|||
27884435|NCT01474512|54504967|FG003|Maintenance Period|Treated but Discontinued in Induction|0|||
27884436|NCT01474512|54504968|FG004|Maintenance Period|Treated but Discontinued in Induction|1|||
27884437|NCT01474512|54504969|FG005|Maintenance Period|Treated but Discontinued in Induction|0|||
27884438|NCT01474512|54504970|FG006|Maintenance Period|Treated but Discontinued in Induction|0|||
27884439|NCT01474512|54504971|FG007|Maintenance Period|Treated but Discontinued in Induction|0|||
27884440|NCT01474512|54504972|FG008|Maintenance Period|Treated but Discontinued in Induction|0|||
27884441|NCT01474512|54504973|FG009|Maintenance Period|Treated but Discontinued in Induction|0|||
27884442|NCT01474512|54504974|FG010|Maintenance Period|Treated but Discontinued in Induction|0|||
27884443|NCT01474512|54504975|FG011|Maintenance Period|Treated but Discontinued in Induction|0|||
27884444|NCT01474512|54504976|FG012|Maintenance Period|Treated but Discontinued in Induction|0|||
27884445|NCT01474512|54504977|FG013|Maintenance Period|Treated but Discontinued in Induction|0|||
27884446|NCT01474512|54504978|FG014|Maintenance Period|Treated but Discontinued in Induction|0|||
27884447|NCT01474512|54504979|FG015|Maintenance Period|Treated but Discontinued in Induction|0|||
27884448|NCT01474512|54504980|FG016|Maintenance Period|Treated but Discontinued in Induction|0|||
27884449|NCT01474512|54504981|FG017|Maintenance Period|Treated but Discontinued in Induction|0|||
27884450|NCT01474512|54504964|FG000|Long-Term Extension Period|Withdrawal by Subject|0|||
27884451|NCT01474512|54504965|FG001|Long-Term Extension Period|Withdrawal by Subject|0|||
27884452|NCT01474512|54504966|FG002|Long-Term Extension Period|Withdrawal by Subject|0|||
27884453|NCT01474512|54504967|FG003|Long-Term Extension Period|Withdrawal by Subject|0|||
27884454|NCT01474512|54504968|FG004|Long-Term Extension Period|Withdrawal by Subject|0|||
27884455|NCT01474512|54504969|FG005|Long-Term Extension Period|Withdrawal by Subject|0|||
27884456|NCT01474512|54504970|FG006|Long-Term Extension Period|Withdrawal by Subject|0|||
27884457|NCT01474512|54504971|FG007|Long-Term Extension Period|Withdrawal by Subject|0|||
27884458|NCT01474512|54504972|FG008|Long-Term Extension Period|Withdrawal by Subject|0|||
27884459|NCT01474512|54504973|FG009|Long-Term Extension Period|Withdrawal by Subject|0|||
27884460|NCT01474512|54504974|FG010|Long-Term Extension Period|Withdrawal by Subject|0|||
27884461|NCT01474512|54504975|FG011|Long-Term Extension Period|Withdrawal by Subject|3|||
27884462|NCT01474512|54504976|FG012|Long-Term Extension Period|Withdrawal by Subject|61|||
27884463|NCT01474512|54504977|FG013|Long-Term Extension Period|Withdrawal by Subject|61|||
27884464|NCT01474512|54504978|FG014|Long-Term Extension Period|Withdrawal by Subject|0|||
27884465|NCT01474512|54504979|FG015|Long-Term Extension Period|Withdrawal by Subject|0|||
27884466|NCT01474512|54504980|FG016|Long-Term Extension Period|Withdrawal by Subject|0|||
27884467|NCT01474512|54504981|FG017|Long-Term Extension Period|Withdrawal by Subject|0|||
27884468|NCT01474512|54504964|FG000|Long-Term Extension Period|Adverse Event|0|||
27884469|NCT01474512|54504965|FG001|Long-Term Extension Period|Adverse Event|0|||
27884470|NCT01474512|54504966|FG002|Long-Term Extension Period|Adverse Event|0|||
27884471|NCT01474512|54504967|FG003|Long-Term Extension Period|Adverse Event|0|||
27884472|NCT01474512|54504968|FG004|Long-Term Extension Period|Adverse Event|0|||
27884473|NCT01474512|54504969|FG005|Long-Term Extension Period|Adverse Event|0|||
27884474|NCT01474512|54504970|FG006|Long-Term Extension Period|Adverse Event|0|||
27884475|NCT01474512|54504971|FG007|Long-Term Extension Period|Adverse Event|0|||
27884476|NCT01474512|54504972|FG008|Long-Term Extension Period|Adverse Event|0|||
27884477|NCT01474512|54504973|FG009|Long-Term Extension Period|Adverse Event|0|||
27884478|NCT01474512|54504974|FG010|Long-Term Extension Period|Adverse Event|0|||
27884479|NCT01474512|54504975|FG011|Long-Term Extension Period|Adverse Event|1|||
27884480|NCT01474512|54504976|FG012|Long-Term Extension Period|Adverse Event|57|||
27884481|NCT01474512|54504977|FG013|Long-Term Extension Period|Adverse Event|58|||
27884482|NCT01474512|54504978|FG014|Long-Term Extension Period|Adverse Event|0|||
27884483|NCT01474512|54504979|FG015|Long-Term Extension Period|Adverse Event|0|||
27884484|NCT01474512|54504980|FG016|Long-Term Extension Period|Adverse Event|0|||
27884485|NCT01474512|54504981|FG017|Long-Term Extension Period|Adverse Event|0|||
27884486|NCT01474512|54504964|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
27884487|NCT01474512|54504965|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
27884488|NCT01474512|54504966|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
27884489|NCT01474512|54504967|FG003|Long-Term Extension Period|Lost to Follow-up|0|||
27884490|NCT01474512|54504968|FG004|Long-Term Extension Period|Lost to Follow-up|0|||
27884491|NCT01474512|54504969|FG005|Long-Term Extension Period|Lost to Follow-up|0|||
27884492|NCT01474512|54504970|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
27884493|NCT01474512|54504971|FG007|Long-Term Extension Period|Lost to Follow-up|0|||
27884494|NCT01474512|54504972|FG008|Long-Term Extension Period|Lost to Follow-up|0|||
27884495|NCT01474512|54504973|FG009|Long-Term Extension Period|Lost to Follow-up|0|||
27884496|NCT01474512|54504974|FG010|Long-Term Extension Period|Lost to Follow-up|0|||
27884497|NCT01474512|54504975|FG011|Long-Term Extension Period|Lost to Follow-up|0|||
27884498|NCT01474512|54504976|FG012|Long-Term Extension Period|Lost to Follow-up|25|||
27884499|NCT01474512|54504977|FG013|Long-Term Extension Period|Lost to Follow-up|25|||
27884500|NCT01474512|54504978|FG014|Long-Term Extension Period|Lost to Follow-up|0|||
27884501|NCT01474512|54504979|FG015|Long-Term Extension Period|Lost to Follow-up|0|||
27884502|NCT01474512|54504980|FG016|Long-Term Extension Period|Lost to Follow-up|0|||
27884503|NCT01474512|54504981|FG017|Long-Term Extension Period|Lost to Follow-up|0|||
27884504|NCT01474512|54504964|FG000|Long-Term Extension Period|Lack of Efficacy|0|||
27884505|NCT01474512|54504965|FG001|Long-Term Extension Period|Lack of Efficacy|0|||
27884506|NCT01474512|54504966|FG002|Long-Term Extension Period|Lack of Efficacy|0|||
27884507|NCT01474512|54504967|FG003|Long-Term Extension Period|Lack of Efficacy|0|||
27884508|NCT01474512|54504968|FG004|Long-Term Extension Period|Lack of Efficacy|0|||
27884509|NCT01474512|54504969|FG005|Long-Term Extension Period|Lack of Efficacy|0|||
27884510|NCT01474512|54504970|FG006|Long-Term Extension Period|Lack of Efficacy|0|||
27884511|NCT01474512|54504971|FG007|Long-Term Extension Period|Lack of Efficacy|0|||
27884512|NCT01474512|54504972|FG008|Long-Term Extension Period|Lack of Efficacy|0|||
27884513|NCT01474512|54504973|FG009|Long-Term Extension Period|Lack of Efficacy|0|||
27884514|NCT01474512|54504974|FG010|Long-Term Extension Period|Lack of Efficacy|0|||
27884515|NCT01474512|54504975|FG011|Long-Term Extension Period|Lack of Efficacy|1|||
27884516|NCT01474512|54504976|FG012|Long-Term Extension Period|Lack of Efficacy|24|||
27884517|NCT01474512|54504977|FG013|Long-Term Extension Period|Lack of Efficacy|25|||
27884518|NCT01474512|54504978|FG014|Long-Term Extension Period|Lack of Efficacy|0|||
27884519|NCT01474512|54504979|FG015|Long-Term Extension Period|Lack of Efficacy|0|||
27884520|NCT01474512|54504980|FG016|Long-Term Extension Period|Lack of Efficacy|0|||
27884521|NCT01474512|54504981|FG017|Long-Term Extension Period|Lack of Efficacy|0|||
27884522|NCT01474512|54504964|FG000|Long-Term Extension Period|Physician Decision|0|||
27884523|NCT01474512|54504965|FG001|Long-Term Extension Period|Physician Decision|0|||
27884524|NCT01474512|54504966|FG002|Long-Term Extension Period|Physician Decision|0|||
27884525|NCT01474512|54504967|FG003|Long-Term Extension Period|Physician Decision|0|||
27984620|NCT00895895|54643345|FG000|Period 2|failed to return|2|||
27884526|NCT01474512|54504968|FG004|Long-Term Extension Period|Physician Decision|0|||
27884527|NCT01474512|54504969|FG005|Long-Term Extension Period|Physician Decision|0|||
27884528|NCT01474512|54504970|FG006|Long-Term Extension Period|Physician Decision|0|||
27884529|NCT01474512|54504971|FG007|Long-Term Extension Period|Physician Decision|0|||
27884530|NCT01474512|54504972|FG008|Long-Term Extension Period|Physician Decision|0|||
27884531|NCT01474512|54504973|FG009|Long-Term Extension Period|Physician Decision|0|||
27884532|NCT01474512|54504974|FG010|Long-Term Extension Period|Physician Decision|0|||
27984621|NCT00895895|54643346|FG001|Period 2|failed to return|0|||
27884533|NCT01474512|54504975|FG011|Long-Term Extension Period|Physician Decision|0|||
27884534|NCT01474512|54504976|FG012|Long-Term Extension Period|Physician Decision|21|||
27884535|NCT01474512|54504977|FG013|Long-Term Extension Period|Physician Decision|21|||
27884536|NCT01474512|54504978|FG014|Long-Term Extension Period|Physician Decision|0|||
27884537|NCT01474512|54504979|FG015|Long-Term Extension Period|Physician Decision|0|||
27884538|NCT01474512|54504980|FG016|Long-Term Extension Period|Physician Decision|0|||
27884539|NCT01474512|54504981|FG017|Long-Term Extension Period|Physician Decision|0|||
27884540|NCT01474512|54504964|FG000|Long-Term Extension Period|Clinical Relapse|0|||
27884541|NCT01474512|54504965|FG001|Long-Term Extension Period|Clinical Relapse|0|||
27884542|NCT01474512|54504966|FG002|Long-Term Extension Period|Clinical Relapse|0|||
27884543|NCT01474512|54504967|FG003|Long-Term Extension Period|Clinical Relapse|0|||
27884544|NCT01474512|54504968|FG004|Long-Term Extension Period|Clinical Relapse|0|||
27884545|NCT01474512|54504969|FG005|Long-Term Extension Period|Clinical Relapse|0|||
27884546|NCT01474512|54504970|FG006|Long-Term Extension Period|Clinical Relapse|0|||
27884547|NCT01474512|54504971|FG007|Long-Term Extension Period|Clinical Relapse|0|||
27884548|NCT01474512|54504972|FG008|Long-Term Extension Period|Clinical Relapse|0|||
27884549|NCT01474512|54504973|FG009|Long-Term Extension Period|Clinical Relapse|0|||
27884550|NCT01474512|54504974|FG010|Long-Term Extension Period|Clinical Relapse|0|||
27884551|NCT01474512|54504975|FG011|Long-Term Extension Period|Clinical Relapse|0|||
27884552|NCT01474512|54504976|FG012|Long-Term Extension Period|Clinical Relapse|9|||
27884553|NCT01474512|54504977|FG013|Long-Term Extension Period|Clinical Relapse|9|||
27884554|NCT01474512|54504978|FG014|Long-Term Extension Period|Clinical Relapse|0|||
27884555|NCT01474512|54504979|FG015|Long-Term Extension Period|Clinical Relapse|0|||
27884556|NCT01474512|54504980|FG016|Long-Term Extension Period|Clinical Relapse|0|||
27884557|NCT01474512|54504981|FG017|Long-Term Extension Period|Clinical Relapse|0|||
27884558|NCT01474512|54504964|FG000|Long-Term Extension Period|Death|0|||
27884559|NCT01474512|54504965|FG001|Long-Term Extension Period|Death|0|||
27884560|NCT01474512|54504966|FG002|Long-Term Extension Period|Death|0|||
27884561|NCT01474512|54504967|FG003|Long-Term Extension Period|Death|0|||
27884562|NCT01474512|54504968|FG004|Long-Term Extension Period|Death|0|||
27884563|NCT01474512|54504969|FG005|Long-Term Extension Period|Death|0|||
27884564|NCT01474512|54504970|FG006|Long-Term Extension Period|Death|0|||
27884565|NCT01474512|54504971|FG007|Long-Term Extension Period|Death|0|||
27884566|NCT01474512|54504972|FG008|Long-Term Extension Period|Death|0|||
27884567|NCT01474512|54504973|FG009|Long-Term Extension Period|Death|0|||
27884568|NCT01474512|54504974|FG010|Long-Term Extension Period|Death|0|||
27884569|NCT01474512|54504975|FG011|Long-Term Extension Period|Death|0|||
27884570|NCT01474512|54504976|FG012|Long-Term Extension Period|Death|9|||
27884571|NCT01474512|54504977|FG013|Long-Term Extension Period|Death|9|||
27884572|NCT01474512|54504978|FG014|Long-Term Extension Period|Death|0|||
27884573|NCT01474512|54504979|FG015|Long-Term Extension Period|Death|0|||
27884574|NCT01474512|54504980|FG016|Long-Term Extension Period|Death|0|||
27884575|NCT01474512|54504981|FG017|Long-Term Extension Period|Death|0|||
27884576|NCT01474512|54504964|FG000|Long-Term Extension Period|Sponsor Decision|0|||
27884577|NCT01474512|54504965|FG001|Long-Term Extension Period|Sponsor Decision|0|||
27884578|NCT01474512|54504966|FG002|Long-Term Extension Period|Sponsor Decision|0|||
27884579|NCT01474512|54504967|FG003|Long-Term Extension Period|Sponsor Decision|0|||
27884580|NCT01474512|54504968|FG004|Long-Term Extension Period|Sponsor Decision|0|||
27884581|NCT01474512|54504969|FG005|Long-Term Extension Period|Sponsor Decision|0|||
27884582|NCT01474512|54504970|FG006|Long-Term Extension Period|Sponsor Decision|0|||
27884583|NCT01474512|54504971|FG007|Long-Term Extension Period|Sponsor Decision|0|||
27884584|NCT01474512|54504972|FG008|Long-Term Extension Period|Sponsor Decision|0|||
27884585|NCT01474512|54504973|FG009|Long-Term Extension Period|Sponsor Decision|0|||
27884586|NCT01474512|54504974|FG010|Long-Term Extension Period|Sponsor Decision|0|||
27884587|NCT01474512|54504975|FG011|Long-Term Extension Period|Sponsor Decision|0|||
27884588|NCT01474512|54504976|FG012|Long-Term Extension Period|Sponsor Decision|6|||
27884589|NCT01474512|54504977|FG013|Long-Term Extension Period|Sponsor Decision|6|||
27884590|NCT01474512|54504978|FG014|Long-Term Extension Period|Sponsor Decision|0|||
27884591|NCT01474512|54504979|FG015|Long-Term Extension Period|Sponsor Decision|0|||
27884592|NCT01474512|54504980|FG016|Long-Term Extension Period|Sponsor Decision|0|||
27884593|NCT01474512|54504981|FG017|Long-Term Extension Period|Sponsor Decision|0|||
27884594|NCT01474512|54504964|FG000|Long-Term Extension Period|Protocol Violation|0|||
27884595|NCT01474512|54504965|FG001|Long-Term Extension Period|Protocol Violation|0|||
27884596|NCT01474512|54504966|FG002|Long-Term Extension Period|Protocol Violation|0|||
27884597|NCT01474512|54504967|FG003|Long-Term Extension Period|Protocol Violation|0|||
27884598|NCT01474512|54504968|FG004|Long-Term Extension Period|Protocol Violation|0|||
27884599|NCT01474512|54504969|FG005|Long-Term Extension Period|Protocol Violation|0|||
27884600|NCT01474512|54504970|FG006|Long-Term Extension Period|Protocol Violation|0|||
27884601|NCT01474512|54504971|FG007|Long-Term Extension Period|Protocol Violation|0|||
27884602|NCT01474512|54504972|FG008|Long-Term Extension Period|Protocol Violation|0|||
27884603|NCT01474512|54504973|FG009|Long-Term Extension Period|Protocol Violation|0|||
27884604|NCT01474512|54504974|FG010|Long-Term Extension Period|Protocol Violation|0|||
27984622|NCT00895895|54643347|FG002|Period 2|failed to return|0|||
27884605|NCT01474512|54504975|FG011|Long-Term Extension Period|Protocol Violation|0|||
27884606|NCT01474512|54504976|FG012|Long-Term Extension Period|Protocol Violation|5|||
27884607|NCT01474512|54504977|FG013|Long-Term Extension Period|Protocol Violation|5|||
27884608|NCT01474512|54504978|FG014|Long-Term Extension Period|Protocol Violation|0|||
27884609|NCT01474512|54504979|FG015|Long-Term Extension Period|Protocol Violation|0|||
27884610|NCT01474512|54504980|FG016|Long-Term Extension Period|Protocol Violation|0|||
27884611|NCT01474512|54504981|FG017|Long-Term Extension Period|Protocol Violation|0|||
27884612|NCT01474512|54504964|FG000|Long-Term Extension Period|Parent/Caregiver Decision|0|||
27884613|NCT01474512|54504965|FG001|Long-Term Extension Period|Parent/Caregiver Decision|0|||
27884614|NCT01474512|54504966|FG002|Long-Term Extension Period|Parent/Caregiver Decision|0|||
27884615|NCT01474512|54504967|FG003|Long-Term Extension Period|Parent/Caregiver Decision|0|||
27884616|NCT01474512|54504968|FG004|Long-Term Extension Period|Parent/Caregiver Decision|0|||
27884617|NCT01474512|54504969|FG005|Long-Term Extension Period|Parent/Caregiver Decision|0|||
27884618|NCT01474512|54504970|FG006|Long-Term Extension Period|Parent/Caregiver Decision|0|||
27884619|NCT01474512|54504971|FG007|Long-Term Extension Period|Parent/Caregiver Decision|0|||
27884620|NCT01474512|54504972|FG008|Long-Term Extension Period|Parent/Caregiver Decision|0|||
27884621|NCT01474512|54504973|FG009|Long-Term Extension Period|Parent/Caregiver Decision|0|||
27884622|NCT01474512|54504974|FG010|Long-Term Extension Period|Parent/Caregiver Decision|0|||
27884623|NCT01474512|54504975|FG011|Long-Term Extension Period|Parent/Caregiver Decision|0|||
27884624|NCT01474512|54504976|FG012|Long-Term Extension Period|Parent/Caregiver Decision|1|||
27884625|NCT01474512|54504977|FG013|Long-Term Extension Period|Parent/Caregiver Decision|1|||
27884626|NCT01474512|54504978|FG014|Long-Term Extension Period|Parent/Caregiver Decision|0|||
27884627|NCT01474512|54504979|FG015|Long-Term Extension Period|Parent/Caregiver Decision|0|||
27884628|NCT01474512|54504980|FG016|Long-Term Extension Period|Parent/Caregiver Decision|0|||
27884629|NCT01474512|54504981|FG017|Long-Term Extension Period|Parent/Caregiver Decision|0|||
27884630|NCT01474512|54504964|FG000|Long-Term Extension Period|Switched From PBO to Ixe|0|||
27884631|NCT01474512|54504965|FG001|Long-Term Extension Period|Switched From PBO to Ixe|0|||
27884632|NCT01474512|54504966|FG002|Long-Term Extension Period|Switched From PBO to Ixe|0|||
27884633|NCT01474512|54504967|FG003|Long-Term Extension Period|Switched From PBO to Ixe|0|||
27884634|NCT01474512|54504968|FG004|Long-Term Extension Period|Switched From PBO to Ixe|0|||
27884635|NCT01474512|54504969|FG005|Long-Term Extension Period|Switched From PBO to Ixe|0|||
27884636|NCT01474512|54504970|FG006|Long-Term Extension Period|Switched From PBO to Ixe|0|||
27884637|NCT01474512|54504971|FG007|Long-Term Extension Period|Switched From PBO to Ixe|0|||
27884638|NCT01474512|54504972|FG008|Long-Term Extension Period|Switched From PBO to Ixe|0|||
27884639|NCT01474512|54504973|FG009|Long-Term Extension Period|Switched From PBO to Ixe|0|||
27884640|NCT01474512|54504974|FG010|Long-Term Extension Period|Switched From PBO to Ixe|0|||
27884641|NCT01474512|54504975|FG011|Long-Term Extension Period|Switched From PBO to Ixe|21|||
27884642|NCT01474512|54504976|FG012|Long-Term Extension Period|Switched From PBO to Ixe|0|||
27884643|NCT01474512|54504977|FG013|Long-Term Extension Period|Switched From PBO to Ixe|0|||
27884644|NCT01474512|54504978|FG014|Long-Term Extension Period|Switched From PBO to Ixe|0|||
27884645|NCT01474512|54504979|FG015|Long-Term Extension Period|Switched From PBO to Ixe|0|||
27884646|NCT01474512|54504980|FG016|Long-Term Extension Period|Switched From PBO to Ixe|0|||
27884647|NCT01474512|54504981|FG017|Long-Term Extension Period|Switched From PBO to Ixe|0|||
27884648|NCT01474512|54504964|FG000|Post-Treatment Follow-Up|Adverse Event|0|||
27884649|NCT01474512|54504965|FG001|Post-Treatment Follow-Up|Adverse Event|0|||
27884650|NCT01474512|54504966|FG002|Post-Treatment Follow-Up|Adverse Event|0|||
27884651|NCT01474512|54504967|FG003|Post-Treatment Follow-Up|Adverse Event|0|||
27884652|NCT01474512|54504968|FG004|Post-Treatment Follow-Up|Adverse Event|0|||
27884653|NCT01474512|54504969|FG005|Post-Treatment Follow-Up|Adverse Event|0|||
27884654|NCT01474512|54504970|FG006|Post-Treatment Follow-Up|Adverse Event|0|||
27884655|NCT01474512|54504971|FG007|Post-Treatment Follow-Up|Adverse Event|0|||
27884656|NCT01474512|54504972|FG008|Post-Treatment Follow-Up|Adverse Event|0|||
27884657|NCT01474512|54504973|FG009|Post-Treatment Follow-Up|Adverse Event|0|||
27884658|NCT01474512|54504974|FG010|Post-Treatment Follow-Up|Adverse Event|0|||
27884659|NCT01474512|54504975|FG011|Post-Treatment Follow-Up|Adverse Event|0|||
27884660|NCT01474512|54504976|FG012|Post-Treatment Follow-Up|Adverse Event|0|||
27884661|NCT01474512|54504977|FG013|Post-Treatment Follow-Up|Adverse Event|0|||
27884662|NCT01474512|54504978|FG014|Post-Treatment Follow-Up|Adverse Event|8|||
27884663|NCT01474512|54504979|FG015|Post-Treatment Follow-Up|Adverse Event|2|||
27884664|NCT01474512|54504980|FG016|Post-Treatment Follow-Up|Adverse Event|58|||
27884665|NCT01474512|54504981|FG017|Post-Treatment Follow-Up|Adverse Event|11|||
27884666|NCT01474512|54504964|FG000|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
27984623|NCT00895895|54643348|FG003|Period 2|failed to return|0|||
27884667|NCT01474512|54504965|FG001|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
27884668|NCT01474512|54504966|FG002|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
27884669|NCT01474512|54504967|FG003|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
27884670|NCT01474512|54504968|FG004|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
27884671|NCT01474512|54504969|FG005|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
27884672|NCT01474512|54504970|FG006|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
27884673|NCT01474512|54504971|FG007|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
27884674|NCT01474512|54504972|FG008|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
27884675|NCT01474512|54504973|FG009|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
27884676|NCT01474512|54504974|FG010|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
27884677|NCT01474512|54504975|FG011|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
27884678|NCT01474512|54504976|FG012|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
27884679|NCT01474512|54504977|FG013|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
27884680|NCT01474512|54504978|FG014|Post-Treatment Follow-Up|Withdrawal by Subject|3|||
27884681|NCT01474512|54504979|FG015|Post-Treatment Follow-Up|Withdrawal by Subject|2|||
27884682|NCT01474512|54504980|FG016|Post-Treatment Follow-Up|Withdrawal by Subject|36|||
27884683|NCT01474512|54504981|FG017|Post-Treatment Follow-Up|Withdrawal by Subject|17|||
27884684|NCT01474512|54504964|FG000|Post-Treatment Follow-Up|Lack of Efficacy|0|||
27884685|NCT01474512|54504965|FG001|Post-Treatment Follow-Up|Lack of Efficacy|0|||
27884686|NCT01474512|54504966|FG002|Post-Treatment Follow-Up|Lack of Efficacy|0|||
27884687|NCT01474512|54504967|FG003|Post-Treatment Follow-Up|Lack of Efficacy|0|||
27884688|NCT01474512|54504968|FG004|Post-Treatment Follow-Up|Lack of Efficacy|0|||
27884689|NCT01474512|54504969|FG005|Post-Treatment Follow-Up|Lack of Efficacy|0|||
27884690|NCT01474512|54504970|FG006|Post-Treatment Follow-Up|Lack of Efficacy|0|||
27884691|NCT01474512|54504971|FG007|Post-Treatment Follow-Up|Lack of Efficacy|0|||
27884692|NCT01474512|54504972|FG008|Post-Treatment Follow-Up|Lack of Efficacy|0|||
27884693|NCT01474512|54504973|FG009|Post-Treatment Follow-Up|Lack of Efficacy|0|||
27884694|NCT01474512|54504974|FG010|Post-Treatment Follow-Up|Lack of Efficacy|0|||
27884695|NCT01474512|54504975|FG011|Post-Treatment Follow-Up|Lack of Efficacy|0|||
27884696|NCT01474512|54504976|FG012|Post-Treatment Follow-Up|Lack of Efficacy|0|||
27884697|NCT01474512|54504977|FG013|Post-Treatment Follow-Up|Lack of Efficacy|0|||
27884698|NCT01474512|54504978|FG014|Post-Treatment Follow-Up|Lack of Efficacy|3|||
27884699|NCT01474512|54504979|FG015|Post-Treatment Follow-Up|Lack of Efficacy|2|||
27884700|NCT01474512|54504980|FG016|Post-Treatment Follow-Up|Lack of Efficacy|31|||
27884701|NCT01474512|54504981|FG017|Post-Treatment Follow-Up|Lack of Efficacy|3|||
27884702|NCT01474512|54504964|FG000|Post-Treatment Follow-Up|Lost to Follow-up|0|||
27884703|NCT01474512|54504965|FG001|Post-Treatment Follow-Up|Lost to Follow-up|0|||
27884704|NCT01474512|54504966|FG002|Post-Treatment Follow-Up|Lost to Follow-up|0|||
27884705|NCT01474512|54504967|FG003|Post-Treatment Follow-Up|Lost to Follow-up|0|||
27884706|NCT01474512|54504968|FG004|Post-Treatment Follow-Up|Lost to Follow-up|0|||
27884707|NCT01474512|54504969|FG005|Post-Treatment Follow-Up|Lost to Follow-up|0|||
27884708|NCT01474512|54504970|FG006|Post-Treatment Follow-Up|Lost to Follow-up|0|||
27884709|NCT01474512|54504971|FG007|Post-Treatment Follow-Up|Lost to Follow-up|0|||
27884710|NCT01474512|54504972|FG008|Post-Treatment Follow-Up|Lost to Follow-up|0|||
27884711|NCT01474512|54504973|FG009|Post-Treatment Follow-Up|Lost to Follow-up|0|||
27884712|NCT01474512|54504974|FG010|Post-Treatment Follow-Up|Lost to Follow-up|0|||
27884713|NCT01474512|54504975|FG011|Post-Treatment Follow-Up|Lost to Follow-up|0|||
27884714|NCT01474512|54504976|FG012|Post-Treatment Follow-Up|Lost to Follow-up|0|||
27884715|NCT01474512|54504977|FG013|Post-Treatment Follow-Up|Lost to Follow-up|0|||
27884716|NCT01474512|54504978|FG014|Post-Treatment Follow-Up|Lost to Follow-up|0|||
27884717|NCT01474512|54504979|FG015|Post-Treatment Follow-Up|Lost to Follow-up|0|||
27884718|NCT01474512|54504980|FG016|Post-Treatment Follow-Up|Lost to Follow-up|12|||
27884719|NCT01474512|54504981|FG017|Post-Treatment Follow-Up|Lost to Follow-up|7|||
27884720|NCT01474512|54504964|FG000|Post-Treatment Follow-Up|Physician Decision|0|||
27884721|NCT01474512|54504965|FG001|Post-Treatment Follow-Up|Physician Decision|0|||
27884722|NCT01474512|54504966|FG002|Post-Treatment Follow-Up|Physician Decision|0|||
27884723|NCT01474512|54504967|FG003|Post-Treatment Follow-Up|Physician Decision|0|||
27884724|NCT01474512|54504968|FG004|Post-Treatment Follow-Up|Physician Decision|0|||
27884725|NCT01474512|54504969|FG005|Post-Treatment Follow-Up|Physician Decision|0|||
27884726|NCT01474512|54504970|FG006|Post-Treatment Follow-Up|Physician Decision|0|||
27884727|NCT01474512|54504971|FG007|Post-Treatment Follow-Up|Physician Decision|0|||
27884728|NCT01474512|54504972|FG008|Post-Treatment Follow-Up|Physician Decision|0|||
27884729|NCT01474512|54504973|FG009|Post-Treatment Follow-Up|Physician Decision|0|||
27884730|NCT01474512|54504974|FG010|Post-Treatment Follow-Up|Physician Decision|0|||
27884731|NCT01474512|54504975|FG011|Post-Treatment Follow-Up|Physician Decision|0|||
27884732|NCT01474512|54504976|FG012|Post-Treatment Follow-Up|Physician Decision|0|||
27884733|NCT01474512|54504977|FG013|Post-Treatment Follow-Up|Physician Decision|0|||
27884734|NCT01474512|54504978|FG014|Post-Treatment Follow-Up|Physician Decision|0|||
27884735|NCT01474512|54504979|FG015|Post-Treatment Follow-Up|Physician Decision|0|||
27884736|NCT01474512|54504980|FG016|Post-Treatment Follow-Up|Physician Decision|4|||
27884737|NCT01474512|54504981|FG017|Post-Treatment Follow-Up|Physician Decision|5|||
27884738|NCT01474512|54504964|FG000|Post-Treatment Follow-Up|Clinical Relapse|0|||
27884739|NCT01474512|54504965|FG001|Post-Treatment Follow-Up|Clinical Relapse|0|||
27884740|NCT01474512|54504966|FG002|Post-Treatment Follow-Up|Clinical Relapse|0|||
27884741|NCT01474512|54504967|FG003|Post-Treatment Follow-Up|Clinical Relapse|0|||
27884742|NCT01474512|54504968|FG004|Post-Treatment Follow-Up|Clinical Relapse|0|||
27884743|NCT01474512|54504969|FG005|Post-Treatment Follow-Up|Clinical Relapse|0|||
27884744|NCT01474512|54504970|FG006|Post-Treatment Follow-Up|Clinical Relapse|0|||
28096604|NCT04110314|54751750|FG004|Overall Study|Did not meet inclusion criteria|35247|||
28096605|NCT04110314|54751751|FG005|Overall Study|Did not meet inclusion criteria|35727|||
27884745|NCT01474512|54504971|FG007|Post-Treatment Follow-Up|Clinical Relapse|0|||
27884746|NCT01474512|54504972|FG008|Post-Treatment Follow-Up|Clinical Relapse|0|||
27884747|NCT01474512|54504973|FG009|Post-Treatment Follow-Up|Clinical Relapse|0|||
27884748|NCT01474512|54504974|FG010|Post-Treatment Follow-Up|Clinical Relapse|0|||
27884749|NCT01474512|54504975|FG011|Post-Treatment Follow-Up|Clinical Relapse|0|||
27884750|NCT01474512|54504976|FG012|Post-Treatment Follow-Up|Clinical Relapse|0|||
27884751|NCT01474512|54504977|FG013|Post-Treatment Follow-Up|Clinical Relapse|0|||
27884752|NCT01474512|54504978|FG014|Post-Treatment Follow-Up|Clinical Relapse|0|||
27884753|NCT01474512|54504979|FG015|Post-Treatment Follow-Up|Clinical Relapse|0|||
27884754|NCT01474512|54504980|FG016|Post-Treatment Follow-Up|Clinical Relapse|6|||
27884755|NCT01474512|54504981|FG017|Post-Treatment Follow-Up|Clinical Relapse|2|||
27884756|NCT01474512|54504964|FG000|Post-Treatment Follow-Up|Protocol Violation|0|||
27884757|NCT01474512|54504965|FG001|Post-Treatment Follow-Up|Protocol Violation|0|||
27884758|NCT01474512|54504966|FG002|Post-Treatment Follow-Up|Protocol Violation|0|||
27884759|NCT01474512|54504967|FG003|Post-Treatment Follow-Up|Protocol Violation|0|||
27884760|NCT01474512|54504968|FG004|Post-Treatment Follow-Up|Protocol Violation|0|||
27884761|NCT01474512|54504969|FG005|Post-Treatment Follow-Up|Protocol Violation|0|||
27884762|NCT01474512|54504970|FG006|Post-Treatment Follow-Up|Protocol Violation|0|||
27884763|NCT01474512|54504971|FG007|Post-Treatment Follow-Up|Protocol Violation|0|||
27884764|NCT01474512|54504972|FG008|Post-Treatment Follow-Up|Protocol Violation|0|||
27884765|NCT01474512|54504973|FG009|Post-Treatment Follow-Up|Protocol Violation|0|||
27884766|NCT01474512|54504974|FG010|Post-Treatment Follow-Up|Protocol Violation|0|||
27884767|NCT01474512|54504975|FG011|Post-Treatment Follow-Up|Protocol Violation|0|||
27884768|NCT01474512|54504976|FG012|Post-Treatment Follow-Up|Protocol Violation|0|||
27884769|NCT01474512|54504977|FG013|Post-Treatment Follow-Up|Protocol Violation|0|||
27884770|NCT01474512|54504978|FG014|Post-Treatment Follow-Up|Protocol Violation|2|||
27884771|NCT01474512|54504979|FG015|Post-Treatment Follow-Up|Protocol Violation|2|||
27884772|NCT01474512|54504980|FG016|Post-Treatment Follow-Up|Protocol Violation|4|||
27884773|NCT01474512|54504981|FG017|Post-Treatment Follow-Up|Protocol Violation|0|||
27884774|NCT01474512|54504964|FG000|Post-Treatment Follow-Up|Sponsor Decision|0|||
27884775|NCT01474512|54504965|FG001|Post-Treatment Follow-Up|Sponsor Decision|0|||
27884776|NCT01474512|54504966|FG002|Post-Treatment Follow-Up|Sponsor Decision|0|||
27884777|NCT01474512|54504967|FG003|Post-Treatment Follow-Up|Sponsor Decision|0|||
27884778|NCT01474512|54504968|FG004|Post-Treatment Follow-Up|Sponsor Decision|0|||
27884779|NCT01474512|54504969|FG005|Post-Treatment Follow-Up|Sponsor Decision|0|||
27884780|NCT01474512|54504970|FG006|Post-Treatment Follow-Up|Sponsor Decision|0|||
27884781|NCT01474512|54504971|FG007|Post-Treatment Follow-Up|Sponsor Decision|0|||
27884782|NCT01474512|54504972|FG008|Post-Treatment Follow-Up|Sponsor Decision|0|||
27884783|NCT01474512|54504973|FG009|Post-Treatment Follow-Up|Sponsor Decision|0|||
27884784|NCT01474512|54504974|FG010|Post-Treatment Follow-Up|Sponsor Decision|0|||
27884785|NCT01474512|54504975|FG011|Post-Treatment Follow-Up|Sponsor Decision|0|||
27884786|NCT01474512|54504976|FG012|Post-Treatment Follow-Up|Sponsor Decision|0|||
27884787|NCT01474512|54504977|FG013|Post-Treatment Follow-Up|Sponsor Decision|0|||
27884788|NCT01474512|54504978|FG014|Post-Treatment Follow-Up|Sponsor Decision|1|||
27884789|NCT01474512|54504979|FG015|Post-Treatment Follow-Up|Sponsor Decision|0|||
27984624|NCT00895895|54643349|FG004|Period 2|failed to return|0|||
27984625|NCT00895895|54643345|FG000|Period 2|investigator request|2|||
27984626|NCT00895895|54643346|FG001|Period 2|investigator request|0|||
27984627|NCT00895895|54643347|FG002|Period 2|investigator request|0|||
27984628|NCT00895895|54643348|FG003|Period 2|investigator request|0|||
27984629|NCT00895895|54643349|FG004|Period 2|investigator request|0|||
27984630|NCT00895895|54643345|FG000|Period 2|Lost to Follow-up|1|||
27984631|NCT00895895|54643346|FG001|Period 2|Lost to Follow-up|2|||
27984632|NCT00895895|54643347|FG002|Period 2|Lost to Follow-up|1|||
27984633|NCT00895895|54643348|FG003|Period 2|Lost to Follow-up|1|||
27984634|NCT00895895|54643349|FG004|Period 2|Lost to Follow-up|0|||
27984635|NCT00895895|54643345|FG000|Period 2|Other|1|||
27984636|NCT00895895|54643346|FG001|Period 2|Other|1|||
28096606|NCT04109222|54751766|FG000|Overall Study|Adverse Event|1|||
28096607|NCT04109222|54751767|FG001|Overall Study|Adverse Event|0|||
28096608|NCT04109222|54751768|FG002|Overall Study|Adverse Event|0|||
28096609|NCT04098458|54751776|FG000|Overall Study|Death|1|||
28096610|NCT04098458|54751776|FG000|Overall Study|did not meet study inclusion criteria|3|||
28096611|NCT03447262|54751781|FG000|Overall Study|Adverse Event|7|||
28096612|NCT03447262|54751781|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
28171770|NCT01651000|54843333|FG001|Overall Study|Subject noncompliance|3|||
27984637|NCT00895895|54643347|FG002|Period 2|Other|3|||
28171771|NCT01651000|54843332|FG000|Overall Study|Lack of Efficacy|1|||
27884790|NCT01474512|54504980|FG016|Post-Treatment Follow-Up|Sponsor Decision|4|||
27884791|NCT01474512|54504981|FG017|Post-Treatment Follow-Up|Sponsor Decision|0|||
27884792|NCT01474512|54504964|FG000|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
27884793|NCT01474512|54504965|FG001|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
27984638|NCT00895895|54643348|FG003|Period 2|Other|1|||
27884794|NCT01474512|54504966|FG002|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
27884795|NCT01474512|54504967|FG003|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
27884796|NCT01474512|54504968|FG004|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
27884797|NCT01474512|54504969|FG005|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
27884798|NCT01474512|54504970|FG006|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
27884799|NCT01474512|54504971|FG007|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
27884800|NCT01474512|54504972|FG008|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
27884801|NCT01474512|54504973|FG009|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
27884802|NCT01474512|54504974|FG010|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
27884803|NCT01474512|54504975|FG011|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
27884804|NCT01474512|54504976|FG012|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
27884805|NCT01474512|54504977|FG013|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
27884806|NCT01474512|54504978|FG014|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
27884807|NCT01474512|54504979|FG015|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
27884808|NCT01474512|54504980|FG016|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
27884809|NCT01474512|54504981|FG017|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
27884810|NCT01474512|54504964|FG000|Post-Treatment Follow-Up|Death|0|||
27884811|NCT01474512|54504965|FG001|Post-Treatment Follow-Up|Death|0|||
27884812|NCT01474512|54504966|FG002|Post-Treatment Follow-Up|Death|0|||
27884813|NCT01474512|54504967|FG003|Post-Treatment Follow-Up|Death|0|||
27884814|NCT01474512|54504968|FG004|Post-Treatment Follow-Up|Death|0|||
27884815|NCT01474512|54504969|FG005|Post-Treatment Follow-Up|Death|0|||
27884816|NCT01474512|54504970|FG006|Post-Treatment Follow-Up|Death|0|||
27884817|NCT01474512|54504971|FG007|Post-Treatment Follow-Up|Death|0|||
27884818|NCT01474512|54504972|FG008|Post-Treatment Follow-Up|Death|0|||
27884819|NCT01474512|54504973|FG009|Post-Treatment Follow-Up|Death|0|||
27884820|NCT01474512|54504974|FG010|Post-Treatment Follow-Up|Death|0|||
27884821|NCT01474512|54504975|FG011|Post-Treatment Follow-Up|Death|0|||
27884822|NCT01474512|54504976|FG012|Post-Treatment Follow-Up|Death|0|||
27884823|NCT01474512|54504977|FG013|Post-Treatment Follow-Up|Death|0|||
27884824|NCT01474512|54504978|FG014|Post-Treatment Follow-Up|Death|0|||
27884825|NCT01474512|54504979|FG015|Post-Treatment Follow-Up|Death|0|||
27884826|NCT01474512|54504980|FG016|Post-Treatment Follow-Up|Death|1|||
27884827|NCT01474512|54504981|FG017|Post-Treatment Follow-Up|Death|0|||
27884828|NCT01474434|54505015|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
27884829|NCT01474434|54505016|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
27884830|NCT01474434|54505017|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
27884831|NCT01474434|54505018|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
27884832|NCT01474434|54505015|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
27884833|NCT01474434|54505016|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
27884834|NCT01474434|54505017|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
27884835|NCT01474434|54505018|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1|||
27884836|NCT01474434|54505015|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1|||
27884837|NCT01474434|54505016|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
27884838|NCT01474434|54505017|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
27884839|NCT01474434|54505018|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
27884840|NCT01473732|54505034|FG000|Overall Study|Adverse Event|1|||
27884841|NCT01473732|54505035|FG001|Overall Study|Adverse Event|0|||
27884842|NCT01473732|54505034|FG000|Overall Study|Death|1|||
27884843|NCT01473732|54505035|FG001|Overall Study|Death|0|||
27884844|NCT01450098|54505043|FG000|Period 3|Protocol Violation|0|||
27884845|NCT01450098|54505044|FG001|Period 3|Protocol Violation|1|||
27884846|NCT01450098|54505043|FG000|Period 3|Withdrawal by Subject|0|||
27884847|NCT01450098|54505044|FG001|Period 3|Withdrawal by Subject|2|||
27884848|NCT01449708|54505059|FG000|Overall Study|Protocol Violation|0|||
27884849|NCT01449708|54505060|FG001|Overall Study|Protocol Violation|1|||
27884850|NCT01449708|54505059|FG000|Overall Study|surgical complication|1|||
27884851|NCT01449708|54505060|FG001|Overall Study|surgical complication|2|||
27884852|NCT01449708|54505059|FG000|Overall Study|respiratory failure|1|||
27884853|NCT01449708|54505060|FG001|Overall Study|respiratory failure|0|||
27884854|NCT01449630|54505078|FG000|Period 1|Physician Decision|1|||
27884855|NCT01449630|54505079|FG001|Period 1|Physician Decision|0|||
27884856|NCT01449630|54505080|FG002|Period 1|Physician Decision|0|||
27884857|NCT01449630|54505081|FG003|Period 1|Physician Decision|1|||
27884858|NCT01449630|54505082|FG004|Period 1|Physician Decision|0|||
27884859|NCT01449630|54505083|FG005|Period 1|Physician Decision|0|||
27884860|NCT01449630|54505084|FG006|Period 1|Physician Decision|0|||
27884861|NCT01449630|54505085|FG007|Period 1|Physician Decision|0|||
27884862|NCT01449630|54505086|FG008|Period 1|Physician Decision|0|||
27884863|NCT01449630|54505078|FG000|Period 1|Sponsor Decision|0|||
27884864|NCT01449630|54505079|FG001|Period 1|Sponsor Decision|0|||
27884865|NCT01449630|54505080|FG002|Period 1|Sponsor Decision|0|||
27884866|NCT01449630|54505081|FG003|Period 1|Sponsor Decision|0|||
27884867|NCT01449630|54505082|FG004|Period 1|Sponsor Decision|0|||
27884868|NCT01449630|54505083|FG005|Period 1|Sponsor Decision|1|||
27884869|NCT01449630|54505084|FG006|Period 1|Sponsor Decision|0|||
27884870|NCT01449630|54505085|FG007|Period 1|Sponsor Decision|0|||
27884871|NCT01449630|54505086|FG008|Period 1|Sponsor Decision|0|||
27884872|NCT01449630|54505078|FG000|Period 2|Sponsor Decision|0|||
27884873|NCT01449630|54505079|FG001|Period 2|Sponsor Decision|0|||
27884874|NCT01449630|54505080|FG002|Period 2|Sponsor Decision|0|||
27884875|NCT01449630|54505081|FG003|Period 2|Sponsor Decision|0|||
27884876|NCT01449630|54505082|FG004|Period 2|Sponsor Decision|0|||
27884877|NCT01449630|54505083|FG005|Period 2|Sponsor Decision|0|||
27884878|NCT01449630|54505084|FG006|Period 2|Sponsor Decision|1|||
27884879|NCT01449630|54505085|FG007|Period 2|Sponsor Decision|0|||
27884880|NCT01449630|54505086|FG008|Period 2|Sponsor Decision|0|||
27884881|NCT01493778|54505108|FG000|Overall Study|Withdrawal by Subject|8|||
27984639|NCT00895895|54643349|FG004|Period 2|Other|1|||
27984640|NCT00895895|54643345|FG000|Period 2|Protocol Violation|1|||
27984641|NCT00895895|54643346|FG001|Period 2|Protocol Violation|0|||
27984642|NCT00895895|54643347|FG002|Period 2|Protocol Violation|1|||
27984643|NCT00895895|54643348|FG003|Period 2|Protocol Violation|1|||
27984644|NCT00895895|54643349|FG004|Period 2|Protocol Violation|1|||
27984645|NCT00895895|54643345|FG000|Period 2|Withdrawal by Subject|0|||
27984646|NCT00895895|54643346|FG001|Period 2|Withdrawal by Subject|2|||
27984647|NCT00895895|54643347|FG002|Period 2|Withdrawal by Subject|0|||
27984648|NCT00895895|54643348|FG003|Period 2|Withdrawal by Subject|3|||
27984649|NCT00895895|54643349|FG004|Period 2|Withdrawal by Subject|5|||
27984650|NCT00895895|54643345|FG000|Period 2|unsatisfactory response-efficacy|2|||
27984651|NCT00895895|54643346|FG001|Period 2|unsatisfactory response-efficacy|1|||
27884882|NCT01473420|54505123|FG000|Titration Period (18 Weeks)|Adverse Event|4|||
27884883|NCT01473420|54505124|FG001|Titration Period (18 Weeks)|Adverse Event|6|||
27984652|NCT00895895|54643347|FG002|Period 2|unsatisfactory response-efficacy|0|||
27984653|NCT00895895|54643348|FG003|Period 2|unsatisfactory response-efficacy|0|||
27984654|NCT00895895|54643349|FG004|Period 2|unsatisfactory response-efficacy|0|||
27984655|NCT00895661|54643367|FG000|Overall Study|Death|1|||
27984656|NCT00895661|54643367|FG000|Overall Study|reason unknown|2|||
27984657|NCT00895583|54643373|FG000|Overall Study|Adverse Event|28|||
27984658|NCT00895583|54643374|FG001|Overall Study|Adverse Event|4|||
27884884|NCT01473420|54505123|FG000|Titration Period (18 Weeks)|Did not meet criteria|32|||
27984659|NCT00895583|54643373|FG000|Overall Study|Death|2|||
27984660|NCT00895583|54643374|FG001|Overall Study|Death|1|||
27984661|NCT00895583|54643373|FG000|Overall Study|Physician Decision|3|||
27984662|NCT00895583|54643374|FG001|Overall Study|Physician Decision|1|||
27984663|NCT00895583|54643373|FG000|Overall Study|Lost to Follow-up|1|||
27984664|NCT00895583|54643374|FG001|Overall Study|Lost to Follow-up|3|||
27984665|NCT00895583|54643373|FG000|Overall Study|Protocol Violation|1|||
27984666|NCT00895583|54643374|FG001|Overall Study|Protocol Violation|0|||
27984667|NCT00895583|54643373|FG000|Overall Study|Withdrawal by Subject|4|||
27984668|NCT00895583|54643374|FG001|Overall Study|Withdrawal by Subject|2|||
27984669|NCT00895583|54643373|FG000|Overall Study|Lack of Efficacy|5|||
27984670|NCT00895583|54643374|FG001|Overall Study|Lack of Efficacy|0|||
27984671|NCT00895583|54643373|FG000|Overall Study|Other|0|||
27984672|NCT00895583|54643374|FG001|Overall Study|Other|1|||
27984673|NCT00894413|54643391|FG000|Overall Study|Physician Decision|0|||
27984674|NCT00894413|54643392|FG001|Overall Study|Physician Decision|2|||
27984675|NCT00894413|54643391|FG000|Overall Study|Adverse Event|0|||
27984676|NCT00894413|54643392|FG001|Overall Study|Adverse Event|2|||
27984677|NCT00894413|54643391|FG000|Overall Study|Withdrawal by Subject|0|||
27984678|NCT00894413|54643392|FG001|Overall Study|Withdrawal by Subject|4|||
27984679|NCT00895037|54643401|FG000|Overall Study|Death|0|||
27984680|NCT00895037|54643402|FG001|Overall Study|Death|2|||
27984681|NCT00895037|54643403|FG002|Overall Study|Death|1|||
27984682|NCT00892151|54643411|FG000|Overall Study|Protocol Violation|1|||
27884885|NCT01473420|54505124|FG001|Titration Period (18 Weeks)|Did not meet criteria|32|||
27984683|NCT01706705|54643415|FG000|Overall Study|Death|1|||
27984684|NCT01706705|54643415|FG000|Overall Study|Lack of Efficacy|13|||
27984685|NCT01706705|54643415|FG000|Overall Study|Non-clinical|6|||
27984686|NCT00894803|54643431|FG000|Overall Study|Death|20|||
27984687|NCT00894803|54643432|FG001|Overall Study|Death|4|||
27984688|NCT00894803|54643431|FG000|Overall Study|Lost to Follow-up|0|||
27984689|NCT00894803|54643432|FG001|Overall Study|Lost to Follow-up|1|||
27984690|NCT00601458|54643441|FG000|Overall Study|Dosing Error|1|||
27984691|NCT00601458|54643442|FG001|Overall Study|Dosing Error|0|||
27984692|NCT00601458|54643443|FG002|Overall Study|Dosing Error|0|||
27884886|NCT01473420|54505123|FG000|Maintenance Period (16 Weeks)|Adverse Event|3|||
27884887|NCT01473420|54505124|FG001|Maintenance Period (16 Weeks)|Adverse Event|2|||
27884888|NCT01473420|54505123|FG000|Maintenance Period (16 Weeks)|Physician Decision|1|||
27884889|NCT01473420|54505124|FG001|Maintenance Period (16 Weeks)|Physician Decision|2|||
27984693|NCT00601458|54643441|FG000|Overall Study|Incomplete Data|0|||
27984694|NCT00601458|54643442|FG001|Overall Study|Incomplete Data|2|||
27984695|NCT00601458|54643443|FG002|Overall Study|Incomplete Data|0|||
27984696|NCT00601458|54643441|FG000|Overall Study|Protocol Violation|3|||
27984697|NCT00601458|54643442|FG001|Overall Study|Protocol Violation|2|||
27884890|NCT01473420|54505123|FG000|Maintenance Period (16 Weeks)|Did not meet criteria|0|||
27884891|NCT01473420|54505124|FG001|Maintenance Period (16 Weeks)|Did not meet criteria|2|||
27884892|NCT01473420|54505123|FG000|Maintenance Period (16 Weeks)|Kidney transplant|3|||
27884893|NCT01473420|54505124|FG001|Maintenance Period (16 Weeks)|Kidney transplant|1|||
27884894|NCT01473420|54505123|FG000|Maintenance Period (16 Weeks)|Lost to Follow-up|1|||
27884895|NCT01473420|54505124|FG001|Maintenance Period (16 Weeks)|Lost to Follow-up|2|||
27884896|NCT01473420|54505123|FG000|Maintenance Period (16 Weeks)|Withdrawal by Subject|4|||
27884897|NCT01473420|54505124|FG001|Maintenance Period (16 Weeks)|Withdrawal by Subject|6|||
27884898|NCT01473420|54505123|FG000|Maintenance Period (16 Weeks)|Site closure|3|||
27884899|NCT01473420|54505124|FG001|Maintenance Period (16 Weeks)|Site closure|1|||
27884900|NCT01473420|54505123|FG000|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1|||
27884901|NCT01473420|54505124|FG001|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0|||
27884902|NCT01473420|54505123|FG000|Maintenance Period (16 Weeks)|Long term hospitalization|0|||
27884903|NCT01473420|54505124|FG001|Maintenance Period (16 Weeks)|Long term hospitalization|1|||
27884904|NCT01473420|54505123|FG000|Maintenance Period (16 Weeks)|Sponsor's Decision|1|||
27884905|NCT01473420|54505124|FG001|Maintenance Period (16 Weeks)|Sponsor's Decision|0|||
27884906|NCT01473420|54505123|FG000|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1|||
27884907|NCT01473420|54505124|FG001|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0|||
27884908|NCT01492686|54505138|FG000|Double-blind Phase|Adverse Event|0|||
27884909|NCT01492686|54505139|FG001|Double-blind Phase|Adverse Event|2|||
27884910|NCT01492686|54505138|FG000|Double-blind Phase|Physician Decision|0|||
27884911|NCT01492686|54505139|FG001|Double-blind Phase|Physician Decision|1|||
27884912|NCT01492686|54505138|FG000|Double-blind Phase|Withdrawal by Subject|0|||
27884913|NCT01492686|54505139|FG001|Double-blind Phase|Withdrawal by Subject|2|||
27884914|NCT01492686|54505138|FG000|Double-blind Phase|Due to a discontinuation criterion|2|||
27884915|NCT01492686|54505139|FG001|Double-blind Phase|Due to a discontinuation criterion|3|||
27884916|NCT01492686|54505138|FG000|Open-label Phase|Adverse Event|1|||
27884917|NCT01492686|54505139|FG001|Open-label Phase|Adverse Event|2|||
27884918|NCT01492686|54505138|FG000|Open-label Phase|Physician Decision|1|||
27884919|NCT01492686|54505139|FG001|Open-label Phase|Physician Decision|0|||
27884920|NCT01492686|54505138|FG000|Open-label Phase|Withdrawal by Subject|6|||
27884921|NCT01492686|54505139|FG001|Open-label Phase|Withdrawal by Subject|7|||
27884922|NCT01492686|54505138|FG000|Open-label Phase|Due to a discontinuation criterion|4|||
27884923|NCT01492686|54505139|FG001|Open-label Phase|Due to a discontinuation criterion|9|||
27925700|NCT01256502|54582236|FG000|Overall Study|Had scaffold removed|4|||
27925701|NCT01256502|54582236|FG000|Overall Study|Personal reasons|5|||
27925702|NCT01256502|54582236|FG000|Overall Study|Protocol deviation|1|||
27925703|NCT01256190|54582247|FG000|Overall Study|Lost to Follow-up|2|||
27925704|NCT01256190|54582248|FG001|Overall Study|Lost to Follow-up|0|||
27925705|NCT01255722|54582257|FG000|Overall Study|Adverse Event|0|||
27925706|NCT01255722|54582258|FG001|Overall Study|Adverse Event|1|||
27925707|NCT01255722|54582259|FG002|Overall Study|Adverse Event|1|||
27925708|NCT01255722|54582257|FG000|Overall Study|asymptomatic patient|1|||
27925709|NCT01255722|54582258|FG001|Overall Study|asymptomatic patient|0|||
27925710|NCT01255722|54582259|FG002|Overall Study|asymptomatic patient|0|||
27925711|NCT01255722|54582257|FG000|Overall Study|beta-blocker contraindicated|2|||
27925712|NCT01255722|54582258|FG001|Overall Study|beta-blocker contraindicated|0|||
27925713|NCT01255722|54582259|FG002|Overall Study|beta-blocker contraindicated|0|||
27925714|NCT01231503|54582276|FG000|Overall Study|Adverse Event|0|||
27925715|NCT01231503|54582277|FG001|Overall Study|Adverse Event|0|||
27925716|NCT01231503|54582278|FG002|Overall Study|Adverse Event|0|||
27925717|NCT01231503|54582279|FG003|Overall Study|Adverse Event|0|||
27925718|NCT01231503|54582280|FG004|Overall Study|Adverse Event|0|||
27925719|NCT01231503|54582281|FG005|Overall Study|Adverse Event|1|||
27925720|NCT01231503|54582282|FG006|Overall Study|Adverse Event|0|||
27925721|NCT01231503|54582283|FG007|Overall Study|Adverse Event|0|||
27925722|NCT01231503|54582276|FG000|Overall Study|Adverse event, serious fatal|0|||
27925723|NCT01231503|54582277|FG001|Overall Study|Adverse event, serious fatal|0|||
27925724|NCT01231503|54582278|FG002|Overall Study|Adverse event, serious fatal|1|||
27925725|NCT01231503|54582279|FG003|Overall Study|Adverse event, serious fatal|1|||
27925726|NCT01231503|54582280|FG004|Overall Study|Adverse event, serious fatal|0|||
27925727|NCT01231503|54582281|FG005|Overall Study|Adverse event, serious fatal|1|||
27925728|NCT01231503|54582282|FG006|Overall Study|Adverse event, serious fatal|0|||
27925729|NCT01231503|54582283|FG007|Overall Study|Adverse event, serious fatal|0|||
27925730|NCT01231503|54582276|FG000|Overall Study|Withdrawal by Subject|6|||
27925731|NCT01231503|54582277|FG001|Overall Study|Withdrawal by Subject|3|||
27739353|NCT02434328|54188930|FG001|Overall Study|Physician Decision|1|||
27925732|NCT01231503|54582278|FG002|Overall Study|Withdrawal by Subject|3|||
27925733|NCT01231503|54582279|FG003|Overall Study|Withdrawal by Subject|1|||
27925734|NCT01231503|54582280|FG004|Overall Study|Withdrawal by Subject|3|||
27925735|NCT01231503|54582281|FG005|Overall Study|Withdrawal by Subject|5|||
27925736|NCT01231503|54582282|FG006|Overall Study|Withdrawal by Subject|1|||
27925737|NCT01231503|54582283|FG007|Overall Study|Withdrawal by Subject|2|||
27884924|NCT01449006|54505149|FG000|Overall Study|Lost to Follow-up|1|||
27884925|NCT01449006|54505150|FG001|Overall Study|Lost to Follow-up|0|||
27884926|NCT01449006|54505149|FG000|Overall Study|Withdrawal by Subject|1|||
27884927|NCT01449006|54505150|FG001|Overall Study|Withdrawal by Subject|0|||
27884928|NCT01449006|54505149|FG000|Overall Study|Protocol Violation|1|||
27884929|NCT01449006|54505150|FG001|Overall Study|Protocol Violation|0|||
27884930|NCT01448850|54505158|FG000|Overall Study|Death|3|||
27884931|NCT01448850|54505159|FG001|Overall Study|Death|6|||
27884932|NCT01448850|54505158|FG000|Overall Study|Withdrawal by Subject|13|||
27884933|NCT01448850|54505159|FG001|Overall Study|Withdrawal by Subject|21|||
27884934|NCT01448850|54505158|FG000|Overall Study|Lost to Follow-up|3|||
27884935|NCT01448850|54505159|FG001|Overall Study|Lost to Follow-up|1|||
27884936|NCT01448850|54505158|FG000|Overall Study|Other|15|||
27884937|NCT01448850|54505159|FG001|Overall Study|Other|12|||
27884938|NCT01491672|54505169|FG000|Overall Study|Lost to Follow-up|0|||
27884939|NCT01491672|54505170|FG001|Overall Study|Lost to Follow-up|4|||
27884940|NCT01491672|54505171|FG002|Overall Study|Lost to Follow-up|1|||
27884941|NCT01491672|54505169|FG000|Overall Study|Withdrawal by Subject|6|||
27884942|NCT01491672|54505170|FG001|Overall Study|Withdrawal by Subject|7|||
27884943|NCT01491672|54505171|FG002|Overall Study|Withdrawal by Subject|0|||
27884944|NCT01491672|54505169|FG000|Overall Study|Adverse Event|8|||
27884945|NCT01491672|54505170|FG001|Overall Study|Adverse Event|10|||
27884946|NCT01491672|54505171|FG002|Overall Study|Adverse Event|4|||
27884947|NCT01491672|54505169|FG000|Overall Study|Disease progression|42|||
27884948|NCT01491672|54505170|FG001|Overall Study|Disease progression|34|||
27884949|NCT01491672|54505171|FG002|Overall Study|Disease progression|6|||
27884950|NCT01491672|54505169|FG000|Overall Study|Protocol deviation|0|||
27884951|NCT01491672|54505170|FG001|Overall Study|Protocol deviation|1|||
27884952|NCT01491672|54505171|FG002|Overall Study|Protocol deviation|0|||
27884953|NCT01491672|54505169|FG000|Overall Study|Death|0|||
27884954|NCT01491672|54505170|FG001|Overall Study|Death|4|||
27884955|NCT01491672|54505171|FG002|Overall Study|Death|0|||
27884956|NCT01447446|54505187|FG000|Overall Study|Death|6|||
27884957|NCT01447446|54505188|FG001|Overall Study|Death|3|||
27884958|NCT01447446|54505189|FG002|Overall Study|Death|2|||
27884959|NCT01447446|54505190|FG003|Overall Study|Death|1|||
27884960|NCT01447446|54505191|FG004|Overall Study|Death|7|||
27884961|NCT01447446|54505192|FG005|Overall Study|Death|0|||
27884962|NCT01447446|54505187|FG000|Overall Study|Adverse Event|3|||
27884963|NCT01447446|54505188|FG001|Overall Study|Adverse Event|0|||
27884964|NCT01447446|54505189|FG002|Overall Study|Adverse Event|1|||
27884965|NCT01447446|54505190|FG003|Overall Study|Adverse Event|0|||
27884966|NCT01447446|54505191|FG004|Overall Study|Adverse Event|2|||
27884967|NCT01447446|54505192|FG005|Overall Study|Adverse Event|0|||
27884968|NCT01447446|54505187|FG000|Overall Study|Failure to Return/Consent Withdrawn|357|||
27884969|NCT01447446|54505188|FG001|Overall Study|Failure to Return/Consent Withdrawn|78|||
27884970|NCT01447446|54505189|FG002|Overall Study|Failure to Return/Consent Withdrawn|31|||
27884971|NCT01447446|54505190|FG003|Overall Study|Failure to Return/Consent Withdrawn|7|||
27884972|NCT01447446|54505191|FG004|Overall Study|Failure to Return/Consent Withdrawn|69|||
27884973|NCT01447446|54505192|FG005|Overall Study|Failure to Return/Consent Withdrawn|9|||
27884974|NCT01447446|54505187|FG000|Overall Study|Insuff. VR/TRT too Short to Expect VR|300|||
27884975|NCT01447446|54505188|FG001|Overall Study|Insuff. VR/TRT too Short to Expect VR|71|||
27884976|NCT01447446|54505189|FG002|Overall Study|Insuff. VR/TRT too Short to Expect VR|52|||
27884977|NCT01447446|54505190|FG003|Overall Study|Insuff. VR/TRT too Short to Expect VR|21|||
27884978|NCT01447446|54505191|FG004|Overall Study|Insuff. VR/TRT too Short to Expect VR|92|||
27884979|NCT01447446|54505192|FG005|Overall Study|Insuff. VR/TRT too Short to Expect VR|14|||
27884980|NCT01447446|54505187|FG000|Overall Study|Administrative/Other|34|||
27884981|NCT01447446|54505188|FG001|Overall Study|Administrative/Other|9|||
27884982|NCT01447446|54505189|FG002|Overall Study|Administrative/Other|10|||
27884983|NCT01447446|54505190|FG003|Overall Study|Administrative/Other|2|||
27884984|NCT01447446|54505191|FG004|Overall Study|Administrative/Other|33|||
27984698|NCT00601458|54643443|FG002|Overall Study|Protocol Violation|1|||
27984699|NCT00601458|54643441|FG000|Overall Study|Early Termination|0|||
27984700|NCT00601458|54643442|FG001|Overall Study|Early Termination|1|||
27984701|NCT00601458|54643443|FG002|Overall Study|Early Termination|1|||
27984702|NCT02141282|54643455|FG000|Overall Study|Adverse event, not related to progression|8|||
28096613|NCT03447262|54751781|FG000|Overall Study|Commercial Drug is Available for Participant|9|||
27884985|NCT01447446|54505192|FG005|Overall Study|Administrative/Other|4|||
27884986|NCT01447446|54505187|FG000|Overall Study|SVR12 Assessment|13|||
27884987|NCT01447446|54505188|FG001|Overall Study|SVR12 Assessment|1|||
27884988|NCT01447446|54505189|FG002|Overall Study|SVR12 Assessment|2|||
27884989|NCT01447446|54505190|FG003|Overall Study|SVR12 Assessment|1|||
27984703|NCT02141282|54643456|FG001|Overall Study|Adverse event, not related to progression|1|||
27884990|NCT01447446|54505191|FG004|Overall Study|SVR12 Assessment|5|||
27884991|NCT01447446|54505192|FG005|Overall Study|SVR12 Assessment|5|||
27884992|NCT01447446|54505187|FG000|Overall Study|New Treatment Started|8|||
27884993|NCT01447446|54505188|FG001|Overall Study|New Treatment Started|2|||
27984704|NCT02141282|54643457|FG002|Overall Study|Adverse event, not related to progression|3|||
27884994|NCT01447446|54505189|FG002|Overall Study|New Treatment Started|1|||
27884995|NCT01447446|54505190|FG003|Overall Study|New Treatment Started|0|||
27884996|NCT01447446|54505191|FG004|Overall Study|New Treatment Started|2|||
27884997|NCT01447446|54505192|FG005|Overall Study|New Treatment Started|0|||
27884998|NCT01447446|54505187|FG000|Overall Study|Reason not Specified|1|||
27884999|NCT01447446|54505188|FG001|Overall Study|Reason not Specified|1|||
27885000|NCT01447446|54505189|FG002|Overall Study|Reason not Specified|1|||
27885001|NCT01447446|54505190|FG003|Overall Study|Reason not Specified|1|||
27885002|NCT01447446|54505191|FG004|Overall Study|Reason not Specified|1|||
27885003|NCT01447446|54505192|FG005|Overall Study|Reason not Specified|0|||
27885004|NCT01490814|54505214|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
27885005|NCT01490814|54505215|FG001|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
27885006|NCT01490814|54505214|FG000|Overall Study|Physician Decision|1|||
27984705|NCT02141282|54643458|FG003|Overall Study|Adverse event, not related to progression|1|||
27984706|NCT02141282|54643455|FG000|Overall Study|Adverse event, related to progression|1|||
27984707|NCT02141282|54643456|FG001|Overall Study|Adverse event, related to progression|0|||
27984708|NCT02141282|54643457|FG002|Overall Study|Adverse event, related to progression|2|||
27984709|NCT02141282|54643458|FG003|Overall Study|Adverse event, related to progression|0|||
27885007|NCT01490814|54505215|FG001|Overall Study|Physician Decision|0|||
27885008|NCT01490814|54505214|FG000|Overall Study|Withdrawal by Subject|0|||
27885009|NCT01490814|54505215|FG001|Overall Study|Withdrawal by Subject|5|||
27885010|NCT01471782|54505227|FG000|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
27885011|NCT01471782|54505228|FG001|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
27885012|NCT01471782|54505229|FG002|Overall Study|Hematopoietic Stem Cell Transplantation|1|||
27885013|NCT01471782|54505230|FG003|Overall Study|Hematopoietic Stem Cell Transplantation|0|||
27885014|NCT01471782|54505231|FG004|Overall Study|Hematopoietic Stem Cell Transplantation|5|||
27885015|NCT01471782|54505232|FG005|Overall Study|Hematopoietic Stem Cell Transplantation|3|||
27885016|NCT01471782|54505227|FG000|Overall Study|Lack of Efficacy|1|||
27885017|NCT01471782|54505228|FG001|Overall Study|Lack of Efficacy|2|||
27885018|NCT01471782|54505229|FG002|Overall Study|Lack of Efficacy|1|||
27885019|NCT01471782|54505230|FG003|Overall Study|Lack of Efficacy|1|||
27885020|NCT01471782|54505231|FG004|Overall Study|Lack of Efficacy|5|||
27885021|NCT01471782|54505232|FG005|Overall Study|Lack of Efficacy|18|||
27885022|NCT01471782|54505227|FG000|Overall Study|Adverse Event|1|||
27885023|NCT01471782|54505228|FG001|Overall Study|Adverse Event|1|||
27885024|NCT01471782|54505229|FG002|Overall Study|Adverse Event|2|||
27885025|NCT01471782|54505230|FG003|Overall Study|Adverse Event|2|||
27885026|NCT01471782|54505231|FG004|Overall Study|Adverse Event|3|||
27885027|NCT01471782|54505232|FG005|Overall Study|Adverse Event|1|||
27885028|NCT01471782|54505227|FG000|Overall Study|Other|0|||
27885029|NCT01471782|54505228|FG001|Overall Study|Other|0|||
27885030|NCT01471782|54505229|FG002|Overall Study|Other|1|||
27885031|NCT01471782|54505230|FG003|Overall Study|Other|1|||
27885032|NCT01471782|54505231|FG004|Overall Study|Other|6|||
27885033|NCT01471782|54505232|FG005|Overall Study|Other|5|||
27885034|NCT01471782|54505227|FG000|Overall Study|Change of Chemotherapy|1|||
27885035|NCT01471782|54505228|FG001|Overall Study|Change of Chemotherapy|1|||
27885036|NCT01471782|54505229|FG002|Overall Study|Change of Chemotherapy|0|||
27885037|NCT01471782|54505230|FG003|Overall Study|Change of Chemotherapy|0|||
27885038|NCT01471782|54505231|FG004|Overall Study|Change of Chemotherapy|1|||
27885039|NCT01471782|54505232|FG005|Overall Study|Change of Chemotherapy|4|||
27885040|NCT01471782|54505227|FG000|Overall Study|Disease Relapse|0|||
27885041|NCT01471782|54505228|FG001|Overall Study|Disease Relapse|0|||
27885042|NCT01471782|54505229|FG002|Overall Study|Disease Relapse|0|||
27885043|NCT01471782|54505230|FG003|Overall Study|Disease Relapse|1|||
27885044|NCT01471782|54505231|FG004|Overall Study|Disease Relapse|2|||
27885045|NCT01471782|54505232|FG005|Overall Study|Disease Relapse|1|||
27885046|NCT01471782|54505227|FG000|Overall Study|Physician Decision|0|||
27885047|NCT01471782|54505228|FG001|Overall Study|Physician Decision|0|||
27885048|NCT01471782|54505229|FG002|Overall Study|Physician Decision|0|||
27885049|NCT01471782|54505230|FG003|Overall Study|Physician Decision|0|||
27885050|NCT01471782|54505231|FG004|Overall Study|Physician Decision|3|||
27885051|NCT01471782|54505232|FG005|Overall Study|Physician Decision|8|||
27885052|NCT01471782|54505227|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
27885053|NCT01471782|54505228|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
27885054|NCT01471782|54505229|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
27885055|NCT01471782|54505230|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
27984710|NCT02141282|54643455|FG000|Overall Study|COVID-19 infection|1|||
27984711|NCT02141282|54643456|FG001|Overall Study|COVID-19 infection|0|||
27984712|NCT02141282|54643457|FG002|Overall Study|COVID-19 infection|0|||
27885056|NCT01471782|54505231|FG004|Overall Study|Withdrawal by Parent/Guardian|1|||
27984713|NCT02141282|54643458|FG003|Overall Study|COVID-19 infection|0|||
28096614|NCT03447262|54751781|FG000|Overall Study|Death|2|||
27885057|NCT01471782|54505232|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
27885058|NCT01471782|54505227|FG000|Overall Study|Death|0|||
27885059|NCT01471782|54505228|FG001|Overall Study|Death|0|||
27885060|NCT01471782|54505229|FG002|Overall Study|Death|0|||
27885061|NCT01471782|54505230|FG003|Overall Study|Death|0|||
27885062|NCT01471782|54505231|FG004|Overall Study|Death|0|||
27885063|NCT01471782|54505232|FG005|Overall Study|Death|1|||
27885064|NCT01490580|54505259|FG000|Overall Study|Parents withdrew consent|0|||
27885065|NCT01490580|54505260|FG001|Overall Study|Parents withdrew consent|2|||
27885066|NCT01490190|54505270|FG000|Overall Study|Withdrawal by Subject|9|||
27885067|NCT01490190|54505270|FG000|Overall Study|Adverse Event|17|||
27885068|NCT01490190|54505270|FG000|Overall Study|Protocol Violation|5|||
27885069|NCT01490190|54505270|FG000|Overall Study|Lost to Follow-up|13|||
27885070|NCT01490190|54505270|FG000|Overall Study|Relocation|1|||
27885071|NCT01490190|54505270|FG000|Overall Study|Inconvenience|1|||
27885072|NCT01490190|54505270|FG000|Overall Study|Ring expulsion|2|||
27885073|NCT01446042|54505277|FG000|Overall Study|Withdrawal by Subject|12|||
27885074|NCT01446042|54505278|FG001|Overall Study|Withdrawal by Subject|2|||
27885075|NCT01446042|54505279|FG002|Overall Study|Withdrawal by Subject|4|||
27885076|NCT01446042|54505277|FG000|Overall Study|Adverse Event|1|||
27885077|NCT01446042|54505278|FG001|Overall Study|Adverse Event|0|||
27885078|NCT01446042|54505279|FG002|Overall Study|Adverse Event|4|||
27885079|NCT01446042|54505277|FG000|Overall Study|Lost to Follow-up|5|||
27885080|NCT01446042|54505278|FG001|Overall Study|Lost to Follow-up|0|||
27885081|NCT01446042|54505279|FG002|Overall Study|Lost to Follow-up|0|||
27885082|NCT01446042|54505277|FG000|Overall Study|Other reasons|2|||
27885083|NCT01446042|54505278|FG001|Overall Study|Other reasons|1|||
27885084|NCT01446042|54505279|FG002|Overall Study|Other reasons|1|||
27885085|NCT01445886|54505287|FG000|Overall Study|Lost to Follow-up|2|||
27885086|NCT01445886|54505287|FG000|Overall Study|Protocol Violation|3|||
27885087|NCT01470612|54505295|FG000|Overall Study|Adverse Event|20|||
27885088|NCT01470612|54505296|FG001|Overall Study|Adverse Event|80|||
27885089|NCT01470612|54505295|FG000|Overall Study|Death|0|||
27885090|NCT01470612|54505296|FG001|Overall Study|Death|1|||
27885091|NCT01470612|54505295|FG000|Overall Study|Lack of Efficacy|20|||
27885092|NCT01470612|54505296|FG001|Overall Study|Lack of Efficacy|326|||
27885093|NCT01470612|54505295|FG000|Overall Study|Lost to Follow-up|2|||
27885094|NCT01470612|54505296|FG001|Overall Study|Lost to Follow-up|5|||
27885095|NCT01470612|54505295|FG000|Overall Study|Did not meet entrance criteria|0|||
27885096|NCT01470612|54505296|FG001|Overall Study|Did not meet entrance criteria|1|||
27885097|NCT01470612|54505295|FG000|Overall Study|Pregnancy|2|||
27885098|NCT01470612|54505296|FG001|Overall Study|Pregnancy|10|||
27885099|NCT01470612|54505295|FG000|Overall Study|Protocol Violation|2|||
27885100|NCT01470612|54505296|FG001|Overall Study|Protocol Violation|7|||
27885101|NCT01470612|54505295|FG000|Overall Study|Withdrawal by Subject|24|||
27885102|NCT01470612|54505296|FG001|Overall Study|Withdrawal by Subject|79|||
27885103|NCT01470612|54505295|FG000|Overall Study|Other|14|||
27885104|NCT01470612|54505296|FG001|Overall Study|Other|156|||
27885105|NCT01445730|54505302|FG000|Overall Study|Adverse Event|1|||
27885106|NCT01445730|54505302|FG000|Overall Study|For the advice of a dentist|1|||
27885107|NCT01445730|54505302|FG000|Overall Study|The data from magnetic resonance examinations were not sufficient|9|||
27885108|NCT01445652|54505308|FG000|Overall Study|Not comfortable in lenses|5|||
27885109|NCT01445652|54505309|FG001|Overall Study|Not comfortable in lenses|0|||
27885110|NCT01445652|54505308|FG000|Overall Study|Failed to attend scheduled visit|2|||
27885111|NCT01445652|54505309|FG001|Overall Study|Failed to attend scheduled visit|3|||
27885112|NCT01445652|54505308|FG000|Overall Study|Failed teach session|2|||
27885113|NCT01445652|54505309|FG001|Overall Study|Failed teach session|0|||
27885114|NCT01445652|54505308|FG000|Overall Study|Adverse Event|1|||
27885115|NCT01445652|54505309|FG001|Overall Study|Adverse Event|0|||
27885116|NCT01470144|54505315|FG000|Overall Study|Adverse Event|2|||
27885117|NCT01470144|54505315|FG000|Overall Study|Death|1|||
27885118|NCT01470144|54505315|FG000|Overall Study|Lung transplant|6|||
27885119|NCT01470144|54505315|FG000|Overall Study|Patient's and investigator's decision|1|||
27885120|NCT01443858|54505322|FG000|Overall Study|Withdrawal by Subject|9|||
27885121|NCT01443858|54505323|FG001|Overall Study|Withdrawal by Subject|8|||
27885122|NCT01443858|54505324|FG002|Overall Study|Withdrawal by Subject|5|||
27885123|NCT01443858|54505322|FG000|Overall Study|Lack of Efficacy|1|||
27885124|NCT01443858|54505323|FG001|Overall Study|Lack of Efficacy|0|||
27885125|NCT01443858|54505324|FG002|Overall Study|Lack of Efficacy|0|||
27885126|NCT01443858|54505322|FG000|Overall Study|Lost to Follow-up|5|||
27885127|NCT01443858|54505323|FG001|Overall Study|Lost to Follow-up|5|||
27739354|NCT02434328|54188929|FG000|Overall Study|Withdrawal by Subject|12|||
27739355|NCT02434328|54188930|FG001|Overall Study|Withdrawal by Subject|21|||
27739356|NCT02434328|54188929|FG000|Overall Study|Death|4|||
27885128|NCT01443858|54505324|FG002|Overall Study|Lost to Follow-up|2|||
27885129|NCT01443078|54505332|FG000|Overall Study|Responded to neoadjuvant platinum txt|27|||
27885130|NCT01443078|54505332|FG000|Overall Study|Withdrawal by Subject|1|||
27885131|NCT01443078|54505332|FG000|Overall Study|Patient had brain mets|1|||
27885132|NCT01439880|54505338|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|24|||
27885133|NCT01439880|54505339|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|38|||
27885134|NCT01439880|54505338|FG000|SOC-controlled Period (Year 1)|Death|2|||
27885135|NCT01439880|54505339|FG001|SOC-controlled Period (Year 1)|Death|1|||
27885136|NCT01439880|54505338|FG000|SOC-controlled Period (Year 1)|Sponsor Decision|0|||
27885137|NCT01439880|54505339|FG001|SOC-controlled Period (Year 1)|Sponsor Decision|1|||
27885138|NCT01439880|54505338|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|10|||
27885139|NCT01439880|54505339|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|5|||
27885140|NCT01439880|54505338|FG000|SOC-controlled Period (Year 1)|Other|8|||
27885141|NCT01439880|54505339|FG001|SOC-controlled Period (Year 1)|Other|13|||
27885142|NCT01439880|54505338|FG000|SOC-controlled Period (Year 1)|Reason Missing|0|||
27885143|NCT01439880|54505339|FG001|SOC-controlled Period (Year 1)|Reason Missing|2|||
27885144|NCT01439880|54505338|FG000|All-IP Period (Years 2 to 5)|Lost to Follow-up|21|||
27885145|NCT01439880|54505339|FG001|All-IP Period (Years 2 to 5)|Lost to Follow-up|30|||
27885146|NCT01439880|54505338|FG000|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30|||
27885147|NCT01439880|54505339|FG001|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66|||
27885148|NCT01439880|54505338|FG000|All-IP Period (Years 2 to 5)|Death|3|||
27885149|NCT01439880|54505339|FG001|All-IP Period (Years 2 to 5)|Death|13|||
27885150|NCT01439880|54505338|FG000|All-IP Period (Years 2 to 5)|Sponsor Decision|1|||
27885151|NCT01439880|54505339|FG001|All-IP Period (Years 2 to 5)|Sponsor Decision|0|||
27885152|NCT01439880|54505338|FG000|All-IP Period (Years 2 to 5)|Other|14|||
27885153|NCT01439880|54505339|FG001|All-IP Period (Years 2 to 5)|Other|31|||
27885154|NCT01439880|54505338|FG000|All-IP Period (Years 2 to 5)|Reason Missing|1|||
27885155|NCT01439880|54505339|FG001|All-IP Period (Years 2 to 5)|Reason Missing|0|||
27885156|NCT01469364|54505356|FG000|Overall Study|Adverse Event|1|||
27885157|NCT01469364|54505356|FG000|Overall Study|Withdrawal by Subject|1|||
27885158|NCT01439724|54505362|FG000|Overall Study|missing consultation|9|||
27885159|NCT01439724|54505363|FG001|Overall Study|missing consultation|8|||
27885160|NCT01439568|54505371|FG000|Overall Study|Lost to Follow-up|1|||
27885161|NCT01439568|54505372|FG001|Overall Study|Lost to Follow-up|0|||
27885162|NCT01439568|54505371|FG000|Overall Study|Withdrawal by Subject|2|||
27885163|NCT01439568|54505372|FG001|Overall Study|Withdrawal by Subject|2|||
27885164|NCT01469052|54505384|FG000|Overall Study|Adverse Event|2|||
27885165|NCT01469052|54505385|FG001|Overall Study|Adverse Event|3|||
27885166|NCT01469052|54505386|FG002|Overall Study|Adverse Event|0|||
27885167|NCT01469052|54505387|FG003|Overall Study|Adverse Event|2|||
27885168|NCT01469052|54505388|FG004|Overall Study|Adverse Event|0|||
27885169|NCT01469052|54505389|FG005|Overall Study|Adverse Event|1|||
27885170|NCT01469052|54505384|FG000|Overall Study|Progressive disease|3|||
27885171|NCT01469052|54505385|FG001|Overall Study|Progressive disease|0|||
27885172|NCT01469052|54505386|FG002|Overall Study|Progressive disease|5|||
27885173|NCT01469052|54505387|FG003|Overall Study|Progressive disease|3|||
27885174|NCT01469052|54505388|FG004|Overall Study|Progressive disease|7|||
27885175|NCT01469052|54505389|FG005|Overall Study|Progressive disease|2|||
27885176|NCT01469052|54505384|FG000|Overall Study|Lack of Efficacy|0|||
27885177|NCT01469052|54505385|FG001|Overall Study|Lack of Efficacy|0|||
27885178|NCT01469052|54505386|FG002|Overall Study|Lack of Efficacy|0|||
27885179|NCT01469052|54505387|FG003|Overall Study|Lack of Efficacy|0|||
27885180|NCT01469052|54505388|FG004|Overall Study|Lack of Efficacy|0|||
27885181|NCT01469052|54505389|FG005|Overall Study|Lack of Efficacy|2|||
27885182|NCT01469052|54505384|FG000|Overall Study|Moved to rollover protocol|1|||
27885183|NCT01469052|54505385|FG001|Overall Study|Moved to rollover protocol|0|||
27885184|NCT01469052|54505386|FG002|Overall Study|Moved to rollover protocol|1|||
27885185|NCT01469052|54505387|FG003|Overall Study|Moved to rollover protocol|0|||
27885186|NCT01469052|54505388|FG004|Overall Study|Moved to rollover protocol|0|||
27885187|NCT01469052|54505389|FG005|Overall Study|Moved to rollover protocol|1|||
27885188|NCT01469052|54505384|FG000|Overall Study|Other|0|||
27885189|NCT01469052|54505385|FG001|Overall Study|Other|1|||
27885190|NCT01469052|54505386|FG002|Overall Study|Other|0|||
27885191|NCT01469052|54505387|FG003|Overall Study|Other|0|||
27885192|NCT01469052|54505388|FG004|Overall Study|Other|1|||
27885193|NCT01469052|54505389|FG005|Overall Study|Other|0|||
27885194|NCT01468818|54505401|FG000|Overall Study|Death during treatment|2|||
27885195|NCT01442376|54505408|FG000|Overall Study|Adverse Event|0|||
27885196|NCT01442376|54505409|FG001|Overall Study|Adverse Event|3|||
27885197|NCT01442376|54505410|FG002|Overall Study|Adverse Event|2|||
27885198|NCT01442376|54505408|FG000|Overall Study|Death|0|||
27885199|NCT01442376|54505409|FG001|Overall Study|Death|1|||
27885200|NCT01442376|54505410|FG002|Overall Study|Death|1|||
27885201|NCT01442376|54505408|FG000|Overall Study|Withdrawal of consent|0|||
27885202|NCT01442376|54505409|FG001|Overall Study|Withdrawal of consent|0|||
27885203|NCT01442376|54505410|FG002|Overall Study|Withdrawal of consent|1|||
27885204|NCT01442376|54505408|FG000|Overall Study|Patients not treated|2|||
27885205|NCT01442376|54505409|FG001|Overall Study|Patients not treated|3|||
27885206|NCT01442376|54505410|FG002|Overall Study|Patients not treated|1|||
27885207|NCT01442376|54505408|FG000|Overall Study|Not eligible for subsequent cycles|1|||
27885208|NCT01442376|54505409|FG001|Overall Study|Not eligible for subsequent cycles|2|||
27885209|NCT01442376|54505410|FG002|Overall Study|Not eligible for subsequent cycles|0|||
27885210|NCT01442064|54505424|FG000|Overall Study|Adverse Event|2|||
27885211|NCT01442064|54505425|FG001|Overall Study|Adverse Event|2|||
27885212|NCT01442064|54505426|FG002|Overall Study|Adverse Event|2|||
27885213|NCT01442064|54505427|FG003|Overall Study|Adverse Event|1|||
27885214|NCT01442064|54505428|FG004|Overall Study|Adverse Event|2|||
27885215|NCT01442064|54505429|FG005|Overall Study|Adverse Event|0|||
27885216|NCT01442064|54505424|FG000|Overall Study|Death|0|||
27885217|NCT01442064|54505425|FG001|Overall Study|Death|1|||
27885218|NCT01442064|54505426|FG002|Overall Study|Death|3|||
27885219|NCT01442064|54505427|FG003|Overall Study|Death|3|||
27885220|NCT01442064|54505428|FG004|Overall Study|Death|1|||
27885221|NCT01442064|54505429|FG005|Overall Study|Death|3|||
27885222|NCT01442064|54505424|FG000|Overall Study|Lost to Follow-up|5|||
27885223|NCT01442064|54505425|FG001|Overall Study|Lost to Follow-up|5|||
27885224|NCT01442064|54505426|FG002|Overall Study|Lost to Follow-up|1|||
27885225|NCT01442064|54505427|FG003|Overall Study|Lost to Follow-up|1|||
27885226|NCT01442064|54505428|FG004|Overall Study|Lost to Follow-up|3|||
27885227|NCT01442064|54505429|FG005|Overall Study|Lost to Follow-up|3|||
27885228|NCT01442064|54505424|FG000|Overall Study|Physician Decision|1|||
27885229|NCT01442064|54505425|FG001|Overall Study|Physician Decision|1|||
27885230|NCT01442064|54505426|FG002|Overall Study|Physician Decision|2|||
27885231|NCT01442064|54505427|FG003|Overall Study|Physician Decision|3|||
27885232|NCT01442064|54505428|FG004|Overall Study|Physician Decision|3|||
27885233|NCT01442064|54505429|FG005|Overall Study|Physician Decision|1|||
27885234|NCT01442064|54505424|FG000|Overall Study|Withdrawal by Subject|6|||
27885235|NCT01442064|54505425|FG001|Overall Study|Withdrawal by Subject|3|||
27885236|NCT01442064|54505426|FG002|Overall Study|Withdrawal by Subject|2|||
27885237|NCT01442064|54505427|FG003|Overall Study|Withdrawal by Subject|2|||
27885238|NCT01442064|54505428|FG004|Overall Study|Withdrawal by Subject|2|||
27885239|NCT01442064|54505429|FG005|Overall Study|Withdrawal by Subject|1|||
27885240|NCT01442064|54505424|FG000|Overall Study|Sponsor decision|82|||
27885241|NCT01442064|54505425|FG001|Overall Study|Sponsor decision|88|||
27885242|NCT01442064|54505426|FG002|Overall Study|Sponsor decision|92|||
27885243|NCT01442064|54505427|FG003|Overall Study|Sponsor decision|88|||
27885244|NCT01442064|54505428|FG004|Overall Study|Sponsor decision|95|||
27885245|NCT01442064|54505429|FG005|Overall Study|Sponsor decision|87|||
27885246|NCT01442064|54505424|FG000|Overall Study|Subject non-compliance|0|||
27885247|NCT01442064|54505425|FG001|Overall Study|Subject non-compliance|0|||
27885248|NCT01442064|54505426|FG002|Overall Study|Subject non-compliance|0|||
27885249|NCT01442064|54505427|FG003|Overall Study|Subject non-compliance|0|||
27885250|NCT01442064|54505428|FG004|Overall Study|Subject non-compliance|0|||
27885251|NCT01442064|54505429|FG005|Overall Study|Subject non-compliance|2|||
27885252|NCT01442064|54505424|FG000|Overall Study|Condition mandated other intervention|1|||
27885253|NCT01442064|54505425|FG001|Overall Study|Condition mandated other intervention|1|||
27885254|NCT01442064|54505426|FG002|Overall Study|Condition mandated other intervention|2|||
27885255|NCT01442064|54505427|FG003|Overall Study|Condition mandated other intervention|0|||
27885256|NCT01442064|54505428|FG004|Overall Study|Condition mandated other intervention|0|||
27885257|NCT01442064|54505429|FG005|Overall Study|Condition mandated other intervention|2|||
27885258|NCT01467960|54505452|FG000|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
27885259|NCT01467960|54505453|FG001|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
27885260|NCT01467960|54505454|FG002|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
27885261|NCT01467960|54505455|FG003|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
27885262|NCT01467960|54505456|FG004|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
27885263|NCT01467960|54505457|FG005|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
27885264|NCT01441596|54505474|FG000|Overall Study|Other reason not defined below|0|||
27885265|NCT01441596|54505475|FG001|Overall Study|Other reason not defined below|2|||
27885266|NCT01441596|54505476|FG002|Overall Study|Other reason not defined below|1|||
27885267|NCT01441596|54505474|FG000|Overall Study|Withdrawal by Subject|4|||
27885268|NCT01441596|54505475|FG001|Overall Study|Withdrawal by Subject|0|||
27885269|NCT01441596|54505476|FG002|Overall Study|Withdrawal by Subject|2|||
27885270|NCT01441596|54505474|FG000|Overall Study|Not treated|0|||
27885271|NCT01441596|54505475|FG001|Overall Study|Not treated|1|||
27885272|NCT01441596|54505476|FG002|Overall Study|Not treated|1|||
27885273|NCT01441440|54505487|FG000|Overall Study|Death|1|||
27885274|NCT01441440|54505488|FG001|Overall Study|Death|0|||
27885275|NCT01441440|54505489|FG002|Overall Study|Death|1|||
27885276|NCT01441440|54505487|FG000|Overall Study|Adverse Event|2|||
27885277|NCT01441440|54505488|FG001|Overall Study|Adverse Event|9|||
27885278|NCT01441440|54505489|FG002|Overall Study|Adverse Event|9|||
27885279|NCT01441440|54505487|FG000|Overall Study|Lost to Follow-up|0|||
27885280|NCT01441440|54505488|FG001|Overall Study|Lost to Follow-up|2|||
27885281|NCT01441440|54505489|FG002|Overall Study|Lost to Follow-up|1|||
27885282|NCT01441440|54505487|FG000|Overall Study|Withdrawal by Subject|11|||
27885283|NCT01441440|54505488|FG001|Overall Study|Withdrawal by Subject|9|||
27885284|NCT01441440|54505489|FG002|Overall Study|Withdrawal by Subject|9|||
27885285|NCT01441440|54505487|FG000|Overall Study|Pregnancy|1|||
27885286|NCT01441440|54505488|FG001|Overall Study|Pregnancy|0|||
27885287|NCT01441440|54505489|FG002|Overall Study|Pregnancy|0|||
27885288|NCT01441440|54505487|FG000|Overall Study|Lack of Efficacy|1|||
27885289|NCT01441440|54505488|FG001|Overall Study|Lack of Efficacy|0|||
27885290|NCT01441440|54505489|FG002|Overall Study|Lack of Efficacy|1|||
27885291|NCT01441440|54505487|FG000|Overall Study|Moving|0|||
27885292|NCT01441440|54505488|FG001|Overall Study|Moving|1|||
27885293|NCT01441440|54505489|FG002|Overall Study|Moving|1|||
27885294|NCT01441440|54505487|FG000|Overall Study|Work-related matter|0|||
27885295|NCT01441440|54505488|FG001|Overall Study|Work-related matter|1|||
27885296|NCT01441440|54505489|FG002|Overall Study|Work-related matter|0|||
27885297|NCT01441440|54505487|FG000|Overall Study|Difficllty in keeping the schedule|1|||
27885298|NCT01441440|54505488|FG001|Overall Study|Difficllty in keeping the schedule|1|||
27885299|NCT01441440|54505489|FG002|Overall Study|Difficllty in keeping the schedule|0|||
27885300|NCT01438476|54505499|FG000|Overall Study|Protocol Violation|1|||
27885301|NCT01438476|54505500|FG001|Overall Study|Protocol Violation|0|||
27885302|NCT01438476|54505499|FG000|Overall Study|Withdrawal by Subject|1|||
27885303|NCT01438476|54505500|FG001|Overall Study|Withdrawal by Subject|0|||
27885304|NCT01438476|54505499|FG000|Overall Study|No Surgery- Disease|8|||
27885305|NCT01438476|54505500|FG001|Overall Study|No Surgery- Disease|10|||
27885306|NCT01438476|54505499|FG000|Overall Study|Communication barrier|0|||
27885307|NCT01438476|54505500|FG001|Overall Study|Communication barrier|1|||
27885308|NCT01467570|54505508|FG000|Overall Study|Lost to Follow-up|8|||
27885309|NCT01467570|54505509|FG001|Overall Study|Lost to Follow-up|9|||
27885310|NCT01437540|54505519|FG000|Overall Study|Not listed below|7|||
27885311|NCT01437540|54505520|FG001|Overall Study|Not listed below|6|||
27885312|NCT01437540|54505519|FG000|Overall Study|COPD exacerbation|13|||
27885313|NCT01437540|54505520|FG001|Overall Study|COPD exacerbation|3|||
27885314|NCT01437540|54505519|FG000|Overall Study|Lost to Follow-up|3|||
27885315|NCT01437540|54505520|FG001|Overall Study|Lost to Follow-up|5|||
27885316|NCT01437540|54505519|FG000|Overall Study|Lack of Efficacy|23|||
27885317|NCT01437540|54505520|FG001|Overall Study|Lack of Efficacy|11|||
27885318|NCT01437540|54505519|FG000|Overall Study|Protocol Violation|24|||
27885319|NCT01437540|54505520|FG001|Overall Study|Protocol Violation|12|||
27885320|NCT01437540|54505519|FG000|Overall Study|Adverse Event|26|||
27885321|NCT01437540|54505520|FG001|Overall Study|Adverse Event|13|||
27885322|NCT01437540|54505519|FG000|Overall Study|Withdrawal by Subject|31|||
27885323|NCT01437540|54505520|FG001|Overall Study|Withdrawal by Subject|15|||
27885324|NCT01440972|54505528|FG000|Overall Study|Withdrawal by Subject|3|||
27885325|NCT01440972|54505529|FG001|Overall Study|Withdrawal by Subject|2|||
27885326|NCT01420536|54505537|FG000|Period 1 (30 Days)|Withdrawal by Subject|3|||
27885327|NCT01420536|54505538|FG001|Period 1 (30 Days)|Withdrawal by Subject|0|||
27885328|NCT01420068|54505548|FG000|Overall Study|Administrative problems|1|||
27885329|NCT01420068|54505549|FG001|Overall Study|Administrative problems|3|||
27885330|NCT01420068|54505548|FG000|Overall Study|Withdrawal by Subject|1|||
27885331|NCT01420068|54505549|FG001|Overall Study|Withdrawal by Subject|2|||
27885332|NCT01467492|54505557|FG000|Overall Study|Withdrawal by Subject|6|||
27885333|NCT01467492|54505558|FG001|Overall Study|Withdrawal by Subject|4|||
27885334|NCT01467492|54505557|FG000|Overall Study|Study Terminated by Sponsor|6|||
27885335|NCT01467492|54505558|FG001|Overall Study|Study Terminated by Sponsor|4|||
27885336|NCT01467492|54505557|FG000|Overall Study|Adverse Event|4|||
27885337|NCT01467492|54505558|FG001|Overall Study|Adverse Event|3|||
27885338|NCT01467492|54505557|FG000|Overall Study|Lost to Follow-up|3|||
27885339|NCT01467492|54505558|FG001|Overall Study|Lost to Follow-up|2|||
27885340|NCT01467492|54505557|FG000|Overall Study|Undefined|2|||
27885341|NCT01467492|54505558|FG001|Overall Study|Undefined|0|||
27885342|NCT01467492|54505557|FG000|Overall Study|Enrolled But Not Treated|1|||
27885343|NCT01467492|54505558|FG001|Overall Study|Enrolled But Not Treated|0|||
27885344|NCT01466790|54505573|FG000|Overall Study|Adverse Event|1|||
27885345|NCT01466790|54505574|FG001|Overall Study|Adverse Event|0|||
27885346|NCT01466790|54505575|FG002|Overall Study|Adverse Event|0|||
27885347|NCT01466790|54505576|FG003|Overall Study|Adverse Event|0|||
27885348|NCT01466790|54505577|FG004|Overall Study|Adverse Event|2|||
27885349|NCT01466790|54505578|FG005|Overall Study|Adverse Event|0|||
27885350|NCT01466790|54505579|FG006|Overall Study|Adverse Event|0|||
27885351|NCT01466790|54505580|FG007|Overall Study|Adverse Event|0|||
27885352|NCT01466790|54505573|FG000|Overall Study|Lost to Follow-up|2|||
27885353|NCT01466790|54505574|FG001|Overall Study|Lost to Follow-up|0|||
27885354|NCT01466790|54505575|FG002|Overall Study|Lost to Follow-up|0|||
27885355|NCT01466790|54505576|FG003|Overall Study|Lost to Follow-up|0|||
27885356|NCT01466790|54505577|FG004|Overall Study|Lost to Follow-up|0|||
27885357|NCT01466790|54505578|FG005|Overall Study|Lost to Follow-up|0|||
27885358|NCT01466790|54505579|FG006|Overall Study|Lost to Follow-up|0|||
27885359|NCT01466790|54505580|FG007|Overall Study|Lost to Follow-up|0|||
27885360|NCT01466790|54505573|FG000|Overall Study|Withdrawal by Subject|1|||
28171772|NCT01651000|54843333|FG001|Overall Study|Lack of Efficacy|1|||
27885361|NCT01466790|54505574|FG001|Overall Study|Withdrawal by Subject|1|||
27885362|NCT01466790|54505575|FG002|Overall Study|Withdrawal by Subject|0|||
27885363|NCT01466790|54505576|FG003|Overall Study|Withdrawal by Subject|0|||
27885364|NCT01466790|54505577|FG004|Overall Study|Withdrawal by Subject|1|||
27885365|NCT01466790|54505578|FG005|Overall Study|Withdrawal by Subject|0|||
27885366|NCT01466790|54505579|FG006|Overall Study|Withdrawal by Subject|1|||
28171773|NCT01651000|54843332|FG000|Overall Study|Physician Decision|1|||
27885367|NCT01466790|54505580|FG007|Overall Study|Withdrawal by Subject|1|||
27885368|NCT01418352|54505598|FG000|Overall Study|Lost to Follow-up|2|||
27885369|NCT01418352|54505599|FG001|Overall Study|Lost to Follow-up|0|||
27885370|NCT01418352|54505600|FG002|Overall Study|Lost to Follow-up|0|||
27885371|NCT01418352|54505601|FG003|Overall Study|Lost to Follow-up|0|||
27885372|NCT01418352|54505598|FG000|Overall Study|Adverse Event|0|||
27885373|NCT01418352|54505599|FG001|Overall Study|Adverse Event|1|||
27885374|NCT01418352|54505600|FG002|Overall Study|Adverse Event|0|||
27885375|NCT01418352|54505601|FG003|Overall Study|Adverse Event|0|||
27885376|NCT01418352|54505598|FG000|Overall Study|Sponsor Discontinued Trial Site|0|||
27885377|NCT01418352|54505599|FG001|Overall Study|Sponsor Discontinued Trial Site|2|||
27885378|NCT01418352|54505600|FG002|Overall Study|Sponsor Discontinued Trial Site|2|||
27885379|NCT01418352|54505601|FG003|Overall Study|Sponsor Discontinued Trial Site|2|||
27885380|NCT01418352|54505598|FG000|Overall Study|Subject Withdrew Consent|0|||
27885381|NCT01418352|54505599|FG001|Overall Study|Subject Withdrew Consent|1|||
27885382|NCT01418352|54505600|FG002|Overall Study|Subject Withdrew Consent|2|||
27885383|NCT01418352|54505601|FG003|Overall Study|Subject Withdrew Consent|1|||
27885384|NCT01418352|54505598|FG000|Overall Study|Protocol Deviation|0|||
27885385|NCT01418352|54505599|FG001|Overall Study|Protocol Deviation|0|||
27885386|NCT01418352|54505600|FG002|Overall Study|Protocol Deviation|1|||
27885387|NCT01418352|54505601|FG003|Overall Study|Protocol Deviation|0|||
27885388|NCT01418352|54505598|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|1|||
27885389|NCT01418352|54505599|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
27885390|NCT01418352|54505600|FG002|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
27885391|NCT01418352|54505601|FG003|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
27885392|NCT01436370|54505619|FG000|Overall Study|Lost to Follow-up|0|||
27885393|NCT01436370|54505620|FG001|Overall Study|Lost to Follow-up|0|||
27885394|NCT01436370|54505621|FG002|Overall Study|Lost to Follow-up|0|||
27885395|NCT01436370|54505622|FG003|Overall Study|Lost to Follow-up|0|||
27885396|NCT01436370|54505623|FG004|Overall Study|Lost to Follow-up|1|||
27885397|NCT01436370|54505624|FG005|Overall Study|Lost to Follow-up|0|||
27885398|NCT01436370|54505625|FG006|Overall Study|Lost to Follow-up|0|||
27885399|NCT01436370|54505626|FG007|Overall Study|Lost to Follow-up|0|||
27885400|NCT01465464|54505654|FG000|Overall Study|Adverse Event|96|||
27885401|NCT01465464|54505655|FG001|Overall Study|Adverse Event|49|||
27885402|NCT01465464|54505654|FG000|Overall Study|Lack of Efficacy|139|||
27885403|NCT01465464|54505655|FG001|Overall Study|Lack of Efficacy|190|||
27885404|NCT01465464|54505654|FG000|Overall Study|Physician Decision|13|||
27885405|NCT01465464|54505655|FG001|Overall Study|Physician Decision|5|||
27885406|NCT01465464|54505654|FG000|Overall Study|Protocol Violation|1|||
27885407|NCT01465464|54505655|FG001|Overall Study|Protocol Violation|1|||
27885408|NCT01465464|54505654|FG000|Overall Study|Withdrawal by Subject|46|||
27885409|NCT01465464|54505655|FG001|Overall Study|Withdrawal by Subject|30|||
27885410|NCT01465464|54505654|FG000|Overall Study|Other|9|||
27885411|NCT01465464|54505655|FG001|Overall Study|Other|3|||
27885412|NCT01465464|54505654|FG000|Overall Study|Ongoing treatment at cutoff date|140|||
27885413|NCT01465464|54505655|FG001|Overall Study|Ongoing treatment at cutoff date|166|||
27885414|NCT01417104|54505663|FG000|Overall Study|Withdrawal by Subject|5|||
27885415|NCT01417104|54505664|FG001|Overall Study|Withdrawal by Subject|1|||
27885416|NCT01417104|54505663|FG000|Overall Study|Failure to make contact|0|||
27885417|NCT01417104|54505664|FG001|Overall Study|Failure to make contact|1|||
27885418|NCT01417104|54505663|FG000|Overall Study|Adverse Event|1|||
27885419|NCT01417104|54505664|FG001|Overall Study|Adverse Event|0|||
27885420|NCT01465386|54505670|FG000|Overall Study|Lack of Efficacy|3|||
27885421|NCT01465386|54505670|FG000|Overall Study|Adverse Event|1|||
27885422|NCT01465230|54505674|FG000|Overall Study|Withdrawal by Subject|2|||
27885423|NCT01435356|54505680|FG000|Overall Study|Adverse Event|2|||
27885424|NCT01435356|54505681|FG001|Overall Study|Adverse Event|0|||
27885425|NCT01435356|54505680|FG000|Overall Study|Disease progression/recurrence|17|||
27885426|NCT01435356|54505681|FG001|Overall Study|Disease progression/recurrence|10|||
27885427|NCT01435356|54505680|FG000|Overall Study|Protocol Violation|0|||
27885428|NCT01435356|54505681|FG001|Overall Study|Protocol Violation|1|||
27885429|NCT01435356|54505680|FG000|Overall Study|Study Discontinuation, amendment 4|5|||
27885430|NCT01435356|54505681|FG001|Overall Study|Study Discontinuation, amendment 4|11|||
27885431|NCT01435356|54505680|FG000|Overall Study|Withdrawal by Subject|1|||
27885432|NCT01435356|54505681|FG001|Overall Study|Withdrawal by Subject|1|||
27984714|NCT02141282|54643455|FG000|Overall Study|Lost to Follow-up|0|||
27984715|NCT02141282|54643456|FG001|Overall Study|Lost to Follow-up|0|||
27885433|NCT01435356|54505680|FG000|Overall Study|Facial palsy|1|||
27885434|NCT01435356|54505681|FG001|Overall Study|Facial palsy|0|||
27885435|NCT01435356|54505680|FG000|Overall Study|IC withdrawal due to study cancellation|1|||
27885436|NCT01435356|54505681|FG001|Overall Study|IC withdrawal due to study cancellation|0|||
27885437|NCT01435356|54505680|FG000|Overall Study|Physician Decision|1|||
27885438|NCT01435356|54505681|FG001|Overall Study|Physician Decision|0|||
27885439|NCT01435356|54505680|FG000|Overall Study|Patient decision|3|||
27885440|NCT01435356|54505681|FG001|Overall Study|Patient decision|0|||
27885441|NCT01435356|54505680|FG000|Overall Study|Patient moved to another city|1|||
27885442|NCT01435356|54505681|FG001|Overall Study|Patient moved to another city|1|||
27885443|NCT01435122|54505687|FG000|Overall Study|Early withdrawal due to toxicity|8|||
27885444|NCT01434810|54505693|FG000|Overall Study|Did not receive treatment|11|||
27885445|NCT01434810|54505694|FG001|Overall Study|Did not receive treatment|3|||
27885446|NCT01434810|54505693|FG000|Overall Study|Missing data/received <5hr phototherapy|12|||
27885447|NCT01434810|54505694|FG001|Overall Study|Missing data/received <5hr phototherapy|7|||
27885448|NCT01393626|54505704|FG000|Overall Study|Adverse Event|2|||
27885449|NCT01393626|54505705|FG001|Overall Study|Adverse Event|1|||
27885450|NCT01393626|54505706|FG002|Overall Study|Adverse Event|5|||
27885451|NCT01393626|54505707|FG003|Overall Study|Adverse Event|0|||
27885452|NCT01393626|54505704|FG000|Overall Study|Did not meet entrance criteria|1|||
27885453|NCT01393626|54505705|FG001|Overall Study|Did not meet entrance criteria|0|||
27885454|NCT01393626|54505706|FG002|Overall Study|Did not meet entrance criteria|0|||
27885455|NCT01393626|54505707|FG003|Overall Study|Did not meet entrance criteria|0|||
27885456|NCT01393626|54505704|FG000|Overall Study|Lack of Efficacy|6|||
27885457|NCT01393626|54505705|FG001|Overall Study|Lack of Efficacy|6|||
27885458|NCT01393626|54505706|FG002|Overall Study|Lack of Efficacy|4|||
27885459|NCT01393626|54505707|FG003|Overall Study|Lack of Efficacy|1|||
27885460|NCT01393626|54505704|FG000|Overall Study|Lost to Follow-up|1|||
27885461|NCT01393626|54505705|FG001|Overall Study|Lost to Follow-up|1|||
27885462|NCT01393626|54505706|FG002|Overall Study|Lost to Follow-up|1|||
27885463|NCT01393626|54505707|FG003|Overall Study|Lost to Follow-up|0|||
27885464|NCT01393626|54505704|FG000|Overall Study|Withdrawal by Subject|6|||
27885465|NCT01393626|54505705|FG001|Overall Study|Withdrawal by Subject|4|||
27885466|NCT01393626|54505706|FG002|Overall Study|Withdrawal by Subject|0|||
27885467|NCT01393626|54505707|FG003|Overall Study|Withdrawal by Subject|0|||
27885468|NCT01393626|54505704|FG000|Overall Study|Other|1|||
27885469|NCT01393626|54505705|FG001|Overall Study|Other|0|||
27885470|NCT01393626|54505706|FG002|Overall Study|Other|0|||
27885471|NCT01393626|54505707|FG003|Overall Study|Other|0|||
27885472|NCT01393626|54505704|FG000|Overall Study|Protocol Violation|1|||
27885473|NCT01393626|54505705|FG001|Overall Study|Protocol Violation|0|||
27885474|NCT01393626|54505706|FG002|Overall Study|Protocol Violation|2|||
27885475|NCT01393626|54505707|FG003|Overall Study|Protocol Violation|0|||
27885476|NCT01434654|54505726|FG000|Overall Study|Withdrawal by Subject|1|||
27885477|NCT01434654|54505727|FG001|Overall Study|Withdrawal by Subject|0|||
27885478|NCT01434654|54505726|FG000|Overall Study|Lost to Follow-up|1|||
27885479|NCT01434654|54505727|FG001|Overall Study|Lost to Follow-up|0|||
27885480|NCT01393158|54505737|FG000|Overall Study|Adverse Event|1|||
27885481|NCT01393158|54505738|FG001|Overall Study|Adverse Event|0|||
27885482|NCT01413360|54505750|FG000|Overall Study|Lost to Follow-up|2|||
27885483|NCT01413360|54505750|FG000|Overall Study|Adverse Event|1|||
27885484|NCT01413204|54505757|FG000|Overall Study|Adverse Event|1|||
27885485|NCT01413204|54505758|FG001|Overall Study|Adverse Event|2|||
27885486|NCT01413204|54505759|FG002|Overall Study|Adverse Event|2|||
27885487|NCT01413204|54505757|FG000|Overall Study|Physician Decision|3|||
27885488|NCT01413204|54505758|FG001|Overall Study|Physician Decision|0|||
27885489|NCT01413204|54505759|FG002|Overall Study|Physician Decision|2|||
27885490|NCT01413204|54505757|FG000|Overall Study|Withdrawal by Subject|1|||
27885491|NCT01413204|54505758|FG001|Overall Study|Withdrawal by Subject|4|||
27885492|NCT01413204|54505759|FG002|Overall Study|Withdrawal by Subject|4|||
27885493|NCT01413204|54505757|FG000|Overall Study|Clearly not eligible for the study|0|||
27885494|NCT01413204|54505758|FG001|Overall Study|Clearly not eligible for the study|0|||
27885495|NCT01413204|54505759|FG002|Overall Study|Clearly not eligible for the study|1|||
27885496|NCT01413204|54505757|FG000|Overall Study|Fasting plasma glucose level increased|1|||
27885497|NCT01413204|54505758|FG001|Overall Study|Fasting plasma glucose level increased|0|||
27885498|NCT01413204|54505759|FG002|Overall Study|Fasting plasma glucose level increased|10|||
27885499|NCT01392378|54505772|FG000|Infant Series|Adverse Event|0|||
27885500|NCT01392378|54505773|FG001|Infant Series|Adverse Event|0|||
27885501|NCT01392378|54505774|FG002|Infant Series|Adverse Event|0|||
27885502|NCT01392378|54505775|FG003|Infant Series|Adverse Event|1|||
27885503|NCT01392378|54505776|FG004|Infant Series|Adverse Event|0|||
27885504|NCT01392378|54505772|FG000|Infant Series|Lost to Follow-up|0|||
27885505|NCT01392378|54505773|FG001|Infant Series|Lost to Follow-up|0|||
27885506|NCT01392378|54505774|FG002|Infant Series|Lost to Follow-up|0|||
27885507|NCT01392378|54505775|FG003|Infant Series|Lost to Follow-up|1|||
27885508|NCT01392378|54505776|FG004|Infant Series|Lost to Follow-up|0|||
27885509|NCT01392378|54505772|FG000|Infant Series|Protocol Violation|0|||
27885510|NCT01392378|54505773|FG001|Infant Series|Protocol Violation|1|||
27885511|NCT01392378|54505774|FG002|Infant Series|Protocol Violation|0|||
28171774|NCT01651000|54843333|FG001|Overall Study|Physician Decision|0|||
28171775|NCT01651000|54843332|FG000|Overall Study|Administrative reason|1|||
27885512|NCT01392378|54505775|FG003|Infant Series|Protocol Violation|0|||
27885513|NCT01392378|54505776|FG004|Infant Series|Protocol Violation|0|||
27885514|NCT01392378|54505772|FG000|Infant Series|Withdrawal by Parent|4|||
27885515|NCT01392378|54505773|FG001|Infant Series|Withdrawal by Parent|1|||
27885516|NCT01392378|54505774|FG002|Infant Series|Withdrawal by Parent|0|||
28171776|NCT01651000|54843333|FG001|Overall Study|Administrative reason|0|||
27885517|NCT01392378|54505775|FG003|Infant Series|Withdrawal by Parent|0|||
27885518|NCT01392378|54505776|FG004|Infant Series|Withdrawal by Parent|0|||
27885519|NCT01392378|54505772|FG000|After Infant Series|Lost to Follow-up|0|||
27885520|NCT01392378|54505773|FG001|After Infant Series|Lost to Follow-up|0|||
27885521|NCT01392378|54505774|FG002|After Infant Series|Lost to Follow-up|1|||
27885522|NCT01392378|54505775|FG003|After Infant Series|Lost to Follow-up|0|||
27885523|NCT01392378|54505776|FG004|After Infant Series|Lost to Follow-up|0|||
27885524|NCT01392378|54505772|FG000|After Infant Series|Withdrawal by Parent|0|||
27885525|NCT01392378|54505773|FG001|After Infant Series|Withdrawal by Parent|1|||
27885526|NCT01392378|54505774|FG002|After Infant Series|Withdrawal by Parent|1|||
27885527|NCT01392378|54505775|FG003|After Infant Series|Withdrawal by Parent|0|||
27885528|NCT01392378|54505776|FG004|After Infant Series|Withdrawal by Parent|1|||
27885529|NCT01392378|54505772|FG000|Toddler Dose|Lost to Follow-up|0|||
27885530|NCT01392378|54505773|FG001|Toddler Dose|Lost to Follow-up|0|||
27885531|NCT01392378|54505774|FG002|Toddler Dose|Lost to Follow-up|0|||
27885532|NCT01392378|54505775|FG003|Toddler Dose|Lost to Follow-up|1|||
27885533|NCT01392378|54505776|FG004|Toddler Dose|Lost to Follow-up|0|||
27885534|NCT01392378|54505772|FG000|Toddler Dose|Withdrawal by Parent|0|||
27885535|NCT01392378|54505773|FG001|Toddler Dose|Withdrawal by Parent|1|||
27885536|NCT01392378|54505774|FG002|Toddler Dose|Withdrawal by Parent|0|||
27885537|NCT01392378|54505775|FG003|Toddler Dose|Withdrawal by Parent|1|||
27885538|NCT01392378|54505776|FG004|Toddler Dose|Withdrawal by Parent|1|||
27885539|NCT01412424|54505798|FG000|Core Treatment Period|Treatment Failure|24|||
27885540|NCT01412424|54505798|FG000|Core Treatment Period|Adverse Event|21|||
27885541|NCT01412424|54505798|FG000|Core Treatment Period|Patient Request|5|||
27885542|NCT01412424|54505798|FG000|Core Treatment Period|Lost to Follow-up|2|||
27885543|NCT01412424|54505798|FG000|Core Treatment Period|Sponsor Request|1|||
27885544|NCT01412424|54505798|FG000|Extension Treatment Period|Adverse Event|2|||
27885545|NCT01412424|54505798|FG000|Extension Treatment Period|Treatment Failure|2|||
27885546|NCT01412424|54505798|FG000|Extension Treatment Period|Patient Request|2|||
27885547|NCT01433250|54505810|FG000|Overall Study|Protocol Violation|0|||
27885548|NCT01433250|54505811|FG001|Overall Study|Protocol Violation|1|||
27885549|NCT01433250|54505810|FG000|Overall Study|Withdrawal by Subject|3|||
27885550|NCT01433250|54505811|FG001|Overall Study|Withdrawal by Subject|2|||
27885551|NCT01433172|54505820|FG000|Overall Study|Withdrawal by Subject|0|||
27885552|NCT01433172|54505821|FG001|Overall Study|Withdrawal by Subject|1|||
27885553|NCT01433172|54505822|FG002|Overall Study|Withdrawal by Subject|0|||
27885554|NCT01433172|54505820|FG000|Overall Study|Disease Progression|0|||
27885555|NCT01433172|54505821|FG001|Overall Study|Disease Progression|0|||
27885556|NCT01433172|54505822|FG002|Overall Study|Disease Progression|1|||
27885557|NCT01433172|54505820|FG000|Overall Study|Death|0|||
27885558|NCT01433172|54505821|FG001|Overall Study|Death|2|||
27885559|NCT01433172|54505822|FG002|Overall Study|Death|0|||
27885560|NCT01432938|54505830|FG000|First Intervention|Protocol Violation|1|||
27885561|NCT01432938|54505831|FG001|First Intervention|Protocol Violation|0|||
27885562|NCT01432938|54505830|FG000|First Intervention|Physician Decision|1|||
27885563|NCT01432938|54505831|FG001|First Intervention|Physician Decision|0|||
27885564|NCT01432938|54505830|FG000|Second Intervention|Adverse Event|1|||
27885565|NCT01432938|54505831|FG001|Second Intervention|Adverse Event|0|||
27885566|NCT01392300|54505840|FG000|Main Period (MP)|Predefined discontinuation criteria|2|||
27885567|NCT01392300|54505841|FG001|Main Period (MP)|Predefined discontinuation criteria|3|||
27885568|NCT01392300|54505842|FG002|Main Period (MP)|Predefined discontinuation criteria|0|||
27885569|NCT01392300|54505840|FG000|Main Period (MP)|Withdrawal by Subject|5|||
27885570|NCT01392300|54505841|FG001|Main Period (MP)|Withdrawal by Subject|1|||
27885571|NCT01392300|54505842|FG002|Main Period (MP)|Withdrawal by Subject|0|||
27885572|NCT01392300|54505840|FG000|Main Period (MP)|Lost to Follow-up|3|||
27885573|NCT01392300|54505841|FG001|Main Period (MP)|Lost to Follow-up|3|||
27885574|NCT01392300|54505842|FG002|Main Period (MP)|Lost to Follow-up|0|||
27885575|NCT01392300|54505840|FG000|Main Period (MP)|Non-compliance|1|||
27885576|NCT01392300|54505841|FG001|Main Period (MP)|Non-compliance|0|||
27885577|NCT01392300|54505842|FG002|Main Period (MP)|Non-compliance|0|||
27885578|NCT01392300|54505840|FG000|Open Label Extension (OLEX) Period|Protocol Violation|0|||
27885579|NCT01392300|54505841|FG001|Open Label Extension (OLEX) Period|Protocol Violation|0|||
27885580|NCT01392300|54505842|FG002|Open Label Extension (OLEX) Period|Protocol Violation|13|||
27885581|NCT01392300|54505840|FG000|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
27885582|NCT01392300|54505841|FG001|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
27885583|NCT01392300|54505842|FG002|Open Label Extension (OLEX) Period|Lack of Efficacy|3|||
27885584|NCT01392300|54505840|FG000|Open Label Extension (OLEX) Period|Non-compliance|0|||
27885585|NCT01392300|54505841|FG001|Open Label Extension (OLEX) Period|Non-compliance|0|||
27885586|NCT01392300|54505842|FG002|Open Label Extension (OLEX) Period|Non-compliance|1|||
27885587|NCT01392300|54505840|FG000|Open Label Extension (OLEX) Period|Death|0|||
27885588|NCT01392300|54505841|FG001|Open Label Extension (OLEX) Period|Death|0|||
27885589|NCT01392300|54505842|FG002|Open Label Extension (OLEX) Period|Death|4|||
27984716|NCT02141282|54643457|FG002|Overall Study|Lost to Follow-up|4|||
27885590|NCT01392300|54505840|FG000|Open Label Extension (OLEX) Period|Adverse Event|0|||
27885591|NCT01392300|54505841|FG001|Open Label Extension (OLEX) Period|Adverse Event|0|||
27885592|NCT01392300|54505842|FG002|Open Label Extension (OLEX) Period|Adverse Event|7|||
27885593|NCT01392300|54505840|FG000|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
27885594|NCT01392300|54505841|FG001|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
27885595|NCT01392300|54505842|FG002|Open Label Extension (OLEX) Period|Withdrawal by Subject|17|||
27885596|NCT01392300|54505840|FG000|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
27885597|NCT01392300|54505841|FG001|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
27885598|NCT01392300|54505842|FG002|Open Label Extension (OLEX) Period|Lost to Follow-up|6|||
27885599|NCT01432626|54505849|FG000|Overall Study|LV function recovered|2|||
27885600|NCT01432626|54505849|FG000|Overall Study|Withdrawal by Subject|2|||
27885601|NCT01432626|54505849|FG000|Overall Study|Only 1 image competed|2|||
27885602|NCT01432626|54505849|FG000|Overall Study|Imaging agent not available|1|||
27885603|NCT01391832|54505855|FG000|Overall Study|Withdrawal by Subject|21|||
27885604|NCT01391832|54505856|FG001|Overall Study|Withdrawal by Subject|22|||
27885605|NCT01391832|54505855|FG000|Overall Study|Lost to Follow-up|0|||
27885606|NCT01391832|54505856|FG001|Overall Study|Lost to Follow-up|1|||
27885607|NCT01410474|54505864|FG000|Overall Study|Withdrawal by Subject|0|||
27885608|NCT01410474|54505865|FG001|Overall Study|Withdrawal by Subject|1|||
27885609|NCT01391130|54505880|FG000|Overall Study|Withdrawal by Subject|3|||
27885610|NCT01391130|54505881|FG001|Overall Study|Withdrawal by Subject|2|||
27885611|NCT01391130|54505880|FG000|Overall Study|Physician Decision|2|||
27885612|NCT01391130|54505881|FG001|Overall Study|Physician Decision|3|||
27885613|NCT01391130|54505880|FG000|Overall Study|Did not Receive Drug|1|||
27885614|NCT01391130|54505881|FG001|Overall Study|Did not Receive Drug|1|||
27885615|NCT01410240|54505890|FG000|Overall Study|Physician Decision|0|||
27885616|NCT01410240|54505891|FG001|Overall Study|Physician Decision|0|||
27885617|NCT01410240|54505892|FG002|Overall Study|Physician Decision|1|||
27885618|NCT01410240|54505890|FG000|Overall Study|Missed week 6 assessments|1|||
27885619|NCT01410240|54505891|FG001|Overall Study|Missed week 6 assessments|1|||
27885620|NCT01410240|54505892|FG002|Overall Study|Missed week 6 assessments|1|||
27885621|NCT01409928|54505901|FG000|Overall Study|Physician Decision|12|||
27885622|NCT01431534|54505908|FG000|Treatment Phase|Adverse Event|0|||
27885623|NCT01431534|54505909|FG001|Treatment Phase|Adverse Event|0|||
27885624|NCT01431534|54505910|FG002|Treatment Phase|Adverse Event|1|||
27885625|NCT01431534|54505908|FG000|Treatment Phase|Progressive Disease|4|||
27885626|NCT01431534|54505909|FG001|Treatment Phase|Progressive Disease|3|||
27885627|NCT01431534|54505910|FG002|Treatment Phase|Progressive Disease|10|||
27885628|NCT01409382|54505920|FG000|Overall Study|Lost to Follow-up|1|||
27885629|NCT01409382|54505921|FG001|Overall Study|Lost to Follow-up|1|||
27885630|NCT01409382|54505920|FG000|Overall Study|Protocol Violation|0|||
27885631|NCT01409382|54505921|FG001|Overall Study|Protocol Violation|3|||
27885632|NCT01409382|54505920|FG000|Overall Study|Multiple pregnancy|2|||
27885633|NCT01409382|54505921|FG001|Overall Study|Multiple pregnancy|4|||
27885634|NCT01409382|54505920|FG000|Overall Study|Still pregnant when study ended|13|||
27885635|NCT01409382|54505921|FG001|Overall Study|Still pregnant when study ended|2|||
27885636|NCT01409382|54505920|FG000|Overall Study|Did not manage to get pregnant|64|||
27885637|NCT01409382|54505921|FG001|Overall Study|Did not manage to get pregnant|70|||
27885638|NCT01409382|54505920|FG000|Overall Study|Had a 2nd trimester loss after accident|1|||
27885639|NCT01409382|54505921|FG001|Overall Study|Had a 2nd trimester loss after accident|0|||
27885640|NCT01408914|54505934|FG000|Overall Study|Could not complete tx in protocol period|5|||
27885641|NCT01408914|54505935|FG001|Overall Study|Could not complete tx in protocol period|5|||
27885642|NCT01408914|54505936|FG002|Overall Study|Could not complete tx in protocol period|6|||
27885643|NCT01408914|54505934|FG000|Overall Study|Lost to Follow-up|4|||
27885644|NCT01408914|54505935|FG001|Overall Study|Lost to Follow-up|1|||
27885645|NCT01408914|54505936|FG002|Overall Study|Lost to Follow-up|2|||
27885646|NCT01408914|54505934|FG000|Overall Study|Physician Decision|1|||
27885647|NCT01408914|54505935|FG001|Overall Study|Physician Decision|1|||
27885648|NCT01408914|54505936|FG002|Overall Study|Physician Decision|0|||
27885649|NCT01408914|54505934|FG000|Overall Study|Withdrawal by Subject|1|||
27885650|NCT01408914|54505935|FG001|Overall Study|Withdrawal by Subject|0|||
27885651|NCT01408914|54505936|FG002|Overall Study|Withdrawal by Subject|1|||
27984717|NCT02141282|54643458|FG003|Overall Study|Lost to Follow-up|2|||
27984718|NCT02141282|54643455|FG000|Overall Study|Other, not specified|14|||
27984719|NCT02141282|54643456|FG001|Overall Study|Other, not specified|11|||
27885652|NCT01408914|54505934|FG000|Overall Study|Moved out of study jurisdiction|1|||
27885653|NCT01408914|54505935|FG001|Overall Study|Moved out of study jurisdiction|1|||
27885654|NCT01408914|54505936|FG002|Overall Study|Moved out of study jurisdiction|0|||
27885655|NCT01408914|54505934|FG000|Overall Study|Late exclusion|0|||
27885656|NCT01408914|54505935|FG001|Overall Study|Late exclusion|3|||
27885657|NCT01408914|54505936|FG002|Overall Study|Late exclusion|3|||
27885658|NCT01408914|54505934|FG000|Overall Study|Change in local TB/HIV norms|0|||
27885659|NCT01408914|54505935|FG001|Overall Study|Change in local TB/HIV norms|1|||
27885660|NCT01408914|54505936|FG002|Overall Study|Change in local TB/HIV norms|1|||
27885661|NCT01431144|54505946|FG000|Overall Study|Implant mobility and removal|2|||
27984720|NCT02141282|54643457|FG002|Overall Study|Other, not specified|23|||
27885662|NCT01431144|54505947|FG001|Overall Study|Implant mobility and removal|0|||
27885663|NCT01430754|54505956|FG000|Run-In Phase|Circadian Period Ineligible|24|||
27885664|NCT01430754|54505957|FG001|Run-In Phase|Circadian Period Ineligible|0|||
27885665|NCT01430754|54505956|FG000|Run-In Phase|Protocol Violation|6|||
27885666|NCT01430754|54505957|FG001|Run-In Phase|Protocol Violation|0|||
27885667|NCT01430754|54505956|FG000|Run-In Phase|Adverse Event|2|||
27885668|NCT01430754|54505957|FG001|Run-In Phase|Adverse Event|0|||
27885669|NCT01430754|54505956|FG000|Run-In Phase|Other|2|||
27984721|NCT02141282|54643458|FG003|Overall Study|Other, not specified|9|||
27984722|NCT02141282|54643455|FG000|Overall Study|Progressive disease, Richter's|4|||
27984723|NCT02141282|54643456|FG001|Overall Study|Progressive disease, Richter's|1|||
27984724|NCT02141282|54643457|FG002|Overall Study|Progressive disease, Richter's|1|||
27984725|NCT02141282|54643458|FG003|Overall Study|Progressive disease, Richter's|1|||
27984726|NCT02141282|54643455|FG000|Overall Study|Progressive disease per protocol|12|||
27984727|NCT02141282|54643456|FG001|Overall Study|Progressive disease per protocol|7|||
27984728|NCT02141282|54643457|FG002|Overall Study|Progressive disease per protocol|9|||
27984729|NCT02141282|54643458|FG003|Overall Study|Progressive disease per protocol|2|||
27984730|NCT02141282|54643455|FG000|Overall Study|Stem cell transplant|1|||
27984731|NCT02141282|54643456|FG001|Overall Study|Stem cell transplant|0|||
27984732|NCT02141282|54643457|FG002|Overall Study|Stem cell transplant|1|||
27984733|NCT02141282|54643458|FG003|Overall Study|Stem cell transplant|0|||
27984734|NCT02141282|54643455|FG000|Overall Study|Study terminated by Sponsor|0|||
27984735|NCT02141282|54643456|FG001|Overall Study|Study terminated by Sponsor|1|||
27984736|NCT02141282|54643457|FG002|Overall Study|Study terminated by Sponsor|0|||
27984737|NCT02141282|54643458|FG003|Overall Study|Study terminated by Sponsor|0|||
27984738|NCT02141282|54643455|FG000|Overall Study|Subject non-compliance|0|||
27984739|NCT02141282|54643456|FG001|Overall Study|Subject non-compliance|0|||
27984740|NCT02141282|54643457|FG002|Overall Study|Subject non-compliance|1|||
27984741|NCT02141282|54643458|FG003|Overall Study|Subject non-compliance|0|||
27984742|NCT02141282|54643455|FG000|Overall Study|Withdrew consent|2|||
27984743|NCT02141282|54643456|FG001|Overall Study|Withdrew consent|0|||
27984744|NCT02141282|54643457|FG002|Overall Study|Withdrew consent|4|||
27984745|NCT02141282|54643458|FG003|Overall Study|Withdrew consent|0|||
27984746|NCT00003479|54643471|FG000|Overall Study|Not evaluable|3|||
27984747|NCT00891839|54643475|FG000|Overall Study|Adverse Event|2|||
27984748|NCT00891839|54643475|FG000|Overall Study|Withdrawal by Subject|2|||
27984749|NCT00891839|54643475|FG000|Overall Study|Disease progression|3|||
27984750|NCT00600756|54643481|FG000|Analysis After 6 Months|Adverse Event|43|||
27984751|NCT00600756|54643482|FG001|Analysis After 6 Months|Adverse Event|33|||
27984752|NCT00600756|54643481|FG000|Analysis After 6 Months|Withdrawal by Subject|38|||
27984753|NCT00600756|54643482|FG001|Analysis After 6 Months|Withdrawal by Subject|30|||
27984754|NCT00600756|54643481|FG000|Analysis After 6 Months|Incorrect Enrollment|12|||
27984755|NCT00600756|54643482|FG001|Analysis After 6 Months|Incorrect Enrollment|21|||
27984756|NCT00600756|54643481|FG000|Analysis After 6 Months|worsening symptom, lack of efficacy|11|||
27984757|NCT00600756|54643482|FG001|Analysis After 6 Months|worsening symptom, lack of efficacy|14|||
27984758|NCT00600756|54643481|FG000|Analysis After 6 Months|Severe non-compliance to protocol|11|||
27984759|NCT00600756|54643482|FG001|Analysis After 6 Months|Severe non-compliance to protocol|11|||
27984760|NCT00600756|54643481|FG000|Analysis After 6 Months|Lost to Follow-up|10|||
27984761|NCT00600756|54643482|FG001|Analysis After 6 Months|Lost to Follow-up|8|||
27984762|NCT00600756|54643481|FG000|Analysis After 6 Months|Study-specific discontinuation criteria|6|||
27984763|NCT00600756|54643482|FG001|Analysis After 6 Months|Study-specific discontinuation criteria|3|||
27984764|NCT00600756|54643481|FG000|Overall Study Analysis After 12 Months|Adverse Event|53|||
27984765|NCT00600756|54643482|FG001|Overall Study Analysis After 12 Months|Adverse Event|44|||
27984766|NCT00600756|54643481|FG000|Overall Study Analysis After 12 Months|Withdrawal by Subject|51|||
27984767|NCT00600756|54643482|FG001|Overall Study Analysis After 12 Months|Withdrawal by Subject|41|||
27984768|NCT00600756|54643481|FG000|Overall Study Analysis After 12 Months|Incorrect enrollment|21|||
27984769|NCT00600756|54643482|FG001|Overall Study Analysis After 12 Months|Incorrect enrollment|29|||
27984770|NCT00600756|54643481|FG000|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17|||
27984771|NCT00600756|54643482|FG001|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20|||
27984772|NCT00600756|54643481|FG000|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16|||
27984773|NCT00600756|54643482|FG001|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20|||
27984774|NCT00600756|54643481|FG000|Overall Study Analysis After 12 Months|Lost to Follow-up|16|||
27984775|NCT00600756|54643482|FG001|Overall Study Analysis After 12 Months|Lost to Follow-up|13|||
27984776|NCT00600756|54643481|FG000|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
27984777|NCT00600756|54643482|FG001|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
27984778|NCT00890825|54643494|FG000|Overall Study|Withdrawal by Subject|1|||
27739357|NCT02434328|54188930|FG001|Overall Study|Death|7|||
27984779|NCT00890825|54643495|FG001|Overall Study|Withdrawal by Subject|0|||
27885670|NCT01430754|54505957|FG001|Run-In Phase|Other|0|||
27885671|NCT01430754|54505956|FG000|Run-In Phase|Withdrawal by Subject|2|||
27885672|NCT01430754|54505957|FG001|Run-In Phase|Withdrawal by Subject|0|||
27885673|NCT01430754|54505956|FG000|Run-In Phase|Lost to Follow-up|1|||
27885674|NCT01430754|54505957|FG001|Run-In Phase|Lost to Follow-up|0|||
27885675|NCT01390428|54505971|FG000|Overall Study|Elective Surgery|0|||
27885676|NCT01390428|54505972|FG001|Overall Study|Elective Surgery|0|||
27885677|NCT01390428|54505973|FG002|Overall Study|Elective Surgery|0|||
27885678|NCT01390428|54505974|FG003|Overall Study|Elective Surgery|0|||
27885679|NCT01390428|54505975|FG004|Overall Study|Elective Surgery|1|||
27885680|NCT01390428|54505976|FG005|Overall Study|Elective Surgery|0|||
27885681|NCT01390428|54505971|FG000|Overall Study|Withdrawal by Subject|0|||
27885682|NCT01390428|54505972|FG001|Overall Study|Withdrawal by Subject|0|||
27885683|NCT01390428|54505973|FG002|Overall Study|Withdrawal by Subject|1|||
27885684|NCT01390428|54505974|FG003|Overall Study|Withdrawal by Subject|0|||
27885685|NCT01390428|54505975|FG004|Overall Study|Withdrawal by Subject|0|||
27885686|NCT01390428|54505976|FG005|Overall Study|Withdrawal by Subject|0|||
27885687|NCT01430130|54505990|FG000|Overall Study|Lost to Follow-up|1|||
27885688|NCT01430130|54505990|FG000|Overall Study|Infection on Control Side of Incision|1|||
27885689|NCT01407354|54505996|FG000|First Intervention|Withdrawal by Subject|0|||
27885690|NCT01407354|54505997|FG001|First Intervention|Withdrawal by Subject|2|||
27885691|NCT01407354|54505996|FG000|First Intervention|Adverse Event|1|||
27885692|NCT01407354|54505997|FG001|First Intervention|Adverse Event|0|||
27885693|NCT01407354|54505996|FG000|First Intervention|Physician Decision|1|||
27885694|NCT01407354|54505997|FG001|First Intervention|Physician Decision|0|||
27885695|NCT01407276|54506012|FG000|Overall Study|Withdrawal by Subject|0|||
27885696|NCT01407276|54506013|FG001|Overall Study|Withdrawal by Subject|0|||
27885697|NCT01407276|54506014|FG002|Overall Study|Withdrawal by Subject|0|||
27885698|NCT01407276|54506015|FG003|Overall Study|Withdrawal by Subject|0|||
27885699|NCT01407276|54506016|FG004|Overall Study|Withdrawal by Subject|0|||
27885700|NCT01407276|54506017|FG005|Overall Study|Withdrawal by Subject|0|||
27885701|NCT01407276|54506018|FG006|Overall Study|Withdrawal by Subject|0|||
27885702|NCT01407276|54506019|FG007|Overall Study|Withdrawal by Subject|1|||
27885703|NCT01390272|54506046|FG000|Overall Study|Death|3|||
27885704|NCT01390272|54506047|FG001|Overall Study|Death|2|||
27885705|NCT01390272|54506046|FG000|Overall Study|Withdrawal by Subject|9|||
27885706|NCT01390272|54506047|FG001|Overall Study|Withdrawal by Subject|5|||
27885707|NCT01390272|54506046|FG000|Overall Study|Patient moved, no longer eligible|5|||
27885708|NCT01390272|54506047|FG001|Overall Study|Patient moved, no longer eligible|8|||
27885709|NCT01429584|54506055|FG000|Overall Study|Withdrawal by Subject|1|||
27885710|NCT01429584|54506056|FG001|Overall Study|Withdrawal by Subject|0|||
27885711|NCT01429584|54506055|FG000|Overall Study|Protocol Violation|0|||
27885712|NCT01429584|54506056|FG001|Overall Study|Protocol Violation|1|||
27885713|NCT01406652|54506064|FG000|Overall Study|Lost-to-follow-up|3|||
27885714|NCT01406652|54506065|FG001|Overall Study|Lost-to-follow-up|4|||
27885715|NCT01406652|54506064|FG000|Overall Study|Withdrawal by Subject|2|||
27885716|NCT01406652|54506065|FG001|Overall Study|Withdrawal by Subject|2|||
27885717|NCT01406652|54506064|FG000|Overall Study|Insufficient follow-up|5|||
27885718|NCT01406652|54506065|FG001|Overall Study|Insufficient follow-up|4|||
27885719|NCT01406652|54506064|FG000|Overall Study|Infection not sure|10|||
27885720|NCT01406652|54506065|FG001|Overall Study|Infection not sure|10|||
27885721|NCT01406574|54506073|FG000|Overall Study|Adverse Event|0|||
27885722|NCT01406574|54506074|FG001|Overall Study|Adverse Event|0|||
27885723|NCT01406574|54506075|FG002|Overall Study|Adverse Event|1|||
27885724|NCT01406574|54506076|FG003|Overall Study|Adverse Event|3|||
27885725|NCT01406574|54506073|FG000|Overall Study|Physician Decision|0|||
27885726|NCT01406574|54506074|FG001|Overall Study|Physician Decision|0|||
27885727|NCT01406574|54506075|FG002|Overall Study|Physician Decision|0|||
27885728|NCT01406574|54506076|FG003|Overall Study|Physician Decision|1|||
27885729|NCT01406574|54506073|FG000|Overall Study|Withdrawal by Subject|0|||
27885730|NCT01406574|54506074|FG001|Overall Study|Withdrawal by Subject|1|||
27885731|NCT01406574|54506075|FG002|Overall Study|Withdrawal by Subject|0|||
27885732|NCT01406574|54506076|FG003|Overall Study|Withdrawal by Subject|0|||
27885733|NCT01406574|54506073|FG000|Overall Study|Definite progression of primary disease|1|||
27885734|NCT01406574|54506074|FG001|Overall Study|Definite progression of primary disease|0|||
27885735|NCT01406574|54506075|FG002|Overall Study|Definite progression of primary disease|0|||
27885736|NCT01406574|54506076|FG003|Overall Study|Definite progression of primary disease|0|||
27885737|NCT01405950|54506089|FG000|Overall Study|Withdrawal by Subject|1|||
27885738|NCT01405950|54506090|FG001|Overall Study|Withdrawal by Subject|0|||
27885739|NCT01405950|54506091|FG002|Overall Study|Withdrawal by Subject|0|||
27885740|NCT01405950|54506092|FG003|Overall Study|Withdrawal by Subject|0|||
27885741|NCT01405560|54506100|FG000|Overall Study|Physician Decision|1|||
27885742|NCT01428882|54506106|FG000|Overall Study|Lack of Efficacy|2|||
27885743|NCT01428882|54506107|FG001|Overall Study|Lack of Efficacy|7|||
27885744|NCT01428882|54506106|FG000|Overall Study|Protocol Violation|4|||
27885745|NCT01428882|54506107|FG001|Overall Study|Protocol Violation|3|||
27885746|NCT01428258|54506115|FG000|Intervention 1|Withdrawal by Subject|2|||
27885747|NCT01428258|54506116|FG001|Intervention 1|Withdrawal by Subject|0|||
27885748|NCT01389882|54506132|FG000|Overall Study|Respiratory rate > 80/min during study|1|||
27885749|NCT01389882|54506133|FG001|Overall Study|Respiratory rate > 80/min during study|3|||
27885750|NCT01389882|54506132|FG000|Overall Study|Withdrawal by Subject|0|||
27885751|NCT01389882|54506133|FG001|Overall Study|Withdrawal by Subject|1|||
27885752|NCT01442688|54506141|FG000|First Intervention|Withdrawal by Subject|1|||
27885753|NCT01442688|54506142|FG001|First Intervention|Withdrawal by Subject|0|||
27885754|NCT01442688|54506141|FG000|First Intervention|subject incarcerated|1|||
27885755|NCT01442688|54506142|FG001|First Intervention|subject incarcerated|0|||
27885756|NCT01442688|54506141|FG000|Second Intervention|Adverse Event|1|||
27885757|NCT01442688|54506142|FG001|Second Intervention|Adverse Event|0|||
27885758|NCT01466166|54506148|FG000|Overall Study|Death|1|||
27885759|NCT01466166|54506148|FG000|Overall Study|Lost to Follow-up|7|||
27885760|NCT01466166|54506148|FG000|Overall Study|Infusion Reaction (IR)|27|||
27885761|NCT01466166|54506148|FG000|Overall Study|Adverse Event (Other than IR)|11|||
27885762|NCT01466166|54506148|FG000|Overall Study|Elevated Serum Uric Acid|78|||
27885763|NCT01466166|54506148|FG000|Overall Study|Withdrawal by Subject|13|||
27885764|NCT01466166|54506148|FG000|Overall Study|Sponsor Decision|4|||
27885765|NCT01466166|54506148|FG000|Overall Study|Protocol Violation/Noncompliance|2|||
27885766|NCT01466166|54506148|FG000|Overall Study|Other|20|||
27885767|NCT01426854|54506154|FG000|Overall Study|Adverse Event|1|||
27885768|NCT01426854|54506155|FG001|Overall Study|Adverse Event|5|||
27885769|NCT01426854|54506154|FG000|Overall Study|Subject Decision Unrelated to AE|5|||
27885770|NCT01426854|54506155|FG001|Overall Study|Subject Decision Unrelated to AE|6|||
27885771|NCT01426854|54506154|FG000|Overall Study|Lost to Follow-up|3|||
27885772|NCT01426854|54506155|FG001|Overall Study|Lost to Follow-up|0|||
27885773|NCT01426854|54506154|FG000|Overall Study|Noncompliance|0|||
27885774|NCT01426854|54506155|FG001|Overall Study|Noncompliance|1|||
27885775|NCT01426854|54506154|FG000|Overall Study|Treatment Failure|0|||
27885776|NCT01426854|54506155|FG001|Overall Study|Treatment Failure|16|||
27885777|NCT01426854|54506154|FG000|Overall Study|Protocol Deviation|0|||
27885778|NCT01426854|54506155|FG001|Overall Study|Protocol Deviation|1|||
27885779|NCT01426854|54506154|FG000|Overall Study|Other|3|||
27885780|NCT01426854|54506155|FG001|Overall Study|Other|2|||
27885781|NCT01426386|54506167|FG000|Overall Study|Adverse Event|0|||
27885782|NCT01426386|54506168|FG001|Overall Study|Adverse Event|1|||
27885783|NCT01426386|54506169|FG002|Overall Study|Adverse Event|0|||
27885784|NCT01426386|54506170|FG003|Overall Study|Adverse Event|0|||
27885785|NCT01426386|54506171|FG004|Overall Study|Adverse Event|0|||
27885786|NCT01426386|54506172|FG005|Overall Study|Adverse Event|0|||
27885787|NCT01426386|54506167|FG000|Overall Study|Did not attend scheduled visit|1|||
27885788|NCT01426386|54506168|FG001|Overall Study|Did not attend scheduled visit|4|||
27885789|NCT01426386|54506169|FG002|Overall Study|Did not attend scheduled visit|0|||
27885790|NCT01426386|54506170|FG003|Overall Study|Did not attend scheduled visit|0|||
27885791|NCT01426386|54506171|FG004|Overall Study|Did not attend scheduled visit|2|||
27885792|NCT01426386|54506172|FG005|Overall Study|Did not attend scheduled visit|1|||
27885793|NCT01426386|54506167|FG000|Overall Study|Poor response|2|||
27885794|NCT01426386|54506168|FG001|Overall Study|Poor response|1|||
27885795|NCT01426386|54506169|FG002|Overall Study|Poor response|2|||
27885796|NCT01426386|54506170|FG003|Overall Study|Poor response|0|||
27885797|NCT01426386|54506171|FG004|Overall Study|Poor response|1|||
27885798|NCT01426386|54506172|FG005|Overall Study|Poor response|0|||
27885799|NCT01426386|54506167|FG000|Overall Study|Personal reasons|0|||
27885800|NCT01426386|54506168|FG001|Overall Study|Personal reasons|0|||
27885801|NCT01426386|54506169|FG002|Overall Study|Personal reasons|0|||
27885802|NCT01426386|54506170|FG003|Overall Study|Personal reasons|0|||
27885803|NCT01426386|54506171|FG004|Overall Study|Personal reasons|1|||
27885804|NCT01426386|54506172|FG005|Overall Study|Personal reasons|0|||
27885805|NCT01404234|54506186|FG000|Overall Study|Withdrawal by Subject|2|||
27885806|NCT01403610|54506194|FG000|Overall Study|Withdrawal by Subject|2|||
27885807|NCT01403610|54506195|FG001|Overall Study|Withdrawal by Subject|0|||
27885808|NCT01403610|54506196|FG002|Overall Study|Withdrawal by Subject|0|||
27885809|NCT01403610|54506197|FG003|Overall Study|Withdrawal by Subject|0|||
27885810|NCT01403610|54506194|FG000|Overall Study|Didn't recover from surgery sufficiently|0|||
27885811|NCT01403610|54506195|FG001|Overall Study|Didn't recover from surgery sufficiently|3|||
27885812|NCT01403610|54506196|FG002|Overall Study|Didn't recover from surgery sufficiently|0|||
27739358|NCT02434328|54188929|FG000|Overall Study|Lost to Follow-up|1|||
27885813|NCT01403610|54506197|FG003|Overall Study|Didn't recover from surgery sufficiently|0|||
27885814|NCT01403064|54506211|FG000|Overall Study|Death|0|||
27885815|NCT01403064|54506212|FG001|Overall Study|Death|0|||
27885816|NCT01403064|54506213|FG002|Overall Study|Death|1|||
27885817|NCT01403064|54506214|FG003|Overall Study|Death|1|||
27885818|NCT01403064|54506211|FG000|Overall Study|Withdrawal by Subject|0|||
27885819|NCT01403064|54506212|FG001|Overall Study|Withdrawal by Subject|0|||
27885820|NCT01403064|54506213|FG002|Overall Study|Withdrawal by Subject|1|||
27885821|NCT01403064|54506214|FG003|Overall Study|Withdrawal by Subject|1|||
27885822|NCT01403064|54506211|FG000|Overall Study|Other|1|||
27885823|NCT01403064|54506212|FG001|Overall Study|Other|0|||
27885824|NCT01403064|54506213|FG002|Overall Study|Other|2|||
27885825|NCT01403064|54506214|FG003|Overall Study|Other|1|||
27885826|NCT01402986|54506233|FG000|Overall Study|Withdrawal by Subject|7|||
27885827|NCT01402986|54506234|FG001|Overall Study|Withdrawal by Subject|10|||
27885828|NCT01402986|54506235|FG002|Overall Study|Withdrawal by Subject|7|||
27885829|NCT01402986|54506236|FG003|Overall Study|Withdrawal by Subject|13|||
27885830|NCT01402986|54506233|FG000|Overall Study|Death|0|||
27885831|NCT01402986|54506234|FG001|Overall Study|Death|0|||
27885832|NCT01402986|54506235|FG002|Overall Study|Death|0|||
27885833|NCT01402986|54506236|FG003|Overall Study|Death|2|||
27885834|NCT01402986|54506233|FG000|Overall Study|Lost to Follow-up|0|||
27885835|NCT01402986|54506234|FG001|Overall Study|Lost to Follow-up|0|||
27885836|NCT01402986|54506235|FG002|Overall Study|Lost to Follow-up|0|||
27885837|NCT01402986|54506236|FG003|Overall Study|Lost to Follow-up|1|||
27885838|NCT01402986|54506233|FG000|Overall Study|Other|2|||
27885839|NCT01402986|54506234|FG001|Overall Study|Other|5|||
27885840|NCT01402986|54506235|FG002|Overall Study|Other|1|||
27885841|NCT01402986|54506236|FG003|Overall Study|Other|6|||
27885842|NCT01402908|54506248|FG000|Overall Study|Withdrawal by Subject|30|||
27885843|NCT01402908|54506249|FG001|Overall Study|Withdrawal by Subject|17|||
27885844|NCT01402908|54506248|FG000|Overall Study|Lost to Follow-up|3|||
27885845|NCT01402908|54506249|FG001|Overall Study|Lost to Follow-up|1|||
27885846|NCT01402908|54506248|FG000|Overall Study|Physician Decision|1|||
27885847|NCT01402908|54506249|FG001|Overall Study|Physician Decision|0|||
27885848|NCT01389258|54506255|FG000|Overall Study|Lost to Follow-up|5|||
27885849|NCT01389102|54506265|FG000|Overall Study|Adverse Event|1|||
27885850|NCT01389102|54506266|FG001|Overall Study|Adverse Event|3|||
27885851|NCT01389102|54506267|FG002|Overall Study|Adverse Event|2|||
27885852|NCT01389102|54506268|FG003|Overall Study|Adverse Event|2|||
27885853|NCT01389102|54506269|FG004|Overall Study|Adverse Event|2|||
27885854|NCT01389102|54506270|FG005|Overall Study|Adverse Event|2|||
27885855|NCT01389102|54506265|FG000|Overall Study|Hurricane Katrina|4|||
27885856|NCT01389102|54506266|FG001|Overall Study|Hurricane Katrina|2|||
27885857|NCT01389102|54506267|FG002|Overall Study|Hurricane Katrina|3|||
27885858|NCT01389102|54506268|FG003|Overall Study|Hurricane Katrina|0|||
27885859|NCT01389102|54506269|FG004|Overall Study|Hurricane Katrina|3|||
27885860|NCT01389102|54506270|FG005|Overall Study|Hurricane Katrina|1|||
27885861|NCT01389102|54506265|FG000|Overall Study|Lost to Follow-up|4|||
27885862|NCT01389102|54506266|FG001|Overall Study|Lost to Follow-up|1|||
27885863|NCT01389102|54506267|FG002|Overall Study|Lost to Follow-up|1|||
27885864|NCT01389102|54506268|FG003|Overall Study|Lost to Follow-up|2|||
27885865|NCT01389102|54506269|FG004|Overall Study|Lost to Follow-up|4|||
27885866|NCT01389102|54506270|FG005|Overall Study|Lost to Follow-up|1|||
27885867|NCT01389102|54506265|FG000|Overall Study|Protocol Violation|0|||
27885868|NCT01389102|54506266|FG001|Overall Study|Protocol Violation|0|||
27885869|NCT01389102|54506267|FG002|Overall Study|Protocol Violation|3|||
27885870|NCT01389102|54506268|FG003|Overall Study|Protocol Violation|0|||
27885871|NCT01389102|54506269|FG004|Overall Study|Protocol Violation|1|||
27885872|NCT01389102|54506270|FG005|Overall Study|Protocol Violation|1|||
27885873|NCT01389102|54506265|FG000|Overall Study|Withdrawal by Subject|7|||
27885874|NCT01389102|54506266|FG001|Overall Study|Withdrawal by Subject|4|||
27885875|NCT01389102|54506267|FG002|Overall Study|Withdrawal by Subject|9|||
27885876|NCT01389102|54506268|FG003|Overall Study|Withdrawal by Subject|2|||
27885877|NCT01389102|54506269|FG004|Overall Study|Withdrawal by Subject|3|||
27885878|NCT01389102|54506270|FG005|Overall Study|Withdrawal by Subject|3|||
27885879|NCT01389102|54506265|FG000|Overall Study|Subject Traveling Out of Country|0|||
27885880|NCT01389102|54506266|FG001|Overall Study|Subject Traveling Out of Country|0|||
27885881|NCT01389102|54506267|FG002|Overall Study|Subject Traveling Out of Country|0|||
27885882|NCT01389102|54506268|FG003|Overall Study|Subject Traveling Out of Country|1|||
27885883|NCT01389102|54506269|FG004|Overall Study|Subject Traveling Out of Country|0|||
27885884|NCT01389102|54506270|FG005|Overall Study|Subject Traveling Out of Country|0|||
27885885|NCT01389102|54506265|FG000|Overall Study|Subject Moved|2|||
27885886|NCT01389102|54506266|FG001|Overall Study|Subject Moved|0|||
27984780|NCT00890825|54643494|FG000|Overall Study|Alive at data cut off (DCO)|13|||
27984781|NCT00890825|54643495|FG001|Overall Study|Alive at data cut off (DCO)|14|||
27984782|NCT00890201|54643503|FG000|Overall Study|Protocol Violation|5|||
27984783|NCT00890201|54643504|FG001|Overall Study|Protocol Violation|56|||
27984784|NCT00891527|54643510|FG000|Overall Study|Withdrawal by Subject|2|||
27984785|NCT03861078|54643515|FG000|Overall Study|COVID-19 shut down|4|||
27885887|NCT01389102|54506267|FG002|Overall Study|Subject Moved|1|||
27885888|NCT01389102|54506268|FG003|Overall Study|Subject Moved|0|||
27885889|NCT01389102|54506269|FG004|Overall Study|Subject Moved|0|||
27885890|NCT01389102|54506270|FG005|Overall Study|Subject Moved|0|||
27885891|NCT01389102|54506265|FG000|Overall Study|Unavailable due to husband's illness|0|||
27885892|NCT01389102|54506266|FG001|Overall Study|Unavailable due to husband's illness|1|||
27885893|NCT01389102|54506267|FG002|Overall Study|Unavailable due to husband's illness|0|||
27885894|NCT01389102|54506268|FG003|Overall Study|Unavailable due to husband's illness|0|||
27885895|NCT01389102|54506269|FG004|Overall Study|Unavailable due to husband's illness|0|||
27885896|NCT01389102|54506270|FG005|Overall Study|Unavailable due to husband's illness|0|||
27885897|NCT01389102|54506265|FG000|Overall Study|Investigator Judgement|0|||
27885898|NCT01389102|54506266|FG001|Overall Study|Investigator Judgement|1|||
27885899|NCT01389102|54506267|FG002|Overall Study|Investigator Judgement|0|||
27885900|NCT01389102|54506268|FG003|Overall Study|Investigator Judgement|0|||
27885901|NCT01389102|54506269|FG004|Overall Study|Investigator Judgement|0|||
27885902|NCT01389102|54506270|FG005|Overall Study|Investigator Judgement|0|||
27885903|NCT01402284|54506290|FG000|Overall Study|Withdrawal consent|2|||
27885904|NCT01402284|54506290|FG000|Overall Study|Follows up at Memorial Sloan Kettering|1|||
27885905|NCT01402284|54506290|FG000|Overall Study|Physician Decision|1|||
27885906|NCT01402284|54506290|FG000|Overall Study|Disease progression on study|10|||
27885907|NCT01388790|54506294|FG000|Overall Study|Ongoing at data cut-off date|8|||
27885908|NCT01388478|54506298|FG000|Overall Study|Adverse Event|4|||
27885909|NCT01388478|54506298|FG000|Overall Study|Withdrawal by Subject|1|||
27885910|NCT01424670|54506304|FG000|6-Month Intensive Period (182 Days)|Adverse Event|2|||
27885911|NCT01424670|54506305|FG001|6-Month Intensive Period (182 Days)|Adverse Event|2|||
27885912|NCT01424670|54506304|FG000|6-Month Intensive Period (182 Days)|Lost to Follow-up|0|||
27885913|NCT01424670|54506305|FG001|6-Month Intensive Period (182 Days)|Lost to Follow-up|1|||
27885914|NCT01424670|54506304|FG000|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2|||
27885915|NCT01424670|54506305|FG001|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1|||
27885916|NCT01424670|54506304|FG000|6-Month Intensive Period (182 Days)|Physician Decision|2|||
27885917|NCT01424670|54506305|FG001|6-Month Intensive Period (182 Days)|Physician Decision|3|||
27885918|NCT01424670|54506304|FG000|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13|||
27885919|NCT01424670|54506305|FG001|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7|||
27885920|NCT01424670|54506304|FG000|Continuation Period|Adverse Event|13|||
27885921|NCT01424670|54506305|FG001|Continuation Period|Adverse Event|5|||
27885922|NCT01424670|54506304|FG000|Continuation Period|Lost to Follow-up|2|||
27885923|NCT01424670|54506305|FG001|Continuation Period|Lost to Follow-up|0|||
27885924|NCT01424670|54506304|FG000|Continuation Period|Met Protocol Withdrawal Criteria|1|||
27885925|NCT01424670|54506305|FG001|Continuation Period|Met Protocol Withdrawal Criteria|1|||
27885926|NCT01424670|54506304|FG000|Continuation Period|Physician Decision|5|||
27885927|NCT01424670|54506305|FG001|Continuation Period|Physician Decision|4|||
27885928|NCT01424670|54506304|FG000|Continuation Period|Withdrawal by Subject|13|||
27885929|NCT01424670|54506305|FG001|Continuation Period|Withdrawal by Subject|4|||
27885930|NCT01424514|54506313|FG000|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
27885931|NCT01424514|54506314|FG001|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
27885932|NCT01424514|54506313|FG000|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1|||
27885933|NCT01424514|54506314|FG001|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0|||
27885934|NCT01400958|54506327|FG000|Overall Study|Physician Decision|0|||
27885935|NCT01400958|54506328|FG001|Overall Study|Physician Decision|1|||
27885936|NCT01400958|54506327|FG000|Overall Study|Withdrawal by Subject|0|||
27885937|NCT01400958|54506328|FG001|Overall Study|Withdrawal by Subject|1|||
27885938|NCT01400958|54506327|FG000|Overall Study|Adverse Event|1|||
27885939|NCT01400958|54506328|FG001|Overall Study|Adverse Event|0|||
27885940|NCT01388166|54506334|FG000|Overall Study|Adverse Event|16|||
27885941|NCT01388166|54506334|FG000|Overall Study|Lost to Follow-up|30|||
27885942|NCT01388166|54506334|FG000|Overall Study|Others than specified above|13|||
27885943|NCT01400412|54506340|FG000|Overall Study|Lost to Follow-up|4|||
27885944|NCT01400412|54506341|FG001|Overall Study|Lost to Follow-up|7|||
27885945|NCT01400412|54506340|FG000|Overall Study|Withdrawal by Subject|3|||
27885946|NCT01400412|54506341|FG001|Overall Study|Withdrawal by Subject|4|||
27885947|NCT01400412|54506340|FG000|Overall Study|Unable to complete|3|||
27885948|NCT01400412|54506341|FG001|Overall Study|Unable to complete|3|||
27885949|NCT01400412|54506340|FG000|Overall Study|Never started study treatment|0|||
27885950|NCT01400412|54506341|FG001|Overall Study|Never started study treatment|3|||
27885951|NCT01422876|54506359|FG000|Week 24|Lost to Follow-up|1|||
27885952|NCT01422876|54506360|FG001|Week 24|Lost to Follow-up|1|||
27885953|NCT01422876|54506361|FG002|Week 24|Lost to Follow-up|2|||
27885954|NCT01422876|54506362|FG003|Week 24|Lost to Follow-up|4|||
27885955|NCT01422876|54506363|FG004|Week 24|Lost to Follow-up|2|||
27885956|NCT01422876|54506364|FG005|Week 24|Lost to Follow-up|0|||
27885957|NCT01422876|54506365|FG006|Week 24|Lost to Follow-up|1|||
27885958|NCT01422876|54506366|FG007|Week 24|Lost to Follow-up|3|||
27739359|NCT02434328|54188930|FG001|Overall Study|Lost to Follow-up|6|||
27739360|NCT02434328|54188929|FG000|Overall Study|Other|4|||
27739361|NCT02434328|54188930|FG001|Overall Study|Other|1|||
27885959|NCT01422876|54506367|FG008|Week 24|Lost to Follow-up|3|||
27885960|NCT01422876|54506368|FG009|Week 24|Lost to Follow-up|4|||
27885961|NCT01422876|54506359|FG000|Week 24|Consent withdrawn|5|||
27885962|NCT01422876|54506360|FG001|Week 24|Consent withdrawn|1|||
27885963|NCT01422876|54506361|FG002|Week 24|Consent withdrawn|3|||
27885964|NCT01422876|54506362|FG003|Week 24|Consent withdrawn|4|||
27885965|NCT01422876|54506363|FG004|Week 24|Consent withdrawn|5|||
27885966|NCT01422876|54506364|FG005|Week 24|Consent withdrawn|6|||
27885967|NCT01422876|54506365|FG006|Week 24|Consent withdrawn|5|||
27885968|NCT01422876|54506366|FG007|Week 24|Consent withdrawn|4|||
27885969|NCT01422876|54506367|FG008|Week 24|Consent withdrawn|3|||
27885970|NCT01422876|54506368|FG009|Week 24|Consent withdrawn|6|||
27885971|NCT01422876|54506359|FG000|Week 24|Death|0|||
27885972|NCT01422876|54506360|FG001|Week 24|Death|1|||
27885973|NCT01422876|54506361|FG002|Week 24|Death|0|||
27885974|NCT01422876|54506362|FG003|Week 24|Death|0|||
27885975|NCT01422876|54506363|FG004|Week 24|Death|0|||
27885976|NCT01422876|54506364|FG005|Week 24|Death|0|||
27885977|NCT01422876|54506365|FG006|Week 24|Death|0|||
27885978|NCT01422876|54506366|FG007|Week 24|Death|0|||
27885979|NCT01422876|54506367|FG008|Week 24|Death|0|||
27885980|NCT01422876|54506368|FG009|Week 24|Death|0|||
27885981|NCT01422876|54506359|FG000|Week 52|Lost to Follow-up|3|||
27885982|NCT01422876|54506360|FG001|Week 52|Lost to Follow-up|5|||
27885983|NCT01422876|54506361|FG002|Week 52|Lost to Follow-up|7|||
27885984|NCT01422876|54506362|FG003|Week 52|Lost to Follow-up|5|||
27885985|NCT01422876|54506363|FG004|Week 52|Lost to Follow-up|8|||
27885986|NCT01422876|54506364|FG005|Week 52|Lost to Follow-up|5|||
27885987|NCT01422876|54506365|FG006|Week 52|Lost to Follow-up|5|||
27885988|NCT01422876|54506366|FG007|Week 52|Lost to Follow-up|8|||
27885989|NCT01422876|54506367|FG008|Week 52|Lost to Follow-up|7|||
27885990|NCT01422876|54506368|FG009|Week 52|Lost to Follow-up|8|||
27885991|NCT01422876|54506359|FG000|Week 52|Consent withdrawn|9|||
27885992|NCT01422876|54506360|FG001|Week 52|Consent withdrawn|4|||
27885993|NCT01422876|54506361|FG002|Week 52|Consent withdrawn|6|||
27885994|NCT01422876|54506362|FG003|Week 52|Consent withdrawn|12|||
27885995|NCT01422876|54506363|FG004|Week 52|Consent withdrawn|7|||
27885996|NCT01422876|54506364|FG005|Week 52|Consent withdrawn|12|||
27885997|NCT01422876|54506365|FG006|Week 52|Consent withdrawn|10|||
27885998|NCT01422876|54506366|FG007|Week 52|Consent withdrawn|12|||
27885999|NCT01422876|54506367|FG008|Week 52|Consent withdrawn|13|||
27886000|NCT01422876|54506368|FG009|Week 52|Consent withdrawn|9|||
27886001|NCT01422876|54506359|FG000|Week 52|Death|0|||
27886002|NCT01422876|54506360|FG001|Week 52|Death|1|||
27886003|NCT01422876|54506361|FG002|Week 52|Death|0|||
27886004|NCT01422876|54506362|FG003|Week 52|Death|1|||
27886005|NCT01422876|54506363|FG004|Week 52|Death|0|||
27886006|NCT01422876|54506364|FG005|Week 52|Death|0|||
27886007|NCT01422876|54506365|FG006|Week 52|Death|1|||
27886008|NCT01422876|54506366|FG007|Week 52|Death|3|||
27886009|NCT01422876|54506367|FG008|Week 52|Death|1|||
27886010|NCT01422876|54506368|FG009|Week 52|Death|0|||
27886011|NCT01422720|54506386|FG000|Overall Study|Adverse Event|16|||
27886012|NCT01422720|54506386|FG000|Overall Study|Lack of Efficacy|1|||
27886013|NCT01422720|54506386|FG000|Overall Study|Withdrawal by Subject|4|||
27886014|NCT01422720|54506386|FG000|Overall Study|Ineligibility|1|||
27886015|NCT01387932|54506396|FG000|Randomized and Treated|Physician Decision|3|||
27886016|NCT01387932|54506397|FG001|Randomized and Treated|Physician Decision|2|||
27886017|NCT01387932|54506396|FG000|Randomized and Treated|Withdrawal by Subject|4|||
27886018|NCT01387932|54506397|FG001|Randomized and Treated|Withdrawal by Subject|2|||
27886019|NCT01387932|54506396|FG000|Survival Follow-up|Liver Transplant|24|||
27886020|NCT01387932|54506397|FG001|Survival Follow-up|Liver Transplant|28|||
27886021|NCT01387932|54506396|FG000|Survival Follow-up|Additional treatment excluding liver transplant|52|||
27886022|NCT01387932|54506397|FG001|Survival Follow-up|Additional treatment excluding liver transplant|53|||
27886023|NCT01387932|54506396|FG000|Survival Follow-up|Withdrawal by Subject|2|||
27886024|NCT01387932|54506397|FG001|Survival Follow-up|Withdrawal by Subject|4|||
27886025|NCT01387932|54506396|FG000|Survival Follow-up|Lost to Follow-up|6|||
27886026|NCT01387932|54506397|FG001|Survival Follow-up|Lost to Follow-up|5|||
27886027|NCT01422408|54506405|FG000|Overall Study|Adverse Event|1|||
27886028|NCT01422408|54506405|FG000|Overall Study|Withdrawal by Subject|3|||
27886029|NCT01399788|54506409|FG000|First Intervention Period|Adverse Event|1|||
27886030|NCT01399788|54506410|FG001|First Intervention Period|Adverse Event|0|||
27886031|NCT01387542|54506416|FG000|Overall Study|Adverse Event|3|||
27886032|NCT01387542|54506416|FG000|Overall Study|Withdrawal by Subject|1|||
27886033|NCT01387542|54506416|FG000|Overall Study|Changed diagnosis|1|||
27886034|NCT01387542|54506416|FG000|Overall Study|Insufficient response|1|||
27886035|NCT01387542|54506416|FG000|Overall Study|Non-compliant|1|||
27886036|NCT01387542|54506416|FG000|Overall Study|Lost to Follow-up|1|||
27886037|NCT01387230|54506423|FG000|Overall Study|Adverse Event|0|||
27886038|NCT01387230|54506424|FG001|Overall Study|Adverse Event|1|||
27886039|NCT01387230|54506425|FG002|Overall Study|Adverse Event|3|||
27886040|NCT01387230|54506423|FG000|Overall Study|Lack of Efficacy|8|||
27886041|NCT01387230|54506424|FG001|Overall Study|Lack of Efficacy|5|||
27886042|NCT01387230|54506425|FG002|Overall Study|Lack of Efficacy|4|||
27886043|NCT01387230|54506423|FG000|Overall Study|Protocol-defined Stopping Criteria|6|||
27886044|NCT01387230|54506424|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
27886045|NCT01387230|54506425|FG002|Overall Study|Protocol-defined Stopping Criteria|5|||
27886046|NCT01387230|54506423|FG000|Overall Study|Lost to Follow-up|0|||
27886047|NCT01387230|54506424|FG001|Overall Study|Lost to Follow-up|0|||
27886048|NCT01387230|54506425|FG002|Overall Study|Lost to Follow-up|1|||
27886049|NCT01387230|54506423|FG000|Overall Study|Withdrawal by Subject|4|||
27886050|NCT01387230|54506424|FG001|Overall Study|Withdrawal by Subject|1|||
27886051|NCT01387230|54506425|FG002|Overall Study|Withdrawal by Subject|0|||
27886052|NCT01387074|54506433|FG000|Overall Study|Lost to Follow-up|7|||
27886053|NCT01387074|54506433|FG000|Overall Study|Lack of Efficacy|1|||
27886054|NCT01386606|54506441|FG000|Overall Study|Adverse Event|0|||
27886055|NCT01386606|54506442|FG001|Overall Study|Adverse Event|1|||
27886056|NCT01386606|54506443|FG002|Overall Study|Adverse Event|0|||
27886057|NCT01386606|54506444|FG003|Overall Study|Adverse Event|0|||
27886058|NCT01386606|54506441|FG000|Overall Study|Withdrawal by Subject|0|||
27886059|NCT01386606|54506442|FG001|Overall Study|Withdrawal by Subject|1|||
27886060|NCT01386606|54506443|FG002|Overall Study|Withdrawal by Subject|1|||
27886061|NCT01386606|54506444|FG003|Overall Study|Withdrawal by Subject|0|||
27886062|NCT01386606|54506441|FG000|Overall Study|Protocol Violation|1|||
27886063|NCT01386606|54506442|FG001|Overall Study|Protocol Violation|0|||
27886064|NCT01386606|54506443|FG002|Overall Study|Protocol Violation|1|||
27886065|NCT01386606|54506444|FG003|Overall Study|Protocol Violation|1|||
27886066|NCT01386606|54506441|FG000|Overall Study|Lost to Follow-up|2|||
27886067|NCT01386606|54506442|FG001|Overall Study|Lost to Follow-up|0|||
27886068|NCT01386606|54506443|FG002|Overall Study|Lost to Follow-up|0|||
27886069|NCT01386606|54506444|FG003|Overall Study|Lost to Follow-up|0|||
27886070|NCT01386606|54506441|FG000|Overall Study|Subject incarcerated|0|||
27886071|NCT01386606|54506442|FG001|Overall Study|Subject incarcerated|1|||
27886072|NCT01386606|54506443|FG002|Overall Study|Subject incarcerated|0|||
27886073|NCT01386606|54506444|FG003|Overall Study|Subject incarcerated|0|||
27886074|NCT01386606|54506441|FG000|Overall Study|Unable to draw PK|1|||
27886075|NCT01386606|54506442|FG001|Overall Study|Unable to draw PK|0|||
27886076|NCT01386606|54506443|FG002|Overall Study|Unable to draw PK|0|||
27886077|NCT01386606|54506444|FG003|Overall Study|Unable to draw PK|0|||
27886078|NCT01386606|54506441|FG000|Overall Study|T levels too high|0|||
27886079|NCT01386606|54506442|FG001|Overall Study|T levels too high|1|||
27886080|NCT01386606|54506443|FG002|Overall Study|T levels too high|1|||
27886081|NCT01386606|54506444|FG003|Overall Study|T levels too high|0|||
27886082|NCT01385748|54506461|FG000|Overall Study|Withdrawal by Subject|7|||
27886083|NCT01385748|54506462|FG001|Overall Study|Withdrawal by Subject|4|||
27886084|NCT01385748|54506463|FG002|Overall Study|Withdrawal by Subject|5|||
27886085|NCT01385748|54506461|FG000|Overall Study|Noncompliance|3|||
27886086|NCT01385748|54506462|FG001|Overall Study|Noncompliance|1|||
27886087|NCT01385748|54506463|FG002|Overall Study|Noncompliance|6|||
27886088|NCT01385748|54506461|FG000|Overall Study|Other|1|||
27886089|NCT01385748|54506462|FG001|Overall Study|Other|7|||
27886090|NCT01385748|54506463|FG002|Overall Study|Other|1|||
27886091|NCT01385748|54506461|FG000|Overall Study|Adverse Event|4|||
27886092|NCT01385748|54506462|FG001|Overall Study|Adverse Event|2|||
27886093|NCT01385748|54506463|FG002|Overall Study|Adverse Event|1|||
27886094|NCT01397448|54506478|FG000|Overall Study|Adverse Event|4|||
27886095|NCT01397448|54506479|FG001|Overall Study|Adverse Event|4|||
27886096|NCT01397448|54506480|FG002|Overall Study|Adverse Event|6|||
27886097|NCT01397448|54506478|FG000|Overall Study|Withdrawal by Subject|4|||
27886098|NCT01397448|54506479|FG001|Overall Study|Withdrawal by Subject|4|||
27886099|NCT01397448|54506480|FG002|Overall Study|Withdrawal by Subject|3|||
27886100|NCT01397448|54506478|FG000|Overall Study|Lack of Efficacy|2|||
27886101|NCT01397448|54506479|FG001|Overall Study|Lack of Efficacy|0|||
27886102|NCT01397448|54506480|FG002|Overall Study|Lack of Efficacy|5|||
27886103|NCT01397448|54506478|FG000|Overall Study|Other|8|||
27886104|NCT01397448|54506479|FG001|Overall Study|Other|7|||
27886105|NCT01397448|54506480|FG002|Overall Study|Other|4|||
27886106|NCT01385202|54506488|FG000|Overall Study|Lost to Follow-up|6|||
27886107|NCT01385202|54506488|FG000|Overall Study|Not Eligible|11|||
27886108|NCT01385202|54506488|FG000|Overall Study|Withdrawn|1|||
27886109|NCT01384734|54506499|FG000|Overall Study|Adverse Event|0|||
27886110|NCT01384734|54506500|FG001|Overall Study|Adverse Event|3|||
27886111|NCT01384734|54506501|FG002|Overall Study|Adverse Event|0|||
27886112|NCT01384734|54506502|FG003|Overall Study|Adverse Event|2|||
27886113|NCT01384734|54506503|FG004|Overall Study|Adverse Event|7|||
27886114|NCT01384734|54506499|FG000|Overall Study|Death|1|||
27886115|NCT01384734|54506500|FG001|Overall Study|Death|0|||
27886116|NCT01384734|54506501|FG002|Overall Study|Death|1|||
27984786|NCT03861078|54643515|FG000|Overall Study|Lost to Follow-up|1|||
27984787|NCT03861078|54643515|FG000|Overall Study|Protocol Violation|2|||
27886117|NCT01384734|54506502|FG003|Overall Study|Death|0|||
27886118|NCT01384734|54506503|FG004|Overall Study|Death|0|||
27984788|NCT03861078|54643515|FG000|Overall Study|lack of venous access|1|||
27984789|NCT00891371|54643523|FG000|Pre-assignment|Inclusion/exclusion|5|||
27886119|NCT01384734|54506499|FG000|Overall Study|Continuation criteria not met|0|||
27886120|NCT01384734|54506500|FG001|Overall Study|Continuation criteria not met|0|||
27886121|NCT01384734|54506501|FG002|Overall Study|Continuation criteria not met|1|||
27886122|NCT01384734|54506502|FG003|Overall Study|Continuation criteria not met|1|||
27886123|NCT01384734|54506503|FG004|Overall Study|Continuation criteria not met|0|||
27886124|NCT01384734|54506499|FG000|Overall Study|Lack of Efficacy|3|||
27886125|NCT01384734|54506500|FG001|Overall Study|Lack of Efficacy|7|||
27886126|NCT01384734|54506501|FG002|Overall Study|Lack of Efficacy|4|||
27886127|NCT01384734|54506502|FG003|Overall Study|Lack of Efficacy|4|||
27886128|NCT01384734|54506503|FG004|Overall Study|Lack of Efficacy|2|||
27886129|NCT01384734|54506499|FG000|Overall Study|Lost to Follow-up|5|||
27984790|NCT00891371|54643523|FG000|Pre-assignment|Consent withdrawal|1|||
27886130|NCT01384734|54506500|FG001|Overall Study|Lost to Follow-up|3|||
27886131|NCT01384734|54506501|FG002|Overall Study|Lost to Follow-up|3|||
27886132|NCT01384734|54506502|FG003|Overall Study|Lost to Follow-up|8|||
27886133|NCT01384734|54506503|FG004|Overall Study|Lost to Follow-up|5|||
27886134|NCT01384734|54506499|FG000|Overall Study|Non-compliance with study drug|1|||
27886135|NCT01384734|54506500|FG001|Overall Study|Non-compliance with study drug|2|||
27886136|NCT01384734|54506501|FG002|Overall Study|Non-compliance with study drug|6|||
27886137|NCT01384734|54506502|FG003|Overall Study|Non-compliance with study drug|0|||
27886138|NCT01384734|54506503|FG004|Overall Study|Non-compliance with study drug|2|||
27886139|NCT01384734|54506499|FG000|Overall Study|Pregnancy|0|||
27886140|NCT01384734|54506500|FG001|Overall Study|Pregnancy|1|||
27886141|NCT01384734|54506501|FG002|Overall Study|Pregnancy|0|||
27886142|NCT01384734|54506502|FG003|Overall Study|Pregnancy|0|||
27886143|NCT01384734|54506503|FG004|Overall Study|Pregnancy|1|||
27886144|NCT01384734|54506499|FG000|Overall Study|Sponsor terminated|0|||
27886145|NCT01384734|54506500|FG001|Overall Study|Sponsor terminated|0|||
27886146|NCT01384734|54506501|FG002|Overall Study|Sponsor terminated|0|||
27886147|NCT01384734|54506502|FG003|Overall Study|Sponsor terminated|0|||
27886148|NCT01384734|54506503|FG004|Overall Study|Sponsor terminated|1|||
27886149|NCT01384734|54506499|FG000|Overall Study|Withdrawal by Subject|5|||
27886150|NCT01384734|54506500|FG001|Overall Study|Withdrawal by Subject|5|||
27886151|NCT01384734|54506501|FG002|Overall Study|Withdrawal by Subject|6|||
27886152|NCT01384734|54506502|FG003|Overall Study|Withdrawal by Subject|7|||
27886153|NCT01384734|54506503|FG004|Overall Study|Withdrawal by Subject|9|||
27984791|NCT00891371|54643523|FG000|Treatment|Lack of Efficacy|5|||
27984792|NCT00891371|54643523|FG000|Treatment|Adverse Event|2|||
27984793|NCT00891371|54643523|FG000|Treatment|Death|1|||
27984794|NCT00891371|54643523|FG000|Treatment|Lost to Follow-up|1|||
27984795|NCT00890045|54643529|FG000|Overall Study|Death|0|||
27984796|NCT00890045|54643530|FG001|Overall Study|Death|1|||
27984797|NCT00890045|54643529|FG000|Overall Study|Did not receive HeRO Graft|0|||
27984798|NCT00890045|54643530|FG001|Overall Study|Did not receive HeRO Graft|2|||
27984799|NCT00890045|54643529|FG000|Overall Study|Lost to Follow-up|5|||
27984800|NCT00890045|54643530|FG001|Overall Study|Lost to Follow-up|7|||
27984801|NCT00891293|54643536|FG000|Overall Study|Adverse Event|2|||
27984802|NCT00891293|54643536|FG000|Overall Study|Protocol Violation|2|||
27984803|NCT00891293|54643536|FG000|Overall Study|Laboratory abnormality|4|||
27984804|NCT00891293|54643536|FG000|Overall Study|Lost to Follow-up|7|||
27984805|NCT00891293|54643536|FG000|Overall Study|Subject withdrew consent|7|||
27984806|NCT00891293|54643536|FG000|Overall Study|Sponsor termination|62|||
27984807|NCT00889421|54643540|FG000|Overall Study|Lack of Efficacy|3|||
27984808|NCT00889265|54643544|FG000|Overall Study|Adverse Event|1|||
27984809|NCT00889265|54643544|FG000|Overall Study|Lost to Follow-up|5|||
27984810|NCT00889265|54643544|FG000|Overall Study|Protocol Violation|1|||
27984811|NCT00603746|54643554|FG000|Overall Study|Adverse Event|2|||
27984812|NCT00603746|54643555|FG001|Overall Study|Adverse Event|3|||
27984813|NCT00603746|54643556|FG002|Overall Study|Adverse Event|0|||
27984814|NCT00603746|54643557|FG003|Overall Study|Adverse Event|1|||
27984815|NCT00603746|54643558|FG004|Overall Study|Adverse Event|0|||
27984816|NCT00603746|54643559|FG005|Overall Study|Adverse Event|4|||
27984817|NCT00603746|54643554|FG000|Overall Study|Lack of Efficacy|34|||
27984818|NCT00603746|54643555|FG001|Overall Study|Lack of Efficacy|11|||
27984819|NCT00603746|54643556|FG002|Overall Study|Lack of Efficacy|6|||
27984820|NCT00603746|54643557|FG003|Overall Study|Lack of Efficacy|11|||
27984821|NCT00603746|54643558|FG004|Overall Study|Lack of Efficacy|12|||
27984822|NCT00603746|54643559|FG005|Overall Study|Lack of Efficacy|8|||
27984823|NCT00603746|54643554|FG000|Overall Study|Protocol Violation|0|||
27984824|NCT00603746|54643555|FG001|Overall Study|Protocol Violation|3|||
28171777|NCT01651000|54843332|FG000|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0|||
27886154|NCT01384734|54506499|FG000|Overall Study|Investigator relocating|0|||
27886155|NCT01384734|54506500|FG001|Overall Study|Investigator relocating|2|||
27886156|NCT01384734|54506501|FG002|Overall Study|Investigator relocating|0|||
27886157|NCT01384734|54506502|FG003|Overall Study|Investigator relocating|3|||
27886158|NCT01384734|54506503|FG004|Overall Study|Investigator relocating|1|||
27886159|NCT01384734|54506499|FG000|Overall Study|Unable to come back for visit|1|||
27886160|NCT01384734|54506500|FG001|Overall Study|Unable to come back for visit|0|||
27886161|NCT01384734|54506501|FG002|Overall Study|Unable to come back for visit|1|||
27984825|NCT00603746|54643556|FG002|Overall Study|Protocol Violation|1|||
27984826|NCT00603746|54643557|FG003|Overall Study|Protocol Violation|0|||
27984827|NCT00603746|54643558|FG004|Overall Study|Protocol Violation|1|||
27984828|NCT00603746|54643559|FG005|Overall Study|Protocol Violation|0|||
27886162|NCT01384734|54506502|FG003|Overall Study|Unable to come back for visit|1|||
27886163|NCT01384734|54506503|FG004|Overall Study|Unable to come back for visit|0|||
27886164|NCT01384734|54506499|FG000|Overall Study|Prison|0|||
27984829|NCT00603746|54643554|FG000|Overall Study|Lost to Follow-up|0|||
27984830|NCT00603746|54643555|FG001|Overall Study|Lost to Follow-up|1|||
27984831|NCT00603746|54643556|FG002|Overall Study|Lost to Follow-up|1|||
27984832|NCT00603746|54643557|FG003|Overall Study|Lost to Follow-up|0|||
27984833|NCT00603746|54643558|FG004|Overall Study|Lost to Follow-up|0|||
27886165|NCT01384734|54506500|FG001|Overall Study|Prison|0|||
27886166|NCT01384734|54506501|FG002|Overall Study|Prison|1|||
27886167|NCT01384734|54506502|FG003|Overall Study|Prison|0|||
27886168|NCT01384734|54506503|FG004|Overall Study|Prison|0|||
27886169|NCT01384734|54506499|FG000|Overall Study|As per Exclusion criteria|0|||
27886170|NCT01384734|54506500|FG001|Overall Study|As per Exclusion criteria|1|||
27886171|NCT01384734|54506501|FG002|Overall Study|As per Exclusion criteria|0|||
27886172|NCT01384734|54506502|FG003|Overall Study|As per Exclusion criteria|0|||
27886173|NCT01384734|54506503|FG004|Overall Study|As per Exclusion criteria|0|||
27886174|NCT01384734|54506499|FG000|Overall Study|Missed End of treatment visit|0|||
27886175|NCT01384734|54506500|FG001|Overall Study|Missed End of treatment visit|0|||
27886176|NCT01384734|54506501|FG002|Overall Study|Missed End of treatment visit|0|||
27886177|NCT01384734|54506502|FG003|Overall Study|Missed End of treatment visit|1|||
27886178|NCT01384734|54506503|FG004|Overall Study|Missed End of treatment visit|0|||
27886179|NCT01384734|54506499|FG000|Overall Study|Adhesion problem|0|||
27886180|NCT01384734|54506500|FG001|Overall Study|Adhesion problem|0|||
27886181|NCT01384734|54506501|FG002|Overall Study|Adhesion problem|0|||
27886182|NCT01384734|54506502|FG003|Overall Study|Adhesion problem|1|||
27886183|NCT01384734|54506503|FG004|Overall Study|Adhesion problem|0|||
27886184|NCT01384734|54506499|FG000|Overall Study|Early termination|0|||
27886185|NCT01384734|54506500|FG001|Overall Study|Early termination|0|||
27984834|NCT00603746|54643559|FG005|Overall Study|Lost to Follow-up|0|||
27984835|NCT00603746|54643554|FG000|Overall Study|Physician Decision|1|||
27984836|NCT00603746|54643555|FG001|Overall Study|Physician Decision|0|||
27984837|NCT00603746|54643556|FG002|Overall Study|Physician Decision|0|||
27984838|NCT00603746|54643557|FG003|Overall Study|Physician Decision|0|||
27984839|NCT00603746|54643558|FG004|Overall Study|Physician Decision|1|||
27984840|NCT00603746|54643559|FG005|Overall Study|Physician Decision|0|||
27984841|NCT00603746|54643554|FG000|Overall Study|Withdrawal by Subject|1|||
27984842|NCT00603746|54643555|FG001|Overall Study|Withdrawal by Subject|0|||
27984843|NCT00603746|54643556|FG002|Overall Study|Withdrawal by Subject|0|||
27984844|NCT00603746|54643557|FG003|Overall Study|Withdrawal by Subject|1|||
27984845|NCT00603746|54643558|FG004|Overall Study|Withdrawal by Subject|3|||
27984846|NCT00603746|54643559|FG005|Overall Study|Withdrawal by Subject|1|||
27984847|NCT00888329|54643575|FG000|Overall Study|Physician Decision|6|||
27886186|NCT01384734|54506501|FG002|Overall Study|Early termination|0|||
27886187|NCT01384734|54506502|FG003|Overall Study|Early termination|0|||
27886188|NCT01384734|54506503|FG004|Overall Study|Early termination|1|||
27886189|NCT01384734|54506499|FG000|Overall Study|Physician Decision|1|||
27886190|NCT01384734|54506500|FG001|Overall Study|Physician Decision|0|||
27886191|NCT01384734|54506501|FG002|Overall Study|Physician Decision|0|||
27886192|NCT01384734|54506502|FG003|Overall Study|Physician Decision|0|||
27886193|NCT01384734|54506503|FG004|Overall Study|Physician Decision|0|||
27886194|NCT01396512|54506514|FG000|Overall Study|Withdrawal by Subject|0|||
27886195|NCT01396512|54506515|FG001|Overall Study|Withdrawal by Subject|1|||
27984848|NCT00888329|54643576|FG001|Overall Study|Physician Decision|9|||
27984849|NCT00603590|54643584|FG000|Overall Study|Did not attend study clinic|39|||
27984850|NCT00603590|54643585|FG001|Overall Study|Did not attend study clinic|30|||
27984851|NCT00603590|54643584|FG000|Overall Study|Refused blood test|5|||
28096615|NCT03447262|54751781|FG000|Overall Study|Study Termination by Sponsor|455|||
28096616|NCT03447262|54751781|FG000|Overall Study|Other|4|||
28096617|NCT04094870|54751790|FG000|Overall Study|Lost to Follow-up|1|||
28096618|NCT04094870|54751791|FG001|Overall Study|Lost to Follow-up|1|||
28171778|NCT01651000|54843333|FG001|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1|||
28171779|NCT02469610|54843341|FG000|Overall Study|Death|1|||
28171780|NCT02469610|54843342|FG001|Overall Study|Death|0|||
28171781|NCT02469610|54843341|FG000|Overall Study|Lost to Follow-up|1|||
28171782|NCT02469610|54843342|FG001|Overall Study|Lost to Follow-up|0|||
28171783|NCT02469610|54843341|FG000|Overall Study|exclusion criteria|2|||
28171784|NCT02469610|54843342|FG001|Overall Study|exclusion criteria|1|||
28171785|NCT02469298|54843352|FG000|Overall Study|Protocol Violation|0|||
28171786|NCT02469298|54843353|FG001|Overall Study|Protocol Violation|1|||
28096619|NCT04399356|54751806|FG000|Overall Study|Lost to Follow-up|1|||
28096620|NCT04399356|54751807|FG001|Overall Study|Lost to Follow-up|1|||
28096621|NCT04399356|54751806|FG000|Overall Study|Discontinued Niclosamide/ Placebo|1|||
28171787|NCT02469298|54843354|FG002|Overall Study|Protocol Violation|1|||
28096622|NCT04399356|54751807|FG001|Overall Study|Discontinued Niclosamide/ Placebo|2|||
27886196|NCT01396434|54506524|FG000|Overall Study|Lost to Follow-up|1|||
27984852|NCT00603590|54643585|FG001|Overall Study|Refused blood test|1|||
27984853|NCT00603590|54643584|FG000|Overall Study|Patient discontinued study drug|22|||
27984854|NCT00603590|54643585|FG001|Overall Study|Patient discontinued study drug|15|||
28096623|NCT04399356|54751806|FG000|Overall Study|Withdrawal by Subject|1|||
28096624|NCT04399356|54751807|FG001|Overall Study|Withdrawal by Subject|0|||
28171788|NCT02469298|54843355|FG003|Overall Study|Protocol Violation|0|||
28171789|NCT02469298|54843352|FG000|Overall Study|Lost to Follow-up|1|||
27886197|NCT01396434|54506525|FG001|Overall Study|Lost to Follow-up|0|||
27886198|NCT01396434|54506526|FG002|Overall Study|Lost to Follow-up|0|||
27886199|NCT01396434|54506524|FG000|Overall Study|Other|10|||
27886200|NCT01396434|54506525|FG001|Overall Study|Other|0|||
27886201|NCT01396434|54506526|FG002|Overall Study|Other|0|||
27886202|NCT01383954|54506534|FG000|Overall Study|Lack of Efficacy|2|||
27886203|NCT01383954|54506534|FG000|Overall Study|Electronic Diary Too Cumbersome to Use|2|||
27886204|NCT01383954|54506534|FG000|Overall Study|Adverse Event|1|||
27886205|NCT01383954|54506534|FG000|Overall Study|Reason Not Specified|9|||
27886206|NCT01383486|54506538|FG000|Overall Study|Lost to Follow-up|10|||
27886207|NCT01383486|54506538|FG000|Overall Study|Incomplete information for analysis|2|||
27886208|NCT01383486|54506538|FG000|Overall Study|Did not take any product|6|||
27886209|NCT01383174|54506545|FG000|3 Month Assessment|Death|0|||
27886210|NCT01383174|54506546|FG001|3 Month Assessment|Death|1|||
27886211|NCT01383174|54506545|FG000|3 Month Assessment|Lost to Follow-up|2|||
27886212|NCT01383174|54506546|FG001|3 Month Assessment|Lost to Follow-up|0|||
27886213|NCT01383174|54506545|FG000|3 Month Assessment|Refused to complete|4|||
27886214|NCT01383174|54506546|FG001|3 Month Assessment|Refused to complete|0|||
27886215|NCT01383174|54506545|FG000|6 Month Assessment|Lost to Follow-up|1|||
27886216|NCT01383174|54506546|FG001|6 Month Assessment|Lost to Follow-up|1|||
27886217|NCT01383174|54506545|FG000|6 Month Assessment|Refused to complete|4|||
27886218|NCT01383174|54506546|FG001|6 Month Assessment|Refused to complete|0|||
27886219|NCT01396278|54506557|FG000|Overall Study|Adverse Event|0|||
27886220|NCT01396278|54506558|FG001|Overall Study|Adverse Event|0|||
27886221|NCT01396278|54506559|FG002|Overall Study|Adverse Event|0|||
27886222|NCT01396278|54506560|FG003|Overall Study|Adverse Event|2|||
27886223|NCT01396278|54506561|FG004|Overall Study|Adverse Event|0|||
27886224|NCT01396278|54506557|FG000|Overall Study|Withdraw due to trial termination|2|||
27886225|NCT01396278|54506558|FG001|Overall Study|Withdraw due to trial termination|1|||
27886226|NCT01396278|54506559|FG002|Overall Study|Withdraw due to trial termination|1|||
27886227|NCT01396278|54506560|FG003|Overall Study|Withdraw due to trial termination|0|||
27886228|NCT01396278|54506561|FG004|Overall Study|Withdraw due to trial termination|2|||
27886229|NCT01383096|54506576|FG000|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
27886230|NCT01383096|54506577|FG001|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
27886231|NCT01383096|54506578|FG002|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
27886232|NCT01383096|54506576|FG000|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
27886233|NCT01383096|54506577|FG001|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
27886234|NCT01383096|54506578|FG002|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
27886235|NCT01383096|54506576|FG000|Third Intervention (8 Days)|Elevated AST|0|||
27886236|NCT01383096|54506577|FG001|Third Intervention (8 Days)|Elevated AST|1|||
27886237|NCT01383096|54506578|FG002|Third Intervention (8 Days)|Elevated AST|0|||
27886238|NCT01383096|54506576|FG000|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
27886239|NCT01383096|54506577|FG001|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3|||
27886240|NCT01383096|54506578|FG002|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
27886241|NCT01383096|54506576|FG000|Third Intervention (8 Days)|Adverse Event|1|||
27886242|NCT01383096|54506577|FG001|Third Intervention (8 Days)|Adverse Event|0|||
27886243|NCT01383096|54506578|FG002|Third Intervention (8 Days)|Adverse Event|0|||
27886244|NCT01383096|54506576|FG000|Third Intervention (8 Days)|Withdrawal by Subject|1|||
27886245|NCT01383096|54506577|FG001|Third Intervention (8 Days)|Withdrawal by Subject|0|||
27886246|NCT01383096|54506578|FG002|Third Intervention (8 Days)|Withdrawal by Subject|0|||
27886247|NCT01383096|54506576|FG000|Third Intervention (8 Days)|QTcF was greater than 450 msec|1|||
27886248|NCT01383096|54506577|FG001|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
27886249|NCT01383096|54506578|FG002|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
27886250|NCT01383096|54506576|FG000|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
27886251|NCT01383096|54506577|FG001|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
27886252|NCT01383096|54506578|FG002|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
27886253|NCT01383096|54506576|FG000|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1|||
27886254|NCT01383096|54506577|FG001|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
27886255|NCT01383096|54506578|FG002|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
27886256|NCT01383096|54506576|FG000|Fifth Intervention (8 Days)|Withdrawal by Subject|1|||
27886257|NCT01383096|54506577|FG001|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
27886258|NCT01383096|54506578|FG002|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
27886259|NCT01383096|54506576|FG000|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1|||
27886260|NCT01383096|54506577|FG001|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
27886261|NCT01383096|54506578|FG002|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
27984855|NCT00603590|54643584|FG000|Overall Study|Adverse Event|2|||
27984856|NCT00603590|54643585|FG001|Overall Study|Adverse Event|0|||
27984857|NCT00603590|54643584|FG000|Overall Study|Lost to Follow-up|8|||
27984858|NCT00603590|54643585|FG001|Overall Study|Lost to Follow-up|4|||
28096625|NCT03692676|54751817|FG000|Overall Study|exclude patients with prior use|4424|||
28096626|NCT03692676|54751818|FG001|Overall Study|exclude patients with prior use|24726|||
28096627|NCT03692676|54751819|FG002|Overall Study|exclude patients with prior use|0|||
28096628|NCT03692676|54751820|FG003|Overall Study|exclude patients with prior use|0|||
28096629|NCT03692676|54751817|FG000|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480|||
27886262|NCT01383018|54506615|FG000|Overall Study|Adverse Event|14|||
27886263|NCT01383018|54506615|FG000|Overall Study|Death|10|||
27886264|NCT01383018|54506615|FG000|Overall Study|Lost to Follow-up|5|||
27886265|NCT01383018|54506615|FG000|Overall Study|Physician Decision|5|||
27886266|NCT01383018|54506615|FG000|Overall Study|Withdrawal by Subject|9|||
27886267|NCT01383018|54506615|FG000|Overall Study|Subject not implanted|76|||
27886268|NCT01383018|54506615|FG000|Overall Study|Missed Visit|247|||
27886269|NCT01383018|54506615|FG000|Overall Study|Site closed early-not compliance related|7|||
27886270|NCT01383018|54506615|FG000|Overall Study|Patient moved away from site|1|||
27886271|NCT01383018|54506615|FG000|Overall Study|Subject Incarcerated|1|||
27886272|NCT01382940|54506629|FG000|Overall Study|Adverse Event|19|||
27886273|NCT01382940|54506629|FG000|Overall Study|Lost to Follow-up|4|||
27886274|NCT01382940|54506629|FG000|Overall Study|Physician Decision|7|||
27886275|NCT01382940|54506629|FG000|Overall Study|Withdrawal by Subject|23|||
27886276|NCT01382940|54506629|FG000|Overall Study|Protocol Violation|20|||
27886277|NCT01381926|54506635|FG000|Low/High Dose of 1st Treatment (2months)|Adverse Event|2|||
27886278|NCT01381926|54506636|FG001|Low/High Dose of 1st Treatment (2months)|Adverse Event|0|||
27886279|NCT01381926|54506635|FG000|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0|||
27886280|NCT01381926|54506636|FG001|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1|||
27886281|NCT01395888|54506646|FG000|2-week Run-in Period|Adverse Event|2|||
27886282|NCT01395888|54506647|FG001|2-week Run-in Period|Adverse Event|0|||
27886283|NCT01395888|54506648|FG002|2-week Run-in Period|Adverse Event|0|||
27886284|NCT01395888|54506646|FG000|2-week Run-in Period|Continuation Criteria Not Met|13|||
27886285|NCT01395888|54506647|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
27886286|NCT01395888|54506648|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
27886287|NCT01395888|54506646|FG000|2-week Run-in Period|Lost to Follow-up|1|||
27886288|NCT01395888|54506647|FG001|2-week Run-in Period|Lost to Follow-up|0|||
27886289|NCT01395888|54506648|FG002|2-week Run-in Period|Lost to Follow-up|0|||
27886290|NCT01395888|54506646|FG000|2-week Run-in Period|Protocol Violation|2|||
27886291|NCT01395888|54506647|FG001|2-week Run-in Period|Protocol Violation|0|||
27886292|NCT01395888|54506648|FG002|2-week Run-in Period|Protocol Violation|0|||
27886293|NCT01395888|54506646|FG000|2-week Run-in Period|Withdrawal by Subject|4|||
27886294|NCT01395888|54506647|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
27886295|NCT01395888|54506648|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
27886296|NCT01395888|54506646|FG000|Treatment Period (TP)|Adverse Event|0|||
27886297|NCT01395888|54506647|FG001|Treatment Period (TP)|Adverse Event|7|||
27886298|NCT01395888|54506648|FG002|Treatment Period (TP)|Adverse Event|6|||
27886299|NCT01395888|54506646|FG000|Treatment Period (TP)|Lack of Efficacy|0|||
27886300|NCT01395888|54506647|FG001|Treatment Period (TP)|Lack of Efficacy|4|||
27886301|NCT01395888|54506648|FG002|Treatment Period (TP)|Lack of Efficacy|3|||
27886302|NCT01395888|54506646|FG000|Treatment Period (TP)|Protocol Violation|0|||
27886303|NCT01395888|54506647|FG001|Treatment Period (TP)|Protocol Violation|1|||
27886304|NCT01395888|54506648|FG002|Treatment Period (TP)|Protocol Violation|5|||
27886305|NCT01395888|54506646|FG000|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
27886306|NCT01395888|54506647|FG001|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1|||
27886307|NCT01395888|54506648|FG002|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
27886308|NCT01395888|54506646|FG000|Treatment Period (TP)|Withdrawal by Subject|0|||
27886309|NCT01395888|54506647|FG001|Treatment Period (TP)|Withdrawal by Subject|2|||
27886310|NCT01395888|54506648|FG002|Treatment Period (TP)|Withdrawal by Subject|3|||
27886311|NCT01395810|54506658|FG000|Overall Study|Adverse Event|0|||
27886312|NCT01395810|54506659|FG001|Overall Study|Adverse Event|1|||
27886313|NCT01395810|54506660|FG002|Overall Study|Adverse Event|0|||
27886314|NCT01395810|54506661|FG003|Overall Study|Adverse Event|0|||
27886315|NCT01395810|54506658|FG000|Overall Study|Lack of Efficacy|0|||
27886316|NCT01395810|54506659|FG001|Overall Study|Lack of Efficacy|1|||
27886317|NCT01395810|54506660|FG002|Overall Study|Lack of Efficacy|0|||
27886318|NCT01395810|54506661|FG003|Overall Study|Lack of Efficacy|0|||
27886319|NCT01395810|54506658|FG000|Overall Study|Withdrawal criteria|0|||
27886320|NCT01395810|54506659|FG001|Overall Study|Withdrawal criteria|2|||
27886321|NCT01395810|54506660|FG002|Overall Study|Withdrawal criteria|0|||
27886322|NCT01395810|54506661|FG003|Overall Study|Withdrawal criteria|0|||
27886323|NCT01395810|54506658|FG000|Overall Study|Unclassified|2|||
27886324|NCT01395810|54506659|FG001|Overall Study|Unclassified|0|||
27886325|NCT01395810|54506660|FG002|Overall Study|Unclassified|0|||
27886326|NCT01395810|54506661|FG003|Overall Study|Unclassified|0|||
27886327|NCT01381692|54506674|FG000|Overall Study|Adverse Event|1|||
27886328|NCT01381692|54506675|FG001|Overall Study|Adverse Event|0|||
27886329|NCT01381692|54506676|FG002|Overall Study|Adverse Event|0|||
27886330|NCT01381692|54506677|FG003|Overall Study|Adverse Event|0|||
27886331|NCT01381692|54506678|FG004|Overall Study|Adverse Event|0|||
27886332|NCT01381692|54506679|FG005|Overall Study|Adverse Event|0|||
27886333|NCT01395030|54506687|FG000|Overall Study|Did not complete FCH PET/CT|7|||
27886334|NCT01381068|54506695|FG000|Overall Study|Death|1|||
27984859|NCT00603590|54643584|FG000|Overall Study|Cardiovascular event|0|||
27984860|NCT00603590|54643585|FG001|Overall Study|Cardiovascular event|1|||
27886335|NCT01381068|54506696|FG001|Overall Study|Death|0|||
27886336|NCT01394952|54506704|FG000|Overall Study|Lost to Follow-up|0|||
27886337|NCT01394952|54506705|FG001|Overall Study|Lost to Follow-up|5|||
27886338|NCT01394952|54506704|FG000|Overall Study|Withdrawal by Subject|10|||
27886339|NCT01394952|54506705|FG001|Overall Study|Withdrawal by Subject|5|||
27886340|NCT01394952|54506704|FG000|Overall Study|Physician Decision|2|||
27886341|NCT01394952|54506705|FG001|Overall Study|Physician Decision|0|||
27886342|NCT01394952|54506704|FG000|Overall Study|Sponsor Decision|5|||
27886343|NCT01394952|54506705|FG001|Overall Study|Sponsor Decision|7|||
27886344|NCT01394718|54506713|FG000|Overall Study|Met protocol-specific stopping criteria|2|||
27886345|NCT01394718|54506714|FG001|Overall Study|Met protocol-specific stopping criteria|1|||
27886346|NCT01394250|54506722|FG000|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14|||
27886347|NCT01394250|54506723|FG001|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13|||
27886348|NCT01394250|54506722|FG000|Successful IV Placement & Follow-Up|Withdrawal by Subject|6|||
27886349|NCT01394250|54506723|FG001|Successful IV Placement & Follow-Up|Withdrawal by Subject|11|||
27886350|NCT01380990|54506731|FG000|Overall Study|Treatment Failure|1|||
27886351|NCT01380990|54506732|FG001|Overall Study|Treatment Failure|0|||
27886352|NCT01380990|54506731|FG000|Overall Study|Death|0|||
27886353|NCT01380990|54506732|FG001|Overall Study|Death|1|||
27886354|NCT01380834|54506744|FG000|Overall Study|Physician Decision|1|||
27886355|NCT01380834|54506745|FG001|Overall Study|Physician Decision|0|||
27886356|NCT00214422|54506754|FG000|Overall Study|Physician Decision|2|||
27886357|NCT00214422|54506755|FG001|Overall Study|Physician Decision|0|||
27886358|NCT00214422|54506756|FG002|Overall Study|Physician Decision|0|||
27886359|NCT00214422|54506754|FG000|Overall Study|Developed esophageal ca|1|||
27886360|NCT00214422|54506755|FG001|Overall Study|Developed esophageal ca|0|||
27886361|NCT00214422|54506756|FG002|Overall Study|Developed esophageal ca|0|||
27886362|NCT00214422|54506754|FG000|Overall Study|Pt taken off study|1|||
27886363|NCT00214422|54506755|FG001|Overall Study|Pt taken off study|1|||
27886364|NCT00214422|54506756|FG002|Overall Study|Pt taken off study|0|||
27886365|NCT00214422|54506754|FG000|Overall Study|Disease progression on study|1|||
27886366|NCT00214422|54506755|FG001|Overall Study|Disease progression on study|0|||
27886367|NCT00214422|54506756|FG002|Overall Study|Disease progression on study|0|||
27886368|NCT00214422|54506754|FG000|Overall Study|Unable to make a radiation treatment|0|||
27886369|NCT00214422|54506755|FG001|Overall Study|Unable to make a radiation treatment|0|||
27886370|NCT00214422|54506756|FG002|Overall Study|Unable to make a radiation treatment|1|||
27886371|NCT00218634|54506770|FG000|Overall Study|Lost to Follow-up|8|||
27886372|NCT00218634|54506771|FG001|Overall Study|Lost to Follow-up|15|||
27886373|NCT00217620|54506780|FG000|Overall Study|Adverse Event|2|||
27886374|NCT00217620|54506780|FG000|Overall Study|Progression|31|||
28171790|NCT02469298|54843353|FG001|Overall Study|Lost to Follow-up|0|||
28171791|NCT02469298|54843354|FG002|Overall Study|Lost to Follow-up|1|||
28171792|NCT02469298|54843355|FG003|Overall Study|Lost to Follow-up|0|||
28171793|NCT02469298|54843352|FG000|Overall Study|Physician Decision|0|||
28171794|NCT02469298|54843353|FG001|Overall Study|Physician Decision|0|||
28171795|NCT02469298|54843354|FG002|Overall Study|Physician Decision|0|||
28171796|NCT02469298|54843355|FG003|Overall Study|Physician Decision|1|||
28171797|NCT02469298|54843352|FG000|Overall Study|Withdrawal by Subject|0|||
28171798|NCT02469298|54843353|FG001|Overall Study|Withdrawal by Subject|0|||
28171799|NCT02469298|54843354|FG002|Overall Study|Withdrawal by Subject|0|||
27886375|NCT00217620|54506780|FG000|Overall Study|Not Protocol Specified|4|||
27886376|NCT00217620|54506780|FG000|Overall Study|Ineligible|13|||
27886377|NCT00217620|54506780|FG000|Overall Study|Never received treatment|1|||
27886378|NCT00217464|54506788|FG000|Overall Study|Progression|15|||
27886379|NCT00217464|54506788|FG000|Overall Study|Other|2|||
27886380|NCT00214500|54506792|FG000|Treatment Period|Adverse Event|1|||
27886381|NCT00214500|54506792|FG000|Extension Period|Withdrawal by Subject|2|||
27886382|NCT00211536|54506801|FG000|Overall Study|Withdrawal by Subject|2|||
27886383|NCT00211536|54506802|FG001|Overall Study|Withdrawal by Subject|2|||
27886384|NCT00211536|54506801|FG000|Overall Study|Physician Decision|0|||
27886385|NCT00211536|54506802|FG001|Overall Study|Physician Decision|5|||
27886386|NCT00211536|54506801|FG000|Overall Study|Adverse Event|2|||
27886387|NCT00211536|54506802|FG001|Overall Study|Adverse Event|0|||
27886388|NCT03028740|54506877|FG000|Overall Study|Did not Receive Study Drug|4|||
27886389|NCT03028740|54506878|FG001|Overall Study|Did not Receive Study Drug|5|||
27886390|NCT03028740|54506877|FG000|Overall Study|Adverse Event|8|||
27886391|NCT03028740|54506878|FG001|Overall Study|Adverse Event|26|||
27886392|NCT03028740|54506877|FG000|Overall Study|Lack of Efficacy|0|||
27886393|NCT03028740|54506878|FG001|Overall Study|Lack of Efficacy|1|||
27886394|NCT03028740|54506877|FG000|Overall Study|Withdrawal by Subject|48|||
27886395|NCT03028740|54506878|FG001|Overall Study|Withdrawal by Subject|101|||
27886396|NCT03028740|54506877|FG000|Overall Study|Lost to Follow-up|30|||
28171800|NCT02469298|54843355|FG003|Overall Study|Withdrawal by Subject|1|||
28171801|NCT04163991|54843377|FG000|Overall Study|Adverse Event|0|||
27886397|NCT03028740|54506878|FG001|Overall Study|Lost to Follow-up|54|||
27886398|NCT03028740|54506877|FG000|Overall Study|Physician Decision|4|||
27886399|NCT03028740|54506878|FG001|Overall Study|Physician Decision|11|||
27886400|NCT03028740|54506877|FG000|Overall Study|Protocol Violation|4|||
27886401|NCT03028740|54506878|FG001|Overall Study|Protocol Violation|8|||
27886402|NCT03028740|54506877|FG000|Overall Study|Non-compliance with Study Drug|0|||
27886403|NCT03028740|54506878|FG001|Overall Study|Non-compliance with Study Drug|2|||
27886404|NCT03028740|54506877|FG000|Overall Study|Study Terminated by Sponsor|467|||
27886405|NCT03028740|54506878|FG001|Overall Study|Study Terminated by Sponsor|917|||
27886406|NCT03028740|54506877|FG000|Overall Study|Protocol-specified Withdrawal Criteria Met|27|||
27886407|NCT03028740|54506878|FG001|Overall Study|Protocol-specified Withdrawal Criteria Met|55|||
27886408|NCT03028740|54506877|FG000|Overall Study|Reason not Specified|1|||
27886409|NCT03028740|54506878|FG001|Overall Study|Reason not Specified|5|||
27886410|NCT02980692|54506901|FG000|Double Blind Placebo Controlled Period|Adverse Event|1|||
27886411|NCT02980692|54506902|FG001|Double Blind Placebo Controlled Period|Adverse Event|2|||
27886412|NCT02980692|54506903|FG002|Double Blind Placebo Controlled Period|Adverse Event|1|||
27886413|NCT02980692|54506904|FG003|Double Blind Placebo Controlled Period|Adverse Event|2|||
27886414|NCT02980692|54506905|FG004|Double Blind Placebo Controlled Period|Adverse Event|0|||
27886415|NCT02980692|54506901|FG000|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
27886416|NCT02980692|54506902|FG001|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
27886417|NCT02980692|54506903|FG002|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
27886418|NCT02980692|54506904|FG003|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
27886419|NCT02980692|54506905|FG004|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
27886420|NCT02980692|54506901|FG000|Double Blind Placebo Controlled Period|Investigator Decision|0|||
27886421|NCT02980692|54506902|FG001|Double Blind Placebo Controlled Period|Investigator Decision|0|||
27886422|NCT02980692|54506903|FG002|Double Blind Placebo Controlled Period|Investigator Decision|0|||
27886423|NCT02980692|54506904|FG003|Double Blind Placebo Controlled Period|Investigator Decision|2|||
27886424|NCT02980692|54506905|FG004|Double Blind Placebo Controlled Period|Investigator Decision|0|||
27886425|NCT02980692|54506901|FG000|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
27886426|NCT02980692|54506902|FG001|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
27886427|NCT02980692|54506903|FG002|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
27886428|NCT02980692|54506904|FG003|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
27886429|NCT02980692|54506905|FG004|Double Blind Placebo Controlled Period|Withdrawal by Subject|4|||
27886430|NCT02980692|54506901|FG000|Double Blind Placebo Controlled Period|Protocol Violation|2|||
27886431|NCT02980692|54506902|FG001|Double Blind Placebo Controlled Period|Protocol Violation|0|||
27886432|NCT02980692|54506903|FG002|Double Blind Placebo Controlled Period|Protocol Violation|1|||
27886433|NCT02980692|54506904|FG003|Double Blind Placebo Controlled Period|Protocol Violation|0|||
27886434|NCT02980692|54506905|FG004|Double Blind Placebo Controlled Period|Protocol Violation|0|||
27886435|NCT02980692|54506901|FG000|Double Blind Placebo Controlled Period|Other|1|||
27886436|NCT02980692|54506902|FG001|Double Blind Placebo Controlled Period|Other|0|||
27886437|NCT02980692|54506903|FG002|Double Blind Placebo Controlled Period|Other|0|||
27886438|NCT02980692|54506904|FG003|Double Blind Placebo Controlled Period|Other|0|||
27886439|NCT02980692|54506905|FG004|Double Blind Placebo Controlled Period|Other|1|||
27886440|NCT02980692|54506901|FG000|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|9|||
27886441|NCT02980692|54506902|FG001|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|12|||
27886442|NCT02980692|54506903|FG002|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|13|||
27886443|NCT02980692|54506904|FG003|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
27886444|NCT02980692|54506905|FG004|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
27886445|NCT02980692|54506901|FG000|Double-blind Follow-up Period|Adverse Event|0|||
27886446|NCT02980692|54506902|FG001|Double-blind Follow-up Period|Adverse Event|0|||
27886447|NCT02980692|54506903|FG002|Double-blind Follow-up Period|Adverse Event|0|||
27886448|NCT02980692|54506904|FG003|Double-blind Follow-up Period|Adverse Event|1|||
27886449|NCT02980692|54506905|FG004|Double-blind Follow-up Period|Adverse Event|1|||
27886450|NCT02980692|54506901|FG000|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
27886451|NCT02980692|54506902|FG001|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|2|||
27886452|NCT02980692|54506903|FG002|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|1|||
27886453|NCT02980692|54506904|FG003|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
27886454|NCT02980692|54506905|FG004|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
27886455|NCT02980692|54506901|FG000|Double-blind Follow-up Period|Lost to Follow-up|0|||
27886456|NCT02980692|54506902|FG001|Double-blind Follow-up Period|Lost to Follow-up|0|||
27886457|NCT02980692|54506903|FG002|Double-blind Follow-up Period|Lost to Follow-up|1|||
27886458|NCT02980692|54506904|FG003|Double-blind Follow-up Period|Lost to Follow-up|0|||
27886459|NCT02980692|54506905|FG004|Double-blind Follow-up Period|Lost to Follow-up|0|||
27886460|NCT02980692|54506901|FG000|Double-blind Follow-up Period|Pregnancy|0|||
27886461|NCT02980692|54506902|FG001|Double-blind Follow-up Period|Pregnancy|0|||
27886462|NCT02980692|54506903|FG002|Double-blind Follow-up Period|Pregnancy|1|||
27886463|NCT02980692|54506904|FG003|Double-blind Follow-up Period|Pregnancy|1|||
27886464|NCT02980692|54506905|FG004|Double-blind Follow-up Period|Pregnancy|0|||
27886465|NCT02980692|54506901|FG000|Double-blind Follow-up Period|Withdrawal by Subject|0|||
27886466|NCT02980692|54506902|FG001|Double-blind Follow-up Period|Withdrawal by Subject|1|||
27886467|NCT02980692|54506903|FG002|Double-blind Follow-up Period|Withdrawal by Subject|0|||
27886468|NCT02980692|54506904|FG003|Double-blind Follow-up Period|Withdrawal by Subject|1|||
27886469|NCT02980692|54506905|FG004|Double-blind Follow-up Period|Withdrawal by Subject|1|||
27886470|NCT02980692|54506901|FG000|Double-blind Follow-up Period|Other|0|||
27886471|NCT02980692|54506902|FG001|Double-blind Follow-up Period|Other|0|||
27886472|NCT02980692|54506903|FG002|Double-blind Follow-up Period|Other|1|||
27886473|NCT02980692|54506904|FG003|Double-blind Follow-up Period|Other|1|||
27886474|NCT02980692|54506905|FG004|Double-blind Follow-up Period|Other|3|||
27886475|NCT00089778|54507211|FG000|Overall Study|Protocol Violation|0|||
27886476|NCT00089778|54507212|FG001|Overall Study|Protocol Violation|0|||
27886477|NCT00089778|54507213|FG002|Overall Study|Protocol Violation|1|||
27886478|NCT00089544|54507225|FG000|Overall Study|Ineligible|1|||
27886479|NCT00089544|54507226|FG001|Overall Study|Ineligible|0|||
27886480|NCT00089076|54507232|FG000|Overall Study|Alternate Therapy|1|||
27886481|NCT00089076|54507232|FG000|Overall Study|Withdrawal by Subject|2|||
27886482|NCT00089076|54507232|FG000|Overall Study|Progression|7|||
27886483|NCT00088374|54507236|FG000|Overall Study|patient did not receive any 17AAG|1|||
27886484|NCT00088374|54507236|FG000|Overall Study|patient received <1 cycle only of 17AAG|1|||
27886485|NCT00087594|54507242|FG000|Overall Study|Adverse Event|2|||
27886486|NCT00087594|54507243|FG001|Overall Study|Adverse Event|3|||
27886487|NCT00087594|54507242|FG000|Overall Study|Lost to Follow-up|0|||
27886488|NCT00087594|54507243|FG001|Overall Study|Lost to Follow-up|2|||
27886489|NCT00087594|54507242|FG000|Overall Study|Withdrawal by Subject|4|||
27886490|NCT00087594|54507243|FG001|Overall Study|Withdrawal by Subject|2|||
27886491|NCT00087594|54507242|FG000|Overall Study|Lack of Efficacy|2|||
27886492|NCT00087594|54507243|FG001|Overall Study|Lack of Efficacy|5|||
27886493|NCT00087516|54507252|FG000|Overall Study|Adverse Event|10|||
27886494|NCT00087516|54507253|FG001|Overall Study|Adverse Event|10|||
27886495|NCT00087516|54507254|FG002|Overall Study|Adverse Event|3|||
27886496|NCT00087516|54507255|FG003|Overall Study|Adverse Event|6|||
27886497|NCT00087516|54507252|FG000|Overall Study|Lack of Efficacy|82|||
27886498|NCT00087516|54507253|FG001|Overall Study|Lack of Efficacy|80|||
27886499|NCT00087516|54507254|FG002|Overall Study|Lack of Efficacy|39|||
27886500|NCT00087516|54507255|FG003|Overall Study|Lack of Efficacy|29|||
27886501|NCT00087516|54507252|FG000|Overall Study|Lost to Follow-up|8|||
27886502|NCT00087516|54507253|FG001|Overall Study|Lost to Follow-up|6|||
27886503|NCT00087516|54507254|FG002|Overall Study|Lost to Follow-up|5|||
27886504|NCT00087516|54507255|FG003|Overall Study|Lost to Follow-up|5|||
27886505|NCT00087516|54507252|FG000|Overall Study|Protocol Violation|4|||
27886506|NCT00087516|54507253|FG001|Overall Study|Protocol Violation|8|||
27886507|NCT00087516|54507254|FG002|Overall Study|Protocol Violation|3|||
27886508|NCT00087516|54507255|FG003|Overall Study|Protocol Violation|6|||
27886509|NCT00087516|54507252|FG000|Overall Study|Withdrawal by Subject|16|||
27886510|NCT00087516|54507253|FG001|Overall Study|Withdrawal by Subject|27|||
27886511|NCT00087516|54507254|FG002|Overall Study|Withdrawal by Subject|11|||
27886512|NCT00087516|54507255|FG003|Overall Study|Withdrawal by Subject|12|||
27886513|NCT00087516|54507252|FG000|Overall Study|Site terminated|0|||
27886514|NCT00087516|54507253|FG001|Overall Study|Site terminated|2|||
27886515|NCT00087516|54507254|FG002|Overall Study|Site terminated|1|||
27886516|NCT00087516|54507255|FG003|Overall Study|Site terminated|0|||
27886517|NCT00087516|54507252|FG000|Overall Study|Protocol specified discontinuation|35|||
27886518|NCT00087516|54507253|FG001|Overall Study|Protocol specified discontinuation|33|||
27886519|NCT00087516|54507254|FG002|Overall Study|Protocol specified discontinuation|33|||
27886520|NCT00087516|54507255|FG003|Overall Study|Protocol specified discontinuation|26|||
27886521|NCT00087516|54507252|FG000|Overall Study|Patient moved|3|||
27886522|NCT00087516|54507253|FG001|Overall Study|Patient moved|2|||
27886523|NCT00087516|54507254|FG002|Overall Study|Patient moved|1|||
27886524|NCT00087516|54507255|FG003|Overall Study|Patient moved|0|||
27886525|NCT00087516|54507252|FG000|Overall Study|Patient was non-compliant|3|||
27886526|NCT00087516|54507253|FG001|Overall Study|Patient was non-compliant|1|||
27886527|NCT00087516|54507254|FG002|Overall Study|Patient was non-compliant|0|||
28171802|NCT04163991|54843378|FG001|Overall Study|Adverse Event|0|||
27886528|NCT00087516|54507255|FG003|Overall Study|Patient was non-compliant|0|||
27886529|NCT00087516|54507252|FG000|Overall Study|Recommendation of Primary Care Physician|0|||
27886530|NCT00087516|54507253|FG001|Overall Study|Recommendation of Primary Care Physician|0|||
27886531|NCT00087516|54507254|FG002|Overall Study|Recommendation of Primary Care Physician|0|||
27886532|NCT00087516|54507255|FG003|Overall Study|Recommendation of Primary Care Physician|1|||
27886533|NCT00087516|54507252|FG000|Overall Study|Other|0|||
27886534|NCT00087516|54507253|FG001|Overall Study|Other|0|||
27886535|NCT00087516|54507254|FG002|Overall Study|Other|1|||
27886536|NCT00087516|54507255|FG003|Overall Study|Other|0|||
27886537|NCT00087126|54507269|FG000|Overall Study|Ineligible - second primary|1|||
27886538|NCT00087126|54507269|FG000|Overall Study|Never treated|1|||
27886539|NCT03490734|54507282|FG000|Pre-intervention Scan Visit|fMRI contraindications|2|||
27886540|NCT03490734|54507283|FG001|Pre-intervention Scan Visit|fMRI contraindications|1|||
27886541|NCT03490734|54507284|FG002|Pre-intervention Scan Visit|fMRI contraindications|0|||
27886542|NCT03490734|54507285|FG003|Pre-intervention Scan Visit|fMRI contraindications|2|||
27886543|NCT03490734|54507282|FG000|Pre-intervention Scan Visit|Lost to Follow-up|0|||
27886544|NCT03490734|54507283|FG001|Pre-intervention Scan Visit|Lost to Follow-up|0|||
27886545|NCT03490734|54507284|FG002|Pre-intervention Scan Visit|Lost to Follow-up|0|||
27886546|NCT03490734|54507285|FG003|Pre-intervention Scan Visit|Lost to Follow-up|1|||
27886547|NCT03490734|54507282|FG000|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
27886548|NCT03490734|54507283|FG001|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
27886549|NCT03490734|54507284|FG002|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
27886550|NCT03490734|54507285|FG003|Pre-intervention Scan Visit|Withdrawal by Subject|1|||
27886551|NCT03490734|54507282|FG000|Post-intervention Scan Visit|Adverse Event|2|||
27886552|NCT03490734|54507283|FG001|Post-intervention Scan Visit|Adverse Event|0|||
27886553|NCT03490734|54507284|FG002|Post-intervention Scan Visit|Adverse Event|0|||
27886554|NCT03490734|54507285|FG003|Post-intervention Scan Visit|Adverse Event|0|||
27886555|NCT03490734|54507282|FG000|Post-intervention Scan Visit|Lost to Follow-up|0|||
27886556|NCT03490734|54507283|FG001|Post-intervention Scan Visit|Lost to Follow-up|1|||
27886557|NCT03490734|54507284|FG002|Post-intervention Scan Visit|Lost to Follow-up|0|||
27886558|NCT03490734|54507285|FG003|Post-intervention Scan Visit|Lost to Follow-up|0|||
27886559|NCT03490734|54507282|FG000|Post-intervention Scan Visit|Withdrawal by Subject|0|||
27886560|NCT03490734|54507283|FG001|Post-intervention Scan Visit|Withdrawal by Subject|2|||
27886561|NCT03490734|54507284|FG002|Post-intervention Scan Visit|Withdrawal by Subject|0|||
27886562|NCT03490734|54507285|FG003|Post-intervention Scan Visit|Withdrawal by Subject|3|||
27886563|NCT00086346|54507296|FG000|Randomization|Did not receive test article|4|||
27886564|NCT00086346|54507297|FG001|Randomization|Did not receive test article|4|||
27886565|NCT00086346|54507296|FG000|Patients Dosed With Test Article|Adverse Event|94|||
27886566|NCT00086346|54507297|FG001|Patients Dosed With Test Article|Adverse Event|11|||
27886567|NCT00086346|54507296|FG000|Patients Dosed With Test Article|Lost to Follow-up|1|||
27886568|NCT00086346|54507297|FG001|Patients Dosed With Test Article|Lost to Follow-up|3|||
27886569|NCT00086346|54507296|FG000|Patients Dosed With Test Article|Nonmedical event|7|||
27886570|NCT00086346|54507297|FG001|Patients Dosed With Test Article|Nonmedical event|3|||
27886571|NCT00086346|54507296|FG000|Patients Dosed With Test Article|Withdrawal by Subject|16|||
27886572|NCT00086346|54507297|FG001|Patients Dosed With Test Article|Withdrawal by Subject|3|||
27886573|NCT00086346|54507296|FG000|Patients Dosed With Test Article|Protocol Violation|11|||
27984861|NCT00888173|54643591|FG000|Overall Study|Wrong Primary|1|||
27984862|NCT00888173|54643591|FG000|Overall Study|Ineligible: required test not done|1|||
27984863|NCT00887549|54643604|FG000|Induction Therapy|Adverse Event|8|||
27984864|NCT00887549|54643604|FG000|Induction Therapy|Physician Decision|1|||
27984865|NCT00887549|54643604|FG000|Induction Therapy|Progressive Disease|13|||
27984866|NCT00887549|54643604|FG000|Induction Therapy|Death due to Study Disease|4|||
27984867|NCT00887549|54643604|FG000|Induction Therapy|Death due to Study Drug Toxicity|1|||
27984868|NCT00887549|54643604|FG000|Maintenance Therapy|Adverse Event|16|||
27984869|NCT00887549|54643604|FG000|Maintenance Therapy|Physician Decision|1|||
27984870|NCT00887549|54643604|FG000|Maintenance Therapy|Progressive Disease|25|||
27984871|NCT00887549|54643604|FG000|Maintenance Therapy|Death due to adverse event|1|||
27984872|NCT00887315|54643610|FG000|Overall Study|Study termination|7|||
27984873|NCT00887315|54643611|FG001|Overall Study|Study termination|4|||
27984874|NCT03608826|54643617|FG000|Overall Study|Death|3|||
27984875|NCT03608826|54643617|FG000|Overall Study|Heart Transplant|3|||
27984876|NCT03608826|54643617|FG000|Overall Study|Physician Decision|4|||
27984877|NCT00887159|54643624|FG000|Overall Study|Disease progression|6|||
27984878|NCT00887159|54643625|FG001|Overall Study|Disease progression|39|||
27984879|NCT00887159|54643626|FG002|Overall Study|Disease progression|33|||
27984880|NCT00887159|54643624|FG000|Overall Study|Adverse Event|3|||
27984881|NCT00887159|54643625|FG001|Overall Study|Adverse Event|4|||
27984882|NCT00887159|54643626|FG002|Overall Study|Adverse Event|17|||
27984883|NCT00887159|54643624|FG000|Overall Study|Death|2|||
27984884|NCT00887159|54643625|FG001|Overall Study|Death|2|||
27984885|NCT00887159|54643626|FG002|Overall Study|Death|0|||
27984886|NCT00887159|54643624|FG000|Overall Study|Withdrawal by Subject|4|||
27984887|NCT00887159|54643625|FG001|Overall Study|Withdrawal by Subject|4|||
27984888|NCT00887159|54643626|FG002|Overall Study|Withdrawal by Subject|2|||
27984889|NCT00887159|54643624|FG000|Overall Study|Alternative therapy|2|||
27984890|NCT00887159|54643625|FG001|Overall Study|Alternative therapy|0|||
27984891|NCT00887159|54643626|FG002|Overall Study|Alternative therapy|0|||
27984892|NCT00887159|54643624|FG000|Overall Study|Physician Decision|1|||
27886574|NCT00086346|54507297|FG001|Patients Dosed With Test Article|Protocol Violation|3|||
27886575|NCT00086346|54507296|FG000|Patients Dosed With Test Article|Lack of Efficacy|11|||
27984893|NCT00887159|54643625|FG001|Overall Study|Physician Decision|1|||
27984894|NCT00887159|54643626|FG002|Overall Study|Physician Decision|0|||
27984895|NCT00887159|54643624|FG000|Overall Study|Sympomatic deterioration|1|||
27984896|NCT00887159|54643625|FG001|Overall Study|Sympomatic deterioration|0|||
27984897|NCT00887159|54643626|FG002|Overall Study|Sympomatic deterioration|0|||
27984898|NCT00887159|54643624|FG000|Overall Study|Treatment delayed|1|||
27984899|NCT00887159|54643625|FG001|Overall Study|Treatment delayed|1|||
27984900|NCT00887159|54643626|FG002|Overall Study|Treatment delayed|0|||
27984901|NCT00887159|54643624|FG000|Overall Study|Pt had PD but was SD when re-measured|0|||
27984902|NCT00887159|54643625|FG001|Overall Study|Pt had PD but was SD when re-measured|1|||
27984903|NCT00887159|54643626|FG002|Overall Study|Pt had PD but was SD when re-measured|0|||
27886576|NCT00086346|54507297|FG001|Patients Dosed With Test Article|Lack of Efficacy|0|||
27886577|NCT00085566|54507306|FG000|Overall Study|Adverse Event|0|||
27886578|NCT00085566|54507307|FG001|Overall Study|Adverse Event|0|||
27886579|NCT00085566|54507308|FG002|Overall Study|Adverse Event|10|||
27886580|NCT00085566|54507306|FG000|Overall Study|Patient Not treated|0|||
27886581|NCT00085566|54507307|FG001|Overall Study|Patient Not treated|0|||
27886582|NCT00085566|54507308|FG002|Overall Study|Patient Not treated|3|||
27886583|NCT00085566|54507306|FG000|Overall Study|Clinical progression|0|||
27886584|NCT00085566|54507307|FG001|Overall Study|Clinical progression|0|||
27886585|NCT00085566|54507308|FG002|Overall Study|Clinical progression|1|||
27886586|NCT00085098|54507318|FG000|Overall Study|Withdrawal by Subject|0|||
27886587|NCT00085098|54507319|FG001|Overall Study|Withdrawal by Subject|1|||
27886588|NCT00085098|54507318|FG000|Overall Study|Ineligible|1|||
27886589|NCT00085098|54507319|FG001|Overall Study|Ineligible|1|||
27886590|NCT00084864|54507332|FG000|Overall Study|Adverse Event|1|||
27886591|NCT00084864|54507333|FG001|Overall Study|Adverse Event|0|||
27886592|NCT00084864|54507334|FG002|Overall Study|Adverse Event|0|||
27886593|NCT00084864|54507335|FG003|Overall Study|Adverse Event|0|||
27886594|NCT00084318|54507347|FG000|Overall Study|Withdrawal by Subject|5|||
27886595|NCT00084318|54507348|FG001|Overall Study|Withdrawal by Subject|2|||
27886596|NCT00084318|54507347|FG000|Overall Study|Protocol Violation|15|||
27886597|NCT00084318|54507348|FG001|Overall Study|Protocol Violation|11|||
27886598|NCT00084318|54507347|FG000|Overall Study|No protocol treatment|2|||
27886599|NCT00084318|54507348|FG001|Overall Study|No protocol treatment|0|||
27886600|NCT00084084|54507356|FG000|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1|||
27886601|NCT00084084|54507356|FG000|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1|||
27886602|NCT00083616|54507361|FG000|Overall Study|Disease Progression|16|||
27886603|NCT00083616|54507361|FG000|Overall Study|Lost to Follow-up|1|||
27886604|NCT00083616|54507361|FG000|Overall Study|Physician Decision|2|||
27886605|NCT00083616|54507361|FG000|Overall Study|Withdrawal by Subject|3|||
27886606|NCT00083616|54507361|FG000|Overall Study|Ineligibility determined|2|||
27886607|NCT00083616|54507361|FG000|Overall Study|Non-compliance|1|||
27886608|NCT00083616|54507361|FG000|Overall Study|Other|6|||
27886609|NCT00083226|54507365|FG000|Overall Study|Lack of Efficacy|19|||
27886610|NCT00083226|54507365|FG000|Overall Study|Adverse Event|9|||
27886611|NCT00083226|54507365|FG000|Overall Study|Death|4|||
27886612|NCT00083226|54507365|FG000|Overall Study|Withdrawal by Subject|4|||
27886613|NCT00083226|54507365|FG000|Overall Study|Other|2|||
27886614|NCT00083226|54507365|FG000|Overall Study|ineligible or not receiving treatment|4|||
27886615|NCT00082758|54507372|FG000|Overall Study|Adverse Event|0|||
27886616|NCT00082758|54507373|FG001|Overall Study|Adverse Event|2|||
27886617|NCT00082758|54507374|FG002|Overall Study|Adverse Event|0|||
27739362|NCT02660229|54188939|FG000|Overall Study|Adverse Event|2|||
27886618|NCT00082758|54507372|FG000|Overall Study|Lack of Efficacy|12|||
27886619|NCT00082758|54507373|FG001|Overall Study|Lack of Efficacy|13|||
27886620|NCT00082758|54507374|FG002|Overall Study|Lack of Efficacy|0|||
27886621|NCT00082758|54507372|FG000|Overall Study|Physician Decision|0|||
27886622|NCT00082758|54507373|FG001|Overall Study|Physician Decision|1|||
27886623|NCT00082758|54507374|FG002|Overall Study|Physician Decision|0|||
27886624|NCT00082758|54507372|FG000|Overall Study|Withdrawal by Subject|3|||
27886625|NCT00082758|54507373|FG001|Overall Study|Withdrawal by Subject|0|||
27886626|NCT00082758|54507374|FG002|Overall Study|Withdrawal by Subject|0|||
27886627|NCT00082758|54507372|FG000|Overall Study|Protocol Violation|0|||
27886628|NCT00082758|54507373|FG001|Overall Study|Protocol Violation|1|||
27886629|NCT00082758|54507374|FG002|Overall Study|Protocol Violation|0|||
27886630|NCT00088452|54507385|FG000|Overall Study|Did not receive intervention|1|||
27886631|NCT00088452|54507386|FG001|Overall Study|Did not receive intervention|0|||
27886632|NCT00088452|54507387|FG002|Overall Study|Did not receive intervention|1|||
27886633|NCT04686084|54507486|FG000|Overall Study|Lost to Follow-up|1|||
27886634|NCT04685538|54507493|FG000|Overall Study|Adverse Event|0|||
27886635|NCT04685538|54507494|FG001|Overall Study|Adverse Event|1|||
27886636|NCT04685538|54507493|FG000|Overall Study|Lost to Follow-up|0|||
27886637|NCT04685538|54507494|FG001|Overall Study|Lost to Follow-up|2|||
27886638|NCT04213326|54507506|FG000|Overall Study|Consent withdrawn|51|||
27886639|NCT04213326|54507507|FG001|Overall Study|Consent withdrawn|241|||
27886640|NCT04213326|54507506|FG000|Overall Study|Lost to Follow-up|50|||
27886641|NCT04213326|54507507|FG001|Overall Study|Lost to Follow-up|902|||
27886642|NCT04213326|54507506|FG000|Overall Study|Protocol Violation|3|||
27886643|NCT04213326|54507507|FG001|Overall Study|Protocol Violation|25|||
27886644|NCT04213326|54507506|FG000|Overall Study|Participant eligibility changed|106|||
27886645|NCT04213326|54507507|FG001|Overall Study|Participant eligibility changed|19|||
27984904|NCT00887159|54643624|FG000|Overall Study|Received more tx instead of observation|1|||
27886646|NCT04213326|54507506|FG000|Overall Study|SCRI confirmed to be withdrawal|0|||
27886647|NCT04213326|54507507|FG001|Overall Study|SCRI confirmed to be withdrawal|16|||
27886648|NCT04213326|54507506|FG000|Overall Study|Incomplete study visit|0|||
27886649|NCT04213326|54507507|FG001|Overall Study|Incomplete study visit|367|||
27886650|NCT01625286|54507520|FG000|Overall Study|Adverse Event|0|||
27886651|NCT01625286|54507521|FG001|Overall Study|Adverse Event|0|||
27886652|NCT01625286|54507522|FG002|Overall Study|Adverse Event|0|||
27886653|NCT01625286|54507523|FG003|Overall Study|Adverse Event|0|||
27886654|NCT01625286|54507524|FG004|Overall Study|Adverse Event|1|||
27886655|NCT01625286|54507525|FG005|Overall Study|Adverse Event|2|||
27886656|NCT01625286|54507526|FG006|Overall Study|Adverse Event|1|||
27886657|NCT01625286|54507520|FG000|Overall Study|Death|0|||
27886658|NCT01625286|54507521|FG001|Overall Study|Death|0|||
27886659|NCT01625286|54507522|FG002|Overall Study|Death|1|||
27886660|NCT01625286|54507523|FG003|Overall Study|Death|1|||
27886661|NCT01625286|54507524|FG004|Overall Study|Death|0|||
27886662|NCT01625286|54507525|FG005|Overall Study|Death|11|||
27886663|NCT01625286|54507526|FG006|Overall Study|Death|16|||
27886664|NCT01625286|54507520|FG000|Overall Study|Withdrawal by Subject|0|||
27886665|NCT01625286|54507521|FG001|Overall Study|Withdrawal by Subject|1|||
27886666|NCT01625286|54507522|FG002|Overall Study|Withdrawal by Subject|0|||
27886667|NCT01625286|54507523|FG003|Overall Study|Withdrawal by Subject|1|||
27886668|NCT01625286|54507524|FG004|Overall Study|Withdrawal by Subject|0|||
27886669|NCT01625286|54507525|FG005|Overall Study|Withdrawal by Subject|0|||
27886670|NCT01625286|54507526|FG006|Overall Study|Withdrawal by Subject|1|||
27886671|NCT01625286|54507520|FG000|Overall Study|Any reason not specifically recorded|0|||
27886672|NCT01625286|54507521|FG001|Overall Study|Any reason not specifically recorded|0|||
27886673|NCT01625286|54507522|FG002|Overall Study|Any reason not specifically recorded|0|||
27886674|NCT01625286|54507523|FG003|Overall Study|Any reason not specifically recorded|0|||
27886675|NCT01625286|54507524|FG004|Overall Study|Any reason not specifically recorded|0|||
27886676|NCT01625286|54507525|FG005|Overall Study|Any reason not specifically recorded|1|||
27886677|NCT01625286|54507526|FG006|Overall Study|Any reason not specifically recorded|0|||
27886678|NCT01625286|54507520|FG000|Overall Study|Progressive disease|6|||
27886679|NCT01625286|54507521|FG001|Overall Study|Progressive disease|3|||
27886680|NCT01625286|54507522|FG002|Overall Study|Progressive disease|4|||
27886681|NCT01625286|54507523|FG003|Overall Study|Progressive disease|5|||
27886682|NCT01625286|54507524|FG004|Overall Study|Progressive disease|5|||
27886683|NCT01625286|54507525|FG005|Overall Study|Progressive disease|0|||
27886684|NCT01625286|54507526|FG006|Overall Study|Progressive disease|0|||
27886685|NCT01625286|54507520|FG000|Overall Study|Lost to Follow-up|0|||
27886686|NCT01625286|54507521|FG001|Overall Study|Lost to Follow-up|0|||
27886687|NCT01625286|54507522|FG002|Overall Study|Lost to Follow-up|0|||
27886688|NCT01625286|54507523|FG003|Overall Study|Lost to Follow-up|0|||
27886689|NCT01625286|54507524|FG004|Overall Study|Lost to Follow-up|0|||
27886690|NCT01625286|54507525|FG005|Overall Study|Lost to Follow-up|0|||
27886691|NCT01625286|54507526|FG006|Overall Study|Lost to Follow-up|1|||
27886692|NCT04083222|54507571|FG000|Overall Study|Voluntary Withdrawal|0|||
27886693|NCT04083222|54507572|FG001|Overall Study|Voluntary Withdrawal|1|||
27886694|NCT04083222|54507571|FG000|Overall Study|Reason not Specified|0|||
27886695|NCT04083222|54507572|FG001|Overall Study|Reason not Specified|1|||
27886696|NCT03286842|54507578|FG000|Overall Study|Patients rolled over to another study|80|||
27886697|NCT00639678|54507593|FG000|Overall Study|Withdrawal by Subject|3|||
27886698|NCT00639678|54507594|FG001|Overall Study|Withdrawal by Subject|0|||
27886699|NCT00639678|54507595|FG002|Overall Study|Withdrawal by Subject|4|||
27886700|NCT00639678|54507596|FG003|Overall Study|Withdrawal by Subject|0|||
27886701|NCT00639678|54507593|FG000|Overall Study|Lost to Follow-up|1|||
27886702|NCT00639678|54507594|FG001|Overall Study|Lost to Follow-up|0|||
27886703|NCT00639678|54507595|FG002|Overall Study|Lost to Follow-up|6|||
27886704|NCT00639678|54507596|FG003|Overall Study|Lost to Follow-up|0|||
27886705|NCT00639678|54507593|FG000|Overall Study|Adverse Event|0|||
27886706|NCT00639678|54507594|FG001|Overall Study|Adverse Event|1|||
27886707|NCT00639678|54507595|FG002|Overall Study|Adverse Event|0|||
27886708|NCT00639678|54507596|FG003|Overall Study|Adverse Event|0|||
27886709|NCT00639678|54507593|FG000|Overall Study|Lack of Compliance|0|||
27886710|NCT00639678|54507594|FG001|Overall Study|Lack of Compliance|0|||
27886711|NCT00639678|54507595|FG002|Overall Study|Lack of Compliance|1|||
27886712|NCT00639678|54507596|FG003|Overall Study|Lack of Compliance|0|||
27886713|NCT00638508|54507621|FG000|Overall Study|Physician Decision|5|||
27886714|NCT00638508|54507622|FG001|Overall Study|Physician Decision|2|||
27886715|NCT00637806|54507635|FG000|Double-blind Phase|Study Discontinued|2|||
27886716|NCT00637806|54507636|FG001|Double-blind Phase|Study Discontinued|0|||
27886717|NCT00637806|54507637|FG002|Double-blind Phase|Study Discontinued|1|||
27886718|NCT00637806|54507638|FG003|Double-blind Phase|Study Discontinued|0|||
27886719|NCT00637806|54507635|FG000|Extension Phase|Study Discontinued|0|||
27886720|NCT00637806|54507636|FG001|Extension Phase|Study Discontinued|0|||
27886721|NCT00637806|54507637|FG002|Extension Phase|Study Discontinued|0|||
27739363|NCT02660229|54188940|FG001|Overall Study|Adverse Event|0|||
27886722|NCT00637806|54507638|FG003|Extension Phase|Study Discontinued|1|||
27886723|NCT00637728|54507649|FG000|Double-blind Phase|Adverse Event|1|||
27886724|NCT00637728|54507650|FG001|Double-blind Phase|Adverse Event|0|||
27886725|NCT00637728|54507651|FG002|Double-blind Phase|Adverse Event|0|||
27886726|NCT00637728|54507649|FG000|Double-blind Phase|Non-compliance|2|||
27886727|NCT00637728|54507650|FG001|Double-blind Phase|Non-compliance|0|||
27886728|NCT00637728|54507651|FG002|Double-blind Phase|Non-compliance|0|||
27886729|NCT00637728|54507649|FG000|Double-blind Phase|Study Discontinued|1|||
27886730|NCT00637728|54507650|FG001|Double-blind Phase|Study Discontinued|1|||
27886731|NCT00637728|54507651|FG002|Double-blind Phase|Study Discontinued|0|||
27886732|NCT00637572|54507660|FG000|Overall Study|Adverse Event|1|||
27886733|NCT00637572|54507661|FG001|Overall Study|Adverse Event|2|||
27886734|NCT00637572|54507660|FG000|Overall Study|Death|0|||
27886735|NCT00637572|54507661|FG001|Overall Study|Death|1|||
27886736|NCT00637572|54507660|FG000|Overall Study|Lost to Follow-up|0|||
27886737|NCT00637572|54507661|FG001|Overall Study|Lost to Follow-up|1|||
27886738|NCT00637572|54507660|FG000|Overall Study|Physician Decision|1|||
27886739|NCT00637572|54507661|FG001|Overall Study|Physician Decision|1|||
27886740|NCT00637572|54507660|FG000|Overall Study|Withdrawal by Subject|0|||
27886741|NCT00637572|54507661|FG001|Overall Study|Withdrawal by Subject|2|||
27886742|NCT00637572|54507660|FG000|Overall Study|Illicit Drug Use|1|||
27886743|NCT00637572|54507661|FG001|Overall Study|Illicit Drug Use|0|||
27886744|NCT00637416|54507669|FG000|Overall Study|Lost to Follow-up|1|||
27886745|NCT00637416|54507670|FG001|Overall Study|Lost to Follow-up|1|||
27886746|NCT00637416|54507669|FG000|Overall Study|Unable to take study drug|0|||
27886747|NCT00637416|54507670|FG001|Overall Study|Unable to take study drug|1|||
27886748|NCT00636792|54507676|FG000|Overall Study|Adverse Event|16|||
27886749|NCT00636792|54507676|FG000|Overall Study|Physician Decision|7|||
27886750|NCT00636792|54507676|FG000|Overall Study|Progressive Disease|4|||
27886751|NCT00636792|54507676|FG000|Overall Study|Withdrawal by Subject|3|||
27886752|NCT00636792|54507676|FG000|Overall Study|Other|3|||
27886753|NCT00636636|54507708|FG000|Overall Study|Other reason|4|||
27886754|NCT00636636|54507709|FG001|Overall Study|Other reason|6|||
27886755|NCT00636636|54507708|FG000|Overall Study|Adverse Event|19|||
27886756|NCT00636636|54507709|FG001|Overall Study|Adverse Event|8|||
27886757|NCT00636636|54507708|FG000|Overall Study|Lack of Efficacy|7|||
27886758|NCT00636636|54507709|FG001|Overall Study|Lack of Efficacy|12|||
27886759|NCT00636636|54507708|FG000|Overall Study|Protocol Violation|2|||
27886760|NCT00636636|54507709|FG001|Overall Study|Protocol Violation|2|||
27886761|NCT00636636|54507708|FG000|Overall Study|Lost to Follow-up|0|||
27886762|NCT00636636|54507709|FG001|Overall Study|Lost to Follow-up|1|||
27886763|NCT00636636|54507708|FG000|Overall Study|Death|0|||
27886764|NCT00636636|54507709|FG001|Overall Study|Death|1|||
27886765|NCT00636636|54507708|FG000|Overall Study|Withdrawal by Subject|4|||
27886766|NCT00636636|54507709|FG001|Overall Study|Withdrawal by Subject|9|||
27886767|NCT00635778|54507722|FG000|Overall Study|Adverse Event|1|||
27886768|NCT00635778|54507723|FG001|Overall Study|Adverse Event|0|||
27886769|NCT00635778|54507724|FG002|Overall Study|Adverse Event|0|||
27886770|NCT00635778|54507725|FG003|Overall Study|Adverse Event|3|||
27886771|NCT00635778|54507726|FG004|Overall Study|Adverse Event|3|||
27886772|NCT00635778|54507727|FG005|Overall Study|Adverse Event|6|||
27886773|NCT00635778|54507728|FG006|Overall Study|Adverse Event|1|||
27886774|NCT00635778|54507722|FG000|Overall Study|Withdrawal by Subject|0|||
27886775|NCT00635778|54507723|FG001|Overall Study|Withdrawal by Subject|0|||
27886776|NCT00635778|54507724|FG002|Overall Study|Withdrawal by Subject|0|||
27886777|NCT00635778|54507725|FG003|Overall Study|Withdrawal by Subject|1|||
27886778|NCT00635778|54507726|FG004|Overall Study|Withdrawal by Subject|0|||
27886779|NCT00635778|54507727|FG005|Overall Study|Withdrawal by Subject|1|||
27886780|NCT00635778|54507728|FG006|Overall Study|Withdrawal by Subject|1|||
27886781|NCT00635778|54507722|FG000|Overall Study|Progressive disease|0|||
27886782|NCT00635778|54507723|FG001|Overall Study|Progressive disease|3|||
27886783|NCT00635778|54507724|FG002|Overall Study|Progressive disease|3|||
28171803|NCT04163991|54843379|FG002|Overall Study|Adverse Event|0|||
27886784|NCT00635778|54507725|FG003|Overall Study|Progressive disease|4|||
27886785|NCT00635778|54507726|FG004|Overall Study|Progressive disease|5|||
27886786|NCT00635778|54507727|FG005|Overall Study|Progressive disease|14|||
27886787|NCT00635778|54507728|FG006|Overall Study|Progressive disease|4|||
27886788|NCT00634920|54507748|FG000|Period 1 - Pre-Randomization|Adverse Event|0|||
27886789|NCT00634920|54507749|FG001|Period 1 - Pre-Randomization|Adverse Event|0|||
27886790|NCT00634920|54507750|FG002|Period 1 - Pre-Randomization|Adverse Event|36|||
27886791|NCT00634920|54507748|FG000|Period 1 - Pre-Randomization|Wound healing problems|0|||
27886792|NCT00634920|54507749|FG001|Period 1 - Pre-Randomization|Wound healing problems|0|||
27886793|NCT00634920|54507750|FG002|Period 1 - Pre-Randomization|Wound healing problems|16|||
27886794|NCT00634920|54507748|FG000|Period 1 - Pre-Randomization|Rejections|0|||
27886795|NCT00634920|54507749|FG001|Period 1 - Pre-Randomization|Rejections|0|||
27886796|NCT00634920|54507750|FG002|Period 1 - Pre-Randomization|Rejections|55|||
27886797|NCT00634920|54507748|FG000|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
27886798|NCT00634920|54507749|FG001|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
27886799|NCT00634920|54507750|FG002|Period 1 - Pre-Randomization|Withdrawal by Subject|21|||
27886800|NCT00634920|54507748|FG000|Period 1 - Pre-Randomization|Non-Compliance|0|||
27886801|NCT00634920|54507749|FG001|Period 1 - Pre-Randomization|Non-Compliance|0|||
27886802|NCT00634920|54507750|FG002|Period 1 - Pre-Randomization|Non-Compliance|3|||
27886803|NCT00634920|54507748|FG000|Period 1 - Pre-Randomization|Other issues|0|||
27886804|NCT00634920|54507749|FG001|Period 1 - Pre-Randomization|Other issues|0|||
27886805|NCT00634920|54507750|FG002|Period 1 - Pre-Randomization|Other issues|6|||
27886806|NCT00634920|54507748|FG000|Period 2 - Post-Randomization|Adverse Event|37|||
27886807|NCT00634920|54507749|FG001|Period 2 - Post-Randomization|Adverse Event|9|||
27886808|NCT00634920|54507750|FG002|Period 2 - Post-Randomization|Adverse Event|0|||
27886809|NCT00634920|54507748|FG000|Period 2 - Post-Randomization|Rejection|11|||
27886810|NCT00634920|54507749|FG001|Period 2 - Post-Randomization|Rejection|5|||
27886811|NCT00634920|54507750|FG002|Period 2 - Post-Randomization|Rejection|0|||
27886812|NCT00634920|54507748|FG000|Period 2 - Post-Randomization|Death|2|||
27886813|NCT00634920|54507749|FG001|Period 2 - Post-Randomization|Death|5|||
27886814|NCT00634920|54507750|FG002|Period 2 - Post-Randomization|Death|0|||
27886815|NCT00634920|54507748|FG000|Period 2 - Post-Randomization|consent withdrawal, non compliance|9|||
27886816|NCT00634920|54507749|FG001|Period 2 - Post-Randomization|consent withdrawal, non compliance|13|||
27886817|NCT00634920|54507750|FG002|Period 2 - Post-Randomization|consent withdrawal, non compliance|0|||
27886818|NCT00634920|54507748|FG000|Period 2 - Post-Randomization|Patients did not receive study drug|2|||
27886819|NCT00634920|54507749|FG001|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
27886820|NCT00634920|54507750|FG002|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
27886821|NCT00634842|54507758|FG000|Overall Study|Adverse Event|2|||
27886822|NCT00634842|54507759|FG001|Overall Study|Adverse Event|3|||
27886823|NCT00634842|54507758|FG000|Overall Study|Protocol Violation|8|||
27886824|NCT00634842|54507759|FG001|Overall Study|Protocol Violation|4|||
27886825|NCT00634842|54507758|FG000|Overall Study|Move to another state|1|||
27886826|NCT00634842|54507759|FG001|Overall Study|Move to another state|0|||
27886827|NCT00634842|54507758|FG000|Overall Study|Inclusion criteria were not met|1|||
27886828|NCT00634842|54507759|FG001|Overall Study|Inclusion criteria were not met|0|||
27886829|NCT00634842|54507758|FG000|Overall Study|Lost to Follow-up|1|||
27886830|NCT00634842|54507759|FG001|Overall Study|Lost to Follow-up|2|||
27886831|NCT00634842|54507758|FG000|Overall Study|Physician Decision|1|||
27886832|NCT00634842|54507759|FG001|Overall Study|Physician Decision|0|||
27886833|NCT00634842|54507758|FG000|Overall Study|Withdrawal by Subject|1|||
27886834|NCT00634842|54507759|FG001|Overall Study|Withdrawal by Subject|3|||
27886835|NCT00634842|54507758|FG000|Overall Study|Lack of time and intolerance to drug|0|||
27886836|NCT00634842|54507759|FG001|Overall Study|Lack of time and intolerance to drug|1|||
27886837|NCT00634842|54507758|FG000|Overall Study|Discontinued due to injection|0|||
27886838|NCT00634842|54507759|FG001|Overall Study|Discontinued due to injection|2|||
27886839|NCT00634842|54507758|FG000|Overall Study|No need of study drug to treat diabetes|0|||
27886840|NCT00634842|54507759|FG001|Overall Study|No need of study drug to treat diabetes|1|||
27886841|NCT00634842|54507758|FG000|Overall Study|No wish to keep taking Avandia|0|||
27886842|NCT00634842|54507759|FG001|Overall Study|No wish to keep taking Avandia|1|||
27886843|NCT00634842|54507758|FG000|Overall Study|Subject off study drug for too long|0|||
27886844|NCT00634842|54507759|FG001|Overall Study|Subject off study drug for too long|1|||
27886845|NCT00633984|54507767|FG000|Overall Study|Lost to Follow-up|0|||
27886846|NCT00633984|54507768|FG001|Overall Study|Lost to Follow-up|6|||
27886847|NCT00633984|54507767|FG000|Overall Study|Withdrawal by Subject|8|||
27886848|NCT00633984|54507768|FG001|Overall Study|Withdrawal by Subject|7|||
27886849|NCT00633984|54507767|FG000|Overall Study|Hospitalized|1|||
27886850|NCT00633984|54507768|FG001|Overall Study|Hospitalized|0|||
27886851|NCT01921218|54507796|FG000|Overall Study|Death|2|||
27886852|NCT01921218|54507797|FG001|Overall Study|Death|1|||
27886853|NCT01921218|54507796|FG000|Overall Study|Withdrawal by Subject|0|||
27886854|NCT01921218|54507797|FG001|Overall Study|Withdrawal by Subject|2|||
27886855|NCT01921218|54507796|FG000|Overall Study|Kidney transplant|1|||
27886856|NCT01921218|54507797|FG001|Overall Study|Kidney transplant|1|||
27886857|NCT00633750|54507803|FG000|Overall Study|Adverse Event|2|||
27886858|NCT00633750|54507803|FG000|Overall Study|Withdrawal by Subject|3|||
27886859|NCT00633360|54507811|FG000|Overall Study|Lost to Follow-up|1|||
27886860|NCT00633360|54507812|FG001|Overall Study|Lost to Follow-up|1|||
27886861|NCT00633360|54507811|FG000|Overall Study|Adverse Event|3|||
27886862|NCT00633360|54507812|FG001|Overall Study|Adverse Event|1|||
27886863|NCT00633360|54507811|FG000|Overall Study|Protocol Violation|0|||
27886864|NCT00633360|54507812|FG001|Overall Study|Protocol Violation|1|||
27886865|NCT00633126|54507820|FG000|Overall Study|Did not receive full dose|1|||
27886866|NCT00989664|54507824|FG000|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1|||
27886867|NCT00989664|54507824|FG000|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2|||
27886868|NCT00989664|54507824|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|49|||
27886869|NCT00989664|54507824|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
27886870|NCT00989664|54507824|FG000|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7|||
27886871|NCT00989664|54507824|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1|||
28171804|NCT04163991|54843380|FG003|Overall Study|Adverse Event|1|||
27886872|NCT00989664|54507824|FG000|Long-Term Follow-Up|Death|3|||
27886873|NCT00632736|54507830|FG000|Overall Study|Adverse Event|104|||
27886874|NCT00632736|54507830|FG000|Overall Study|Lost to Follow-up|15|||
27886875|NCT00632736|54507830|FG000|Overall Study|Protocol Violation|14|||
27886876|NCT00632736|54507830|FG000|Overall Study|Withdrawal by Subject|99|||
27886877|NCT00632736|54507830|FG000|Overall Study|Lack of Efficacy|5|||
27886878|NCT00632736|54507830|FG000|Overall Study|Sponsor terminated study|5|||
27886879|NCT00632736|54507830|FG000|Overall Study|Non-compliance|10|||
27886880|NCT00632736|54507830|FG000|Overall Study|Other|16|||
27886881|NCT00989196|54507834|FG000|Treatment Period|Lost to Follow-up|1|||
27886882|NCT00989196|54507835|FG001|Treatment Period|Lost to Follow-up|0|||
27886883|NCT00632502|54507843|FG000|Overall Study|Adverse Event|0|||
27886884|NCT00632502|54507844|FG001|Overall Study|Adverse Event|1|||
27886885|NCT00632502|54507843|FG000|Overall Study|Randomized not treated|3|||
27886886|NCT00632502|54507844|FG001|Overall Study|Randomized not treated|0|||
27886887|NCT00632424|54507854|FG000|Overall Study|Disease Progression|17|||
27886888|NCT00632424|54507854|FG000|Overall Study|Study Drug Toxicity|1|||
27886889|NCT00631488|54507871|FG000|Overall Study|Adverse Event|1|||
27886890|NCT00631488|54507872|FG001|Overall Study|Adverse Event|0|||
27886891|NCT00631488|54507873|FG002|Overall Study|Adverse Event|0|||
27886892|NCT00631488|54507871|FG000|Overall Study|Lost to Follow-up|2|||
27886893|NCT00631488|54507872|FG001|Overall Study|Lost to Follow-up|2|||
27886894|NCT00631488|54507873|FG002|Overall Study|Lost to Follow-up|0|||
27886895|NCT00631488|54507871|FG000|Overall Study|Physician Decision|1|||
27886896|NCT00631488|54507872|FG001|Overall Study|Physician Decision|0|||
27886897|NCT00631488|54507873|FG002|Overall Study|Physician Decision|1|||
27886898|NCT00631488|54507871|FG000|Overall Study|Protocol Violation|0|||
27886899|NCT00631488|54507872|FG001|Overall Study|Protocol Violation|0|||
27886900|NCT00631488|54507873|FG002|Overall Study|Protocol Violation|1|||
27886901|NCT00988884|54507883|FG000|Overall Study|Adverse Event|0|||
27886902|NCT00988884|54507884|FG001|Overall Study|Adverse Event|1|||
27886903|NCT00988884|54507883|FG000|Overall Study|Lost to Follow-up|20|||
27886904|NCT00988884|54507884|FG001|Overall Study|Lost to Follow-up|16|||
27886905|NCT00988884|54507883|FG000|Overall Study|Protocol Violation|0|||
27886906|NCT00988884|54507884|FG001|Overall Study|Protocol Violation|1|||
27886907|NCT00988884|54507883|FG000|Overall Study|Withdrawal by Subject|15|||
27886908|NCT00988884|54507884|FG001|Overall Study|Withdrawal by Subject|18|||
27886909|NCT00631020|54507890|FG000|Overall Study|Lost to Follow-up|7|||
27886910|NCT00631020|54507890|FG000|Overall Study|Incarcerated|1|||
27886911|NCT00987402|54507896|FG000|Overall Study|Insufficient data entry|86|||
27886912|NCT00987402|54507897|FG001|Overall Study|Insufficient data entry|98|||
27886913|NCT00630864|54507903|FG000|Part 1 (up to Week 6)|Adverse Event|1|||
27886914|NCT00630864|54507903|FG000|Part 2 (After Week 6 up to Month 12)|Liver transplant|2|||
27886915|NCT00630786|54507910|FG000|Overall Study|Physician Decision|0|||
27886916|NCT00630786|54507911|FG001|Overall Study|Physician Decision|0|||
27886917|NCT00630786|54507912|FG002|Overall Study|Physician Decision|1|||
27886918|NCT00630786|54507910|FG000|Overall Study|Withdrawal by Subject|0|||
27886919|NCT00630786|54507911|FG001|Overall Study|Withdrawal by Subject|1|||
27886920|NCT00630786|54507912|FG002|Overall Study|Withdrawal by Subject|1|||
27886921|NCT00630786|54507910|FG000|Overall Study|Lost to Follow-up|0|||
27886922|NCT00630786|54507911|FG001|Overall Study|Lost to Follow-up|1|||
27886923|NCT00630786|54507912|FG002|Overall Study|Lost to Follow-up|0|||
27886924|NCT00630786|54507910|FG000|Overall Study|Other|1|||
27886925|NCT00630786|54507911|FG001|Overall Study|Other|0|||
27886926|NCT00630786|54507912|FG002|Overall Study|Other|0|||
27886927|NCT00630396|54507918|FG000|Overall Study|Death|4|||
27886928|NCT00630396|54507918|FG000|Overall Study|Lost to Follow-up|3|||
27886929|NCT00985686|54507926|FG000|Overall Study|Lost to Follow-up|1|||
27886930|NCT00985686|54507927|FG001|Overall Study|Lost to Follow-up|1|||
27886931|NCT00985686|54507928|FG002|Overall Study|Lost to Follow-up|0|||
27886932|NCT00985686|54507929|FG003|Overall Study|Lost to Follow-up|2|||
27886933|NCT00984594|54507939|FG000|Overall Study|Lost to Follow-up|1|||
27886934|NCT00984594|54507940|FG001|Overall Study|Lost to Follow-up|0|||
27886935|NCT00984594|54507939|FG000|Overall Study|Withdrawal by Subject|0|||
27886936|NCT00984594|54507940|FG001|Overall Study|Withdrawal by Subject|1|||
27886937|NCT00984204|54507948|FG000|Overall Study|Death|1|||
27886938|NCT00984204|54507948|FG000|Overall Study|Lost to Follow-up|4|||
27886939|NCT00984204|54507948|FG000|Overall Study|Lack of Efficacy|10|||
27886940|NCT00983892|54507954|FG000|Overall Study|Withdrawal by Subject|10|||
27886941|NCT00983892|54507955|FG001|Overall Study|Withdrawal by Subject|12|||
27886942|NCT00983580|54507963|FG000|Overall Study|Cancel Prior to treatment|1|||
27739364|NCT02660229|54188939|FG000|Overall Study|Withdrawal by Subject|0|||
27886943|NCT00983580|54507964|FG001|Overall Study|Cancel Prior to treatment|3|||
27886944|NCT00983580|54507963|FG000|Overall Study|Protocol Violation|1|||
27886945|NCT00983580|54507964|FG001|Overall Study|Protocol Violation|1|||
27886946|NCT00983580|54507963|FG000|Overall Study|Ineligible|3|||
27886947|NCT00983580|54507964|FG001|Overall Study|Ineligible|0|||
27886948|NCT00982878|54507971|FG000|Overall Study|Physician Decision|1|||
27886949|NCT00982488|54507980|FG000|Overall Study|Administrative reason by sponsor|81|||
27886950|NCT00982488|54507981|FG001|Overall Study|Administrative reason by sponsor|3|||
27886951|NCT00982488|54507982|FG002|Overall Study|Administrative reason by sponsor|11|||
27886952|NCT00982488|54507983|FG003|Overall Study|Administrative reason by sponsor|0|||
27886953|NCT00982488|54507984|FG004|Overall Study|Administrative reason by sponsor|0|||
27886954|NCT00982488|54507980|FG000|Overall Study|Adverse event unrelated to study drug|5|||
27886955|NCT00982488|54507981|FG001|Overall Study|Adverse event unrelated to study drug|1|||
27886956|NCT00982488|54507982|FG002|Overall Study|Adverse event unrelated to study drug|0|||
27886957|NCT00982488|54507983|FG003|Overall Study|Adverse event unrelated to study drug|0|||
27886958|NCT00982488|54507984|FG004|Overall Study|Adverse event unrelated to study drug|0|||
27886959|NCT00982488|54507980|FG000|Overall Study|Death|11|||
27886960|NCT00982488|54507981|FG001|Overall Study|Death|0|||
27886961|NCT00982488|54507982|FG002|Overall Study|Death|2|||
27886962|NCT00982488|54507983|FG003|Overall Study|Death|0|||
27886963|NCT00982488|54507984|FG004|Overall Study|Death|0|||
27886964|NCT00982488|54507980|FG000|Overall Study|Disease progression|30|||
27886965|NCT00982488|54507981|FG001|Overall Study|Disease progression|5|||
27886966|NCT00982488|54507982|FG002|Overall Study|Disease progression|10|||
27886967|NCT00982488|54507983|FG003|Overall Study|Disease progression|1|||
27886968|NCT00982488|54507984|FG004|Overall Study|Disease progression|1|||
27886969|NCT00982488|54507980|FG000|Overall Study|Lost to Follow-up|1|||
27886970|NCT00982488|54507981|FG001|Overall Study|Lost to Follow-up|0|||
27886971|NCT00982488|54507982|FG002|Overall Study|Lost to Follow-up|0|||
27886972|NCT00982488|54507983|FG003|Overall Study|Lost to Follow-up|0|||
27886973|NCT00982488|54507984|FG004|Overall Study|Lost to Follow-up|0|||
27886974|NCT00982488|54507980|FG000|Overall Study|Maximum clinical benefit|1|||
27886975|NCT00982488|54507981|FG001|Overall Study|Maximum clinical benefit|1|||
27886976|NCT00982488|54507982|FG002|Overall Study|Maximum clinical benefit|1|||
27886977|NCT00982488|54507983|FG003|Overall Study|Maximum clinical benefit|0|||
27886978|NCT00982488|54507984|FG004|Overall Study|Maximum clinical benefit|0|||
27886979|NCT00982488|54507980|FG000|Overall Study|Other|15|||
27886980|NCT00982488|54507981|FG001|Overall Study|Other|1|||
27886981|NCT00982488|54507982|FG002|Overall Study|Other|3|||
27886982|NCT00982488|54507983|FG003|Overall Study|Other|1|||
27886983|NCT00982488|54507984|FG004|Overall Study|Other|0|||
27886984|NCT00982488|54507980|FG000|Overall Study|Poor compliance/noncompliance|0|||
27886985|NCT00982488|54507981|FG001|Overall Study|Poor compliance/noncompliance|1|||
27886986|NCT00982488|54507982|FG002|Overall Study|Poor compliance/noncompliance|0|||
27886987|NCT00982488|54507983|FG003|Overall Study|Poor compliance/noncompliance|0|||
27886988|NCT00982488|54507984|FG004|Overall Study|Poor compliance/noncompliance|0|||
27886989|NCT00982488|54507980|FG000|Overall Study|Stem cell transplant|2|||
27886990|NCT00982488|54507981|FG001|Overall Study|Stem cell transplant|0|||
27886991|NCT00982488|54507982|FG002|Overall Study|Stem cell transplant|0|||
27886992|NCT00982488|54507983|FG003|Overall Study|Stem cell transplant|1|||
27886993|NCT00982488|54507984|FG004|Overall Study|Stem cell transplant|0|||
27886994|NCT00982488|54507980|FG000|Overall Study|Study drug toxicity|34|||
27886995|NCT00982488|54507981|FG001|Overall Study|Study drug toxicity|1|||
27886996|NCT00982488|54507982|FG002|Overall Study|Study drug toxicity|6|||
27886997|NCT00982488|54507983|FG003|Overall Study|Study drug toxicity|0|||
27886998|NCT00982488|54507984|FG004|Overall Study|Study drug toxicity|0|||
27886999|NCT00982488|54507980|FG000|Overall Study|Withdrawal by Subject|5|||
27887000|NCT00982488|54507981|FG001|Overall Study|Withdrawal by Subject|1|||
27887001|NCT00982488|54507982|FG002|Overall Study|Withdrawal by Subject|1|||
27887002|NCT00982488|54507983|FG003|Overall Study|Withdrawal by Subject|0|||
27887003|NCT00982488|54507984|FG004|Overall Study|Withdrawal by Subject|0|||
27887004|NCT00982410|54507998|FG000|3-month Follow-up Assessment|Could not reach to schedule|8|||
27887005|NCT00982410|54507999|FG001|3-month Follow-up Assessment|Could not reach to schedule|9|||
27887006|NCT00982410|54507998|FG000|3-month Follow-up Assessment|Scheduled, no-show|1|||
27887007|NCT00982410|54507999|FG001|3-month Follow-up Assessment|Scheduled, no-show|2|||
27887008|NCT00982410|54507998|FG000|3-month Follow-up Assessment|Withdrawal by Subject|0|||
27887009|NCT00982410|54507999|FG001|3-month Follow-up Assessment|Withdrawal by Subject|2|||
27887010|NCT00982410|54507998|FG000|6-month Follow-up Assessment|Could not reach to schedule|5|||
27887011|NCT00982410|54507999|FG001|6-month Follow-up Assessment|Could not reach to schedule|7|||
27887012|NCT00982410|54507998|FG000|6-month Follow-up Assessment|participant no transportation|1|||
27887013|NCT00982410|54507999|FG001|6-month Follow-up Assessment|participant no transportation|0|||
27887014|NCT00982410|54507998|FG000|6-month Follow-up Assessment|incarceration|0|||
27887015|NCT00982410|54507999|FG001|6-month Follow-up Assessment|incarceration|2|||
27887016|NCT00982410|54507998|FG000|6-month Follow-up Assessment|patent surgery|0|||
27887017|NCT00982410|54507999|FG001|6-month Follow-up Assessment|patent surgery|1|||
27887018|NCT00982410|54507998|FG000|6-month Follow-up Assessment|scheduled, no-show|0|||
27887019|NCT00982410|54507999|FG001|6-month Follow-up Assessment|scheduled, no-show|1|||
27887020|NCT00982410|54507998|FG000|12-month Follow-up Assessment|Death|0|||
27887021|NCT00982410|54507999|FG001|12-month Follow-up Assessment|Death|2|||
27887022|NCT00982410|54507998|FG000|12-month Follow-up Assessment|could not reach to schedule|6|||
27887023|NCT00982410|54507999|FG001|12-month Follow-up Assessment|could not reach to schedule|5|||
27887024|NCT00982410|54507998|FG000|12-month Follow-up Assessment|Withdrawal by Subject|0|||
27887025|NCT00982410|54507999|FG001|12-month Follow-up Assessment|Withdrawal by Subject|1|||
27887026|NCT00982410|54507998|FG000|12-month Follow-up Assessment|incarceration|2|||
27887027|NCT00982410|54507999|FG001|12-month Follow-up Assessment|incarceration|1|||
27887028|NCT00982410|54507998|FG000|12-month Follow-up Assessment|scheduled, no-show|1|||
27887029|NCT00982410|54507999|FG001|12-month Follow-up Assessment|scheduled, no-show|0|||
27887030|NCT00982020|54508008|FG000|Overall Study|Adverse Event|19|||
27887031|NCT00982020|54508009|FG001|Overall Study|Adverse Event|15|||
27887032|NCT00982020|54508008|FG000|Overall Study|Withdrawal by Subject|11|||
27887033|NCT00982020|54508009|FG001|Overall Study|Withdrawal by Subject|14|||
27887034|NCT00982020|54508008|FG000|Overall Study|Lost to Follow-up|5|||
27887035|NCT00982020|54508009|FG001|Overall Study|Lost to Follow-up|11|||
27887036|NCT00982020|54508008|FG000|Overall Study|Lack of Efficacy|10|||
27887037|NCT00982020|54508009|FG001|Overall Study|Lack of Efficacy|4|||
27887038|NCT00982020|54508008|FG000|Overall Study|Parent/Caregiver Decision|5|||
27887039|NCT00982020|54508009|FG001|Overall Study|Parent/Caregiver Decision|5|||
27887040|NCT00982020|54508008|FG000|Overall Study|Treatment Non-compliance|3|||
27887041|NCT00982020|54508009|FG001|Overall Study|Treatment Non-compliance|6|||
27887042|NCT00982020|54508008|FG000|Overall Study|Physician Decision|2|||
27887043|NCT00982020|54508009|FG001|Overall Study|Physician Decision|5|||
27887044|NCT00982020|54508008|FG000|Overall Study|Entry Criteria Not Met|2|||
27887045|NCT00982020|54508009|FG001|Overall Study|Entry Criteria Not Met|1|||
27887046|NCT00982020|54508008|FG000|Overall Study|Protocol Violation|0|||
27887047|NCT00982020|54508009|FG001|Overall Study|Protocol Violation|2|||
27887048|NCT00982020|54508008|FG000|Overall Study|Clinical Relapse|0|||
27887049|NCT00982020|54508009|FG001|Overall Study|Clinical Relapse|1|||
27887050|NCT00981084|54508022|FG000|Post Intervention (Data Analysis)|poor effort|1|||
27887051|NCT00981084|54508023|FG001|Post Intervention (Data Analysis)|poor effort|1|||
27887052|NCT00981084|54508022|FG000|Post Intervention (Data Analysis)|imbalance in disease subtype|1|||
27887053|NCT00981084|54508023|FG001|Post Intervention (Data Analysis)|imbalance in disease subtype|0|||
27887054|NCT00980148|54508033|FG000|Overall Study|Discharged from facility|89|||
27887055|NCT00980148|54508034|FG001|Overall Study|Discharged from facility|96|||
27887056|NCT00980148|54508033|FG000|Overall Study|Received other antichlamydia treatment|20|||
27887057|NCT00980148|54508034|FG001|Overall Study|Received other antichlamydia treatment|14|||
27887058|NCT00980148|54508033|FG000|Overall Study|Negative for chlamydia at enrollment|12|||
27887059|NCT00980148|54508034|FG001|Overall Study|Negative for chlamydia at enrollment|9|||
27887060|NCT00980148|54508033|FG000|Overall Study|Various other reasons|8|||
27887061|NCT00980148|54508034|FG001|Overall Study|Various other reasons|9|||
27887062|NCT04553406|54508071|FG000|Overall Study|Study Discontinuation|0|||
27887063|NCT04553406|54508072|FG001|Overall Study|Study Discontinuation|1|||
27887064|NCT03033576|54508088|FG000|Overall Study|Ineligible|1|||
27887065|NCT03033576|54508089|FG001|Overall Study|Ineligible|1|||
27887066|NCT03033576|54508088|FG000|Overall Study|Adverse Event|4|||
27887067|NCT03033576|54508089|FG001|Overall Study|Adverse Event|20|||
27887068|NCT03033576|54508088|FG000|Overall Study|Progression/relapse|9|||
27887069|NCT03033576|54508089|FG001|Overall Study|Progression/relapse|36|||
27887070|NCT03033576|54508088|FG000|Overall Study|Death|1|||
27887071|NCT03033576|54508089|FG001|Overall Study|Death|1|||
27887072|NCT03033576|54508088|FG000|Overall Study|Patient refusal|1|||
27887073|NCT03033576|54508089|FG001|Overall Study|Patient refusal|6|||
27887074|NCT03033576|54508088|FG000|Overall Study|Other, unspecified reasons|0|||
27887075|NCT03033576|54508089|FG001|Overall Study|Other, unspecified reasons|4|||
27887076|NCT03033576|54508088|FG000|Overall Study|Currently on protocol therapy|0|||
27887077|NCT03033576|54508089|FG001|Overall Study|Currently on protocol therapy|2|||
27887078|NCT04129944|54508099|FG000|Overall Study|Death|0|||
27887079|NCT04129944|54508100|FG001|Overall Study|Death|0|||
27887080|NCT04129944|54508101|FG002|Overall Study|Death|0|||
27887081|NCT04129944|54508102|FG003|Overall Study|Death|1|||
27887082|NCT04129944|54508099|FG000|Overall Study|Lost to Follow-up|1|||
27887083|NCT04129944|54508100|FG001|Overall Study|Lost to Follow-up|0|||
28171805|NCT04163991|54843381|FG004|Overall Study|Adverse Event|0|||
27887084|NCT04129944|54508101|FG002|Overall Study|Lost to Follow-up|0|||
27887085|NCT04129944|54508102|FG003|Overall Study|Lost to Follow-up|0|||
27887086|NCT04129944|54508099|FG000|Overall Study|Withdrawal by Subject|1|||
27925738|NCT01231503|54582276|FG000|Overall Study|Lost to Follow-up|8|||
27925739|NCT01231503|54582277|FG001|Overall Study|Lost to Follow-up|10|||
27925740|NCT01231503|54582278|FG002|Overall Study|Lost to Follow-up|8|||
27925741|NCT01231503|54582279|FG003|Overall Study|Lost to Follow-up|5|||
27925742|NCT01231503|54582280|FG004|Overall Study|Lost to Follow-up|7|||
27925743|NCT01231503|54582281|FG005|Overall Study|Lost to Follow-up|9|||
27925744|NCT01231503|54582282|FG006|Overall Study|Lost to Follow-up|6|||
27925745|NCT01231503|54582283|FG007|Overall Study|Lost to Follow-up|6|||
27925746|NCT01231503|54582276|FG000|Overall Study|Protocol Violation|0|||
27925747|NCT01231503|54582277|FG001|Overall Study|Protocol Violation|0|||
27925748|NCT01231503|54582278|FG002|Overall Study|Protocol Violation|0|||
27925749|NCT01231503|54582279|FG003|Overall Study|Protocol Violation|1|||
27925750|NCT01231503|54582280|FG004|Overall Study|Protocol Violation|0|||
27925751|NCT01231503|54582281|FG005|Overall Study|Protocol Violation|0|||
27887087|NCT04129944|54508100|FG001|Overall Study|Withdrawal by Subject|0|||
27887088|NCT04129944|54508101|FG002|Overall Study|Withdrawal by Subject|1|||
27887089|NCT04129944|54508102|FG003|Overall Study|Withdrawal by Subject|2|||
27887090|NCT03829332|54508166|FG000|Overall Study|Death|145|||
27887091|NCT03829332|54508167|FG001|Overall Study|Death|135|||
27887092|NCT03829332|54508166|FG000|Overall Study|Withdrawal by Subject|10|||
27887093|NCT03829332|54508167|FG001|Overall Study|Withdrawal by Subject|4|||
27887094|NCT03829332|54508166|FG000|Overall Study|Ongoing in Study|154|||
27887095|NCT03829332|54508167|FG001|Overall Study|Ongoing in Study|175|||
27887096|NCT01899144|54509801|FG000|Treatment Period 2|Other|1|||
27887097|NCT01899144|54509801|FG000|Treatment Period 3|Other|2|||
27887098|NCT01899144|54509801|FG000|Treatment Period 5|Other|1|||
27887099|NCT03821844|54510415|FG000|Overall Study|Death|37|||
27887100|NCT03821844|54510416|FG001|Overall Study|Death|31|||
27887101|NCT03821844|54510415|FG000|Overall Study|Discharged|10|||
27887102|NCT03821844|54510416|FG001|Overall Study|Discharged|14|||
27887103|NCT03821844|54510415|FG000|Overall Study|Not present in facility at followup|2|||
27887104|NCT03821844|54510416|FG001|Overall Study|Not present in facility at followup|3|||
27887105|NCT01796106|54511876|FG000|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|5|||
27887106|NCT01796106|54511877|FG001|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|7|||
27887107|NCT01168219|54513069|FG000|Overall Study|off study before starting treatment|2|||
27887108|NCT01168219|54513069|FG000|Overall Study|withdrew before transplant|1|||
27887109|NCT01168219|54513069|FG000|Overall Study|ineligible due to CML|2|||
27887110|NCT01115803|54513080|FG000|Overall Study|Withdrawal by Subject|0|||
27887111|NCT01115803|54513081|FG001|Overall Study|Withdrawal by Subject|0|||
27887112|NCT01115803|54513082|FG002|Overall Study|Withdrawal by Subject|0|||
27887113|NCT01115803|54513083|FG003|Overall Study|Withdrawal by Subject|0|||
27887114|NCT01115803|54513084|FG004|Overall Study|Withdrawal by Subject|0|||
27887115|NCT01115803|54513085|FG005|Overall Study|Withdrawal by Subject|0|||
27887116|NCT01115803|54513086|FG006|Overall Study|Withdrawal by Subject|1|||
27887117|NCT01115803|54513080|FG000|Overall Study|Lost to Follow-up|0|||
27887118|NCT01115803|54513081|FG001|Overall Study|Lost to Follow-up|0|||
27887119|NCT01115803|54513082|FG002|Overall Study|Lost to Follow-up|1|||
27887120|NCT01115803|54513083|FG003|Overall Study|Lost to Follow-up|0|||
27887121|NCT01115803|54513084|FG004|Overall Study|Lost to Follow-up|0|||
27887122|NCT01115803|54513085|FG005|Overall Study|Lost to Follow-up|0|||
27887123|NCT01115803|54513086|FG006|Overall Study|Lost to Follow-up|0|||
27887124|NCT01115803|54513080|FG000|Overall Study|Progressive Disease during Cycle1|0|||
27887125|NCT01115803|54513081|FG001|Overall Study|Progressive Disease during Cycle1|0|||
27887126|NCT01115803|54513082|FG002|Overall Study|Progressive Disease during Cycle1|0|||
27887127|NCT01115803|54513083|FG003|Overall Study|Progressive Disease during Cycle1|0|||
27887128|NCT01115803|54513084|FG004|Overall Study|Progressive Disease during Cycle1|0|||
27887129|NCT01115803|54513085|FG005|Overall Study|Progressive Disease during Cycle1|0|||
27887130|NCT01115803|54513086|FG006|Overall Study|Progressive Disease during Cycle1|1|||
27887131|NCT01115569|54513107|FG000|Conversion/Titration Phase|Adverse Event|59|||
27887132|NCT01115569|54513108|FG001|Conversion/Titration Phase|Adverse Event|0|||
27887133|NCT01115569|54513107|FG000|Conversion/Titration Phase|Lost to Follow-up|3|||
27887134|NCT01115569|54513108|FG001|Conversion/Titration Phase|Lost to Follow-up|0|||
27887135|NCT01115569|54513107|FG000|Conversion/Titration Phase|Physician Decision|5|||
27887136|NCT01115569|54513108|FG001|Conversion/Titration Phase|Physician Decision|0|||
27887137|NCT01115569|54513107|FG000|Conversion/Titration Phase|Protocol Violation|68|||
27887138|NCT01115569|54513108|FG001|Conversion/Titration Phase|Protocol Violation|0|||
27887139|NCT01115569|54513107|FG000|Conversion/Titration Phase|Withdrawal by Subject|26|||
27887140|NCT01115569|54513108|FG001|Conversion/Titration Phase|Withdrawal by Subject|0|||
27887141|NCT01115569|54513107|FG000|Conversion/Titration Phase|Non-Compliance with Study Drug|53|||
27887142|NCT01115569|54513108|FG001|Conversion/Titration Phase|Non-Compliance with Study Drug|0|||
27887143|NCT01115569|54513107|FG000|Maintenance Phase|Adverse Event|0|||
27887144|NCT01115569|54513108|FG001|Maintenance Phase|Adverse Event|43|||
27887145|NCT01115569|54513107|FG000|Maintenance Phase|Lost to Follow-up|0|||
27887146|NCT01115569|54513108|FG001|Maintenance Phase|Lost to Follow-up|8|||
27887147|NCT01115569|54513107|FG000|Maintenance Phase|Physician Decision|0|||
27887148|NCT01115569|54513108|FG001|Maintenance Phase|Physician Decision|3|||
27887149|NCT01115569|54513107|FG000|Maintenance Phase|Protocol Violation|0|||
27887150|NCT01115569|54513108|FG001|Maintenance Phase|Protocol Violation|9|||
27887151|NCT01115569|54513107|FG000|Maintenance Phase|Withdrawal by Subject|0|||
28171806|NCT04163991|54843377|FG000|Overall Study|Death|0|||
27887152|NCT01115569|54513108|FG001|Maintenance Phase|Withdrawal by Subject|27|||
27887153|NCT01115569|54513107|FG000|Maintenance Phase|Non-Compliance with Study Drug|0|||
27887154|NCT01115569|54513108|FG001|Maintenance Phase|Non-Compliance with Study Drug|48|||
27887155|NCT01115569|54513107|FG000|Maintenance Phase|Administrative|0|||
27887156|NCT01115569|54513108|FG001|Maintenance Phase|Administrative|1|||
27887157|NCT01107886|54513115|FG000|Overall Study|Lost to Follow-up|15|||
27887158|NCT01107886|54513116|FG001|Overall Study|Lost to Follow-up|13|||
27887159|NCT01107886|54513115|FG000|Overall Study|Withdrawal by Subject|180|||
27887160|NCT01107886|54513116|FG001|Overall Study|Withdrawal by Subject|196|||
27887161|NCT01107886|54513115|FG000|Overall Study|Administrative withdrawal of consent|7|||
27887162|NCT01107886|54513116|FG001|Overall Study|Administrative withdrawal of consent|5|||
27887163|NCT01107457|54513127|FG000|Part A|Adverse Event|1|||
27887164|NCT01107457|54513128|FG001|Part A|Adverse Event|2|||
27887165|NCT01107457|54513129|FG002|Part A|Adverse Event|1|||
27887166|NCT01107457|54513130|FG003|Part A|Adverse Event|0|||
27887167|NCT01107457|54513131|FG004|Part A|Adverse Event|0|||
27887168|NCT01107457|54513132|FG005|Part A|Adverse Event|0|||
27887169|NCT01107457|54513127|FG000|Part A|Withdrawal by Subject|3|||
27887170|NCT01107457|54513128|FG001|Part A|Withdrawal by Subject|3|||
27887171|NCT01107457|54513129|FG002|Part A|Withdrawal by Subject|0|||
27887172|NCT01107457|54513130|FG003|Part A|Withdrawal by Subject|3|||
27887173|NCT01107457|54513131|FG004|Part A|Withdrawal by Subject|1|||
27887174|NCT01107457|54513132|FG005|Part A|Withdrawal by Subject|0|||
27887175|NCT01107457|54513127|FG000|Part A|Lost to Follow-up|0|||
27887176|NCT01107457|54513128|FG001|Part A|Lost to Follow-up|1|||
27887177|NCT01107457|54513129|FG002|Part A|Lost to Follow-up|0|||
27887178|NCT01107457|54513130|FG003|Part A|Lost to Follow-up|0|||
27887179|NCT01107457|54513131|FG004|Part A|Lost to Follow-up|0|||
27887180|NCT01107457|54513132|FG005|Part A|Lost to Follow-up|0|||
27887181|NCT01107457|54513127|FG000|Part A|Lack of Efficacy|1|||
27887182|NCT01107457|54513128|FG001|Part A|Lack of Efficacy|0|||
27887183|NCT01107457|54513129|FG002|Part A|Lack of Efficacy|0|||
27887184|NCT01107457|54513130|FG003|Part A|Lack of Efficacy|0|||
27887185|NCT01107457|54513131|FG004|Part A|Lack of Efficacy|0|||
27887186|NCT01107457|54513132|FG005|Part A|Lack of Efficacy|0|||
27887187|NCT01107457|54513127|FG000|Part A|Protocol Violation|0|||
27887188|NCT01107457|54513128|FG001|Part A|Protocol Violation|1|||
27887189|NCT01107457|54513129|FG002|Part A|Protocol Violation|0|||
27887190|NCT01107457|54513130|FG003|Part A|Protocol Violation|0|||
27887191|NCT01107457|54513131|FG004|Part A|Protocol Violation|0|||
27887192|NCT01107457|54513132|FG005|Part A|Protocol Violation|0|||
27887193|NCT01107457|54513127|FG000|Part B and C|Adverse Event|0|||
27887194|NCT01107457|54513128|FG001|Part B and C|Adverse Event|0|||
27887195|NCT01107457|54513129|FG002|Part B and C|Adverse Event|0|||
27887196|NCT01107457|54513130|FG003|Part B and C|Adverse Event|0|||
27887197|NCT01107457|54513131|FG004|Part B and C|Adverse Event|0|||
27887198|NCT01107457|54513132|FG005|Part B and C|Adverse Event|12|||
27887199|NCT01107457|54513127|FG000|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
27887200|NCT01107457|54513128|FG001|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
27887201|NCT01107457|54513129|FG002|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
27887202|NCT01107457|54513130|FG003|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
27887203|NCT01107457|54513131|FG004|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
27887204|NCT01107457|54513132|FG005|Part B and C|Inclusion/Exclusion Criteria Not Met|1|||
27887205|NCT01107457|54513127|FG000|Part B and C|Physician Decision|0|||
27887206|NCT01107457|54513128|FG001|Part B and C|Physician Decision|0|||
27887207|NCT01107457|54513129|FG002|Part B and C|Physician Decision|0|||
27887208|NCT01107457|54513130|FG003|Part B and C|Physician Decision|0|||
27887209|NCT01107457|54513131|FG004|Part B and C|Physician Decision|0|||
27887210|NCT01107457|54513132|FG005|Part B and C|Physician Decision|3|||
27887211|NCT01107457|54513127|FG000|Part B and C|Lack of Efficacy|0|||
27887212|NCT01107457|54513128|FG001|Part B and C|Lack of Efficacy|0|||
27887213|NCT01107457|54513129|FG002|Part B and C|Lack of Efficacy|0|||
27887214|NCT01107457|54513130|FG003|Part B and C|Lack of Efficacy|0|||
27887215|NCT01107457|54513131|FG004|Part B and C|Lack of Efficacy|0|||
27887216|NCT01107457|54513132|FG005|Part B and C|Lack of Efficacy|7|||
27887217|NCT01107457|54513127|FG000|Part B and C|Lost to Follow-up|0|||
27887218|NCT01107457|54513128|FG001|Part B and C|Lost to Follow-up|0|||
27887219|NCT01107457|54513129|FG002|Part B and C|Lost to Follow-up|0|||
27887220|NCT01107457|54513130|FG003|Part B and C|Lost to Follow-up|0|||
27887221|NCT01107457|54513131|FG004|Part B and C|Lost to Follow-up|0|||
27887222|NCT01107457|54513132|FG005|Part B and C|Lost to Follow-up|10|||
27887223|NCT01107457|54513127|FG000|Part B and C|Protocol Violation|0|||
27887224|NCT01107457|54513128|FG001|Part B and C|Protocol Violation|0|||
27887225|NCT01107457|54513129|FG002|Part B and C|Protocol Violation|0|||
27887226|NCT01107457|54513130|FG003|Part B and C|Protocol Violation|0|||
27887227|NCT01107457|54513131|FG004|Part B and C|Protocol Violation|0|||
27887228|NCT01107457|54513132|FG005|Part B and C|Protocol Violation|1|||
27887229|NCT01107457|54513127|FG000|Part B and C|Sponsor Decision|0|||
27887230|NCT01107457|54513128|FG001|Part B and C|Sponsor Decision|0|||
28171807|NCT04163991|54843378|FG001|Overall Study|Death|0|||
27887231|NCT01107457|54513129|FG002|Part B and C|Sponsor Decision|0|||
27887232|NCT01107457|54513130|FG003|Part B and C|Sponsor Decision|0|||
27887233|NCT01107457|54513131|FG004|Part B and C|Sponsor Decision|0|||
27887234|NCT01107457|54513132|FG005|Part B and C|Sponsor Decision|66|||
27887235|NCT01107457|54513127|FG000|Part B and C|Withdrawal by Subject|0|||
27887236|NCT01107457|54513128|FG001|Part B and C|Withdrawal by Subject|0|||
27887237|NCT01107457|54513129|FG002|Part B and C|Withdrawal by Subject|0|||
27887238|NCT01107457|54513130|FG003|Part B and C|Withdrawal by Subject|0|||
27887239|NCT01107457|54513131|FG004|Part B and C|Withdrawal by Subject|0|||
28171808|NCT04163991|54843379|FG002|Overall Study|Death|1|||
28171809|NCT04163991|54843380|FG003|Overall Study|Death|0|||
27887240|NCT01107457|54513132|FG005|Part B and C|Withdrawal by Subject|16|||
27887241|NCT01107457|54513127|FG000|Part B and C|Clinical Relapse|0|||
27887242|NCT01107457|54513128|FG001|Part B and C|Clinical Relapse|0|||
27887243|NCT01107457|54513129|FG002|Part B and C|Clinical Relapse|0|||
27887244|NCT01107457|54513130|FG003|Part B and C|Clinical Relapse|0|||
27887245|NCT01107457|54513131|FG004|Part B and C|Clinical Relapse|0|||
27887246|NCT01107457|54513132|FG005|Part B and C|Clinical Relapse|4|||
27887247|NCT04545385|54513162|FG000|Overall Study|Withdrawal by Subject|2|||
27887248|NCT04545385|54513163|FG001|Overall Study|Withdrawal by Subject|0|||
27887249|NCT04545385|54513162|FG000|Overall Study|Loss of asthma control (LoAC)|0|||
27887250|NCT04545385|54513163|FG001|Overall Study|Loss of asthma control (LoAC)|1|||
27887251|NCT04545385|54513162|FG000|Overall Study|Study termination|10|||
27887252|NCT04545385|54513163|FG001|Overall Study|Study termination|10|||
27887253|NCT04545385|54513162|FG000|Overall Study|Sponsor decision|2|||
27887254|NCT04545385|54513163|FG001|Overall Study|Sponsor decision|2|||
27887255|NCT04545385|54513162|FG000|Overall Study|Other than specified|1|||
27887256|NCT04545385|54513163|FG001|Overall Study|Other than specified|0|||
27887257|NCT04099251|54513180|FG000|Pre-Treatment|Other reasons|1|||
27887258|NCT04099251|54513181|FG001|Pre-Treatment|Other reasons|0|||
27887259|NCT04099251|54513180|FG000|Pre-Treatment|Participant no longer meets study criteria|1|||
27887260|NCT04099251|54513181|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
27887261|NCT04099251|54513180|FG000|Blinded Treatment Phase|Other reasons|16|||
27887262|NCT04099251|54513181|FG001|Blinded Treatment Phase|Other reasons|7|||
27887263|NCT04099251|54513180|FG000|Blinded Treatment Phase|Disease recurrence|26|||
27887264|NCT04099251|54513181|FG001|Blinded Treatment Phase|Disease recurrence|41|||
27887265|NCT04099251|54513180|FG000|Blinded Treatment Phase|Adverse event unrelated to study drug|11|||
27887266|NCT04099251|54513181|FG001|Blinded Treatment Phase|Adverse event unrelated to study drug|1|||
27887267|NCT04099251|54513180|FG000|Blinded Treatment Phase|Study drug toxicity|94|||
27887268|NCT04099251|54513181|FG001|Blinded Treatment Phase|Study drug toxicity|7|||
27887269|NCT04099251|54513180|FG000|Blinded Treatment Phase|Participant no longer meets study criteria|1|||
27887270|NCT04099251|54513181|FG001|Blinded Treatment Phase|Participant no longer meets study criteria|0|||
27887271|NCT04099251|54513180|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
27887272|NCT04099251|54513181|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
27887273|NCT04099251|54513180|FG000|Blinded Treatment Phase|Death|6|||
27887274|NCT04099251|54513181|FG001|Blinded Treatment Phase|Death|2|||
27887275|NCT04099251|54513180|FG000|Blinded Treatment Phase|Withdrawal by Subject|18|||
27887276|NCT04099251|54513181|FG001|Blinded Treatment Phase|Withdrawal by Subject|7|||
27887277|NCT04099251|54513180|FG000|Blinded Treatment Phase|Participant request to discontinue study treatment|29|||
27887278|NCT04099251|54513181|FG001|Blinded Treatment Phase|Participant request to discontinue study treatment|0|||
27887279|NCT04099251|54513180|FG000|Blinded Treatment Phase|Ongoing treatment|64|||
27887280|NCT04099251|54513181|FG001|Blinded Treatment Phase|Ongoing treatment|39|||
27887281|NCT04099251|54513180|FG000|Blinded Treatment Phase|Maximum clinical benefit|1|||
27887282|NCT04099251|54513181|FG001|Blinded Treatment Phase|Maximum clinical benefit|2|||
27887283|NCT04099251|54513180|FG000|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|0|||
27887284|NCT04099251|54513181|FG001|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|2|||
27887285|NCT04099251|54513180|FG000|Optional Open-Label Phase Treatment|Disease progression/recurrence|0|||
27887286|NCT04099251|54513181|FG001|Optional Open-Label Phase Treatment|Disease progression/recurrence|5|||
27887287|NCT04099251|54513180|FG000|Optional Open-Label Phase Treatment|Decision by Principal Investigator|0|||
27887288|NCT04099251|54513181|FG001|Optional Open-Label Phase Treatment|Decision by Principal Investigator|1|||
27887289|NCT04099251|54513180|FG000|Optional Open-Label Phase Treatment|Study drug toxicity|0|||
27887290|NCT04099251|54513181|FG001|Optional Open-Label Phase Treatment|Study drug toxicity|2|||
27887291|NCT04099251|54513180|FG000|Optional Open-Label Phase Treatment|Ongoing treatment|2|||
27887292|NCT04099251|54513181|FG001|Optional Open-Label Phase Treatment|Ongoing treatment|17|||
27887293|NCT03783026|54513188|FG000|Treatment Phase|Adverse Event|15|||
27887294|NCT03783026|54513188|FG000|Treatment Phase|Lack of Efficacy|11|||
27887295|NCT03783026|54513188|FG000|Treatment Phase|Withdrawal by Subject|6|||
27887296|NCT03783026|54513188|FG000|Treatment Phase|Lost to Follow-up|2|||
27887297|NCT03783026|54513188|FG000|Treatment Phase|Protocol Deviation|8|||
27887298|NCT03783026|54513188|FG000|Treatment Phase|Did Not Receive Treatment|1|||
27887299|NCT03783026|54513188|FG000|Observational Follow-up Phase|Lost to Follow-up|3|||
27887300|NCT03635112|54513205|FG000|Overall Study|Adverse Event|5|||
27984905|NCT00887159|54643625|FG001|Overall Study|Received more tx instead of observation|0|||
27984906|NCT00887159|54643626|FG002|Overall Study|Received more tx instead of observation|0|||
27984907|NCT00887159|54643624|FG000|Overall Study|Ineligible|5|||
27887301|NCT03635112|54513206|FG001|Overall Study|Adverse Event|9|||
27887302|NCT03635112|54513207|FG002|Overall Study|Adverse Event|14|||
27887303|NCT03635112|54513205|FG000|Overall Study|Lost to Follow-up|1|||
27887304|NCT03635112|54513206|FG001|Overall Study|Lost to Follow-up|0|||
27887305|NCT03635112|54513207|FG002|Overall Study|Lost to Follow-up|1|||
27887306|NCT03635112|54513205|FG000|Overall Study|Physician Decision|5|||
27887307|NCT03635112|54513206|FG001|Overall Study|Physician Decision|7|||
27887308|NCT03635112|54513207|FG002|Overall Study|Physician Decision|5|||
27887309|NCT03635112|54513205|FG000|Overall Study|Protocol Violation|0|||
27887310|NCT03635112|54513206|FG001|Overall Study|Protocol Violation|0|||
27887311|NCT03635112|54513207|FG002|Overall Study|Protocol Violation|1|||
27887312|NCT03635112|54513205|FG000|Overall Study|Study Terminated by Sponsor|11|||
27887313|NCT03635112|54513206|FG001|Overall Study|Study Terminated by Sponsor|17|||
27887314|NCT03635112|54513207|FG002|Overall Study|Study Terminated by Sponsor|21|||
27887315|NCT03635112|54513205|FG000|Overall Study|Withdrawal by Subject|4|||
27984908|NCT00887159|54643625|FG001|Overall Study|Ineligible|1|||
27984909|NCT00887159|54643626|FG002|Overall Study|Ineligible|0|||
27984910|NCT00887159|54643624|FG000|Overall Study|Never started assigned therapy|3|||
27984911|NCT00887159|54643625|FG001|Overall Study|Never started assigned therapy|3|||
27984912|NCT00887159|54643626|FG002|Overall Study|Never started assigned therapy|4|||
27984913|NCT00886769|54643638|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
27984914|NCT00886769|54643639|FG001|Overall Study|Unsatisfactory therapeutic effect|37|||
27984915|NCT00886613|54643648|FG000|Overall Study|Protocol deviation (Part B)|1|||
27984916|NCT00886613|54643649|FG001|Overall Study|Protocol deviation (Part B)|0|||
27984917|NCT00886613|54643650|FG002|Overall Study|Protocol deviation (Part B)|0|||
27984918|NCT00886613|54643648|FG000|Overall Study|Lost to follow-up (Part B)|1|||
27984919|NCT00886613|54643649|FG001|Overall Study|Lost to follow-up (Part B)|0|||
27984920|NCT00886613|54643650|FG002|Overall Study|Lost to follow-up (Part B)|1|||
27984921|NCT00886613|54643648|FG000|Overall Study|Subject withdrew consent (Part A)|0|||
27984922|NCT00886613|54643649|FG001|Overall Study|Subject withdrew consent (Part A)|0|||
27984923|NCT00886613|54643650|FG002|Overall Study|Subject withdrew consent (Part A)|2|||
27984924|NCT00886379|54643666|FG000|Overall Study|Transferred Schools|0|||
27984925|NCT00886379|54643667|FG001|Overall Study|Transferred Schools|0|||
27984926|NCT00886379|54643668|FG002|Overall Study|Transferred Schools|2|||
27984927|NCT00886379|54643669|FG003|Overall Study|Transferred Schools|1|||
27984928|NCT00886379|54643670|FG004|Overall Study|Transferred Schools|1|||
27984929|NCT00886379|54643666|FG000|Overall Study|Final blood draw not obtained|3|||
27984930|NCT00886379|54643667|FG001|Overall Study|Final blood draw not obtained|3|||
27984931|NCT00886379|54643668|FG002|Overall Study|Final blood draw not obtained|4|||
27984932|NCT00886379|54643669|FG003|Overall Study|Final blood draw not obtained|2|||
27984933|NCT00886379|54643670|FG004|Overall Study|Final blood draw not obtained|2|||
27984934|NCT00599196|54643682|FG000|Overall Study|Lack of Efficacy|22|||
27984935|NCT00599196|54643682|FG000|Overall Study|Adverse Event|93|||
27984936|NCT00599196|54643682|FG000|Overall Study|Unsatisfactory compliance of subject|3|||
27984937|NCT00599196|54643682|FG000|Overall Study|Subject withdrew consent|43|||
27984938|NCT00599196|54643682|FG000|Overall Study|Study ended per sponsor|197|||
27984939|NCT00599196|54643682|FG000|Overall Study|Lost to Follow-up|17|||
27984940|NCT00599196|54643682|FG000|Overall Study|Other: Patient Leaving For Israel|1|||
27984941|NCT00599196|54643682|FG000|Overall Study|Other: Spouse Withdrew Consent|1|||
27984942|NCT00599196|54643682|FG000|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1|||
27984943|NCT00599196|54643682|FG000|Overall Study|Other: Pt Moved To Australia|1|||
27984944|NCT00599196|54643682|FG000|Overall Study|Other: Patient Stopped Due To Moving|1|||
27984945|NCT00599196|54643682|FG000|Overall Study|Other: Inv Switched Dopamine Agonist|1|||
27984946|NCT00603512|54643691|FG000|Overall Study|Adverse Event|0|||
27984947|NCT00603512|54643692|FG001|Overall Study|Adverse Event|2|||
27984948|NCT00603512|54643693|FG002|Overall Study|Adverse Event|4|||
27984949|NCT00603512|54643694|FG003|Overall Study|Adverse Event|4|||
27984950|NCT00603512|54643695|FG004|Overall Study|Adverse Event|2|||
27984951|NCT00603512|54643691|FG000|Overall Study|Lack of Efficacy|0|||
27887316|NCT03635112|54513206|FG001|Overall Study|Withdrawal by Subject|9|||
27887317|NCT03635112|54513207|FG002|Overall Study|Withdrawal by Subject|7|||
27887318|NCT03635112|54513205|FG000|Overall Study|Miscellaneous|0|||
27887319|NCT03635112|54513206|FG001|Overall Study|Miscellaneous|0|||
27887320|NCT03635112|54513207|FG002|Overall Study|Miscellaneous|1|||
27887321|NCT03588728|54513220|FG000|Overall Study|Did not meet eligibility ctriteria|0|||
27887322|NCT03588728|54513221|FG001|Overall Study|Did not meet eligibility ctriteria|0|||
27887323|NCT03588728|54513222|FG002|Overall Study|Did not meet eligibility ctriteria|3|||
27887324|NCT03588728|54513223|FG003|Overall Study|Did not meet eligibility ctriteria|2|||
27984952|NCT00603512|54643692|FG001|Overall Study|Lack of Efficacy|1|||
27984953|NCT00603512|54643693|FG002|Overall Study|Lack of Efficacy|0|||
27984954|NCT00603512|54643694|FG003|Overall Study|Lack of Efficacy|0|||
27887325|NCT03588728|54513220|FG000|Overall Study|Lab shut down due to COVID-19|0|||
27887326|NCT03588728|54513221|FG001|Overall Study|Lab shut down due to COVID-19|0|||
27984955|NCT00603512|54643695|FG004|Overall Study|Lack of Efficacy|1|||
27984956|NCT00603512|54643691|FG000|Overall Study|Other|2|||
27984957|NCT00603512|54643692|FG001|Overall Study|Other|1|||
27887327|NCT03588728|54513222|FG002|Overall Study|Lab shut down due to COVID-19|0|||
27984958|NCT00603512|54643693|FG002|Overall Study|Other|0|||
27984959|NCT00603512|54643694|FG003|Overall Study|Other|1|||
27984960|NCT00603512|54643695|FG004|Overall Study|Other|1|||
27984961|NCT00603512|54643691|FG000|Overall Study|Withdrawal by Subject|0|||
27984962|NCT00603512|54643692|FG001|Overall Study|Withdrawal by Subject|0|||
27984963|NCT00603512|54643693|FG002|Overall Study|Withdrawal by Subject|0|||
27984964|NCT00603512|54643694|FG003|Overall Study|Withdrawal by Subject|0|||
27984965|NCT00603512|54643695|FG004|Overall Study|Withdrawal by Subject|1|||
27984966|NCT00603512|54643691|FG000|Overall Study|Randomized but not treated|0|||
27984967|NCT00603512|54643692|FG001|Overall Study|Randomized but not treated|1|||
27887328|NCT03588728|54513223|FG003|Overall Study|Lab shut down due to COVID-19|1|||
27887329|NCT03588728|54513220|FG000|Overall Study|multiple technical issues|1|||
27887330|NCT03588728|54513221|FG001|Overall Study|multiple technical issues|0|||
27887331|NCT03588728|54513222|FG002|Overall Study|multiple technical issues|0|||
27887332|NCT03588728|54513223|FG003|Overall Study|multiple technical issues|0|||
27887333|NCT03588728|54513220|FG000|Overall Study|Hospitalized for COVID|1|||
27887334|NCT03588728|54513221|FG001|Overall Study|Hospitalized for COVID|0|||
27887335|NCT03588728|54513222|FG002|Overall Study|Hospitalized for COVID|0|||
27887336|NCT03588728|54513223|FG003|Overall Study|Hospitalized for COVID|0|||
27887337|NCT03588728|54513220|FG000|Overall Study|Schedule change unable to attend sessions|1|||
27887338|NCT03588728|54513221|FG001|Overall Study|Schedule change unable to attend sessions|0|||
27887339|NCT03588728|54513222|FG002|Overall Study|Schedule change unable to attend sessions|0|||
27887340|NCT03588728|54513223|FG003|Overall Study|Schedule change unable to attend sessions|0|||
27984968|NCT00603512|54643693|FG002|Overall Study|Randomized but not treated|1|||
27984969|NCT00603512|54643694|FG003|Overall Study|Randomized but not treated|2|||
27984970|NCT00603512|54643695|FG004|Overall Study|Randomized but not treated|0|||
27984971|NCT04242875|54643707|FG000|Overall Study|Adverse Event|2|||
27984972|NCT00603278|54643721|FG000|Overall Study|Lack of Efficacy|35|||
27984973|NCT00603278|54643722|FG001|Overall Study|Lack of Efficacy|10|||
27984974|NCT00603278|54643723|FG002|Overall Study|Lack of Efficacy|11|||
27984975|NCT00603278|54643724|FG003|Overall Study|Lack of Efficacy|8|||
27984976|NCT00603278|54643725|FG004|Overall Study|Lack of Efficacy|7|||
27984977|NCT00603278|54643726|FG005|Overall Study|Lack of Efficacy|14|||
27984978|NCT00603278|54643721|FG000|Overall Study|Adverse Event|0|||
27984979|NCT00603278|54643722|FG001|Overall Study|Adverse Event|3|||
27984980|NCT00603278|54643723|FG002|Overall Study|Adverse Event|1|||
27984981|NCT00603278|54643724|FG003|Overall Study|Adverse Event|0|||
27887341|NCT02987543|54513245|FG000|Overall Study|Ongoing study at data cut off|49|||
27887342|NCT02987543|54513246|FG001|Overall Study|Ongoing study at data cut off|21|||
27887343|NCT02987543|54513247|FG002|Overall Study|Ongoing study at data cut off|19|||
27887344|NCT02987543|54513248|FG003|Overall Study|Ongoing study at data cut off|12|||
27887345|NCT02987543|54513245|FG000|Overall Study|Death|88|||
27887346|NCT02987543|54513246|FG001|Overall Study|Death|54|||
27984982|NCT00603278|54643725|FG004|Overall Study|Adverse Event|2|||
27984983|NCT00603278|54643726|FG005|Overall Study|Adverse Event|1|||
27984984|NCT00603278|54643721|FG000|Overall Study|Withdrawal by Subject|2|||
27984985|NCT00603278|54643722|FG001|Overall Study|Withdrawal by Subject|3|||
27984986|NCT00603278|54643723|FG002|Overall Study|Withdrawal by Subject|1|||
27984987|NCT00603278|54643724|FG003|Overall Study|Withdrawal by Subject|2|||
27984988|NCT00603278|54643725|FG004|Overall Study|Withdrawal by Subject|1|||
27984989|NCT00603278|54643726|FG005|Overall Study|Withdrawal by Subject|2|||
27984990|NCT00603278|54643721|FG000|Overall Study|Protocol Violation|3|||
27984991|NCT00603278|54643722|FG001|Overall Study|Protocol Violation|0|||
27984992|NCT00603278|54643723|FG002|Overall Study|Protocol Violation|1|||
28171810|NCT04163991|54843381|FG004|Overall Study|Death|0|||
27887347|NCT02987543|54513247|FG002|Overall Study|Death|67|||
27887348|NCT02987543|54513248|FG003|Overall Study|Death|28|||
27887349|NCT02987543|54513245|FG000|Overall Study|Lost to Follow-up|3|||
27887350|NCT02987543|54513246|FG001|Overall Study|Lost to Follow-up|0|||
27887351|NCT02987543|54513247|FG002|Overall Study|Lost to Follow-up|1|||
27887352|NCT02987543|54513248|FG003|Overall Study|Lost to Follow-up|0|||
27887353|NCT02987543|54513245|FG000|Overall Study|Screen failure|0|||
27887354|NCT02987543|54513246|FG001|Overall Study|Screen failure|0|||
27887355|NCT02987543|54513247|FG002|Overall Study|Screen failure|0|||
27887356|NCT02987543|54513248|FG003|Overall Study|Screen failure|1|||
27887357|NCT02987543|54513245|FG000|Overall Study|Withdrawal by Subject|21|||
27887358|NCT02987543|54513246|FG001|Overall Study|Withdrawal by Subject|7|||
27887359|NCT02987543|54513247|FG002|Overall Study|Withdrawal by Subject|7|||
27887360|NCT02987543|54513248|FG003|Overall Study|Withdrawal by Subject|6|||
27887361|NCT02987543|54513245|FG000|Overall Study|Study terminated by sponsor|1|||
27984993|NCT00603278|54643724|FG003|Overall Study|Protocol Violation|1|||
27984994|NCT00603278|54643725|FG004|Overall Study|Protocol Violation|0|||
27984995|NCT00603278|54643726|FG005|Overall Study|Protocol Violation|1|||
27984996|NCT00603278|54643721|FG000|Overall Study|Physician Decision|0|||
27984997|NCT00603278|54643722|FG001|Overall Study|Physician Decision|1|||
27984998|NCT00603278|54643723|FG002|Overall Study|Physician Decision|0|||
27887362|NCT02987543|54513246|FG001|Overall Study|Study terminated by sponsor|0|||
27984999|NCT00603278|54643724|FG003|Overall Study|Physician Decision|0|||
28171811|NCT04163991|54843377|FG000|Overall Study|Lost to Follow-up|0|||
27887363|NCT02987543|54513247|FG002|Overall Study|Study terminated by sponsor|0|||
27887364|NCT02987543|54513248|FG003|Overall Study|Study terminated by sponsor|0|||
27887365|NCT02987543|54513245|FG000|Overall Study|Investigator decision|0|||
27985000|NCT00603278|54643725|FG004|Overall Study|Physician Decision|2|||
27887366|NCT02987543|54513246|FG001|Overall Study|Investigator decision|1|||
27887367|NCT02987543|54513247|FG002|Overall Study|Investigator decision|0|||
27887368|NCT02987543|54513248|FG003|Overall Study|Investigator decision|0|||
27887369|NCT02987543|54513245|FG000|Overall Study|Disease progression|0|||
27887370|NCT02987543|54513246|FG001|Overall Study|Disease progression|0|||
27887371|NCT02987543|54513247|FG002|Overall Study|Disease progression|0|||
27887372|NCT02987543|54513248|FG003|Overall Study|Disease progression|1|||
27887373|NCT02983045|54513264|FG000|Overall Study|Withdrawal by Subject|0|||
27887374|NCT02983045|54513265|FG001|Overall Study|Withdrawal by Subject|1|||
27887375|NCT02983045|54513266|FG002|Overall Study|Withdrawal by Subject|0|||
27887376|NCT02983045|54513267|FG003|Overall Study|Withdrawal by Subject|5|||
27887377|NCT02983045|54513268|FG004|Overall Study|Withdrawal by Subject|0|||
27887378|NCT02983045|54513269|FG005|Overall Study|Withdrawal by Subject|72|||
27887379|NCT02983045|54513270|FG006|Overall Study|Withdrawal by Subject|0|||
27887380|NCT02983045|54513271|FG007|Overall Study|Withdrawal by Subject|0|||
27887381|NCT02983045|54513272|FG008|Overall Study|Withdrawal by Subject|0|||
27887382|NCT02983045|54513273|FG009|Overall Study|Withdrawal by Subject|2|||
27887383|NCT02983045|54513264|FG000|Overall Study|Lost to Follow-up|0|||
27887384|NCT02983045|54513265|FG001|Overall Study|Lost to Follow-up|0|||
27887385|NCT02983045|54513266|FG002|Overall Study|Lost to Follow-up|0|||
27887386|NCT02983045|54513267|FG003|Overall Study|Lost to Follow-up|0|||
27887387|NCT02983045|54513268|FG004|Overall Study|Lost to Follow-up|0|||
27887388|NCT02983045|54513269|FG005|Overall Study|Lost to Follow-up|10|||
27985001|NCT00603278|54643726|FG005|Overall Study|Physician Decision|1|||
27985002|NCT00603278|54643721|FG000|Overall Study|Lost to Follow-up|1|||
27985003|NCT00603278|54643722|FG001|Overall Study|Lost to Follow-up|0|||
27985004|NCT00603278|54643723|FG002|Overall Study|Lost to Follow-up|0|||
27887389|NCT02983045|54513270|FG006|Overall Study|Lost to Follow-up|0|||
27887390|NCT02983045|54513271|FG007|Overall Study|Lost to Follow-up|0|||
27887391|NCT02983045|54513272|FG008|Overall Study|Lost to Follow-up|0|||
27887392|NCT02983045|54513273|FG009|Overall Study|Lost to Follow-up|0|||
27887393|NCT02564263|54513297|FG000|Overall Study|Adverse Event|31|||
27887394|NCT02564263|54513298|FG001|Overall Study|Adverse Event|29|||
27985005|NCT00603278|54643724|FG003|Overall Study|Lost to Follow-up|0|||
27985006|NCT00603278|54643725|FG004|Overall Study|Lost to Follow-up|1|||
27985007|NCT00603278|54643726|FG005|Overall Study|Lost to Follow-up|0|||
27985008|NCT00876447|54643742|FG000|Overall Study|Other miscellaneous reasons|3|||
27985009|NCT00876447|54643743|FG001|Overall Study|Other miscellaneous reasons|8|||
27985010|NCT00876447|54643742|FG000|Overall Study|Site closure|19|||
28171812|NCT04163991|54843378|FG001|Overall Study|Lost to Follow-up|1|||
28171813|NCT04163991|54843379|FG002|Overall Study|Lost to Follow-up|0|||
27887395|NCT02564263|54513297|FG000|Overall Study|Death|270|||
27887396|NCT02564263|54513298|FG001|Overall Study|Death|262|||
27887397|NCT02564263|54513297|FG000|Overall Study|Withdrawal by Subject|4|||
27887398|NCT02564263|54513298|FG001|Overall Study|Withdrawal by Subject|19|||
27887399|NCT02564263|54513297|FG000|Overall Study|Sponsor's decision|9|||
27887400|NCT02564263|54513298|FG001|Overall Study|Sponsor's decision|4|||
27887401|NCT02379819|54513305|FG000|Overall Study|Withdrawal by Subject|10|||
27887402|NCT02379819|54513305|FG000|Overall Study|Death|2|||
27887403|NCT02379819|54513305|FG000|Overall Study|Lack of Efficacy|1|||
27887404|NCT02379819|54513305|FG000|Overall Study|Lost to Follow-up|1|||
27887405|NCT02368886|54513313|FG000|Overall Study|Cancel|1|||
27887406|NCT02368886|54513314|FG001|Overall Study|Cancel|1|||
27887407|NCT02368886|54513315|FG002|Overall Study|Cancel|1|||
27887408|NCT02368886|54513316|FG003|Overall Study|Cancel|3|||
27887409|NCT02368886|54513313|FG000|Overall Study|Ineligible|0|||
27887410|NCT02368886|54513314|FG001|Overall Study|Ineligible|0|||
27887411|NCT02368886|54513315|FG002|Overall Study|Ineligible|0|||
27887412|NCT02368886|54513316|FG003|Overall Study|Ineligible|1|||
27887413|NCT02227238|54513330|FG000|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
27887414|NCT02227238|54513331|FG001|Randomized Phase (Up to Week 52)|Reached stopping criteria|1|||
27887415|NCT02227238|54513332|FG002|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
27887416|NCT02227238|54513330|FG000|Randomized Phase (Up to Week 52)|Adverse Event|8|||
27887417|NCT02227238|54513331|FG001|Randomized Phase (Up to Week 52)|Adverse Event|18|||
27887418|NCT02227238|54513332|FG002|Randomized Phase (Up to Week 52)|Adverse Event|0|||
27887419|NCT02227238|54513330|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|10|||
27887420|NCT02227238|54513331|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|22|||
27887421|NCT02227238|54513332|FG002|Randomized Phase (Up to Week 52)|Lack of Efficacy|0|||
27985011|NCT00876447|54643743|FG001|Overall Study|Site closure|14|||
27887422|NCT02227238|54513330|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|7|||
27887423|NCT02227238|54513331|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|8|||
27887424|NCT02227238|54513332|FG002|Randomized Phase (Up to Week 52)|Protocol Violation|0|||
27985012|NCT00876447|54643742|FG000|Overall Study|Protocol Violation|9|||
27887425|NCT02227238|54513330|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|5|||
27887426|NCT02227238|54513331|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|4|||
27985013|NCT00876447|54643743|FG001|Overall Study|Protocol Violation|3|||
27985014|NCT00876447|54643742|FG000|Overall Study|Personal reasons|30|||
27887427|NCT02227238|54513332|FG002|Randomized Phase (Up to Week 52)|Withdrawal by Subject|0|||
28171814|NCT04163991|54843380|FG003|Overall Study|Lost to Follow-up|0|||
27887428|NCT02227238|54513330|FG000|Randomized Phase (Up to Week 52)|Physician Decision|0|||
27887429|NCT02227238|54513331|FG001|Randomized Phase (Up to Week 52)|Physician Decision|9|||
27887430|NCT02227238|54513332|FG002|Randomized Phase (Up to Week 52)|Physician Decision|0|||
27887431|NCT02227238|54513330|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|7|||
27887432|NCT02227238|54513331|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|5|||
27887433|NCT02227238|54513332|FG002|Randomized Phase (Up to Week 52)|Lost to Follow-up|0|||
27887434|NCT02227238|54513330|FG000|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
27887435|NCT02227238|54513331|FG001|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|3|||
27887436|NCT02227238|54513332|FG002|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
27887437|NCT02227238|54513330|FG000|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
27887438|NCT02227238|54513331|FG001|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
27887439|NCT02227238|54513332|FG002|Continuation Phase(From Weeks 52 to 295)|Adverse Event|8|||
27887440|NCT02227238|54513330|FG000|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
27887441|NCT02227238|54513331|FG001|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
27887442|NCT02227238|54513332|FG002|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|16|||
27887443|NCT02227238|54513330|FG000|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
27887444|NCT02227238|54513331|FG001|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
27887445|NCT02227238|54513332|FG002|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|8|||
27887446|NCT02227238|54513330|FG000|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
27887447|NCT02227238|54513331|FG001|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
27887448|NCT02227238|54513332|FG002|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|6|||
27887449|NCT02227238|54513330|FG000|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
27887450|NCT02227238|54513331|FG001|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
27887451|NCT02227238|54513332|FG002|Continuation Phase(From Weeks 52 to 295)|Physician Decision|4|||
27887452|NCT02227238|54513330|FG000|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
27887453|NCT02227238|54513331|FG001|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
27887454|NCT02227238|54513332|FG002|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|7|||
27887455|NCT02126969|54513353|FG000|Overall Study|Withdrawal by Subject|1|||
27887456|NCT02126969|54513354|FG001|Overall Study|Withdrawal by Subject|2|||
27887457|NCT01715285|54513362|FG000|Double Blind Period (Up to 23 Months)|Adverse Event|53|||
27887458|NCT01715285|54513363|FG001|Double Blind Period (Up to 23 Months)|Adverse Event|31|||
27887459|NCT01715285|54513364|FG002|Double Blind Period (Up to 23 Months)|Adverse Event|0|||
27887460|NCT01715285|54513362|FG000|Double Blind Period (Up to 23 Months)|Death|43|||
27887461|NCT01715285|54513363|FG001|Double Blind Period (Up to 23 Months)|Death|25|||
27887462|NCT01715285|54513364|FG002|Double Blind Period (Up to 23 Months)|Death|0|||
27887463|NCT01715285|54513362|FG000|Double Blind Period (Up to 23 Months)|Lost to Follow-up|3|||
27887464|NCT01715285|54513363|FG001|Double Blind Period (Up to 23 Months)|Lost to Follow-up|2|||
27887465|NCT01715285|54513364|FG002|Double Blind Period (Up to 23 Months)|Lost to Follow-up|0|||
27887466|NCT01715285|54513362|FG000|Double Blind Period (Up to 23 Months)|Physician Decision|21|||
27887467|NCT01715285|54513363|FG001|Double Blind Period (Up to 23 Months)|Physician Decision|23|||
27887468|NCT01715285|54513364|FG002|Double Blind Period (Up to 23 Months)|Physician Decision|0|||
27887469|NCT01715285|54513362|FG000|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|52|||
27887470|NCT01715285|54513363|FG001|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|47|||
27887471|NCT01715285|54513364|FG002|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|0|||
27887472|NCT01715285|54513362|FG000|Double Blind Period (Up to 23 Months)|Progressive Disease|254|||
27887473|NCT01715285|54513363|FG001|Double Blind Period (Up to 23 Months)|Progressive Disease|388|||
27887474|NCT01715285|54513364|FG002|Double Blind Period (Up to 23 Months)|Progressive Disease|0|||
27887475|NCT01715285|54513362|FG000|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|4|||
27887476|NCT01715285|54513363|FG001|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|2|||
27887477|NCT01715285|54513364|FG002|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|0|||
27887478|NCT01715285|54513362|FG000|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
27887479|NCT01715285|54513363|FG001|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|72|||
27887480|NCT01715285|54513364|FG002|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
27887481|NCT01715285|54513362|FG000|Double Blind Period (Up to 23 Months)|Other|167|||
27887482|NCT01715285|54513363|FG001|Double Blind Period (Up to 23 Months)|Other|12|||
27887483|NCT01715285|54513364|FG002|Double Blind Period (Up to 23 Months)|Other|0|||
27887484|NCT01715285|54513362|FG000|OLE Phase (Up to 15.6 Months)|Death|0|||
27887485|NCT01715285|54513363|FG001|OLE Phase (Up to 15.6 Months)|Death|0|||
27887486|NCT01715285|54513364|FG002|OLE Phase (Up to 15.6 Months)|Death|4|||
27887487|NCT01715285|54513362|FG000|OLE Phase (Up to 15.6 Months)|Other|0|||
27887488|NCT01715285|54513363|FG001|OLE Phase (Up to 15.6 Months)|Other|0|||
28171815|NCT04163991|54843381|FG004|Overall Study|Lost to Follow-up|0|||
28171816|NCT04163991|54843377|FG000|Overall Study|Withdrawal by Subject|1|||
27887489|NCT01715285|54513364|FG002|OLE Phase (Up to 15.6 Months)|Other|60|||
27887490|NCT01715285|54513362|FG000|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
27887491|NCT01715285|54513363|FG001|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
27887492|NCT01715285|54513364|FG002|OLE Phase (Up to 15.6 Months)|Progressive Disease|1|||
27887493|NCT01715285|54513362|FG000|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
27887494|NCT01715285|54513363|FG001|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
27887495|NCT01715285|54513364|FG002|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|6|||
27887496|NCT01715285|54513362|FG000|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
27887497|NCT01715285|54513363|FG001|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
27887498|NCT01715285|54513364|FG002|OLE Phase (Up to 15.6 Months)|Adverse Event|1|||
27887499|NCT01250496|54513373|FG000|Overall Study|Study terminated|124|||
27887500|NCT01250496|54513374|FG001|Overall Study|Study terminated|124|||
27887501|NCT01105975|54513390|FG000|Overall Study|Adverse Event|2|||
27887502|NCT01105975|54513391|FG001|Overall Study|Adverse Event|1|||
27887503|NCT01105975|54513392|FG002|Overall Study|Adverse Event|5|||
27887504|NCT01105975|54513393|FG003|Overall Study|Adverse Event|1|||
27887505|NCT01105975|54513394|FG004|Overall Study|Adverse Event|0|||
27887506|NCT01105975|54513395|FG005|Overall Study|Adverse Event|1|||
27887507|NCT01105975|54513396|FG006|Overall Study|Adverse Event|2|||
27887508|NCT01105975|54513397|FG007|Overall Study|Adverse Event|4|||
27887509|NCT01105975|54513398|FG008|Overall Study|Adverse Event|1|||
27887510|NCT01105975|54513399|FG009|Overall Study|Adverse Event|4|||
27887511|NCT01105975|54513390|FG000|Overall Study|Withdrawal by Subject|2|||
27887512|NCT01105975|54513391|FG001|Overall Study|Withdrawal by Subject|2|||
27887513|NCT01105975|54513392|FG002|Overall Study|Withdrawal by Subject|2|||
27887514|NCT01105975|54513393|FG003|Overall Study|Withdrawal by Subject|0|||
27887515|NCT01105975|54513394|FG004|Overall Study|Withdrawal by Subject|4|||
27887516|NCT01105975|54513395|FG005|Overall Study|Withdrawal by Subject|1|||
27887517|NCT01105975|54513396|FG006|Overall Study|Withdrawal by Subject|2|||
27887518|NCT01105975|54513397|FG007|Overall Study|Withdrawal by Subject|1|||
27887519|NCT01105975|54513398|FG008|Overall Study|Withdrawal by Subject|0|||
27887520|NCT01105975|54513399|FG009|Overall Study|Withdrawal by Subject|3|||
27887521|NCT01105975|54513390|FG000|Overall Study|Lost to Follow-up|1|||
27887522|NCT01105975|54513391|FG001|Overall Study|Lost to Follow-up|0|||
27887523|NCT01105975|54513392|FG002|Overall Study|Lost to Follow-up|0|||
27887524|NCT01105975|54513393|FG003|Overall Study|Lost to Follow-up|1|||
27887525|NCT01105975|54513394|FG004|Overall Study|Lost to Follow-up|1|||
27887526|NCT01105975|54513395|FG005|Overall Study|Lost to Follow-up|0|||
27887527|NCT01105975|54513396|FG006|Overall Study|Lost to Follow-up|0|||
27887528|NCT01105975|54513397|FG007|Overall Study|Lost to Follow-up|0|||
28171817|NCT04163991|54843378|FG001|Overall Study|Withdrawal by Subject|1|||
27985015|NCT00876447|54643743|FG001|Overall Study|Personal reasons|28|||
27985016|NCT00876447|54643742|FG000|Overall Study|Lost to Follow-up|6|||
27985017|NCT00876447|54643743|FG001|Overall Study|Lost to Follow-up|15|||
27985018|NCT00876447|54643742|FG000|Overall Study|Pregnancy|4|||
27985019|NCT00876447|54643743|FG001|Overall Study|Pregnancy|2|||
27985020|NCT00876447|54643742|FG000|Overall Study|Lack of Efficacy|5|||
27985021|NCT00876447|54643743|FG001|Overall Study|Lack of Efficacy|3|||
27985022|NCT00876447|54643742|FG000|Overall Study|Adverse Event|4|||
27985023|NCT00876447|54643743|FG001|Overall Study|Adverse Event|8|||
27985024|NCT00598650|54643773|FG000|Overall Study|Withdrawal by Subject|3|||
27985025|NCT00598650|54643773|FG000|Overall Study|Adverse Event|18|||
27985026|NCT00598650|54643773|FG000|Overall Study|No treatment for 3 weeks|1|||
27985027|NCT00598650|54643773|FG000|Overall Study|Not eligible|1|||
28171818|NCT04163991|54843379|FG002|Overall Study|Withdrawal by Subject|3|||
28171819|NCT04163991|54843380|FG003|Overall Study|Withdrawal by Subject|1|||
28171820|NCT04163991|54843381|FG004|Overall Study|Withdrawal by Subject|1|||
27887529|NCT01105975|54513398|FG008|Overall Study|Lost to Follow-up|1|||
27887530|NCT01105975|54513399|FG009|Overall Study|Lost to Follow-up|0|||
27887531|NCT01105975|54513390|FG000|Overall Study|Physician Decision|0|||
27887532|NCT01105975|54513391|FG001|Overall Study|Physician Decision|0|||
27887533|NCT01105975|54513392|FG002|Overall Study|Physician Decision|0|||
27887534|NCT01105975|54513393|FG003|Overall Study|Physician Decision|0|||
27739365|NCT02660229|54188940|FG001|Overall Study|Withdrawal by Subject|1|||
27887535|NCT01105975|54513394|FG004|Overall Study|Physician Decision|0|||
27887536|NCT01105975|54513395|FG005|Overall Study|Physician Decision|0|||
27739366|NCT02232178|54188949|FG000|Overall Study|Lost to Follow-up|0|||
27985028|NCT00598650|54643773|FG000|Overall Study|Prohibited Concomitant Medication|2|||
27985029|NCT00598650|54643773|FG000|Overall Study|Physician Decision|2|||
27985030|NCT04249076|54643780|FG000|Overall Study|Adverse Event|1|||
28171821|NCT04163991|54843377|FG000|Overall Study|Other, Not Specified|0|||
28171822|NCT04163991|54843378|FG001|Overall Study|Other, Not Specified|1|||
27887537|NCT01105975|54513396|FG006|Overall Study|Physician Decision|2|||
27887538|NCT01105975|54513397|FG007|Overall Study|Physician Decision|0|||
27887539|NCT01105975|54513398|FG008|Overall Study|Physician Decision|0|||
27887540|NCT01105975|54513399|FG009|Overall Study|Physician Decision|0|||
27887541|NCT01105975|54513390|FG000|Overall Study|Protocol Violation|0|||
27985031|NCT04249076|54643781|FG001|Overall Study|Adverse Event|1|||
27985032|NCT04249076|54643780|FG000|Overall Study|Protocol Violation|1|||
27985033|NCT04249076|54643781|FG001|Overall Study|Protocol Violation|2|||
27985034|NCT04249076|54643780|FG000|Overall Study|Lack of Efficacy|0|||
27985035|NCT04249076|54643781|FG001|Overall Study|Lack of Efficacy|1|||
27985036|NCT04249076|54643780|FG000|Overall Study|Withdrawal by Subject|0|||
27985037|NCT04249076|54643781|FG001|Overall Study|Withdrawal by Subject|1|||
27985038|NCT04150107|54643789|FG000|Period 3 Crossover-Treatment B or A|Adverse Event|2|||
27985039|NCT04150107|54643790|FG001|Period 3 Crossover-Treatment B or A|Adverse Event|0|||
27985040|NCT04150107|54643789|FG000|Period 3 Crossover-Treatment B or A|Patient non-compliance|0|||
27985041|NCT04150107|54643790|FG001|Period 3 Crossover-Treatment B or A|Patient non-compliance|1|||
27985042|NCT04173494|54643800|FG000|Randomized Double-Blind Treatment Period|Adverse Event|16|||
27985043|NCT04173494|54643801|FG001|Randomized Double-Blind Treatment Period|Adverse Event|11|||
27985044|NCT04173494|54643800|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|6|||
27985045|NCT04173494|54643801|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|5|||
27985046|NCT04173494|54643800|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|6|||
27985047|NCT04173494|54643801|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|3|||
27985048|NCT04173494|54643800|FG000|Randomized Double-Blind Treatment Period|Death|4|||
27985049|NCT04173494|54643801|FG001|Randomized Double-Blind Treatment Period|Death|3|||
27985050|NCT04173494|54643800|FG000|Randomized Double-Blind Treatment Period|Leukemic Transformation|2|||
27985051|NCT04173494|54643801|FG001|Randomized Double-Blind Treatment Period|Leukemic Transformation|2|||
27985052|NCT04173494|54643800|FG000|Randomized Double-Blind Treatment Period|Disease Progression|1|||
27985053|NCT04173494|54643801|FG001|Randomized Double-Blind Treatment Period|Disease Progression|2|||
27985054|NCT04173494|54643800|FG000|Randomized Double-Blind Treatment Period|Lost to Follow-up|1|||
27985055|NCT04173494|54643801|FG001|Randomized Double-Blind Treatment Period|Lost to Follow-up|0|||
27985056|NCT04173494|54643800|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0|||
27985057|NCT04173494|54643801|FG001|Randomized Double-Blind Treatment Period|Physician Decision|1|||
27985058|NCT04173494|54643800|FG000|Open-Label Extended Treatment Period|Open-label treatment ongoing|52|||
27985059|NCT04173494|54643801|FG001|Open-Label Extended Treatment Period|Open-label treatment ongoing|22|||
27985060|NCT04173494|54643800|FG000|Open-Label Extended Treatment Period|Continuing in MMB extension study|24|||
27985061|NCT04173494|54643801|FG001|Open-Label Extended Treatment Period|Continuing in MMB extension study|9|||
27985062|NCT04173494|54643800|FG000|Open-Label Extended Treatment Period|Adverse Event|8|||
27985063|NCT04173494|54643801|FG001|Open-Label Extended Treatment Period|Adverse Event|1|||
27985064|NCT04173494|54643800|FG000|Open-Label Extended Treatment Period|Withdrawal by Subject|2|||
27985065|NCT04173494|54643801|FG001|Open-Label Extended Treatment Period|Withdrawal by Subject|3|||
27985066|NCT04173494|54643800|FG000|Open-Label Extended Treatment Period|Death|3|||
27985067|NCT04173494|54643801|FG001|Open-Label Extended Treatment Period|Death|1|||
27985068|NCT04173494|54643800|FG000|Open-Label Extended Treatment Period|Physician Decision|2|||
27985069|NCT04173494|54643801|FG001|Open-Label Extended Treatment Period|Physician Decision|2|||
27985070|NCT04173494|54643800|FG000|Open-Label Extended Treatment Period|Lack of Efficacy|1|||
27985071|NCT04173494|54643801|FG001|Open-Label Extended Treatment Period|Lack of Efficacy|1|||
27985072|NCT04173494|54643800|FG000|Open-Label Extended Treatment Period|Leukemic transformation|0|||
27985073|NCT04173494|54643801|FG001|Open-Label Extended Treatment Period|Leukemic transformation|1|||
27985074|NCT00875979|54643809|FG000|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1|||
27985075|NCT00875979|54643810|FG001|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0|||
27985076|NCT00875979|54643809|FG000|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1|||
27985077|NCT00875979|54643810|FG001|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0|||
27985078|NCT00875979|54643809|FG000|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1|||
27985079|NCT00875979|54643810|FG001|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0|||
27985080|NCT00875979|54643809|FG000|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0|||
27985081|NCT00875979|54643810|FG001|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6|||
27985082|NCT00875979|54643809|FG000|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0|||
27985083|NCT00875979|54643810|FG001|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37|||
27985084|NCT00875979|54643809|FG000|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0|||
27985085|NCT00875979|54643810|FG001|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3|||
27985086|NCT00875979|54643809|FG000|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0|||
27985087|NCT00875979|54643810|FG001|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3|||
27985088|NCT00875979|54643809|FG000|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0|||
28096630|NCT03692676|54751818|FG001|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037|||
28096631|NCT03692676|54751819|FG002|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
28096632|NCT03692676|54751820|FG003|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
28096633|NCT03692676|54751817|FG000|Overall Study|exclude patients without prior recorded asthma diagnosis|881|||
28096634|NCT03692676|54751818|FG001|Overall Study|exclude patients without prior recorded asthma diagnosis|563|||
28096635|NCT03692676|54751819|FG002|Overall Study|exclude patients without prior recorded asthma diagnosis|6281|||
28171823|NCT04163991|54843379|FG002|Overall Study|Other, Not Specified|1|||
27985089|NCT00875979|54643810|FG001|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3|||
27985090|NCT00875979|54643809|FG000|Dose Expansion Phase - 3.6 mg/kg|Death|0|||
27985091|NCT00875979|54643810|FG001|Dose Expansion Phase - 3.6 mg/kg|Death|1|||
27985092|NCT00602420|54643818|FG000|Overall Study|Death|1|||
27985093|NCT00602420|54643819|FG001|Overall Study|Death|4|||
27985094|NCT00602420|54643818|FG000|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5|||
27985095|NCT00602420|54643819|FG001|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3|||
27985096|NCT00602420|54643818|FG000|Overall Study|Withdrawal by Subject|18|||
27985097|NCT00602420|54643819|FG001|Overall Study|Withdrawal by Subject|17|||
27985098|NCT00602420|54643818|FG000|Overall Study|Adverse Event|1|||
27985099|NCT00602420|54643819|FG001|Overall Study|Adverse Event|0|||
27985100|NCT00875667|54643833|FG000|Overall Study|Adverse Event|29|||
27985101|NCT00875667|54643834|FG001|Overall Study|Adverse Event|10|||
27985102|NCT00875667|54643833|FG000|Overall Study|Withdrawal by Subject|17|||
27985103|NCT00875667|54643834|FG001|Overall Study|Withdrawal by Subject|5|||
27985104|NCT00875667|54643833|FG000|Overall Study|Death|7|||
27985105|NCT00875667|54643834|FG001|Overall Study|Death|2|||
27985106|NCT00875667|54643833|FG000|Overall Study|Protocol Violation|2|||
27985107|NCT00875667|54643834|FG001|Overall Study|Protocol Violation|0|||
27985108|NCT00875667|54643833|FG000|Overall Study|Disease Progression|100|||
27985109|NCT00875667|54643834|FG001|Overall Study|Disease Progression|49|||
27985110|NCT00875667|54643833|FG000|Overall Study|Miscellaneous|12|||
27985111|NCT00875667|54643834|FG001|Overall Study|Miscellaneous|6|||
27985112|NCT00875667|54643833|FG000|Overall Study|Randomized but no Study Drug Given|3|||
27887542|NCT01105975|54513391|FG001|Overall Study|Protocol Violation|2|||
27887543|NCT01105975|54513392|FG002|Overall Study|Protocol Violation|2|||
27887544|NCT01105975|54513393|FG003|Overall Study|Protocol Violation|0|||
27887545|NCT01105975|54513394|FG004|Overall Study|Protocol Violation|1|||
27887546|NCT01105975|54513395|FG005|Overall Study|Protocol Violation|1|||
27887547|NCT01105975|54513396|FG006|Overall Study|Protocol Violation|1|||
27887548|NCT01105975|54513397|FG007|Overall Study|Protocol Violation|1|||
27887549|NCT01105975|54513398|FG008|Overall Study|Protocol Violation|2|||
27887550|NCT01105975|54513399|FG009|Overall Study|Protocol Violation|2|||
27887551|NCT01105975|54513390|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
27887552|NCT01105975|54513391|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
27887553|NCT01105975|54513392|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
27887554|NCT01105975|54513393|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
27887555|NCT01105975|54513394|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
27887556|NCT01105975|54513395|FG005|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
27887557|NCT01105975|54513396|FG006|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
27887558|NCT01105975|54513397|FG007|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
27887559|NCT01105975|54513398|FG008|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
27887560|NCT01105975|54513399|FG009|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
27887561|NCT00831623|54513440|FG000|Overall Study|Withdrawal by Subject|9|||
27887562|NCT00831623|54513440|FG000|Overall Study|Lost to Follow-up|1|||
27887563|NCT00831623|54513440|FG000|Overall Study|Not 2 years post-treatment|12|||
27887564|NCT00079417|54513444|FG000|Overall Study|Physician Decision|2|||
27887565|NCT00079417|54513444|FG000|Overall Study|Ineligible|7|||
27887566|NCT05292755|54518472|FG000|Overall Study|Lost to Follow-up|5|||
27887567|NCT05292755|54518473|FG001|Overall Study|Lost to Follow-up|9|||
27887568|NCT04590781|54518487|FG000|Overall Study|Death|0|||
27887569|NCT04590781|54518488|FG001|Overall Study|Death|2|||
27887570|NCT04590781|54518487|FG000|Overall Study|Withdrawal by Subject|2|||
27887571|NCT04590781|54518488|FG001|Overall Study|Withdrawal by Subject|0|||
27887572|NCT04248868|54518495|FG000|Overall Study|Death|1|||
27887573|NCT04248868|54518495|FG000|Overall Study|Lost to Follow-up|3|||
27887574|NCT04248868|54518495|FG000|Overall Study|Protocol Violation|2|||
27887575|NCT04211831|54518502|FG000|Overall Study|Withdrawal by Subject|4|||
27985113|NCT00875667|54643834|FG001|Overall Study|Randomized but no Study Drug Given|1|||
27985114|NCT00602030|54643844|FG000|Lead-in Phase|Disease Progression|2|||
27985115|NCT00602030|54643845|FG001|Lead-in Phase|Disease Progression|3|||
28096636|NCT03692676|54751820|FG003|Overall Study|exclude patients without prior recorded asthma diagnosis|558|||
28096637|NCT03692676|54751817|FG000|Overall Study|exclude patients less than 18 years of age on index date|8|||
28096638|NCT03692676|54751818|FG001|Overall Study|exclude patients less than 18 years of age on index date|613|||
27985116|NCT00602030|54643846|FG002|Lead-in Phase|Disease Progression|0|||
28096639|NCT03692676|54751819|FG002|Overall Study|exclude patients less than 18 years of age on index date|836|||
27887576|NCT04211831|54518503|FG001|Overall Study|Withdrawal by Subject|1|||
27887577|NCT04211831|54518504|FG002|Overall Study|Withdrawal by Subject|1|||
27887578|NCT04211831|54518502|FG000|Overall Study|Protocol Violation|0|||
27887579|NCT04211831|54518503|FG001|Overall Study|Protocol Violation|0|||
27887580|NCT04211831|54518504|FG002|Overall Study|Protocol Violation|1|||
27887581|NCT04211831|54518502|FG000|Overall Study|Adverse Event|0|||
27887582|NCT04211831|54518503|FG001|Overall Study|Adverse Event|1|||
27985117|NCT00602030|54643847|FG003|Lead-in Phase|Disease Progression|0|||
27985118|NCT00602030|54643848|FG004|Lead-in Phase|Disease Progression|0|||
27985119|NCT00602030|54643844|FG000|Lead-in Phase|Adverse Event|0|||
27985120|NCT00602030|54643845|FG001|Lead-in Phase|Adverse Event|2|||
27985121|NCT00602030|54643846|FG002|Lead-in Phase|Adverse Event|0|||
27985122|NCT00602030|54643847|FG003|Lead-in Phase|Adverse Event|0|||
27985123|NCT00602030|54643848|FG004|Lead-in Phase|Adverse Event|0|||
27985124|NCT00602030|54643844|FG000|Double-blind Phase|Disease progression|0|||
27985125|NCT00602030|54643845|FG001|Double-blind Phase|Disease progression|0|||
27985126|NCT00602030|54643846|FG002|Double-blind Phase|Disease progression|33|||
27985127|NCT00602030|54643847|FG003|Double-blind Phase|Disease progression|30|||
27985128|NCT00602030|54643848|FG004|Double-blind Phase|Disease progression|0|||
27985129|NCT00602030|54643844|FG000|Double-blind Phase|Adverse Event|0|||
27985130|NCT00602030|54643845|FG001|Double-blind Phase|Adverse Event|0|||
27985131|NCT00602030|54643846|FG002|Double-blind Phase|Adverse Event|9|||
27985132|NCT00602030|54643847|FG003|Double-blind Phase|Adverse Event|18|||
27985133|NCT00602030|54643848|FG004|Double-blind Phase|Adverse Event|0|||
27985134|NCT00602030|54643844|FG000|Double-blind Phase|Consent withdrawal|0|||
27985135|NCT00602030|54643845|FG001|Double-blind Phase|Consent withdrawal|0|||
27985136|NCT00602030|54643846|FG002|Double-blind Phase|Consent withdrawal|4|||
27985137|NCT00602030|54643847|FG003|Double-blind Phase|Consent withdrawal|3|||
27985138|NCT00602030|54643848|FG004|Double-blind Phase|Consent withdrawal|0|||
27985139|NCT00602030|54643844|FG000|Double-blind Phase|Death|0|||
27985140|NCT00602030|54643845|FG001|Double-blind Phase|Death|0|||
27985141|NCT00602030|54643846|FG002|Double-blind Phase|Death|3|||
27985142|NCT00602030|54643847|FG003|Double-blind Phase|Death|3|||
27985143|NCT00602030|54643848|FG004|Double-blind Phase|Death|0|||
27985144|NCT00602030|54643844|FG000|Double-blind Phase|Administrative decision|0|||
27985145|NCT00602030|54643845|FG001|Double-blind Phase|Administrative decision|0|||
27985146|NCT00602030|54643846|FG002|Double-blind Phase|Administrative decision|0|||
27985147|NCT00602030|54643847|FG003|Double-blind Phase|Administrative decision|2|||
27985148|NCT00602030|54643848|FG004|Double-blind Phase|Administrative decision|0|||
27985149|NCT00602030|54643844|FG000|Double-blind Phase|Ineligibility|0|||
27985150|NCT00602030|54643845|FG001|Double-blind Phase|Ineligibility|0|||
27985151|NCT00602030|54643846|FG002|Double-blind Phase|Ineligibility|0|||
27985152|NCT00602030|54643847|FG003|Double-blind Phase|Ineligibility|1|||
27985153|NCT00602030|54643848|FG004|Double-blind Phase|Ineligibility|0|||
27985154|NCT00602030|54643844|FG000|Double-blind Phase|Protocol deviation/noncompliance|0|||
27887583|NCT04211831|54518504|FG002|Overall Study|Adverse Event|0|||
27887584|NCT04211831|54518502|FG000|Overall Study|Lack of Efficacy|0|||
27887585|NCT04211831|54518503|FG001|Overall Study|Lack of Efficacy|0|||
27887586|NCT04211831|54518504|FG002|Overall Study|Lack of Efficacy|1|||
27887587|NCT04211831|54518502|FG000|Overall Study|Lost to Follow-up|0|||
27887588|NCT04211831|54518503|FG001|Overall Study|Lost to Follow-up|0|||
27887589|NCT04211831|54518504|FG002|Overall Study|Lost to Follow-up|2|||
27887590|NCT04211831|54518502|FG000|Overall Study|Unable to Complete the Procedures Successfully|0|||
27887591|NCT04211831|54518503|FG001|Overall Study|Unable to Complete the Procedures Successfully|1|||
27887592|NCT04211831|54518504|FG002|Overall Study|Unable to Complete the Procedures Successfully|0|||
27887593|NCT04211831|54518502|FG000|Overall Study|Other|0|||
27887594|NCT04211831|54518503|FG001|Overall Study|Other|1|||
27887595|NCT04211831|54518504|FG002|Overall Study|Other|0|||
27887596|NCT04067518|54518562|FG000|Overall Study|Adverse Event|1|||
27887597|NCT04067518|54518563|FG001|Overall Study|Adverse Event|3|||
27887598|NCT04067518|54518562|FG000|Overall Study|Screen failures|0|||
27887599|NCT04067518|54518563|FG001|Overall Study|Screen failures|1|||
27887600|NCT04067518|54518562|FG000|Overall Study|Enrolled but not treated|0|||
27887601|NCT04067518|54518563|FG001|Overall Study|Enrolled but not treated|1|||
27887602|NCT03912233|54518604|FG000|Overall Study|Adverse Event|1|||
27887603|NCT03912233|54518605|FG001|Overall Study|Adverse Event|0|||
27985155|NCT00602030|54643845|FG001|Double-blind Phase|Protocol deviation/noncompliance|0|||
27985156|NCT00602030|54643846|FG002|Double-blind Phase|Protocol deviation/noncompliance|1|||
27985157|NCT00602030|54643847|FG003|Double-blind Phase|Protocol deviation/noncompliance|0|||
27985158|NCT00602030|54643848|FG004|Double-blind Phase|Protocol deviation/noncompliance|0|||
27887604|NCT03912233|54518606|FG002|Overall Study|Adverse Event|0|||
27887605|NCT03912233|54518607|FG003|Overall Study|Adverse Event|0|||
27887606|NCT03912233|54518608|FG004|Overall Study|Adverse Event|0|||
27887607|NCT03912233|54518609|FG005|Overall Study|Adverse Event|0|||
27887608|NCT03912233|54518604|FG000|Overall Study|Physician Decision|1|||
27887609|NCT03912233|54518605|FG001|Overall Study|Physician Decision|0|||
27887610|NCT03912233|54518606|FG002|Overall Study|Physician Decision|0|||
27887611|NCT03912233|54518607|FG003|Overall Study|Physician Decision|0|||
27985159|NCT00602030|54643844|FG000|Double-blind Phase|Reason not specified|0|||
27985160|NCT00602030|54643845|FG001|Double-blind Phase|Reason not specified|0|||
27985161|NCT00602030|54643846|FG002|Double-blind Phase|Reason not specified|4|||
27985162|NCT00602030|54643847|FG003|Double-blind Phase|Reason not specified|2|||
27887612|NCT03912233|54518608|FG004|Overall Study|Physician Decision|0|||
27887613|NCT03912233|54518609|FG005|Overall Study|Physician Decision|0|||
27887614|NCT03912233|54518604|FG000|Overall Study|Other|0|||
27887615|NCT03912233|54518605|FG001|Overall Study|Other|0|||
27985163|NCT00602030|54643848|FG004|Double-blind Phase|Reason not specified|0|||
27985164|NCT00602030|54643844|FG000|Crossover Phase|Disease Progression|0|||
27887616|NCT03912233|54518606|FG002|Overall Study|Other|0|||
27887617|NCT03912233|54518607|FG003|Overall Study|Other|0|||
27887618|NCT03912233|54518608|FG004|Overall Study|Other|7|||
27887619|NCT03912233|54518609|FG005|Overall Study|Other|12|||
27887620|NCT03834519|54518633|FG000|Overall Study|Ongoing|234|||
27887621|NCT03834519|54518634|FG001|Overall Study|Ongoing|111|||
27887622|NCT03834519|54518633|FG000|Overall Study|Withdrawal by Subject|4|||
27887623|NCT03834519|54518634|FG001|Overall Study|Withdrawal by Subject|7|||
27887624|NCT03834519|54518633|FG000|Overall Study|Death|291|||
27887625|NCT03834519|54518634|FG001|Overall Study|Death|146|||
27887626|NCT03546062|54518661|FG000|Overall Study|Adverse Event|6|||
27887627|NCT03546062|54518662|FG001|Overall Study|Adverse Event|5|||
27887628|NCT03546062|54518663|FG002|Overall Study|Adverse Event|8|||
27887629|NCT03539952|54518673|FG000|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|24|||
27887630|NCT03539952|54518674|FG001|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|0|||
27887631|NCT03539952|54518673|FG000|Post-randomization Period (Week 12-36)|Withdrawal by Subject|1|||
27887632|NCT03539952|54518674|FG001|Post-randomization Period (Week 12-36)|Withdrawal by Subject|0|||
27887633|NCT03539952|54518673|FG000|Extension Post Random. (Week 36-60)|Adverse Event|1|||
27887634|NCT03539952|54518674|FG001|Extension Post Random. (Week 36-60)|Adverse Event|1|||
27887635|NCT03539952|54518673|FG000|Extension Post Random. (Week 36-60)|Withdrawal by Subject|3|||
27887636|NCT03539952|54518674|FG001|Extension Post Random. (Week 36-60)|Withdrawal by Subject|1|||
27887637|NCT03539952|54518673|FG000|Extension Post Random. (Week 36-60)|Not further documented|3|||
27887638|NCT03539952|54518674|FG001|Extension Post Random. (Week 36-60)|Not further documented|1|||
27887639|NCT03539952|54518673|FG000|All on TETA 4HCl, From wk 60 Till 108max|Death|0|||
27887640|NCT03539952|54518674|FG001|All on TETA 4HCl, From wk 60 Till 108max|Death|1|||
27887641|NCT03539952|54518673|FG000|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|0|||
27887642|NCT03539952|54518674|FG001|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|1|||
27887643|NCT03471078|54518701|FG000|Overall Study|Withdrawal by Subject|9|||
27887644|NCT03471078|54518702|FG001|Overall Study|Withdrawal by Subject|1|||
27887645|NCT03471078|54518701|FG000|Overall Study|Adverse Event|4|||
27887646|NCT03471078|54518702|FG001|Overall Study|Adverse Event|1|||
27887647|NCT03471078|54518701|FG000|Overall Study|Physician Decision|3|||
27887648|NCT03471078|54518702|FG001|Overall Study|Physician Decision|2|||
27887649|NCT03471078|54518701|FG000|Overall Study|Death|2|||
27887650|NCT03471078|54518702|FG001|Overall Study|Death|0|||
27887651|NCT03471078|54518701|FG000|Overall Study|Other|3|||
27887652|NCT03471078|54518702|FG001|Overall Study|Other|2|||
27887653|NCT02929108|54518715|FG000|Overall Study|Hospice patient death|100|||
27887654|NCT02929108|54518716|FG001|Overall Study|Hospice patient death|64|||
27887655|NCT02929108|54518717|FG002|Overall Study|Hospice patient death|28|||
27887656|NCT02929108|54518718|FG003|Overall Study|Hospice patient death|46|||
27887657|NCT02929108|54518719|FG004|Overall Study|Hospice patient death|55|||
27887658|NCT02929108|54518720|FG005|Overall Study|Hospice patient death|28|||
27887659|NCT02929108|54518721|FG006|Overall Study|Hospice patient death|78|||
27887660|NCT02661295|54518729|FG000|Overall Study|Death|1|||
27887661|NCT02661295|54518729|FG000|Overall Study|Transferred Out|1|||
27887662|NCT02661295|54518729|FG000|Overall Study|Kidney Transplant|1|||
27887663|NCT02661295|54518729|FG000|Overall Study|Withdrawn due to side effects|8|||
27887664|NCT02661295|54518729|FG000|Overall Study|Withdrawn due to access type|1|||
27887665|NCT02661295|54518729|FG000|Overall Study|Withdrawn due to allergies|1|||
27887666|NCT02661295|54518729|FG000|Overall Study|Withdrawn due to non-compliance|1|||
27887667|NCT02661295|54518729|FG000|Overall Study|Withdrawal by Subject|3|||
27887668|NCT02661295|54518729|FG000|Overall Study|Failed screening|2|||
27887669|NCT02527434|54518736|FG000|Overall Study|Lost to Follow-up|2|||
27887670|NCT02527434|54518737|FG001|Overall Study|Lost to Follow-up|2|||
27887671|NCT02527434|54518738|FG002|Overall Study|Lost to Follow-up|0|||
27887672|NCT02527434|54518736|FG000|Overall Study|Death|19|||
27887673|NCT02527434|54518737|FG001|Overall Study|Death|6|||
27887674|NCT02527434|54518738|FG002|Overall Study|Death|17|||
27887675|NCT02527434|54518736|FG000|Overall Study|Withdrawal by Subject|5|||
27887676|NCT02527434|54518737|FG001|Overall Study|Withdrawal by Subject|3|||
27887677|NCT02527434|54518738|FG002|Overall Study|Withdrawal by Subject|3|||
27887678|NCT02527434|54518736|FG000|Overall Study|Reason Not Specified|1|||
27887679|NCT02527434|54518737|FG001|Overall Study|Reason Not Specified|0|||
27887680|NCT02527434|54518738|FG002|Overall Study|Reason Not Specified|0|||
27887681|NCT02527434|54518736|FG000|Overall Study|Site closure|1|||
27887682|NCT02527434|54518737|FG001|Overall Study|Site closure|0|||
27887683|NCT02527434|54518738|FG002|Overall Study|Site closure|0|||
27887684|NCT02412748|54518767|FG000|Overall Study|Lost to Follow-up|38|||
27739367|NCT02232178|54188950|FG001|Overall Study|Lost to Follow-up|1|||
27739368|NCT02232178|54188951|FG002|Overall Study|Lost to Follow-up|0|||
27887685|NCT02412748|54518768|FG001|Overall Study|Lost to Follow-up|39|||
27887686|NCT01844726|54518793|FG000|Overall Study|Withdrawal by Subject|0|||
27887687|NCT01844726|54518794|FG001|Overall Study|Withdrawal by Subject|1|||
27887688|NCT01844726|54518793|FG000|Overall Study|Excessive motion in MRI resulted in discontinuation.|1|||
27887689|NCT01844726|54518794|FG001|Overall Study|Excessive motion in MRI resulted in discontinuation.|0|||
27887690|NCT03180840|54524372|FG000|Overall Study|Withdrawal by Subject|1|||
27887691|NCT02538666|54524384|FG000|Pre-Treatment|Disease progression|1|||
27887692|NCT02538666|54524385|FG001|Pre-Treatment|Disease progression|0|||
27985165|NCT00602030|54643845|FG001|Crossover Phase|Disease Progression|0|||
27985166|NCT00602030|54643846|FG002|Crossover Phase|Disease Progression|0|||
27985167|NCT00602030|54643847|FG003|Crossover Phase|Disease Progression|0|||
27985168|NCT00602030|54643848|FG004|Crossover Phase|Disease Progression|11|||
27985169|NCT00602030|54643844|FG000|Crossover Phase|Adverse Event|0|||
27985170|NCT00602030|54643845|FG001|Crossover Phase|Adverse Event|0|||
27887693|NCT02538666|54524386|FG002|Pre-Treatment|Disease progression|0|||
27887694|NCT02538666|54524384|FG000|Pre-Treatment|no longer meets study criteria|1|||
27887695|NCT02538666|54524385|FG001|Pre-Treatment|no longer meets study criteria|0|||
27887696|NCT02538666|54524386|FG002|Pre-Treatment|no longer meets study criteria|0|||
27887697|NCT02538666|54524384|FG000|Pre-Treatment|Withdrew Consent|0|||
27887698|NCT02538666|54524385|FG001|Pre-Treatment|Withdrew Consent|1|||
27887699|NCT02538666|54524386|FG002|Pre-Treatment|Withdrew Consent|1|||
27887700|NCT02538666|54524384|FG000|Treatment|Disease progression|270|||
27887701|NCT02538666|54524385|FG001|Treatment|Disease progression|227|||
27887702|NCT02538666|54524386|FG002|Treatment|Disease progression|165|||
27887703|NCT02538666|54524384|FG000|Treatment|Study drug toxicity|1|||
27887704|NCT02538666|54524385|FG001|Treatment|Study drug toxicity|29|||
27985171|NCT00602030|54643846|FG002|Crossover Phase|Adverse Event|0|||
27985172|NCT00602030|54643847|FG003|Crossover Phase|Adverse Event|0|||
27985173|NCT00602030|54643848|FG004|Crossover Phase|Adverse Event|3|||
27985174|NCT00602030|54643844|FG000|Crossover Phase|Consent withdrawal|0|||
27985175|NCT00602030|54643845|FG001|Crossover Phase|Consent withdrawal|0|||
27985176|NCT00602030|54643846|FG002|Crossover Phase|Consent withdrawal|0|||
27887705|NCT02538666|54524386|FG002|Treatment|Study drug toxicity|92|||
27887706|NCT02538666|54524384|FG000|Treatment|Death|0|||
27887707|NCT02538666|54524385|FG001|Treatment|Death|2|||
27887708|NCT02538666|54524386|FG002|Treatment|Death|3|||
27887709|NCT02538666|54524384|FG000|Treatment|Adverse event unrelated to study drug|8|||
27887710|NCT02538666|54524385|FG001|Treatment|Adverse event unrelated to study drug|10|||
27887711|NCT02538666|54524386|FG002|Treatment|Adverse event unrelated to study drug|15|||
27887712|NCT02538666|54524384|FG000|Treatment|Participant request to discontinue study treatment|3|||
27887713|NCT02538666|54524385|FG001|Treatment|Participant request to discontinue study treatment|6|||
27887714|NCT02538666|54524386|FG002|Treatment|Participant request to discontinue study treatment|11|||
27887715|NCT02538666|54524384|FG000|Treatment|Participant withdrew consent|2|||
27887716|NCT02538666|54524385|FG001|Treatment|Participant withdrew consent|5|||
27887717|NCT02538666|54524386|FG002|Treatment|Participant withdrew consent|3|||
27887718|NCT02538666|54524384|FG000|Treatment|Lost to Follow-up|0|||
27887719|NCT02538666|54524385|FG001|Treatment|Lost to Follow-up|1|||
27887720|NCT02538666|54524386|FG002|Treatment|Lost to Follow-up|1|||
27887721|NCT02538666|54524384|FG000|Treatment|Maximum clinical benefit|4|||
27887722|NCT02538666|54524385|FG001|Treatment|Maximum clinical benefit|3|||
27887723|NCT02538666|54524386|FG002|Treatment|Maximum clinical benefit|4|||
27887724|NCT02538666|54524384|FG000|Treatment|Poor/non-compliance|0|||
27887725|NCT02538666|54524385|FG001|Treatment|Poor/non-compliance|1|||
27887726|NCT02538666|54524386|FG002|Treatment|Poor/non-compliance|0|||
27887727|NCT02538666|54524384|FG000|Treatment|Participant no longer meets study criteria|0|||
27887728|NCT02538666|54524385|FG001|Treatment|Participant no longer meets study criteria|2|||
27887729|NCT02538666|54524386|FG002|Treatment|Participant no longer meets study criteria|0|||
27887730|NCT02538666|54524384|FG000|Treatment|Administrative reason by sponsor|0|||
27887731|NCT02538666|54524385|FG001|Treatment|Administrative reason by sponsor|0|||
27887732|NCT02538666|54524386|FG002|Treatment|Administrative reason by sponsor|1|||
27887733|NCT02538666|54524384|FG000|Treatment|Other reasons|8|||
27887734|NCT02538666|54524385|FG001|Treatment|Other reasons|15|||
27887735|NCT02538666|54524386|FG002|Treatment|Other reasons|5|||
27887736|NCT02538666|54524384|FG000|Treatment|Not reported|2|||
27887737|NCT02538666|54524385|FG001|Treatment|Not reported|2|||
27887738|NCT02538666|54524386|FG002|Treatment|Not reported|2|||
27887739|NCT02407236|54524440|FG000|Induction Study (8 Weeks)|Adverse Event|3|||
27887740|NCT02407236|54524441|FG001|Induction Study (8 Weeks)|Adverse Event|0|||
27887741|NCT02407236|54524442|FG002|Induction Study (8 Weeks)|Adverse Event|1|||
27887742|NCT02407236|54524443|FG003|Induction Study (8 Weeks)|Adverse Event|0|||
27887743|NCT02407236|54524444|FG004|Induction Study (8 Weeks)|Adverse Event|0|||
27985177|NCT00602030|54643847|FG003|Crossover Phase|Consent withdrawal|0|||
27985178|NCT00602030|54643848|FG004|Crossover Phase|Consent withdrawal|2|||
27887744|NCT02407236|54524445|FG005|Induction Study (8 Weeks)|Adverse Event|0|||
27887745|NCT02407236|54524446|FG006|Induction Study (8 Weeks)|Adverse Event|0|||
27887746|NCT02407236|54524447|FG007|Induction Study (8 Weeks)|Adverse Event|0|||
27887747|NCT02407236|54524448|FG008|Induction Study (8 Weeks)|Adverse Event|0|||
27887748|NCT02407236|54524449|FG009|Induction Study (8 Weeks)|Adverse Event|0|||
27887749|NCT02407236|54524450|FG010|Induction Study (8 Weeks)|Adverse Event|0|||
27985179|NCT00549757|54643862|FG000|Active Treatment Phase: Max. 50 Months|Adverse Event|590|||
27985180|NCT00549757|54643863|FG001|Active Treatment Phase: Max. 50 Months|Adverse Event|462|||
27887750|NCT02407236|54524451|FG011|Induction Study (8 Weeks)|Adverse Event|0|||
27887751|NCT02407236|54524452|FG012|Induction Study (8 Weeks)|Adverse Event|0|||
27887752|NCT02407236|54524440|FG000|Induction Study (8 Weeks)|Death|0|||
27887753|NCT02407236|54524441|FG001|Induction Study (8 Weeks)|Death|0|||
27887754|NCT02407236|54524442|FG002|Induction Study (8 Weeks)|Death|1|||
27887755|NCT02407236|54524443|FG003|Induction Study (8 Weeks)|Death|0|||
27887756|NCT02407236|54524444|FG004|Induction Study (8 Weeks)|Death|0|||
27887757|NCT02407236|54524445|FG005|Induction Study (8 Weeks)|Death|0|||
27887758|NCT02407236|54524446|FG006|Induction Study (8 Weeks)|Death|0|||
27887759|NCT02407236|54524447|FG007|Induction Study (8 Weeks)|Death|0|||
27887760|NCT02407236|54524448|FG008|Induction Study (8 Weeks)|Death|0|||
27887761|NCT02407236|54524449|FG009|Induction Study (8 Weeks)|Death|0|||
27887762|NCT02407236|54524450|FG010|Induction Study (8 Weeks)|Death|0|||
27887763|NCT02407236|54524451|FG011|Induction Study (8 Weeks)|Death|0|||
27887764|NCT02407236|54524452|FG012|Induction Study (8 Weeks)|Death|0|||
27887765|NCT02407236|54524440|FG000|Induction Study (8 Weeks)|Withdrawal by Subject|17|||
27887766|NCT02407236|54524441|FG001|Induction Study (8 Weeks)|Withdrawal by Subject|9|||
27887767|NCT02407236|54524442|FG002|Induction Study (8 Weeks)|Withdrawal by Subject|7|||
27887768|NCT02407236|54524443|FG003|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
27887769|NCT02407236|54524444|FG004|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
27985181|NCT00549757|54643862|FG000|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98|||
27985182|NCT00549757|54643863|FG001|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58|||
27985183|NCT00549757|54643862|FG000|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
27985184|NCT00549757|54643863|FG001|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
27985185|NCT00549757|54643862|FG000|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47|||
27985186|NCT00549757|54643863|FG001|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53|||
27985187|NCT00549757|54643862|FG000|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
27985188|NCT00549757|54643863|FG001|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
27985189|NCT00549757|54643862|FG000|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41|||
27985190|NCT00549757|54643863|FG001|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29|||
27985191|NCT00549757|54643862|FG000|Active Treatment Phase: Max. 50 Months|Administrative problems|2857|||
27985192|NCT00549757|54643863|FG001|Active Treatment Phase: Max. 50 Months|Administrative problems|3019|||
27985193|NCT00549757|54643862|FG000|Active Treatment Phase: Max. 50 Months|Death|188|||
27985194|NCT00549757|54643863|FG001|Active Treatment Phase: Max. 50 Months|Death|200|||
27985195|NCT00549757|54643862|FG000|Active Treatment Phase: Max. 50 Months|Patient's request|353|||
27985196|NCT00549757|54643863|FG001|Active Treatment Phase: Max. 50 Months|Patient's request|380|||
27985197|NCT00549757|54643862|FG000|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69|||
27985198|NCT00549757|54643863|FG001|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55|||
27985199|NCT00549757|54643862|FG000|Active Treatment Phase: Max. 50 Months|Missing data|8|||
27985200|NCT00549757|54643863|FG001|Active Treatment Phase: Max. 50 Months|Missing data|9|||
27985201|NCT00549757|54643862|FG000|Extension Period (in Average 9 Months)|Death|143|||
27985202|NCT00549757|54643863|FG001|Extension Period (in Average 9 Months)|Death|136|||
27985203|NCT00549757|54643862|FG000|Extension Period (in Average 9 Months)|Lost to Follow-up|52|||
27985204|NCT00549757|54643863|FG001|Extension Period (in Average 9 Months)|Lost to Follow-up|47|||
27985205|NCT00549757|54643862|FG000|Extension Period (in Average 9 Months)|Withdrawal by Subject|9|||
27985206|NCT00549757|54643863|FG001|Extension Period (in Average 9 Months)|Withdrawal by Subject|16|||
27985207|NCT00549757|54643862|FG000|Extension Period (in Average 9 Months)|Patient's request|421|||
27985208|NCT00549757|54643863|FG001|Extension Period (in Average 9 Months)|Patient's request|436|||
27985209|NCT00549601|54643878|FG000|Randomized|Protocol Violation|0|||
27985210|NCT00549601|54643879|FG001|Randomized|Protocol Violation|0|||
27985211|NCT00549601|54643880|FG002|Randomized|Protocol Violation|1|||
27985212|NCT00549601|54643878|FG000|Randomized|Withdrawal by Subject|0|||
27985213|NCT00549601|54643879|FG001|Randomized|Withdrawal by Subject|1|||
27985214|NCT00549601|54643880|FG002|Randomized|Withdrawal by Subject|1|||
27985215|NCT00549601|54643878|FG000|Received Study Drug|Adverse Event|2|||
27985216|NCT00549601|54643879|FG001|Received Study Drug|Adverse Event|5|||
27985217|NCT00549601|54643880|FG002|Received Study Drug|Adverse Event|1|||
27985218|NCT00549601|54643878|FG000|Received Study Drug|Death|0|||
27985219|NCT00549601|54643879|FG001|Received Study Drug|Death|1|||
27985220|NCT00549601|54643880|FG002|Received Study Drug|Death|0|||
27985221|NCT00549601|54643878|FG000|Received Study Drug|Lost to Follow-up|0|||
27985222|NCT00549601|54643879|FG001|Received Study Drug|Lost to Follow-up|1|||
27985223|NCT00549601|54643880|FG002|Received Study Drug|Lost to Follow-up|1|||
27985224|NCT00549601|54643878|FG000|Received Study Drug|Protocol Violation|3|||
27887770|NCT02407236|54524445|FG005|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
27985225|NCT00549601|54643879|FG001|Received Study Drug|Protocol Violation|4|||
27985226|NCT00549601|54643880|FG002|Received Study Drug|Protocol Violation|1|||
27985227|NCT00549601|54643878|FG000|Received Study Drug|Withdrawal by Subject|2|||
27985228|NCT00549601|54643879|FG001|Received Study Drug|Withdrawal by Subject|0|||
27887771|NCT02407236|54524446|FG006|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
27887772|NCT02407236|54524447|FG007|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
27985229|NCT00549601|54643880|FG002|Received Study Drug|Withdrawal by Subject|1|||
27985230|NCT00601640|54643906|FG000|Overall Study|Withdrawal by Subject|3|||
27985231|NCT00601640|54643907|FG001|Overall Study|Withdrawal by Subject|0|||
27985232|NCT00601640|54643908|FG002|Overall Study|Withdrawal by Subject|7|||
27985233|NCT00601640|54643906|FG000|Overall Study|Death|1|||
27985234|NCT00601640|54643907|FG001|Overall Study|Death|0|||
27985235|NCT00601640|54643908|FG002|Overall Study|Death|0|||
27985236|NCT00601640|54643906|FG000|Overall Study|Adverse Event|0|||
27985237|NCT00601640|54643907|FG001|Overall Study|Adverse Event|4|||
27985238|NCT00601640|54643908|FG002|Overall Study|Adverse Event|2|||
27985239|NCT00601640|54643906|FG000|Overall Study|intercurrent illness|1|||
27985240|NCT00601640|54643907|FG001|Overall Study|intercurrent illness|0|||
27985241|NCT00601640|54643908|FG002|Overall Study|intercurrent illness|0|||
27985242|NCT00601640|54643906|FG000|Overall Study|change in eligibility status|0|||
27985243|NCT00601640|54643907|FG001|Overall Study|change in eligibility status|1|||
27985244|NCT00601640|54643908|FG002|Overall Study|change in eligibility status|1|||
27985245|NCT02805725|54643923|FG000|Phase I (Dose Escalation Part)|Clinical progression|0|||
27985246|NCT02805725|54643924|FG001|Phase I (Dose Escalation Part)|Clinical progression|0|||
27985247|NCT02805725|54643925|FG002|Phase I (Dose Escalation Part)|Clinical progression|1|||
27985248|NCT02805725|54643926|FG003|Phase I (Dose Escalation Part)|Clinical progression|0|||
27985249|NCT02805725|54643927|FG004|Phase I (Dose Escalation Part)|Clinical progression|0|||
27985250|NCT02805725|54643923|FG000|Phase I (Dose Escalation Part)|Adverse Event|0|||
27985251|NCT02805725|54643924|FG001|Phase I (Dose Escalation Part)|Adverse Event|0|||
27887773|NCT02407236|54524448|FG008|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
27887774|NCT02407236|54524449|FG009|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
27887775|NCT02407236|54524450|FG010|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
27887776|NCT02407236|54524451|FG011|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
27887777|NCT02407236|54524452|FG012|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
27887778|NCT02407236|54524440|FG000|Induction Study (8 Weeks)|Lack of Efficacy|0|||
27887779|NCT02407236|54524441|FG001|Induction Study (8 Weeks)|Lack of Efficacy|0|||
27887780|NCT02407236|54524442|FG002|Induction Study (8 Weeks)|Lack of Efficacy|1|||
27887781|NCT02407236|54524443|FG003|Induction Study (8 Weeks)|Lack of Efficacy|0|||
27887782|NCT02407236|54524444|FG004|Induction Study (8 Weeks)|Lack of Efficacy|0|||
27887783|NCT02407236|54524445|FG005|Induction Study (8 Weeks)|Lack of Efficacy|0|||
27887784|NCT02407236|54524446|FG006|Induction Study (8 Weeks)|Lack of Efficacy|0|||
27887785|NCT02407236|54524447|FG007|Induction Study (8 Weeks)|Lack of Efficacy|0|||
27887786|NCT02407236|54524448|FG008|Induction Study (8 Weeks)|Lack of Efficacy|0|||
27887787|NCT02407236|54524449|FG009|Induction Study (8 Weeks)|Lack of Efficacy|0|||
27887788|NCT02407236|54524450|FG010|Induction Study (8 Weeks)|Lack of Efficacy|0|||
27887789|NCT02407236|54524451|FG011|Induction Study (8 Weeks)|Lack of Efficacy|0|||
27887790|NCT02407236|54524452|FG012|Induction Study (8 Weeks)|Lack of Efficacy|0|||
27887791|NCT02407236|54524440|FG000|Induction Study (8 Weeks)|Physician Decision|1|||
27887792|NCT02407236|54524441|FG001|Induction Study (8 Weeks)|Physician Decision|1|||
27887793|NCT02407236|54524442|FG002|Induction Study (8 Weeks)|Physician Decision|0|||
27887794|NCT02407236|54524443|FG003|Induction Study (8 Weeks)|Physician Decision|0|||
27887795|NCT02407236|54524444|FG004|Induction Study (8 Weeks)|Physician Decision|0|||
27887796|NCT02407236|54524445|FG005|Induction Study (8 Weeks)|Physician Decision|0|||
27887797|NCT02407236|54524446|FG006|Induction Study (8 Weeks)|Physician Decision|0|||
27887798|NCT02407236|54524447|FG007|Induction Study (8 Weeks)|Physician Decision|0|||
27887799|NCT02407236|54524448|FG008|Induction Study (8 Weeks)|Physician Decision|0|||
27887800|NCT02407236|54524449|FG009|Induction Study (8 Weeks)|Physician Decision|0|||
27887801|NCT02407236|54524450|FG010|Induction Study (8 Weeks)|Physician Decision|0|||
27887802|NCT02407236|54524451|FG011|Induction Study (8 Weeks)|Physician Decision|0|||
27887803|NCT02407236|54524452|FG012|Induction Study (8 Weeks)|Physician Decision|0|||
27887804|NCT02407236|54524440|FG000|Induction Study (8 Weeks)|Other|2|||
27887805|NCT02407236|54524441|FG001|Induction Study (8 Weeks)|Other|1|||
27887806|NCT02407236|54524442|FG002|Induction Study (8 Weeks)|Other|5|||
27887807|NCT02407236|54524443|FG003|Induction Study (8 Weeks)|Other|0|||
27887808|NCT02407236|54524444|FG004|Induction Study (8 Weeks)|Other|0|||
27887809|NCT02407236|54524445|FG005|Induction Study (8 Weeks)|Other|0|||
27887810|NCT02407236|54524446|FG006|Induction Study (8 Weeks)|Other|0|||
27887811|NCT02407236|54524447|FG007|Induction Study (8 Weeks)|Other|0|||
27887812|NCT02407236|54524448|FG008|Induction Study (8 Weeks)|Other|0|||
27887813|NCT02407236|54524449|FG009|Induction Study (8 Weeks)|Other|0|||
27887814|NCT02407236|54524450|FG010|Induction Study (8 Weeks)|Other|0|||
27887815|NCT02407236|54524451|FG011|Induction Study (8 Weeks)|Other|0|||
27887816|NCT02407236|54524452|FG012|Induction Study (8 Weeks)|Other|0|||
27887817|NCT02407236|54524440|FG000|Maintenance Study (44 Weeks)|Adverse Event|0|||
27887818|NCT02407236|54524441|FG001|Maintenance Study (44 Weeks)|Adverse Event|0|||
27887819|NCT02407236|54524442|FG002|Maintenance Study (44 Weeks)|Adverse Event|0|||
27985252|NCT02805725|54643925|FG002|Phase I (Dose Escalation Part)|Adverse Event|1|||
27887820|NCT02407236|54524443|FG003|Maintenance Study (44 Weeks)|Adverse Event|19|||
27925752|NCT01231503|54582282|FG006|Overall Study|Protocol Violation|0|||
27887821|NCT02407236|54524444|FG004|Maintenance Study (44 Weeks)|Adverse Event|8|||
27887822|NCT02407236|54524445|FG005|Maintenance Study (44 Weeks)|Adverse Event|4|||
27887823|NCT02407236|54524446|FG006|Maintenance Study (44 Weeks)|Adverse Event|11|||
27887824|NCT02407236|54524447|FG007|Maintenance Study (44 Weeks)|Adverse Event|10|||
27887825|NCT02407236|54524448|FG008|Maintenance Study (44 Weeks)|Adverse Event|0|||
27887826|NCT02407236|54524449|FG009|Maintenance Study (44 Weeks)|Adverse Event|0|||
27887827|NCT02407236|54524450|FG010|Maintenance Study (44 Weeks)|Adverse Event|0|||
27887828|NCT02407236|54524451|FG011|Maintenance Study (44 Weeks)|Adverse Event|0|||
27887829|NCT02407236|54524452|FG012|Maintenance Study (44 Weeks)|Adverse Event|0|||
27887830|NCT02407236|54524440|FG000|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
27887831|NCT02407236|54524441|FG001|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
27887832|NCT02407236|54524442|FG002|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
27887833|NCT02407236|54524443|FG003|Maintenance Study (44 Weeks)|Lack of Efficacy|19|||
27887834|NCT02407236|54524444|FG004|Maintenance Study (44 Weeks)|Lack of Efficacy|9|||
27887835|NCT02407236|54524445|FG005|Maintenance Study (44 Weeks)|Lack of Efficacy|6|||
27887836|NCT02407236|54524446|FG006|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
27887837|NCT02407236|54524447|FG007|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
27985253|NCT02805725|54643926|FG003|Phase I (Dose Escalation Part)|Adverse Event|2|||
27985254|NCT02805725|54643927|FG004|Phase I (Dose Escalation Part)|Adverse Event|0|||
27985255|NCT02805725|54643923|FG000|Phase II|Protocol Violation|0|||
27985256|NCT02805725|54643924|FG001|Phase II|Protocol Violation|0|||
27985257|NCT02805725|54643925|FG002|Phase II|Protocol Violation|0|||
27985258|NCT02805725|54643926|FG003|Phase II|Protocol Violation|0|||
27985259|NCT02805725|54643927|FG004|Phase II|Protocol Violation|6|||
27985260|NCT00546871|54643944|FG000|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1|||
27985261|NCT00546871|54643945|FG001|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0|||
27985262|NCT00546871|54643944|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1|||
27985263|NCT00546871|54643945|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2|||
27985264|NCT00546871|54643944|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0|||
27985265|NCT00546871|54643945|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1|||
27985266|NCT00546871|54643944|FG000|Study Extension Period|Protocol Violation|1|||
27985267|NCT00546871|54643945|FG001|Study Extension Period|Protocol Violation|0|||
27985268|NCT00546871|54643944|FG000|Study Extension Period|Withdrawal by Subject|0|||
27985269|NCT00546871|54643945|FG001|Study Extension Period|Withdrawal by Subject|1|||
27985270|NCT03951805|54643978|FG000|Overall Study|Adverse Event|1|||
27985271|NCT03951805|54643979|FG001|Overall Study|Adverse Event|0|||
27985272|NCT03951805|54643980|FG002|Overall Study|Adverse Event|0|||
27985273|NCT03951805|54643981|FG003|Overall Study|Adverse Event|0|||
27985274|NCT03944707|54643993|FG000|Overall Study|Adverse Event|0|||
27985275|NCT03944707|54643994|FG001|Overall Study|Adverse Event|2|||
27985276|NCT03944707|54643993|FG000|Overall Study|Study terminated by sponsor|12|||
27985277|NCT03944707|54643994|FG001|Overall Study|Study terminated by sponsor|7|||
27985278|NCT03944707|54643993|FG000|Overall Study|Subject decision|0|||
27985279|NCT03944707|54643994|FG001|Overall Study|Subject decision|1|||
27985280|NCT00549055|54644000|FG000|Overall Study|Adverse Event|4|||
27985281|NCT00549055|54644000|FG000|Overall Study|Lack of Efficacy|18|||
27985282|NCT00549055|54644000|FG000|Overall Study|Stabilization|5|||
27887838|NCT02407236|54524448|FG008|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
27887839|NCT02407236|54524449|FG009|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
27887840|NCT02407236|54524450|FG010|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
27887841|NCT02407236|54524451|FG011|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
27887842|NCT02407236|54524452|FG012|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
27887843|NCT02407236|54524440|FG000|Maintenance Study (44 Weeks)|Other|0|||
27887844|NCT02407236|54524441|FG001|Maintenance Study (44 Weeks)|Other|0|||
27985283|NCT00549055|54644000|FG000|Overall Study|Progression to fibrosis|2|||
27985284|NCT00549055|54644000|FG000|Overall Study|Decrease of size|1|||
27985285|NCT00549055|54644000|FG000|Overall Study|Active choroidal neovascula increased|1|||
27985286|NCT00549055|54644000|FG000|Overall Study|Vitreous hemorrhage|1|||
27985287|NCT00549055|54644000|FG000|Overall Study|Growth choroidal neovascularisation|1|||
27985288|NCT00549055|54644000|FG000|Overall Study|Choroidal neovascularization|1|||
27985289|NCT00549055|54644000|FG000|Overall Study|Very low visual acuity (VA)|1|||
27985290|NCT00883116|54644006|FG000|Overall Study|Adverse event unrelated to study drug|5|||
27887845|NCT02407236|54524442|FG002|Maintenance Study (44 Weeks)|Other|0|||
27887846|NCT02407236|54524443|FG003|Maintenance Study (44 Weeks)|Other|5|||
27887847|NCT02407236|54524444|FG004|Maintenance Study (44 Weeks)|Other|7|||
27985291|NCT00883116|54644007|FG001|Overall Study|Adverse event unrelated to study drug|10|||
27985292|NCT00883116|54644006|FG000|Overall Study|Death|6|||
27985293|NCT00883116|54644007|FG001|Overall Study|Death|2|||
27887848|NCT02407236|54524445|FG005|Maintenance Study (44 Weeks)|Other|8|||
27985294|NCT00883116|54644006|FG000|Overall Study|Disease progression|130|||
27985295|NCT00883116|54644007|FG001|Overall Study|Disease progression|128|||
27985296|NCT00883116|54644006|FG000|Overall Study|Lost to Follow-up|0|||
27985297|NCT00883116|54644007|FG001|Overall Study|Lost to Follow-up|1|||
27985298|NCT00883116|54644006|FG000|Overall Study|Maximum clinical benefit|13|||
27985299|NCT00883116|54644007|FG001|Overall Study|Maximum clinical benefit|46|||
27985300|NCT00883116|54644006|FG000|Overall Study|Not identified|3|||
27985301|NCT00883116|54644007|FG001|Overall Study|Not identified|6|||
27985302|NCT00883116|54644006|FG000|Overall Study|Study drug toxicity|36|||
27985303|NCT00883116|54644007|FG001|Overall Study|Study drug toxicity|16|||
27985304|NCT00883116|54644006|FG000|Overall Study|Withdrawal by Subject|14|||
27985305|NCT00883116|54644007|FG001|Overall Study|Withdrawal by Subject|8|||
27985306|NCT00883116|54644006|FG000|Overall Study|No longer meets study criteria|2|||
27887849|NCT02407236|54524446|FG006|Maintenance Study (44 Weeks)|Other|4|||
27887850|NCT02407236|54524447|FG007|Maintenance Study (44 Weeks)|Other|6|||
27887851|NCT02407236|54524448|FG008|Maintenance Study (44 Weeks)|Other|0|||
27887852|NCT02407236|54524449|FG009|Maintenance Study (44 Weeks)|Other|0|||
27887853|NCT02407236|54524450|FG010|Maintenance Study (44 Weeks)|Other|0|||
27887854|NCT02407236|54524451|FG011|Maintenance Study (44 Weeks)|Other|0|||
27887855|NCT02407236|54524452|FG012|Maintenance Study (44 Weeks)|Other|0|||
27887856|NCT02407236|54524440|FG000|Maintenance Study (44 Weeks)|Death|0|||
27887857|NCT02407236|54524441|FG001|Maintenance Study (44 Weeks)|Death|0|||
27887858|NCT02407236|54524442|FG002|Maintenance Study (44 Weeks)|Death|0|||
27887859|NCT02407236|54524443|FG003|Maintenance Study (44 Weeks)|Death|0|||
27887860|NCT02407236|54524444|FG004|Maintenance Study (44 Weeks)|Death|0|||
27887861|NCT02407236|54524445|FG005|Maintenance Study (44 Weeks)|Death|0|||
27887862|NCT02407236|54524446|FG006|Maintenance Study (44 Weeks)|Death|0|||
27887863|NCT02407236|54524447|FG007|Maintenance Study (44 Weeks)|Death|1|||
27887864|NCT02407236|54524448|FG008|Maintenance Study (44 Weeks)|Death|0|||
27887865|NCT02407236|54524449|FG009|Maintenance Study (44 Weeks)|Death|0|||
27887866|NCT02407236|54524450|FG010|Maintenance Study (44 Weeks)|Death|0|||
27887867|NCT02407236|54524451|FG011|Maintenance Study (44 Weeks)|Death|0|||
27887868|NCT02407236|54524452|FG012|Maintenance Study (44 Weeks)|Death|0|||
27887869|NCT02407236|54524440|FG000|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
27887870|NCT02407236|54524441|FG001|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
27887871|NCT02407236|54524442|FG002|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
27887872|NCT02407236|54524443|FG003|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
27887873|NCT02407236|54524444|FG004|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
27887874|NCT02407236|54524445|FG005|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
27887875|NCT02407236|54524446|FG006|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
27887876|NCT02407236|54524447|FG007|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
27887877|NCT02407236|54524448|FG008|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
27887878|NCT02407236|54524449|FG009|Long-term Extension Period (176 Weeks)|Adverse Event|17|||
27887879|NCT02407236|54524450|FG010|Long-term Extension Period (176 Weeks)|Adverse Event|10|||
27887880|NCT02407236|54524451|FG011|Long-term Extension Period (176 Weeks)|Adverse Event|11|||
27887881|NCT02407236|54524452|FG012|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
27887882|NCT02407236|54524440|FG000|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
27887883|NCT02407236|54524441|FG001|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
27887884|NCT02407236|54524442|FG002|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
27887885|NCT02407236|54524443|FG003|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
27887886|NCT02407236|54524444|FG004|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
27887887|NCT02407236|54524445|FG005|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
27887888|NCT02407236|54524446|FG006|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
27887889|NCT02407236|54524447|FG007|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
27887890|NCT02407236|54524448|FG008|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
27887891|NCT02407236|54524449|FG009|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
27887892|NCT02407236|54524450|FG010|Long-term Extension Period (176 Weeks)|Lost to Follow-up|1|||
27887893|NCT02407236|54524451|FG011|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
27887894|NCT02407236|54524452|FG012|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
27887895|NCT02407236|54524440|FG000|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
27887896|NCT02407236|54524441|FG001|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
27887897|NCT02407236|54524442|FG002|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
27887898|NCT02407236|54524443|FG003|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
27887899|NCT02407236|54524444|FG004|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
27887900|NCT02407236|54524445|FG005|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
27887901|NCT02407236|54524446|FG006|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
27887902|NCT02407236|54524447|FG007|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
27887903|NCT02407236|54524448|FG008|Long-term Extension Period (176 Weeks)|Lack of Efficacy|9|||
27887904|NCT02407236|54524449|FG009|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
27887905|NCT02407236|54524450|FG010|Long-term Extension Period (176 Weeks)|Lack of Efficacy|12|||
27887906|NCT02407236|54524451|FG011|Long-term Extension Period (176 Weeks)|Lack of Efficacy|7|||
27887907|NCT02407236|54524452|FG012|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
27887908|NCT02407236|54524440|FG000|Long-term Extension Period (176 Weeks)|Other|0|||
27985307|NCT00883116|54644007|FG001|Overall Study|No longer meets study criteria|2|||
27887909|NCT02407236|54524441|FG001|Long-term Extension Period (176 Weeks)|Other|0|||
27887910|NCT02407236|54524442|FG002|Long-term Extension Period (176 Weeks)|Other|0|||
27887911|NCT02407236|54524443|FG003|Long-term Extension Period (176 Weeks)|Other|0|||
27887912|NCT02407236|54524444|FG004|Long-term Extension Period (176 Weeks)|Other|0|||
27887913|NCT02407236|54524445|FG005|Long-term Extension Period (176 Weeks)|Other|0|||
27887914|NCT02407236|54524446|FG006|Long-term Extension Period (176 Weeks)|Other|0|||
27887915|NCT02407236|54524447|FG007|Long-term Extension Period (176 Weeks)|Other|0|||
27887916|NCT02407236|54524448|FG008|Long-term Extension Period (176 Weeks)|Other|63|||
27887917|NCT02407236|54524449|FG009|Long-term Extension Period (176 Weeks)|Other|19|||
27887918|NCT02407236|54524450|FG010|Long-term Extension Period (176 Weeks)|Other|19|||
27887919|NCT02407236|54524451|FG011|Long-term Extension Period (176 Weeks)|Other|55|||
27887920|NCT02407236|54524452|FG012|Long-term Extension Period (176 Weeks)|Other|6|||
27887921|NCT01893138|54524480|FG000|Double-Blind Period|Withdrawal by Subject|1|||
27887922|NCT01893138|54524481|FG001|Double-Blind Period|Withdrawal by Subject|1|||
27887923|NCT01893138|54524480|FG000|Open Label - Unblinded Period|Lack of Efficacy|9|||
27887924|NCT01893138|54524481|FG001|Open Label - Unblinded Period|Lack of Efficacy|0|||
27887925|NCT01893138|54524480|FG000|Open Label - Unblinded Period|Lost to Follow-up|4|||
27887926|NCT01893138|54524481|FG001|Open Label - Unblinded Period|Lost to Follow-up|3|||
27887927|NCT01893138|54524480|FG000|Open Label - Unblinded Period|Withdrawal by Subject|18|||
27887928|NCT01893138|54524481|FG001|Open Label - Unblinded Period|Withdrawal by Subject|7|||
27887929|NCT01893138|54524480|FG000|Open Label - Unblinded Period|Adverse Event|1|||
27887930|NCT01893138|54524481|FG001|Open Label - Unblinded Period|Adverse Event|0|||
27887931|NCT04309500|54524493|FG000|Overall Study|Lost to Follow-up|1|||
27887932|NCT04309500|54524494|FG001|Overall Study|Lost to Follow-up|0|||
27887933|NCT04309500|54524495|FG002|Overall Study|Lost to Follow-up|0|||
27887934|NCT04309500|54524496|FG003|Overall Study|Lost to Follow-up|0|||
27887935|NCT03671304|54525831|FG000|Overall Study|study terminated|7|||
27887936|NCT03517722|54525837|FG000|Double Blind Period: Week 0-52|Adverse Event|9|||
27887937|NCT03517722|54525838|FG001|Double Blind Period: Week 0-52|Adverse Event|11|||
27887938|NCT03517722|54525837|FG000|Double Blind Period: Week 0-52|Death|0|||
27887939|NCT03517722|54525838|FG001|Double Blind Period: Week 0-52|Death|4|||
27887940|NCT03517722|54525837|FG000|Double Blind Period: Week 0-52|Lack of Efficacy|2|||
27887941|NCT03517722|54525838|FG001|Double Blind Period: Week 0-52|Lack of Efficacy|3|||
27887942|NCT03517722|54525837|FG000|Double Blind Period: Week 0-52|Pregnancy|0|||
27887943|NCT03517722|54525838|FG001|Double Blind Period: Week 0-52|Pregnancy|1|||
27887944|NCT03517722|54525837|FG000|Double Blind Period: Week 0-52|Protocol Violation|1|||
27887945|NCT03517722|54525838|FG001|Double Blind Period: Week 0-52|Protocol Violation|0|||
27887946|NCT03517722|54525837|FG000|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
27887947|NCT03517722|54525838|FG001|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
27887948|NCT03517722|54525837|FG000|Double Blind Period: Week 0-52|Study Terminated by Sponsor|76|||
27887949|NCT03517722|54525838|FG001|Double Blind Period: Week 0-52|Study Terminated by Sponsor|120|||
27887950|NCT03517722|54525837|FG000|Double Blind Period: Week 0-52|Other|4|||
27887951|NCT03517722|54525838|FG001|Double Blind Period: Week 0-52|Other|3|||
27887952|NCT03517722|54525837|FG000|Double Blind Period: Week 0-52|Initiated prohibited medication|0|||
27887953|NCT03517722|54525838|FG001|Double Blind Period: Week 0-52|Initiated prohibited medication|2|||
27887954|NCT03517722|54525837|FG000|Open-label Extension Period: Week 52-113|Adverse Event|0|||
27887955|NCT03517722|54525838|FG001|Open-label Extension Period: Week 52-113|Adverse Event|1|||
27887956|NCT03517722|54525837|FG000|Open-label Extension Period: Week 52-113|Lack of Efficacy|0|||
27887957|NCT03517722|54525838|FG001|Open-label Extension Period: Week 52-113|Lack of Efficacy|1|||
27887958|NCT03517722|54525837|FG000|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
27887959|NCT03517722|54525838|FG001|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
27887960|NCT03517722|54525837|FG000|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|87|||
27887961|NCT03517722|54525838|FG001|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|134|||
27887962|NCT03447990|54525852|FG000|Overall Study|Withdrawal by Subject|0|||
27887963|NCT03447990|54525853|FG001|Overall Study|Withdrawal by Subject|0|||
27887964|NCT03447990|54525854|FG002|Overall Study|Withdrawal by Subject|0|||
27887965|NCT03447990|54525855|FG003|Overall Study|Withdrawal by Subject|0|||
27887966|NCT03447990|54525856|FG004|Overall Study|Withdrawal by Subject|0|||
28171824|NCT04163991|54843380|FG003|Overall Study|Other, Not Specified|1|||
28171825|NCT04163991|54843381|FG004|Overall Study|Other, Not Specified|0|||
28171826|NCT02442622|54843399|FG000|Overall Study|Withdrawal by Subject|3|||
28171827|NCT02442622|54843400|FG001|Overall Study|Withdrawal by Subject|1|||
28171828|NCT02411578|54843408|FG000|Crossover Trial Phase|Pregnancy|0|||
27739369|NCT02232178|54188949|FG000|Overall Study|ineligibility|0|||
27887967|NCT03447990|54525857|FG005|Overall Study|Withdrawal by Subject|0|||
27887968|NCT03447990|54525858|FG006|Overall Study|Withdrawal by Subject|1|||
27887969|NCT01376778|54525910|FG000|Overall Study|Lost to Follow-up|3|||
27887970|NCT01376778|54525911|FG001|Overall Study|Lost to Follow-up|2|||
27925753|NCT01231503|54582283|FG007|Overall Study|Protocol Violation|0|||
28171829|NCT02411578|54843409|FG001|Crossover Trial Phase|Pregnancy|1|||
28171830|NCT02442310|54843417|FG000|Overall Study|Adverse Event|2|||
28171831|NCT02442310|54843417|FG000|Overall Study|Withdrawal by Subject|1|||
28171832|NCT02411110|54843429|FG000|Treatment Period 1|Adverse Event|4|||
28171833|NCT02411110|54843430|FG001|Treatment Period 1|Adverse Event|2|||
28171834|NCT02411110|54843429|FG000|Treatment Period 1|Lost to Follow-up|1|||
28171835|NCT02411110|54843430|FG001|Treatment Period 1|Lost to Follow-up|0|||
28171836|NCT02411110|54843429|FG000|Treatment Period 1|Personal Reasons|2|||
28171837|NCT02411110|54843430|FG001|Treatment Period 1|Personal Reasons|5|||
28171838|NCT02411110|54843429|FG000|Treatment Period 1|Other Miscellaneous Reasons|2|||
28171839|NCT02411110|54843430|FG001|Treatment Period 1|Other Miscellaneous Reasons|0|||
28171840|NCT02411110|54843429|FG000|Treatment Period 2|Adverse Event|1|||
27887971|NCT01074294|54525920|FG000|Phase A (Day 1 to Week 5)|Lost to Follow-up|16|||
27887972|NCT01074294|54525921|FG001|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
27887973|NCT01074294|54525922|FG002|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
27887974|NCT01074294|54525923|FG003|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
27887975|NCT01074294|54525920|FG000|Phase A (Day 1 to Week 5)|Adverse Event|51|||
27887976|NCT01074294|54525921|FG001|Phase A (Day 1 to Week 5)|Adverse Event|0|||
27887977|NCT01074294|54525922|FG002|Phase A (Day 1 to Week 5)|Adverse Event|0|||
27887978|NCT01074294|54525923|FG003|Phase A (Day 1 to Week 5)|Adverse Event|0|||
27887979|NCT01074294|54525920|FG000|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|47|||
27887980|NCT01074294|54525921|FG001|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
27887981|NCT01074294|54525922|FG002|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
27887982|NCT01074294|54525923|FG003|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
27887983|NCT01074294|54525920|FG000|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|3|||
27887984|NCT01074294|54525921|FG001|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
27887985|NCT01074294|54525922|FG002|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
27887986|NCT01074294|54525923|FG003|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
27887987|NCT01074294|54525920|FG000|Phase A (Day 1 to Week 5)|Withdrawal by Subject|32|||
27887988|NCT01074294|54525921|FG001|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
27887989|NCT01074294|54525922|FG002|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
27887990|NCT01074294|54525923|FG003|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
27887991|NCT01074294|54525920|FG000|Phase A (Day 1 to Week 5)|Protocol deviation|10|||
27887992|NCT01074294|54525921|FG001|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
28171841|NCT02411110|54843430|FG001|Treatment Period 2|Adverse Event|0|||
28171842|NCT02411110|54843429|FG000|Treatment Period 2|Lost to Follow-up|0|||
28171843|NCT02411110|54843430|FG001|Treatment Period 2|Lost to Follow-up|2|||
28171844|NCT02411110|54843429|FG000|Treatment Period 2|Personal Reasons|0|||
27887993|NCT01074294|54525922|FG002|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
27887994|NCT01074294|54525923|FG003|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
27887995|NCT01074294|54525920|FG000|Phase A (Day 1 to Week 5)|Participants not Dosed|7|||
27887996|NCT01074294|54525921|FG001|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
27887997|NCT01074294|54525922|FG002|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
27887998|NCT01074294|54525923|FG003|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
27887999|NCT01074294|54525920|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|0|||
27888000|NCT01074294|54525921|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
27888001|NCT01074294|54525922|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
27888002|NCT01074294|54525923|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|11|||
27888003|NCT01074294|54525920|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|0|||
27888004|NCT01074294|54525921|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|2|||
27888005|NCT01074294|54525922|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|3|||
27888006|NCT01074294|54525923|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|8|||
27888007|NCT01074294|54525920|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
27888008|NCT01074294|54525921|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|2|||
27888009|NCT01074294|54525922|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
27888010|NCT01074294|54525923|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
27888011|NCT01074294|54525920|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|0|||
27888012|NCT01074294|54525921|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
27888013|NCT01074294|54525922|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
27888014|NCT01074294|54525923|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|4|||
27888015|NCT01074294|54525920|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
27985308|NCT00594399|54644026|FG000|Initial 3 Month Counseling|Not ready to exercise|1|||
27985309|NCT00594399|54644027|FG001|Initial 3 Month Counseling|Not ready to exercise|0|||
28171845|NCT02411110|54843430|FG001|Treatment Period 2|Personal Reasons|2|||
27985310|NCT00594399|54644028|FG002|Initial 3 Month Counseling|Not ready to exercise|0|||
28171846|NCT01369849|54843441|FG000|Overall Study|Ineligible prior to treatment|0|||
27739370|NCT02232178|54188950|FG001|Overall Study|ineligibility|0|||
28171847|NCT01369849|54843442|FG001|Overall Study|Ineligible prior to treatment|0|||
28171848|NCT01369849|54843443|FG002|Overall Study|Ineligible prior to treatment|1|||
27985311|NCT00594399|54644026|FG000|Initial 3 Month Counseling|Lack of Interest|3|||
27985312|NCT00594399|54644027|FG001|Initial 3 Month Counseling|Lack of Interest|3|||
27985313|NCT00594399|54644028|FG002|Initial 3 Month Counseling|Lack of Interest|0|||
27985314|NCT00594399|54644026|FG000|Initial 3 Month Counseling|Personal issues|2|||
27985315|NCT00594399|54644027|FG001|Initial 3 Month Counseling|Personal issues|0|||
27985316|NCT00594399|54644028|FG002|Initial 3 Month Counseling|Personal issues|0|||
27985317|NCT00594399|54644026|FG000|Initial 3 Month Counseling|Too busy|7|||
27888016|NCT01074294|54525921|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
27888017|NCT01074294|54525922|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|3|||
27985318|NCT00594399|54644027|FG001|Initial 3 Month Counseling|Too busy|1|||
27985319|NCT00594399|54644028|FG002|Initial 3 Month Counseling|Too busy|0|||
27985320|NCT00594399|54644026|FG000|Initial 3 Month Counseling|Pain|2|||
27985321|NCT00594399|54644027|FG001|Initial 3 Month Counseling|Pain|0|||
27888018|NCT01074294|54525923|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|2|||
27888019|NCT01074294|54525920|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
27888020|NCT01074294|54525921|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|1|||
27888021|NCT01074294|54525922|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
27888022|NCT01074294|54525923|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
27888023|NCT04556838|54527736|FG000|Overall Study|Withdrawal by Subject|3|||
27888024|NCT04556838|54527737|FG001|Overall Study|Withdrawal by Subject|1|||
27888025|NCT04556838|54527738|FG002|Overall Study|Withdrawal by Subject|2|||
27888026|NCT04556838|54527736|FG000|Overall Study|Adverse Event|0|||
27888027|NCT04556838|54527737|FG001|Overall Study|Adverse Event|1|||
27985322|NCT00594399|54644028|FG002|Initial 3 Month Counseling|Pain|0|||
27985323|NCT00594399|54644026|FG000|Initial 3 Month Counseling|Moved|1|||
27985324|NCT00594399|54644027|FG001|Initial 3 Month Counseling|Moved|0|||
27985325|NCT00594399|54644028|FG002|Initial 3 Month Counseling|Moved|0|||
27985326|NCT00594399|54644026|FG000|Initial 3 Month Counseling|Family illness|1|||
27985327|NCT00594399|54644027|FG001|Initial 3 Month Counseling|Family illness|0|||
27985328|NCT00594399|54644028|FG002|Initial 3 Month Counseling|Family illness|0|||
27985329|NCT00594399|54644026|FG000|Rerandomization Arm 1 Only|Death|2|||
27985330|NCT00594399|54644027|FG001|Rerandomization Arm 1 Only|Death|1|||
27985331|NCT00594399|54644028|FG002|Rerandomization Arm 1 Only|Death|0|||
27985332|NCT00594399|54644026|FG000|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
27985333|NCT00594399|54644027|FG001|Rerandomization Arm 1 Only|Withdrawal by Subject|3|||
27985334|NCT00594399|54644028|FG002|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
27985335|NCT00546715|54644038|FG000|Overall Study|Withdrawal by Subject|0|||
27985336|NCT00546715|54644039|FG001|Overall Study|Withdrawal by Subject|1|||
27985337|NCT00546715|54644040|FG002|Overall Study|Withdrawal by Subject|0|||
27985338|NCT00546715|54644041|FG003|Overall Study|Withdrawal by Subject|0|||
27985339|NCT00874029|54644051|FG000|Overall Study|Withdrawal by Subject|10|||
27985340|NCT00874029|54644051|FG000|Overall Study|Pregnancy|4|||
27985341|NCT00874029|54644051|FG000|Overall Study|Physician Decision|1|||
27985342|NCT00874029|54644051|FG000|Overall Study|Adverse Event|1|||
27985343|NCT00874029|54644051|FG000|Overall Study|Lost to Follow-up|5|||
27985344|NCT00546637|54644067|FG000|Overall Study|Adverse Event|46|||
27985345|NCT00546637|54644068|FG001|Overall Study|Adverse Event|20|||
27985346|NCT00546637|54644067|FG000|Overall Study|Lack of Efficacy|5|||
27985347|NCT00546637|54644068|FG001|Overall Study|Lack of Efficacy|5|||
27985348|NCT00546637|54644067|FG000|Overall Study|Lost to Follow-up|2|||
27985349|NCT00546637|54644068|FG001|Overall Study|Lost to Follow-up|2|||
27985350|NCT00546637|54644067|FG000|Overall Study|Other|10|||
28096640|NCT03692676|54751820|FG003|Overall Study|exclude patients less than 18 years of age on index date|193|||
28096641|NCT03692676|54751817|FG000|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149|||
28096642|NCT03692676|54751818|FG001|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717|||
28096643|NCT03692676|54751819|FG002|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723|||
28096644|NCT03692676|54751820|FG003|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273|||
28096645|NCT03692676|54751817|FG000|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208|||
28096646|NCT03692676|54751818|FG001|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759|||
27739371|NCT02232178|54188951|FG002|Overall Study|ineligibility|1|||
27888028|NCT04556838|54527738|FG002|Overall Study|Adverse Event|1|||
27985351|NCT00546637|54644068|FG001|Overall Study|Other|12|||
27985352|NCT00546637|54644067|FG000|Overall Study|Withdrawal by Subject|7|||
27985353|NCT00546637|54644068|FG001|Overall Study|Withdrawal by Subject|9|||
27985354|NCT00546637|54644067|FG000|Overall Study|Randomized, but not treated|3|||
27985355|NCT00546637|54644068|FG001|Overall Study|Randomized, but not treated|1|||
27985356|NCT00546481|54644076|FG000|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1|||
27888029|NCT04556838|54527736|FG000|Overall Study|Lost to Follow-up|0|||
27888030|NCT04556838|54527737|FG001|Overall Study|Lost to Follow-up|0|||
27888031|NCT04556838|54527738|FG002|Overall Study|Lost to Follow-up|2|||
27985357|NCT00546481|54644077|FG001|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
27985358|NCT00546481|54644078|FG002|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
27985359|NCT00546481|54644076|FG000|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1|||
27985360|NCT00546481|54644077|FG001|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3|||
27985361|NCT00546481|54644078|FG002|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0|||
27985362|NCT00546481|54644076|FG000|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1|||
27985363|NCT00546481|54644077|FG001|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
27985364|NCT00546481|54644078|FG002|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
27985365|NCT00546481|54644076|FG000|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2|||
27985366|NCT00546481|54644077|FG001|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
27985367|NCT00546481|54644078|FG002|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
27985368|NCT00546481|54644076|FG000|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
27985369|NCT00546481|54644077|FG001|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
27985370|NCT00546481|54644078|FG002|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0|||
27985371|NCT00546481|54644076|FG000|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
27985372|NCT00546481|54644077|FG001|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1|||
27985373|NCT00546481|54644078|FG002|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
27985374|NCT00546481|54644076|FG000|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
27985375|NCT00546481|54644077|FG001|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
27985376|NCT00546481|54644078|FG002|Maintenance Phase (CERA)|Withdrawal by Subject|2|||
27985377|NCT00546481|54644076|FG000|Maintenance Phase (CERA)|Kidney transplantation|0|||
27985378|NCT00546481|54644077|FG001|Maintenance Phase (CERA)|Kidney transplantation|0|||
27985379|NCT00546481|54644078|FG002|Maintenance Phase (CERA)|Kidney transplantation|1|||
27985380|NCT00546481|54644076|FG000|Maintenance Phase (CERA)|Other Reason|0|||
27985381|NCT00546481|54644077|FG001|Maintenance Phase (CERA)|Other Reason|0|||
27985382|NCT00546481|54644078|FG002|Maintenance Phase (CERA)|Other Reason|1|||
27985383|NCT00880698|54644090|FG000|Overall Study|Death|0|||
27985384|NCT00880698|54644091|FG001|Overall Study|Death|0|||
27985385|NCT00880698|54644092|FG002|Overall Study|Death|1|||
27985386|NCT00880698|54644093|FG003|Overall Study|Death|2|||
27985387|NCT00880698|54644090|FG000|Overall Study|Lost to Follow-up|1|||
27985388|NCT00880698|54644091|FG001|Overall Study|Lost to Follow-up|3|||
27985389|NCT00880698|54644092|FG002|Overall Study|Lost to Follow-up|0|||
27985390|NCT00880698|54644093|FG003|Overall Study|Lost to Follow-up|1|||
27985391|NCT00880620|54644109|FG000|Overall Study|Adverse Event|4|||
27888032|NCT04556838|54527736|FG000|Overall Study|Subject travel|0|||
27888033|NCT04556838|54527737|FG001|Overall Study|Subject travel|1|||
27888034|NCT04556838|54527738|FG002|Overall Study|Subject travel|0|||
27888035|NCT04556838|54527736|FG000|Overall Study|Physician Decision|1|||
27888036|NCT04556838|54527737|FG001|Overall Study|Physician Decision|0|||
27888037|NCT04556838|54527738|FG002|Overall Study|Physician Decision|0|||
27985392|NCT00880620|54644110|FG001|Overall Study|Adverse Event|5|||
27985393|NCT00880620|54644111|FG002|Overall Study|Adverse Event|15|||
27985394|NCT00880620|54644112|FG003|Overall Study|Adverse Event|15|||
27985395|NCT00880620|54644109|FG000|Overall Study|Death|0|||
28171849|NCT01369849|54843441|FG000|Overall Study|Ineligible after receiving treatment|0|||
27888038|NCT03734016|54527761|FG000|Overall Study|Participants Remaining in the Study|260|||
27888039|NCT03734016|54527762|FG001|Overall Study|Participants Remaining in the Study|240|||
27888040|NCT03734016|54527761|FG000|Overall Study|Death|48|||
27888041|NCT03734016|54527762|FG001|Overall Study|Death|60|||
27888042|NCT03734016|54527761|FG000|Overall Study|Withdrawal by Subject|14|||
27888043|NCT03734016|54527762|FG001|Overall Study|Withdrawal by Subject|16|||
27888044|NCT03734016|54527761|FG000|Overall Study|Physician Decision|0|||
27888045|NCT03734016|54527762|FG001|Overall Study|Physician Decision|7|||
27888046|NCT03734016|54527761|FG000|Overall Study|Lost to Follow-up|3|||
27888047|NCT03734016|54527762|FG001|Overall Study|Lost to Follow-up|1|||
27888048|NCT03734016|54527761|FG000|Overall Study|Adverse Event|2|||
27888049|NCT03734016|54527762|FG001|Overall Study|Adverse Event|1|||
27888050|NCT03671148|54527771|FG000|Overall Study|Adverse Event|3|||
27888051|NCT03671148|54527772|FG001|Overall Study|Adverse Event|2|||
27888052|NCT03671148|54527771|FG000|Overall Study|Withdrawal by Subject|8|||
27888053|NCT03671148|54527772|FG001|Overall Study|Withdrawal by Subject|2|||
27888054|NCT03671148|54527771|FG000|Overall Study|Lost to Follow-up|1|||
27985396|NCT00880620|54644110|FG001|Overall Study|Death|0|||
27985397|NCT00880620|54644111|FG002|Overall Study|Death|1|||
27985398|NCT00880620|54644112|FG003|Overall Study|Death|0|||
27985399|NCT00880620|54644109|FG000|Overall Study|Lack of Efficacy|12|||
27985400|NCT00880620|54644110|FG001|Overall Study|Lack of Efficacy|4|||
27985401|NCT00880620|54644111|FG002|Overall Study|Lack of Efficacy|0|||
27985402|NCT00880620|54644112|FG003|Overall Study|Lack of Efficacy|1|||
27985403|NCT00880620|54644109|FG000|Overall Study|Lost to Follow-up|0|||
27888055|NCT03671148|54527772|FG001|Overall Study|Lost to Follow-up|2|||
27888056|NCT03671148|54527771|FG000|Overall Study|Lack of Efficacy|7|||
27888057|NCT03671148|54527772|FG001|Overall Study|Lack of Efficacy|2|||
27888058|NCT03671148|54527771|FG000|Overall Study|COVID-19 Logistical Restrictions|0|||
27985404|NCT00880620|54644110|FG001|Overall Study|Lost to Follow-up|1|||
27985405|NCT00880620|54644111|FG002|Overall Study|Lost to Follow-up|1|||
27985406|NCT00880620|54644112|FG003|Overall Study|Lost to Follow-up|0|||
27985407|NCT00880620|54644109|FG000|Overall Study|Protocol Violation|0|||
27985408|NCT00880620|54644110|FG001|Overall Study|Protocol Violation|1|||
27985409|NCT00880620|54644111|FG002|Overall Study|Protocol Violation|0|||
27985410|NCT00880620|54644112|FG003|Overall Study|Protocol Violation|2|||
27985411|NCT00880620|54644109|FG000|Overall Study|Withdrawal by Subject|4|||
27985412|NCT00880620|54644110|FG001|Overall Study|Withdrawal by Subject|3|||
27985413|NCT00880620|54644111|FG002|Overall Study|Withdrawal by Subject|1|||
27985414|NCT00880620|54644112|FG003|Overall Study|Withdrawal by Subject|3|||
27985415|NCT00880620|54644109|FG000|Overall Study|Noncompliance|0|||
27985416|NCT00880620|54644110|FG001|Overall Study|Noncompliance|0|||
27985417|NCT00880620|54644111|FG002|Overall Study|Noncompliance|1|||
27985418|NCT00880620|54644112|FG003|Overall Study|Noncompliance|1|||
27985419|NCT00880620|54644109|FG000|Overall Study|Other|1|||
27985420|NCT00880620|54644110|FG001|Overall Study|Other|1|||
27985421|NCT00880620|54644111|FG002|Overall Study|Other|2|||
27985422|NCT00880620|54644112|FG003|Overall Study|Other|2|||
27985423|NCT00881868|54644138|FG000|Overall Study|Adverse Event|0|||
27985424|NCT00881868|54644139|FG001|Overall Study|Adverse Event|1|||
27985425|NCT00881868|54644138|FG000|Overall Study|Lost to Follow-up|2|||
27985426|NCT00881868|54644139|FG001|Overall Study|Lost to Follow-up|1|||
27985427|NCT00881868|54644138|FG000|Overall Study|Physician Decision|4|||
27985428|NCT00881868|54644139|FG001|Overall Study|Physician Decision|0|||
27985429|NCT00881868|54644138|FG000|Overall Study|Protocol Violation|2|||
27985430|NCT00881868|54644139|FG001|Overall Study|Protocol Violation|0|||
27985431|NCT00881712|54644148|FG000|Overall Study|Death|1|||
27985432|NCT00881712|54644149|FG001|Overall Study|Death|0|||
27985433|NCT00881712|54644150|FG002|Overall Study|Death|0|||
27985434|NCT00881712|54644148|FG000|Overall Study|Withdrawal by Subject|1|||
27985435|NCT00881712|54644149|FG001|Overall Study|Withdrawal by Subject|0|||
27985436|NCT00881712|54644150|FG002|Overall Study|Withdrawal by Subject|0|||
27985437|NCT03955471|54644158|FG000|Overall Study|Death|22|||
27985438|NCT03955471|54644158|FG000|Overall Study|Lost to Follow-up|1|||
27985439|NCT03955471|54644158|FG000|Overall Study|Withdrawal by Subject|6|||
27985440|NCT03955471|54644158|FG000|Overall Study|Sponsor Decision to Terminate Study|11|||
27985441|NCT00880542|54644162|FG000|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1|||
27985442|NCT00880542|54644162|FG000|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2|||
27985443|NCT00880542|54644162|FG000|REP: Surgical Resection|progressive disease|1|||
27985444|NCT00885534|54644166|FG000|Overall Study|Patient deemed ineligible|1|||
27985445|NCT00885378|54644172|FG000|Overall Study|Lack of Efficacy|2|||
27985446|NCT00885378|54644173|FG001|Overall Study|Lack of Efficacy|2|||
27985447|NCT00885378|54644172|FG000|Overall Study|Withdrawal by Subject|1|||
27985448|NCT00885378|54644173|FG001|Overall Study|Withdrawal by Subject|2|||
27985449|NCT00885378|54644172|FG000|Overall Study|Lost to Follow-up|1|||
27985450|NCT00885378|54644173|FG001|Overall Study|Lost to Follow-up|2|||
27985451|NCT00885378|54644172|FG000|Overall Study|Poor/Noncompliance|2|||
27985452|NCT00885378|54644173|FG001|Overall Study|Poor/Noncompliance|2|||
27985453|NCT00885378|54644172|FG000|Overall Study|Protocol Violation|2|||
27985454|NCT00885378|54644173|FG001|Overall Study|Protocol Violation|0|||
27985455|NCT00545779|54644179|FG000|Overall Study|Violation of selection criteria at entry|8|||
27985456|NCT00545779|54644179|FG000|Overall Study|Other protocol violation|1|||
27985457|NCT00545779|54644179|FG000|Overall Study|Did not cooperate|7|||
27985458|NCT00545779|54644179|FG000|Overall Study|Withdrawal by Subject|20|||
27985459|NCT00545779|54644179|FG000|Overall Study|Adverse Event/intercurrent illness|5|||
27985460|NCT00545779|54644179|FG000|Overall Study|Failure to return|3|||
27985461|NCT00597714|54644189|FG000|Overall Study|Death|56|||
27985462|NCT00597714|54644190|FG001|Overall Study|Death|46|||
27985463|NCT00597714|54644191|FG002|Overall Study|Death|0|||
27985464|NCT00597714|54644189|FG000|Overall Study|Recipient death|0|||
27985465|NCT00597714|54644190|FG001|Overall Study|Recipient death|0|||
27985466|NCT00597714|54644191|FG002|Overall Study|Recipient death|10|||
27985467|NCT03938857|54644204|FG000|Overall Study|Physician Decision|1|||
27985468|NCT03938857|54644205|FG001|Overall Study|Physician Decision|0|||
27985469|NCT03938857|54644206|FG002|Overall Study|Physician Decision|0|||
27985470|NCT03938857|54644207|FG003|Overall Study|Physician Decision|0|||
27985471|NCT00884832|54644219|FG000|Overall Study|Withdrawal by Subject|0|||
27985472|NCT00884832|54644220|FG001|Overall Study|Withdrawal by Subject|1|||
27985473|NCT03938545|54644230|FG000|Overall Study|Lost to Follow-up|0|||
27985474|NCT03938545|54644231|FG001|Overall Study|Lost to Follow-up|0|||
27985475|NCT03938545|54644232|FG002|Overall Study|Lost to Follow-up|0|||
27985476|NCT03938545|54644233|FG003|Overall Study|Lost to Follow-up|1|||
27985477|NCT03938545|54644230|FG000|Overall Study|Non-compliance with study drug|0|||
27985478|NCT03938545|54644231|FG001|Overall Study|Non-compliance with study drug|0|||
27985479|NCT03938545|54644232|FG002|Overall Study|Non-compliance with study drug|1|||
27985480|NCT03938545|54644233|FG003|Overall Study|Non-compliance with study drug|0|||
27888059|NCT03671148|54527772|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
27985481|NCT03938545|54644230|FG000|Overall Study|Pregnancy|1|||
27985482|NCT03938545|54644231|FG001|Overall Study|Pregnancy|0|||
27985483|NCT03938545|54644232|FG002|Overall Study|Pregnancy|0|||
27985484|NCT03938545|54644233|FG003|Overall Study|Pregnancy|0|||
27985485|NCT03938545|54644230|FG000|Overall Study|Study terminated by sponsor|6|||
27985486|NCT03938545|54644231|FG001|Overall Study|Study terminated by sponsor|4|||
27985487|NCT03938545|54644232|FG002|Overall Study|Study terminated by sponsor|2|||
27985488|NCT03938545|54644233|FG003|Overall Study|Study terminated by sponsor|4|||
27985489|NCT03938545|54644230|FG000|Overall Study|Withdrawal by Subject|0|||
27985490|NCT03938545|54644231|FG001|Overall Study|Withdrawal by Subject|1|||
27985491|NCT03938545|54644232|FG002|Overall Study|Withdrawal by Subject|0|||
27985492|NCT03938545|54644233|FG003|Overall Study|Withdrawal by Subject|0|||
27985493|NCT03938545|54644230|FG000|Overall Study|Adverse Event|1|||
27985494|NCT03938545|54644231|FG001|Overall Study|Adverse Event|0|||
27985495|NCT03938545|54644232|FG002|Overall Study|Adverse Event|0|||
27985496|NCT03938545|54644233|FG003|Overall Study|Adverse Event|0|||
27985497|NCT00879996|54644245|FG000|Overall Study|Lost to Follow-up|7|||
27888060|NCT03671148|54527771|FG000|Overall Study|Other|1|||
27888061|NCT03671148|54527772|FG001|Overall Study|Other|0|||
27888062|NCT03671148|54527771|FG000|Overall Study|Incomplete Randomization Visit|1|||
27985498|NCT00879996|54644246|FG001|Overall Study|Lost to Follow-up|6|||
27985499|NCT00879996|54644245|FG000|Overall Study|non-compliance|6|||
27985500|NCT00879996|54644246|FG001|Overall Study|non-compliance|4|||
27985501|NCT00879996|54644245|FG000|Overall Study|Physician Decision|1|||
27985502|NCT00879996|54644246|FG001|Overall Study|Physician Decision|2|||
27985503|NCT00879996|54644245|FG000|Overall Study|psychiatric problem|0|||
27985504|NCT00879996|54644246|FG001|Overall Study|psychiatric problem|1|||
27985505|NCT00879996|54644245|FG000|Overall Study|put on parole|1|||
27985506|NCT00879996|54644246|FG001|Overall Study|put on parole|0|||
27985507|NCT00873093|54644259|FG000|Overall Study|Adverse Event|0|||
27985508|NCT00873093|54644260|FG001|Overall Study|Adverse Event|2|||
27985509|NCT00873093|54644261|FG002|Overall Study|Adverse Event|0|||
27985510|NCT00873093|54644262|FG003|Overall Study|Adverse Event|0|||
27985511|NCT00873093|54644263|FG004|Overall Study|Adverse Event|0|||
27985512|NCT00873093|54644259|FG000|Overall Study|Death|0|||
27985513|NCT00873093|54644260|FG001|Overall Study|Death|3|||
27985514|NCT00873093|54644261|FG002|Overall Study|Death|2|||
27985515|NCT00873093|54644262|FG003|Overall Study|Death|0|||
27985516|NCT00873093|54644263|FG004|Overall Study|Death|0|||
28096647|NCT03692676|54751819|FG002|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419|||
28096648|NCT03692676|54751820|FG003|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684|||
28096649|NCT03692676|54751817|FG000|Overall Study|exclude patients with prior recorded COPD diagnosis|275|||
28096650|NCT03692676|54751818|FG001|Overall Study|exclude patients with prior recorded COPD diagnosis|218|||
28096651|NCT03692676|54751819|FG002|Overall Study|exclude patients with prior recorded COPD diagnosis|1515|||
28096652|NCT03692676|54751820|FG003|Overall Study|exclude patients with prior recorded COPD diagnosis|173|||
28096653|NCT03692676|54751817|FG000|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
28096654|NCT03692676|54751818|FG001|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
28171850|NCT01369849|54843442|FG001|Overall Study|Ineligible after receiving treatment|1|||
27985517|NCT00873093|54644259|FG000|Overall Study|Physician Decision|0|||
27985518|NCT00873093|54644260|FG001|Overall Study|Physician Decision|17|||
27985519|NCT00873093|54644261|FG002|Overall Study|Physician Decision|10|||
27985520|NCT00873093|54644262|FG003|Overall Study|Physician Decision|10|||
27985521|NCT00873093|54644263|FG004|Overall Study|Physician Decision|2|||
27985522|NCT00873093|54644259|FG000|Overall Study|Withdrawal by Subject|1|||
27985523|NCT00873093|54644260|FG001|Overall Study|Withdrawal by Subject|4|||
27985524|NCT00873093|54644261|FG002|Overall Study|Withdrawal by Subject|4|||
27985525|NCT00873093|54644262|FG003|Overall Study|Withdrawal by Subject|0|||
27985526|NCT00873093|54644263|FG004|Overall Study|Withdrawal by Subject|0|||
27985527|NCT00873093|54644259|FG000|Overall Study|Ineligible|0|||
27985528|NCT00873093|54644260|FG001|Overall Study|Ineligible|1|||
27985529|NCT00873093|54644261|FG002|Overall Study|Ineligible|0|||
28171851|NCT01369849|54843443|FG002|Overall Study|Ineligible after receiving treatment|0|||
28171852|NCT02716779|54843456|FG000|Monotherapy|Adverse Event|0|||
27888063|NCT03671148|54527772|FG001|Overall Study|Incomplete Randomization Visit|0|||
27985530|NCT00873093|54644262|FG003|Overall Study|Ineligible|1|||
27985531|NCT00873093|54644263|FG004|Overall Study|Ineligible|0|||
27985532|NCT00884286|54644287|FG000|Overall Study|Progressive disease|21|||
27985533|NCT00884286|54644288|FG001|Overall Study|Progressive disease|28|||
27985534|NCT00884286|54644287|FG000|Overall Study|Toxicity|4|||
27985535|NCT00884286|54644288|FG001|Overall Study|Toxicity|1|||
27985536|NCT00884286|54644287|FG000|Overall Study|Death|2|||
27985537|NCT00884286|54644288|FG001|Overall Study|Death|2|||
28096655|NCT03692676|54751819|FG002|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147|||
28096656|NCT03692676|54751820|FG003|Overall Study|exclude patients with multiple FDC prescriptions on index date|4|||
28171853|NCT02716779|54843457|FG001|Monotherapy|Adverse Event|1|||
27985538|NCT00884286|54644287|FG000|Overall Study|Physician Decision|1|||
27985539|NCT00884286|54644288|FG001|Overall Study|Physician Decision|0|||
27985540|NCT00884286|54644287|FG000|Overall Study|Septic shock|1|||
27888064|NCT02004522|54527780|FG000|Overall Study|Adverse Event|55|||
27985541|NCT00884286|54644288|FG001|Overall Study|Septic shock|0|||
27985542|NCT00884286|54644287|FG000|Overall Study|Thrombus in right auricle|1|||
27888065|NCT02004522|54527781|FG001|Overall Study|Adverse Event|6|||
27888066|NCT02004522|54527780|FG000|Overall Study|Withdrawal by Subject|13|||
27888067|NCT02004522|54527781|FG001|Overall Study|Withdrawal by Subject|7|||
27888068|NCT02004522|54527780|FG000|Overall Study|Death|12|||
27888069|NCT02004522|54527781|FG001|Overall Study|Death|3|||
27888070|NCT02004522|54527780|FG000|Overall Study|Physician Decision|3|||
27888071|NCT02004522|54527781|FG001|Overall Study|Physician Decision|4|||
27888072|NCT02004522|54527780|FG000|Overall Study|Protocol Violation|1|||
27888073|NCT02004522|54527781|FG001|Overall Study|Protocol Violation|0|||
27888074|NCT02004522|54527780|FG000|Overall Study|Other is reason listed by PI|4|||
27888075|NCT02004522|54527781|FG001|Overall Study|Other is reason listed by PI|1|||
27888076|NCT02004522|54527780|FG000|Overall Study|Never Dosed|2|||
27888077|NCT02004522|54527781|FG001|Overall Study|Never Dosed|4|||
27888078|NCT02004522|54527780|FG000|Overall Study|Disease Progression|35|||
27888079|NCT02004522|54527781|FG001|Overall Study|Disease Progression|31|||
27888080|NCT02004522|54527780|FG000|Overall Study|Completed Treatment Cycles Per Protocol|1|||
27888081|NCT02004522|54527781|FG001|Overall Study|Completed Treatment Cycles Per Protocol|103|||
27888082|NCT01430442|54527799|FG000|Overall Study|Subject Withdrew Consent|3|||
27888083|NCT01430442|54527800|FG001|Overall Study|Subject Withdrew Consent|0|||
27888084|NCT01430442|54527801|FG002|Overall Study|Subject Withdrew Consent|1|||
27888085|NCT01430442|54527802|FG003|Overall Study|Subject Withdrew Consent|0|||
27888086|NCT01430442|54527803|FG004|Overall Study|Subject Withdrew Consent|2|||
27888087|NCT01430442|54527804|FG005|Overall Study|Subject Withdrew Consent|1|||
27888088|NCT01430442|54527805|FG006|Overall Study|Subject Withdrew Consent|5|||
27888089|NCT01430442|54527806|FG007|Overall Study|Subject Withdrew Consent|2|||
27888090|NCT01430442|54527799|FG000|Overall Study|Lost to Follow-up|2|||
27888091|NCT01430442|54527800|FG001|Overall Study|Lost to Follow-up|0|||
27888092|NCT01430442|54527801|FG002|Overall Study|Lost to Follow-up|1|||
27888093|NCT01430442|54527802|FG003|Overall Study|Lost to Follow-up|2|||
27888094|NCT01430442|54527803|FG004|Overall Study|Lost to Follow-up|2|||
27888095|NCT01430442|54527804|FG005|Overall Study|Lost to Follow-up|1|||
27888096|NCT01430442|54527805|FG006|Overall Study|Lost to Follow-up|5|||
27888097|NCT01430442|54527806|FG007|Overall Study|Lost to Follow-up|1|||
27888098|NCT01430442|54527799|FG000|Overall Study|Pregnancy|1|||
27888099|NCT01430442|54527800|FG001|Overall Study|Pregnancy|0|||
27888100|NCT01430442|54527801|FG002|Overall Study|Pregnancy|0|||
27888101|NCT01430442|54527802|FG003|Overall Study|Pregnancy|0|||
27888102|NCT01430442|54527803|FG004|Overall Study|Pregnancy|0|||
27888103|NCT01430442|54527804|FG005|Overall Study|Pregnancy|1|||
27888104|NCT01430442|54527805|FG006|Overall Study|Pregnancy|0|||
27888105|NCT01430442|54527806|FG007|Overall Study|Pregnancy|0|||
27888106|NCT01430442|54527799|FG000|Overall Study|Patient No Longer Meets Study Criteria|7|||
27888107|NCT01430442|54527800|FG001|Overall Study|Patient No Longer Meets Study Criteria|6|||
27888108|NCT01430442|54527801|FG002|Overall Study|Patient No Longer Meets Study Criteria|3|||
27888109|NCT01430442|54527802|FG003|Overall Study|Patient No Longer Meets Study Criteria|2|||
27888110|NCT01430442|54527803|FG004|Overall Study|Patient No Longer Meets Study Criteria|5|||
27888111|NCT01430442|54527804|FG005|Overall Study|Patient No Longer Meets Study Criteria|5|||
27888112|NCT01430442|54527805|FG006|Overall Study|Patient No Longer Meets Study Criteria|9|||
27888113|NCT01430442|54527806|FG007|Overall Study|Patient No Longer Meets Study Criteria|6|||
27888114|NCT01420926|54527826|FG000|Overall Study|Adverse Event|6|||
27888115|NCT01420926|54527827|FG001|Overall Study|Adverse Event|4|||
27888116|NCT01420926|54527826|FG000|Overall Study|Death|18|||
27888117|NCT01420926|54527827|FG001|Overall Study|Death|17|||
27888118|NCT01420926|54527826|FG000|Overall Study|Withdrawal by Subject|11|||
27888119|NCT01420926|54527827|FG001|Overall Study|Withdrawal by Subject|17|||
27888120|NCT01420926|54527826|FG000|Overall Study|Non-protocol treatment|17|||
27888121|NCT01420926|54527827|FG001|Overall Study|Non-protocol treatment|20|||
27888122|NCT01420926|54527826|FG000|Overall Study|Physician Decision|8|||
27888123|NCT01420926|54527827|FG001|Overall Study|Physician Decision|5|||
27888124|NCT04303572|54528383|FG000|Overall Study|Study closed due to poor enrollment|1|||
27888125|NCT04150068|54528390|FG000|Maintenance Period (Week 26 Analysis)|Still on study|24|||
27888126|NCT04150068|54528391|FG001|Maintenance Period (Week 26 Analysis)|Still on study|12|||
27888127|NCT04150068|54528392|FG002|Maintenance Period (Week 26 Analysis)|Still on study|35|||
27888128|NCT04150068|54528390|FG000|Maintenance Period (Week 26 Analysis)|Death|0|||
27888129|NCT04150068|54528391|FG001|Maintenance Period (Week 26 Analysis)|Death|0|||
27888130|NCT04150068|54528392|FG002|Maintenance Period (Week 26 Analysis)|Death|1|||
27888131|NCT03551730|54528427|FG000|Overall Study|Adverse Event|1|||
27888132|NCT03551730|54528428|FG001|Overall Study|Adverse Event|0|||
27888133|NCT03551730|54528429|FG002|Overall Study|Adverse Event|0|||
27888134|NCT03551730|54528430|FG003|Overall Study|Adverse Event|0|||
27888135|NCT02656290|54528440|FG000|Overall Study|Subjects Remain On Study|26|||
27985543|NCT00884286|54644288|FG001|Overall Study|Thrombus in right auricle|0|||
28096657|NCT03692676|54751817|FG000|Overall Study|exclude patients with prior use of same substances and device|0|||
27888136|NCT02534844|54528446|FG000|Part B|Withdrawal by Subject|0|||
27888137|NCT02534844|54528447|FG001|Part B|Withdrawal by Subject|0|||
27888138|NCT02534844|54528448|FG002|Part B|Withdrawal by Subject|0|||
27888139|NCT02534844|54528449|FG003|Part B|Withdrawal by Subject|0|||
27888140|NCT02534844|54528450|FG004|Part B|Withdrawal by Subject|2|||
27888141|NCT02534844|54528451|FG005|Part B|Withdrawal by Subject|1|||
27888142|NCT01818492|54528468|FG000|Overall Study|Adverse Event|2|||
27888143|NCT01818492|54528468|FG000|Overall Study|Death|3|||
27888144|NCT01818492|54528468|FG000|Overall Study|Withdrawal by Subject|1|||
27888145|NCT01818492|54528468|FG000|Overall Study|Additional therapy when not allowed PP|4|||
27888146|NCT01239030|54528478|FG000|Double Blind|Adverse Event|0|||
27888147|NCT01239030|54528479|FG001|Double Blind|Adverse Event|1|||
27888148|NCT01239030|54528480|FG002|Double Blind|Adverse Event|0|||
27888149|NCT01239030|54528481|FG003|Double Blind|Adverse Event|2|||
27888150|NCT01239030|54528482|FG004|Double Blind|Adverse Event|0|||
27888151|NCT01239030|54528478|FG000|Double Blind|Withdrawal by Subject|0|||
27888152|NCT01239030|54528479|FG001|Double Blind|Withdrawal by Subject|1|||
27888153|NCT01239030|54528480|FG002|Double Blind|Withdrawal by Subject|1|||
27888154|NCT01239030|54528481|FG003|Double Blind|Withdrawal by Subject|0|||
27888155|NCT01239030|54528482|FG004|Double Blind|Withdrawal by Subject|1|||
27888156|NCT01239030|54528478|FG000|Double Blind|Lost to Follow-up|1|||
27888157|NCT01239030|54528479|FG001|Double Blind|Lost to Follow-up|1|||
27888158|NCT01239030|54528480|FG002|Double Blind|Lost to Follow-up|0|||
27888159|NCT01239030|54528481|FG003|Double Blind|Lost to Follow-up|0|||
27888160|NCT01239030|54528482|FG004|Double Blind|Lost to Follow-up|0|||
27888161|NCT01239030|54528478|FG000|Double Blind|Physician Decision|0|||
27888162|NCT01239030|54528479|FG001|Double Blind|Physician Decision|1|||
27888163|NCT01239030|54528480|FG002|Double Blind|Physician Decision|0|||
27888164|NCT01239030|54528481|FG003|Double Blind|Physician Decision|0|||
27888165|NCT01239030|54528482|FG004|Double Blind|Physician Decision|0|||
27888166|NCT01239030|54528478|FG000|Dose Optimization (Open Label)|Adverse Event|2|||
27888167|NCT01239030|54528479|FG001|Dose Optimization (Open Label)|Adverse Event|0|||
27888168|NCT01239030|54528480|FG002|Dose Optimization (Open Label)|Adverse Event|2|||
27888169|NCT01239030|54528481|FG003|Dose Optimization (Open Label)|Adverse Event|0|||
27888170|NCT01239030|54528482|FG004|Dose Optimization (Open Label)|Adverse Event|5|||
27888171|NCT01239030|54528478|FG000|Dose Optimization (Open Label)|Withdrawal by Subject|4|||
27888172|NCT01239030|54528479|FG001|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
27888173|NCT01239030|54528480|FG002|Dose Optimization (Open Label)|Withdrawal by Subject|0|||
27888174|NCT01239030|54528481|FG003|Dose Optimization (Open Label)|Withdrawal by Subject|2|||
27888175|NCT01239030|54528482|FG004|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
27888176|NCT01239030|54528478|FG000|Dose Optimization (Open Label)|Lost to Follow-up|1|||
27888177|NCT01239030|54528479|FG001|Dose Optimization (Open Label)|Lost to Follow-up|1|||
27888178|NCT01239030|54528480|FG002|Dose Optimization (Open Label)|Lost to Follow-up|0|||
27888179|NCT01239030|54528481|FG003|Dose Optimization (Open Label)|Lost to Follow-up|0|||
27888180|NCT01239030|54528482|FG004|Dose Optimization (Open Label)|Lost to Follow-up|1|||
27888181|NCT01239030|54528478|FG000|Dose Optimization (Open Label)|Physician Decision|0|||
27888182|NCT01239030|54528479|FG001|Dose Optimization (Open Label)|Physician Decision|0|||
27888183|NCT01239030|54528480|FG002|Dose Optimization (Open Label)|Physician Decision|0|||
27888184|NCT01239030|54528481|FG003|Dose Optimization (Open Label)|Physician Decision|1|||
27888185|NCT01239030|54528482|FG004|Dose Optimization (Open Label)|Physician Decision|0|||
27888186|NCT01086540|54528497|FG000|Overall Study|Death|3|||
27888187|NCT01086540|54528498|FG001|Overall Study|Death|1|||
27888188|NCT01086540|54528497|FG000|Overall Study|Physician Decision|2|||
27888189|NCT01086540|54528498|FG001|Overall Study|Physician Decision|1|||
27888190|NCT01086540|54528497|FG000|Overall Study|Addition of new therapy for PAH|1|||
27888191|NCT01086540|54528498|FG001|Overall Study|Addition of new therapy for PAH|0|||
27888192|NCT04567524|54531813|FG000|Overall Study|Adverse Event|1|||
27888193|NCT04567524|54531814|FG001|Overall Study|Adverse Event|1|||
27888194|NCT04567524|54531815|FG002|Overall Study|Adverse Event|0|||
27888195|NCT04567524|54531816|FG003|Overall Study|Adverse Event|0|||
27888196|NCT04567524|54531813|FG000|Overall Study|Withdrawal by Subject|2|||
27888197|NCT04567524|54531814|FG001|Overall Study|Withdrawal by Subject|0|||
27888198|NCT04567524|54531815|FG002|Overall Study|Withdrawal by Subject|0|||
27888199|NCT04567524|54531816|FG003|Overall Study|Withdrawal by Subject|1|||
27888200|NCT03370302|54531852|FG000|Dose Escalation Phase|Other|0|||
27888201|NCT03370302|54531853|FG001|Dose Escalation Phase|Other|1|||
27888202|NCT03370302|54531854|FG002|Dose Escalation Phase|Other|1|||
27888203|NCT03370302|54531855|FG003|Dose Escalation Phase|Other|0|||
27888204|NCT03370302|54531856|FG004|Dose Escalation Phase|Other|0|||
27888205|NCT03370302|54531857|FG005|Dose Escalation Phase|Other|0|||
27888206|NCT03370302|54531852|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
27888207|NCT03370302|54531853|FG001|Dose Escalation Phase|Withdrawal by Subject|1|||
27888208|NCT03370302|54531854|FG002|Dose Escalation Phase|Withdrawal by Subject|2|||
27888209|NCT03370302|54531855|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
27888210|NCT03370302|54531856|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
27888211|NCT03370302|54531857|FG005|Dose Escalation Phase|Withdrawal by Subject|2|||
27888212|NCT03370302|54531852|FG000|Dose Escalation Phase|Adverse Event|1|||
27888213|NCT03370302|54531853|FG001|Dose Escalation Phase|Adverse Event|0|||
27888214|NCT03370302|54531854|FG002|Dose Escalation Phase|Adverse Event|2|||
27888215|NCT03370302|54531855|FG003|Dose Escalation Phase|Adverse Event|0|||
27888216|NCT03370302|54531856|FG004|Dose Escalation Phase|Adverse Event|0|||
27888217|NCT03370302|54531857|FG005|Dose Escalation Phase|Adverse Event|0|||
27888218|NCT03370302|54531852|FG000|Dose Escalation Phase|Progressive Disease|2|||
27888219|NCT03370302|54531853|FG001|Dose Escalation Phase|Progressive Disease|4|||
27888220|NCT03370302|54531854|FG002|Dose Escalation Phase|Progressive Disease|2|||
27888221|NCT03370302|54531855|FG003|Dose Escalation Phase|Progressive Disease|0|||
27888222|NCT03370302|54531856|FG004|Dose Escalation Phase|Progressive Disease|3|||
27888223|NCT03370302|54531857|FG005|Dose Escalation Phase|Progressive Disease|1|||
27888224|NCT03370302|54531852|FG000|Dose Expansion Phase|Progressive Disease|0|||
27888225|NCT03370302|54531853|FG001|Dose Expansion Phase|Progressive Disease|0|||
27888226|NCT03370302|54531854|FG002|Dose Expansion Phase|Progressive Disease|0|||
27888227|NCT03370302|54531855|FG003|Dose Expansion Phase|Progressive Disease|6|||
27888228|NCT03370302|54531856|FG004|Dose Expansion Phase|Progressive Disease|0|||
27888229|NCT03370302|54531857|FG005|Dose Expansion Phase|Progressive Disease|0|||
27888230|NCT03327324|54531881|FG000|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
27888231|NCT03327324|54531882|FG001|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
27888232|NCT03327324|54531883|FG002|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
27888233|NCT03327324|54531884|FG003|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
27888234|NCT03327324|54531885|FG004|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
27888235|NCT03327324|54531886|FG005|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|5|||
27888236|NCT03327324|54531881|FG000|Baseline (Month 0-Month 3)|Refused|0|||
27888237|NCT03327324|54531882|FG001|Baseline (Month 0-Month 3)|Refused|0|||
27888238|NCT03327324|54531883|FG002|Baseline (Month 0-Month 3)|Refused|0|||
27888239|NCT03327324|54531884|FG003|Baseline (Month 0-Month 3)|Refused|0|||
27888240|NCT03327324|54531885|FG004|Baseline (Month 0-Month 3)|Refused|1|||
27888241|NCT03327324|54531886|FG005|Baseline (Month 0-Month 3)|Refused|0|||
27888242|NCT03327324|54531881|FG000|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
27888243|NCT03327324|54531882|FG001|Baseline (Month 0-Month 3)|Withdrawal by Subject|2|||
27888244|NCT03327324|54531883|FG002|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
27888245|NCT03327324|54531884|FG003|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
27888246|NCT03327324|54531885|FG004|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
27888247|NCT03327324|54531886|FG005|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
27888248|NCT03327324|54531881|FG000|Baseline (Month 0-Month 3)|Death|0|||
27888249|NCT03327324|54531882|FG001|Baseline (Month 0-Month 3)|Death|0|||
27888250|NCT03327324|54531883|FG002|Baseline (Month 0-Month 3)|Death|0|||
27888251|NCT03327324|54531884|FG003|Baseline (Month 0-Month 3)|Death|0|||
27888252|NCT03327324|54531885|FG004|Baseline (Month 0-Month 3)|Death|1|||
27888253|NCT03327324|54531886|FG005|Baseline (Month 0-Month 3)|Death|0|||
27888254|NCT03327324|54531881|FG000|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
27888255|NCT03327324|54531882|FG001|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
27888256|NCT03327324|54531883|FG002|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
27888257|NCT03327324|54531884|FG003|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
27888258|NCT03327324|54531885|FG004|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
27888259|NCT03327324|54531886|FG005|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|1|||
27888260|NCT03327324|54531881|FG000|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
27888261|NCT03327324|54531882|FG001|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
27888262|NCT03327324|54531883|FG002|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|1|||
27888263|NCT03327324|54531884|FG003|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
27888264|NCT03327324|54531885|FG004|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
27888265|NCT03327324|54531886|FG005|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
27888266|NCT03327324|54531881|FG000|Intervention (Month 3-Month 6)|Withdrawal by Subject|2|||
27888267|NCT03327324|54531882|FG001|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
27888268|NCT03327324|54531883|FG002|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
27888269|NCT03327324|54531884|FG003|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
27888270|NCT03327324|54531885|FG004|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
27888271|NCT03327324|54531886|FG005|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
27888272|NCT03327324|54531881|FG000|Intervention (Month 3-Month 6)|Left Nursing Home Facility|2|||
27888273|NCT03327324|54531882|FG001|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
27888274|NCT03327324|54531883|FG002|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
27888275|NCT03327324|54531884|FG003|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
27888276|NCT03327324|54531885|FG004|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
27888277|NCT03327324|54531886|FG005|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
27888278|NCT03327324|54531881|FG000|Intervention (Month 3-Month 6)|Death|1|||
27888279|NCT03327324|54531882|FG001|Intervention (Month 3-Month 6)|Death|0|||
27888280|NCT03327324|54531883|FG002|Intervention (Month 3-Month 6)|Death|1|||
27888281|NCT03327324|54531884|FG003|Intervention (Month 3-Month 6)|Death|1|||
27888282|NCT03327324|54531885|FG004|Intervention (Month 3-Month 6)|Death|1|||
27888283|NCT03327324|54531886|FG005|Intervention (Month 3-Month 6)|Death|0|||
27888284|NCT03327324|54531881|FG000|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
27888285|NCT03327324|54531882|FG001|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
27888286|NCT03327324|54531883|FG002|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
27888287|NCT03327324|54531884|FG003|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
27888288|NCT03327324|54531885|FG004|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
27888289|NCT03327324|54531886|FG005|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|14|||
27888290|NCT03327324|54531881|FG000|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|1|||
27888291|NCT03327324|54531882|FG001|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
27888292|NCT03327324|54531883|FG002|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
27888293|NCT03327324|54531884|FG003|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
27888294|NCT03327324|54531885|FG004|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
27888295|NCT03327324|54531886|FG005|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
27888296|NCT03327324|54531881|FG000|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|2|||
27888297|NCT03327324|54531882|FG001|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|1|||
27888298|NCT03327324|54531883|FG002|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
27888299|NCT03327324|54531884|FG003|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
27888300|NCT03327324|54531885|FG004|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
27888301|NCT03327324|54531886|FG005|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
27888302|NCT03327324|54531881|FG000|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
27888303|NCT03327324|54531882|FG001|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
27888304|NCT03327324|54531883|FG002|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
27888305|NCT03327324|54531884|FG003|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
27888306|NCT03327324|54531885|FG004|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
27888307|NCT03327324|54531886|FG005|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
27888308|NCT03327324|54531881|FG000|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
27888309|NCT03327324|54531882|FG001|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
27888310|NCT03327324|54531883|FG002|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
27888311|NCT03327324|54531884|FG003|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|3|||
27888312|NCT03327324|54531885|FG004|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|5|||
27888313|NCT03327324|54531886|FG005|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
27888314|NCT03327324|54531881|FG000|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|1|||
27888315|NCT03327324|54531882|FG001|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
27888316|NCT03327324|54531883|FG002|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
27888317|NCT03327324|54531884|FG003|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
27888318|NCT03327324|54531885|FG004|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
27888319|NCT03327324|54531886|FG005|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
27888320|NCT03327324|54531881|FG000|Sustainability Follow-Up 2 (Month 9-12)|Death|1|||
27888321|NCT03327324|54531882|FG001|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
27888322|NCT03327324|54531883|FG002|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
27888323|NCT03327324|54531884|FG003|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
27888324|NCT03327324|54531885|FG004|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
27888325|NCT03327324|54531886|FG005|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
27888326|NCT03252522|54531892|FG000|Phase 1: Intervention & Placebo|Adverse Event|3|||
27888327|NCT03252522|54531893|FG001|Phase 1: Intervention & Placebo|Adverse Event|1|||
27888328|NCT03252522|54531894|FG002|Phase 1: Intervention & Placebo|Adverse Event|0|||
27888329|NCT03252522|54531892|FG000|Phase 1: Intervention & Placebo|Unable to swallow pills|4|||
27888330|NCT03252522|54531893|FG001|Phase 1: Intervention & Placebo|Unable to swallow pills|1|||
27888331|NCT03252522|54531894|FG002|Phase 1: Intervention & Placebo|Unable to swallow pills|0|||
27888332|NCT03252522|54531892|FG000|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
27888333|NCT03252522|54531893|FG001|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
27888334|NCT03252522|54531894|FG002|Phase 1: Intervention & Placebo|Commenced stimulant medication|0|||
27888335|NCT03252522|54531892|FG000|Phase 1: Intervention & Placebo|Protocol Violation|1|||
27888336|NCT03252522|54531893|FG001|Phase 1: Intervention & Placebo|Protocol Violation|0|||
27888337|NCT03252522|54531894|FG002|Phase 1: Intervention & Placebo|Protocol Violation|0|||
27888338|NCT03252522|54531892|FG000|Phase 2: Open Label|Commenced stimulant medication|0|||
27888339|NCT03252522|54531893|FG001|Phase 2: Open Label|Commenced stimulant medication|0|||
27888340|NCT03252522|54531894|FG002|Phase 2: Open Label|Commenced stimulant medication|3|||
27888341|NCT03252522|54531892|FG000|Phase 2: Open Label|Lack of Efficacy|0|||
27888342|NCT03252522|54531893|FG001|Phase 2: Open Label|Lack of Efficacy|0|||
27888343|NCT03252522|54531894|FG002|Phase 2: Open Label|Lack of Efficacy|3|||
27888344|NCT03252522|54531892|FG000|Phase 2: Open Label|Adverse Event|0|||
27888345|NCT03252522|54531893|FG001|Phase 2: Open Label|Adverse Event|0|||
27888346|NCT03252522|54531894|FG002|Phase 2: Open Label|Adverse Event|2|||
27888347|NCT03252522|54531892|FG000|Phase 2: Open Label|Lost to Follow-up|0|||
27888348|NCT03252522|54531893|FG001|Phase 2: Open Label|Lost to Follow-up|0|||
27888349|NCT03252522|54531894|FG002|Phase 2: Open Label|Lost to Follow-up|16|||
27888350|NCT02756364|54531909|FG000|Overall Study|Site Terminated by Sponsor|24|||
27888351|NCT02756364|54531910|FG001|Overall Study|Site Terminated by Sponsor|30|||
27888352|NCT02756364|54531911|FG002|Overall Study|Site Terminated by Sponsor|21|||
27888353|NCT02756364|54531909|FG000|Overall Study|Death|20|||
27888354|NCT02756364|54531910|FG001|Overall Study|Death|15|||
27888355|NCT02756364|54531911|FG002|Overall Study|Death|18|||
27888356|NCT02756364|54531909|FG000|Overall Study|Withdrawal by Patient|2|||
27888357|NCT02756364|54531910|FG001|Overall Study|Withdrawal by Patient|1|||
27888358|NCT02756364|54531911|FG002|Overall Study|Withdrawal by Patient|8|||
27888359|NCT02756364|54531909|FG000|Overall Study|Lost to Follow-up|0|||
27888360|NCT02756364|54531910|FG001|Overall Study|Lost to Follow-up|1|||
27888361|NCT02756364|54531911|FG002|Overall Study|Lost to Follow-up|1|||
27888362|NCT02272842|54531921|FG000|Overall Study|Lost to Follow-up|8|||
27888363|NCT02272842|54531922|FG001|Overall Study|Lost to Follow-up|8|||
27888364|NCT02272842|54531921|FG000|Overall Study|Withdrawal by Subject|8|||
27888365|NCT02272842|54531922|FG001|Overall Study|Withdrawal by Subject|2|||
27888366|NCT01906476|54531931|FG000|Overall Study|Lost to Follow-up|17|||
27888367|NCT01906476|54531932|FG001|Overall Study|Lost to Follow-up|16|||
27888368|NCT05343624|54531938|FG000|Overall Study|Chart review not completed|1|||
27888369|NCT04208412|54531980|FG000|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|8|||
27888370|NCT04208412|54531981|FG001|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|5|||
27888371|NCT04208412|54531980|FG000|Overall Study|Withdrawal by Subject|1|||
27888372|NCT04208412|54531981|FG001|Overall Study|Withdrawal by Subject|0|||
27888373|NCT04208412|54531980|FG000|Overall Study|Lost to Follow-up|0|||
27888374|NCT04208412|54531981|FG001|Overall Study|Lost to Follow-up|1|||
27888375|NCT04095858|54531991|FG000|Overall Study|Death|1|||
27888376|NCT04095858|54531992|FG001|Overall Study|Death|0|||
27888377|NCT04095858|54531991|FG000|Overall Study|Study terminated by Sponsor|2|||
27888378|NCT04095858|54531992|FG001|Overall Study|Study terminated by Sponsor|4|||
27888379|NCT03937986|54531998|FG000|Overall Study|COVID-19 Pandemic|1|||
27888380|NCT03738150|54532013|FG000|Base Study|Withdrawal by Subject|1|||
27888381|NCT03738150|54532013|FG000|Extension Study|Withdrawal by Subject|1|||
27888382|NCT03567174|54532029|FG000|Overall Study|Death|24|||
27888383|NCT03567174|54532030|FG001|Overall Study|Death|31|||
27888384|NCT03567174|54532029|FG000|Overall Study|Lost to Follow-up|165|||
27888385|NCT03567174|54532030|FG001|Overall Study|Lost to Follow-up|174|||
27888386|NCT03529110|54532041|FG000|Overall Study|Progressive Disease|66|||
27888387|NCT03529110|54532042|FG001|Overall Study|Progressive Disease|158|||
27888388|NCT03529110|54532041|FG000|Overall Study|Clinical Progression|4|||
27888389|NCT03529110|54532042|FG001|Overall Study|Clinical Progression|12|||
27888390|NCT03529110|54532041|FG000|Overall Study|Adverse Event|35|||
27888391|NCT03529110|54532042|FG001|Overall Study|Adverse Event|17|||
27888392|NCT03529110|54532041|FG000|Overall Study|Withdrawal by Subject (from treatment only)|13|||
27888393|NCT03529110|54532042|FG001|Overall Study|Withdrawal by Subject (from treatment only)|11|||
28096658|NCT03692676|54751818|FG001|Overall Study|exclude patients with prior use of same substances and device|0|||
27888394|NCT03529110|54532041|FG000|Overall Study|Lack of Efficacy|3|||
27888395|NCT03529110|54532042|FG001|Overall Study|Lack of Efficacy|3|||
27888396|NCT03529110|54532041|FG000|Overall Study|Physician Decision|2|||
27888397|NCT03529110|54532042|FG001|Overall Study|Physician Decision|8|||
27888398|NCT03529110|54532041|FG000|Overall Study|Miscellaneous|2|||
27888399|NCT03529110|54532042|FG001|Overall Study|Miscellaneous|5|||
27888400|NCT02663622|54532086|FG000|Overall Study|Death|3|||
27888401|NCT02663622|54532087|FG001|Overall Study|Death|1|||
27888402|NCT02663622|54532088|FG002|Overall Study|Death|1|||
27888403|NCT02663622|54532089|FG003|Overall Study|Death|8|||
27888404|NCT02663622|54532086|FG000|Overall Study|Protocol Violation|0|||
27888405|NCT02663622|54532087|FG001|Overall Study|Protocol Violation|0|||
28171854|NCT02716779|54843458|FG002|Monotherapy|Adverse Event|1|||
27888406|NCT02663622|54532088|FG002|Overall Study|Protocol Violation|0|||
27888407|NCT02663622|54532089|FG003|Overall Study|Protocol Violation|1|||
27888408|NCT02545998|54532115|FG000|Overall Study|Lost to Follow-up|12|||
27888409|NCT02545998|54532116|FG001|Overall Study|Lost to Follow-up|3|||
27888410|NCT02545998|54532115|FG000|Overall Study|Withdrawal by Subject|3|||
27888411|NCT02545998|54532116|FG001|Overall Study|Withdrawal by Subject|2|||
27888412|NCT02257242|54532140|FG000|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|1|||
27888413|NCT02257242|54532141|FG001|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
27888414|NCT02257242|54532142|FG002|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
27888415|NCT02257242|54532143|FG003|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
27888416|NCT02257242|54532144|FG004|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
27888417|NCT02257242|54532145|FG005|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
27888418|NCT02257242|54532146|FG006|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
27888419|NCT02257242|54532147|FG007|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
27888420|NCT02257242|54532148|FG008|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
27888421|NCT01943916|54532178|FG000|Overall Study|Technically invalid images|10|||
27888422|NCT01943916|54532178|FG000|Overall Study|Enrollment Failure|23|||
27888423|NCT01943916|54532178|FG000|Overall Study|Pilot Phase exclusion|100|||
27888424|NCT01943916|54532178|FG000|Overall Study|Quality Assurance Reader Fail|130|||
27888425|NCT01943916|54532178|FG000|Overall Study|Technical Failure|39|||
27888426|NCT01943916|54532178|FG000|Overall Study|Protocol Deviation No Biopsy|25|||
27888427|NCT01943916|54532178|FG000|Overall Study|No Truth Panel Review|38|||
27888428|NCT01943916|54532178|FG000|Overall Study|Protocol Deviation|1|||
27888429|NCT01564368|54532187|FG000|Overall Study|Ineligible|18|||
27888430|NCT01564368|54532187|FG000|Overall Study|Not Randomized in Parent study|116|||
27888431|NCT01564368|54532187|FG000|Overall Study|Baseline Imaging failed QC requirements|9|||
27888432|NCT01564368|54532187|FG000|Overall Study|No Acceptable post-baseline imaging|21|||
27888433|NCT00281658|54532195|FG000|Randomized Phase|Adverse Event|0|||
27888434|NCT00281658|54532196|FG001|Randomized Phase|Adverse Event|2|||
27888435|NCT00281658|54532197|FG002|Randomized Phase|Adverse Event|0|||
27888436|NCT00281658|54532198|FG003|Randomized Phase|Adverse Event|0|||
27888437|NCT00281658|54532195|FG000|Randomized Phase|Lost to Follow-up|34|||
27888438|NCT00281658|54532196|FG001|Randomized Phase|Lost to Follow-up|27|||
27888439|NCT00281658|54532197|FG002|Randomized Phase|Lost to Follow-up|0|||
27888440|NCT00281658|54532198|FG003|Randomized Phase|Lost to Follow-up|0|||
27888441|NCT00281658|54532195|FG000|Randomized Phase|Withdrawal by Subject|8|||
27888442|NCT00281658|54532196|FG001|Randomized Phase|Withdrawal by Subject|7|||
27888443|NCT00281658|54532197|FG002|Randomized Phase|Withdrawal by Subject|0|||
27888444|NCT00281658|54532198|FG003|Randomized Phase|Withdrawal by Subject|0|||
27888445|NCT00281658|54532195|FG000|Randomized Phase|Study closed/terminated|1|||
27888446|NCT00281658|54532196|FG001|Randomized Phase|Study closed/terminated|1|||
27888447|NCT00281658|54532197|FG002|Randomized Phase|Study closed/terminated|0|||
27888448|NCT00281658|54532198|FG003|Randomized Phase|Study closed/terminated|0|||
27888449|NCT00281658|54532195|FG000|Randomized Phase|Disease progression|36|||
27888450|NCT00281658|54532196|FG001|Randomized Phase|Disease progression|27|||
27888451|NCT00281658|54532197|FG002|Randomized Phase|Disease progression|0|||
27888452|NCT00281658|54532198|FG003|Randomized Phase|Disease progression|0|||
27888453|NCT00281658|54532195|FG000|Randomized Phase|Physician Decision|1|||
27888454|NCT00281658|54532196|FG001|Randomized Phase|Physician Decision|1|||
27888455|NCT00281658|54532197|FG002|Randomized Phase|Physician Decision|0|||
27888456|NCT00281658|54532198|FG003|Randomized Phase|Physician Decision|0|||
27888457|NCT00281658|54532195|FG000|Randomized Phase|Other reasons as defined per protocol|4|||
27888458|NCT00281658|54532196|FG001|Randomized Phase|Other reasons as defined per protocol|3|||
27888459|NCT00281658|54532197|FG002|Randomized Phase|Other reasons as defined per protocol|0|||
27888460|NCT00281658|54532198|FG003|Randomized Phase|Other reasons as defined per protocol|0|||
27888461|NCT00281658|54532195|FG000|Randomized Phase|Reason for withdrawal unspecified|4|||
27888462|NCT00281658|54532196|FG001|Randomized Phase|Reason for withdrawal unspecified|5|||
27888463|NCT00281658|54532197|FG002|Randomized Phase|Reason for withdrawal unspecified|0|||
27888464|NCT00281658|54532198|FG003|Randomized Phase|Reason for withdrawal unspecified|0|||
27888465|NCT00281658|54532195|FG000|Randomized Phase|Treatment ongoing|1|||
27888466|NCT00281658|54532196|FG001|Randomized Phase|Treatment ongoing|0|||
27888467|NCT00281658|54532197|FG002|Randomized Phase|Treatment ongoing|0|||
27888468|NCT00281658|54532198|FG003|Randomized Phase|Treatment ongoing|0|||
27888469|NCT00281658|54532195|FG000|Open Label Phase|Adverse Event|0|||
27888470|NCT00281658|54532196|FG001|Open Label Phase|Adverse Event|0|||
27985544|NCT00884286|54644287|FG000|Overall Study|Not treated|2|||
27985545|NCT00884286|54644288|FG001|Overall Study|Not treated|1|||
27985546|NCT00884286|54644287|FG000|Overall Study|Comprised lung carcinoma|0|||
27985547|NCT00884286|54644288|FG001|Overall Study|Comprised lung carcinoma|1|||
27888471|NCT00281658|54532197|FG002|Open Label Phase|Adverse Event|1|||
27888472|NCT00281658|54532198|FG003|Open Label Phase|Adverse Event|0|||
27888473|NCT00281658|54532195|FG000|Open Label Phase|Lost to Follow-up|0|||
27888474|NCT00281658|54532196|FG001|Open Label Phase|Lost to Follow-up|0|||
27888475|NCT00281658|54532197|FG002|Open Label Phase|Lost to Follow-up|16|||
27888476|NCT00281658|54532198|FG003|Open Label Phase|Lost to Follow-up|2|||
27888477|NCT00281658|54532195|FG000|Open Label Phase|Withdrawal by Subject|0|||
27888478|NCT00281658|54532196|FG001|Open Label Phase|Withdrawal by Subject|0|||
27888479|NCT00281658|54532197|FG002|Open Label Phase|Withdrawal by Subject|3|||
27888480|NCT00281658|54532198|FG003|Open Label Phase|Withdrawal by Subject|2|||
27888481|NCT00281658|54532195|FG000|Open Label Phase|Disease progression|0|||
27888482|NCT00281658|54532196|FG001|Open Label Phase|Disease progression|0|||
27888483|NCT00281658|54532197|FG002|Open Label Phase|Disease progression|18|||
27888484|NCT00281658|54532198|FG003|Open Label Phase|Disease progression|0|||
27888485|NCT00281658|54532195|FG000|Open Label Phase|Physician Decision|0|||
27888486|NCT00281658|54532196|FG001|Open Label Phase|Physician Decision|0|||
27888487|NCT00281658|54532197|FG002|Open Label Phase|Physician Decision|1|||
27888488|NCT00281658|54532198|FG003|Open Label Phase|Physician Decision|0|||
27888489|NCT00281658|54532195|FG000|Open Label Phase|Relocation of patient|0|||
27888490|NCT00281658|54532196|FG001|Open Label Phase|Relocation of patient|0|||
27888491|NCT00281658|54532197|FG002|Open Label Phase|Relocation of patient|1|||
27888492|NCT00281658|54532198|FG003|Open Label Phase|Relocation of patient|0|||
27888493|NCT00281658|54532195|FG000|Open Label Phase|Reason for withdrawal unspecified|0|||
27888494|NCT00281658|54532196|FG001|Open Label Phase|Reason for withdrawal unspecified|0|||
27888495|NCT00281658|54532197|FG002|Open Label Phase|Reason for withdrawal unspecified|5|||
27888496|NCT00281658|54532198|FG003|Open Label Phase|Reason for withdrawal unspecified|0|||
27888497|NCT02758626|54533591|FG000|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|1|||
27888498|NCT02758626|54533592|FG001|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|0|||
27888499|NCT02758626|54533591|FG000|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
27888500|NCT02758626|54533592|FG001|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
27888501|NCT02758626|54533591|FG000|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
27888502|NCT02758626|54533592|FG001|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
27888503|NCT02758626|54533591|FG000|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|0|||
27888504|NCT02758626|54533592|FG001|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|1|||
27888505|NCT02357784|54533598|FG000|Overall Study|Withdrawal by Subject|1|||
27888506|NCT01448616|54533605|FG000|Lead-In (Observational Phase)|Collected no genital swabs|3|||
27888507|NCT01448616|54533606|FG001|Lead-In (Observational Phase)|Collected no genital swabs|0|||
27888508|NCT01448616|54533607|FG002|Lead-In (Observational Phase)|Collected no genital swabs|0|||
27888509|NCT01448616|54533608|FG003|Lead-In (Observational Phase)|Collected no genital swabs|0|||
27888510|NCT01448616|54533605|FG000|Lead-In (Observational Phase)|Collected <90% of required swabs|6|||
27888511|NCT01448616|54533606|FG001|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
27888512|NCT01448616|54533607|FG002|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
27888513|NCT01448616|54533608|FG003|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
27888514|NCT01448616|54533605|FG000|Study Drug (Treatment Phase)|Adverse Event|0|||
27888515|NCT01448616|54533606|FG001|Study Drug (Treatment Phase)|Adverse Event|1|||
27888516|NCT01448616|54533607|FG002|Study Drug (Treatment Phase)|Adverse Event|1|||
27888517|NCT01448616|54533608|FG003|Study Drug (Treatment Phase)|Adverse Event|0|||
27888518|NCT01448616|54533605|FG000|Study Drug (Treatment Phase)|Never initiated study drug|0|||
27888519|NCT01448616|54533606|FG001|Study Drug (Treatment Phase)|Never initiated study drug|0|||
27888520|NCT01448616|54533607|FG002|Study Drug (Treatment Phase)|Never initiated study drug|1|||
27888521|NCT01448616|54533608|FG003|Study Drug (Treatment Phase)|Never initiated study drug|2|||
27888522|NCT01448616|54533605|FG000|Study Drug (Treatment Phase)|Withdrawal by Subject|0|||
27888523|NCT01448616|54533606|FG001|Study Drug (Treatment Phase)|Withdrawal by Subject|1|||
27888524|NCT01448616|54533607|FG002|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
27888525|NCT01448616|54533608|FG003|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
27888526|NCT00074412|54533645|FG000|Overall Study|Death|30|||
27888527|NCT00074412|54533646|FG001|Overall Study|Death|26|||
27888528|NCT00074412|54533645|FG000|Overall Study|Lost to Follow-up|52|||
27888529|NCT00074412|54533646|FG001|Overall Study|Lost to Follow-up|58|||
27985548|NCT00873015|54644299|FG000|Overall Study|Withdrawal by Subject|0|||
27985549|NCT00873015|54644300|FG001|Overall Study|Withdrawal by Subject|1|||
27985550|NCT00873015|54644301|FG002|Overall Study|Withdrawal by Subject|0|||
27985551|NCT00873015|54644302|FG003|Overall Study|Withdrawal by Subject|0|||
27985552|NCT03921151|54644317|FG000|Overall Study|Withdrawal by Subject|11|||
27739372|NCT02232178|54188949|FG000|Overall Study|surgical complication|1|||
27739373|NCT02232178|54188950|FG001|Overall Study|surgical complication|0|||
27739374|NCT02232178|54188951|FG002|Overall Study|surgical complication|0|||
27888530|NCT04505592|54534652|FG000|Overall Study|Death|2|||
27888531|NCT04505592|54534653|FG001|Overall Study|Death|1|||
27985553|NCT03921151|54644318|FG001|Overall Study|Withdrawal by Subject|16|||
27739375|NCT01678131|54188962|FG000|Overall Study|Adverse Event|0|||
27888532|NCT04521114|54541030|FG000|Overall Study|Lost to Follow-up|1|||
27888533|NCT04521114|54541031|FG001|Overall Study|Lost to Follow-up|2|||
27888534|NCT04521114|54541032|FG002|Overall Study|Lost to Follow-up|0|||
27888535|NCT04521114|54541030|FG000|Overall Study|Withdrawal by Subject|1|||
27888536|NCT04521114|54541031|FG001|Overall Study|Withdrawal by Subject|2|||
27888537|NCT04521114|54541032|FG002|Overall Study|Withdrawal by Subject|2|||
27888538|NCT04521114|54541030|FG000|Overall Study|Adverse Event|1|||
27888539|NCT04521114|54541031|FG001|Overall Study|Adverse Event|0|||
27888540|NCT04521114|54541032|FG002|Overall Study|Adverse Event|0|||
27888541|NCT04521114|54541030|FG000|Overall Study|Sponsor Wish|1|||
27888542|NCT04521114|54541031|FG001|Overall Study|Sponsor Wish|0|||
27888543|NCT04521114|54541032|FG002|Overall Study|Sponsor Wish|0|||
27888544|NCT04521114|54541030|FG000|Overall Study|Withdrawal of Consent|2|||
27888545|NCT04521114|54541031|FG001|Overall Study|Withdrawal of Consent|2|||
27888546|NCT04521114|54541032|FG002|Overall Study|Withdrawal of Consent|0|||
27888547|NCT04360824|54541054|FG000|Overall Study|Withdrawal by Subject|2|||
27888548|NCT04360824|54541055|FG001|Overall Study|Withdrawal by Subject|1|||
27888549|NCT04360824|54541054|FG000|Overall Study|Did not receive assigned treatment|1|||
27888550|NCT04360824|54541055|FG001|Overall Study|Did not receive assigned treatment|3|||
27888551|NCT03711786|54541064|FG000|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|13|||
27888552|NCT03711786|54541065|FG001|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|4|||
27888553|NCT03711786|54541064|FG000|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|0|||
27888554|NCT03711786|54541065|FG001|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|1|||
27888555|NCT03711786|54541064|FG000|Period 1: Recruited in Study Months 1-5|Death|7|||
27888556|NCT03711786|54541065|FG001|Period 1: Recruited in Study Months 1-5|Death|1|||
27888557|NCT03711786|54541064|FG000|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|17|||
27888558|NCT03711786|54541065|FG001|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|21|||
27888559|NCT03711786|54541064|FG000|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|0|||
27888560|NCT03711786|54541065|FG001|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|5|||
27888561|NCT03711786|54541064|FG000|Period 1: Recruited in Study Months 6-32|Death|5|||
27888562|NCT03711786|54541065|FG001|Period 1: Recruited in Study Months 6-32|Death|4|||
27888563|NCT03691974|54541075|FG000|Overall Study|Physician Decision|1|||
27888564|NCT03691974|54541076|FG001|Overall Study|Physician Decision|0|||
27888565|NCT03691974|54541075|FG000|Overall Study|Adverse Event|1|||
27888566|NCT03691974|54541076|FG001|Overall Study|Adverse Event|0|||
27888567|NCT03691974|54541075|FG000|Overall Study|Withdrawal by Subject|11|||
27888568|NCT03691974|54541076|FG001|Overall Study|Withdrawal by Subject|9|||
27888569|NCT03691974|54541075|FG000|Overall Study|Protocol Violation|1|||
27888570|NCT03691974|54541076|FG001|Overall Study|Protocol Violation|0|||
27888571|NCT03691974|54541075|FG000|Overall Study|Lost to Follow-up|8|||
27888572|NCT03691974|54541076|FG001|Overall Study|Lost to Follow-up|7|||
27888573|NCT03525678|54541097|FG000|Overall Study|Ongoing at the time of interim analysis|60|||
27888574|NCT03525678|54541098|FG001|Overall Study|Ongoing at the time of interim analysis|65|||
27888575|NCT03525678|54541099|FG002|Overall Study|Ongoing at the time of interim analysis|21|||
27888576|NCT03525678|54541097|FG000|Overall Study|Withdrawal by Subject|3|||
27888577|NCT03525678|54541098|FG001|Overall Study|Withdrawal by Subject|1|||
27888578|NCT03525678|54541099|FG002|Overall Study|Withdrawal by Subject|0|||
27888579|NCT03525678|54541097|FG000|Overall Study|Physician Decision|1|||
27888580|NCT03525678|54541098|FG001|Overall Study|Physician Decision|2|||
27888581|NCT03525678|54541099|FG002|Overall Study|Physician Decision|0|||
27888582|NCT03525678|54541097|FG000|Overall Study|Lost to Follow-up|1|||
27888583|NCT03525678|54541098|FG001|Overall Study|Lost to Follow-up|0|||
27888584|NCT03525678|54541099|FG002|Overall Study|Lost to Follow-up|0|||
27888585|NCT03525678|54541097|FG000|Overall Study|Death|32|||
27888586|NCT03525678|54541098|FG001|Overall Study|Death|31|||
27888587|NCT03525678|54541099|FG002|Overall Study|Death|4|||
27888588|NCT02829918|54541107|FG000|Overall Study|Death|2|||
27888589|NCT02829918|54541107|FG000|Overall Study|Withdrawal by Subject|4|||
27888590|NCT02829918|54541107|FG000|Overall Study|Adverse Event|1|||
27888591|NCT02829918|54541107|FG000|Overall Study|Progression|1|||
27888592|NCT02454972|54541120|FG000|Overall Study|Progressive disease|17|||
27985554|NCT00872001|54644330|FG000|Overall Study|Adverse Event|34|||
27985555|NCT00872001|54644331|FG001|Overall Study|Adverse Event|23|||
27739376|NCT01678131|54188963|FG001|Overall Study|Adverse Event|1|||
27888593|NCT02454972|54541121|FG001|Overall Study|Progressive disease|16|||
27888594|NCT02454972|54541122|FG002|Overall Study|Progressive disease|59|||
27888595|NCT02454972|54541123|FG003|Overall Study|Progressive disease|23|||
27888596|NCT02454972|54541124|FG004|Overall Study|Progressive disease|16|||
27888597|NCT02454972|54541125|FG005|Overall Study|Progressive disease|12|||
27888598|NCT02454972|54541126|FG006|Overall Study|Progressive disease|19|||
27888599|NCT02454972|54541127|FG007|Overall Study|Progressive disease|27|||
27888600|NCT02454972|54541128|FG008|Overall Study|Progressive disease|0|||
27888601|NCT02454972|54541120|FG000|Overall Study|Death|0|||
27888602|NCT02454972|54541121|FG001|Overall Study|Death|0|||
27888603|NCT02454972|54541122|FG002|Overall Study|Death|5|||
27888604|NCT02454972|54541123|FG003|Overall Study|Death|1|||
27985556|NCT00872001|54644330|FG000|Overall Study|Protocol Defined Clinical Event|5|||
27888605|NCT02454972|54541124|FG004|Overall Study|Death|0|||
27888606|NCT02454972|54541125|FG005|Overall Study|Death|0|||
27888607|NCT02454972|54541126|FG006|Overall Study|Death|0|||
27888608|NCT02454972|54541127|FG007|Overall Study|Death|0|||
27888609|NCT02454972|54541128|FG008|Overall Study|Death|95|||
27888610|NCT02454972|54541120|FG000|Overall Study|Physician Decision|0|||
27888611|NCT02454972|54541121|FG001|Overall Study|Physician Decision|1|||
27888612|NCT02454972|54541122|FG002|Overall Study|Physician Decision|2|||
27888613|NCT02454972|54541123|FG003|Overall Study|Physician Decision|1|||
27888614|NCT02454972|54541124|FG004|Overall Study|Physician Decision|2|||
27888615|NCT02454972|54541125|FG005|Overall Study|Physician Decision|0|||
27888616|NCT02454972|54541126|FG006|Overall Study|Physician Decision|0|||
27888617|NCT02454972|54541127|FG007|Overall Study|Physician Decision|1|||
27888618|NCT02454972|54541128|FG008|Overall Study|Physician Decision|0|||
27888619|NCT02454972|54541120|FG000|Overall Study|Non treatment-related adverse event|2|||
27888620|NCT02454972|54541121|FG001|Overall Study|Non treatment-related adverse event|0|||
27888621|NCT02454972|54541122|FG002|Overall Study|Non treatment-related adverse event|1|||
27888622|NCT02454972|54541123|FG003|Overall Study|Non treatment-related adverse event|0|||
27888623|NCT02454972|54541124|FG004|Overall Study|Non treatment-related adverse event|0|||
27888624|NCT02454972|54541125|FG005|Overall Study|Non treatment-related adverse event|1|||
27888625|NCT02454972|54541126|FG006|Overall Study|Non treatment-related adverse event|0|||
27888626|NCT02454972|54541127|FG007|Overall Study|Non treatment-related adverse event|1|||
27888627|NCT02454972|54541128|FG008|Overall Study|Non treatment-related adverse event|0|||
27888628|NCT02454972|54541120|FG000|Overall Study|Treatment-related adverse events|0|||
27888629|NCT02454972|54541121|FG001|Overall Study|Treatment-related adverse events|1|||
27888630|NCT02454972|54541122|FG002|Overall Study|Treatment-related adverse events|1|||
27888631|NCT02454972|54541123|FG003|Overall Study|Treatment-related adverse events|0|||
27888632|NCT02454972|54541124|FG004|Overall Study|Treatment-related adverse events|2|||
27888633|NCT02454972|54541125|FG005|Overall Study|Treatment-related adverse events|0|||
27888634|NCT02454972|54541126|FG006|Overall Study|Treatment-related adverse events|0|||
27888635|NCT02454972|54541127|FG007|Overall Study|Treatment-related adverse events|2|||
27888636|NCT02454972|54541128|FG008|Overall Study|Treatment-related adverse events|0|||
27888637|NCT02454972|54541120|FG000|Overall Study|Patient moves to compassionate use|0|||
27888638|NCT02454972|54541121|FG001|Overall Study|Patient moves to compassionate use|0|||
27888639|NCT02454972|54541122|FG002|Overall Study|Patient moves to compassionate use|0|||
27888640|NCT02454972|54541123|FG003|Overall Study|Patient moves to compassionate use|0|||
27888641|NCT02454972|54541124|FG004|Overall Study|Patient moves to compassionate use|0|||
27888642|NCT02454972|54541125|FG005|Overall Study|Patient moves to compassionate use|0|||
27888643|NCT02454972|54541126|FG006|Overall Study|Patient moves to compassionate use|2|||
27888644|NCT02454972|54541127|FG007|Overall Study|Patient moves to compassionate use|0|||
27888645|NCT02454972|54541128|FG008|Overall Study|Patient moves to compassionate use|0|||
27888646|NCT02454972|54541120|FG000|Overall Study|Withdrawal by Subject|0|||
27888647|NCT02454972|54541121|FG001|Overall Study|Withdrawal by Subject|1|||
27888648|NCT02454972|54541122|FG002|Overall Study|Withdrawal by Subject|5|||
27888649|NCT02454972|54541123|FG003|Overall Study|Withdrawal by Subject|2|||
27888650|NCT02454972|54541124|FG004|Overall Study|Withdrawal by Subject|3|||
27888651|NCT02454972|54541125|FG005|Overall Study|Withdrawal by Subject|2|||
27888652|NCT02454972|54541126|FG006|Overall Study|Withdrawal by Subject|0|||
27888653|NCT02454972|54541127|FG007|Overall Study|Withdrawal by Subject|1|||
27888654|NCT02454972|54541128|FG008|Overall Study|Withdrawal by Subject|2|||
27888655|NCT02454972|54541120|FG000|Overall Study|Multiple delay/holds on treatment|0|||
27888656|NCT02454972|54541121|FG001|Overall Study|Multiple delay/holds on treatment|0|||
27888657|NCT02454972|54541122|FG002|Overall Study|Multiple delay/holds on treatment|0|||
27888658|NCT02454972|54541123|FG003|Overall Study|Multiple delay/holds on treatment|1|||
27888659|NCT02454972|54541124|FG004|Overall Study|Multiple delay/holds on treatment|0|||
27888660|NCT02454972|54541125|FG005|Overall Study|Multiple delay/holds on treatment|0|||
27888661|NCT02454972|54541126|FG006|Overall Study|Multiple delay/holds on treatment|0|||
27888662|NCT02454972|54541127|FG007|Overall Study|Multiple delay/holds on treatment|0|||
27888663|NCT02454972|54541128|FG008|Overall Study|Multiple delay/holds on treatment|0|||
27888664|NCT02454972|54541120|FG000|Overall Study|Never treated|0|||
27888665|NCT02454972|54541121|FG001|Overall Study|Never treated|0|||
27888666|NCT02454972|54541122|FG002|Overall Study|Never treated|3|||
27888667|NCT02454972|54541123|FG003|Overall Study|Never treated|1|||
27888668|NCT02454972|54541124|FG004|Overall Study|Never treated|1|||
27888669|NCT02454972|54541125|FG005|Overall Study|Never treated|0|||
27888670|NCT02454972|54541126|FG006|Overall Study|Never treated|0|||
27888671|NCT02454972|54541127|FG007|Overall Study|Never treated|0|||
27888672|NCT02454972|54541128|FG008|Overall Study|Never treated|5|||
27888673|NCT02454972|54541120|FG000|Overall Study|Lost to Follow-up|0|||
27888674|NCT02454972|54541121|FG001|Overall Study|Lost to Follow-up|0|||
27888675|NCT02454972|54541122|FG002|Overall Study|Lost to Follow-up|0|||
27888676|NCT02454972|54541123|FG003|Overall Study|Lost to Follow-up|0|||
27888677|NCT02454972|54541124|FG004|Overall Study|Lost to Follow-up|0|||
27888678|NCT02454972|54541125|FG005|Overall Study|Lost to Follow-up|0|||
27888679|NCT02454972|54541126|FG006|Overall Study|Lost to Follow-up|0|||
27888680|NCT02454972|54541127|FG007|Overall Study|Lost to Follow-up|0|||
27888681|NCT02454972|54541128|FG008|Overall Study|Lost to Follow-up|2|||
27888682|NCT02454972|54541120|FG000|Overall Study|Study termination|0|||
27888683|NCT02454972|54541121|FG001|Overall Study|Study termination|0|||
27888684|NCT02454972|54541122|FG002|Overall Study|Study termination|0|||
27888685|NCT02454972|54541123|FG003|Overall Study|Study termination|0|||
27888686|NCT02454972|54541124|FG004|Overall Study|Study termination|0|||
27888687|NCT02454972|54541125|FG005|Overall Study|Study termination|0|||
27888688|NCT02454972|54541126|FG006|Overall Study|Study termination|0|||
27888689|NCT02454972|54541127|FG007|Overall Study|Study termination|0|||
27888690|NCT02454972|54541128|FG008|Overall Study|Study termination|6|||
27888691|NCT01096368|54541145|FG000|Overall Study|Death|0|||
27888692|NCT01096368|54541146|FG001|Overall Study|Death|1|||
27888693|NCT01096368|54541147|FG002|Overall Study|Death|0|||
27888694|NCT01096368|54541148|FG003|Overall Study|Death|0|||
27888695|NCT01096368|54541149|FG004|Overall Study|Death|0|||
27888696|NCT01096368|54541145|FG000|Overall Study|Physician Decision|0|||
27888697|NCT01096368|54541146|FG001|Overall Study|Physician Decision|13|||
27888698|NCT01096368|54541147|FG002|Overall Study|Physician Decision|2|||
27888699|NCT01096368|54541148|FG003|Overall Study|Physician Decision|4|||
27888700|NCT01096368|54541149|FG004|Overall Study|Physician Decision|6|||
27888701|NCT01096368|54541145|FG000|Overall Study|Withdrawal by Subject|0|||
27888702|NCT01096368|54541146|FG001|Overall Study|Withdrawal by Subject|52|||
27888703|NCT01096368|54541147|FG002|Overall Study|Withdrawal by Subject|0|||
27888704|NCT01096368|54541148|FG003|Overall Study|Withdrawal by Subject|10|||
27888705|NCT01096368|54541149|FG004|Overall Study|Withdrawal by Subject|14|||
27888706|NCT01096368|54541145|FG000|Overall Study|Ineligible|0|||
27888707|NCT01096368|54541146|FG001|Overall Study|Ineligible|3|||
27888708|NCT01096368|54541147|FG002|Overall Study|Ineligible|2|||
27888709|NCT01096368|54541148|FG003|Overall Study|Ineligible|0|||
27888710|NCT01096368|54541149|FG004|Overall Study|Ineligible|25|||
27888711|NCT01096368|54541145|FG000|Overall Study|Did not start treatment|0|||
27888712|NCT01096368|54541146|FG001|Overall Study|Did not start treatment|4|||
27888713|NCT01096368|54541147|FG002|Overall Study|Did not start treatment|4|||
27888714|NCT01096368|54541148|FG003|Overall Study|Did not start treatment|0|||
27888715|NCT01096368|54541149|FG004|Overall Study|Did not start treatment|0|||
27888716|NCT01096368|54541145|FG000|Overall Study|Progressive disease|0|||
27888717|NCT01096368|54541146|FG001|Overall Study|Progressive disease|6|||
27888718|NCT01096368|54541147|FG002|Overall Study|Progressive disease|0|||
27888719|NCT01096368|54541148|FG003|Overall Study|Progressive disease|10|||
27888720|NCT01096368|54541149|FG004|Overall Study|Progressive disease|3|||
27888721|NCT01096368|54541145|FG000|Overall Study|Other|0|||
27888722|NCT01096368|54541146|FG001|Overall Study|Other|0|||
27888723|NCT01096368|54541147|FG002|Overall Study|Other|1|||
27888724|NCT01096368|54541148|FG003|Overall Study|Other|0|||
27888725|NCT01096368|54541149|FG004|Overall Study|Other|0|||
27888726|NCT01096368|54541145|FG000|Overall Study|Treated with institutional review|0|||
27888727|NCT01096368|54541146|FG001|Overall Study|Treated with institutional review|0|||
27888728|NCT01096368|54541147|FG002|Overall Study|Treated with institutional review|0|||
27888729|NCT01096368|54541148|FG003|Overall Study|Treated with institutional review|0|||
27888730|NCT01096368|54541149|FG004|Overall Study|Treated with institutional review|1|||
27888731|NCT00063882|54541170|FG000|Overall Study|Protocol Violation|3|||
27888732|NCT00063882|54541171|FG001|Overall Study|Protocol Violation|3|||
27888733|NCT00063882|54541170|FG000|Overall Study|Withdrawal by Subject|2|||
27888734|NCT00063882|54541171|FG001|Overall Study|Withdrawal by Subject|1|||
27888735|NCT01279044|54541180|FG000|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0|||
27888736|NCT01279044|54541181|FG001|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3|||
27888737|NCT01279044|54541182|FG002|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2|||
27888738|NCT01279044|54541180|FG000|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
27888739|NCT01279044|54541181|FG001|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8|||
27888740|NCT01279044|54541182|FG002|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
27888741|NCT01279044|54541180|FG000|PHASE 2 - Randmonized Controlled Trial|Death|0|||
27888742|NCT01279044|54541181|FG001|PHASE 2 - Randmonized Controlled Trial|Death|0|||
27888743|NCT01279044|54541182|FG002|PHASE 2 - Randmonized Controlled Trial|Death|1|||
27888744|NCT01278342|54541191|FG000|Overall Study|Physician Decision|0|||
27888745|NCT01278342|54541192|FG001|Overall Study|Physician Decision|1|||
27888746|NCT01278342|54541193|FG002|Overall Study|Physician Decision|0|||
27888747|NCT01278342|54541191|FG000|Overall Study|Lost to Follow-up|1|||
27888748|NCT01278342|54541192|FG001|Overall Study|Lost to Follow-up|0|||
27888749|NCT01278342|54541193|FG002|Overall Study|Lost to Follow-up|0|||
27888750|NCT01278342|54541191|FG000|Overall Study|Administrative problems|2|||
27888751|NCT01278342|54541192|FG001|Overall Study|Administrative problems|0|||
27888752|NCT01278342|54541193|FG002|Overall Study|Administrative problems|0|||
27888753|NCT01278342|54541191|FG000|Overall Study|Other|1|||
27888754|NCT01278342|54541192|FG001|Overall Study|Other|0|||
27888755|NCT01278342|54541193|FG002|Overall Study|Other|0|||
27888756|NCT01278030|54541203|FG000|Overall Study|Withdrawal by Subject|8|||
27888757|NCT01278030|54541204|FG001|Overall Study|Withdrawal by Subject|4|||
27888758|NCT01277718|54541210|FG000|Period 2 - Second Intervention|Protocol Violation|0|||
27888759|NCT01277718|54541211|FG001|Period 2 - Second Intervention|Protocol Violation|1|||
27888760|NCT01277718|54541210|FG000|Period 2 - Second Intervention|Physician Decision|0|||
27888761|NCT01277718|54541211|FG001|Period 2 - Second Intervention|Physician Decision|2|||
27888762|NCT01276236|54541219|FG000|Overall Study|Lack of Efficacy|2|||
27888763|NCT01276236|54541219|FG000|Overall Study|Withdrawal by Subject|4|||
27888764|NCT01275222|54541229|FG000|Phase l by Treatment|Adverse Event|1|||
27888765|NCT01275222|54541230|FG001|Phase l by Treatment|Adverse Event|4|||
27888766|NCT01275222|54541231|FG002|Phase l by Treatment|Adverse Event|2|||
27888767|NCT01275222|54541232|FG003|Phase l by Treatment|Adverse Event|3|||
27888768|NCT01275222|54541233|FG004|Phase l by Treatment|Adverse Event|0|||
27888769|NCT01275222|54541234|FG005|Phase l by Treatment|Adverse Event|0|||
27888770|NCT01275222|54541229|FG000|Phase l by Treatment|Abnormal laboratory value(s)|0|||
27888771|NCT01275222|54541230|FG001|Phase l by Treatment|Abnormal laboratory value(s)|0|||
27888772|NCT01275222|54541231|FG002|Phase l by Treatment|Abnormal laboratory value(s)|1|||
27888773|NCT01275222|54541232|FG003|Phase l by Treatment|Abnormal laboratory value(s)|0|||
27888774|NCT01275222|54541233|FG004|Phase l by Treatment|Abnormal laboratory value(s)|0|||
27888775|NCT01275222|54541234|FG005|Phase l by Treatment|Abnormal laboratory value(s)|0|||
27888776|NCT01275222|54541229|FG000|Phase l by Treatment|Abnormal test procedure result(s)|0|||
27888777|NCT01275222|54541230|FG001|Phase l by Treatment|Abnormal test procedure result(s)|0|||
27888778|NCT01275222|54541231|FG002|Phase l by Treatment|Abnormal test procedure result(s)|0|||
27888779|NCT01275222|54541232|FG003|Phase l by Treatment|Abnormal test procedure result(s)|1|||
27888780|NCT01275222|54541233|FG004|Phase l by Treatment|Abnormal test procedure result(s)|0|||
27888781|NCT01275222|54541234|FG005|Phase l by Treatment|Abnormal test procedure result(s)|0|||
27888782|NCT01275222|54541229|FG000|Phase l by Treatment|Disease progression|12|||
27888783|NCT01275222|54541230|FG001|Phase l by Treatment|Disease progression|8|||
27888784|NCT01275222|54541231|FG002|Phase l by Treatment|Disease progression|2|||
27888785|NCT01275222|54541232|FG003|Phase l by Treatment|Disease progression|5|||
27888786|NCT01275222|54541233|FG004|Phase l by Treatment|Disease progression|0|||
27888787|NCT01275222|54541234|FG005|Phase l by Treatment|Disease progression|0|||
27888788|NCT01275222|54541229|FG000|Phase l by Treatment|Withdrawal by Subject|0|||
27888789|NCT01275222|54541230|FG001|Phase l by Treatment|Withdrawal by Subject|0|||
27888790|NCT01275222|54541231|FG002|Phase l by Treatment|Withdrawal by Subject|0|||
27888791|NCT01275222|54541232|FG003|Phase l by Treatment|Withdrawal by Subject|1|||
27888792|NCT01275222|54541233|FG004|Phase l by Treatment|Withdrawal by Subject|0|||
27888793|NCT01275222|54541234|FG005|Phase l by Treatment|Withdrawal by Subject|0|||
27888794|NCT01275222|54541229|FG000|Phase l by Treatment|Death|0|||
27888795|NCT01275222|54541230|FG001|Phase l by Treatment|Death|1|||
27888796|NCT01275222|54541231|FG002|Phase l by Treatment|Death|0|||
27888797|NCT01275222|54541232|FG003|Phase l by Treatment|Death|1|||
27888798|NCT01275222|54541233|FG004|Phase l by Treatment|Death|0|||
27888799|NCT01275222|54541234|FG005|Phase l by Treatment|Death|0|||
27888800|NCT01275222|54541229|FG000|Phase ll by Stratum|Adverse Event|0|||
27888801|NCT01275222|54541230|FG001|Phase ll by Stratum|Adverse Event|0|||
27888802|NCT01275222|54541231|FG002|Phase ll by Stratum|Adverse Event|0|||
27888803|NCT01275222|54541232|FG003|Phase ll by Stratum|Adverse Event|0|||
27888804|NCT01275222|54541233|FG004|Phase ll by Stratum|Adverse Event|2|||
27888805|NCT01275222|54541234|FG005|Phase ll by Stratum|Adverse Event|10|||
27888806|NCT01275222|54541229|FG000|Phase ll by Stratum|Abnormal laboratory values|0|||
27888807|NCT01275222|54541230|FG001|Phase ll by Stratum|Abnormal laboratory values|0|||
27888808|NCT01275222|54541231|FG002|Phase ll by Stratum|Abnormal laboratory values|0|||
27888809|NCT01275222|54541232|FG003|Phase ll by Stratum|Abnormal laboratory values|0|||
27888810|NCT01275222|54541233|FG004|Phase ll by Stratum|Abnormal laboratory values|0|||
27888811|NCT01275222|54541234|FG005|Phase ll by Stratum|Abnormal laboratory values|1|||
27888812|NCT01275222|54541229|FG000|Phase ll by Stratum|Disease progression|0|||
27888813|NCT01275222|54541230|FG001|Phase ll by Stratum|Disease progression|0|||
27888814|NCT01275222|54541231|FG002|Phase ll by Stratum|Disease progression|0|||
27888815|NCT01275222|54541232|FG003|Phase ll by Stratum|Disease progression|0|||
27888816|NCT01275222|54541233|FG004|Phase ll by Stratum|Disease progression|23|||
27888817|NCT01275222|54541234|FG005|Phase ll by Stratum|Disease progression|31|||
27888818|NCT01275222|54541229|FG000|Phase ll by Stratum|Withdrawal by Subject|0|||
27888819|NCT01275222|54541230|FG001|Phase ll by Stratum|Withdrawal by Subject|0|||
27888820|NCT01275222|54541231|FG002|Phase ll by Stratum|Withdrawal by Subject|0|||
27888821|NCT01275222|54541232|FG003|Phase ll by Stratum|Withdrawal by Subject|0|||
27888822|NCT01275222|54541233|FG004|Phase ll by Stratum|Withdrawal by Subject|2|||
27888823|NCT01275222|54541234|FG005|Phase ll by Stratum|Withdrawal by Subject|3|||
27888824|NCT01275222|54541229|FG000|Phase ll by Stratum|Death|0|||
27888825|NCT01275222|54541230|FG001|Phase ll by Stratum|Death|0|||
27888826|NCT01275222|54541231|FG002|Phase ll by Stratum|Death|0|||
27888827|NCT01275222|54541232|FG003|Phase ll by Stratum|Death|0|||
27888828|NCT01275222|54541233|FG004|Phase ll by Stratum|Death|1|||
27888829|NCT01275222|54541234|FG005|Phase ll by Stratum|Death|1|||
27888830|NCT01275144|54541252|FG000|Second Intervention (6 Days)|Withdrawal by Subject|1|||
27888831|NCT01275144|54541253|FG001|Second Intervention (6 Days)|Withdrawal by Subject|0|||
27888832|NCT01275066|54541264|FG000|Overall Study|Withdrawal by Subject|0|||
27888833|NCT01275066|54541265|FG001|Overall Study|Withdrawal by Subject|0|||
27888834|NCT01275066|54541266|FG002|Overall Study|Withdrawal by Subject|1|||
27888835|NCT01275066|54541264|FG000|Overall Study|Not Diagnosed w/ Disease|1|||
27888836|NCT01275066|54541265|FG001|Overall Study|Not Diagnosed w/ Disease|0|||
27888837|NCT01275066|54541266|FG002|Overall Study|Not Diagnosed w/ Disease|0|||
27888838|NCT01273038|54541276|FG000|Second Intervention (14 Days)|Adverse Event|0|||
27888839|NCT01273038|54541277|FG001|Second Intervention (14 Days)|Adverse Event|1|||
27888840|NCT01273038|54541276|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
27888841|NCT01273038|54541277|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
27888842|NCT01272180|54541287|FG000|Overall Study|Adverse Event|0|||
27888843|NCT01272180|54541288|FG001|Overall Study|Adverse Event|0|||
27888844|NCT01272180|54541289|FG002|Overall Study|Adverse Event|1|||
27888845|NCT01272180|54541290|FG003|Overall Study|Adverse Event|0|||
27888846|NCT01272180|54541287|FG000|Overall Study|Withdrawal by Subject|2|||
27888847|NCT01272180|54541288|FG001|Overall Study|Withdrawal by Subject|6|||
27888848|NCT01272180|54541289|FG002|Overall Study|Withdrawal by Subject|3|||
27888849|NCT01272180|54541290|FG003|Overall Study|Withdrawal by Subject|2|||
27888850|NCT01272180|54541287|FG000|Overall Study|Lost to Follow-up|15|||
27888851|NCT01272180|54541288|FG001|Overall Study|Lost to Follow-up|14|||
27888852|NCT01272180|54541289|FG002|Overall Study|Lost to Follow-up|8|||
27888853|NCT01272180|54541290|FG003|Overall Study|Lost to Follow-up|10|||
27888854|NCT01272180|54541287|FG000|Overall Study|Inappropriate enrollment|0|||
27888855|NCT01272180|54541288|FG001|Overall Study|Inappropriate enrollment|0|||
27888856|NCT01272180|54541289|FG002|Overall Study|Inappropriate enrollment|1|||
27888857|NCT01272180|54541290|FG003|Overall Study|Inappropriate enrollment|1|||
27888858|NCT01272180|54541287|FG000|Overall Study|Protocol Violation|0|||
27888859|NCT01272180|54541288|FG001|Overall Study|Protocol Violation|1|||
27888860|NCT01272180|54541289|FG002|Overall Study|Protocol Violation|0|||
27888861|NCT01272180|54541290|FG003|Overall Study|Protocol Violation|1|||
27888862|NCT01271712|54541306|FG000|Double Blind Treatment|Death|2|||
27888863|NCT01271712|54541307|FG001|Double Blind Treatment|Death|0|||
27888864|NCT01271712|54541306|FG000|Double Blind Treatment|Lack of Efficacy|1|||
27888865|NCT01271712|54541307|FG001|Double Blind Treatment|Lack of Efficacy|0|||
27888866|NCT01271712|54541306|FG000|Double Blind Treatment|Adverse Event|9|||
27888867|NCT01271712|54541307|FG001|Double Blind Treatment|Adverse Event|4|||
27888868|NCT01271712|54541306|FG000|Double Blind Treatment|Progressive disease|23|||
27888869|NCT01271712|54541307|FG001|Double Blind Treatment|Progressive disease|3|||
27888870|NCT01271712|54541306|FG000|Double Blind Treatment|Withdrawal by Subject|4|||
27888871|NCT01271712|54541307|FG001|Double Blind Treatment|Withdrawal by Subject|1|||
27888872|NCT01271712|54541306|FG000|Double Blind Treatment|Non compliance with study drug|2|||
27888873|NCT01271712|54541307|FG001|Double Blind Treatment|Non compliance with study drug|0|||
27888874|NCT01271712|54541306|FG000|Double Blind Treatment|receive no study drug|1|||
27888875|NCT01271712|54541307|FG001|Double Blind Treatment|receive no study drug|0|||
27888876|NCT01271712|54541306|FG000|Open Label Treatment|Death|6|||
27888877|NCT01271712|54541307|FG001|Open Label Treatment|Death|5|||
27888878|NCT01271712|54541306|FG000|Open Label Treatment|Withdrawal by Subject|6|||
27739377|NCT01678131|54188964|FG002|Overall Study|Adverse Event|0|||
27739378|NCT01678131|54188962|FG000|Overall Study|Withdrawal by Subject|0|||
27888879|NCT01271712|54541307|FG001|Open Label Treatment|Withdrawal by Subject|11|||
27888880|NCT01271712|54541306|FG000|Open Label Treatment|Physician Decision|2|||
27888881|NCT01271712|54541307|FG001|Open Label Treatment|Physician Decision|0|||
27888882|NCT01271712|54541306|FG000|Open Label Treatment|Adverse Event|14|||
27888883|NCT01271712|54541307|FG001|Open Label Treatment|Adverse Event|8|||
27888884|NCT01271712|54541306|FG000|Open Label Treatment|Progressive disease|59|||
27888885|NCT01271712|54541307|FG001|Open Label Treatment|Progressive disease|32|||
27888886|NCT01271712|54541306|FG000|Open Label Treatment|transferred to rollover study|1|||
27888887|NCT01271712|54541307|FG001|Open Label Treatment|transferred to rollover study|0|||
27888888|NCT01271712|54541306|FG000|Open Label Treatment|Non-compliance with study drug|1|||
27888889|NCT01271712|54541307|FG001|Open Label Treatment|Non-compliance with study drug|0|||
27888890|NCT01271712|54541306|FG000|Open Label Treatment|Protocol Violation|0|||
27888891|NCT01271712|54541307|FG001|Open Label Treatment|Protocol Violation|1|||
27888892|NCT01271712|54541306|FG000|Open Label Treatment|Switching to other therapy|2|||
27888893|NCT01271712|54541307|FG001|Open Label Treatment|Switching to other therapy|1|||
27888894|NCT01271712|54541306|FG000|Safety Follow-up|Death|11|||
27888895|NCT01271712|54541307|FG001|Safety Follow-up|Death|7|||
27888896|NCT01271712|54541306|FG000|Safety Follow-up|Withdrawal by Subject|4|||
27888897|NCT01271712|54541307|FG001|Safety Follow-up|Withdrawal by Subject|2|||
27888898|NCT01271712|54541306|FG000|Safety Follow-up|Protocol Violation|1|||
27888899|NCT01271712|54541307|FG001|Safety Follow-up|Protocol Violation|1|||
27888900|NCT01271712|54541306|FG000|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3|||
27888901|NCT01271712|54541307|FG001|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4|||
27888902|NCT01271712|54541306|FG000|Safety Follow-up|No follow-up|1|||
27888903|NCT01271712|54541307|FG001|Safety Follow-up|No follow-up|1|||
27925754|NCT01230489|54582311|FG000|Overall Study|Death|2|||
27888904|NCT01271712|54541306|FG000|Safety Follow-up|Progressive disease|1|||
27888905|NCT01271712|54541307|FG001|Safety Follow-up|Progressive disease|0|||
27888906|NCT01271712|54541306|FG000|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15|||
27888907|NCT01271712|54541307|FG001|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6|||
27888908|NCT01271010|54541316|FG000|Overall Study|Reason not specified|11|||
27888909|NCT01271010|54541316|FG000|Overall Study|Start of new CLL therapy|1|||
27888910|NCT01271010|54541316|FG000|Overall Study|Protocol Violation|1|||
27888911|NCT01271010|54541316|FG000|Overall Study|Death|2|||
27888912|NCT01271010|54541316|FG000|Overall Study|Progression and relapse of disease|1|||
27888913|NCT01271010|54541316|FG000|Overall Study|Withdrawal by Subject|18|||
27888914|NCT01271010|54541316|FG000|Overall Study|Disease progression|27|||
27888915|NCT01270620|54541322|FG000|Overall Study|Withdrawal by Subject|1|||
27888916|NCT01270620|54541323|FG001|Overall Study|Withdrawal by Subject|3|||
27888917|NCT01270464|54541338|FG000|Overall Study|Protocol Violation|4|||
27888918|NCT01270464|54541339|FG001|Overall Study|Protocol Violation|3|||
27888919|NCT01270464|54541340|FG002|Overall Study|Protocol Violation|2|||
27888920|NCT01270464|54541338|FG000|Overall Study|Lack of Efficacy|2|||
27888921|NCT01270464|54541339|FG001|Overall Study|Lack of Efficacy|3|||
27888922|NCT01270464|54541340|FG002|Overall Study|Lack of Efficacy|1|||
27888923|NCT01270464|54541338|FG000|Overall Study|Adverse Event|9|||
27888924|NCT01270464|54541339|FG001|Overall Study|Adverse Event|1|||
27888925|NCT01270464|54541340|FG002|Overall Study|Adverse Event|7|||
27888926|NCT01270464|54541338|FG000|Overall Study|Withdrawal by Subject|2|||
27888927|NCT01270464|54541339|FG001|Overall Study|Withdrawal by Subject|1|||
27888928|NCT01270464|54541340|FG002|Overall Study|Withdrawal by Subject|4|||
27888929|NCT01270464|54541338|FG000|Overall Study|Lost to Follow-up|2|||
27888930|NCT01270464|54541339|FG001|Overall Study|Lost to Follow-up|3|||
27888931|NCT01270464|54541340|FG002|Overall Study|Lost to Follow-up|1|||
27888932|NCT01270464|54541338|FG000|Overall Study|Other|1|||
27888933|NCT01270464|54541339|FG001|Overall Study|Other|1|||
27888934|NCT01270464|54541340|FG002|Overall Study|Other|3|||
27888935|NCT00249834|54541356|FG000|Overall Study|Ovarian stimulation failed|1|||
27888936|NCT00249834|54541357|FG001|Overall Study|Ovarian stimulation failed|0|||
27888937|NCT00249834|54541358|FG002|Overall Study|Ovarian stimulation failed|0|||
27888938|NCT00249834|54541359|FG003|Overall Study|Ovarian stimulation failed|0|||
27888939|NCT00249834|54541360|FG004|Overall Study|Ovarian stimulation failed|0|||
27888940|NCT00249834|54541361|FG005|Overall Study|Ovarian stimulation failed|0|||
27888941|NCT00249834|54541362|FG006|Overall Study|Ovarian stimulation failed|0|||
27888942|NCT00249834|54541363|FG007|Overall Study|Ovarian stimulation failed|0|||
27888943|NCT00249834|54541356|FG000|Overall Study|Failure of down-regulation|0|||
27888944|NCT00249834|54541357|FG001|Overall Study|Failure of down-regulation|0|||
27888945|NCT00249834|54541358|FG002|Overall Study|Failure of down-regulation|0|||
27888946|NCT00249834|54541359|FG003|Overall Study|Failure of down-regulation|0|||
27888947|NCT00249834|54541360|FG004|Overall Study|Failure of down-regulation|0|||
27888948|NCT00249834|54541361|FG005|Overall Study|Failure of down-regulation|0|||
27888949|NCT00249834|54541362|FG006|Overall Study|Failure of down-regulation|1|||
27888950|NCT00249834|54541363|FG007|Overall Study|Failure of down-regulation|0|||
27888951|NCT00249834|54541356|FG000|Overall Study|Protocol Violation|0|||
27888952|NCT00249834|54541357|FG001|Overall Study|Protocol Violation|19|||
27888953|NCT00249834|54541358|FG002|Overall Study|Protocol Violation|14|||
27888954|NCT00249834|54541359|FG003|Overall Study|Protocol Violation|8|||
27888955|NCT00249834|54541360|FG004|Overall Study|Protocol Violation|5|||
27888956|NCT00249834|54541361|FG005|Overall Study|Protocol Violation|2|||
27888957|NCT00249834|54541362|FG006|Overall Study|Protocol Violation|0|||
27888958|NCT00249834|54541363|FG007|Overall Study|Protocol Violation|0|||
27888959|NCT00249444|54541377|FG000|Overall Study|Lost to Follow-up|2|||
27888960|NCT00249444|54541378|FG001|Overall Study|Lost to Follow-up|2|||
27888961|NCT00249444|54541377|FG000|Overall Study|non-compliant|9|||
27888962|NCT00249444|54541378|FG001|Overall Study|non-compliant|11|||
28171855|NCT02716779|54843456|FG000|Combination Therapy|Adverse Event|0|||
27888963|NCT00249444|54541377|FG000|Overall Study|Adverse Event|1|||
27888964|NCT00249444|54541378|FG001|Overall Study|Adverse Event|1|||
27888965|NCT00249444|54541377|FG000|Overall Study|life event|0|||
27888966|NCT00249444|54541378|FG001|Overall Study|life event|1|||
27888967|NCT00249288|54541386|FG000|Overall Study|Lost to Follow-up|3|||
27888968|NCT00249288|54541387|FG001|Overall Study|Lost to Follow-up|3|||
27888969|NCT00249288|54541386|FG000|Overall Study|Withdrawal by Subject|2|||
27888970|NCT00249288|54541387|FG001|Overall Study|Withdrawal by Subject|2|||
27888971|NCT00248040|54541404|FG000|Overall Study|transplantectomy|2|||
27888972|NCT00248040|54541405|FG001|Overall Study|transplantectomy|1|||
28171856|NCT02716779|54843457|FG001|Combination Therapy|Adverse Event|2|||
28171857|NCT02716779|54843458|FG002|Combination Therapy|Adverse Event|1|||
27888973|NCT00248040|54541406|FG002|Overall Study|transplantectomy|3|||
27888974|NCT00248040|54541404|FG000|Overall Study|transplant cancelled post treat start|1|||
27888975|NCT00248040|54541405|FG001|Overall Study|transplant cancelled post treat start|0|||
27888976|NCT00248040|54541406|FG002|Overall Study|transplant cancelled post treat start|0|||
27888977|NCT00248040|54541404|FG000|Overall Study|Death|0|||
27888978|NCT00248040|54541405|FG001|Overall Study|Death|0|||
27888979|NCT00248040|54541406|FG002|Overall Study|Death|1|||
27888980|NCT00247962|54541417|FG000|Overall Study|Adverse Event|15|||
27888981|NCT00247962|54541418|FG001|Overall Study|Adverse Event|12|||
27888982|NCT00247962|54541417|FG000|Overall Study|Lost to Follow-up|3|||
27888983|NCT00247962|54541418|FG001|Overall Study|Lost to Follow-up|1|||
27888984|NCT00247962|54541417|FG000|Overall Study|Physician Decision|0|||
27888985|NCT00247962|54541418|FG001|Overall Study|Physician Decision|1|||
27888986|NCT00247962|54541417|FG000|Overall Study|Protocol Violation|1|||
27888987|NCT00247962|54541418|FG001|Overall Study|Protocol Violation|1|||
27888988|NCT00247962|54541417|FG000|Overall Study|Withdrawal by Subject|3|||
27888989|NCT00247962|54541418|FG001|Overall Study|Withdrawal by Subject|2|||
27888990|NCT00247962|54541417|FG000|Overall Study|Lack of Efficacy|4|||
27888991|NCT00247962|54541418|FG001|Overall Study|Lack of Efficacy|2|||
27888992|NCT00247416|54541426|FG000|Overall Study|3 patients were found to be ineligible|1|||
27888993|NCT00247416|54541427|FG001|Overall Study|3 patients were found to be ineligible|2|||
27888994|NCT00246090|54541435|FG000|Overall Study|Adverse Event|25|||
27888995|NCT00246090|54541435|FG000|Overall Study|Withdrawal by Subject|7|||
27888996|NCT00246090|54541435|FG000|Overall Study|Progressive Disease|212|||
27888997|NCT00246090|54541435|FG000|Overall Study|Clinical Progression|30|||
27888998|NCT00246090|54541435|FG000|Overall Study|Physician Decision|11|||
27888999|NCT00246090|54541435|FG000|Overall Study|Not Otherwise Specified|10|||
27889000|NCT00246012|54541448|FG000|Overall Study|Adverse Event|0|||
27889001|NCT00246012|54541449|FG001|Overall Study|Adverse Event|0|||
27889002|NCT00246012|54541450|FG002|Overall Study|Adverse Event|0|||
27889003|NCT00246012|54541451|FG003|Overall Study|Adverse Event|0|||
27889004|NCT00246012|54541452|FG004|Overall Study|Adverse Event|0|||
27889005|NCT00246012|54541453|FG005|Overall Study|Adverse Event|1|||
27889006|NCT00246012|54541454|FG006|Overall Study|Adverse Event|0|||
27889007|NCT00246012|54541455|FG007|Overall Study|Adverse Event|0|||
27889008|NCT00246012|54541456|FG008|Overall Study|Adverse Event|2|||
27889009|NCT00246012|54541448|FG000|Overall Study|Withdrawal by Subject|0|||
27889010|NCT00246012|54541449|FG001|Overall Study|Withdrawal by Subject|0|||
27889011|NCT00246012|54541450|FG002|Overall Study|Withdrawal by Subject|0|||
27889012|NCT00246012|54541451|FG003|Overall Study|Withdrawal by Subject|0|||
27889013|NCT00246012|54541452|FG004|Overall Study|Withdrawal by Subject|0|||
27889014|NCT00246012|54541453|FG005|Overall Study|Withdrawal by Subject|1|||
27889015|NCT00246012|54541454|FG006|Overall Study|Withdrawal by Subject|0|||
27889016|NCT00246012|54541455|FG007|Overall Study|Withdrawal by Subject|0|||
27889017|NCT00246012|54541456|FG008|Overall Study|Withdrawal by Subject|0|||
27889018|NCT00246012|54541448|FG000|Overall Study|Disease progression|3|||
27889019|NCT00246012|54541449|FG001|Overall Study|Disease progression|1|||
27889020|NCT00246012|54541450|FG002|Overall Study|Disease progression|2|||
27889021|NCT00246012|54541451|FG003|Overall Study|Disease progression|3|||
27889022|NCT00246012|54541452|FG004|Overall Study|Disease progression|3|||
27889023|NCT00246012|54541453|FG005|Overall Study|Disease progression|25|||
27889024|NCT00246012|54541454|FG006|Overall Study|Disease progression|30|||
27889025|NCT00246012|54541455|FG007|Overall Study|Disease progression|27|||
27889026|NCT00246012|54541456|FG008|Overall Study|Disease progression|26|||
27889027|NCT00246012|54541448|FG000|Overall Study|Other|0|||
27889028|NCT00246012|54541449|FG001|Overall Study|Other|0|||
27889029|NCT00246012|54541450|FG002|Overall Study|Other|0|||
27889030|NCT00246012|54541451|FG003|Overall Study|Other|0|||
27889031|NCT00246012|54541452|FG004|Overall Study|Other|0|||
27889032|NCT00246012|54541453|FG005|Overall Study|Other|0|||
27889033|NCT00246012|54541454|FG006|Overall Study|Other|0|||
27739379|NCT01678131|54188963|FG001|Overall Study|Withdrawal by Subject|0|||
27739380|NCT01678131|54188964|FG002|Overall Study|Withdrawal by Subject|2|||
27739381|NCT02231164|54188974|FG000|Overall Study|Adverse Event|1|||
27739382|NCT02231164|54188975|FG001|Overall Study|Adverse Event|1|||
27739383|NCT02231164|54188974|FG000|Overall Study|Lack of Efficacy|4|||
27739384|NCT02231164|54188975|FG001|Overall Study|Lack of Efficacy|3|||
27889034|NCT00246012|54541455|FG007|Overall Study|Other|1|||
27889035|NCT00246012|54541456|FG008|Overall Study|Other|0|||
27889036|NCT00246012|54541448|FG000|Overall Study|Randomly assigned but not treated|0|||
27889037|NCT00246012|54541449|FG001|Overall Study|Randomly assigned but not treated|0|||
27889038|NCT00246012|54541450|FG002|Overall Study|Randomly assigned but not treated|0|||
27889039|NCT00246012|54541451|FG003|Overall Study|Randomly assigned but not treated|0|||
27889040|NCT00246012|54541452|FG004|Overall Study|Randomly assigned but not treated|0|||
27889041|NCT00246012|54541453|FG005|Overall Study|Randomly assigned but not treated|1|||
27889042|NCT00246012|54541454|FG006|Overall Study|Randomly assigned but not treated|1|||
27889043|NCT00246012|54541455|FG007|Overall Study|Randomly assigned but not treated|0|||
27889044|NCT00246012|54541456|FG008|Overall Study|Randomly assigned but not treated|0|||
27739385|NCT02231164|54188974|FG000|Overall Study|Withdrawal by Subject|1|||
27889045|NCT00245856|54541478|FG000|Period Two|Withdrawal by Subject|0|||
27889046|NCT00245856|54541479|FG001|Period Two|Withdrawal by Subject|1|||
27889047|NCT00245466|54541489|FG000|Overall Study|Adverse Event|2|||
27739386|NCT02231164|54188975|FG001|Overall Study|Withdrawal by Subject|2|||
27889048|NCT00245466|54541490|FG001|Overall Study|Adverse Event|8|||
27889049|NCT00245466|54541491|FG002|Overall Study|Adverse Event|4|||
27889050|NCT00245466|54541489|FG000|Overall Study|Low prostate specific antigen suppr|16|||
27889051|NCT00245466|54541490|FG001|Overall Study|Low prostate specific antigen suppr|14|||
27889052|NCT00245466|54541491|FG002|Overall Study|Low prostate specific antigen suppr|5|||
27889053|NCT00245466|54541489|FG000|Overall Study|Insufficient testosterone suppr|12|||
27889054|NCT00245466|54541490|FG001|Overall Study|Insufficient testosterone suppr|12|||
27889055|NCT00245466|54541491|FG002|Overall Study|Insufficient testosterone suppr|21|||
27889056|NCT00245466|54541489|FG000|Overall Study|Insufficient PSA and testosterone suppr|0|||
27889057|NCT00245466|54541490|FG001|Overall Study|Insufficient PSA and testosterone suppr|0|||
27889058|NCT00245466|54541491|FG002|Overall Study|Insufficient PSA and testosterone suppr|3|||
27889059|NCT00245466|54541489|FG000|Overall Study|Withdrawal by Subject|2|||
27889060|NCT00245466|54541490|FG001|Overall Study|Withdrawal by Subject|2|||
27889061|NCT00245466|54541491|FG002|Overall Study|Withdrawal by Subject|1|||
27889062|NCT00245466|54541489|FG000|Overall Study|Lost to Follow-up|3|||
27889063|NCT00245466|54541490|FG001|Overall Study|Lost to Follow-up|0|||
27889064|NCT00245466|54541491|FG002|Overall Study|Lost to Follow-up|0|||
27889065|NCT00245466|54541489|FG000|Overall Study|Disease progression|0|||
27889066|NCT00245466|54541490|FG001|Overall Study|Disease progression|3|||
27889067|NCT00245466|54541491|FG002|Overall Study|Disease progression|1|||
27889068|NCT00245466|54541489|FG000|Overall Study|Protocol Violation|1|||
27889069|NCT00245466|54541490|FG001|Overall Study|Protocol Violation|2|||
27889070|NCT00245466|54541491|FG002|Overall Study|Protocol Violation|2|||
27889071|NCT00245466|54541489|FG000|Overall Study|Death|0|||
27889072|NCT00245466|54541490|FG001|Overall Study|Death|2|||
27889073|NCT00245466|54541491|FG002|Overall Study|Death|0|||
27889074|NCT00245466|54541489|FG000|Overall Study|Administrative reasons|0|||
27889075|NCT00245466|54541490|FG001|Overall Study|Administrative reasons|1|||
27889076|NCT00245466|54541491|FG002|Overall Study|Administrative reasons|0|||
27889077|NCT00244764|54541499|FG000|Overall Study|Adverse Event|37|||
27889078|NCT00244764|54541499|FG000|Overall Study|Lost to Follow-up|23|||
27889079|NCT00244764|54541499|FG000|Overall Study|Withdrawal by Subject|12|||
27889080|NCT00244764|54541499|FG000|Overall Study|Disease Progression|13|||
27889081|NCT00244764|54541499|FG000|Overall Study|Protocol Violation|2|||
27889082|NCT00244764|54541499|FG000|Overall Study|Death|1|||
27889083|NCT00244764|54541499|FG000|Overall Study|Off Study Medication for >21 Days|1|||
27889084|NCT00244764|54541499|FG000|Overall Study|Declining Performance Status|1|||
27889085|NCT00244764|54541499|FG000|Overall Study|Participant was Hospitalized until Death|1|||
27889086|NCT00244764|54541499|FG000|Overall Study|Primary Investigator Discretion|2|||
27889087|NCT00244764|54541499|FG000|Overall Study|Sponsor Terminated Study|2|||
27889088|NCT00244764|54541499|FG000|Overall Study|Developed Secondary Malignancy|1|||
27889089|NCT00244374|54541504|FG000|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105|||
27889090|NCT00244374|54541505|FG001|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
27889091|NCT00244374|54541506|FG002|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
27889092|NCT00244374|54541507|FG003|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
27889093|NCT00244374|54541508|FG004|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
27889094|NCT00244374|54541504|FG000|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17|||
27889095|NCT00244374|54541505|FG001|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
27889096|NCT00244374|54541506|FG002|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
27889097|NCT00244374|54541507|FG003|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
27889098|NCT00244374|54541508|FG004|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
27889099|NCT00244374|54541504|FG000|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14|||
27889100|NCT00244374|54541505|FG001|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
27889101|NCT00244374|54541506|FG002|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
27889102|NCT00244374|54541507|FG003|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
27889103|NCT00244374|54541508|FG004|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
27889104|NCT00244374|54541504|FG000|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1|||
27889105|NCT00244374|54541505|FG001|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
27889106|NCT00244374|54541506|FG002|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
27889107|NCT00244374|54541507|FG003|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
27889108|NCT00244374|54541508|FG004|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
27889109|NCT00244374|54541504|FG000|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172|||
27889110|NCT00244374|54541505|FG001|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
27925755|NCT01230489|54582311|FG000|Overall Study|Adverse Event|2|||
28171858|NCT01369615|54843474|FG000|Overall Study|Withdrawal by Subject|0|||
28171859|NCT01369615|54843475|FG001|Overall Study|Withdrawal by Subject|1|||
28171860|NCT01369615|54843474|FG000|Overall Study|Lost to Follow-up|0|||
28171861|NCT01369615|54843475|FG001|Overall Study|Lost to Follow-up|1|||
28171862|NCT02468674|54843499|FG000|Overall Study|Adverse Event|0|||
28171863|NCT02468674|54843500|FG001|Overall Study|Adverse Event|0|||
27889111|NCT00244374|54541506|FG002|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
27889112|NCT00244374|54541507|FG003|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
27889113|NCT00244374|54541508|FG004|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
27889114|NCT00244374|54541504|FG000|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51|||
27889115|NCT00244374|54541505|FG001|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
27889116|NCT00244374|54541506|FG002|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
27889117|NCT00244374|54541507|FG003|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
27889118|NCT00244374|54541508|FG004|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
27889119|NCT00244374|54541504|FG000|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34|||
27889120|NCT00244374|54541505|FG001|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
27889121|NCT00244374|54541506|FG002|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
27889122|NCT00244374|54541507|FG003|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
27889123|NCT00244374|54541508|FG004|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
27889124|NCT00244374|54541504|FG000|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4|||
27889125|NCT00244374|54541505|FG001|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
27889126|NCT00244374|54541506|FG002|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
27889127|NCT00244374|54541507|FG003|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
27889128|NCT00244374|54541508|FG004|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
27889129|NCT00244374|54541504|FG000|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12|||
27889130|NCT00244374|54541505|FG001|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
27889131|NCT00244374|54541506|FG002|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
27889132|NCT00244374|54541507|FG003|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
27889133|NCT00244374|54541508|FG004|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
27889134|NCT00242658|54541526|FG000|Overall Study|Lost to Follow-up|22|||
27889135|NCT00242658|54541527|FG001|Overall Study|Lost to Follow-up|19|||
27889136|NCT00242580|54541536|FG000|Overall Study|Adverse Event|3|||
27889137|NCT00242580|54541537|FG001|Overall Study|Adverse Event|0|||
27889138|NCT00242580|54541538|FG002|Overall Study|Adverse Event|2|||
27889139|NCT00242580|54541536|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
27889140|NCT00242580|54541537|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
27889141|NCT00242580|54541538|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
27889142|NCT00242580|54541536|FG000|Overall Study|Protocol Violation|0|||
27889143|NCT00242580|54541537|FG001|Overall Study|Protocol Violation|0|||
27889144|NCT00242580|54541538|FG002|Overall Study|Protocol Violation|1|||
27889145|NCT00242580|54541536|FG000|Overall Study|Subject withdrew consent|2|||
27889146|NCT00242580|54541537|FG001|Overall Study|Subject withdrew consent|2|||
27889147|NCT00242580|54541538|FG002|Overall Study|Subject withdrew consent|5|||
27889148|NCT00242580|54541536|FG000|Overall Study|Lost to Follow-up|0|||
27889149|NCT00242580|54541537|FG001|Overall Study|Lost to Follow-up|3|||
27889150|NCT00242580|54541538|FG002|Overall Study|Lost to Follow-up|0|||
27889151|NCT00242580|54541536|FG000|Overall Study|Death|1|||
27889152|NCT00242580|54541537|FG001|Overall Study|Death|2|||
27889153|NCT00242580|54541538|FG002|Overall Study|Death|1|||
27889154|NCT00241644|54541550|FG000|First Efficacy Period (Year 1)|Adverse Event|46|||
27889155|NCT00241644|54541551|FG001|First Efficacy Period (Year 1)|Adverse Event|45|||
27889156|NCT00241644|54541552|FG002|First Efficacy Period (Year 1)|Adverse Event|45|||
27889157|NCT00241644|54541553|FG003|First Efficacy Period (Year 1)|Adverse Event|91|||
27889158|NCT00241644|54541550|FG000|First Efficacy Period (Year 1)|Protocol Violation|3|||
27889159|NCT00241644|54541551|FG001|First Efficacy Period (Year 1)|Protocol Violation|5|||
27889160|NCT00241644|54541552|FG002|First Efficacy Period (Year 1)|Protocol Violation|4|||
27889161|NCT00241644|54541553|FG003|First Efficacy Period (Year 1)|Protocol Violation|8|||
27889162|NCT00241644|54541550|FG000|First Efficacy Period (Year 1)|Withdrawal by Subject|59|||
27889163|NCT00241644|54541551|FG001|First Efficacy Period (Year 1)|Withdrawal by Subject|74|||
27889164|NCT00241644|54541552|FG002|First Efficacy Period (Year 1)|Withdrawal by Subject|81|||
27889165|NCT00241644|54541553|FG003|First Efficacy Period (Year 1)|Withdrawal by Subject|133|||
27889166|NCT00241644|54541550|FG000|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
27889167|NCT00241644|54541551|FG001|First Efficacy Period (Year 1)|Lost to Follow-up|142|||
27889168|NCT00241644|54541552|FG002|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
27889169|NCT00241644|54541553|FG003|First Efficacy Period (Year 1)|Lost to Follow-up|258|||
27889170|NCT00241644|54541550|FG000|First Efficacy Period (Year 1)|Non-compliance|2|||
27889171|NCT00241644|54541551|FG001|First Efficacy Period (Year 1)|Non-compliance|1|||
27889172|NCT00241644|54541552|FG002|First Efficacy Period (Year 1)|Non-compliance|2|||
27889173|NCT00241644|54541553|FG003|First Efficacy Period (Year 1)|Non-compliance|3|||
27889174|NCT00241644|54541550|FG000|First Efficacy Period (Year 1)|Return dates not reliable|1|||
27889175|NCT00241644|54541551|FG001|First Efficacy Period (Year 1)|Return dates not reliable|0|||
27889176|NCT00241644|54541552|FG002|First Efficacy Period (Year 1)|Return dates not reliable|0|||
27889177|NCT00241644|54541553|FG003|First Efficacy Period (Year 1)|Return dates not reliable|1|||
27889178|NCT00241644|54541550|FG000|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
27889179|NCT00241644|54541551|FG001|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
27889180|NCT00241644|54541552|FG002|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1|||
27889181|NCT00241644|54541553|FG003|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
27889182|NCT00241644|54541550|FG000|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
27889183|NCT00241644|54541551|FG001|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
27889184|NCT00241644|54541552|FG002|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
27889185|NCT00241644|54541553|FG003|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
27889186|NCT00241644|54541550|FG000|Second Efficacy Period (Year 2)|Adverse Event|11|||
27889187|NCT00241644|54541551|FG001|Second Efficacy Period (Year 2)|Adverse Event|9|||
27889188|NCT00241644|54541552|FG002|Second Efficacy Period (Year 2)|Adverse Event|12|||
27889189|NCT00241644|54541553|FG003|Second Efficacy Period (Year 2)|Adverse Event|20|||
27889190|NCT00241644|54541550|FG000|Second Efficacy Period (Year 2)|Protocol Violation|2|||
27889191|NCT00241644|54541551|FG001|Second Efficacy Period (Year 2)|Protocol Violation|1|||
27889192|NCT00241644|54541552|FG002|Second Efficacy Period (Year 2)|Protocol Violation|2|||
27889193|NCT00241644|54541553|FG003|Second Efficacy Period (Year 2)|Protocol Violation|3|||
27889194|NCT00241644|54541550|FG000|Second Efficacy Period (Year 2)|Withdrawal by Subject|4|||
27889195|NCT00241644|54541551|FG001|Second Efficacy Period (Year 2)|Withdrawal by Subject|3|||
27889196|NCT00241644|54541552|FG002|Second Efficacy Period (Year 2)|Withdrawal by Subject|2|||
27889197|NCT00241644|54541553|FG003|Second Efficacy Period (Year 2)|Withdrawal by Subject|7|||
27889198|NCT00241644|54541550|FG000|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
27889199|NCT00241644|54541551|FG001|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
27889200|NCT00241644|54541552|FG002|Second Efficacy Period (Year 2)|Lost to Follow-up|46|||
27889201|NCT00241644|54541553|FG003|Second Efficacy Period (Year 2)|Lost to Follow-up|86|||
27889202|NCT00241644|54541550|FG000|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
27889203|NCT00241644|54541551|FG001|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
27889204|NCT00241644|54541552|FG002|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
27889205|NCT00241644|54541553|FG003|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
27889206|NCT03804684|54541574|FG000|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|3|||
27889207|NCT03804684|54541575|FG001|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|18|||
27889208|NCT04295772|54541590|FG000|Overall Study|Protocol Violation|1|||
27889209|NCT04295772|54541591|FG001|Overall Study|Protocol Violation|0|||
27889210|NCT04295772|54541590|FG000|Overall Study|Ongoing for safety monitoring|14|||
27889211|NCT04295772|54541591|FG001|Overall Study|Ongoing for safety monitoring|1|||
27889212|NCT04295772|54541590|FG000|Overall Study|Excluded from results due to informed consent issue|2|||
27889213|NCT04295772|54541591|FG001|Overall Study|Excluded from results due to informed consent issue|0|||
27889214|NCT03888066|54541600|FG000|Run-in Phase|Randomization Criterion #1|24|||
27889215|NCT03888066|54541601|FG001|Run-in Phase|Randomization Criterion #1|0|||
27889216|NCT03888066|54541600|FG000|Run-in Phase|Randomization Criteria #1, #2|5|||
27889217|NCT03888066|54541601|FG001|Run-in Phase|Randomization Criteria #1, #2|0|||
27889218|NCT03888066|54541600|FG000|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
27889219|NCT03888066|54541601|FG001|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
27889220|NCT03888066|54541600|FG000|Run-in Phase|Randomization Criteria #1, #3|1|||
27889221|NCT03888066|54541601|FG001|Run-in Phase|Randomization Criteria #1, #3|0|||
27889222|NCT03888066|54541600|FG000|Run-in Phase|Randomization Criteria #1, #4|1|||
27889223|NCT03888066|54541601|FG001|Run-in Phase|Randomization Criteria #1, #4|0|||
27889224|NCT03888066|54541600|FG000|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
27889225|NCT03888066|54541601|FG001|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
27889226|NCT03888066|54541600|FG000|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
27889227|NCT03888066|54541601|FG001|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
27889228|NCT03888066|54541600|FG000|Run-in Phase|Randomization Criterion #1; AE|4|||
27889229|NCT03888066|54541601|FG001|Run-in Phase|Randomization Criterion #1; AE|0|||
27889230|NCT03888066|54541600|FG000|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
27889231|NCT03888066|54541601|FG001|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
27889232|NCT03888066|54541600|FG000|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
27889233|NCT03888066|54541601|FG001|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
27889234|NCT03888066|54541600|FG000|Run-in Phase|Randomization Criterion #2|5|||
27889235|NCT03888066|54541601|FG001|Run-in Phase|Randomization Criterion #2|0|||
27889236|NCT03888066|54541600|FG000|Run-in Phase|Randomization Criteria #2, #3|1|||
27889237|NCT03888066|54541601|FG001|Run-in Phase|Randomization Criteria #2, #3|0|||
27985557|NCT00872001|54644331|FG001|Overall Study|Protocol Defined Clinical Event|7|||
27985558|NCT00872001|54644330|FG000|Overall Study|Lost to Follow-up|13|||
27889238|NCT03888066|54541600|FG000|Run-in Phase|Randomization Criteria #2, #3, #4|1|||
27889239|NCT03888066|54541601|FG001|Run-in Phase|Randomization Criteria #2, #3, #4|0|||
27889240|NCT03888066|54541600|FG000|Run-in Phase|Randomization Criteria #2, #4|4|||
27889241|NCT03888066|54541601|FG001|Run-in Phase|Randomization Criteria #2, #4|0|||
27889242|NCT03888066|54541600|FG000|Run-in Phase|Randomization Criterion #3|11|||
27889243|NCT03888066|54541601|FG001|Run-in Phase|Randomization Criterion #3|0|||
27889244|NCT03888066|54541600|FG000|Run-in Phase|Randomization Criteria #3, #4|1|||
27889245|NCT03888066|54541601|FG001|Run-in Phase|Randomization Criteria #3, #4|0|||
27889246|NCT03888066|54541600|FG000|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
27889247|NCT03888066|54541601|FG001|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
27889248|NCT03888066|54541600|FG000|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
27889249|NCT03888066|54541601|FG001|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
27889250|NCT03888066|54541600|FG000|Run-in Phase|Randomization Criterion #4|3|||
27889251|NCT03888066|54541601|FG001|Run-in Phase|Randomization Criterion #4|0|||
27889252|NCT03888066|54541600|FG000|Run-in Phase|Randomization Criterion #3; Physician Decision|1|||
27889253|NCT03888066|54541601|FG001|Run-in Phase|Randomization Criterion #3; Physician Decision|0|||
27889254|NCT03888066|54541600|FG000|Run-in Phase|Randomization Criterion #4; AE|4|||
27889255|NCT03888066|54541601|FG001|Run-in Phase|Randomization Criterion #4; AE|0|||
27889256|NCT03888066|54541600|FG000|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
27889257|NCT03888066|54541601|FG001|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
27889258|NCT03888066|54541600|FG000|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|1|||
27889259|NCT03888066|54541601|FG001|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|0|||
27889260|NCT03888066|54541600|FG000|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
27889261|NCT03888066|54541601|FG001|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
27889262|NCT03888066|54541600|FG000|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
27889263|NCT03888066|54541601|FG001|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
27889264|NCT03888066|54541600|FG000|Run-in Phase|AE (Adverse Event)|17|||
27889265|NCT03888066|54541601|FG001|Run-in Phase|AE (Adverse Event)|0|||
27889266|NCT03888066|54541600|FG000|Run-in Phase|AE; Withdrawal By Subject|3|||
27889267|NCT03888066|54541601|FG001|Run-in Phase|AE; Withdrawal By Subject|0|||
27889268|NCT03888066|54541600|FG000|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
27889269|NCT03888066|54541601|FG001|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
27889270|NCT03888066|54541600|FG000|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
27889271|NCT03888066|54541601|FG001|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
27889272|NCT03888066|54541600|FG000|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
27889273|NCT03888066|54541601|FG001|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
27889274|NCT03888066|54541600|FG000|Run-in Phase|Withdrawal by Subject|43|||
27889275|NCT03888066|54541601|FG001|Run-in Phase|Withdrawal by Subject|0|||
27889276|NCT03888066|54541600|FG000|Run-in Phase|AE; Physician Decision|1|||
27889277|NCT03888066|54541601|FG001|Run-in Phase|AE; Physician Decision|0|||
27889278|NCT03888066|54541600|FG000|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|10|||
27889279|NCT03888066|54541601|FG001|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
27889280|NCT03888066|54541600|FG000|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|1|||
27889281|NCT03888066|54541601|FG001|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|0|||
27889282|NCT03888066|54541600|FG000|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|6|||
27889283|NCT03888066|54541601|FG001|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
27889284|NCT03888066|54541600|FG000|Run-in Phase|Death|1|||
27889285|NCT03888066|54541601|FG001|Run-in Phase|Death|0|||
27889286|NCT03888066|54541600|FG000|Run-in Phase|Non-Compliance With Study Drug|2|||
27889287|NCT03888066|54541601|FG001|Run-in Phase|Non-Compliance With Study Drug|0|||
27889288|NCT03888066|54541600|FG000|Run-in Phase|Physician Decision|1|||
27889289|NCT03888066|54541601|FG001|Run-in Phase|Physician Decision|0|||
27889290|NCT03888066|54541600|FG000|Run-in Phase|Protocol Violation|13|||
27889291|NCT03888066|54541601|FG001|Run-in Phase|Protocol Violation|0|||
27889292|NCT03888066|54541600|FG000|Run-in Phase|Sponsor Request|34|||
27889293|NCT03888066|54541601|FG001|Run-in Phase|Sponsor Request|0|||
27889294|NCT03888066|54541600|FG000|Run-in Phase|Study Terminated By Sponsor|71|||
27889295|NCT03888066|54541601|FG001|Run-in Phase|Study Terminated By Sponsor|0|||
27889296|NCT03888066|54541600|FG000|Run-in Phase|Withdrawal Of Consent|1|||
27889297|NCT03888066|54541601|FG001|Run-in Phase|Withdrawal Of Consent|0|||
27889298|NCT03888066|54541600|FG000|Run-in Phase|Exceeded 12 Weeks Of Run In|2|||
27889299|NCT03888066|54541601|FG001|Run-in Phase|Exceeded 12 Weeks Of Run In|0|||
27889300|NCT03888066|54541600|FG000|Run-in Phase|Not treated with Patiromer during Run-in|27|||
27889301|NCT03888066|54541601|FG001|Run-in Phase|Not treated with Patiromer during Run-in|0|||
27889302|NCT03888066|54541600|FG000|Treatment Phase (Overall Study)|Protocol Violation|0|||
27889303|NCT03888066|54541601|FG001|Treatment Phase (Overall Study)|Protocol Violation|1|||
27889304|NCT03888066|54541600|FG000|Treatment Phase (Overall Study)|Physician Decision|20|||
27889305|NCT03888066|54541601|FG001|Treatment Phase (Overall Study)|Physician Decision|13|||
27889306|NCT03888066|54541600|FG000|Treatment Phase (Overall Study)|Adverse Event|27|||
27889307|NCT03888066|54541601|FG001|Treatment Phase (Overall Study)|Adverse Event|21|||
27889308|NCT03888066|54541600|FG000|Treatment Phase (Overall Study)|Lost to Follow-up|1|||
27889309|NCT03888066|54541601|FG001|Treatment Phase (Overall Study)|Lost to Follow-up|0|||
27889310|NCT03888066|54541600|FG000|Treatment Phase (Overall Study)|Consent withdrawn by subject|21|||
27889311|NCT03888066|54541601|FG001|Treatment Phase (Overall Study)|Consent withdrawn by subject|25|||
27889312|NCT03888066|54541600|FG000|Treatment Phase (Overall Study)|End of study visit not completed/delayed|1|||
27889313|NCT03888066|54541601|FG001|Treatment Phase (Overall Study)|End of study visit not completed/delayed|3|||
27889314|NCT03888066|54541600|FG000|Treatment Phase (Overall Study)|Early study termination|0|||
27889315|NCT03888066|54541601|FG001|Treatment Phase (Overall Study)|Early study termination|1|||
27889316|NCT03888066|54541600|FG000|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
27889317|NCT03888066|54541601|FG001|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
27889318|NCT03888066|54541600|FG000|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
27889319|NCT03888066|54541601|FG001|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
27889320|NCT03888066|54541600|FG000|Treatment Phase (Overall Study)|Sponsor's decision|1|||
27889321|NCT03888066|54541601|FG001|Treatment Phase (Overall Study)|Sponsor's decision|0|||
27889322|NCT02017704|54541610|FG000|Overall Study|Withdrawal by Subject|2|||
27889323|NCT02017704|54541611|FG001|Overall Study|Withdrawal by Subject|0|||
27889324|NCT01049334|54541621|FG000|Overall Study|Withdrawal by Subject|5|||
27889325|NCT01049334|54541622|FG001|Overall Study|Withdrawal by Subject|3|||
27889326|NCT01049334|54541621|FG000|Overall Study|Adverse Event|2|||
27889327|NCT01049334|54541622|FG001|Overall Study|Adverse Event|3|||
27889328|NCT01049334|54541621|FG000|Overall Study|Physician Decision|2|||
27889329|NCT01049334|54541622|FG001|Overall Study|Physician Decision|0|||
27889330|NCT01049334|54541621|FG000|Overall Study|Protocol Violation|0|||
27889331|NCT01049334|54541622|FG001|Overall Study|Protocol Violation|1|||
27889332|NCT01048944|54541632|FG000|Overall Study|Protocol Violation|8|||
27889333|NCT01048944|54541633|FG001|Overall Study|Protocol Violation|10|||
27889334|NCT01048944|54541634|FG002|Overall Study|Protocol Violation|10|||
27889335|NCT01048944|54541635|FG003|Overall Study|Protocol Violation|2|||
27889336|NCT01048866|54541647|FG000|Overall Study|Adverse Event|1|||
27889337|NCT01048866|54541648|FG001|Overall Study|Adverse Event|0|||
27889338|NCT01048866|54541647|FG000|Overall Study|Protocol Violation|1|||
27889339|NCT01048866|54541648|FG001|Overall Study|Protocol Violation|0|||
27889340|NCT01048866|54541647|FG000|Overall Study|Physician Decision|1|||
27889341|NCT01048866|54541648|FG001|Overall Study|Physician Decision|0|||
27889342|NCT01048866|54541647|FG000|Overall Study|Withdrawal by Subject|0|||
27889343|NCT01048866|54541648|FG001|Overall Study|Withdrawal by Subject|2|||
27889344|NCT01048866|54541647|FG000|Overall Study|Lost to Follow-up|0|||
27889345|NCT01048866|54541648|FG001|Overall Study|Lost to Follow-up|2|||
27889346|NCT01048866|54541647|FG000|Overall Study|Other|1|||
27889347|NCT01048866|54541648|FG001|Overall Study|Other|1|||
27889348|NCT01048788|54541657|FG000|Overall Study|Adverse Event|5|||
27889349|NCT01048788|54541658|FG001|Overall Study|Adverse Event|1|||
27889350|NCT01048788|54541659|FG002|Overall Study|Adverse Event|1|||
27889351|NCT01048788|54541657|FG000|Overall Study|Lack of Efficacy|0|||
27889352|NCT01048788|54541658|FG001|Overall Study|Lack of Efficacy|0|||
27889353|NCT01048788|54541659|FG002|Overall Study|Lack of Efficacy|1|||
27889354|NCT01048788|54541657|FG000|Overall Study|Withdrawal by Subject|0|||
27889355|NCT01048788|54541658|FG001|Overall Study|Withdrawal by Subject|1|||
27889356|NCT01048788|54541659|FG002|Overall Study|Withdrawal by Subject|0|||
27889357|NCT01048242|54541669|FG000|Overall Study|See study flow chart|4|||
27889358|NCT01048242|54541670|FG001|Overall Study|See study flow chart|2|||
27889359|NCT01047306|54541678|FG000|Overall Study|Withdrawal by Subject|2|||
27889360|NCT01047306|54541679|FG001|Overall Study|Withdrawal by Subject|0|||
27889361|NCT01047306|54541678|FG000|Overall Study|Lost to Follow-up|1|||
27889362|NCT01047306|54541679|FG001|Overall Study|Lost to Follow-up|0|||
27889363|NCT01046682|54541689|FG000|Overall Study|Adverse Event|2|||
27889364|NCT01046682|54541690|FG001|Overall Study|Adverse Event|0|||
27889365|NCT01044732|54541698|FG000|Overall Study|Lost to Follow-up|2|||
27889366|NCT01044732|54541699|FG001|Overall Study|Lost to Follow-up|1|||
27889367|NCT01044732|54541698|FG000|Overall Study|Physician Decision|5|||
27889368|NCT01044732|54541699|FG001|Overall Study|Physician Decision|3|||
27889369|NCT01044732|54541698|FG000|Overall Study|Protocol Violation|11|||
27889370|NCT01044732|54541699|FG001|Overall Study|Protocol Violation|12|||
27889371|NCT01044732|54541698|FG000|Overall Study|Withdrawal by Subject|0|||
27889372|NCT01044732|54541699|FG001|Overall Study|Withdrawal by Subject|1|||
27889373|NCT01044732|54541698|FG000|Overall Study|Inadequate bowel preparation|11|||
27889374|NCT01044732|54541699|FG001|Overall Study|Inadequate bowel preparation|17|||
27889375|NCT01044732|54541698|FG000|Overall Study|Inability to reach cecum|5|||
27889376|NCT01044732|54541699|FG001|Overall Study|Inability to reach cecum|2|||
27985559|NCT00872001|54644331|FG001|Overall Study|Lost to Follow-up|12|||
27889377|NCT01044732|54541698|FG000|Overall Study|Technical error or malfunction|15|||
27889378|NCT01044732|54541699|FG001|Overall Study|Technical error or malfunction|14|||
27889379|NCT01044498|54541709|FG000|Overall Study|Withdrew consent|1|||
27889380|NCT01044498|54541710|FG001|Overall Study|Withdrew consent|1|||
27889381|NCT01044498|54541709|FG000|Overall Study|Adverse Event|1|||
27889382|NCT01044498|54541710|FG001|Overall Study|Adverse Event|1|||
27889383|NCT01044498|54541709|FG000|Overall Study|Other|1|||
27889384|NCT01044498|54541710|FG001|Overall Study|Other|0|||
27889385|NCT01043874|54541716|FG000|Overall Study|Adverse Event|3|||
27889386|NCT01043874|54541716|FG000|Overall Study|Withdrawal by Subject|1|||
27889387|NCT01043874|54541716|FG000|Overall Study|Lack of Efficacy|1|||
27889388|NCT01043874|54541716|FG000|Overall Study|Administrative Problems|1|||
27889389|NCT01042938|54541722|FG000|Overall Study|Withdrawal by Subject|1|||
27889390|NCT01042938|54541723|FG001|Overall Study|Withdrawal by Subject|1|||
27889391|NCT01042938|54541722|FG000|Overall Study|Protocol Violation|1|||
27889392|NCT01042938|54541723|FG001|Overall Study|Protocol Violation|1|||
27889393|NCT01042938|54541722|FG000|Overall Study|Ineligible: RTOG study conflict|1|||
27889394|NCT01042938|54541723|FG001|Overall Study|Ineligible: RTOG study conflict|0|||
27889395|NCT01042158|54541731|FG000|Overall Study|Physician Decision|1|||
27889396|NCT03408444|54541739|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
27889397|NCT03408444|54541740|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
27889398|NCT03408444|54541741|FG002|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
27889399|NCT03408444|54541742|FG003|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
27889400|NCT03408444|54541739|FG000|Overall Study|Lens Discomfort|0|||
27889401|NCT03408444|54541740|FG001|Overall Study|Lens Discomfort|1|||
27889402|NCT03408444|54541741|FG002|Overall Study|Lens Discomfort|0|||
27889403|NCT03408444|54541742|FG003|Overall Study|Lens Discomfort|0|||
27889404|NCT03408444|54541739|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
27889405|NCT03408444|54541740|FG001|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
27889406|NCT03408444|54541741|FG002|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
27889407|NCT03408444|54541742|FG003|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
27889408|NCT03408444|54541739|FG000|Overall Study|Withdrawal by Subject|0|||
27889409|NCT03408444|54541740|FG001|Overall Study|Withdrawal by Subject|2|||
27889410|NCT03408444|54541741|FG002|Overall Study|Withdrawal by Subject|3|||
27889411|NCT03408444|54541742|FG003|Overall Study|Withdrawal by Subject|0|||
27889412|NCT03408444|54541739|FG000|Overall Study|Lost to Follow-up|0|||
27889413|NCT03408444|54541740|FG001|Overall Study|Lost to Follow-up|0|||
27889414|NCT03408444|54541741|FG002|Overall Study|Lost to Follow-up|1|||
27889415|NCT03408444|54541742|FG003|Overall Study|Lost to Follow-up|0|||
27889416|NCT03408444|54541739|FG000|Overall Study|Adverse Event|0|||
27889417|NCT03408444|54541740|FG001|Overall Study|Adverse Event|0|||
27889418|NCT03408444|54541741|FG002|Overall Study|Adverse Event|0|||
27889419|NCT03408444|54541742|FG003|Overall Study|Adverse Event|1|||
27889420|NCT03408444|54541739|FG000|Overall Study|Lens Handling Difficulties|0|||
27889421|NCT03408444|54541740|FG001|Overall Study|Lens Handling Difficulties|0|||
27889422|NCT03408444|54541741|FG002|Overall Study|Lens Handling Difficulties|1|||
27889423|NCT03408444|54541742|FG003|Overall Study|Lens Handling Difficulties|0|||
27889424|NCT03408444|54541739|FG000|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
27889425|NCT03408444|54541740|FG001|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
27889426|NCT03408444|54541741|FG002|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
27889427|NCT03408444|54541742|FG003|Overall Study|Subject Decided to Not Wear Contact Lenses|3|||
27889428|NCT03400956|54541772|FG000|Treatment Period 1|Adverse Event|0|||
27889429|NCT03400956|54541773|FG001|Treatment Period 1|Adverse Event|1|||
27889430|NCT03400956|54541774|FG002|Treatment Period 1|Adverse Event|0|||
27889431|NCT03400956|54541772|FG000|Treatment Period 1|Lost to Follow-up|0|||
27889432|NCT03400956|54541773|FG001|Treatment Period 1|Lost to Follow-up|0|||
27889433|NCT03400956|54541774|FG002|Treatment Period 1|Lost to Follow-up|1|||
27889434|NCT03400956|54541772|FG000|Treatment Period 1|Protocol Violation|0|||
27889435|NCT03400956|54541773|FG001|Treatment Period 1|Protocol Violation|2|||
27889436|NCT03400956|54541774|FG002|Treatment Period 1|Protocol Violation|0|||
27889437|NCT03400956|54541772|FG000|Treatment Period 1|Study terminated by sponsor|3|||
27889438|NCT03400956|54541773|FG001|Treatment Period 1|Study terminated by sponsor|1|||
27889439|NCT03400956|54541774|FG002|Treatment Period 1|Study terminated by sponsor|1|||
27889440|NCT03400956|54541772|FG000|Treatment Period 1|Withdrawal by Subject|0|||
27889441|NCT03400956|54541773|FG001|Treatment Period 1|Withdrawal by Subject|2|||
27889442|NCT03400956|54541774|FG002|Treatment Period 1|Withdrawal by Subject|4|||
27889443|NCT03400956|54541772|FG000|Treatment Period 1|Other|1|||
27889444|NCT03400956|54541773|FG001|Treatment Period 1|Other|2|||
27889445|NCT03400956|54541774|FG002|Treatment Period 1|Other|3|||
27889446|NCT03400956|54541772|FG000|Post-treatment Period 1|Adverse Event|0|||
27889447|NCT03400956|54541773|FG001|Post-treatment Period 1|Adverse Event|0|||
27889448|NCT03400956|54541774|FG002|Post-treatment Period 1|Adverse Event|1|||
27889449|NCT03400956|54541772|FG000|Post-treatment Period 1|Physician Decision|2|||
27889450|NCT03400956|54541773|FG001|Post-treatment Period 1|Physician Decision|3|||
27889451|NCT03400956|54541774|FG002|Post-treatment Period 1|Physician Decision|0|||
27889452|NCT03400956|54541772|FG000|Post-treatment Period 1|Study terminated by sponsor|11|||
27889453|NCT03400956|54541773|FG001|Post-treatment Period 1|Study terminated by sponsor|10|||
27889454|NCT03400956|54541774|FG002|Post-treatment Period 1|Study terminated by sponsor|11|||
27889455|NCT03400956|54541772|FG000|Post-treatment Period 1|Withdrawal by Subject|5|||
27889456|NCT03400956|54541773|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
27889457|NCT03400956|54541774|FG002|Post-treatment Period 1|Withdrawal by Subject|0|||
27889458|NCT03400956|54541772|FG000|Post-treatment Period 1|Other|4|||
27889459|NCT03400956|54541773|FG001|Post-treatment Period 1|Other|3|||
27889460|NCT03400956|54541774|FG002|Post-treatment Period 1|Other|4|||
27889461|NCT03400956|54541772|FG000|Treatment Period 2|Adverse Event|2|||
27889462|NCT03400956|54541773|FG001|Treatment Period 2|Adverse Event|1|||
27889463|NCT03400956|54541774|FG002|Treatment Period 2|Adverse Event|1|||
27889464|NCT03400956|54541772|FG000|Treatment Period 2|Lost to Follow-up|1|||
27889465|NCT03400956|54541773|FG001|Treatment Period 2|Lost to Follow-up|1|||
27889466|NCT03400956|54541774|FG002|Treatment Period 2|Lost to Follow-up|0|||
27889467|NCT03400956|54541772|FG000|Treatment Period 2|Withdrawal by Subject|0|||
27889468|NCT03400956|54541773|FG001|Treatment Period 2|Withdrawal by Subject|0|||
27889469|NCT03400956|54541774|FG002|Treatment Period 2|Withdrawal by Subject|3|||
27889470|NCT03400956|54541772|FG000|Treatment Period 2|Other|1|||
27889471|NCT03400956|54541773|FG001|Treatment Period 2|Other|1|||
27889472|NCT03400956|54541774|FG002|Treatment Period 2|Other|0|||
27889473|NCT03400956|54541772|FG000|Follow-up Period|Withdrawal by Subject|0|||
27889474|NCT03400956|54541773|FG001|Follow-up Period|Withdrawal by Subject|0|||
27889475|NCT03400956|54541774|FG002|Follow-up Period|Withdrawal by Subject|1|||
27889476|NCT03400956|54541772|FG000|Follow-up Period|Other|0|||
27889477|NCT03400956|54541773|FG001|Follow-up Period|Other|0|||
27889478|NCT03400956|54541774|FG002|Follow-up Period|Other|1|||
27889479|NCT00012012|54541787|FG000|Overall Study|Protocol Violation|1|||
27889480|NCT00012012|54541788|FG001|Overall Study|Protocol Violation|1|||
27889481|NCT00012012|54541787|FG000|Overall Study|Withdrawal by Subject|0|||
27889482|NCT00012012|54541788|FG001|Overall Study|Withdrawal by Subject|2|||
27889483|NCT00010374|54541794|FG000|Overall Study|False positive phrenic nerve test|1|||
27889484|NCT00559962|54541816|FG000|Overall Study|Adverse Event|1|||
27889485|NCT00559962|54541817|FG001|Overall Study|Adverse Event|7|||
27889486|NCT00559962|54541818|FG002|Overall Study|Adverse Event|8|||
27889487|NCT00559962|54541819|FG003|Overall Study|Adverse Event|5|||
27889488|NCT00559962|54541820|FG004|Overall Study|Adverse Event|11|||
27889489|NCT00559962|54541821|FG005|Overall Study|Adverse Event|4|||
27889490|NCT00559962|54541822|FG006|Overall Study|Adverse Event|4|||
27889491|NCT00559962|54541823|FG007|Overall Study|Adverse Event|2|||
27889492|NCT00559962|54541816|FG000|Overall Study|Lost to Follow-up|0|||
27889493|NCT00559962|54541817|FG001|Overall Study|Lost to Follow-up|1|||
27889494|NCT00559962|54541818|FG002|Overall Study|Lost to Follow-up|0|||
27889495|NCT00559962|54541819|FG003|Overall Study|Lost to Follow-up|0|||
27889496|NCT00559962|54541820|FG004|Overall Study|Lost to Follow-up|0|||
27889497|NCT00559962|54541821|FG005|Overall Study|Lost to Follow-up|0|||
27889498|NCT00559962|54541822|FG006|Overall Study|Lost to Follow-up|0|||
27889499|NCT00559962|54541823|FG007|Overall Study|Lost to Follow-up|0|||
27889500|NCT00559962|54541816|FG000|Overall Study|Withdrawal by Subject|1|||
27889501|NCT00559962|54541817|FG001|Overall Study|Withdrawal by Subject|1|||
27889502|NCT00559962|54541818|FG002|Overall Study|Withdrawal by Subject|2|||
27889503|NCT00559962|54541819|FG003|Overall Study|Withdrawal by Subject|0|||
27889504|NCT00559962|54541820|FG004|Overall Study|Withdrawal by Subject|3|||
27889505|NCT00559962|54541821|FG005|Overall Study|Withdrawal by Subject|1|||
27889506|NCT00559962|54541822|FG006|Overall Study|Withdrawal by Subject|0|||
27889507|NCT00559962|54541823|FG007|Overall Study|Withdrawal by Subject|2|||
27889508|NCT00559962|54541816|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
27889509|NCT00559962|54541817|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
27889510|NCT00559962|54541818|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
27889511|NCT00559962|54541819|FG003|Overall Study|Inclusion/exclusion criteria not met|0|||
28096659|NCT03692676|54751819|FG002|Overall Study|exclude patients with prior use of same substances and device|3700|||
28096660|NCT03692676|54751820|FG003|Overall Study|exclude patients with prior use of same substances and device|0|||
27889512|NCT00559962|54541820|FG004|Overall Study|Inclusion/exclusion criteria not met|0|||
27889513|NCT00559962|54541821|FG005|Overall Study|Inclusion/exclusion criteria not met|0|||
27889514|NCT00559962|54541822|FG006|Overall Study|Inclusion/exclusion criteria not met|1|||
27889515|NCT00559962|54541823|FG007|Overall Study|Inclusion/exclusion criteria not met|0|||
27889516|NCT00559104|54541844|FG000|Overall Study|Lack of Efficacy|9|||
27985560|NCT00872001|54644330|FG000|Overall Study|Withdrawal by Subject|18|||
28171864|NCT02468674|54843501|FG002|Overall Study|Adverse Event|0|||
27889517|NCT00559104|54541845|FG001|Overall Study|Lack of Efficacy|0|||
27889518|NCT00558636|54541853|FG000|Treatment|Adverse Event|9|||
27889519|NCT00558636|54541854|FG001|Treatment|Adverse Event|2|||
27889520|NCT00558636|54541853|FG000|Treatment|Withdrawal by Subject|2|||
27889521|NCT00558636|54541854|FG001|Treatment|Withdrawal by Subject|0|||
27889522|NCT00558636|54541853|FG000|Treatment|Premature termination of the study|35|||
27889523|NCT00558636|54541854|FG001|Treatment|Premature termination of the study|37|||
27889524|NCT00558636|54541853|FG000|Treatment|Disease progression|1|||
27889525|NCT00558636|54541854|FG001|Treatment|Disease progression|5|||
27889526|NCT00558636|54541853|FG000|Follow-up|Premature termination of the study|12|||
27889527|NCT00558636|54541854|FG001|Follow-up|Premature termination of the study|7|||
27889528|NCT00558558|54541860|FG000|Overall Study|Unable to swallow|1|||
27889529|NCT00558558|54541860|FG000|Overall Study|Withdrawal by Subject|1|||
27889530|NCT00558558|54541860|FG000|Overall Study|Lack of Efficacy|4|||
27889531|NCT00557622|54541866|FG000|4-Week Run-in Phase|Withdrawal by Subject|1|||
27889532|NCT00557622|54541867|FG001|4-Week Run-in Phase|Withdrawal by Subject|0|||
27889533|NCT00557622|54541866|FG000|4-Week Run-in Phase|Protocol-defined stopping criteria|1|||
27889534|NCT00557622|54541867|FG001|4-Week Run-in Phase|Protocol-defined stopping criteria|0|||
27889535|NCT00557622|54541866|FG000|12-Week Treatment Phase|Lost to Follow-up|0|||
27889536|NCT00557622|54541867|FG001|12-Week Treatment Phase|Lost to Follow-up|1|||
27889537|NCT00557466|54541879|FG000|Overall Study|Adverse Event|3|||
27889538|NCT00557466|54541880|FG001|Overall Study|Adverse Event|1|||
27889539|NCT00557466|54541881|FG002|Overall Study|Adverse Event|4|||
27889540|NCT00557466|54541882|FG003|Overall Study|Adverse Event|1|||
27889541|NCT00557466|54541883|FG004|Overall Study|Adverse Event|2|||
27889542|NCT00557466|54541884|FG005|Overall Study|Adverse Event|4|||
27889543|NCT00557466|54541879|FG000|Overall Study|Abnormal laboratory value(s)|1|||
27889544|NCT00557466|54541880|FG001|Overall Study|Abnormal laboratory value(s)|2|||
27889545|NCT00557466|54541881|FG002|Overall Study|Abnormal laboratory value(s)|0|||
27889546|NCT00557466|54541882|FG003|Overall Study|Abnormal laboratory value(s)|0|||
27889547|NCT00557466|54541883|FG004|Overall Study|Abnormal laboratory value(s)|0|||
27889548|NCT00557466|54541884|FG005|Overall Study|Abnormal laboratory value(s)|0|||
27889549|NCT00557466|54541879|FG000|Overall Study|Protocol deviation|0|||
27889550|NCT00557466|54541880|FG001|Overall Study|Protocol deviation|1|||
27889551|NCT00557466|54541881|FG002|Overall Study|Protocol deviation|0|||
27889552|NCT00557466|54541882|FG003|Overall Study|Protocol deviation|2|||
27889553|NCT00557466|54541883|FG004|Overall Study|Protocol deviation|0|||
27889554|NCT00557466|54541884|FG005|Overall Study|Protocol deviation|0|||
27889555|NCT00557466|54541879|FG000|Overall Study|Subject withdrew consent|0|||
27889556|NCT00557466|54541880|FG001|Overall Study|Subject withdrew consent|0|||
27889557|NCT00557466|54541881|FG002|Overall Study|Subject withdrew consent|0|||
27889558|NCT00557466|54541882|FG003|Overall Study|Subject withdrew consent|0|||
27889559|NCT00557466|54541883|FG004|Overall Study|Subject withdrew consent|1|||
27889560|NCT00557466|54541884|FG005|Overall Study|Subject withdrew consent|2|||
27889561|NCT00557466|54541879|FG000|Overall Study|Administrative problems|0|||
27889562|NCT00557466|54541880|FG001|Overall Study|Administrative problems|1|||
27889563|NCT00557466|54541881|FG002|Overall Study|Administrative problems|1|||
27889564|NCT00557466|54541882|FG003|Overall Study|Administrative problems|0|||
27889565|NCT00557466|54541883|FG004|Overall Study|Administrative problems|0|||
27889566|NCT00557466|54541884|FG005|Overall Study|Administrative problems|0|||
27889567|NCT00557466|54541879|FG000|Overall Study|Abnormal test procedure results|0|||
27889568|NCT00557466|54541880|FG001|Overall Study|Abnormal test procedure results|0|||
27889569|NCT00557466|54541881|FG002|Overall Study|Abnormal test procedure results|1|||
27889570|NCT00557466|54541882|FG003|Overall Study|Abnormal test procedure results|0|||
27889571|NCT00557466|54541883|FG004|Overall Study|Abnormal test procedure results|0|||
27889572|NCT00557466|54541884|FG005|Overall Study|Abnormal test procedure results|0|||
27889573|NCT00557466|54541879|FG000|Overall Study|Lost to Follow-up|0|||
27889574|NCT00557466|54541880|FG001|Overall Study|Lost to Follow-up|0|||
27889575|NCT00557466|54541881|FG002|Overall Study|Lost to Follow-up|0|||
27889576|NCT00557466|54541882|FG003|Overall Study|Lost to Follow-up|1|||
27889577|NCT00557466|54541883|FG004|Overall Study|Lost to Follow-up|0|||
27889578|NCT00557466|54541884|FG005|Overall Study|Lost to Follow-up|0|||
27889579|NCT00557310|54541898|FG000|Main Study (0 - 18 Months)|Adverse Event|4|||
27889580|NCT00557310|54541898|FG000|Main Study (0 - 18 Months)|Withdrawal by Subject|1|||
27889581|NCT00557310|54541898|FG000|Extension Phase (18 - 24 Months)|Adverse Event|1|||
27889582|NCT00557310|54541898|FG000|Extension Phase (18 - 24 Months)|Lost to Follow-up|1|||
27889583|NCT00557310|54541898|FG000|Extension Phase (18 - 24 Months)|Physician Decision|2|||
27889584|NCT00557310|54541898|FG000|Extension Phase (18 - 24 Months)|Protocol Violation|1|||
27889585|NCT00555438|54541902|FG000|10 Days Post-operative|Death|4|||
27889586|NCT00555438|54541902|FG000|Between 10 Days and 30 Days Postoperativ|Death|5|||
27889587|NCT00553644|54541906|FG000|Overall Study|Adverse Event|17|||
27889588|NCT00553644|54541906|FG000|Overall Study|Withdrawal by Subject|4|||
27889589|NCT00553644|54541906|FG000|Overall Study|Physician Decision|1|||
27889590|NCT00553644|54541906|FG000|Overall Study|Alternative therapy|6|||
27739387|NCT02457182|54188983|FG000|Overall Study|Lost to Follow-up|1|||
27889591|NCT00553332|54541910|FG000|Overall Study|ineligible, incorrect diagnosis|1|||
27889592|NCT00552396|54541921|FG000|Overall Study|protocol withdrawal criteria|3|||
27889593|NCT00552396|54541922|FG001|Overall Study|protocol withdrawal criteria|3|||
27889594|NCT00552396|54541923|FG002|Overall Study|protocol withdrawal criteria|3|||
27889595|NCT00552396|54541924|FG003|Overall Study|protocol withdrawal criteria|6|||
27889596|NCT00552396|54541925|FG004|Overall Study|protocol withdrawal criteria|3|||
27889597|NCT00552396|54541926|FG005|Overall Study|protocol withdrawal criteria|3|||
27889598|NCT00552396|54541927|FG006|Overall Study|protocol withdrawal criteria|9|||
27889599|NCT00552240|54541963|FG000|Overall Study|Adverse Event|9|||
27889600|NCT00552240|54541964|FG001|Overall Study|Adverse Event|9|||
27889601|NCT00552240|54541963|FG000|Overall Study|Protocol Violation|1|||
27889602|NCT00552240|54541964|FG001|Overall Study|Protocol Violation|1|||
27889603|NCT00552240|54541963|FG000|Overall Study|Lost to Follow-up|5|||
27889604|NCT00552240|54541964|FG001|Overall Study|Lost to Follow-up|6|||
27889605|NCT00552240|54541963|FG000|Overall Study|Withdrawal by Subject|2|||
27889606|NCT00552240|54541964|FG001|Overall Study|Withdrawal by Subject|2|||
27889607|NCT00552240|54541963|FG000|Overall Study|Lack of Efficacy|6|||
27889608|NCT00552240|54541964|FG001|Overall Study|Lack of Efficacy|0|||
27889609|NCT00552240|54541963|FG000|Overall Study|Other|1|||
27889610|NCT00552240|54541964|FG001|Overall Study|Other|0|||
27889611|NCT00552084|54541972|FG000|Overall Study|Adverse Event|2|||
27889612|NCT00552084|54541973|FG001|Overall Study|Adverse Event|3|||
27889613|NCT00552084|54541972|FG000|Overall Study|Withdrawal by Subject|4|||
27889614|NCT00552084|54541973|FG001|Overall Study|Withdrawal by Subject|5|||
27889615|NCT00552084|54541972|FG000|Overall Study|Protocol Violation|1|||
27889616|NCT00552084|54541973|FG001|Overall Study|Protocol Violation|0|||
27889617|NCT00552084|54541972|FG000|Overall Study|change in anti-arrythmic drug|1|||
27889618|NCT00552084|54541973|FG001|Overall Study|change in anti-arrythmic drug|1|||
27889619|NCT00550836|54541981|FG000|Overall Study|Withdrawal by Subject|3|||
27889620|NCT00550836|54541982|FG001|Overall Study|Withdrawal by Subject|9|||
27889621|NCT00550680|54541988|FG000|Overall Study|Administrative Reasons|1|||
27889622|NCT00550680|54541988|FG000|Overall Study|Adverse Event|5|||
27889623|NCT00550680|54541988|FG000|Overall Study|Death|3|||
27889624|NCT00550680|54541988|FG000|Overall Study|Early Improvement|1|||
27889625|NCT00550680|54541988|FG000|Overall Study|Lost to Follow-up|3|||
27889626|NCT00550680|54541988|FG000|Overall Study|Lack of Efficacy|1|||
27889627|NCT00550680|54541988|FG000|Overall Study|Other|10|||
27889628|NCT00550680|54541988|FG000|Overall Study|Protocol Violation|7|||
27889629|NCT00550680|54541988|FG000|Overall Study|Refused Treatment|19|||
27889630|NCT00550680|54541988|FG000|Overall Study|Screen Failure|6|||
27889631|NCT00554190|54541992|FG000|Overall Study|Termination forms not completed|10|||
27889632|NCT00556374|54541998|FG000|Overall Study|Withdrawal by Subject|235|||
27889633|NCT00556374|54541999|FG001|Overall Study|Withdrawal by Subject|205|||
27889634|NCT00556374|54541998|FG000|Overall Study|Death|158|||
27889635|NCT00556374|54541999|FG001|Overall Study|Death|127|||
27889636|NCT00556374|54541998|FG000|Overall Study|Lost to Follow-up|24|||
27889637|NCT00556374|54541999|FG001|Overall Study|Lost to Follow-up|17|||
27889638|NCT00556374|54541998|FG000|Overall Study|Continuing into Zoledronic Acid Substudy|50|||
27889639|NCT00556374|54541999|FG001|Overall Study|Continuing into Zoledronic Acid Substudy|0|||
27889640|NCT04677959|54542030|FG000|Overall Study|Adverse Event|1|||
27889641|NCT04677959|54542031|FG001|Overall Study|Adverse Event|9|||
27889642|NCT04677959|54542030|FG000|Overall Study|Withdrawal by Subject|2|||
27889643|NCT04677959|54542031|FG001|Overall Study|Withdrawal by Subject|15|||
27889644|NCT04677959|54542030|FG000|Overall Study|Withdrawal by parent/guardian|0|||
27889645|NCT04677959|54542031|FG001|Overall Study|Withdrawal by parent/guardian|1|||
27889646|NCT04677959|54542030|FG000|Overall Study|Non-compliance with study drug|0|||
27889647|NCT04677959|54542031|FG001|Overall Study|Non-compliance with study drug|2|||
27889648|NCT04677959|54542030|FG000|Overall Study|Protocol deviation|0|||
27889649|NCT04677959|54542031|FG001|Overall Study|Protocol deviation|11|||
27889650|NCT04677959|54542030|FG000|Overall Study|Lost to Follow-up|9|||
27889651|NCT04677959|54542031|FG001|Overall Study|Lost to Follow-up|13|||
27889652|NCT04677959|54542030|FG000|Overall Study|Other than specified|0|||
27889653|NCT04677959|54542031|FG001|Overall Study|Other than specified|8|||
27889654|NCT04330638|54542058|FG000|Overall Study|Adverse Event|9|||
27889655|NCT04330638|54542059|FG001|Overall Study|Adverse Event|10|||
27889656|NCT04330638|54542060|FG002|Overall Study|Adverse Event|15|||
27889657|NCT04330638|54542061|FG003|Overall Study|Adverse Event|6|||
27889658|NCT04330638|54542062|FG004|Overall Study|Adverse Event|10|||
27889659|NCT04330638|54542063|FG005|Overall Study|Adverse Event|5|||
27889660|NCT04330638|54542058|FG000|Overall Study|Other|2|||
27889661|NCT04330638|54542059|FG001|Overall Study|Other|2|||
27889662|NCT04330638|54542060|FG002|Overall Study|Other|5|||
27889663|NCT04330638|54542061|FG003|Overall Study|Other|1|||
27889664|NCT04330638|54542062|FG004|Overall Study|Other|3|||
27889665|NCT04330638|54542063|FG005|Overall Study|Other|2|||
27889666|NCT04330638|54542058|FG000|Overall Study|Withdrawal by Subject|4|||
27889667|NCT04330638|54542059|FG001|Overall Study|Withdrawal by Subject|0|||
27889668|NCT04330638|54542060|FG002|Overall Study|Withdrawal by Subject|0|||
27889669|NCT04330638|54542061|FG003|Overall Study|Withdrawal by Subject|0|||
27889670|NCT04330638|54542062|FG004|Overall Study|Withdrawal by Subject|0|||
27889671|NCT04330638|54542063|FG005|Overall Study|Withdrawal by Subject|0|||
27889672|NCT04330638|54542058|FG000|Overall Study|Lost to Follow-up|3|||
27889673|NCT04330638|54542059|FG001|Overall Study|Lost to Follow-up|2|||
27889674|NCT04330638|54542060|FG002|Overall Study|Lost to Follow-up|3|||
27889675|NCT04330638|54542061|FG003|Overall Study|Lost to Follow-up|2|||
27889676|NCT04330638|54542062|FG004|Overall Study|Lost to Follow-up|3|||
27889677|NCT04330638|54542063|FG005|Overall Study|Lost to Follow-up|0|||
27889678|NCT04194541|54542084|FG000|Day 1 Through 13|Lost to Follow-up|3|||
27889679|NCT04194541|54542084|FG000|Day 1 Through 13|Coronavirus Disease of 2019 (COVID-19) shut down|6|||
27889680|NCT04194541|54542084|FG000|Day 15 Through Week 6|Lost to Follow-up|5|||
27889681|NCT04006392|54542102|FG000|Overall Study|Lost to Follow-up|0|||
27889682|NCT04006392|54542103|FG001|Overall Study|Lost to Follow-up|1|||
27889683|NCT03959423|54542111|FG000|Overall Study|Withdrawal by Subject|2|||
27889684|NCT03959423|54542112|FG001|Overall Study|Withdrawal by Subject|3|||
27889685|NCT03959423|54542111|FG000|Overall Study|Physician Decision|0|||
27889686|NCT03959423|54542112|FG001|Overall Study|Physician Decision|1|||
27889687|NCT03959423|54542111|FG000|Overall Study|Lost to Follow-up|1|||
27985561|NCT00872001|54644331|FG001|Overall Study|Withdrawal by Subject|30|||
27985562|NCT00872001|54644330|FG000|Overall Study|Protocol Violation|5|||
27985563|NCT00872001|54644331|FG001|Overall Study|Protocol Violation|8|||
27985564|NCT00872001|54644330|FG000|Overall Study|Did Not Meet Protocol Eligibility|38|||
27985565|NCT00872001|54644331|FG001|Overall Study|Did Not Meet Protocol Eligibility|36|||
27985566|NCT00872001|54644330|FG000|Overall Study|Administrative|23|||
27985567|NCT00872001|54644331|FG001|Overall Study|Administrative|15|||
27985568|NCT00871923|54644339|FG000|Overall Study|Death|1|||
27985569|NCT00871923|54644339|FG000|Overall Study|Withdrawal by Subject|1|||
27985570|NCT03922945|54644346|FG000|Overall Study|Adverse Event|1|||
28096661|NCT03692676|54751817|FG000|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
28096662|NCT03692676|54751818|FG001|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
28096663|NCT03692676|54751819|FG002|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965|||
28096664|NCT03692676|54751820|FG003|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198|||
28096665|NCT03692676|54751817|FG000|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
28096666|NCT03692676|54751818|FG001|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
28096667|NCT03692676|54751819|FG002|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
28096668|NCT03692676|54751820|FG003|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223|||
27889688|NCT03959423|54542112|FG001|Overall Study|Lost to Follow-up|0|||
27889689|NCT03959423|54542111|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
27889690|NCT03959423|54542112|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
27889691|NCT03786783|54542118|FG000|Overall Study|Death|1|||
27889692|NCT03786783|54542118|FG000|Overall Study|Physician Decision|6|||
27889693|NCT03786783|54542118|FG000|Overall Study|Withdrawal by Subject|2|||
27889694|NCT03786783|54542118|FG000|Overall Study|Disease Progression|7|||
27889695|NCT03786783|54542118|FG000|Overall Study|Patient/Parent Refusal|4|||
27889696|NCT03432494|54542132|FG000|Overall Study|Death|1|||
27889697|NCT03432494|54542132|FG000|Overall Study|Noncompliance|1|||
27889698|NCT03312634|54542138|FG000|Overall Study|Adverse Event|6|||
27889699|NCT03312634|54542139|FG001|Overall Study|Adverse Event|0|||
27889700|NCT03312634|54542138|FG000|Overall Study|Sponsor request|2|||
27889701|NCT03312634|54542139|FG001|Overall Study|Sponsor request|0|||
27889702|NCT03312634|54542138|FG000|Overall Study|Withdrawal by Subject|11|||
27889703|NCT03312634|54542139|FG001|Overall Study|Withdrawal by Subject|9|||
27889704|NCT03312634|54542138|FG000|Overall Study|Ongoing in study at DCO|88|||
27889705|NCT03312634|54542139|FG001|Overall Study|Ongoing in study at DCO|0|||
27889706|NCT03312634|54542138|FG000|Overall Study|Enrolled in an interventional study|0|||
27889707|NCT03312634|54542139|FG001|Overall Study|Enrolled in an interventional study|52|||
27889708|NCT03312634|54542138|FG000|Overall Study|Enrolled in an interventional study at time of a flare-up|0|||
27889709|NCT03312634|54542139|FG001|Overall Study|Enrolled in an interventional study at time of a flare-up|9|||
27889710|NCT03312634|54542138|FG000|Overall Study|Death|0|||
27889711|NCT03312634|54542139|FG001|Overall Study|Death|1|||
27889712|NCT03312634|54542138|FG000|Overall Study|Non-compliance|0|||
27889713|NCT03312634|54542139|FG001|Overall Study|Non-compliance|2|||
27889714|NCT03312634|54542138|FG000|Overall Study|Lost to Follow-up|0|||
27889715|NCT03312634|54542139|FG001|Overall Study|Lost to Follow-up|1|||
27889716|NCT03312634|54542138|FG000|Overall Study|Enrolled into non-interventional study|0|||
27889717|NCT03312634|54542139|FG001|Overall Study|Enrolled into non-interventional study|5|||
27889718|NCT03312634|54542138|FG000|Overall Study|Worsening clinical condition|0|||
27889719|NCT03312634|54542139|FG001|Overall Study|Worsening clinical condition|1|||
27889720|NCT03312634|54542138|FG000|Overall Study|Participant did not want to travel|0|||
27889721|NCT03312634|54542139|FG001|Overall Study|Participant did not want to travel|1|||
27889722|NCT03287830|54542150|FG000|Overall Study|Withdrawal by Subject|1|||
27889723|NCT03287830|54542151|FG001|Overall Study|Withdrawal by Subject|1|||
27889724|NCT03287830|54542150|FG000|Overall Study|not meeting inclusion criteria|5|||
27889725|NCT03287830|54542151|FG001|Overall Study|not meeting inclusion criteria|12|||
27889726|NCT03181633|54542161|FG000|Overall Study|Withdrawal by Subject|1|||
27889727|NCT03181633|54542161|FG000|Overall Study|Missing follow-up visit|1|||
27889728|NCT03122223|54542178|FG000|Overall Study|Withdrawal by Subject|2|||
27889729|NCT03122223|54542179|FG001|Overall Study|Withdrawal by Subject|2|||
27889730|NCT03122223|54542180|FG002|Overall Study|Withdrawal by Subject|1|||
27889731|NCT03122223|54542181|FG003|Overall Study|Withdrawal by Subject|0|||
27889732|NCT03122223|54542178|FG000|Overall Study|Lost to Follow-up|0|||
27889733|NCT03122223|54542179|FG001|Overall Study|Lost to Follow-up|2|||
27889734|NCT03122223|54542180|FG002|Overall Study|Lost to Follow-up|2|||
27889735|NCT03122223|54542181|FG003|Overall Study|Lost to Follow-up|0|||
27889736|NCT03122223|54542178|FG000|Overall Study|Participant unable to adhere|1|||
27889737|NCT03122223|54542179|FG001|Overall Study|Participant unable to adhere|1|||
27889738|NCT03122223|54542180|FG002|Overall Study|Participant unable to adhere|1|||
27889739|NCT03122223|54542181|FG003|Overall Study|Participant unable to adhere|0|||
27889740|NCT03077087|54542191|FG000|Overall Study|Physician Decision|2|||
27889741|NCT03075527|54542195|FG000|Overall Study|Ongoing treatment|2|||
27889742|NCT02853604|54542201|FG000|Overall Study|Withdrawal by Subject|12|||
27889743|NCT02853604|54542202|FG001|Overall Study|Withdrawal by Subject|35|||
27889744|NCT02853604|54542201|FG000|Overall Study|Lost to Follow-up|4|||
27889745|NCT02853604|54542202|FG001|Overall Study|Lost to Follow-up|8|||
27889746|NCT02853604|54542201|FG000|Overall Study|Death|1|||
27889747|NCT02853604|54542202|FG001|Overall Study|Death|5|||
27889748|NCT02853604|54542201|FG000|Overall Study|Miscellaneous|11|||
27889749|NCT02853604|54542202|FG001|Overall Study|Miscellaneous|2|||
27889750|NCT02853604|54542201|FG000|Overall Study|Progressive Disease|0|||
27889751|NCT02853604|54542202|FG001|Overall Study|Progressive Disease|2|||
27889752|NCT02632552|54542228|FG000|Overall Study|Lost to Follow-up|14|||
27889753|NCT02632552|54542229|FG001|Overall Study|Lost to Follow-up|8|||
27889754|NCT02632552|54542228|FG000|Overall Study|Withdrawal by Subject|2|||
27889755|NCT02632552|54542229|FG001|Overall Study|Withdrawal by Subject|0|||
27889756|NCT02632552|54542228|FG000|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|7|||
27889757|NCT02632552|54542229|FG001|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|2|||
27889758|NCT02525562|54542276|FG000|Overall Study|Death|9|||
27889759|NCT02525562|54542277|FG001|Overall Study|Death|0|||
27889760|NCT02525562|54542278|FG002|Overall Study|Death|0|||
27889761|NCT02525562|54542276|FG000|Overall Study|Lost to Follow-up|19|||
27889762|NCT02525562|54542277|FG001|Overall Study|Lost to Follow-up|0|||
27889763|NCT02525562|54542278|FG002|Overall Study|Lost to Follow-up|0|||
27889764|NCT02525562|54542276|FG000|Overall Study|Withdrawal by Subject|37|||
27889765|NCT02525562|54542277|FG001|Overall Study|Withdrawal by Subject|0|||
27889766|NCT02525562|54542278|FG002|Overall Study|Withdrawal by Subject|0|||
27889767|NCT02525562|54542276|FG000|Overall Study|Revision/Removal of Study Device|4|||
27889768|NCT02525562|54542277|FG001|Overall Study|Revision/Removal of Study Device|0|||
27889769|NCT02525562|54542278|FG002|Overall Study|Revision/Removal of Study Device|0|||
27889770|NCT02525562|54542276|FG000|Overall Study|Study Closed by Sponsor|154|||
27889771|NCT02525562|54542277|FG001|Overall Study|Study Closed by Sponsor|0|||
27889772|NCT02525562|54542278|FG002|Overall Study|Study Closed by Sponsor|0|||
27889773|NCT01992653|54542291|FG000|Overall Study|Death|0|||
27889774|NCT01992653|54542292|FG001|Overall Study|Death|0|||
27889775|NCT01992653|54542293|FG002|Overall Study|Death|1|||
27889776|NCT01992653|54542294|FG003|Overall Study|Death|0|||
27889777|NCT01992653|54542295|FG004|Overall Study|Death|1|||
27889778|NCT01992653|54542296|FG005|Overall Study|Death|0|||
27889779|NCT01992653|54542297|FG006|Overall Study|Death|4|||
27889780|NCT01992653|54542298|FG007|Overall Study|Death|2|||
27889781|NCT01992653|54542291|FG000|Overall Study|Lost to Follow-up|0|||
27889782|NCT01992653|54542292|FG001|Overall Study|Lost to Follow-up|0|||
27889783|NCT01992653|54542293|FG002|Overall Study|Lost to Follow-up|0|||
27889784|NCT01992653|54542294|FG003|Overall Study|Lost to Follow-up|0|||
27889785|NCT01992653|54542295|FG004|Overall Study|Lost to Follow-up|0|||
27889786|NCT01992653|54542296|FG005|Overall Study|Lost to Follow-up|0|||
27889787|NCT01992653|54542297|FG006|Overall Study|Lost to Follow-up|0|||
27889788|NCT01992653|54542298|FG007|Overall Study|Lost to Follow-up|1|||
27985571|NCT03922945|54644347|FG001|Overall Study|Adverse Event|1|||
27985572|NCT03922945|54644348|FG002|Overall Study|Adverse Event|2|||
27985573|NCT03922945|54644346|FG000|Overall Study|Lost to Follow-up|13|||
27985574|NCT03922945|54644347|FG001|Overall Study|Lost to Follow-up|9|||
27889789|NCT01992653|54542291|FG000|Overall Study|Study Completed|0|||
27889790|NCT01992653|54542292|FG001|Overall Study|Study Completed|0|||
27889791|NCT01992653|54542293|FG002|Overall Study|Study Completed|0|||
27889792|NCT01992653|54542294|FG003|Overall Study|Study Completed|0|||
27889793|NCT01992653|54542295|FG004|Overall Study|Study Completed|0|||
27889794|NCT01992653|54542296|FG005|Overall Study|Study Completed|0|||
27889795|NCT01992653|54542297|FG006|Overall Study|Study Completed|0|||
27889796|NCT01992653|54542298|FG007|Overall Study|Study Completed|1|||
27889797|NCT01992653|54542291|FG000|Overall Study|Disease Progression|0|||
27889798|NCT01992653|54542292|FG001|Overall Study|Disease Progression|0|||
27889799|NCT01992653|54542293|FG002|Overall Study|Disease Progression|0|||
27889800|NCT01992653|54542294|FG003|Overall Study|Disease Progression|0|||
27889801|NCT01992653|54542295|FG004|Overall Study|Disease Progression|0|||
27889802|NCT01992653|54542296|FG005|Overall Study|Disease Progression|0|||
27889803|NCT01992653|54542297|FG006|Overall Study|Disease Progression|4|||
27889804|NCT01992653|54542298|FG007|Overall Study|Disease Progression|0|||
27889805|NCT01682083|54542335|FG000|Overall Study|Lost to Follow-up|11|||
27889806|NCT01682083|54542336|FG001|Overall Study|Lost to Follow-up|18|||
27889807|NCT01682083|54542335|FG000|Overall Study|Withdrawal by Subject|31|||
27889808|NCT01682083|54542336|FG001|Overall Study|Withdrawal by Subject|40|||
27889809|NCT01682083|54542335|FG000|Overall Study|Death|60|||
27889810|NCT01682083|54542336|FG001|Overall Study|Death|93|||
27889811|NCT01682083|54542335|FG000|Overall Study|Physician Decision|5|||
27889812|NCT01682083|54542336|FG001|Overall Study|Physician Decision|4|||
27889813|NCT01654276|54542342|FG000|Overall Study|Lack of Efficacy|1|||
27889814|NCT01654276|54542342|FG000|Overall Study|Lost to Follow-up|4|||
27889815|NCT01654276|54542342|FG000|Overall Study|Withdrawal by Subject|1|||
27889816|NCT01399658|54542346|FG000|Overall Study|Ineligible|1|||
27889817|NCT01399658|54542346|FG000|Overall Study|Machine Technical Issue|3|||
27889818|NCT01399658|54542346|FG000|Overall Study|Alternative therapy|1|||
27889819|NCT01399658|54542346|FG000|Overall Study|No reason given|1|||
27889820|NCT00590122|54542352|FG000|Overall Study|swallowed oral dissolving dose|1|||
27889821|NCT00590122|54542353|FG001|Overall Study|swallowed oral dissolving dose|0|||
27889822|NCT01386658|54542382|FG000|Initial Icatibant Exposure|Withdrawal by Subject|0|||
27889823|NCT01386658|54542383|FG001|Initial Icatibant Exposure|Withdrawal by Subject|9|||
27889824|NCT01386658|54542382|FG000|Initial Icatibant Exposure|Lack of adherence and poor compliance|0|||
27889825|NCT01386658|54542383|FG001|Initial Icatibant Exposure|Lack of adherence and poor compliance|3|||
27889826|NCT01386684|54542393|FG000|Overall Study|Lost to Follow-up|51|||
27889827|NCT01386684|54542393|FG000|Overall Study|Other|51|||
27889828|NCT01386684|54542393|FG000|Overall Study|Death|47|||
27889829|NCT01386684|54542393|FG000|Overall Study|Withdrawal of Consent|44|||
27889830|NCT01386684|54542393|FG000|Overall Study|Alternative Therapy Required|37|||
27889831|NCT01386684|54542393|FG000|Overall Study|Disease Progression|28|||
27889832|NCT01386684|54542393|FG000|Overall Study|Adverse Event|20|||
27889833|NCT01386684|54542393|FG000|Overall Study|Noncompliance|8|||
27889834|NCT01386684|54542393|FG000|Overall Study|Protocol Violation|4|||
27889835|NCT01386684|54542393|FG000|Overall Study|Missing|3|||
27889836|NCT04980014|54542410|FG000|Overall Study|Participants who are Duplicated|1|||
27889837|NCT04980014|54542410|FG000|Overall Study|Follow-up Failure|13|||
27889838|NCT04980014|54542410|FG000|Overall Study|Participants who did not Receive NesinaAct® Tablet|2|||
27889839|NCT04980014|54542410|FG000|Overall Study|Participants who Have Been Administered NesinaAct® Tablet prior to the consent|2|||
27889840|NCT04980014|54542410|FG000|Overall Study|Participants who Violated Inclusion/Exclusion Criteria|57|||
27889841|NCT03735849|54542434|FG000|Overall Study|Lost to Follow-up|1|||
27889842|NCT03735849|54542435|FG001|Overall Study|Lost to Follow-up|0|||
27889843|NCT03735849|54542436|FG002|Overall Study|Lost to Follow-up|0|||
27889844|NCT03735849|54542434|FG000|Overall Study|Participant unable to adhere to visit|1|||
27889845|NCT03735849|54542435|FG001|Overall Study|Participant unable to adhere to visit|0|||
27889846|NCT03735849|54542436|FG002|Overall Study|Participant unable to adhere to visit|0|||
27889847|NCT03735849|54542434|FG000|Overall Study|Not Randomized|0|||
27889848|NCT03735849|54542435|FG001|Overall Study|Not Randomized|0|||
27889849|NCT03735849|54542436|FG002|Overall Study|Not Randomized|4|||
27889850|NCT03552393|54542443|FG000|Core Period|Kidney Transplant|1|||
27889851|NCT03552393|54542443|FG000|Core Period|Prohibited Medication|1|||
27889852|NCT03552393|54542443|FG000|Safety Extension Period|Kidney Transplant|4|||
27889853|NCT03333382|54542449|FG000|Overall Study|Lost to Follow-up|1|||
27889854|NCT03333382|54542450|FG001|Overall Study|Lost to Follow-up|0|||
27889855|NCT03107611|54542489|FG000|Overall Study|Adverse Event|1|||
27889856|NCT03107611|54542490|FG001|Overall Study|Adverse Event|0|||
27889857|NCT03107611|54542491|FG002|Overall Study|Adverse Event|2|||
27889858|NCT03107611|54542489|FG000|Overall Study|Lost to Follow-up|3|||
27889859|NCT03107611|54542490|FG001|Overall Study|Lost to Follow-up|3|||
27889860|NCT03107611|54542491|FG002|Overall Study|Lost to Follow-up|3|||
27889861|NCT03107611|54542489|FG000|Overall Study|Protocol Violation|0|||
27889862|NCT03107611|54542490|FG001|Overall Study|Protocol Violation|0|||
27889863|NCT03107611|54542491|FG002|Overall Study|Protocol Violation|1|||
27889864|NCT03107611|54542489|FG000|Overall Study|Withdrawal by Subject|1|||
27889865|NCT03107611|54542490|FG001|Overall Study|Withdrawal by Subject|0|||
27889866|NCT03107611|54542491|FG002|Overall Study|Withdrawal by Subject|1|||
27985575|NCT03922945|54644348|FG002|Overall Study|Lost to Follow-up|20|||
28096669|NCT03692676|54751817|FG000|Overall Study|Other|0|||
27889867|NCT03107611|54542489|FG000|Overall Study|Worsening signs/symptoms|2|||
27889868|NCT03107611|54542490|FG001|Overall Study|Worsening signs/symptoms|1|||
27889869|NCT03107611|54542491|FG002|Overall Study|Worsening signs/symptoms|2|||
27889870|NCT02720016|54542502|FG000|Overall Study|Separation of couple|6|||
27889871|NCT02720016|54542503|FG001|Overall Study|Separation of couple|8|||
27889872|NCT02720016|54542504|FG002|Overall Study|Separation of couple|2|||
27889873|NCT02720016|54542502|FG000|Overall Study|Withdrawal by Subject|6|||
27889874|NCT02720016|54542503|FG001|Overall Study|Withdrawal by Subject|6|||
27889875|NCT02720016|54542504|FG002|Overall Study|Withdrawal by Subject|4|||
27889876|NCT02720016|54542502|FG000|Overall Study|Scheduling issues|2|||
27889877|NCT02720016|54542503|FG001|Overall Study|Scheduling issues|4|||
27889878|NCT02720016|54542504|FG002|Overall Study|Scheduling issues|7|||
27889879|NCT02720016|54542502|FG000|Overall Study|Childcare|2|||
27889880|NCT02720016|54542503|FG001|Overall Study|Childcare|0|||
27889881|NCT02720016|54542504|FG002|Overall Study|Childcare|2|||
27889882|NCT02720016|54542502|FG000|Overall Study|Withdrawal by PI|2|||
27889883|NCT02720016|54542503|FG001|Overall Study|Withdrawal by PI|2|||
27889884|NCT02720016|54542504|FG002|Overall Study|Withdrawal by PI|0|||
27889885|NCT02720016|54542502|FG000|Overall Study|Moved away|2|||
27889886|NCT02720016|54542503|FG001|Overall Study|Moved away|0|||
27889887|NCT02720016|54542504|FG002|Overall Study|Moved away|0|||
27889888|NCT02720016|54542502|FG000|Overall Study|Not Primary Health Concern|0|||
27889889|NCT02720016|54542503|FG001|Overall Study|Not Primary Health Concern|0|||
27889890|NCT02720016|54542504|FG002|Overall Study|Not Primary Health Concern|2|||
27889891|NCT02720016|54542502|FG000|Overall Study|Transportation issues|0|||
27889892|NCT02720016|54542503|FG001|Overall Study|Transportation issues|0|||
27889893|NCT02720016|54542504|FG002|Overall Study|Transportation issues|1|||
27889894|NCT02720016|54542502|FG000|Overall Study|Other|0|||
27889895|NCT02720016|54542503|FG001|Overall Study|Other|0|||
27889896|NCT02720016|54542504|FG002|Overall Study|Other|2|||
27889897|NCT02607956|54542515|FG000|Double-Blinded Phase|Withdrew Consent|17|||
27889898|NCT02607956|54542516|FG001|Double-Blinded Phase|Withdrew Consent|19|||
27889899|NCT02607956|54542517|FG002|Double-Blinded Phase|Withdrew Consent|0|||
27889900|NCT02607956|54542518|FG003|Double-Blinded Phase|Withdrew Consent|0|||
27889901|NCT02607956|54542515|FG000|Double-Blinded Phase|Lost to Follow-up|19|||
27889902|NCT02607956|54542516|FG001|Double-Blinded Phase|Lost to Follow-up|16|||
27889903|NCT02607956|54542517|FG002|Double-Blinded Phase|Lost to Follow-up|0|||
27889904|NCT02607956|54542518|FG003|Double-Blinded Phase|Lost to Follow-up|0|||
27889905|NCT02607956|54542515|FG000|Double-Blinded Phase|Randomized but never treated|7|||
27889906|NCT02607956|54542516|FG001|Double-Blinded Phase|Randomized but never treated|5|||
27889907|NCT02607956|54542517|FG002|Double-Blinded Phase|Randomized but never treated|0|||
27889908|NCT02607956|54542518|FG003|Double-Blinded Phase|Randomized but never treated|0|||
27889909|NCT02607956|54542515|FG000|Double-Blinded Phase|Investigator's Discretion|7|||
27889910|NCT02607956|54542516|FG001|Double-Blinded Phase|Investigator's Discretion|2|||
27889911|NCT02607956|54542517|FG002|Double-Blinded Phase|Investigator's Discretion|0|||
27889912|NCT02607956|54542518|FG003|Double-Blinded Phase|Investigator's Discretion|0|||
27889913|NCT02607956|54542515|FG000|Double-Blinded Phase|Death|4|||
27889914|NCT02607956|54542516|FG001|Double-Blinded Phase|Death|4|||
27889915|NCT02607956|54542517|FG002|Double-Blinded Phase|Death|0|||
27889916|NCT02607956|54542518|FG003|Double-Blinded Phase|Death|0|||
27889917|NCT02607956|54542515|FG000|Double-Blinded Phase|Adverse Event|4|||
27889918|NCT02607956|54542516|FG001|Double-Blinded Phase|Adverse Event|3|||
27889919|NCT02607956|54542517|FG002|Double-Blinded Phase|Adverse Event|0|||
27889920|NCT02607956|54542518|FG003|Double-Blinded Phase|Adverse Event|0|||
27889921|NCT02607956|54542515|FG000|Double-Blinded Phase|Protocol Violation|3|||
27889922|NCT02607956|54542516|FG001|Double-Blinded Phase|Protocol Violation|1|||
27889923|NCT02607956|54542517|FG002|Double-Blinded Phase|Protocol Violation|0|||
27889924|NCT02607956|54542518|FG003|Double-Blinded Phase|Protocol Violation|0|||
27889925|NCT02607956|54542515|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
27889926|NCT02607956|54542516|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|3|||
27889927|NCT02607956|54542517|FG002|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
27889928|NCT02607956|54542518|FG003|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
27889929|NCT02607956|54542515|FG000|Open-Label Extension Phase|Withdrew Consent|0|||
27889930|NCT02607956|54542516|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
27889931|NCT02607956|54542517|FG002|Open-Label Extension Phase|Withdrew Consent|10|||
27889932|NCT02607956|54542518|FG003|Open-Label Extension Phase|Withdrew Consent|16|||
27889933|NCT02607956|54542515|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
27889934|NCT02607956|54542516|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
27889935|NCT02607956|54542517|FG002|Open-Label Extension Phase|Lost to Follow-up|14|||
27889936|NCT02607956|54542518|FG003|Open-Label Extension Phase|Lost to Follow-up|6|||
27889937|NCT02607956|54542515|FG000|Open-Label Extension Phase|Death|0|||
27889938|NCT02607956|54542516|FG001|Open-Label Extension Phase|Death|0|||
27889939|NCT02607956|54542517|FG002|Open-Label Extension Phase|Death|1|||
27889940|NCT02607956|54542518|FG003|Open-Label Extension Phase|Death|3|||
27889941|NCT02607956|54542515|FG000|Open-Label Extension Phase|Investigator's Discretion|0|||
27889942|NCT02607956|54542516|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
27889943|NCT02607956|54542517|FG002|Open-Label Extension Phase|Investigator's Discretion|2|||
27889944|NCT02607956|54542518|FG003|Open-Label Extension Phase|Investigator's Discretion|2|||
27889945|NCT02607956|54542515|FG000|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
27889946|NCT02607956|54542516|FG001|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
27889947|NCT02607956|54542517|FG002|Open-Label Extension Phase|Non Compliance with Study Drug|2|||
27889948|NCT02607956|54542518|FG003|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
27889949|NCT02607956|54542515|FG000|Open-Label Extension Phase|Protocol Violation|0|||
27889950|NCT02607956|54542516|FG001|Open-Label Extension Phase|Protocol Violation|0|||
27889951|NCT02607956|54542517|FG002|Open-Label Extension Phase|Protocol Violation|0|||
27889952|NCT02607956|54542518|FG003|Open-Label Extension Phase|Protocol Violation|2|||
27889953|NCT02607956|54542515|FG000|Open-Label Extension Phase|Pregnancy|0|||
27889954|NCT02607956|54542516|FG001|Open-Label Extension Phase|Pregnancy|0|||
27889955|NCT02607956|54542517|FG002|Open-Label Extension Phase|Pregnancy|0|||
27889956|NCT02607956|54542518|FG003|Open-Label Extension Phase|Pregnancy|1|||
27889957|NCT02564523|54542548|FG000|Overall Study|Withdrawal by Subject|3|||
27889958|NCT02564523|54542549|FG001|Overall Study|Withdrawal by Subject|0|||
27889959|NCT02564523|54542550|FG002|Overall Study|Withdrawal by Subject|1|||
27889960|NCT02564523|54542551|FG003|Overall Study|Withdrawal by Subject|0|||
27889961|NCT02564523|54542552|FG004|Overall Study|Withdrawal by Subject|1|||
27889962|NCT02564523|54542553|FG005|Overall Study|Withdrawal by Subject|0|||
27889963|NCT02564523|54542554|FG006|Overall Study|Withdrawal by Subject|1|||
27889964|NCT02564523|54542555|FG007|Overall Study|Withdrawal by Subject|0|||
27889965|NCT02564523|54542556|FG008|Overall Study|Withdrawal by Subject|0|||
27889966|NCT02564523|54542557|FG009|Overall Study|Withdrawal by Subject|0|||
27889967|NCT02564523|54542558|FG010|Overall Study|Withdrawal by Subject|1|||
27889968|NCT02564523|54542559|FG011|Overall Study|Withdrawal by Subject|0|||
27889969|NCT02564523|54542560|FG012|Overall Study|Withdrawal by Subject|1|||
27889970|NCT02564523|54542561|FG013|Overall Study|Withdrawal by Subject|0|||
27889971|NCT02564523|54542562|FG014|Overall Study|Withdrawal by Subject|0|||
27889972|NCT02564523|54542563|FG015|Overall Study|Withdrawal by Subject|0|||
27889973|NCT02564523|54542564|FG016|Overall Study|Withdrawal by Subject|0|||
27889974|NCT02564523|54542565|FG017|Overall Study|Withdrawal by Subject|0|||
27889975|NCT02564523|54542548|FG000|Overall Study|Adverse Event|0|||
27889976|NCT02564523|54542549|FG001|Overall Study|Adverse Event|0|||
27889977|NCT02564523|54542550|FG002|Overall Study|Adverse Event|0|||
27889978|NCT02564523|54542551|FG003|Overall Study|Adverse Event|0|||
27889979|NCT02564523|54542552|FG004|Overall Study|Adverse Event|0|||
27889980|NCT02564523|54542553|FG005|Overall Study|Adverse Event|0|||
27889981|NCT02564523|54542554|FG006|Overall Study|Adverse Event|0|||
27889982|NCT02564523|54542555|FG007|Overall Study|Adverse Event|0|||
27889983|NCT02564523|54542556|FG008|Overall Study|Adverse Event|0|||
27889984|NCT02564523|54542557|FG009|Overall Study|Adverse Event|0|||
27889985|NCT02564523|54542558|FG010|Overall Study|Adverse Event|0|||
27889986|NCT02564523|54542559|FG011|Overall Study|Adverse Event|0|||
27889987|NCT02564523|54542560|FG012|Overall Study|Adverse Event|0|||
27889988|NCT02564523|54542561|FG013|Overall Study|Adverse Event|0|||
27889989|NCT02564523|54542562|FG014|Overall Study|Adverse Event|0|||
27889990|NCT02564523|54542563|FG015|Overall Study|Adverse Event|0|||
27889991|NCT02564523|54542564|FG016|Overall Study|Adverse Event|0|||
27889992|NCT02564523|54542565|FG017|Overall Study|Adverse Event|1|||
27889993|NCT02564523|54542548|FG000|Overall Study|Death|0|||
27889994|NCT02564523|54542549|FG001|Overall Study|Death|0|||
27889995|NCT02564523|54542550|FG002|Overall Study|Death|0|||
27889996|NCT02564523|54542551|FG003|Overall Study|Death|0|||
27889997|NCT02564523|54542552|FG004|Overall Study|Death|0|||
27889998|NCT02564523|54542553|FG005|Overall Study|Death|0|||
27889999|NCT02564523|54542554|FG006|Overall Study|Death|1|||
27890000|NCT02564523|54542555|FG007|Overall Study|Death|0|||
27890001|NCT02564523|54542556|FG008|Overall Study|Death|0|||
27890002|NCT02564523|54542557|FG009|Overall Study|Death|0|||
27890003|NCT02564523|54542558|FG010|Overall Study|Death|1|||
27890004|NCT02564523|54542559|FG011|Overall Study|Death|0|||
27890005|NCT02564523|54542560|FG012|Overall Study|Death|0|||
27890006|NCT02564523|54542561|FG013|Overall Study|Death|0|||
27890007|NCT02564523|54542562|FG014|Overall Study|Death|0|||
27890008|NCT02564523|54542563|FG015|Overall Study|Death|0|||
27890009|NCT02564523|54542564|FG016|Overall Study|Death|0|||
27890010|NCT02564523|54542565|FG017|Overall Study|Death|0|||
27890011|NCT02564523|54542548|FG000|Overall Study|Lost to Follow-up|2|||
27890012|NCT02564523|54542549|FG001|Overall Study|Lost to Follow-up|1|||
27890013|NCT02564523|54542550|FG002|Overall Study|Lost to Follow-up|4|||
27890014|NCT02564523|54542551|FG003|Overall Study|Lost to Follow-up|0|||
27890015|NCT02564523|54542552|FG004|Overall Study|Lost to Follow-up|1|||
27890016|NCT02564523|54542553|FG005|Overall Study|Lost to Follow-up|0|||
27890017|NCT02564523|54542554|FG006|Overall Study|Lost to Follow-up|1|||
27890018|NCT02564523|54542555|FG007|Overall Study|Lost to Follow-up|0|||
27890019|NCT02564523|54542556|FG008|Overall Study|Lost to Follow-up|0|||
27890020|NCT02564523|54542557|FG009|Overall Study|Lost to Follow-up|0|||
27890021|NCT02564523|54542558|FG010|Overall Study|Lost to Follow-up|0|||
27890022|NCT02564523|54542559|FG011|Overall Study|Lost to Follow-up|1|||
27890023|NCT02564523|54542560|FG012|Overall Study|Lost to Follow-up|1|||
28171865|NCT02468674|54843502|FG003|Overall Study|Adverse Event|1|||
27890024|NCT02564523|54542561|FG013|Overall Study|Lost to Follow-up|0|||
27890025|NCT02564523|54542562|FG014|Overall Study|Lost to Follow-up|0|||
27890026|NCT02564523|54542563|FG015|Overall Study|Lost to Follow-up|0|||
27890027|NCT02564523|54542564|FG016|Overall Study|Lost to Follow-up|0|||
27890028|NCT02564523|54542565|FG017|Overall Study|Lost to Follow-up|0|||
27890029|NCT02564523|54542548|FG000|Overall Study|Physician Decision|0|||
27890030|NCT02564523|54542549|FG001|Overall Study|Physician Decision|0|||
27890031|NCT02564523|54542550|FG002|Overall Study|Physician Decision|0|||
27890032|NCT02564523|54542551|FG003|Overall Study|Physician Decision|0|||
27890033|NCT02564523|54542552|FG004|Overall Study|Physician Decision|1|||
27890034|NCT02564523|54542553|FG005|Overall Study|Physician Decision|0|||
27890035|NCT02564523|54542554|FG006|Overall Study|Physician Decision|0|||
27890036|NCT02564523|54542555|FG007|Overall Study|Physician Decision|0|||
27890037|NCT02564523|54542556|FG008|Overall Study|Physician Decision|0|||
27890038|NCT02564523|54542557|FG009|Overall Study|Physician Decision|0|||
27890039|NCT02564523|54542558|FG010|Overall Study|Physician Decision|1|||
27890040|NCT02564523|54542559|FG011|Overall Study|Physician Decision|0|||
27890041|NCT02564523|54542560|FG012|Overall Study|Physician Decision|0|||
27890042|NCT02564523|54542561|FG013|Overall Study|Physician Decision|0|||
27890043|NCT02564523|54542562|FG014|Overall Study|Physician Decision|0|||
27890044|NCT02564523|54542563|FG015|Overall Study|Physician Decision|0|||
27890045|NCT02564523|54542564|FG016|Overall Study|Physician Decision|0|||
27890046|NCT02564523|54542565|FG017|Overall Study|Physician Decision|0|||
27890047|NCT02564523|54542548|FG000|Overall Study|Protocol Violation|2|||
27890048|NCT02564523|54542549|FG001|Overall Study|Protocol Violation|2|||
27890049|NCT02564523|54542550|FG002|Overall Study|Protocol Violation|5|||
27890050|NCT02564523|54542551|FG003|Overall Study|Protocol Violation|0|||
27890051|NCT02564523|54542552|FG004|Overall Study|Protocol Violation|1|||
27890052|NCT02564523|54542553|FG005|Overall Study|Protocol Violation|0|||
27890053|NCT02564523|54542554|FG006|Overall Study|Protocol Violation|0|||
27890054|NCT02564523|54542555|FG007|Overall Study|Protocol Violation|0|||
27890055|NCT02564523|54542556|FG008|Overall Study|Protocol Violation|0|||
27890056|NCT02564523|54542557|FG009|Overall Study|Protocol Violation|0|||
27890057|NCT02564523|54542558|FG010|Overall Study|Protocol Violation|0|||
27890058|NCT02564523|54542559|FG011|Overall Study|Protocol Violation|0|||
27890059|NCT02564523|54542560|FG012|Overall Study|Protocol Violation|0|||
27890060|NCT02564523|54542561|FG013|Overall Study|Protocol Violation|0|||
27890061|NCT02564523|54542562|FG014|Overall Study|Protocol Violation|0|||
27890062|NCT02564523|54542563|FG015|Overall Study|Protocol Violation|0|||
27890063|NCT02564523|54542564|FG016|Overall Study|Protocol Violation|0|||
27890064|NCT02564523|54542565|FG017|Overall Study|Protocol Violation|0|||
27890065|NCT02564523|54542548|FG000|Overall Study|Other|3|||
27890066|NCT02564523|54542549|FG001|Overall Study|Other|0|||
27890067|NCT02564523|54542550|FG002|Overall Study|Other|0|||
27890068|NCT02564523|54542551|FG003|Overall Study|Other|1|||
27890069|NCT02564523|54542552|FG004|Overall Study|Other|0|||
27890070|NCT02564523|54542553|FG005|Overall Study|Other|0|||
27890071|NCT02564523|54542554|FG006|Overall Study|Other|0|||
27890072|NCT02564523|54542555|FG007|Overall Study|Other|0|||
27890073|NCT02564523|54542556|FG008|Overall Study|Other|0|||
27890074|NCT02564523|54542557|FG009|Overall Study|Other|0|||
27890075|NCT02564523|54542558|FG010|Overall Study|Other|0|||
27890076|NCT02564523|54542559|FG011|Overall Study|Other|0|||
27890077|NCT02564523|54542560|FG012|Overall Study|Other|0|||
27890078|NCT02564523|54542561|FG013|Overall Study|Other|0|||
27890079|NCT02564523|54542562|FG014|Overall Study|Other|0|||
27890080|NCT02564523|54542563|FG015|Overall Study|Other|0|||
27890081|NCT02564523|54542564|FG016|Overall Study|Other|0|||
27890082|NCT02564523|54542565|FG017|Overall Study|Other|0|||
27890083|NCT01447628|54542672|FG000|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
27890084|NCT01447628|54542673|FG001|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
27890085|NCT01447628|54542674|FG002|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
27890086|NCT01447628|54542675|FG003|Week 0 to Week 12 (1st Intervention)|Adverse Event|1|||
27890087|NCT00515853|54542697|FG000|Overall Study|Lost to Follow-up|9|||
27890088|NCT00515853|54542698|FG001|Overall Study|Lost to Follow-up|13|||
27890089|NCT00515853|54542697|FG000|Overall Study|Withdrawal by Subject|6|||
27890090|NCT00515853|54542698|FG001|Overall Study|Withdrawal by Subject|4|||
27890091|NCT00003458|54542704|FG000|Overall Study|Not evaluable|4|||
27890092|NCT05032872|54542711|FG000|Overall Study|Adverse Event|1|||
27890093|NCT05032872|54542712|FG001|Overall Study|Adverse Event|0|||
27890094|NCT05032872|54542711|FG000|Overall Study|Lost to Follow-up|2|||
27890095|NCT05032872|54542712|FG001|Overall Study|Lost to Follow-up|4|||
27890096|NCT05032872|54542711|FG000|Overall Study|Withdrawal by Subject|4|||
27890097|NCT05032872|54542712|FG001|Overall Study|Withdrawal by Subject|3|||
27890098|NCT04613739|54542738|FG000|Overall Study|Lost to Follow-up|6|||
27890099|NCT04613739|54542739|FG001|Overall Study|Lost to Follow-up|9|||
27890100|NCT04613739|54542738|FG000|Overall Study|potentially duplicative/fraudulent|1|||
27890101|NCT04613739|54542739|FG001|Overall Study|potentially duplicative/fraudulent|3|||
27890102|NCT04407806|54542766|FG000|Overall Study|Withdrawal by Subject|1|||
27890103|NCT04407806|54542767|FG001|Overall Study|Withdrawal by Subject|2|||
27890104|NCT04324021|54542776|FG000|Overall Study|Adverse Event|1|||
27890105|NCT04324021|54542777|FG001|Overall Study|Adverse Event|0|||
27890106|NCT04324021|54542778|FG002|Overall Study|Adverse Event|0|||
27890107|NCT04324021|54542776|FG000|Overall Study|Lack of Efficacy|0|||
27890108|NCT04324021|54542777|FG001|Overall Study|Lack of Efficacy|0|||
27890109|NCT04324021|54542778|FG002|Overall Study|Lack of Efficacy|1|||
27985576|NCT03922945|54644346|FG000|Overall Study|Lack of Efficacy|2|||
27890110|NCT04324021|54542776|FG000|Overall Study|Death|1|||
27890111|NCT04324021|54542777|FG001|Overall Study|Death|1|||
27890112|NCT04324021|54542778|FG002|Overall Study|Death|0|||
27890113|NCT04209621|54542789|FG000|Overall Study|Death|1|||
27890114|NCT04209621|54542789|FG000|Overall Study|Study Terminated Early|2|||
27890115|NCT04186663|54542794|FG000|Overall Study|Lost to Follow-up|1|||
27890116|NCT04186663|54542794|FG000|Overall Study|Unable to complete blood draw|3|||
27890117|NCT04158219|54542798|FG000|Overall Study|Lost to Follow-up|1|||
27890118|NCT03954743|54542831|FG000|Overall Study|Adverse Event|1|||
27890119|NCT03954743|54542832|FG001|Overall Study|Adverse Event|0|||
27890120|NCT03954743|54542831|FG000|Overall Study|Lost to Follow-up|6|||
27890121|NCT03954743|54542832|FG001|Overall Study|Lost to Follow-up|4|||
27890122|NCT03954743|54542831|FG000|Overall Study|Protocol Violation|1|||
27890123|NCT03954743|54542832|FG001|Overall Study|Protocol Violation|0|||
27890124|NCT03954743|54542831|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|13|||
27890125|NCT03954743|54542832|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|12|||
27890126|NCT03954743|54542831|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
27890127|NCT03954743|54542832|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
27890128|NCT03880565|54542853|FG000|Overall Study|Withdrawal by Subject|1|||
27890129|NCT03880565|54542854|FG001|Overall Study|Withdrawal by Subject|0|||
27890130|NCT03782792|54542862|FG000|Overall Study|Patient left the country|0|||
27890131|NCT03782792|54542863|FG001|Overall Study|Patient left the country|1|||
27890132|NCT03782792|54542862|FG000|Overall Study|Withdrawal by Subject|1|||
27890133|NCT03782792|54542863|FG001|Overall Study|Withdrawal by Subject|2|||
27890134|NCT03733119|54542873|FG000|Overall Study|Physician Decision|2|||
27890135|NCT03733119|54542874|FG001|Overall Study|Physician Decision|1|||
27890136|NCT03733119|54542873|FG000|Overall Study|ineligible to treat per protocol|0|||
27890137|NCT03733119|54542874|FG001|Overall Study|ineligible to treat per protocol|1|||
27890138|NCT03661996|54542885|FG000|Overall Study|Adverse Event|0|||
27890139|NCT03661996|54542886|FG001|Overall Study|Adverse Event|0|||
27890140|NCT03661996|54542887|FG002|Overall Study|Adverse Event|1|||
27890141|NCT03661996|54542888|FG003|Overall Study|Adverse Event|1|||
27890142|NCT03661996|54542889|FG004|Overall Study|Adverse Event|0|||
27890143|NCT03661996|54542885|FG000|Overall Study|Lost to Follow-up|5|||
27890144|NCT03661996|54542886|FG001|Overall Study|Lost to Follow-up|1|||
27890145|NCT03661996|54542887|FG002|Overall Study|Lost to Follow-up|2|||
27890146|NCT03661996|54542888|FG003|Overall Study|Lost to Follow-up|2|||
27890147|NCT03661996|54542889|FG004|Overall Study|Lost to Follow-up|6|||
27890148|NCT03661996|54542885|FG000|Overall Study|Physician Decision|1|||
27890149|NCT03661996|54542886|FG001|Overall Study|Physician Decision|1|||
27890150|NCT03661996|54542887|FG002|Overall Study|Physician Decision|1|||
27890151|NCT03661996|54542888|FG003|Overall Study|Physician Decision|2|||
27890152|NCT03661996|54542889|FG004|Overall Study|Physician Decision|0|||
27890153|NCT03661996|54542885|FG000|Overall Study|Protocol Violation|0|||
27890154|NCT03661996|54542886|FG001|Overall Study|Protocol Violation|0|||
27890155|NCT03661996|54542887|FG002|Overall Study|Protocol Violation|0|||
27890156|NCT03661996|54542888|FG003|Overall Study|Protocol Violation|0|||
27890157|NCT03661996|54542889|FG004|Overall Study|Protocol Violation|1|||
27890158|NCT03661996|54542885|FG000|Overall Study|Withdrawal by Subject|3|||
27890159|NCT03661996|54542886|FG001|Overall Study|Withdrawal by Subject|5|||
27890160|NCT03661996|54542887|FG002|Overall Study|Withdrawal by Subject|1|||
27890161|NCT03661996|54542888|FG003|Overall Study|Withdrawal by Subject|7|||
27890162|NCT03661996|54542889|FG004|Overall Study|Withdrawal by Subject|7|||
27890163|NCT03661996|54542885|FG000|Overall Study|Sponsors Decision|2|||
27890164|NCT03661996|54542886|FG001|Overall Study|Sponsors Decision|0|||
27890165|NCT03661996|54542887|FG002|Overall Study|Sponsors Decision|0|||
27890166|NCT03661996|54542888|FG003|Overall Study|Sponsors Decision|0|||
27890167|NCT03661996|54542889|FG004|Overall Study|Sponsors Decision|0|||
27890168|NCT03661996|54542885|FG000|Overall Study|Other|1|||
27890169|NCT03661996|54542886|FG001|Overall Study|Other|1|||
27890170|NCT03661996|54542887|FG002|Overall Study|Other|1|||
27890171|NCT03661996|54542888|FG003|Overall Study|Other|1|||
27890172|NCT03661996|54542889|FG004|Overall Study|Other|0|||
27890173|NCT03633461|54542906|FG000|Overall Study|Lost to Follow-up|0|||
27890174|NCT03633461|54542907|FG001|Overall Study|Lost to Follow-up|1|||
27890175|NCT03499314|54542935|FG000|Overall Study|Time Commitment|1|||
27890176|NCT03499314|54542936|FG001|Overall Study|Time Commitment|2|||
27890177|NCT03499314|54542935|FG000|Overall Study|Medical issue unrelated to research study|1|||
27890178|NCT03499314|54542936|FG001|Overall Study|Medical issue unrelated to research study|1|||
27985577|NCT03922945|54644347|FG001|Overall Study|Lack of Efficacy|0|||
27890179|NCT03369431|54542944|FG000|Overall Study|Lost to Follow-up|1|||
27985578|NCT03922945|54644348|FG002|Overall Study|Lack of Efficacy|1|||
27890180|NCT03369431|54542945|FG001|Overall Study|Lost to Follow-up|3|||
27890181|NCT03369431|54542944|FG000|Overall Study|Withdrawal by Subject|2|||
27890182|NCT03369431|54542945|FG001|Overall Study|Withdrawal by Subject|3|||
27890183|NCT03369431|54542944|FG000|Overall Study|Protocol Violation|1|||
27890184|NCT03369431|54542945|FG001|Overall Study|Protocol Violation|1|||
27890185|NCT03336866|54542954|FG000|Overall Study|Lost to Follow-up|2|||
27890186|NCT03336866|54542955|FG001|Overall Study|Lost to Follow-up|0|||
27890187|NCT03336866|54542956|FG002|Overall Study|Lost to Follow-up|3|||
27890188|NCT03336866|54542954|FG000|Overall Study|Withdrawal by Subject|1|||
27890189|NCT03336866|54542955|FG001|Overall Study|Withdrawal by Subject|1|||
27890190|NCT03336866|54542956|FG002|Overall Study|Withdrawal by Subject|0|||
27890191|NCT03336866|54542954|FG000|Overall Study|Noncompliance with clinic house rules|0|||
27890192|NCT03336866|54542955|FG001|Overall Study|Noncompliance with clinic house rules|0|||
27890193|NCT03336866|54542956|FG002|Overall Study|Noncompliance with clinic house rules|1|||
27890194|NCT03332173|54542969|FG000|Overall Study|Death|7|||
27890195|NCT03332173|54542969|FG000|Overall Study|Withdrawal by Subject|6|||
27890196|NCT03332173|54542969|FG000|Overall Study|Lost to Follow-up|2|||
27890197|NCT03332173|54542969|FG000|Overall Study|Transferred to long-term extension study|29|||
27890198|NCT03322293|54542976|FG000|Overall Study|Lost to Follow-up|0|||
27890199|NCT03322293|54542977|FG001|Overall Study|Lost to Follow-up|0|||
27890200|NCT03322293|54542978|FG002|Overall Study|Lost to Follow-up|1|||
27890201|NCT03254394|54543000|FG000|Overall Study|Withdrawal by Subject|0|||
27890202|NCT03254394|54543001|FG001|Overall Study|Withdrawal by Subject|2|||
27890203|NCT03253809|54543007|FG000|Overall Study|Unable to obtain study related data|14|||
27890204|NCT02998476|54543086|FG000|Overall Study|Lost to Follow-up|1|||
27890205|NCT02998476|54543087|FG001|Overall Study|Lost to Follow-up|0|||
27890206|NCT02998476|54543086|FG000|Overall Study|Participants transferred to rollover study INCB50465-801|2|||
27890207|NCT02998476|54543087|FG001|Overall Study|Participants transferred to rollover study INCB50465-801|0|||
27890208|NCT02998476|54543086|FG000|Overall Study|Withdrawal by Subject|1|||
27890209|NCT02998476|54543087|FG001|Overall Study|Withdrawal by Subject|2|||
27890210|NCT02998476|54543086|FG000|Overall Study|Death|45|||
27890211|NCT02998476|54543087|FG001|Overall Study|Death|2|||
27890212|NCT02998476|54543086|FG000|Overall Study|Other|6|||
27890213|NCT02998476|54543087|FG001|Overall Study|Other|1|||
27890214|NCT02924064|54543105|FG000|Overall Study|Adverse Event|2|||
27890215|NCT02924064|54543106|FG001|Overall Study|Adverse Event|2|||
27890216|NCT02924064|54543105|FG000|Overall Study|Lost to Follow-up|0|||
27890217|NCT02924064|54543106|FG001|Overall Study|Lost to Follow-up|2|||
27890218|NCT02924064|54543105|FG000|Overall Study|Physician Decision|0|||
27890219|NCT02924064|54543106|FG001|Overall Study|Physician Decision|2|||
27890220|NCT02924064|54543105|FG000|Overall Study|Protocol Violation|1|||
27890221|NCT02924064|54543106|FG001|Overall Study|Protocol Violation|3|||
27890222|NCT02924064|54543105|FG000|Overall Study|Withdrawal by Subject|4|||
27890223|NCT02924064|54543106|FG001|Overall Study|Withdrawal by Subject|5|||
27890224|NCT02924064|54543105|FG000|Overall Study|Other|17|||
27890225|NCT02924064|54543106|FG001|Overall Study|Other|29|||
27890226|NCT02916706|54543114|FG000|Overall Study|Adverse Event|0|||
27890227|NCT02916706|54543115|FG001|Overall Study|Adverse Event|1|||
27890228|NCT02916706|54543114|FG000|Overall Study|Lost to Follow-up|0|||
27890229|NCT02916706|54543115|FG001|Overall Study|Lost to Follow-up|1|||
27890230|NCT02916706|54543114|FG000|Overall Study|Physician Decision|1|||
27890231|NCT02916706|54543115|FG001|Overall Study|Physician Decision|0|||
27890232|NCT02916706|54543114|FG000|Overall Study|Protocol Violation|3|||
27890233|NCT02916706|54543115|FG001|Overall Study|Protocol Violation|1|||
27890234|NCT02916706|54543114|FG000|Overall Study|Withdrawal by Subject|6|||
27890235|NCT02916706|54543115|FG001|Overall Study|Withdrawal by Subject|9|||
27890236|NCT02916706|54543114|FG000|Overall Study|Other|5|||
27890237|NCT02916706|54543115|FG001|Overall Study|Other|19|||
27890238|NCT02889900|54543121|FG000|Overall Study|Adverse Event|11|||
27890239|NCT02889900|54543121|FG000|Overall Study|Condition under investigation worsened|32|||
27890240|NCT02889900|54543121|FG000|Overall Study|Other|5|||
27890241|NCT02889900|54543121|FG000|Overall Study|Withdrawal by Subject|7|||
27890242|NCT02889900|54543121|FG000|Overall Study|Not treated|2|||
27890243|NCT02866695|54543125|FG000|Overall Study|Adverse Event|1|||
27890244|NCT02866695|54543125|FG000|Overall Study|Lost to Follow-up|1|||
27890245|NCT02834793|54543131|FG000|Core Study (Up to 18 Weeks)|Withdrawal by Subject|2|||
27890246|NCT02834793|54543132|FG001|Core Study (Up to 18 Weeks)|Withdrawal by Subject|1|||
27890247|NCT02834793|54543133|FG002|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
27890248|NCT02834793|54543134|FG003|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
27890249|NCT02834793|54543131|FG000|Core Study (Up to 18 Weeks)|Lack of Efficacy|1|||
27890250|NCT02834793|54543132|FG001|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
27890251|NCT02834793|54543133|FG002|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
27890252|NCT02834793|54543134|FG003|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
27890253|NCT02834793|54543131|FG000|Core Study (Up to 18 Weeks)|Lost to Follow-up|1|||
27890254|NCT02834793|54543132|FG001|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
27890255|NCT02834793|54543133|FG002|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
27890256|NCT02834793|54543134|FG003|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
27890257|NCT02834793|54543131|FG000|Core Study (Up to 18 Weeks)|Adverse Event|0|||
27890258|NCT02834793|54543132|FG001|Core Study (Up to 18 Weeks)|Adverse Event|3|||
27890259|NCT02834793|54543133|FG002|Core Study (Up to 18 Weeks)|Adverse Event|0|||
27890260|NCT02834793|54543134|FG003|Core Study (Up to 18 Weeks)|Adverse Event|0|||
27890261|NCT02834793|54543131|FG000|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
27890262|NCT02834793|54543132|FG001|Core Study (Up to 18 Weeks)|Study terminated by sponsor|1|||
27890263|NCT02834793|54543133|FG002|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
27890264|NCT02834793|54543134|FG003|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
27890265|NCT02834793|54543131|FG000|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
27890266|NCT02834793|54543132|FG001|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
27890267|NCT02834793|54543133|FG002|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|7|||
27890268|NCT02834793|54543134|FG003|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
27890269|NCT02834793|54543131|FG000|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
27890270|NCT02834793|54543132|FG001|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
27890271|NCT02834793|54543133|FG002|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|4|||
27890272|NCT02834793|54543134|FG003|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
27890273|NCT02834793|54543131|FG000|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
27890274|NCT02834793|54543132|FG001|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
27890275|NCT02834793|54543133|FG002|Extension Phase A (up to 52 Weeks)|Adverse Event|5|||
27890276|NCT02834793|54543134|FG003|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
27890277|NCT02834793|54543131|FG000|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
27890278|NCT02834793|54543132|FG001|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
27890279|NCT02834793|54543133|FG002|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|9|||
27890280|NCT02834793|54543134|FG003|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
27890281|NCT02834793|54543131|FG000|Extension Phase A (up to 52 Weeks)|Other|0|||
27890282|NCT02834793|54543132|FG001|Extension Phase A (up to 52 Weeks)|Other|0|||
27890283|NCT02834793|54543133|FG002|Extension Phase A (up to 52 Weeks)|Other|1|||
27890284|NCT02834793|54543134|FG003|Extension Phase A (up to 52 Weeks)|Other|0|||
27890285|NCT02834793|54543131|FG000|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
27890286|NCT02834793|54543132|FG001|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
27890287|NCT02834793|54543133|FG002|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
27890288|NCT02834793|54543134|FG003|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|1|||
27890289|NCT02834793|54543131|FG000|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
27890290|NCT02834793|54543132|FG001|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
27890291|NCT02834793|54543133|FG002|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
27890292|NCT02834793|54543134|FG003|Extension Phase B (up to 188 Weeks)|Adverse Event|1|||
27890293|NCT02834793|54543131|FG000|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
27890294|NCT02834793|54543132|FG001|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
27890295|NCT02834793|54543133|FG002|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
27890296|NCT02834793|54543134|FG003|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|8|||
27890297|NCT02834793|54543131|FG000|Extension Phase B (up to 188 Weeks)|Other|0|||
27890298|NCT02834793|54543132|FG001|Extension Phase B (up to 188 Weeks)|Other|0|||
27890299|NCT02834793|54543133|FG002|Extension Phase B (up to 188 Weeks)|Other|0|||
27890300|NCT02834793|54543134|FG003|Extension Phase B (up to 188 Weeks)|Other|1|||
27890301|NCT02834793|54543131|FG000|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
27890302|NCT02834793|54543132|FG001|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
27890303|NCT02834793|54543133|FG002|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
27890304|NCT02834793|54543134|FG003|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|1|||
27890305|NCT02810457|54543144|FG000|Overall Study|Randomised but no treatment received|2|||
27890306|NCT02810457|54543145|FG001|Overall Study|Randomised but no treatment received|1|||
27890307|NCT02810457|54543144|FG000|Overall Study|Objective PD assessed by RECIST v1.1|191|||
27890308|NCT02810457|54543145|FG001|Overall Study|Objective PD assessed by RECIST v1.1|199|||
27890309|NCT02810457|54543144|FG000|Overall Study|Adverse Event|37|||
27890310|NCT02810457|54543145|FG001|Overall Study|Adverse Event|43|||
27890311|NCT02810457|54543144|FG000|Overall Study|Patient decision|31|||
27890312|NCT02810457|54543145|FG001|Overall Study|Patient decision|35|||
27890313|NCT02810457|54543144|FG000|Overall Study|Patient lost to follow-up|2|||
27890314|NCT02810457|54543145|FG001|Overall Study|Patient lost to follow-up|2|||
27890315|NCT02810457|54543144|FG000|Overall Study|Death|39|||
27890316|NCT02810457|54543145|FG001|Overall Study|Death|28|||
27890317|NCT02810457|54543144|FG000|Overall Study|Ongoing at data cutoff and discontinued|3|||
27890318|NCT02810457|54543145|FG001|Overall Study|Ongoing at data cutoff and discontinued|2|||
27890319|NCT02810457|54543144|FG000|Overall Study|Clinical progression|15|||
27890320|NCT02810457|54543145|FG001|Overall Study|Clinical progression|16|||
27890321|NCT02810457|54543144|FG000|Overall Study|Investigator decision|3|||
27890322|NCT02810457|54543145|FG001|Overall Study|Investigator decision|2|||
27890323|NCT02810457|54543144|FG000|Overall Study|Patient ineligibility|3|||
27890324|NCT02810457|54543145|FG001|Overall Study|Patient ineligibility|0|||
27890325|NCT02810457|54543144|FG000|Overall Study|Miscalculated PD|1|||
27890326|NCT02810457|54543145|FG001|Overall Study|Miscalculated PD|0|||
27890327|NCT02810457|54543144|FG000|Overall Study|Physician Decision|0|||
27890328|NCT02810457|54543145|FG001|Overall Study|Physician Decision|1|||
27890329|NCT02745535|54543151|FG000|Overall Study|Death|1|||
27890330|NCT02745535|54543151|FG000|Overall Study|Adverse Event|3|||
27890331|NCT02745535|54543151|FG000|Overall Study|Lost to Follow-up|2|||
27890332|NCT02625090|54543185|FG000|Overall Study|Participant wants to be pregnant|2|||
27890333|NCT02625090|54543185|FG000|Overall Study|For the Promoter|1|||
27890334|NCT02625090|54543185|FG000|Overall Study|Sponsor's Decision|9|||
27890335|NCT02625090|54543185|FG000|Overall Study|Somnolence|1|||
27890336|NCT02625090|54543185|FG000|Overall Study|Study terminated by Sponsor|7|||
27890337|NCT02625090|54543185|FG000|Overall Study|Negative Benefit/Risk|1|||
27890338|NCT02625090|54543185|FG000|Overall Study|Protocol Deviation|2|||
27890339|NCT02625090|54543185|FG000|Overall Study|Lack of Efficacy|16|||
27890340|NCT02625090|54543185|FG000|Overall Study|Adverse Event|3|||
27890341|NCT02539225|54543192|FG000|Part A|Adverse Event|13|||
27890342|NCT02539225|54543193|FG001|Part A|Adverse Event|4|||
27890343|NCT02539225|54543192|FG000|Part A|Withdrawal by Subject|2|||
27890344|NCT02539225|54543193|FG001|Part A|Withdrawal by Subject|4|||
27890345|NCT02539225|54543192|FG000|Part A|Physician Decision|4|||
27739388|NCT02457182|54188984|FG001|Overall Study|Lost to Follow-up|0|||
27739389|NCT02230384|54188992|FG000|Phase 1|Lost to Follow-up|1|||
27739390|NCT02230384|54188993|FG001|Phase 1|Lost to Follow-up|0|||
27739391|NCT02230384|54188992|FG000|Phase 1|Physician Decision|0|||
27739392|NCT02230384|54188993|FG001|Phase 1|Physician Decision|1|||
27739393|NCT02230384|54188992|FG000|Phase 2 - Switch|Withdrawal by Subject|0|||
27739394|NCT02230384|54188993|FG001|Phase 2 - Switch|Withdrawal by Subject|1|||
27890346|NCT02539225|54543193|FG001|Part A|Physician Decision|7|||
27890347|NCT02539225|54543192|FG000|Part A|Did Not Receive study Drug|1|||
27890348|NCT02539225|54543193|FG001|Part A|Did Not Receive study Drug|1|||
27890349|NCT02539225|54543192|FG000|Pre Treatment for Part B|Progressive disease|1|||
27890350|NCT02539225|54543193|FG001|Pre Treatment for Part B|Progressive disease|1|||
27890351|NCT02539225|54543192|FG000|Pre Treatment for Part B|Adverse Event|1|||
27890352|NCT02539225|54543193|FG001|Pre Treatment for Part B|Adverse Event|1|||
27890353|NCT02539225|54543192|FG000|Pre Treatment for Part B|Withdrawal by Subject|1|||
27890354|NCT02539225|54543193|FG001|Pre Treatment for Part B|Withdrawal by Subject|0|||
27890355|NCT02539225|54543192|FG000|Pre Treatment for Part B|Physician Decision|2|||
27890356|NCT02539225|54543193|FG001|Pre Treatment for Part B|Physician Decision|0|||
27890357|NCT02539225|54543192|FG000|Part B|Adverse Event|4|||
27890358|NCT02539225|54543193|FG001|Part B|Adverse Event|4|||
27890359|NCT02539225|54543192|FG000|Part B|Withdrawal by Subject|0|||
27890360|NCT02539225|54543193|FG001|Part B|Withdrawal by Subject|3|||
27890361|NCT02539225|54543192|FG000|Part B|Physician Decision|0|||
27890362|NCT02539225|54543193|FG001|Part B|Physician Decision|9|||
27890363|NCT02526017|54543213|FG000|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
27890364|NCT02526017|54543214|FG001|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
27890365|NCT02526017|54543215|FG002|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
27890366|NCT02526017|54543216|FG003|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
27890367|NCT02526017|54543217|FG004|Overall Study|Withdrew Consent Before Receiving Study Treatment|1|||
27890368|NCT02526017|54543218|FG005|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
27890369|NCT02526017|54543219|FG006|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
27890370|NCT02526017|54543220|FG007|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
27890371|NCT02526017|54543221|FG008|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
27890372|NCT02369653|54543290|FG000|Overall Study|Lost to Follow-up|0|||
27890373|NCT02369653|54543291|FG001|Overall Study|Lost to Follow-up|1|||
27890374|NCT02369653|54543290|FG000|Overall Study|Administrative reason by sponsor|0|||
27890375|NCT02369653|54543291|FG001|Overall Study|Administrative reason by sponsor|1|||
27890376|NCT02369653|54543290|FG000|Overall Study|Death|1|||
27890377|NCT02369653|54543291|FG001|Overall Study|Death|2|||
27890378|NCT02369653|54543290|FG000|Overall Study|Participant withdrew consent|13|||
27890379|NCT02369653|54543291|FG001|Overall Study|Participant withdrew consent|3|||
27890380|NCT02284568|54543304|FG000|Overall Study|Adverse Event|2|||
27890381|NCT02284568|54543305|FG001|Overall Study|Adverse Event|9|||
27890382|NCT02284568|54543306|FG002|Overall Study|Adverse Event|4|||
27890383|NCT02284568|54543304|FG000|Overall Study|Withdrawal by Subject|22|||
27890384|NCT02284568|54543305|FG001|Overall Study|Withdrawal by Subject|21|||
27890385|NCT02284568|54543306|FG002|Overall Study|Withdrawal by Subject|1|||
27890386|NCT02284568|54543304|FG000|Overall Study|Noncompliance with study drug admin|1|||
27890387|NCT02284568|54543305|FG001|Overall Study|Noncompliance with study drug admin|2|||
27890388|NCT02284568|54543306|FG002|Overall Study|Noncompliance with study drug admin|0|||
27890389|NCT02284568|54543304|FG000|Overall Study|Noncompliance|1|||
27890390|NCT02284568|54543305|FG001|Overall Study|Noncompliance|0|||
27890391|NCT02284568|54543306|FG002|Overall Study|Noncompliance|0|||
27890392|NCT02284568|54543304|FG000|Overall Study|Protocol Violation|0|||
27890393|NCT02284568|54543305|FG001|Overall Study|Protocol Violation|1|||
27890394|NCT02284568|54543306|FG002|Overall Study|Protocol Violation|0|||
27890395|NCT02284568|54543304|FG000|Overall Study|Sponsor requested patient stop treatment|0|||
27890396|NCT02284568|54543305|FG001|Overall Study|Sponsor requested patient stop treatment|0|||
28096670|NCT03692676|54751818|FG001|Overall Study|Other|805|||
27739395|NCT02230384|54188992|FG000|Phase 2 - Switch|Lost to Follow-up|1|||
27890397|NCT02284568|54543306|FG002|Overall Study|Sponsor requested patient stop treatment|90|||
27890398|NCT02284568|54543304|FG000|Overall Study|Lost to Follow-up|0|||
27890399|NCT02284568|54543305|FG001|Overall Study|Lost to Follow-up|3|||
27890400|NCT02284568|54543306|FG002|Overall Study|Lost to Follow-up|0|||
27890401|NCT02284568|54543304|FG000|Overall Study|Lack of Efficacy|4|||
27890402|NCT02284568|54543305|FG001|Overall Study|Lack of Efficacy|7|||
27739396|NCT02230384|54188993|FG001|Phase 2 - Switch|Lost to Follow-up|0|||
27890403|NCT02284568|54543306|FG002|Overall Study|Lack of Efficacy|0|||
27890404|NCT02284568|54543304|FG000|Overall Study|Other|1|||
27890405|NCT02284568|54543305|FG001|Overall Study|Other|2|||
27890406|NCT02284568|54543306|FG002|Overall Study|Other|0|||
27890407|NCT02284568|54543304|FG000|Overall Study|Withdrew before taking study drug|0|||
27890408|NCT02284568|54543305|FG001|Overall Study|Withdrew before taking study drug|1|||
27890409|NCT02284568|54543306|FG002|Overall Study|Withdrew before taking study drug|0|||
27890410|NCT02195986|54543321|FG000|Overall Study|Adverse Event|3|||
27890411|NCT02195986|54543322|FG001|Overall Study|Adverse Event|0|||
27890412|NCT02195986|54543323|FG002|Overall Study|Adverse Event|0|||
27890413|NCT02195986|54543321|FG000|Overall Study|Withdrawal by Subject|0|||
27890414|NCT02195986|54543322|FG001|Overall Study|Withdrawal by Subject|3|||
27890415|NCT02195986|54543323|FG002|Overall Study|Withdrawal by Subject|0|||
27890416|NCT02195986|54543321|FG000|Overall Study|Family Emergency|0|||
27890417|NCT02195986|54543322|FG001|Overall Study|Family Emergency|0|||
27890418|NCT02195986|54543323|FG002|Overall Study|Family Emergency|1|||
27890419|NCT02195986|54543321|FG000|Overall Study|Protocol Violation|0|||
27890420|NCT02195986|54543322|FG001|Overall Study|Protocol Violation|1|||
27890421|NCT02195986|54543323|FG002|Overall Study|Protocol Violation|1|||
27890422|NCT02195986|54543321|FG000|Overall Study|Non-compliance|0|||
27890423|NCT02195986|54543322|FG001|Overall Study|Non-compliance|1|||
27890424|NCT02195986|54543323|FG002|Overall Study|Non-compliance|0|||
27890425|NCT01982630|54543339|FG000|Overall Study|Adverse Event|2|||
27890426|NCT01982630|54543340|FG001|Overall Study|Adverse Event|0|||
27890427|NCT01982630|54543341|FG002|Overall Study|Adverse Event|1|||
27890428|NCT01982630|54543342|FG003|Overall Study|Adverse Event|0|||
27890429|NCT01982630|54543343|FG004|Overall Study|Adverse Event|1|||
27890430|NCT01982630|54543344|FG005|Overall Study|Adverse Event|2|||
27890431|NCT01982630|54543345|FG006|Overall Study|Adverse Event|1|||
27890432|NCT01982630|54543346|FG007|Overall Study|Adverse Event|0|||
27890433|NCT01982630|54543339|FG000|Overall Study|Physician Decision|1|||
27890434|NCT01982630|54543340|FG001|Overall Study|Physician Decision|0|||
27890435|NCT01982630|54543341|FG002|Overall Study|Physician Decision|2|||
27890436|NCT01982630|54543342|FG003|Overall Study|Physician Decision|1|||
27890437|NCT01982630|54543343|FG004|Overall Study|Physician Decision|2|||
27890438|NCT01982630|54543344|FG005|Overall Study|Physician Decision|0|||
27890439|NCT01982630|54543345|FG006|Overall Study|Physician Decision|0|||
27890440|NCT01982630|54543346|FG007|Overall Study|Physician Decision|0|||
27890441|NCT01982630|54543339|FG000|Overall Study|Did Not Receive Drug-Technical Issues|0|||
27890442|NCT01982630|54543340|FG001|Overall Study|Did Not Receive Drug-Technical Issues|0|||
27890443|NCT01982630|54543341|FG002|Overall Study|Did Not Receive Drug-Technical Issues|2|||
27890444|NCT01982630|54543342|FG003|Overall Study|Did Not Receive Drug-Technical Issues|0|||
27890445|NCT01982630|54543343|FG004|Overall Study|Did Not Receive Drug-Technical Issues|0|||
27890446|NCT01982630|54543344|FG005|Overall Study|Did Not Receive Drug-Technical Issues|0|||
27890447|NCT01982630|54543345|FG006|Overall Study|Did Not Receive Drug-Technical Issues|0|||
27890448|NCT01982630|54543346|FG007|Overall Study|Did Not Receive Drug-Technical Issues|0|||
27890449|NCT01982630|54543339|FG000|Overall Study|Withdrawal by Subject|0|||
27890450|NCT01982630|54543340|FG001|Overall Study|Withdrawal by Subject|0|||
27890451|NCT01982630|54543341|FG002|Overall Study|Withdrawal by Subject|0|||
27890452|NCT01982630|54543342|FG003|Overall Study|Withdrawal by Subject|0|||
27890453|NCT01982630|54543343|FG004|Overall Study|Withdrawal by Subject|0|||
27890454|NCT01982630|54543344|FG005|Overall Study|Withdrawal by Subject|1|||
27890455|NCT01982630|54543345|FG006|Overall Study|Withdrawal by Subject|0|||
27890456|NCT01982630|54543346|FG007|Overall Study|Withdrawal by Subject|0|||
27890457|NCT01740297|54543411|FG000|Overall Study|Withdrawal by Subject|4|||
27890458|NCT01740297|54543412|FG001|Overall Study|Withdrawal by Subject|16|||
27890459|NCT01740297|54543413|FG002|Overall Study|Withdrawal by Subject|17|||
27890460|NCT01740297|54543411|FG000|Overall Study|Death|8|||
27890461|NCT01740297|54543412|FG001|Overall Study|Death|46|||
27890462|NCT01740297|54543413|FG002|Overall Study|Death|40|||
27890463|NCT01740297|54543411|FG000|Overall Study|Lost to Follow-up|1|||
27890464|NCT01740297|54543412|FG001|Overall Study|Lost to Follow-up|2|||
27890465|NCT01740297|54543413|FG002|Overall Study|Lost to Follow-up|4|||
27890466|NCT01729754|54543427|FG000|Part 1|Adverse Event|2|||
27890467|NCT01729754|54543428|FG001|Part 1|Adverse Event|0|||
27890468|NCT01729754|54543429|FG002|Part 1|Adverse Event|0|||
27890469|NCT01729754|54543430|FG003|Part 1|Adverse Event|1|||
27739397|NCT02230384|54188992|FG000|Phase 2 - Switch|Adverse Event|2|||
27890470|NCT01729754|54543431|FG004|Part 1|Adverse Event|0|||
27890471|NCT01729754|54543432|FG005|Part 1|Adverse Event|0|||
27890472|NCT01729754|54543433|FG006|Part 1|Adverse Event|2|||
27890473|NCT01729754|54543434|FG007|Part 1|Adverse Event|0|||
27739398|NCT02230384|54188993|FG001|Phase 2 - Switch|Adverse Event|0|||
27890474|NCT01729754|54543435|FG008|Part 1|Adverse Event|0|||
27890475|NCT01729754|54543436|FG009|Part 1|Adverse Event|5|||
27890476|NCT01729754|54543427|FG000|Part 1|Lack of Efficacy|1|||
27890477|NCT01729754|54543428|FG001|Part 1|Lack of Efficacy|0|||
27985579|NCT03922945|54644346|FG000|Overall Study|Protocol Non-Compliance|0|||
27890478|NCT01729754|54543429|FG002|Part 1|Lack of Efficacy|0|||
27890479|NCT01729754|54543430|FG003|Part 1|Lack of Efficacy|0|||
27890480|NCT01729754|54543431|FG004|Part 1|Lack of Efficacy|0|||
27890481|NCT01729754|54543432|FG005|Part 1|Lack of Efficacy|0|||
27890482|NCT01729754|54543433|FG006|Part 1|Lack of Efficacy|2|||
27890483|NCT01729754|54543434|FG007|Part 1|Lack of Efficacy|0|||
27890484|NCT01729754|54543435|FG008|Part 1|Lack of Efficacy|0|||
27890485|NCT01729754|54543436|FG009|Part 1|Lack of Efficacy|0|||
27890486|NCT01729754|54543427|FG000|Part 1|Lost to Follow-up|1|||
27890487|NCT01729754|54543428|FG001|Part 1|Lost to Follow-up|0|||
27890488|NCT01729754|54543429|FG002|Part 1|Lost to Follow-up|0|||
27890489|NCT01729754|54543430|FG003|Part 1|Lost to Follow-up|2|||
27890490|NCT01729754|54543431|FG004|Part 1|Lost to Follow-up|0|||
27890491|NCT01729754|54543432|FG005|Part 1|Lost to Follow-up|0|||
27890492|NCT01729754|54543433|FG006|Part 1|Lost to Follow-up|3|||
27890493|NCT01729754|54543434|FG007|Part 1|Lost to Follow-up|0|||
27890494|NCT01729754|54543435|FG008|Part 1|Lost to Follow-up|0|||
27890495|NCT01729754|54543436|FG009|Part 1|Lost to Follow-up|3|||
27890496|NCT01729754|54543427|FG000|Part 1|Non-compliance with Study Drug|1|||
27890497|NCT01729754|54543428|FG001|Part 1|Non-compliance with Study Drug|0|||
27890498|NCT01729754|54543429|FG002|Part 1|Non-compliance with Study Drug|0|||
27890499|NCT01729754|54543430|FG003|Part 1|Non-compliance with Study Drug|0|||
27890500|NCT01729754|54543431|FG004|Part 1|Non-compliance with Study Drug|0|||
27890501|NCT01729754|54543432|FG005|Part 1|Non-compliance with Study Drug|0|||
27890502|NCT01729754|54543433|FG006|Part 1|Non-compliance with Study Drug|0|||
27890503|NCT01729754|54543434|FG007|Part 1|Non-compliance with Study Drug|0|||
27890504|NCT01729754|54543435|FG008|Part 1|Non-compliance with Study Drug|0|||
27890505|NCT01729754|54543436|FG009|Part 1|Non-compliance with Study Drug|0|||
27890506|NCT01729754|54543427|FG000|Part 1|Physician Decision|0|||
27890507|NCT01729754|54543428|FG001|Part 1|Physician Decision|0|||
27890508|NCT01729754|54543429|FG002|Part 1|Physician Decision|0|||
27890509|NCT01729754|54543430|FG003|Part 1|Physician Decision|0|||
27890510|NCT01729754|54543431|FG004|Part 1|Physician Decision|0|||
27890511|NCT01729754|54543432|FG005|Part 1|Physician Decision|0|||
27890512|NCT01729754|54543433|FG006|Part 1|Physician Decision|0|||
27890513|NCT01729754|54543434|FG007|Part 1|Physician Decision|0|||
27890514|NCT01729754|54543435|FG008|Part 1|Physician Decision|0|||
27890515|NCT01729754|54543436|FG009|Part 1|Physician Decision|4|||
27890516|NCT01729754|54543427|FG000|Part 1|Pregnancy|0|||
27890517|NCT01729754|54543428|FG001|Part 1|Pregnancy|0|||
27890518|NCT01729754|54543429|FG002|Part 1|Pregnancy|0|||
27890519|NCT01729754|54543430|FG003|Part 1|Pregnancy|1|||
27890520|NCT01729754|54543431|FG004|Part 1|Pregnancy|0|||
27890521|NCT01729754|54543432|FG005|Part 1|Pregnancy|0|||
27890522|NCT01729754|54543433|FG006|Part 1|Pregnancy|0|||
27890523|NCT01729754|54543434|FG007|Part 1|Pregnancy|0|||
27890524|NCT01729754|54543435|FG008|Part 1|Pregnancy|0|||
27890525|NCT01729754|54543436|FG009|Part 1|Pregnancy|1|||
27890526|NCT01729754|54543427|FG000|Part 1|Progressive Disease|0|||
27890527|NCT01729754|54543428|FG001|Part 1|Progressive Disease|0|||
27890528|NCT01729754|54543429|FG002|Part 1|Progressive Disease|0|||
27890529|NCT01729754|54543430|FG003|Part 1|Progressive Disease|0|||
27890530|NCT01729754|54543431|FG004|Part 1|Progressive Disease|0|||
27890531|NCT01729754|54543432|FG005|Part 1|Progressive Disease|0|||
27890532|NCT01729754|54543433|FG006|Part 1|Progressive Disease|0|||
27890533|NCT01729754|54543434|FG007|Part 1|Progressive Disease|0|||
27890534|NCT01729754|54543435|FG008|Part 1|Progressive Disease|0|||
27890535|NCT01729754|54543436|FG009|Part 1|Progressive Disease|1|||
27890536|NCT01729754|54543427|FG000|Part 1|Protocol Violation|2|||
27890537|NCT01729754|54543428|FG001|Part 1|Protocol Violation|0|||
27890538|NCT01729754|54543429|FG002|Part 1|Protocol Violation|0|||
27890539|NCT01729754|54543430|FG003|Part 1|Protocol Violation|1|||
27890540|NCT01729754|54543431|FG004|Part 1|Protocol Violation|0|||
27890541|NCT01729754|54543432|FG005|Part 1|Protocol Violation|0|||
27890542|NCT01729754|54543433|FG006|Part 1|Protocol Violation|1|||
27890543|NCT01729754|54543434|FG007|Part 1|Protocol Violation|0|||
27890544|NCT01729754|54543435|FG008|Part 1|Protocol Violation|0|||
27890545|NCT01729754|54543436|FG009|Part 1|Protocol Violation|0|||
27890546|NCT01729754|54543427|FG000|Part 1|Withdrawal by Subject|5|||
27890547|NCT01729754|54543428|FG001|Part 1|Withdrawal by Subject|0|||
27890548|NCT01729754|54543429|FG002|Part 1|Withdrawal by Subject|0|||
27890549|NCT01729754|54543430|FG003|Part 1|Withdrawal by Subject|7|||
27890550|NCT01729754|54543431|FG004|Part 1|Withdrawal by Subject|0|||
27890551|NCT01729754|54543432|FG005|Part 1|Withdrawal by Subject|0|||
27890552|NCT01729754|54543433|FG006|Part 1|Withdrawal by Subject|5|||
27890553|NCT01729754|54543434|FG007|Part 1|Withdrawal by Subject|0|||
27890554|NCT01729754|54543435|FG008|Part 1|Withdrawal by Subject|0|||
27985580|NCT03922945|54644347|FG001|Overall Study|Protocol Non-Compliance|0|||
27890555|NCT01729754|54543436|FG009|Part 1|Withdrawal by Subject|6|||
27890556|NCT01729754|54543427|FG000|Part 1|Other Protocol Specified Criteria|2|||
27890557|NCT01729754|54543428|FG001|Part 1|Other Protocol Specified Criteria|0|||
27890558|NCT01729754|54543429|FG002|Part 1|Other Protocol Specified Criteria|0|||
27890559|NCT01729754|54543430|FG003|Part 1|Other Protocol Specified Criteria|0|||
27890560|NCT01729754|54543431|FG004|Part 1|Other Protocol Specified Criteria|0|||
27890561|NCT01729754|54543432|FG005|Part 1|Other Protocol Specified Criteria|0|||
27890562|NCT01729754|54543433|FG006|Part 1|Other Protocol Specified Criteria|1|||
27890563|NCT01729754|54543434|FG007|Part 1|Other Protocol Specified Criteria|0|||
27890564|NCT01729754|54543435|FG008|Part 1|Other Protocol Specified Criteria|0|||
27890565|NCT01729754|54543436|FG009|Part 1|Other Protocol Specified Criteria|4|||
27890566|NCT01729754|54543427|FG000|Part 2|Adverse Event|2|||
27890567|NCT01729754|54543428|FG001|Part 2|Adverse Event|0|||
27890568|NCT01729754|54543429|FG002|Part 2|Adverse Event|0|||
27890569|NCT01729754|54543430|FG003|Part 2|Adverse Event|0|||
27890570|NCT01729754|54543431|FG004|Part 2|Adverse Event|0|||
27890571|NCT01729754|54543432|FG005|Part 2|Adverse Event|0|||
27890572|NCT01729754|54543433|FG006|Part 2|Adverse Event|0|||
27890573|NCT01729754|54543434|FG007|Part 2|Adverse Event|0|||
27890574|NCT01729754|54543435|FG008|Part 2|Adverse Event|1|||
27890575|NCT01729754|54543436|FG009|Part 2|Adverse Event|2|||
27890576|NCT01729754|54543427|FG000|Part 2|Lack of Efficacy|0|||
27890577|NCT01729754|54543428|FG001|Part 2|Lack of Efficacy|0|||
27890578|NCT01729754|54543429|FG002|Part 2|Lack of Efficacy|0|||
27890579|NCT01729754|54543430|FG003|Part 2|Lack of Efficacy|0|||
27890580|NCT01729754|54543431|FG004|Part 2|Lack of Efficacy|0|||
27890581|NCT01729754|54543432|FG005|Part 2|Lack of Efficacy|0|||
27890582|NCT01729754|54543433|FG006|Part 2|Lack of Efficacy|0|||
27890583|NCT01729754|54543434|FG007|Part 2|Lack of Efficacy|0|||
27890584|NCT01729754|54543435|FG008|Part 2|Lack of Efficacy|2|||
27890585|NCT01729754|54543436|FG009|Part 2|Lack of Efficacy|2|||
27890586|NCT01729754|54543427|FG000|Part 2|Lost to Follow-up|0|||
27890587|NCT01729754|54543428|FG001|Part 2|Lost to Follow-up|0|||
27890588|NCT01729754|54543429|FG002|Part 2|Lost to Follow-up|0|||
27890589|NCT01729754|54543430|FG003|Part 2|Lost to Follow-up|2|||
27890590|NCT01729754|54543431|FG004|Part 2|Lost to Follow-up|0|||
27890591|NCT01729754|54543432|FG005|Part 2|Lost to Follow-up|0|||
27890592|NCT01729754|54543433|FG006|Part 2|Lost to Follow-up|0|||
27890593|NCT01729754|54543434|FG007|Part 2|Lost to Follow-up|1|||
27890594|NCT01729754|54543435|FG008|Part 2|Lost to Follow-up|0|||
27890595|NCT01729754|54543436|FG009|Part 2|Lost to Follow-up|2|||
27890596|NCT01729754|54543427|FG000|Part 2|Non-Compliance with Study Drug|0|||
27890597|NCT01729754|54543428|FG001|Part 2|Non-Compliance with Study Drug|0|||
27890598|NCT01729754|54543429|FG002|Part 2|Non-Compliance with Study Drug|0|||
27890599|NCT01729754|54543430|FG003|Part 2|Non-Compliance with Study Drug|0|||
27890600|NCT01729754|54543431|FG004|Part 2|Non-Compliance with Study Drug|0|||
27890601|NCT01729754|54543432|FG005|Part 2|Non-Compliance with Study Drug|0|||
27890602|NCT01729754|54543433|FG006|Part 2|Non-Compliance with Study Drug|0|||
27890603|NCT01729754|54543434|FG007|Part 2|Non-Compliance with Study Drug|0|||
27890604|NCT01729754|54543435|FG008|Part 2|Non-Compliance with Study Drug|0|||
27890605|NCT01729754|54543436|FG009|Part 2|Non-Compliance with Study Drug|1|||
27890606|NCT01729754|54543427|FG000|Part 2|Pregnancy|0|||
27890607|NCT01729754|54543428|FG001|Part 2|Pregnancy|0|||
27890608|NCT01729754|54543429|FG002|Part 2|Pregnancy|0|||
27890609|NCT01729754|54543430|FG003|Part 2|Pregnancy|1|||
27890610|NCT01729754|54543431|FG004|Part 2|Pregnancy|0|||
27890611|NCT01729754|54543432|FG005|Part 2|Pregnancy|0|||
27890612|NCT01729754|54543433|FG006|Part 2|Pregnancy|0|||
27890613|NCT01729754|54543434|FG007|Part 2|Pregnancy|0|||
27890614|NCT01729754|54543435|FG008|Part 2|Pregnancy|0|||
27890615|NCT01729754|54543436|FG009|Part 2|Pregnancy|1|||
27890616|NCT01729754|54543427|FG000|Part 2|Withdrawal by Subject|3|||
27890617|NCT01729754|54543428|FG001|Part 2|Withdrawal by Subject|0|||
27890618|NCT01729754|54543429|FG002|Part 2|Withdrawal by Subject|0|||
27890619|NCT01729754|54543430|FG003|Part 2|Withdrawal by Subject|2|||
27890620|NCT01729754|54543431|FG004|Part 2|Withdrawal by Subject|0|||
27890621|NCT01729754|54543432|FG005|Part 2|Withdrawal by Subject|0|||
27890622|NCT01729754|54543433|FG006|Part 2|Withdrawal by Subject|0|||
27985581|NCT03922945|54644348|FG002|Overall Study|Protocol Non-Compliance|1|||
27985582|NCT03922945|54644346|FG000|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|10|||
27890623|NCT01729754|54543434|FG007|Part 2|Withdrawal by Subject|1|||
27890624|NCT01729754|54543435|FG008|Part 2|Withdrawal by Subject|1|||
27890625|NCT01729754|54543436|FG009|Part 2|Withdrawal by Subject|4|||
27985583|NCT03922945|54644347|FG001|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|6|||
27890626|NCT01729754|54543427|FG000|Part 2|Other Protocol Specified Criteria|1|||
27890627|NCT01729754|54543428|FG001|Part 2|Other Protocol Specified Criteria|0|||
27890628|NCT01729754|54543429|FG002|Part 2|Other Protocol Specified Criteria|0|||
27890629|NCT01729754|54543430|FG003|Part 2|Other Protocol Specified Criteria|0|||
27890630|NCT01729754|54543431|FG004|Part 2|Other Protocol Specified Criteria|0|||
27890631|NCT01729754|54543432|FG005|Part 2|Other Protocol Specified Criteria|0|||
27890632|NCT01729754|54543433|FG006|Part 2|Other Protocol Specified Criteria|0|||
27890633|NCT01729754|54543434|FG007|Part 2|Other Protocol Specified Criteria|1|||
27890634|NCT01729754|54543435|FG008|Part 2|Other Protocol Specified Criteria|0|||
27890635|NCT01729754|54543436|FG009|Part 2|Other Protocol Specified Criteria|0|||
27890636|NCT01729754|54543427|FG000|Part 3|Adverse Event|0|||
27890637|NCT01729754|54543428|FG001|Part 3|Adverse Event|0|||
27890638|NCT01729754|54543429|FG002|Part 3|Adverse Event|1|||
27890639|NCT01729754|54543430|FG003|Part 3|Adverse Event|0|||
27890640|NCT01729754|54543431|FG004|Part 3|Adverse Event|0|||
27890641|NCT01729754|54543432|FG005|Part 3|Adverse Event|5|||
27890642|NCT01729754|54543433|FG006|Part 3|Adverse Event|0|||
27890643|NCT01729754|54543434|FG007|Part 3|Adverse Event|0|||
27890644|NCT01729754|54543435|FG008|Part 3|Adverse Event|0|||
27890645|NCT01729754|54543436|FG009|Part 3|Adverse Event|3|||
27890646|NCT01729754|54543427|FG000|Part 3|Death|0|||
27890647|NCT01729754|54543428|FG001|Part 3|Death|0|||
27890648|NCT01729754|54543429|FG002|Part 3|Death|0|||
27890649|NCT01729754|54543430|FG003|Part 3|Death|0|||
27890650|NCT01729754|54543431|FG004|Part 3|Death|0|||
27890651|NCT01729754|54543432|FG005|Part 3|Death|2|||
27890652|NCT01729754|54543433|FG006|Part 3|Death|0|||
27890653|NCT01729754|54543434|FG007|Part 3|Death|0|||
27890654|NCT01729754|54543435|FG008|Part 3|Death|0|||
27890655|NCT01729754|54543436|FG009|Part 3|Death|0|||
27890656|NCT01729754|54543427|FG000|Part 3|Lack of Efficacy|0|||
27890657|NCT01729754|54543428|FG001|Part 3|Lack of Efficacy|0|||
27890658|NCT01729754|54543429|FG002|Part 3|Lack of Efficacy|0|||
27890659|NCT01729754|54543430|FG003|Part 3|Lack of Efficacy|0|||
27890660|NCT01729754|54543431|FG004|Part 3|Lack of Efficacy|2|||
27890661|NCT01729754|54543432|FG005|Part 3|Lack of Efficacy|0|||
27890662|NCT01729754|54543433|FG006|Part 3|Lack of Efficacy|0|||
27890663|NCT01729754|54543434|FG007|Part 3|Lack of Efficacy|0|||
27890664|NCT01729754|54543435|FG008|Part 3|Lack of Efficacy|0|||
27890665|NCT01729754|54543436|FG009|Part 3|Lack of Efficacy|4|||
27890666|NCT01729754|54543427|FG000|Part 3|Lost to Follow-up|0|||
27890667|NCT01729754|54543428|FG001|Part 3|Lost to Follow-up|1|||
27890668|NCT01729754|54543429|FG002|Part 3|Lost to Follow-up|2|||
27890669|NCT01729754|54543430|FG003|Part 3|Lost to Follow-up|0|||
27890670|NCT01729754|54543431|FG004|Part 3|Lost to Follow-up|0|||
27890671|NCT01729754|54543432|FG005|Part 3|Lost to Follow-up|3|||
27890672|NCT01729754|54543433|FG006|Part 3|Lost to Follow-up|0|||
27890673|NCT01729754|54543434|FG007|Part 3|Lost to Follow-up|0|||
27890674|NCT01729754|54543435|FG008|Part 3|Lost to Follow-up|1|||
27890675|NCT01729754|54543436|FG009|Part 3|Lost to Follow-up|0|||
27890676|NCT01729754|54543427|FG000|Part 3|Physician Decision|0|||
27890677|NCT01729754|54543428|FG001|Part 3|Physician Decision|0|||
27890678|NCT01729754|54543429|FG002|Part 3|Physician Decision|1|||
27890679|NCT01729754|54543430|FG003|Part 3|Physician Decision|0|||
27890680|NCT01729754|54543431|FG004|Part 3|Physician Decision|0|||
27890681|NCT01729754|54543432|FG005|Part 3|Physician Decision|0|||
27890682|NCT01729754|54543433|FG006|Part 3|Physician Decision|0|||
27890683|NCT01729754|54543434|FG007|Part 3|Physician Decision|0|||
27890684|NCT01729754|54543435|FG008|Part 3|Physician Decision|0|||
27890685|NCT01729754|54543436|FG009|Part 3|Physician Decision|0|||
27890686|NCT01729754|54543427|FG000|Part 3|Withdrawal by Subject|0|||
27890687|NCT01729754|54543428|FG001|Part 3|Withdrawal by Subject|4|||
27890688|NCT01729754|54543429|FG002|Part 3|Withdrawal by Subject|1|||
27890689|NCT01729754|54543430|FG003|Part 3|Withdrawal by Subject|0|||
27890690|NCT01729754|54543431|FG004|Part 3|Withdrawal by Subject|2|||
27890691|NCT01729754|54543432|FG005|Part 3|Withdrawal by Subject|1|||
27890692|NCT01729754|54543433|FG006|Part 3|Withdrawal by Subject|0|||
27890693|NCT01729754|54543434|FG007|Part 3|Withdrawal by Subject|2|||
27890694|NCT01729754|54543435|FG008|Part 3|Withdrawal by Subject|0|||
27890695|NCT01729754|54543436|FG009|Part 3|Withdrawal by Subject|0|||
27890696|NCT01729754|54543427|FG000|Part 3|Other Protocol Specified Criteria|0|||
27890697|NCT01729754|54543428|FG001|Part 3|Other Protocol Specified Criteria|0|||
27890698|NCT01729754|54543429|FG002|Part 3|Other Protocol Specified Criteria|0|||
27890699|NCT01729754|54543430|FG003|Part 3|Other Protocol Specified Criteria|0|||
27890700|NCT01729754|54543431|FG004|Part 3|Other Protocol Specified Criteria|0|||
27890701|NCT01729754|54543432|FG005|Part 3|Other Protocol Specified Criteria|2|||
27890702|NCT01729754|54543433|FG006|Part 3|Other Protocol Specified Criteria|0|||
27890703|NCT01729754|54543434|FG007|Part 3|Other Protocol Specified Criteria|1|||
27890704|NCT01729754|54543435|FG008|Part 3|Other Protocol Specified Criteria|0|||
27890705|NCT01729754|54543436|FG009|Part 3|Other Protocol Specified Criteria|0|||
27890706|NCT01515306|54543481|FG000|Overall Study|Adverse Event|3|||
27890707|NCT01515306|54543482|FG001|Overall Study|Adverse Event|2|||
27890708|NCT01515306|54543481|FG000|Overall Study|Progressive Disease|19|||
27890709|NCT01515306|54543482|FG001|Overall Study|Progressive Disease|9|||
27890710|NCT01515306|54543481|FG000|Overall Study|Withdrawal by Subject|1|||
27890711|NCT01515306|54543482|FG001|Overall Study|Withdrawal by Subject|2|||
27890712|NCT01515306|54543481|FG000|Overall Study|Physician Decision|1|||
27890713|NCT01515306|54543482|FG001|Overall Study|Physician Decision|1|||
27890714|NCT01423851|54543503|FG000|Whole Study|Disease progression|2|||
27890715|NCT01423851|54543504|FG001|Whole Study|Disease progression|1|||
27890716|NCT01423851|54543505|FG002|Whole Study|Disease progression|1|||
27890717|NCT01423851|54543506|FG003|Whole Study|Disease progression|4|||
27890718|NCT01423851|54543507|FG004|Whole Study|Disease progression|1|||
27890719|NCT01423851|54543508|FG005|Whole Study|Disease progression|3|||
27890720|NCT01423851|54543509|FG006|Whole Study|Disease progression|1|||
27890721|NCT01423851|54543510|FG007|Whole Study|Disease progression|4|||
27890722|NCT01423851|54543511|FG008|Whole Study|Disease progression|0|||
27890723|NCT01423851|54543512|FG009|Whole Study|Disease progression|2|||
27890724|NCT01423851|54543513|FG010|Whole Study|Disease progression|10|||
27890725|NCT01423851|54543503|FG000|Whole Study|Physician Decision|0|||
27890726|NCT01423851|54543504|FG001|Whole Study|Physician Decision|1|||
27890727|NCT01423851|54543505|FG002|Whole Study|Physician Decision|2|||
27890728|NCT01423851|54543506|FG003|Whole Study|Physician Decision|0|||
27890729|NCT01423851|54543507|FG004|Whole Study|Physician Decision|2|||
27890730|NCT01423851|54543508|FG005|Whole Study|Physician Decision|0|||
27890731|NCT01423851|54543509|FG006|Whole Study|Physician Decision|2|||
27890732|NCT01423851|54543510|FG007|Whole Study|Physician Decision|1|||
27890733|NCT01423851|54543511|FG008|Whole Study|Physician Decision|3|||
27890734|NCT01423851|54543512|FG009|Whole Study|Physician Decision|4|||
27890735|NCT01423851|54543513|FG010|Whole Study|Physician Decision|12|||
27890736|NCT01423851|54543503|FG000|Whole Study|Withdrawal by Subject|1|||
27890737|NCT01423851|54543504|FG001|Whole Study|Withdrawal by Subject|1|||
27890738|NCT01423851|54543505|FG002|Whole Study|Withdrawal by Subject|0|||
27890739|NCT01423851|54543506|FG003|Whole Study|Withdrawal by Subject|0|||
27890740|NCT01423851|54543507|FG004|Whole Study|Withdrawal by Subject|0|||
27890741|NCT01423851|54543508|FG005|Whole Study|Withdrawal by Subject|0|||
27890742|NCT01423851|54543509|FG006|Whole Study|Withdrawal by Subject|0|||
27890743|NCT01423851|54543510|FG007|Whole Study|Withdrawal by Subject|0|||
27890744|NCT01423851|54543511|FG008|Whole Study|Withdrawal by Subject|2|||
27890745|NCT01423851|54543512|FG009|Whole Study|Withdrawal by Subject|0|||
27890746|NCT01423851|54543513|FG010|Whole Study|Withdrawal by Subject|4|||
27890747|NCT01423851|54543503|FG000|Whole Study|Adverse Event|0|||
27890748|NCT01423851|54543504|FG001|Whole Study|Adverse Event|0|||
27890749|NCT01423851|54543505|FG002|Whole Study|Adverse Event|0|||
27890750|NCT01423851|54543506|FG003|Whole Study|Adverse Event|2|||
27890751|NCT01423851|54543507|FG004|Whole Study|Adverse Event|0|||
27890752|NCT01423851|54543508|FG005|Whole Study|Adverse Event|0|||
27890753|NCT01423851|54543509|FG006|Whole Study|Adverse Event|0|||
27890754|NCT01423851|54543510|FG007|Whole Study|Adverse Event|3|||
27890755|NCT01423851|54543511|FG008|Whole Study|Adverse Event|3|||
27890756|NCT01423851|54543512|FG009|Whole Study|Adverse Event|2|||
27890757|NCT01423851|54543513|FG010|Whole Study|Adverse Event|3|||
27890758|NCT01334606|54543555|FG000|Overall Study|Study Terminated due to slow enrolment|18|||
27890759|NCT01317875|54543571|FG000|Overall Study|Other|0|||
27890760|NCT01317875|54543572|FG001|Overall Study|Other|0|||
27890761|NCT01317875|54543573|FG002|Overall Study|Other|1|||
27890762|NCT01317875|54543574|FG003|Overall Study|Other|0|||
27890763|NCT01317875|54543575|FG004|Overall Study|Other|0|||
27890764|NCT01317875|54543576|FG005|Overall Study|Other|0|||
27890765|NCT01317875|54543577|FG006|Overall Study|Other|0|||
27890766|NCT01317875|54543578|FG007|Overall Study|Other|0|||
27890767|NCT01317875|54543579|FG008|Overall Study|Other|0|||
27890768|NCT01317875|54543580|FG009|Overall Study|Other|0|||
27890769|NCT01317875|54543571|FG000|Overall Study|Noncompliance with study drug|0|||
27890770|NCT01317875|54543572|FG001|Overall Study|Noncompliance with study drug|0|||
27890771|NCT01317875|54543573|FG002|Overall Study|Noncompliance with study drug|1|||
27890772|NCT01317875|54543574|FG003|Overall Study|Noncompliance with study drug|0|||
27890773|NCT01317875|54543575|FG004|Overall Study|Noncompliance with study drug|0|||
27890774|NCT01317875|54543576|FG005|Overall Study|Noncompliance with study drug|0|||
27890775|NCT01317875|54543577|FG006|Overall Study|Noncompliance with study drug|0|||
27890776|NCT01317875|54543578|FG007|Overall Study|Noncompliance with study drug|0|||
27890777|NCT01317875|54543579|FG008|Overall Study|Noncompliance with study drug|0|||
27890778|NCT01317875|54543580|FG009|Overall Study|Noncompliance with study drug|0|||
27890779|NCT01317875|54543571|FG000|Overall Study|Progressive Disease|1|||
27890780|NCT01317875|54543572|FG001|Overall Study|Progressive Disease|0|||
27890781|NCT01317875|54543573|FG002|Overall Study|Progressive Disease|2|||
27890782|NCT01317875|54543574|FG003|Overall Study|Progressive Disease|0|||
27890783|NCT01317875|54543575|FG004|Overall Study|Progressive Disease|1|||
27890784|NCT01317875|54543576|FG005|Overall Study|Progressive Disease|0|||
27890785|NCT01317875|54543577|FG006|Overall Study|Progressive Disease|0|||
27890786|NCT01317875|54543578|FG007|Overall Study|Progressive Disease|1|||
27890787|NCT01317875|54543579|FG008|Overall Study|Progressive Disease|0|||
27890788|NCT01317875|54543580|FG009|Overall Study|Progressive Disease|0|||
27890789|NCT01317875|54543571|FG000|Overall Study|Withdrawal by Subject|0|||
27890790|NCT01317875|54543572|FG001|Overall Study|Withdrawal by Subject|0|||
27890791|NCT01317875|54543573|FG002|Overall Study|Withdrawal by Subject|0|||
27890792|NCT01317875|54543574|FG003|Overall Study|Withdrawal by Subject|0|||
27890793|NCT01317875|54543575|FG004|Overall Study|Withdrawal by Subject|1|||
27890794|NCT01317875|54543576|FG005|Overall Study|Withdrawal by Subject|0|||
27890795|NCT01317875|54543577|FG006|Overall Study|Withdrawal by Subject|0|||
27890796|NCT01317875|54543578|FG007|Overall Study|Withdrawal by Subject|3|||
27890797|NCT01317875|54543579|FG008|Overall Study|Withdrawal by Subject|0|||
27890798|NCT01317875|54543580|FG009|Overall Study|Withdrawal by Subject|0|||
27890799|NCT01317875|54543571|FG000|Overall Study|Physician Decision|0|||
27890800|NCT01317875|54543572|FG001|Overall Study|Physician Decision|1|||
27890801|NCT01317875|54543573|FG002|Overall Study|Physician Decision|1|||
27985584|NCT03922945|54644348|FG002|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|14|||
27890802|NCT01317875|54543574|FG003|Overall Study|Physician Decision|0|||
27890803|NCT01317875|54543575|FG004|Overall Study|Physician Decision|2|||
27890804|NCT01317875|54543576|FG005|Overall Study|Physician Decision|0|||
27890805|NCT01317875|54543577|FG006|Overall Study|Physician Decision|0|||
27890806|NCT01317875|54543578|FG007|Overall Study|Physician Decision|2|||
27890807|NCT01317875|54543579|FG008|Overall Study|Physician Decision|0|||
27890808|NCT01317875|54543580|FG009|Overall Study|Physician Decision|0|||
27890809|NCT01317875|54543571|FG000|Overall Study|Death|0|||
27890810|NCT01317875|54543572|FG001|Overall Study|Death|0|||
27890811|NCT01317875|54543573|FG002|Overall Study|Death|2|||
27890812|NCT01317875|54543574|FG003|Overall Study|Death|1|||
27890813|NCT01317875|54543575|FG004|Overall Study|Death|0|||
27890814|NCT01317875|54543576|FG005|Overall Study|Death|1|||
27890815|NCT01317875|54543577|FG006|Overall Study|Death|0|||
27890816|NCT01317875|54543578|FG007|Overall Study|Death|4|||
27890817|NCT01317875|54543579|FG008|Overall Study|Death|0|||
27890818|NCT01317875|54543580|FG009|Overall Study|Death|0|||
27890819|NCT01317875|54543571|FG000|Overall Study|Adverse Event|2|||
27890820|NCT01317875|54543572|FG001|Overall Study|Adverse Event|1|||
27890821|NCT01317875|54543573|FG002|Overall Study|Adverse Event|2|||
27890822|NCT01317875|54543574|FG003|Overall Study|Adverse Event|1|||
27890823|NCT01317875|54543575|FG004|Overall Study|Adverse Event|5|||
27890824|NCT01317875|54543576|FG005|Overall Study|Adverse Event|1|||
27890825|NCT01317875|54543577|FG006|Overall Study|Adverse Event|2|||
27890826|NCT01317875|54543578|FG007|Overall Study|Adverse Event|5|||
27890827|NCT01317875|54543579|FG008|Overall Study|Adverse Event|0|||
27890828|NCT01317875|54543580|FG009|Overall Study|Adverse Event|0|||
27890829|NCT00500071|54543656|FG000|Screening and Washout Phase|Protocol Violation|1|||
27890830|NCT00500071|54543656|FG000|Dose-optimization and Maintenance Phase|Adverse Event|13|||
27890831|NCT00500071|54543656|FG000|Dose-optimization and Maintenance Phase|Protocol Violation|2|||
27890832|NCT00500071|54543656|FG000|Dose-optimization and Maintenance Phase|Lack of Efficacy|2|||
27890833|NCT00500071|54543656|FG000|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1|||
27890834|NCT00500071|54543656|FG000|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4|||
27890835|NCT00500071|54543656|FG000|30-day Safety Follow-up|Lost to Follow-up|17|||
27890836|NCT00447122|54543664|FG000|Overall Study|worsening medical condition -came off|0|||
27890837|NCT00447122|54543665|FG001|Overall Study|worsening medical condition -came off|1|||
27890838|NCT00447122|54543666|FG002|Overall Study|worsening medical condition -came off|0|||
27890839|NCT00447122|54543667|FG003|Overall Study|worsening medical condition -came off|0|||
27890840|NCT00382252|54543677|FG000|Overall Study|Death|4|||
27890841|NCT00382252|54543677|FG000|Overall Study|Protocol Violation|8|||
27890842|NCT00382252|54543677|FG000|Overall Study|Not treated by RFA|1|||
27890843|NCT00290251|54543684|FG000|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
27890844|NCT00290251|54543685|FG001|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
27890845|NCT00290251|54543686|FG002|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
27890846|NCT00290251|54543687|FG003|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
27890847|NCT00290251|54543688|FG004|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
27890848|NCT00290251|54543689|FG005|Treatment 1 (Months 2-4)|Withdrawal by Subject|2|||
27890849|NCT00290251|54543684|FG000|Treatment 1 (Months 2-4)|headache|0|||
27890850|NCT00290251|54543685|FG001|Treatment 1 (Months 2-4)|headache|0|||
27890851|NCT00290251|54543686|FG002|Treatment 1 (Months 2-4)|headache|0|||
27890852|NCT00290251|54543687|FG003|Treatment 1 (Months 2-4)|headache|0|||
27890853|NCT00290251|54543688|FG004|Treatment 1 (Months 2-4)|headache|1|||
27890854|NCT00290251|54543689|FG005|Treatment 1 (Months 2-4)|headache|0|||
27890855|NCT00290251|54543684|FG000|Treatment 1 (Months 2-4)|Out of body experience|0|||
27890856|NCT00290251|54543685|FG001|Treatment 1 (Months 2-4)|Out of body experience|0|||
27890857|NCT00290251|54543686|FG002|Treatment 1 (Months 2-4)|Out of body experience|0|||
27890858|NCT00290251|54543687|FG003|Treatment 1 (Months 2-4)|Out of body experience|1|||
27890859|NCT00290251|54543688|FG004|Treatment 1 (Months 2-4)|Out of body experience|0|||
27890860|NCT00290251|54543689|FG005|Treatment 1 (Months 2-4)|Out of body experience|0|||
27890861|NCT01403948|54543725|FG000|Overall Study|Progressive disease|0|||
27890862|NCT01403948|54543726|FG001|Overall Study|Progressive disease|2|||
27890863|NCT01403948|54543727|FG002|Overall Study|Progressive disease|2|||
27890864|NCT01403948|54543728|FG003|Overall Study|Progressive disease|4|||
27890865|NCT01403948|54543729|FG004|Overall Study|Progressive disease|2|||
27890866|NCT01403948|54543730|FG005|Overall Study|Progressive disease|6|||
27890867|NCT01403948|54543731|FG006|Overall Study|Progressive disease|2|||
27890868|NCT01403948|54543732|FG007|Overall Study|Progressive disease|4|||
27890869|NCT01403948|54543733|FG008|Overall Study|Progressive disease|5|||
27890870|NCT01403948|54543734|FG009|Overall Study|Progressive disease|5|||
27890871|NCT01403948|54543725|FG000|Overall Study|Other Adverse Event (Other than DLT)|0|||
27890872|NCT01403948|54543726|FG001|Overall Study|Other Adverse Event (Other than DLT)|0|||
27890873|NCT01403948|54543727|FG002|Overall Study|Other Adverse Event (Other than DLT)|0|||
27890874|NCT01403948|54543728|FG003|Overall Study|Other Adverse Event (Other than DLT)|0|||
27890875|NCT01403948|54543729|FG004|Overall Study|Other Adverse Event (Other than DLT)|2|||
27890876|NCT01403948|54543730|FG005|Overall Study|Other Adverse Event (Other than DLT)|0|||
27890877|NCT01403948|54543731|FG006|Overall Study|Other Adverse Event (Other than DLT)|2|||
27890878|NCT01403948|54543732|FG007|Overall Study|Other Adverse Event (Other than DLT)|0|||
27890879|NCT01403948|54543733|FG008|Overall Study|Other Adverse Event (Other than DLT)|1|||
27890880|NCT01403948|54543734|FG009|Overall Study|Other Adverse Event (Other than DLT)|0|||
27890881|NCT01403948|54543725|FG000|Overall Study|Lost to Follow-up|0|||
27890882|NCT01403948|54543726|FG001|Overall Study|Lost to Follow-up|0|||
27890883|NCT01403948|54543727|FG002|Overall Study|Lost to Follow-up|0|||
27890884|NCT01403948|54543728|FG003|Overall Study|Lost to Follow-up|0|||
27890885|NCT01403948|54543729|FG004|Overall Study|Lost to Follow-up|0|||
27890886|NCT01403948|54543730|FG005|Overall Study|Lost to Follow-up|0|||
27890887|NCT01403948|54543731|FG006|Overall Study|Lost to Follow-up|0|||
27890888|NCT01403948|54543732|FG007|Overall Study|Lost to Follow-up|0|||
27890889|NCT01403948|54543733|FG008|Overall Study|Lost to Follow-up|0|||
27890890|NCT01403948|54543734|FG009|Overall Study|Lost to Follow-up|1|||
27890891|NCT01403948|54543725|FG000|Overall Study|Refused cont. medication|0|||
28171866|NCT02468674|54843503|FG004|Overall Study|Adverse Event|0|||
28171867|NCT02468674|54843504|FG005|Overall Study|Adverse Event|1|||
27890892|NCT01403948|54543726|FG001|Overall Study|Refused cont. medication|0|||
27890893|NCT01403948|54543727|FG002|Overall Study|Refused cont. medication|0|||
27890894|NCT01403948|54543728|FG003|Overall Study|Refused cont. medication|0|||
27890895|NCT01403948|54543729|FG004|Overall Study|Refused cont. medication|1|||
27890896|NCT01403948|54543730|FG005|Overall Study|Refused cont. medication|0|||
27890897|NCT01403948|54543731|FG006|Overall Study|Refused cont. medication|0|||
27890898|NCT01403948|54543732|FG007|Overall Study|Refused cont. medication|0|||
27890899|NCT01403948|54543733|FG008|Overall Study|Refused cont. medication|0|||
27890900|NCT01403948|54543734|FG009|Overall Study|Refused cont. medication|1|||
27890901|NCT01403948|54543725|FG000|Overall Study|other than above|1|||
27890902|NCT01403948|54543726|FG001|Overall Study|other than above|2|||
27890903|NCT01403948|54543727|FG002|Overall Study|other than above|1|||
27890904|NCT01403948|54543728|FG003|Overall Study|other than above|0|||
27890905|NCT01403948|54543729|FG004|Overall Study|other than above|1|||
27890906|NCT01403948|54543730|FG005|Overall Study|other than above|1|||
27890907|NCT01403948|54543731|FG006|Overall Study|other than above|2|||
27890908|NCT01403948|54543732|FG007|Overall Study|other than above|0|||
27890909|NCT01403948|54543733|FG008|Overall Study|other than above|0|||
27890910|NCT01403948|54543734|FG009|Overall Study|other than above|0|||
27890911|NCT01404312|54543762|FG000|Overall Study|Death|21|||
27890912|NCT01404312|54543763|FG001|Overall Study|Death|27|||
27890913|NCT01404312|54543762|FG000|Overall Study|Withdrawal by Subject|15|||
27890914|NCT01404312|54543763|FG001|Overall Study|Withdrawal by Subject|18|||
27890915|NCT01404312|54543762|FG000|Overall Study|Participant Unable to get to clinic|93|||
27890916|NCT01404312|54543763|FG001|Overall Study|Participant Unable to get to clinic|103|||
27890917|NCT01404312|54543762|FG000|Overall Study|Lost to Follow-up|115|||
27890918|NCT01404312|54543763|FG001|Overall Study|Lost to Follow-up|111|||
27890919|NCT01404312|54543762|FG000|Overall Study|Site closed|22|||
27890920|NCT01404312|54543763|FG001|Overall Study|Site closed|21|||
27890921|NCT01404312|54543762|FG000|Overall Study|Participant not willing to adhere to req|31|||
27890922|NCT01404312|54543763|FG001|Overall Study|Participant not willing to adhere to req|29|||
27890923|NCT01404312|54543762|FG000|Overall Study|Severe debilitation, unable to continue|1|||
27890924|NCT01404312|54543763|FG001|Overall Study|Severe debilitation, unable to continue|2|||
27890925|NCT01414608|54543772|FG000|Overall Study|Ineligible|5|||
27890926|NCT01414608|54543773|FG001|Overall Study|Ineligible|2|||
27890927|NCT01425008|54543802|FG000|Dose Escalation Phase|Progressive Disease|2|||
27890928|NCT01425008|54543803|FG001|Dose Escalation Phase|Progressive Disease|3|||
27890929|NCT01425008|54543804|FG002|Dose Escalation Phase|Progressive Disease|2|||
27890930|NCT01425008|54543805|FG003|Dose Escalation Phase|Progressive Disease|3|||
27890931|NCT01425008|54543806|FG004|Dose Escalation Phase|Progressive Disease|5|||
28096671|NCT03692676|54751819|FG002|Overall Study|Other|758|||
28096672|NCT03692676|54751820|FG003|Overall Study|Other|277|||
28096673|NCT03692676|54751817|FG000|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
28096674|NCT03692676|54751818|FG001|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
28096675|NCT03692676|54751819|FG002|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
28096676|NCT03692676|54751820|FG003|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3|||
28096677|NCT03691428|54751832|FG000|Overall Study|Withdrawal by Subject|6|||
28096678|NCT03691428|54751833|FG001|Overall Study|Withdrawal by Subject|8|||
28096679|NCT04124952|54751839|FG000|Overall Study|Lost to Follow-up|1|||
28096680|NCT04122534|54751843|FG000|Overall Study|Lost to Follow-up|4|||
27890932|NCT01425008|54543807|FG005|Dose Escalation Phase|Progressive Disease|4|||
27890933|NCT01425008|54543808|FG006|Dose Escalation Phase|Progressive Disease|0|||
27890934|NCT01425008|54543809|FG007|Dose Escalation Phase|Progressive Disease|2|||
27890935|NCT01425008|54543810|FG008|Dose Escalation Phase|Progressive Disease|6|||
27890936|NCT01425008|54543811|FG009|Dose Escalation Phase|Progressive Disease|2|||
27890937|NCT01425008|54543812|FG010|Dose Escalation Phase|Progressive Disease|0|||
27890938|NCT01425008|54543813|FG011|Dose Escalation Phase|Progressive Disease|0|||
27890939|NCT01425008|54543814|FG012|Dose Escalation Phase|Progressive Disease|0|||
27890940|NCT01425008|54543815|FG013|Dose Escalation Phase|Progressive Disease|0|||
27890941|NCT01425008|54543816|FG014|Dose Escalation Phase|Progressive Disease|0|||
27890942|NCT01425008|54543817|FG015|Dose Escalation Phase|Progressive Disease|0|||
27890943|NCT01425008|54543818|FG016|Dose Escalation Phase|Progressive Disease|0|||
27890944|NCT01425008|54543819|FG017|Dose Escalation Phase|Progressive Disease|0|||
27890945|NCT01425008|54543820|FG018|Dose Escalation Phase|Progressive Disease|0|||
27890946|NCT01425008|54543802|FG000|Dose Escalation Phase|Adverse Event|2|||
27890947|NCT01425008|54543803|FG001|Dose Escalation Phase|Adverse Event|0|||
27890948|NCT01425008|54543804|FG002|Dose Escalation Phase|Adverse Event|0|||
27890949|NCT01425008|54543805|FG003|Dose Escalation Phase|Adverse Event|0|||
27890950|NCT01425008|54543806|FG004|Dose Escalation Phase|Adverse Event|0|||
27890951|NCT01425008|54543807|FG005|Dose Escalation Phase|Adverse Event|2|||
27890952|NCT01425008|54543808|FG006|Dose Escalation Phase|Adverse Event|0|||
27890953|NCT01425008|54543809|FG007|Dose Escalation Phase|Adverse Event|0|||
27890954|NCT01425008|54543810|FG008|Dose Escalation Phase|Adverse Event|2|||
27890955|NCT01425008|54543811|FG009|Dose Escalation Phase|Adverse Event|0|||
27890956|NCT01425008|54543812|FG010|Dose Escalation Phase|Adverse Event|0|||
27890957|NCT01425008|54543813|FG011|Dose Escalation Phase|Adverse Event|0|||
27890958|NCT01425008|54543814|FG012|Dose Escalation Phase|Adverse Event|0|||
27890959|NCT01425008|54543815|FG013|Dose Escalation Phase|Adverse Event|0|||
27890960|NCT01425008|54543816|FG014|Dose Escalation Phase|Adverse Event|0|||
27890961|NCT01425008|54543817|FG015|Dose Escalation Phase|Adverse Event|0|||
27890962|NCT01425008|54543818|FG016|Dose Escalation Phase|Adverse Event|0|||
27890963|NCT01425008|54543819|FG017|Dose Escalation Phase|Adverse Event|0|||
27890964|NCT01425008|54543820|FG018|Dose Escalation Phase|Adverse Event|0|||
27890965|NCT01425008|54543802|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
27890966|NCT01425008|54543803|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
27890967|NCT01425008|54543804|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
27890968|NCT01425008|54543805|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
27890969|NCT01425008|54543806|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
27890970|NCT01425008|54543807|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
27890971|NCT01425008|54543808|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2|||
27890972|NCT01425008|54543809|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
27890973|NCT01425008|54543810|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
27890974|NCT01425008|54543811|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
27890975|NCT01425008|54543812|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
27890976|NCT01425008|54543813|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
27890977|NCT01425008|54543814|FG012|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
27890978|NCT01425008|54543815|FG013|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
27890979|NCT01425008|54543816|FG014|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
27890980|NCT01425008|54543817|FG015|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
27890981|NCT01425008|54543818|FG016|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
27890982|NCT01425008|54543819|FG017|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
27890983|NCT01425008|54543820|FG018|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
27890984|NCT01425008|54543802|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
27890985|NCT01425008|54543803|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
27890986|NCT01425008|54543804|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
27890987|NCT01425008|54543805|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
27890988|NCT01425008|54543806|FG004|Dose Escalation Phase|Withdrawal by Subject|1|||
27890989|NCT01425008|54543807|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
27890990|NCT01425008|54543808|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
27890991|NCT01425008|54543809|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
27890992|NCT01425008|54543810|FG008|Dose Escalation Phase|Withdrawal by Subject|1|||
27890993|NCT01425008|54543811|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
27890994|NCT01425008|54543812|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
27890995|NCT01425008|54543813|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
27890996|NCT01425008|54543814|FG012|Dose Escalation Phase|Withdrawal by Subject|0|||
27890997|NCT01425008|54543815|FG013|Dose Escalation Phase|Withdrawal by Subject|0|||
27890998|NCT01425008|54543816|FG014|Dose Escalation Phase|Withdrawal by Subject|0|||
27890999|NCT01425008|54543817|FG015|Dose Escalation Phase|Withdrawal by Subject|0|||
27891000|NCT01425008|54543818|FG016|Dose Escalation Phase|Withdrawal by Subject|0|||
27891001|NCT01425008|54543819|FG017|Dose Escalation Phase|Withdrawal by Subject|0|||
27891002|NCT01425008|54543820|FG018|Dose Escalation Phase|Withdrawal by Subject|0|||
27891003|NCT01425008|54543802|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
27891004|NCT01425008|54543803|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
27891005|NCT01425008|54543804|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
27891006|NCT01425008|54543805|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
27891007|NCT01425008|54543806|FG004|Dose Escalation Phase|Symptomatic Deterioration|0|||
27891008|NCT01425008|54543807|FG005|Dose Escalation Phase|Symptomatic Deterioration|0|||
27891009|NCT01425008|54543808|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
27985585|NCT03922945|54644346|FG000|Overall Study|All Other Personal Reasons|1|||
27891010|NCT01425008|54543809|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
27891011|NCT01425008|54543810|FG008|Dose Escalation Phase|Symptomatic Deterioration|2|||
27891012|NCT01425008|54543811|FG009|Dose Escalation Phase|Symptomatic Deterioration|2|||
27891013|NCT01425008|54543812|FG010|Dose Escalation Phase|Symptomatic Deterioration|0|||
27891014|NCT01425008|54543813|FG011|Dose Escalation Phase|Symptomatic Deterioration|0|||
27891015|NCT01425008|54543814|FG012|Dose Escalation Phase|Symptomatic Deterioration|0|||
27891016|NCT01425008|54543815|FG013|Dose Escalation Phase|Symptomatic Deterioration|0|||
27891017|NCT01425008|54543816|FG014|Dose Escalation Phase|Symptomatic Deterioration|0|||
27891018|NCT01425008|54543817|FG015|Dose Escalation Phase|Symptomatic Deterioration|0|||
27891019|NCT01425008|54543818|FG016|Dose Escalation Phase|Symptomatic Deterioration|0|||
27891020|NCT01425008|54543819|FG017|Dose Escalation Phase|Symptomatic Deterioration|0|||
27891021|NCT01425008|54543820|FG018|Dose Escalation Phase|Symptomatic Deterioration|0|||
27891022|NCT01425008|54543802|FG000|Dose Escalation Phase|Other|0|||
27891023|NCT01425008|54543803|FG001|Dose Escalation Phase|Other|0|||
27891024|NCT01425008|54543804|FG002|Dose Escalation Phase|Other|0|||
27891025|NCT01425008|54543805|FG003|Dose Escalation Phase|Other|0|||
27891026|NCT01425008|54543806|FG004|Dose Escalation Phase|Other|0|||
27891027|NCT01425008|54543807|FG005|Dose Escalation Phase|Other|0|||
27891028|NCT01425008|54543808|FG006|Dose Escalation Phase|Other|0|||
27891029|NCT01425008|54543809|FG007|Dose Escalation Phase|Other|0|||
27891030|NCT01425008|54543810|FG008|Dose Escalation Phase|Other|1|||
27891031|NCT01425008|54543811|FG009|Dose Escalation Phase|Other|0|||
27891032|NCT01425008|54543812|FG010|Dose Escalation Phase|Other|0|||
27891033|NCT01425008|54543813|FG011|Dose Escalation Phase|Other|0|||
27891034|NCT01425008|54543814|FG012|Dose Escalation Phase|Other|0|||
27891035|NCT01425008|54543815|FG013|Dose Escalation Phase|Other|0|||
27891036|NCT01425008|54543816|FG014|Dose Escalation Phase|Other|0|||
27891037|NCT01425008|54543817|FG015|Dose Escalation Phase|Other|0|||
27891038|NCT01425008|54543818|FG016|Dose Escalation Phase|Other|0|||
27891039|NCT01425008|54543819|FG017|Dose Escalation Phase|Other|0|||
27891040|NCT01425008|54543820|FG018|Dose Escalation Phase|Other|0|||
27891041|NCT01425008|54543802|FG000|Dose Expansion Phase|Progressive Disease|0|||
27891042|NCT01425008|54543803|FG001|Dose Expansion Phase|Progressive Disease|0|||
27891043|NCT01425008|54543804|FG002|Dose Expansion Phase|Progressive Disease|0|||
27891044|NCT01425008|54543805|FG003|Dose Expansion Phase|Progressive Disease|0|||
27891045|NCT01425008|54543806|FG004|Dose Expansion Phase|Progressive Disease|0|||
27891046|NCT01425008|54543807|FG005|Dose Expansion Phase|Progressive Disease|0|||
27891047|NCT01425008|54543808|FG006|Dose Expansion Phase|Progressive Disease|0|||
27891048|NCT01425008|54543809|FG007|Dose Expansion Phase|Progressive Disease|0|||
27891049|NCT01425008|54543810|FG008|Dose Expansion Phase|Progressive Disease|0|||
27891050|NCT01425008|54543811|FG009|Dose Expansion Phase|Progressive Disease|0|||
27891051|NCT01425008|54543812|FG010|Dose Expansion Phase|Progressive Disease|10|||
27891052|NCT01425008|54543813|FG011|Dose Expansion Phase|Progressive Disease|4|||
27891053|NCT01425008|54543814|FG012|Dose Expansion Phase|Progressive Disease|12|||
27891054|NCT01425008|54543815|FG013|Dose Expansion Phase|Progressive Disease|1|||
27891055|NCT01425008|54543816|FG014|Dose Expansion Phase|Progressive Disease|5|||
27891056|NCT01425008|54543817|FG015|Dose Expansion Phase|Progressive Disease|8|||
27891057|NCT01425008|54543818|FG016|Dose Expansion Phase|Progressive Disease|9|||
27891058|NCT01425008|54543819|FG017|Dose Expansion Phase|Progressive Disease|2|||
27891059|NCT01425008|54543820|FG018|Dose Expansion Phase|Progressive Disease|10|||
27891060|NCT01425008|54543802|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
27891061|NCT01425008|54543803|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
27891062|NCT01425008|54543804|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
27891063|NCT01425008|54543805|FG003|Dose Expansion Phase|Withdrawal by Subject|0|||
27891064|NCT01425008|54543806|FG004|Dose Expansion Phase|Withdrawal by Subject|0|||
27891065|NCT01425008|54543807|FG005|Dose Expansion Phase|Withdrawal by Subject|0|||
27891066|NCT01425008|54543808|FG006|Dose Expansion Phase|Withdrawal by Subject|0|||
27891067|NCT01425008|54543809|FG007|Dose Expansion Phase|Withdrawal by Subject|0|||
27891068|NCT01425008|54543810|FG008|Dose Expansion Phase|Withdrawal by Subject|0|||
27891069|NCT01425008|54543811|FG009|Dose Expansion Phase|Withdrawal by Subject|0|||
27891070|NCT01425008|54543812|FG010|Dose Expansion Phase|Withdrawal by Subject|1|||
27891071|NCT01425008|54543813|FG011|Dose Expansion Phase|Withdrawal by Subject|0|||
27891072|NCT01425008|54543814|FG012|Dose Expansion Phase|Withdrawal by Subject|0|||
27891073|NCT01425008|54543815|FG013|Dose Expansion Phase|Withdrawal by Subject|0|||
27985586|NCT03922945|54644347|FG001|Overall Study|All Other Personal Reasons|1|||
27985587|NCT03922945|54644348|FG002|Overall Study|All Other Personal Reasons|2|||
27891074|NCT01425008|54543816|FG014|Dose Expansion Phase|Withdrawal by Subject|0|||
27891075|NCT01425008|54543817|FG015|Dose Expansion Phase|Withdrawal by Subject|1|||
27891076|NCT01425008|54543818|FG016|Dose Expansion Phase|Withdrawal by Subject|1|||
27891077|NCT01425008|54543819|FG017|Dose Expansion Phase|Withdrawal by Subject|0|||
27891078|NCT01425008|54543820|FG018|Dose Expansion Phase|Withdrawal by Subject|0|||
27891079|NCT01425008|54543802|FG000|Dose Expansion Phase|Other|0|||
27891080|NCT01425008|54543803|FG001|Dose Expansion Phase|Other|0|||
27891081|NCT01425008|54543804|FG002|Dose Expansion Phase|Other|0|||
27891082|NCT01425008|54543805|FG003|Dose Expansion Phase|Other|0|||
27891083|NCT01425008|54543806|FG004|Dose Expansion Phase|Other|0|||
27891084|NCT01425008|54543807|FG005|Dose Expansion Phase|Other|0|||
27891085|NCT01425008|54543808|FG006|Dose Expansion Phase|Other|0|||
27891086|NCT01425008|54543809|FG007|Dose Expansion Phase|Other|0|||
27891087|NCT01425008|54543810|FG008|Dose Expansion Phase|Other|0|||
27891088|NCT01425008|54543811|FG009|Dose Expansion Phase|Other|0|||
27891089|NCT01425008|54543812|FG010|Dose Expansion Phase|Other|0|||
27891090|NCT01425008|54543813|FG011|Dose Expansion Phase|Other|0|||
27891091|NCT01425008|54543814|FG012|Dose Expansion Phase|Other|1|||
27891092|NCT01425008|54543815|FG013|Dose Expansion Phase|Other|0|||
27891093|NCT01425008|54543816|FG014|Dose Expansion Phase|Other|0|||
27891094|NCT01425008|54543817|FG015|Dose Expansion Phase|Other|0|||
27891095|NCT01425008|54543818|FG016|Dose Expansion Phase|Other|2|||
27891096|NCT01425008|54543819|FG017|Dose Expansion Phase|Other|0|||
27891097|NCT01425008|54543820|FG018|Dose Expansion Phase|Other|4|||
27891098|NCT01425008|54543802|FG000|Dose Expansion Phase|Symptomatic Deterioration|0|||
27891099|NCT01425008|54543803|FG001|Dose Expansion Phase|Symptomatic Deterioration|0|||
27891100|NCT01425008|54543804|FG002|Dose Expansion Phase|Symptomatic Deterioration|0|||
27891101|NCT01425008|54543805|FG003|Dose Expansion Phase|Symptomatic Deterioration|0|||
27891102|NCT01425008|54543806|FG004|Dose Expansion Phase|Symptomatic Deterioration|0|||
27891103|NCT01425008|54543807|FG005|Dose Expansion Phase|Symptomatic Deterioration|0|||
27891104|NCT01425008|54543808|FG006|Dose Expansion Phase|Symptomatic Deterioration|0|||
27891105|NCT01425008|54543809|FG007|Dose Expansion Phase|Symptomatic Deterioration|0|||
27891106|NCT01425008|54543810|FG008|Dose Expansion Phase|Symptomatic Deterioration|0|||
27891107|NCT01425008|54543811|FG009|Dose Expansion Phase|Symptomatic Deterioration|0|||
27891108|NCT01425008|54543812|FG010|Dose Expansion Phase|Symptomatic Deterioration|2|||
27891109|NCT01425008|54543813|FG011|Dose Expansion Phase|Symptomatic Deterioration|1|||
27891110|NCT01425008|54543814|FG012|Dose Expansion Phase|Symptomatic Deterioration|0|||
27891111|NCT01425008|54543815|FG013|Dose Expansion Phase|Symptomatic Deterioration|0|||
27891112|NCT01425008|54543816|FG014|Dose Expansion Phase|Symptomatic Deterioration|0|||
27891113|NCT01425008|54543817|FG015|Dose Expansion Phase|Symptomatic Deterioration|1|||
27891114|NCT01425008|54543818|FG016|Dose Expansion Phase|Symptomatic Deterioration|2|||
27891115|NCT01425008|54543819|FG017|Dose Expansion Phase|Symptomatic Deterioration|0|||
27891116|NCT01425008|54543820|FG018|Dose Expansion Phase|Symptomatic Deterioration|1|||
27891117|NCT01425008|54543802|FG000|Dose Expansion Phase|Adverse Event|0|||
27891118|NCT01425008|54543803|FG001|Dose Expansion Phase|Adverse Event|0|||
27891119|NCT01425008|54543804|FG002|Dose Expansion Phase|Adverse Event|0|||
27891120|NCT01425008|54543805|FG003|Dose Expansion Phase|Adverse Event|0|||
27891121|NCT01425008|54543806|FG004|Dose Expansion Phase|Adverse Event|0|||
27891122|NCT01425008|54543807|FG005|Dose Expansion Phase|Adverse Event|0|||
27891123|NCT01425008|54543808|FG006|Dose Expansion Phase|Adverse Event|0|||
27891124|NCT01425008|54543809|FG007|Dose Expansion Phase|Adverse Event|0|||
27891125|NCT01425008|54543810|FG008|Dose Expansion Phase|Adverse Event|0|||
27891126|NCT01425008|54543811|FG009|Dose Expansion Phase|Adverse Event|0|||
27891127|NCT01425008|54543812|FG010|Dose Expansion Phase|Adverse Event|2|||
27891128|NCT01425008|54543813|FG011|Dose Expansion Phase|Adverse Event|3|||
27891129|NCT01425008|54543814|FG012|Dose Expansion Phase|Adverse Event|3|||
27891130|NCT01425008|54543815|FG013|Dose Expansion Phase|Adverse Event|0|||
27891131|NCT01425008|54543816|FG014|Dose Expansion Phase|Adverse Event|1|||
27891132|NCT01425008|54543817|FG015|Dose Expansion Phase|Adverse Event|1|||
27891133|NCT01425008|54543818|FG016|Dose Expansion Phase|Adverse Event|5|||
27891134|NCT01425008|54543819|FG017|Dose Expansion Phase|Adverse Event|0|||
27891135|NCT01425008|54543820|FG018|Dose Expansion Phase|Adverse Event|3|||
27891136|NCT01425008|54543802|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
27891137|NCT01425008|54543803|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
27891138|NCT01425008|54543804|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
27891139|NCT01425008|54543805|FG003|Dose Expansion Phase|Lost to Follow-up|0|||
27891140|NCT01425008|54543806|FG004|Dose Expansion Phase|Lost to Follow-up|0|||
27891141|NCT01425008|54543807|FG005|Dose Expansion Phase|Lost to Follow-up|0|||
27891142|NCT01425008|54543808|FG006|Dose Expansion Phase|Lost to Follow-up|0|||
27891143|NCT01425008|54543809|FG007|Dose Expansion Phase|Lost to Follow-up|0|||
27985588|NCT03922477|54644359|FG000|Overall Study|Death|9|||
27891144|NCT01425008|54543810|FG008|Dose Expansion Phase|Lost to Follow-up|0|||
27891145|NCT01425008|54543811|FG009|Dose Expansion Phase|Lost to Follow-up|0|||
27891146|NCT01425008|54543812|FG010|Dose Expansion Phase|Lost to Follow-up|0|||
27891147|NCT01425008|54543813|FG011|Dose Expansion Phase|Lost to Follow-up|0|||
27891148|NCT01425008|54543814|FG012|Dose Expansion Phase|Lost to Follow-up|0|||
27891149|NCT01425008|54543815|FG013|Dose Expansion Phase|Lost to Follow-up|0|||
27891150|NCT01425008|54543816|FG014|Dose Expansion Phase|Lost to Follow-up|0|||
27891151|NCT01425008|54543817|FG015|Dose Expansion Phase|Lost to Follow-up|0|||
27891152|NCT01425008|54543818|FG016|Dose Expansion Phase|Lost to Follow-up|1|||
27891153|NCT01425008|54543819|FG017|Dose Expansion Phase|Lost to Follow-up|0|||
27891154|NCT01425008|54543820|FG018|Dose Expansion Phase|Lost to Follow-up|0|||
27891155|NCT01425008|54543802|FG000|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
27891156|NCT01425008|54543803|FG001|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
27891157|NCT01425008|54543804|FG002|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
27891158|NCT01425008|54543805|FG003|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
27891159|NCT01425008|54543806|FG004|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
27891160|NCT01425008|54543807|FG005|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
27891161|NCT01425008|54543808|FG006|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
27891162|NCT01425008|54543809|FG007|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
27891163|NCT01425008|54543810|FG008|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
27891164|NCT01425008|54543811|FG009|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
27891165|NCT01425008|54543812|FG010|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
27891166|NCT01425008|54543813|FG011|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
27891167|NCT01425008|54543814|FG012|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
27891168|NCT01425008|54543815|FG013|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
27891169|NCT01425008|54543816|FG014|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
27891170|NCT01425008|54543817|FG015|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
27891171|NCT01425008|54543818|FG016|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
27891172|NCT01425008|54543819|FG017|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
27891173|NCT01425008|54543820|FG018|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1|||
27891174|NCT04425902|54543873|FG000|Treatment Period 2 (Days 11 to 20)|Adverse Event|1|||
27891175|NCT04072146|54543886|FG000|Overall Study|Adverse Event|0|||
27891176|NCT04072146|54543887|FG001|Overall Study|Adverse Event|1|||
27891177|NCT03861481|54543901|FG000|Overall Study|COVID-19 pandemic circumstances|0|||
27891178|NCT03861481|54543902|FG001|Overall Study|COVID-19 pandemic circumstances|1|||
27891179|NCT03861481|54543901|FG000|Overall Study|Participant not plan to participate in the study CIDP04|1|||
27891180|NCT03861481|54543902|FG001|Overall Study|Participant not plan to participate in the study CIDP04|0|||
27891181|NCT03861481|54543901|FG000|Overall Study|Relapse|1|||
27891182|NCT03861481|54543902|FG001|Overall Study|Relapse|0|||
27891183|NCT03861481|54543901|FG000|Overall Study|Withdrawal by Subject|0|||
27891184|NCT03861481|54543902|FG001|Overall Study|Withdrawal by Subject|1|||
27891185|NCT03861481|54543901|FG000|Overall Study|Lack of Efficacy|4|||
27891186|NCT03861481|54543902|FG001|Overall Study|Lack of Efficacy|5|||
27891187|NCT03648476|54543914|FG000|Overall Study|Withdrawal by Subject|2|||
27891188|NCT03648476|54543915|FG001|Overall Study|Withdrawal by Subject|1|||
27891189|NCT04660799|54543933|FG000|Overall Study|Ongoing in Study|9|||
27891190|NCT04660799|54543934|FG001|Overall Study|Ongoing in Study|13|||
27891191|NCT04660799|54543933|FG000|Overall Study|Progressive Disease|1|||
27891192|NCT04660799|54543934|FG001|Overall Study|Progressive Disease|1|||
27891193|NCT04660799|54543933|FG000|Overall Study|Death|2|||
27891194|NCT04660799|54543934|FG001|Overall Study|Death|1|||
27891195|NCT04660799|54543933|FG000|Overall Study|Adverse Event|2|||
27891196|NCT04660799|54543934|FG001|Overall Study|Adverse Event|1|||
27891197|NCT04660799|54543933|FG000|Overall Study|Withdrawal by Subject|2|||
27891198|NCT04660799|54543934|FG001|Overall Study|Withdrawal by Subject|4|||
27891199|NCT04545060|54543942|FG000|Overall Study|Adverse Event|0|||
27891200|NCT04545060|54543943|FG001|Overall Study|Adverse Event|1|||
27891201|NCT04545060|54543942|FG000|Overall Study|Death|0|||
27891202|NCT04545060|54543943|FG001|Overall Study|Death|5|||
27891203|NCT04545060|54543942|FG000|Overall Study|Lost to Follow-up|10|||
27985589|NCT03922477|54644359|FG000|Overall Study|Fall leading to death prior to treatment initiation.|1|||
27985590|NCT03922477|54644359|FG000|Overall Study|Physician Decision|1|||
27985591|NCT03922477|54644359|FG000|Overall Study|Withdrawal by Subject|2|||
27985592|NCT00867165|54644365|FG000|Overall Study|Adverse Event|3|||
27985593|NCT00867165|54644366|FG001|Overall Study|Adverse Event|0|||
27985594|NCT00867165|54644365|FG000|Overall Study|Withdrawal by Subject|1|||
27985595|NCT00867165|54644366|FG001|Overall Study|Withdrawal by Subject|0|||
27985596|NCT00867087|54644372|FG000|Overall Study|Other|1|||
27985597|NCT00867087|54644372|FG000|Overall Study|Withdrawal by Subject|4|||
27985598|NCT00867087|54644372|FG000|Overall Study|Death|37|||
27985599|NCT00545233|54644378|FG000|Overall Study|Adverse Event|10|||
27891204|NCT04545060|54543943|FG001|Overall Study|Lost to Follow-up|13|||
27891205|NCT04545060|54543942|FG000|Overall Study|Physician Decision|3|||
27891206|NCT04545060|54543943|FG001|Overall Study|Physician Decision|0|||
27891207|NCT04545060|54543942|FG000|Overall Study|Withdrawal by Subject|17|||
27891208|NCT04545060|54543943|FG001|Overall Study|Withdrawal by Subject|22|||
27891209|NCT03533660|54543999|FG000|Overall Study|Withdrawal by Subject|2|||
27891210|NCT03533660|54544000|FG001|Overall Study|Withdrawal by Subject|2|||
27985600|NCT00545233|54644379|FG001|Overall Study|Adverse Event|5|||
28096681|NCT04091360|54751853|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
27891211|NCT03533660|54543999|FG000|Overall Study|Death|2|||
27891212|NCT03533660|54544000|FG001|Overall Study|Death|4|||
27891213|NCT03533660|54543999|FG000|Overall Study|Adverse Event|0|||
27891214|NCT03533660|54544000|FG001|Overall Study|Adverse Event|2|||
27891215|NCT03416127|54544014|FG000|Overall Study|Withdrawal by Subject|0|||
27891216|NCT03416127|54544015|FG001|Overall Study|Withdrawal by Subject|1|||
27891217|NCT03416127|54544016|FG002|Overall Study|Withdrawal by Subject|1|||
27891218|NCT03260140|54544027|FG000|Overall Study|Death|4|||
27891219|NCT03260140|54544028|FG001|Overall Study|Death|1|||
27985601|NCT00545233|54644378|FG000|Overall Study|Violation of Selection Criteria at Entry|5|||
27891220|NCT03260140|54544027|FG000|Overall Study|Withdrawal by Subject|1|||
27891221|NCT03260140|54544028|FG001|Overall Study|Withdrawal by Subject|4|||
27891222|NCT02986334|54544059|FG000|Overall Study|Withdrawal by Subject|0|||
27891223|NCT02986334|54544060|FG001|Overall Study|Withdrawal by Subject|1|||
27891224|NCT02986334|54544061|FG002|Overall Study|Withdrawal by Subject|2|||
27891225|NCT02986334|54544059|FG000|Overall Study|Lost to Follow-up|1|||
27891226|NCT02986334|54544060|FG001|Overall Study|Lost to Follow-up|2|||
27891227|NCT02986334|54544061|FG002|Overall Study|Lost to Follow-up|1|||
27891228|NCT02986334|54544059|FG000|Overall Study|Adverse Event|0|||
27891229|NCT02986334|54544060|FG001|Overall Study|Adverse Event|2|||
27891230|NCT02986334|54544061|FG002|Overall Study|Adverse Event|1|||
27891231|NCT02986334|54544059|FG000|Overall Study|non compliance in phone ratings|2|||
27891232|NCT02986334|54544060|FG001|Overall Study|non compliance in phone ratings|1|||
27891233|NCT02986334|54544061|FG002|Overall Study|non compliance in phone ratings|2|||
27891234|NCT02986334|54544059|FG000|Overall Study|undisclosed comorbidities|0|||
27891235|NCT02986334|54544060|FG001|Overall Study|undisclosed comorbidities|1|||
27891236|NCT02986334|54544061|FG002|Overall Study|undisclosed comorbidities|1|||
27891237|NCT02210221|54544083|FG000|Overall Study|Lack of Efficacy|7|||
27891238|NCT02210221|54544083|FG000|Overall Study|Withdrawal by Subject|43|||
27891239|NCT02124902|54544096|FG000|Overall Study|Adverse Event|7|||
27891240|NCT02124902|54544097|FG001|Overall Study|Adverse Event|2|||
27891241|NCT02124902|54544096|FG000|Overall Study|Went to alternative treatment|4|||
27891242|NCT02124902|54544097|FG001|Overall Study|Went to alternative treatment|0|||
27891243|NCT02124902|54544096|FG000|Overall Study|Withdrawal by Subject|2|||
27891244|NCT02124902|54544097|FG001|Overall Study|Withdrawal by Subject|1|||
27891245|NCT02124902|54544096|FG000|Overall Study|Physician Decision|2|||
27891246|NCT02124902|54544097|FG001|Overall Study|Physician Decision|0|||
27891247|NCT02124902|54544096|FG000|Overall Study|Not eligible|1|||
27891248|NCT02124902|54544097|FG001|Overall Study|Not eligible|0|||
27891249|NCT02124902|54544096|FG000|Overall Study|Did not receive carboplatin in cycle 6|1|||
27891250|NCT02124902|54544097|FG001|Overall Study|Did not receive carboplatin in cycle 6|3|||
27891251|NCT01940341|54544105|FG000|Double-Blind Phase|Randomized but Never Treated|0|||
27891252|NCT01940341|54544106|FG001|Double-Blind Phase|Randomized but Never Treated|1|||
27891253|NCT01940341|54544105|FG000|Double-Blind Phase|Adverse Event|3|||
27891254|NCT01940341|54544106|FG001|Double-Blind Phase|Adverse Event|2|||
27891255|NCT01940341|54544105|FG000|Double-Blind Phase|Withdrew Consent|3|||
27891256|NCT01940341|54544106|FG001|Double-Blind Phase|Withdrew Consent|2|||
27891257|NCT01940341|54544105|FG000|Double-Blind Phase|Lost to Follow-up|4|||
27891258|NCT01940341|54544106|FG001|Double-Blind Phase|Lost to Follow-up|1|||
27891259|NCT01940341|54544105|FG000|Double-Blind Phase|Pregnancy|0|||
27891260|NCT01940341|54544106|FG001|Double-Blind Phase|Pregnancy|1|||
27891261|NCT01940341|54544105|FG000|Double-Blind Phase|Investigator's Discretion|1|||
27891262|NCT01940341|54544106|FG001|Double-Blind Phase|Investigator's Discretion|0|||
27891263|NCT01940341|54544105|FG000|Double-Blind Phase|Non-Compliance with Study Drug|0|||
27891264|NCT01940341|54544106|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
27891265|NCT01940341|54544105|FG000|Double-Blind Phase|Protocol Specified Criteria|1|||
27891266|NCT01940341|54544106|FG001|Double-Blind Phase|Protocol Specified Criteria|0|||
27891267|NCT01940341|54544105|FG000|Double-Blind Phase|Still on Double-Blind Treatment|269|||
27891268|NCT01940341|54544106|FG001|Double-Blind Phase|Still on Double-Blind Treatment|132|||
27891269|NCT01940341|54544105|FG000|Open-label Extension Phase|Still on Study|4|||
27891270|NCT01940341|54544106|FG001|Open-label Extension Phase|Still on Study|1|||
27891271|NCT01877837|54544114|FG000|Overall Study|Lost to Follow-up|1|||
27891272|NCT01877837|54544114|FG000|Overall Study|Ineligible|4|||
27891273|NCT01624142|54544134|FG000|Overall Study|Withdrawal by Subject|14|||
27891274|NCT01624142|54544135|FG001|Overall Study|Withdrawal by Subject|4|||
27891275|NCT01624142|54544134|FG000|Overall Study|Death|3|||
27891276|NCT01624142|54544135|FG001|Overall Study|Death|6|||
27891277|NCT01624142|54544134|FG000|Overall Study|Study Closure|12|||
27891278|NCT01624142|54544135|FG001|Overall Study|Study Closure|6|||
27891279|NCT01624142|54544134|FG000|Overall Study|Lost to Follow-up|2|||
27891280|NCT01624142|54544135|FG001|Overall Study|Lost to Follow-up|0|||
27891281|NCT01624142|54544134|FG000|Overall Study|Other|1|||
27891282|NCT01624142|54544135|FG001|Overall Study|Other|0|||
27891283|NCT01535807|54544144|FG000|Overall Study|Withdrawal by Subject|1|||
27891284|NCT01535807|54544145|FG001|Overall Study|Withdrawal by Subject|1|||
27891285|NCT01535807|54544144|FG000|Overall Study|Data collection error|1|||
27891286|NCT01535807|54544145|FG001|Overall Study|Data collection error|1|||
27891287|NCT01375764|54544157|FG000|Overall Study|Lost to Follow-up|0|||
27891288|NCT01375764|54544158|FG001|Overall Study|Lost to Follow-up|1|||
27891289|NCT01375764|54544159|FG002|Overall Study|Lost to Follow-up|0|||
27891290|NCT01375764|54544160|FG003|Overall Study|Lost to Follow-up|0|||
27891291|NCT01375764|54544161|FG004|Overall Study|Lost to Follow-up|0|||
27891292|NCT01375764|54544157|FG000|Overall Study|Withdrawal by Subject|2|||
27891293|NCT01375764|54544158|FG001|Overall Study|Withdrawal by Subject|0|||
27891294|NCT01375764|54544159|FG002|Overall Study|Withdrawal by Subject|0|||
27891295|NCT01375764|54544160|FG003|Overall Study|Withdrawal by Subject|0|||
27891296|NCT01375764|54544161|FG004|Overall Study|Withdrawal by Subject|1|||
27891297|NCT01375764|54544157|FG000|Overall Study|Other|0|||
27891298|NCT01375764|54544158|FG001|Overall Study|Other|0|||
27891299|NCT01375764|54544159|FG002|Overall Study|Other|0|||
27891300|NCT01375764|54544160|FG003|Overall Study|Other|1|||
27891301|NCT01375764|54544161|FG004|Overall Study|Other|0|||
27891302|NCT00722046|54544180|FG000|Overall Study|Adverse Event|0|||
27891303|NCT00722046|54544181|FG001|Overall Study|Adverse Event|1|||
27891304|NCT00722046|54544182|FG002|Overall Study|Adverse Event|2|||
27891305|NCT00722046|54544183|FG003|Overall Study|Adverse Event|1|||
27891306|NCT00722046|54544184|FG004|Overall Study|Adverse Event|2|||
27891307|NCT00722046|54544185|FG005|Overall Study|Adverse Event|1|||
27891308|NCT00722046|54544186|FG006|Overall Study|Adverse Event|0|||
27891309|NCT00722046|54544180|FG000|Overall Study|Death|0|||
27891310|NCT00722046|54544181|FG001|Overall Study|Death|1|||
27891311|NCT00722046|54544182|FG002|Overall Study|Death|0|||
27891312|NCT00722046|54544183|FG003|Overall Study|Death|0|||
27891313|NCT00722046|54544184|FG004|Overall Study|Death|0|||
27891314|NCT00722046|54544185|FG005|Overall Study|Death|0|||
27891315|NCT00722046|54544186|FG006|Overall Study|Death|2|||
27891316|NCT00722046|54544180|FG000|Overall Study|Protocol Violation|1|||
27891317|NCT00722046|54544181|FG001|Overall Study|Protocol Violation|0|||
27891318|NCT00722046|54544182|FG002|Overall Study|Protocol Violation|0|||
27891319|NCT00722046|54544183|FG003|Overall Study|Protocol Violation|0|||
27891320|NCT00722046|54544184|FG004|Overall Study|Protocol Violation|0|||
27891321|NCT00722046|54544185|FG005|Overall Study|Protocol Violation|1|||
27891322|NCT00722046|54544186|FG006|Overall Study|Protocol Violation|0|||
27891323|NCT00722046|54544180|FG000|Overall Study|Withdrawal by Subject|3|||
27891324|NCT00722046|54544181|FG001|Overall Study|Withdrawal by Subject|3|||
27891325|NCT00722046|54544182|FG002|Overall Study|Withdrawal by Subject|4|||
27891326|NCT00722046|54544183|FG003|Overall Study|Withdrawal by Subject|4|||
27891327|NCT00722046|54544184|FG004|Overall Study|Withdrawal by Subject|4|||
27891328|NCT00722046|54544185|FG005|Overall Study|Withdrawal by Subject|7|||
27891329|NCT00722046|54544186|FG006|Overall Study|Withdrawal by Subject|3|||
27891330|NCT00722046|54544180|FG000|Overall Study|Randomized, but not treated|1|||
27891331|NCT00722046|54544181|FG001|Overall Study|Randomized, but not treated|1|||
27891332|NCT00722046|54544182|FG002|Overall Study|Randomized, but not treated|0|||
27891333|NCT00722046|54544183|FG003|Overall Study|Randomized, but not treated|2|||
27891334|NCT00722046|54544184|FG004|Overall Study|Randomized, but not treated|0|||
27891335|NCT00722046|54544185|FG005|Overall Study|Randomized, but not treated|0|||
27891336|NCT00722046|54544186|FG006|Overall Study|Randomized, but not treated|0|||
27891337|NCT00722046|54544180|FG000|Overall Study|Other|0|||
27891338|NCT00722046|54544181|FG001|Overall Study|Other|0|||
27891339|NCT00722046|54544182|FG002|Overall Study|Other|1|||
27891340|NCT00722046|54544183|FG003|Overall Study|Other|1|||
27891341|NCT00722046|54544184|FG004|Overall Study|Other|3|||
27891342|NCT00722046|54544185|FG005|Overall Study|Other|2|||
27891343|NCT00722046|54544186|FG006|Overall Study|Other|1|||
27891344|NCT00614523|54544206|FG000|Overall Study|Adverse Event|4|||
27891345|NCT00614523|54544207|FG001|Overall Study|Adverse Event|20|||
27891346|NCT00614523|54544206|FG000|Overall Study|Death|5|||
27891347|NCT00614523|54544207|FG001|Overall Study|Death|8|||
27891348|NCT00614523|54544206|FG000|Overall Study|Lack of Efficacy|9|||
27891349|NCT00614523|54544207|FG001|Overall Study|Lack of Efficacy|11|||
27891350|NCT00614523|54544206|FG000|Overall Study|Lost to Follow-up|0|||
27891351|NCT00614523|54544207|FG001|Overall Study|Lost to Follow-up|1|||
27891352|NCT00614523|54544206|FG000|Overall Study|Protocol Violation|3|||
27891353|NCT00614523|54544207|FG001|Overall Study|Protocol Violation|2|||
27891354|NCT00614523|54544206|FG000|Overall Study|Withdrawal by Subject|12|||
27891355|NCT00614523|54544207|FG001|Overall Study|Withdrawal by Subject|22|||
28096682|NCT04091360|54751854|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
28096683|NCT04091360|54751855|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
28096684|NCT04091360|54751856|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
28096685|NCT04091360|54751857|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
27891356|NCT00614523|54544206|FG000|Overall Study|Other|6|||
27891357|NCT00614523|54544207|FG001|Overall Study|Other|11|||
27891358|NCT00614523|54544206|FG000|Overall Study|Ineligibility Determined|1|||
27891359|NCT00614523|54544207|FG001|Overall Study|Ineligibility Determined|2|||
27891360|NCT00614523|54544206|FG000|Overall Study|Disease Progression|0|||
27891361|NCT00614523|54544207|FG001|Overall Study|Disease Progression|8|||
27891362|NCT00614523|54544206|FG000|Overall Study|Administrative Decision|23|||
27891363|NCT00614523|54544207|FG001|Overall Study|Administrative Decision|46|||
27891364|NCT00523341|54544215|FG000|Overall Study|Withdrawal by Subject|399|||
27891365|NCT00523341|54544216|FG001|Overall Study|Withdrawal by Subject|427|||
27891366|NCT00523341|54544215|FG000|Overall Study|Other|181|||
27891367|NCT00523341|54544216|FG001|Overall Study|Other|198|||
27891368|NCT00523341|54544215|FG000|Overall Study|Adverse Event|122|||
27891369|NCT00523341|54544216|FG001|Overall Study|Adverse Event|155|||
27891370|NCT00523341|54544215|FG000|Overall Study|Death|101|||
27891371|NCT00523341|54544216|FG001|Overall Study|Death|110|||
27891372|NCT00523341|54544215|FG000|Overall Study|Lost to Follow-up|73|||
27891373|NCT00523341|54544216|FG001|Overall Study|Lost to Follow-up|61|||
27891374|NCT00523341|54544215|FG000|Overall Study|Non-compliance|20|||
27891375|NCT00523341|54544216|FG001|Overall Study|Non-compliance|13|||
27891376|NCT00523341|54544215|FG000|Overall Study|Physician Decision|14|||
27891377|NCT00523341|54544216|FG001|Overall Study|Physician Decision|13|||
27891378|NCT00523341|54544215|FG000|Overall Study|Requirement for Alternative Therapy|4|||
27891379|NCT00523341|54544216|FG001|Overall Study|Requirement for Alternative Therapy|14|||
27891380|NCT00523341|54544215|FG000|Overall Study|Protocol Deviation|6|||
27891381|NCT00523341|54544216|FG001|Overall Study|Protocol Deviation|5|||
27891382|NCT00523341|54544215|FG000|Overall Study|Ineligibility Determined|3|||
27891383|NCT00523341|54544216|FG001|Overall Study|Ineligibility Determined|4|||
27891384|NCT00523341|54544215|FG000|Overall Study|Disease Progression|1|||
27891385|NCT00523341|54544216|FG001|Overall Study|Disease Progression|0|||
27891386|NCT00364013|54544224|FG000|Overall Study|Ineligibility determined|4|||
27891387|NCT00364013|54544225|FG001|Overall Study|Ineligibility determined|2|||
27891388|NCT00364013|54544224|FG000|Overall Study|Adverse Event|4|||
27891389|NCT00364013|54544225|FG001|Overall Study|Adverse Event|3|||
27891390|NCT00364013|54544224|FG000|Overall Study|Withdrawal by Subject|13|||
27891391|NCT00364013|54544225|FG001|Overall Study|Withdrawal by Subject|18|||
27891392|NCT00364013|54544224|FG000|Overall Study|Physician Decision|3|||
27891393|NCT00364013|54544225|FG001|Overall Study|Physician Decision|3|||
27891394|NCT00364013|54544224|FG000|Overall Study|Lost to Follow-up|10|||
27891395|NCT00364013|54544225|FG001|Overall Study|Lost to Follow-up|3|||
27891396|NCT00364013|54544224|FG000|Overall Study|Protocol-specified criteria|6|||
27891397|NCT00364013|54544225|FG001|Overall Study|Protocol-specified criteria|6|||
27891398|NCT00364013|54544224|FG000|Overall Study|Other|41|||
27891399|NCT00364013|54544225|FG001|Overall Study|Other|47|||
27891400|NCT00364013|54544224|FG000|Overall Study|Ongoing|20|||
27891401|NCT00364013|54544225|FG001|Overall Study|Ongoing|13|||
27891402|NCT00345839|54544237|FG000|Overall Study|Withdrawal by Subject|91|||
27891403|NCT00345839|54544238|FG001|Overall Study|Withdrawal by Subject|98|||
27891404|NCT00345839|54544237|FG000|Overall Study|Lost to Follow-up|58|||
27891405|NCT00345839|54544238|FG001|Overall Study|Lost to Follow-up|61|||
27891406|NCT00330759|54544246|FG000|Overall Study|Death|316|||
27891407|NCT00330759|54544247|FG001|Overall Study|Death|310|||
27891408|NCT00330759|54544246|FG000|Overall Study|Disease progression|104|||
27891409|NCT00330759|54544247|FG001|Overall Study|Disease progression|126|||
27891410|NCT00330759|54544246|FG000|Overall Study|Withdrawal by Subject|143|||
27891411|NCT00330759|54544247|FG001|Overall Study|Withdrawal by Subject|124|||
27891412|NCT00330759|54544246|FG000|Overall Study|Adverse Event|48|||
27891413|NCT00330759|54544247|FG001|Overall Study|Adverse Event|36|||
27891414|NCT00330759|54544246|FG000|Overall Study|Participant request|31|||
27891415|NCT00330759|54544247|FG001|Overall Study|Participant request|22|||
27891416|NCT00330759|54544246|FG000|Overall Study|Lost to Follow-up|16|||
27891417|NCT00330759|54544247|FG001|Overall Study|Lost to Follow-up|22|||
27891418|NCT00330759|54544246|FG000|Overall Study|Noncompliance|15|||
27891419|NCT00330759|54544247|FG001|Overall Study|Noncompliance|17|||
27891420|NCT00330759|54544246|FG000|Overall Study|Physician Decision|1|||
27891421|NCT00330759|54544247|FG001|Overall Study|Physician Decision|2|||
27891422|NCT00330759|54544246|FG000|Overall Study|Protocol deviation|0|||
27891423|NCT00330759|54544247|FG001|Overall Study|Protocol deviation|2|||
27891424|NCT00330759|54544246|FG000|Overall Study|Ineligibility determined|2|||
27891425|NCT00330759|54544247|FG001|Overall Study|Ineligibility determined|1|||
27891426|NCT00330759|54544246|FG000|Overall Study|Other|36|||
27891427|NCT00330759|54544247|FG001|Overall Study|Other|44|||
27891428|NCT00113763|54544255|FG000|Overall Study|Adverse Event|5|||
27891429|NCT00113763|54544256|FG001|Overall Study|Adverse Event|2|||
27891430|NCT00113763|54544255|FG000|Overall Study|Disease Progression|28|||
27891431|NCT00113763|54544256|FG001|Overall Study|Disease Progression|14|||
27891432|NCT00113763|54544255|FG000|Overall Study|Lost to Follow-up|10|||
27891433|NCT00113763|54544256|FG001|Overall Study|Lost to Follow-up|0|||
27891434|NCT00113763|54544255|FG000|Overall Study|Withdrawal by Subject|1|||
27891435|NCT00113763|54544256|FG001|Overall Study|Withdrawal by Subject|4|||
27891436|NCT00113763|54544255|FG000|Overall Study|Other|27|||
27891437|NCT00113763|54544256|FG001|Overall Study|Other|6|||
27891438|NCT00113763|54544255|FG000|Overall Study|Non-compliance|1|||
27891439|NCT00113763|54544256|FG001|Overall Study|Non-compliance|0|||
27891440|NCT00113763|54544255|FG000|Overall Study|Ongoing|1|||
27891441|NCT00113763|54544256|FG001|Overall Study|Ongoing|0|||
27891442|NCT05166902|54544270|FG000|First Intervention|Lost to Follow-up|0|||
27891443|NCT05166902|54544271|FG001|First Intervention|Lost to Follow-up|1|||
27891444|NCT05142566|54544277|FG000|Overall Study|Protocol Violation|1|||
27891445|NCT05083949|54544283|FG000|Period 1|Positive doping for Tetrahydrocannabinol (THC)|2|||
27891446|NCT05083949|54544284|FG001|Period 1|Positive doping for Tetrahydrocannabinol (THC)|1|||
27891447|NCT05083949|54544283|FG000|Period 1|Adverse Event|1|||
27891448|NCT05083949|54544284|FG001|Period 1|Adverse Event|1|||
27891449|NCT05083949|54544283|FG000|Period 2|The patient was not able to eat the full content of the breakfast|1|||
27985602|NCT00545233|54644379|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
27891450|NCT05083949|54544284|FG001|Period 2|The patient was not able to eat the full content of the breakfast|0|||
27891451|NCT05083949|54544283|FG000|Period 2|Adverse Event|0|||
27891452|NCT05083949|54544284|FG001|Period 2|Adverse Event|2|||
27891453|NCT04982575|54544296|FG000|Overall Study|Withdrawal by Subject|2|||
27891454|NCT04982575|54544297|FG001|Overall Study|Withdrawal by Subject|0|||
27891455|NCT04982575|54544298|FG002|Overall Study|Withdrawal by Subject|2|||
27891456|NCT04811664|54544332|FG000|Overall Study|Lost to Follow-up|78|||
27891457|NCT04811664|54544333|FG001|Overall Study|Lost to Follow-up|125|||
27891458|NCT04811664|54544334|FG002|Overall Study|Lost to Follow-up|46|||
27891459|NCT04811664|54544332|FG000|Overall Study|Withdrawal by Subject|39|||
27891460|NCT04811664|54544333|FG001|Overall Study|Withdrawal by Subject|76|||
27891461|NCT04811664|54544334|FG002|Overall Study|Withdrawal by Subject|12|||
27891462|NCT04811664|54544332|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|6|||
27891463|NCT04811664|54544333|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
27891464|NCT04811664|54544334|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|17|||
27891465|NCT04811664|54544332|FG000|Overall Study|Participant is unwilling or unable to comply with required study|24|||
27891466|NCT04811664|54544333|FG001|Overall Study|Participant is unwilling or unable to comply with required study|47|||
27891467|NCT04811664|54544334|FG002|Overall Study|Participant is unwilling or unable to comply with required study|16|||
27891468|NCT04811664|54544332|FG000|Overall Study|Protocol Violation|0|||
27891469|NCT04811664|54544333|FG001|Overall Study|Protocol Violation|5|||
27891470|NCT04811664|54544334|FG002|Overall Study|Protocol Violation|11|||
27891471|NCT04811664|54544332|FG000|Overall Study|Study Terminated by Sponsor|4|||
27891472|NCT04811664|54544333|FG001|Overall Study|Study Terminated by Sponsor|3|||
27891473|NCT04811664|54544334|FG002|Overall Study|Study Terminated by Sponsor|34|||
27891474|NCT04811664|54544332|FG000|Overall Study|Early Study Closure|3|||
27891475|NCT04811664|54544333|FG001|Overall Study|Early Study Closure|7|||
27891476|NCT04811664|54544334|FG002|Overall Study|Early Study Closure|79|||
27891477|NCT04811664|54544332|FG000|Overall Study|Other (Unable to receive payment visa status)|0|||
27891478|NCT04811664|54544333|FG001|Overall Study|Other (Unable to receive payment visa status)|2|||
27891479|NCT04811664|54544334|FG002|Overall Study|Other (Unable to receive payment visa status)|0|||
27891480|NCT04554394|54544365|FG000|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
27891481|NCT04554394|54544366|FG001|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
27891482|NCT04554394|54544365|FG000|Overall Study|Withdrawal by Subject|2|||
27891483|NCT04554394|54544366|FG001|Overall Study|Withdrawal by Subject|2|||
27891484|NCT04554394|54544365|FG000|Overall Study|Lost to Follow-up|2|||
27891485|NCT04554394|54544366|FG001|Overall Study|Lost to Follow-up|2|||
27891486|NCT04554394|54544365|FG000|Overall Study|Physician Decision|1|||
27891487|NCT04554394|54544366|FG001|Overall Study|Physician Decision|1|||
27891488|NCT04518410|54544396|FG000|Overall Study|Lost to Follow-up|1|||
27891489|NCT04518410|54544397|FG001|Overall Study|Lost to Follow-up|1|||
27891490|NCT04518410|54544398|FG002|Overall Study|Lost to Follow-up|8|||
27891491|NCT04518410|54544399|FG003|Overall Study|Lost to Follow-up|5|||
27891492|NCT04518410|54544400|FG004|Overall Study|Lost to Follow-up|92|||
27891493|NCT04518410|54544401|FG005|Overall Study|Lost to Follow-up|27|||
27891494|NCT04518410|54544402|FG006|Overall Study|Lost to Follow-up|26|||
27891495|NCT04518410|54544403|FG007|Overall Study|Lost to Follow-up|3|||
27891496|NCT04518410|54544404|FG008|Overall Study|Lost to Follow-up|2|||
27891497|NCT04518410|54544405|FG009|Overall Study|Lost to Follow-up|15|||
27891498|NCT04518410|54544406|FG010|Overall Study|Lost to Follow-up|9|||
27891499|NCT04518410|54544407|FG011|Overall Study|Lost to Follow-up|13|||
27891500|NCT04518410|54544408|FG012|Overall Study|Lost to Follow-up|9|||
27891501|NCT04518410|54544409|FG013|Overall Study|Lost to Follow-up|14|||
27891502|NCT04518410|54544410|FG014|Overall Study|Lost to Follow-up|8|||
27891503|NCT04518410|54544411|FG015|Overall Study|Lost to Follow-up|10|||
27891504|NCT04518410|54544412|FG016|Overall Study|Lost to Follow-up|6|||
27891505|NCT04518410|54544413|FG017|Overall Study|Lost to Follow-up|8|||
27891506|NCT04518410|54544414|FG018|Overall Study|Lost to Follow-up|20|||
27891507|NCT04518410|54544415|FG019|Overall Study|Lost to Follow-up|6|||
27891508|NCT04518410|54544416|FG020|Overall Study|Lost to Follow-up|4|||
27891509|NCT04518410|54544417|FG021|Overall Study|Lost to Follow-up|22|||
27891510|NCT04518410|54544418|FG022|Overall Study|Lost to Follow-up|1|||
27891511|NCT04518410|54544419|FG023|Overall Study|Lost to Follow-up|7|||
27891512|NCT04518410|54544420|FG024|Overall Study|Lost to Follow-up|6|||
27891513|NCT04518410|54544396|FG000|Overall Study|Withdrawal by Subject|1|||
27891514|NCT04518410|54544397|FG001|Overall Study|Withdrawal by Subject|2|||
27891515|NCT04518410|54544398|FG002|Overall Study|Withdrawal by Subject|2|||
27891516|NCT04518410|54544399|FG003|Overall Study|Withdrawal by Subject|3|||
27891517|NCT04518410|54544400|FG004|Overall Study|Withdrawal by Subject|20|||
27891518|NCT04518410|54544401|FG005|Overall Study|Withdrawal by Subject|21|||
27891519|NCT04518410|54544402|FG006|Overall Study|Withdrawal by Subject|27|||
27891520|NCT04518410|54544403|FG007|Overall Study|Withdrawal by Subject|6|||
27891521|NCT04518410|54544404|FG008|Overall Study|Withdrawal by Subject|2|||
27891522|NCT04518410|54544405|FG009|Overall Study|Withdrawal by Subject|12|||
27891523|NCT04518410|54544406|FG010|Overall Study|Withdrawal by Subject|6|||
27891524|NCT04518410|54544407|FG011|Overall Study|Withdrawal by Subject|7|||
27891525|NCT04518410|54544408|FG012|Overall Study|Withdrawal by Subject|2|||
27891526|NCT04518410|54544409|FG013|Overall Study|Withdrawal by Subject|13|||
27891527|NCT04518410|54544410|FG014|Overall Study|Withdrawal by Subject|4|||
27891528|NCT04518410|54544411|FG015|Overall Study|Withdrawal by Subject|9|||
27891529|NCT04518410|54544412|FG016|Overall Study|Withdrawal by Subject|0|||
27891530|NCT04518410|54544413|FG017|Overall Study|Withdrawal by Subject|14|||
27891531|NCT04518410|54544414|FG018|Overall Study|Withdrawal by Subject|13|||
27891532|NCT04518410|54544415|FG019|Overall Study|Withdrawal by Subject|9|||
27891533|NCT04518410|54544416|FG020|Overall Study|Withdrawal by Subject|13|||
27891534|NCT04518410|54544417|FG021|Overall Study|Withdrawal by Subject|3|||
27891535|NCT04518410|54544418|FG022|Overall Study|Withdrawal by Subject|2|||
27891536|NCT04518410|54544419|FG023|Overall Study|Withdrawal by Subject|9|||
27891537|NCT04518410|54544420|FG024|Overall Study|Withdrawal by Subject|8|||
27891538|NCT04518410|54544396|FG000|Overall Study|Other|1|||
27891539|NCT04518410|54544397|FG001|Overall Study|Other|0|||
27891540|NCT04518410|54544398|FG002|Overall Study|Other|0|||
27891541|NCT04518410|54544399|FG003|Overall Study|Other|1|||
27891542|NCT04518410|54544400|FG004|Overall Study|Other|6|||
27891543|NCT04518410|54544401|FG005|Overall Study|Other|6|||
27891544|NCT04518410|54544402|FG006|Overall Study|Other|5|||
27891545|NCT04518410|54544403|FG007|Overall Study|Other|2|||
27891546|NCT04518410|54544404|FG008|Overall Study|Other|0|||
27891547|NCT04518410|54544405|FG009|Overall Study|Other|1|||
27891548|NCT04518410|54544406|FG010|Overall Study|Other|0|||
27891549|NCT04518410|54544407|FG011|Overall Study|Other|2|||
27891550|NCT04518410|54544408|FG012|Overall Study|Other|0|||
27891551|NCT04518410|54544409|FG013|Overall Study|Other|0|||
27891552|NCT04518410|54544410|FG014|Overall Study|Other|0|||
27891553|NCT04518410|54544411|FG015|Overall Study|Other|3|||
27891554|NCT04518410|54544412|FG016|Overall Study|Other|1|||
27891555|NCT04518410|54544413|FG017|Overall Study|Other|1|||
27891556|NCT04518410|54544414|FG018|Overall Study|Other|1|||
27891557|NCT04518410|54544415|FG019|Overall Study|Other|0|||
27891558|NCT04518410|54544416|FG020|Overall Study|Other|0|||
27891559|NCT04518410|54544417|FG021|Overall Study|Other|0|||
27891560|NCT04518410|54544418|FG022|Overall Study|Other|1|||
27891561|NCT04518410|54544419|FG023|Overall Study|Other|2|||
27891562|NCT04518410|54544420|FG024|Overall Study|Other|2|||
27891563|NCT04518410|54544396|FG000|Overall Study|Protocol Violation|0|||
27891564|NCT04518410|54544397|FG001|Overall Study|Protocol Violation|0|||
27891565|NCT04518410|54544398|FG002|Overall Study|Protocol Violation|0|||
27891566|NCT04518410|54544399|FG003|Overall Study|Protocol Violation|2|||
27891567|NCT04518410|54544400|FG004|Overall Study|Protocol Violation|17|||
27891568|NCT04518410|54544401|FG005|Overall Study|Protocol Violation|1|||
27891569|NCT04518410|54544402|FG006|Overall Study|Protocol Violation|2|||
27891570|NCT04518410|54544403|FG007|Overall Study|Protocol Violation|1|||
27891571|NCT04518410|54544404|FG008|Overall Study|Protocol Violation|0|||
27891572|NCT04518410|54544405|FG009|Overall Study|Protocol Violation|0|||
27891573|NCT04518410|54544406|FG010|Overall Study|Protocol Violation|0|||
27891574|NCT04518410|54544407|FG011|Overall Study|Protocol Violation|0|||
27891575|NCT04518410|54544408|FG012|Overall Study|Protocol Violation|0|||
27891576|NCT04518410|54544409|FG013|Overall Study|Protocol Violation|0|||
27891577|NCT04518410|54544410|FG014|Overall Study|Protocol Violation|0|||
27891578|NCT04518410|54544411|FG015|Overall Study|Protocol Violation|0|||
27891579|NCT04518410|54544412|FG016|Overall Study|Protocol Violation|1|||
27891580|NCT04518410|54544413|FG017|Overall Study|Protocol Violation|1|||
27891581|NCT04518410|54544414|FG018|Overall Study|Protocol Violation|0|||
27891582|NCT04518410|54544415|FG019|Overall Study|Protocol Violation|0|||
27891583|NCT04518410|54544416|FG020|Overall Study|Protocol Violation|1|||
27891584|NCT04518410|54544417|FG021|Overall Study|Protocol Violation|2|||
27891585|NCT04518410|54544418|FG022|Overall Study|Protocol Violation|0|||
27891586|NCT04518410|54544419|FG023|Overall Study|Protocol Violation|3|||
27891587|NCT04518410|54544420|FG024|Overall Study|Protocol Violation|0|||
27891588|NCT04518410|54544396|FG000|Overall Study|Death|0|||
27891589|NCT04518410|54544397|FG001|Overall Study|Death|0|||
28096686|NCT04091360|54751858|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
27891590|NCT04518410|54544398|FG002|Overall Study|Death|0|||
27891591|NCT04518410|54544399|FG003|Overall Study|Death|0|||
27891592|NCT04518410|54544400|FG004|Overall Study|Death|12|||
27891593|NCT04518410|54544401|FG005|Overall Study|Death|2|||
27891594|NCT04518410|54544402|FG006|Overall Study|Death|11|||
27891595|NCT04518410|54544403|FG007|Overall Study|Death|0|||
27891596|NCT04518410|54544404|FG008|Overall Study|Death|1|||
27891597|NCT04518410|54544405|FG009|Overall Study|Death|0|||
27891598|NCT04518410|54544406|FG010|Overall Study|Death|0|||
27891599|NCT04518410|54544407|FG011|Overall Study|Death|0|||
27891600|NCT04518410|54544408|FG012|Overall Study|Death|0|||
27891601|NCT04518410|54544409|FG013|Overall Study|Death|1|||
27891602|NCT04518410|54544410|FG014|Overall Study|Death|1|||
27891603|NCT04518410|54544411|FG015|Overall Study|Death|0|||
27891604|NCT04518410|54544412|FG016|Overall Study|Death|0|||
27891605|NCT04518410|54544413|FG017|Overall Study|Death|1|||
27891606|NCT04518410|54544414|FG018|Overall Study|Death|3|||
27891607|NCT04518410|54544415|FG019|Overall Study|Death|4|||
27891608|NCT04518410|54544416|FG020|Overall Study|Death|1|||
27891609|NCT04518410|54544417|FG021|Overall Study|Death|0|||
27891610|NCT04518410|54544418|FG022|Overall Study|Death|0|||
27891611|NCT04518410|54544419|FG023|Overall Study|Death|0|||
27891612|NCT04518410|54544420|FG024|Overall Study|Death|0|||
27891613|NCT04518410|54544396|FG000|Overall Study|Requirement to start alternative therapy|0|||
27891614|NCT04518410|54544397|FG001|Overall Study|Requirement to start alternative therapy|0|||
27891615|NCT04518410|54544398|FG002|Overall Study|Requirement to start alternative therapy|1|||
27891616|NCT04518410|54544399|FG003|Overall Study|Requirement to start alternative therapy|0|||
27891617|NCT04518410|54544400|FG004|Overall Study|Requirement to start alternative therapy|0|||
27891618|NCT04518410|54544401|FG005|Overall Study|Requirement to start alternative therapy|0|||
27891619|NCT04518410|54544402|FG006|Overall Study|Requirement to start alternative therapy|0|||
27891620|NCT04518410|54544403|FG007|Overall Study|Requirement to start alternative therapy|0|||
27891621|NCT04518410|54544404|FG008|Overall Study|Requirement to start alternative therapy|0|||
27891622|NCT04518410|54544405|FG009|Overall Study|Requirement to start alternative therapy|0|||
27891623|NCT04518410|54544406|FG010|Overall Study|Requirement to start alternative therapy|0|||
27891624|NCT04518410|54544407|FG011|Overall Study|Requirement to start alternative therapy|0|||
27891625|NCT04518410|54544408|FG012|Overall Study|Requirement to start alternative therapy|0|||
27891626|NCT04518410|54544409|FG013|Overall Study|Requirement to start alternative therapy|0|||
27891627|NCT04518410|54544410|FG014|Overall Study|Requirement to start alternative therapy|0|||
27891628|NCT04518410|54544411|FG015|Overall Study|Requirement to start alternative therapy|0|||
27891629|NCT04518410|54544412|FG016|Overall Study|Requirement to start alternative therapy|0|||
27891630|NCT04518410|54544413|FG017|Overall Study|Requirement to start alternative therapy|0|||
27891631|NCT04518410|54544414|FG018|Overall Study|Requirement to start alternative therapy|0|||
27891632|NCT04518410|54544415|FG019|Overall Study|Requirement to start alternative therapy|0|||
27891633|NCT04518410|54544416|FG020|Overall Study|Requirement to start alternative therapy|0|||
27891634|NCT04518410|54544417|FG021|Overall Study|Requirement to start alternative therapy|0|||
27891635|NCT04518410|54544418|FG022|Overall Study|Requirement to start alternative therapy|1|||
27891636|NCT04518410|54544419|FG023|Overall Study|Requirement to start alternative therapy|0|||
27891637|NCT04518410|54544420|FG024|Overall Study|Requirement to start alternative therapy|0|||
27891638|NCT04518410|54544396|FG000|Overall Study|Ongoing in study|0|||
27891639|NCT04518410|54544397|FG001|Overall Study|Ongoing in study|0|||
27891640|NCT04518410|54544398|FG002|Overall Study|Ongoing in study|0|||
27891641|NCT04518410|54544399|FG003|Overall Study|Ongoing in study|0|||
27891642|NCT04518410|54544400|FG004|Overall Study|Ongoing in study|0|||
27891643|NCT04518410|54544401|FG005|Overall Study|Ongoing in study|0|||
27891644|NCT04518410|54544402|FG006|Overall Study|Ongoing in study|0|||
27891645|NCT04518410|54544403|FG007|Overall Study|Ongoing in study|0|||
27891646|NCT04518410|54544404|FG008|Overall Study|Ongoing in study|0|||
27891647|NCT04518410|54544405|FG009|Overall Study|Ongoing in study|0|||
27891648|NCT04518410|54544406|FG010|Overall Study|Ongoing in study|0|||
27891649|NCT04518410|54544407|FG011|Overall Study|Ongoing in study|0|||
27891650|NCT04518410|54544408|FG012|Overall Study|Ongoing in study|0|||
27891651|NCT04518410|54544409|FG013|Overall Study|Ongoing in study|0|||
27891652|NCT04518410|54544410|FG014|Overall Study|Ongoing in study|0|||
27891653|NCT04518410|54544411|FG015|Overall Study|Ongoing in study|0|||
27891654|NCT04518410|54544412|FG016|Overall Study|Ongoing in study|0|||
27891655|NCT04518410|54544413|FG017|Overall Study|Ongoing in study|193|||
27891656|NCT04518410|54544414|FG018|Overall Study|Ongoing in study|173|||
27891657|NCT04518410|54544415|FG019|Overall Study|Ongoing in study|50|||
27985603|NCT00545233|54644378|FG000|Overall Study|Protocol Violation|2|||
27985604|NCT00545233|54644379|FG001|Overall Study|Protocol Violation|0|||
27985605|NCT00545233|54644378|FG000|Overall Study|Refused Treatment|9|||
28171868|NCT02468674|54843505|FG006|Overall Study|Adverse Event|0|||
28171869|NCT02468674|54843506|FG007|Overall Study|Adverse Event|0|||
28171870|NCT02468674|54843507|FG008|Overall Study|Adverse Event|0|||
28171871|NCT02468674|54843499|FG000|Overall Study|Lost to Follow-up|1|||
28171872|NCT02468674|54843500|FG001|Overall Study|Lost to Follow-up|0|||
28171873|NCT02468674|54843501|FG002|Overall Study|Lost to Follow-up|0|||
28171874|NCT02468674|54843502|FG003|Overall Study|Lost to Follow-up|0|||
28171875|NCT02468674|54843503|FG004|Overall Study|Lost to Follow-up|0|||
28171876|NCT02468674|54843504|FG005|Overall Study|Lost to Follow-up|0|||
28171877|NCT02468674|54843505|FG006|Overall Study|Lost to Follow-up|0|||
28171878|NCT02468674|54843506|FG007|Overall Study|Lost to Follow-up|1|||
28171879|NCT02468674|54843507|FG008|Overall Study|Lost to Follow-up|1|||
27891658|NCT04518410|54544416|FG020|Overall Study|Ongoing in study|65|||
27891659|NCT04518410|54544417|FG021|Overall Study|Ongoing in study|0|||
27891660|NCT04518410|54544418|FG022|Overall Study|Ongoing in study|0|||
27891661|NCT04518410|54544419|FG023|Overall Study|Ongoing in study|0|||
27891662|NCT04518410|54544420|FG024|Overall Study|Ongoing in study|0|||
27891663|NCT04518410|54544396|FG000|Overall Study|Randomized but not treated|0|||
27985606|NCT00545233|54644379|FG001|Overall Study|Refused Treatment|7|||
27985607|NCT00545233|54644378|FG000|Overall Study|Failure to Return|4|||
28171880|NCT02468674|54843499|FG000|Overall Study|Physician Decision|0|||
28171881|NCT02468674|54843500|FG001|Overall Study|Physician Decision|0|||
28171882|NCT02468674|54843501|FG002|Overall Study|Physician Decision|0|||
27891664|NCT04518410|54544397|FG001|Overall Study|Randomized but not treated|0|||
27891665|NCT04518410|54544398|FG002|Overall Study|Randomized but not treated|0|||
27891666|NCT04518410|54544399|FG003|Overall Study|Randomized but not treated|2|||
27891667|NCT04518410|54544400|FG004|Overall Study|Randomized but not treated|6|||
27891668|NCT04518410|54544401|FG005|Overall Study|Randomized but not treated|6|||
27891669|NCT04518410|54544402|FG006|Overall Study|Randomized but not treated|3|||
27891670|NCT04518410|54544403|FG007|Overall Study|Randomized but not treated|3|||
27891671|NCT04518410|54544404|FG008|Overall Study|Randomized but not treated|0|||
27891672|NCT04518410|54544405|FG009|Overall Study|Randomized but not treated|4|||
27891673|NCT04518410|54544406|FG010|Overall Study|Randomized but not treated|0|||
27891674|NCT04518410|54544407|FG011|Overall Study|Randomized but not treated|0|||
27891675|NCT04518410|54544408|FG012|Overall Study|Randomized but not treated|1|||
27891676|NCT04518410|54544409|FG013|Overall Study|Randomized but not treated|4|||
27891677|NCT04518410|54544410|FG014|Overall Study|Randomized but not treated|3|||
27891678|NCT04518410|54544411|FG015|Overall Study|Randomized but not treated|3|||
27891679|NCT04518410|54544412|FG016|Overall Study|Randomized but not treated|4|||
27891680|NCT04518410|54544413|FG017|Overall Study|Randomized but not treated|6|||
27891681|NCT04518410|54544414|FG018|Overall Study|Randomized but not treated|4|||
27891682|NCT04518410|54544415|FG019|Overall Study|Randomized but not treated|0|||
27891683|NCT04518410|54544416|FG020|Overall Study|Randomized but not treated|0|||
27891684|NCT04518410|54544417|FG021|Overall Study|Randomized but not treated|5|||
27891685|NCT04518410|54544418|FG022|Overall Study|Randomized but not treated|0|||
27891686|NCT04518410|54544419|FG023|Overall Study|Randomized but not treated|3|||
27891687|NCT04518410|54544420|FG024|Overall Study|Randomized but not treated|1|||
27891688|NCT04518410|54544396|FG000|Overall Study|Screen Fail but Randomized|0|||
27891689|NCT04518410|54544397|FG001|Overall Study|Screen Fail but Randomized|0|||
27891690|NCT04518410|54544398|FG002|Overall Study|Screen Fail but Randomized|0|||
27891691|NCT04518410|54544399|FG003|Overall Study|Screen Fail but Randomized|0|||
27891692|NCT04518410|54544400|FG004|Overall Study|Screen Fail but Randomized|2|||
27891693|NCT04518410|54544401|FG005|Overall Study|Screen Fail but Randomized|0|||
27891694|NCT04518410|54544402|FG006|Overall Study|Screen Fail but Randomized|0|||
27891695|NCT04518410|54544403|FG007|Overall Study|Screen Fail but Randomized|0|||
27891696|NCT04518410|54544404|FG008|Overall Study|Screen Fail but Randomized|0|||
27891697|NCT04518410|54544405|FG009|Overall Study|Screen Fail but Randomized|0|||
27891698|NCT04518410|54544406|FG010|Overall Study|Screen Fail but Randomized|0|||
27891699|NCT04518410|54544407|FG011|Overall Study|Screen Fail but Randomized|0|||
27891700|NCT04518410|54544408|FG012|Overall Study|Screen Fail but Randomized|0|||
27891701|NCT04518410|54544409|FG013|Overall Study|Screen Fail but Randomized|0|||
27891702|NCT04518410|54544410|FG014|Overall Study|Screen Fail but Randomized|0|||
27891703|NCT04518410|54544411|FG015|Overall Study|Screen Fail but Randomized|0|||
27891704|NCT04518410|54544412|FG016|Overall Study|Screen Fail but Randomized|0|||
27891705|NCT04518410|54544413|FG017|Overall Study|Screen Fail but Randomized|0|||
27891706|NCT04518410|54544414|FG018|Overall Study|Screen Fail but Randomized|0|||
27891707|NCT04518410|54544415|FG019|Overall Study|Screen Fail but Randomized|0|||
27891708|NCT04518410|54544416|FG020|Overall Study|Screen Fail but Randomized|0|||
27891709|NCT04518410|54544417|FG021|Overall Study|Screen Fail but Randomized|0|||
27891710|NCT04518410|54544418|FG022|Overall Study|Screen Fail but Randomized|0|||
27891711|NCT04518410|54544419|FG023|Overall Study|Screen Fail but Randomized|0|||
27891712|NCT04518410|54544420|FG024|Overall Study|Screen Fail but Randomized|0|||
27891713|NCT04518410|54544396|FG000|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
27891714|NCT04518410|54544397|FG001|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
27891715|NCT04518410|54544398|FG002|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
27891716|NCT04518410|54544399|FG003|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
27891717|NCT04518410|54544400|FG004|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|81|||
27891718|NCT04518410|54544401|FG005|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
27891719|NCT04518410|54544402|FG006|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|9|||
27891720|NCT04518410|54544403|FG007|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
27891721|NCT04518410|54544404|FG008|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
27891722|NCT04518410|54544405|FG009|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
27891723|NCT04518410|54544406|FG010|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
27891724|NCT04518410|54544407|FG011|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
27891725|NCT04518410|54544408|FG012|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
27891726|NCT04518410|54544409|FG013|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
27891727|NCT04518410|54544410|FG014|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
27925756|NCT01230489|54582311|FG000|Overall Study|Treatment modality changed|1|||
27891728|NCT04518410|54544411|FG015|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
27891729|NCT04518410|54544412|FG016|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
27891730|NCT04518410|54544413|FG017|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
27891731|NCT04518410|54544414|FG018|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
27891732|NCT04518410|54544415|FG019|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
27891733|NCT04518410|54544416|FG020|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
27891734|NCT04518410|54544417|FG021|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
27891735|NCT04518410|54544418|FG022|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
27891736|NCT04518410|54544419|FG023|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
27891737|NCT04518410|54544420|FG024|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
27891738|NCT04518410|54544396|FG000|Overall Study|Dual Enrolled Subject|0|||
27891739|NCT04518410|54544397|FG001|Overall Study|Dual Enrolled Subject|0|||
27891740|NCT04518410|54544398|FG002|Overall Study|Dual Enrolled Subject|0|||
27891741|NCT04518410|54544399|FG003|Overall Study|Dual Enrolled Subject|0|||
27891742|NCT04518410|54544400|FG004|Overall Study|Dual Enrolled Subject|0|||
27891743|NCT04518410|54544401|FG005|Overall Study|Dual Enrolled Subject|0|||
27891744|NCT04518410|54544402|FG006|Overall Study|Dual Enrolled Subject|0|||
27891745|NCT04518410|54544403|FG007|Overall Study|Dual Enrolled Subject|0|||
27891746|NCT04518410|54544404|FG008|Overall Study|Dual Enrolled Subject|0|||
27891747|NCT04518410|54544405|FG009|Overall Study|Dual Enrolled Subject|0|||
27891748|NCT04518410|54544406|FG010|Overall Study|Dual Enrolled Subject|0|||
27891749|NCT04518410|54544407|FG011|Overall Study|Dual Enrolled Subject|0|||
27891750|NCT04518410|54544408|FG012|Overall Study|Dual Enrolled Subject|0|||
27891751|NCT04518410|54544409|FG013|Overall Study|Dual Enrolled Subject|0|||
27891752|NCT04518410|54544410|FG014|Overall Study|Dual Enrolled Subject|0|||
27891753|NCT04518410|54544411|FG015|Overall Study|Dual Enrolled Subject|0|||
27891754|NCT04518410|54544412|FG016|Overall Study|Dual Enrolled Subject|0|||
27891755|NCT04518410|54544413|FG017|Overall Study|Dual Enrolled Subject|1|||
27891756|NCT04518410|54544414|FG018|Overall Study|Dual Enrolled Subject|0|||
27891757|NCT04518410|54544415|FG019|Overall Study|Dual Enrolled Subject|0|||
27891758|NCT04518410|54544416|FG020|Overall Study|Dual Enrolled Subject|0|||
27891759|NCT04518410|54544417|FG021|Overall Study|Dual Enrolled Subject|0|||
27891760|NCT04518410|54544418|FG022|Overall Study|Dual Enrolled Subject|0|||
27891761|NCT04518410|54544419|FG023|Overall Study|Dual Enrolled Subject|0|||
27891762|NCT04518410|54544420|FG024|Overall Study|Dual Enrolled Subject|0|||
27891763|NCT04517864|54544480|FG000|Placebo-Controlled Phase|Adverse Event|1|||
27891764|NCT04517864|54544481|FG001|Placebo-Controlled Phase|Adverse Event|0|||
27891765|NCT04517864|54544480|FG000|Placebo-Controlled Phase|Lost to Follow-up|1|||
27891766|NCT04517864|54544481|FG001|Placebo-Controlled Phase|Lost to Follow-up|1|||
27891767|NCT04517864|54544480|FG000|Placebo-Controlled Phase|Protocol Violation|1|||
27891768|NCT04517864|54544481|FG001|Placebo-Controlled Phase|Protocol Violation|0|||
27891769|NCT04517864|54544480|FG000|Placebo-Controlled Phase|Withdrawal by Subject|1|||
27891770|NCT04517864|54544481|FG001|Placebo-Controlled Phase|Withdrawal by Subject|1|||
27891771|NCT04517864|54544480|FG000|Active Therapy Extension Phase|Adverse Event|1|||
27891772|NCT04517864|54544481|FG001|Active Therapy Extension Phase|Adverse Event|0|||
27891773|NCT04507204|54544502|FG000|Overall Study|Adverse Event|8|||
27891774|NCT04507204|54544503|FG001|Overall Study|Adverse Event|13|||
27891775|NCT04507204|54544502|FG000|Overall Study|Death|0|||
27891776|NCT04507204|54544503|FG001|Overall Study|Death|1|||
27891777|NCT04507204|54544502|FG000|Overall Study|Lost to Follow-up|15|||
27891778|NCT04507204|54544503|FG001|Overall Study|Lost to Follow-up|14|||
27891779|NCT04507204|54544502|FG000|Overall Study|Poor Compliance with Protocol|2|||
27891780|NCT04507204|54544503|FG001|Overall Study|Poor Compliance with Protocol|4|||
27891781|NCT04507204|54544502|FG000|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|4|||
27891782|NCT04507204|54544503|FG001|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|3|||
27891783|NCT04507204|54544502|FG000|Overall Study|Withdrawal of Patient Consent|21|||
27891784|NCT04507204|54544503|FG001|Overall Study|Withdrawal of Patient Consent|13|||
27891785|NCT04288154|54544529|FG000|Overall Study|Withdrawal by Subject|9|||
27891786|NCT04288154|54544530|FG001|Overall Study|Withdrawal by Subject|9|||
27891787|NCT04158648|54544536|FG000|Overall Study|Ongoing in the Study|69|||
27891788|NCT04158648|54544536|FG000|Overall Study|Withdrawal by Subject|4|||
27891789|NCT04135937|54544543|FG000|Overall Study|Lost to Follow-up|2|||
27891790|NCT04135937|54544543|FG000|Overall Study|Withdrawal by Subject|1|||
27891791|NCT04060147|54544547|FG000|Overall Study|Withdrew consent|1|||
27891792|NCT04045132|54544553|FG000|Overall Study|Lost to Follow-up|3|||
27891793|NCT04045132|54544554|FG001|Overall Study|Lost to Follow-up|6|||
27891794|NCT04019041|54544592|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|3|||
27739399|NCT02738801|54189009|FG000|Overall Study|Adverse Event|1|||
27891795|NCT04019041|54544593|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|5|||
27891796|NCT04019041|54544594|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
27891797|NCT04019041|54544595|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
27891798|NCT04019041|54544596|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
27891799|NCT04019041|54544597|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
27891800|NCT04019041|54544592|FG000|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
27891801|NCT04019041|54544593|FG001|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
27891802|NCT04019041|54544594|FG002|Placebo Controlled Period (Weeks 0-16)|Adverse Event|2|||
27891803|NCT04019041|54544595|FG003|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
27891804|NCT04019041|54544596|FG004|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
27891805|NCT04019041|54544597|FG005|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
27891806|NCT04019041|54544592|FG000|Placebo Controlled Period (Weeks 0-16)|Other|1|||
27891807|NCT04019041|54544593|FG001|Placebo Controlled Period (Weeks 0-16)|Other|2|||
27891808|NCT04019041|54544594|FG002|Placebo Controlled Period (Weeks 0-16)|Other|1|||
27891809|NCT04019041|54544595|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
27891810|NCT04019041|54544596|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
27891811|NCT04019041|54544597|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
27891812|NCT04019041|54544592|FG000|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
27891813|NCT04019041|54544593|FG001|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
27891814|NCT04019041|54544594|FG002|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|1|||
27891815|NCT04019041|54544595|FG003|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
27891816|NCT04019041|54544596|FG004|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
27891817|NCT04019041|54544597|FG005|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
27891818|NCT04019041|54544592|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
27891819|NCT04019041|54544593|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
27891820|NCT04019041|54544594|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
27891821|NCT04019041|54544595|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|4|||
27891822|NCT04019041|54544596|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
27891823|NCT04019041|54544597|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
27891824|NCT04019041|54544592|FG000|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
27891825|NCT04019041|54544593|FG001|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
27891826|NCT04019041|54544594|FG002|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
27891827|NCT04019041|54544595|FG003|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|1|||
27891828|NCT04019041|54544596|FG004|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
27891829|NCT04019041|54544597|FG005|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
27891830|NCT04019041|54544592|FG000|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
27891831|NCT04019041|54544593|FG001|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
27891832|NCT04019041|54544594|FG002|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
27891833|NCT04019041|54544595|FG003|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
27891834|NCT04019041|54544596|FG004|Active Treatment+Safety F-U (Week 17-36)|Death|1|||
27891835|NCT04019041|54544597|FG005|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
27891836|NCT04019041|54544592|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
27891837|NCT04019041|54544593|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
27891838|NCT04019041|54544594|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
27891839|NCT04019041|54544595|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
27891840|NCT04019041|54544596|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|2|||
27891841|NCT04019041|54544597|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
27891842|NCT04019041|54544592|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
27891843|NCT04019041|54544593|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
27891844|NCT04019041|54544594|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
27891845|NCT04019041|54544595|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
27891846|NCT04019041|54544596|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|3|||
27891847|NCT04019041|54544597|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|1|||
27891848|NCT03919448|54544626|FG000|Overall Study|Withdrawal by Subject|1|||
27891849|NCT03919448|54544627|FG001|Overall Study|Withdrawal by Subject|0|||
27891850|NCT03919448|54544628|FG002|Overall Study|Withdrawal by Subject|0|||
27891851|NCT03795922|54544655|FG000|Overall Study|Adverse Event|2|||
27891852|NCT03795922|54544656|FG001|Overall Study|Adverse Event|1|||
27891853|NCT03795922|54544655|FG000|Overall Study|Withdrawal by Subject|5|||
27891854|NCT03795922|54544656|FG001|Overall Study|Withdrawal by Subject|13|||
27891855|NCT03795922|54544655|FG000|Overall Study|Lost to Follow-up|2|||
27891856|NCT03795922|54544656|FG001|Overall Study|Lost to Follow-up|3|||
27891857|NCT03795922|54544655|FG000|Overall Study|Pregnancy|0|||
27891858|NCT03795922|54544656|FG001|Overall Study|Pregnancy|1|||
27891859|NCT03795922|54544655|FG000|Overall Study|Physician Decision|1|||
27891860|NCT03795922|54544656|FG001|Overall Study|Physician Decision|2|||
28171883|NCT02468674|54843502|FG003|Overall Study|Physician Decision|0|||
27891861|NCT03795922|54544655|FG000|Overall Study|Protocol Violation|0|||
27891862|NCT03795922|54544656|FG001|Overall Study|Protocol Violation|1|||
27891863|NCT03795922|54544655|FG000|Overall Study|Other (Early termination, COVID, Family issue)|3|||
27891864|NCT03795922|54544656|FG001|Overall Study|Other (Early termination, COVID, Family issue)|4|||
27891865|NCT03794089|54544666|FG000|Overall Study|Lost to Follow-up|4|||
27891866|NCT03794089|54544667|FG001|Overall Study|Lost to Follow-up|1|||
27891867|NCT03794089|54544666|FG000|Overall Study|Withdrawal by Subject|2|||
27891868|NCT03794089|54544667|FG001|Overall Study|Withdrawal by Subject|0|||
27891869|NCT03769025|54544675|FG000|Overall Study|Withdrawal by Subject|1|||
27891870|NCT03769025|54544676|FG001|Overall Study|Withdrawal by Subject|1|||
27891871|NCT03769025|54544675|FG000|Overall Study|Lost to Follow-up|4|||
27891872|NCT03769025|54544676|FG001|Overall Study|Lost to Follow-up|3|||
27891873|NCT03762473|54544684|FG000|Overall Study|Death|1|||
27891874|NCT03762473|54544685|FG001|Overall Study|Death|0|||
27891875|NCT03761056|54544691|FG000|Overall Study|Still on Study|34|||
27891876|NCT03761056|54544691|FG000|Overall Study|Death|6|||
27891877|NCT03761056|54544691|FG000|Overall Study|Investigator Decision|1|||
27891878|NCT03761056|54544691|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|1|||
27891879|NCT03759366|54544697|FG000|Primary Evaluation Period (26 Weeks)|Ongoing during the Primary Evaluation Period|1|||
27891880|NCT03759366|54544697|FG000|Extension Period (Up to 208 Weeks)|Ongoing during the Extension Period|10|||
27891881|NCT03745989|54544704|FG000|Overall Study|Death|3|||
27891882|NCT03745989|54544705|FG001|Overall Study|Death|7|||
27891883|NCT03745989|54544706|FG002|Overall Study|Death|4|||
27891884|NCT03745989|54544704|FG000|Overall Study|Lost to Follow-up|0|||
27891885|NCT03745989|54544705|FG001|Overall Study|Lost to Follow-up|2|||
27891886|NCT03745989|54544706|FG002|Overall Study|Lost to Follow-up|0|||
27891887|NCT03745989|54544704|FG000|Overall Study|Sponsor Decision|0|||
27891888|NCT03745989|54544705|FG001|Overall Study|Sponsor Decision|2|||
27891889|NCT03745989|54544706|FG002|Overall Study|Sponsor Decision|8|||
27891890|NCT03745989|54544704|FG000|Overall Study|Withdrawal by Subject|0|||
27891891|NCT03745989|54544705|FG001|Overall Study|Withdrawal by Subject|1|||
27891892|NCT03745989|54544706|FG002|Overall Study|Withdrawal by Subject|3|||
27891893|NCT03646656|54544736|FG000|Overall Study|Lost to Follow-up|1|||
27891894|NCT03646656|54544737|FG001|Overall Study|Lost to Follow-up|0|||
27891895|NCT03646656|54544736|FG000|Overall Study|Withdrawal by Subject|2|||
27891896|NCT03646656|54544737|FG001|Overall Study|Withdrawal by Subject|0|||
27891897|NCT03594110|54544749|FG000|Overall Study|Participant concerned about study treatment|23|||
27891898|NCT03594110|54544750|FG001|Overall Study|Participant concerned about study treatment|28|||
27891899|NCT03594110|54544749|FG000|Overall Study|Doctor advice|38|||
27891900|NCT03594110|54544750|FG001|Overall Study|Doctor advice|40|||
27891901|NCT03594110|54544749|FG000|Overall Study|Participants' wish|89|||
27891902|NCT03594110|54544750|FG001|Overall Study|Participants' wish|68|||
27891903|NCT03594110|54544749|FG000|Overall Study|Adverse Event|119|||
27891904|NCT03594110|54544750|FG001|Overall Study|Adverse Event|116|||
27891905|NCT03594110|54544749|FG000|Overall Study|Study drug stopped, reason missing|337|||
27891906|NCT03594110|54544750|FG001|Overall Study|Study drug stopped, reason missing|295|||
27891907|NCT03594110|54544749|FG000|Overall Study|Cannot attend clinic because of personal problems|8|||
27891908|NCT03594110|54544750|FG001|Overall Study|Cannot attend clinic because of personal problems|16|||
27891909|NCT03594110|54544749|FG000|Overall Study|Cannot attend clinic because moving out of the area|15|||
27891910|NCT03594110|54544750|FG001|Overall Study|Cannot attend clinic because moving out of the area|9|||
27891911|NCT03594110|54544749|FG000|Overall Study|Contraindicated drug started|32|||
27891912|NCT03594110|54544750|FG001|Overall Study|Contraindicated drug started|18|||
27891913|NCT03594110|54544749|FG000|Overall Study|Other reasons (include any category with a frequency <20 patients in total)|58|||
27891914|NCT03594110|54544750|FG001|Overall Study|Other reasons (include any category with a frequency <20 patients in total)|45|||
27891915|NCT03594110|54544749|FG000|Overall Study|Death|129|||
27891916|NCT03594110|54544750|FG001|Overall Study|Death|120|||
27891917|NCT03555435|54544759|FG000|Overall Study|Lost to Follow-up|17|||
27891918|NCT03555435|54544760|FG001|Overall Study|Lost to Follow-up|19|||
27891919|NCT03555435|54544761|FG002|Overall Study|Lost to Follow-up|8|||
27891920|NCT03521115|54544771|FG000|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|56|||
27891921|NCT03521115|54544772|FG001|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|40|||
27891922|NCT03521115|54544771|FG000|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|3|||
27891923|NCT03521115|54544772|FG001|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|1|||
27891924|NCT03520413|54544786|FG000|Overall Study|Lost to Follow-up|1|||
27985608|NCT00545233|54644379|FG001|Overall Study|Failure to Return|6|||
27891925|NCT03520413|54544787|FG001|Overall Study|Lost to Follow-up|1|||
27891926|NCT03520413|54544786|FG000|Overall Study|Withdrawal by Subject|1|||
27891927|NCT03520413|54544787|FG001|Overall Study|Withdrawal by Subject|2|||
27891928|NCT03520413|54544786|FG000|Overall Study|Death|0|||
27891929|NCT03520413|54544787|FG001|Overall Study|Death|1|||
27891930|NCT03520413|54544786|FG000|Overall Study|Physician Decision|3|||
27891931|NCT03520413|54544787|FG001|Overall Study|Physician Decision|3|||
27985609|NCT00545233|54644378|FG000|Overall Study|Insufficient response|14|||
27985610|NCT00545233|54644379|FG001|Overall Study|Insufficient response|15|||
27891932|NCT03520413|54544786|FG000|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
27891933|NCT03520413|54544787|FG001|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
27891934|NCT03419897|54544794|FG000|Overall Study|Death|180|||
27891935|NCT03419897|54544794|FG000|Overall Study|Lost to Follow-up|1|||
27891936|NCT03419897|54544794|FG000|Overall Study|Withdrawal by Subject|6|||
27891937|NCT03419897|54544794|FG000|Overall Study|Sponsor Decision|61|||
27891938|NCT03419897|54544794|FG000|Overall Study|Physician Decision|1|||
27891939|NCT03418129|54544801|FG000|Overall Study|Lost to Follow-up|11|||
27891940|NCT03418129|54544802|FG001|Overall Study|Lost to Follow-up|20|||
27891941|NCT03418129|54544803|FG002|Overall Study|Lost to Follow-up|15|||
27891942|NCT03418129|54544801|FG000|Overall Study|Withdrawal by Subject|3|||
27891943|NCT03418129|54544802|FG001|Overall Study|Withdrawal by Subject|6|||
27891944|NCT03418129|54544803|FG002|Overall Study|Withdrawal by Subject|4|||
27891945|NCT03344796|54544821|FG000|Overall Study|Lost to Follow-up|0|||
27891946|NCT03344796|54544822|FG001|Overall Study|Lost to Follow-up|0|||
27891947|NCT03344796|54544823|FG002|Overall Study|Lost to Follow-up|0|||
27891948|NCT03344796|54544824|FG003|Overall Study|Lost to Follow-up|0|||
27891949|NCT03344796|54544825|FG004|Overall Study|Lost to Follow-up|0|||
27891950|NCT03344796|54544826|FG005|Overall Study|Lost to Follow-up|2|||
27891951|NCT03335488|54544849|FG000|Maintenance Period|Withdrawal by Parent/Guardian|1|||
27891952|NCT03335488|54544850|FG001|Maintenance Period|Withdrawal by Parent/Guardian|0|||
27891953|NCT03335488|54544849|FG000|Safety Extension Period|Adverse Event|1|||
27891954|NCT03335488|54544850|FG001|Safety Extension Period|Adverse Event|0|||
27891955|NCT03335488|54544849|FG000|Safety Extension Period|Did Not Return to Study Visit|1|||
27891956|NCT03335488|54544850|FG001|Safety Extension Period|Did Not Return to Study Visit|0|||
27891957|NCT03261700|54544878|FG000|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|1|||
27891958|NCT03261700|54544879|FG001|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|0|||
27891959|NCT03238417|54544890|FG000|Overall|non-response|955|||
27891960|NCT03238417|54544891|FG001|Overall|non-response|1920|||
27891961|NCT03238417|54544890|FG000|Overall|partial completion|48|||
27891962|NCT03238417|54544891|FG001|Overall|partial completion|68|||
27891963|NCT03238417|54544890|FG000|Baseline|Partial completion|17|||
27891964|NCT03238417|54544891|FG001|Baseline|Partial completion|48|||
27891965|NCT03238417|54544890|FG000|Baseline|non-response|372|||
27891966|NCT03238417|54544891|FG001|Baseline|non-response|669|||
27891967|NCT03238417|54544890|FG000|12-month|non-response|296|||
27891968|NCT03238417|54544891|FG001|12-month|non-response|669|||
27891969|NCT03238417|54544890|FG000|12-month|partial completion|23|||
27891970|NCT03238417|54544891|FG001|12-month|partial completion|37|||
27891971|NCT03238417|54544890|FG000|24-month|non-response|287|||
27891972|NCT03238417|54544891|FG001|24-month|non-response|594|||
27891973|NCT03238417|54544890|FG000|24-month|partial completion|8|||
27891974|NCT03238417|54544891|FG001|24-month|partial completion|31|||
27891975|NCT03215277|54544899|FG000|Overall Study|Adverse Event|2|||
27891976|NCT03215277|54544900|FG001|Overall Study|Adverse Event|3|||
27891977|NCT03215277|54544899|FG000|Overall Study|Death|1|||
27891978|NCT03215277|54544900|FG001|Overall Study|Death|0|||
27891979|NCT03215277|54544899|FG000|Overall Study|Lost to Follow-up|0|||
27891980|NCT03215277|54544900|FG001|Overall Study|Lost to Follow-up|1|||
27891981|NCT03215277|54544899|FG000|Overall Study|Participant was unable to attend clinic visit|0|||
27891982|NCT03215277|54544900|FG001|Overall Study|Participant was unable to attend clinic visit|1|||
27891983|NCT03185013|54544910|FG000|Overall Study|Withdrawal by Subject|5|||
27891984|NCT03185013|54544911|FG001|Overall Study|Withdrawal by Subject|3|||
27891985|NCT03185013|54544910|FG000|Overall Study|Adverse Event|1|||
27891986|NCT03185013|54544911|FG001|Overall Study|Adverse Event|0|||
27891987|NCT03185013|54544910|FG000|Overall Study|Progressive Disease|1|||
27891988|NCT03185013|54544911|FG001|Overall Study|Progressive Disease|0|||
27891989|NCT03185013|54544910|FG000|Overall Study|Lost to Follow-up|8|||
27891990|NCT03185013|54544911|FG001|Overall Study|Lost to Follow-up|2|||
27891991|NCT03185013|54544910|FG000|Overall Study|Physician Decision|1|||
27891992|NCT03185013|54544911|FG001|Overall Study|Physician Decision|0|||
27891993|NCT03185013|54544910|FG000|Overall Study|Protocol Deviation|2|||
27891994|NCT03185013|54544911|FG001|Overall Study|Protocol Deviation|0|||
27891995|NCT03185013|54544910|FG000|Overall Study|Reason not Specified|3|||
27891996|NCT03185013|54544911|FG001|Overall Study|Reason not Specified|2|||
27891997|NCT03185013|54544910|FG000|Overall Study|Death|1|||
27891998|NCT03185013|54544911|FG001|Overall Study|Death|0|||
27891999|NCT03182907|54544919|FG000|Overall Study|Death|3|||
27892000|NCT03182907|54544920|FG001|Overall Study|Death|0|||
27892001|NCT03182907|54544919|FG000|Overall Study|Protocol Violation|4|||
27892002|NCT03182907|54544920|FG001|Overall Study|Protocol Violation|0|||
27892003|NCT03182907|54544919|FG000|Overall Study|Lost to Follow-up|1|||
27892004|NCT03182907|54544920|FG001|Overall Study|Lost to Follow-up|0|||
28096687|NCT04091360|54751859|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
28096688|NCT04091360|54751860|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
28096689|NCT04091360|54751861|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
28096690|NCT04091360|54751862|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
27892005|NCT03182907|54544919|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
27892006|NCT03182907|54544920|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
27892007|NCT03126019|54544931|FG000|Overall Study|Participants Still Ongoing in the Study|17|||
27892008|NCT03126019|54544932|FG001|Overall Study|Participants Still Ongoing in the Study|87|||
27892009|NCT03126019|54544931|FG000|Overall Study|Death|2|||
27892010|NCT03126019|54544932|FG001|Overall Study|Death|7|||
27892011|NCT03126019|54544931|FG000|Overall Study|Lost to Follow-up|2|||
27892012|NCT03126019|54544932|FG001|Overall Study|Lost to Follow-up|3|||
27892013|NCT03126019|54544931|FG000|Overall Study|Withdrawal by Participant|1|||
27892014|NCT03126019|54544932|FG001|Overall Study|Withdrawal by Participant|3|||
27892015|NCT03126019|54544931|FG000|Overall Study|Reason not Specified|1|||
27892016|NCT03126019|54544932|FG001|Overall Study|Reason not Specified|3|||
27892017|NCT03036813|54544942|FG000|Overall Study|Adverse Event|6|||
27892018|NCT03036813|54544943|FG001|Overall Study|Adverse Event|11|||
27892019|NCT03036813|54544944|FG002|Overall Study|Adverse Event|6|||
27892020|NCT03036813|54544942|FG000|Overall Study|Withdrawal by Subject|12|||
27892021|NCT03036813|54544943|FG001|Overall Study|Withdrawal by Subject|6|||
27892022|NCT03036813|54544944|FG002|Overall Study|Withdrawal by Subject|10|||
27892023|NCT03036813|54544942|FG000|Overall Study|Lost to Follow-up|1|||
27892024|NCT03036813|54544943|FG001|Overall Study|Lost to Follow-up|1|||
27892025|NCT03036813|54544944|FG002|Overall Study|Lost to Follow-up|0|||
27892026|NCT03036813|54544942|FG000|Overall Study|Physician Decision|2|||
27892027|NCT03036813|54544943|FG001|Overall Study|Physician Decision|1|||
27892028|NCT03036813|54544944|FG002|Overall Study|Physician Decision|1|||
27892029|NCT03036813|54544942|FG000|Overall Study|Non-Compliance|1|||
27892030|NCT03036813|54544943|FG001|Overall Study|Non-Compliance|5|||
27892031|NCT03036813|54544944|FG002|Overall Study|Non-Compliance|3|||
27892032|NCT03036813|54544942|FG000|Overall Study|Pregnancy|0|||
27892033|NCT03036813|54544943|FG001|Overall Study|Pregnancy|0|||
27892034|NCT03036813|54544944|FG002|Overall Study|Pregnancy|1|||
27892035|NCT03036813|54544942|FG000|Overall Study|Other|0|||
27892036|NCT03036813|54544943|FG001|Overall Study|Other|3|||
27892037|NCT03036813|54544944|FG002|Overall Study|Other|5|||
27892038|NCT03007953|54544957|FG000|Overall Study|Withdrawal by Subject|5|||
27892039|NCT03007953|54544958|FG001|Overall Study|Withdrawal by Subject|2|||
27892040|NCT03007953|54544957|FG000|Overall Study|Death|5|||
27892041|NCT03007953|54544958|FG001|Overall Study|Death|7|||
27892042|NCT03007953|54544957|FG000|Overall Study|Lost to Follow-up|3|||
27892043|NCT03007953|54544958|FG001|Overall Study|Lost to Follow-up|2|||
27892044|NCT03007953|54544957|FG000|Overall Study|Enrolled in Hospice|3|||
27892045|NCT03007953|54544958|FG001|Overall Study|Enrolled in Hospice|2|||
27892046|NCT02919618|54544973|FG000|Overall Study|Death|1|||
27892047|NCT02911701|54544990|FG000|Overall Study|Withdrawal by Subject|2|||
27892048|NCT02911701|54544991|FG001|Overall Study|Withdrawal by Subject|4|||
27892049|NCT02911701|54544990|FG000|Overall Study|Adverse Event|1|||
27892050|NCT02911701|54544991|FG001|Overall Study|Adverse Event|0|||
27892051|NCT02903368|54544999|FG000|Overall Study|Adverse Event|3|||
27892052|NCT02903368|54545000|FG001|Overall Study|Adverse Event|0|||
27892053|NCT02903368|54544999|FG000|Overall Study|Withdrawal by Subject|1|||
27892054|NCT02903368|54545000|FG001|Overall Study|Withdrawal by Subject|0|||
27892055|NCT02896257|54545010|FG000|Providers|Without eligible patients|21|||
27892056|NCT02896257|54545011|FG001|Providers|Without eligible patients|28|||
27892057|NCT02896257|54545010|FG000|Patients|PFT entry criteria not met|43|||
27892058|NCT02896257|54545011|FG001|Patients|PFT entry criteria not met|50|||
27892059|NCT02896257|54545010|FG000|Patients|No capacity to review|8|||
27892060|NCT02896257|54545011|FG001|Patients|No capacity to review|11|||
27892061|NCT02896257|54545010|FG000|Patients|Appointment rescheduled/cancelled|5|||
27892062|NCT02896257|54545011|FG001|Patients|Appointment rescheduled/cancelled|7|||
27892063|NCT02896257|54545010|FG000|Patients|PCP not assigned a clinic|4|||
27892064|NCT02896257|54545011|FG001|Patients|PCP not assigned a clinic|0|||
27892065|NCT02896257|54545010|FG000|Patients|No history of COPD|0|||
27892066|NCT02896257|54545011|FG001|Patients|No history of COPD|1|||
27892067|NCT02896257|54545010|FG000|Patients|Deceased between review and index date|0|||
27892068|NCT02896257|54545011|FG001|Patients|Deceased between review and index date|1|||
27892069|NCT02896257|54545010|FG000|Patients|No ICS Rx upon review|1|||
27892070|NCT02896257|54545011|FG001|Patients|No ICS Rx upon review|1|||
27892071|NCT02896257|54545010|FG000|Patients|Protocol Violation|2|||
27892072|NCT02896257|54545011|FG001|Patients|Protocol Violation|1|||
27892073|NCT02896257|54545010|FG000|Patients|Hospice care|0|||
27892074|NCT02896257|54545011|FG001|Patients|Hospice care|1|||
27892075|NCT02874742|54545021|FG000|Overall Study|Death|0|||
27892076|NCT02874742|54545022|FG001|Overall Study|Death|1|||
27892077|NCT02874742|54545023|FG002|Overall Study|Death|0|||
27892078|NCT02874742|54545021|FG000|Overall Study|Lost to Follow-up|5|||
27892079|NCT02874742|54545022|FG001|Overall Study|Lost to Follow-up|4|||
27892080|NCT02874742|54545023|FG002|Overall Study|Lost to Follow-up|1|||
27892081|NCT02874742|54545021|FG000|Overall Study|Withdrawal by Subject|17|||
27892082|NCT02874742|54545022|FG001|Overall Study|Withdrawal by Subject|8|||
27892083|NCT02874742|54545023|FG002|Overall Study|Withdrawal by Subject|0|||
27892084|NCT02874742|54545021|FG000|Overall Study|Other|4|||
27892085|NCT02874742|54545022|FG001|Overall Study|Other|1|||
27892086|NCT02874742|54545023|FG002|Overall Study|Other|0|||
27892087|NCT02874742|54545021|FG000|Overall Study|Progressive Disease|1|||
27892088|NCT02874742|54545022|FG001|Overall Study|Progressive Disease|0|||
27892089|NCT02874742|54545023|FG002|Overall Study|Progressive Disease|0|||
27892090|NCT02874742|54545021|FG000|Overall Study|Screen Failure|0|||
27892091|NCT02874742|54545022|FG001|Overall Study|Screen Failure|2|||
27892092|NCT02874742|54545023|FG002|Overall Study|Screen Failure|0|||
27892093|NCT02749292|54545033|FG000|Overall Study|Physician Decision|1|||
27892094|NCT02749292|54545034|FG001|Overall Study|Physician Decision|0|||
27892095|NCT02749292|54545033|FG000|Overall Study|Withdrawal by Subject|5|||
27892096|NCT02749292|54545034|FG001|Overall Study|Withdrawal by Subject|7|||
27892097|NCT02749292|54545033|FG000|Overall Study|Minor relapse, BVAS-WG = 2|1|||
27892098|NCT02749292|54545034|FG001|Overall Study|Minor relapse, BVAS-WG = 2|7|||
27892099|NCT02749292|54545033|FG000|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|2|||
27892100|NCT02749292|54545034|FG001|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|4|||
27892101|NCT02749292|54545033|FG000|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|2|||
27892102|NCT02749292|54545034|FG001|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|3|||
27892103|NCT02749292|54545033|FG000|Overall Study|Adverse Event|4|||
27892104|NCT02749292|54545034|FG001|Overall Study|Adverse Event|1|||
27892105|NCT02749292|54545033|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|2|||
27892106|NCT02749292|54545034|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|0|||
27892107|NCT02749292|54545033|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|4|||
27892108|NCT02749292|54545034|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|1|||
27892109|NCT02749292|54545033|FG000|Overall Study|Requiring glucocorticoids|0|||
27892110|NCT02749292|54545034|FG001|Overall Study|Requiring glucocorticoids|3|||
27892111|NCT02749292|54545033|FG000|Overall Study|Cancer|1|||
27892112|NCT02749292|54545034|FG001|Overall Study|Cancer|0|||
27892113|NCT02689076|54545053|FG000|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|172|||
27892114|NCT02689076|54545054|FG001|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|213|||
27892115|NCT02689076|54545055|FG002|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|0|||
27892116|NCT02689076|54545053|FG000|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|3|||
27892117|NCT02689076|54545054|FG001|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|1|||
27892118|NCT02689076|54545055|FG002|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|0|||
27892119|NCT02689076|54545053|FG000|Overall Study|Did not have an HIE match|2|||
27892120|NCT02689076|54545054|FG001|Overall Study|Did not have an HIE match|0|||
27892121|NCT02689076|54545055|FG002|Overall Study|Did not have an HIE match|0|||
27892122|NCT02689076|54545053|FG000|Overall Study|Death during non-VA encounter|2|||
27892123|NCT02689076|54545054|FG001|Overall Study|Death during non-VA encounter|5|||
27892124|NCT02689076|54545055|FG002|Overall Study|Death during non-VA encounter|0|||
27892125|NCT02689076|54545053|FG000|Overall Study|Provider declined to participate after participant assignment|1|||
27892126|NCT02689076|54545054|FG001|Overall Study|Provider declined to participate after participant assignment|1|||
27892127|NCT02689076|54545055|FG002|Overall Study|Provider declined to participate after participant assignment|0|||
27892128|NCT02689076|54545053|FG000|Overall Study|Participant no longer active in VA system|1|||
27892129|NCT02689076|54545054|FG001|Overall Study|Participant no longer active in VA system|0|||
27892130|NCT02689076|54545055|FG002|Overall Study|Participant no longer active in VA system|0|||
27892131|NCT02689076|54545053|FG000|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
27892132|NCT02689076|54545054|FG001|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|2|||
27892133|NCT02689076|54545055|FG002|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
27892134|NCT02670525|54545065|FG000|Overall Study|Death|94|||
27892135|NCT02670525|54545066|FG001|Overall Study|Death|14|||
27892136|NCT02670525|54545065|FG000|Overall Study|Lost to Follow-up|4|||
27892137|NCT02670525|54545066|FG001|Overall Study|Lost to Follow-up|1|||
27892138|NCT02670525|54545065|FG000|Overall Study|Subject withdrew consent|1|||
27892139|NCT02670525|54545066|FG001|Overall Study|Subject withdrew consent|0|||
27892140|NCT02670525|54545065|FG000|Overall Study|Unknown, data entry delayed|123|||
27892141|NCT02670525|54545066|FG001|Overall Study|Unknown, data entry delayed|78|||
27892142|NCT02576990|54545074|FG000|Overall Study|Death|29|||
27892143|NCT02576990|54545075|FG001|Overall Study|Death|18|||
27892144|NCT02576990|54545074|FG000|Overall Study|Physician Decision|1|||
27892145|NCT02576990|54545075|FG001|Overall Study|Physician Decision|0|||
27892146|NCT02576990|54545074|FG000|Overall Study|Screen failure|2|||
27892147|NCT02576990|54545075|FG001|Overall Study|Screen failure|0|||
27892148|NCT02576990|54545074|FG000|Overall Study|Sponsor's decision|24|||
27892149|NCT02576990|54545075|FG001|Overall Study|Sponsor's decision|4|||
27892150|NCT02576990|54545074|FG000|Overall Study|Withdrawal by Subject|0|||
27892151|NCT02576990|54545075|FG001|Overall Study|Withdrawal by Subject|2|||
27892152|NCT02550561|54545081|FG000|Overall Study|Lost to Follow-up|5|||
27892153|NCT02550561|54545081|FG000|Overall Study|Withdrawal by Subject|1|||
27892154|NCT02524171|54545091|FG000|6-month Follow-up|Lost to Follow-up|53|||
27892155|NCT02524171|54545092|FG001|6-month Follow-up|Lost to Follow-up|45|||
27892156|NCT02524171|54545091|FG000|12-month Follow-up Interview|Lost to Follow-up|45|||
27892157|NCT02524171|54545092|FG001|12-month Follow-up Interview|Lost to Follow-up|41|||
27892158|NCT02511106|54545100|FG000|Overall Study|Lost to Follow-up|1|||
27892159|NCT02511106|54545101|FG001|Overall Study|Lost to Follow-up|2|||
27892160|NCT02511106|54545100|FG000|Overall Study|Withdrawal by Subject|19|||
27892161|NCT02511106|54545101|FG001|Overall Study|Withdrawal by Subject|14|||
27892162|NCT02511106|54545100|FG000|Overall Study|Ongoing study at data cut-off|309|||
27892163|NCT02511106|54545101|FG001|Overall Study|Ongoing study at data cut-off|307|||
27892164|NCT02511106|54545100|FG000|Overall Study|Without specified reason|1|||
27892165|NCT02511106|54545101|FG001|Overall Study|Without specified reason|0|||
27892166|NCT02511106|54545100|FG000|Overall Study|Missing|1|||
27892167|NCT02511106|54545101|FG001|Overall Study|Missing|0|||
27892168|NCT02500589|54545111|FG000|Overall Study|Withdrawal by Subject|11|||
27892169|NCT02500589|54545112|FG001|Overall Study|Withdrawal by Subject|14|||
27892170|NCT02500589|54545111|FG000|Overall Study|Lost to Follow-up|10|||
27892171|NCT02500589|54545112|FG001|Overall Study|Lost to Follow-up|12|||
27892172|NCT02500589|54545111|FG000|Overall Study|Excluded post rand: cognitive impairment|0|||
27892173|NCT02500589|54545112|FG001|Overall Study|Excluded post rand: cognitive impairment|1|||
27892174|NCT02500589|54545111|FG000|Overall Study|Death|7|||
27892175|NCT02500589|54545112|FG001|Overall Study|Death|5|||
27892176|NCT02481830|54545124|FG000|Pre-treatment|Participant no longer meets Study Criteria|1|||
27892177|NCT02481830|54545125|FG001|Pre-treatment|Participant no longer meets Study Criteria|4|||
27892178|NCT02481830|54545124|FG000|Pre-treatment|Withdrawal by Subject|0|||
27892179|NCT02481830|54545125|FG001|Pre-treatment|Withdrawal by Subject|10|||
27892180|NCT02481830|54545124|FG000|Pre-treatment|Disease Progression|1|||
27892181|NCT02481830|54545125|FG001|Pre-treatment|Disease Progression|1|||
27892182|NCT02481830|54545124|FG000|Pre-treatment|Other reasons|0|||
27892183|NCT02481830|54545125|FG001|Pre-treatment|Other reasons|1|||
27892184|NCT02481830|54545124|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
27892185|NCT02481830|54545125|FG001|Pre-treatment|Participant request to discontinue study treatment|4|||
27892186|NCT02481830|54545124|FG000|Treatment|Disease Progression|233|||
27892187|NCT02481830|54545125|FG001|Treatment|Disease Progression|171|||
27892188|NCT02481830|54545124|FG000|Treatment|Study drug toxicity|18|||
27892189|NCT02481830|54545125|FG001|Treatment|Study drug toxicity|38|||
27892190|NCT02481830|54545124|FG000|Treatment|Death|1|||
27892191|NCT02481830|54545125|FG001|Treatment|Death|1|||
27892192|NCT02481830|54545124|FG000|Treatment|Adverse Event unrelated to Study drug|14|||
27892193|NCT02481830|54545125|FG001|Treatment|Adverse Event unrelated to Study drug|11|||
27892194|NCT02481830|54545124|FG000|Treatment|Participants request to discontinue Study treatment|6|||
27892195|NCT02481830|54545125|FG001|Treatment|Participants request to discontinue Study treatment|34|||
27892196|NCT02481830|54545124|FG000|Treatment|Withdrawal by Subject|2|||
27892197|NCT02481830|54545125|FG001|Treatment|Withdrawal by Subject|3|||
27892198|NCT02481830|54545124|FG000|Treatment|Lost to Follow-up|1|||
27892199|NCT02481830|54545125|FG001|Treatment|Lost to Follow-up|0|||
27892200|NCT02481830|54545124|FG000|Treatment|Maximum Clinical Benefit|0|||
27892201|NCT02481830|54545125|FG001|Treatment|Maximum Clinical Benefit|5|||
27892202|NCT02481830|54545124|FG000|Treatment|Administrative reason by sponsor|1|||
27892203|NCT02481830|54545125|FG001|Treatment|Administrative reason by sponsor|1|||
27892204|NCT02481830|54545124|FG000|Treatment|Other reasons|6|||
27892205|NCT02481830|54545125|FG001|Treatment|Other reasons|1|||
27892206|NCT02477111|54545131|FG000|Overall Study|Death|5|||
27892207|NCT02477111|54545131|FG000|Overall Study|Withdrawal by Subject|2|||
27892208|NCT02477111|54545131|FG000|Overall Study|missed visit|4|||
27892209|NCT02425943|54545139|FG000|Overall Study|Adverse Event|3|||
27892210|NCT02425943|54545140|FG001|Overall Study|Adverse Event|1|||
27892211|NCT02425943|54545139|FG000|Overall Study|Lost to Follow-up|59|||
27892212|NCT02425943|54545140|FG001|Overall Study|Lost to Follow-up|37|||
27892213|NCT02425943|54545139|FG000|Overall Study|Protocol Violation|4|||
27892214|NCT02425943|54545140|FG001|Overall Study|Protocol Violation|1|||
27892215|NCT02425943|54545139|FG000|Overall Study|Withdrawal by Subject|64|||
27892216|NCT02425943|54545140|FG001|Overall Study|Withdrawal by Subject|31|||
27892217|NCT02425943|54545139|FG000|Overall Study|Other|6|||
27892218|NCT02425943|54545140|FG001|Overall Study|Other|0|||
27892219|NCT02383173|54545150|FG000|Overall Study|Palliative Care Team withdrew|0|||
27892220|NCT02383173|54545151|FG001|Overall Study|Palliative Care Team withdrew|2|||
27892221|NCT02380690|54545159|FG000|Overall Study|Lost to Follow-up|14|||
27892222|NCT02380690|54545160|FG001|Overall Study|Lost to Follow-up|4|||
27892223|NCT02380690|54545159|FG000|Overall Study|Withdrawal by Subject|20|||
27892224|NCT02380690|54545160|FG001|Overall Study|Withdrawal by Subject|8|||
27892225|NCT02311673|54545202|FG000|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
27892226|NCT02311673|54545203|FG001|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
27892227|NCT02311673|54545204|FG002|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|1|||
27925757|NCT01229397|54582317|FG000|Overall Study|Withdrawal by Subject|3|||
27892228|NCT02311673|54545205|FG003|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
27892229|NCT02286089|54545241|FG000|Overall Study|Ongoing in Study|1|||
27892230|NCT02286089|54545242|FG001|Overall Study|Ongoing in Study|1|||
27892231|NCT02286089|54545243|FG002|Overall Study|Ongoing in Study|4|||
27892232|NCT02286089|54545244|FG003|Overall Study|Ongoing in Study|10|||
27892233|NCT02286089|54545241|FG000|Overall Study|Withdrawal by Subject|0|||
27892234|NCT02286089|54545242|FG001|Overall Study|Withdrawal by Subject|0|||
27892235|NCT02286089|54545243|FG002|Overall Study|Withdrawal by Subject|2|||
27892236|NCT02286089|54545244|FG003|Overall Study|Withdrawal by Subject|2|||
27892237|NCT02284113|54545256|FG000|Overall Study|Adverse Event|1|||
27892238|NCT02284113|54545257|FG001|Overall Study|Adverse Event|0|||
27892239|NCT02284113|54545256|FG000|Overall Study|non-compliance|0|||
27892240|NCT02284113|54545257|FG001|Overall Study|non-compliance|1|||
27892241|NCT02284113|54545256|FG000|Overall Study|Withdrawal by Subject|0|||
27892242|NCT02284113|54545257|FG001|Overall Study|Withdrawal by Subject|1|||
27892243|NCT02284113|54545256|FG000|Overall Study|not provided|0|||
27892244|NCT02284113|54545257|FG001|Overall Study|not provided|1|||
27892245|NCT02284113|54545256|FG000|Overall Study|surgery cancelled|2|||
27892246|NCT02284113|54545257|FG001|Overall Study|surgery cancelled|0|||
27892247|NCT02233738|54545265|FG000|Overall Study|Lost to Follow-up|5|||
27892248|NCT02233738|54545266|FG001|Overall Study|Lost to Follow-up|12|||
27892249|NCT02233738|54545265|FG000|Overall Study|Death|0|||
27892250|NCT02233738|54545266|FG001|Overall Study|Death|1|||
27892251|NCT02233738|54545265|FG000|Overall Study|Withdrawal by Subject|0|||
27892252|NCT02233738|54545266|FG001|Overall Study|Withdrawal by Subject|1|||
27892253|NCT02233738|54545265|FG000|Overall Study|Did not return after Baseline|3|||
27892254|NCT02233738|54545266|FG001|Overall Study|Did not return after Baseline|2|||
27892255|NCT01959698|54545454|FG000|Overall Study|Adverse Event|0|||
27892256|NCT01959698|54545455|FG001|Overall Study|Adverse Event|0|||
27892257|NCT01959698|54545456|FG002|Overall Study|Adverse Event|0|||
27892258|NCT01959698|54545457|FG003|Overall Study|Adverse Event|0|||
27892259|NCT01959698|54545458|FG004|Overall Study|Adverse Event|0|||
27892260|NCT01959698|54545459|FG005|Overall Study|Adverse Event|0|||
27892261|NCT01959698|54545460|FG006|Overall Study|Adverse Event|1|||
27892262|NCT01959698|54545454|FG000|Overall Study|Physician Decision|1|||
27892263|NCT01959698|54545455|FG001|Overall Study|Physician Decision|0|||
27892264|NCT01959698|54545456|FG002|Overall Study|Physician Decision|1|||
27892265|NCT01959698|54545457|FG003|Overall Study|Physician Decision|2|||
27892266|NCT01959698|54545458|FG004|Overall Study|Physician Decision|0|||
27892267|NCT01959698|54545459|FG005|Overall Study|Physician Decision|3|||
27892268|NCT01959698|54545460|FG006|Overall Study|Physician Decision|3|||
27892269|NCT01910402|54545479|FG000|Randomized Phase (Up to 48 Weeks)|Adverse Event|10|||
27892270|NCT01910402|54545480|FG001|Randomized Phase (Up to 48 Weeks)|Adverse Event|18|||
27892271|NCT01910402|54545481|FG002|Randomized Phase (Up to 48 Weeks)|Adverse Event|0|||
27892272|NCT01910402|54545479|FG000|Randomized Phase (Up to 48 Weeks)|Physician Decision|1|||
27892273|NCT01910402|54545480|FG001|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
27892274|NCT01910402|54545481|FG002|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
27892275|NCT01910402|54545479|FG000|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|5|||
27892276|NCT01910402|54545480|FG001|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|4|||
27892277|NCT01910402|54545481|FG002|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|0|||
27892278|NCT01910402|54545479|FG000|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|11|||
27892279|NCT01910402|54545480|FG001|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|13|||
27892280|NCT01910402|54545481|FG002|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|0|||
27892281|NCT01910402|54545479|FG000|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|5|||
27892282|NCT01910402|54545480|FG001|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|7|||
27892283|NCT01910402|54545481|FG002|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|0|||
27892284|NCT01910402|54545479|FG000|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
27892285|NCT01910402|54545480|FG001|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
27892286|NCT01910402|54545481|FG002|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|0|||
27892287|NCT01910402|54545479|FG000|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|10|||
27892288|NCT01910402|54545480|FG001|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|13|||
28171884|NCT02468674|54843503|FG004|Overall Study|Physician Decision|0|||
28171885|NCT02468674|54843504|FG005|Overall Study|Physician Decision|0|||
28171886|NCT02468674|54843505|FG006|Overall Study|Physician Decision|1|||
27892289|NCT01910402|54545481|FG002|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|0|||
27892290|NCT01910402|54545479|FG000|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
27892291|NCT01910402|54545480|FG001|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
27892292|NCT01910402|54545481|FG002|Continuation Phase(From Weeks 48 to 432)|Physician Decision|1|||
27892293|NCT01910402|54545479|FG000|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
27892294|NCT01910402|54545480|FG001|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
27892295|NCT01910402|54545481|FG002|Continuation Phase(From Weeks 48 to 432)|Adverse Event|4|||
27892296|NCT01910402|54545479|FG000|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
27892297|NCT01910402|54545480|FG001|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
27892298|NCT01910402|54545481|FG002|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|7|||
27892299|NCT01910402|54545479|FG000|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
27892300|NCT01910402|54545480|FG001|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
27892301|NCT01910402|54545481|FG002|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|8|||
27892302|NCT01910402|54545479|FG000|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
27892303|NCT01910402|54545480|FG001|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
27892304|NCT01910402|54545481|FG002|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|1|||
27892305|NCT01910402|54545479|FG000|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
27892306|NCT01910402|54545480|FG001|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
27892307|NCT01910402|54545481|FG002|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|15|||
27892308|NCT01757535|54545508|FG000|Overall Study|Disease Relapse|143|||
27892309|NCT01757535|54545509|FG001|Overall Study|Disease Relapse|180|||
27892310|NCT01757535|54545508|FG000|Overall Study|Adverse Event|29|||
27892311|NCT01757535|54545509|FG001|Overall Study|Adverse Event|11|||
27892312|NCT01757535|54545508|FG000|Overall Study|Withdrawal by Subject|9|||
27892313|NCT01757535|54545509|FG001|Overall Study|Withdrawal by Subject|13|||
27892314|NCT01757535|54545508|FG000|Overall Study|Miscellaneous|5|||
27892315|NCT01757535|54545509|FG001|Overall Study|Miscellaneous|2|||
27892316|NCT01757535|54545508|FG000|Overall Study|Physician Decision|6|||
27892317|NCT01757535|54545509|FG001|Overall Study|Physician Decision|0|||
27892318|NCT01757535|54545508|FG000|Overall Study|Death|1|||
27892319|NCT01757535|54545509|FG001|Overall Study|Death|2|||
27892320|NCT01614197|54545523|FG000|Overall Study|Withdrawal by Subject|0|||
27892321|NCT01614197|54545524|FG001|Overall Study|Withdrawal by Subject|1|||
27892322|NCT01614197|54545525|FG002|Overall Study|Withdrawal by Subject|0|||
27892323|NCT01614197|54545526|FG003|Overall Study|Withdrawal by Subject|0|||
27892324|NCT01236521|54545560|FG000|Overall Study|Withdrawal by Subject|12|||
27892325|NCT01236521|54545561|FG001|Overall Study|Withdrawal by Subject|17|||
27892326|NCT01236521|54545560|FG000|Overall Study|Death|2|||
27892327|NCT01236521|54545561|FG001|Overall Study|Death|1|||
27892328|NCT01236521|54545560|FG000|Overall Study|Lost to Follow-up|9|||
27892329|NCT01236521|54545561|FG001|Overall Study|Lost to Follow-up|7|||
27892330|NCT01226797|54545569|FG000|Overall Study|Adverse Event|1|||
27892331|NCT01226797|54545570|FG001|Overall Study|Adverse Event|0|||
27892332|NCT01226797|54545569|FG000|Overall Study|No longer willing to participate|1|||
27892333|NCT01226797|54545570|FG001|Overall Study|No longer willing to participate|0|||
27892334|NCT01226797|54545569|FG000|Overall Study|Protocol Violation|0|||
27892335|NCT01226797|54545570|FG001|Overall Study|Protocol Violation|1|||
27892336|NCT01142908|54545578|FG000|Overall Study|Lost to Follow-up|19|||
27892337|NCT01142908|54545579|FG001|Overall Study|Lost to Follow-up|13|||
27892338|NCT01142908|54545578|FG000|Overall Study|Death|1|||
27892339|NCT01142908|54545579|FG001|Overall Study|Death|4|||
27892340|NCT01142908|54545578|FG000|Overall Study|Excluded - did not meet criteria|9|||
27892341|NCT01142908|54545579|FG001|Overall Study|Excluded - did not meet criteria|5|||
27892342|NCT01142908|54545578|FG000|Overall Study|Withdrawal by Subject|3|||
27892343|NCT01142908|54545579|FG001|Overall Study|Withdrawal by Subject|0|||
27892344|NCT01101438|54545587|FG000|Overall Study|Withdrawal by Subject|8|||
27892345|NCT01101438|54545588|FG001|Overall Study|Withdrawal by Subject|9|||
27925758|NCT01229397|54582318|FG001|Overall Study|Withdrawal by Subject|3|||
27925759|NCT01229397|54582317|FG000|Overall Study|Lost to Follow-up|7|||
27925760|NCT01229397|54582318|FG001|Overall Study|Lost to Follow-up|6|||
27925761|NCT01229397|54582317|FG000|Overall Study|Migrated/moved from study area|1|||
27925762|NCT01229397|54582318|FG001|Overall Study|Migrated/moved from study area|0|||
27925763|NCT01228071|54582328|FG000|Overall Study|Protocol Violation|1|||
27925764|NCT01228071|54582328|FG000|Overall Study|Withdrawal by Subject|1|||
27925765|NCT01008475|54582339|FG000|Overall Study|Ongoing treatment at data cut-off date|0|||
27925766|NCT01008475|54582340|FG001|Overall Study|Ongoing treatment at data cut-off date|0|||
27925767|NCT01008475|54582341|FG002|Overall Study|Ongoing treatment at data cut-off date|0|||
27925768|NCT01008475|54582342|FG003|Overall Study|Ongoing treatment at data cut-off date|0|||
27925769|NCT01008475|54582343|FG004|Overall Study|Ongoing treatment at data cut-off date|5|||
27925770|NCT01008475|54582344|FG005|Overall Study|Ongoing treatment at data cut-off date|6|||
27925771|NCT01008475|54582345|FG006|Overall Study|Ongoing treatment at data cut-off date|4|||
27925772|NCT01226745|54582367|FG000|Overall Study|Did not complete schedule of assessments|8|||
28096691|NCT04091360|54751853|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
28096692|NCT04091360|54751854|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
28096693|NCT04091360|54751855|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
27925773|NCT01226745|54582368|FG001|Overall Study|Did not complete schedule of assessments|3|||
27925774|NCT01226745|54582369|FG002|Overall Study|Did not complete schedule of assessments|6|||
27925775|NCT01226745|54582370|FG003|Overall Study|Did not complete schedule of assessments|0|||
27925776|NCT01226745|54582371|FG004|Overall Study|Did not complete schedule of assessments|0|||
27925777|NCT01226745|54582372|FG005|Overall Study|Did not complete schedule of assessments|1|||
27892346|NCT01470326|54545652|FG000|Overall Study|Protocol Violation|32|||
27892347|NCT01470326|54545652|FG000|Overall Study|No Drug Administration Information|2|||
27892348|NCT01470326|54545652|FG000|Overall Study|No Visit After 1st Day of Treatment|119|||
27892349|NCT01480180|54545667|FG000|Main Phase|Withdrawal criteria|12|||
27892350|NCT01480180|54545668|FG001|Main Phase|Withdrawal criteria|1|||
27892351|NCT01480180|54545669|FG002|Main Phase|Withdrawal criteria|0|||
27892352|NCT01480180|54545670|FG003|Main Phase|Withdrawal criteria|0|||
27892353|NCT01480180|54545671|FG004|Main Phase|Withdrawal criteria|0|||
27892354|NCT01480180|54545672|FG005|Main Phase|Withdrawal criteria|0|||
27892355|NCT01480180|54545667|FG000|Main Phase|Lack of Efficacy|1|||
27892356|NCT01480180|54545668|FG001|Main Phase|Lack of Efficacy|0|||
27892357|NCT01480180|54545669|FG002|Main Phase|Lack of Efficacy|0|||
27892358|NCT01480180|54545670|FG003|Main Phase|Lack of Efficacy|0|||
27892359|NCT01480180|54545671|FG004|Main Phase|Lack of Efficacy|0|||
27892360|NCT01480180|54545672|FG005|Main Phase|Lack of Efficacy|0|||
27892361|NCT01480180|54545667|FG000|Main Phase|Non-compliance|3|||
27892362|NCT01480180|54545668|FG001|Main Phase|Non-compliance|0|||
27892363|NCT01480180|54545669|FG002|Main Phase|Non-compliance|0|||
27892364|NCT01480180|54545670|FG003|Main Phase|Non-compliance|0|||
27892365|NCT01480180|54545671|FG004|Main Phase|Non-compliance|0|||
27892366|NCT01480180|54545672|FG005|Main Phase|Non-compliance|0|||
27892367|NCT01480180|54545667|FG000|Main Phase|Unclassified|3|||
27892368|NCT01480180|54545668|FG001|Main Phase|Unclassified|0|||
27892369|NCT01480180|54545669|FG002|Main Phase|Unclassified|0|||
27892370|NCT01480180|54545670|FG003|Main Phase|Unclassified|0|||
27892371|NCT01480180|54545671|FG004|Main Phase|Unclassified|0|||
27892372|NCT01480180|54545672|FG005|Main Phase|Unclassified|0|||
27892373|NCT01480180|54545667|FG000|Extension Phase, Part 1|Withdrawal criteria|0|||
27892374|NCT01480180|54545668|FG001|Extension Phase, Part 1|Withdrawal criteria|0|||
27892375|NCT01480180|54545669|FG002|Extension Phase, Part 1|Withdrawal criteria|5|||
27892376|NCT01480180|54545670|FG003|Extension Phase, Part 1|Withdrawal criteria|0|||
27892377|NCT01480180|54545671|FG004|Extension Phase, Part 1|Withdrawal criteria|0|||
27892378|NCT01480180|54545672|FG005|Extension Phase, Part 1|Withdrawal criteria|0|||
27892379|NCT01480180|54545667|FG000|Extension Phase, Part 1|Unclassified|0|||
27892380|NCT01480180|54545668|FG001|Extension Phase, Part 1|Unclassified|0|||
27892381|NCT01480180|54545669|FG002|Extension Phase, Part 1|Unclassified|1|||
27892382|NCT01480180|54545670|FG003|Extension Phase, Part 1|Unclassified|0|||
27892383|NCT01480180|54545671|FG004|Extension Phase, Part 1|Unclassified|0|||
27892384|NCT01480180|54545672|FG005|Extension Phase, Part 1|Unclassified|0|||
27892385|NCT01480180|54545667|FG000|Extension Phase, Part 1|Adverse Event|0|||
27892386|NCT01480180|54545668|FG001|Extension Phase, Part 1|Adverse Event|0|||
27892387|NCT01480180|54545669|FG002|Extension Phase, Part 1|Adverse Event|4|||
27892388|NCT01480180|54545670|FG003|Extension Phase, Part 1|Adverse Event|1|||
27892389|NCT01480180|54545671|FG004|Extension Phase, Part 1|Adverse Event|0|||
27892390|NCT01480180|54545672|FG005|Extension Phase, Part 1|Adverse Event|0|||
27892391|NCT01480180|54545667|FG000|Extension Phase, Part 1|Change of treatment|0|||
27892392|NCT01480180|54545668|FG001|Extension Phase, Part 1|Change of treatment|0|||
27892393|NCT01480180|54545669|FG002|Extension Phase, Part 1|Change of treatment|0|||
27892394|NCT01480180|54545670|FG003|Extension Phase, Part 1|Change of treatment|9|||
27892395|NCT01480180|54545671|FG004|Extension Phase, Part 1|Change of treatment|0|||
27892396|NCT01480180|54545672|FG005|Extension Phase, Part 1|Change of treatment|0|||
27892397|NCT01480180|54545667|FG000|Extension Phase, Part 2|Withdrawal criteria|0|||
27892398|NCT01480180|54545668|FG001|Extension Phase, Part 2|Withdrawal criteria|0|||
27892399|NCT01480180|54545669|FG002|Extension Phase, Part 2|Withdrawal criteria|10|||
27892400|NCT01480180|54545670|FG003|Extension Phase, Part 2|Withdrawal criteria|6|||
27892401|NCT01480180|54545671|FG004|Extension Phase, Part 2|Withdrawal criteria|1|||
27892402|NCT01480180|54545672|FG005|Extension Phase, Part 2|Withdrawal criteria|0|||
27892403|NCT01480180|54545667|FG000|Extension Phase, Part 2|Lack of Efficacy|0|||
27892404|NCT01480180|54545668|FG001|Extension Phase, Part 2|Lack of Efficacy|0|||
27892405|NCT01480180|54545669|FG002|Extension Phase, Part 2|Lack of Efficacy|4|||
27892406|NCT01480180|54545670|FG003|Extension Phase, Part 2|Lack of Efficacy|0|||
27892407|NCT01480180|54545671|FG004|Extension Phase, Part 2|Lack of Efficacy|0|||
27892408|NCT01480180|54545672|FG005|Extension Phase, Part 2|Lack of Efficacy|0|||
27892409|NCT01480180|54545667|FG000|Extension Phase, Part 2|Unclassified|0|||
27892410|NCT01480180|54545668|FG001|Extension Phase, Part 2|Unclassified|0|||
27892411|NCT01480180|54545669|FG002|Extension Phase, Part 2|Unclassified|3|||
27892412|NCT01480180|54545670|FG003|Extension Phase, Part 2|Unclassified|1|||
27892413|NCT01480180|54545671|FG004|Extension Phase, Part 2|Unclassified|1|||
27892414|NCT01480180|54545672|FG005|Extension Phase, Part 2|Unclassified|0|||
27892415|NCT01545050|54545708|FG000|Overall Study|Lack of Efficacy|0|||
27892416|NCT01545050|54545709|FG001|Overall Study|Lack of Efficacy|0|||
27892417|NCT01545050|54545710|FG002|Overall Study|Lack of Efficacy|0|||
27892418|NCT01545050|54545711|FG003|Overall Study|Lack of Efficacy|3|||
27892419|NCT01545050|54545712|FG004|Overall Study|Lack of Efficacy|2|||
27892420|NCT01545050|54545708|FG000|Overall Study|Adverse Event|1|||
27892421|NCT01545050|54545709|FG001|Overall Study|Adverse Event|1|||
27985611|NCT00545233|54644378|FG000|Overall Study|Physician Decision|2|||
27892422|NCT01545050|54545710|FG002|Overall Study|Adverse Event|2|||
27892423|NCT01545050|54545711|FG003|Overall Study|Adverse Event|2|||
27892424|NCT01545050|54545712|FG004|Overall Study|Adverse Event|0|||
27892425|NCT01545050|54545708|FG000|Overall Study|Discontinued study treatment|1|||
27892426|NCT01545050|54545709|FG001|Overall Study|Discontinued study treatment|0|||
27892427|NCT01545050|54545710|FG002|Overall Study|Discontinued study treatment|0|||
27892428|NCT01545050|54545711|FG003|Overall Study|Discontinued study treatment|0|||
27892429|NCT01545050|54545712|FG004|Overall Study|Discontinued study treatment|0|||
27892430|NCT01545050|54545708|FG000|Overall Study|Withdrawal by Subject|1|||
27892431|NCT01545050|54545709|FG001|Overall Study|Withdrawal by Subject|0|||
27892432|NCT01545050|54545710|FG002|Overall Study|Withdrawal by Subject|0|||
27892433|NCT01545050|54545711|FG003|Overall Study|Withdrawal by Subject|2|||
27892434|NCT01545050|54545712|FG004|Overall Study|Withdrawal by Subject|1|||
27892435|NCT01545050|54545708|FG000|Overall Study|Participant no longer meets study criteria|0|||
27892436|NCT01545050|54545709|FG001|Overall Study|Participant no longer meets study criteria|2|||
27892437|NCT01545050|54545710|FG002|Overall Study|Participant no longer meets study criteria|0|||
27892438|NCT01545050|54545711|FG003|Overall Study|Participant no longer meets study criteria|0|||
27892439|NCT01545050|54545712|FG004|Overall Study|Participant no longer meets study criteria|1|||
27892440|NCT01545050|54545708|FG000|Overall Study|Administrative reason by sponsor|4|||
27892441|NCT01545050|54545709|FG001|Overall Study|Administrative reason by sponsor|2|||
27892442|NCT01545050|54545710|FG002|Overall Study|Administrative reason by sponsor|3|||
27892443|NCT01545050|54545711|FG003|Overall Study|Administrative reason by sponsor|5|||
27892444|NCT01545050|54545712|FG004|Overall Study|Administrative reason by sponsor|5|||
27892445|NCT01555021|54545739|FG000|Overall Study|Lost to Follow-up|1|||
27892446|NCT01555021|54545740|FG001|Overall Study|Lost to Follow-up|2|||
27892447|NCT04721925|54545754|FG000|2-Month Assessment|Lost to Follow-up|5|||
27892448|NCT04721925|54545755|FG001|2-Month Assessment|Lost to Follow-up|3|||
27892449|NCT04721925|54545754|FG000|4-Month Assessment|Lost to Follow-up|3|||
27892450|NCT04721925|54545755|FG001|4-Month Assessment|Lost to Follow-up|6|||
27892451|NCT04710368|54545760|FG000|Overall Study|Withdrawal by Subject|9|||
27892452|NCT04710368|54545760|FG000|Overall Study|Lost to Follow-up|4|||
27892453|NCT04710368|54545760|FG000|Overall Study|Death|2|||
27892454|NCT04710368|54545760|FG000|Overall Study|Patient preference|11|||
27892455|NCT04710368|54545760|FG000|Overall Study|Treatment discontinuation|1|||
27892456|NCT04677660|54545766|FG000|Overall Study|Lost to Follow-up|0|||
27892457|NCT04677660|54545767|FG001|Overall Study|Lost to Follow-up|2|||
27892458|NCT04677660|54545766|FG000|Overall Study|Withdrawal by Subject|0|||
27892459|NCT04677660|54545767|FG001|Overall Study|Withdrawal by Subject|1|||
27892460|NCT04677660|54545766|FG000|Overall Study|Chose Publicly Available Vaccine|43|||
27892461|NCT04677660|54545767|FG001|Overall Study|Chose Publicly Available Vaccine|10|||
27892462|NCT04518995|54545776|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|2|||
27892463|NCT04518995|54545777|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|8|||
27892464|NCT04518995|54545778|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|4|||
27892465|NCT04518995|54545776|FG000|Overall Study|Lack of Efficacy|2|||
27892466|NCT04518995|54545777|FG001|Overall Study|Lack of Efficacy|1|||
27892467|NCT04518995|54545778|FG002|Overall Study|Lack of Efficacy|0|||
27892468|NCT04518995|54545776|FG000|Overall Study|Non-compliance With Study Drug|0|||
27892469|NCT04518995|54545777|FG001|Overall Study|Non-compliance With Study Drug|3|||
27892470|NCT04518995|54545778|FG002|Overall Study|Non-compliance With Study Drug|2|||
27892471|NCT04518995|54545776|FG000|Overall Study|Pregnancy|0|||
27892472|NCT04518995|54545777|FG001|Overall Study|Pregnancy|0|||
27892473|NCT04518995|54545778|FG002|Overall Study|Pregnancy|1|||
27892474|NCT04518995|54545776|FG000|Overall Study|Protocol Violation|2|||
27892475|NCT04518995|54545777|FG001|Overall Study|Protocol Violation|0|||
27892476|NCT04518995|54545778|FG002|Overall Study|Protocol Violation|1|||
27892477|NCT04518995|54545776|FG000|Overall Study|Reason not Specified|4|||
27892478|NCT04518995|54545777|FG001|Overall Study|Reason not Specified|11|||
27892479|NCT04518995|54545778|FG002|Overall Study|Reason not Specified|2|||
27892480|NCT04518995|54545776|FG000|Overall Study|Lost to Follow-up|1|||
27892481|NCT04518995|54545777|FG001|Overall Study|Lost to Follow-up|10|||
27892482|NCT04518995|54545778|FG002|Overall Study|Lost to Follow-up|6|||
27892483|NCT04505722|54545788|FG000|Overall Study|Adverse Event|1|||
27892484|NCT04505722|54545789|FG001|Overall Study|Adverse Event|2|||
27892485|NCT04505722|54545788|FG000|Overall Study|Death|34|||
28171887|NCT02468674|54843506|FG007|Overall Study|Physician Decision|0|||
27892486|NCT04505722|54545789|FG001|Overall Study|Death|63|||
27892487|NCT04505722|54545788|FG000|Overall Study|Lost to Follow-up|271|||
28171888|NCT02468674|54843507|FG008|Overall Study|Physician Decision|0|||
27892488|NCT04505722|54545789|FG001|Overall Study|Lost to Follow-up|333|||
27892489|NCT04505722|54545788|FG000|Overall Study|Physician Decision|17|||
28171889|NCT02468674|54843499|FG000|Overall Study|Patient/Guardian Decision|0|||
27892490|NCT04505722|54545789|FG001|Overall Study|Physician Decision|17|||
27892491|NCT04505722|54545788|FG000|Overall Study|Protocol Violation|0|||
27892492|NCT04505722|54545789|FG001|Overall Study|Protocol Violation|1|||
27892493|NCT04505722|54545788|FG000|Overall Study|Withdrawal by Subject|376|||
28171890|NCT02468674|54843500|FG001|Overall Study|Patient/Guardian Decision|0|||
27892494|NCT04505722|54545789|FG001|Overall Study|Withdrawal by Subject|714|||
27892495|NCT04505722|54545788|FG000|Overall Study|Other|61|||
27892496|NCT04505722|54545789|FG001|Overall Study|Other|98|||
27892497|NCT04505722|54545788|FG000|Overall Study|Still ongoing|21138|||
27892498|NCT04505722|54545789|FG001|Overall Study|Still ongoing|20662|||
27892499|NCT04505722|54545788|FG000|Overall Study|Randomized not vaccinated|276|||
27892500|NCT04505722|54545789|FG001|Overall Study|Randomized not vaccinated|260|||
27892501|NCT04474691|54545795|FG000|Overall Study|Withdrawal by Subject|9|||
27892502|NCT04014075|54545827|FG000|Overall Study|Progressive Disease|48|||
27892503|NCT04014075|54545827|FG000|Overall Study|Adverse Event|11|||
27892504|NCT04014075|54545827|FG000|Overall Study|Clinical Progression|4|||
27892505|NCT04014075|54545827|FG000|Overall Study|Death|2|||
27892506|NCT04014075|54545827|FG000|Overall Study|Withdrawal by Subject|2|||
27892507|NCT04014075|54545827|FG000|Overall Study|Miscellaneous|1|||
27892508|NCT04014075|54545827|FG000|Overall Study|Physician Decision|1|||
27892509|NCT03840174|54545835|FG000|Overall Study|Withdrawal by Subject|1|||
27892510|NCT03840174|54545836|FG001|Overall Study|Withdrawal by Subject|0|||
27892511|NCT03840174|54545837|FG002|Overall Study|Withdrawal by Subject|0|||
27892512|NCT03840174|54545838|FG003|Overall Study|Withdrawal by Subject|0|||
27892513|NCT03786718|54545849|FG000|Overall Study|Lost to Follow-up|3|||
27892514|NCT03786718|54545849|FG000|Overall Study|Withdrawal by Subject|1|||
27892515|NCT03786718|54545849|FG000|Overall Study|Did not use the intervention|2|||
27892516|NCT03786718|54545849|FG000|Overall Study|diagnosis changed from type 2 to type 1|1|||
27892517|NCT03400943|54545882|FG000|Treatment Period 1|Adverse Event|0|||
27892518|NCT03400943|54545883|FG001|Treatment Period 1|Adverse Event|0|||
27892519|NCT03400943|54545884|FG002|Treatment Period 1|Adverse Event|0|||
27892520|NCT03400943|54545885|FG003|Treatment Period 1|Adverse Event|1|||
27892521|NCT03400943|54545882|FG000|Treatment Period 1|Lost to Follow-up|1|||
27892522|NCT03400943|54545883|FG001|Treatment Period 1|Lost to Follow-up|0|||
27892523|NCT03400943|54545884|FG002|Treatment Period 1|Lost to Follow-up|0|||
27892524|NCT03400943|54545885|FG003|Treatment Period 1|Lost to Follow-up|0|||
27892525|NCT03400943|54545882|FG000|Treatment Period 1|Protocol Violation|0|||
27892526|NCT03400943|54545883|FG001|Treatment Period 1|Protocol Violation|1|||
27892527|NCT03400943|54545884|FG002|Treatment Period 1|Protocol Violation|1|||
27892528|NCT03400943|54545885|FG003|Treatment Period 1|Protocol Violation|0|||
27892529|NCT03400943|54545882|FG000|Treatment Period 1|Study terminated by sponsor|2|||
27892530|NCT03400943|54545883|FG001|Treatment Period 1|Study terminated by sponsor|0|||
27892531|NCT03400943|54545884|FG002|Treatment Period 1|Study terminated by sponsor|0|||
27892532|NCT03400943|54545885|FG003|Treatment Period 1|Study terminated by sponsor|1|||
27892533|NCT03400943|54545882|FG000|Treatment Period 1|Withdrawal by Subject|0|||
27892534|NCT03400943|54545883|FG001|Treatment Period 1|Withdrawal by Subject|0|||
27892535|NCT03400943|54545884|FG002|Treatment Period 1|Withdrawal by Subject|3|||
27892536|NCT03400943|54545885|FG003|Treatment Period 1|Withdrawal by Subject|1|||
27892537|NCT03400943|54545882|FG000|Treatment Period 1|Other|2|||
27892538|NCT03400943|54545883|FG001|Treatment Period 1|Other|1|||
27892539|NCT03400943|54545884|FG002|Treatment Period 1|Other|2|||
27892540|NCT03400943|54545885|FG003|Treatment Period 1|Other|2|||
27892541|NCT03400943|54545882|FG000|Post-treatment Period 1|Adverse Event|2|||
27892542|NCT03400943|54545883|FG001|Post-treatment Period 1|Adverse Event|0|||
27892543|NCT03400943|54545884|FG002|Post-treatment Period 1|Adverse Event|0|||
27892544|NCT03400943|54545885|FG003|Post-treatment Period 1|Adverse Event|0|||
27892545|NCT03400943|54545882|FG000|Post-treatment Period 1|Protocol Violation|1|||
27892546|NCT03400943|54545883|FG001|Post-treatment Period 1|Protocol Violation|0|||
27892547|NCT03400943|54545884|FG002|Post-treatment Period 1|Protocol Violation|0|||
27892548|NCT03400943|54545885|FG003|Post-treatment Period 1|Protocol Violation|0|||
27892549|NCT03400943|54545882|FG000|Post-treatment Period 1|Study terminated by sponsor|5|||
27892550|NCT03400943|54545883|FG001|Post-treatment Period 1|Study terminated by sponsor|0|||
27892551|NCT03400943|54545884|FG002|Post-treatment Period 1|Study terminated by sponsor|5|||
27892552|NCT03400943|54545885|FG003|Post-treatment Period 1|Study terminated by sponsor|6|||
27892553|NCT03400943|54545882|FG000|Post-treatment Period 1|Withdrawal by Subject|1|||
27892554|NCT03400943|54545883|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
27892555|NCT03400943|54545884|FG002|Post-treatment Period 1|Withdrawal by Subject|2|||
27892556|NCT03400943|54545885|FG003|Post-treatment Period 1|Withdrawal by Subject|2|||
27892557|NCT03400943|54545882|FG000|Post-treatment Period 1|Other|2|||
27892558|NCT03400943|54545883|FG001|Post-treatment Period 1|Other|0|||
27892559|NCT03400943|54545884|FG002|Post-treatment Period 1|Other|4|||
27892560|NCT03400943|54545885|FG003|Post-treatment Period 1|Other|5|||
27892561|NCT03400943|54545882|FG000|Treatment Period 2|Study terminated by sponsor|0|||
27892562|NCT03400943|54545883|FG001|Treatment Period 2|Study terminated by sponsor|1|||
27892563|NCT03400943|54545884|FG002|Treatment Period 2|Study terminated by sponsor|0|||
28096694|NCT04091360|54751856|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
27892564|NCT03400943|54545885|FG003|Treatment Period 2|Study terminated by sponsor|0|||
27892565|NCT03400943|54545882|FG000|Treatment Period 2|Withdrawal by Subject|0|||
27892566|NCT03400943|54545883|FG001|Treatment Period 2|Withdrawal by Subject|1|||
27892567|NCT03400943|54545884|FG002|Treatment Period 2|Withdrawal by Subject|0|||
27892568|NCT03400943|54545885|FG003|Treatment Period 2|Withdrawal by Subject|0|||
27892569|NCT03400943|54545882|FG000|Treatment Period 2|Other|1|||
27892570|NCT03400943|54545883|FG001|Treatment Period 2|Other|6|||
27892571|NCT03400943|54545884|FG002|Treatment Period 2|Other|0|||
27892572|NCT03400943|54545885|FG003|Treatment Period 2|Other|0|||
27892573|NCT03400943|54545882|FG000|Follow-up Period|Withdrawal by Subject|1|||
27892574|NCT03400943|54545883|FG001|Follow-up Period|Withdrawal by Subject|0|||
27892575|NCT03400943|54545884|FG002|Follow-up Period|Withdrawal by Subject|0|||
27892576|NCT03400943|54545885|FG003|Follow-up Period|Withdrawal by Subject|0|||
27892577|NCT03366103|54545900|FG000|Overall Study|Disease Progression|3|||
27892578|NCT03366103|54545901|FG001|Overall Study|Disease Progression|1|||
27892579|NCT03366103|54545902|FG002|Overall Study|Disease Progression|0|||
27892580|NCT03366103|54545900|FG000|Overall Study|Adverse Event|0|||
27892581|NCT03366103|54545901|FG001|Overall Study|Adverse Event|1|||
27892582|NCT03366103|54545902|FG002|Overall Study|Adverse Event|0|||
27892583|NCT03321526|54545915|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
27892584|NCT03321526|54545916|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
27892585|NCT03321526|54545915|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|9|||
27892586|NCT03321526|54545916|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|3|||
27892587|NCT03321526|54545915|FG000|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|1|||
27892588|NCT03321526|54545916|FG001|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|3|||
27892589|NCT03321526|54545915|FG000|Double-blind Treatment Phase (24 Weeks)|Adverse Event|7|||
27892590|NCT03321526|54545916|FG001|Double-blind Treatment Phase (24 Weeks)|Adverse Event|8|||
27892591|NCT03321526|54545915|FG000|Double-blind Treatment Phase (24 Weeks)|Death|1|||
27892592|NCT03321526|54545916|FG001|Double-blind Treatment Phase (24 Weeks)|Death|0|||
27892593|NCT03321526|54545915|FG000|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|3|||
27892594|NCT03321526|54545916|FG001|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|6|||
27892595|NCT03321526|54545915|FG000|Double-blind Treatment Phase (24 Weeks)|Other|1|||
27892596|NCT03321526|54545916|FG001|Double-blind Treatment Phase (24 Weeks)|Other|4|||
27892597|NCT03321526|54545915|FG000|Follow-up Phase (2 Weeks)|Other|24|||
27892598|NCT03321526|54545916|FG001|Follow-up Phase (2 Weeks)|Other|24|||
27892599|NCT03153111|54545930|FG000|Overall Study|Death|2|||
27892600|NCT03153111|54545931|FG001|Overall Study|Death|5|||
27892601|NCT03153111|54545930|FG000|Overall Study|Lost to Follow-up|1|||
27892602|NCT03153111|54545931|FG001|Overall Study|Lost to Follow-up|0|||
27892603|NCT03153111|54545930|FG000|Overall Study|Physician Decision|5|||
27892604|NCT03153111|54545931|FG001|Overall Study|Physician Decision|1|||
27892605|NCT03153111|54545930|FG000|Overall Study|Withdrawal by Subject|3|||
27892606|NCT03153111|54545931|FG001|Overall Study|Withdrawal by Subject|3|||
27892607|NCT03126435|54545939|FG000|Overall Study|Death|90|||
27892608|NCT03126435|54545940|FG001|Overall Study|Death|84|||
27892609|NCT03126435|54545939|FG000|Overall Study|Lost to Follow-up|4|||
27892610|NCT03126435|54545940|FG001|Overall Study|Lost to Follow-up|3|||
27892611|NCT03126435|54545939|FG000|Overall Study|Physician Decision|0|||
27892612|NCT03126435|54545940|FG001|Overall Study|Physician Decision|1|||
27985612|NCT00545233|54644379|FG001|Overall Study|Physician Decision|1|||
27985613|NCT02393248|54644411|FG000|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
27985614|NCT02393248|54644412|FG001|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
27985615|NCT02393248|54644413|FG002|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
27985616|NCT02393248|54644414|FG003|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
27985617|NCT02393248|54644415|FG004|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
27985618|NCT02393248|54644416|FG005|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
27985619|NCT02393248|54644417|FG006|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
27985620|NCT02393248|54644418|FG007|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
27985621|NCT02393248|54644419|FG008|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
27985622|NCT02393248|54644420|FG009|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
27985623|NCT02393248|54644421|FG010|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
27985624|NCT02393248|54644422|FG011|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
27985625|NCT02393248|54644423|FG012|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
27985626|NCT02393248|54644424|FG013|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
27985627|NCT02393248|54644425|FG014|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
27985628|NCT02393248|54644426|FG015|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
27985629|NCT02393248|54644427|FG016|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
27985630|NCT02393248|54644428|FG017|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
27985631|NCT02393248|54644429|FG018|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
27985632|NCT02393248|54644430|FG019|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
27985633|NCT02393248|54644431|FG020|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
27985634|NCT02393248|54644432|FG021|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
27739400|NCT02738801|54189010|FG001|Overall Study|Adverse Event|1|||
27892613|NCT03126435|54545939|FG000|Overall Study|Withdrawal by Subject|6|||
27892614|NCT03126435|54545940|FG001|Overall Study|Withdrawal by Subject|12|||
27892615|NCT03126435|54545939|FG000|Overall Study|e.g. Sponsor Decision, General Deterioration...|6|||
27892616|NCT03126435|54545940|FG001|Overall Study|e.g. Sponsor Decision, General Deterioration...|4|||
27892617|NCT02823574|54545961|FG000|Randomization|Disease Progression|0|||
27892618|NCT02823574|54545962|FG001|Randomization|Disease Progression|0|||
27892619|NCT02823574|54545963|FG002|Randomization|Disease Progression|1|||
27892620|NCT02823574|54545964|FG003|Randomization|Disease Progression|0|||
27892621|NCT02823574|54545961|FG000|Randomization|AE unrelated to Study Drug|1|||
27892622|NCT02823574|54545962|FG001|Randomization|AE unrelated to Study Drug|0|||
27892623|NCT02823574|54545963|FG002|Randomization|AE unrelated to Study Drug|0|||
27892624|NCT02823574|54545964|FG003|Randomization|AE unrelated to Study Drug|0|||
27892625|NCT02823574|54545961|FG000|Treatment Period|Poor/Non Compliance|1|||
27892626|NCT02823574|54545962|FG001|Treatment Period|Poor/Non Compliance|0|||
27892627|NCT02823574|54545963|FG002|Treatment Period|Poor/Non Compliance|0|||
27892628|NCT02823574|54545964|FG003|Treatment Period|Poor/Non Compliance|1|||
27892629|NCT02823574|54545961|FG000|Treatment Period|Maximum Clinical Benefit|8|||
27892630|NCT02823574|54545962|FG001|Treatment Period|Maximum Clinical Benefit|4|||
27892631|NCT02823574|54545963|FG002|Treatment Period|Maximum Clinical Benefit|7|||
27892632|NCT02823574|54545964|FG003|Treatment Period|Maximum Clinical Benefit|1|||
27892633|NCT02823574|54545961|FG000|Treatment Period|Lost to Follow-up|1|||
27892634|NCT02823574|54545962|FG001|Treatment Period|Lost to Follow-up|1|||
27892635|NCT02823574|54545963|FG002|Treatment Period|Lost to Follow-up|0|||
27892636|NCT02823574|54545964|FG003|Treatment Period|Lost to Follow-up|0|||
27892637|NCT02823574|54545961|FG000|Treatment Period|Participant withdrew consent|4|||
27892638|NCT02823574|54545962|FG001|Treatment Period|Participant withdrew consent|0|||
27892639|NCT02823574|54545963|FG002|Treatment Period|Participant withdrew consent|0|||
27892640|NCT02823574|54545964|FG003|Treatment Period|Participant withdrew consent|1|||
27892641|NCT02823574|54545961|FG000|Treatment Period|Participant request to discontinue|5|||
27892642|NCT02823574|54545962|FG001|Treatment Period|Participant request to discontinue|0|||
27892643|NCT02823574|54545963|FG002|Treatment Period|Participant request to discontinue|3|||
27892644|NCT02823574|54545964|FG003|Treatment Period|Participant request to discontinue|2|||
27892645|NCT02823574|54545961|FG000|Treatment Period|Adverse Event unrelated to to study Drug|10|||
27892646|NCT02823574|54545962|FG001|Treatment Period|Adverse Event unrelated to to study Drug|2|||
27892647|NCT02823574|54545963|FG002|Treatment Period|Adverse Event unrelated to to study Drug|9|||
27892648|NCT02823574|54545964|FG003|Treatment Period|Adverse Event unrelated to to study Drug|2|||
27892649|NCT02823574|54545961|FG000|Treatment Period|Study Drug Toxicity|11|||
27892650|NCT02823574|54545962|FG001|Treatment Period|Study Drug Toxicity|2|||
27892651|NCT02823574|54545963|FG002|Treatment Period|Study Drug Toxicity|14|||
27892652|NCT02823574|54545964|FG003|Treatment Period|Study Drug Toxicity|4|||
27892653|NCT02823574|54545961|FG000|Treatment Period|Disease Progression|113|||
27892654|NCT02823574|54545962|FG001|Treatment Period|Disease Progression|64|||
27892655|NCT02823574|54545963|FG002|Treatment Period|Disease Progression|82|||
27892656|NCT02823574|54545964|FG003|Treatment Period|Disease Progression|43|||
27892657|NCT02823574|54545961|FG000|Treatment Period|Other reasons|5|||
27892658|NCT02823574|54545962|FG001|Treatment Period|Other reasons|9|||
27892659|NCT02823574|54545963|FG002|Treatment Period|Other reasons|3|||
27892660|NCT02823574|54545964|FG003|Treatment Period|Other reasons|6|||
27892661|NCT02823574|54545961|FG000|Treatment Period|Participant no longer meets study criteria|0|||
27892662|NCT02823574|54545962|FG001|Treatment Period|Participant no longer meets study criteria|0|||
27892663|NCT02823574|54545963|FG002|Treatment Period|Participant no longer meets study criteria|1|||
27892664|NCT02823574|54545964|FG003|Treatment Period|Participant no longer meets study criteria|0|||
27892665|NCT02823574|54545961|FG000|Treatment Period|Death|0|||
27892666|NCT02823574|54545962|FG001|Treatment Period|Death|0|||
27892667|NCT02823574|54545963|FG002|Treatment Period|Death|3|||
27892668|NCT02823574|54545964|FG003|Treatment Period|Death|1|||
27892669|NCT02746809|54545977|FG000|Enrollment|Inclusion Exclusion not met|9|||
27892670|NCT02746809|54545977|FG000|Enrollment|Withdrawal by Subject|1|||
27892671|NCT02746809|54545977|FG000|Enrollment|Expected Enrollment Met|2|||
27892672|NCT02746809|54545977|FG000|Procedure|Death|1|||
27892673|NCT02746809|54545977|FG000|1-Month|Death|5|||
27892674|NCT02746809|54545977|FG000|6-Month|Death|2|||
27892675|NCT02746809|54545977|FG000|6-Month|Withdrawal by Subject|1|||
27892676|NCT02746809|54545977|FG000|12-Month|Death|3|||
27892677|NCT02746809|54545977|FG000|12-Month|Withdrawal by Subject|2|||
27892678|NCT02746809|54545977|FG000|24-Month|Death|1|||
27892679|NCT02746809|54545977|FG000|24-Month|Withdrawal by Subject|1|||
27892680|NCT02746809|54545977|FG000|36-Month|Death|8|||
27892681|NCT02746809|54545977|FG000|36-Month|Withdrawal by Subject|1|||
27892682|NCT02746809|54545977|FG000|48-Month|Death|7|||
27892683|NCT02746809|54545977|FG000|48-Month|Withdrawal by Subject|1|||
27892684|NCT02746809|54545977|FG000|60-Month|Death|1|||
27892685|NCT02746809|54545977|FG000|60-Month|Lost to Follow-up|2|||
27892686|NCT02525796|54545986|FG000|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
27892687|NCT02525796|54545987|FG001|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
27892688|NCT02525796|54545988|FG002|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
27892689|NCT02525796|54545986|FG000|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|1|||
27892690|NCT02525796|54545987|FG001|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
27892691|NCT02525796|54545988|FG002|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
27892692|NCT02525796|54545986|FG000|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
27892693|NCT02525796|54545987|FG001|Randomization to Monotherapy for 4 Weeks|Physician Decision|1|||
27892694|NCT02525796|54545988|FG002|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
27892695|NCT02525796|54545986|FG000|Open-label Addition of Cinacalcet|Withdrawal by Subject|2|||
27892696|NCT02525796|54545987|FG001|Open-label Addition of Cinacalcet|Withdrawal by Subject|0|||
27892697|NCT02525796|54545988|FG002|Open-label Addition of Cinacalcet|Withdrawal by Subject|1|||
27892698|NCT02525796|54545986|FG000|Open-label Addition of Cinacalcet|Adverse Event|2|||
27892699|NCT02525796|54545987|FG001|Open-label Addition of Cinacalcet|Adverse Event|2|||
27892700|NCT02525796|54545988|FG002|Open-label Addition of Cinacalcet|Adverse Event|2|||
27892701|NCT02360280|54546004|FG000|Overall Study|Withdrawal by Subject|2|||
27892702|NCT02360280|54546005|FG001|Overall Study|Withdrawal by Subject|0|||
27892703|NCT02360280|54546004|FG000|Overall Study|Adverse Event|0|||
27892704|NCT02360280|54546005|FG001|Overall Study|Adverse Event|1|||
27892705|NCT02360280|54546004|FG000|Overall Study|Lost to Follow-up|1|||
27892706|NCT02360280|54546005|FG001|Overall Study|Lost to Follow-up|0|||
27892707|NCT02201251|54546013|FG000|Overall Study|Adverse Event|1|||
27892708|NCT02201251|54546014|FG001|Overall Study|Adverse Event|1|||
27892709|NCT02201251|54546013|FG000|Overall Study|Protocol Violation|1|||
27892710|NCT02201251|54546014|FG001|Overall Study|Protocol Violation|0|||
27892711|NCT02201251|54546013|FG000|Overall Study|Noncompliance with Study Drug|0|||
27892712|NCT02201251|54546014|FG001|Overall Study|Noncompliance with Study Drug|1|||
27892713|NCT02201251|54546013|FG000|Overall Study|Withdrawal by Subject|2|||
27892714|NCT02201251|54546014|FG001|Overall Study|Withdrawal by Subject|1|||
27892715|NCT02027545|54546022|FG000|Overall Study|Failed to sign HIPAA|0|||
27892716|NCT02027545|54546023|FG001|Overall Study|Failed to sign HIPAA|2|||
27892717|NCT02027545|54546022|FG000|Overall Study|Failed to attend study visit|2|||
27892718|NCT02027545|54546023|FG001|Overall Study|Failed to attend study visit|0|||
27892719|NCT02027545|54546022|FG000|Overall Study|Protocol Violation|1|||
27892720|NCT02027545|54546023|FG001|Overall Study|Protocol Violation|0|||
27892721|NCT01867242|54546053|FG000|Overall Study|Lost to follow-up, personal reasons|24|||
27892722|NCT01867242|54546054|FG001|Overall Study|Lost to follow-up, personal reasons|16|||
27892723|NCT01867242|54546055|FG002|Overall Study|Lost to follow-up, personal reasons|8|||
27892724|NCT01858688|54546063|FG000|Overall Study|Withdrawal by Subject|8|||
27892725|NCT01858688|54546063|FG000|Overall Study|Participant began another therapy|3|||
27892726|NCT01858688|54546063|FG000|Overall Study|Physician Decision|2|||
27892727|NCT01858688|54546063|FG000|Overall Study|Progressive Disease|2|||
27892728|NCT01858688|54546063|FG000|Overall Study|Reason not reproted|5|||
27892729|NCT01599234|54546082|FG000|Overall Study|Adverse Event|9|||
27892730|NCT01599234|54546083|FG001|Overall Study|Adverse Event|5|||
27892731|NCT01599234|54546082|FG000|Overall Study|Withdrawal by Subject|2|||
27892732|NCT01599234|54546083|FG001|Overall Study|Withdrawal by Subject|1|||
27892733|NCT01599234|54546082|FG000|Overall Study|Lost to Follow-up|1|||
27892734|NCT01599234|54546083|FG001|Overall Study|Lost to Follow-up|2|||
27892735|NCT01599234|54546082|FG000|Overall Study|Lack of Efficacy|2|||
27892736|NCT01599234|54546083|FG001|Overall Study|Lack of Efficacy|4|||
27892737|NCT01599234|54546082|FG000|Overall Study|Unable to operate spray|1|||
27892738|NCT01599234|54546083|FG001|Overall Study|Unable to operate spray|0|||
27892739|NCT01599234|54546082|FG000|Overall Study|Sponsor request as creatinine levels <50|0|||
27892740|NCT01599234|54546083|FG001|Overall Study|Sponsor request as creatinine levels <50|1|||
27892741|NCT01599234|54546082|FG000|Overall Study|Death|1|||
27892742|NCT01599234|54546083|FG001|Overall Study|Death|0|||
27892743|NCT01599234|54546082|FG000|Overall Study|Patient would not stop driving|1|||
27892744|NCT01599234|54546083|FG001|Overall Study|Patient would not stop driving|0|||
27892745|NCT01599234|54546082|FG000|Overall Study|Contra-indication discovered|0|||
27892746|NCT01599234|54546083|FG001|Overall Study|Contra-indication discovered|1|||
27892747|NCT01599234|54546082|FG000|Overall Study|Pregnancy|0|||
27892748|NCT01599234|54546083|FG001|Overall Study|Pregnancy|1|||
27892749|NCT01586910|54546091|FG000|Overall Study|Death|4|||
27892750|NCT01586910|54546092|FG001|Overall Study|Death|4|||
28171891|NCT02468674|54843501|FG002|Overall Study|Patient/Guardian Decision|0|||
28171892|NCT02468674|54843502|FG003|Overall Study|Patient/Guardian Decision|0|||
28171893|NCT02468674|54843503|FG004|Overall Study|Patient/Guardian Decision|1|||
28171894|NCT02468674|54843504|FG005|Overall Study|Patient/Guardian Decision|0|||
27892751|NCT01586910|54546091|FG000|Overall Study|Withdrawal by Subject|6|||
27892752|NCT01586910|54546092|FG001|Overall Study|Withdrawal by Subject|43|||
27892753|NCT01586910|54546091|FG000|Overall Study|Physician withdrew Subject|5|||
27892754|NCT01586910|54546092|FG001|Overall Study|Physician withdrew Subject|24|||
27892755|NCT01393301|54546112|FG000|Overall Study|Lost to Follow-up|5|||
27892756|NCT01393301|54546113|FG001|Overall Study|Lost to Follow-up|3|||
27892757|NCT01393301|54546112|FG000|Overall Study|Withdrawal by Subject|2|||
27892758|NCT01393301|54546113|FG001|Overall Study|Withdrawal by Subject|0|||
27892759|NCT01393301|54546112|FG000|Overall Study|Completed <7 sessions (intervention)|2|||
27892760|NCT01393301|54546113|FG001|Overall Study|Completed <7 sessions (intervention)|0|||
28171895|NCT02468674|54843505|FG006|Overall Study|Patient/Guardian Decision|0|||
27892761|NCT01251861|54546121|FG000|Overall Study|Disease progression|6|||
27892762|NCT01251861|54546122|FG001|Overall Study|Disease progression|6|||
27892763|NCT01251861|54546121|FG000|Overall Study|Adverse Event|2|||
27892764|NCT01251861|54546122|FG001|Overall Study|Adverse Event|17|||
27892765|NCT01251861|54546121|FG000|Overall Study|Withdrawal by Subject|2|||
27892766|NCT01251861|54546122|FG001|Overall Study|Withdrawal by Subject|2|||
27892767|NCT01251861|54546121|FG000|Overall Study|Alternative therapy|1|||
27892768|NCT01251861|54546122|FG001|Overall Study|Alternative therapy|0|||
27892769|NCT01251861|54546121|FG000|Overall Study|Other complicating disease|0|||
27892770|NCT01251861|54546122|FG001|Overall Study|Other complicating disease|1|||
27892771|NCT01251861|54546121|FG000|Overall Study|Physician Decision|1|||
27892772|NCT01251861|54546122|FG001|Overall Study|Physician Decision|0|||
27892773|NCT01251861|54546121|FG000|Overall Study|Continued treatment beyond 18 cycles|1|||
27892774|NCT01251861|54546122|FG001|Overall Study|Continued treatment beyond 18 cycles|0|||
27892775|NCT01251861|54546121|FG000|Overall Study|Other|1|||
27892776|NCT01251861|54546122|FG001|Overall Study|Other|0|||
27892777|NCT01251861|54546121|FG000|Overall Study|Never started therapy|4|||
27892778|NCT01251861|54546122|FG001|Overall Study|Never started therapy|1|||
27892779|NCT01251861|54546121|FG000|Overall Study|Potential interaction of drugs|0|||
27892780|NCT01251861|54546122|FG001|Overall Study|Potential interaction of drugs|1|||
27892781|NCT01236560|54546134|FG000|Overall Study|Adverse Event|0|||
27892782|NCT01236560|54546135|FG001|Overall Study|Adverse Event|2|||
27892783|NCT01236560|54546136|FG002|Overall Study|Adverse Event|1|||
27892784|NCT01236560|54546137|FG003|Overall Study|Adverse Event|3|||
27892785|NCT01236560|54546138|FG004|Overall Study|Adverse Event|0|||
27892786|NCT01236560|54546139|FG005|Overall Study|Adverse Event|0|||
27892787|NCT01236560|54546134|FG000|Overall Study|Death|0|||
27892788|NCT01236560|54546135|FG001|Overall Study|Death|1|||
27892789|NCT01236560|54546136|FG002|Overall Study|Death|0|||
27892790|NCT01236560|54546137|FG003|Overall Study|Death|1|||
27892791|NCT01236560|54546138|FG004|Overall Study|Death|0|||
27892792|NCT01236560|54546139|FG005|Overall Study|Death|0|||
27892793|NCT01236560|54546134|FG000|Overall Study|Lost to Follow-up|0|||
27892794|NCT01236560|54546135|FG001|Overall Study|Lost to Follow-up|1|||
27892795|NCT01236560|54546136|FG002|Overall Study|Lost to Follow-up|1|||
27892796|NCT01236560|54546137|FG003|Overall Study|Lost to Follow-up|0|||
27892797|NCT01236560|54546138|FG004|Overall Study|Lost to Follow-up|0|||
27892798|NCT01236560|54546139|FG005|Overall Study|Lost to Follow-up|0|||
27892799|NCT01236560|54546134|FG000|Overall Study|Physician Decision|0|||
27892800|NCT01236560|54546135|FG001|Overall Study|Physician Decision|1|||
27892801|NCT01236560|54546136|FG002|Overall Study|Physician Decision|8|||
27892802|NCT01236560|54546137|FG003|Overall Study|Physician Decision|0|||
27892803|NCT01236560|54546138|FG004|Overall Study|Physician Decision|0|||
27892804|NCT01236560|54546139|FG005|Overall Study|Physician Decision|0|||
27892805|NCT01236560|54546134|FG000|Overall Study|Withdrawal by Subject|0|||
27892806|NCT01236560|54546135|FG001|Overall Study|Withdrawal by Subject|0|||
27892807|NCT01236560|54546136|FG002|Overall Study|Withdrawal by Subject|1|||
27892808|NCT01236560|54546137|FG003|Overall Study|Withdrawal by Subject|2|||
27892809|NCT01236560|54546138|FG004|Overall Study|Withdrawal by Subject|0|||
27892810|NCT01236560|54546139|FG005|Overall Study|Withdrawal by Subject|0|||
27892811|NCT01236560|54546134|FG000|Overall Study|Progressive disease|5|||
27892812|NCT01236560|54546135|FG001|Overall Study|Progressive disease|19|||
27892813|NCT01236560|54546136|FG002|Overall Study|Progressive disease|9|||
27892814|NCT01236560|54546137|FG003|Overall Study|Progressive disease|16|||
27892815|NCT01236560|54546138|FG004|Overall Study|Progressive disease|0|||
27892816|NCT01236560|54546139|FG005|Overall Study|Progressive disease|0|||
27892817|NCT00843882|54546152|FG000|Step 1|Lack of Efficacy|14|||
27892818|NCT00843882|54546153|FG001|Step 1|Lack of Efficacy|10|||
27892819|NCT00843882|54546154|FG002|Step 1|Lack of Efficacy|21|||
27892820|NCT00843882|54546152|FG000|Step 1|Adverse Event|8|||
27892821|NCT00843882|54546153|FG001|Step 1|Adverse Event|17|||
27892822|NCT00843882|54546154|FG002|Step 1|Adverse Event|20|||
27892823|NCT00843882|54546152|FG000|Step 1|Death|1|||
27892824|NCT00843882|54546153|FG001|Step 1|Death|2|||
27892825|NCT00843882|54546154|FG002|Step 1|Death|4|||
27892826|NCT00843882|54546152|FG000|Step 1|Withdrawal by Subject|6|||
27892827|NCT00843882|54546153|FG001|Step 1|Withdrawal by Subject|12|||
27892828|NCT00843882|54546154|FG002|Step 1|Withdrawal by Subject|9|||
27892829|NCT00843882|54546152|FG000|Step 1|Physician Decision|0|||
27892830|NCT00843882|54546153|FG001|Step 1|Physician Decision|5|||
27892831|NCT00843882|54546154|FG002|Step 1|Physician Decision|1|||
27892832|NCT00843882|54546152|FG000|Step 1|Patient and physician's decision|0|||
27892833|NCT00843882|54546153|FG001|Step 1|Patient and physician's decision|0|||
27892834|NCT00843882|54546154|FG002|Step 1|Patient and physician's decision|1|||
27892835|NCT00843882|54546152|FG000|Step 1|Other complicating disease|1|||
27892836|NCT00843882|54546153|FG001|Step 1|Other complicating disease|3|||
27892837|NCT00843882|54546154|FG002|Step 1|Other complicating disease|4|||
27892838|NCT00843882|54546152|FG000|Step 1|Alternative therapy|0|||
27892839|NCT00843882|54546153|FG001|Step 1|Alternative therapy|1|||
27892840|NCT00843882|54546154|FG002|Step 1|Alternative therapy|1|||
27892841|NCT00843882|54546152|FG000|Step 1|Patient switched treatment early due to DSMC announcement|0|||
27892842|NCT00843882|54546153|FG001|Step 1|Patient switched treatment early due to DSMC announcement|4|||
27892843|NCT00843882|54546154|FG002|Step 1|Patient switched treatment early due to DSMC announcement|0|||
27892844|NCT00843882|54546152|FG000|Step 1|Off treatment reason unknown|0|||
27892845|NCT00843882|54546153|FG001|Step 1|Off treatment reason unknown|1|||
27892846|NCT00843882|54546154|FG002|Step 1|Off treatment reason unknown|4|||
27892847|NCT00843882|54546152|FG000|Step 1|Never started treatment|2|||
27892848|NCT00843882|54546153|FG001|Step 1|Never started treatment|0|||
27892849|NCT00843882|54546154|FG002|Step 1|Never started treatment|0|||
27892850|NCT00843882|54546152|FG000|Step 2 (Cross-over to Arm B)|Lack of Efficacy|1|||
27892851|NCT00843882|54546153|FG001|Step 2 (Cross-over to Arm B)|Lack of Efficacy|9|||
27892852|NCT00843882|54546154|FG002|Step 2 (Cross-over to Arm B)|Lack of Efficacy|0|||
27892853|NCT00843882|54546152|FG000|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
27892854|NCT00843882|54546153|FG001|Step 2 (Cross-over to Arm B)|Adverse Event|6|||
27892855|NCT00843882|54546154|FG002|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
27892856|NCT00843882|54546152|FG000|Step 2 (Cross-over to Arm B)|Death|0|||
27892857|NCT00843882|54546153|FG001|Step 2 (Cross-over to Arm B)|Death|3|||
27892858|NCT00843882|54546154|FG002|Step 2 (Cross-over to Arm B)|Death|0|||
27892859|NCT00843882|54546152|FG000|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|2|||
27892860|NCT00843882|54546153|FG001|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|5|||
27892861|NCT00843882|54546154|FG002|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|0|||
27892862|NCT00843882|54546152|FG000|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
27892863|NCT00843882|54546153|FG001|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
27892864|NCT00843882|54546154|FG002|Step 2 (Cross-over to Arm B)|Physician Decision|0|||
27892865|NCT00843882|54546152|FG000|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
27892866|NCT00843882|54546153|FG001|Step 2 (Cross-over to Arm B)|Alternative treatment|1|||
27892867|NCT00843882|54546154|FG002|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
27892868|NCT00843882|54546152|FG000|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
27892869|NCT00843882|54546153|FG001|Step 2 (Cross-over to Arm B)|Prolonged wound healing|1|||
27892870|NCT00843882|54546154|FG002|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
27892871|NCT00716625|54546167|FG000|Overall Study|Safety was not Assessable|1|||
27892872|NCT00713323|54546194|FG000|Overall Study|Adverse Event|75|||
27892873|NCT00713323|54546194|FG000|Overall Study|Withdrawal by Subject|15|||
27892874|NCT00713323|54546194|FG000|Overall Study|Lost to Follow-up|11|||
27892875|NCT00713323|54546194|FG000|Overall Study|Lack of Efficacy|36|||
27892876|NCT00713323|54546194|FG000|Overall Study|Low creatine clearance at screening|1|||
27892877|NCT00713323|54546194|FG000|Overall Study|Withdrawn due to exclusion criteria 11|1|||
27892878|NCT00713323|54546194|FG000|Overall Study|Surgery cured allodynic pain|1|||
27892879|NCT00713323|54546194|FG000|Overall Study|Pain free|1|||
27892880|NCT00713323|54546194|FG000|Overall Study|Non-compliance|1|||
27892881|NCT00713323|54546194|FG000|Overall Study|Pain resolved|1|||
27892882|NCT00713323|54546194|FG000|Overall Study|Subject travelling to USA|1|||
27892883|NCT00713323|54546194|FG000|Overall Study|Subject travelling to Dominica Republic|1|||
27892884|NCT00713323|54546194|FG000|Overall Study|Treatment that may interact with Sativex|1|||
27892885|NCT00710554|54546211|FG000|Overall Study|Adverse Event|24|||
27892886|NCT00710554|54546212|FG001|Overall Study|Adverse Event|7|||
27892887|NCT00710554|54546211|FG000|Overall Study|Withdrawal by Subject|7|||
27892888|NCT00710554|54546212|FG001|Overall Study|Withdrawal by Subject|3|||
27892889|NCT00710554|54546211|FG000|Overall Study|Lost to Follow-up|7|||
27892890|NCT00710554|54546212|FG001|Overall Study|Lost to Follow-up|1|||
27892891|NCT00710554|54546211|FG000|Overall Study|Lack of Efficacy|11|||
27892892|NCT00710554|54546212|FG001|Overall Study|Lack of Efficacy|12|||
27892893|NCT00710554|54546211|FG000|Overall Study|Receiving radiotherapy - prostate cancer|0|||
27892894|NCT00710554|54546212|FG001|Overall Study|Receiving radiotherapy - prostate cancer|1|||
27892895|NCT00710424|54546220|FG000|Overall Study|Adverse Event|30|||
27892896|NCT00710424|54546221|FG001|Overall Study|Adverse Event|12|||
27892897|NCT00710424|54546220|FG000|Overall Study|Lack of Efficacy|4|||
27892898|NCT00710424|54546221|FG001|Overall Study|Lack of Efficacy|5|||
27892899|NCT00710424|54546220|FG000|Overall Study|Withdrawal by Subject|5|||
27892900|NCT00710424|54546221|FG001|Overall Study|Withdrawal by Subject|3|||
27892901|NCT00710424|54546220|FG000|Overall Study|Lost to Follow-up|0|||
27892902|NCT00710424|54546221|FG001|Overall Study|Lost to Follow-up|1|||
27892903|NCT00710424|54546220|FG000|Overall Study|Refused medication, no side effects|1|||
27892904|NCT00710424|54546221|FG001|Overall Study|Refused medication, no side effects|0|||
27892905|NCT00710424|54546220|FG000|Overall Study|Non-compliance with stable analgesia|1|||
27892906|NCT00710424|54546221|FG001|Overall Study|Non-compliance with stable analgesia|0|||
27892907|NCT00710424|54546220|FG000|Overall Study|Did not meet entry criteria at visit 1|1|||
27892908|NCT00710424|54546221|FG001|Overall Study|Did not meet entry criteria at visit 1|0|||
27892909|NCT00710424|54546220|FG000|Overall Study|Subject thought medication changed|1|||
27892910|NCT00710424|54546221|FG001|Overall Study|Subject thought medication changed|0|||
27892911|NCT00710424|54546220|FG000|Overall Study|Ceased treatment due to travel|1|||
27892912|NCT00710424|54546221|FG001|Overall Study|Ceased treatment due to travel|0|||
27892913|NCT00710424|54546220|FG000|Overall Study|Subject preferred paracetamol|0|||
27892914|NCT00710424|54546221|FG001|Overall Study|Subject preferred paracetamol|1|||
27892915|NCT00710424|54546220|FG000|Overall Study|Felt good so stopped treatment|0|||
27892916|NCT00710424|54546221|FG001|Overall Study|Felt good so stopped treatment|1|||
27892917|NCT00118846|54546251|FG000|Overall Study|Gastrointestinal (GI) intolerance|3|||
27892918|NCT00118846|54546252|FG001|Overall Study|Gastrointestinal (GI) intolerance|3|||
27892919|NCT00118846|54546251|FG000|Overall Study|Started menopausal hormone replacement therapy (HRT)|3|||
27892920|NCT00118846|54546252|FG001|Overall Study|Started menopausal hormone replacement therapy (HRT)|0|||
27892921|NCT00118846|54546251|FG000|Overall Study|Physician Decision|1|||
27892922|NCT00118846|54546252|FG001|Overall Study|Physician Decision|0|||
27892923|NCT00118846|54546251|FG000|Overall Study|Medical condition|2|||
27892924|NCT00118846|54546252|FG001|Overall Study|Medical condition|2|||
27892925|NCT00118846|54546251|FG000|Overall Study|Lost to Follow-up|0|||
27892926|NCT00118846|54546252|FG001|Overall Study|Lost to Follow-up|2|||
27892927|NCT00118846|54546251|FG000|Overall Study|Personal reason|4|||
27892928|NCT00118846|54546252|FG001|Overall Study|Personal reason|5|||
27892929|NCT00026312|54546260|FG000|Overall Study|Adverse Event|0|||
27892930|NCT00026312|54546261|FG001|Overall Study|Adverse Event|32|||
27892931|NCT00026312|54546260|FG000|Overall Study|Death|1|||
27892932|NCT00026312|54546261|FG001|Overall Study|Death|7|||
27892933|NCT00026312|54546260|FG000|Overall Study|Lack of Efficacy|19|||
27892934|NCT00026312|54546261|FG001|Overall Study|Lack of Efficacy|114|||
27892935|NCT00026312|54546260|FG000|Overall Study|Lost to Follow-up|0|||
27892936|NCT00026312|54546261|FG001|Overall Study|Lost to Follow-up|5|||
27892937|NCT00026312|54546260|FG000|Overall Study|Physician Decision|1|||
27892938|NCT00026312|54546261|FG001|Overall Study|Physician Decision|37|||
27892939|NCT00026312|54546260|FG000|Overall Study|Protocol Violation|0|||
27892940|NCT00026312|54546261|FG001|Overall Study|Protocol Violation|3|||
27892941|NCT00026312|54546260|FG000|Overall Study|Withdrawal by Subject|1|||
27892942|NCT00026312|54546261|FG001|Overall Study|Withdrawal by Subject|6|||
27892943|NCT00026312|54546260|FG000|Overall Study|Ineligible|4|||
27892944|NCT00026312|54546261|FG001|Overall Study|Ineligible|5|||
27892945|NCT00026312|54546260|FG000|Overall Study|Entry onto another COG study|0|||
27892946|NCT00026312|54546261|FG001|Overall Study|Entry onto another COG study|1|||
27892947|NCT00026312|54546260|FG000|Overall Study|Refusal by patient/parent/guardian|8|||
27892948|NCT00026312|54546261|FG001|Overall Study|Refusal by patient/parent/guardian|59|||
27892949|NCT04705051|54546271|FG000|Overall Study|Enrolled but not treated|1|||
27892950|NCT04705051|54546271|FG000|Overall Study|Study terminated by sponsor|23|||
27892951|NCT04464421|54546278|FG000|Overall Study|Lost to Follow-up|2|||
27892952|NCT04464421|54546279|FG001|Overall Study|Lost to Follow-up|2|||
27892953|NCT04112784|54546297|FG000|Overall Study|Did Not Proceed Due to Time Constraints|9|||
28096695|NCT04091360|54751857|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
27892954|NCT04112784|54546297|FG000|Overall Study|Screen Failures|4|||
27892955|NCT04049617|54546307|FG000|Overall Study|Adverse Event|0|||
27892956|NCT04049617|54546308|FG001|Overall Study|Adverse Event|0|||
27892957|NCT04049617|54546309|FG002|Overall Study|Adverse Event|0|||
27892958|NCT04049617|54546310|FG003|Overall Study|Adverse Event|1|||
27892959|NCT04049617|54546311|FG004|Overall Study|Adverse Event|0|||
27892960|NCT04049617|54546312|FG005|Overall Study|Adverse Event|0|||
27892961|NCT04049617|54546307|FG000|Overall Study|Death|0|||
27892962|NCT04049617|54546308|FG001|Overall Study|Death|0|||
27892963|NCT04049617|54546309|FG002|Overall Study|Death|0|||
27892964|NCT04049617|54546310|FG003|Overall Study|Death|0|||
27892965|NCT04049617|54546311|FG004|Overall Study|Death|0|||
27892966|NCT04049617|54546312|FG005|Overall Study|Death|1|||
27892967|NCT04049617|54546307|FG000|Overall Study|Lost to Follow-up|0|||
27892968|NCT04049617|54546308|FG001|Overall Study|Lost to Follow-up|0|||
27892969|NCT04049617|54546309|FG002|Overall Study|Lost to Follow-up|0|||
27892970|NCT04049617|54546310|FG003|Overall Study|Lost to Follow-up|1|||
28096696|NCT04091360|54751858|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
28096697|NCT04091360|54751859|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
27892971|NCT04049617|54546311|FG004|Overall Study|Lost to Follow-up|0|||
27892972|NCT04049617|54546312|FG005|Overall Study|Lost to Follow-up|0|||
27892973|NCT04049617|54546307|FG000|Overall Study|Withdrew consent|0|||
27892974|NCT04049617|54546308|FG001|Overall Study|Withdrew consent|0|||
27985635|NCT02393248|54644433|FG022|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
27892975|NCT04049617|54546309|FG002|Overall Study|Withdrew consent|1|||
27892976|NCT04049617|54546310|FG003|Overall Study|Withdrew consent|0|||
27892977|NCT04049617|54546311|FG004|Overall Study|Withdrew consent|0|||
27892978|NCT04049617|54546312|FG005|Overall Study|Withdrew consent|0|||
27892979|NCT03911154|54546328|FG000|Overall Study|Withdrawal by Subject|1|||
27892980|NCT03781778|54546346|FG000|Overall Study|Withdrawal by Subject|2|||
27892981|NCT03781778|54546347|FG001|Overall Study|Withdrawal by Subject|2|||
27985636|NCT02393248|54644434|FG023|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
27892982|NCT03710590|54546355|FG000|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|10|||
27892983|NCT03710590|54546356|FG001|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|8|||
27892984|NCT03470922|54546408|FG000|Overall Study|Death|107|||
27892985|NCT03470922|54546409|FG001|Overall Study|Death|118|||
27892986|NCT03470922|54546408|FG000|Overall Study|Lost to Follow-up|5|||
27892987|NCT03470922|54546409|FG001|Overall Study|Lost to Follow-up|5|||
27892988|NCT03470922|54546408|FG000|Overall Study|Participant Withdrew Consent|4|||
27892989|NCT03470922|54546409|FG001|Overall Study|Participant Withdrew Consent|9|||
27892990|NCT03470922|54546408|FG000|Overall Study|Other reasons|1|||
27892991|NCT03470922|54546409|FG001|Overall Study|Other reasons|0|||
27892992|NCT03470922|54546408|FG000|Overall Study|Not reported|1|||
27892993|NCT03470922|54546409|FG001|Overall Study|Not reported|0|||
27892994|NCT03465722|54546417|FG000|Overall Study|Withdrawal by Subject|21|||
27892995|NCT03465722|54546418|FG001|Overall Study|Withdrawal by Subject|14|||
27892996|NCT03465722|54546417|FG000|Overall Study|Death|89|||
27892997|NCT03465722|54546418|FG001|Overall Study|Death|87|||
27892998|NCT03465722|54546417|FG000|Overall Study|Lost to Follow-up|5|||
27892999|NCT03465722|54546418|FG001|Overall Study|Lost to Follow-up|3|||
27893000|NCT03465722|54546417|FG000|Overall Study|Administrative/Other|33|||
27893001|NCT03465722|54546418|FG001|Overall Study|Administrative/Other|32|||
27893002|NCT03465722|54546417|FG000|Overall Study|Not treated|1|||
27893003|NCT03465722|54546418|FG001|Overall Study|Not treated|2|||
27893004|NCT03465722|54546417|FG000|Overall Study|Sponsor decision|91|||
27893005|NCT03465722|54546418|FG001|Overall Study|Sponsor decision|98|||
27893006|NCT03205423|54546424|FG000|Overall Study|Personal|1|||
27893007|NCT03205423|54546425|FG001|Overall Study|Personal|1|||
27893008|NCT03205423|54546424|FG000|Overall Study|Physician Decision|0|||
27893009|NCT03205423|54546425|FG001|Overall Study|Physician Decision|2|||
27893010|NCT03104400|54546436|FG000|Overall Study|Adverse Event|5|||
27893011|NCT03104400|54546437|FG001|Overall Study|Adverse Event|7|||
27893012|NCT03104400|54546438|FG002|Overall Study|Adverse Event|11|||
27893013|NCT03104400|54546439|FG003|Overall Study|Adverse Event|9|||
27893014|NCT03104400|54546440|FG004|Overall Study|Adverse Event|21|||
27893015|NCT03104400|54546436|FG000|Overall Study|Withdrawal by Subject|17|||
27893016|NCT03104400|54546437|FG001|Overall Study|Withdrawal by Subject|19|||
27893017|NCT03104400|54546438|FG002|Overall Study|Withdrawal by Subject|29|||
27893018|NCT03104400|54546439|FG003|Overall Study|Withdrawal by Subject|25|||
27893019|NCT03104400|54546440|FG004|Overall Study|Withdrawal by Subject|24|||
27893020|NCT03104400|54546436|FG000|Overall Study|Lost to Follow-up|4|||
27893021|NCT03104400|54546437|FG001|Overall Study|Lost to Follow-up|1|||
27893022|NCT03104400|54546438|FG002|Overall Study|Lost to Follow-up|4|||
27893023|NCT03104400|54546439|FG003|Overall Study|Lost to Follow-up|8|||
27893024|NCT03104400|54546440|FG004|Overall Study|Lost to Follow-up|7|||
27893025|NCT03104400|54546436|FG000|Overall Study|Lack of Efficacy|6|||
27893026|NCT03104400|54546437|FG001|Overall Study|Lack of Efficacy|3|||
27893027|NCT03104400|54546438|FG002|Overall Study|Lack of Efficacy|8|||
27893028|NCT03104400|54546439|FG003|Overall Study|Lack of Efficacy|2|||
27893029|NCT03104400|54546440|FG004|Overall Study|Lack of Efficacy|1|||
27893030|NCT03104400|54546436|FG000|Overall Study|COVID Logistical Restrictions|0|||
27893031|NCT03104400|54546437|FG001|Overall Study|COVID Logistical Restrictions|0|||
27893032|NCT03104400|54546438|FG002|Overall Study|COVID Logistical Restrictions|0|||
27893033|NCT03104400|54546439|FG003|Overall Study|COVID Logistical Restrictions|1|||
27893034|NCT03104400|54546440|FG004|Overall Study|COVID Logistical Restrictions|0|||
27893035|NCT03104400|54546436|FG000|Overall Study|Other|2|||
27893036|NCT03104400|54546437|FG001|Overall Study|Other|3|||
27893037|NCT03104400|54546438|FG002|Overall Study|Other|7|||
27893038|NCT03104400|54546439|FG003|Overall Study|Other|6|||
27893039|NCT03104400|54546440|FG004|Overall Study|Other|4|||
27893040|NCT03104400|54546436|FG000|Overall Study|Other|0|||
27893041|NCT03104400|54546437|FG001|Overall Study|Other|1|||
27893042|NCT03104400|54546438|FG002|Overall Study|Other|0|||
27893043|NCT03104400|54546439|FG003|Overall Study|Other|0|||
27893044|NCT03104400|54546440|FG004|Overall Study|Other|0|||
27893045|NCT03104374|54546457|FG000|Overall Study|Adverse Event|7|||
27893046|NCT03104374|54546458|FG001|Overall Study|Adverse Event|6|||
27893047|NCT03104374|54546459|FG002|Overall Study|Adverse Event|12|||
27893048|NCT03104374|54546460|FG003|Overall Study|Adverse Event|15|||
27893049|NCT03104374|54546457|FG000|Overall Study|Withdrawal by Subject|18|||
27893050|NCT03104374|54546458|FG001|Overall Study|Withdrawal by Subject|10|||
27893051|NCT03104374|54546459|FG002|Overall Study|Withdrawal by Subject|10|||
27893052|NCT03104374|54546460|FG003|Overall Study|Withdrawal by Subject|17|||
27893053|NCT03104374|54546457|FG000|Overall Study|Lost to Follow-up|4|||
27893054|NCT03104374|54546458|FG001|Overall Study|Lost to Follow-up|4|||
27893055|NCT03104374|54546459|FG002|Overall Study|Lost to Follow-up|6|||
27893056|NCT03104374|54546460|FG003|Overall Study|Lost to Follow-up|8|||
27893057|NCT03104374|54546457|FG000|Overall Study|Lack of Efficacy|6|||
27893058|NCT03104374|54546458|FG001|Overall Study|Lack of Efficacy|7|||
27893059|NCT03104374|54546459|FG002|Overall Study|Lack of Efficacy|12|||
27893060|NCT03104374|54546460|FG003|Overall Study|Lack of Efficacy|6|||
27893061|NCT03104374|54546457|FG000|Overall Study|Other|2|||
27893062|NCT03104374|54546458|FG001|Overall Study|Other|2|||
27893063|NCT03104374|54546459|FG002|Overall Study|Other|4|||
27893064|NCT03104374|54546460|FG003|Overall Study|Other|7|||
27893065|NCT03073603|54546472|FG000|Overall Study|Noncompliance|3|||
27893066|NCT03073603|54546473|FG001|Overall Study|Noncompliance|1|||
27893067|NCT03073603|54546472|FG000|Overall Study|Adverse Event|5|||
27893068|NCT03073603|54546473|FG001|Overall Study|Adverse Event|3|||
27893069|NCT03073603|54546472|FG000|Overall Study|Physician Decision|1|||
27893070|NCT03073603|54546473|FG001|Overall Study|Physician Decision|2|||
27893071|NCT03073603|54546472|FG000|Overall Study|Required treatment not allowed by protocol|1|||
27893072|NCT03073603|54546473|FG001|Overall Study|Required treatment not allowed by protocol|0|||
27893073|NCT03073603|54546472|FG000|Overall Study|Financial or insurance-related|8|||
27893074|NCT03073603|54546473|FG001|Overall Study|Financial or insurance-related|0|||
27893075|NCT03073603|54546472|FG000|Overall Study|Withdrawal by Subject|0|||
27893076|NCT03073603|54546473|FG001|Overall Study|Withdrawal by Subject|1|||
27893077|NCT03073603|54546472|FG000|Overall Study|Discontinued DMT|4|||
27893078|NCT03073603|54546473|FG001|Overall Study|Discontinued DMT|0|||
27893079|NCT03073603|54546472|FG000|Overall Study|Restarted DMT|0|||
27893080|NCT03073603|54546473|FG001|Overall Study|Restarted DMT|1|||
27893081|NCT03002155|54546485|FG000|Overall Study|Lost to Follow-up|1|||
27893082|NCT03002155|54546486|FG001|Overall Study|Lost to Follow-up|2|||
27893083|NCT03002155|54546485|FG000|Overall Study|Withdrawal by Subject|1|||
27893084|NCT03002155|54546486|FG001|Overall Study|Withdrawal by Subject|0|||
27893085|NCT03002155|54546485|FG000|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
27893086|NCT03002155|54546486|FG001|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
27893087|NCT02918006|54546496|FG000|Allocation and Follow-Up|Lost to Follow-up|1|||
27893088|NCT02918006|54546497|FG001|Allocation and Follow-Up|Lost to Follow-up|2|||
27893089|NCT02918006|54546498|FG002|Allocation and Follow-Up|Lost to Follow-up|1|||
27893090|NCT02918006|54546496|FG000|Allocation and Follow-Up|Withdrawal by Subject|1|||
27893091|NCT02918006|54546497|FG001|Allocation and Follow-Up|Withdrawal by Subject|0|||
27893092|NCT02918006|54546498|FG002|Allocation and Follow-Up|Withdrawal by Subject|0|||
27893093|NCT02918006|54546496|FG000|Vaccination Phase Analysis|Withdrawal by Subject|3|||
27893094|NCT02918006|54546497|FG001|Vaccination Phase Analysis|Withdrawal by Subject|7|||
27893095|NCT02918006|54546498|FG002|Vaccination Phase Analysis|Withdrawal by Subject|2|||
27893096|NCT02918006|54546496|FG000|Vaccination Phase Analysis|Biofire Positive|5|||
27893097|NCT02918006|54546497|FG001|Vaccination Phase Analysis|Biofire Positive|5|||
27893098|NCT02918006|54546498|FG002|Vaccination Phase Analysis|Biofire Positive|0|||
27893099|NCT02918006|54546496|FG000|Vaccination Phase Analysis|Symptoms of Sinusitis|1|||
27893100|NCT02918006|54546497|FG001|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
27893101|NCT02918006|54546498|FG002|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
27893102|NCT02918006|54546496|FG000|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
27893103|NCT02918006|54546497|FG001|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|3|||
27893104|NCT02918006|54546498|FG002|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
27893105|NCT02918006|54546496|FG000|Vaccination Phase Analysis|Seasonal allergies|0|||
27893106|NCT02918006|54546497|FG001|Vaccination Phase Analysis|Seasonal allergies|1|||
27893107|NCT02918006|54546498|FG002|Vaccination Phase Analysis|Seasonal allergies|0|||
27893108|NCT02918006|54546496|FG000|Challenge Phase Analysis|Withdrawal by Subject|0|||
27893109|NCT02918006|54546497|FG001|Challenge Phase Analysis|Withdrawal by Subject|0|||
27893110|NCT02918006|54546498|FG002|Challenge Phase Analysis|Withdrawal by Subject|1|||
27893111|NCT02918006|54546496|FG000|Challenge Phase Analysis|Lost to Follow-up|0|||
27893112|NCT02918006|54546497|FG001|Challenge Phase Analysis|Lost to Follow-up|0|||
27893113|NCT02918006|54546498|FG002|Challenge Phase Analysis|Lost to Follow-up|1|||
27893114|NCT02658487|54546523|FG000|Overall Study|Death|2|||
27893115|NCT02658487|54546523|FG000|Overall Study|Disease progression|10|||
27893116|NCT02658487|54546523|FG000|Overall Study|Alternative therapy|1|||
27893117|NCT02658487|54546523|FG000|Overall Study|Adverse Event|1|||
27893118|NCT02658487|54546523|FG000|Overall Study|Treatment Failure, circulating blasts|1|||
27893119|NCT02658487|54546523|FG000|Overall Study|Refractory AML|1|||
27893120|NCT02179749|54546552|FG000|Overall Study|Adverse Event|0|||
27893121|NCT02179749|54546553|FG001|Overall Study|Adverse Event|0|||
27893122|NCT02179749|54546554|FG002|Overall Study|Adverse Event|1|||
27893123|NCT02179749|54546552|FG000|Overall Study|Withdrawal by Subject|0|||
27893124|NCT02179749|54546553|FG001|Overall Study|Withdrawal by Subject|0|||
27893125|NCT02179749|54546554|FG002|Overall Study|Withdrawal by Subject|1|||
27893126|NCT02075593|54546565|FG000|Overall Study|Withdrawal by Subject|1|||
27893127|NCT00641186|54546598|FG000|Overall Study|Adverse Event|3|||
27893128|NCT01595009|54546604|FG000|Core|Patients completed per protocol|85|||
27893129|NCT01595009|54546605|FG001|Core|Patients completed per protocol|44|||
27893130|NCT01595009|54546606|FG002|Core|Patients completed per protocol|0|||
27893131|NCT01595009|54546607|FG003|Core|Patients completed per protocol|0|||
27893132|NCT01595009|54546604|FG000|Core|Adverse Event|19|||
28171896|NCT02468674|54843506|FG007|Overall Study|Patient/Guardian Decision|2|||
27893133|NCT01595009|54546605|FG001|Core|Adverse Event|23|||
27893134|NCT01595009|54546606|FG002|Core|Adverse Event|0|||
28171897|NCT02468674|54843507|FG008|Overall Study|Patient/Guardian Decision|1|||
28171898|NCT02468674|54843499|FG000|Overall Study|Protocol Deviation|0|||
28171899|NCT02468674|54843500|FG001|Overall Study|Protocol Deviation|0|||
27893135|NCT01595009|54546607|FG003|Core|Adverse Event|0|||
27893136|NCT01595009|54546604|FG000|Core|Disease progression|14|||
27893137|NCT01595009|54546605|FG001|Core|Disease progression|26|||
27893138|NCT01595009|54546606|FG002|Core|Disease progression|0|||
27893139|NCT01595009|54546607|FG003|Core|Disease progression|0|||
27893140|NCT01595009|54546604|FG000|Core|Withdrawal by Subject|4|||
27893141|NCT01595009|54546605|FG001|Core|Withdrawal by Subject|17|||
27893142|NCT01595009|54546606|FG002|Core|Withdrawal by Subject|0|||
27893143|NCT01595009|54546607|FG003|Core|Withdrawal by Subject|0|||
27893144|NCT01595009|54546604|FG000|Core|Death|3|||
27893145|NCT01595009|54546605|FG001|Core|Death|6|||
27893146|NCT01595009|54546606|FG002|Core|Death|0|||
27893147|NCT01595009|54546607|FG003|Core|Death|0|||
27893148|NCT01595009|54546604|FG000|Core|Lost to Follow-up|1|||
27893149|NCT01595009|54546605|FG001|Core|Lost to Follow-up|2|||
27893150|NCT01595009|54546606|FG002|Core|Lost to Follow-up|0|||
27893151|NCT01595009|54546607|FG003|Core|Lost to Follow-up|0|||
27893152|NCT01595009|54546604|FG000|Core|Protocol deviation|0|||
27893153|NCT01595009|54546605|FG001|Core|Protocol deviation|1|||
27893154|NCT01595009|54546606|FG002|Core|Protocol deviation|0|||
27893155|NCT01595009|54546607|FG003|Core|Protocol deviation|0|||
27893156|NCT01595009|54546604|FG000|Core|Administrative problems|0|||
27893157|NCT01595009|54546605|FG001|Core|Administrative problems|1|||
27893158|NCT01595009|54546606|FG002|Core|Administrative problems|0|||
27893159|NCT01595009|54546607|FG003|Core|Administrative problems|0|||
27893160|NCT01595009|54546604|FG000|Extension|Administrative problems|0|||
27893161|NCT01595009|54546605|FG001|Extension|Administrative problems|0|||
27893162|NCT01595009|54546606|FG002|Extension|Administrative problems|0|||
27893163|NCT01595009|54546607|FG003|Extension|Administrative problems|1|||
27893164|NCT01595009|54546604|FG000|Extension|Patients completed per protocol|0|||
27893165|NCT01595009|54546605|FG001|Extension|Patients completed per protocol|0|||
27893166|NCT01595009|54546606|FG002|Extension|Patients completed per protocol|0|||
27893167|NCT01595009|54546607|FG003|Extension|Patients completed per protocol|2|||
27893168|NCT01595009|54546604|FG000|Extension|Disease progression|0|||
27893169|NCT01595009|54546605|FG001|Extension|Disease progression|0|||
27893170|NCT01595009|54546606|FG002|Extension|Disease progression|4|||
27893171|NCT01595009|54546607|FG003|Extension|Disease progression|7|||
27893172|NCT01595009|54546604|FG000|Extension|Adverse Event|0|||
27893173|NCT01595009|54546605|FG001|Extension|Adverse Event|0|||
27893174|NCT01595009|54546606|FG002|Extension|Adverse Event|0|||
27893175|NCT01595009|54546607|FG003|Extension|Adverse Event|1|||
27893176|NCT05553808|54546624|FG000|Overall Study|Death|25|||
27893177|NCT05553808|54546625|FG001|Overall Study|Death|62|||
27893178|NCT05553808|54546624|FG000|Overall Study|Site Closed|6|||
27893179|NCT05553808|54546625|FG001|Overall Study|Site Closed|6|||
27893180|NCT05553808|54546624|FG000|Overall Study|Lost to Follow-up|1|||
27893181|NCT05553808|54546625|FG001|Overall Study|Lost to Follow-up|0|||
27893182|NCT05553808|54546624|FG000|Overall Study|Withdrawal by Subject|3|||
27893183|NCT05553808|54546625|FG001|Overall Study|Withdrawal by Subject|2|||
27893184|NCT04997161|54546641|FG000|Overall Study|Study terminated by sponsor|3|||
27893185|NCT04753216|54546645|FG000|Screening - 1st Response Assessment|Adverse Event|1|||
27893186|NCT04753216|54546645|FG000|Cycle 3 - 2nd Response Assessment|Disease Progression|1|||
27893187|NCT04753216|54546645|FG000|Cycle 5 - 3rd Response Assessment|Withdrawal by Subject|1|||
27893188|NCT04530747|54546678|FG000|Overall Study|Withdrawal by Subject|1|||
27893189|NCT04530747|54546679|FG001|Overall Study|Withdrawal by Subject|0|||
27893190|NCT04493242|54546690|FG000|Overall Study|Death|10|||
27893191|NCT04493242|54546691|FG001|Overall Study|Death|14|||
27893192|NCT04493242|54546692|FG002|Overall Study|Death|16|||
27893193|NCT04493242|54546690|FG000|Overall Study|Lost to Follow-up|1|||
27893194|NCT04493242|54546691|FG001|Overall Study|Lost to Follow-up|1|||
27893195|NCT04493242|54546692|FG002|Overall Study|Lost to Follow-up|0|||
27893196|NCT04493242|54546690|FG000|Overall Study|Withdrawal by Subject|1|||
27893197|NCT04493242|54546691|FG001|Overall Study|Withdrawal by Subject|0|||
27893198|NCT04493242|54546692|FG002|Overall Study|Withdrawal by Subject|0|||
27893199|NCT04493242|54546690|FG000|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
27893200|NCT04493242|54546691|FG001|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
27893201|NCT04493242|54546692|FG002|Overall Study|Subjects Discharged from Hospital Prior to End of Study|0|||
27893202|NCT04493242|54546690|FG000|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
27893203|NCT04493242|54546691|FG001|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|2|||
27893204|NCT04493242|54546692|FG002|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
27893205|NCT04040751|54546713|FG000|Overall Study|Withdrawal by Subject|2|||
27893206|NCT04040751|54546714|FG001|Overall Study|Withdrawal by Subject|0|||
27893207|NCT04040751|54546715|FG002|Overall Study|Withdrawal by Subject|2|||
27893208|NCT04040751|54546716|FG003|Overall Study|Withdrawal by Subject|0|||
27893209|NCT03997916|54546726|FG000|Overall Study|Protocol Violation|35|||
27893210|NCT03596177|54546745|FG000|Single Blind Period|Withdrawal by Subject|1|||
27893211|NCT03596177|54546746|FG001|Single Blind Period|Withdrawal by Subject|1|||
27893212|NCT03596177|54546745|FG000|Single Blind Period|Other|1|||
27893213|NCT03596177|54546746|FG001|Single Blind Period|Other|0|||
27893214|NCT03596177|54546745|FG000|Double Blind Period|Withdrawal by Subject|0|||
27893215|NCT03596177|54546746|FG001|Double Blind Period|Withdrawal by Subject|1|||
27893216|NCT03596177|54546745|FG000|Double Blind Period|Other|0|||
27893217|NCT03596177|54546746|FG001|Double Blind Period|Other|4|||
27893218|NCT03596177|54546745|FG000|Double Blind Period|Death during safety follow-up|0|||
27893219|NCT03596177|54546746|FG001|Double Blind Period|Death during safety follow-up|1|||
27893220|NCT03579459|54546756|FG000|Overall Study|Adverse Event|7|||
27893221|NCT03579459|54546757|FG001|Overall Study|Adverse Event|6|||
27893222|NCT03579459|54546758|FG002|Overall Study|Adverse Event|2|||
27893223|NCT03579459|54546759|FG003|Overall Study|Adverse Event|6|||
27893224|NCT03579459|54546756|FG000|Overall Study|Death|1|||
27893225|NCT03579459|54546757|FG001|Overall Study|Death|0|||
27893226|NCT03579459|54546758|FG002|Overall Study|Death|1|||
27893227|NCT03579459|54546759|FG003|Overall Study|Death|2|||
27893228|NCT03579459|54546756|FG000|Overall Study|Lost to Follow-up|6|||
27893229|NCT03579459|54546757|FG001|Overall Study|Lost to Follow-up|2|||
27893230|NCT03579459|54546758|FG002|Overall Study|Lost to Follow-up|4|||
27893231|NCT03579459|54546759|FG003|Overall Study|Lost to Follow-up|1|||
27893232|NCT03579459|54546756|FG000|Overall Study|Physician Decision|0|||
27893233|NCT03579459|54546757|FG001|Overall Study|Physician Decision|1|||
27893234|NCT03579459|54546758|FG002|Overall Study|Physician Decision|0|||
27893235|NCT03579459|54546759|FG003|Overall Study|Physician Decision|1|||
27893236|NCT03579459|54546756|FG000|Overall Study|Protocol Violation|1|||
27893237|NCT03579459|54546757|FG001|Overall Study|Protocol Violation|2|||
27893238|NCT03579459|54546758|FG002|Overall Study|Protocol Violation|3|||
27893239|NCT03579459|54546759|FG003|Overall Study|Protocol Violation|5|||
27893240|NCT03579459|54546756|FG000|Overall Study|Withdrawal by Subject|12|||
27893241|NCT03579459|54546757|FG001|Overall Study|Withdrawal by Subject|8|||
27893242|NCT03579459|54546758|FG002|Overall Study|Withdrawal by Subject|11|||
27893243|NCT03579459|54546759|FG003|Overall Study|Withdrawal by Subject|8|||
27893244|NCT03579459|54546756|FG000|Overall Study|Medication error without associated adverse event|2|||
27893245|NCT03579459|54546757|FG001|Overall Study|Medication error without associated adverse event|1|||
27893246|NCT03579459|54546758|FG002|Overall Study|Medication error without associated adverse event|1|||
27893247|NCT03579459|54546759|FG003|Overall Study|Medication error without associated adverse event|0|||
27893248|NCT03579459|54546756|FG000|Overall Study|Other|0|||
27893249|NCT03579459|54546757|FG001|Overall Study|Other|1|||
27893250|NCT03579459|54546758|FG002|Overall Study|Other|1|||
27893251|NCT03579459|54546759|FG003|Overall Study|Other|0|||
27893252|NCT03579459|54546756|FG000|Overall Study|Randomized not vaccinated|0|||
27893253|NCT03579459|54546757|FG001|Overall Study|Randomized not vaccinated|2|||
27893254|NCT03579459|54546758|FG002|Overall Study|Randomized not vaccinated|0|||
27893255|NCT03579459|54546759|FG003|Overall Study|Randomized not vaccinated|1|||
27893256|NCT03340766|54546772|FG000|Overall Study|Death|6|||
27893257|NCT03340766|54546773|FG001|Overall Study|Death|6|||
27893258|NCT03340766|54546774|FG002|Overall Study|Death|2|||
27893259|NCT03340766|54546772|FG000|Overall Study|Withdrawal by Subject|2|||
27893260|NCT03340766|54546773|FG001|Overall Study|Withdrawal by Subject|1|||
27893261|NCT03340766|54546774|FG002|Overall Study|Withdrawal by Subject|2|||
27893262|NCT03340766|54546772|FG000|Overall Study|Continuing Study|3|||
27893263|NCT03340766|54546773|FG001|Overall Study|Continuing Study|3|||
27893264|NCT03340766|54546774|FG002|Overall Study|Continuing Study|5|||
27893265|NCT04449276|54546805|FG000|Overall Study|Adverse Event|1|||
27893266|NCT04449276|54546806|FG001|Overall Study|Adverse Event|2|||
27893267|NCT04449276|54546807|FG002|Overall Study|Adverse Event|0|||
27893268|NCT04449276|54546808|FG003|Overall Study|Adverse Event|0|||
27893269|NCT04449276|54546809|FG004|Overall Study|Adverse Event|2|||
27893270|NCT04449276|54546810|FG005|Overall Study|Adverse Event|0|||
27893271|NCT04449276|54546811|FG006|Overall Study|Adverse Event|0|||
27893272|NCT04449276|54546812|FG007|Overall Study|Adverse Event|1|||
27893273|NCT04449276|54546805|FG000|Overall Study|Withdrawal by Subject|2|||
27893274|NCT04449276|54546806|FG001|Overall Study|Withdrawal by Subject|0|||
27893275|NCT04449276|54546807|FG002|Overall Study|Withdrawal by Subject|0|||
27893276|NCT04449276|54546808|FG003|Overall Study|Withdrawal by Subject|1|||
27893277|NCT04449276|54546809|FG004|Overall Study|Withdrawal by Subject|0|||
27893278|NCT04449276|54546810|FG005|Overall Study|Withdrawal by Subject|0|||
27893279|NCT04449276|54546811|FG006|Overall Study|Withdrawal by Subject|0|||
27893280|NCT04449276|54546812|FG007|Overall Study|Withdrawal by Subject|0|||
27893281|NCT04449276|54546805|FG000|Overall Study|Other|0|||
28096698|NCT04091360|54751860|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
28096699|NCT04091360|54751861|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
27893282|NCT04449276|54546806|FG001|Overall Study|Other|2|||
27893283|NCT04449276|54546807|FG002|Overall Study|Other|3|||
27893284|NCT04449276|54546808|FG003|Overall Study|Other|2|||
27893285|NCT04449276|54546809|FG004|Overall Study|Other|0|||
27893286|NCT04449276|54546810|FG005|Overall Study|Other|0|||
27893287|NCT04449276|54546811|FG006|Overall Study|Other|0|||
27893288|NCT04449276|54546812|FG007|Overall Study|Other|1|||
27893289|NCT04391894|54546852|FG000|Overall Study|Adverse Event|1|||
27893290|NCT04391894|54546853|FG001|Overall Study|Adverse Event|1|||
27893291|NCT04391894|54546854|FG002|Overall Study|Adverse Event|1|||
27893292|NCT04391894|54546855|FG003|Overall Study|Adverse Event|1|||
27893293|NCT04391894|54546856|FG004|Overall Study|Adverse Event|1|||
27893294|NCT04391894|54546852|FG000|Overall Study|Lost to Follow-up|1|||
27893295|NCT04391894|54546853|FG001|Overall Study|Lost to Follow-up|0|||
27893296|NCT04391894|54546854|FG002|Overall Study|Lost to Follow-up|0|||
27893297|NCT04391894|54546855|FG003|Overall Study|Lost to Follow-up|0|||
27893298|NCT04391894|54546856|FG004|Overall Study|Lost to Follow-up|0|||
27893299|NCT04391894|54546852|FG000|Overall Study|Protocol Violation|0|||
27893300|NCT04391894|54546853|FG001|Overall Study|Protocol Violation|0|||
27893301|NCT04391894|54546854|FG002|Overall Study|Protocol Violation|0|||
27893302|NCT04391894|54546855|FG003|Overall Study|Protocol Violation|1|||
27893303|NCT04391894|54546856|FG004|Overall Study|Protocol Violation|0|||
27893304|NCT04391894|54546852|FG000|Overall Study|Withdrawal by Subject|2|||
27893305|NCT04391894|54546853|FG001|Overall Study|Withdrawal by Subject|0|||
27893306|NCT04391894|54546854|FG002|Overall Study|Withdrawal by Subject|3|||
27893307|NCT04391894|54546855|FG003|Overall Study|Withdrawal by Subject|0|||
27893308|NCT04391894|54546856|FG004|Overall Study|Withdrawal by Subject|1|||
27893309|NCT04391894|54546852|FG000|Overall Study|Unsatisfactory Therapeutic effect|0|||
27893310|NCT04391894|54546853|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
27893311|NCT04391894|54546854|FG002|Overall Study|Unsatisfactory Therapeutic effect|0|||
27893312|NCT04391894|54546855|FG003|Overall Study|Unsatisfactory Therapeutic effect|0|||
27893313|NCT04391894|54546856|FG004|Overall Study|Unsatisfactory Therapeutic effect|1|||
27893314|NCT04166435|54546872|FG000|Overall Study|2 patients ineligible for response|2|||
27893315|NCT03851705|54546878|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|2|||
27893316|NCT03851705|54546879|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
27893317|NCT03851705|54546880|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
27893318|NCT03851705|54546881|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
27893319|NCT03851705|54546878|FG000|Part 1: Double-Blind Period|Other reason|1|||
27893320|NCT03851705|54546879|FG001|Part 1: Double-Blind Period|Other reason|0|||
27893321|NCT03851705|54546880|FG002|Part 1: Double-Blind Period|Other reason|0|||
27893322|NCT03851705|54546881|FG003|Part 1: Double-Blind Period|Other reason|0|||
27893323|NCT03851705|54546878|FG000|Part 2: Open-Label Period|Other reason|0|||
27893324|NCT03851705|54546879|FG001|Part 2: Open-Label Period|Other reason|0|||
27893325|NCT03851705|54546880|FG002|Part 2: Open-Label Period|Other reason|0|||
27893326|NCT03851705|54546881|FG003|Part 2: Open-Label Period|Other reason|1|||
27893327|NCT03851705|54546878|FG000|Part 2: Open-Label Period|Death|0|||
27893328|NCT03851705|54546879|FG001|Part 2: Open-Label Period|Death|0|||
27893329|NCT03851705|54546880|FG002|Part 2: Open-Label Period|Death|3|||
27893330|NCT03851705|54546881|FG003|Part 2: Open-Label Period|Death|0|||
27893331|NCT03851705|54546878|FG000|Part 2: Open-Label Period|Withdrawal by Subject|0|||
27893332|NCT03851705|54546879|FG001|Part 2: Open-Label Period|Withdrawal by Subject|0|||
27893333|NCT03851705|54546880|FG002|Part 2: Open-Label Period|Withdrawal by Subject|2|||
27893334|NCT03851705|54546881|FG003|Part 2: Open-Label Period|Withdrawal by Subject|0|||
27893335|NCT03824366|54546894|FG000|Overall Study|Death|1|||
27893336|NCT03824366|54546894|FG000|Overall Study|Previously unidentified metal artifact|1|||
27893337|NCT03824366|54546894|FG000|Overall Study|Unable to tolerate lying flat on MR table|1|||
27893338|NCT03824366|54546894|FG000|Overall Study|Withdrawal by Subject|1|||
27893339|NCT03810313|54546900|FG000|Overall Study|Study terminated by sponsor|164|||
27893340|NCT03810313|54546901|FG001|Overall Study|Study terminated by sponsor|159|||
27739401|NCT02738801|54189009|FG000|Overall Study|Withdrawal by Subject|0|||
27893341|NCT03810313|54546900|FG000|Overall Study|Subject decision|10|||
27893342|NCT03810313|54546901|FG001|Overall Study|Subject decision|11|||
27893343|NCT03810313|54546900|FG000|Overall Study|Lost to Follow-up|3|||
27893344|NCT03810313|54546901|FG001|Overall Study|Lost to Follow-up|3|||
27893345|NCT03810313|54546900|FG000|Overall Study|Adverse Event|2|||
27893346|NCT03810313|54546901|FG001|Overall Study|Adverse Event|1|||
27893347|NCT03810313|54546900|FG000|Overall Study|Death|2|||
27893348|NCT03810313|54546901|FG001|Overall Study|Death|1|||
27893349|NCT03810313|54546900|FG000|Overall Study|Physician Decision|0|||
27893350|NCT03810313|54546901|FG001|Overall Study|Physician Decision|1|||
27893351|NCT03802630|54546910|FG000|Overall Study|Study terminated by sponsor|130|||
27893352|NCT03802630|54546911|FG001|Overall Study|Study terminated by sponsor|134|||
27893353|NCT03802630|54546910|FG000|Overall Study|Subject decision|16|||
27893354|NCT03802630|54546911|FG001|Overall Study|Subject decision|9|||
27893355|NCT03802630|54546910|FG000|Overall Study|Adverse Event|3|||
27893356|NCT03802630|54546911|FG001|Overall Study|Adverse Event|1|||
27893357|NCT03802630|54546910|FG000|Overall Study|Lost to Follow-up|2|||
27893358|NCT03802630|54546911|FG001|Overall Study|Lost to Follow-up|2|||
27893359|NCT03802630|54546910|FG000|Overall Study|Physician Decision|2|||
27893360|NCT03802630|54546911|FG001|Overall Study|Physician Decision|0|||
27893361|NCT03802630|54546910|FG000|Overall Study|Death|0|||
27893362|NCT03802630|54546911|FG001|Overall Study|Death|2|||
27893363|NCT03775213|54546920|FG000|Overall Study|Withdrawal by Subject|51|||
27893364|NCT03775213|54546921|FG001|Overall Study|Withdrawal by Subject|53|||
27893365|NCT03775213|54546920|FG000|Overall Study|Incomplete Survey|7|||
27893366|NCT03775213|54546921|FG001|Overall Study|Incomplete Survey|7|||
27893367|NCT03710564|54546929|FG000|Overall Study|Study Terminated by Sponsor|104|||
27893368|NCT03710564|54546930|FG001|Overall Study|Study Terminated by Sponsor|55|||
27893369|NCT03710564|54546929|FG000|Overall Study|Withdrawal by Subject|57|||
27893370|NCT03710564|54546930|FG001|Overall Study|Withdrawal by Subject|25|||
27893371|NCT03710564|54546929|FG000|Overall Study|Death|10|||
27985637|NCT02393248|54644435|FG024|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
27985638|NCT02393248|54644411|FG000|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
27985639|NCT02393248|54644412|FG001|Part 1: Monotherapy Dose Escalation|Disease Progression|1|||
27985640|NCT02393248|54644413|FG002|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
27985641|NCT02393248|54644414|FG003|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
27985642|NCT02393248|54644415|FG004|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
27985643|NCT02393248|54644416|FG005|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
27985644|NCT02393248|54644417|FG006|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
27985645|NCT02393248|54644418|FG007|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
27985646|NCT02393248|54644419|FG008|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
27985647|NCT02393248|54644420|FG009|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
27985648|NCT02393248|54644421|FG010|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
28096700|NCT04091360|54751862|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
28096701|NCT04091360|54751853|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
28096702|NCT04091360|54751854|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
28096703|NCT04091360|54751855|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
28096704|NCT04091360|54751856|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
28096705|NCT04091360|54751857|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
27893372|NCT03710564|54546930|FG001|Overall Study|Death|4|||
27893373|NCT03710564|54546929|FG000|Overall Study|Lost to Follow-up|5|||
27893374|NCT03710564|54546930|FG001|Overall Study|Lost to Follow-up|4|||
27893375|NCT03710564|54546929|FG000|Overall Study|Protocol Violation|3|||
27893376|NCT03710564|54546930|FG001|Overall Study|Protocol Violation|2|||
27893377|NCT03710564|54546929|FG000|Overall Study|Adverse Event|3|||
27893378|NCT03710564|54546930|FG001|Overall Study|Adverse Event|0|||
27893379|NCT03710564|54546929|FG000|Overall Study|Physician Decision|2|||
27893380|NCT03710564|54546930|FG001|Overall Study|Physician Decision|3|||
27893381|NCT03624127|54546940|FG000|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
27893382|NCT03624127|54546941|FG001|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|1|||
27893383|NCT03624127|54546942|FG002|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
27893384|NCT03624127|54546940|FG000|Treatment Week 0 - Week 16|Adverse Event|5|||
27893385|NCT03624127|54546941|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
27893386|NCT03624127|54546942|FG002|Treatment Week 0 - Week 16|Adverse Event|10|||
27893387|NCT03624127|54546940|FG000|Treatment Week 0 - Week 16|Death|0|||
27893388|NCT03624127|54546941|FG001|Treatment Week 0 - Week 16|Death|1|||
27893389|NCT03624127|54546942|FG002|Treatment Week 0 - Week 16|Death|0|||
27893390|NCT03624127|54546940|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|0|||
27893391|NCT03624127|54546941|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
27893392|NCT03624127|54546942|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
27893393|NCT03624127|54546940|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|7|||
27893394|NCT03624127|54546941|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
27893395|NCT03624127|54546942|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|4|||
27893396|NCT03624127|54546940|FG000|Treatment Week 0 - Week 16|Protocol Violation|1|||
27893397|NCT03624127|54546941|FG001|Treatment Week 0 - Week 16|Protocol Violation|1|||
27893398|NCT03624127|54546942|FG002|Treatment Week 0 - Week 16|Protocol Violation|2|||
27893399|NCT03624127|54546940|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|4|||
27893400|NCT03624127|54546941|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
27893401|NCT03624127|54546942|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
27893402|NCT03624127|54546940|FG000|Treatment Week 0 - Week 16|Other reasons|8|||
27893403|NCT03624127|54546941|FG001|Treatment Week 0 - Week 16|Other reasons|5|||
27893404|NCT03624127|54546942|FG002|Treatment Week 0 - Week 16|Other reasons|3|||
27893405|NCT03624127|54546940|FG000|Treatment Week 16 - Week 24|Adverse Event|1|||
27893406|NCT03624127|54546941|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
27893407|NCT03624127|54546942|FG002|Treatment Week 16 - Week 24|Adverse Event|1|||
27893408|NCT03624127|54546940|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|3|||
27893409|NCT03624127|54546941|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
27893410|NCT03624127|54546942|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
27893411|NCT03624127|54546940|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
27893412|NCT03624127|54546941|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
27893413|NCT03624127|54546942|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
27893414|NCT03624127|54546940|FG000|Treatment Week 16 - Week 24|Protocol Violation|1|||
27985649|NCT02393248|54644422|FG011|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
27985650|NCT02393248|54644423|FG012|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
27985651|NCT02393248|54644424|FG013|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
28171900|NCT02468674|54843501|FG002|Overall Study|Protocol Deviation|0|||
27893415|NCT03624127|54546941|FG001|Treatment Week 16 - Week 24|Protocol Violation|0|||
27893416|NCT03624127|54546942|FG002|Treatment Week 16 - Week 24|Protocol Violation|0|||
27893417|NCT03624127|54546940|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
27893418|NCT03624127|54546941|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
27893419|NCT03624127|54546942|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
27893420|NCT03624127|54546940|FG000|Treatment Week 16 - Week 24|Other reasons|3|||
27893421|NCT03624127|54546941|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
27893422|NCT03624127|54546942|FG002|Treatment Week 16 - Week 24|Other reasons|0|||
27893423|NCT03624127|54546940|FG000|Treatment Week 24 - Week 52|Adverse Event|8|||
27893424|NCT03624127|54546941|FG001|Treatment Week 24 - Week 52|Adverse Event|0|||
27893425|NCT03624127|54546942|FG002|Treatment Week 24 - Week 52|Adverse Event|1|||
27893426|NCT03624127|54546940|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|6|||
27893427|NCT03624127|54546941|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
27893428|NCT03624127|54546942|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
27893429|NCT03624127|54546940|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|5|||
27893430|NCT03624127|54546941|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
27893431|NCT03624127|54546942|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|1|||
27893432|NCT03624127|54546940|FG000|Treatment Week 24 - Week 52|Protocol Violation|2|||
27893433|NCT03624127|54546941|FG001|Treatment Week 24 - Week 52|Protocol Violation|0|||
27893434|NCT03624127|54546942|FG002|Treatment Week 24 - Week 52|Protocol Violation|0|||
27893435|NCT03624127|54546940|FG000|Treatment Week 24 - Week 52|Site terminated by sponsor|2|||
27893436|NCT03624127|54546941|FG001|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
27893437|NCT03624127|54546942|FG002|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
27893438|NCT03624127|54546940|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|10|||
27893439|NCT03624127|54546941|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
27893440|NCT03624127|54546942|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
27893441|NCT03624127|54546940|FG000|Treatment Week 24 - Week 52|Other reasons|19|||
27893442|NCT03624127|54546941|FG001|Treatment Week 24 - Week 52|Other reasons|0|||
27893443|NCT03624127|54546942|FG002|Treatment Week 24 - Week 52|Other reasons|2|||
27893444|NCT03616912|54546960|FG000|Overall Study|Adverse Event|17|||
27893445|NCT03616912|54546961|FG001|Overall Study|Adverse Event|21|||
27893446|NCT03616912|54546962|FG002|Overall Study|Adverse Event|9|||
27893447|NCT03616912|54546963|FG003|Overall Study|Adverse Event|0|||
27893448|NCT03616912|54546964|FG004|Overall Study|Adverse Event|0|||
27893449|NCT03616912|54546965|FG005|Overall Study|Adverse Event|0|||
27893450|NCT03616912|54546960|FG000|Overall Study|Death|1|||
27893451|NCT03616912|54546961|FG001|Overall Study|Death|1|||
27893452|NCT03616912|54546962|FG002|Overall Study|Death|0|||
27893453|NCT03616912|54546963|FG003|Overall Study|Death|0|||
27893454|NCT03616912|54546964|FG004|Overall Study|Death|0|||
27893455|NCT03616912|54546965|FG005|Overall Study|Death|0|||
27893456|NCT03616912|54546960|FG000|Overall Study|Lack of Efficacy|13|||
27893457|NCT03616912|54546961|FG001|Overall Study|Lack of Efficacy|6|||
27893458|NCT03616912|54546962|FG002|Overall Study|Lack of Efficacy|8|||
27893459|NCT03616912|54546963|FG003|Overall Study|Lack of Efficacy|4|||
27893460|NCT03616912|54546964|FG004|Overall Study|Lack of Efficacy|5|||
27893461|NCT03616912|54546965|FG005|Overall Study|Lack of Efficacy|1|||
27893462|NCT03616912|54546960|FG000|Overall Study|Lost to Follow-up|1|||
27893463|NCT03616912|54546961|FG001|Overall Study|Lost to Follow-up|2|||
27893464|NCT03616912|54546962|FG002|Overall Study|Lost to Follow-up|3|||
27893465|NCT03616912|54546963|FG003|Overall Study|Lost to Follow-up|0|||
27893466|NCT03616912|54546964|FG004|Overall Study|Lost to Follow-up|0|||
27893467|NCT03616912|54546965|FG005|Overall Study|Lost to Follow-up|0|||
27893468|NCT03616912|54546960|FG000|Overall Study|Due to Epidemic/Pandemic|4|||
27893469|NCT03616912|54546961|FG001|Overall Study|Due to Epidemic/Pandemic|2|||
27893470|NCT03616912|54546962|FG002|Overall Study|Due to Epidemic/Pandemic|5|||
27893471|NCT03616912|54546963|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
27893472|NCT03616912|54546964|FG004|Overall Study|Due to Epidemic/Pandemic|0|||
27893473|NCT03616912|54546965|FG005|Overall Study|Due to Epidemic/Pandemic|0|||
27893474|NCT03616912|54546960|FG000|Overall Study|Withdrawal by Subject|12|||
27893475|NCT03616912|54546961|FG001|Overall Study|Withdrawal by Subject|12|||
27893476|NCT03616912|54546962|FG002|Overall Study|Withdrawal by Subject|15|||
27893477|NCT03616912|54546963|FG003|Overall Study|Withdrawal by Subject|2|||
27893478|NCT03616912|54546964|FG004|Overall Study|Withdrawal by Subject|0|||
27893479|NCT03616912|54546965|FG005|Overall Study|Withdrawal by Subject|2|||
27893480|NCT03616912|54546960|FG000|Overall Study|Study Terminated by Sponsor|0|||
27893481|NCT03616912|54546961|FG001|Overall Study|Study Terminated by Sponsor|0|||
27893482|NCT03616912|54546962|FG002|Overall Study|Study Terminated by Sponsor|0|||
27893483|NCT03616912|54546963|FG003|Overall Study|Study Terminated by Sponsor|10|||
27893484|NCT03616912|54546964|FG004|Overall Study|Study Terminated by Sponsor|9|||
27893485|NCT03616912|54546965|FG005|Overall Study|Study Terminated by Sponsor|11|||
27893486|NCT03616912|54546960|FG000|Overall Study|Protocol Deviation|1|||
27893487|NCT03616912|54546961|FG001|Overall Study|Protocol Deviation|1|||
27893488|NCT03616912|54546962|FG002|Overall Study|Protocol Deviation|0|||
27893489|NCT03616912|54546963|FG003|Overall Study|Protocol Deviation|0|||
27893490|NCT03616912|54546964|FG004|Overall Study|Protocol Deviation|0|||
27893491|NCT03616912|54546965|FG005|Overall Study|Protocol Deviation|0|||
27893492|NCT03616912|54546960|FG000|Overall Study|Pregnancy|1|||
27893493|NCT03616912|54546961|FG001|Overall Study|Pregnancy|0|||
27893494|NCT03616912|54546962|FG002|Overall Study|Pregnancy|4|||
27893495|NCT03616912|54546963|FG003|Overall Study|Pregnancy|0|||
27893496|NCT03616912|54546964|FG004|Overall Study|Pregnancy|0|||
27893497|NCT03616912|54546965|FG005|Overall Study|Pregnancy|0|||
27985652|NCT02393248|54644425|FG014|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
27985653|NCT02393248|54644426|FG015|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
27985654|NCT02393248|54644427|FG016|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
27985655|NCT02393248|54644428|FG017|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
27985656|NCT02393248|54644429|FG018|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
27985657|NCT02393248|54644430|FG019|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
27985658|NCT02393248|54644431|FG020|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
27985659|NCT02393248|54644432|FG021|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
27985660|NCT02393248|54644433|FG022|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
27985661|NCT02393248|54644434|FG023|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
27985662|NCT02393248|54644435|FG024|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
27985663|NCT02393248|54644411|FG000|Part 1: Monotherapy Dose Escalation|Death|2|||
27985664|NCT02393248|54644412|FG001|Part 1: Monotherapy Dose Escalation|Death|2|||
27985665|NCT02393248|54644413|FG002|Part 1: Monotherapy Dose Escalation|Death|3|||
27985666|NCT02393248|54644414|FG003|Part 1: Monotherapy Dose Escalation|Death|6|||
27985667|NCT02393248|54644415|FG004|Part 1: Monotherapy Dose Escalation|Death|6|||
27985668|NCT02393248|54644416|FG005|Part 1: Monotherapy Dose Escalation|Death|6|||
27985669|NCT02393248|54644417|FG006|Part 1: Monotherapy Dose Escalation|Death|5|||
27985670|NCT02393248|54644418|FG007|Part 1: Monotherapy Dose Escalation|Death|8|||
27985671|NCT02393248|54644419|FG008|Part 1: Monotherapy Dose Escalation|Death|4|||
27985672|NCT02393248|54644420|FG009|Part 1: Monotherapy Dose Escalation|Death|2|||
27985673|NCT02393248|54644421|FG010|Part 1: Monotherapy Dose Escalation|Death|0|||
27985674|NCT02393248|54644422|FG011|Part 1: Monotherapy Dose Escalation|Death|0|||
27985675|NCT02393248|54644423|FG012|Part 1: Monotherapy Dose Escalation|Death|0|||
27985676|NCT02393248|54644424|FG013|Part 1: Monotherapy Dose Escalation|Death|0|||
27985677|NCT02393248|54644425|FG014|Part 1: Monotherapy Dose Escalation|Death|0|||
27985678|NCT02393248|54644426|FG015|Part 1: Monotherapy Dose Escalation|Death|0|||
27985679|NCT02393248|54644427|FG016|Part 1: Monotherapy Dose Escalation|Death|0|||
27985680|NCT02393248|54644428|FG017|Part 1: Monotherapy Dose Escalation|Death|0|||
27985681|NCT02393248|54644429|FG018|Part 1: Monotherapy Dose Escalation|Death|0|||
27985682|NCT02393248|54644430|FG019|Part 1: Monotherapy Dose Escalation|Death|0|||
27985683|NCT02393248|54644431|FG020|Part 1: Monotherapy Dose Escalation|Death|0|||
27985684|NCT02393248|54644432|FG021|Part 1: Monotherapy Dose Escalation|Death|0|||
27985685|NCT02393248|54644433|FG022|Part 1: Monotherapy Dose Escalation|Death|0|||
27985686|NCT02393248|54644434|FG023|Part 1: Monotherapy Dose Escalation|Death|0|||
27985687|NCT02393248|54644435|FG024|Part 1: Monotherapy Dose Escalation|Death|0|||
27985688|NCT02393248|54644411|FG000|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|1|||
27985689|NCT02393248|54644412|FG001|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
27985690|NCT02393248|54644413|FG002|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
27985691|NCT02393248|54644414|FG003|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
27985692|NCT02393248|54644415|FG004|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
27985693|NCT02393248|54644416|FG005|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
27985694|NCT02393248|54644417|FG006|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
27985695|NCT02393248|54644418|FG007|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
27985696|NCT02393248|54644419|FG008|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
27985697|NCT02393248|54644420|FG009|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
27985698|NCT02393248|54644421|FG010|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
28096706|NCT04091360|54751858|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
28096707|NCT04091360|54751859|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
28096708|NCT04091360|54751860|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
28096709|NCT04091360|54751861|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
28171901|NCT02468674|54843502|FG003|Overall Study|Protocol Deviation|0|||
27893498|NCT03616912|54546960|FG000|Overall Study|Protocol Violation|1|||
27893499|NCT03616912|54546961|FG001|Overall Study|Protocol Violation|0|||
27985699|NCT02393248|54644422|FG011|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
27985700|NCT02393248|54644423|FG012|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
27985701|NCT02393248|54644424|FG013|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
27985702|NCT02393248|54644425|FG014|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
27985703|NCT02393248|54644426|FG015|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
27985704|NCT02393248|54644427|FG016|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
27985705|NCT02393248|54644428|FG017|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
27985706|NCT02393248|54644429|FG018|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
27985707|NCT02393248|54644430|FG019|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
27985708|NCT02393248|54644431|FG020|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
27893500|NCT03616912|54546962|FG002|Overall Study|Protocol Violation|2|||
27893501|NCT03616912|54546963|FG003|Overall Study|Protocol Violation|0|||
27893502|NCT03616912|54546964|FG004|Overall Study|Protocol Violation|0|||
27893503|NCT03616912|54546965|FG005|Overall Study|Protocol Violation|0|||
27893504|NCT03616912|54546960|FG000|Overall Study|Physician Decision|2|||
27893505|NCT03616912|54546961|FG001|Overall Study|Physician Decision|0|||
27893506|NCT03616912|54546962|FG002|Overall Study|Physician Decision|0|||
27893507|NCT03616912|54546963|FG003|Overall Study|Physician Decision|0|||
27893508|NCT03616912|54546964|FG004|Overall Study|Physician Decision|1|||
27893509|NCT03616912|54546965|FG005|Overall Study|Physician Decision|0|||
27893510|NCT03616912|54546960|FG000|Overall Study|Randomized But Never Treated|0|||
27893511|NCT03616912|54546961|FG001|Overall Study|Randomized But Never Treated|2|||
27893512|NCT03616912|54546962|FG002|Overall Study|Randomized But Never Treated|0|||
27893513|NCT03616912|54546963|FG003|Overall Study|Randomized But Never Treated|0|||
27893514|NCT03616912|54546964|FG004|Overall Study|Randomized But Never Treated|0|||
27893515|NCT03616912|54546965|FG005|Overall Study|Randomized But Never Treated|0|||
27893516|NCT03499899|54546982|FG000|Overall Study|Adverse Event|2|||
27893517|NCT03499899|54546983|FG001|Overall Study|Adverse Event|3|||
27893518|NCT03499899|54546984|FG002|Overall Study|Adverse Event|3|||
27893519|NCT03499899|54546982|FG000|Overall Study|Death|0|||
27893520|NCT03499899|54546983|FG001|Overall Study|Death|0|||
27893521|NCT03499899|54546984|FG002|Overall Study|Death|1|||
27893522|NCT03499899|54546982|FG000|Overall Study|Physician Decision|3|||
27893523|NCT03499899|54546983|FG001|Overall Study|Physician Decision|6|||
27893524|NCT03499899|54546984|FG002|Overall Study|Physician Decision|6|||
27893525|NCT03499899|54546982|FG000|Overall Study|Progressive disease|15|||
27893526|NCT03499899|54546983|FG001|Overall Study|Progressive disease|23|||
27893527|NCT03499899|54546984|FG002|Overall Study|Progressive disease|23|||
27893528|NCT03499899|54546982|FG000|Overall Study|Patient decision|0|||
27893529|NCT03499899|54546983|FG001|Overall Study|Patient decision|1|||
27893530|NCT03499899|54546984|FG002|Overall Study|Patient decision|1|||
27893531|NCT03499899|54546982|FG000|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
27893532|NCT03499899|54546983|FG001|Overall Study|Terminated by sponsor (end of study definition was met)|1|||
27893533|NCT03499899|54546984|FG002|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
27893534|NCT03481634|54547000|FG000|Overall Study|Withdrawal by Subject|16|||
27893535|NCT03481634|54547001|FG001|Overall Study|Withdrawal by Subject|19|||
27893536|NCT03481634|54547002|FG002|Overall Study|Withdrawal by Subject|14|||
27893537|NCT03481634|54547000|FG000|Overall Study|Protocol Violation|1|||
27893538|NCT03481634|54547001|FG001|Overall Study|Protocol Violation|0|||
27893539|NCT03481634|54547002|FG002|Overall Study|Protocol Violation|1|||
27893540|NCT03481634|54547000|FG000|Overall Study|Progressive disease|0|||
27893541|NCT03481634|54547001|FG001|Overall Study|Progressive disease|1|||
27893542|NCT03481634|54547002|FG002|Overall Study|Progressive disease|0|||
27893543|NCT03481634|54547000|FG000|Overall Study|Physician Decision|3|||
27893544|NCT03481634|54547001|FG001|Overall Study|Physician Decision|0|||
27893545|NCT03481634|54547002|FG002|Overall Study|Physician Decision|1|||
27893546|NCT03481634|54547000|FG000|Overall Study|Lost to Follow-up|3|||
27893547|NCT03481634|54547001|FG001|Overall Study|Lost to Follow-up|4|||
27893548|NCT03481634|54547002|FG002|Overall Study|Lost to Follow-up|4|||
27893549|NCT03481634|54547000|FG000|Overall Study|Death|4|||
27985709|NCT02393248|54644432|FG021|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
27985710|NCT02393248|54644433|FG022|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
27985711|NCT02393248|54644434|FG023|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
27985712|NCT02393248|54644435|FG024|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
27985713|NCT02393248|54644411|FG000|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
27985714|NCT02393248|54644412|FG001|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
27985715|NCT02393248|54644413|FG002|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
27985716|NCT02393248|54644414|FG003|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
27985717|NCT02393248|54644415|FG004|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
27985718|NCT02393248|54644416|FG005|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
27985719|NCT02393248|54644417|FG006|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
27985720|NCT02393248|54644418|FG007|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
27985721|NCT02393248|54644419|FG008|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
27985722|NCT02393248|54644420|FG009|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|1|||
27739402|NCT02738801|54189010|FG001|Overall Study|Withdrawal by Subject|1|||
27739403|NCT02230306|54189026|FG000|Overall Study|Did not receive study treatment|1|||
27893550|NCT03481634|54547001|FG001|Overall Study|Death|8|||
27893551|NCT03481634|54547002|FG002|Overall Study|Death|7|||
27893552|NCT03481634|54547000|FG000|Overall Study|Adverse Event|6|||
27893553|NCT03481634|54547001|FG001|Overall Study|Adverse Event|3|||
27893554|NCT03481634|54547002|FG002|Overall Study|Adverse Event|7|||
27893555|NCT03460756|54547015|FG000|Overall Study|Adverse Event|0|||
27893556|NCT03460756|54547016|FG001|Overall Study|Adverse Event|0|||
27893557|NCT03460756|54547017|FG002|Overall Study|Adverse Event|0|||
27893558|NCT03460756|54547018|FG003|Overall Study|Adverse Event|1|||
27893559|NCT03460756|54547015|FG000|Overall Study|Lack of Efficacy|0|||
27893560|NCT03460756|54547016|FG001|Overall Study|Lack of Efficacy|0|||
27893561|NCT03460756|54547017|FG002|Overall Study|Lack of Efficacy|0|||
27893562|NCT03460756|54547018|FG003|Overall Study|Lack of Efficacy|2|||
27893563|NCT03460756|54547015|FG000|Overall Study|Lost to Follow-up|0|||
27893564|NCT03460756|54547016|FG001|Overall Study|Lost to Follow-up|1|||
27893565|NCT03460756|54547017|FG002|Overall Study|Lost to Follow-up|2|||
27893566|NCT03460756|54547018|FG003|Overall Study|Lost to Follow-up|1|||
27893567|NCT03460756|54547015|FG000|Overall Study|Pregnancy|0|||
27893568|NCT03460756|54547016|FG001|Overall Study|Pregnancy|0|||
27893569|NCT03460756|54547017|FG002|Overall Study|Pregnancy|0|||
27893570|NCT03460756|54547018|FG003|Overall Study|Pregnancy|1|||
27893571|NCT03460756|54547015|FG000|Overall Study|Protocol Violation|0|||
27893572|NCT03460756|54547016|FG001|Overall Study|Protocol Violation|0|||
27893573|NCT03460756|54547017|FG002|Overall Study|Protocol Violation|0|||
27893574|NCT03460756|54547018|FG003|Overall Study|Protocol Violation|1|||
27893575|NCT03460756|54547015|FG000|Overall Study|Withdrawal by Subject|0|||
27893576|NCT03460756|54547016|FG001|Overall Study|Withdrawal by Subject|4|||
27893577|NCT03460756|54547017|FG002|Overall Study|Withdrawal by Subject|7|||
27893578|NCT03460756|54547018|FG003|Overall Study|Withdrawal by Subject|3|||
27893579|NCT03373461|54547035|FG000|Part 2|Adverse Event|0|||
27893580|NCT03373461|54547036|FG001|Part 2|Adverse Event|1|||
27893581|NCT03373461|54547037|FG002|Part 2|Adverse Event|0|||
27893582|NCT03373461|54547038|FG003|Part 2|Adverse Event|0|||
27893583|NCT03373461|54547039|FG004|Part 2|Adverse Event|1|||
27893584|NCT03364751|54547090|FG000|Overall Study|Withdrawal by Subject|1|||
27893585|NCT03364751|54547091|FG001|Overall Study|Withdrawal by Subject|0|||
27893586|NCT03364751|54547092|FG002|Overall Study|Withdrawal by Subject|0|||
27893587|NCT03364751|54547093|FG003|Overall Study|Withdrawal by Subject|0|||
27893588|NCT03364751|54547090|FG000|Overall Study|Lost to Follow-up|0|||
27893589|NCT03364751|54547091|FG001|Overall Study|Lost to Follow-up|1|||
27893590|NCT03364751|54547092|FG002|Overall Study|Lost to Follow-up|0|||
27893591|NCT03364751|54547093|FG003|Overall Study|Lost to Follow-up|0|||
27893592|NCT03149003|54547114|FG000|Overall Study|Randomized but not treated|0|||
27893593|NCT03149003|54547115|FG001|Overall Study|Randomized but not treated|1|||
27893594|NCT03149003|54547116|FG002|Overall Study|Randomized but not treated|18|||
27893595|NCT02990806|54547126|FG000|Stage 1 (22 Weeks)|Adverse Event|1|||
27893596|NCT02990806|54547127|FG001|Stage 1 (22 Weeks)|Adverse Event|15|||
27893597|NCT02990806|54547128|FG002|Stage 1 (22 Weeks)|Adverse Event|0|||
27893598|NCT02990806|54547129|FG003|Stage 1 (22 Weeks)|Adverse Event|0|||
27893599|NCT02990806|54547126|FG000|Stage 1 (22 Weeks)|Physician Decision|1|||
27893600|NCT02990806|54547127|FG001|Stage 1 (22 Weeks)|Physician Decision|1|||
27893601|NCT02990806|54547128|FG002|Stage 1 (22 Weeks)|Physician Decision|0|||
27893602|NCT02990806|54547129|FG003|Stage 1 (22 Weeks)|Physician Decision|0|||
27893603|NCT02990806|54547126|FG000|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
27893604|NCT02990806|54547127|FG001|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
27893605|NCT02990806|54547128|FG002|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
27893606|NCT02990806|54547129|FG003|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
27893607|NCT02990806|54547126|FG000|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
27893608|NCT02990806|54547127|FG001|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
27893609|NCT02990806|54547128|FG002|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
27893610|NCT02990806|54547129|FG003|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
27893611|NCT02990806|54547126|FG000|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
27893612|NCT02990806|54547127|FG001|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
27893613|NCT02990806|54547128|FG002|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
27893614|NCT02990806|54547129|FG003|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
27893615|NCT02990806|54547126|FG000|Stage 1 (22 Weeks)|Withdrawal by Subject|4|||
27893616|NCT02990806|54547127|FG001|Stage 1 (22 Weeks)|Withdrawal by Subject|26|||
27893617|NCT02990806|54547128|FG002|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
27893618|NCT02990806|54547129|FG003|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
27893619|NCT02990806|54547126|FG000|Stage 1 (22 Weeks)|Lack of Efficacy|1|||
27893620|NCT02990806|54547127|FG001|Stage 1 (22 Weeks)|Lack of Efficacy|2|||
27893621|NCT02990806|54547128|FG002|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
27893622|NCT02990806|54547129|FG003|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
27893623|NCT02990806|54547126|FG000|Stage 1 (22 Weeks)|Death|0|||
27893624|NCT02990806|54547127|FG001|Stage 1 (22 Weeks)|Death|1|||
27893625|NCT02990806|54547128|FG002|Stage 1 (22 Weeks)|Death|0|||
27893626|NCT02990806|54547129|FG003|Stage 1 (22 Weeks)|Death|0|||
27893627|NCT02990806|54547126|FG000|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
27893628|NCT02990806|54547127|FG001|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|1|||
27893629|NCT02990806|54547128|FG002|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
27893630|NCT02990806|54547129|FG003|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
27893631|NCT02990806|54547126|FG000|Stage 1 (22 Weeks)|Protocol deviation|0|||
27893632|NCT02990806|54547127|FG001|Stage 1 (22 Weeks)|Protocol deviation|1|||
27893633|NCT02990806|54547128|FG002|Stage 1 (22 Weeks)|Protocol deviation|0|||
27893634|NCT02990806|54547129|FG003|Stage 1 (22 Weeks)|Protocol deviation|0|||
27893635|NCT02990806|54547126|FG000|Stage 1 (22 Weeks)|Other|1|||
27893636|NCT02990806|54547127|FG001|Stage 1 (22 Weeks)|Other|3|||
27893637|NCT02990806|54547128|FG002|Stage 1 (22 Weeks)|Other|0|||
27893638|NCT02990806|54547129|FG003|Stage 1 (22 Weeks)|Other|0|||
27893639|NCT02990806|54547126|FG000|Stage 2 (32 Weeks)|Adverse Event|9|||
27893640|NCT02990806|54547127|FG001|Stage 2 (32 Weeks)|Adverse Event|0|||
27893641|NCT02990806|54547128|FG002|Stage 2 (32 Weeks)|Adverse Event|7|||
27893642|NCT02990806|54547129|FG003|Stage 2 (32 Weeks)|Adverse Event|7|||
27893643|NCT02990806|54547126|FG000|Stage 2 (32 Weeks)|Death|1|||
27893644|NCT02990806|54547127|FG001|Stage 2 (32 Weeks)|Death|0|||
27893645|NCT02990806|54547128|FG002|Stage 2 (32 Weeks)|Death|0|||
27893646|NCT02990806|54547129|FG003|Stage 2 (32 Weeks)|Death|0|||
27893647|NCT02990806|54547126|FG000|Stage 2 (32 Weeks)|Physician Decision|3|||
27893648|NCT02990806|54547127|FG001|Stage 2 (32 Weeks)|Physician Decision|0|||
27893649|NCT02990806|54547128|FG002|Stage 2 (32 Weeks)|Physician Decision|1|||
27893650|NCT02990806|54547129|FG003|Stage 2 (32 Weeks)|Physician Decision|0|||
27893651|NCT02990806|54547126|FG000|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
27893652|NCT02990806|54547127|FG001|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
27893653|NCT02990806|54547128|FG002|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
27893654|NCT02990806|54547129|FG003|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
27893655|NCT02990806|54547126|FG000|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
27893656|NCT02990806|54547127|FG001|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|0|||
27893657|NCT02990806|54547128|FG002|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
27893658|NCT02990806|54547129|FG003|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
27893659|NCT02990806|54547126|FG000|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|1|||
27893660|NCT02990806|54547127|FG001|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
27893661|NCT02990806|54547128|FG002|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
27893662|NCT02990806|54547129|FG003|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|2|||
27893663|NCT02990806|54547126|FG000|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
27893664|NCT02990806|54547127|FG001|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
27893665|NCT02990806|54547128|FG002|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|6|||
27893666|NCT02990806|54547129|FG003|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|5|||
27893667|NCT02990806|54547126|FG000|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
27893668|NCT02990806|54547127|FG001|Stage 2 (32 Weeks)|Lost to Follow-up|0|||
27893669|NCT02990806|54547128|FG002|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
27893670|NCT02990806|54547129|FG003|Stage 2 (32 Weeks)|Lost to Follow-up|2|||
27893671|NCT02990806|54547126|FG000|Stage 2 (32 Weeks)|Protocol deviation|2|||
27893672|NCT02990806|54547127|FG001|Stage 2 (32 Weeks)|Protocol deviation|0|||
27893673|NCT02990806|54547128|FG002|Stage 2 (32 Weeks)|Protocol deviation|2|||
27893674|NCT02990806|54547129|FG003|Stage 2 (32 Weeks)|Protocol deviation|3|||
27893675|NCT02990806|54547126|FG000|Stage 2 (32 Weeks)|Withdrawal by Subject|14|||
27893676|NCT02990806|54547127|FG001|Stage 2 (32 Weeks)|Withdrawal by Subject|0|||
27893677|NCT02990806|54547128|FG002|Stage 2 (32 Weeks)|Withdrawal by Subject|4|||
27893678|NCT02990806|54547129|FG003|Stage 2 (32 Weeks)|Withdrawal by Subject|8|||
27893679|NCT02990806|54547126|FG000|Stage 2 (32 Weeks)|Lack of Efficacy|4|||
27893680|NCT02990806|54547127|FG001|Stage 2 (32 Weeks)|Lack of Efficacy|0|||
27893681|NCT02990806|54547128|FG002|Stage 2 (32 Weeks)|Lack of Efficacy|2|||
27893682|NCT02990806|54547129|FG003|Stage 2 (32 Weeks)|Lack of Efficacy|3|||
27893683|NCT02990806|54547126|FG000|Stage 2 (32 Weeks)|Other|3|||
27893684|NCT02990806|54547127|FG001|Stage 2 (32 Weeks)|Other|0|||
27893685|NCT02990806|54547128|FG002|Stage 2 (32 Weeks)|Other|4|||
27893686|NCT02990806|54547129|FG003|Stage 2 (32 Weeks)|Other|1|||
27893687|NCT02990806|54547126|FG000|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
27893688|NCT02990806|54547127|FG001|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
27985723|NCT02393248|54644421|FG010|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
27985724|NCT02393248|54644422|FG011|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
27985725|NCT02393248|54644423|FG012|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
27985726|NCT02393248|54644424|FG013|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
27985727|NCT02393248|54644425|FG014|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
27985728|NCT02393248|54644426|FG015|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
27985729|NCT02393248|54644427|FG016|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
27985730|NCT02393248|54644428|FG017|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
27893689|NCT02990806|54547128|FG002|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
27893690|NCT02990806|54547129|FG003|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|1|||
27893691|NCT02990806|54547126|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|5|||
27893692|NCT02990806|54547127|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|0|||
27893693|NCT02990806|54547128|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|4|||
27893694|NCT02990806|54547129|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|3|||
27985731|NCT02393248|54644429|FG018|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
27893695|NCT02990806|54547126|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
27893696|NCT02990806|54547127|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|0|||
27893697|NCT02990806|54547128|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
27893698|NCT02990806|54547129|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
27893699|NCT02990806|54547126|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
27893700|NCT02990806|54547127|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
27893701|NCT02990806|54547128|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
27893702|NCT02990806|54547129|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
27893703|NCT02990806|54547126|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
27893704|NCT02990806|54547127|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
27893705|NCT02990806|54547128|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
27893706|NCT02990806|54547129|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
27893707|NCT02990806|54547126|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
27893708|NCT02990806|54547127|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
27893709|NCT02990806|54547128|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|2|||
27893710|NCT02990806|54547129|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|1|||
27893711|NCT02990806|54547126|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
27893712|NCT02990806|54547127|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
27893713|NCT02990806|54547128|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|1|||
27893714|NCT02990806|54547129|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
27893715|NCT02990806|54547126|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
27893716|NCT02990806|54547127|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
27893717|NCT02990806|54547128|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
27893718|NCT02990806|54547129|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Other|2|||
27893719|NCT02990806|54547126|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
27893720|NCT02990806|54547127|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
27893721|NCT02990806|54547128|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|1|||
27893722|NCT02990806|54547129|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
27893723|NCT02420821|54547200|FG000|Overall Study|Lost to Follow-up|6|||
27893724|NCT02420821|54547201|FG001|Overall Study|Lost to Follow-up|6|||
27893725|NCT02420821|54547200|FG000|Overall Study|Non-compliance|0|||
27893726|NCT02420821|54547201|FG001|Overall Study|Non-compliance|2|||
27893727|NCT02420821|54547200|FG000|Overall Study|Physician Decision|6|||
27893728|NCT02420821|54547201|FG001|Overall Study|Physician Decision|2|||
27893729|NCT02420821|54547200|FG000|Overall Study|Withdrawal by Subject|32|||
27893730|NCT02420821|54547201|FG001|Overall Study|Withdrawal by Subject|25|||
27893731|NCT02420821|54547200|FG000|Overall Study|Death|270|||
27893732|NCT02420821|54547201|FG001|Overall Study|Death|263|||
27893733|NCT02420821|54547200|FG000|Overall Study|Study Terminated By Sponsor|145|||
27893734|NCT02420821|54547201|FG001|Overall Study|Study Terminated By Sponsor|149|||
27893735|NCT02420821|54547200|FG000|Overall Study|Patient refused end of treatment visit due to Covid-19|0|||
27893736|NCT02420821|54547201|FG001|Overall Study|Patient refused end of treatment visit due to Covid-19|1|||
27893737|NCT02420821|54547200|FG000|Overall Study|Adverse Event|0|||
27893738|NCT02420821|54547201|FG001|Overall Study|Adverse Event|1|||
27893739|NCT02420821|54547200|FG000|Overall Study|Protinuria|0|||
27893740|NCT02420821|54547201|FG001|Overall Study|Protinuria|1|||
27893741|NCT02420821|54547200|FG000|Overall Study|Progressive Disease|1|||
27893742|NCT02420821|54547201|FG001|Overall Study|Progressive Disease|1|||
27893743|NCT02420821|54547200|FG000|Overall Study|Disease Progression|0|||
27893744|NCT02420821|54547201|FG001|Overall Study|Disease Progression|1|||
27893745|NCT02420821|54547200|FG000|Overall Study|Patient missing record of discontinuation from Atezo.|0|||
27893746|NCT02420821|54547201|FG001|Overall Study|Patient missing record of discontinuation from Atezo.|1|||
27893747|NCT02039063|54547232|FG000|Treatment Phase|Inadequate therapeutic effect|3|||
27893748|NCT02039063|54547233|FG001|Treatment Phase|Inadequate therapeutic effect|2|||
27893749|NCT02039063|54547234|FG002|Treatment Phase|Inadequate therapeutic effect|1|||
27893750|NCT02039063|54547235|FG003|Treatment Phase|Inadequate therapeutic effect|1|||
27893751|NCT02039063|54547232|FG000|Treatment Phase|Progression of disease|0|||
27893752|NCT02039063|54547233|FG001|Treatment Phase|Progression of disease|0|||
27893753|NCT02039063|54547234|FG002|Treatment Phase|Progression of disease|1|||
27893754|NCT02039063|54547235|FG003|Treatment Phase|Progression of disease|1|||
27893755|NCT02039063|54547232|FG000|Extension Phase|Inadequate therapeutic effect|0|||
27893756|NCT02039063|54547233|FG001|Extension Phase|Inadequate therapeutic effect|1|||
27893757|NCT02039063|54547234|FG002|Extension Phase|Inadequate therapeutic effect|2|||
27893758|NCT02039063|54547235|FG003|Extension Phase|Inadequate therapeutic effect|0|||
27893759|NCT02039063|54547232|FG000|Extension Phase|Progression of disease|0|||
27893760|NCT02039063|54547233|FG001|Extension Phase|Progression of disease|0|||
27893761|NCT02039063|54547234|FG002|Extension Phase|Progression of disease|0|||
27893762|NCT02039063|54547235|FG003|Extension Phase|Progression of disease|1|||
27893763|NCT02039063|54547232|FG000|Extension Phase|Adverse Event|0|||
27893764|NCT02039063|54547233|FG001|Extension Phase|Adverse Event|0|||
27893765|NCT02039063|54547234|FG002|Extension Phase|Adverse Event|1|||
27893766|NCT02039063|54547235|FG003|Extension Phase|Adverse Event|0|||
27893767|NCT01746173|54547256|FG000|Overall Study|Disease Progression|2|||
27893768|NCT02995733|54547296|FG000|Overall Study|Study site closed|9|||
27893769|NCT02995733|54547297|FG001|Overall Study|Study site closed|10|||
27893770|NCT02995733|54547296|FG000|Overall Study|Death|3|||
27893771|NCT02995733|54547297|FG001|Overall Study|Death|4|||
27893772|NCT02995733|54547296|FG000|Overall Study|Withdrawal by Subject|6|||
27893773|NCT02995733|54547297|FG001|Overall Study|Withdrawal by Subject|2|||
27893774|NCT02995733|54547296|FG000|Overall Study|Removed by study team due to inappropriate behavior|1|||
27893775|NCT02995733|54547297|FG001|Overall Study|Removed by study team due to inappropriate behavior|0|||
27893776|NCT02995733|54547296|FG000|Overall Study|Lost to Follow-up|48|||
27893777|NCT02995733|54547297|FG001|Overall Study|Lost to Follow-up|37|||
27893778|NCT02995733|54547296|FG000|Overall Study|Other|0|||
27893779|NCT02995733|54547297|FG001|Overall Study|Other|1|||
27893780|NCT02815566|54547314|FG000|Overall Study|Adverse Event|1|||
27893781|NCT02815566|54547315|FG001|Overall Study|Adverse Event|1|||
27893782|NCT02815566|54547314|FG000|Overall Study|Withdrawal by Subject|1|||
27893783|NCT02815566|54547315|FG001|Overall Study|Withdrawal by Subject|0|||
27893784|NCT02815566|54547314|FG000|Overall Study|Lost to Follow-up|0|||
27893785|NCT02815566|54547315|FG001|Overall Study|Lost to Follow-up|1|||
27893786|NCT02525783|54547322|FG000|Overall Study|Lost to Follow-up|10|||
27893787|NCT02466243|54547338|FG000|Part B Open-label Treatment Period|Adverse Event|1|||
27893788|NCT02466243|54547339|FG001|Part B Open-label Treatment Period|Adverse Event|0|||
27893789|NCT02466243|54547338|FG000|Part B Open-label Treatment Period|Withdrawal by Subject|0|||
27893790|NCT02466243|54547339|FG001|Part B Open-label Treatment Period|Withdrawal by Subject|2|||
27893791|NCT02466243|54547338|FG000|Part B Open-label Treatment Period|Sponsor Decision|8|||
27893792|NCT02466243|54547339|FG001|Part B Open-label Treatment Period|Sponsor Decision|6|||
27893793|NCT02466243|54547338|FG000|Part B Open-label Treatment Period|Missing|2|||
27893794|NCT02466243|54547339|FG001|Part B Open-label Treatment Period|Missing|2|||
27893795|NCT02321098|54547352|FG000|12 Weeks Treament|Lost to Follow-up|1|||
27893796|NCT02321098|54547353|FG001|12 Weeks Treament|Lost to Follow-up|1|||
27893797|NCT02321098|54547354|FG002|12 Weeks Treament|Lost to Follow-up|0|||
27893798|NCT02321098|54547352|FG000|Additional 15 Months Treatment|Lack of Efficacy|0|||
27893799|NCT02321098|54547353|FG001|Additional 15 Months Treatment|Lack of Efficacy|0|||
27893800|NCT02321098|54547354|FG002|Additional 15 Months Treatment|Lack of Efficacy|6|||
27893801|NCT02321098|54547352|FG000|Additional 15 Months Treatment|Lost to Follow-up|0|||
27893802|NCT02321098|54547353|FG001|Additional 15 Months Treatment|Lost to Follow-up|0|||
27893803|NCT02321098|54547354|FG002|Additional 15 Months Treatment|Lost to Follow-up|1|||
27893804|NCT02321098|54547352|FG000|Additional 15 Months Treatment|Withdrawal by Subject|0|||
27893805|NCT02321098|54547353|FG001|Additional 15 Months Treatment|Withdrawal by Subject|0|||
27893806|NCT02321098|54547354|FG002|Additional 15 Months Treatment|Withdrawal by Subject|1|||
27893807|NCT01966731|54547363|FG000|Overall Study|Death|2|||
27893808|NCT01966731|54547363|FG000|Overall Study|Lost to Follow-up|1|||
27893809|NCT01966731|54547363|FG000|Overall Study|Physician Decision|2|||
27893810|NCT01966731|54547363|FG000|Overall Study|Follow up is not complete|600|||
27893811|NCT01966731|54547363|FG000|Overall Study|Screening Failure|29|||
27893812|NCT01966731|54547363|FG000|Overall Study|Found to be ineligible|1|||
27893813|NCT01843374|54547369|FG000|Overall Study|Death|155|||
27893814|NCT01843374|54547370|FG001|Overall Study|Death|313|||
27893815|NCT01843374|54547369|FG000|Overall Study|Withdrawal by Subject|14|||
27893816|NCT01843374|54547370|FG001|Overall Study|Withdrawal by Subject|20|||
27893817|NCT01843374|54547369|FG000|Overall Study|Withdrawing due to Other reason|20|||
27893818|NCT01843374|54547370|FG001|Overall Study|Withdrawing due to Other reason|46|||
27893819|NCT01620944|54547392|FG000|Overall Study|Early termination of Study|2|||
27893820|NCT01620944|54547393|FG001|Overall Study|Early termination of Study|1|||
27893821|NCT01627561|54547401|FG000|Overall Study|Lost to Follow-up|1|||
27893822|NCT01627561|54547402|FG001|Overall Study|Lost to Follow-up|0|||
27893823|NCT01627561|54547401|FG000|Overall Study|Withdrawal by Subject|0|||
27893824|NCT01627561|54547402|FG001|Overall Study|Withdrawal by Subject|1|||
27893825|NCT01627561|54547401|FG000|Overall Study|Migrated/moved from study area|0|||
27893826|NCT01627561|54547402|FG001|Overall Study|Migrated/moved from study area|2|||
27893827|NCT01652534|54547436|FG000|Overall Study|Lack of Efficacy|1|||
28171902|NCT02468674|54843503|FG004|Overall Study|Protocol Deviation|0|||
27893828|NCT01652534|54547437|FG001|Overall Study|Lack of Efficacy|0|||
27893829|NCT04709575|54547445|FG000|Overall Study|Withdrawal by Subject|6|||
27893830|NCT04709575|54547446|FG001|Overall Study|Withdrawal by Subject|2|||
27893831|NCT04709575|54547445|FG000|Overall Study|Lost to Follow-up|2|||
27893832|NCT04709575|54547446|FG001|Overall Study|Lost to Follow-up|2|||
27893833|NCT04709575|54547445|FG000|Overall Study|Adverse Event|1|||
27893834|NCT04709575|54547446|FG001|Overall Study|Adverse Event|0|||
27893835|NCT04709575|54547445|FG000|Overall Study|Protocol Violation|1|||
27893836|NCT04709575|54547446|FG001|Overall Study|Protocol Violation|1|||
27893837|NCT04450407|54547455|FG000|Overall Study|Withdrawal by Subject|10|||
27925778|NCT01226745|54582367|FG000|Overall Study|Lost to Follow-up|2|||
27893838|NCT04450407|54547456|FG001|Overall Study|Withdrawal by Subject|1|||
27893839|NCT04450407|54547457|FG002|Overall Study|Withdrawal by Subject|4|||
27893840|NCT04450407|54547455|FG000|Overall Study|Adverse Event|0|||
27893841|NCT04450407|54547456|FG001|Overall Study|Adverse Event|0|||
27893842|NCT04450407|54547457|FG002|Overall Study|Adverse Event|1|||
27893843|NCT04450407|54547455|FG000|Overall Study|Lost to Follow-up|1|||
27893844|NCT04450407|54547456|FG001|Overall Study|Lost to Follow-up|0|||
27893845|NCT04450407|54547457|FG002|Overall Study|Lost to Follow-up|0|||
27893846|NCT04450407|54547455|FG000|Overall Study|Physician Decision|0|||
27893847|NCT04450407|54547456|FG001|Overall Study|Physician Decision|0|||
27893848|NCT04450407|54547457|FG002|Overall Study|Physician Decision|1|||
27893849|NCT04450407|54547455|FG000|Overall Study|Pregnancy|1|||
27893850|NCT04450407|54547456|FG001|Overall Study|Pregnancy|0|||
27893851|NCT04450407|54547457|FG002|Overall Study|Pregnancy|0|||
27893852|NCT04450407|54547455|FG000|Overall Study|Protocol Violation|2|||
27893853|NCT04450407|54547456|FG001|Overall Study|Protocol Violation|0|||
27893854|NCT04450407|54547457|FG002|Overall Study|Protocol Violation|0|||
27893855|NCT04450407|54547455|FG000|Overall Study|Investigational site terminated by sponsor|3|||
27893856|NCT04450407|54547456|FG001|Overall Study|Investigational site terminated by sponsor|0|||
27893857|NCT04450407|54547457|FG002|Overall Study|Investigational site terminated by sponsor|2|||
27893858|NCT04418765|54547467|FG000|Overall Study|Adverse Event|1|||
27893859|NCT04418765|54547468|FG001|Overall Study|Adverse Event|1|||
27893860|NCT04418765|54547469|FG002|Overall Study|Adverse Event|6|||
27893861|NCT04418765|54547467|FG000|Overall Study|Lack of Efficacy|1|||
27893862|NCT04418765|54547468|FG001|Overall Study|Lack of Efficacy|3|||
27893863|NCT04418765|54547469|FG002|Overall Study|Lack of Efficacy|0|||
27893864|NCT04418765|54547467|FG000|Overall Study|Protocol Violation|0|||
27893865|NCT04418765|54547468|FG001|Overall Study|Protocol Violation|1|||
27893866|NCT04418765|54547469|FG002|Overall Study|Protocol Violation|1|||
27893867|NCT04418765|54547467|FG000|Overall Study|Withdrawal by Subject|1|||
27893868|NCT04418765|54547468|FG001|Overall Study|Withdrawal by Subject|5|||
27893869|NCT04418765|54547469|FG002|Overall Study|Withdrawal by Subject|2|||
27893870|NCT04418765|54547467|FG000|Overall Study|Lost to Follow-up|0|||
27893871|NCT04418765|54547468|FG001|Overall Study|Lost to Follow-up|1|||
27893872|NCT04418765|54547469|FG002|Overall Study|Lost to Follow-up|0|||
27893873|NCT04418765|54547467|FG000|Overall Study|Other than specified|2|||
27893874|NCT04418765|54547468|FG001|Overall Study|Other than specified|0|||
27893875|NCT04418765|54547469|FG002|Overall Study|Other than specified|1|||
27893876|NCT04418765|54547467|FG000|Overall Study|Randomized but not treated|1|||
27893877|NCT04418765|54547468|FG001|Overall Study|Randomized but not treated|0|||
27893878|NCT04418765|54547469|FG002|Overall Study|Randomized but not treated|0|||
27893879|NCT04388826|54547479|FG000|Overall Study|Lost to Follow-up|3|||
27893880|NCT04388826|54547480|FG001|Overall Study|Lost to Follow-up|2|||
27893881|NCT04388826|54547479|FG000|Overall Study|Adverse Event|1|||
27893882|NCT04388826|54547480|FG001|Overall Study|Adverse Event|0|||
27893883|NCT04218266|54547502|FG000|Overall Study|Death|1|||
27893884|NCT04218266|54547503|FG001|Overall Study|Death|2|||
27893885|NCT04218266|54547504|FG002|Overall Study|Death|3|||
27893886|NCT04218266|54547502|FG000|Overall Study|Adverse Event|13|||
27893887|NCT04218266|54547503|FG001|Overall Study|Adverse Event|14|||
27893888|NCT04218266|54547504|FG002|Overall Study|Adverse Event|11|||
27893889|NCT04218266|54547502|FG000|Overall Study|Other|7|||
27893890|NCT04218266|54547503|FG001|Overall Study|Other|5|||
27893891|NCT04218266|54547504|FG002|Overall Study|Other|14|||
27893892|NCT04218266|54547502|FG000|Overall Study|Physician Decision|1|||
27893893|NCT04218266|54547503|FG001|Overall Study|Physician Decision|3|||
27893894|NCT04218266|54547504|FG002|Overall Study|Physician Decision|2|||
27893895|NCT04218266|54547502|FG000|Overall Study|Non-compliance with study drug|0|||
27893896|NCT04218266|54547503|FG001|Overall Study|Non-compliance with study drug|0|||
27893897|NCT04218266|54547504|FG002|Overall Study|Non-compliance with study drug|1|||
27893898|NCT04218266|54547502|FG000|Overall Study|Withdrawal by Subject|1|||
27893899|NCT04218266|54547503|FG001|Overall Study|Withdrawal by Subject|3|||
27893900|NCT04218266|54547504|FG002|Overall Study|Withdrawal by Subject|1|||
27893901|NCT04218266|54547502|FG000|Overall Study|Study drug never administered|2|||
27893902|NCT04218266|54547503|FG001|Overall Study|Study drug never administered|0|||
27893903|NCT04218266|54547504|FG002|Overall Study|Study drug never administered|0|||
27893904|NCT03894904|54547526|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|2|||
27893905|NCT03894904|54547527|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|3|||
27893906|NCT03894904|54547526|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|2|||
27893907|NCT03894904|54547527|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|1|||
27893908|NCT03518086|54547544|FG000|Overall Study|Adverse Event|23|||
27893909|NCT03518086|54547545|FG001|Overall Study|Adverse Event|15|||
27893910|NCT03518086|54547546|FG002|Overall Study|Adverse Event|0|||
27893911|NCT03518086|54547547|FG003|Overall Study|Adverse Event|0|||
27893912|NCT03518086|54547544|FG000|Overall Study|Withdrawal by Subject|8|||
27893913|NCT03518086|54547545|FG001|Overall Study|Withdrawal by Subject|5|||
27893914|NCT03518086|54547546|FG002|Overall Study|Withdrawal by Subject|0|||
27893915|NCT03518086|54547547|FG003|Overall Study|Withdrawal by Subject|0|||
27893916|NCT03518086|54547544|FG000|Overall Study|Lack of Efficacy|5|||
27893917|NCT03518086|54547545|FG001|Overall Study|Lack of Efficacy|5|||
27893918|NCT03518086|54547546|FG002|Overall Study|Lack of Efficacy|0|||
27893919|NCT03518086|54547547|FG003|Overall Study|Lack of Efficacy|0|||
27893920|NCT03518086|54547544|FG000|Overall Study|Protocol Violation|1|||
27893921|NCT03518086|54547545|FG001|Overall Study|Protocol Violation|5|||
27893922|NCT03518086|54547546|FG002|Overall Study|Protocol Violation|0|||
27893923|NCT03518086|54547547|FG003|Overall Study|Protocol Violation|0|||
27893924|NCT03518086|54547544|FG000|Overall Study|Lost to Follow-up|0|||
27893925|NCT03518086|54547545|FG001|Overall Study|Lost to Follow-up|3|||
27893926|NCT03518086|54547546|FG002|Overall Study|Lost to Follow-up|0|||
27893927|NCT03518086|54547547|FG003|Overall Study|Lost to Follow-up|0|||
27893928|NCT03518086|54547544|FG000|Overall Study|Insufficient Diary Data|0|||
27893929|NCT03518086|54547545|FG001|Overall Study|Insufficient Diary Data|2|||
27893930|NCT03518086|54547546|FG002|Overall Study|Insufficient Diary Data|0|||
27893931|NCT03518086|54547547|FG003|Overall Study|Insufficient Diary Data|0|||
27893932|NCT03518086|54547544|FG000|Overall Study|Non- compliance to Protocol|0|||
27893933|NCT03518086|54547545|FG001|Overall Study|Non- compliance to Protocol|1|||
27893934|NCT03518086|54547546|FG002|Overall Study|Non- compliance to Protocol|0|||
27893935|NCT03518086|54547547|FG003|Overall Study|Non- compliance to Protocol|0|||
27893936|NCT03518086|54547544|FG000|Overall Study|COVID-19 Related Study Disruption|0|||
27893937|NCT03518086|54547545|FG001|Overall Study|COVID-19 Related Study Disruption|2|||
27893938|NCT03518086|54547546|FG002|Overall Study|COVID-19 Related Study Disruption|0|||
27893939|NCT03518086|54547547|FG003|Overall Study|COVID-19 Related Study Disruption|0|||
27893940|NCT03518086|54547544|FG000|Overall Study|Site Terminated by Sponsor|0|||
27893941|NCT03518086|54547545|FG001|Overall Study|Site Terminated by Sponsor|1|||
27893942|NCT03518086|54547546|FG002|Overall Study|Site Terminated by Sponsor|0|||
27893943|NCT03518086|54547547|FG003|Overall Study|Site Terminated by Sponsor|0|||
27893944|NCT03225287|54547562|FG000|Overall Study|Adverse Event|0|||
27893945|NCT03225287|54547563|FG001|Overall Study|Adverse Event|0|||
27893946|NCT03225287|54547564|FG002|Overall Study|Adverse Event|1|||
27893947|NCT03225287|54547562|FG000|Overall Study|Protocol non-compliance|0|||
27893948|NCT03225287|54547563|FG001|Overall Study|Protocol non-compliance|0|||
27893949|NCT03225287|54547564|FG002|Overall Study|Protocol non-compliance|1|||
27893950|NCT03225287|54547562|FG000|Overall Study|Subject withdraws consent|3|||
27893951|NCT03225287|54547563|FG001|Overall Study|Subject withdraws consent|0|||
27893952|NCT03225287|54547564|FG002|Overall Study|Subject withdraws consent|0|||
27893953|NCT03225287|54547562|FG000|Overall Study|Sponsor, regulatory, or EC/IRB request|7|||
27893954|NCT03225287|54547563|FG001|Overall Study|Sponsor, regulatory, or EC/IRB request|3|||
27893955|NCT03225287|54547564|FG002|Overall Study|Sponsor, regulatory, or EC/IRB request|1|||
27893956|NCT03225287|54547562|FG000|Overall Study|Trial drug not effective|0|||
27893957|NCT03225287|54547563|FG001|Overall Study|Trial drug not effective|1|||
27893958|NCT03225287|54547564|FG002|Overall Study|Trial drug not effective|0|||
27893959|NCT03225287|54547562|FG000|Overall Study|Need of transfusions and signs of hemolysis|0|||
27893960|NCT03225287|54547563|FG001|Overall Study|Need of transfusions and signs of hemolysis|1|||
27893961|NCT03225287|54547564|FG002|Overall Study|Need of transfusions and signs of hemolysis|0|||
27893962|NCT03225287|54547562|FG000|Overall Study|Stem cell transplantation|0|||
27893963|NCT03225287|54547563|FG001|Overall Study|Stem cell transplantation|1|||
27893964|NCT03225287|54547564|FG002|Overall Study|Stem cell transplantation|0|||
27893965|NCT03099265|54547572|FG000|Overall Study|Adverse Event|1|||
27893966|NCT02658656|54547590|FG000|Screening|Failed eligibility criteria|0|||
27893967|NCT02658656|54547591|FG001|Screening|Failed eligibility criteria|0|||
27893968|NCT02658656|54547592|FG002|Screening|Failed eligibility criteria|263|||
27893969|NCT02658656|54547590|FG000|Randomization|Withdrawal by Subject|8|||
27893970|NCT02658656|54547591|FG001|Randomization|Withdrawal by Subject|7|||
27893971|NCT02658656|54547592|FG002|Randomization|Withdrawal by Subject|0|||
27893972|NCT02658656|54547590|FG000|Randomization|Lost to Follow-up|1|||
27893973|NCT02658656|54547591|FG001|Randomization|Lost to Follow-up|3|||
27893974|NCT02658656|54547592|FG002|Randomization|Lost to Follow-up|0|||
27893975|NCT02658656|54547590|FG000|Randomization|Adverse Event|4|||
27893976|NCT02658656|54547591|FG001|Randomization|Adverse Event|0|||
27893977|NCT02658656|54547592|FG002|Randomization|Adverse Event|0|||
27893978|NCT02658656|54547590|FG000|Randomization|Administrative Termination|3|||
27893979|NCT02658656|54547591|FG001|Randomization|Administrative Termination|1|||
27893980|NCT02658656|54547592|FG002|Randomization|Administrative Termination|0|||
27893981|NCT02658656|54547590|FG000|Randomization|Administrative Termination due to COVID-19 Restrictions|13|||
27893982|NCT02658656|54547591|FG001|Randomization|Administrative Termination due to COVID-19 Restrictions|15|||
27893983|NCT02658656|54547592|FG002|Randomization|Administrative Termination due to COVID-19 Restrictions|0|||
27893984|NCT02658656|54547590|FG000|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|2|||
27893985|NCT02658656|54547591|FG001|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
27893986|NCT02658656|54547592|FG002|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
27893987|NCT02658656|54547590|FG000|Randomization|Not eligible for Randomization|1|||
27893988|NCT02658656|54547591|FG001|Randomization|Not eligible for Randomization|0|||
27893989|NCT02658656|54547592|FG002|Randomization|Not eligible for Randomization|0|||
27893990|NCT02658656|54547590|FG000|Randomization|Protocol Violation|1|||
27893991|NCT02658656|54547591|FG001|Randomization|Protocol Violation|0|||
27893992|NCT02658656|54547592|FG002|Randomization|Protocol Violation|0|||
27893993|NCT05141175|54547650|FG000|Overall Study|Withdrawal by Subject|1|||
27893994|NCT04869345|54547656|FG000|Overall Study|Lost to Follow-up|8|||
27893995|NCT04869345|54547657|FG001|Overall Study|Lost to Follow-up|3|||
27893996|NCT03610737|54547729|FG000|Overall Study|Withdrawal by Subject|1|||
27893997|NCT03610737|54547730|FG001|Overall Study|Withdrawal by Subject|5|||
27893998|NCT03610737|54547729|FG000|Overall Study|Death|1|||
27893999|NCT03610737|54547730|FG001|Overall Study|Death|0|||
27894000|NCT03610737|54547729|FG000|Overall Study|Not treated|5|||
27894001|NCT03610737|54547730|FG001|Overall Study|Not treated|2|||
27894002|NCT03610737|54547729|FG000|Overall Study|Missed Visit|1|||
27894003|NCT03610737|54547730|FG001|Overall Study|Missed Visit|2|||
27894004|NCT03321929|54547740|FG000|Overall Study|Withdrawn prior to LUM Imaging Procedure completed|4|||
27894005|NCT03250624|54547747|FG000|Overall Study|Lack of Efficacy|1|||
27894006|NCT03250624|54547748|FG001|Overall Study|Lack of Efficacy|4|||
27894007|NCT03250624|54547747|FG000|Overall Study|Adverse Event|0|||
27894008|NCT03250624|54547748|FG001|Overall Study|Adverse Event|1|||
27894009|NCT03250624|54547747|FG000|Overall Study|Other|1|||
27894010|NCT03250624|54547748|FG001|Overall Study|Other|2|||
27894011|NCT02507297|54547756|FG000|Overall Study|Withdrawal by Subject|1|||
27894012|NCT02507297|54547757|FG001|Overall Study|Withdrawal by Subject|0|||
27894013|NCT02507297|54547756|FG000|Overall Study|Lost to Follow-up|0|||
27894014|NCT02507297|54547757|FG001|Overall Study|Lost to Follow-up|1|||
27894015|NCT01333514|54547765|FG000|Overall Study|Withdrawal by Subject|1|||
27894016|NCT01333514|54547766|FG001|Overall Study|Withdrawal by Subject|0|||
27894017|NCT02066636|54547775|FG000|Overall Study|Disease progression|51|||
27894018|NCT02066636|54547776|FG001|Overall Study|Disease progression|60|||
27894019|NCT02066636|54547777|FG002|Overall Study|Disease progression|700|||
27894020|NCT02066636|54547775|FG000|Overall Study|Study drug toxicity|13|||
27894021|NCT02066636|54547776|FG001|Overall Study|Study drug toxicity|2|||
27894022|NCT02066636|54547777|FG002|Overall Study|Study drug toxicity|58|||
27894023|NCT02066636|54547775|FG000|Overall Study|Death|4|||
27894024|NCT02066636|54547776|FG001|Overall Study|Death|2|||
27894025|NCT02066636|54547777|FG002|Overall Study|Death|158|||
27894026|NCT02066636|54547775|FG000|Overall Study|Adverse event unrelated to study drug|6|||
27894027|NCT02066636|54547776|FG001|Overall Study|Adverse event unrelated to study drug|4|||
27894028|NCT02066636|54547777|FG002|Overall Study|Adverse event unrelated to study drug|45|||
27894029|NCT02066636|54547775|FG000|Overall Study|Participant request to discontinue treatment|12|||
27894030|NCT02066636|54547776|FG001|Overall Study|Participant request to discontinue treatment|12|||
27894031|NCT02066636|54547777|FG002|Overall Study|Participant request to discontinue treatment|70|||
27894032|NCT02066636|54547775|FG000|Overall Study|Participant withdrew consent|10|||
27894033|NCT02066636|54547776|FG001|Overall Study|Participant withdrew consent|18|||
27894034|NCT02066636|54547777|FG002|Overall Study|Participant withdrew consent|61|||
27894035|NCT02066636|54547775|FG000|Overall Study|Lost to Follow-up|0|||
27894036|NCT02066636|54547776|FG001|Overall Study|Lost to Follow-up|2|||
27894037|NCT02066636|54547777|FG002|Overall Study|Lost to Follow-up|2|||
27894038|NCT02066636|54547775|FG000|Overall Study|Maximum clinical benefit|2|||
27894039|NCT02066636|54547776|FG001|Overall Study|Maximum clinical benefit|2|||
27894040|NCT02066636|54547777|FG002|Overall Study|Maximum clinical benefit|3|||
27894041|NCT02066636|54547775|FG000|Overall Study|Poor/non-compliance|2|||
27894042|NCT02066636|54547776|FG001|Overall Study|Poor/non-compliance|1|||
27894043|NCT02066636|54547777|FG002|Overall Study|Poor/non-compliance|1|||
27894044|NCT02066636|54547775|FG000|Overall Study|Participant no loner meets study criteria|3|||
27894045|NCT02066636|54547776|FG001|Overall Study|Participant no loner meets study criteria|2|||
27894046|NCT02066636|54547777|FG002|Overall Study|Participant no loner meets study criteria|28|||
27894047|NCT02066636|54547775|FG000|Overall Study|Administrative reasons by sponsor|8|||
27894048|NCT02066636|54547776|FG001|Overall Study|Administrative reasons by sponsor|5|||
27894049|NCT02066636|54547777|FG002|Overall Study|Administrative reasons by sponsor|0|||
27894050|NCT02066636|54547775|FG000|Overall Study|Other reasons|16|||
27894051|NCT02066636|54547776|FG001|Overall Study|Other reasons|15|||
27894052|NCT02066636|54547777|FG002|Overall Study|Other reasons|50|||
27894053|NCT01486264|54547789|FG000|Overall Study|Death|1|||
27894054|NCT01486264|54547790|FG001|Overall Study|Death|1|||
27894055|NCT01486264|54547789|FG000|Overall Study|Adverse Event|3|||
27894056|NCT01486264|54547790|FG001|Overall Study|Adverse Event|3|||
27894057|NCT01486264|54547789|FG000|Overall Study|Lack of Efficacy|6|||
27894058|NCT01486264|54547790|FG001|Overall Study|Lack of Efficacy|10|||
27894059|NCT01486264|54547789|FG000|Overall Study|Withdrawal by Subject|7|||
27894060|NCT01486264|54547790|FG001|Overall Study|Withdrawal by Subject|18|||
27894061|NCT01486264|54547789|FG000|Overall Study|Physician Decision|1|||
27894062|NCT01486264|54547790|FG001|Overall Study|Physician Decision|1|||
27894063|NCT01486264|54547789|FG000|Overall Study|Protocol Violation|3|||
27894064|NCT01486264|54547790|FG001|Overall Study|Protocol Violation|0|||
27894065|NCT01486264|54547789|FG000|Overall Study|Lost to Follow-up|3|||
27894066|NCT01486264|54547790|FG001|Overall Study|Lost to Follow-up|2|||
27894067|NCT01486264|54547789|FG000|Overall Study|Other|5|||
27894068|NCT01486264|54547790|FG001|Overall Study|Other|11|||
27894069|NCT01486264|54547789|FG000|Overall Study|Not treated|0|||
27894070|NCT01486264|54547790|FG001|Overall Study|Not treated|1|||
27894071|NCT01323270|54547798|FG000|Overall Study|Withdrawal by Subject|19|||
27894072|NCT01323270|54547799|FG001|Overall Study|Withdrawal by Subject|10|||
27894073|NCT01323270|54547798|FG000|Overall Study|Protocol Violation|9|||
27894074|NCT01323270|54547799|FG001|Overall Study|Protocol Violation|7|||
27894075|NCT01323270|54547798|FG000|Overall Study|Lost to Follow-up|4|||
27894076|NCT01323270|54547799|FG001|Overall Study|Lost to Follow-up|6|||
27894077|NCT01323270|54547798|FG000|Overall Study|Adverse Event|8|||
27894078|NCT01323270|54547799|FG001|Overall Study|Adverse Event|0|||
27894079|NCT01323270|54547798|FG000|Overall Study|Other|0|||
27894080|NCT01323270|54547799|FG001|Overall Study|Other|3|||
27894081|NCT01323270|54547798|FG000|Overall Study|Physician Decision|0|||
27894082|NCT01323270|54547799|FG001|Overall Study|Physician Decision|2|||
27894083|NCT01323270|54547798|FG000|Overall Study|Not eligible|1|||
27894084|NCT01323270|54547799|FG001|Overall Study|Not eligible|1|||
27894085|NCT01323270|54547798|FG000|Overall Study|Death|1|||
27894086|NCT01323270|54547799|FG001|Overall Study|Death|0|||
27894087|NCT01323270|54547798|FG000|Overall Study|Randomized, but not vaccinated|1|||
27894088|NCT01323270|54547799|FG001|Overall Study|Randomized, but not vaccinated|0|||
27894089|NCT01300728|54547808|FG000|Overall Study|Withdrawal by Subject|1|||
27894090|NCT01300728|54547809|FG001|Overall Study|Withdrawal by Subject|1|||
27894091|NCT01300728|54547808|FG000|Overall Study|Physician Decision|1|||
27894092|NCT01300728|54547809|FG001|Overall Study|Physician Decision|0|||
27894093|NCT01299480|54547820|FG000|Overall Study|No longer willing to participate|19|||
27894094|NCT01299480|54547821|FG001|Overall Study|No longer willing to participate|17|||
27894095|NCT01299480|54547822|FG002|Overall Study|No longer willing to participate|14|||
27894096|NCT01299480|54547823|FG003|Overall Study|No longer willing to participate|13|||
27894097|NCT01299480|54547824|FG004|Overall Study|No longer willing to participate|10|||
27894098|NCT01299480|54547820|FG000|Overall Study|Protocol Violation|7|||
27894099|NCT01299480|54547821|FG001|Overall Study|Protocol Violation|5|||
27894100|NCT01299480|54547822|FG002|Overall Study|Protocol Violation|8|||
27894101|NCT01299480|54547823|FG003|Overall Study|Protocol Violation|1|||
27894102|NCT01299480|54547824|FG004|Overall Study|Protocol Violation|1|||
27894103|NCT01299480|54547820|FG000|Overall Study|Withdrawal by Subject|3|||
27894104|NCT01299480|54547821|FG001|Overall Study|Withdrawal by Subject|4|||
27894105|NCT01299480|54547822|FG002|Overall Study|Withdrawal by Subject|7|||
27894106|NCT01299480|54547823|FG003|Overall Study|Withdrawal by Subject|3|||
27894107|NCT01299480|54547824|FG004|Overall Study|Withdrawal by Subject|4|||
27894108|NCT01299480|54547820|FG000|Overall Study|Adverse Event|6|||
27894109|NCT01299480|54547821|FG001|Overall Study|Adverse Event|4|||
27894110|NCT01299480|54547822|FG002|Overall Study|Adverse Event|5|||
27894111|NCT01299480|54547823|FG003|Overall Study|Adverse Event|4|||
27894112|NCT01299480|54547824|FG004|Overall Study|Adverse Event|0|||
27894113|NCT01299480|54547820|FG000|Overall Study|Withdrawal due to pregnancy|0|||
27894114|NCT01299480|54547821|FG001|Overall Study|Withdrawal due to pregnancy|1|||
27894115|NCT01299480|54547822|FG002|Overall Study|Withdrawal due to pregnancy|1|||
27894116|NCT01299480|54547823|FG003|Overall Study|Withdrawal due to pregnancy|0|||
27894117|NCT01299480|54547824|FG004|Overall Study|Withdrawal due to pregnancy|0|||
27894118|NCT01299480|54547820|FG000|Overall Study|Physician Decision|1|||
27894119|NCT01299480|54547821|FG001|Overall Study|Physician Decision|1|||
27894120|NCT01299480|54547822|FG002|Overall Study|Physician Decision|0|||
27894121|NCT01299480|54547823|FG003|Overall Study|Physician Decision|2|||
27894122|NCT01299480|54547824|FG004|Overall Study|Physician Decision|0|||
27894123|NCT01299480|54547820|FG000|Overall Study|Lost to Follow-up|3|||
27894124|NCT01299480|54547821|FG001|Overall Study|Lost to Follow-up|1|||
27894125|NCT01299480|54547822|FG002|Overall Study|Lost to Follow-up|2|||
27894126|NCT01299480|54547823|FG003|Overall Study|Lost to Follow-up|1|||
27894127|NCT01299480|54547824|FG004|Overall Study|Lost to Follow-up|2|||
27894128|NCT01299480|54547820|FG000|Overall Study|Other|3|||
27894129|NCT01299480|54547821|FG001|Overall Study|Other|2|||
27894130|NCT01299480|54547822|FG002|Overall Study|Other|3|||
27894131|NCT01299480|54547823|FG003|Overall Study|Other|0|||
27894132|NCT01299480|54547824|FG004|Overall Study|Other|3|||
27894133|NCT01299480|54547820|FG000|Overall Study|Started, but not vaccinated|0|||
27894134|NCT01299480|54547821|FG001|Overall Study|Started, but not vaccinated|0|||
27894135|NCT01299480|54547822|FG002|Overall Study|Started, but not vaccinated|1|||
27894136|NCT01299480|54547823|FG003|Overall Study|Started, but not vaccinated|1|||
27894137|NCT01299480|54547824|FG004|Overall Study|Started, but not vaccinated|0|||
27894138|NCT04799405|54547846|FG000|Phase 1 - Acute Stimulation, Daily tDCS|Withdrawal by Subject|2|||
27894139|NCT04688671|54547856|FG000|Overall Study|Adverse Event|3|||
27894140|NCT04688671|54547857|FG001|Overall Study|Adverse Event|1|||
27894141|NCT04688671|54547856|FG000|Overall Study|Withdrawal by Subject|3|||
27894142|NCT04688671|54547857|FG001|Overall Study|Withdrawal by Subject|1|||
27894143|NCT04688671|54547856|FG000|Overall Study|Lack of Efficacy|1|||
27894144|NCT04688671|54547857|FG001|Overall Study|Lack of Efficacy|1|||
27894145|NCT04688671|54547856|FG000|Overall Study|Protocol Violation|1|||
27894146|NCT04688671|54547857|FG001|Overall Study|Protocol Violation|0|||
27894147|NCT04688671|54547856|FG000|Overall Study|Lost to Follow-up|0|||
27894148|NCT04688671|54547857|FG001|Overall Study|Lost to Follow-up|1|||
27894149|NCT04529499|54547865|FG000|Overall Study|Withdrawal by Subject|9|||
27894150|NCT04529499|54547866|FG001|Overall Study|Withdrawal by Subject|11|||
27894151|NCT04529499|54547865|FG000|Overall Study|Physician Decision|1|||
27894152|NCT04529499|54547866|FG001|Overall Study|Physician Decision|2|||
27894153|NCT04529499|54547865|FG000|Overall Study|Adverse Event|4|||
27894154|NCT04529499|54547866|FG001|Overall Study|Adverse Event|4|||
27894155|NCT04529499|54547865|FG000|Overall Study|Death|14|||
27894156|NCT04529499|54547866|FG001|Overall Study|Death|11|||
27894157|NCT04529499|54547865|FG000|Overall Study|Lost to Follow-up|1|||
27894158|NCT04529499|54547866|FG001|Overall Study|Lost to Follow-up|1|||
27894159|NCT04529499|54547865|FG000|Overall Study|Others|7|||
27894160|NCT04529499|54547866|FG001|Overall Study|Others|11|||
27894161|NCT04501094|54547874|FG000|Overall Study|Death (unrelated to research)|1|||
27894162|NCT04501094|54547875|FG001|Overall Study|Death (unrelated to research)|0|||
27894163|NCT04414618|54547883|FG000|Overall Study|Death|3|||
27894164|NCT04414618|54547884|FG001|Overall Study|Death|3|||
27894165|NCT04414618|54547883|FG000|Overall Study|Withdrawal by Subject|2|||
27894166|NCT04414618|54547884|FG001|Overall Study|Withdrawal by Subject|1|||
27894167|NCT04414618|54547883|FG000|Overall Study|Lost to Follow-up|2|||
27894168|NCT04414618|54547884|FG001|Overall Study|Lost to Follow-up|3|||
27894169|NCT04414618|54547883|FG000|Overall Study|Physician Decision|1|||
27894170|NCT04414618|54547884|FG001|Overall Study|Physician Decision|0|||
27894171|NCT04412057|54547893|FG000|Overall Study|Death|3|||
27894172|NCT04412057|54547894|FG001|Overall Study|Death|7|||
27894173|NCT04412057|54547893|FG000|Overall Study|Discharged prior to receiving study treatment|1|||
27894174|NCT04412057|54547894|FG001|Overall Study|Discharged prior to receiving study treatment|0|||
27985732|NCT02393248|54644430|FG019|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
27985733|NCT02393248|54644431|FG020|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
27985734|NCT02393248|54644432|FG021|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
27985735|NCT02393248|54644433|FG022|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
27985736|NCT02393248|54644434|FG023|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
27985737|NCT02393248|54644435|FG024|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
27985738|NCT02393248|54644411|FG000|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
27985739|NCT02393248|54644412|FG001|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
27985740|NCT02393248|54644413|FG002|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
27985741|NCT02393248|54644414|FG003|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
27985742|NCT02393248|54644415|FG004|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
27985743|NCT02393248|54644416|FG005|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
27985744|NCT02393248|54644417|FG006|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|1|||
27985745|NCT02393248|54644418|FG007|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
27985746|NCT02393248|54644419|FG008|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
27985747|NCT02393248|54644420|FG009|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
27985748|NCT02393248|54644421|FG010|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
27985749|NCT02393248|54644422|FG011|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
27985750|NCT02393248|54644423|FG012|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
27985751|NCT02393248|54644424|FG013|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
27985752|NCT02393248|54644425|FG014|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
27985753|NCT02393248|54644426|FG015|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
27985754|NCT02393248|54644427|FG016|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
27985755|NCT02393248|54644428|FG017|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
27985756|NCT02393248|54644429|FG018|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
27985757|NCT02393248|54644430|FG019|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
27985758|NCT02393248|54644431|FG020|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
27985759|NCT02393248|54644432|FG021|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
27985760|NCT02393248|54644433|FG022|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
27985761|NCT02393248|54644434|FG023|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
27894175|NCT04402060|54547903|FG000|Overall Study|Death|1|||
27894176|NCT04402060|54547904|FG001|Overall Study|Death|12|||
27894177|NCT04402060|54547905|FG002|Overall Study|Death|7|||
27894178|NCT04402060|54547903|FG000|Overall Study|Adverse Event|0|||
27894179|NCT04402060|54547904|FG001|Overall Study|Adverse Event|0|||
27894180|NCT04402060|54547905|FG002|Overall Study|Adverse Event|1|||
27894181|NCT04402060|54547903|FG000|Overall Study|Withdrawal by Subject|0|||
27894182|NCT04402060|54547904|FG001|Overall Study|Withdrawal by Subject|1|||
27894183|NCT04402060|54547905|FG002|Overall Study|Withdrawal by Subject|2|||
27894184|NCT04402060|54547903|FG000|Overall Study|Sponsor Request|0|||
27894185|NCT04402060|54547904|FG001|Overall Study|Sponsor Request|2|||
27894186|NCT04402060|54547905|FG002|Overall Study|Sponsor Request|0|||
27894187|NCT04402060|54547903|FG000|Overall Study|Physician Decision|0|||
27894188|NCT04402060|54547904|FG001|Overall Study|Physician Decision|0|||
27894189|NCT04402060|54547905|FG002|Overall Study|Physician Decision|1|||
27894190|NCT04402060|54547903|FG000|Overall Study|Other|0|||
27894191|NCT04402060|54547904|FG001|Overall Study|Other|1|||
27894192|NCT04402060|54547905|FG002|Overall Study|Other|0|||
27894193|NCT04376684|54547940|FG000|Part 1 (Up to Day 60)|Withdrawal by Subject|7|||
27894194|NCT04376684|54547941|FG001|Part 1 (Up to Day 60)|Withdrawal by Subject|8|||
27894195|NCT04376684|54547942|FG002|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
27894196|NCT04376684|54547943|FG003|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
27894197|NCT04376684|54547940|FG000|Part 1 (Up to Day 60)|Protocol Violation|2|||
27894198|NCT04376684|54547941|FG001|Part 1 (Up to Day 60)|Protocol Violation|3|||
27894199|NCT04376684|54547942|FG002|Part 1 (Up to Day 60)|Protocol Violation|0|||
27894200|NCT04376684|54547943|FG003|Part 1 (Up to Day 60)|Protocol Violation|0|||
27894201|NCT04376684|54547940|FG000|Part 1 (Up to Day 60)|Physician Decision|2|||
27894202|NCT04376684|54547941|FG001|Part 1 (Up to Day 60)|Physician Decision|5|||
27894203|NCT04376684|54547942|FG002|Part 1 (Up to Day 60)|Physician Decision|0|||
27894204|NCT04376684|54547943|FG003|Part 1 (Up to Day 60)|Physician Decision|0|||
27894205|NCT04376684|54547940|FG000|Part 1 (Up to Day 60)|Lost to Follow-up|4|||
27894206|NCT04376684|54547941|FG001|Part 1 (Up to Day 60)|Lost to Follow-up|8|||
27894207|NCT04376684|54547942|FG002|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
27894208|NCT04376684|54547943|FG003|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
27894209|NCT04376684|54547940|FG000|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
27894210|NCT04376684|54547941|FG001|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
27894211|NCT04376684|54547942|FG002|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
27894212|NCT04376684|54547943|FG003|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
27894213|NCT04376684|54547940|FG000|Part 2 (Up to Day 60)|Physician Decision|0|||
27894214|NCT04376684|54547941|FG001|Part 2 (Up to Day 60)|Physician Decision|0|||
27894215|NCT04376684|54547942|FG002|Part 2 (Up to Day 60)|Physician Decision|1|||
27894216|NCT04376684|54547943|FG003|Part 2 (Up to Day 60)|Physician Decision|1|||
27894217|NCT04376684|54547940|FG000|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
27894218|NCT04376684|54547941|FG001|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
27894219|NCT04376684|54547942|FG002|Part 2 (Up to Day 60)|Lost to Follow-up|3|||
27894220|NCT04376684|54547943|FG003|Part 2 (Up to Day 60)|Lost to Follow-up|2|||
27894221|NCT04353284|54547955|FG000|Overall Study|Adverse Event|1|||
27894222|NCT04353284|54547956|FG001|Overall Study|Adverse Event|1|||
27894223|NCT04353284|54547955|FG000|Overall Study|Lost to Follow-up|1|||
27894224|NCT04353284|54547956|FG001|Overall Study|Lost to Follow-up|0|||
27894225|NCT04294147|54547964|FG000|Overall Study|Protocol Violation|2|||
27894226|NCT04294147|54547965|FG001|Overall Study|Protocol Violation|0|||
27894227|NCT04231825|54547977|FG000|Overall Study|Protocol Violation|3|||
27894228|NCT04231825|54547978|FG001|Overall Study|Protocol Violation|3|||
27894229|NCT04231825|54547977|FG000|Overall Study|Lost to Follow-up|0|||
27894230|NCT04231825|54547978|FG001|Overall Study|Lost to Follow-up|1|||
27894231|NCT04178772|54547984|FG000|Overall Study|Unsatisfacotry VIsual Response|1|||
27894232|NCT04178772|54547984|FG000|Overall Study|study terminated early due to COVID-19|7|||
27894233|NCT04148651|54547988|FG000|Overall Study|Lost to Follow-up|2|||
27894234|NCT03924427|54548001|FG000|Overall Study|Adverse Event|4|||
27894235|NCT03924427|54548001|FG000|Overall Study|Lack of Efficacy|1|||
27894236|NCT03924427|54548001|FG000|Overall Study|Withdrawal by Subject|1|||
27894237|NCT03642132|54548035|FG000|Chemotherapy Period|Adverse Event|1|||
27894238|NCT03642132|54548036|FG001|Chemotherapy Period|Adverse Event|1|||
27894239|NCT03642132|54548037|FG002|Chemotherapy Period|Adverse Event|0|||
27894240|NCT03642132|54548035|FG000|Chemotherapy Period|Physician's decision|4|||
27894241|NCT03642132|54548036|FG001|Chemotherapy Period|Physician's decision|1|||
27894242|NCT03642132|54548037|FG002|Chemotherapy Period|Physician's decision|0|||
27894243|NCT03642132|54548035|FG000|Chemotherapy Period|Progressive disease|0|||
27894244|NCT03642132|54548036|FG001|Chemotherapy Period|Progressive disease|0|||
27894245|NCT03642132|54548037|FG002|Chemotherapy Period|Progressive disease|1|||
27894246|NCT03642132|54548035|FG000|Chemotherapy Period|Study terminated by sponsor|0|||
27894247|NCT03642132|54548036|FG001|Chemotherapy Period|Study terminated by sponsor|0|||
27894248|NCT03642132|54548037|FG002|Chemotherapy Period|Study terminated by sponsor|3|||
27894249|NCT03642132|54548035|FG000|Chemotherapy Period|Other|1|||
27894250|NCT03642132|54548036|FG001|Chemotherapy Period|Other|0|||
27894251|NCT03642132|54548037|FG002|Chemotherapy Period|Other|2|||
28096710|NCT04091360|54751862|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
27894252|NCT03642132|54548035|FG000|Chemotherapy Period|Withdrawal by Subject|7|||
27894253|NCT03642132|54548036|FG001|Chemotherapy Period|Withdrawal by Subject|3|||
27894254|NCT03642132|54548037|FG002|Chemotherapy Period|Withdrawal by Subject|1|||
27894255|NCT03642132|54548035|FG000|Maintenance Period|Adverse Event|1|||
28096711|NCT04118166|54751884|FG000|Overall Study|Adverse Event|1|||
27894256|NCT03642132|54548036|FG001|Maintenance Period|Adverse Event|2|||
27894257|NCT03642132|54548037|FG002|Maintenance Period|Adverse Event|0|||
27894258|NCT03642132|54548035|FG000|Maintenance Period|Non-compliance with study drug|0|||
27894259|NCT03642132|54548036|FG001|Maintenance Period|Non-compliance with study drug|0|||
27894260|NCT03642132|54548037|FG002|Maintenance Period|Non-compliance with study drug|1|||
27894261|NCT03642132|54548035|FG000|Maintenance Period|Physician's decision|2|||
27894262|NCT03642132|54548036|FG001|Maintenance Period|Physician's decision|2|||
27894263|NCT03642132|54548037|FG002|Maintenance Period|Physician's decision|2|||
27894264|NCT03642132|54548035|FG000|Maintenance Period|Progressive disease|9|||
27894265|NCT03642132|54548036|FG001|Maintenance Period|Progressive disease|3|||
27894266|NCT03642132|54548037|FG002|Maintenance Period|Progressive disease|6|||
27894267|NCT03642132|54548035|FG000|Maintenance Period|Other|0|||
27894268|NCT03642132|54548036|FG001|Maintenance Period|Other|0|||
27894269|NCT03642132|54548037|FG002|Maintenance Period|Other|3|||
27894270|NCT03642132|54548035|FG000|Maintenance Period|Withdrawal by Subject|1|||
27894271|NCT03642132|54548036|FG001|Maintenance Period|Withdrawal by Subject|1|||
27894272|NCT03642132|54548037|FG002|Maintenance Period|Withdrawal by Subject|2|||
27894273|NCT03642132|54548035|FG000|Follow-up Period|Other|0|||
27894274|NCT03642132|54548036|FG001|Follow-up Period|Other|0|||
27894275|NCT03642132|54548037|FG002|Follow-up Period|Other|1|||
27894276|NCT03642132|54548035|FG000|Follow-up Period|Withdrawal by Subject|1|||
27894277|NCT03642132|54548036|FG001|Follow-up Period|Withdrawal by Subject|2|||
27894278|NCT03642132|54548037|FG002|Follow-up Period|Withdrawal by Subject|0|||
27894279|NCT03642132|54548035|FG000|Follow-up Period|Study terminated by sponsor|1|||
27894280|NCT03642132|54548036|FG001|Follow-up Period|Study terminated by sponsor|0|||
27894281|NCT03642132|54548037|FG002|Follow-up Period|Study terminated by sponsor|1|||
27894282|NCT03642132|54548035|FG000|Follow-up Period|Lack of Efficacy|1|||
27894283|NCT03642132|54548036|FG001|Follow-up Period|Lack of Efficacy|0|||
27894284|NCT03642132|54548037|FG002|Follow-up Period|Lack of Efficacy|0|||
27894285|NCT03642132|54548035|FG000|Follow-up Period|Death|1|||
27894286|NCT03642132|54548036|FG001|Follow-up Period|Death|0|||
27894287|NCT03642132|54548037|FG002|Follow-up Period|Death|2|||
27894288|NCT03642132|54548035|FG000|Follow-up Period|Adverse Event|1|||
27894289|NCT03642132|54548036|FG001|Follow-up Period|Adverse Event|0|||
27894290|NCT03642132|54548037|FG002|Follow-up Period|Adverse Event|0|||
27894291|NCT03008122|54548052|FG000|Overall Study|Physician Decision|3|||
27894292|NCT03008122|54548053|FG001|Overall Study|Physician Decision|2|||
27894293|NCT03008122|54548054|FG002|Overall Study|Physician Decision|0|||
27894294|NCT03008122|54548052|FG000|Overall Study|Withdrawal by Subject|1|||
27894295|NCT03008122|54548053|FG001|Overall Study|Withdrawal by Subject|3|||
27894296|NCT03008122|54548054|FG002|Overall Study|Withdrawal by Subject|0|||
27894297|NCT03008122|54548052|FG000|Overall Study|Lost to Follow-up|4|||
27894298|NCT03008122|54548053|FG001|Overall Study|Lost to Follow-up|8|||
27894299|NCT03008122|54548054|FG002|Overall Study|Lost to Follow-up|3|||
27894300|NCT03008122|54548052|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
27894301|NCT03008122|54548053|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
27894302|NCT03008122|54548054|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
27894303|NCT03008122|54548052|FG000|Overall Study|Subject Unable to Attend Clinical Visit|1|||
27894304|NCT03008122|54548053|FG001|Overall Study|Subject Unable to Attend Clinical Visit|0|||
27894305|NCT03008122|54548054|FG002|Overall Study|Subject Unable to Attend Clinical Visit|0|||
27894306|NCT03008122|54548052|FG000|Overall Study|Death|0|||
27894307|NCT03008122|54548053|FG001|Overall Study|Death|0|||
27894308|NCT03008122|54548054|FG002|Overall Study|Death|1|||
27894309|NCT02003924|54548093|FG000|Double-blind Phase|Lost to Follow-up|2|||
27894310|NCT02003924|54548094|FG001|Double-blind Phase|Lost to Follow-up|1|||
27894311|NCT02003924|54548095|FG002|Double-blind Phase|Lost to Follow-up|0|||
27894312|NCT02003924|54548093|FG000|Double-blind Phase|Protocol Violation|1|||
27894313|NCT02003924|54548094|FG001|Double-blind Phase|Protocol Violation|2|||
27894314|NCT02003924|54548095|FG002|Double-blind Phase|Protocol Violation|0|||
27894315|NCT02003924|54548093|FG000|Double-blind Phase|Withdrawal Consent to Continue Treatment|71|||
27894316|NCT02003924|54548094|FG001|Double-blind Phase|Withdrawal Consent to Continue Treatment|47|||
27894317|NCT02003924|54548095|FG002|Double-blind Phase|Withdrawal Consent to Continue Treatment|0|||
27985762|NCT02393248|54644435|FG024|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
27894318|NCT02003924|54548093|FG000|Double-blind Phase|Disease Progression|229|||
27894319|NCT02003924|54548094|FG001|Double-blind Phase|Disease Progression|247|||
27894320|NCT02003924|54548095|FG002|Double-blind Phase|Disease Progression|0|||
27985763|NCT02393248|54644411|FG000|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
27894321|NCT02003924|54548093|FG000|Double-blind Phase|Adverse Event|120|||
27894322|NCT02003924|54548094|FG001|Double-blind Phase|Adverse Event|31|||
27894323|NCT02003924|54548095|FG002|Double-blind Phase|Adverse Event|0|||
27894324|NCT02003924|54548093|FG000|Double-blind Phase|Randomized But not Treated|3|||
27894325|NCT02003924|54548094|FG001|Double-blind Phase|Randomized But not Treated|3|||
27894326|NCT02003924|54548095|FG002|Double-blind Phase|Randomized But not Treated|0|||
28096712|NCT04346628|54751891|FG000|Overall Study|Lost to Follow-up|4|||
28096713|NCT04346628|54751892|FG001|Overall Study|Lost to Follow-up|4|||
27894327|NCT02003924|54548093|FG000|Double-blind Phase|Other|29|||
27894328|NCT02003924|54548094|FG001|Double-blind Phase|Other|50|||
27894329|NCT02003924|54548095|FG002|Double-blind Phase|Other|0|||
27894330|NCT02003924|54548093|FG000|Open-label Phase|Lost to Follow-up|0|||
27894331|NCT02003924|54548094|FG001|Open-label Phase|Lost to Follow-up|0|||
27894332|NCT02003924|54548095|FG002|Open-label Phase|Lost to Follow-up|1|||
27894333|NCT02003924|54548093|FG000|Open-label Phase|Withdrawal Consent to Continue Treatment|9|||
27894334|NCT02003924|54548094|FG001|Open-label Phase|Withdrawal Consent to Continue Treatment|0|||
27894335|NCT02003924|54548095|FG002|Open-label Phase|Withdrawal Consent to Continue Treatment|1|||
27894336|NCT02003924|54548093|FG000|Open-label Phase|Disease Progression|59|||
27894337|NCT02003924|54548094|FG001|Open-label Phase|Disease Progression|0|||
27894338|NCT02003924|54548095|FG002|Open-label Phase|Disease Progression|5|||
27894339|NCT02003924|54548093|FG000|Open-label Phase|Adverse Event|25|||
27894340|NCT02003924|54548094|FG001|Open-label Phase|Adverse Event|0|||
27894341|NCT02003924|54548095|FG002|Open-label Phase|Adverse Event|10|||
27894342|NCT02003924|54548093|FG000|Open-label Phase|Other|7|||
27894343|NCT02003924|54548094|FG001|Open-label Phase|Other|0|||
27894344|NCT02003924|54548095|FG002|Open-label Phase|Other|0|||
27894345|NCT02003924|54548093|FG000|Long-term Follow-up Phase|Death|288|||
27894346|NCT02003924|54548094|FG001|Long-term Follow-up Phase|Death|174|||
27894347|NCT02003924|54548095|FG002|Long-term Follow-up Phase|Death|4|||
27894348|NCT02003924|54548093|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
27894349|NCT02003924|54548094|FG001|Long-term Follow-up Phase|Lost to Follow-up|6|||
27894350|NCT02003924|54548095|FG002|Long-term Follow-up Phase|Lost to Follow-up|1|||
27894351|NCT02003924|54548093|FG000|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66|||
27894352|NCT02003924|54548094|FG001|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55|||
27894353|NCT02003924|54548095|FG002|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1|||
27894354|NCT02003924|54548093|FG000|Long-term Follow-up Phase|Other|5|||
27894355|NCT02003924|54548094|FG001|Long-term Follow-up Phase|Other|2|||
27894356|NCT02003924|54548095|FG002|Long-term Follow-up Phase|Other|1|||
27894357|NCT01817751|54548107|FG000|Overall Study|Physician Decision|1|||
27894358|NCT01349322|54548123|FG000|Overall Study|Protocol Violation|45|||
27894359|NCT01349322|54548124|FG001|Overall Study|Protocol Violation|47|||
27894360|NCT01182415|54548136|FG000|Overall Study|Lost to Follow-up|1|||
27894361|NCT01030523|54548142|FG000|Initial Study (5 Years)|Death|1|||
27894362|NCT01030523|54548143|FG001|Initial Study (5 Years)|Death|0|||
27894363|NCT01030523|54548142|FG000|Initial Study (5 Years)|Lost to Follow-up|4|||
27894364|NCT01030523|54548143|FG001|Initial Study (5 Years)|Lost to Follow-up|5|||
27894365|NCT01030523|54548142|FG000|Initial Study (5 Years)|Implant failure|1|||
27894366|NCT01030523|54548143|FG001|Initial Study (5 Years)|Implant failure|0|||
27894367|NCT01030523|54548142|FG000|Follow-up Extension (10 Years)|Lost to Follow-up|5|||
27894368|NCT01030523|54548143|FG001|Follow-up Extension (10 Years)|Lost to Follow-up|4|||
27894369|NCT01030523|54548142|FG000|Follow-up Extension (10 Years)|Withdrawal by Subject|1|||
27894370|NCT01030523|54548143|FG001|Follow-up Extension (10 Years)|Withdrawal by Subject|3|||
27894371|NCT01030523|54548142|FG000|Follow-up Extension (10 Years)|Adverse Event|1|||
27894372|NCT01030523|54548143|FG001|Follow-up Extension (10 Years)|Adverse Event|2|||
27894373|NCT03893448|54548151|FG000|Overall Study|Withdrawal by Parent/Guardian|59|||
27894374|NCT03893448|54548152|FG001|Overall Study|Withdrawal by Parent/Guardian|85|||
27894375|NCT03893448|54548151|FG000|Overall Study|Physician Decision|8|||
27894376|NCT03893448|54548152|FG001|Overall Study|Physician Decision|14|||
27894377|NCT03893448|54548151|FG000|Overall Study|Lost to Follow-up|34|||
27894378|NCT03893448|54548152|FG001|Overall Study|Lost to Follow-up|27|||
27894379|NCT03893448|54548151|FG000|Overall Study|Death|1|||
27894380|NCT03893448|54548152|FG001|Overall Study|Death|0|||
27894381|NCT03811574|54548192|FG000|Overall Study|Withdrawal by Subject|2|||
27894382|NCT03811574|54548193|FG001|Overall Study|Withdrawal by Subject|4|||
27894383|NCT03811574|54548194|FG002|Overall Study|Withdrawal by Subject|0|||
27894384|NCT03727750|54548217|FG000|Overall Study|Death|45|||
27894385|NCT03727750|54548217|FG000|Overall Study|Withdrawal by Subject|2|||
27894386|NCT03727750|54548217|FG000|Overall Study|Lost to Follow-up|1|||
27894387|NCT03727750|54548217|FG000|Overall Study|Other|1|||
27894388|NCT03715829|54548227|FG000|Dose Ranging Period|Adverse Event|2|||
27894389|NCT03715829|54548228|FG001|Dose Ranging Period|Adverse Event|4|||
27894390|NCT03715829|54548229|FG002|Dose Ranging Period|Adverse Event|5|||
27894391|NCT03715829|54548230|FG003|Dose Ranging Period|Adverse Event|2|||
27894392|NCT03715829|54548231|FG004|Dose Ranging Period|Adverse Event|3|||
27894393|NCT03715829|54548232|FG005|Dose Ranging Period|Adverse Event|3|||
27894394|NCT03715829|54548233|FG006|Dose Ranging Period|Adverse Event|0|||
27894395|NCT03715829|54548234|FG007|Dose Ranging Period|Adverse Event|0|||
27894396|NCT03715829|54548235|FG008|Dose Ranging Period|Adverse Event|0|||
27894397|NCT03715829|54548236|FG009|Dose Ranging Period|Adverse Event|0|||
27894398|NCT03715829|54548237|FG010|Dose Ranging Period|Adverse Event|0|||
27894399|NCT03715829|54548227|FG000|Dose Ranging Period|Lack of Efficacy|0|||
27894400|NCT03715829|54548228|FG001|Dose Ranging Period|Lack of Efficacy|1|||
27894401|NCT03715829|54548229|FG002|Dose Ranging Period|Lack of Efficacy|0|||
27894402|NCT03715829|54548230|FG003|Dose Ranging Period|Lack of Efficacy|1|||
27894403|NCT03715829|54548231|FG004|Dose Ranging Period|Lack of Efficacy|0|||
27894404|NCT03715829|54548232|FG005|Dose Ranging Period|Lack of Efficacy|0|||
27894405|NCT03715829|54548233|FG006|Dose Ranging Period|Lack of Efficacy|0|||
27894406|NCT03715829|54548234|FG007|Dose Ranging Period|Lack of Efficacy|0|||
27894407|NCT03715829|54548235|FG008|Dose Ranging Period|Lack of Efficacy|0|||
27894408|NCT03715829|54548236|FG009|Dose Ranging Period|Lack of Efficacy|0|||
27894409|NCT03715829|54548237|FG010|Dose Ranging Period|Lack of Efficacy|0|||
27894410|NCT03715829|54548227|FG000|Dose Ranging Period|Lost to Follow-up|2|||
27894411|NCT03715829|54548228|FG001|Dose Ranging Period|Lost to Follow-up|0|||
27894412|NCT03715829|54548229|FG002|Dose Ranging Period|Lost to Follow-up|1|||
27894413|NCT03715829|54548230|FG003|Dose Ranging Period|Lost to Follow-up|1|||
27894414|NCT03715829|54548231|FG004|Dose Ranging Period|Lost to Follow-up|1|||
27894415|NCT03715829|54548232|FG005|Dose Ranging Period|Lost to Follow-up|2|||
27894416|NCT03715829|54548233|FG006|Dose Ranging Period|Lost to Follow-up|0|||
27894417|NCT03715829|54548234|FG007|Dose Ranging Period|Lost to Follow-up|0|||
27894418|NCT03715829|54548235|FG008|Dose Ranging Period|Lost to Follow-up|0|||
27894419|NCT03715829|54548236|FG009|Dose Ranging Period|Lost to Follow-up|0|||
27894420|NCT03715829|54548237|FG010|Dose Ranging Period|Lost to Follow-up|0|||
27894421|NCT03715829|54548227|FG000|Dose Ranging Period|Protocol Violation|0|||
27894422|NCT03715829|54548228|FG001|Dose Ranging Period|Protocol Violation|0|||
27894423|NCT03715829|54548229|FG002|Dose Ranging Period|Protocol Violation|0|||
27894424|NCT03715829|54548230|FG003|Dose Ranging Period|Protocol Violation|1|||
27894425|NCT03715829|54548231|FG004|Dose Ranging Period|Protocol Violation|0|||
27894426|NCT03715829|54548232|FG005|Dose Ranging Period|Protocol Violation|0|||
27894427|NCT03715829|54548233|FG006|Dose Ranging Period|Protocol Violation|0|||
27894428|NCT03715829|54548234|FG007|Dose Ranging Period|Protocol Violation|0|||
27894429|NCT03715829|54548235|FG008|Dose Ranging Period|Protocol Violation|0|||
27894430|NCT03715829|54548236|FG009|Dose Ranging Period|Protocol Violation|0|||
27894431|NCT03715829|54548237|FG010|Dose Ranging Period|Protocol Violation|0|||
27894432|NCT03715829|54548227|FG000|Dose Ranging Period|Withdrawal by Subject|8|||
27894433|NCT03715829|54548228|FG001|Dose Ranging Period|Withdrawal by Subject|4|||
27894434|NCT03715829|54548229|FG002|Dose Ranging Period|Withdrawal by Subject|3|||
27894435|NCT03715829|54548230|FG003|Dose Ranging Period|Withdrawal by Subject|9|||
27894436|NCT03715829|54548231|FG004|Dose Ranging Period|Withdrawal by Subject|2|||
27894437|NCT03715829|54548232|FG005|Dose Ranging Period|Withdrawal by Subject|3|||
27894438|NCT03715829|54548233|FG006|Dose Ranging Period|Withdrawal by Subject|0|||
27894439|NCT03715829|54548234|FG007|Dose Ranging Period|Withdrawal by Subject|0|||
27894440|NCT03715829|54548235|FG008|Dose Ranging Period|Withdrawal by Subject|0|||
27894441|NCT03715829|54548236|FG009|Dose Ranging Period|Withdrawal by Subject|0|||
27894442|NCT03715829|54548237|FG010|Dose Ranging Period|Withdrawal by Subject|0|||
27894443|NCT03715829|54548227|FG000|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
27894444|NCT03715829|54548228|FG001|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
27894445|NCT03715829|54548229|FG002|Dose Ranging Period|Medication Error Without Associated Adverse Event|1|||
27894446|NCT03715829|54548230|FG003|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
27894447|NCT03715829|54548231|FG004|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
27894448|NCT03715829|54548232|FG005|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
27894449|NCT03715829|54548233|FG006|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
27894450|NCT03715829|54548234|FG007|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
27894451|NCT03715829|54548235|FG008|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
27894452|NCT03715829|54548236|FG009|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
27894453|NCT03715829|54548237|FG010|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
27894454|NCT03715829|54548227|FG000|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
27894455|NCT03715829|54548228|FG001|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
27894456|NCT03715829|54548229|FG002|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
27894457|NCT03715829|54548230|FG003|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
27894458|NCT03715829|54548231|FG004|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
27985764|NCT02393248|54644412|FG001|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
27985765|NCT02393248|54644413|FG002|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
27894459|NCT03715829|54548232|FG005|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
27894460|NCT03715829|54548233|FG006|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
27894461|NCT03715829|54548234|FG007|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
27894462|NCT03715829|54548235|FG008|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
27894463|NCT03715829|54548236|FG009|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
27894464|NCT03715829|54548237|FG010|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
27894465|NCT03715829|54548227|FG000|Dose Ranging Period|Other|0|||
27894466|NCT03715829|54548228|FG001|Dose Ranging Period|Other|0|||
27894467|NCT03715829|54548229|FG002|Dose Ranging Period|Other|2|||
27894468|NCT03715829|54548230|FG003|Dose Ranging Period|Other|0|||
27985766|NCT02393248|54644414|FG003|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
27985767|NCT02393248|54644415|FG004|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
27985768|NCT02393248|54644416|FG005|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
27985769|NCT02393248|54644417|FG006|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
27894469|NCT03715829|54548231|FG004|Dose Ranging Period|Other|0|||
27894470|NCT03715829|54548232|FG005|Dose Ranging Period|Other|3|||
27894471|NCT03715829|54548233|FG006|Dose Ranging Period|Other|0|||
27894472|NCT03715829|54548234|FG007|Dose Ranging Period|Other|0|||
27894473|NCT03715829|54548235|FG008|Dose Ranging Period|Other|0|||
27894474|NCT03715829|54548236|FG009|Dose Ranging Period|Other|0|||
27894475|NCT03715829|54548237|FG010|Dose Ranging Period|Other|0|||
27894476|NCT03715829|54548227|FG000|Extension Period|Adverse Event|0|||
27985770|NCT02393248|54644418|FG007|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
27985771|NCT02393248|54644419|FG008|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
27985772|NCT02393248|54644420|FG009|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
27985773|NCT02393248|54644421|FG010|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
27985774|NCT02393248|54644422|FG011|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|13|||
27985775|NCT02393248|54644423|FG012|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|1|||
27985776|NCT02393248|54644424|FG013|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|2|||
27985777|NCT02393248|54644425|FG014|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|3|||
27985778|NCT02393248|54644426|FG015|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
27985779|NCT02393248|54644427|FG016|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
27985780|NCT02393248|54644428|FG017|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
27985781|NCT02393248|54644429|FG018|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
27985782|NCT02393248|54644430|FG019|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
27985783|NCT02393248|54644431|FG020|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
27985784|NCT02393248|54644432|FG021|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
27985785|NCT02393248|54644433|FG022|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
27985786|NCT02393248|54644434|FG023|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
27985787|NCT02393248|54644435|FG024|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
27985788|NCT02393248|54644411|FG000|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
27985789|NCT02393248|54644412|FG001|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
27985790|NCT02393248|54644413|FG002|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
27985791|NCT02393248|54644414|FG003|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
27985792|NCT02393248|54644415|FG004|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
27985793|NCT02393248|54644416|FG005|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
27985794|NCT02393248|54644417|FG006|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
27985795|NCT02393248|54644418|FG007|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
27985796|NCT02393248|54644419|FG008|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
27985797|NCT02393248|54644420|FG009|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
27985798|NCT02393248|54644421|FG010|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
27985799|NCT02393248|54644422|FG011|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
27985800|NCT02393248|54644423|FG012|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
27985801|NCT02393248|54644424|FG013|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
27985802|NCT02393248|54644425|FG014|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
27985803|NCT02393248|54644426|FG015|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
27985804|NCT02393248|54644427|FG016|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
27985805|NCT02393248|54644428|FG017|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
27985806|NCT02393248|54644429|FG018|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
27985807|NCT02393248|54644430|FG019|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
27985808|NCT02393248|54644431|FG020|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
27985809|NCT02393248|54644432|FG021|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
27985810|NCT02393248|54644433|FG022|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
27985811|NCT02393248|54644434|FG023|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
27985812|NCT02393248|54644435|FG024|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
27985813|NCT02393248|54644411|FG000|Part 2: Monotherapy Dose Expansion|Death|0|||
27985814|NCT02393248|54644412|FG001|Part 2: Monotherapy Dose Expansion|Death|0|||
27985815|NCT02393248|54644413|FG002|Part 2: Monotherapy Dose Expansion|Death|0|||
27985816|NCT02393248|54644414|FG003|Part 2: Monotherapy Dose Expansion|Death|0|||
27985817|NCT02393248|54644415|FG004|Part 2: Monotherapy Dose Expansion|Death|0|||
27985818|NCT02393248|54644416|FG005|Part 2: Monotherapy Dose Expansion|Death|0|||
28096714|NCT04346628|54751891|FG000|Overall Study|Withdrew (had personal reasons)|2|||
28096715|NCT04346628|54751892|FG001|Overall Study|Withdrew (had personal reasons)|5|||
28096716|NCT04346628|54751891|FG000|Overall Study|Withdrew (medication intolerant)|0|||
28096717|NCT04346628|54751892|FG001|Overall Study|Withdrew (medication intolerant)|3|||
28096718|NCT04346628|54751891|FG000|Overall Study|Withdrew (declined intervention)|0|||
28096719|NCT04346628|54751892|FG001|Overall Study|Withdrew (declined intervention)|1|||
27985819|NCT02393248|54644417|FG006|Part 2: Monotherapy Dose Expansion|Death|0|||
27985820|NCT02393248|54644418|FG007|Part 2: Monotherapy Dose Expansion|Death|0|||
27894477|NCT03715829|54548228|FG001|Extension Period|Adverse Event|0|||
27894478|NCT03715829|54548229|FG002|Extension Period|Adverse Event|0|||
27894479|NCT03715829|54548230|FG003|Extension Period|Adverse Event|0|||
27894480|NCT03715829|54548231|FG004|Extension Period|Adverse Event|0|||
27894481|NCT03715829|54548232|FG005|Extension Period|Adverse Event|0|||
27894482|NCT03715829|54548233|FG006|Extension Period|Adverse Event|3|||
27894483|NCT03715829|54548234|FG007|Extension Period|Adverse Event|1|||
27894484|NCT03715829|54548235|FG008|Extension Period|Adverse Event|6|||
27894485|NCT03715829|54548236|FG009|Extension Period|Adverse Event|0|||
27894486|NCT03715829|54548237|FG010|Extension Period|Adverse Event|0|||
27894487|NCT03715829|54548227|FG000|Extension Period|Lack of Efficacy|0|||
27894488|NCT03715829|54548228|FG001|Extension Period|Lack of Efficacy|0|||
27894489|NCT03715829|54548229|FG002|Extension Period|Lack of Efficacy|0|||
27894490|NCT03715829|54548230|FG003|Extension Period|Lack of Efficacy|0|||
27894491|NCT03715829|54548231|FG004|Extension Period|Lack of Efficacy|0|||
27894492|NCT03715829|54548232|FG005|Extension Period|Lack of Efficacy|0|||
27894493|NCT03715829|54548233|FG006|Extension Period|Lack of Efficacy|1|||
27894494|NCT03715829|54548234|FG007|Extension Period|Lack of Efficacy|9|||
27894495|NCT03715829|54548235|FG008|Extension Period|Lack of Efficacy|2|||
27894496|NCT03715829|54548236|FG009|Extension Period|Lack of Efficacy|0|||
27894497|NCT03715829|54548237|FG010|Extension Period|Lack of Efficacy|0|||
27894498|NCT03715829|54548227|FG000|Extension Period|Lost to Follow-up|0|||
27894499|NCT03715829|54548228|FG001|Extension Period|Lost to Follow-up|0|||
27894500|NCT03715829|54548229|FG002|Extension Period|Lost to Follow-up|0|||
27894501|NCT03715829|54548230|FG003|Extension Period|Lost to Follow-up|0|||
27894502|NCT03715829|54548231|FG004|Extension Period|Lost to Follow-up|0|||
27894503|NCT03715829|54548232|FG005|Extension Period|Lost to Follow-up|0|||
27894504|NCT03715829|54548233|FG006|Extension Period|Lost to Follow-up|0|||
27894505|NCT03715829|54548234|FG007|Extension Period|Lost to Follow-up|0|||
27894506|NCT03715829|54548235|FG008|Extension Period|Lost to Follow-up|2|||
27894507|NCT03715829|54548236|FG009|Extension Period|Lost to Follow-up|0|||
27894508|NCT03715829|54548237|FG010|Extension Period|Lost to Follow-up|0|||
27894509|NCT03715829|54548227|FG000|Extension Period|Protocol Violation|0|||
27894510|NCT03715829|54548228|FG001|Extension Period|Protocol Violation|0|||
27894511|NCT03715829|54548229|FG002|Extension Period|Protocol Violation|0|||
27894512|NCT03715829|54548230|FG003|Extension Period|Protocol Violation|0|||
27894513|NCT03715829|54548231|FG004|Extension Period|Protocol Violation|0|||
27894514|NCT03715829|54548232|FG005|Extension Period|Protocol Violation|0|||
27894515|NCT03715829|54548233|FG006|Extension Period|Protocol Violation|0|||
27894516|NCT03715829|54548234|FG007|Extension Period|Protocol Violation|0|||
27894517|NCT03715829|54548235|FG008|Extension Period|Protocol Violation|1|||
27894518|NCT03715829|54548236|FG009|Extension Period|Protocol Violation|0|||
27894519|NCT03715829|54548237|FG010|Extension Period|Protocol Violation|0|||
27894520|NCT03715829|54548227|FG000|Extension Period|Withdrawal by Subject|0|||
27894521|NCT03715829|54548228|FG001|Extension Period|Withdrawal by Subject|0|||
27894522|NCT03715829|54548229|FG002|Extension Period|Withdrawal by Subject|0|||
27894523|NCT03715829|54548230|FG003|Extension Period|Withdrawal by Subject|0|||
27894524|NCT03715829|54548231|FG004|Extension Period|Withdrawal by Subject|0|||
27894525|NCT03715829|54548232|FG005|Extension Period|Withdrawal by Subject|0|||
27894526|NCT03715829|54548233|FG006|Extension Period|Withdrawal by Subject|3|||
27894527|NCT03715829|54548234|FG007|Extension Period|Withdrawal by Subject|3|||
27894528|NCT03715829|54548235|FG008|Extension Period|Withdrawal by Subject|12|||
27894529|NCT03715829|54548236|FG009|Extension Period|Withdrawal by Subject|3|||
27894530|NCT03715829|54548237|FG010|Extension Period|Withdrawal by Subject|0|||
27894531|NCT03715829|54548227|FG000|Extension Period|Medication Error Without Associated Adverse Event|0|||
27894532|NCT03715829|54548228|FG001|Extension Period|Medication Error Without Associated Adverse Event|0|||
27894533|NCT03715829|54548229|FG002|Extension Period|Medication Error Without Associated Adverse Event|0|||
27894534|NCT03715829|54548230|FG003|Extension Period|Medication Error Without Associated Adverse Event|0|||
27894535|NCT03715829|54548231|FG004|Extension Period|Medication Error Without Associated Adverse Event|0|||
27894536|NCT03715829|54548232|FG005|Extension Period|Medication Error Without Associated Adverse Event|0|||
27894537|NCT03715829|54548233|FG006|Extension Period|Medication Error Without Associated Adverse Event|0|||
27894538|NCT03715829|54548234|FG007|Extension Period|Medication Error Without Associated Adverse Event|1|||
27894539|NCT03715829|54548235|FG008|Extension Period|Medication Error Without Associated Adverse Event|1|||
27894540|NCT03715829|54548236|FG009|Extension Period|Medication Error Without Associated Adverse Event|0|||
27894541|NCT03715829|54548237|FG010|Extension Period|Medication Error Without Associated Adverse Event|0|||
27894542|NCT03715829|54548227|FG000|Extension Period|No Longer Meets Eligibility Criteria|0|||
27894543|NCT03715829|54548228|FG001|Extension Period|No Longer Meets Eligibility Criteria|0|||
27894544|NCT03715829|54548229|FG002|Extension Period|No Longer Meets Eligibility Criteria|0|||
27894545|NCT03715829|54548230|FG003|Extension Period|No Longer Meets Eligibility Criteria|0|||
27894546|NCT03715829|54548231|FG004|Extension Period|No Longer Meets Eligibility Criteria|0|||
27894547|NCT03715829|54548232|FG005|Extension Period|No Longer Meets Eligibility Criteria|0|||
27894548|NCT03715829|54548233|FG006|Extension Period|No Longer Meets Eligibility Criteria|0|||
27894549|NCT03715829|54548234|FG007|Extension Period|No Longer Meets Eligibility Criteria|0|||
27894550|NCT03715829|54548235|FG008|Extension Period|No Longer Meets Eligibility Criteria|1|||
27894551|NCT03715829|54548236|FG009|Extension Period|No Longer Meets Eligibility Criteria|0|||
27894552|NCT03715829|54548237|FG010|Extension Period|No Longer Meets Eligibility Criteria|0|||
27894553|NCT03715829|54548227|FG000|Extension Period|Other|0|||
27894554|NCT03715829|54548228|FG001|Extension Period|Other|0|||
27894555|NCT03715829|54548229|FG002|Extension Period|Other|0|||
27894556|NCT03715829|54548230|FG003|Extension Period|Other|0|||
27894557|NCT03715829|54548231|FG004|Extension Period|Other|0|||
27894558|NCT03715829|54548232|FG005|Extension Period|Other|0|||
27894559|NCT03715829|54548233|FG006|Extension Period|Other|1|||
27894560|NCT03715829|54548234|FG007|Extension Period|Other|2|||
27894561|NCT03715829|54548235|FG008|Extension Period|Other|4|||
27894562|NCT03715829|54548236|FG009|Extension Period|Other|0|||
27894563|NCT03715829|54548237|FG010|Extension Period|Other|0|||
27894564|NCT03575104|54548299|FG000|Overall Study|Adverse Event|4|||
27894565|NCT03575104|54548300|FG001|Overall Study|Adverse Event|3|||
27894566|NCT03575104|54548301|FG002|Overall Study|Adverse Event|4|||
27894567|NCT03575104|54548299|FG000|Overall Study|Withdrawal by Subject|13|||
27894568|NCT03575104|54548300|FG001|Overall Study|Withdrawal by Subject|16|||
27894569|NCT03575104|54548301|FG002|Overall Study|Withdrawal by Subject|11|||
27894570|NCT03575104|54548299|FG000|Overall Study|Other reasons|6|||
27894571|NCT03575104|54548300|FG001|Overall Study|Other reasons|8|||
27894572|NCT03575104|54548301|FG002|Overall Study|Other reasons|6|||
27894573|NCT03575104|54548299|FG000|Overall Study|Lost to Follow-up|1|||
27894574|NCT03575104|54548300|FG001|Overall Study|Lost to Follow-up|2|||
27894575|NCT03575104|54548301|FG002|Overall Study|Lost to Follow-up|1|||
27894576|NCT03569475|54548312|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
27894577|NCT03569475|54548313|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|2|||
27894578|NCT03569475|54548314|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|5|||
27894579|NCT03569475|54548312|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
27894580|NCT03569475|54548313|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
27894581|NCT03569475|54548314|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
27894582|NCT03569475|54548312|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|7|||
27894583|NCT03569475|54548313|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|10|||
27894584|NCT03569475|54548314|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|9|||
27894585|NCT03569475|54548312|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
27894586|NCT03569475|54548313|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
27894587|NCT03569475|54548314|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|6|||
27894588|NCT03569475|54548312|FG000|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
27894589|NCT03569475|54548313|FG001|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
27894590|NCT03569475|54548314|FG002|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
27894591|NCT03569475|54548312|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
27894592|NCT03569475|54548313|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
27894593|NCT03569475|54548314|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
27894594|NCT03569475|54548312|FG000|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
27894595|NCT03569475|54548313|FG001|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
27894596|NCT03569475|54548314|FG002|Double-blind Treatment Period (8 Weeks)|Reason not Specified|2|||
27894597|NCT03569475|54548312|FG000|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|0|||
27894598|NCT03569475|54548313|FG001|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
27894599|NCT03569475|54548314|FG002|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
27894600|NCT03569475|54548312|FG000|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|0|||
27894601|NCT03569475|54548313|FG001|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
27894602|NCT03569475|54548314|FG002|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
27894603|NCT03545191|54548368|FG000|Overall Study|Death|1|||
27894604|NCT03545191|54548369|FG001|Overall Study|Death|0|||
27894605|NCT03545191|54548370|FG002|Overall Study|Death|0|||
27894606|NCT03545191|54548368|FG000|Overall Study|Adverse Event|4|||
27894607|NCT03545191|54548369|FG001|Overall Study|Adverse Event|2|||
27894608|NCT03545191|54548370|FG002|Overall Study|Adverse Event|7|||
27894609|NCT03545191|54548368|FG000|Overall Study|Other reasons|3|||
27894610|NCT03545191|54548369|FG001|Overall Study|Other reasons|11|||
27894611|NCT03545191|54548370|FG002|Overall Study|Other reasons|8|||
27894612|NCT03545191|54548368|FG000|Overall Study|Withdrawal by Subject|13|||
27894613|NCT03545191|54548369|FG001|Overall Study|Withdrawal by Subject|10|||
27894614|NCT03545191|54548370|FG002|Overall Study|Withdrawal by Subject|12|||
27894615|NCT03545191|54548368|FG000|Overall Study|Lost to Follow-up|1|||
27894616|NCT03545191|54548369|FG001|Overall Study|Lost to Follow-up|2|||
27894617|NCT03545191|54548370|FG002|Overall Study|Lost to Follow-up|3|||
27894618|NCT03500549|54548380|FG000|RCP (Day 1 - Week 16)|Adverse Event|3|||
27894619|NCT03500549|54548381|FG001|RCP (Day 1 - Week 16)|Adverse Event|0|||
27894620|NCT03500549|54548380|FG000|Open-label Period (Week 17 to Week 48)|Adverse Event|3|||
27894621|NCT03500549|54548381|FG001|Open-label Period (Week 17 to Week 48)|Adverse Event|7|||
27894622|NCT03366792|54548401|FG000|Overall Study|Withdrawal by Subject|7|||
27894623|NCT03366792|54548401|FG000|Overall Study|Lost to Follow-up|2|||
27894624|NCT03366792|54548401|FG000|Overall Study|Ineligible (could not reach perinium)|2|||
27925779|NCT01226745|54582368|FG001|Overall Study|Lost to Follow-up|6|||
27894625|NCT03366792|54548401|FG000|Overall Study|Study Closure (interim analysis showed no significant results)|4|||
27894626|NCT03366337|54548409|FG000|Overall Study|Lost to Follow-up|1|||
27894627|NCT03366337|54548410|FG001|Overall Study|Lost to Follow-up|0|||
27894628|NCT03366337|54548411|FG002|Overall Study|Lost to Follow-up|1|||
27894629|NCT03366337|54548412|FG003|Overall Study|Lost to Follow-up|0|||
27894630|NCT03366337|54548409|FG000|Overall Study|Withdrawal by Subject|2|||
27894631|NCT03366337|54548410|FG001|Overall Study|Withdrawal by Subject|0|||
27894632|NCT03366337|54548411|FG002|Overall Study|Withdrawal by Subject|1|||
27894633|NCT03366337|54548412|FG003|Overall Study|Withdrawal by Subject|1|||
27894634|NCT03342053|54548424|FG000|Overall Study|Adverse Event|2|||
27894635|NCT03342053|54548425|FG001|Overall Study|Adverse Event|0|||
27894636|NCT03342053|54548424|FG000|Overall Study|Withdrawal by Subject|0|||
27894637|NCT03342053|54548425|FG001|Overall Study|Withdrawal by Subject|1|||
27894638|NCT03325777|54548433|FG000|Overall Study|Lost to Follow-up|9|||
27894639|NCT03325777|54548434|FG001|Overall Study|Lost to Follow-up|12|||
27894640|NCT03283241|54548442|FG000|Overall Study|Adverse Event|4|||
27894641|NCT03283241|54548443|FG001|Overall Study|Adverse Event|1|||
27894642|NCT03283241|54548442|FG000|Overall Study|Withdrawal by Subject|0|||
27894643|NCT03283241|54548443|FG001|Overall Study|Withdrawal by Subject|1|||
27894644|NCT03283241|54548442|FG000|Overall Study|Subject relocated to Finland|0|||
27894645|NCT03283241|54548443|FG001|Overall Study|Subject relocated to Finland|1|||
27894646|NCT03242772|54548451|FG000|Overall Study|Lost to Follow-up|2|||
27894647|NCT03242772|54548452|FG001|Overall Study|Lost to Follow-up|0|||
27894648|NCT03242772|54548451|FG000|Overall Study|Physician Decision|0|||
27894649|NCT03242772|54548452|FG001|Overall Study|Physician Decision|1|||
27894650|NCT03242772|54548451|FG000|Overall Study|Withdrawal by Subject|1|||
27894651|NCT03242772|54548452|FG001|Overall Study|Withdrawal by Subject|0|||
27894652|NCT03236311|54548460|FG000|Overall Study|Study terminated by sponsor|0|||
27894653|NCT03236311|54548461|FG001|Overall Study|Study terminated by sponsor|2|||
27894654|NCT03236311|54548460|FG000|Overall Study|Adverse Event|0|||
27894655|NCT03236311|54548461|FG001|Overall Study|Adverse Event|1|||
27894656|NCT03192046|54548469|FG000|Overall Study|Withdrawal by Subject|1|||
27894657|NCT03192046|54548470|FG001|Overall Study|Withdrawal by Subject|1|||
27894658|NCT03190369|54548478|FG000|Overall Study|Poor compliance to protocol|0|||
27894659|NCT03190369|54548479|FG001|Overall Study|Poor compliance to protocol|1|||
27894660|NCT03190369|54548478|FG000|Overall Study|Withdraw before treatment|1|||
27894661|NCT03190369|54548479|FG001|Overall Study|Withdraw before treatment|5|||
27894662|NCT03190369|54548478|FG000|Overall Study|Randomized but not treated|0|||
27894663|NCT03190369|54548479|FG001|Overall Study|Randomized but not treated|2|||
27894664|NCT04657198|54548488|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|1|||
27894665|NCT04657198|54548489|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
27894666|NCT04657198|54548490|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
27894667|NCT04590586|54548504|FG000|Overall Study|Death|7|||
27894668|NCT04590586|54548505|FG001|Overall Study|Death|1|||
27894669|NCT04590586|54548506|FG002|Overall Study|Death|37|||
27894670|NCT04590586|54548507|FG003|Overall Study|Death|34|||
27894671|NCT04590586|54548508|FG004|Overall Study|Death|19|||
27894672|NCT04590586|54548509|FG005|Overall Study|Death|3|||
27894673|NCT04590586|54548504|FG000|Overall Study|Lost to Follow-up|3|||
27894674|NCT04590586|54548505|FG001|Overall Study|Lost to Follow-up|0|||
27894675|NCT04590586|54548506|FG002|Overall Study|Lost to Follow-up|11|||
27894676|NCT04590586|54548507|FG003|Overall Study|Lost to Follow-up|11|||
27894677|NCT04590586|54548508|FG004|Overall Study|Lost to Follow-up|6|||
27894678|NCT04590586|54548509|FG005|Overall Study|Lost to Follow-up|0|||
27894679|NCT04590586|54548504|FG000|Overall Study|Withdrawal by Subject|0|||
27894680|NCT04590586|54548505|FG001|Overall Study|Withdrawal by Subject|0|||
27894681|NCT04590586|54548506|FG002|Overall Study|Withdrawal by Subject|6|||
27894682|NCT04590586|54548507|FG003|Overall Study|Withdrawal by Subject|0|||
27894683|NCT04590586|54548508|FG004|Overall Study|Withdrawal by Subject|3|||
27894684|NCT04590586|54548509|FG005|Overall Study|Withdrawal by Subject|0|||
27894685|NCT04590586|54548504|FG000|Overall Study|Other|3|||
27894686|NCT04590586|54548505|FG001|Overall Study|Other|0|||
27894687|NCT04590586|54548506|FG002|Overall Study|Other|1|||
27894688|NCT04590586|54548507|FG003|Overall Study|Other|1|||
27894689|NCT04590586|54548508|FG004|Overall Study|Other|2|||
27894690|NCT04590586|54548509|FG005|Overall Study|Other|1|||
27894691|NCT04312009|54548535|FG000|Overall Study|Withdrawal by Subject|2|||
27894692|NCT04312009|54548536|FG001|Overall Study|Withdrawal by Subject|1|||
27894693|NCT03937466|54548551|FG000|Overall Study|not eligbile after the 2-week diary|9|||
27894694|NCT03937466|54548551|FG000|Overall Study|never returned their diary|6|||
27894695|NCT03937466|54548551|FG000|Overall Study|dropped out of study before getting Chilipad|5|||
27894696|NCT03937466|54548551|FG000|Overall Study|3 did not complete follow-up questionnaire.|3|||
27894697|NCT03850483|54548564|FG000|Treatment for Stage 1|Adverse Event|1|||
27894698|NCT03850483|54548565|FG001|Treatment for Stage 1|Adverse Event|1|||
27894699|NCT03850483|54548566|FG002|Treatment for Stage 1|Adverse Event|3|||
27894700|NCT03850483|54548567|FG003|Treatment for Stage 1|Adverse Event|0|||
27894701|NCT03850483|54548568|FG004|Treatment for Stage 1|Adverse Event|2|||
27894702|NCT03850483|54548569|FG005|Treatment for Stage 1|Adverse Event|0|||
27894703|NCT03850483|54548570|FG006|Treatment for Stage 1|Adverse Event|2|||
27894704|NCT03850483|54548571|FG007|Treatment for Stage 1|Adverse Event|2|||
27894705|NCT03850483|54548572|FG008|Treatment for Stage 1|Adverse Event|0|||
27894706|NCT03850483|54548573|FG009|Treatment for Stage 1|Adverse Event|0|||
27894707|NCT03850483|54548564|FG000|Treatment for Stage 1|Withdrawal by Subject|4|||
27894708|NCT03850483|54548565|FG001|Treatment for Stage 1|Withdrawal by Subject|4|||
27894709|NCT03850483|54548566|FG002|Treatment for Stage 1|Withdrawal by Subject|2|||
27894710|NCT03850483|54548567|FG003|Treatment for Stage 1|Withdrawal by Subject|2|||
27894711|NCT03850483|54548568|FG004|Treatment for Stage 1|Withdrawal by Subject|2|||
27894712|NCT03850483|54548569|FG005|Treatment for Stage 1|Withdrawal by Subject|1|||
27894713|NCT03850483|54548570|FG006|Treatment for Stage 1|Withdrawal by Subject|2|||
27894714|NCT03850483|54548571|FG007|Treatment for Stage 1|Withdrawal by Subject|3|||
27894715|NCT03850483|54548572|FG008|Treatment for Stage 1|Withdrawal by Subject|0|||
27894716|NCT03850483|54548573|FG009|Treatment for Stage 1|Withdrawal by Subject|0|||
27894717|NCT03850483|54548564|FG000|Treatment for Stage 1|Protocol Violation|1|||
27894718|NCT03850483|54548565|FG001|Treatment for Stage 1|Protocol Violation|0|||
27894719|NCT03850483|54548566|FG002|Treatment for Stage 1|Protocol Violation|0|||
27894720|NCT03850483|54548567|FG003|Treatment for Stage 1|Protocol Violation|0|||
27894721|NCT03850483|54548568|FG004|Treatment for Stage 1|Protocol Violation|0|||
27894722|NCT03850483|54548569|FG005|Treatment for Stage 1|Protocol Violation|0|||
27894723|NCT03850483|54548570|FG006|Treatment for Stage 1|Protocol Violation|1|||
27894724|NCT03850483|54548571|FG007|Treatment for Stage 1|Protocol Violation|0|||
27894725|NCT03850483|54548572|FG008|Treatment for Stage 1|Protocol Violation|0|||
27894726|NCT03850483|54548573|FG009|Treatment for Stage 1|Protocol Violation|0|||
27894727|NCT03850483|54548564|FG000|Treatment for Stage 1|Physician Decision|0|||
27894728|NCT03850483|54548565|FG001|Treatment for Stage 1|Physician Decision|0|||
27894729|NCT03850483|54548566|FG002|Treatment for Stage 1|Physician Decision|0|||
27894730|NCT03850483|54548567|FG003|Treatment for Stage 1|Physician Decision|0|||
27894731|NCT03850483|54548568|FG004|Treatment for Stage 1|Physician Decision|0|||
27894732|NCT03850483|54548569|FG005|Treatment for Stage 1|Physician Decision|1|||
27894733|NCT03850483|54548570|FG006|Treatment for Stage 1|Physician Decision|0|||
27894734|NCT03850483|54548571|FG007|Treatment for Stage 1|Physician Decision|0|||
27894735|NCT03850483|54548572|FG008|Treatment for Stage 1|Physician Decision|0|||
27894736|NCT03850483|54548573|FG009|Treatment for Stage 1|Physician Decision|0|||
27894737|NCT03850483|54548564|FG000|Treatment for Stage 1|Other|0|||
27894738|NCT03850483|54548565|FG001|Treatment for Stage 1|Other|0|||
27894739|NCT03850483|54548566|FG002|Treatment for Stage 1|Other|0|||
27894740|NCT03850483|54548567|FG003|Treatment for Stage 1|Other|0|||
27894741|NCT03850483|54548568|FG004|Treatment for Stage 1|Other|2|||
27894742|NCT03850483|54548569|FG005|Treatment for Stage 1|Other|1|||
27894743|NCT03850483|54548570|FG006|Treatment for Stage 1|Other|0|||
27894744|NCT03850483|54548571|FG007|Treatment for Stage 1|Other|0|||
27894745|NCT03850483|54548572|FG008|Treatment for Stage 1|Other|0|||
27894746|NCT03850483|54548573|FG009|Treatment for Stage 1|Other|0|||
27894747|NCT03850483|54548564|FG000|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
27894748|NCT03850483|54548565|FG001|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
27894749|NCT03850483|54548566|FG002|Treatment for Stage 1|Non-Compliance With Study Drug|1|||
27894750|NCT03850483|54548567|FG003|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
27894751|NCT03850483|54548568|FG004|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
27894752|NCT03850483|54548569|FG005|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
27894753|NCT03850483|54548570|FG006|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
27894754|NCT03850483|54548571|FG007|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
27894755|NCT03850483|54548572|FG008|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
27894756|NCT03850483|54548573|FG009|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
27894757|NCT03850483|54548564|FG000|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
27894758|NCT03850483|54548565|FG001|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
27894759|NCT03850483|54548566|FG002|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
27894760|NCT03850483|54548567|FG003|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
27894761|NCT03850483|54548568|FG004|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
27894762|NCT03850483|54548569|FG005|Treatment for Stage 1|No Longer Met Eligibility Criteria|1|||
27894763|NCT03850483|54548570|FG006|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
27894764|NCT03850483|54548571|FG007|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
27894765|NCT03850483|54548572|FG008|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
27894766|NCT03850483|54548573|FG009|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
27894767|NCT03850483|54548564|FG000|Treatment for Stage 1|Lost to Follow-up|0|||
27985821|NCT02393248|54644419|FG008|Part 2: Monotherapy Dose Expansion|Death|0|||
27894768|NCT03850483|54548565|FG001|Treatment for Stage 1|Lost to Follow-up|1|||
27894769|NCT03850483|54548566|FG002|Treatment for Stage 1|Lost to Follow-up|1|||
27894770|NCT03850483|54548567|FG003|Treatment for Stage 1|Lost to Follow-up|1|||
27894771|NCT03850483|54548568|FG004|Treatment for Stage 1|Lost to Follow-up|0|||
27985822|NCT02393248|54644420|FG009|Part 2: Monotherapy Dose Expansion|Death|0|||
27894772|NCT03850483|54548569|FG005|Treatment for Stage 1|Lost to Follow-up|1|||
27894773|NCT03850483|54548570|FG006|Treatment for Stage 1|Lost to Follow-up|2|||
27894774|NCT03850483|54548571|FG007|Treatment for Stage 1|Lost to Follow-up|0|||
27894775|NCT03850483|54548572|FG008|Treatment for Stage 1|Lost to Follow-up|0|||
27894776|NCT03850483|54548573|FG009|Treatment for Stage 1|Lost to Follow-up|0|||
27894777|NCT03850483|54548564|FG000|Treatment for Stage 1|Lack of Efficacy|1|||
27894778|NCT03850483|54548565|FG001|Treatment for Stage 1|Lack of Efficacy|2|||
27894779|NCT03850483|54548566|FG002|Treatment for Stage 1|Lack of Efficacy|2|||
27894780|NCT03850483|54548567|FG003|Treatment for Stage 1|Lack of Efficacy|3|||
27894781|NCT03850483|54548568|FG004|Treatment for Stage 1|Lack of Efficacy|2|||
27894782|NCT03850483|54548569|FG005|Treatment for Stage 1|Lack of Efficacy|4|||
27894783|NCT03850483|54548570|FG006|Treatment for Stage 1|Lack of Efficacy|3|||
27894784|NCT03850483|54548571|FG007|Treatment for Stage 1|Lack of Efficacy|1|||
27894785|NCT03850483|54548572|FG008|Treatment for Stage 1|Lack of Efficacy|0|||
27894786|NCT03850483|54548573|FG009|Treatment for Stage 1|Lack of Efficacy|0|||
27894787|NCT03850483|54548564|FG000|Treatment for Stage 1|Death|0|||
27894788|NCT03850483|54548565|FG001|Treatment for Stage 1|Death|0|||
27894789|NCT03850483|54548566|FG002|Treatment for Stage 1|Death|0|||
27894790|NCT03850483|54548567|FG003|Treatment for Stage 1|Death|0|||
27894791|NCT03850483|54548568|FG004|Treatment for Stage 1|Death|0|||
27894792|NCT03850483|54548569|FG005|Treatment for Stage 1|Death|1|||
27894793|NCT03850483|54548570|FG006|Treatment for Stage 1|Death|0|||
27894794|NCT03850483|54548571|FG007|Treatment for Stage 1|Death|0|||
27894795|NCT03850483|54548572|FG008|Treatment for Stage 1|Death|0|||
27894796|NCT03850483|54548573|FG009|Treatment for Stage 1|Death|0|||
27894797|NCT03850483|54548564|FG000|Treatment for Stage 1|Refused Further Treatment|1|||
27894798|NCT03850483|54548565|FG001|Treatment for Stage 1|Refused Further Treatment|0|||
27894799|NCT03850483|54548566|FG002|Treatment for Stage 1|Refused Further Treatment|2|||
27894800|NCT03850483|54548567|FG003|Treatment for Stage 1|Refused Further Treatment|0|||
27894801|NCT03850483|54548568|FG004|Treatment for Stage 1|Refused Further Treatment|1|||
27894802|NCT03850483|54548569|FG005|Treatment for Stage 1|Refused Further Treatment|0|||
27894803|NCT03850483|54548570|FG006|Treatment for Stage 1|Refused Further Treatment|1|||
27894804|NCT03850483|54548571|FG007|Treatment for Stage 1|Refused Further Treatment|0|||
27894805|NCT03850483|54548572|FG008|Treatment for Stage 1|Refused Further Treatment|0|||
27894806|NCT03850483|54548573|FG009|Treatment for Stage 1|Refused Further Treatment|0|||
27894807|NCT03850483|54548564|FG000|Treatment for Stage 1|Randomized but not Treated|0|||
27894808|NCT03850483|54548565|FG001|Treatment for Stage 1|Randomized but not Treated|0|||
27894809|NCT03850483|54548566|FG002|Treatment for Stage 1|Randomized but not Treated|0|||
27894810|NCT03850483|54548567|FG003|Treatment for Stage 1|Randomized but not Treated|0|||
27894811|NCT03850483|54548568|FG004|Treatment for Stage 1|Randomized but not Treated|0|||
27894812|NCT03850483|54548569|FG005|Treatment for Stage 1|Randomized but not Treated|1|||
27894813|NCT03850483|54548570|FG006|Treatment for Stage 1|Randomized but not Treated|0|||
27894814|NCT03850483|54548571|FG007|Treatment for Stage 1|Randomized but not Treated|0|||
27894815|NCT03850483|54548572|FG008|Treatment for Stage 1|Randomized but not Treated|0|||
27894816|NCT03850483|54548573|FG009|Treatment for Stage 1|Randomized but not Treated|0|||
27894817|NCT03850483|54548564|FG000|Follow-up for Stage 1|Withdrawal by Subject|0|||
27894818|NCT03850483|54548565|FG001|Follow-up for Stage 1|Withdrawal by Subject|0|||
27894819|NCT03850483|54548566|FG002|Follow-up for Stage 1|Withdrawal by Subject|0|||
27894820|NCT03850483|54548567|FG003|Follow-up for Stage 1|Withdrawal by Subject|0|||
27894821|NCT03850483|54548568|FG004|Follow-up for Stage 1|Withdrawal by Subject|0|||
27894822|NCT03850483|54548569|FG005|Follow-up for Stage 1|Withdrawal by Subject|0|||
27894823|NCT03850483|54548570|FG006|Follow-up for Stage 1|Withdrawal by Subject|1|||
27894824|NCT03850483|54548571|FG007|Follow-up for Stage 1|Withdrawal by Subject|2|||
27894825|NCT03850483|54548572|FG008|Follow-up for Stage 1|Withdrawal by Subject|0|||
27894826|NCT03850483|54548573|FG009|Follow-up for Stage 1|Withdrawal by Subject|0|||
27894827|NCT03850483|54548564|FG000|Follow-up for Stage 1|Physician Decision|0|||
27894828|NCT03850483|54548565|FG001|Follow-up for Stage 1|Physician Decision|0|||
27894829|NCT03850483|54548566|FG002|Follow-up for Stage 1|Physician Decision|0|||
27894830|NCT03850483|54548567|FG003|Follow-up for Stage 1|Physician Decision|0|||
27894831|NCT03850483|54548568|FG004|Follow-up for Stage 1|Physician Decision|1|||
27894832|NCT03850483|54548569|FG005|Follow-up for Stage 1|Physician Decision|0|||
27894833|NCT03850483|54548570|FG006|Follow-up for Stage 1|Physician Decision|1|||
27894834|NCT03850483|54548571|FG007|Follow-up for Stage 1|Physician Decision|0|||
27894835|NCT03850483|54548572|FG008|Follow-up for Stage 1|Physician Decision|0|||
27894836|NCT03850483|54548573|FG009|Follow-up for Stage 1|Physician Decision|0|||
27894837|NCT03850483|54548564|FG000|Follow-up for Stage 1|Lack of Efficacy|0|||
27894838|NCT03850483|54548565|FG001|Follow-up for Stage 1|Lack of Efficacy|0|||
27894839|NCT03850483|54548566|FG002|Follow-up for Stage 1|Lack of Efficacy|1|||
27894840|NCT03850483|54548567|FG003|Follow-up for Stage 1|Lack of Efficacy|0|||
27894841|NCT03850483|54548568|FG004|Follow-up for Stage 1|Lack of Efficacy|0|||
27894842|NCT03850483|54548569|FG005|Follow-up for Stage 1|Lack of Efficacy|0|||
28096720|NCT03681470|54751898|FG000|Overall Study|Lack of Efficacy|3|||
27894843|NCT03850483|54548570|FG006|Follow-up for Stage 1|Lack of Efficacy|0|||
27894844|NCT03850483|54548571|FG007|Follow-up for Stage 1|Lack of Efficacy|1|||
27894845|NCT03850483|54548572|FG008|Follow-up for Stage 1|Lack of Efficacy|0|||
27894846|NCT03850483|54548573|FG009|Follow-up for Stage 1|Lack of Efficacy|0|||
27894847|NCT03850483|54548564|FG000|Follow-up for Stage 1|Adverse Event|0|||
27894848|NCT03850483|54548565|FG001|Follow-up for Stage 1|Adverse Event|0|||
27894849|NCT03850483|54548566|FG002|Follow-up for Stage 1|Adverse Event|1|||
27894850|NCT03850483|54548567|FG003|Follow-up for Stage 1|Adverse Event|0|||
27894851|NCT03850483|54548568|FG004|Follow-up for Stage 1|Adverse Event|0|||
27894852|NCT03850483|54548569|FG005|Follow-up for Stage 1|Adverse Event|1|||
27894853|NCT03850483|54548570|FG006|Follow-up for Stage 1|Adverse Event|0|||
27894854|NCT03850483|54548571|FG007|Follow-up for Stage 1|Adverse Event|0|||
27894855|NCT03850483|54548572|FG008|Follow-up for Stage 1|Adverse Event|0|||
27894856|NCT03850483|54548573|FG009|Follow-up for Stage 1|Adverse Event|0|||
27894857|NCT03850483|54548564|FG000|Follow-up for Stage 1|Refused Further Study Procedures|0|||
27894858|NCT03850483|54548565|FG001|Follow-up for Stage 1|Refused Further Study Procedures|1|||
27894859|NCT03850483|54548566|FG002|Follow-up for Stage 1|Refused Further Study Procedures|0|||
27894860|NCT03850483|54548567|FG003|Follow-up for Stage 1|Refused Further Study Procedures|0|||
27894861|NCT03850483|54548568|FG004|Follow-up for Stage 1|Refused Further Study Procedures|2|||
27894862|NCT03850483|54548569|FG005|Follow-up for Stage 1|Refused Further Study Procedures|2|||
27894863|NCT03850483|54548570|FG006|Follow-up for Stage 1|Refused Further Study Procedures|0|||
27894864|NCT03850483|54548571|FG007|Follow-up for Stage 1|Refused Further Study Procedures|0|||
27894865|NCT03850483|54548572|FG008|Follow-up for Stage 1|Refused Further Study Procedures|0|||
27894866|NCT03850483|54548573|FG009|Follow-up for Stage 1|Refused Further Study Procedures|0|||
27894867|NCT03850483|54548564|FG000|Follow-up for Stage 1|Other|0|||
27894868|NCT03850483|54548565|FG001|Follow-up for Stage 1|Other|2|||
27894869|NCT03850483|54548566|FG002|Follow-up for Stage 1|Other|0|||
27894870|NCT03850483|54548567|FG003|Follow-up for Stage 1|Other|2|||
27894871|NCT03850483|54548568|FG004|Follow-up for Stage 1|Other|0|||
27894872|NCT03850483|54548569|FG005|Follow-up for Stage 1|Other|1|||
27894873|NCT03850483|54548570|FG006|Follow-up for Stage 1|Other|0|||
27894874|NCT03850483|54548571|FG007|Follow-up for Stage 1|Other|0|||
27894875|NCT03850483|54548572|FG008|Follow-up for Stage 1|Other|0|||
27894876|NCT03850483|54548573|FG009|Follow-up for Stage 1|Other|0|||
27894877|NCT03850483|54548564|FG000|Treatment for Stage 2|Adverse Event|0|||
27894878|NCT03850483|54548565|FG001|Treatment for Stage 2|Adverse Event|0|||
27894879|NCT03850483|54548566|FG002|Treatment for Stage 2|Adverse Event|0|||
27894880|NCT03850483|54548567|FG003|Treatment for Stage 2|Adverse Event|0|||
27894881|NCT03850483|54548568|FG004|Treatment for Stage 2|Adverse Event|0|||
27894882|NCT03850483|54548569|FG005|Treatment for Stage 2|Adverse Event|0|||
27894883|NCT03850483|54548570|FG006|Treatment for Stage 2|Adverse Event|0|||
27894884|NCT03850483|54548571|FG007|Treatment for Stage 2|Adverse Event|0|||
27894885|NCT03850483|54548572|FG008|Treatment for Stage 2|Adverse Event|0|||
27894886|NCT03850483|54548573|FG009|Treatment for Stage 2|Adverse Event|1|||
27894887|NCT03850483|54548564|FG000|Treatment for Stage 2|Lack of Efficacy|0|||
27894888|NCT03850483|54548565|FG001|Treatment for Stage 2|Lack of Efficacy|0|||
27894889|NCT03850483|54548566|FG002|Treatment for Stage 2|Lack of Efficacy|0|||
27894890|NCT03850483|54548567|FG003|Treatment for Stage 2|Lack of Efficacy|0|||
27894891|NCT03850483|54548568|FG004|Treatment for Stage 2|Lack of Efficacy|0|||
27894892|NCT03850483|54548569|FG005|Treatment for Stage 2|Lack of Efficacy|0|||
27894893|NCT03850483|54548570|FG006|Treatment for Stage 2|Lack of Efficacy|0|||
27894894|NCT03850483|54548571|FG007|Treatment for Stage 2|Lack of Efficacy|0|||
27894895|NCT03850483|54548572|FG008|Treatment for Stage 2|Lack of Efficacy|1|||
27894896|NCT03850483|54548573|FG009|Treatment for Stage 2|Lack of Efficacy|0|||
27894897|NCT03850483|54548564|FG000|Treatment for Stage 2|Lost to Follow-up|0|||
27894898|NCT03850483|54548565|FG001|Treatment for Stage 2|Lost to Follow-up|0|||
27894899|NCT03850483|54548566|FG002|Treatment for Stage 2|Lost to Follow-up|0|||
27894900|NCT03850483|54548567|FG003|Treatment for Stage 2|Lost to Follow-up|0|||
27894901|NCT03850483|54548568|FG004|Treatment for Stage 2|Lost to Follow-up|0|||
27894902|NCT03850483|54548569|FG005|Treatment for Stage 2|Lost to Follow-up|0|||
27894903|NCT03850483|54548570|FG006|Treatment for Stage 2|Lost to Follow-up|0|||
27894904|NCT03850483|54548571|FG007|Treatment for Stage 2|Lost to Follow-up|0|||
27894905|NCT03850483|54548572|FG008|Treatment for Stage 2|Lost to Follow-up|0|||
27894906|NCT03850483|54548573|FG009|Treatment for Stage 2|Lost to Follow-up|3|||
27894907|NCT03850483|54548564|FG000|Treatment for Stage 2|Physician Decision|0|||
27894908|NCT03850483|54548565|FG001|Treatment for Stage 2|Physician Decision|0|||
27894909|NCT03850483|54548566|FG002|Treatment for Stage 2|Physician Decision|0|||
27894910|NCT03850483|54548567|FG003|Treatment for Stage 2|Physician Decision|0|||
27894911|NCT03850483|54548568|FG004|Treatment for Stage 2|Physician Decision|0|||
27894912|NCT03850483|54548569|FG005|Treatment for Stage 2|Physician Decision|0|||
27894913|NCT03850483|54548570|FG006|Treatment for Stage 2|Physician Decision|0|||
27894914|NCT03850483|54548571|FG007|Treatment for Stage 2|Physician Decision|0|||
27894915|NCT03850483|54548572|FG008|Treatment for Stage 2|Physician Decision|0|||
27894916|NCT03850483|54548573|FG009|Treatment for Stage 2|Physician Decision|1|||
27894917|NCT03850483|54548564|FG000|Treatment for Stage 2|Protocol Violation|0|||
27894918|NCT03850483|54548565|FG001|Treatment for Stage 2|Protocol Violation|0|||
27894919|NCT03850483|54548566|FG002|Treatment for Stage 2|Protocol Violation|0|||
27894920|NCT03850483|54548567|FG003|Treatment for Stage 2|Protocol Violation|0|||
27894921|NCT03850483|54548568|FG004|Treatment for Stage 2|Protocol Violation|0|||
27894922|NCT03850483|54548569|FG005|Treatment for Stage 2|Protocol Violation|0|||
27894923|NCT03850483|54548570|FG006|Treatment for Stage 2|Protocol Violation|0|||
27894924|NCT03850483|54548571|FG007|Treatment for Stage 2|Protocol Violation|0|||
27894925|NCT03850483|54548572|FG008|Treatment for Stage 2|Protocol Violation|1|||
27894926|NCT03850483|54548573|FG009|Treatment for Stage 2|Protocol Violation|0|||
27894927|NCT03850483|54548564|FG000|Treatment for Stage 2|Withdrawal by Subject|0|||
27894928|NCT03850483|54548565|FG001|Treatment for Stage 2|Withdrawal by Subject|0|||
27894929|NCT03850483|54548566|FG002|Treatment for Stage 2|Withdrawal by Subject|0|||
27894930|NCT03850483|54548567|FG003|Treatment for Stage 2|Withdrawal by Subject|0|||
27894931|NCT03850483|54548568|FG004|Treatment for Stage 2|Withdrawal by Subject|0|||
27894932|NCT03850483|54548569|FG005|Treatment for Stage 2|Withdrawal by Subject|0|||
27894933|NCT03850483|54548570|FG006|Treatment for Stage 2|Withdrawal by Subject|0|||
27894934|NCT03850483|54548571|FG007|Treatment for Stage 2|Withdrawal by Subject|0|||
27894935|NCT03850483|54548572|FG008|Treatment for Stage 2|Withdrawal by Subject|2|||
27894936|NCT03850483|54548573|FG009|Treatment for Stage 2|Withdrawal by Subject|5|||
27894937|NCT03850483|54548564|FG000|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
27894938|NCT03850483|54548565|FG001|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
27894939|NCT03850483|54548566|FG002|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
27894940|NCT03850483|54548567|FG003|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
27894941|NCT03850483|54548568|FG004|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
27894942|NCT03850483|54548569|FG005|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
27894943|NCT03850483|54548570|FG006|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
27894944|NCT03850483|54548571|FG007|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
27894945|NCT03850483|54548572|FG008|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
27894946|NCT03850483|54548573|FG009|Treatment for Stage 2|No Longer Meets Eligibility Criteria|1|||
27894947|NCT03850483|54548564|FG000|Treatment for Stage 2|Refused Further Treatment|0|||
27894948|NCT03850483|54548565|FG001|Treatment for Stage 2|Refused Further Treatment|0|||
27894949|NCT03850483|54548566|FG002|Treatment for Stage 2|Refused Further Treatment|0|||
27894950|NCT03850483|54548567|FG003|Treatment for Stage 2|Refused Further Treatment|0|||
27894951|NCT03850483|54548568|FG004|Treatment for Stage 2|Refused Further Treatment|0|||
27894952|NCT03850483|54548569|FG005|Treatment for Stage 2|Refused Further Treatment|0|||
27894953|NCT03850483|54548570|FG006|Treatment for Stage 2|Refused Further Treatment|0|||
27894954|NCT03850483|54548571|FG007|Treatment for Stage 2|Refused Further Treatment|0|||
27894955|NCT03850483|54548572|FG008|Treatment for Stage 2|Refused Further Treatment|1|||
27894956|NCT03850483|54548573|FG009|Treatment for Stage 2|Refused Further Treatment|0|||
27894957|NCT03850483|54548564|FG000|Follow-up For Stage 2|Lost to Follow-up|0|||
27894958|NCT03850483|54548565|FG001|Follow-up For Stage 2|Lost to Follow-up|0|||
27894959|NCT03850483|54548566|FG002|Follow-up For Stage 2|Lost to Follow-up|0|||
27894960|NCT03850483|54548567|FG003|Follow-up For Stage 2|Lost to Follow-up|0|||
27894961|NCT03850483|54548568|FG004|Follow-up For Stage 2|Lost to Follow-up|0|||
27894962|NCT03850483|54548569|FG005|Follow-up For Stage 2|Lost to Follow-up|0|||
27894963|NCT03850483|54548570|FG006|Follow-up For Stage 2|Lost to Follow-up|0|||
27894964|NCT03850483|54548571|FG007|Follow-up For Stage 2|Lost to Follow-up|0|||
27894965|NCT03850483|54548572|FG008|Follow-up For Stage 2|Lost to Follow-up|0|||
27894966|NCT03850483|54548573|FG009|Follow-up For Stage 2|Lost to Follow-up|1|||
27894967|NCT03850483|54548564|FG000|Follow-up For Stage 2|Other|0|||
27894968|NCT03850483|54548565|FG001|Follow-up For Stage 2|Other|0|||
27894969|NCT03850483|54548566|FG002|Follow-up For Stage 2|Other|0|||
27894970|NCT03850483|54548567|FG003|Follow-up For Stage 2|Other|0|||
27894971|NCT03850483|54548568|FG004|Follow-up For Stage 2|Other|0|||
27894972|NCT03850483|54548569|FG005|Follow-up For Stage 2|Other|0|||
27894973|NCT03850483|54548570|FG006|Follow-up For Stage 2|Other|0|||
27894974|NCT03850483|54548571|FG007|Follow-up For Stage 2|Other|0|||
27894975|NCT03850483|54548572|FG008|Follow-up For Stage 2|Other|0|||
27894976|NCT03850483|54548573|FG009|Follow-up For Stage 2|Other|1|||
27894977|NCT03473925|54548604|FG000|Overall Study|Death|48|||
27894978|NCT03473925|54548605|FG001|Overall Study|Death|44|||
27894979|NCT03473925|54548604|FG000|Overall Study|Sponsor Decision|2|||
28171903|NCT02468674|54843504|FG005|Overall Study|Protocol Deviation|0|||
27894980|NCT03473925|54548605|FG001|Overall Study|Sponsor Decision|7|||
27894981|NCT03473925|54548604|FG000|Overall Study|Withdrawal by Subject|1|||
27894982|NCT03473925|54548605|FG001|Overall Study|Withdrawal by Subject|3|||
27894983|NCT03473925|54548604|FG000|Overall Study|Not Treated|1|||
27894984|NCT03473925|54548605|FG001|Overall Study|Not Treated|1|||
27894985|NCT03230097|54548613|FG000|Overall Study|Adverse Event|2|||
27894986|NCT03230097|54548614|FG001|Overall Study|Adverse Event|1|||
27894987|NCT03230097|54548613|FG000|Overall Study|non-compliance|0|||
27894988|NCT03230097|54548614|FG001|Overall Study|non-compliance|1|||
27894989|NCT03230097|54548613|FG000|Overall Study|Lost to Follow-up|2|||
28171904|NCT02468674|54843505|FG006|Overall Study|Protocol Deviation|0|||
28171905|NCT02468674|54843506|FG007|Overall Study|Protocol Deviation|1|||
27894990|NCT03230097|54548614|FG001|Overall Study|Lost to Follow-up|4|||
27894991|NCT03230097|54548613|FG000|Overall Study|Withdrawal by Subject|7|||
27894992|NCT03230097|54548614|FG001|Overall Study|Withdrawal by Subject|3|||
27894993|NCT03230097|54548613|FG000|Overall Study|Trial termination|4|||
27894994|NCT03230097|54548614|FG001|Overall Study|Trial termination|5|||
27894995|NCT03230097|54548613|FG000|Overall Study|Covid-19 pandemic outbreak|0|||
27894996|NCT03230097|54548614|FG001|Overall Study|Covid-19 pandemic outbreak|1|||
27894997|NCT03230097|54548613|FG000|Overall Study|outcome event|0|||
27894998|NCT03230097|54548614|FG001|Overall Study|outcome event|1|||
27894999|NCT02803593|54548639|FG000|Overall Study|Lost to Follow-up|17|||
27895000|NCT02803593|54548640|FG001|Overall Study|Lost to Follow-up|35|||
27895001|NCT02663908|54548648|FG000|Overall Study|Withdrawal by Subject|8|||
27895002|NCT02663908|54548649|FG001|Overall Study|Withdrawal by Subject|5|||
27895003|NCT02663908|54548648|FG000|Overall Study|Lost to Follow-up|1|||
27895004|NCT02663908|54548649|FG001|Overall Study|Lost to Follow-up|5|||
27895005|NCT02663908|54548648|FG000|Overall Study|Adverse Event|13|||
27895006|NCT02663908|54548649|FG001|Overall Study|Adverse Event|11|||
27895007|NCT02663908|54548648|FG000|Overall Study|Protocol Violation|1|||
27895008|NCT02663908|54548649|FG001|Overall Study|Protocol Violation|2|||
27895009|NCT02663908|54548648|FG000|Overall Study|Lack of therapeutic response|2|||
27895010|NCT02663908|54548649|FG001|Overall Study|Lack of therapeutic response|0|||
27895011|NCT02663908|54548648|FG000|Overall Study|COVID-19|1|||
27895012|NCT02663908|54548649|FG001|Overall Study|COVID-19|0|||
27895013|NCT02663908|54548648|FG000|Overall Study|Site closed|1|||
27895014|NCT02663908|54548649|FG001|Overall Study|Site closed|0|||
27895015|NCT02663908|54548648|FG000|Overall Study|Subject to begin treatment with an exclusionary medication|1|||
27895016|NCT02663908|54548649|FG001|Overall Study|Subject to begin treatment with an exclusionary medication|0|||
27895017|NCT02663908|54548648|FG000|Overall Study|Subject ended trial due to being prescribed prohibited medication|1|||
27895018|NCT02663908|54548649|FG001|Overall Study|Subject ended trial due to being prescribed prohibited medication|0|||
27895019|NCT02663908|54548648|FG000|Overall Study|Intolerance to FIRMAGON therapy|1|||
27895020|NCT02663908|54548649|FG001|Overall Study|Intolerance to FIRMAGON therapy|0|||
27895021|NCT02663908|54548648|FG000|Overall Study|Death|1|||
27895022|NCT02663908|54548649|FG001|Overall Study|Death|0|||
27895023|NCT02663908|54548648|FG000|Overall Study|Subject randomized in error and did not receive the IMP|1|||
27895024|NCT02663908|54548649|FG001|Overall Study|Subject randomized in error and did not receive the IMP|0|||
27895025|NCT02663908|54548648|FG000|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|0|||
27895026|NCT02663908|54548649|FG001|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|1|||
27895027|NCT02650284|54548657|FG000|Overall Study|Lost to Follow-up|3|||
27895028|NCT02650284|54548658|FG001|Overall Study|Lost to Follow-up|3|||
27895029|NCT02650284|54548657|FG000|Overall Study|Consent incorrectly taken|0|||
27895030|NCT02650284|54548658|FG001|Overall Study|Consent incorrectly taken|1|||
27895031|NCT02175030|54548666|FG000|Overall Study|Failed screen after consent|7|||
27895032|NCT02175030|54548667|FG001|Overall Study|Failed screen after consent|6|||
27895033|NCT02175030|54548666|FG000|Overall Study|Failed IUD Insertion|20|||
27895034|NCT02175030|54548667|FG001|Overall Study|Failed IUD Insertion|21|||
27895035|NCT02175030|54548666|FG000|Overall Study|Physician Decision|1|||
27895036|NCT02175030|54548667|FG001|Overall Study|Physician Decision|1|||
27895037|NCT02175030|54548666|FG000|Overall Study|Lost to Follow-up|6|||
27895038|NCT02175030|54548667|FG001|Overall Study|Lost to Follow-up|6|||
27895039|NCT02175030|54548666|FG000|Overall Study|Withdrawal by Subject|1|||
27895040|NCT02175030|54548667|FG001|Overall Study|Withdrawal by Subject|4|||
27895041|NCT03096834|54548692|FG000|Double-Blind Treatment Epoch|Protocol deviation|2|||
27895042|NCT03096834|54548693|FG001|Double-Blind Treatment Epoch|Protocol deviation|1|||
27895043|NCT03096834|54548694|FG002|Double-Blind Treatment Epoch|Protocol deviation|0|||
27895044|NCT03096834|54548695|FG003|Double-Blind Treatment Epoch|Protocol deviation|0|||
27895045|NCT03096834|54548692|FG000|Double-Blind Treatment Epoch|Pregnancy|0|||
27895046|NCT03096834|54548693|FG001|Double-Blind Treatment Epoch|Pregnancy|1|||
27895047|NCT03096834|54548694|FG002|Double-Blind Treatment Epoch|Pregnancy|0|||
27895048|NCT03096834|54548695|FG003|Double-Blind Treatment Epoch|Pregnancy|0|||
27895049|NCT03096834|54548692|FG000|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
27895050|NCT03096834|54548693|FG001|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
27895051|NCT03096834|54548694|FG002|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
27895052|NCT03096834|54548695|FG003|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
27895053|NCT03096834|54548692|FG000|Open-Label Treatment Epoch|Lack of Efficacy|0|||
27895054|NCT03096834|54548693|FG001|Open-Label Treatment Epoch|Lack of Efficacy|0|||
27895055|NCT03096834|54548694|FG002|Open-Label Treatment Epoch|Lack of Efficacy|15|||
27895056|NCT03096834|54548695|FG003|Open-Label Treatment Epoch|Lack of Efficacy|15|||
27895057|NCT03096834|54548692|FG000|Open-Label Treatment Epoch|Adverse Event|0|||
27895058|NCT03096834|54548693|FG001|Open-Label Treatment Epoch|Adverse Event|0|||
27895059|NCT03096834|54548694|FG002|Open-Label Treatment Epoch|Adverse Event|5|||
27895060|NCT03096834|54548695|FG003|Open-Label Treatment Epoch|Adverse Event|6|||
27895061|NCT03096834|54548692|FG000|Open-Label Treatment Epoch|New therapy for study indication|0|||
27925780|NCT01226745|54582369|FG002|Overall Study|Lost to Follow-up|6|||
27895062|NCT03096834|54548693|FG001|Open-Label Treatment Epoch|New therapy for study indication|0|||
27895063|NCT03096834|54548694|FG002|Open-Label Treatment Epoch|New therapy for study indication|1|||
27895064|NCT03096834|54548695|FG003|Open-Label Treatment Epoch|New therapy for study indication|1|||
27895065|NCT03096834|54548692|FG000|Open-Label Treatment Epoch|Physician Decision|0|||
27895066|NCT03096834|54548693|FG001|Open-Label Treatment Epoch|Physician Decision|0|||
27895067|NCT03096834|54548694|FG002|Open-Label Treatment Epoch|Physician Decision|1|||
27895068|NCT03096834|54548695|FG003|Open-Label Treatment Epoch|Physician Decision|0|||
27895069|NCT03096834|54548692|FG000|Open-Label Treatment Epoch|Pregnancy|0|||
27895070|NCT03096834|54548693|FG001|Open-Label Treatment Epoch|Pregnancy|0|||
27895071|NCT03096834|54548694|FG002|Open-Label Treatment Epoch|Pregnancy|1|||
27895072|NCT03096834|54548695|FG003|Open-Label Treatment Epoch|Pregnancy|0|||
27895073|NCT03096834|54548692|FG000|Open-Label Treatment Epoch|Subject/guardian decision|0|||
27895074|NCT03096834|54548693|FG001|Open-Label Treatment Epoch|Subject/guardian decision|0|||
27895075|NCT03096834|54548694|FG002|Open-Label Treatment Epoch|Subject/guardian decision|9|||
27895076|NCT03096834|54548695|FG003|Open-Label Treatment Epoch|Subject/guardian decision|17|||
27895077|NCT03096834|54548692|FG000|Safety Follow-Up Epoch|New therapy for study indication|0|||
27895078|NCT03096834|54548693|FG001|Safety Follow-Up Epoch|New therapy for study indication|0|||
27895079|NCT03096834|54548694|FG002|Safety Follow-Up Epoch|New therapy for study indication|0|||
27895080|NCT03096834|54548695|FG003|Safety Follow-Up Epoch|New therapy for study indication|1|||
27895081|NCT03096834|54548692|FG000|Safety Follow-Up Epoch|Protocol deviation|0|||
27895082|NCT03096834|54548693|FG001|Safety Follow-Up Epoch|Protocol deviation|0|||
27895083|NCT03096834|54548694|FG002|Safety Follow-Up Epoch|Protocol deviation|0|||
27895084|NCT03096834|54548695|FG003|Safety Follow-Up Epoch|Protocol deviation|1|||
27895085|NCT03096834|54548692|FG000|Safety Follow-Up Epoch|Lost to Follow-up|0|||
27895086|NCT03096834|54548693|FG001|Safety Follow-Up Epoch|Lost to Follow-up|0|||
27895087|NCT03096834|54548694|FG002|Safety Follow-Up Epoch|Lost to Follow-up|1|||
27895088|NCT03096834|54548695|FG003|Safety Follow-Up Epoch|Lost to Follow-up|0|||
27895089|NCT03015194|54548704|FG000|Overall Study|Death|10|||
27895090|NCT03015194|54548704|FG000|Overall Study|Withdrawal by Subject|2|||
27895091|NCT03012815|54548711|FG000|Overall Study|Lost to Follow-up|1|||
27895092|NCT03012815|54548712|FG001|Overall Study|Lost to Follow-up|0|||
27895093|NCT03012815|54548711|FG000|Overall Study|Physician Decision|3|||
27895094|NCT03012815|54548712|FG001|Overall Study|Physician Decision|2|||
27895095|NCT03012815|54548711|FG000|Overall Study|Adverse Event|1|||
27895096|NCT03012815|54548712|FG001|Overall Study|Adverse Event|0|||
27895097|NCT03001011|54548721|FG000|Overall Study|Adverse Event|9|||
27895098|NCT03001011|54548722|FG001|Overall Study|Adverse Event|3|||
27895099|NCT03001011|54548721|FG000|Overall Study|Chronic kidney disease lead to dialysis|15|||
27895100|NCT03001011|54548722|FG001|Overall Study|Chronic kidney disease lead to dialysis|10|||
27895101|NCT03001011|54548721|FG000|Overall Study|Other than specified above|3|||
27895102|NCT03001011|54548722|FG001|Overall Study|Other than specified above|8|||
27895103|NCT02993757|54548731|FG000|Overall Study|Non compliance with the protocol|155|||
27895104|NCT02993757|54548732|FG001|Overall Study|Non compliance with the protocol|170|||
27895105|NCT02993757|54548731|FG000|Overall Study|Lost to Follow-up|1|||
27895106|NCT02993757|54548732|FG001|Overall Study|Lost to Follow-up|0|||
27895107|NCT02993757|54548731|FG000|Overall Study|Voluntary withdraw not due adverse event|8|||
27895108|NCT02993757|54548732|FG001|Overall Study|Voluntary withdraw not due adverse event|8|||
27895109|NCT02979535|54548740|FG000|Overall Study|Non compliance with the protocol|78|||
27895110|NCT02979535|54548741|FG001|Overall Study|Non compliance with the protocol|82|||
27895111|NCT02979535|54548740|FG000|Overall Study|Consent withdrawn by participant|11|||
27895112|NCT02979535|54548741|FG001|Overall Study|Consent withdrawn by participant|18|||
27895113|NCT02979535|54548740|FG000|Overall Study|Lost to Follow-up|6|||
27895114|NCT02979535|54548741|FG001|Overall Study|Lost to Follow-up|1|||
27895115|NCT02978716|54548750|FG000|Overall Study|Death|25|||
27895116|NCT02978716|54548751|FG001|Overall Study|Death|13|||
27895117|NCT02978716|54548752|FG002|Overall Study|Death|20|||
27895118|NCT02978716|54548750|FG000|Overall Study|Lost to Follow-up|0|||
27895119|NCT02978716|54548751|FG001|Overall Study|Lost to Follow-up|0|||
27895120|NCT02978716|54548752|FG002|Overall Study|Lost to Follow-up|1|||
27895121|NCT02978716|54548750|FG000|Overall Study|Withdrawal by Subject|6|||
27895122|NCT02978716|54548751|FG001|Overall Study|Withdrawal by Subject|4|||
27895123|NCT02978716|54548752|FG002|Overall Study|Withdrawal by Subject|5|||
27895124|NCT02978716|54548750|FG000|Overall Study|Sponsor terminated|2|||
27895125|NCT02978716|54548751|FG001|Overall Study|Sponsor terminated|13|||
27895126|NCT02978716|54548752|FG002|Overall Study|Sponsor terminated|9|||
27895127|NCT02978716|54548750|FG000|Overall Study|Other|1|||
27895128|NCT02978716|54548751|FG001|Overall Study|Other|3|||
27895129|NCT02978716|54548752|FG002|Overall Study|Other|0|||
27895130|NCT02973321|54548767|FG000|Overall Study|Other than specified|0|||
27895131|NCT02973321|54548768|FG001|Overall Study|Other than specified|5|||
27895132|NCT02973321|54548769|FG002|Overall Study|Other than specified|3|||
27895133|NCT02973321|54548770|FG003|Overall Study|Other than specified|3|||
27895134|NCT02973321|54548771|FG004|Overall Study|Other than specified|1|||
27895135|NCT02973321|54548767|FG000|Overall Study|Lack of Efficacy|0|||
27895136|NCT02973321|54548768|FG001|Overall Study|Lack of Efficacy|0|||
27895137|NCT02973321|54548769|FG002|Overall Study|Lack of Efficacy|0|||
27895138|NCT02973321|54548770|FG003|Overall Study|Lack of Efficacy|0|||
27895139|NCT02973321|54548771|FG004|Overall Study|Lack of Efficacy|1|||
27895140|NCT02973321|54548767|FG000|Overall Study|Adverse Event|1|||
27895141|NCT02973321|54548768|FG001|Overall Study|Adverse Event|10|||
27895142|NCT02973321|54548769|FG002|Overall Study|Adverse Event|11|||
27895143|NCT02973321|54548770|FG003|Overall Study|Adverse Event|13|||
27895144|NCT02973321|54548771|FG004|Overall Study|Adverse Event|3|||
27895145|NCT02943785|54548786|FG000|Overall Study|Adverse Event|112|||
27895146|NCT02943785|54548787|FG001|Overall Study|Adverse Event|97|||
27895147|NCT02943785|54548786|FG000|Overall Study|Withdrawal by Subject|63|||
27895148|NCT02943785|54548787|FG001|Overall Study|Withdrawal by Subject|126|||
27895149|NCT02943785|54548786|FG000|Overall Study|Physician Decision|23|||
27895150|NCT02943785|54548787|FG001|Overall Study|Physician Decision|47|||
27895151|NCT02943785|54548786|FG000|Overall Study|Death|46|||
27895152|NCT02943785|54548787|FG001|Overall Study|Death|46|||
27895153|NCT02943785|54548786|FG000|Overall Study|Lost to Follow-up|1|||
27895154|NCT02943785|54548787|FG001|Overall Study|Lost to Follow-up|0|||
27895155|NCT02943785|54548786|FG000|Overall Study|Other|16|||
27895156|NCT02943785|54548787|FG001|Overall Study|Other|19|||
27895157|NCT02943785|54548786|FG000|Overall Study|Did not receive any study medication|21|||
27895158|NCT02943785|54548787|FG001|Overall Study|Did not receive any study medication|28|||
27895159|NCT02923674|54548796|FG000|Overall Study|Clinic Closed Due to COVID-19|14|||
27895160|NCT02923674|54548797|FG001|Overall Study|Clinic Closed Due to COVID-19|11|||
27895161|NCT02923674|54548798|FG002|Overall Study|Clinic Closed Due to COVID-19|14|||
27895162|NCT02923674|54548796|FG000|Overall Study|Lost to Follow-up|7|||
27895163|NCT02923674|54548797|FG001|Overall Study|Lost to Follow-up|12|||
27895164|NCT02923674|54548798|FG002|Overall Study|Lost to Follow-up|7|||
27895165|NCT02923674|54548796|FG000|Overall Study|Problem with intervention|2|||
27895166|NCT02923674|54548797|FG001|Overall Study|Problem with intervention|2|||
27895167|NCT02923674|54548798|FG002|Overall Study|Problem with intervention|1|||
27895168|NCT02923674|54548796|FG000|Overall Study|Adverse Event|3|||
27895169|NCT02923674|54548797|FG001|Overall Study|Adverse Event|1|||
27895170|NCT02923674|54548798|FG002|Overall Study|Adverse Event|1|||
27895171|NCT02923674|54548796|FG000|Overall Study|Withdrawal by Subject|2|||
27895172|NCT02923674|54548797|FG001|Overall Study|Withdrawal by Subject|2|||
27895173|NCT02923674|54548798|FG002|Overall Study|Withdrawal by Subject|2|||
27895174|NCT02921971|54548808|FG000|Overall Study|Adverse Event|1|||
27895175|NCT02921971|54548809|FG001|Overall Study|Adverse Event|2|||
27895176|NCT02921971|54548808|FG000|Overall Study|Lack of Efficacy|3|||
27895177|NCT02921971|54548809|FG001|Overall Study|Lack of Efficacy|1|||
27895178|NCT02921971|54548808|FG000|Overall Study|Other than specified above|2|||
27895179|NCT02921971|54548809|FG001|Overall Study|Other than specified above|1|||
27895180|NCT02886286|54548817|FG000|Overall Study|pump motor stall|0|||
27895181|NCT02886286|54548818|FG001|Overall Study|pump motor stall|1|||
27895182|NCT02865187|54548826|FG000|Overall Study|Lost to Follow-up|12|||
27895183|NCT02865187|54548827|FG001|Overall Study|Lost to Follow-up|7|||
27895184|NCT02865187|54548826|FG000|Overall Study|Adverse Event|1|||
27895185|NCT02865187|54548827|FG001|Overall Study|Adverse Event|0|||
27895186|NCT02824198|54548835|FG000|Overall Study|Non-compliance with the protocol|5|||
27895187|NCT02824198|54548836|FG001|Overall Study|Non-compliance with the protocol|1|||
27895188|NCT02824198|54548835|FG000|Overall Study|Lost to Follow-up|5|||
27895189|NCT02824198|54548836|FG001|Overall Study|Lost to Follow-up|2|||
27895190|NCT02824198|54548835|FG000|Overall Study|Withdrawal by Subject|5|||
27895191|NCT02824198|54548836|FG001|Overall Study|Withdrawal by Subject|0|||
27895192|NCT02787551|54548846|FG000|Core Period: 26 Weeks|Adverse Event|10|||
27895193|NCT02787551|54548847|FG001|Core Period: 26 Weeks|Adverse Event|0|||
27895194|NCT02787551|54548846|FG000|Core Period: 26 Weeks|Lack of Efficacy|1|||
27895195|NCT02787551|54548847|FG001|Core Period: 26 Weeks|Lack of Efficacy|0|||
27895196|NCT02787551|54548846|FG000|Core Period: 26 Weeks|Poor compliance to protocol|2|||
27895197|NCT02787551|54548847|FG001|Core Period: 26 Weeks|Poor compliance to protocol|0|||
27895198|NCT02787551|54548846|FG000|Core Period: 26 Weeks|Withdrawal by Subject|9|||
27895199|NCT02787551|54548847|FG001|Core Period: 26 Weeks|Withdrawal by Subject|9|||
27895200|NCT02787551|54548846|FG000|Core Period: 26 Weeks|Randomized but not treated|2|||
27895201|NCT02787551|54548847|FG001|Core Period: 26 Weeks|Randomized but not treated|1|||
27895202|NCT02787551|54548846|FG000|Core Period: 26 Weeks|Other than specified|3|||
27895203|NCT02787551|54548847|FG001|Core Period: 26 Weeks|Other than specified|1|||
28096721|NCT03681470|54751898|FG000|Overall Study|Lost to Follow-up|1|||
27739404|NCT01680861|54189032|FG000|Early Post-transplant Period|Protocol Violation|1|||
27895204|NCT02787551|54548846|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1|||
27895205|NCT02787551|54548847|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0|||
27895206|NCT02787551|54548846|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3|||
27895207|NCT02787551|54548847|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0|||
27895208|NCT02787551|54548846|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5|||
27895209|NCT02787551|54548847|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0|||
27895210|NCT02735044|54548867|FG000|Overall Study|Adverse Event|3|||
27895211|NCT02735044|54548868|FG001|Overall Study|Adverse Event|3|||
27895212|NCT02735044|54548867|FG000|Overall Study|Lack of Efficacy|1|||
27895213|NCT02735044|54548868|FG001|Overall Study|Lack of Efficacy|0|||
27895214|NCT02735044|54548867|FG000|Overall Study|Poor compliance to protocol|7|||
27895215|NCT02735044|54548868|FG001|Overall Study|Poor compliance to protocol|7|||
27895216|NCT02735044|54548867|FG000|Overall Study|Randomized and not treated|0|||
27895217|NCT02735044|54548868|FG001|Overall Study|Randomized and not treated|2|||
27895218|NCT02735044|54548867|FG000|Overall Study|Other, not specified above|5|||
27895219|NCT02735044|54548868|FG001|Overall Study|Other, not specified above|11|||
27895220|NCT02720744|54548876|FG000|Overall Study|Protocol Violation|0|||
27895221|NCT02720744|54548877|FG001|Overall Study|Protocol Violation|2|||
27895222|NCT02720744|54548876|FG000|Overall Study|Pregnancy|2|||
27895223|NCT02720744|54548877|FG001|Overall Study|Pregnancy|0|||
27895224|NCT02720744|54548876|FG000|Overall Study|Lack of Efficacy|2|||
27895225|NCT02720744|54548877|FG001|Overall Study|Lack of Efficacy|8|||
27895226|NCT02720744|54548876|FG000|Overall Study|Adverse Event|21|||
27895227|NCT02720744|54548877|FG001|Overall Study|Adverse Event|3|||
27895228|NCT02720744|54548876|FG000|Overall Study|Withdrawal by Subject|11|||
27895229|NCT02720744|54548877|FG001|Overall Study|Withdrawal by Subject|11|||
27895230|NCT02720744|54548876|FG000|Overall Study|Lost to follow up|2|||
27895231|NCT02720744|54548877|FG001|Overall Study|Lost to follow up|0|||
27895232|NCT02720744|54548876|FG000|Overall Study|Non Compliance with Investigational Product|0|||
27895233|NCT02720744|54548877|FG001|Overall Study|Non Compliance with Investigational Product|1|||
27895234|NCT02720744|54548876|FG000|Overall Study|Excluded Concomitant Medication|0|||
27895235|NCT02720744|54548877|FG001|Overall Study|Excluded Concomitant Medication|1|||
27895236|NCT02694185|54548885|FG000|Overall Study|Withdrawal by Subject|45|||
27895237|NCT02694185|54548886|FG001|Overall Study|Withdrawal by Subject|0|||
27895238|NCT02692651|54548894|FG000|Study Treatment|Death|7|||
27895239|NCT02692651|54548895|FG001|Study Treatment|Death|3|||
27895240|NCT02692651|54548894|FG000|Study Treatment|comfort care|1|||
27895241|NCT02692651|54548895|FG001|Study Treatment|comfort care|1|||
27895242|NCT02692651|54548894|FG000|Study Treatment|Protocol violation per treating team preference|8|||
27895243|NCT02692651|54548895|FG001|Study Treatment|Protocol violation per treating team preference|6|||
27895244|NCT02692651|54548894|FG000|Post Study Treatment Follow-up|Death|4|||
27895245|NCT02692651|54548895|FG001|Post Study Treatment Follow-up|Death|4|||
27895246|NCT02686658|54548907|FG000|Overall Study|Adverse Event|0|||
27895247|NCT02686658|54548908|FG001|Overall Study|Adverse Event|0|||
27895248|NCT02686658|54548909|FG002|Overall Study|Adverse Event|1|||
27895249|NCT02686658|54548910|FG003|Overall Study|Adverse Event|1|||
27895250|NCT02686658|54548911|FG004|Overall Study|Adverse Event|2|||
27895251|NCT02686658|54548912|FG005|Overall Study|Adverse Event|1|||
27895252|NCT02686658|54548907|FG000|Overall Study|Investigator decision|0|||
27895253|NCT02686658|54548908|FG001|Overall Study|Investigator decision|0|||
27895254|NCT02686658|54548909|FG002|Overall Study|Investigator decision|0|||
27895255|NCT02686658|54548910|FG003|Overall Study|Investigator decision|1|||
27895256|NCT02686658|54548911|FG004|Overall Study|Investigator decision|2|||
27895257|NCT02686658|54548912|FG005|Overall Study|Investigator decision|1|||
27895258|NCT02686658|54548907|FG000|Overall Study|Sponsor decision|1|||
27895259|NCT02686658|54548908|FG001|Overall Study|Sponsor decision|2|||
27895260|NCT02686658|54548909|FG002|Overall Study|Sponsor decision|1|||
27895261|NCT02686658|54548910|FG003|Overall Study|Sponsor decision|5|||
27895262|NCT02686658|54548911|FG004|Overall Study|Sponsor decision|13|||
27895263|NCT02686658|54548912|FG005|Overall Study|Sponsor decision|2|||
27895264|NCT02686658|54548907|FG000|Overall Study|Lost to Follow-up|0|||
27895265|NCT02686658|54548908|FG001|Overall Study|Lost to Follow-up|0|||
27895266|NCT02686658|54548909|FG002|Overall Study|Lost to Follow-up|2|||
27895267|NCT02686658|54548910|FG003|Overall Study|Lost to Follow-up|0|||
27895268|NCT02686658|54548911|FG004|Overall Study|Lost to Follow-up|0|||
27895269|NCT02686658|54548912|FG005|Overall Study|Lost to Follow-up|1|||
28171906|NCT02468674|54843507|FG008|Overall Study|Protocol Deviation|1|||
28171907|NCT02467192|54843527|FG000|Overall Study|Death|1|||
27895270|NCT02686658|54548907|FG000|Overall Study|Death|1|||
27895271|NCT02686658|54548908|FG001|Overall Study|Death|0|||
27895272|NCT02686658|54548909|FG002|Overall Study|Death|0|||
27895273|NCT02686658|54548910|FG003|Overall Study|Death|1|||
27895274|NCT02686658|54548911|FG004|Overall Study|Death|1|||
27895275|NCT02686658|54548912|FG005|Overall Study|Death|1|||
27895276|NCT02686658|54548907|FG000|Overall Study|Withdrawal by Subject|2|||
27895277|NCT02686658|54548908|FG001|Overall Study|Withdrawal by Subject|5|||
27895278|NCT02686658|54548909|FG002|Overall Study|Withdrawal by Subject|4|||
27895279|NCT02686658|54548910|FG003|Overall Study|Withdrawal by Subject|4|||
27895280|NCT02686658|54548911|FG004|Overall Study|Withdrawal by Subject|17|||
27895281|NCT02686658|54548912|FG005|Overall Study|Withdrawal by Subject|8|||
27895282|NCT02686658|54548907|FG000|Overall Study|Placed in hospice care|0|||
27895283|NCT02686658|54548908|FG001|Overall Study|Placed in hospice care|0|||
27895284|NCT02686658|54548909|FG002|Overall Study|Placed in hospice care|1|||
27895285|NCT02686658|54548910|FG003|Overall Study|Placed in hospice care|0|||
27895286|NCT02686658|54548911|FG004|Overall Study|Placed in hospice care|0|||
27895287|NCT02686658|54548912|FG005|Overall Study|Placed in hospice care|0|||
27895288|NCT02686658|54548907|FG000|Overall Study|Participant non-compliance|0|||
27895289|NCT02686658|54548908|FG001|Overall Study|Participant non-compliance|0|||
27895290|NCT02686658|54548909|FG002|Overall Study|Participant non-compliance|0|||
27895291|NCT02686658|54548910|FG003|Overall Study|Participant non-compliance|0|||
27895292|NCT02686658|54548911|FG004|Overall Study|Participant non-compliance|0|||
27895293|NCT02686658|54548912|FG005|Overall Study|Participant non-compliance|1|||
27895294|NCT02686658|54548907|FG000|Overall Study|Concern over coronavirus disease care|0|||
27895295|NCT02686658|54548908|FG001|Overall Study|Concern over coronavirus disease care|0|||
27895296|NCT02686658|54548909|FG002|Overall Study|Concern over coronavirus disease care|0|||
27895297|NCT02686658|54548910|FG003|Overall Study|Concern over coronavirus disease care|0|||
27895298|NCT02686658|54548911|FG004|Overall Study|Concern over coronavirus disease care|2|||
27895299|NCT02686658|54548912|FG005|Overall Study|Concern over coronavirus disease care|1|||
27895300|NCT02674061|54548928|FG000|Overall Study|Death|229|||
27895301|NCT02674061|54548929|FG001|Overall Study|Death|77|||
27895302|NCT02674061|54548928|FG000|Overall Study|Lost to Follow-up|3|||
28171908|NCT02467192|54843527|FG000|Overall Study|revealed to have pneumonia before|2|||
28171909|NCT02410954|54843537|FG000|Overall Study|Unable to collect usable data due to initial protocol issues|6|||
28171910|NCT02410954|54843538|FG001|Overall Study|Unable to collect usable data due to initial protocol issues|0|||
28171911|NCT02410954|54843537|FG000|Overall Study|Instrument malfunction generated unusable data|8|||
28171912|NCT02410954|54843538|FG001|Overall Study|Instrument malfunction generated unusable data|0|||
28171913|NCT02689453|54843547|FG000|Overall Study|Progressive disease|0|||
28171914|NCT02689453|54843548|FG001|Overall Study|Progressive disease|1|||
28171915|NCT02689453|54843549|FG002|Overall Study|Progressive disease|1|||
28171916|NCT00701103|54843580|FG000|Overall Study|Adverse Event|0|||
28171917|NCT00701103|54843581|FG001|Overall Study|Adverse Event|0|||
28171918|NCT00701103|54843582|FG002|Overall Study|Adverse Event|1|||
28171919|NCT00701103|54843583|FG003|Overall Study|Adverse Event|1|||
28171920|NCT00701103|54843584|FG004|Overall Study|Adverse Event|0|||
28171921|NCT00701103|54843585|FG005|Overall Study|Adverse Event|1|||
28171922|NCT00701103|54843586|FG006|Overall Study|Adverse Event|1|||
28171923|NCT00701103|54843587|FG007|Overall Study|Adverse Event|0|||
28171924|NCT00701103|54843588|FG008|Overall Study|Adverse Event|0|||
28171925|NCT00701103|54843589|FG009|Overall Study|Adverse Event|2|||
28171926|NCT00701103|54843590|FG010|Overall Study|Adverse Event|0|||
28171927|NCT00701103|54843580|FG000|Overall Study|Progressive Disease|5|||
28171928|NCT00701103|54843581|FG001|Overall Study|Progressive Disease|2|||
27895303|NCT02674061|54548929|FG001|Overall Study|Lost to Follow-up|3|||
27895304|NCT02674061|54548928|FG000|Overall Study|Withdrawal by Subject|9|||
27895305|NCT02674061|54548929|FG001|Overall Study|Withdrawal by Subject|1|||
27895306|NCT02674061|54548928|FG000|Overall Study|Participation in Study Discontinued by Sponsor|44|||
27895307|NCT02674061|54548929|FG001|Overall Study|Participation in Study Discontinued by Sponsor|10|||
27895308|NCT02628444|54548949|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1|||
27895309|NCT02628444|54548950|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
27895310|NCT02628444|54548951|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
27895311|NCT02628444|54548952|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
27895312|NCT02628444|54548953|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
27895313|NCT02628444|54548954|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
27895314|NCT02628444|54548955|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
27895315|NCT02628444|54548956|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
27895316|NCT02628444|54548957|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
27895317|NCT02628444|54548949|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
27895318|NCT02628444|54548950|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4|||
27895319|NCT02628444|54548951|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3|||
27895320|NCT02628444|54548952|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
27895321|NCT02628444|54548953|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
27895322|NCT02628444|54548954|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
27895323|NCT02628444|54548955|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
27895324|NCT02628444|54548956|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
27895325|NCT02628444|54548957|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
27895326|NCT02628444|54548949|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21|||
27895327|NCT02628444|54548950|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16|||
27895328|NCT02628444|54548951|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25|||
28171929|NCT00701103|54843582|FG002|Overall Study|Progressive Disease|6|||
28171930|NCT00701103|54843583|FG003|Overall Study|Progressive Disease|5|||
28171931|NCT00701103|54843584|FG004|Overall Study|Progressive Disease|6|||
27895329|NCT02628444|54548952|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
27895330|NCT02628444|54548953|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
27895331|NCT02628444|54548954|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
27895332|NCT02628444|54548955|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
27895333|NCT02628444|54548956|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
27895334|NCT02628444|54548957|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
27895335|NCT02628444|54548949|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
27895336|NCT02628444|54548950|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16|||
27895337|NCT02628444|54548951|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
27895338|NCT02628444|54548952|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
27895339|NCT02628444|54548953|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
27895340|NCT02628444|54548954|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
27895341|NCT02628444|54548955|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
27895342|NCT02628444|54548956|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
27895343|NCT02628444|54548957|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
27895344|NCT02628444|54548949|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
27895345|NCT02628444|54548950|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3|||
27895346|NCT02628444|54548951|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
27895347|NCT02628444|54548952|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
27895348|NCT02628444|54548953|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
27895349|NCT02628444|54548954|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
27895350|NCT02628444|54548955|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
27895351|NCT02628444|54548956|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
27895352|NCT02628444|54548957|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
27895353|NCT02628444|54548949|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
27895354|NCT02628444|54548950|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
27895355|NCT02628444|54548951|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
27895356|NCT02628444|54548952|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1|||
27895357|NCT02628444|54548953|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
27895358|NCT02628444|54548954|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
27895359|NCT02628444|54548955|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
27895360|NCT02628444|54548956|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
27895361|NCT02628444|54548957|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
27895362|NCT02628444|54548949|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
27895363|NCT02628444|54548950|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
27895364|NCT02628444|54548951|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
27895365|NCT02628444|54548952|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
27895366|NCT02628444|54548953|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
27895367|NCT02628444|54548954|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
27895368|NCT02628444|54548955|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81|||
27895369|NCT02628444|54548956|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84|||
27895370|NCT02628444|54548957|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85|||
27895371|NCT02628444|54548949|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
27895372|NCT02628444|54548950|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
27895373|NCT02628444|54548951|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
27895374|NCT02628444|54548952|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5|||
27895375|NCT02628444|54548953|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6|||
27895376|NCT02628444|54548954|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10|||
27895377|NCT02628444|54548955|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12|||
27895378|NCT02628444|54548956|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11|||
27895379|NCT02628444|54548957|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9|||
27895380|NCT02628444|54548949|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
27895381|NCT02628444|54548950|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
27895382|NCT02628444|54548951|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
27895383|NCT02628444|54548952|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
27895384|NCT02628444|54548953|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
27895385|NCT02628444|54548954|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
27895386|NCT02628444|54548955|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
27895387|NCT02628444|54548956|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2|||
27895388|NCT02628444|54548957|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
27895389|NCT02628444|54548949|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
27895390|NCT02628444|54548950|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
27895391|NCT02628444|54548951|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
27895392|NCT02628444|54548952|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
27895393|NCT02628444|54548953|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
27895394|NCT02628444|54548954|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
27895395|NCT02628444|54548955|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3|||
27895396|NCT02628444|54548956|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
27895397|NCT02628444|54548957|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
27895398|NCT02623725|54548993|FG000|Overall Study|Non compliance with protocol|9|||
27895399|NCT02623725|54548994|FG001|Overall Study|Non compliance with protocol|3|||
27895400|NCT02623725|54548993|FG000|Overall Study|Serious adverse event|0|||
27895401|NCT02623725|54548994|FG001|Overall Study|Serious adverse event|2|||
27895402|NCT02623725|54548993|FG000|Overall Study|Withdrawal by Subject|7|||
27895403|NCT02623725|54548994|FG001|Overall Study|Withdrawal by Subject|1|||
27895404|NCT02608684|54549002|FG000|Overall Study|Physician Decision|2|||
27895405|NCT02608684|54549002|FG000|Overall Study|Withdrawal by Subject|1|||
27895406|NCT02587520|54549024|FG000|Overall Study|Protocol Violation|2|||
27895407|NCT02587520|54549025|FG001|Overall Study|Protocol Violation|0|||
27895408|NCT02587520|54549026|FG002|Overall Study|Protocol Violation|0|||
27895409|NCT02587520|54549027|FG003|Overall Study|Protocol Violation|2|||
27895410|NCT02587520|54549028|FG004|Overall Study|Protocol Violation|0|||
27895411|NCT02587520|54549029|FG005|Overall Study|Protocol Violation|1|||
27895412|NCT02587520|54549030|FG006|Overall Study|Protocol Violation|1|||
27895413|NCT02587520|54549031|FG007|Overall Study|Protocol Violation|1|||
27895414|NCT02587520|54549032|FG008|Overall Study|Protocol Violation|3|||
27895415|NCT02587520|54549033|FG009|Overall Study|Protocol Violation|3|||
27895416|NCT02587520|54549034|FG010|Overall Study|Protocol Violation|1|||
27895417|NCT02587520|54549035|FG011|Overall Study|Protocol Violation|2|||
27895418|NCT02587520|54549036|FG012|Overall Study|Protocol Violation|0|||
27895419|NCT02587520|54549037|FG013|Overall Study|Protocol Violation|0|||
27895420|NCT02587520|54549038|FG014|Overall Study|Protocol Violation|0|||
27895421|NCT02587520|54549039|FG015|Overall Study|Protocol Violation|0|||
27895422|NCT02587520|54549040|FG016|Overall Study|Protocol Violation|0|||
27895423|NCT02587520|54549041|FG017|Overall Study|Protocol Violation|0|||
27895424|NCT02587520|54549024|FG000|Overall Study|Adverse Event|0|||
27895425|NCT02587520|54549025|FG001|Overall Study|Adverse Event|0|||
27895426|NCT02587520|54549026|FG002|Overall Study|Adverse Event|0|||
27895427|NCT02587520|54549027|FG003|Overall Study|Adverse Event|0|||
27895428|NCT02587520|54549028|FG004|Overall Study|Adverse Event|0|||
27895429|NCT02587520|54549029|FG005|Overall Study|Adverse Event|0|||
27895430|NCT02587520|54549030|FG006|Overall Study|Adverse Event|0|||
27895431|NCT02587520|54549031|FG007|Overall Study|Adverse Event|0|||
27895432|NCT02587520|54549032|FG008|Overall Study|Adverse Event|0|||
27895433|NCT02587520|54549033|FG009|Overall Study|Adverse Event|0|||
27895434|NCT02587520|54549034|FG010|Overall Study|Adverse Event|0|||
27895435|NCT02587520|54549035|FG011|Overall Study|Adverse Event|1|||
27895436|NCT02587520|54549036|FG012|Overall Study|Adverse Event|0|||
27895437|NCT02587520|54549037|FG013|Overall Study|Adverse Event|0|||
27895438|NCT02587520|54549038|FG014|Overall Study|Adverse Event|0|||
27895439|NCT02587520|54549039|FG015|Overall Study|Adverse Event|0|||
27895440|NCT02587520|54549040|FG016|Overall Study|Adverse Event|0|||
27895441|NCT02587520|54549041|FG017|Overall Study|Adverse Event|0|||
27895442|NCT02587520|54549024|FG000|Overall Study|Withdrawal by Subject|0|||
27895443|NCT02587520|54549025|FG001|Overall Study|Withdrawal by Subject|0|||
27895444|NCT02587520|54549026|FG002|Overall Study|Withdrawal by Subject|1|||
27895445|NCT02587520|54549027|FG003|Overall Study|Withdrawal by Subject|1|||
27895446|NCT02587520|54549028|FG004|Overall Study|Withdrawal by Subject|0|||
27895447|NCT02587520|54549029|FG005|Overall Study|Withdrawal by Subject|1|||
27895448|NCT02587520|54549030|FG006|Overall Study|Withdrawal by Subject|1|||
27895449|NCT02587520|54549031|FG007|Overall Study|Withdrawal by Subject|0|||
27895450|NCT02587520|54549032|FG008|Overall Study|Withdrawal by Subject|0|||
27895451|NCT02587520|54549033|FG009|Overall Study|Withdrawal by Subject|0|||
27895452|NCT02587520|54549034|FG010|Overall Study|Withdrawal by Subject|0|||
27895453|NCT02587520|54549035|FG011|Overall Study|Withdrawal by Subject|0|||
27895454|NCT02587520|54549036|FG012|Overall Study|Withdrawal by Subject|0|||
27895455|NCT02587520|54549037|FG013|Overall Study|Withdrawal by Subject|1|||
27895456|NCT02587520|54549038|FG014|Overall Study|Withdrawal by Subject|0|||
27895457|NCT02587520|54549039|FG015|Overall Study|Withdrawal by Subject|0|||
27895458|NCT02587520|54549040|FG016|Overall Study|Withdrawal by Subject|0|||
27895459|NCT02587520|54549041|FG017|Overall Study|Withdrawal by Subject|0|||
27895460|NCT02587520|54549024|FG000|Overall Study|Lost to Follow-up|0|||
27895461|NCT02587520|54549025|FG001|Overall Study|Lost to Follow-up|2|||
27895462|NCT02587520|54549026|FG002|Overall Study|Lost to Follow-up|0|||
27895463|NCT02587520|54549027|FG003|Overall Study|Lost to Follow-up|2|||
27895464|NCT02587520|54549028|FG004|Overall Study|Lost to Follow-up|0|||
27895465|NCT02587520|54549029|FG005|Overall Study|Lost to Follow-up|1|||
27895466|NCT02587520|54549030|FG006|Overall Study|Lost to Follow-up|1|||
27895467|NCT02587520|54549031|FG007|Overall Study|Lost to Follow-up|1|||
27895468|NCT02587520|54549032|FG008|Overall Study|Lost to Follow-up|0|||
27895469|NCT02587520|54549033|FG009|Overall Study|Lost to Follow-up|2|||
27895470|NCT02587520|54549034|FG010|Overall Study|Lost to Follow-up|2|||
27895471|NCT02587520|54549035|FG011|Overall Study|Lost to Follow-up|1|||
27895472|NCT02587520|54549036|FG012|Overall Study|Lost to Follow-up|0|||
27895473|NCT02587520|54549037|FG013|Overall Study|Lost to Follow-up|0|||
27895474|NCT02587520|54549038|FG014|Overall Study|Lost to Follow-up|0|||
27895475|NCT02587520|54549039|FG015|Overall Study|Lost to Follow-up|0|||
27895476|NCT02587520|54549040|FG016|Overall Study|Lost to Follow-up|0|||
27895477|NCT02587520|54549041|FG017|Overall Study|Lost to Follow-up|0|||
27895478|NCT02584829|54549081|FG000|Overall Study|Physician Decision|1|||
27895479|NCT02584829|54549082|FG001|Overall Study|Physician Decision|0|||
27895480|NCT02584829|54549081|FG000|Overall Study|Withdrawal by Subject|0|||
27895481|NCT02584829|54549082|FG001|Overall Study|Withdrawal by Subject|1|||
27895482|NCT02584829|54549081|FG000|Overall Study|Progressive Disease|0|||
27895483|NCT02584829|54549082|FG001|Overall Study|Progressive Disease|3|||
27895484|NCT02570308|54549095|FG000|Overall Study|Death|1|||
27895485|NCT02570308|54549096|FG001|Overall Study|Death|5|||
27895486|NCT02570308|54549097|FG002|Overall Study|Death|4|||
27895487|NCT02570308|54549098|FG003|Overall Study|Death|4|||
27895488|NCT02570308|54549099|FG004|Overall Study|Death|69|||
27895489|NCT02570308|54549095|FG000|Overall Study|Lost to Follow-up|0|||
27895490|NCT02570308|54549096|FG001|Overall Study|Lost to Follow-up|0|||
27895491|NCT02570308|54549097|FG002|Overall Study|Lost to Follow-up|0|||
27895492|NCT02570308|54549098|FG003|Overall Study|Lost to Follow-up|0|||
27895493|NCT02570308|54549099|FG004|Overall Study|Lost to Follow-up|2|||
27895494|NCT02570308|54549095|FG000|Overall Study|Withdrawal by Subject|0|||
27895495|NCT02570308|54549096|FG001|Overall Study|Withdrawal by Subject|0|||
27895496|NCT02570308|54549097|FG002|Overall Study|Withdrawal by Subject|0|||
27895497|NCT02570308|54549098|FG003|Overall Study|Withdrawal by Subject|0|||
27895498|NCT02570308|54549099|FG004|Overall Study|Withdrawal by Subject|1|||
27895499|NCT02570308|54549095|FG000|Overall Study|Other|0|||
27985823|NCT02393248|54644421|FG010|Part 2: Monotherapy Dose Expansion|Death|3|||
27985824|NCT02393248|54644422|FG011|Part 2: Monotherapy Dose Expansion|Death|29|||
27985825|NCT02393248|54644423|FG012|Part 2: Monotherapy Dose Expansion|Death|4|||
27985826|NCT02393248|54644424|FG013|Part 2: Monotherapy Dose Expansion|Death|15|||
27985827|NCT02393248|54644425|FG014|Part 2: Monotherapy Dose Expansion|Death|2|||
27985828|NCT02393248|54644426|FG015|Part 2: Monotherapy Dose Expansion|Death|0|||
27985829|NCT02393248|54644427|FG016|Part 2: Monotherapy Dose Expansion|Death|0|||
27985830|NCT02393248|54644428|FG017|Part 2: Monotherapy Dose Expansion|Death|0|||
27985831|NCT02393248|54644429|FG018|Part 2: Monotherapy Dose Expansion|Death|0|||
27985832|NCT02393248|54644430|FG019|Part 2: Monotherapy Dose Expansion|Death|0|||
27985833|NCT02393248|54644431|FG020|Part 2: Monotherapy Dose Expansion|Death|0|||
27985834|NCT02393248|54644432|FG021|Part 2: Monotherapy Dose Expansion|Death|0|||
27985835|NCT02393248|54644433|FG022|Part 2: Monotherapy Dose Expansion|Death|0|||
27985836|NCT02393248|54644434|FG023|Part 2: Monotherapy Dose Expansion|Death|0|||
27985837|NCT02393248|54644435|FG024|Part 2: Monotherapy Dose Expansion|Death|0|||
27895500|NCT02570308|54549096|FG001|Overall Study|Other|0|||
27895501|NCT02570308|54549097|FG002|Overall Study|Other|0|||
27895502|NCT02570308|54549098|FG003|Overall Study|Other|0|||
27895503|NCT02570308|54549099|FG004|Overall Study|Other|2|||
27895504|NCT02497612|54549121|FG000|Overall Study|Met >=1 anti-malarial treatment criteria|57|||
27895505|NCT02497612|54549122|FG001|Overall Study|Met >=1 anti-malarial treatment criteria|51|||
27895506|NCT02497612|54549123|FG002|Overall Study|Met >=1 anti-malarial treatment criteria|39|||
27895507|NCT02497612|54549124|FG003|Overall Study|Met >=1 anti-malarial treatment criteria|41|||
27985838|NCT02393248|54644411|FG000|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
27985839|NCT02393248|54644412|FG001|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
27985840|NCT02393248|54644413|FG002|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
27985841|NCT02393248|54644414|FG003|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
27985842|NCT02393248|54644415|FG004|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
27985843|NCT02393248|54644416|FG005|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
27985844|NCT02393248|54644417|FG006|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
28096722|NCT03681470|54751898|FG000|Overall Study|Protocol Violation|3|||
28096723|NCT03681470|54751898|FG000|Overall Study|Withdrawal by Subject|1|||
27895508|NCT02497612|54549121|FG000|Overall Study|Participant's request|2|||
27895509|NCT02497612|54549122|FG001|Overall Study|Participant's request|3|||
27895510|NCT02497612|54549123|FG002|Overall Study|Participant's request|4|||
27895511|NCT02497612|54549124|FG003|Overall Study|Participant's request|1|||
27895512|NCT02497612|54549121|FG000|Overall Study|Investigator's judgement|1|||
27895513|NCT02497612|54549122|FG001|Overall Study|Investigator's judgement|0|||
27895514|NCT02497612|54549123|FG002|Overall Study|Investigator's judgement|0|||
27895515|NCT02497612|54549124|FG003|Overall Study|Investigator's judgement|2|||
27895516|NCT02497612|54549121|FG000|Overall Study|Adverse Event|3|||
27895517|NCT02497612|54549122|FG001|Overall Study|Adverse Event|1|||
27895518|NCT02497612|54549123|FG002|Overall Study|Adverse Event|4|||
27895519|NCT02497612|54549124|FG003|Overall Study|Adverse Event|1|||
27895520|NCT02497612|54549121|FG000|Overall Study|Lost to Follow-up|1|||
27895521|NCT02497612|54549122|FG001|Overall Study|Lost to Follow-up|1|||
27895522|NCT02497612|54549123|FG002|Overall Study|Lost to Follow-up|0|||
27895523|NCT02497612|54549124|FG003|Overall Study|Lost to Follow-up|1|||
27895524|NCT02497612|54549121|FG000|Overall Study|Other unspecified|1|||
27895525|NCT02497612|54549122|FG001|Overall Study|Other unspecified|1|||
27895526|NCT02497612|54549123|FG002|Overall Study|Other unspecified|2|||
27895527|NCT02497612|54549124|FG003|Overall Study|Other unspecified|0|||
27895528|NCT02497612|54549121|FG000|Overall Study|Not eligible|1|||
27895529|NCT02497612|54549122|FG001|Overall Study|Not eligible|0|||
27895530|NCT02497612|54549123|FG002|Overall Study|Not eligible|0|||
27895531|NCT02497612|54549124|FG003|Overall Study|Not eligible|1|||
27895532|NCT02460458|54549134|FG000|Confirmatory Phase|Patients excluded basing on phenotype central analyses|47|||
27895533|NCT02460458|54549134|FG000|Confirmatory Phase|Patients excluded due to lack of samples for central analyses|27|||
27895534|NCT02460458|54549134|FG000|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|14|||
27895535|NCT02460458|54549134|FG000|First Prospective Phase|Lost to Follow-up|16|||
27895536|NCT02460458|54549134|FG000|Confirmation of Clinical Phase Data|Lost to Follow-up|9|||
27895537|NCT02457559|54549149|FG000|Overall Study|Progressive Disease|1|||
27895538|NCT02457559|54549150|FG001|Overall Study|Progressive Disease|2|||
27895539|NCT02457559|54549151|FG002|Overall Study|Progressive Disease|3|||
27895540|NCT02457559|54549152|FG003|Overall Study|Progressive Disease|0|||
27895541|NCT02457559|54549153|FG004|Overall Study|Progressive Disease|0|||
27895542|NCT02457559|54549154|FG005|Overall Study|Progressive Disease|2|||
27895543|NCT02457559|54549155|FG006|Overall Study|Progressive Disease|1|||
27895544|NCT02457559|54549156|FG007|Overall Study|Progressive Disease|0|||
27895545|NCT02457559|54549157|FG008|Overall Study|Progressive Disease|1|||
27895546|NCT02457559|54549158|FG009|Overall Study|Progressive Disease|1|||
27895547|NCT02457559|54549159|FG010|Overall Study|Progressive Disease|1|||
27895548|NCT02457559|54549149|FG000|Overall Study|Investigator's Discretion|0|||
27895549|NCT02457559|54549150|FG001|Overall Study|Investigator's Discretion|0|||
27895550|NCT02457559|54549151|FG002|Overall Study|Investigator's Discretion|2|||
27895551|NCT02457559|54549152|FG003|Overall Study|Investigator's Discretion|0|||
27895552|NCT02457559|54549153|FG004|Overall Study|Investigator's Discretion|1|||
27895553|NCT02457559|54549154|FG005|Overall Study|Investigator's Discretion|0|||
27895554|NCT02457559|54549155|FG006|Overall Study|Investigator's Discretion|1|||
27895555|NCT02457559|54549156|FG007|Overall Study|Investigator's Discretion|0|||
27895556|NCT02457559|54549157|FG008|Overall Study|Investigator's Discretion|1|||
27895557|NCT02457559|54549158|FG009|Overall Study|Investigator's Discretion|0|||
27895558|NCT02457559|54549159|FG010|Overall Study|Investigator's Discretion|1|||
27895559|NCT02457559|54549149|FG000|Overall Study|Adverse Event|0|||
27895560|NCT02457559|54549150|FG001|Overall Study|Adverse Event|1|||
27895561|NCT02457559|54549151|FG002|Overall Study|Adverse Event|2|||
27895562|NCT02457559|54549152|FG003|Overall Study|Adverse Event|0|||
27895563|NCT02457559|54549153|FG004|Overall Study|Adverse Event|0|||
27895564|NCT02457559|54549154|FG005|Overall Study|Adverse Event|0|||
27895565|NCT02457559|54549155|FG006|Overall Study|Adverse Event|0|||
27895566|NCT02457559|54549156|FG007|Overall Study|Adverse Event|0|||
27895567|NCT02457559|54549157|FG008|Overall Study|Adverse Event|0|||
27895568|NCT02457559|54549158|FG009|Overall Study|Adverse Event|0|||
27895569|NCT02457559|54549159|FG010|Overall Study|Adverse Event|0|||
27895570|NCT02457559|54549149|FG000|Overall Study|Reason not Specified|1|||
27895571|NCT02457559|54549150|FG001|Overall Study|Reason not Specified|0|||
27895572|NCT02457559|54549151|FG002|Overall Study|Reason not Specified|0|||
27895573|NCT02457559|54549152|FG003|Overall Study|Reason not Specified|0|||
27895574|NCT02457559|54549153|FG004|Overall Study|Reason not Specified|0|||
27895575|NCT02457559|54549154|FG005|Overall Study|Reason not Specified|0|||
27895576|NCT02457559|54549155|FG006|Overall Study|Reason not Specified|0|||
27895577|NCT02457559|54549156|FG007|Overall Study|Reason not Specified|0|||
27895578|NCT02457559|54549157|FG008|Overall Study|Reason not Specified|0|||
27895579|NCT02457559|54549158|FG009|Overall Study|Reason not Specified|2|||
27895580|NCT02457559|54549159|FG010|Overall Study|Reason not Specified|0|||
27895581|NCT02457559|54549149|FG000|Overall Study|Death|0|||
27985845|NCT02393248|54644418|FG007|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
27985846|NCT02393248|54644419|FG008|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
27895582|NCT02457559|54549150|FG001|Overall Study|Death|0|||
27895583|NCT02457559|54549151|FG002|Overall Study|Death|0|||
27895584|NCT02457559|54549152|FG003|Overall Study|Death|0|||
27895585|NCT02457559|54549153|FG004|Overall Study|Death|0|||
27895586|NCT02457559|54549154|FG005|Overall Study|Death|0|||
27895587|NCT02457559|54549155|FG006|Overall Study|Death|0|||
27895588|NCT02457559|54549156|FG007|Overall Study|Death|0|||
27895589|NCT02457559|54549157|FG008|Overall Study|Death|1|||
27895590|NCT02457559|54549158|FG009|Overall Study|Death|1|||
27895591|NCT02457559|54549159|FG010|Overall Study|Death|0|||
27895592|NCT02381652|54549209|FG000|Overall Study|Withdrawal by Subject|0|||
27895593|NCT02381652|54549210|FG001|Overall Study|Withdrawal by Subject|0|||
27895594|NCT02381652|54549211|FG002|Overall Study|Withdrawal by Subject|1|||
27895595|NCT02367794|54549220|FG000|Overall Study|Death|252|||
27895596|NCT02367794|54549221|FG001|Overall Study|Death|245|||
27895597|NCT02367794|54549222|FG002|Overall Study|Death|243|||
27895598|NCT02367794|54549220|FG000|Overall Study|Lost to Follow-up|1|||
27895599|NCT02367794|54549221|FG001|Overall Study|Lost to Follow-up|2|||
27895600|NCT02367794|54549222|FG002|Overall Study|Lost to Follow-up|2|||
27895601|NCT02367794|54549220|FG000|Overall Study|Physician Decision|0|||
27895602|NCT02367794|54549221|FG001|Overall Study|Physician Decision|5|||
27895603|NCT02367794|54549222|FG002|Overall Study|Physician Decision|3|||
27895604|NCT02367794|54549220|FG000|Overall Study|Protocol Violation|1|||
27895605|NCT02367794|54549221|FG001|Overall Study|Protocol Violation|0|||
27895606|NCT02367794|54549222|FG002|Overall Study|Protocol Violation|1|||
27895607|NCT02367794|54549220|FG000|Overall Study|Withdrawal by Subject|25|||
27895608|NCT02367794|54549221|FG001|Overall Study|Withdrawal by Subject|12|||
27895609|NCT02367794|54549222|FG002|Overall Study|Withdrawal by Subject|20|||
27895610|NCT02367794|54549220|FG000|Overall Study|Brain metastasis|1|||
27895611|NCT02367794|54549221|FG001|Overall Study|Brain metastasis|0|||
27895612|NCT02367794|54549222|FG002|Overall Study|Brain metastasis|0|||
27895613|NCT02367794|54549220|FG000|Overall Study|Randomized in error|0|||
27895614|NCT02367794|54549221|FG001|Overall Study|Randomized in error|0|||
27895615|NCT02367794|54549222|FG002|Overall Study|Randomized in error|1|||
27895616|NCT02367794|54549220|FG000|Overall Study|Patient unable to receive carboplatin|0|||
27895617|NCT02367794|54549221|FG001|Overall Study|Patient unable to receive carboplatin|0|||
27895618|NCT02367794|54549222|FG002|Overall Study|Patient unable to receive carboplatin|1|||
27895619|NCT02367794|54549220|FG000|Overall Study|Hypercalcemia prior to C1D1|0|||
27895620|NCT02367794|54549221|FG001|Overall Study|Hypercalcemia prior to C1D1|0|||
27895621|NCT02367794|54549222|FG002|Overall Study|Hypercalcemia prior to C1D1|1|||
27895622|NCT02367794|54549220|FG000|Overall Study|Adverse Event|0|||
27895623|NCT02367794|54549221|FG001|Overall Study|Adverse Event|0|||
27895624|NCT02367794|54549222|FG002|Overall Study|Adverse Event|2|||
27895625|NCT02367794|54549220|FG000|Overall Study|Study Terminated By Sponsor|0|||
27895626|NCT02367794|54549221|FG001|Overall Study|Study Terminated By Sponsor|1|||
27895627|NCT02367794|54549222|FG002|Overall Study|Study Terminated By Sponsor|1|||
27895628|NCT02367794|54549220|FG000|Overall Study|Moved to Roll-Over Study|0|||
27895629|NCT02367794|54549221|FG001|Overall Study|Moved to Roll-Over Study|15|||
27895630|NCT02367794|54549222|FG002|Overall Study|Moved to Roll-Over Study|13|||
27895631|NCT02367794|54549220|FG000|Overall Study|Sponsor Request|60|||
27895632|NCT02367794|54549221|FG001|Overall Study|Sponsor Request|57|||
27895633|NCT02367794|54549222|FG002|Overall Study|Sponsor Request|45|||
27895634|NCT02367794|54549220|FG000|Overall Study|Moved into PTAP Study|0|||
27895635|NCT02367794|54549221|FG001|Overall Study|Moved into PTAP Study|2|||
27895636|NCT02367794|54549222|FG002|Overall Study|Moved into PTAP Study|3|||
27895637|NCT02367794|54549220|FG000|Overall Study|Moved to Commercial Atezolizumab Use|0|||
27895638|NCT02367794|54549221|FG001|Overall Study|Moved to Commercial Atezolizumab Use|2|||
27895639|NCT02367794|54549222|FG002|Overall Study|Moved to Commercial Atezolizumab Use|1|||
27895640|NCT02367794|54549220|FG000|Overall Study|Investigational Product Availability in Commercial Stock|0|||
27895641|NCT02367794|54549221|FG001|Overall Study|Investigational Product Availability in Commercial Stock|1|||
27895642|NCT02367794|54549222|FG002|Overall Study|Investigational Product Availability in Commercial Stock|0|||
27895643|NCT02367794|54549220|FG000|Overall Study|Participant Enrolled in Extended Protocol|0|||
27895644|NCT02367794|54549221|FG001|Overall Study|Participant Enrolled in Extended Protocol|1|||
27895645|NCT02367794|54549222|FG002|Overall Study|Participant Enrolled in Extended Protocol|0|||
27895646|NCT02367794|54549220|FG000|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
27895647|NCT02367794|54549221|FG001|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
27895648|NCT02367794|54549222|FG002|Overall Study|Discontinuation Matched Treatment Discontinuation|1|||
27895649|NCT02353832|54549255|FG000|Overall Study|Ineligible after enrollment|1|||
27895650|NCT02353832|54549255|FG000|Overall Study|Lost to Follow-up|1|||
27895651|NCT02353728|54549259|FG000|Overall Study|Subject non-compliance|1|||
28171932|NCT00701103|54843585|FG005|Overall Study|Progressive Disease|5|||
27895652|NCT02345070|54549266|FG000|Overall Study|Adverse Event|12|||
27895653|NCT02345070|54549267|FG001|Overall Study|Adverse Event|8|||
27895654|NCT02345070|54549268|FG002|Overall Study|Adverse Event|16|||
27895655|NCT02345070|54549266|FG000|Overall Study|Poor compliance to protocol|2|||
27895656|NCT02345070|54549267|FG001|Overall Study|Poor compliance to protocol|0|||
27895657|NCT02345070|54549268|FG002|Overall Study|Poor compliance to protocol|0|||
27895658|NCT02345070|54549266|FG000|Overall Study|Other than specified above|6|||
28171933|NCT00701103|54843586|FG006|Overall Study|Progressive Disease|7|||
27895659|NCT02345070|54549267|FG001|Overall Study|Other than specified above|3|||
27895660|NCT02345070|54549268|FG002|Overall Study|Other than specified above|7|||
27895661|NCT02325466|54549276|FG000|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
27895662|NCT02325466|54549277|FG001|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
27895663|NCT02325466|54549278|FG002|Period 1 Timeframe - Baseline to Week 4|Adverse Event|1|||
27895664|NCT02325466|54549276|FG000|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
27895665|NCT02325466|54549277|FG001|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|2|||
27895666|NCT02325466|54549278|FG002|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
27895667|NCT02325466|54549276|FG000|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|1|||
27895668|NCT02325466|54549277|FG001|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|0|||
27895669|NCT02325466|54549278|FG002|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|2|||
27895670|NCT02325466|54549276|FG000|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|1|||
27895671|NCT02325466|54549277|FG001|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
27895672|NCT02325466|54549278|FG002|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
27895673|NCT02325466|54549276|FG000|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
27895674|NCT02325466|54549277|FG001|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
27895675|NCT02325466|54549278|FG002|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|0|||
27895676|NCT02325466|54549276|FG000|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|1|||
27895677|NCT02325466|54549277|FG001|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
27895678|NCT02325466|54549278|FG002|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
27895679|NCT02325466|54549276|FG000|3rd Crossover - Week 10 to Week 16|Adverse Event|1|||
27895680|NCT02325466|54549277|FG001|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
27895681|NCT02325466|54549278|FG002|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
27895682|NCT02325466|54549276|FG000|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
27895683|NCT02325466|54549277|FG001|3rd Crossover - Week 10 to Week 16|Protocol Violation|1|||
27895684|NCT02325466|54549278|FG002|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
27895685|NCT02325466|54549276|FG000|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
27895686|NCT02325466|54549277|FG001|3rd Crossover - Week 10 to Week 16|urgent vascularization|1|||
27895687|NCT02325466|54549278|FG002|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
27895688|NCT02322710|54549289|FG000|Overall Study|No efficacy assessment post-baseline|0|||
27895689|NCT02322710|54549290|FG001|Overall Study|No efficacy assessment post-baseline|1|||
27895690|NCT02322710|54549289|FG000|Overall Study|Protocol Violation|20|||
27895691|NCT02322710|54549290|FG001|Overall Study|Protocol Violation|25|||
27895692|NCT02234310|54549333|FG000|Overall Study|Physician Decision|1|||
27895693|NCT02234310|54549333|FG000|Overall Study|Adverse Event|1|||
27895694|NCT02234310|54549333|FG000|Overall Study|Eligibility Criteria not fulfilled|2|||
27895695|NCT02234310|54549333|FG000|Overall Study|Withdrawal by Subject|2|||
27895696|NCT02106195|54549366|FG000|Overall Study|Adverse Event|2|||
27895697|NCT02106195|54549366|FG000|Overall Study|Protocol Violation|1|||
27895698|NCT02104180|54549378|FG000|Overall Study|Protocol Violation|1|||
27895699|NCT02104180|54549379|FG001|Overall Study|Protocol Violation|0|||
27895700|NCT02040857|54549389|FG000|Overall Study|Adverse Event|14|||
27895701|NCT02040857|54549389|FG000|Overall Study|Physician Decision|5|||
27895702|NCT02040857|54549389|FG000|Overall Study|Withdrawal by Subject|31|||
27895703|NCT02040857|54549389|FG000|Overall Study|patient non-compliance|3|||
28096724|NCT04343976|54751904|FG000|Overall Study|Withdrawal by Subject|0|||
28096725|NCT04343976|54751905|FG001|Overall Study|Withdrawal by Subject|1|||
28096726|NCT03322540|54751913|FG000|Overall Study|Death|21|||
28096727|NCT03322540|54751914|FG001|Overall Study|Death|28|||
28096728|NCT03322540|54751913|FG000|Overall Study|Lost to Follow-up|0|||
28096729|NCT03322540|54751914|FG001|Overall Study|Lost to Follow-up|1|||
28096730|NCT03322540|54751913|FG000|Overall Study|Physician Decision|7|||
28096731|NCT03322540|54751914|FG001|Overall Study|Physician Decision|6|||
28096732|NCT03322540|54751913|FG000|Overall Study|Withdrawal by Subject|3|||
28096733|NCT03322540|54751914|FG001|Overall Study|Withdrawal by Subject|1|||
28096734|NCT03322540|54751913|FG000|Overall Study|Study terminated by sponsor|0|||
28096735|NCT03322540|54751914|FG001|Overall Study|Study terminated by sponsor|1|||
28096736|NCT04339296|54751924|FG000|Overall Study|Refuse to participate after allocation|1|||
28096737|NCT04339296|54751925|FG001|Overall Study|Refuse to participate after allocation|1|||
28096738|NCT04339296|54751924|FG000|Overall Study|Withdrew after completion of baseline|2|||
28096739|NCT04339296|54751925|FG001|Overall Study|Withdrew after completion of baseline|1|||
28096740|NCT04339296|54751924|FG000|Overall Study|Lost to Follow-up|0|||
28096741|NCT04339296|54751925|FG001|Overall Study|Lost to Follow-up|4|||
28096742|NCT04339296|54751924|FG000|Overall Study|Discontinued intervention|5|||
28096743|NCT04339296|54751925|FG001|Overall Study|Discontinued intervention|3|||
28096744|NCT02025556|54751934|FG000|Overall Study|Adverse Event|0|||
28096745|NCT02025556|54751935|FG001|Overall Study|Adverse Event|4|||
28096746|NCT02025556|54751936|FG002|Overall Study|Adverse Event|2|||
27895704|NCT02040857|54549389|FG000|Overall Study|Lost to Follow-up|2|||
28096747|NCT02025556|54751934|FG000|Overall Study|Lack of Efficacy|2|||
28096748|NCT02025556|54751935|FG001|Overall Study|Lack of Efficacy|1|||
27895705|NCT02040857|54549389|FG000|Overall Study|recurrence|4|||
27895706|NCT02040857|54549389|FG000|Overall Study|ineligible|1|||
27895707|NCT01943825|54549409|FG000|Overall Study|Lost to Follow-up|9|||
27895708|NCT01943825|54549410|FG001|Overall Study|Lost to Follow-up|3|||
27895709|NCT01943825|54549411|FG002|Overall Study|Lost to Follow-up|12|||
28096749|NCT02025556|54751936|FG002|Overall Study|Lack of Efficacy|0|||
28096750|NCT02025556|54751934|FG000|Overall Study|Protocol Violation|2|||
28096751|NCT02025556|54751935|FG001|Overall Study|Protocol Violation|1|||
28096752|NCT02025556|54751936|FG002|Overall Study|Protocol Violation|0|||
27895710|NCT01943825|54549412|FG003|Overall Study|Lost to Follow-up|8|||
27895711|NCT01943825|54549409|FG000|Overall Study|Withdrawal by Subject|1|||
27895712|NCT01943825|54549410|FG001|Overall Study|Withdrawal by Subject|0|||
27895713|NCT01943825|54549411|FG002|Overall Study|Withdrawal by Subject|3|||
27895714|NCT01943825|54549412|FG003|Overall Study|Withdrawal by Subject|2|||
27895715|NCT01943825|54549409|FG000|Overall Study|Other than specified above|0|||
27895716|NCT01943825|54549410|FG001|Overall Study|Other than specified above|1|||
27895717|NCT01943825|54549411|FG002|Overall Study|Other than specified above|0|||
27895718|NCT01943825|54549412|FG003|Overall Study|Other than specified above|1|||
27895719|NCT01722331|54549444|FG000|Part 1|Adverse Event|5|||
27895720|NCT01722331|54549445|FG001|Part 1|Adverse Event|0|||
27895721|NCT01722331|54549446|FG002|Part 1|Adverse Event|0|||
27895722|NCT01722331|54549447|FG003|Part 1|Adverse Event|0|||
27895723|NCT01722331|54549448|FG004|Part 1|Adverse Event|0|||
27895724|NCT01722331|54549449|FG005|Part 1|Adverse Event|0|||
27895725|NCT01722331|54549450|FG006|Part 1|Adverse Event|0|||
27895726|NCT01722331|54549444|FG000|Part 1|Lack of Efficacy|0|||
27895727|NCT01722331|54549445|FG001|Part 1|Lack of Efficacy|0|||
27895728|NCT01722331|54549446|FG002|Part 1|Lack of Efficacy|1|||
27895729|NCT01722331|54549447|FG003|Part 1|Lack of Efficacy|0|||
27895730|NCT01722331|54549448|FG004|Part 1|Lack of Efficacy|2|||
27895731|NCT01722331|54549449|FG005|Part 1|Lack of Efficacy|0|||
27895732|NCT01722331|54549450|FG006|Part 1|Lack of Efficacy|0|||
27895733|NCT01722331|54549444|FG000|Part 1|Lost to Follow-up|1|||
27895734|NCT01722331|54549445|FG001|Part 1|Lost to Follow-up|0|||
27895735|NCT01722331|54549446|FG002|Part 1|Lost to Follow-up|2|||
27895736|NCT01722331|54549447|FG003|Part 1|Lost to Follow-up|0|||
27895737|NCT01722331|54549448|FG004|Part 1|Lost to Follow-up|1|||
27895738|NCT01722331|54549449|FG005|Part 1|Lost to Follow-up|0|||
27895739|NCT01722331|54549450|FG006|Part 1|Lost to Follow-up|0|||
27895740|NCT01722331|54549444|FG000|Part 1|Physician Decision|0|||
27895741|NCT01722331|54549445|FG001|Part 1|Physician Decision|0|||
27895742|NCT01722331|54549446|FG002|Part 1|Physician Decision|3|||
27895743|NCT01722331|54549447|FG003|Part 1|Physician Decision|0|||
27895744|NCT01722331|54549448|FG004|Part 1|Physician Decision|1|||
27895745|NCT01722331|54549449|FG005|Part 1|Physician Decision|0|||
27895746|NCT01722331|54549450|FG006|Part 1|Physician Decision|0|||
27895747|NCT01722331|54549444|FG000|Part 1|Pregnancy|1|||
27895748|NCT01722331|54549445|FG001|Part 1|Pregnancy|0|||
27895749|NCT01722331|54549446|FG002|Part 1|Pregnancy|0|||
27895750|NCT01722331|54549447|FG003|Part 1|Pregnancy|0|||
27895751|NCT01722331|54549448|FG004|Part 1|Pregnancy|0|||
27895752|NCT01722331|54549449|FG005|Part 1|Pregnancy|0|||
27895753|NCT01722331|54549450|FG006|Part 1|Pregnancy|0|||
27895754|NCT01722331|54549444|FG000|Part 1|Progressive Disease|0|||
27895755|NCT01722331|54549445|FG001|Part 1|Progressive Disease|0|||
27895756|NCT01722331|54549446|FG002|Part 1|Progressive Disease|0|||
27895757|NCT01722331|54549447|FG003|Part 1|Progressive Disease|0|||
27895758|NCT01722331|54549448|FG004|Part 1|Progressive Disease|1|||
27895759|NCT01722331|54549449|FG005|Part 1|Progressive Disease|0|||
27895760|NCT01722331|54549450|FG006|Part 1|Progressive Disease|0|||
27895761|NCT01722331|54549444|FG000|Part 1|Protocol Violation|1|||
27895762|NCT01722331|54549445|FG001|Part 1|Protocol Violation|0|||
27895763|NCT01722331|54549446|FG002|Part 1|Protocol Violation|0|||
27895764|NCT01722331|54549447|FG003|Part 1|Protocol Violation|0|||
27895765|NCT01722331|54549448|FG004|Part 1|Protocol Violation|1|||
27895766|NCT01722331|54549449|FG005|Part 1|Protocol Violation|0|||
27895767|NCT01722331|54549450|FG006|Part 1|Protocol Violation|0|||
27895768|NCT01722331|54549444|FG000|Part 1|Withdrawal by Subject|2|||
27895769|NCT01722331|54549445|FG001|Part 1|Withdrawal by Subject|0|||
27895770|NCT01722331|54549446|FG002|Part 1|Withdrawal by Subject|3|||
27895771|NCT01722331|54549447|FG003|Part 1|Withdrawal by Subject|0|||
27895772|NCT01722331|54549448|FG004|Part 1|Withdrawal by Subject|3|||
27895773|NCT01722331|54549449|FG005|Part 1|Withdrawal by Subject|0|||
27895774|NCT01722331|54549450|FG006|Part 1|Withdrawal by Subject|0|||
27895775|NCT01722331|54549444|FG000|Part 2|Adverse Event|3|||
27895776|NCT01722331|54549445|FG001|Part 2|Adverse Event|0|||
27895777|NCT01722331|54549446|FG002|Part 2|Adverse Event|0|||
27895778|NCT01722331|54549447|FG003|Part 2|Adverse Event|0|||
27895779|NCT01722331|54549448|FG004|Part 2|Adverse Event|0|||
27895780|NCT01722331|54549449|FG005|Part 2|Adverse Event|1|||
27895781|NCT01722331|54549450|FG006|Part 2|Adverse Event|0|||
27895782|NCT01722331|54549444|FG000|Part 2|Lack of Efficacy|3|||
27895783|NCT01722331|54549445|FG001|Part 2|Lack of Efficacy|0|||
27895784|NCT01722331|54549446|FG002|Part 2|Lack of Efficacy|11|||
27895785|NCT01722331|54549447|FG003|Part 2|Lack of Efficacy|0|||
27895786|NCT01722331|54549448|FG004|Part 2|Lack of Efficacy|0|||
27895787|NCT01722331|54549449|FG005|Part 2|Lack of Efficacy|3|||
27895788|NCT01722331|54549450|FG006|Part 2|Lack of Efficacy|3|||
27895789|NCT01722331|54549444|FG000|Part 2|Lost to Follow-up|0|||
27895790|NCT01722331|54549445|FG001|Part 2|Lost to Follow-up|0|||
27895791|NCT01722331|54549446|FG002|Part 2|Lost to Follow-up|3|||
27895792|NCT01722331|54549447|FG003|Part 2|Lost to Follow-up|0|||
27895793|NCT01722331|54549448|FG004|Part 2|Lost to Follow-up|0|||
27895794|NCT01722331|54549449|FG005|Part 2|Lost to Follow-up|1|||
27895795|NCT01722331|54549450|FG006|Part 2|Lost to Follow-up|1|||
27895796|NCT01722331|54549444|FG000|Part 2|Non-Compliance with Study Drug|1|||
27895797|NCT01722331|54549445|FG001|Part 2|Non-Compliance with Study Drug|0|||
27895798|NCT01722331|54549446|FG002|Part 2|Non-Compliance with Study Drug|1|||
27895799|NCT01722331|54549447|FG003|Part 2|Non-Compliance with Study Drug|0|||
27895800|NCT01722331|54549448|FG004|Part 2|Non-Compliance with Study Drug|0|||
27895801|NCT01722331|54549449|FG005|Part 2|Non-Compliance with Study Drug|0|||
27895802|NCT01722331|54549450|FG006|Part 2|Non-Compliance with Study Drug|0|||
27895803|NCT01722331|54549444|FG000|Part 2|Physician Decision|0|||
27895804|NCT01722331|54549445|FG001|Part 2|Physician Decision|0|||
27895805|NCT01722331|54549446|FG002|Part 2|Physician Decision|2|||
27895806|NCT01722331|54549447|FG003|Part 2|Physician Decision|0|||
27895807|NCT01722331|54549448|FG004|Part 2|Physician Decision|0|||
27895808|NCT01722331|54549449|FG005|Part 2|Physician Decision|0|||
27895809|NCT01722331|54549450|FG006|Part 2|Physician Decision|0|||
27895810|NCT01722331|54549444|FG000|Part 2|Pregnancy|0|||
27895811|NCT01722331|54549445|FG001|Part 2|Pregnancy|0|||
27895812|NCT01722331|54549446|FG002|Part 2|Pregnancy|0|||
27895813|NCT01722331|54549447|FG003|Part 2|Pregnancy|0|||
27895814|NCT01722331|54549448|FG004|Part 2|Pregnancy|0|||
27895815|NCT01722331|54549449|FG005|Part 2|Pregnancy|1|||
27895816|NCT01722331|54549450|FG006|Part 2|Pregnancy|0|||
27895817|NCT01722331|54549444|FG000|Part 2|Progressive Disease|0|||
27895818|NCT01722331|54549445|FG001|Part 2|Progressive Disease|0|||
27895819|NCT01722331|54549446|FG002|Part 2|Progressive Disease|1|||
27895820|NCT01722331|54549447|FG003|Part 2|Progressive Disease|0|||
27895821|NCT01722331|54549448|FG004|Part 2|Progressive Disease|0|||
27895822|NCT01722331|54549449|FG005|Part 2|Progressive Disease|0|||
27895823|NCT01722331|54549450|FG006|Part 2|Progressive Disease|0|||
27895824|NCT01722331|54549444|FG000|Part 2|Protocol Violation|1|||
27895825|NCT01722331|54549445|FG001|Part 2|Protocol Violation|0|||
27895826|NCT01722331|54549446|FG002|Part 2|Protocol Violation|0|||
27895827|NCT01722331|54549447|FG003|Part 2|Protocol Violation|0|||
27895828|NCT01722331|54549448|FG004|Part 2|Protocol Violation|0|||
27895829|NCT01722331|54549449|FG005|Part 2|Protocol Violation|0|||
27895830|NCT01722331|54549450|FG006|Part 2|Protocol Violation|0|||
27895831|NCT01722331|54549444|FG000|Part 2|Withdrawal by Subject|5|||
27895832|NCT01722331|54549445|FG001|Part 2|Withdrawal by Subject|0|||
27895833|NCT01722331|54549446|FG002|Part 2|Withdrawal by Subject|3|||
27895834|NCT01722331|54549447|FG003|Part 2|Withdrawal by Subject|0|||
27895835|NCT01722331|54549448|FG004|Part 2|Withdrawal by Subject|0|||
27895836|NCT01722331|54549449|FG005|Part 2|Withdrawal by Subject|2|||
27895837|NCT01722331|54549450|FG006|Part 2|Withdrawal by Subject|2|||
27895838|NCT01722331|54549444|FG000|Part 2|Other Protocol Specified Criteria|6|||
27895839|NCT01722331|54549445|FG001|Part 2|Other Protocol Specified Criteria|0|||
27895840|NCT01722331|54549446|FG002|Part 2|Other Protocol Specified Criteria|10|||
27895841|NCT01722331|54549447|FG003|Part 2|Other Protocol Specified Criteria|0|||
27895842|NCT01722331|54549448|FG004|Part 2|Other Protocol Specified Criteria|0|||
27895843|NCT01722331|54549449|FG005|Part 2|Other Protocol Specified Criteria|2|||
27895844|NCT01722331|54549450|FG006|Part 2|Other Protocol Specified Criteria|1|||
27895845|NCT01722331|54549444|FG000|Part 3|Adverse Event|2|||
27895846|NCT01722331|54549445|FG001|Part 3|Adverse Event|2|||
27895847|NCT01722331|54549446|FG002|Part 3|Adverse Event|0|||
27895848|NCT01722331|54549447|FG003|Part 3|Adverse Event|1|||
27895849|NCT01722331|54549448|FG004|Part 3|Adverse Event|0|||
27895850|NCT01722331|54549449|FG005|Part 3|Adverse Event|0|||
27895851|NCT01722331|54549450|FG006|Part 3|Adverse Event|0|||
27895852|NCT01722331|54549444|FG000|Part 3|Death|1|||
27895853|NCT01722331|54549445|FG001|Part 3|Death|0|||
27895854|NCT01722331|54549446|FG002|Part 3|Death|0|||
27895855|NCT01722331|54549447|FG003|Part 3|Death|0|||
27895856|NCT01722331|54549448|FG004|Part 3|Death|0|||
27895857|NCT01722331|54549449|FG005|Part 3|Death|0|||
27895858|NCT01722331|54549450|FG006|Part 3|Death|0|||
27895859|NCT01722331|54549444|FG000|Part 3|Lack of Efficacy|1|||
27895860|NCT01722331|54549445|FG001|Part 3|Lack of Efficacy|0|||
27895861|NCT01722331|54549446|FG002|Part 3|Lack of Efficacy|0|||
27895862|NCT01722331|54549447|FG003|Part 3|Lack of Efficacy|0|||
27895863|NCT01722331|54549448|FG004|Part 3|Lack of Efficacy|0|||
27895864|NCT01722331|54549449|FG005|Part 3|Lack of Efficacy|0|||
27895865|NCT01722331|54549450|FG006|Part 3|Lack of Efficacy|0|||
27895866|NCT01722331|54549444|FG000|Part 3|Lost to Follow-up|3|||
27895867|NCT01722331|54549445|FG001|Part 3|Lost to Follow-up|4|||
27895868|NCT01722331|54549446|FG002|Part 3|Lost to Follow-up|0|||
27895869|NCT01722331|54549447|FG003|Part 3|Lost to Follow-up|0|||
27895870|NCT01722331|54549448|FG004|Part 3|Lost to Follow-up|0|||
27895871|NCT01722331|54549449|FG005|Part 3|Lost to Follow-up|1|||
27895872|NCT01722331|54549450|FG006|Part 3|Lost to Follow-up|0|||
27895873|NCT01722331|54549444|FG000|Part 3|Non-Compliance with Study Drug|0|||
27895874|NCT01722331|54549445|FG001|Part 3|Non-Compliance with Study Drug|1|||
27895875|NCT01722331|54549446|FG002|Part 3|Non-Compliance with Study Drug|0|||
27895876|NCT01722331|54549447|FG003|Part 3|Non-Compliance with Study Drug|0|||
27895877|NCT01722331|54549448|FG004|Part 3|Non-Compliance with Study Drug|0|||
27895878|NCT01722331|54549449|FG005|Part 3|Non-Compliance with Study Drug|0|||
27895879|NCT01722331|54549450|FG006|Part 3|Non-Compliance with Study Drug|0|||
27895880|NCT01722331|54549444|FG000|Part 3|Physician Decision|1|||
27895881|NCT01722331|54549445|FG001|Part 3|Physician Decision|1|||
27895882|NCT01722331|54549446|FG002|Part 3|Physician Decision|0|||
27895883|NCT01722331|54549447|FG003|Part 3|Physician Decision|0|||
27895884|NCT01722331|54549448|FG004|Part 3|Physician Decision|0|||
27895885|NCT01722331|54549449|FG005|Part 3|Physician Decision|0|||
27895886|NCT01722331|54549450|FG006|Part 3|Physician Decision|1|||
27895887|NCT01722331|54549444|FG000|Part 3|Protocol Violation|2|||
27895888|NCT01722331|54549445|FG001|Part 3|Protocol Violation|1|||
27895889|NCT01722331|54549446|FG002|Part 3|Protocol Violation|0|||
27895890|NCT01722331|54549447|FG003|Part 3|Protocol Violation|0|||
27895891|NCT01722331|54549448|FG004|Part 3|Protocol Violation|0|||
27895892|NCT01722331|54549449|FG005|Part 3|Protocol Violation|0|||
27895893|NCT01722331|54549450|FG006|Part 3|Protocol Violation|0|||
27895894|NCT01722331|54549444|FG000|Part 3|Withdrawal by Subject|4|||
27895895|NCT01722331|54549445|FG001|Part 3|Withdrawal by Subject|7|||
27895896|NCT01722331|54549446|FG002|Part 3|Withdrawal by Subject|0|||
27895897|NCT01722331|54549447|FG003|Part 3|Withdrawal by Subject|0|||
27895898|NCT01722331|54549448|FG004|Part 3|Withdrawal by Subject|0|||
27895899|NCT01722331|54549449|FG005|Part 3|Withdrawal by Subject|2|||
27895900|NCT01722331|54549450|FG006|Part 3|Withdrawal by Subject|1|||
27895901|NCT01722331|54549444|FG000|Part 3|Other Protocol Specified Criteria|1|||
27895902|NCT01722331|54549445|FG001|Part 3|Other Protocol Specified Criteria|1|||
27895903|NCT01722331|54549446|FG002|Part 3|Other Protocol Specified Criteria|0|||
27895904|NCT01722331|54549447|FG003|Part 3|Other Protocol Specified Criteria|0|||
27895905|NCT01722331|54549448|FG004|Part 3|Other Protocol Specified Criteria|0|||
27895906|NCT01722331|54549449|FG005|Part 3|Other Protocol Specified Criteria|0|||
27895907|NCT01722331|54549450|FG006|Part 3|Other Protocol Specified Criteria|0|||
27895908|NCT01630590|54549462|FG000|Overall Study|Adverse Event|9|||
27895909|NCT01630590|54549462|FG000|Overall Study|Lack of Efficacy|37|||
27895910|NCT01630590|54549462|FG000|Overall Study|Withdrawal by Subject|4|||
27895911|NCT01630590|54549462|FG000|Overall Study|2nd primary tumor|2|||
27895912|NCT01630590|54549462|FG000|Overall Study|Automobile accident|1|||
27895913|NCT01630590|54549462|FG000|Overall Study|Maximum benefit|4|||
27895914|NCT01619085|54549466|FG000|Overall Study|Adverse Event|231|||
27895915|NCT01619085|54549466|FG000|Overall Study|Protocol Violation|4|||
27895916|NCT01619085|54549466|FG000|Overall Study|Lost to Follow-up|3|||
27895917|NCT01619085|54549466|FG000|Overall Study|Withdrawal by Subject|45|||
27895918|NCT01619085|54549466|FG000|Overall Study|Other than specified|96|||
27895919|NCT01619085|54549466|FG000|Overall Study|Not treated|1|||
27895920|NCT01619085|54549466|FG000|Overall Study|Death|145|||
27895921|NCT01499095|54549479|FG000|Overall Study|Randomized But Not Treated|1|||
27895922|NCT01499095|54549480|FG001|Overall Study|Randomized But Not Treated|1|||
27895923|NCT01499095|54549479|FG000|Overall Study|Adverse Event|12|||
27895924|NCT01499095|54549480|FG001|Overall Study|Adverse Event|7|||
27895925|NCT01499095|54549479|FG000|Overall Study|Lack of Efficacy|2|||
27895926|NCT01499095|54549480|FG001|Overall Study|Lack of Efficacy|1|||
27895927|NCT01499095|54549479|FG000|Overall Study|Protocol Violation|6|||
27895928|NCT01499095|54549480|FG001|Overall Study|Protocol Violation|7|||
27895929|NCT01499095|54549479|FG000|Overall Study|Received Rescue Therapy|32|||
27895930|NCT01499095|54549480|FG001|Overall Study|Received Rescue Therapy|40|||
27895931|NCT01499095|54549479|FG000|Overall Study|Diverse Reasons|22|||
27895932|NCT01499095|54549480|FG001|Overall Study|Diverse Reasons|25|||
27895933|NCT01499095|54549479|FG000|Overall Study|Lost to Follow-up|6|||
27895934|NCT01499095|54549480|FG001|Overall Study|Lost to Follow-up|4|||
27895935|NCT01499095|54549479|FG000|Overall Study|Insulin Dropped Below Authorized Dose|0|||
27895936|NCT01499095|54549480|FG001|Overall Study|Insulin Dropped Below Authorized Dose|5|||
27895937|NCT01499095|54549479|FG000|Overall Study|Hypoglycemia|3|||
27895938|NCT01499095|54549480|FG001|Overall Study|Hypoglycemia|1|||
27895939|NCT01499095|54549479|FG000|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2|||
27895940|NCT01499095|54549480|FG001|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1|||
27895941|NCT01499095|54549479|FG000|Overall Study|Change in Injection Schedule|2|||
27895942|NCT01499095|54549480|FG001|Overall Study|Change in Injection Schedule|0|||
27895943|NCT01499095|54549479|FG000|Overall Study|Perceived Lack of Efficacy|1|||
27895944|NCT01499095|54549480|FG001|Overall Study|Perceived Lack of Efficacy|1|||
27895945|NCT01499082|54549491|FG000|Overall Study|Randomized but not Treated|0|||
27895946|NCT01499082|54549492|FG001|Overall Study|Randomized but not Treated|1|||
27895947|NCT01499082|54549491|FG000|Overall Study|Adverse Event|12|||
27895948|NCT01499082|54549492|FG001|Overall Study|Adverse Event|16|||
27895949|NCT01499082|54549491|FG000|Overall Study|Lack of Efficacy|1|||
27895950|NCT01499082|54549492|FG001|Overall Study|Lack of Efficacy|1|||
27895951|NCT01499082|54549491|FG000|Overall Study|Protocol Violation|6|||
27895952|NCT01499082|54549492|FG001|Overall Study|Protocol Violation|8|||
27895953|NCT01499082|54549491|FG000|Overall Study|Diverse Reasons|18|||
27895954|NCT01499082|54549492|FG001|Overall Study|Diverse Reasons|14|||
27895955|NCT01499082|54549491|FG000|Overall Study|Site Closure for Noncompliance|5|||
27895956|NCT01499082|54549492|FG001|Overall Study|Site Closure for Noncompliance|2|||
27895957|NCT01499082|54549491|FG000|Overall Study|Hypoglycemia|2|||
27895958|NCT01499082|54549492|FG001|Overall Study|Hypoglycemia|3|||
27895959|NCT01499082|54549491|FG000|Overall Study|Lost to Follow-up|1|||
27895960|NCT01499082|54549492|FG001|Overall Study|Lost to Follow-up|3|||
27895961|NCT01488890|54549504|FG000|Overall Study|Serious adverse event|2|||
27895962|NCT01488890|54549505|FG001|Overall Study|Serious adverse event|0|||
27895963|NCT01488890|54549506|FG002|Overall Study|Serious adverse event|0|||
27895964|NCT01488890|54549507|FG003|Overall Study|Serious adverse event|0|||
27895965|NCT01488890|54549504|FG000|Overall Study|Protocol Violation|3|||
27895966|NCT01488890|54549505|FG001|Overall Study|Protocol Violation|0|||
27895967|NCT01488890|54549506|FG002|Overall Study|Protocol Violation|4|||
27895968|NCT01488890|54549507|FG003|Overall Study|Protocol Violation|0|||
27895969|NCT01488890|54549504|FG000|Overall Study|Lost to Follow-up|13|||
27895970|NCT01488890|54549505|FG001|Overall Study|Lost to Follow-up|10|||
27895971|NCT01488890|54549506|FG002|Overall Study|Lost to Follow-up|20|||
27895972|NCT01488890|54549507|FG003|Overall Study|Lost to Follow-up|3|||
27895973|NCT01488890|54549504|FG000|Overall Study|Withdrawal by Subject|14|||
27895974|NCT01488890|54549505|FG001|Overall Study|Withdrawal by Subject|10|||
27895975|NCT01488890|54549506|FG002|Overall Study|Withdrawal by Subject|11|||
27895976|NCT01488890|54549507|FG003|Overall Study|Withdrawal by Subject|2|||
27895977|NCT01436396|54549523|FG000|Overall Study|Protocol Violation|7|||
27895978|NCT01436396|54549524|FG001|Overall Study|Protocol Violation|5|||
27895979|NCT01436396|54549523|FG000|Overall Study|Adverse Event|1|||
27895980|NCT01436396|54549524|FG001|Overall Study|Adverse Event|2|||
27895981|NCT01436396|54549523|FG000|Overall Study|Withdrawal by Subject|19|||
27895982|NCT01436396|54549524|FG001|Overall Study|Withdrawal by Subject|29|||
27895983|NCT01436396|54549523|FG000|Overall Study|Serious adverse event|2|||
27895984|NCT01436396|54549524|FG001|Overall Study|Serious adverse event|3|||
27895985|NCT01436396|54549523|FG000|Overall Study|Lost to Follow-up|3|||
27895986|NCT01436396|54549524|FG001|Overall Study|Lost to Follow-up|3|||
27895987|NCT01411241|54549532|FG000|Overall Study|Protocol Violation|0|||
27895988|NCT01411241|54549533|FG001|Overall Study|Protocol Violation|5|||
27895989|NCT01411241|54549532|FG000|Overall Study|Withdrawal by Subject|9|||
27895990|NCT01411241|54549533|FG001|Overall Study|Withdrawal by Subject|10|||
27895991|NCT01411241|54549532|FG000|Overall Study|Serious Adverse Event|0|||
27895992|NCT01411241|54549533|FG001|Overall Study|Serious Adverse Event|3|||
27895993|NCT01411241|54549532|FG000|Overall Study|Lost to Follow-up|2|||
27895994|NCT01411241|54549533|FG001|Overall Study|Lost to Follow-up|4|||
27895995|NCT01374516|54549541|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|43|||
27895996|NCT01374516|54549542|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|14|||
27895997|NCT01374516|54549541|FG000|Vaccination Phase (Up to 25 Months)|Adverse Event|3|||
27895998|NCT01374516|54549542|FG001|Vaccination Phase (Up to 25 Months)|Adverse Event|0|||
27895999|NCT01374516|54549541|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480|||
27896000|NCT01374516|54549542|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240|||
27896001|NCT01374516|54549541|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106|||
27896002|NCT01374516|54549542|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46|||
27896003|NCT01374516|54549541|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|7|||
27896004|NCT01374516|54549542|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|9|||
27896005|NCT01374516|54549541|FG000|Surveillance Expansion Period|Protocol Violation|386|||
27896006|NCT01374516|54549542|FG001|Surveillance Expansion Period|Protocol Violation|217|||
27896007|NCT01374516|54549541|FG000|Surveillance Expansion Period|Withdrawal by Subject|1870|||
27896008|NCT01374516|54549542|FG001|Surveillance Expansion Period|Withdrawal by Subject|986|||
27896009|NCT01374516|54549541|FG000|Surveillance Expansion Period|Lost to Follow-up|73|||
27896010|NCT01374516|54549542|FG001|Surveillance Expansion Period|Lost to Follow-up|45|||
27896011|NCT01374516|54549541|FG000|Surveillance Expansion Period|Serious adverse event|20|||
27896012|NCT01374516|54549542|FG001|Surveillance Expansion Period|Serious adverse event|5|||
27896013|NCT01373281|54549557|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40|||
27896014|NCT01373281|54549558|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23|||
27896015|NCT01373281|54549557|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|5|||
27896016|NCT01373281|54549558|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|2|||
27896017|NCT01373281|54549557|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5|||
27896018|NCT01373281|54549558|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1|||
27896019|NCT01373281|54549557|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|4|||
27896020|NCT01373281|54549558|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|1|||
27896021|NCT01373281|54549557|FG000|Surveillance Expansion Period|Withdrawal by Subject|180|||
27896022|NCT01373281|54549558|FG001|Surveillance Expansion Period|Withdrawal by Subject|105|||
27896023|NCT01373281|54549557|FG000|Surveillance Expansion Period|Protocol Violation|9|||
27896024|NCT01373281|54549558|FG001|Surveillance Expansion Period|Protocol Violation|1|||
27896025|NCT01373281|54549557|FG000|Surveillance Expansion Period|Lost to Follow-up|10|||
27896026|NCT01373281|54549558|FG001|Surveillance Expansion Period|Lost to Follow-up|8|||
27896027|NCT01373281|54549557|FG000|Surveillance Expansion Period|Serious adverse event|3|||
27896028|NCT01373281|54549558|FG001|Surveillance Expansion Period|Serious adverse event|4|||
27896029|NCT01287611|54549573|FG000|Overall Study|Lost to Follow-up|29|||
27896030|NCT01287611|54549574|FG001|Overall Study|Lost to Follow-up|16|||
27896031|NCT01287611|54549573|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
27896032|NCT01287611|54549574|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
27896033|NCT01254422|54549584|FG000|Overall Study|Protocol Violation|1|||
27896034|NCT01254422|54549585|FG001|Overall Study|Protocol Violation|0|||
27896035|NCT01254422|54549584|FG000|Overall Study|Adverse Event|1|||
27896036|NCT01254422|54549585|FG001|Overall Study|Adverse Event|0|||
27896037|NCT01254422|54549584|FG000|Overall Study|Serious adverse event|0|||
27896038|NCT01254422|54549585|FG001|Overall Study|Serious adverse event|1|||
27896039|NCT01254422|54549584|FG000|Overall Study|Lost to Follow-up|1|||
27896040|NCT01254422|54549585|FG001|Overall Study|Lost to Follow-up|0|||
27896041|NCT01187433|54549593|FG000|Overall Study|Protocol Violation|6|||
27896042|NCT01187433|54549594|FG001|Overall Study|Protocol Violation|2|||
27896043|NCT01187433|54549593|FG000|Overall Study|Withdrawal by Subject|5|||
27896044|NCT01187433|54549594|FG001|Overall Study|Withdrawal by Subject|2|||
27896045|NCT01150045|54549604|FG000|Overall Study|Protocol Violation|0|||
27896046|NCT01150045|54549605|FG001|Overall Study|Protocol Violation|1|||
27896047|NCT01150045|54549606|FG002|Overall Study|Protocol Violation|0|||
27896048|NCT01150045|54549607|FG003|Overall Study|Protocol Violation|1|||
27896049|NCT01098032|54549617|FG000|Overall Study|Withdrawal by Subject|1|||
27896050|NCT01098032|54549618|FG001|Overall Study|Withdrawal by Subject|1|||
27896051|NCT01034306|54549626|FG000|Overall Study|Adverse Event|1|||
27896052|NCT01034306|54549627|FG001|Overall Study|Adverse Event|0|||
27896053|NCT01034306|54549626|FG000|Overall Study|Lost to Follow-up|0|||
27896054|NCT01034306|54549627|FG001|Overall Study|Lost to Follow-up|1|||
27896055|NCT01034306|54549626|FG000|Overall Study|Withdrawal by Subject|2|||
27896056|NCT01034306|54549627|FG001|Overall Study|Withdrawal by Subject|2|||
27896057|NCT01034306|54549626|FG000|Overall Study|hospitalized and decided to stop|1|||
27896058|NCT01034306|54549627|FG001|Overall Study|hospitalized and decided to stop|0|||
27896059|NCT01034306|54549626|FG000|Overall Study|Noncomplience|1|||
27896060|NCT01034306|54549627|FG001|Overall Study|Noncomplience|0|||
27896061|NCT00993447|54549635|FG000|Overall Study|Withdrawal by Subject|23|||
27896062|NCT00993447|54549636|FG001|Overall Study|Withdrawal by Subject|8|||
27896063|NCT00993447|54549635|FG000|Overall Study|Protocol Violation|12|||
27896064|NCT00993447|54549636|FG001|Overall Study|Protocol Violation|8|||
27896065|NCT00993447|54549635|FG000|Overall Study|Lost to Follow-up|1|||
27896066|NCT00993447|54549636|FG001|Overall Study|Lost to Follow-up|3|||
27896067|NCT00993447|54549635|FG000|Overall Study|Adverse Event|1|||
27896068|NCT00993447|54549636|FG001|Overall Study|Adverse Event|0|||
27896069|NCT00945009|54549645|FG000|Overall Study|Lack of Efficacy|10|||
27896070|NCT00945009|54549646|FG001|Overall Study|Lack of Efficacy|0|||
27896071|NCT00945009|54549647|FG002|Overall Study|Lack of Efficacy|0|||
27896072|NCT00945009|54549645|FG000|Overall Study|Physician Decision|21|||
27896073|NCT00945009|54549646|FG001|Overall Study|Physician Decision|4|||
27896074|NCT00945009|54549647|FG002|Overall Study|Physician Decision|3|||
27896075|NCT00945009|54549645|FG000|Overall Study|Protocol Violation|6|||
27896076|NCT00945009|54549646|FG001|Overall Study|Protocol Violation|1|||
27896077|NCT00945009|54549647|FG002|Overall Study|Protocol Violation|0|||
27896078|NCT00945009|54549645|FG000|Overall Study|Withdrawal by Subject|1|||
27896079|NCT00945009|54549646|FG001|Overall Study|Withdrawal by Subject|0|||
27896080|NCT00945009|54549647|FG002|Overall Study|Withdrawal by Subject|0|||
27896081|NCT00945009|54549645|FG000|Overall Study|Ineligible|6|||
27896082|NCT00945009|54549646|FG001|Overall Study|Ineligible|1|||
27896083|NCT00945009|54549647|FG002|Overall Study|Ineligible|0|||
27896084|NCT00945009|54549645|FG000|Overall Study|Inevaluable|0|||
27896085|NCT00945009|54549646|FG001|Overall Study|Inevaluable|1|||
27896086|NCT00945009|54549647|FG002|Overall Study|Inevaluable|0|||
27896087|NCT00945009|54549645|FG000|Overall Study|Refusal of further protocol|1|||
27896088|NCT00945009|54549646|FG001|Overall Study|Refusal of further protocol|0|||
27896089|NCT00945009|54549647|FG002|Overall Study|Refusal of further protocol|0|||
27896090|NCT00942877|54549657|FG000|Overall Study|Refused further treatment|1|||
27896091|NCT00942877|54549658|FG001|Overall Study|Refused further treatment|1|||
27896092|NCT00942877|54549657|FG000|Overall Study|Patient was not treated|1|||
27896093|NCT00942877|54549658|FG001|Overall Study|Patient was not treated|0|||
27896094|NCT00942877|54549657|FG000|Overall Study|Adverse Event|1|||
27896095|NCT00942877|54549658|FG001|Overall Study|Adverse Event|0|||
27896096|NCT00942877|54549657|FG000|Overall Study|Progressive disease|42|||
27896097|NCT00942877|54549658|FG001|Overall Study|Progressive disease|3|||
27896098|NCT00880893|54549673|FG000|Overall Study|Protocol Violation|13|||
27896099|NCT00880893|54549674|FG001|Overall Study|Protocol Violation|1|||
27896100|NCT00880893|54549673|FG000|Overall Study|Withdrawal by Subject|15|||
27896101|NCT00880893|54549674|FG001|Overall Study|Withdrawal by Subject|11|||
27896102|NCT00880893|54549673|FG000|Overall Study|Lost to Follow-up|76|||
27896103|NCT00880893|54549674|FG001|Overall Study|Lost to Follow-up|33|||
27896104|NCT00880893|54549673|FG000|Overall Study|Serious adverse event|3|||
27896105|NCT00880893|54549674|FG001|Overall Study|Serious adverse event|0|||
27896106|NCT00587301|54549680|FG000|Overall Study|Screen Failure|9|||
27896107|NCT00587301|54549680|FG000|Overall Study|Lost to Follow-up|22|||
27896108|NCT00587301|54549680|FG000|Overall Study|Withdrawal by Subject|7|||
27896109|NCT00587301|54549680|FG000|Overall Study|Protocol Violation|7|||
27896110|NCT00579527|54549684|FG000|Overall Study|Death|4|||
27896111|NCT00576836|54549689|FG000|Overall Study|Death|0|||
27896112|NCT00576836|54549690|FG001|Overall Study|Death|1|||
27896113|NCT00576836|54549689|FG000|Overall Study|Physician Decision|0|||
27896114|NCT00576836|54549690|FG001|Overall Study|Physician Decision|1|||
27896115|NCT00576407|54549694|FG000|Overall Study|Death|7|||
27896116|NCT00576407|54549694|FG000|Overall Study|Physician Decision|1|||
27896117|NCT00531232|54549702|FG000|Overall Study|Investigator decision|0|||
27896118|NCT00531232|54549703|FG001|Overall Study|Investigator decision|0|||
27896119|NCT00531232|54549704|FG002|Overall Study|Investigator decision|4|||
27896120|NCT00531232|54549702|FG000|Overall Study|Participants refused further treatment|0|||
27896121|NCT00531232|54549703|FG001|Overall Study|Participants refused further treatment|1|||
27896122|NCT00531232|54549704|FG002|Overall Study|Participants refused further treatment|2|||
27896123|NCT00531232|54549702|FG000|Overall Study|Adverse events (AEs)|1|||
27896124|NCT00531232|54549703|FG001|Overall Study|Adverse events (AEs)|2|||
27896125|NCT00531232|54549704|FG002|Overall Study|Adverse events (AEs)|2|||
27896126|NCT00531232|54549702|FG000|Overall Study|Treatment failure|1|||
27896127|NCT00531232|54549703|FG001|Overall Study|Treatment failure|3|||
27896128|NCT00531232|54549704|FG002|Overall Study|Treatment failure|7|||
27896129|NCT00531232|54549702|FG000|Overall Study|Disease recurrence|0|||
27896130|NCT00531232|54549703|FG001|Overall Study|Disease recurrence|0|||
27896131|NCT00531232|54549704|FG002|Overall Study|Disease recurrence|1|||
27896132|NCT00531232|54549702|FG000|Overall Study|Deceased|2|||
27896133|NCT00531232|54549703|FG001|Overall Study|Deceased|2|||
27896134|NCT00531232|54549704|FG002|Overall Study|Deceased|2|||
27896135|NCT00531232|54549702|FG000|Overall Study|Withdrawal by Subject|0|||
27896136|NCT00531232|54549703|FG001|Overall Study|Withdrawal by Subject|1|||
27896137|NCT00531232|54549704|FG002|Overall Study|Withdrawal by Subject|2|||
27896138|NCT00531232|54549702|FG000|Overall Study|Other|0|||
27896139|NCT00531232|54549703|FG001|Overall Study|Other|0|||
27896140|NCT00531232|54549704|FG002|Overall Study|Other|5|||
27896141|NCT01701583|54549717|FG000|Overall Study|Withdrawal by Subject|2|||
27896142|NCT01701583|54549718|FG001|Overall Study|Withdrawal by Subject|0|||
27896143|NCT01714817|54549727|FG000|Year 1 Period|Lack of Efficacy|11|||
27896144|NCT01714817|54549728|FG001|Year 1 Period|Lack of Efficacy|9|||
27896145|NCT01714817|54549727|FG000|Year 1 Period|Adverse Event|20|||
27896146|NCT01714817|54549728|FG001|Year 1 Period|Adverse Event|17|||
27896147|NCT01714817|54549727|FG000|Year 1 Period|Withdrawal by Subject|6|||
27896148|NCT01714817|54549728|FG001|Year 1 Period|Withdrawal by Subject|7|||
27896149|NCT01714817|54549727|FG000|Year 1 Period|Death|1|||
27896150|NCT01714817|54549728|FG001|Year 1 Period|Death|1|||
27896151|NCT01714817|54549727|FG000|Year 1 Period|Lost to Follow-up|0|||
27896152|NCT01714817|54549728|FG001|Year 1 Period|Lost to Follow-up|2|||
27896153|NCT01714817|54549727|FG000|Year 1 Period|Poor / non-compliance|0|||
27896154|NCT01714817|54549728|FG001|Year 1 Period|Poor / non-compliance|1|||
27896155|NCT01714817|54549727|FG000|Year 1 Period|Pregnancy|2|||
27896156|NCT01714817|54549728|FG001|Year 1 Period|Pregnancy|0|||
27896157|NCT01714817|54549727|FG000|Year 1 Period|Participant no longer meets criteria|6|||
27896158|NCT01714817|54549728|FG001|Year 1 Period|Participant no longer meets criteria|2|||
27896159|NCT01714817|54549727|FG000|Year 1 Period|Not treated- received ACE inhibition|1|||
27896160|NCT01714817|54549728|FG001|Year 1 Period|Not treated- received ACE inhibition|0|||
27896161|NCT01714817|54549727|FG000|Year 1 Period|Change in Concomitant Medication|0|||
27896162|NCT01714817|54549728|FG001|Year 1 Period|Change in Concomitant Medication|1|||
27896163|NCT01714817|54549727|FG000|Year 1 Period|Need of use of Prohibited Medications|1|||
27896164|NCT01714817|54549728|FG001|Year 1 Period|Need of use of Prohibited Medications|0|||
27896165|NCT01714817|54549727|FG000|Year 1 Period|Antiproteinuric changed/dose increased|0|||
27896166|NCT01714817|54549728|FG001|Year 1 Period|Antiproteinuric changed/dose increased|1|||
27896167|NCT01714817|54549727|FG000|Year 1 Period|Hypersensitivity to the medication|0|||
27896168|NCT01714817|54549728|FG001|Year 1 Period|Hypersensitivity to the medication|1|||
27896169|NCT01714817|54549727|FG000|Year 2 Period|Lack of Efficacy|4|||
27896170|NCT01714817|54549728|FG001|Year 2 Period|Lack of Efficacy|12|||
27896171|NCT01714817|54549727|FG000|Year 2 Period|Adverse Event|7|||
27896172|NCT01714817|54549728|FG001|Year 2 Period|Adverse Event|6|||
27896173|NCT01714817|54549727|FG000|Year 2 Period|Participant request to stop treatment|4|||
27896174|NCT01714817|54549728|FG001|Year 2 Period|Participant request to stop treatment|4|||
27896175|NCT01714817|54549727|FG000|Year 2 Period|Administrative reason by Sponsor|4|||
27896176|NCT01714817|54549728|FG001|Year 2 Period|Administrative reason by Sponsor|3|||
27896177|NCT01714817|54549727|FG000|Year 2 Period|Participant withdrew consent|1|||
27896178|NCT01714817|54549728|FG001|Year 2 Period|Participant withdrew consent|5|||
27896179|NCT01714817|54549727|FG000|Year 2 Period|Participant no longer meets criteria|1|||
27896180|NCT01714817|54549728|FG001|Year 2 Period|Participant no longer meets criteria|4|||
27896181|NCT01714817|54549727|FG000|Year 2 Period|Lost to Follow-up|2|||
27896182|NCT01714817|54549728|FG001|Year 2 Period|Lost to Follow-up|0|||
27896183|NCT01714817|54549727|FG000|Year 2 Period|Participant went to US stopped treatment|0|||
27896184|NCT01714817|54549728|FG001|Year 2 Period|Participant went to US stopped treatment|1|||
27896185|NCT01714817|54549727|FG000|Year 2 Period|Pregnancy|1|||
27896186|NCT01714817|54549728|FG001|Year 2 Period|Pregnancy|1|||
27896187|NCT01714817|54549727|FG000|Year 2 Period|Completed Year 1, did not enter Year 2|2|||
27896188|NCT01714817|54549728|FG001|Year 2 Period|Completed Year 1, did not enter Year 2|1|||
27896189|NCT01714817|54549727|FG000|Year 2 Period|Given cyclophosphamide, corticosteroids|0|||
27896190|NCT01714817|54549728|FG001|Year 2 Period|Given cyclophosphamide, corticosteroids|1|||
27896191|NCT01714817|54549727|FG000|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27|||
27896192|NCT01714817|54549728|FG001|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21|||
27896193|NCT01714817|54549727|FG000|Long-Term Extension (LTE) Period|Disease progression|1|||
27896194|NCT01714817|54549728|FG001|Long-Term Extension (LTE) Period|Disease progression|4|||
27896195|NCT01714817|54549727|FG000|Long-Term Extension (LTE) Period|Not effective|0|||
27896196|NCT01714817|54549728|FG001|Long-Term Extension (LTE) Period|Not effective|1|||
27896197|NCT01714817|54549727|FG000|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
27896198|NCT01714817|54549728|FG001|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
27896199|NCT01714817|54549727|FG000|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
27896200|NCT01714817|54549728|FG001|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
27896201|NCT01714817|54549727|FG000|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1|||
27896202|NCT01714817|54549728|FG001|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0|||
27896203|NCT01714817|54549727|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
27896204|NCT01714817|54549728|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
27896205|NCT01714817|54549727|FG000|Long-Term Extension (LTE) Period|Pregnancy|1|||
27896206|NCT01714817|54549728|FG001|Long-Term Extension (LTE) Period|Pregnancy|0|||
27896207|NCT01714817|54549727|FG000|Long-Term Extension (LTE) Period|Study drug toxicity|1|||
27896208|NCT01714817|54549728|FG001|Long-Term Extension (LTE) Period|Study drug toxicity|0|||
27896209|NCT01714817|54549727|FG000|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1|||
27896210|NCT01714817|54549728|FG001|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0|||
27896211|NCT01714817|54549727|FG000|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33|||
27896212|NCT01714817|54549728|FG001|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38|||
27896213|NCT01714817|54549727|FG000|Long-Term Extension (LTE) Period|Absence of renal response|0|||
27896214|NCT01714817|54549728|FG001|Long-Term Extension (LTE) Period|Absence of renal response|1|||
27896215|NCT01714817|54549727|FG000|Long-Term Extension (LTE) Period|Investigator decision, study termination|0|||
27896216|NCT01714817|54549728|FG001|Long-Term Extension (LTE) Period|Investigator decision, study termination|1|||
27896217|NCT01714817|54549727|FG000|Long-Term Extension (LTE) Period|Study was terminated|0|||
27896218|NCT01714817|54549728|FG001|Long-Term Extension (LTE) Period|Study was terminated|1|||
27896219|NCT01755689|54549752|FG000|Overall Study|Withdrawal by Subject|1|||
27896220|NCT01755689|54549753|FG001|Overall Study|Withdrawal by Subject|3|||
27896221|NCT01755689|54549754|FG002|Overall Study|Withdrawal by Subject|2|||
27896222|NCT01755689|54549755|FG003|Overall Study|Withdrawal by Subject|1|||
27896223|NCT01755689|54549756|FG004|Overall Study|Withdrawal by Subject|1|||
27896224|NCT01755689|54549752|FG000|Overall Study|Migrated/moved from study area|0|||
27896225|NCT01755689|54549753|FG001|Overall Study|Migrated/moved from study area|1|||
27896226|NCT01755689|54549754|FG002|Overall Study|Migrated/moved from study area|1|||
27896227|NCT01755689|54549755|FG003|Overall Study|Migrated/moved from study area|1|||
27896228|NCT01755689|54549756|FG004|Overall Study|Migrated/moved from study area|1|||
27896229|NCT01755689|54549752|FG000|Overall Study|Lost to Follow-up|1|||
27896230|NCT01755689|54549753|FG001|Overall Study|Lost to Follow-up|0|||
27896231|NCT01755689|54549754|FG002|Overall Study|Lost to Follow-up|1|||
27896232|NCT01755689|54549755|FG003|Overall Study|Lost to Follow-up|0|||
27896233|NCT01755689|54549756|FG004|Overall Study|Lost to Follow-up|2|||
27896234|NCT01755689|54549752|FG000|Overall Study|Pregnancy|1|||
27896235|NCT01755689|54549753|FG001|Overall Study|Pregnancy|1|||
27896236|NCT01755689|54549754|FG002|Overall Study|Pregnancy|2|||
27896237|NCT01755689|54549755|FG003|Overall Study|Pregnancy|4|||
27896238|NCT01755689|54549756|FG004|Overall Study|Pregnancy|2|||
27896239|NCT01762761|54549778|FG000|Overall Study|Adverse Event|15|||
27896240|NCT01762761|54549779|FG001|Overall Study|Adverse Event|17|||
27896241|NCT01762761|54549778|FG000|Overall Study|Lack of Efficacy|9|||
27896242|NCT01762761|54549779|FG001|Overall Study|Lack of Efficacy|25|||
27896243|NCT01762761|54549778|FG000|Overall Study|Protocol Violation|1|||
27896244|NCT01762761|54549779|FG001|Overall Study|Protocol Violation|1|||
27896245|NCT01762761|54549778|FG000|Overall Study|Study closed/terminated|0|||
27896246|NCT01762761|54549779|FG001|Overall Study|Study closed/terminated|2|||
27896247|NCT01762761|54549778|FG000|Overall Study|Lost to Follow-up|3|||
28171934|NCT00701103|54843587|FG007|Overall Study|Progressive Disease|7|||
27896248|NCT01762761|54549779|FG001|Overall Study|Lost to Follow-up|6|||
27896249|NCT01762761|54549778|FG000|Overall Study|Physician Decision|4|||
27896250|NCT01762761|54549779|FG001|Overall Study|Physician Decision|6|||
27896251|NCT01762761|54549778|FG000|Overall Study|Withdrawal by Subject|7|||
27896252|NCT01762761|54549779|FG001|Overall Study|Withdrawal by Subject|8|||
27896253|NCT01763788|54549790|FG000|Overall Study|Lost to Follow-up|0|||
27896254|NCT01763788|54549791|FG001|Overall Study|Lost to Follow-up|0|||
28171935|NCT00701103|54843588|FG008|Overall Study|Progressive Disease|8|||
28171936|NCT00701103|54843589|FG009|Overall Study|Progressive Disease|8|||
27896255|NCT01763788|54549792|FG002|Overall Study|Lost to Follow-up|1|||
27896256|NCT01763788|54549793|FG003|Overall Study|Lost to Follow-up|0|||
27896257|NCT01774370|54549803|FG000|Overall Study|Never taken the PRADAXA during the study|4|||
27896258|NCT01774370|54549803|FG000|Overall Study|Administered prior to the contract date|4|||
27896259|NCT01774370|54549803|FG000|Overall Study|Subjects of contraindications|34|||
27896260|NCT01774370|54549803|FG000|Overall Study|Violated inclusion/exclusion criteria|53|||
27896261|NCT01774370|54549803|FG000|Overall Study|Follow-up failure|34|||
27896262|NCT01777295|54549809|FG000|Overall Study|Withdrawal by Subject|2|||
27896263|NCT01777295|54549810|FG001|Overall Study|Withdrawal by Subject|2|||
27896264|NCT01777295|54549809|FG000|Overall Study|Pregnancy|0|||
27896265|NCT01777295|54549810|FG001|Overall Study|Pregnancy|1|||
27896266|NCT01777295|54549809|FG000|Overall Study|Personal problem|1|||
27896267|NCT01777295|54549810|FG001|Overall Study|Personal problem|0|||
27896268|NCT01777295|54549809|FG000|Overall Study|Investigator call for AEs check|1|||
27896269|NCT01777295|54549810|FG001|Overall Study|Investigator call for AEs check|0|||
27896270|NCT01787552|54549847|FG000|Overall Study|Withdrawal by Subject|2|||
27896271|NCT01787552|54549848|FG001|Overall Study|Withdrawal by Subject|0|||
27896272|NCT01787552|54549849|FG002|Overall Study|Withdrawal by Subject|0|||
27896273|NCT01787552|54549850|FG003|Overall Study|Withdrawal by Subject|4|||
27896274|NCT01787552|54549847|FG000|Overall Study|Physician Decision|2|||
27896275|NCT01787552|54549848|FG001|Overall Study|Physician Decision|2|||
27896276|NCT01787552|54549849|FG002|Overall Study|Physician Decision|1|||
27896277|NCT01787552|54549850|FG003|Overall Study|Physician Decision|2|||
27896278|NCT01787552|54549847|FG000|Overall Study|Death|0|||
27896279|NCT01787552|54549848|FG001|Overall Study|Death|0|||
27896280|NCT01787552|54549849|FG002|Overall Study|Death|0|||
27896281|NCT01787552|54549850|FG003|Overall Study|Death|1|||
27896282|NCT01787552|54549847|FG000|Overall Study|Adverse Event|2|||
27896283|NCT01787552|54549848|FG001|Overall Study|Adverse Event|5|||
27896284|NCT01787552|54549849|FG002|Overall Study|Adverse Event|2|||
27896285|NCT01787552|54549850|FG003|Overall Study|Adverse Event|16|||
27896286|NCT01787552|54549847|FG000|Overall Study|Study terminated by Sponsor|0|||
27896287|NCT01787552|54549848|FG001|Overall Study|Study terminated by Sponsor|0|||
27896288|NCT01787552|54549849|FG002|Overall Study|Study terminated by Sponsor|1|||
27896289|NCT01787552|54549850|FG003|Overall Study|Study terminated by Sponsor|3|||
27896290|NCT01787552|54549847|FG000|Overall Study|Progressive Disease|2|||
27896291|NCT01787552|54549848|FG001|Overall Study|Progressive Disease|2|||
27896292|NCT01787552|54549849|FG002|Overall Study|Progressive Disease|1|||
27896293|NCT01787552|54549850|FG003|Overall Study|Progressive Disease|1|||
27896294|NCT01808261|54549867|FG000|Overall Study|Physician Decision|0|||
27896295|NCT01808261|54549868|FG001|Overall Study|Physician Decision|2|||
27896296|NCT01808261|54549867|FG000|Overall Study|Study Closed/Terminated|25|||
27896297|NCT01808261|54549868|FG001|Overall Study|Study Closed/Terminated|23|||
27896298|NCT01808261|54549867|FG000|Overall Study|Adverse event, non-fatal|2|||
27896299|NCT01808261|54549868|FG001|Overall Study|Adverse event, non-fatal|0|||
27896300|NCT01808261|54549867|FG000|Overall Study|Consent withdrawn by subject|6|||
27896301|NCT01808261|54549868|FG001|Overall Study|Consent withdrawn by subject|7|||
27896302|NCT01808261|54549867|FG000|Overall Study|Lost to Follow-up|3|||
27896303|NCT01808261|54549868|FG001|Overall Study|Lost to Follow-up|1|||
27896304|NCT01814826|54549887|FG000|Overall Study|Other|3|||
27896305|NCT01814826|54549888|FG001|Overall Study|Other|5|||
27896306|NCT01814826|54549889|FG002|Overall Study|Other|0|||
27896307|NCT01814826|54549887|FG000|Overall Study|Death|29|||
27896308|NCT01814826|54549888|FG001|Overall Study|Death|24|||
27896309|NCT01814826|54549889|FG002|Overall Study|Death|3|||
27896310|NCT01829711|54549898|FG000|Overall Study|Lost to Follow-up|2|||
27896311|NCT01829711|54549898|FG000|Overall Study|Withdrawal by Subject|3|||
27896312|NCT01829711|54549898|FG000|Overall Study|Death|4|||
27896313|NCT01829711|54549898|FG000|Overall Study|Started new therapies|17|||
27896314|NCT01829711|54549898|FG000|Overall Study|Adverse Event|3|||
27896315|NCT01829711|54549898|FG000|Overall Study|Due to progression of disease|13|||
27896316|NCT01829711|54549898|FG000|Overall Study|Due to lack of response|1|||
27896317|NCT01846273|54549905|FG000|Overall Study|Adverse Event|9|||
27896318|NCT01846273|54549906|FG001|Overall Study|Adverse Event|7|||
27896319|NCT01846273|54549907|FG002|Overall Study|Adverse Event|0|||
27896320|NCT01846273|54549905|FG000|Overall Study|Subject withdrew consent|5|||
27896321|NCT01846273|54549906|FG001|Overall Study|Subject withdrew consent|8|||
27896322|NCT01846273|54549907|FG002|Overall Study|Subject withdrew consent|0|||
27896323|NCT01846273|54549905|FG000|Overall Study|Lost to Follow-up|2|||
27896324|NCT01846273|54549906|FG001|Overall Study|Lost to Follow-up|1|||
27896325|NCT01846273|54549907|FG002|Overall Study|Lost to Follow-up|0|||
27896326|NCT01846273|54549905|FG000|Overall Study|Administrative problems|1|||
27896327|NCT01846273|54549906|FG001|Overall Study|Administrative problems|0|||
27896328|NCT01846273|54549907|FG002|Overall Study|Administrative problems|0|||
27985847|NCT02393248|54644420|FG009|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
27896329|NCT01846273|54549905|FG000|Overall Study|Death|2|||
27896330|NCT01846273|54549906|FG001|Overall Study|Death|1|||
27896331|NCT01846273|54549907|FG002|Overall Study|Death|0|||
27896332|NCT01846273|54549905|FG000|Overall Study|Disease Progression|0|||
27896333|NCT01846273|54549906|FG001|Overall Study|Disease Progression|4|||
27896334|NCT01846273|54549907|FG002|Overall Study|Disease Progression|0|||
27896335|NCT01846273|54549905|FG000|Overall Study|Protocol Deviation|2|||
27896336|NCT01846273|54549906|FG001|Overall Study|Protocol Deviation|3|||
27896337|NCT01846273|54549907|FG002|Overall Study|Protocol Deviation|0|||
27896338|NCT01846273|54549905|FG000|Overall Study|Physician Decision|1|||
27896339|NCT01846273|54549906|FG001|Overall Study|Physician Decision|2|||
27896340|NCT01846273|54549907|FG002|Overall Study|Physician Decision|0|||
27896341|NCT04752475|54549917|FG000|Overall Study|Withdrawal by Subject|1|||
27896342|NCT04752475|54549918|FG001|Overall Study|Withdrawal by Subject|1|||
27896343|NCT03846947|54549964|FG000|Overall Study|technical issues with imaging sequence|2|||
27896344|NCT03675308|54549977|FG000|Overall Study|Adverse Event|3|||
27896345|NCT03675308|54549978|FG001|Overall Study|Adverse Event|2|||
27896346|NCT03675308|54549977|FG000|Overall Study|Withdrawal by Subject|6|||
27896347|NCT03675308|54549978|FG001|Overall Study|Withdrawal by Subject|4|||
27896348|NCT03675308|54549977|FG000|Overall Study|Lost to Follow-up|3|||
27896349|NCT03675308|54549978|FG001|Overall Study|Lost to Follow-up|0|||
27896350|NCT03675308|54549977|FG000|Overall Study|Lack of Efficacy|1|||
27896351|NCT03675308|54549978|FG001|Overall Study|Lack of Efficacy|1|||
27896352|NCT03675308|54549977|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|1|||
27896353|NCT03675308|54549978|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|2|||
27896354|NCT03675308|54549977|FG000|Overall Study|Other|0|||
27896355|NCT03675308|54549978|FG001|Overall Study|Other|1|||
27896356|NCT03476798|54549984|FG000|Overall Study|Death|1|||
27896357|NCT03476798|54549984|FG000|Overall Study|Withdrawal by Subject|2|||
27896358|NCT03476798|54549984|FG000|Overall Study|Protocol Violation|2|||
27896359|NCT03334253|54549990|FG000|Overall Study|Withdrawal by Subject|1|||
27896360|NCT03334253|54549991|FG001|Overall Study|Withdrawal by Subject|0|||
27896361|NCT03334253|54549990|FG000|Overall Study|Lost to Follow-up|4|||
27896362|NCT03334253|54549991|FG001|Overall Study|Lost to Follow-up|3|||
27896363|NCT03334253|54549990|FG000|Overall Study|Moved residence|2|||
27896364|NCT03334253|54549991|FG001|Overall Study|Moved residence|2|||
27896365|NCT03131219|54549999|FG000|Initial Evaluation Period|Adverse Event|1|||
27896366|NCT03131219|54550000|FG001|Initial Evaluation Period|Adverse Event|0|||
27896367|NCT03131219|54549999|FG000|Initial Evaluation Period|Protocol Violation|1|||
27896368|NCT03131219|54550000|FG001|Initial Evaluation Period|Protocol Violation|0|||
27896369|NCT03131219|54549999|FG000|Initial Evaluation Period|Deemed ineligible post treatment|2|||
27896370|NCT03131219|54550000|FG001|Initial Evaluation Period|Deemed ineligible post treatment|0|||
27896371|NCT02914613|54550008|FG000|Overall Study|Withdrawal by Subject|1|||
27896372|NCT02914613|54550009|FG001|Overall Study|Withdrawal by Subject|2|||
27896373|NCT02914613|54550008|FG000|Overall Study|Adverse Event|1|||
27896374|NCT02914613|54550009|FG001|Overall Study|Adverse Event|0|||
27896375|NCT02586207|54550019|FG000|Overall Study|Physician Decision|1|||
27896376|NCT02586207|54550019|FG000|Overall Study|Withdrawal by Subject|1|||
27896377|NCT02573324|54550026|FG000|Overall Study|Withdrawal by Subject|26|||
27896378|NCT02573324|54550027|FG001|Overall Study|Withdrawal by Subject|23|||
27896379|NCT02573324|54550028|FG002|Overall Study|Withdrawal by Subject|3|||
27896380|NCT02573324|54550026|FG000|Overall Study|Lost to Follow-up|4|||
27896381|NCT02573324|54550027|FG001|Overall Study|Lost to Follow-up|5|||
27896382|NCT02573324|54550028|FG002|Overall Study|Lost to Follow-up|0|||
27896383|NCT02573324|54550026|FG000|Overall Study|Study Terminated by Sponsor|107|||
27896384|NCT02573324|54550027|FG001|Overall Study|Study Terminated by Sponsor|89|||
27896385|NCT02573324|54550028|FG002|Overall Study|Study Terminated by Sponsor|2|||
27896386|NCT02573324|54550026|FG000|Overall Study|Death|182|||
27896387|NCT02573324|54550027|FG001|Overall Study|Death|200|||
27896388|NCT02573324|54550028|FG002|Overall Study|Death|1|||
27896389|NCT02573324|54550026|FG000|Overall Study|Other, Not Specified|20|||
27896390|NCT02573324|54550027|FG001|Overall Study|Other, Not Specified|27|||
27896391|NCT02573324|54550028|FG002|Overall Study|Other, Not Specified|0|||
27896392|NCT02573324|54550026|FG000|Overall Study|Unknown Reason|2|||
27896393|NCT02573324|54550027|FG001|Overall Study|Unknown Reason|0|||
27896394|NCT02573324|54550028|FG002|Overall Study|Unknown Reason|0|||
27896395|NCT02296684|54550044|FG000|Overall Study|Withdrawal by Subject|0|||
27896396|NCT02296684|54550045|FG001|Overall Study|Withdrawal by Subject|1|||
27896397|NCT02296684|54550046|FG002|Overall Study|Withdrawal by Subject|1|||
27896398|NCT02296684|54550044|FG000|Overall Study|Death|2|||
27896399|NCT02296684|54550045|FG001|Overall Study|Death|0|||
27896400|NCT02296684|54550046|FG002|Overall Study|Death|0|||
27985848|NCT02393248|54644421|FG010|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
28171937|NCT00701103|54843590|FG010|Overall Study|Progressive Disease|11|||
27896401|NCT02107261|54550055|FG000|Washout: Weakness Back to Baseline|Lost to Follow-up|1|||
27896402|NCT02107261|54550056|FG001|Washout: Weakness Back to Baseline|Lost to Follow-up|0|||
27896403|NCT02107261|54550055|FG000|Cycle 2: Week 12-15|Withdrawal by Subject|0|||
27896404|NCT02107261|54550056|FG001|Cycle 2: Week 12-15|Withdrawal by Subject|1|||
27896405|NCT02014597|54550066|FG000|Overall Study|Unable to record log contrast sensitivity|2|||
27896406|NCT02014597|54550067|FG001|Overall Study|Unable to record log contrast sensitivity|1|||
27896407|NCT01342367|54550079|FG000|Overall Study|Death|1|||
27896408|NCT01342367|54550080|FG001|Overall Study|Death|0|||
27896409|NCT01342367|54550079|FG000|Overall Study|Withdrawal by Subject|1|||
27896410|NCT01342367|54550080|FG001|Overall Study|Withdrawal by Subject|2|||
27896411|NCT01185171|54550086|FG000|Induction Chemotherapy|Withdrawal by Subject|1|||
27896412|NCT01185171|54550086|FG000|Induction Chemotherapy|Duodenal Ulcer|1|||
27896413|NCT01185171|54550086|FG000|Concurrent Chemo and Radiation Treatment|Death|3|||
27896414|NCT01185171|54550086|FG000|Maintenance|Elevated liver transaminases|3|||
27896415|NCT01185171|54550086|FG000|Maintenance|Rush|2|||
27896416|NCT01185171|54550086|FG000|Maintenance|Diarrhea|1|||
27896417|NCT01185171|54550086|FG000|Maintenance|Xerostomia|1|||
27896418|NCT01185171|54550086|FG000|Maintenance|Nausea|1|||
27896419|NCT01185171|54550086|FG000|Maintenance|Comorbid Illness|2|||
27896420|NCT01185171|54550086|FG000|Maintenance|Withdrawal by Subject|1|||
27896421|NCT01185171|54550086|FG000|Maintenance|Disease Recurrence|1|||
27896422|NCT00896493|54550090|FG000|Overall Study|Early disease relapse|3|||
27896423|NCT00408005|54550096|FG000|Induction|Adverse Event|19|||
27896424|NCT00408005|54550097|FG001|Induction|Adverse Event|3|||
27896425|NCT00408005|54550098|FG002|Induction|Adverse Event|0|||
27896426|NCT00408005|54550099|FG003|Induction|Adverse Event|0|||
27896427|NCT00408005|54550100|FG004|Induction|Adverse Event|0|||
27896428|NCT00408005|54550101|FG005|Induction|Adverse Event|0|||
27896429|NCT00408005|54550102|FG006|Induction|Adverse Event|0|||
27896430|NCT00408005|54550103|FG007|Induction|Adverse Event|0|||
27896431|NCT00408005|54550096|FG000|Induction|Death|6|||
27896432|NCT00408005|54550097|FG001|Induction|Death|0|||
27896433|NCT00408005|54550098|FG002|Induction|Death|0|||
27896434|NCT00408005|54550099|FG003|Induction|Death|0|||
27896435|NCT00408005|54550100|FG004|Induction|Death|0|||
27896436|NCT00408005|54550101|FG005|Induction|Death|0|||
27896437|NCT00408005|54550102|FG006|Induction|Death|0|||
27896438|NCT00408005|54550103|FG007|Induction|Death|0|||
27896439|NCT00408005|54550096|FG000|Induction|Physician Decision|83|||
27896440|NCT00408005|54550097|FG001|Induction|Physician Decision|9|||
27896441|NCT00408005|54550098|FG002|Induction|Physician Decision|0|||
27896442|NCT00408005|54550099|FG003|Induction|Physician Decision|0|||
27896443|NCT00408005|54550100|FG004|Induction|Physician Decision|0|||
27896444|NCT00408005|54550101|FG005|Induction|Physician Decision|0|||
27896445|NCT00408005|54550102|FG006|Induction|Physician Decision|0|||
27896446|NCT00408005|54550103|FG007|Induction|Physician Decision|0|||
27896447|NCT00408005|54550096|FG000|Induction|Withdrawal by Subject|2|||
27896448|NCT00408005|54550097|FG001|Induction|Withdrawal by Subject|4|||
27896449|NCT00408005|54550098|FG002|Induction|Withdrawal by Subject|0|||
27896450|NCT00408005|54550099|FG003|Induction|Withdrawal by Subject|0|||
27896451|NCT00408005|54550100|FG004|Induction|Withdrawal by Subject|0|||
27896452|NCT00408005|54550101|FG005|Induction|Withdrawal by Subject|0|||
27896453|NCT00408005|54550102|FG006|Induction|Withdrawal by Subject|0|||
27896454|NCT00408005|54550103|FG007|Induction|Withdrawal by Subject|0|||
27896455|NCT00408005|54550096|FG000|Induction|Ineligible|33|||
27896456|NCT00408005|54550097|FG001|Induction|Ineligible|14|||
27896457|NCT00408005|54550098|FG002|Induction|Ineligible|0|||
27896458|NCT00408005|54550099|FG003|Induction|Ineligible|0|||
27896459|NCT00408005|54550100|FG004|Induction|Ineligible|0|||
27896460|NCT00408005|54550101|FG005|Induction|Ineligible|0|||
27896461|NCT00408005|54550102|FG006|Induction|Ineligible|0|||
27896462|NCT00408005|54550103|FG007|Induction|Ineligible|0|||
27896463|NCT00408005|54550096|FG000|Induction|Refusal of Further Protocol Therapy|225|||
27896464|NCT00408005|54550097|FG001|Induction|Refusal of Further Protocol Therapy|44|||
27896465|NCT00408005|54550098|FG002|Induction|Refusal of Further Protocol Therapy|0|||
27896466|NCT00408005|54550099|FG003|Induction|Refusal of Further Protocol Therapy|0|||
27896467|NCT00408005|54550100|FG004|Induction|Refusal of Further Protocol Therapy|0|||
27896468|NCT00408005|54550101|FG005|Induction|Refusal of Further Protocol Therapy|0|||
27896469|NCT00408005|54550102|FG006|Induction|Refusal of Further Protocol Therapy|0|||
27896470|NCT00408005|54550103|FG007|Induction|Refusal of Further Protocol Therapy|0|||
27896471|NCT00408005|54550096|FG000|Induction|Entered another COG therapeutic protocol|4|||
27896472|NCT00408005|54550097|FG001|Induction|Entered another COG therapeutic protocol|0|||
27896473|NCT00408005|54550098|FG002|Induction|Entered another COG therapeutic protocol|0|||
27896474|NCT00408005|54550099|FG003|Induction|Entered another COG therapeutic protocol|0|||
27896475|NCT00408005|54550100|FG004|Induction|Entered another COG therapeutic protocol|0|||
27896476|NCT00408005|54550101|FG005|Induction|Entered another COG therapeutic protocol|0|||
27896477|NCT00408005|54550102|FG006|Induction|Entered another COG therapeutic protocol|0|||
27896478|NCT00408005|54550103|FG007|Induction|Entered another COG therapeutic protocol|0|||
27896479|NCT00408005|54550096|FG000|Induction|Patient transferred Tx to Non-COG Site|3|||
27896480|NCT00408005|54550097|FG001|Induction|Patient transferred Tx to Non-COG Site|2|||
27896481|NCT00408005|54550098|FG002|Induction|Patient transferred Tx to Non-COG Site|0|||
27896482|NCT00408005|54550099|FG003|Induction|Patient transferred Tx to Non-COG Site|0|||
27896483|NCT00408005|54550100|FG004|Induction|Patient transferred Tx to Non-COG Site|0|||
27896484|NCT00408005|54550101|FG005|Induction|Patient transferred Tx to Non-COG Site|0|||
27896485|NCT00408005|54550102|FG006|Induction|Patient transferred Tx to Non-COG Site|0|||
27896486|NCT00408005|54550103|FG007|Induction|Patient transferred Tx to Non-COG Site|0|||
27896487|NCT00408005|54550096|FG000|Induction|Identified as Philadelphia Chr. Positive|6|||
27896488|NCT00408005|54550097|FG001|Induction|Identified as Philadelphia Chr. Positive|0|||
27896489|NCT00408005|54550098|FG002|Induction|Identified as Philadelphia Chr. Positive|0|||
27896490|NCT00408005|54550099|FG003|Induction|Identified as Philadelphia Chr. Positive|0|||
27896491|NCT00408005|54550100|FG004|Induction|Identified as Philadelphia Chr. Positive|0|||
27896492|NCT00408005|54550101|FG005|Induction|Identified as Philadelphia Chr. Positive|0|||
27896493|NCT00408005|54550102|FG006|Induction|Identified as Philadelphia Chr. Positive|0|||
27896494|NCT00408005|54550103|FG007|Induction|Identified as Philadelphia Chr. Positive|0|||
27896495|NCT00408005|54550096|FG000|Induction|Progressive Disease|0|||
27896496|NCT00408005|54550097|FG001|Induction|Progressive Disease|1|||
27896497|NCT00408005|54550098|FG002|Induction|Progressive Disease|0|||
27896498|NCT00408005|54550099|FG003|Induction|Progressive Disease|0|||
27896499|NCT00408005|54550100|FG004|Induction|Progressive Disease|0|||
27896500|NCT00408005|54550101|FG005|Induction|Progressive Disease|0|||
27896501|NCT00408005|54550102|FG006|Induction|Progressive Disease|0|||
27896502|NCT00408005|54550103|FG007|Induction|Progressive Disease|0|||
27896503|NCT00408005|54550096|FG000|Induction|Inevaluable|18|||
27896504|NCT00408005|54550097|FG001|Induction|Inevaluable|14|||
27896505|NCT00408005|54550098|FG002|Induction|Inevaluable|0|||
27896506|NCT00408005|54550099|FG003|Induction|Inevaluable|0|||
27896507|NCT00408005|54550100|FG004|Induction|Inevaluable|0|||
27896508|NCT00408005|54550101|FG005|Induction|Inevaluable|0|||
27896509|NCT00408005|54550102|FG006|Induction|Inevaluable|0|||
27896510|NCT00408005|54550103|FG007|Induction|Inevaluable|0|||
27896511|NCT00408005|54550096|FG000|Induction|Failed to Complete Randomization|3|||
27896512|NCT00408005|54550097|FG001|Induction|Failed to Complete Randomization|2|||
27896513|NCT00408005|54550098|FG002|Induction|Failed to Complete Randomization|0|||
27896514|NCT00408005|54550099|FG003|Induction|Failed to Complete Randomization|0|||
27896515|NCT00408005|54550100|FG004|Induction|Failed to Complete Randomization|0|||
27896516|NCT00408005|54550101|FG005|Induction|Failed to Complete Randomization|0|||
27896517|NCT00408005|54550102|FG006|Induction|Failed to Complete Randomization|0|||
27896518|NCT00408005|54550103|FG007|Induction|Failed to Complete Randomization|0|||
27896519|NCT00408005|54550096|FG000|Induction|Protocol Deviation|3|||
27896520|NCT00408005|54550097|FG001|Induction|Protocol Deviation|1|||
27896521|NCT00408005|54550098|FG002|Induction|Protocol Deviation|0|||
27896522|NCT00408005|54550099|FG003|Induction|Protocol Deviation|0|||
27896523|NCT00408005|54550100|FG004|Induction|Protocol Deviation|0|||
27896524|NCT00408005|54550101|FG005|Induction|Protocol Deviation|0|||
27896525|NCT00408005|54550102|FG006|Induction|Protocol Deviation|0|||
27896526|NCT00408005|54550103|FG007|Induction|Protocol Deviation|0|||
27896527|NCT00408005|54550096|FG000|Induction|Hematopoietic Stem Cell Transplantation|1|||
27896528|NCT00408005|54550097|FG001|Induction|Hematopoietic Stem Cell Transplantation|0|||
27896529|NCT00408005|54550098|FG002|Induction|Hematopoietic Stem Cell Transplantation|0|||
27896530|NCT00408005|54550099|FG003|Induction|Hematopoietic Stem Cell Transplantation|0|||
27896531|NCT00408005|54550100|FG004|Induction|Hematopoietic Stem Cell Transplantation|0|||
27896532|NCT00408005|54550101|FG005|Induction|Hematopoietic Stem Cell Transplantation|0|||
27896533|NCT00408005|54550102|FG006|Induction|Hematopoietic Stem Cell Transplantation|0|||
27896534|NCT00408005|54550103|FG007|Induction|Hematopoietic Stem Cell Transplantation|0|||
27896535|NCT00408005|54550096|FG000|Induction|Recurrent leukemia|1|||
27896536|NCT00408005|54550097|FG001|Induction|Recurrent leukemia|0|||
27896537|NCT00408005|54550098|FG002|Induction|Recurrent leukemia|0|||
27896538|NCT00408005|54550099|FG003|Induction|Recurrent leukemia|0|||
27896539|NCT00408005|54550100|FG004|Induction|Recurrent leukemia|0|||
27896540|NCT00408005|54550101|FG005|Induction|Recurrent leukemia|0|||
27896541|NCT00408005|54550102|FG006|Induction|Recurrent leukemia|0|||
27896542|NCT00408005|54550103|FG007|Induction|Recurrent leukemia|0|||
27896543|NCT00408005|54550096|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
27896544|NCT00408005|54550097|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
27896545|NCT00408005|54550098|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|7|||
27896546|NCT00408005|54550099|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|4|||
27896547|NCT00408005|54550100|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|8|||
27896548|NCT00408005|54550101|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|12|||
27896549|NCT00408005|54550102|FG006|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
27896550|NCT00408005|54550103|FG007|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
27896551|NCT00408005|54550096|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
27896552|NCT00408005|54550097|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
27896553|NCT00408005|54550098|FG002|Post Induction Therapy by Tx Assignment|Death|3|||
27896554|NCT00408005|54550099|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
27896555|NCT00408005|54550100|FG004|Post Induction Therapy by Tx Assignment|Death|5|||
27896556|NCT00408005|54550101|FG005|Post Induction Therapy by Tx Assignment|Death|5|||
27896557|NCT00408005|54550102|FG006|Post Induction Therapy by Tx Assignment|Death|3|||
27896558|NCT00408005|54550103|FG007|Post Induction Therapy by Tx Assignment|Death|1|||
27896559|NCT00408005|54550096|FG000|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
27896560|NCT00408005|54550097|FG001|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
27896561|NCT00408005|54550098|FG002|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2|||
27896562|NCT00408005|54550099|FG003|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
27896563|NCT00408005|54550100|FG004|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1|||
27896564|NCT00408005|54550101|FG005|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
27896565|NCT00408005|54550102|FG006|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
27896566|NCT00408005|54550103|FG007|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
27896567|NCT00408005|54550096|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
27896568|NCT00408005|54550097|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
27896569|NCT00408005|54550098|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|24|||
27896570|NCT00408005|54550099|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|19|||
27896571|NCT00408005|54550100|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|27|||
27896572|NCT00408005|54550101|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|45|||
27896573|NCT00408005|54550102|FG006|Post Induction Therapy by Tx Assignment|Physician Decision|10|||
27896574|NCT00408005|54550103|FG007|Post Induction Therapy by Tx Assignment|Physician Decision|4|||
27896575|NCT00408005|54550096|FG000|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
27896576|NCT00408005|54550097|FG001|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
27896577|NCT00408005|54550098|FG002|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
27896578|NCT00408005|54550099|FG003|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
27896579|NCT00408005|54550100|FG004|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
27896580|NCT00408005|54550101|FG005|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2|||
27896581|NCT00408005|54550102|FG006|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
27896582|NCT00408005|54550103|FG007|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
27896583|NCT00408005|54550096|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
27896584|NCT00408005|54550097|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
27896585|NCT00408005|54550098|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27|||
27896586|NCT00408005|54550099|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10|||
27896587|NCT00408005|54550100|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36|||
27896588|NCT00408005|54550101|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16|||
27896589|NCT00408005|54550102|FG006|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4|||
27896590|NCT00408005|54550103|FG007|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2|||
27896591|NCT00408005|54550096|FG000|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
27896592|NCT00408005|54550097|FG001|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
27896593|NCT00408005|54550098|FG002|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
27896594|NCT00408005|54550099|FG003|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
27896595|NCT00408005|54550100|FG004|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1|||
27896596|NCT00408005|54550101|FG005|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
27896597|NCT00408005|54550102|FG006|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
27896598|NCT00408005|54550103|FG007|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
27896599|NCT00408005|54550096|FG000|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
27896600|NCT00408005|54550097|FG001|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
27896601|NCT00408005|54550098|FG002|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3|||
27896602|NCT00408005|54550099|FG003|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
27896603|NCT00408005|54550100|FG004|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
27896604|NCT00408005|54550101|FG005|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
27896605|NCT00408005|54550102|FG006|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
27896606|NCT00408005|54550103|FG007|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
27896607|NCT00408005|54550096|FG000|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
27896608|NCT00408005|54550097|FG001|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
27896609|NCT00408005|54550098|FG002|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
27896610|NCT00408005|54550099|FG003|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
27896611|NCT00408005|54550100|FG004|Post Induction Therapy by Tx Assignment|Progressive Disease|1|||
27896612|NCT00408005|54550101|FG005|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
27896613|NCT00408005|54550102|FG006|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
27896614|NCT00408005|54550103|FG007|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
27896615|NCT00408005|54550096|FG000|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
27896616|NCT00408005|54550097|FG001|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
27896617|NCT00408005|54550098|FG002|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
27896618|NCT00408005|54550099|FG003|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
27985849|NCT02393248|54644422|FG011|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|1|||
27896619|NCT00408005|54550100|FG004|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
27896620|NCT00408005|54550101|FG005|Post Induction Therapy by Tx Assignment|Inevaluable|1|||
27896621|NCT00408005|54550102|FG006|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
27896622|NCT00408005|54550103|FG007|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
27896623|NCT00408005|54550096|FG000|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
27896624|NCT00408005|54550097|FG001|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
27896625|NCT00408005|54550098|FG002|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
27896626|NCT00408005|54550099|FG003|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
27896627|NCT00408005|54550100|FG004|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
27896628|NCT00408005|54550101|FG005|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
27896629|NCT00408005|54550102|FG006|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
27896630|NCT00408005|54550103|FG007|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
27896631|NCT00408005|54550096|FG000|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
27896632|NCT00408005|54550097|FG001|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
27896633|NCT00408005|54550098|FG002|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
27896634|NCT00408005|54550099|FG003|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
27896635|NCT00408005|54550100|FG004|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1|||
27896636|NCT00408005|54550101|FG005|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2|||
27896637|NCT00408005|54550102|FG006|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
27896638|NCT00408005|54550103|FG007|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
27896639|NCT00408005|54550096|FG000|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
27896640|NCT00408005|54550097|FG001|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
27896641|NCT00408005|54550098|FG002|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13|||
27896642|NCT00408005|54550099|FG003|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7|||
27896643|NCT00408005|54550100|FG004|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49|||
27896644|NCT00408005|54550101|FG005|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15|||
27896645|NCT00408005|54550102|FG006|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1|||
27896646|NCT00408005|54550103|FG007|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
27896647|NCT00408005|54550096|FG000|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
27896648|NCT00408005|54550097|FG001|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
27896649|NCT00408005|54550098|FG002|Post Induction Therapy by Tx Assignment|Development of SMN|3|||
27896650|NCT00408005|54550099|FG003|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
27896651|NCT00408005|54550100|FG004|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
27896652|NCT00408005|54550101|FG005|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
27896653|NCT00408005|54550102|FG006|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
27896654|NCT00408005|54550103|FG007|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
27896655|NCT01875185|54550134|FG000|Overall Study|study was terminated|52|||
27896656|NCT01875185|54550135|FG001|Overall Study|study was terminated|48|||
27896657|NCT01901432|54550164|FG000|Overall Study|Adverse Event|0|||
27896658|NCT01901432|54550165|FG001|Overall Study|Adverse Event|1|||
27896659|NCT01901432|54550166|FG002|Overall Study|Adverse Event|1|||
27896660|NCT01901432|54550167|FG003|Overall Study|Adverse Event|0|||
27896661|NCT01901432|54550168|FG004|Overall Study|Adverse Event|1|||
27896662|NCT01901432|54550164|FG000|Overall Study|Withdrawal by Subject|0|||
27896663|NCT01901432|54550165|FG001|Overall Study|Withdrawal by Subject|0|||
27896664|NCT01901432|54550166|FG002|Overall Study|Withdrawal by Subject|1|||
27896665|NCT01901432|54550167|FG003|Overall Study|Withdrawal by Subject|0|||
27896666|NCT01901432|54550168|FG004|Overall Study|Withdrawal by Subject|5|||
27896667|NCT01901432|54550164|FG000|Overall Study|Physician Decision|0|||
27896668|NCT01901432|54550165|FG001|Overall Study|Physician Decision|0|||
27896669|NCT01901432|54550166|FG002|Overall Study|Physician Decision|0|||
27896670|NCT01901432|54550167|FG003|Overall Study|Physician Decision|0|||
27739405|NCT01680861|54189033|FG001|Early Post-transplant Period|Protocol Violation|1|||
27739406|NCT02229214|54189043|FG000|Overall Study|Adverse Event|2|||
27739407|NCT02229214|54189044|FG001|Overall Study|Adverse Event|0|||
27739408|NCT02229214|54189043|FG000|Overall Study|Withdrawal by Subject|4|||
27739409|NCT02229214|54189044|FG001|Overall Study|Withdrawal by Subject|0|||
27739410|NCT02228980|54189056|FG000|Overall Study|Adverse Event|14|||
27739411|NCT02228980|54189057|FG001|Overall Study|Adverse Event|0|||
27739412|NCT02228980|54189058|FG002|Overall Study|Adverse Event|0|||
27739413|NCT02228980|54189059|FG003|Overall Study|Adverse Event|0|||
27739414|NCT02228980|54189056|FG000|Overall Study|Protocol Violation|7|||
27739415|NCT02228980|54189057|FG001|Overall Study|Protocol Violation|0|||
27896671|NCT01901432|54550168|FG004|Overall Study|Physician Decision|2|||
27896672|NCT01901432|54550164|FG000|Overall Study|Patient decision to stop study drug|0|||
27739416|NCT02228980|54189058|FG002|Overall Study|Protocol Violation|0|||
27896673|NCT01901432|54550165|FG001|Overall Study|Patient decision to stop study drug|0|||
27896674|NCT01901432|54550166|FG002|Overall Study|Patient decision to stop study drug|0|||
27896675|NCT01901432|54550167|FG003|Overall Study|Patient decision to stop study drug|0|||
27896676|NCT01901432|54550168|FG004|Overall Study|Patient decision to stop study drug|1|||
27896677|NCT01904279|54550189|FG000|Overall Study|Lack of Efficacy|2|||
27896678|NCT01904279|54550190|FG001|Overall Study|Lack of Efficacy|3|||
27896679|NCT01904279|54550189|FG000|Overall Study|Withdrawal by Subject|1|||
27896680|NCT01904279|54550190|FG001|Overall Study|Withdrawal by Subject|0|||
27896681|NCT01917318|54550199|FG000|First Treatment|Withdrawal by Subject|0|||
27896682|NCT01917318|54550200|FG001|First Treatment|Withdrawal by Subject|1|||
27896683|NCT01923168|54550209|FG000|Overall Study|Protocol Violation|1|||
27896684|NCT01923168|54550210|FG001|Overall Study|Protocol Violation|1|||
27896685|NCT01923168|54550211|FG002|Overall Study|Protocol Violation|0|||
27896686|NCT01923168|54550209|FG000|Overall Study|Subject/guardian decision|14|||
27896687|NCT01923168|54550210|FG001|Overall Study|Subject/guardian decision|14|||
27896688|NCT01923168|54550211|FG002|Overall Study|Subject/guardian decision|4|||
27896689|NCT01923168|54550209|FG000|Overall Study|Adverse Event|12|||
27896690|NCT01923168|54550210|FG001|Overall Study|Adverse Event|12|||
27896691|NCT01923168|54550211|FG002|Overall Study|Adverse Event|0|||
27896692|NCT01923168|54550209|FG000|Overall Study|Physician Decision|6|||
27896693|NCT01923168|54550210|FG001|Overall Study|Physician Decision|9|||
27896694|NCT01923168|54550211|FG002|Overall Study|Physician Decision|5|||
27896695|NCT01923168|54550209|FG000|Overall Study|Progressive disease|4|||
27896696|NCT01923168|54550210|FG001|Overall Study|Progressive disease|3|||
27896697|NCT01923168|54550211|FG002|Overall Study|Progressive disease|7|||
27896698|NCT01923168|54550209|FG000|Overall Study|Death|0|||
27896699|NCT01923168|54550210|FG001|Overall Study|Death|0|||
27896700|NCT01923168|54550211|FG002|Overall Study|Death|1|||
27896701|NCT01931098|54550221|FG000|Overall Study|Withdrawal by Subject|0|||
27896702|NCT01931098|54550222|FG001|Overall Study|Withdrawal by Subject|1|||
27896703|NCT01931098|54550221|FG000|Overall Study|Enrolled in different protocol|0|||
27896704|NCT01931098|54550222|FG001|Overall Study|Enrolled in different protocol|1|||
27896705|NCT01931098|54550221|FG000|Overall Study|Unable to begin trmt:active infection|0|||
27896706|NCT01931098|54550222|FG001|Overall Study|Unable to begin trmt:active infection|1|||
27896707|NCT01931098|54550221|FG000|Overall Study|Refused further treatment|0|||
27896708|NCT01931098|54550222|FG001|Overall Study|Refused further treatment|1|||
27896709|NCT01945021|54550230|FG000|Overall Study|Adverse Event|1|||
27896710|NCT01945021|54550230|FG000|Overall Study|Withdrawal of consent|12|||
27896711|NCT01945021|54550230|FG000|Overall Study|Lost to Follow-up|5|||
27896712|NCT01945021|54550230|FG000|Overall Study|Death|65|||
27896713|NCT03951077|54550271|FG000|Overall Study|Adverse Event|1|||
27896714|NCT03951077|54550272|FG001|Overall Study|Adverse Event|0|||
27896715|NCT03951077|54550273|FG002|Overall Study|Adverse Event|0|||
27985850|NCT02393248|54644423|FG012|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
27985851|NCT02393248|54644424|FG013|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|3|||
27985852|NCT02393248|54644425|FG014|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
27985853|NCT02393248|54644426|FG015|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
27985854|NCT02393248|54644427|FG016|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
27985855|NCT02393248|54644428|FG017|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
27985856|NCT02393248|54644429|FG018|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
27985857|NCT02393248|54644430|FG019|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
27985858|NCT02393248|54644431|FG020|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
27985859|NCT02393248|54644432|FG021|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
27985860|NCT02393248|54644433|FG022|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
27985861|NCT02393248|54644434|FG023|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
27985862|NCT02393248|54644435|FG024|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
27985863|NCT02393248|54644411|FG000|Part 3: Combination Therapy|Withdrawal by Subject|0|||
27985864|NCT02393248|54644412|FG001|Part 3: Combination Therapy|Withdrawal by Subject|0|||
27985865|NCT02393248|54644413|FG002|Part 3: Combination Therapy|Withdrawal by Subject|0|||
27985866|NCT02393248|54644414|FG003|Part 3: Combination Therapy|Withdrawal by Subject|0|||
27985867|NCT02393248|54644415|FG004|Part 3: Combination Therapy|Withdrawal by Subject|0|||
27985868|NCT02393248|54644416|FG005|Part 3: Combination Therapy|Withdrawal by Subject|0|||
27985869|NCT02393248|54644417|FG006|Part 3: Combination Therapy|Withdrawal by Subject|0|||
27985870|NCT02393248|54644418|FG007|Part 3: Combination Therapy|Withdrawal by Subject|0|||
28171938|NCT00701103|54843580|FG000|Overall Study|Withdrawal by Subject|0|||
28171939|NCT00701103|54843581|FG001|Overall Study|Withdrawal by Subject|1|||
27896716|NCT03951077|54550274|FG003|Overall Study|Adverse Event|0|||
27896717|NCT03951077|54550275|FG004|Overall Study|Adverse Event|0|||
27896718|NCT03951077|54550276|FG005|Overall Study|Adverse Event|0|||
27896719|NCT03951077|54550271|FG000|Overall Study|Withdrawal by Subject|3|||
27896720|NCT03951077|54550272|FG001|Overall Study|Withdrawal by Subject|3|||
27896721|NCT03951077|54550273|FG002|Overall Study|Withdrawal by Subject|0|||
27896722|NCT03951077|54550274|FG003|Overall Study|Withdrawal by Subject|3|||
27896723|NCT03951077|54550275|FG004|Overall Study|Withdrawal by Subject|3|||
27896724|NCT03951077|54550276|FG005|Overall Study|Withdrawal by Subject|2|||
27896725|NCT03951077|54550271|FG000|Overall Study|Lost to Follow-up|1|||
27896726|NCT03951077|54550272|FG001|Overall Study|Lost to Follow-up|1|||
27896727|NCT03951077|54550273|FG002|Overall Study|Lost to Follow-up|2|||
27896728|NCT03951077|54550274|FG003|Overall Study|Lost to Follow-up|3|||
27896729|NCT03951077|54550275|FG004|Overall Study|Lost to Follow-up|2|||
27896730|NCT03951077|54550276|FG005|Overall Study|Lost to Follow-up|3|||
27896731|NCT03951077|54550271|FG000|Overall Study|Non-Compliance With Study Procedures|0|||
27896732|NCT03951077|54550272|FG001|Overall Study|Non-Compliance With Study Procedures|0|||
27896733|NCT03951077|54550273|FG002|Overall Study|Non-Compliance With Study Procedures|0|||
27896734|NCT03951077|54550274|FG003|Overall Study|Non-Compliance With Study Procedures|0|||
27896735|NCT03951077|54550275|FG004|Overall Study|Non-Compliance With Study Procedures|1|||
27896736|NCT03951077|54550276|FG005|Overall Study|Non-Compliance With Study Procedures|0|||
27896737|NCT03951077|54550271|FG000|Overall Study|Other, Not Specified|12|||
27896738|NCT03951077|54550272|FG001|Overall Study|Other, Not Specified|10|||
27896739|NCT03951077|54550273|FG002|Overall Study|Other, Not Specified|10|||
27896740|NCT03951077|54550274|FG003|Overall Study|Other, Not Specified|5|||
27896741|NCT03951077|54550275|FG004|Overall Study|Other, Not Specified|9|||
27896742|NCT03951077|54550276|FG005|Overall Study|Other, Not Specified|6|||
27896743|NCT03951077|54550271|FG000|Overall Study|Did Not Receive Any Study Drug|1|||
27896744|NCT03951077|54550272|FG001|Overall Study|Did Not Receive Any Study Drug|0|||
27896745|NCT03951077|54550273|FG002|Overall Study|Did Not Receive Any Study Drug|1|||
27896746|NCT03951077|54550274|FG003|Overall Study|Did Not Receive Any Study Drug|1|||
27896747|NCT03951077|54550275|FG004|Overall Study|Did Not Receive Any Study Drug|1|||
27896748|NCT03951077|54550276|FG005|Overall Study|Did Not Receive Any Study Drug|0|||
27896749|NCT03873246|54550293|FG000|Overall Study|Adverse Event|1|||
27896750|NCT03873246|54550294|FG001|Overall Study|Adverse Event|3|||
27896751|NCT03873246|54550295|FG002|Overall Study|Adverse Event|3|||
27896752|NCT03873246|54550293|FG000|Overall Study|Lost to Follow-up|4|||
27896753|NCT03873246|54550294|FG001|Overall Study|Lost to Follow-up|4|||
27896754|NCT03873246|54550295|FG002|Overall Study|Lost to Follow-up|5|||
27896755|NCT03873246|54550293|FG000|Overall Study|Protocol Violation|0|||
27896756|NCT03873246|54550294|FG001|Overall Study|Protocol Violation|1|||
27896757|NCT03873246|54550295|FG002|Overall Study|Protocol Violation|0|||
27896758|NCT03873246|54550293|FG000|Overall Study|Withdrawal by Subject|0|||
27896759|NCT03873246|54550294|FG001|Overall Study|Withdrawal by Subject|4|||
27896760|NCT03873246|54550295|FG002|Overall Study|Withdrawal by Subject|1|||
27896761|NCT03769649|54550304|FG000|Overall Study|Lost to Follow-up|4|||
27896762|NCT02862548|54550330|FG000|Randomized Phase (Up to Week 48)|Death|0|||
27896763|NCT02862548|54550331|FG001|Randomized Phase (Up to Week 48)|Death|1|||
27896764|NCT02862548|54550330|FG000|OLE Phase (Week 49 to Week 192)|Death|2|||
27896765|NCT02862548|54550331|FG001|OLE Phase (Week 49 to Week 192)|Death|0|||
27896766|NCT02862548|54550330|FG000|OLE Phase (Week 49 to Week 192)|Adverse Event|1|||
27896767|NCT02862548|54550331|FG001|OLE Phase (Week 49 to Week 192)|Adverse Event|0|||
27896768|NCT02862548|54550330|FG000|OLE Phase (Week 49 to Week 192)|Withdrew Consent|0|||
27896769|NCT02862548|54550331|FG001|OLE Phase (Week 49 to Week 192)|Withdrew Consent|1|||
27896770|NCT02335099|54550350|FG000|Treatment|Withdrawal by Subject|1|||
27896771|NCT02335099|54550351|FG001|Treatment|Withdrawal by Subject|3|||
27896772|NCT02335099|54550350|FG000|Treatment|Lost to Follow-up|2|||
27896773|NCT02335099|54550351|FG001|Treatment|Lost to Follow-up|0|||
27896774|NCT02335099|54550350|FG000|Treatment|Death|1|||
27896775|NCT02335099|54550351|FG001|Treatment|Death|0|||
27896776|NCT02335099|54550350|FG000|Treatment|Adverse Event|1|||
27896777|NCT02335099|54550351|FG001|Treatment|Adverse Event|2|||
27896778|NCT02335099|54550350|FG000|Follow-up|Death|0|||
27896779|NCT02335099|54550351|FG001|Follow-up|Death|1|||
27896780|NCT02330562|54550368|FG000|Overall Study|Adverse Event|0|||
27896781|NCT02330562|54550369|FG001|Overall Study|Adverse Event|0|||
27896782|NCT02330562|54550370|FG002|Overall Study|Adverse Event|3|||
27896783|NCT02330562|54550371|FG003|Overall Study|Adverse Event|0|||
27896784|NCT02330562|54550372|FG004|Overall Study|Adverse Event|3|||
27896785|NCT02330562|54550373|FG005|Overall Study|Adverse Event|1|||
27896786|NCT02330562|54550374|FG006|Overall Study|Adverse Event|0|||
27896787|NCT02330562|54550375|FG007|Overall Study|Adverse Event|0|||
27896788|NCT02330562|54550376|FG008|Overall Study|Adverse Event|0|||
27896789|NCT02330562|54550377|FG009|Overall Study|Adverse Event|1|||
27896790|NCT02330562|54550378|FG010|Overall Study|Adverse Event|1|||
27896791|NCT02330562|54550368|FG000|Overall Study|Participant decision|1|||
27896792|NCT02330562|54550369|FG001|Overall Study|Participant decision|0|||
27896793|NCT02330562|54550370|FG002|Overall Study|Participant decision|4|||
27896794|NCT02330562|54550371|FG003|Overall Study|Participant decision|1|||
27896795|NCT02330562|54550372|FG004|Overall Study|Participant decision|5|||
27896796|NCT02330562|54550373|FG005|Overall Study|Participant decision|2|||
27896797|NCT02330562|54550374|FG006|Overall Study|Participant decision|0|||
27896798|NCT02330562|54550375|FG007|Overall Study|Participant decision|0|||
27896799|NCT02330562|54550376|FG008|Overall Study|Participant decision|0|||
27896800|NCT02330562|54550377|FG009|Overall Study|Participant decision|3|||
27896801|NCT02330562|54550378|FG010|Overall Study|Participant decision|0|||
27896802|NCT02330562|54550368|FG000|Overall Study|Disease progression|5|||
27896803|NCT02330562|54550369|FG001|Overall Study|Disease progression|3|||
27896804|NCT02330562|54550370|FG002|Overall Study|Disease progression|20|||
27896805|NCT02330562|54550371|FG003|Overall Study|Disease progression|28|||
27896806|NCT02330562|54550372|FG004|Overall Study|Disease progression|23|||
27896807|NCT02330562|54550373|FG005|Overall Study|Disease progression|7|||
27896808|NCT02330562|54550374|FG006|Overall Study|Disease progression|1|||
27896809|NCT02330562|54550375|FG007|Overall Study|Disease progression|1|||
27896810|NCT02330562|54550376|FG008|Overall Study|Disease progression|1|||
27896811|NCT02330562|54550377|FG009|Overall Study|Disease progression|0|||
27896812|NCT02330562|54550378|FG010|Overall Study|Disease progression|5|||
27896813|NCT02330562|54550368|FG000|Overall Study|Other reasons|0|||
27896814|NCT02330562|54550369|FG001|Overall Study|Other reasons|0|||
27896815|NCT02330562|54550370|FG002|Overall Study|Other reasons|0|||
27896816|NCT02330562|54550371|FG003|Overall Study|Other reasons|1|||
27896817|NCT02330562|54550372|FG004|Overall Study|Other reasons|0|||
27896818|NCT02330562|54550373|FG005|Overall Study|Other reasons|0|||
27896819|NCT02330562|54550374|FG006|Overall Study|Other reasons|0|||
27896820|NCT02330562|54550375|FG007|Overall Study|Other reasons|0|||
27896821|NCT02330562|54550376|FG008|Overall Study|Other reasons|0|||
27896822|NCT02330562|54550377|FG009|Overall Study|Other reasons|0|||
27896823|NCT02330562|54550378|FG010|Overall Study|Other reasons|0|||
27896824|NCT02330562|54550368|FG000|Overall Study|Withdrawal by Subject|0|||
27896825|NCT02330562|54550369|FG001|Overall Study|Withdrawal by Subject|0|||
27896826|NCT02330562|54550370|FG002|Overall Study|Withdrawal by Subject|0|||
27896827|NCT02330562|54550371|FG003|Overall Study|Withdrawal by Subject|0|||
27896828|NCT02330562|54550372|FG004|Overall Study|Withdrawal by Subject|0|||
27896829|NCT02330562|54550373|FG005|Overall Study|Withdrawal by Subject|0|||
27896830|NCT02330562|54550374|FG006|Overall Study|Withdrawal by Subject|0|||
27896831|NCT02330562|54550375|FG007|Overall Study|Withdrawal by Subject|0|||
27896832|NCT02330562|54550376|FG008|Overall Study|Withdrawal by Subject|0|||
27896833|NCT02330562|54550377|FG009|Overall Study|Withdrawal by Subject|1|||
27896834|NCT02330562|54550378|FG010|Overall Study|Withdrawal by Subject|0|||
27896835|NCT03703102|54550492|FG000|Overall Study|Adverse Event|4|||
27896836|NCT03703102|54550493|FG001|Overall Study|Adverse Event|3|||
27896837|NCT03703102|54550494|FG002|Overall Study|Adverse Event|7|||
27896838|NCT03703102|54550495|FG003|Overall Study|Adverse Event|3|||
27896839|NCT03703102|54550496|FG004|Overall Study|Adverse Event|13|||
27896840|NCT03703102|54550492|FG000|Overall Study|Lack of Efficacy|4|||
27896841|NCT03703102|54550493|FG001|Overall Study|Lack of Efficacy|0|||
27896842|NCT03703102|54550494|FG002|Overall Study|Lack of Efficacy|1|||
27896843|NCT03703102|54550495|FG003|Overall Study|Lack of Efficacy|4|||
27896844|NCT03703102|54550496|FG004|Overall Study|Lack of Efficacy|1|||
27896845|NCT03703102|54550492|FG000|Overall Study|Lost to Follow-up|0|||
27896846|NCT03703102|54550493|FG001|Overall Study|Lost to Follow-up|0|||
27896847|NCT03703102|54550494|FG002|Overall Study|Lost to Follow-up|1|||
27896848|NCT03703102|54550495|FG003|Overall Study|Lost to Follow-up|2|||
27896849|NCT03703102|54550496|FG004|Overall Study|Lost to Follow-up|2|||
27896850|NCT03703102|54550492|FG000|Overall Study|Physician Decision|2|||
27896851|NCT03703102|54550493|FG001|Overall Study|Physician Decision|2|||
27896852|NCT03703102|54550494|FG002|Overall Study|Physician Decision|2|||
27896853|NCT03703102|54550495|FG003|Overall Study|Physician Decision|2|||
27896854|NCT03703102|54550496|FG004|Overall Study|Physician Decision|4|||
27896855|NCT03703102|54550492|FG000|Overall Study|Withdrawal by Subject|7|||
27896856|NCT03703102|54550493|FG001|Overall Study|Withdrawal by Subject|5|||
27896857|NCT03703102|54550494|FG002|Overall Study|Withdrawal by Subject|5|||
27896858|NCT03703102|54550495|FG003|Overall Study|Withdrawal by Subject|5|||
27896859|NCT03703102|54550496|FG004|Overall Study|Withdrawal by Subject|9|||
27896860|NCT03703102|54550492|FG000|Overall Study|Ineligibility|0|||
27896861|NCT03703102|54550493|FG001|Overall Study|Ineligibility|0|||
27896862|NCT03703102|54550494|FG002|Overall Study|Ineligibility|1|||
27896863|NCT03703102|54550495|FG003|Overall Study|Ineligibility|0|||
27896864|NCT03703102|54550496|FG004|Overall Study|Ineligibility|0|||
27896865|NCT03703102|54550492|FG000|Overall Study|Protocol Deviation|4|||
27896866|NCT03703102|54550493|FG001|Overall Study|Protocol Deviation|4|||
27896867|NCT03703102|54550494|FG002|Overall Study|Protocol Deviation|3|||
27896868|NCT03703102|54550495|FG003|Overall Study|Protocol Deviation|0|||
27896869|NCT03703102|54550496|FG004|Overall Study|Protocol Deviation|0|||
27896870|NCT03703102|54550492|FG000|Overall Study|Non-Compliance with Study Drug|1|||
27896871|NCT03703102|54550493|FG001|Overall Study|Non-Compliance with Study Drug|1|||
27896872|NCT03703102|54550494|FG002|Overall Study|Non-Compliance with Study Drug|2|||
27896873|NCT03703102|54550495|FG003|Overall Study|Non-Compliance with Study Drug|1|||
27896874|NCT03703102|54550496|FG004|Overall Study|Non-Compliance with Study Drug|4|||
27896875|NCT03395704|54550515|FG000|Overall Study|Adverse Event|2|||
27896876|NCT03395704|54550516|FG001|Overall Study|Adverse Event|1|||
27896877|NCT03395704|54550515|FG000|Overall Study|Withdrawal by Subject|2|||
27896878|NCT03395704|54550516|FG001|Overall Study|Withdrawal by Subject|1|||
27896879|NCT03395704|54550515|FG000|Overall Study|Physician Decision|0|||
27896880|NCT03395704|54550516|FG001|Overall Study|Physician Decision|1|||
27896881|NCT03335813|54550522|FG000|Overall Study|Withdrawal by Subject|1|||
27896882|NCT03246503|54550526|FG000|Overall Study|Lost to Follow-up|23|||
27896883|NCT03246503|54550526|FG000|Overall Study|Withdrawal by Subject|20|||
27896884|NCT03246503|54550526|FG000|Overall Study|Physician Decision|5|||
27896885|NCT03246503|54550526|FG000|Overall Study|Received phtototherapy prior to study visit=4, blood specimen not obtained =1|5|||
27896886|NCT02514447|54550587|FG000|Overall Study|Withdrawal by Subject|3|||
27896887|NCT02514447|54550588|FG001|Overall Study|Withdrawal by Subject|1|||
27896888|NCT02514447|54550589|FG002|Overall Study|Withdrawal by Subject|1|||
27896889|NCT02514447|54550590|FG003|Overall Study|Withdrawal by Subject|0|||
27896890|NCT02514447|54550591|FG004|Overall Study|Withdrawal by Subject|0|||
27896891|NCT02514447|54550592|FG005|Overall Study|Withdrawal by Subject|0|||
27896892|NCT02514447|54550593|FG006|Overall Study|Withdrawal by Subject|0|||
27896893|NCT02514447|54550594|FG007|Overall Study|Withdrawal by Subject|1|||
27896894|NCT02514447|54550595|FG008|Overall Study|Withdrawal by Subject|1|||
27896895|NCT02514447|54550587|FG000|Overall Study|Death|24|||
27896896|NCT02514447|54550588|FG001|Overall Study|Death|28|||
27896897|NCT02514447|54550589|FG002|Overall Study|Death|29|||
27896898|NCT02514447|54550590|FG003|Overall Study|Death|0|||
27896899|NCT02514447|54550591|FG004|Overall Study|Death|3|||
27896900|NCT02514447|54550592|FG005|Overall Study|Death|4|||
27896901|NCT02514447|54550593|FG006|Overall Study|Death|8|||
27896902|NCT02514447|54550594|FG007|Overall Study|Death|6|||
27896903|NCT02514447|54550595|FG008|Overall Study|Death|5|||
27896904|NCT02514447|54550587|FG000|Overall Study|Lost to Follow-up|1|||
27896905|NCT02514447|54550588|FG001|Overall Study|Lost to Follow-up|0|||
27896906|NCT02514447|54550589|FG002|Overall Study|Lost to Follow-up|0|||
27896907|NCT02514447|54550590|FG003|Overall Study|Lost to Follow-up|0|||
27896908|NCT02514447|54550591|FG004|Overall Study|Lost to Follow-up|0|||
27896909|NCT02514447|54550592|FG005|Overall Study|Lost to Follow-up|0|||
27896910|NCT02514447|54550593|FG006|Overall Study|Lost to Follow-up|0|||
27896911|NCT02514447|54550594|FG007|Overall Study|Lost to Follow-up|0|||
27896912|NCT02514447|54550595|FG008|Overall Study|Lost to Follow-up|1|||
27896913|NCT02514447|54550587|FG000|Overall Study|Sponsor Termination of Study|0|||
27896914|NCT02514447|54550588|FG001|Overall Study|Sponsor Termination of Study|1|||
27896915|NCT02514447|54550589|FG002|Overall Study|Sponsor Termination of Study|1|||
27896916|NCT02514447|54550590|FG003|Overall Study|Sponsor Termination of Study|0|||
27896917|NCT02514447|54550591|FG004|Overall Study|Sponsor Termination of Study|0|||
27896918|NCT02514447|54550592|FG005|Overall Study|Sponsor Termination of Study|0|||
27896919|NCT02514447|54550593|FG006|Overall Study|Sponsor Termination of Study|0|||
27896920|NCT02514447|54550594|FG007|Overall Study|Sponsor Termination of Study|0|||
27896921|NCT02514447|54550595|FG008|Overall Study|Sponsor Termination of Study|0|||
27896922|NCT02514447|54550587|FG000|Overall Study|Study completion per Investigator|1|||
27896923|NCT02514447|54550588|FG001|Overall Study|Study completion per Investigator|0|||
27896924|NCT02514447|54550589|FG002|Overall Study|Study completion per Investigator|1|||
27896925|NCT02514447|54550590|FG003|Overall Study|Study completion per Investigator|2|||
27896926|NCT02514447|54550591|FG004|Overall Study|Study completion per Investigator|0|||
27896927|NCT02514447|54550592|FG005|Overall Study|Study completion per Investigator|0|||
27896928|NCT02514447|54550593|FG006|Overall Study|Study completion per Investigator|0|||
27896929|NCT02514447|54550594|FG007|Overall Study|Study completion per Investigator|0|||
27896930|NCT02514447|54550595|FG008|Overall Study|Study completion per Investigator|1|||
27896931|NCT01785563|54550639|FG000|Overall Study|Physician Decision|10|||
27896932|NCT01785563|54550639|FG000|Overall Study|Withdrawal by Subject|1|||
27896933|NCT01785563|54550639|FG000|Overall Study|Protocol Violation|2|||
27896934|NCT01434290|54550645|FG000|Overall Study|Protocol Violation|6|||
27896935|NCT01434290|54550646|FG001|Overall Study|Protocol Violation|3|||
27896936|NCT01434290|54550645|FG000|Overall Study|No protocol treatment|2|||
27896937|NCT01434290|54550646|FG001|Overall Study|No protocol treatment|4|||
27896938|NCT00750269|54550658|FG000|Overall Study|Protocol Violation|0|||
27896939|NCT00750269|54550659|FG001|Overall Study|Protocol Violation|1|||
27896940|NCT00750269|54550660|FG002|Overall Study|Protocol Violation|1|||
27896941|NCT00750269|54550661|FG003|Overall Study|Protocol Violation|2|||
27896942|NCT00750269|54550662|FG004|Overall Study|Protocol Violation|4|||
27896943|NCT00750269|54550658|FG000|Overall Study|Withdrawal by Subject|0|||
27896944|NCT00750269|54550659|FG001|Overall Study|Withdrawal by Subject|0|||
27896945|NCT00750269|54550660|FG002|Overall Study|Withdrawal by Subject|2|||
27896946|NCT00750269|54550661|FG003|Overall Study|Withdrawal by Subject|2|||
27896947|NCT00750269|54550662|FG004|Overall Study|Withdrawal by Subject|2|||
27896948|NCT00750269|54550658|FG000|Overall Study|Physician Decision|0|||
27896949|NCT00750269|54550659|FG001|Overall Study|Physician Decision|0|||
27896950|NCT00750269|54550660|FG002|Overall Study|Physician Decision|0|||
27896951|NCT00750269|54550661|FG003|Overall Study|Physician Decision|0|||
27896952|NCT00750269|54550662|FG004|Overall Study|Physician Decision|2|||
27896953|NCT00750269|54550658|FG000|Overall Study|Patient too large for positioning|0|||
27896954|NCT00750269|54550659|FG001|Overall Study|Patient too large for positioning|0|||
27896955|NCT00750269|54550660|FG002|Overall Study|Patient too large for positioning|1|||
27896956|NCT00750269|54550661|FG003|Overall Study|Patient too large for positioning|0|||
27896957|NCT00750269|54550662|FG004|Overall Study|Patient too large for positioning|0|||
27896958|NCT00750269|54550658|FG000|Overall Study|Site error|0|||
27896959|NCT00750269|54550659|FG001|Overall Study|Site error|0|||
27896960|NCT00750269|54550660|FG002|Overall Study|Site error|0|||
27896961|NCT00750269|54550661|FG003|Overall Study|Site error|1|||
27896962|NCT00750269|54550662|FG004|Overall Study|Site error|0|||
27896963|NCT00750269|54550658|FG000|Overall Study|SBRT plan could not be drawn|0|||
27896964|NCT00750269|54550659|FG001|Overall Study|SBRT plan could not be drawn|0|||
27896965|NCT00750269|54550660|FG002|Overall Study|SBRT plan could not be drawn|0|||
27896966|NCT00750269|54550661|FG003|Overall Study|SBRT plan could not be drawn|0|||
27896967|NCT00750269|54550662|FG004|Overall Study|SBRT plan could not be drawn|1|||
27896968|NCT00750269|54550658|FG000|Overall Study|Fiducials could not be placed|0|||
27896969|NCT00750269|54550659|FG001|Overall Study|Fiducials could not be placed|0|||
27896970|NCT00750269|54550660|FG002|Overall Study|Fiducials could not be placed|0|||
27896971|NCT00750269|54550661|FG003|Overall Study|Fiducials could not be placed|0|||
27896972|NCT00750269|54550662|FG004|Overall Study|Fiducials could not be placed|1|||
27896973|NCT00712322|54550684|FG000|Overall Study|Protocol deviation|0|||
27896974|NCT00712322|54550685|FG001|Overall Study|Protocol deviation|1|||
27896975|NCT00712322|54550686|FG002|Overall Study|Protocol deviation|0|||
27896976|NCT00323856|54550694|FG000|Overall Study|Withdrawal by Subject|1|||
27896977|NCT00323856|54550694|FG000|Overall Study|Was uncooperative and noncompliant|1|||
27896978|NCT00323856|54550694|FG000|Overall Study|Reason not specified|1|||
27896979|NCT00323856|54550694|FG000|Overall Study|Missing|2|||
27896980|NCT04524663|54550707|FG000|Overall Study|Withdrawal by Subject|0|||
27896981|NCT04524663|54550708|FG001|Overall Study|Withdrawal by Subject|2|||
27896982|NCT03738423|54550737|FG000|Overall Study|Withdrawal by Subject|9|||
27896983|NCT03738423|54550738|FG001|Overall Study|Withdrawal by Subject|12|||
27896984|NCT03738423|54550739|FG002|Overall Study|Withdrawal by Subject|9|||
27896985|NCT03738423|54550740|FG003|Overall Study|Withdrawal by Subject|12|||
27896986|NCT03738423|54550741|FG004|Overall Study|Withdrawal by Subject|10|||
27896987|NCT03738423|54550737|FG000|Overall Study|Lack of Efficacy|3|||
27896988|NCT03738423|54550738|FG001|Overall Study|Lack of Efficacy|1|||
27896989|NCT03738423|54550739|FG002|Overall Study|Lack of Efficacy|1|||
27896990|NCT03738423|54550740|FG003|Overall Study|Lack of Efficacy|1|||
27896991|NCT03738423|54550741|FG004|Overall Study|Lack of Efficacy|2|||
27896992|NCT03738423|54550737|FG000|Overall Study|Lost to Follow-up|1|||
27896993|NCT03738423|54550738|FG001|Overall Study|Lost to Follow-up|0|||
27896994|NCT03738423|54550739|FG002|Overall Study|Lost to Follow-up|1|||
27896995|NCT03738423|54550740|FG003|Overall Study|Lost to Follow-up|1|||
27896996|NCT03738423|54550741|FG004|Overall Study|Lost to Follow-up|0|||
27896997|NCT03738423|54550737|FG000|Overall Study|Protocol Violation|1|||
27896998|NCT03738423|54550738|FG001|Overall Study|Protocol Violation|0|||
27896999|NCT03738423|54550739|FG002|Overall Study|Protocol Violation|0|||
27897000|NCT03738423|54550740|FG003|Overall Study|Protocol Violation|0|||
27897001|NCT03738423|54550741|FG004|Overall Study|Protocol Violation|1|||
27897002|NCT03738423|54550737|FG000|Overall Study|Physician Decision|0|||
27897003|NCT03738423|54550738|FG001|Overall Study|Physician Decision|0|||
27897004|NCT03738423|54550739|FG002|Overall Study|Physician Decision|1|||
27897005|NCT03738423|54550740|FG003|Overall Study|Physician Decision|0|||
27897006|NCT03738423|54550741|FG004|Overall Study|Physician Decision|1|||
27897007|NCT03738423|54550737|FG000|Overall Study|Death|0|||
27897008|NCT03738423|54550738|FG001|Overall Study|Death|0|||
27897009|NCT03738423|54550739|FG002|Overall Study|Death|0|||
27897010|NCT03738423|54550740|FG003|Overall Study|Death|0|||
27897011|NCT03738423|54550741|FG004|Overall Study|Death|1|||
27897012|NCT03738423|54550737|FG000|Overall Study|Randomized but never treated|0|||
27897013|NCT03738423|54550738|FG001|Overall Study|Randomized but never treated|0|||
27897014|NCT03738423|54550739|FG002|Overall Study|Randomized but never treated|1|||
27897015|NCT03738423|54550740|FG003|Overall Study|Randomized but never treated|1|||
27897016|NCT03738423|54550741|FG004|Overall Study|Randomized but never treated|0|||
27897017|NCT03712228|54550759|FG000|Treatment Period 1|Lack of Efficacy|0|||
27897018|NCT03712228|54550760|FG001|Treatment Period 1|Lack of Efficacy|0|||
27897019|NCT03712228|54550761|FG002|Treatment Period 1|Lack of Efficacy|0|||
27897020|NCT03712228|54550762|FG003|Treatment Period 1|Lack of Efficacy|0|||
27897021|NCT03712228|54550763|FG004|Treatment Period 1|Lack of Efficacy|0|||
27897022|NCT03712228|54550764|FG005|Treatment Period 1|Lack of Efficacy|1|||
27897023|NCT03712228|54550759|FG000|Treatment Period 2|Pregnancy|0|||
27897024|NCT03712228|54550760|FG001|Treatment Period 2|Pregnancy|0|||
27897025|NCT03712228|54550761|FG002|Treatment Period 2|Pregnancy|0|||
27897026|NCT03712228|54550762|FG003|Treatment Period 2|Pregnancy|1|||
27897027|NCT03712228|54550763|FG004|Treatment Period 2|Pregnancy|0|||
27897028|NCT03712228|54550764|FG005|Treatment Period 2|Pregnancy|0|||
27897029|NCT03712228|54550759|FG000|Treatment Period 2|Withdrawal by Subject|0|||
27897030|NCT03712228|54550760|FG001|Treatment Period 2|Withdrawal by Subject|0|||
27897031|NCT03712228|54550761|FG002|Treatment Period 2|Withdrawal by Subject|0|||
27897032|NCT03712228|54550762|FG003|Treatment Period 2|Withdrawal by Subject|1|||
27897033|NCT03712228|54550763|FG004|Treatment Period 2|Withdrawal by Subject|0|||
27897034|NCT03712228|54550764|FG005|Treatment Period 2|Withdrawal by Subject|0|||
27897035|NCT03600818|54550783|FG000|Overall Study|Adverse Event|4|||
27897036|NCT03600818|54550784|FG001|Overall Study|Adverse Event|7|||
27897037|NCT03600818|54550783|FG000|Overall Study|Lack of Efficacy|9|||
27897038|NCT03600818|54550784|FG001|Overall Study|Lack of Efficacy|4|||
27897039|NCT03600818|54550783|FG000|Overall Study|Withdrawal by Subject|4|||
27897040|NCT03600818|54550784|FG001|Overall Study|Withdrawal by Subject|3|||
27897041|NCT03600818|54550783|FG000|Overall Study|Other-unspecified|5|||
27897042|NCT03600818|54550784|FG001|Overall Study|Other-unspecified|3|||
27897043|NCT03600818|54550783|FG000|Overall Study|Randomized and not treated|0|||
27897044|NCT03600818|54550784|FG001|Overall Study|Randomized and not treated|1|||
27897045|NCT03578276|54550793|FG000|Overall Study|Subjects did not comply with study protocol instructions.|2|||
27897046|NCT03578276|54550794|FG001|Overall Study|Subjects did not comply with study protocol instructions.|2|||
27897047|NCT01627574|54550866|FG000|Overall Study|Withdrawal by Subject|8|||
27897048|NCT01627574|54550867|FG001|Overall Study|Withdrawal by Subject|5|||
27897049|NCT01627574|54550866|FG000|Overall Study|Lost to Follow-up|13|||
27897050|NCT01627574|54550867|FG001|Overall Study|Lost to Follow-up|13|||
27897051|NCT01498458|54550873|FG000|Overall Study|Adverse Event|4|||
27897052|NCT01498458|54550873|FG000|Overall Study|Physician Decision|3|||
27897053|NCT01427712|54550882|FG000|Overall Study|Transfer to a different hospital|2|||
27897054|NCT01427712|54550882|FG000|Overall Study|Lost to Follow-up|1|||
27897055|NCT01427712|54550882|FG000|Overall Study|Aggravation of cystic fibrosis|3|||
27897056|NCT01427712|54550882|FG000|Overall Study|Failure to visit|1|||
27897057|NCT01369147|54550889|FG000|Overall Study|All collected data were unintentionally destroyed|0|||
27897058|NCT01369147|54550890|FG001|Overall Study|All collected data were unintentionally destroyed|1|||
27897059|NCT01369147|54550891|FG002|Overall Study|All collected data were unintentionally destroyed|0|||
27897060|NCT04846231|54550907|FG000|Overall Study|Lost to Follow-up|1|||
27897061|NCT04846231|54550908|FG001|Overall Study|Lost to Follow-up|0|||
27897062|NCT04846231|54550909|FG002|Overall Study|Lost to Follow-up|0|||
27897063|NCT04846231|54550910|FG003|Overall Study|Lost to Follow-up|0|||
27897064|NCT04846231|54550911|FG004|Overall Study|Lost to Follow-up|0|||
27897065|NCT04846231|54550912|FG005|Overall Study|Lost to Follow-up|0|||
27897066|NCT04846231|54550913|FG006|Overall Study|Lost to Follow-up|0|||
27897067|NCT04846231|54550914|FG007|Overall Study|Lost to Follow-up|1|||
27897068|NCT04846231|54550907|FG000|Overall Study|Withdrawal by Subject|0|||
27897069|NCT04846231|54550908|FG001|Overall Study|Withdrawal by Subject|1|||
27897070|NCT04846231|54550909|FG002|Overall Study|Withdrawal by Subject|2|||
27897071|NCT04846231|54550910|FG003|Overall Study|Withdrawal by Subject|1|||
27897072|NCT04846231|54550911|FG004|Overall Study|Withdrawal by Subject|0|||
27897073|NCT04846231|54550912|FG005|Overall Study|Withdrawal by Subject|0|||
27897074|NCT04846231|54550913|FG006|Overall Study|Withdrawal by Subject|0|||
27897075|NCT04846231|54550914|FG007|Overall Study|Withdrawal by Subject|0|||
27897076|NCT04846231|54550907|FG000|Overall Study|Protocol Violation|0|||
27897077|NCT04846231|54550908|FG001|Overall Study|Protocol Violation|1|||
27897078|NCT04846231|54550909|FG002|Overall Study|Protocol Violation|0|||
27897079|NCT04846231|54550910|FG003|Overall Study|Protocol Violation|0|||
27897080|NCT04846231|54550911|FG004|Overall Study|Protocol Violation|0|||
27897081|NCT04846231|54550912|FG005|Overall Study|Protocol Violation|0|||
27897082|NCT04846231|54550913|FG006|Overall Study|Protocol Violation|0|||
27897083|NCT04846231|54550914|FG007|Overall Study|Protocol Violation|0|||
27897084|NCT04846231|54550907|FG000|Overall Study|Adverse Event|0|||
27897085|NCT04846231|54550908|FG001|Overall Study|Adverse Event|0|||
27897086|NCT04846231|54550909|FG002|Overall Study|Adverse Event|0|||
27897087|NCT04846231|54550910|FG003|Overall Study|Adverse Event|0|||
27897088|NCT04846231|54550911|FG004|Overall Study|Adverse Event|0|||
27897089|NCT04846231|54550912|FG005|Overall Study|Adverse Event|0|||
27897090|NCT04846231|54550913|FG006|Overall Study|Adverse Event|1|||
27897091|NCT04846231|54550914|FG007|Overall Study|Adverse Event|1|||
27897092|NCT04533594|54550940|FG000|Overall Study|Death|26|||
27897093|NCT04533438|54550946|FG000|Crossover Period|Did not meet Eligibility to Crossover|0|||
27897094|NCT04533438|54550947|FG001|Crossover Period|Did not meet Eligibility to Crossover|11|||
27897095|NCT04447846|54550955|FG000|Overall Study|Withdrew due to moderate side effects (fatigue)|1|||
27897096|NCT04405245|54550962|FG000|Overall Study|Adverse Event|0|||
27739417|NCT02228980|54189059|FG003|Overall Study|Protocol Violation|0|||
27739418|NCT02228980|54189056|FG000|Overall Study|Withdrawal by Subject|3|||
27739419|NCT02228980|54189057|FG001|Overall Study|Withdrawal by Subject|3|||
27739420|NCT02228980|54189058|FG002|Overall Study|Withdrawal by Subject|2|||
27897097|NCT04405245|54550963|FG001|Overall Study|Adverse Event|1|||
27897098|NCT04405245|54550964|FG002|Overall Study|Adverse Event|0|||
27897099|NCT04277507|54550972|FG000|Overall Study|Lost to Follow-up|17|||
27897100|NCT04277507|54550972|FG000|Overall Study|Completed through 24M but not interested in extension to 36M|3|||
27897101|NCT04277507|54550972|FG000|Overall Study|Received Treatment Outside of Study that could affect study results|2|||
27739421|NCT02228980|54189059|FG003|Overall Study|Withdrawal by Subject|3|||
27739422|NCT02228590|54189073|FG000|Overall Study|Withdrawal by Subject|1|||
27897102|NCT04277507|54550972|FG000|Overall Study|Withdrawal by Subject|3|||
27739423|NCT02227108|54189078|FG000|Overall Study|Did not receive treatment|2|||
27739424|NCT02227108|54189078|FG000|Overall Study|Other|3|||
27739425|NCT02227108|54189078|FG000|Overall Study|Progressive disease|17|||
27739426|NCT02227108|54189078|FG000|Overall Study|Initiation of alternative therapy|2|||
27739427|NCT02227108|54189078|FG000|Overall Study|Investigator discretion|1|||
27739428|NCT02227108|54189078|FG000|Overall Study|Adverse Event|6|||
27739429|NCT03564145|54189082|FG000|Overall Study|Adverse Event|4|||
27739430|NCT03564145|54189082|FG000|Overall Study|Lost to Follow-up|21|||
27739431|NCT03564145|54189082|FG000|Overall Study|Protocol Violation|2|||
27897103|NCT04277507|54550972|FG000|Overall Study|Death due to COVID-19|1|||
27897104|NCT04277507|54550972|FG000|Overall Study|Data missing for full evaluation|5|||
27897105|NCT04198805|54550993|FG000|Overall Study|Death|0|||
27897106|NCT04198805|54550994|FG001|Overall Study|Death|0|||
27897107|NCT04198805|54550995|FG002|Overall Study|Death|0|||
27897108|NCT04198805|54550996|FG003|Overall Study|Death|1|||
27897109|NCT04198805|54550993|FG000|Overall Study|Early Termination|8|||
27897110|NCT04198805|54550994|FG001|Overall Study|Early Termination|4|||
27897111|NCT04198805|54550995|FG002|Overall Study|Early Termination|6|||
27897112|NCT04198805|54550996|FG003|Overall Study|Early Termination|9|||
27897113|NCT04179890|54551012|FG000|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|3|||
27897114|NCT04179890|54551013|FG001|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|0|||
27897115|NCT04179890|54551012|FG000|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|1|||
27897116|NCT04179890|54551013|FG001|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|0|||
27897117|NCT04179890|54551012|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|3|||
27897118|NCT04179890|54551013|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|0|||
27897119|NCT04179890|54551012|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|2|||
27897120|NCT04179890|54551013|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|0|||
27897121|NCT04179890|54551012|FG000|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|0|||
27897122|NCT04179890|54551013|FG001|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|8|||
27897123|NCT04179890|54551012|FG000|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|0|||
27985871|NCT02393248|54644419|FG008|Part 3: Combination Therapy|Withdrawal by Subject|0|||
27985872|NCT02393248|54644420|FG009|Part 3: Combination Therapy|Withdrawal by Subject|0|||
27985873|NCT02393248|54644421|FG010|Part 3: Combination Therapy|Withdrawal by Subject|0|||
27985874|NCT02393248|54644422|FG011|Part 3: Combination Therapy|Withdrawal by Subject|0|||
27985875|NCT02393248|54644423|FG012|Part 3: Combination Therapy|Withdrawal by Subject|0|||
27985876|NCT02393248|54644424|FG013|Part 3: Combination Therapy|Withdrawal by Subject|0|||
27985877|NCT02393248|54644425|FG014|Part 3: Combination Therapy|Withdrawal by Subject|0|||
27985878|NCT02393248|54644426|FG015|Part 3: Combination Therapy|Withdrawal by Subject|0|||
27985879|NCT02393248|54644427|FG016|Part 3: Combination Therapy|Withdrawal by Subject|0|||
27985880|NCT02393248|54644428|FG017|Part 3: Combination Therapy|Withdrawal by Subject|0|||
27985881|NCT02393248|54644429|FG018|Part 3: Combination Therapy|Withdrawal by Subject|1|||
27985882|NCT02393248|54644430|FG019|Part 3: Combination Therapy|Withdrawal by Subject|0|||
27985883|NCT02393248|54644431|FG020|Part 3: Combination Therapy|Withdrawal by Subject|2|||
27985884|NCT02393248|54644432|FG021|Part 3: Combination Therapy|Withdrawal by Subject|1|||
27985885|NCT02393248|54644433|FG022|Part 3: Combination Therapy|Withdrawal by Subject|0|||
27985886|NCT02393248|54644434|FG023|Part 3: Combination Therapy|Withdrawal by Subject|1|||
27985887|NCT02393248|54644435|FG024|Part 3: Combination Therapy|Withdrawal by Subject|0|||
27985888|NCT02393248|54644411|FG000|Part 3: Combination Therapy|Death|0|||
27985889|NCT02393248|54644412|FG001|Part 3: Combination Therapy|Death|0|||
27985890|NCT02393248|54644413|FG002|Part 3: Combination Therapy|Death|0|||
27985891|NCT02393248|54644414|FG003|Part 3: Combination Therapy|Death|0|||
27985892|NCT02393248|54644415|FG004|Part 3: Combination Therapy|Death|0|||
27985893|NCT02393248|54644416|FG005|Part 3: Combination Therapy|Death|0|||
27985894|NCT02393248|54644417|FG006|Part 3: Combination Therapy|Death|0|||
27985895|NCT02393248|54644418|FG007|Part 3: Combination Therapy|Death|0|||
27985896|NCT02393248|54644419|FG008|Part 3: Combination Therapy|Death|0|||
27985897|NCT02393248|54644420|FG009|Part 3: Combination Therapy|Death|0|||
27985898|NCT02393248|54644421|FG010|Part 3: Combination Therapy|Death|0|||
27985899|NCT02393248|54644422|FG011|Part 3: Combination Therapy|Death|0|||
27985900|NCT02393248|54644423|FG012|Part 3: Combination Therapy|Death|0|||
27985901|NCT02393248|54644424|FG013|Part 3: Combination Therapy|Death|0|||
27985902|NCT02393248|54644425|FG014|Part 3: Combination Therapy|Death|0|||
27985903|NCT02393248|54644426|FG015|Part 3: Combination Therapy|Death|1|||
27985904|NCT02393248|54644427|FG016|Part 3: Combination Therapy|Death|7|||
27985905|NCT02393248|54644428|FG017|Part 3: Combination Therapy|Death|5|||
27985906|NCT02393248|54644429|FG018|Part 3: Combination Therapy|Death|5|||
27985907|NCT02393248|54644430|FG019|Part 3: Combination Therapy|Death|3|||
27985908|NCT02393248|54644431|FG020|Part 3: Combination Therapy|Death|7|||
27739432|NCT03564145|54189082|FG000|Overall Study|Withdrawal by Subject|48|||
27739433|NCT03564145|54189082|FG000|Overall Study|Study Terminated by Sponsor|146|||
27739434|NCT03564145|54189082|FG000|Overall Study|Physician Decision|1|||
27739435|NCT03564145|54189082|FG000|Overall Study|Other Than Specified|1|||
27897124|NCT04179890|54551013|FG001|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|4|||
27897125|NCT04179890|54551012|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|0|||
27897126|NCT04179890|54551013|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|2|||
27897127|NCT04179890|54551012|FG000|Overall Study|Patients without common EGFR mutations (Del19, L858R)|0|||
27897128|NCT04179890|54551013|FG001|Overall Study|Patients without common EGFR mutations (Del19, L858R)|1|||
27897129|NCT04179890|54551012|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|0|||
27897130|NCT04179890|54551013|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|1|||
27897131|NCT03721016|54551054|FG000|Overall Study|Adverse Event|0|||
27897132|NCT03721016|54551055|FG001|Overall Study|Adverse Event|1|||
27897133|NCT03721016|54551056|FG002|Overall Study|Adverse Event|1|||
27897134|NCT03721016|54551054|FG000|Overall Study|Withdrawal by Subject|8|||
27897135|NCT03721016|54551055|FG001|Overall Study|Withdrawal by Subject|16|||
27897136|NCT03721016|54551056|FG002|Overall Study|Withdrawal by Subject|13|||
27897137|NCT03721016|54551054|FG000|Overall Study|Lost to Follow-up|4|||
27897138|NCT03721016|54551055|FG001|Overall Study|Lost to Follow-up|6|||
28171940|NCT00701103|54843582|FG002|Overall Study|Withdrawal by Subject|1|||
28171941|NCT00701103|54843583|FG003|Overall Study|Withdrawal by Subject|0|||
28171942|NCT00701103|54843584|FG004|Overall Study|Withdrawal by Subject|0|||
28171943|NCT00701103|54843585|FG005|Overall Study|Withdrawal by Subject|0|||
28171944|NCT00701103|54843586|FG006|Overall Study|Withdrawal by Subject|0|||
27897139|NCT03721016|54551056|FG002|Overall Study|Lost to Follow-up|5|||
27897140|NCT03721016|54551054|FG000|Overall Study|Physician Decision|0|||
27897141|NCT03721016|54551055|FG001|Overall Study|Physician Decision|1|||
27897142|NCT03721016|54551056|FG002|Overall Study|Physician Decision|2|||
27897143|NCT03721016|54551054|FG000|Overall Study|Protocol Violation|0|||
27897144|NCT03721016|54551055|FG001|Overall Study|Protocol Violation|1|||
27897145|NCT03721016|54551056|FG002|Overall Study|Protocol Violation|0|||
27897146|NCT03721016|54551054|FG000|Overall Study|Site terminated by sponsor|3|||
27897147|NCT03721016|54551055|FG001|Overall Study|Site terminated by sponsor|7|||
27897148|NCT03721016|54551056|FG002|Overall Study|Site terminated by sponsor|6|||
27897149|NCT03721016|54551054|FG000|Overall Study|Subject exited early due to COVID-19|1|||
27897150|NCT03721016|54551055|FG001|Overall Study|Subject exited early due to COVID-19|0|||
27897151|NCT03721016|54551056|FG002|Overall Study|Subject exited early due to COVID-19|0|||
27897152|NCT03563716|54551066|FG000|Overall Study|Death|20|||
27897153|NCT03563716|54551067|FG001|Overall Study|Death|14|||
27897154|NCT03563716|54551066|FG000|Overall Study|Withdrawal by Subject|3|||
27897155|NCT03563716|54551067|FG001|Overall Study|Withdrawal by Subject|3|||
27897156|NCT03563716|54551066|FG000|Overall Study|Still on Study|45|||
27897157|NCT03563716|54551067|FG001|Overall Study|Still on Study|50|||
27897158|NCT03117998|54551101|FG000|Overall Study|Adverse Event|1|||
27897159|NCT03117998|54551102|FG001|Overall Study|Adverse Event|0|||
27897160|NCT03117998|54551103|FG002|Overall Study|Adverse Event|0|||
27897161|NCT03117998|54551104|FG003|Overall Study|Adverse Event|0|||
27897162|NCT03117998|54551105|FG004|Overall Study|Adverse Event|0|||
27897163|NCT03117998|54551106|FG005|Overall Study|Adverse Event|0|||
27897164|NCT03117998|54551101|FG000|Overall Study|Withdrawal by Subject|0|||
27897165|NCT03117998|54551102|FG001|Overall Study|Withdrawal by Subject|0|||
27897166|NCT03117998|54551103|FG002|Overall Study|Withdrawal by Subject|2|||
27897167|NCT03117998|54551104|FG003|Overall Study|Withdrawal by Subject|3|||
27897168|NCT03117998|54551105|FG004|Overall Study|Withdrawal by Subject|3|||
27897169|NCT03117998|54551106|FG005|Overall Study|Withdrawal by Subject|0|||
27897170|NCT03117998|54551101|FG000|Overall Study|Physician Decision|0|||
27897171|NCT03117998|54551102|FG001|Overall Study|Physician Decision|1|||
27897172|NCT03117998|54551103|FG002|Overall Study|Physician Decision|1|||
27897173|NCT03117998|54551104|FG003|Overall Study|Physician Decision|0|||
27897174|NCT03117998|54551105|FG004|Overall Study|Physician Decision|0|||
27897175|NCT03117998|54551106|FG005|Overall Study|Physician Decision|0|||
27897176|NCT03117998|54551101|FG000|Overall Study|Lost to Follow-up|0|||
27897177|NCT03117998|54551102|FG001|Overall Study|Lost to Follow-up|0|||
27897178|NCT03117998|54551103|FG002|Overall Study|Lost to Follow-up|0|||
27897179|NCT03117998|54551104|FG003|Overall Study|Lost to Follow-up|1|||
27897180|NCT03117998|54551105|FG004|Overall Study|Lost to Follow-up|4|||
27897181|NCT03117998|54551106|FG005|Overall Study|Lost to Follow-up|0|||
27897182|NCT03117998|54551101|FG000|Overall Study|Subject noncompliance|0|||
27897183|NCT03117998|54551102|FG001|Overall Study|Subject noncompliance|0|||
27897184|NCT03117998|54551103|FG002|Overall Study|Subject noncompliance|1|||
27897185|NCT03117998|54551104|FG003|Overall Study|Subject noncompliance|0|||
27897186|NCT03117998|54551105|FG004|Overall Study|Subject noncompliance|0|||
28171945|NCT00701103|54843587|FG007|Overall Study|Withdrawal by Subject|0|||
28171946|NCT00701103|54843588|FG008|Overall Study|Withdrawal by Subject|0|||
27897187|NCT03117998|54551106|FG005|Overall Study|Subject noncompliance|2|||
27897188|NCT03117998|54551101|FG000|Overall Study|Protocol Violation|0|||
27897189|NCT03117998|54551102|FG001|Overall Study|Protocol Violation|0|||
27897190|NCT03117998|54551103|FG002|Overall Study|Protocol Violation|0|||
27897191|NCT03117998|54551104|FG003|Overall Study|Protocol Violation|0|||
27897192|NCT03117998|54551105|FG004|Overall Study|Protocol Violation|0|||
27897193|NCT03117998|54551106|FG005|Overall Study|Protocol Violation|1|||
27897194|NCT03100370|54551131|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
27897195|NCT03100370|54551132|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
27897196|NCT03100370|54551133|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
27897197|NCT03100370|54551134|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
27897198|NCT03100370|54551135|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
27897199|NCT03100370|54551136|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
27897200|NCT02920008|54551146|FG000|Overall Study|Death|117|||
27897201|NCT02920008|54551147|FG001|Overall Study|Death|127|||
27897202|NCT02920008|54551146|FG000|Overall Study|Withdrawal by Subject|3|||
27897203|NCT02920008|54551147|FG001|Overall Study|Withdrawal by Subject|6|||
27897204|NCT02920008|54551146|FG000|Overall Study|Lost to Follow-up|0|||
27897205|NCT02920008|54551147|FG001|Overall Study|Lost to Follow-up|1|||
27897206|NCT02766335|54551155|FG000|Initial Registration|Adverse Event|6|||
27897207|NCT02766335|54551156|FG001|Initial Registration|Adverse Event|3|||
27897208|NCT02766335|54551157|FG002|Initial Registration|Adverse Event|0|||
27897209|NCT02766335|54551155|FG000|Initial Registration|Refusal unrelated to adverse event|1|||
27897210|NCT02766335|54551156|FG001|Initial Registration|Refusal unrelated to adverse event|0|||
27897211|NCT02766335|54551157|FG002|Initial Registration|Refusal unrelated to adverse event|0|||
27897212|NCT02766335|54551155|FG000|Initial Registration|Progression/relapse|49|||
27897213|NCT02766335|54551156|FG001|Initial Registration|Progression/relapse|15|||
27897214|NCT02766335|54551157|FG002|Initial Registration|Progression/relapse|0|||
27897215|NCT02766335|54551155|FG000|Initial Registration|Death|1|||
27897216|NCT02766335|54551156|FG001|Initial Registration|Death|3|||
27897217|NCT02766335|54551157|FG002|Initial Registration|Death|0|||
27897218|NCT02766335|54551155|FG000|Initial Registration|not protocol specified|1|||
27897219|NCT02766335|54551156|FG001|Initial Registration|not protocol specified|9|||
27897220|NCT02766335|54551157|FG002|Initial Registration|not protocol specified|0|||
27897221|NCT02766335|54551155|FG000|Re-registration of Arm I to MEDI4738|Death|0|||
27897222|NCT02766335|54551156|FG001|Re-registration of Arm I to MEDI4738|Death|0|||
27897223|NCT02766335|54551157|FG002|Re-registration of Arm I to MEDI4738|Death|1|||
27897224|NCT02766335|54551155|FG000|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
27897225|NCT02766335|54551156|FG001|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
27897226|NCT02766335|54551157|FG002|Re-registration of Arm I to MEDI4738|Progression/relapse|1|||
27897227|NCT02577523|54551165|FG000|Overall Study|Adverse Event|1|||
27897228|NCT02577523|54551166|FG001|Overall Study|Adverse Event|1|||
27897229|NCT02577523|54551165|FG000|Overall Study|Lack of Efficacy|1|||
27897230|NCT02577523|54551166|FG001|Overall Study|Lack of Efficacy|1|||
27897231|NCT02577523|54551165|FG000|Overall Study|Withdrawal by Subject|1|||
27897232|NCT02577523|54551166|FG001|Overall Study|Withdrawal by Subject|0|||
27897233|NCT02516241|54551175|FG000|Overall Study|Death|255|||
27897234|NCT02516241|54551176|FG001|Overall Study|Death|262|||
27897235|NCT02516241|54551177|FG002|Overall Study|Death|270|||
27897236|NCT02516241|54551175|FG000|Overall Study|Lost to Follow-up|1|||
27897237|NCT02516241|54551176|FG001|Overall Study|Lost to Follow-up|1|||
27897238|NCT02516241|54551177|FG002|Overall Study|Lost to Follow-up|3|||
27897239|NCT02516241|54551175|FG000|Overall Study|Withdrawal by Subject|2|||
27897240|NCT02516241|54551176|FG001|Overall Study|Withdrawal by Subject|7|||
27897241|NCT02516241|54551177|FG002|Overall Study|Withdrawal by Subject|12|||
27897242|NCT02516241|54551175|FG000|Overall Study|participants ongoing at data cut-off|84|||
27897243|NCT02516241|54551176|FG001|Overall Study|participants ongoing at data cut-off|76|||
27897244|NCT02516241|54551177|FG002|Overall Study|participants ongoing at data cut-off|59|||
27897245|NCT02499328|54551209|FG000|Overall Study|Withdrawal by Subject|1|||
27897246|NCT02499328|54551210|FG001|Overall Study|Withdrawal by Subject|1|||
27897247|NCT02499328|54551211|FG002|Overall Study|Withdrawal by Subject|5|||
27897248|NCT02499328|54551212|FG003|Overall Study|Withdrawal by Subject|3|||
27897249|NCT02499328|54551213|FG004|Overall Study|Withdrawal by Subject|5|||
27897250|NCT02499328|54551214|FG005|Overall Study|Withdrawal by Subject|0|||
27897251|NCT02499328|54551215|FG006|Overall Study|Withdrawal by Subject|0|||
27897252|NCT02499328|54551216|FG007|Overall Study|Withdrawal by Subject|0|||
27897253|NCT02499328|54551217|FG008|Overall Study|Withdrawal by Subject|2|||
27897254|NCT02499328|54551218|FG009|Overall Study|Withdrawal by Subject|2|||
27897255|NCT02499328|54551219|FG010|Overall Study|Withdrawal by Subject|0|||
27897256|NCT02499328|54551220|FG011|Overall Study|Withdrawal by Subject|3|||
27897257|NCT02499328|54551221|FG012|Overall Study|Withdrawal by Subject|7|||
27897258|NCT02499328|54551222|FG013|Overall Study|Withdrawal by Subject|3|||
27897259|NCT02499328|54551223|FG014|Overall Study|Withdrawal by Subject|1|||
27897260|NCT02499328|54551224|FG015|Overall Study|Withdrawal by Subject|0|||
27897261|NCT02499328|54551225|FG016|Overall Study|Withdrawal by Subject|0|||
27897262|NCT02499328|54551226|FG017|Overall Study|Withdrawal by Subject|3|||
27897263|NCT02499328|54551227|FG018|Overall Study|Withdrawal by Subject|0|||
27897264|NCT02499328|54551209|FG000|Overall Study|Lost to Follow-up|0|||
27897265|NCT02499328|54551210|FG001|Overall Study|Lost to Follow-up|1|||
27897266|NCT02499328|54551211|FG002|Overall Study|Lost to Follow-up|1|||
27897267|NCT02499328|54551212|FG003|Overall Study|Lost to Follow-up|2|||
27897268|NCT02499328|54551213|FG004|Overall Study|Lost to Follow-up|0|||
27897269|NCT02499328|54551214|FG005|Overall Study|Lost to Follow-up|0|||
27897270|NCT02499328|54551215|FG006|Overall Study|Lost to Follow-up|0|||
27897271|NCT02499328|54551216|FG007|Overall Study|Lost to Follow-up|2|||
27897272|NCT02499328|54551217|FG008|Overall Study|Lost to Follow-up|3|||
27897273|NCT02499328|54551218|FG009|Overall Study|Lost to Follow-up|0|||
27897274|NCT02499328|54551219|FG010|Overall Study|Lost to Follow-up|0|||
27897275|NCT02499328|54551220|FG011|Overall Study|Lost to Follow-up|0|||
27897276|NCT02499328|54551221|FG012|Overall Study|Lost to Follow-up|0|||
27897277|NCT02499328|54551222|FG013|Overall Study|Lost to Follow-up|0|||
27897278|NCT02499328|54551223|FG014|Overall Study|Lost to Follow-up|0|||
27897279|NCT02499328|54551224|FG015|Overall Study|Lost to Follow-up|0|||
27897280|NCT02499328|54551225|FG016|Overall Study|Lost to Follow-up|0|||
27897281|NCT02499328|54551226|FG017|Overall Study|Lost to Follow-up|0|||
27897282|NCT02499328|54551227|FG018|Overall Study|Lost to Follow-up|1|||
27897283|NCT02499328|54551209|FG000|Overall Study|Death|0|||
27897284|NCT02499328|54551210|FG001|Overall Study|Death|3|||
27897285|NCT02499328|54551211|FG002|Overall Study|Death|3|||
27897286|NCT02499328|54551212|FG003|Overall Study|Death|2|||
27897287|NCT02499328|54551213|FG004|Overall Study|Death|4|||
27897288|NCT02499328|54551214|FG005|Overall Study|Death|7|||
27897289|NCT02499328|54551215|FG006|Overall Study|Death|3|||
27897290|NCT02499328|54551216|FG007|Overall Study|Death|0|||
27897291|NCT02499328|54551217|FG008|Overall Study|Death|2|||
27897292|NCT02499328|54551218|FG009|Overall Study|Death|6|||
27897293|NCT02499328|54551219|FG010|Overall Study|Death|6|||
27897294|NCT02499328|54551220|FG011|Overall Study|Death|20|||
27897295|NCT02499328|54551221|FG012|Overall Study|Death|9|||
27897296|NCT02499328|54551222|FG013|Overall Study|Death|7|||
28096753|NCT02025556|54751934|FG000|Overall Study|Withdrawal by Subject|0|||
28096754|NCT02025556|54751935|FG001|Overall Study|Withdrawal by Subject|3|||
28096755|NCT02025556|54751936|FG002|Overall Study|Withdrawal by Subject|6|||
28096756|NCT02025556|54751934|FG000|Overall Study|Lost to Follow-up|2|||
28096757|NCT02025556|54751935|FG001|Overall Study|Lost to Follow-up|4|||
28096758|NCT02025556|54751936|FG002|Overall Study|Lost to Follow-up|0|||
28096759|NCT02025556|54751934|FG000|Overall Study|Reason not reported|0|||
28096760|NCT02025556|54751935|FG001|Overall Study|Reason not reported|0|||
27897297|NCT02499328|54551223|FG014|Overall Study|Death|3|||
27897298|NCT02499328|54551224|FG015|Overall Study|Death|1|||
28096761|NCT02025556|54751936|FG002|Overall Study|Reason not reported|1|||
28096762|NCT04334460|54751946|FG000|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|4|||
27897299|NCT02499328|54551225|FG016|Overall Study|Death|1|||
27897300|NCT02499328|54551226|FG017|Overall Study|Death|16|||
27897301|NCT02499328|54551227|FG018|Overall Study|Death|5|||
27897302|NCT02499328|54551209|FG000|Overall Study|"Other"|2|||
27897303|NCT02499328|54551210|FG001|Overall Study|"Other"|2|||
27897304|NCT02499328|54551211|FG002|Overall Study|"Other"|1|||
27897305|NCT02499328|54551212|FG003|Overall Study|"Other"|3|||
27897306|NCT02499328|54551213|FG004|Overall Study|"Other"|6|||
28096763|NCT04334460|54751947|FG001|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|1|||
28096764|NCT04334460|54751946|FG000|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|4|||
28096765|NCT04334460|54751947|FG001|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|1|||
28096766|NCT04334148|54751956|FG000|Overall Study|positive nasal swab at baseline|0|||
28096767|NCT04334148|54751957|FG001|Overall Study|positive nasal swab at baseline|1|||
28096768|NCT04399122|54751965|FG000|Overall Study|Lost to Follow-up|2|||
28096769|NCT04399122|54751966|FG001|Overall Study|Lost to Follow-up|0|||
28096770|NCT04399122|54751965|FG000|Overall Study|Withdrawal by Subject|1|||
28096771|NCT04399122|54751966|FG001|Overall Study|Withdrawal by Subject|0|||
28096772|NCT04398732|54751987|FG000|Overall Study|Participants Who Did Not Meet Entrance Criteria|50|||
28096773|NCT04398030|54751993|FG000|Treatment Period 1 (1 Week)|Withdrawal by Subject|0|||
28096774|NCT04398030|54751994|FG001|Treatment Period 1 (1 Week)|Withdrawal by Subject|1|||
27897307|NCT02499328|54551214|FG005|Overall Study|"Other"|2|||
27897308|NCT02499328|54551215|FG006|Overall Study|"Other"|3|||
27897309|NCT02499328|54551216|FG007|Overall Study|"Other"|4|||
28096775|NCT04398030|54751993|FG000|Treatment Period 2 (1 Week)|Physician Decision|1|||
28096776|NCT04398030|54751994|FG001|Treatment Period 2 (1 Week)|Physician Decision|0|||
27897310|NCT02499328|54551217|FG008|Overall Study|"Other"|6|||
27897311|NCT02499328|54551218|FG009|Overall Study|"Other"|16|||
27897312|NCT02499328|54551219|FG010|Overall Study|"Other"|13|||
27897313|NCT02499328|54551220|FG011|Overall Study|"Other"|31|||
27897314|NCT02499328|54551221|FG012|Overall Study|"Other"|8|||
27897315|NCT02499328|54551222|FG013|Overall Study|"Other"|7|||
27897316|NCT02499328|54551223|FG014|Overall Study|"Other"|6|||
27897317|NCT02499328|54551224|FG015|Overall Study|"Other"|0|||
27897318|NCT02499328|54551225|FG016|Overall Study|"Other"|0|||
27897319|NCT02499328|54551226|FG017|Overall Study|"Other"|34|||
28096777|NCT03064438|54752002|FG000|Overall Study|Lost to Follow-up|1|||
27897320|NCT02499328|54551227|FG018|Overall Study|"Other"|43|||
27897321|NCT02499328|54551209|FG000|Overall Study|Disease Progression|0|||
27897322|NCT02499328|54551210|FG001|Overall Study|Disease Progression|0|||
27897323|NCT02499328|54551211|FG002|Overall Study|Disease Progression|0|||
27897324|NCT02499328|54551212|FG003|Overall Study|Disease Progression|0|||
27897325|NCT02499328|54551213|FG004|Overall Study|Disease Progression|0|||
27897326|NCT02499328|54551214|FG005|Overall Study|Disease Progression|0|||
27897327|NCT02499328|54551215|FG006|Overall Study|Disease Progression|1|||
27897328|NCT02499328|54551216|FG007|Overall Study|Disease Progression|0|||
27897329|NCT02499328|54551217|FG008|Overall Study|Disease Progression|1|||
27897330|NCT02499328|54551218|FG009|Overall Study|Disease Progression|0|||
27897331|NCT02499328|54551219|FG010|Overall Study|Disease Progression|1|||
27897332|NCT02499328|54551220|FG011|Overall Study|Disease Progression|0|||
27897333|NCT02499328|54551221|FG012|Overall Study|Disease Progression|0|||
27897334|NCT02499328|54551222|FG013|Overall Study|Disease Progression|0|||
27897335|NCT02499328|54551223|FG014|Overall Study|Disease Progression|0|||
27897336|NCT02499328|54551224|FG015|Overall Study|Disease Progression|0|||
27897337|NCT02499328|54551225|FG016|Overall Study|Disease Progression|0|||
28096778|NCT03064438|54752003|FG001|Overall Study|Lost to Follow-up|0|||
28096779|NCT03064438|54752002|FG000|Overall Study|Withdrawal by Subject|0|||
28096780|NCT03064438|54752003|FG001|Overall Study|Withdrawal by Subject|1|||
28096781|NCT04327986|54752009|FG000|Overall Study|Physician Decision|2|||
28096782|NCT04327986|54752010|FG001|Overall Study|Physician Decision|0|||
28096783|NCT04327986|54752011|FG002|Overall Study|Physician Decision|0|||
28096784|NCT04327986|54752009|FG000|Overall Study|Death|1|||
28096785|NCT04327986|54752010|FG001|Overall Study|Death|0|||
28096786|NCT04327986|54752011|FG002|Overall Study|Death|0|||
28096787|NCT04322682|54752017|FG000|Overall Study|Withdrawal by Subject|33|||
28096788|NCT04322682|54752018|FG001|Overall Study|Withdrawal by Subject|47|||
28096789|NCT04322682|54752017|FG000|Overall Study|Death|5|||
28096790|NCT04322682|54752018|FG001|Overall Study|Death|9|||
28096791|NCT04322682|54752017|FG000|Overall Study|Lost to Follow-up|4|||
28096792|NCT04322682|54752018|FG001|Overall Study|Lost to Follow-up|8|||
28096793|NCT04322682|54752017|FG000|Overall Study|Admitted to Hospital and Intubated|1|||
28096794|NCT04322682|54752018|FG001|Overall Study|Admitted to Hospital and Intubated|0|||
28096795|NCT04322526|54752026|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
28096796|NCT04322526|54752027|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
28096797|NCT04322526|54752026|FG000|Washout (1 Week)|Lost to Follow-up|1|||
28096798|NCT04322526|54752027|FG001|Washout (1 Week)|Lost to Follow-up|2|||
28096799|NCT04115358|54752036|FG000|Overall Study|exfoliation|0|||
28096800|NCT04115358|54752037|FG001|Overall Study|exfoliation|0|||
28096801|NCT04115358|54752038|FG002|Overall Study|exfoliation|1|||
28096802|NCT04109118|54752047|FG000|Overall Study|Lost to Follow-up|3|||
28096803|NCT04105998|54752054|FG000|Second Study Day|Altered frequency and times of measurements on both study days|2|||
28096804|NCT04105998|54752055|FG001|Second Study Day|Altered frequency and times of measurements on both study days|0|||
28096805|NCT04397718|54752063|FG000|Overall Study|Death|7|||
28096806|NCT04397718|54752064|FG001|Overall Study|Death|11|||
28096807|NCT04397718|54752063|FG000|Overall Study|Lost to Follow-up|0|||
28096808|NCT04397718|54752064|FG001|Overall Study|Lost to Follow-up|4|||
28096809|NCT04105218|54752072|FG000|Overall Study|Withdrawal by Subject|3|||
28096810|NCT04105218|54752073|FG001|Overall Study|Withdrawal by Subject|2|||
28096811|NCT04105218|54752072|FG000|Overall Study|Study was terminated; unable to complete study visits|1|||
28096812|NCT04105218|54752073|FG001|Overall Study|Study was terminated; unable to complete study visits|3|||
28096813|NCT04105218|54752072|FG000|Overall Study|Failed screening tests|2|||
28096814|NCT04105218|54752073|FG001|Overall Study|Failed screening tests|1|||
28096815|NCT04317690|54752084|FG000|Overall Study|did not have complete information for primary outcome|0|||
28096816|NCT04317690|54752085|FG001|Overall Study|did not have complete information for primary outcome|4|||
28096817|NCT04317690|54752086|FG002|Overall Study|did not have complete information for primary outcome|0|||
28096818|NCT04317690|54752087|FG003|Overall Study|did not have complete information for primary outcome|2|||
28096819|NCT04317690|54752088|FG004|Overall Study|did not have complete information for primary outcome|0|||
28096820|NCT03721276|54752115|FG000|Overall Study|Lost to Follow-up|5|||
28096821|NCT03721276|54752116|FG001|Overall Study|Lost to Follow-up|3|||
28096822|NCT03721276|54752115|FG000|Overall Study|Adverse Event|0|||
27897338|NCT02499328|54551226|FG017|Overall Study|Disease Progression|2|||
27897339|NCT02499328|54551227|FG018|Overall Study|Disease Progression|0|||
27897340|NCT02499328|54551209|FG000|Overall Study|Adverse Event|1|||
27897341|NCT02499328|54551210|FG001|Overall Study|Adverse Event|0|||
27897342|NCT02499328|54551211|FG002|Overall Study|Adverse Event|0|||
27897343|NCT02499328|54551212|FG003|Overall Study|Adverse Event|1|||
27897344|NCT02499328|54551213|FG004|Overall Study|Adverse Event|0|||
27897345|NCT02499328|54551214|FG005|Overall Study|Adverse Event|0|||
28096823|NCT03721276|54752116|FG001|Overall Study|Adverse Event|1|||
28096824|NCT03269344|54752131|FG000|Overall Study|Protocol Violation|4|||
28096825|NCT03269344|54752132|FG001|Overall Study|Protocol Violation|3|||
28096826|NCT04389840|54752144|FG000|Overall Study|Adverse Event|0|||
28096827|NCT04389840|54752145|FG001|Overall Study|Adverse Event|0|||
27897346|NCT02499328|54551215|FG006|Overall Study|Adverse Event|0|||
27897347|NCT02499328|54551216|FG007|Overall Study|Adverse Event|0|||
27897348|NCT02499328|54551217|FG008|Overall Study|Adverse Event|0|||
27897349|NCT02499328|54551218|FG009|Overall Study|Adverse Event|0|||
27897350|NCT02499328|54551219|FG010|Overall Study|Adverse Event|0|||
27897351|NCT02499328|54551220|FG011|Overall Study|Adverse Event|0|||
27897352|NCT02499328|54551221|FG012|Overall Study|Adverse Event|1|||
27897353|NCT02499328|54551222|FG013|Overall Study|Adverse Event|0|||
27897354|NCT02499328|54551223|FG014|Overall Study|Adverse Event|0|||
27897355|NCT02499328|54551224|FG015|Overall Study|Adverse Event|0|||
27897356|NCT02499328|54551225|FG016|Overall Study|Adverse Event|0|||
27897357|NCT02499328|54551226|FG017|Overall Study|Adverse Event|0|||
27897358|NCT02499328|54551227|FG018|Overall Study|Adverse Event|0|||
27897359|NCT02388906|54551312|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
27897360|NCT02388906|54551313|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
27897361|NCT02388906|54551312|FG000|Treatment Period|Disease progression|121|||
27897362|NCT02388906|54551313|FG001|Treatment Period|Disease progression|101|||
27897363|NCT02388906|54551312|FG000|Treatment Period|Study drug toxicity|41|||
27897364|NCT02388906|54551313|FG001|Treatment Period|Study drug toxicity|208|||
27897365|NCT02388906|54551312|FG000|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
27897366|NCT02388906|54551313|FG001|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
27897367|NCT02388906|54551312|FG000|Treatment Period|Participant request to stop treatment|5|||
27897368|NCT02388906|54551313|FG001|Treatment Period|Participant request to stop treatment|9|||
27897369|NCT02388906|54551312|FG000|Treatment Period|Participant withdrew consent|2|||
27985909|NCT02393248|54644432|FG021|Part 3: Combination Therapy|Death|5|||
28096828|NCT04389840|54752146|FG002|Overall Study|Adverse Event|0|||
28096829|NCT04389840|54752147|FG003|Overall Study|Adverse Event|1|||
28096830|NCT04389840|54752148|FG004|Overall Study|Adverse Event|0|||
28096831|NCT04389840|54752149|FG005|Overall Study|Adverse Event|0|||
28096832|NCT04389840|54752144|FG000|Overall Study|Subject request and prohibited concomitant medication|2|||
28096833|NCT04389840|54752145|FG001|Overall Study|Subject request and prohibited concomitant medication|0|||
28096834|NCT04389840|54752146|FG002|Overall Study|Subject request and prohibited concomitant medication|0|||
28096835|NCT04389840|54752147|FG003|Overall Study|Subject request and prohibited concomitant medication|0|||
28096836|NCT04389840|54752148|FG004|Overall Study|Subject request and prohibited concomitant medication|1|||
28096837|NCT04389840|54752149|FG005|Overall Study|Subject request and prohibited concomitant medication|0|||
28096838|NCT04389840|54752144|FG000|Overall Study|Death|0|||
28096839|NCT04389840|54752145|FG001|Overall Study|Death|1|||
28096840|NCT04389840|54752146|FG002|Overall Study|Death|0|||
28096841|NCT04389840|54752147|FG003|Overall Study|Death|0|||
28096842|NCT04389840|54752148|FG004|Overall Study|Death|0|||
28096843|NCT04389840|54752149|FG005|Overall Study|Death|0|||
28096844|NCT04307940|54752172|FG000|Overall Study|Adverse Event|1|||
28096845|NCT04307940|54752173|FG001|Overall Study|Adverse Event|0|||
28096846|NCT04307940|54752174|FG002|Overall Study|Adverse Event|0|||
28096847|NCT04307940|54752172|FG000|Overall Study|Withdrawal by Subject|2|||
28096848|NCT04307940|54752173|FG001|Overall Study|Withdrawal by Subject|3|||
28096849|NCT04307940|54752174|FG002|Overall Study|Withdrawal by Subject|1|||
28096850|NCT04307940|54752172|FG000|Overall Study|Lost to Follow-up|2|||
28096851|NCT04307940|54752173|FG001|Overall Study|Lost to Follow-up|0|||
28096852|NCT04307940|54752174|FG002|Overall Study|Lost to Follow-up|1|||
28096853|NCT02054104|54752184|FG000|Overall Study|Did not want to continue due to college classes|1|||
28171947|NCT00701103|54843589|FG009|Overall Study|Withdrawal by Subject|0|||
28171948|NCT00701103|54843590|FG010|Overall Study|Withdrawal by Subject|0|||
27739436|NCT03564145|54189082|FG000|Overall Study|Pregnancy|1|||
27739437|NCT02226562|54189088|FG000|Overall Study|Lost to Follow-up|0|||
27739438|NCT02226562|54189089|FG001|Overall Study|Lost to Follow-up|1|||
27739439|NCT02456636|54189123|FG000|Overall Study|Death|0|||
27739440|NCT02456636|54189124|FG001|Overall Study|Death|3|||
27739441|NCT02456636|54189125|FG002|Overall Study|Death|0|||
27739442|NCT02456636|54189123|FG000|Overall Study|Pregnancy|1|||
27739443|NCT02456636|54189124|FG001|Overall Study|Pregnancy|3|||
27739444|NCT02456636|54189125|FG002|Overall Study|Pregnancy|5|||
27739445|NCT02456636|54189123|FG000|Overall Study|Physician Decision|4|||
27739446|NCT02456636|54189124|FG001|Overall Study|Physician Decision|5|||
27739447|NCT02456636|54189125|FG002|Overall Study|Physician Decision|4|||
27739448|NCT02456636|54189123|FG000|Overall Study|Withdrawal by Subject|13|||
27739449|NCT02456636|54189124|FG001|Overall Study|Withdrawal by Subject|14|||
27739450|NCT02456636|54189125|FG002|Overall Study|Withdrawal by Subject|16|||
27739451|NCT02456636|54189123|FG000|Overall Study|Lost to Follow-up|50|||
27739452|NCT02456636|54189124|FG001|Overall Study|Lost to Follow-up|44|||
28096854|NCT02054104|54752185|FG001|Overall Study|Did not want to continue due to college classes|0|||
28096855|NCT02054104|54752184|FG000|Overall Study|Biopsy positive for malignancy, appears to be new primary|1|||
27739453|NCT02456636|54189125|FG002|Overall Study|Lost to Follow-up|50|||
27739454|NCT02226172|54189133|FG000|Overall Study|Participant refused further follow-up|4|||
27739455|NCT02226172|54189133|FG000|Overall Study|Other|5|||
28096856|NCT02054104|54752185|FG001|Overall Study|Biopsy positive for malignancy, appears to be new primary|0|||
28096857|NCT02054104|54752184|FG000|Overall Study|No evidence of immunologic response|2|||
28096858|NCT02054104|54752185|FG001|Overall Study|No evidence of immunologic response|2|||
28096859|NCT02054104|54752184|FG000|Overall Study|Disease Progression On Study|4|||
28096860|NCT02054104|54752185|FG001|Overall Study|Disease Progression On Study|5|||
28096861|NCT02054104|54752184|FG000|Overall Study|Diagnosis of lymphoma|0|||
28096862|NCT02054104|54752185|FG001|Overall Study|Diagnosis of lymphoma|1|||
28096863|NCT02054104|54752184|FG000|Overall Study|Inconclusive response|0|||
28096864|NCT02054104|54752185|FG001|Overall Study|Inconclusive response|1|||
28096865|NCT04090242|54752193|FG000|Overall Study|Withdrawal by Subject|1|||
28096866|NCT04090242|54752194|FG001|Overall Study|Withdrawal by Subject|0|||
28096867|NCT04090164|54752203|FG000|Overall Study|incomplete data on file|245|||
28096868|NCT04090164|54752204|FG001|Overall Study|incomplete data on file|0|||
28096869|NCT04292730|54752233|FG000|Overall Study|Lost to Follow-up|8|||
28096870|NCT04292730|54752234|FG001|Overall Study|Lost to Follow-up|12|||
28096871|NCT04292730|54752235|FG002|Overall Study|Lost to Follow-up|12|||
28096872|NCT04292730|54752236|FG003|Overall Study|Lost to Follow-up|48|||
28096873|NCT04292730|54752233|FG000|Overall Study|Death|2|||
28096874|NCT04292730|54752234|FG001|Overall Study|Death|2|||
28096875|NCT04292730|54752235|FG002|Overall Study|Death|4|||
28096876|NCT04292730|54752236|FG003|Overall Study|Death|12|||
28096877|NCT04292730|54752233|FG000|Overall Study|Withdrew Consent|2|||
28096878|NCT04292730|54752234|FG001|Overall Study|Withdrew Consent|2|||
28096879|NCT04292730|54752235|FG002|Overall Study|Withdrew Consent|5|||
28096880|NCT04292730|54752236|FG003|Overall Study|Withdrew Consent|6|||
28096881|NCT04292730|54752233|FG000|Overall Study|Non-Compliance with Study Drug|0|||
28096882|NCT04292730|54752234|FG001|Overall Study|Non-Compliance with Study Drug|1|||
28096883|NCT04292730|54752235|FG002|Overall Study|Non-Compliance with Study Drug|0|||
28096884|NCT04292730|54752236|FG003|Overall Study|Non-Compliance with Study Drug|0|||
28096885|NCT04292730|54752233|FG000|Overall Study|Protocol Violation|0|||
28096886|NCT04292730|54752234|FG001|Overall Study|Protocol Violation|0|||
28096887|NCT04292730|54752235|FG002|Overall Study|Protocol Violation|1|||
28096888|NCT04292730|54752236|FG003|Overall Study|Protocol Violation|0|||
28096889|NCT04292730|54752233|FG000|Overall Study|Randomized but not Treated|8|||
28096890|NCT04292730|54752234|FG001|Overall Study|Randomized but not Treated|4|||
28096891|NCT04292730|54752235|FG002|Overall Study|Randomized but not Treated|0|||
28096892|NCT04292730|54752236|FG003|Overall Study|Randomized but not Treated|14|||
28096893|NCT02861014|54752245|FG000|Primary Analysis|Adverse Event|7|||
28096894|NCT02861014|54752245|FG000|Primary Analysis|Death|1|||
28096895|NCT02861014|54752245|FG000|Primary Analysis|Lack of Efficacy|3|||
28096896|NCT02861014|54752245|FG000|Primary Analysis|Physician Decision|2|||
28096897|NCT02861014|54752245|FG000|Primary Analysis|Pregnancy|4|||
28096898|NCT02861014|54752245|FG000|Primary Analysis|Protocol Violation|2|||
28096899|NCT02861014|54752245|FG000|Primary Analysis|Study Terminated By Sponsor|3|||
28096900|NCT02861014|54752245|FG000|Primary Analysis|Withdrawal by Subject|14|||
28096901|NCT02861014|54752245|FG000|Primary Analysis|Commercial ocrelizumab|3|||
28096902|NCT02861014|54752245|FG000|Safety Follow-up|Adverse Event|1|||
28096903|NCT02861014|54752245|FG000|Safety Follow-up|Pregnancy|1|||
27897370|NCT02388906|54551313|FG001|Treatment Period|Participant withdrew consent|3|||
27897371|NCT02388906|54551312|FG000|Treatment Period|Poor/non-compliance|0|||
27897372|NCT02388906|54551313|FG001|Treatment Period|Poor/non-compliance|1|||
27897373|NCT02388906|54551312|FG000|Treatment Period|Participant no longer meets study criteria|0|||
27897374|NCT02388906|54551313|FG001|Treatment Period|Participant no longer meets study criteria|1|||
27897375|NCT02388906|54551312|FG000|Treatment Period|Other reasons|3|||
27897376|NCT02388906|54551313|FG001|Treatment Period|Other reasons|3|||
27897377|NCT02177695|54551332|FG000|ITT Analysis|Ineligible|5|||
27897378|NCT02177695|54551333|FG001|ITT Analysis|Ineligible|5|||
27897379|NCT02177695|54551332|FG000|Primary COXEN Analysis|inadequate tissue submitted|5|||
27897380|NCT02177695|54551333|FG001|Primary COXEN Analysis|inadequate tissue submitted|6|||
27897381|NCT02177695|54551332|FG000|Primary COXEN Analysis|insufficient amount of chemotherapy received|15|||
27897382|NCT02177695|54551333|FG001|Primary COXEN Analysis|insufficient amount of chemotherapy received|8|||
27897383|NCT02177695|54551332|FG000|Primary COXEN Analysis|Pathologic response not evaluated|13|||
27897384|NCT02177695|54551333|FG001|Primary COXEN Analysis|Pathologic response not evaluated|13|||
27897385|NCT01719237|54551348|FG000|Overall Study|Physician Decision|0|||
27897386|NCT01719237|54551349|FG001|Overall Study|Physician Decision|1|||
27897387|NCT01956669|54551372|FG000|Overall Study|Disease Progression|12|||
27897388|NCT01956669|54551373|FG001|Overall Study|Disease Progression|7|||
28096904|NCT02861014|54752245|FG000|Safety Follow-up|Withdrawal by Subject|9|||
28096905|NCT02861014|54752245|FG000|Safety Follow-up|Study terminated by sponsor|1|||
28096906|NCT02861014|54752245|FG000|Safety Follow-up|Physician Decision|1|||
28096907|NCT02861014|54752245|FG000|Safety Follow-up|Roll-over to a long term extension study|1|||
28096908|NCT02861014|54752245|FG000|Safety Follow-up|Commercial ocrelizumab|36|||
28096909|NCT04382586|54752253|FG000|Overall Study|Death|3|||
28096910|NCT04382586|54752254|FG001|Overall Study|Death|4|||
28096911|NCT04382586|54752253|FG000|Overall Study|Lost to Follow-up|11|||
28096912|NCT04382586|54752254|FG001|Overall Study|Lost to Follow-up|8|||
28096913|NCT04382586|54752253|FG000|Overall Study|Withdrawal by Subject|3|||
27897389|NCT01956669|54551374|FG002|Overall Study|Disease Progression|7|||
27897390|NCT01956669|54551375|FG003|Overall Study|Disease Progression|8|||
27897391|NCT01956669|54551376|FG004|Overall Study|Disease Progression|4|||
27897392|NCT01956669|54551377|FG005|Overall Study|Disease Progression|3|||
27897393|NCT01956669|54551378|FG006|Overall Study|Disease Progression|5|||
27897394|NCT01956669|54551372|FG000|Overall Study|Adverse Event|0|||
27897395|NCT01956669|54551373|FG001|Overall Study|Adverse Event|2|||
27897396|NCT01956669|54551374|FG002|Overall Study|Adverse Event|2|||
27897397|NCT01956669|54551375|FG003|Overall Study|Adverse Event|1|||
27897398|NCT01956669|54551376|FG004|Overall Study|Adverse Event|0|||
27897399|NCT01956669|54551377|FG005|Overall Study|Adverse Event|0|||
28096914|NCT04382586|54752254|FG001|Overall Study|Withdrawal by Subject|1|||
28096915|NCT04382586|54752253|FG000|Overall Study|Physician Decision|0|||
28096916|NCT04382586|54752254|FG001|Overall Study|Physician Decision|3|||
28096917|NCT04275336|54752263|FG000|Overall Study|First venipuncture failed|4|||
28096918|NCT04275336|54752264|FG001|Overall Study|First venipuncture failed|6|||
28096919|NCT04275336|54752265|FG002|Overall Study|First venipuncture failed|5|||
27897400|NCT01956669|54551378|FG006|Overall Study|Adverse Event|0|||
27897401|NCT01956669|54551372|FG000|Overall Study|Physician Decision|0|||
27897402|NCT01956669|54551373|FG001|Overall Study|Physician Decision|2|||
27897403|NCT01956669|54551374|FG002|Overall Study|Physician Decision|0|||
27897404|NCT01956669|54551375|FG003|Overall Study|Physician Decision|0|||
27897405|NCT01956669|54551376|FG004|Overall Study|Physician Decision|0|||
27897406|NCT01956669|54551377|FG005|Overall Study|Physician Decision|1|||
27897407|NCT01956669|54551378|FG006|Overall Study|Physician Decision|0|||
27897408|NCT01956669|54551372|FG000|Overall Study|Withdrawal by Subject|0|||
27897409|NCT01956669|54551373|FG001|Overall Study|Withdrawal by Subject|0|||
27897410|NCT01956669|54551374|FG002|Overall Study|Withdrawal by Subject|1|||
27985910|NCT02393248|54644433|FG022|Part 3: Combination Therapy|Death|6|||
28096920|NCT04275336|54752263|FG000|Overall Study|Unscheduled venipuncture|9|||
28171949|NCT00701103|54843580|FG000|Overall Study|Other|0|||
28171950|NCT00701103|54843581|FG001|Overall Study|Other|0|||
28171951|NCT00701103|54843582|FG002|Overall Study|Other|0|||
28171952|NCT00701103|54843583|FG003|Overall Study|Other|0|||
28171953|NCT00701103|54843584|FG004|Overall Study|Other|0|||
28171954|NCT00701103|54843585|FG005|Overall Study|Other|0|||
28171955|NCT00701103|54843586|FG006|Overall Study|Other|0|||
28171956|NCT00701103|54843587|FG007|Overall Study|Other|0|||
28171957|NCT00701103|54843588|FG008|Overall Study|Other|1|||
28171958|NCT00701103|54843589|FG009|Overall Study|Other|1|||
28171959|NCT00701103|54843590|FG010|Overall Study|Other|0|||
28171960|NCT01369225|54843624|FG000|Overall Study|Withdrawal by Subject|1|||
28171961|NCT01369225|54843625|FG001|Overall Study|Withdrawal by Subject|0|||
28171962|NCT01369225|54843626|FG002|Overall Study|Withdrawal by Subject|2|||
28171963|NCT01369225|54843627|FG003|Overall Study|Withdrawal by Subject|1|||
28171964|NCT01369225|54843628|FG004|Overall Study|Withdrawal by Subject|0|||
28171965|NCT01369225|54843629|FG005|Overall Study|Withdrawal by Subject|0|||
27739456|NCT02226172|54189133|FG000|Overall Study|Death|1|||
28171966|NCT01369225|54843624|FG000|Overall Study|Does Not Meet Entrance Criteria|0|||
28171967|NCT01369225|54843625|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
28171968|NCT01369225|54843626|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
28171969|NCT01369225|54843627|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
28171970|NCT01369225|54843628|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
28171971|NCT01369225|54843629|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
28171972|NCT01369225|54843624|FG000|Overall Study|Other|1|||
28171973|NCT01369225|54843625|FG001|Overall Study|Other|0|||
28096921|NCT04275336|54752264|FG001|Overall Study|Unscheduled venipuncture|13|||
28096922|NCT04275336|54752265|FG002|Overall Study|Unscheduled venipuncture|7|||
28096923|NCT04275336|54752263|FG000|Overall Study|Failed specimen of saliva|4|||
28096924|NCT04275336|54752264|FG001|Overall Study|Failed specimen of saliva|3|||
28096925|NCT04275336|54752265|FG002|Overall Study|Failed specimen of saliva|4|||
28096926|NCT04480710|54752280|FG000|Overall Study|Adverse Event|0|||
28096927|NCT04480710|54752281|FG001|Overall Study|Adverse Event|2|||
28171974|NCT01369225|54843626|FG002|Overall Study|Other|0|||
28171975|NCT01369225|54843627|FG003|Overall Study|Other|0|||
28171976|NCT01369225|54843628|FG004|Overall Study|Other|1|||
27739457|NCT02226172|54189133|FG000|Overall Study|Study terminated by sponsor|1|||
27739458|NCT02226172|54189133|FG000|Overall Study|Adverse Event|6|||
27739459|NCT01676961|54189137|FG000|Overall Study|Death|3|||
27739460|NCT01676961|54189137|FG000|Overall Study|Lost to Follow-up|1|||
28171977|NCT01369225|54843629|FG005|Overall Study|Other|0|||
28171978|NCT01369225|54843624|FG000|Overall Study|Adverse Event|0|||
27739461|NCT01676961|54189137|FG000|Overall Study|Withdrawal by Subject|1|||
27739462|NCT01676727|54189159|FG000|Overall Study|Death|18|||
27897411|NCT01956669|54551375|FG003|Overall Study|Withdrawal by Subject|1|||
27897412|NCT01956669|54551376|FG004|Overall Study|Withdrawal by Subject|0|||
27897413|NCT01956669|54551377|FG005|Overall Study|Withdrawal by Subject|0|||
28096928|NCT04480710|54752282|FG002|Overall Study|Adverse Event|0|||
28096929|NCT04480710|54752283|FG003|Overall Study|Adverse Event|0|||
28096930|NCT04480710|54752280|FG000|Overall Study|Withdrawal by Subject|0|||
28171979|NCT01369225|54843625|FG001|Overall Study|Adverse Event|0|||
28171980|NCT01369225|54843626|FG002|Overall Study|Adverse Event|0|||
28171981|NCT01369225|54843627|FG003|Overall Study|Adverse Event|1|||
28171982|NCT01369225|54843628|FG004|Overall Study|Adverse Event|1|||
28171983|NCT01369225|54843629|FG005|Overall Study|Adverse Event|0|||
28171984|NCT02639546|54843651|FG000|Overall Study|Death|2|||
28171985|NCT02639546|54843652|FG001|Overall Study|Death|2|||
28171986|NCT02639546|54843653|FG002|Overall Study|Death|1|||
28171987|NCT02639546|54843654|FG003|Overall Study|Death|2|||
28171988|NCT02639546|54843655|FG004|Overall Study|Death|2|||
28171989|NCT02639546|54843656|FG005|Overall Study|Death|2|||
28171990|NCT02639546|54843657|FG006|Overall Study|Death|0|||
28096931|NCT04480710|54752281|FG001|Overall Study|Withdrawal by Subject|1|||
28096932|NCT04480710|54752282|FG002|Overall Study|Withdrawal by Subject|0|||
28096933|NCT04480710|54752283|FG003|Overall Study|Withdrawal by Subject|0|||
28096934|NCT04480710|54752280|FG000|Overall Study|Physician Decision|0|||
28171991|NCT02639546|54843658|FG007|Overall Study|Death|0|||
28171992|NCT02639546|54843651|FG000|Overall Study|Lost to Follow-up|0|||
28171993|NCT02639546|54843652|FG001|Overall Study|Lost to Follow-up|0|||
28171994|NCT02639546|54843653|FG002|Overall Study|Lost to Follow-up|1|||
28171995|NCT02639546|54843654|FG003|Overall Study|Lost to Follow-up|0|||
28171996|NCT02639546|54843655|FG004|Overall Study|Lost to Follow-up|1|||
28171997|NCT02639546|54843656|FG005|Overall Study|Lost to Follow-up|1|||
28171998|NCT02639546|54843657|FG006|Overall Study|Lost to Follow-up|0|||
28171999|NCT02639546|54843658|FG007|Overall Study|Lost to Follow-up|1|||
28172000|NCT02639546|54843651|FG000|Overall Study|PI, physician decision; no response to trt.|2|||
28172001|NCT02639546|54843652|FG001|Overall Study|PI, physician decision; no response to trt.|0|||
28172002|NCT02639546|54843653|FG002|Overall Study|PI, physician decision; no response to trt.|0|||
28096935|NCT04480710|54752281|FG001|Overall Study|Physician Decision|0|||
28096936|NCT04480710|54752282|FG002|Overall Study|Physician Decision|1|||
28172003|NCT02639546|54843654|FG003|Overall Study|PI, physician decision; no response to trt.|0|||
28172004|NCT02639546|54843655|FG004|Overall Study|PI, physician decision; no response to trt.|0|||
28172005|NCT02639546|54843656|FG005|Overall Study|PI, physician decision; no response to trt.|1|||
28172006|NCT02639546|54843657|FG006|Overall Study|PI, physician decision; no response to trt.|0|||
28172007|NCT02639546|54843658|FG007|Overall Study|PI, physician decision; no response to trt.|1|||
28172008|NCT02639546|54843651|FG000|Overall Study|Study Terminated By Sponsor|0|||
27739463|NCT01676727|54189159|FG000|Overall Study|Withdrawal by Subject|6|||
27897414|NCT01956669|54551378|FG006|Overall Study|Withdrawal by Subject|1|||
27897415|NCT01967823|54551403|FG000|Overall Study|Died prior to completing therapy (before the six-week mark).|1|||
27897416|NCT01985022|54551413|FG000|Overall Study|Lost to Follow-up|0|||
27897417|NCT01985022|54551414|FG001|Overall Study|Lost to Follow-up|1|||
27897418|NCT01985022|54551413|FG000|Overall Study|Protocol Violation|0|||
27897419|NCT01985022|54551414|FG001|Overall Study|Protocol Violation|1|||
27897420|NCT01985022|54551413|FG000|Overall Study|Withdrawal by Subject|4|||
27897421|NCT01985022|54551414|FG001|Overall Study|Withdrawal by Subject|1|||
27897422|NCT01989676|54551422|FG000|Overall Study|Death|52|||
27897423|NCT01989676|54551423|FG001|Overall Study|Death|60|||
27897424|NCT01989676|54551422|FG000|Overall Study|Protocol Violation|2|||
27897425|NCT01989676|54551423|FG001|Overall Study|Protocol Violation|1|||
27897426|NCT01989676|54551422|FG000|Overall Study|Lost to Follow-up|8|||
27897427|NCT01989676|54551423|FG001|Overall Study|Lost to Follow-up|18|||
27897428|NCT01989676|54551422|FG000|Overall Study|No longer willing to participate in study|26|||
27897429|NCT01989676|54551423|FG001|Overall Study|No longer willing to participate in study|26|||
27897430|NCT01989676|54551422|FG000|Overall Study|Participants terminated from study by Sponsor|26|||
27897431|NCT01989676|54551423|FG001|Overall Study|Participants terminated from study by Sponsor|30|||
27897432|NCT01989676|54551422|FG000|Overall Study|Other|4|||
27897433|NCT01989676|54551423|FG001|Overall Study|Other|3|||
27897434|NCT02001974|54551433|FG000|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|2|||
27897435|NCT02001974|54551434|FG001|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|3|||
27925781|NCT01226745|54582370|FG003|Overall Study|Lost to Follow-up|1|||
27985911|NCT02393248|54644434|FG023|Part 3: Combination Therapy|Death|3|||
27985912|NCT02393248|54644435|FG024|Part 3: Combination Therapy|Death|0|||
27985913|NCT02393248|54644411|FG000|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
28096937|NCT04480710|54752283|FG003|Overall Study|Physician Decision|0|||
28096938|NCT04268316|54752302|FG000|Overall Study|Withdrawal by Subject|2|||
28096939|NCT04268316|54752303|FG001|Overall Study|Withdrawal by Subject|1|||
28096940|NCT04268316|54752304|FG002|Overall Study|Withdrawal by Subject|0|||
27985914|NCT02393248|54644412|FG001|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
27985915|NCT02393248|54644413|FG002|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
28096941|NCT01971970|54752314|FG000|Baseline Until Week 6|Stopped anti-TNF use|1|||
28096942|NCT01971970|54752315|FG001|Baseline Until Week 6|Stopped anti-TNF use|0|||
28172009|NCT02639546|54843652|FG001|Overall Study|Study Terminated By Sponsor|2|||
28172010|NCT02639546|54843653|FG002|Overall Study|Study Terminated By Sponsor|3|||
28172011|NCT02639546|54843654|FG003|Overall Study|Study Terminated By Sponsor|4|||
28172012|NCT02639546|54843655|FG004|Overall Study|Study Terminated By Sponsor|4|||
28172013|NCT02639546|54843656|FG005|Overall Study|Study Terminated By Sponsor|3|||
27897436|NCT02001974|54551435|FG002|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|14|||
27897437|NCT02001974|54551433|FG000|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|1|||
27897438|NCT02001974|54551434|FG001|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|0|||
27897439|NCT02001974|54551435|FG002|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|4|||
27897440|NCT02001974|54551433|FG000|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|1|||
27897441|NCT02001974|54551434|FG001|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|0|||
27897442|NCT02001974|54551435|FG002|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|6|||
27897443|NCT02001974|54551433|FG000|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
27897444|NCT02001974|54551434|FG001|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
27897445|NCT02001974|54551435|FG002|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|2|||
27897446|NCT04983589|54551445|FG000|Overall Study|Withdrawal by Subject|0|||
27897447|NCT04983589|54551446|FG001|Overall Study|Withdrawal by Subject|3|||
27897448|NCT04983589|54551445|FG000|Overall Study|COVID-19 Infection|1|||
27897449|NCT04983589|54551446|FG001|Overall Study|COVID-19 Infection|0|||
27897450|NCT04983589|54551445|FG000|Overall Study|COVID-19 Logistical Restrictions|2|||
27897451|NCT04983589|54551446|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
27897452|NCT04556591|54551466|FG000|Overall Study|Lost to Follow-up|1|||
27897453|NCT04556591|54551467|FG001|Overall Study|Lost to Follow-up|0|||
27897454|NCT04556591|54551466|FG000|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|2|||
27897455|NCT04556591|54551467|FG001|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|0|||
27897456|NCT04428034|54551476|FG000|Enrollment to Intervention Completion|Protocol Violation|6|||
27897457|NCT04364984|54551487|FG000|Overall Study|Death|2|||
27897458|NCT04364984|54551488|FG001|Overall Study|Death|2|||
27897459|NCT04364984|54551489|FG002|Overall Study|Death|0|||
27897460|NCT04294095|54551499|FG000|Overall Study|Adverse Event|1|||
27897461|NCT04294095|54551500|FG001|Overall Study|Adverse Event|0|||
27897462|NCT04266028|54551516|FG000|Overall Study|Adverse Event|0|||
27897463|NCT04266028|54551517|FG001|Overall Study|Adverse Event|0|||
27897464|NCT04266028|54551518|FG002|Overall Study|Adverse Event|1|||
27897465|NCT04266028|54551519|FG003|Overall Study|Adverse Event|0|||
27897466|NCT04266028|54551520|FG004|Overall Study|Adverse Event|1|||
27897467|NCT04266028|54551521|FG005|Overall Study|Adverse Event|0|||
27897468|NCT04266028|54551522|FG006|Overall Study|Adverse Event|2|||
27897469|NCT04266028|54551523|FG007|Overall Study|Adverse Event|0|||
27897470|NCT04266028|54551516|FG000|Overall Study|temporary halt of the study|0|||
27897471|NCT04266028|54551517|FG001|Overall Study|temporary halt of the study|0|||
28172014|NCT02639546|54843657|FG006|Overall Study|Study Terminated By Sponsor|3|||
28172015|NCT02639546|54843658|FG007|Overall Study|Study Terminated By Sponsor|9|||
28172016|NCT02639546|54843651|FG000|Overall Study|Withdrawal by Subject|2|||
28172017|NCT02639546|54843652|FG001|Overall Study|Withdrawal by Subject|2|||
28172018|NCT02639546|54843653|FG002|Overall Study|Withdrawal by Subject|1|||
28172019|NCT02639546|54843654|FG003|Overall Study|Withdrawal by Subject|0|||
28172020|NCT02639546|54843655|FG004|Overall Study|Withdrawal by Subject|0|||
28172021|NCT02639546|54843656|FG005|Overall Study|Withdrawal by Subject|1|||
28172022|NCT02639546|54843657|FG006|Overall Study|Withdrawal by Subject|2|||
28172023|NCT02639546|54843658|FG007|Overall Study|Withdrawal by Subject|1|||
28172024|NCT02639390|54843692|FG000|Overall Study|Subject unable to comply with treatment schedule.|0|||
28172025|NCT02639390|54843693|FG001|Overall Study|Subject unable to comply with treatment schedule.|2|||
28172026|NCT02718417|54843702|FG000|Chemotherapy Phase (CP)|Adverse Event|9|||
28172027|NCT02718417|54843703|FG001|Chemotherapy Phase (CP)|Adverse Event|14|||
28172028|NCT02718417|54843704|FG002|Chemotherapy Phase (CP)|Adverse Event|13|||
28172029|NCT02718417|54843702|FG000|Chemotherapy Phase (CP)|Death leading to discontinuation|5|||
28172030|NCT02718417|54843703|FG001|Chemotherapy Phase (CP)|Death leading to discontinuation|4|||
28172031|NCT02718417|54843704|FG002|Chemotherapy Phase (CP)|Death leading to discontinuation|1|||
28172032|NCT02718417|54843702|FG000|Chemotherapy Phase (CP)|Global deterioration of health status|3|||
28172033|NCT02718417|54843703|FG001|Chemotherapy Phase (CP)|Global deterioration of health status|2|||
28172034|NCT02718417|54843704|FG002|Chemotherapy Phase (CP)|Global deterioration of health status|1|||
28172035|NCT02718417|54843702|FG000|Chemotherapy Phase (CP)|No longer met eligibility criteria|4|||
28172036|NCT02718417|54843703|FG001|Chemotherapy Phase (CP)|No longer met eligibility criteria|2|||
28172037|NCT02718417|54843704|FG002|Chemotherapy Phase (CP)|No longer met eligibility criteria|1|||
28172038|NCT02718417|54843702|FG000|Chemotherapy Phase (CP)|Physician's decision|5|||
27897472|NCT04266028|54551518|FG002|Overall Study|temporary halt of the study|0|||
27897473|NCT04266028|54551519|FG003|Overall Study|temporary halt of the study|0|||
27897474|NCT04266028|54551520|FG004|Overall Study|temporary halt of the study|0|||
27897475|NCT04266028|54551521|FG005|Overall Study|temporary halt of the study|0|||
28172039|NCT02718417|54843703|FG001|Chemotherapy Phase (CP)|Physician's decision|0|||
28172040|NCT02718417|54843704|FG002|Chemotherapy Phase (CP)|Physician's decision|4|||
28172041|NCT02718417|54843702|FG000|Chemotherapy Phase (CP)|Progressive disease|11|||
28172042|NCT02718417|54843703|FG001|Chemotherapy Phase (CP)|Progressive disease|7|||
27897476|NCT04266028|54551522|FG006|Overall Study|temporary halt of the study|2|||
27897477|NCT04266028|54551523|FG007|Overall Study|temporary halt of the study|1|||
27897478|NCT04266028|54551516|FG000|Overall Study|Onset of birch pollen season|0|||
27897479|NCT04266028|54551517|FG001|Overall Study|Onset of birch pollen season|0|||
27897480|NCT04266028|54551518|FG002|Overall Study|Onset of birch pollen season|0|||
27897481|NCT04266028|54551519|FG003|Overall Study|Onset of birch pollen season|0|||
27897482|NCT04266028|54551520|FG004|Overall Study|Onset of birch pollen season|1|||
27897483|NCT04266028|54551521|FG005|Overall Study|Onset of birch pollen season|0|||
27897484|NCT04266028|54551522|FG006|Overall Study|Onset of birch pollen season|0|||
27897485|NCT04266028|54551523|FG007|Overall Study|Onset of birch pollen season|0|||
27897486|NCT03994731|54551573|FG000|Pegloticase + IMM Period|Death|2|||
27897487|NCT03994731|54551574|FG001|Pegloticase + IMM Period|Death|0|||
27897488|NCT03994731|54551573|FG000|Pegloticase + IMM Period|Lost to Follow-up|3|||
27897489|NCT03994731|54551574|FG001|Pegloticase + IMM Period|Lost to Follow-up|6|||
27985916|NCT02393248|54644414|FG003|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
28096943|NCT01971970|54752314|FG000|Week 6 Until Week 8|Stopped anti-TNF use|0|||
28096944|NCT01971970|54752315|FG001|Week 6 Until Week 8|Stopped anti-TNF use|1|||
28096945|NCT01971970|54752314|FG000|Week 14 Until Week 22|Lost to Follow-up|0|||
28096946|NCT01971970|54752315|FG001|Week 14 Until Week 22|Lost to Follow-up|1|||
28096947|NCT01971970|54752314|FG000|Week 22 Until Week 52|Stopped anti-TNF use|7|||
28096948|NCT01971970|54752315|FG001|Week 22 Until Week 52|Stopped anti-TNF use|3|||
28096949|NCT01971970|54752314|FG000|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|1|||
28096950|NCT01971970|54752315|FG001|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|0|||
27897490|NCT03994731|54551573|FG000|Pegloticase + IMM Period|Withdrawal by Subject|15|||
27897491|NCT03994731|54551574|FG001|Pegloticase + IMM Period|Withdrawal by Subject|9|||
27897492|NCT03829683|54551585|FG000|Overall Study|Lost to Follow-up|1|||
27897493|NCT03829683|54551586|FG001|Overall Study|Lost to Follow-up|0|||
27897494|NCT03829683|54551585|FG000|Overall Study|Physician Decision|3|||
27897495|NCT03829683|54551586|FG001|Overall Study|Physician Decision|1|||
27897496|NCT03829683|54551585|FG000|Overall Study|Withdrawal by Subject|0|||
27897497|NCT03829683|54551586|FG001|Overall Study|Withdrawal by Subject|1|||
27897498|NCT03829683|54551585|FG000|Overall Study|Discharge from hospital|1|||
27897499|NCT03829683|54551586|FG001|Overall Study|Discharge from hospital|0|||
27897500|NCT03801915|54551595|FG000|Overall Study|Screen failure|0|||
27897501|NCT03801915|54551596|FG001|Overall Study|Screen failure|0|||
27897502|NCT03801915|54551597|FG002|Overall Study|Screen failure|1|||
27897503|NCT03801915|54551595|FG000|Overall Study|Ineligible|1|||
27897504|NCT03801915|54551596|FG001|Overall Study|Ineligible|0|||
27897505|NCT03801915|54551597|FG002|Overall Study|Ineligible|0|||
27897506|NCT03801915|54551595|FG000|Overall Study|Physician Decision|2|||
27897507|NCT03801915|54551596|FG001|Overall Study|Physician Decision|1|||
27897508|NCT03801915|54551597|FG002|Overall Study|Physician Decision|0|||
27897509|NCT03581305|54551611|FG000|Dopaminergic Study|Withdrawal by Subject|1|||
27897510|NCT03581305|54551612|FG001|Dopaminergic Study|Withdrawal by Subject|1|||
27897511|NCT03581305|54551611|FG000|Dopaminergic Study|could not finish FDOPA scan|2|||
27897512|NCT03581305|54551612|FG001|Dopaminergic Study|could not finish FDOPA scan|0|||
27897513|NCT03581305|54551611|FG000|Serotonergic Study|Withdrawal by Subject|5|||
27897514|NCT03581305|54551612|FG001|Serotonergic Study|Withdrawal by Subject|1|||
27897515|NCT03556202|54551623|FG000|Extension Treatment Period|Adverse Event|18|||
27897516|NCT03556202|54551624|FG001|Extension Treatment Period|Adverse Event|14|||
27897517|NCT03556202|54551625|FG002|Extension Treatment Period|Adverse Event|9|||
27897518|NCT03556202|54551623|FG000|Extension Treatment Period|Death|2|||
27897519|NCT03556202|54551624|FG001|Extension Treatment Period|Death|6|||
28096951|NCT01971970|54752314|FG000|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|0|||
28096952|NCT01971970|54752315|FG001|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|1|||
28096953|NCT01971970|54752314|FG000|Week 52 Until Week 78|Stopped anti-TNF use|1|||
28096954|NCT01971970|54752315|FG001|Week 52 Until Week 78|Stopped anti-TNF use|3|||
28096955|NCT04079790|54752330|FG000|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1|||
28096956|NCT04079790|54752331|FG001|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
28096957|NCT04079790|54752332|FG002|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
28096958|NCT04079790|54752333|FG003|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
28096959|NCT04079790|54752330|FG000|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
28096960|NCT04079790|54752331|FG001|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
28096961|NCT04079790|54752332|FG002|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1|||
28096962|NCT04079790|54752333|FG003|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
28096963|NCT04079790|54752330|FG000|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
28096964|NCT04079790|54752331|FG001|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
28096965|NCT04079790|54752332|FG002|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2|||
28096966|NCT04079790|54752333|FG003|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
28096967|NCT04259346|54752361|FG000|Overall Study|Lost to Follow-up|1|||
27897520|NCT03556202|54551625|FG002|Extension Treatment Period|Death|0|||
27897521|NCT03556202|54551623|FG000|Extension Treatment Period|Lack of Efficacy|5|||
28096968|NCT04259346|54752362|FG001|Overall Study|Lost to Follow-up|3|||
27897522|NCT03556202|54551624|FG001|Extension Treatment Period|Lack of Efficacy|12|||
27897523|NCT03556202|54551625|FG002|Extension Treatment Period|Lack of Efficacy|18|||
27897524|NCT03556202|54551623|FG000|Extension Treatment Period|Lost to Follow-up|9|||
27897525|NCT03556202|54551624|FG001|Extension Treatment Period|Lost to Follow-up|20|||
27897526|NCT03556202|54551625|FG002|Extension Treatment Period|Lost to Follow-up|2|||
27897527|NCT03556202|54551623|FG000|Extension Treatment Period|Pregnancy|2|||
27897528|NCT03556202|54551624|FG001|Extension Treatment Period|Pregnancy|4|||
27897529|NCT03556202|54551625|FG002|Extension Treatment Period|Pregnancy|3|||
27897530|NCT03556202|54551623|FG000|Extension Treatment Period|Study Terminated by Sponsor|469|||
27897531|NCT03556202|54551624|FG001|Extension Treatment Period|Study Terminated by Sponsor|907|||
27897532|NCT03556202|54551625|FG002|Extension Treatment Period|Study Terminated by Sponsor|331|||
27897533|NCT03556202|54551623|FG000|Extension Treatment Period|Withdrawal by Subject|22|||
27897534|NCT03556202|54551624|FG001|Extension Treatment Period|Withdrawal by Subject|47|||
27897535|NCT03556202|54551625|FG002|Extension Treatment Period|Withdrawal by Subject|22|||
27897536|NCT03556202|54551623|FG000|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
27897537|NCT03556202|54551624|FG001|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
27897538|NCT03556202|54551625|FG002|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|1|||
27897539|NCT03556202|54551623|FG000|Extension Treatment Period|Physician Decision|0|||
27897540|NCT03556202|54551624|FG001|Extension Treatment Period|Physician Decision|8|||
27897541|NCT03556202|54551625|FG002|Extension Treatment Period|Physician Decision|2|||
27897542|NCT03556202|54551623|FG000|Extension Treatment Period|Protocol Violation|0|||
27897543|NCT03556202|54551624|FG001|Extension Treatment Period|Protocol Violation|1|||
27897544|NCT03556202|54551625|FG002|Extension Treatment Period|Protocol Violation|1|||
27897545|NCT03556202|54551623|FG000|Extension Treatment Period|Sponsor Decision|0|||
27897546|NCT03556202|54551624|FG001|Extension Treatment Period|Sponsor Decision|1|||
27897547|NCT03556202|54551625|FG002|Extension Treatment Period|Sponsor Decision|0|||
27897548|NCT03556202|54551623|FG000|Follow-Up Period (12 Weeks)|Adverse Event|11|||
27897549|NCT03556202|54551624|FG001|Follow-Up Period (12 Weeks)|Adverse Event|11|||
27897550|NCT03556202|54551625|FG002|Follow-Up Period (12 Weeks)|Adverse Event|8|||
27897551|NCT03556202|54551623|FG000|Follow-Up Period (12 Weeks)|Death|1|||
27897552|NCT03556202|54551624|FG001|Follow-Up Period (12 Weeks)|Death|0|||
27897553|NCT03556202|54551625|FG002|Follow-Up Period (12 Weeks)|Death|0|||
27897554|NCT03556202|54551623|FG000|Follow-Up Period (12 Weeks)|Lack of Efficacy|4|||
27897555|NCT03556202|54551624|FG001|Follow-Up Period (12 Weeks)|Lack of Efficacy|9|||
28096969|NCT04259346|54752361|FG000|Overall Study|Protocol Violation|1|||
28096970|NCT04259346|54752362|FG001|Overall Study|Protocol Violation|0|||
28096971|NCT04259346|54752361|FG000|Overall Study|Withdrawal by Subject|1|||
28096972|NCT04259346|54752362|FG001|Overall Study|Withdrawal by Subject|0|||
28096973|NCT04259346|54752361|FG000|Overall Study|Adverse Event|1|||
28096974|NCT04259346|54752362|FG001|Overall Study|Adverse Event|1|||
28096975|NCT04230876|54752370|FG000|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
28096976|NCT04230876|54752371|FG001|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
28096977|NCT04228302|54752383|FG000|Overall Study|Adverse Event|0|||
28096978|NCT04228302|54752384|FG001|Overall Study|Adverse Event|0|||
28096979|NCT04228302|54752385|FG002|Overall Study|Adverse Event|0|||
28172043|NCT02718417|54843704|FG002|Chemotherapy Phase (CP)|Progressive disease|10|||
28172044|NCT02718417|54843702|FG000|Chemotherapy Phase (CP)|Withdrawal by Subject|13|||
28172045|NCT02718417|54843703|FG001|Chemotherapy Phase (CP)|Withdrawal by Subject|8|||
28172046|NCT02718417|54843704|FG002|Chemotherapy Phase (CP)|Withdrawal by Subject|15|||
28172047|NCT02718417|54843702|FG000|Chemotherapy Phase (CP)|Other|2|||
28172048|NCT02718417|54843703|FG001|Chemotherapy Phase (CP)|Other|0|||
28172049|NCT02718417|54843704|FG002|Chemotherapy Phase (CP)|Other|1|||
28172050|NCT02718417|54843702|FG000|Maintenance Phase (MP)|Adverse Event|21|||
28172051|NCT02718417|54843703|FG001|Maintenance Phase (MP)|Adverse Event|26|||
28172052|NCT02718417|54843704|FG002|Maintenance Phase (MP)|Adverse Event|0|||
28172053|NCT02718417|54843702|FG000|Maintenance Phase (MP)|Death leading to discontinuation|1|||
28172054|NCT02718417|54843703|FG001|Maintenance Phase (MP)|Death leading to discontinuation|1|||
28172055|NCT02718417|54843704|FG002|Maintenance Phase (MP)|Death leading to discontinuation|0|||
28172056|NCT02718417|54843702|FG000|Maintenance Phase (MP)|Global deterioration of health status|5|||
28172057|NCT02718417|54843703|FG001|Maintenance Phase (MP)|Global deterioration of health status|3|||
28172058|NCT02718417|54843704|FG002|Maintenance Phase (MP)|Global deterioration of health status|0|||
28172059|NCT02718417|54843702|FG000|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
28172060|NCT02718417|54843703|FG001|Maintenance Phase (MP)|No longer met eligibility criteria|1|||
28172061|NCT02718417|54843704|FG002|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
28096980|NCT04228302|54752386|FG003|Overall Study|Adverse Event|0|||
28096981|NCT04228302|54752387|FG004|Overall Study|Adverse Event|1|||
28096982|NCT04228302|54752388|FG005|Overall Study|Adverse Event|0|||
28096983|NCT01348100|54752409|FG000|Overall Study|Subject Withdrew Consent|0|||
28172062|NCT02718417|54843702|FG000|Maintenance Phase (MP)|Physician's decision|6|||
28172063|NCT02718417|54843703|FG001|Maintenance Phase (MP)|Physician's decision|7|||
28172064|NCT02718417|54843704|FG002|Maintenance Phase (MP)|Physician's decision|0|||
28096984|NCT01348100|54752410|FG001|Overall Study|Subject Withdrew Consent|0|||
28096985|NCT01348100|54752411|FG002|Overall Study|Subject Withdrew Consent|2|||
28096986|NCT01348100|54752412|FG003|Overall Study|Subject Withdrew Consent|0|||
28096987|NCT01348100|54752413|FG004|Overall Study|Subject Withdrew Consent|1|||
28096988|NCT01348100|54752414|FG005|Overall Study|Subject Withdrew Consent|0|||
28096989|NCT01348100|54752415|FG006|Overall Study|Subject Withdrew Consent|1|||
28096990|NCT01348100|54752409|FG000|Overall Study|Protocol Deviation|0|||
28096991|NCT01348100|54752410|FG001|Overall Study|Protocol Deviation|0|||
28096992|NCT01348100|54752411|FG002|Overall Study|Protocol Deviation|0|||
28096993|NCT01348100|54752412|FG003|Overall Study|Protocol Deviation|1|||
28096994|NCT01348100|54752413|FG004|Overall Study|Protocol Deviation|0|||
28096995|NCT01348100|54752414|FG005|Overall Study|Protocol Deviation|0|||
28096996|NCT01348100|54752415|FG006|Overall Study|Protocol Deviation|0|||
28096997|NCT01348100|54752409|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
28096998|NCT01348100|54752410|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
28096999|NCT01348100|54752411|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
28097000|NCT01348100|54752412|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
28097001|NCT01348100|54752413|FG004|Overall Study|Unsatisfactory Therapeutic Effect|0|||
28097002|NCT01348100|54752414|FG005|Overall Study|Unsatisfactory Therapeutic Effect|1|||
28097003|NCT01348100|54752415|FG006|Overall Study|Unsatisfactory Therapeutic Effect|0|||
28097004|NCT01348100|54752409|FG000|Overall Study|Lost to Follow-up|0|||
28097005|NCT01348100|54752410|FG001|Overall Study|Lost to Follow-up|0|||
28097006|NCT01348100|54752411|FG002|Overall Study|Lost to Follow-up|0|||
28097007|NCT01348100|54752412|FG003|Overall Study|Lost to Follow-up|0|||
28097008|NCT01348100|54752413|FG004|Overall Study|Lost to Follow-up|0|||
28097009|NCT01348100|54752414|FG005|Overall Study|Lost to Follow-up|0|||
28097010|NCT01348100|54752415|FG006|Overall Study|Lost to Follow-up|1|||
28097011|NCT01348100|54752409|FG000|Overall Study|Administrative Problems|0|||
28097012|NCT01348100|54752410|FG001|Overall Study|Administrative Problems|0|||
28097013|NCT01348100|54752411|FG002|Overall Study|Administrative Problems|0|||
28097014|NCT01348100|54752412|FG003|Overall Study|Administrative Problems|0|||
28097015|NCT01348100|54752413|FG004|Overall Study|Administrative Problems|0|||
28097016|NCT01348100|54752414|FG005|Overall Study|Administrative Problems|1|||
28097017|NCT01348100|54752415|FG006|Overall Study|Administrative Problems|1|||
28097018|NCT03676634|54752436|FG000|Overall Study|Red blood cell loss|1|||
28097019|NCT03676634|54752436|FG000|Overall Study|Out-of-limit pulse|2|||
28097020|NCT03675776|54752443|FG000|Double Blind Treatment Period|Study Terminated by Sponsor|5|||
28097021|NCT03675776|54752444|FG001|Double Blind Treatment Period|Study Terminated by Sponsor|6|||
28097022|NCT03675776|54752445|FG002|Double Blind Treatment Period|Study Terminated by Sponsor|8|||
28097023|NCT03675776|54752443|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
28097024|NCT03675776|54752444|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
28097025|NCT03675776|54752445|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
28097026|NCT03673670|54752459|FG000|Treatment Period 1 (3 Days)|Withdrawal by Subject|1|||
28097027|NCT03673670|54752460|FG001|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
28097028|NCT03673670|54752461|FG002|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
28097029|NCT03673670|54752462|FG003|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
28097030|NCT03673670|54752463|FG004|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
28097031|NCT03673670|54752464|FG005|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
28097032|NCT03673670|54752459|FG000|Treatment Period 1 (3 Days)|Physician Decision|0|||
28097033|NCT03673670|54752460|FG001|Treatment Period 1 (3 Days)|Physician Decision|0|||
28097034|NCT03673670|54752461|FG002|Treatment Period 1 (3 Days)|Physician Decision|1|||
28097035|NCT03673670|54752462|FG003|Treatment Period 1 (3 Days)|Physician Decision|0|||
28097036|NCT03673670|54752463|FG004|Treatment Period 1 (3 Days)|Physician Decision|0|||
28097037|NCT03673670|54752464|FG005|Treatment Period 1 (3 Days)|Physician Decision|0|||
27985917|NCT02393248|54644415|FG004|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
27985918|NCT02393248|54644416|FG005|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
27985919|NCT02393248|54644417|FG006|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
28097038|NCT03673670|54752459|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
28097039|NCT03673670|54752460|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
28097040|NCT03673670|54752461|FG002|Treatment Period 1 (3 Days)|Adverse Event|0|||
28097041|NCT03673670|54752462|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
27897556|NCT03556202|54551625|FG002|Follow-Up Period (12 Weeks)|Lack of Efficacy|13|||
27897557|NCT03556202|54551623|FG000|Follow-Up Period (12 Weeks)|Lost to Follow-up|4|||
27897558|NCT03556202|54551624|FG001|Follow-Up Period (12 Weeks)|Lost to Follow-up|14|||
27897559|NCT03556202|54551625|FG002|Follow-Up Period (12 Weeks)|Lost to Follow-up|3|||
27897560|NCT03556202|54551623|FG000|Follow-Up Period (12 Weeks)|Pregnancy|1|||
27897561|NCT03556202|54551624|FG001|Follow-Up Period (12 Weeks)|Pregnancy|4|||
27897562|NCT03556202|54551625|FG002|Follow-Up Period (12 Weeks)|Pregnancy|1|||
27897563|NCT03556202|54551623|FG000|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|396|||
27897564|NCT03556202|54551624|FG001|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|750|||
27897565|NCT03556202|54551625|FG002|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|273|||
27897566|NCT03556202|54551623|FG000|Follow-Up Period (12 Weeks)|Withdrawal by Subject|36|||
27897567|NCT03556202|54551624|FG001|Follow-Up Period (12 Weeks)|Withdrawal by Subject|65|||
28097042|NCT03673670|54752463|FG004|Treatment Period 1 (3 Days)|Adverse Event|0|||
28097043|NCT03673670|54752464|FG005|Treatment Period 1 (3 Days)|Adverse Event|1|||
28097044|NCT03673670|54752459|FG000|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
28097045|NCT03673670|54752460|FG001|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
28097046|NCT03673670|54752461|FG002|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
28097047|NCT03673670|54752462|FG003|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
28097048|NCT03673670|54752463|FG004|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
28097049|NCT03673670|54752464|FG005|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1|||
28097050|NCT03673670|54752459|FG000|Treatment Period 2 (3 Days)|Adverse Event|0|||
28097051|NCT03673670|54752460|FG001|Treatment Period 2 (3 Days)|Adverse Event|0|||
28097052|NCT03673670|54752461|FG002|Treatment Period 2 (3 Days)|Adverse Event|1|||
28097053|NCT03673670|54752462|FG003|Treatment Period 2 (3 Days)|Adverse Event|0|||
28097054|NCT03673670|54752463|FG004|Treatment Period 2 (3 Days)|Adverse Event|1|||
28097055|NCT03673670|54752464|FG005|Treatment Period 2 (3 Days)|Adverse Event|0|||
28097056|NCT03673670|54752459|FG000|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
28097057|NCT03673670|54752460|FG001|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
28097058|NCT03673670|54752461|FG002|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
28097059|NCT03673670|54752462|FG003|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
28097060|NCT03673670|54752463|FG004|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1|||
28097061|NCT03673670|54752464|FG005|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
28097062|NCT03673670|54752459|FG000|Treatment Period 3 (3 Days)|Adverse Event|0|||
28097063|NCT03673670|54752460|FG001|Treatment Period 3 (3 Days)|Adverse Event|0|||
28097064|NCT03673670|54752461|FG002|Treatment Period 3 (3 Days)|Adverse Event|0|||
28097065|NCT03673670|54752462|FG003|Treatment Period 3 (3 Days)|Adverse Event|0|||
28097066|NCT03673670|54752463|FG004|Treatment Period 3 (3 Days)|Adverse Event|1|||
28097067|NCT03673670|54752464|FG005|Treatment Period 3 (3 Days)|Adverse Event|0|||
28097068|NCT04369742|54752483|FG000|Overall Study|Lost to Follow-Up (Day 14)|7|||
28097069|NCT04369742|54752484|FG001|Overall Study|Lost to Follow-Up (Day 14)|4|||
28097070|NCT04369742|54752483|FG000|Overall Study|Lost to Follow-Up (Day 30)|7|||
28097071|NCT04369742|54752484|FG001|Overall Study|Lost to Follow-Up (Day 30)|7|||
28097072|NCT04369430|54752492|FG000|Overall Study|Adverse Event|2|||
28097073|NCT04369430|54752493|FG001|Overall Study|Adverse Event|3|||
28097074|NCT04369430|54752492|FG000|Overall Study|Death|1|||
28097075|NCT04369430|54752493|FG001|Overall Study|Death|0|||
28097076|NCT04369430|54752492|FG000|Overall Study|Withdrawal by Subject|4|||
28097077|NCT04369430|54752493|FG001|Overall Study|Withdrawal by Subject|3|||
28097078|NCT04369430|54752492|FG000|Overall Study|COVID concern, Sponsor's decision|2|||
28097079|NCT04369430|54752493|FG001|Overall Study|COVID concern, Sponsor's decision|1|||
28097080|NCT04369430|54752492|FG000|Overall Study|Lost to Follow-up|0|||
28097081|NCT04369430|54752493|FG001|Overall Study|Lost to Follow-up|1|||
28097082|NCT04363736|54752501|FG000|Overall Study|Withdrawal by Subject|1|||
28097083|NCT04363736|54752502|FG001|Overall Study|Withdrawal by Subject|0|||
28097084|NCT04363736|54752501|FG000|Overall Study|Lost to Follow-up|10|||
28097085|NCT04363736|54752502|FG001|Overall Study|Lost to Follow-up|7|||
28097086|NCT04363736|54752501|FG000|Overall Study|Death|8|||
28097087|NCT04363736|54752502|FG001|Overall Study|Death|6|||
28097088|NCT04362176|54752510|FG000|Overall Study|Lost to Follow-up|5|||
28097089|NCT04362176|54752511|FG001|Overall Study|Lost to Follow-up|8|||
28097090|NCT04362176|54752510|FG000|Overall Study|Withdrawn (Participant/PI withdrew consent)|8|||
28097091|NCT04362176|54752511|FG001|Overall Study|Withdrawn (Participant/PI withdrew consent)|6|||
28097092|NCT04079816|54752517|FG000|Overall Study|Request of Subject|2|||
28097093|NCT04079816|54752517|FG000|Overall Study|Unable to draw samples|1|||
28097094|NCT04079114|54752521|FG000|Overall Study|Study prematuely terminated.|166|||
28097095|NCT03055936|54752529|FG000|Overall Study|Adverse Event|0|||
28097096|NCT03055936|54752530|FG001|Overall Study|Adverse Event|1|||
28097097|NCT03055936|54752531|FG002|Overall Study|Adverse Event|1|||
28097098|NCT03055936|54752532|FG003|Overall Study|Adverse Event|1|||
28097099|NCT03055936|54752529|FG000|Overall Study|Personal reason|2|||
28097100|NCT03055936|54752530|FG001|Overall Study|Personal reason|0|||
28097101|NCT03055936|54752531|FG002|Overall Study|Personal reason|1|||
28097102|NCT03055936|54752532|FG003|Overall Study|Personal reason|0|||
28097103|NCT03891524|54752574|FG000|Overall Study|Death|0|||
28097104|NCT03891524|54752575|FG001|Overall Study|Death|0|||
28097105|NCT03891524|54752576|FG002|Overall Study|Death|0|||
28097106|NCT03891524|54752577|FG003|Overall Study|Death|0|||
28097107|NCT03891524|54752578|FG004|Overall Study|Death|0|||
28097108|NCT03891524|54752579|FG005|Overall Study|Death|0|||
28097109|NCT03891524|54752580|FG006|Overall Study|Death|0|||
27897568|NCT03556202|54551625|FG002|Follow-Up Period (12 Weeks)|Withdrawal by Subject|31|||
27897569|NCT03556202|54551623|FG000|Follow-Up Period (12 Weeks)|Physician Decision|0|||
28097110|NCT03891524|54752581|FG007|Overall Study|Death|1|||
28097111|NCT03891524|54752574|FG000|Overall Study|Withdrawal by Subject|0|||
28097112|NCT03891524|54752575|FG001|Overall Study|Withdrawal by Subject|1|||
28097113|NCT03891524|54752576|FG002|Overall Study|Withdrawal by Subject|2|||
28097114|NCT03891524|54752577|FG003|Overall Study|Withdrawal by Subject|1|||
28097115|NCT03891524|54752578|FG004|Overall Study|Withdrawal by Subject|2|||
28097116|NCT03891524|54752579|FG005|Overall Study|Withdrawal by Subject|2|||
28097117|NCT03891524|54752580|FG006|Overall Study|Withdrawal by Subject|2|||
28097118|NCT03891524|54752581|FG007|Overall Study|Withdrawal by Subject|1|||
28097119|NCT03055624|54752616|FG000|Overall Study|Study closed|9|||
28097120|NCT01346176|54752623|FG000|Recruited|Protocol Violation|1|||
28097121|NCT01346176|54752624|FG001|Recruited|Protocol Violation|0|||
28097122|NCT01346176|54752625|FG002|Recruited|Protocol Violation|0|||
28097123|NCT01346176|54752623|FG000|Completed Advance Directive|Death|3|||
28097124|NCT01346176|54752624|FG001|Completed Advance Directive|Death|2|||
28097125|NCT01346176|54752625|FG002|Completed Advance Directive|Death|2|||
28097126|NCT01346176|54752623|FG000|Completed Advance Directive|Became Ineligible|3|||
28097127|NCT01346176|54752624|FG001|Completed Advance Directive|Became Ineligible|0|||
28097128|NCT01346176|54752625|FG002|Completed Advance Directive|Became Ineligible|1|||
28097129|NCT01346176|54752623|FG000|Completed Advance Directive|Other reason did not complete AD|7|||
28097130|NCT01346176|54752624|FG001|Completed Advance Directive|Other reason did not complete AD|12|||
28097131|NCT01346176|54752625|FG002|Completed Advance Directive|Other reason did not complete AD|7|||
28097132|NCT01346176|54752623|FG000|Completed Satisfaction Survey|Death|3|||
28097133|NCT01346176|54752624|FG001|Completed Satisfaction Survey|Death|0|||
28097134|NCT01346176|54752625|FG002|Completed Satisfaction Survey|Death|2|||
28097135|NCT01346176|54752623|FG000|Completed Satisfaction Survey|Lost to Follow-up|3|||
28097136|NCT01346176|54752624|FG001|Completed Satisfaction Survey|Lost to Follow-up|4|||
28097137|NCT01346176|54752625|FG002|Completed Satisfaction Survey|Lost to Follow-up|4|||
28097138|NCT04075604|54752636|FG000|Overall Study|Adverse Event|0|||
28097139|NCT04075604|54752637|FG001|Overall Study|Adverse Event|0|||
28097140|NCT04075604|54752638|FG002|Overall Study|Adverse Event|3|||
28097141|NCT04075604|54752636|FG000|Overall Study|Participant request to discontinue study treatment|0|||
28097142|NCT04075604|54752637|FG001|Overall Study|Participant request to discontinue study treatment|0|||
28097143|NCT04075604|54752638|FG002|Overall Study|Participant request to discontinue study treatment|1|||
28097144|NCT04075604|54752636|FG000|Overall Study|Participant withdrew consent|0|||
28097145|NCT04075604|54752637|FG001|Overall Study|Participant withdrew consent|0|||
28097146|NCT04075604|54752638|FG002|Overall Study|Participant withdrew consent|1|||
28097147|NCT04075604|54752636|FG000|Overall Study|Other reasons|1|||
28097148|NCT04075604|54752637|FG001|Overall Study|Other reasons|0|||
28097149|NCT04075604|54752638|FG002|Overall Study|Other reasons|0|||
28097150|NCT04075604|54752636|FG000|Overall Study|Disease progression|0|||
28097151|NCT04075604|54752637|FG001|Overall Study|Disease progression|1|||
28097152|NCT04075604|54752638|FG002|Overall Study|Disease progression|0|||
28097153|NCT04075604|54752636|FG000|Overall Study|Study drug toxicity|0|||
28097154|NCT04075604|54752637|FG001|Overall Study|Study drug toxicity|5|||
28097155|NCT04075604|54752638|FG002|Overall Study|Study drug toxicity|1|||
28097156|NCT03796208|54752657|FG000|Overall Study|Withdrawal by Subject|3|||
28097157|NCT03796208|54752658|FG001|Overall Study|Withdrawal by Subject|0|||
28097158|NCT03796208|54752657|FG000|Overall Study|Loss of pregnancy|1|||
28097159|NCT03796208|54752658|FG001|Overall Study|Loss of pregnancy|1|||
28097160|NCT03796208|54752657|FG000|Overall Study|Changed prenatal clinics|0|||
28097161|NCT03796208|54752658|FG001|Overall Study|Changed prenatal clinics|5|||
28097162|NCT03796208|54752657|FG000|Overall Study|Lost to Follow-up|20|||
28097163|NCT03796208|54752658|FG001|Overall Study|Lost to Follow-up|16|||
28097164|NCT01318876|54752664|FG000|Day 8 Survey|email address invalid|96|||
28097165|NCT01318876|54752664|FG000|Day 8 Survey|survey not completed-don't know why|1724|||
28097166|NCT01318876|54752664|FG000|Day 29 Survey|survey not completed-don't know why|1825|||
28097167|NCT03668600|54752668|FG000|Overall Study|Study Terminated by the Sponsor|157|||
28097168|NCT03668600|54752668|FG000|Overall Study|Protocol Violation|1|||
28097169|NCT03668600|54752668|FG000|Overall Study|Pregnancy|1|||
28097170|NCT03668600|54752668|FG000|Overall Study|Lost to Follow-up|7|||
28097171|NCT03668600|54752668|FG000|Overall Study|Withdrawal by Subject|56|||
28097172|NCT03668600|54752668|FG000|Overall Study|Lack of Efficacy|7|||
28097173|NCT03668600|54752668|FG000|Overall Study|Adverse Event|1|||
28097174|NCT04073186|54752672|FG000|First Wearing Cycle|Time required to complete last two study visits exceeds study deadline|1|||
28097175|NCT04073186|54752672|FG000|First Wearing Cycle|Withdrawal by Subject|1|||
28097176|NCT04073186|54752672|FG000|First Wearing Cycle|Protocol Violation|1|||
28097177|NCT04073186|54752672|FG000|First Wearing Cycle|Lens Discomfort|2|||
28097178|NCT04073186|54752672|FG000|First Wearing Cycle|Unsatisfactory Visual Response due to Test Article|1|||
28097179|NCT04073186|54752672|FG000|Second Wearing Cycle|Adverse Event|1|||
28097180|NCT03054064|54752677|FG000|Overall Study|Lower Extremity Deep Vein Thrombosis|1|||
28097181|NCT03054064|54752677|FG000|Overall Study|Investigator Decision|2|||
28097182|NCT03054064|54752677|FG000|Overall Study|Bladder Issue|1|||
28097183|NCT03054064|54752677|FG000|Overall Study|High Blood Pressure|1|||
28097184|NCT03054064|54752677|FG000|Overall Study|Change in Status|1|||
28097185|NCT03053518|54752681|FG000|Overall Study|Withdrawal by Subject|3|||
28097186|NCT03053518|54752681|FG000|Overall Study|Lost to Follow-up|2|||
28097187|NCT03053518|54752681|FG000|Overall Study|Ineligible|5|||
28097188|NCT04015336|54752685|FG000|Overall Study|Participant signed consent and was later deemed a screen failure. Participant was not treated|1|||
28097189|NCT04071158|54752708|FG000|Overall Study|Lost to Follow-up|1|||
28097190|NCT04071158|54752709|FG001|Overall Study|Lost to Follow-up|2|||
28097191|NCT04071158|54752710|FG002|Overall Study|Lost to Follow-up|3|||
28097192|NCT04071158|54752711|FG003|Overall Study|Lost to Follow-up|3|||
28097193|NCT04071158|54752712|FG004|Overall Study|Lost to Follow-up|5|||
28097194|NCT04071158|54752708|FG000|Overall Study|Randomized but not treated|2|||
28097195|NCT04071158|54752709|FG001|Overall Study|Randomized but not treated|2|||
28097196|NCT04071158|54752710|FG002|Overall Study|Randomized but not treated|0|||
27897570|NCT03556202|54551624|FG001|Follow-Up Period (12 Weeks)|Physician Decision|3|||
27897571|NCT03556202|54551625|FG002|Follow-Up Period (12 Weeks)|Physician Decision|1|||
27897572|NCT03556202|54551623|FG000|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
27897573|NCT03556202|54551624|FG001|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|1|||
27897574|NCT03556202|54551625|FG002|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
27897575|NCT03556202|54551623|FG000|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|0|||
27897576|NCT03556202|54551624|FG001|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|2|||
27897577|NCT03556202|54551625|FG002|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|1|||
27897578|NCT03556202|54551623|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
27897579|NCT03556202|54551624|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|1|||
27897580|NCT03556202|54551625|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
27897581|NCT03556202|54551623|FG000|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
27897582|NCT03556202|54551624|FG001|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|1|||
27897583|NCT03556202|54551625|FG002|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
27897584|NCT03556202|54551623|FG000|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
27897585|NCT03556202|54551624|FG001|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
27897586|NCT03556202|54551625|FG002|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|1|||
27897587|NCT03556202|54551623|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
27897588|NCT03556202|54551624|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
27897589|NCT03556202|54551625|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|1|||
27897590|NCT03541174|54551639|FG000|Part 1 Double-Blind|Adverse Event|6|||
27897591|NCT03541174|54551640|FG001|Part 1 Double-Blind|Adverse Event|5|||
27897592|NCT03541174|54551641|FG002|Part 1 Double-Blind|Adverse Event|2|||
27897593|NCT03541174|54551642|FG003|Part 1 Double-Blind|Adverse Event|0|||
27897594|NCT03541174|54551643|FG004|Part 1 Double-Blind|Adverse Event|0|||
27897595|NCT03541174|54551644|FG005|Part 1 Double-Blind|Adverse Event|0|||
27897596|NCT03541174|54551639|FG000|Part 1 Double-Blind|Withdrawal by Subject|2|||
27897597|NCT03541174|54551640|FG001|Part 1 Double-Blind|Withdrawal by Subject|2|||
27897598|NCT03541174|54551641|FG002|Part 1 Double-Blind|Withdrawal by Subject|1|||
27897599|NCT03541174|54551642|FG003|Part 1 Double-Blind|Withdrawal by Subject|0|||
27897600|NCT03541174|54551643|FG004|Part 1 Double-Blind|Withdrawal by Subject|0|||
27897601|NCT03541174|54551644|FG005|Part 1 Double-Blind|Withdrawal by Subject|0|||
27897602|NCT03541174|54551639|FG000|Part 1 Double-Blind|Other reasons|3|||
27897603|NCT03541174|54551640|FG001|Part 1 Double-Blind|Other reasons|2|||
27897604|NCT03541174|54551641|FG002|Part 1 Double-Blind|Other reasons|3|||
27897605|NCT03541174|54551642|FG003|Part 1 Double-Blind|Other reasons|0|||
27897606|NCT03541174|54551643|FG004|Part 1 Double-Blind|Other reasons|0|||
27897607|NCT03541174|54551644|FG005|Part 1 Double-Blind|Other reasons|0|||
27897608|NCT03541174|54551639|FG000|Part 2 Single-Blind|Adverse Event|0|||
27897609|NCT03541174|54551640|FG001|Part 2 Single-Blind|Adverse Event|0|||
27897610|NCT03541174|54551641|FG002|Part 2 Single-Blind|Adverse Event|0|||
27897611|NCT03541174|54551642|FG003|Part 2 Single-Blind|Adverse Event|25|||
27897612|NCT03541174|54551643|FG004|Part 2 Single-Blind|Adverse Event|0|||
27897613|NCT03541174|54551644|FG005|Part 2 Single-Blind|Adverse Event|0|||
27897614|NCT03541174|54551639|FG000|Part 2 Single-Blind|Lack of Efficacy|0|||
27897615|NCT03541174|54551640|FG001|Part 2 Single-Blind|Lack of Efficacy|0|||
27897616|NCT03541174|54551641|FG002|Part 2 Single-Blind|Lack of Efficacy|0|||
27897617|NCT03541174|54551642|FG003|Part 2 Single-Blind|Lack of Efficacy|1|||
27897618|NCT03541174|54551643|FG004|Part 2 Single-Blind|Lack of Efficacy|0|||
27897619|NCT03541174|54551644|FG005|Part 2 Single-Blind|Lack of Efficacy|0|||
27897620|NCT03541174|54551639|FG000|Part 2 Single-Blind|Withdrawal by Subject|0|||
27897621|NCT03541174|54551640|FG001|Part 2 Single-Blind|Withdrawal by Subject|0|||
27897622|NCT03541174|54551641|FG002|Part 2 Single-Blind|Withdrawal by Subject|0|||
27897623|NCT03541174|54551642|FG003|Part 2 Single-Blind|Withdrawal by Subject|19|||
27897624|NCT03541174|54551643|FG004|Part 2 Single-Blind|Withdrawal by Subject|0|||
27897625|NCT03541174|54551644|FG005|Part 2 Single-Blind|Withdrawal by Subject|0|||
28097197|NCT04071158|54752711|FG003|Overall Study|Randomized but not treated|0|||
28097198|NCT04071158|54752712|FG004|Overall Study|Randomized but not treated|0|||
28097199|NCT01317940|54752736|FG000|Overall Study|Death|1|||
27897626|NCT03541174|54551639|FG000|Part 2 Single-Blind|Lost to Follow-up|0|||
27897627|NCT03541174|54551640|FG001|Part 2 Single-Blind|Lost to Follow-up|0|||
27897628|NCT03541174|54551641|FG002|Part 2 Single-Blind|Lost to Follow-up|0|||
28097200|NCT01317940|54752737|FG001|Overall Study|Death|0|||
28172065|NCT02718417|54843702|FG000|Maintenance Phase (MP)|Progressive disease|100|||
28097201|NCT01317940|54752738|FG002|Overall Study|Death|1|||
28097202|NCT01317940|54752739|FG003|Overall Study|Death|0|||
28097203|NCT01317940|54752740|FG004|Overall Study|Death|0|||
28097204|NCT01317940|54752741|FG005|Overall Study|Death|0|||
28097205|NCT01317940|54752736|FG000|Overall Study|Lost to Follow-up|0|||
28097206|NCT01317940|54752737|FG001|Overall Study|Lost to Follow-up|0|||
28097207|NCT01317940|54752738|FG002|Overall Study|Lost to Follow-up|1|||
28097208|NCT01317940|54752739|FG003|Overall Study|Lost to Follow-up|1|||
28097209|NCT01317940|54752740|FG004|Overall Study|Lost to Follow-up|1|||
27897629|NCT03541174|54551642|FG003|Part 2 Single-Blind|Lost to Follow-up|8|||
27897630|NCT03541174|54551643|FG004|Part 2 Single-Blind|Lost to Follow-up|0|||
27897631|NCT03541174|54551644|FG005|Part 2 Single-Blind|Lost to Follow-up|0|||
27897632|NCT03541174|54551639|FG000|Part 2 Single-Blind|Death|0|||
27897633|NCT03541174|54551640|FG001|Part 2 Single-Blind|Death|0|||
27897634|NCT03541174|54551641|FG002|Part 2 Single-Blind|Death|0|||
27897635|NCT03541174|54551642|FG003|Part 2 Single-Blind|Death|5|||
27897636|NCT03541174|54551643|FG004|Part 2 Single-Blind|Death|0|||
27897637|NCT03541174|54551644|FG005|Part 2 Single-Blind|Death|0|||
27897638|NCT03541174|54551639|FG000|Part 2 Single-Blind|Pregnancy|0|||
27897639|NCT03541174|54551640|FG001|Part 2 Single-Blind|Pregnancy|0|||
27897640|NCT03541174|54551641|FG002|Part 2 Single-Blind|Pregnancy|0|||
27897641|NCT03541174|54551642|FG003|Part 2 Single-Blind|Pregnancy|1|||
27897642|NCT03541174|54551643|FG004|Part 2 Single-Blind|Pregnancy|0|||
27897643|NCT03541174|54551644|FG005|Part 2 Single-Blind|Pregnancy|0|||
27897644|NCT03541174|54551639|FG000|Part 2 Single-Blind|Other reasons|0|||
27897645|NCT03541174|54551640|FG001|Part 2 Single-Blind|Other reasons|0|||
27897646|NCT03541174|54551641|FG002|Part 2 Single-Blind|Other reasons|0|||
27897647|NCT03541174|54551642|FG003|Part 2 Single-Blind|Other reasons|32|||
27897648|NCT03541174|54551643|FG004|Part 2 Single-Blind|Other reasons|0|||
27897649|NCT03541174|54551644|FG005|Part 2 Single-Blind|Other reasons|0|||
27897650|NCT03541174|54551639|FG000|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
27897651|NCT03541174|54551640|FG001|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
27897652|NCT03541174|54551641|FG002|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
28097210|NCT01317940|54752741|FG005|Overall Study|Lost to Follow-up|0|||
28097211|NCT01317940|54752736|FG000|Overall Study|Change in therapy plan|0|||
27897653|NCT03541174|54551642|FG003|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
27897654|NCT03541174|54551643|FG004|Part 3 Double-Blind Withdrawal|Adverse Event|8|||
27897655|NCT03541174|54551644|FG005|Part 3 Double-Blind Withdrawal|Adverse Event|7|||
27897656|NCT03541174|54551639|FG000|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
27897657|NCT03541174|54551640|FG001|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
27897658|NCT03541174|54551641|FG002|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
27897659|NCT03541174|54551642|FG003|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
27897660|NCT03541174|54551643|FG004|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|1|||
27897661|NCT03541174|54551644|FG005|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|4|||
27897662|NCT03541174|54551639|FG000|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
27897663|NCT03541174|54551640|FG001|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
27897664|NCT03541174|54551641|FG002|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
27897665|NCT03541174|54551642|FG003|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
27897666|NCT03541174|54551643|FG004|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
27985920|NCT02393248|54644418|FG007|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
27985921|NCT02393248|54644419|FG008|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
27985922|NCT02393248|54644420|FG009|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
27985923|NCT02393248|54644421|FG010|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
27985924|NCT02393248|54644422|FG011|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
27985925|NCT02393248|54644423|FG012|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
27985926|NCT02393248|54644424|FG013|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
28097212|NCT01317940|54752737|FG001|Overall Study|Change in therapy plan|0|||
28097213|NCT01317940|54752738|FG002|Overall Study|Change in therapy plan|3|||
28097214|NCT01317940|54752739|FG003|Overall Study|Change in therapy plan|0|||
28097215|NCT01317940|54752740|FG004|Overall Study|Change in therapy plan|0|||
28097216|NCT01317940|54752741|FG005|Overall Study|Change in therapy plan|0|||
27897667|NCT03541174|54551644|FG005|Part 3 Double-Blind Withdrawal|Lost to Follow-up|1|||
27897668|NCT03541174|54551639|FG000|Part 3 Double-Blind Withdrawal|Other reasons|0|||
27897669|NCT03541174|54551640|FG001|Part 3 Double-Blind Withdrawal|Other reasons|0|||
27897670|NCT03541174|54551641|FG002|Part 3 Double-Blind Withdrawal|Other reasons|0|||
27897671|NCT03541174|54551642|FG003|Part 3 Double-Blind Withdrawal|Other reasons|0|||
27897672|NCT03541174|54551643|FG004|Part 3 Double-Blind Withdrawal|Other reasons|9|||
27897673|NCT03541174|54551644|FG005|Part 3 Double-Blind Withdrawal|Other reasons|6|||
27897674|NCT03541174|54551639|FG000|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
27897675|NCT03541174|54551640|FG001|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
27897676|NCT03541174|54551641|FG002|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
28097217|NCT01345786|54752760|FG000|Overall Study|Adverse Event|0|||
28097218|NCT01345786|54752761|FG001|Overall Study|Adverse Event|1|||
28097219|NCT01345786|54752762|FG002|Overall Study|Adverse Event|3|||
27897677|NCT03541174|54551642|FG003|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
27897678|NCT03541174|54551643|FG004|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|1|||
27897679|NCT03541174|54551644|FG005|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
27897680|NCT03289039|54551676|FG000|Overall Study|Withdrawal by Subject|0|||
27897681|NCT03289039|54551677|FG001|Overall Study|Withdrawal by Subject|1|||
27897682|NCT03289039|54551676|FG000|Overall Study|Became ineligible prior to treatment start|0|||
27897683|NCT03289039|54551677|FG001|Overall Study|Became ineligible prior to treatment start|1|||
27897684|NCT03289039|54551676|FG000|Overall Study|progressed before treatment start|1|||
27897685|NCT03289039|54551677|FG001|Overall Study|progressed before treatment start|0|||
27897686|NCT03281304|54551685|FG000|Treatment Phase (up to 42 Months)|Adverse Event|10|||
27897687|NCT03281304|54551686|FG001|Treatment Phase (up to 42 Months)|Adverse Event|10|||
27897688|NCT03281304|54551685|FG000|Treatment Phase (up to 42 Months)|Lack of Efficacy|3|||
27897689|NCT03281304|54551686|FG001|Treatment Phase (up to 42 Months)|Lack of Efficacy|2|||
27897690|NCT03281304|54551685|FG000|Treatment Phase (up to 42 Months)|Pregnancy|1|||
27897691|NCT03281304|54551686|FG001|Treatment Phase (up to 42 Months)|Pregnancy|0|||
27897692|NCT03281304|54551685|FG000|Treatment Phase (up to 42 Months)|Withdrawal by Subject|5|||
27897693|NCT03281304|54551686|FG001|Treatment Phase (up to 42 Months)|Withdrawal by Subject|12|||
27897694|NCT03281304|54551685|FG000|Treatment Phase (up to 42 Months)|Death|0|||
27897695|NCT03281304|54551686|FG001|Treatment Phase (up to 42 Months)|Death|1|||
27897696|NCT03281304|54551685|FG000|Treatment Phase (up to 42 Months)|Study terminated by sponsor|15|||
27897697|NCT03281304|54551686|FG001|Treatment Phase (up to 42 Months)|Study terminated by sponsor|16|||
27897698|NCT03281304|54551685|FG000|Treatment Phase (up to 42 Months)|Other|0|||
27897699|NCT03281304|54551686|FG001|Treatment Phase (up to 42 Months)|Other|2|||
27897700|NCT03281304|54551685|FG000|Follow-up Phase (up to 4 Weeks)|Other|2|||
27897701|NCT03281304|54551686|FG001|Follow-up Phase (up to 4 Weeks)|Other|1|||
27897702|NCT03204305|54551695|FG000|Overall Study|Lost to Follow-up|6|||
27897703|NCT03204305|54551696|FG001|Overall Study|Lost to Follow-up|4|||
27897704|NCT03204305|54551697|FG002|Overall Study|Lost to Follow-up|0|||
27897705|NCT03204305|54551698|FG003|Overall Study|Lost to Follow-up|0|||
27897706|NCT03204305|54551695|FG000|Overall Study|Physician Decision|1|||
27897707|NCT03204305|54551696|FG001|Overall Study|Physician Decision|0|||
27897708|NCT03204305|54551697|FG002|Overall Study|Physician Decision|0|||
27897709|NCT03204305|54551698|FG003|Overall Study|Physician Decision|0|||
27897710|NCT03204305|54551695|FG000|Overall Study|failure to place arterial line|2|||
27897711|NCT03204305|54551696|FG001|Overall Study|failure to place arterial line|1|||
27897712|NCT03204305|54551697|FG002|Overall Study|failure to place arterial line|0|||
27897713|NCT03204305|54551698|FG003|Overall Study|failure to place arterial line|0|||
27897714|NCT03204305|54551695|FG000|Overall Study|Withdrawal by Subject|2|||
27897715|NCT03204305|54551696|FG001|Overall Study|Withdrawal by Subject|0|||
27897716|NCT03204305|54551697|FG002|Overall Study|Withdrawal by Subject|0|||
27897717|NCT03204305|54551698|FG003|Overall Study|Withdrawal by Subject|0|||
27897718|NCT03200717|54551710|FG000|Overall Study|Progressive disease|24|||
27897719|NCT03200717|54551711|FG001|Overall Study|Progressive disease|5|||
27897720|NCT03200717|54551710|FG000|Overall Study|Adverse Event|11|||
27897721|NCT03200717|54551711|FG001|Overall Study|Adverse Event|8|||
27897722|NCT03200717|54551710|FG000|Overall Study|Physician Decision|3|||
27897723|NCT03200717|54551711|FG001|Overall Study|Physician Decision|2|||
27897724|NCT03200717|54551710|FG000|Overall Study|Death|2|||
27897725|NCT03200717|54551711|FG001|Overall Study|Death|0|||
27897726|NCT03200717|54551710|FG000|Overall Study|Subject/Guardian Decision|1|||
27897727|NCT03200717|54551711|FG001|Overall Study|Subject/Guardian Decision|0|||
27897728|NCT03105700|54551720|FG000|Overall Study|screen fail|3|||
27897729|NCT03105700|54551720|FG000|Overall Study|Lost to Follow-up|4|||
27897730|NCT02738853|54551743|FG000|Enrollment|Inclusion/Exclusion not met|21|||
27897731|NCT02738853|54551743|FG000|Enrollment|Withdrawal by Subject|3|||
27897732|NCT02738853|54551743|FG000|Enrollment|Subject treated with commercially available device|6|||
27897733|NCT02738853|54551743|FG000|Enrollment|Study Enrollment Closed|3|||
27897734|NCT02738853|54551743|FG000|Procedure|Death|1|||
27897735|NCT02738853|54551743|FG000|1 Month|Death|2|||
27897736|NCT02738853|54551743|FG000|6 Month|Death|4|||
27985927|NCT02393248|54644425|FG014|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
27897737|NCT02738853|54551743|FG000|6 Month|Withdrawal by Subject|2|||
27897738|NCT02738853|54551743|FG000|1 Year|Death|6|||
27897739|NCT02738853|54551743|FG000|1 Year|Withdrawal by Subject|1|||
27897740|NCT02738853|54551743|FG000|2 Year|Death|2|||
27897741|NCT02738853|54551743|FG000|2 Year|Lost to Follow-up|1|||
27897742|NCT02738853|54551743|FG000|3 Year|Death|2|||
27897743|NCT02738853|54551743|FG000|3 Year|Withdrawal by Subject|1|||
28097220|NCT01345786|54752763|FG003|Overall Study|Adverse Event|1|||
27897744|NCT02738853|54551743|FG000|4 Year|Death|9|||
27897745|NCT02738853|54551743|FG000|5 Year|Lost to Follow-up|4|||
27897746|NCT02358538|54551751|FG000|Through Week 26|Adverse Event|0|||
27897747|NCT02358538|54551752|FG001|Through Week 26|Adverse Event|1|||
27897748|NCT02358538|54551753|FG002|Through Week 26|Adverse Event|1|||
27897749|NCT02358538|54551754|FG003|Through Week 26|Adverse Event|2|||
27897750|NCT02358538|54551751|FG000|Through Week 26|Lack of Efficacy|1|||
27897751|NCT02358538|54551752|FG001|Through Week 26|Lack of Efficacy|1|||
27897752|NCT02358538|54551753|FG002|Through Week 26|Lack of Efficacy|3|||
27897753|NCT02358538|54551754|FG003|Through Week 26|Lack of Efficacy|3|||
27897754|NCT02358538|54551751|FG000|Through Week 26|Withdrawal by Subject|1|||
27897755|NCT02358538|54551752|FG001|Through Week 26|Withdrawal by Subject|0|||
27897756|NCT02358538|54551753|FG002|Through Week 26|Withdrawal by Subject|0|||
27897757|NCT02358538|54551754|FG003|Through Week 26|Withdrawal by Subject|0|||
27897758|NCT02358538|54551751|FG000|Through Week 26|Non-Compliance|0|||
27985928|NCT02393248|54644426|FG015|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
27985929|NCT02393248|54644427|FG016|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
28097221|NCT01345786|54752760|FG000|Overall Study|Subject withdrew consent|2|||
28097222|NCT01345786|54752761|FG001|Overall Study|Subject withdrew consent|2|||
28097223|NCT01345786|54752762|FG002|Overall Study|Subject withdrew consent|1|||
28097224|NCT01345786|54752763|FG003|Overall Study|Subject withdrew consent|0|||
28097225|NCT01345786|54752760|FG000|Overall Study|Noncompliance with protocol|1|||
28097226|NCT01345786|54752761|FG001|Overall Study|Noncompliance with protocol|0|||
28097227|NCT01345786|54752762|FG002|Overall Study|Noncompliance with protocol|1|||
28097228|NCT01345786|54752763|FG003|Overall Study|Noncompliance with protocol|0|||
28097229|NCT01345786|54752760|FG000|Overall Study|Administrative|3|||
28097230|NCT01345786|54752761|FG001|Overall Study|Administrative|5|||
28097231|NCT01345786|54752762|FG002|Overall Study|Administrative|0|||
28097232|NCT01345786|54752763|FG003|Overall Study|Administrative|0|||
28097233|NCT01345786|54752760|FG000|Overall Study|Lost to Follow-up|0|||
28097234|NCT01345786|54752761|FG001|Overall Study|Lost to Follow-up|0|||
27985930|NCT02393248|54644428|FG017|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
27985931|NCT02393248|54644429|FG018|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
27985932|NCT02393248|54644430|FG019|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
27985933|NCT02393248|54644431|FG020|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
27985934|NCT02393248|54644432|FG021|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
27985935|NCT02393248|54644433|FG022|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
27985936|NCT02393248|54644434|FG023|Part 3: Combination Therapy|Study Terminated by Sponsor|2|||
27985937|NCT02393248|54644435|FG024|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
27985938|NCT02393248|54644411|FG000|Part 3: Combination Therapy|Disease Progression|0|||
27985939|NCT02393248|54644412|FG001|Part 3: Combination Therapy|Disease Progression|0|||
27985940|NCT02393248|54644413|FG002|Part 3: Combination Therapy|Disease Progression|0|||
27985941|NCT02393248|54644414|FG003|Part 3: Combination Therapy|Disease Progression|0|||
27985942|NCT02393248|54644415|FG004|Part 3: Combination Therapy|Disease Progression|0|||
27985943|NCT02393248|54644416|FG005|Part 3: Combination Therapy|Disease Progression|0|||
27985944|NCT02393248|54644417|FG006|Part 3: Combination Therapy|Disease Progression|0|||
27985945|NCT02393248|54644418|FG007|Part 3: Combination Therapy|Disease Progression|0|||
27985946|NCT02393248|54644419|FG008|Part 3: Combination Therapy|Disease Progression|0|||
27985947|NCT02393248|54644420|FG009|Part 3: Combination Therapy|Disease Progression|0|||
27985948|NCT02393248|54644421|FG010|Part 3: Combination Therapy|Disease Progression|0|||
27985949|NCT02393248|54644422|FG011|Part 3: Combination Therapy|Disease Progression|0|||
27985950|NCT02393248|54644423|FG012|Part 3: Combination Therapy|Disease Progression|0|||
27985951|NCT02393248|54644424|FG013|Part 3: Combination Therapy|Disease Progression|0|||
27985952|NCT02393248|54644425|FG014|Part 3: Combination Therapy|Disease Progression|0|||
27985953|NCT02393248|54644426|FG015|Part 3: Combination Therapy|Disease Progression|0|||
27985954|NCT02393248|54644427|FG016|Part 3: Combination Therapy|Disease Progression|0|||
27985955|NCT02393248|54644428|FG017|Part 3: Combination Therapy|Disease Progression|0|||
27985956|NCT02393248|54644429|FG018|Part 3: Combination Therapy|Disease Progression|0|||
27985957|NCT02393248|54644430|FG019|Part 3: Combination Therapy|Disease Progression|0|||
27985958|NCT02393248|54644431|FG020|Part 3: Combination Therapy|Disease Progression|2|||
27985959|NCT02393248|54644432|FG021|Part 3: Combination Therapy|Disease Progression|1|||
27985960|NCT02393248|54644433|FG022|Part 3: Combination Therapy|Disease Progression|0|||
27985961|NCT02393248|54644434|FG023|Part 3: Combination Therapy|Disease Progression|0|||
27985962|NCT02393248|54644435|FG024|Part 3: Combination Therapy|Disease Progression|0|||
27985963|NCT02393248|54644411|FG000|Part 3: Combination Therapy|Lost to Follow-up|0|||
27985964|NCT02393248|54644412|FG001|Part 3: Combination Therapy|Lost to Follow-up|0|||
27985965|NCT02393248|54644413|FG002|Part 3: Combination Therapy|Lost to Follow-up|0|||
27985966|NCT02393248|54644414|FG003|Part 3: Combination Therapy|Lost to Follow-up|0|||
27985967|NCT02393248|54644415|FG004|Part 3: Combination Therapy|Lost to Follow-up|0|||
28097235|NCT01345786|54752762|FG002|Overall Study|Lost to Follow-up|0|||
28097236|NCT01345786|54752763|FG003|Overall Study|Lost to Follow-up|2|||
28097237|NCT01317550|54752777|FG000|Overall Study|Withdrawal by Subject|1|||
28097238|NCT01317550|54752778|FG001|Overall Study|Withdrawal by Subject|0|||
28097239|NCT01317550|54752779|FG002|Overall Study|Withdrawal by Subject|0|||
27985968|NCT02393248|54644416|FG005|Part 3: Combination Therapy|Lost to Follow-up|0|||
27985969|NCT02393248|54644417|FG006|Part 3: Combination Therapy|Lost to Follow-up|0|||
27985970|NCT02393248|54644418|FG007|Part 3: Combination Therapy|Lost to Follow-up|0|||
28097240|NCT01317550|54752780|FG003|Overall Study|Withdrawal by Subject|0|||
27897759|NCT02358538|54551752|FG001|Through Week 26|Non-Compliance|0|||
27897760|NCT02358538|54551753|FG002|Through Week 26|Non-Compliance|1|||
27897761|NCT02358538|54551754|FG003|Through Week 26|Non-Compliance|0|||
27897762|NCT02358538|54551751|FG000|Through Week 26|Family did not see benefit from IP|1|||
27897763|NCT02358538|54551752|FG001|Through Week 26|Family did not see benefit from IP|0|||
27897764|NCT02358538|54551753|FG002|Through Week 26|Family did not see benefit from IP|0|||
27897765|NCT02358538|54551754|FG003|Through Week 26|Family did not see benefit from IP|0|||
27897766|NCT02358538|54551751|FG000|52 Week Extension Period|Lack of Efficacy|0|||
27897767|NCT02358538|54551752|FG001|52 Week Extension Period|Lack of Efficacy|0|||
27897768|NCT02358538|54551753|FG002|52 Week Extension Period|Lack of Efficacy|2|||
27897769|NCT02358538|54551754|FG003|52 Week Extension Period|Lack of Efficacy|4|||
27897770|NCT02056119|54551789|FG000|Overall Study|Death|1|||
27897771|NCT02056119|54551790|FG001|Overall Study|Death|2|||
27897772|NCT02056119|54551789|FG000|Overall Study|Intubated for less than 24 hrs|2|||
27897773|NCT02056119|54551790|FG001|Overall Study|Intubated for less than 24 hrs|7|||
27897774|NCT02056119|54551789|FG000|Overall Study|No aerosol treatments were given.|3|||
27897775|NCT02056119|54551790|FG001|Overall Study|No aerosol treatments were given.|2|||
27897776|NCT02056119|54551789|FG000|Overall Study|Received Metaneb treatment|0|||
27897777|NCT02056119|54551790|FG001|Overall Study|Received Metaneb treatment|2|||
27897778|NCT02056119|54551789|FG000|Overall Study|Protocol Violation|4|||
27897779|NCT02056119|54551790|FG001|Overall Study|Protocol Violation|7|||
27897780|NCT02038452|54551798|FG000|Overall Study|Withdrawal by Subject|7|||
27897781|NCT02038452|54551799|FG001|Overall Study|Withdrawal by Subject|9|||
27897782|NCT02038452|54551798|FG000|Overall Study|Lost to Follow-up|31|||
27897783|NCT02038452|54551799|FG001|Overall Study|Lost to Follow-up|28|||
27897784|NCT01238172|54551838|FG000|Overall Study|Ineligible: based on Eligibility Review|2|||
27897785|NCT01238172|54551839|FG001|Overall Study|Ineligible: based on Eligibility Review|5|||
27897786|NCT01238172|54551838|FG000|Overall Study|Ineligible: based on Central Path Review|9|||
27897787|NCT01238172|54551839|FG001|Overall Study|Ineligible: based on Central Path Review|19|||
27897788|NCT00967005|54551847|FG000|Overall Study|Lost to Follow-up|7|||
27897789|NCT00967005|54551848|FG001|Overall Study|Lost to Follow-up|10|||
27897790|NCT00203996|54551906|FG000|Overall Study|Lost to Follow-up|0|||
27897791|NCT00203996|54551907|FG001|Overall Study|Lost to Follow-up|0|||
27897792|NCT00203996|54551908|FG002|Overall Study|Lost to Follow-up|0|||
27897793|NCT00203996|54551909|FG003|Overall Study|Lost to Follow-up|1|||
27897794|NCT00203996|54551910|FG004|Overall Study|Lost to Follow-up|0|||
27897795|NCT00203996|54551911|FG005|Overall Study|Lost to Follow-up|0|||
27897796|NCT00203996|54551912|FG006|Overall Study|Lost to Follow-up|0|||
27897797|NCT00203996|54551913|FG007|Overall Study|Lost to Follow-up|0|||
27897798|NCT00203996|54551914|FG008|Overall Study|Lost to Follow-up|0|||
27897799|NCT00203996|54551915|FG009|Overall Study|Lost to Follow-up|0|||
27897800|NCT00203996|54551906|FG000|Overall Study|Protocol Violation|0|||
27897801|NCT00203996|54551907|FG001|Overall Study|Protocol Violation|0|||
27897802|NCT00203996|54551908|FG002|Overall Study|Protocol Violation|0|||
27897803|NCT00203996|54551909|FG003|Overall Study|Protocol Violation|6|||
27897804|NCT00203996|54551910|FG004|Overall Study|Protocol Violation|1|||
27897805|NCT00203996|54551911|FG005|Overall Study|Protocol Violation|0|||
27897806|NCT00203996|54551912|FG006|Overall Study|Protocol Violation|0|||
27897807|NCT00203996|54551913|FG007|Overall Study|Protocol Violation|0|||
27897808|NCT00203996|54551914|FG008|Overall Study|Protocol Violation|0|||
27897809|NCT00203996|54551915|FG009|Overall Study|Protocol Violation|0|||
27897810|NCT00203996|54551906|FG000|Overall Study|Physician Decision|0|||
27897811|NCT00203996|54551907|FG001|Overall Study|Physician Decision|0|||
27897812|NCT00203996|54551908|FG002|Overall Study|Physician Decision|0|||
27897813|NCT00203996|54551909|FG003|Overall Study|Physician Decision|2|||
27897814|NCT00203996|54551910|FG004|Overall Study|Physician Decision|0|||
27897815|NCT00203996|54551911|FG005|Overall Study|Physician Decision|0|||
27897816|NCT00203996|54551912|FG006|Overall Study|Physician Decision|0|||
27897817|NCT00203996|54551913|FG007|Overall Study|Physician Decision|0|||
27897818|NCT00203996|54551914|FG008|Overall Study|Physician Decision|0|||
27897819|NCT00203996|54551915|FG009|Overall Study|Physician Decision|1|||
27897820|NCT00203996|54551906|FG000|Overall Study|CPAP machine malfunction|0|||
27897821|NCT00203996|54551907|FG001|Overall Study|CPAP machine malfunction|0|||
27897822|NCT00203996|54551908|FG002|Overall Study|CPAP machine malfunction|0|||
27897823|NCT00203996|54551909|FG003|Overall Study|CPAP machine malfunction|1|||
27897824|NCT00203996|54551910|FG004|Overall Study|CPAP machine malfunction|0|||
27897825|NCT00203996|54551911|FG005|Overall Study|CPAP machine malfunction|0|||
27897826|NCT00203996|54551912|FG006|Overall Study|CPAP machine malfunction|0|||
27897827|NCT00203996|54551913|FG007|Overall Study|CPAP machine malfunction|0|||
27897828|NCT00203996|54551914|FG008|Overall Study|CPAP machine malfunction|0|||
27897829|NCT00203996|54551915|FG009|Overall Study|CPAP machine malfunction|0|||
27897830|NCT00203996|54551906|FG000|Overall Study|Scheduling issue|0|||
27897831|NCT00203996|54551907|FG001|Overall Study|Scheduling issue|0|||
27897832|NCT00203996|54551908|FG002|Overall Study|Scheduling issue|0|||
27897833|NCT00203996|54551909|FG003|Overall Study|Scheduling issue|0|||
27897834|NCT00203996|54551910|FG004|Overall Study|Scheduling issue|0|||
27897835|NCT00203996|54551911|FG005|Overall Study|Scheduling issue|0|||
27897836|NCT00203996|54551912|FG006|Overall Study|Scheduling issue|0|||
27897837|NCT00203996|54551913|FG007|Overall Study|Scheduling issue|2|||
27897838|NCT00203996|54551914|FG008|Overall Study|Scheduling issue|0|||
27897839|NCT00203996|54551915|FG009|Overall Study|Scheduling issue|0|||
27897840|NCT02014558|54551944|FG000|Overall Study|Never Received Study Drug|0|||
27897841|NCT02014558|54551945|FG001|Overall Study|Never Received Study Drug|0|||
27897842|NCT02014558|54551946|FG002|Overall Study|Never Received Study Drug|0|||
27897843|NCT02014558|54551947|FG003|Overall Study|Never Received Study Drug|0|||
27985971|NCT02393248|54644419|FG008|Part 3: Combination Therapy|Lost to Follow-up|0|||
27985972|NCT02393248|54644420|FG009|Part 3: Combination Therapy|Lost to Follow-up|0|||
27985973|NCT02393248|54644421|FG010|Part 3: Combination Therapy|Lost to Follow-up|0|||
27985974|NCT02393248|54644422|FG011|Part 3: Combination Therapy|Lost to Follow-up|0|||
27985975|NCT02393248|54644423|FG012|Part 3: Combination Therapy|Lost to Follow-up|0|||
27985976|NCT02393248|54644424|FG013|Part 3: Combination Therapy|Lost to Follow-up|0|||
27985977|NCT02393248|54644425|FG014|Part 3: Combination Therapy|Lost to Follow-up|0|||
27985978|NCT02393248|54644426|FG015|Part 3: Combination Therapy|Lost to Follow-up|0|||
27985979|NCT02393248|54644427|FG016|Part 3: Combination Therapy|Lost to Follow-up|0|||
27985980|NCT02393248|54644428|FG017|Part 3: Combination Therapy|Lost to Follow-up|0|||
27985981|NCT02393248|54644429|FG018|Part 3: Combination Therapy|Lost to Follow-up|0|||
27985982|NCT02393248|54644430|FG019|Part 3: Combination Therapy|Lost to Follow-up|0|||
27985983|NCT02393248|54644431|FG020|Part 3: Combination Therapy|Lost to Follow-up|1|||
27985984|NCT02393248|54644432|FG021|Part 3: Combination Therapy|Lost to Follow-up|1|||
27985985|NCT02393248|54644433|FG022|Part 3: Combination Therapy|Lost to Follow-up|0|||
27985986|NCT02393248|54644434|FG023|Part 3: Combination Therapy|Lost to Follow-up|0|||
27985987|NCT02393248|54644435|FG024|Part 3: Combination Therapy|Lost to Follow-up|0|||
27985988|NCT02393248|54644411|FG000|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
27985989|NCT02393248|54644412|FG001|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
27985990|NCT02393248|54644413|FG002|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
27985991|NCT02393248|54644414|FG003|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
27985992|NCT02393248|54644415|FG004|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
27985993|NCT02393248|54644416|FG005|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
27985994|NCT02393248|54644417|FG006|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
27985995|NCT02393248|54644418|FG007|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
27985996|NCT02393248|54644419|FG008|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
27985997|NCT02393248|54644420|FG009|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
27897844|NCT02014558|54551948|FG004|Overall Study|Never Received Study Drug|1|||
27897845|NCT02014558|54551949|FG005|Overall Study|Never Received Study Drug|0|||
27897846|NCT02014558|54551950|FG006|Overall Study|Never Received Study Drug|1|||
27897847|NCT02014558|54551951|FG007|Overall Study|Never Received Study Drug|0|||
27897848|NCT02014558|54551952|FG008|Overall Study|Never Received Study Drug|2|||
27897849|NCT02014558|54551953|FG009|Overall Study|Never Received Study Drug|0|||
27897850|NCT02014558|54551954|FG010|Overall Study|Never Received Study Drug|2|||
27897851|NCT02014558|54551955|FG011|Overall Study|Never Received Study Drug|2|||
27897852|NCT02014558|54551956|FG012|Overall Study|Never Received Study Drug|0|||
27897853|NCT02014558|54551944|FG000|Overall Study|Adverse Event|0|||
27897854|NCT02014558|54551945|FG001|Overall Study|Adverse Event|0|||
27897855|NCT02014558|54551946|FG002|Overall Study|Adverse Event|0|||
27897856|NCT02014558|54551947|FG003|Overall Study|Adverse Event|0|||
27897857|NCT02014558|54551948|FG004|Overall Study|Adverse Event|1|||
27897858|NCT02014558|54551949|FG005|Overall Study|Adverse Event|0|||
27897859|NCT02014558|54551950|FG006|Overall Study|Adverse Event|0|||
27897860|NCT02014558|54551951|FG007|Overall Study|Adverse Event|0|||
27897861|NCT02014558|54551952|FG008|Overall Study|Adverse Event|2|||
27897862|NCT02014558|54551953|FG009|Overall Study|Adverse Event|2|||
27897863|NCT02014558|54551954|FG010|Overall Study|Adverse Event|5|||
27897864|NCT02014558|54551955|FG011|Overall Study|Adverse Event|21|||
27897865|NCT02014558|54551956|FG012|Overall Study|Adverse Event|3|||
27897866|NCT02014558|54551944|FG000|Overall Study|Death|1|||
27897867|NCT02014558|54551945|FG001|Overall Study|Death|0|||
27897868|NCT02014558|54551946|FG002|Overall Study|Death|0|||
27897869|NCT02014558|54551947|FG003|Overall Study|Death|0|||
27897870|NCT02014558|54551948|FG004|Overall Study|Death|0|||
27897871|NCT02014558|54551949|FG005|Overall Study|Death|0|||
27897872|NCT02014558|54551950|FG006|Overall Study|Death|1|||
27897873|NCT02014558|54551951|FG007|Overall Study|Death|1|||
27897874|NCT02014558|54551952|FG008|Overall Study|Death|2|||
27897875|NCT02014558|54551953|FG009|Overall Study|Death|5|||
27897876|NCT02014558|54551954|FG010|Overall Study|Death|5|||
28097241|NCT01317550|54752777|FG000|Overall Study|Lack of compliance study med|1|||
27897877|NCT02014558|54551955|FG011|Overall Study|Death|19|||
27897878|NCT02014558|54551956|FG012|Overall Study|Death|2|||
27897879|NCT02014558|54551944|FG000|Overall Study|Lack of Efficacy|1|||
27897880|NCT02014558|54551945|FG001|Overall Study|Lack of Efficacy|2|||
27897881|NCT02014558|54551946|FG002|Overall Study|Lack of Efficacy|1|||
27897882|NCT02014558|54551947|FG003|Overall Study|Lack of Efficacy|1|||
27897883|NCT02014558|54551948|FG004|Overall Study|Lack of Efficacy|0|||
27897884|NCT02014558|54551949|FG005|Overall Study|Lack of Efficacy|0|||
27897885|NCT02014558|54551950|FG006|Overall Study|Lack of Efficacy|1|||
27897886|NCT02014558|54551951|FG007|Overall Study|Lack of Efficacy|3|||
27897887|NCT02014558|54551952|FG008|Overall Study|Lack of Efficacy|3|||
27897888|NCT02014558|54551953|FG009|Overall Study|Lack of Efficacy|3|||
27897889|NCT02014558|54551954|FG010|Overall Study|Lack of Efficacy|16|||
27897890|NCT02014558|54551955|FG011|Overall Study|Lack of Efficacy|8|||
27897891|NCT02014558|54551956|FG012|Overall Study|Lack of Efficacy|5|||
27897892|NCT02014558|54551944|FG000|Overall Study|Lost to Follow-up|0|||
27897893|NCT02014558|54551945|FG001|Overall Study|Lost to Follow-up|0|||
27897894|NCT02014558|54551946|FG002|Overall Study|Lost to Follow-up|0|||
27897895|NCT02014558|54551947|FG003|Overall Study|Lost to Follow-up|0|||
27897896|NCT02014558|54551948|FG004|Overall Study|Lost to Follow-up|0|||
27897897|NCT02014558|54551949|FG005|Overall Study|Lost to Follow-up|0|||
27897898|NCT02014558|54551950|FG006|Overall Study|Lost to Follow-up|0|||
27897899|NCT02014558|54551951|FG007|Overall Study|Lost to Follow-up|0|||
27897900|NCT02014558|54551952|FG008|Overall Study|Lost to Follow-up|0|||
27897901|NCT02014558|54551953|FG009|Overall Study|Lost to Follow-up|0|||
27897902|NCT02014558|54551954|FG010|Overall Study|Lost to Follow-up|1|||
27897903|NCT02014558|54551955|FG011|Overall Study|Lost to Follow-up|0|||
27897904|NCT02014558|54551956|FG012|Overall Study|Lost to Follow-up|0|||
27897905|NCT02014558|54551944|FG000|Overall Study|Progressive Disease|1|||
27897906|NCT02014558|54551945|FG001|Overall Study|Progressive Disease|0|||
27897907|NCT02014558|54551946|FG002|Overall Study|Progressive Disease|1|||
27897908|NCT02014558|54551947|FG003|Overall Study|Progressive Disease|1|||
27897909|NCT02014558|54551948|FG004|Overall Study|Progressive Disease|1|||
27897910|NCT02014558|54551949|FG005|Overall Study|Progressive Disease|2|||
27897911|NCT02014558|54551950|FG006|Overall Study|Progressive Disease|1|||
27897912|NCT02014558|54551951|FG007|Overall Study|Progressive Disease|6|||
27897913|NCT02014558|54551952|FG008|Overall Study|Progressive Disease|5|||
27897914|NCT02014558|54551953|FG009|Overall Study|Progressive Disease|6|||
27897915|NCT02014558|54551954|FG010|Overall Study|Progressive Disease|22|||
27897916|NCT02014558|54551955|FG011|Overall Study|Progressive Disease|31|||
27897917|NCT02014558|54551956|FG012|Overall Study|Progressive Disease|6|||
27897918|NCT02014558|54551944|FG000|Overall Study|Withdrawal by Subject|0|||
27897919|NCT02014558|54551945|FG001|Overall Study|Withdrawal by Subject|0|||
27897920|NCT02014558|54551946|FG002|Overall Study|Withdrawal by Subject|0|||
27897921|NCT02014558|54551947|FG003|Overall Study|Withdrawal by Subject|0|||
27897922|NCT02014558|54551948|FG004|Overall Study|Withdrawal by Subject|1|||
27897923|NCT02014558|54551949|FG005|Overall Study|Withdrawal by Subject|0|||
27897924|NCT02014558|54551950|FG006|Overall Study|Withdrawal by Subject|0|||
27897925|NCT02014558|54551951|FG007|Overall Study|Withdrawal by Subject|0|||
27897926|NCT02014558|54551952|FG008|Overall Study|Withdrawal by Subject|0|||
27897927|NCT02014558|54551953|FG009|Overall Study|Withdrawal by Subject|2|||
27897928|NCT02014558|54551954|FG010|Overall Study|Withdrawal by Subject|6|||
27897929|NCT02014558|54551955|FG011|Overall Study|Withdrawal by Subject|10|||
27897930|NCT02014558|54551956|FG012|Overall Study|Withdrawal by Subject|0|||
27897931|NCT02014558|54551944|FG000|Overall Study|Miscellaneous|2|||
27897932|NCT02014558|54551945|FG001|Overall Study|Miscellaneous|1|||
27897933|NCT02014558|54551946|FG002|Overall Study|Miscellaneous|1|||
27897934|NCT02014558|54551947|FG003|Overall Study|Miscellaneous|1|||
27897935|NCT02014558|54551948|FG004|Overall Study|Miscellaneous|0|||
27897936|NCT02014558|54551949|FG005|Overall Study|Miscellaneous|1|||
27897937|NCT02014558|54551950|FG006|Overall Study|Miscellaneous|0|||
27897938|NCT02014558|54551951|FG007|Overall Study|Miscellaneous|1|||
27897939|NCT02014558|54551952|FG008|Overall Study|Miscellaneous|1|||
27897940|NCT02014558|54551953|FG009|Overall Study|Miscellaneous|3|||
27897941|NCT02014558|54551954|FG010|Overall Study|Miscellaneous|12|||
27897942|NCT02014558|54551955|FG011|Overall Study|Miscellaneous|11|||
27897943|NCT02014558|54551956|FG012|Overall Study|Miscellaneous|1|||
27985998|NCT02393248|54644421|FG010|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
27897944|NCT02024555|54552011|FG000|Overall Study|Lost to Follow-up|1|||
27897945|NCT02024555|54552012|FG001|Overall Study|Lost to Follow-up|1|||
27897946|NCT02024555|54552011|FG000|Overall Study|Withdrawal by Subject|5|||
28097242|NCT01317550|54752778|FG001|Overall Study|Lack of compliance study med|0|||
27897947|NCT02024555|54552012|FG001|Overall Study|Withdrawal by Subject|1|||
27897948|NCT02040584|54552020|FG000|Overall Study|Adverse Event|13|||
27897949|NCT02040584|54552021|FG001|Overall Study|Adverse Event|6|||
27897950|NCT02040584|54552020|FG000|Overall Study|Protocol Violation|9|||
27897951|NCT02040584|54552021|FG001|Overall Study|Protocol Violation|11|||
27897952|NCT02040584|54552020|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
27897953|NCT02040584|54552021|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
27897954|NCT02040584|54552020|FG000|Overall Study|Death|6|||
27897955|NCT02040584|54552021|FG001|Overall Study|Death|3|||
27897956|NCT02040584|54552020|FG000|Overall Study|Transplant rejection/retransplant|0|||
27897957|NCT02040584|54552021|FG001|Overall Study|Transplant rejection/retransplant|1|||
27897958|NCT02040584|54552020|FG000|Overall Study|Immunosuppressant/prohibited med use|7|||
27897959|NCT02040584|54552021|FG001|Overall Study|Immunosuppressant/prohibited med use|10|||
27897960|NCT02045797|54552040|FG000|Overall Study|Adverse Event|3|||
27897961|NCT02045797|54552041|FG001|Overall Study|Adverse Event|1|||
27897962|NCT02045797|54552042|FG002|Overall Study|Adverse Event|0|||
27897963|NCT02045797|54552040|FG000|Overall Study|Lack of Efficacy|1|||
27897964|NCT02045797|54552041|FG001|Overall Study|Lack of Efficacy|0|||
27897965|NCT02045797|54552042|FG002|Overall Study|Lack of Efficacy|0|||
27897966|NCT02045797|54552040|FG000|Overall Study|Lost to Follow-up|2|||
27897967|NCT02045797|54552041|FG001|Overall Study|Lost to Follow-up|3|||
27897968|NCT02045797|54552042|FG002|Overall Study|Lost to Follow-up|1|||
27897969|NCT02045797|54552040|FG000|Overall Study|Physician Decision|0|||
27897970|NCT02045797|54552041|FG001|Overall Study|Physician Decision|1|||
27897971|NCT02045797|54552042|FG002|Overall Study|Physician Decision|0|||
27897972|NCT02045797|54552040|FG000|Overall Study|Withdrawal by Subject|1|||
27897973|NCT02045797|54552041|FG001|Overall Study|Withdrawal by Subject|2|||
27897974|NCT02045797|54552042|FG002|Overall Study|Withdrawal by Subject|0|||
27897975|NCT03385239|54552072|FG000|Overall Study|Voluntary Withdrawal|2|||
27897976|NCT03385239|54552073|FG001|Overall Study|Voluntary Withdrawal|3|||
27897977|NCT03385239|54552074|FG002|Overall Study|Voluntary Withdrawal|2|||
27897978|NCT03385239|54552075|FG003|Overall Study|Voluntary Withdrawal|3|||
27897979|NCT03385239|54552076|FG004|Overall Study|Voluntary Withdrawal|0|||
27897980|NCT03385239|54552072|FG000|Overall Study|Adverse Event|0|||
27897981|NCT03385239|54552073|FG001|Overall Study|Adverse Event|0|||
27897982|NCT03385239|54552074|FG002|Overall Study|Adverse Event|1|||
27897983|NCT03385239|54552075|FG003|Overall Study|Adverse Event|0|||
27897984|NCT03385239|54552076|FG004|Overall Study|Adverse Event|0|||
27897985|NCT03385239|54552072|FG000|Overall Study|Other|0|||
27897986|NCT03385239|54552073|FG001|Overall Study|Other|0|||
27897987|NCT03385239|54552074|FG002|Overall Study|Other|0|||
27897988|NCT03385239|54552075|FG003|Overall Study|Other|1|||
27897989|NCT03385239|54552076|FG004|Overall Study|Other|0|||
27897990|NCT03020160|54552094|FG000|Overall Study|Withdrawal by Subject|1|||
27897991|NCT03020160|54552095|FG001|Overall Study|Withdrawal by Subject|0|||
27897992|NCT02593110|54552106|FG000|Overall Study|Withdrawal by Subject|0|||
27897993|NCT02593110|54552107|FG001|Overall Study|Withdrawal by Subject|3|||
27897994|NCT02593110|54552108|FG002|Overall Study|Withdrawal by Subject|3|||
27897995|NCT02593110|54552109|FG003|Overall Study|Withdrawal by Subject|2|||
27897996|NCT02593110|54552106|FG000|Overall Study|Death|0|||
27897997|NCT02593110|54552107|FG001|Overall Study|Death|0|||
27897998|NCT02593110|54552108|FG002|Overall Study|Death|1|||
27897999|NCT02593110|54552109|FG003|Overall Study|Death|0|||
27898000|NCT02373813|54552122|FG000|Run-In Period|Other, Not Specified|5|||
27898001|NCT02373813|54552123|FG001|Run-In Period|Other, Not Specified|0|||
27898002|NCT02373813|54552124|FG002|Run-In Period|Other, Not Specified|0|||
27898003|NCT02373813|54552125|FG003|Run-In Period|Other, Not Specified|0|||
27898004|NCT02373813|54552122|FG000|Run-In Period|Withdrawal by Subject|16|||
27898005|NCT02373813|54552123|FG001|Run-In Period|Withdrawal by Subject|0|||
27898006|NCT02373813|54552124|FG002|Run-In Period|Withdrawal by Subject|0|||
27898007|NCT02373813|54552125|FG003|Run-In Period|Withdrawal by Subject|0|||
27898008|NCT02373813|54552122|FG000|Run-In Period|Decision by Sponsor|11|||
27898009|NCT02373813|54552123|FG001|Run-In Period|Decision by Sponsor|0|||
27898010|NCT02373813|54552124|FG002|Run-In Period|Decision by Sponsor|0|||
27898011|NCT02373813|54552125|FG003|Run-In Period|Decision by Sponsor|0|||
27898012|NCT02373813|54552122|FG000|Run-In Period|Protocol Violation|75|||
27898013|NCT02373813|54552123|FG001|Run-In Period|Protocol Violation|0|||
27898014|NCT02373813|54552124|FG002|Run-In Period|Protocol Violation|0|||
27898015|NCT02373813|54552125|FG003|Run-In Period|Protocol Violation|0|||
27898016|NCT02373813|54552122|FG000|Run-In Period|Lost to Follow-up|2|||
27898017|NCT02373813|54552123|FG001|Run-In Period|Lost to Follow-up|0|||
27898018|NCT02373813|54552124|FG002|Run-In Period|Lost to Follow-up|0|||
27898019|NCT02373813|54552125|FG003|Run-In Period|Lost to Follow-up|0|||
27898020|NCT02373813|54552122|FG000|Run-In Period|Adverse Event|3|||
27898021|NCT02373813|54552123|FG001|Run-In Period|Adverse Event|0|||
27898022|NCT02373813|54552124|FG002|Run-In Period|Adverse Event|0|||
27898023|NCT02373813|54552125|FG003|Run-In Period|Adverse Event|0|||
27898024|NCT02373813|54552122|FG000|Run-In Period|Noncompliance|1|||
27898025|NCT02373813|54552123|FG001|Run-In Period|Noncompliance|0|||
27898026|NCT02373813|54552124|FG002|Run-In Period|Noncompliance|0|||
27898027|NCT02373813|54552125|FG003|Run-In Period|Noncompliance|0|||
27898028|NCT02373813|54552122|FG000|Run-In Period|Ineligibility Determined|3|||
27898029|NCT02373813|54552123|FG001|Run-In Period|Ineligibility Determined|0|||
27898030|NCT02373813|54552124|FG002|Run-In Period|Ineligibility Determined|0|||
27898031|NCT02373813|54552125|FG003|Run-In Period|Ineligibility Determined|0|||
27898032|NCT02373813|54552122|FG000|Double-Blind Treatment Period|Decision by Sponsor|0|||
27898033|NCT02373813|54552123|FG001|Double-Blind Treatment Period|Decision by Sponsor|1|||
27898034|NCT02373813|54552124|FG002|Double-Blind Treatment Period|Decision by Sponsor|2|||
27898035|NCT02373813|54552125|FG003|Double-Blind Treatment Period|Decision by Sponsor|0|||
27898036|NCT02373813|54552122|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
27898037|NCT02373813|54552123|FG001|Double-Blind Treatment Period|Protocol Violation|2|||
27898038|NCT02373813|54552124|FG002|Double-Blind Treatment Period|Protocol Violation|0|||
27898039|NCT02373813|54552125|FG003|Double-Blind Treatment Period|Protocol Violation|0|||
27898040|NCT02373813|54552122|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
27898041|NCT02373813|54552123|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
27898042|NCT02373813|54552124|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
27898043|NCT02373813|54552125|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
27898044|NCT02373813|54552122|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
27898045|NCT02373813|54552123|FG001|Double-Blind Treatment Period|Withdrawal by Subject|10|||
27898046|NCT02373813|54552124|FG002|Double-Blind Treatment Period|Withdrawal by Subject|6|||
27898047|NCT02373813|54552125|FG003|Double-Blind Treatment Period|Withdrawal by Subject|3|||
27898048|NCT01853748|54552142|FG000|Allocation|Withdrawal by Subject|1|||
27898049|NCT01853748|54552143|FG001|Allocation|Withdrawal by Subject|13|||
27898050|NCT01853748|54552142|FG000|Allocation|not sufficient to receive intervention|0|||
27898051|NCT01853748|54552143|FG001|Allocation|not sufficient to receive intervention|1|||
27898052|NCT01853748|54552142|FG000|Follow-Up|Withdrawal by Subject|7|||
27898053|NCT01853748|54552143|FG001|Follow-Up|Withdrawal by Subject|6|||
27898054|NCT01853748|54552142|FG000|Follow-Up|Adverse Event|67|||
27898055|NCT01853748|54552143|FG001|Follow-Up|Adverse Event|7|||
27898056|NCT01853748|54552142|FG000|Follow-Up|not available for data collection|16|||
28172066|NCT02718417|54843703|FG001|Maintenance Phase (MP)|Progressive disease|88|||
28172067|NCT02718417|54843704|FG002|Maintenance Phase (MP)|Progressive disease|0|||
28172068|NCT02718417|54843702|FG000|Maintenance Phase (MP)|Other|2|||
28172069|NCT02718417|54843703|FG001|Maintenance Phase (MP)|Other|1|||
28172070|NCT02718417|54843704|FG002|Maintenance Phase (MP)|Other|0|||
28172071|NCT02718417|54843702|FG000|Maintenance Phase (MP)|Withdrawal by Subject|17|||
28172072|NCT02718417|54843703|FG001|Maintenance Phase (MP)|Withdrawal by Subject|20|||
28172073|NCT02718417|54843704|FG002|Maintenance Phase (MP)|Withdrawal by Subject|0|||
28172074|NCT02718417|54843702|FG000|Maintenance Phase (MP)|Study terminated by sponsor|114|||
28172075|NCT02718417|54843703|FG001|Maintenance Phase (MP)|Study terminated by sponsor|140|||
27898057|NCT01853748|54552143|FG001|Follow-Up|not available for data collection|4|||
27898058|NCT03116347|54552190|FG000|Overall Study|Withdrawal by Subject|1|||
27898059|NCT03116347|54552191|FG001|Overall Study|Withdrawal by Subject|2|||
27898060|NCT00001213|54552237|FG000|Overall Study|Death|18|||
27898061|NCT00000135|54552243|FG000|Overall Study|Death|27|||
27898062|NCT00000135|54552244|FG001|Overall Study|Death|14|||
27898063|NCT00001723|54552252|FG000|Overall Study|Lack of Efficacy|6|||
27898064|NCT00001723|54552253|FG001|Overall Study|Lack of Efficacy|7|||
27898065|NCT00001723|54552252|FG000|Overall Study|Lack of family interest|4|||
27898066|NCT00001723|54552253|FG001|Overall Study|Lack of family interest|5|||
27898067|NCT00001723|54552252|FG000|Overall Study|Lost to Follow-up|2|||
27898068|NCT00001723|54552253|FG001|Overall Study|Lost to Follow-up|2|||
27898069|NCT00001723|54552252|FG000|Overall Study|medication intolerance|1|||
27898070|NCT00001723|54552253|FG001|Overall Study|medication intolerance|2|||
27898071|NCT00000378|54552275|FG000|Overall Study|Lack of Efficacy|16|||
27898072|NCT00000378|54552276|FG001|Overall Study|Lack of Efficacy|14|||
27898073|NCT01350115|54552284|FG000|Long Term Follow-Up (All Patients)|Lost to Follow-up|0|||
27898074|NCT01350115|54552285|FG001|Long Term Follow-Up (All Patients)|Lost to Follow-up|1|||
27898075|NCT01350115|54552284|FG000|Long Term Follow-Up (All Patients)|Adverse Event|0|||
27898076|NCT01350115|54552285|FG001|Long Term Follow-Up (All Patients)|Adverse Event|1|||
27898077|NCT01350115|54552284|FG000|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1|||
27898078|NCT01350115|54552285|FG001|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0|||
27898079|NCT04142983|54552293|FG000|Overall Study|Lost to Follow-up|73|||
27898080|NCT04142983|54552293|FG000|Overall Study|Withdrawal by Subject|10|||
27898081|NCT04142983|54552293|FG000|Overall Study|Physician Decision|1|||
27898082|NCT04142983|54552293|FG000|Overall Study|Adverse Event|1|||
27898083|NCT04142983|54552293|FG000|Overall Study|No longer eligible|4|||
27898084|NCT04142983|54552293|FG000|Overall Study|Screen Failure|10|||
27898085|NCT03801031|54552300|FG000|Overall Study|Lost to Follow-up|1|||
27898086|NCT03801031|54552301|FG001|Overall Study|Lost to Follow-up|0|||
27898087|NCT03801031|54552300|FG000|Overall Study|Unable to comply|1|||
27898088|NCT03801031|54552301|FG001|Overall Study|Unable to comply|0|||
27898089|NCT03801031|54552300|FG000|Overall Study|Withdrawal by Subject|0|||
27898090|NCT03801031|54552301|FG001|Overall Study|Withdrawal by Subject|1|||
28172076|NCT02718417|54843704|FG002|Maintenance Phase (MP)|Study terminated by sponsor|0|||
28172077|NCT02718417|54843702|FG000|Observation Phase (OP)|Adverse Event|0|||
28172078|NCT02718417|54843703|FG001|Observation Phase (OP)|Adverse Event|0|||
27898091|NCT03357952|54552309|FG000|Overall Study|Withdrawal by Subject|0|||
27898092|NCT03357952|54552310|FG001|Overall Study|Withdrawal by Subject|1|||
27898093|NCT03357952|54552309|FG000|Overall Study|Sponsor Decision|9|||
27898094|NCT03357952|54552310|FG001|Overall Study|Sponsor Decision|0|||
27898095|NCT03055858|54552316|FG000|Overall Study|Death|9|||
27898096|NCT03055858|54552316|FG000|Overall Study|Withdrawal by Subject|11|||
27898097|NCT03055858|54552316|FG000|Overall Study|Lost to Follow-up|6|||
27898098|NCT03055858|54552316|FG000|Overall Study|Missed Follow-Up Visits|18|||
27898099|NCT02773849|54552343|FG000|Overall Study|Adverse Event|3|||
27898100|NCT02773849|54552343|FG000|Overall Study|Lack of Efficacy|89|||
27898101|NCT02773849|54552343|FG000|Overall Study|Withdrawal by Subject|1|||
27898102|NCT02773849|54552343|FG000|Overall Study|Withdrawal of Consent|1|||
27898103|NCT02393716|54552351|FG000|Overall Study|Death|29|||
27898104|NCT02393716|54552351|FG000|Overall Study|Withdrawal by Subject|8|||
27898105|NCT02393716|54552351|FG000|Overall Study|Device Explanted|8|||
27898106|NCT02393716|54552351|FG000|Overall Study|Missed visit|16|||
27898107|NCT01804816|54552356|FG000|No Acupuncture (Initial 5 Weeks)|Withdrawal by Subject|3|||
27898108|NCT01804816|54552356|FG000|Acupuncture (Second 5 Weeks)|Physician Decision|1|||
27898109|NCT00584233|54552363|FG000|Overall Study|Withdrawal by Subject|5|||
27898110|NCT00584233|54552363|FG000|Overall Study|Subjects did not complete both CT and MRI to be evaluated in results|13|||
27898111|NCT00001566|54552375|FG000|Overall Study|patients' choice to discontinue protocol|3|||
27898112|NCT00001566|54552375|FG000|Overall Study|stopped after C3 due to symptomatic PD|1|||
27898113|NCT00001566|54552375|FG000|Overall Study|Death|13|||
27898114|NCT00001566|54552375|FG000|Overall Study|Lost to Follow-up|1|||
27985999|NCT02393248|54644422|FG011|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
27986000|NCT02393248|54644423|FG012|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
27986001|NCT02393248|54644424|FG013|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
27986002|NCT02393248|54644425|FG014|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
27986003|NCT02393248|54644426|FG015|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
27986004|NCT02393248|54644427|FG016|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
27986005|NCT02393248|54644428|FG017|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
27986006|NCT02393248|54644429|FG018|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
27986007|NCT02393248|54644430|FG019|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
27986008|NCT02393248|54644431|FG020|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|1|||
27986009|NCT02393248|54644432|FG021|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
27986010|NCT02393248|54644433|FG022|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
27986011|NCT02393248|54644434|FG023|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
27986012|NCT02393248|54644435|FG024|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
27986013|NCT02393248|54644411|FG000|Part 3: Combination Therapy|Adverse Event|0|||
27986014|NCT02393248|54644412|FG001|Part 3: Combination Therapy|Adverse Event|0|||
27986015|NCT02393248|54644413|FG002|Part 3: Combination Therapy|Adverse Event|0|||
27986016|NCT02393248|54644414|FG003|Part 3: Combination Therapy|Adverse Event|0|||
27986017|NCT02393248|54644415|FG004|Part 3: Combination Therapy|Adverse Event|0|||
27986018|NCT02393248|54644416|FG005|Part 3: Combination Therapy|Adverse Event|0|||
27986019|NCT02393248|54644417|FG006|Part 3: Combination Therapy|Adverse Event|0|||
27986020|NCT02393248|54644418|FG007|Part 3: Combination Therapy|Adverse Event|0|||
27986021|NCT02393248|54644419|FG008|Part 3: Combination Therapy|Adverse Event|0|||
27986022|NCT02393248|54644420|FG009|Part 3: Combination Therapy|Adverse Event|0|||
27986023|NCT02393248|54644421|FG010|Part 3: Combination Therapy|Adverse Event|0|||
27986024|NCT02393248|54644422|FG011|Part 3: Combination Therapy|Adverse Event|0|||
27986025|NCT02393248|54644423|FG012|Part 3: Combination Therapy|Adverse Event|0|||
27986026|NCT02393248|54644424|FG013|Part 3: Combination Therapy|Adverse Event|0|||
27986027|NCT02393248|54644425|FG014|Part 3: Combination Therapy|Adverse Event|0|||
27986028|NCT02393248|54644426|FG015|Part 3: Combination Therapy|Adverse Event|0|||
27986029|NCT02393248|54644427|FG016|Part 3: Combination Therapy|Adverse Event|0|||
27986030|NCT02393248|54644428|FG017|Part 3: Combination Therapy|Adverse Event|0|||
27986031|NCT02393248|54644429|FG018|Part 3: Combination Therapy|Adverse Event|0|||
27986032|NCT02393248|54644430|FG019|Part 3: Combination Therapy|Adverse Event|0|||
27986033|NCT02393248|54644431|FG020|Part 3: Combination Therapy|Adverse Event|0|||
27986034|NCT02393248|54644432|FG021|Part 3: Combination Therapy|Adverse Event|0|||
27986035|NCT02393248|54644433|FG022|Part 3: Combination Therapy|Adverse Event|0|||
27986036|NCT02393248|54644434|FG023|Part 3: Combination Therapy|Adverse Event|1|||
27986037|NCT02393248|54644435|FG024|Part 3: Combination Therapy|Adverse Event|0|||
27986038|NCT02393248|54644411|FG000|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
27986039|NCT02393248|54644412|FG001|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
27986040|NCT02393248|54644413|FG002|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
27986041|NCT02393248|54644414|FG003|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
27986042|NCT02393248|54644415|FG004|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
27986043|NCT02393248|54644416|FG005|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
27986044|NCT02393248|54644417|FG006|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
27986045|NCT02393248|54644418|FG007|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
28097243|NCT01317550|54752779|FG002|Overall Study|Lack of compliance study med|0|||
27898115|NCT00001566|54552375|FG000|Overall Study|unable to complete initial apheresis|1|||
27898116|NCT00001575|54552379|FG000|Overall Study|Screening failures-Ph I portion|22|||
27898117|NCT00001575|54552379|FG000|Overall Study|Withdrawn/deaths|23|||
27898118|NCT00001596|54552385|FG000|Overall Study|Death|1|||
27898119|NCT00001596|54552386|FG001|Overall Study|Death|0|||
27898120|NCT00001596|54552385|FG000|Overall Study|Withdrawal by Subject|3|||
27898121|NCT00001596|54552386|FG001|Overall Study|Withdrawal by Subject|1|||
27898122|NCT00001596|54552385|FG000|Overall Study|Study Termination|12|||
27898123|NCT00001596|54552386|FG001|Overall Study|Study Termination|9|||
27898124|NCT00001596|54552385|FG000|Overall Study|Adverse Event|1|||
27898125|NCT00001596|54552386|FG001|Overall Study|Adverse Event|0|||
27898126|NCT01349803|54552423|FG000|Overall Study|Adverse Event|0|||
27898127|NCT01349803|54552424|FG001|Overall Study|Adverse Event|0|||
27898128|NCT01349803|54552425|FG002|Overall Study|Adverse Event|0|||
27898129|NCT01349803|54552426|FG003|Overall Study|Adverse Event|2|||
27898130|NCT01349803|54552423|FG000|Overall Study|Withdrawal by Subject|1|||
27898131|NCT01349803|54552424|FG001|Overall Study|Withdrawal by Subject|0|||
27898132|NCT01349803|54552425|FG002|Overall Study|Withdrawal by Subject|0|||
27898133|NCT01349803|54552426|FG003|Overall Study|Withdrawal by Subject|0|||
27898134|NCT01349803|54552423|FG000|Overall Study|Protocol-specified criteria|0|||
27898135|NCT01349803|54552424|FG001|Overall Study|Protocol-specified criteria|1|||
27898136|NCT01349803|54552425|FG002|Overall Study|Protocol-specified criteria|3|||
28172079|NCT02718417|54843704|FG002|Observation Phase (OP)|Adverse Event|1|||
28172080|NCT02718417|54843702|FG000|Observation Phase (OP)|Death leading to discontinuation|0|||
28172081|NCT02718417|54843703|FG001|Observation Phase (OP)|Death leading to discontinuation|0|||
28172082|NCT02718417|54843704|FG002|Observation Phase (OP)|Death leading to discontinuation|2|||
27898137|NCT01349803|54552426|FG003|Overall Study|Protocol-specified criteria|0|||
27898138|NCT04059146|54552568|FG000|Overall Study|Withdrawal by Subject|0|||
27898139|NCT04059146|54552569|FG001|Overall Study|Withdrawal by Subject|1|||
27898140|NCT03969641|54552590|FG000|Overall Study|Lost to Follow-up|5|||
27898141|NCT03969641|54552591|FG001|Overall Study|Lost to Follow-up|3|||
27898142|NCT03969641|54552590|FG000|Overall Study|Withdrawal by Subject|1|||
27898143|NCT03969641|54552591|FG001|Overall Study|Withdrawal by Subject|2|||
27898144|NCT03969641|54552590|FG000|Overall Study|Found to be ineligible|1|||
27898145|NCT03969641|54552591|FG001|Overall Study|Found to be ineligible|1|||
27986046|NCT02393248|54644419|FG008|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
27986047|NCT02393248|54644420|FG009|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
27986048|NCT02393248|54644421|FG010|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
27986049|NCT02393248|54644422|FG011|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
27986050|NCT02393248|54644423|FG012|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
27986051|NCT02393248|54644424|FG013|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
27986052|NCT02393248|54644425|FG014|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
27986053|NCT02393248|54644426|FG015|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
27986054|NCT02393248|54644427|FG016|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
27986055|NCT02393248|54644428|FG017|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
27986056|NCT02393248|54644429|FG018|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
27986057|NCT02393248|54644430|FG019|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
27986058|NCT02393248|54644431|FG020|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
27986059|NCT02393248|54644432|FG021|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
27986060|NCT02393248|54644433|FG022|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
27986061|NCT02393248|54644434|FG023|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|1|||
27986062|NCT02393248|54644435|FG024|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
27986063|NCT00601484|54644498|FG000|Overall Study|Adverse Event|0|||
27986064|NCT00601484|54644499|FG001|Overall Study|Adverse Event|1|||
27986065|NCT00601484|54644498|FG000|Overall Study|Lost to Follow-up|4|||
27986066|NCT00601484|54644499|FG001|Overall Study|Lost to Follow-up|3|||
27986067|NCT00601484|54644498|FG000|Overall Study|Lack of Efficacy|0|||
27986068|NCT00601484|54644499|FG001|Overall Study|Lack of Efficacy|2|||
27986069|NCT00601484|54644498|FG000|Overall Study|Withdrawal by Subject|1|||
27986070|NCT00601484|54644499|FG001|Overall Study|Withdrawal by Subject|1|||
28172083|NCT02718417|54843702|FG000|Observation Phase (OP)|Lost to Follow-up|0|||
28172084|NCT02718417|54843703|FG001|Observation Phase (OP)|Lost to Follow-up|0|||
28172085|NCT02718417|54843704|FG002|Observation Phase (OP)|Lost to Follow-up|1|||
28172086|NCT02718417|54843702|FG000|Observation Phase (OP)|Physician Decision|0|||
27898146|NCT03969641|54552590|FG000|Overall Study|Intrauterine fetal demise (IUFD)|0|||
27898147|NCT03969641|54552591|FG001|Overall Study|Intrauterine fetal demise (IUFD)|2|||
27898148|NCT03969641|54552590|FG000|Overall Study|Spontaneous abortion (SAB)|2|||
27898149|NCT03969641|54552591|FG001|Overall Study|Spontaneous abortion (SAB)|1|||
27898150|NCT03969641|54552590|FG000|Overall Study|Elective termination|0|||
27898151|NCT03969641|54552591|FG001|Overall Study|Elective termination|1|||
27898152|NCT03721172|54552637|FG000|Placebo-controlled Phase|Adverse Event|7|||
27898153|NCT03721172|54552638|FG001|Placebo-controlled Phase|Adverse Event|7|||
27898154|NCT03721172|54552639|FG002|Placebo-controlled Phase|Adverse Event|0|||
27898155|NCT03721172|54552637|FG000|Placebo-controlled Phase|Lack of Efficacy|4|||
27898156|NCT03721172|54552638|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
27898157|NCT03721172|54552639|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
27898158|NCT03721172|54552637|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
27898159|NCT03721172|54552638|FG001|Placebo-controlled Phase|Non-compliance with study drug|1|||
27898160|NCT03721172|54552639|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
27898161|NCT03721172|54552637|FG000|Placebo-controlled Phase|Lost to Follow-up|15|||
27898162|NCT03721172|54552638|FG001|Placebo-controlled Phase|Lost to Follow-up|13|||
27898163|NCT03721172|54552639|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
27898164|NCT03721172|54552637|FG000|Placebo-controlled Phase|Withdrawal by Subject|23|||
27898165|NCT03721172|54552638|FG001|Placebo-controlled Phase|Withdrawal by Subject|18|||
27898166|NCT03721172|54552639|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
27898167|NCT03721172|54552637|FG000|Placebo-controlled Phase|Other|3|||
27898168|NCT03721172|54552638|FG001|Placebo-controlled Phase|Other|0|||
27898169|NCT03721172|54552639|FG002|Placebo-controlled Phase|Other|0|||
27898170|NCT03721172|54552637|FG000|Apremilast Extension Phase|Adverse Event|0|||
27898171|NCT03721172|54552638|FG001|Apremilast Extension Phase|Adverse Event|0|||
27898172|NCT03721172|54552639|FG002|Apremilast Extension Phase|Adverse Event|10|||
27898173|NCT03721172|54552637|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
27898174|NCT03721172|54552638|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
27898175|NCT03721172|54552639|FG002|Apremilast Extension Phase|Lack of Efficacy|2|||
27898176|NCT03721172|54552637|FG000|Apremilast Extension Phase|Non-compliance with study drug|0|||
27898177|NCT03721172|54552638|FG001|Apremilast Extension Phase|Non-compliance with study drug|0|||
27898178|NCT03721172|54552639|FG002|Apremilast Extension Phase|Non-compliance with study drug|1|||
27898179|NCT03721172|54552637|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
27898180|NCT03721172|54552638|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
27898181|NCT03721172|54552639|FG002|Apremilast Extension Phase|Lost to Follow-up|20|||
27898182|NCT03721172|54552637|FG000|Apremilast Extension Phase|Protocol Violation|0|||
27898183|NCT03721172|54552638|FG001|Apremilast Extension Phase|Protocol Violation|0|||
27898184|NCT03721172|54552639|FG002|Apremilast Extension Phase|Protocol Violation|1|||
27898185|NCT03721172|54552637|FG000|Apremilast Extension Phase|Physician Decision|0|||
27898186|NCT03721172|54552638|FG001|Apremilast Extension Phase|Physician Decision|0|||
27898187|NCT03721172|54552639|FG002|Apremilast Extension Phase|Physician Decision|1|||
27898188|NCT03721172|54552637|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
27898189|NCT03721172|54552638|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
27898190|NCT03721172|54552639|FG002|Apremilast Extension Phase|Withdrawal by Subject|21|||
27898191|NCT03721172|54552637|FG000|Apremilast Extension Phase|Other|0|||
27898192|NCT03721172|54552638|FG001|Apremilast Extension Phase|Other|0|||
27898193|NCT03721172|54552639|FG002|Apremilast Extension Phase|Other|3|||
27898194|NCT03721172|54552637|FG000|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
27898195|NCT03721172|54552638|FG001|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
27898196|NCT03721172|54552639|FG002|Apremilast Extension Phase|Other (Related to COVID-19)|7|||
27898197|NCT02337686|54552673|FG000|Overall Study|Adverse Event|1|||
27898198|NCT04540887|54552699|FG000|Overall Study|Withdrawal by Subject|2|||
27898199|NCT04294680|54552710|FG000|Overall Study|Withdrawal by Subject|2|||
27898200|NCT04294680|54552711|FG001|Overall Study|Withdrawal by Subject|1|||
27898201|NCT04294680|54552710|FG000|Overall Study|Follow-up visits completed outside of window|1|||
27898202|NCT04294680|54552711|FG001|Overall Study|Follow-up visits completed outside of window|0|||
27898203|NCT01350102|54552721|FG000|Overall Study|Adverse Event|0|||
27898204|NCT01350102|54552722|FG001|Overall Study|Adverse Event|0|||
27898205|NCT01350102|54552723|FG002|Overall Study|Adverse Event|1|||
27898206|NCT01350102|54552724|FG003|Overall Study|Adverse Event|0|||
27898207|NCT04059549|54552738|FG000|Overall Study|Withdrawal by Subject|2|||
27898208|NCT04059549|54552739|FG001|Overall Study|Withdrawal by Subject|0|||
27898209|NCT04041570|54552751|FG000|Overall Study|Moved from Area|0|||
27898210|NCT04041570|54552752|FG001|Overall Study|Moved from Area|2|||
27898211|NCT03879408|54552764|FG000|Overall Study|Lost to Follow-up|0|||
27898212|NCT03879408|54552765|FG001|Overall Study|Lost to Follow-up|3|||
27898213|NCT03879408|54552766|FG002|Overall Study|Lost to Follow-up|2|||
27898214|NCT03879408|54552767|FG003|Overall Study|Lost to Follow-up|1|||
27898215|NCT03879408|54552768|FG004|Overall Study|Lost to Follow-up|0|||
27898216|NCT03879408|54552764|FG000|Overall Study|Withdrawal by Subject|2|||
27898217|NCT03879408|54552765|FG001|Overall Study|Withdrawal by Subject|1|||
27898218|NCT03879408|54552766|FG002|Overall Study|Withdrawal by Subject|1|||
27898219|NCT03879408|54552767|FG003|Overall Study|Withdrawal by Subject|0|||
27898220|NCT03879408|54552768|FG004|Overall Study|Withdrawal by Subject|1|||
27898221|NCT00819780|54552792|FG000|Overall Study|Did not receive study drug|3|||
27898222|NCT00819780|54552793|FG001|Overall Study|Did not receive study drug|4|||
27898223|NCT00819780|54552792|FG000|Overall Study|Still in treatment|25|||
27898224|NCT00819780|54552793|FG001|Overall Study|Still in treatment|17|||
27898225|NCT00000620|54552932|FG000|Overall Study|Death|86|||
27898226|NCT00000620|54552933|FG001|Overall Study|Death|67|||
27898227|NCT00000620|54552934|FG002|Overall Study|Death|112|||
27898228|NCT00000620|54552935|FG003|Overall Study|Death|126|||
27898229|NCT00000620|54552936|FG004|Overall Study|Death|64|||
27898230|NCT00000620|54552937|FG005|Overall Study|Death|77|||
27898231|NCT00000620|54552938|FG006|Overall Study|Death|91|||
27898232|NCT00000620|54552939|FG007|Overall Study|Death|95|||
27898233|NCT00000620|54552932|FG000|Overall Study|Lost to Follow-up|14|||
27898234|NCT00000620|54552933|FG001|Overall Study|Lost to Follow-up|14|||
27898235|NCT00000620|54552934|FG002|Overall Study|Lost to Follow-up|14|||
27898236|NCT00000620|54552935|FG003|Overall Study|Lost to Follow-up|14|||
27898237|NCT00000620|54552936|FG004|Overall Study|Lost to Follow-up|15|||
27898238|NCT00000620|54552937|FG005|Overall Study|Lost to Follow-up|15|||
27898239|NCT00000620|54552938|FG006|Overall Study|Lost to Follow-up|13|||
27898240|NCT00000620|54552939|FG007|Overall Study|Lost to Follow-up|14|||
27898241|NCT00000620|54552932|FG000|Overall Study|Withdrawal by Subject|40|||
27898242|NCT00000620|54552933|FG001|Overall Study|Withdrawal by Subject|27|||
27898243|NCT00000620|54552934|FG002|Overall Study|Withdrawal by Subject|28|||
27898244|NCT00000620|54552935|FG003|Overall Study|Withdrawal by Subject|27|||
27898245|NCT00000620|54552936|FG004|Overall Study|Withdrawal by Subject|30|||
27898246|NCT00000620|54552937|FG005|Overall Study|Withdrawal by Subject|32|||
27898247|NCT00000620|54552938|FG006|Overall Study|Withdrawal by Subject|32|||
27898248|NCT00000620|54552939|FG007|Overall Study|Withdrawal by Subject|21|||
27898249|NCT00000620|54552932|FG000|Overall Study|missed closeout visit|22|||
27898250|NCT00000620|54552933|FG001|Overall Study|missed closeout visit|28|||
27898251|NCT00000620|54552934|FG002|Overall Study|missed closeout visit|16|||
27898252|NCT00000620|54552935|FG003|Overall Study|missed closeout visit|11|||
27898253|NCT00000620|54552936|FG004|Overall Study|missed closeout visit|26|||
27898254|NCT00000620|54552937|FG005|Overall Study|missed closeout visit|28|||
27898255|NCT00000620|54552938|FG006|Overall Study|missed closeout visit|13|||
27898256|NCT00000620|54552939|FG007|Overall Study|missed closeout visit|16|||
27898257|NCT00001262|54553002|FG000|Overall Study|Death|10|||
27898258|NCT00001262|54553003|FG001|Overall Study|Death|11|||
27898259|NCT00001262|54553004|FG002|Overall Study|Death|0|||
27898260|NCT00001262|54553002|FG000|Overall Study|Withdrawal by Subject|0|||
27898261|NCT00001262|54553003|FG001|Overall Study|Withdrawal by Subject|3|||
27898262|NCT00001262|54553004|FG002|Overall Study|Withdrawal by Subject|0|||
27898263|NCT00001277|54553021|FG000|Overall Study|Adverse Event|0|||
27898264|NCT00001277|54553022|FG001|Overall Study|Adverse Event|0|||
27898265|NCT00001277|54553023|FG002|Overall Study|Adverse Event|1|||
27898266|NCT00001277|54553021|FG000|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
27898267|NCT00001277|54553022|FG001|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
27898268|NCT00001277|54553023|FG002|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|2|||
27898269|NCT00001703|54553065|FG000|Overall Study|progressed disease|2|||
27898270|NCT00001703|54553065|FG000|Overall Study|No evidence of disease|1|||
27898271|NCT00001703|54553065|FG000|Overall Study|recurrent disease|2|||
27898272|NCT01349907|54553089|FG000|Overall Study|Adverse Event|37|||
27898273|NCT01349907|54553090|FG001|Overall Study|Adverse Event|11|||
27898274|NCT01349907|54553089|FG000|Overall Study|Treatment failure|13|||
27898275|NCT01349907|54553090|FG001|Overall Study|Treatment failure|4|||
27898276|NCT01349907|54553089|FG000|Overall Study|Lost to Follow-up|25|||
27898277|NCT01349907|54553090|FG001|Overall Study|Lost to Follow-up|6|||
27898278|NCT01349907|54553089|FG000|Overall Study|Withdrawal by Subject|30|||
27898279|NCT01349907|54553090|FG001|Overall Study|Withdrawal by Subject|8|||
27898280|NCT01349907|54553089|FG000|Overall Study|Protocol Violation|33|||
27898281|NCT01349907|54553090|FG001|Overall Study|Protocol Violation|13|||
27898282|NCT01349907|54553089|FG000|Overall Study|Administrative|1|||
27898283|NCT01349907|54553090|FG001|Overall Study|Administrative|1|||
27898284|NCT04847141|54553099|FG000|Overall Study|Adverse Event|1|||
27898285|NCT04847141|54553100|FG001|Overall Study|Adverse Event|0|||
27898286|NCT04847141|54553101|FG002|Overall Study|Adverse Event|1|||
27898287|NCT04847141|54553099|FG000|Overall Study|Withdrawal by Subject|2|||
27898288|NCT04847141|54553100|FG001|Overall Study|Withdrawal by Subject|4|||
27898289|NCT04847141|54553101|FG002|Overall Study|Withdrawal by Subject|3|||
27898290|NCT04847141|54553099|FG000|Overall Study|Lost to Follow-up|7|||
27898291|NCT04847141|54553100|FG001|Overall Study|Lost to Follow-up|5|||
27898292|NCT04847141|54553101|FG002|Overall Study|Lost to Follow-up|7|||
27898293|NCT04847141|54553099|FG000|Overall Study|Reason not Specified|0|||
27898294|NCT04847141|54553100|FG001|Overall Study|Reason not Specified|1|||
27898295|NCT04847141|54553101|FG002|Overall Study|Reason not Specified|0|||
27898296|NCT01349829|54553111|FG000|Overall Study|Lost to Follow-up|4|||
27739464|NCT01676727|54189159|FG000|Overall Study|Screening failure|5|||
27986071|NCT00601484|54644498|FG000|Overall Study|Randomized, but not treated|0|||
27898297|NCT01349829|54553112|FG001|Overall Study|Lost to Follow-up|8|||
27898298|NCT01349829|54553111|FG000|Overall Study|Consent withdrawal|3|||
27898299|NCT01349829|54553112|FG001|Overall Study|Consent withdrawal|8|||
27898300|NCT01349829|54553111|FG000|Overall Study|Migrated/moved|2|||
27898301|NCT01349829|54553112|FG001|Overall Study|Migrated/moved|7|||
27898302|NCT01350128|54553120|FG000|Overall Study|Withdrawal by Subject|3|||
27898303|NCT01350128|54553120|FG000|Overall Study|Protocol discontinuation criteria|8|||
27898304|NCT01350128|54553120|FG000|Overall Study|Physician Decision|1|||
27898305|NCT01350128|54553120|FG000|Overall Study|Lost to Follow-up|2|||
27898306|NCT03893825|54553187|FG000|Overall Study|Death|2|||
27898307|NCT03893825|54553188|FG001|Overall Study|Death|1|||
27898308|NCT03893825|54553187|FG000|Overall Study|Adverse Event|0|||
27898309|NCT03893825|54553188|FG001|Overall Study|Adverse Event|2|||
27898310|NCT03893825|54553187|FG000|Overall Study|Withdrawal by Subject|19|||
27898311|NCT03893825|54553188|FG001|Overall Study|Withdrawal by Subject|21|||
27898312|NCT03893825|54553187|FG000|Overall Study|Protocol deviation|1|||
27898313|NCT03893825|54553188|FG001|Overall Study|Protocol deviation|0|||
27898314|NCT03893825|54553187|FG000|Overall Study|Lost to Follow-up|10|||
27898315|NCT03893825|54553188|FG001|Overall Study|Lost to Follow-up|10|||
27898316|NCT03893825|54553187|FG000|Overall Study|Other than specified|7|||
27898317|NCT03893825|54553188|FG001|Overall Study|Other than specified|6|||
27898318|NCT03890666|54553196|FG000|Overall Study|Withdrawal by Subject|0|||
27898319|NCT03890666|54553197|FG001|Overall Study|Withdrawal by Subject|1|||
27898320|NCT03890666|54553196|FG000|Overall Study|Protocol deviation|1|||
27898321|NCT03890666|54553197|FG001|Overall Study|Protocol deviation|4|||
27898322|NCT03890666|54553196|FG000|Overall Study|Lost to Follow-up|2|||
27898323|NCT03890666|54553197|FG001|Overall Study|Lost to Follow-up|5|||
27898324|NCT03890666|54553196|FG000|Overall Study|Other than specified|1|||
27898325|NCT03890666|54553197|FG001|Overall Study|Other than specified|8|||
27898326|NCT03276572|54553251|FG000|Overall Study|In follow-up|0|||
27898327|NCT03276572|54553252|FG001|Overall Study|In follow-up|0|||
27898328|NCT03276572|54553253|FG002|Overall Study|In follow-up|0|||
27898329|NCT03276572|54553254|FG003|Overall Study|In follow-up|0|||
27898330|NCT03276572|54553255|FG004|Overall Study|In follow-up|0|||
27898331|NCT03276572|54553256|FG005|Overall Study|In follow-up|1|||
27898332|NCT03276572|54553257|FG006|Overall Study|In follow-up|1|||
27898333|NCT03276572|54553251|FG000|Overall Study|Lost to Follow-up|0|||
27898334|NCT03276572|54553252|FG001|Overall Study|Lost to Follow-up|0|||
27898335|NCT03276572|54553253|FG002|Overall Study|Lost to Follow-up|0|||
27898336|NCT03276572|54553254|FG003|Overall Study|Lost to Follow-up|0|||
27898337|NCT03276572|54553255|FG004|Overall Study|Lost to Follow-up|0|||
27898338|NCT03276572|54553256|FG005|Overall Study|Lost to Follow-up|0|||
27898339|NCT03276572|54553257|FG006|Overall Study|Lost to Follow-up|1|||
27898340|NCT03090737|54553282|FG000|Overall Study|Other reasons|1|||
27898341|NCT03090737|54553282|FG000|Overall Study|Completed treatment as per protocol|17|||
27898342|NCT03090737|54553282|FG000|Overall Study|Maximum clinical benefit|2|||
27898343|NCT03090737|54553282|FG000|Overall Study|Adverse event unrelated to study drug|7|||
27898344|NCT03090737|54553282|FG000|Overall Study|Study drug toxicity|4|||
27898345|NCT03090737|54553282|FG000|Overall Study|Disease progression|98|||
27898346|NCT03004976|54553327|FG000|Overall Study|Lost to Follow-up|7|||
27898347|NCT03004976|54553328|FG001|Overall Study|Lost to Follow-up|5|||
27898348|NCT03004976|54553327|FG000|Overall Study|Physician Decision|1|||
27898349|NCT03004976|54553328|FG001|Overall Study|Physician Decision|0|||
27898350|NCT03004976|54553327|FG000|Overall Study|Withdrawal by Subject|1|||
27898351|NCT03004976|54553328|FG001|Overall Study|Withdrawal by Subject|0|||
27898352|NCT03004976|54553327|FG000|Overall Study|Death|4|||
27898353|NCT03004976|54553328|FG001|Overall Study|Death|1|||
27898354|NCT02985866|54553336|FG000|Overall Study|Poor CGM data|1|||
27898355|NCT02985866|54553337|FG001|Overall Study|Poor CGM data|1|||
27898356|NCT02762981|54553362|FG000|Overall Study|Adverse Event|2|||
27898357|NCT02762981|54553363|FG001|Overall Study|Adverse Event|3|||
27898358|NCT02762981|54553364|FG002|Overall Study|Adverse Event|1|||
27898359|NCT02762981|54553365|FG003|Overall Study|Adverse Event|1|||
27898360|NCT02762981|54553366|FG004|Overall Study|Adverse Event|3|||
27898361|NCT02762981|54553362|FG000|Overall Study|Physician Decision|0|||
27898362|NCT02762981|54553363|FG001|Overall Study|Physician Decision|1|||
27898363|NCT02762981|54553364|FG002|Overall Study|Physician Decision|0|||
27898364|NCT02762981|54553365|FG003|Overall Study|Physician Decision|0|||
27898365|NCT02762981|54553366|FG004|Overall Study|Physician Decision|1|||
27898366|NCT02762981|54553362|FG000|Overall Study|Disease progression|11|||
27898367|NCT02762981|54553363|FG001|Overall Study|Disease progression|23|||
27898368|NCT02762981|54553364|FG002|Overall Study|Disease progression|4|||
27898369|NCT02762981|54553365|FG003|Overall Study|Disease progression|10|||
27898370|NCT02762981|54553366|FG004|Overall Study|Disease progression|1|||
27898371|NCT02762981|54553362|FG000|Overall Study|Enrolled not treated|1|||
27898372|NCT02762981|54553363|FG001|Overall Study|Enrolled not treated|5|||
27898373|NCT02762981|54553364|FG002|Overall Study|Enrolled not treated|0|||
27898374|NCT02762981|54553365|FG003|Overall Study|Enrolled not treated|2|||
27898375|NCT02762981|54553366|FG004|Overall Study|Enrolled not treated|0|||
27898376|NCT02762981|54553362|FG000|Overall Study|Other|2|||
27898377|NCT02762981|54553363|FG001|Overall Study|Other|3|||
27898378|NCT02762981|54553364|FG002|Overall Study|Other|1|||
27898379|NCT02762981|54553365|FG003|Overall Study|Other|0|||
27898380|NCT02762981|54553366|FG004|Overall Study|Other|0|||
27898381|NCT02762981|54553362|FG000|Overall Study|Missing|1|||
27898382|NCT02762981|54553363|FG001|Overall Study|Missing|0|||
27898383|NCT02762981|54553364|FG002|Overall Study|Missing|0|||
27898384|NCT02762981|54553365|FG003|Overall Study|Missing|0|||
27898385|NCT02762981|54553366|FG004|Overall Study|Missing|0|||
27898386|NCT02762981|54553362|FG000|Overall Study|Withdrawal by Subject|0|||
27898387|NCT02762981|54553363|FG001|Overall Study|Withdrawal by Subject|5|||
27898388|NCT02762981|54553364|FG002|Overall Study|Withdrawal by Subject|1|||
27898389|NCT02762981|54553365|FG003|Overall Study|Withdrawal by Subject|3|||
27898390|NCT02762981|54553366|FG004|Overall Study|Withdrawal by Subject|0|||
27898391|NCT02255435|54553406|FG000|Overall Study|Patient's Limited Time Availability|0|||
27898392|NCT02255435|54553407|FG001|Overall Study|Patient's Limited Time Availability|0|||
27898393|NCT02255435|54553408|FG002|Overall Study|Patient's Limited Time Availability|0|||
27898394|NCT02255435|54553409|FG003|Overall Study|Patient's Limited Time Availability|0|||
27898395|NCT02255435|54553410|FG004|Overall Study|Patient's Limited Time Availability|0|||
27898396|NCT02255435|54553411|FG005|Overall Study|Patient's Limited Time Availability|0|||
27898397|NCT02255435|54553412|FG006|Overall Study|Patient's Limited Time Availability|0|||
27898398|NCT02255435|54553413|FG007|Overall Study|Patient's Limited Time Availability|1|||
27898399|NCT02255435|54553414|FG008|Overall Study|Patient's Limited Time Availability|0|||
27898400|NCT02255435|54553415|FG009|Overall Study|Patient's Limited Time Availability|0|||
27898401|NCT02255435|54553406|FG000|Overall Study|Withdrawal by Subject|0|||
27898402|NCT02255435|54553407|FG001|Overall Study|Withdrawal by Subject|0|||
27898403|NCT02255435|54553408|FG002|Overall Study|Withdrawal by Subject|0|||
27898404|NCT02255435|54553409|FG003|Overall Study|Withdrawal by Subject|0|||
27898405|NCT02255435|54553410|FG004|Overall Study|Withdrawal by Subject|0|||
27898406|NCT02255435|54553411|FG005|Overall Study|Withdrawal by Subject|0|||
27898407|NCT02255435|54553412|FG006|Overall Study|Withdrawal by Subject|0|||
27898408|NCT02255435|54553413|FG007|Overall Study|Withdrawal by Subject|0|||
27898409|NCT02255435|54553414|FG008|Overall Study|Withdrawal by Subject|1|||
27898410|NCT02255435|54553415|FG009|Overall Study|Withdrawal by Subject|4|||
27898411|NCT02255435|54553406|FG000|Overall Study|Administrative reasons|0|||
27898412|NCT02255435|54553407|FG001|Overall Study|Administrative reasons|0|||
27898413|NCT02255435|54553408|FG002|Overall Study|Administrative reasons|0|||
27898414|NCT02255435|54553409|FG003|Overall Study|Administrative reasons|0|||
27898415|NCT02255435|54553410|FG004|Overall Study|Administrative reasons|0|||
27898416|NCT02255435|54553411|FG005|Overall Study|Administrative reasons|0|||
27898417|NCT02255435|54553412|FG006|Overall Study|Administrative reasons|0|||
27898418|NCT02255435|54553413|FG007|Overall Study|Administrative reasons|0|||
27898419|NCT02255435|54553414|FG008|Overall Study|Administrative reasons|0|||
27898420|NCT02255435|54553415|FG009|Overall Study|Administrative reasons|2|||
27898421|NCT00001832|54553486|FG000|Apheresis Period|not able to manufacture treatment cells|60|||
27898422|NCT00001832|54553487|FG001|Apheresis Period|not able to manufacture treatment cells|0|||
27898423|NCT00001832|54553488|FG002|Apheresis Period|not able to manufacture treatment cells|0|||
27898424|NCT00001832|54553489|FG003|Apheresis Period|not able to manufacture treatment cells|0|||
27898425|NCT00001832|54553490|FG004|Apheresis Period|not able to manufacture treatment cells|0|||
27898426|NCT00001832|54553491|FG005|Apheresis Period|not able to manufacture treatment cells|0|||
27898427|NCT00001832|54553492|FG006|Apheresis Period|not able to manufacture treatment cells|0|||
27898428|NCT00001832|54553493|FG007|Apheresis Period|not able to manufacture treatment cells|0|||
27898429|NCT00001832|54553494|FG008|Apheresis Period|not able to manufacture treatment cells|0|||
27898430|NCT00001832|54553495|FG009|Apheresis Period|not able to manufacture treatment cells|0|||
27898431|NCT00001832|54553496|FG010|Apheresis Period|not able to manufacture treatment cells|0|||
27898432|NCT00001832|54553497|FG011|Apheresis Period|not able to manufacture treatment cells|0|||
27898433|NCT00001832|54553498|FG012|Apheresis Period|not able to manufacture treatment cells|0|||
27898434|NCT00001832|54553499|FG013|Apheresis Period|not able to manufacture treatment cells|0|||
27898435|NCT00001832|54553500|FG014|Apheresis Period|not able to manufacture treatment cells|0|||
27898436|NCT00001832|54553486|FG000|Treatment Period|Death during treatment|0|||
27898437|NCT00001832|54553487|FG001|Treatment Period|Death during treatment|0|||
27898438|NCT00001832|54553488|FG002|Treatment Period|Death during treatment|0|||
27898439|NCT00001832|54553489|FG003|Treatment Period|Death during treatment|0|||
27898440|NCT00001832|54553490|FG004|Treatment Period|Death during treatment|0|||
27898441|NCT00001832|54553491|FG005|Treatment Period|Death during treatment|1|||
27898442|NCT00001832|54553492|FG006|Treatment Period|Death during treatment|0|||
27986072|NCT00601484|54644499|FG001|Overall Study|Randomized, but not treated|1|||
27898443|NCT00001832|54553493|FG007|Treatment Period|Death during treatment|0|||
27898444|NCT00001832|54553494|FG008|Treatment Period|Death during treatment|0|||
27898445|NCT00001832|54553495|FG009|Treatment Period|Death during treatment|0|||
27898446|NCT00001832|54553496|FG010|Treatment Period|Death during treatment|0|||
27898447|NCT00001832|54553497|FG011|Treatment Period|Death during treatment|0|||
27898448|NCT00001832|54553498|FG012|Treatment Period|Death during treatment|0|||
27898449|NCT00001832|54553499|FG013|Treatment Period|Death during treatment|0|||
27898450|NCT00001832|54553500|FG014|Treatment Period|Death during treatment|0|||
27898451|NCT00001832|54553486|FG000|Treatment Period|Not treated|0|||
27898452|NCT00001832|54553487|FG001|Treatment Period|Not treated|0|||
27898453|NCT00001832|54553488|FG002|Treatment Period|Not treated|0|||
27898454|NCT00001832|54553489|FG003|Treatment Period|Not treated|0|||
27898455|NCT00001832|54553490|FG004|Treatment Period|Not treated|0|||
27898456|NCT00001832|54553491|FG005|Treatment Period|Not treated|0|||
27898457|NCT00001832|54553492|FG006|Treatment Period|Not treated|0|||
27898458|NCT00001832|54553493|FG007|Treatment Period|Not treated|1|||
27898459|NCT00001832|54553494|FG008|Treatment Period|Not treated|0|||
27898460|NCT00001832|54553495|FG009|Treatment Period|Not treated|0|||
27898461|NCT00001832|54553496|FG010|Treatment Period|Not treated|0|||
27898462|NCT00001832|54553497|FG011|Treatment Period|Not treated|0|||
27898463|NCT00001832|54553498|FG012|Treatment Period|Not treated|0|||
27898464|NCT00001832|54553499|FG013|Treatment Period|Not treated|0|||
27898465|NCT00001832|54553500|FG014|Treatment Period|Not treated|0|||
27898466|NCT01349816|54553734|FG000|Overall Study|Withdrawal by Subject|4|||
27898467|NCT01349816|54553734|FG000|Overall Study|Physician Decision|1|||
27898468|NCT01349816|54553734|FG000|Overall Study|Adverse Event|14|||
27898469|NCT01349816|54553734|FG000|Overall Study|Lost to Follow-up|2|||
27898470|NCT01349816|54553734|FG000|Overall Study|Protocol Violation|1|||
27898471|NCT01349816|54553734|FG000|Overall Study|Protocol-specified criteria|8|||
27898472|NCT02971137|54553850|FG000|Overall Study|Lost to Follow-up|44|||
27898473|NCT02971137|54553851|FG001|Overall Study|Lost to Follow-up|56|||
27898474|NCT05201807|54553922|FG000|Overall Study|Adverse Event|1|||
27898475|NCT05201807|54553922|FG000|Overall Study|COVID-19 Related|1|||
27898476|NCT04978337|54553928|FG000|Overall Study|Withdrawal by Subject|0|||
27898477|NCT04978337|54553929|FG001|Overall Study|Withdrawal by Subject|1|||
27898478|NCT04828707|54553938|FG000|Overall Study|Lost to Follow-up|3|||
27898479|NCT04828707|54553939|FG001|Overall Study|Lost to Follow-up|2|||
27898480|NCT04828707|54553938|FG000|Overall Study|Withdrawal by Subject|2|||
27898481|NCT04828707|54553939|FG001|Overall Study|Withdrawal by Subject|1|||
27898482|NCT04629534|54553947|FG000|Overall Study|Physician Decision|1|||
27898483|NCT04629534|54553948|FG001|Overall Study|Physician Decision|0|||
27898484|NCT04629534|54553947|FG000|Overall Study|Protocol Violation|0|||
27898485|NCT04629534|54553948|FG001|Overall Study|Protocol Violation|2|||
27898486|NCT04481191|54553960|FG000|Overall Study|Withdrawn by parent/guardian|15|||
27898487|NCT04481191|54553961|FG001|Overall Study|Withdrawn by parent/guardian|10|||
27898488|NCT03695185|54553984|FG000|Induction Period (Week 0 to Week 12)|Adverse Event|1|||
27898489|NCT03695185|54553984|FG000|Induction Period (Week 0 to Week 12)|Withdrew consent|2|||
27898490|NCT03695185|54553984|FG000|Induction Period (Week 0 to Week 12)|Lack of Efficacy|10|||
27898491|NCT03695185|54553984|FG000|Maintenance Period (Week 12 to Week 102)|Withdrew consent|3|||
27898492|NCT03695185|54553984|FG000|Maintenance Period (Week 12 to Week 102)|Lack of Efficacy|2|||
27898493|NCT03695185|54553984|FG000|Maintenance Period (Week 12 to Week 102)|Reason not specified|23|||
27898494|NCT03596164|54553991|FG000|Overall Study|Adverse Event|0|||
27898495|NCT03596164|54553992|FG001|Overall Study|Adverse Event|1|||
27898496|NCT03596164|54553991|FG000|Overall Study|Death|1|||
27898497|NCT03596164|54553992|FG001|Overall Study|Death|0|||
27898498|NCT03547908|54554002|FG000|Overall Study|Still On Study|115|||
27898499|NCT03547908|54554003|FG001|Overall Study|Still On Study|118|||
27898500|NCT03547908|54554002|FG000|Overall Study|Lost to Follow-up|2|||
27898501|NCT03547908|54554003|FG001|Overall Study|Lost to Follow-up|2|||
27898502|NCT03547908|54554002|FG000|Overall Study|Withdrew Consent|2|||
27898503|NCT03547908|54554003|FG001|Overall Study|Withdrew Consent|1|||
27898504|NCT03547908|54554002|FG000|Overall Study|Adverse Event|1|||
27898505|NCT03547908|54554003|FG001|Overall Study|Adverse Event|0|||
27898506|NCT03547908|54554002|FG000|Overall Study|Death|1|||
27898507|NCT03547908|54554003|FG001|Overall Study|Death|0|||
27898508|NCT03547908|54554002|FG000|Overall Study|Investigator's Discretion|0|||
27898509|NCT03547908|54554003|FG001|Overall Study|Investigator's Discretion|1|||
27898510|NCT03547908|54554002|FG000|Overall Study|Randomized But Never Treated|1|||
27898511|NCT03547908|54554003|FG001|Overall Study|Randomized But Never Treated|0|||
27898512|NCT03240874|54554013|FG000|Overall Study|Lost to Follow-up|0|||
27898513|NCT03240874|54554014|FG001|Overall Study|Lost to Follow-up|2|||
27898514|NCT03240874|54554015|FG002|Overall Study|Lost to Follow-up|4|||
27898515|NCT03240874|54554016|FG003|Overall Study|Lost to Follow-up|1|||
27898516|NCT03173560|54554026|FG000|Overall Study|Ongoing on Treatment|38|||
27898517|NCT03173560|54554027|FG001|Overall Study|Ongoing on Treatment|50|||
27898518|NCT03173560|54554026|FG000|Overall Study|Ongoing Survival Follow-up|56|||
27898519|NCT03173560|54554027|FG001|Overall Study|Ongoing Survival Follow-up|57|||
27898520|NCT03173560|54554026|FG000|Overall Study|Lost to Follow-up|1|||
27898521|NCT03173560|54554027|FG001|Overall Study|Lost to Follow-up|4|||
27898522|NCT03173560|54554026|FG000|Overall Study|Withdrawal by Subject|10|||
27898523|NCT03173560|54554027|FG001|Overall Study|Withdrawal by Subject|5|||
27898524|NCT03173560|54554026|FG000|Overall Study|Other|0|||
27898525|NCT03173560|54554027|FG001|Overall Study|Other|1|||
27898526|NCT02990468|54554036|FG000|Phase 2: MTD|Change in treatment|0|||
27898527|NCT02990468|54554037|FG001|Phase 2: MTD|Change in treatment|0|||
27898528|NCT02990468|54554038|FG002|Phase 2: MTD|Change in treatment|1|||
27898529|NCT02855944|54554048|FG000|Period 1: Treatment|Ongoing|14|||
27898530|NCT02855944|54554049|FG001|Period 1: Treatment|Ongoing|0|||
27898531|NCT02855944|54554048|FG000|Period 1: Treatment|Discontinued prior to starting study drug|1|||
27898532|NCT02855944|54554049|FG001|Period 1: Treatment|Discontinued prior to starting study drug|3|||
27898533|NCT02855944|54554048|FG000|Period 2: Crossover to Rucaparib|Ongoing|0|||
27898534|NCT02855944|54554049|FG001|Period 2: Crossover to Rucaparib|Ongoing|5|||
27898535|NCT02681055|54554060|FG000|Weeks 5-12|Adverse Event|1|||
27898536|NCT02577354|54554067|FG000|Overall Study|Lack of Efficacy|4|||
27898537|NCT02577354|54554068|FG001|Overall Study|Lack of Efficacy|4|||
27898538|NCT02577354|54554067|FG000|Overall Study|Lost to Follow-up|3|||
27898539|NCT02577354|54554068|FG001|Overall Study|Lost to Follow-up|1|||
27898540|NCT02577354|54554067|FG000|Overall Study|Missed Visit|4|||
27898541|NCT02577354|54554068|FG001|Overall Study|Missed Visit|3|||
27898542|NCT02577354|54554067|FG000|Overall Study|Adverse Event|4|||
27898543|NCT02577354|54554068|FG001|Overall Study|Adverse Event|5|||
27898544|NCT02451943|54554086|FG000|Overall Study|On Treatment|4|||
27898545|NCT02451943|54554087|FG001|Overall Study|On Treatment|4|||
27898546|NCT02451943|54554086|FG000|Overall Study|Withdrawal by Subject|13|||
27898547|NCT02451943|54554087|FG001|Overall Study|Withdrawal by Subject|16|||
27898548|NCT02451943|54554086|FG000|Overall Study|Lost to Follow-up|3|||
27898549|NCT02451943|54554087|FG001|Overall Study|Lost to Follow-up|4|||
27898550|NCT02409342|54554095|FG000|Overall Study|Death|211|||
27898551|NCT02409342|54554096|FG001|Overall Study|Death|201|||
27898552|NCT02409342|54554095|FG000|Overall Study|Withdrawal by Subject|24|||
27898553|NCT02409342|54554096|FG001|Overall Study|Withdrawal by Subject|17|||
27898554|NCT02409342|54554095|FG000|Overall Study|Study Terminated By Sponsor|48|||
27898555|NCT02409342|54554096|FG001|Overall Study|Study Terminated By Sponsor|59|||
27898556|NCT02409342|54554095|FG000|Overall Study|Lost to Follow-up|3|||
27898557|NCT02409342|54554096|FG001|Overall Study|Lost to Follow-up|5|||
27898558|NCT02409342|54554095|FG000|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|0|||
27898559|NCT02409342|54554096|FG001|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|1|||
27898560|NCT02409342|54554095|FG000|Overall Study|Participant Moved Into Roll-Over Study|0|||
27898561|NCT02409342|54554096|FG001|Overall Study|Participant Moved Into Roll-Over Study|2|||
27898562|NCT02409342|54554095|FG000|Overall Study|Sponsor Decision|1|||
27898563|NCT02409342|54554096|FG001|Overall Study|Sponsor Decision|0|||
27898564|NCT02336503|54554112|FG000|Overall Study|Lost to Follow-up|0|||
27898565|NCT02336503|54554113|FG001|Overall Study|Lost to Follow-up|3|||
27898566|NCT02336503|54554114|FG002|Overall Study|Lost to Follow-up|0|||
27898567|NCT02336503|54554115|FG003|Overall Study|Lost to Follow-up|2|||
27898568|NCT02336503|54554112|FG000|Overall Study|Withdrawal by Subject|2|||
27898569|NCT02336503|54554113|FG001|Overall Study|Withdrawal by Subject|0|||
27898570|NCT02336503|54554114|FG002|Overall Study|Withdrawal by Subject|0|||
27898571|NCT02336503|54554115|FG003|Overall Study|Withdrawal by Subject|4|||
27898572|NCT02336503|54554112|FG000|Overall Study|Adverse Event|0|||
27898573|NCT02336503|54554113|FG001|Overall Study|Adverse Event|0|||
27898574|NCT02336503|54554114|FG002|Overall Study|Adverse Event|1|||
27898575|NCT02336503|54554115|FG003|Overall Study|Adverse Event|0|||
27898576|NCT02255409|54554131|FG000|Overall Study|Administrative Reason|3|||
27898577|NCT02255409|54554132|FG001|Overall Study|Administrative Reason|7|||
27898578|NCT02255409|54554131|FG000|Overall Study|Withdrawal by Subject|1|||
27898579|NCT02255409|54554132|FG001|Overall Study|Withdrawal by Subject|5|||
27898580|NCT02255409|54554131|FG000|Overall Study|Lost to Follow-up|10|||
27898581|NCT02255409|54554132|FG001|Overall Study|Lost to Follow-up|19|||
27898582|NCT00630032|54554163|FG000|Overall Study|Death|55|||
27898583|NCT00630032|54554164|FG001|Overall Study|Death|49|||
27898584|NCT00630032|54554163|FG000|Overall Study|Withdrawal by Subject|3|||
27898585|NCT00630032|54554164|FG001|Overall Study|Withdrawal by Subject|2|||
27898586|NCT00630032|54554163|FG000|Overall Study|Lost to Follow-up|18|||
27898587|NCT00630032|54554164|FG001|Overall Study|Lost to Follow-up|31|||
27898588|NCT00630032|54554163|FG000|Overall Study|Protocol Violation|1|||
27898589|NCT00630032|54554164|FG001|Overall Study|Protocol Violation|0|||
27898590|NCT00630032|54554163|FG000|Overall Study|Patient has moved|1|||
27898591|NCT00630032|54554164|FG001|Overall Study|Patient has moved|1|||
27898592|NCT00630032|54554163|FG000|Overall Study|Disease progression|1|||
27898593|NCT00630032|54554164|FG001|Overall Study|Disease progression|1|||
27898594|NCT00630032|54554163|FG000|Overall Study|End of monitoring in US centers|11|||
27898595|NCT00630032|54554164|FG001|Overall Study|End of monitoring in US centers|11|||
27898596|NCT00465517|54554172|FG000|Overall Study|Adverse Event|7|||
27898597|NCT00465517|54554173|FG001|Overall Study|Adverse Event|3|||
27898598|NCT00465517|54554172|FG000|Overall Study|Lost to Follow-up|1|||
27898599|NCT00465517|54554173|FG001|Overall Study|Lost to Follow-up|0|||
27898600|NCT00465517|54554172|FG000|Overall Study|Withdrawal by Subject|4|||
27898601|NCT00465517|54554173|FG001|Overall Study|Withdrawal by Subject|1|||
27898602|NCT05050578|54554181|FG000|Period 1, 30 Days|Lost to Follow-up|1|||
27898603|NCT05050578|54554182|FG001|Period 1, 30 Days|Lost to Follow-up|1|||
27898604|NCT05050578|54554181|FG000|Period 1, 30 Days|Withdrawal by Subject|1|||
27898605|NCT05050578|54554182|FG001|Period 1, 30 Days|Withdrawal by Subject|0|||
27898606|NCT05050578|54554181|FG000|Period 2, 30 Days|Protocol Violation|0|||
27898607|NCT05050578|54554182|FG001|Period 2, 30 Days|Protocol Violation|1|||
27898608|NCT04490278|54554191|FG000|Overall Study|Lost to Follow-up|6|||
27898609|NCT04004221|54554195|FG000|Overall Study|Death|89|||
27898610|NCT04004221|54554195|FG000|Overall Study|Withdrawal by Subject|5|||
27925782|NCT01226745|54582371|FG004|Overall Study|Lost to Follow-up|1|||
27898611|NCT04004221|54554195|FG000|Overall Study|Participants transferred to Long-Term Extension (LTE) study|9|||
27898612|NCT04004221|54554195|FG000|Overall Study|Sponsor Decision|9|||
27898613|NCT04004221|54554195|FG000|Overall Study|Participant refused to enter LTE|1|||
27898614|NCT03775512|54554205|FG000|Overall Study|Death|1|||
27898615|NCT03775512|54554206|FG001|Overall Study|Death|1|||
27898616|NCT03775512|54554205|FG000|Overall Study|Withdrawal by Subject|7|||
27898617|NCT03775512|54554206|FG001|Overall Study|Withdrawal by Subject|4|||
27898618|NCT03775512|54554205|FG000|Overall Study|Lost to Follow-up|5|||
27898619|NCT03775512|54554206|FG001|Overall Study|Lost to Follow-up|5|||
27898620|NCT03775512|54554205|FG000|Overall Study|Excluded before Catheter insertion|14|||
27898621|NCT03775512|54554206|FG001|Overall Study|Excluded before Catheter insertion|5|||
27898622|NCT03775512|54554205|FG000|Overall Study|Discontinued before RF energy applied on inserted catheter|2|||
27898623|NCT03775512|54554206|FG001|Overall Study|Discontinued before RF energy applied on inserted catheter|1|||
27898624|NCT03775512|54554205|FG000|Overall Study|Due to a late entrance criteria deviation|0|||
27898625|NCT03775512|54554206|FG001|Overall Study|Due to a late entrance criteria deviation|1|||
27898626|NCT03620747|54554212|FG000|Overall Study|Participant decision|7|||
27898627|NCT03620747|54554212|FG000|Overall Study|Adverse Event|6|||
27898628|NCT03620747|54554212|FG000|Overall Study|Lack of Efficacy|1|||
27898629|NCT03620747|54554212|FG000|Overall Study|Poor compliance to protocol|2|||
27898630|NCT03620747|54554212|FG000|Overall Study|Other-unspecified|3|||
27898631|NCT03338790|54554237|FG000|Overall Study|Disease Progression|65|||
27898632|NCT03338790|54554238|FG001|Overall Study|Disease Progression|43|||
27898633|NCT03338790|54554239|FG002|Overall Study|Disease Progression|50|||
27898634|NCT03338790|54554240|FG003|Overall Study|Disease Progression|37|||
27898635|NCT03338790|54554237|FG000|Overall Study|Study Drug Toxicity|9|||
27898636|NCT03338790|54554238|FG001|Overall Study|Study Drug Toxicity|8|||
27898637|NCT03338790|54554239|FG002|Overall Study|Study Drug Toxicity|15|||
27898638|NCT03338790|54554240|FG003|Overall Study|Study Drug Toxicity|0|||
27898639|NCT03338790|54554237|FG000|Overall Study|Death|1|||
27898640|NCT03338790|54554238|FG001|Overall Study|Death|1|||
27898641|NCT03338790|54554239|FG002|Overall Study|Death|1|||
27898642|NCT03338790|54554240|FG003|Overall Study|Death|0|||
27898643|NCT03338790|54554237|FG000|Overall Study|Adverse Event unrelated to Study Drug|4|||
27898644|NCT03338790|54554238|FG001|Overall Study|Adverse Event unrelated to Study Drug|4|||
27898645|NCT03338790|54554239|FG002|Overall Study|Adverse Event unrelated to Study Drug|6|||
27898646|NCT03338790|54554240|FG003|Overall Study|Adverse Event unrelated to Study Drug|4|||
27898647|NCT03338790|54554237|FG000|Overall Study|Participant request to discontinue study treatment|3|||
27898648|NCT03338790|54554238|FG001|Overall Study|Participant request to discontinue study treatment|3|||
27898649|NCT03338790|54554239|FG002|Overall Study|Participant request to discontinue study treatment|2|||
27898650|NCT03338790|54554240|FG003|Overall Study|Participant request to discontinue study treatment|1|||
27898651|NCT03338790|54554237|FG000|Overall Study|Poor/non-compliance|0|||
27898652|NCT03338790|54554238|FG001|Overall Study|Poor/non-compliance|1|||
27898653|NCT03338790|54554239|FG002|Overall Study|Poor/non-compliance|0|||
27898654|NCT03338790|54554240|FG003|Overall Study|Poor/non-compliance|0|||
27898655|NCT03338790|54554237|FG000|Overall Study|Participant withdrew consent|1|||
27898656|NCT03338790|54554238|FG001|Overall Study|Participant withdrew consent|0|||
27898657|NCT03338790|54554239|FG002|Overall Study|Participant withdrew consent|1|||
27898658|NCT03338790|54554240|FG003|Overall Study|Participant withdrew consent|1|||
27898659|NCT03338790|54554237|FG000|Overall Study|Other reasons|0|||
27898660|NCT03338790|54554238|FG001|Overall Study|Other reasons|5|||
27898661|NCT03338790|54554239|FG002|Overall Study|Other reasons|0|||
27898662|NCT03338790|54554240|FG003|Overall Study|Other reasons|2|||
27898663|NCT03338790|54554237|FG000|Overall Study|Not reported|0|||
27898664|NCT03338790|54554238|FG001|Overall Study|Not reported|0|||
27898665|NCT03338790|54554239|FG002|Overall Study|Not reported|1|||
27898666|NCT03338790|54554240|FG003|Overall Study|Not reported|0|||
27898667|NCT03338790|54554237|FG000|Overall Study|Completed treatment period|1|||
27898668|NCT03338790|54554238|FG001|Overall Study|Completed treatment period|2|||
27898669|NCT03338790|54554239|FG002|Overall Study|Completed treatment period|0|||
27898670|NCT03338790|54554240|FG003|Overall Study|Completed treatment period|0|||
27898671|NCT02954536|54554267|FG000|Overall Study|Adverse Event|2|||
27898672|NCT02954536|54554267|FG000|Overall Study|Death|12|||
27898673|NCT02919670|54554273|FG000|Overall Study|Only 17 participants met compliance|43|||
27898674|NCT02919670|54554274|FG001|Overall Study|Only 17 participants met compliance|39|||
27898675|NCT02250326|54554373|FG000|Treatment Period|Death|1|||
27898676|NCT02250326|54554374|FG001|Treatment Period|Death|12|||
27898677|NCT02250326|54554375|FG002|Treatment Period|Death|2|||
27898678|NCT02250326|54554373|FG000|Treatment Period|Adverse Event|8|||
27898679|NCT02250326|54554374|FG001|Treatment Period|Adverse Event|4|||
27898680|NCT02250326|54554375|FG002|Treatment Period|Adverse Event|8|||
27898681|NCT02250326|54554373|FG000|Treatment Period|Progressive Disease|42|||
27898682|NCT02250326|54554374|FG001|Treatment Period|Progressive Disease|36|||
27898683|NCT02250326|54554375|FG002|Treatment Period|Progressive Disease|45|||
27898684|NCT02250326|54554373|FG000|Treatment Period|Symptomatic Deterioration|9|||
27898685|NCT02250326|54554374|FG001|Treatment Period|Symptomatic Deterioration|4|||
27898686|NCT02250326|54554375|FG002|Treatment Period|Symptomatic Deterioration|10|||
27898687|NCT02250326|54554373|FG000|Treatment Period|Withdrawal by Subject|11|||
27898688|NCT02250326|54554374|FG001|Treatment Period|Withdrawal by Subject|5|||
27898689|NCT02250326|54554375|FG002|Treatment Period|Withdrawal by Subject|4|||
27898690|NCT02250326|54554373|FG000|Treatment Period|Miscellaneous|8|||
27898691|NCT02250326|54554374|FG001|Treatment Period|Miscellaneous|2|||
27898692|NCT02250326|54554375|FG002|Treatment Period|Miscellaneous|7|||
27898693|NCT02250326|54554373|FG000|Treatment Period|Randomized or assigned; not treated|2|||
27898694|NCT02250326|54554374|FG001|Treatment Period|Randomized or assigned; not treated|1|||
27898695|NCT02250326|54554375|FG002|Treatment Period|Randomized or assigned; not treated|1|||
27898696|NCT02250326|54554373|FG000|Follow-Up Period|Death|46|||
27898697|NCT02250326|54554374|FG001|Follow-Up Period|Death|26|||
27898698|NCT02250326|54554375|FG002|Follow-Up Period|Death|32|||
27898699|NCT02250326|54554373|FG000|Follow-Up Period|Unknown or Missing|2|||
27898700|NCT02250326|54554374|FG001|Follow-Up Period|Unknown or Missing|3|||
27898701|NCT02250326|54554375|FG002|Follow-Up Period|Unknown or Missing|3|||
27898702|NCT02250326|54554373|FG000|Follow-Up Period|Lost to Follow-up|1|||
27898703|NCT02250326|54554374|FG001|Follow-Up Period|Lost to Follow-up|1|||
27898704|NCT02250326|54554375|FG002|Follow-Up Period|Lost to Follow-up|3|||
27898705|NCT01567722|54554387|FG000|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|1|||
27898706|NCT01567722|54554388|FG001|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
27898707|NCT01567722|54554389|FG002|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
27898708|NCT01567722|54554387|FG000|Overall Study|Insufficient tissue available to satisfy the protocol requirements|2|||
27898709|NCT01567722|54554388|FG001|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
27898710|NCT01567722|54554389|FG002|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
27898711|NCT01567722|54554387|FG000|Overall Study|Protocol closure by the OCG|2|||
27898712|NCT01567722|54554388|FG001|Overall Study|Protocol closure by the OCG|0|||
27898713|NCT01567722|54554389|FG002|Overall Study|Protocol closure by the OCG|0|||
27898714|NCT01567722|54554387|FG000|Overall Study|Not enough tissue left for the tissue scrolls|1|||
27898715|NCT01567722|54554388|FG001|Overall Study|Not enough tissue left for the tissue scrolls|0|||
27898716|NCT01567722|54554389|FG002|Overall Study|Not enough tissue left for the tissue scrolls|0|||
27898717|NCT01349790|54554414|FG000|Overall Study|Investigator Judgement|3|||
27898718|NCT01349790|54554414|FG000|Overall Study|Death|2|||
27898719|NCT01349790|54554414|FG000|Overall Study|Withdrawal by Patient|2|||
27898720|NCT01349790|54554414|FG000|Overall Study|Adverse Event|1|||
27898721|NCT01349790|54554414|FG000|Overall Study|Lost to Follow-up|1|||
27898722|NCT01349595|54554420|FG000|Overall Study|Lack of funding|2|||
27898723|NCT01349595|54554421|FG001|Overall Study|Lack of funding|2|||
27898724|NCT01349673|54554431|FG000|Overall Study|Progression Of Disease Past 40 cm|1|||
27898725|NCT01349673|54554431|FG000|Overall Study|No Longer Qualified For Study|1|||
27898726|NCT01349673|54554431|FG000|Overall Study|Site Closure|10|||
27898727|NCT01349673|54554431|FG000|Overall Study|Withdrawal by Subject|21|||
27898728|NCT01349673|54554431|FG000|Overall Study|Lost to Follow-up|6|||
27898729|NCT01349673|54554431|FG000|Overall Study|Adverse Event|17|||
27898730|NCT01349673|54554431|FG000|Overall Study|Study Terminated By Sponsor|50|||
27898731|NCT01349673|54554431|FG000|Overall Study|Lack of Efficacy|8|||
27898732|NCT01349660|54554540|FG000|Overall Study|Still Receiving Study Treatment|0|||
27898733|NCT01349660|54554541|FG001|Overall Study|Still Receiving Study Treatment|0|||
27898734|NCT01349660|54554542|FG002|Overall Study|Still Receiving Study Treatment|1|||
27898735|NCT01349660|54554540|FG000|Overall Study|Disease Progression|2|||
27898736|NCT01349660|54554541|FG001|Overall Study|Disease Progression|4|||
27898737|NCT01349660|54554542|FG002|Overall Study|Disease Progression|50|||
27898738|NCT01349660|54554540|FG000|Overall Study|Adverse Event|1|||
27898739|NCT01349660|54554541|FG001|Overall Study|Adverse Event|1|||
27898740|NCT01349660|54554542|FG002|Overall Study|Adverse Event|12|||
27898741|NCT01349660|54554540|FG000|Overall Study|Withdrawal by Subject|2|||
27898742|NCT01349660|54554541|FG001|Overall Study|Withdrawal by Subject|0|||
27898743|NCT01349660|54554542|FG002|Overall Study|Withdrawal by Subject|9|||
27898744|NCT01349660|54554540|FG000|Overall Study|Death|1|||
27898745|NCT01349660|54554541|FG001|Overall Study|Death|1|||
27898746|NCT01349660|54554542|FG002|Overall Study|Death|0|||
27898747|NCT01349660|54554540|FG000|Overall Study|Non-Permitted Interventions|0|||
27898748|NCT01349660|54554541|FG001|Overall Study|Non-Permitted Interventions|0|||
28172087|NCT02718417|54843703|FG001|Observation Phase (OP)|Physician Decision|0|||
28172088|NCT02718417|54843704|FG002|Observation Phase (OP)|Physician Decision|9|||
27898749|NCT01349660|54554542|FG002|Overall Study|Non-Permitted Interventions|2|||
27898750|NCT01349660|54554540|FG000|Overall Study|Study Compliance|0|||
27898751|NCT01349660|54554541|FG001|Overall Study|Study Compliance|0|||
27898752|NCT01349660|54554542|FG002|Overall Study|Study Compliance|1|||
27898753|NCT01349660|54554540|FG000|Overall Study|Declining Performance Status|0|||
27898754|NCT01349660|54554541|FG001|Overall Study|Declining Performance Status|0|||
27898755|NCT01349660|54554542|FG002|Overall Study|Declining Performance Status|1|||
27898756|NCT01349569|54554561|FG000|Overall Study|Lack of Efficacy|4|||
27898757|NCT04642079|54554708|FG000|Overall Study|Lost to Follow-up|2|||
27898758|NCT04642079|54554709|FG001|Overall Study|Lost to Follow-up|5|||
27898759|NCT04642079|54554710|FG002|Overall Study|Lost to Follow-up|2|||
27898760|NCT04642079|54554711|FG003|Overall Study|Lost to Follow-up|0|||
27898761|NCT04642079|54554708|FG000|Overall Study|Withdrawal by Subject|0|||
27898762|NCT04642079|54554709|FG001|Overall Study|Withdrawal by Subject|4|||
27898763|NCT04642079|54554710|FG002|Overall Study|Withdrawal by Subject|1|||
27898764|NCT04642079|54554711|FG003|Overall Study|Withdrawal by Subject|2|||
27898765|NCT04642079|54554708|FG000|Overall Study|Other|0|||
27898766|NCT04642079|54554709|FG001|Overall Study|Other|0|||
27898767|NCT04642079|54554710|FG002|Overall Study|Other|0|||
27898768|NCT04642079|54554711|FG003|Overall Study|Other|1|||
27898769|NCT04642079|54554708|FG000|Overall Study|No longer met eligibility criteria|1|||
27898770|NCT04642079|54554709|FG001|Overall Study|No longer met eligibility criteria|0|||
27898771|NCT04642079|54554710|FG002|Overall Study|No longer met eligibility criteria|1|||
27898772|NCT04642079|54554711|FG003|Overall Study|No longer met eligibility criteria|1|||
27898773|NCT04419493|54554730|FG000|Wash-out After Period 1|Adverse Event|1|||
27898774|NCT04419493|54554731|FG001|Wash-out After Period 1|Adverse Event|2|||
27898775|NCT04419493|54554732|FG002|Wash-out After Period 1|Adverse Event|1|||
27898776|NCT04419493|54554733|FG003|Wash-out After Period 1|Adverse Event|0|||
27898777|NCT04359901|54554746|FG000|Overall Study|Withdrawal by Subject|0|||
27898778|NCT04359901|54554747|FG001|Overall Study|Withdrawal by Subject|1|||
27986073|NCT00883896|54644509|FG000|Overall Study|Lost to Follow-up|0|||
27986074|NCT00883896|54644510|FG001|Overall Study|Lost to Follow-up|0|||
27986075|NCT00883896|54644511|FG002|Overall Study|Lost to Follow-up|0|||
27986076|NCT00883896|54644512|FG003|Overall Study|Lost to Follow-up|2|||
27986077|NCT00883896|54644509|FG000|Overall Study|Withdrawal by Subject|5|||
27986078|NCT00883896|54644510|FG001|Overall Study|Withdrawal by Subject|0|||
27986079|NCT00883896|54644511|FG002|Overall Study|Withdrawal by Subject|1|||
27986080|NCT00883896|54644512|FG003|Overall Study|Withdrawal by Subject|3|||
27986081|NCT00883896|54644509|FG000|Overall Study|Lack of Efficacy|0|||
27986082|NCT00883896|54644510|FG001|Overall Study|Lack of Efficacy|0|||
27986083|NCT00883896|54644511|FG002|Overall Study|Lack of Efficacy|0|||
27986084|NCT00883896|54644512|FG003|Overall Study|Lack of Efficacy|2|||
27986085|NCT00883896|54644509|FG000|Overall Study|Other|1|||
27986086|NCT00883896|54644510|FG001|Overall Study|Other|0|||
27986087|NCT00883896|54644511|FG002|Overall Study|Other|0|||
27986088|NCT00883896|54644512|FG003|Overall Study|Other|0|||
27986089|NCT03920293|54644524|FG000|Overall Study|Withdrawal by Subject|2|||
27986090|NCT03920293|54644525|FG001|Overall Study|Withdrawal by Subject|1|||
27986091|NCT03920293|54644524|FG000|Overall Study|Physician Decision|1|||
27986092|NCT03920293|54644525|FG001|Overall Study|Physician Decision|2|||
27986093|NCT03920293|54644524|FG000|Overall Study|Adverse Event|0|||
27986094|NCT03920293|54644525|FG001|Overall Study|Adverse Event|2|||
27986095|NCT03920293|54644524|FG000|Overall Study|Sponsor Decision|0|||
27986096|NCT03920293|54644525|FG001|Overall Study|Sponsor Decision|1|||
27986097|NCT03920293|54644524|FG000|Overall Study|Death|2|||
27986098|NCT03920293|54644525|FG001|Overall Study|Death|0|||
27986099|NCT03920293|54644524|FG000|Overall Study|Protocol Violation|1|||
27986100|NCT03920293|54644525|FG001|Overall Study|Protocol Violation|0|||
27986101|NCT03920293|54644524|FG000|Overall Study|Noncompliance|1|||
27986102|NCT03920293|54644525|FG001|Overall Study|Noncompliance|0|||
27986103|NCT00867009|54644531|FG000|Induction Period|Nonserious Adverse Event|5|||
27986104|NCT00867009|54644531|FG000|Induction Period|Serious Adverse Event|10|||
27986105|NCT00867009|54644531|FG000|Induction Period|Death due to serious adverse event|6|||
27986106|NCT00867009|54644531|FG000|Induction Period|Death due to Study Disease|4|||
27986107|NCT00867009|54644531|FG000|Induction Period|Protocol Violation|1|||
27986108|NCT00867009|54644531|FG000|Induction Period|Withdrawal by Subject|8|||
27986109|NCT00867009|54644531|FG000|Induction Period|Physician Decision|3|||
27986110|NCT00867009|54644531|FG000|Induction Period|Progressive Disease (PD)|25|||
27986111|NCT00867009|54644531|FG000|Maintenance Period|On-going in the Study at Data Cut-off|4|||
27986112|NCT00601250|54644537|FG000|Overall Study|Adverse Event|3|||
27986113|NCT00601250|54644538|FG001|Overall Study|Adverse Event|9|||
27986114|NCT00601250|54644537|FG000|Overall Study|Protocol Violation|3|||
27986115|NCT00601250|54644538|FG001|Overall Study|Protocol Violation|2|||
27986116|NCT00601250|54644537|FG000|Overall Study|Lost to Follow-up|2|||
27986117|NCT00601250|54644538|FG001|Overall Study|Lost to Follow-up|6|||
27986118|NCT00601250|54644537|FG000|Overall Study|Withdrawal by Subject|4|||
27986119|NCT00601250|54644538|FG001|Overall Study|Withdrawal by Subject|13|||
27986120|NCT00601250|54644537|FG000|Overall Study|Other incl. lack of efficacy|2|||
27739465|NCT01676727|54189159|FG000|Overall Study|Not willing to attend 1-year visit|2|||
27898779|NCT04359901|54554746|FG000|Overall Study|Death|6|||
27986121|NCT00601250|54644538|FG001|Overall Study|Other incl. lack of efficacy|9|||
27898780|NCT04359901|54554747|FG001|Overall Study|Death|2|||
27898781|NCT04147611|54554770|FG000|Overall Study|Physician Decision|0|||
27898782|NCT04147611|54554771|FG001|Overall Study|Physician Decision|1|||
27898783|NCT03765788|54554804|FG000|Overall Study|Subject decision|2|||
27898784|NCT03765788|54554805|FG001|Overall Study|Subject decision|3|||
27898785|NCT03765788|54554804|FG000|Overall Study|Physician Decision|2|||
27898786|NCT03765788|54554805|FG001|Overall Study|Physician Decision|4|||
27898787|NCT03765788|54554804|FG000|Overall Study|Death|0|||
27898788|NCT03765788|54554805|FG001|Overall Study|Death|1|||
27898789|NCT03765788|54554804|FG000|Overall Study|Lost to Follow-up|1|||
27898790|NCT03765788|54554805|FG001|Overall Study|Lost to Follow-up|0|||
27898791|NCT03635424|54554812|FG000|Overall Study|Adverse Event|1|||
27898792|NCT03635424|54554812|FG000|Overall Study|Death|1|||
27898793|NCT03635424|54554812|FG000|Overall Study|Device not implanted|1|||
27898794|NCT03603964|54554816|FG000|Overall Study|Death|9|||
27898795|NCT03603964|54554816|FG000|Overall Study|Withdrawal by participant|7|||
27898796|NCT03603964|54554816|FG000|Overall Study|Study terminated by Sponsor|19|||
27898797|NCT03191864|54554845|FG000|Baseline Symptom Assessment|Lost to Follow-up|0|||
27898798|NCT03191864|54554846|FG001|Baseline Symptom Assessment|Lost to Follow-up|0|||
27898799|NCT03191864|54554847|FG002|Baseline Symptom Assessment|Lost to Follow-up|0|||
27898800|NCT03191864|54554848|FG003|Baseline Symptom Assessment|Lost to Follow-up|0|||
27898801|NCT03191864|54554849|FG004|Baseline Symptom Assessment|Lost to Follow-up|0|||
27898802|NCT03191864|54554850|FG005|Baseline Symptom Assessment|Lost to Follow-up|1|||
27898803|NCT03191864|54554845|FG000|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
27898804|NCT03191864|54554846|FG001|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
27898805|NCT03191864|54554847|FG002|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
27898806|NCT03191864|54554848|FG003|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
27898807|NCT03191864|54554849|FG004|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
27898808|NCT03191864|54554850|FG005|Baseline Symptom Assessment|Patient Diary Unavailable at Site|1|||
27898809|NCT03191864|54554845|FG000|Baseline Symptom Assessment|Adverse Event|0|||
27898810|NCT03191864|54554846|FG001|Baseline Symptom Assessment|Adverse Event|0|||
27898811|NCT03191864|54554847|FG002|Baseline Symptom Assessment|Adverse Event|0|||
27898812|NCT03191864|54554848|FG003|Baseline Symptom Assessment|Adverse Event|0|||
27898813|NCT03191864|54554849|FG004|Baseline Symptom Assessment|Adverse Event|0|||
27898814|NCT03191864|54554850|FG005|Baseline Symptom Assessment|Adverse Event|2|||
27898815|NCT03191864|54554845|FG000|Baseline Symptom Assessment|Withdrawal by Subject|0|||
27898816|NCT03191864|54554846|FG001|Baseline Symptom Assessment|Withdrawal by Subject|0|||
27898817|NCT03191864|54554847|FG002|Baseline Symptom Assessment|Withdrawal by Subject|0|||
27898818|NCT03191864|54554848|FG003|Baseline Symptom Assessment|Withdrawal by Subject|0|||
27898819|NCT03191864|54554849|FG004|Baseline Symptom Assessment|Withdrawal by Subject|0|||
27898820|NCT03191864|54554850|FG005|Baseline Symptom Assessment|Withdrawal by Subject|19|||
27898821|NCT03191864|54554845|FG000|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
27898822|NCT03191864|54554846|FG001|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
27898823|NCT03191864|54554847|FG002|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
27898824|NCT03191864|54554848|FG003|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
27898825|NCT03191864|54554849|FG004|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
27898826|NCT03191864|54554850|FG005|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|179|||
27898827|NCT03191864|54554845|FG000|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
27898828|NCT03191864|54554846|FG001|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
27898829|NCT03191864|54554847|FG002|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
27898830|NCT03191864|54554848|FG003|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
27898831|NCT03191864|54554849|FG004|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
27898832|NCT03191864|54554850|FG005|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
27898833|NCT03191864|54554845|FG000|Part 1 - Induction|Adverse Event|0|||
27898834|NCT03191864|54554846|FG001|Part 1 - Induction|Adverse Event|2|||
27898835|NCT03191864|54554847|FG002|Part 1 - Induction|Adverse Event|0|||
27898836|NCT03191864|54554848|FG003|Part 1 - Induction|Adverse Event|1|||
27898837|NCT03191864|54554849|FG004|Part 1 - Induction|Adverse Event|0|||
27898838|NCT03191864|54554850|FG005|Part 1 - Induction|Adverse Event|2|||
27986122|NCT00866775|54644546|FG000|Overall Study|Adverse Event|5|||
27986123|NCT00866775|54644547|FG001|Overall Study|Adverse Event|19|||
28172089|NCT02718417|54843702|FG000|Observation Phase (OP)|Progressive disease|0|||
28097244|NCT01317550|54752780|FG003|Overall Study|Lack of compliance study med|0|||
28097245|NCT01317472|54752792|FG000|Overall Study|Withdrawal by Subject|1|||
28097246|NCT01317472|54752793|FG001|Overall Study|Withdrawal by Subject|0|||
28172090|NCT02718417|54843703|FG001|Observation Phase (OP)|Progressive disease|0|||
28097247|NCT01317472|54752792|FG000|Overall Study|Unrelated hospitalization|1|||
28097248|NCT01317472|54752793|FG001|Overall Study|Unrelated hospitalization|0|||
28097249|NCT01345630|54752801|FG000|Overall Study|Adverse Event|22|||
28172091|NCT02718417|54843704|FG002|Observation Phase (OP)|Progressive disease|92|||
28097250|NCT01345630|54752802|FG001|Overall Study|Adverse Event|23|||
28097251|NCT01345630|54752801|FG000|Overall Study|Lost to Follow-up|17|||
27898839|NCT03191864|54554845|FG000|Part 1 - Induction|Randomized but never dosed|0|||
27898840|NCT03191864|54554846|FG001|Part 1 - Induction|Randomized but never dosed|0|||
27898841|NCT03191864|54554847|FG002|Part 1 - Induction|Randomized but never dosed|1|||
28097252|NCT01345630|54752802|FG001|Overall Study|Lost to Follow-up|16|||
27898842|NCT03191864|54554848|FG003|Part 1 - Induction|Randomized but never dosed|0|||
27898843|NCT03191864|54554849|FG004|Part 1 - Induction|Randomized but never dosed|0|||
27898844|NCT03191864|54554850|FG005|Part 1 - Induction|Randomized but never dosed|0|||
27898845|NCT03191864|54554845|FG000|Part 1 - Induction|Withdrawal by Subject|3|||
27898846|NCT03191864|54554846|FG001|Part 1 - Induction|Withdrawal by Subject|1|||
27898847|NCT03191864|54554847|FG002|Part 1 - Induction|Withdrawal by Subject|0|||
27898848|NCT03191864|54554848|FG003|Part 1 - Induction|Withdrawal by Subject|0|||
27898849|NCT03191864|54554849|FG004|Part 1 - Induction|Withdrawal by Subject|0|||
27898850|NCT03191864|54554850|FG005|Part 1 - Induction|Withdrawal by Subject|2|||
27898851|NCT03191864|54554845|FG000|Part 2 - Maintenance|Refused EGD at Week 26|0|||
27898852|NCT03191864|54554846|FG001|Part 2 - Maintenance|Refused EGD at Week 26|0|||
27898853|NCT03191864|54554847|FG002|Part 2 - Maintenance|Refused EGD at Week 26|1|||
27898854|NCT03191864|54554848|FG003|Part 2 - Maintenance|Refused EGD at Week 26|0|||
27898855|NCT03191864|54554849|FG004|Part 2 - Maintenance|Refused EGD at Week 26|0|||
27898856|NCT03191864|54554850|FG005|Part 2 - Maintenance|Refused EGD at Week 26|0|||
27898857|NCT03191864|54554845|FG000|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|1|||
27898858|NCT03191864|54554846|FG001|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
27898859|NCT03191864|54554847|FG002|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
27898860|NCT03191864|54554848|FG003|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
27898861|NCT03191864|54554849|FG004|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
27898862|NCT03191864|54554850|FG005|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
27898863|NCT03191864|54554845|FG000|Part 2 - Maintenance|Physician Decision|1|||
27898864|NCT03191864|54554846|FG001|Part 2 - Maintenance|Physician Decision|0|||
27898865|NCT03191864|54554847|FG002|Part 2 - Maintenance|Physician Decision|0|||
27898866|NCT03191864|54554848|FG003|Part 2 - Maintenance|Physician Decision|0|||
27898867|NCT03191864|54554849|FG004|Part 2 - Maintenance|Physician Decision|0|||
27898868|NCT03191864|54554850|FG005|Part 2 - Maintenance|Physician Decision|0|||
27898869|NCT03191864|54554845|FG000|Part 2 - Maintenance|Lack of Efficacy|1|||
27898870|NCT03191864|54554846|FG001|Part 2 - Maintenance|Lack of Efficacy|2|||
27898871|NCT03191864|54554847|FG002|Part 2 - Maintenance|Lack of Efficacy|2|||
27898872|NCT03191864|54554848|FG003|Part 2 - Maintenance|Lack of Efficacy|2|||
27898873|NCT03191864|54554849|FG004|Part 2 - Maintenance|Lack of Efficacy|10|||
27898874|NCT03191864|54554850|FG005|Part 2 - Maintenance|Lack of Efficacy|0|||
27898875|NCT03191864|54554845|FG000|Part 2 - Maintenance|Adverse Event|0|||
27898876|NCT03191864|54554846|FG001|Part 2 - Maintenance|Adverse Event|0|||
27898877|NCT03191864|54554847|FG002|Part 2 - Maintenance|Adverse Event|0|||
27898878|NCT03191864|54554848|FG003|Part 2 - Maintenance|Adverse Event|0|||
27898879|NCT03191864|54554849|FG004|Part 2 - Maintenance|Adverse Event|1|||
27898880|NCT03191864|54554850|FG005|Part 2 - Maintenance|Adverse Event|0|||
27898881|NCT03191864|54554845|FG000|Part 2 - Maintenance|Withdrawal by Subject|2|||
27898882|NCT03191864|54554846|FG001|Part 2 - Maintenance|Withdrawal by Subject|0|||
27898883|NCT03191864|54554847|FG002|Part 2 - Maintenance|Withdrawal by Subject|0|||
27898884|NCT03191864|54554848|FG003|Part 2 - Maintenance|Withdrawal by Subject|0|||
27898885|NCT03191864|54554849|FG004|Part 2 - Maintenance|Withdrawal by Subject|3|||
27986124|NCT00866775|54644546|FG000|Overall Study|Death|1|||
27986125|NCT00866775|54644547|FG001|Overall Study|Death|0|||
27986126|NCT00866775|54644546|FG000|Overall Study|Lost to Follow-up|0|||
27986127|NCT00866775|54644547|FG001|Overall Study|Lost to Follow-up|4|||
27986128|NCT00866775|54644546|FG000|Overall Study|Physician Decision|0|||
27986129|NCT00866775|54644547|FG001|Overall Study|Physician Decision|3|||
27986130|NCT00866775|54644546|FG000|Overall Study|Protocol Violation|3|||
27986131|NCT00866775|54644547|FG001|Overall Study|Protocol Violation|4|||
27986132|NCT00866775|54644546|FG000|Overall Study|Withdrawal by Subject|4|||
27986133|NCT00866775|54644547|FG001|Overall Study|Withdrawal by Subject|4|||
27986134|NCT00866775|54644546|FG000|Overall Study|met exit criteria|23|||
27986135|NCT00866775|54644547|FG001|Overall Study|met exit criteria|17|||
27986136|NCT00866775|54644546|FG000|Overall Study|discontinued due to communication error|0|||
27986137|NCT00866775|54644547|FG001|Overall Study|discontinued due to communication error|1|||
27986138|NCT03265210|54644557|FG000|Overall Study|Withdrawal by Subject|7|||
28097253|NCT01345630|54752801|FG000|Overall Study|Protocol Violation|4|||
28097254|NCT01345630|54752802|FG001|Overall Study|Protocol Violation|1|||
27898886|NCT03191864|54554850|FG005|Part 2 - Maintenance|Withdrawal by Subject|0|||
27898887|NCT03191864|54554845|FG000|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
27898888|NCT03191864|54554846|FG001|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
27898889|NCT03191864|54554847|FG002|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
27898890|NCT03191864|54554848|FG003|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
27898891|NCT03191864|54554849|FG004|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|1|||
27898892|NCT03191864|54554850|FG005|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
27898893|NCT02975882|54554882|FG000|Overall Study|Adverse Event|1|||
27986139|NCT03265210|54644558|FG001|Overall Study|Withdrawal by Subject|9|||
28097255|NCT01345630|54752801|FG000|Overall Study|Medication error without associated AE|0|||
27898894|NCT02975882|54554883|FG001|Overall Study|Adverse Event|2|||
27898895|NCT02975882|54554884|FG002|Overall Study|Adverse Event|1|||
27898896|NCT02975882|54554885|FG003|Overall Study|Adverse Event|1|||
27898897|NCT02975882|54554882|FG000|Overall Study|Death|0|||
27898898|NCT02975882|54554883|FG001|Overall Study|Death|1|||
27898899|NCT02975882|54554884|FG002|Overall Study|Death|0|||
27898900|NCT02975882|54554885|FG003|Overall Study|Death|0|||
27898901|NCT02975882|54554882|FG000|Overall Study|Lack of Efficacy|3|||
27898902|NCT02975882|54554883|FG001|Overall Study|Lack of Efficacy|7|||
27898903|NCT02975882|54554884|FG002|Overall Study|Lack of Efficacy|4|||
27898904|NCT02975882|54554885|FG003|Overall Study|Lack of Efficacy|3|||
27898905|NCT02975882|54554882|FG000|Overall Study|Physician Decision|0|||
27898906|NCT02975882|54554883|FG001|Overall Study|Physician Decision|2|||
27898907|NCT02975882|54554884|FG002|Overall Study|Physician Decision|4|||
27898908|NCT02975882|54554885|FG003|Overall Study|Physician Decision|2|||
27898909|NCT02975882|54554882|FG000|Overall Study|Ineligible|0|||
27898910|NCT02975882|54554883|FG001|Overall Study|Ineligible|1|||
27898911|NCT02975882|54554884|FG002|Overall Study|Ineligible|0|||
27898912|NCT02975882|54554885|FG003|Overall Study|Ineligible|0|||
27898913|NCT02636725|54554931|FG000|Baseline|Adverse Event|1|||
27898914|NCT02636725|54554931|FG000|Baseline|Lack of Efficacy|2|||
27898915|NCT02573493|54554939|FG000|Overall Study|Determined to not be eligible after enrollment|0|||
27898916|NCT02573493|54554940|FG001|Overall Study|Determined to not be eligible after enrollment|0|||
27898917|NCT02573493|54554941|FG002|Overall Study|Determined to not be eligible after enrollment|0|||
27898918|NCT02573493|54554942|FG003|Overall Study|Determined to not be eligible after enrollment|1|||
27898919|NCT02327078|54554975|FG000|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
27898920|NCT02327078|54554976|FG001|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
27898921|NCT02327078|54554977|FG002|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|2|||
27898922|NCT02327078|54554978|FG003|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
27898923|NCT02327078|54554979|FG004|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
27898924|NCT02327078|54554980|FG005|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
27898925|NCT02327078|54554981|FG006|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
27898926|NCT02327078|54554982|FG007|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|11|||
27898927|NCT02327078|54554983|FG008|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|25|||
27898928|NCT02327078|54554975|FG000|Overall Study|Death|2|||
27898929|NCT02327078|54554976|FG001|Overall Study|Death|4|||
27898930|NCT02327078|54554977|FG002|Overall Study|Death|10|||
27898931|NCT02327078|54554978|FG003|Overall Study|Death|6|||
27898932|NCT02327078|54554979|FG004|Overall Study|Death|4|||
27898933|NCT02327078|54554980|FG005|Overall Study|Death|3|||
27898934|NCT02327078|54554981|FG006|Overall Study|Death|2|||
27898935|NCT02327078|54554982|FG007|Overall Study|Death|51|||
27898936|NCT02327078|54554983|FG008|Overall Study|Death|97|||
27898937|NCT02327078|54554975|FG000|Overall Study|Lost to Follow-up|0|||
27898938|NCT02327078|54554976|FG001|Overall Study|Lost to Follow-up|1|||
27898939|NCT02327078|54554977|FG002|Overall Study|Lost to Follow-up|1|||
27898940|NCT02327078|54554978|FG003|Overall Study|Lost to Follow-up|0|||
27898941|NCT02327078|54554979|FG004|Overall Study|Lost to Follow-up|0|||
27898942|NCT02327078|54554980|FG005|Overall Study|Lost to Follow-up|0|||
27898943|NCT02327078|54554981|FG006|Overall Study|Lost to Follow-up|0|||
27898944|NCT02327078|54554982|FG007|Overall Study|Lost to Follow-up|2|||
27898945|NCT02327078|54554983|FG008|Overall Study|Lost to Follow-up|5|||
27898946|NCT02327078|54554975|FG000|Overall Study|Site Terminated by Sponsor|1|||
27898947|NCT02327078|54554976|FG001|Overall Study|Site Terminated by Sponsor|0|||
27898948|NCT02327078|54554977|FG002|Overall Study|Site Terminated by Sponsor|1|||
27898949|NCT02327078|54554978|FG003|Overall Study|Site Terminated by Sponsor|4|||
27898950|NCT02327078|54554979|FG004|Overall Study|Site Terminated by Sponsor|0|||
27898951|NCT02327078|54554980|FG005|Overall Study|Site Terminated by Sponsor|0|||
27898952|NCT02327078|54554981|FG006|Overall Study|Site Terminated by Sponsor|0|||
27898953|NCT02327078|54554982|FG007|Overall Study|Site Terminated by Sponsor|11|||
27898954|NCT02327078|54554983|FG008|Overall Study|Site Terminated by Sponsor|25|||
27898955|NCT02327078|54554975|FG000|Overall Study|Physician Decision|0|||
27898956|NCT02327078|54554976|FG001|Overall Study|Physician Decision|0|||
27898957|NCT02327078|54554977|FG002|Overall Study|Physician Decision|0|||
27898958|NCT02327078|54554978|FG003|Overall Study|Physician Decision|1|||
27898959|NCT02327078|54554979|FG004|Overall Study|Physician Decision|0|||
27898960|NCT02327078|54554980|FG005|Overall Study|Physician Decision|0|||
27898961|NCT02327078|54554981|FG006|Overall Study|Physician Decision|0|||
27898962|NCT02327078|54554982|FG007|Overall Study|Physician Decision|0|||
27898963|NCT02327078|54554983|FG008|Overall Study|Physician Decision|1|||
27898964|NCT02327078|54554975|FG000|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
27898965|NCT02327078|54554976|FG001|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
27898966|NCT02327078|54554977|FG002|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
27898967|NCT02327078|54554978|FG003|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
27898968|NCT02327078|54554979|FG004|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
27898969|NCT02327078|54554980|FG005|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
27898970|NCT02327078|54554981|FG006|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
27898971|NCT02327078|54554982|FG007|Overall Study|Completed 100 Day Safety Follow-up Period|3|||
27898972|NCT02327078|54554983|FG008|Overall Study|Completed 100 Day Safety Follow-up Period|11|||
27898973|NCT02327078|54554975|FG000|Overall Study|Reason not Specified|0|||
27898974|NCT02327078|54554976|FG001|Overall Study|Reason not Specified|0|||
27898975|NCT02327078|54554977|FG002|Overall Study|Reason not Specified|0|||
27898976|NCT02327078|54554978|FG003|Overall Study|Reason not Specified|0|||
27898977|NCT02327078|54554979|FG004|Overall Study|Reason not Specified|0|||
27898978|NCT02327078|54554980|FG005|Overall Study|Reason not Specified|0|||
27898979|NCT02327078|54554981|FG006|Overall Study|Reason not Specified|0|||
27898980|NCT02327078|54554982|FG007|Overall Study|Reason not Specified|5|||
27898981|NCT02327078|54554983|FG008|Overall Study|Reason not Specified|12|||
27898982|NCT02304458|54555026|FG000|Overall Study|Adverse Event|0|||
27898983|NCT02304458|54555027|FG001|Overall Study|Adverse Event|0|||
27898984|NCT02304458|54555028|FG002|Overall Study|Adverse Event|7|||
27898985|NCT02304458|54555029|FG003|Overall Study|Adverse Event|0|||
27898986|NCT02304458|54555030|FG004|Overall Study|Adverse Event|0|||
27898987|NCT02304458|54555031|FG005|Overall Study|Adverse Event|0|||
27898988|NCT02304458|54555032|FG006|Overall Study|Adverse Event|3|||
27898989|NCT02304458|54555033|FG007|Overall Study|Adverse Event|4|||
27898990|NCT02304458|54555026|FG000|Overall Study|Death|0|||
27898991|NCT02304458|54555027|FG001|Overall Study|Death|0|||
27898992|NCT02304458|54555028|FG002|Overall Study|Death|2|||
27898993|NCT02304458|54555029|FG003|Overall Study|Death|0|||
27898994|NCT02304458|54555030|FG004|Overall Study|Death|0|||
27898995|NCT02304458|54555031|FG005|Overall Study|Death|0|||
27898996|NCT02304458|54555032|FG006|Overall Study|Death|1|||
27898997|NCT02304458|54555033|FG007|Overall Study|Death|0|||
27898998|NCT02304458|54555026|FG000|Overall Study|Lack of Efficacy|4|||
27898999|NCT02304458|54555027|FG001|Overall Study|Lack of Efficacy|6|||
27899000|NCT02304458|54555028|FG002|Overall Study|Lack of Efficacy|38|||
27899001|NCT02304458|54555029|FG003|Overall Study|Lack of Efficacy|5|||
27899002|NCT02304458|54555030|FG004|Overall Study|Lack of Efficacy|6|||
27899003|NCT02304458|54555031|FG005|Overall Study|Lack of Efficacy|6|||
27899004|NCT02304458|54555032|FG006|Overall Study|Lack of Efficacy|21|||
27899005|NCT02304458|54555033|FG007|Overall Study|Lack of Efficacy|4|||
27899006|NCT02304458|54555026|FG000|Overall Study|Physician Decision|2|||
27899007|NCT02304458|54555027|FG001|Overall Study|Physician Decision|0|||
27899008|NCT02304458|54555028|FG002|Overall Study|Physician Decision|16|||
27899009|NCT02304458|54555029|FG003|Overall Study|Physician Decision|1|||
27899010|NCT02304458|54555030|FG004|Overall Study|Physician Decision|0|||
27899011|NCT02304458|54555031|FG005|Overall Study|Physician Decision|0|||
27899012|NCT02304458|54555032|FG006|Overall Study|Physician Decision|3|||
27899013|NCT02304458|54555033|FG007|Overall Study|Physician Decision|0|||
27899014|NCT02304458|54555026|FG000|Overall Study|Protocol Violation|0|||
27899015|NCT02304458|54555027|FG001|Overall Study|Protocol Violation|0|||
27899016|NCT02304458|54555028|FG002|Overall Study|Protocol Violation|1|||
27899017|NCT02304458|54555029|FG003|Overall Study|Protocol Violation|0|||
27899018|NCT02304458|54555030|FG004|Overall Study|Protocol Violation|0|||
27899019|NCT02304458|54555031|FG005|Overall Study|Protocol Violation|0|||
27899020|NCT02304458|54555032|FG006|Overall Study|Protocol Violation|0|||
27899021|NCT02304458|54555033|FG007|Overall Study|Protocol Violation|0|||
27899022|NCT02304458|54555026|FG000|Overall Study|Withdrawal by Subject|1|||
27899023|NCT02304458|54555027|FG001|Overall Study|Withdrawal by Subject|0|||
27899024|NCT02304458|54555028|FG002|Overall Study|Withdrawal by Subject|7|||
27899025|NCT02304458|54555029|FG003|Overall Study|Withdrawal by Subject|0|||
27899026|NCT02304458|54555030|FG004|Overall Study|Withdrawal by Subject|0|||
27899027|NCT02304458|54555031|FG005|Overall Study|Withdrawal by Subject|0|||
27899028|NCT02304458|54555032|FG006|Overall Study|Withdrawal by Subject|1|||
27899029|NCT02304458|54555033|FG007|Overall Study|Withdrawal by Subject|0|||
27899030|NCT02187224|54555069|FG000|Overall Study|Did not show up for test day|1|||
27899031|NCT02187224|54555070|FG001|Overall Study|Did not show up for test day|0|||
27899032|NCT02176226|54555080|FG000|Overall Study|Lost to Follow-up|3|||
27899033|NCT02176226|54555080|FG000|Overall Study|Withdrew prior to treatment|6|||
27899034|NCT02032823|54555086|FG000|Overall Study|Death|75|||
27899035|NCT02032823|54555087|FG001|Overall Study|Death|109|||
27899036|NCT02032823|54555086|FG000|Overall Study|Lost to Follow-up|18|||
27899037|NCT02032823|54555087|FG001|Overall Study|Lost to Follow-up|17|||
27899038|NCT02032823|54555086|FG000|Overall Study|Withdrawal by Subject|70|||
27899039|NCT02032823|54555087|FG001|Overall Study|Withdrawal by Subject|53|||
27899040|NCT02032823|54555086|FG000|Overall Study|Ongoing study at data cut-off|755|||
27899041|NCT02032823|54555087|FG001|Overall Study|Ongoing study at data cut-off|731|||
27899042|NCT02032823|54555086|FG000|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|3|||
27899043|NCT02032823|54555087|FG001|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|5|||
27899044|NCT01958021|54555095|FG000|Overall Study|Progressive disease|87|||
27899045|NCT01958021|54555096|FG001|Overall Study|Progressive disease|146|||
27899046|NCT01958021|54555095|FG000|Overall Study|Adverse Event|25|||
27899047|NCT01958021|54555096|FG001|Overall Study|Adverse Event|7|||
27899048|NCT01958021|54555095|FG000|Overall Study|Subject/guardian decision|12|||
27899049|NCT01958021|54555096|FG001|Overall Study|Subject/guardian decision|13|||
27899050|NCT01958021|54555095|FG000|Overall Study|Physician Decision|10|||
27899051|NCT01958021|54555096|FG001|Overall Study|Physician Decision|13|||
27899052|NCT01958021|54555095|FG000|Overall Study|Protocol Violation|3|||
27899053|NCT01958021|54555096|FG001|Overall Study|Protocol Violation|1|||
27899054|NCT01958021|54555095|FG000|Overall Study|Death|2|||
27899055|NCT01958021|54555096|FG001|Overall Study|Death|0|||
27899056|NCT05059600|54555102|FG000|Overall Study|Enrolled but not Treated|10|||
27899057|NCT04608448|54555115|FG000|Overall Study|Withdrawal by Subject|1|||
27899058|NCT04608448|54555115|FG000|Overall Study|Adverse Event|1|||
27899059|NCT04530344|54555125|FG000|Overall Study|Lost to Follow-up|3|||
27899060|NCT04530344|54555126|FG001|Overall Study|Lost to Follow-up|3|||
27899061|NCT04530344|54555127|FG002|Overall Study|Lost to Follow-up|3|||
27899062|NCT04530344|54555128|FG003|Overall Study|Lost to Follow-up|10|||
27899063|NCT04530344|54555125|FG000|Overall Study|Withdrawal by Subject|14|||
27899064|NCT04530344|54555126|FG001|Overall Study|Withdrawal by Subject|5|||
27899065|NCT04530344|54555127|FG002|Overall Study|Withdrawal by Subject|18|||
27899066|NCT04530344|54555128|FG003|Overall Study|Withdrawal by Subject|33|||
27899067|NCT04530344|54555125|FG000|Overall Study|Adverse Event|0|||
27899068|NCT04530344|54555126|FG001|Overall Study|Adverse Event|0|||
27899069|NCT04530344|54555127|FG002|Overall Study|Adverse Event|0|||
27899070|NCT04530344|54555128|FG003|Overall Study|Adverse Event|1|||
27899071|NCT04530344|54555125|FG000|Overall Study|Lack of Efficacy|0|||
27899072|NCT04530344|54555126|FG001|Overall Study|Lack of Efficacy|0|||
27899073|NCT04530344|54555127|FG002|Overall Study|Lack of Efficacy|0|||
27899074|NCT04530344|54555128|FG003|Overall Study|Lack of Efficacy|1|||
27899075|NCT04530344|54555125|FG000|Overall Study|Physician Decision|0|||
27899076|NCT04530344|54555126|FG001|Overall Study|Physician Decision|0|||
27899077|NCT04530344|54555127|FG002|Overall Study|Physician Decision|1|||
27899078|NCT04530344|54555128|FG003|Overall Study|Physician Decision|1|||
27899079|NCT04530344|54555125|FG000|Overall Study|Pregnancy|0|||
27899080|NCT04530344|54555126|FG001|Overall Study|Pregnancy|0|||
27899081|NCT04530344|54555127|FG002|Overall Study|Pregnancy|2|||
27899082|NCT04530344|54555128|FG003|Overall Study|Pregnancy|1|||
27899083|NCT04530344|54555125|FG000|Overall Study|Protocol Violation|0|||
27899084|NCT04530344|54555126|FG001|Overall Study|Protocol Violation|0|||
27899085|NCT04530344|54555127|FG002|Overall Study|Protocol Violation|0|||
27899086|NCT04530344|54555128|FG003|Overall Study|Protocol Violation|1|||
27899087|NCT04530344|54555125|FG000|Overall Study|Site Closed Due to Noncompliance|0|||
27899088|NCT04530344|54555126|FG001|Overall Study|Site Closed Due to Noncompliance|0|||
27899089|NCT04530344|54555127|FG002|Overall Study|Site Closed Due to Noncompliance|0|||
27899090|NCT04530344|54555128|FG003|Overall Study|Site Closed Due to Noncompliance|1|||
27899091|NCT04530344|54555125|FG000|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
27899092|NCT04530344|54555126|FG001|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
27899093|NCT04530344|54555127|FG002|Overall Study|Discontinued due to COVID-19 Pandemic|1|||
27899094|NCT04530344|54555128|FG003|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
27899095|NCT04530344|54555125|FG000|Overall Study|Missed Safety Follow-up Visit|0|||
27899096|NCT04530344|54555126|FG001|Overall Study|Missed Safety Follow-up Visit|0|||
27899097|NCT04530344|54555127|FG002|Overall Study|Missed Safety Follow-up Visit|1|||
27899098|NCT04530344|54555128|FG003|Overall Study|Missed Safety Follow-up Visit|0|||
27899099|NCT04530344|54555125|FG000|Overall Study|Personal Reasons|0|||
27899100|NCT04530344|54555126|FG001|Overall Study|Personal Reasons|0|||
27899101|NCT04530344|54555127|FG002|Overall Study|Personal Reasons|0|||
27899102|NCT04530344|54555128|FG003|Overall Study|Personal Reasons|1|||
27899103|NCT04530344|54555125|FG000|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
27899104|NCT04530344|54555126|FG001|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
27899105|NCT04530344|54555127|FG002|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
27899106|NCT04530344|54555128|FG003|Overall Study|Not Compliant with Protocol-specific Visit Window|1|||
27899107|NCT04503096|54555144|FG000|Overall Study|Withdrawal by Subject|3|||
27899108|NCT04058886|54555166|FG000|Overall Study|Withdrawal by Subject|4|||
27899109|NCT04058886|54555166|FG000|Overall Study|Inadequate deafness interpreter service|1|||
27899110|NCT03704194|54555189|FG000|Overall Study|Withdrawal by Subject|0|||
27899111|NCT03704194|54555190|FG001|Overall Study|Withdrawal by Subject|1|||
27899112|NCT03451422|54555204|FG000|Overall Study|Lost to Follow-up|0|||
27899113|NCT03451422|54555205|FG001|Overall Study|Lost to Follow-up|0|||
27899114|NCT03451422|54555206|FG002|Overall Study|Lost to Follow-up|0|||
27899115|NCT03451422|54555207|FG003|Overall Study|Lost to Follow-up|0|||
27899116|NCT03451422|54555208|FG004|Overall Study|Lost to Follow-up|0|||
27899117|NCT03451422|54555209|FG005|Overall Study|Lost to Follow-up|1|||
27899118|NCT03451422|54555204|FG000|Overall Study|Decision by sponsor|1|||
27986140|NCT03265210|54644557|FG000|Overall Study|Lost to Follow-up|2|||
27986141|NCT03265210|54644558|FG001|Overall Study|Lost to Follow-up|0|||
27899119|NCT03451422|54555205|FG001|Overall Study|Decision by sponsor|0|||
27899120|NCT03451422|54555206|FG002|Overall Study|Decision by sponsor|1|||
27899121|NCT03451422|54555207|FG003|Overall Study|Decision by sponsor|0|||
27899122|NCT03451422|54555208|FG004|Overall Study|Decision by sponsor|0|||
27899123|NCT03451422|54555209|FG005|Overall Study|Decision by sponsor|0|||
27899124|NCT03451422|54555204|FG000|Overall Study|Withdrawal by Subject|0|||
27899125|NCT03451422|54555205|FG001|Overall Study|Withdrawal by Subject|0|||
27899126|NCT03451422|54555206|FG002|Overall Study|Withdrawal by Subject|2|||
27899127|NCT03451422|54555207|FG003|Overall Study|Withdrawal by Subject|3|||
27899128|NCT03451422|54555208|FG004|Overall Study|Withdrawal by Subject|2|||
27899129|NCT03451422|54555209|FG005|Overall Study|Withdrawal by Subject|1|||
27899130|NCT03446573|54555230|FG000|Early Switch Phase (Day 1 to Week 148)|Adverse Event|23|||
27899131|NCT03446573|54555231|FG001|Early Switch Phase (Day 1 to Week 148)|Adverse Event|7|||
27899132|NCT03446573|54555230|FG000|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|0|||
27899133|NCT03446573|54555231|FG001|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|6|||
27899134|NCT03446573|54555230|FG000|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|5|||
27899135|NCT03446573|54555231|FG001|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|6|||
27899136|NCT03446573|54555230|FG000|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|4|||
27899137|NCT03446573|54555231|FG001|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|10|||
27899138|NCT03446573|54555230|FG000|Early Switch Phase (Day 1 to Week 148)|Physician Decision|2|||
27899139|NCT03446573|54555231|FG001|Early Switch Phase (Day 1 to Week 148)|Physician Decision|11|||
27899140|NCT03446573|54555230|FG000|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|16|||
27899141|NCT03446573|54555231|FG001|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|33|||
27899142|NCT03446573|54555230|FG000|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|2|||
27899143|NCT03446573|54555231|FG001|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|0|||
27899144|NCT03446573|54555230|FG000|Late Switch Phase (Week 148 to Week 196)|Adverse Event|2|||
27899145|NCT03446573|54555231|FG001|Late Switch Phase (Week 148 to Week 196)|Adverse Event|9|||
27899146|NCT03446573|54555230|FG000|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
27899147|NCT03446573|54555231|FG001|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
27899148|NCT03446573|54555230|FG000|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|0|||
27899149|NCT03446573|54555231|FG001|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|1|||
27899150|NCT03446573|54555230|FG000|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|5|||
27899151|NCT03446573|54555231|FG001|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|6|||
27899152|NCT03446573|54555230|FG000|Late Switch Phase (Week 148 to Week 196)|Physician Decision|0|||
27899153|NCT03446573|54555231|FG001|Late Switch Phase (Week 148 to Week 196)|Physician Decision|1|||
27899154|NCT03446573|54555230|FG000|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|4|||
27899155|NCT03446573|54555231|FG001|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|6|||
27899156|NCT03422536|54555249|FG000|Randomized|Physician Decision|1|||
27899157|NCT03422536|54555250|FG001|Randomized|Physician Decision|1|||
27899158|NCT03422536|54555249|FG000|Allocation - Received Intervention|Disease progression|19|||
27899159|NCT03422536|54555250|FG001|Allocation - Received Intervention|Disease progression|25|||
27899160|NCT03422536|54555249|FG000|Allocation - Received Intervention|Death|1|||
27899161|NCT03422536|54555250|FG001|Allocation - Received Intervention|Death|3|||
27899162|NCT03422536|54555249|FG000|Allocation - Received Intervention|Adverse Event|1|||
27899163|NCT03422536|54555250|FG001|Allocation - Received Intervention|Adverse Event|0|||
27899164|NCT03422536|54555249|FG000|Allocation - Received Intervention|Physician Decision|1|||
27899165|NCT03422536|54555250|FG001|Allocation - Received Intervention|Physician Decision|1|||
27899166|NCT03422536|54555249|FG000|Allocation - Received Intervention|Withdrawal by Subject|3|||
27899167|NCT03422536|54555250|FG001|Allocation - Received Intervention|Withdrawal by Subject|2|||
27899168|NCT03422536|54555249|FG000|Allocation - Received Intervention|Lost to Follow-up|1|||
27899169|NCT03422536|54555250|FG001|Allocation - Received Intervention|Lost to Follow-up|0|||
27899170|NCT03228394|54555264|FG000|Overall Study|Lost to Follow-up|0|||
27899171|NCT03228394|54555265|FG001|Overall Study|Lost to Follow-up|0|||
27899172|NCT03228394|54555266|FG002|Overall Study|Lost to Follow-up|1|||
27899173|NCT03228394|54555267|FG003|Overall Study|Lost to Follow-up|1|||
27899174|NCT03228394|54555268|FG004|Overall Study|Lost to Follow-up|0|||
27899175|NCT03228394|54555269|FG005|Overall Study|Lost to Follow-up|0|||
27899176|NCT03228394|54555270|FG006|Overall Study|Lost to Follow-up|2|||
27899177|NCT03228394|54555271|FG007|Overall Study|Lost to Follow-up|0|||
27899178|NCT03228394|54555264|FG000|Overall Study|Withdrawal by Subject|0|||
27899179|NCT03228394|54555265|FG001|Overall Study|Withdrawal by Subject|0|||
27899180|NCT03228394|54555266|FG002|Overall Study|Withdrawal by Subject|1|||
27899181|NCT03228394|54555267|FG003|Overall Study|Withdrawal by Subject|0|||
27899182|NCT03228394|54555268|FG004|Overall Study|Withdrawal by Subject|0|||
27899183|NCT03228394|54555269|FG005|Overall Study|Withdrawal by Subject|0|||
27899184|NCT03228394|54555270|FG006|Overall Study|Withdrawal by Subject|1|||
27899185|NCT03228394|54555271|FG007|Overall Study|Withdrawal by Subject|3|||
27899186|NCT03228394|54555264|FG000|Overall Study|Protocol Violation|0|||
27899187|NCT03228394|54555265|FG001|Overall Study|Protocol Violation|0|||
27899188|NCT03228394|54555266|FG002|Overall Study|Protocol Violation|0|||
27986142|NCT03265210|54644557|FG000|Overall Study|Physician Decision|2|||
28097256|NCT01345630|54752802|FG001|Overall Study|Medication error without associated AE|1|||
28097257|NCT01345630|54752801|FG000|Overall Study|Study terminated by sponsor|254|||
27899189|NCT03228394|54555267|FG003|Overall Study|Protocol Violation|1|||
27899190|NCT03228394|54555268|FG004|Overall Study|Protocol Violation|0|||
27899191|NCT03228394|54555269|FG005|Overall Study|Protocol Violation|0|||
27899192|NCT03228394|54555270|FG006|Overall Study|Protocol Violation|0|||
27899193|NCT03228394|54555271|FG007|Overall Study|Protocol Violation|0|||
27899194|NCT03228394|54555264|FG000|Overall Study|Physician Decision|0|||
27899195|NCT03228394|54555265|FG001|Overall Study|Physician Decision|0|||
27899196|NCT03228394|54555266|FG002|Overall Study|Physician Decision|0|||
27899197|NCT03228394|54555267|FG003|Overall Study|Physician Decision|0|||
27899198|NCT03228394|54555268|FG004|Overall Study|Physician Decision|0|||
27899199|NCT03228394|54555269|FG005|Overall Study|Physician Decision|0|||
27899200|NCT03228394|54555270|FG006|Overall Study|Physician Decision|1|||
27899201|NCT03228394|54555271|FG007|Overall Study|Physician Decision|0|||
27899202|NCT03228394|54555264|FG000|Overall Study|Noncompliance|0|||
27899203|NCT03228394|54555265|FG001|Overall Study|Noncompliance|0|||
27899204|NCT03228394|54555266|FG002|Overall Study|Noncompliance|0|||
27899205|NCT03228394|54555267|FG003|Overall Study|Noncompliance|0|||
27899206|NCT03228394|54555268|FG004|Overall Study|Noncompliance|0|||
27899207|NCT03228394|54555269|FG005|Overall Study|Noncompliance|0|||
27899208|NCT03228394|54555270|FG006|Overall Study|Noncompliance|1|||
27899209|NCT03228394|54555271|FG007|Overall Study|Noncompliance|0|||
27899210|NCT03043872|54555293|FG000|Overall Study|Withdrawal by Subject|6|||
27899211|NCT03043872|54555294|FG001|Overall Study|Withdrawal by Subject|6|||
27899212|NCT03043872|54555295|FG002|Overall Study|Withdrawal by Subject|15|||
27899213|NCT03043872|54555293|FG000|Overall Study|Lost to Follow-up|2|||
27899214|NCT03043872|54555294|FG001|Overall Study|Lost to Follow-up|1|||
27899215|NCT03043872|54555295|FG002|Overall Study|Lost to Follow-up|1|||
27899216|NCT03043872|54555293|FG000|Overall Study|Death|270|||
27899217|NCT03043872|54555294|FG001|Overall Study|Death|269|||
27899218|NCT03043872|54555295|FG002|Overall Study|Death|296|||
27899219|NCT03008070|54555316|FG000|Overall Study|Adverse Event|3|||
27899220|NCT03008070|54555317|FG001|Overall Study|Adverse Event|3|||
27899221|NCT03008070|54555318|FG002|Overall Study|Adverse Event|3|||
27899222|NCT03008070|54555316|FG000|Overall Study|Lost to Follow-up|1|||
27899223|NCT03008070|54555317|FG001|Overall Study|Lost to Follow-up|1|||
27899224|NCT03008070|54555318|FG002|Overall Study|Lost to Follow-up|0|||
27899225|NCT03008070|54555316|FG000|Overall Study|Non compliance|0|||
27899226|NCT03008070|54555317|FG001|Overall Study|Non compliance|1|||
27899227|NCT03008070|54555318|FG002|Overall Study|Non compliance|1|||
27899228|NCT03008070|54555316|FG000|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
27899229|NCT03008070|54555317|FG001|Overall Study|Withdrawal by patient and adverse event non fatal|1|||
27899230|NCT03008070|54555318|FG002|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
27899231|NCT03008070|54555316|FG000|Overall Study|Withdrawal by Subject|2|||
27899232|NCT03008070|54555317|FG001|Overall Study|Withdrawal by Subject|0|||
27899233|NCT03008070|54555318|FG002|Overall Study|Withdrawal by Subject|1|||
27899234|NCT03008070|54555316|FG000|Overall Study|Use of prohibited drug|0|||
27899235|NCT03008070|54555317|FG001|Overall Study|Use of prohibited drug|0|||
27899236|NCT03008070|54555318|FG002|Overall Study|Use of prohibited drug|2|||
27899237|NCT02979353|54555330|FG000|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|24|||
27899238|NCT02979353|54555331|FG001|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|29|||
27899239|NCT02979353|54555330|FG000|Overall Study|Withdrawal by Subject|16|||
27899240|NCT02979353|54555331|FG001|Overall Study|Withdrawal by Subject|12|||
27899241|NCT02979353|54555330|FG000|Overall Study|Death|10|||
27899242|NCT02979353|54555331|FG001|Overall Study|Death|11|||
27899243|NCT02979353|54555330|FG000|Overall Study|Transfer to Hospice Care|19|||
27899244|NCT02979353|54555331|FG001|Overall Study|Transfer to Hospice Care|14|||
27899245|NCT02979353|54555330|FG000|Overall Study|Lost to Follow-up|1|||
27899246|NCT02979353|54555331|FG001|Overall Study|Lost to Follow-up|5|||
27899247|NCT02633397|54555354|FG000|Overall Study|Adverse Event|8|||
27899248|NCT02633397|54555355|FG001|Overall Study|Adverse Event|8|||
27986143|NCT03265210|54644558|FG001|Overall Study|Physician Decision|0|||
27986144|NCT03265210|54644557|FG000|Overall Study|Adverse Event|1|||
27986145|NCT03265210|54644558|FG001|Overall Study|Adverse Event|0|||
27899249|NCT02633397|54555354|FG000|Overall Study|Study Burden|4|||
27899250|NCT02633397|54555355|FG001|Overall Study|Study Burden|1|||
27899251|NCT02633397|54555354|FG000|Overall Study|Treatment interruption|2|||
27986146|NCT00543985|54644564|FG000|Overall Study|Withdrawal by Subject|4|||
27986147|NCT00582556|54644579|FG000|Overall Study|Withdrawal by Subject|0|||
27899252|NCT02633397|54555355|FG001|Overall Study|Treatment interruption|5|||
27899253|NCT02633397|54555354|FG000|Overall Study|Death|2|||
27986148|NCT00582556|54644580|FG001|Overall Study|Withdrawal by Subject|1|||
27986149|NCT00582556|54644581|FG002|Overall Study|Withdrawal by Subject|1|||
27986150|NCT00582556|54644579|FG000|Overall Study|Physician Decision|0|||
27986151|NCT00582556|54644580|FG001|Overall Study|Physician Decision|0|||
27899254|NCT02633397|54555355|FG001|Overall Study|Death|2|||
27899255|NCT02633397|54555354|FG000|Overall Study|Physician Decision|0|||
27899256|NCT02633397|54555355|FG001|Overall Study|Physician Decision|1|||
27899257|NCT02592707|54555365|FG000|Overall Study|Consent Withdrawn|0|||
27899258|NCT02592707|54555366|FG001|Overall Study|Consent Withdrawn|1|||
27899259|NCT02592707|54555367|FG002|Overall Study|Consent Withdrawn|2|||
27899260|NCT02592707|54555368|FG003|Overall Study|Consent Withdrawn|0|||
27899261|NCT02592707|54555365|FG000|Overall Study|Death|1|||
27899262|NCT02592707|54555366|FG001|Overall Study|Death|0|||
27899263|NCT02592707|54555367|FG002|Overall Study|Death|0|||
27899264|NCT02592707|54555368|FG003|Overall Study|Death|0|||
27899265|NCT02592707|54555365|FG000|Overall Study|Progressive Disease|4|||
27899266|NCT02592707|54555366|FG001|Overall Study|Progressive Disease|4|||
27899267|NCT02592707|54555367|FG002|Overall Study|Progressive Disease|3|||
27899268|NCT02592707|54555368|FG003|Overall Study|Progressive Disease|3|||
27899269|NCT02592707|54555365|FG000|Overall Study|Other|0|||
27899270|NCT02592707|54555366|FG001|Overall Study|Other|0|||
27986152|NCT00582556|54644581|FG002|Overall Study|Physician Decision|1|||
27986153|NCT00542269|54644593|FG000|Overall Study|Adverse Event|10|||
27986154|NCT00542269|54644594|FG001|Overall Study|Adverse Event|4|||
27986155|NCT00542269|54644595|FG002|Overall Study|Adverse Event|5|||
27986156|NCT00542269|54644593|FG000|Overall Study|Protocol Violation|1|||
27986157|NCT00542269|54644594|FG001|Overall Study|Protocol Violation|1|||
27986158|NCT00542269|54644595|FG002|Overall Study|Protocol Violation|0|||
27986159|NCT00542269|54644593|FG000|Overall Study|Withdrawal by Subject|1|||
27986160|NCT00542269|54644594|FG001|Overall Study|Withdrawal by Subject|0|||
27986161|NCT00542269|54644595|FG002|Overall Study|Withdrawal by Subject|0|||
27986162|NCT00542269|54644593|FG000|Overall Study|Administrative problems|1|||
27986163|NCT00542269|54644594|FG001|Overall Study|Administrative problems|1|||
27986164|NCT00542269|54644595|FG002|Overall Study|Administrative problems|1|||
27986165|NCT00866697|54644607|FG000|Overall Study|Study closed/terminated|156|||
27986166|NCT00866697|54644608|FG001|Overall Study|Study closed/terminated|138|||
27986167|NCT00866697|54644607|FG000|Overall Study|Lost to Follow-up|22|||
27986168|NCT00866697|54644608|FG001|Overall Study|Lost to Follow-up|28|||
27986169|NCT00866697|54644607|FG000|Overall Study|Physician Decision|3|||
28097258|NCT01345630|54752802|FG001|Overall Study|Study terminated by sponsor|285|||
28097259|NCT01345630|54752801|FG000|Overall Study|Other reasons|6|||
28097260|NCT01345630|54752802|FG001|Overall Study|Other reasons|8|||
28097261|NCT01345630|54752801|FG000|Overall Study|Withdrawn due to pregnancy|1|||
28097262|NCT01345630|54752802|FG001|Overall Study|Withdrawn due to pregnancy|2|||
28097263|NCT01345630|54752801|FG000|Overall Study|No longer willing to participate|9|||
28097264|NCT01345630|54752802|FG001|Overall Study|No longer willing to participate|12|||
28097265|NCT01345630|54752801|FG000|Overall Study|Insufficient clinical response|48|||
27899271|NCT02592707|54555367|FG002|Overall Study|Other|1|||
27986170|NCT00866697|54644608|FG001|Overall Study|Physician Decision|5|||
27986171|NCT00866697|54644607|FG000|Overall Study|Withdrawal by Subject|33|||
27986172|NCT00866697|54644608|FG001|Overall Study|Withdrawal by Subject|57|||
27986173|NCT00542191|54644614|FG000|Overall Study|Death|3|||
27986174|NCT00600938|54644620|FG000|Core Study|Abnormal test procedure result(s)|3|||
27986175|NCT00600938|54644621|FG001|Core Study|Abnormal test procedure result(s)|2|||
27986176|NCT00600938|54644622|FG002|Core Study|Abnormal test procedure result(s)|0|||
27986177|NCT00600938|54644623|FG003|Core Study|Abnormal test procedure result(s)|0|||
27986178|NCT00600938|54644620|FG000|Core Study|Unsatisfactory therapeutic effect|1|||
27986179|NCT00600938|54644621|FG001|Core Study|Unsatisfactory therapeutic effect|2|||
27986180|NCT00600938|54644622|FG002|Core Study|Unsatisfactory therapeutic effect|0|||
28097266|NCT01345630|54752802|FG001|Overall Study|Insufficient clinical response|11|||
28097267|NCT03693612|54752819|FG000|Overall Study|Lost to Follow-up|0|||
27899272|NCT02592707|54555368|FG003|Overall Study|Other|2|||
27899273|NCT02592707|54555365|FG000|Overall Study|Never entered LTFU period|1|||
27899274|NCT02592707|54555366|FG001|Overall Study|Never entered LTFU period|0|||
27899275|NCT02592707|54555367|FG002|Overall Study|Never entered LTFU period|0|||
27899276|NCT02592707|54555368|FG003|Overall Study|Never entered LTFU period|2|||
28097268|NCT03693612|54752820|FG001|Overall Study|Lost to Follow-up|0|||
28097269|NCT03693612|54752821|FG002|Overall Study|Lost to Follow-up|0|||
27899277|NCT02421939|54555387|FG000|Overall Study|Progressive disease|70|||
27899278|NCT02421939|54555388|FG001|Overall Study|Progressive disease|16|||
27899279|NCT02421939|54555387|FG000|Overall Study|Lack of Efficacy|21|||
27899280|NCT02421939|54555388|FG001|Overall Study|Lack of Efficacy|31|||
27899281|NCT02421939|54555387|FG000|Overall Study|Death|36|||
27899282|NCT02421939|54555388|FG001|Overall Study|Death|10|||
27986181|NCT00600938|54644623|FG003|Core Study|Unsatisfactory therapeutic effect|0|||
28097270|NCT03693612|54752822|FG003|Overall Study|Lost to Follow-up|0|||
28097271|NCT03693612|54752823|FG004|Overall Study|Lost to Follow-up|1|||
28097272|NCT03693612|54752824|FG005|Overall Study|Lost to Follow-up|0|||
27899283|NCT02421939|54555387|FG000|Overall Study|Disease relapse|33|||
27899284|NCT02421939|54555388|FG001|Overall Study|Disease relapse|2|||
27986182|NCT00600938|54644620|FG000|Core Study|Patient withdrew consent|7|||
27986183|NCT00600938|54644621|FG001|Core Study|Patient withdrew consent|12|||
27986184|NCT00600938|54644622|FG002|Core Study|Patient withdrew consent|0|||
27986185|NCT00600938|54644623|FG003|Core Study|Patient withdrew consent|0|||
27899285|NCT02421939|54555387|FG000|Overall Study|Adverse Event|28|||
27899286|NCT02421939|54555388|FG001|Overall Study|Adverse Event|5|||
27899287|NCT02421939|54555387|FG000|Overall Study|Withdrawal by Subject|5|||
27899288|NCT02421939|54555388|FG001|Overall Study|Withdrawal by Subject|24|||
27899289|NCT02421939|54555387|FG000|Overall Study|Physician Decision|11|||
27899290|NCT02421939|54555388|FG001|Overall Study|Physician Decision|11|||
27899291|NCT02421939|54555387|FG000|Overall Study|Completed 1 or 2 chemo cycles with CRs|0|||
27899292|NCT02421939|54555388|FG001|Overall Study|Completed 1 or 2 chemo cycles with CRs|19|||
27899293|NCT02421939|54555387|FG000|Overall Study|Miscellaneous|4|||
27899294|NCT02421939|54555388|FG001|Overall Study|Miscellaneous|5|||
27899295|NCT02421939|54555387|FG000|Overall Study|Protocol deviation|1|||
27899296|NCT02421939|54555388|FG001|Overall Study|Protocol deviation|1|||
27899297|NCT02288247|54555403|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Adverse Event|52|||
27899298|NCT02288247|54555404|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Adverse Event|0|||
27899299|NCT02288247|54555403|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Death|35|||
27899300|NCT02288247|54555404|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Death|0|||
27899301|NCT02288247|54555403|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Lost to Follow-up|1|||
27899302|NCT02288247|54555404|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Lost to Follow-up|0|||
27899303|NCT02288247|54555403|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Progressive Disease|392|||
27899304|NCT02288247|54555404|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Progressive Disease|0|||
27899305|NCT02288247|54555403|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Protocol Violation|9|||
27899306|NCT02288247|54555404|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Protocol Violation|0|||
27899307|NCT02288247|54555403|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Withdrawal by Subject|52|||
27899308|NCT02288247|54555404|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Withdrawal by Subject|0|||
27899309|NCT02288247|54555403|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Other|106|||
27899310|NCT02288247|54555404|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Other|0|||
27899311|NCT02288247|54555403|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|10|||
27899312|NCT02288247|54555404|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|8|||
27899313|NCT02288247|54555403|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Death|8|||
27899314|NCT02288247|54555404|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Death|4|||
27899315|NCT02288247|54555403|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|1|||
27899316|NCT02288247|54555404|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|0|||
27899317|NCT02288247|54555403|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|87|||
27899318|NCT02288247|54555404|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|94|||
27899319|NCT02288247|54555403|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|2|||
27899320|NCT02288247|54555404|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|1|||
27899321|NCT02288247|54555403|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
27899322|NCT02288247|54555404|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
27899323|NCT02288247|54555403|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Other|20|||
27899324|NCT02288247|54555404|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
27899325|NCT02288247|54555403|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|1|||
27899326|NCT02288247|54555404|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|0|||
27899327|NCT02108964|54555420|FG000|Overall Study|Progressive disease|12|||
27899328|NCT02108964|54555421|FG001|Overall Study|Progressive disease|25|||
27899329|NCT02108964|54555422|FG002|Overall Study|Progressive disease|50|||
27899330|NCT02108964|54555423|FG003|Overall Study|Progressive disease|6|||
27899331|NCT02108964|54555424|FG004|Overall Study|Progressive disease|18|||
27899332|NCT02108964|54555425|FG005|Overall Study|Progressive disease|5|||
27899333|NCT02108964|54555426|FG006|Overall Study|Progressive disease|7|||
27899334|NCT02108964|54555427|FG007|Overall Study|Progressive disease|9|||
27899335|NCT02108964|54555420|FG000|Overall Study|Physician Decision|1|||
27899336|NCT02108964|54555421|FG001|Overall Study|Physician Decision|5|||
27899337|NCT02108964|54555422|FG002|Overall Study|Physician Decision|6|||
27899338|NCT02108964|54555423|FG003|Overall Study|Physician Decision|0|||
27899339|NCT02108964|54555424|FG004|Overall Study|Physician Decision|1|||
27899340|NCT02108964|54555425|FG005|Overall Study|Physician Decision|0|||
27899341|NCT02108964|54555426|FG006|Overall Study|Physician Decision|0|||
27899342|NCT02108964|54555427|FG007|Overall Study|Physician Decision|0|||
27899343|NCT02108964|54555420|FG000|Overall Study|Adverse Event|0|||
27899344|NCT02108964|54555421|FG001|Overall Study|Adverse Event|0|||
27899345|NCT02108964|54555422|FG002|Overall Study|Adverse Event|4|||
27899346|NCT02108964|54555423|FG003|Overall Study|Adverse Event|0|||
27899347|NCT02108964|54555424|FG004|Overall Study|Adverse Event|1|||
27899348|NCT02108964|54555425|FG005|Overall Study|Adverse Event|0|||
27899349|NCT02108964|54555426|FG006|Overall Study|Adverse Event|3|||
27899350|NCT02108964|54555427|FG007|Overall Study|Adverse Event|1|||
27899351|NCT02108964|54555420|FG000|Overall Study|Death|1|||
27899352|NCT02108964|54555421|FG001|Overall Study|Death|1|||
27899353|NCT02108964|54555422|FG002|Overall Study|Death|2|||
27899354|NCT02108964|54555423|FG003|Overall Study|Death|0|||
27986186|NCT00600938|54644620|FG000|Core Study|Lost to Follow-up|3|||
27986187|NCT00600938|54644621|FG001|Core Study|Lost to Follow-up|2|||
28172092|NCT02718417|54843702|FG000|Observation Phase (OP)|Study terminated by sponsor|0|||
27899355|NCT02108964|54555424|FG004|Overall Study|Death|3|||
27986188|NCT00600938|54644622|FG002|Core Study|Lost to Follow-up|0|||
27899356|NCT02108964|54555425|FG005|Overall Study|Death|0|||
27899357|NCT02108964|54555426|FG006|Overall Study|Death|0|||
27899358|NCT02108964|54555427|FG007|Overall Study|Death|1|||
27899359|NCT02108964|54555420|FG000|Overall Study|Subject/Guardian decision|0|||
27899360|NCT02108964|54555421|FG001|Overall Study|Subject/Guardian decision|1|||
27899361|NCT02108964|54555422|FG002|Overall Study|Subject/Guardian decision|3|||
27899362|NCT02108964|54555423|FG003|Overall Study|Subject/Guardian decision|0|||
27899363|NCT02108964|54555424|FG004|Overall Study|Subject/Guardian decision|2|||
27899364|NCT02108964|54555425|FG005|Overall Study|Subject/Guardian decision|0|||
27899365|NCT02108964|54555426|FG006|Overall Study|Subject/Guardian decision|1|||
27899366|NCT02108964|54555427|FG007|Overall Study|Subject/Guardian decision|1|||
27899367|NCT01423812|54555448|FG000|Overall Study|Lost to Follow-up|2|||
27899368|NCT01423812|54555449|FG001|Overall Study|Lost to Follow-up|2|||
27899369|NCT01423812|54555448|FG000|Overall Study|Withdrawal by Subject|1|||
27899370|NCT01423812|54555449|FG001|Overall Study|Withdrawal by Subject|2|||
27899371|NCT00965718|54555457|FG000|Overall Study|Withdrawal by Subject|4|||
27899372|NCT00792740|54555472|FG000|Overall Study|Disease Worsening|3|||
27899373|NCT00792740|54555473|FG001|Overall Study|Disease Worsening|2|||
27899374|NCT00792740|54555472|FG000|Overall Study|Personal Reason|1|||
27899375|NCT00792740|54555473|FG001|Overall Study|Personal Reason|0|||
27899376|NCT00792740|54555472|FG000|Overall Study|Adverse Event|1|||
27899377|NCT00792740|54555473|FG001|Overall Study|Adverse Event|3|||
27899378|NCT00792740|54555472|FG000|Overall Study|Patient's withdrawal of consent|0|||
27899379|NCT00792740|54555473|FG001|Overall Study|Patient's withdrawal of consent|1|||
27899380|NCT00792740|54555472|FG000|Overall Study|Termination of the trial by the Sponsor|2|||
27899381|NCT00792740|54555473|FG001|Overall Study|Termination of the trial by the Sponsor|0|||
27899382|NCT00792740|54555472|FG000|Overall Study|Other reasons|0|||
27899383|NCT00792740|54555473|FG001|Overall Study|Other reasons|1|||
27899384|NCT00567580|54555492|FG000|Overall Study|Protocol Violation|28|||
27899385|NCT00567580|54555493|FG001|Overall Study|Protocol Violation|24|||
27899386|NCT00567580|54555494|FG002|Overall Study|Protocol Violation|24|||
27899387|NCT01058863|54555505|FG000|Overall Study|Lost to Follow-up|1|||
27899388|NCT01058863|54555505|FG000|Overall Study|Withdrawal by Subject|1|||
27899389|NCT01058863|54555505|FG000|Overall Study|Sponsor requested withdrawal|1|||
27899390|NCT01058863|54555505|FG000|Overall Study|Randomized in error|1|||
27899391|NCT01058395|54555520|FG000|Overall Study|Death|2|||
27899392|NCT01058395|54555521|FG001|Overall Study|Death|1|||
27899393|NCT01058395|54555520|FG000|Overall Study|Lost to Follow-up|1|||
27899394|NCT01058395|54555521|FG001|Overall Study|Lost to Follow-up|0|||
27899395|NCT01058356|54555527|FG000|Overall Study|Adverse Event|5|||
27899396|NCT01058356|54555527|FG000|Overall Study|Administration of contraindicated drugs|12|||
27899397|NCT01058356|54555527|FG000|Overall Study|Withdrawal by Subject|21|||
27986189|NCT00600938|54644623|FG003|Core Study|Lost to Follow-up|0|||
27986190|NCT00600938|54644620|FG000|Core Study|Death|1|||
27986191|NCT00600938|54644621|FG001|Core Study|Death|1|||
27986192|NCT00600938|54644622|FG002|Core Study|Death|0|||
27986193|NCT00600938|54644623|FG003|Core Study|Death|0|||
27986194|NCT00600938|54644620|FG000|Core Study|Protocol Violation|1|||
27986195|NCT00600938|54644621|FG001|Core Study|Protocol Violation|2|||
27986196|NCT00600938|54644622|FG002|Core Study|Protocol Violation|0|||
27986197|NCT00600938|54644623|FG003|Core Study|Protocol Violation|0|||
27986198|NCT00600938|54644620|FG000|Extension Study|Adverse Event|1|||
27986199|NCT00600938|54644621|FG001|Extension Study|Adverse Event|0|||
27986200|NCT00600938|54644622|FG002|Extension Study|Adverse Event|2|||
27986201|NCT00600938|54644623|FG003|Extension Study|Adverse Event|0|||
27986202|NCT00600938|54644620|FG000|Extension Study|Abnormal test procedure results|0|||
27986203|NCT00600938|54644621|FG001|Extension Study|Abnormal test procedure results|1|||
27986204|NCT00600938|54644622|FG002|Extension Study|Abnormal test procedure results|1|||
27986205|NCT00600938|54644623|FG003|Extension Study|Abnormal test procedure results|1|||
27986206|NCT00600938|54644620|FG000|Extension Study|Unsatisfactory therapeutic effect|4|||
27986207|NCT00600938|54644621|FG001|Extension Study|Unsatisfactory therapeutic effect|1|||
27986208|NCT00600938|54644622|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
27986209|NCT00600938|54644623|FG003|Extension Study|Unsatisfactory therapeutic effect|0|||
27986210|NCT00600938|54644620|FG000|Extension Study|Withdrawal by Subject|2|||
27986211|NCT00600938|54644621|FG001|Extension Study|Withdrawal by Subject|2|||
27986212|NCT00600938|54644622|FG002|Extension Study|Withdrawal by Subject|3|||
27899398|NCT01058356|54555527|FG000|Overall Study|Lost to Follow-up|4|||
27899399|NCT01058005|54555534|FG000|Overall Study|Adverse Event|0|||
27899400|NCT01058005|54555535|FG001|Overall Study|Adverse Event|2|||
27899401|NCT01058005|54555536|FG002|Overall Study|Adverse Event|1|||
27899402|NCT01058005|54555534|FG000|Overall Study|Physician Decision|2|||
27986213|NCT00600938|54644623|FG003|Extension Study|Withdrawal by Subject|0|||
27986214|NCT00600938|54644620|FG000|Extension Study|Lost to Follow-up|1|||
27986215|NCT00600938|54644621|FG001|Extension Study|Lost to Follow-up|1|||
27899403|NCT01058005|54555535|FG001|Overall Study|Physician Decision|2|||
27899404|NCT01058005|54555536|FG002|Overall Study|Physician Decision|0|||
27899405|NCT01058005|54555534|FG000|Overall Study|Withdrawal by Subject|4|||
27899406|NCT01058005|54555535|FG001|Overall Study|Withdrawal by Subject|5|||
27899407|NCT01058005|54555536|FG002|Overall Study|Withdrawal by Subject|11|||
27899408|NCT01058005|54555534|FG000|Overall Study|Withdrawn Due to Study Termination|27|||
27899409|NCT01058005|54555535|FG001|Overall Study|Withdrawn Due to Study Termination|13|||
27899410|NCT01058005|54555536|FG002|Overall Study|Withdrawn Due to Study Termination|7|||
27899411|NCT01058005|54555534|FG000|Overall Study|Reason Missing|5|||
27899412|NCT01058005|54555535|FG001|Overall Study|Reason Missing|3|||
27899413|NCT01058005|54555536|FG002|Overall Study|Reason Missing|1|||
27899414|NCT01056640|54555546|FG000|Overall Study|Withdrawal by Subject|11|||
27986216|NCT00600938|54644622|FG002|Extension Study|Lost to Follow-up|2|||
27986217|NCT00600938|54644623|FG003|Extension Study|Lost to Follow-up|0|||
27986218|NCT00600938|54644620|FG000|Extension Study|Death|1|||
27986219|NCT00600938|54644621|FG001|Extension Study|Death|0|||
27986220|NCT00600938|54644622|FG002|Extension Study|Death|0|||
27986221|NCT00600938|54644623|FG003|Extension Study|Death|0|||
27986222|NCT00543439|54644664|FG000|Period 1|Adverse Event|0|||
27986223|NCT00543439|54644665|FG001|Period 1|Adverse Event|2|||
27986224|NCT00543439|54644666|FG002|Period 1|Adverse Event|1|||
27986225|NCT00543439|54644664|FG000|Period 1|Withdrawal by Subject|1|||
27986226|NCT00543439|54644665|FG001|Period 1|Withdrawal by Subject|1|||
27986227|NCT00543439|54644666|FG002|Period 1|Withdrawal by Subject|0|||
27986228|NCT00543439|54644664|FG000|Period 1|Physician Decision|0|||
27986229|NCT00543439|54644665|FG001|Period 1|Physician Decision|0|||
27986230|NCT00543439|54644666|FG002|Period 1|Physician Decision|1|||
27986231|NCT00543439|54644664|FG000|Period 2|Protocol Violation|1|||
27986232|NCT00543439|54644665|FG001|Period 2|Protocol Violation|0|||
27986233|NCT00543439|54644666|FG002|Period 2|Protocol Violation|1|||
27986234|NCT00543439|54644664|FG000|Period 2|Adverse Event|0|||
27986235|NCT00543439|54644665|FG001|Period 2|Adverse Event|1|||
27986236|NCT00543439|54644666|FG002|Period 2|Adverse Event|1|||
27986237|NCT00582166|54644683|FG000|Overall Study|Death|1|||
27986238|NCT00582166|54644683|FG000|Overall Study|Ineligible pathology|1|||
27986239|NCT00601172|54644689|FG000|Overall Study|Adverse Event|43|||
27986240|NCT00601172|54644690|FG001|Overall Study|Adverse Event|32|||
27986241|NCT00601172|54644689|FG000|Overall Study|Lack of Efficacy|11|||
27986242|NCT00601172|54644690|FG001|Overall Study|Lack of Efficacy|12|||
27986243|NCT00601172|54644689|FG000|Overall Study|Protocol Violation|2|||
27986244|NCT00601172|54644690|FG001|Overall Study|Protocol Violation|5|||
27986245|NCT00601172|54644689|FG000|Overall Study|Lost to Follow-up|4|||
27986246|NCT00601172|54644690|FG001|Overall Study|Lost to Follow-up|3|||
27986247|NCT00601172|54644689|FG000|Overall Study|Physician Decision|27|||
27986248|NCT00601172|54644690|FG001|Overall Study|Physician Decision|28|||
27986249|NCT00601172|54644689|FG000|Overall Study|Withdrawal by Subject|35|||
27986250|NCT00601172|54644690|FG001|Overall Study|Withdrawal by Subject|27|||
27986251|NCT00601172|54644689|FG000|Overall Study|Did not meet continuation criteria|19|||
27986252|NCT00601172|54644690|FG001|Overall Study|Did not meet continuation criteria|20|||
27986253|NCT00582010|54644699|FG000|Overall Study|Death|0|||
27986254|NCT00582010|54644700|FG001|Overall Study|Death|1|||
27986255|NCT03920215|54644714|FG000|Overall Study|Lost to Follow-up|1|||
27986256|NCT03920215|54644715|FG001|Overall Study|Lost to Follow-up|2|||
27986257|NCT03920215|54644716|FG002|Overall Study|Lost to Follow-up|0|||
27986258|NCT03920215|54644717|FG003|Overall Study|Lost to Follow-up|0|||
27986259|NCT03920215|54644714|FG000|Overall Study|Death|0|||
27986260|NCT03920215|54644715|FG001|Overall Study|Death|0|||
27986261|NCT03920215|54644716|FG002|Overall Study|Death|0|||
27986262|NCT03920215|54644717|FG003|Overall Study|Death|1|||
27986263|NCT00580840|54644727|FG000|Run-in|Adverse Event|17|||
27986264|NCT00580840|54644728|FG001|Run-in|Adverse Event|0|||
27986265|NCT00580840|54644729|FG002|Run-in|Adverse Event|0|||
27986266|NCT00580840|54644730|FG003|Run-in|Adverse Event|0|||
27986267|NCT00580840|54644727|FG000|Run-in|Lack of Efficacy|93|||
27986268|NCT00580840|54644728|FG001|Run-in|Lack of Efficacy|0|||
27986269|NCT00580840|54644729|FG002|Run-in|Lack of Efficacy|0|||
27986270|NCT00580840|54644730|FG003|Run-in|Lack of Efficacy|0|||
27986271|NCT00580840|54644727|FG000|Run-in|Loss of Efficacy|1|||
27986272|NCT00580840|54644728|FG001|Run-in|Loss of Efficacy|0|||
27986273|NCT00580840|54644729|FG002|Run-in|Loss of Efficacy|0|||
27986274|NCT00580840|54644730|FG003|Run-in|Loss of Efficacy|0|||
27986275|NCT00580840|54644727|FG000|Run-in|Lost to Follow-up|4|||
27986276|NCT00580840|54644728|FG001|Run-in|Lost to Follow-up|0|||
27986277|NCT00580840|54644729|FG002|Run-in|Lost to Follow-up|0|||
27986278|NCT00580840|54644730|FG003|Run-in|Lost to Follow-up|0|||
27986279|NCT00580840|54644727|FG000|Run-in|Withdrawal by Subject|5|||
27986280|NCT00580840|54644728|FG001|Run-in|Withdrawal by Subject|0|||
27986281|NCT00580840|54644729|FG002|Run-in|Withdrawal by Subject|0|||
28097273|NCT03693612|54752825|FG006|Overall Study|Lost to Follow-up|0|||
27899415|NCT01056640|54555547|FG001|Overall Study|Withdrawal by Subject|8|||
27986282|NCT00580840|54644730|FG003|Run-in|Withdrawal by Subject|0|||
27986283|NCT00580840|54644727|FG000|Run-in|Other: Per Sponsor Request|2|||
27986284|NCT00580840|54644728|FG001|Run-in|Other: Per Sponsor Request|0|||
27986285|NCT00580840|54644729|FG002|Run-in|Other: Per Sponsor Request|0|||
27986286|NCT00580840|54644730|FG003|Run-in|Other: Per Sponsor Request|0|||
27986287|NCT00580840|54644727|FG000|Run-in|Other: Did Not Meet Joint Count Criteria|1|||
27899416|NCT01056640|54555546|FG000|Overall Study|Death|15|||
27899417|NCT01056640|54555547|FG001|Overall Study|Death|4|||
27899418|NCT01056523|54555553|FG000|Overall Study|Death|1|||
27899419|NCT01056523|54555554|FG001|Overall Study|Death|0|||
27899420|NCT01056523|54555555|FG002|Overall Study|Death|2|||
27899421|NCT01056523|54555556|FG003|Overall Study|Death|3|||
27899422|NCT01056523|54555557|FG004|Overall Study|Death|0|||
27899423|NCT01056523|54555558|FG005|Overall Study|Death|0|||
27899424|NCT01056523|54555559|FG006|Overall Study|Death|1|||
27899425|NCT01056484|54555566|FG000|Randomized Controlled Trial|Withdrawal by Subject|6|||
27899426|NCT01056484|54555567|FG001|Randomized Controlled Trial|Withdrawal by Subject|1|||
27899427|NCT01056484|54555566|FG000|Randomized Controlled Trial|Physician Decision|1|||
27899428|NCT01056484|54555567|FG001|Randomized Controlled Trial|Physician Decision|0|||
27899429|NCT01056484|54555566|FG000|Follow up - Non-randomized|Withdrawal by Subject|0|||
27899430|NCT01056484|54555567|FG001|Follow up - Non-randomized|Withdrawal by Subject|2|||
27899431|NCT01055314|54555576|FG000|Overall Study|Adverse Event|7|||
27899432|NCT01055314|54555577|FG001|Overall Study|Adverse Event|4|||
27899433|NCT01055314|54555576|FG000|Overall Study|Death|2|||
27899434|NCT01055314|54555577|FG001|Overall Study|Death|1|||
27899435|NCT01055314|54555576|FG000|Overall Study|Lack of Efficacy|11|||
27899436|NCT01055314|54555577|FG001|Overall Study|Lack of Efficacy|19|||
27899437|NCT01055314|54555576|FG000|Overall Study|Physician Decision|10|||
27899438|NCT01055314|54555577|FG001|Overall Study|Physician Decision|5|||
27899439|NCT01055314|54555576|FG000|Overall Study|Withdrawal by Subject|1|||
27899440|NCT01055314|54555577|FG001|Overall Study|Withdrawal by Subject|0|||
27899441|NCT01055314|54555576|FG000|Overall Study|Ineligible|3|||
27899442|NCT01055314|54555577|FG001|Overall Study|Ineligible|5|||
27899443|NCT01055314|54555576|FG000|Overall Study|Refusal of further protocol therapy|10|||
27899444|NCT01055314|54555577|FG001|Overall Study|Refusal of further protocol therapy|4|||
27899445|NCT01055314|54555576|FG000|Overall Study|No treatment|1|||
27899446|NCT01055314|54555577|FG001|Overall Study|No treatment|0|||
27899447|NCT01055197|54555586|FG000|Overall Study|Protocol Violation|7|||
27899448|NCT01055197|54555587|FG001|Overall Study|Protocol Violation|2|||
27899449|NCT01055197|54555586|FG000|Overall Study|Withdrawal by Subject|2|||
27899450|NCT01055197|54555587|FG001|Overall Study|Withdrawal by Subject|0|||
27899451|NCT01054885|54555599|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246|||
27899452|NCT01054885|54555600|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
27899453|NCT01054885|54555601|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
27899454|NCT01054885|54555602|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
27899455|NCT01054885|54555603|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
27899456|NCT01054885|54555604|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
27899457|NCT01054885|54555605|FG006|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
27899458|NCT01054885|54555599|FG000|2-week, Single-blind Run-In Period|Physician Decision|6|||
27899459|NCT01054885|54555600|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
27899460|NCT01054885|54555601|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
27899461|NCT01054885|54555602|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
27899462|NCT01054885|54555603|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
27899463|NCT01054885|54555604|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
27899464|NCT01054885|54555605|FG006|2-week, Single-blind Run-In Period|Physician Decision|0|||
27899465|NCT01054885|54555599|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|23|||
27899466|NCT01054885|54555600|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
27899467|NCT01054885|54555601|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
27899468|NCT01054885|54555602|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
27899469|NCT01054885|54555603|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
27899470|NCT01054885|54555604|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
27899471|NCT01054885|54555605|FG006|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
27899472|NCT01054885|54555599|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
27899473|NCT01054885|54555600|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
27986288|NCT00580840|54644728|FG001|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
27986289|NCT00580840|54644729|FG002|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
27986290|NCT00580840|54644730|FG003|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
27986291|NCT00580840|54644727|FG000|Run-in|Other: Exclusionary Lab Value|1|||
27899474|NCT01054885|54555601|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
27899475|NCT01054885|54555602|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
27899476|NCT01054885|54555603|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
27899477|NCT01054885|54555604|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
27899478|NCT01054885|54555605|FG006|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
27899479|NCT01054885|54555599|FG000|2-week, Single-blind Run-In Period|Adverse Event|7|||
27899480|NCT01054885|54555600|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
27899481|NCT01054885|54555601|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
27925783|NCT01226745|54582372|FG005|Overall Study|Lost to Follow-up|2|||
27899482|NCT01054885|54555602|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
27899483|NCT01054885|54555603|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
27899484|NCT01054885|54555604|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
27899485|NCT01054885|54555605|FG006|2-week, Single-blind Run-In Period|Adverse Event|0|||
27899486|NCT01054885|54555599|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|68|||
27899487|NCT01054885|54555600|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
27899488|NCT01054885|54555601|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
27899489|NCT01054885|54555602|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
27899490|NCT01054885|54555603|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
27899491|NCT01054885|54555604|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
27899492|NCT01054885|54555605|FG006|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
27899493|NCT01054885|54555599|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
27899494|NCT01054885|54555600|FG001|24-week, Double-blind Treatment Period|Adverse Event|18|||
27899495|NCT01054885|54555601|FG002|24-week, Double-blind Treatment Period|Adverse Event|12|||
27899496|NCT01054885|54555602|FG003|24-week, Double-blind Treatment Period|Adverse Event|15|||
27899497|NCT01054885|54555603|FG004|24-week, Double-blind Treatment Period|Adverse Event|15|||
27899498|NCT01054885|54555604|FG005|24-week, Double-blind Treatment Period|Adverse Event|17|||
27899499|NCT01054885|54555605|FG006|24-week, Double-blind Treatment Period|Adverse Event|19|||
27986292|NCT00580840|54644728|FG001|Run-in|Other: Exclusionary Lab Value|0|||
27986293|NCT00580840|54644729|FG002|Run-in|Other: Exclusionary Lab Value|0|||
27986294|NCT00580840|54644730|FG003|Run-in|Other: Exclusionary Lab Value|0|||
27986295|NCT00580840|54644727|FG000|Double-Blind|Adverse Event|0|||
27986296|NCT00580840|54644728|FG001|Double-Blind|Adverse Event|3|||
27986297|NCT00580840|54644729|FG002|Double-Blind|Adverse Event|4|||
27986298|NCT00580840|54644730|FG003|Double-Blind|Adverse Event|1|||
27986299|NCT00580840|54644727|FG000|Double-Blind|Loss of Efficacy|0|||
27986300|NCT00580840|54644728|FG001|Double-Blind|Loss of Efficacy|1|||
27986301|NCT00580840|54644729|FG002|Double-Blind|Loss of Efficacy|2|||
27986302|NCT00580840|54644730|FG003|Double-Blind|Loss of Efficacy|10|||
27986303|NCT00580840|54644727|FG000|Double-Blind|Lost to Follow-up|0|||
27986304|NCT00580840|54644728|FG001|Double-Blind|Lost to Follow-up|1|||
27986305|NCT00580840|54644729|FG002|Double-Blind|Lost to Follow-up|0|||
27986306|NCT00580840|54644730|FG003|Double-Blind|Lost to Follow-up|2|||
27986307|NCT00580840|54644727|FG000|Double-Blind|Withdrawal by Subject|0|||
27986308|NCT00580840|54644728|FG001|Double-Blind|Withdrawal by Subject|1|||
27986309|NCT00580840|54644729|FG002|Double-Blind|Withdrawal by Subject|2|||
27986310|NCT00580840|54644730|FG003|Double-Blind|Withdrawal by Subject|2|||
27986311|NCT00580840|54644727|FG000|Double-Blind|Other: Discontinued Methotrexate|0|||
27986312|NCT00580840|54644728|FG001|Double-Blind|Other: Discontinued Methotrexate|1|||
27986313|NCT00580840|54644729|FG002|Double-Blind|Other: Discontinued Methotrexate|0|||
27986314|NCT00580840|54644730|FG003|Double-Blind|Other: Discontinued Methotrexate|0|||
27986315|NCT00580840|54644727|FG000|Double-Blind|Other: Forbidden Medication|0|||
27986316|NCT00580840|54644728|FG001|Double-Blind|Other: Forbidden Medication|0|||
27986317|NCT00580840|54644729|FG002|Double-Blind|Other: Forbidden Medication|1|||
27986318|NCT00580840|54644730|FG003|Double-Blind|Other: Forbidden Medication|0|||
27986319|NCT00879684|54644740|FG000|Stage 1: Dose Escalation|Adverse Event|1|||
27986320|NCT00879684|54644741|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
27986321|NCT00879684|54644742|FG002|Stage 1: Dose Escalation|Adverse Event|0|||
27986322|NCT00879684|54644743|FG003|Stage 1: Dose Escalation|Adverse Event|0|||
27986323|NCT00879684|54644744|FG004|Stage 1: Dose Escalation|Adverse Event|0|||
27986324|NCT00879684|54644745|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
27986325|NCT00879684|54644746|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
27986326|NCT00879684|54644740|FG000|Stage 1: Dose Escalation|Progressive Disease|2|||
27986327|NCT00879684|54644741|FG001|Stage 1: Dose Escalation|Progressive Disease|3|||
27986328|NCT00879684|54644742|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
27986329|NCT00879684|54644743|FG003|Stage 1: Dose Escalation|Progressive Disease|4|||
27986330|NCT00879684|54644744|FG004|Stage 1: Dose Escalation|Progressive Disease|3|||
27986331|NCT00879684|54644745|FG005|Stage 1: Dose Escalation|Progressive Disease|3|||
27986332|NCT00879684|54644746|FG006|Stage 1: Dose Escalation|Progressive Disease|0|||
27986333|NCT00879684|54644740|FG000|Stage 1: Dose Escalation|Investigator declined participation|0|||
27986334|NCT00879684|54644741|FG001|Stage 1: Dose Escalation|Investigator declined participation|0|||
27986335|NCT00879684|54644742|FG002|Stage 1: Dose Escalation|Investigator declined participation|2|||
27986336|NCT00879684|54644743|FG003|Stage 1: Dose Escalation|Investigator declined participation|2|||
27986337|NCT00879684|54644744|FG004|Stage 1: Dose Escalation|Investigator declined participation|0|||
28097274|NCT03693612|54752819|FG000|Overall Study|Withdrawal by Subject|0|||
28097275|NCT03693612|54752820|FG001|Overall Study|Withdrawal by Subject|0|||
28097276|NCT03693612|54752821|FG002|Overall Study|Withdrawal by Subject|1|||
27986338|NCT00879684|54644745|FG005|Stage 1: Dose Escalation|Investigator declined participation|0|||
28097277|NCT03693612|54752822|FG003|Overall Study|Withdrawal by Subject|0|||
28097278|NCT03693612|54752823|FG004|Overall Study|Withdrawal by Subject|2|||
27899500|NCT01054885|54555599|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
27899501|NCT01054885|54555600|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
27899502|NCT01054885|54555601|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
27899503|NCT01054885|54555602|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
27899504|NCT01054885|54555603|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
27899505|NCT01054885|54555604|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
27899506|NCT01054885|54555605|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
27899507|NCT01054885|54555599|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
27899508|NCT01054885|54555600|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
27899509|NCT01054885|54555601|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2|||
27899510|NCT01054885|54555602|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5|||
27899511|NCT01054885|54555603|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11|||
27899512|NCT01054885|54555604|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
27899513|NCT01054885|54555605|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
27899514|NCT01054885|54555599|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
27899515|NCT01054885|54555600|FG001|24-week, Double-blind Treatment Period|Protocol Violation|7|||
27899516|NCT01054885|54555601|FG002|24-week, Double-blind Treatment Period|Protocol Violation|7|||
27899517|NCT01054885|54555602|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
27899518|NCT01054885|54555603|FG004|24-week, Double-blind Treatment Period|Protocol Violation|3|||
27899519|NCT01054885|54555604|FG005|24-week, Double-blind Treatment Period|Protocol Violation|8|||
27899520|NCT01054885|54555605|FG006|24-week, Double-blind Treatment Period|Protocol Violation|4|||
27899521|NCT01054885|54555599|FG000|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0|||
27899522|NCT01054885|54555600|FG001|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
27899523|NCT01054885|54555601|FG002|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
27899524|NCT01054885|54555602|FG003|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
27899525|NCT01054885|54555603|FG004|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
27899526|NCT01054885|54555604|FG005|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15|||
27899527|NCT01054885|54555605|FG006|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
27899528|NCT01054885|54555599|FG000|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
27899529|NCT01054885|54555600|FG001|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
27899530|NCT01054885|54555601|FG002|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
27899531|NCT01054885|54555602|FG003|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
27899532|NCT01054885|54555603|FG004|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
27899533|NCT01054885|54555604|FG005|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
27899534|NCT01054885|54555605|FG006|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
27899535|NCT01054885|54555599|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
27899536|NCT01054885|54555600|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
27899537|NCT01054885|54555601|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
27899538|NCT01054885|54555602|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
27899539|NCT01054885|54555603|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
27899540|NCT01054885|54555604|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
27899541|NCT01054885|54555605|FG006|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
27899542|NCT01054885|54555599|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
27899543|NCT01054885|54555600|FG001|24-week, Double-blind Treatment Period|Physician Decision|4|||
27899544|NCT01054885|54555601|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
27899545|NCT01054885|54555602|FG003|24-week, Double-blind Treatment Period|Physician Decision|6|||
27899546|NCT01054885|54555603|FG004|24-week, Double-blind Treatment Period|Physician Decision|3|||
27899547|NCT01054885|54555604|FG005|24-week, Double-blind Treatment Period|Physician Decision|1|||
27899548|NCT01054885|54555605|FG006|24-week, Double-blind Treatment Period|Physician Decision|1|||
27899549|NCT01054885|54555599|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
27899550|NCT01054885|54555600|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|8|||
27899551|NCT01054885|54555601|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
27899552|NCT01054885|54555602|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
27899553|NCT01054885|54555603|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
27899554|NCT01054885|54555604|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
27899555|NCT01054885|54555605|FG006|24-week, Double-blind Treatment Period|Withdrawal by Subject|2|||
27899556|NCT01054846|54555622|FG000|Overall Study|Lost to Follow-up|76|||
27899557|NCT01054846|54555623|FG001|Overall Study|Lost to Follow-up|17|||
27899558|NCT01054729|54555632|FG000|Overall Study|Randomized but Not Treated|0|||
27899559|NCT01054729|54555633|FG001|Overall Study|Randomized but Not Treated|1|||
27899560|NCT01054729|54555634|FG002|Overall Study|Randomized but Not Treated|0|||
27899561|NCT01054729|54555635|FG003|Overall Study|Randomized but Not Treated|0|||
27899562|NCT01054729|54555632|FG000|Overall Study|Adverse Event|1|||
27899563|NCT01054729|54555633|FG001|Overall Study|Adverse Event|1|||
27899564|NCT01054729|54555634|FG002|Overall Study|Adverse Event|2|||
27899565|NCT01054729|54555635|FG003|Overall Study|Adverse Event|1|||
27899566|NCT01054729|54555632|FG000|Overall Study|Withdrawal by Subject|1|||
27899567|NCT01054729|54555633|FG001|Overall Study|Withdrawal by Subject|0|||
27899568|NCT01054729|54555634|FG002|Overall Study|Withdrawal by Subject|1|||
27899569|NCT01054729|54555635|FG003|Overall Study|Withdrawal by Subject|0|||
27899570|NCT01054729|54555632|FG000|Overall Study|Lost to Follow-up|0|||
27899571|NCT01054729|54555633|FG001|Overall Study|Lost to Follow-up|1|||
27899572|NCT01054729|54555634|FG002|Overall Study|Lost to Follow-up|0|||
27899573|NCT01054729|54555635|FG003|Overall Study|Lost to Follow-up|0|||
27899574|NCT01054729|54555632|FG000|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
27899575|NCT01054729|54555633|FG001|Overall Study|Lost to Follow-up, Later Contacted Site|1|||
27899576|NCT01054729|54555634|FG002|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
27899577|NCT01054729|54555635|FG003|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
27899578|NCT01054729|54555632|FG000|Overall Study|Non-responder|1|||
27899579|NCT01054729|54555633|FG001|Overall Study|Non-responder|0|||
27899580|NCT01054729|54555634|FG002|Overall Study|Non-responder|1|||
27899581|NCT01054729|54555635|FG003|Overall Study|Non-responder|1|||
27899582|NCT01054729|54555632|FG000|Overall Study|PEG/RBV Non-responder|1|||
27899583|NCT01054729|54555633|FG001|Overall Study|PEG/RBV Non-responder|0|||
27899584|NCT01054729|54555634|FG002|Overall Study|PEG/RBV Non-responder|1|||
27899585|NCT01054729|54555635|FG003|Overall Study|PEG/RBV Non-responder|0|||
27899586|NCT01054729|54555632|FG000|Overall Study|Personal/Obligations|0|||
27899587|NCT01054729|54555633|FG001|Overall Study|Personal/Obligations|1|||
27986339|NCT00879684|54644746|FG006|Stage 1: Dose Escalation|Investigator declined participation|0|||
27986340|NCT00879684|54644740|FG000|Stage 1: Dose Escalation|Death|0|||
27986341|NCT00879684|54644741|FG001|Stage 1: Dose Escalation|Death|0|||
27986342|NCT00879684|54644742|FG002|Stage 1: Dose Escalation|Death|1|||
27986343|NCT00879684|54644743|FG003|Stage 1: Dose Escalation|Death|0|||
27986344|NCT00879684|54644744|FG004|Stage 1: Dose Escalation|Death|0|||
27986345|NCT00879684|54644745|FG005|Stage 1: Dose Escalation|Death|0|||
27986346|NCT00879684|54644746|FG006|Stage 1: Dose Escalation|Death|0|||
27986347|NCT00879684|54644740|FG000|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
27986348|NCT00879684|54644741|FG001|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
27986349|NCT00879684|54644742|FG002|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
27986350|NCT00879684|54644743|FG003|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
27986351|NCT00879684|54644744|FG004|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
27986352|NCT00879684|54644745|FG005|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
27986353|NCT00879684|54644746|FG006|Stage 2: Expanded Cohort|Lost to Follow-up|1|||
27986354|NCT00879684|54644740|FG000|Stage 2: Expanded Cohort|Progressive Disease|0|||
27986355|NCT00879684|54644741|FG001|Stage 2: Expanded Cohort|Progressive Disease|0|||
27986356|NCT00879684|54644742|FG002|Stage 2: Expanded Cohort|Progressive Disease|0|||
27986357|NCT00879684|54644743|FG003|Stage 2: Expanded Cohort|Progressive Disease|0|||
27986358|NCT00879684|54644744|FG004|Stage 2: Expanded Cohort|Progressive Disease|0|||
27986359|NCT00879684|54644745|FG005|Stage 2: Expanded Cohort|Progressive Disease|0|||
27986360|NCT00879684|54644746|FG006|Stage 2: Expanded Cohort|Progressive Disease|11|||
27986361|NCT00879684|54644740|FG000|Stage 2: Expanded Cohort|Investigator declined participation|0|||
27986362|NCT00879684|54644741|FG001|Stage 2: Expanded Cohort|Investigator declined participation|0|||
27986363|NCT00879684|54644742|FG002|Stage 2: Expanded Cohort|Investigator declined participation|0|||
27986364|NCT00879684|54644743|FG003|Stage 2: Expanded Cohort|Investigator declined participation|0|||
27986365|NCT00879684|54644744|FG004|Stage 2: Expanded Cohort|Investigator declined participation|0|||
27986366|NCT00879684|54644745|FG005|Stage 2: Expanded Cohort|Investigator declined participation|0|||
27986367|NCT00879684|54644746|FG006|Stage 2: Expanded Cohort|Investigator declined participation|1|||
27986368|NCT00581776|54644765|FG000|Overall Study|Disease progression or no response|3|||
27986369|NCT00883740|54644769|FG000|First Intervention|Lost to Follow-up|1|||
27986370|NCT00883740|54644770|FG001|First Intervention|Lost to Follow-up|0|||
27986371|NCT00883740|54644769|FG000|First Intervention|No longer willing to participate|2|||
27986372|NCT00883740|54644770|FG001|First Intervention|No longer willing to participate|0|||
27986373|NCT00883740|54644769|FG000|First Intervention|Protocol Violation|3|||
27986374|NCT00883740|54644770|FG001|First Intervention|Protocol Violation|6|||
27986375|NCT00883740|54644769|FG000|First Intervention|Adverse Event|1|||
27986376|NCT00883740|54644770|FG001|First Intervention|Adverse Event|2|||
27986377|NCT00883740|54644769|FG000|Second Intervention|Protocol Violation|1|||
27986378|NCT00883740|54644770|FG001|Second Intervention|Protocol Violation|0|||
27899588|NCT01054729|54555634|FG002|Overall Study|Personal/Obligations|0|||
27899589|NCT01054729|54555635|FG003|Overall Study|Personal/Obligations|0|||
27899590|NCT01054729|54555632|FG000|Overall Study|Subject moved|0|||
27899591|NCT01054729|54555633|FG001|Overall Study|Subject moved|0|||
27899592|NCT01054729|54555634|FG002|Overall Study|Subject moved|1|||
27899593|NCT01054729|54555635|FG003|Overall Study|Subject moved|0|||
27899594|NCT01054729|54555632|FG000|Overall Study|Lack of Efficacy|0|||
27899595|NCT01054729|54555633|FG001|Overall Study|Lack of Efficacy|0|||
27899596|NCT01054729|54555634|FG002|Overall Study|Lack of Efficacy|0|||
27899597|NCT01054729|54555635|FG003|Overall Study|Lack of Efficacy|1|||
27899598|NCT01054573|54555649|FG000|Overall Study|Adverse Event|1|||
27899599|NCT01054573|54555650|FG001|Overall Study|Adverse Event|0|||
27899600|NCT01054573|54555651|FG002|Overall Study|Adverse Event|1|||
27899601|NCT01054573|54555652|FG003|Overall Study|Adverse Event|1|||
27899602|NCT01054573|54555649|FG000|Overall Study|Lost to Follow-up|0|||
27899603|NCT01054573|54555650|FG001|Overall Study|Lost to Follow-up|2|||
27899604|NCT01054573|54555651|FG002|Overall Study|Lost to Follow-up|0|||
27899605|NCT01054573|54555652|FG003|Overall Study|Lost to Follow-up|0|||
27899606|NCT01054573|54555649|FG000|Overall Study|Withdrawal by Subject|0|||
27899607|NCT01054573|54555650|FG001|Overall Study|Withdrawal by Subject|2|||
27899608|NCT01054573|54555651|FG002|Overall Study|Withdrawal by Subject|2|||
27899609|NCT01054573|54555652|FG003|Overall Study|Withdrawal by Subject|1|||
27899610|NCT01054456|54555671|FG000|Overall Study|Other|1|||
27899611|NCT01054300|54555677|FG000|Period 1|Adverse Event|1|||
27899612|NCT01054300|54555678|FG001|Period 1|Adverse Event|0|||
27899613|NCT01054300|54555679|FG002|Period 1|Adverse Event|0|||
27899614|NCT01054300|54555680|FG003|Period 1|Adverse Event|0|||
27899615|NCT01054300|54555677|FG000|Period 2|Withdrawal by Subject|0|||
27899616|NCT01054300|54555678|FG001|Period 2|Withdrawal by Subject|0|||
27899617|NCT01054300|54555679|FG002|Period 2|Withdrawal by Subject|1|||
27899618|NCT01054300|54555680|FG003|Period 2|Withdrawal by Subject|0|||
27899619|NCT01053988|54555695|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220|||
27899620|NCT01053988|54555696|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
27899621|NCT01053988|54555697|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
27899622|NCT01053988|54555698|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
27899623|NCT01053988|54555699|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
27899624|NCT01053988|54555700|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
27899625|NCT01053988|54555695|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|98|||
27899626|NCT01053988|54555696|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
27899627|NCT01053988|54555697|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
27899628|NCT01053988|54555698|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
27899629|NCT01053988|54555699|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
27899630|NCT01053988|54555700|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
27899631|NCT01053988|54555695|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|30|||
27899632|NCT01053988|54555696|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
27899633|NCT01053988|54555697|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
27899634|NCT01053988|54555698|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
27899635|NCT01053988|54555699|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
27899636|NCT01053988|54555700|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
27899637|NCT01053988|54555695|FG000|2-week, Single-blind Run-In Period|Adverse Event|6|||
27899638|NCT01053988|54555696|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
27899639|NCT01053988|54555697|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
27899640|NCT01053988|54555698|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
27899641|NCT01053988|54555699|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
27899642|NCT01053988|54555700|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
27899643|NCT01053988|54555695|FG000|2-week, Single-blind Run-In Period|Physician Decision|5|||
27899644|NCT01053988|54555696|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
27899645|NCT01053988|54555697|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
27899646|NCT01053988|54555698|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
27899647|NCT01053988|54555699|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
27899648|NCT01053988|54555700|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
27899649|NCT01053988|54555695|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
27899650|NCT01053988|54555696|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
27899651|NCT01053988|54555697|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
27899652|NCT01053988|54555698|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
27899653|NCT01053988|54555699|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
27899654|NCT01053988|54555700|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
27899655|NCT01053988|54555695|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
27899656|NCT01053988|54555696|FG001|24-week, Double-blind Treatment Period|Adverse Event|15|||
27899657|NCT01053988|54555697|FG002|24-week, Double-blind Treatment Period|Adverse Event|23|||
27986379|NCT00883740|54644769|FG000|Second Intervention|No longer willing to participate|0|||
27986380|NCT00883740|54644770|FG001|Second Intervention|No longer willing to participate|1|||
27986381|NCT00597012|54644778|FG000|Overall Study|Death|1|||
27986382|NCT00597012|54644779|FG001|Overall Study|Death|1|||
27986383|NCT00597012|54644778|FG000|Overall Study|Underwent Total Knee Replacement (TKR)|3|||
27899658|NCT01053988|54555698|FG003|24-week, Double-blind Treatment Period|Adverse Event|24|||
27899659|NCT01053988|54555699|FG004|24-week, Double-blind Treatment Period|Adverse Event|17|||
27899660|NCT01053988|54555700|FG005|24-week, Double-blind Treatment Period|Adverse Event|14|||
27899661|NCT01053988|54555695|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
27899662|NCT01053988|54555696|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
27899663|NCT01053988|54555697|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
27899664|NCT01053988|54555698|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
27899665|NCT01053988|54555699|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
27899666|NCT01053988|54555700|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
27899667|NCT01053988|54555695|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
27899668|NCT01053988|54555696|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17|||
27899669|NCT01053988|54555697|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16|||
27899670|NCT01053988|54555698|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
27899671|NCT01053988|54555699|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9|||
27899672|NCT01053988|54555700|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
27899673|NCT01053988|54555695|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
27899674|NCT01053988|54555696|FG001|24-week, Double-blind Treatment Period|Protocol Violation|3|||
27899675|NCT01053988|54555697|FG002|24-week, Double-blind Treatment Period|Protocol Violation|4|||
27899676|NCT01053988|54555698|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
27899677|NCT01053988|54555699|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
27899678|NCT01053988|54555700|FG005|24-week, Double-blind Treatment Period|Protocol Violation|4|||
27899679|NCT01053988|54555695|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
27899680|NCT01053988|54555696|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
27899681|NCT01053988|54555697|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5|||
27899682|NCT01053988|54555698|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8|||
27899683|NCT01053988|54555699|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
27899684|NCT01053988|54555700|FG005|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
27899685|NCT01053988|54555695|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
27899686|NCT01053988|54555696|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|4|||
27925784|NCT01226745|54582367|FG000|Overall Study|Death|1|||
27986384|NCT00597012|54644779|FG001|Overall Study|Underwent Total Knee Replacement (TKR)|1|||
27986385|NCT00597012|54644778|FG000|Overall Study|Withdrawal by Subject|7|||
27986386|NCT00597012|54644779|FG001|Overall Study|Withdrawal by Subject|4|||
27986387|NCT00597012|54644778|FG000|Overall Study|Ineligible|2|||
27986388|NCT00597012|54644779|FG001|Overall Study|Ineligible|0|||
27986389|NCT00597012|54644778|FG000|Overall Study|Lost to Follow-up|0|||
27986390|NCT00597012|54644779|FG001|Overall Study|Lost to Follow-up|2|||
27986391|NCT00542815|54644790|FG000|Overall Study|Adverse Event|19|||
27986392|NCT00542815|54644791|FG001|Overall Study|Adverse Event|6|||
27986393|NCT00542815|54644792|FG002|Overall Study|Adverse Event|9|||
27986394|NCT00542815|54644790|FG000|Overall Study|Death|10|||
27986395|NCT00542815|54644791|FG001|Overall Study|Death|7|||
27986396|NCT00542815|54644792|FG002|Overall Study|Death|3|||
27986397|NCT00542815|54644790|FG000|Overall Study|Lack of Efficacy|9|||
27986398|NCT00542815|54644791|FG001|Overall Study|Lack of Efficacy|2|||
27986399|NCT00542815|54644792|FG002|Overall Study|Lack of Efficacy|0|||
27986400|NCT00542815|54644790|FG000|Overall Study|Physician Decision|2|||
27986401|NCT00542815|54644791|FG001|Overall Study|Physician Decision|1|||
27986402|NCT00542815|54644792|FG002|Overall Study|Physician Decision|0|||
27986403|NCT00542815|54644790|FG000|Overall Study|Protocol Violation|1|||
27986404|NCT00542815|54644791|FG001|Overall Study|Protocol Violation|1|||
27986405|NCT00542815|54644792|FG002|Overall Study|Protocol Violation|2|||
27986406|NCT00542815|54644790|FG000|Overall Study|Withdrawal by Subject|41|||
27986407|NCT00542815|54644791|FG001|Overall Study|Withdrawal by Subject|5|||
27986408|NCT00542815|54644792|FG002|Overall Study|Withdrawal by Subject|8|||
27986409|NCT00542815|54644790|FG000|Overall Study|Other reasons|24|||
27986410|NCT00542815|54644791|FG001|Overall Study|Other reasons|10|||
27986411|NCT00542815|54644792|FG002|Overall Study|Other reasons|10|||
27986412|NCT00542425|54644805|FG000|Initial 24 Weeks|Administrative reasons|0|||
27986413|NCT00542425|54644806|FG001|Initial 24 Weeks|Administrative reasons|0|||
27986414|NCT00542425|54644807|FG002|Initial 24 Weeks|Administrative reasons|1|||
28097279|NCT03693612|54752824|FG005|Overall Study|Withdrawal by Subject|0|||
28097280|NCT03693612|54752825|FG006|Overall Study|Withdrawal by Subject|0|||
28097281|NCT03693612|54752819|FG000|Overall Study|Study Terminated by Sponsor|0|||
28097282|NCT03693612|54752820|FG001|Overall Study|Study Terminated by Sponsor|1|||
28097283|NCT03693612|54752821|FG002|Overall Study|Study Terminated by Sponsor|0|||
28097284|NCT03693612|54752822|FG003|Overall Study|Study Terminated by Sponsor|0|||
28097285|NCT03693612|54752823|FG004|Overall Study|Study Terminated by Sponsor|3|||
28097286|NCT03693612|54752824|FG005|Overall Study|Study Terminated by Sponsor|0|||
28097287|NCT03693612|54752825|FG006|Overall Study|Study Terminated by Sponsor|0|||
28097288|NCT03692910|54752841|FG000|Overall Study|Lost to Follow-up|4|||
28097289|NCT03692910|54752842|FG001|Overall Study|Lost to Follow-up|0|||
28097290|NCT03692910|54752843|FG002|Overall Study|Lost to Follow-up|0|||
27899687|NCT01053988|54555697|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
27899688|NCT01053988|54555698|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
27899689|NCT01053988|54555699|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
27899690|NCT01053988|54555700|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
27899691|NCT01053988|54555695|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
27899692|NCT01053988|54555696|FG001|24-week, Double-blind Treatment Period|Physician Decision|5|||
27899693|NCT01053988|54555697|FG002|24-week, Double-blind Treatment Period|Physician Decision|2|||
27899694|NCT01053988|54555698|FG003|24-week, Double-blind Treatment Period|Physician Decision|5|||
27899695|NCT01053988|54555699|FG004|24-week, Double-blind Treatment Period|Physician Decision|5|||
27899696|NCT01053988|54555700|FG005|24-week, Double-blind Treatment Period|Physician Decision|4|||
27899697|NCT01053988|54555695|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
27899698|NCT01053988|54555696|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|11|||
27899699|NCT01053988|54555697|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
27899700|NCT01053988|54555698|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
27899701|NCT01053988|54555699|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|10|||
27899702|NCT01053988|54555700|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
27899703|NCT01053247|54555715|FG000|Overall Study|Withdrawal by Subject|9|||
27899704|NCT01053247|54555716|FG001|Overall Study|Withdrawal by Subject|4|||
27899705|NCT01053247|54555717|FG002|Overall Study|Withdrawal by Subject|15|||
27899706|NCT01053247|54555715|FG000|Overall Study|Lack of Efficacy|1|||
27899707|NCT01053247|54555716|FG001|Overall Study|Lack of Efficacy|0|||
27899708|NCT01053247|54555717|FG002|Overall Study|Lack of Efficacy|1|||
27899709|NCT01053247|54555715|FG000|Overall Study|Protocol Violation|2|||
27899710|NCT01053247|54555716|FG001|Overall Study|Protocol Violation|1|||
27899711|NCT01053247|54555717|FG002|Overall Study|Protocol Violation|2|||
27899712|NCT01053247|54555715|FG000|Overall Study|Lost to Follow-up|8|||
27899713|NCT01053247|54555716|FG001|Overall Study|Lost to Follow-up|5|||
27899714|NCT01053247|54555717|FG002|Overall Study|Lost to Follow-up|7|||
27899715|NCT01053247|54555715|FG000|Overall Study|Adverse Event|0|||
27899716|NCT01053247|54555716|FG001|Overall Study|Adverse Event|9|||
27899717|NCT01053247|54555717|FG002|Overall Study|Adverse Event|3|||
27899718|NCT01052662|54555728|FG000|Overall Study|Lost to Follow-up|15|||
27899719|NCT01052662|54555729|FG001|Overall Study|Lost to Follow-up|13|||
27899720|NCT01052662|54555730|FG002|Overall Study|Lost to Follow-up|18|||
27899721|NCT01052662|54555728|FG000|Overall Study|Withdrawal by Subject|3|||
27899722|NCT01052662|54555729|FG001|Overall Study|Withdrawal by Subject|2|||
27899723|NCT01052662|54555730|FG002|Overall Study|Withdrawal by Subject|1|||
27899724|NCT01052662|54555728|FG000|Overall Study|Pharmacy issue|1|||
27899725|NCT01052662|54555729|FG001|Overall Study|Pharmacy issue|3|||
27899726|NCT01052662|54555730|FG002|Overall Study|Pharmacy issue|3|||
27899727|NCT01052662|54555728|FG000|Overall Study|Adverse Event|1|||
27899728|NCT01052662|54555729|FG001|Overall Study|Adverse Event|1|||
27899729|NCT01052662|54555730|FG002|Overall Study|Adverse Event|0|||
27899730|NCT01052662|54555728|FG000|Overall Study|Legal Problem|2|||
27899731|NCT01052662|54555729|FG001|Overall Study|Legal Problem|0|||
27899732|NCT01052662|54555730|FG002|Overall Study|Legal Problem|0|||
27899733|NCT01052662|54555728|FG000|Overall Study|Administrative|0|||
27899734|NCT01052662|54555729|FG001|Overall Study|Administrative|3|||
27899735|NCT01052662|54555730|FG002|Overall Study|Administrative|0|||
27899736|NCT01052116|54555740|FG000|Overall Study|Lost to Follow-up|11|||
27899737|NCT01052116|54555741|FG001|Overall Study|Lost to Follow-up|17|||
27899738|NCT01052116|54555740|FG000|Overall Study|Withdrawal by Subject|3|||
27899739|NCT01052116|54555741|FG001|Overall Study|Withdrawal by Subject|6|||
27899740|NCT01052116|54555740|FG000|Overall Study|Spirometry not performed|0|||
27899741|NCT01052116|54555741|FG001|Overall Study|Spirometry not performed|4|||
27899742|NCT01052077|54555749|FG000|Phase A|Lost to Follow-up|22|||
27899743|NCT01052077|54555750|FG001|Phase A|Lost to Follow-up|0|||
27899744|NCT01052077|54555751|FG002|Phase A|Lost to Follow-up|0|||
27899745|NCT01052077|54555752|FG003|Phase A|Lost to Follow-up|0|||
27899746|NCT01052077|54555749|FG000|Phase A|Adverse Event|32|||
27899747|NCT01052077|54555750|FG001|Phase A|Adverse Event|0|||
27899748|NCT01052077|54555751|FG002|Phase A|Adverse Event|0|||
27899749|NCT01052077|54555752|FG003|Phase A|Adverse Event|0|||
27899750|NCT01052077|54555749|FG000|Phase A|Met Withdrawal Criteria|26|||
27899751|NCT01052077|54555750|FG001|Phase A|Met Withdrawal Criteria|0|||
27899752|NCT01052077|54555751|FG002|Phase A|Met Withdrawal Criteria|0|||
27899753|NCT01052077|54555752|FG003|Phase A|Met Withdrawal Criteria|0|||
27899754|NCT01052077|54555749|FG000|Phase A|Physician Decision|10|||
27899755|NCT01052077|54555750|FG001|Phase A|Physician Decision|0|||
27899756|NCT01052077|54555751|FG002|Phase A|Physician Decision|0|||
27899757|NCT01052077|54555752|FG003|Phase A|Physician Decision|0|||
27899758|NCT01052077|54555749|FG000|Phase A|Withdrawal by Subject|29|||
27899759|NCT01052077|54555750|FG001|Phase A|Withdrawal by Subject|0|||
27899760|NCT01052077|54555751|FG002|Phase A|Withdrawal by Subject|0|||
28097291|NCT03692910|54752841|FG000|Overall Study|Withdrawal by Subject|2|||
27899761|NCT01052077|54555752|FG003|Phase A|Withdrawal by Subject|0|||
28097292|NCT03692910|54752842|FG001|Overall Study|Withdrawal by Subject|0|||
27899762|NCT01052077|54555749|FG000|Phase A|Protocol Deviation|27|||
27899763|NCT01052077|54555750|FG001|Phase A|Protocol Deviation|0|||
27899764|NCT01052077|54555751|FG002|Phase A|Protocol Deviation|0|||
27899765|NCT01052077|54555752|FG003|Phase A|Protocol Deviation|0|||
27899766|NCT01052077|54555749|FG000|Phase B|Lost to Follow-up|0|||
27899767|NCT01052077|54555750|FG001|Phase B|Lost to Follow-up|2|||
27899768|NCT01052077|54555751|FG002|Phase B|Lost to Follow-up|3|||
27899769|NCT01052077|54555752|FG003|Phase B|Lost to Follow-up|0|||
27899770|NCT01052077|54555749|FG000|Phase B|Adverse Event|0|||
27899771|NCT01052077|54555750|FG001|Phase B|Adverse Event|9|||
27899772|NCT01052077|54555751|FG002|Phase B|Adverse Event|2|||
27899773|NCT01052077|54555752|FG003|Phase B|Adverse Event|0|||
27899774|NCT01052077|54555749|FG000|Phase B|Met Withdrawal Criteria|0|||
27899775|NCT01052077|54555750|FG001|Phase B|Met Withdrawal Criteria|2|||
27899776|NCT01052077|54555751|FG002|Phase B|Met Withdrawal Criteria|1|||
27899777|NCT01052077|54555752|FG003|Phase B|Met Withdrawal Criteria|0|||
27899778|NCT01052077|54555749|FG000|Phase B|Physician Decision|0|||
27899779|NCT01052077|54555750|FG001|Phase B|Physician Decision|1|||
27899780|NCT01052077|54555751|FG002|Phase B|Physician Decision|1|||
27899781|NCT01052077|54555752|FG003|Phase B|Physician Decision|0|||
27899782|NCT01052077|54555749|FG000|Phase B|Withdrawal by Subject|0|||
27899783|NCT01052077|54555750|FG001|Phase B|Withdrawal by Subject|0|||
27899784|NCT01052077|54555751|FG002|Phase B|Withdrawal by Subject|5|||
27899785|NCT01052077|54555752|FG003|Phase B|Withdrawal by Subject|0|||
27899786|NCT01052077|54555749|FG000|Phase B|Protocol Deviation|0|||
27899787|NCT01052077|54555750|FG001|Phase B|Protocol Deviation|3|||
27899788|NCT01052077|54555751|FG002|Phase B|Protocol Deviation|4|||
27899789|NCT01052077|54555752|FG003|Phase B|Protocol Deviation|0|||
27899790|NCT01052077|54555749|FG000|Phase B|Lack of Efficacy|0|||
27899791|NCT01052077|54555750|FG001|Phase B|Lack of Efficacy|1|||
27899792|NCT01052077|54555751|FG002|Phase B|Lack of Efficacy|0|||
27899793|NCT01052077|54555752|FG003|Phase B|Lack of Efficacy|0|||
27986415|NCT00542425|54644808|FG003|Initial 24 Weeks|Administrative reasons|1|||
27986416|NCT00542425|54644809|FG004|Initial 24 Weeks|Administrative reasons|0|||
27986417|NCT00542425|54644805|FG000|Initial 24 Weeks|Adverse Event|0|||
27986418|NCT00542425|54644806|FG001|Initial 24 Weeks|Adverse Event|1|||
27986419|NCT00542425|54644807|FG002|Initial 24 Weeks|Adverse Event|1|||
27986420|NCT00542425|54644808|FG003|Initial 24 Weeks|Adverse Event|3|||
27986421|NCT00542425|54644809|FG004|Initial 24 Weeks|Adverse Event|2|||
27986422|NCT00542425|54644805|FG000|Initial 24 Weeks|Inability to complete procedures|0|||
27986423|NCT00542425|54644806|FG001|Initial 24 Weeks|Inability to complete procedures|3|||
27986424|NCT00542425|54644807|FG002|Initial 24 Weeks|Inability to complete procedures|2|||
27986425|NCT00542425|54644808|FG003|Initial 24 Weeks|Inability to complete procedures|1|||
27986426|NCT00542425|54644809|FG004|Initial 24 Weeks|Inability to complete procedures|2|||
27986427|NCT00542425|54644805|FG000|Initial 24 Weeks|Lost to Follow-up|2|||
27986428|NCT00542425|54644806|FG001|Initial 24 Weeks|Lost to Follow-up|2|||
27986429|NCT00542425|54644807|FG002|Initial 24 Weeks|Lost to Follow-up|1|||
27986430|NCT00542425|54644808|FG003|Initial 24 Weeks|Lost to Follow-up|0|||
27986431|NCT00542425|54644809|FG004|Initial 24 Weeks|Lost to Follow-up|0|||
27986432|NCT00542425|54644805|FG000|Initial 24 Weeks|Non-compliance|0|||
27986433|NCT00542425|54644806|FG001|Initial 24 Weeks|Non-compliance|0|||
27986434|NCT00542425|54644807|FG002|Initial 24 Weeks|Non-compliance|0|||
27986435|NCT00542425|54644808|FG003|Initial 24 Weeks|Non-compliance|1|||
27986436|NCT00542425|54644809|FG004|Initial 24 Weeks|Non-compliance|1|||
27986437|NCT00542425|54644805|FG000|Initial 24 Weeks|Protocol Violation|0|||
27986438|NCT00542425|54644806|FG001|Initial 24 Weeks|Protocol Violation|0|||
27986439|NCT00542425|54644807|FG002|Initial 24 Weeks|Protocol Violation|0|||
27986440|NCT00542425|54644808|FG003|Initial 24 Weeks|Protocol Violation|1|||
27986441|NCT00542425|54644809|FG004|Initial 24 Weeks|Protocol Violation|0|||
27986442|NCT00542425|54644805|FG000|Initial 24 Weeks|Refusal of treatment|2|||
27986443|NCT00542425|54644806|FG001|Initial 24 Weeks|Refusal of treatment|2|||
27986444|NCT00542425|54644807|FG002|Initial 24 Weeks|Refusal of treatment|1|||
27899794|NCT01052077|54555749|FG000|Phase A+|Lost to Follow-up|0|||
27899795|NCT01052077|54555750|FG001|Phase A+|Lost to Follow-up|0|||
27899796|NCT01052077|54555751|FG002|Phase A+|Lost to Follow-up|0|||
27899797|NCT01052077|54555752|FG003|Phase A+|Lost to Follow-up|8|||
27899798|NCT01052077|54555749|FG000|Phase A+|Adverse Event|0|||
27899799|NCT01052077|54555750|FG001|Phase A+|Adverse Event|0|||
27899800|NCT01052077|54555751|FG002|Phase A+|Adverse Event|0|||
27899801|NCT01052077|54555752|FG003|Phase A+|Adverse Event|4|||
27899802|NCT01052077|54555749|FG000|Phase A+|Met Withdrawal Criteria|0|||
27899803|NCT01052077|54555750|FG001|Phase A+|Met Withdrawal Criteria|0|||
27986445|NCT00542425|54644808|FG003|Initial 24 Weeks|Refusal of treatment|4|||
27986446|NCT00542425|54644809|FG004|Initial 24 Weeks|Refusal of treatment|1|||
27899804|NCT01052077|54555751|FG002|Phase A+|Met Withdrawal Criteria|0|||
27899805|NCT01052077|54555752|FG003|Phase A+|Met Withdrawal Criteria|2|||
27899806|NCT01052077|54555749|FG000|Phase A+|Withdrawal by Subject|0|||
27899807|NCT01052077|54555750|FG001|Phase A+|Withdrawal by Subject|0|||
27899808|NCT01052077|54555751|FG002|Phase A+|Withdrawal by Subject|0|||
27899809|NCT01052077|54555752|FG003|Phase A+|Withdrawal by Subject|7|||
27899810|NCT01052038|54555761|FG000|Overall Study|Lost to Follow-up|2|||
27899811|NCT01052038|54555762|FG001|Overall Study|Lost to Follow-up|3|||
27899812|NCT01052038|54555763|FG002|Overall Study|Lost to Follow-up|1|||
27899813|NCT01052038|54555761|FG000|Overall Study|Protocol Violation|2|||
27899814|NCT01052038|54555762|FG001|Overall Study|Protocol Violation|3|||
27899815|NCT01052038|54555763|FG002|Overall Study|Protocol Violation|3|||
27899816|NCT01051960|54555771|FG000|Overall Study|Adverse Event|1|||
27899817|NCT01051921|54555775|FG000|Overall Study|Physician Decision|9|||
27899818|NCT01051921|54555775|FG000|Overall Study|Adverse Event|8|||
27899819|NCT01051921|54555775|FG000|Overall Study|Withdrawal by Subject|7|||
27899820|NCT01051921|54555775|FG000|Overall Study|Lost to Follow-up|4|||
27899821|NCT01051921|54555775|FG000|Overall Study|virological failure|1|||
27899822|NCT01051921|54555775|FG000|Overall Study|patient moved|1|||
27899823|NCT01051063|54555781|FG000|Overall Study|Death|2|||
27899824|NCT01051063|54555782|FG001|Overall Study|Death|2|||
27899825|NCT01051063|54555781|FG000|Overall Study|Withdrawal by Subject|1|||
27899826|NCT01051063|54555782|FG001|Overall Study|Withdrawal by Subject|1|||
27899827|NCT01051063|54555781|FG000|Overall Study|Termination of the study|5|||
27899828|NCT01051063|54555782|FG001|Overall Study|Termination of the study|0|||
27899829|NCT01051063|54555781|FG000|Overall Study|Moved from the study site area|1|||
27899830|NCT01051063|54555782|FG001|Overall Study|Moved from the study site area|0|||
27899831|NCT01051063|54555781|FG000|Overall Study|Other|1|||
27899832|NCT01051063|54555782|FG001|Overall Study|Other|0|||
27899833|NCT01051063|54555781|FG000|Overall Study|Lost to Follow-up|0|||
27899834|NCT01051063|54555782|FG001|Overall Study|Lost to Follow-up|1|||
27899835|NCT01050790|54555789|FG000|Overall Study|Adverse Event|1|||
27899836|NCT01050673|54555796|FG000|Overall Study|Physician Decision|4|||
27899837|NCT01050673|54555797|FG001|Overall Study|Physician Decision|5|||
27899838|NCT01050205|54555805|FG000|Overall Study|Lost to Follow-up|7|||
27899839|NCT01050205|54555806|FG001|Overall Study|Lost to Follow-up|1|||
27899840|NCT01050205|54555805|FG000|Overall Study|Withdrawal by Subject|1|||
27899841|NCT01050205|54555806|FG001|Overall Study|Withdrawal by Subject|1|||
27899842|NCT01050205|54555805|FG000|Overall Study|Relocated from area|1|||
27899843|NCT01050205|54555806|FG001|Overall Study|Relocated from area|2|||
27899844|NCT01050205|54555805|FG000|Overall Study|Discontinued Intervention|2|||
27899845|NCT01050205|54555806|FG001|Overall Study|Discontinued Intervention|0|||
27899846|NCT01059448|54555816|FG000|Overall Study|Adverse Event|1|||
27899847|NCT01059448|54555817|FG001|Overall Study|Adverse Event|3|||
27899848|NCT01059448|54555818|FG002|Overall Study|Adverse Event|0|||
27899849|NCT01059448|54555819|FG003|Overall Study|Adverse Event|1|||
27899850|NCT01059448|54555816|FG000|Overall Study|Withdrawal by Subject|2|||
27899851|NCT01059448|54555817|FG001|Overall Study|Withdrawal by Subject|0|||
27899852|NCT01059448|54555818|FG002|Overall Study|Withdrawal by Subject|2|||
27899853|NCT01059448|54555819|FG003|Overall Study|Withdrawal by Subject|4|||
27899854|NCT01059448|54555816|FG000|Overall Study|Disease Progression|2|||
27899855|NCT01059448|54555817|FG001|Overall Study|Disease Progression|1|||
27899856|NCT01059448|54555818|FG002|Overall Study|Disease Progression|4|||
27899857|NCT01059448|54555819|FG003|Overall Study|Disease Progression|2|||
27986447|NCT00542425|54644805|FG000|Initial 24 Weeks|Other|0|||
27986448|NCT00542425|54644806|FG001|Initial 24 Weeks|Other|2|||
27986449|NCT00542425|54644807|FG002|Initial 24 Weeks|Other|1|||
27986450|NCT00542425|54644808|FG003|Initial 24 Weeks|Other|0|||
27986451|NCT00542425|54644809|FG004|Initial 24 Weeks|Other|0|||
27986452|NCT00542425|54644805|FG000|Extended 24 Weeks of Treatment|Adverse Event|0|||
28097293|NCT03692910|54752843|FG002|Overall Study|Withdrawal by Subject|0|||
28097294|NCT04223232|54752849|FG000|Overall Study|Withdrawal by Subject|1|||
28097295|NCT04206384|54752853|FG000|Overall Study|Withdrawal by Subject|8|||
28097296|NCT04206384|54752853|FG000|Overall Study|Adverse Event|2|||
28097297|NCT04051944|54752859|FG000|Overall Study|Study ending|1|||
27899858|NCT01059448|54555816|FG000|Overall Study|Administrative Decision|43|||
27899859|NCT01059448|54555817|FG001|Overall Study|Administrative Decision|49|||
27899860|NCT01059448|54555818|FG002|Overall Study|Administrative Decision|45|||
27899861|NCT01059448|54555819|FG003|Overall Study|Administrative Decision|46|||
27899862|NCT01059448|54555816|FG000|Overall Study|Lost to Follow-up|0|||
27899863|NCT01059448|54555817|FG001|Overall Study|Lost to Follow-up|0|||
27899864|NCT01059448|54555818|FG002|Overall Study|Lost to Follow-up|2|||
27899865|NCT01059448|54555819|FG003|Overall Study|Lost to Follow-up|0|||
27899866|NCT01059448|54555816|FG000|Overall Study|Death|0|||
27899867|NCT01059448|54555817|FG001|Overall Study|Death|1|||
27899868|NCT01059448|54555818|FG002|Overall Study|Death|0|||
27899869|NCT01059448|54555819|FG003|Overall Study|Death|0|||
28097298|NCT04051944|54752860|FG001|Overall Study|Study ending|1|||
28097299|NCT04051944|54752859|FG000|Overall Study|Early study termination by participant|1|||
28097300|NCT04051944|54752860|FG001|Overall Study|Early study termination by participant|0|||
27899870|NCT01059448|54555816|FG000|Overall Study|Other|1|||
27899871|NCT01059448|54555817|FG001|Overall Study|Other|1|||
27899872|NCT01059448|54555818|FG002|Overall Study|Other|0|||
27899873|NCT01059448|54555819|FG003|Overall Study|Other|1|||
27899874|NCT01058707|54555836|FG000|Overall Study|Disease Progression|15|||
27986453|NCT00542425|54644806|FG001|Extended 24 Weeks of Treatment|Adverse Event|0|||
27899875|NCT01058707|54555837|FG001|Overall Study|Disease Progression|20|||
27899876|NCT01058707|54555838|FG002|Overall Study|Disease Progression|20|||
27899877|NCT01058707|54555839|FG003|Overall Study|Disease Progression|15|||
27899878|NCT01058707|54555840|FG004|Overall Study|Disease Progression|23|||
27899879|NCT01058707|54555841|FG005|Overall Study|Disease Progression|10|||
27899880|NCT01058707|54555842|FG006|Overall Study|Disease Progression|12|||
27899881|NCT01058707|54555836|FG000|Overall Study|Adverse Event|11|||
27899882|NCT01058707|54555837|FG001|Overall Study|Adverse Event|4|||
27899883|NCT01058707|54555838|FG002|Overall Study|Adverse Event|7|||
27899884|NCT01058707|54555839|FG003|Overall Study|Adverse Event|6|||
27986454|NCT00542425|54644807|FG002|Extended 24 Weeks of Treatment|Adverse Event|1|||
27986455|NCT00542425|54644808|FG003|Extended 24 Weeks of Treatment|Adverse Event|1|||
27986456|NCT00542425|54644809|FG004|Extended 24 Weeks of Treatment|Adverse Event|0|||
27986457|NCT00542425|54644805|FG000|Extended 24 Weeks of Treatment|Protocol Violation|0|||
27986458|NCT00542425|54644806|FG001|Extended 24 Weeks of Treatment|Protocol Violation|0|||
27986459|NCT00542425|54644807|FG002|Extended 24 Weeks of Treatment|Protocol Violation|1|||
27986460|NCT00542425|54644808|FG003|Extended 24 Weeks of Treatment|Protocol Violation|0|||
27986461|NCT00542425|54644809|FG004|Extended 24 Weeks of Treatment|Protocol Violation|0|||
27986462|NCT00542425|54644805|FG000|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
27986463|NCT00542425|54644806|FG001|Extended 24 Weeks of Treatment|Refusal of treatment|1|||
27986464|NCT00542425|54644807|FG002|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
27986465|NCT00542425|54644808|FG003|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
27986466|NCT00542425|54644809|FG004|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
27986467|NCT00542425|54644805|FG000|Extended 24 Weeks of Treatment|Other|1|||
27986468|NCT00542425|54644806|FG001|Extended 24 Weeks of Treatment|Other|1|||
27986469|NCT00542425|54644807|FG002|Extended 24 Weeks of Treatment|Other|0|||
27986470|NCT00542425|54644808|FG003|Extended 24 Weeks of Treatment|Other|0|||
27986471|NCT00542425|54644809|FG004|Extended 24 Weeks of Treatment|Other|1|||
27986472|NCT00541099|54644821|FG000|Overall Study|Ineligible|3|||
27986473|NCT00580606|54644827|FG000|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2|||
27986474|NCT00580606|54644828|FG001|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1|||
27986475|NCT00580606|54644827|FG000|Open Label (OL)|Withdrawal by Subject|4|||
27986476|NCT00580606|54644828|FG001|Open Label (OL)|Withdrawal by Subject|6|||
27986477|NCT00580606|54644827|FG000|Open Label (OL)|Dosing Symptoms|0|||
27986478|NCT00580606|54644828|FG001|Open Label (OL)|Dosing Symptoms|1|||
27986479|NCT00580606|54644827|FG000|Open Label (OL)|Lost to Follow-up|0|||
27986480|NCT00580606|54644828|FG001|Open Label (OL)|Lost to Follow-up|1|||
27986481|NCT00580606|54644827|FG000|Open Label (OL)|Pregnancy|0|||
27986482|NCT00580606|54644828|FG001|Open Label (OL)|Pregnancy|1|||
27986483|NCT00580606|54644827|FG000|Open Label (OL)|Non-compliance|2|||
27986484|NCT00580606|54644828|FG001|Open Label (OL)|Non-compliance|0|||
27986485|NCT00580606|54644827|FG000|Open Label (OL)|Physician Decision|1|||
27986486|NCT00580606|54644828|FG001|Open Label (OL)|Physician Decision|1|||
27986487|NCT00580606|54644827|FG000|Open Label (OL)|Needed Prohibited Medication|0|||
27986488|NCT00580606|54644828|FG001|Open Label (OL)|Needed Prohibited Medication|1|||
27986489|NCT00579982|54644842|FG000|Overall Study|Adverse Event|4|||
27986490|NCT00579982|54644842|FG000|Overall Study|Protocol Violation|4|||
27986491|NCT00596466|54644846|FG000|Overall Study|Lack of Efficacy|5|||
27986492|NCT00596466|54644846|FG000|Overall Study|Adverse Event|4|||
27986493|NCT00596466|54644846|FG000|Overall Study|Withdrawal by Subject|2|||
27986494|NCT00596466|54644846|FG000|Overall Study|Protocol Violation|2|||
27986495|NCT00596466|54644846|FG000|Overall Study|Unpecified|2|||
27899885|NCT01058707|54555840|FG004|Overall Study|Adverse Event|7|||
27899886|NCT01058707|54555841|FG005|Overall Study|Adverse Event|3|||
27899887|NCT01058707|54555842|FG006|Overall Study|Adverse Event|1|||
27899888|NCT01058707|54555836|FG000|Overall Study|Subject Decision|5|||
27986496|NCT00596466|54644846|FG000|Overall Study|Enrolled, not treated|2|||
27986497|NCT00596934|54644850|FG000|Overall Study|Protocol Violation|1|||
28097301|NCT04051944|54752859|FG000|Overall Study|Withdrawal by Subject|2|||
28097302|NCT04051944|54752860|FG001|Overall Study|Withdrawal by Subject|2|||
28097303|NCT04051944|54752859|FG000|Overall Study|Lack of Efficacy|3|||
28097304|NCT04051944|54752860|FG001|Overall Study|Lack of Efficacy|0|||
28097305|NCT04051944|54752859|FG000|Overall Study|Adverse event, non- fatal|1|||
28097306|NCT04051944|54752860|FG001|Overall Study|Adverse event, non- fatal|1|||
28097307|NCT04050618|54752868|FG000|First Intervention|Withdrawal by Subject|2|||
28097308|NCT04050618|54752869|FG001|First Intervention|Withdrawal by Subject|0|||
28172093|NCT02718417|54843703|FG001|Observation Phase (OP)|Study terminated by sponsor|0|||
27899889|NCT01058707|54555837|FG001|Overall Study|Subject Decision|3|||
27899890|NCT01058707|54555838|FG002|Overall Study|Subject Decision|3|||
27986498|NCT00596934|54644850|FG000|Overall Study|Withdrawal by Subject|1|||
27986499|NCT03911401|54644859|FG000|Overall Study|Adverse Event|1|||
27986500|NCT03911401|54644860|FG001|Overall Study|Adverse Event|2|||
27986501|NCT03911401|54644861|FG002|Overall Study|Adverse Event|5|||
27986502|NCT03911401|54644859|FG000|Overall Study|Lack of Efficacy|1|||
27986503|NCT03911401|54644860|FG001|Overall Study|Lack of Efficacy|1|||
27986504|NCT03911401|54644861|FG002|Overall Study|Lack of Efficacy|8|||
27899891|NCT01058707|54555839|FG003|Overall Study|Subject Decision|1|||
27899892|NCT01058707|54555840|FG004|Overall Study|Subject Decision|2|||
27899893|NCT01058707|54555841|FG005|Overall Study|Subject Decision|3|||
27899894|NCT01058707|54555842|FG006|Overall Study|Subject Decision|6|||
27899895|NCT01058707|54555836|FG000|Overall Study|Lost to Follow-up|0|||
27899896|NCT01058707|54555837|FG001|Overall Study|Lost to Follow-up|0|||
27899897|NCT01058707|54555838|FG002|Overall Study|Lost to Follow-up|1|||
27899898|NCT01058707|54555839|FG003|Overall Study|Lost to Follow-up|0|||
27899899|NCT01058707|54555840|FG004|Overall Study|Lost to Follow-up|0|||
27899900|NCT01058707|54555841|FG005|Overall Study|Lost to Follow-up|0|||
27899901|NCT01058707|54555842|FG006|Overall Study|Lost to Follow-up|0|||
27899902|NCT01058707|54555836|FG000|Overall Study|Reason Not Specified|0|||
27899903|NCT01058707|54555837|FG001|Overall Study|Reason Not Specified|3|||
27899904|NCT01058707|54555838|FG002|Overall Study|Reason Not Specified|2|||
27899905|NCT01058707|54555839|FG003|Overall Study|Reason Not Specified|0|||
27899906|NCT01058707|54555840|FG004|Overall Study|Reason Not Specified|7|||
27899907|NCT01058707|54555841|FG005|Overall Study|Reason Not Specified|1|||
27899908|NCT01058707|54555842|FG006|Overall Study|Reason Not Specified|7|||
27899909|NCT01054144|54555880|FG000|Overall Study|Death|2|||
27899910|NCT00105586|54555889|FG000|Overall Study|Adverse Event|4|||
27899911|NCT00105586|54555890|FG001|Overall Study|Adverse Event|3|||
27899912|NCT00105586|54555889|FG000|Overall Study|Physician Decision|13|||
27899913|NCT00105586|54555890|FG001|Overall Study|Physician Decision|13|||
27899914|NCT01059643|54555898|FG000|Overall Study|Adverse Event|3|||
27899915|NCT01059643|54555898|FG000|Overall Study|Withdrawal by Subject|2|||
27899916|NCT01059643|54555898|FG000|Overall Study|Physician Decision|1|||
27899917|NCT01059565|54555907|FG000|24-Week Randomized Phase|Randomized but not treated|1|||
27899918|NCT01059565|54555908|FG001|24-Week Randomized Phase|Randomized but not treated|0|||
27899919|NCT01059565|54555907|FG000|24-Week Randomized Phase|Adverse Event|5|||
27899920|NCT01059565|54555908|FG001|24-Week Randomized Phase|Adverse Event|0|||
27899921|NCT01059565|54555907|FG000|24-Week Randomized Phase|Withdrawal by Subject|3|||
27899922|NCT01059565|54555908|FG001|24-Week Randomized Phase|Withdrawal by Subject|1|||
27899923|NCT01059565|54555907|FG000|24-Week Randomized Phase|Lost to Follow-up|0|||
27899924|NCT01059565|54555908|FG001|24-Week Randomized Phase|Lost to Follow-up|1|||
27899925|NCT01059565|54555907|FG000|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1|||
27899926|NCT01059565|54555908|FG001|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5|||
27899927|NCT01059565|54555907|FG000|24-Week Open-Label Phase|Adverse Event|2|||
27899928|NCT01059565|54555908|FG001|24-Week Open-Label Phase|Adverse Event|0|||
27899929|NCT01059565|54555907|FG000|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
27899930|NCT01059565|54555908|FG001|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
27899931|NCT01059565|54555907|FG000|24-Week Open-Label Phase|Withdrawal by Subject|1|||
27899932|NCT01059565|54555908|FG001|24-Week Open-Label Phase|Withdrawal by Subject|0|||
27899933|NCT01059565|54555907|FG000|24-Week Open-Label Phase|Subject noncompliance|1|||
27899934|NCT01059565|54555908|FG001|24-Week Open-Label Phase|Subject noncompliance|0|||
27899935|NCT01059565|54555907|FG000|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0|||
27899936|NCT01059565|54555908|FG001|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1|||
27899937|NCT01059565|54555907|FG000|24-Week Open-Label Phase|Pulmonologist/participant decision|0|||
27899938|NCT01059565|54555908|FG001|24-Week Open-Label Phase|Pulmonologist/participant decision|1|||
27899939|NCT01059526|54555918|FG000|Overall Study|Patient enrolled but not treated|20|||
27899940|NCT01059526|54555919|FG001|Overall Study|Patient enrolled but not treated|17|||
27899941|NCT01059526|54555918|FG000|Overall Study|Adverse Event|2|||
27899942|NCT01059526|54555919|FG001|Overall Study|Adverse Event|2|||
27899943|NCT01059526|54555918|FG000|Overall Study|Protocol Violation|0|||
27899944|NCT01059526|54555919|FG001|Overall Study|Protocol Violation|1|||
27899945|NCT01059526|54555918|FG000|Overall Study|Withdrawal by Subject|3|||
27899946|NCT01059526|54555919|FG001|Overall Study|Withdrawal by Subject|1|||
27899947|NCT01059526|54555918|FG000|Overall Study|Lost to Follow-up|4|||
27899948|NCT01059526|54555919|FG001|Overall Study|Lost to Follow-up|1|||
27899949|NCT01059526|54555918|FG000|Overall Study|Patient found to be dermatographic|1|||
27899950|NCT01059526|54555919|FG001|Overall Study|Patient found to be dermatographic|0|||
27899951|NCT03277261|54555927|FG000|Overall Study|Adverse Event|17|||
27899952|NCT03277261|54555928|FG001|Overall Study|Adverse Event|1|||
27899953|NCT03277261|54555927|FG000|Overall Study|Participant Withdrawal of Consent|6|||
27899954|NCT03277261|54555928|FG001|Overall Study|Participant Withdrawal of Consent|15|||
27899955|NCT03277261|54555927|FG000|Overall Study|Investigator / Sponsor Decision|4|||
27899956|NCT03277261|54555928|FG001|Overall Study|Investigator / Sponsor Decision|2|||
27899957|NCT03277261|54555927|FG000|Overall Study|Pregnancy|2|||
27899958|NCT03277261|54555928|FG001|Overall Study|Pregnancy|0|||
27899959|NCT03277261|54555927|FG000|Overall Study|Lost to Follow-up|2|||
27899960|NCT03277261|54555928|FG001|Overall Study|Lost to Follow-up|2|||
27899961|NCT03277261|54555927|FG000|Overall Study|Lack of Efficacy|2|||
27899962|NCT03277261|54555928|FG001|Overall Study|Lack of Efficacy|2|||
27899963|NCT03277261|54555927|FG000|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
27899964|NCT03277261|54555928|FG001|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
27899965|NCT03277690|54555950|FG000|Dose Titration and Maintenance|Protocol Violation|3|||
27899966|NCT03277690|54555951|FG001|Dose Titration and Maintenance|Protocol Violation|0|||
27899967|NCT03277690|54555950|FG000|Dose Titration and Maintenance|Physician Decision|1|||
27899968|NCT03277690|54555951|FG001|Dose Titration and Maintenance|Physician Decision|0|||
27899969|NCT03277690|54555950|FG000|Dose Titration and Maintenance|Sponsor decision - Randomization closed|4|||
27899970|NCT03277690|54555951|FG001|Dose Titration and Maintenance|Sponsor decision - Randomization closed|0|||
27899971|NCT03277690|54555950|FG000|Dose Titration and Maintenance|Lack of Efficacy|9|||
27899972|NCT03277690|54555951|FG001|Dose Titration and Maintenance|Lack of Efficacy|0|||
27899973|NCT03277690|54555950|FG000|Dose Titration and Maintenance|Adverse Event|15|||
27899974|NCT03277690|54555951|FG001|Dose Titration and Maintenance|Adverse Event|0|||
27899975|NCT03277690|54555950|FG000|Dose Titration and Maintenance|Withdrawal by Subject|8|||
27899976|NCT03277690|54555951|FG001|Dose Titration and Maintenance|Withdrawal by Subject|0|||
27899977|NCT03277690|54555950|FG000|Randomized Withdrawal|Withdrawal by Subject|1|||
27899978|NCT03277690|54555951|FG001|Randomized Withdrawal|Withdrawal by Subject|0|||
27899979|NCT03271021|54555960|FG000|Overall Study|Adverse Event|3|||
27899980|NCT03271021|54555961|FG001|Overall Study|Adverse Event|2|||
27899981|NCT03271021|54555960|FG000|Overall Study|Withdrawal by Subject|36|||
27899982|NCT03271021|54555961|FG001|Overall Study|Withdrawal by Subject|53|||
27899983|NCT03271021|54555960|FG000|Overall Study|Lost to Follow-up|34|||
27899984|NCT03271021|54555961|FG001|Overall Study|Lost to Follow-up|39|||
27899985|NCT03271021|54555960|FG000|Overall Study|Protocol Violation|6|||
27899986|NCT03271021|54555961|FG001|Overall Study|Protocol Violation|4|||
27899987|NCT03271021|54555960|FG000|Overall Study|Abnormal Lab Results|1|||
27899988|NCT03271021|54555961|FG001|Overall Study|Abnormal Lab Results|0|||
27899989|NCT03271021|54555960|FG000|Overall Study|Miscellaneous|9|||
27899990|NCT03271021|54555961|FG001|Overall Study|Miscellaneous|8|||
27899991|NCT01249651|54555982|FG000|Overall Study|Withdrawal by Subject|4|||
27899992|NCT01249651|54555982|FG000|Overall Study|Adverse Event|1|||
27899993|NCT01249651|54555982|FG000|Overall Study|Protocol Violation|1|||
27899994|NCT01249651|54555982|FG000|Overall Study|Sponsor Decision|1|||
27899995|NCT01249417|54555989|FG000|Randomised Population|Study treatment not received|0|||
27899996|NCT01249417|54555990|FG001|Randomised Population|Study treatment not received|0|||
27899997|NCT01249417|54555991|FG002|Randomised Population|Study treatment not received|2|||
27899998|NCT01249417|54555989|FG000|Randomised Population|No MAS score at baseline and/or Week 4|1|||
27899999|NCT01249417|54555990|FG001|Randomised Population|No MAS score at baseline and/or Week 4|1|||
27900000|NCT01249417|54555991|FG002|Randomised Population|No MAS score at baseline and/or Week 4|2|||
27900001|NCT01249417|54555989|FG000|Treatment Phase - ITT Population|Other|0|||
27900002|NCT01249417|54555990|FG001|Treatment Phase - ITT Population|Other|0|||
27900003|NCT01249417|54555991|FG002|Treatment Phase - ITT Population|Other|1|||
27900004|NCT01249417|54555989|FG000|Treatment Phase - ITT Population|Adverse Event|0|||
27900005|NCT01249417|54555990|FG001|Treatment Phase - ITT Population|Adverse Event|0|||
27900006|NCT01249417|54555991|FG002|Treatment Phase - ITT Population|Adverse Event|1|||
27900007|NCT01249417|54555989|FG000|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
27900008|NCT01249417|54555990|FG001|Treatment Phase - ITT Population|Withdrawal by Subject|3|||
27900009|NCT01249417|54555991|FG002|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
27900010|NCT01249417|54555989|FG000|Treatment Phase - ITT Population|Lost to Follow-up|0|||
27900011|NCT01249417|54555990|FG001|Treatment Phase - ITT Population|Lost to Follow-up|1|||
27900012|NCT01249417|54555991|FG002|Treatment Phase - ITT Population|Lost to Follow-up|1|||
27900013|NCT01249261|54556001|FG000|Overall Study|Withdrawal by Subject|1|||
27900014|NCT01249261|54556002|FG001|Overall Study|Withdrawal by Subject|0|||
27900015|NCT01248949|54556022|FG000|Overall Study|Lost to Follow-up|2|||
27900016|NCT01248949|54556023|FG001|Overall Study|Lost to Follow-up|2|||
27900017|NCT01248949|54556024|FG002|Overall Study|Lost to Follow-up|2|||
27900018|NCT01248949|54556025|FG003|Overall Study|Lost to Follow-up|1|||
27900019|NCT01248949|54556026|FG004|Overall Study|Lost to Follow-up|0|||
27900020|NCT01248949|54556022|FG000|Overall Study|Withdrawal by Subject|5|||
27900021|NCT01248949|54556023|FG001|Overall Study|Withdrawal by Subject|3|||
27900022|NCT01248949|54556024|FG002|Overall Study|Withdrawal by Subject|11|||
27900023|NCT01248949|54556025|FG003|Overall Study|Withdrawal by Subject|3|||
27986505|NCT03911401|54644859|FG000|Overall Study|Physician Decision|0|||
27986506|NCT03911401|54644860|FG001|Overall Study|Physician Decision|0|||
27986507|NCT03911401|54644861|FG002|Overall Study|Physician Decision|1|||
27900024|NCT01248949|54556026|FG004|Overall Study|Withdrawal by Subject|1|||
27900025|NCT01248949|54556022|FG000|Overall Study|Death|22|||
27900026|NCT01248949|54556023|FG001|Overall Study|Death|7|||
27900027|NCT01248949|54556024|FG002|Overall Study|Death|21|||
27900028|NCT01248949|54556025|FG003|Overall Study|Death|6|||
27900029|NCT01248949|54556026|FG004|Overall Study|Death|2|||
27900030|NCT01248949|54556022|FG000|Overall Study|Alternative Therapy|1|||
27900031|NCT01248949|54556023|FG001|Overall Study|Alternative Therapy|0|||
27900032|NCT01248949|54556024|FG002|Overall Study|Alternative Therapy|0|||
27900033|NCT01248949|54556025|FG003|Overall Study|Alternative Therapy|0|||
27900034|NCT01248949|54556026|FG004|Overall Study|Alternative Therapy|0|||
27925785|NCT01226745|54582368|FG001|Overall Study|Death|0|||
27900035|NCT01248949|54556022|FG000|Overall Study|Alternative Therapy.|1|||
27900036|NCT01248949|54556023|FG001|Overall Study|Alternative Therapy.|0|||
27900037|NCT01248949|54556024|FG002|Overall Study|Alternative Therapy.|0|||
27900038|NCT01248949|54556025|FG003|Overall Study|Alternative Therapy.|0|||
27900039|NCT01248949|54556026|FG004|Overall Study|Alternative Therapy.|0|||
27900040|NCT01248949|54556022|FG000|Overall Study|Palliative Radiation To Brain Metastases|1|||
27900041|NCT01248949|54556023|FG001|Overall Study|Palliative Radiation To Brain Metastases|0|||
27900042|NCT01248949|54556024|FG002|Overall Study|Palliative Radiation To Brain Metastases|0|||
27900043|NCT01248949|54556025|FG003|Overall Study|Palliative Radiation To Brain Metastases|0|||
27900044|NCT01248949|54556026|FG004|Overall Study|Palliative Radiation To Brain Metastases|0|||
27900045|NCT01248949|54556022|FG000|Overall Study|Entered Hospice And Refused Follow Up|0|||
27900046|NCT01248949|54556023|FG001|Overall Study|Entered Hospice And Refused Follow Up|0|||
27900047|NCT01248949|54556024|FG002|Overall Study|Entered Hospice And Refused Follow Up|0|||
27900048|NCT01248949|54556025|FG003|Overall Study|Entered Hospice And Refused Follow Up|0|||
27900049|NCT01248949|54556026|FG004|Overall Study|Entered Hospice And Refused Follow Up|1|||
27900050|NCT01248949|54556022|FG000|Overall Study|Participant Went To Hospice|0|||
27900051|NCT01248949|54556023|FG001|Overall Study|Participant Went To Hospice|0|||
27900052|NCT01248949|54556024|FG002|Overall Study|Participant Went To Hospice|1|||
27900053|NCT01248949|54556025|FG003|Overall Study|Participant Went To Hospice|0|||
27900054|NCT01248949|54556026|FG004|Overall Study|Participant Went To Hospice|0|||
27900055|NCT01248949|54556022|FG000|Overall Study|Per Sponsor Request o Discontinue Drug|1|||
27900056|NCT01248949|54556023|FG001|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
27900057|NCT01248949|54556024|FG002|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
27900058|NCT01248949|54556025|FG003|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
27900059|NCT01248949|54556026|FG004|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
27900060|NCT01248949|54556022|FG000|Overall Study|Pi Decision Due To Declining Status|0|||
27900061|NCT01248949|54556023|FG001|Overall Study|Pi Decision Due To Declining Status|0|||
27900062|NCT01248949|54556024|FG002|Overall Study|Pi Decision Due To Declining Status|1|||
27900063|NCT01248949|54556025|FG003|Overall Study|Pi Decision Due To Declining Status|0|||
27900064|NCT01248949|54556026|FG004|Overall Study|Pi Decision Due To Declining Status|0|||
27900065|NCT01248949|54556022|FG000|Overall Study|Pi Discretion Due To Hospitalisation|0|||
27900066|NCT01248949|54556023|FG001|Overall Study|Pi Discretion Due To Hospitalisation|1|||
27900067|NCT01248949|54556024|FG002|Overall Study|Pi Discretion Due To Hospitalisation|0|||
27900068|NCT01248949|54556025|FG003|Overall Study|Pi Discretion Due To Hospitalisation|0|||
27900069|NCT01248949|54556026|FG004|Overall Study|Pi Discretion Due To Hospitalisation|0|||
27900070|NCT01248949|54556022|FG000|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
28172094|NCT02718417|54843704|FG002|Observation Phase (OP)|Study terminated by sponsor|135|||
28172095|NCT02718417|54843702|FG000|Observation Phase (OP)|Withdrawal by Subject|0|||
28172096|NCT02718417|54843703|FG001|Observation Phase (OP)|Withdrawal by Subject|0|||
27900071|NCT01248949|54556023|FG001|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
27900072|NCT01248949|54556024|FG002|Overall Study|Lesion In ThoracicSpine Requires Therapy|1|||
27900073|NCT01248949|54556025|FG003|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
27900074|NCT01248949|54556026|FG004|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
27900075|NCT01248793|54556040|FG000|Overall Study|Lost to Follow-up|0|||
27900076|NCT01248793|54556041|FG001|Overall Study|Lost to Follow-up|1|||
27900077|NCT01248793|54556040|FG000|Overall Study|Adverse Event|1|||
27900078|NCT01248793|54556041|FG001|Overall Study|Adverse Event|1|||
27900079|NCT01248793|54556040|FG000|Overall Study|Protocol Violation|0|||
27900080|NCT01248793|54556041|FG001|Overall Study|Protocol Violation|1|||
27900081|NCT01248793|54556040|FG000|Overall Study|Withdrawal by Subject|3|||
28097309|NCT04050618|54752868|FG000|Second Intervention|Withdrawal by Subject|1|||
28097310|NCT04050618|54752869|FG001|Second Intervention|Withdrawal by Subject|0|||
28097311|NCT04067492|54752886|FG000|Overall Study|Lost to Follow-up|0|||
28097312|NCT04067492|54752887|FG001|Overall Study|Lost to Follow-up|0|||
28097313|NCT04067492|54752888|FG002|Overall Study|Lost to Follow-up|0|||
28097314|NCT04067492|54752889|FG003|Overall Study|Lost to Follow-up|0|||
28097315|NCT04067492|54752890|FG004|Overall Study|Lost to Follow-up|0|||
28097316|NCT04067492|54752891|FG005|Overall Study|Lost to Follow-up|1|||
28097317|NCT04067492|54752886|FG000|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
28097318|NCT04067492|54752887|FG001|Overall Study|closure of city borders because of COVID-19 quarantine|1|||
28097319|NCT04067492|54752888|FG002|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
28097320|NCT04067492|54752889|FG003|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
27900082|NCT01248793|54556041|FG001|Overall Study|Withdrawal by Subject|3|||
27900083|NCT01248364|54556051|FG000|Overall Study|Adverse Event|0|||
27900084|NCT01248364|54556052|FG001|Overall Study|Adverse Event|1|||
27900085|NCT01248364|54556053|FG002|Overall Study|Adverse Event|0|||
27900086|NCT01248364|54556054|FG003|Overall Study|Adverse Event|0|||
27900087|NCT01248130|54556066|FG000|Overall Study|Protocol Violation|1|||
27900088|NCT01248130|54556067|FG001|Overall Study|Protocol Violation|0|||
27900089|NCT01248130|54556066|FG000|Overall Study|Ineligible|1|||
27900090|NCT01248130|54556067|FG001|Overall Study|Ineligible|0|||
27900091|NCT01248013|54556073|FG000|Overall Study|Withdrawal by Subject|14|||
27900092|NCT01247350|54556082|FG000|Overall Study|Adverse Event|0|||
27900093|NCT01247350|54556083|FG001|Overall Study|Adverse Event|0|||
27900094|NCT01247350|54556084|FG002|Overall Study|Adverse Event|1|||
27900095|NCT01247350|54556085|FG003|Overall Study|Adverse Event|0|||
27900096|NCT01247350|54556086|FG004|Overall Study|Adverse Event|0|||
27900097|NCT01247350|54556082|FG000|Overall Study|Withdrawal by Subject|0|||
27900098|NCT01247350|54556083|FG001|Overall Study|Withdrawal by Subject|0|||
27900099|NCT01247350|54556084|FG002|Overall Study|Withdrawal by Subject|0|||
27900100|NCT01247350|54556085|FG003|Overall Study|Withdrawal by Subject|1|||
27900101|NCT01247350|54556086|FG004|Overall Study|Withdrawal by Subject|0|||
27900102|NCT01247350|54556082|FG000|Overall Study|Entry criteria not met|0|||
27900103|NCT01247350|54556083|FG001|Overall Study|Entry criteria not met|0|||
27900104|NCT01247350|54556084|FG002|Overall Study|Entry criteria not met|0|||
27900105|NCT01247350|54556085|FG003|Overall Study|Entry criteria not met|0|||
27900106|NCT01247350|54556086|FG004|Overall Study|Entry criteria not met|1|||
27900107|NCT01246999|54556116|FG000|Overall Study|Lost to Follow-up|0|||
27900108|NCT01246999|54556117|FG001|Overall Study|Lost to Follow-up|1|||
27900109|NCT01246999|54556118|FG002|Overall Study|Lost to Follow-up|0|||
27900110|NCT01246999|54556119|FG003|Overall Study|Lost to Follow-up|0|||
27900111|NCT01246999|54556116|FG000|Overall Study|Withdrawal by Subject|0|||
27900112|NCT01246999|54556117|FG001|Overall Study|Withdrawal by Subject|0|||
27900113|NCT01246999|54556118|FG002|Overall Study|Withdrawal by Subject|0|||
27900114|NCT01246999|54556119|FG003|Overall Study|Withdrawal by Subject|2|||
27900115|NCT01245751|54556141|FG000|Part 1: Day 1 to Week 52 (1 Year)|Death|2|||
27900116|NCT01245751|54556142|FG001|Part 1: Day 1 to Week 52 (1 Year)|Death|1|||
27900117|NCT01245751|54556143|FG002|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
27900118|NCT01245751|54556144|FG003|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
27900119|NCT01245751|54556141|FG000|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
27900120|NCT01245751|54556142|FG001|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
27900121|NCT01245751|54556143|FG002|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
27900122|NCT01245751|54556144|FG003|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2|||
27900123|NCT01245751|54556141|FG000|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
27900124|NCT01245751|54556142|FG001|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4|||
27900125|NCT01245751|54556143|FG002|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
27900126|NCT01245751|54556144|FG003|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
27900127|NCT01245673|54556155|FG000|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1|||
27900128|NCT01245283|54556162|FG000|Overall Study|Lost to Follow-up|14|||
27900129|NCT01245283|54556163|FG001|Overall Study|Lost to Follow-up|11|||
27900130|NCT01245283|54556164|FG002|Overall Study|Lost to Follow-up|11|||
27900131|NCT01245049|54556177|FG000|Overall Study|Migrated/moved from study area|0|||
27900132|NCT01245049|54556178|FG001|Overall Study|Migrated/moved from study area|1|||
27900133|NCT01245049|54556177|FG000|Overall Study|Withdrawal by Subject|0|||
27900134|NCT01245049|54556178|FG001|Overall Study|Withdrawal by Subject|1|||
27900135|NCT01245049|54556177|FG000|Overall Study|Lost to Follow-up|1|||
27900136|NCT01245049|54556178|FG001|Overall Study|Lost to Follow-up|2|||
27900137|NCT01244893|54556184|FG000|Baseline|Protocol Violation|0|||
27900138|NCT01244893|54556185|FG001|Baseline|Protocol Violation|1|||
27900139|NCT01244893|54556184|FG000|1-Week Follow Up|Lost to Follow-up|1|||
27900140|NCT01244893|54556185|FG001|1-Week Follow Up|Lost to Follow-up|0|||
27900141|NCT01244815|54556200|FG000|Overall Study|Not Treated|0|||
27900142|NCT01244815|54556201|FG001|Overall Study|Not Treated|1|||
27900143|NCT01244815|54556202|FG002|Overall Study|Not Treated|0|||
27900144|NCT01244815|54556203|FG003|Overall Study|Not Treated|0|||
27900145|NCT01244815|54556200|FG000|Overall Study|Adverse Event|4|||
27900146|NCT01244815|54556201|FG001|Overall Study|Adverse Event|7|||
27900147|NCT01244815|54556202|FG002|Overall Study|Adverse Event|5|||
27900148|NCT01244815|54556203|FG003|Overall Study|Adverse Event|5|||
27900149|NCT01244815|54556200|FG000|Overall Study|Treatment Failure|0|||
27900150|NCT01244815|54556201|FG001|Overall Study|Treatment Failure|0|||
27900151|NCT01244815|54556202|FG002|Overall Study|Treatment Failure|0|||
27900152|NCT01244815|54556203|FG003|Overall Study|Treatment Failure|1|||
27900153|NCT01244815|54556200|FG000|Overall Study|Lost to Follow-up|3|||
27900154|NCT01244815|54556201|FG001|Overall Study|Lost to Follow-up|2|||
27900155|NCT01244815|54556202|FG002|Overall Study|Lost to Follow-up|3|||
27900156|NCT01244815|54556203|FG003|Overall Study|Lost to Follow-up|2|||
27900157|NCT01244815|54556200|FG000|Overall Study|Withdrawal by Subject|0|||
27900158|NCT01244815|54556201|FG001|Overall Study|Withdrawal by Subject|2|||
27900159|NCT01244815|54556202|FG002|Overall Study|Withdrawal by Subject|0|||
27900160|NCT01244815|54556203|FG003|Overall Study|Withdrawal by Subject|3|||
27900161|NCT01244815|54556200|FG000|Overall Study|Protocol Violation|7|||
27900162|NCT01244815|54556201|FG001|Overall Study|Protocol Violation|4|||
27900163|NCT01244815|54556202|FG002|Overall Study|Protocol Violation|3|||
27900164|NCT01244815|54556203|FG003|Overall Study|Protocol Violation|1|||
27900165|NCT01244815|54556200|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
27900166|NCT01244815|54556201|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
27900167|NCT01244815|54556202|FG002|Overall Study|Did Not Meet Protocol Eligibility|0|||
27900168|NCT01244815|54556203|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
27900169|NCT01244425|54556215|FG000|Overall Study|Withdrawal by Subject|2|||
27900170|NCT01244425|54556216|FG001|Overall Study|Withdrawal by Subject|2|||
27900171|NCT01244425|54556215|FG000|Overall Study|Adverse Event|1|||
27900172|NCT01244425|54556216|FG001|Overall Study|Adverse Event|1|||
27900173|NCT01244191|54556232|FG000|Overall Study|Progressive disease|295|||
27900174|NCT01244191|54556233|FG001|Overall Study|Progressive disease|350|||
27900175|NCT01244191|54556232|FG000|Overall Study|Clinical disease progression|54|||
27900176|NCT01244191|54556233|FG001|Overall Study|Clinical disease progression|36|||
27900177|NCT01244191|54556232|FG000|Overall Study|Adverse Event|65|||
27900178|NCT01244191|54556233|FG001|Overall Study|Adverse Event|48|||
27900179|NCT01244191|54556232|FG000|Overall Study|Death|22|||
27900180|NCT01244191|54556233|FG001|Overall Study|Death|29|||
27900181|NCT01244191|54556232|FG000|Overall Study|Lost to Follow-up|0|||
27900182|NCT01244191|54556233|FG001|Overall Study|Lost to Follow-up|2|||
27900183|NCT01244191|54556232|FG000|Overall Study|Protocol Violation|1|||
27900184|NCT01244191|54556233|FG001|Overall Study|Protocol Violation|2|||
27900185|NCT01244191|54556232|FG000|Overall Study|Withdrawal by Subject|31|||
27900186|NCT01244191|54556233|FG001|Overall Study|Withdrawal by Subject|23|||
27900187|NCT01244191|54556232|FG000|Overall Study|'Missing' or 'Terminated by sponsor'|12|||
27900188|NCT01244191|54556233|FG001|Overall Study|'Missing' or 'Terminated by sponsor'|8|||
27900189|NCT01244035|54556239|FG000|Part 1: Period 1|Adverse Event|0|||
27900190|NCT01244035|54556240|FG001|Part 1: Period 1|Adverse Event|0|||
27900191|NCT01244035|54556241|FG002|Part 1: Period 1|Adverse Event|0|||
27900192|NCT01244035|54556242|FG003|Part 1: Period 1|Adverse Event|0|||
27900193|NCT01244035|54556243|FG004|Part 1: Period 1|Adverse Event|0|||
27900194|NCT01244035|54556244|FG005|Part 1: Period 1|Adverse Event|1|||
27900195|NCT01244035|54556239|FG000|Part 1: Period 1|Withdrawal by Subject|0|||
27900196|NCT01244035|54556240|FG001|Part 1: Period 1|Withdrawal by Subject|2|||
27900197|NCT01244035|54556241|FG002|Part 1: Period 1|Withdrawal by Subject|0|||
27900198|NCT01244035|54556242|FG003|Part 1: Period 1|Withdrawal by Subject|0|||
27900199|NCT01244035|54556243|FG004|Part 1: Period 1|Withdrawal by Subject|0|||
27900200|NCT01244035|54556244|FG005|Part 1: Period 1|Withdrawal by Subject|0|||
27900201|NCT01244035|54556239|FG000|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
27900202|NCT01244035|54556240|FG001|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
27900203|NCT01244035|54556241|FG002|Part 1: Period 1|Fulfilled Stopping Criteria|2|||
27900204|NCT01244035|54556242|FG003|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
27900205|NCT01244035|54556243|FG004|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
27900206|NCT01244035|54556244|FG005|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
27900207|NCT01244035|54556239|FG000|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
27900208|NCT01244035|54556240|FG001|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
27986508|NCT03911401|54644859|FG000|Overall Study|Withdrawal by Subject|1|||
27986509|NCT03911401|54644860|FG001|Overall Study|Withdrawal by Subject|2|||
27986510|NCT03911401|54644861|FG002|Overall Study|Withdrawal by Subject|0|||
27986511|NCT03911401|54644859|FG000|Overall Study|Withdrawal by parent/guardian|4|||
27986512|NCT03911401|54644860|FG001|Overall Study|Withdrawal by parent/guardian|4|||
27986513|NCT03911401|54644861|FG002|Overall Study|Withdrawal by parent/guardian|11|||
27986514|NCT00579670|54644874|FG000|Overall Study|Death|1|||
27986515|NCT00579670|54644875|FG001|Overall Study|Death|0|||
27986516|NCT00579670|54644876|FG002|Overall Study|Death|0|||
27986517|NCT00579670|54644877|FG003|Overall Study|Death|0|||
27986518|NCT00579670|54644878|FG004|Overall Study|Death|0|||
27986519|NCT00579670|54644874|FG000|Overall Study|Adverse Event|1|||
27986520|NCT00579670|54644875|FG001|Overall Study|Adverse Event|0|||
27986521|NCT00579670|54644876|FG002|Overall Study|Adverse Event|1|||
27986522|NCT00579670|54644877|FG003|Overall Study|Adverse Event|2|||
27986523|NCT00579670|54644878|FG004|Overall Study|Adverse Event|0|||
27986524|NCT00579670|54644874|FG000|Overall Study|Lack of Efficacy|0|||
27986525|NCT00579670|54644875|FG001|Overall Study|Lack of Efficacy|0|||
28097321|NCT04067492|54752890|FG004|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
28097322|NCT04067492|54752891|FG005|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
28097323|NCT04067492|54752886|FG000|Overall Study|COVID-19 epidemiological situation|0|||
28097324|NCT04067492|54752887|FG001|Overall Study|COVID-19 epidemiological situation|0|||
28097325|NCT04067492|54752888|FG002|Overall Study|COVID-19 epidemiological situation|0|||
27986526|NCT00579670|54644876|FG002|Overall Study|Lack of Efficacy|1|||
27986527|NCT00579670|54644877|FG003|Overall Study|Lack of Efficacy|14|||
27986528|NCT00579670|54644878|FG004|Overall Study|Lack of Efficacy|0|||
28172097|NCT02718417|54843704|FG002|Observation Phase (OP)|Withdrawal by Subject|34|||
27900209|NCT01244035|54556241|FG002|Part 1: Period 2|Fulfilled Stopping Criteria|1|||
27900210|NCT01244035|54556242|FG003|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
27900211|NCT01244035|54556243|FG004|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
27900212|NCT01244035|54556244|FG005|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
27900213|NCT01244035|54556239|FG000|Part 1: Period 3|Adverse Event|0|||
27900214|NCT01244035|54556240|FG001|Part 1: Period 3|Adverse Event|0|||
27900215|NCT01244035|54556241|FG002|Part 1: Period 3|Adverse Event|0|||
27900216|NCT01244035|54556242|FG003|Part 1: Period 3|Adverse Event|0|||
27900217|NCT01244035|54556243|FG004|Part 1: Period 3|Adverse Event|0|||
27900218|NCT01244035|54556244|FG005|Part 1: Period 3|Adverse Event|1|||
27900219|NCT01244035|54556239|FG000|Part 1: Period 3|Withdrawal by Subject|0|||
27900220|NCT01244035|54556240|FG001|Part 1: Period 3|Withdrawal by Subject|0|||
27900221|NCT01244035|54556241|FG002|Part 1: Period 3|Withdrawal by Subject|0|||
27900222|NCT01244035|54556242|FG003|Part 1: Period 3|Withdrawal by Subject|0|||
27900223|NCT01244035|54556243|FG004|Part 1: Period 3|Withdrawal by Subject|1|||
27900224|NCT01244035|54556244|FG005|Part 1: Period 3|Withdrawal by Subject|0|||
27900225|NCT01244035|54556239|FG000|Part 1: Period 3|Protocol Deviation|0|||
27900226|NCT01244035|54556240|FG001|Part 1: Period 3|Protocol Deviation|1|||
27900227|NCT01244035|54556241|FG002|Part 1: Period 3|Protocol Deviation|0|||
27900228|NCT01244035|54556242|FG003|Part 1: Period 3|Protocol Deviation|0|||
27900229|NCT01244035|54556243|FG004|Part 1: Period 3|Protocol Deviation|0|||
27900230|NCT01244035|54556244|FG005|Part 1: Period 3|Protocol Deviation|0|||
27900231|NCT01243762|54556280|FG000|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
27900232|NCT01243762|54556281|FG001|Part 1 (Dose Escalation/MTD)|Adverse Event|2|||
27900233|NCT01243762|54556282|FG002|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
27900234|NCT01243762|54556283|FG003|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
27900235|NCT01243762|54556284|FG004|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
27900236|NCT01243762|54556285|FG005|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
27900237|NCT01243762|54556286|FG006|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
27900238|NCT01243762|54556280|FG000|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
27900239|NCT01243762|54556281|FG001|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
27900240|NCT01243762|54556282|FG002|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
27900241|NCT01243762|54556283|FG003|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
27900242|NCT01243762|54556284|FG004|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
27900243|NCT01243762|54556285|FG005|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
27900244|NCT01243762|54556286|FG006|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
27900245|NCT01243762|54556280|FG000|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
27900246|NCT01243762|54556281|FG001|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
27900247|NCT01243762|54556282|FG002|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
27900248|NCT01243762|54556283|FG003|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
27900249|NCT01243762|54556284|FG004|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
27900250|NCT01243762|54556285|FG005|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
27900251|NCT01243762|54556286|FG006|Part 1 (Dose Escalation/MTD)|Progressive Disease|0|||
27900252|NCT01243762|54556280|FG000|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
27900253|NCT01243762|54556281|FG001|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3|||
27900254|NCT01243762|54556282|FG002|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
27900255|NCT01243762|54556283|FG003|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
27900256|NCT01243762|54556284|FG004|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
27900257|NCT01243762|54556285|FG005|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
27900258|NCT01243762|54556286|FG006|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
27900259|NCT01243762|54556280|FG000|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
27900260|NCT01243762|54556281|FG001|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1|||
27900261|NCT01243762|54556282|FG002|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
27900262|NCT01243762|54556283|FG003|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
27900263|NCT01243762|54556284|FG004|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
27900264|NCT01243762|54556285|FG005|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
27900265|NCT01243762|54556286|FG006|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3|||
27900266|NCT01243762|54556280|FG000|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
27900267|NCT01243762|54556281|FG001|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
27900268|NCT01243762|54556282|FG002|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
27900269|NCT01243762|54556283|FG003|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
27900270|NCT01243762|54556284|FG004|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2|||
27900271|NCT01243762|54556285|FG005|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
27900272|NCT01243762|54556286|FG006|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
27900273|NCT01243762|54556280|FG000|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
27900274|NCT01243762|54556281|FG001|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
27900275|NCT01243762|54556282|FG002|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
27900276|NCT01243762|54556283|FG003|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
27900277|NCT01243762|54556284|FG004|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
27900278|NCT01243762|54556285|FG005|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
27986529|NCT00579670|54644874|FG000|Overall Study|Lost to Follow-up|0|||
27986530|NCT00579670|54644875|FG001|Overall Study|Lost to Follow-up|1|||
27986531|NCT00579670|54644876|FG002|Overall Study|Lost to Follow-up|0|||
27986532|NCT00579670|54644877|FG003|Overall Study|Lost to Follow-up|4|||
27986533|NCT00579670|54644878|FG004|Overall Study|Lost to Follow-up|0|||
28172098|NCT02718417|54843702|FG000|Observation Phase (OP)|Global deterioration of health status|0|||
27900279|NCT01243762|54556286|FG006|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
27900280|NCT01243762|54556280|FG000|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
27900281|NCT01243762|54556281|FG001|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
27900282|NCT01243762|54556282|FG002|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
27900283|NCT01243762|54556283|FG003|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
27900284|NCT01243762|54556284|FG004|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
27900285|NCT01243762|54556285|FG005|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
27900286|NCT01243762|54556286|FG006|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
27900287|NCT01243411|54556305|FG000|Overall Study|Withdrawal by Subject|18|||
27900288|NCT01243411|54556305|FG000|Overall Study|Lost to Follow-up|10|||
27900289|NCT01243411|54556305|FG000|Overall Study|Adverse Event|5|||
27900290|NCT01243411|54556305|FG000|Overall Study|Other|8|||
27900291|NCT01243177|54556311|FG000|Overall Study|Lack of Efficacy|47|||
27900292|NCT01243177|54556312|FG001|Overall Study|Lack of Efficacy|31|||
27900293|NCT01243177|54556311|FG000|Overall Study|Protocol Violation|11|||
27900294|NCT01243177|54556312|FG001|Overall Study|Protocol Violation|10|||
27900295|NCT01243177|54556311|FG000|Overall Study|Lost to Follow-up|15|||
27900296|NCT01243177|54556312|FG001|Overall Study|Lost to Follow-up|18|||
27900297|NCT01243177|54556311|FG000|Overall Study|Withdrawal by Subject|46|||
27900298|NCT01243177|54556312|FG001|Overall Study|Withdrawal by Subject|38|||
27900299|NCT01243177|54556311|FG000|Overall Study|AE, serious fatal|0|||
27900300|NCT01243177|54556312|FG001|Overall Study|AE, serious fatal|1|||
27900301|NCT01243177|54556311|FG000|Overall Study|SAE, non-fatal|7|||
27900302|NCT01243177|54556312|FG001|Overall Study|SAE, non-fatal|9|||
27900303|NCT01243177|54556311|FG000|Overall Study|AE, non-serious non-fatal|40|||
27900304|NCT01243177|54556312|FG001|Overall Study|AE, non-serious non-fatal|58|||
27900305|NCT01243177|54556311|FG000|Overall Study|SAE, fatal + SAE, non-fatal|1|||
27900306|NCT01243177|54556312|FG001|Overall Study|SAE, fatal + SAE, non-fatal|0|||
27900307|NCT01243177|54556311|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
27900308|NCT01243177|54556312|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
27900309|NCT01243177|54556311|FG000|Overall Study|Other Reason|11|||
27900310|NCT01243177|54556312|FG001|Overall Study|Other Reason|12|||
27900311|NCT01242748|54556320|FG000|Overall Study|Adverse Event|10|||
27900312|NCT01242748|54556321|FG001|Overall Study|Adverse Event|5|||
27900313|NCT01242748|54556320|FG000|Overall Study|Lost to Follow-up|6|||
27900314|NCT01242748|54556321|FG001|Overall Study|Lost to Follow-up|2|||
27900315|NCT01242748|54556320|FG000|Overall Study|Physician Decision|3|||
27900316|NCT01242748|54556321|FG001|Overall Study|Physician Decision|2|||
27900317|NCT01242748|54556320|FG000|Overall Study|Protocol Violation|1|||
27900318|NCT01242748|54556321|FG001|Overall Study|Protocol Violation|0|||
27900319|NCT01242748|54556320|FG000|Overall Study|Withdrawal by Subject|10|||
27900320|NCT01242748|54556321|FG001|Overall Study|Withdrawal by Subject|2|||
27900321|NCT01242748|54556320|FG000|Overall Study|Miscellaneous reasons|8|||
27900322|NCT01242748|54556321|FG001|Overall Study|Miscellaneous reasons|3|||
27900323|NCT01242514|54556330|FG000|Overall Study|e.g., project closure|1042|||
27900324|NCT01242514|54556331|FG001|Overall Study|e.g., project closure|305|||
27900325|NCT01242514|54556332|FG002|Overall Study|e.g., project closure|171|||
27900326|NCT01242514|54556330|FG000|Overall Study|Subject decision|33|||
27900327|NCT01242514|54556331|FG001|Overall Study|Subject decision|8|||
27900328|NCT01242514|54556332|FG002|Overall Study|Subject decision|2|||
27900329|NCT01242514|54556330|FG000|Overall Study|Severe non-compliance to protocol|5|||
27900330|NCT01242514|54556331|FG001|Overall Study|Severe non-compliance to protocol|2|||
27900331|NCT01242514|54556332|FG002|Overall Study|Severe non-compliance to protocol|1|||
27900332|NCT01242514|54556330|FG000|Overall Study|Lack of therapeutic response|99|||
27900333|NCT01242514|54556331|FG001|Overall Study|Lack of therapeutic response|16|||
27900334|NCT01242514|54556332|FG002|Overall Study|Lack of therapeutic response|10|||
27900335|NCT01242514|54556330|FG000|Overall Study|Dev. of study specific discont. criteria|21|||
27900336|NCT01242514|54556331|FG001|Overall Study|Dev. of study specific discont. criteria|3|||
27900337|NCT01242514|54556332|FG002|Overall Study|Dev. of study specific discont. criteria|5|||
27900338|NCT01242514|54556330|FG000|Overall Study|Lost to Follow-up|14|||
27900339|NCT01242514|54556331|FG001|Overall Study|Lost to Follow-up|5|||
27986534|NCT00579670|54644874|FG000|Overall Study|Other|0|||
27986535|NCT00579670|54644875|FG001|Overall Study|Other|0|||
27986536|NCT00579670|54644876|FG002|Overall Study|Other|1|||
27986537|NCT00579670|54644877|FG003|Overall Study|Other|2|||
27986538|NCT00579670|54644878|FG004|Overall Study|Other|0|||
27986539|NCT00579670|54644874|FG000|Overall Study|Withdrawal by Subject|0|||
27900340|NCT01242514|54556332|FG002|Overall Study|Lost to Follow-up|4|||
27900341|NCT01242514|54556330|FG000|Overall Study|Adverse Event|129|||
27986540|NCT00579670|54644875|FG001|Overall Study|Withdrawal by Subject|0|||
27900342|NCT01242514|54556331|FG001|Overall Study|Adverse Event|18|||
27900343|NCT01242514|54556332|FG002|Overall Study|Adverse Event|19|||
27900344|NCT01242085|54556343|FG000|Overall Study|Withdrawal by Subject|4|||
27900345|NCT01242085|54556344|FG001|Overall Study|Withdrawal by Subject|2|||
27900346|NCT01242085|54556345|FG002|Overall Study|Withdrawal by Subject|0|||
27986541|NCT00579670|54644876|FG002|Overall Study|Withdrawal by Subject|1|||
27986542|NCT00579670|54644877|FG003|Overall Study|Withdrawal by Subject|0|||
27900347|NCT01242085|54556343|FG000|Overall Study|medically unable to have surgery|4|||
27900348|NCT01242085|54556344|FG001|Overall Study|medically unable to have surgery|5|||
27900349|NCT01242085|54556345|FG002|Overall Study|medically unable to have surgery|0|||
27900350|NCT01241461|54556353|FG000|Overall Study|Progressive Disease|3|||
27900351|NCT01241461|54556354|FG001|Overall Study|Progressive Disease|6|||
27900352|NCT01240135|54556366|FG000|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
27900353|NCT01240135|54556367|FG001|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
27900354|NCT01240135|54556366|FG000|Period Two, 14 Days of Wear|Adverse Event|0|||
27900355|NCT01240135|54556367|FG001|Period Two, 14 Days of Wear|Adverse Event|1|||
27900356|NCT01247701|54556373|FG000|Overall Study|Death|2|||
27900357|NCT01247701|54556373|FG000|Overall Study|Relapsed|8|||
27900358|NCT01248247|54556381|FG000|Overall Study|Adverse Event|2|||
27900359|NCT01248247|54556382|FG001|Overall Study|Adverse Event|4|||
27900360|NCT01248247|54556383|FG002|Overall Study|Adverse Event|4|||
27900361|NCT01248247|54556384|FG003|Overall Study|Adverse Event|2|||
27900362|NCT01248247|54556381|FG000|Overall Study|Death|0|||
27900363|NCT01248247|54556382|FG001|Overall Study|Death|1|||
27900364|NCT01248247|54556383|FG002|Overall Study|Death|4|||
27900365|NCT01248247|54556384|FG003|Overall Study|Death|7|||
27900366|NCT01248247|54556381|FG000|Overall Study|Lost to Follow-up|0|||
27900367|NCT01248247|54556382|FG001|Overall Study|Lost to Follow-up|1|||
27900368|NCT01248247|54556383|FG002|Overall Study|Lost to Follow-up|1|||
27900369|NCT01248247|54556384|FG003|Overall Study|Lost to Follow-up|0|||
27900370|NCT01248247|54556381|FG000|Overall Study|Alternative treatment|0|||
27900371|NCT01248247|54556382|FG001|Overall Study|Alternative treatment|1|||
27900372|NCT01248247|54556383|FG002|Overall Study|Alternative treatment|0|||
27900373|NCT01248247|54556384|FG003|Overall Study|Alternative treatment|0|||
27900374|NCT01248247|54556381|FG000|Overall Study|Other|2|||
27900375|NCT01248247|54556382|FG001|Overall Study|Other|8|||
27900376|NCT01248247|54556383|FG002|Overall Study|Other|8|||
27900377|NCT01248247|54556384|FG003|Overall Study|Other|5|||
27900378|NCT01248247|54556381|FG000|Overall Study|Progression|18|||
27900379|NCT01248247|54556382|FG001|Overall Study|Progression|27|||
27900380|NCT01248247|54556383|FG002|Overall Study|Progression|56|||
27900381|NCT01248247|54556384|FG003|Overall Study|Progression|44|||
27900382|NCT01248247|54556381|FG000|Overall Study|Refuse further treatment|0|||
27900383|NCT01248247|54556382|FG001|Overall Study|Refuse further treatment|0|||
27900384|NCT01248247|54556383|FG002|Overall Study|Refuse further treatment|1|||
27900385|NCT01248247|54556384|FG003|Overall Study|Refuse further treatment|2|||
27900386|NCT01248247|54556381|FG000|Overall Study|Complicating disease|0|||
27900387|NCT01248247|54556382|FG001|Overall Study|Complicating disease|0|||
27900388|NCT01248247|54556383|FG002|Overall Study|Complicating disease|1|||
27900389|NCT01248247|54556384|FG003|Overall Study|Complicating disease|1|||
27900390|NCT02598583|54556396|FG000|Extension Period|Withdrawal by Subject|1|||
27900391|NCT02598583|54556397|FG001|Extension Period|Withdrawal by Subject|0|||
27900392|NCT04831736|54556414|FG000|Overall Study|Withdrawal by Subject|0|||
27900393|NCT04831736|54556415|FG001|Overall Study|Withdrawal by Subject|1|||
27900394|NCT04583956|54556430|FG000|Overall Study|Death|9|||
27900395|NCT04583956|54556431|FG001|Overall Study|Death|11|||
27900396|NCT04583956|54556430|FG000|Overall Study|Lost to Follow-up|7|||
27900397|NCT04583956|54556431|FG001|Overall Study|Lost to Follow-up|9|||
27900398|NCT04583956|54556430|FG000|Overall Study|Protocol Violation|2|||
27900399|NCT04583956|54556431|FG001|Overall Study|Protocol Violation|0|||
27900400|NCT04583956|54556430|FG000|Overall Study|Withdrawal by Subject|0|||
27900401|NCT04583956|54556431|FG001|Overall Study|Withdrawal by Subject|2|||
27900402|NCT04583956|54556430|FG000|Overall Study|Randomized but not dosed|2|||
27900403|NCT04583956|54556431|FG001|Overall Study|Randomized but not dosed|3|||
27900404|NCT04583956|54556430|FG000|Overall Study|Withdrawal of consent before product administration|1|||
27900405|NCT04583956|54556431|FG001|Overall Study|Withdrawal of consent before product administration|0|||
27900406|NCT04463680|54556447|FG000|Overall Study|Not eligible due to laboratory criteria|5|||
27900407|NCT04463680|54556447|FG000|Overall Study|Not eligible due to implant duration of use|1|||
27900408|NCT04463680|54556447|FG000|Overall Study|Withdrawal by Subject|3|||
27900409|NCT04449029|54556459|FG000|Overall Study|Adverse Event|0|||
27900410|NCT04449029|54556460|FG001|Overall Study|Adverse Event|1|||
27900411|NCT04449029|54556461|FG002|Overall Study|Adverse Event|1|||
27900412|NCT04449029|54556462|FG003|Overall Study|Adverse Event|0|||
27900413|NCT04449029|54556463|FG004|Overall Study|Adverse Event|1|||
27900414|NCT04449029|54556464|FG005|Overall Study|Adverse Event|0|||
27900415|NCT04449029|54556465|FG006|Overall Study|Adverse Event|1|||
27900416|NCT04449029|54556466|FG007|Overall Study|Adverse Event|0|||
27739466|NCT01676727|54189159|FG000|Overall Study|Valve explanted|1|||
27900417|NCT04449029|54556459|FG000|Overall Study|Lost to Follow-up|0|||
27900418|NCT04449029|54556460|FG001|Overall Study|Lost to Follow-up|1|||
27900419|NCT04449029|54556461|FG002|Overall Study|Lost to Follow-up|0|||
27900420|NCT04449029|54556462|FG003|Overall Study|Lost to Follow-up|0|||
27900421|NCT04449029|54556463|FG004|Overall Study|Lost to Follow-up|0|||
27900422|NCT04449029|54556464|FG005|Overall Study|Lost to Follow-up|0|||
27900423|NCT04449029|54556465|FG006|Overall Study|Lost to Follow-up|0|||
27900424|NCT04449029|54556466|FG007|Overall Study|Lost to Follow-up|0|||
27900425|NCT04449029|54556459|FG000|Overall Study|Protocol Violation|0|||
27900426|NCT04449029|54556460|FG001|Overall Study|Protocol Violation|1|||
27900427|NCT04449029|54556461|FG002|Overall Study|Protocol Violation|0|||
27900428|NCT04449029|54556462|FG003|Overall Study|Protocol Violation|0|||
27900429|NCT04449029|54556463|FG004|Overall Study|Protocol Violation|0|||
27900430|NCT04449029|54556464|FG005|Overall Study|Protocol Violation|0|||
27986543|NCT00579670|54644878|FG004|Overall Study|Withdrawal by Subject|0|||
27986544|NCT03909295|54644902|FG000|Overall Study|Adverse Event|2|||
27986545|NCT03909295|54644902|FG000|Overall Study|Study terminated by sponsor|50|||
27986546|NCT00599924|54644913|FG000|Overall Study|Lack of Efficacy|3|||
27986547|NCT00599924|54644914|FG001|Overall Study|Lack of Efficacy|5|||
27986548|NCT00599924|54644915|FG002|Overall Study|Lack of Efficacy|1|||
27986549|NCT00599924|54644916|FG003|Overall Study|Lack of Efficacy|2|||
27986550|NCT00599924|54644917|FG004|Overall Study|Lack of Efficacy|3|||
27986551|NCT00599924|54644918|FG005|Overall Study|Lack of Efficacy|2|||
27986552|NCT00599924|54644919|FG006|Overall Study|Lack of Efficacy|0|||
27986553|NCT00599924|54644913|FG000|Overall Study|Adverse Event|0|||
27986554|NCT00599924|54644914|FG001|Overall Study|Adverse Event|0|||
27986555|NCT00599924|54644915|FG002|Overall Study|Adverse Event|0|||
27986556|NCT00599924|54644916|FG003|Overall Study|Adverse Event|2|||
27986557|NCT00599924|54644917|FG004|Overall Study|Adverse Event|0|||
27986558|NCT00599924|54644918|FG005|Overall Study|Adverse Event|0|||
27986559|NCT00599924|54644919|FG006|Overall Study|Adverse Event|2|||
27986560|NCT00599924|54644913|FG000|Overall Study|Death|0|||
27986561|NCT00599924|54644914|FG001|Overall Study|Death|0|||
27986562|NCT00599924|54644915|FG002|Overall Study|Death|0|||
27986563|NCT00599924|54644916|FG003|Overall Study|Death|2|||
27986564|NCT00599924|54644917|FG004|Overall Study|Death|0|||
27986565|NCT00599924|54644918|FG005|Overall Study|Death|2|||
27986566|NCT00599924|54644919|FG006|Overall Study|Death|1|||
27986567|NCT00599924|54644913|FG000|Overall Study|Protocol Violation|0|||
27986568|NCT00599924|54644914|FG001|Overall Study|Protocol Violation|0|||
27986569|NCT00599924|54644915|FG002|Overall Study|Protocol Violation|0|||
27986570|NCT00599924|54644916|FG003|Overall Study|Protocol Violation|1|||
27986571|NCT00599924|54644917|FG004|Overall Study|Protocol Violation|0|||
27986572|NCT00599924|54644918|FG005|Overall Study|Protocol Violation|0|||
27986573|NCT00599924|54644919|FG006|Overall Study|Protocol Violation|0|||
27986574|NCT00599924|54644913|FG000|Overall Study|Withdrawal by Subject|0|||
27986575|NCT00599924|54644914|FG001|Overall Study|Withdrawal by Subject|0|||
27986576|NCT00599924|54644915|FG002|Overall Study|Withdrawal by Subject|1|||
27986577|NCT00599924|54644916|FG003|Overall Study|Withdrawal by Subject|0|||
27986578|NCT00599924|54644917|FG004|Overall Study|Withdrawal by Subject|1|||
27986579|NCT00599924|54644918|FG005|Overall Study|Withdrawal by Subject|0|||
27986580|NCT00599924|54644919|FG006|Overall Study|Withdrawal by Subject|0|||
27986581|NCT00599924|54644913|FG000|Overall Study|Other|0|||
27986582|NCT00599924|54644914|FG001|Overall Study|Other|0|||
27986583|NCT00599924|54644915|FG002|Overall Study|Other|0|||
27986584|NCT00599924|54644916|FG003|Overall Study|Other|1|||
27986585|NCT00599924|54644917|FG004|Overall Study|Other|2|||
27986586|NCT00599924|54644918|FG005|Overall Study|Other|0|||
27986587|NCT00599924|54644919|FG006|Overall Study|Other|2|||
27986588|NCT00581542|54644942|FG000|Overall Study|they met an exclusion criteria|2|||
27986589|NCT00581542|54644943|FG001|Overall Study|they met an exclusion criteria|2|||
27986590|NCT00581542|54644942|FG000|Overall Study|Lost to Follow-up|9|||
27986591|NCT00581542|54644943|FG001|Overall Study|Lost to Follow-up|21|||
27986592|NCT03912337|54644953|FG000|Overall Study|Withdrawal of Consent From Study|1|||
27986593|NCT03912337|54644954|FG001|Overall Study|Withdrawal of Consent From Study|0|||
27986594|NCT03912337|54644953|FG000|Overall Study|Lost to Follow-up|1|||
27900431|NCT04449029|54556465|FG006|Overall Study|Protocol Violation|0|||
27900432|NCT04449029|54556466|FG007|Overall Study|Protocol Violation|0|||
27900433|NCT04449029|54556459|FG000|Overall Study|Physician Decision|0|||
27900434|NCT04449029|54556460|FG001|Overall Study|Physician Decision|0|||
27900435|NCT04449029|54556461|FG002|Overall Study|Physician Decision|0|||
27986595|NCT03912337|54644954|FG001|Overall Study|Lost to Follow-up|1|||
27986596|NCT03912259|54644962|FG000|Overall Study|Adverse Event (AE)|2|||
27986597|NCT03912259|54644963|FG001|Overall Study|Adverse Event (AE)|4|||
27986598|NCT03912259|54644962|FG000|Overall Study|Lack of Efficacy|4|||
27986599|NCT03912259|54644963|FG001|Overall Study|Lack of Efficacy|1|||
27986600|NCT03912259|54644962|FG000|Overall Study|Withdrawal by Subject|11|||
27986601|NCT03912259|54644963|FG001|Overall Study|Withdrawal by Subject|1|||
27986602|NCT02121652|54644972|FG000|Overall Study|Lost to Follow-up|2|||
27986603|NCT02121652|54644973|FG001|Overall Study|Lost to Follow-up|1|||
27986604|NCT02121652|54644972|FG000|Overall Study|Death|1|||
27986605|NCT02121652|54644973|FG001|Overall Study|Death|0|||
27986606|NCT02121652|54644972|FG000|Overall Study|Withdrawal by Subject|3|||
27986607|NCT02121652|54644973|FG001|Overall Study|Withdrawal by Subject|3|||
27986608|NCT00595920|54644992|FG000|Overall Study|The OLTERMS study was discontinued by th|116|||
27986609|NCT00595764|54644998|FG000|Overall Study|Protocol Violation|24|||
27986610|NCT00595764|54644999|FG001|Overall Study|Protocol Violation|19|||
27986611|NCT00595764|54644998|FG000|Overall Study|Missed Medication >1 week|10|||
27900436|NCT04449029|54556462|FG003|Overall Study|Physician Decision|0|||
27900437|NCT04449029|54556463|FG004|Overall Study|Physician Decision|0|||
27900438|NCT04449029|54556464|FG005|Overall Study|Physician Decision|1|||
27900439|NCT04449029|54556465|FG006|Overall Study|Physician Decision|0|||
27900440|NCT04449029|54556466|FG007|Overall Study|Physician Decision|0|||
27900441|NCT04449029|54556459|FG000|Overall Study|Withdrawal by Subject|3|||
27900442|NCT04449029|54556460|FG001|Overall Study|Withdrawal by Subject|0|||
27900443|NCT04449029|54556461|FG002|Overall Study|Withdrawal by Subject|1|||
27900444|NCT04449029|54556462|FG003|Overall Study|Withdrawal by Subject|1|||
27900445|NCT04449029|54556463|FG004|Overall Study|Withdrawal by Subject|5|||
27900446|NCT04449029|54556464|FG005|Overall Study|Withdrawal by Subject|1|||
27900447|NCT04449029|54556465|FG006|Overall Study|Withdrawal by Subject|4|||
27900448|NCT04449029|54556466|FG007|Overall Study|Withdrawal by Subject|0|||
27900449|NCT04428333|54556496|FG000|Overall Study|Physician Decision|2|||
27900450|NCT04428333|54556497|FG001|Overall Study|Physician Decision|0|||
27900451|NCT04428333|54556496|FG000|Overall Study|Withdrawal by Subject|0|||
27900452|NCT04428333|54556497|FG001|Overall Study|Withdrawal by Subject|1|||
27900453|NCT04428333|54556496|FG000|Overall Study|In Follow-Up|5|||
27900454|NCT04428333|54556497|FG001|Overall Study|In Follow-Up|10|||
27900455|NCT04428333|54556496|FG000|Overall Study|On Study Treatment (pembrolizumab) All participants discontinued feladilimab/placebo|47|||
27900456|NCT04428333|54556497|FG001|Overall Study|On Study Treatment (pembrolizumab) All participants discontinued feladilimab/placebo|47|||
27900457|NCT04193202|54556505|FG000|Overall Study|Adverse Event|2|||
27900458|NCT04193202|54556506|FG001|Overall Study|Adverse Event|1|||
27900459|NCT04193202|54556505|FG000|Overall Study|Death|0|||
27900460|NCT04193202|54556506|FG001|Overall Study|Death|1|||
27900461|NCT04193202|54556505|FG000|Overall Study|Physician Decision|1|||
27900462|NCT04193202|54556506|FG001|Overall Study|Physician Decision|1|||
27900463|NCT04193202|54556505|FG000|Overall Study|Protocol Violation|2|||
27900464|NCT04193202|54556506|FG001|Overall Study|Protocol Violation|2|||
27900465|NCT04193202|54556505|FG000|Overall Study|Withdrawal by Subject|11|||
27900466|NCT04193202|54556506|FG001|Overall Study|Withdrawal by Subject|5|||
27900467|NCT04159935|54556514|FG000|Overall Study|Study terminated due to COVID-19|1|||
27900468|NCT04159935|54556515|FG001|Overall Study|Study terminated due to COVID-19|3|||
27900469|NCT04128696|54556523|FG000|Overall Study|Lost to Follow-up|0|||
27900470|NCT04128696|54556524|FG001|Overall Study|Lost to Follow-up|1|||
27900471|NCT04128696|54556523|FG000|Overall Study|Withdrawal by Subject|8|||
27900472|NCT04128696|54556524|FG001|Overall Study|Withdrawal by Subject|5|||
27900473|NCT04128696|54556523|FG000|Overall Study|In Follow-up|47|||
27900474|NCT04128696|54556524|FG001|Overall Study|In Follow-up|51|||
27900475|NCT04128696|54556523|FG000|Overall Study|On Study Treatment (pembrolizumab) All participants discontinued feladilimab/placebo|52|||
27900476|NCT04128696|54556524|FG001|Overall Study|On Study Treatment (pembrolizumab) All participants discontinued feladilimab/placebo|62|||
27900477|NCT03871543|54556548|FG000|Period 1|Unsatisfactory Lens Fitting due Test Article|10|||
27900478|NCT03871543|54556548|FG000|Period 1|Investigator Error|1|||
27900479|NCT03871543|54556548|FG000|Period 1|Protocol Violation|2|||
27900480|NCT03871543|54556548|FG000|Period 1|COVID-19 Related|1|||
27900481|NCT03871543|54556548|FG000|Period 1|Subject No Longer meets Eligibility Criteria|112|||
27900482|NCT03871543|54556548|FG000|Period 1|Withdrawal by Subject|10|||
27900483|NCT03871543|54556548|FG000|Period 2|Adverse Event|1|||
27900484|NCT03871543|54556548|FG000|Period 2|Withdrawal by Subject|1|||
27900485|NCT03843125|54556560|FG000|Overall Study|Adverse Event|17|||
27900486|NCT03843125|54556561|FG001|Overall Study|Adverse Event|13|||
27900487|NCT03843125|54556562|FG002|Overall Study|Adverse Event|5|||
27900488|NCT03843125|54556563|FG003|Overall Study|Adverse Event|9|||
27900489|NCT03843125|54556560|FG000|Overall Study|Death|0|||
27900490|NCT03843125|54556561|FG001|Overall Study|Death|6|||
27900491|NCT03843125|54556562|FG002|Overall Study|Death|2|||
27900492|NCT03843125|54556563|FG003|Overall Study|Death|0|||
27900493|NCT03843125|54556560|FG000|Overall Study|Lack of Efficacy|14|||
27900494|NCT03843125|54556561|FG001|Overall Study|Lack of Efficacy|11|||
27900495|NCT03843125|54556562|FG002|Overall Study|Lack of Efficacy|9|||
27900496|NCT03843125|54556563|FG003|Overall Study|Lack of Efficacy|4|||
27900497|NCT03843125|54556560|FG000|Overall Study|Lost to Follow-up|3|||
27900498|NCT03843125|54556561|FG001|Overall Study|Lost to Follow-up|4|||
27900499|NCT03843125|54556562|FG002|Overall Study|Lost to Follow-up|0|||
27900500|NCT03843125|54556563|FG003|Overall Study|Lost to Follow-up|2|||
27900501|NCT03843125|54556560|FG000|Overall Study|Other|12|||
27900502|NCT03843125|54556561|FG001|Overall Study|Other|14|||
27900503|NCT03843125|54556562|FG002|Overall Study|Other|3|||
27900504|NCT03843125|54556563|FG003|Overall Study|Other|4|||
27900505|NCT03843125|54556560|FG000|Overall Study|Due to Epidemic/Pandemic|1|||
27900506|NCT03843125|54556561|FG001|Overall Study|Due to Epidemic/Pandemic|0|||
27900507|NCT03843125|54556562|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
27900508|NCT03843125|54556563|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
27900509|NCT03843125|54556560|FG000|Overall Study|Study Terminated by Sponsor|318|||
27900510|NCT03843125|54556561|FG001|Overall Study|Study Terminated by Sponsor|318|||
27900511|NCT03843125|54556562|FG002|Overall Study|Study Terminated by Sponsor|163|||
27900512|NCT03843125|54556563|FG003|Overall Study|Study Terminated by Sponsor|163|||
27900513|NCT03843125|54556560|FG000|Overall Study|Withdrawal by Subject|23|||
27900514|NCT03843125|54556561|FG001|Overall Study|Withdrawal by Subject|12|||
27900515|NCT03843125|54556562|FG002|Overall Study|Withdrawal by Subject|6|||
27900516|NCT03843125|54556563|FG003|Overall Study|Withdrawal by Subject|9|||
27900517|NCT03843125|54556560|FG000|Overall Study|Missing data|0|||
27900518|NCT03843125|54556561|FG001|Overall Study|Missing data|1|||
27900519|NCT03843125|54556562|FG002|Overall Study|Missing data|1|||
27900520|NCT03843125|54556563|FG003|Overall Study|Missing data|0|||
27900521|NCT03695237|54556576|FG000|Overall Study|Discontinued to Restart Puberty|1|||
27900522|NCT03695237|54556577|FG001|Overall Study|Discontinued to Restart Puberty|0|||
27900523|NCT03603509|54556586|FG000|Overall Study|Lost to Follow-up|3|||
27900524|NCT03603509|54556587|FG001|Overall Study|Lost to Follow-up|4|||
27900525|NCT03275285|54556604|FG000|Overall Study|Ongoing|61|||
27900526|NCT03275285|54556605|FG001|Overall Study|Ongoing|105|||
27900527|NCT03100149|54556622|FG000|Overall Study|Adverse Event|0|||
27900528|NCT03100149|54556623|FG001|Overall Study|Adverse Event|1|||
27900529|NCT03100149|54556624|FG002|Overall Study|Adverse Event|0|||
27900530|NCT03100149|54556622|FG000|Overall Study|Participant Moved out of Country|0|||
27900531|NCT03100149|54556623|FG001|Overall Study|Participant Moved out of Country|0|||
27900532|NCT03100149|54556624|FG002|Overall Study|Participant Moved out of Country|1|||
27900533|NCT03100149|54556622|FG000|Overall Study|Withdrawal by Subject|0|||
27900534|NCT03100149|54556623|FG001|Overall Study|Withdrawal by Subject|3|||
27900535|NCT03100149|54556624|FG002|Overall Study|Withdrawal by Subject|1|||
27900536|NCT03066258|54556637|FG000|Overall Study|Death|1|||
27900537|NCT03066258|54556638|FG001|Overall Study|Death|0|||
27900538|NCT03066258|54556639|FG002|Overall Study|Death|0|||
27900539|NCT03066258|54556640|FG003|Overall Study|Death|0|||
27900540|NCT03066258|54556641|FG004|Overall Study|Death|1|||
27900541|NCT03024255|54556657|FG000|Overall Study|Adverse Event|1|||
27900542|NCT03024255|54556658|FG001|Overall Study|Adverse Event|4|||
27900543|NCT03024255|54556659|FG002|Overall Study|Adverse Event|8|||
27900544|NCT03024255|54556660|FG003|Overall Study|Adverse Event|0|||
27900545|NCT03024255|54556657|FG000|Overall Study|Withdrawal by Subject|3|||
27900546|NCT03024255|54556658|FG001|Overall Study|Withdrawal by Subject|1|||
27900547|NCT03024255|54556659|FG002|Overall Study|Withdrawal by Subject|0|||
27900548|NCT03024255|54556660|FG003|Overall Study|Withdrawal by Subject|3|||
27900549|NCT03024255|54556657|FG000|Overall Study|Protocol Violation|0|||
27900550|NCT03024255|54556658|FG001|Overall Study|Protocol Violation|0|||
27900551|NCT03024255|54556659|FG002|Overall Study|Protocol Violation|2|||
27900552|NCT03024255|54556660|FG003|Overall Study|Protocol Violation|0|||
27900553|NCT03024255|54556657|FG000|Overall Study|Lost to Follow-up|1|||
27900554|NCT03024255|54556658|FG001|Overall Study|Lost to Follow-up|2|||
27900555|NCT03024255|54556659|FG002|Overall Study|Lost to Follow-up|1|||
27900556|NCT03024255|54556660|FG003|Overall Study|Lost to Follow-up|1|||
27900557|NCT03024255|54556657|FG000|Overall Study|Lack of Efficacy|1|||
27900558|NCT03024255|54556658|FG001|Overall Study|Lack of Efficacy|0|||
27900559|NCT03024255|54556659|FG002|Overall Study|Lack of Efficacy|0|||
27900560|NCT03024255|54556660|FG003|Overall Study|Lack of Efficacy|0|||
27900561|NCT03024255|54556657|FG000|Overall Study|Protocol Noncompliance|1|||
27900562|NCT03024255|54556658|FG001|Overall Study|Protocol Noncompliance|1|||
27900563|NCT03024255|54556659|FG002|Overall Study|Protocol Noncompliance|0|||
27900564|NCT03024255|54556660|FG003|Overall Study|Protocol Noncompliance|1|||
27900565|NCT02636582|54556679|FG000|Overall Study|Surgical Pathology|1|||
27900566|NCT02636582|54556680|FG001|Overall Study|Surgical Pathology|0|||
27900567|NCT02367040|54556688|FG000|Overall Study|Lost to Follow-up|1|||
27900568|NCT02367040|54556689|FG001|Overall Study|Lost to Follow-up|1|||
27900569|NCT02367040|54556688|FG000|Overall Study|Lack of Efficacy|1|||
27900570|NCT02367040|54556689|FG001|Overall Study|Lack of Efficacy|0|||
27900571|NCT02367040|54556688|FG000|Overall Study|Additional primary malignancy|0|||
27900572|NCT02367040|54556689|FG001|Overall Study|Additional primary malignancy|1|||
27900573|NCT02367040|54556688|FG000|Overall Study|AE not associated with clinical disease progression|104|||
27900574|NCT02367040|54556689|FG001|Overall Study|AE not associated with clinical disease progression|9|||
27900575|NCT02367040|54556688|FG000|Overall Study|AE associated with clinical disease progression|1|||
27900576|NCT02367040|54556689|FG001|Overall Study|AE associated with clinical disease progression|3|||
27900577|NCT02367040|54556688|FG000|Overall Study|Physician Decision|2|||
27900578|NCT02367040|54556689|FG001|Overall Study|Physician Decision|8|||
27900579|NCT02367040|54556688|FG000|Overall Study|Non-compliance with study drug|1|||
27900580|NCT02367040|54556689|FG001|Overall Study|Non-compliance with study drug|0|||
27900581|NCT02367040|54556688|FG000|Overall Study|Failure to meet continuation criteria|1|||
27900582|NCT02367040|54556689|FG001|Overall Study|Failure to meet continuation criteria|0|||
27900583|NCT02367040|54556688|FG000|Overall Study|Switching to other therapy|2|||
27900584|NCT02367040|54556689|FG001|Overall Study|Switching to other therapy|0|||
27900585|NCT02367040|54556688|FG000|Overall Study|Withdrawal by Subject|41|||
27900586|NCT02367040|54556689|FG001|Overall Study|Withdrawal by Subject|14|||
27900587|NCT02367040|54556688|FG000|Overall Study|Patient decision: COVID-19 pandemic related|1|||
27900588|NCT02367040|54556689|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
27900589|NCT02367040|54556688|FG000|Overall Study|Patient decision|35|||
27900590|NCT02367040|54556689|FG001|Overall Study|Patient decision|11|||
27900591|NCT02367040|54556688|FG000|Overall Study|Required procedure failed|1|||
27900592|NCT02367040|54556689|FG001|Overall Study|Required procedure failed|0|||
27900593|NCT02367040|54556688|FG000|Overall Study|Randomized by mistake with study treatment|1|||
27900594|NCT02367040|54556689|FG001|Overall Study|Randomized by mistake with study treatment|0|||
27900595|NCT02367040|54556688|FG000|Overall Study|Protocol Violation|1|||
27900596|NCT02367040|54556689|FG001|Overall Study|Protocol Violation|0|||
27900597|NCT02367040|54556688|FG000|Overall Study|Progressive disease - radiological progression|39|||
27900598|NCT02367040|54556689|FG001|Overall Study|Progressive disease - radiological progression|67|||
27900599|NCT02367040|54556688|FG000|Overall Study|Progressive disease - clinical progression|2|||
27900600|NCT02367040|54556689|FG001|Overall Study|Progressive disease - clinical progression|6|||
27900601|NCT02367040|54556688|FG000|Overall Study|Drug not administered|3|||
27900602|NCT02367040|54556689|FG001|Overall Study|Drug not administered|2|||
27900603|NCT01252953|54556701|FG000|Overall Study|Withdrawal by Subject|16|||
27900604|NCT01252953|54556702|FG001|Overall Study|Withdrawal by Subject|17|||
27900605|NCT01252953|54556701|FG000|Overall Study|Lost to Follow-up|22|||
27900606|NCT01252953|54556702|FG001|Overall Study|Lost to Follow-up|21|||
27900607|NCT01234480|54556709|FG000|Overall Study|Pregnancy|88|||
27900608|NCT01234480|54556709|FG000|Overall Study|>36/Normal History|50|||
27900609|NCT01234480|54556709|FG000|Overall Study|Age|3|||
27900610|NCT01234480|54556709|FG000|Overall Study|HPV Vaccine History|28|||
27900611|NCT01234480|54556709|FG000|Overall Study|HPV Vaccine after Enrollment|17|||
27900612|NCT01234480|54556709|FG000|Overall Study|Hysterectomy|2|||
27900613|NCT01234480|54556709|FG000|Overall Study|Hysterectomy post enrollment|1|||
27900614|NCT01234480|54556709|FG000|Overall Study|Inclusion/Exclusion Violation|3|||
27900615|NCT01234480|54556709|FG000|Overall Study|Informed Consent Form Violation|30|||
27900616|NCT01234480|54556709|FG000|Overall Study|Incorrect Visit|3|||
27900617|NCT01234480|54556709|FG000|Overall Study|No Florida Lab License|20|||
27900618|NCT01234480|54556709|FG000|Overall Study|Out of Window|42|||
27900619|NCT01234480|54556709|FG000|Overall Study|Sample Processing/Storage|92|||
27900620|NCT01234480|54556709|FG000|Overall Study|Site Amendment prohibited colposcopy|11|||
27900621|NCT01234480|54556709|FG000|Overall Study|Site/Subject non-compliance|44|||
27900622|NCT01234480|54556709|FG000|Overall Study|Missing Sample|9|||
27900623|NCT01038778|54556718|FG000|Overall Study|Withdrawal by Subject|0|||
27900624|NCT01038778|54556719|FG001|Overall Study|Withdrawal by Subject|2|||
27900625|NCT01038778|54556720|FG002|Overall Study|Withdrawal by Subject|3|||
27900626|NCT00877851|54556729|FG000|Overall Study|Lost to Follow-up|5|||
27900627|NCT00877851|54556730|FG001|Overall Study|Lost to Follow-up|5|||
27900628|NCT00877851|54556729|FG000|Overall Study|computer problem|3|||
27900629|NCT00877851|54556730|FG001|Overall Study|computer problem|0|||
27900630|NCT00877851|54556729|FG000|Overall Study|no longer interested in participating|1|||
27900631|NCT00877851|54556730|FG001|Overall Study|no longer interested in participating|0|||
27900632|NCT00846742|54556736|FG000|Overall Study|Withdrawal by Subject|1|||
27900633|NCT00837616|54556743|FG000|Overall Study|Withdrawal by Subject|0|||
27900634|NCT00837616|54556744|FG001|Overall Study|Withdrawal by Subject|1|||
27900635|NCT00176254|54556750|FG000|Overall Study|Lost to Follow-up|1|||
27900636|NCT04834726|54556781|FG000|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|82|||
27900637|NCT04834726|54556782|FG001|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|422|||
27900638|NCT04834726|54556783|FG002|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|404|||
27900639|NCT04834726|54556784|FG003|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|415|||
27900640|NCT04834726|54556785|FG004|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|428|||
27900641|NCT04834726|54556786|FG005|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|462|||
27900642|NCT04834726|54556787|FG006|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|447|||
27900643|NCT04834726|54556788|FG007|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|449|||
27900644|NCT04834726|54556789|FG008|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|400|||
27900645|NCT04732949|54556805|FG000|Overall Study|Withdrawal by Subject|23|||
27900646|NCT04732949|54556806|FG001|Overall Study|Withdrawal by Subject|27|||
27900647|NCT04732949|54556805|FG000|Overall Study|Protocol Violation|0|||
27900648|NCT04732949|54556806|FG001|Overall Study|Protocol Violation|1|||
27900649|NCT04732949|54556805|FG000|Overall Study|Non-compliance|0|||
27900650|NCT04732949|54556806|FG001|Overall Study|Non-compliance|2|||
27900651|NCT04732949|54556805|FG000|Overall Study|Physician Decision|2|||
27900652|NCT04732949|54556806|FG001|Overall Study|Physician Decision|1|||
28097326|NCT04067492|54752889|FG003|Overall Study|COVID-19 epidemiological situation|1|||
28097327|NCT04067492|54752890|FG004|Overall Study|COVID-19 epidemiological situation|0|||
27900653|NCT04732949|54556805|FG000|Overall Study|Serious adverse event (Fatal)|16|||
27900654|NCT04732949|54556806|FG001|Overall Study|Serious adverse event (Fatal)|18|||
27900655|NCT04732949|54556805|FG000|Overall Study|Serious adverse event (Non fatal)|2|||
27900656|NCT04732949|54556806|FG001|Overall Study|Serious adverse event (Non fatal)|1|||
27900657|NCT04732949|54556805|FG000|Overall Study|Non-serious adverse event|1|||
27900658|NCT04732949|54556806|FG001|Overall Study|Non-serious adverse event|3|||
27900659|NCT04732949|54556805|FG000|Overall Study|Lost to Follow-up|26|||
27900660|NCT04732949|54556806|FG001|Overall Study|Lost to Follow-up|27|||
27900661|NCT04732949|54556805|FG000|Overall Study|Other|6|||
27900662|NCT04732949|54556806|FG001|Overall Study|Other|3|||
27900663|NCT04235504|54556861|FG000|Study Phase|Withdrawal by Subject|5|||
27900664|NCT04235504|54556862|FG001|Study Phase|Withdrawal by Subject|2|||
27900665|NCT04235504|54556863|FG002|Study Phase|Withdrawal by Subject|0|||
27900666|NCT04235504|54556864|FG003|Study Phase|Withdrawal by Subject|0|||
27900667|NCT04235504|54556861|FG000|Continuation Phase|Withdrawal by Subject|0|||
27900668|NCT04235504|54556862|FG001|Continuation Phase|Withdrawal by Subject|4|||
27900669|NCT04235504|54556863|FG002|Continuation Phase|Withdrawal by Subject|0|||
27900670|NCT04235504|54556864|FG003|Continuation Phase|Withdrawal by Subject|0|||
27900671|NCT04235504|54556861|FG000|Continuation Phase|Adverse Event|0|||
27900672|NCT04235504|54556862|FG001|Continuation Phase|Adverse Event|1|||
27900673|NCT04235504|54556863|FG002|Continuation Phase|Adverse Event|0|||
27900674|NCT04235504|54556864|FG003|Continuation Phase|Adverse Event|0|||
27900675|NCT04235504|54556861|FG000|Continuation Phase|Physician Decision|1|||
27900676|NCT04235504|54556862|FG001|Continuation Phase|Physician Decision|2|||
27900677|NCT04235504|54556863|FG002|Continuation Phase|Physician Decision|1|||
27900678|NCT04235504|54556864|FG003|Continuation Phase|Physician Decision|0|||
27900679|NCT04172987|54556879|FG000|Lead In Period|Adverse Event|1|||
27900680|NCT04172987|54556879|FG000|Lead In Period|Protocol Violation|1|||
27900681|NCT04172987|54556879|FG000|Period 1|Physician Decision|1|||
27900682|NCT04172987|54556879|FG000|Period 2|Adverse Event|5|||
27900683|NCT04172987|54556879|FG000|Period 2|Dosing Termination by Sponsor|4|||
27900684|NCT03705832|54556888|FG000|Overall Study|Physician Decision|0|||
27900685|NCT03705832|54556889|FG001|Overall Study|Physician Decision|1|||
27900686|NCT03705832|54556888|FG000|Overall Study|Withdrawal by Subject|1|||
27900687|NCT03705832|54556889|FG001|Overall Study|Withdrawal by Subject|0|||
27900688|NCT03447743|54556895|FG000|Overall Study|Withdrawal by Subject|2|||
27900689|NCT03447743|54556895|FG000|Overall Study|Lost to Follow-up|3|||
27986612|NCT00595764|54644999|FG001|Overall Study|Missed Medication >1 week|17|||
27900690|NCT03447743|54556895|FG000|Overall Study|Adverse Event|1|||
27900691|NCT03447743|54556895|FG000|Overall Study|Did not meet criteria to continue|1|||
27900692|NCT03433755|54556903|FG000|Overall Study|Lost to Follow-up|1|||
27900693|NCT03433755|54556904|FG001|Overall Study|Lost to Follow-up|0|||
27900694|NCT03433755|54556905|FG002|Overall Study|Lost to Follow-up|0|||
27900695|NCT03433755|54556906|FG003|Overall Study|Lost to Follow-up|0|||
27900696|NCT03433755|54556903|FG000|Overall Study|Decision by Sponsor|1|||
27900697|NCT03433755|54556904|FG001|Overall Study|Decision by Sponsor|0|||
27900698|NCT03433755|54556905|FG002|Overall Study|Decision by Sponsor|0|||
27900699|NCT03433755|54556906|FG003|Overall Study|Decision by Sponsor|0|||
27900700|NCT03406507|54556929|FG000|Extension Period|Lack of Efficacy|0|||
27900701|NCT03406507|54556930|FG001|Extension Period|Lack of Efficacy|1|||
27900702|NCT03283150|54556939|FG000|Overall Study|Withdrawal by Subject|6|||
27900703|NCT03283150|54556940|FG001|Overall Study|Withdrawal by Subject|0|||
27900704|NCT03283150|54556941|FG002|Overall Study|Withdrawal by Subject|0|||
27986613|NCT00595764|54644998|FG000|Overall Study|Missed 3 PM visits|1|||
27986614|NCT00595764|54644999|FG001|Overall Study|Missed 3 PM visits|7|||
27986615|NCT00595764|54644998|FG000|Overall Study|Withdrawal by Subject|4|||
27986616|NCT00595764|54644999|FG001|Overall Study|Withdrawal by Subject|0|||
27986617|NCT00581308|54645019|FG000|Pre Discharge|Lost to Follow-up|1|||
27986618|NCT00581308|54645019|FG000|Pre Discharge|Device Removed|1|||
27986619|NCT00581308|54645019|FG000|Month 1|Lost to Follow-up|3|||
27986620|NCT00581308|54645019|FG000|Month 1|Withdrawal by Subject|2|||
27986621|NCT00581308|54645019|FG000|Month 1|Device Removed|2|||
27986622|NCT00581308|54645019|FG000|Month 1|Uknown|1|||
27986623|NCT00581308|54645019|FG000|Month 6|Lost to Follow-up|1|||
27986624|NCT00581308|54645019|FG000|Month 6|Withdrawal by Subject|2|||
27986625|NCT00581308|54645019|FG000|Month 12|Death|1|||
27986626|NCT00581308|54645019|FG000|Month 12|Lost to Follow-up|14|||
27986627|NCT00581308|54645019|FG000|Month 12|Withdrawal by Subject|3|||
27986628|NCT00581308|54645019|FG000|Month 12|Device Removed|1|||
28097328|NCT04067492|54752891|FG005|Overall Study|COVID-19 epidemiological situation|0|||
27900705|NCT03218917|54556952|FG000|Overall Study|Adverse Event|3|||
27900706|NCT03218917|54556953|FG001|Overall Study|Adverse Event|3|||
28097329|NCT04046250|54752907|FG000|Overall Study|Death|0|||
28097330|NCT04046250|54752908|FG001|Overall Study|Death|1|||
28097331|NCT04046250|54752907|FG000|Overall Study|Withdrawal by Subject|3|||
28097332|NCT04046250|54752908|FG001|Overall Study|Withdrawal by Subject|3|||
28097333|NCT04375878|54752918|FG000|Crossover First and Second Interventions|Withdrawal by Subject|1|||
27900707|NCT03218917|54556954|FG002|Overall Study|Adverse Event|2|||
27900708|NCT03218917|54556952|FG000|Overall Study|Subject withdrew consent|2|||
27900709|NCT03218917|54556953|FG001|Overall Study|Subject withdrew consent|4|||
27900710|NCT03218917|54556954|FG002|Overall Study|Subject withdrew consent|10|||
27986629|NCT00581308|54645019|FG000|Month 12|Other|1|||
27986630|NCT00877890|54645028|FG000|Overall Study|Adverse Event|6|||
27986631|NCT00877890|54645029|FG001|Overall Study|Adverse Event|6|||
27986632|NCT00877890|54645028|FG000|Overall Study|Lost to Follow-up|5|||
27986633|NCT00877890|54645029|FG001|Overall Study|Lost to Follow-up|5|||
28097334|NCT04375878|54752919|FG001|Crossover First and Second Interventions|Withdrawal by Subject|1|||
27900711|NCT03218917|54556952|FG000|Overall Study|Physician Decision|0|||
27900712|NCT03218917|54556953|FG001|Overall Study|Physician Decision|1|||
27900713|NCT03218917|54556954|FG002|Overall Study|Physician Decision|1|||
27900714|NCT03218917|54556952|FG000|Overall Study|Lost to Follow-up|1|||
27900715|NCT03218917|54556953|FG001|Overall Study|Lost to Follow-up|0|||
27900716|NCT03218917|54556954|FG002|Overall Study|Lost to Follow-up|0|||
27900717|NCT03218917|54556952|FG000|Overall Study|Reason Missing|0|||
27900718|NCT03218917|54556953|FG001|Overall Study|Reason Missing|2|||
27900719|NCT03218917|54556954|FG002|Overall Study|Reason Missing|0|||
28172099|NCT02718417|54843703|FG001|Observation Phase (OP)|Global deterioration of health status|0|||
27900720|NCT03218917|54556952|FG000|Overall Study|Death|0|||
27900721|NCT03218917|54556953|FG001|Overall Study|Death|1|||
27900722|NCT03218917|54556954|FG002|Overall Study|Death|0|||
27900723|NCT03218917|54556952|FG000|Overall Study|Non-Compliance with Study Drug|0|||
27900724|NCT03218917|54556953|FG001|Overall Study|Non-Compliance with Study Drug|1|||
27900725|NCT03218917|54556954|FG002|Overall Study|Non-Compliance with Study Drug|0|||
27900726|NCT03056040|54556965|FG000|Primary Evaluation Period|Withdrawal by Subject|1|||
27900727|NCT03056040|54556966|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
27900728|NCT03056040|54556965|FG000|Primary Evaluation Period|Lack of Efficacy|0|||
27900729|NCT03056040|54556966|FG001|Primary Evaluation Period|Lack of Efficacy|1|||
27900730|NCT03056040|54556965|FG000|Primary Evaluation Period|Pregnancy|0|||
27900731|NCT03056040|54556966|FG001|Primary Evaluation Period|Pregnancy|1|||
27900732|NCT03056040|54556965|FG000|Extension Period|Physician Decision|3|||
27900733|NCT03056040|54556966|FG001|Extension Period|Physician Decision|3|||
27900734|NCT03056040|54556965|FG000|Extension Period|Lost to Follow-up|0|||
27900735|NCT03056040|54556966|FG001|Extension Period|Lost to Follow-up|1|||
27900736|NCT03056040|54556965|FG000|Extension Period|Death|0|||
27900737|NCT03056040|54556966|FG001|Extension Period|Death|3|||
27900738|NCT03056040|54556965|FG000|Extension Period|Withdrawal by Subject|1|||
27986634|NCT00877890|54645028|FG000|Overall Study|Protocol Violation|0|||
27986635|NCT00877890|54645029|FG001|Overall Study|Protocol Violation|1|||
27986636|NCT00877890|54645028|FG000|Overall Study|Withdrawal of Consent|6|||
27986637|NCT00877890|54645029|FG001|Overall Study|Withdrawal of Consent|12|||
27986638|NCT00877890|54645028|FG000|Overall Study|Investigator Decision|0|||
27986639|NCT00877890|54645029|FG001|Overall Study|Investigator Decision|2|||
27986640|NCT00877890|54645028|FG000|Overall Study|Loss of Glucose Control|3|||
27986641|NCT00877890|54645029|FG001|Overall Study|Loss of Glucose Control|4|||
27986642|NCT03474679|54645039|FG000|Overall Study|Death|7|||
27986643|NCT03474679|54645039|FG000|Overall Study|Withdrawal by Subject|1|||
27986644|NCT03472885|54645043|FG000|Overall Study|Adverse Event|1|||
27986645|NCT03905863|54645049|FG000|Overall Study|Adverse Event|2|||
27986646|NCT03905863|54645050|FG001|Overall Study|Adverse Event|4|||
27986647|NCT03905863|54645049|FG000|Overall Study|Withdrawal by Subject|2|||
27986648|NCT03905863|54645050|FG001|Overall Study|Withdrawal by Subject|2|||
27900739|NCT03056040|54556966|FG001|Extension Period|Withdrawal by Subject|0|||
27900740|NCT03021499|54556977|FG000|Overall Study|Adverse Event|1|||
27900741|NCT03021499|54556978|FG001|Overall Study|Adverse Event|0|||
27900742|NCT03021499|54556977|FG000|Overall Study|Death|1|||
27900743|NCT03021499|54556978|FG001|Overall Study|Death|5|||
27900744|NCT03021499|54556977|FG000|Overall Study|Lack of Efficacy|0|||
27900745|NCT03021499|54556978|FG001|Overall Study|Lack of Efficacy|1|||
27900746|NCT03021499|54556977|FG000|Overall Study|Lost to Follow-up|1|||
27986649|NCT03905863|54645049|FG000|Overall Study|Physician Decision|0|||
27986650|NCT03905863|54645050|FG001|Overall Study|Physician Decision|3|||
27986651|NCT03905863|54645049|FG000|Overall Study|Lost to Follow-up|1|||
27986652|NCT03905863|54645050|FG001|Overall Study|Lost to Follow-up|0|||
27986653|NCT03905863|54645049|FG000|Overall Study|Protocol Violation|0|||
27986654|NCT03905863|54645050|FG001|Overall Study|Protocol Violation|2|||
27986655|NCT03905863|54645049|FG000|Overall Study|Death|0|||
27986656|NCT03905863|54645050|FG001|Overall Study|Death|1|||
27900747|NCT03021499|54556978|FG001|Overall Study|Lost to Follow-up|3|||
27900748|NCT03021499|54556977|FG000|Overall Study|Physician Decision|2|||
27900749|NCT03021499|54556978|FG001|Overall Study|Physician Decision|3|||
27900750|NCT03021499|54556977|FG000|Overall Study|Pregnancy|1|||
27900751|NCT03021499|54556978|FG001|Overall Study|Pregnancy|0|||
27900752|NCT03021499|54556977|FG000|Overall Study|Withdrawal by Subject|7|||
27900753|NCT03021499|54556978|FG001|Overall Study|Withdrawal by Subject|14|||
27900754|NCT03021499|54556977|FG000|Overall Study|Prohibited medication required|1|||
27986657|NCT04067011|54645059|FG000|Overall Study|Not Treated|8|||
27900755|NCT03021499|54556978|FG001|Overall Study|Prohibited medication required|0|||
27900756|NCT03021499|54556977|FG000|Overall Study|Protocol non-compliance|1|||
27900757|NCT03021499|54556978|FG001|Overall Study|Protocol non-compliance|1|||
27986658|NCT04067011|54645060|FG001|Overall Study|Not Treated|7|||
27900758|NCT03021499|54556977|FG000|Overall Study|None of the above|0|||
27900759|NCT03021499|54556978|FG001|Overall Study|None of the above|4|||
27900760|NCT03021499|54556977|FG000|Overall Study|Adverse Event (AE) Prior to First Dose|1|||
27986659|NCT04067011|54645061|FG002|Overall Study|Not Treated|5|||
27986660|NCT04067011|54645059|FG000|Overall Study|Adverse Event|2|||
27986661|NCT04067011|54645060|FG001|Overall Study|Adverse Event|1|||
27986662|NCT04067011|54645061|FG002|Overall Study|Adverse Event|0|||
27986663|NCT04067011|54645059|FG000|Overall Study|Withdrawal by Subject|6|||
27986664|NCT04067011|54645060|FG001|Overall Study|Withdrawal by Subject|2|||
27986665|NCT04067011|54645061|FG002|Overall Study|Withdrawal by Subject|1|||
27986666|NCT04067011|54645059|FG000|Overall Study|Lost to Follow-up|0|||
27986667|NCT04067011|54645060|FG001|Overall Study|Lost to Follow-up|0|||
27986668|NCT04067011|54645061|FG002|Overall Study|Lost to Follow-up|1|||
27900761|NCT03021499|54556978|FG001|Overall Study|Adverse Event (AE) Prior to First Dose|0|||
27900762|NCT02726581|54557007|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
27900763|NCT02726581|54557008|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
27900764|NCT02726581|54557009|FG002|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
27900765|NCT02726581|54557007|FG000|Pre-Treatment Period|Administrative reason by sponsor|2|||
27900766|NCT02726581|54557008|FG001|Pre-Treatment Period|Administrative reason by sponsor|0|||
27900767|NCT02726581|54557009|FG002|Pre-Treatment Period|Administrative reason by sponsor|0|||
27900768|NCT02726581|54557007|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
27900769|NCT02726581|54557008|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
27900770|NCT02726581|54557009|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
27900771|NCT02726581|54557007|FG000|Treatment Period|Disease progression|47|||
27900772|NCT02726581|54557008|FG001|Treatment Period|Disease progression|50|||
27900773|NCT02726581|54557009|FG002|Treatment Period|Disease progression|16|||
27900774|NCT02726581|54557007|FG000|Treatment Period|Other reasons|9|||
27900775|NCT02726581|54557008|FG001|Treatment Period|Other reasons|8|||
27900776|NCT02726581|54557009|FG002|Treatment Period|Other reasons|2|||
27900777|NCT02726581|54557007|FG000|Treatment Period|Study drug toxicity|6|||
27900778|NCT02726581|54557008|FG001|Treatment Period|Study drug toxicity|3|||
27900779|NCT02726581|54557009|FG002|Treatment Period|Study drug toxicity|2|||
27900780|NCT02726581|54557007|FG000|Treatment Period|Adverse event unrelated to study drug|4|||
27900781|NCT02726581|54557008|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
27986669|NCT04067011|54645059|FG000|Overall Study|Physician Decision|1|||
27986670|NCT04067011|54645060|FG001|Overall Study|Physician Decision|1|||
27986671|NCT04067011|54645061|FG002|Overall Study|Physician Decision|0|||
27986672|NCT04067011|54645059|FG000|Overall Study|Other Reasons|2|||
27900782|NCT02726581|54557009|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
27900783|NCT02726581|54557007|FG000|Treatment Period|Participant withdrew consent|3|||
27900784|NCT02726581|54557008|FG001|Treatment Period|Participant withdrew consent|1|||
27900785|NCT02726581|54557009|FG002|Treatment Period|Participant withdrew consent|1|||
27900786|NCT02726581|54557007|FG000|Treatment Period|Participant request to discontinue study treatment|1|||
27900787|NCT02726581|54557008|FG001|Treatment Period|Participant request to discontinue study treatment|1|||
27900788|NCT02726581|54557009|FG002|Treatment Period|Participant request to discontinue study treatment|1|||
27900789|NCT02726581|54557007|FG000|Treatment Period|Maximum clinical benefit|0|||
27900790|NCT02726581|54557008|FG001|Treatment Period|Maximum clinical benefit|2|||
27900791|NCT02726581|54557009|FG002|Treatment Period|Maximum clinical benefit|0|||
27900792|NCT02726581|54557007|FG000|Treatment Period|Death|1|||
27900793|NCT02726581|54557008|FG001|Treatment Period|Death|0|||
27900794|NCT02726581|54557009|FG002|Treatment Period|Death|0|||
27900795|NCT02726581|54557007|FG000|Treatment Period|Poor/non-compliance|1|||
27900796|NCT02726581|54557008|FG001|Treatment Period|Poor/non-compliance|0|||
27900797|NCT02726581|54557009|FG002|Treatment Period|Poor/non-compliance|0|||
27900798|NCT02726581|54557007|FG000|Treatment Period|Participant no longer meets study criteria|0|||
27900799|NCT02726581|54557008|FG001|Treatment Period|Participant no longer meets study criteria|1|||
27900800|NCT02726581|54557009|FG002|Treatment Period|Participant no longer meets study criteria|0|||
27900801|NCT02700048|54557019|FG000|Overall Study|The device failed so the study wasn't completed and participants were dropped|0|||
27900802|NCT02700048|54557020|FG001|Overall Study|The device failed so the study wasn't completed and participants were dropped|3|||
27900803|NCT02425904|54557037|FG000|Overall Study|Lost to Follow-up|1|||
27900804|NCT02425904|54557038|FG001|Overall Study|Lost to Follow-up|0|||
27900805|NCT02425904|54557037|FG000|Overall Study|Withdrawal by Subject|2|||
27900806|NCT02425904|54557038|FG001|Overall Study|Withdrawal by Subject|0|||
27900807|NCT02425904|54557037|FG000|Overall Study|Death|0|||
27900808|NCT02425904|54557038|FG001|Overall Study|Death|3|||
27900809|NCT02097420|54557058|FG000|Overall Study|Death|4|||
27900810|NCT02097420|54557058|FG000|Overall Study|Device explanted|3|||
27900811|NCT02097420|54557058|FG000|Overall Study|Not reached 12-month visit|7|||
27900812|NCT01964989|54557064|FG000|Overall Study|Protocol Violation|3|||
27900813|NCT01964989|54557065|FG001|Overall Study|Protocol Violation|4|||
27900814|NCT01964989|54557064|FG000|Overall Study|Administrative Reason|103|||
27925786|NCT01226745|54582369|FG002|Overall Study|Death|0|||
27986673|NCT04067011|54645060|FG001|Overall Study|Other Reasons|0|||
27986674|NCT04067011|54645061|FG002|Overall Study|Other Reasons|1|||
27986675|NCT04067011|54645059|FG000|Overall Study|Missing|0|||
27986676|NCT04067011|54645060|FG001|Overall Study|Missing|2|||
28097335|NCT04375878|54752920|FG002|Crossover First and Second Interventions|Withdrawal by Subject|0|||
28097336|NCT04375878|54752921|FG003|Crossover First and Second Interventions|Withdrawal by Subject|0|||
27900815|NCT01964989|54557065|FG001|Overall Study|Administrative Reason|95|||
27900816|NCT01964989|54557064|FG000|Overall Study|Adverse Event|0|||
27900817|NCT01964989|54557065|FG001|Overall Study|Adverse Event|1|||
27900818|NCT01964989|54557064|FG000|Overall Study|Death|1|||
27900819|NCT01964989|54557065|FG001|Overall Study|Death|3|||
27900820|NCT01964989|54557064|FG000|Overall Study|Withdrawal by Subject|156|||
27900821|NCT01964989|54557065|FG001|Overall Study|Withdrawal by Subject|160|||
27900822|NCT01964989|54557064|FG000|Overall Study|Lost to Follow-up|254|||
27900823|NCT01964989|54557065|FG001|Overall Study|Lost to Follow-up|232|||
27900824|NCT01964989|54557064|FG000|Overall Study|Other|267|||
27900825|NCT01964989|54557065|FG001|Overall Study|Other|252|||
27986677|NCT04067011|54645061|FG002|Overall Study|Missing|0|||
27986678|NCT00539305|54645105|FG000|Overall Study|Adverse Event|1|||
27986679|NCT00539305|54645106|FG001|Overall Study|Adverse Event|0|||
27986680|NCT00539305|54645105|FG000|Overall Study|Substance Use|0|||
27986681|NCT00539305|54645106|FG001|Overall Study|Substance Use|1|||
27986682|NCT00539305|54645105|FG000|Overall Study|Withdrawal by Subject|0|||
27986683|NCT00539305|54645106|FG001|Overall Study|Withdrawal by Subject|1|||
27986684|NCT04469465|54645133|FG000|Overall Study|Adverse Event|2|||
27986685|NCT04469465|54645134|FG001|Overall Study|Adverse Event|1|||
27986686|NCT04469465|54645133|FG000|Overall Study|Ongoing treatment|7|||
27986687|NCT04469465|54645134|FG001|Overall Study|Ongoing treatment|4|||
27986688|NCT04469465|54645133|FG000|Overall Study|Withdrawal by Subject|0|||
27986689|NCT04469465|54645134|FG001|Overall Study|Withdrawal by Subject|1|||
27986690|NCT00877032|54645147|FG000|Overall Study|Did not meet entrance criteria|0|||
27986691|NCT00877032|54645148|FG001|Overall Study|Did not meet entrance criteria|0|||
27986692|NCT00877032|54645149|FG002|Overall Study|Did not meet entrance criteria|0|||
27986693|NCT00877032|54645150|FG003|Overall Study|Did not meet entrance criteria|1|||
27986694|NCT00877032|54645151|FG004|Overall Study|Did not meet entrance criteria|0|||
27986695|NCT00877032|54645152|FG005|Overall Study|Did not meet entrance criteria|0|||
27986696|NCT00877032|54645153|FG006|Overall Study|Did not meet entrance criteria|2|||
27986697|NCT00538681|54645192|FG000|Overall Study|Progressive Disease|7|||
27986698|NCT00538681|54645193|FG001|Overall Study|Progressive Disease|0|||
27986699|NCT00538681|54645194|FG002|Overall Study|Progressive Disease|1|||
27986700|NCT00538681|54645195|FG003|Overall Study|Progressive Disease|0|||
27986701|NCT00538681|54645192|FG000|Overall Study|Sponsor Decision|1|||
27986702|NCT00538681|54645193|FG001|Overall Study|Sponsor Decision|3|||
27986703|NCT00538681|54645194|FG002|Overall Study|Sponsor Decision|8|||
27986704|NCT00538681|54645195|FG003|Overall Study|Sponsor Decision|9|||
27986705|NCT00538681|54645192|FG000|Overall Study|Adverse Event|1|||
27986706|NCT00538681|54645193|FG001|Overall Study|Adverse Event|1|||
27986707|NCT00538681|54645194|FG002|Overall Study|Adverse Event|1|||
27986708|NCT00538681|54645195|FG003|Overall Study|Adverse Event|0|||
27986709|NCT00538681|54645192|FG000|Overall Study|Death|0|||
27986710|NCT00538681|54645193|FG001|Overall Study|Death|0|||
27986711|NCT00538681|54645194|FG002|Overall Study|Death|1|||
27986712|NCT00538681|54645195|FG003|Overall Study|Death|1|||
27986713|NCT00538681|54645192|FG000|Overall Study|Investigator Decision|0|||
27986714|NCT00538681|54645193|FG001|Overall Study|Investigator Decision|0|||
27986715|NCT00538681|54645194|FG002|Overall Study|Investigator Decision|0|||
27986716|NCT00538681|54645195|FG003|Overall Study|Investigator Decision|1|||
27986717|NCT00876018|54645209|FG000|Overall Study|Lost to Follow-up|0|||
27900826|NCT01575860|54557093|FG000|Overall Study|Withdrawal by Subject|1|||
27900827|NCT01575860|54557093|FG000|Overall Study|Progression Prior to Lenalidomide Maint.|1|||
27900828|NCT01416831|54557100|FG000|Cycles 1 & 2 (Weeks 1-14)|Death|1|||
27900829|NCT01416831|54557101|FG001|Cycles 1 & 2 (Weeks 1-14)|Death|2|||
27900830|NCT01267955|54557107|FG000|Stage 1 (6 Months)|Death|3|||
27900831|NCT01267955|54557107|FG000|Stage 2 (6 Months)|Death|5|||
27900832|NCT01267955|54557107|FG000|Stage 2 (6 Months)|Protocol Violation|1|||
27900833|NCT01064648|54557114|FG000|Phase I Cohort1: Dose Level 1|Progression|5|||
27900834|NCT01064648|54557115|FG001|Phase I Cohort1: Dose Level 1|Progression|0|||
27986718|NCT00876018|54645210|FG001|Overall Study|Lost to Follow-up|1|||
27986719|NCT00876018|54645211|FG002|Overall Study|Lost to Follow-up|1|||
27986720|NCT00876018|54645209|FG000|Overall Study|Withdrew Consent due to Adverse Event|5|||
27986721|NCT00876018|54645210|FG001|Overall Study|Withdrew Consent due to Adverse Event|4|||
27986722|NCT00876018|54645211|FG002|Overall Study|Withdrew Consent due to Adverse Event|2|||
27986723|NCT03885934|54645236|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
27986724|NCT03885934|54645237|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
27986725|NCT03885934|54645238|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
27986726|NCT03885934|54645239|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
27986727|NCT03885934|54645240|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
27986728|NCT03885934|54645241|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
27986729|NCT00875706|54645258|FG000|Overall Study|Withdrawal by Subject|1|||
27986730|NCT00875706|54645259|FG001|Overall Study|Withdrawal by Subject|0|||
27900835|NCT01064648|54557116|FG002|Phase I Cohort1: Dose Level 1|Progression|0|||
27900836|NCT01064648|54557117|FG003|Phase I Cohort1: Dose Level 1|Progression|0|||
27900837|NCT01064648|54557114|FG000|Phase I Cohort1: Dose Level 1|Non-protocol specified|2|||
27900838|NCT01064648|54557115|FG001|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
27900839|NCT01064648|54557116|FG002|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
27900840|NCT01064648|54557117|FG003|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
27900841|NCT01064648|54557114|FG000|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
27900842|NCT01064648|54557115|FG001|Phase I Cohort 2: Dose Level 2|Adverse Event|3|||
27900843|NCT01064648|54557116|FG002|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
27900844|NCT01064648|54557117|FG003|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
27900845|NCT01064648|54557114|FG000|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
27900846|NCT01064648|54557115|FG001|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1|||
27900847|NCT01064648|54557116|FG002|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
27900848|NCT01064648|54557117|FG003|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
27900849|NCT01064648|54557114|FG000|Phase I Cohort 2: Dose Level 2|Progression|0|||
27900850|NCT01064648|54557115|FG001|Phase I Cohort 2: Dose Level 2|Progression|5|||
27900851|NCT01064648|54557116|FG002|Phase I Cohort 2: Dose Level 2|Progression|0|||
27900852|NCT01064648|54557117|FG003|Phase I Cohort 2: Dose Level 2|Progression|0|||
27900853|NCT01064648|54557114|FG000|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
27900854|NCT01064648|54557115|FG001|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4|||
27900855|NCT01064648|54557116|FG002|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
27900856|NCT01064648|54557117|FG003|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
27900857|NCT01064648|54557114|FG000|Phase II|Adverse Event|0|||
27900858|NCT01064648|54557115|FG001|Phase II|Adverse Event|0|||
27900859|NCT01064648|54557116|FG002|Phase II|Adverse Event|15|||
27900860|NCT01064648|54557117|FG003|Phase II|Adverse Event|8|||
27900861|NCT01064648|54557114|FG000|Phase II|Death|0|||
27900862|NCT01064648|54557115|FG001|Phase II|Death|0|||
27900863|NCT01064648|54557116|FG002|Phase II|Death|4|||
27900864|NCT01064648|54557117|FG003|Phase II|Death|5|||
27900865|NCT01064648|54557114|FG000|Phase II|Withdrawal by Subject|0|||
27900866|NCT01064648|54557115|FG001|Phase II|Withdrawal by Subject|0|||
27900867|NCT01064648|54557116|FG002|Phase II|Withdrawal by Subject|2|||
27900868|NCT01064648|54557117|FG003|Phase II|Withdrawal by Subject|5|||
27900869|NCT01064648|54557114|FG000|Phase II|Progression|0|||
27900870|NCT01064648|54557115|FG001|Phase II|Progression|0|||
27900871|NCT01064648|54557116|FG002|Phase II|Progression|21|||
27986731|NCT00875706|54645260|FG002|Overall Study|Withdrawal by Subject|0|||
27986732|NCT04399889|54645271|FG000|Overall Study|Death|5|||
27986733|NCT04399889|54645272|FG001|Overall Study|Death|1|||
27986734|NCT04399889|54645273|FG002|Overall Study|Death|1|||
27986735|NCT00837265|54645288|FG000|Pilot Phase|Withdrawal by Subject|0|||
27986736|NCT00837265|54645289|FG001|Pilot Phase|Withdrawal by Subject|2|||
27986737|NCT00837265|54645290|FG002|Pilot Phase|Withdrawal by Subject|3|||
27986738|NCT00837265|54645291|FG003|Pilot Phase|Withdrawal by Subject|2|||
27986739|NCT00837265|54645292|FG004|Pilot Phase|Withdrawal by Subject|0|||
27986740|NCT00837265|54645293|FG005|Pilot Phase|Withdrawal by Subject|0|||
27986741|NCT00837265|54645294|FG006|Pilot Phase|Withdrawal by Subject|0|||
27986742|NCT00837265|54645288|FG000|Pilot Phase|Decision of the investigator|2|||
27986743|NCT00837265|54645289|FG001|Pilot Phase|Decision of the investigator|1|||
27986744|NCT00837265|54645290|FG002|Pilot Phase|Decision of the investigator|0|||
27986745|NCT00837265|54645291|FG003|Pilot Phase|Decision of the investigator|0|||
27986746|NCT00837265|54645292|FG004|Pilot Phase|Decision of the investigator|0|||
27986747|NCT00837265|54645293|FG005|Pilot Phase|Decision of the investigator|0|||
27986748|NCT00837265|54645294|FG006|Pilot Phase|Decision of the investigator|0|||
27986749|NCT00837265|54645288|FG000|Pilot Phase|Adverse Event|1|||
27986750|NCT00837265|54645289|FG001|Pilot Phase|Adverse Event|0|||
27986751|NCT00837265|54645290|FG002|Pilot Phase|Adverse Event|0|||
27986752|NCT00837265|54645291|FG003|Pilot Phase|Adverse Event|0|||
27986753|NCT00837265|54645292|FG004|Pilot Phase|Adverse Event|0|||
27986754|NCT00837265|54645293|FG005|Pilot Phase|Adverse Event|0|||
27986755|NCT00837265|54645294|FG006|Pilot Phase|Adverse Event|0|||
27986756|NCT00837265|54645288|FG000|Pilot Phase|Disease progression|0|||
27986757|NCT00837265|54645289|FG001|Pilot Phase|Disease progression|0|||
27986758|NCT00837265|54645290|FG002|Pilot Phase|Disease progression|0|||
27986759|NCT00837265|54645291|FG003|Pilot Phase|Disease progression|1|||
27986760|NCT00837265|54645292|FG004|Pilot Phase|Disease progression|0|||
27986761|NCT00837265|54645293|FG005|Pilot Phase|Disease progression|0|||
27900872|NCT01064648|54557117|FG003|Phase II|Progression|27|||
27900873|NCT01064648|54557114|FG000|Phase II|Non-protocol specified|0|||
27900874|NCT01064648|54557115|FG001|Phase II|Non-protocol specified|0|||
27900875|NCT01064648|54557116|FG002|Phase II|Non-protocol specified|5|||
27986762|NCT00837265|54645294|FG006|Pilot Phase|Disease progression|0|||
27986763|NCT00837265|54645288|FG000|Pilot Phase|Participant left the city|0|||
27986764|NCT00837265|54645289|FG001|Pilot Phase|Participant left the city|0|||
27986765|NCT00837265|54645290|FG002|Pilot Phase|Participant left the city|0|||
27986766|NCT00837265|54645291|FG003|Pilot Phase|Participant left the city|1|||
27900876|NCT01064648|54557117|FG003|Phase II|Non-protocol specified|3|||
27986767|NCT00837265|54645292|FG004|Pilot Phase|Participant left the city|0|||
27986768|NCT00837265|54645293|FG005|Pilot Phase|Participant left the city|0|||
27986769|NCT00837265|54645294|FG006|Pilot Phase|Participant left the city|0|||
27900877|NCT01064648|54557114|FG000|Phase II|Under Review|0|||
27900878|NCT01064648|54557115|FG001|Phase II|Under Review|0|||
27900879|NCT01064648|54557116|FG002|Phase II|Under Review|2|||
27900880|NCT01064648|54557117|FG003|Phase II|Under Review|0|||
27900881|NCT00542451|54557143|FG000|Overall Study|Adverse Event|31|||
27900882|NCT00542451|54557143|FG000|Overall Study|Withdrawal by Subject|30|||
27900883|NCT00542451|54557143|FG000|Overall Study|Physician Decision|4|||
27900884|NCT00542451|54557143|FG000|Overall Study|Recurrent disease|1|||
27900885|NCT00542451|54557143|FG000|Overall Study|unknown reason|1|||
27900886|NCT00542451|54557143|FG000|Overall Study|Death|2|||
27900887|NCT00542451|54557143|FG000|Overall Study|Lost to Follow-up|10|||
27900888|NCT00382070|54557152|FG000|Overall Study|No follow up data mapped to Other|17|||
27900889|NCT00382070|54557153|FG001|Overall Study|No follow up data mapped to Other|19|||
27900890|NCT00382070|54557152|FG000|Overall Study|Patient not at risk for primary endpoint mapped to Other|7|||
27900891|NCT00382070|54557153|FG001|Overall Study|Patient not at risk for primary endpoint mapped to Other|0|||
27900892|NCT00382070|54557152|FG000|Overall Study|No clinical assessment|9|||
27986770|NCT00837265|54645288|FG000|Main Phase|Withdrawal by Subject|0|||
27986771|NCT00837265|54645289|FG001|Main Phase|Withdrawal by Subject|0|||
27986772|NCT00837265|54645290|FG002|Main Phase|Withdrawal by Subject|0|||
27986773|NCT00837265|54645291|FG003|Main Phase|Withdrawal by Subject|0|||
27986774|NCT00837265|54645292|FG004|Main Phase|Withdrawal by Subject|4|||
27986775|NCT00837265|54645293|FG005|Main Phase|Withdrawal by Subject|2|||
27900893|NCT00382070|54557153|FG001|Overall Study|No clinical assessment|11|||
27900894|NCT02921269|54557176|FG000|Overall Study|Did not complete DLT period|1|||
27900895|NCT04303559|54557215|FG000|Overall Study|Study closed due to poor enrollment.|1|||
27900896|NCT03784820|54557221|FG000|Overall Study|Lost to Follow-up|5|||
27900897|NCT03784820|54557222|FG001|Overall Study|Lost to Follow-up|5|||
27900898|NCT03784820|54557223|FG002|Overall Study|Lost to Follow-up|3|||
27900899|NCT03784820|54557224|FG003|Overall Study|Lost to Follow-up|3|||
27900900|NCT03769675|54557232|FG000|Overall Study|Lost to Follow-up|1|||
27986776|NCT00837265|54645294|FG006|Main Phase|Withdrawal by Subject|1|||
27986777|NCT00837265|54645288|FG000|Main Phase|Decision of the investigator|0|||
27986778|NCT00837265|54645289|FG001|Main Phase|Decision of the investigator|0|||
27986779|NCT00837265|54645290|FG002|Main Phase|Decision of the investigator|0|||
28172100|NCT02718417|54843704|FG002|Observation Phase (OP)|Global deterioration of health status|1|||
28172101|NCT02718417|54843702|FG000|Observation Phase (OP)|Other|0|||
28172102|NCT02718417|54843703|FG001|Observation Phase (OP)|Other|0|||
27900901|NCT03729245|54557238|FG000|Overall Study|Lost to Follow-up|5|||
27900902|NCT03729245|54557239|FG001|Overall Study|Lost to Follow-up|6|||
27900903|NCT03729245|54557238|FG000|Overall Study|Withdrawal by Subject|16|||
27900904|NCT03729245|54557239|FG001|Overall Study|Withdrawal by Subject|19|||
27900905|NCT03729245|54557238|FG000|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|1|||
27900906|NCT03729245|54557239|FG001|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|0|||
27900907|NCT03311711|54557259|FG000|Overall Study|Death|1|||
27900908|NCT03311711|54557260|FG001|Overall Study|Death|0|||
27900909|NCT03311711|54557261|FG002|Overall Study|Death|0|||
27900910|NCT03311711|54557262|FG003|Overall Study|Death|0|||
27900911|NCT03311711|54557263|FG004|Overall Study|Death|0|||
27900912|NCT03311711|54557264|FG005|Overall Study|Death|0|||
27900913|NCT03311711|54557265|FG006|Overall Study|Death|1|||
27900914|NCT03311711|54557266|FG007|Overall Study|Death|0|||
27900915|NCT03311711|54557267|FG008|Overall Study|Death|1|||
27900916|NCT03311711|54557268|FG009|Overall Study|Death|0|||
27900917|NCT03311711|54557259|FG000|Overall Study|Death of dyad partner|0|||
27900918|NCT03311711|54557260|FG001|Overall Study|Death of dyad partner|1|||
27900919|NCT03311711|54557261|FG002|Overall Study|Death of dyad partner|0|||
27900920|NCT03311711|54557262|FG003|Overall Study|Death of dyad partner|0|||
27900921|NCT03311711|54557263|FG004|Overall Study|Death of dyad partner|0|||
27900922|NCT03311711|54557264|FG005|Overall Study|Death of dyad partner|0|||
27900923|NCT03311711|54557265|FG006|Overall Study|Death of dyad partner|0|||
27900924|NCT03311711|54557266|FG007|Overall Study|Death of dyad partner|1|||
27900925|NCT03311711|54557267|FG008|Overall Study|Death of dyad partner|0|||
27900926|NCT03311711|54557268|FG009|Overall Study|Death of dyad partner|1|||
27900927|NCT03311711|54557259|FG000|Overall Study|Lost to Follow-up|2|||
27900928|NCT03311711|54557260|FG001|Overall Study|Lost to Follow-up|2|||
27900929|NCT03311711|54557261|FG002|Overall Study|Lost to Follow-up|0|||
27900930|NCT03311711|54557262|FG003|Overall Study|Lost to Follow-up|0|||
27900931|NCT03311711|54557263|FG004|Overall Study|Lost to Follow-up|0|||
27900932|NCT03311711|54557264|FG005|Overall Study|Lost to Follow-up|0|||
27900933|NCT03311711|54557265|FG006|Overall Study|Lost to Follow-up|1|||
27900934|NCT03311711|54557266|FG007|Overall Study|Lost to Follow-up|1|||
27986780|NCT00837265|54645291|FG003|Main Phase|Decision of the investigator|0|||
28172103|NCT02718417|54843704|FG002|Observation Phase (OP)|Other|7|||
27900935|NCT03311711|54557267|FG008|Overall Study|Lost to Follow-up|0|||
27900936|NCT03311711|54557268|FG009|Overall Study|Lost to Follow-up|0|||
27900937|NCT03311711|54557259|FG000|Overall Study|Withdrawal by Subject|1|||
27986781|NCT00837265|54645292|FG004|Main Phase|Decision of the investigator|0|||
28172104|NCT02718417|54843702|FG000|Follow-up Phase|Adverse Event|3|||
27900938|NCT03311711|54557260|FG001|Overall Study|Withdrawal by Subject|1|||
27900939|NCT03311711|54557261|FG002|Overall Study|Withdrawal by Subject|0|||
27900940|NCT03311711|54557262|FG003|Overall Study|Withdrawal by Subject|0|||
27900941|NCT03311711|54557263|FG004|Overall Study|Withdrawal by Subject|0|||
27900942|NCT03311711|54557264|FG005|Overall Study|Withdrawal by Subject|0|||
27900943|NCT03311711|54557265|FG006|Overall Study|Withdrawal by Subject|3|||
27900944|NCT03311711|54557266|FG007|Overall Study|Withdrawal by Subject|3|||
27900945|NCT03311711|54557267|FG008|Overall Study|Withdrawal by Subject|0|||
27900946|NCT03311711|54557268|FG009|Overall Study|Withdrawal by Subject|0|||
27900947|NCT03270891|54557298|FG000|Overall Study|Lost to Follow-up|3|||
27900948|NCT03270891|54557299|FG001|Overall Study|Lost to Follow-up|6|||
27900949|NCT03270891|54557300|FG002|Overall Study|Lost to Follow-up|0|||
27900950|NCT03270891|54557298|FG000|Overall Study|Withdrawal by Subject|1|||
27900951|NCT03270891|54557299|FG001|Overall Study|Withdrawal by Subject|0|||
27900952|NCT03270891|54557300|FG002|Overall Study|Withdrawal by Subject|0|||
27900953|NCT03270891|54557298|FG000|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
27900954|NCT03270891|54557299|FG001|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
27986782|NCT00837265|54645293|FG005|Main Phase|Decision of the investigator|2|||
27986783|NCT00837265|54645294|FG006|Main Phase|Decision of the investigator|1|||
27986784|NCT00837265|54645288|FG000|Main Phase|Adverse Event|0|||
27986785|NCT00837265|54645289|FG001|Main Phase|Adverse Event|0|||
27986786|NCT00837265|54645290|FG002|Main Phase|Adverse Event|0|||
28172105|NCT02718417|54843703|FG001|Follow-up Phase|Adverse Event|1|||
28172106|NCT02718417|54843704|FG002|Follow-up Phase|Adverse Event|1|||
28172107|NCT02718417|54843702|FG000|Follow-up Phase|Other|4|||
28172108|NCT02718417|54843703|FG001|Follow-up Phase|Other|6|||
28172109|NCT02718417|54843704|FG002|Follow-up Phase|Other|4|||
28172110|NCT02718417|54843702|FG000|Follow-up Phase|Withdrawal by Subject|19|||
28172111|NCT02718417|54843703|FG001|Follow-up Phase|Withdrawal by Subject|17|||
28172112|NCT02718417|54843704|FG002|Follow-up Phase|Withdrawal by Subject|5|||
28172113|NCT02718417|54843702|FG000|Follow-up Phase|Study terminated by sponsor|100|||
28172114|NCT02718417|54843703|FG001|Follow-up Phase|Study terminated by sponsor|138|||
28172115|NCT02718417|54843704|FG002|Follow-up Phase|Study terminated by sponsor|6|||
28172116|NCT02718417|54843702|FG000|Follow-up Phase|Lost to Follow-up|2|||
28172117|NCT02718417|54843703|FG001|Follow-up Phase|Lost to Follow-up|3|||
28172118|NCT02718417|54843704|FG002|Follow-up Phase|Lost to Follow-up|0|||
28172119|NCT02718417|54843702|FG000|Follow-up Phase|Death leading to discontinuation|7|||
28172120|NCT02718417|54843703|FG001|Follow-up Phase|Death leading to discontinuation|7|||
28172121|NCT02718417|54843704|FG002|Follow-up Phase|Death leading to discontinuation|3|||
28172122|NCT02718417|54843702|FG000|Long-term Follow-up Phase|Death leading to discontinuation|20|||
28172123|NCT02718417|54843703|FG001|Long-term Follow-up Phase|Death leading to discontinuation|17|||
28172124|NCT02718417|54843704|FG002|Long-term Follow-up Phase|Death leading to discontinuation|11|||
28172125|NCT02718417|54843702|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
27986787|NCT00837265|54645291|FG003|Main Phase|Adverse Event|0|||
27986788|NCT00837265|54645292|FG004|Main Phase|Adverse Event|0|||
27986789|NCT00837265|54645293|FG005|Main Phase|Adverse Event|1|||
27986790|NCT00837265|54645294|FG006|Main Phase|Adverse Event|0|||
27986791|NCT00837265|54645288|FG000|Main Phase|Death|0|||
27986792|NCT00837265|54645289|FG001|Main Phase|Death|0|||
27986793|NCT00837265|54645290|FG002|Main Phase|Death|0|||
27986794|NCT00837265|54645291|FG003|Main Phase|Death|0|||
27986795|NCT00837265|54645292|FG004|Main Phase|Death|2|||
27986796|NCT00837265|54645293|FG005|Main Phase|Death|0|||
27986797|NCT00837265|54645294|FG006|Main Phase|Death|1|||
27986798|NCT00837265|54645288|FG000|Main Phase|Lost to Follow-up|0|||
27986799|NCT00837265|54645289|FG001|Main Phase|Lost to Follow-up|0|||
27986800|NCT00837265|54645290|FG002|Main Phase|Lost to Follow-up|0|||
27986801|NCT00837265|54645291|FG003|Main Phase|Lost to Follow-up|0|||
27986802|NCT00837265|54645292|FG004|Main Phase|Lost to Follow-up|1|||
27986803|NCT00837265|54645293|FG005|Main Phase|Lost to Follow-up|0|||
27986804|NCT00837265|54645294|FG006|Main Phase|Lost to Follow-up|0|||
27986805|NCT00837265|54645288|FG000|Main Phase|Principal investigator resignation|0|||
28172126|NCT02718417|54843703|FG001|Long-term Follow-up Phase|Lost to Follow-up|4|||
28172127|NCT02718417|54843704|FG002|Long-term Follow-up Phase|Lost to Follow-up|3|||
28172128|NCT02718417|54843702|FG000|Long-term Follow-up Phase|Study terminated by sponsor|105|||
28172129|NCT02718417|54843703|FG001|Long-term Follow-up Phase|Study terminated by sponsor|80|||
27900955|NCT03270891|54557300|FG002|Overall Study|For Physician arm only; those physicians who did not have patients who participated|7|||
27900956|NCT02992743|54557312|FG000|Overall Study|Withdrawal by Subject|1|||
27900957|NCT02992743|54557313|FG001|Overall Study|Withdrawal by Subject|1|||
27900958|NCT02992743|54557312|FG000|Overall Study|Death-Prior to T-Cell Infusion|1|||
27986806|NCT00837265|54645289|FG001|Main Phase|Principal investigator resignation|0|||
27986807|NCT00837265|54645290|FG002|Main Phase|Principal investigator resignation|0|||
27986808|NCT00837265|54645291|FG003|Main Phase|Principal investigator resignation|0|||
27986809|NCT00837265|54645292|FG004|Main Phase|Principal investigator resignation|2|||
27986810|NCT00837265|54645293|FG005|Main Phase|Principal investigator resignation|0|||
27986811|NCT00837265|54645294|FG006|Main Phase|Principal investigator resignation|0|||
27986812|NCT00837265|54645288|FG000|Main Phase|Participant's personal reason|0|||
27986813|NCT00837265|54645289|FG001|Main Phase|Participant's personal reason|0|||
27986814|NCT00837265|54645290|FG002|Main Phase|Participant's personal reason|0|||
27986815|NCT00837265|54645291|FG003|Main Phase|Participant's personal reason|0|||
27986816|NCT00837265|54645292|FG004|Main Phase|Participant's personal reason|1|||
27986817|NCT00837265|54645293|FG005|Main Phase|Participant's personal reason|0|||
27986818|NCT00837265|54645294|FG006|Main Phase|Participant's personal reason|0|||
27986819|NCT00594516|54645307|FG000|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4|||
27986820|NCT00594516|54645308|FG001|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
27986821|NCT00594516|54645309|FG002|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
27986822|NCT00594516|54645307|FG000|Open Label (OL): Tapentadol IR|Lost to Follow-up|2|||
27986823|NCT00594516|54645308|FG001|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
27986824|NCT00594516|54645309|FG002|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
27986825|NCT00594516|54645307|FG000|Open Label (OL): Tapentadol IR|Adverse Event|16|||
27986826|NCT00594516|54645308|FG001|Open Label (OL): Tapentadol IR|Adverse Event|0|||
27986827|NCT00594516|54645309|FG002|Open Label (OL): Tapentadol IR|Adverse Event|0|||
27986828|NCT00594516|54645307|FG000|Open Label (OL): Tapentadol IR|Lack of Efficacy|1|||
27986829|NCT00594516|54645308|FG001|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
27986830|NCT00594516|54645309|FG002|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
27986831|NCT00594516|54645307|FG000|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6|||
27986832|NCT00594516|54645308|FG001|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
27986833|NCT00594516|54645309|FG002|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
27986834|NCT00594516|54645307|FG000|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0|||
27986835|NCT00594516|54645308|FG001|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
27986836|NCT00594516|54645309|FG002|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
27986837|NCT00594516|54645307|FG000|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0|||
27986838|NCT00594516|54645308|FG001|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3|||
27986839|NCT00594516|54645309|FG002|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2|||
27986840|NCT00594516|54645307|FG000|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0|||
27986841|NCT00594516|54645308|FG001|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
27986842|NCT00594516|54645309|FG002|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
27986843|NCT00594516|54645307|FG000|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
28172130|NCT02718417|54843704|FG002|Long-term Follow-up Phase|Study terminated by sponsor|112|||
28172131|NCT02718417|54843702|FG000|Long-term Follow-up Phase|Withdrawal by Subject|6|||
28172132|NCT02718417|54843703|FG001|Long-term Follow-up Phase|Withdrawal by Subject|9|||
28172133|NCT02718417|54843704|FG002|Long-term Follow-up Phase|Withdrawal by Subject|9|||
28172134|NCT02718417|54843702|FG000|Long-term Follow-up Phase|Other|0|||
28172135|NCT02718417|54843703|FG001|Long-term Follow-up Phase|Other|2|||
28172136|NCT02718417|54843704|FG002|Long-term Follow-up Phase|Other|0|||
28172137|NCT02640404|54843721|FG000|Overall Study|Protocol Violation|1|||
28172138|NCT02640404|54843722|FG001|Overall Study|Protocol Violation|0|||
28172139|NCT02640404|54843721|FG000|Overall Study|Withdrawal by Subject|1|||
28172140|NCT02640404|54843722|FG001|Overall Study|Withdrawal by Subject|0|||
28172141|NCT00701727|54843728|FG000|First Treatment Period|Adverse Event|0|||
28172142|NCT00701727|54843729|FG001|First Treatment Period|Adverse Event|0|||
28172143|NCT00701727|54843728|FG000|First Treatment Period|Withdrawal by Subject|1|||
28172144|NCT00701727|54843729|FG001|First Treatment Period|Withdrawal by Subject|0|||
28172145|NCT00701727|54843728|FG000|First Treatment Period|sponsor decision|0|||
28172146|NCT00701727|54843729|FG001|First Treatment Period|sponsor decision|1|||
28172147|NCT00701727|54843728|FG000|First Treatment Period|Lost to Follow-up|0|||
28172148|NCT00701727|54843729|FG001|First Treatment Period|Lost to Follow-up|1|||
28172149|NCT00701727|54843728|FG000|Second Treatment Period|Withdrawal by Subject|2|||
28172150|NCT00701727|54843729|FG001|Second Treatment Period|Withdrawal by Subject|0|||
28172151|NCT01369069|54843746|FG000|Overall Study|Lost to Follow-up|8|||
28172152|NCT01369069|54843747|FG001|Overall Study|Lost to Follow-up|9|||
28172153|NCT01369069|54843746|FG000|Overall Study|Withdrawal by Subject|9|||
28172154|NCT01369069|54843747|FG001|Overall Study|Withdrawal by Subject|7|||
28172155|NCT02441218|54843755|FG000|Overall Study|Death|503|||
28172156|NCT02441218|54843756|FG001|Overall Study|Death|553|||
28172157|NCT02441218|54843755|FG000|Overall Study|Withdrawal by Subject|73|||
28172158|NCT02441218|54843756|FG001|Overall Study|Withdrawal by Subject|58|||
28172159|NCT02441218|54843755|FG000|Overall Study|Lost to Follow-up|2|||
28172160|NCT02441218|54843756|FG001|Overall Study|Lost to Follow-up|1|||
28172161|NCT02410252|54843762|FG000|Overall Study|Withdrawal by Subject|4|||
28172162|NCT02410252|54843762|FG000|Overall Study|Physician Decision|2|||
27986844|NCT00594516|54645308|FG001|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
28172163|NCT02440594|54843776|FG000|Overall Study|Lost to Follow-up|34|||
28172164|NCT02440594|54843777|FG001|Overall Study|Lost to Follow-up|33|||
28172165|NCT02440594|54843778|FG002|Overall Study|Lost to Follow-up|54|||
27739467|NCT03745651|54189167|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
27986845|NCT00594516|54645309|FG002|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2|||
28172166|NCT02440594|54843779|FG003|Overall Study|Lost to Follow-up|47|||
28172167|NCT02440594|54843780|FG004|Overall Study|Lost to Follow-up|5|||
28172168|NCT02440594|54843781|FG005|Overall Study|Lost to Follow-up|4|||
28172169|NCT02440594|54843782|FG006|Overall Study|Lost to Follow-up|28|||
28172170|NCT02440594|54843783|FG007|Overall Study|Lost to Follow-up|48|||
28172171|NCT02440594|54843776|FG000|Overall Study|Cognitive Impairment/Communication Issue|14|||
28172172|NCT02440594|54843777|FG001|Overall Study|Cognitive Impairment/Communication Issue|6|||
28172173|NCT02440594|54843778|FG002|Overall Study|Cognitive Impairment/Communication Issue|4|||
28172174|NCT02440594|54843779|FG003|Overall Study|Cognitive Impairment/Communication Issue|4|||
28172175|NCT02440594|54843780|FG004|Overall Study|Cognitive Impairment/Communication Issue|2|||
28172176|NCT02440594|54843781|FG005|Overall Study|Cognitive Impairment/Communication Issue|1|||
28172177|NCT02440594|54843782|FG006|Overall Study|Cognitive Impairment/Communication Issue|0|||
28172178|NCT02440594|54843783|FG007|Overall Study|Cognitive Impairment/Communication Issue|0|||
28172179|NCT02440594|54843776|FG000|Overall Study|Withdrawal by Subject|81|||
28172180|NCT02440594|54843777|FG001|Overall Study|Withdrawal by Subject|67|||
28172181|NCT02440594|54843778|FG002|Overall Study|Withdrawal by Subject|59|||
28172182|NCT02440594|54843779|FG003|Overall Study|Withdrawal by Subject|38|||
28172183|NCT02440594|54843780|FG004|Overall Study|Withdrawal by Subject|2|||
28172184|NCT02440594|54843781|FG005|Overall Study|Withdrawal by Subject|2|||
28172185|NCT02440594|54843782|FG006|Overall Study|Withdrawal by Subject|7|||
28172186|NCT02440594|54843783|FG007|Overall Study|Withdrawal by Subject|7|||
28172187|NCT02440594|54843776|FG000|Overall Study|Administratively w/drawn|3|||
28172188|NCT02440594|54843777|FG001|Overall Study|Administratively w/drawn|2|||
28172189|NCT02440594|54843778|FG002|Overall Study|Administratively w/drawn|0|||
27900959|NCT02992743|54557313|FG001|Overall Study|Death-Prior to T-Cell Infusion|0|||
27900960|NCT02992743|54557312|FG000|Overall Study|Did Not Meet Inclusion/Exclusion|1|||
27900961|NCT02992743|54557313|FG001|Overall Study|Did Not Meet Inclusion/Exclusion|0|||
27900962|NCT02992743|54557312|FG000|Overall Study|No measurable disease|1|||
27900963|NCT02992743|54557313|FG001|Overall Study|No measurable disease|0|||
27900964|NCT02992743|54557312|FG000|Overall Study|Lost to Follow-up|0|||
27900965|NCT02992743|54557313|FG001|Overall Study|Lost to Follow-up|1|||
27900966|NCT02853344|54557321|FG000|Overall Study|Lost to Follow-up|1|||
27900967|NCT02853344|54557322|FG001|Overall Study|Lost to Follow-up|1|||
27900968|NCT02853344|54557321|FG000|Overall Study|Withdrawal by Subject|2|||
27900969|NCT02853344|54557322|FG001|Overall Study|Withdrawal by Subject|4|||
27900970|NCT02853344|54557321|FG000|Overall Study|Participation in Study Terminated by Sponsor|37|||
27900971|NCT02853344|54557322|FG001|Overall Study|Participation in Study Terminated by Sponsor|48|||
27900972|NCT02853344|54557321|FG000|Overall Study|Death|70|||
27900973|NCT02853344|54557322|FG001|Overall Study|Death|112|||
27900974|NCT02739620|54557333|FG000|Overall Study|Lost to Follow-up|3|||
27900975|NCT02739620|54557334|FG001|Overall Study|Lost to Follow-up|1|||
27900976|NCT02739620|54557333|FG000|Overall Study|Adverse Event|0|||
27900977|NCT02739620|54557334|FG001|Overall Study|Adverse Event|1|||
27900978|NCT02675426|54557343|FG000|Period 1: Week 1 to Week 12|Adverse Event|3|||
27900979|NCT02675426|54557344|FG001|Period 1: Week 1 to Week 12|Adverse Event|3|||
27900980|NCT02675426|54557345|FG002|Period 1: Week 1 to Week 12|Adverse Event|3|||
27900981|NCT02675426|54557346|FG003|Period 1: Week 1 to Week 12|Adverse Event|9|||
27900982|NCT02675426|54557343|FG000|Period 1: Week 1 to Week 12|Withdrawal by Subject|1|||
27900983|NCT02675426|54557344|FG001|Period 1: Week 1 to Week 12|Withdrawal by Subject|2|||
27900984|NCT02675426|54557345|FG002|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
27900985|NCT02675426|54557346|FG003|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
27900986|NCT02675426|54557343|FG000|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
27900987|NCT02675426|54557344|FG001|Period 1: Week 1 to Week 12|Lost to Follow-up|1|||
27900988|NCT02675426|54557345|FG002|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
27900989|NCT02675426|54557346|FG003|Period 1: Week 1 to Week 12|Lost to Follow-up|2|||
27900990|NCT02675426|54557343|FG000|Period 1: Week 1 to Week 12|Other|2|||
27900991|NCT02675426|54557344|FG001|Period 1: Week 1 to Week 12|Other|1|||
27900992|NCT02675426|54557345|FG002|Period 1: Week 1 to Week 12|Other|0|||
28172190|NCT02440594|54843779|FG003|Overall Study|Administratively w/drawn|0|||
27900993|NCT02675426|54557346|FG003|Period 1: Week 1 to Week 12|Other|2|||
27900994|NCT02675426|54557343|FG000|Period 2: Week 12 to Week 260|Adverse Event|13|||
27900995|NCT02675426|54557344|FG001|Period 2: Week 12 to Week 260|Adverse Event|16|||
27900996|NCT02675426|54557345|FG002|Period 2: Week 12 to Week 260|Adverse Event|17|||
27900997|NCT02675426|54557346|FG003|Period 2: Week 12 to Week 260|Adverse Event|30|||
27900998|NCT02675426|54557343|FG000|Period 2: Week 12 to Week 260|Withdrawal by Subject|14|||
27900999|NCT02675426|54557344|FG001|Period 2: Week 12 to Week 260|Withdrawal by Subject|21|||
27901000|NCT02675426|54557345|FG002|Period 2: Week 12 to Week 260|Withdrawal by Subject|31|||
27901001|NCT02675426|54557346|FG003|Period 2: Week 12 to Week 260|Withdrawal by Subject|30|||
27901002|NCT02675426|54557343|FG000|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
27901003|NCT02675426|54557344|FG001|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
28172191|NCT02440594|54843780|FG004|Overall Study|Administratively w/drawn|0|||
28172192|NCT02440594|54843781|FG005|Overall Study|Administratively w/drawn|0|||
28172193|NCT02440594|54843782|FG006|Overall Study|Administratively w/drawn|2|||
27901004|NCT02675426|54557345|FG002|Period 2: Week 12 to Week 260|Lost to Follow-up|10|||
27901005|NCT02675426|54557346|FG003|Period 2: Week 12 to Week 260|Lost to Follow-up|4|||
27901006|NCT02675426|54557343|FG000|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
27901007|NCT02675426|54557344|FG001|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
27901008|NCT02675426|54557345|FG002|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
27901009|NCT02675426|54557346|FG003|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
27901010|NCT02675426|54557343|FG000|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
27986846|NCT00538291|54645313|FG000|Overall Study|Adverse Event|2|||
27986847|NCT00538291|54645313|FG000|Overall Study|Withdrawal by Subject|1|||
27986848|NCT00594906|54645319|FG000|Overall Study|Physician Decision|1|||
27986849|NCT00594906|54645320|FG001|Overall Study|Physician Decision|0|||
28097337|NCT04375878|54752922|FG004|Crossover First and Second Interventions|Withdrawal by Subject|0|||
27739468|NCT03745651|54189168|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
27739469|NCT03745651|54189169|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
27739470|NCT03745651|54189170|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
27901011|NCT02675426|54557344|FG001|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
27901012|NCT02675426|54557345|FG002|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
27901013|NCT02675426|54557346|FG003|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
27901014|NCT02675426|54557343|FG000|Period 2: Week 12 to Week 260|Other|8|||
27739471|NCT03745651|54189171|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
27739472|NCT03745651|54189172|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
27739473|NCT03745651|54189173|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
27739474|NCT03745651|54189167|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|3|||
27901015|NCT02675426|54557344|FG001|Period 2: Week 12 to Week 260|Other|12|||
27901016|NCT02675426|54557345|FG002|Period 2: Week 12 to Week 260|Other|23|||
27901017|NCT02675426|54557346|FG003|Period 2: Week 12 to Week 260|Other|15|||
27901018|NCT02060721|54557387|FG000|Overall Study|Lost to Follow-up|1|||
27901019|NCT02060721|54557387|FG000|Overall Study|Physician Decision|2|||
27901020|NCT02060721|54557387|FG000|Overall Study|Death|14|||
27901021|NCT02060721|54557387|FG000|Overall Study|Withdrawal by Subject|2|||
27901022|NCT02060721|54557387|FG000|Overall Study|Compliance with local regulation: enrolled in China|19|||
27901023|NCT01527149|54557391|FG000|Overall Study|Death|2|||
27739475|NCT03745651|54189168|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|13|||
27901024|NCT01359956|54557399|FG000|Overall Study|Death|58|||
27901025|NCT01359956|54557400|FG001|Overall Study|Death|60|||
27901026|NCT01359956|54557401|FG002|Overall Study|Death|66|||
27901027|NCT01359956|54557402|FG003|Overall Study|Death|57|||
27901028|NCT01359956|54557399|FG000|Overall Study|Lost to Follow-up|3|||
27901029|NCT01359956|54557400|FG001|Overall Study|Lost to Follow-up|4|||
27901030|NCT01359956|54557401|FG002|Overall Study|Lost to Follow-up|1|||
27901031|NCT01359956|54557402|FG003|Overall Study|Lost to Follow-up|1|||
27901032|NCT01306045|54557415|FG000|Met General Eligibility Criteria|Screen failures|193|||
27901033|NCT01306045|54557416|FG001|Met General Eligibility Criteria|Screen failures|11|||
27901034|NCT01306045|54557417|FG002|Met General Eligibility Criteria|Screen failures|8|||
27901035|NCT01356940|54557469|FG000|First Intervention (28 Days)|Adverse Event|1|||
27901036|NCT01356940|54557470|FG001|First Intervention (28 Days)|Adverse Event|0|||
27901037|NCT01356940|54557469|FG000|Second Intervention (28 Days)|Withdrawal by Subject|1|||
27901038|NCT01356940|54557470|FG001|Second Intervention (28 Days)|Withdrawal by Subject|0|||
27901039|NCT01330030|54557489|FG000|Overall Study|Lost to Follow-up|16|||
27901040|NCT01330030|54557490|FG001|Overall Study|Lost to Follow-up|17|||
27901041|NCT00477295|54557610|FG000|Overall Study|Adverse Event|31|||
27901042|NCT00477295|54557611|FG001|Overall Study|Adverse Event|35|||
27901043|NCT00477295|54557610|FG000|Overall Study|Withdrawal by Subject|35|||
27986850|NCT00594906|54645319|FG000|Overall Study|Physician Decision|0|||
28097338|NCT04375878|54752923|FG005|Crossover First and Second Interventions|Withdrawal by Subject|0|||
28097339|NCT04375878|54752918|FG000|Crossover First and Second Interventions|Adverse Event|0|||
28097340|NCT04375878|54752919|FG001|Crossover First and Second Interventions|Adverse Event|0|||
28097341|NCT04375878|54752920|FG002|Crossover First and Second Interventions|Adverse Event|1|||
28097342|NCT04375878|54752921|FG003|Crossover First and Second Interventions|Adverse Event|0|||
28097343|NCT04375878|54752922|FG004|Crossover First and Second Interventions|Adverse Event|0|||
28097344|NCT04375878|54752923|FG005|Crossover First and Second Interventions|Adverse Event|0|||
28097345|NCT04375878|54752918|FG000|Extension Phase|Withdrawal by Subject|0|||
28097346|NCT04375878|54752919|FG001|Extension Phase|Withdrawal by Subject|0|||
28097347|NCT04375878|54752920|FG002|Extension Phase|Withdrawal by Subject|0|||
28097348|NCT04375878|54752921|FG003|Extension Phase|Withdrawal by Subject|0|||
27901044|NCT00477295|54557611|FG001|Overall Study|Withdrawal by Subject|24|||
27901045|NCT00477295|54557610|FG000|Overall Study|Lack of Efficacy|23|||
27901046|NCT00477295|54557611|FG001|Overall Study|Lack of Efficacy|23|||
27901047|NCT00477295|54557610|FG000|Overall Study|Protocol Violation|3|||
27986851|NCT00594906|54645320|FG001|Overall Study|Physician Decision|1|||
27986852|NCT00594906|54645319|FG000|Overall Study|Death|0|||
27901048|NCT00477295|54557611|FG001|Overall Study|Protocol Violation|8|||
27901049|NCT00477295|54557610|FG000|Overall Study|Physician Decision|4|||
27901050|NCT00477295|54557611|FG001|Overall Study|Physician Decision|5|||
27901051|NCT00477295|54557610|FG000|Overall Study|Lost to Follow-up|21|||
27901052|NCT00477295|54557611|FG001|Overall Study|Lost to Follow-up|11|||
27901053|NCT00477295|54557610|FG000|Overall Study|Other|4|||
27901054|NCT00477295|54557611|FG001|Overall Study|Other|3|||
27901055|NCT00476593|54557623|FG000|Overall Study|Lost to Follow-up|10|||
27901056|NCT00476593|54557624|FG001|Overall Study|Lost to Follow-up|2|||
27901057|NCT00476593|54557625|FG002|Overall Study|Lost to Follow-up|8|||
27901058|NCT00476593|54557626|FG003|Overall Study|Lost to Follow-up|22|||
27901059|NCT00476476|54557638|FG000|Overall Study|Adverse Event|2|||
27739476|NCT03745651|54189169|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|4|||
27901060|NCT00476476|54557639|FG001|Overall Study|Adverse Event|7|||
27901061|NCT00476476|54557638|FG000|Overall Study|Progressive Disease|0|||
27901062|NCT00476476|54557639|FG001|Overall Study|Progressive Disease|17|||
27901063|NCT00476086|54557644|FG000|Overall Study|Alternative therapy|1|||
27901064|NCT00476086|54557644|FG000|Overall Study|Progressive Disease|4|||
27901065|NCT00476047|54557650|FG000|Overall Study|Lost to Follow-up|1|||
27901066|NCT00476008|54557658|FG000|Overall Study|Adverse Event|4|||
27901067|NCT00476008|54557659|FG001|Overall Study|Adverse Event|4|||
27901068|NCT00476008|54557658|FG000|Overall Study|Placebo concerns|2|||
27901069|NCT00476008|54557659|FG001|Overall Study|Placebo concerns|2|||
27901070|NCT00476008|54557658|FG000|Overall Study|Physician Decision: Medication Noncompli|2|||
27901071|NCT00476008|54557659|FG001|Overall Study|Physician Decision: Medication Noncompli|1|||
27901072|NCT00476008|54557658|FG000|Overall Study|Withdrawal by Subject|0|||
27901073|NCT00476008|54557659|FG001|Overall Study|Withdrawal by Subject|1|||
27901074|NCT00476008|54557658|FG000|Overall Study|Death|1|||
27901075|NCT00476008|54557659|FG001|Overall Study|Death|0|||
27901076|NCT00475735|54557675|FG000|Treatment Period 1|Adverse Event|2|||
27901077|NCT00475735|54557676|FG001|Treatment Period 1|Adverse Event|0|||
27901078|NCT00475735|54557677|FG002|Treatment Period 1|Adverse Event|0|||
27901079|NCT00475735|54557678|FG003|Treatment Period 1|Adverse Event|0|||
27901080|NCT00475735|54557679|FG004|Treatment Period 1|Adverse Event|0|||
27901081|NCT00475735|54557680|FG005|Treatment Period 1|Adverse Event|0|||
27901082|NCT00475735|54557675|FG000|Treatment Period 1|Lack of Efficacy|1|||
27901083|NCT00475735|54557676|FG001|Treatment Period 1|Lack of Efficacy|0|||
27901084|NCT00475735|54557677|FG002|Treatment Period 1|Lack of Efficacy|0|||
27901085|NCT00475735|54557678|FG003|Treatment Period 1|Lack of Efficacy|0|||
27901086|NCT00475735|54557679|FG004|Treatment Period 1|Lack of Efficacy|0|||
27901087|NCT00475735|54557680|FG005|Treatment Period 1|Lack of Efficacy|0|||
27901088|NCT00475735|54557675|FG000|Treatment Period 1|Lost to Follow-up|0|||
27901089|NCT00475735|54557676|FG001|Treatment Period 1|Lost to Follow-up|0|||
27901090|NCT00475735|54557677|FG002|Treatment Period 1|Lost to Follow-up|0|||
27901091|NCT00475735|54557678|FG003|Treatment Period 1|Lost to Follow-up|0|||
27901092|NCT00475735|54557679|FG004|Treatment Period 1|Lost to Follow-up|0|||
27901093|NCT00475735|54557680|FG005|Treatment Period 1|Lost to Follow-up|1|||
27901094|NCT00475735|54557675|FG000|Treatment Period 1|Protocol Violation|0|||
27901095|NCT00475735|54557676|FG001|Treatment Period 1|Protocol Violation|0|||
27901096|NCT00475735|54557677|FG002|Treatment Period 1|Protocol Violation|0|||
27901097|NCT00475735|54557678|FG003|Treatment Period 1|Protocol Violation|1|||
27901098|NCT00475735|54557679|FG004|Treatment Period 1|Protocol Violation|0|||
27901099|NCT00475735|54557680|FG005|Treatment Period 1|Protocol Violation|0|||
27901100|NCT00475735|54557675|FG000|Treatment Period 1|Withdrawal by Subject|1|||
27901101|NCT00475735|54557676|FG001|Treatment Period 1|Withdrawal by Subject|1|||
27901102|NCT00475735|54557677|FG002|Treatment Period 1|Withdrawal by Subject|0|||
27901103|NCT00475735|54557678|FG003|Treatment Period 1|Withdrawal by Subject|0|||
27901104|NCT00475735|54557679|FG004|Treatment Period 1|Withdrawal by Subject|0|||
27901105|NCT00475735|54557680|FG005|Treatment Period 1|Withdrawal by Subject|0|||
27901106|NCT00475735|54557675|FG000|Treatment Period 1|DC due to AE but continuing|0|||
27901107|NCT00475735|54557676|FG001|Treatment Period 1|DC due to AE but continuing|0|||
27901108|NCT00475735|54557677|FG002|Treatment Period 1|DC due to AE but continuing|0|||
27901109|NCT00475735|54557678|FG003|Treatment Period 1|DC due to AE but continuing|1|||
27901110|NCT00475735|54557679|FG004|Treatment Period 1|DC due to AE but continuing|2|||
27901111|NCT00475735|54557680|FG005|Treatment Period 1|DC due to AE but continuing|2|||
27901112|NCT00475735|54557675|FG000|Treatment Period 1|DC due to no efficacy but Continuing|0|||
27901113|NCT00475735|54557676|FG001|Treatment Period 1|DC due to no efficacy but Continuing|1|||
27901114|NCT00475735|54557677|FG002|Treatment Period 1|DC due to no efficacy but Continuing|0|||
27901115|NCT00475735|54557678|FG003|Treatment Period 1|DC due to no efficacy but Continuing|0|||
27901116|NCT00475735|54557679|FG004|Treatment Period 1|DC due to no efficacy but Continuing|0|||
27901117|NCT00475735|54557680|FG005|Treatment Period 1|DC due to no efficacy but Continuing|0|||
27901118|NCT00475735|54557675|FG000|Treatment Washout|Lost to Follow-up|0|||
27901119|NCT00475735|54557676|FG001|Treatment Washout|Lost to Follow-up|1|||
27901120|NCT00475735|54557677|FG002|Treatment Washout|Lost to Follow-up|0|||
27901121|NCT00475735|54557678|FG003|Treatment Washout|Lost to Follow-up|0|||
27901122|NCT00475735|54557679|FG004|Treatment Washout|Lost to Follow-up|0|||
27986853|NCT00594906|54645320|FG001|Overall Study|Death|1|||
27986854|NCT00537979|54645328|FG000|Overall Study|Adverse Event|2|||
27986855|NCT00537979|54645329|FG001|Overall Study|Adverse Event|2|||
27986856|NCT00537979|54645328|FG000|Overall Study|Withdrawal by Subject|1|||
27986857|NCT00537979|54645329|FG001|Overall Study|Withdrawal by Subject|4|||
27986858|NCT00537979|54645328|FG000|Overall Study|Lost to Follow-up|1|||
27986859|NCT00537979|54645329|FG001|Overall Study|Lost to Follow-up|4|||
27986860|NCT00537979|54645328|FG000|Overall Study|Lack of Efficacy|0|||
27986861|NCT00537979|54645329|FG001|Overall Study|Lack of Efficacy|1|||
27986862|NCT00537979|54645328|FG000|Overall Study|Non-compliance with treatment/procedure|2|||
27986863|NCT00537979|54645329|FG001|Overall Study|Non-compliance with treatment/procedure|2|||
27986864|NCT00537979|54645328|FG000|Overall Study|Death|0|||
27986865|NCT00537979|54645329|FG001|Overall Study|Death|3|||
27986866|NCT00537979|54645328|FG000|Overall Study|Kidney transplant|0|||
27901123|NCT00475735|54557680|FG005|Treatment Washout|Lost to Follow-up|0|||
27901124|NCT00475735|54557675|FG000|Treatment Washout|Protocol Violation|0|||
27901125|NCT00475735|54557676|FG001|Treatment Washout|Protocol Violation|1|||
27901126|NCT00475735|54557677|FG002|Treatment Washout|Protocol Violation|0|||
27901127|NCT00475735|54557678|FG003|Treatment Washout|Protocol Violation|0|||
27901128|NCT00475735|54557679|FG004|Treatment Washout|Protocol Violation|0|||
27901129|NCT00475735|54557680|FG005|Treatment Washout|Protocol Violation|0|||
27901130|NCT00475735|54557675|FG000|Treatment Period 2|Adverse Event|0|||
27901131|NCT00475735|54557676|FG001|Treatment Period 2|Adverse Event|1|||
27901132|NCT00475735|54557677|FG002|Treatment Period 2|Adverse Event|0|||
27901133|NCT00475735|54557678|FG003|Treatment Period 2|Adverse Event|2|||
27901134|NCT00475735|54557679|FG004|Treatment Period 2|Adverse Event|0|||
27901135|NCT00475735|54557680|FG005|Treatment Period 2|Adverse Event|0|||
27901136|NCT00475735|54557675|FG000|Treatment Period 2|Lack of Efficacy|0|||
27901137|NCT00475735|54557676|FG001|Treatment Period 2|Lack of Efficacy|0|||
27901138|NCT00475735|54557677|FG002|Treatment Period 2|Lack of Efficacy|0|||
27901139|NCT00475735|54557678|FG003|Treatment Period 2|Lack of Efficacy|0|||
27901140|NCT00475735|54557679|FG004|Treatment Period 2|Lack of Efficacy|0|||
27901141|NCT00475735|54557680|FG005|Treatment Period 2|Lack of Efficacy|1|||
27901142|NCT00475735|54557675|FG000|Treatment Period 2|Withdrawal by Subject|0|||
27901143|NCT00475735|54557676|FG001|Treatment Period 2|Withdrawal by Subject|0|||
27901144|NCT00475735|54557677|FG002|Treatment Period 2|Withdrawal by Subject|0|||
27901145|NCT00475735|54557678|FG003|Treatment Period 2|Withdrawal by Subject|0|||
27901146|NCT00475735|54557679|FG004|Treatment Period 2|Withdrawal by Subject|1|||
27986867|NCT00537979|54645329|FG001|Overall Study|Kidney transplant|3|||
27986868|NCT00537979|54645328|FG000|Overall Study|Heart failure|0|||
27901147|NCT00475735|54557680|FG005|Treatment Period 2|Withdrawal by Subject|0|||
27901148|NCT00475657|54557688|FG000|Overall Study|Death|1|||
27901149|NCT00475657|54557688|FG000|Overall Study|Sponsor's Decision|3|||
27901150|NCT00475423|54557692|FG000|Overall Study|Protocol Violation|5|||
27901151|NCT00475423|54557692|FG000|Overall Study|Adverse Event|4|||
27901152|NCT00475423|54557692|FG000|Overall Study|Withdrawal by Subject|6|||
27901153|NCT00475423|54557692|FG000|Overall Study|Lack of Efficacy|8|||
27901154|NCT00475423|54557692|FG000|Overall Study|Death|1|||
27901155|NCT00475423|54557692|FG000|Overall Study|Reason not specified|1|||
27901156|NCT00475423|54557692|FG000|Overall Study|Lost to Follow-up|7|||
27901157|NCT00475306|54557700|FG000|Overall Study|Protocol Violation|1|||
27901158|NCT00475306|54557701|FG001|Overall Study|Protocol Violation|1|||
27901159|NCT00475306|54557702|FG002|Overall Study|Protocol Violation|0|||
27901160|NCT00475306|54557703|FG003|Overall Study|Protocol Violation|1|||
27901161|NCT00475228|54557715|FG000|Overall Study|Lost to Follow-up|17|||
27901162|NCT00475228|54557716|FG001|Overall Study|Lost to Follow-up|17|||
27901163|NCT00475033|54557728|FG000|Infant Series|Failed to return|3|||
27901164|NCT00475033|54557729|FG001|Infant Series|Failed to return|4|||
27901165|NCT00475033|54557728|FG000|Infant Series|Parent or legal guardian request|1|||
27901166|NCT00475033|54557729|FG001|Infant Series|Parent or legal guardian request|5|||
27901167|NCT00475033|54557728|FG000|Infant Series|Protocol Violation|1|||
27901168|NCT00475033|54557729|FG001|Infant Series|Protocol Violation|2|||
27901169|NCT00475033|54557728|FG000|Infant Series|Lost to Follow-up|2|||
27901170|NCT00475033|54557729|FG001|Infant Series|Lost to Follow-up|0|||
27986869|NCT00537979|54645329|FG001|Overall Study|Heart failure|1|||
27739477|NCT03745651|54189170|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
27739478|NCT03745651|54189171|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
27901171|NCT00475033|54557728|FG000|Infant Series|Adverse Event|0|||
27901172|NCT00475033|54557729|FG001|Infant Series|Adverse Event|2|||
27901173|NCT00475033|54557728|FG000|After the Infant Series|Adverse Event|0|||
27901174|NCT00475033|54557729|FG001|After the Infant Series|Adverse Event|4|||
27901175|NCT00475033|54557728|FG000|After the Infant Series|Parent or legal guardian request|2|||
27901176|NCT00475033|54557729|FG001|After the Infant Series|Parent or legal guardian request|2|||
27986870|NCT00537823|54645338|FG000|Overall Study|Adverse Event|2|||
27986871|NCT00537823|54645339|FG001|Overall Study|Adverse Event|0|||
27986872|NCT00537277|54645346|FG000|Overall Study|Adverse Event|1|||
27986873|NCT00537277|54645346|FG000|Overall Study|Lack of Efficacy|2|||
27986874|NCT00537277|54645346|FG000|Overall Study|Lost to Follow-up|12|||
27901177|NCT00475033|54557728|FG000|After the Infant Series|Failed to return|2|||
27901178|NCT00475033|54557729|FG001|After the Infant Series|Failed to return|1|||
27901179|NCT00475033|54557728|FG000|After the Infant Series|Protocol Violation|1|||
27901180|NCT00475033|54557729|FG001|After the Infant Series|Protocol Violation|0|||
27901181|NCT00475033|54557728|FG000|After the Infant Series|Lost to Follow-up|1|||
27901182|NCT00475033|54557729|FG001|After the Infant Series|Lost to Follow-up|0|||
27901183|NCT00475033|54557728|FG000|After the Infant Series|Other|0|||
27901184|NCT00475033|54557729|FG001|After the Infant Series|Other|1|||
27901185|NCT00475033|54557728|FG000|Toddler Dose|Parent or legal guardian request|2|||
27901186|NCT00475033|54557729|FG001|Toddler Dose|Parent or legal guardian request|0|||
27901187|NCT00475033|54557728|FG000|Toddler Dose|Failed to return|1|||
27901188|NCT00475033|54557729|FG001|Toddler Dose|Failed to return|0|||
27901189|NCT00475033|54557728|FG000|Toddler Dose|Lost to Follow-up|1|||
27901190|NCT00475033|54557729|FG001|Toddler Dose|Lost to Follow-up|0|||
27901191|NCT00474994|54557742|FG000|Overall Study|Patient Not treated|1|||
27901192|NCT00474994|54557742|FG000|Overall Study|Patient evaluable for toxicity only|3|||
27901193|NCT00474994|54557742|FG000|Overall Study|Patient found to be ineligible|1|||
27901194|NCT00474955|54557746|FG000|Overall Study|Adverse Event|2|||
27901195|NCT00474955|54557746|FG000|Overall Study|Drug unavailability|1|||
27901196|NCT00474955|54557746|FG000|Overall Study|Personal reasons|5|||
27901197|NCT00474487|54557754|FG000|Overall Study|Withdrawal by Subject|6|||
27901198|NCT00474487|54557755|FG001|Overall Study|Withdrawal by Subject|0|||
27901199|NCT00474487|54557756|FG002|Overall Study|Withdrawal by Subject|0|||
27901200|NCT00474487|54557757|FG003|Overall Study|Withdrawal by Subject|0|||
27901201|NCT00474487|54557754|FG000|Overall Study|Lost to Follow-up|20|||
27901202|NCT00474487|54557755|FG001|Overall Study|Lost to Follow-up|1|||
27901203|NCT00474487|54557756|FG002|Overall Study|Lost to Follow-up|7|||
27901204|NCT00474487|54557757|FG003|Overall Study|Lost to Follow-up|0|||
27901205|NCT00474487|54557754|FG000|Overall Study|Inappropriate enrollment|4|||
27901206|NCT00474487|54557755|FG001|Overall Study|Inappropriate enrollment|0|||
27901207|NCT00474487|54557756|FG002|Overall Study|Inappropriate enrollment|7|||
27901208|NCT00474487|54557757|FG003|Overall Study|Inappropriate enrollment|0|||
27901209|NCT00474487|54557754|FG000|Overall Study|Death|0|||
27901210|NCT00474487|54557755|FG001|Overall Study|Death|1|||
27901211|NCT00474487|54557756|FG002|Overall Study|Death|0|||
27901212|NCT00474487|54557757|FG003|Overall Study|Death|0|||
27901213|NCT00474253|54557769|FG000|Overall Study|Withdrew consent|2|||
27901214|NCT00474253|54557770|FG001|Overall Study|Withdrew consent|0|||
27901215|NCT00474253|54557769|FG000|Overall Study|Withdrew due to surgery-related issues|0|||
27901216|NCT00474253|54557770|FG001|Overall Study|Withdrew due to surgery-related issues|3|||
27901217|NCT00474253|54557769|FG000|Overall Study|Lost to Follow-up|1|||
27901218|NCT00474253|54557770|FG001|Overall Study|Lost to Follow-up|0|||
27901219|NCT00474253|54557769|FG000|Overall Study|Discharged prior to study completion|0|||
27901220|NCT00474253|54557770|FG001|Overall Study|Discharged prior to study completion|1|||
27901221|NCT00474058|54557778|FG000|Overall Study|Adverse Event|11|||
27901222|NCT00474058|54557779|FG001|Overall Study|Adverse Event|6|||
27901223|NCT00474058|54557778|FG000|Overall Study|Lack of Efficacy|0|||
27901224|NCT00474058|54557779|FG001|Overall Study|Lack of Efficacy|4|||
27901225|NCT00474058|54557778|FG000|Overall Study|Withdrawal by Subject|11|||
27901226|NCT00474058|54557779|FG001|Overall Study|Withdrawal by Subject|7|||
27901227|NCT00474058|54557778|FG000|Overall Study|Other|2|||
27901228|NCT00474058|54557779|FG001|Overall Study|Other|0|||
27901229|NCT00473824|54557787|FG000|Overall Study|Virologic Breakthrough|1|||
27901230|NCT00473824|54557788|FG001|Overall Study|Virologic Breakthrough|0|||
27901231|NCT00473824|54557787|FG000|Overall Study|Adverse Event|1|||
27901232|NCT00473824|54557788|FG001|Overall Study|Adverse Event|0|||
27901233|NCT00473824|54557787|FG000|Overall Study|Death|1|||
27901234|NCT00473824|54557788|FG001|Overall Study|Death|0|||
27901235|NCT00473824|54557787|FG000|Overall Study|Lost to Follow-up|1|||
27901236|NCT00473824|54557788|FG001|Overall Study|Lost to Follow-up|0|||
27901237|NCT00473824|54557787|FG000|Overall Study|Withdrawal by physician|1|||
27901238|NCT00473824|54557788|FG001|Overall Study|Withdrawal by physician|0|||
27901239|NCT00473746|54557799|FG000|Period 1 (Phase 1)|Adverse Event|1|||
27901240|NCT00473746|54557800|FG001|Period 1 (Phase 1)|Adverse Event|0|||
27901241|NCT00473746|54557801|FG002|Period 1 (Phase 1)|Adverse Event|0|||
27901242|NCT00473746|54557802|FG003|Period 1 (Phase 1)|Adverse Event|0|||
27901243|NCT00473746|54557803|FG004|Period 1 (Phase 1)|Adverse Event|0|||
27901244|NCT00473746|54557799|FG000|Period 1 (Phase 1)|Withdrawal by Subject|0|||
27901245|NCT00473746|54557800|FG001|Period 1 (Phase 1)|Withdrawal by Subject|1|||
27986875|NCT00537277|54645346|FG000|Overall Study|Protocol Violation|11|||
27901246|NCT00473746|54557801|FG002|Period 1 (Phase 1)|Withdrawal by Subject|0|||
27901247|NCT00473746|54557802|FG003|Period 1 (Phase 1)|Withdrawal by Subject|0|||
27901248|NCT00473746|54557803|FG004|Period 1 (Phase 1)|Withdrawal by Subject|0|||
27901249|NCT00473746|54557799|FG000|Period 1 (Phase 1)|Progressive Disease|5|||
27901250|NCT00473746|54557800|FG001|Period 1 (Phase 1)|Progressive Disease|6|||
27901251|NCT00473746|54557801|FG002|Period 1 (Phase 1)|Progressive Disease|6|||
27901252|NCT00473746|54557802|FG003|Period 1 (Phase 1)|Progressive Disease|10|||
27986876|NCT00537277|54645346|FG000|Overall Study|Unclassified|4|||
27901253|NCT00473746|54557803|FG004|Period 1 (Phase 1)|Progressive Disease|0|||
27901254|NCT00473746|54557799|FG000|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
27901255|NCT00473746|54557800|FG001|Period 1 (Phase 1)|Symptomatic Deterioration|1|||
27901256|NCT00473746|54557801|FG002|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
27901257|NCT00473746|54557802|FG003|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
27901258|NCT00473746|54557803|FG004|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
27901259|NCT00473746|54557799|FG000|Period 1 (Phase 1)|Reason not specified|0|||
27901260|NCT00473746|54557800|FG001|Period 1 (Phase 1)|Reason not specified|1|||
27901261|NCT00473746|54557801|FG002|Period 1 (Phase 1)|Reason not specified|0|||
27901262|NCT00473746|54557802|FG003|Period 1 (Phase 1)|Reason not specified|0|||
27901263|NCT00473746|54557803|FG004|Period 1 (Phase 1)|Reason not specified|0|||
27901264|NCT00473746|54557799|FG000|Period 2 (Phase 2)|Adverse Event|0|||
27901265|NCT00473746|54557800|FG001|Period 2 (Phase 2)|Adverse Event|0|||
27901266|NCT00473746|54557801|FG002|Period 2 (Phase 2)|Adverse Event|0|||
27901267|NCT00473746|54557802|FG003|Period 2 (Phase 2)|Adverse Event|0|||
27901268|NCT00473746|54557803|FG004|Period 2 (Phase 2)|Adverse Event|3|||
27901269|NCT00473746|54557799|FG000|Period 2 (Phase 2)|Death|0|||
27901270|NCT00473746|54557800|FG001|Period 2 (Phase 2)|Death|0|||
27901271|NCT00473746|54557801|FG002|Period 2 (Phase 2)|Death|0|||
27901272|NCT00473746|54557802|FG003|Period 2 (Phase 2)|Death|0|||
27901273|NCT00473746|54557803|FG004|Period 2 (Phase 2)|Death|1|||
27901274|NCT00473746|54557799|FG000|Period 2 (Phase 2)|Progressive Disease|0|||
27901275|NCT00473746|54557800|FG001|Period 2 (Phase 2)|Progressive Disease|0|||
27901276|NCT00473746|54557801|FG002|Period 2 (Phase 2)|Progressive Disease|0|||
27901277|NCT00473746|54557802|FG003|Period 2 (Phase 2)|Progressive Disease|0|||
27901278|NCT00473746|54557803|FG004|Period 2 (Phase 2)|Progressive Disease|20|||
27901279|NCT00473746|54557799|FG000|Period 2 (Phase 2)|Reason not specified|0|||
27901280|NCT00473746|54557800|FG001|Period 2 (Phase 2)|Reason not specified|0|||
27901281|NCT00473746|54557801|FG002|Period 2 (Phase 2)|Reason not specified|0|||
27901282|NCT00473746|54557802|FG003|Period 2 (Phase 2)|Reason not specified|0|||
27901283|NCT00473746|54557803|FG004|Period 2 (Phase 2)|Reason not specified|3|||
27901284|NCT00473668|54557820|FG000|Overall Study|Withdrawal by Subject|0|||
27901285|NCT00473668|54557821|FG001|Overall Study|Withdrawal by Subject|2|||
27901286|NCT00473668|54557822|FG002|Overall Study|Withdrawal by Subject|0|||
27901287|NCT00473668|54557820|FG000|Overall Study|Migrated/moved from study area|3|||
27901288|NCT00473668|54557821|FG001|Overall Study|Migrated/moved from study area|2|||
27901289|NCT00473668|54557822|FG002|Overall Study|Migrated/moved from study area|0|||
27901290|NCT00473668|54557820|FG000|Overall Study|Lost to Follow-up|0|||
27901291|NCT00473668|54557821|FG001|Overall Study|Lost to Follow-up|4|||
27901292|NCT00473668|54557822|FG002|Overall Study|Lost to Follow-up|6|||
27901293|NCT00473668|54557820|FG000|Overall Study|Other|2|||
27901294|NCT00473668|54557821|FG001|Overall Study|Other|3|||
27901295|NCT00473668|54557822|FG002|Overall Study|Other|4|||
27901296|NCT00473590|54557832|FG000|Overall Study|Adverse Event|3|||
27901297|NCT00473590|54557833|FG001|Overall Study|Adverse Event|3|||
27901298|NCT00473590|54557832|FG000|Overall Study|Death|4|||
27901299|NCT00473590|54557833|FG001|Overall Study|Death|2|||
27901300|NCT00473590|54557832|FG000|Overall Study|Progression not resulting in death|24|||
27901301|NCT00473590|54557833|FG001|Overall Study|Progression not resulting in death|20|||
27901302|NCT00473590|54557832|FG000|Overall Study|Non-protocol-specified therapy|7|||
27901303|NCT00473590|54557833|FG001|Overall Study|Non-protocol-specified therapy|5|||
27901304|NCT00473590|54557832|FG000|Overall Study|Physician Decision|2|||
27901305|NCT00473590|54557833|FG001|Overall Study|Physician Decision|4|||
27901306|NCT00473590|54557832|FG000|Overall Study|Withdrawal by Subject|5|||
27901307|NCT00473590|54557833|FG001|Overall Study|Withdrawal by Subject|3|||
27901308|NCT00473590|54557832|FG000|Overall Study|Other|0|||
27901309|NCT00473590|54557833|FG001|Overall Study|Other|1|||
27901310|NCT00473512|54557844|FG000|Period 1 (Phase 1)|Adverse Event|0|||
27901311|NCT00473512|54557845|FG001|Period 1 (Phase 1)|Adverse Event|0|||
27901312|NCT00473512|54557846|FG002|Period 1 (Phase 1)|Adverse Event|0|||
27901313|NCT00473512|54557847|FG003|Period 1 (Phase 1)|Adverse Event|5|||
27901314|NCT00473512|54557848|FG004|Period 1 (Phase 1)|Adverse Event|0|||
27901315|NCT00473512|54557844|FG000|Period 1 (Phase 1)|Death|0|||
27901316|NCT00473512|54557845|FG001|Period 1 (Phase 1)|Death|0|||
27901317|NCT00473512|54557846|FG002|Period 1 (Phase 1)|Death|0|||
27901318|NCT00473512|54557847|FG003|Period 1 (Phase 1)|Death|1|||
27901319|NCT00473512|54557848|FG004|Period 1 (Phase 1)|Death|0|||
27901320|NCT00473512|54557844|FG000|Period 1 (Phase 1)|Disease Progression|1|||
27901321|NCT00473512|54557845|FG001|Period 1 (Phase 1)|Disease Progression|1|||
27901322|NCT00473512|54557846|FG002|Period 1 (Phase 1)|Disease Progression|0|||
27901323|NCT00473512|54557847|FG003|Period 1 (Phase 1)|Disease Progression|10|||
27901324|NCT00473512|54557848|FG004|Period 1 (Phase 1)|Disease Progression|1|||
27901325|NCT00473512|54557844|FG000|Period 1 (Phase 1)|Other|0|||
27901326|NCT00473512|54557845|FG001|Period 1 (Phase 1)|Other|0|||
27901327|NCT00473512|54557846|FG002|Period 1 (Phase 1)|Other|0|||
27901328|NCT00473512|54557847|FG003|Period 1 (Phase 1)|Other|1|||
27901329|NCT00473512|54557848|FG004|Period 1 (Phase 1)|Other|0|||
27901330|NCT00473512|54557844|FG000|Period 2 (Phase 2)|Adverse Event|0|||
27901331|NCT00473512|54557845|FG001|Period 2 (Phase 2)|Adverse Event|0|||
27901332|NCT00473512|54557846|FG002|Period 2 (Phase 2)|Adverse Event|0|||
27901333|NCT00473512|54557847|FG003|Period 2 (Phase 2)|Adverse Event|1|||
27901334|NCT00473512|54557848|FG004|Period 2 (Phase 2)|Adverse Event|0|||
27901335|NCT00473512|54557844|FG000|Period 2 (Phase 2)|Death|0|||
27901336|NCT00473512|54557845|FG001|Period 2 (Phase 2)|Death|0|||
27901337|NCT00473512|54557846|FG002|Period 2 (Phase 2)|Death|0|||
27901338|NCT00473512|54557847|FG003|Period 2 (Phase 2)|Death|1|||
27901339|NCT00473512|54557848|FG004|Period 2 (Phase 2)|Death|1|||
27901340|NCT00473512|54557844|FG000|Period 2 (Phase 2)|Disease Progression|0|||
27901341|NCT00473512|54557845|FG001|Period 2 (Phase 2)|Disease Progression|2|||
27901342|NCT00473512|54557846|FG002|Period 2 (Phase 2)|Disease Progression|2|||
27901343|NCT00473512|54557847|FG003|Period 2 (Phase 2)|Disease Progression|17|||
27901344|NCT00473512|54557848|FG004|Period 2 (Phase 2)|Disease Progression|1|||
27901345|NCT00473512|54557844|FG000|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
27901346|NCT00473512|54557845|FG001|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
27901347|NCT00473512|54557846|FG002|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
27901348|NCT00473512|54557847|FG003|Period 2 (Phase 2)|Symptomatic Deterioration|1|||
27901349|NCT00473512|54557848|FG004|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
27901350|NCT00473512|54557844|FG000|Period 2 (Phase 2)|Other|1|||
27901351|NCT00473512|54557845|FG001|Period 2 (Phase 2)|Other|0|||
27901352|NCT00473512|54557846|FG002|Period 2 (Phase 2)|Other|0|||
27901353|NCT00473512|54557847|FG003|Period 2 (Phase 2)|Other|3|||
27901354|NCT00473512|54557848|FG004|Period 2 (Phase 2)|Other|0|||
27901355|NCT00473434|54557868|FG000|Overall Study|Physician Decision|3|||
27901356|NCT00473434|54557868|FG000|Overall Study|Withdrawal by Subject|9|||
27901357|NCT00473434|54557868|FG000|Overall Study|Compliance|3|||
27901358|NCT00473434|54557868|FG000|Overall Study|Lack of Efficacy|3|||
27901359|NCT00473434|54557868|FG000|Overall Study|Adverse Event|3|||
27901360|NCT00473434|54557868|FG000|Overall Study|Patient was selling medication to others|1|||
27901361|NCT00473434|54557868|FG000|Overall Study|Safety evaluation|1|||
27901362|NCT00473434|54557868|FG000|Overall Study|Reason not specified|6|||
27901363|NCT00473434|54557868|FG000|Overall Study|Ceased in favor of Paliperidone|1|||
27901364|NCT00473434|54557868|FG000|Overall Study|Switching to trial medication|1|||
27901365|NCT00473434|54557868|FG000|Overall Study|No longer required|1|||
27901366|NCT00473083|54557888|FG000|Overall Study|Adverse Event|1|||
27901367|NCT00473083|54557889|FG001|Overall Study|Adverse Event|0|||
27901368|NCT00473083|54557890|FG002|Overall Study|Adverse Event|0|||
27901369|NCT00472420|54557901|FG000|Induction Treatment Period|Physician Decision|9|||
27901370|NCT00472420|54557901|FG000|Induction Treatment Period|Adverse Event|3|||
27901371|NCT00472420|54557901|FG000|Induction Treatment Period|Non-compliance|1|||
27901372|NCT00472420|54557901|FG000|Induction Treatment Period|Death|3|||
27901373|NCT00472420|54557901|FG000|Follow-up Period|Death|5|||
27901374|NCT00472420|54557901|FG000|Follow-up Period|Physician Decision|9|||
27901375|NCT00472420|54557901|FG000|Follow-up Period|Lost to Follow-up|2|||
27901376|NCT00472420|54557901|FG000|Follow-up Period|Protocol Violation|1|||
27901377|NCT00472303|54557907|FG000|Titration Phase|Adverse Event|22|||
27986877|NCT00537277|54645346|FG000|Overall Study|Inability to tolerate trial medication|4|||
27986878|NCT00537277|54645346|FG000|Overall Study|Non-compliance with trial procedures|15|||
27986879|NCT00537199|54645350|FG000|Overall Study|Study Terminated|1|||
27986880|NCT03898063|54645356|FG000|Overall Study|Withdrawal by Subject|10|||
27986881|NCT03898063|54645357|FG001|Overall Study|Withdrawal by Subject|8|||
27986882|NCT00873912|54645365|FG000|Overall Study|Withdrawal by Subject|1|||
27986883|NCT00873912|54645366|FG001|Overall Study|Withdrawal by Subject|0|||
27986884|NCT00873912|54645365|FG000|Overall Study|Lost to Follow-up|2|||
27986885|NCT00873912|54645366|FG001|Overall Study|Lost to Follow-up|0|||
27986886|NCT03823300|54645378|FG000|Overall Study|Withdrawal by Subject|16|||
27986887|NCT03823300|54645379|FG001|Overall Study|Withdrawal by Subject|22|||
27986888|NCT03823300|54645378|FG000|Overall Study|Death|10|||
27986889|NCT03823300|54645379|FG001|Overall Study|Death|14|||
27986890|NCT03823300|54645378|FG000|Overall Study|Adverse Event|3|||
27901378|NCT00472303|54557908|FG001|Titration Phase|Adverse Event|12|||
27901379|NCT00472303|54557909|FG002|Titration Phase|Adverse Event|0|||
27901380|NCT00472303|54557907|FG000|Titration Phase|Death|4|||
27901381|NCT00472303|54557908|FG001|Titration Phase|Death|2|||
27901382|NCT00472303|54557909|FG002|Titration Phase|Death|0|||
27901383|NCT00472303|54557907|FG000|Titration Phase|Lack of Efficacy|10|||
27901384|NCT00472303|54557908|FG001|Titration Phase|Lack of Efficacy|0|||
27901385|NCT00472303|54557909|FG002|Titration Phase|Lack of Efficacy|0|||
27901386|NCT00472303|54557907|FG000|Titration Phase|Withdrawal by Subject|16|||
27901387|NCT00472303|54557908|FG001|Titration Phase|Withdrawal by Subject|13|||
27901388|NCT00472303|54557909|FG002|Titration Phase|Withdrawal by Subject|0|||
27901389|NCT00472303|54557907|FG000|Titration Phase|Trial Medication non-compliant|4|||
27986891|NCT03823300|54645379|FG001|Overall Study|Adverse Event|5|||
27986892|NCT03823300|54645378|FG000|Overall Study|Physician Decision|1|||
27986893|NCT03823300|54645379|FG001|Overall Study|Physician Decision|7|||
27986894|NCT03823300|54645378|FG000|Overall Study|Lost to Follow-up|1|||
27986895|NCT03823300|54645379|FG001|Overall Study|Lost to Follow-up|3|||
27986896|NCT03823300|54645378|FG000|Overall Study|Protocol Violation|1|||
27901390|NCT00472303|54557908|FG001|Titration Phase|Trial Medication non-compliant|1|||
27901391|NCT00472303|54557909|FG002|Titration Phase|Trial Medication non-compliant|0|||
27901392|NCT00472303|54557907|FG000|Titration Phase|Other|3|||
27901393|NCT00472303|54557908|FG001|Titration Phase|Other|1|||
27901394|NCT00472303|54557909|FG002|Titration Phase|Other|0|||
27901395|NCT00472303|54557907|FG000|Discontinuations After Titration Phase|Adverse Event|6|||
27901396|NCT00472303|54557908|FG001|Discontinuations After Titration Phase|Adverse Event|0|||
27901397|NCT00472303|54557909|FG002|Discontinuations After Titration Phase|Adverse Event|0|||
27901398|NCT00472303|54557907|FG000|Discontinuations After Titration Phase|Lack of Efficacy|48|||
27901399|NCT00472303|54557908|FG001|Discontinuations After Titration Phase|Lack of Efficacy|17|||
27901400|NCT00472303|54557909|FG002|Discontinuations After Titration Phase|Lack of Efficacy|0|||
27901401|NCT00472303|54557907|FG000|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
27901402|NCT00472303|54557908|FG001|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
27901403|NCT00472303|54557909|FG002|Discontinuations After Titration Phase|Withdrawal by Subject|0|||
27901404|NCT00472303|54557907|FG000|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
27901405|NCT00472303|54557908|FG001|Discontinuations After Titration Phase|Trial Medication non-compliant|1|||
27901406|NCT00472303|54557909|FG002|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
27901407|NCT00472303|54557907|FG000|Discontinuations After Titration Phase|Other|5|||
27901408|NCT00472303|54557908|FG001|Discontinuations After Titration Phase|Other|0|||
27901409|NCT00472303|54557909|FG002|Discontinuations After Titration Phase|Other|0|||
27901410|NCT00472303|54557907|FG000|Maintenance Phase|Adverse Event|5|||
27901411|NCT00472303|54557908|FG001|Maintenance Phase|Adverse Event|6|||
27901412|NCT00472303|54557909|FG002|Maintenance Phase|Adverse Event|6|||
27901413|NCT00472303|54557907|FG000|Maintenance Phase|Death|3|||
27901414|NCT00472303|54557908|FG001|Maintenance Phase|Death|0|||
27901415|NCT00472303|54557909|FG002|Maintenance Phase|Death|2|||
27901416|NCT00472303|54557907|FG000|Maintenance Phase|Lack of Efficacy|2|||
27901417|NCT00472303|54557908|FG001|Maintenance Phase|Lack of Efficacy|2|||
27901418|NCT00472303|54557909|FG002|Maintenance Phase|Lack of Efficacy|4|||
27901419|NCT00472303|54557907|FG000|Maintenance Phase|Withdrawal by Subject|6|||
27901420|NCT00472303|54557908|FG001|Maintenance Phase|Withdrawal by Subject|7|||
27901421|NCT00472303|54557909|FG002|Maintenance Phase|Withdrawal by Subject|3|||
27901422|NCT00472303|54557907|FG000|Maintenance Phase|Trial medication non-compliant|0|||
27901423|NCT00472303|54557908|FG001|Maintenance Phase|Trial medication non-compliant|0|||
27901424|NCT00472303|54557909|FG002|Maintenance Phase|Trial medication non-compliant|1|||
27901425|NCT00472303|54557907|FG000|Maintenance Phase|Resolution of pain|0|||
27901426|NCT00472303|54557908|FG001|Maintenance Phase|Resolution of pain|0|||
27901427|NCT00472303|54557909|FG002|Maintenance Phase|Resolution of pain|1|||
27901428|NCT00472303|54557907|FG000|Maintenance Phase|Other|1|||
27901429|NCT00472303|54557908|FG001|Maintenance Phase|Other|1|||
27901430|NCT00472303|54557909|FG002|Maintenance Phase|Other|0|||
27901431|NCT00471718|54557937|FG000|Overall Study|Adverse Event|3|||
27901432|NCT00471718|54557937|FG000|Overall Study|other complicating disease|1|||
27901433|NCT00471718|54557937|FG000|Overall Study|disease progression|22|||
27901434|NCT00471718|54557937|FG000|Overall Study|Withdrawal by Subject|1|||
27901435|NCT00471445|54557947|FG000|Overall Study|Withdrawal by Subject|1|||
27901436|NCT00471445|54557948|FG001|Overall Study|Withdrawal by Subject|1|||
27901437|NCT00471445|54557947|FG000|Overall Study|Ineligible|1|||
27901438|NCT00471445|54557948|FG001|Overall Study|Ineligible|0|||
27901439|NCT00471445|54557947|FG000|Overall Study|Protocol Violation|0|||
27901440|NCT00471445|54557948|FG001|Overall Study|Protocol Violation|1|||
27901441|NCT00471328|54557956|FG000|Core Phase|Adverse Event|18|||
27901442|NCT00471328|54557957|FG001|Core Phase|Adverse Event|6|||
27901443|NCT00471328|54557956|FG000|Core Phase|Death|8|||
27901444|NCT00471328|54557957|FG001|Core Phase|Death|4|||
27901445|NCT00471328|54557956|FG000|Core Phase|Withdrawal by Subject|2|||
27901446|NCT00471328|54557957|FG001|Core Phase|Withdrawal by Subject|2|||
27901447|NCT00471328|54557956|FG000|Core Phase|Abnormal laboratory value|1|||
27901448|NCT00471328|54557957|FG001|Core Phase|Abnormal laboratory value|0|||
27901449|NCT00471328|54557956|FG000|Core Phase|Disease Progression|78|||
27986897|NCT03823300|54645379|FG001|Overall Study|Protocol Violation|1|||
27986898|NCT03823300|54645378|FG000|Overall Study|Lack of Efficacy|1|||
28172194|NCT02440594|54843783|FG007|Overall Study|Administratively w/drawn|1|||
27901450|NCT00471328|54557957|FG001|Core Phase|Disease Progression|53|||
27901451|NCT00471328|54557956|FG000|Core Phase|Administrative Problem|0|||
27901452|NCT00471328|54557957|FG001|Core Phase|Administrative Problem|1|||
27901453|NCT00471328|54557956|FG000|Core Phase|Protocol Deviation|0|||
27901454|NCT00471328|54557957|FG001|Core Phase|Protocol Deviation|1|||
27901455|NCT00471328|54557956|FG000|Extension Phase|Adverse Event|3|||
27901456|NCT00471328|54557957|FG001|Extension Phase|Adverse Event|12|||
27901457|NCT00471328|54557956|FG000|Extension Phase|Withdrawal by Subject|0|||
27901458|NCT00471328|54557957|FG001|Extension Phase|Withdrawal by Subject|2|||
27901459|NCT00471328|54557956|FG000|Extension Phase|Death|1|||
27901460|NCT00471328|54557957|FG001|Extension Phase|Death|7|||
27901461|NCT00471328|54557956|FG000|Extension Phase|Protocol Deviation|3|||
27986899|NCT03823300|54645379|FG001|Overall Study|Lack of Efficacy|1|||
27901462|NCT00471328|54557957|FG001|Extension Phase|Protocol Deviation|1|||
27901463|NCT00471328|54557956|FG000|Extension Phase|Treatment duration as per protocol|0|||
27901464|NCT00471328|54557957|FG001|Extension Phase|Treatment duration as per protocol|1|||
27901465|NCT00471328|54557956|FG000|Extension Phase|Disease Progression|32|||
27901466|NCT00471328|54557957|FG001|Extension Phase|Disease Progression|44|||
27901467|NCT00471328|54557956|FG000|Extension Phase|New cancer Therapy|1|||
27901468|NCT00471328|54557957|FG001|Extension Phase|New cancer Therapy|0|||
27901469|NCT00471328|54557956|FG000|Extension Phase|Administrative Problem|1|||
27901470|NCT00471328|54557957|FG001|Extension Phase|Administrative Problem|0|||
27901471|NCT00470470|54557965|FG000|Overall Study|Adverse Event|2|||
27901472|NCT00470470|54557965|FG000|Overall Study|Death|2|||
27901473|NCT00470470|54557965|FG000|Overall Study|Not treated|1|||
27901474|NCT00470275|54557969|FG000|Overall Study|Death|1|||
27901475|NCT00470275|54557969|FG000|Overall Study|Lack of Efficacy|7|||
27901476|NCT00470275|54557969|FG000|Overall Study|Withdrawal by Subject|2|||
27901477|NCT00470158|54557978|FG000|Overall Study|Death|0|||
27901478|NCT00470158|54557979|FG001|Overall Study|Death|0|||
27901479|NCT00470158|54557980|FG002|Overall Study|Death|0|||
27901480|NCT00470158|54557981|FG003|Overall Study|Death|0|||
27901481|NCT00470158|54557982|FG004|Overall Study|Death|2|||
27901482|NCT00470158|54557978|FG000|Overall Study|Lost to Follow-up|7|||
27901483|NCT00470158|54557979|FG001|Overall Study|Lost to Follow-up|8|||
27901484|NCT00470158|54557980|FG002|Overall Study|Lost to Follow-up|8|||
27901485|NCT00470158|54557981|FG003|Overall Study|Lost to Follow-up|5|||
27901486|NCT00470158|54557982|FG004|Overall Study|Lost to Follow-up|4|||
27901487|NCT00470158|54557978|FG000|Overall Study|Protocol Violation|1|||
27901488|NCT00470158|54557979|FG001|Overall Study|Protocol Violation|0|||
28172195|NCT03836001|54843810|FG000|Blinded Phase (2 Months)|Adverse Event|0|||
28172196|NCT03836001|54843811|FG001|Blinded Phase (2 Months)|Adverse Event|1|||
28172197|NCT03836001|54843812|FG002|Blinded Phase (2 Months)|Adverse Event|0|||
28172198|NCT03836001|54843810|FG000|Blinded Phase (2 Months)|Physician Decision|0|||
28172199|NCT03836001|54843811|FG001|Blinded Phase (2 Months)|Physician Decision|1|||
28172200|NCT03836001|54843812|FG002|Blinded Phase (2 Months)|Physician Decision|0|||
27901489|NCT00470158|54557980|FG002|Overall Study|Protocol Violation|0|||
27901490|NCT00470158|54557981|FG003|Overall Study|Protocol Violation|0|||
28097349|NCT04375878|54752922|FG004|Extension Phase|Withdrawal by Subject|1|||
28097350|NCT04375878|54752923|FG005|Extension Phase|Withdrawal by Subject|0|||
27901491|NCT00470158|54557982|FG004|Overall Study|Protocol Violation|0|||
27901492|NCT00475540|54557996|FG000|36 Months|Lost to Follow-up|4|||
27901493|NCT00475540|54557997|FG001|36 Months|Lost to Follow-up|4|||
27901494|NCT00475540|54557996|FG000|36 Months|Death|1|||
27901495|NCT00475540|54557997|FG001|36 Months|Death|2|||
27901496|NCT00475540|54557996|FG000|36 Months|Censored due to reoperation|3|||
27901497|NCT00475540|54557997|FG001|36 Months|Censored due to reoperation|0|||
27901498|NCT00472186|54558005|FG000|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|1|||
27901499|NCT00472186|54558006|FG001|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|0|||
27901500|NCT00479713|54558016|FG000|Overall Study|Adverse Event|8|||
27901501|NCT00479713|54558017|FG001|Overall Study|Adverse Event|6|||
27901502|NCT00479713|54558016|FG000|Overall Study|Death|1|||
27901503|NCT00479713|54558017|FG001|Overall Study|Death|0|||
28097351|NCT04189224|54752943|FG000|Period 2|Adverse Event|0|||
28097352|NCT04189224|54752944|FG001|Period 2|Adverse Event|1|||
28097353|NCT04186806|54752952|FG000|Period 1: 7 Days|Adverse Event|1|||
28097354|NCT04186806|54752953|FG001|Period 1: 7 Days|Adverse Event|0|||
28097355|NCT04041414|54752962|FG000|Overall Study|Lost to Follow-up|1|||
28097356|NCT04041414|54752963|FG001|Overall Study|Lost to Follow-up|2|||
28097357|NCT04370028|54752972|FG000|Overall Study|Withdrawal by Subject|695|||
28097358|NCT04370028|54752972|FG000|Overall Study|Protocol Violation|9|||
28097359|NCT04370028|54752972|FG000|Overall Study|Adverse Event|3|||
28097360|NCT04037748|54752985|FG000|Treatment Period 1|Withdrawal by Subject|3|||
28097361|NCT04037748|54752986|FG001|Treatment Period 1|Withdrawal by Subject|0|||
28097362|NCT04037748|54752985|FG000|Treatment Period 1|Adverse Event|1|||
28097363|NCT04037748|54752986|FG001|Treatment Period 1|Adverse Event|1|||
28097364|NCT04037748|54752985|FG000|Treatment Period 1|Protocol Violation|4|||
28172201|NCT03836001|54843810|FG000|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
28172202|NCT03836001|54843811|FG001|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
27901504|NCT00479713|54558016|FG000|Overall Study|Lost to Follow-up|0|||
27901505|NCT00479713|54558017|FG001|Overall Study|Lost to Follow-up|1|||
27901506|NCT00479713|54558016|FG000|Overall Study|Protocol Violation|0|||
27901507|NCT00479713|54558017|FG001|Overall Study|Protocol Violation|1|||
27901508|NCT00479713|54558016|FG000|Overall Study|Withdrawal by Subject|4|||
27901509|NCT00479713|54558017|FG001|Overall Study|Withdrawal by Subject|1|||
27901510|NCT00474526|54558049|FG000|Overall Study|ADMINISTRATIVE REASON|11|||
27901511|NCT00474526|54558050|FG001|Overall Study|ADMINISTRATIVE REASON|9|||
27901512|NCT00474526|54558051|FG002|Overall Study|ADMINISTRATIVE REASON|9|||
28097365|NCT04037748|54752986|FG001|Treatment Period 1|Protocol Violation|5|||
28097366|NCT04037748|54752985|FG000|Treatment Period 2|Adverse Event|0|||
28097367|NCT04037748|54752986|FG001|Treatment Period 2|Adverse Event|1|||
27901513|NCT00474526|54558052|FG003|Overall Study|ADMINISTRATIVE REASON|20|||
27901514|NCT00474526|54558053|FG004|Overall Study|ADMINISTRATIVE REASON|9|||
27901515|NCT00474526|54558054|FG005|Overall Study|ADMINISTRATIVE REASON|1|||
27901516|NCT00474526|54558055|FG006|Overall Study|ADMINISTRATIVE REASON|1|||
27901517|NCT00474526|54558056|FG007|Overall Study|ADMINISTRATIVE REASON|0|||
27901518|NCT00474526|54558057|FG008|Overall Study|ADMINISTRATIVE REASON|2|||
27901519|NCT00474526|54558058|FG009|Overall Study|ADMINISTRATIVE REASON|1|||
27901520|NCT00474526|54558059|FG010|Overall Study|ADMINISTRATIVE REASON|1|||
27986900|NCT03823300|54645378|FG000|Overall Study|Not Eligible|0|||
27986901|NCT03823300|54645379|FG001|Overall Study|Not Eligible|1|||
27986902|NCT03823300|54645378|FG000|Overall Study|Other|1|||
27986903|NCT03823300|54645379|FG001|Overall Study|Other|0|||
27986904|NCT00537745|54645385|FG000|Overall Study|Did not meet eligibility criteria|2|||
27986905|NCT00537745|54645385|FG000|Overall Study|Withdrawal by Subject|2|||
27986906|NCT00537745|54645385|FG000|Overall Study|Subject unable to provide Interlock info|1|||
27986907|NCT00874848|54645392|FG000|Overall Study|Adverse Event|13|||
27986908|NCT00874848|54645393|FG001|Overall Study|Adverse Event|2|||
27986909|NCT00874848|54645392|FG000|Overall Study|Progressive neoplastic disease|38|||
27986910|NCT00874848|54645393|FG001|Overall Study|Progressive neoplastic disease|18|||
27986911|NCT00874848|54645392|FG000|Overall Study|Withdrawal by Subject|7|||
27986912|NCT00874848|54645393|FG001|Overall Study|Withdrawal by Subject|4|||
27986913|NCT00874848|54645392|FG000|Overall Study|Noncompliance|1|||
27986914|NCT00874848|54645393|FG001|Overall Study|Noncompliance|1|||
27986915|NCT00874848|54645392|FG000|Overall Study|Failure to comply with protocol|0|||
28097368|NCT04037748|54752985|FG000|Treatment Period 2|Protocol Violation|2|||
27901521|NCT00474526|54558060|FG011|Overall Study|ADMINISTRATIVE REASON|1|||
27901522|NCT00474526|54558061|FG012|Overall Study|ADMINISTRATIVE REASON|1|||
27901523|NCT00474526|54558062|FG013|Overall Study|ADMINISTRATIVE REASON|1|||
27901524|NCT00474526|54558063|FG014|Overall Study|ADMINISTRATIVE REASON|2|||
27901525|NCT00474526|54558064|FG015|Overall Study|ADMINISTRATIVE REASON|0|||
27901526|NCT00474526|54558065|FG016|Overall Study|ADMINISTRATIVE REASON|0|||
27901527|NCT00474526|54558049|FG000|Overall Study|Adverse Event|2|||
27901528|NCT00474526|54558050|FG001|Overall Study|Adverse Event|0|||
27901529|NCT00474526|54558051|FG002|Overall Study|Adverse Event|2|||
27901530|NCT00474526|54558052|FG003|Overall Study|Adverse Event|4|||
27901531|NCT00474526|54558053|FG004|Overall Study|Adverse Event|2|||
27901532|NCT00474526|54558054|FG005|Overall Study|Adverse Event|1|||
27901533|NCT00474526|54558055|FG006|Overall Study|Adverse Event|1|||
27901534|NCT00474526|54558056|FG007|Overall Study|Adverse Event|0|||
27901535|NCT00474526|54558057|FG008|Overall Study|Adverse Event|0|||
27901536|NCT00474526|54558058|FG009|Overall Study|Adverse Event|0|||
27901537|NCT00474526|54558059|FG010|Overall Study|Adverse Event|0|||
27901538|NCT00474526|54558060|FG011|Overall Study|Adverse Event|0|||
27901539|NCT00474526|54558061|FG012|Overall Study|Adverse Event|0|||
27901540|NCT00474526|54558062|FG013|Overall Study|Adverse Event|0|||
27901541|NCT00474526|54558063|FG014|Overall Study|Adverse Event|1|||
27901542|NCT00474526|54558064|FG015|Overall Study|Adverse Event|1|||
27901543|NCT00474526|54558065|FG016|Overall Study|Adverse Event|0|||
27901544|NCT00474526|54558049|FG000|Overall Study|Death|0|||
27901545|NCT00474526|54558050|FG001|Overall Study|Death|0|||
27901546|NCT00474526|54558051|FG002|Overall Study|Death|0|||
27901547|NCT00474526|54558052|FG003|Overall Study|Death|0|||
27901548|NCT00474526|54558053|FG004|Overall Study|Death|0|||
27901549|NCT00474526|54558054|FG005|Overall Study|Death|0|||
27901550|NCT00474526|54558055|FG006|Overall Study|Death|0|||
27901551|NCT00474526|54558056|FG007|Overall Study|Death|0|||
27901552|NCT00474526|54558057|FG008|Overall Study|Death|0|||
27901553|NCT00474526|54558058|FG009|Overall Study|Death|0|||
27901554|NCT00474526|54558059|FG010|Overall Study|Death|0|||
27901555|NCT00474526|54558060|FG011|Overall Study|Death|0|||
27901556|NCT00474526|54558061|FG012|Overall Study|Death|0|||
27901557|NCT00474526|54558062|FG013|Overall Study|Death|3|||
28097369|NCT04037748|54752986|FG001|Treatment Period 2|Protocol Violation|0|||
28097370|NCT04036110|54752995|FG000|Overall Study|Lost to Follow-up|3|||
27901558|NCT00474526|54558063|FG014|Overall Study|Death|0|||
27901559|NCT00474526|54558064|FG015|Overall Study|Death|0|||
27901560|NCT00474526|54558065|FG016|Overall Study|Death|0|||
27901561|NCT00474526|54558049|FG000|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
27901562|NCT00474526|54558050|FG001|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
27901563|NCT00474526|54558051|FG002|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
27901564|NCT00474526|54558052|FG003|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
27901565|NCT00474526|54558053|FG004|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
27901566|NCT00474526|54558054|FG005|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
27901567|NCT00474526|54558055|FG006|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
27986916|NCT00874848|54645393|FG001|Overall Study|Failure to comply with protocol|1|||
27986917|NCT00874848|54645392|FG000|Overall Study|Physician Decision|0|||
27986918|NCT00874848|54645393|FG001|Overall Study|Physician Decision|2|||
27986919|NCT00578812|54645401|FG000|Overall Study|Not treated|6|||
27986920|NCT00578812|54645402|FG001|Overall Study|Not treated|7|||
28097371|NCT04036110|54752996|FG001|Overall Study|Lost to Follow-up|2|||
27901568|NCT00474526|54558056|FG007|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
27901569|NCT00474526|54558057|FG008|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
27901570|NCT00474526|54558058|FG009|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
27901571|NCT00474526|54558059|FG010|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
27901572|NCT00474526|54558060|FG011|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
27901573|NCT00474526|54558061|FG012|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
27901574|NCT00474526|54558062|FG013|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
27901575|NCT00474526|54558063|FG014|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
27901576|NCT00474526|54558064|FG015|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
27901577|NCT00474526|54558065|FG016|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
27901578|NCT00474526|54558049|FG000|Overall Study|Lost to Follow-up|8|||
27901579|NCT00474526|54558050|FG001|Overall Study|Lost to Follow-up|6|||
27901580|NCT00474526|54558051|FG002|Overall Study|Lost to Follow-up|13|||
27901581|NCT00474526|54558052|FG003|Overall Study|Lost to Follow-up|29|||
27901582|NCT00474526|54558053|FG004|Overall Study|Lost to Follow-up|11|||
27901583|NCT00474526|54558054|FG005|Overall Study|Lost to Follow-up|5|||
27901584|NCT00474526|54558055|FG006|Overall Study|Lost to Follow-up|8|||
27901585|NCT00474526|54558056|FG007|Overall Study|Lost to Follow-up|1|||
27901586|NCT00474526|54558057|FG008|Overall Study|Lost to Follow-up|0|||
27901587|NCT00474526|54558058|FG009|Overall Study|Lost to Follow-up|6|||
27901588|NCT00474526|54558059|FG010|Overall Study|Lost to Follow-up|2|||
27901589|NCT00474526|54558060|FG011|Overall Study|Lost to Follow-up|4|||
27901590|NCT00474526|54558061|FG012|Overall Study|Lost to Follow-up|6|||
27901591|NCT00474526|54558062|FG013|Overall Study|Lost to Follow-up|74|||
27901592|NCT00474526|54558063|FG014|Overall Study|Lost to Follow-up|29|||
27901593|NCT00474526|54558064|FG015|Overall Study|Lost to Follow-up|4|||
27901594|NCT00474526|54558065|FG016|Overall Study|Lost to Follow-up|5|||
27901595|NCT00474526|54558049|FG000|Overall Study|Protocol Violation|2|||
27901596|NCT00474526|54558050|FG001|Overall Study|Protocol Violation|6|||
27901597|NCT00474526|54558051|FG002|Overall Study|Protocol Violation|4|||
27901598|NCT00474526|54558052|FG003|Overall Study|Protocol Violation|12|||
27901599|NCT00474526|54558053|FG004|Overall Study|Protocol Violation|3|||
27901600|NCT00474526|54558054|FG005|Overall Study|Protocol Violation|1|||
27901601|NCT00474526|54558055|FG006|Overall Study|Protocol Violation|3|||
27901602|NCT00474526|54558056|FG007|Overall Study|Protocol Violation|0|||
27901603|NCT00474526|54558057|FG008|Overall Study|Protocol Violation|0|||
27901604|NCT00474526|54558058|FG009|Overall Study|Protocol Violation|4|||
27986921|NCT04043806|54645409|FG000|Overall Study|Commercial drug is available for participants|13|||
27986922|NCT04043806|54645409|FG000|Overall Study|Physician Decision|2|||
27986923|NCT04043806|54645409|FG000|Overall Study|Other|12|||
27986924|NCT04043806|54645409|FG000|Overall Study|Adverse Event|2|||
27986925|NCT04043806|54645409|FG000|Overall Study|Lost to Follow-up|6|||
27986926|NCT04043806|54645409|FG000|Overall Study|Other non-compliance|2|||
27986927|NCT04043806|54645409|FG000|Overall Study|Withdrawal of Consent (not due to AE)|8|||
27986928|NCT04043806|54645409|FG000|Overall Study|Never Dosed|1|||
27986929|NCT00536809|54645414|FG000|Phase II|Adverse Event|1|||
27986930|NCT00536809|54645414|FG000|Phase II|Referred for surgical resection|1|||
27986931|NCT00536731|54645425|FG000|Overall Study|Adverse Event|3|||
27986932|NCT00536731|54645426|FG001|Overall Study|Adverse Event|2|||
27986933|NCT00536731|54645427|FG002|Overall Study|Adverse Event|3|||
27986934|NCT00536731|54645425|FG000|Overall Study|Withdrawal by Subject|0|||
27986935|NCT00536731|54645426|FG001|Overall Study|Withdrawal by Subject|2|||
27986936|NCT00536731|54645427|FG002|Overall Study|Withdrawal by Subject|0|||
27986937|NCT00536731|54645425|FG000|Overall Study|Intake of prohibited conc. medication|0|||
27986938|NCT00536731|54645426|FG001|Overall Study|Intake of prohibited conc. medication|0|||
27986939|NCT00536731|54645427|FG002|Overall Study|Intake of prohibited conc. medication|1|||
27986940|NCT00536731|54645425|FG000|Overall Study|Safety reasons|0|||
27986941|NCT00536731|54645426|FG001|Overall Study|Safety reasons|0|||
27986942|NCT00536731|54645427|FG002|Overall Study|Safety reasons|1|||
27986943|NCT00536731|54645425|FG000|Overall Study|Other|1|||
27986944|NCT00536731|54645426|FG001|Overall Study|Other|1|||
27901605|NCT00474526|54558059|FG010|Overall Study|Protocol Violation|2|||
27901606|NCT00474526|54558060|FG011|Overall Study|Protocol Violation|2|||
27901607|NCT00474526|54558061|FG012|Overall Study|Protocol Violation|4|||
27901608|NCT00474526|54558062|FG013|Overall Study|Protocol Violation|19|||
27901609|NCT00474526|54558063|FG014|Overall Study|Protocol Violation|9|||
27901610|NCT00474526|54558064|FG015|Overall Study|Protocol Violation|6|||
27901611|NCT00474526|54558065|FG016|Overall Study|Protocol Violation|2|||
27901612|NCT00474526|54558049|FG000|Overall Study|UNABLE TO CLASSIFY|1|||
27901613|NCT00474526|54558050|FG001|Overall Study|UNABLE TO CLASSIFY|0|||
27901614|NCT00474526|54558051|FG002|Overall Study|UNABLE TO CLASSIFY|0|||
27901615|NCT00474526|54558052|FG003|Overall Study|UNABLE TO CLASSIFY|1|||
27986945|NCT00536731|54645427|FG002|Overall Study|Other|0|||
27986946|NCT00536575|54645435|FG000|Overall Study|Withdrawal by Subject|1|||
27986947|NCT00536575|54645435|FG000|Overall Study|Death|1|||
27986948|NCT03214250|54645446|FG000|Overall Study|Death|5|||
27986949|NCT03214250|54645447|FG001|Overall Study|Death|5|||
27986950|NCT03214250|54645448|FG002|Overall Study|Death|7|||
27986951|NCT03214250|54645449|FG003|Overall Study|Death|4|||
27986952|NCT03214250|54645450|FG004|Overall Study|Death|23|||
27986953|NCT03214250|54645451|FG005|Overall Study|Death|23|||
27901616|NCT00474526|54558053|FG004|Overall Study|UNABLE TO CLASSIFY|3|||
27901617|NCT00474526|54558054|FG005|Overall Study|UNABLE TO CLASSIFY|2|||
27901618|NCT00474526|54558055|FG006|Overall Study|UNABLE TO CLASSIFY|0|||
27901619|NCT00474526|54558056|FG007|Overall Study|UNABLE TO CLASSIFY|1|||
27901620|NCT00474526|54558057|FG008|Overall Study|UNABLE TO CLASSIFY|0|||
27901621|NCT00474526|54558058|FG009|Overall Study|UNABLE TO CLASSIFY|3|||
27986954|NCT03214250|54645452|FG006|Overall Study|Death|24|||
27986955|NCT03214250|54645446|FG000|Overall Study|Lost to Follow-up|0|||
27986956|NCT03214250|54645447|FG001|Overall Study|Lost to Follow-up|0|||
27986957|NCT03214250|54645448|FG002|Overall Study|Lost to Follow-up|0|||
27986958|NCT03214250|54645449|FG003|Overall Study|Lost to Follow-up|1|||
27986959|NCT03214250|54645450|FG004|Overall Study|Lost to Follow-up|1|||
27986960|NCT03214250|54645451|FG005|Overall Study|Lost to Follow-up|2|||
27986961|NCT03214250|54645452|FG006|Overall Study|Lost to Follow-up|0|||
27986962|NCT03214250|54645446|FG000|Overall Study|Other|0|||
27986963|NCT03214250|54645447|FG001|Overall Study|Other|0|||
27986964|NCT03214250|54645448|FG002|Overall Study|Other|0|||
27986965|NCT03214250|54645449|FG003|Overall Study|Other|0|||
27986966|NCT03214250|54645450|FG004|Overall Study|Other|1|||
27986967|NCT03214250|54645451|FG005|Overall Study|Other|1|||
27986968|NCT03214250|54645452|FG006|Overall Study|Other|2|||
27986969|NCT03214250|54645446|FG000|Overall Study|Remains on Study|2|||
27986970|NCT03214250|54645447|FG001|Overall Study|Remains on Study|2|||
27986971|NCT03214250|54645448|FG002|Overall Study|Remains on Study|0|||
27986972|NCT03214250|54645449|FG003|Overall Study|Remains on Study|1|||
27986973|NCT03214250|54645450|FG004|Overall Study|Remains on Study|7|||
27986974|NCT03214250|54645451|FG005|Overall Study|Remains on Study|5|||
27986975|NCT03214250|54645452|FG006|Overall Study|Remains on Study|3|||
27986976|NCT03214250|54645446|FG000|Overall Study|Withdrawal by Subject|0|||
27986977|NCT03214250|54645447|FG001|Overall Study|Withdrawal by Subject|0|||
27986978|NCT03214250|54645448|FG002|Overall Study|Withdrawal by Subject|1|||
27986979|NCT03214250|54645449|FG003|Overall Study|Withdrawal by Subject|2|||
27986980|NCT03214250|54645450|FG004|Overall Study|Withdrawal by Subject|5|||
27986981|NCT03214250|54645451|FG005|Overall Study|Withdrawal by Subject|0|||
27986982|NCT03214250|54645452|FG006|Overall Study|Withdrawal by Subject|2|||
27986983|NCT00874770|54645476|FG000|Overall Study|Lack of Efficacy|2|||
27986984|NCT00874770|54645477|FG001|Overall Study|Lack of Efficacy|0|||
27986985|NCT00874770|54645478|FG002|Overall Study|Lack of Efficacy|0|||
27901622|NCT00474526|54558059|FG010|Overall Study|UNABLE TO CLASSIFY|0|||
27901623|NCT00474526|54558060|FG011|Overall Study|UNABLE TO CLASSIFY|0|||
27901624|NCT00474526|54558061|FG012|Overall Study|UNABLE TO CLASSIFY|0|||
27901625|NCT00474526|54558062|FG013|Overall Study|UNABLE TO CLASSIFY|20|||
27901626|NCT00474526|54558063|FG014|Overall Study|UNABLE TO CLASSIFY|12|||
27901627|NCT00474526|54558064|FG015|Overall Study|UNABLE TO CLASSIFY|6|||
27901628|NCT00474526|54558065|FG016|Overall Study|UNABLE TO CLASSIFY|1|||
27901629|NCT00474526|54558049|FG000|Overall Study|Withdrawal by Subject|9|||
27901630|NCT00474526|54558050|FG001|Overall Study|Withdrawal by Subject|24|||
27901631|NCT00474526|54558051|FG002|Overall Study|Withdrawal by Subject|21|||
27901632|NCT00474526|54558052|FG003|Overall Study|Withdrawal by Subject|52|||
27901633|NCT00474526|54558053|FG004|Overall Study|Withdrawal by Subject|38|||
27901634|NCT00474526|54558054|FG005|Overall Study|Withdrawal by Subject|6|||
27901635|NCT00474526|54558055|FG006|Overall Study|Withdrawal by Subject|12|||
27986986|NCT00874770|54645479|FG003|Overall Study|Lack of Efficacy|2|||
27986987|NCT00874770|54645476|FG000|Overall Study|Adverse Event|1|||
27986988|NCT00874770|54645477|FG001|Overall Study|Adverse Event|1|||
27986989|NCT00874770|54645478|FG002|Overall Study|Adverse Event|4|||
27986990|NCT00874770|54645479|FG003|Overall Study|Adverse Event|2|||
27986991|NCT00874770|54645476|FG000|Overall Study|Lost to Follow-up|1|||
27986992|NCT00874770|54645477|FG001|Overall Study|Lost to Follow-up|0|||
27986993|NCT00874770|54645478|FG002|Overall Study|Lost to Follow-up|0|||
27901636|NCT00474526|54558056|FG007|Overall Study|Withdrawal by Subject|4|||
27901637|NCT00474526|54558057|FG008|Overall Study|Withdrawal by Subject|4|||
27901638|NCT00474526|54558058|FG009|Overall Study|Withdrawal by Subject|13|||
27901639|NCT00474526|54558059|FG010|Overall Study|Withdrawal by Subject|5|||
27901640|NCT00474526|54558060|FG011|Overall Study|Withdrawal by Subject|4|||
27901641|NCT00474526|54558061|FG012|Overall Study|Withdrawal by Subject|4|||
27901642|NCT00474526|54558062|FG013|Overall Study|Withdrawal by Subject|37|||
27901643|NCT00474526|54558063|FG014|Overall Study|Withdrawal by Subject|22|||
27901644|NCT00474526|54558064|FG015|Overall Study|Withdrawal by Subject|1|||
27901645|NCT00474526|54558065|FG016|Overall Study|Withdrawal by Subject|1|||
27901646|NCT00478426|54558151|FG000|Overall Study|Withdrawal by Subject|1|||
27986994|NCT00874770|54645479|FG003|Overall Study|Lost to Follow-up|1|||
27986995|NCT00874770|54645476|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
27986996|NCT00874770|54645477|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
27986997|NCT00874770|54645478|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
27986998|NCT00874770|54645479|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
27986999|NCT00536263|54645502|FG000|Overall Study|Adverse Event|5|||
27987000|NCT00536263|54645503|FG001|Overall Study|Adverse Event|5|||
27987001|NCT00536263|54645504|FG002|Overall Study|Adverse Event|7|||
27987002|NCT00536263|54645502|FG000|Overall Study|Lost to Follow-up|3|||
27987003|NCT00536263|54645503|FG001|Overall Study|Lost to Follow-up|4|||
27987004|NCT00536263|54645504|FG002|Overall Study|Lost to Follow-up|4|||
27987005|NCT00536263|54645502|FG000|Overall Study|Subject withdrew - not treatment related|2|||
27987006|NCT00536263|54645503|FG001|Overall Study|Subject withdrew - not treatment related|0|||
27987007|NCT00536263|54645504|FG002|Overall Study|Subject withdrew - not treatment related|5|||
27987008|NCT00536263|54645502|FG000|Overall Study|Subject withdrew - treatment related|0|||
27987009|NCT00536263|54645503|FG001|Overall Study|Subject withdrew - treatment related|3|||
27987010|NCT00536263|54645504|FG002|Overall Study|Subject withdrew - treatment related|2|||
27987011|NCT00536263|54645502|FG000|Overall Study|Noncompliance with protocol|0|||
27987012|NCT00536263|54645503|FG001|Overall Study|Noncompliance with protocol|0|||
27987013|NCT00536263|54645504|FG002|Overall Study|Noncompliance with protocol|1|||
27987014|NCT00536263|54645502|FG000|Overall Study|Did not meet protocol eligibility|1|||
27901647|NCT00477412|54558159|FG000|Overall Study|Death|0|||
27987015|NCT00536263|54645503|FG001|Overall Study|Did not meet protocol eligibility|2|||
27987016|NCT00536263|54645504|FG002|Overall Study|Did not meet protocol eligibility|2|||
27987017|NCT00578344|54645512|FG000|Overall Study|Insurance problems|1|||
27987018|NCT00578344|54645512|FG000|Overall Study|Graft failure|1|||
27987019|NCT00873366|54645516|FG000|Overall Study|Off tamoxifen for reconstructive surgery|1|||
27987020|NCT00873366|54645516|FG000|Overall Study|Off tamoxifen due to side effects|2|||
27987021|NCT00873366|54645516|FG000|Overall Study|Refused to continue DM-BT testing|3|||
27987022|NCT00536107|54645522|FG000|Overall Study|Death|5|||
27987023|NCT00536107|54645523|FG001|Overall Study|Death|1|||
27987024|NCT00536107|54645522|FG000|Overall Study|Incorrect enrolment|1|||
27987025|NCT00536107|54645523|FG001|Overall Study|Incorrect enrolment|0|||
27987026|NCT00536107|54645522|FG000|Overall Study|Withdrawal by Subject|0|||
27987027|NCT00536107|54645523|FG001|Overall Study|Withdrawal by Subject|1|||
27987028|NCT00536107|54645522|FG000|Overall Study|Study Termination|2|||
27987029|NCT00536107|54645523|FG001|Overall Study|Study Termination|4|||
27987030|NCT00885482|54645552|FG000|Overall Study|Pregnancy|1|||
27987031|NCT00885482|54645552|FG000|Overall Study|Lack of Efficacy|1|||
27987032|NCT00885482|54645552|FG000|Overall Study|Death|1|||
27901648|NCT00477412|54558160|FG001|Overall Study|Death|0|||
27901649|NCT00477412|54558161|FG002|Overall Study|Death|0|||
27901650|NCT00477412|54558162|FG003|Overall Study|Death|4|||
27901651|NCT00477412|54558159|FG000|Overall Study|Lost to Follow-up|0|||
27901652|NCT00477412|54558160|FG001|Overall Study|Lost to Follow-up|0|||
27901653|NCT00477412|54558161|FG002|Overall Study|Lost to Follow-up|0|||
27901654|NCT00477412|54558162|FG003|Overall Study|Lost to Follow-up|1|||
27901655|NCT00477412|54558159|FG000|Overall Study|Withdrawal by Subject|0|||
27901656|NCT00477412|54558160|FG001|Overall Study|Withdrawal by Subject|0|||
27901657|NCT00477412|54558161|FG002|Overall Study|Withdrawal by Subject|0|||
27901658|NCT00477412|54558162|FG003|Overall Study|Withdrawal by Subject|2|||
27901659|NCT00477412|54558159|FG000|Overall Study|Second Malignancy|0|||
27901660|NCT00477412|54558160|FG001|Overall Study|Second Malignancy|0|||
27901661|NCT00477412|54558161|FG002|Overall Study|Second Malignancy|0|||
27901662|NCT00477412|54558162|FG003|Overall Study|Second Malignancy|1|||
27901663|NCT00477412|54558159|FG000|Overall Study|Adverse Event|1|||
27901664|NCT00477412|54558160|FG001|Overall Study|Adverse Event|0|||
27901665|NCT00477412|54558161|FG002|Overall Study|Adverse Event|1|||
27901666|NCT00477412|54558162|FG003|Overall Study|Adverse Event|0|||
27901667|NCT01089556|54558172|FG000|Study Period II (Weeks 1-8)|Adverse Event|35|||
27901668|NCT01089556|54558173|FG001|Study Period II (Weeks 1-8)|Adverse Event|39|||
27901669|NCT01089556|54558174|FG002|Study Period II (Weeks 1-8)|Adverse Event|0|||
27901670|NCT01089556|54558175|FG003|Study Period II (Weeks 1-8)|Adverse Event|0|||
27901671|NCT01089556|54558176|FG004|Study Period II (Weeks 1-8)|Adverse Event|0|||
27901672|NCT01089556|54558177|FG005|Study Period II (Weeks 1-8)|Adverse Event|0|||
27901673|NCT01089556|54558172|FG000|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12|||
27901674|NCT01089556|54558173|FG001|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8|||
27901675|NCT01089556|54558174|FG002|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
27901676|NCT01089556|54558175|FG003|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
27987033|NCT00885482|54645552|FG000|Overall Study|low Therapeutic drug monitoring (TDM)|1|||
27987034|NCT00885170|54645576|FG000|Overall Study|Adverse Event|12|||
27987035|NCT00885170|54645577|FG001|Overall Study|Adverse Event|4|||
27987036|NCT00885170|54645576|FG000|Overall Study|Excessive bone loss|6|||
27987037|NCT00885170|54645577|FG001|Overall Study|Excessive bone loss|3|||
27987038|NCT00885170|54645576|FG000|Overall Study|Lost to Follow-up|2|||
27987039|NCT00885170|54645577|FG001|Overall Study|Lost to Follow-up|1|||
27987040|NCT00885170|54645576|FG000|Overall Study|Physician Decision|2|||
28172203|NCT03836001|54843812|FG002|Open-label Extension (3 or 12 Months)|Lost to Follow-up|1|||
27901677|NCT01089556|54558176|FG004|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
27901678|NCT01089556|54558177|FG005|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
27901679|NCT01089556|54558172|FG000|Study Period II (Weeks 1-8)|Lack of Efficacy|1|||
27901680|NCT01089556|54558173|FG001|Study Period II (Weeks 1-8)|Lack of Efficacy|2|||
27901681|NCT01089556|54558174|FG002|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
27901682|NCT01089556|54558175|FG003|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
27901683|NCT01089556|54558176|FG004|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
27901684|NCT01089556|54558177|FG005|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
27901685|NCT01089556|54558172|FG000|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
27901686|NCT01089556|54558173|FG001|Study Period II (Weeks 1-8)|Lost to Follow-up|3|||
27901687|NCT01089556|54558174|FG002|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
27901688|NCT01089556|54558175|FG003|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
27901689|NCT01089556|54558176|FG004|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
27901690|NCT01089556|54558177|FG005|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
27901691|NCT01089556|54558172|FG000|Study Period II (Weeks 1-8)|Physician Decision|4|||
27901692|NCT01089556|54558173|FG001|Study Period II (Weeks 1-8)|Physician Decision|0|||
27901693|NCT01089556|54558174|FG002|Study Period II (Weeks 1-8)|Physician Decision|0|||
27901694|NCT01089556|54558175|FG003|Study Period II (Weeks 1-8)|Physician Decision|0|||
27901695|NCT01089556|54558176|FG004|Study Period II (Weeks 1-8)|Physician Decision|0|||
27901696|NCT01089556|54558177|FG005|Study Period II (Weeks 1-8)|Physician Decision|0|||
27901697|NCT01089556|54558172|FG000|Study Period II (Weeks 1-8)|Protocol Violation|4|||
27901698|NCT01089556|54558173|FG001|Study Period II (Weeks 1-8)|Protocol Violation|4|||
27901699|NCT01089556|54558174|FG002|Study Period II (Weeks 1-8)|Protocol Violation|0|||
27901700|NCT01089556|54558175|FG003|Study Period II (Weeks 1-8)|Protocol Violation|0|||
27901701|NCT01089556|54558176|FG004|Study Period II (Weeks 1-8)|Protocol Violation|0|||
27901702|NCT01089556|54558177|FG005|Study Period II (Weeks 1-8)|Protocol Violation|0|||
27901703|NCT01089556|54558172|FG000|Study Period II (Weeks 1-8)|Withdrawal by Subject|12|||
27901704|NCT01089556|54558173|FG001|Study Period II (Weeks 1-8)|Withdrawal by Subject|14|||
27901705|NCT01089556|54558174|FG002|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
27901706|NCT01089556|54558175|FG003|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
27901707|NCT01089556|54558176|FG004|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
27901708|NCT01089556|54558177|FG005|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
27901709|NCT01089556|54558172|FG000|Study Period II (Weeks 1-8)|Not received any study drug|3|||
27987041|NCT00885170|54645577|FG001|Overall Study|Physician Decision|1|||
27987042|NCT00885170|54645576|FG000|Overall Study|Protocol Violation|3|||
27987043|NCT00885170|54645577|FG001|Overall Study|Protocol Violation|1|||
27987044|NCT00885170|54645576|FG000|Overall Study|Withdrawal by Subject|13|||
27987045|NCT00885170|54645577|FG001|Overall Study|Withdrawal by Subject|13|||
27987046|NCT00866619|54645604|FG000|Overall Study|Adverse Event|112|||
27987047|NCT00866619|54645605|FG001|Overall Study|Adverse Event|106|||
27987048|NCT00866619|54645606|FG002|Overall Study|Adverse Event|47|||
27987049|NCT00866619|54645607|FG003|Overall Study|Adverse Event|44|||
27987050|NCT00866619|54645604|FG000|Overall Study|Protocol Violation|2|||
27987051|NCT00866619|54645605|FG001|Overall Study|Protocol Violation|39|||
27987052|NCT00866619|54645606|FG002|Overall Study|Protocol Violation|2|||
27987053|NCT00866619|54645607|FG003|Overall Study|Protocol Violation|17|||
27987054|NCT00866619|54645604|FG000|Overall Study|Withdrawal by Subject|587|||
27987055|NCT00866619|54645605|FG001|Overall Study|Withdrawal by Subject|295|||
27987056|NCT00866619|54645606|FG002|Overall Study|Withdrawal by Subject|272|||
27987057|NCT00866619|54645607|FG003|Overall Study|Withdrawal by Subject|144|||
27987058|NCT00866619|54645604|FG000|Overall Study|Lost to Follow-up|1145|||
27987059|NCT00866619|54645605|FG001|Overall Study|Lost to Follow-up|830|||
27987060|NCT00866619|54645606|FG002|Overall Study|Lost to Follow-up|568|||
27987061|NCT00866619|54645607|FG003|Overall Study|Lost to Follow-up|425|||
27987062|NCT00884390|54645654|FG000|Overall Study|Adverse Event|0|||
27987063|NCT00884390|54645655|FG001|Overall Study|Adverse Event|1|||
27987064|NCT00884390|54645654|FG000|Overall Study|Lost to Follow-up|0|||
27987065|NCT00884390|54645655|FG001|Overall Study|Lost to Follow-up|1|||
27987066|NCT00884390|54645654|FG000|Overall Study|Physician Decision|2|||
27987067|NCT00884390|54645655|FG001|Overall Study|Physician Decision|1|||
27987068|NCT00884390|54645654|FG000|Overall Study|Protocol Violation|4|||
27987069|NCT00884390|54645655|FG001|Overall Study|Protocol Violation|1|||
27987070|NCT00884390|54645654|FG000|Overall Study|Withdrawal by Subject|4|||
27987071|NCT00884390|54645655|FG001|Overall Study|Withdrawal by Subject|1|||
27987072|NCT00884390|54645654|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
27987073|NCT00884390|54645655|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
27987074|NCT00884390|54645654|FG000|Overall Study|Other|11|||
27987075|NCT00884390|54645655|FG001|Overall Study|Other|1|||
27901710|NCT01089556|54558173|FG001|Study Period II (Weeks 1-8)|Not received any study drug|4|||
27987076|NCT00872898|54645692|FG000|Part Two - Double Blind|Adverse Event|4|||
27987077|NCT00872898|54645693|FG001|Part Two - Double Blind|Adverse Event|3|||
27987078|NCT00872898|54645692|FG000|Part Two - Double Blind|Lack of Efficacy|1|||
27987079|NCT00872898|54645693|FG001|Part Two - Double Blind|Lack of Efficacy|0|||
27987080|NCT00872898|54645692|FG000|Part Two - Double Blind|Protocol Violation|1|||
27987081|NCT00872898|54645693|FG001|Part Two - Double Blind|Protocol Violation|0|||
27901711|NCT01089556|54558174|FG002|Study Period II (Weeks 1-8)|Not received any study drug|0|||
27901712|NCT01089556|54558175|FG003|Study Period II (Weeks 1-8)|Not received any study drug|0|||
27987082|NCT00872898|54645692|FG000|Part Two - Double Blind|Withdrawal by Subject|3|||
27987083|NCT00872898|54645693|FG001|Part Two - Double Blind|Withdrawal by Subject|1|||
27901713|NCT01089556|54558176|FG004|Study Period II (Weeks 1-8)|Not received any study drug|0|||
27901714|NCT01089556|54558177|FG005|Study Period II (Weeks 1-8)|Not received any study drug|0|||
27901715|NCT01089556|54558172|FG000|Study Period III (Weeks 9-16)|Adverse Event|0|||
27901716|NCT01089556|54558173|FG001|Study Period III (Weeks 9-16)|Adverse Event|0|||
27901717|NCT01089556|54558174|FG002|Study Period III (Weeks 9-16)|Adverse Event|4|||
27901718|NCT01089556|54558175|FG003|Study Period III (Weeks 9-16)|Adverse Event|2|||
27901719|NCT01089556|54558176|FG004|Study Period III (Weeks 9-16)|Adverse Event|4|||
27901720|NCT01089556|54558177|FG005|Study Period III (Weeks 9-16)|Adverse Event|3|||
27901721|NCT01089556|54558172|FG000|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
27901722|NCT01089556|54558173|FG001|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
27901723|NCT01089556|54558174|FG002|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
27901724|NCT01089556|54558175|FG003|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
27901725|NCT01089556|54558176|FG004|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
27901726|NCT01089556|54558177|FG005|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
27901727|NCT01089556|54558172|FG000|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
27901728|NCT01089556|54558173|FG001|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
27901729|NCT01089556|54558174|FG002|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
27901730|NCT01089556|54558175|FG003|Study Period III (Weeks 9-16)|Lack of Efficacy|2|||
27901731|NCT01089556|54558176|FG004|Study Period III (Weeks 9-16)|Lack of Efficacy|1|||
27901732|NCT01089556|54558177|FG005|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
27901733|NCT01089556|54558172|FG000|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
27901734|NCT01089556|54558173|FG001|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
27901735|NCT01089556|54558174|FG002|Study Period III (Weeks 9-16)|Lost to Follow-up|1|||
27901736|NCT01089556|54558175|FG003|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
27901737|NCT01089556|54558176|FG004|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
27901738|NCT01089556|54558177|FG005|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
27901739|NCT01089556|54558172|FG000|Study Period III (Weeks 9-16)|Protocol Violation|0|||
27901740|NCT01089556|54558173|FG001|Study Period III (Weeks 9-16)|Protocol Violation|0|||
27901741|NCT01089556|54558174|FG002|Study Period III (Weeks 9-16)|Protocol Violation|1|||
27901742|NCT01089556|54558175|FG003|Study Period III (Weeks 9-16)|Protocol Violation|1|||
27901743|NCT01089556|54558176|FG004|Study Period III (Weeks 9-16)|Protocol Violation|1|||
27901744|NCT01089556|54558177|FG005|Study Period III (Weeks 9-16)|Protocol Violation|0|||
27901745|NCT01089556|54558172|FG000|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
27901746|NCT01089556|54558173|FG001|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
27901747|NCT01089556|54558174|FG002|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
27901748|NCT01089556|54558175|FG003|Study Period III (Weeks 9-16)|Satisfactory Response|3|||
27901749|NCT01089556|54558176|FG004|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
27901750|NCT01089556|54558177|FG005|Study Period III (Weeks 9-16)|Satisfactory Response|1|||
27901751|NCT01089556|54558172|FG000|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
27901752|NCT01089556|54558173|FG001|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
27901753|NCT01089556|54558174|FG002|Study Period III (Weeks 9-16)|Withdrawal by Subject|3|||
27901754|NCT01089556|54558175|FG003|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
27901755|NCT01089556|54558176|FG004|Study Period III (Weeks 9-16)|Withdrawal by Subject|1|||
27901756|NCT01089556|54558177|FG005|Study Period III (Weeks 9-16)|Withdrawal by Subject|2|||
27901757|NCT01089127|54558195|FG000|Overall Study|Adverse Event|5|||
27987084|NCT00872898|54645692|FG000|Part Two - Double Blind|Lost to Follow-up|0|||
27987085|NCT00872898|54645693|FG001|Part Two - Double Blind|Lost to Follow-up|2|||
27987086|NCT00872898|54645692|FG000|Part Two - Double Blind|Other reasons|2|||
27987087|NCT00872898|54645693|FG001|Part Two - Double Blind|Other reasons|0|||
27987088|NCT00884312|54645704|FG000|Overall Study|Non-fatal Progressive Disease|0|||
27987089|NCT00884312|54645705|FG001|Overall Study|Non-fatal Progressive Disease|8|||
27987090|NCT00884312|54645704|FG000|Overall Study|Fatal Progressive Disease|0|||
27987091|NCT00884312|54645705|FG001|Overall Study|Fatal Progressive Disease|1|||
27987092|NCT00884312|54645704|FG000|Overall Study|Non-fatal Adverse Event|1|||
27987093|NCT00884312|54645705|FG001|Overall Study|Non-fatal Adverse Event|0|||
27987094|NCT00884312|54645704|FG000|Overall Study|Fatal Adverse Event|1|||
27987095|NCT00884312|54645705|FG001|Overall Study|Fatal Adverse Event|4|||
27987096|NCT00884312|54645704|FG000|Overall Study|Withdrawal by Subject|0|||
27987097|NCT00884312|54645705|FG001|Overall Study|Withdrawal by Subject|6|||
27987098|NCT00884312|54645704|FG000|Overall Study|Physician Decision|0|||
27987099|NCT00884312|54645705|FG001|Overall Study|Physician Decision|1|||
27987100|NCT00884312|54645704|FG000|Overall Study|Other|0|||
27987101|NCT00884312|54645705|FG001|Overall Study|Other|4|||
27901758|NCT01089127|54558196|FG001|Overall Study|Adverse Event|1|||
27901759|NCT01089127|54558197|FG002|Overall Study|Adverse Event|1|||
27901760|NCT01089127|54558198|FG003|Overall Study|Adverse Event|0|||
27901761|NCT01089127|54558199|FG004|Overall Study|Adverse Event|0|||
27987102|NCT00884312|54645704|FG000|Overall Study|Did Not Receive Study Drug|0|||
27987103|NCT00884312|54645705|FG001|Overall Study|Did Not Receive Study Drug|1|||
27987104|NCT00534313|54645715|FG000|Short-term Period|Adverse Event|1|||
27901762|NCT01089127|54558200|FG005|Overall Study|Adverse Event|1|||
27901763|NCT01089127|54558195|FG000|Overall Study|Subject withdrew consent|0|||
27901764|NCT01089127|54558196|FG001|Overall Study|Subject withdrew consent|1|||
27901765|NCT01089127|54558197|FG002|Overall Study|Subject withdrew consent|1|||
27901766|NCT01089127|54558198|FG003|Overall Study|Subject withdrew consent|1|||
27901767|NCT01089127|54558199|FG004|Overall Study|Subject withdrew consent|0|||
27987105|NCT00534313|54645716|FG001|Short-term Period|Adverse Event|2|||
27987106|NCT00534313|54645717|FG002|Short-term Period|Adverse Event|1|||
27987107|NCT00534313|54645718|FG003|Short-term Period|Adverse Event|3|||
27987108|NCT00534313|54645715|FG000|Short-term Period|Lack of Efficacy|3|||
27987109|NCT00534313|54645716|FG001|Short-term Period|Lack of Efficacy|4|||
27987110|NCT00534313|54645717|FG002|Short-term Period|Lack of Efficacy|0|||
27987111|NCT00534313|54645718|FG003|Short-term Period|Lack of Efficacy|3|||
27987112|NCT00534313|54645715|FG000|Short-term Period|Participant not meeting study criteria|0|||
27987113|NCT00534313|54645716|FG001|Short-term Period|Participant not meeting study criteria|0|||
27987114|NCT00534313|54645717|FG002|Short-term Period|Participant not meeting study criteria|0|||
27987115|NCT00534313|54645718|FG003|Short-term Period|Participant not meeting study criteria|1|||
27987116|NCT00534313|54645715|FG000|Short-term Period|Participant withdrew consent|2|||
27987117|NCT00534313|54645716|FG001|Short-term Period|Participant withdrew consent|0|||
27987118|NCT00534313|54645717|FG002|Short-term Period|Participant withdrew consent|0|||
27987119|NCT00534313|54645718|FG003|Short-term Period|Participant withdrew consent|2|||
27987120|NCT00534313|54645715|FG000|Short-term Period|Pregnancy|0|||
27987121|NCT00534313|54645716|FG001|Short-term Period|Pregnancy|0|||
27987122|NCT00534313|54645717|FG002|Short-term Period|Pregnancy|1|||
27987123|NCT00534313|54645718|FG003|Short-term Period|Pregnancy|0|||
27987124|NCT00534313|54645715|FG000|Long-term Period|Adverse Event|2|||
27987125|NCT00534313|54645716|FG001|Long-term Period|Adverse Event|1|||
27987126|NCT00534313|54645717|FG002|Long-term Period|Adverse Event|0|||
27987127|NCT00534313|54645718|FG003|Long-term Period|Adverse Event|1|||
27987128|NCT00534313|54645715|FG000|Long-term Period|Lack of Efficacy|14|||
27987129|NCT00534313|54645716|FG001|Long-term Period|Lack of Efficacy|10|||
27987130|NCT00534313|54645717|FG002|Long-term Period|Lack of Efficacy|14|||
27987131|NCT00534313|54645718|FG003|Long-term Period|Lack of Efficacy|12|||
27987132|NCT00534313|54645715|FG000|Long-term Period|Lost to Follow-up|1|||
27987133|NCT00534313|54645716|FG001|Long-term Period|Lost to Follow-up|2|||
27987134|NCT00534313|54645717|FG002|Long-term Period|Lost to Follow-up|0|||
27987135|NCT00534313|54645718|FG003|Long-term Period|Lost to Follow-up|0|||
27987136|NCT00534313|54645715|FG000|Long-term Period|Withdrawal by Subject|2|||
27987137|NCT00534313|54645716|FG001|Long-term Period|Withdrawal by Subject|2|||
27987138|NCT00534313|54645717|FG002|Long-term Period|Withdrawal by Subject|0|||
27987139|NCT00534313|54645718|FG003|Long-term Period|Withdrawal by Subject|0|||
27987140|NCT00534313|54645715|FG000|Long-term Period|No longer meets study criteria|0|||
27987141|NCT00534313|54645716|FG001|Long-term Period|No longer meets study criteria|1|||
27987142|NCT00534313|54645717|FG002|Long-term Period|No longer meets study criteria|0|||
27987143|NCT00534313|54645718|FG003|Long-term Period|No longer meets study criteria|0|||
27987144|NCT00534313|54645715|FG000|Long-term Period|Poor compliance/noncompliance|0|||
27987145|NCT00534313|54645716|FG001|Long-term Period|Poor compliance/noncompliance|1|||
27987146|NCT00534313|54645717|FG002|Long-term Period|Poor compliance/noncompliance|1|||
27987147|NCT00534313|54645718|FG003|Long-term Period|Poor compliance/noncompliance|0|||
27987148|NCT00534313|54645715|FG000|Long-term Period|Administrative reason by sponsor|17|||
27987149|NCT00534313|54645716|FG001|Long-term Period|Administrative reason by sponsor|15|||
27987150|NCT00534313|54645717|FG002|Long-term Period|Administrative reason by sponsor|26|||
27987151|NCT00534313|54645718|FG003|Long-term Period|Administrative reason by sponsor|18|||
27987152|NCT00534313|54645715|FG000|Long-term Period|Other|1|||
27987153|NCT00534313|54645716|FG001|Long-term Period|Other|2|||
27987154|NCT00534313|54645717|FG002|Long-term Period|Other|2|||
27987155|NCT00534313|54645718|FG003|Long-term Period|Other|2|||
27987156|NCT03888391|54645763|FG000|Overall Study|Lost to Follow-up|15|||
27987157|NCT00594204|54645769|FG000|Overall Study|Adverse Event|15|||
27987158|NCT00594204|54645770|FG001|Overall Study|Adverse Event|3|||
27987159|NCT00594204|54645769|FG000|Overall Study|Lost to Follow-up|9|||
27987160|NCT00594204|54645770|FG001|Overall Study|Lost to Follow-up|5|||
27987161|NCT00594204|54645769|FG000|Overall Study|Withdrawal by Subject|23|||
27987162|NCT00594204|54645770|FG001|Overall Study|Withdrawal by Subject|29|||
27987163|NCT00594204|54645769|FG000|Overall Study|Other|4|||
27987164|NCT00594204|54645770|FG001|Overall Study|Other|3|||
27987165|NCT00594204|54645769|FG000|Overall Study|Lack of Efficacy|3|||
27901768|NCT01089127|54558200|FG005|Overall Study|Subject withdrew consent|2|||
27901769|NCT01089127|54558195|FG000|Overall Study|Abnormal test procedure result(s)|2|||
27987166|NCT00594204|54645770|FG001|Overall Study|Lack of Efficacy|4|||
27987167|NCT00594204|54645769|FG000|Overall Study|Randomized but not treated|4|||
27987168|NCT00594204|54645770|FG001|Overall Study|Randomized but not treated|1|||
27987169|NCT03888235|54645788|FG000|Overall Study|Lost to Follow-up|1|||
27987170|NCT03888235|54645789|FG001|Overall Study|Lost to Follow-up|1|||
27987171|NCT03888235|54645790|FG002|Overall Study|Lost to Follow-up|0|||
27901770|NCT01089127|54558196|FG001|Overall Study|Abnormal test procedure result(s)|1|||
27901771|NCT01089127|54558197|FG002|Overall Study|Abnormal test procedure result(s)|0|||
27901772|NCT01089127|54558198|FG003|Overall Study|Abnormal test procedure result(s)|0|||
27901773|NCT01089127|54558199|FG004|Overall Study|Abnormal test procedure result(s)|0|||
27901774|NCT01089127|54558200|FG005|Overall Study|Abnormal test procedure result(s)|0|||
27901775|NCT01089127|54558195|FG000|Overall Study|Lost to Follow-up|1|||
27901776|NCT01089127|54558196|FG001|Overall Study|Lost to Follow-up|1|||
27901777|NCT01089127|54558197|FG002|Overall Study|Lost to Follow-up|0|||
27901778|NCT01089127|54558198|FG003|Overall Study|Lost to Follow-up|0|||
27901779|NCT01089127|54558199|FG004|Overall Study|Lost to Follow-up|1|||
27901780|NCT01089127|54558200|FG005|Overall Study|Lost to Follow-up|0|||
27901781|NCT01089127|54558195|FG000|Overall Study|Protocol deviation|0|||
27901782|NCT01089127|54558196|FG001|Overall Study|Protocol deviation|1|||
27901783|NCT01089127|54558197|FG002|Overall Study|Protocol deviation|0|||
27901784|NCT01089127|54558198|FG003|Overall Study|Protocol deviation|0|||
27901785|NCT01089127|54558199|FG004|Overall Study|Protocol deviation|1|||
27901786|NCT01089127|54558200|FG005|Overall Study|Protocol deviation|0|||
27901787|NCT01087957|54558216|FG000|Overall Study|Death|2|||
27987172|NCT00866307|54645821|FG000|Induction|Adverse Event|5|||
27987173|NCT00866307|54645822|FG001|Induction|Adverse Event|0|||
27987174|NCT00866307|54645823|FG002|Induction|Adverse Event|0|||
27987175|NCT00866307|54645821|FG000|Induction|Death|2|||
27987176|NCT00866307|54645822|FG001|Induction|Death|0|||
27987177|NCT00866307|54645823|FG002|Induction|Death|0|||
27987178|NCT00866307|54645821|FG000|Induction|Physician Decision|5|||
27987179|NCT00866307|54645822|FG001|Induction|Physician Decision|0|||
27987180|NCT00866307|54645823|FG002|Induction|Physician Decision|0|||
27987181|NCT00866307|54645821|FG000|Induction|Progressive Disease|1|||
27987182|NCT00866307|54645822|FG001|Induction|Progressive Disease|0|||
27987183|NCT00866307|54645823|FG002|Induction|Progressive Disease|0|||
27987184|NCT00866307|54645821|FG000|Induction|Identification of Patients with Day 29 M|3|||
27987185|NCT00866307|54645822|FG001|Induction|Identification of Patients with Day 29 M|0|||
27987186|NCT00866307|54645823|FG002|Induction|Identification of Patients with Day 29 M|0|||
27901788|NCT01087957|54558217|FG001|Overall Study|Death|2|||
27901789|NCT01087957|54558216|FG000|Overall Study|Lost to Follow-up|3|||
27901790|NCT01087957|54558217|FG001|Overall Study|Lost to Follow-up|4|||
27901791|NCT01087957|54558216|FG000|Overall Study|Protocol Violation|13|||
27901792|NCT01087957|54558217|FG001|Overall Study|Protocol Violation|25|||
27901793|NCT01087957|54558216|FG000|Overall Study|Withdrawal by Subject|18|||
27901794|NCT01087957|54558217|FG001|Overall Study|Withdrawal by Subject|15|||
27901795|NCT01087957|54558216|FG000|Overall Study|Physician Decision|5|||
27901796|NCT01087957|54558217|FG001|Overall Study|Physician Decision|9|||
27901797|NCT01087723|54558225|FG000|Overall Study|1 Year Visit Too Early (<335 days)|0|||
27901798|NCT01087723|54558226|FG001|Overall Study|1 Year Visit Too Early (<335 days)|1|||
27901799|NCT01087723|54558225|FG000|Overall Study|Withdrawal by Subject|10|||
27901800|NCT01087723|54558226|FG001|Overall Study|Withdrawal by Subject|13|||
27901801|NCT01087723|54558225|FG000|Overall Study|Physician Decision|2|||
27901802|NCT01087723|54558226|FG001|Overall Study|Physician Decision|0|||
27901803|NCT01087723|54558225|FG000|Overall Study|Lost to Follow-up|1|||
27901804|NCT01087723|54558226|FG001|Overall Study|Lost to Follow-up|4|||
27901805|NCT01087723|54558225|FG000|Overall Study|Reason Not Specified|1|||
27901806|NCT01087723|54558226|FG001|Overall Study|Reason Not Specified|2|||
27901807|NCT01087528|54558232|FG000|Overall Study|Withdrawal by Subject|1|||
27901808|NCT01087528|54558232|FG000|Overall Study|Incomplete CE procedure|6|||
27901809|NCT01085812|54558238|FG000|Open-Label Period|Adverse Event|0|||
27901810|NCT01085812|54558239|FG001|Open-Label Period|Adverse Event|80|||
27901811|NCT01085812|54558238|FG000|Open-Label Period|Lack of Efficacy|0|||
27901812|NCT01085812|54558239|FG001|Open-Label Period|Lack of Efficacy|26|||
27901813|NCT01085812|54558238|FG000|Open-Label Period|Protocol Violation|0|||
27901814|NCT01085812|54558239|FG001|Open-Label Period|Protocol Violation|39|||
27901815|NCT01085812|54558238|FG000|Open-Label Period|Withdrawal by Subject|0|||
27901816|NCT01085812|54558239|FG001|Open-Label Period|Withdrawal by Subject|53|||
27901817|NCT01085812|54558238|FG000|Open-Label Period|Lost to Follow-up|0|||
27987187|NCT00866307|54645821|FG000|Induction|Inadequate cytognetic samples th|1|||
27987188|NCT00866307|54645822|FG001|Induction|Inadequate cytognetic samples th|0|||
27901818|NCT01085812|54558239|FG001|Open-Label Period|Lost to Follow-up|42|||
27901819|NCT01085812|54558238|FG000|Double-Blind Period|Adverse Event|3|||
27901820|NCT01085812|54558239|FG001|Double-Blind Period|Adverse Event|8|||
27901821|NCT01085812|54558238|FG000|Double-Blind Period|Protocol Violation|2|||
27901822|NCT01085812|54558239|FG001|Double-Blind Period|Protocol Violation|7|||
27987189|NCT00866307|54645823|FG002|Induction|Inadequate cytognetic samples th|0|||
27987190|NCT00866307|54645821|FG000|Induction|Improper post-induction consent|2|||
27987191|NCT00866307|54645822|FG001|Induction|Improper post-induction consent|0|||
27901823|NCT01085812|54558238|FG000|Double-Blind Period|Withdrawal by Subject|11|||
27901824|NCT01085812|54558239|FG001|Double-Blind Period|Withdrawal by Subject|24|||
27901825|NCT01085812|54558238|FG000|Double-Blind Period|Lost to Follow-up|5|||
27901826|NCT01085812|54558239|FG001|Double-Blind Period|Lost to Follow-up|17|||
27901827|NCT01085812|54558238|FG000|Double-Blind Period|Other Reasons|0|||
27901828|NCT01085812|54558239|FG001|Double-Blind Period|Other Reasons|2|||
27901829|NCT01085812|54558238|FG000|Double-blind Intent-to-treat Population|Adverse Event|3|||
27901830|NCT01085812|54558239|FG001|Double-blind Intent-to-treat Population|Adverse Event|8|||
27901831|NCT01085812|54558238|FG000|Double-blind Intent-to-treat Population|Protocol Violation|2|||
27901832|NCT01085812|54558239|FG001|Double-blind Intent-to-treat Population|Protocol Violation|7|||
27901833|NCT01085812|54558238|FG000|Double-blind Intent-to-treat Population|Withdrawal by Subject|11|||
27901834|NCT01085812|54558239|FG001|Double-blind Intent-to-treat Population|Withdrawal by Subject|22|||
27901835|NCT01085812|54558238|FG000|Double-blind Intent-to-treat Population|Lost to Follow-up|4|||
27901836|NCT01085812|54558239|FG001|Double-blind Intent-to-treat Population|Lost to Follow-up|17|||
27901837|NCT01085812|54558238|FG000|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0|||
27901838|NCT01085812|54558239|FG001|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2|||
27901839|NCT01085734|54558248|FG000|Overall Study|Adverse Event|0|||
27901840|NCT01085734|54558249|FG001|Overall Study|Adverse Event|2|||
27901841|NCT01085734|54558248|FG000|Overall Study|Death|1|||
27901842|NCT01085734|54558249|FG001|Overall Study|Death|0|||
27901843|NCT01085734|54558248|FG000|Overall Study|Lost to Follow-up|0|||
27901844|NCT01085734|54558249|FG001|Overall Study|Lost to Follow-up|1|||
27901845|NCT01085734|54558248|FG000|Overall Study|Withdrawal by Subject|0|||
27901846|NCT01085734|54558249|FG001|Overall Study|Withdrawal by Subject|1|||
27901847|NCT01084603|54558256|FG000|Baseline|Withdrawal by Subject|2|||
27901848|NCT01084603|54558256|FG000|NiQuitinTM Lozenge|Withdrawal by Subject|1|||
27901849|NCT01084603|54558256|FG000|Nicorette® Gum|Withdrawal by Subject|1|||
27901850|NCT01084603|54558256|FG000|Oral Nicotine 1|Withdrawal by Subject|1|||
27901851|NCT01084603|54558256|FG000|Washout Period 4|Adverse Event|1|||
27901852|NCT01084174|54558271|FG000|Overall Study|gastrointestinal symptoms|1|||
27901853|NCT01084174|54558272|FG001|Overall Study|gastrointestinal symptoms|1|||
27901854|NCT01084174|54558271|FG000|Overall Study|Eosinophilic esophagitis|0|||
27901855|NCT01084174|54558272|FG001|Overall Study|Eosinophilic esophagitis|1|||
27901856|NCT01084174|54558271|FG000|Overall Study|Anaphylaxis|0|||
27901857|NCT01084174|54558272|FG001|Overall Study|Anaphylaxis|1|||
27901858|NCT01084174|54558271|FG000|Overall Study|Participant noncompliance|0|||
27901859|NCT01084174|54558272|FG001|Overall Study|Participant noncompliance|1|||
27901860|NCT01084135|54558282|FG000|20 Week|Physician Decision|0|||
27901861|NCT01084135|54558283|FG001|20 Week|Physician Decision|1|||
27901862|NCT01083316|54558291|FG000|Overall Study|Adverse Event|2|||
27901863|NCT01083316|54558291|FG000|Overall Study|Withdrawal by Subject|1|||
27901864|NCT01083160|54558296|FG000|Overall Study|Adverse Event|1|||
27901865|NCT01083121|54558300|FG000|Overall Study|Use of Humira outside the approved label|81|||
27901866|NCT01082614|54558310|FG000|Overall Study|Adverse Event|1|||
27901867|NCT01082614|54558311|FG001|Overall Study|Adverse Event|4|||
27901868|NCT01082614|54558310|FG000|Overall Study|Equipment Malfunction|0|||
27901869|NCT01082614|54558311|FG001|Overall Study|Equipment Malfunction|1|||
27901870|NCT01082614|54558310|FG000|Overall Study|Physician Decision|2|||
27901871|NCT01082614|54558311|FG001|Overall Study|Physician Decision|0|||
27901872|NCT01081873|54558317|FG000|Overall Study|Death|86|||
27901873|NCT01081873|54558317|FG000|Overall Study|Withdrawal by Subject|10|||
27901874|NCT01081873|54558317|FG000|Overall Study|Lost to Follow-up|142|||
27901875|NCT01081873|54558317|FG000|Overall Study|Progression of prostate cancer|13|||
27901876|NCT01081873|54558317|FG000|Overall Study|Other|47|||
27901877|NCT01081795|54558349|FG000|Overall Study|Adverse Event|18|||
27901878|NCT01081795|54558350|FG001|Overall Study|Adverse Event|23|||
27901879|NCT01081795|54558351|FG002|Overall Study|Adverse Event|6|||
27901880|NCT01081795|54558349|FG000|Overall Study|Lack of Efficacy|7|||
27901881|NCT01081795|54558350|FG001|Overall Study|Lack of Efficacy|5|||
27901882|NCT01081795|54558351|FG002|Overall Study|Lack of Efficacy|19|||
27901883|NCT01081795|54558349|FG000|Overall Study|Subject's schedule|1|||
27901884|NCT01081795|54558350|FG001|Overall Study|Subject's schedule|1|||
27901885|NCT01081795|54558351|FG002|Overall Study|Subject's schedule|2|||
27901886|NCT01081795|54558349|FG000|Overall Study|Revocation of informed consent|2|||
27901887|NCT01081795|54558350|FG001|Overall Study|Revocation of informed consent|0|||
27901888|NCT01081795|54558351|FG002|Overall Study|Revocation of informed consent|0|||
27901889|NCT01081795|54558349|FG000|Overall Study|Ineligible for participation|1|||
27901890|NCT01081795|54558350|FG001|Overall Study|Ineligible for participation|0|||
27901891|NCT01081795|54558351|FG002|Overall Study|Ineligible for participation|0|||
27901892|NCT01081795|54558349|FG000|Overall Study|Use of a prohibited concomitant drug|1|||
27901893|NCT01081795|54558350|FG001|Overall Study|Use of a prohibited concomitant drug|1|||
27901894|NCT01081795|54558351|FG002|Overall Study|Use of a prohibited concomitant drug|1|||
27901895|NCT01081795|54558349|FG000|Overall Study|Using drug with restricted days of use|2|||
27901896|NCT01081795|54558350|FG001|Overall Study|Using drug with restricted days of use|3|||
27901897|NCT01081795|54558351|FG002|Overall Study|Using drug with restricted days of use|2|||
27901898|NCT01081795|54558349|FG000|Overall Study|Other|1|||
27901899|NCT01081795|54558350|FG001|Overall Study|Other|2|||
27901900|NCT01081795|54558351|FG002|Overall Study|Other|0|||
27901901|NCT01081678|54558363|FG000|Overall Study|Ineligibility Determined|0|||
27901902|NCT01081678|54558364|FG001|Overall Study|Ineligibility Determined|0|||
27901903|NCT01081678|54558365|FG002|Overall Study|Ineligibility Determined|1|||
27901904|NCT01081678|54558366|FG003|Overall Study|Ineligibility Determined|1|||
27901905|NCT01081678|54558363|FG000|Overall Study|Noncompliance|3|||
27901906|NCT01081678|54558364|FG001|Overall Study|Noncompliance|4|||
27901907|NCT01081678|54558365|FG002|Overall Study|Noncompliance|5|||
27901908|NCT01081678|54558366|FG003|Overall Study|Noncompliance|2|||
27901909|NCT01081678|54558363|FG000|Overall Study|Adverse Event|2|||
27901910|NCT01081678|54558364|FG001|Overall Study|Adverse Event|1|||
27901911|NCT01081678|54558365|FG002|Overall Study|Adverse Event|2|||
27901912|NCT01081678|54558366|FG003|Overall Study|Adverse Event|2|||
27901913|NCT01081678|54558363|FG000|Overall Study|Withdrawal by Subject|15|||
27901914|NCT01081678|54558364|FG001|Overall Study|Withdrawal by Subject|7|||
27901915|NCT01081678|54558365|FG002|Overall Study|Withdrawal by Subject|17|||
27901916|NCT01081678|54558366|FG003|Overall Study|Withdrawal by Subject|14|||
27901917|NCT01081678|54558363|FG000|Overall Study|Administrative Decision|1|||
27901918|NCT01081678|54558364|FG001|Overall Study|Administrative Decision|0|||
27901919|NCT01081678|54558365|FG002|Overall Study|Administrative Decision|0|||
27901920|NCT01081678|54558366|FG003|Overall Study|Administrative Decision|1|||
27901921|NCT01081678|54558363|FG000|Overall Study|Lost to Follow-up|4|||
27901922|NCT01081678|54558364|FG001|Overall Study|Lost to Follow-up|1|||
27901923|NCT01081678|54558365|FG002|Overall Study|Lost to Follow-up|4|||
27901924|NCT01081678|54558366|FG003|Overall Study|Lost to Follow-up|3|||
27901925|NCT01081678|54558363|FG000|Overall Study|Death|2|||
27901926|NCT01081678|54558364|FG001|Overall Study|Death|2|||
27901927|NCT01081678|54558365|FG002|Overall Study|Death|2|||
27901928|NCT01081678|54558366|FG003|Overall Study|Death|6|||
27901929|NCT01081678|54558363|FG000|Overall Study|Other|0|||
27901930|NCT01081678|54558364|FG001|Overall Study|Other|1|||
27901931|NCT01081678|54558365|FG002|Overall Study|Other|0|||
27901932|NCT01081678|54558366|FG003|Overall Study|Other|0|||
27901933|NCT01081249|54558376|FG000|Overall Study|Diagnosed with Bipolar Disorder|0|||
27901934|NCT01081249|54558377|FG001|Overall Study|Diagnosed with Bipolar Disorder|1|||
27901935|NCT01081132|54558385|FG000|Overall Study|Lack of Efficacy|25|||
27901936|NCT01081132|54558386|FG001|Overall Study|Lack of Efficacy|9|||
27901937|NCT01081132|54558385|FG000|Overall Study|Withdrawal by Subject|13|||
27901938|NCT01081132|54558386|FG001|Overall Study|Withdrawal by Subject|16|||
27901939|NCT01081132|54558385|FG000|Overall Study|Lost to Follow-up|4|||
27901940|NCT01081132|54558386|FG001|Overall Study|Lost to Follow-up|11|||
27901941|NCT01081132|54558385|FG000|Overall Study|Adverse Event|3|||
27901942|NCT01081132|54558386|FG001|Overall Study|Adverse Event|9|||
27901943|NCT01081132|54558385|FG000|Overall Study|Non Compliance|4|||
27901944|NCT01081132|54558386|FG001|Overall Study|Non Compliance|2|||
27901945|NCT01081132|54558385|FG000|Overall Study|Lack Of Compliance|0|||
27901946|NCT01081132|54558386|FG001|Overall Study|Lack Of Compliance|1|||
27901947|NCT01081132|54558385|FG000|Overall Study|Missed Visits|1|||
27901948|NCT01081132|54558386|FG001|Overall Study|Missed Visits|1|||
27987192|NCT00866307|54645823|FG002|Induction|Improper post-induction consent|0|||
27987193|NCT00866307|54645821|FG000|Induction|Study was closed at the time|1|||
27987194|NCT00866307|54645822|FG001|Induction|Study was closed at the time|0|||
27987195|NCT00866307|54645823|FG002|Induction|Study was closed at the time|0|||
27987196|NCT00866307|54645821|FG000|Consolidation/Maintenance|Adverse Event|0|||
27987197|NCT00866307|54645822|FG001|Consolidation/Maintenance|Adverse Event|0|||
27987198|NCT00866307|54645823|FG002|Consolidation/Maintenance|Adverse Event|8|||
27987199|NCT00866307|54645821|FG000|Consolidation/Maintenance|Death|0|||
27987200|NCT00866307|54645822|FG001|Consolidation/Maintenance|Death|0|||
27987201|NCT00866307|54645823|FG002|Consolidation/Maintenance|Death|1|||
27987202|NCT00866307|54645821|FG000|Consolidation/Maintenance|Physician Decision|0|||
27987203|NCT00866307|54645822|FG001|Consolidation/Maintenance|Physician Decision|3|||
27987204|NCT00866307|54645823|FG002|Consolidation/Maintenance|Physician Decision|2|||
27987205|NCT00866307|54645821|FG000|Consolidation/Maintenance|Withdrawal by Subject|0|||
27987206|NCT00866307|54645822|FG001|Consolidation/Maintenance|Withdrawal by Subject|1|||
27987207|NCT00866307|54645823|FG002|Consolidation/Maintenance|Withdrawal by Subject|1|||
27987208|NCT00866307|54645821|FG000|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
27901949|NCT01081132|54558385|FG000|Overall Study|Stopped Taking Meds|2|||
27901950|NCT01081132|54558386|FG001|Overall Study|Stopped Taking Meds|0|||
27901951|NCT01081132|54558385|FG000|Overall Study|Patient Did Not Complete Wk14 and 15|0|||
27901952|NCT01081132|54558386|FG001|Overall Study|Patient Did Not Complete Wk14 and 15|1|||
27901953|NCT01081132|54558385|FG000|Overall Study|Declined Taper Phase|0|||
27901954|NCT01081132|54558386|FG001|Overall Study|Declined Taper Phase|1|||
27901955|NCT01081132|54558385|FG000|Overall Study|Protocol Violation|3|||
27901956|NCT01081132|54558386|FG001|Overall Study|Protocol Violation|1|||
27901957|NCT01080625|54558395|FG000|Overall Study|Physician Decision|0|||
27901958|NCT01080625|54558396|FG001|Overall Study|Physician Decision|2|||
27901959|NCT01080625|54558397|FG002|Overall Study|Physician Decision|1|||
27901960|NCT01059903|54558407|FG000|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
27901961|NCT01059903|54558408|FG001|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
27901962|NCT00199888|54558464|FG000|Overall Study|Lost to Follow-up|1|||
27901963|NCT00199849|54558471|FG000|Overall Study|Unrelated illness or complication|0|||
27901964|NCT00199849|54558472|FG001|Overall Study|Unrelated illness or complication|1|||
27901965|NCT00199849|54558473|FG002|Overall Study|Unrelated illness or complication|0|||
27901966|NCT00199849|54558471|FG000|Overall Study|Progressive disease requiring intervention|0|||
27901967|NCT00199849|54558472|FG001|Overall Study|Progressive disease requiring intervention|0|||
27901968|NCT00199849|54558473|FG002|Overall Study|Progressive disease requiring intervention|1|||
27901969|NCT00199849|54558471|FG000|Overall Study|Did not meet eligibility criteria - not dosed|0|||
27901970|NCT00199849|54558472|FG001|Overall Study|Did not meet eligibility criteria - not dosed|0|||
27901971|NCT00199849|54558473|FG002|Overall Study|Did not meet eligibility criteria - not dosed|1|||
27901972|NCT00199381|54558481|FG000|Overall Study|Withdrawal by Subject|38|||
27901973|NCT00199381|54558481|FG000|Overall Study|Adverse Event|73|||
27901974|NCT00199381|54558481|FG000|Overall Study|Protocol Violation|6|||
27901975|NCT00199381|54558481|FG000|Overall Study|Lack of Efficacy|27|||
27901976|NCT00199381|54558481|FG000|Overall Study|Not including due to early termination|37|||
27901977|NCT00199381|54558481|FG000|Overall Study|Study termination by Sponsor|323|||
27901978|NCT00198133|54558487|FG000|Overall Study|Disease progression|2|||
27901979|NCT00198133|54558488|FG001|Overall Study|Disease progression|5|||
27901980|NCT00198133|54558487|FG000|Overall Study|Adverse Event|1|||
27901981|NCT00198133|54558488|FG001|Overall Study|Adverse Event|3|||
27901982|NCT00198133|54558487|FG000|Overall Study|Withdrawal by Subject|1|||
27901983|NCT00198133|54558488|FG001|Overall Study|Withdrawal by Subject|0|||
27901984|NCT00198133|54558487|FG000|Overall Study|Physician Decision|1|||
27901985|NCT00198133|54558488|FG001|Overall Study|Physician Decision|0|||
27901986|NCT00197236|54558497|FG000|Overall Study|Adverse Event|1|||
27901987|NCT00197236|54558498|FG001|Overall Study|Adverse Event|0|||
27901988|NCT00197236|54558499|FG002|Overall Study|Adverse Event|1|||
27901989|NCT00197236|54558497|FG000|Overall Study|Lost to Follow-up|5|||
27901990|NCT00197236|54558498|FG001|Overall Study|Lost to Follow-up|14|||
27901991|NCT00197236|54558499|FG002|Overall Study|Lost to Follow-up|6|||
27901992|NCT00197236|54558497|FG000|Overall Study|Protocol Violation|0|||
27901993|NCT00197236|54558498|FG001|Overall Study|Protocol Violation|0|||
27901994|NCT00197236|54558499|FG002|Overall Study|Protocol Violation|1|||
27901995|NCT00197236|54558497|FG000|Overall Study|Withdrawal by Subject|7|||
27901996|NCT00197236|54558498|FG001|Overall Study|Withdrawal by Subject|3|||
27901997|NCT00197236|54558499|FG002|Overall Study|Withdrawal by Subject|11|||
27901998|NCT00197236|54558497|FG000|Overall Study|Study drug/medication expiration|1|||
27901999|NCT00197236|54558498|FG001|Overall Study|Study drug/medication expiration|0|||
27902000|NCT00197236|54558499|FG002|Overall Study|Study drug/medication expiration|3|||
27902001|NCT00197236|54558497|FG000|Overall Study|Returned out of specified time window|0|||
27902002|NCT00197236|54558498|FG001|Overall Study|Returned out of specified time window|0|||
27902003|NCT00197236|54558499|FG002|Overall Study|Returned out of specified time window|1|||
27902004|NCT00197002|54558513|FG000|Overall Study|Adverse Event|0|||
27902005|NCT00197002|54558514|FG001|Overall Study|Adverse Event|1|||
27902006|NCT00197002|54558515|FG002|Overall Study|Adverse Event|0|||
27902007|NCT00197002|54558513|FG000|Overall Study|Protocol Violation|1|||
27902008|NCT00197002|54558514|FG001|Overall Study|Protocol Violation|0|||
27902009|NCT00197002|54558515|FG002|Overall Study|Protocol Violation|2|||
27902010|NCT00197002|54558513|FG000|Overall Study|Withdrawal by Subject|9|||
27902011|NCT00197002|54558514|FG001|Overall Study|Withdrawal by Subject|5|||
27902012|NCT00197002|54558515|FG002|Overall Study|Withdrawal by Subject|7|||
27902013|NCT00197002|54558513|FG000|Overall Study|Migrated/moved from study area|3|||
27902014|NCT00197002|54558514|FG001|Overall Study|Migrated/moved from study area|5|||
27902015|NCT00197002|54558515|FG002|Overall Study|Migrated/moved from study area|1|||
27902016|NCT00197002|54558513|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
27902017|NCT00197002|54558514|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
27902018|NCT00197002|54558515|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|5|||
27902019|NCT00197002|54558513|FG000|Overall Study|Lost to follow-up (compl. vaccination)|2|||
27902020|NCT00197002|54558514|FG001|Overall Study|Lost to follow-up (compl. vaccination)|2|||
27902021|NCT00197002|54558515|FG002|Overall Study|Lost to follow-up (compl. vaccination)|1|||
27902022|NCT00197002|54558513|FG000|Overall Study|Others|3|||
27902023|NCT00197002|54558514|FG001|Overall Study|Others|1|||
27902024|NCT00197002|54558515|FG002|Overall Study|Others|1|||
27902025|NCT00196105|54558529|FG000|Overall Study|Lost to Follow-up|4|||
27902026|NCT00196105|54558530|FG001|Overall Study|Lost to Follow-up|5|||
27902027|NCT00196105|54558531|FG002|Overall Study|Lost to Follow-up|7|||
27902028|NCT00195715|54558539|FG000|Overall Study|Adverse Event|122|||
27902029|NCT00195715|54558539|FG000|Overall Study|Withdrawal by Subject|58|||
27902030|NCT00195715|54558539|FG000|Overall Study|Lost to Follow-up|27|||
27902031|NCT00195715|54558539|FG000|Overall Study|Protocol Violation|13|||
27902032|NCT00195715|54558539|FG000|Overall Study|Lack of Efficacy|93|||
27902033|NCT00195715|54558539|FG000|Overall Study|Pregnancy|14|||
27902034|NCT00195715|54558539|FG000|Overall Study|Investigative site closure|8|||
27902035|NCT00195715|54558539|FG000|Overall Study|Subject moved/relocated|7|||
27902036|NCT00195715|54558539|FG000|Overall Study|Subject non-compliance|6|||
27902037|NCT00195715|54558539|FG000|Overall Study|Subject started commercial Humira|5|||
27902038|NCT00195715|54558539|FG000|Overall Study|Subject choice|3|||
27902039|NCT00195715|54558539|FG000|Overall Study|Loss of response/no improvement|3|||
27902040|NCT00195715|54558539|FG000|Overall Study|Sponsor stopped study|1|||
27902041|NCT00195715|54558539|FG000|Overall Study|Administrative reasons|2|||
27902042|NCT00195715|54558539|FG000|Overall Study|Investigator's decision|2|||
27902043|NCT00195715|54558539|FG000|Overall Study|Subject wants to get pregnant|4|||
27902044|NCT00195715|54558539|FG000|Overall Study|Use of prohibited medication|2|||
27902045|NCT00195715|54558539|FG000|Overall Study|Planned surgery|2|||
27902046|NCT00195715|54558539|FG000|Overall Study|Increased infection rate|1|||
27902047|NCT00195715|54558539|FG000|Overall Study|Ineligible|1|||
27902048|NCT00195715|54558539|FG000|Overall Study|Colonic stricture|1|||
27902049|NCT00195715|54558539|FG000|Overall Study|Sponsor discontinued trial|1|||
27902050|NCT00195715|54558539|FG000|Overall Study|Sponsor discretion - trial ended early|1|||
27902051|NCT00195676|54558543|FG000|Period O - Open-label Treatment|Adverse Event|82|||
27902052|NCT00195676|54558543|FG000|Period O - Open-label Treatment|Death|6|||
27902053|NCT00195676|54558543|FG000|Period O - Open-label Treatment|Lack of Efficacy|198|||
27902054|NCT00195676|54558543|FG000|Period O - Open-label Treatment|Lost to Follow-up|91|||
27902055|NCT00195676|54558543|FG000|Period O - Open-label Treatment|Protocol Violation|12|||
27902056|NCT00195676|54558543|FG000|Period O - Open-label Treatment|Withdrawal by Subject|147|||
27902057|NCT00195676|54558543|FG000|Period O - Open-label Treatment|Administrative reasons|2|||
27902058|NCT00195676|54558543|FG000|Period O - Open-label Treatment|Other reasons|68|||
27902059|NCT00195676|54558543|FG000|Period W (Withdrawal) - No Treatment|Adverse Event|4|||
27902060|NCT00195676|54558543|FG000|Period W (Withdrawal) - No Treatment|Death|2|||
27739479|NCT03745651|54189172|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
27739480|NCT03745651|54189173|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
27739481|NCT03745651|54189167|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|3|||
27739482|NCT03745651|54189168|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
27739483|NCT03745651|54189169|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
27739484|NCT03745651|54189170|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
27739485|NCT03745651|54189171|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
27739486|NCT03745651|54189172|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
27739487|NCT03745651|54189173|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
27902061|NCT00195676|54558543|FG000|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11|||
27902062|NCT00195676|54558543|FG000|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46|||
27902063|NCT00195676|54558543|FG000|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397|||
27902064|NCT00195676|54558543|FG000|Period W (Withdrawal) - No Treatment|Period W Close-out|129|||
27902065|NCT00195676|54558543|FG000|Period W (Withdrawal) - No Treatment|Administrative reasons|1|||
27902066|NCT00195676|54558543|FG000|Period W (Withdrawal) - No Treatment|Other reasons|18|||
27902067|NCT00195676|54558543|FG000|Period R - Retreatment 16 Weeks|Adverse Event|4|||
27902068|NCT00195676|54558543|FG000|Period R - Retreatment 16 Weeks|Lack of Efficacy|5|||
27902069|NCT00195676|54558543|FG000|Period R - Retreatment 16 Weeks|Lost to Follow-up|11|||
27902070|NCT00195676|54558543|FG000|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9|||
27902071|NCT00195676|54558543|FG000|Period R - Retreatment 16 Weeks|Other reasons|6|||
27902072|NCT00194077|54558553|FG000|Overall Study|Lack of Efficacy|22|||
27902073|NCT00194077|54558554|FG001|Overall Study|Lack of Efficacy|29|||
27902074|NCT00194077|54558553|FG000|Overall Study|Study nonadherence|1|||
27902075|NCT00194077|54558554|FG001|Overall Study|Study nonadherence|0|||
27902076|NCT00194077|54558553|FG000|Overall Study|Withdrawal by Subject|1|||
27902077|NCT00194077|54558554|FG001|Overall Study|Withdrawal by Subject|1|||
27902078|NCT00193609|54558560|FG000|Overall Study|Lack of Efficacy|2|||
27902079|NCT00193609|54558560|FG000|Overall Study|Adverse Event|2|||
27902080|NCT00193180|54558564|FG000|Overall Study|Lack of Efficacy|1|||
27902081|NCT00193180|54558564|FG000|Overall Study|Adverse Event|8|||
27902082|NCT00193180|54558564|FG000|Overall Study|Protocol Violation|1|||
27902083|NCT00193063|54558569|FG000|Overall Study|Lack of Efficacy|3|||
27902084|NCT00193063|54558569|FG000|Overall Study|Adverse Event|1|||
27902085|NCT00191854|54558576|FG000|Overall Study|Death|26|||
27902086|NCT00191854|54558577|FG001|Overall Study|Death|23|||
27902087|NCT00191854|54558578|FG002|Overall Study|Death|29|||
27902088|NCT00191854|54558576|FG000|Overall Study|Lost to Follow-up|7|||
27902089|NCT00191854|54558577|FG001|Overall Study|Lost to Follow-up|5|||
27902090|NCT00191854|54558578|FG002|Overall Study|Lost to Follow-up|5|||
27902091|NCT00191854|54558576|FG000|Overall Study|Withdrawal by Subject|4|||
27902092|NCT00191854|54558577|FG001|Overall Study|Withdrawal by Subject|2|||
27902093|NCT00191854|54558578|FG002|Overall Study|Withdrawal by Subject|3|||
27902094|NCT00191854|54558576|FG000|Overall Study|Sponsor Decision|0|||
27902095|NCT00191854|54558577|FG001|Overall Study|Sponsor Decision|0|||
27902096|NCT00191854|54558578|FG002|Overall Study|Sponsor Decision|1|||
27902097|NCT00191854|54558576|FG000|Overall Study|Screen Failure|0|||
27902098|NCT00191854|54558577|FG001|Overall Study|Screen Failure|0|||
27902099|NCT00191854|54558578|FG002|Overall Study|Screen Failure|1|||
27902100|NCT00191815|54558586|FG000|Overall Study|Adverse Event|2|||
27902101|NCT00191815|54558586|FG000|Overall Study|Disease progression or relapse|24|||
27902102|NCT00191815|54558586|FG000|Overall Study|Death|2|||
27902103|NCT00191815|54558586|FG000|Overall Study|Protocol Violation|3|||
27902104|NCT00191815|54558586|FG000|Overall Study|Physician Decision|2|||
27902105|NCT00191815|54558586|FG000|Overall Study|Withdrawal by Subject|7|||
27902106|NCT00191386|54558590|FG000|Overall Study|Adverse Event|16|||
27902107|NCT00191386|54558590|FG000|Overall Study|Lost to Follow-up|1|||
27902108|NCT00191386|54558590|FG000|Overall Study|Entry Criteria Exclusion|3|||
27902109|NCT00191386|54558590|FG000|Overall Study|Protocol Violation|18|||
27902110|NCT00191386|54558590|FG000|Overall Study|Withdrawal by Subject|96|||
27902111|NCT00191386|54558590|FG000|Overall Study|Physician Decision|11|||
27902112|NCT00191386|54558590|FG000|Overall Study|Lack of Efficacy|15|||
27902113|NCT00191308|54558594|FG000|Overall Study|Adverse Event|1|||
27902114|NCT00191269|54558600|FG000|Overall Study|Protocol Violation|0|||
27902115|NCT00191269|54558601|FG001|Overall Study|Protocol Violation|2|||
27902116|NCT00191269|54558600|FG000|Overall Study|Adverse Event|1|||
27902117|NCT00191269|54558601|FG001|Overall Study|Adverse Event|4|||
27902118|NCT00191269|54558600|FG000|Overall Study|Progression of Disease|4|||
27902119|NCT00191269|54558601|FG001|Overall Study|Progression of Disease|42|||
27902120|NCT00191269|54558600|FG000|Overall Study|Lack of Efficacy|1|||
27902121|NCT00191269|54558601|FG001|Overall Study|Lack of Efficacy|5|||
27902122|NCT00191269|54558600|FG000|Overall Study|Withdrawal by Subject|0|||
27902123|NCT00191269|54558601|FG001|Overall Study|Withdrawal by Subject|1|||
27902124|NCT00191269|54558600|FG000|Overall Study|Pathologic Aggrevation|0|||
27902125|NCT00191269|54558601|FG001|Overall Study|Pathologic Aggrevation|1|||
27902126|NCT00191269|54558600|FG000|Overall Study|Physician Decision|0|||
27902127|NCT00191269|54558601|FG001|Overall Study|Physician Decision|3|||
27902128|NCT00191191|54558610|FG000|Overall Study|Entry Criteria Exclusion|2|||
27902129|NCT00191191|54558611|FG001|Overall Study|Entry Criteria Exclusion|0|||
27902130|NCT00191191|54558610|FG000|Overall Study|Treated with Another Systemic Agent|1|||
27902131|NCT00191191|54558611|FG001|Overall Study|Treated with Another Systemic Agent|1|||
27902132|NCT00191191|54558610|FG000|Overall Study|Adverse Event|11|||
27902133|NCT00191191|54558611|FG001|Overall Study|Adverse Event|21|||
27902134|NCT00191191|54558610|FG000|Overall Study|Progressive Disease|84|||
27902135|NCT00191191|54558611|FG001|Overall Study|Progressive Disease|72|||
27902136|NCT00191191|54558610|FG000|Overall Study|Toxicity After Dose Reduction|7|||
27902137|NCT00191191|54558611|FG001|Overall Study|Toxicity After Dose Reduction|8|||
27902138|NCT00191191|54558610|FG000|Overall Study|Family/Caregiver Decision|5|||
27902139|NCT00191191|54558611|FG001|Overall Study|Family/Caregiver Decision|7|||
27902140|NCT00191191|54558610|FG000|Overall Study|Lost to Follow-up|1|||
27902141|NCT00191191|54558611|FG001|Overall Study|Lost to Follow-up|0|||
27902142|NCT00191191|54558610|FG000|Overall Study|Physician Decision|3|||
27902143|NCT00191191|54558611|FG001|Overall Study|Physician Decision|2|||
27902144|NCT00191191|54558610|FG000|Overall Study|Good Clinical Practice Violation|0|||
27902145|NCT00191191|54558611|FG001|Overall Study|Good Clinical Practice Violation|1|||
27902146|NCT00191152|54558619|FG000|Initial Treatment|Adverse Event|43|||
27902147|NCT00191152|54558620|FG001|Initial Treatment|Adverse Event|67|||
27902148|NCT00191152|54558619|FG000|Initial Treatment|Physician Decision|40|||
27902149|NCT00191152|54558620|FG001|Initial Treatment|Physician Decision|31|||
27902150|NCT00191152|54558619|FG000|Initial Treatment|Withdrawal by Subject|40|||
27902151|NCT00191152|54558620|FG001|Initial Treatment|Withdrawal by Subject|28|||
27902152|NCT00191152|54558619|FG000|Initial Treatment|Lost to Follow-up|0|||
27902153|NCT00191152|54558620|FG001|Initial Treatment|Lost to Follow-up|6|||
27902154|NCT00191152|54558619|FG000|Initial Treatment|Other|18|||
27902155|NCT00191152|54558620|FG001|Initial Treatment|Other|21|||
27902156|NCT00191152|54558619|FG000|Crossover Treatment|Adverse Event|8|||
27902157|NCT00191152|54558620|FG001|Crossover Treatment|Adverse Event|8|||
27987209|NCT00866307|54645822|FG001|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
27987210|NCT00866307|54645823|FG002|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2|||
27987211|NCT00866307|54645821|FG000|Consolidation/Maintenance|Recurrent leukemia following remission|0|||
27987212|NCT00866307|54645822|FG001|Consolidation/Maintenance|Recurrent leukemia following remission|3|||
27987213|NCT00866307|54645823|FG002|Consolidation/Maintenance|Recurrent leukemia following remission|1|||
27987214|NCT00866307|54645821|FG000|Consolidation/Maintenance|Therapy error|0|||
27987215|NCT00866307|54645822|FG001|Consolidation/Maintenance|Therapy error|1|||
27987216|NCT00866307|54645823|FG002|Consolidation/Maintenance|Therapy error|0|||
28097372|NCT04036110|54752997|FG002|Overall Study|Lost to Follow-up|1|||
27902158|NCT00191152|54558619|FG000|Crossover Treatment|Physician Decision|7|||
27902159|NCT00191152|54558620|FG001|Crossover Treatment|Physician Decision|7|||
27902160|NCT00191152|54558619|FG000|Crossover Treatment|Withdrawal by Subject|6|||
27902161|NCT00191152|54558620|FG001|Crossover Treatment|Withdrawal by Subject|9|||
27902162|NCT00191152|54558619|FG000|Crossover Treatment|Lost to Follow-up|2|||
27902163|NCT00191152|54558620|FG001|Crossover Treatment|Lost to Follow-up|1|||
27902164|NCT00191152|54558619|FG000|Crossover Treatment|Other|4|||
27902165|NCT00191152|54558620|FG001|Crossover Treatment|Other|3|||
27902166|NCT00190684|54558638|FG000|Overall Study|Adverse Event|86|||
27902167|NCT00190684|54558638|FG000|Overall Study|Satisfactory response|80|||
27902168|NCT00190684|54558638|FG000|Overall Study|Lack of efficacy|204|||
27902169|NCT00190684|54558638|FG000|Overall Study|Lost to Follow-up|232|||
27902170|NCT00190684|54558638|FG000|Overall Study|Patient moved|60|||
27902171|NCT00190684|54558638|FG000|Overall Study|Patient Decision|432|||
27902172|NCT00190684|54558638|FG000|Overall Study|Clinical relapse|67|||
27902173|NCT00190684|54558638|FG000|Overall Study|Sponsor's decision|17|||
27987217|NCT00866307|54645821|FG000|Consolidation/Maintenance|Non-compliance|0|||
27987218|NCT00866307|54645822|FG001|Consolidation/Maintenance|Non-compliance|0|||
27987219|NCT00866307|54645823|FG002|Consolidation/Maintenance|Non-compliance|1|||
27987220|NCT00866307|54645821|FG000|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
27987221|NCT00866307|54645822|FG001|Consolidation/Maintenance|Patient moved to non-participating inst|1|||
27987222|NCT00866307|54645823|FG002|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
27987223|NCT00531427|54645831|FG000|Overall Study|Withdrawal by Subject|7|||
27987224|NCT00531427|54645832|FG001|Overall Study|Withdrawal by Subject|13|||
27987225|NCT00531427|54645831|FG000|Overall Study|Adverse Event|44|||
27987226|NCT00531427|54645832|FG001|Overall Study|Adverse Event|30|||
27987227|NCT00531427|54645831|FG000|Overall Study|Lost to Follow-up|4|||
27987228|NCT00531427|54645832|FG001|Overall Study|Lost to Follow-up|3|||
27987229|NCT00531427|54645831|FG000|Overall Study|Lack of Efficacy|14|||
27987230|NCT00531427|54645832|FG001|Overall Study|Lack of Efficacy|39|||
27987231|NCT00531427|54645831|FG000|Overall Study|Administrative|4|||
27987232|NCT00531427|54645832|FG001|Overall Study|Administrative|9|||
27987233|NCT00871728|54645839|FG000|Overall Study|Adverse Event|1|||
27987234|NCT00871728|54645839|FG000|Overall Study|Protocol Violation|7|||
27987235|NCT00871728|54645839|FG000|Overall Study|Lost to Follow-up|2|||
27987236|NCT00871728|54645839|FG000|Overall Study|Failed to Visit Hospital|4|||
27902174|NCT00190684|54558638|FG000|Overall Study|Physician Decision|84|||
27902175|NCT00190684|54558638|FG000|Overall Study|Protocol Violation|123|||
27902176|NCT00190684|54558638|FG000|Overall Study|Study Period III Completed|103|||
27902177|NCT00190684|54558638|FG000|Overall Study|Study Period V Completed|1|||
27902178|NCT00179959|54558649|FG000|Overall Study|Lost to Follow-up|3|||
27902179|NCT00179959|54558650|FG001|Overall Study|Lost to Follow-up|1|||
27902180|NCT00179959|54558649|FG000|Overall Study|Withdrawal by Subject|3|||
27902181|NCT00179959|54558650|FG001|Overall Study|Withdrawal by Subject|2|||
27902182|NCT00179647|54558656|FG000|Overall Study|Adverse Event|294|||
27902183|NCT00179647|54558656|FG000|Overall Study|Lack of Efficacy|478|||
27902184|NCT00179647|54558656|FG000|Overall Study|Withdrawal by Subject|83|||
27902185|NCT00179647|54558656|FG000|Overall Study|Lost to Follow-up|4|||
27902186|NCT00179647|54558656|FG000|Overall Study|Death|94|||
27902187|NCT00179647|54558656|FG000|Overall Study|Other|960|||
27902188|NCT00179413|54558662|FG000|Overall Study|Adverse Event|38|||
27902189|NCT00179413|54558663|FG001|Overall Study|Adverse Event|20|||
27902190|NCT00179413|54558662|FG000|Overall Study|Withdrawal by Subject|87|||
27902191|NCT00179413|54558663|FG001|Overall Study|Withdrawal by Subject|95|||
27902192|NCT00178633|54558669|FG000|Overall Study|Lost to Follow-up|6|||
27902193|NCT00178399|54558674|FG000|Overall Study|Physician Decision|4|||
27902194|NCT00178399|54558674|FG000|Overall Study|Withdrawal by Subject|8|||
27902195|NCT00178399|54558674|FG000|Overall Study|Lost to Follow-up|1|||
27902196|NCT00178126|54558681|FG000|Overall Study|Lost to Follow-up|21|||
27902197|NCT00178126|54558682|FG001|Overall Study|Lost to Follow-up|21|||
27902198|NCT00178126|54558681|FG000|Overall Study|did not receive intervention|4|||
27902199|NCT00178126|54558682|FG001|Overall Study|did not receive intervention|6|||
27902200|NCT00177307|54558688|FG000|Overall Study|Withdrawal by Subject|1|||
27902201|NCT00176644|54558692|FG000|Overall Study|Withdrawal by Subject|1|||
27902202|NCT00176605|54558700|FG000|Overall Study|Withdrawal by Subject|2|||
27902203|NCT00176488|54558704|FG000|Overall Study|Initiated Cycle 1 Day 1 only|1|||
27902204|NCT00175825|54558712|FG000|Overall Study|Adverse Event|3|||
27902205|NCT00175825|54558713|FG001|Overall Study|Adverse Event|2|||
27902206|NCT00175825|54558714|FG002|Overall Study|Adverse Event|1|||
27902207|NCT00175825|54558715|FG003|Overall Study|Adverse Event|1|||
27902208|NCT00175825|54558712|FG000|Overall Study|Lost to Follow-up|1|||
27902209|NCT00175825|54558713|FG001|Overall Study|Lost to Follow-up|2|||
27902210|NCT00175825|54558714|FG002|Overall Study|Lost to Follow-up|0|||
27902211|NCT00175825|54558715|FG003|Overall Study|Lost to Follow-up|0|||
27902212|NCT00175825|54558712|FG000|Overall Study|Withdrawal by Subject|1|||
27902213|NCT00175825|54558713|FG001|Overall Study|Withdrawal by Subject|0|||
27902214|NCT00175825|54558714|FG002|Overall Study|Withdrawal by Subject|0|||
27902215|NCT00175825|54558715|FG003|Overall Study|Withdrawal by Subject|0|||
27902216|NCT00174967|54558729|FG000|Overall Study|Adverse Event|1|||
27902217|NCT00174967|54558730|FG001|Overall Study|Adverse Event|2|||
27902218|NCT00174967|54558731|FG002|Overall Study|Adverse Event|2|||
27902219|NCT00174967|54558732|FG003|Overall Study|Adverse Event|1|||
27987237|NCT00871728|54645839|FG000|Overall Study|Participant Non-compliance|1|||
27902220|NCT00174967|54558729|FG000|Overall Study|Gout Flare|0|||
27902221|NCT00174967|54558730|FG001|Overall Study|Gout Flare|0|||
27902222|NCT00174967|54558731|FG002|Overall Study|Gout Flare|0|||
27902223|NCT00174967|54558732|FG003|Overall Study|Gout Flare|1|||
27902224|NCT00174967|54558729|FG000|Overall Study|Other|0|||
27902225|NCT00174967|54558730|FG001|Overall Study|Other|1|||
27902226|NCT00174967|54558731|FG002|Overall Study|Other|0|||
27902227|NCT00174967|54558732|FG003|Overall Study|Other|0|||
27902228|NCT00174265|54558744|FG000|Overall Study|Adverse Event|7|||
27902229|NCT00174265|54558745|FG001|Overall Study|Adverse Event|4|||
27902230|NCT00174265|54558744|FG000|Overall Study|Lack of Efficacy|2|||
27902231|NCT00174265|54558745|FG001|Overall Study|Lack of Efficacy|2|||
27902232|NCT00174265|54558744|FG000|Overall Study|Withdrawal by Subject|3|||
27902233|NCT00174265|54558745|FG001|Overall Study|Withdrawal by Subject|5|||
27902234|NCT00174265|54558744|FG000|Overall Study|Lost to Follow-up|1|||
27902235|NCT00174265|54558745|FG001|Overall Study|Lost to Follow-up|0|||
27902236|NCT00174265|54558744|FG000|Overall Study|Other (Not specified)|16|||
27902237|NCT00174265|54558745|FG001|Overall Study|Other (Not specified)|10|||
27902238|NCT00172042|54558753|FG000|Overall Study|Adverse Event|27|||
27902239|NCT00172042|54558754|FG001|Overall Study|Adverse Event|13|||
27902240|NCT00172042|54558753|FG000|Overall Study|Abnormal laboratory value(s)|5|||
27902241|NCT00172042|54558754|FG001|Overall Study|Abnormal laboratory value(s)|1|||
27902242|NCT00172042|54558753|FG000|Overall Study|Abnormal test procedure(s)|0|||
27902243|NCT00172042|54558754|FG001|Overall Study|Abnormal test procedure(s)|3|||
27902244|NCT00172042|54558753|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
27902245|NCT00172042|54558754|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
27902246|NCT00172042|54558753|FG000|Overall Study|Patient no longer requires study drug|10|||
27902247|NCT00172042|54558754|FG001|Overall Study|Patient no longer requires study drug|8|||
27902248|NCT00172042|54558753|FG000|Overall Study|Protocol Violation|8|||
27902249|NCT00172042|54558754|FG001|Overall Study|Protocol Violation|7|||
27902250|NCT00172042|54558753|FG000|Overall Study|Withdrawal by Subject|37|||
27902251|NCT00172042|54558754|FG001|Overall Study|Withdrawal by Subject|25|||
27902252|NCT00172042|54558753|FG000|Overall Study|Lost to Follow-up|3|||
27902253|NCT00172042|54558754|FG001|Overall Study|Lost to Follow-up|5|||
27902254|NCT00172042|54558753|FG000|Overall Study|Administrative problems|13|||
27902255|NCT00172042|54558754|FG001|Overall Study|Administrative problems|10|||
27902256|NCT00172042|54558753|FG000|Overall Study|Death|42|||
27902257|NCT00172042|54558754|FG001|Overall Study|Death|42|||
27902258|NCT00171925|54558762|FG000|Overall Study|Adverse Event|10|||
27902259|NCT00171925|54558763|FG001|Overall Study|Adverse Event|6|||
27902260|NCT00171925|54558762|FG000|Overall Study|Protocol Violation|1|||
27902261|NCT00171925|54558763|FG001|Overall Study|Protocol Violation|1|||
27902262|NCT00171925|54558762|FG000|Overall Study|Withdrawal by Subject|6|||
27902263|NCT00171925|54558763|FG001|Overall Study|Withdrawal by Subject|9|||
27902264|NCT00171925|54558762|FG000|Overall Study|Lost to Follow-up|2|||
27902265|NCT00171925|54558763|FG001|Overall Study|Lost to Follow-up|2|||
27902266|NCT00171925|54558762|FG000|Overall Study|Administrative problems|10|||
27987238|NCT00871728|54645839|FG000|Overall Study|Withdrawal of Informed Consent|5|||
27987239|NCT00868998|54645843|FG000|Overall Study|Screen Failure|1|||
27987240|NCT00868998|54645843|FG000|Overall Study|Withdrawal by Subject|1|||
27987241|NCT00868998|54645843|FG000|Overall Study|Progression of disease|2|||
27987242|NCT00868998|54645843|FG000|Overall Study|Death|1|||
27987243|NCT00533845|54645858|FG000|Overall Study|Physician Decision|1|||
27987244|NCT00533845|54645859|FG001|Overall Study|Physician Decision|0|||
27987245|NCT00857649|54645867|FG000|Overall Study|Adverse Event|15|||
27987246|NCT00857649|54645868|FG001|Overall Study|Adverse Event|10|||
27987247|NCT00857649|54645867|FG000|Overall Study|Non-compliance|1|||
27987248|NCT00857649|54645868|FG001|Overall Study|Non-compliance|1|||
27987249|NCT00857649|54645867|FG000|Overall Study|Protocol Violation|2|||
27987250|NCT00857649|54645868|FG001|Overall Study|Protocol Violation|2|||
27987251|NCT00857649|54645867|FG000|Overall Study|Withdrawal of Consent|10|||
27987252|NCT00857649|54645868|FG001|Overall Study|Withdrawal of Consent|7|||
27987253|NCT00857649|54645867|FG000|Overall Study|Nursing Home Placement|2|||
27987254|NCT00857649|54645868|FG001|Overall Study|Nursing Home Placement|9|||
27987255|NCT00857649|54645867|FG000|Overall Study|Other Reasons|1|||
27987256|NCT00857649|54645868|FG001|Overall Study|Other Reasons|3|||
27987257|NCT00857415|54645876|FG000|Overall Study|Image acquisition failure|2|||
27987258|NCT00857415|54645877|FG001|Overall Study|Image acquisition failure|0|||
27987259|NCT00857415|54645876|FG000|Overall Study|Invalid image or not imaged|3|||
27987260|NCT00857415|54645877|FG001|Overall Study|Invalid image or not imaged|0|||
27987261|NCT00857415|54645876|FG000|Overall Study|Subject still living at end of study|110|||
27987262|NCT00857415|54645877|FG001|Overall Study|Subject still living at end of study|0|||
27987263|NCT00857415|54645876|FG000|Overall Study|Deceased with no autopsy|2|||
28172204|NCT03836001|54843810|FG000|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
27902267|NCT00171925|54558763|FG001|Overall Study|Administrative problems|11|||
27902268|NCT00171925|54558762|FG000|Overall Study|Death|1|||
27902269|NCT00171925|54558763|FG001|Overall Study|Death|2|||
27902270|NCT00171340|54558771|FG000|Overall Study|Adverse Event|46|||
27902271|NCT00171340|54558772|FG001|Overall Study|Adverse Event|42|||
27902272|NCT00171340|54558771|FG000|Overall Study|Lack of Efficacy|29|||
27902273|NCT00171340|54558772|FG001|Overall Study|Lack of Efficacy|41|||
27902274|NCT00171340|54558771|FG000|Overall Study|Protocol Violation|7|||
27902275|NCT00171340|54558772|FG001|Overall Study|Protocol Violation|8|||
27902276|NCT00171340|54558771|FG000|Overall Study|Withdrawal by Subject|22|||
27987264|NCT00857415|54645877|FG001|Overall Study|Deceased with no autopsy|0|||
27902277|NCT00171340|54558772|FG001|Overall Study|Withdrawal by Subject|19|||
27902278|NCT00171340|54558771|FG000|Overall Study|Lost to Follow-up|0|||
27902279|NCT00171340|54558772|FG001|Overall Study|Lost to Follow-up|5|||
27902280|NCT00171340|54558771|FG000|Overall Study|Abnormal Laboratory Results|2|||
27902281|NCT00171340|54558772|FG001|Overall Study|Abnormal Laboratory Results|0|||
27902282|NCT00171340|54558771|FG000|Overall Study|Abnormal Test Procedure Results|6|||
27902283|NCT00171340|54558772|FG001|Overall Study|Abnormal Test Procedure Results|11|||
27902284|NCT00171340|54558771|FG000|Overall Study|No Longer Required Study Drug|1|||
27902285|NCT00171340|54558772|FG001|Overall Study|No Longer Required Study Drug|1|||
27902286|NCT00171340|54558771|FG000|Overall Study|Administrative Problems|5|||
27902287|NCT00171340|54558772|FG001|Overall Study|Administrative Problems|2|||
27902288|NCT00171340|54558771|FG000|Overall Study|Death|6|||
27987265|NCT00532441|54645883|FG000|Overall Study|Death|1|||
27987266|NCT00532441|54645884|FG001|Overall Study|Death|0|||
27987267|NCT00857259|54645905|FG000|Overall Study|Protocol Violation|1|||
27987268|NCT00857259|54645906|FG001|Overall Study|Protocol Violation|0|||
27987269|NCT00857259|54645907|FG002|Overall Study|Protocol Violation|1|||
27987270|NCT00868608|54645920|FG000|Overall Study|Withdrawal by Subject|3|||
27987271|NCT00868608|54645921|FG001|Overall Study|Withdrawal by Subject|1|||
27987272|NCT00868608|54645922|FG002|Overall Study|Withdrawal by Subject|0|||
27987273|NCT00868608|54645920|FG000|Overall Study|Lost to Follow-up|3|||
27902289|NCT00171340|54558772|FG001|Overall Study|Death|6|||
27902290|NCT00171301|54558782|FG000|Overall Study|Death|1|||
27902291|NCT00171301|54558783|FG001|Overall Study|Death|2|||
27902292|NCT00171301|54558782|FG000|Overall Study|Adverse Event|1|||
27902293|NCT00171301|54558783|FG001|Overall Study|Adverse Event|2|||
27902294|NCT00171301|54558782|FG000|Overall Study|Lost to Follow-up|6|||
27902295|NCT00171301|54558783|FG001|Overall Study|Lost to Follow-up|2|||
27902296|NCT00171301|54558782|FG000|Overall Study|Protocol Violation|0|||
27902297|NCT00171301|54558783|FG001|Overall Study|Protocol Violation|2|||
27902298|NCT00171301|54558782|FG000|Overall Study|Withdrawal by Subject|0|||
27902299|NCT00171301|54558783|FG001|Overall Study|Withdrawal by Subject|1|||
27902300|NCT00171223|54558793|FG000|Overall Study|Adverse Event (Non-fatal)|6|||
27902301|NCT00171223|54558794|FG001|Overall Study|Adverse Event (Non-fatal)|5|||
27902302|NCT00171223|54558795|FG002|Overall Study|Adverse Event (Non-fatal)|19|||
27902303|NCT00171223|54558793|FG000|Overall Study|Abnormal Laboratory Value (s)|4|||
27902304|NCT00171223|54558794|FG001|Overall Study|Abnormal Laboratory Value (s)|2|||
27902305|NCT00171223|54558795|FG002|Overall Study|Abnormal Laboratory Value (s)|3|||
27902306|NCT00171223|54558793|FG000|Overall Study|Abnormal Procedure|1|||
27902307|NCT00171223|54558794|FG001|Overall Study|Abnormal Procedure|0|||
27902308|NCT00171223|54558795|FG002|Overall Study|Abnormal Procedure|0|||
27902309|NCT00171223|54558793|FG000|Overall Study|Unsatisfactory Therapeutic Effect|57|||
27987274|NCT00868608|54645921|FG001|Overall Study|Lost to Follow-up|0|||
27987275|NCT00868608|54645922|FG002|Overall Study|Lost to Follow-up|1|||
27987276|NCT00868608|54645920|FG000|Overall Study|Death|16|||
27987277|NCT00868608|54645921|FG001|Overall Study|Death|2|||
27987278|NCT00868608|54645922|FG002|Overall Study|Death|4|||
27987279|NCT00868608|54645920|FG000|Overall Study|Other - Unspecified|1|||
27987280|NCT00868608|54645921|FG001|Overall Study|Other - Unspecified|0|||
27987281|NCT00868608|54645922|FG002|Overall Study|Other - Unspecified|0|||
27987282|NCT00856635|54645932|FG000|Overall Study|Lost to Follow-up|2|||
27987283|NCT00856635|54645933|FG001|Overall Study|Lost to Follow-up|5|||
27987284|NCT00856635|54645932|FG000|Overall Study|Pregnancy|1|||
27987285|NCT00856635|54645933|FG001|Overall Study|Pregnancy|0|||
27987286|NCT00856635|54645932|FG000|Overall Study|Withdrawal by Subject|3|||
27987287|NCT00856635|54645933|FG001|Overall Study|Withdrawal by Subject|1|||
27987288|NCT00856635|54645932|FG000|Overall Study|Serious Adverse Event|1|||
27987289|NCT00856635|54645933|FG001|Overall Study|Serious Adverse Event|0|||
27902310|NCT00171223|54558794|FG001|Overall Study|Unsatisfactory Therapeutic Effect|43|||
27987290|NCT00856635|54645932|FG000|Overall Study|Other|1|||
27987291|NCT00856635|54645933|FG001|Overall Study|Other|0|||
27987292|NCT00856635|54645932|FG000|Overall Study|Discontinued at Randomization|2|||
27987293|NCT00856635|54645933|FG001|Overall Study|Discontinued at Randomization|2|||
27902311|NCT00171223|54558795|FG002|Overall Study|Unsatisfactory Therapeutic Effect|52|||
27902312|NCT00171223|54558793|FG000|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
27902313|NCT00171223|54558794|FG001|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|4|||
27902314|NCT00171223|54558795|FG002|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
27987294|NCT00856557|54645943|FG000|Overall Study|No patients with contextual flags|12|||
27987295|NCT00856557|54645944|FG001|Overall Study|No patients with contextual flags|16|||
27987296|NCT00856323|54645950|FG000|Overall Study|Withdrawal by Subject|2|||
27987297|NCT00856245|54645958|FG000|Overall Study|Was not transplanted|5|||
27987298|NCT00855933|54645964|FG000|Overall Study|Withdrawal by Subject|0|||
27902315|NCT00171223|54558793|FG000|Overall Study|Protocol Violation|2|||
27902316|NCT00171223|54558794|FG001|Overall Study|Protocol Violation|2|||
27902317|NCT00171223|54558795|FG002|Overall Study|Protocol Violation|3|||
27987299|NCT00855933|54645965|FG001|Overall Study|Withdrawal by Subject|1|||
27987300|NCT00871572|54645975|FG000|Overall Study|Adverse Event|0|||
27902318|NCT00171223|54558793|FG000|Overall Study|Participant Withdrew Consent|12|||
27902319|NCT00171223|54558794|FG001|Overall Study|Participant Withdrew Consent|21|||
27902320|NCT00171223|54558795|FG002|Overall Study|Participant Withdrew Consent|15|||
27902321|NCT00171223|54558793|FG000|Overall Study|Lost to Follow-up|5|||
27902322|NCT00171223|54558794|FG001|Overall Study|Lost to Follow-up|2|||
27902323|NCT00171223|54558795|FG002|Overall Study|Lost to Follow-up|3|||
27902324|NCT00171223|54558793|FG000|Overall Study|Administrative Problems|4|||
27902325|NCT00171223|54558794|FG001|Overall Study|Administrative Problems|7|||
27902326|NCT00171223|54558795|FG002|Overall Study|Administrative Problems|6|||
27902327|NCT00171223|54558793|FG000|Overall Study|Adverse Event (Serious Fatal)|6|||
27902328|NCT00171223|54558794|FG001|Overall Study|Adverse Event (Serious Fatal)|8|||
27902329|NCT00171223|54558795|FG002|Overall Study|Adverse Event (Serious Fatal)|9|||
27902330|NCT00171223|54558793|FG000|Overall Study|Not Specified (No Data Collected After Cut-off)|41|||
27902331|NCT00171223|54558794|FG001|Overall Study|Not Specified (No Data Collected After Cut-off)|47|||
27902332|NCT00171223|54558795|FG002|Overall Study|Not Specified (No Data Collected After Cut-off)|58|||
27902333|NCT00479674|54558801|FG000|Overall Study|Adverse Event|18|||
27902334|NCT00479674|54558801|FG000|Overall Study|Withdrawal by Subject|6|||
27902335|NCT00479674|54558801|FG000|Overall Study|Physician Decision|14|||
27902336|NCT00479674|54558801|FG000|Overall Study|none provided|3|||
27902337|NCT00479401|54558808|FG000|Overall Study|Adverse Event|24|||
27902338|NCT00479401|54558809|FG001|Overall Study|Adverse Event|20|||
27902339|NCT00479401|54558810|FG002|Overall Study|Adverse Event|4|||
27902340|NCT00479401|54558808|FG000|Overall Study|Lack of Efficacy|2|||
27902341|NCT00479401|54558809|FG001|Overall Study|Lack of Efficacy|2|||
27902342|NCT00479401|54558810|FG002|Overall Study|Lack of Efficacy|4|||
27902343|NCT00479401|54558808|FG000|Overall Study|Protocol Violation|2|||
27902344|NCT00479401|54558809|FG001|Overall Study|Protocol Violation|1|||
27902345|NCT00479401|54558810|FG002|Overall Study|Protocol Violation|1|||
27902346|NCT00479401|54558808|FG000|Overall Study|Lost to Follow-up|1|||
27902347|NCT00479401|54558809|FG001|Overall Study|Lost to Follow-up|1|||
27902348|NCT00479401|54558810|FG002|Overall Study|Lost to Follow-up|1|||
27902349|NCT00479401|54558808|FG000|Overall Study|Withdrawal by Subject|16|||
27902350|NCT00479401|54558809|FG001|Overall Study|Withdrawal by Subject|10|||
27902351|NCT00479401|54558810|FG002|Overall Study|Withdrawal by Subject|2|||
27902352|NCT00479401|54558808|FG000|Overall Study|Exclusion criteria, relocation|4|||
27902353|NCT00479401|54558809|FG001|Overall Study|Exclusion criteria, relocation|3|||
27987301|NCT00871572|54645976|FG001|Overall Study|Adverse Event|2|||
27902354|NCT00479401|54558810|FG002|Overall Study|Exclusion criteria, relocation|0|||
27902355|NCT00478777|54558818|FG000|Overall Study|Adverse Event|29|||
27902356|NCT00478777|54558818|FG000|Overall Study|Lack of Efficacy|23|||
27902357|NCT00478777|54558818|FG000|Overall Study|Withdrawal by Subject|4|||
27902358|NCT00478777|54558818|FG000|Overall Study|Death|3|||
27902359|NCT00478777|54558818|FG000|Overall Study|Protocol Violation|3|||
27902360|NCT00478777|54558818|FG000|Overall Study|Lost to Follow-up|3|||
27902361|NCT00478777|54558818|FG000|Overall Study|Physician Decision|1|||
27902362|NCT00478777|54558818|FG000|Overall Study|Intolerance of therapy|1|||
27902363|NCT00478777|54558818|FG000|Overall Study|Lack of compliance|1|||
27902364|NCT00478777|54558818|FG000|Overall Study|Lymphocytes infusion|1|||
27902365|NCT00478777|54558818|FG000|Overall Study|End of therapy|2|||
27902366|NCT00478777|54558818|FG000|Overall Study|Not treated with lenalidomide|6|||
27902367|NCT00477607|54558824|FG000|Overall Study|Lost to Follow-up|7|||
27902368|NCT00477607|54558825|FG001|Overall Study|Lost to Follow-up|7|||
27902369|NCT00477490|54558836|FG000|Part I: 4 Week Efficacy|Adverse Event|1|||
27902370|NCT00477490|54558837|FG001|Part I: 4 Week Efficacy|Adverse Event|4|||
27902371|NCT00477490|54558838|FG002|Part I: 4 Week Efficacy|Adverse Event|0|||
27902372|NCT00477490|54558839|FG003|Part I: 4 Week Efficacy|Adverse Event|5|||
27902373|NCT00477490|54558840|FG004|Part I: 4 Week Efficacy|Adverse Event|6|||
27902374|NCT00477490|54558841|FG005|Part I: 4 Week Efficacy|Adverse Event|0|||
27902375|NCT00477490|54558842|FG006|Part I: 4 Week Efficacy|Adverse Event|0|||
27902376|NCT00477490|54558843|FG007|Part I: 4 Week Efficacy|Adverse Event|0|||
27902377|NCT00477490|54558844|FG008|Part I: 4 Week Efficacy|Adverse Event|0|||
27902378|NCT00477490|54558836|FG000|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1|||
27902379|NCT00477490|54558837|FG001|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
27902380|NCT00477490|54558838|FG002|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
27902381|NCT00477490|54558839|FG003|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5|||
27987302|NCT00871572|54645977|FG002|Overall Study|Adverse Event|0|||
27987303|NCT00871572|54645978|FG003|Overall Study|Adverse Event|3|||
27902382|NCT00477490|54558840|FG004|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4|||
27902383|NCT00477490|54558841|FG005|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
27902384|NCT00477490|54558842|FG006|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
27902385|NCT00477490|54558843|FG007|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
27902386|NCT00477490|54558844|FG008|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
27902387|NCT00477490|54558836|FG000|Part I: 4 Week Efficacy|Protocol Violation|2|||
27902388|NCT00477490|54558837|FG001|Part I: 4 Week Efficacy|Protocol Violation|0|||
27902389|NCT00477490|54558838|FG002|Part I: 4 Week Efficacy|Protocol Violation|0|||
27902390|NCT00477490|54558839|FG003|Part I: 4 Week Efficacy|Protocol Violation|0|||
27902391|NCT00477490|54558840|FG004|Part I: 4 Week Efficacy|Protocol Violation|1|||
27902392|NCT00477490|54558841|FG005|Part I: 4 Week Efficacy|Protocol Violation|0|||
27902393|NCT00477490|54558842|FG006|Part I: 4 Week Efficacy|Protocol Violation|0|||
27902394|NCT00477490|54558843|FG007|Part I: 4 Week Efficacy|Protocol Violation|0|||
27902395|NCT00477490|54558844|FG008|Part I: 4 Week Efficacy|Protocol Violation|0|||
27902396|NCT00477490|54558836|FG000|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
27902397|NCT00477490|54558837|FG001|Part I: 4 Week Efficacy|Withdrawal by Subject|5|||
27902398|NCT00477490|54558838|FG002|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
27902399|NCT00477490|54558839|FG003|Part I: 4 Week Efficacy|Withdrawal by Subject|4|||
27902400|NCT00477490|54558840|FG004|Part I: 4 Week Efficacy|Withdrawal by Subject|9|||
27902401|NCT00477490|54558841|FG005|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
27902402|NCT00477490|54558842|FG006|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
27902403|NCT00477490|54558843|FG007|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
27902404|NCT00477490|54558844|FG008|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
27902405|NCT00477490|54558836|FG000|Part I: 4 Week Efficacy|Lost to Follow-up|2|||
27902406|NCT00477490|54558837|FG001|Part I: 4 Week Efficacy|Lost to Follow-up|4|||
27902407|NCT00477490|54558838|FG002|Part I: 4 Week Efficacy|Lost to Follow-up|1|||
27902408|NCT00477490|54558839|FG003|Part I: 4 Week Efficacy|Lost to Follow-up|5|||
27902409|NCT00477490|54558840|FG004|Part I: 4 Week Efficacy|Lost to Follow-up|3|||
27902410|NCT00477490|54558841|FG005|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
27902411|NCT00477490|54558842|FG006|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
27902412|NCT00477490|54558843|FG007|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
27902413|NCT00477490|54558844|FG008|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
27902414|NCT00477490|54558836|FG000|Part I: 4 Week Efficacy|Other, not specified|2|||
27902415|NCT00477490|54558837|FG001|Part I: 4 Week Efficacy|Other, not specified|4|||
27987304|NCT00871572|54645975|FG000|Overall Study|Investigator Decision|0|||
27987305|NCT00871572|54645976|FG001|Overall Study|Investigator Decision|1|||
27987306|NCT00871572|54645977|FG002|Overall Study|Investigator Decision|0|||
27987307|NCT00871572|54645978|FG003|Overall Study|Investigator Decision|1|||
27902416|NCT00477490|54558838|FG002|Part I: 4 Week Efficacy|Other, not specified|0|||
27902417|NCT00477490|54558839|FG003|Part I: 4 Week Efficacy|Other, not specified|1|||
27902418|NCT00477490|54558840|FG004|Part I: 4 Week Efficacy|Other, not specified|1|||
27902419|NCT00477490|54558841|FG005|Part I: 4 Week Efficacy|Other, not specified|0|||
27902420|NCT00477490|54558842|FG006|Part I: 4 Week Efficacy|Other, not specified|0|||
27902421|NCT00477490|54558843|FG007|Part I: 4 Week Efficacy|Other, not specified|0|||
27902422|NCT00477490|54558844|FG008|Part I: 4 Week Efficacy|Other, not specified|0|||
27902423|NCT00477490|54558836|FG000|Part I: 4 Week Efficacy|Not Reported|1|||
27902424|NCT00477490|54558837|FG001|Part I: 4 Week Efficacy|Not Reported|2|||
27902425|NCT00477490|54558838|FG002|Part I: 4 Week Efficacy|Not Reported|3|||
27902426|NCT00477490|54558839|FG003|Part I: 4 Week Efficacy|Not Reported|0|||
27902427|NCT00477490|54558840|FG004|Part I: 4 Week Efficacy|Not Reported|1|||
27902428|NCT00477490|54558841|FG005|Part I: 4 Week Efficacy|Not Reported|0|||
27902429|NCT00477490|54558842|FG006|Part I: 4 Week Efficacy|Not Reported|0|||
27902430|NCT00477490|54558843|FG007|Part I: 4 Week Efficacy|Not Reported|0|||
27902431|NCT00477490|54558844|FG008|Part I: 4 Week Efficacy|Not Reported|0|||
27902432|NCT00477490|54558836|FG000|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0|||
27902433|NCT00477490|54558837|FG001|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15|||
27902434|NCT00477490|54558838|FG002|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
27902435|NCT00477490|54558839|FG003|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
27902436|NCT00477490|54558840|FG004|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10|||
27902437|NCT00477490|54558841|FG005|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4|||
27902438|NCT00477490|54558842|FG006|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
27902439|NCT00477490|54558843|FG007|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3|||
27902440|NCT00477490|54558844|FG008|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
27902441|NCT00477490|54558836|FG000|Part II: Extension Week 5 up to Day 169|Adverse Event|0|||
27902442|NCT00477490|54558837|FG001|Part II: Extension Week 5 up to Day 169|Adverse Event|2|||
27902443|NCT00477490|54558838|FG002|Part II: Extension Week 5 up to Day 169|Adverse Event|3|||
27902444|NCT00477490|54558839|FG003|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
27902445|NCT00477490|54558840|FG004|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
27902446|NCT00477490|54558841|FG005|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
27902447|NCT00477490|54558842|FG006|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
27902448|NCT00477490|54558843|FG007|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
27902449|NCT00477490|54558844|FG008|Part II: Extension Week 5 up to Day 169|Adverse Event|4|||
27902450|NCT00477490|54558836|FG000|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
27987308|NCT00871572|54645975|FG000|Overall Study|Lost to Follow-up|0|||
27987309|NCT00871572|54645976|FG001|Overall Study|Lost to Follow-up|1|||
27902451|NCT00477490|54558837|FG001|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3|||
27902452|NCT00477490|54558838|FG002|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2|||
27987310|NCT00871572|54645977|FG002|Overall Study|Lost to Follow-up|0|||
27902453|NCT00477490|54558839|FG003|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
27902454|NCT00477490|54558840|FG004|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5|||
27902455|NCT00477490|54558841|FG005|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
27902456|NCT00477490|54558842|FG006|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1|||
27902457|NCT00477490|54558843|FG007|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
27902458|NCT00477490|54558844|FG008|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
27902459|NCT00477490|54558836|FG000|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
27902460|NCT00477490|54558837|FG001|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
27902461|NCT00477490|54558838|FG002|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
27902462|NCT00477490|54558839|FG003|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
27902463|NCT00477490|54558840|FG004|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
27902464|NCT00477490|54558841|FG005|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
27902465|NCT00477490|54558842|FG006|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
27902466|NCT00477490|54558843|FG007|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
27902467|NCT00477490|54558844|FG008|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
27902468|NCT00477490|54558836|FG000|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
27902469|NCT00477490|54558837|FG001|Part II: Extension Week 5 up to Day 169|Excluded medication|1|||
27902470|NCT00477490|54558838|FG002|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
27902471|NCT00477490|54558839|FG003|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
27902472|NCT00477490|54558840|FG004|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
27902473|NCT00477490|54558841|FG005|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
27902474|NCT00477490|54558842|FG006|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
27902475|NCT00477490|54558843|FG007|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
27902476|NCT00477490|54558844|FG008|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
27902477|NCT00477490|54558836|FG000|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
27902478|NCT00477490|54558837|FG001|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
27902479|NCT00477490|54558838|FG002|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
27902480|NCT00477490|54558839|FG003|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
27902481|NCT00477490|54558840|FG004|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
27902482|NCT00477490|54558841|FG005|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
27902483|NCT00477490|54558842|FG006|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
27902484|NCT00477490|54558843|FG007|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
27902485|NCT00477490|54558844|FG008|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
27902486|NCT00477490|54558836|FG000|Part II: Extension Week 5 up to Day 169|Not reported|0|||
27902487|NCT00477490|54558837|FG001|Part II: Extension Week 5 up to Day 169|Not reported|3|||
27902488|NCT00477490|54558838|FG002|Part II: Extension Week 5 up to Day 169|Not reported|1|||
27902489|NCT00477490|54558839|FG003|Part II: Extension Week 5 up to Day 169|Not reported|0|||
27902490|NCT00477490|54558840|FG004|Part II: Extension Week 5 up to Day 169|Not reported|1|||
27902491|NCT00477490|54558841|FG005|Part II: Extension Week 5 up to Day 169|Not reported|0|||
27902492|NCT00477490|54558842|FG006|Part II: Extension Week 5 up to Day 169|Not reported|0|||
27902493|NCT00477490|54558843|FG007|Part II: Extension Week 5 up to Day 169|Not reported|0|||
27902494|NCT00477490|54558844|FG008|Part II: Extension Week 5 up to Day 169|Not reported|0|||
27902495|NCT00477334|54558874|FG000|Overall Study|Discontinued prior to taking study drug|106|||
27902496|NCT00477334|54558875|FG001|Overall Study|Discontinued prior to taking study drug|53|||
27902497|NCT00477334|54558874|FG000|Overall Study|Adverse Event|1|||
27902498|NCT00477334|54558875|FG001|Overall Study|Adverse Event|2|||
27902499|NCT00477334|54558874|FG000|Overall Study|Withdrawal by Subject|2|||
27902500|NCT00477334|54558875|FG001|Overall Study|Withdrawal by Subject|1|||
27902501|NCT00477334|54558874|FG000|Overall Study|Lost to Follow-up|15|||
27902502|NCT00477334|54558875|FG001|Overall Study|Lost to Follow-up|4|||
27902503|NCT00477334|54558874|FG000|Overall Study|Administrative Problems|39|||
27902504|NCT00477334|54558875|FG001|Overall Study|Administrative Problems|15|||
27902505|NCT00477334|54558874|FG000|Overall Study|Protocol Violation|7|||
27902506|NCT00477334|54558875|FG001|Overall Study|Protocol Violation|1|||
27902507|NCT04971967|54559019|FG000|Overall Study|Lost to Follow-up|6|||
27902508|NCT04971967|54559020|FG001|Overall Study|Lost to Follow-up|7|||
27902509|NCT04716881|54559034|FG000|Overall Study|Adverse Event|1|||
27902510|NCT04716881|54559034|FG000|Overall Study|Lost to Follow-up|1|||
27902511|NCT04582266|54559051|FG000|Overall Study|Lost to Follow-up|7|||
27902512|NCT04582266|54559052|FG001|Overall Study|Lost to Follow-up|5|||
27902513|NCT04582266|54559051|FG000|Overall Study|Withdrawal by Subject|1|||
27902514|NCT04582266|54559052|FG001|Overall Study|Withdrawal by Subject|0|||
27902515|NCT04582266|54559051|FG000|Overall Study|Logistical and Personnel Constraints at Time of Infusion|1|||
27902516|NCT04582266|54559052|FG001|Overall Study|Logistical and Personnel Constraints at Time of Infusion|0|||
27902517|NCT04459338|54559062|FG000|Overall Study|Loss of IV during study|1|||
27902518|NCT04459338|54559063|FG001|Overall Study|Loss of IV during study|0|||
27925787|NCT01226745|54582370|FG003|Overall Study|Death|0|||
27902519|NCT04166383|54559069|FG000|Drug Administration|Prior to treatment (tx), had a medical emergency requiring surgery & was unable to have further tx.|1|||
27902520|NCT04166383|54559069|FG000|TAC 1 - Second Biopsy Cycle 2 Day 1|Did not complete 2nd biopsy.|2|||
27902521|NCT04166383|54559069|FG000|TAC 2 - Second Biopsy Cycle 4 Day 1|Did not complete 2nd biopsy.|1|||
27902522|NCT03908437|54559128|FG000|Overall Study|Death|0|||
27902523|NCT03908437|54559129|FG001|Overall Study|Death|1|||
27902524|NCT03908437|54559128|FG000|Overall Study|Lost to Follow-up|31|||
27902525|NCT03908437|54559129|FG001|Overall Study|Lost to Follow-up|24|||
27902526|NCT03740048|54559137|FG000|Overall Study|Withdrawal by Subject|1|||
27902527|NCT03740048|54559138|FG001|Overall Study|Withdrawal by Subject|1|||
27902528|NCT03740048|54559137|FG000|Overall Study|Death|1|||
27902529|NCT03740048|54559138|FG001|Overall Study|Death|6|||
27902530|NCT03740048|54559137|FG000|Overall Study|Switched to thrice-weekly HD|2|||
27902531|NCT03740048|54559138|FG001|Overall Study|Switched to thrice-weekly HD|0|||
27902532|NCT03740048|54559137|FG000|Overall Study|Switched to Peritoneal Dialysis|2|||
27902533|NCT03740048|54559138|FG001|Overall Study|Switched to Peritoneal Dialysis|0|||
27902534|NCT03740048|54559137|FG000|Overall Study|Lost to Follow-up|0|||
27902535|NCT03740048|54559138|FG001|Overall Study|Lost to Follow-up|1|||
27902536|NCT03740048|54559137|FG000|Overall Study|Non-compliance with HD|0|||
27902537|NCT03740048|54559138|FG001|Overall Study|Non-compliance with HD|1|||
27902538|NCT03436862|54559198|FG000|Overall Study|Adverse Event|4|||
27902539|NCT03436862|54559198|FG000|Overall Study|Progressive Disease|2|||
27902540|NCT03373760|54559219|FG000|Overall Study|Adverse Event|8|||
27902541|NCT03373760|54559219|FG000|Overall Study|Disease Progression|46|||
27902542|NCT03373760|54559219|FG000|Overall Study|Death|4|||
27902543|NCT03324880|54559228|FG000|Overall Study|Adverse Event|0|||
27902544|NCT03324880|54559229|FG001|Overall Study|Adverse Event|2|||
27902545|NCT03324880|54559228|FG000|Overall Study|Withdrawal by Subject|2|||
27902546|NCT03324880|54559229|FG001|Overall Study|Withdrawal by Subject|2|||
27902547|NCT03324880|54559228|FG000|Overall Study|Lost to Follow-up|0|||
27902548|NCT03324880|54559229|FG001|Overall Study|Lost to Follow-up|1|||
27902549|NCT03324880|54559228|FG000|Overall Study|Product Recall|0|||
27902550|NCT03324880|54559229|FG001|Overall Study|Product Recall|1|||
27902551|NCT03053440|54559239|FG000|Overall Study|Sponsor's Decision to End the Study|20|||
27902552|NCT03053440|54559240|FG001|Overall Study|Sponsor's Decision to End the Study|13|||
27902553|NCT03053440|54559239|FG000|Overall Study|Death|18|||
27902554|NCT03053440|54559240|FG001|Overall Study|Death|14|||
27902555|NCT03053440|54559239|FG000|Overall Study|Withdrawal by Subject|9|||
27902556|NCT03053440|54559240|FG001|Overall Study|Withdrawal by Subject|8|||
27902557|NCT03053440|54559239|FG000|Overall Study|Lost to Follow-up|1|||
27902558|NCT03053440|54559240|FG001|Overall Study|Lost to Follow-up|0|||
27902559|NCT03053440|54559239|FG000|Overall Study|Enrolled in Long-term Extension Study|48|||
27902560|NCT03053440|54559240|FG001|Overall Study|Enrolled in Long-term Extension Study|66|||
27902561|NCT03053440|54559239|FG000|Overall Study|Physician Decision|2|||
27902562|NCT03053440|54559240|FG001|Overall Study|Physician Decision|1|||
27902563|NCT03053440|54559239|FG000|Overall Study|Participant Randomized but died before dosing|1|||
27902564|NCT03053440|54559240|FG001|Overall Study|Participant Randomized but died before dosing|0|||
27902565|NCT02985684|54559247|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|5|||
27902566|NCT02985684|54559247|FG000|6-Month Closure Success Evaluation|Technical Failure (No Device)|5|||
27902567|NCT02985684|54559247|FG000|6-Month Closure Success Evaluation|Device Removal|3|||
27902568|NCT02949934|54559286|FG000|Natural Drinking Period|Adverse Event|1|||
27902569|NCT02949934|54559287|FG001|Natural Drinking Period|Adverse Event|0|||
27902570|NCT02949934|54559288|FG002|Natural Drinking Period|Adverse Event|0|||
27902571|NCT02949934|54559289|FG003|Natural Drinking Period|Adverse Event|1|||
27902572|NCT02949934|54559290|FG004|Natural Drinking Period|Adverse Event|0|||
27902573|NCT02949934|54559291|FG005|Natural Drinking Period|Adverse Event|0|||
27902574|NCT02949934|54559286|FG000|Natural Drinking Period|Lost to Follow-up|0|||
27902575|NCT02949934|54559287|FG001|Natural Drinking Period|Lost to Follow-up|0|||
27902576|NCT02949934|54559288|FG002|Natural Drinking Period|Lost to Follow-up|0|||
27902577|NCT02949934|54559289|FG003|Natural Drinking Period|Lost to Follow-up|0|||
27902578|NCT02949934|54559290|FG004|Natural Drinking Period|Lost to Follow-up|1|||
27902579|NCT02949934|54559291|FG005|Natural Drinking Period|Lost to Follow-up|0|||
28097373|NCT04036110|54752995|FG000|Overall Study|Study Suspended|4|||
27902580|NCT02949934|54559286|FG000|Neuroimaging|Protocol Violation|2|||
27902581|NCT02949934|54559287|FG001|Neuroimaging|Protocol Violation|0|||
27902582|NCT02949934|54559288|FG002|Neuroimaging|Protocol Violation|0|||
28097374|NCT04036110|54752996|FG001|Overall Study|Study Suspended|5|||
28097375|NCT04036110|54752997|FG002|Overall Study|Study Suspended|1|||
28097376|NCT03053050|54753008|FG000|Randomized Phase|Study Terminated by Sponsor|259|||
28097377|NCT03053050|54753009|FG001|Randomized Phase|Study Terminated by Sponsor|260|||
28097378|NCT03053050|54753010|FG002|Randomized Phase|Study Terminated by Sponsor|128|||
28097379|NCT03053050|54753011|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
27902583|NCT02949934|54559289|FG003|Neuroimaging|Protocol Violation|0|||
27902584|NCT02949934|54559290|FG004|Neuroimaging|Protocol Violation|1|||
27902585|NCT02949934|54559291|FG005|Neuroimaging|Protocol Violation|0|||
28097380|NCT03053050|54753008|FG000|Randomized Phase|Withdrew Consent|16|||
27739488|NCT03745651|54189167|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
27739489|NCT03745651|54189168|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|2|||
27739490|NCT03745651|54189169|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
27739491|NCT03745651|54189170|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
27739492|NCT03745651|54189171|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
27739493|NCT03745651|54189172|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
27739494|NCT03745651|54189173|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
27739495|NCT03745651|54189167|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
27739496|NCT03745651|54189168|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|21|||
27739497|NCT03745651|54189169|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|15|||
27739498|NCT03745651|54189170|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
27739499|NCT03745651|54189171|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
27739500|NCT03745651|54189172|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
27739501|NCT03745651|54189173|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
27739502|NCT03745651|54189167|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|1|||
27739503|NCT03745651|54189168|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
27739504|NCT03745651|54189169|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
27739505|NCT03745651|54189170|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
27739506|NCT03745651|54189171|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
27739507|NCT03745651|54189172|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
27739508|NCT03745651|54189173|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
27739509|NCT03745651|54189167|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
27739510|NCT03745651|54189168|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
27739511|NCT03745651|54189169|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
27739512|NCT03745651|54189170|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
27739513|NCT03745651|54189171|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
27739514|NCT03745651|54189172|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|4|||
27739515|NCT03745651|54189173|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
27739516|NCT03745651|54189167|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
27739517|NCT03745651|54189168|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
27739518|NCT03745651|54189169|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
27739519|NCT03745651|54189170|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
27739520|NCT03745651|54189171|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
27739521|NCT03745651|54189172|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
27739522|NCT03745651|54189173|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
27739523|NCT03745651|54189167|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
27739524|NCT03745651|54189168|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
27739525|NCT03745651|54189169|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
27902586|NCT02949934|54559286|FG000|Neuroimaging|Motion artifacts in imaging data|1|||
27902587|NCT02949934|54559287|FG001|Neuroimaging|Motion artifacts in imaging data|0|||
27902588|NCT02949934|54559288|FG002|Neuroimaging|Motion artifacts in imaging data|1|||
27902589|NCT02949934|54559289|FG003|Neuroimaging|Motion artifacts in imaging data|0|||
27902590|NCT02949934|54559290|FG004|Neuroimaging|Motion artifacts in imaging data|1|||
27902591|NCT02949934|54559291|FG005|Neuroimaging|Motion artifacts in imaging data|0|||
27902592|NCT02949934|54559286|FG000|Neuroimaging|Not scanned|0|||
27902593|NCT02949934|54559287|FG001|Neuroimaging|Not scanned|0|||
27902594|NCT02949934|54559288|FG002|Neuroimaging|Not scanned|1|||
27902595|NCT02949934|54559289|FG003|Neuroimaging|Not scanned|0|||
27902596|NCT02949934|54559290|FG004|Neuroimaging|Not scanned|0|||
27902597|NCT02949934|54559291|FG005|Neuroimaging|Not scanned|2|||
27902598|NCT02949934|54559286|FG000|Bar Laboratory|Procedure not done due to COVID-19 pandemic|0|||
27902599|NCT02949934|54559287|FG001|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
27902600|NCT02949934|54559288|FG002|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
27902601|NCT02949934|54559289|FG003|Bar Laboratory|Procedure not done due to COVID-19 pandemic|3|||
27902602|NCT02949934|54559290|FG004|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
27902603|NCT02949934|54559291|FG005|Bar Laboratory|Procedure not done due to COVID-19 pandemic|1|||
27902604|NCT02949934|54559286|FG000|Bar Laboratory|Adverse Event|1|||
27902605|NCT02949934|54559287|FG001|Bar Laboratory|Adverse Event|0|||
27902606|NCT02949934|54559288|FG002|Bar Laboratory|Adverse Event|2|||
27902607|NCT02949934|54559289|FG003|Bar Laboratory|Adverse Event|0|||
27902608|NCT02949934|54559290|FG004|Bar Laboratory|Adverse Event|1|||
27902609|NCT02949934|54559291|FG005|Bar Laboratory|Adverse Event|0|||
27902610|NCT02949934|54559286|FG000|Bar Laboratory|Protocol Violation|0|||
27902611|NCT02949934|54559287|FG001|Bar Laboratory|Protocol Violation|0|||
27902612|NCT02949934|54559288|FG002|Bar Laboratory|Protocol Violation|0|||
27987311|NCT00871572|54645978|FG003|Overall Study|Lost to Follow-up|1|||
27987312|NCT00871572|54645975|FG000|Overall Study|Protocol Violation|0|||
27902613|NCT02949934|54559289|FG003|Bar Laboratory|Protocol Violation|1|||
27902614|NCT02949934|54559290|FG004|Bar Laboratory|Protocol Violation|0|||
27902615|NCT02949934|54559291|FG005|Bar Laboratory|Protocol Violation|0|||
27902616|NCT02935634|54559323|FG000|Randomization|Participant withdrew consent|0|||
27902617|NCT02935634|54559324|FG001|Randomization|Participant withdrew consent|1|||
27902618|NCT02935634|54559325|FG002|Randomization|Participant withdrew consent|0|||
27902619|NCT02935634|54559326|FG003|Randomization|Participant withdrew consent|0|||
27902620|NCT02935634|54559327|FG004|Randomization|Participant withdrew consent|0|||
27902621|NCT02935634|54559328|FG005|Randomization|Participant withdrew consent|0|||
28172205|NCT03836001|54843811|FG001|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
28172206|NCT03836001|54843812|FG002|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|1|||
28172207|NCT02465866|54843819|FG000|Period 3|Withdrawal by Subject|0|||
28172208|NCT02465866|54843820|FG001|Period 3|Withdrawal by Subject|1|||
28172209|NCT02465866|54843821|FG002|Period 3|Withdrawal by Subject|0|||
28172210|NCT02465866|54843822|FG003|Period 3|Withdrawal by Subject|0|||
28172211|NCT02439970|54843834|FG000|Overall Study|Study Terminated|2|||
28172212|NCT02439970|54843835|FG001|Overall Study|Study Terminated|3|||
28172213|NCT02437864|54843843|FG000|Overall Study|Protocol Violation|4|||
27739526|NCT03745651|54189170|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|4|||
27739527|NCT03745651|54189171|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|2|||
27739528|NCT03745651|54189172|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
27902622|NCT02935634|54559323|FG000|Randomization|Death|2|||
27902623|NCT02935634|54559324|FG001|Randomization|Death|1|||
27902624|NCT02935634|54559325|FG002|Randomization|Death|1|||
27902625|NCT02935634|54559326|FG003|Randomization|Death|0|||
27902626|NCT02935634|54559327|FG004|Randomization|Death|0|||
27902627|NCT02935634|54559328|FG005|Randomization|Death|0|||
27902628|NCT02935634|54559323|FG000|Randomization|Other reasons|0|||
27902629|NCT02935634|54559324|FG001|Randomization|Other reasons|2|||
27902630|NCT02935634|54559325|FG002|Randomization|Other reasons|2|||
27902631|NCT02935634|54559326|FG003|Randomization|Other reasons|0|||
27987313|NCT00871572|54645976|FG001|Overall Study|Protocol Violation|0|||
27987314|NCT00871572|54645977|FG002|Overall Study|Protocol Violation|1|||
27987315|NCT00871572|54645978|FG003|Overall Study|Protocol Violation|1|||
27987316|NCT00871572|54645975|FG000|Overall Study|Sponsor Decision|1|||
27987317|NCT00871572|54645976|FG001|Overall Study|Sponsor Decision|0|||
27739529|NCT03745651|54189173|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|10|||
27739530|NCT03745651|54189167|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
27739531|NCT03745651|54189168|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
27739532|NCT03745651|54189169|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
27739533|NCT03745651|54189170|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
27739534|NCT03745651|54189171|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
27739535|NCT03745651|54189172|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|4|||
27902632|NCT02935634|54559327|FG004|Randomization|Other reasons|0|||
27987318|NCT00871572|54645977|FG002|Overall Study|Sponsor Decision|0|||
27987319|NCT00871572|54645978|FG003|Overall Study|Sponsor Decision|0|||
27987320|NCT00871572|54645975|FG000|Overall Study|Withdrawal by Subject|1|||
27987321|NCT00871572|54645976|FG001|Overall Study|Withdrawal by Subject|2|||
27987322|NCT00871572|54645977|FG002|Overall Study|Withdrawal by Subject|3|||
27987323|NCT00871572|54645978|FG003|Overall Study|Withdrawal by Subject|1|||
27987324|NCT03885661|54645990|FG000|Overall Study|Withdrawal by Subject|0|||
27987325|NCT03885661|54645991|FG001|Overall Study|Withdrawal by Subject|1|||
27987326|NCT03885661|54645990|FG000|Overall Study|Unwilling to undergo required study procedure|1|||
27987327|NCT03885661|54645991|FG001|Overall Study|Unwilling to undergo required study procedure|0|||
27987328|NCT00868530|54645997|FG000|Overall Study|Adverse Event|3|||
27987329|NCT00868530|54645997|FG000|Overall Study|Lost to Follow-up|1|||
27987330|NCT00855465|54646003|FG000|Treatment Period|Adverse Event|4|||
27987331|NCT00855465|54646004|FG001|Treatment Period|Adverse Event|2|||
27987332|NCT00855465|54646003|FG000|Treatment Period|Death|2|||
27987333|NCT00855465|54646004|FG001|Treatment Period|Death|2|||
27987334|NCT00855465|54646003|FG000|Treatment Period|Lack of Efficacy|2|||
27987335|NCT00855465|54646004|FG001|Treatment Period|Lack of Efficacy|1|||
27987336|NCT00855465|54646003|FG000|Treatment Period|Non-compliance|1|||
27987337|NCT00855465|54646004|FG001|Treatment Period|Non-compliance|0|||
27987338|NCT00855465|54646003|FG000|Treatment Period|Protocol Violation|2|||
27987339|NCT00855465|54646004|FG001|Treatment Period|Protocol Violation|0|||
27987340|NCT00855465|54646003|FG000|Treatment Period|Withdrawal by Subject|2|||
27987341|NCT00855465|54646004|FG001|Treatment Period|Withdrawal by Subject|0|||
27987342|NCT00855465|54646003|FG000|Treatment Period|Not treated|1|||
28172214|NCT02437864|54843844|FG001|Overall Study|Protocol Violation|0|||
27902633|NCT02935634|54559328|FG005|Randomization|Other reasons|0|||
27902634|NCT02935634|54559323|FG000|Treatment: Track 1|Disease progression|15|||
27902635|NCT02935634|54559324|FG001|Treatment: Track 1|Disease progression|17|||
27902636|NCT02935634|54559325|FG002|Treatment: Track 1|Disease progression|28|||
27987343|NCT00855465|54646004|FG001|Treatment Period|Not treated|0|||
27987344|NCT00855465|54646003|FG000|Follow-up Period (FUP)|Adverse Event|0|||
27739536|NCT03745651|54189173|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|2|||
27739537|NCT03745651|54189167|FG000|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
27739538|NCT03745651|54189168|FG001|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
27739539|NCT03745651|54189169|FG002|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
27739540|NCT03745651|54189170|FG003|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
27739541|NCT03745651|54189171|FG004|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
27739542|NCT03745651|54189172|FG005|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
27739543|NCT03745651|54189173|FG006|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
27739544|NCT03745651|54189167|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
27739545|NCT03745651|54189168|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
27739546|NCT03745651|54189169|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
27739547|NCT03745651|54189170|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
27739548|NCT03745651|54189171|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
27739549|NCT03745651|54189172|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
27739550|NCT03745651|54189173|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
27739551|NCT03745651|54189167|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
27739552|NCT03745651|54189168|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
27739553|NCT03745651|54189169|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
27739554|NCT03745651|54189170|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|12|||
27902637|NCT02935634|54559326|FG003|Treatment: Track 1|Disease progression|4|||
27902638|NCT02935634|54559327|FG004|Treatment: Track 1|Disease progression|6|||
27902639|NCT02935634|54559328|FG005|Treatment: Track 1|Disease progression|2|||
27902640|NCT02935634|54559323|FG000|Treatment: Track 1|Adverse event unrelated to study drug|1|||
27902641|NCT02935634|54559324|FG001|Treatment: Track 1|Adverse event unrelated to study drug|1|||
27902642|NCT02935634|54559325|FG002|Treatment: Track 1|Adverse event unrelated to study drug|2|||
27902643|NCT02935634|54559326|FG003|Treatment: Track 1|Adverse event unrelated to study drug|3|||
27902644|NCT02935634|54559327|FG004|Treatment: Track 1|Adverse event unrelated to study drug|0|||
27902645|NCT02935634|54559328|FG005|Treatment: Track 1|Adverse event unrelated to study drug|3|||
27902646|NCT02935634|54559323|FG000|Treatment: Track 1|Lost to Follow-up|1|||
27902647|NCT02935634|54559324|FG001|Treatment: Track 1|Lost to Follow-up|0|||
27902648|NCT02935634|54559325|FG002|Treatment: Track 1|Lost to Follow-up|0|||
27902649|NCT02935634|54559326|FG003|Treatment: Track 1|Lost to Follow-up|0|||
27902650|NCT02935634|54559327|FG004|Treatment: Track 1|Lost to Follow-up|0|||
27902651|NCT02935634|54559328|FG005|Treatment: Track 1|Lost to Follow-up|0|||
27902652|NCT02935634|54559323|FG000|Treatment: Track 1|Study drug toxicity|2|||
27902653|NCT02935634|54559324|FG001|Treatment: Track 1|Study drug toxicity|1|||
27902654|NCT02935634|54559325|FG002|Treatment: Track 1|Study drug toxicity|3|||
27902655|NCT02935634|54559326|FG003|Treatment: Track 1|Study drug toxicity|0|||
27902656|NCT02935634|54559327|FG004|Treatment: Track 1|Study drug toxicity|0|||
27902657|NCT02935634|54559328|FG005|Treatment: Track 1|Study drug toxicity|1|||
27902658|NCT02935634|54559323|FG000|Treatment: Track 1|Participant request to discontinue treatment|1|||
27902659|NCT02935634|54559324|FG001|Treatment: Track 1|Participant request to discontinue treatment|0|||
27902660|NCT02935634|54559325|FG002|Treatment: Track 1|Participant request to discontinue treatment|1|||
27902661|NCT02935634|54559326|FG003|Treatment: Track 1|Participant request to discontinue treatment|0|||
27902662|NCT02935634|54559327|FG004|Treatment: Track 1|Participant request to discontinue treatment|1|||
27902663|NCT02935634|54559328|FG005|Treatment: Track 1|Participant request to discontinue treatment|0|||
27902664|NCT02935634|54559323|FG000|Treatment: Track 1|Participant withdrew consent|2|||
27902665|NCT02935634|54559324|FG001|Treatment: Track 1|Participant withdrew consent|0|||
27902666|NCT02935634|54559325|FG002|Treatment: Track 1|Participant withdrew consent|1|||
27902667|NCT02935634|54559326|FG003|Treatment: Track 1|Participant withdrew consent|0|||
27902668|NCT02935634|54559327|FG004|Treatment: Track 1|Participant withdrew consent|1|||
27902669|NCT02935634|54559328|FG005|Treatment: Track 1|Participant withdrew consent|0|||
27902670|NCT02935634|54559323|FG000|Treatment: Track 1|Other reasons|0|||
27902671|NCT02935634|54559324|FG001|Treatment: Track 1|Other reasons|0|||
27902672|NCT02935634|54559325|FG002|Treatment: Track 1|Other reasons|2|||
27902673|NCT02935634|54559326|FG003|Treatment: Track 1|Other reasons|0|||
27902674|NCT02935634|54559327|FG004|Treatment: Track 1|Other reasons|0|||
27902675|NCT02935634|54559328|FG005|Treatment: Track 1|Other reasons|0|||
27902676|NCT02935634|54559323|FG000|Treatment: Track 2|Disease progression|13|||
27902677|NCT02935634|54559324|FG001|Treatment: Track 2|Disease progression|26|||
27902678|NCT02935634|54559325|FG002|Treatment: Track 2|Disease progression|20|||
27902679|NCT02935634|54559326|FG003|Treatment: Track 2|Disease progression|5|||
27902680|NCT02935634|54559327|FG004|Treatment: Track 2|Disease progression|1|||
27902681|NCT02935634|54559328|FG005|Treatment: Track 2|Disease progression|4|||
28172215|NCT02408068|54843850|FG000|Treatment 3 (1.5 Days)|Adverse Event|0|||
27902682|NCT02935634|54559323|FG000|Treatment: Track 2|Adverse event unrelated to study drug|2|||
28172216|NCT02408068|54843851|FG001|Treatment 3 (1.5 Days)|Adverse Event|0|||
28172217|NCT02408068|54843852|FG002|Treatment 3 (1.5 Days)|Adverse Event|1|||
27902683|NCT02935634|54559324|FG001|Treatment: Track 2|Adverse event unrelated to study drug|2|||
27902684|NCT02935634|54559325|FG002|Treatment: Track 2|Adverse event unrelated to study drug|0|||
27902685|NCT02935634|54559326|FG003|Treatment: Track 2|Adverse event unrelated to study drug|0|||
27902686|NCT02935634|54559327|FG004|Treatment: Track 2|Adverse event unrelated to study drug|0|||
27902687|NCT02935634|54559328|FG005|Treatment: Track 2|Adverse event unrelated to study drug|0|||
27902688|NCT02935634|54559323|FG000|Treatment: Track 2|Study drug toxicity|7|||
27902689|NCT02935634|54559324|FG001|Treatment: Track 2|Study drug toxicity|3|||
27902690|NCT02935634|54559325|FG002|Treatment: Track 2|Study drug toxicity|0|||
27902691|NCT02935634|54559326|FG003|Treatment: Track 2|Study drug toxicity|0|||
27902692|NCT02935634|54559327|FG004|Treatment: Track 2|Study drug toxicity|0|||
27902693|NCT02935634|54559328|FG005|Treatment: Track 2|Study drug toxicity|0|||
27902694|NCT02935634|54559323|FG000|Treatment: Track 2|Participant request to discontinue treatment|0|||
27902695|NCT02935634|54559324|FG001|Treatment: Track 2|Participant request to discontinue treatment|2|||
27902696|NCT02935634|54559325|FG002|Treatment: Track 2|Participant request to discontinue treatment|1|||
27902697|NCT02935634|54559326|FG003|Treatment: Track 2|Participant request to discontinue treatment|0|||
27902698|NCT02935634|54559327|FG004|Treatment: Track 2|Participant request to discontinue treatment|0|||
27902699|NCT02935634|54559328|FG005|Treatment: Track 2|Participant request to discontinue treatment|0|||
27902700|NCT02935634|54559323|FG000|Treatment: Track 2|Participant withdrew consent|0|||
27902701|NCT02935634|54559324|FG001|Treatment: Track 2|Participant withdrew consent|1|||
27902702|NCT02935634|54559325|FG002|Treatment: Track 2|Participant withdrew consent|1|||
27902703|NCT02935634|54559326|FG003|Treatment: Track 2|Participant withdrew consent|0|||
27902704|NCT02935634|54559327|FG004|Treatment: Track 2|Participant withdrew consent|1|||
27902705|NCT02935634|54559328|FG005|Treatment: Track 2|Participant withdrew consent|0|||
27902706|NCT02864992|54559357|FG000|Overall Study|still on treatment|15|||
27902707|NCT02864992|54559358|FG001|Overall Study|still on treatment|1|||
27902708|NCT02864992|54559359|FG002|Overall Study|still on treatment|33|||
27902709|NCT02684578|54559367|FG000|Overall Study|Withdrawal by Subject|10|||
27987345|NCT00855465|54646004|FG001|Follow-up Period (FUP)|Adverse Event|1|||
27987346|NCT00855465|54646003|FG000|Follow-up Period (FUP)|Death|0|||
27987347|NCT00855465|54646004|FG001|Follow-up Period (FUP)|Death|1|||
27987348|NCT00855465|54646003|FG000|Follow-up Period (FUP)|Lost to Follow-up|3|||
27987349|NCT00855465|54646004|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
27987350|NCT00855465|54646003|FG000|Follow-up Period (FUP)|Withdrawal by Subject|4|||
27987351|NCT00855465|54646004|FG001|Follow-up Period (FUP)|Withdrawal by Subject|0|||
27987352|NCT00855465|54646003|FG000|Follow-up Period (FUP)|Missing|1|||
27987353|NCT00855465|54646004|FG001|Follow-up Period (FUP)|Missing|0|||
27987354|NCT00598442|54646013|FG000|Overall Study|Adverse Event|3|||
27987355|NCT00598442|54646014|FG001|Overall Study|Adverse Event|0|||
27987356|NCT00598442|54646015|FG002|Overall Study|Adverse Event|0|||
27987357|NCT00598442|54646013|FG000|Overall Study|Death|19|||
27987358|NCT00598442|54646014|FG001|Overall Study|Death|11|||
27987359|NCT00598442|54646015|FG002|Overall Study|Death|11|||
27902710|NCT02684578|54559368|FG001|Overall Study|Withdrawal by Subject|7|||
27902711|NCT02684578|54559367|FG000|Overall Study|Lost to Follow-up|0|||
27902712|NCT02684578|54559368|FG001|Overall Study|Lost to Follow-up|3|||
27902713|NCT02684578|54559367|FG000|Overall Study|Ineligible after reviewing baseline imaging|1|||
27902714|NCT02684578|54559368|FG001|Overall Study|Ineligible after reviewing baseline imaging|0|||
27902715|NCT02684578|54559367|FG000|Overall Study|Missing follow-up data|0|||
27902716|NCT02684578|54559368|FG001|Overall Study|Missing follow-up data|1|||
27902717|NCT02612129|54559376|FG000|Single Dose Treatment Period|Screening Failure|1|||
27902718|NCT02612129|54559377|FG001|Single Dose Treatment Period|Screening Failure|0|||
27902719|NCT02612129|54559378|FG002|Single Dose Treatment Period|Screening Failure|0|||
27902720|NCT02612129|54559376|FG000|Continuous Treatment Period|Early Escape|0|||
27902721|NCT02612129|54559377|FG001|Continuous Treatment Period|Early Escape|2|||
27902722|NCT02612129|54559378|FG002|Continuous Treatment Period|Early Escape|0|||
27902723|NCT02612129|54559376|FG000|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
27902724|NCT02612129|54559377|FG001|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|1|||
27902725|NCT02612129|54559378|FG002|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
27902726|NCT02612129|54559376|FG000|Continuous Treatment Period|Safety Reasons|0|||
27902727|NCT02612129|54559377|FG001|Continuous Treatment Period|Safety Reasons|3|||
27902728|NCT02612129|54559378|FG002|Continuous Treatment Period|Safety Reasons|0|||
27902729|NCT02612129|54559376|FG000|Continuous Treatment Period|Death|0|||
27902730|NCT02612129|54559377|FG001|Continuous Treatment Period|Death|1|||
27987360|NCT00598442|54646013|FG000|Overall Study|Lost to Follow-up|4|||
27987361|NCT00598442|54646014|FG001|Overall Study|Lost to Follow-up|3|||
27987362|NCT00598442|54646015|FG002|Overall Study|Lost to Follow-up|3|||
27902731|NCT02612129|54559378|FG002|Continuous Treatment Period|Death|0|||
27902732|NCT02612129|54559376|FG000|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
27987363|NCT00598442|54646013|FG000|Overall Study|Physician Decision|2|||
27987364|NCT00598442|54646014|FG001|Overall Study|Physician Decision|1|||
27987365|NCT00598442|54646015|FG002|Overall Study|Physician Decision|1|||
27987366|NCT00598442|54646013|FG000|Overall Study|Withdrawal by Subject|8|||
27987367|NCT00598442|54646014|FG001|Overall Study|Withdrawal by Subject|16|||
27902733|NCT02612129|54559377|FG001|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
27987368|NCT00598442|54646015|FG002|Overall Study|Withdrawal by Subject|6|||
27902734|NCT02612129|54559378|FG002|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|1|||
27902735|NCT02580305|54559388|FG000|Overall Study|Adverse Event|15|||
27902736|NCT02580305|54559389|FG001|Overall Study|Adverse Event|19|||
27987369|NCT00598442|54646013|FG000|Overall Study|Noncompliance|0|||
27902737|NCT02580305|54559390|FG002|Overall Study|Adverse Event|10|||
27902738|NCT02580305|54559388|FG000|Overall Study|Lack of Efficacy|5|||
27902739|NCT02580305|54559389|FG001|Overall Study|Lack of Efficacy|0|||
27902740|NCT02580305|54559390|FG002|Overall Study|Lack of Efficacy|2|||
27902741|NCT02580305|54559388|FG000|Overall Study|Protocol Violation|4|||
27902742|NCT02580305|54559389|FG001|Overall Study|Protocol Violation|9|||
27902743|NCT02580305|54559390|FG002|Overall Study|Protocol Violation|6|||
27902744|NCT02580305|54559388|FG000|Overall Study|Lost to Follow-up|4|||
27902745|NCT02580305|54559389|FG001|Overall Study|Lost to Follow-up|4|||
27902746|NCT02580305|54559390|FG002|Overall Study|Lost to Follow-up|2|||
27902747|NCT02580305|54559388|FG000|Overall Study|Withdrawal by Subject|11|||
27902748|NCT02580305|54559389|FG001|Overall Study|Withdrawal by Subject|9|||
27902749|NCT02580305|54559390|FG002|Overall Study|Withdrawal by Subject|7|||
27902750|NCT02580305|54559388|FG000|Overall Study|Randomized in error and never treated|4|||
27902751|NCT02580305|54559389|FG001|Overall Study|Randomized in error and never treated|8|||
27902752|NCT02580305|54559390|FG002|Overall Study|Randomized in error and never treated|5|||
27902753|NCT02054741|54559409|FG000|Overall Study|Protocol Violation|13|||
27902754|NCT02054741|54559410|FG001|Overall Study|Protocol Violation|2|||
27987370|NCT00598442|54646014|FG001|Overall Study|Noncompliance|2|||
27987371|NCT00598442|54646015|FG002|Overall Study|Noncompliance|1|||
27987372|NCT00598442|54646013|FG000|Overall Study|Relocation|1|||
27987373|NCT00598442|54646014|FG001|Overall Study|Relocation|4|||
27987374|NCT00598442|54646015|FG002|Overall Study|Relocation|0|||
27987375|NCT00598442|54646013|FG000|Overall Study|Renal transplant|0|||
27987376|NCT00598442|54646014|FG001|Overall Study|Renal transplant|0|||
27987377|NCT00598442|54646015|FG002|Overall Study|Renal transplant|1|||
27987378|NCT00598442|54646013|FG000|Overall Study|Site closed by sponsor|5|||
27987379|NCT00598442|54646014|FG001|Overall Study|Site closed by sponsor|2|||
27987380|NCT00598442|54646015|FG002|Overall Study|Site closed by sponsor|1|||
27987381|NCT00598442|54646013|FG000|Overall Study|Started dialysis|1|||
27987382|NCT00598442|54646014|FG001|Overall Study|Started dialysis|0|||
27987383|NCT00598442|54646015|FG002|Overall Study|Started dialysis|0|||
27987384|NCT00593814|54646025|FG000|Overall Study|Death|7|||
27987385|NCT00593814|54646026|FG001|Overall Study|Death|0|||
27987386|NCT00593814|54646025|FG000|Overall Study|Withdrawal by Subject|7|||
27987387|NCT00593814|54646026|FG001|Overall Study|Withdrawal by Subject|0|||
27987388|NCT00593814|54646025|FG000|Overall Study|Lost to Follow-up|7|||
27987389|NCT00593814|54646026|FG001|Overall Study|Lost to Follow-up|0|||
27987390|NCT00593814|54646025|FG000|Overall Study|Physician Decision|3|||
28097381|NCT03053050|54753009|FG001|Randomized Phase|Withdrew Consent|8|||
28097382|NCT03053050|54753010|FG002|Randomized Phase|Withdrew Consent|9|||
28097383|NCT03053050|54753011|FG003|Randomized Phase|Withdrew Consent|0|||
28097384|NCT03053050|54753008|FG000|Randomized Phase|Investigator's Discretion|6|||
28097385|NCT03053050|54753009|FG001|Randomized Phase|Investigator's Discretion|6|||
28097386|NCT03053050|54753010|FG002|Randomized Phase|Investigator's Discretion|3|||
28097387|NCT03053050|54753011|FG003|Randomized Phase|Investigator's Discretion|0|||
28097388|NCT03053050|54753008|FG000|Randomized Phase|Lost to Follow-up|5|||
28097389|NCT03053050|54753009|FG001|Randomized Phase|Lost to Follow-up|1|||
28097390|NCT03053050|54753010|FG002|Randomized Phase|Lost to Follow-up|1|||
28097391|NCT03053050|54753011|FG003|Randomized Phase|Lost to Follow-up|0|||
28097392|NCT03053050|54753008|FG000|Randomized Phase|Adverse Event|0|||
28097393|NCT03053050|54753009|FG001|Randomized Phase|Adverse Event|1|||
28097394|NCT03053050|54753010|FG002|Randomized Phase|Adverse Event|0|||
28097395|NCT03053050|54753011|FG003|Randomized Phase|Adverse Event|0|||
28097396|NCT03053050|54753008|FG000|Randomized Phase|Randomized but Never Treated|2|||
28097397|NCT03053050|54753009|FG001|Randomized Phase|Randomized but Never Treated|2|||
28097398|NCT03053050|54753010|FG002|Randomized Phase|Randomized but Never Treated|2|||
27902755|NCT02054741|54559409|FG000|Overall Study|Withdrawal by Subject|10|||
27987391|NCT00593814|54646026|FG001|Overall Study|Physician Decision|0|||
27987392|NCT00855309|54646034|FG000|Overall Study|patient never recieved drug|1|||
28097399|NCT03053050|54753011|FG003|Randomized Phase|Randomized but Never Treated|0|||
28097400|NCT03053050|54753008|FG000|Randomized Phase|Entered the Open-Label Phase|36|||
28097401|NCT03053050|54753009|FG001|Randomized Phase|Entered the Open-Label Phase|45|||
28097402|NCT03053050|54753010|FG002|Randomized Phase|Entered the Open-Label Phase|18|||
27902756|NCT02054741|54559410|FG001|Overall Study|Withdrawal by Subject|5|||
27902757|NCT02054741|54559409|FG000|Overall Study|Death|94|||
27902758|NCT02054741|54559410|FG001|Overall Study|Death|90|||
27902759|NCT02054741|54559409|FG000|Overall Study|Subject passively continued participation only with data obtained from their medical records|35|||
27987393|NCT00855309|54646035|FG001|Overall Study|patient never recieved drug|0|||
27902760|NCT02054741|54559410|FG001|Overall Study|Subject passively continued participation only with data obtained from their medical records|32|||
27902761|NCT01555463|54559418|FG000|Treatment|Adverse Event|6|||
27902762|NCT01555463|54559419|FG001|Treatment|Adverse Event|12|||
27902763|NCT01555463|54559418|FG000|Treatment|Withdrawal by Subject|24|||
27987394|NCT00532129|54646041|FG000|Treatment Period|Adverse event/Serious adverse event|25|||
27987395|NCT00532129|54646041|FG000|Treatment Period|Physician Decision|15|||
27987396|NCT00532129|54646041|FG000|Treatment Period|Disease progression|3|||
27987397|NCT00532129|54646041|FG000|Treatment Period|Protocol Violation|1|||
27987398|NCT00532129|54646041|FG000|Treatment Period|Other|5|||
27987399|NCT00532129|54646041|FG000|Follow-up Period|Adverse event/Serious adverse event|1|||
27987400|NCT00532129|54646041|FG000|Follow-up Period|Disease progression|57|||
27987401|NCT00532129|54646041|FG000|Follow-up Period|Lost to Follow-up|1|||
27987402|NCT00532129|54646041|FG000|Follow-up Period|Other|6|||
27987403|NCT00854607|54646045|FG000|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65|||
27987404|NCT00854373|54646058|FG000|Overall Study|Withdrawal by Subject|1|||
27902764|NCT01555463|54559419|FG001|Treatment|Withdrawal by Subject|36|||
27902765|NCT01555463|54559418|FG000|Treatment|Lost to Follow-up|28|||
27902766|NCT01555463|54559419|FG001|Treatment|Lost to Follow-up|23|||
27987405|NCT00854373|54646059|FG001|Overall Study|Withdrawal by Subject|3|||
27902767|NCT01555463|54559418|FG000|Treatment|Protocol Violation|4|||
27902768|NCT01555463|54559419|FG001|Treatment|Protocol Violation|5|||
27902769|NCT01555463|54559418|FG000|Treatment|Other reason|2|||
27902770|NCT01555463|54559419|FG001|Treatment|Other reason|3|||
27902771|NCT01555463|54559418|FG000|Follow up|Adverse Event|2|||
27902772|NCT01555463|54559419|FG001|Follow up|Adverse Event|5|||
27902773|NCT01555463|54559418|FG000|Follow up|Death|0|||
27902774|NCT01555463|54559419|FG001|Follow up|Death|1|||
27902775|NCT01555463|54559418|FG000|Follow up|Withdrawal by Subject|22|||
27902776|NCT01555463|54559419|FG001|Follow up|Withdrawal by Subject|22|||
27902777|NCT01555463|54559418|FG000|Follow up|Lost to Follow-up|9|||
27902778|NCT01555463|54559419|FG001|Follow up|Lost to Follow-up|10|||
27902779|NCT01555463|54559418|FG000|Follow up|Protocol Violation|2|||
27902780|NCT01555463|54559419|FG001|Follow up|Protocol Violation|4|||
27902781|NCT01555463|54559418|FG000|Follow up|Other reason|3|||
27902782|NCT01555463|54559419|FG001|Follow up|Other reason|3|||
27902783|NCT01081951|54559497|FG000|Overall Study|Death|54|||
27902784|NCT01081951|54559498|FG001|Overall Study|Death|47|||
27902785|NCT01081951|54559497|FG000|Overall Study|Withdrawal by Subject|2|||
27902786|NCT01081951|54559498|FG001|Overall Study|Withdrawal by Subject|6|||
27902787|NCT01081951|54559497|FG000|Overall Study|Allocated treatment but did not take it|0|||
27902788|NCT01081951|54559498|FG001|Overall Study|Allocated treatment but did not take it|1|||
27902789|NCT01081951|54559497|FG000|Overall Study|Lost to Follow-up|0|||
27902790|NCT01081951|54559498|FG001|Overall Study|Lost to Follow-up|1|||
27902791|NCT02277106|54559504|FG000|Stage 2|Adverse Event|0|||
27902792|NCT02277106|54559505|FG001|Stage 2|Adverse Event|0|||
27902793|NCT02277106|54559506|FG002|Stage 2|Adverse Event|1|||
27902794|NCT02215096|54559529|FG000|Run-In Period (Up to Week 2)|Adverse Event|1|||
27902795|NCT02215096|54559530|FG001|Run-In Period (Up to Week 2)|Adverse Event|0|||
27902796|NCT02215096|54559531|FG002|Run-In Period (Up to Week 2)|Adverse Event|0|||
27902797|NCT02215096|54559532|FG003|Run-In Period (Up to Week 2)|Adverse Event|0|||
27902798|NCT02215096|54559533|FG004|Run-In Period (Up to Week 2)|Adverse Event|0|||
27902799|NCT02215096|54559529|FG000|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
27902800|NCT02215096|54559530|FG001|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
27902801|NCT02215096|54559531|FG002|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
27902802|NCT02215096|54559532|FG003|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
27902803|NCT02215096|54559533|FG004|Combination TP (Up to Maximum 654 Days)|Physician Decision|1|||
27902804|NCT02215096|54559529|FG000|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
27902805|NCT02215096|54559530|FG001|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
27902806|NCT02215096|54559531|FG002|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
27902807|NCT02215096|54559532|FG003|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1|||
27902808|NCT02215096|54559533|FG004|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
27902809|NCT02215096|54559529|FG000|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
27902810|NCT02215096|54559530|FG001|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2|||
27902811|NCT02215096|54559531|FG002|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
27987406|NCT00854373|54646058|FG000|Overall Study|Forgot to take study drug|1|||
27987407|NCT00854373|54646059|FG001|Overall Study|Forgot to take study drug|1|||
27987408|NCT00853905|54646067|FG000|Overall Study|Lost to Follow-up|1|||
27987409|NCT00853905|54646068|FG001|Overall Study|Lost to Follow-up|3|||
27987410|NCT00853905|54646067|FG000|Overall Study|Withdrawal by Subject|0|||
27902812|NCT02215096|54559532|FG003|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
27902813|NCT02215096|54559533|FG004|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
27902814|NCT02214160|54559552|FG000|Overall Study|Withdrawal by Subject|1|||
27902815|NCT02214160|54559553|FG001|Overall Study|Withdrawal by Subject|0|||
27902816|NCT02214160|54559554|FG002|Overall Study|Withdrawal by Subject|6|||
27902817|NCT02214160|54559552|FG000|Overall Study|Death|2|||
27902818|NCT02214160|54559553|FG001|Overall Study|Death|2|||
27902819|NCT02214160|54559554|FG002|Overall Study|Death|1|||
27902820|NCT02214160|54559552|FG000|Overall Study|Subject Non-Compliance|0|||
27902821|NCT02214160|54559553|FG001|Overall Study|Subject Non-Compliance|3|||
27902822|NCT02214160|54559554|FG002|Overall Study|Subject Non-Compliance|1|||
27902823|NCT02214160|54559552|FG000|Overall Study|Adverse Event|0|||
27902824|NCT02214160|54559553|FG001|Overall Study|Adverse Event|1|||
27902825|NCT02214160|54559554|FG002|Overall Study|Adverse Event|1|||
27902826|NCT02214160|54559552|FG000|Overall Study|Sponsor Decision|0|||
27902827|NCT02214160|54559553|FG001|Overall Study|Sponsor Decision|2|||
27902828|NCT02214160|54559554|FG002|Overall Study|Sponsor Decision|0|||
27987411|NCT00853905|54646068|FG001|Overall Study|Withdrawal by Subject|1|||
27987412|NCT00853905|54646067|FG000|Overall Study|never had surgery|1|||
27902829|NCT02214160|54559552|FG000|Overall Study|Protocol Violation|1|||
27902830|NCT02214160|54559553|FG001|Overall Study|Protocol Violation|0|||
27902831|NCT02214160|54559554|FG002|Overall Study|Protocol Violation|0|||
27902832|NCT02214160|54559552|FG000|Overall Study|Physician Decision|0|||
27902833|NCT02214160|54559553|FG001|Overall Study|Physician Decision|0|||
27902834|NCT02214160|54559554|FG002|Overall Study|Physician Decision|1|||
27902835|NCT03189862|54559585|FG000|Overall Study|Withdrawal by Subject|1|||
27902836|NCT03189862|54559586|FG001|Overall Study|Withdrawal by Subject|0|||
27902837|NCT03189862|54559585|FG000|Overall Study|Lost to Follow-up|54|||
27902838|NCT03189862|54559586|FG001|Overall Study|Lost to Follow-up|62|||
27902839|NCT00107614|54559618|FG000|Overall Study|Physician Decision|10|||
27902840|NCT00107614|54559618|FG000|Overall Study|Death|2|||
27902841|NCT00107380|54559622|FG000|Overall Study|Adverse Event|7|||
27902842|NCT00107380|54559622|FG000|Overall Study|Refusal Unrelated to Adverse Event|7|||
27902843|NCT00107380|54559622|FG000|Overall Study|Progression/relapse|4|||
27902844|NCT00107380|54559622|FG000|Overall Study|Death|3|||
27902845|NCT00107380|54559622|FG000|Overall Study|Other - not protocol specified|7|||
27902846|NCT00107380|54559622|FG000|Overall Study|Ineligible|2|||
27902847|NCT01340014|54559629|FG000|Period 1, First 7 Days|Adverse Event|1|||
27902848|NCT01340014|54559630|FG001|Period 1, First 7 Days|Adverse Event|0|||
27902849|NCT01340014|54559629|FG000|Period 1, First 7 Days|Personal Reasons|1|||
27902850|NCT01340014|54559630|FG001|Period 1, First 7 Days|Personal Reasons|0|||
27902851|NCT01340014|54559629|FG000|Period 2, Second 7 Days|Adverse Event|0|||
27902852|NCT01340014|54559630|FG001|Period 2, Second 7 Days|Adverse Event|1|||
27902853|NCT01339897|54559640|FG000|Overall Study|Adverse Event|1|||
27902854|NCT01339897|54559641|FG001|Overall Study|Adverse Event|0|||
27902855|NCT01339897|54559642|FG002|Overall Study|Adverse Event|0|||
27902856|NCT01339897|54559643|FG003|Overall Study|Adverse Event|1|||
27902857|NCT01339429|54559655|FG000|Overall Study|Withdrawal by Subject|1|||
27902858|NCT01339429|54559655|FG000|Overall Study|Physician Decision|3|||
27902859|NCT01339390|54559661|FG000|Overall Study|Death|32|||
27902860|NCT01339390|54559662|FG001|Overall Study|Death|29|||
27902861|NCT01339390|54559661|FG000|Overall Study|Lost to Follow-up|125|||
27902862|NCT01339390|54559662|FG001|Overall Study|Lost to Follow-up|127|||
27987413|NCT00853905|54646068|FG001|Overall Study|never had surgery|0|||
27902863|NCT01339273|54559670|FG000|Overall Study|Lost to Follow-up|8|||
27902864|NCT01339273|54559671|FG001|Overall Study|Lost to Follow-up|8|||
27902865|NCT01334866|54559677|FG000|Overall Study|Withdrawal by Subject|10|||
27902866|NCT01334866|54559677|FG000|Overall Study|Lost to Follow-up|3|||
27902867|NCT01334866|54559677|FG000|Overall Study|Physician Decision|3|||
27902868|NCT01334866|54559677|FG000|Overall Study|medically necessary prior to procedure|2|||
27902869|NCT01334866|54559677|FG000|Overall Study|medically necessary post-procedure|1|||
27902870|NCT01334710|54559683|FG000|Overall Study|Trial was terminated|3|||
27902871|NCT01334554|54559690|FG000|Overall Study|Adverse Event|4|||
27902872|NCT01334554|54559691|FG001|Overall Study|Adverse Event|2|||
27902873|NCT01332799|54559701|FG000|Overall Study|Insufficient funding|10|||
27987414|NCT00868296|54646079|FG000|Overall Study|Adverse Event|0|||
28172218|NCT02408068|54843853|FG003|Treatment 3 (1.5 Days)|Adverse Event|0|||
27902874|NCT01332799|54559702|FG001|Overall Study|Insufficient funding|10|||
27902875|NCT01332331|54559710|FG000|Overall Study|Lost to Follow-up|0|||
27902876|NCT01332331|54559711|FG001|Overall Study|Lost to Follow-up|1|||
27902877|NCT01332331|54559710|FG000|Overall Study|Adverse Event|1|||
27902878|NCT01332331|54559711|FG001|Overall Study|Adverse Event|1|||
27902879|NCT01332331|54559710|FG000|Overall Study|Physician Decision|1|||
27902880|NCT01332331|54559711|FG001|Overall Study|Physician Decision|0|||
27902881|NCT01332292|54559718|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
27902882|NCT01332292|54559719|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
27902883|NCT01332292|54559718|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
27902884|NCT01332292|54559719|FG001|Treatment Period 1 (14 Days)|Protocol Violation|1|||
27902885|NCT01332292|54559718|FG000|Treatment Period 2 (14 Days)|Physician Decision|1|||
27902886|NCT01332292|54559719|FG001|Treatment Period 2 (14 Days)|Physician Decision|1|||
27902887|NCT01332019|54559729|FG000|Overall Study|Was Not Dosed|1|||
27902888|NCT01332019|54559730|FG001|Overall Study|Was Not Dosed|0|||
27902889|NCT01332019|54559729|FG000|Overall Study|Other|16|||
27987415|NCT00868296|54646080|FG001|Overall Study|Adverse Event|2|||
27987416|NCT00868296|54646079|FG000|Overall Study|Withdrawal by Subject|0|||
27987417|NCT00868296|54646080|FG001|Overall Study|Withdrawal by Subject|1|||
27987418|NCT00867360|54646088|FG000|Overall Study|Withdrawal by Subject|1|||
27987419|NCT00867360|54646089|FG001|Overall Study|Withdrawal by Subject|0|||
27987420|NCT00867360|54646088|FG000|Overall Study|Physician Decision|0|||
27987421|NCT00867360|54646089|FG001|Overall Study|Physician Decision|1|||
27987422|NCT00593736|54646100|FG000|Screening Period and Placebo Run-in|Adverse Event|0|||
27987423|NCT00593736|54646101|FG001|Screening Period and Placebo Run-in|Adverse Event|0|||
27902890|NCT01332019|54559730|FG001|Overall Study|Other|18|||
27902891|NCT01332019|54559729|FG000|Overall Study|Death|2|||
27902892|NCT01332019|54559730|FG001|Overall Study|Death|1|||
27902893|NCT01332019|54559729|FG000|Overall Study|Physician Decision|4|||
27902894|NCT01332019|54559730|FG001|Overall Study|Physician Decision|3|||
27902895|NCT01332019|54559729|FG000|Overall Study|Withdrawal by Subject|73|||
27902896|NCT01332019|54559730|FG001|Overall Study|Withdrawal by Subject|71|||
27902897|NCT01332019|54559729|FG000|Overall Study|Lost to Follow-up|4|||
27902898|NCT01332019|54559730|FG001|Overall Study|Lost to Follow-up|7|||
27902899|NCT01332019|54559729|FG000|Overall Study|Adverse Event|13|||
27902900|NCT01332019|54559730|FG001|Overall Study|Adverse Event|22|||
27902901|NCT01331239|54559738|FG000|Part II: Core Study|Adverse Event|0|||
27902902|NCT01331239|54559739|FG001|Part II: Core Study|Adverse Event|3|||
27902903|NCT01331239|54559740|FG002|Part II: Core Study|Adverse Event|0|||
27902904|NCT01331239|54559738|FG000|Part II: Core Study|Subj's cond. no longer require treatment|0|||
27902905|NCT01331239|54559739|FG001|Part II: Core Study|Subj's cond. no longer require treatment|2|||
27902906|NCT01331239|54559740|FG002|Part II: Core Study|Subj's cond. no longer require treatment|1|||
27902907|NCT01331239|54559738|FG000|Part II: Core Study|Withdrawal by Subject|0|||
27902908|NCT01331239|54559739|FG001|Part II: Core Study|Withdrawal by Subject|2|||
27902909|NCT01331239|54559740|FG002|Part II: Core Study|Withdrawal by Subject|0|||
27902910|NCT01331239|54559738|FG000|Part II: Core Study|Administrative problems|0|||
27902911|NCT01331239|54559739|FG001|Part II: Core Study|Administrative problems|1|||
27902912|NCT01331239|54559740|FG002|Part II: Core Study|Administrative problems|0|||
27902913|NCT01331161|54559758|FG000|Overall Study|Physician Decision|1|||
27902914|NCT01331161|54559759|FG001|Overall Study|Physician Decision|0|||
27902915|NCT01331161|54559758|FG000|Overall Study|Lost to Follow-up|0|||
27902916|NCT01331161|54559759|FG001|Overall Study|Lost to Follow-up|1|||
27902917|NCT01331161|54559758|FG000|Overall Study|Pregnancy|0|||
27902918|NCT01331161|54559759|FG001|Overall Study|Pregnancy|1|||
27902919|NCT01331005|54559769|FG000|Overall Study|Lost to Follow-up|2|||
27902920|NCT01331005|54559770|FG001|Overall Study|Lost to Follow-up|1|||
27902921|NCT01331005|54559769|FG000|Overall Study|Withdrawal by Subject|2|||
27902922|NCT01331005|54559770|FG001|Overall Study|Withdrawal by Subject|3|||
27902923|NCT01330459|54559778|FG000|Overall Study|Physician Decision|0|||
27902924|NCT01330459|54559779|FG001|Overall Study|Physician Decision|2|||
27902925|NCT01330381|54559789|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
27902926|NCT01330381|54559790|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4|||
27902927|NCT01330381|54559791|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
27902928|NCT01330381|54559789|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance|2|||
27902929|NCT01330381|54559790|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance|1|||
27902930|NCT01330381|54559791|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance|0|||
27902931|NCT01330381|54559789|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
27902932|NCT01330381|54559790|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
27902933|NCT01330381|54559791|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|0|||
27902934|NCT01330381|54559789|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1|||
27902935|NCT01330381|54559790|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
27902936|NCT01330381|54559791|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
27902937|NCT01330381|54559789|FG000|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1|||
27902938|NCT01330381|54559790|FG001|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
27902939|NCT01330381|54559791|FG002|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
27987424|NCT00593736|54646102|FG002|Screening Period and Placebo Run-in|Adverse Event|0|||
27987425|NCT00593736|54646103|FG003|Screening Period and Placebo Run-in|Adverse Event|3|||
27987426|NCT00593736|54646100|FG000|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
27987427|NCT00593736|54646101|FG001|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
27987428|NCT00593736|54646102|FG002|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
27987429|NCT00593736|54646103|FG003|Screening Period and Placebo Run-in|Lost to Follow-up|9|||
27987430|NCT00593736|54646100|FG000|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
27902940|NCT01330381|54559789|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
27902941|NCT01330381|54559790|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
27987431|NCT00593736|54646101|FG001|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
27902942|NCT01330381|54559791|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
27902943|NCT01330381|54559789|FG000|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7|||
28097403|NCT03053050|54753011|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
27987432|NCT00593736|54646102|FG002|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
27987433|NCT00593736|54646103|FG003|Screening Period and Placebo Run-in|Withdrawal by Subject|43|||
27987434|NCT00593736|54646100|FG000|Screening Period and Placebo Run-in|Study Termination|0|||
27987435|NCT00593736|54646101|FG001|Screening Period and Placebo Run-in|Study Termination|0|||
27987436|NCT00593736|54646102|FG002|Screening Period and Placebo Run-in|Study Termination|0|||
27902944|NCT01330381|54559790|FG001|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0|||
27902945|NCT01330381|54559791|FG002|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16|||
27902946|NCT01330381|54559789|FG000|Open-label Treatment Period (16 Weeks)|Adverse Event|2|||
27902947|NCT01330381|54559790|FG001|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
27902948|NCT01330381|54559791|FG002|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
27902949|NCT01330381|54559789|FG000|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
27902950|NCT01330381|54559790|FG001|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0|||
27902951|NCT01330381|54559791|FG002|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
27987437|NCT00593736|54646103|FG003|Screening Period and Placebo Run-in|Study Termination|15|||
27987438|NCT00593736|54646100|FG000|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
27902952|NCT01330381|54559789|FG000|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
27902953|NCT01330381|54559790|FG001|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
27902954|NCT01330381|54559791|FG002|Open-label Treatment Period (16 Weeks)|Non-compliance|1|||
27902955|NCT01330303|54559800|FG000|Period 1|Adverse Event|1|||
27902956|NCT01330303|54559801|FG001|Period 1|Adverse Event|0|||
27987439|NCT00593736|54646101|FG001|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
27987440|NCT00593736|54646102|FG002|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
27987441|NCT00593736|54646103|FG003|Screening Period and Placebo Run-in|Did Not Meet Criteria|322|||
27987442|NCT00593736|54646100|FG000|Screening Period and Placebo Run-in|Various|0|||
27987443|NCT00593736|54646101|FG001|Screening Period and Placebo Run-in|Various|0|||
27987444|NCT00593736|54646102|FG002|Screening Period and Placebo Run-in|Various|0|||
27987445|NCT00593736|54646103|FG003|Screening Period and Placebo Run-in|Various|25|||
27987446|NCT00593736|54646100|FG000|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
27987447|NCT00593736|54646101|FG001|Treatment Period and Placebo Run-out|Lost to Follow-up|1|||
27987448|NCT00593736|54646102|FG002|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
27987449|NCT00593736|54646103|FG003|Treatment Period and Placebo Run-out|Lost to Follow-up|0|||
27987450|NCT00593736|54646100|FG000|Treatment Period and Placebo Run-out|Protocol Violation|0|||
27987451|NCT00593736|54646101|FG001|Treatment Period and Placebo Run-out|Protocol Violation|0|||
27902957|NCT01330303|54559800|FG000|Period 1|Protocol Violation|0|||
27902958|NCT01330303|54559801|FG001|Period 1|Protocol Violation|1|||
27902959|NCT01330303|54559800|FG000|Period 1|Withdrawal by Subject|0|||
27902960|NCT01330303|54559801|FG001|Period 1|Withdrawal by Subject|1|||
27902961|NCT01330108|54559808|FG000|Overall Study|Withdrawal by Subject|4|||
27902962|NCT01059825|54559818|FG000|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
27902963|NCT01059825|54559819|FG001|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
27902964|NCT01059825|54559820|FG002|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
27902965|NCT01059825|54559821|FG003|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
27902966|NCT01059825|54559822|FG004|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
27902967|NCT01059825|54559823|FG005|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
27902968|NCT01059825|54559824|FG006|Enrolled, Run-in Period|Adverse event not related to study drug|3|||
27902969|NCT01059825|54559818|FG000|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
27902970|NCT01059825|54559819|FG001|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
27902971|NCT01059825|54559820|FG002|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
27902972|NCT01059825|54559821|FG003|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
28097404|NCT03053050|54753008|FG000|Open-label Phase|Study Terminated by Sponsor|0|||
27902973|NCT01059825|54559822|FG004|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
27902974|NCT01059825|54559823|FG005|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
27902975|NCT01059825|54559824|FG006|Enrolled, Run-in Period|Did not meet entrance criteria|14|||
27902976|NCT01059825|54559818|FG000|Enrolled, Run-in Period|Lost to Follow-up|0|||
27902977|NCT01059825|54559819|FG001|Enrolled, Run-in Period|Lost to Follow-up|0|||
27902978|NCT01059825|54559820|FG002|Enrolled, Run-in Period|Lost to Follow-up|0|||
27902979|NCT01059825|54559821|FG003|Enrolled, Run-in Period|Lost to Follow-up|0|||
28097405|NCT03053050|54753009|FG001|Open-label Phase|Study Terminated by Sponsor|0|||
27902980|NCT01059825|54559822|FG004|Enrolled, Run-in Period|Lost to Follow-up|0|||
27902981|NCT01059825|54559823|FG005|Enrolled, Run-in Period|Lost to Follow-up|0|||
27902982|NCT01059825|54559824|FG006|Enrolled, Run-in Period|Lost to Follow-up|5|||
27902983|NCT01059825|54559818|FG000|Enrolled, Run-in Period|Withdrawal by Subject|0|||
27902984|NCT01059825|54559819|FG001|Enrolled, Run-in Period|Withdrawal by Subject|0|||
27987452|NCT00593736|54646102|FG002|Treatment Period and Placebo Run-out|Protocol Violation|1|||
27987453|NCT00593736|54646103|FG003|Treatment Period and Placebo Run-out|Protocol Violation|1|||
27987454|NCT00593736|54646100|FG000|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
27987455|NCT00593736|54646101|FG001|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
28097406|NCT03053050|54753010|FG002|Open-label Phase|Study Terminated by Sponsor|0|||
27902985|NCT01059825|54559820|FG002|Enrolled, Run-in Period|Withdrawal by Subject|0|||
27987456|NCT00593736|54646102|FG002|Treatment Period and Placebo Run-out|Withdrawal by Subject|1|||
27987457|NCT00593736|54646103|FG003|Treatment Period and Placebo Run-out|Withdrawal by Subject|3|||
27987458|NCT00593736|54646100|FG000|Treatment Period and Placebo Run-out|Various|1|||
27987459|NCT00593736|54646101|FG001|Treatment Period and Placebo Run-out|Various|1|||
27987460|NCT00593736|54646102|FG002|Treatment Period and Placebo Run-out|Various|1|||
27987461|NCT00593736|54646103|FG003|Treatment Period and Placebo Run-out|Various|0|||
27902986|NCT01059825|54559821|FG003|Enrolled, Run-in Period|Withdrawal by Subject|0|||
27987462|NCT00883688|54646113|FG000|Overall Study|Ineligible|2|||
27987463|NCT03883477|54646119|FG000|Overall Study|Death|1|||
27987464|NCT03883477|54646120|FG001|Overall Study|Death|0|||
28097407|NCT03053050|54753011|FG003|Open-label Phase|Study Terminated by Sponsor|89|||
28097408|NCT03053050|54753008|FG000|Open-label Phase|Withdrew Consent|0|||
28097409|NCT03053050|54753009|FG001|Open-label Phase|Withdrew Consent|0|||
28097410|NCT03053050|54753010|FG002|Open-label Phase|Withdrew Consent|0|||
28097411|NCT03053050|54753011|FG003|Open-label Phase|Withdrew Consent|6|||
28097412|NCT03053050|54753008|FG000|Open-label Phase|Investigator's Discretion|0|||
27902987|NCT01059825|54559822|FG004|Enrolled, Run-in Period|Withdrawal by Subject|0|||
27902988|NCT01059825|54559823|FG005|Enrolled, Run-in Period|Withdrawal by Subject|0|||
27902989|NCT01059825|54559824|FG006|Enrolled, Run-in Period|Withdrawal by Subject|13|||
27902990|NCT01059825|54559818|FG000|Enrolled, Run-in Period|Other reason not specified|0|||
27902991|NCT01059825|54559819|FG001|Enrolled, Run-in Period|Other reason not specified|0|||
27902992|NCT01059825|54559820|FG002|Enrolled, Run-in Period|Other reason not specified|0|||
27902993|NCT01059825|54559821|FG003|Enrolled, Run-in Period|Other reason not specified|0|||
27902994|NCT01059825|54559822|FG004|Enrolled, Run-in Period|Other reason not specified|0|||
27902995|NCT01059825|54559823|FG005|Enrolled, Run-in Period|Other reason not specified|0|||
27902996|NCT01059825|54559824|FG006|Enrolled, Run-in Period|Other reason not specified|7|||
27902997|NCT01059825|54559818|FG000|Enrolled, Run-in Period|Protocol Violation|0|||
27902998|NCT01059825|54559819|FG001|Enrolled, Run-in Period|Protocol Violation|0|||
27902999|NCT01059825|54559820|FG002|Enrolled, Run-in Period|Protocol Violation|0|||
27903000|NCT01059825|54559821|FG003|Enrolled, Run-in Period|Protocol Violation|0|||
27903001|NCT01059825|54559822|FG004|Enrolled, Run-in Period|Protocol Violation|0|||
27903002|NCT01059825|54559823|FG005|Enrolled, Run-in Period|Protocol Violation|0|||
27903003|NCT01059825|54559824|FG006|Enrolled, Run-in Period|Protocol Violation|5|||
27903004|NCT01059825|54559818|FG000|Treatment Period|Lost to Follow-up|2|||
27903005|NCT01059825|54559819|FG001|Treatment Period|Lost to Follow-up|1|||
27903006|NCT01059825|54559820|FG002|Treatment Period|Lost to Follow-up|0|||
27903007|NCT01059825|54559821|FG003|Treatment Period|Lost to Follow-up|1|||
27903008|NCT01059825|54559822|FG004|Treatment Period|Lost to Follow-up|2|||
27903009|NCT01059825|54559823|FG005|Treatment Period|Lost to Follow-up|0|||
27903010|NCT01059825|54559824|FG006|Treatment Period|Lost to Follow-up|0|||
27903011|NCT01059825|54559818|FG000|Treatment Period|Withdrawal by Subject|3|||
27903012|NCT01059825|54559819|FG001|Treatment Period|Withdrawal by Subject|0|||
27903013|NCT01059825|54559820|FG002|Treatment Period|Withdrawal by Subject|1|||
27903014|NCT01059825|54559821|FG003|Treatment Period|Withdrawal by Subject|5|||
27903015|NCT01059825|54559822|FG004|Treatment Period|Withdrawal by Subject|4|||
27903016|NCT01059825|54559823|FG005|Treatment Period|Withdrawal by Subject|1|||
28097413|NCT03053050|54753009|FG001|Open-label Phase|Investigator's Discretion|0|||
28097414|NCT03053050|54753010|FG002|Open-label Phase|Investigator's Discretion|0|||
28097415|NCT03053050|54753011|FG003|Open-label Phase|Investigator's Discretion|4|||
28097416|NCT04369950|54753022|FG000|Overall Study|Protocol Violation|2|||
28097417|NCT04369950|54753023|FG001|Overall Study|Protocol Violation|2|||
28097418|NCT04035564|54753031|FG000|Overall Study|Protocol Violation|1|||
27903017|NCT01059825|54559824|FG006|Treatment Period|Withdrawal by Subject|0|||
27903018|NCT01059825|54559818|FG000|Treatment Period|Other reason not specified|1|||
27903019|NCT01059825|54559819|FG001|Treatment Period|Other reason not specified|2|||
27903020|NCT01059825|54559820|FG002|Treatment Period|Other reason not specified|1|||
27903021|NCT01059825|54559821|FG003|Treatment Period|Other reason not specified|2|||
27903022|NCT01059825|54559822|FG004|Treatment Period|Other reason not specified|0|||
27903023|NCT01059825|54559823|FG005|Treatment Period|Other reason not specified|0|||
27903024|NCT01059825|54559824|FG006|Treatment Period|Other reason not specified|0|||
28097419|NCT04035564|54753032|FG001|Overall Study|Protocol Violation|2|||
28097420|NCT04035564|54753031|FG000|Overall Study|No laboratory available|2|||
28097421|NCT04035564|54753032|FG001|Overall Study|No laboratory available|2|||
28097422|NCT04035564|54753031|FG000|Overall Study|Guardian declined consent|1|||
28172219|NCT02408068|54843854|FG004|Treatment 3 (1.5 Days)|Adverse Event|0|||
28172220|NCT02408068|54843855|FG005|Treatment 3 (1.5 Days)|Adverse Event|0|||
28172221|NCT01361126|54843868|FG000|Overall Study|Sponsor decision|0|||
27903025|NCT01059825|54559818|FG000|Treatment Period|Protocol Violation|0|||
27903026|NCT01059825|54559819|FG001|Treatment Period|Protocol Violation|0|||
27903027|NCT01059825|54559820|FG002|Treatment Period|Protocol Violation|1|||
27903028|NCT01059825|54559821|FG003|Treatment Period|Protocol Violation|1|||
28172222|NCT01361126|54843869|FG001|Overall Study|Sponsor decision|2|||
27903029|NCT01059825|54559822|FG004|Treatment Period|Protocol Violation|1|||
27903030|NCT01059825|54559823|FG005|Treatment Period|Protocol Violation|1|||
27903031|NCT01059825|54559824|FG006|Treatment Period|Protocol Violation|0|||
27903032|NCT01059825|54559818|FG000|Treatment Period|Adverse event related to study drug|1|||
27903033|NCT01059825|54559819|FG001|Treatment Period|Adverse event related to study drug|0|||
27903034|NCT01059825|54559820|FG002|Treatment Period|Adverse event related to study drug|1|||
27903035|NCT01059825|54559821|FG003|Treatment Period|Adverse event related to study drug|1|||
27903036|NCT01059825|54559822|FG004|Treatment Period|Adverse event related to study drug|0|||
27903037|NCT01059825|54559823|FG005|Treatment Period|Adverse event related to study drug|0|||
27903038|NCT01059825|54559824|FG006|Treatment Period|Adverse event related to study drug|0|||
27903039|NCT01059825|54559818|FG000|Treatment Period|Insufficient clinical response|3|||
27903040|NCT01059825|54559819|FG001|Treatment Period|Insufficient clinical response|0|||
27903041|NCT01059825|54559820|FG002|Treatment Period|Insufficient clinical response|0|||
27903042|NCT01059825|54559821|FG003|Treatment Period|Insufficient clinical response|0|||
27903043|NCT01059825|54559822|FG004|Treatment Period|Insufficient clinical response|0|||
27903044|NCT01059825|54559823|FG005|Treatment Period|Insufficient clinical response|0|||
27903045|NCT01059825|54559824|FG006|Treatment Period|Insufficient clinical response|0|||
27903046|NCT01059825|54559818|FG000|Treatment Period|Adverse event not related to study drug|0|||
27903047|NCT01059825|54559819|FG001|Treatment Period|Adverse event not related to study drug|1|||
27903048|NCT01059825|54559820|FG002|Treatment Period|Adverse event not related to study drug|2|||
27903049|NCT01059825|54559821|FG003|Treatment Period|Adverse event not related to study drug|1|||
27903050|NCT01059825|54559822|FG004|Treatment Period|Adverse event not related to study drug|1|||
27903051|NCT01059825|54559823|FG005|Treatment Period|Adverse event not related to study drug|1|||
27903052|NCT01059825|54559824|FG006|Treatment Period|Adverse event not related to study drug|0|||
27903053|NCT01059773|54559883|FG000|Overall Study|Adverse Event|2|||
27903054|NCT01059773|54559884|FG001|Overall Study|Adverse Event|2|||
27903055|NCT01059773|54559883|FG000|Overall Study|Withdrawal by Subject|1|||
27903056|NCT01059773|54559884|FG001|Overall Study|Withdrawal by Subject|5|||
27903057|NCT01059773|54559883|FG000|Overall Study|Lost to Follow-up|1|||
27903058|NCT01059773|54559884|FG001|Overall Study|Lost to Follow-up|1|||
27903059|NCT01059773|54559883|FG000|Overall Study|Pregnancy|1|||
27903060|NCT01059773|54559884|FG001|Overall Study|Pregnancy|1|||
27903061|NCT01059773|54559883|FG000|Overall Study|Protocol Violation|6|||
27903062|NCT01059773|54559884|FG001|Overall Study|Protocol Violation|2|||
27903063|NCT01059773|54559883|FG000|Overall Study|Physician Decision|5|||
27903064|NCT01059773|54559884|FG001|Overall Study|Physician Decision|4|||
27903065|NCT01059773|54559883|FG000|Overall Study|Lack of Efficacy|3|||
27903066|NCT01059773|54559884|FG001|Overall Study|Lack of Efficacy|3|||
27903067|NCT01059773|54559883|FG000|Overall Study|Death|0|||
27903068|NCT01059773|54559884|FG001|Overall Study|Death|1|||
27903069|NCT01059773|54559883|FG000|Overall Study|Malignancy including squamous cell skin|0|||
27903070|NCT01059773|54559884|FG001|Overall Study|Malignancy including squamous cell skin|1|||
27903071|NCT01059773|54559883|FG000|Overall Study|Ineligible follow TB screening criteria|0|||
27903072|NCT01059773|54559884|FG001|Overall Study|Ineligible follow TB screening criteria|1|||
27903073|NCT01059773|54559883|FG000|Overall Study|Other|1|||
27903074|NCT01059773|54559884|FG001|Overall Study|Other|3|||
27903075|NCT01059318|54559895|FG000|Core Study (26 Week)|Adverse Event|3|||
27903076|NCT01059318|54559895|FG000|Core Study (26 Week)|Withdrawal by Subject|1|||
27903077|NCT01059318|54559895|FG000|Extension (36 Week)|Adverse Event|3|||
27903078|NCT01058655|54559906|FG000|Overall Study|Withdrawal by Subject|1|||
27903079|NCT01058655|54559907|FG001|Overall Study|Withdrawal by Subject|0|||
27903080|NCT01058655|54559908|FG002|Overall Study|Withdrawal by Subject|3|||
27903081|NCT01058655|54559909|FG003|Overall Study|Withdrawal by Subject|4|||
27903082|NCT01058655|54559906|FG000|Overall Study|Prolonged Treatment Delay|0|||
27903083|NCT01058655|54559907|FG001|Overall Study|Prolonged Treatment Delay|0|||
27903084|NCT01058655|54559908|FG002|Overall Study|Prolonged Treatment Delay|0|||
27903085|NCT01058655|54559909|FG003|Overall Study|Prolonged Treatment Delay|2|||
27903086|NCT01058655|54559906|FG000|Overall Study|Symptomatic Deterioration|0|||
27903087|NCT01058655|54559907|FG001|Overall Study|Symptomatic Deterioration|0|||
27987465|NCT03883477|54646119|FG000|Overall Study|Protocol Violation|0|||
27987466|NCT03883477|54646120|FG001|Overall Study|Protocol Violation|1|||
27903088|NCT01058655|54559908|FG002|Overall Study|Symptomatic Deterioration|0|||
27903089|NCT01058655|54559909|FG003|Overall Study|Symptomatic Deterioration|1|||
27903090|NCT01058655|54559906|FG000|Overall Study|Clinical Progression (non-RECIST)|1|||
27903091|NCT01058655|54559907|FG001|Overall Study|Clinical Progression (non-RECIST)|0|||
27903092|NCT01058655|54559908|FG002|Overall Study|Clinical Progression (non-RECIST)|0|||
27903093|NCT01058655|54559909|FG003|Overall Study|Clinical Progression (non-RECIST)|7|||
27903094|NCT01058655|54559906|FG000|Overall Study|Death|0|||
27903095|NCT01058655|54559907|FG001|Overall Study|Death|1|||
27903096|NCT01058655|54559908|FG002|Overall Study|Death|1|||
27987467|NCT00853827|54646128|FG000|Single Blind Period (1 Week)|Other|4|||
27903097|NCT01058655|54559909|FG003|Overall Study|Death|0|||
27903098|NCT01058655|54559906|FG000|Overall Study|Disease Progression|1|||
27903099|NCT01058655|54559907|FG001|Overall Study|Disease Progression|2|||
27903100|NCT01058655|54559908|FG002|Overall Study|Disease Progression|4|||
27903101|NCT01058655|54559909|FG003|Overall Study|Disease Progression|24|||
27903102|NCT01058655|54559906|FG000|Overall Study|Other|0|||
27903103|NCT01058655|54559907|FG001|Overall Study|Other|0|||
27903104|NCT01058655|54559908|FG002|Overall Study|Other|0|||
27903105|NCT01058655|54559909|FG003|Overall Study|Other|4|||
27903106|NCT01058421|54559922|FG000|1 Month Outcomes|Death|10|||
27903107|NCT01058421|54559923|FG001|1 Month Outcomes|Death|6|||
27903108|NCT01058421|54559922|FG000|1 Month Outcomes|Lost to Follow-up|8|||
27903109|NCT01058421|54559923|FG001|1 Month Outcomes|Lost to Follow-up|7|||
27903110|NCT01058421|54559922|FG000|1 Month Outcomes|Remained in Hospital|5|||
27903111|NCT01058421|54559923|FG001|1 Month Outcomes|Remained in Hospital|12|||
27903112|NCT01058421|54559922|FG000|1 Month Outcomes|Remained in Other Facility|16|||
27903113|NCT01058421|54559923|FG001|1 Month Outcomes|Remained in Other Facility|17|||
27903114|NCT01058421|54559922|FG000|3 Month Outcomes|Death|3|||
27903115|NCT01058421|54559923|FG001|3 Month Outcomes|Death|5|||
27903116|NCT01058421|54559922|FG000|3 Month Outcomes|Lost to Follow-up|12|||
27903117|NCT01058421|54559923|FG001|3 Month Outcomes|Lost to Follow-up|11|||
27903118|NCT01058421|54559922|FG000|3 Month Outcomes|Remained in Hospital|0|||
27903119|NCT01058421|54559923|FG001|3 Month Outcomes|Remained in Hospital|2|||
27903120|NCT01058421|54559922|FG000|3 Month Outcomes|Remained in Other Facility|5|||
27903121|NCT01058421|54559923|FG001|3 Month Outcomes|Remained in Other Facility|8|||
27903122|NCT01058421|54559922|FG000|6 Month Outcomes|Death|2|||
27903123|NCT01058421|54559923|FG001|6 Month Outcomes|Death|2|||
27903124|NCT01058421|54559922|FG000|6 Month Outcomes|Lost to Follow-up|16|||
27903125|NCT01058421|54559923|FG001|6 Month Outcomes|Lost to Follow-up|21|||
27903126|NCT01058421|54559922|FG000|6 Month Outcomes|Remained in Other Facility|1|||
27903127|NCT01058421|54559923|FG001|6 Month Outcomes|Remained in Other Facility|3|||
27903128|NCT01058304|54559931|FG000|Overall Study|Withdrawal by Subject|8|||
27903129|NCT01058304|54559932|FG001|Overall Study|Withdrawal by Subject|5|||
27903130|NCT01058304|54559931|FG000|Overall Study|Lost to Follow-up|13|||
27903131|NCT01058304|54559932|FG001|Overall Study|Lost to Follow-up|16|||
27903132|NCT01058304|54559931|FG000|Overall Study|Developed exclusion criterion|6|||
27903133|NCT01058304|54559932|FG001|Overall Study|Developed exclusion criterion|12|||
27903134|NCT01058265|54559940|FG000|Overall Study|Lost to Follow-up|11|||
27903135|NCT01058265|54559941|FG001|Overall Study|Lost to Follow-up|12|||
27903136|NCT01057251|54559949|FG000|Overall Study|Did not meet InclusionExclusion criteria|4|||
27903137|NCT01057251|54559950|FG001|Overall Study|Did not meet InclusionExclusion criteria|2|||
27903138|NCT01057251|54559949|FG000|Overall Study|Adverse Event|4|||
27903139|NCT01057251|54559950|FG001|Overall Study|Adverse Event|2|||
27903140|NCT01057251|54559949|FG000|Overall Study|Lack of Efficacy|2|||
27903141|NCT01057251|54559950|FG001|Overall Study|Lack of Efficacy|11|||
27903142|NCT01057251|54559949|FG000|Overall Study|Protocol Violation|6|||
27903143|NCT01057251|54559950|FG001|Overall Study|Protocol Violation|2|||
27903144|NCT01057251|54559949|FG000|Overall Study|Withdrawal by Subject|4|||
27903145|NCT01057251|54559950|FG001|Overall Study|Withdrawal by Subject|5|||
27987468|NCT00853827|54646129|FG001|Single Blind Period (1 Week)|Other|0|||
27987469|NCT00853827|54646128|FG000|Single Blind Period (1 Week)|Adverse Event|9|||
27987470|NCT00853827|54646129|FG001|Single Blind Period (1 Week)|Adverse Event|0|||
27987471|NCT00853827|54646128|FG000|Single Blind Period (1 Week)|Abnormal laboratory value|3|||
27987472|NCT00853827|54646129|FG001|Single Blind Period (1 Week)|Abnormal laboratory value|0|||
27987473|NCT00853827|54646128|FG000|Single Blind Period (1 Week)|Abnormal test procedure result|1|||
27987474|NCT00853827|54646129|FG001|Single Blind Period (1 Week)|Abnormal test procedure result|0|||
27987475|NCT00853827|54646128|FG000|Single Blind Period (1 Week)|Withdrawal by Subject|9|||
27987476|NCT00853827|54646129|FG001|Single Blind Period (1 Week)|Withdrawal by Subject|0|||
27987477|NCT00853827|54646128|FG000|Single Blind Period (1 Week)|Lost to Follow-up|1|||
27987478|NCT00853827|54646129|FG001|Single Blind Period (1 Week)|Lost to Follow-up|0|||
27987479|NCT00853827|54646128|FG000|Single Blind Period (1 Week)|Protocol Violation|12|||
27987480|NCT00853827|54646129|FG001|Single Blind Period (1 Week)|Protocol Violation|0|||
27987481|NCT00853827|54646128|FG000|Double Blind Period (103 Weeks)|Adverse Event|25|||
27987482|NCT00853827|54646129|FG001|Double Blind Period (103 Weeks)|Adverse Event|14|||
27903146|NCT01057251|54559949|FG000|Overall Study|Lost to Follow-up|7|||
27903147|NCT01057251|54559950|FG001|Overall Study|Lost to Follow-up|6|||
27903148|NCT01057251|54559949|FG000|Overall Study|Other Reason|1|||
27903149|NCT01057251|54559950|FG001|Overall Study|Other Reason|1|||
27903150|NCT01056822|54559958|FG000|Overall Study|Adverse Event|0|||
27903151|NCT01056822|54559959|FG001|Overall Study|Adverse Event|1|||
27903152|NCT01056822|54559958|FG000|Overall Study|Protocol Violation|6|||
27903153|NCT01056822|54559959|FG001|Overall Study|Protocol Violation|5|||
27903154|NCT01056822|54559958|FG000|Overall Study|Withdrawal by Subject|1|||
27903155|NCT01056822|54559959|FG001|Overall Study|Withdrawal by Subject|1|||
27903156|NCT01056822|54559958|FG000|Overall Study|Lost to Follow-up|1|||
27903157|NCT01056822|54559959|FG001|Overall Study|Lost to Follow-up|0|||
27903158|NCT01051791|54559966|FG000|Overall Study|Failed screening|3|||
27903159|NCT01051791|54559966|FG000|Overall Study|Withdrawal by Subject|1|||
27987483|NCT00853827|54646128|FG000|Double Blind Period (103 Weeks)|Abnormal laboratory values|0|||
27987484|NCT00853827|54646129|FG001|Double Blind Period (103 Weeks)|Abnormal laboratory values|3|||
27987485|NCT00853827|54646128|FG000|Double Blind Period (103 Weeks)|Lack of Efficacy|1|||
27987486|NCT00853827|54646129|FG001|Double Blind Period (103 Weeks)|Lack of Efficacy|0|||
27987487|NCT00853827|54646128|FG000|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3|||
27987488|NCT00853827|54646129|FG001|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1|||
27987489|NCT00853827|54646128|FG000|Double Blind Period (103 Weeks)|Protocol Violation|2|||
27987490|NCT00853827|54646129|FG001|Double Blind Period (103 Weeks)|Protocol Violation|1|||
27987491|NCT00853827|54646128|FG000|Double Blind Period (103 Weeks)|Withdrawal by Subject|19|||
27987492|NCT00853827|54646129|FG001|Double Blind Period (103 Weeks)|Withdrawal by Subject|18|||
27987493|NCT00853827|54646128|FG000|Double Blind Period (103 Weeks)|Lost to Follow-up|8|||
27903160|NCT01056510|54559978|FG000|Overall Study|Dropout Before Start of Treatment|1|||
27903161|NCT01056510|54559979|FG001|Overall Study|Dropout Before Start of Treatment|1|||
27903162|NCT01056510|54559978|FG000|Overall Study|Withdrawal by Subject|4|||
27903163|NCT01056510|54559979|FG001|Overall Study|Withdrawal by Subject|2|||
27903164|NCT01056510|54559978|FG000|Overall Study|Death|29|||
27903165|NCT01056510|54559979|FG001|Overall Study|Death|34|||
27903166|NCT01056510|54559978|FG000|Overall Study|Noncompliance|1|||
27903167|NCT01056510|54559979|FG001|Overall Study|Noncompliance|3|||
27903168|NCT01056510|54559978|FG000|Overall Study|Physician Decision|4|||
27903169|NCT01056510|54559979|FG001|Overall Study|Physician Decision|5|||
27903170|NCT01056510|54559978|FG000|Overall Study|Lost to Follow-up|5|||
27903171|NCT01056510|54559979|FG001|Overall Study|Lost to Follow-up|6|||
27903172|NCT01056510|54559978|FG000|Overall Study|Other|10|||
27903173|NCT01056510|54559979|FG001|Overall Study|Other|12|||
27903174|NCT01056510|54559978|FG000|Overall Study|Missing|0|||
27903175|NCT01056510|54559979|FG001|Overall Study|Missing|1|||
27903176|NCT01051323|54559987|FG000|Overall Study|Discontinuation of treatment|103|||
27903177|NCT01051323|54559987|FG000|Overall Study|Transplantation|28|||
27903178|NCT01051323|54559987|FG000|Overall Study|Dialysis dependency|22|||
27903179|NCT01051323|54559987|FG000|Overall Study|Withdrawal by Subject|13|||
27903180|NCT01051323|54559987|FG000|Overall Study|Lost to Follow-up|31|||
27903181|NCT01051323|54559987|FG000|Overall Study|Death|129|||
27903182|NCT01051323|54559987|FG000|Overall Study|Hospitalization|28|||
27903183|NCT01051323|54559987|FG000|Overall Study|Other|148|||
27903184|NCT01051323|54559987|FG000|Overall Study|Missing|37|||
27903185|NCT01056276|54559997|FG000|Treatment Period-Cycles 1-8|Toxicity|2|||
27903186|NCT01056276|54559998|FG001|Treatment Period-Cycles 1-8|Toxicity|1|||
27903187|NCT01056276|54559997|FG000|Treatment Period-Cycles 1-8|Withdrawal by Subject|1|||
27903188|NCT01056276|54559998|FG001|Treatment Period-Cycles 1-8|Withdrawal by Subject|2|||
27903189|NCT01056276|54559997|FG000|Treatment Period-Cycles 1-8|Disease Progression|2|||
27903190|NCT01056276|54559998|FG001|Treatment Period-Cycles 1-8|Disease Progression|2|||
27903191|NCT01056276|54559997|FG000|Treatment Period-Cycles 1-8|Intercurrent Illness|1|||
27903192|NCT01056276|54559998|FG001|Treatment Period-Cycles 1-8|Intercurrent Illness|2|||
27903193|NCT01056276|54559997|FG000|Treatment Period-Cycles 1-8|Physician Decision|3|||
27903194|NCT01056276|54559998|FG001|Treatment Period-Cycles 1-8|Physician Decision|0|||
27903195|NCT01056276|54559997|FG000|Treatment Period-Cycles 1-8|Death|3|||
27903196|NCT01056276|54559998|FG001|Treatment Period-Cycles 1-8|Death|1|||
27903197|NCT01056276|54559997|FG000|Treatment Period-Cycles 1-8|Lost to Follow-up|1|||
27903198|NCT01056276|54559998|FG001|Treatment Period-Cycles 1-8|Lost to Follow-up|0|||
27903199|NCT01056276|54559997|FG000|Maintenance Therapy|Toxicity|0|||
27903200|NCT01056276|54559998|FG001|Maintenance Therapy|Toxicity|2|||
27903201|NCT01056276|54559997|FG000|Maintenance Therapy|Progressive Disease|0|||
27987494|NCT00853827|54646129|FG001|Double Blind Period (103 Weeks)|Lost to Follow-up|10|||
27987495|NCT00853827|54646128|FG000|Double Blind Period (103 Weeks)|Administrative problems|45|||
27987496|NCT00853827|54646129|FG001|Double Blind Period (103 Weeks)|Administrative problems|56|||
27987497|NCT00853827|54646128|FG000|Double Blind Period (103 Weeks)|Death|1|||
27987498|NCT00853827|54646129|FG001|Double Blind Period (103 Weeks)|Death|6|||
27987499|NCT00853749|54646137|FG000|Overall Study|Lost to Follow-up|0|||
27987500|NCT00853749|54646138|FG001|Overall Study|Lost to Follow-up|1|||
28097423|NCT04035564|54753032|FG001|Overall Study|Guardian declined consent|2|||
28097424|NCT02955602|54753041|FG000|Overall Study|Adverse Event|0|||
28097425|NCT02955602|54753042|FG001|Overall Study|Adverse Event|3|||
27987501|NCT00592839|54646147|FG000|Overall Study|Withdrawal by Subject|1|||
27987502|NCT00592839|54646148|FG001|Overall Study|Withdrawal by Subject|1|||
28097426|NCT02955602|54753043|FG002|Overall Study|Adverse Event|0|||
27903202|NCT01056276|54559998|FG001|Maintenance Therapy|Progressive Disease|9|||
27903203|NCT01056276|54559997|FG000|Maintenance Therapy|Physician Decision|0|||
27903204|NCT01056276|54559998|FG001|Maintenance Therapy|Physician Decision|1|||
27903205|NCT01056276|54559997|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
27903206|NCT01056276|54559998|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
27903207|NCT01056276|54559997|FG000|Maintenance Therapy|Intercurrent Illness|0|||
27903208|NCT01056276|54559998|FG001|Maintenance Therapy|Intercurrent Illness|1|||
27903209|NCT01056276|54559997|FG000|Maintenance Therapy|Continuing maintenance therapy|0|||
27925788|NCT01226745|54582371|FG004|Overall Study|Death|0|||
27987503|NCT00592839|54646149|FG002|Overall Study|Withdrawal by Subject|3|||
27987504|NCT00592839|54646147|FG000|Overall Study|Protocol Violation|1|||
27987505|NCT00592839|54646148|FG001|Overall Study|Protocol Violation|1|||
27987506|NCT00592839|54646149|FG002|Overall Study|Protocol Violation|2|||
27987507|NCT00592839|54646147|FG000|Overall Study|Adverse Event|0|||
27987508|NCT00592839|54646148|FG001|Overall Study|Adverse Event|1|||
27987509|NCT00592839|54646149|FG002|Overall Study|Adverse Event|0|||
27903210|NCT01056276|54559998|FG001|Maintenance Therapy|Continuing maintenance therapy|14|||
27903211|NCT01055886|54560011|FG000|Overall Study|Withdrawal by Subject|4|||
27903212|NCT01055886|54560012|FG001|Overall Study|Withdrawal by Subject|9|||
27903213|NCT01055886|54560011|FG000|Overall Study|Lost to Follow-up|1|||
27903214|NCT01055886|54560012|FG001|Overall Study|Lost to Follow-up|1|||
27903215|NCT01055886|54560011|FG000|Overall Study|Withdrawal by PI|0|||
27903216|NCT01055886|54560012|FG001|Overall Study|Withdrawal by PI|1|||
27903217|NCT01055613|54560020|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
27903218|NCT01055613|54560021|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
27987510|NCT00592839|54646147|FG000|Overall Study|Lost to Follow-up|0|||
27987511|NCT00592839|54646148|FG001|Overall Study|Lost to Follow-up|1|||
27987512|NCT00592839|54646149|FG002|Overall Study|Lost to Follow-up|1|||
27987513|NCT00598832|54646159|FG000|Overall Study|Lack of Efficacy|3|||
27987514|NCT00598832|54646160|FG001|Overall Study|Lack of Efficacy|7|||
27987515|NCT00598832|54646159|FG000|Overall Study|Adverse Event|6|||
27987516|NCT00598832|54646160|FG001|Overall Study|Adverse Event|2|||
27987517|NCT00598832|54646159|FG000|Overall Study|Withdrawal by Subject|25|||
27987518|NCT00598832|54646160|FG001|Overall Study|Withdrawal by Subject|36|||
28172223|NCT04428645|54843876|FG000|Second at Home Period (8 Weeks)|Withdrawal by Subject|1|||
27903219|NCT01055613|54560020|FG000|Overall Study|Unacceptable lens fit|1|||
27903220|NCT01055613|54560021|FG001|Overall Study|Unacceptable lens fit|0|||
27903221|NCT01055613|54560020|FG000|Overall Study|Discomfort|2|||
27903222|NCT01055613|54560021|FG001|Overall Study|Discomfort|1|||
27903223|NCT01055613|54560020|FG000|Overall Study|Lost to Follow-up|1|||
27903224|NCT01055613|54560021|FG001|Overall Study|Lost to Follow-up|1|||
27903225|NCT01055613|54560020|FG000|Overall Study|Protocol Violation|1|||
27903226|NCT01055613|54560021|FG001|Overall Study|Protocol Violation|1|||
27903227|NCT01055613|54560020|FG000|Overall Study|Subject Disinterest|1|||
27903228|NCT01055613|54560021|FG001|Overall Study|Subject Disinterest|1|||
27903229|NCT01055457|54560037|FG000|Overall Study|Lost to Follow-up|0|||
27903230|NCT01055457|54560038|FG001|Overall Study|Lost to Follow-up|1|||
27903231|NCT01055457|54560039|FG002|Overall Study|Lost to Follow-up|0|||
27903232|NCT01055457|54560040|FG003|Overall Study|Lost to Follow-up|0|||
27903233|NCT01055457|54560041|FG004|Overall Study|Lost to Follow-up|0|||
27903234|NCT01055457|54560042|FG005|Overall Study|Lost to Follow-up|1|||
27903235|NCT01055457|54560043|FG006|Overall Study|Lost to Follow-up|0|||
27903236|NCT01055457|54560044|FG007|Overall Study|Lost to Follow-up|0|||
27903237|NCT01055457|54560045|FG008|Overall Study|Lost to Follow-up|0|||
27903238|NCT01055457|54560046|FG009|Overall Study|Lost to Follow-up|0|||
27903239|NCT01055457|54560037|FG000|Overall Study|Protocol Violation|0|||
27903240|NCT01055457|54560038|FG001|Overall Study|Protocol Violation|0|||
27903241|NCT01055457|54560039|FG002|Overall Study|Protocol Violation|1|||
27903242|NCT01055457|54560040|FG003|Overall Study|Protocol Violation|1|||
27903243|NCT01055457|54560041|FG004|Overall Study|Protocol Violation|1|||
27903244|NCT01055457|54560042|FG005|Overall Study|Protocol Violation|2|||
27903245|NCT01055457|54560043|FG006|Overall Study|Protocol Violation|1|||
27903246|NCT01055457|54560044|FG007|Overall Study|Protocol Violation|0|||
27903247|NCT01055457|54560045|FG008|Overall Study|Protocol Violation|0|||
27903248|NCT01055457|54560046|FG009|Overall Study|Protocol Violation|1|||
27903249|NCT01055457|54560037|FG000|Overall Study|Subject Disinterest|0|||
27903250|NCT01055457|54560038|FG001|Overall Study|Subject Disinterest|0|||
27903251|NCT01055457|54560039|FG002|Overall Study|Subject Disinterest|0|||
27903252|NCT01055457|54560040|FG003|Overall Study|Subject Disinterest|0|||
27903253|NCT01055457|54560041|FG004|Overall Study|Subject Disinterest|0|||
27903254|NCT01055457|54560042|FG005|Overall Study|Subject Disinterest|0|||
27903255|NCT01055457|54560043|FG006|Overall Study|Subject Disinterest|0|||
27903256|NCT01055457|54560044|FG007|Overall Study|Subject Disinterest|1|||
27987519|NCT00598832|54646159|FG000|Overall Study|Protocol Violation|0|||
27987520|NCT00598832|54646160|FG001|Overall Study|Protocol Violation|2|||
27987521|NCT00598832|54646159|FG000|Overall Study|Lost to Follow-up|24|||
27903257|NCT01055457|54560045|FG008|Overall Study|Subject Disinterest|0|||
27903258|NCT01055457|54560046|FG009|Overall Study|Subject Disinterest|0|||
27903259|NCT01055457|54560037|FG000|Overall Study|Subject Ineligible|1|||
27903260|NCT01055457|54560038|FG001|Overall Study|Subject Ineligible|0|||
27903261|NCT01055457|54560039|FG002|Overall Study|Subject Ineligible|1|||
27903262|NCT01055457|54560040|FG003|Overall Study|Subject Ineligible|0|||
27903263|NCT01055457|54560041|FG004|Overall Study|Subject Ineligible|1|||
27903264|NCT01055457|54560042|FG005|Overall Study|Subject Ineligible|0|||
27987522|NCT00598832|54646160|FG001|Overall Study|Lost to Follow-up|29|||
27903265|NCT01055457|54560043|FG006|Overall Study|Subject Ineligible|0|||
27903266|NCT01055457|54560044|FG007|Overall Study|Subject Ineligible|0|||
27903267|NCT01055457|54560045|FG008|Overall Study|Subject Ineligible|0|||
27987523|NCT00598832|54646159|FG000|Overall Study|Pregnancy|2|||
27903268|NCT01055457|54560046|FG009|Overall Study|Subject Ineligible|0|||
27903269|NCT01055457|54560037|FG000|Overall Study|Discomfort|0|||
27903270|NCT01055457|54560038|FG001|Overall Study|Discomfort|0|||
27903271|NCT01055457|54560039|FG002|Overall Study|Discomfort|0|||
27987524|NCT00598832|54646160|FG001|Overall Study|Pregnancy|2|||
27987525|NCT00598832|54646159|FG000|Overall Study|Physician Decision|1|||
28172224|NCT01368835|54843880|FG000|Overall Study|Inclusion criteria/photography quality|22|||
28172225|NCT01368835|54843880|FG000|Overall Study|Lost to Follow-up|11|||
28172226|NCT02407990|54843899|FG000|Overall Study|Death|2|||
28172227|NCT02407990|54843900|FG001|Overall Study|Death|22|||
28172228|NCT02407990|54843901|FG002|Overall Study|Death|23|||
28172229|NCT02407990|54843902|FG003|Overall Study|Death|7|||
28172230|NCT02407990|54843903|FG004|Overall Study|Death|17|||
28172231|NCT02407990|54843904|FG005|Overall Study|Death|16|||
28172232|NCT02407990|54843905|FG006|Overall Study|Death|10|||
28172233|NCT02407990|54843906|FG007|Overall Study|Death|248|||
28172234|NCT02407990|54843899|FG000|Overall Study|Lost to Follow-up|0|||
28172235|NCT02407990|54843900|FG001|Overall Study|Lost to Follow-up|1|||
28172236|NCT02407990|54843901|FG002|Overall Study|Lost to Follow-up|0|||
28172237|NCT02407990|54843902|FG003|Overall Study|Lost to Follow-up|0|||
28172238|NCT02407990|54843903|FG004|Overall Study|Lost to Follow-up|0|||
28172239|NCT02407990|54843904|FG005|Overall Study|Lost to Follow-up|0|||
28172240|NCT02407990|54843905|FG006|Overall Study|Lost to Follow-up|0|||
28172241|NCT02407990|54843906|FG007|Overall Study|Lost to Follow-up|17|||
28172242|NCT02407990|54843899|FG000|Overall Study|Progressive Disease|0|||
28172243|NCT02407990|54843900|FG001|Overall Study|Progressive Disease|0|||
28172244|NCT02407990|54843901|FG002|Overall Study|Progressive Disease|0|||
28172245|NCT02407990|54843902|FG003|Overall Study|Progressive Disease|0|||
28172246|NCT02407990|54843903|FG004|Overall Study|Progressive Disease|0|||
28172247|NCT02407990|54843904|FG005|Overall Study|Progressive Disease|0|||
28172248|NCT02407990|54843905|FG006|Overall Study|Progressive Disease|0|||
28172249|NCT02407990|54843906|FG007|Overall Study|Progressive Disease|1|||
28172250|NCT02407990|54843899|FG000|Overall Study|Withdrawal by Subject|0|||
28172251|NCT02407990|54843900|FG001|Overall Study|Withdrawal by Subject|0|||
28172252|NCT02407990|54843901|FG002|Overall Study|Withdrawal by Subject|0|||
28172253|NCT02407990|54843902|FG003|Overall Study|Withdrawal by Subject|0|||
28172254|NCT02407990|54843903|FG004|Overall Study|Withdrawal by Subject|1|||
28172255|NCT02407990|54843904|FG005|Overall Study|Withdrawal by Subject|0|||
28172256|NCT02407990|54843905|FG006|Overall Study|Withdrawal by Subject|0|||
28172257|NCT02407990|54843906|FG007|Overall Study|Withdrawal by Subject|30|||
28172258|NCT02407990|54843899|FG000|Overall Study|Study Terminated by Sponsor|1|||
28172259|NCT02407990|54843900|FG001|Overall Study|Study Terminated by Sponsor|3|||
28172260|NCT02407990|54843901|FG002|Overall Study|Study Terminated by Sponsor|3|||
28172261|NCT02407990|54843902|FG003|Overall Study|Study Terminated by Sponsor|0|||
28172262|NCT02407990|54843903|FG004|Overall Study|Study Terminated by Sponsor|3|||
28172263|NCT02407990|54843904|FG005|Overall Study|Study Terminated by Sponsor|4|||
28172264|NCT02407990|54843905|FG006|Overall Study|Study Terminated by Sponsor|3|||
28172265|NCT02407990|54843906|FG007|Overall Study|Study Terminated by Sponsor|37|||
28172266|NCT02407990|54843899|FG000|Overall Study|Logistics|0|||
28172267|NCT02407990|54843900|FG001|Overall Study|Logistics|0|||
28172268|NCT02407990|54843901|FG002|Overall Study|Logistics|0|||
28172269|NCT02407990|54843902|FG003|Overall Study|Logistics|0|||
28172270|NCT02407990|54843903|FG004|Overall Study|Logistics|0|||
28172271|NCT02407990|54843904|FG005|Overall Study|Logistics|0|||
28172272|NCT02407990|54843905|FG006|Overall Study|Logistics|0|||
28172273|NCT02407990|54843906|FG007|Overall Study|Logistics|1|||
28172274|NCT02407990|54843899|FG000|Overall Study|Rolled into long-term extension study|0|||
28172275|NCT02407990|54843900|FG001|Overall Study|Rolled into long-term extension study|0|||
28172276|NCT02407990|54843901|FG002|Overall Study|Rolled into long-term extension study|0|||
28172277|NCT02407990|54843902|FG003|Overall Study|Rolled into long-term extension study|0|||
27987526|NCT00598832|54646160|FG001|Overall Study|Physician Decision|4|||
28172278|NCT02407990|54843903|FG004|Overall Study|Rolled into long-term extension study|0|||
28172279|NCT02407990|54843904|FG005|Overall Study|Rolled into long-term extension study|0|||
28172280|NCT02407990|54843905|FG006|Overall Study|Rolled into long-term extension study|0|||
28172281|NCT02407990|54843906|FG007|Overall Study|Rolled into long-term extension study|1|||
28172282|NCT03288129|54843930|FG000|Overall Study|Adverse Event|10|||
28172283|NCT03288129|54843930|FG000|Overall Study|Lost to Follow-up|3|||
28172284|NCT03288129|54843930|FG000|Overall Study|Withdrawal by Subject|3|||
27903272|NCT01055457|54560040|FG003|Overall Study|Discomfort|0|||
27903273|NCT01055457|54560041|FG004|Overall Study|Discomfort|1|||
27903274|NCT01055457|54560042|FG005|Overall Study|Discomfort|0|||
27903275|NCT01055457|54560043|FG006|Overall Study|Discomfort|0|||
28172285|NCT03288129|54843930|FG000|Overall Study|Withdrawal of consent/assent|1|||
28172286|NCT03288129|54843930|FG000|Overall Study|Other|5|||
28172287|NCT01673282|54843936|FG000|Overall Study|Adverse Drug Reaction - Vimpat|9|||
28172288|NCT01673282|54843937|FG001|Overall Study|Adverse Drug Reaction - Vimpat|5|||
28172289|NCT01673282|54843936|FG000|Overall Study|Lack of Efficacy|9|||
27903276|NCT01055457|54560044|FG007|Overall Study|Discomfort|0|||
28172290|NCT01673282|54843937|FG001|Overall Study|Lack of Efficacy|2|||
27739555|NCT03745651|54189171|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|8|||
27739556|NCT03745651|54189172|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|26|||
27739557|NCT03745651|54189173|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|34|||
27739558|NCT03745651|54189167|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
27739559|NCT03745651|54189168|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
27739560|NCT03745651|54189169|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
27739561|NCT03745651|54189170|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
27739562|NCT03745651|54189171|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
27739563|NCT03745651|54189172|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
27739564|NCT03745651|54189173|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
27739565|NCT02738879|54189191|FG000|Overall Study|Adverse Event|1|||
27739566|NCT02738879|54189192|FG001|Overall Study|Adverse Event|1|||
27987527|NCT00598832|54646159|FG000|Overall Study|Non compliance|1|||
27987528|NCT00598832|54646160|FG001|Overall Study|Non compliance|0|||
27987529|NCT00853593|54646166|FG000|Overall Study|Subjects did not receive a 4396 lead|12|||
27987530|NCT00853593|54646166|FG000|Overall Study|Model 4396 lead not attempted|29|||
27987531|NCT00853593|54646166|FG000|Overall Study|Implant not attempted|4|||
27987532|NCT00853125|54646187|FG000|Overall Study|Study participant's donor was CMV +|1|||
27987533|NCT00530023|54646194|FG000|Overall Study|Withdrawal by Subject|0|||
27987534|NCT00530023|54646195|FG001|Overall Study|Withdrawal by Subject|1|||
27739567|NCT02738879|54189191|FG000|Overall Study|Death|0|||
27739568|NCT02738879|54189192|FG001|Overall Study|Death|2|||
27739569|NCT02738879|54189191|FG000|Overall Study|Lost to Follow-up|1|||
27739570|NCT02738879|54189192|FG001|Overall Study|Lost to Follow-up|5|||
27739571|NCT02738879|54189191|FG000|Overall Study|Protocol Violation|1|||
27903277|NCT01055457|54560045|FG008|Overall Study|Discomfort|0|||
27903278|NCT01055457|54560046|FG009|Overall Study|Discomfort|0|||
27903279|NCT01055457|54560037|FG000|Overall Study|Pregnancy|0|||
27903280|NCT01055457|54560038|FG001|Overall Study|Pregnancy|0|||
27903281|NCT01055457|54560039|FG002|Overall Study|Pregnancy|0|||
27903282|NCT01055457|54560040|FG003|Overall Study|Pregnancy|1|||
27903283|NCT01055457|54560041|FG004|Overall Study|Pregnancy|0|||
27903284|NCT01055457|54560042|FG005|Overall Study|Pregnancy|0|||
27903285|NCT01055457|54560043|FG006|Overall Study|Pregnancy|0|||
27903286|NCT01055457|54560044|FG007|Overall Study|Pregnancy|0|||
27903287|NCT01055457|54560045|FG008|Overall Study|Pregnancy|0|||
27903288|NCT01055457|54560046|FG009|Overall Study|Pregnancy|0|||
27903289|NCT01055457|54560037|FG000|Overall Study|Adverse Event|0|||
27903290|NCT01055457|54560038|FG001|Overall Study|Adverse Event|0|||
27903291|NCT01055457|54560039|FG002|Overall Study|Adverse Event|0|||
27903292|NCT01055457|54560040|FG003|Overall Study|Adverse Event|1|||
27903293|NCT01055457|54560041|FG004|Overall Study|Adverse Event|0|||
27903294|NCT01055457|54560042|FG005|Overall Study|Adverse Event|0|||
27903295|NCT01055457|54560043|FG006|Overall Study|Adverse Event|0|||
27903296|NCT01055457|54560044|FG007|Overall Study|Adverse Event|0|||
27903297|NCT01055457|54560045|FG008|Overall Study|Adverse Event|0|||
27903298|NCT01055457|54560046|FG009|Overall Study|Adverse Event|0|||
27903299|NCT01055028|54560070|FG000|Screening|Screen Failure|1|||
27903300|NCT01055028|54560071|FG001|Screening|Screen Failure|1|||
27903301|NCT01055028|54560070|FG000|Treatment Cycles 1 to 3|Adverse Event|0|||
27903302|NCT01055028|54560071|FG001|Treatment Cycles 1 to 3|Adverse Event|1|||
27903303|NCT01055028|54560070|FG000|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
27903304|NCT01055028|54560071|FG001|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
27903305|NCT01055028|54560070|FG000|Inter-treatment Period|Did not start Cycle 4|0|||
28097427|NCT02955602|54753041|FG000|Overall Study|Withdrawal of informed consent|1|||
28097428|NCT02955602|54753042|FG001|Overall Study|Withdrawal of informed consent|3|||
28097429|NCT02955602|54753043|FG002|Overall Study|Withdrawal of informed consent|2|||
28097430|NCT02955602|54753041|FG000|Overall Study|Lost to Follow-up|0|||
28097431|NCT02955602|54753042|FG001|Overall Study|Lost to Follow-up|0|||
28097432|NCT02955602|54753043|FG002|Overall Study|Lost to Follow-up|1|||
28097433|NCT02955602|54753041|FG000|Overall Study|Other|0|||
28097434|NCT02955602|54753042|FG001|Overall Study|Other|1|||
28097435|NCT02955602|54753043|FG002|Overall Study|Other|3|||
28097436|NCT04179786|54753051|FG000|Overall Study|Withdrawal by Subject|8|||
28097437|NCT04175808|54753055|FG000|Part A|Miscellaneous|2|||
28097438|NCT04175808|54753056|FG001|Part A|Miscellaneous|0|||
28097439|NCT04175808|54753057|FG002|Part A|Miscellaneous|0|||
27739572|NCT02738879|54189192|FG001|Overall Study|Protocol Violation|3|||
27987535|NCT00529087|54646204|FG000|Overall Study|Adverse Event|10|||
27987536|NCT00529087|54646205|FG001|Overall Study|Adverse Event|13|||
27987537|NCT00529087|54646206|FG002|Overall Study|Adverse Event|4|||
28097440|NCT04175808|54753058|FG003|Part A|Miscellaneous|0|||
27739573|NCT02738879|54189191|FG000|Overall Study|Physician Decision|3|||
27739574|NCT02738879|54189192|FG001|Overall Study|Physician Decision|4|||
27903306|NCT01055028|54560071|FG001|Inter-treatment Period|Did not start Cycle 4|3|||
27903307|NCT01050816|54560103|FG000|Overall Study|Lost to Follow-up|2|||
28097441|NCT04175808|54753059|FG004|Part A|Miscellaneous|0|||
28097442|NCT04175808|54753060|FG005|Part A|Miscellaneous|0|||
27903308|NCT01050816|54560103|FG000|Overall Study|patient's refusal|2|||
27903309|NCT01054560|54560109|FG000|Overall Study|Death|10|||
27903310|NCT01054560|54560110|FG001|Overall Study|Death|21|||
27903311|NCT01054560|54560109|FG000|Overall Study|Lost to Follow-up|2|||
27903312|NCT01054560|54560110|FG001|Overall Study|Lost to Follow-up|5|||
27903313|NCT01054560|54560109|FG000|Overall Study|Withdrawal by Subject|0|||
27903314|NCT01054560|54560110|FG001|Overall Study|Withdrawal by Subject|2|||
27903315|NCT01054560|54560109|FG000|Overall Study|Physician Decision|1|||
27903316|NCT01054560|54560110|FG001|Overall Study|Physician Decision|0|||
27903317|NCT01054443|54560122|FG000|Overall Study|Withdrawal by Subject|0|||
27903318|NCT01054443|54560123|FG001|Overall Study|Withdrawal by Subject|0|||
27903319|NCT01054443|54560124|FG002|Overall Study|Withdrawal by Subject|0|||
27903320|NCT01054443|54560125|FG003|Overall Study|Withdrawal by Subject|1|||
27903321|NCT01050543|54560140|FG000|Overall Study|Withdrawal by Subject|0|||
27903322|NCT01050543|54560141|FG001|Overall Study|Withdrawal by Subject|2|||
27903323|NCT01050543|54560140|FG000|Overall Study|Protocol Violation|0|||
27903324|NCT01050543|54560141|FG001|Overall Study|Protocol Violation|1|||
27903325|NCT01050543|54560140|FG000|Overall Study|Administrative|4|||
27903326|NCT01050543|54560141|FG001|Overall Study|Administrative|1|||
27903327|NCT01051557|54560154|FG000|Overall Study|Physician Decision|1|||
27903328|NCT01051557|54560155|FG001|Overall Study|Physician Decision|0|||
27903329|NCT01051557|54560156|FG002|Overall Study|Physician Decision|0|||
27903330|NCT01051557|54560157|FG003|Overall Study|Physician Decision|0|||
27903331|NCT01051557|54560158|FG004|Overall Study|Physician Decision|0|||
27903332|NCT01051557|54560159|FG005|Overall Study|Physician Decision|0|||
27903333|NCT01051557|54560160|FG006|Overall Study|Physician Decision|0|||
27903334|NCT01051557|54560154|FG000|Overall Study|disease progression|3|||
27903335|NCT01051557|54560155|FG001|Overall Study|disease progression|3|||
27903336|NCT01051557|54560156|FG002|Overall Study|disease progression|5|||
27903337|NCT01051557|54560157|FG003|Overall Study|disease progression|2|||
27903338|NCT01051557|54560158|FG004|Overall Study|disease progression|4|||
27903339|NCT01051557|54560159|FG005|Overall Study|disease progression|3|||
27903340|NCT01051557|54560160|FG006|Overall Study|disease progression|1|||
27903341|NCT01051557|54560154|FG000|Overall Study|Withdrawal by Subject|0|||
27903342|NCT01051557|54560155|FG001|Overall Study|Withdrawal by Subject|0|||
27903343|NCT01051557|54560156|FG002|Overall Study|Withdrawal by Subject|1|||
27903344|NCT01051557|54560157|FG003|Overall Study|Withdrawal by Subject|0|||
27903345|NCT01051557|54560158|FG004|Overall Study|Withdrawal by Subject|2|||
27903346|NCT01051557|54560159|FG005|Overall Study|Withdrawal by Subject|0|||
27903347|NCT01051557|54560160|FG006|Overall Study|Withdrawal by Subject|1|||
27903348|NCT01051557|54560154|FG000|Overall Study|Adverse Event|0|||
27987538|NCT00529087|54646204|FG000|Overall Study|Lost to Follow-up|6|||
27987539|NCT00529087|54646205|FG001|Overall Study|Lost to Follow-up|4|||
27987540|NCT00529087|54646206|FG002|Overall Study|Lost to Follow-up|1|||
27987541|NCT00529087|54646204|FG000|Overall Study|Protocol Violation|8|||
27987542|NCT00529087|54646205|FG001|Overall Study|Protocol Violation|7|||
27987543|NCT00529087|54646206|FG002|Overall Study|Protocol Violation|6|||
27987544|NCT00529087|54646204|FG000|Overall Study|Withdrawal by Subject|3|||
27987545|NCT00529087|54646205|FG001|Overall Study|Withdrawal by Subject|3|||
27903349|NCT01051557|54560155|FG001|Overall Study|Adverse Event|0|||
27987546|NCT00529087|54646206|FG002|Overall Study|Withdrawal by Subject|3|||
27987547|NCT00529087|54646204|FG000|Overall Study|Protocol deviation|1|||
27903350|NCT01051557|54560156|FG002|Overall Study|Adverse Event|0|||
27903351|NCT01051557|54560157|FG003|Overall Study|Adverse Event|1|||
27903352|NCT01051557|54560158|FG004|Overall Study|Adverse Event|1|||
27903353|NCT01051557|54560159|FG005|Overall Study|Adverse Event|3|||
27903354|NCT01051557|54560160|FG006|Overall Study|Adverse Event|4|||
27903355|NCT01054170|54560179|FG000|Overall Study|Protocol Violation|1|||
27903356|NCT01054170|54560180|FG001|Overall Study|Protocol Violation|0|||
27903357|NCT01054170|54560179|FG000|Overall Study|Withdrawal by Subject|3|||
27903358|NCT01054170|54560180|FG001|Overall Study|Withdrawal by Subject|2|||
27903359|NCT01054170|54560179|FG000|Overall Study|Adverse Event|0|||
27987548|NCT00529087|54646205|FG001|Overall Study|Protocol deviation|1|||
28097443|NCT04175808|54753061|FG006|Part A|Miscellaneous|0|||
27903360|NCT01054170|54560180|FG001|Overall Study|Adverse Event|4|||
27903361|NCT01053741|54560188|FG000|2nd Study Intervention|Physician Decision|0|||
27987549|NCT00529087|54646206|FG002|Overall Study|Protocol deviation|2|||
28097444|NCT04057196|54753077|FG000|Overall Study|Withdrawal by Subject|3|||
27903362|NCT01053741|54560189|FG001|2nd Study Intervention|Physician Decision|1|||
27903363|NCT01052493|54560195|FG000|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1|||
27903364|NCT01052493|54560196|FG001|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
27903365|NCT01052493|54560197|FG002|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
27903366|NCT01052103|54560212|FG000|Overall Study|Adverse Event|10|||
27903367|NCT01052103|54560213|FG001|Overall Study|Adverse Event|6|||
27903368|NCT01052103|54560212|FG000|Overall Study|Entry Criteria Not Met|3|||
27903369|NCT01052103|54560213|FG001|Overall Study|Entry Criteria Not Met|1|||
27987550|NCT00870870|54646241|FG000|Overall Study|Withdrawal by Subject|0|||
27987551|NCT00870870|54646242|FG001|Overall Study|Withdrawal by Subject|1|||
28097445|NCT04057196|54753077|FG000|Overall Study|Death|3|||
27903370|NCT01052103|54560212|FG000|Overall Study|Lost to Follow-up|3|||
27903371|NCT01052103|54560213|FG001|Overall Study|Lost to Follow-up|5|||
27903372|NCT01052103|54560212|FG000|Overall Study|Protocol Violation|10|||
27987552|NCT00870870|54646243|FG002|Overall Study|Withdrawal by Subject|1|||
27987553|NCT00870870|54646244|FG003|Overall Study|Withdrawal by Subject|3|||
27987554|NCT00870870|54646241|FG000|Overall Study|Adverse Event|0|||
27903373|NCT01052103|54560213|FG001|Overall Study|Protocol Violation|4|||
27903374|NCT01052103|54560212|FG000|Overall Study|Scheduling conflict|2|||
27903375|NCT01052103|54560213|FG001|Overall Study|Scheduling conflict|1|||
27903376|NCT01052103|54560212|FG000|Overall Study|Sponsor Decision|2|||
27903377|NCT01052103|54560213|FG001|Overall Study|Sponsor Decision|0|||
27903378|NCT01052103|54560212|FG000|Overall Study|Withdrawal by Subject|3|||
27903379|NCT01052103|54560213|FG001|Overall Study|Withdrawal by Subject|6|||
27903380|NCT01052103|54560212|FG000|Overall Study|Perceived Lack of Efficacy|1|||
27903381|NCT01052103|54560213|FG001|Overall Study|Perceived Lack of Efficacy|0|||
27903382|NCT01051986|54560222|FG000|Overall Study|Death|1|||
27903383|NCT01051986|54560223|FG001|Overall Study|Death|0|||
27903384|NCT01051986|54560222|FG000|Overall Study|Withdrawal by Subject|2|||
27987555|NCT00870870|54646242|FG001|Overall Study|Adverse Event|0|||
27987556|NCT00870870|54646243|FG002|Overall Study|Adverse Event|2|||
27987557|NCT00870870|54646244|FG003|Overall Study|Adverse Event|2|||
27987558|NCT03877237|54646261|FG000|Overall Study|Adverse Event|1|||
27987559|NCT03877237|54646262|FG001|Overall Study|Adverse Event|2|||
27987560|NCT03877237|54646261|FG000|Overall Study|Death|3|||
27987561|NCT03877237|54646262|FG001|Overall Study|Death|2|||
27987562|NCT03877237|54646261|FG000|Overall Study|Physician Decision|1|||
27987563|NCT03877237|54646262|FG001|Overall Study|Physician Decision|0|||
27987564|NCT03877237|54646261|FG000|Overall Study|Withdrawal by Subject|0|||
27987565|NCT03877237|54646262|FG001|Overall Study|Withdrawal by Subject|2|||
27987566|NCT00528931|54646268|FG000|Overall Study|Lost to Follow-up|1|||
27987567|NCT00866814|54646273|FG000|Overall Study|Lost to Follow-up|12|||
27987568|NCT00866814|54646273|FG000|Overall Study|Adverse Event|2|||
27987569|NCT00866814|54646273|FG000|Overall Study|Physician Decision|1|||
27987570|NCT00866814|54646273|FG000|Overall Study|Death|1|||
27987571|NCT00866814|54646273|FG000|Overall Study|No longer wished to participate|1|||
27987572|NCT00866814|54646273|FG000|Overall Study|Unable to meet follow-up requirements|2|||
27987573|NCT00866814|54646273|FG000|Overall Study|Moved to area without study site|1|||
27987574|NCT00871494|54646277|FG000|Overall Study|Protocol Violation|5|||
27987575|NCT00871494|54646277|FG000|Overall Study|Lack of Efficacy|4|||
27987576|NCT00871494|54646277|FG000|Overall Study|Adverse Event|4|||
27987577|NCT00871494|54646277|FG000|Overall Study|Lost to Follow-up|1|||
27987578|NCT00529789|54646281|FG000|Study Period II/III|Parent/Caregiver Decision|9|||
27987579|NCT00529789|54646281|FG000|Study Period II/III|Adverse Event|3|||
27987580|NCT00529789|54646281|FG000|Study Period II/III|Lack of Efficacy|2|||
27903385|NCT01051986|54560223|FG001|Overall Study|Withdrawal by Subject|1|||
27903386|NCT01051986|54560222|FG000|Overall Study|Protocol Violation|2|||
27903387|NCT01051986|54560223|FG001|Overall Study|Protocol Violation|3|||
27903388|NCT00105534|54560235|FG000|Overall Study|Adverse Event|2|||
27903389|NCT00105534|54560236|FG001|Overall Study|Adverse Event|5|||
27903390|NCT00105534|54560235|FG000|Overall Study|Protocol Violation|1|||
27987581|NCT00529789|54646281|FG000|Study Period II/III|Withdrawal by Subject|1|||
27903391|NCT00105534|54560236|FG001|Overall Study|Protocol Violation|4|||
27903392|NCT00105534|54560235|FG000|Overall Study|Withdrawal by Subject|6|||
27903393|NCT00105534|54560236|FG001|Overall Study|Withdrawal by Subject|6|||
27903394|NCT00105534|54560235|FG000|Overall Study|Lost to Follow-up|5|||
27903395|NCT00105534|54560236|FG001|Overall Study|Lost to Follow-up|1|||
27903396|NCT00105534|54560235|FG000|Overall Study|Lack of Efficacy|7|||
27903397|NCT00105534|54560236|FG001|Overall Study|Lack of Efficacy|15|||
27903398|NCT00105534|54560235|FG000|Overall Study|Treatment unmasked|1|||
27903399|NCT00105534|54560236|FG001|Overall Study|Treatment unmasked|0|||
27903400|NCT00105534|54560235|FG000|Overall Study|Other Reason|0|||
27903401|NCT00105534|54560236|FG001|Overall Study|Other Reason|2|||
27903402|NCT00105183|54560245|FG000|Overall Study|Death|19|||
27987582|NCT00529789|54646281|FG000|Study Period II/III|Protocol Violation|3|||
27987583|NCT00529789|54646281|FG000|Study Period II/III|Physician Decision|3|||
27987584|NCT00529789|54646281|FG000|Study Period II/III|Lost to Follow-up|3|||
27903403|NCT00105183|54560246|FG001|Overall Study|Death|13|||
27903404|NCT00105183|54560247|FG002|Overall Study|Death|15|||
27903405|NCT00105183|54560245|FG000|Overall Study|Withdrawal by Subject|1|||
27903406|NCT00105183|54560246|FG001|Overall Study|Withdrawal by Subject|1|||
27903407|NCT00105183|54560247|FG002|Overall Study|Withdrawal by Subject|4|||
27903408|NCT00105183|54560245|FG000|Overall Study|Physician Decision|1|||
27987585|NCT00529789|54646281|FG000|Study Period IV|Parent/Caregiver Decision|1|||
27987586|NCT00529789|54646281|FG000|Study Period IV|Adverse Event|1|||
27903409|NCT00105183|54560246|FG001|Overall Study|Physician Decision|2|||
27903410|NCT00105183|54560247|FG002|Overall Study|Physician Decision|3|||
27903411|NCT00105183|54560245|FG000|Overall Study|Lost to Follow-up|0|||
27987587|NCT00529789|54646281|FG000|Study Period IV|Lack of Efficacy|1|||
27987588|NCT00529789|54646281|FG000|Study Period IV|Lost to Follow-up|3|||
27903412|NCT00105183|54560246|FG001|Overall Study|Lost to Follow-up|1|||
27987589|NCT00577642|54646291|FG000|Overall Study|Clinical Disease Progression|1|||
27987590|NCT00866658|54646297|FG000|Overall Study|Adverse Event|5|||
27903413|NCT00105183|54560247|FG002|Overall Study|Lost to Follow-up|1|||
27903414|NCT00105183|54560245|FG000|Overall Study|Other reason|1|||
27903415|NCT00105183|54560246|FG001|Overall Study|Other reason|2|||
27903416|NCT00105183|54560247|FG002|Overall Study|Other reason|0|||
27903417|NCT01059617|54560259|FG000|Overall Study|Other|7|||
27903418|NCT01059617|54560260|FG001|Overall Study|Other|1|||
27903419|NCT01059617|54560261|FG002|Overall Study|Other|8|||
27903420|NCT01059617|54560262|FG003|Overall Study|Other|6|||
27903421|NCT01059344|54560282|FG000|Overall Study|Adverse Event|12|||
27903422|NCT01059344|54560283|FG001|Overall Study|Adverse Event|30|||
27903423|NCT01059344|54560282|FG000|Overall Study|Withdrawal by Subject|6|||
27903424|NCT01059344|54560283|FG001|Overall Study|Withdrawal by Subject|9|||
27903425|NCT01059344|54560282|FG000|Overall Study|Lost to Follow-up|1|||
27903426|NCT01059344|54560283|FG001|Overall Study|Lost to Follow-up|1|||
27903427|NCT01059344|54560282|FG000|Overall Study|Other|3|||
27903428|NCT01059344|54560283|FG001|Overall Study|Other|6|||
27903429|NCT01059071|54560291|FG000|Overall Study|Lack of Efficacy|1|||
27903430|NCT01059071|54560292|FG001|Overall Study|Lack of Efficacy|4|||
27903431|NCT01059071|54560293|FG002|Overall Study|Lack of Efficacy|2|||
27903432|NCT01059071|54560294|FG003|Overall Study|Lack of Efficacy|3|||
27903433|NCT01059071|54560291|FG000|Overall Study|Withdrawal by Subject|1|||
27903434|NCT01059071|54560292|FG001|Overall Study|Withdrawal by Subject|0|||
27903435|NCT01059071|54560293|FG002|Overall Study|Withdrawal by Subject|0|||
27903436|NCT01059071|54560294|FG003|Overall Study|Withdrawal by Subject|2|||
27903437|NCT01059071|54560291|FG000|Overall Study|Physician Decision|0|||
27903438|NCT01059071|54560292|FG001|Overall Study|Physician Decision|0|||
27903439|NCT01059071|54560293|FG002|Overall Study|Physician Decision|0|||
27903440|NCT01059071|54560294|FG003|Overall Study|Physician Decision|1|||
27903441|NCT01058369|54560302|FG000|Overall Study|Adverse Event|1|||
27903442|NCT01058369|54560302|FG000|Overall Study|Early termination study|1|||
27903443|NCT01057433|54560306|FG000|Overall Study|Adverse Event|1|||
27903444|NCT01057394|54560310|FG000|Overall Study|Not eligible|0|||
27903445|NCT01057394|54560311|FG001|Overall Study|Not eligible|2|||
27903446|NCT01058642|54560319|FG000|Treatment Period 1|Adverse Event|0|||
28097446|NCT04027686|54753083|FG000|Overall Study|Lost to Follow-up|2|||
27903447|NCT01058642|54560320|FG001|Treatment Period 1|Adverse Event|1|||
27903448|NCT01058642|54560321|FG002|Treatment Period 1|Adverse Event|1|||
27903449|NCT01058642|54560322|FG003|Treatment Period 1|Adverse Event|0|||
27987591|NCT00866658|54646298|FG001|Overall Study|Adverse Event|14|||
27987592|NCT00866658|54646297|FG000|Overall Study|Lack of Efficacy|2|||
27987593|NCT00866658|54646298|FG001|Overall Study|Lack of Efficacy|1|||
27987594|NCT00866658|54646297|FG000|Overall Study|Withdrawal by Subject|1|||
27987595|NCT00866658|54646298|FG001|Overall Study|Withdrawal by Subject|0|||
27987596|NCT00866658|54646297|FG000|Overall Study|Protocol Violation|1|||
27987597|NCT00866658|54646298|FG001|Overall Study|Protocol Violation|1|||
27987598|NCT00866658|54646297|FG000|Overall Study|Familial and Personal Reasons|4|||
27987599|NCT00866658|54646298|FG001|Overall Study|Familial and Personal Reasons|5|||
27987600|NCT03872453|54646308|FG000|Overall Study|Adverse Event|1|||
27987601|NCT03872453|54646309|FG001|Overall Study|Adverse Event|1|||
27987602|NCT03872453|54646310|FG002|Overall Study|Adverse Event|0|||
27987603|NCT03872453|54646311|FG003|Overall Study|Adverse Event|0|||
27987604|NCT03872453|54646308|FG000|Overall Study|Lost to Follow-up|8|||
27987605|NCT03872453|54646309|FG001|Overall Study|Lost to Follow-up|7|||
27987606|NCT03872453|54646310|FG002|Overall Study|Lost to Follow-up|4|||
27987607|NCT03872453|54646311|FG003|Overall Study|Lost to Follow-up|4|||
27987608|NCT03872453|54646308|FG000|Overall Study|Never Treated Migraine|19|||
27987609|NCT03872453|54646309|FG001|Overall Study|Never Treated Migraine|17|||
27987610|NCT03872453|54646310|FG002|Overall Study|Never Treated Migraine|13|||
27987611|NCT03872453|54646311|FG003|Overall Study|Never Treated Migraine|12|||
27987612|NCT03872453|54646308|FG000|Overall Study|Pregnancy|1|||
27987613|NCT03872453|54646309|FG001|Overall Study|Pregnancy|0|||
27987614|NCT03872453|54646310|FG002|Overall Study|Pregnancy|0|||
27987615|NCT03872453|54646311|FG003|Overall Study|Pregnancy|0|||
27987616|NCT03872453|54646308|FG000|Overall Study|Protocol Deviation|2|||
27987617|NCT03872453|54646309|FG001|Overall Study|Protocol Deviation|0|||
27987618|NCT03872453|54646310|FG002|Overall Study|Protocol Deviation|0|||
27987619|NCT03872453|54646311|FG003|Overall Study|Protocol Deviation|2|||
28097447|NCT04027686|54753084|FG001|Overall Study|Lost to Follow-up|0|||
27903450|NCT01058642|54560319|FG000|Treatment Period 1|Physician Decision|0|||
27903451|NCT01058642|54560320|FG001|Treatment Period 1|Physician Decision|0|||
27903452|NCT01058642|54560321|FG002|Treatment Period 1|Physician Decision|1|||
27903453|NCT01058642|54560322|FG003|Treatment Period 1|Physician Decision|0|||
27987620|NCT03872453|54646308|FG000|Overall Study|Withdrawal by Subject|0|||
27987621|NCT03872453|54646309|FG001|Overall Study|Withdrawal by Subject|1|||
28097448|NCT04027686|54753083|FG000|Overall Study|Withdrawal by Subject|0|||
27903454|NCT01058642|54560319|FG000|Treatment Period 1|Withdrawal by Subject|1|||
27903455|NCT01058642|54560320|FG001|Treatment Period 1|Withdrawal by Subject|0|||
27903456|NCT01058642|54560321|FG002|Treatment Period 1|Withdrawal by Subject|0|||
27903457|NCT01058642|54560322|FG003|Treatment Period 1|Withdrawal by Subject|0|||
27903458|NCT01058642|54560319|FG000|Treatment Period 1|Lack of Efficacy|0|||
27903459|NCT01058642|54560320|FG001|Treatment Period 1|Lack of Efficacy|0|||
27903460|NCT01058642|54560321|FG002|Treatment Period 1|Lack of Efficacy|0|||
27903461|NCT01058642|54560322|FG003|Treatment Period 1|Lack of Efficacy|1|||
27903462|NCT01058642|54560319|FG000|Treatment Period 1|Protocol Violation|0|||
27903463|NCT01058642|54560320|FG001|Treatment Period 1|Protocol Violation|0|||
27903464|NCT01058642|54560321|FG002|Treatment Period 1|Protocol Violation|0|||
27903465|NCT01058642|54560322|FG003|Treatment Period 1|Protocol Violation|1|||
27903466|NCT01058642|54560319|FG000|Treatment Period 1|Lack of Compliance with Study Drug|1|||
27903467|NCT01058642|54560320|FG001|Treatment Period 1|Lack of Compliance with Study Drug|0|||
27903468|NCT01058642|54560321|FG002|Treatment Period 1|Lack of Compliance with Study Drug|0|||
27903469|NCT01058642|54560322|FG003|Treatment Period 1|Lack of Compliance with Study Drug|0|||
27903470|NCT01056653|54560333|FG000|Overall Study|Lost to Follow-up|0|||
27903471|NCT01056653|54560334|FG001|Overall Study|Lost to Follow-up|0|||
27903472|NCT01056653|54560335|FG002|Overall Study|Lost to Follow-up|2|||
27903473|NCT01056536|54560347|FG000|Overall Study|Lost to Follow-up|202|||
27903474|NCT01056536|54560348|FG001|Overall Study|Lost to Follow-up|116|||
27903475|NCT01056536|54560349|FG002|Overall Study|Lost to Follow-up|248|||
27903476|NCT01056380|54560359|FG000|Overall Study|Lost to Follow-up|2|||
27903477|NCT01056380|54560360|FG001|Overall Study|Lost to Follow-up|3|||
27903478|NCT01055834|54560370|FG000|Treatment Period I|Adverse Event|1|||
27903479|NCT01055834|54560371|FG001|Treatment Period I|Adverse Event|0|||
27903480|NCT01055639|54560382|FG000|Overall Study|Adverse Event|0|||
27903481|NCT01055639|54560383|FG001|Overall Study|Adverse Event|1|||
27903482|NCT01055639|54560382|FG000|Overall Study|Lack of Efficacy|0|||
27903483|NCT01055639|54560383|FG001|Overall Study|Lack of Efficacy|1|||
27903484|NCT01055639|54560382|FG000|Overall Study|Lost to Follow-up|8|||
27903485|NCT01055639|54560383|FG001|Overall Study|Lost to Follow-up|11|||
27903486|NCT01055639|54560382|FG000|Overall Study|Protocol Violation|5|||
27903487|NCT01055639|54560383|FG001|Overall Study|Protocol Violation|5|||
27903488|NCT01055639|54560382|FG000|Overall Study|Withdrawal by Subject|8|||
27903489|NCT01055639|54560383|FG001|Overall Study|Withdrawal by Subject|11|||
27903490|NCT01055132|54560398|FG000|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1|||
27903491|NCT01055132|54560399|FG001|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0|||
27903492|NCT01055132|54560398|FG000|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0|||
27903493|NCT01055132|54560399|FG001|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1|||
27987622|NCT03872453|54646310|FG002|Overall Study|Withdrawal by Subject|2|||
27987623|NCT03872453|54646311|FG003|Overall Study|Withdrawal by Subject|0|||
27987624|NCT03872453|54646308|FG000|Overall Study|Other Than Specified|1|||
27987625|NCT03872453|54646309|FG001|Overall Study|Other Than Specified|0|||
27987626|NCT03872453|54646310|FG002|Overall Study|Other Than Specified|0|||
27987627|NCT03872453|54646311|FG003|Overall Study|Other Than Specified|0|||
27987628|NCT00597584|54646323|FG000|Overall Study|Adverse Event|4|||
27987629|NCT00597584|54646324|FG001|Overall Study|Adverse Event|2|||
27987630|NCT00597584|54646323|FG000|Overall Study|Death|53|||
27987631|NCT00597584|54646324|FG001|Overall Study|Death|30|||
27987632|NCT00597584|54646323|FG000|Overall Study|Lack of Efficacy|1|||
27987633|NCT00597584|54646324|FG001|Overall Study|Lack of Efficacy|0|||
27987634|NCT00597584|54646323|FG000|Overall Study|Lost to Follow-up|2|||
27987635|NCT00597584|54646324|FG001|Overall Study|Lost to Follow-up|4|||
27987636|NCT00597584|54646323|FG000|Overall Study|Physician Decision|3|||
27987637|NCT00597584|54646324|FG001|Overall Study|Physician Decision|0|||
27987638|NCT00597584|54646323|FG000|Overall Study|Pregnancy|2|||
27987639|NCT00597584|54646324|FG001|Overall Study|Pregnancy|0|||
27987640|NCT00597584|54646323|FG000|Overall Study|Withdrawal by Subject|44|||
27903494|NCT01054976|54560409|FG000|Overall Study|Adverse Event|16|||
27903495|NCT01054976|54560409|FG000|Overall Study|Uncooperative participations to study|7|||
27903496|NCT01054976|54560409|FG000|Overall Study|Withdrawal by Subject|4|||
27903497|NCT01054976|54560409|FG000|Overall Study|Other|8|||
27987641|NCT00597584|54646324|FG001|Overall Study|Withdrawal by Subject|12|||
27987642|NCT00597584|54646323|FG000|Overall Study|Discontinued Dialysis|0|||
27987643|NCT00597584|54646324|FG001|Overall Study|Discontinued Dialysis|1|||
28172291|NCT01673282|54843936|FG000|Overall Study|Lost to Follow-up|11|||
28172292|NCT01673282|54843937|FG001|Overall Study|Lost to Follow-up|10|||
28172293|NCT01673282|54843936|FG000|Overall Study|Withdrawal by Subject|3|||
27903498|NCT01053962|54560418|FG000|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
27903499|NCT01053962|54560419|FG001|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
27903500|NCT01053962|54560420|FG002|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
27903501|NCT01053962|54560421|FG003|Pretreatment Period|Withdrew Consent (Patient/PI)|1|||
27987644|NCT00597584|54646323|FG000|Overall Study|Lost ability to consent|1|||
27987645|NCT00597584|54646324|FG001|Overall Study|Lost ability to consent|1|||
27903502|NCT01053962|54560422|FG004|Pretreatment Period|Withdrew Consent (Patient/PI)|2|||
27903503|NCT01053962|54560418|FG000|Pretreatment Period|Venipuncture Failure|0|||
27903504|NCT01053962|54560419|FG001|Pretreatment Period|Venipuncture Failure|0|||
27903505|NCT01053962|54560420|FG002|Pretreatment Period|Venipuncture Failure|1|||
27903506|NCT01053962|54560421|FG003|Pretreatment Period|Venipuncture Failure|0|||
27903507|NCT01053962|54560422|FG004|Pretreatment Period|Venipuncture Failure|0|||
27903508|NCT01053962|54560418|FG000|Pretreatment Period|Failed Urine drug screen Day 1|0|||
27903509|NCT01053962|54560419|FG001|Pretreatment Period|Failed Urine drug screen Day 1|1|||
27903510|NCT01053962|54560420|FG002|Pretreatment Period|Failed Urine drug screen Day 1|0|||
27903511|NCT01053962|54560421|FG003|Pretreatment Period|Failed Urine drug screen Day 1|0|||
27903512|NCT01053962|54560422|FG004|Pretreatment Period|Failed Urine drug screen Day 1|0|||
27903513|NCT01053962|54560418|FG000|Pretreatment Period|Abnormal Lab values Exl 16|0|||
27903514|NCT01053962|54560419|FG001|Pretreatment Period|Abnormal Lab values Exl 16|0|||
27903515|NCT01053962|54560420|FG002|Pretreatment Period|Abnormal Lab values Exl 16|0|||
27987646|NCT00597584|54646323|FG000|Overall Study|Never dosed|1|||
27987647|NCT00597584|54646324|FG001|Overall Study|Never dosed|0|||
27987648|NCT00597584|54646323|FG000|Overall Study|Relocation|8|||
27987649|NCT00597584|54646324|FG001|Overall Study|Relocation|6|||
27903516|NCT01053962|54560421|FG003|Pretreatment Period|Abnormal Lab values Exl 16|1|||
27903517|NCT01053962|54560422|FG004|Pretreatment Period|Abnormal Lab values Exl 16|0|||
27903518|NCT01053962|54560418|FG000|Treatment Period|Lack of Efficacy|0|||
27987650|NCT00597584|54646323|FG000|Overall Study|Renal transplant|9|||
27987651|NCT00597584|54646324|FG001|Overall Study|Renal transplant|7|||
27987652|NCT00529633|54646332|FG000|Overall Study|Withdrawal by Subject|1|||
27987653|NCT00529633|54646333|FG001|Overall Study|Withdrawal by Subject|1|||
27987654|NCT00530335|54646339|FG000|Overall Study|Adverse Event|3|||
27987655|NCT00530335|54646339|FG000|Overall Study|Protocol Violation|1|||
27987656|NCT00530335|54646339|FG000|Overall Study|Withdrawal by Subject|1|||
27903519|NCT01053962|54560419|FG001|Treatment Period|Lack of Efficacy|0|||
27903520|NCT01053962|54560420|FG002|Treatment Period|Lack of Efficacy|0|||
27903521|NCT01053962|54560421|FG003|Treatment Period|Lack of Efficacy|0|||
27903522|NCT01053962|54560422|FG004|Treatment Period|Lack of Efficacy|1|||
27903523|NCT01053962|54560418|FG000|Treatment Period|Adverse Event|0|||
27903524|NCT01053962|54560419|FG001|Treatment Period|Adverse Event|0|||
27903525|NCT01053962|54560420|FG002|Treatment Period|Adverse Event|0|||
27903526|NCT01053962|54560421|FG003|Treatment Period|Adverse Event|0|||
27903527|NCT01053962|54560422|FG004|Treatment Period|Adverse Event|1|||
27903528|NCT01053962|54560418|FG000|Treatment Period|Withdrawal by Subject|0|||
27903529|NCT01053962|54560419|FG001|Treatment Period|Withdrawal by Subject|0|||
27903530|NCT01053962|54560420|FG002|Treatment Period|Withdrawal by Subject|0|||
27903531|NCT01053962|54560421|FG003|Treatment Period|Withdrawal by Subject|0|||
27903532|NCT01053962|54560422|FG004|Treatment Period|Withdrawal by Subject|1|||
27903533|NCT01053962|54560418|FG000|Treatment Period|Noncompliance with protocol|1|||
27903534|NCT01053962|54560419|FG001|Treatment Period|Noncompliance with protocol|0|||
27903535|NCT01053962|54560420|FG002|Treatment Period|Noncompliance with protocol|0|||
27903536|NCT01053962|54560421|FG003|Treatment Period|Noncompliance with protocol|0|||
27903537|NCT01053962|54560422|FG004|Treatment Period|Noncompliance with protocol|0|||
27903538|NCT01053221|54560441|FG000|Overall Study|The study was closed prematurely|5|||
27903539|NCT01053221|54560442|FG001|Overall Study|The study was closed prematurely|9|||
27903540|NCT01052012|54560454|FG000|Overall Study|Not treated|2|||
27903541|NCT01052012|54560455|FG001|Overall Study|Not treated|5|||
27903542|NCT01052012|54560456|FG002|Overall Study|Not treated|0|||
27903543|NCT01052012|54560457|FG003|Overall Study|Not treated|0|||
27903544|NCT01052012|54560458|FG004|Overall Study|Not treated|11|||
27903545|NCT01052012|54560459|FG005|Overall Study|Not treated|8|||
27903546|NCT01052012|54560454|FG000|Overall Study|Adverse Event|1|||
27903547|NCT01052012|54560455|FG001|Overall Study|Adverse Event|0|||
27903548|NCT01052012|54560456|FG002|Overall Study|Adverse Event|0|||
27903549|NCT01052012|54560457|FG003|Overall Study|Adverse Event|1|||
27903550|NCT01052012|54560458|FG004|Overall Study|Adverse Event|0|||
27903551|NCT01052012|54560459|FG005|Overall Study|Adverse Event|0|||
27903552|NCT01052012|54560454|FG000|Overall Study|Lost to Follow-up|0|||
27903553|NCT01052012|54560455|FG001|Overall Study|Lost to Follow-up|0|||
27903554|NCT01052012|54560456|FG002|Overall Study|Lost to Follow-up|0|||
27903555|NCT01052012|54560457|FG003|Overall Study|Lost to Follow-up|0|||
27903556|NCT01052012|54560458|FG004|Overall Study|Lost to Follow-up|1|||
27903557|NCT01052012|54560459|FG005|Overall Study|Lost to Follow-up|0|||
27903558|NCT01052012|54560454|FG000|Overall Study|Withdrawal by Subject|1|||
27903559|NCT01052012|54560455|FG001|Overall Study|Withdrawal by Subject|1|||
27987657|NCT00530335|54646339|FG000|Overall Study|Physician Decision|1|||
27987658|NCT00712270|54646346|FG000|Overall Study|Withdrawal by Subject|11|||
27739575|NCT02738879|54189191|FG000|Overall Study|Pregnancy|0|||
27903560|NCT01052012|54560456|FG002|Overall Study|Withdrawal by Subject|0|||
27903561|NCT01052012|54560457|FG003|Overall Study|Withdrawal by Subject|0|||
27903562|NCT01052012|54560458|FG004|Overall Study|Withdrawal by Subject|3|||
27987659|NCT00712270|54646346|FG000|Overall Study|Screen Failure|3|||
27903563|NCT01052012|54560459|FG005|Overall Study|Withdrawal by Subject|1|||
27903564|NCT01052012|54560454|FG000|Overall Study|Physician Decision|0|||
27903565|NCT01052012|54560455|FG001|Overall Study|Physician Decision|0|||
27903566|NCT01052012|54560456|FG002|Overall Study|Physician Decision|0|||
27903567|NCT01052012|54560457|FG003|Overall Study|Physician Decision|0|||
27903568|NCT01052012|54560458|FG004|Overall Study|Physician Decision|0|||
27903569|NCT01052012|54560459|FG005|Overall Study|Physician Decision|1|||
27903570|NCT01052012|54560454|FG000|Overall Study|Other|0|||
27903571|NCT01052012|54560455|FG001|Overall Study|Other|0|||
27903572|NCT01052012|54560456|FG002|Overall Study|Other|0|||
27903573|NCT01052012|54560457|FG003|Overall Study|Other|0|||
27903574|NCT01052012|54560458|FG004|Overall Study|Other|1|||
27903575|NCT01052012|54560459|FG005|Overall Study|Other|0|||
27903576|NCT01051817|54560475|FG000|Overall Study|Adverse Event|0|||
27903577|NCT01051817|54560476|FG001|Overall Study|Adverse Event|2|||
27903578|NCT01051817|54560475|FG000|Overall Study|Abnormal Test Proceedure reults|0|||
27903579|NCT01051817|54560476|FG001|Overall Study|Abnormal Test Proceedure reults|1|||
27903580|NCT01051817|54560475|FG000|Overall Study|Withdrawal by Subject|3|||
27903581|NCT01051817|54560476|FG001|Overall Study|Withdrawal by Subject|5|||
27903582|NCT01051817|54560475|FG000|Overall Study|Protocol Violation|0|||
27903583|NCT01051817|54560476|FG001|Overall Study|Protocol Violation|1|||
27903584|NCT01327846|54560486|FG000|Core Phase|Subject decision (vital status: missing)|1|||
27903585|NCT01327846|54560487|FG001|Core Phase|Subject decision (vital status: missing)|2|||
27903586|NCT01327846|54560488|FG002|Core Phase|Subject decision (vital status: missing)|2|||
27903587|NCT01327846|54560489|FG003|Core Phase|Subject decision (vital status: missing)|1|||
27903588|NCT01327846|54560486|FG000|Core Phase|Subject decision (vital stat: unkn)|0|||
27903589|NCT01327846|54560487|FG001|Core Phase|Subject decision (vital stat: unkn)|0|||
27903590|NCT01327846|54560488|FG002|Core Phase|Subject decision (vital stat: unkn)|3|||
27987660|NCT00530257|54646372|FG000|Overall Study|Lost to Follow-up|1|||
27987661|NCT00869778|54646382|FG000|Overall Study|Adverse Event|2|||
27987662|NCT00869778|54646383|FG001|Overall Study|Adverse Event|0|||
27987663|NCT00869778|54646384|FG002|Overall Study|Adverse Event|0|||
27987664|NCT00869778|54646382|FG000|Overall Study|Withdrawal by Subject|3|||
27987665|NCT00869778|54646383|FG001|Overall Study|Withdrawal by Subject|4|||
27903591|NCT01327846|54560489|FG003|Core Phase|Subject decision (vital stat: unkn)|3|||
27903592|NCT01327846|54560486|FG000|Core Phase|Subject decision (vital stat: dead)|1|||
27903593|NCT01327846|54560487|FG001|Core Phase|Subject decision (vital stat: dead)|3|||
27903594|NCT01327846|54560488|FG002|Core Phase|Subject decision (vital stat: dead)|4|||
27903595|NCT01327846|54560489|FG003|Core Phase|Subject decision (vital stat: dead)|4|||
27903596|NCT01327846|54560486|FG000|Core Phase|Subject decision (vital stat: alive)|23|||
27903597|NCT01327846|54560487|FG001|Core Phase|Subject decision (vital stat: alive)|24|||
27903598|NCT01327846|54560488|FG002|Core Phase|Subject decision (vital stat: alive)|13|||
27903599|NCT01327846|54560489|FG003|Core Phase|Subject decision (vital stat: alive)|20|||
27903600|NCT01327846|54560486|FG000|Core Phase|Lost to Follow-up|3|||
27903601|NCT01327846|54560487|FG001|Core Phase|Lost to Follow-up|3|||
27903602|NCT01327846|54560488|FG002|Core Phase|Lost to Follow-up|4|||
27903603|NCT01327846|54560489|FG003|Core Phase|Lost to Follow-up|5|||
27903604|NCT01327846|54560486|FG000|Extension Phase|Study terminated by sponsor|1073|||
27903605|NCT01327846|54560487|FG001|Extension Phase|Study terminated by sponsor|1124|||
27903606|NCT01327846|54560488|FG002|Extension Phase|Study terminated by sponsor|1067|||
27903607|NCT01327846|54560489|FG003|Extension Phase|Study terminated by sponsor|1660|||
27987666|NCT00869778|54646384|FG002|Overall Study|Withdrawal by Subject|5|||
27987667|NCT00869778|54646382|FG000|Overall Study|Pregnancy|1|||
27987668|NCT00869778|54646383|FG001|Overall Study|Pregnancy|0|||
27987669|NCT00869778|54646384|FG002|Overall Study|Pregnancy|0|||
27987670|NCT00869778|54646382|FG000|Overall Study|Protocol Violation|5|||
28097449|NCT04027686|54753084|FG001|Overall Study|Withdrawal by Subject|1|||
27903608|NCT01327846|54560486|FG000|Extension Phase|Withdrawal by Subject|20|||
27903609|NCT01327846|54560487|FG001|Extension Phase|Withdrawal by Subject|13|||
27903610|NCT01327846|54560488|FG002|Extension Phase|Withdrawal by Subject|19|||
27903611|NCT01327846|54560489|FG003|Extension Phase|Withdrawal by Subject|37|||
27903612|NCT01327846|54560486|FG000|Extension Phase|Lost to Follow-up|4|||
27903613|NCT01327846|54560487|FG001|Extension Phase|Lost to Follow-up|3|||
27903614|NCT01327846|54560488|FG002|Extension Phase|Lost to Follow-up|4|||
27903615|NCT01327846|54560489|FG003|Extension Phase|Lost to Follow-up|7|||
27903616|NCT01327846|54560486|FG000|Extension Phase|Technical Problems|2|||
27903617|NCT01327846|54560487|FG001|Extension Phase|Technical Problems|4|||
27987671|NCT00869778|54646383|FG001|Overall Study|Protocol Violation|3|||
27903618|NCT01327846|54560488|FG002|Extension Phase|Technical Problems|2|||
27987672|NCT00869778|54646384|FG002|Overall Study|Protocol Violation|5|||
27987673|NCT00869778|54646382|FG000|Overall Study|Unblinding|1|||
27987674|NCT00869778|54646383|FG001|Overall Study|Unblinding|0|||
28097450|NCT03052426|54753097|FG000|Overall Study|Withdrawal by Subject|0|||
27903619|NCT01327846|54560489|FG003|Extension Phase|Technical Problems|2|||
27903620|NCT01051739|54560502|FG000|Overall Study|Death|3|||
27903621|NCT01051739|54560503|FG001|Overall Study|Death|3|||
27903622|NCT01051739|54560502|FG000|Overall Study|Withdrawal by Subject|25|||
27903623|NCT01051739|54560503|FG001|Overall Study|Withdrawal by Subject|10|||
27987675|NCT00869778|54646384|FG002|Overall Study|Unblinding|0|||
27903624|NCT01051661|54560515|FG000|Overall Study|Adverse Event|1|||
27987676|NCT00711958|54646415|FG000|Overall Study|Withdrawal by Subject|6|||
27903625|NCT01051661|54560516|FG001|Overall Study|Adverse Event|1|||
27903626|NCT01051661|54560517|FG002|Overall Study|Adverse Event|1|||
27903627|NCT01051661|54560518|FG003|Overall Study|Adverse Event|1|||
27903628|NCT01051661|54560519|FG004|Overall Study|Adverse Event|0|||
27903629|NCT01051661|54560520|FG005|Overall Study|Adverse Event|0|||
27903630|NCT01051661|54560515|FG000|Overall Study|Lost to Follow-up|13|||
27903631|NCT01051661|54560516|FG001|Overall Study|Lost to Follow-up|22|||
27903632|NCT01051661|54560517|FG002|Overall Study|Lost to Follow-up|15|||
27903633|NCT01051661|54560518|FG003|Overall Study|Lost to Follow-up|17|||
27903634|NCT01051661|54560519|FG004|Overall Study|Lost to Follow-up|10|||
27903635|NCT01051661|54560520|FG005|Overall Study|Lost to Follow-up|24|||
27903636|NCT01051661|54560515|FG000|Overall Study|Migrated/moved from study area|1|||
27903637|NCT01051661|54560516|FG001|Overall Study|Migrated/moved from study area|6|||
27903638|NCT01051661|54560517|FG002|Overall Study|Migrated/moved from study area|6|||
27903639|NCT01051661|54560518|FG003|Overall Study|Migrated/moved from study area|8|||
27903640|NCT01051661|54560519|FG004|Overall Study|Migrated/moved from study area|7|||
27903641|NCT01051661|54560520|FG005|Overall Study|Migrated/moved from study area|3|||
27903642|NCT01051661|54560515|FG000|Overall Study|Refused blood sampling|0|||
27903643|NCT01051661|54560516|FG001|Overall Study|Refused blood sampling|0|||
27903644|NCT01051661|54560517|FG002|Overall Study|Refused blood sampling|0|||
27903645|NCT01051661|54560518|FG003|Overall Study|Refused blood sampling|0|||
27903646|NCT01051661|54560519|FG004|Overall Study|Refused blood sampling|0|||
27903647|NCT01051661|54560520|FG005|Overall Study|Refused blood sampling|1|||
27903648|NCT01051661|54560515|FG000|Overall Study|Data not reliable|1|||
27903649|NCT01051661|54560516|FG001|Overall Study|Data not reliable|0|||
27903650|NCT01051661|54560517|FG002|Overall Study|Data not reliable|0|||
27903651|NCT01051661|54560518|FG003|Overall Study|Data not reliable|0|||
27903652|NCT01051661|54560519|FG004|Overall Study|Data not reliable|0|||
27903653|NCT01051661|54560520|FG005|Overall Study|Data not reliable|1|||
27903654|NCT01051661|54560515|FG000|Overall Study|Unable to attend visit(s)|2|||
27903655|NCT01051661|54560516|FG001|Overall Study|Unable to attend visit(s)|4|||
27903656|NCT01051661|54560517|FG002|Overall Study|Unable to attend visit(s)|2|||
27903657|NCT01051661|54560518|FG003|Overall Study|Unable to attend visit(s)|1|||
27903658|NCT01051661|54560519|FG004|Overall Study|Unable to attend visit(s)|3|||
27903659|NCT01051661|54560520|FG005|Overall Study|Unable to attend visit(s)|2|||
27903660|NCT01051661|54560515|FG000|Overall Study|Consent not received from both parents|0|||
27903661|NCT01051661|54560516|FG001|Overall Study|Consent not received from both parents|0|||
27903662|NCT01051661|54560517|FG002|Overall Study|Consent not received from both parents|0|||
27903663|NCT01051661|54560518|FG003|Overall Study|Consent not received from both parents|0|||
27903664|NCT01051661|54560519|FG004|Overall Study|Consent not received from both parents|0|||
27903665|NCT01051661|54560520|FG005|Overall Study|Consent not received from both parents|1|||
27903666|NCT01051661|54560515|FG000|Overall Study|Failure to comply with protocol|0|||
27903667|NCT01051661|54560516|FG001|Overall Study|Failure to comply with protocol|0|||
27903668|NCT01051661|54560517|FG002|Overall Study|Failure to comply with protocol|2|||
27903669|NCT01051661|54560518|FG003|Overall Study|Failure to comply with protocol|0|||
27903670|NCT01051661|54560519|FG004|Overall Study|Failure to comply with protocol|0|||
27903671|NCT01051661|54560520|FG005|Overall Study|Failure to comply with protocol|0|||
27903672|NCT01051661|54560515|FG000|Overall Study|Subject lost legal representation|0|||
27903673|NCT01051661|54560516|FG001|Overall Study|Subject lost legal representation|0|||
27903674|NCT01051661|54560517|FG002|Overall Study|Subject lost legal representation|0|||
27903675|NCT01051661|54560518|FG003|Overall Study|Subject lost legal representation|0|||
27903676|NCT01051661|54560519|FG004|Overall Study|Subject lost legal representation|1|||
27903677|NCT01051661|54560520|FG005|Overall Study|Subject lost legal representation|0|||
27903678|NCT01051661|54560515|FG000|Overall Study|Protocol Violation|0|||
27903679|NCT01051661|54560516|FG001|Overall Study|Protocol Violation|0|||
27903680|NCT01051661|54560517|FG002|Overall Study|Protocol Violation|0|||
27903681|NCT01051661|54560518|FG003|Overall Study|Protocol Violation|1|||
27987677|NCT00711958|54646416|FG001|Overall Study|Withdrawal by Subject|8|||
27987678|NCT00711958|54646415|FG000|Overall Study|Lack of Efficacy|3|||
27987679|NCT00711958|54646416|FG001|Overall Study|Lack of Efficacy|1|||
27903682|NCT01051661|54560519|FG004|Overall Study|Protocol Violation|2|||
28097451|NCT03052426|54753098|FG001|Overall Study|Withdrawal by Subject|1|||
27903683|NCT01051661|54560520|FG005|Overall Study|Protocol Violation|1|||
28097452|NCT03052426|54753099|FG002|Overall Study|Withdrawal by Subject|0|||
27903684|NCT01051661|54560515|FG000|Overall Study|Withdrawal by Subject|16|||
27903685|NCT01051661|54560516|FG001|Overall Study|Withdrawal by Subject|30|||
27903686|NCT01051661|54560517|FG002|Overall Study|Withdrawal by Subject|13|||
27903687|NCT01051661|54560518|FG003|Overall Study|Withdrawal by Subject|28|||
27903688|NCT01051661|54560519|FG004|Overall Study|Withdrawal by Subject|12|||
27903689|NCT01051661|54560520|FG005|Overall Study|Withdrawal by Subject|34|||
27987680|NCT00711958|54646415|FG000|Overall Study|Clinical deterioration|1|||
27903690|NCT01051466|54560557|FG000|Overall Study|Adverse Event|1|||
27903691|NCT01051466|54560558|FG001|Overall Study|Adverse Event|0|||
27987681|NCT00711958|54646416|FG001|Overall Study|Clinical deterioration|0|||
27987682|NCT00711958|54646415|FG000|Overall Study|Adverse Event|9|||
27987683|NCT00711958|54646416|FG001|Overall Study|Adverse Event|7|||
27987684|NCT00711958|54646415|FG000|Overall Study|Protocol Violation|1|||
27987685|NCT00711958|54646416|FG001|Overall Study|Protocol Violation|0|||
27987686|NCT00711958|54646415|FG000|Overall Study|Lost to Follow-up|2|||
27987687|NCT00711958|54646416|FG001|Overall Study|Lost to Follow-up|2|||
27987688|NCT00711958|54646415|FG000|Overall Study|Death|10|||
27987689|NCT00711958|54646416|FG001|Overall Study|Death|5|||
27987690|NCT00711958|54646415|FG000|Overall Study|Progression of disease|1|||
27987691|NCT00711958|54646416|FG001|Overall Study|Progression of disease|0|||
27987692|NCT00711880|54646424|FG000|Overall Study|Adverse Event|11|||
27987693|NCT00711880|54646425|FG001|Overall Study|Adverse Event|2|||
27987694|NCT00711880|54646424|FG000|Overall Study|Patient non-compliance|1|||
27987695|NCT00711880|54646425|FG001|Overall Study|Patient non-compliance|0|||
27987696|NCT00711880|54646424|FG000|Overall Study|Lack of Efficacy|1|||
27987697|NCT00711880|54646425|FG001|Overall Study|Lack of Efficacy|5|||
27987698|NCT00528775|54646431|FG000|Overall Study|Other not specified|1|||
27903692|NCT01051466|54560557|FG000|Overall Study|Lost to Follow-up|1|||
27903693|NCT01051466|54560558|FG001|Overall Study|Lost to Follow-up|1|||
27987699|NCT00529399|54646438|FG000|Overall Study|Lost to Follow-up|1|||
27987700|NCT00529399|54646439|FG001|Overall Study|Lost to Follow-up|0|||
27903694|NCT01051466|54560557|FG000|Overall Study|Withdrawal by Subject|5|||
27903695|NCT01051466|54560558|FG001|Overall Study|Withdrawal by Subject|1|||
27903696|NCT01051466|54560557|FG000|Overall Study|Entry Criteria Not Met|0|||
27903697|NCT01051466|54560558|FG001|Overall Study|Entry Criteria Not Met|3|||
27903698|NCT01051466|54560557|FG000|Overall Study|Physician Decision|1|||
27903699|NCT01051466|54560558|FG001|Overall Study|Physician Decision|0|||
27903700|NCT01051349|54560572|FG000|Overall Study|Adverse Event|88|||
27903701|NCT01051349|54560572|FG000|Overall Study|Consent Withdrawn|54|||
27903702|NCT01051349|54560572|FG000|Overall Study|Investigator Decision|6|||
27903703|NCT01051349|54560572|FG000|Overall Study|Lost to Follow-up|6|||
27903704|NCT01051349|54560572|FG000|Overall Study|Subject non-compliance|7|||
27903705|NCT01051349|54560572|FG000|Overall Study|Reason not Specified|12|||
27987701|NCT00529399|54646440|FG002|Overall Study|Lost to Follow-up|1|||
27987702|NCT00529399|54646438|FG000|Overall Study|Withdrawal by Subject|1|||
27987703|NCT00529399|54646439|FG001|Overall Study|Withdrawal by Subject|0|||
27987704|NCT00529399|54646440|FG002|Overall Study|Withdrawal by Subject|1|||
27987705|NCT00529399|54646438|FG000|Overall Study|Non-compliant|0|||
27987706|NCT00529399|54646439|FG001|Overall Study|Non-compliant|1|||
27987707|NCT00529399|54646440|FG002|Overall Study|Non-compliant|0|||
27987708|NCT00852969|54646450|FG000|Overall Study|Adverse Event|0|||
27987709|NCT00852969|54646451|FG001|Overall Study|Adverse Event|1|||
27987710|NCT00852969|54646450|FG000|Overall Study|Lost to Follow-up|0|||
27987711|NCT00852969|54646451|FG001|Overall Study|Lost to Follow-up|1|||
27987712|NCT03870997|54646463|FG000|Overall Study|Did not complete mid-study/final survey|10544|||
27987713|NCT03870997|54646464|FG001|Overall Study|Did not complete mid-study/final survey|10431|||
27903706|NCT01050998|54560584|FG000|Overall Study|Adverse Event|1|||
27903707|NCT01050998|54560585|FG001|Overall Study|Adverse Event|0|||
27903708|NCT01050998|54560586|FG002|Overall Study|Adverse Event|1|||
27903709|NCT01050998|54560587|FG003|Overall Study|Adverse Event|0|||
27903710|NCT01050998|54560588|FG004|Overall Study|Adverse Event|2|||
27903711|NCT01050998|54560584|FG000|Overall Study|Withdrawal by Subject|0|||
27903712|NCT01050998|54560585|FG001|Overall Study|Withdrawal by Subject|0|||
27903713|NCT01050998|54560586|FG002|Overall Study|Withdrawal by Subject|0|||
27903714|NCT01050998|54560587|FG003|Overall Study|Withdrawal by Subject|1|||
27903715|NCT01050998|54560588|FG004|Overall Study|Withdrawal by Subject|3|||
27987714|NCT03870997|54646465|FG002|Overall Study|Did not complete mid-study/final survey|10978|||
27903716|NCT01050998|54560584|FG000|Overall Study|Other|3|||
27903717|NCT01050998|54560585|FG001|Overall Study|Other|2|||
27903718|NCT01050998|54560586|FG002|Overall Study|Other|1|||
27903719|NCT01050998|54560587|FG003|Overall Study|Other|1|||
27903720|NCT01050998|54560588|FG004|Overall Study|Other|5|||
27903721|NCT01050998|54560584|FG000|Overall Study|Data integrity issues|0|||
27903722|NCT01050998|54560585|FG001|Overall Study|Data integrity issues|0|||
27903723|NCT01050998|54560586|FG002|Overall Study|Data integrity issues|1|||
27903724|NCT01050998|54560587|FG003|Overall Study|Data integrity issues|1|||
27987715|NCT03870997|54646466|FG003|Overall Study|Did not complete mid-study/final survey|10947|||
28097453|NCT03052426|54753097|FG000|Overall Study|Lost to Follow-up|2|||
27987716|NCT03870997|54646467|FG004|Overall Study|Did not complete mid-study/final survey|10588|||
27987717|NCT03870997|54646468|FG005|Overall Study|Did not complete mid-study/final survey|10531|||
27987718|NCT00521365|54646477|FG000|Overall Study|Adverse Event|3|||
28097454|NCT03052426|54753098|FG001|Overall Study|Lost to Follow-up|0|||
27987719|NCT00521365|54646477|FG000|Overall Study|Lost to Follow-up|6|||
27903725|NCT01050998|54560588|FG004|Overall Study|Data integrity issues|4|||
27903726|NCT00106028|54560606|FG000|Overall Study|Adverse Event|3|||
27903727|NCT00106028|54560607|FG001|Overall Study|Adverse Event|2|||
27903728|NCT00106028|54560606|FG000|Overall Study|Protocol Violation|1|||
27903729|NCT00106028|54560607|FG001|Overall Study|Protocol Violation|1|||
27987720|NCT00521365|54646477|FG000|Overall Study|Protocol deviation|2|||
27987721|NCT00521365|54646477|FG000|Overall Study|Drug compliance|3|||
27987722|NCT00521365|54646477|FG000|Overall Study|Usage of not allowed drugs|6|||
27987723|NCT00711802|54646489|FG000|Overall Study|Not treated (no further detail)|2|||
27987724|NCT00711802|54646490|FG001|Overall Study|Not treated (no further detail)|1|||
27987725|NCT00711802|54646491|FG002|Overall Study|Not treated (no further detail)|2|||
27987726|NCT00711802|54646492|FG003|Overall Study|Not treated (no further detail)|0|||
27987727|NCT00711802|54646493|FG004|Overall Study|Not treated (no further detail)|2|||
27987728|NCT00711802|54646494|FG005|Overall Study|Not treated (no further detail)|0|||
27987729|NCT00711802|54646495|FG006|Overall Study|Not treated (no further detail)|0|||
27987730|NCT00711802|54646496|FG007|Overall Study|Not treated (no further detail)|0|||
27903730|NCT00106028|54560606|FG000|Overall Study|Withdrawal by Subject|2|||
28172294|NCT01673282|54843937|FG001|Overall Study|Withdrawal by Subject|3|||
27987731|NCT00711802|54646489|FG000|Overall Study|Adverse Event|0|||
27987732|NCT00711802|54646490|FG001|Overall Study|Adverse Event|0|||
27987733|NCT00711802|54646491|FG002|Overall Study|Adverse Event|0|||
27987734|NCT00711802|54646492|FG003|Overall Study|Adverse Event|0|||
27987735|NCT00711802|54646493|FG004|Overall Study|Adverse Event|1|||
27987736|NCT00711802|54646494|FG005|Overall Study|Adverse Event|1|||
27987737|NCT00711802|54646495|FG006|Overall Study|Adverse Event|0|||
27987738|NCT00711802|54646496|FG007|Overall Study|Adverse Event|0|||
27987739|NCT00711802|54646489|FG000|Overall Study|Microbiological failure|0|||
27987740|NCT00711802|54646490|FG001|Overall Study|Microbiological failure|1|||
27987741|NCT00711802|54646491|FG002|Overall Study|Microbiological failure|0|||
27987742|NCT00711802|54646492|FG003|Overall Study|Microbiological failure|0|||
27987743|NCT00711802|54646493|FG004|Overall Study|Microbiological failure|0|||
27987744|NCT00711802|54646494|FG005|Overall Study|Microbiological failure|1|||
27987745|NCT00711802|54646495|FG006|Overall Study|Microbiological failure|0|||
27987746|NCT00711802|54646496|FG007|Overall Study|Microbiological failure|0|||
27987747|NCT00711802|54646489|FG000|Overall Study|Protocol Violation|0|||
27987748|NCT00711802|54646490|FG001|Overall Study|Protocol Violation|0|||
27987749|NCT00711802|54646491|FG002|Overall Study|Protocol Violation|0|||
27987750|NCT00711802|54646492|FG003|Overall Study|Protocol Violation|1|||
27987751|NCT00711802|54646493|FG004|Overall Study|Protocol Violation|0|||
27987752|NCT00711802|54646494|FG005|Overall Study|Protocol Violation|0|||
28097455|NCT03052426|54753099|FG002|Overall Study|Lost to Follow-up|1|||
28097456|NCT03688880|54753114|FG000|Overall Study|Withdrawal by Subject|0|||
28172295|NCT01673282|54843936|FG000|Overall Study|Other|1|||
28172296|NCT01673282|54843937|FG001|Overall Study|Other|6|||
28172297|NCT04157751|54843945|FG000|Overall Study|Withdrawal by Subject|12|||
28172298|NCT04157751|54843946|FG001|Overall Study|Withdrawal by Subject|17|||
28172299|NCT04157751|54843945|FG000|Overall Study|Lost to Follow-up|6|||
28172300|NCT04157751|54843946|FG001|Overall Study|Lost to Follow-up|2|||
28172301|NCT04157751|54843945|FG000|Overall Study|Adverse Event|34|||
28172302|NCT04157751|54843946|FG001|Overall Study|Adverse Event|23|||
28172303|NCT04157751|54843945|FG000|Overall Study|Not treated|1|||
28172304|NCT04157751|54843946|FG001|Overall Study|Not treated|5|||
28172305|NCT04157751|54843945|FG000|Overall Study|Other reason not stated above|10|||
27903731|NCT00106028|54560607|FG001|Overall Study|Withdrawal by Subject|8|||
27903732|NCT00106028|54560606|FG000|Overall Study|Lost to Follow-up|0|||
27903733|NCT00106028|54560607|FG001|Overall Study|Lost to Follow-up|1|||
27903734|NCT01050764|54560615|FG000|Overall Study|Death, before HSCT|1|||
27903735|NCT01050764|54560615|FG000|Overall Study|Donor mobilization failure, death|1|||
27903736|NCT01050764|54560615|FG000|Overall Study|Death after HSCT, before T-cell infusion|1|||
27903737|NCT01050569|54560622|FG000|Overall Study|Lost to Follow-up|20|||
27903738|NCT01050569|54560623|FG001|Overall Study|Lost to Follow-up|14|||
27987753|NCT00711802|54646495|FG006|Overall Study|Protocol Violation|0|||
27987754|NCT00711802|54646496|FG007|Overall Study|Protocol Violation|0|||
28097457|NCT03688880|54753115|FG001|Overall Study|Withdrawal by Subject|2|||
28097458|NCT03688880|54753114|FG000|Overall Study|Use of non-permitted concurrent therapy|0|||
28097459|NCT03688880|54753115|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
28097460|NCT03688880|54753114|FG000|Overall Study|Lost to Follow-up|4|||
28097461|NCT03688880|54753115|FG001|Overall Study|Lost to Follow-up|7|||
28097462|NCT03688880|54753114|FG000|Overall Study|Adverse Event|0|||
28097463|NCT03688880|54753115|FG001|Overall Study|Adverse Event|2|||
28097464|NCT03688880|54753114|FG000|Overall Study|Device deficiencies|0|||
28097465|NCT03688880|54753115|FG001|Overall Study|Device deficiencies|2|||
28097466|NCT03688880|54753114|FG000|Overall Study|Other|10|||
28097467|NCT03688880|54753115|FG001|Overall Study|Other|16|||
28097468|NCT03051178|54753121|FG000|Overall Study|Withdrawal by Subject|5|||
27987755|NCT00711802|54646489|FG000|Overall Study|Physician Decision|0|||
27987756|NCT00711802|54646490|FG001|Overall Study|Physician Decision|2|||
27987757|NCT00711802|54646491|FG002|Overall Study|Physician Decision|0|||
28097469|NCT03051100|54753127|FG000|Overall Study|Withdrawal by Subject|1|||
28172306|NCT04157751|54843946|FG001|Overall Study|Other reason not stated above|10|||
27903739|NCT01050569|54560624|FG002|Overall Study|Lost to Follow-up|16|||
27987758|NCT00711802|54646492|FG003|Overall Study|Physician Decision|0|||
27987759|NCT00711802|54646493|FG004|Overall Study|Physician Decision|0|||
28172307|NCT01673126|54843954|FG000|Overall Study|change of diagnosis|4|||
28172308|NCT01673126|54843955|FG001|Overall Study|change of diagnosis|3|||
28172309|NCT02407054|54843964|FG000|Overall Study|Adverse Event|1|||
27903740|NCT01050569|54560622|FG000|Overall Study|Withdrawal by Subject|9|||
27903741|NCT01050569|54560623|FG001|Overall Study|Withdrawal by Subject|3|||
27903742|NCT01050569|54560624|FG002|Overall Study|Withdrawal by Subject|11|||
27903743|NCT01050569|54560622|FG000|Overall Study|Lack of Efficacy|5|||
27903744|NCT01050569|54560623|FG001|Overall Study|Lack of Efficacy|4|||
27903745|NCT01050569|54560624|FG002|Overall Study|Lack of Efficacy|3|||
27903746|NCT01050569|54560622|FG000|Overall Study|Adverse Event|1|||
27903747|NCT01050569|54560623|FG001|Overall Study|Adverse Event|0|||
27903748|NCT01050569|54560624|FG002|Overall Study|Adverse Event|0|||
27903749|NCT01050569|54560622|FG000|Overall Study|Physician Decision|3|||
27903750|NCT01050569|54560623|FG001|Overall Study|Physician Decision|3|||
27903751|NCT01050569|54560624|FG002|Overall Study|Physician Decision|3|||
27903752|NCT01050530|54560638|FG000|Overall Study|Adverse Event|6|||
27903753|NCT01050530|54560639|FG001|Overall Study|Adverse Event|3|||
27903754|NCT01050530|54560638|FG000|Overall Study|Lack of Efficacy|1|||
27903755|NCT01050530|54560639|FG001|Overall Study|Lack of Efficacy|4|||
27903756|NCT01050530|54560638|FG000|Overall Study|Withdrawal by Subject|0|||
27903757|NCT01050530|54560639|FG001|Overall Study|Withdrawal by Subject|3|||
27903758|NCT01050530|54560638|FG000|Overall Study|Protocol Violation|1|||
27903759|NCT01050530|54560639|FG001|Overall Study|Protocol Violation|0|||
27903760|NCT01050257|54560648|FG000|Overall Study|Adverse Event|4|||
27903761|NCT01050257|54560649|FG001|Overall Study|Adverse Event|4|||
27903762|NCT01050257|54560650|FG002|Overall Study|Adverse Event|2|||
27903763|NCT01050257|54560648|FG000|Overall Study|Admin/Other (did not switch to oral)|6|||
27903764|NCT01050257|54560649|FG001|Overall Study|Admin/Other (did not switch to oral)|2|||
27903765|NCT01050257|54560650|FG002|Overall Study|Admin/Other (did not switch to oral)|2|||
27903766|NCT01050257|54560648|FG000|Overall Study|Withdrawal by Subject|0|||
27903767|NCT01050257|54560649|FG001|Overall Study|Withdrawal by Subject|3|||
27903768|NCT01050257|54560650|FG002|Overall Study|Withdrawal by Subject|0|||
27903769|NCT01050257|54560648|FG000|Overall Study|No reason specified|0|||
27903770|NCT01050257|54560649|FG001|Overall Study|No reason specified|0|||
27903771|NCT01050257|54560650|FG002|Overall Study|No reason specified|2|||
27903772|NCT01050257|54560648|FG000|Overall Study|Refused treatment/ Did not Cooperate|1|||
27903773|NCT01050257|54560649|FG001|Overall Study|Refused treatment/ Did not Cooperate|1|||
27987760|NCT00711802|54646494|FG005|Overall Study|Physician Decision|0|||
27987761|NCT00711802|54646495|FG006|Overall Study|Physician Decision|0|||
27987762|NCT00711802|54646496|FG007|Overall Study|Physician Decision|0|||
27987763|NCT00711802|54646489|FG000|Overall Study|Withdrawal by Subject|0|||
27987764|NCT00711802|54646490|FG001|Overall Study|Withdrawal by Subject|1|||
27987765|NCT00711802|54646491|FG002|Overall Study|Withdrawal by Subject|0|||
27987766|NCT00711802|54646492|FG003|Overall Study|Withdrawal by Subject|1|||
27987767|NCT00711802|54646493|FG004|Overall Study|Withdrawal by Subject|0|||
27987768|NCT00711802|54646494|FG005|Overall Study|Withdrawal by Subject|0|||
27987769|NCT00711802|54646495|FG006|Overall Study|Withdrawal by Subject|0|||
27987770|NCT00711802|54646496|FG007|Overall Study|Withdrawal by Subject|0|||
27987771|NCT00711802|54646489|FG000|Overall Study|Lost to Follow-up|0|||
27987772|NCT00711802|54646490|FG001|Overall Study|Lost to Follow-up|0|||
27987773|NCT00711802|54646491|FG002|Overall Study|Lost to Follow-up|3|||
27987774|NCT00711802|54646492|FG003|Overall Study|Lost to Follow-up|1|||
27987775|NCT00711802|54646493|FG004|Overall Study|Lost to Follow-up|10|||
27987776|NCT00711802|54646494|FG005|Overall Study|Lost to Follow-up|6|||
27987777|NCT00711802|54646495|FG006|Overall Study|Lost to Follow-up|4|||
27987778|NCT00711802|54646496|FG007|Overall Study|Lost to Follow-up|2|||
27987779|NCT00711802|54646489|FG000|Overall Study|Reason not reported|0|||
27987780|NCT00711802|54646490|FG001|Overall Study|Reason not reported|1|||
27987781|NCT00711802|54646491|FG002|Overall Study|Reason not reported|1|||
27987782|NCT00711802|54646492|FG003|Overall Study|Reason not reported|0|||
27987783|NCT00711802|54646493|FG004|Overall Study|Reason not reported|1|||
27987784|NCT00711802|54646494|FG005|Overall Study|Reason not reported|0|||
27987785|NCT00711802|54646495|FG006|Overall Study|Reason not reported|1|||
27987786|NCT00711802|54646496|FG007|Overall Study|Reason not reported|0|||
27987787|NCT00851877|54646517|FG000|Phase I-1|Death|1|||
27987788|NCT00851877|54646518|FG001|Phase I-1|Death|0|||
27987789|NCT00851877|54646519|FG002|Phase I-1|Death|0|||
27987790|NCT00851877|54646517|FG000|Phase II|Withdrawal by Subject|0|||
27987791|NCT00851877|54646518|FG001|Phase II|Withdrawal by Subject|0|||
27987792|NCT00851877|54646519|FG002|Phase II|Withdrawal by Subject|3|||
27987793|NCT00882908|54646530|FG000|Overall Study|Adverse Event|0|||
27903774|NCT01050257|54560650|FG002|Overall Study|Refused treatment/ Did not Cooperate|0|||
27903775|NCT01050257|54560648|FG000|Overall Study|Violation criteria|0|||
27903776|NCT01050257|54560649|FG001|Overall Study|Violation criteria|1|||
27903777|NCT01050257|54560650|FG002|Overall Study|Violation criteria|0|||
27903778|NCT01050257|54560648|FG000|Overall Study|Failure to return|0|||
27987794|NCT00882908|54646531|FG001|Overall Study|Adverse Event|0|||
27987795|NCT00882908|54646532|FG002|Overall Study|Adverse Event|1|||
27987796|NCT00882908|54646533|FG003|Overall Study|Adverse Event|0|||
28172310|NCT02407054|54843965|FG001|Overall Study|Adverse Event|4|||
27903779|NCT01050257|54560649|FG001|Overall Study|Failure to return|2|||
27903780|NCT01050257|54560650|FG002|Overall Study|Failure to return|0|||
27903781|NCT01050257|54560648|FG000|Overall Study|Death|0|||
27903782|NCT01050257|54560649|FG001|Overall Study|Death|0|||
27987797|NCT00882908|54646534|FG004|Overall Study|Adverse Event|1|||
27987798|NCT00882908|54646530|FG000|Overall Study|Lost to Follow-up|3|||
27987799|NCT00882908|54646531|FG001|Overall Study|Lost to Follow-up|5|||
27987800|NCT00882908|54646532|FG002|Overall Study|Lost to Follow-up|3|||
27987801|NCT00882908|54646533|FG003|Overall Study|Lost to Follow-up|1|||
27987802|NCT00882908|54646534|FG004|Overall Study|Lost to Follow-up|2|||
27903783|NCT01050257|54560650|FG002|Overall Study|Death|1|||
27903784|NCT01050218|54560658|FG000|Overall Study|Adverse Event|37|||
27903785|NCT01050218|54560658|FG000|Overall Study|Lack of Efficacy|8|||
27903786|NCT01050218|54560658|FG000|Overall Study|Protocol Violation|3|||
27903787|NCT01050218|54560658|FG000|Overall Study|Withdrawal by Subject|18|||
27903788|NCT01050218|54560658|FG000|Overall Study|Discontinued by sponsor|18|||
27903789|NCT01050218|54560658|FG000|Overall Study|Compliance|2|||
27903790|NCT01050218|54560658|FG000|Overall Study|Failed to return|7|||
27903791|NCT01050218|54560658|FG000|Overall Study|Serious Adverse Event|1|||
27903792|NCT01050218|54560658|FG000|Overall Study|Family emergency|1|||
27903793|NCT01050062|54560664|FG000|Overall Study|Adverse Event|75|||
27903794|NCT01050062|54560665|FG001|Overall Study|Adverse Event|22|||
27903795|NCT01050062|54560664|FG000|Overall Study|Lost to Follow-up|83|||
27903796|NCT01050062|54560665|FG001|Overall Study|Lost to Follow-up|35|||
27903797|NCT01050062|54560664|FG000|Overall Study|Lack of Efficacy|22|||
27903798|NCT01050062|54560665|FG001|Overall Study|Lack of Efficacy|35|||
27903799|NCT01050062|54560664|FG000|Overall Study|Physician Decision|74|||
27903800|NCT01050062|54560665|FG001|Overall Study|Physician Decision|9|||
27903801|NCT01050062|54560664|FG000|Overall Study|Others|17|||
27903802|NCT01050062|54560665|FG001|Overall Study|Others|11|||
27903803|NCT00105989|54560683|FG000|Acute - Open Label: Week 0-10|Adverse Event|33|||
27903804|NCT00105989|54560684|FG001|Acute - Open Label: Week 0-10|Adverse Event|0|||
27903805|NCT00105989|54560683|FG000|Acute - Open Label: Week 0-10|Withdrawal by Subject|24|||
27903806|NCT00105989|54560684|FG001|Acute - Open Label: Week 0-10|Withdrawal by Subject|0|||
27903807|NCT00105989|54560683|FG000|Acute - Open Label: Week 0-10|Lack of Efficacy|17|||
27903808|NCT00105989|54560684|FG001|Acute - Open Label: Week 0-10|Lack of Efficacy|0|||
27903809|NCT00105989|54560683|FG000|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14|||
27903810|NCT00105989|54560684|FG001|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0|||
27903811|NCT00105989|54560683|FG000|Acute - Open Label: Week 0-10|Protocol Violation|8|||
27903812|NCT00105989|54560684|FG001|Acute - Open Label: Week 0-10|Protocol Violation|0|||
27903813|NCT00105989|54560683|FG000|Acute - Open Label: Week 0-10|Lost to Follow-up|4|||
27903814|NCT00105989|54560684|FG001|Acute - Open Label: Week 0-10|Lost to Follow-up|0|||
27903815|NCT00105989|54560683|FG000|Acute - Open Label: Week 0-10|Physician Decision|0|||
27903816|NCT00105989|54560684|FG001|Acute - Open Label: Week 0-10|Physician Decision|0|||
27903817|NCT00105989|54560683|FG000|Acute - Open Label: Week 0-10|Death|1|||
27903818|NCT00105989|54560684|FG001|Acute - Open Label: Week 0-10|Death|0|||
27903819|NCT00105989|54560683|FG000|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
27903820|NCT00105989|54560684|FG001|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
27903821|NCT00105989|54560683|FG000|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
27903822|NCT00105989|54560684|FG001|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
27903823|NCT00105989|54560683|FG000|Continuation - Open Label:Week 10-34|Adverse Event|25|||
27903824|NCT00105989|54560684|FG001|Continuation - Open Label:Week 10-34|Adverse Event|0|||
27903825|NCT00105989|54560683|FG000|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50|||
27903826|NCT00105989|54560684|FG001|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0|||
27903827|NCT00105989|54560683|FG000|Continuation - Open Label:Week 10-34|Lack of Efficacy|15|||
27903828|NCT00105989|54560684|FG001|Continuation - Open Label:Week 10-34|Lack of Efficacy|0|||
27903829|NCT00105989|54560683|FG000|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16|||
27903830|NCT00105989|54560684|FG001|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0|||
27903831|NCT00105989|54560683|FG000|Continuation - Open Label:Week 10-34|Protocol Violation|5|||
27903832|NCT00105989|54560684|FG001|Continuation - Open Label:Week 10-34|Protocol Violation|0|||
27903833|NCT00105989|54560683|FG000|Continuation - Open Label:Week 10-34|Lost to Follow-up|9|||
27903834|NCT00105989|54560684|FG001|Continuation - Open Label:Week 10-34|Lost to Follow-up|0|||
27987803|NCT00882908|54646530|FG000|Overall Study|Protocol Violation|0|||
28097470|NCT03051100|54753128|FG001|Overall Study|Withdrawal by Subject|0|||
28097471|NCT01343368|54753136|FG000|Overall Study|Death|1|||
28097472|NCT01343368|54753137|FG001|Overall Study|Death|0|||
28097473|NCT01343368|54753136|FG000|Overall Study|Lost to Follow-up|1|||
27903835|NCT00105989|54560683|FG000|Continuation - Open Label:Week 10-34|Physician Decision|3|||
27987804|NCT00882908|54646531|FG001|Overall Study|Protocol Violation|1|||
27903836|NCT00105989|54560684|FG001|Continuation - Open Label:Week 10-34|Physician Decision|0|||
27903837|NCT00105989|54560683|FG000|Continuation - Open Label:Week 10-34|Death|0|||
27903838|NCT00105989|54560684|FG001|Continuation - Open Label:Week 10-34|Death|0|||
27987805|NCT00882908|54646532|FG002|Overall Study|Protocol Violation|0|||
27987806|NCT00882908|54646533|FG003|Overall Study|Protocol Violation|0|||
27987807|NCT00882908|54646534|FG004|Overall Study|Protocol Violation|0|||
27987808|NCT00882908|54646530|FG000|Overall Study|Withdrawal by Subject|0|||
27987809|NCT00882908|54646531|FG001|Overall Study|Withdrawal by Subject|0|||
27987810|NCT00882908|54646532|FG002|Overall Study|Withdrawal by Subject|3|||
27987811|NCT00882908|54646533|FG003|Overall Study|Withdrawal by Subject|5|||
27987812|NCT00882908|54646534|FG004|Overall Study|Withdrawal by Subject|2|||
27987813|NCT00882908|54646530|FG000|Overall Study|Subject reached a virologic endpoint|0|||
27987814|NCT00882908|54646531|FG001|Overall Study|Subject reached a virologic endpoint|0|||
27987815|NCT00882908|54646532|FG002|Overall Study|Subject reached a virologic endpoint|0|||
27987816|NCT00882908|54646533|FG003|Overall Study|Subject reached a virologic endpoint|0|||
27987817|NCT00882908|54646534|FG004|Overall Study|Subject reached a virologic endpoint|1|||
27987818|NCT00882908|54646530|FG000|Overall Study|Study terminated in error|0|||
27987819|NCT00882908|54646531|FG001|Overall Study|Study terminated in error|0|||
27987820|NCT00882908|54646532|FG002|Overall Study|Study terminated in error|0|||
27987821|NCT00882908|54646533|FG003|Overall Study|Study terminated in error|1|||
27987822|NCT00882908|54646534|FG004|Overall Study|Study terminated in error|0|||
27987823|NCT00851799|54646550|FG000|Overall Study|Death|1|||
27987824|NCT00851799|54646551|FG001|Overall Study|Death|0|||
27987825|NCT00851799|54646552|FG002|Overall Study|Death|1|||
27987826|NCT00851799|54646550|FG000|Overall Study|Lost to Follow-up|5|||
27903839|NCT00105989|54560683|FG000|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2|||
27903840|NCT00105989|54560684|FG001|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0|||
27987827|NCT00851799|54646551|FG001|Overall Study|Lost to Follow-up|3|||
27987828|NCT00851799|54646552|FG002|Overall Study|Lost to Follow-up|10|||
27987829|NCT00851799|54646550|FG000|Overall Study|Not able to get to clinic|8|||
27987830|NCT00851799|54646551|FG001|Overall Study|Not able to get to clinic|5|||
27987831|NCT00851799|54646552|FG002|Overall Study|Not able to get to clinic|9|||
27987832|NCT00851799|54646550|FG000|Overall Study|Not willing to adhere to requirements|1|||
27987833|NCT00851799|54646551|FG001|Overall Study|Not willing to adhere to requirements|2|||
27987834|NCT00851799|54646552|FG002|Overall Study|Not willing to adhere to requirements|2|||
27987835|NCT00851799|54646550|FG000|Overall Study|Withdrew consent prior study completion|1|||
27987836|NCT00851799|54646551|FG001|Overall Study|Withdrew consent prior study completion|2|||
27987837|NCT00851799|54646552|FG002|Overall Study|Withdrew consent prior study completion|1|||
27987838|NCT00851799|54646550|FG000|Overall Study|Severe Debilitation|0|||
27987839|NCT00851799|54646551|FG001|Overall Study|Severe Debilitation|1|||
27987840|NCT00851799|54646552|FG002|Overall Study|Severe Debilitation|0|||
27987841|NCT00851799|54646550|FG000|Overall Study|Completed protocol due to pregnancy|0|||
27987842|NCT00851799|54646551|FG001|Overall Study|Completed protocol due to pregnancy|0|||
27987843|NCT00851799|54646552|FG002|Overall Study|Completed protocol due to pregnancy|1|||
27987844|NCT00521053|54646560|FG000|Observation Phase|Disease Progression|55|||
27987845|NCT00521053|54646560|FG000|Observation Phase|Additional PV-10 via alternate protocol|8|||
27987846|NCT00521053|54646560|FG000|Observation Phase|Death|2|||
27987847|NCT00521053|54646560|FG000|Observation Phase|Adverse Event|1|||
27987848|NCT00521053|54646560|FG000|Observation Phase|Other non-study melanoma treatment|1|||
27987849|NCT00521053|54646560|FG000|Observation Phase|Physician Decision|1|||
27987850|NCT00853047|54646572|FG000|Core Phase|Participant Request|0|||
27987851|NCT00853047|54646573|FG001|Core Phase|Participant Request|0|||
27987852|NCT00853047|54646574|FG002|Core Phase|Participant Request|0|||
27903841|NCT00105989|54560683|FG000|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
27903842|NCT00105989|54560684|FG001|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
27903843|NCT00105989|54560683|FG000|Maintenance - Double-Blind:Week 34-86|Adverse Event|6|||
27903844|NCT00105989|54560684|FG001|Maintenance - Double-Blind:Week 34-86|Adverse Event|3|||
27903845|NCT00105989|54560683|FG000|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17|||
27903846|NCT00105989|54560684|FG001|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18|||
27903847|NCT00105989|54560683|FG000|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
27903848|NCT00105989|54560684|FG001|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
27903849|NCT00105989|54560683|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
27903850|NCT00105989|54560684|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
27903851|NCT00105989|54560683|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5|||
27987853|NCT00853047|54646575|FG003|Core Phase|Participant Request|1|||
27987854|NCT00853047|54646576|FG004|Core Phase|Participant Request|0|||
27987855|NCT00853047|54646577|FG005|Core Phase|Participant Request|0|||
27903852|NCT00105989|54560684|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4|||
27903853|NCT00105989|54560683|FG000|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4|||
27903854|NCT00105989|54560684|FG001|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0|||
27987856|NCT00853047|54646572|FG000|Open-Label Extension Phase|Participant Request|0|||
27987857|NCT00853047|54646573|FG001|Open-Label Extension Phase|Participant Request|0|||
27987858|NCT00853047|54646574|FG002|Open-Label Extension Phase|Participant Request|0|||
27987859|NCT00853047|54646575|FG003|Open-Label Extension Phase|Participant Request|0|||
27987860|NCT00853047|54646576|FG004|Open-Label Extension Phase|Participant Request|0|||
27987861|NCT00853047|54646577|FG005|Open-Label Extension Phase|Participant Request|7|||
27987862|NCT00853047|54646572|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
27987863|NCT00853047|54646573|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
27987864|NCT00853047|54646574|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
27987865|NCT00853047|54646575|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
27987866|NCT00853047|54646576|FG004|Open-Label Extension Phase|Lost to Follow-up|0|||
27987867|NCT00853047|54646577|FG005|Open-Label Extension Phase|Lost to Follow-up|1|||
27987868|NCT00853047|54646572|FG000|Open-Label Extension Phase|Transfer to LX1606-302|0|||
27987869|NCT00853047|54646573|FG001|Open-Label Extension Phase|Transfer to LX1606-302|0|||
27987870|NCT00853047|54646574|FG002|Open-Label Extension Phase|Transfer to LX1606-302|0|||
27987871|NCT00853047|54646575|FG003|Open-Label Extension Phase|Transfer to LX1606-302|0|||
27903855|NCT00105989|54560683|FG000|Maintenance - Double-Blind:Week 34-86|Physician Decision|4|||
27903856|NCT00105989|54560684|FG001|Maintenance - Double-Blind:Week 34-86|Physician Decision|1|||
27903857|NCT00105989|54560683|FG000|Maintenance - Double-Blind:Week 34-86|Death|0|||
27903858|NCT00105989|54560684|FG001|Maintenance - Double-Blind:Week 34-86|Death|0|||
27903859|NCT00105989|54560683|FG000|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14|||
27903860|NCT00105989|54560684|FG001|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43|||
27903861|NCT00105989|54560683|FG000|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
27903862|NCT00105989|54560684|FG001|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
27903863|NCT03277248|54560702|FG000|Overall Study|Adverse Event|3|||
27903864|NCT03277248|54560703|FG001|Overall Study|Adverse Event|1|||
27903865|NCT03277248|54560702|FG000|Overall Study|Subject Withdrawal of Consent|6|||
27903866|NCT03277248|54560703|FG001|Overall Study|Subject Withdrawal of Consent|23|||
27903867|NCT03277248|54560702|FG000|Overall Study|Investigator/Sponsor Decision|2|||
27903868|NCT03277248|54560703|FG001|Overall Study|Investigator/Sponsor Decision|2|||
27903869|NCT03277248|54560702|FG000|Overall Study|Pregnancy|4|||
27903870|NCT03277248|54560703|FG001|Overall Study|Pregnancy|1|||
27903871|NCT03277248|54560702|FG000|Overall Study|Lost to Follow-up|0|||
27903872|NCT03277248|54560703|FG001|Overall Study|Lost to Follow-up|2|||
27903873|NCT03277248|54560702|FG000|Overall Study|Lack of Efficacy|0|||
27903874|NCT03277248|54560703|FG001|Overall Study|Lack of Efficacy|2|||
27987872|NCT00853047|54646576|FG004|Open-Label Extension Phase|Transfer to LX1606-302|0|||
27987873|NCT00853047|54646577|FG005|Open-Label Extension Phase|Transfer to LX1606-302|2|||
27987874|NCT00853047|54646572|FG000|Open-Label Extension Phase|Investigator Decision|0|||
27987875|NCT00853047|54646573|FG001|Open-Label Extension Phase|Investigator Decision|0|||
27987876|NCT00853047|54646574|FG002|Open-Label Extension Phase|Investigator Decision|0|||
27987877|NCT00853047|54646575|FG003|Open-Label Extension Phase|Investigator Decision|0|||
27987878|NCT00853047|54646576|FG004|Open-Label Extension Phase|Investigator Decision|0|||
27987879|NCT00853047|54646577|FG005|Open-Label Extension Phase|Investigator Decision|1|||
27987880|NCT00853047|54646572|FG000|Open-Label Extension Phase|Reason Not Specified|0|||
27987881|NCT00853047|54646573|FG001|Open-Label Extension Phase|Reason Not Specified|0|||
27987882|NCT00853047|54646574|FG002|Open-Label Extension Phase|Reason Not Specified|0|||
27987883|NCT00853047|54646575|FG003|Open-Label Extension Phase|Reason Not Specified|0|||
27987884|NCT00853047|54646576|FG004|Open-Label Extension Phase|Reason Not Specified|0|||
27987885|NCT00853047|54646577|FG005|Open-Label Extension Phase|Reason Not Specified|6|||
27903875|NCT03277248|54560702|FG000|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
27903876|NCT03277248|54560703|FG001|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
27903877|NCT03276780|54560711|FG000|Overall Study|Withdrawal by Subject|5|||
27903878|NCT03276780|54560712|FG001|Overall Study|Withdrawal by Subject|3|||
27903879|NCT03276780|54560711|FG000|Overall Study|Lost to Follow-up|3|||
27903880|NCT03276780|54560712|FG001|Overall Study|Lost to Follow-up|5|||
27903881|NCT03276780|54560711|FG000|Overall Study|Moved out of state|1|||
27903882|NCT03276780|54560712|FG001|Overall Study|Moved out of state|1|||
27903883|NCT03276780|54560711|FG000|Overall Study|Already enrolled in another smoking cessation study providing NRT|1|||
27903884|NCT03276780|54560712|FG001|Overall Study|Already enrolled in another smoking cessation study providing NRT|0|||
27903885|NCT03276780|54560711|FG000|Overall Study|No show to appointments after baseline through Week 5|8|||
27903886|NCT03276780|54560712|FG001|Overall Study|No show to appointments after baseline through Week 5|1|||
27903887|NCT03271047|54560728|FG000|Phase 1b: Dose Finding Period|Death|8|||
27903888|NCT03271047|54560729|FG001|Phase 1b: Dose Finding Period|Death|8|||
27903889|NCT03271047|54560730|FG002|Phase 1b: Dose Finding Period|Death|0|||
27903890|NCT03271047|54560731|FG003|Phase 1b: Dose Finding Period|Death|0|||
27903891|NCT03271047|54560728|FG000|Phase 1b: Dose Finding Period|Lost to Follow-up|1|||
27903892|NCT03271047|54560729|FG001|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
27903893|NCT03271047|54560730|FG002|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
27903894|NCT03271047|54560731|FG003|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
27903895|NCT03271047|54560728|FG000|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
27903896|NCT03271047|54560729|FG001|Phase 1b: Dose Finding Period|Withdrawal by Subject|2|||
27987886|NCT00520975|54646594|FG000|Overall Study|Disease progression|31|||
27987887|NCT00520975|54646595|FG001|Overall Study|Disease progression|23|||
27987888|NCT00520975|54646594|FG000|Overall Study|Adverse Event|7|||
27903897|NCT03271047|54560730|FG002|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
27903898|NCT03271047|54560731|FG003|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
27903899|NCT03271047|54560728|FG000|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
27903900|NCT03271047|54560729|FG001|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
27903901|NCT03271047|54560730|FG002|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
27903902|NCT03271047|54560731|FG003|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
27903903|NCT03271047|54560728|FG000|Randomized Phase 2 Period|Other|0|||
27903904|NCT03271047|54560729|FG001|Randomized Phase 2 Period|Other|0|||
27903905|NCT03271047|54560730|FG002|Randomized Phase 2 Period|Other|0|||
27903906|NCT03271047|54560731|FG003|Randomized Phase 2 Period|Other|1|||
27903907|NCT03271047|54560728|FG000|Randomized Phase 2 Period|Death|0|||
27903908|NCT03271047|54560729|FG001|Randomized Phase 2 Period|Death|0|||
27903909|NCT03271047|54560730|FG002|Randomized Phase 2 Period|Death|20|||
27903910|NCT03271047|54560731|FG003|Randomized Phase 2 Period|Death|21|||
27903911|NCT03271047|54560728|FG000|Randomized Phase 2 Period|Lost to Follow-up|0|||
27903912|NCT03271047|54560729|FG001|Randomized Phase 2 Period|Lost to Follow-up|0|||
27903913|NCT03271047|54560730|FG002|Randomized Phase 2 Period|Lost to Follow-up|2|||
27903914|NCT03271047|54560731|FG003|Randomized Phase 2 Period|Lost to Follow-up|1|||
27903915|NCT03271047|54560728|FG000|Randomized Phase 2 Period|Withdrawal by Subject|0|||
27903916|NCT03271047|54560729|FG001|Randomized Phase 2 Period|Withdrawal by Subject|0|||
27903917|NCT03271047|54560730|FG002|Randomized Phase 2 Period|Withdrawal by Subject|5|||
27987889|NCT00520975|54646595|FG001|Overall Study|Adverse Event|10|||
27987890|NCT00520975|54646594|FG000|Overall Study|Death|0|||
27903918|NCT03271047|54560731|FG003|Randomized Phase 2 Period|Withdrawal by Subject|0|||
27903919|NCT03271047|54560728|FG000|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
27903920|NCT03271047|54560729|FG001|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
27903921|NCT03271047|54560730|FG002|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
27903922|NCT03271047|54560731|FG003|Randomized Phase 2 Period|Completed follow-up per protocol|4|||
27903923|NCT03276936|54560745|FG000|Overall Study|Adverse Event|4|||
27903924|NCT03276936|54560746|FG001|Overall Study|Adverse Event|2|||
27903925|NCT03276936|54560745|FG000|Overall Study|Lost to Follow-up|16|||
27903926|NCT03276936|54560746|FG001|Overall Study|Lost to Follow-up|13|||
27903927|NCT03276936|54560745|FG000|Overall Study|Withdrawal by Subject|30|||
27903928|NCT03276936|54560746|FG001|Overall Study|Withdrawal by Subject|20|||
27903929|NCT03276936|54560745|FG000|Overall Study|Not mentioned|6|||
27903930|NCT03276936|54560746|FG001|Overall Study|Not mentioned|3|||
27903931|NCT00106002|54560752|FG000|Overall Study|Did not take any study drug|1|||
27903932|NCT00106002|54560752|FG000|Overall Study|Ineligible after Registration|1|||
27903933|NCT00105482|54560770|FG000|Overall Study|Adverse Event|1|||
27903934|NCT00105482|54560771|FG001|Overall Study|Adverse Event|1|||
27903935|NCT00105482|54560770|FG000|Overall Study|Lost to Follow-up|26|||
27903936|NCT00105482|54560771|FG001|Overall Study|Lost to Follow-up|17|||
27903937|NCT00105482|54560770|FG000|Overall Study|Withdrawal by Subject|0|||
27903938|NCT00105482|54560771|FG001|Overall Study|Withdrawal by Subject|1|||
27903939|NCT00105482|54560770|FG000|Overall Study|Lost Interest|29|||
27903940|NCT00105482|54560771|FG001|Overall Study|Lost Interest|32|||
27903941|NCT00105482|54560770|FG000|Overall Study|Scheduling Conflict|2|||
27903942|NCT00105482|54560771|FG001|Overall Study|Scheduling Conflict|3|||
27903943|NCT00105482|54560770|FG000|Overall Study|Withdrawn by PI|1|||
27903944|NCT00105482|54560771|FG001|Overall Study|Withdrawn by PI|1|||
27903945|NCT01327651|54560786|FG000|Self-administered Dosing Period|Lost to Follow-up|3|||
27903946|NCT01327651|54560787|FG001|Self-administered Dosing Period|Lost to Follow-up|2|||
27903947|NCT01327651|54560788|FG002|Self-administered Dosing Period|Lost to Follow-up|4|||
27903948|NCT01327651|54560789|FG003|Self-administered Dosing Period|Lost to Follow-up|2|||
27903949|NCT01327651|54560790|FG004|Self-administered Dosing Period|Lost to Follow-up|3|||
27903950|NCT01327651|54560791|FG005|Self-administered Dosing Period|Lost to Follow-up|0|||
27903951|NCT01327651|54560792|FG006|Self-administered Dosing Period|Lost to Follow-up|8|||
27903952|NCT01327651|54560793|FG007|Self-administered Dosing Period|Lost to Follow-up|9|||
27903953|NCT01327651|54560794|FG008|Self-administered Dosing Period|Lost to Follow-up|10|||
27903954|NCT01327651|54560786|FG000|Self-administered Dosing Period|Ineligible (retrospective result)|1|||
27903955|NCT01327651|54560787|FG001|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
27903956|NCT01327651|54560788|FG002|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
27903957|NCT01327651|54560789|FG003|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
27987891|NCT00520975|54646595|FG001|Overall Study|Death|2|||
27987892|NCT00520975|54646594|FG000|Overall Study|Withdrawal by Subject|3|||
27903958|NCT01327651|54560790|FG004|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
27903959|NCT01327651|54560791|FG005|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
27903960|NCT01327651|54560792|FG006|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
27903961|NCT01327651|54560793|FG007|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
27903962|NCT01327651|54560794|FG008|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
27903963|NCT01327651|54560786|FG000|Self-administered Dosing Period|Withdrawal by Subject|0|||
27987893|NCT00520975|54646595|FG001|Overall Study|Withdrawal by Subject|5|||
27903964|NCT01327651|54560787|FG001|Self-administered Dosing Period|Withdrawal by Subject|1|||
27903965|NCT01327651|54560788|FG002|Self-administered Dosing Period|Withdrawal by Subject|0|||
27903966|NCT01327651|54560789|FG003|Self-administered Dosing Period|Withdrawal by Subject|1|||
27903967|NCT01327651|54560790|FG004|Self-administered Dosing Period|Withdrawal by Subject|0|||
27903968|NCT01327651|54560791|FG005|Self-administered Dosing Period|Withdrawal by Subject|0|||
27903969|NCT01327651|54560792|FG006|Self-administered Dosing Period|Withdrawal by Subject|2|||
27903970|NCT01327651|54560793|FG007|Self-administered Dosing Period|Withdrawal by Subject|1|||
27903971|NCT01327651|54560794|FG008|Self-administered Dosing Period|Withdrawal by Subject|1|||
27903972|NCT01327651|54560786|FG000|Post Study Follow-up|Lost to Follow-up|0|||
27903973|NCT01327651|54560787|FG001|Post Study Follow-up|Lost to Follow-up|1|||
27903974|NCT01327651|54560788|FG002|Post Study Follow-up|Lost to Follow-up|1|||
27903975|NCT01327651|54560789|FG003|Post Study Follow-up|Lost to Follow-up|0|||
27903976|NCT01327651|54560790|FG004|Post Study Follow-up|Lost to Follow-up|0|||
27903977|NCT01327651|54560791|FG005|Post Study Follow-up|Lost to Follow-up|0|||
27903978|NCT01327651|54560792|FG006|Post Study Follow-up|Lost to Follow-up|4|||
27903979|NCT01327651|54560793|FG007|Post Study Follow-up|Lost to Follow-up|1|||
27903980|NCT01327651|54560794|FG008|Post Study Follow-up|Lost to Follow-up|2|||
27903981|NCT00105443|54560835|FG000|Double-Blind Treatment|Adverse Event|1|||
27903982|NCT00105443|54560836|FG001|Double-Blind Treatment|Adverse Event|0|||
27903983|NCT00105443|54560837|FG002|Double-Blind Treatment|Adverse Event|0|||
27903984|NCT00105443|54560838|FG003|Double-Blind Treatment|Adverse Event|0|||
27903985|NCT00105443|54560835|FG000|Double-Blind Treatment|Lost to Follow-up|0|||
27903986|NCT00105443|54560836|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
27903987|NCT00105443|54560837|FG002|Double-Blind Treatment|Lost to Follow-up|1|||
27903988|NCT00105443|54560838|FG003|Double-Blind Treatment|Lost to Follow-up|0|||
27903989|NCT00105443|54560835|FG000|Double-Blind Treatment|Withdrawal by Subject|8|||
27903990|NCT00105443|54560836|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
27903991|NCT00105443|54560837|FG002|Double-Blind Treatment|Withdrawal by Subject|7|||
27903992|NCT00105443|54560838|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
27903993|NCT00105443|54560835|FG000|Double-Blind Treatment|Physician Decision|1|||
27903994|NCT00105443|54560836|FG001|Double-Blind Treatment|Physician Decision|0|||
27903995|NCT00105443|54560837|FG002|Double-Blind Treatment|Physician Decision|2|||
27987894|NCT00520975|54646594|FG000|Overall Study|Other therapy|2|||
27987895|NCT00520975|54646595|FG001|Overall Study|Other therapy|4|||
27987896|NCT00520975|54646594|FG000|Overall Study|Other reasons|4|||
27987897|NCT00520975|54646595|FG001|Overall Study|Other reasons|2|||
27987898|NCT00520975|54646594|FG000|Overall Study|Not start protocol therapy|1|||
27987899|NCT00520975|54646595|FG001|Overall Study|Not start protocol therapy|2|||
27987900|NCT00851721|54646603|FG000|Overall Study|planned surgery|1|||
27987901|NCT00851721|54646604|FG001|Overall Study|planned surgery|0|||
27987902|NCT00851721|54646603|FG000|Overall Study|Death|1|||
27903996|NCT00105443|54560838|FG003|Double-Blind Treatment|Physician Decision|0|||
27903997|NCT00105443|54560835|FG000|Double-Blind Treatment|Radiological and symptomatic progression|4|||
27903998|NCT00105443|54560836|FG001|Double-Blind Treatment|Radiological and symptomatic progression|0|||
27903999|NCT00105443|54560837|FG002|Double-Blind Treatment|Radiological and symptomatic progression|1|||
27904000|NCT00105443|54560838|FG003|Double-Blind Treatment|Radiological and symptomatic progression|0|||
27987903|NCT00851721|54646604|FG001|Overall Study|Death|0|||
27987904|NCT00851721|54646603|FG000|Overall Study|Adverse Event|0|||
27987905|NCT00851721|54646604|FG001|Overall Study|Adverse Event|1|||
27987906|NCT00520741|54646618|FG000|Overall Study|Adverse Event|16|||
27987907|NCT00520741|54646619|FG001|Overall Study|Adverse Event|56|||
27987908|NCT00520741|54646618|FG000|Overall Study|Lack of Efficacy|11|||
27987909|NCT00520741|54646619|FG001|Overall Study|Lack of Efficacy|30|||
27987910|NCT00520741|54646618|FG000|Overall Study|Withdrawal by Subject|0|||
27987911|NCT00520741|54646619|FG001|Overall Study|Withdrawal by Subject|11|||
27987912|NCT00520741|54646618|FG000|Overall Study|Protocol Violation|2|||
27987913|NCT00520741|54646619|FG001|Overall Study|Protocol Violation|15|||
28097474|NCT01343368|54753137|FG001|Overall Study|Lost to Follow-up|0|||
27904001|NCT00105443|54560835|FG000|Follow-up and/or Open Label Nexavar|Death|180|||
27904002|NCT00105443|54560836|FG001|Follow-up and/or Open Label Nexavar|Death|7|||
27904003|NCT00105443|54560837|FG002|Follow-up and/or Open Label Nexavar|Death|219|||
27904004|NCT00105443|54560838|FG003|Follow-up and/or Open Label Nexavar|Death|4|||
27904005|NCT00105443|54560835|FG000|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14|||
27904006|NCT00105443|54560836|FG001|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
27987914|NCT00520741|54646618|FG000|Overall Study|Unsatisfactory compliance of subject|4|||
28097475|NCT02955212|54753145|FG000|Period 1: Double-blind Treatment Period|Adverse Event|4|||
27904007|NCT00105443|54560837|FG002|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10|||
27904008|NCT00105443|54560838|FG003|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
27987915|NCT00520741|54646619|FG001|Overall Study|Unsatisfactory compliance of subject|3|||
27987916|NCT00520741|54646618|FG000|Overall Study|Lost to Follow-up|4|||
27987917|NCT00520741|54646619|FG001|Overall Study|Lost to Follow-up|4|||
27987918|NCT00520741|54646618|FG000|Overall Study|Other reasons for premature termination|0|||
27987919|NCT00520741|54646619|FG001|Overall Study|Other reasons for premature termination|6|||
27904009|NCT00105443|54560835|FG000|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24|||
27904010|NCT00105443|54560836|FG001|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3|||
27904011|NCT00105443|54560837|FG002|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13|||
27987920|NCT00882518|54646629|FG000|Overall Study|Adverse Event|9|||
27987921|NCT00882518|54646630|FG001|Overall Study|Adverse Event|18|||
27987922|NCT00882518|54646629|FG000|Overall Study|Withdrawal by Subject|9|||
27987923|NCT00882518|54646630|FG001|Overall Study|Withdrawal by Subject|13|||
27987924|NCT00882518|54646629|FG000|Overall Study|Lack of Efficacy|12|||
27987925|NCT00882518|54646630|FG001|Overall Study|Lack of Efficacy|9|||
27987926|NCT00882518|54646629|FG000|Overall Study|Severe non-compliance to protocol|3|||
27987927|NCT00882518|54646630|FG001|Overall Study|Severe non-compliance to protocol|1|||
27904012|NCT00105443|54560838|FG003|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4|||
27904013|NCT00105443|54560835|FG000|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
27904014|NCT00105443|54560836|FG001|Follow-up and/or Open Label Nexavar|Adverse Event|14|||
27987928|NCT00882518|54646629|FG000|Overall Study|Incorrect enrolment|4|||
27987929|NCT00882518|54646630|FG001|Overall Study|Incorrect enrolment|2|||
27987930|NCT00882518|54646629|FG000|Overall Study|Central lab closure for National day|1|||
27987931|NCT00882518|54646630|FG001|Overall Study|Central lab closure for National day|0|||
27987932|NCT00882518|54646629|FG000|Overall Study|Allocating random number by mistake|0|||
27987933|NCT00882518|54646630|FG001|Overall Study|Allocating random number by mistake|1|||
27987934|NCT00882362|54646647|FG000|Overall Study|Adverse Event|13|||
27987935|NCT00882362|54646648|FG001|Overall Study|Adverse Event|10|||
27987936|NCT00882362|54646647|FG000|Overall Study|Withdrawal by Subject|13|||
27987937|NCT00882362|54646648|FG001|Overall Study|Withdrawal by Subject|10|||
27987938|NCT00882362|54646647|FG000|Overall Study|Lack of Efficacy|3|||
27987939|NCT00882362|54646648|FG001|Overall Study|Lack of Efficacy|0|||
27987940|NCT00882362|54646647|FG000|Overall Study|Protocol Violation|7|||
27987941|NCT00882362|54646648|FG001|Overall Study|Protocol Violation|2|||
27987942|NCT00882362|54646647|FG000|Overall Study|Pregnancy|1|||
27987943|NCT00882362|54646648|FG001|Overall Study|Pregnancy|0|||
27987944|NCT00882362|54646647|FG000|Overall Study|Physician Decision|5|||
27987945|NCT00882362|54646648|FG001|Overall Study|Physician Decision|1|||
27987946|NCT00882362|54646647|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2|||
27987947|NCT00882362|54646648|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
27987948|NCT00882362|54646647|FG000|Overall Study|change of residence or other commitments|5|||
27987949|NCT00882362|54646648|FG001|Overall Study|change of residence or other commitments|0|||
27987950|NCT00851643|54646660|FG000|Base Study (Up to 12 Months)|Withdrawal by Subject|1|||
27987951|NCT00851643|54646661|FG001|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
27987952|NCT00851643|54646662|FG002|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
27987953|NCT00851643|54646663|FG003|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
27987954|NCT00851643|54646664|FG004|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
27987955|NCT00851643|54646665|FG005|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
27904015|NCT00105443|54560837|FG002|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
27904016|NCT00105443|54560838|FG003|Follow-up and/or Open Label Nexavar|Adverse Event|16|||
27904017|NCT00105443|54560835|FG000|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
27904018|NCT00105443|54560836|FG001|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
27904019|NCT00105443|54560837|FG002|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
27904020|NCT00105443|54560838|FG003|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
27904021|NCT00105443|54560835|FG000|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
27904022|NCT00105443|54560836|FG001|Follow-up and/or Open Label Nexavar|Protocol Violation|2|||
27904023|NCT00105443|54560837|FG002|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
27904024|NCT00105443|54560838|FG003|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
27904025|NCT00105443|54560835|FG000|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
27904026|NCT00105443|54560836|FG001|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2|||
27904027|NCT00105443|54560837|FG002|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
27904028|NCT00105443|54560838|FG003|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5|||
27904029|NCT00105443|54560835|FG000|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
27904030|NCT00105443|54560836|FG001|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
27904031|NCT00105443|54560837|FG002|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
27904032|NCT00105443|54560838|FG003|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
27904033|NCT00105443|54560835|FG000|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6|||
27904034|NCT00105443|54560836|FG001|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
27904035|NCT00105443|54560837|FG002|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1|||
27904036|NCT00105443|54560838|FG003|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
27904037|NCT00105443|54560835|FG000|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
27904038|NCT00105443|54560836|FG001|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
27987956|NCT00851643|54646660|FG000|Base Study (Up to 12 Months)|Other|0|||
27987957|NCT00851643|54646661|FG001|Base Study (Up to 12 Months)|Other|0|||
27904039|NCT00105443|54560837|FG002|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1|||
27904040|NCT00105443|54560838|FG003|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
27904041|NCT00105443|54560835|FG000|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1|||
27904042|NCT00105443|54560836|FG001|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
27987958|NCT00851643|54646662|FG002|Base Study (Up to 12 Months)|Other|0|||
27987959|NCT00851643|54646663|FG003|Base Study (Up to 12 Months)|Other|0|||
27987960|NCT00851643|54646664|FG004|Base Study (Up to 12 Months)|Other|0|||
27987961|NCT00851643|54646665|FG005|Base Study (Up to 12 Months)|Other|1|||
27987962|NCT00851643|54646660|FG000|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
27987963|NCT00851643|54646661|FG001|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
27987964|NCT00851643|54646662|FG002|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
27987965|NCT00851643|54646663|FG003|Extension Study (Up to 36 Months)|Lost to Follow-up|1|||
27987966|NCT00851643|54646664|FG004|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
27987967|NCT00851643|54646665|FG005|Extension Study (Up to 36 Months)|Lost to Follow-up|0|||
27987968|NCT00851643|54646660|FG000|Extension Study (Up to 36 Months)|Moved|0|||
27987969|NCT00851643|54646661|FG001|Extension Study (Up to 36 Months)|Moved|2|||
27987970|NCT00851643|54646662|FG002|Extension Study (Up to 36 Months)|Moved|1|||
27987971|NCT00851643|54646663|FG003|Extension Study (Up to 36 Months)|Moved|1|||
27987972|NCT00851643|54646664|FG004|Extension Study (Up to 36 Months)|Moved|0|||
27987973|NCT00851643|54646665|FG005|Extension Study (Up to 36 Months)|Moved|1|||
27987974|NCT00529243|54646678|FG000|Overall Study|Adverse Event|1|||
27987975|NCT00529243|54646678|FG000|Overall Study|Death|1|||
27987976|NCT00529243|54646678|FG000|Overall Study|Relocated|1|||
27987977|NCT03728309|54646684|FG000|Overall Study|Randomized but not Treated|0|||
27987978|NCT03728309|54646685|FG001|Overall Study|Randomized but not Treated|1|||
27987979|NCT03728309|54646684|FG000|Overall Study|Adverse Event|0|||
27987980|NCT03728309|54646685|FG001|Overall Study|Adverse Event|1|||
27987981|NCT03728309|54646684|FG000|Overall Study|Withdrawal by Subject|2|||
27987982|NCT03728309|54646685|FG001|Overall Study|Withdrawal by Subject|8|||
27987983|NCT03728309|54646684|FG000|Overall Study|Lost to Follow-up|9|||
27987984|NCT03728309|54646685|FG001|Overall Study|Lost to Follow-up|10|||
27987985|NCT03728309|54646684|FG000|Overall Study|Protocol Deviation|0|||
27987986|NCT03728309|54646685|FG001|Overall Study|Protocol Deviation|1|||
27987987|NCT03728309|54646684|FG000|Overall Study|Due to COVID|1|||
27987988|NCT03728309|54646685|FG001|Overall Study|Due to COVID|3|||
27987989|NCT03683719|54646702|FG000|Overall Study|Lack of Efficacy|1|||
27987990|NCT03683719|54646703|FG001|Overall Study|Lack of Efficacy|3|||
27904043|NCT00105443|54560837|FG002|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
27904044|NCT00105443|54560838|FG003|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
27904045|NCT00105443|54560835|FG000|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
27904046|NCT00105443|54560836|FG001|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
27904047|NCT00105443|54560837|FG002|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
27904048|NCT00105443|54560838|FG003|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1|||
27904049|NCT00105443|54560835|FG000|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
27904050|NCT00105443|54560836|FG001|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
27904051|NCT00105443|54560837|FG002|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
27904052|NCT00105443|54560838|FG003|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
27904053|NCT00105443|54560835|FG000|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
27904054|NCT00105443|54560836|FG001|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23|||
27904055|NCT00105443|54560837|FG002|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
27904056|NCT00105443|54560838|FG003|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11|||
27904057|NCT01327612|54560854|FG000|Overall Study|Withdrawal by Subject|0|||
27904058|NCT01327612|54560855|FG001|Overall Study|Withdrawal by Subject|0|||
27904059|NCT01327612|54560856|FG002|Overall Study|Withdrawal by Subject|0|||
27904060|NCT01327612|54560857|FG003|Overall Study|Withdrawal by Subject|0|||
27904061|NCT01327612|54560858|FG004|Overall Study|Withdrawal by Subject|0|||
27904062|NCT01327612|54560859|FG005|Overall Study|Withdrawal by Subject|1|||
27904063|NCT01327612|54560860|FG006|Overall Study|Withdrawal by Subject|0|||
27904064|NCT01327612|54560854|FG000|Overall Study|Disease Progression|1|||
27904065|NCT01327612|54560855|FG001|Overall Study|Disease Progression|1|||
27904066|NCT01327612|54560856|FG002|Overall Study|Disease Progression|1|||
27904067|NCT01327612|54560857|FG003|Overall Study|Disease Progression|0|||
27904068|NCT01327612|54560858|FG004|Overall Study|Disease Progression|1|||
27904069|NCT01327612|54560859|FG005|Overall Study|Disease Progression|2|||
27904070|NCT01327612|54560860|FG006|Overall Study|Disease Progression|2|||
27904071|NCT01327612|54560854|FG000|Overall Study|Administrative Decision|0|||
27904072|NCT01327612|54560855|FG001|Overall Study|Administrative Decision|0|||
27987991|NCT03683719|54646704|FG002|Overall Study|Lack of Efficacy|4|||
27987992|NCT03683719|54646705|FG003|Overall Study|Lack of Efficacy|0|||
27987993|NCT03683719|54646706|FG004|Overall Study|Lack of Efficacy|4|||
27987994|NCT03683719|54646702|FG000|Overall Study|Adverse Event|6|||
27987995|NCT03683719|54646703|FG001|Overall Study|Adverse Event|6|||
27904073|NCT01327612|54560856|FG002|Overall Study|Administrative Decision|0|||
27904074|NCT01327612|54560857|FG003|Overall Study|Administrative Decision|1|||
27904075|NCT01327612|54560858|FG004|Overall Study|Administrative Decision|0|||
27904076|NCT01327612|54560859|FG005|Overall Study|Administrative Decision|0|||
27904077|NCT01327612|54560860|FG006|Overall Study|Administrative Decision|0|||
27904078|NCT01327612|54560854|FG000|Overall Study|Death|0|||
27987996|NCT03683719|54646704|FG002|Overall Study|Adverse Event|0|||
27987997|NCT03683719|54646705|FG003|Overall Study|Adverse Event|1|||
27987998|NCT03683719|54646706|FG004|Overall Study|Adverse Event|3|||
27987999|NCT03683719|54646702|FG000|Overall Study|Withdrawal by Subject|4|||
27988000|NCT03683719|54646703|FG001|Overall Study|Withdrawal by Subject|4|||
27988001|NCT03683719|54646704|FG002|Overall Study|Withdrawal by Subject|3|||
27988002|NCT03683719|54646705|FG003|Overall Study|Withdrawal by Subject|5|||
27988003|NCT03683719|54646706|FG004|Overall Study|Withdrawal by Subject|5|||
27988004|NCT03683719|54646702|FG000|Overall Study|Lost to Follow-up|1|||
27988005|NCT03683719|54646703|FG001|Overall Study|Lost to Follow-up|0|||
27988006|NCT03683719|54646704|FG002|Overall Study|Lost to Follow-up|0|||
27988007|NCT03683719|54646705|FG003|Overall Study|Lost to Follow-up|1|||
27988008|NCT03683719|54646706|FG004|Overall Study|Lost to Follow-up|1|||
27988009|NCT03683719|54646702|FG000|Overall Study|Other personal reasons|0|||
27988010|NCT03683719|54646703|FG001|Overall Study|Other personal reasons|0|||
27988011|NCT03683719|54646704|FG002|Overall Study|Other personal reasons|1|||
27988012|NCT03683719|54646705|FG003|Overall Study|Other personal reasons|0|||
27988013|NCT03683719|54646706|FG004|Overall Study|Other personal reasons|1|||
27988014|NCT00851253|54646720|FG000|Overall Study|Disease Progression|1|||
27988015|NCT00851253|54646721|FG001|Overall Study|Disease Progression|0|||
27988016|NCT00520351|54646729|FG000|First Intervention|Withdrawal by Subject|1|||
27988017|NCT00520351|54646730|FG001|First Intervention|Withdrawal by Subject|1|||
27988018|NCT00850395|54646740|FG000|Overall Study|Death|1|||
27988019|NCT00850395|54646740|FG000|Overall Study|Adverse Event|1|||
27988020|NCT00850395|54646740|FG000|Overall Study|Insufficient clinical response|3|||
27988021|NCT00850395|54646740|FG000|Overall Study|Other|5|||
27988022|NCT00520039|54646746|FG000|Overall Study|Exclusion criteria met at first visit|7|||
27988023|NCT00520039|54646747|FG001|Overall Study|Exclusion criteria met at first visit|5|||
27988024|NCT00577720|54646759|FG000|Overall Study|Adverse Event|2|||
27988025|NCT00577720|54646760|FG001|Overall Study|Adverse Event|1|||
27988026|NCT00577720|54646761|FG002|Overall Study|Adverse Event|0|||
27988027|NCT00577720|54646762|FG003|Overall Study|Adverse Event|4|||
27988028|NCT00577720|54646759|FG000|Overall Study|Lost to Follow-up|0|||
27988029|NCT00577720|54646760|FG001|Overall Study|Lost to Follow-up|0|||
27988030|NCT00577720|54646761|FG002|Overall Study|Lost to Follow-up|1|||
27988031|NCT00577720|54646762|FG003|Overall Study|Lost to Follow-up|0|||
27988032|NCT00577720|54646759|FG000|Overall Study|Protocol Violation|0|||
27988033|NCT00577720|54646760|FG001|Overall Study|Protocol Violation|0|||
27988034|NCT00577720|54646761|FG002|Overall Study|Protocol Violation|0|||
27988035|NCT00577720|54646762|FG003|Overall Study|Protocol Violation|1|||
27988036|NCT00577720|54646759|FG000|Overall Study|Withdrawal by Subject|2|||
27988037|NCT00577720|54646760|FG001|Overall Study|Withdrawal by Subject|0|||
27988038|NCT00577720|54646761|FG002|Overall Study|Withdrawal by Subject|0|||
28097476|NCT02955212|54753146|FG001|Period 1: Double-blind Treatment Period|Adverse Event|7|||
28097477|NCT02955212|54753145|FG000|Period 1: Double-blind Treatment Period|Withdrawal by Subject|8|||
28097478|NCT02955212|54753146|FG001|Period 1: Double-blind Treatment Period|Withdrawal by Subject|3|||
28097479|NCT02955212|54753145|FG000|Period 1: Double-blind Treatment Period|Lost to Follow-up|1|||
28097480|NCT02955212|54753146|FG001|Period 1: Double-blind Treatment Period|Lost to Follow-up|0|||
28097481|NCT02955212|54753145|FG000|Period 1: Double-blind Treatment Period|Other|3|||
27904079|NCT01327612|54560855|FG001|Overall Study|Death|0|||
27904080|NCT01327612|54560856|FG002|Overall Study|Death|0|||
27904081|NCT01327612|54560857|FG003|Overall Study|Death|0|||
27988039|NCT00577720|54646762|FG003|Overall Study|Withdrawal by Subject|2|||
27988040|NCT00519649|54646772|FG000|Overall Study|Withdrawal by Subject|1|||
27988041|NCT00512707|54646790|FG000|Overall Study|Lost to Follow-up|5|||
27988042|NCT00512707|54646791|FG001|Overall Study|Lost to Follow-up|11|||
27988043|NCT00512707|54646790|FG000|Overall Study|Developed skin irritation|2|||
27988044|NCT00512707|54646791|FG001|Overall Study|Developed skin irritation|1|||
27988045|NCT00512707|54646790|FG000|Overall Study|Developed a hematocrit exceeding 0.54|2|||
27988046|NCT00512707|54646791|FG001|Overall Study|Developed a hematocrit exceeding 0.54|0|||
27988047|NCT00512707|54646790|FG000|Overall Study|Unable to tolerate the smell of the gel|1|||
27988048|NCT00512707|54646791|FG001|Overall Study|Unable to tolerate the smell of the gel|0|||
27988049|NCT03471767|54646799|FG000|Overall Study|Withdrawal by Subject|3|||
27904082|NCT01327612|54560858|FG004|Overall Study|Death|1|||
27904083|NCT01327612|54560859|FG005|Overall Study|Death|0|||
27904084|NCT01327612|54560860|FG006|Overall Study|Death|0|||
27988050|NCT03471767|54646800|FG001|Overall Study|Withdrawal by Subject|1|||
27988051|NCT03471767|54646799|FG000|Overall Study|Adverse Event|1|||
27988052|NCT03471767|54646800|FG001|Overall Study|Adverse Event|0|||
27988053|NCT03471767|54646799|FG000|Overall Study|Lost to Follow-up|1|||
27988054|NCT03471767|54646800|FG001|Overall Study|Lost to Follow-up|0|||
27904085|NCT01327573|54560879|FG000|Overall Study|Physician Decision|3|||
27904086|NCT01327573|54560880|FG001|Overall Study|Physician Decision|1|||
27904087|NCT01327495|54560893|FG000|Overall Study|Adverse Event|2|||
27904088|NCT01327495|54560894|FG001|Overall Study|Adverse Event|1|||
27904089|NCT01327495|54560895|FG002|Overall Study|Adverse Event|1|||
27904090|NCT01327495|54560896|FG003|Overall Study|Adverse Event|0|||
27904091|NCT01327495|54560897|FG004|Overall Study|Adverse Event|0|||
27904092|NCT01327495|54560898|FG005|Overall Study|Adverse Event|2|||
27904093|NCT01327495|54560893|FG000|Overall Study|Withdrawal by Subject|0|||
27904094|NCT01327495|54560894|FG001|Overall Study|Withdrawal by Subject|1|||
27904095|NCT01327495|54560895|FG002|Overall Study|Withdrawal by Subject|1|||
27904096|NCT01327495|54560896|FG003|Overall Study|Withdrawal by Subject|0|||
27904097|NCT01327495|54560897|FG004|Overall Study|Withdrawal by Subject|1|||
27904098|NCT01327495|54560898|FG005|Overall Study|Withdrawal by Subject|0|||
27904099|NCT01327495|54560893|FG000|Overall Study|Physician Decision|0|||
27904100|NCT01327495|54560894|FG001|Overall Study|Physician Decision|0|||
27904101|NCT01327495|54560895|FG002|Overall Study|Physician Decision|0|||
27904102|NCT01327495|54560896|FG003|Overall Study|Physician Decision|0|||
27904103|NCT01327495|54560897|FG004|Overall Study|Physician Decision|2|||
27904104|NCT01327495|54560898|FG005|Overall Study|Physician Decision|0|||
27904105|NCT01327339|54560918|FG000|Overall Study|Protocol Violation|8|||
27904106|NCT01327300|54560922|FG000|Washout (3 Weeks)|Withdrawal by Subject|1|||
27904107|NCT01327300|54560923|FG001|Washout (3 Weeks)|Withdrawal by Subject|0|||
27904108|NCT01379521|54560941|FG000|Overall Study -Treatment Period|Adverse Event|3|||
27904109|NCT01379521|54560942|FG001|Overall Study -Treatment Period|Adverse Event|0|||
27904110|NCT01379521|54560941|FG000|Overall Study -Treatment Period|Abnormal test procedure results|0|||
27904111|NCT01379521|54560942|FG001|Overall Study -Treatment Period|Abnormal test procedure results|1|||
27904112|NCT01379521|54560941|FG000|Overall Study -Treatment Period|Disease Progression|23|||
27904113|NCT01379521|54560942|FG001|Overall Study -Treatment Period|Disease Progression|22|||
27904114|NCT01379521|54560941|FG000|Overall Study -Treatment Period|New Cancer Therapy|1|||
27904115|NCT01379521|54560942|FG001|Overall Study -Treatment Period|New Cancer Therapy|0|||
27904116|NCT01379521|54560941|FG000|Overall Study -Treatment Period|Protocol Deviation|0|||
27904117|NCT01379521|54560942|FG001|Overall Study -Treatment Period|Protocol Deviation|2|||
27904118|NCT01379521|54560941|FG000|Overall Study -Treatment Period|Withdrawal by Subject|3|||
27904119|NCT01379521|54560942|FG001|Overall Study -Treatment Period|Withdrawal by Subject|0|||
27988055|NCT03471767|54646799|FG000|Overall Study|PI Withdrawal|1|||
27988056|NCT03471767|54646800|FG001|Overall Study|PI Withdrawal|3|||
27988057|NCT00849693|54646810|FG000|Acute Treatment Phase|Adverse Event|12|||
27988058|NCT00849693|54646811|FG001|Acute Treatment Phase|Adverse Event|7|||
27988059|NCT00849693|54646812|FG002|Acute Treatment Phase|Adverse Event|6|||
27988060|NCT00849693|54646813|FG003|Acute Treatment Phase|Adverse Event|4|||
27988061|NCT00849693|54646810|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
27988062|NCT00849693|54646811|FG001|Acute Treatment Phase|Lost to Follow-up|8|||
27988063|NCT00849693|54646812|FG002|Acute Treatment Phase|Lost to Follow-up|11|||
27988064|NCT00849693|54646813|FG003|Acute Treatment Phase|Lost to Follow-up|9|||
27988065|NCT00849693|54646810|FG000|Acute Treatment Phase|Protocol Violation|1|||
27988066|NCT00849693|54646811|FG001|Acute Treatment Phase|Protocol Violation|5|||
27988067|NCT00849693|54646812|FG002|Acute Treatment Phase|Protocol Violation|2|||
27988068|NCT00849693|54646813|FG003|Acute Treatment Phase|Protocol Violation|6|||
27988069|NCT00849693|54646810|FG000|Acute Treatment Phase|Withdrawal by Subject|5|||
27988070|NCT00849693|54646811|FG001|Acute Treatment Phase|Withdrawal by Subject|5|||
27988071|NCT00849693|54646812|FG002|Acute Treatment Phase|Withdrawal by Subject|3|||
27988072|NCT00849693|54646813|FG003|Acute Treatment Phase|Withdrawal by Subject|8|||
27988073|NCT00849693|54646810|FG000|Acute Treatment Phase|Parent or caregiver decision|7|||
27988074|NCT00849693|54646811|FG001|Acute Treatment Phase|Parent or caregiver decision|6|||
27988075|NCT00849693|54646812|FG002|Acute Treatment Phase|Parent or caregiver decision|7|||
27988076|NCT00849693|54646813|FG003|Acute Treatment Phase|Parent or caregiver decision|7|||
27988077|NCT00849693|54646810|FG000|Acute Treatment Phase|Physician Decision|2|||
27988078|NCT00849693|54646811|FG001|Acute Treatment Phase|Physician Decision|1|||
27988079|NCT00849693|54646812|FG002|Acute Treatment Phase|Physician Decision|2|||
27988080|NCT00849693|54646813|FG003|Acute Treatment Phase|Physician Decision|1|||
27988081|NCT00849693|54646810|FG000|Acute Treatment Phase|Sponsor decision|0|||
27988082|NCT00849693|54646811|FG001|Acute Treatment Phase|Sponsor decision|0|||
27988083|NCT00849693|54646812|FG002|Acute Treatment Phase|Sponsor decision|1|||
27988084|NCT00849693|54646813|FG003|Acute Treatment Phase|Sponsor decision|0|||
27988085|NCT00849693|54646810|FG000|Acute Treatment Phase|Lack of Efficacy|1|||
27988086|NCT00849693|54646811|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
27988087|NCT00849693|54646812|FG002|Acute Treatment Phase|Lack of Efficacy|1|||
27988088|NCT00849693|54646813|FG003|Acute Treatment Phase|Lack of Efficacy|2|||
27988089|NCT00849693|54646810|FG000|Extension Phase|Adverse Event|4|||
28097482|NCT02955212|54753146|FG001|Period 1: Double-blind Treatment Period|Other|2|||
27925789|NCT01226745|54582372|FG005|Overall Study|Death|1|||
27988090|NCT00849693|54646811|FG001|Extension Phase|Adverse Event|6|||
27988091|NCT00849693|54646812|FG002|Extension Phase|Adverse Event|3|||
27988092|NCT00849693|54646813|FG003|Extension Phase|Adverse Event|7|||
27988093|NCT00849693|54646810|FG000|Extension Phase|Lost to Follow-up|7|||
27988094|NCT00849693|54646811|FG001|Extension Phase|Lost to Follow-up|5|||
27988095|NCT00849693|54646812|FG002|Extension Phase|Lost to Follow-up|6|||
27904120|NCT01379521|54560941|FG000|Overall Study -Treatment Period|Administrative Problems|1|||
27904121|NCT01379521|54560942|FG001|Overall Study -Treatment Period|Administrative Problems|0|||
27904122|NCT01379521|54560941|FG000|Overall Study -Treatment Period|Death|2|||
27904123|NCT01379521|54560942|FG001|Overall Study -Treatment Period|Death|1|||
27904124|NCT01379521|54560941|FG000|Post-Treatment Evaluations|Disease Progression|22|||
27904125|NCT01379521|54560942|FG001|Post-Treatment Evaluations|Disease Progression|20|||
27904126|NCT01379521|54560941|FG000|Post-Treatment Evaluations|Withdrawal by Subject|2|||
27904127|NCT01379521|54560942|FG001|Post-Treatment Evaluations|Withdrawal by Subject|1|||
27904128|NCT01379521|54560941|FG000|Post-Treatment Evaluations|Death|1|||
27904129|NCT01379521|54560942|FG001|Post-Treatment Evaluations|Death|0|||
27988096|NCT00849693|54646813|FG003|Extension Phase|Lost to Follow-up|6|||
27988097|NCT00849693|54646810|FG000|Extension Phase|Protocol Violation|0|||
27988098|NCT00849693|54646811|FG001|Extension Phase|Protocol Violation|3|||
27988099|NCT00849693|54646812|FG002|Extension Phase|Protocol Violation|2|||
27988100|NCT00849693|54646813|FG003|Extension Phase|Protocol Violation|3|||
27988101|NCT00849693|54646810|FG000|Extension Phase|Withdrawal by Subject|6|||
27988102|NCT00849693|54646811|FG001|Extension Phase|Withdrawal by Subject|9|||
27988103|NCT00849693|54646812|FG002|Extension Phase|Withdrawal by Subject|10|||
27988104|NCT00849693|54646813|FG003|Extension Phase|Withdrawal by Subject|15|||
27988105|NCT00849693|54646810|FG000|Extension Phase|Parent or caregiver decision|9|||
27988106|NCT00849693|54646811|FG001|Extension Phase|Parent or caregiver decision|4|||
27988107|NCT00849693|54646812|FG002|Extension Phase|Parent or caregiver decision|10|||
27988108|NCT00849693|54646813|FG003|Extension Phase|Parent or caregiver decision|5|||
27988109|NCT00849693|54646810|FG000|Extension Phase|Physician Decision|1|||
27988110|NCT00849693|54646811|FG001|Extension Phase|Physician Decision|1|||
27988111|NCT00849693|54646812|FG002|Extension Phase|Physician Decision|2|||
27904130|NCT01371994|54560950|FG000|Overall Study|Adverse Event|3|||
27904131|NCT01371994|54560951|FG001|Overall Study|Adverse Event|6|||
27904132|NCT01371994|54560950|FG000|Overall Study|Lack of Efficacy|3|||
27904133|NCT01371994|54560951|FG001|Overall Study|Lack of Efficacy|0|||
27904134|NCT01371994|54560950|FG000|Overall Study|Withdrawal by Subject|13|||
27904135|NCT01371994|54560951|FG001|Overall Study|Withdrawal by Subject|7|||
27904136|NCT01371994|54560950|FG000|Overall Study|Lost to Follow-up|1|||
27904137|NCT01371994|54560951|FG001|Overall Study|Lost to Follow-up|1|||
27904138|NCT01371994|54560950|FG000|Overall Study|Protocol Violation|24|||
27904139|NCT01371994|54560951|FG001|Overall Study|Protocol Violation|17|||
27904140|NCT01371994|54560950|FG000|Overall Study|Randomized but Never Received Study Drug|6|||
27904141|NCT01371994|54560951|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
27904142|NCT01371994|54560950|FG000|Overall Study|Physician Decision|1|||
27904143|NCT01371994|54560951|FG001|Overall Study|Physician Decision|1|||
27904144|NCT01371994|54560950|FG000|Overall Study|Miscellaneous Reasons|6|||
27904145|NCT01371994|54560951|FG001|Overall Study|Miscellaneous Reasons|4|||
27904146|NCT01371877|54560959|FG000|Overall Study|3 for unknown reasons and 1 pregnant|0|||
27904147|NCT01371877|54560960|FG001|Overall Study|3 for unknown reasons and 1 pregnant|4|||
27904148|NCT01371838|54560968|FG000|Overall Study|Withdrawal by Subject|27|||
27904149|NCT01371838|54560969|FG001|Overall Study|Withdrawal by Subject|33|||
27904150|NCT01371838|54560968|FG000|Overall Study|Lost to Follow-up|10|||
27904151|NCT01371838|54560969|FG001|Overall Study|Lost to Follow-up|20|||
27904152|NCT01371838|54560968|FG000|Overall Study|Death|3|||
27904153|NCT01371838|54560969|FG001|Overall Study|Death|4|||
27904154|NCT01371838|54560968|FG000|Overall Study|Protocol Violation|3|||
27904155|NCT01371838|54560969|FG001|Overall Study|Protocol Violation|0|||
27904156|NCT01371838|54560968|FG000|Overall Study|Investigator Decision|3|||
27904157|NCT01371838|54560969|FG001|Overall Study|Investigator Decision|8|||
27904158|NCT01371838|54560968|FG000|Overall Study|Last follow-up visit not conducted|2|||
27904159|NCT01371838|54560969|FG001|Overall Study|Last follow-up visit not conducted|0|||
27904160|NCT01371838|54560968|FG000|Overall Study|Lack of therapeutic response|0|||
27904161|NCT01371838|54560969|FG001|Overall Study|Lack of therapeutic response|1|||
27904162|NCT01371838|54560968|FG000|Overall Study|Surgery|1|||
27904163|NCT01371838|54560969|FG001|Overall Study|Surgery|0|||
27904164|NCT01371721|54560978|FG000|Overall Study|Adverse Event|5|||
27904165|NCT01371721|54560979|FG001|Overall Study|Adverse Event|4|||
27904166|NCT01371721|54560980|FG002|Overall Study|Adverse Event|5|||
27904167|NCT01371721|54560978|FG000|Overall Study|Protocol Violation|6|||
27904168|NCT01371721|54560979|FG001|Overall Study|Protocol Violation|4|||
27904169|NCT01371721|54560980|FG002|Overall Study|Protocol Violation|5|||
27904170|NCT01371721|54560978|FG000|Overall Study|Lost to Follow-up|8|||
27904171|NCT01371721|54560979|FG001|Overall Study|Lost to Follow-up|2|||
27904172|NCT01371721|54560980|FG002|Overall Study|Lost to Follow-up|6|||
27904173|NCT01371721|54560978|FG000|Overall Study|Withdrawal by Subject|5|||
27988112|NCT00849693|54646813|FG003|Extension Phase|Physician Decision|0|||
27904174|NCT01371721|54560979|FG001|Overall Study|Withdrawal by Subject|7|||
27904175|NCT01371721|54560980|FG002|Overall Study|Withdrawal by Subject|11|||
27904176|NCT01371721|54560978|FG000|Overall Study|Other|2|||
27904177|NCT01371721|54560979|FG001|Overall Study|Other|3|||
27904178|NCT01371721|54560980|FG002|Overall Study|Other|0|||
27904179|NCT01371721|54560978|FG000|Overall Study|Lack of Efficacy|2|||
27904180|NCT01371721|54560979|FG001|Overall Study|Lack of Efficacy|4|||
27904181|NCT01371721|54560980|FG002|Overall Study|Lack of Efficacy|3|||
27988113|NCT00849693|54646810|FG000|Extension Phase|Sponsor decision|1|||
27904182|NCT01371721|54560978|FG000|Overall Study|Randomized but not treated|1|||
27904183|NCT01371721|54560979|FG001|Overall Study|Randomized but not treated|0|||
27904184|NCT01371721|54560980|FG002|Overall Study|Randomized but not treated|0|||
27904185|NCT01366534|54560993|FG000|Overall Study|Lost to Follow-up|1|||
27904186|NCT01366534|54560994|FG001|Overall Study|Lost to Follow-up|0|||
27904187|NCT01366534|54560995|FG002|Overall Study|Lost to Follow-up|0|||
27904188|NCT01366534|54560993|FG000|Overall Study|Migrated|1|||
27904189|NCT01366534|54560994|FG001|Overall Study|Migrated|1|||
27904190|NCT01366534|54560995|FG002|Overall Study|Migrated|0|||
27904191|NCT01366534|54560993|FG000|Overall Study|Declined challenged|0|||
27904192|NCT01366534|54560994|FG001|Overall Study|Declined challenged|1|||
27904193|NCT01366534|54560995|FG002|Overall Study|Declined challenged|0|||
27904194|NCT01365910|54561003|FG000|Overall Study|Withdrawal by Subject|7|||
27904195|NCT01365910|54561003|FG000|Overall Study|disease progression|18|||
27904196|NCT01365910|54561003|FG000|Overall Study|Adverse Event|3|||
27904197|NCT01365910|54561003|FG000|Overall Study|other complicating disease|1|||
27904198|NCT01365910|54561003|FG000|Overall Study|pt did not get tx, nausea/vomiting|1|||
27904199|NCT01365481|54561011|FG000|Overall Study|Adverse Event|6|||
27904200|NCT01365481|54561012|FG001|Overall Study|Adverse Event|9|||
27904201|NCT01365481|54561013|FG002|Overall Study|Adverse Event|0|||
27904202|NCT01365481|54561014|FG003|Overall Study|Adverse Event|2|||
27904203|NCT01365481|54561011|FG000|Overall Study|Withdrawal by Subject|0|||
27904204|NCT01365481|54561012|FG001|Overall Study|Withdrawal by Subject|2|||
27904205|NCT01365481|54561013|FG002|Overall Study|Withdrawal by Subject|1|||
27904206|NCT01365481|54561014|FG003|Overall Study|Withdrawal by Subject|1|||
27904207|NCT01365481|54561011|FG000|Overall Study|Lost to Follow-up|1|||
27904208|NCT01365481|54561012|FG001|Overall Study|Lost to Follow-up|1|||
27904209|NCT01365481|54561013|FG002|Overall Study|Lost to Follow-up|2|||
27904210|NCT01365481|54561014|FG003|Overall Study|Lost to Follow-up|3|||
27904211|NCT01365481|54561011|FG000|Overall Study|Abnormal laboratory value(s)|0|||
27904212|NCT01365481|54561012|FG001|Overall Study|Abnormal laboratory value(s)|1|||
27988114|NCT00849693|54646811|FG001|Extension Phase|Sponsor decision|0|||
27988115|NCT00849693|54646812|FG002|Extension Phase|Sponsor decision|0|||
27988116|NCT00849693|54646813|FG003|Extension Phase|Sponsor decision|1|||
27988117|NCT00849693|54646810|FG000|Extension Phase|Lack of Efficacy|2|||
27988118|NCT00849693|54646811|FG001|Extension Phase|Lack of Efficacy|2|||
27988119|NCT00849693|54646812|FG002|Extension Phase|Lack of Efficacy|2|||
27988120|NCT00849693|54646813|FG003|Extension Phase|Lack of Efficacy|1|||
27988121|NCT00527605|54646837|FG000|Overall Study|Adverse Event|3|||
27988122|NCT00527605|54646838|FG001|Overall Study|Adverse Event|0|||
27988123|NCT00527605|54646837|FG000|Overall Study|Withdrawal by Subject|3|||
27988124|NCT00527605|54646838|FG001|Overall Study|Withdrawal by Subject|7|||
27988125|NCT00527605|54646837|FG000|Overall Study|Lost to Follow-up|6|||
27988126|NCT00527605|54646838|FG001|Overall Study|Lost to Follow-up|2|||
27988127|NCT00527605|54646837|FG000|Overall Study|Protocol Violation|1|||
27904213|NCT01365481|54561013|FG002|Overall Study|Abnormal laboratory value(s)|0|||
27904214|NCT01365481|54561014|FG003|Overall Study|Abnormal laboratory value(s)|0|||
27904215|NCT01365481|54561011|FG000|Overall Study|Administrative problems|0|||
27904216|NCT01365481|54561012|FG001|Overall Study|Administrative problems|1|||
27904217|NCT01365481|54561013|FG002|Overall Study|Administrative problems|0|||
27904218|NCT01365481|54561014|FG003|Overall Study|Administrative problems|0|||
27904219|NCT01365481|54561011|FG000|Overall Study|Protocol deviation|0|||
27904220|NCT01365481|54561012|FG001|Overall Study|Protocol deviation|1|||
27904221|NCT01365481|54561013|FG002|Overall Study|Protocol deviation|0|||
27904222|NCT01365481|54561014|FG003|Overall Study|Protocol deviation|1|||
27988128|NCT00527605|54646838|FG001|Overall Study|Protocol Violation|2|||
27988129|NCT00849381|54646844|FG000|Overall Study|Adverse Event|1|||
27988130|NCT00849381|54646844|FG000|Overall Study|Lost to Follow-up|129|||
27988131|NCT00849381|54646844|FG000|Overall Study|Protocol Violation|5|||
27904223|NCT01365481|54561011|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
27904224|NCT01365481|54561012|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
27904225|NCT01365481|54561013|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
27904226|NCT01365481|54561014|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
27988132|NCT00849381|54646844|FG000|Overall Study|Withdrawal by Subject|6|||
27988133|NCT00849381|54646844|FG000|Overall Study|Other|4|||
27904227|NCT01357915|54561026|FG000|Overall Study|Lost to Follow-up|3|||
27904228|NCT01357915|54561027|FG001|Overall Study|Lost to Follow-up|0|||
27988134|NCT00711412|54646848|FG000|Induction Treatment|Death|2|||
27988135|NCT00711412|54646848|FG000|Induction Treatment|Adverse Event|1|||
27904229|NCT01350973|54561036|FG000|Overall Study|Adverse Event|4|||
27988136|NCT00711412|54646848|FG000|Induction Treatment|Other|1|||
27904230|NCT01350973|54561037|FG001|Overall Study|Adverse Event|7|||
27904231|NCT01350973|54561038|FG002|Overall Study|Adverse Event|7|||
27904232|NCT01350973|54561036|FG000|Overall Study|Voluntary Withdrawal|2|||
27904233|NCT01350973|54561037|FG001|Overall Study|Voluntary Withdrawal|1|||
27904234|NCT01350973|54561038|FG002|Overall Study|Voluntary Withdrawal|1|||
27904235|NCT01350544|54561048|FG000|Overall Study|Administrative Withdrawal|0|||
27904236|NCT01350544|54561049|FG001|Overall Study|Administrative Withdrawal|1|||
27904237|NCT01350544|54561048|FG000|Overall Study|Death|1|||
27904238|NCT01350544|54561049|FG001|Overall Study|Death|2|||
27904239|NCT01350544|54561048|FG000|Overall Study|Moved out of LA County|2|||
27904240|NCT01350544|54561049|FG001|Overall Study|Moved out of LA County|2|||
27988137|NCT00711412|54646848|FG000|Evaluated for Combination Treatment|Adverse Event|2|||
27988138|NCT00711412|54646848|FG000|Evaluated for Combination Treatment|Death|1|||
27988139|NCT00711412|54646848|FG000|Evaluated for Combination Treatment|Withdrawal by Subject|1|||
27988140|NCT00711412|54646848|FG000|Evaluated for Combination Treatment|Progressive disease|2|||
27988141|NCT00711412|54646848|FG000|Combination Treatment|Progressive Disease|1|||
27988142|NCT00711412|54646848|FG000|Evaluation for Response and Surgery|Progressive Disease|2|||
27988143|NCT00711412|54646848|FG000|Evaluation for Response and Surgery|Too high risk for surgery|2|||
27988144|NCT00711412|54646848|FG000|Evaluation for Response and Surgery|Withdrawal by Subject|1|||
27988145|NCT00711412|54646848|FG000|Evaluation for Response and Surgery|Death|1|||
27988146|NCT00711412|54646848|FG000|Survival Follow up Until Death|Other|12|||
27988147|NCT00577408|54646864|FG000|Overall Study|Stopped attending study visits|9|||
27988148|NCT00577408|54646865|FG001|Overall Study|Stopped attending study visits|11|||
27988149|NCT00577408|54646864|FG000|Overall Study|Continued opioid use|3|||
27988150|NCT00577408|54646865|FG001|Overall Study|Continued opioid use|2|||
27988151|NCT00577408|54646864|FG000|Overall Study|Non-compliance with study meds|0|||
27988152|NCT00577408|54646865|FG001|Overall Study|Non-compliance with study meds|3|||
27988153|NCT00577408|54646864|FG000|Overall Study|Refused Oral Naltrexone|0|||
27988154|NCT00577408|54646865|FG001|Overall Study|Refused Oral Naltrexone|1|||
27988155|NCT00577408|54646864|FG000|Overall Study|Moved out of state|0|||
27988156|NCT00577408|54646865|FG001|Overall Study|Moved out of state|1|||
27988157|NCT00577408|54646864|FG000|Overall Study|Scheduling Issues|0|||
27988158|NCT00577408|54646865|FG001|Overall Study|Scheduling Issues|3|||
27988159|NCT00577408|54646864|FG000|Overall Study|Death|0|||
27988160|NCT00577408|54646865|FG001|Overall Study|Death|1|||
27988161|NCT00577408|54646864|FG000|Overall Study|Psychiatric hospitalization|0|||
27988162|NCT00577408|54646865|FG001|Overall Study|Psychiatric hospitalization|1|||
27988163|NCT00713596|54646874|FG000|Overall Study|Study was terminated|2|||
27988164|NCT00713596|54646875|FG001|Overall Study|Study was terminated|3|||
27988165|NCT00713596|54646876|FG002|Overall Study|Study was terminated|2|||
27988166|NCT00880568|54646893|FG000|Overall Study|Disease progression|3|||
27988167|NCT00880568|54646894|FG001|Overall Study|Disease progression|3|||
27988168|NCT00880568|54646895|FG002|Overall Study|Disease progression|3|||
27988169|NCT00880568|54646896|FG003|Overall Study|Disease progression|1|||
27904241|NCT01350544|54561048|FG000|Overall Study|Medical Issues|1|||
27904242|NCT01350544|54561049|FG001|Overall Study|Medical Issues|1|||
27988170|NCT00880568|54646897|FG004|Overall Study|Disease progression|3|||
27988171|NCT00880568|54646898|FG005|Overall Study|Disease progression|3|||
27988172|NCT00880568|54646899|FG006|Overall Study|Disease progression|5|||
27988173|NCT00880568|54646900|FG007|Overall Study|Disease progression|0|||
27988174|NCT00880568|54646901|FG008|Overall Study|Disease progression|3|||
27988175|NCT00880568|54646893|FG000|Overall Study|Adverse Event|0|||
27988176|NCT00880568|54646894|FG001|Overall Study|Adverse Event|0|||
27988177|NCT00880568|54646895|FG002|Overall Study|Adverse Event|0|||
27988178|NCT00880568|54646896|FG003|Overall Study|Adverse Event|0|||
27988179|NCT00880568|54646897|FG004|Overall Study|Adverse Event|0|||
27904243|NCT01350544|54561048|FG000|Overall Study|Withdrawal by Subject|0|||
27904244|NCT01350544|54561049|FG001|Overall Study|Withdrawal by Subject|1|||
27904245|NCT01350544|54561048|FG000|Overall Study|Incarceration|1|||
27988180|NCT00880568|54646898|FG005|Overall Study|Adverse Event|0|||
27988181|NCT00880568|54646899|FG006|Overall Study|Adverse Event|1|||
27988182|NCT00880568|54646900|FG007|Overall Study|Adverse Event|1|||
27988183|NCT00880568|54646901|FG008|Overall Study|Adverse Event|0|||
27904246|NCT01350544|54561049|FG001|Overall Study|Incarceration|0|||
27904247|NCT01350544|54561048|FG000|Overall Study|Lost to Follow-up|18|||
27904248|NCT01350544|54561049|FG001|Overall Study|Lost to Follow-up|15|||
27904249|NCT01350505|54561055|FG000|Overall Study|Lost to Follow-up|4|||
27904250|NCT01350271|54561062|FG000|Overall Study|Lost to Follow-up|21|||
27988184|NCT00880568|54646893|FG000|Overall Study|Withdrawal by Subject|0|||
27988185|NCT00880568|54646894|FG001|Overall Study|Withdrawal by Subject|0|||
27739576|NCT02738879|54189192|FG001|Overall Study|Pregnancy|1|||
27904251|NCT01350271|54561063|FG001|Overall Study|Lost to Follow-up|17|||
27904252|NCT01350271|54561064|FG002|Overall Study|Lost to Follow-up|26|||
27904253|NCT01348828|54561075|FG000|Overall Study|Death|20|||
27904254|NCT01348828|54561075|FG000|Overall Study|Withdrawals/Lost to Follow-up|10|||
28172311|NCT02407054|54843966|FG002|Overall Study|Adverse Event|1|||
27904255|NCT01348828|54561075|FG000|Overall Study|Conversion|2|||
27904256|NCT01348828|54561075|FG000|Overall Study|missed visit|1|||
27988186|NCT00880568|54646895|FG002|Overall Study|Withdrawal by Subject|0|||
27988187|NCT00880568|54646896|FG003|Overall Study|Withdrawal by Subject|0|||
27988188|NCT00880568|54646897|FG004|Overall Study|Withdrawal by Subject|0|||
27988189|NCT00880568|54646898|FG005|Overall Study|Withdrawal by Subject|0|||
27988190|NCT00880568|54646899|FG006|Overall Study|Withdrawal by Subject|0|||
27988191|NCT00880568|54646900|FG007|Overall Study|Withdrawal by Subject|1|||
27988192|NCT00880568|54646901|FG008|Overall Study|Withdrawal by Subject|0|||
27988193|NCT00881894|54646928|FG000|Overall Study|Consent withdrawn|0|||
27904257|NCT01348789|54561079|FG000|Overall Study|Protocol Violation|2|||
27904258|NCT01348789|54561079|FG000|Overall Study|Withdrawal by Subject|2|||
27904259|NCT01342510|54561094|FG000|Overall Study|Protocol Violation|12|||
27904260|NCT01342510|54561095|FG001|Overall Study|Protocol Violation|6|||
27988194|NCT00881894|54646929|FG001|Overall Study|Consent withdrawn|1|||
27988195|NCT00881894|54646928|FG000|Overall Study|Other reasons for premature termination|1|||
27988196|NCT00881894|54646929|FG001|Overall Study|Other reasons for premature termination|2|||
27988197|NCT00711100|54646935|FG000|Overall Study|Lack of Efficacy|5|||
27988198|NCT00711100|54646935|FG000|Overall Study|Withdrawal by Subject|8|||
27988199|NCT00827931|54646953|FG000|Overall Study|Death|3|||
27988200|NCT00827931|54646954|FG001|Overall Study|Death|5|||
27988201|NCT00827931|54646953|FG000|Overall Study|Adverse Event|1|||
27988202|NCT00827931|54646954|FG001|Overall Study|Adverse Event|0|||
27988203|NCT00827931|54646953|FG000|Overall Study|Lost to Follow-up|1|||
27988204|NCT00827931|54646954|FG001|Overall Study|Lost to Follow-up|0|||
27988205|NCT00827931|54646953|FG000|Overall Study|Withdrawal by Subject|0|||
27988206|NCT00827931|54646954|FG001|Overall Study|Withdrawal by Subject|1|||
27988207|NCT00827931|54646953|FG000|Overall Study|Other|1|||
27988208|NCT00827931|54646954|FG001|Overall Study|Other|0|||
27988209|NCT00526669|54646960|FG000|Combined Treatment Phase|Lost to Follow-up|0|||
27988210|NCT00526669|54646961|FG001|Combined Treatment Phase|Lost to Follow-up|2|||
27904261|NCT01342510|54561096|FG002|Overall Study|Protocol Violation|13|||
27904262|NCT01342510|54561097|FG003|Overall Study|Protocol Violation|11|||
27904263|NCT01340872|54561117|FG000|Double-blind Phase|Adverse Event|6|||
27904264|NCT01340872|54561118|FG001|Double-blind Phase|Adverse Event|4|||
27904265|NCT01340872|54561119|FG002|Double-blind Phase|Adverse Event|0|||
27904266|NCT01340872|54561120|FG003|Double-blind Phase|Adverse Event|0|||
27904267|NCT01340872|54561117|FG000|Double-blind Phase|Withdrawal by Subject|3|||
27904268|NCT01340872|54561118|FG001|Double-blind Phase|Withdrawal by Subject|5|||
27904269|NCT01340872|54561119|FG002|Double-blind Phase|Withdrawal by Subject|0|||
27904270|NCT01340872|54561120|FG003|Double-blind Phase|Withdrawal by Subject|0|||
27904271|NCT01340872|54561117|FG000|Double-blind Phase|Lost to Follow-up|0|||
27904272|NCT01340872|54561118|FG001|Double-blind Phase|Lost to Follow-up|1|||
27904273|NCT01340872|54561119|FG002|Double-blind Phase|Lost to Follow-up|0|||
27904274|NCT01340872|54561120|FG003|Double-blind Phase|Lost to Follow-up|0|||
27904275|NCT01340872|54561117|FG000|Double-blind Phase|Protocol Violation|0|||
27904276|NCT01340872|54561118|FG001|Double-blind Phase|Protocol Violation|1|||
27904277|NCT01340872|54561119|FG002|Double-blind Phase|Protocol Violation|0|||
27904278|NCT01340872|54561120|FG003|Double-blind Phase|Protocol Violation|0|||
27904279|NCT01340872|54561117|FG000|Open-label Phase|Physician Decision|0|||
27904280|NCT01340872|54561118|FG001|Open-label Phase|Physician Decision|0|||
27904281|NCT01340872|54561119|FG002|Open-label Phase|Physician Decision|2|||
27904282|NCT01340872|54561120|FG003|Open-label Phase|Physician Decision|1|||
27904283|NCT01340872|54561117|FG000|Open-label Phase|Pregnancy|0|||
27904284|NCT01340872|54561118|FG001|Open-label Phase|Pregnancy|0|||
27904285|NCT01340872|54561119|FG002|Open-label Phase|Pregnancy|1|||
27904286|NCT01340872|54561120|FG003|Open-label Phase|Pregnancy|0|||
27904287|NCT01340872|54561117|FG000|Open-label Phase|Adverse Event|0|||
27904288|NCT01340872|54561118|FG001|Open-label Phase|Adverse Event|0|||
27904289|NCT01340872|54561119|FG002|Open-label Phase|Adverse Event|8|||
27904290|NCT01340872|54561120|FG003|Open-label Phase|Adverse Event|4|||
27904291|NCT01340872|54561117|FG000|Open-label Phase|Withdrawal by Subject|0|||
27904292|NCT01340872|54561118|FG001|Open-label Phase|Withdrawal by Subject|0|||
27904293|NCT01340872|54561119|FG002|Open-label Phase|Withdrawal by Subject|1|||
27988211|NCT00526669|54646960|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
27988212|NCT00526669|54646961|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
27988213|NCT00526669|54646960|FG000|Combined Treatment Phase|Sponsor Terminated Study|0|||
27988214|NCT00526669|54646961|FG001|Combined Treatment Phase|Sponsor Terminated Study|2|||
27904294|NCT01340872|54561120|FG003|Open-label Phase|Withdrawal by Subject|6|||
27904295|NCT01340872|54561117|FG000|Open-label Phase|Worsening of IBD|0|||
27904296|NCT01340872|54561118|FG001|Open-label Phase|Worsening of IBD|0|||
27904297|NCT01340872|54561119|FG002|Open-label Phase|Worsening of IBD|1|||
27904298|NCT01340872|54561120|FG003|Open-label Phase|Worsening of IBD|0|||
27988215|NCT00526669|54646960|FG000|Combined Treatment Phase|Death|0|||
27988216|NCT00526669|54646961|FG001|Combined Treatment Phase|Death|2|||
27988217|NCT00710866|54646973|FG000|Overall Study|Protocol Violation|5|||
27988218|NCT00710866|54646974|FG001|Overall Study|Protocol Violation|4|||
27988219|NCT00710866|54646973|FG000|Overall Study|Withdrawal by Subject|2|||
27904299|NCT01340794|54561134|FG000|Overall Study|Withdrawal by Subject|0|||
27904300|NCT01340794|54561135|FG001|Overall Study|Withdrawal by Subject|1|||
27904301|NCT01340482|54561146|FG000|Overall Study|Adverse Event|2|||
27904302|NCT01340482|54561147|FG001|Overall Study|Adverse Event|0|||
27904303|NCT01340482|54561148|FG002|Overall Study|Adverse Event|0|||
27904304|NCT01340209|54561161|FG000|Overall Study|Adverse Event|1|||
27904305|NCT01340209|54561162|FG001|Overall Study|Adverse Event|1|||
27904306|NCT01340209|54561163|FG002|Overall Study|Adverse Event|2|||
27904307|NCT01340209|54561161|FG000|Overall Study|Protocol Violation|1|||
27904308|NCT01340209|54561162|FG001|Overall Study|Protocol Violation|2|||
27904309|NCT01340209|54561163|FG002|Overall Study|Protocol Violation|1|||
27904310|NCT01340209|54561161|FG000|Overall Study|Withdrawal by Subject|0|||
27904311|NCT01340209|54561162|FG001|Overall Study|Withdrawal by Subject|0|||
27904312|NCT01340209|54561163|FG002|Overall Study|Withdrawal by Subject|1|||
27988220|NCT00710866|54646974|FG001|Overall Study|Withdrawal by Subject|1|||
27988221|NCT00710866|54646973|FG000|Overall Study|Lost to Follow-up|1|||
27988222|NCT00710866|54646974|FG001|Overall Study|Lost to Follow-up|0|||
27904313|NCT01340209|54561161|FG000|Overall Study|Other reason not defined above|3|||
27904314|NCT01340209|54561162|FG001|Overall Study|Other reason not defined above|5|||
27904315|NCT01340209|54561163|FG002|Overall Study|Other reason not defined above|4|||
27904316|NCT01326910|54561173|FG000|Overall Study|Withdrawal by Subject|3|||
27904317|NCT01326910|54561174|FG001|Overall Study|Withdrawal by Subject|2|||
27904318|NCT01326910|54561173|FG000|Overall Study|Protocol Violation|1|||
27904319|NCT01326910|54561174|FG001|Overall Study|Protocol Violation|1|||
27904320|NCT01326481|54561180|FG000|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1|||
27904321|NCT01325701|54561188|FG000|Overall Study|Adverse Event|12|||
27904322|NCT01325701|54561189|FG001|Overall Study|Adverse Event|0|||
27904323|NCT01325701|54561188|FG000|Overall Study|Protocol Violation|1|||
27904324|NCT01325701|54561189|FG001|Overall Study|Protocol Violation|0|||
27904325|NCT01325701|54561188|FG000|Overall Study|Physician Decision|2|||
27904326|NCT01325701|54561189|FG001|Overall Study|Physician Decision|2|||
27904327|NCT01325701|54561188|FG000|Overall Study|Withdrawal by Subject|2|||
27904328|NCT01325701|54561189|FG001|Overall Study|Withdrawal by Subject|1|||
27904329|NCT01325701|54561188|FG000|Overall Study|Rollerover Extension Study|4|||
27904330|NCT01325701|54561189|FG001|Overall Study|Rollerover Extension Study|0|||
27904331|NCT01325623|54561196|FG000|Overall Study|Withdrawal by Subject|3|||
27904332|NCT01325584|54561233|FG000|Overall Study|Death|1|||
27904333|NCT01325428|54561237|FG000|Part A|Progressive disease according to RECIST|9|||
27904334|NCT01325428|54561237|FG000|Part A|Clinical signs, symptoms of progression|2|||
27904335|NCT01325428|54561237|FG000|Part A|Other adverse event|1|||
27904336|NCT01325428|54561237|FG000|Part A|Refused continue taking trial medication|2|||
27904337|NCT01325428|54561237|FG000|Part A|Other reason not defined above|2|||
27904338|NCT01325428|54561237|FG000|Part B|Refused continue taking trial medication|2|||
27904339|NCT01325428|54561237|FG000|Part B|Other reason not defined above|1|||
27904340|NCT01325350|54561251|FG000|Overall Study|Adverse Event|3|||
27904341|NCT01325350|54561252|FG001|Overall Study|Adverse Event|3|||
27904342|NCT01325350|54561253|FG002|Overall Study|Adverse Event|3|||
27904343|NCT01325350|54561254|FG003|Overall Study|Adverse Event|1|||
27904344|NCT01325350|54561255|FG004|Overall Study|Adverse Event|2|||
27904345|NCT01325350|54561251|FG000|Overall Study|Pregnancy|0|||
27904346|NCT01325350|54561252|FG001|Overall Study|Pregnancy|0|||
27904347|NCT01325350|54561253|FG002|Overall Study|Pregnancy|1|||
27904348|NCT01325350|54561254|FG003|Overall Study|Pregnancy|0|||
27904349|NCT01325350|54561255|FG004|Overall Study|Pregnancy|1|||
27904350|NCT01325350|54561251|FG000|Overall Study|Lost to Follow-up|1|||
27904351|NCT01325350|54561252|FG001|Overall Study|Lost to Follow-up|0|||
27904352|NCT01325350|54561253|FG002|Overall Study|Lost to Follow-up|5|||
27904353|NCT01325350|54561254|FG003|Overall Study|Lost to Follow-up|1|||
27904354|NCT01325350|54561255|FG004|Overall Study|Lost to Follow-up|5|||
27904355|NCT01325350|54561251|FG000|Overall Study|Personal Reasons|2|||
27904356|NCT01325350|54561252|FG001|Overall Study|Personal Reasons|1|||
27904357|NCT01325350|54561253|FG002|Overall Study|Personal Reasons|6|||
27904358|NCT01325350|54561254|FG003|Overall Study|Personal Reasons|5|||
27988223|NCT00710866|54646973|FG000|Overall Study|Failed to meet eligibility|1|||
27988224|NCT00710866|54646974|FG001|Overall Study|Failed to meet eligibility|1|||
27904359|NCT01325350|54561255|FG004|Overall Study|Personal Reasons|3|||
27904360|NCT01325350|54561251|FG000|Overall Study|Protocol Violation|0|||
27904361|NCT01325350|54561252|FG001|Overall Study|Protocol Violation|0|||
27904362|NCT01325350|54561253|FG002|Overall Study|Protocol Violation|0|||
27904363|NCT01325350|54561254|FG003|Overall Study|Protocol Violation|1|||
27904364|NCT01325350|54561255|FG004|Overall Study|Protocol Violation|0|||
27904365|NCT01325350|54561251|FG000|Overall Study|Withdrawal by Subject|0|||
27904366|NCT01325350|54561252|FG001|Overall Study|Withdrawal by Subject|0|||
27904367|NCT01325350|54561253|FG002|Overall Study|Withdrawal by Subject|1|||
27904368|NCT01325350|54561254|FG003|Overall Study|Withdrawal by Subject|1|||
27904369|NCT01325350|54561255|FG004|Overall Study|Withdrawal by Subject|0|||
27904370|NCT01325350|54561251|FG000|Overall Study|Did Not Receive Treatment|0|||
27904371|NCT01325350|54561252|FG001|Overall Study|Did Not Receive Treatment|1|||
27904372|NCT01325350|54561253|FG002|Overall Study|Did Not Receive Treatment|1|||
27904373|NCT01325350|54561254|FG003|Overall Study|Did Not Receive Treatment|0|||
27904374|NCT01325350|54561255|FG004|Overall Study|Did Not Receive Treatment|1|||
27904375|NCT01324999|54561267|FG000|Overall Study|Adverse Event|3|||
27904376|NCT01324999|54561267|FG000|Overall Study|Withdrawal by Subject|2|||
27904377|NCT01324570|54561273|FG000|Overall Study|Adverse Event|4|||
27904378|NCT01324570|54561274|FG001|Overall Study|Adverse Event|7|||
27988225|NCT00827775|54646991|FG000|Overall Study|Withdrawal by Subject|0|||
27988226|NCT00827775|54646992|FG001|Overall Study|Withdrawal by Subject|5|||
27988227|NCT00827541|54647000|FG000|Overall Study|Exitus|1|||
27988228|NCT00827541|54647001|FG001|Overall Study|Exitus|8|||
27988229|NCT00827541|54647000|FG000|Overall Study|Other|1|||
27988230|NCT00827541|54647001|FG001|Overall Study|Other|3|||
27988231|NCT00827541|54647000|FG000|Overall Study|Pathogen not susceptible|1|||
27988232|NCT00827541|54647001|FG001|Overall Study|Pathogen not susceptible|0|||
27988233|NCT00827541|54647000|FG000|Overall Study|Lack of effectiveness|1|||
27988234|NCT00827541|54647001|FG001|Overall Study|Lack of effectiveness|0|||
27988235|NCT00518323|54647011|FG000|Overall Study|Lack of Efficacy|14|||
27988236|NCT00518323|54647012|FG001|Overall Study|Lack of Efficacy|2|||
27988237|NCT00518323|54647013|FG002|Overall Study|Lack of Efficacy|4|||
27988238|NCT00518323|54647014|FG003|Overall Study|Lack of Efficacy|20|||
27988239|NCT00518323|54647011|FG000|Overall Study|Withdrawal by Subject|1|||
27988240|NCT00518323|54647012|FG001|Overall Study|Withdrawal by Subject|2|||
27988241|NCT00518323|54647013|FG002|Overall Study|Withdrawal by Subject|4|||
27988242|NCT00518323|54647014|FG003|Overall Study|Withdrawal by Subject|2|||
27988243|NCT00518323|54647011|FG000|Overall Study|Lost to Follow-up|0|||
27988244|NCT00518323|54647012|FG001|Overall Study|Lost to Follow-up|2|||
27988245|NCT00518323|54647013|FG002|Overall Study|Lost to Follow-up|1|||
27988246|NCT00518323|54647014|FG003|Overall Study|Lost to Follow-up|3|||
27988247|NCT00518323|54647011|FG000|Overall Study|Adverse Event|1|||
27988248|NCT00518323|54647012|FG001|Overall Study|Adverse Event|1|||
27988249|NCT00518323|54647013|FG002|Overall Study|Adverse Event|1|||
27988250|NCT00518323|54647014|FG003|Overall Study|Adverse Event|0|||
27988251|NCT00518323|54647011|FG000|Overall Study|Prohibited medication and others|3|||
27988252|NCT00518323|54647012|FG001|Overall Study|Prohibited medication and others|1|||
27988253|NCT00518323|54647013|FG002|Overall Study|Prohibited medication and others|1|||
27988254|NCT00518323|54647014|FG003|Overall Study|Prohibited medication and others|0|||
27988255|NCT00826449|54647026|FG000|Overall Study|Disease Progression|4|||
27988256|NCT00826449|54647026|FG000|Overall Study|Withdrawal by Subject|1|||
27988257|NCT00825825|54647031|FG000|First Medication Period (14 Days)|Adverse Event|1|||
27988258|NCT00825825|54647032|FG001|First Medication Period (14 Days)|Adverse Event|0|||
27988259|NCT00825825|54647033|FG002|First Medication Period (14 Days)|Adverse Event|0|||
27988260|NCT00825825|54647034|FG003|First Medication Period (14 Days)|Adverse Event|0|||
27988261|NCT00825825|54647035|FG004|First Medication Period (14 Days)|Adverse Event|0|||
27988262|NCT00825825|54647036|FG005|First Medication Period (14 Days)|Adverse Event|1|||
27988263|NCT00825825|54647031|FG000|First Medication Period (14 Days)|Physician Decision|2|||
27988264|NCT00825825|54647032|FG001|First Medication Period (14 Days)|Physician Decision|0|||
27988265|NCT00825825|54647033|FG002|First Medication Period (14 Days)|Physician Decision|1|||
27904379|NCT01324570|54561273|FG000|Overall Study|Withdrawal by Subject|0|||
27904380|NCT01324570|54561274|FG001|Overall Study|Withdrawal by Subject|3|||
27904381|NCT01324570|54561273|FG000|Overall Study|Lack of Efficacy|0|||
27904382|NCT01324570|54561274|FG001|Overall Study|Lack of Efficacy|1|||
27904383|NCT01324570|54561273|FG000|Overall Study|Confirmed or suspected diversion|0|||
27904384|NCT01324570|54561274|FG001|Overall Study|Confirmed or suspected diversion|1|||
27904385|NCT01324570|54561273|FG000|Overall Study|Administrative|0|||
27904386|NCT01324570|54561274|FG001|Overall Study|Administrative|2|||
27904387|NCT01324141|54561282|FG000|Overall Study|Declined to participate before treatment started|1|||
27904388|NCT01324141|54561282|FG000|Overall Study|Disease progression on study|1|||
27904389|NCT01324102|54561298|FG000|Overall Study|illness|1|||
27904390|NCT01324102|54561299|FG001|Overall Study|illness|6|||
27904391|NCT01324024|54561306|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
27904392|NCT01324024|54561307|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
27904393|NCT01323946|54561320|FG000|Overall Study|Lost to Follow-up|0|||
27904394|NCT01323946|54561321|FG001|Overall Study|Lost to Follow-up|1|||
27988266|NCT00825825|54647034|FG003|First Medication Period (14 Days)|Physician Decision|0|||
27988267|NCT00825825|54647035|FG004|First Medication Period (14 Days)|Physician Decision|0|||
27988268|NCT00825825|54647036|FG005|First Medication Period (14 Days)|Physician Decision|1|||
27988269|NCT00825825|54647031|FG000|Second Medication Period (14 Days)|Physician Decision|1|||
27988270|NCT00825825|54647032|FG001|Second Medication Period (14 Days)|Physician Decision|0|||
27988271|NCT00825825|54647033|FG002|Second Medication Period (14 Days)|Physician Decision|0|||
27988272|NCT00825825|54647034|FG003|Second Medication Period (14 Days)|Physician Decision|2|||
27739577|NCT02738879|54189191|FG000|Overall Study|Screen Failure|1|||
27739578|NCT02738879|54189192|FG001|Overall Study|Screen Failure|2|||
27904395|NCT01323946|54561322|FG002|Overall Study|Lost to Follow-up|0|||
27904396|NCT01323946|54561320|FG000|Overall Study|Parents refused the last blood draw|1|||
27904397|NCT01323946|54561321|FG001|Overall Study|Parents refused the last blood draw|0|||
27988273|NCT00825825|54647035|FG004|Second Medication Period (14 Days)|Physician Decision|0|||
27988274|NCT00825825|54647036|FG005|Second Medication Period (14 Days)|Physician Decision|0|||
27988275|NCT00825825|54647031|FG000|Second Medication Period (14 Days)|Protocol Violation|1|||
27988276|NCT00825825|54647032|FG001|Second Medication Period (14 Days)|Protocol Violation|0|||
27988277|NCT00825825|54647033|FG002|Second Medication Period (14 Days)|Protocol Violation|0|||
27988278|NCT00825825|54647034|FG003|Second Medication Period (14 Days)|Protocol Violation|0|||
27988279|NCT00825825|54647035|FG004|Second Medication Period (14 Days)|Protocol Violation|1|||
27904398|NCT01323946|54561322|FG002|Overall Study|Parents refused the last blood draw|0|||
27904399|NCT01323946|54561320|FG000|Overall Study|Withdrawal by Subject|2|||
27904400|NCT01323946|54561321|FG001|Overall Study|Withdrawal by Subject|2|||
27904401|NCT01323946|54561322|FG002|Overall Study|Withdrawal by Subject|0|||
27904402|NCT01323790|54561335|FG000|Overall Study|Other|3|||
27904403|NCT01323790|54561336|FG001|Overall Study|Other|2|||
27904404|NCT01323790|54561337|FG002|Overall Study|Other|1|||
27904405|NCT01323790|54561335|FG000|Overall Study|Lost to Follow-up|11|||
27988280|NCT00825825|54647036|FG005|Second Medication Period (14 Days)|Protocol Violation|0|||
27988281|NCT00825825|54647031|FG000|Third Medication Period (14 Days)|Adverse Event|0|||
27988282|NCT00825825|54647032|FG001|Third Medication Period (14 Days)|Adverse Event|1|||
27988283|NCT00825825|54647033|FG002|Third Medication Period (14 Days)|Adverse Event|0|||
27988284|NCT00825825|54647034|FG003|Third Medication Period (14 Days)|Adverse Event|0|||
27988285|NCT00825825|54647035|FG004|Third Medication Period (14 Days)|Adverse Event|0|||
27988286|NCT00825825|54647036|FG005|Third Medication Period (14 Days)|Adverse Event|0|||
27988287|NCT00825825|54647031|FG000|Third Medication Period (14 Days)|Protocol Violation|0|||
27988288|NCT00825825|54647032|FG001|Third Medication Period (14 Days)|Protocol Violation|0|||
27988289|NCT00825825|54647033|FG002|Third Medication Period (14 Days)|Protocol Violation|0|||
27988290|NCT00825825|54647034|FG003|Third Medication Period (14 Days)|Protocol Violation|0|||
27988291|NCT00825825|54647035|FG004|Third Medication Period (14 Days)|Protocol Violation|0|||
27988292|NCT00825825|54647036|FG005|Third Medication Period (14 Days)|Protocol Violation|2|||
27988293|NCT00825825|54647031|FG000|Third Medication Period (14 Days)|poor data quality|0|||
27988294|NCT00825825|54647032|FG001|Third Medication Period (14 Days)|poor data quality|1|||
27988295|NCT00825825|54647033|FG002|Third Medication Period (14 Days)|poor data quality|0|||
27988296|NCT00825825|54647034|FG003|Third Medication Period (14 Days)|poor data quality|0|||
27988297|NCT00825825|54647035|FG004|Third Medication Period (14 Days)|poor data quality|0|||
27988298|NCT00825825|54647036|FG005|Third Medication Period (14 Days)|poor data quality|0|||
27988299|NCT00710710|54647045|FG000|Overall Study|Consent withdrawn|2|||
27988300|NCT00710710|54647046|FG001|Overall Study|Consent withdrawn|2|||
27988301|NCT00710710|54647045|FG000|Overall Study|Protocol Violation|0|||
27988302|NCT00710710|54647046|FG001|Overall Study|Protocol Violation|1|||
27988303|NCT00710710|54647045|FG000|Overall Study|Adverse Event|3|||
27988304|NCT00710710|54647046|FG001|Overall Study|Adverse Event|3|||
27988305|NCT00710710|54647045|FG000|Overall Study|Progressive disease|40|||
27988306|NCT00710710|54647046|FG001|Overall Study|Progressive disease|38|||
27988307|NCT00880334|54647054|FG000|Randomized Phase|Physician Decision|1|||
27988308|NCT00880334|54647055|FG001|Randomized Phase|Physician Decision|0|||
27988309|NCT00880334|54647054|FG000|Randomized Phase|Withdrawal by Subject|2|||
27988310|NCT00880334|54647055|FG001|Randomized Phase|Withdrawal by Subject|1|||
27988311|NCT00880334|54647054|FG000|Randomized Phase|Inadequate Labs|1|||
27988312|NCT00880334|54647055|FG001|Randomized Phase|Inadequate Labs|1|||
27988313|NCT00880334|54647054|FG000|Randomized Phase|Brain Metastasis|0|||
27988314|NCT00880334|54647055|FG001|Randomized Phase|Brain Metastasis|1|||
27988315|NCT00880334|54647054|FG000|Randomized Phase|Crossover Participants|0|||
27988316|NCT00880334|54647055|FG001|Randomized Phase|Crossover Participants|37|||
27988317|NCT00865566|54647071|FG000|Overall Study|Death|1|||
27988318|NCT00865566|54647072|FG001|Overall Study|Death|11|||
27988319|NCT00865566|54647071|FG000|Overall Study|Lost to Follow-up|314|||
27988320|NCT00865566|54647072|FG001|Overall Study|Lost to Follow-up|315|||
27988321|NCT00865566|54647071|FG000|Overall Study|Withdrawal by Subject|45|||
27988322|NCT00865566|54647072|FG001|Overall Study|Withdrawal by Subject|65|||
27988323|NCT00865566|54647071|FG000|Overall Study|Physician Decision|0|||
27988324|NCT00865566|54647072|FG001|Overall Study|Physician Decision|1|||
27988325|NCT00865566|54647071|FG000|Overall Study|Participant relocated|78|||
27988326|NCT00865566|54647072|FG001|Overall Study|Participant relocated|107|||
27988327|NCT00865566|54647071|FG000|Overall Study|Participant unable to adhere|27|||
27988328|NCT00865566|54647072|FG001|Overall Study|Participant unable to adhere|42|||
28097483|NCT02955212|54753145|FG000|Period 2: Open-label Extension|Adverse Event|11|||
28097484|NCT02955212|54753146|FG001|Period 2: Open-label Extension|Adverse Event|7|||
27988329|NCT00865566|54647071|FG000|Overall Study|Other; N=245 due to early study closure|154|||
28097485|NCT02955212|54753145|FG000|Period 2: Open-label Extension|Withdrawal by Subject|1|||
28097486|NCT02955212|54753146|FG001|Period 2: Open-label Extension|Withdrawal by Subject|4|||
28097487|NCT02955212|54753145|FG000|Period 2: Open-label Extension|Lack of Efficacy|3|||
28097488|NCT02955212|54753146|FG001|Period 2: Open-label Extension|Lack of Efficacy|2|||
27904406|NCT01323790|54561336|FG001|Overall Study|Lost to Follow-up|9|||
27904407|NCT01323790|54561337|FG002|Overall Study|Lost to Follow-up|9|||
27988330|NCT00865566|54647072|FG001|Overall Study|Other; N=245 due to early study closure|139|||
27988331|NCT00865566|54647071|FG000|Overall Study|HIV infection|5|||
27988332|NCT00865566|54647072|FG001|Overall Study|HIV infection|7|||
27988333|NCT03866473|54647080|FG000|Phase 1|Death|1|||
27988334|NCT03866473|54647081|FG001|Phase 1|Death|0|||
27988335|NCT03866473|54647080|FG000|Phase 2|Death|0|||
27988336|NCT03866473|54647081|FG001|Phase 2|Death|2|||
27988337|NCT03866473|54647080|FG000|Phase 2|Dropped|1|||
27988338|NCT03866473|54647081|FG001|Phase 2|Dropped|1|||
27988339|NCT03866473|54647080|FG000|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|1|||
27988340|NCT03866473|54647081|FG001|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|0|||
27988341|NCT00525499|54647095|FG000|Overall Study|Lost to Follow-up|2|||
27988342|NCT00525499|54647096|FG001|Overall Study|Lost to Follow-up|4|||
27988343|NCT00525499|54647097|FG002|Overall Study|Lost to Follow-up|1|||
27988344|NCT00525499|54647098|FG003|Overall Study|Lost to Follow-up|4|||
27988345|NCT00525499|54647095|FG000|Overall Study|Adverse Event|0|||
27988346|NCT00525499|54647096|FG001|Overall Study|Adverse Event|1|||
27988347|NCT00525499|54647097|FG002|Overall Study|Adverse Event|0|||
27988348|NCT00525499|54647098|FG003|Overall Study|Adverse Event|1|||
27988349|NCT00525499|54647095|FG000|Overall Study|Withdrawal by Subject|5|||
27988350|NCT00525499|54647096|FG001|Overall Study|Withdrawal by Subject|1|||
27988351|NCT00525499|54647097|FG002|Overall Study|Withdrawal by Subject|5|||
27988352|NCT00525499|54647098|FG003|Overall Study|Withdrawal by Subject|2|||
27988353|NCT00525499|54647095|FG000|Overall Study|Protocol Violation|0|||
27988354|NCT00525499|54647096|FG001|Overall Study|Protocol Violation|1|||
27988355|NCT00525499|54647097|FG002|Overall Study|Protocol Violation|1|||
27988356|NCT00525499|54647098|FG003|Overall Study|Protocol Violation|0|||
27988357|NCT00824655|54647110|FG000|Toddler Dose (12 Months of Age)|Adverse Event|1|||
27988358|NCT00824655|54647111|FG001|Toddler Dose (12 Months of Age)|Adverse Event|0|||
27988359|NCT00824655|54647110|FG000|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1|||
27988360|NCT00824655|54647111|FG001|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0|||
27988361|NCT00525265|54647121|FG000|Overall Study|Protocol Violation|1|||
27988362|NCT00525265|54647122|FG001|Overall Study|Protocol Violation|0|||
27904408|NCT01323790|54561335|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
27904409|NCT01323790|54561336|FG001|Overall Study|Study-Specific Withdrawal Criteria|3|||
27904410|NCT01323790|54561337|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
27904411|NCT01323790|54561335|FG000|Overall Study|Lack of Efficacy|3|||
27904412|NCT01323790|54561336|FG001|Overall Study|Lack of Efficacy|0|||
27904413|NCT01323790|54561337|FG002|Overall Study|Lack of Efficacy|3|||
27904414|NCT01323790|54561335|FG000|Overall Study|Adverse Event|11|||
27904415|NCT01323790|54561336|FG001|Overall Study|Adverse Event|24|||
27904416|NCT01323790|54561337|FG002|Overall Study|Adverse Event|12|||
27904417|NCT01323790|54561335|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
27904418|NCT01323790|54561336|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
27904419|NCT01323790|54561337|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
27904420|NCT01323790|54561335|FG000|Overall Study|Withdrawal by Subject|23|||
27904421|NCT01323790|54561336|FG001|Overall Study|Withdrawal by Subject|20|||
27904422|NCT01323790|54561337|FG002|Overall Study|Withdrawal by Subject|13|||
27904423|NCT01323790|54561335|FG000|Overall Study|Did Not Receive Treatment|2|||
27904424|NCT01323790|54561336|FG001|Overall Study|Did Not Receive Treatment|0|||
27904425|NCT01323790|54561337|FG002|Overall Study|Did Not Receive Treatment|1|||
27904426|NCT01323790|54561335|FG000|Overall Study|Severe non-compliance with protocol|2|||
27904427|NCT01323790|54561336|FG001|Overall Study|Severe non-compliance with protocol|2|||
27904428|NCT01323790|54561337|FG002|Overall Study|Severe non-compliance with protocol|2|||
27904429|NCT01323673|54561347|FG000|Overall Study|Adverse Event|0|||
27904430|NCT01323673|54561348|FG001|Overall Study|Adverse Event|1|||
27904431|NCT01323673|54561347|FG000|Overall Study|Lost to Follow-up|0|||
27904432|NCT01323673|54561348|FG001|Overall Study|Lost to Follow-up|1|||
27904433|NCT01323673|54561347|FG000|Overall Study|Protocol Violation|1|||
27904434|NCT01323673|54561348|FG001|Overall Study|Protocol Violation|0|||
27904435|NCT01323673|54561347|FG000|Overall Study|Withdrawal by Subject|2|||
27904436|NCT01323673|54561348|FG001|Overall Study|Withdrawal by Subject|3|||
27904437|NCT01323634|54561356|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125|||
27904438|NCT01323634|54561357|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
27988363|NCT00880256|54647128|FG000|Overall Study|Lost to Follow-up|28|||
27988364|NCT03865381|54647137|FG000|Overall Study|Protocol Violation/Non-Compliance|3|||
27988365|NCT03865381|54647137|FG000|Overall Study|Withdrawal by Subject|2|||
27988366|NCT00865098|54647141|FG000|Overall Study|Progressive disease|1|||
27988367|NCT00880100|54647145|FG000|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1|||
27988368|NCT00880100|54647145|FG000|Treatment Phase With Ultrase® MT12|Adverse Event|1|||
27904439|NCT01323634|54561358|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
27904440|NCT01323634|54561356|FG000|2-week Run-in Period|Continuation Criteria not Met|73|||
27925790|NCT01226745|54582367|FG000|Overall Study|Other|6|||
27988369|NCT00880100|54647145|FG000|Treatment Phase With Ultrase® MT12|Protocol Violation|2|||
27988370|NCT00518011|54647151|FG000|Overall Study|Death|1|||
27904441|NCT01323634|54561357|FG001|2-week Run-in Period|Continuation Criteria not Met|0|||
27904442|NCT01323634|54561358|FG002|2-week Run-in Period|Continuation Criteria not Met|0|||
27904443|NCT01323634|54561356|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
27904444|NCT01323634|54561357|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
27904445|NCT01323634|54561358|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
27904446|NCT01323634|54561356|FG000|2-week Run-in Period|Physician Decision|5|||
27904447|NCT01323634|54561357|FG001|2-week Run-in Period|Physician Decision|0|||
27904448|NCT01323634|54561358|FG002|2-week Run-in Period|Physician Decision|0|||
27904449|NCT01323634|54561356|FG000|2-week Run-in Period|Protocol Violation|1|||
27904450|NCT01323634|54561357|FG001|2-week Run-in Period|Protocol Violation|0|||
27904451|NCT01323634|54561358|FG002|2-week Run-in Period|Protocol Violation|0|||
27904452|NCT01323634|54561356|FG000|2-week Run-in Period|Adverse Event|1|||
27904453|NCT01323634|54561357|FG001|2-week Run-in Period|Adverse Event|0|||
27904454|NCT01323634|54561358|FG002|2-week Run-in Period|Adverse Event|0|||
27904455|NCT01323634|54561356|FG000|Double-Blind (DB) Treatment Period|Adverse Event|0|||
27904456|NCT01323634|54561357|FG001|Double-Blind (DB) Treatment Period|Adverse Event|8|||
27904457|NCT01323634|54561358|FG002|Double-Blind (DB) Treatment Period|Adverse Event|4|||
27904458|NCT01323634|54561356|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
27904459|NCT01323634|54561357|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
27904460|NCT01323634|54561358|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
27904461|NCT01323634|54561356|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
27904462|NCT01323634|54561357|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|6|||
27904463|NCT01323634|54561358|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|7|||
27904464|NCT01323634|54561356|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
27904465|NCT01323634|54561357|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
27904466|NCT01323634|54561358|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
27904467|NCT01323634|54561356|FG000|Double-Blind (DB) Treatment Period|Physician Decision|0|||
27904468|NCT01323634|54561357|FG001|Double-Blind (DB) Treatment Period|Physician Decision|2|||
27904469|NCT01323634|54561358|FG002|Double-Blind (DB) Treatment Period|Physician Decision|3|||
27904470|NCT01323634|54561356|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
27904471|NCT01323634|54561357|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7|||
27904472|NCT01323634|54561358|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4|||
27904473|NCT01323634|54561356|FG000|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0|||
27904474|NCT01323634|54561357|FG001|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
27904475|NCT01323634|54561358|FG002|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
27904476|NCT01323478|54561364|FG000|Overall Study|Adverse Event|7|||
27904477|NCT01323478|54561364|FG000|Overall Study|Lack of Efficacy|4|||
27904478|NCT01323478|54561364|FG000|Overall Study|Non-compliance With Study Product|3|||
27904479|NCT01323478|54561364|FG000|Overall Study|Protocol Violation|1|||
27904480|NCT01323478|54561364|FG000|Overall Study|Withdrawal of Consent|1|||
27904481|NCT01323478|54561364|FG000|Overall Study|Administrative or Other Reasons|8|||
27904482|NCT01322386|54561370|FG000|Overall Study|Protocol Violation|0|||
27904483|NCT01322386|54561371|FG001|Overall Study|Protocol Violation|1|||
27904484|NCT01322386|54561370|FG000|Overall Study|Physician Decision|0|||
27904485|NCT01322386|54561371|FG001|Overall Study|Physician Decision|1|||
27904486|NCT01322347|54561381|FG000|Overall Study|Adverse Event|7|||
27904487|NCT01322347|54561382|FG001|Overall Study|Adverse Event|2|||
27904488|NCT01322347|54561381|FG000|Overall Study|Death|5|||
27904489|NCT01322347|54561382|FG001|Overall Study|Death|3|||
27904490|NCT01322347|54561381|FG000|Overall Study|Physician Decision|2|||
27904491|NCT01322347|54561382|FG001|Overall Study|Physician Decision|1|||
27904492|NCT01322347|54561381|FG000|Overall Study|Protocol Violation|5|||
27904493|NCT01322347|54561382|FG001|Overall Study|Protocol Violation|2|||
27988371|NCT00518011|54647152|FG001|Overall Study|Death|1|||
27988372|NCT00518011|54647151|FG000|Overall Study|Adverse Event|2|||
27988373|NCT00518011|54647152|FG001|Overall Study|Adverse Event|3|||
27988374|NCT00518011|54647151|FG000|Overall Study|Disease Progression|2|||
27988375|NCT00518011|54647152|FG001|Overall Study|Disease Progression|2|||
27988376|NCT00518011|54647151|FG000|Overall Study|Other Reasons|3|||
27988377|NCT00518011|54647152|FG001|Overall Study|Other Reasons|2|||
27988378|NCT00518011|54647151|FG000|Overall Study|Withdrawal by Subject|1|||
27988379|NCT00518011|54647152|FG001|Overall Study|Withdrawal by Subject|0|||
27988380|NCT00865020|54647161|FG000|Overall Study|Withdrawal by Subject|22|||
27904494|NCT01322347|54561381|FG000|Overall Study|Withdrawal by Subject|1|||
27904495|NCT01322347|54561382|FG001|Overall Study|Withdrawal by Subject|4|||
27904496|NCT01322347|54561381|FG000|Overall Study|non-protocol change to ESA or IV iron|14|||
27904497|NCT01322347|54561382|FG001|Overall Study|non-protocol change to ESA or IV iron|6|||
27904498|NCT01322347|54561381|FG000|Overall Study|blood transfusion|5|||
27904499|NCT01322347|54561382|FG001|Overall Study|blood transfusion|5|||
27988381|NCT00865020|54647162|FG001|Overall Study|Withdrawal by Subject|16|||
27988382|NCT00865020|54647161|FG000|Overall Study|Adverse Event|9|||
27904500|NCT01322347|54561381|FG000|Overall Study|sponsor decision|1|||
27904501|NCT01322347|54561382|FG001|Overall Study|sponsor decision|3|||
27988383|NCT00865020|54647162|FG001|Overall Study|Adverse Event|14|||
27988384|NCT00865020|54647161|FG000|Overall Study|Abnormal test procedure result(s)|6|||
27988385|NCT00865020|54647162|FG001|Overall Study|Abnormal test procedure result(s)|8|||
27988386|NCT00865020|54647161|FG000|Overall Study|Lost to Follow-up|6|||
27988387|NCT00865020|54647162|FG001|Overall Study|Lost to Follow-up|4|||
27988388|NCT00865020|54647161|FG000|Overall Study|Protocol deviation|4|||
27988389|NCT00865020|54647162|FG001|Overall Study|Protocol deviation|1|||
27988390|NCT00865020|54647161|FG000|Overall Study|Administrative problems|0|||
27988391|NCT00865020|54647162|FG001|Overall Study|Administrative problems|2|||
27988392|NCT00865020|54647161|FG000|Overall Study|Abnormal laboratory value(s)|0|||
27988393|NCT00865020|54647162|FG001|Overall Study|Abnormal laboratory value(s)|1|||
27988394|NCT00865020|54647161|FG000|Overall Study|Death|0|||
27988395|NCT00865020|54647162|FG001|Overall Study|Death|1|||
27988396|NCT00865020|54647161|FG000|Overall Study|Randomized but discontinued|2|||
27988397|NCT00865020|54647162|FG001|Overall Study|Randomized but discontinued|4|||
27988398|NCT00517933|54647170|FG000|Period 1|Death|2|||
27988399|NCT00517933|54647171|FG001|Period 1|Death|1|||
27988400|NCT00517933|54647170|FG000|Period 1|Adverse Event|4|||
27988401|NCT00517933|54647171|FG001|Period 1|Adverse Event|4|||
27988402|NCT00517933|54647170|FG000|Period 1|Lost to Follow-up|2|||
27904502|NCT01322347|54561381|FG000|Overall Study|ineligible|6|||
27904503|NCT01322347|54561382|FG001|Overall Study|ineligible|3|||
28172312|NCT02407054|54843964|FG000|Overall Study|Non-compliance with Study|0|||
28172313|NCT02407054|54843965|FG001|Overall Study|Non-compliance with Study|2|||
28172314|NCT02407054|54843966|FG002|Overall Study|Non-compliance with Study|1|||
28172315|NCT02407054|54843964|FG000|Overall Study|Physician Decision|1|||
28172316|NCT02407054|54843965|FG001|Overall Study|Physician Decision|3|||
28172317|NCT02407054|54843966|FG002|Overall Study|Physician Decision|3|||
28172318|NCT02407054|54843964|FG000|Overall Study|Withdrawal by Subject|5|||
28172319|NCT02407054|54843965|FG001|Overall Study|Withdrawal by Subject|9|||
28172320|NCT02407054|54843966|FG002|Overall Study|Withdrawal by Subject|2|||
28172321|NCT01652716|54843977|FG000|Overall Study|Loss of glucose control|1|||
28172322|NCT01652716|54843978|FG001|Overall Study|Loss of glucose control|0|||
28172323|NCT01652716|54843977|FG000|Overall Study|Administrative|0|||
28172324|NCT01652716|54843978|FG001|Overall Study|Administrative|2|||
28172325|NCT01652716|54843977|FG000|Overall Study|Investigator decision|1|||
28172326|NCT01652716|54843978|FG001|Overall Study|Investigator decision|4|||
28172327|NCT01652716|54843977|FG000|Overall Study|Lost to Follow-up|12|||
27904504|NCT01322347|54561381|FG000|Overall Study|kidney transplant|3|||
27904505|NCT01322347|54561382|FG001|Overall Study|kidney transplant|1|||
27904506|NCT01322347|54561381|FG000|Overall Study|study drug withheld > 12 wks|0|||
27904507|NCT01322347|54561382|FG001|Overall Study|study drug withheld > 12 wks|1|||
27904508|NCT01322347|54561381|FG000|Overall Study|moved/changed dialysis|2|||
27904509|NCT01322347|54561382|FG001|Overall Study|moved/changed dialysis|4|||
27904510|NCT01321879|54561389|FG000|Overall Study|Lack of Efficacy|5|||
27904511|NCT01321879|54561389|FG000|Overall Study|Adverse Event|5|||
27904512|NCT01321879|54561389|FG000|Overall Study|Death|3|||
27988403|NCT00517933|54647171|FG001|Period 1|Lost to Follow-up|0|||
27988404|NCT00517933|54647170|FG000|Period 1|Underwent lung transplant|0|||
27988405|NCT00517933|54647171|FG001|Period 1|Underwent lung transplant|1|||
27988406|NCT00517933|54647170|FG000|Period 2|Death|2|||
27988407|NCT00517933|54647171|FG001|Period 2|Death|4|||
27988408|NCT00517933|54647170|FG000|Period 2|Adverse Event|2|||
27988409|NCT00517933|54647171|FG001|Period 2|Adverse Event|4|||
27988410|NCT00517933|54647170|FG000|Period 2|Physician Decision|1|||
27988411|NCT00517933|54647171|FG001|Period 2|Physician Decision|0|||
27988412|NCT00517933|54647170|FG000|Period 2|Withdrawal by Subject|1|||
27988413|NCT00517933|54647171|FG001|Period 2|Withdrawal by Subject|3|||
27904513|NCT01321879|54561389|FG000|Overall Study|Withdrawal by Subject|1|||
27904514|NCT01321723|54561396|FG000|Overall Study|Adverse Event|3|||
27904515|NCT01321723|54561397|FG001|Overall Study|Adverse Event|5|||
27904516|NCT01321723|54561398|FG002|Overall Study|Adverse Event|2|||
27904517|NCT01321723|54561396|FG000|Overall Study|Withdrawal by Subject|2|||
27904518|NCT01321723|54561397|FG001|Overall Study|Withdrawal by Subject|0|||
27904519|NCT01321723|54561398|FG002|Overall Study|Withdrawal by Subject|2|||
27904520|NCT01321606|54561408|FG000|Overall Study|Lost to Follow-up|0|||
27904521|NCT01321606|54561409|FG001|Overall Study|Lost to Follow-up|0|||
27904522|NCT01321606|54561410|FG002|Overall Study|Lost to Follow-up|0|||
27988414|NCT00517933|54647170|FG000|Period 2|Underwent lung transplant|0|||
27988415|NCT00517933|54647171|FG001|Period 2|Underwent lung transplant|2|||
27988416|NCT00701038|54647182|FG000|Overall Study|study amended pilot group of patients|4|||
27988417|NCT00701038|54647183|FG001|Overall Study|study amended pilot group of patients|4|||
27988418|NCT00857766|54647191|FG000|Overall Study|Adverse Event|13|||
27988419|NCT00857766|54647192|FG001|Overall Study|Adverse Event|12|||
27988420|NCT00857766|54647191|FG000|Overall Study|Protocol Violation|11|||
27988421|NCT00857766|54647192|FG001|Overall Study|Protocol Violation|11|||
27988422|NCT00857766|54647191|FG000|Overall Study|Lost to Follow-up|1|||
28172328|NCT01652716|54843978|FG001|Overall Study|Lost to Follow-up|11|||
28172329|NCT01652716|54843977|FG000|Overall Study|Protocol Violation|2|||
27988423|NCT00857766|54647192|FG001|Overall Study|Lost to Follow-up|0|||
27988424|NCT00857766|54647191|FG000|Overall Study|Investigator Discretion|2|||
27988425|NCT00857766|54647192|FG001|Overall Study|Investigator Discretion|3|||
27988426|NCT00857766|54647191|FG000|Overall Study|Participant Withdrew Consent|4|||
27988427|NCT00857766|54647192|FG001|Overall Study|Participant Withdrew Consent|4|||
27988428|NCT00517699|54647198|FG000|Overall Study|Withdrawal by Subject|1|||
27988429|NCT00517699|54647198|FG000|Overall Study|Lack of Efficacy|1|||
27988430|NCT00517699|54647198|FG000|Overall Study|Administrative error|1|||
27988431|NCT00517699|54647198|FG000|Overall Study|Study terminated by Sponsor|2|||
27988432|NCT00857454|54647202|FG000|Overall Study|Withdrawal by Subject|2|||
27988433|NCT00857454|54647202|FG000|Overall Study|Lost to Follow-up|1|||
27988434|NCT00857454|54647202|FG000|Overall Study|Adverse Event|2|||
27988435|NCT00857454|54647202|FG000|Overall Study|Total Testosterone >1050 ng/dL|1|||
27988436|NCT00857454|54647202|FG000|Overall Study|Total Testosterone <300 ng/dL|8|||
27988437|NCT00857454|54647202|FG000|Overall Study|MTE09 enrollment criteria not met|6|||
27988438|NCT00525031|54647208|FG000|Overall Study|Disease Progression|1|||
27988439|NCT00525031|54647209|FG001|Overall Study|Disease Progression|1|||
27988440|NCT00524485|54647216|FG000|Overall Study|Withdrawal by Subject|5|||
27988441|NCT00857220|54647220|FG000|Overall Study|Adverse Event|35|||
27988442|NCT00857220|54647220|FG000|Overall Study|Death|1|||
27988443|NCT00857220|54647220|FG000|Overall Study|Lack of Efficacy|11|||
27988444|NCT00857220|54647220|FG000|Overall Study|Lost to Follow-up|30|||
27988445|NCT00857220|54647220|FG000|Overall Study|Physician Decision|4|||
27988446|NCT00857220|54647220|FG000|Overall Study|Protocol Violation|16|||
27988447|NCT00857220|54647220|FG000|Overall Study|Withdrawal by Subject|67|||
27988448|NCT00857220|54647220|FG000|Overall Study|Clinical Hold|6|||
27988449|NCT00857220|54647220|FG000|Overall Study|Site Closed|5|||
27988450|NCT00857220|54647220|FG000|Overall Study|Miscellaneous|8|||
27988451|NCT00524173|54647226|FG000|Overall Study|Lost to Follow-up|0|||
27988452|NCT00524173|54647227|FG001|Overall Study|Lost to Follow-up|1|||
27988453|NCT00524173|54647226|FG000|Overall Study|Death|1|||
27988454|NCT00524173|54647227|FG001|Overall Study|Death|0|||
27988455|NCT00524173|54647226|FG000|Overall Study|Had not reached endpoint at study close|4|||
27988456|NCT00524173|54647227|FG001|Overall Study|Had not reached endpoint at study close|1|||
27988457|NCT00879710|54647235|FG000|Phase 1 - 6 Weeks|Lost to Follow-up|2|||
27988458|NCT00879710|54647236|FG001|Phase 1 - 6 Weeks|Lost to Follow-up|3|||
27988459|NCT00879710|54647237|FG002|Phase 1 - 6 Weeks|Lost to Follow-up|1|||
27988460|NCT00879710|54647238|FG003|Phase 1 - 6 Weeks|Lost to Follow-up|4|||
27904523|NCT01321606|54561411|FG003|Overall Study|Lost to Follow-up|1|||
27904524|NCT01320943|54561423|FG000|Overall Study|Lost to Follow-up|1|||
27904525|NCT01320943|54561424|FG001|Overall Study|Lost to Follow-up|0|||
27904526|NCT01320943|54561423|FG000|Overall Study|Physician Decision|0|||
27904527|NCT01320943|54561424|FG001|Overall Study|Physician Decision|1|||
27904528|NCT01320943|54561423|FG000|Overall Study|Randomized but not Treated|0|||
27904529|NCT01320943|54561424|FG001|Overall Study|Randomized but not Treated|1|||
27904530|NCT02482233|54561439|FG000|Overall Study|Lost to Follow-up|1|||
27904531|NCT02482233|54561440|FG001|Overall Study|Lost to Follow-up|1|||
27904532|NCT01320202|54561450|FG000|Overall Study|Adverse Event|5|||
27988461|NCT00879710|54647235|FG000|Phase 1 - 6 Weeks|Adverse Event|0|||
27988462|NCT00879710|54647236|FG001|Phase 1 - 6 Weeks|Adverse Event|0|||
27904533|NCT01320202|54561451|FG001|Overall Study|Adverse Event|5|||
27904534|NCT01320202|54561450|FG000|Overall Study|Death|5|||
27904535|NCT01320202|54561451|FG001|Overall Study|Death|3|||
27988463|NCT00879710|54647237|FG002|Phase 1 - 6 Weeks|Adverse Event|1|||
27988464|NCT00879710|54647238|FG003|Phase 1 - 6 Weeks|Adverse Event|0|||
27988465|NCT00597506|54647246|FG000|Overall Study|Subject is being followed for survival|1|||
27988466|NCT00708682|54647259|FG000|Infant Series|Adverse Event|1|||
27988467|NCT00708682|54647259|FG000|Infant Series|Lost to Follow-up|4|||
27988468|NCT00708682|54647259|FG000|Infant Series|Protocol Violation|1|||
27988469|NCT00708682|54647259|FG000|Infant Series|Parent/legal guardian request|6|||
27988470|NCT00708682|54647259|FG000|Infant Series|Failed to return|2|||
27988471|NCT00708682|54647259|FG000|Infant Series|Other|19|||
27988472|NCT00708682|54647259|FG000|After Infant Series|Parent/Legal Guardian Request|1|||
27988473|NCT00708682|54647259|FG000|Toddler Dose|Parent/Legal Guardian Request|1|||
27988474|NCT00708682|54647259|FG000|Toddler Dose|Lost to Follow-up|3|||
27988475|NCT00708682|54647259|FG000|Toddler Dose|Failed to Return|4|||
27988476|NCT00712348|54647265|FG000|Overall Study|Withdrawal by Subject|1|||
28172330|NCT01652716|54843978|FG001|Overall Study|Protocol Violation|1|||
27988477|NCT00881504|54647269|FG000|Overall Study|Withdrawal by Subject|1|||
27988478|NCT01936831|54647282|FG000|Step 2: Arm Randomization|Withdrawal by Subject|0|||
27988479|NCT01936831|54647283|FG001|Step 2: Arm Randomization|Withdrawal by Subject|0|||
27904536|NCT01320202|54561450|FG000|Overall Study|Lost to Follow-up|1|||
27904537|NCT01320202|54561451|FG001|Overall Study|Lost to Follow-up|0|||
27904538|NCT01320202|54561450|FG000|Overall Study|Physician Decision|3|||
27904539|NCT01320202|54561451|FG001|Overall Study|Physician Decision|1|||
27904540|NCT01320202|54561450|FG000|Overall Study|Protocol Violation|2|||
27988480|NCT01936831|54647284|FG002|Step 2: Arm Randomization|Withdrawal by Subject|0|||
27988481|NCT01936831|54647285|FG003|Step 2: Arm Randomization|Withdrawal by Subject|0|||
27988482|NCT01936831|54647286|FG004|Step 2: Arm Randomization|Withdrawal by Subject|0|||
27988483|NCT01936831|54647287|FG005|Step 2: Arm Randomization|Withdrawal by Subject|1|||
27988484|NCT01936831|54647288|FG006|Step 2: Arm Randomization|Withdrawal by Subject|0|||
27904541|NCT01320202|54561451|FG001|Overall Study|Protocol Violation|1|||
27904542|NCT01320202|54561450|FG000|Overall Study|Withdrawal by Subject|10|||
27904543|NCT01320202|54561451|FG001|Overall Study|Withdrawal by Subject|3|||
27904544|NCT01320202|54561450|FG000|Overall Study|non-protocol change to ESA or IV iron|17|||
27904545|NCT01320202|54561451|FG001|Overall Study|non-protocol change to ESA or IV iron|20|||
27904546|NCT01320202|54561450|FG000|Overall Study|kidney transplant|1|||
27904547|NCT01320202|54561451|FG001|Overall Study|kidney transplant|2|||
27904548|NCT01320202|54561450|FG000|Overall Study|blood transfusion|1|||
27904549|NCT01320202|54561451|FG001|Overall Study|blood transfusion|7|||
27904550|NCT01320202|54561450|FG000|Overall Study|moved/changed dialysis|5|||
27904551|NCT01320202|54561451|FG001|Overall Study|moved/changed dialysis|2|||
27904552|NCT01320202|54561450|FG000|Overall Study|sponsor request|2|||
27904553|NCT01320202|54561451|FG001|Overall Study|sponsor request|0|||
27904554|NCT01320202|54561450|FG000|Overall Study|ineligible|3|||
27904555|NCT01320202|54561451|FG001|Overall Study|ineligible|0|||
27904556|NCT01320202|54561450|FG000|Overall Study|regained renal function|1|||
27904557|NCT01320202|54561451|FG001|Overall Study|regained renal function|0|||
27904558|NCT01319383|54561460|FG000|Overall Study|No ex vivo or in vivo response|4|||
27904559|NCT01319383|54561461|FG001|Overall Study|No ex vivo or in vivo response|0|||
27904560|NCT01319383|54561460|FG000|Overall Study|Physician Decision|3|||
27904561|NCT01319383|54561461|FG001|Overall Study|Physician Decision|0|||
27904562|NCT01319383|54561460|FG000|Overall Study|Lack of Efficacy|5|||
27904563|NCT01319383|54561461|FG001|Overall Study|Lack of Efficacy|9|||
27904564|NCT01319383|54561460|FG000|Overall Study|No in vivo response to interval doses|0|||
27904565|NCT01319383|54561461|FG001|Overall Study|No in vivo response to interval doses|1|||
27904566|NCT01316614|54561478|FG000|Overall Study|No solid lesion and FNA not indicated|25|||
27904567|NCT01316614|54561478|FG000|Overall Study|Cytology slides not available for review|4|||
27904568|NCT01316614|54561478|FG000|Overall Study|Cystic lesion|5|||
27904569|NCT01316614|54561478|FG000|Overall Study|Inadequate number of passes|2|||
27904570|NCT01316614|54561478|FG000|Overall Study|Medically unstable|1|||
27904571|NCT01316575|54561485|FG000|Overall Study|Withdrawal by Subject|2|||
27904572|NCT01316575|54561486|FG001|Overall Study|Withdrawal by Subject|0|||
27904573|NCT01316575|54561485|FG000|Overall Study|Required alternate treatment|0|||
27904574|NCT01316575|54561486|FG001|Overall Study|Required alternate treatment|1|||
27904575|NCT01315678|54561494|FG000|Overall Study|Withdrawal by Subject|7|||
27904576|NCT01315678|54561495|FG001|Overall Study|Withdrawal by Subject|3|||
27904577|NCT01315678|54561494|FG000|Overall Study|Adverse Event|3|||
27904578|NCT01315678|54561495|FG001|Overall Study|Adverse Event|1|||
27904579|NCT01315678|54561494|FG000|Overall Study|Lost to Follow-up|1|||
27904580|NCT01315678|54561495|FG001|Overall Study|Lost to Follow-up|0|||
27904581|NCT01315678|54561494|FG000|Overall Study|similar reason to those listed above|3|||
27904582|NCT01315678|54561495|FG001|Overall Study|similar reason to those listed above|2|||
27904583|NCT01315249|54561505|FG000|Overall Study|Adverse Event|22|||
27904584|NCT01315249|54561506|FG001|Overall Study|Adverse Event|26|||
27904585|NCT01315249|54561505|FG000|Overall Study|Withdrawal by Subject|11|||
27904586|NCT01315249|54561506|FG001|Overall Study|Withdrawal by Subject|10|||
27904587|NCT01315249|54561505|FG000|Overall Study|Protocol Violation|8|||
27904588|NCT01315249|54561506|FG001|Overall Study|Protocol Violation|5|||
27904589|NCT01315249|54561505|FG000|Overall Study|Abnormal test results|1|||
27904590|NCT01315249|54561506|FG001|Overall Study|Abnormal test results|2|||
27904591|NCT01315249|54561505|FG000|Overall Study|Administrative problems|1|||
27904592|NCT01315249|54561506|FG001|Overall Study|Administrative problems|0|||
27904593|NCT01315249|54561505|FG000|Overall Study|inability to use device|1|||
27904594|NCT01315249|54561506|FG001|Overall Study|inability to use device|0|||
27904595|NCT01315249|54561505|FG000|Overall Study|Lack of Efficacy|0|||
27904596|NCT01315249|54561506|FG001|Overall Study|Lack of Efficacy|1|||
27904597|NCT01315249|54561505|FG000|Overall Study|Lost to Follow-up|0|||
27988485|NCT01936831|54647289|FG007|Step 2: Arm Randomization|Withdrawal by Subject|0|||
27988486|NCT01936831|54647290|FG008|Step 2: Arm Randomization|Withdrawal by Subject|0|||
27988487|NCT03863353|54647307|FG000|Overall Study|incomplete baseline; surgical complication; no opioid prescription|24|||
27988488|NCT03863353|54647308|FG001|Overall Study|incomplete baseline; surgical complication; no opioid prescription|20|||
27988489|NCT00523705|54647316|FG000|Overall Study|No time for study.|0|||
27904598|NCT01315249|54561506|FG001|Overall Study|Lost to Follow-up|2|||
27904599|NCT01315249|54561505|FG000|Overall Study|Death|0|||
27904600|NCT01315249|54561506|FG001|Overall Study|Death|1|||
27904601|NCT01315132|54561512|FG000|Overall Study|not treated due to disease progression|1|||
27904602|NCT01313767|54561518|FG000|Overall Study|Adverse Event|1|||
27904603|NCT01313767|54561519|FG001|Overall Study|Adverse Event|0|||
27904604|NCT01313767|54561518|FG000|Overall Study|Lost to Follow-up|1|||
27904605|NCT01313767|54561519|FG001|Overall Study|Lost to Follow-up|0|||
27904606|NCT01313767|54561518|FG000|Overall Study|Withdrawal by Subject|2|||
27904607|NCT01313767|54561519|FG001|Overall Study|Withdrawal by Subject|1|||
27988490|NCT00523705|54647317|FG001|Overall Study|No time for study.|1|||
27988491|NCT00523549|54647330|FG000|Overall Study|Adverse Event|6|||
27988492|NCT00523549|54647331|FG001|Overall Study|Adverse Event|3|||
27988493|NCT00523549|54647330|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
27988494|NCT00523549|54647331|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
27988495|NCT00523549|54647330|FG000|Overall Study|Protocol Deviation|3|||
27988496|NCT00523549|54647331|FG001|Overall Study|Protocol Deviation|1|||
27988497|NCT00523549|54647330|FG000|Overall Study|Patient withdrew consent|7|||
27988498|NCT00523549|54647331|FG001|Overall Study|Patient withdrew consent|6|||
27988499|NCT00523549|54647330|FG000|Overall Study|Lost to Follow-up|3|||
27988500|NCT00523549|54647331|FG001|Overall Study|Lost to Follow-up|5|||
27988501|NCT03504085|54647339|FG000|End of Intervention - 12 Weeks|Lost to Follow-up|3|||
27988502|NCT03504085|54647340|FG001|End of Intervention - 12 Weeks|Lost to Follow-up|4|||
27988503|NCT03504085|54647339|FG000|Final Assessment - 6 Months|Lost to Follow-up|5|||
27988504|NCT03504085|54647340|FG001|Final Assessment - 6 Months|Lost to Follow-up|5|||
27988505|NCT00700102|54647348|FG000|Overall Study|Died|394|||
27988506|NCT00700102|54647349|FG001|Overall Study|Died|385|||
27988507|NCT00700102|54647348|FG000|Overall Study|Lost to Follow-up|8|||
27988508|NCT00700102|54647349|FG001|Overall Study|Lost to Follow-up|10|||
27988509|NCT00595478|54647357|FG000|36-week Follow-up Period|Lost to Follow-up|5|||
27988510|NCT00595478|54647358|FG001|36-week Follow-up Period|Lost to Follow-up|4|||
27988511|NCT00595478|54647357|FG000|36-week Follow-up Period|Withdrawal by Subject|4|||
27988512|NCT00595478|54647358|FG001|36-week Follow-up Period|Withdrawal by Subject|4|||
27988513|NCT00516295|54647367|FG000|Overall Study|Lack of Efficacy|2|||
27988514|NCT00516295|54647368|FG001|Overall Study|Lack of Efficacy|0|||
27988515|NCT00516295|54647369|FG002|Overall Study|Lack of Efficacy|0|||
28097489|NCT02955212|54753145|FG000|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|0|||
28097490|NCT02955212|54753146|FG001|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|1|||
28097491|NCT02955212|54753145|FG000|Period 2: Open-label Extension|Other|2|||
28097492|NCT02955212|54753146|FG001|Period 2: Open-label Extension|Other|4|||
28097493|NCT03050398|54753153|FG000|Overall Study|Study terminated by sponsor|8|||
28097494|NCT03662750|54753157|FG000|Overall Study|Withdrawal by Subject|1|||
28097495|NCT04052204|54753161|FG000|Overall Study|Death|1|||
28097496|NCT04052204|54753162|FG001|Overall Study|Death|0|||
28097497|NCT04052204|54753163|FG002|Overall Study|Death|0|||
28097498|NCT04052204|54753161|FG000|Overall Study|Progressive disease|1|||
28097499|NCT04052204|54753162|FG001|Overall Study|Progressive disease|0|||
28097500|NCT04052204|54753163|FG002|Overall Study|Progressive disease|0|||
28097501|NCT04052204|54753161|FG000|Overall Study|Other|1|||
28097502|NCT04052204|54753162|FG001|Overall Study|Other|0|||
28097503|NCT04052204|54753163|FG002|Overall Study|Other|0|||
28097504|NCT04050722|54753169|FG000|Overall Study|Withdrawal by Subject|1|||
28097505|NCT04050722|54753170|FG001|Overall Study|Withdrawal by Subject|0|||
28097506|NCT04049552|54753176|FG000|Overall Study|Lost to Follow-up|1|||
28097507|NCT03048058|54753184|FG000|Overall Study|Lost to Follow-up|4|||
28097508|NCT03048058|54753185|FG001|Overall Study|Lost to Follow-up|0|||
28097509|NCT03048058|54753184|FG000|Overall Study|Withdrawal by Subject|0|||
28097510|NCT03048058|54753185|FG001|Overall Study|Withdrawal by Subject|4|||
27904608|NCT01313767|54561518|FG000|Overall Study|Protocol Violation|3|||
27904609|NCT01313767|54561519|FG001|Overall Study|Protocol Violation|1|||
27904610|NCT01313728|54561525|FG000|Informed Consent to Baseline|Withdrawal by Subject|1|||
27904611|NCT01313650|54561534|FG000|Overall Study|Adverse Event|9|||
28097511|NCT03047980|54753191|FG000|Overall Study|Adverse Event|1|||
28097512|NCT04048382|54753197|FG000|3-Month Follow Up|Enrolled but did not complete survey|2|||
28097513|NCT04048382|54753198|FG001|3-Month Follow Up|Enrolled but did not complete survey|0|||
28097514|NCT04048382|54753197|FG000|3-Month Follow Up|Withdrawal by Subject|0|||
28172331|NCT01652716|54843977|FG000|Overall Study|Adverse Event|7|||
27904612|NCT01313650|54561535|FG001|Overall Study|Adverse Event|34|||
27904613|NCT01313650|54561536|FG002|Overall Study|Adverse Event|24|||
27904614|NCT01313650|54561537|FG003|Overall Study|Adverse Event|23|||
27904615|NCT01313650|54561534|FG000|Overall Study|Lack of Efficacy|37|||
27904616|NCT01313650|54561535|FG001|Overall Study|Lack of Efficacy|20|||
27904617|NCT01313650|54561536|FG002|Overall Study|Lack of Efficacy|32|||
27904618|NCT01313650|54561537|FG003|Overall Study|Lack of Efficacy|20|||
27904619|NCT01313650|54561534|FG000|Overall Study|Lost to Follow-up|1|||
27904620|NCT01313650|54561535|FG001|Overall Study|Lost to Follow-up|0|||
27904621|NCT01313650|54561536|FG002|Overall Study|Lost to Follow-up|3|||
27904622|NCT01313650|54561537|FG003|Overall Study|Lost to Follow-up|2|||
27904623|NCT01313650|54561534|FG000|Overall Study|Withdrawal by Subject|16|||
28097515|NCT04048382|54753198|FG001|3-Month Follow Up|Withdrawal by Subject|1|||
28097516|NCT04048382|54753197|FG000|6-Month Follow up|Enrolled but did not complete survey|2|||
27925791|NCT01226745|54582368|FG001|Overall Study|Other|7|||
27988516|NCT00516295|54647367|FG000|Overall Study|Ineligible|1|||
27988517|NCT00516295|54647368|FG001|Overall Study|Ineligible|0|||
28097517|NCT04048382|54753198|FG001|6-Month Follow up|Enrolled but did not complete survey|0|||
28097518|NCT04047446|54753206|FG000|Overall Study|Physician Decision|1|||
28097519|NCT04047446|54753207|FG001|Overall Study|Physician Decision|0|||
28172332|NCT01652716|54843978|FG001|Overall Study|Adverse Event|10|||
27988518|NCT00516295|54647369|FG002|Overall Study|Ineligible|0|||
27988519|NCT03861559|54647379|FG000|Overall Study|Adverse Event|0|||
27988520|NCT03861559|54647380|FG001|Overall Study|Adverse Event|2|||
27988521|NCT03861559|54647379|FG000|Overall Study|Treatment failure|0|||
27988522|NCT03861559|54647380|FG001|Overall Study|Treatment failure|2|||
27988523|NCT03861559|54647379|FG000|Overall Study|Noncompliance|1|||
27988524|NCT03861559|54647380|FG001|Overall Study|Noncompliance|1|||
27988525|NCT03861559|54647379|FG000|Overall Study|Did not meet eligibility requirements|1|||
27988526|NCT03861559|54647380|FG001|Overall Study|Did not meet eligibility requirements|0|||
27988527|NCT00516139|54647386|FG000|Overall Study|Adverse Event|27|||
27988528|NCT00516139|54647386|FG000|Overall Study|Lost to Follow-up|1|||
27988529|NCT00516139|54647386|FG000|Overall Study|Protocol Violation|1|||
27988530|NCT00516139|54647386|FG000|Overall Study|Withdrawal by Subject|8|||
27988531|NCT00516139|54647386|FG000|Overall Study|Lack of Efficacy|1|||
27988532|NCT00515827|54647396|FG000|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
27988533|NCT00515827|54647397|FG001|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
27988534|NCT00515827|54647396|FG000|Second Intervention (12 Weeks)|Consent withdraw|1|||
27988535|NCT00515827|54647397|FG001|Second Intervention (12 Weeks)|Consent withdraw|0|||
27988536|NCT00522457|54647405|FG000|Overall Study|Due to disease progression|16|||
27988537|NCT00522457|54647405|FG000|Overall Study|Adverse Event|2|||
27988538|NCT00856986|54647414|FG000|Run-in Period, Weeks -12-0|Adverse Event|0|||
27988539|NCT00856986|54647415|FG001|Run-in Period, Weeks -12-0|Adverse Event|0|||
27988540|NCT00856986|54647416|FG002|Run-in Period, Weeks -12-0|Adverse Event|0|||
27988541|NCT00856986|54647417|FG003|Run-in Period, Weeks -12-0|Adverse Event|92|||
27988542|NCT00856986|54647418|FG004|Run-in Period, Weeks -12-0|Adverse Event|0|||
27988543|NCT00856986|54647414|FG000|Run-in Period, Weeks -12-0|Protocol Violation|0|||
27988544|NCT00856986|54647415|FG001|Run-in Period, Weeks -12-0|Protocol Violation|0|||
27988545|NCT00856986|54647416|FG002|Run-in Period, Weeks -12-0|Protocol Violation|0|||
27988546|NCT00856986|54647417|FG003|Run-in Period, Weeks -12-0|Protocol Violation|24|||
27988547|NCT00856986|54647418|FG004|Run-in Period, Weeks -12-0|Protocol Violation|0|||
27988548|NCT00856986|54647414|FG000|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
27904624|NCT01313650|54561535|FG001|Overall Study|Withdrawal by Subject|20|||
27904625|NCT01313650|54561536|FG002|Overall Study|Withdrawal by Subject|15|||
27904626|NCT01313650|54561537|FG003|Overall Study|Withdrawal by Subject|15|||
27904627|NCT01313650|54561534|FG000|Overall Study|Protocol Violation|4|||
27904628|NCT01313650|54561535|FG001|Overall Study|Protocol Violation|7|||
27904629|NCT01313650|54561536|FG002|Overall Study|Protocol Violation|5|||
27904630|NCT01313650|54561537|FG003|Overall Study|Protocol Violation|6|||
27904631|NCT01313650|54561534|FG000|Overall Study|Met Protocol-defined Stopping Criteria|9|||
27904632|NCT01313650|54561535|FG001|Overall Study|Met Protocol-defined Stopping Criteria|13|||
27904633|NCT01313650|54561536|FG002|Overall Study|Met Protocol-defined Stopping Criteria|24|||
27904634|NCT01313650|54561537|FG003|Overall Study|Met Protocol-defined Stopping Criteria|15|||
27904635|NCT01313299|54561550|FG000|Overall Study|Adverse Event|3|||
27904636|NCT01313299|54561551|FG001|Overall Study|Adverse Event|1|||
27904637|NCT01313299|54561552|FG002|Overall Study|Adverse Event|1|||
27904638|NCT01313299|54561550|FG000|Overall Study|Lost to Follow-up|1|||
27904639|NCT01313299|54561551|FG001|Overall Study|Lost to Follow-up|0|||
27904640|NCT01313299|54561552|FG002|Overall Study|Lost to Follow-up|0|||
27904641|NCT01313299|54561550|FG000|Overall Study|Protocol Violation|2|||
27904642|NCT01313299|54561551|FG001|Overall Study|Protocol Violation|0|||
27904643|NCT01313299|54561552|FG002|Overall Study|Protocol Violation|0|||
27904644|NCT01313299|54561550|FG000|Overall Study|Withdrawal by Subject|1|||
27904645|NCT01313299|54561551|FG001|Overall Study|Withdrawal by Subject|0|||
27904646|NCT01313299|54561552|FG002|Overall Study|Withdrawal by Subject|2|||
27904647|NCT01313299|54561550|FG000|Overall Study|Family reason and moved out of state|0|||
27904648|NCT01313299|54561551|FG001|Overall Study|Family reason and moved out of state|2|||
27904649|NCT01313299|54561552|FG002|Overall Study|Family reason and moved out of state|0|||
27904650|NCT01313299|54561550|FG000|Overall Study|Lack of subject compliance|0|||
27904651|NCT01313299|54561551|FG001|Overall Study|Lack of subject compliance|0|||
27904652|NCT01313299|54561552|FG002|Overall Study|Lack of subject compliance|1|||
27988549|NCT00856986|54647415|FG001|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
27904653|NCT01313221|54561563|FG000|Overall Study|Protocol Violation|0|||
27988550|NCT00856986|54647416|FG002|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
27988551|NCT00856986|54647417|FG003|Run-in Period, Weeks -12-0|Withdrawal Criteria|10|||
27988552|NCT00856986|54647418|FG004|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
27988553|NCT00856986|54647414|FG000|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
27988554|NCT00856986|54647415|FG001|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
27988555|NCT00856986|54647416|FG002|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
27904654|NCT01313221|54561564|FG001|Overall Study|Protocol Violation|1|||
27904655|NCT01313221|54561565|FG002|Overall Study|Protocol Violation|1|||
27904656|NCT01313221|54561563|FG000|Overall Study|Non-compliance|3|||
27904657|NCT01313221|54561564|FG001|Overall Study|Non-compliance|0|||
27904658|NCT01313221|54561565|FG002|Overall Study|Non-compliance|2|||
27904659|NCT01313221|54561563|FG000|Overall Study|Withdrawal by Subject|2|||
27904660|NCT01313221|54561564|FG001|Overall Study|Withdrawal by Subject|3|||
27904661|NCT01313221|54561565|FG002|Overall Study|Withdrawal by Subject|5|||
27904662|NCT01313221|54561563|FG000|Overall Study|Requirement for alternative therapy|0|||
27904663|NCT01313221|54561564|FG001|Overall Study|Requirement for alternative therapy|1|||
27904664|NCT01313221|54561565|FG002|Overall Study|Requirement for alternative therapy|1|||
27904665|NCT01313221|54561563|FG000|Overall Study|Lost to Follow-up|6|||
27904666|NCT01313221|54561564|FG001|Overall Study|Lost to Follow-up|3|||
27904667|NCT01313221|54561565|FG002|Overall Study|Lost to Follow-up|1|||
27904668|NCT01313221|54561563|FG000|Overall Study|Other|1|||
27904669|NCT01313221|54561564|FG001|Overall Study|Other|0|||
27988556|NCT00856986|54647417|FG003|Run-in Period, Weeks -12-0|Lost to Follow-up|11|||
27988557|NCT00856986|54647418|FG004|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
27988558|NCT00856986|54647414|FG000|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
27988559|NCT00856986|54647415|FG001|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
27988560|NCT00856986|54647416|FG002|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
27988561|NCT00856986|54647417|FG003|Run-in Period, Weeks -12-0|Lack of Efficacy|6|||
27988562|NCT00856986|54647418|FG004|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
27988563|NCT00856986|54647414|FG000|Run-in Period, Weeks -12-0|Unclassified|0|||
27988564|NCT00856986|54647415|FG001|Run-in Period, Weeks -12-0|Unclassified|0|||
27988565|NCT00856986|54647416|FG002|Run-in Period, Weeks -12-0|Unclassified|0|||
27988566|NCT00856986|54647417|FG003|Run-in Period, Weeks -12-0|Unclassified|24|||
27988567|NCT00856986|54647418|FG004|Run-in Period, Weeks -12-0|Unclassified|0|||
27988568|NCT00856986|54647414|FG000|Main Period, Weeks 0-26|Adverse Event|6|||
27988569|NCT00856986|54647415|FG001|Main Period, Weeks 0-26|Adverse Event|4|||
27988570|NCT00856986|54647416|FG002|Main Period, Weeks 0-26|Adverse Event|9|||
27988571|NCT00856986|54647417|FG003|Main Period, Weeks 0-26|Adverse Event|0|||
27988572|NCT00856986|54647418|FG004|Main Period, Weeks 0-26|Adverse Event|0|||
27988573|NCT00856986|54647414|FG000|Main Period, Weeks 0-26|Protocol Violation|4|||
27988574|NCT00856986|54647415|FG001|Main Period, Weeks 0-26|Protocol Violation|5|||
27988575|NCT00856986|54647416|FG002|Main Period, Weeks 0-26|Protocol Violation|7|||
27988576|NCT00856986|54647417|FG003|Main Period, Weeks 0-26|Protocol Violation|0|||
27988577|NCT00856986|54647418|FG004|Main Period, Weeks 0-26|Protocol Violation|0|||
27988578|NCT00856986|54647414|FG000|Main Period, Weeks 0-26|Withdrawal Criteria|11|||
27904670|NCT01313221|54561565|FG002|Overall Study|Other|0|||
27904671|NCT01313221|54561563|FG000|Overall Study|Adverse Event|0|||
27904672|NCT01313221|54561564|FG001|Overall Study|Adverse Event|0|||
27904673|NCT01313221|54561565|FG002|Overall Study|Adverse Event|7|||
27904674|NCT01313221|54561563|FG000|Overall Study|Disease progression|0|||
27904675|NCT01313221|54561564|FG001|Overall Study|Disease progression|0|||
27904676|NCT01313221|54561565|FG002|Overall Study|Disease progression|2|||
27904677|NCT01313221|54561563|FG000|Overall Study|Physician Decision|0|||
27904678|NCT01313221|54561564|FG001|Overall Study|Physician Decision|0|||
27904679|NCT01313221|54561565|FG002|Overall Study|Physician Decision|2|||
27904680|NCT01313221|54561563|FG000|Overall Study|Pregnancy|0|||
27904681|NCT01313221|54561564|FG001|Overall Study|Pregnancy|0|||
27904682|NCT01313221|54561565|FG002|Overall Study|Pregnancy|2|||
27988579|NCT00856986|54647415|FG001|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
27988580|NCT00856986|54647416|FG002|Main Period, Weeks 0-26|Withdrawal Criteria|3|||
27988581|NCT00856986|54647417|FG003|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
27988582|NCT00856986|54647418|FG004|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
27988583|NCT00856986|54647414|FG000|Main Period, Weeks 0-26|Lost to Follow-up|1|||
27988584|NCT00856986|54647415|FG001|Main Period, Weeks 0-26|Lost to Follow-up|1|||
27988585|NCT00856986|54647416|FG002|Main Period, Weeks 0-26|Lost to Follow-up|2|||
27988586|NCT00856986|54647417|FG003|Main Period, Weeks 0-26|Lost to Follow-up|0|||
27988587|NCT00856986|54647418|FG004|Main Period, Weeks 0-26|Lost to Follow-up|0|||
27988588|NCT00856986|54647414|FG000|Main Period, Weeks 0-26|Lack of Efficacy|5|||
27988589|NCT00856986|54647415|FG001|Main Period, Weeks 0-26|Lack of Efficacy|2|||
27988590|NCT00856986|54647416|FG002|Main Period, Weeks 0-26|Lack of Efficacy|0|||
27904683|NCT01313182|54561575|FG000|Overall Study|Protocol Violation|66|||
27904684|NCT01313182|54561576|FG001|Overall Study|Protocol Violation|92|||
27988591|NCT00856986|54647417|FG003|Main Period, Weeks 0-26|Lack of Efficacy|0|||
27904685|NCT01312909|54561585|FG000|Overall Study|Randomized but not treated|1|||
27988592|NCT00856986|54647418|FG004|Main Period, Weeks 0-26|Lack of Efficacy|0|||
27988593|NCT00856986|54647414|FG000|Main Period, Weeks 0-26|Unclassified|7|||
27988594|NCT00856986|54647415|FG001|Main Period, Weeks 0-26|Unclassified|6|||
27988595|NCT00856986|54647416|FG002|Main Period, Weeks 0-26|Unclassified|7|||
27988596|NCT00856986|54647417|FG003|Main Period, Weeks 0-26|Unclassified|0|||
27988597|NCT00856986|54647418|FG004|Main Period, Weeks 0-26|Unclassified|0|||
28097520|NCT03655106|54753215|FG000|Overall Study|Withdrawal by Subject|3|||
28097521|NCT03655106|54753216|FG001|Overall Study|Withdrawal by Subject|2|||
27904686|NCT01312909|54561586|FG001|Overall Study|Randomized but not treated|3|||
27904687|NCT01312909|54561587|FG002|Overall Study|Randomized but not treated|1|||
27904688|NCT01312909|54561585|FG000|Overall Study|Adverse Event|1|||
27904689|NCT01312909|54561586|FG001|Overall Study|Adverse Event|0|||
27904690|NCT01312909|54561587|FG002|Overall Study|Adverse Event|3|||
27904691|NCT01312909|54561585|FG000|Overall Study|Protocol Violation|2|||
27988598|NCT00856986|54647414|FG000|Extension Period, Weeks 26-52|Adverse Event|3|||
27988599|NCT00856986|54647415|FG001|Extension Period, Weeks 26-52|Adverse Event|3|||
27988600|NCT00856986|54647416|FG002|Extension Period, Weeks 26-52|Adverse Event|10|||
27988601|NCT00856986|54647417|FG003|Extension Period, Weeks 26-52|Adverse Event|0|||
27988602|NCT00856986|54647418|FG004|Extension Period, Weeks 26-52|Adverse Event|0|||
27988603|NCT00856986|54647414|FG000|Extension Period, Weeks 26-52|Protocol Violation|6|||
27988604|NCT00856986|54647415|FG001|Extension Period, Weeks 26-52|Protocol Violation|2|||
27988605|NCT00856986|54647416|FG002|Extension Period, Weeks 26-52|Protocol Violation|5|||
27988606|NCT00856986|54647417|FG003|Extension Period, Weeks 26-52|Protocol Violation|0|||
27988607|NCT00856986|54647418|FG004|Extension Period, Weeks 26-52|Protocol Violation|0|||
27988608|NCT00856986|54647414|FG000|Extension Period, Weeks 26-52|Withdrawal Criteria|2|||
27988609|NCT00856986|54647415|FG001|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
27904692|NCT01312909|54561586|FG001|Overall Study|Protocol Violation|0|||
27904693|NCT01312909|54561587|FG002|Overall Study|Protocol Violation|2|||
27904694|NCT01312909|54561585|FG000|Overall Study|Other|9|||
27904695|NCT01312909|54561586|FG001|Overall Study|Other|6|||
27988610|NCT00856986|54647416|FG002|Extension Period, Weeks 26-52|Withdrawal Criteria|8|||
27988611|NCT00856986|54647417|FG003|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
27988612|NCT00856986|54647418|FG004|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
27988613|NCT00856986|54647414|FG000|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
27988614|NCT00856986|54647415|FG001|Extension Period, Weeks 26-52|Lost to Follow-up|5|||
27988615|NCT00856986|54647416|FG002|Extension Period, Weeks 26-52|Lost to Follow-up|2|||
27988616|NCT00856986|54647417|FG003|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
27988617|NCT00856986|54647418|FG004|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
27988618|NCT00856986|54647414|FG000|Extension Period, Weeks 26-52|Lack of Efficacy|4|||
27988619|NCT00856986|54647415|FG001|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
27988620|NCT00856986|54647416|FG002|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
27988621|NCT00856986|54647417|FG003|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
27988622|NCT00856986|54647418|FG004|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
27988623|NCT00856986|54647414|FG000|Extension Period, Weeks 26-52|Unclassified|4|||
27904696|NCT01312909|54561587|FG002|Overall Study|Other|11|||
27904697|NCT01312909|54561585|FG000|Overall Study|Withdrawal by Subject|8|||
27904698|NCT01312909|54561586|FG001|Overall Study|Withdrawal by Subject|10|||
27904699|NCT01312909|54561587|FG002|Overall Study|Withdrawal by Subject|7|||
27904700|NCT01312909|54561585|FG000|Overall Study|Lost to Follow-up|21|||
27904701|NCT01312909|54561586|FG001|Overall Study|Lost to Follow-up|17|||
27904702|NCT01312909|54561587|FG002|Overall Study|Lost to Follow-up|20|||
27904703|NCT01312909|54561585|FG000|Overall Study|Insufficient clinical response|0|||
27904704|NCT01312909|54561586|FG001|Overall Study|Insufficient clinical response|0|||
27904705|NCT01312909|54561587|FG002|Overall Study|Insufficient clinical response|1|||
27904706|NCT01312909|54561585|FG000|Overall Study|Entrance criteria not met|0|||
27904707|NCT01312909|54561586|FG001|Overall Study|Entrance criteria not met|0|||
27904708|NCT01312909|54561587|FG002|Overall Study|Entrance criteria not met|2|||
27904709|NCT01312129|54561597|FG000|Second Intervention (24 Hours)|Lost to Follow-up|0|||
27904710|NCT01312129|54561598|FG001|Second Intervention (24 Hours)|Lost to Follow-up|1|||
27904711|NCT01311661|54561604|FG000|Overall Study|Adverse Event|2|||
27904712|NCT01311661|54561604|FG000|Overall Study|Protocol Violation|3|||
27904713|NCT01311661|54561604|FG000|Overall Study|Withdrawal by Subject|2|||
27904714|NCT01311505|54561616|FG000|First Intervention Period|Protocol Violation|0|||
27904715|NCT01311505|54561617|FG001|First Intervention Period|Protocol Violation|1|||
27904716|NCT01310803|54561628|FG000|Overall Study|Subject terminated by Sponsor|1|||
27904717|NCT01310803|54561629|FG001|Overall Study|Subject terminated by Sponsor|0|||
27904718|NCT01310413|54561641|FG000|Day 0 to Day 385|Withdrawal by Subject|5|||
27904719|NCT01310413|54561642|FG001|Day 0 to Day 385|Withdrawal by Subject|2|||
27904720|NCT01310413|54561643|FG002|Day 0 to Day 385|Withdrawal by Subject|0|||
27904721|NCT01310413|54561644|FG003|Day 0 to Day 385|Withdrawal by Subject|2|||
27904722|NCT01310413|54561645|FG004|Day 0 to Day 385|Withdrawal by Subject|1|||
27904723|NCT01310413|54561646|FG005|Day 0 to Day 385|Withdrawal by Subject|1|||
27904724|NCT01310413|54561647|FG006|Day 0 to Day 385|Withdrawal by Subject|0|||
27904725|NCT01310413|54561641|FG000|Day 0 to Day 385|Lost to Follow-up|18|||
27904726|NCT01310413|54561642|FG001|Day 0 to Day 385|Lost to Follow-up|3|||
27904727|NCT01310413|54561643|FG002|Day 0 to Day 385|Lost to Follow-up|3|||
27904728|NCT01310413|54561644|FG003|Day 0 to Day 385|Lost to Follow-up|5|||
27904729|NCT01310413|54561645|FG004|Day 0 to Day 385|Lost to Follow-up|1|||
27904730|NCT01310413|54561646|FG005|Day 0 to Day 385|Lost to Follow-up|2|||
27904731|NCT01310413|54561647|FG006|Day 0 to Day 385|Lost to Follow-up|0|||
27904732|NCT01310413|54561641|FG000|Day 0 to Day 385|Migrated/moved from study area|3|||
27904733|NCT01310413|54561642|FG001|Day 0 to Day 385|Migrated/moved from study area|3|||
27904734|NCT01310413|54561643|FG002|Day 0 to Day 385|Migrated/moved from study area|1|||
27988624|NCT00856986|54647415|FG001|Extension Period, Weeks 26-52|Unclassified|2|||
27988625|NCT00856986|54647416|FG002|Extension Period, Weeks 26-52|Unclassified|11|||
27988626|NCT00856986|54647417|FG003|Extension Period, Weeks 26-52|Unclassified|0|||
27904735|NCT01310413|54561644|FG003|Day 0 to Day 385|Migrated/moved from study area|1|||
27988627|NCT00856986|54647418|FG004|Extension Period, Weeks 26-52|Unclassified|0|||
27988628|NCT00707746|54647432|FG000|Treatment Period|Adverse Event|2|||
27904736|NCT01310413|54561645|FG004|Day 0 to Day 385|Migrated/moved from study area|1|||
27904737|NCT01310413|54561646|FG005|Day 0 to Day 385|Migrated/moved from study area|0|||
27904738|NCT01310413|54561647|FG006|Day 0 to Day 385|Migrated/moved from study area|0|||
27904739|NCT01310413|54561641|FG000|Day 0 to Day 385|Other|1|||
27904740|NCT01310413|54561642|FG001|Day 0 to Day 385|Other|0|||
27904741|NCT01310413|54561643|FG002|Day 0 to Day 385|Other|3|||
27904742|NCT01310413|54561644|FG003|Day 0 to Day 385|Other|0|||
27904743|NCT01310413|54561645|FG004|Day 0 to Day 385|Other|0|||
27904744|NCT01310413|54561646|FG005|Day 0 to Day 385|Other|0|||
27904745|NCT01310413|54561647|FG006|Day 0 to Day 385|Other|0|||
27904746|NCT01310413|54561641|FG000|From Day U0 to Day U385|Withdrawal by Subject|0|||
27904747|NCT01310413|54561642|FG001|From Day U0 to Day U385|Withdrawal by Subject|0|||
27904748|NCT01310413|54561643|FG002|From Day U0 to Day U385|Withdrawal by Subject|0|||
27904749|NCT01310413|54561644|FG003|From Day U0 to Day U385|Withdrawal by Subject|0|||
27904750|NCT01310413|54561645|FG004|From Day U0 to Day U385|Withdrawal by Subject|0|||
27988629|NCT00707746|54647433|FG001|Treatment Period|Adverse Event|4|||
27988630|NCT00707746|54647432|FG000|Treatment Period|Ineligibility|0|||
27988631|NCT00707746|54647433|FG001|Treatment Period|Ineligibility|1|||
27988632|NCT00856908|54647441|FG000|Overall Study|Lost to Follow-up|1|||
27988633|NCT00856908|54647442|FG001|Overall Study|Lost to Follow-up|0|||
27988634|NCT00522379|54647453|FG000|Overall Study|Adverse Event|12|||
27904751|NCT01310413|54561646|FG005|From Day U0 to Day U385|Withdrawal by Subject|0|||
27904752|NCT01310413|54561647|FG006|From Day U0 to Day U385|Withdrawal by Subject|1|||
27904753|NCT01310413|54561641|FG000|From Day U0 to Day U385|Lost to Follow-up|0|||
27904754|NCT01310413|54561642|FG001|From Day U0 to Day U385|Lost to Follow-up|0|||
27904755|NCT01310413|54561643|FG002|From Day U0 to Day U385|Lost to Follow-up|0|||
27904756|NCT01310413|54561644|FG003|From Day U0 to Day U385|Lost to Follow-up|0|||
27904757|NCT01310413|54561645|FG004|From Day U0 to Day U385|Lost to Follow-up|0|||
27904758|NCT01310413|54561646|FG005|From Day U0 to Day U385|Lost to Follow-up|0|||
27904759|NCT01310413|54561647|FG006|From Day U0 to Day U385|Lost to Follow-up|2|||
27904760|NCT01309828|54561678|FG000|Overall Study|Adverse Event|10|||
27904761|NCT01309828|54561679|FG001|Overall Study|Adverse Event|11|||
27904762|NCT01309828|54561678|FG000|Overall Study|Voluntary Withdrawal|5|||
27904763|NCT01309828|54561679|FG001|Overall Study|Voluntary Withdrawal|4|||
27904764|NCT01309828|54561678|FG000|Overall Study|Major Protocol Deviation|0|||
27904765|NCT01309828|54561679|FG001|Overall Study|Major Protocol Deviation|1|||
27904766|NCT01309828|54561678|FG000|Overall Study|Other|1|||
27904767|NCT01309828|54561679|FG001|Overall Study|Other|0|||
27904768|NCT01309282|54561685|FG000|Overall Study|Lost to Follow-up|1|||
27904769|NCT01309243|54561691|FG000|Randomized Phase Through Week 96|Randomized but not treated|6|||
27904770|NCT01309243|54561692|FG001|Randomized Phase Through Week 96|Randomized but not treated|7|||
27988635|NCT00522379|54647454|FG001|Overall Study|Adverse Event|15|||
27988636|NCT00522379|54647455|FG002|Overall Study|Adverse Event|12|||
27988637|NCT00522379|54647456|FG003|Overall Study|Adverse Event|5|||
27988638|NCT00522379|54647457|FG004|Overall Study|Adverse Event|17|||
27988639|NCT00522379|54647453|FG000|Overall Study|Lack of Efficacy|3|||
27988640|NCT00522379|54647454|FG001|Overall Study|Lack of Efficacy|0|||
27988641|NCT00522379|54647455|FG002|Overall Study|Lack of Efficacy|2|||
27988642|NCT00522379|54647456|FG003|Overall Study|Lack of Efficacy|2|||
27988643|NCT00522379|54647457|FG004|Overall Study|Lack of Efficacy|7|||
27988644|NCT00522379|54647453|FG000|Overall Study|Withdrawal by Subject|2|||
27988645|NCT00522379|54647454|FG001|Overall Study|Withdrawal by Subject|3|||
27988646|NCT00522379|54647455|FG002|Overall Study|Withdrawal by Subject|1|||
27988647|NCT00522379|54647456|FG003|Overall Study|Withdrawal by Subject|2|||
27988648|NCT00522379|54647457|FG004|Overall Study|Withdrawal by Subject|0|||
27988649|NCT00522379|54647453|FG000|Overall Study|Protocol Violation|1|||
27988650|NCT00522379|54647454|FG001|Overall Study|Protocol Violation|1|||
27988651|NCT00522379|54647455|FG002|Overall Study|Protocol Violation|2|||
27988652|NCT00522379|54647456|FG003|Overall Study|Protocol Violation|0|||
27988653|NCT00522379|54647457|FG004|Overall Study|Protocol Violation|0|||
27988654|NCT00522379|54647453|FG000|Overall Study|Unsatisfactory Subject Compliance|1|||
27988655|NCT00522379|54647454|FG001|Overall Study|Unsatisfactory Subject Compliance|2|||
27988656|NCT00522379|54647455|FG002|Overall Study|Unsatisfactory Subject Compliance|0|||
27988657|NCT00522379|54647456|FG003|Overall Study|Unsatisfactory Subject Compliance|0|||
27988658|NCT00522379|54647457|FG004|Overall Study|Unsatisfactory Subject Compliance|0|||
27988659|NCT00522379|54647453|FG000|Overall Study|Lost to Follow-up|1|||
27988660|NCT00522379|54647454|FG001|Overall Study|Lost to Follow-up|0|||
27988661|NCT00522379|54647455|FG002|Overall Study|Lost to Follow-up|4|||
27988662|NCT00522379|54647456|FG003|Overall Study|Lost to Follow-up|2|||
27904771|NCT01309243|54561691|FG000|Randomized Phase Through Week 96|Adverse Event|12|||
27904772|NCT01309243|54561692|FG001|Randomized Phase Through Week 96|Adverse Event|43|||
27988663|NCT00522379|54647457|FG004|Overall Study|Lost to Follow-up|2|||
27988664|NCT00522379|54647453|FG000|Overall Study|Randomization error|0|||
27988665|NCT00522379|54647454|FG001|Overall Study|Randomization error|0|||
27988666|NCT00522379|54647455|FG002|Overall Study|Randomization error|0|||
27988667|NCT00522379|54647456|FG003|Overall Study|Randomization error|0|||
27988668|NCT00522379|54647457|FG004|Overall Study|Randomization error|1|||
27988669|NCT00522379|54647453|FG000|Overall Study|Dispensing error|1|||
27988670|NCT00522379|54647454|FG001|Overall Study|Dispensing error|0|||
27988671|NCT00522379|54647455|FG002|Overall Study|Dispensing error|0|||
27988672|NCT00522379|54647456|FG003|Overall Study|Dispensing error|1|||
27988673|NCT00522379|54647457|FG004|Overall Study|Dispensing error|0|||
27988674|NCT00522379|54647453|FG000|Overall Study|Subject Moved|1|||
27988675|NCT00522379|54647454|FG001|Overall Study|Subject Moved|1|||
27988676|NCT00522379|54647455|FG002|Overall Study|Subject Moved|0|||
27988677|NCT00522379|54647456|FG003|Overall Study|Subject Moved|0|||
27988678|NCT00522379|54647457|FG004|Overall Study|Subject Moved|0|||
27988679|NCT00522379|54647453|FG000|Overall Study|Sponsor Request|0|||
27988680|NCT00522379|54647454|FG001|Overall Study|Sponsor Request|1|||
27904773|NCT01309243|54561691|FG000|Randomized Phase Through Week 96|Death|0|||
27904774|NCT01309243|54561692|FG001|Randomized Phase Through Week 96|Death|1|||
27904775|NCT01309243|54561691|FG000|Randomized Phase Through Week 96|Pregnancy|2|||
27904776|NCT01309243|54561692|FG001|Randomized Phase Through Week 96|Pregnancy|0|||
27904777|NCT01309243|54561691|FG000|Randomized Phase Through Week 96|Lack of Efficacy|16|||
27904778|NCT01309243|54561692|FG001|Randomized Phase Through Week 96|Lack of Efficacy|4|||
27904779|NCT01309243|54561691|FG000|Randomized Phase Through Week 96|Investigators Discretion|3|||
27904780|NCT01309243|54561692|FG001|Randomized Phase Through Week 96|Investigators Discretion|6|||
27904781|NCT01309243|54561691|FG000|Randomized Phase Through Week 96|Withdrew Consent|12|||
27904782|NCT01309243|54561692|FG001|Randomized Phase Through Week 96|Withdrew Consent|18|||
27904783|NCT01309243|54561691|FG000|Randomized Phase Through Week 96|Lost to Follow-up|23|||
27904784|NCT01309243|54561692|FG001|Randomized Phase Through Week 96|Lost to Follow-up|22|||
27904785|NCT01309243|54561691|FG000|Randomized Phase Through Week 96|Subject Non-Compliance|9|||
27904786|NCT01309243|54561692|FG001|Randomized Phase Through Week 96|Subject Non-Compliance|7|||
27904787|NCT01309243|54561691|FG000|Randomized Phase Through Week 96|Protocol Violation|1|||
27904788|NCT01309243|54561692|FG001|Randomized Phase Through Week 96|Protocol Violation|1|||
27904789|NCT01309243|54561691|FG000|Extension Phase|Lost to Follow-up|6|||
27904790|NCT01309243|54561692|FG001|Extension Phase|Lost to Follow-up|0|||
27904791|NCT01309204|54561700|FG000|Overall Study|Adverse Event|48|||
27904792|NCT01309204|54561701|FG001|Overall Study|Adverse Event|58|||
27988681|NCT00522379|54647455|FG002|Overall Study|Sponsor Request|0|||
27988682|NCT00522379|54647456|FG003|Overall Study|Sponsor Request|0|||
27988683|NCT00522379|54647457|FG004|Overall Study|Sponsor Request|0|||
27988684|NCT00522379|54647453|FG000|Overall Study|Family Problem|0|||
27988685|NCT00522379|54647454|FG001|Overall Study|Family Problem|0|||
27988686|NCT00522379|54647455|FG002|Overall Study|Family Problem|1|||
27988687|NCT00522379|54647456|FG003|Overall Study|Family Problem|0|||
27988688|NCT00522379|54647457|FG004|Overall Study|Family Problem|0|||
27988689|NCT00522379|54647453|FG000|Overall Study|Site Closed|0|||
27988690|NCT00522379|54647454|FG001|Overall Study|Site Closed|0|||
27988691|NCT00522379|54647455|FG002|Overall Study|Site Closed|0|||
27988692|NCT00522379|54647456|FG003|Overall Study|Site Closed|1|||
27904793|NCT01309204|54561700|FG000|Overall Study|Lost to Follow-up|2|||
27904794|NCT01309204|54561701|FG001|Overall Study|Lost to Follow-up|2|||
27904795|NCT01309204|54561700|FG000|Overall Study|Subject's decision unrelated to an AE|9|||
27904796|NCT01309204|54561701|FG001|Overall Study|Subject's decision unrelated to an AE|10|||
27904797|NCT01309204|54561700|FG000|Overall Study|Inadequate control of IOP|4|||
27904798|NCT01309204|54561701|FG001|Overall Study|Inadequate control of IOP|4|||
27904799|NCT01309204|54561700|FG000|Overall Study|Other|4|||
27904800|NCT01309204|54561701|FG001|Overall Study|Other|1|||
27904801|NCT01309165|54561709|FG000|Overall Study|Lost to Follow-up|4|||
27904802|NCT01309165|54561710|FG001|Overall Study|Lost to Follow-up|3|||
27904803|NCT01309165|54561709|FG000|Overall Study|Return to work|1|||
27904804|NCT01309165|54561710|FG001|Overall Study|Return to work|2|||
27904805|NCT01309165|54561709|FG000|Overall Study|Left country|0|||
27904806|NCT01309165|54561710|FG001|Overall Study|Left country|1|||
27904807|NCT01309165|54561709|FG000|Overall Study|No transportation|0|||
27904808|NCT01309165|54561710|FG001|Overall Study|No transportation|1|||
27904809|NCT01309165|54561709|FG000|Overall Study|Admitted to hospital for second stroke|1|||
27904810|NCT01309165|54561710|FG001|Overall Study|Admitted to hospital for second stroke|0|||
27904811|NCT01308853|54561717|FG000|Overall Study|Adverse Event|1|||
27904812|NCT01308853|54561717|FG000|Overall Study|Lost to Follow-up|2|||
27904813|NCT01308853|54561717|FG000|Overall Study|Insertion of permanent implants|1|||
27904814|NCT01308736|54561723|FG000|Overall Study|Did not attend a single session|6|||
27988693|NCT00522379|54647457|FG004|Overall Study|Site Closed|0|||
27988694|NCT00522379|54647453|FG000|Overall Study|Subject Withdrawal|0|||
27904815|NCT01308736|54561724|FG001|Overall Study|Did not attend a single session|5|||
27988695|NCT00522379|54647454|FG001|Overall Study|Subject Withdrawal|0|||
27988696|NCT00522379|54647455|FG002|Overall Study|Subject Withdrawal|0|||
27988697|NCT00522379|54647456|FG003|Overall Study|Subject Withdrawal|1|||
27988698|NCT00522379|54647457|FG004|Overall Study|Subject Withdrawal|0|||
27988699|NCT00856830|54647473|FG000|Irinotecan & Bendamustine|Death|0|||
27988700|NCT00856830|54647474|FG001|Irinotecan & Bendamustine|Death|0|||
27988701|NCT00856830|54647475|FG002|Irinotecan & Bendamustine|Death|0|||
27904816|NCT01308580|54561732|FG000|Overall Study|Lost to Follow-up|12|||
27904817|NCT01308580|54561733|FG001|Overall Study|Lost to Follow-up|7|||
27904818|NCT01308463|54561740|FG000|Overall Study|Study Discontinued|23|||
27904819|NCT01308463|54561740|FG000|Overall Study|Death|4|||
27904820|NCT01308463|54561740|FG000|Overall Study|Revision|2|||
27904821|NCT01308424|54561746|FG000|Baseline Eligibility|Screen Failures|71|||
27904822|NCT01308424|54561747|FG001|Baseline Eligibility|Screen Failures|0|||
27904823|NCT01308424|54561748|FG002|Baseline Eligibility|Screen Failures|0|||
27904824|NCT01308424|54561746|FG000|Randomization|Adverse Event|0|||
27904825|NCT01308424|54561747|FG001|Randomization|Adverse Event|1|||
27904826|NCT01308424|54561748|FG002|Randomization|Adverse Event|1|||
27904827|NCT01308424|54561746|FG000|Randomization|Lost to Follow-up|0|||
27904828|NCT01308424|54561747|FG001|Randomization|Lost to Follow-up|1|||
27904829|NCT01308424|54561748|FG002|Randomization|Lost to Follow-up|0|||
27904830|NCT01308424|54561746|FG000|Randomization|Physician Decision|0|||
27904831|NCT01308424|54561747|FG001|Randomization|Physician Decision|1|||
27904832|NCT01308424|54561748|FG002|Randomization|Physician Decision|1|||
27904833|NCT01307800|54561759|FG000|Overall Study|Adverse Event|9|||
27904834|NCT01307800|54561760|FG001|Overall Study|Adverse Event|8|||
27904835|NCT01307800|54561761|FG002|Overall Study|Adverse Event|10|||
27904836|NCT01307800|54561762|FG003|Overall Study|Adverse Event|14|||
27904837|NCT01307800|54561759|FG000|Overall Study|Entry Criteria Not Met|0|||
27904838|NCT01307800|54561760|FG001|Overall Study|Entry Criteria Not Met|0|||
27904839|NCT01307800|54561761|FG002|Overall Study|Entry Criteria Not Met|0|||
27904840|NCT01307800|54561762|FG003|Overall Study|Entry Criteria Not Met|2|||
27904841|NCT01307800|54561759|FG000|Overall Study|Lost to Follow-up|5|||
27904842|NCT01307800|54561760|FG001|Overall Study|Lost to Follow-up|6|||
27904843|NCT01307800|54561761|FG002|Overall Study|Lost to Follow-up|2|||
27904844|NCT01307800|54561762|FG003|Overall Study|Lost to Follow-up|8|||
27904845|NCT01307800|54561759|FG000|Overall Study|Perceived Lack of Efficacy|24|||
27904846|NCT01307800|54561760|FG001|Overall Study|Perceived Lack of Efficacy|23|||
27904847|NCT01307800|54561761|FG002|Overall Study|Perceived Lack of Efficacy|20|||
27904848|NCT01307800|54561762|FG003|Overall Study|Perceived Lack of Efficacy|33|||
27904849|NCT01307800|54561759|FG000|Overall Study|Protocol Violation|0|||
27904850|NCT01307800|54561760|FG001|Overall Study|Protocol Violation|3|||
27904851|NCT01307800|54561761|FG002|Overall Study|Protocol Violation|4|||
27904852|NCT01307800|54561762|FG003|Overall Study|Protocol Violation|5|||
27904853|NCT01307800|54561759|FG000|Overall Study|Schedule Conflict Prevented Continuation|0|||
27904854|NCT01307800|54561760|FG001|Overall Study|Schedule Conflict Prevented Continuation|3|||
27904855|NCT01307800|54561761|FG002|Overall Study|Schedule Conflict Prevented Continuation|1|||
27904856|NCT01307800|54561762|FG003|Overall Study|Schedule Conflict Prevented Continuation|2|||
27904857|NCT01307800|54561759|FG000|Overall Study|Sponsor Decision|6|||
27904858|NCT01307800|54561760|FG001|Overall Study|Sponsor Decision|9|||
27904859|NCT01307800|54561761|FG002|Overall Study|Sponsor Decision|12|||
27904860|NCT01307800|54561762|FG003|Overall Study|Sponsor Decision|28|||
27904861|NCT01307800|54561759|FG000|Overall Study|Withdrawal by Subject|10|||
27904862|NCT01307800|54561760|FG001|Overall Study|Withdrawal by Subject|11|||
27904863|NCT01307800|54561761|FG002|Overall Study|Withdrawal by Subject|8|||
27904864|NCT01307800|54561762|FG003|Overall Study|Withdrawal by Subject|15|||
27904865|NCT01307800|54561759|FG000|Overall Study|Participant Moved|0|||
27904866|NCT01307800|54561760|FG001|Overall Study|Participant Moved|2|||
27904867|NCT01307800|54561761|FG002|Overall Study|Participant Moved|1|||
27904868|NCT01307800|54561762|FG003|Overall Study|Participant Moved|3|||
27904869|NCT01307449|54561776|FG000|Overall Study|Adverse Event|1|||
27904870|NCT01307449|54561777|FG001|Overall Study|Adverse Event|0|||
27904871|NCT01307449|54561778|FG002|Overall Study|Adverse Event|0|||
27904872|NCT01307449|54561779|FG003|Overall Study|Adverse Event|0|||
28097522|NCT03655106|54753215|FG000|Overall Study|Lost to Follow-up|2|||
28097523|NCT03655106|54753216|FG001|Overall Study|Lost to Follow-up|1|||
28097524|NCT03655106|54753215|FG000|Overall Study|Duplicate Enrollment|1|||
28097525|NCT03655106|54753216|FG001|Overall Study|Duplicate Enrollment|1|||
28097526|NCT03655106|54753215|FG000|Overall Study|Protocol Violation|3|||
28097527|NCT03655106|54753216|FG001|Overall Study|Protocol Violation|0|||
28097528|NCT03630302|54753222|FG000|Surgery|hardware issue prevented LFP recordings|1|||
28097529|NCT03630302|54753222|FG000|3 Month Visit|Adverse Event|2|||
27904873|NCT01307020|54561799|FG000|Overall Study|Lost to Follow-up|0|||
27904874|NCT01307020|54561800|FG001|Overall Study|Lost to Follow-up|0|||
27904875|NCT01307020|54561801|FG002|Overall Study|Lost to Follow-up|1|||
27904876|NCT01307020|54561802|FG003|Overall Study|Lost to Follow-up|1|||
27904877|NCT01307020|54561803|FG004|Overall Study|Lost to Follow-up|0|||
27904878|NCT01307020|54561804|FG005|Overall Study|Lost to Follow-up|0|||
27904879|NCT01307020|54561805|FG006|Overall Study|Lost to Follow-up|1|||
27904880|NCT01307020|54561806|FG007|Overall Study|Lost to Follow-up|0|||
27904881|NCT01307020|54561807|FG008|Overall Study|Lost to Follow-up|0|||
27904882|NCT01307020|54561808|FG009|Overall Study|Lost to Follow-up|0|||
27904883|NCT01307020|54561799|FG000|Overall Study|Electronic data capture failure|0|||
27904884|NCT01307020|54561800|FG001|Overall Study|Electronic data capture failure|1|||
27988702|NCT00856830|54647476|FG003|Irinotecan & Bendamustine|Death|2|||
27988703|NCT00856830|54647473|FG000|Irinotecan & Bendamustine|Physician Decision|0|||
27988704|NCT00856830|54647474|FG001|Irinotecan & Bendamustine|Physician Decision|0|||
27988705|NCT00856830|54647475|FG002|Irinotecan & Bendamustine|Physician Decision|0|||
27988706|NCT00856830|54647476|FG003|Irinotecan & Bendamustine|Physician Decision|1|||
27988707|NCT00522301|54647481|FG000|Overall Study|Withdrawal by Subject|1|||
27988708|NCT00522301|54647481|FG000|Overall Study|Adverse Event|5|||
27988709|NCT00863928|54647487|FG000|Overall Study|Protocol Violation|26|||
27988710|NCT00863928|54647488|FG001|Overall Study|Protocol Violation|0|||
27988711|NCT00863928|54647487|FG000|Overall Study|Withdrawal by Subject|3|||
27988712|NCT00863928|54647488|FG001|Overall Study|Withdrawal by Subject|0|||
27988713|NCT00863928|54647487|FG000|Overall Study|surgery cancellation|4|||
27988714|NCT00863928|54647488|FG001|Overall Study|surgery cancellation|0|||
27988715|NCT00863928|54647487|FG000|Overall Study|medication allergy|3|||
27988716|NCT00863928|54647488|FG001|Overall Study|medication allergy|0|||
27988717|NCT00856518|54647496|FG000|Overall Study|Lost to Follow-up|4|||
27988718|NCT00856518|54647497|FG001|Overall Study|Lost to Follow-up|2|||
27904885|NCT01307020|54561801|FG002|Overall Study|Electronic data capture failure|0|||
27904886|NCT01307020|54561802|FG003|Overall Study|Electronic data capture failure|0|||
27904887|NCT01307020|54561803|FG004|Overall Study|Electronic data capture failure|0|||
27904888|NCT01307020|54561804|FG005|Overall Study|Electronic data capture failure|0|||
27904889|NCT01307020|54561805|FG006|Overall Study|Electronic data capture failure|0|||
27904890|NCT01307020|54561806|FG007|Overall Study|Electronic data capture failure|0|||
27904891|NCT01307020|54561807|FG008|Overall Study|Electronic data capture failure|0|||
27904892|NCT01307020|54561808|FG009|Overall Study|Electronic data capture failure|0|||
27904893|NCT01306201|54561830|FG000|Overall Study|Arrhythmia|4|||
27904894|NCT01306201|54561830|FG000|Overall Study|Files could not be processed|3|||
27988719|NCT00506389|54647508|FG000|In-treatment Period|Other|3|||
27988720|NCT00506389|54647509|FG001|In-treatment Period|Other|3|||
27988721|NCT00506389|54647510|FG002|In-treatment Period|Other|4|||
27988722|NCT00506389|54647508|FG000|In-treatment Period|Lost to Follow-up|0|||
27988723|NCT00506389|54647509|FG001|In-treatment Period|Lost to Follow-up|0|||
27988724|NCT00506389|54647510|FG002|In-treatment Period|Lost to Follow-up|1|||
27988725|NCT00506389|54647508|FG000|In-treatment Period|Lack of compliance|1|||
27988726|NCT00506389|54647509|FG001|In-treatment Period|Lack of compliance|0|||
27988727|NCT00506389|54647510|FG002|In-treatment Period|Lack of compliance|0|||
27988728|NCT00506389|54647508|FG000|In-treatment Period|Reasons not related to trial|4|||
27988729|NCT00506389|54647509|FG001|In-treatment Period|Reasons not related to trial|1|||
27988730|NCT00506389|54647510|FG002|In-treatment Period|Reasons not related to trial|0|||
27988731|NCT00506389|54647508|FG000|In-treatment Period|Withdrawal by Subject|3|||
27988732|NCT00506389|54647509|FG001|In-treatment Period|Withdrawal by Subject|3|||
27988733|NCT00506389|54647510|FG002|In-treatment Period|Withdrawal by Subject|4|||
27988734|NCT00506389|54647508|FG000|In-treatment Period|Lack of Efficacy|0|||
27988735|NCT00506389|54647509|FG001|In-treatment Period|Lack of Efficacy|2|||
27988736|NCT00506389|54647510|FG002|In-treatment Period|Lack of Efficacy|0|||
27988737|NCT00506389|54647508|FG000|In-treatment Period|Adverse Event|11|||
27988738|NCT00506389|54647509|FG001|In-treatment Period|Adverse Event|5|||
27988739|NCT00506389|54647510|FG002|In-treatment Period|Adverse Event|2|||
27988740|NCT00506389|54647508|FG000|In-treatment Period|Randomized but not treated|4|||
27988741|NCT00506389|54647509|FG001|In-treatment Period|Randomized but not treated|1|||
27988742|NCT00506389|54647510|FG002|In-treatment Period|Randomized but not treated|1|||
27988743|NCT00871338|54647523|FG000|Prior to Booster|Withdrawal by Subject|1|||
27988744|NCT00871338|54647524|FG001|Prior to Booster|Withdrawal by Subject|3|||
27988745|NCT00871338|54647523|FG000|Prior to Booster|Lost to Follow-up|1|||
27988746|NCT00871338|54647524|FG001|Prior to Booster|Lost to Follow-up|0|||
27988747|NCT00824421|54647533|FG000|Overall Study|Adverse Event|6|||
27988748|NCT00824421|54647534|FG001|Overall Study|Adverse Event|6|||
27988749|NCT00824421|54647535|FG002|Overall Study|Adverse Event|6|||
27988750|NCT00824421|54647533|FG000|Overall Study|Death|0|||
27988751|NCT00824421|54647534|FG001|Overall Study|Death|1|||
27904895|NCT01306201|54561830|FG000|Overall Study|Files unreadable|3|||
27904896|NCT01306162|54561842|FG000|Period 1|Adverse Event|0|||
27988752|NCT00824421|54647535|FG002|Overall Study|Death|0|||
27988753|NCT00824421|54647533|FG000|Overall Study|Lack of Efficacy|5|||
27988754|NCT00824421|54647534|FG001|Overall Study|Lack of Efficacy|7|||
27988755|NCT00824421|54647535|FG002|Overall Study|Lack of Efficacy|4|||
27988756|NCT00824421|54647533|FG000|Overall Study|Lost to Follow-up|2|||
27904897|NCT01306162|54561843|FG001|Period 1|Adverse Event|0|||
27904898|NCT01306162|54561844|FG002|Period 1|Adverse Event|0|||
27904899|NCT01306162|54561845|FG003|Period 1|Adverse Event|1|||
27904900|NCT01306162|54561842|FG000|Washout 1|Non-compliance to protocol|0|||
27988757|NCT00824421|54647534|FG001|Overall Study|Lost to Follow-up|3|||
27925792|NCT01226745|54582369|FG002|Overall Study|Other|8|||
27988758|NCT00824421|54647535|FG002|Overall Study|Lost to Follow-up|0|||
27988759|NCT00824421|54647533|FG000|Overall Study|Pregnancy|1|||
27988760|NCT00824421|54647534|FG001|Overall Study|Pregnancy|0|||
27988761|NCT00824421|54647535|FG002|Overall Study|Pregnancy|1|||
27988762|NCT00824421|54647533|FG000|Overall Study|Withdrawal by Subject|2|||
27904901|NCT01306162|54561843|FG001|Washout 1|Non-compliance to protocol|1|||
27904902|NCT01306162|54561844|FG002|Washout 1|Non-compliance to protocol|0|||
27904903|NCT01306162|54561845|FG003|Washout 1|Non-compliance to protocol|0|||
27904904|NCT01305577|54561861|FG000|Overall Study|Adverse Event|2|||
27904905|NCT01305577|54561862|FG001|Overall Study|Adverse Event|2|||
27904906|NCT01305577|54561863|FG002|Overall Study|Adverse Event|1|||
27988763|NCT00824421|54647534|FG001|Overall Study|Withdrawal by Subject|3|||
27988764|NCT00824421|54647535|FG002|Overall Study|Withdrawal by Subject|3|||
27988765|NCT00824421|54647533|FG000|Overall Study|Randomized but not Treated|1|||
27988766|NCT00824421|54647534|FG001|Overall Study|Randomized but not Treated|1|||
27904907|NCT01305577|54561861|FG000|Overall Study|Withdrawal by Subject|7|||
27904908|NCT01305577|54561862|FG001|Overall Study|Withdrawal by Subject|5|||
27904909|NCT01305577|54561863|FG002|Overall Study|Withdrawal by Subject|6|||
27904910|NCT01305577|54561861|FG000|Overall Study|Lost to Follow-up|4|||
27904911|NCT01305577|54561862|FG001|Overall Study|Lost to Follow-up|3|||
27904912|NCT01305577|54561863|FG002|Overall Study|Lost to Follow-up|2|||
27904913|NCT01305577|54561861|FG000|Overall Study|Protocol Deviation|0|||
27904914|NCT01305577|54561862|FG001|Overall Study|Protocol Deviation|1|||
27904915|NCT01305577|54561863|FG002|Overall Study|Protocol Deviation|1|||
27904916|NCT01304329|54561871|FG000|Third Intervention (3 Days)|Adverse Event|0|||
27988767|NCT00824421|54647535|FG002|Overall Study|Randomized but not Treated|0|||
27988768|NCT00824421|54647533|FG000|Overall Study|Other|0|||
27988769|NCT00824421|54647534|FG001|Overall Study|Other|1|||
27988770|NCT00824421|54647535|FG002|Overall Study|Other|0|||
27988771|NCT00514813|54647549|FG000|Overall Study|Study terminated|14|||
27988772|NCT00514813|54647550|FG001|Overall Study|Study terminated|74|||
27988773|NCT00514813|54647551|FG002|Overall Study|Study terminated|40|||
27988774|NCT00514813|54647552|FG003|Overall Study|Study terminated|2|||
27988775|NCT00514813|54647549|FG000|Overall Study|Adverse Event|0|||
27988776|NCT00514813|54647550|FG001|Overall Study|Adverse Event|2|||
27988777|NCT00514813|54647551|FG002|Overall Study|Adverse Event|2|||
27988778|NCT00514813|54647552|FG003|Overall Study|Adverse Event|0|||
27988779|NCT00514813|54647549|FG000|Overall Study|Protocol Violation|1|||
27988780|NCT00514813|54647550|FG001|Overall Study|Protocol Violation|0|||
27988781|NCT00514813|54647551|FG002|Overall Study|Protocol Violation|0|||
27988782|NCT00514813|54647552|FG003|Overall Study|Protocol Violation|0|||
27988783|NCT00514813|54647549|FG000|Overall Study|Withdrawal by Subject|0|||
27988784|NCT00514813|54647550|FG001|Overall Study|Withdrawal by Subject|1|||
27988785|NCT00514813|54647551|FG002|Overall Study|Withdrawal by Subject|0|||
27988786|NCT00514813|54647552|FG003|Overall Study|Withdrawal by Subject|0|||
27988787|NCT00514813|54647549|FG000|Overall Study|Lack of Efficacy|0|||
27988788|NCT00514813|54647550|FG001|Overall Study|Lack of Efficacy|1|||
27988789|NCT00514813|54647551|FG002|Overall Study|Lack of Efficacy|0|||
27988790|NCT00514813|54647552|FG003|Overall Study|Lack of Efficacy|0|||
27988791|NCT00514813|54647549|FG000|Overall Study|Kidney transplant|0|||
27988792|NCT00514813|54647550|FG001|Overall Study|Kidney transplant|6|||
27988793|NCT00514813|54647551|FG002|Overall Study|Kidney transplant|2|||
27988794|NCT00514813|54647552|FG003|Overall Study|Kidney transplant|0|||
27988795|NCT00514813|54647549|FG000|Overall Study|Death|0|||
27988796|NCT00514813|54647550|FG001|Overall Study|Death|2|||
27988797|NCT00514813|54647551|FG002|Overall Study|Death|3|||
27988798|NCT00514813|54647552|FG003|Overall Study|Death|2|||
27988799|NCT00597116|54647564|FG000|Overall Study|Adverse Event|2|||
27988800|NCT00597116|54647565|FG001|Overall Study|Adverse Event|1|||
27988801|NCT00597116|54647564|FG000|Overall Study|Withdrawal by Subject|0|||
27988802|NCT00597116|54647565|FG001|Overall Study|Withdrawal by Subject|2|||
27988803|NCT00597116|54647564|FG000|Overall Study|Physician Decision|0|||
27988804|NCT00597116|54647565|FG001|Overall Study|Physician Decision|1|||
27988805|NCT00597116|54647564|FG000|Overall Study|Death|0|||
27988806|NCT00597116|54647565|FG001|Overall Study|Death|1|||
27988807|NCT00597116|54647564|FG000|Overall Study|Lost to Follow-up|1|||
27988808|NCT00597116|54647565|FG001|Overall Study|Lost to Follow-up|0|||
27988809|NCT00597116|54647564|FG000|Overall Study|Progressive disease|11|||
27904917|NCT01304329|54561872|FG001|Third Intervention (3 Days)|Adverse Event|1|||
27988810|NCT00597116|54647565|FG001|Overall Study|Progressive disease|6|||
27988811|NCT00514735|54647573|FG000|Overall Study|Withdrawal by Subject|13|||
27904918|NCT01304329|54561873|FG002|Third Intervention (3 Days)|Adverse Event|0|||
27904919|NCT01304329|54561874|FG003|Third Intervention (3 Days)|Adverse Event|0|||
27988812|NCT00514735|54647574|FG001|Overall Study|Withdrawal by Subject|5|||
27988813|NCT00514735|54647573|FG000|Overall Study|Death|1|||
27988814|NCT00514735|54647574|FG001|Overall Study|Death|0|||
27988815|NCT00514735|54647573|FG000|Overall Study|Lost to Follow-up|0|||
27904920|NCT01304329|54561875|FG004|Third Intervention (3 Days)|Adverse Event|0|||
27904921|NCT01304329|54561876|FG005|Third Intervention (3 Days)|Adverse Event|0|||
27904922|NCT01303861|54561889|FG000|Overall Study|Lost to Follow-up|34|||
27988816|NCT00514735|54647574|FG001|Overall Study|Lost to Follow-up|1|||
27988817|NCT03252587|54647586|FG000|Overall Study|Adverse Event|3|||
27988818|NCT03252587|54647587|FG001|Overall Study|Adverse Event|8|||
27988819|NCT03252587|54647588|FG002|Overall Study|Adverse Event|6|||
27988820|NCT03252587|54647589|FG003|Overall Study|Adverse Event|12|||
27988821|NCT03252587|54647586|FG000|Overall Study|Lack of Efficacy|7|||
27988822|NCT03252587|54647587|FG001|Overall Study|Lack of Efficacy|2|||
27988823|NCT03252587|54647588|FG002|Overall Study|Lack of Efficacy|2|||
27988824|NCT03252587|54647589|FG003|Overall Study|Lack of Efficacy|4|||
27988825|NCT03252587|54647586|FG000|Overall Study|Lost to Follow-up|2|||
27988826|NCT03252587|54647587|FG001|Overall Study|Lost to Follow-up|0|||
27988827|NCT03252587|54647588|FG002|Overall Study|Lost to Follow-up|0|||
27988828|NCT03252587|54647589|FG003|Overall Study|Lost to Follow-up|2|||
27988829|NCT03252587|54647586|FG000|Overall Study|Pregnancy|2|||
27988830|NCT03252587|54647587|FG001|Overall Study|Pregnancy|1|||
27988831|NCT03252587|54647588|FG002|Overall Study|Pregnancy|0|||
27988832|NCT03252587|54647589|FG003|Overall Study|Pregnancy|1|||
27988833|NCT03252587|54647586|FG000|Overall Study|Withdrawal by Subject|8|||
27988834|NCT03252587|54647587|FG001|Overall Study|Withdrawal by Subject|4|||
27988835|NCT03252587|54647588|FG002|Overall Study|Withdrawal by Subject|4|||
27988836|NCT03252587|54647589|FG003|Overall Study|Withdrawal by Subject|4|||
27988837|NCT03252587|54647586|FG000|Overall Study|Other Reasons|2|||
27988838|NCT03252587|54647587|FG001|Overall Study|Other Reasons|5|||
27988839|NCT03252587|54647588|FG002|Overall Study|Other Reasons|5|||
27988840|NCT03252587|54647589|FG003|Overall Study|Other Reasons|4|||
27988841|NCT00511147|54647602|FG000|Overall Study|Withdrawal by Subject|1|||
27988842|NCT00511147|54647602|FG000|Overall Study|Disease progression|5|||
27988843|NCT00511147|54647602|FG000|Overall Study|Required platelet transfusion|1|||
27988844|NCT00510835|54647609|FG000|Overall Study|Withdrawal by Subject|6|||
27988845|NCT00510835|54647610|FG001|Overall Study|Withdrawal by Subject|2|||
27988846|NCT00510835|54647611|FG002|Overall Study|Withdrawal by Subject|2|||
27988847|NCT00506077|54647621|FG000|Treatment Period 1|Adverse Event|2|||
27988848|NCT00506077|54647622|FG001|Treatment Period 1|Adverse Event|1|||
27988849|NCT00506077|54647621|FG000|Treatment Period 1|Lost to Follow-up|0|||
27988850|NCT00506077|54647622|FG001|Treatment Period 1|Lost to Follow-up|2|||
27988851|NCT00506077|54647621|FG000|Treatment Period 1|Withdrawal by Subject|2|||
27988852|NCT00506077|54647622|FG001|Treatment Period 1|Withdrawal by Subject|0|||
27988853|NCT00506077|54647621|FG000|Treatment Period 2|Adverse Event|0|||
27988854|NCT00506077|54647622|FG001|Treatment Period 2|Adverse Event|1|||
27988855|NCT00506077|54647621|FG000|Treatment Period 2|Withdrawal by Subject|1|||
27988856|NCT00506077|54647622|FG001|Treatment Period 2|Withdrawal by Subject|0|||
27988857|NCT00505921|54647628|FG000|Overall Study|Ineligible|1|||
27988858|NCT00505921|54647628|FG000|Overall Study|Failed to Mobilize|8|||
27988859|NCT00596960|54647634|FG000|Overall Study|Death|1|||
27988860|NCT00596960|54647635|FG001|Overall Study|Death|2|||
27904923|NCT01303861|54561890|FG001|Overall Study|Lost to Follow-up|14|||
27904924|NCT01303861|54561891|FG002|Overall Study|Lost to Follow-up|27|||
27904925|NCT01303861|54561892|FG003|Overall Study|Lost to Follow-up|31|||
27904926|NCT01303861|54561889|FG000|Overall Study|Lack of Efficacy|3|||
27904927|NCT01303861|54561890|FG001|Overall Study|Lack of Efficacy|2|||
27904928|NCT01303861|54561891|FG002|Overall Study|Lack of Efficacy|1|||
27904929|NCT01303861|54561892|FG003|Overall Study|Lack of Efficacy|0|||
27904930|NCT01303861|54561889|FG000|Overall Study|Withdrawal by Subject|16|||
27904931|NCT01303861|54561890|FG001|Overall Study|Withdrawal by Subject|8|||
27904932|NCT01303861|54561891|FG002|Overall Study|Withdrawal by Subject|8|||
27904933|NCT01303861|54561892|FG003|Overall Study|Withdrawal by Subject|23|||
27904934|NCT01303861|54561889|FG000|Overall Study|Adverse Event|4|||
27904935|NCT01303861|54561890|FG001|Overall Study|Adverse Event|1|||
27904936|NCT01303861|54561891|FG002|Overall Study|Adverse Event|0|||
27904937|NCT01303861|54561892|FG003|Overall Study|Adverse Event|5|||
27904938|NCT01303861|54561889|FG000|Overall Study|Pregnancy|1|||
27904939|NCT01303861|54561890|FG001|Overall Study|Pregnancy|0|||
27904940|NCT01303861|54561891|FG002|Overall Study|Pregnancy|0|||
27904941|NCT01303861|54561892|FG003|Overall Study|Pregnancy|0|||
27904942|NCT01303627|54561905|FG000|Overall Study|the failure while performing URS|0|||
27904943|NCT01303627|54561906|FG001|Overall Study|the failure while performing URS|1|||
27904944|NCT01303510|54561914|FG000|Overall Study|Lost to Follow-up|1|||
27904945|NCT01303510|54561915|FG001|Overall Study|Lost to Follow-up|0|||
27904946|NCT01303159|54561921|FG000|Overall Study|Death|16|||
27904947|NCT01303159|54561921|FG000|Overall Study|Study Termination|7|||
27904948|NCT01302964|54561927|FG000|Overall Study|Adverse Event|1|||
27904949|NCT01302964|54561928|FG001|Overall Study|Adverse Event|0|||
28097530|NCT03630302|54753222|FG000|Data Post Analyses|IRB issues prevented data from being analyzed and transferred|2|||
28097531|NCT04041440|54753228|FG000|Overall Study|Withdrawal by Subject|0|||
27988861|NCT00596960|54647634|FG000|Overall Study|Lost to Follow-up|6|||
27988862|NCT00596960|54647635|FG001|Overall Study|Lost to Follow-up|5|||
27904950|NCT01302691|54561936|FG000|Overall Study|Adverse Event|2|||
27904951|NCT01302691|54561937|FG001|Overall Study|Adverse Event|0|||
27904952|NCT01302691|54561936|FG000|Overall Study|Death|0|||
27988863|NCT00596960|54647634|FG000|Overall Study|Withdrawal by Subject|1|||
27988864|NCT00596960|54647635|FG001|Overall Study|Withdrawal by Subject|0|||
27904953|NCT01302691|54561937|FG001|Overall Study|Death|1|||
27904954|NCT01302691|54561936|FG000|Overall Study|Lost to Follow-up|1|||
27904955|NCT01302691|54561937|FG001|Overall Study|Lost to Follow-up|0|||
27988865|NCT00596960|54647634|FG000|Overall Study|Incarcerated|2|||
27904956|NCT01302691|54561936|FG000|Overall Study|Blood Pressure/Potassium Criteria Met|6|||
27904957|NCT01302691|54561937|FG001|Overall Study|Blood Pressure/Potassium Criteria Met|4|||
27904958|NCT01302691|54561936|FG000|Overall Study|Physician Decision|0|||
27904959|NCT01302691|54561937|FG001|Overall Study|Physician Decision|1|||
27904960|NCT01302691|54561936|FG000|Overall Study|Protocol Violation|1|||
27904961|NCT01302691|54561937|FG001|Overall Study|Protocol Violation|0|||
27904962|NCT01302418|54561943|FG000|Overall Study|Protocol Violation|9|||
27904963|NCT01302418|54561943|FG000|Overall Study|Non-evaluable|9|||
27904964|NCT01302067|54561950|FG000|Overall Study|Death|0|||
27904965|NCT01302067|54561951|FG001|Overall Study|Death|0|||
27904966|NCT01302067|54561952|FG002|Overall Study|Death|1|||
27904967|NCT01302067|54561950|FG000|Overall Study|Physician Decision|9|||
27904968|NCT01302067|54561951|FG001|Overall Study|Physician Decision|5|||
27904969|NCT01302067|54561952|FG002|Overall Study|Physician Decision|14|||
27904970|NCT01302067|54561950|FG000|Overall Study|Lack of Efficacy|8|||
27904971|NCT01302067|54561951|FG001|Overall Study|Lack of Efficacy|4|||
27904972|NCT01302067|54561952|FG002|Overall Study|Lack of Efficacy|2|||
27904973|NCT01302067|54561950|FG000|Overall Study|Lost to Follow-up|9|||
27904974|NCT01302067|54561951|FG001|Overall Study|Lost to Follow-up|4|||
27904975|NCT01302067|54561952|FG002|Overall Study|Lost to Follow-up|15|||
27904976|NCT01302067|54561950|FG000|Overall Study|Withdrawal by Subject|13|||
27904977|NCT01302067|54561951|FG001|Overall Study|Withdrawal by Subject|6|||
27904978|NCT01302067|54561952|FG002|Overall Study|Withdrawal by Subject|10|||
27904979|NCT01302067|54561950|FG000|Overall Study|Other|1|||
27904980|NCT01302067|54561951|FG001|Overall Study|Other|1|||
27904981|NCT01302067|54561952|FG002|Overall Study|Other|3|||
27904982|NCT01302067|54561950|FG000|Overall Study|Protocol Violation|11|||
27904983|NCT01302067|54561951|FG001|Overall Study|Protocol Violation|0|||
27904984|NCT01302067|54561952|FG002|Overall Study|Protocol Violation|8|||
27904985|NCT01302067|54561950|FG000|Overall Study|Adverse Event|27|||
27904986|NCT01302067|54561951|FG001|Overall Study|Adverse Event|14|||
27904987|NCT01302067|54561952|FG002|Overall Study|Adverse Event|45|||
27904988|NCT01301950|54561962|FG000|Overall Study|Surgery was cancelled by patient|0|||
27904989|NCT01301950|54561963|FG001|Overall Study|Surgery was cancelled by patient|1|||
27904990|NCT01301833|54561973|FG000|Overall Study|Adverse Event|7|||
27904991|NCT01301833|54561974|FG001|Overall Study|Adverse Event|5|||
27904992|NCT01301833|54561975|FG002|Overall Study|Adverse Event|5|||
27988866|NCT00596960|54647635|FG001|Overall Study|Incarcerated|0|||
27988867|NCT00596960|54647634|FG000|Overall Study|Physician Decision|1|||
27988868|NCT00596960|54647635|FG001|Overall Study|Physician Decision|0|||
27988869|NCT00596960|54647634|FG000|Overall Study|Protocol Violation|0|||
27988870|NCT00596960|54647635|FG001|Overall Study|Protocol Violation|1|||
27988871|NCT00596960|54647634|FG000|Overall Study|No alcohol use data|0|||
27988872|NCT00596960|54647635|FG001|Overall Study|No alcohol use data|1|||
27988873|NCT00505765|54647644|FG000|Overall Study|Withdrawal by Subject|1|||
27988874|NCT00505765|54647645|FG001|Overall Study|Withdrawal by Subject|0|||
27988875|NCT00505765|54647646|FG002|Overall Study|Withdrawal by Subject|0|||
27988876|NCT00505765|54647644|FG000|Overall Study|Adverse Event|1|||
27988877|NCT00505765|54647645|FG001|Overall Study|Adverse Event|2|||
27988878|NCT00505765|54647646|FG002|Overall Study|Adverse Event|0|||
27988879|NCT00505765|54647644|FG000|Overall Study|Noncompliance|0|||
27988880|NCT00505765|54647645|FG001|Overall Study|Noncompliance|1|||
27988881|NCT00505765|54647646|FG002|Overall Study|Noncompliance|3|||
27988882|NCT00505687|54647654|FG000|Overall Study|Important protocol violation|2|||
27988883|NCT00505687|54647654|FG000|Overall Study|Lack of Efficacy|15|||
27988884|NCT00505687|54647654|FG000|Overall Study|Adverse Event|48|||
27988885|NCT00505687|54647654|FG000|Overall Study|Subject withdrew consent|15|||
27988886|NCT00505687|54647654|FG000|Overall Study|Lost to Follow-up|1|||
27988887|NCT00505687|54647654|FG000|Overall Study|Other: Underwent Implantation Of DBS|1|||
27988888|NCT00505687|54647654|FG000|Overall Study|Other: Scheduled DBS Surgery|1|||
27988889|NCT00505687|54647654|FG000|Overall Study|Other: Prolonged Hospitalization|1|||
27988890|NCT00505687|54647654|FG000|Overall Study|Other: Patches Would Not Stick D/T Sweat|1|||
27988891|NCT00505687|54647654|FG000|Overall Study|Other: Neupro Given In Hospital|1|||
27988892|NCT00505687|54647654|FG000|Overall Study|Other: Disease Progression|1|||
27988893|NCT00505687|54647654|FG000|Overall Study|Other: As Per Sponsor|8|||
27988894|NCT00505375|54647660|FG000|Overall Study|Death|1|||
27988895|NCT00505375|54647661|FG001|Overall Study|Death|0|||
27904993|NCT01301833|54561976|FG003|Overall Study|Adverse Event|5|||
27904994|NCT01301833|54561973|FG000|Overall Study|Lack of Efficacy|1|||
27904995|NCT01301833|54561974|FG001|Overall Study|Lack of Efficacy|1|||
27904996|NCT01301833|54561975|FG002|Overall Study|Lack of Efficacy|0|||
27904997|NCT01301833|54561976|FG003|Overall Study|Lack of Efficacy|0|||
27904998|NCT01301833|54561973|FG000|Overall Study|Physician Decision|3|||
27904999|NCT01301833|54561974|FG001|Overall Study|Physician Decision|1|||
27905000|NCT01301833|54561975|FG002|Overall Study|Physician Decision|1|||
27905001|NCT01301833|54561976|FG003|Overall Study|Physician Decision|0|||
27988896|NCT00505375|54647660|FG000|Overall Study|Withdrawal by Subject|2|||
27988897|NCT00505375|54647661|FG001|Overall Study|Withdrawal by Subject|2|||
27988898|NCT00505375|54647660|FG000|Overall Study|Lost to Follow-up|0|||
27988899|NCT00505375|54647661|FG001|Overall Study|Lost to Follow-up|2|||
27988900|NCT00505375|54647660|FG000|Overall Study|Pregnancy|1|||
27905002|NCT01301833|54561973|FG000|Overall Study|Withdrawal by Subject|3|||
27905003|NCT01301833|54561974|FG001|Overall Study|Withdrawal by Subject|1|||
27905004|NCT01301833|54561975|FG002|Overall Study|Withdrawal by Subject|1|||
27905005|NCT01301833|54561976|FG003|Overall Study|Withdrawal by Subject|2|||
27905006|NCT01301833|54561973|FG000|Overall Study|Personal matter|1|||
27905007|NCT01301833|54561974|FG001|Overall Study|Personal matter|0|||
27905008|NCT01301833|54561975|FG002|Overall Study|Personal matter|0|||
27905009|NCT01301833|54561976|FG003|Overall Study|Personal matter|0|||
27905010|NCT01301092|54561989|FG000|Overall Study|Lost to Follow-up|0|||
27905011|NCT01301092|54561990|FG001|Overall Study|Lost to Follow-up|0|||
27905012|NCT01301092|54561991|FG002|Overall Study|Lost to Follow-up|1|||
27905013|NCT01300819|54562006|FG000|Overall Study|Adverse Event|9|||
27905014|NCT01300819|54562007|FG001|Overall Study|Adverse Event|27|||
27905015|NCT01300819|54562006|FG000|Overall Study|Lack of Efficacy|2|||
27988901|NCT00505375|54647661|FG001|Overall Study|Pregnancy|0|||
27988902|NCT00505375|54647660|FG000|Overall Study|Travel issues|0|||
27905016|NCT01300819|54562007|FG001|Overall Study|Lack of Efficacy|1|||
27988903|NCT00505375|54647661|FG001|Overall Study|Travel issues|1|||
27988904|NCT00594932|54647669|FG000|First 3 Months|Withdrawal by Subject|1|||
27988905|NCT00594932|54647670|FG001|First 3 Months|Withdrawal by Subject|3|||
27988906|NCT00594932|54647669|FG000|Final 3 Months|Withdrawal by Subject|4|||
27988907|NCT00594932|54647670|FG001|Final 3 Months|Withdrawal by Subject|3|||
27988908|NCT00504829|54647679|FG000|Overall Study|Protocol Violation|6|||
27988909|NCT00504829|54647680|FG001|Overall Study|Protocol Violation|4|||
27905017|NCT01300819|54562006|FG000|Overall Study|Withdrawal by Subject|10|||
27905018|NCT01300819|54562007|FG001|Overall Study|Withdrawal by Subject|12|||
27988910|NCT00504829|54647681|FG002|Overall Study|Protocol Violation|10|||
27988911|NCT00504595|54647693|FG000|Overall Study|Lack of Efficacy|1|||
27988912|NCT00504595|54647694|FG001|Overall Study|Lack of Efficacy|0|||
27988913|NCT00504595|54647695|FG002|Overall Study|Lack of Efficacy|0|||
27988914|NCT00504595|54647696|FG003|Overall Study|Lack of Efficacy|0|||
27988915|NCT00504595|54647693|FG000|Overall Study|Other|0|||
27988916|NCT00504595|54647694|FG001|Overall Study|Other|0|||
27988917|NCT00504595|54647695|FG002|Overall Study|Other|2|||
27988918|NCT00504595|54647696|FG003|Overall Study|Other|0|||
27988919|NCT00513409|54647708|FG000|Overall Study|Adverse Event|0|||
27988920|NCT00513409|54647709|FG001|Overall Study|Adverse Event|1|||
27988921|NCT00513409|54647708|FG000|Overall Study|Withdrawal by Subject|0|||
27988922|NCT00513409|54647709|FG001|Overall Study|Withdrawal by Subject|2|||
27988923|NCT00513409|54647708|FG000|Overall Study|Lost to Follow-up|0|||
27988924|NCT00513409|54647709|FG001|Overall Study|Lost to Follow-up|1|||
27988925|NCT00513409|54647708|FG000|Overall Study|Physician Decision|1|||
27988926|NCT00513409|54647709|FG001|Overall Study|Physician Decision|0|||
27988927|NCT00513409|54647708|FG000|Overall Study|Visit 3 not done|1|||
27988928|NCT00513409|54647709|FG001|Overall Study|Visit 3 not done|2|||
27988929|NCT03150095|54647717|FG000|Overall Study|Death|0|||
27988930|NCT03150095|54647718|FG001|Overall Study|Death|1|||
27988931|NCT03150095|54647717|FG000|Overall Study|Lost to Follow-up|1|||
27988932|NCT03150095|54647718|FG001|Overall Study|Lost to Follow-up|1|||
27988933|NCT03150095|54647717|FG000|Overall Study|Withdrawal by Subject|4|||
27905019|NCT01300819|54562006|FG000|Overall Study|Patient was 1 month late for Visit 10|0|||
27905020|NCT01300819|54562007|FG001|Overall Study|Patient was 1 month late for Visit 10|1|||
27905021|NCT01300819|54562006|FG000|Overall Study|Refusal to down titrate study drug|0|||
27905022|NCT01300819|54562007|FG001|Overall Study|Refusal to down titrate study drug|1|||
27905023|NCT01300819|54562006|FG000|Overall Study|Administrative reason|0|||
27905024|NCT01300819|54562007|FG001|Overall Study|Administrative reason|1|||
27905025|NCT01300819|54562006|FG000|Overall Study|Safety follow up not done by mistake|0|||
27905026|NCT01300819|54562007|FG001|Overall Study|Safety follow up not done by mistake|1|||
27905027|NCT01300819|54562006|FG000|Overall Study|Follow up call was not done|1|||
27905028|NCT01300819|54562007|FG001|Overall Study|Follow up call was not done|0|||
27905029|NCT01300741|54562013|FG000|Overall Study|Lens deposits|1|||
27905030|NCT01300741|54562013|FG000|Overall Study|Lost to Follow-up|1|||
27988934|NCT03150095|54647718|FG001|Overall Study|Withdrawal by Subject|0|||
27988935|NCT03150095|54647717|FG000|Overall Study|unable or unwilling to continue health coaching|4|||
27988936|NCT03150095|54647718|FG001|Overall Study|unable or unwilling to continue health coaching|0|||
27988937|NCT00705016|54647727|FG000|Overall Study|Adverse Event|6|||
27905031|NCT01300741|54562013|FG000|Overall Study|Discomfort|1|||
27905032|NCT01300546|54562021|FG000|Overall Study|Withdrawal by Subject|1|||
27988938|NCT00705016|54647728|FG001|Overall Study|Adverse Event|11|||
27988939|NCT00705016|54647729|FG002|Overall Study|Adverse Event|10|||
27988940|NCT00705016|54647727|FG000|Overall Study|Death|5|||
27988941|NCT00705016|54647728|FG001|Overall Study|Death|7|||
27988942|NCT00705016|54647729|FG002|Overall Study|Death|5|||
27988943|NCT00705016|54647727|FG000|Overall Study|Protocol Violation|0|||
27988944|NCT00705016|54647728|FG001|Overall Study|Protocol Violation|1|||
27988945|NCT00705016|54647729|FG002|Overall Study|Protocol Violation|1|||
27988946|NCT00705016|54647727|FG000|Overall Study|Withdrawal by Subject|4|||
27905033|NCT01300546|54562022|FG001|Overall Study|Withdrawal by Subject|0|||
27988947|NCT00705016|54647728|FG001|Overall Study|Withdrawal by Subject|3|||
27988948|NCT00705016|54647729|FG002|Overall Study|Withdrawal by Subject|2|||
27905034|NCT01300546|54562021|FG000|Overall Study|Lost to Follow-up|0|||
27988949|NCT00705016|54647727|FG000|Overall Study|Progressive Disease|33|||
27988950|NCT00705016|54647728|FG001|Overall Study|Progressive Disease|29|||
27905035|NCT01300546|54562022|FG001|Overall Study|Lost to Follow-up|2|||
27905036|NCT01300546|54562021|FG000|Overall Study|Lack of Efficacy|0|||
27905037|NCT01300546|54562022|FG001|Overall Study|Lack of Efficacy|3|||
27988951|NCT00705016|54647729|FG002|Overall Study|Progressive Disease|33|||
27988952|NCT00705016|54647727|FG000|Overall Study|Symptomatic Deterioration|3|||
27988953|NCT00705016|54647728|FG001|Overall Study|Symptomatic Deterioration|1|||
27988954|NCT00705016|54647729|FG002|Overall Study|Symptomatic Deterioration|1|||
27988955|NCT00705016|54647727|FG000|Overall Study|Other|9|||
27988956|NCT00705016|54647728|FG001|Overall Study|Other|6|||
27988957|NCT00705016|54647729|FG002|Overall Study|Other|6|||
27988958|NCT00595868|54647739|FG000|Overall Study|Lost to Follow-up|45|||
27988959|NCT00595868|54647740|FG001|Overall Study|Lost to Follow-up|50|||
27905038|NCT01300546|54562021|FG000|Overall Study|Adverse Event|0|||
27905039|NCT01300546|54562022|FG001|Overall Study|Adverse Event|1|||
27905040|NCT01300351|54562030|FG000|Overall Study|Did not receive treatment|2|||
27905041|NCT01300351|54562031|FG001|Overall Study|Did not receive treatment|0|||
27905042|NCT01300351|54562030|FG000|Overall Study|Ongoing treatment at data cut-off|27|||
27905043|NCT01300351|54562031|FG001|Overall Study|Ongoing treatment at data cut-off|23|||
27905044|NCT01300351|54562030|FG000|Overall Study|Lost to Follow-up|0|||
27905045|NCT01300351|54562031|FG001|Overall Study|Lost to Follow-up|1|||
27905046|NCT01300351|54562030|FG000|Overall Study|Adverse Event|0|||
27905047|NCT01300351|54562031|FG001|Overall Study|Adverse Event|4|||
27988960|NCT00856284|54647770|FG000|Overall Study|Hyperglycemic rescue|231|||
27988961|NCT00856284|54647771|FG001|Overall Study|Hyperglycemic rescue|201|||
27988962|NCT00856284|54647772|FG002|Overall Study|Hyperglycemic rescue|235|||
27988963|NCT00856284|54647770|FG000|Overall Study|Adverse Event|60|||
27988964|NCT00856284|54647771|FG001|Overall Study|Adverse Event|74|||
27988965|NCT00856284|54647772|FG002|Overall Study|Adverse Event|82|||
27988966|NCT00856284|54647770|FG000|Overall Study|Major protocol deviation|24|||
27988967|NCT00856284|54647771|FG001|Overall Study|Major protocol deviation|16|||
27988968|NCT00856284|54647772|FG002|Overall Study|Major protocol deviation|15|||
27988969|NCT00856284|54647770|FG000|Overall Study|Lost to Follow-up|20|||
27988970|NCT00856284|54647771|FG001|Overall Study|Lost to Follow-up|22|||
27988971|NCT00856284|54647772|FG002|Overall Study|Lost to Follow-up|28|||
27988972|NCT00856284|54647770|FG000|Overall Study|Voluntary withdrawal|48|||
27988973|NCT00856284|54647771|FG001|Overall Study|Voluntary withdrawal|52|||
27988974|NCT00856284|54647772|FG002|Overall Study|Voluntary withdrawal|62|||
27905048|NCT01300351|54562030|FG000|Overall Study|Withdrawal by Subject|7|||
27905049|NCT01300351|54562031|FG001|Overall Study|Withdrawal by Subject|10|||
27905050|NCT01300234|54562039|FG000|Overall Study|Adverse Event|1|||
27905051|NCT01300234|54562040|FG001|Overall Study|Adverse Event|1|||
27905052|NCT01300234|54562039|FG000|Overall Study|Protocol Violation|2|||
27905053|NCT01300234|54562040|FG001|Overall Study|Protocol Violation|3|||
27905054|NCT01300234|54562039|FG000|Overall Study|Withdrawal by Subject|5|||
27905055|NCT01300234|54562040|FG001|Overall Study|Withdrawal by Subject|9|||
27905056|NCT01300234|54562039|FG000|Overall Study|Lost to Follow-up|14|||
27905057|NCT01300234|54562040|FG001|Overall Study|Lost to Follow-up|12|||
27905058|NCT01300234|54562039|FG000|Overall Study|Pregnancy|2|||
27905059|NCT01300234|54562040|FG001|Overall Study|Pregnancy|1|||
27905060|NCT01300234|54562039|FG000|Overall Study|Participant reached stopping critera|2|||
27905061|NCT01300234|54562040|FG001|Overall Study|Participant reached stopping critera|0|||
27905062|NCT01300234|54562039|FG000|Overall Study|Participant stopped medication|1|||
27905063|NCT01300234|54562040|FG001|Overall Study|Participant stopped medication|1|||
27905064|NCT01300234|54562039|FG000|Overall Study|Participant refused return to hospital|1|||
27905065|NCT01300234|54562040|FG001|Overall Study|Participant refused return to hospital|0|||
27905066|NCT01299961|54562057|FG000|Overall Study|Adverse Event|3|||
27905067|NCT01299961|54562057|FG000|Overall Study|Lack of Efficacy|2|||
27905068|NCT01299961|54562057|FG000|Overall Study|Lost to Follow-up|1|||
27905069|NCT01299805|54562063|FG000|Overall Study|Adverse Event|2|||
27988975|NCT00856284|54647770|FG000|Overall Study|Pregnancy|1|||
27905070|NCT01299805|54562064|FG001|Overall Study|Adverse Event|0|||
27905071|NCT01299766|54562072|FG000|Overall Study|Death|5|||
27905072|NCT01299766|54562073|FG001|Overall Study|Death|4|||
27905073|NCT01299766|54562072|FG000|Overall Study|Withdrawal by Subject|29|||
27905074|NCT01299766|54562073|FG001|Overall Study|Withdrawal by Subject|19|||
27905075|NCT01299727|54562082|FG000|Overall Study|Withdrawal by Subject|1|||
27988976|NCT00856284|54647771|FG001|Overall Study|Pregnancy|2|||
27988977|NCT00856284|54647772|FG002|Overall Study|Pregnancy|0|||
27905076|NCT01299727|54562083|FG001|Overall Study|Withdrawal by Subject|0|||
27905077|NCT01299727|54562084|FG002|Overall Study|Withdrawal by Subject|0|||
27905078|NCT01299727|54562082|FG000|Overall Study|Adverse Event|0|||
27988978|NCT00856284|54647770|FG000|Overall Study|Investigator discretion|9|||
27905079|NCT01299727|54562083|FG001|Overall Study|Adverse Event|0|||
27905080|NCT01299727|54562084|FG002|Overall Study|Adverse Event|1|||
27905081|NCT01299727|54562082|FG000|Overall Study|Completed the Treatment Period|3|||
27905082|NCT01299727|54562083|FG001|Overall Study|Completed the Treatment Period|4|||
27905083|NCT01299727|54562084|FG002|Overall Study|Completed the Treatment Period|3|||
27905084|NCT01299571|54562092|FG000|Overall Study|Protocol Violation|107|||
27905085|NCT01299376|54562099|FG000|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1|||
27905086|NCT01299376|54562100|FG001|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2|||
27905087|NCT01299376|54562099|FG000|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0|||
27905088|NCT01299376|54562100|FG001|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1|||
27905089|NCT01299376|54562099|FG000|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0|||
27905090|NCT01299376|54562100|FG001|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1|||
27905091|NCT01299376|54562099|FG000|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4|||
27905092|NCT01299376|54562100|FG001|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7|||
27905093|NCT01299376|54562099|FG000|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1|||
27905094|NCT01299376|54562100|FG001|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0|||
27905095|NCT01299376|54562099|FG000|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
27905096|NCT01299376|54562100|FG001|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
27905097|NCT01299376|54562099|FG000|Extension (Weeks 9 to 52)|Withdrawal by Subject|2|||
27905098|NCT01299376|54562100|FG001|Extension (Weeks 9 to 52)|Withdrawal by Subject|1|||
27905099|NCT01299376|54562099|FG000|Extension (Weeks 9 to 52)|Adverse Event|2|||
27905100|NCT01299376|54562100|FG001|Extension (Weeks 9 to 52)|Adverse Event|3|||
27905101|NCT01299376|54562099|FG000|Extension (Weeks 9 to 52)|Lost to Follow-up|1|||
27905102|NCT01299376|54562100|FG001|Extension (Weeks 9 to 52)|Lost to Follow-up|2|||
27905103|NCT01299376|54562099|FG000|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4|||
27905104|NCT01299376|54562100|FG001|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9|||
27905105|NCT01299376|54562099|FG000|Extension (Weeks 9 to 52)|Physician Decision|1|||
27905106|NCT01299376|54562100|FG001|Extension (Weeks 9 to 52)|Physician Decision|0|||
27905107|NCT01299025|54562112|FG000|Overall Study|Withdrawal by Subject|2|||
27905108|NCT01299025|54562113|FG001|Overall Study|Withdrawal by Subject|1|||
27905109|NCT01299025|54562112|FG000|Overall Study|Lost to Follow-up|1|||
27905110|NCT01299025|54562113|FG001|Overall Study|Lost to Follow-up|0|||
27905111|NCT01298596|54562121|FG000|Overall Study|Withdrawal by Subject|1|||
27905112|NCT01298596|54562122|FG001|Overall Study|Withdrawal by Subject|1|||
27905113|NCT01298596|54562121|FG000|Overall Study|Death|5|||
27905114|NCT01298596|54562122|FG001|Overall Study|Death|3|||
27905115|NCT01298596|54562121|FG000|Overall Study|Lost to Follow-up|6|||
27905116|NCT01298596|54562122|FG001|Overall Study|Lost to Follow-up|14|||
27905117|NCT01298596|54562121|FG000|Overall Study|Referred for further management|16|||
27905118|NCT01298596|54562122|FG001|Overall Study|Referred for further management|15|||
27905119|NCT01298518|54562131|FG000|Overall Study|Withdrawal by Subject|0|||
27905120|NCT01298518|54562132|FG001|Overall Study|Withdrawal by Subject|0|||
27905121|NCT01298518|54562133|FG002|Overall Study|Withdrawal by Subject|1|||
27905122|NCT01298362|54562143|FG000|Overall Study|Did not provide 12month BMD measurements|38|||
27905123|NCT01298362|54562144|FG001|Overall Study|Did not provide 12month BMD measurements|43|||
27905124|NCT01298323|54562154|FG000|Overall Study|Adverse Event|2|||
27905125|NCT01298323|54562155|FG001|Overall Study|Adverse Event|4|||
27905126|NCT01298323|54562154|FG000|Overall Study|Death|11|||
27905127|NCT01298323|54562155|FG001|Overall Study|Death|16|||
27905128|NCT01298323|54562154|FG000|Overall Study|Lost to Follow-up|1|||
27905129|NCT01298323|54562155|FG001|Overall Study|Lost to Follow-up|0|||
27905130|NCT01298323|54562154|FG000|Overall Study|Withdrawal by Subject|6|||
27905131|NCT01298323|54562155|FG001|Overall Study|Withdrawal by Subject|3|||
27905132|NCT01298323|54562154|FG000|Overall Study|Protocol Violation|1|||
27905133|NCT01298323|54562155|FG001|Overall Study|Protocol Violation|0|||
27905134|NCT01298323|54562154|FG000|Overall Study|Other|10|||
27905135|NCT01298323|54562155|FG001|Overall Study|Other|9|||
27905136|NCT01298323|54562154|FG000|Overall Study|Ongoing|55|||
27905137|NCT01298323|54562155|FG001|Overall Study|Ongoing|55|||
27905138|NCT01298323|54562154|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
27905139|NCT01298323|54562155|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
27905140|NCT01297504|54562161|FG000|Overall Study|Invalid Consent|1|||
27905141|NCT01297504|54562161|FG000|Overall Study|Received Palivizumab in Previous Season|1|||
27905142|NCT01297504|54562161|FG000|Overall Study|No Study Visits|4|||
27905143|NCT01297504|54562161|FG000|Overall Study|Death|3|||
27905144|NCT01297504|54562161|FG000|Overall Study|Lost to Follow-up|43|||
27905145|NCT01297504|54562161|FG000|Overall Study|Withdrawal by Subject|9|||
27905146|NCT01297504|54562161|FG000|Overall Study|Site Closure|3|||
27905147|NCT01297504|54562161|FG000|Overall Study|Protocol Violation|3|||
27905148|NCT01297465|54562171|FG000|Overall Study|Lack of Ovarian Response|1|||
27905149|NCT01297465|54562172|FG001|Overall Study|Lack of Ovarian Response|1|||
27905150|NCT01297465|54562171|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
27905151|NCT01297465|54562172|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
27905152|NCT01297465|54562171|FG000|Overall Study|No Oocytes Retrieved|1|||
27905153|NCT01297465|54562172|FG001|Overall Study|No Oocytes Retrieved|1|||
27905154|NCT01297465|54562171|FG000|Overall Study|Poor oocyte quality|0|||
27905155|NCT01297465|54562172|FG001|Overall Study|Poor oocyte quality|1|||
27905156|NCT01297465|54562171|FG000|Overall Study|No Fertilization|6|||
27905157|NCT01297465|54562172|FG001|Overall Study|No Fertilization|4|||
27905158|NCT01297465|54562171|FG000|Overall Study|All Embryos Discarded|0|||
27905159|NCT01297465|54562172|FG001|Overall Study|All Embryos Discarded|1|||
27905160|NCT01297465|54562171|FG000|Overall Study|Intention to Freeze all Embryos|0|||
27905161|NCT01297465|54562172|FG001|Overall Study|Intention to Freeze all Embryos|1|||
27905162|NCT01297309|54562178|FG000|Overall Study|Eligibility failure|2|||
27905163|NCT01297309|54562178|FG000|Overall Study|Screen failure|2|||
27905164|NCT01297309|54562178|FG000|Overall Study|Withdrawal by Subject|5|||
27905165|NCT01297309|54562178|FG000|Overall Study|Adverse Event|1|||
27905166|NCT01297309|54562178|FG000|Overall Study|Investigator Decision|2|||
27905167|NCT01297309|54562178|FG000|Overall Study|Death|1|||
27905168|NCT01297309|54562178|FG000|Overall Study|Participant not entering extensionperiod|1|||
27988979|NCT00856284|54647771|FG001|Overall Study|Investigator discretion|8|||
27988980|NCT00856284|54647772|FG002|Overall Study|Investigator discretion|10|||
27988981|NCT00856284|54647770|FG000|Overall Study|Other|15|||
27988982|NCT00856284|54647771|FG001|Overall Study|Other|17|||
27988983|NCT00856284|54647772|FG002|Overall Study|Other|14|||
27988984|NCT00856284|54647770|FG000|Overall Study|Randomized in error|0|||
27988985|NCT00856284|54647771|FG001|Overall Study|Randomized in error|0|||
27988986|NCT00856284|54647772|FG002|Overall Study|Randomized in error|1|||
27988987|NCT00510289|54647780|FG000|Overall Study|Withdrawal by Subject|7|||
27988988|NCT00510289|54647780|FG000|Overall Study|Refused bone marrow biopsy|2|||
27988989|NCT00510289|54647780|FG000|Overall Study|Lost to Follow-up|1|||
27988990|NCT00510289|54647780|FG000|Overall Study|Progressed prior to starting drug|2|||
27988991|NCT00492115|54647787|FG000|Overall Study|Withdrawal by Subject|3|||
27988992|NCT00492115|54647788|FG001|Overall Study|Withdrawal by Subject|4|||
27988993|NCT00856206|54647796|FG000|Overall Study|Protocol Violation|6|||
27988994|NCT00856206|54647797|FG001|Overall Study|Protocol Violation|18|||
27988995|NCT00856206|54647796|FG000|Overall Study|Adverse Event|10|||
27988996|NCT00856206|54647797|FG001|Overall Study|Adverse Event|46|||
27988997|NCT00856206|54647796|FG000|Overall Study|Lack of Efficacy|1|||
27988998|NCT00856206|54647797|FG001|Overall Study|Lack of Efficacy|2|||
27988999|NCT00856206|54647796|FG000|Overall Study|Withdrawal by Subject|15|||
27989000|NCT00856206|54647797|FG001|Overall Study|Withdrawal by Subject|36|||
27989001|NCT00856206|54647796|FG000|Overall Study|Lost to Follow-up|13|||
27989002|NCT00856206|54647797|FG001|Overall Study|Lost to Follow-up|39|||
27989003|NCT00856206|54647796|FG000|Overall Study|Death|2|||
27989004|NCT00856206|54647797|FG001|Overall Study|Death|2|||
27989005|NCT00856206|54647796|FG000|Overall Study|Decision by the Sponsor|4|||
27989006|NCT00856206|54647797|FG001|Overall Study|Decision by the Sponsor|8|||
27989007|NCT00856206|54647796|FG000|Overall Study|Other than specified above|3|||
27989008|NCT00856206|54647797|FG001|Overall Study|Other than specified above|10|||
27989009|NCT00593112|54647805|FG000|Overall Study|Scan Anxiety|3|||
27989010|NCT00593112|54647806|FG001|Overall Study|Scan Anxiety|0|||
27989011|NCT00593112|54647805|FG000|Overall Study|Abnormal Scan|1|||
27905169|NCT04518462|54562185|FG000|Overall Study|Withdrawal by Subject|0|||
27905170|NCT04518462|54562186|FG001|Overall Study|Withdrawal by Subject|0|||
27905171|NCT04518462|54562187|FG002|Overall Study|Withdrawal by Subject|1|||
27905172|NCT04518462|54562185|FG000|Overall Study|Physician Decision|1|||
27905173|NCT04518462|54562186|FG001|Overall Study|Physician Decision|1|||
27905174|NCT04518462|54562187|FG002|Overall Study|Physician Decision|0|||
27905175|NCT01297270|54562198|FG000|Overall Study|Adverse Event|19|||
27905176|NCT01297270|54562199|FG001|Overall Study|Adverse Event|32|||
27905177|NCT01297270|54562200|FG002|Overall Study|Adverse Event|5|||
27905178|NCT01297270|54562198|FG000|Overall Study|Lack of Efficacy|15|||
27905179|NCT01297270|54562199|FG001|Overall Study|Lack of Efficacy|17|||
27905180|NCT01297270|54562200|FG002|Overall Study|Lack of Efficacy|15|||
27905181|NCT01297270|54562198|FG000|Overall Study|Lost to Follow-up|1|||
27905182|NCT01297270|54562199|FG001|Overall Study|Lost to Follow-up|2|||
27905183|NCT01297270|54562200|FG002|Overall Study|Lost to Follow-up|1|||
27989012|NCT00593112|54647806|FG001|Overall Study|Abnormal Scan|0|||
27989013|NCT00593112|54647805|FG000|Overall Study|Unreadable Scan|1|||
27905184|NCT01297270|54562198|FG000|Overall Study|Protocol Violation|0|||
27905185|NCT01297270|54562199|FG001|Overall Study|Protocol Violation|2|||
27905186|NCT01297270|54562200|FG002|Overall Study|Protocol Violation|0|||
27905187|NCT01297270|54562198|FG000|Overall Study|Withdrawal by Subject|7|||
27905188|NCT01297270|54562199|FG001|Overall Study|Withdrawal by Subject|15|||
27905189|NCT01297270|54562200|FG002|Overall Study|Withdrawal by Subject|7|||
27905190|NCT01297270|54562198|FG000|Overall Study|Other reason not defined above|3|||
27989014|NCT00593112|54647806|FG001|Overall Study|Unreadable Scan|0|||
27989015|NCT00593112|54647805|FG000|Overall Study|Withdrawal by Subject|5|||
27905191|NCT01297270|54562199|FG001|Overall Study|Other reason not defined above|3|||
27925793|NCT01226745|54582370|FG003|Overall Study|Other|4|||
27989016|NCT00593112|54647806|FG001|Overall Study|Withdrawal by Subject|0|||
27905192|NCT01297270|54562200|FG002|Overall Study|Other reason not defined above|1|||
27905193|NCT01297270|54562198|FG000|Overall Study|Not treated|0|||
27905194|NCT01297270|54562199|FG001|Overall Study|Not treated|1|||
27905195|NCT01297270|54562200|FG002|Overall Study|Not treated|0|||
27905196|NCT01296568|54562208|FG000|Continued Access Phase|Lost to Follow-up|1|||
27905197|NCT01296568|54562208|FG000|Continued Access Phase|Withdrawal by Subject|1|||
27905198|NCT01296568|54562208|FG000|Continued Access Phase|Disease Progression|1|||
27905199|NCT01296412|54562216|FG000|Overall Study|Adverse Event|8|||
27905200|NCT01296412|54562217|FG001|Overall Study|Adverse Event|29|||
27905201|NCT01296412|54562216|FG000|Overall Study|Lack of Efficacy|1|||
27905202|NCT01296412|54562217|FG001|Overall Study|Lack of Efficacy|0|||
27905203|NCT01296412|54562216|FG000|Overall Study|Lost to Follow-up|10|||
27905204|NCT01296412|54562217|FG001|Overall Study|Lost to Follow-up|7|||
27989017|NCT00491179|54647814|FG000|Overall Study|Adverse Event|5|||
27989018|NCT00491179|54647815|FG001|Overall Study|Adverse Event|1|||
27989019|NCT00491179|54647814|FG000|Overall Study|Withdrawal by Subject|2|||
27989020|NCT00491179|54647815|FG001|Overall Study|Withdrawal by Subject|1|||
27989021|NCT00503581|54647824|FG000|Overall Study|Study closed|3|||
27989022|NCT00503581|54647825|FG001|Overall Study|Study closed|4|||
27989023|NCT00503581|54647826|FG002|Overall Study|Study closed|2|||
27989024|NCT00703534|54647836|FG000|Overall Study|Adverse Event|14|||
27905205|NCT01296412|54562216|FG000|Overall Study|Non-compliance with study drug|1|||
27905206|NCT01296412|54562217|FG001|Overall Study|Non-compliance with study drug|2|||
27905207|NCT01296412|54562216|FG000|Overall Study|Other reason not specified|20|||
27905208|NCT01296412|54562217|FG001|Overall Study|Other reason not specified|15|||
27905209|NCT01296412|54562216|FG000|Overall Study|Physician Decision|1|||
27905210|NCT01296412|54562217|FG001|Overall Study|Physician Decision|3|||
27905211|NCT01296412|54562216|FG000|Overall Study|Pregnancy|0|||
27905212|NCT01296412|54562217|FG001|Overall Study|Pregnancy|1|||
27905213|NCT01296412|54562216|FG000|Overall Study|Withdrawal by Subject|10|||
27905214|NCT01296412|54562217|FG001|Overall Study|Withdrawal by Subject|13|||
27905215|NCT01295905|54562225|FG000|Overall Study|Did not meet inclusion criteria|1|||
27905216|NCT01295905|54562226|FG001|Overall Study|Did not meet inclusion criteria|0|||
27905217|NCT01295905|54562225|FG000|Overall Study|Met exclusion criteria|1|||
27905218|NCT01295905|54562226|FG001|Overall Study|Met exclusion criteria|0|||
27905219|NCT02596035|54562235|FG000|Overall Study|Disease Progression|64|||
27905220|NCT02596035|54562236|FG001|Overall Study|Disease Progression|32|||
27905221|NCT02596035|54562237|FG002|Overall Study|Disease Progression|1|||
27905222|NCT02596035|54562235|FG000|Overall Study|study drug toxicity|12|||
27905223|NCT02596035|54562236|FG001|Overall Study|study drug toxicity|3|||
27905224|NCT02596035|54562237|FG002|Overall Study|study drug toxicity|0|||
27905225|NCT02596035|54562235|FG000|Overall Study|AE unrelated to study drug|5|||
27905226|NCT02596035|54562236|FG001|Overall Study|AE unrelated to study drug|2|||
27905227|NCT02596035|54562237|FG002|Overall Study|AE unrelated to study drug|0|||
27905228|NCT02596035|54562235|FG000|Overall Study|participant request to discontinue study treatment|2|||
27905229|NCT02596035|54562236|FG001|Overall Study|participant request to discontinue study treatment|0|||
27905230|NCT02596035|54562237|FG002|Overall Study|participant request to discontinue study treatment|0|||
27905231|NCT02596035|54562235|FG000|Overall Study|participant withdrew consent|2|||
27905232|NCT02596035|54562236|FG001|Overall Study|participant withdrew consent|2|||
27905233|NCT02596035|54562237|FG002|Overall Study|participant withdrew consent|0|||
27905234|NCT02596035|54562235|FG000|Overall Study|Poor/Non Comlpiance|0|||
27905235|NCT02596035|54562236|FG001|Overall Study|Poor/Non Comlpiance|1|||
27905236|NCT02596035|54562237|FG002|Overall Study|Poor/Non Comlpiance|0|||
27905237|NCT02596035|54562235|FG000|Overall Study|participant no longer meets study criteria|1|||
27905238|NCT02596035|54562236|FG001|Overall Study|participant no longer meets study criteria|0|||
27905239|NCT02596035|54562237|FG002|Overall Study|participant no longer meets study criteria|0|||
27905240|NCT02596035|54562235|FG000|Overall Study|other reasons|11|||
27905241|NCT02596035|54562236|FG001|Overall Study|other reasons|4|||
27905242|NCT02596035|54562237|FG002|Overall Study|other reasons|0|||
27905243|NCT02595372|54562246|FG000|Overall Study|Adverse Event|6|||
27905244|NCT02595372|54562246|FG000|Overall Study|Physician Decision|2|||
27905245|NCT02595372|54562246|FG000|Overall Study|Disease Progression|1|||
27905246|NCT01248962|54562266|FG000|Overall Study|Withdrawal by Subject|1|||
27905247|NCT01248962|54562267|FG001|Overall Study|Withdrawal by Subject|1|||
27905248|NCT01248962|54562266|FG000|Overall Study|Adverse Event|2|||
27905249|NCT01248962|54562267|FG001|Overall Study|Adverse Event|1|||
27905250|NCT01248962|54562266|FG000|Overall Study|Complete Response after 4 Cycles|1|||
27905251|NCT01248962|54562267|FG001|Overall Study|Complete Response after 4 Cycles|0|||
27905252|NCT01248962|54562266|FG000|Overall Study|Complete Response after 3 Cycles|0|||
27905253|NCT01248962|54562267|FG001|Overall Study|Complete Response after 3 Cycles|1|||
27905254|NCT01248962|54562266|FG000|Overall Study|Progression of Disease prior to 5 Cycles|12|||
27905255|NCT01248962|54562267|FG001|Overall Study|Progression of Disease prior to 5 Cycles|13|||
27905256|NCT01248455|54562274|FG000|Overall Study|switched to alternate treatment|1|||
27905257|NCT01247090|54562281|FG000|Overall Study|Physician Decision|1|||
27989025|NCT00703534|54647837|FG001|Overall Study|Adverse Event|3|||
27905258|NCT01247090|54562282|FG001|Overall Study|Physician Decision|0|||
27905259|NCT01247090|54562283|FG002|Overall Study|Physician Decision|0|||
27905260|NCT01247090|54562281|FG000|Overall Study|Withdrawal by Subject|0|||
27905261|NCT01247090|54562282|FG001|Overall Study|Withdrawal by Subject|1|||
27905262|NCT01247090|54562283|FG002|Overall Study|Withdrawal by Subject|0|||
27905263|NCT01249664|54562293|FG000|Overall Study|Withdrawal by Subject|5|||
27905264|NCT01249664|54562294|FG001|Overall Study|Withdrawal by Subject|0|||
27905265|NCT01249664|54562293|FG000|Overall Study|Adverse Event|1|||
27905266|NCT01249664|54562294|FG001|Overall Study|Adverse Event|0|||
27905267|NCT01249274|54562304|FG000|Overall Study|Lost to Follow-up|3|||
27905268|NCT01249274|54562305|FG001|Overall Study|Lost to Follow-up|4|||
27905269|NCT01249274|54562304|FG000|Overall Study|Received inpatient substance treatment|1|||
27905270|NCT01249274|54562305|FG001|Overall Study|Received inpatient substance treatment|2|||
27905271|NCT01249157|54562313|FG000|Overall Study|Withdrawal by Subject|1|||
27905272|NCT01249118|54562317|FG000|First Washout Period|Physician Decision|0|||
27905273|NCT01249118|54562318|FG001|First Washout Period|Physician Decision|1|||
27905274|NCT01249118|54562319|FG002|First Washout Period|Physician Decision|0|||
27905275|NCT01248884|54562329|FG000|Overall Study|Withdrawal by Subject|1|||
27905276|NCT01248884|54562330|FG001|Overall Study|Withdrawal by Subject|3|||
27905277|NCT01248884|54562331|FG002|Overall Study|Withdrawal by Subject|1|||
27905278|NCT01248884|54562329|FG000|Overall Study|Adverse Event|1|||
27905279|NCT01248884|54562330|FG001|Overall Study|Adverse Event|0|||
27905280|NCT01248884|54562331|FG002|Overall Study|Adverse Event|0|||
27905281|NCT01248728|54562343|FG000|Overall Study|Adverse Event|1|||
27905282|NCT01248728|54562344|FG001|Overall Study|Adverse Event|1|||
27905283|NCT01248728|54562343|FG000|Overall Study|Withdrawal by Subject|2|||
27905284|NCT01248728|54562344|FG001|Overall Study|Withdrawal by Subject|1|||
27905285|NCT01248728|54562343|FG000|Overall Study|Lack of Efficacy|1|||
27905286|NCT01248728|54562344|FG001|Overall Study|Lack of Efficacy|0|||
27905287|NCT01246973|54562354|FG000|Overall Study|Other|38|||
27905288|NCT01246973|54562355|FG001|Overall Study|Other|25|||
27905289|NCT01246973|54562354|FG000|Overall Study|Adverse Event|16|||
27905290|NCT01246973|54562355|FG001|Overall Study|Adverse Event|9|||
27905291|NCT01246973|54562354|FG000|Overall Study|Withdrawal by Subject|7|||
27905292|NCT01246973|54562355|FG001|Overall Study|Withdrawal by Subject|13|||
27905293|NCT01246466|54562361|FG000|Overall Study|Death|1|||
27905294|NCT01246466|54562361|FG000|Overall Study|Withdrawal by Subject|1|||
27905295|NCT01245764|54562370|FG000|Study Phase A|Other|3|||
27905296|NCT01245764|54562371|FG001|Study Phase A|Other|2|||
27905297|NCT01245764|54562372|FG002|Study Phase A|Other|3|||
27905298|NCT01245764|54562373|FG003|Study Phase A|Other|1|||
27905299|NCT01245764|54562370|FG000|Study Phase A|Protocol Violation|6|||
27905300|NCT01245764|54562371|FG001|Study Phase A|Protocol Violation|3|||
27905301|NCT01245764|54562372|FG002|Study Phase A|Protocol Violation|2|||
27905302|NCT01245764|54562373|FG003|Study Phase A|Protocol Violation|2|||
27905303|NCT01245764|54562370|FG000|Study Phase A|Lost to Follow-up|0|||
27905304|NCT01245764|54562371|FG001|Study Phase A|Lost to Follow-up|0|||
27905305|NCT01245764|54562372|FG002|Study Phase A|Lost to Follow-up|5|||
27989026|NCT00703534|54647836|FG000|Overall Study|Withdrawal by Subject|8|||
27989027|NCT00703534|54647837|FG001|Overall Study|Withdrawal by Subject|7|||
27989028|NCT00703534|54647836|FG000|Overall Study|Incorrect Enrollment|6|||
27989029|NCT00703534|54647837|FG001|Overall Study|Incorrect Enrollment|6|||
27989030|NCT00703534|54647836|FG000|Overall Study|Lost to Follow-up|1|||
27989031|NCT00703534|54647837|FG001|Overall Study|Lost to Follow-up|4|||
27989032|NCT00703534|54647836|FG000|Overall Study|Severe Non Compliance|1|||
27989033|NCT00703534|54647837|FG001|Overall Study|Severe Non Compliance|5|||
27989034|NCT00503425|54647843|FG000|Overall Study|Participant files lost|6|||
27989035|NCT00503425|54647843|FG000|Overall Study|Adverse Event|5|||
27989036|NCT00503425|54647843|FG000|Overall Study|Lack of Efficacy|25|||
27989037|NCT00503425|54647843|FG000|Overall Study|Withdrawal by Subject|8|||
27989038|NCT00503425|54647843|FG000|Overall Study|Lost to Follow-up|3|||
27989039|NCT00503425|54647843|FG000|Overall Study|Death|3|||
27989040|NCT00503425|54647843|FG000|Overall Study|Missing Data/Unknown|4|||
27989041|NCT00863772|54647851|FG000|Overall Study|Adverse Event|1|||
27989042|NCT00863772|54647852|FG001|Overall Study|Adverse Event|4|||
27989043|NCT00863772|54647853|FG002|Overall Study|Adverse Event|0|||
27989044|NCT00863772|54647851|FG000|Overall Study|Lack of Efficacy|4|||
27989045|NCT00863772|54647852|FG001|Overall Study|Lack of Efficacy|2|||
27989046|NCT00863772|54647853|FG002|Overall Study|Lack of Efficacy|4|||
27989047|NCT00863772|54647851|FG000|Overall Study|Lost to Follow-up|5|||
27989048|NCT00863772|54647852|FG001|Overall Study|Lost to Follow-up|1|||
27989049|NCT00863772|54647853|FG002|Overall Study|Lost to Follow-up|1|||
27989050|NCT00863772|54647851|FG000|Overall Study|Protocol Violation|2|||
27989051|NCT00863772|54647852|FG001|Overall Study|Protocol Violation|0|||
27905306|NCT01245764|54562373|FG003|Study Phase A|Lost to Follow-up|0|||
27989052|NCT00863772|54647853|FG002|Overall Study|Protocol Violation|2|||
27989053|NCT00863772|54647851|FG000|Overall Study|Withdrawal by Subject|4|||
27989054|NCT00863772|54647852|FG001|Overall Study|Withdrawal by Subject|7|||
27989055|NCT00863772|54647853|FG002|Overall Study|Withdrawal by Subject|5|||
27989056|NCT00863772|54647851|FG000|Overall Study|Study terminated by sponsor|44|||
27905307|NCT01245140|54562393|FG000|Overall Study|Adverse Event|1|||
27905308|NCT01245140|54562394|FG001|Overall Study|Adverse Event|3|||
27905309|NCT01245140|54562393|FG000|Overall Study|Lack of Efficacy|2|||
27905310|NCT01245140|54562394|FG001|Overall Study|Lack of Efficacy|4|||
27905311|NCT01245140|54562393|FG000|Overall Study|Protocol Violation|0|||
27989057|NCT00863772|54647852|FG001|Overall Study|Study terminated by sponsor|45|||
27989058|NCT00863772|54647853|FG002|Overall Study|Study terminated by sponsor|36|||
27989059|NCT00863772|54647851|FG000|Overall Study|Entered extension study|6|||
27989060|NCT00863772|54647852|FG001|Overall Study|Entered extension study|4|||
27989061|NCT00863772|54647853|FG002|Overall Study|Entered extension study|9|||
27989062|NCT00863772|54647851|FG000|Overall Study|Other|1|||
27905312|NCT01245140|54562394|FG001|Overall Study|Protocol Violation|1|||
27905313|NCT01245140|54562393|FG000|Overall Study|Withdrawal by Subject|0|||
27905314|NCT01245140|54562394|FG001|Overall Study|Withdrawal by Subject|1|||
27905315|NCT01245140|54562393|FG000|Overall Study|Refused Treatment/Did Not Coopera|0|||
27905316|NCT01245140|54562394|FG001|Overall Study|Refused Treatment/Did Not Coopera|1|||
27905317|NCT01245101|54562402|FG000|Period 1 (Treatment)|Withdrawal by Subject|2|||
27989063|NCT00863772|54647852|FG001|Overall Study|Other|2|||
27989064|NCT00863772|54647853|FG002|Overall Study|Other|4|||
27989065|NCT00863772|54647851|FG000|Overall Study|Randomized but not Treated|1|||
27989066|NCT00863772|54647852|FG001|Overall Study|Randomized but not Treated|0|||
27989067|NCT00863772|54647853|FG002|Overall Study|Randomized but not Treated|0|||
27989068|NCT00502801|54647861|FG000|Treatment Period|Withdrawal by Subject|3|||
27989069|NCT00502801|54647861|FG000|Treatment Period|Adverse Event|7|||
27989070|NCT00502801|54647861|FG000|Treatment Period|Death|14|||
27989071|NCT00502801|54647861|FG000|Treatment Period|OTHER|30|||
27989072|NCT00502801|54647861|FG000|End of Therapy to Test of Cure|Withdrawal by Subject|1|||
27989073|NCT00502801|54647861|FG000|End of Therapy to Test of Cure|Lost to Follow-up|2|||
27989074|NCT00502801|54647861|FG000|End of Therapy to Test of Cure|Death|3|||
27989075|NCT00502801|54647861|FG000|End of Therapy to Test of Cure|OTHER|2|||
27989076|NCT00824265|54647867|FG000|Treatment Phase|Adverse Event,non-fatal|50|||
27989077|NCT00824265|54647868|FG001|Treatment Phase|Adverse Event,non-fatal|52|||
27989078|NCT00824265|54647867|FG000|Treatment Phase|Protocol Violation|1|||
27989079|NCT00824265|54647868|FG001|Treatment Phase|Protocol Violation|0|||
27989080|NCT00824265|54647867|FG000|Treatment Phase|Lost to Follow-up|1|||
27989081|NCT00824265|54647868|FG001|Treatment Phase|Lost to Follow-up|1|||
27989082|NCT00824265|54647867|FG000|Treatment Phase|Physician Decision|6|||
27989083|NCT00824265|54647868|FG001|Treatment Phase|Physician Decision|12|||
27989084|NCT00824265|54647867|FG000|Treatment Phase|Withdrawal by Subject|6|||
27989085|NCT00824265|54647868|FG001|Treatment Phase|Withdrawal by Subject|15|||
27989086|NCT00824265|54647867|FG000|Follow-up Phase|w/drew consent, no f/u, or MD choice|18|||
27989087|NCT00824265|54647868|FG001|Follow-up Phase|w/drew consent, no f/u, or MD choice|31|||
27989088|NCT00824265|54647867|FG000|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9|||
27989089|NCT00824265|54647868|FG001|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16|||
27989090|NCT00855894|54647878|FG000|Overall Study|Death|31|||
27989091|NCT00855894|54647878|FG000|Overall Study|Patient's decision|1|||
27989092|NCT00855894|54647878|FG000|Overall Study|Disease progression|1|||
27989093|NCT00855816|54647884|FG000|Overall Study|Withdrawal by Subject|22|||
27989094|NCT00855816|54647885|FG001|Overall Study|Withdrawal by Subject|15|||
27989095|NCT00855816|54647884|FG000|Overall Study|Lost to Follow-up|3|||
27989096|NCT00855816|54647885|FG001|Overall Study|Lost to Follow-up|5|||
27989097|NCT00855816|54647884|FG000|Overall Study|Death|1|||
27989098|NCT00855816|54647885|FG001|Overall Study|Death|0|||
27989099|NCT00855816|54647884|FG000|Overall Study|Became ineligible|0|||
27905318|NCT01245101|54562403|FG001|Period 1 (Treatment)|Withdrawal by Subject|0|||
27905319|NCT01245101|54562402|FG000|Period 2 (Washout)|Withdrawal by Subject|1|||
27905320|NCT01245101|54562403|FG001|Period 2 (Washout)|Withdrawal by Subject|0|||
27905321|NCT01245101|54562402|FG000|Period 3 (Treatment)|Withdrawal by Subject|1|||
27905322|NCT01245101|54562403|FG001|Period 3 (Treatment)|Withdrawal by Subject|0|||
27905323|NCT01245062|54562411|FG000|Randomization and Crossover Phase|Lost to Follow-up|4|||
27905324|NCT01245062|54562412|FG001|Randomization and Crossover Phase|Lost to Follow-up|2|||
27905325|NCT01245062|54562413|FG002|Randomization and Crossover Phase|Lost to Follow-up|0|||
27905326|NCT01245062|54562411|FG000|Randomization and Crossover Phase|Physician Decision|2|||
27905327|NCT01245062|54562412|FG001|Randomization and Crossover Phase|Physician Decision|4|||
27905328|NCT01245062|54562413|FG002|Randomization and Crossover Phase|Physician Decision|0|||
27905329|NCT01245062|54562411|FG000|Randomization and Crossover Phase|Withdrew Consent|12|||
27905330|NCT01245062|54562412|FG001|Randomization and Crossover Phase|Withdrew Consent|11|||
27989100|NCT00855816|54647885|FG001|Overall Study|Became ineligible|1|||
27989101|NCT00855738|54647891|FG000|Overall Study|Lost to Follow-up|2|||
27989102|NCT00855738|54647891|FG000|Overall Study|Adverse Event|1|||
27989103|NCT00855738|54647891|FG000|Overall Study|Subject Defaulted|1|||
27989104|NCT00855738|54647891|FG000|Overall Study|Death|1|||
27989105|NCT00490945|54647902|FG000|Overall Study|Adverse Event|0|||
27989106|NCT00490945|54647903|FG001|Overall Study|Adverse Event|1|||
27989107|NCT00490945|54647904|FG002|Overall Study|Adverse Event|0|||
27989108|NCT00490945|54647905|FG003|Overall Study|Adverse Event|0|||
27905331|NCT01245062|54562413|FG002|Randomization and Crossover Phase|Withdrew Consent|0|||
27905332|NCT01245062|54562411|FG000|Randomization and Crossover Phase|Study closed/ terminated|23|||
27905333|NCT01245062|54562412|FG001|Randomization and Crossover Phase|Study closed/ terminated|14|||
27905334|NCT01245062|54562413|FG002|Randomization and Crossover Phase|Study closed/ terminated|0|||
27905335|NCT01245062|54562411|FG000|Cross-over Phase|Lost to Follow-up|0|||
27905336|NCT01245062|54562412|FG001|Cross-over Phase|Lost to Follow-up|0|||
27905337|NCT01245062|54562413|FG002|Cross-over Phase|Lost to Follow-up|1|||
27905338|NCT01245062|54562411|FG000|Cross-over Phase|Physician Decision|0|||
27905339|NCT01245062|54562412|FG001|Cross-over Phase|Physician Decision|0|||
27905340|NCT01245062|54562413|FG002|Cross-over Phase|Physician Decision|1|||
27905341|NCT01245062|54562411|FG000|Cross-over Phase|Withdrew Consent|0|||
27905342|NCT01245062|54562412|FG001|Cross-over Phase|Withdrew Consent|0|||
27905343|NCT01245062|54562413|FG002|Cross-over Phase|Withdrew Consent|4|||
27905344|NCT01245062|54562411|FG000|Cross-over Phase|Study closed/ terminated|0|||
27905345|NCT01245062|54562412|FG001|Cross-over Phase|Study closed/ terminated|0|||
27905346|NCT01245062|54562413|FG002|Cross-over Phase|Study closed/ terminated|11|||
27905347|NCT01244984|54562424|FG000|Overall Study|Adverse Event|2|||
27905348|NCT01244984|54562425|FG001|Overall Study|Adverse Event|11|||
27905349|NCT01244984|54562426|FG002|Overall Study|Adverse Event|2|||
27905350|NCT01244984|54562424|FG000|Overall Study|Protocol Violation|1|||
27905351|NCT01244984|54562425|FG001|Overall Study|Protocol Violation|0|||
27905352|NCT01244984|54562426|FG002|Overall Study|Protocol Violation|0|||
27905353|NCT01244984|54562424|FG000|Overall Study|Protocol Defined Stopping Criteria|1|||
27905354|NCT01244984|54562425|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
27905355|NCT01244984|54562426|FG002|Overall Study|Protocol Defined Stopping Criteria|0|||
27905356|NCT01244984|54562424|FG000|Overall Study|Withdrawal by Subject|1|||
27905357|NCT01244984|54562425|FG001|Overall Study|Withdrawal by Subject|2|||
27905358|NCT01244984|54562426|FG002|Overall Study|Withdrawal by Subject|2|||
27905359|NCT01244516|54562438|FG000|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4|||
27905360|NCT01244516|54562439|FG001|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5|||
27905361|NCT01244516|54562440|FG002|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2|||
27905362|NCT01244516|54562438|FG000|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
27905363|NCT01244516|54562439|FG001|Period 1 (Baseline to 1-week Visit)|Poor Vision|1|||
27905364|NCT01244516|54562440|FG002|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
27905365|NCT01244516|54562438|FG000|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
27905366|NCT01244516|54562439|FG001|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
27905367|NCT01244516|54562440|FG002|Period 1 (Baseline to 1-week Visit)|Poor comfort|1|||
27905368|NCT01244516|54562438|FG000|Period 2 (1-week to 2-week Visit)|Adverse Event|2|||
27905369|NCT01244516|54562439|FG001|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
27905370|NCT01244516|54562440|FG002|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
27905371|NCT01244516|54562438|FG000|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
27905372|NCT01244516|54562439|FG001|Period 2 (1-week to 2-week Visit)|Protocol Violation|0|||
27905373|NCT01244516|54562440|FG002|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
27905374|NCT01244516|54562438|FG000|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
27905375|NCT01244516|54562439|FG001|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1|||
27905376|NCT01244516|54562440|FG002|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
27905377|NCT01244516|54562438|FG000|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
27905378|NCT01244516|54562439|FG001|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
27905379|NCT01244516|54562440|FG002|Period 2 (1-week to 2-week Visit)|Poor Comfort|1|||
27905380|NCT01244126|54562452|FG000|Overall Study|Protocol Violation|3|||
27905381|NCT01244126|54562453|FG001|Overall Study|Protocol Violation|3|||
27905382|NCT01244126|54562454|FG002|Overall Study|Protocol Violation|9|||
27905383|NCT01243892|54562464|FG000|Overall Study|Did not meet eligibility criteria|2|||
27905384|NCT01243892|54562465|FG001|Overall Study|Did not meet eligibility criteria|0|||
27905385|NCT01243775|54562471|FG000|Overall Study|Withdrawal by Subject|2|||
27905386|NCT01243268|54562475|FG000|Overall Study|Lost to Follow-up|4|||
27905387|NCT01243268|54562475|FG000|Overall Study|Protocol Violation|51|||
27989109|NCT00490945|54647906|FG004|Overall Study|Adverse Event|0|||
27989110|NCT00879398|54647924|FG000|Overall Study|Visit Stop|399|||
27989111|NCT00879398|54647924|FG000|Overall Study|Lack of Efficacy|64|||
27905388|NCT01243268|54562475|FG000|Overall Study|Deviation with contract date|7|||
27905389|NCT01243268|54562475|FG000|Overall Study|Duplicate subject|2|||
27905390|NCT01242371|54562481|FG000|Overall Study|Withdrawal by Subject|2|||
27905391|NCT01242371|54562482|FG001|Overall Study|Withdrawal by Subject|2|||
27905392|NCT01242371|54562481|FG000|Overall Study|Protocol Violation|0|||
27905393|NCT01242371|54562482|FG001|Overall Study|Protocol Violation|3|||
27905394|NCT01242176|54562488|FG000|Washout Period of 7 Days|Adverse Event|0|||
27905395|NCT01242176|54562489|FG001|Washout Period of 7 Days|Adverse Event|2|||
27905396|NCT01242176|54562488|FG000|Washout Period of 7 Days|Non-compliant with protocol|1|||
27905397|NCT01242176|54562489|FG001|Washout Period of 7 Days|Non-compliant with protocol|0|||
27989112|NCT00879398|54647924|FG000|Overall Study|Adverse Event|41|||
27989113|NCT00879398|54647924|FG000|Overall Study|Other Reasons|171|||
27989114|NCT00696436|54647933|FG000|Overall Study|Adverse Event|7|||
27905398|NCT01242020|54562497|FG000|Overall Study|Withdrawal by Subject|2|||
27905399|NCT01242020|54562498|FG001|Overall Study|Withdrawal by Subject|0|||
27905400|NCT01242020|54562497|FG000|Overall Study|Failed screening|1|||
27905401|NCT01242020|54562498|FG001|Overall Study|Failed screening|0|||
27905402|NCT01241786|54562504|FG000|Overall Study|Lack of Efficacy|5|||
27905403|NCT01241318|54562511|FG000|Overall Study|Woman: false pregnancies|27|||
27905404|NCT01241318|54562512|FG001|Overall Study|Woman: false pregnancies|15|||
27905405|NCT01241318|54562511|FG000|Overall Study|Woman: miscarriage/abortion|46|||
27905406|NCT01241318|54562512|FG001|Overall Study|Woman: miscarriage/abortion|38|||
27905407|NCT01241318|54562511|FG000|Overall Study|Withdrawal by Subject|175|||
27905408|NCT01241318|54562512|FG001|Overall Study|Withdrawal by Subject|46|||
27905409|NCT01241318|54562511|FG000|Overall Study|Lost to Follow-up|740|||
27905410|NCT01241318|54562512|FG001|Overall Study|Lost to Follow-up|455|||
27905411|NCT01241318|54562511|FG000|Overall Study|Death|2|||
27905412|NCT01241318|54562512|FG001|Overall Study|Death|4|||
27905413|NCT01241318|54562511|FG000|Overall Study|Withdrew/Lost to Follow after delivery|60|||
27905414|NCT01241318|54562512|FG001|Overall Study|Withdrew/Lost to Follow after delivery|38|||
27905415|NCT01241318|54562511|FG000|Overall Study|Woman: Stillborn infant|129|||
27905416|NCT01241318|54562512|FG001|Overall Study|Woman: Stillborn infant|146|||
27905417|NCT01241279|54562523|FG000|Overall Study|Lost to Follow-up|0|||
27905418|NCT01241279|54562524|FG001|Overall Study|Lost to Follow-up|1|||
27905419|NCT01241240|54562532|FG000|Overall Study|Adverse Event|5|||
27905420|NCT01241240|54562533|FG001|Overall Study|Adverse Event|4|||
27905421|NCT01241240|54562532|FG000|Overall Study|Lost to Follow-up|2|||
27905422|NCT01241240|54562533|FG001|Overall Study|Lost to Follow-up|4|||
27905423|NCT01241240|54562532|FG000|Overall Study|Personal Reasons|1|||
27905424|NCT01241240|54562533|FG001|Overall Study|Personal Reasons|1|||
27905425|NCT01240811|54562542|FG000|Overall Study|Physician Decision|0|||
27905426|NCT01240811|54562543|FG001|Overall Study|Physician Decision|1|||
27905427|NCT01240811|54562544|FG002|Overall Study|Physician Decision|0|||
27905428|NCT01240811|54562542|FG000|Overall Study|Withdrawal by Subject|0|||
27905429|NCT01240811|54562543|FG001|Overall Study|Withdrawal by Subject|0|||
27989115|NCT00696436|54647934|FG001|Overall Study|Adverse Event|9|||
27989116|NCT00696436|54647935|FG002|Overall Study|Adverse Event|8|||
27989117|NCT00696436|54647936|FG003|Overall Study|Adverse Event|6|||
27989118|NCT00696436|54647937|FG004|Overall Study|Adverse Event|4|||
27989119|NCT00696436|54647933|FG000|Overall Study|Protocol Violation|3|||
27989120|NCT00696436|54647934|FG001|Overall Study|Protocol Violation|2|||
27989121|NCT00696436|54647935|FG002|Overall Study|Protocol Violation|2|||
27989122|NCT00696436|54647936|FG003|Overall Study|Protocol Violation|0|||
27989123|NCT00696436|54647937|FG004|Overall Study|Protocol Violation|1|||
27989124|NCT00696436|54647933|FG000|Overall Study|Lost to Follow-up|1|||
27989125|NCT00696436|54647934|FG001|Overall Study|Lost to Follow-up|6|||
27989126|NCT00696436|54647935|FG002|Overall Study|Lost to Follow-up|2|||
27989127|NCT00696436|54647936|FG003|Overall Study|Lost to Follow-up|4|||
27989128|NCT00696436|54647937|FG004|Overall Study|Lost to Follow-up|3|||
27989129|NCT00696436|54647933|FG000|Overall Study|Withdrawal by Subject|4|||
27989130|NCT00696436|54647934|FG001|Overall Study|Withdrawal by Subject|11|||
27989131|NCT00696436|54647935|FG002|Overall Study|Withdrawal by Subject|5|||
27989132|NCT00696436|54647936|FG003|Overall Study|Withdrawal by Subject|7|||
27989133|NCT00696436|54647937|FG004|Overall Study|Withdrawal by Subject|1|||
27989134|NCT00696436|54647933|FG000|Overall Study|Lack of Efficacy|3|||
28097532|NCT04041440|54753229|FG001|Overall Study|Withdrawal by Subject|1|||
27905430|NCT01240811|54562544|FG002|Overall Study|Withdrawal by Subject|1|||
27905431|NCT01240382|54562556|FG000|Overall Study|Adverse Event|2|||
27905432|NCT01240382|54562557|FG001|Overall Study|Adverse Event|1|||
27905433|NCT01240382|54562556|FG000|Overall Study|Lack of Efficacy|0|||
27905434|NCT01240382|54562557|FG001|Overall Study|Lack of Efficacy|2|||
27905435|NCT01240382|54562556|FG000|Overall Study|Fear of adverse events|0|||
27905436|NCT01240382|54562557|FG001|Overall Study|Fear of adverse events|1|||
27905437|NCT01244828|54562563|FG000|Overall Study|Adverse Event|37|||
28097533|NCT04041440|54753228|FG000|Overall Study|Lost to Follow-up|0|||
27905438|NCT01244828|54562563|FG000|Overall Study|Withdrawal by Subject|31|||
27905439|NCT01244828|54562563|FG000|Overall Study|Lack of Efficacy|7|||
27905440|NCT01244828|54562563|FG000|Overall Study|Lost to Follow-up|2|||
27905441|NCT01244828|54562563|FG000|Overall Study|Other reason (not specified)|1|||
27905442|NCT01249833|54562569|FG000|Overall Study|Lost to Follow-up|0|||
27905443|NCT01249833|54562570|FG001|Overall Study|Lost to Follow-up|1|||
27905444|NCT01249404|54562579|FG000|Overall Study|Study treatment not received|0|||
27989135|NCT00696436|54647934|FG001|Overall Study|Lack of Efficacy|1|||
27989136|NCT00696436|54647935|FG002|Overall Study|Lack of Efficacy|5|||
27989137|NCT00696436|54647936|FG003|Overall Study|Lack of Efficacy|2|||
27989138|NCT00696436|54647937|FG004|Overall Study|Lack of Efficacy|4|||
27905445|NCT01249404|54562580|FG001|Overall Study|Study treatment not received|1|||
27905446|NCT01249404|54562581|FG002|Overall Study|Study treatment not received|2|||
27905447|NCT01249404|54562579|FG000|Overall Study|No MAS Score at baseline and/or Week 4|2|||
27989139|NCT00696436|54647933|FG000|Overall Study|Participant Unavailability|2|||
27989140|NCT00696436|54647934|FG001|Overall Study|Participant Unavailability|0|||
27905448|NCT01249404|54562580|FG001|Overall Study|No MAS Score at baseline and/or Week 4|0|||
27905449|NCT01249404|54562581|FG002|Overall Study|No MAS Score at baseline and/or Week 4|2|||
27905450|NCT01249404|54562579|FG000|Overall Study|Adverse Event|2|||
27905451|NCT01249404|54562580|FG001|Overall Study|Adverse Event|2|||
27905452|NCT01249404|54562581|FG002|Overall Study|Adverse Event|2|||
27905453|NCT01249404|54562579|FG000|Overall Study|Withdrawal by Subject|2|||
27905454|NCT01249404|54562580|FG001|Overall Study|Withdrawal by Subject|2|||
27905455|NCT01249404|54562581|FG002|Overall Study|Withdrawal by Subject|0|||
27905456|NCT01249404|54562579|FG000|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
27905457|NCT01249404|54562580|FG001|Overall Study|Botulinum toxin (BTX) in upper limb|2|||
27905458|NCT01249404|54562581|FG002|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
27905459|NCT01249404|54562579|FG000|Overall Study|Non compliance to visit schedule|0|||
27905460|NCT01249404|54562580|FG001|Overall Study|Non compliance to visit schedule|1|||
27905461|NCT01249404|54562581|FG002|Overall Study|Non compliance to visit schedule|0|||
27905462|NCT01249365|54562589|FG000|Overall Study|Lost to Follow-up|1|||
27905463|NCT01249131|54562593|FG000|Washout Period of 10 Days|Adverse Event|0|||
27905464|NCT01249131|54562594|FG001|Washout Period of 10 Days|Adverse Event|0|||
27905465|NCT01249131|54562595|FG002|Washout Period of 10 Days|Adverse Event|0|||
27905466|NCT01249131|54562596|FG003|Washout Period of 10 Days|Adverse Event|0|||
27905467|NCT01249131|54562597|FG004|Washout Period of 10 Days|Adverse Event|1|||
27905468|NCT01249131|54562598|FG005|Washout Period of 10 Days|Adverse Event|0|||
27905469|NCT01249092|54562606|FG000|Overall Study|Expected side effect of nausea/dyspepsia|1|||
27905470|NCT01249092|54562606|FG000|Overall Study|Unable to tolerate expected SE -nausea|1|||
27905471|NCT01248936|54562612|FG000|Overall Study|Sponsor Decision|259|||
27905472|NCT01248936|54562612|FG000|Overall Study|Progression of Disease|50|||
27905473|NCT01248936|54562612|FG000|Overall Study|Death|26|||
27905474|NCT01248936|54562612|FG000|Overall Study|Withdrawal of Consent|20|||
27905475|NCT01248936|54562612|FG000|Overall Study|Adverse Event|8|||
27905476|NCT01248936|54562612|FG000|Overall Study|Lost to Follow-up|7|||
27905477|NCT01248936|54562612|FG000|Overall Study|Refused Treatment|1|||
27905478|NCT01248936|54562612|FG000|Overall Study|Other reason|3|||
27905479|NCT01248780|54562619|FG000|Overall Study|Lack of Efficacy|2|||
27905480|NCT01248780|54562620|FG001|Overall Study|Lack of Efficacy|0|||
27905481|NCT01248780|54562619|FG000|Overall Study|Lost to Follow-up|0|||
27905482|NCT01248780|54562620|FG001|Overall Study|Lost to Follow-up|1|||
27905483|NCT01248780|54562619|FG000|Overall Study|Death|0|||
27905484|NCT01248780|54562620|FG001|Overall Study|Death|1|||
27905485|NCT01248780|54562619|FG000|Overall Study|Adverse Event|2|||
27905486|NCT01248780|54562620|FG001|Overall Study|Adverse Event|7|||
27905487|NCT01248780|54562619|FG000|Overall Study|Protocol Violation|1|||
27905488|NCT01248780|54562620|FG001|Overall Study|Protocol Violation|1|||
27905489|NCT01248780|54562619|FG000|Overall Study|Withdrawal by Subject|4|||
27905490|NCT01248780|54562620|FG001|Overall Study|Withdrawal by Subject|4|||
27905491|NCT01248780|54562619|FG000|Overall Study|Not treated|0|||
27905492|NCT01248780|54562620|FG001|Overall Study|Not treated|1|||
27905493|NCT01248468|54562629|FG000|Overall Study|Administrative problem|1|||
27905494|NCT01248468|54562630|FG001|Overall Study|Administrative problem|0|||
27905495|NCT01248468|54562631|FG002|Overall Study|Administrative problem|0|||
27905496|NCT01248468|54562629|FG000|Overall Study|Lost to Follow-up|9|||
27905497|NCT01248468|54562630|FG001|Overall Study|Lost to Follow-up|12|||
27905498|NCT01248468|54562631|FG002|Overall Study|Lost to Follow-up|4|||
27905499|NCT01248468|54562629|FG000|Overall Study|Pregnancy|1|||
27905500|NCT01248468|54562630|FG001|Overall Study|Pregnancy|0|||
27905501|NCT01248468|54562631|FG002|Overall Study|Pregnancy|0|||
27905502|NCT01248468|54562629|FG000|Overall Study|Withdrawal by Subject|4|||
27905503|NCT01248468|54562630|FG001|Overall Study|Withdrawal by Subject|2|||
27989141|NCT00696436|54647935|FG002|Overall Study|Participant Unavailability|2|||
27989142|NCT00696436|54647936|FG003|Overall Study|Participant Unavailability|1|||
27989143|NCT00696436|54647937|FG004|Overall Study|Participant Unavailability|0|||
27989144|NCT00696436|54647933|FG000|Overall Study|Administrative Error|2|||
27989145|NCT00696436|54647934|FG001|Overall Study|Administrative Error|0|||
27989146|NCT00696436|54647935|FG002|Overall Study|Administrative Error|2|||
27989147|NCT00696436|54647936|FG003|Overall Study|Administrative Error|0|||
27905504|NCT01248468|54562631|FG002|Overall Study|Withdrawal by Subject|0|||
27905505|NCT01247922|54562639|FG000|Overall Study|Disease progression|4|||
27905506|NCT01246206|54562643|FG000|Overall Study|Patient did not receive study regiments.|1|||
27989148|NCT00696436|54647937|FG004|Overall Study|Administrative Error|0|||
27905507|NCT01246011|54562650|FG000|Overall Study|If needed warfarin clinically, withdrawn|0|||
27989149|NCT00696436|54647933|FG000|Overall Study|Participant Non-compliance|0|||
27905508|NCT01246011|54562651|FG001|Overall Study|If needed warfarin clinically, withdrawn|0|||
27905509|NCT01246011|54562652|FG002|Overall Study|If needed warfarin clinically, withdrawn|3|||
27905510|NCT01246011|54562650|FG000|Overall Study|Withdrawal by Subject|0|||
27905511|NCT01246011|54562651|FG001|Overall Study|Withdrawal by Subject|0|||
27905512|NCT01246011|54562652|FG002|Overall Study|Withdrawal by Subject|1|||
27905513|NCT01244490|54562664|FG000|Overall Study|Lack of Efficacy|14|||
27905514|NCT01244490|54562665|FG001|Overall Study|Lack of Efficacy|5|||
27989150|NCT00696436|54647934|FG001|Overall Study|Participant Non-compliance|0|||
27905515|NCT01244490|54562666|FG002|Overall Study|Lack of Efficacy|5|||
27905516|NCT01244490|54562664|FG000|Overall Study|Withdrawal by Subject|4|||
27905517|NCT01244490|54562665|FG001|Overall Study|Withdrawal by Subject|4|||
27905518|NCT01244490|54562666|FG002|Overall Study|Withdrawal by Subject|9|||
27905519|NCT01244490|54562664|FG000|Overall Study|Adverse Event|1|||
27905520|NCT01244490|54562665|FG001|Overall Study|Adverse Event|9|||
27905521|NCT01244490|54562666|FG002|Overall Study|Adverse Event|5|||
27905522|NCT01244490|54562664|FG000|Overall Study|Lost to Follow-up|0|||
27905523|NCT01244490|54562665|FG001|Overall Study|Lost to Follow-up|6|||
27905524|NCT01244490|54562666|FG002|Overall Study|Lost to Follow-up|3|||
27989151|NCT00696436|54647935|FG002|Overall Study|Participant Non-compliance|1|||
27905525|NCT01244490|54562664|FG000|Overall Study|Other|0|||
27905526|NCT01244490|54562665|FG001|Overall Study|Other|0|||
27905527|NCT01244490|54562666|FG002|Overall Study|Other|1|||
27905528|NCT01243944|54562676|FG000|Overall Study|Adverse Event|15|||
27905529|NCT01243944|54562677|FG001|Overall Study|Adverse Event|13|||
27905530|NCT01243944|54562676|FG000|Overall Study|Lost to Follow-up|2|||
27905531|NCT01243944|54562677|FG001|Overall Study|Lost to Follow-up|1|||
27905532|NCT01243944|54562676|FG000|Overall Study|Physician Decision|2|||
27905533|NCT01243944|54562677|FG001|Overall Study|Physician Decision|7|||
27905534|NCT01243944|54562676|FG000|Overall Study|Disease progression|12|||
27905535|NCT01243944|54562677|FG001|Overall Study|Disease progression|11|||
27905536|NCT01243944|54562676|FG000|Overall Study|Protocol deviation|1|||
27905537|NCT01243944|54562677|FG001|Overall Study|Protocol deviation|1|||
27905538|NCT01243944|54562676|FG000|Overall Study|Participant decision|10|||
27905539|NCT01243944|54562677|FG001|Overall Study|Participant decision|15|||
27989152|NCT00696436|54647936|FG003|Overall Study|Participant Non-compliance|2|||
27989153|NCT00696436|54647937|FG004|Overall Study|Participant Non-compliance|0|||
27989154|NCT00696436|54647933|FG000|Overall Study|Administrative Decision|1|||
27989155|NCT00696436|54647934|FG001|Overall Study|Administrative Decision|0|||
27989156|NCT00696436|54647935|FG002|Overall Study|Administrative Decision|0|||
27989157|NCT00696436|54647936|FG003|Overall Study|Administrative Decision|0|||
27989158|NCT00696436|54647937|FG004|Overall Study|Administrative Decision|0|||
27989159|NCT00696436|54647933|FG000|Overall Study|Missing|0|||
27989160|NCT00696436|54647934|FG001|Overall Study|Missing|1|||
27989161|NCT00696436|54647935|FG002|Overall Study|Missing|1|||
27989162|NCT00696436|54647936|FG003|Overall Study|Missing|0|||
27989163|NCT00696436|54647937|FG004|Overall Study|Missing|0|||
27989164|NCT00878072|54647949|FG000|Overall Study|Withdrew consent|2|||
27989165|NCT00594854|54647977|FG000|Overall Study|Study terminated|7|||
27989166|NCT00594854|54647978|FG001|Overall Study|Study terminated|10|||
27989167|NCT00855582|54647987|FG000|Overall Study|Adverse Event|2|||
27989168|NCT00855582|54647988|FG001|Overall Study|Adverse Event|6|||
27989169|NCT00855582|54647989|FG002|Overall Study|Adverse Event|3|||
27989170|NCT00855582|54647987|FG000|Overall Study|Death|1|||
27989171|NCT00855582|54647988|FG001|Overall Study|Death|0|||
27989172|NCT00855582|54647989|FG002|Overall Study|Death|0|||
27989173|NCT00855582|54647987|FG000|Overall Study|Lack of Efficacy|1|||
27989174|NCT00855582|54647988|FG001|Overall Study|Lack of Efficacy|3|||
27989175|NCT00855582|54647989|FG002|Overall Study|Lack of Efficacy|8|||
27989176|NCT00855582|54647987|FG000|Overall Study|Lost to Follow-up|1|||
27989177|NCT00855582|54647988|FG001|Overall Study|Lost to Follow-up|3|||
27989178|NCT00855582|54647989|FG002|Overall Study|Lost to Follow-up|1|||
27989179|NCT00855582|54647987|FG000|Overall Study|Physician Decision|0|||
27989180|NCT00855582|54647988|FG001|Overall Study|Physician Decision|0|||
27989181|NCT00855582|54647989|FG002|Overall Study|Physician Decision|1|||
27989182|NCT00855582|54647987|FG000|Overall Study|Protocol Violation|6|||
27989183|NCT00855582|54647988|FG001|Overall Study|Protocol Violation|2|||
27989184|NCT00855582|54647989|FG002|Overall Study|Protocol Violation|6|||
27989185|NCT00855582|54647987|FG000|Overall Study|Entry Criteria Not Met|8|||
27989186|NCT00855582|54647988|FG001|Overall Study|Entry Criteria Not Met|6|||
27989187|NCT00855582|54647989|FG002|Overall Study|Entry Criteria Not Met|3|||
27989188|NCT00855582|54647987|FG000|Overall Study|Withdrawal by Subject|7|||
27905540|NCT01243944|54562676|FG000|Overall Study|Death|2|||
27905541|NCT01243944|54562677|FG001|Overall Study|Death|3|||
27905542|NCT01243944|54562676|FG000|Overall Study|Non-compliance with study treatment|1|||
27905543|NCT01243944|54562677|FG001|Overall Study|Non-compliance with study treatment|0|||
27905544|NCT01243242|54562686|FG000|Overall Study|Adverse Event|1|||
27905545|NCT01243242|54562687|FG001|Overall Study|Adverse Event|1|||
27905546|NCT01243242|54562686|FG000|Overall Study|Withdrawal by Subject|1|||
27905547|NCT01243242|54562687|FG001|Overall Study|Withdrawal by Subject|1|||
27905548|NCT01243242|54562686|FG000|Overall Study|Physician Decision|0|||
27989189|NCT00855582|54647988|FG001|Overall Study|Withdrawal by Subject|4|||
27989190|NCT00855582|54647989|FG002|Overall Study|Withdrawal by Subject|8|||
27989191|NCT00854724|54648002|FG000|First Intervention|Withdrawal by Subject|1|||
27989192|NCT00854724|54648003|FG001|First Intervention|Withdrawal by Subject|1|||
27989193|NCT00854724|54648002|FG000|Washout|Protocol Violation|1|||
27989194|NCT00854724|54648003|FG001|Washout|Protocol Violation|0|||
27989195|NCT00854724|54648002|FG000|Washout|Withdrawal by Subject|0|||
27905549|NCT01243242|54562687|FG001|Overall Study|Physician Decision|1|||
27905550|NCT01243242|54562686|FG000|Overall Study|sponsor decision|0|||
27905551|NCT01243242|54562687|FG001|Overall Study|sponsor decision|1|||
27905552|NCT01243242|54562686|FG000|Overall Study|non compliance|1|||
27905553|NCT01243242|54562687|FG001|Overall Study|non compliance|0|||
27905554|NCT01242813|54562693|FG000|Overall Study|Lost to Follow-up|2|||
27905555|NCT01242111|54562697|FG000|Overall Study|Adverse Event|1|||
27905556|NCT01242111|54562697|FG000|Overall Study|Withdrawal by Subject|1|||
27905557|NCT01242111|54562697|FG000|Overall Study|Did not consent to MOR-100 follow-up|1|||
27905558|NCT01241604|54562701|FG000|Screening Period|Screen Failure|3|||
27905559|NCT01241604|54562702|FG001|Screening Period|Screen Failure|0|||
27905560|NCT01241604|54562703|FG002|Screening Period|Screen Failure|0|||
27905561|NCT01241292|54562712|FG000|Overall Study|Administrative Reason by Sponsor|1|||
27905562|NCT01241292|54562713|FG001|Overall Study|Administrative Reason by Sponsor|0|||
27905563|NCT01241292|54562712|FG000|Overall Study|Disease Progression|2|||
27905564|NCT01241292|54562713|FG001|Overall Study|Disease Progression|0|||
27905565|NCT01241292|54562712|FG000|Overall Study|Study Drug Toxicity|0|||
27905566|NCT01241292|54562713|FG001|Overall Study|Study Drug Toxicity|1|||
27905567|NCT01241292|54562712|FG000|Overall Study|Participant Discontinued Treatment|0|||
27905568|NCT01241292|54562713|FG001|Overall Study|Participant Discontinued Treatment|2|||
27905569|NCT01240863|54562725|FG000|Open-label Titration Period|Adverse Event|47|||
27905570|NCT01240863|54562726|FG001|Open-label Titration Period|Adverse Event|0|||
27905571|NCT01240863|54562727|FG002|Open-label Titration Period|Adverse Event|0|||
27905572|NCT01240863|54562725|FG000|Open-label Titration Period|Lack of Efficacy|19|||
27905573|NCT01240863|54562726|FG001|Open-label Titration Period|Lack of Efficacy|0|||
27905574|NCT01240863|54562727|FG002|Open-label Titration Period|Lack of Efficacy|0|||
27905575|NCT01240863|54562725|FG000|Open-label Titration Period|Withdrawal by Subject|9|||
27905576|NCT01240863|54562726|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
27905577|NCT01240863|54562727|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
27905578|NCT01240863|54562725|FG000|Open-label Titration Period|Protocol Violation|7|||
27905579|NCT01240863|54562726|FG001|Open-label Titration Period|Protocol Violation|0|||
27905580|NCT01240863|54562727|FG002|Open-label Titration Period|Protocol Violation|0|||
27905581|NCT01240863|54562725|FG000|Open-label Titration Period|Noncompliance to study drug admin|3|||
27905582|NCT01240863|54562726|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
27905583|NCT01240863|54562727|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
27989196|NCT00854724|54648003|FG001|Washout|Withdrawal by Subject|1|||
27989197|NCT00854724|54648002|FG000|Second Intervention|Protocol Violation|1|||
27989198|NCT00854724|54648003|FG001|Second Intervention|Protocol Violation|0|||
27989199|NCT00854724|54648002|FG000|Second Intervention|Physician Decision|0|||
27989200|NCT00854724|54648003|FG001|Second Intervention|Physician Decision|1|||
27989201|NCT00698932|54648041|FG000|Overall Study|Adverse Event|0|||
27989202|NCT00698932|54648042|FG001|Overall Study|Adverse Event|2|||
27989203|NCT00698932|54648041|FG000|Overall Study|Incorrect enrollment|0|||
27989204|NCT00698932|54648042|FG001|Overall Study|Incorrect enrollment|2|||
27989205|NCT00698932|54648041|FG000|Overall Study|Study specific discontinuation criteria|3|||
27989206|NCT00698932|54648042|FG001|Overall Study|Study specific discontinuation criteria|4|||
27989207|NCT00698932|54648041|FG000|Overall Study|Withdrawal by Subject|11|||
27989208|NCT00698932|54648042|FG001|Overall Study|Withdrawal by Subject|23|||
27989209|NCT00698932|54648041|FG000|Overall Study|Lost to Follow-up|6|||
27989210|NCT00698932|54648042|FG001|Overall Study|Lost to Follow-up|1|||
28097534|NCT04041440|54753229|FG001|Overall Study|Lost to Follow-up|1|||
28097535|NCT03654560|54753238|FG000|Overall Study|Death|3|||
28097536|NCT03654560|54753239|FG001|Overall Study|Death|1|||
28097537|NCT03654560|54753238|FG000|Overall Study|Lost to Follow-up|1|||
27989211|NCT00698932|54648041|FG000|Overall Study|Severe non-compliance to protocol|1|||
27989212|NCT00698932|54648042|FG001|Overall Study|Severe non-compliance to protocol|2|||
27989213|NCT00698932|54648041|FG000|Overall Study|Safety reasons|0|||
27989214|NCT00698932|54648042|FG001|Overall Study|Safety reasons|2|||
27989215|NCT00698932|54648041|FG000|Overall Study|Death|1|||
27989216|NCT00698932|54648042|FG001|Overall Study|Death|0|||
28097538|NCT03654560|54753239|FG001|Overall Study|Lost to Follow-up|0|||
28097539|NCT03629054|54753247|FG000|Period 2 (4 Days)|Not treated|0|||
28097540|NCT03629054|54753248|FG001|Period 2 (4 Days)|Not treated|1|||
28097541|NCT03628898|54753254|FG000|Overall Study|Device deficiency|1|||
28097542|NCT03628508|54753258|FG000|Overall Study|Lost to Follow-up|1|||
28097543|NCT03045328|54753262|FG000|Overall Study|Withdrawal by Subject|2|||
27989217|NCT00823719|54648050|FG000|Overall Study|Adverse Event|1|||
27989218|NCT00823719|54648051|FG001|Overall Study|Adverse Event|2|||
27905584|NCT01240863|54562725|FG000|Open-label Titration Period|Noncompliance to study procedures|3|||
27989219|NCT00823719|54648050|FG000|Overall Study|Physician Decision|1|||
27989220|NCT00823719|54648051|FG001|Overall Study|Physician Decision|4|||
27989221|NCT00823719|54648050|FG000|Overall Study|Withdrawal by Subject|0|||
27989222|NCT00823719|54648051|FG001|Overall Study|Withdrawal by Subject|1|||
28097544|NCT02154490|54753268|FG000|Overall Study|No tissue submitted|23|||
28097545|NCT02154490|54753268|FG000|Overall Study|No biomarker results|167|||
27989223|NCT00823719|54648050|FG000|Overall Study|Disease Progression|4|||
27989224|NCT00823719|54648051|FG001|Overall Study|Disease Progression|4|||
27989225|NCT00875420|54648064|FG000|Overall Study|Adverse Event|0|||
27989226|NCT00875420|54648065|FG001|Overall Study|Adverse Event|1|||
27989227|NCT00875420|54648066|FG002|Overall Study|Adverse Event|1|||
27989228|NCT00875420|54648067|FG003|Overall Study|Adverse Event|0|||
27989229|NCT00875420|54648068|FG004|Overall Study|Adverse Event|0|||
27989230|NCT00875420|54648064|FG000|Overall Study|Inability to complete study procedures|1|||
27989231|NCT00875420|54648065|FG001|Overall Study|Inability to complete study procedures|0|||
27989232|NCT00875420|54648066|FG002|Overall Study|Inability to complete study procedures|1|||
27989233|NCT00875420|54648067|FG003|Overall Study|Inability to complete study procedures|1|||
27989234|NCT00875420|54648068|FG004|Overall Study|Inability to complete study procedures|1|||
27989235|NCT00875420|54648064|FG000|Overall Study|Lost to Follow-up|1|||
27989236|NCT00875420|54648065|FG001|Overall Study|Lost to Follow-up|0|||
27989237|NCT00875420|54648066|FG002|Overall Study|Lost to Follow-up|0|||
27989238|NCT00875420|54648067|FG003|Overall Study|Lost to Follow-up|0|||
27989239|NCT00875420|54648068|FG004|Overall Study|Lost to Follow-up|0|||
27989240|NCT00875420|54648064|FG000|Overall Study|Personal reason|0|||
27989241|NCT00875420|54648065|FG001|Overall Study|Personal reason|0|||
27989242|NCT00875420|54648066|FG002|Overall Study|Personal reason|0|||
27989243|NCT00875420|54648067|FG003|Overall Study|Personal reason|0|||
27989244|NCT00875420|54648068|FG004|Overall Study|Personal reason|1|||
27989245|NCT00875420|54648064|FG000|Overall Study|Prohibited medication|0|||
27989246|NCT00875420|54648065|FG001|Overall Study|Prohibited medication|0|||
27905585|NCT01240863|54562726|FG001|Open-label Titration Period|Noncompliance to study procedures|0|||
27905586|NCT01240863|54562727|FG002|Open-label Titration Period|Noncompliance to study procedures|0|||
27905587|NCT01240863|54562725|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
27905588|NCT01240863|54562726|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
27905589|NCT01240863|54562727|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
27905590|NCT01240863|54562725|FG000|Open-label Titration Period|Other|7|||
27989247|NCT00875420|54648066|FG002|Overall Study|Prohibited medication|0|||
27905591|NCT01240863|54562726|FG001|Open-label Titration Period|Other|0|||
27905592|NCT01240863|54562727|FG002|Open-label Titration Period|Other|0|||
27989248|NCT00875420|54648067|FG003|Overall Study|Prohibited medication|1|||
27989249|NCT00875420|54648068|FG004|Overall Study|Prohibited medication|0|||
27989250|NCT00875420|54648064|FG000|Overall Study|Sponsor decision|0|||
27989251|NCT00875420|54648065|FG001|Overall Study|Sponsor decision|1|||
27905593|NCT01240863|54562725|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
27905594|NCT01240863|54562726|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|4|||
27989252|NCT00875420|54648066|FG002|Overall Study|Sponsor decision|0|||
27989253|NCT00875420|54648067|FG003|Overall Study|Sponsor decision|0|||
27989254|NCT00875420|54648068|FG004|Overall Study|Sponsor decision|0|||
27989255|NCT00875420|54648064|FG000|Overall Study|Withdrawal by Subject|0|||
27989256|NCT00875420|54648065|FG001|Overall Study|Withdrawal by Subject|0|||
27989257|NCT00875420|54648066|FG002|Overall Study|Withdrawal by Subject|1|||
27989258|NCT00875420|54648067|FG003|Overall Study|Withdrawal by Subject|0|||
27989259|NCT00875420|54648068|FG004|Overall Study|Withdrawal by Subject|0|||
27989260|NCT00822237|54648082|FG000|Dose 1 Vaccination|Not vaccinated|3|||
27989261|NCT00822237|54648083|FG001|Dose 1 Vaccination|Not vaccinated|0|||
27905595|NCT01240863|54562727|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|10|||
27905596|NCT01240863|54562725|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
27905597|NCT01240863|54562726|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
27905598|NCT01240863|54562727|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
27989262|NCT00822237|54648082|FG000|Dose 1 Vaccination|Withdrawal by Subject|13|||
27989263|NCT00822237|54648083|FG001|Dose 1 Vaccination|Withdrawal by Subject|14|||
27905599|NCT01240863|54562725|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
27905600|NCT01240863|54562726|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
27989264|NCT00822237|54648082|FG000|Dose 1 Vaccination|Lost to Follow-up|9|||
27989265|NCT00822237|54648083|FG001|Dose 1 Vaccination|Lost to Follow-up|12|||
27989266|NCT00822237|54648082|FG000|Dose 2 Vaccination|Withdrawal by Subject|2|||
27989267|NCT00822237|54648083|FG001|Dose 2 Vaccination|Withdrawal by Subject|2|||
27989268|NCT00822237|54648082|FG000|Dose 2 Vaccination|Lost to Follow-up|2|||
27989269|NCT00822237|54648083|FG001|Dose 2 Vaccination|Lost to Follow-up|9|||
27989270|NCT00577096|54648090|FG000|Short Term Participation|withdrew from multiple myeloma treatment|3|||
27989271|NCT00577096|54648091|FG001|Short Term Participation|withdrew from multiple myeloma treatment|2|||
27989272|NCT00577096|54648090|FG000|Short Term Participation|Withdrawal by Subject|3|||
27989273|NCT00577096|54648091|FG001|Short Term Participation|Withdrawal by Subject|5|||
28097546|NCT02154490|54753268|FG000|Overall Study|Not assigned to a sub-study|270|||
27905601|NCT01240863|54562727|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
27905602|NCT01240863|54562725|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
27989274|NCT00577096|54648090|FG000|Short Term Participation|Death|1|||
27989275|NCT00577096|54648091|FG001|Short Term Participation|Death|1|||
27989276|NCT00863304|54648101|FG000|Overall Study|Adverse Event|10|||
27989277|NCT00863304|54648102|FG001|Overall Study|Adverse Event|4|||
27989278|NCT00863304|54648103|FG002|Overall Study|Adverse Event|14|||
27989279|NCT00863304|54648104|FG003|Overall Study|Adverse Event|16|||
27905603|NCT01240863|54562726|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
27989280|NCT00863304|54648101|FG000|Overall Study|Lost to Follow-up|1|||
27905604|NCT01240863|54562727|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14|||
27905605|NCT01240863|54562725|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
27905606|NCT01240863|54562726|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9|||
27905607|NCT01240863|54562727|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11|||
27905608|NCT01240863|54562725|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0|||
27905609|NCT01240863|54562726|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
27905610|NCT01240863|54562727|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
27905611|NCT01240863|54562725|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
27905612|NCT01240863|54562726|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
27905613|NCT01240863|54562727|FG002|Double-blind Treatment Period (12 Weeks)|Other|5|||
27905614|NCT01240863|54562725|FG000|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
27905615|NCT01240863|54562726|FG001|Double-blind Treatment Period (12 Weeks)|Physician Decision|1|||
27905616|NCT01240863|54562727|FG002|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
27905617|NCT01240746|54562742|FG000|Overall Study|Adverse Event|2|||
27905618|NCT01240746|54562743|FG001|Overall Study|Adverse Event|0|||
27905619|NCT01240746|54562744|FG002|Overall Study|Adverse Event|10|||
27905620|NCT01240746|54562742|FG000|Overall Study|Lost to Follow-up|23|||
27905621|NCT01240746|54562743|FG001|Overall Study|Lost to Follow-up|20|||
27905622|NCT01240746|54562744|FG002|Overall Study|Lost to Follow-up|102|||
27905623|NCT01240746|54562742|FG000|Overall Study|Protocol Violation|24|||
27905624|NCT01240746|54562743|FG001|Overall Study|Protocol Violation|15|||
27905625|NCT01240746|54562744|FG002|Overall Study|Protocol Violation|72|||
27905626|NCT01240746|54562742|FG000|Overall Study|Withdrawal by Subject|10|||
27905627|NCT01240746|54562743|FG001|Overall Study|Withdrawal by Subject|13|||
27989281|NCT00863304|54648102|FG001|Overall Study|Lost to Follow-up|5|||
27989282|NCT00863304|54648103|FG002|Overall Study|Lost to Follow-up|4|||
27989283|NCT00863304|54648104|FG003|Overall Study|Lost to Follow-up|2|||
27989284|NCT00863304|54648101|FG000|Overall Study|Lack of Efficacy|57|||
27989285|NCT00863304|54648102|FG001|Overall Study|Lack of Efficacy|26|||
27989286|NCT00863304|54648103|FG002|Overall Study|Lack of Efficacy|30|||
27989287|NCT00863304|54648104|FG003|Overall Study|Lack of Efficacy|28|||
27989288|NCT00863304|54648101|FG000|Overall Study|Withdrawal by Subject|19|||
27989289|NCT00863304|54648102|FG001|Overall Study|Withdrawal by Subject|14|||
27989290|NCT00863304|54648103|FG002|Overall Study|Withdrawal by Subject|20|||
27989291|NCT00863304|54648104|FG003|Overall Study|Withdrawal by Subject|18|||
27989292|NCT00863304|54648101|FG000|Overall Study|Other|1|||
27989293|NCT00863304|54648102|FG001|Overall Study|Other|0|||
27989294|NCT00863304|54648103|FG002|Overall Study|Other|0|||
27989295|NCT00863304|54648104|FG003|Overall Study|Other|1|||
27989296|NCT00863304|54648101|FG000|Overall Study|Protocol Violation|2|||
27989297|NCT00863304|54648102|FG001|Overall Study|Protocol Violation|6|||
27989298|NCT00863304|54648103|FG002|Overall Study|Protocol Violation|2|||
27989299|NCT00863304|54648104|FG003|Overall Study|Protocol Violation|0|||
27989300|NCT00863304|54648101|FG000|Overall Study|Randomized, but not Treated|3|||
27989301|NCT00863304|54648102|FG001|Overall Study|Randomized, but not Treated|1|||
27989302|NCT00863304|54648103|FG002|Overall Study|Randomized, but not Treated|4|||
27989303|NCT00863304|54648104|FG003|Overall Study|Randomized, but not Treated|1|||
27989304|NCT00863304|54648101|FG000|Overall Study|Entered extension study|101|||
27989305|NCT00863304|54648102|FG001|Overall Study|Entered extension study|129|||
27989306|NCT00863304|54648103|FG002|Overall Study|Entered extension study|113|||
27989307|NCT00863304|54648104|FG003|Overall Study|Entered extension study|125|||
27989308|NCT00695110|54648116|FG000|Treatment Period 1|Adverse Event|1|||
27989309|NCT00695110|54648116|FG000|Treatment Period 1|Withdrawal by Subject|2|||
27989310|NCT00695110|54648116|FG000|Treatment Period 3|Withdrawal by Subject|1|||
28097547|NCT02154490|54753268|FG000|Overall Study|Did not register to a sub-study|749|||
28097548|NCT01286272|54753274|FG000|Overall Study|Ineligible after beginning treatment|1|||
28097549|NCT01286272|54753275|FG001|Overall Study|Ineligible after beginning treatment|3|||
27905628|NCT01240746|54562744|FG002|Overall Study|Withdrawal by Subject|59|||
27989311|NCT00695110|54648116|FG000|Treatment Period 4|Adverse Event|1|||
27989312|NCT00594386|54648123|FG000|Overall Study|Major protocol violation|2|||
27989313|NCT00594386|54648123|FG000|Overall Study|Lack of Efficacy|12|||
27905629|NCT01240590|54562757|FG000|Phase I|Refused further treatment|0|||
27905630|NCT01240590|54562758|FG001|Phase I|Refused further treatment|0|||
27989314|NCT00594386|54648123|FG000|Overall Study|Adverse Event|68|||
27989315|NCT00594386|54648123|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
27989316|NCT00594386|54648123|FG000|Overall Study|Subject withdrew consent|35|||
27989317|NCT00594386|54648123|FG000|Overall Study|Study ended per sponsor|115|||
28097550|NCT03627494|54753293|FG000|Part A Washout 2 (7 Days)|Adverse Event|1|||
27989318|NCT00594386|54648123|FG000|Overall Study|Lost to Follow-up|6|||
27989319|NCT00594386|54648123|FG000|Overall Study|Other: Patient went off patch (hospital)|1|||
27989320|NCT00594386|54648123|FG000|Overall Study|Other: Subject moved to Seattle|1|||
27989321|NCT00594386|54648123|FG000|Overall Study|Other: Subject admitted to nursing home|1|||
27989322|NCT00594386|54648123|FG000|Overall Study|Other: Study terminated per investigator|2|||
27989323|NCT00594386|54648123|FG000|Overall Study|Other: Sponsor closure of study|1|||
27989324|NCT00594386|54648123|FG000|Overall Study|Other: Site terminated participation|1|||
27989325|NCT00594386|54648123|FG000|Overall Study|Other: Patient wants prescription Neupro|1|||
27905631|NCT01240590|54562759|FG002|Phase I|Refused further treatment|3|||
27905632|NCT01240590|54562760|FG003|Phase I|Refused further treatment|0|||
27905633|NCT01240590|54562761|FG004|Phase I|Refused further treatment|0|||
27905634|NCT01240590|54562757|FG000|Phase II|Refused further treatment|0|||
27989326|NCT00594386|54648123|FG000|Overall Study|Other: Loss of drivers license|1|||
27989327|NCT00862992|54648130|FG000|Overall Study|Adverse Event|2|||
27989328|NCT00862992|54648131|FG001|Overall Study|Adverse Event|1|||
27989329|NCT00862992|54648132|FG002|Overall Study|Adverse Event|1|||
27989330|NCT00862992|54648130|FG000|Overall Study|Physician Decision|1|||
27905635|NCT01240590|54562758|FG001|Phase II|Refused further treatment|0|||
27905636|NCT01240590|54562759|FG002|Phase II|Refused further treatment|0|||
27905637|NCT01240590|54562760|FG003|Phase II|Refused further treatment|2|||
27905638|NCT01240590|54562761|FG004|Phase II|Refused further treatment|1|||
27905639|NCT01240200|54562789|FG000|12-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
27905640|NCT01240200|54562790|FG001|12-week Crossover Phase - Period 1|Withdrawal by Subject|1|||
27989331|NCT00862992|54648131|FG001|Overall Study|Physician Decision|0|||
27989332|NCT00862992|54648132|FG002|Overall Study|Physician Decision|0|||
27989333|NCT00862992|54648130|FG000|Overall Study|Withdrawal by Subject|0|||
27989334|NCT00862992|54648131|FG001|Overall Study|Withdrawal by Subject|0|||
27989335|NCT00862992|54648132|FG002|Overall Study|Withdrawal by Subject|2|||
27989336|NCT00694096|54648140|FG000|Overall Study|Withdrawal by Subject|5|||
27989337|NCT00854100|54648147|FG000|Overall Study|Inability to complete the study visits|0|||
27989338|NCT00854100|54648148|FG001|Overall Study|Inability to complete the study visits|0|||
27989339|NCT00854100|54648149|FG002|Overall Study|Inability to complete the study visits|1|||
27989340|NCT00854100|54648147|FG000|Overall Study|Lost to Follow-up|2|||
27989341|NCT00854100|54648148|FG001|Overall Study|Lost to Follow-up|0|||
27989342|NCT00854100|54648149|FG002|Overall Study|Lost to Follow-up|3|||
27989343|NCT00854100|54648147|FG000|Overall Study|Withdrawal by Subject|3|||
27989344|NCT00854100|54648148|FG001|Overall Study|Withdrawal by Subject|1|||
27989345|NCT00854100|54648149|FG002|Overall Study|Withdrawal by Subject|2|||
27989346|NCT00854100|54648147|FG000|Overall Study|Protocol Violation|2|||
27989347|NCT00854100|54648148|FG001|Overall Study|Protocol Violation|4|||
27989348|NCT00854100|54648149|FG002|Overall Study|Protocol Violation|3|||
27989349|NCT00854100|54648147|FG000|Overall Study|Adverse Event|2|||
27989350|NCT00854100|54648148|FG001|Overall Study|Adverse Event|1|||
27989351|NCT00854100|54648149|FG002|Overall Study|Adverse Event|2|||
27989352|NCT00509899|54648166|FG000|Overall Study|Progressive disease|1|||
27989353|NCT00509899|54648167|FG001|Overall Study|Progressive disease|3|||
27989354|NCT00509899|54648168|FG002|Overall Study|Progressive disease|5|||
27989355|NCT00509899|54648169|FG003|Overall Study|Progressive disease|1|||
27989356|NCT00509899|54648170|FG004|Overall Study|Progressive disease|0|||
27989357|NCT00509899|54648171|FG005|Overall Study|Progressive disease|1|||
27989358|NCT00509899|54648172|FG006|Overall Study|Progressive disease|0|||
27989359|NCT00509899|54648173|FG007|Overall Study|Progressive disease|0|||
27989360|NCT00509899|54648166|FG000|Overall Study|Unacceptable Toxicity|1|||
27989361|NCT00509899|54648167|FG001|Overall Study|Unacceptable Toxicity|0|||
27989362|NCT00509899|54648168|FG002|Overall Study|Unacceptable Toxicity|0|||
27989363|NCT00509899|54648169|FG003|Overall Study|Unacceptable Toxicity|2|||
27989364|NCT00509899|54648170|FG004|Overall Study|Unacceptable Toxicity|0|||
27989365|NCT00509899|54648171|FG005|Overall Study|Unacceptable Toxicity|0|||
27989366|NCT00509899|54648172|FG006|Overall Study|Unacceptable Toxicity|0|||
27989367|NCT00509899|54648173|FG007|Overall Study|Unacceptable Toxicity|0|||
27989368|NCT00509899|54648166|FG000|Overall Study|Withdrawal by Subject|6|||
27989369|NCT00509899|54648167|FG001|Overall Study|Withdrawal by Subject|2|||
27989370|NCT00509899|54648168|FG002|Overall Study|Withdrawal by Subject|3|||
27989371|NCT00509899|54648169|FG003|Overall Study|Withdrawal by Subject|0|||
27989372|NCT00509899|54648170|FG004|Overall Study|Withdrawal by Subject|3|||
27905641|NCT01356966|54562801|FG000|Overall Study|Withdrawal by Subject|1|||
27989373|NCT00509899|54648171|FG005|Overall Study|Withdrawal by Subject|2|||
27989374|NCT00509899|54648172|FG006|Overall Study|Withdrawal by Subject|0|||
27989375|NCT00509899|54648173|FG007|Overall Study|Withdrawal by Subject|0|||
27989376|NCT00509899|54648166|FG000|Overall Study|Physician Decision|4|||
27905642|NCT01356966|54562802|FG001|Overall Study|Withdrawal by Subject|2|||
27905643|NCT01356966|54562801|FG000|Overall Study|Physician Decision|1|||
27989377|NCT00509899|54648167|FG001|Overall Study|Physician Decision|2|||
27989378|NCT00509899|54648168|FG002|Overall Study|Physician Decision|7|||
27989379|NCT00509899|54648169|FG003|Overall Study|Physician Decision|0|||
27989380|NCT00509899|54648170|FG004|Overall Study|Physician Decision|1|||
27989381|NCT00509899|54648171|FG005|Overall Study|Physician Decision|4|||
27989382|NCT00509899|54648172|FG006|Overall Study|Physician Decision|0|||
27989383|NCT00509899|54648173|FG007|Overall Study|Physician Decision|0|||
27989384|NCT00509899|54648166|FG000|Overall Study|Intercurrent Illness|1|||
27989385|NCT00509899|54648167|FG001|Overall Study|Intercurrent Illness|0|||
27989386|NCT00509899|54648168|FG002|Overall Study|Intercurrent Illness|0|||
27989387|NCT00509899|54648169|FG003|Overall Study|Intercurrent Illness|1|||
27989388|NCT00509899|54648170|FG004|Overall Study|Intercurrent Illness|0|||
27989389|NCT00509899|54648171|FG005|Overall Study|Intercurrent Illness|1|||
27989390|NCT00509899|54648172|FG006|Overall Study|Intercurrent Illness|0|||
27989391|NCT00509899|54648173|FG007|Overall Study|Intercurrent Illness|0|||
27989392|NCT00509899|54648166|FG000|Overall Study|Death|2|||
27989393|NCT00509899|54648167|FG001|Overall Study|Death|2|||
27989394|NCT00509899|54648168|FG002|Overall Study|Death|3|||
27989395|NCT00509899|54648169|FG003|Overall Study|Death|0|||
27989396|NCT00509899|54648170|FG004|Overall Study|Death|1|||
27989397|NCT00509899|54648171|FG005|Overall Study|Death|1|||
27989398|NCT00509899|54648172|FG006|Overall Study|Death|1|||
27989399|NCT00509899|54648173|FG007|Overall Study|Death|1|||
27905644|NCT01356966|54562802|FG001|Overall Study|Physician Decision|0|||
27905645|NCT01295827|54562831|FG000|Overall Study|Adverse Event|1|||
27905646|NCT01295827|54562832|FG001|Overall Study|Adverse Event|2|||
27905647|NCT01295827|54562833|FG002|Overall Study|Adverse Event|2|||
27905648|NCT01295827|54562834|FG003|Overall Study|Adverse Event|1|||
27905649|NCT01295827|54562835|FG004|Overall Study|Adverse Event|1|||
27905650|NCT01295827|54562836|FG005|Overall Study|Adverse Event|4|||
27905651|NCT01295827|54562837|FG006|Overall Study|Adverse Event|15|||
27989400|NCT00509899|54648166|FG000|Overall Study|Lack of Efficacy|1|||
27989401|NCT00509899|54648167|FG001|Overall Study|Lack of Efficacy|0|||
27989402|NCT00509899|54648168|FG002|Overall Study|Lack of Efficacy|2|||
27989403|NCT00509899|54648169|FG003|Overall Study|Lack of Efficacy|0|||
27989404|NCT00509899|54648170|FG004|Overall Study|Lack of Efficacy|0|||
27989405|NCT00509899|54648171|FG005|Overall Study|Lack of Efficacy|1|||
27989406|NCT00509899|54648172|FG006|Overall Study|Lack of Efficacy|0|||
27989407|NCT00509899|54648173|FG007|Overall Study|Lack of Efficacy|0|||
27989408|NCT00862836|54648187|FG000|Overall Study|Withdrawal by Subject|1|||
27905652|NCT01295827|54562838|FG007|Overall Study|Adverse Event|49|||
27905653|NCT01295827|54562839|FG008|Overall Study|Adverse Event|22|||
27905654|NCT01295827|54562840|FG009|Overall Study|Adverse Event|7|||
27905655|NCT01295827|54562841|FG010|Overall Study|Adverse Event|50|||
27905656|NCT01295827|54562842|FG011|Overall Study|Adverse Event|21|||
27905657|NCT01295827|54562843|FG012|Overall Study|Adverse Event|0|||
27905658|NCT01295827|54562844|FG013|Overall Study|Adverse Event|0|||
27905659|NCT01295827|54562845|FG014|Overall Study|Adverse Event|0|||
27905660|NCT01295827|54562831|FG000|Overall Study|Lost to Follow-up|0|||
27905661|NCT01295827|54562832|FG001|Overall Study|Lost to Follow-up|0|||
27989409|NCT00820755|54648191|FG000|Period 1: Combination Therapy Phase|Adverse Event|77|||
27905662|NCT01295827|54562833|FG002|Overall Study|Lost to Follow-up|3|||
27905663|NCT01295827|54562834|FG003|Overall Study|Lost to Follow-up|0|||
27905664|NCT01295827|54562835|FG004|Overall Study|Lost to Follow-up|1|||
27905665|NCT01295827|54562836|FG005|Overall Study|Lost to Follow-up|0|||
27905666|NCT01295827|54562837|FG006|Overall Study|Lost to Follow-up|4|||
27905667|NCT01295827|54562838|FG007|Overall Study|Lost to Follow-up|8|||
27905668|NCT01295827|54562839|FG008|Overall Study|Lost to Follow-up|7|||
27905669|NCT01295827|54562840|FG009|Overall Study|Lost to Follow-up|4|||
27905670|NCT01295827|54562841|FG010|Overall Study|Lost to Follow-up|7|||
27905671|NCT01295827|54562842|FG011|Overall Study|Lost to Follow-up|3|||
27905672|NCT01295827|54562843|FG012|Overall Study|Lost to Follow-up|0|||
27905673|NCT01295827|54562844|FG013|Overall Study|Lost to Follow-up|0|||
27905674|NCT01295827|54562845|FG014|Overall Study|Lost to Follow-up|0|||
27905675|NCT01295827|54562831|FG000|Overall Study|Not Reported|0|||
27905676|NCT01295827|54562832|FG001|Overall Study|Not Reported|0|||
27905677|NCT01295827|54562833|FG002|Overall Study|Not Reported|0|||
27905678|NCT01295827|54562834|FG003|Overall Study|Not Reported|1|||
27905679|NCT01295827|54562835|FG004|Overall Study|Not Reported|0|||
27989410|NCT00820755|54648192|FG001|Period 1: Combination Therapy Phase|Adverse Event|0|||
27989411|NCT00820755|54648193|FG002|Period 1: Combination Therapy Phase|Adverse Event|0|||
27989412|NCT00820755|54648191|FG000|Period 1: Combination Therapy Phase|Death|28|||
27739579|NCT02738879|54189191|FG000|Overall Study|Site Discontinued Study Participation|1|||
27739580|NCT02738879|54189192|FG001|Overall Study|Site Discontinued Study Participation|0|||
27905680|NCT01295827|54562836|FG005|Overall Study|Not Reported|0|||
27905681|NCT01295827|54562837|FG006|Overall Study|Not Reported|24|||
27905682|NCT01295827|54562838|FG007|Overall Study|Not Reported|58|||
27905683|NCT01295827|54562839|FG008|Overall Study|Not Reported|41|||
27905684|NCT01295827|54562840|FG009|Overall Study|Not Reported|2|||
27989413|NCT00820755|54648192|FG001|Period 1: Combination Therapy Phase|Death|0|||
27989414|NCT00820755|54648193|FG002|Period 1: Combination Therapy Phase|Death|0|||
27905685|NCT01295827|54562841|FG010|Overall Study|Not Reported|23|||
27905686|NCT01295827|54562842|FG011|Overall Study|Not Reported|13|||
27905687|NCT01295827|54562843|FG012|Overall Study|Not Reported|0|||
27989415|NCT00820755|54648191|FG000|Period 1: Combination Therapy Phase|Protocol Violation|4|||
27905688|NCT01295827|54562844|FG013|Overall Study|Not Reported|0|||
27905689|NCT01295827|54562845|FG014|Overall Study|Not Reported|0|||
27905690|NCT01295827|54562831|FG000|Overall Study|Progressive Disease|2|||
27905691|NCT01295827|54562832|FG001|Overall Study|Progressive Disease|1|||
27905692|NCT01295827|54562833|FG002|Overall Study|Progressive Disease|5|||
27905693|NCT01295827|54562834|FG003|Overall Study|Progressive Disease|2|||
27905694|NCT01295827|54562835|FG004|Overall Study|Progressive Disease|0|||
27905695|NCT01295827|54562836|FG005|Overall Study|Progressive Disease|1|||
27905696|NCT01295827|54562837|FG006|Overall Study|Progressive Disease|87|||
27905697|NCT01295827|54562838|FG007|Overall Study|Progressive Disease|144|||
27905698|NCT01295827|54562839|FG008|Overall Study|Progressive Disease|85|||
27905699|NCT01295827|54562840|FG009|Overall Study|Progressive Disease|40|||
27905700|NCT01295827|54562841|FG010|Overall Study|Progressive Disease|175|||
27905701|NCT01295827|54562842|FG011|Overall Study|Progressive Disease|136|||
27905702|NCT01295827|54562843|FG012|Overall Study|Progressive Disease|0|||
27905703|NCT01295827|54562844|FG013|Overall Study|Progressive Disease|0|||
27905704|NCT01295827|54562845|FG014|Overall Study|Progressive Disease|0|||
27905705|NCT01295827|54562831|FG000|Overall Study|Screen Failure|0|||
27905706|NCT01295827|54562832|FG001|Overall Study|Screen Failure|0|||
27905707|NCT01295827|54562833|FG002|Overall Study|Screen Failure|0|||
27905708|NCT01295827|54562834|FG003|Overall Study|Screen Failure|0|||
27905709|NCT01295827|54562835|FG004|Overall Study|Screen Failure|0|||
27905710|NCT01295827|54562836|FG005|Overall Study|Screen Failure|0|||
27905711|NCT01295827|54562837|FG006|Overall Study|Screen Failure|2|||
27905712|NCT01295827|54562838|FG007|Overall Study|Screen Failure|2|||
27905713|NCT01295827|54562839|FG008|Overall Study|Screen Failure|2|||
27905714|NCT01295827|54562840|FG009|Overall Study|Screen Failure|0|||
27905715|NCT01295827|54562841|FG010|Overall Study|Screen Failure|1|||
27905716|NCT01295827|54562842|FG011|Overall Study|Screen Failure|0|||
27905717|NCT01295827|54562843|FG012|Overall Study|Screen Failure|0|||
27905718|NCT01295827|54562844|FG013|Overall Study|Screen Failure|0|||
27905719|NCT01295827|54562845|FG014|Overall Study|Screen Failure|0|||
27905720|NCT01295827|54562831|FG000|Overall Study|Withdrawal by Subject|1|||
27905721|NCT01295827|54562832|FG001|Overall Study|Withdrawal by Subject|0|||
27905722|NCT01295827|54562833|FG002|Overall Study|Withdrawal by Subject|2|||
27905723|NCT01295827|54562834|FG003|Overall Study|Withdrawal by Subject|0|||
27905724|NCT01295827|54562835|FG004|Overall Study|Withdrawal by Subject|0|||
27905725|NCT01295827|54562836|FG005|Overall Study|Withdrawal by Subject|1|||
27905726|NCT01295827|54562837|FG006|Overall Study|Withdrawal by Subject|13|||
27905727|NCT01295827|54562838|FG007|Overall Study|Withdrawal by Subject|35|||
27905728|NCT01295827|54562839|FG008|Overall Study|Withdrawal by Subject|11|||
27905729|NCT01295827|54562840|FG009|Overall Study|Withdrawal by Subject|2|||
27905730|NCT01295827|54562841|FG010|Overall Study|Withdrawal by Subject|18|||
27905731|NCT01295827|54562842|FG011|Overall Study|Withdrawal by Subject|13|||
27905732|NCT01295827|54562843|FG012|Overall Study|Withdrawal by Subject|0|||
27905733|NCT01295827|54562844|FG013|Overall Study|Withdrawal by Subject|0|||
27905734|NCT01295827|54562845|FG014|Overall Study|Withdrawal by Subject|0|||
27905735|NCT01295827|54562831|FG000|Overall Study|Other|0|||
27905736|NCT01295827|54562832|FG001|Overall Study|Other|0|||
27905737|NCT01295827|54562833|FG002|Overall Study|Other|0|||
27905738|NCT01295827|54562834|FG003|Overall Study|Other|0|||
27905739|NCT01295827|54562835|FG004|Overall Study|Other|0|||
27905740|NCT01295827|54562836|FG005|Overall Study|Other|0|||
27905741|NCT01295827|54562837|FG006|Overall Study|Other|1|||
27905742|NCT01295827|54562838|FG007|Overall Study|Other|1|||
27905743|NCT01295827|54562839|FG008|Overall Study|Other|1|||
27905744|NCT01295827|54562840|FG009|Overall Study|Other|0|||
27905745|NCT01295827|54562841|FG010|Overall Study|Other|2|||
27905746|NCT01295827|54562842|FG011|Overall Study|Other|0|||
27905747|NCT01295827|54562843|FG012|Overall Study|Other|0|||
27905748|NCT01295827|54562844|FG013|Overall Study|Other|0|||
27905749|NCT01295827|54562845|FG014|Overall Study|Other|0|||
27905750|NCT01295671|54562901|FG000|Overall Study|Lost to Follow-up|4|||
27905751|NCT01295671|54562902|FG001|Overall Study|Lost to Follow-up|6|||
27905752|NCT01295671|54562903|FG002|Overall Study|Lost to Follow-up|3|||
27905753|NCT01295671|54562901|FG000|Overall Study|Withdrawal by Subject|3|||
27905754|NCT01295671|54562902|FG001|Overall Study|Withdrawal by Subject|1|||
28172333|NCT01652716|54843977|FG000|Overall Study|Withdrawal by Subject|33|||
27905755|NCT01295671|54562903|FG002|Overall Study|Withdrawal by Subject|0|||
27905756|NCT01295320|54562911|FG000|Overall Study|Adverse Event|2|||
27905757|NCT01295320|54562911|FG000|Overall Study|Lost to Follow-up|4|||
27905758|NCT01295320|54562911|FG000|Overall Study|Withdrawal by Subject|2|||
27905759|NCT01295320|54562911|FG000|Overall Study|Subject was bedridden|1|||
27905760|NCT01295320|54562911|FG000|Overall Study|Unable to travel|1|||
27905761|NCT01295281|54562917|FG000|First Intervention (7 Days)|Death|0|||
28172334|NCT01652716|54843978|FG001|Overall Study|Withdrawal by Subject|18|||
27905762|NCT01295281|54562918|FG001|First Intervention (7 Days)|Death|1|||
27905763|NCT01294696|54562926|FG000|Overall Study|Screening failures|7|||
27905764|NCT01294696|54562926|FG000|Overall Study|Protocol Violation|8|||
27905765|NCT01294696|54562926|FG000|Overall Study|Missing BPI Response|7|||
27905766|NCT01294696|54562926|FG000|Overall Study|Site closure|52|||
27905767|NCT01294579|54562931|FG000|Overall Study|Disease progression|12|||
27905768|NCT01294579|54562931|FG000|Overall Study|Adverse Event|11|||
27989416|NCT00820755|54648192|FG001|Period 1: Combination Therapy Phase|Protocol Violation|0|||
27989417|NCT00820755|54648193|FG002|Period 1: Combination Therapy Phase|Protocol Violation|0|||
27989418|NCT00820755|54648191|FG000|Period 1: Combination Therapy Phase|Lost to Follow-up|1|||
27989419|NCT00820755|54648192|FG001|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
27989420|NCT00820755|54648193|FG002|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
27989421|NCT00820755|54648191|FG000|Period 1: Combination Therapy Phase|Withdrawal by Subject|21|||
28097551|NCT03627494|54753294|FG001|Part A Washout 2 (7 Days)|Adverse Event|0|||
28097552|NCT03627494|54753295|FG002|Part A Washout 2 (7 Days)|Adverse Event|1|||
28097553|NCT03627494|54753296|FG003|Part A Washout 2 (7 Days)|Adverse Event|0|||
28097554|NCT03627494|54753297|FG004|Part A Washout 2 (7 Days)|Adverse Event|0|||
28097555|NCT03627494|54753298|FG005|Part A Washout 2 (7 Days)|Adverse Event|0|||
28097556|NCT03627494|54753299|FG006|Part A Washout 2 (7 Days)|Adverse Event|0|||
28097557|NCT03627494|54753300|FG007|Part A Washout 2 (7 Days)|Adverse Event|0|||
28097558|NCT03627494|54753301|FG008|Part A Washout 2 (7 Days)|Adverse Event|0|||
28097559|NCT03627494|54753302|FG009|Part A Washout 2 (7 Days)|Adverse Event|0|||
28097560|NCT03627494|54753303|FG010|Part A Washout 2 (7 Days)|Adverse Event|0|||
28097561|NCT03627494|54753304|FG011|Part A Washout 2 (7 Days)|Adverse Event|0|||
28097562|NCT03627494|54753293|FG000|Part B (Maximum of 34 Days)|Adverse Event|0|||
28097563|NCT03627494|54753294|FG001|Part B (Maximum of 34 Days)|Adverse Event|0|||
28097564|NCT03627494|54753295|FG002|Part B (Maximum of 34 Days)|Adverse Event|0|||
28097565|NCT03627494|54753296|FG003|Part B (Maximum of 34 Days)|Adverse Event|0|||
28097566|NCT03627494|54753297|FG004|Part B (Maximum of 34 Days)|Adverse Event|0|||
28097567|NCT03627494|54753298|FG005|Part B (Maximum of 34 Days)|Adverse Event|0|||
28097568|NCT03627494|54753299|FG006|Part B (Maximum of 34 Days)|Adverse Event|0|||
28097569|NCT03627494|54753300|FG007|Part B (Maximum of 34 Days)|Adverse Event|0|||
28097570|NCT03627494|54753301|FG008|Part B (Maximum of 34 Days)|Adverse Event|2|||
28097571|NCT03627494|54753302|FG009|Part B (Maximum of 34 Days)|Adverse Event|0|||
28097572|NCT03627494|54753303|FG010|Part B (Maximum of 34 Days)|Adverse Event|0|||
28097573|NCT03627494|54753304|FG011|Part B (Maximum of 34 Days)|Adverse Event|0|||
28097574|NCT03627494|54753293|FG000|Part C Washout 1 (7 Days)|Adverse Event|0|||
28097575|NCT03627494|54753294|FG001|Part C Washout 1 (7 Days)|Adverse Event|0|||
28097576|NCT03627494|54753295|FG002|Part C Washout 1 (7 Days)|Adverse Event|0|||
28097577|NCT03627494|54753296|FG003|Part C Washout 1 (7 Days)|Adverse Event|0|||
28097578|NCT03627494|54753297|FG004|Part C Washout 1 (7 Days)|Adverse Event|0|||
28097579|NCT03627494|54753298|FG005|Part C Washout 1 (7 Days)|Adverse Event|0|||
28097580|NCT03627494|54753299|FG006|Part C Washout 1 (7 Days)|Adverse Event|0|||
28097581|NCT03627494|54753300|FG007|Part C Washout 1 (7 Days)|Adverse Event|0|||
28097582|NCT03627494|54753301|FG008|Part C Washout 1 (7 Days)|Adverse Event|0|||
28097583|NCT03627494|54753302|FG009|Part C Washout 1 (7 Days)|Adverse Event|0|||
28097584|NCT03627494|54753303|FG010|Part C Washout 1 (7 Days)|Adverse Event|1|||
28097585|NCT03627494|54753304|FG011|Part C Washout 1 (7 Days)|Adverse Event|1|||
28097586|NCT03627416|54753345|FG000|Overall Study|Adverse Event|0|||
28097587|NCT03627416|54753346|FG001|Overall Study|Adverse Event|1|||
28097588|NCT00972478|54753354|FG000|Overall Study|Adverse Event|3|||
28097589|NCT00972478|54753355|FG001|Overall Study|Adverse Event|16|||
28097590|NCT00972478|54753354|FG000|Overall Study|Withdrawal by Subject|1|||
28097591|NCT00972478|54753355|FG001|Overall Study|Withdrawal by Subject|8|||
28097592|NCT00972478|54753354|FG000|Overall Study|Progression/Relapse|0|||
28097593|NCT00972478|54753355|FG001|Overall Study|Progression/Relapse|2|||
28097594|NCT00972478|54753354|FG000|Overall Study|Death|0|||
28097595|NCT00972478|54753355|FG001|Overall Study|Death|2|||
28097596|NCT00972478|54753354|FG000|Overall Study|Not protocol specified|1|||
28097597|NCT00972478|54753355|FG001|Overall Study|Not protocol specified|1|||
28097598|NCT00972478|54753354|FG000|Overall Study|Ineligible|1|||
28097599|NCT00972478|54753355|FG001|Overall Study|Ineligible|7|||
28097600|NCT00972478|54753354|FG000|Overall Study|Not start protocol treatment|1|||
28097601|NCT00972478|54753355|FG001|Overall Study|Not start protocol treatment|2|||
28097602|NCT00097539|54753369|FG000|Overall Study|Status Unknown (Or no final evaluation)|11959|||
27905769|NCT01294579|54562931|FG000|Overall Study|Study closed/terminated|3|||
27905770|NCT01294579|54562931|FG000|Overall Study|Lost to Follow-up|1|||
27905771|NCT01294579|54562931|FG000|Overall Study|Physician Decision|3|||
27905772|NCT01294579|54562931|FG000|Overall Study|Withdrawal by Subject|5|||
27905773|NCT01294462|54562937|FG000|Overall Study|Lost to Follow-up|1|||
28097603|NCT00097539|54753370|FG001|Overall Study|Status Unknown (Or no final evaluation)|3948|||
28097604|NCT00097539|54753371|FG002|Overall Study|Status Unknown (Or no final evaluation)|5646|||
28097605|NCT00097539|54753372|FG003|Overall Study|Status Unknown (Or no final evaluation)|2170|||
28097606|NCT00097539|54753373|FG004|Overall Study|Status Unknown (Or no final evaluation)|1106|||
28097607|NCT00097539|54753374|FG005|Overall Study|Status Unknown (Or no final evaluation)|3546|||
28097608|NCT00097539|54753375|FG006|Overall Study|Status Unknown (Or no final evaluation)|108|||
28097609|NCT00097539|54753369|FG000|Overall Study|Withdrawal by Subject|925|||
28097610|NCT00097539|54753370|FG001|Overall Study|Withdrawal by Subject|323|||
28172335|NCT02790073|54843984|FG000|Overall Study|Death|1|||
27905774|NCT01294462|54562938|FG001|Overall Study|Lost to Follow-up|0|||
27905775|NCT01294462|54562937|FG000|Overall Study|Withdrawal by Subject|65|||
27905776|NCT01294462|54562938|FG001|Overall Study|Withdrawal by Subject|63|||
27905777|NCT01294423|54562947|FG000|Overall Study|Adverse Event|1|||
27905778|NCT01294423|54562948|FG001|Overall Study|Adverse Event|2|||
27905779|NCT01294423|54562949|FG002|Overall Study|Adverse Event|3|||
27905780|NCT01294423|54562947|FG000|Overall Study|Withdrawal by Subject|1|||
27905781|NCT01294423|54562948|FG001|Overall Study|Withdrawal by Subject|2|||
27905782|NCT01294423|54562949|FG002|Overall Study|Withdrawal by Subject|2|||
27905783|NCT01294423|54562947|FG000|Overall Study|subject no longer meets study criteria|2|||
27905784|NCT01294423|54562948|FG001|Overall Study|subject no longer meets study criteria|5|||
27905785|NCT01294423|54562949|FG002|Overall Study|subject no longer meets study criteria|2|||
27905786|NCT01294423|54562947|FG000|Overall Study|poor/non-compliance|1|||
27905787|NCT01294423|54562948|FG001|Overall Study|poor/non-compliance|0|||
27905788|NCT01294423|54562949|FG002|Overall Study|poor/non-compliance|1|||
27905789|NCT01294150|54562959|FG000|Overall Study|Physician Decision|2|||
27905790|NCT01294150|54562960|FG001|Overall Study|Physician Decision|2|||
27905791|NCT01292473|54562972|FG000|Overall Study|Adverse Event|1|||
27905792|NCT01292473|54562973|FG001|Overall Study|Adverse Event|0|||
27989422|NCT00820755|54648192|FG001|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
27989423|NCT00820755|54648193|FG002|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
27989424|NCT00820755|54648191|FG000|Period 1: Combination Therapy Phase|Progressive disease|114|||
27989425|NCT00820755|54648192|FG001|Period 1: Combination Therapy Phase|Progressive disease|0|||
27989426|NCT00820755|54648193|FG002|Period 1: Combination Therapy Phase|Progressive disease|0|||
27989427|NCT00820755|54648191|FG000|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14|||
27905793|NCT01292473|54562974|FG002|Overall Study|Adverse Event|1|||
27905794|NCT01292473|54562975|FG003|Overall Study|Adverse Event|1|||
27905795|NCT01292473|54562972|FG000|Overall Study|Lost to Follow-up|1|||
27905796|NCT01292473|54562973|FG001|Overall Study|Lost to Follow-up|1|||
27905797|NCT01292473|54562974|FG002|Overall Study|Lost to Follow-up|2|||
27905798|NCT01292473|54562975|FG003|Overall Study|Lost to Follow-up|2|||
27905799|NCT01292473|54562972|FG000|Overall Study|Withdrawal by Subject|3|||
27905800|NCT01292473|54562973|FG001|Overall Study|Withdrawal by Subject|4|||
27905801|NCT01292473|54562974|FG002|Overall Study|Withdrawal by Subject|3|||
27905802|NCT01292473|54562975|FG003|Overall Study|Withdrawal by Subject|3|||
27905803|NCT01292473|54562972|FG000|Overall Study|Physician Decision|0|||
27905804|NCT01292473|54562973|FG001|Overall Study|Physician Decision|1|||
27905805|NCT01292473|54562974|FG002|Overall Study|Physician Decision|0|||
27905806|NCT01292473|54562975|FG003|Overall Study|Physician Decision|0|||
27905807|NCT01292473|54562972|FG000|Overall Study|Disease Progression|0|||
27905808|NCT01292473|54562973|FG001|Overall Study|Disease Progression|1|||
27905809|NCT01292473|54562974|FG002|Overall Study|Disease Progression|3|||
27905810|NCT01292473|54562975|FG003|Overall Study|Disease Progression|6|||
27905811|NCT01292239|54562991|FG000|Overall Study|Other|1|||
27905812|NCT01292239|54562992|FG001|Overall Study|Other|1|||
27905813|NCT01292239|54562991|FG000|Overall Study|Withdrawal by Subject|3|||
27905814|NCT01292239|54562992|FG001|Overall Study|Withdrawal by Subject|6|||
27905815|NCT01291225|54563000|FG000|Overall Study|Lost to Follow-up|85|||
27905816|NCT01291225|54563001|FG001|Overall Study|Lost to Follow-up|39|||
27905817|NCT01290796|54563011|FG000|Overall Study|Lost to Follow-up|21|||
27905818|NCT01290796|54563011|FG000|Overall Study|Withdrawal by Subject|4|||
27905819|NCT01290796|54563011|FG000|Overall Study|Physician Decision|2|||
27905820|NCT01290796|54563011|FG000|Overall Study|Secondary Surgical Intervention|2|||
27905821|NCT01290796|54563011|FG000|Overall Study|Withdrawal by Sponsor|1|||
27905822|NCT01290757|54563017|FG000|Overall Study|Adverse Event|1|||
27905823|NCT01290757|54563018|FG001|Overall Study|Adverse Event|0|||
27905824|NCT01290757|54563017|FG000|Overall Study|Protocol Violation|1|||
27905825|NCT01290757|54563018|FG001|Overall Study|Protocol Violation|1|||
27905826|NCT01290757|54563017|FG000|Overall Study|Other|0|||
27905827|NCT01290757|54563018|FG001|Overall Study|Other|1|||
27905828|NCT01290718|54563024|FG000|Overall Study|Early termination of the study|4|||
27905829|NCT01290679|54563030|FG000|Overall Study|Adverse Event|2|||
27905830|NCT01290679|54563031|FG001|Overall Study|Adverse Event|0|||
27905831|NCT01290679|54563030|FG000|Overall Study|Lost to Follow-up|8|||
27905832|NCT01290679|54563031|FG001|Overall Study|Lost to Follow-up|10|||
27905833|NCT01290679|54563030|FG000|Overall Study|Protocol Violation|0|||
27905834|NCT01290679|54563031|FG001|Overall Study|Protocol Violation|1|||
27905835|NCT01290679|54563030|FG000|Overall Study|Withdrawal by Subject|6|||
27905836|NCT01290679|54563031|FG001|Overall Study|Withdrawal by Subject|5|||
27989428|NCT00820755|54648192|FG001|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
28172336|NCT02790073|54843984|FG000|Overall Study|Withdrawal from HD|1|||
27905837|NCT01290679|54563030|FG000|Overall Study|Subject Entered Another Trial|0|||
27905838|NCT01290679|54563031|FG001|Overall Study|Subject Entered Another Trial|5|||
27905839|NCT01290601|54563039|FG000|Overall Study|Adverse Event|0|||
27905840|NCT01290601|54563040|FG001|Overall Study|Adverse Event|2|||
27905841|NCT01290601|54563041|FG002|Overall Study|Adverse Event|0|||
27905842|NCT01290601|54563042|FG003|Overall Study|Adverse Event|0|||
27905843|NCT01290601|54563039|FG000|Overall Study|Lack of Efficacy|2|||
27905844|NCT01290601|54563040|FG001|Overall Study|Lack of Efficacy|1|||
27905845|NCT01290601|54563041|FG002|Overall Study|Lack of Efficacy|0|||
28097611|NCT00097539|54753371|FG002|Overall Study|Withdrawal by Subject|346|||
28097612|NCT00097539|54753372|FG003|Overall Study|Withdrawal by Subject|217|||
28097613|NCT00097539|54753373|FG004|Overall Study|Withdrawal by Subject|68|||
27989429|NCT00820755|54648193|FG002|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
27989430|NCT00820755|54648191|FG000|Period 1: Combination Therapy Phase|Other|11|||
27989431|NCT00820755|54648192|FG001|Period 1: Combination Therapy Phase|Other|0|||
27989432|NCT00820755|54648193|FG002|Period 1: Combination Therapy Phase|Other|0|||
27989433|NCT00820755|54648191|FG000|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0|||
27989434|NCT00820755|54648192|FG001|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
27989435|NCT00820755|54648193|FG002|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
27989436|NCT00820599|54648201|FG000|Overall Study|Death|129|||
27989437|NCT00820599|54648201|FG000|Overall Study|Withdrawal by Subject|2|||
27989438|NCT00819741|54648207|FG000|Overall Study|Adverse Event|5|||
27989439|NCT00819741|54648208|FG001|Overall Study|Adverse Event|2|||
27989440|NCT00819741|54648207|FG000|Overall Study|Lack of Efficacy|0|||
27989441|NCT00819741|54648208|FG001|Overall Study|Lack of Efficacy|2|||
27989442|NCT00819741|54648207|FG000|Overall Study|Lost to Follow-up|3|||
27989443|NCT00819741|54648208|FG001|Overall Study|Lost to Follow-up|1|||
27989444|NCT00819741|54648207|FG000|Overall Study|Protocol Violation|3|||
27989445|NCT00819741|54648208|FG001|Overall Study|Protocol Violation|4|||
27989446|NCT00819741|54648207|FG000|Overall Study|Withdrawal by Subject|2|||
27989447|NCT00819741|54648208|FG001|Overall Study|Withdrawal by Subject|2|||
27989448|NCT00819741|54648207|FG000|Overall Study|Unclassified|6|||
27989449|NCT00819741|54648208|FG001|Overall Study|Unclassified|0|||
27989450|NCT00819741|54648207|FG000|Overall Study|Reasons unknown|3|||
27989451|NCT00819741|54648208|FG001|Overall Study|Reasons unknown|3|||
27989452|NCT00862134|54648216|FG000|Overall Study|Death|1|||
27989453|NCT00862134|54648217|FG001|Overall Study|Death|0|||
27989454|NCT00862134|54648216|FG000|Overall Study|Physician Decision|0|||
27989455|NCT00862134|54648217|FG001|Overall Study|Physician Decision|1|||
27989456|NCT00862134|54648216|FG000|Overall Study|Withdrawal by Subject|1|||
27989457|NCT00862134|54648217|FG001|Overall Study|Withdrawal by Subject|2|||
27989458|NCT00862134|54648216|FG000|Overall Study|Sponsor terminated study|5|||
27989459|NCT00862134|54648217|FG001|Overall Study|Sponsor terminated study|7|||
27989460|NCT00862134|54648216|FG000|Overall Study|Adverse Event|2|||
27989461|NCT00862134|54648217|FG001|Overall Study|Adverse Event|2|||
27989462|NCT00862134|54648216|FG000|Overall Study|Withdrew prior to dosing|2|||
27989463|NCT00862134|54648217|FG001|Overall Study|Withdrew prior to dosing|0|||
27989464|NCT00848484|54648225|FG000|First Intervention (Treatment Period 1)|Adverse Event|2|||
27989465|NCT00848484|54648226|FG001|First Intervention (Treatment Period 1)|Adverse Event|1|||
27989466|NCT00848484|54648225|FG000|First Intervention (Treatment Period 1)|Physician Decision|0|||
27989467|NCT00848484|54648226|FG001|First Intervention (Treatment Period 1)|Physician Decision|1|||
27905846|NCT01290601|54563042|FG003|Overall Study|Lack of Efficacy|0|||
27905847|NCT01290601|54563039|FG000|Overall Study|Lost to Follow-up|7|||
27905848|NCT01290601|54563040|FG001|Overall Study|Lost to Follow-up|2|||
27905849|NCT01290601|54563041|FG002|Overall Study|Lost to Follow-up|0|||
27905850|NCT01290601|54563042|FG003|Overall Study|Lost to Follow-up|0|||
27905851|NCT01290601|54563039|FG000|Overall Study|Other|1|||
27905852|NCT01290601|54563040|FG001|Overall Study|Other|0|||
27905853|NCT01290601|54563041|FG002|Overall Study|Other|0|||
27905854|NCT01290601|54563042|FG003|Overall Study|Other|0|||
27905855|NCT01290601|54563039|FG000|Overall Study|Protocol Violation|1|||
27905856|NCT01290601|54563040|FG001|Overall Study|Protocol Violation|0|||
27905857|NCT01290601|54563041|FG002|Overall Study|Protocol Violation|0|||
27905858|NCT01290601|54563042|FG003|Overall Study|Protocol Violation|0|||
27905859|NCT01290523|54563048|FG000|Overall Study|Death|3|||
27905860|NCT01290094|54563052|FG000|Overall Study|Withdrawal by Subject|1|||
27905861|NCT01290094|54563052|FG000|Overall Study|Lost to Follow-up|5|||
27905862|NCT01289821|54563065|FG000|Treatment Period|Withdrawal by Subject|1|||
27905863|NCT01289821|54563065|FG000|Treatment Period|Physician Decision|3|||
27905864|NCT01289821|54563065|FG000|Treatment Period|Adverse Event|4|||
27905865|NCT01289821|54563065|FG000|Treatment Period|Radiological Progression|43|||
27989468|NCT00848484|54648225|FG000|First Intervention (Treatment Period 1)|Withdrawal by Subject|0|||
27989469|NCT00848484|54648226|FG001|First Intervention (Treatment Period 1)|Withdrawal by Subject|1|||
28097614|NCT00097539|54753374|FG005|Overall Study|Withdrawal by Subject|229|||
28097615|NCT00097539|54753375|FG006|Overall Study|Withdrawal by Subject|3|||
28097616|NCT00097539|54753369|FG000|Overall Study|Participant Non-compliant|2140|||
27989470|NCT00848484|54648225|FG000|Washout Period of Two Weeks|Withdrawal by Subject|0|||
28097617|NCT00097539|54753370|FG001|Overall Study|Participant Non-compliant|567|||
28097618|NCT00097539|54753371|FG002|Overall Study|Participant Non-compliant|1067|||
27905866|NCT01289821|54563065|FG000|Treatment Period|Clinical Progression|2|||
27905867|NCT01289821|54563065|FG000|Treatment Period|Therapeutic procedure required|1|||
27905868|NCT01289821|54563065|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
27905869|NCT01289821|54563065|FG000|Safety Follow-up Period|Protocol Violation|3|||
27905870|NCT01289821|54563065|FG000|Safety Follow-up Period|Unspecified reason|1|||
27905871|NCT01289821|54563065|FG000|Survival Follow-up Period|Protocol Violation|1|||
27905872|NCT01289821|54563065|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
27905873|NCT01289821|54563065|FG000|Survival Follow-up Period|Clinical endpoint reached|16|||
27905874|NCT01289782|54563071|FG000|Overall Study|Lost to Follow-up|14|||
27905875|NCT01289782|54563072|FG001|Overall Study|Lost to Follow-up|7|||
27905876|NCT01289782|54563071|FG000|Overall Study|Protocol Violation|1|||
27905877|NCT01289782|54563072|FG001|Overall Study|Protocol Violation|1|||
27905878|NCT01289782|54563071|FG000|Overall Study|Withdrawal by Subject|8|||
27989471|NCT00848484|54648226|FG001|Washout Period of Two Weeks|Withdrawal by Subject|3|||
27989472|NCT00848484|54648225|FG000|Second Intervention (Treatment Period 2)|Lost to Follow-up|0|||
27989473|NCT00848484|54648226|FG001|Second Intervention (Treatment Period 2)|Lost to Follow-up|1|||
27989474|NCT00509821|54648234|FG000|Study Period 1 (Induction)|Death|0|||
27989475|NCT00509821|54648235|FG001|Study Period 1 (Induction)|Death|1|||
27989476|NCT00509821|54648234|FG000|Study Period 1 (Induction)|Adverse Event|0|||
27989477|NCT00509821|54648235|FG001|Study Period 1 (Induction)|Adverse Event|2|||
27989478|NCT00509821|54648234|FG000|Study Period 1 (Induction)|Progressive Disease|0|||
27989479|NCT00509821|54648235|FG001|Study Period 1 (Induction)|Progressive Disease|1|||
27989480|NCT00508651|54648248|FG000|Overall Study|Lost to Follow-up|3|||
27989481|NCT00508651|54648249|FG001|Overall Study|Lost to Follow-up|1|||
27989482|NCT00508651|54648248|FG000|Overall Study|Withdrawal by Subject|1|||
27989483|NCT00508651|54648249|FG001|Overall Study|Withdrawal by Subject|1|||
27989484|NCT00490555|54648259|FG000|Overall Study|noncompliant with drug administration|0|||
27989485|NCT00490555|54648260|FG001|Overall Study|noncompliant with drug administration|0|||
27989486|NCT00490555|54648261|FG002|Overall Study|noncompliant with drug administration|2|||
27989487|NCT00490555|54648262|FG003|Overall Study|noncompliant with drug administration|0|||
27905879|NCT01289782|54563072|FG001|Overall Study|Withdrawal by Subject|2|||
27905880|NCT01289782|54563071|FG000|Overall Study|Sponsor's Decision|1|||
27905881|NCT01289782|54563072|FG001|Overall Study|Sponsor's Decision|0|||
27905882|NCT01289782|54563071|FG000|Overall Study|Reason not specified|1|||
27905883|NCT01289782|54563072|FG001|Overall Study|Reason not specified|2|||
27905884|NCT01289353|54563078|FG000|Overall Study|Lost to Follow-up|2|||
27989488|NCT00501085|54648272|FG000|Overall Study|Lost to Follow-up|195|||
27989489|NCT00501085|54648272|FG000|Overall Study|Withdrawal by Subject|34|||
27905885|NCT01289119|54563088|FG000|Overall Study|Adverse Event|2|||
27905886|NCT01289119|54563089|FG001|Overall Study|Adverse Event|1|||
27905887|NCT01289119|54563090|FG002|Overall Study|Adverse Event|0|||
27905888|NCT01289119|54563091|FG003|Overall Study|Adverse Event|2|||
27905889|NCT01289119|54563092|FG004|Overall Study|Adverse Event|1|||
27905890|NCT01289119|54563093|FG005|Overall Study|Adverse Event|0|||
27905891|NCT01289119|54563088|FG000|Overall Study|Major Protocol Deviation|2|||
27905892|NCT01289119|54563089|FG001|Overall Study|Major Protocol Deviation|1|||
27905893|NCT01289119|54563090|FG002|Overall Study|Major Protocol Deviation|3|||
27905894|NCT01289119|54563091|FG003|Overall Study|Major Protocol Deviation|0|||
27905895|NCT01289119|54563092|FG004|Overall Study|Major Protocol Deviation|2|||
27905896|NCT01289119|54563093|FG005|Overall Study|Major Protocol Deviation|1|||
27905897|NCT01289119|54563088|FG000|Overall Study|Lost to Follow-up|0|||
27905898|NCT01289119|54563089|FG001|Overall Study|Lost to Follow-up|3|||
27905899|NCT01289119|54563090|FG002|Overall Study|Lost to Follow-up|0|||
27905900|NCT01289119|54563091|FG003|Overall Study|Lost to Follow-up|0|||
27989490|NCT00501085|54648272|FG000|Overall Study|Subject Decision|1|||
27989491|NCT00501085|54648272|FG000|Overall Study|Revision Surgery|7|||
27989492|NCT00501085|54648272|FG000|Overall Study|Explantation Surgery|26|||
27989493|NCT00501085|54648272|FG000|Overall Study|Adverse Event|4|||
27905901|NCT01289119|54563092|FG004|Overall Study|Lost to Follow-up|0|||
27905902|NCT01289119|54563093|FG005|Overall Study|Lost to Follow-up|1|||
27905903|NCT01289119|54563088|FG000|Overall Study|Withdrawal by Subject|4|||
27989494|NCT00501085|54648272|FG000|Overall Study|Non-Compliance|24|||
27905904|NCT01289119|54563089|FG001|Overall Study|Withdrawal by Subject|2|||
27905905|NCT01289119|54563090|FG002|Overall Study|Withdrawal by Subject|4|||
27905906|NCT01289119|54563091|FG003|Overall Study|Withdrawal by Subject|3|||
27905907|NCT01289119|54563092|FG004|Overall Study|Withdrawal by Subject|1|||
27989495|NCT00501085|54648272|FG000|Overall Study|Study closed by sponsor|109|||
27989496|NCT00501085|54648272|FG000|Overall Study|Other loss to follow-up|32|||
27989497|NCT00501007|54648276|FG000|Overall Study|Inclusion criteria not met.|29|||
27989498|NCT00501007|54648277|FG001|Overall Study|Inclusion criteria not met.|25|||
27989499|NCT00873860|54648287|FG000|Overall Study|Lost to Follow-up|1|||
27989500|NCT00873860|54648288|FG001|Overall Study|Lost to Follow-up|0|||
27905908|NCT01289119|54563093|FG005|Overall Study|Withdrawal by Subject|1|||
27905909|NCT01289119|54563088|FG000|Overall Study|Pregnancy|0|||
27905910|NCT01289119|54563089|FG001|Overall Study|Pregnancy|1|||
27905911|NCT01289119|54563090|FG002|Overall Study|Pregnancy|0|||
27989501|NCT00873860|54648289|FG002|Overall Study|Lost to Follow-up|0|||
27989502|NCT00873860|54648290|FG003|Overall Study|Lost to Follow-up|1|||
27989503|NCT00873860|54648287|FG000|Overall Study|Withdrawal by Subject|1|||
27989504|NCT00873860|54648288|FG001|Overall Study|Withdrawal by Subject|0|||
27905912|NCT01289119|54563091|FG003|Overall Study|Pregnancy|0|||
27905913|NCT01289119|54563092|FG004|Overall Study|Pregnancy|0|||
27905914|NCT01289119|54563093|FG005|Overall Study|Pregnancy|0|||
27905915|NCT01289119|54563088|FG000|Overall Study|Lack of Efficacy|0|||
27905916|NCT01289119|54563089|FG001|Overall Study|Lack of Efficacy|1|||
27905917|NCT01289119|54563090|FG002|Overall Study|Lack of Efficacy|1|||
27905918|NCT01289119|54563091|FG003|Overall Study|Lack of Efficacy|1|||
27905919|NCT01289119|54563092|FG004|Overall Study|Lack of Efficacy|1|||
27905920|NCT01289119|54563093|FG005|Overall Study|Lack of Efficacy|1|||
27905921|NCT01289119|54563088|FG000|Overall Study|Other|1|||
27905922|NCT01289119|54563089|FG001|Overall Study|Other|0|||
27905923|NCT01289119|54563090|FG002|Overall Study|Other|1|||
27989505|NCT00873860|54648289|FG002|Overall Study|Withdrawal by Subject|2|||
27989506|NCT00873860|54648290|FG003|Overall Study|Withdrawal by Subject|0|||
27989507|NCT00873860|54648287|FG000|Overall Study|Death|1|||
27905924|NCT01289119|54563091|FG003|Overall Study|Other|0|||
27905925|NCT01289119|54563092|FG004|Overall Study|Other|0|||
27905926|NCT01289119|54563093|FG005|Overall Study|Other|0|||
27989508|NCT00873860|54648288|FG001|Overall Study|Death|0|||
27989509|NCT00873860|54648289|FG002|Overall Study|Death|0|||
27989510|NCT00873860|54648290|FG003|Overall Study|Death|0|||
27989511|NCT00873860|54648287|FG000|Overall Study|Other|1|||
27989512|NCT00873860|54648288|FG001|Overall Study|Other|0|||
27989513|NCT00873860|54648289|FG002|Overall Study|Other|1|||
27989514|NCT00873860|54648290|FG003|Overall Study|Other|0|||
27989515|NCT03853291|54648313|FG000|Overall Study|Lost to Follow-up|1|||
27989516|NCT03853291|54648314|FG001|Overall Study|Lost to Follow-up|2|||
27989517|NCT03853291|54648315|FG002|Overall Study|Lost to Follow-up|0|||
27989518|NCT03853291|54648316|FG003|Overall Study|Lost to Follow-up|0|||
27989519|NCT03853291|54648317|FG004|Overall Study|Lost to Follow-up|0|||
27989520|NCT03853291|54648318|FG005|Overall Study|Lost to Follow-up|0|||
27989521|NCT03853291|54648313|FG000|Overall Study|Determined to be ineligible|1|||
27989522|NCT03853291|54648314|FG001|Overall Study|Determined to be ineligible|1|||
27989523|NCT03853291|54648315|FG002|Overall Study|Determined to be ineligible|0|||
27989524|NCT03853291|54648316|FG003|Overall Study|Determined to be ineligible|0|||
27989525|NCT03853291|54648317|FG004|Overall Study|Determined to be ineligible|0|||
27989526|NCT03853291|54648318|FG005|Overall Study|Determined to be ineligible|0|||
27989527|NCT03853213|54648331|FG000|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|1|||
27989528|NCT03853213|54648332|FG001|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|0|||
27989529|NCT03853213|54648331|FG000|Overall Study|Other (e.g., too busy)|0|||
27989530|NCT03853213|54648332|FG001|Overall Study|Other (e.g., too busy)|2|||
27989531|NCT02666105|54648358|FG000|Overall Study|Death|1|||
27905927|NCT01289041|54563107|FG000|Overall Study|Adverse Event|24|||
27905928|NCT01289041|54563107|FG000|Overall Study|Physician Decision|1|||
27905929|NCT01289041|54563107|FG000|Overall Study|Progressive Disease|41|||
27989532|NCT00819585|54648377|FG000|Core Study|Adverse Event|2|||
27905930|NCT01289041|54563107|FG000|Overall Study|Withdrawal by Subject|3|||
27905931|NCT01289041|54563107|FG000|Overall Study|Death|1|||
27905932|NCT01288729|54563115|FG000|Overall Study|Withdrawal by Subject|1|||
27905933|NCT01288729|54563116|FG001|Overall Study|Withdrawal by Subject|0|||
27905934|NCT01288612|54563125|FG000|Overall Study|Unable to contact|11|||
27905935|NCT01288612|54563126|FG001|Overall Study|Unable to contact|16|||
27905936|NCT01288612|54563127|FG002|Overall Study|Unable to contact|20|||
27905937|NCT01288612|54563125|FG000|Overall Study|Declined|78|||
27905938|NCT01288612|54563126|FG001|Overall Study|Declined|63|||
27905939|NCT01288612|54563127|FG002|Overall Study|Declined|62|||
27905940|NCT01288612|54563125|FG000|Overall Study|Unable to intubate|0|||
27905941|NCT01288612|54563126|FG001|Overall Study|Unable to intubate|3|||
27905942|NCT01288612|54563127|FG002|Overall Study|Unable to intubate|0|||
27905943|NCT01287832|54563137|FG000|Overall Study|Adverse Event|1|||
27905944|NCT01287832|54563138|FG001|Overall Study|Adverse Event|0|||
27905945|NCT01287832|54563137|FG000|Overall Study|Death|0|||
27905946|NCT01287832|54563138|FG001|Overall Study|Death|1|||
27905947|NCT01287754|54563146|FG000|Overall Study|Death|2|||
27905948|NCT01287754|54563147|FG001|Overall Study|Death|12|||
27989533|NCT00819585|54648378|FG001|Core Study|Adverse Event|1|||
27989534|NCT00819585|54648379|FG002|Core Study|Adverse Event|1|||
27989535|NCT00819585|54648380|FG003|Core Study|Adverse Event|4|||
28097619|NCT00097539|54753372|FG003|Overall Study|Participant Non-compliant|353|||
28097620|NCT00097539|54753373|FG004|Overall Study|Participant Non-compliant|136|||
27905949|NCT01287754|54563146|FG000|Overall Study|Lost to Follow-up|1|||
27905950|NCT01287754|54563147|FG001|Overall Study|Lost to Follow-up|6|||
27905951|NCT01287754|54563146|FG000|Overall Study|Protocol Violation|0|||
27905952|NCT01287754|54563147|FG001|Overall Study|Protocol Violation|3|||
27905953|NCT01287520|54563162|FG000|Overall Study|Adverse Event|2|||
27905954|NCT01287520|54563163|FG001|Overall Study|Adverse Event|2|||
27989536|NCT00819585|54648381|FG004|Core Study|Adverse Event|1|||
27989537|NCT00819585|54648382|FG005|Core Study|Adverse Event|0|||
28097621|NCT00097539|54753374|FG005|Overall Study|Participant Non-compliant|543|||
27905955|NCT01287520|54563164|FG002|Overall Study|Adverse Event|2|||
27989538|NCT00819585|54648383|FG006|Core Study|Adverse Event|2|||
27989539|NCT00819585|54648384|FG007|Core Study|Adverse Event|0|||
27905956|NCT01287520|54563165|FG003|Overall Study|Adverse Event|1|||
27905957|NCT01287520|54563166|FG004|Overall Study|Adverse Event|1|||
27905958|NCT01287520|54563167|FG005|Overall Study|Adverse Event|2|||
27905959|NCT01287520|54563168|FG006|Overall Study|Adverse Event|0|||
27905960|NCT01287520|54563169|FG007|Overall Study|Adverse Event|2|||
27905961|NCT01287520|54563170|FG008|Overall Study|Adverse Event|0|||
28097622|NCT00097539|54753375|FG006|Overall Study|Participant Non-compliant|18|||
28097623|NCT00097539|54753369|FG000|Overall Study|Lack of Efficacy|249|||
28097624|NCT00097539|54753370|FG001|Overall Study|Lack of Efficacy|122|||
28097625|NCT00097539|54753371|FG002|Overall Study|Lack of Efficacy|202|||
28097626|NCT00097539|54753372|FG003|Overall Study|Lack of Efficacy|105|||
28097627|NCT00097539|54753373|FG004|Overall Study|Lack of Efficacy|45|||
28097628|NCT00097539|54753374|FG005|Overall Study|Lack of Efficacy|228|||
28097629|NCT00097539|54753375|FG006|Overall Study|Lack of Efficacy|5|||
28097630|NCT00097539|54753369|FG000|Overall Study|Adverse Event|78|||
28097631|NCT00097539|54753370|FG001|Overall Study|Adverse Event|133|||
28097632|NCT00097539|54753371|FG002|Overall Study|Adverse Event|37|||
28097633|NCT00097539|54753372|FG003|Overall Study|Adverse Event|27|||
28097634|NCT00097539|54753373|FG004|Overall Study|Adverse Event|30|||
27905962|NCT01287520|54563162|FG000|Overall Study|Physician Decision|1|||
27905963|NCT01287520|54563163|FG001|Overall Study|Physician Decision|1|||
27905964|NCT01287520|54563164|FG002|Overall Study|Physician Decision|2|||
27905965|NCT01287520|54563165|FG003|Overall Study|Physician Decision|0|||
27905966|NCT01287520|54563166|FG004|Overall Study|Physician Decision|1|||
27905967|NCT01287520|54563167|FG005|Overall Study|Physician Decision|1|||
27905968|NCT01287520|54563168|FG006|Overall Study|Physician Decision|0|||
27905969|NCT01287520|54563169|FG007|Overall Study|Physician Decision|1|||
27905970|NCT01287520|54563170|FG008|Overall Study|Physician Decision|0|||
27905971|NCT01287520|54563162|FG000|Overall Study|Progressive disease|0|||
27905972|NCT01287520|54563163|FG001|Overall Study|Progressive disease|4|||
27905973|NCT01287520|54563164|FG002|Overall Study|Progressive disease|1|||
27905974|NCT01287520|54563165|FG003|Overall Study|Progressive disease|6|||
27905975|NCT01287520|54563166|FG004|Overall Study|Progressive disease|1|||
27905976|NCT01287520|54563167|FG005|Overall Study|Progressive disease|0|||
27905977|NCT01287520|54563168|FG006|Overall Study|Progressive disease|2|||
27905978|NCT01287520|54563169|FG007|Overall Study|Progressive disease|2|||
27905979|NCT01287520|54563170|FG008|Overall Study|Progressive disease|4|||
27905980|NCT01287520|54563162|FG000|Overall Study|Withdrawal by Subject|0|||
27905981|NCT01287520|54563163|FG001|Overall Study|Withdrawal by Subject|0|||
27905982|NCT01287520|54563164|FG002|Overall Study|Withdrawal by Subject|0|||
27905983|NCT01287520|54563165|FG003|Overall Study|Withdrawal by Subject|0|||
27905984|NCT01287520|54563166|FG004|Overall Study|Withdrawal by Subject|0|||
27905985|NCT01287520|54563167|FG005|Overall Study|Withdrawal by Subject|1|||
27905986|NCT01287520|54563168|FG006|Overall Study|Withdrawal by Subject|0|||
27905987|NCT01287520|54563169|FG007|Overall Study|Withdrawal by Subject|0|||
27905988|NCT01287520|54563170|FG008|Overall Study|Withdrawal by Subject|1|||
27905989|NCT01287403|54563219|FG000|1st Intervention (1 Day)|Adverse Event|1|||
27905990|NCT01287364|54563235|FG000|Overall Study|Adverse Event|0|||
27905991|NCT01287364|54563236|FG001|Overall Study|Adverse Event|3|||
27905992|NCT01287364|54563235|FG000|Overall Study|Protocol Violation|5|||
27905993|NCT01287364|54563236|FG001|Overall Study|Protocol Violation|5|||
27905994|NCT01287364|54563235|FG000|Overall Study|Other Reason|4|||
27905995|NCT01287364|54563236|FG001|Overall Study|Other Reason|2|||
27905996|NCT01287013|54563258|FG000|Overall Study|Non-evaluable|3|||
27905997|NCT01287013|54563259|FG001|Overall Study|Non-evaluable|5|||
27989540|NCT00819585|54648385|FG008|Core Study|Adverse Event|0|||
27989541|NCT00819585|54648386|FG009|Core Study|Adverse Event|0|||
27989542|NCT00819585|54648387|FG010|Core Study|Adverse Event|0|||
27989543|NCT00819585|54648377|FG000|Core Study|Abnormal Laboratory Value(s)|2|||
27989544|NCT00819585|54648378|FG001|Core Study|Abnormal Laboratory Value(s)|0|||
27989545|NCT00819585|54648379|FG002|Core Study|Abnormal Laboratory Value(s)|0|||
27989546|NCT00819585|54648380|FG003|Core Study|Abnormal Laboratory Value(s)|0|||
27989547|NCT00819585|54648381|FG004|Core Study|Abnormal Laboratory Value(s)|0|||
27989548|NCT00819585|54648382|FG005|Core Study|Abnormal Laboratory Value(s)|0|||
27989549|NCT00819585|54648383|FG006|Core Study|Abnormal Laboratory Value(s)|0|||
27989550|NCT00819585|54648384|FG007|Core Study|Abnormal Laboratory Value(s)|0|||
27989551|NCT00819585|54648385|FG008|Core Study|Abnormal Laboratory Value(s)|0|||
28097635|NCT00097539|54753374|FG005|Overall Study|Adverse Event|59|||
28097636|NCT00097539|54753375|FG006|Overall Study|Adverse Event|1|||
27905998|NCT01287013|54563260|FG002|Overall Study|Non-evaluable|21|||
27905999|NCT01286779|54563268|FG000|Overall Study|Withdrawal by Subject|9|||
27906000|NCT01286779|54563268|FG000|Overall Study|Protocol Violation|5|||
27906001|NCT01286779|54563268|FG000|Overall Study|Physician Decision|2|||
27989552|NCT00819585|54648386|FG009|Core Study|Abnormal Laboratory Value(s)|0|||
27989553|NCT00819585|54648387|FG010|Core Study|Abnormal Laboratory Value(s)|0|||
27989554|NCT00819585|54648377|FG000|Core Study|Unsatisfactory Therapeutic Effect|0|||
28097637|NCT00097539|54753369|FG000|Overall Study|Death|2|||
28097638|NCT00097539|54753370|FG001|Overall Study|Death|7|||
27906002|NCT01286779|54563268|FG000|Overall Study|Participant had scheduled surgery|1|||
28097639|NCT00097539|54753371|FG002|Overall Study|Death|0|||
27906003|NCT01286779|54563268|FG000|Overall Study|Participant moved to another country|1|||
27906004|NCT01286779|54563268|FG000|Overall Study|Discontinued by sponsor|1|||
27906005|NCT01286740|54563282|FG000|Overall Study|Enrolled but not treated|1|||
27906006|NCT01286740|54563282|FG000|Overall Study|Protocol Violation|1|||
27906007|NCT01286311|54563288|FG000|Overall Study|Physician did not want outreach sent|14|||
27906008|NCT01286311|54563289|FG001|Overall Study|Physician did not want outreach sent|0|||
27906009|NCT01286077|54563297|FG000|Overall Study|Adverse Event|2|||
27906010|NCT01286077|54563298|FG001|Overall Study|Adverse Event|0|||
27906011|NCT01286077|54563297|FG000|Overall Study|Death|1|||
27906012|NCT01286077|54563298|FG001|Overall Study|Death|0|||
27906013|NCT01286077|54563297|FG000|Overall Study|Protocol Violation|1|||
27906014|NCT01286077|54563298|FG001|Overall Study|Protocol Violation|1|||
27906015|NCT01286077|54563297|FG000|Overall Study|Withdrawal by Subject|0|||
27906016|NCT01286077|54563298|FG001|Overall Study|Withdrawal by Subject|2|||
27906017|NCT01286077|54563297|FG000|Overall Study|Intercurrent illness|1|||
27906018|NCT01286077|54563298|FG001|Overall Study|Intercurrent illness|0|||
27906019|NCT01286077|54563297|FG000|Overall Study|Non-compliance|1|||
27906020|NCT01286077|54563298|FG001|Overall Study|Non-compliance|0|||
27906021|NCT01286077|54563297|FG000|Overall Study|The subject starts with alternative MMY|0|||
27906022|NCT01286077|54563298|FG001|Overall Study|The subject starts with alternative MMY|3|||
27906023|NCT01286077|54563297|FG000|Overall Study|Patient's decision to stop treatment|3|||
27906024|NCT01286077|54563298|FG001|Overall Study|Patient's decision to stop treatment|0|||
27906025|NCT01286077|54563297|FG000|Overall Study|Progression of disease|0|||
27906026|NCT01286077|54563298|FG001|Overall Study|Progression of disease|1|||
27906027|NCT01286077|54563297|FG000|Overall Study|refill medication not received in time|1|||
27906028|NCT01286077|54563298|FG001|Overall Study|refill medication not received in time|0|||
27906029|NCT01285960|54563304|FG000|Overall Study|Withdrawal by Subject|2|||
27906030|NCT01285960|54563304|FG000|Overall Study|Lost to Follow-up|2|||
27906031|NCT01285960|54563304|FG000|Overall Study|2 subjects received less 10 sonications|2|||
27906032|NCT01285609|54563315|FG000|Randomized|Progressive Disease|41|||
27989555|NCT00819585|54648378|FG001|Core Study|Unsatisfactory Therapeutic Effect|1|||
27989556|NCT00819585|54648379|FG002|Core Study|Unsatisfactory Therapeutic Effect|0|||
27989557|NCT00819585|54648380|FG003|Core Study|Unsatisfactory Therapeutic Effect|0|||
27989558|NCT00819585|54648381|FG004|Core Study|Unsatisfactory Therapeutic Effect|0|||
27989559|NCT00819585|54648382|FG005|Core Study|Unsatisfactory Therapeutic Effect|0|||
27989560|NCT00819585|54648383|FG006|Core Study|Unsatisfactory Therapeutic Effect|1|||
27989561|NCT00819585|54648384|FG007|Core Study|Unsatisfactory Therapeutic Effect|0|||
27989562|NCT00819585|54648385|FG008|Core Study|Unsatisfactory Therapeutic Effect|0|||
27989563|NCT00819585|54648386|FG009|Core Study|Unsatisfactory Therapeutic Effect|0|||
27989564|NCT00819585|54648387|FG010|Core Study|Unsatisfactory Therapeutic Effect|0|||
27989565|NCT00819585|54648377|FG000|Core Study|Subject No Longer Requires Study Drug|0|||
27989566|NCT00819585|54648378|FG001|Core Study|Subject No Longer Requires Study Drug|0|||
27989567|NCT00819585|54648379|FG002|Core Study|Subject No Longer Requires Study Drug|0|||
27989568|NCT00819585|54648380|FG003|Core Study|Subject No Longer Requires Study Drug|0|||
27989569|NCT00819585|54648381|FG004|Core Study|Subject No Longer Requires Study Drug|1|||
27989570|NCT00819585|54648382|FG005|Core Study|Subject No Longer Requires Study Drug|0|||
27989571|NCT00819585|54648383|FG006|Core Study|Subject No Longer Requires Study Drug|0|||
27989572|NCT00819585|54648384|FG007|Core Study|Subject No Longer Requires Study Drug|0|||
27989573|NCT00819585|54648385|FG008|Core Study|Subject No Longer Requires Study Drug|0|||
27989574|NCT00819585|54648386|FG009|Core Study|Subject No Longer Requires Study Drug|0|||
27989575|NCT00819585|54648387|FG010|Core Study|Subject No Longer Requires Study Drug|0|||
27989576|NCT00819585|54648377|FG000|Core Study|Subject Withdrew Consent|0|||
27989577|NCT00819585|54648378|FG001|Core Study|Subject Withdrew Consent|3|||
27989578|NCT00819585|54648379|FG002|Core Study|Subject Withdrew Consent|2|||
27989579|NCT00819585|54648380|FG003|Core Study|Subject Withdrew Consent|1|||
27989580|NCT00819585|54648381|FG004|Core Study|Subject Withdrew Consent|0|||
27989581|NCT00819585|54648382|FG005|Core Study|Subject Withdrew Consent|0|||
27989582|NCT00819585|54648383|FG006|Core Study|Subject Withdrew Consent|3|||
27989583|NCT00819585|54648384|FG007|Core Study|Subject Withdrew Consent|0|||
27906033|NCT01285609|54563316|FG001|Randomized|Progressive Disease|61|||
27906034|NCT01285609|54563315|FG000|Randomized|Adverse Event Unrelated to Study Drug|18|||
27906035|NCT01285609|54563316|FG001|Randomized|Adverse Event Unrelated to Study Drug|18|||
27906036|NCT01285609|54563315|FG000|Randomized|Study Drug Toxicity|13|||
27906037|NCT01285609|54563316|FG001|Randomized|Study Drug Toxicity|14|||
27906038|NCT01285609|54563315|FG000|Randomized|Death|5|||
27989584|NCT00819585|54648385|FG008|Core Study|Subject Withdrew Consent|0|||
27906039|NCT01285609|54563316|FG001|Randomized|Death|7|||
27906040|NCT01285609|54563315|FG000|Randomized|Withdrawal by Subject|8|||
27906041|NCT01285609|54563316|FG001|Randomized|Withdrawal by Subject|11|||
27906042|NCT01285609|54563315|FG000|Randomized|Subject No Longer Met Study Criteria|1|||
27906043|NCT01285609|54563316|FG001|Randomized|Subject No Longer Met Study Criteria|1|||
27906044|NCT01285609|54563315|FG000|Randomized|Undisclosed Reasons|1|||
27906045|NCT01285609|54563316|FG001|Randomized|Undisclosed Reasons|0|||
28097640|NCT00097539|54753372|FG003|Overall Study|Death|0|||
27906046|NCT01285609|54563315|FG000|Randomized|Randomized but not Treated|4|||
27906047|NCT01285609|54563316|FG001|Randomized|Randomized but not Treated|4|||
27906048|NCT01285609|54563315|FG000|Treated With Blinded Therapy|Progressive Disease|223|||
27906049|NCT01285609|54563316|FG001|Treated With Blinded Therapy|Progressive Disease|305|||
27906050|NCT01285609|54563315|FG000|Treated With Blinded Therapy|Study Drug Toxicity|87|||
27906051|NCT01285609|54563316|FG001|Treated With Blinded Therapy|Study Drug Toxicity|14|||
27906052|NCT01285609|54563315|FG000|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36|||
27906053|NCT01285609|54563316|FG001|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14|||
27906054|NCT01285609|54563315|FG000|Treated With Blinded Therapy|Withdrawal by Subject|20|||
27906055|NCT01285609|54563316|FG001|Treated With Blinded Therapy|Withdrawal by Subject|7|||
27906056|NCT01285609|54563315|FG000|Treated With Blinded Therapy|Death|11|||
27906057|NCT01285609|54563316|FG001|Treated With Blinded Therapy|Death|3|||
27906058|NCT01285609|54563315|FG000|Treated With Blinded Therapy|Maximum Clinical Benefit|2|||
27906059|NCT01285609|54563316|FG001|Treated With Blinded Therapy|Maximum Clinical Benefit|4|||
27906060|NCT01285609|54563315|FG000|Treated With Blinded Therapy|Not Reported|0|||
27906061|NCT01285609|54563316|FG001|Treated With Blinded Therapy|Not Reported|2|||
27906062|NCT01285609|54563315|FG000|Treated With Blinded Therapy|Poor/Non-Compliance|1|||
27906063|NCT01285609|54563316|FG001|Treated With Blinded Therapy|Poor/Non-Compliance|2|||
27906064|NCT01285609|54563315|FG000|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1|||
27906065|NCT01285609|54563316|FG001|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0|||
27906066|NCT01285609|54563315|FG000|Treated With Blinded Therapy|Administrative Reason by Sponsor|1|||
27906067|NCT01285609|54563316|FG001|Treated With Blinded Therapy|Administrative Reason by Sponsor|3|||
27906068|NCT01285609|54563315|FG000|Treated With Blinded Therapy|Physician and Patient decision|1|||
27906069|NCT01285609|54563316|FG001|Treated With Blinded Therapy|Physician and Patient decision|3|||
27906070|NCT01285609|54563315|FG000|Treated With Blinded Therapy|Participant refused participation|1|||
27906071|NCT01285609|54563316|FG001|Treated With Blinded Therapy|Participant refused participation|0|||
27906072|NCT01285609|54563315|FG000|Treated With Blinded Therapy|Participant started radiotherapy|1|||
27906073|NCT01285609|54563316|FG001|Treated With Blinded Therapy|Participant started radiotherapy|0|||
27906074|NCT01285609|54563315|FG000|Treated With Blinded Therapy|Participant hospitalized|1|||
27989585|NCT00819585|54648386|FG009|Core Study|Subject Withdrew Consent|0|||
27989586|NCT00819585|54648387|FG010|Core Study|Subject Withdrew Consent|0|||
27989587|NCT00819585|54648377|FG000|Core Study|Lost to Follow-up|2|||
27989588|NCT00819585|54648378|FG001|Core Study|Lost to Follow-up|1|||
27989589|NCT00819585|54648379|FG002|Core Study|Lost to Follow-up|2|||
27989590|NCT00819585|54648380|FG003|Core Study|Lost to Follow-up|0|||
27989591|NCT00819585|54648381|FG004|Core Study|Lost to Follow-up|1|||
27989592|NCT00819585|54648382|FG005|Core Study|Lost to Follow-up|1|||
27989593|NCT00819585|54648383|FG006|Core Study|Lost to Follow-up|1|||
27989594|NCT00819585|54648384|FG007|Core Study|Lost to Follow-up|0|||
27989595|NCT00819585|54648385|FG008|Core Study|Lost to Follow-up|0|||
27989596|NCT00819585|54648386|FG009|Core Study|Lost to Follow-up|0|||
27989597|NCT00819585|54648387|FG010|Core Study|Lost to Follow-up|0|||
27989598|NCT00819585|54648377|FG000|Core Study|Administrative Problems|0|||
27989599|NCT00819585|54648378|FG001|Core Study|Administrative Problems|0|||
27989600|NCT00819585|54648379|FG002|Core Study|Administrative Problems|0|||
27989601|NCT00819585|54648380|FG003|Core Study|Administrative Problems|0|||
27989602|NCT00819585|54648381|FG004|Core Study|Administrative Problems|0|||
27989603|NCT00819585|54648382|FG005|Core Study|Administrative Problems|0|||
27989604|NCT00819585|54648383|FG006|Core Study|Administrative Problems|2|||
27989605|NCT00819585|54648384|FG007|Core Study|Administrative Problems|0|||
27989606|NCT00819585|54648385|FG008|Core Study|Administrative Problems|0|||
27989607|NCT00819585|54648386|FG009|Core Study|Administrative Problems|0|||
27989608|NCT00819585|54648387|FG010|Core Study|Administrative Problems|0|||
27989609|NCT00819585|54648377|FG000|Core Study|Death|0|||
27989610|NCT00819585|54648378|FG001|Core Study|Death|0|||
27989611|NCT00819585|54648379|FG002|Core Study|Death|0|||
27989612|NCT00819585|54648380|FG003|Core Study|Death|0|||
27989613|NCT00819585|54648381|FG004|Core Study|Death|0|||
27989614|NCT00819585|54648382|FG005|Core Study|Death|0|||
27989615|NCT00819585|54648383|FG006|Core Study|Death|1|||
27989616|NCT00819585|54648384|FG007|Core Study|Death|0|||
27989617|NCT00819585|54648385|FG008|Core Study|Death|0|||
27989618|NCT00819585|54648386|FG009|Core Study|Death|0|||
27906075|NCT01285609|54563316|FG001|Treated With Blinded Therapy|Participant hospitalized|0|||
27989619|NCT00819585|54648387|FG010|Core Study|Death|0|||
27989620|NCT00819585|54648377|FG000|Core Study|Protocol Violation|0|||
27989621|NCT00819585|54648378|FG001|Core Study|Protocol Violation|0|||
27906076|NCT01285609|54563315|FG000|Treated With Blinded Therapy|Investigator's assessment|1|||
27989622|NCT00819585|54648379|FG002|Core Study|Protocol Violation|1|||
27989623|NCT00819585|54648380|FG003|Core Study|Protocol Violation|0|||
27989624|NCT00819585|54648381|FG004|Core Study|Protocol Violation|0|||
27989625|NCT00819585|54648382|FG005|Core Study|Protocol Violation|1|||
27989626|NCT00819585|54648383|FG006|Core Study|Protocol Violation|3|||
27989627|NCT00819585|54648384|FG007|Core Study|Protocol Violation|0|||
27989628|NCT00819585|54648385|FG008|Core Study|Protocol Violation|0|||
27989629|NCT00819585|54648386|FG009|Core Study|Protocol Violation|0|||
27906077|NCT01285609|54563316|FG001|Treated With Blinded Therapy|Investigator's assessment|0|||
27906078|NCT01285609|54563315|FG000|Treated With Blinded Therapy|PI decision to discontinue|0|||
27906079|NCT01285609|54563316|FG001|Treated With Blinded Therapy|PI decision to discontinue|1|||
27906080|NCT01285609|54563315|FG000|Treated With Blinded Therapy|Worsening of general condition|0|||
27906081|NCT01285609|54563316|FG001|Treated With Blinded Therapy|Worsening of general condition|1|||
27906082|NCT01285492|54563326|FG000|Overall Study|Adverse Event|11|||
27906083|NCT01285492|54563327|FG001|Overall Study|Adverse Event|0|||
27906084|NCT01285492|54563326|FG000|Overall Study|Protocol Violation|3|||
27906085|NCT01285492|54563327|FG001|Overall Study|Protocol Violation|0|||
27906086|NCT01285492|54563326|FG000|Overall Study|Withdrawal by Subject|2|||
27906087|NCT01285492|54563327|FG001|Overall Study|Withdrawal by Subject|1|||
27906088|NCT01285492|54563326|FG000|Overall Study|Death|1|||
27906089|NCT01285492|54563327|FG001|Overall Study|Death|0|||
27906090|NCT01284634|54563337|FG000|Overall Study|Adverse Event|1|||
27906091|NCT01284634|54563338|FG001|Overall Study|Adverse Event|0|||
27906092|NCT01284634|54563339|FG002|Overall Study|Adverse Event|2|||
27906093|NCT01284634|54563340|FG003|Overall Study|Adverse Event|1|||
27906094|NCT01284361|54563350|FG000|Overall Study|Withdrawal by Subject|1|||
27906095|NCT01284361|54563350|FG000|Overall Study|Protocol Violation|5|||
27906096|NCT01284361|54563350|FG000|Overall Study|Adverse Event|1|||
27906097|NCT01284361|54563350|FG000|Overall Study|Lost to Follow-up|2|||
27906098|NCT01284127|54563357|FG000|Overall Study|Adverse Event|2|||
27906099|NCT01284127|54563357|FG000|Overall Study|Withdrawal by Subject|4|||
27906100|NCT01284127|54563357|FG000|Overall Study|Physician Decision|1|||
27906101|NCT01283971|54563363|FG000|Overall Study|Adverse Event|3|||
27906102|NCT01283971|54563364|FG001|Overall Study|Adverse Event|5|||
27906103|NCT01283971|54563363|FG000|Overall Study|Insufficient therapeutic responses|3|||
27906104|NCT01283971|54563364|FG001|Overall Study|Insufficient therapeutic responses|3|||
27906105|NCT01283971|54563363|FG000|Overall Study|Protocol Violation|5|||
27906106|NCT01283971|54563364|FG001|Overall Study|Protocol Violation|1|||
27906107|NCT01283971|54563363|FG000|Overall Study|Refused treatment|3|||
27906108|NCT01283971|54563364|FG001|Overall Study|Refused treatment|1|||
27906109|NCT01283971|54563363|FG000|Overall Study|Failure to return|0|||
27906110|NCT01283971|54563364|FG001|Overall Study|Failure to return|1|||
27906111|NCT01283971|54563363|FG000|Overall Study|Administrative reasons|1|||
27906112|NCT01283971|54563364|FG001|Overall Study|Administrative reasons|1|||
27906113|NCT01283581|54563373|FG000|Overall Study|Lost to Follow-up|8|||
27906114|NCT01283581|54563374|FG001|Overall Study|Lost to Follow-up|6|||
27906115|NCT01283581|54563375|FG002|Overall Study|Lost to Follow-up|8|||
27906116|NCT01283581|54563373|FG000|Overall Study|Withdrawal by Subject|2|||
27906117|NCT01283581|54563374|FG001|Overall Study|Withdrawal by Subject|5|||
27906118|NCT01283581|54563375|FG002|Overall Study|Withdrawal by Subject|2|||
27906119|NCT01283581|54563373|FG000|Overall Study|Adverse Event|1|||
27989630|NCT00819585|54648387|FG010|Core Study|Protocol Violation|0|||
27989631|NCT00819585|54648377|FG000|Extension Study|Abnormal Laboratory Value(s)|0|||
27989632|NCT00819585|54648378|FG001|Extension Study|Abnormal Laboratory Value(s)|0|||
27989633|NCT00819585|54648379|FG002|Extension Study|Abnormal Laboratory Value(s)|0|||
27906120|NCT01283581|54563374|FG001|Overall Study|Adverse Event|1|||
27906121|NCT01283581|54563375|FG002|Overall Study|Adverse Event|4|||
27906122|NCT01283581|54563373|FG000|Overall Study|Physician Decision|0|||
27906123|NCT01283581|54563374|FG001|Overall Study|Physician Decision|1|||
27906124|NCT01283581|54563375|FG002|Overall Study|Physician Decision|2|||
27906125|NCT01283581|54563373|FG000|Overall Study|Protocol Violation|0|||
27906126|NCT01283581|54563374|FG001|Overall Study|Protocol Violation|1|||
27906127|NCT01283581|54563375|FG002|Overall Study|Protocol Violation|2|||
27906128|NCT01283581|54563373|FG000|Overall Study|Noncompliance|1|||
27906129|NCT01283581|54563374|FG001|Overall Study|Noncompliance|0|||
27906130|NCT01283581|54563375|FG002|Overall Study|Noncompliance|0|||
27906131|NCT01283581|54563373|FG000|Overall Study|Investigator unblinded|0|||
27906132|NCT01283581|54563374|FG001|Overall Study|Investigator unblinded|0|||
27906133|NCT01283581|54563375|FG002|Overall Study|Investigator unblinded|1|||
27989634|NCT00819585|54648380|FG003|Extension Study|Abnormal Laboratory Value(s)|0|||
27989635|NCT00819585|54648381|FG004|Extension Study|Abnormal Laboratory Value(s)|0|||
27906134|NCT01283581|54563373|FG000|Overall Study|"Early termination"|0|||
27906135|NCT01283581|54563374|FG001|Overall Study|"Early termination"|0|||
27906136|NCT01283581|54563375|FG002|Overall Study|"Early termination"|1|||
27989636|NCT00819585|54648382|FG005|Extension Study|Abnormal Laboratory Value(s)|0|||
27906137|NCT01283542|54563386|FG000|Main Phase|Acute or progressive vision loss|1|||
27906138|NCT01283542|54563386|FG000|Main Phase|Uncontrolled diabetes mellitus|1|||
27906139|NCT01283542|54563386|FG000|Main Phase|abnormal laboratory values|5|||
27906140|NCT01283542|54563386|FG000|Extension Phase|Physician Decision|1|||
27906141|NCT01283542|54563386|FG000|Extension Phase|Adverse Event|1|||
27906142|NCT01283542|54563386|FG000|Extension Phase|Administrative problems|1|||
27906143|NCT01283386|54563410|FG000|Overall Study|Death|2|||
27906144|NCT01283386|54563411|FG001|Overall Study|Death|0|||
27906145|NCT01283386|54563410|FG000|Overall Study|Withdrawal by Subject|2|||
27906146|NCT01283386|54563411|FG001|Overall Study|Withdrawal by Subject|1|||
27906147|NCT01283386|54563410|FG000|Overall Study|Relapse of underlying disease|1|||
27906148|NCT01283386|54563411|FG001|Overall Study|Relapse of underlying disease|3|||
27906149|NCT01283386|54563410|FG000|Overall Study|Progression of underlying disease|2|||
27906150|NCT01283386|54563411|FG001|Overall Study|Progression of underlying disease|7|||
27906151|NCT01283386|54563410|FG000|Overall Study|Reason not specified|1|||
27906152|NCT01283386|54563411|FG001|Overall Study|Reason not specified|0|||
27906153|NCT01283386|54563410|FG000|Overall Study|Protocol Violation|0|||
27906154|NCT01283386|54563411|FG001|Overall Study|Protocol Violation|1|||
27906155|NCT01283152|54563419|FG000|Overall Study|Discharged prior to 24 hr assessment|1|||
27906156|NCT01283152|54563420|FG001|Overall Study|Discharged prior to 24 hr assessment|0|||
27906157|NCT01283152|54563419|FG000|Overall Study|Refused HESA|1|||
27906158|NCT01283152|54563420|FG001|Overall Study|Refused HESA|0|||
27906159|NCT01283035|54563426|FG000|Overall Study|Subject later found ineligible|1|||
27906160|NCT01283464|54563432|FG000|Overall Study|Lost to Follow-up|0|||
27906161|NCT01283464|54563433|FG001|Overall Study|Lost to Follow-up|1|||
27906162|NCT01283464|54563432|FG000|Overall Study|Withdrawal by Subject|1|||
27906163|NCT01283464|54563433|FG001|Overall Study|Withdrawal by Subject|0|||
27906164|NCT01283464|54563432|FG000|Overall Study|Physician Decision|1|||
27906165|NCT01283464|54563433|FG001|Overall Study|Physician Decision|0|||
27906166|NCT01282801|54563441|FG000|Second Intervention|Emesis During Critical Breakfast|0|||
27906167|NCT01282801|54563442|FG001|Second Intervention|Emesis During Critical Breakfast|1|||
27906168|NCT01282372|54563448|FG000|Overall Study|Lack of Efficacy / Exacerbation|25|||
27906169|NCT01282372|54563448|FG000|Overall Study|Lost to Follow-up|23|||
27906170|NCT01282372|54563448|FG000|Overall Study|Withdrawal by Subject|11|||
27906171|NCT01282372|54563448|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 1|4|||
27906172|NCT01282372|54563448|FG000|Overall Study|Death|1|||
27906173|NCT01282372|54563448|FG000|Overall Study|Presence of AE, Lack of Efficacy|1|||
27906174|NCT01282372|54563448|FG000|Overall Study|Presence of AE, Regression of Symptoms|1|||
27906175|NCT01282372|54563448|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 2|1|||
27906176|NCT01282372|54563448|FG000|Overall Study|Adverse Event|12|||
27906177|NCT01282294|54563459|FG000|Overall Study|Lost to Follow-up|14|||
27906178|NCT01282294|54563459|FG000|Overall Study|Screening failure|1|||
27906179|NCT01282294|54563459|FG000|Overall Study|Adverse Event|1|||
27906180|NCT01282294|54563459|FG000|Overall Study|Patient non-compliance|2|||
27906181|NCT01282294|54563459|FG000|Overall Study|Physician Decision|1|||
27906182|NCT01282216|54563465|FG000|Overall Study|Graft failure|0|||
27906183|NCT01282216|54563466|FG001|Overall Study|Graft failure|0|||
27906184|NCT01282216|54563467|FG002|Overall Study|Graft failure|3|||
27906185|NCT01282216|54563468|FG003|Overall Study|Graft failure|2|||
27906186|NCT01282216|54563465|FG000|Overall Study|Physician Decision|0|||
27906187|NCT01282216|54563466|FG001|Overall Study|Physician Decision|0|||
27906188|NCT01282216|54563467|FG002|Overall Study|Physician Decision|11|||
27906189|NCT01282216|54563468|FG003|Overall Study|Physician Decision|0|||
27906190|NCT01282216|54563465|FG000|Overall Study|Relapse|0|||
27906191|NCT01282216|54563466|FG001|Overall Study|Relapse|0|||
27906192|NCT01282216|54563467|FG002|Overall Study|Relapse|17|||
27906193|NCT01282216|54563468|FG003|Overall Study|Relapse|6|||
27906194|NCT01282216|54563465|FG000|Overall Study|Death|0|||
27906195|NCT01282216|54563466|FG001|Overall Study|Death|0|||
27906196|NCT01282216|54563467|FG002|Overall Study|Death|2|||
27906197|NCT01282216|54563468|FG003|Overall Study|Death|0|||
27906198|NCT01281865|54563476|FG000|Overall Study|Adverse Event|1|||
27906199|NCT01281865|54563477|FG001|Overall Study|Adverse Event|1|||
27906200|NCT01281865|54563476|FG000|Overall Study|Withdrawal by Subject|1|||
27906201|NCT01281865|54563477|FG001|Overall Study|Withdrawal by Subject|0|||
27906202|NCT01281865|54563476|FG000|Overall Study|Lack of Efficacy|1|||
27906203|NCT01281865|54563477|FG001|Overall Study|Lack of Efficacy|0|||
27906204|NCT01281202|54563485|FG000|Overall Study|Adverse Event|2|||
27906205|NCT01281202|54563486|FG001|Overall Study|Adverse Event|0|||
27906206|NCT01281202|54563485|FG000|Overall Study|Withdrawal by Subject|2|||
27989637|NCT00819585|54648383|FG006|Extension Study|Abnormal Laboratory Value(s)|0|||
27989638|NCT00819585|54648384|FG007|Extension Study|Abnormal Laboratory Value(s)|0|||
27989639|NCT00819585|54648385|FG008|Extension Study|Abnormal Laboratory Value(s)|1|||
27989640|NCT00819585|54648386|FG009|Extension Study|Abnormal Laboratory Value(s)|0|||
27906207|NCT01281202|54563486|FG001|Overall Study|Withdrawal by Subject|2|||
27906208|NCT01281202|54563485|FG000|Overall Study|Protocol Violation|11|||
27906209|NCT01281202|54563486|FG001|Overall Study|Protocol Violation|10|||
27906210|NCT01281202|54563485|FG000|Overall Study|Administrative|2|||
27989641|NCT00819585|54648387|FG010|Extension Study|Abnormal Laboratory Value(s)|0|||
27906211|NCT01281202|54563486|FG001|Overall Study|Administrative|8|||
27906212|NCT01281202|54563485|FG000|Overall Study|Lost to Follow-up|11|||
27906213|NCT01281202|54563486|FG001|Overall Study|Lost to Follow-up|13|||
27906214|NCT01281202|54563485|FG000|Overall Study|Incarceration|0|||
27906215|NCT01281202|54563486|FG001|Overall Study|Incarceration|3|||
27906216|NCT01281124|54563494|FG000|Overall Study|Death|1|||
27906217|NCT01280968|54563502|FG000|Overall Study|Lost to Follow-up|8|||
27906218|NCT01280968|54563503|FG001|Overall Study|Lost to Follow-up|2|||
27906219|NCT01280968|54563502|FG000|Overall Study|Unable to Follow Experimental Protocol|2|||
27906220|NCT01280968|54563503|FG001|Overall Study|Unable to Follow Experimental Protocol|0|||
27906221|NCT01280968|54563502|FG000|Overall Study|Commuting Problems|2|||
27906222|NCT01280968|54563503|FG001|Overall Study|Commuting Problems|0|||
27906223|NCT01280968|54563502|FG000|Overall Study|Anxiety|2|||
27906224|NCT01280968|54563503|FG001|Overall Study|Anxiety|0|||
27906225|NCT01280968|54563502|FG000|Overall Study|Adverse Event|1|||
27906226|NCT01280968|54563503|FG001|Overall Study|Adverse Event|0|||
27906227|NCT01280968|54563502|FG000|Overall Study|Scheduling Conflicts|1|||
27906228|NCT01280968|54563503|FG001|Overall Study|Scheduling Conflicts|1|||
27906229|NCT01280968|54563502|FG000|Overall Study|Pre-existing Neurological Condition|1|||
27906230|NCT01280968|54563503|FG001|Overall Study|Pre-existing Neurological Condition|0|||
27906231|NCT01280968|54563502|FG000|Overall Study|Unable to Smoke in Supine Position|1|||
27906232|NCT01280968|54563503|FG001|Overall Study|Unable to Smoke in Supine Position|0|||
27906233|NCT01280812|54563513|FG000|Overall Study|Withdrawal by Subject|2|||
27906234|NCT01280812|54563514|FG001|Overall Study|Withdrawal by Subject|1|||
27906235|NCT01280812|54563515|FG002|Overall Study|Withdrawal by Subject|0|||
27906236|NCT01280812|54563513|FG000|Overall Study|Lost to Follow-up|1|||
27989642|NCT00819585|54648377|FG000|Extension Study|Subject Withdrew Consent|0|||
27989643|NCT00819585|54648378|FG001|Extension Study|Subject Withdrew Consent|0|||
27989644|NCT00819585|54648379|FG002|Extension Study|Subject Withdrew Consent|0|||
27989645|NCT00819585|54648380|FG003|Extension Study|Subject Withdrew Consent|0|||
27989646|NCT00819585|54648381|FG004|Extension Study|Subject Withdrew Consent|0|||
27989647|NCT00819585|54648382|FG005|Extension Study|Subject Withdrew Consent|0|||
27989648|NCT00819585|54648383|FG006|Extension Study|Subject Withdrew Consent|0|||
27906237|NCT01280812|54563514|FG001|Overall Study|Lost to Follow-up|1|||
27906238|NCT01280812|54563515|FG002|Overall Study|Lost to Follow-up|1|||
27906239|NCT01280656|54563527|FG000|Overall Study|Adverse Event|1|||
27906240|NCT01280656|54563528|FG001|Overall Study|Adverse Event|14|||
27906241|NCT01280656|54563529|FG002|Overall Study|Adverse Event|13|||
27906242|NCT01280656|54563527|FG000|Overall Study|Lack of Efficacy|1|||
27906243|NCT01280656|54563528|FG001|Overall Study|Lack of Efficacy|22|||
27906244|NCT01280656|54563529|FG002|Overall Study|Lack of Efficacy|38|||
27906245|NCT01280656|54563527|FG000|Overall Study|Treatment shortening (RGT)|0|||
27906246|NCT01280656|54563528|FG001|Overall Study|Treatment shortening (RGT)|4|||
27906247|NCT01280656|54563529|FG002|Overall Study|Treatment shortening (RGT)|5|||
27906248|NCT01280656|54563527|FG000|Overall Study|Other|1|||
27906249|NCT01280656|54563528|FG001|Overall Study|Other|7|||
27906250|NCT01280656|54563529|FG002|Overall Study|Other|7|||
27906251|NCT01280617|54563539|FG000|Overall Study|Adverse Event|0|||
27906252|NCT01280617|54563540|FG001|Overall Study|Adverse Event|1|||
27906253|NCT01280266|54563548|FG000|First Intervention (Week 1-4)|Adverse Event|1|||
27906254|NCT01280266|54563549|FG001|First Intervention (Week 1-4)|Adverse Event|0|||
27989649|NCT00819585|54648384|FG007|Extension Study|Subject Withdrew Consent|0|||
27989650|NCT00819585|54648385|FG008|Extension Study|Subject Withdrew Consent|3|||
27989651|NCT00819585|54648386|FG009|Extension Study|Subject Withdrew Consent|0|||
27989652|NCT00819585|54648387|FG010|Extension Study|Subject Withdrew Consent|1|||
27989653|NCT00819585|54648377|FG000|Extension Study|Lost to Follow-up|0|||
27989654|NCT00819585|54648378|FG001|Extension Study|Lost to Follow-up|0|||
27989655|NCT00819585|54648379|FG002|Extension Study|Lost to Follow-up|0|||
27906255|NCT01280266|54563548|FG000|First Intervention (Week 1-4)|Withdrawal by Subject|0|||
27906256|NCT01280266|54563549|FG001|First Intervention (Week 1-4)|Withdrawal by Subject|2|||
27906257|NCT01279447|54563561|FG000|Overall Study|Lost to Follow-up|3|||
27906258|NCT01279447|54563562|FG001|Overall Study|Lost to Follow-up|1|||
27906259|NCT01276639|54563584|FG000|Week 0 to 16|Death|1|||
27906260|NCT01276639|54563585|FG001|Week 0 to 16|Death|0|||
27906261|NCT01276639|54563586|FG002|Week 0 to 16|Death|0|||
27906262|NCT01276639|54563587|FG003|Week 0 to 16|Death|0|||
27906263|NCT01276639|54563588|FG004|Week 0 to 16|Death|0|||
27906264|NCT01276639|54563584|FG000|Week 0 to 16|Adverse Event|11|||
27906265|NCT01276639|54563585|FG001|Week 0 to 16|Adverse Event|8|||
27906266|NCT01276639|54563586|FG002|Week 0 to 16|Adverse Event|11|||
27906267|NCT01276639|54563587|FG003|Week 0 to 16|Adverse Event|0|||
27906268|NCT01276639|54563588|FG004|Week 0 to 16|Adverse Event|0|||
27906269|NCT01276639|54563584|FG000|Week 0 to 16|Lack of Efficacy|20|||
27989656|NCT00819585|54648380|FG003|Extension Study|Lost to Follow-up|0|||
27989657|NCT00819585|54648381|FG004|Extension Study|Lost to Follow-up|0|||
27906270|NCT01276639|54563585|FG001|Week 0 to 16|Lack of Efficacy|15|||
27906271|NCT01276639|54563586|FG002|Week 0 to 16|Lack of Efficacy|25|||
27989658|NCT00819585|54648382|FG005|Extension Study|Lost to Follow-up|0|||
27906272|NCT01276639|54563587|FG003|Week 0 to 16|Lack of Efficacy|0|||
27906273|NCT01276639|54563588|FG004|Week 0 to 16|Lack of Efficacy|0|||
27906274|NCT01276639|54563584|FG000|Week 0 to 16|Lost to Follow-up|3|||
27906275|NCT01276639|54563585|FG001|Week 0 to 16|Lost to Follow-up|5|||
27989659|NCT00819585|54648383|FG006|Extension Study|Lost to Follow-up|0|||
27989660|NCT00819585|54648384|FG007|Extension Study|Lost to Follow-up|0|||
27989661|NCT00819585|54648385|FG008|Extension Study|Lost to Follow-up|2|||
27989662|NCT00819585|54648386|FG009|Extension Study|Lost to Follow-up|1|||
27989663|NCT00819585|54648387|FG010|Extension Study|Lost to Follow-up|1|||
27989664|NCT00819585|54648377|FG000|Extension Study|Death|0|||
27989665|NCT00819585|54648378|FG001|Extension Study|Death|0|||
27989666|NCT00819585|54648379|FG002|Extension Study|Death|0|||
27989667|NCT00819585|54648380|FG003|Extension Study|Death|0|||
27989668|NCT00819585|54648381|FG004|Extension Study|Death|0|||
27989669|NCT00819585|54648382|FG005|Extension Study|Death|0|||
27989670|NCT00819585|54648383|FG006|Extension Study|Death|0|||
27989671|NCT00819585|54648384|FG007|Extension Study|Death|0|||
27989672|NCT00819585|54648385|FG008|Extension Study|Death|2|||
27989673|NCT00819585|54648386|FG009|Extension Study|Death|0|||
27989674|NCT00819585|54648387|FG010|Extension Study|Death|0|||
27989675|NCT00508261|54648419|FG000|Overall Study|Other|0|||
27989676|NCT00508261|54648420|FG001|Overall Study|Other|1|||
27989677|NCT00508261|54648421|FG002|Overall Study|Other|1|||
27989678|NCT00508261|54648422|FG003|Overall Study|Other|0|||
27989679|NCT00508261|54648419|FG000|Overall Study|Serious Adverse Event|0|||
27989680|NCT00508261|54648420|FG001|Overall Study|Serious Adverse Event|1|||
27989681|NCT00508261|54648421|FG002|Overall Study|Serious Adverse Event|0|||
27989682|NCT00508261|54648422|FG003|Overall Study|Serious Adverse Event|0|||
27989683|NCT00508261|54648419|FG000|Overall Study|Withdrawal by Subject|3|||
27989684|NCT00508261|54648420|FG001|Overall Study|Withdrawal by Subject|4|||
27989685|NCT00508261|54648421|FG002|Overall Study|Withdrawal by Subject|4|||
27989686|NCT00508261|54648422|FG003|Overall Study|Withdrawal by Subject|0|||
27989687|NCT00508261|54648419|FG000|Overall Study|Migrated/ moved from study area|0|||
27989688|NCT00508261|54648420|FG001|Overall Study|Migrated/ moved from study area|1|||
27989689|NCT00508261|54648421|FG002|Overall Study|Migrated/ moved from study area|0|||
27989690|NCT00508261|54648422|FG003|Overall Study|Migrated/ moved from study area|0|||
27989691|NCT00508261|54648419|FG000|Overall Study|Lost to Follow-up|0|||
27989692|NCT00508261|54648420|FG001|Overall Study|Lost to Follow-up|1|||
27989693|NCT00508261|54648421|FG002|Overall Study|Lost to Follow-up|1|||
27906276|NCT01276639|54563586|FG002|Week 0 to 16|Lost to Follow-up|3|||
27906277|NCT01276639|54563587|FG003|Week 0 to 16|Lost to Follow-up|0|||
27906278|NCT01276639|54563588|FG004|Week 0 to 16|Lost to Follow-up|0|||
27989694|NCT00508261|54648422|FG003|Overall Study|Lost to Follow-up|1|||
27989695|NCT00819039|54648461|FG000|Overall Study|Physician Decision|1|||
27989696|NCT00819039|54648462|FG001|Overall Study|Physician Decision|0|||
27989697|NCT00819039|54648463|FG002|Overall Study|Physician Decision|1|||
27989698|NCT00819039|54648461|FG000|Overall Study|Protocol Violation|1|||
27989699|NCT00819039|54648462|FG001|Overall Study|Protocol Violation|0|||
27989700|NCT00819039|54648463|FG002|Overall Study|Protocol Violation|0|||
27989701|NCT00500539|54648473|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
27989702|NCT00500539|54648473|FG000|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1|||
27989703|NCT00500539|54648473|FG000|Treatment Period (24 Weeks)|Subject withdrew consent|1|||
27989704|NCT00500539|54648473|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|2|||
27989705|NCT00500539|54648473|FG000|Treatment Period (24 Weeks)|Administrative problems|2|||
27989706|NCT00500539|54648473|FG000|Treatment Period (24 Weeks)|Protocol Deviation|5|||
27989707|NCT00500539|54648473|FG000|Follow-up Period (16 Weeks)|Adverse Event|1|||
27989708|NCT00500539|54648473|FG000|Follow-up Period (16 Weeks)|Subject withdrew consent|2|||
27989709|NCT00500539|54648473|FG000|Follow-up Period (16 Weeks)|Lost to Follow-up|3|||
27989710|NCT00500539|54648473|FG000|Follow-up Period (16 Weeks)|Administrative problems|1|||
27989711|NCT00500539|54648473|FG000|Follow-up Period (16 Weeks)|Death|1|||
27989712|NCT00500539|54648473|FG000|Follow-up Period (16 Weeks)|Protocol Deviation|1|||
27989713|NCT00500539|54648473|FG000|Follow-up Period (16 Weeks)|Missing|3|||
28097641|NCT00097539|54753373|FG004|Overall Study|Death|1|||
28097642|NCT00097539|54753374|FG005|Overall Study|Death|3|||
27989714|NCT00818883|54648482|FG000|Overall Study|Adverse Event|28|||
27989715|NCT00818883|54648483|FG001|Overall Study|Adverse Event|19|||
27906279|NCT01276639|54563584|FG000|Week 0 to 16|Withdrawal by Subject|8|||
27906280|NCT01276639|54563585|FG001|Week 0 to 16|Withdrawal by Subject|5|||
27906281|NCT01276639|54563586|FG002|Week 0 to 16|Withdrawal by Subject|4|||
27906282|NCT01276639|54563587|FG003|Week 0 to 16|Withdrawal by Subject|0|||
27906283|NCT01276639|54563588|FG004|Week 0 to 16|Withdrawal by Subject|0|||
27906284|NCT01276639|54563584|FG000|Week 0 to 16|Other|7|||
27906285|NCT01276639|54563585|FG001|Week 0 to 16|Other|7|||
27906286|NCT01276639|54563586|FG002|Week 0 to 16|Other|2|||
27906287|NCT01276639|54563587|FG003|Week 0 to 16|Other|0|||
27989716|NCT00818883|54648482|FG000|Overall Study|Protocol Violation|2|||
28097643|NCT00097539|54753375|FG006|Overall Study|Death|0|||
28097644|NCT00097539|54753369|FG000|Overall Study|Reasons Other Than Above|3602|||
28097645|NCT00097539|54753370|FG001|Overall Study|Reasons Other Than Above|1382|||
28097646|NCT00097539|54753371|FG002|Overall Study|Reasons Other Than Above|1757|||
28097647|NCT00097539|54753372|FG003|Overall Study|Reasons Other Than Above|692|||
28097648|NCT00097539|54753373|FG004|Overall Study|Reasons Other Than Above|361|||
28097649|NCT00097539|54753374|FG005|Overall Study|Reasons Other Than Above|1244|||
28097650|NCT00097539|54753375|FG006|Overall Study|Reasons Other Than Above|34|||
28097651|NCT00097539|54753369|FG000|Overall Study|Reason not Specified|111|||
28097652|NCT00097539|54753370|FG001|Overall Study|Reason not Specified|49|||
27906288|NCT01276639|54563588|FG004|Week 0 to 16|Other|0|||
27906289|NCT01276639|54563584|FG000|Week 0 to 16|Randomized, But Not Treated|0|||
27906290|NCT01276639|54563585|FG001|Week 0 to 16|Randomized, But Not Treated|1|||
27906291|NCT01276639|54563586|FG002|Week 0 to 16|Randomized, But Not Treated|0|||
27906292|NCT01276639|54563587|FG003|Week 0 to 16|Randomized, But Not Treated|0|||
27906293|NCT01276639|54563588|FG004|Week 0 to 16|Randomized, But Not Treated|0|||
27906294|NCT01276639|54563584|FG000|Week 16 to 52|Death|1|||
27906295|NCT01276639|54563585|FG001|Week 16 to 52|Death|0|||
27906296|NCT01276639|54563586|FG002|Week 16 to 52|Death|0|||
27906297|NCT01276639|54563587|FG003|Week 16 to 52|Death|0|||
27906298|NCT01276639|54563588|FG004|Week 16 to 52|Death|0|||
27906299|NCT01276639|54563584|FG000|Week 16 to 52|Adverse Event|10|||
27906300|NCT01276639|54563585|FG001|Week 16 to 52|Adverse Event|13|||
27906301|NCT01276639|54563586|FG002|Week 16 to 52|Adverse Event|0|||
27906302|NCT01276639|54563587|FG003|Week 16 to 52|Adverse Event|1|||
27906303|NCT01276639|54563588|FG004|Week 16 to 52|Adverse Event|3|||
27906304|NCT01276639|54563584|FG000|Week 16 to 52|Lack of Efficacy|99|||
27906305|NCT01276639|54563585|FG001|Week 16 to 52|Lack of Efficacy|71|||
27906306|NCT01276639|54563586|FG002|Week 16 to 52|Lack of Efficacy|0|||
27906307|NCT01276639|54563587|FG003|Week 16 to 52|Lack of Efficacy|14|||
27906308|NCT01276639|54563588|FG004|Week 16 to 52|Lack of Efficacy|13|||
27906309|NCT01276639|54563584|FG000|Week 16 to 52|Lost to Follow-up|3|||
27906310|NCT01276639|54563585|FG001|Week 16 to 52|Lost to Follow-up|1|||
27906311|NCT01276639|54563586|FG002|Week 16 to 52|Lost to Follow-up|0|||
27906312|NCT01276639|54563587|FG003|Week 16 to 52|Lost to Follow-up|0|||
27906313|NCT01276639|54563588|FG004|Week 16 to 52|Lost to Follow-up|1|||
28172337|NCT02790073|54843984|FG000|Overall Study|Withdrawal by Subject|1|||
28172338|NCT02789137|54843988|FG000|Overall Study|Dropped out/Died|58|||
28172339|NCT01672970|54843993|FG000|Overall Study|Lack of Efficacy|12|||
28172340|NCT01672970|54843993|FG000|Overall Study|Adverse Event|18|||
28172341|NCT01672970|54843993|FG000|Overall Study|Withdrawal by Subject|2|||
28172342|NCT01672970|54843993|FG000|Overall Study|Lost to Follow-up|5|||
28172343|NCT01672970|54843993|FG000|Overall Study|Other|9|||
28172344|NCT01672970|54843993|FG000|Overall Study|Enrolled but not treated|1|||
28172345|NCT02788747|54844017|FG000|Overall Study|Adverse Event|1|||
28172346|NCT02788747|54844018|FG001|Overall Study|Adverse Event|0|||
28172347|NCT02788747|54844019|FG002|Overall Study|Adverse Event|0|||
28172348|NCT02406742|54844033|FG000|Overall Study|Progression of Disease|5|||
28172349|NCT02406742|54844034|FG001|Overall Study|Progression of Disease|1|||
28172350|NCT02406742|54844035|FG002|Overall Study|Progression of Disease|6|||
28172351|NCT02406742|54844033|FG000|Overall Study|Adverse Event|3|||
28172352|NCT02406742|54844034|FG001|Overall Study|Adverse Event|0|||
28172353|NCT02406742|54844035|FG002|Overall Study|Adverse Event|2|||
28172354|NCT02406742|54844033|FG000|Overall Study|Death|1|||
27906314|NCT01276639|54563584|FG000|Week 16 to 52|Withdrawal by Subject|4|||
27906315|NCT01276639|54563585|FG001|Week 16 to 52|Withdrawal by Subject|4|||
27906316|NCT01276639|54563586|FG002|Week 16 to 52|Withdrawal by Subject|0|||
27906317|NCT01276639|54563587|FG003|Week 16 to 52|Withdrawal by Subject|0|||
27906318|NCT01276639|54563588|FG004|Week 16 to 52|Withdrawal by Subject|1|||
27906319|NCT01276639|54563584|FG000|Week 16 to 52|Other|10|||
27989717|NCT00818883|54648483|FG001|Overall Study|Protocol Violation|2|||
27989718|NCT00818883|54648482|FG000|Overall Study|Lost to Follow-up|3|||
27989719|NCT00818883|54648483|FG001|Overall Study|Lost to Follow-up|2|||
27989720|NCT00818883|54648482|FG000|Overall Study|Withdrawal by Subject|16|||
27989721|NCT00818883|54648483|FG001|Overall Study|Withdrawal by Subject|14|||
27989722|NCT00818883|54648482|FG000|Overall Study|Lack of Efficacy|0|||
27989723|NCT00818883|54648483|FG001|Overall Study|Lack of Efficacy|2|||
27989724|NCT00818883|54648482|FG000|Overall Study|Other|2|||
27989725|NCT00818883|54648483|FG001|Overall Study|Other|7|||
27989726|NCT00508027|54648489|FG000|Dose Level 1|Lost to Follow-up|4|||
27989727|NCT00508027|54648489|FG000|Dose Level 1|Withdrawal by Subject|2|||
27989728|NCT00508027|54648489|FG000|Dose Level 1|Physician Decision|2|||
27989729|NCT00508027|54648489|FG000|Dose Level 2|Lost to Follow-up|2|||
27989730|NCT00508027|54648489|FG000|Dose Level 2|Withdrawal by Subject|2|||
27989731|NCT00500149|54648518|FG000|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3|||
27989732|NCT00500149|54648519|FG001|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0|||
27906320|NCT01276639|54563585|FG001|Week 16 to 52|Other|12|||
27906321|NCT01276639|54563586|FG002|Week 16 to 52|Other|0|||
27906322|NCT01276639|54563587|FG003|Week 16 to 52|Other|1|||
27906323|NCT01276639|54563588|FG004|Week 16 to 52|Other|3|||
27906324|NCT01275625|54563603|FG000|Overall Study|Death|1|||
27989733|NCT00500149|54648518|FG000|Enrolled (Dose-optimization Phase)|Adverse Event|8|||
27989734|NCT00500149|54648519|FG001|Enrolled (Dose-optimization Phase)|Adverse Event|0|||
27906325|NCT01275625|54563603|FG000|Overall Study|Lack of Efficacy|2|||
27989735|NCT00500149|54648518|FG000|Enrolled (Dose-optimization Phase)|Protocol Violation|1|||
27989736|NCT00500149|54648519|FG001|Enrolled (Dose-optimization Phase)|Protocol Violation|0|||
27989737|NCT00500149|54648518|FG000|First Intervention (Cross-over Phase)|Adverse Event|0|||
28172355|NCT02406742|54844034|FG001|Overall Study|Death|0|||
28172356|NCT02406742|54844035|FG002|Overall Study|Death|0|||
28172357|NCT02406742|54844033|FG000|Overall Study|Lack of Efficacy|0|||
27906326|NCT01275625|54563603|FG000|Overall Study|Lost to Follow-up|1|||
27906327|NCT01275625|54563603|FG000|Overall Study|Withdrawal by Subject|3|||
27906328|NCT01275625|54563603|FG000|Overall Study|Protocol Violation|1|||
27906329|NCT01275625|54563603|FG000|Overall Study|Adverse Event|4|||
27989738|NCT00500149|54648519|FG001|First Intervention (Cross-over Phase)|Adverse Event|1|||
27989739|NCT00500149|54648518|FG000|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
27989740|NCT00500149|54648519|FG001|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
27989741|NCT00500149|54648518|FG000|First Intervention (Cross-over Phase)|Protocol Violation|1|||
27989742|NCT00500149|54648519|FG001|First Intervention (Cross-over Phase)|Protocol Violation|0|||
27989743|NCT00500149|54648518|FG000|Second Intervention (Cross-over Phase)|Lost to Follow-up|2|||
27989744|NCT00500149|54648519|FG001|Second Intervention (Cross-over Phase)|Lost to Follow-up|0|||
27989745|NCT00489853|54648525|FG000|Wash-out Period 1|Withdrawal by Subject|1|||
27989746|NCT00489853|54648526|FG001|Wash-out Period 1|Withdrawal by Subject|0|||
27989747|NCT00489853|54648527|FG002|Wash-out Period 1|Withdrawal by Subject|0|||
27989748|NCT00489853|54648525|FG000|Wash-out Period 1|Adverse Event|0|||
27989749|NCT00489853|54648526|FG001|Wash-out Period 1|Adverse Event|1|||
27989750|NCT00489853|54648527|FG002|Wash-out Period 1|Adverse Event|1|||
27989751|NCT00489853|54648525|FG000|Wash-out Period 1|Protocol Violation|0|||
27989752|NCT00489853|54648526|FG001|Wash-out Period 1|Protocol Violation|1|||
27989753|NCT00489853|54648527|FG002|Wash-out Period 1|Protocol Violation|1|||
27989754|NCT00489853|54648525|FG000|Wash-out Period 1|Study-specific discontinuation criteria|0|||
27989755|NCT00489853|54648526|FG001|Wash-out Period 1|Study-specific discontinuation criteria|1|||
27906330|NCT01275625|54563603|FG000|Overall Study|Other|1|||
27989756|NCT00489853|54648527|FG002|Wash-out Period 1|Study-specific discontinuation criteria|4|||
27989757|NCT00489853|54648525|FG000|Wash-out Period 2|Adverse Event|1|||
27989758|NCT00489853|54648526|FG001|Wash-out Period 2|Adverse Event|1|||
27989759|NCT00489853|54648527|FG002|Wash-out Period 2|Adverse Event|0|||
27989760|NCT00489853|54648525|FG000|Wash-out Period 2|Study specific discontinuation criteria|3|||
27989761|NCT00489853|54648526|FG001|Wash-out Period 2|Study specific discontinuation criteria|2|||
27989762|NCT00489853|54648527|FG002|Wash-out Period 2|Study specific discontinuation criteria|2|||
27989763|NCT00489853|54648525|FG000|Treatment Period 3|Study specific discontinuation criteria|0|||
27989764|NCT00489853|54648526|FG001|Treatment Period 3|Study specific discontinuation criteria|1|||
27989765|NCT00489853|54648527|FG002|Treatment Period 3|Study specific discontinuation criteria|0|||
27989766|NCT03686423|54648535|FG000|Overall Study|Withdrawal by Subject|9|||
27989767|NCT03686423|54648535|FG000|Overall Study|lost to follow up (study interrupted by COVID)|6|||
27989768|NCT00499681|54648541|FG000|Overall Study|toxicity|0|||
27989769|NCT00499681|54648542|FG001|Overall Study|toxicity|1|||
27989770|NCT00499681|54648541|FG000|Overall Study|disease progression|0|||
27989771|NCT00499681|54648542|FG001|Overall Study|disease progression|1|||
27989772|NCT00875810|54648553|FG000|Overall Study|Withdrawal by Subject|1|||
27989773|NCT00875810|54648553|FG000|Overall Study|Physician Decision|3|||
27989774|NCT00875810|54648553|FG000|Overall Study|Lost to Follow-up|39|||
28097653|NCT00097539|54753371|FG002|Overall Study|Reason not Specified|53|||
28097654|NCT00097539|54753372|FG003|Overall Study|Reason not Specified|21|||
27906331|NCT01272193|54563609|FG000|Overall Study|Adverse Event|1|||
27906332|NCT01272193|54563610|FG001|Overall Study|Adverse Event|1|||
27906333|NCT01272193|54563609|FG000|Overall Study|Lack of Efficacy|0|||
27906334|NCT01272193|54563610|FG001|Overall Study|Lack of Efficacy|3|||
27906335|NCT01272193|54563609|FG000|Overall Study|Withdrawal Criteria|1|||
27906336|NCT01272193|54563610|FG001|Overall Study|Withdrawal Criteria|1|||
27906337|NCT01272193|54563609|FG000|Overall Study|Unclassified|8|||
27906338|NCT01272193|54563610|FG001|Overall Study|Unclassified|7|||
27906339|NCT01270828|54563622|FG000|Pregabalin CR SB|Reason Unspecified|0|||
27906340|NCT01270828|54563623|FG001|Pregabalin CR SB|Reason Unspecified|0|||
27906341|NCT01270828|54563624|FG002|Pregabalin CR SB|Reason Unspecified|8|||
27906342|NCT01270828|54563622|FG000|Pregabalin CR SB|Enrolled but not treated|0|||
27906343|NCT01270828|54563623|FG001|Pregabalin CR SB|Enrolled but not treated|0|||
27906344|NCT01270828|54563624|FG002|Pregabalin CR SB|Enrolled but not treated|5|||
27906345|NCT01270828|54563622|FG000|Pregabalin CR SB|Related adverse event|0|||
27906346|NCT01270828|54563623|FG001|Pregabalin CR SB|Related adverse event|0|||
27906347|NCT01270828|54563624|FG002|Pregabalin CR SB|Related adverse event|46|||
27989775|NCT00875810|54648553|FG000|Overall Study|Patient enroled but not implanted|2|||
27989776|NCT00875810|54648553|FG000|Overall Study|Device explanted|1|||
27989777|NCT00499603|54648559|FG000|Overall Study|Adverse Event|0|||
27989778|NCT00499603|54648560|FG001|Overall Study|Adverse Event|1|||
27989779|NCT00810069|54648579|FG000|Lead-in Period I|Adverse Event|43|||
27989780|NCT00810069|54648580|FG001|Lead-in Period I|Adverse Event|0|||
27989781|NCT00810069|54648581|FG002|Lead-in Period I|Adverse Event|0|||
27989782|NCT00810069|54648579|FG000|Lead-in Period I|Lack of Efficacy|1|||
28097655|NCT00097539|54753373|FG004|Overall Study|Reason not Specified|11|||
27989783|NCT00810069|54648580|FG001|Lead-in Period I|Lack of Efficacy|0|||
28097656|NCT00097539|54753374|FG005|Overall Study|Reason not Specified|40|||
27906348|NCT01270828|54563622|FG000|Pregabalin CR SB|Lack of Efficacy|0|||
27906349|NCT01270828|54563623|FG001|Pregabalin CR SB|Lack of Efficacy|0|||
27906350|NCT01270828|54563624|FG002|Pregabalin CR SB|Lack of Efficacy|32|||
27989784|NCT00810069|54648581|FG002|Lead-in Period I|Lack of Efficacy|0|||
27989785|NCT00810069|54648579|FG000|Lead-in Period I|Lost to Follow-up|19|||
27989786|NCT00810069|54648580|FG001|Lead-in Period I|Lost to Follow-up|0|||
27989787|NCT00810069|54648581|FG002|Lead-in Period I|Lost to Follow-up|0|||
27989788|NCT00810069|54648579|FG000|Lead-in Period I|Physician Decision|1|||
27989789|NCT00810069|54648580|FG001|Lead-in Period I|Physician Decision|0|||
27989790|NCT00810069|54648581|FG002|Lead-in Period I|Physician Decision|0|||
27989791|NCT00810069|54648579|FG000|Lead-in Period I|Protocol Violation|1|||
27989792|NCT00810069|54648580|FG001|Lead-in Period I|Protocol Violation|0|||
27989793|NCT00810069|54648581|FG002|Lead-in Period I|Protocol Violation|0|||
27989794|NCT00810069|54648579|FG000|Lead-in Period I|Withdrawal by Subject|46|||
27989795|NCT00810069|54648580|FG001|Lead-in Period I|Withdrawal by Subject|0|||
27989796|NCT00810069|54648581|FG002|Lead-in Period I|Withdrawal by Subject|0|||
27989797|NCT00810069|54648579|FG000|Lead-in Period I|Protocol entry criterion not met|5|||
27989798|NCT00810069|54648580|FG001|Lead-in Period I|Protocol entry criterion not met|0|||
27989799|NCT00810069|54648581|FG002|Lead-in Period I|Protocol entry criterion not met|0|||
27989800|NCT00810069|54648579|FG000|Lead-in Period I|Randomization criteria not met|158|||
27989801|NCT00810069|54648580|FG001|Lead-in Period I|Randomization criteria not met|0|||
27989802|NCT00810069|54648581|FG002|Lead-in Period I|Randomization criteria not met|0|||
27989803|NCT00810069|54648579|FG000|Double-Blind Period II|Adverse Event|0|||
28097657|NCT00097539|54753375|FG006|Overall Study|Reason not Specified|2|||
28097658|NCT03925324|54753393|FG000|Overall Study|Death|1|||
28097659|NCT03925324|54753394|FG001|Overall Study|Death|1|||
28097660|NCT03042910|54753400|FG000|Overall Study|Adverse Event|1|||
27906351|NCT01270828|54563622|FG000|Pregabalin CR SB|Withdrawal by Subject|0|||
27906352|NCT01270828|54563623|FG001|Pregabalin CR SB|Withdrawal by Subject|0|||
27906353|NCT01270828|54563624|FG002|Pregabalin CR SB|Withdrawal by Subject|29|||
27906354|NCT01270828|54563622|FG000|Pregabalin CR SB|Lost to Follow-up|0|||
27906355|NCT01270828|54563623|FG001|Pregabalin CR SB|Lost to Follow-up|0|||
27906356|NCT01270828|54563624|FG002|Pregabalin CR SB|Lost to Follow-up|10|||
27906357|NCT01270828|54563622|FG000|Pregabalin CR SB|Unrelated AE|0|||
27906358|NCT01270828|54563623|FG001|Pregabalin CR SB|Unrelated AE|0|||
27906359|NCT01270828|54563624|FG002|Pregabalin CR SB|Unrelated AE|8|||
27906360|NCT01270828|54563622|FG000|Pregabalin CR SB|Protocol Violation|0|||
27906361|NCT01270828|54563623|FG001|Pregabalin CR SB|Protocol Violation|0|||
27906362|NCT01270828|54563624|FG002|Pregabalin CR SB|Protocol Violation|8|||
27906363|NCT01270828|54563622|FG000|Double Blind Phase|Death|0|||
27906364|NCT01270828|54563623|FG001|Double Blind Phase|Death|1|||
27906365|NCT01270828|54563624|FG002|Double Blind Phase|Death|0|||
27906366|NCT01270828|54563622|FG000|Double Blind Phase|Protocol Violation|0|||
27906367|NCT01270828|54563623|FG001|Double Blind Phase|Protocol Violation|1|||
27906368|NCT01270828|54563624|FG002|Double Blind Phase|Protocol Violation|0|||
27906369|NCT01270828|54563622|FG000|Double Blind Phase|Protocol and GCP non-compliance|4|||
27906370|NCT01270828|54563623|FG001|Double Blind Phase|Protocol and GCP non-compliance|3|||
27906371|NCT01270828|54563624|FG002|Double Blind Phase|Protocol and GCP non-compliance|0|||
27906372|NCT01270828|54563622|FG000|Double Blind Phase|Reason Unspecified|7|||
27906373|NCT01270828|54563623|FG001|Double Blind Phase|Reason Unspecified|4|||
27906374|NCT01270828|54563624|FG002|Double Blind Phase|Reason Unspecified|0|||
27906375|NCT01270828|54563622|FG000|Double Blind Phase|Withdrawal by Subject|6|||
27906376|NCT01270828|54563623|FG001|Double Blind Phase|Withdrawal by Subject|15|||
27906377|NCT01270828|54563624|FG002|Double Blind Phase|Withdrawal by Subject|0|||
27906378|NCT01270828|54563622|FG000|Double Blind Phase|Lost to Follow-up|1|||
27906379|NCT01270828|54563623|FG001|Double Blind Phase|Lost to Follow-up|2|||
27906380|NCT01270828|54563624|FG002|Double Blind Phase|Lost to Follow-up|0|||
27906381|NCT01270828|54563622|FG000|Double Blind Phase|Lack of Efficacy|2|||
27906382|NCT01270828|54563623|FG001|Double Blind Phase|Lack of Efficacy|11|||
27906383|NCT01270828|54563624|FG002|Double Blind Phase|Lack of Efficacy|0|||
27906384|NCT01270828|54563622|FG000|Double Blind Phase|Adverse event not related to study drug|1|||
27906385|NCT01270828|54563623|FG001|Double Blind Phase|Adverse event not related to study drug|1|||
27906386|NCT01270828|54563624|FG002|Double Blind Phase|Adverse event not related to study drug|0|||
27906387|NCT01270828|54563622|FG000|Double Blind Phase|Adverse event related to study drug|5|||
27906388|NCT01270828|54563623|FG001|Double Blind Phase|Adverse event related to study drug|7|||
27906389|NCT01270828|54563624|FG002|Double Blind Phase|Adverse event related to study drug|0|||
27989804|NCT00810069|54648580|FG001|Double-Blind Period II|Adverse Event|9|||
27989805|NCT00810069|54648581|FG002|Double-Blind Period II|Adverse Event|8|||
27989806|NCT00810069|54648579|FG000|Double-Blind Period II|Lack of Efficacy|0|||
27989807|NCT00810069|54648580|FG001|Double-Blind Period II|Lack of Efficacy|7|||
28097661|NCT03042910|54753400|FG000|Overall Study|Disease Progression|2|||
27906390|NCT01269385|54563632|FG000|Overall Study|Adverse Event|1|||
27906391|NCT01269385|54563633|FG001|Overall Study|Adverse Event|1|||
27906392|NCT01269385|54563634|FG002|Overall Study|Adverse Event|0|||
27906393|NCT01269385|54563635|FG003|Overall Study|Adverse Event|0|||
27989808|NCT00810069|54648581|FG002|Double-Blind Period II|Lack of Efficacy|12|||
27989809|NCT00810069|54648579|FG000|Double-Blind Period II|Lost to Follow-up|0|||
28097662|NCT03042910|54753400|FG000|Overall Study|Withdrawal by Subject|3|||
27906394|NCT01268683|54563645|FG000|Overall Study|Lost to Follow-up|1|||
27989810|NCT00810069|54648580|FG001|Double-Blind Period II|Lost to Follow-up|9|||
27989811|NCT00810069|54648581|FG002|Double-Blind Period II|Lost to Follow-up|9|||
27989812|NCT00810069|54648579|FG000|Double-Blind Period II|Physician Decision|0|||
27989813|NCT00810069|54648580|FG001|Double-Blind Period II|Physician Decision|0|||
27906395|NCT01268683|54563645|FG000|Overall Study|Death|1|||
27906396|NCT01268566|54563649|FG000|Overall Study|Lost to Follow-up|1|||
27906397|NCT01268566|54563649|FG000|Overall Study|Withdrawal by Subject|12|||
27906398|NCT01268566|54563649|FG000|Overall Study|Death|30|||
27906399|NCT01268488|54563653|FG000|Overall Study|Adverse Event|3|||
27906400|NCT01268488|54563653|FG000|Overall Study|Physician Decision|2|||
27906401|NCT01268098|54563660|FG000|Overall Study|Adverse Event|1|||
27906402|NCT01268098|54563661|FG001|Overall Study|Adverse Event|0|||
27906403|NCT01268059|54563671|FG000|Overall Study|Lost to Follow-up|0|||
27906404|NCT01268059|54563672|FG001|Overall Study|Lost to Follow-up|1|||
27906405|NCT01268059|54563673|FG002|Overall Study|Lost to Follow-up|0|||
27906406|NCT01268059|54563674|FG003|Overall Study|Lost to Follow-up|0|||
27906407|NCT01268059|54563671|FG000|Overall Study|Withdrawal by Subject|7|||
27906408|NCT01268059|54563672|FG001|Overall Study|Withdrawal by Subject|4|||
27906409|NCT01268059|54563673|FG002|Overall Study|Withdrawal by Subject|0|||
27906410|NCT01268059|54563674|FG003|Overall Study|Withdrawal by Subject|0|||
27906411|NCT01268059|54563671|FG000|Overall Study|Death|20|||
27906412|NCT01268059|54563672|FG001|Overall Study|Death|30|||
27906413|NCT01268059|54563673|FG002|Overall Study|Death|3|||
27906414|NCT01268059|54563674|FG003|Overall Study|Death|5|||
27906415|NCT01268059|54563671|FG000|Overall Study|Progression of disease|1|||
27906416|NCT01268059|54563672|FG001|Overall Study|Progression of disease|0|||
27906417|NCT01268059|54563673|FG002|Overall Study|Progression of disease|0|||
27989814|NCT00810069|54648581|FG002|Double-Blind Period II|Physician Decision|1|||
27989815|NCT00810069|54648579|FG000|Double-Blind Period II|Withdrawal by Subject|0|||
27989816|NCT00810069|54648580|FG001|Double-Blind Period II|Withdrawal by Subject|21|||
27989817|NCT00810069|54648581|FG002|Double-Blind Period II|Withdrawal by Subject|35|||
27989818|NCT00810069|54648579|FG000|Double-Blind Period II|Protocol entry criterion not met|0|||
27989819|NCT00810069|54648580|FG001|Double-Blind Period II|Protocol entry criterion not met|0|||
27989820|NCT00810069|54648581|FG002|Double-Blind Period II|Protocol entry criterion not met|1|||
27989821|NCT00810069|54648579|FG000|Double-Blind Period II|Clinical relapse|0|||
27989822|NCT00810069|54648580|FG001|Double-Blind Period II|Clinical relapse|3|||
27989823|NCT00810069|54648581|FG002|Double-Blind Period II|Clinical relapse|0|||
27989824|NCT00810069|54648579|FG000|Double-Blind Period II|Protocol Violation|0|||
27989825|NCT00810069|54648580|FG001|Double-Blind Period II|Protocol Violation|7|||
27989826|NCT00810069|54648581|FG002|Double-Blind Period II|Protocol Violation|6|||
27989827|NCT00489541|54648592|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|2|||
27989828|NCT00489541|54648593|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|3|||
27989829|NCT00489541|54648592|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
27989830|NCT00489541|54648593|FG001|12-Month Clinical Follow-up|Lost to Follow-up|0|||
27989831|NCT00489541|54648592|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|2|||
27989832|NCT00489541|54648593|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|0|||
27989833|NCT00489541|54648592|FG000|12-Month Clinical Follow-up|Death|3|||
28097663|NCT03042910|54753400|FG000|Overall Study|Enrolled but not treated|1|||
27906418|NCT01268059|54563674|FG003|Overall Study|Progression of disease|0|||
27906419|NCT01267825|54563689|FG000|Overall Study|study terminated. no data collected.|1|||
27906420|NCT01267825|54563690|FG001|Overall Study|study terminated. no data collected.|0|||
27906421|NCT01260181|54563696|FG000|Overall Study|Decision of Investigator|1|||
27906422|NCT01260142|54563706|FG000|Treatment Period 1|Study on hold|1|||
27906423|NCT01260142|54563707|FG001|Treatment Period 1|Study on hold|1|||
27906424|NCT01260142|54563708|FG002|Treatment Period 1|Study on hold|0|||
27906425|NCT01260142|54563709|FG003|Treatment Period 1|Study on hold|0|||
27906426|NCT01260142|54563710|FG004|Treatment Period 1|Study on hold|1|||
27906427|NCT01260142|54563711|FG005|Treatment Period 1|Study on hold|2|||
27906428|NCT01260142|54563706|FG000|Treatment Period 1|Unexplained elevated sys. BP|0|||
27906429|NCT01260142|54563707|FG001|Treatment Period 1|Unexplained elevated sys. BP|0|||
27906430|NCT01260142|54563708|FG002|Treatment Period 1|Unexplained elevated sys. BP|0|||
27906431|NCT01260142|54563709|FG003|Treatment Period 1|Unexplained elevated sys. BP|0|||
27906432|NCT01260142|54563710|FG004|Treatment Period 1|Unexplained elevated sys. BP|1|||
27906433|NCT01260142|54563711|FG005|Treatment Period 1|Unexplained elevated sys. BP|0|||
27906434|NCT01260142|54563706|FG000|Treatment Period 1|Withdrawal by Subject|0|||
27906435|NCT01260142|54563707|FG001|Treatment Period 1|Withdrawal by Subject|0|||
27989834|NCT00489541|54648593|FG001|12-Month Clinical Follow-up|Death|2|||
27989835|NCT00489541|54648592|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23|||
28097664|NCT03059446|54753404|FG000|Overall Study|Adverse Event|11|||
28097665|NCT03059446|54753404|FG000|Overall Study|Withdrawal of Consent|16|||
27906436|NCT01260142|54563708|FG002|Treatment Period 1|Withdrawal by Subject|0|||
27906437|NCT01260142|54563709|FG003|Treatment Period 1|Withdrawal by Subject|0|||
27989836|NCT00489541|54648593|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12|||
27989837|NCT00489541|54648592|FG000|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4|||
27989838|NCT00489541|54648593|FG001|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5|||
27989839|NCT00809835|54648603|FG000|Overall Study|Lost to Follow-up|7|||
27989840|NCT00809835|54648604|FG001|Overall Study|Lost to Follow-up|6|||
27989841|NCT00809835|54648605|FG002|Overall Study|Lost to Follow-up|10|||
27989842|NCT00809835|54648606|FG003|Overall Study|Lost to Follow-up|2|||
27989843|NCT00809835|54648603|FG000|Overall Study|Withdrawal by Subject|1|||
27989844|NCT00809835|54648604|FG001|Overall Study|Withdrawal by Subject|1|||
27906438|NCT01260142|54563710|FG004|Treatment Period 1|Withdrawal by Subject|0|||
27906439|NCT01260142|54563711|FG005|Treatment Period 1|Withdrawal by Subject|1|||
27906440|NCT01259869|54563731|FG000|Overall Study|Duplicated registration|1|||
27906441|NCT01259713|54563737|FG000|Overall Study|Adverse Event|54|||
27906442|NCT01259713|54563738|FG001|Overall Study|Adverse Event|23|||
27906443|NCT01259713|54563737|FG000|Overall Study|Death Not Related to IFI|8|||
27906444|NCT01259713|54563738|FG001|Overall Study|Death Not Related to IFI|1|||
27906445|NCT01259713|54563737|FG000|Overall Study|Investigators Discretion|14|||
27989845|NCT00809835|54648605|FG002|Overall Study|Withdrawal by Subject|1|||
27989846|NCT00809835|54648606|FG003|Overall Study|Withdrawal by Subject|0|||
27989847|NCT00853242|54648623|FG000|Overall Study|Adverse Event|0|||
27989848|NCT00853242|54648624|FG001|Overall Study|Adverse Event|1|||
27989849|NCT00853242|54648625|FG002|Overall Study|Adverse Event|1|||
27989850|NCT00853242|54648626|FG003|Overall Study|Adverse Event|0|||
27906446|NCT01259713|54563738|FG001|Overall Study|Investigators Discretion|6|||
27906447|NCT01259713|54563737|FG000|Overall Study|Lack of Efficacy|2|||
27906448|NCT01259713|54563738|FG001|Overall Study|Lack of Efficacy|0|||
27906449|NCT01259713|54563737|FG000|Overall Study|Protocol Violation|5|||
27906450|NCT01259713|54563738|FG001|Overall Study|Protocol Violation|4|||
27906451|NCT01259713|54563737|FG000|Overall Study|Subject Withdrew Consent|12|||
27906452|NCT01259713|54563738|FG001|Overall Study|Subject Withdrew Consent|7|||
27906453|NCT01259401|54563746|FG000|4-month Follow-up|Death|0|||
27906454|NCT01259401|54563747|FG001|4-month Follow-up|Death|1|||
27906455|NCT01259401|54563746|FG000|4-month Follow-up|Lost to Follow-up|0|||
27906456|NCT01259401|54563747|FG001|4-month Follow-up|Lost to Follow-up|1|||
27906457|NCT01313923|54563762|FG000|Overall Study|Physician Decision|3|||
27906458|NCT01313884|54563766|FG000|Overall Study|Per insurance pvdr, pt can't be on cl tr|1|||
27906459|NCT01135459|54563772|FG000|Overall Study|Adverse Event|8|||
27906460|NCT01135459|54563773|FG001|Overall Study|Adverse Event|10|||
27906461|NCT01135459|54563772|FG000|Overall Study|Lack of Efficacy|3|||
27906462|NCT01135459|54563773|FG001|Overall Study|Lack of Efficacy|1|||
27906463|NCT01135459|54563772|FG000|Overall Study|Withdrawal by Subject|2|||
27989851|NCT00853242|54648627|FG004|Overall Study|Adverse Event|3|||
27989852|NCT00853242|54648628|FG005|Overall Study|Adverse Event|1|||
27989853|NCT00853242|54648629|FG006|Overall Study|Adverse Event|1|||
27989854|NCT00853242|54648623|FG000|Overall Study|Noncompliant|0|||
27989855|NCT00853242|54648624|FG001|Overall Study|Noncompliant|0|||
27989856|NCT00853242|54648625|FG002|Overall Study|Noncompliant|0|||
27989857|NCT00853242|54648626|FG003|Overall Study|Noncompliant|0|||
27989858|NCT00853242|54648627|FG004|Overall Study|Noncompliant|1|||
27989859|NCT00853242|54648628|FG005|Overall Study|Noncompliant|0|||
27989860|NCT00853242|54648629|FG006|Overall Study|Noncompliant|0|||
27989861|NCT00853242|54648623|FG000|Overall Study|Withdrawal by Subject|1|||
27989862|NCT00853242|54648624|FG001|Overall Study|Withdrawal by Subject|2|||
27989863|NCT00853242|54648625|FG002|Overall Study|Withdrawal by Subject|0|||
27989864|NCT00853242|54648626|FG003|Overall Study|Withdrawal by Subject|4|||
27989865|NCT00853242|54648627|FG004|Overall Study|Withdrawal by Subject|0|||
27989866|NCT00853242|54648628|FG005|Overall Study|Withdrawal by Subject|0|||
27989867|NCT00853242|54648629|FG006|Overall Study|Withdrawal by Subject|2|||
27989868|NCT00853242|54648623|FG000|Overall Study|Other|2|||
27989869|NCT00853242|54648624|FG001|Overall Study|Other|0|||
27989870|NCT00853242|54648625|FG002|Overall Study|Other|2|||
27989871|NCT00853242|54648626|FG003|Overall Study|Other|0|||
27989872|NCT00853242|54648627|FG004|Overall Study|Other|0|||
28172358|NCT02406742|54844034|FG001|Overall Study|Lack of Efficacy|0|||
27906464|NCT01135459|54563773|FG001|Overall Study|Withdrawal by Subject|3|||
27906465|NCT01135459|54563772|FG000|Overall Study|Protocol Violation|5|||
28172359|NCT02406742|54844035|FG002|Overall Study|Lack of Efficacy|1|||
27906466|NCT01135459|54563773|FG001|Overall Study|Protocol Violation|3|||
27906467|NCT01135459|54563772|FG000|Overall Study|Lost to Follow-up|2|||
27989873|NCT00853242|54648628|FG005|Overall Study|Other|1|||
27989874|NCT00853242|54648629|FG006|Overall Study|Other|2|||
27989875|NCT00848250|54648653|FG000|Overall Study|surgery was completed without cardiopulm|0|||
27989876|NCT00848250|54648654|FG001|Overall Study|surgery was completed without cardiopulm|1|||
27989877|NCT00809757|54648664|FG000|Overall Study|Adverse Event|2|||
27989878|NCT00809757|54648665|FG001|Overall Study|Adverse Event|3|||
27989879|NCT00809757|54648666|FG002|Overall Study|Adverse Event|3|||
27989880|NCT00809757|54648664|FG000|Overall Study|Lost to Follow-up|0|||
27989881|NCT00809757|54648665|FG001|Overall Study|Lost to Follow-up|0|||
27989882|NCT00809757|54648666|FG002|Overall Study|Lost to Follow-up|1|||
27989883|NCT00809757|54648664|FG000|Overall Study|Protocol Violation|1|||
28172360|NCT02406742|54844033|FG000|Overall Study|Withdrawal by Participant|1|||
27989884|NCT00809757|54648665|FG001|Overall Study|Protocol Violation|1|||
27989885|NCT00809757|54648666|FG002|Overall Study|Protocol Violation|1|||
27906468|NCT01135459|54563773|FG001|Overall Study|Lost to Follow-up|1|||
27906469|NCT01135459|54563772|FG000|Overall Study|Non-compliance to study procedures|0|||
27989886|NCT00809757|54648664|FG000|Overall Study|Withdrawal by Subject|2|||
27989887|NCT00809757|54648665|FG001|Overall Study|Withdrawal by Subject|1|||
27989888|NCT00809757|54648666|FG002|Overall Study|Withdrawal by Subject|3|||
27989889|NCT00809757|54648664|FG000|Overall Study|Subject Uncooperative|1|||
27989890|NCT00809757|54648665|FG001|Overall Study|Subject Uncooperative|0|||
27989891|NCT00809757|54648666|FG002|Overall Study|Subject Uncooperative|2|||
27989892|NCT00809757|54648664|FG000|Overall Study|Noncompliance with Medication|0|||
27989893|NCT00809757|54648665|FG001|Overall Study|Noncompliance with Medication|0|||
27989894|NCT00809757|54648666|FG002|Overall Study|Noncompliance with Medication|1|||
27989895|NCT00594464|54648680|FG000|Overall Study|Withdrawal by Subject|1|||
27989896|NCT00594464|54648680|FG000|Overall Study|Delay in operation|2|||
27989897|NCT00809445|54648693|FG000|1 Month Follow-up|Lost contact|1|||
27989898|NCT00809445|54648694|FG001|1 Month Follow-up|Lost contact|2|||
27989899|NCT00809445|54648695|FG002|1 Month Follow-up|Lost contact|1|||
27989900|NCT00809445|54648693|FG000|1 Month Follow-up|Withdrew consent|1|||
27989901|NCT00809445|54648694|FG001|1 Month Follow-up|Withdrew consent|1|||
27989902|NCT00809445|54648695|FG002|1 Month Follow-up|Withdrew consent|1|||
27989903|NCT00809445|54648693|FG000|1 Month Follow-up|Death|0|||
27989904|NCT00809445|54648694|FG001|1 Month Follow-up|Death|1|||
27989905|NCT00809445|54648695|FG002|1 Month Follow-up|Death|1|||
27989906|NCT00809445|54648693|FG000|1 Month Follow-up|Incarcerated|0|||
27989907|NCT00809445|54648694|FG001|1 Month Follow-up|Incarcerated|0|||
27989908|NCT00809445|54648695|FG002|1 Month Follow-up|Incarcerated|1|||
27989909|NCT00809445|54648693|FG000|6 Month Follow-up|Lost contact|16|||
27906470|NCT01135459|54563773|FG001|Overall Study|Non-compliance to study procedures|1|||
27906471|NCT01135459|54563772|FG000|Overall Study|Other than specified|1|||
27906472|NCT01135459|54563773|FG001|Overall Study|Other than specified|1|||
27989910|NCT00809445|54648694|FG001|6 Month Follow-up|Lost contact|14|||
27989911|NCT00809445|54648695|FG002|6 Month Follow-up|Lost contact|14|||
27989912|NCT00809445|54648693|FG000|6 Month Follow-up|Death|2|||
27989913|NCT00809445|54648694|FG001|6 Month Follow-up|Death|1|||
27989914|NCT00809445|54648695|FG002|6 Month Follow-up|Death|1|||
27989915|NCT00809445|54648693|FG000|6 Month Follow-up|Incarcerated|6|||
27989916|NCT00809445|54648694|FG001|6 Month Follow-up|Incarcerated|8|||
27989917|NCT00809445|54648695|FG002|6 Month Follow-up|Incarcerated|8|||
27906473|NCT01259284|54563782|FG000|Overall Study|Study Termination|2|||
27906474|NCT01259284|54563783|FG001|Overall Study|Study Termination|0|||
27906475|NCT01259284|54563784|FG002|Overall Study|Study Termination|0|||
27906476|NCT01259245|54563794|FG000|Overall Study|Withdrawal by Subject|27|||
27906477|NCT01259245|54563795|FG001|Overall Study|Withdrawal by Subject|24|||
27906478|NCT01259245|54563794|FG000|Overall Study|Death|1|||
27906479|NCT01259245|54563795|FG001|Overall Study|Death|2|||
27906480|NCT01259089|54563803|FG000|Reached First Response at 4 Weeks|Patient not treated on study|0|||
27906481|NCT01259089|54563804|FG001|Reached First Response at 4 Weeks|Patient not treated on study|0|||
27906482|NCT01259089|54563805|FG002|Reached First Response at 4 Weeks|Patient not treated on study|0|||
27906483|NCT01259089|54563806|FG003|Reached First Response at 4 Weeks|Patient not treated on study|0|||
27906484|NCT01259089|54563807|FG004|Reached First Response at 4 Weeks|Patient not treated on study|0|||
27906485|NCT01259089|54563808|FG005|Reached First Response at 4 Weeks|Patient not treated on study|1|||
27906486|NCT01259089|54563803|FG000|Reached First Response at 4 Weeks|Adverse Event|0|||
27906487|NCT01259089|54563804|FG001|Reached First Response at 4 Weeks|Adverse Event|0|||
27906488|NCT01259089|54563805|FG002|Reached First Response at 4 Weeks|Adverse Event|0|||
27906489|NCT01259089|54563806|FG003|Reached First Response at 4 Weeks|Adverse Event|0|||
27906490|NCT01259089|54563807|FG004|Reached First Response at 4 Weeks|Adverse Event|0|||
27906491|NCT01259089|54563808|FG005|Reached First Response at 4 Weeks|Adverse Event|1|||
27906492|NCT01259089|54563803|FG000|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
27906493|NCT01259089|54563804|FG001|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
27906494|NCT01259089|54563805|FG002|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
27906495|NCT01259089|54563806|FG003|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
27906496|NCT01259089|54563807|FG004|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
27989918|NCT00809445|54648693|FG000|6 Month Follow-up|Withdrew consent|0|||
27989919|NCT00809445|54648694|FG001|6 Month Follow-up|Withdrew consent|0|||
27989920|NCT00809445|54648695|FG002|6 Month Follow-up|Withdrew consent|1|||
27906497|NCT01259089|54563808|FG005|Confirmed Response at 8 Weeks|Withdrawal by Subject|1|||
27906498|NCT01259089|54563803|FG000|Confirmed Response at 8 Weeks|Adverse Event|0|||
27989921|NCT00593918|54648718|FG000|Overall Study|Withdrawal by Subject|5|||
27989922|NCT00593918|54648719|FG001|Overall Study|Withdrawal by Subject|24|||
27989923|NCT00499369|54648730|FG000|Overall Study|Adverse Event|2|||
27989924|NCT00499369|54648731|FG001|Overall Study|Adverse Event|2|||
27989925|NCT00499369|54648732|FG002|Overall Study|Adverse Event|3|||
27989926|NCT00499369|54648733|FG003|Overall Study|Adverse Event|1|||
27989927|NCT00499369|54648734|FG004|Overall Study|Adverse Event|2|||
27906499|NCT01259089|54563804|FG001|Confirmed Response at 8 Weeks|Adverse Event|0|||
27906500|NCT01259089|54563805|FG002|Confirmed Response at 8 Weeks|Adverse Event|0|||
27906501|NCT01259089|54563806|FG003|Confirmed Response at 8 Weeks|Adverse Event|0|||
27906502|NCT01259089|54563807|FG004|Confirmed Response at 8 Weeks|Adverse Event|1|||
27906503|NCT01259089|54563808|FG005|Confirmed Response at 8 Weeks|Adverse Event|2|||
27906504|NCT01259089|54563803|FG000|Confirmed Response at 8 Weeks|Progressive disease|0|||
27906505|NCT01259089|54563804|FG001|Confirmed Response at 8 Weeks|Progressive disease|0|||
27906506|NCT01259089|54563805|FG002|Confirmed Response at 8 Weeks|Progressive disease|1|||
27906507|NCT01259089|54563806|FG003|Confirmed Response at 8 Weeks|Progressive disease|1|||
27906508|NCT01259089|54563807|FG004|Confirmed Response at 8 Weeks|Progressive disease|3|||
27906509|NCT01259089|54563808|FG005|Confirmed Response at 8 Weeks|Progressive disease|7|||
27906510|NCT01259089|54563803|FG000|Continued Treatment After 8 Weeks|Withdrawal by Subject|1|||
27906511|NCT01259089|54563804|FG001|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
27906512|NCT01259089|54563805|FG002|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
27906513|NCT01259089|54563806|FG003|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
27906514|NCT01259089|54563807|FG004|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
27906515|NCT01259089|54563808|FG005|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
27906516|NCT01259089|54563803|FG000|Continued Treatment After 8 Weeks|Adverse Event|0|||
27906517|NCT01259089|54563804|FG001|Continued Treatment After 8 Weeks|Adverse Event|0|||
27906518|NCT01259089|54563805|FG002|Continued Treatment After 8 Weeks|Adverse Event|0|||
27906519|NCT01259089|54563806|FG003|Continued Treatment After 8 Weeks|Adverse Event|0|||
27906520|NCT01259089|54563807|FG004|Continued Treatment After 8 Weeks|Adverse Event|2|||
27906521|NCT01259089|54563808|FG005|Continued Treatment After 8 Weeks|Adverse Event|1|||
27906522|NCT01259089|54563803|FG000|Continued Treatment After 8 Weeks|Progressive disease|1|||
27906523|NCT01259089|54563804|FG001|Continued Treatment After 8 Weeks|Progressive disease|1|||
27906524|NCT01259089|54563805|FG002|Continued Treatment After 8 Weeks|Progressive disease|1|||
27906525|NCT01259089|54563806|FG003|Continued Treatment After 8 Weeks|Progressive disease|1|||
27906526|NCT01259089|54563807|FG004|Continued Treatment After 8 Weeks|Progressive disease|0|||
27906527|NCT01259089|54563808|FG005|Continued Treatment After 8 Weeks|Progressive disease|0|||
27906528|NCT01259089|54563803|FG000|Survival Follow up for Two Years|Death|3|||
27906529|NCT01259089|54563804|FG001|Survival Follow up for Two Years|Death|2|||
27739581|NCT02738879|54189191|FG000|Overall Study|Withdrawal by Subject|5|||
27739582|NCT02738879|54189192|FG001|Overall Study|Withdrawal by Subject|7|||
27739583|NCT03502811|54189198|FG000|Overall Study|Death|157|||
27739584|NCT03502811|54189198|FG000|Overall Study|Withdrawal by Subject|105|||
27739585|NCT03502811|54189198|FG000|Overall Study|Lost to Follow-up|26|||
27739586|NCT03502811|54189198|FG000|Overall Study|No Visits (Missed)|31|||
27739587|NCT00515671|54189210|FG000|Overall Study|Lost to Follow-up|13|||
27739588|NCT00515671|54189211|FG001|Overall Study|Lost to Follow-up|10|||
27906530|NCT01259089|54563805|FG002|Survival Follow up for Two Years|Death|2|||
27989928|NCT00499369|54648730|FG000|Overall Study|Withdrawal by Subject|0|||
27989929|NCT00499369|54648731|FG001|Overall Study|Withdrawal by Subject|1|||
27989930|NCT00499369|54648732|FG002|Overall Study|Withdrawal by Subject|1|||
27739589|NCT00515671|54189210|FG000|Overall Study|Withdrawal by Subject|3|||
27739590|NCT00515671|54189211|FG001|Overall Study|Withdrawal by Subject|5|||
27739591|NCT00515671|54189210|FG000|Overall Study|incarcerated|1|||
27739592|NCT00515671|54189211|FG001|Overall Study|incarcerated|2|||
27739593|NCT01677195|54189220|FG000|Overall Study|Lost to Follow-up|14|||
27739594|NCT01677195|54189221|FG001|Overall Study|Lost to Follow-up|22|||
27739595|NCT01677195|54189222|FG002|Overall Study|Lost to Follow-up|22|||
27739596|NCT01677195|54189220|FG000|Overall Study|Withdrawal by Subject|1|||
27739597|NCT01677195|54189221|FG001|Overall Study|Withdrawal by Subject|0|||
27739598|NCT01677195|54189222|FG002|Overall Study|Withdrawal by Subject|1|||
27739599|NCT01677195|54189220|FG000|Overall Study|Adverse Event|6|||
27739600|NCT01677195|54189221|FG001|Overall Study|Adverse Event|4|||
27739601|NCT01677195|54189222|FG002|Overall Study|Adverse Event|1|||
27739602|NCT01677195|54189220|FG000|Overall Study|Physician Decision|1|||
27739603|NCT01677195|54189221|FG001|Overall Study|Physician Decision|2|||
27739604|NCT01677195|54189222|FG002|Overall Study|Physician Decision|2|||
27739605|NCT01677195|54189220|FG000|Overall Study|Pregnancy|0|||
27739606|NCT01677195|54189221|FG001|Overall Study|Pregnancy|1|||
27739607|NCT01677195|54189222|FG002|Overall Study|Pregnancy|0|||
27739608|NCT01677195|54189220|FG000|Overall Study|Protocol Violation|7|||
27739609|NCT01677195|54189221|FG001|Overall Study|Protocol Violation|3|||
27906531|NCT01259089|54563806|FG003|Survival Follow up for Two Years|Death|3|||
27906532|NCT01259089|54563807|FG004|Survival Follow up for Two Years|Death|6|||
27989931|NCT00499369|54648733|FG003|Overall Study|Withdrawal by Subject|0|||
27739610|NCT01677195|54189222|FG002|Overall Study|Protocol Violation|4|||
27739611|NCT00928447|54189234|FG000|Overall Study|Withdrawal by Subject|1|||
27739612|NCT00928447|54189234|FG000|Overall Study|Investigator's decision|1|||
27739613|NCT02224846|54189240|FG000|Period 1 (Month 3)|Adverse Event|2|||
27739614|NCT02224846|54189241|FG001|Period 1 (Month 3)|Adverse Event|1|||
27739615|NCT02224846|54189240|FG000|Period 1 (Month 3)|Lost to Follow-up|3|||
27739616|NCT02224846|54189241|FG001|Period 1 (Month 3)|Lost to Follow-up|8|||
27906533|NCT01259089|54563808|FG005|Survival Follow up for Two Years|Death|13|||
27989932|NCT00499369|54648734|FG004|Overall Study|Withdrawal by Subject|0|||
27989933|NCT00499369|54648730|FG000|Overall Study|Progression|10|||
27989934|NCT00499369|54648731|FG001|Overall Study|Progression|12|||
27989935|NCT00499369|54648732|FG002|Overall Study|Progression|9|||
27989936|NCT00499369|54648733|FG003|Overall Study|Progression|6|||
27989937|NCT00499369|54648734|FG004|Overall Study|Progression|10|||
27989938|NCT00499369|54648730|FG000|Overall Study|Death|0|||
27989939|NCT00499369|54648731|FG001|Overall Study|Death|1|||
27989940|NCT00499369|54648732|FG002|Overall Study|Death|0|||
27989941|NCT00499369|54648733|FG003|Overall Study|Death|0|||
27989942|NCT00499369|54648734|FG004|Overall Study|Death|0|||
27989943|NCT00499369|54648730|FG000|Overall Study|Not protocol specified|2|||
27989944|NCT00499369|54648731|FG001|Overall Study|Not protocol specified|0|||
27989945|NCT00499369|54648732|FG002|Overall Study|Not protocol specified|3|||
27989946|NCT00499369|54648733|FG003|Overall Study|Not protocol specified|1|||
27989947|NCT00499369|54648734|FG004|Overall Study|Not protocol specified|0|||
27989948|NCT00499369|54648730|FG000|Overall Study|Ineligible|2|||
27989949|NCT00499369|54648731|FG001|Overall Study|Ineligible|2|||
27906534|NCT01259089|54563803|FG000|Survival Follow up for Two Years|Lost to Follow-up|0|||
27906535|NCT01259089|54563804|FG001|Survival Follow up for Two Years|Lost to Follow-up|0|||
27989950|NCT00499369|54648732|FG002|Overall Study|Ineligible|1|||
27989951|NCT00499369|54648733|FG003|Overall Study|Ineligible|1|||
27989952|NCT00499369|54648734|FG004|Overall Study|Ineligible|0|||
27989953|NCT00869258|54648746|FG000|Overall Study|Physician Decision|1|||
27989954|NCT00693784|54648750|FG000|Overall Study|Lost to Follow-up|2|||
27989955|NCT00693784|54648750|FG000|Overall Study|Withdrawal by Subject|2|||
27989956|NCT00693706|54648756|FG000|Overall Study|Protocol Violation|0|||
27989957|NCT00693706|54648757|FG001|Overall Study|Protocol Violation|1|||
27906536|NCT01259089|54563805|FG002|Survival Follow up for Two Years|Lost to Follow-up|0|||
27906537|NCT01259089|54563806|FG003|Survival Follow up for Two Years|Lost to Follow-up|0|||
27906538|NCT01259089|54563807|FG004|Survival Follow up for Two Years|Lost to Follow-up|0|||
27906539|NCT01259089|54563808|FG005|Survival Follow up for Two Years|Lost to Follow-up|2|||
27906540|NCT01259089|54563803|FG000|Survival Follow up for Two Years|stopped being followed as study closed|0|||
27906541|NCT01259089|54563804|FG001|Survival Follow up for Two Years|stopped being followed as study closed|0|||
27906542|NCT01259089|54563805|FG002|Survival Follow up for Two Years|stopped being followed as study closed|0|||
27906543|NCT01259089|54563806|FG003|Survival Follow up for Two Years|stopped being followed as study closed|0|||
27906544|NCT01259089|54563807|FG004|Survival Follow up for Two Years|stopped being followed as study closed|0|||
27906545|NCT01259089|54563808|FG005|Survival Follow up for Two Years|stopped being followed as study closed|4|||
27906546|NCT01258738|54563824|FG000|Double-blind Period|Did not meet inclusion criteria|3|||
27906547|NCT01258738|54563825|FG001|Double-blind Period|Did not meet inclusion criteria|3|||
27906548|NCT01258738|54563824|FG000|Double-blind Period|Withdrawal by Subject|2|||
27906549|NCT01258738|54563825|FG001|Double-blind Period|Withdrawal by Subject|2|||
27906550|NCT01258738|54563824|FG000|Double-blind Period|Protocol Violation|1|||
27906551|NCT01258738|54563825|FG001|Double-blind Period|Protocol Violation|1|||
27906552|NCT01258738|54563824|FG000|Double-blind Period|Adverse Event|3|||
27906553|NCT01258738|54563825|FG001|Double-blind Period|Adverse Event|1|||
27906554|NCT01258738|54563824|FG000|Open-label Period|Did not meet inclusion criteria|0|||
27906555|NCT01258738|54563825|FG001|Open-label Period|Did not meet inclusion criteria|1|||
27906556|NCT01258738|54563824|FG000|Open-label Period|Insufficient clinical response|5|||
27906557|NCT01258738|54563825|FG001|Open-label Period|Insufficient clinical response|3|||
27906558|NCT01258738|54563824|FG000|Open-label Period|Lost to Follow-up|0|||
27906559|NCT01258738|54563825|FG001|Open-label Period|Lost to Follow-up|2|||
27906560|NCT01258738|54563824|FG000|Open-label Period|Withdrawal by Subject|5|||
27906561|NCT01258738|54563825|FG001|Open-label Period|Withdrawal by Subject|6|||
27906562|NCT01258738|54563824|FG000|Open-label Period|Protocol Violation|2|||
27906563|NCT01258738|54563825|FG001|Open-label Period|Protocol Violation|2|||
27906564|NCT01258738|54563824|FG000|Open-label Period|Adverse Event|4|||
27906565|NCT01258738|54563825|FG001|Open-label Period|Adverse Event|5|||
27906566|NCT01258738|54563824|FG000|Open-label Period|Other Reasons|0|||
27906567|NCT01258738|54563825|FG001|Open-label Period|Other Reasons|1|||
27906568|NCT01258738|54563824|FG000|Open-label Period|Withdrawn due to pregnancy|1|||
27906569|NCT01258738|54563825|FG001|Open-label Period|Withdrawn due to pregnancy|1|||
27906570|NCT01258660|54563833|FG000|Overall Study|Adverse Event|2|||
27989958|NCT00488683|54648766|FG000|Overall Study|Withdrawal by Subject|1|||
27989959|NCT00488683|54648767|FG001|Overall Study|Withdrawal by Subject|2|||
27989960|NCT00488683|54648768|FG002|Overall Study|Withdrawal by Subject|2|||
27989961|NCT00488683|54648766|FG000|Overall Study|Lost to Follow-up|5|||
27906571|NCT01258660|54563834|FG001|Overall Study|Adverse Event|4|||
27906572|NCT01258660|54563833|FG000|Overall Study|Withdrawal by Subject|3|||
27906573|NCT01258660|54563834|FG001|Overall Study|Withdrawal by Subject|0|||
27906574|NCT01258660|54563833|FG000|Overall Study|due to relocation|2|||
27906575|NCT01258660|54563834|FG001|Overall Study|due to relocation|0|||
27989962|NCT00488683|54648767|FG001|Overall Study|Lost to Follow-up|3|||
27989963|NCT00488683|54648768|FG002|Overall Study|Lost to Follow-up|0|||
27989964|NCT00488683|54648766|FG000|Overall Study|Protocol Violation|5|||
27989965|NCT00488683|54648767|FG001|Overall Study|Protocol Violation|1|||
27989966|NCT00488683|54648768|FG002|Overall Study|Protocol Violation|0|||
27989967|NCT00488683|54648766|FG000|Overall Study|Unable to Classify|1|||
27989968|NCT00488683|54648767|FG001|Overall Study|Unable to Classify|0|||
27989969|NCT00488683|54648768|FG002|Overall Study|Unable to Classify|0|||
27989970|NCT00693472|54648802|FG000|Part 1|Adverse Event|1|||
27989971|NCT00693472|54648803|FG001|Part 1|Adverse Event|1|||
27989972|NCT00693472|54648804|FG002|Part 1|Adverse Event|0|||
27989973|NCT00693472|54648805|FG003|Part 1|Adverse Event|0|||
27989974|NCT00693472|54648802|FG000|Part 1|Lost to Follow-up|0|||
27989975|NCT00693472|54648803|FG001|Part 1|Lost to Follow-up|1|||
27989976|NCT00693472|54648804|FG002|Part 1|Lost to Follow-up|0|||
27989977|NCT00693472|54648805|FG003|Part 1|Lost to Follow-up|0|||
27989978|NCT00693472|54648802|FG000|Part 1|Withdrew - reason unrelated to treatment|5|||
27989979|NCT00693472|54648803|FG001|Part 1|Withdrew - reason unrelated to treatment|2|||
27989980|NCT00693472|54648804|FG002|Part 1|Withdrew - reason unrelated to treatment|0|||
27989981|NCT00693472|54648805|FG003|Part 1|Withdrew - reason unrelated to treatment|0|||
27906576|NCT01258660|54563833|FG000|Overall Study|Protocol Violation|0|||
27906577|NCT01258660|54563834|FG001|Overall Study|Protocol Violation|1|||
27906578|NCT01258660|54563833|FG000|Overall Study|Invalid for primary analysis data set|4|||
27906579|NCT01258660|54563834|FG001|Overall Study|Invalid for primary analysis data set|6|||
27906580|NCT01258348|54563841|FG000|Overall Study|Adverse Event|1|||
27906581|NCT01258348|54563842|FG001|Overall Study|Adverse Event|1|||
27906582|NCT01258348|54563843|FG002|Overall Study|Adverse Event|3|||
27906583|NCT01258348|54563844|FG003|Overall Study|Adverse Event|2|||
27906584|NCT01258348|54563845|FG004|Overall Study|Adverse Event|4|||
27906585|NCT01258348|54563841|FG000|Overall Study|Progressive Disease|0|||
27906586|NCT01258348|54563842|FG001|Overall Study|Progressive Disease|3|||
27906587|NCT01258348|54563843|FG002|Overall Study|Progressive Disease|0|||
27906588|NCT01258348|54563844|FG003|Overall Study|Progressive Disease|2|||
27906589|NCT01258348|54563845|FG004|Overall Study|Progressive Disease|2|||
27906590|NCT01258348|54563841|FG000|Overall Study|Physician Decision|0|||
27906591|NCT01258348|54563842|FG001|Overall Study|Physician Decision|0|||
27906592|NCT01258348|54563843|FG002|Overall Study|Physician Decision|0|||
27906593|NCT01258348|54563844|FG003|Overall Study|Physician Decision|2|||
27906594|NCT01258348|54563845|FG004|Overall Study|Physician Decision|0|||
27906595|NCT01258348|54563841|FG000|Overall Study|Withdrawal by Subject|0|||
27906596|NCT01258348|54563842|FG001|Overall Study|Withdrawal by Subject|1|||
27906597|NCT01258348|54563843|FG002|Overall Study|Withdrawal by Subject|0|||
27906598|NCT01258348|54563844|FG003|Overall Study|Withdrawal by Subject|0|||
27906599|NCT01258348|54563845|FG004|Overall Study|Withdrawal by Subject|0|||
27989982|NCT00693472|54648802|FG000|Part 2|Adverse Event|0|||
27989983|NCT00693472|54648803|FG001|Part 2|Adverse Event|0|||
27989984|NCT00693472|54648804|FG002|Part 2|Adverse Event|1|||
27989985|NCT00693472|54648805|FG003|Part 2|Adverse Event|0|||
27989986|NCT00693472|54648802|FG000|Part 2|Withdrew - reason unrelated to treatment|0|||
27989987|NCT00693472|54648803|FG001|Part 2|Withdrew - reason unrelated to treatment|0|||
27989988|NCT00693472|54648804|FG002|Part 2|Withdrew - reason unrelated to treatment|1|||
27989989|NCT00693472|54648805|FG003|Part 2|Withdrew - reason unrelated to treatment|2|||
27989990|NCT00498433|54648818|FG000|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2|||
27989991|NCT00498433|54648819|FG001|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
27989992|NCT00498433|54648820|FG002|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
27989993|NCT00498433|54648818|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2|||
27989994|NCT00498433|54648819|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
27989995|NCT00498433|54648820|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
27989996|NCT00498433|54648818|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15|||
27989997|NCT00498433|54648819|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
27989998|NCT00498433|54648820|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
27989999|NCT00498433|54648818|FG000|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1|||
27990000|NCT00498433|54648819|FG001|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
27990001|NCT00498433|54648820|FG002|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
28097666|NCT03059446|54753404|FG000|Overall Study|Lost to Follow-up|3|||
28097667|NCT03059446|54753404|FG000|Overall Study|Protocol Violation|1|||
28097668|NCT03059446|54753404|FG000|Overall Study|Study Terminated by Sponsor|131|||
27906600|NCT01258075|54563861|FG000|Overall Study|Adverse Event|8|||
27906601|NCT01258075|54563862|FG001|Overall Study|Adverse Event|3|||
27990002|NCT00498355|54648837|FG000|Overall Study|Lost to Follow-up|1|||
28097669|NCT03059446|54753404|FG000|Overall Study|Reason not Specified|5|||
28097670|NCT00090519|54753410|FG000|Overall Study|Adverse Event|5|||
27906602|NCT01258075|54563861|FG000|Overall Study|Lost to Follow-up|11|||
27906603|NCT01258075|54563862|FG001|Overall Study|Lost to Follow-up|6|||
27906604|NCT01258075|54563861|FG000|Overall Study|Withdrawal by Subject|10|||
27906605|NCT01258075|54563862|FG001|Overall Study|Withdrawal by Subject|7|||
27990003|NCT04327271|54648844|FG000|Overall Study|Death|1|||
27990004|NCT04327271|54648845|FG001|Overall Study|Death|0|||
27990005|NCT04327271|54648844|FG000|Overall Study|Withdrawal by Subject|1|||
27990006|NCT04327271|54648845|FG001|Overall Study|Withdrawal by Subject|0|||
27990007|NCT04327271|54648844|FG000|Overall Study|randomization error (data capture)|4|||
27990008|NCT04327271|54648845|FG001|Overall Study|randomization error (data capture)|3|||
27990009|NCT00688636|54648862|FG000|Overall Study|Adverse Event|2|||
27990010|NCT00688636|54648863|FG001|Overall Study|Adverse Event|1|||
27990011|NCT00870740|54648875|FG000|Overall Study|Adverse Event|2|||
27990012|NCT00870740|54648876|FG001|Overall Study|Adverse Event|1|||
27990013|NCT00870740|54648877|FG002|Overall Study|Adverse Event|3|||
27990014|NCT00870740|54648878|FG003|Overall Study|Adverse Event|2|||
27990015|NCT00870740|54648879|FG004|Overall Study|Adverse Event|1|||
27990016|NCT00870740|54648880|FG005|Overall Study|Adverse Event|6|||
27990017|NCT00870740|54648875|FG000|Overall Study|Consent Withdrawn|6|||
27990018|NCT00870740|54648876|FG001|Overall Study|Consent Withdrawn|3|||
27990019|NCT00870740|54648877|FG002|Overall Study|Consent Withdrawn|4|||
27990020|NCT00870740|54648878|FG003|Overall Study|Consent Withdrawn|6|||
27990021|NCT00870740|54648879|FG004|Overall Study|Consent Withdrawn|6|||
27990022|NCT00870740|54648880|FG005|Overall Study|Consent Withdrawn|5|||
27990023|NCT00870740|54648875|FG000|Overall Study|Investigator Decision|2|||
27990024|NCT00870740|54648876|FG001|Overall Study|Investigator Decision|0|||
27990025|NCT00870740|54648877|FG002|Overall Study|Investigator Decision|1|||
27990026|NCT00870740|54648878|FG003|Overall Study|Investigator Decision|0|||
27990027|NCT00870740|54648879|FG004|Overall Study|Investigator Decision|0|||
27990028|NCT00870740|54648880|FG005|Overall Study|Investigator Decision|0|||
27990029|NCT00870740|54648875|FG000|Overall Study|Subject Non-compliance|0|||
27990030|NCT00870740|54648876|FG001|Overall Study|Subject Non-compliance|0|||
27990031|NCT00870740|54648877|FG002|Overall Study|Subject Non-compliance|0|||
27990032|NCT00870740|54648878|FG003|Overall Study|Subject Non-compliance|0|||
27990033|NCT00870740|54648879|FG004|Overall Study|Subject Non-compliance|0|||
27990034|NCT00870740|54648880|FG005|Overall Study|Subject Non-compliance|1|||
27990035|NCT00870740|54648875|FG000|Overall Study|Death|0|||
27990036|NCT00870740|54648876|FG001|Overall Study|Death|0|||
27990037|NCT00870740|54648877|FG002|Overall Study|Death|0|||
27990038|NCT00870740|54648878|FG003|Overall Study|Death|0|||
27990039|NCT00870740|54648879|FG004|Overall Study|Death|1|||
27990040|NCT00870740|54648880|FG005|Overall Study|Death|0|||
27990041|NCT00870740|54648875|FG000|Overall Study|Other|2|||
27990042|NCT00870740|54648876|FG001|Overall Study|Other|5|||
27990043|NCT00870740|54648877|FG002|Overall Study|Other|2|||
27990044|NCT00870740|54648878|FG003|Overall Study|Other|4|||
27990045|NCT00870740|54648879|FG004|Overall Study|Other|3|||
27990046|NCT00870740|54648880|FG005|Overall Study|Other|5|||
27990047|NCT00869024|54648907|FG000|Overall Study|Death|2|||
27990048|NCT00869024|54648908|FG001|Overall Study|Death|3|||
27990049|NCT00869024|54648907|FG000|Overall Study|Lost to Follow-up|0|||
27990050|NCT00869024|54648908|FG001|Overall Study|Lost to Follow-up|1|||
27990051|NCT00869024|54648907|FG000|Overall Study|Protocol Violation|0|||
28097671|NCT00090519|54753411|FG001|Overall Study|Adverse Event|4|||
28097672|NCT00090519|54753410|FG000|Overall Study|Death|9|||
27906606|NCT01258075|54563861|FG000|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1|||
27906607|NCT01258075|54563862|FG001|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2|||
27906608|NCT01258075|54563861|FG000|Overall Study|Other|12|||
27906609|NCT01258075|54563862|FG001|Overall Study|Other|5|||
27906610|NCT01257568|54563868|FG000|Overall Study|Lost to Follow-up|2|||
27906611|NCT01257568|54563868|FG000|Overall Study|Withdrawal by Subject|6|||
27906612|NCT01257568|54563868|FG000|Overall Study|Terminated|1|||
27906613|NCT01257568|54563868|FG000|Overall Study|Component Revision|24|||
27906614|NCT01256788|54563877|FG000|Overall Study|Lost to Follow-up|5|||
27906615|NCT01256788|54563878|FG001|Overall Study|Lost to Follow-up|8|||
27906616|NCT01256788|54563879|FG002|Overall Study|Lost to Follow-up|3|||
27906617|NCT01256671|54563887|FG000|Overall Study|Adverse Event|29|||
27906618|NCT01256671|54563887|FG000|Overall Study|Lost to Follow-up|16|||
27906619|NCT01256671|54563887|FG000|Overall Study|Withdrawal by Subject|31|||
27906620|NCT01256671|54563887|FG000|Overall Study|Physician Decision|3|||
27906621|NCT01256671|54563887|FG000|Overall Study|Lack of Efficacy|4|||
27906622|NCT01256671|54563887|FG000|Overall Study|Non-compliance/Sponsor Decision/Other|12|||
27906623|NCT01256593|54563891|FG000|Overall Study|Protocol Violation|26|||
27990052|NCT00869024|54648908|FG001|Overall Study|Protocol Violation|1|||
27990053|NCT00506779|54648916|FG000|Overall Study|Withdrawal by Subject|1|||
27990054|NCT00506779|54648917|FG001|Overall Study|Withdrawal by Subject|0|||
27990055|NCT00506779|54648918|FG002|Overall Study|Withdrawal by Subject|1|||
27990056|NCT00506779|54648919|FG003|Overall Study|Withdrawal by Subject|0|||
27990057|NCT00506779|54648916|FG000|Overall Study|Adverse Event|0|||
27990058|NCT00506779|54648917|FG001|Overall Study|Adverse Event|1|||
27990059|NCT00506779|54648918|FG002|Overall Study|Adverse Event|1|||
27990060|NCT00506779|54648919|FG003|Overall Study|Adverse Event|1|||
27990061|NCT00488293|54648932|FG000|Overall Study|Lost to Follow-up|28|||
27990062|NCT00488293|54648933|FG001|Overall Study|Lost to Follow-up|25|||
27990063|NCT00488293|54648932|FG000|Overall Study|Withdrawal by Subject|5|||
27990064|NCT00488293|54648933|FG001|Overall Study|Withdrawal by Subject|3|||
28097673|NCT00090519|54753411|FG001|Overall Study|Death|9|||
27906624|NCT01256593|54563891|FG000|Overall Study|No Drug Administration Information|2|||
27906625|NCT01256593|54563891|FG000|Overall Study|No Visit After Treatment|186|||
27906626|NCT01256476|54563897|FG000|Overall Study|Adverse Event|2|||
27906627|NCT01256476|54563898|FG001|Overall Study|Adverse Event|1|||
27906628|NCT01256476|54563897|FG000|Overall Study|Withdrawal by Subject|2|||
27990065|NCT00488293|54648932|FG000|Overall Study|Death|2|||
27990066|NCT00488293|54648933|FG001|Overall Study|Death|1|||
27990067|NCT00488293|54648932|FG000|Overall Study|Misrandomization/Other Unspecified|1|||
27990068|NCT00488293|54648933|FG001|Overall Study|Misrandomization/Other Unspecified|1|||
27990069|NCT00868790|54648939|FG000|Period 1|Adverse Event|1|||
27990070|NCT00868790|54648940|FG001|Period 1|Adverse Event|0|||
27990071|NCT00868790|54648941|FG002|Period 1|Adverse Event|0|||
27990072|NCT00868790|54648942|FG003|Period 1|Adverse Event|0|||
27990073|NCT00868790|54648943|FG004|Period 1|Adverse Event|0|||
27990074|NCT00868790|54648944|FG005|Period 1|Adverse Event|0|||
27990075|NCT00868790|54648945|FG006|Period 1|Adverse Event|0|||
27990076|NCT00868790|54648946|FG007|Period 1|Adverse Event|3|||
27990077|NCT00868790|54648947|FG008|Period 1|Adverse Event|1|||
27990078|NCT00868790|54648948|FG009|Period 1|Adverse Event|0|||
27990079|NCT00868790|54648949|FG010|Period 1|Adverse Event|0|||
27990080|NCT00868790|54648950|FG011|Period 1|Adverse Event|0|||
27990081|NCT00868790|54648951|FG012|Period 1|Adverse Event|0|||
27990082|NCT00868790|54648952|FG013|Period 1|Adverse Event|1|||
27990083|NCT00868790|54648939|FG000|Period 1|Protocol Violation|1|||
27990084|NCT00868790|54648940|FG001|Period 1|Protocol Violation|0|||
27990085|NCT00868790|54648941|FG002|Period 1|Protocol Violation|0|||
27990086|NCT00868790|54648942|FG003|Period 1|Protocol Violation|0|||
27990087|NCT00868790|54648943|FG004|Period 1|Protocol Violation|0|||
27990088|NCT00868790|54648944|FG005|Period 1|Protocol Violation|0|||
27990089|NCT00868790|54648945|FG006|Period 1|Protocol Violation|0|||
27990090|NCT00868790|54648946|FG007|Period 1|Protocol Violation|0|||
27990091|NCT00868790|54648947|FG008|Period 1|Protocol Violation|0|||
27990092|NCT00868790|54648948|FG009|Period 1|Protocol Violation|0|||
27990093|NCT00868790|54648949|FG010|Period 1|Protocol Violation|0|||
27990094|NCT00868790|54648950|FG011|Period 1|Protocol Violation|0|||
27990095|NCT00868790|54648951|FG012|Period 1|Protocol Violation|0|||
27990096|NCT00868790|54648952|FG013|Period 1|Protocol Violation|0|||
27990097|NCT00868790|54648939|FG000|Period 1|Withdrawal by Subject|0|||
27990098|NCT00868790|54648940|FG001|Period 1|Withdrawal by Subject|1|||
27906629|NCT01256476|54563898|FG001|Overall Study|Withdrawal by Subject|1|||
27906630|NCT01256476|54563897|FG000|Overall Study|Lost to Follow-up|1|||
27906631|NCT01256476|54563898|FG001|Overall Study|Lost to Follow-up|2|||
27906632|NCT01256476|54563897|FG000|Overall Study|Persistent ALT or AST elevation|1|||
27906633|NCT01256476|54563898|FG001|Overall Study|Persistent ALT or AST elevation|0|||
27906634|NCT01256476|54563897|FG000|Overall Study|Physician Decision|0|||
27906635|NCT01256476|54563898|FG001|Overall Study|Physician Decision|1|||
27906636|NCT01256476|54563897|FG000|Overall Study|Subject non-compliance|0|||
27906637|NCT01256476|54563898|FG001|Overall Study|Subject non-compliance|1|||
27906638|NCT01256476|54563897|FG000|Overall Study|LDL-C elevation exceeding 250 mg/dL|0|||
27906639|NCT01256476|54563898|FG001|Overall Study|LDL-C elevation exceeding 250 mg/dL|1|||
27906640|NCT01256008|54563907|FG000|Overall Study|Lost to Follow-up|6|||
27906641|NCT01256008|54563908|FG001|Overall Study|Lost to Follow-up|4|||
27906642|NCT01256008|54563909|FG002|Overall Study|Lost to Follow-up|11|||
27906643|NCT01256008|54563907|FG000|Overall Study|Withdrawal by Subject|2|||
27906644|NCT01256008|54563908|FG001|Overall Study|Withdrawal by Subject|3|||
27906645|NCT01256008|54563909|FG002|Overall Study|Withdrawal by Subject|10|||
27906646|NCT01255423|54563921|FG000|Overall Study|Abnormal Laboratory value|3|||
27906647|NCT01255423|54563922|FG001|Overall Study|Abnormal Laboratory value|2|||
27906648|NCT01255423|54563921|FG000|Overall Study|Use of prohibited medications|0|||
27906649|NCT01255423|54563922|FG001|Overall Study|Use of prohibited medications|1|||
27906650|NCT01255306|54563930|FG000|Overall Study|Physician Decision|1|||
27906651|NCT01255306|54563931|FG001|Overall Study|Physician Decision|1|||
27906652|NCT01254721|54563942|FG000|Overall Study|Lost to Follow-up|0|||
27906653|NCT01254721|54563943|FG001|Overall Study|Lost to Follow-up|4|||
27990099|NCT00868790|54648941|FG002|Period 1|Withdrawal by Subject|0|||
27990100|NCT00868790|54648942|FG003|Period 1|Withdrawal by Subject|0|||
27990101|NCT00868790|54648943|FG004|Period 1|Withdrawal by Subject|0|||
27990102|NCT00868790|54648944|FG005|Period 1|Withdrawal by Subject|0|||
27990103|NCT00868790|54648945|FG006|Period 1|Withdrawal by Subject|0|||
27990104|NCT00868790|54648946|FG007|Period 1|Withdrawal by Subject|0|||
27906654|NCT01254721|54563942|FG000|Overall Study|Lack of Efficacy|4|||
27906655|NCT01254721|54563943|FG001|Overall Study|Lack of Efficacy|2|||
27906656|NCT01254721|54563942|FG000|Overall Study|Death|0|||
27906657|NCT01254721|54563943|FG001|Overall Study|Death|1|||
27990105|NCT00868790|54648947|FG008|Period 1|Withdrawal by Subject|0|||
27990106|NCT00868790|54648948|FG009|Period 1|Withdrawal by Subject|0|||
27990107|NCT00868790|54648949|FG010|Period 1|Withdrawal by Subject|0|||
27990108|NCT00868790|54648950|FG011|Period 1|Withdrawal by Subject|0|||
27990109|NCT00868790|54648951|FG012|Period 1|Withdrawal by Subject|0|||
27990110|NCT00868790|54648952|FG013|Period 1|Withdrawal by Subject|1|||
27906658|NCT01254721|54563942|FG000|Overall Study|technical problum|1|||
27906659|NCT01254721|54563943|FG001|Overall Study|technical problum|0|||
27906660|NCT01254721|54563942|FG000|Overall Study|Adverse Event|2|||
27906661|NCT01254721|54563943|FG001|Overall Study|Adverse Event|3|||
27906662|NCT01254721|54563942|FG000|Overall Study|Withdrawal by Subject|8|||
27906663|NCT01254721|54563943|FG001|Overall Study|Withdrawal by Subject|11|||
27906664|NCT01254721|54563942|FG000|Overall Study|Wrongly randomization|0|||
27906665|NCT01254721|54563943|FG001|Overall Study|Wrongly randomization|1|||
27906666|NCT01254643|54563949|FG000|Overall Study|Withdrawal by Subject|1|||
27906667|NCT01254604|54563955|FG000|Overall Study|Lost to Follow-up|1|||
27990111|NCT00868790|54648939|FG000|Period 1|Abnormal Triglycerides|0|||
27990112|NCT00868790|54648940|FG001|Period 1|Abnormal Triglycerides|0|||
27906668|NCT01254604|54563956|FG001|Overall Study|Lost to Follow-up|1|||
27906669|NCT01254604|54563955|FG000|Overall Study|Protocol Violation|2|||
27990113|NCT00868790|54648941|FG002|Period 1|Abnormal Triglycerides|0|||
27990114|NCT00868790|54648942|FG003|Period 1|Abnormal Triglycerides|0|||
27990115|NCT00868790|54648943|FG004|Period 1|Abnormal Triglycerides|1|||
27990116|NCT00868790|54648944|FG005|Period 1|Abnormal Triglycerides|0|||
27990117|NCT00868790|54648945|FG006|Period 1|Abnormal Triglycerides|0|||
27990118|NCT00868790|54648946|FG007|Period 1|Abnormal Triglycerides|0|||
27990119|NCT00868790|54648947|FG008|Period 1|Abnormal Triglycerides|0|||
27990120|NCT00868790|54648948|FG009|Period 1|Abnormal Triglycerides|0|||
27990121|NCT00868790|54648949|FG010|Period 1|Abnormal Triglycerides|0|||
27990122|NCT00868790|54648950|FG011|Period 1|Abnormal Triglycerides|0|||
27990123|NCT00868790|54648951|FG012|Period 1|Abnormal Triglycerides|0|||
27990124|NCT00868790|54648952|FG013|Period 1|Abnormal Triglycerides|0|||
27990125|NCT00868790|54648939|FG000|Period 1|Lost to Follow-up|0|||
27990126|NCT00868790|54648940|FG001|Period 1|Lost to Follow-up|0|||
27990127|NCT00868790|54648941|FG002|Period 1|Lost to Follow-up|0|||
27990128|NCT00868790|54648942|FG003|Period 1|Lost to Follow-up|0|||
27990129|NCT00868790|54648943|FG004|Period 1|Lost to Follow-up|0|||
27990130|NCT00868790|54648944|FG005|Period 1|Lost to Follow-up|1|||
27990131|NCT00868790|54648945|FG006|Period 1|Lost to Follow-up|0|||
27990132|NCT00868790|54648946|FG007|Period 1|Lost to Follow-up|0|||
27990133|NCT00868790|54648947|FG008|Period 1|Lost to Follow-up|0|||
27990134|NCT00868790|54648948|FG009|Period 1|Lost to Follow-up|0|||
27990135|NCT00868790|54648949|FG010|Period 1|Lost to Follow-up|0|||
27990136|NCT00868790|54648950|FG011|Period 1|Lost to Follow-up|0|||
27990137|NCT00868790|54648951|FG012|Period 1|Lost to Follow-up|0|||
27990138|NCT00868790|54648952|FG013|Period 1|Lost to Follow-up|0|||
27990139|NCT00868790|54648939|FG000|Period 2|Adverse Event|0|||
27990140|NCT00868790|54648940|FG001|Period 2|Adverse Event|0|||
27990141|NCT00868790|54648941|FG002|Period 2|Adverse Event|0|||
27990142|NCT00868790|54648942|FG003|Period 2|Adverse Event|0|||
27906670|NCT01254604|54563956|FG001|Overall Study|Protocol Violation|2|||
27906671|NCT01254604|54563955|FG000|Overall Study|Withdrawal by Subject|2|||
27906672|NCT01254604|54563956|FG001|Overall Study|Withdrawal by Subject|4|||
27906673|NCT01254604|54563955|FG000|Overall Study|Adverse Event|3|||
27906674|NCT01254604|54563956|FG001|Overall Study|Adverse Event|2|||
27906675|NCT01254565|54563968|FG000|Overall Study|Non-compliance to Study Procedures|0|||
27906676|NCT01254565|54563969|FG001|Overall Study|Non-compliance to Study Procedures|0|||
27906677|NCT01254565|54563970|FG002|Overall Study|Non-compliance to Study Procedures|0|||
27906678|NCT01254565|54563971|FG003|Overall Study|Non-compliance to Study Procedures|0|||
27906679|NCT01254565|54563972|FG004|Overall Study|Non-compliance to Study Procedures|1|||
27906680|NCT01254565|54563973|FG005|Overall Study|Non-compliance to Study Procedures|0|||
27906681|NCT01254565|54563968|FG000|Overall Study|Did not Receive Treatment|1|||
27906682|NCT01254565|54563969|FG001|Overall Study|Did not Receive Treatment|1|||
27906683|NCT01254565|54563970|FG002|Overall Study|Did not Receive Treatment|0|||
27906684|NCT01254565|54563971|FG003|Overall Study|Did not Receive Treatment|0|||
27990143|NCT00868790|54648943|FG004|Period 2|Adverse Event|0|||
27990144|NCT00868790|54648944|FG005|Period 2|Adverse Event|0|||
27990145|NCT00868790|54648945|FG006|Period 2|Adverse Event|0|||
27990146|NCT00868790|54648946|FG007|Period 2|Adverse Event|0|||
27906685|NCT01254565|54563972|FG004|Overall Study|Did not Receive Treatment|3|||
27906686|NCT01254565|54563973|FG005|Overall Study|Did not Receive Treatment|4|||
27906687|NCT01254565|54563968|FG000|Overall Study|Other|0|||
27906688|NCT01254565|54563969|FG001|Overall Study|Other|0|||
27906689|NCT01254565|54563970|FG002|Overall Study|Other|0|||
27990147|NCT00868790|54648947|FG008|Period 2|Adverse Event|1|||
27990148|NCT00868790|54648948|FG009|Period 2|Adverse Event|0|||
27990149|NCT00868790|54648949|FG010|Period 2|Adverse Event|0|||
27990150|NCT00868790|54648950|FG011|Period 2|Adverse Event|0|||
27990151|NCT00868790|54648951|FG012|Period 2|Adverse Event|0|||
27906690|NCT01254565|54563971|FG003|Overall Study|Other|1|||
27990152|NCT00868790|54648952|FG013|Period 2|Adverse Event|0|||
27990153|NCT00868790|54648939|FG000|Period 2|Lost to Follow-up|0|||
27990154|NCT00868790|54648940|FG001|Period 2|Lost to Follow-up|1|||
27990155|NCT00868790|54648941|FG002|Period 2|Lost to Follow-up|0|||
27990156|NCT00868790|54648942|FG003|Period 2|Lost to Follow-up|0|||
27906691|NCT01254565|54563972|FG004|Overall Study|Other|0|||
27990157|NCT00868790|54648943|FG004|Period 2|Lost to Follow-up|0|||
27990158|NCT00868790|54648944|FG005|Period 2|Lost to Follow-up|1|||
27990159|NCT00868790|54648945|FG006|Period 2|Lost to Follow-up|0|||
27990160|NCT00868790|54648946|FG007|Period 2|Lost to Follow-up|0|||
27990161|NCT00868790|54648947|FG008|Period 2|Lost to Follow-up|0|||
27990162|NCT00868790|54648948|FG009|Period 2|Lost to Follow-up|0|||
27990163|NCT00868790|54648949|FG010|Period 2|Lost to Follow-up|0|||
27990164|NCT00868790|54648950|FG011|Period 2|Lost to Follow-up|0|||
27990165|NCT00868790|54648951|FG012|Period 2|Lost to Follow-up|0|||
27990166|NCT00868790|54648952|FG013|Period 2|Lost to Follow-up|0|||
27990167|NCT00868790|54648939|FG000|Period 2|Withdrawal by Subject|0|||
27990168|NCT00868790|54648940|FG001|Period 2|Withdrawal by Subject|0|||
27990169|NCT00868790|54648941|FG002|Period 2|Withdrawal by Subject|0|||
27990170|NCT00868790|54648942|FG003|Period 2|Withdrawal by Subject|0|||
27990171|NCT00868790|54648943|FG004|Period 2|Withdrawal by Subject|0|||
27990172|NCT00868790|54648944|FG005|Period 2|Withdrawal by Subject|0|||
27990173|NCT00868790|54648945|FG006|Period 2|Withdrawal by Subject|0|||
27990174|NCT00868790|54648946|FG007|Period 2|Withdrawal by Subject|0|||
27990175|NCT00868790|54648947|FG008|Period 2|Withdrawal by Subject|1|||
27990176|NCT00868790|54648948|FG009|Period 2|Withdrawal by Subject|0|||
27990177|NCT00868790|54648949|FG010|Period 2|Withdrawal by Subject|0|||
27990178|NCT00868790|54648950|FG011|Period 2|Withdrawal by Subject|0|||
27990179|NCT00868790|54648951|FG012|Period 2|Withdrawal by Subject|0|||
27990180|NCT00868790|54648952|FG013|Period 2|Withdrawal by Subject|1|||
27990181|NCT00868790|54648939|FG000|Period 3|Adverse Event|0|||
27990182|NCT00868790|54648940|FG001|Period 3|Adverse Event|0|||
27990183|NCT00868790|54648941|FG002|Period 3|Adverse Event|0|||
27990184|NCT00868790|54648942|FG003|Period 3|Adverse Event|0|||
27990185|NCT00868790|54648943|FG004|Period 3|Adverse Event|0|||
27990186|NCT00868790|54648944|FG005|Period 3|Adverse Event|0|||
27990187|NCT00868790|54648945|FG006|Period 3|Adverse Event|0|||
27990188|NCT00868790|54648946|FG007|Period 3|Adverse Event|0|||
27990189|NCT00868790|54648947|FG008|Period 3|Adverse Event|0|||
27990190|NCT00868790|54648948|FG009|Period 3|Adverse Event|1|||
27990191|NCT00868790|54648949|FG010|Period 3|Adverse Event|0|||
27990192|NCT00868790|54648950|FG011|Period 3|Adverse Event|0|||
27990193|NCT00868790|54648951|FG012|Period 3|Adverse Event|0|||
27990194|NCT00868790|54648952|FG013|Period 3|Adverse Event|0|||
27990195|NCT00868790|54648939|FG000|Period 3|Protocol Violation|0|||
27990196|NCT00868790|54648940|FG001|Period 3|Protocol Violation|0|||
27990197|NCT00868790|54648941|FG002|Period 3|Protocol Violation|0|||
27990198|NCT00868790|54648942|FG003|Period 3|Protocol Violation|0|||
27990199|NCT00868790|54648943|FG004|Period 3|Protocol Violation|0|||
27990200|NCT00868790|54648944|FG005|Period 3|Protocol Violation|0|||
27906692|NCT01254565|54563973|FG005|Overall Study|Other|0|||
27906693|NCT01254409|54563991|FG000|Overall Study|Adverse Event|0|||
27906694|NCT01254409|54563992|FG001|Overall Study|Adverse Event|1|||
27906695|NCT01254409|54563993|FG002|Overall Study|Adverse Event|0|||
27906696|NCT01254409|54563994|FG003|Overall Study|Adverse Event|0|||
27906697|NCT01254331|54564007|FG000|Initial Phase|Adverse Event|3|||
27906698|NCT01254331|54564007|FG000|Initial Phase|Withdrawal by Subject|1|||
27906699|NCT01254331|54564007|FG000|Initial Phase|Pregnancy|1|||
27906700|NCT01254331|54564007|FG000|Extension Phase|Lack of Efficacy|1|||
27906701|NCT01254331|54564007|FG000|Extension Phase|Lost to Follow-up|3|||
27990201|NCT00868790|54648945|FG006|Period 3|Protocol Violation|0|||
27990202|NCT00868790|54648946|FG007|Period 3|Protocol Violation|0|||
27990203|NCT00868790|54648947|FG008|Period 3|Protocol Violation|0|||
27990204|NCT00868790|54648948|FG009|Period 3|Protocol Violation|0|||
27990205|NCT00868790|54648949|FG010|Period 3|Protocol Violation|1|||
27990206|NCT00868790|54648950|FG011|Period 3|Protocol Violation|0|||
27990207|NCT00868790|54648951|FG012|Period 3|Protocol Violation|0|||
27990208|NCT00868790|54648952|FG013|Period 3|Protocol Violation|0|||
27906702|NCT01254292|54564022|FG000|Comparative Phase|Adverse Event|25|||
27906703|NCT01254292|54564023|FG001|Comparative Phase|Adverse Event|25|||
27906704|NCT01254292|54564022|FG000|Comparative Phase|Lost to Follow-up|3|||
27990209|NCT00868790|54648939|FG000|Period 3|Study Terminated by Sponsor|0|||
27990210|NCT00868790|54648940|FG001|Period 3|Study Terminated by Sponsor|0|||
27990211|NCT00868790|54648941|FG002|Period 3|Study Terminated by Sponsor|0|||
27990212|NCT00868790|54648942|FG003|Period 3|Study Terminated by Sponsor|1|||
27990213|NCT00868790|54648943|FG004|Period 3|Study Terminated by Sponsor|0|||
27990214|NCT00868790|54648944|FG005|Period 3|Study Terminated by Sponsor|0|||
27990215|NCT00868790|54648945|FG006|Period 3|Study Terminated by Sponsor|0|||
27990216|NCT00868790|54648946|FG007|Period 3|Study Terminated by Sponsor|0|||
27990217|NCT00868790|54648947|FG008|Period 3|Study Terminated by Sponsor|0|||
27990218|NCT00868790|54648948|FG009|Period 3|Study Terminated by Sponsor|0|||
27990219|NCT00868790|54648949|FG010|Period 3|Study Terminated by Sponsor|0|||
27990220|NCT00868790|54648950|FG011|Period 3|Study Terminated by Sponsor|0|||
27990221|NCT00868790|54648951|FG012|Period 3|Study Terminated by Sponsor|0|||
27990222|NCT00868790|54648952|FG013|Period 3|Study Terminated by Sponsor|0|||
27906705|NCT01254292|54564023|FG001|Comparative Phase|Lost to Follow-up|21|||
27906706|NCT01254292|54564022|FG000|Comparative Phase|Pregnancy|2|||
27906707|NCT01254292|54564023|FG001|Comparative Phase|Pregnancy|6|||
27990223|NCT00868790|54648939|FG000|Period 4|Adverse Event|0|||
27990224|NCT00868790|54648940|FG001|Period 4|Adverse Event|0|||
27990225|NCT00868790|54648941|FG002|Period 4|Adverse Event|0|||
27990226|NCT00868790|54648942|FG003|Period 4|Adverse Event|0|||
27990227|NCT00868790|54648943|FG004|Period 4|Adverse Event|0|||
27990228|NCT00868790|54648944|FG005|Period 4|Adverse Event|0|||
27990229|NCT00868790|54648945|FG006|Period 4|Adverse Event|0|||
27990230|NCT00868790|54648946|FG007|Period 4|Adverse Event|1|||
27990231|NCT00868790|54648947|FG008|Period 4|Adverse Event|0|||
27990232|NCT00868790|54648948|FG009|Period 4|Adverse Event|0|||
27990233|NCT00868790|54648949|FG010|Period 4|Adverse Event|1|||
27990234|NCT00868790|54648950|FG011|Period 4|Adverse Event|0|||
27990235|NCT00868790|54648951|FG012|Period 4|Adverse Event|1|||
27990236|NCT00868790|54648952|FG013|Period 4|Adverse Event|0|||
27990237|NCT00868790|54648939|FG000|Period 4|Lost to Follow-up|0|||
27990238|NCT00868790|54648940|FG001|Period 4|Lost to Follow-up|0|||
27990239|NCT00868790|54648941|FG002|Period 4|Lost to Follow-up|0|||
27990240|NCT00868790|54648942|FG003|Period 4|Lost to Follow-up|0|||
27990241|NCT00868790|54648943|FG004|Period 4|Lost to Follow-up|0|||
27990242|NCT00868790|54648944|FG005|Period 4|Lost to Follow-up|0|||
27990243|NCT00868790|54648945|FG006|Period 4|Lost to Follow-up|0|||
27990244|NCT00868790|54648946|FG007|Period 4|Lost to Follow-up|1|||
27990245|NCT00868790|54648947|FG008|Period 4|Lost to Follow-up|0|||
27990246|NCT00868790|54648948|FG009|Period 4|Lost to Follow-up|0|||
27990247|NCT00868790|54648949|FG010|Period 4|Lost to Follow-up|0|||
27990248|NCT00868790|54648950|FG011|Period 4|Lost to Follow-up|0|||
27906708|NCT01254292|54564022|FG000|Comparative Phase|Withdrawal by Subject|20|||
27906709|NCT01254292|54564023|FG001|Comparative Phase|Withdrawal by Subject|21|||
27906710|NCT01254292|54564022|FG000|Comparative Phase|Protocol Violation|1|||
27906711|NCT01254292|54564023|FG001|Comparative Phase|Protocol Violation|2|||
27906712|NCT01254292|54564022|FG000|Comparative Phase|Wish for pregnancy|4|||
27906713|NCT01254292|54564023|FG001|Comparative Phase|Wish for pregnancy|6|||
27906714|NCT01254292|54564022|FG000|LCS12 Extension Phase|Wish for pregnancy|14|||
27906715|NCT01254292|54564023|FG001|LCS12 Extension Phase|Wish for pregnancy|0|||
27906716|NCT01254292|54564022|FG000|LCS12 Extension Phase|Adverse Event|9|||
27906717|NCT01254292|54564023|FG001|LCS12 Extension Phase|Adverse Event|0|||
27906718|NCT01254292|54564022|FG000|LCS12 Extension Phase|Withdrawal by Subject|7|||
27906719|NCT01254292|54564023|FG001|LCS12 Extension Phase|Withdrawal by Subject|0|||
27906720|NCT01254292|54564022|FG000|LCS12 Extension Phase|Other unknown|4|||
27906721|NCT01254292|54564023|FG001|LCS12 Extension Phase|Other unknown|0|||
27906722|NCT01254292|54564022|FG000|LCS12 Extension Phase|Pregnancy|2|||
27906723|NCT01254292|54564023|FG001|LCS12 Extension Phase|Pregnancy|0|||
27906724|NCT01254292|54564022|FG000|LCS12 Extension Phase|Lost to Follow-up|1|||
27906725|NCT01254292|54564023|FG001|LCS12 Extension Phase|Lost to Follow-up|0|||
27906726|NCT01254019|54564032|FG000|Overall Study|Adverse Event|0|||
27906727|NCT01254019|54564033|FG001|Overall Study|Adverse Event|2|||
27906728|NCT01254019|54564032|FG000|Overall Study|Protocol Violation|1|||
27906729|NCT01254019|54564033|FG001|Overall Study|Protocol Violation|0|||
27906730|NCT01254019|54564032|FG000|Overall Study|Withdrawal by Subject|0|||
27906731|NCT01254019|54564033|FG001|Overall Study|Withdrawal by Subject|2|||
27906732|NCT01253317|54564042|FG000|Overall Study|Adverse Event|2|||
27906733|NCT01253200|54564055|FG000|Overall Study|Death|1|||
27906734|NCT01253200|54564056|FG001|Overall Study|Death|0|||
27906735|NCT01253200|54564057|FG002|Overall Study|Death|0|||
27990249|NCT00868790|54648951|FG012|Period 4|Lost to Follow-up|0|||
27990250|NCT00868790|54648952|FG013|Period 4|Lost to Follow-up|0|||
27990251|NCT00868790|54648939|FG000|Period 4|Study Terminated by Sponsor|2|||
27990252|NCT00868790|54648940|FG001|Period 4|Study Terminated by Sponsor|0|||
27990253|NCT00868790|54648941|FG002|Period 4|Study Terminated by Sponsor|0|||
27990254|NCT00868790|54648942|FG003|Period 4|Study Terminated by Sponsor|0|||
27990255|NCT00868790|54648943|FG004|Period 4|Study Terminated by Sponsor|0|||
27990256|NCT00868790|54648944|FG005|Period 4|Study Terminated by Sponsor|0|||
27990257|NCT00868790|54648945|FG006|Period 4|Study Terminated by Sponsor|0|||
27990258|NCT00868790|54648946|FG007|Period 4|Study Terminated by Sponsor|1|||
27990259|NCT00868790|54648947|FG008|Period 4|Study Terminated by Sponsor|2|||
27990260|NCT00868790|54648948|FG009|Period 4|Study Terminated by Sponsor|0|||
27990261|NCT00868790|54648949|FG010|Period 4|Study Terminated by Sponsor|2|||
27990262|NCT00868790|54648950|FG011|Period 4|Study Terminated by Sponsor|1|||
27990263|NCT00868790|54648951|FG012|Period 4|Study Terminated by Sponsor|0|||
27990264|NCT00868790|54648952|FG013|Period 4|Study Terminated by Sponsor|1|||
27990265|NCT00868790|54648939|FG000|Period 4|Abnormal ALT/AST|0|||
27990266|NCT00868790|54648940|FG001|Period 4|Abnormal ALT/AST|0|||
27990267|NCT00868790|54648941|FG002|Period 4|Abnormal ALT/AST|1|||
27906736|NCT01253200|54564058|FG003|Overall Study|Death|0|||
27906737|NCT01253200|54564059|FG004|Overall Study|Death|0|||
27906738|NCT01253200|54564055|FG000|Overall Study|Lost to Follow-up|1|||
27906739|NCT01253200|54564056|FG001|Overall Study|Lost to Follow-up|1|||
27906740|NCT01253200|54564057|FG002|Overall Study|Lost to Follow-up|0|||
27906741|NCT01253200|54564058|FG003|Overall Study|Lost to Follow-up|0|||
27906742|NCT01253200|54564059|FG004|Overall Study|Lost to Follow-up|0|||
27906743|NCT01253200|54564055|FG000|Overall Study|Withdrawal by Subject|2|||
27906744|NCT01253200|54564056|FG001|Overall Study|Withdrawal by Subject|0|||
27906745|NCT01253200|54564057|FG002|Overall Study|Withdrawal by Subject|0|||
27906746|NCT01253200|54564058|FG003|Overall Study|Withdrawal by Subject|0|||
27906747|NCT01253200|54564059|FG004|Overall Study|Withdrawal by Subject|0|||
27906748|NCT01253200|54564055|FG000|Overall Study|Protocol Violation|1|||
27906749|NCT01253200|54564056|FG001|Overall Study|Protocol Violation|4|||
27906750|NCT01253200|54564057|FG002|Overall Study|Protocol Violation|0|||
27906751|NCT01253200|54564058|FG003|Overall Study|Protocol Violation|0|||
27906752|NCT01253200|54564059|FG004|Overall Study|Protocol Violation|5|||
27990268|NCT00868790|54648942|FG003|Period 4|Abnormal ALT/AST|0|||
27990269|NCT00868790|54648943|FG004|Period 4|Abnormal ALT/AST|0|||
27990270|NCT00868790|54648944|FG005|Period 4|Abnormal ALT/AST|0|||
27990271|NCT00868790|54648945|FG006|Period 4|Abnormal ALT/AST|0|||
27990272|NCT00868790|54648946|FG007|Period 4|Abnormal ALT/AST|0|||
27990273|NCT00868790|54648947|FG008|Period 4|Abnormal ALT/AST|0|||
27990274|NCT00868790|54648948|FG009|Period 4|Abnormal ALT/AST|0|||
27990275|NCT00868790|54648949|FG010|Period 4|Abnormal ALT/AST|0|||
27990276|NCT00868790|54648950|FG011|Period 4|Abnormal ALT/AST|0|||
27990277|NCT00868790|54648951|FG012|Period 4|Abnormal ALT/AST|0|||
27990278|NCT00868790|54648952|FG013|Period 4|Abnormal ALT/AST|0|||
27906753|NCT01253200|54564055|FG000|Overall Study|intents|10|||
27906754|NCT01253200|54564056|FG001|Overall Study|intents|10|||
27906755|NCT01253200|54564057|FG002|Overall Study|intents|1|||
27906756|NCT01253200|54564058|FG003|Overall Study|intents|3|||
27906757|NCT01253200|54564059|FG004|Overall Study|intents|0|||
27906758|NCT01253200|54564055|FG000|Overall Study|Attempts|6|||
27906759|NCT01253200|54564056|FG001|Overall Study|Attempts|4|||
27906760|NCT01253200|54564057|FG002|Overall Study|Attempts|1|||
27906761|NCT01253200|54564058|FG003|Overall Study|Attempts|2|||
27906762|NCT01253200|54564059|FG004|Overall Study|Attempts|0|||
27906763|NCT01253044|54564070|FG000|Overall Study|Lost to Follow-up|38|||
27906764|NCT01253044|54564071|FG001|Overall Study|Lost to Follow-up|29|||
27906765|NCT01252966|54564079|FG000|Overall Study|Lost to Follow-up|16|||
27906766|NCT01252966|54564080|FG001|Overall Study|Lost to Follow-up|10|||
27906767|NCT01252966|54564079|FG000|Overall Study|Withdrawal by Subject|7|||
27906768|NCT01252966|54564080|FG001|Overall Study|Withdrawal by Subject|3|||
27906769|NCT01252810|54564090|FG000|Overall Study|Withdrawal by Subject|4|||
27906770|NCT01252810|54564091|FG001|Overall Study|Withdrawal by Subject|1|||
27906771|NCT01252810|54564090|FG000|Overall Study|Lost to Follow-up|0|||
27906772|NCT01252810|54564091|FG001|Overall Study|Lost to Follow-up|1|||
27906773|NCT01252810|54564090|FG000|Overall Study|Physician Decision|2|||
27906774|NCT01252810|54564091|FG001|Overall Study|Physician Decision|1|||
27906775|NCT01252810|54564090|FG000|Overall Study|Various reasons|8|||
27906776|NCT01252810|54564091|FG001|Overall Study|Various reasons|0|||
27906777|NCT01252186|54564100|FG000|Overall Study|Adverse Event|9|||
27906778|NCT01252186|54564101|FG001|Overall Study|Adverse Event|6|||
27906779|NCT01252186|54564102|FG002|Overall Study|Adverse Event|8|||
27906780|NCT01252186|54564100|FG000|Overall Study|Withdrawal by Subject|2|||
27906781|NCT01252186|54564101|FG001|Overall Study|Withdrawal by Subject|5|||
27906782|NCT01252186|54564102|FG002|Overall Study|Withdrawal by Subject|2|||
27906783|NCT01252186|54564100|FG000|Overall Study|Physician Decision|0|||
27906784|NCT01252186|54564101|FG001|Overall Study|Physician Decision|0|||
27906785|NCT01252186|54564102|FG002|Overall Study|Physician Decision|1|||
27906786|NCT01252186|54564100|FG000|Overall Study|Non-compliance|0|||
27906787|NCT01252186|54564101|FG001|Overall Study|Non-compliance|3|||
27906788|NCT01252186|54564102|FG002|Overall Study|Non-compliance|4|||
27906789|NCT01252186|54564100|FG000|Overall Study|Protocol Violation|0|||
27906790|NCT01252186|54564101|FG001|Overall Study|Protocol Violation|0|||
27906791|NCT01252186|54564102|FG002|Overall Study|Protocol Violation|1|||
27906792|NCT01252186|54564100|FG000|Overall Study|Pregnancy|2|||
27906793|NCT01252186|54564101|FG001|Overall Study|Pregnancy|2|||
27990279|NCT00868790|54648939|FG000|Post-study|Withdrawal by Subject|0|||
27990280|NCT00868790|54648940|FG001|Post-study|Withdrawal by Subject|0|||
27906794|NCT01252186|54564102|FG002|Overall Study|Pregnancy|0|||
27990281|NCT00868790|54648941|FG002|Post-study|Withdrawal by Subject|0|||
28097674|NCT00090519|54753410|FG000|Overall Study|Lost to Follow-up|26|||
28097675|NCT00090519|54753411|FG001|Overall Study|Lost to Follow-up|29|||
27906795|NCT01252186|54564100|FG000|Overall Study|Sponsor Request|2|||
27906796|NCT01252186|54564101|FG001|Overall Study|Sponsor Request|1|||
27906797|NCT01252186|54564102|FG002|Overall Study|Sponsor Request|0|||
27906798|NCT01252186|54564100|FG000|Overall Study|Lost to Follow-up|10|||
27906799|NCT01252186|54564101|FG001|Overall Study|Lost to Follow-up|10|||
27990282|NCT00868790|54648942|FG003|Post-study|Withdrawal by Subject|0|||
27990283|NCT00868790|54648943|FG004|Post-study|Withdrawal by Subject|1|||
27990284|NCT00868790|54648944|FG005|Post-study|Withdrawal by Subject|0|||
27906800|NCT01252186|54564102|FG002|Overall Study|Lost to Follow-up|11|||
27906801|NCT01252186|54564100|FG000|Overall Study|Other - Miscellaneous Reasons|5|||
27906802|NCT01252186|54564101|FG001|Overall Study|Other - Miscellaneous Reasons|5|||
27906803|NCT01252186|54564102|FG002|Overall Study|Other - Miscellaneous Reasons|7|||
27906804|NCT01251952|54564137|FG000|Overall Study|Adverse Event|1|||
27990285|NCT00868790|54648945|FG006|Post-study|Withdrawal by Subject|0|||
27906805|NCT01251367|54564141|FG000|Overall Study|Protocol Violation|1|||
27906806|NCT01251367|54564141|FG000|Overall Study|Lack of Efficacy|2|||
27906807|NCT01251367|54564141|FG000|Overall Study|Adverse Event|19|||
27906808|NCT01251367|54564141|FG000|Overall Study|Withdrawal by Subject|36|||
27906809|NCT01251367|54564141|FG000|Overall Study|Lost to Follow-up|5|||
27906810|NCT01251367|54564141|FG000|Overall Study|Subject Required Alternative Treatment|7|||
27906811|NCT01251367|54564141|FG000|Overall Study|No Study Drug Available|1|||
27906812|NCT01251367|54564141|FG000|Overall Study|Subject had Personal or Medical Issues|4|||
27990286|NCT00868790|54648946|FG007|Post-study|Withdrawal by Subject|0|||
27990287|NCT00868790|54648947|FG008|Post-study|Withdrawal by Subject|0|||
27990288|NCT00868790|54648948|FG009|Post-study|Withdrawal by Subject|0|||
27990289|NCT00868790|54648949|FG010|Post-study|Withdrawal by Subject|0|||
27990290|NCT00868790|54648950|FG011|Post-study|Withdrawal by Subject|0|||
27990291|NCT00868790|54648951|FG012|Post-study|Withdrawal by Subject|0|||
27990292|NCT00868790|54648952|FG013|Post-study|Withdrawal by Subject|0|||
27990293|NCT00868790|54648939|FG000|Post-study|Excluded Medication|0|||
27990294|NCT00868790|54648940|FG001|Post-study|Excluded Medication|0|||
27990295|NCT00868790|54648941|FG002|Post-study|Excluded Medication|0|||
27990296|NCT00868790|54648942|FG003|Post-study|Excluded Medication|0|||
27990297|NCT00868790|54648943|FG004|Post-study|Excluded Medication|0|||
27990298|NCT00868790|54648944|FG005|Post-study|Excluded Medication|0|||
27990299|NCT00868790|54648945|FG006|Post-study|Excluded Medication|0|||
27990300|NCT00868790|54648946|FG007|Post-study|Excluded Medication|2|||
27990301|NCT00868790|54648947|FG008|Post-study|Excluded Medication|0|||
27990302|NCT00868790|54648948|FG009|Post-study|Excluded Medication|1|||
27990303|NCT00868790|54648949|FG010|Post-study|Excluded Medication|0|||
27990304|NCT00868790|54648950|FG011|Post-study|Excluded Medication|0|||
27990305|NCT00868790|54648951|FG012|Post-study|Excluded Medication|0|||
27990306|NCT00868790|54648952|FG013|Post-study|Excluded Medication|0|||
27990307|NCT00496483|54648968|FG000|Overall Study|Not dosed|9|||
27990308|NCT00496483|54648968|FG000|Overall Study|Adverse Event|2|||
27990309|NCT00496483|54648968|FG000|Overall Study|Lack of Efficacy|1|||
27990310|NCT03528551|54648978|FG000|Overall Study|Lost to Follow-up|0|||
27990311|NCT03528551|54648979|FG001|Overall Study|Lost to Follow-up|1|||
27990312|NCT03528551|54648980|FG002|Overall Study|Lost to Follow-up|0|||
27990313|NCT03528551|54648978|FG000|Overall Study|Transferred to other arm/group|2|||
27990314|NCT03528551|54648979|FG001|Overall Study|Transferred to other arm/group|3|||
27990315|NCT03528551|54648980|FG002|Overall Study|Transferred to other arm/group|0|||
27990316|NCT03528551|54648978|FG000|Overall Study|Withdrawal by parent/guardian|0|||
27990317|NCT03528551|54648979|FG001|Overall Study|Withdrawal by parent/guardian|5|||
27990318|NCT03528551|54648980|FG002|Overall Study|Withdrawal by parent/guardian|0|||
27990319|NCT03528551|54648978|FG000|Overall Study|Protocol Violation|0|||
27990320|NCT03528551|54648979|FG001|Overall Study|Protocol Violation|3|||
27990321|NCT03528551|54648980|FG002|Overall Study|Protocol Violation|0|||
27990322|NCT03528551|54648978|FG000|Overall Study|Withdrawal by Subject|0|||
27990323|NCT03528551|54648979|FG001|Overall Study|Withdrawal by Subject|7|||
27990324|NCT03528551|54648980|FG002|Overall Study|Withdrawal by Subject|0|||
27990325|NCT00487981|54648989|FG000|Overall Study|Hypothyroidism diagnosis|1|||
27990326|NCT00861744|54648997|FG000|Overall Study|Adverse Event|0|||
27990327|NCT00861744|54648998|FG001|Overall Study|Adverse Event|0|||
27990328|NCT00861744|54648999|FG002|Overall Study|Adverse Event|0|||
27990329|NCT00861744|54649000|FG003|Overall Study|Adverse Event|1|||
27990330|NCT00861744|54648997|FG000|Overall Study|Lost to Follow-up|7|||
27990331|NCT00861744|54648998|FG001|Overall Study|Lost to Follow-up|19|||
27990332|NCT00861744|54648999|FG002|Overall Study|Lost to Follow-up|17|||
27990333|NCT00861744|54649000|FG003|Overall Study|Lost to Follow-up|12|||
27990334|NCT00861744|54648997|FG000|Overall Study|Withdrawal by Subject|10|||
27990335|NCT00861744|54648998|FG001|Overall Study|Withdrawal by Subject|6|||
27990336|NCT00861744|54648999|FG002|Overall Study|Withdrawal by Subject|6|||
27990337|NCT00861744|54649000|FG003|Overall Study|Withdrawal by Subject|19|||
27990338|NCT00861744|54648997|FG000|Overall Study|Protocol Violation|0|||
27990339|NCT00861744|54648998|FG001|Overall Study|Protocol Violation|1|||
27990340|NCT00861744|54648999|FG002|Overall Study|Protocol Violation|0|||
27990341|NCT00861744|54649000|FG003|Overall Study|Protocol Violation|0|||
27990342|NCT00861744|54648997|FG000|Overall Study|Migration from study area|0|||
27990343|NCT00861744|54648998|FG001|Overall Study|Migration from study area|3|||
27990344|NCT00861744|54648999|FG002|Overall Study|Migration from study area|1|||
27906813|NCT01251367|54564141|FG000|Overall Study|End of Study Visit Performed in Error|1|||
27906814|NCT01250509|54564147|FG000|Overall Study|Lost to Follow-up|5|||
27990345|NCT00861744|54649000|FG003|Overall Study|Migration from study area|0|||
27990346|NCT00861744|54648997|FG000|Overall Study|Blood draws|0|||
27990347|NCT00861744|54648998|FG001|Overall Study|Blood draws|0|||
27990348|NCT00861744|54648999|FG002|Overall Study|Blood draws|0|||
27990349|NCT00861744|54649000|FG003|Overall Study|Blood draws|1|||
27990350|NCT00603239|54649012|FG000|Overall Study|Adverse Event|4|||
27990351|NCT00603239|54649013|FG001|Overall Study|Adverse Event|1|||
27990352|NCT00603239|54649012|FG000|Overall Study|Entry criteria not met|0|||
27990353|NCT00603239|54649013|FG001|Overall Study|Entry criteria not met|1|||
27906815|NCT01250509|54564148|FG001|Overall Study|Lost to Follow-up|2|||
27906816|NCT01250119|54564156|FG000|Diagnostic Phase|Failed to Produce a Test Results|69|||
27906817|NCT01250119|54564157|FG001|Diagnostic Phase|Failed to Produce a Test Results|0|||
27906818|NCT01250119|54564156|FG000|Diagnostic Phase|Participants Not Tested|44|||
27906819|NCT01250119|54564157|FG001|Diagnostic Phase|Participants Not Tested|0|||
27906820|NCT01250119|54564156|FG000|Treatment Phase|Progressive Disease|0|||
27906821|NCT01250119|54564157|FG001|Treatment Phase|Progressive Disease|32|||
27906822|NCT01250119|54564156|FG000|Treatment Phase|Death|0|||
27906823|NCT01250119|54564157|FG001|Treatment Phase|Death|2|||
27906824|NCT01250119|54564156|FG000|Treatment Phase|Withdrawal by Subject|0|||
27906825|NCT01250119|54564157|FG001|Treatment Phase|Withdrawal by Subject|1|||
27906826|NCT01250119|54564156|FG000|Treatment Phase|Adverse Event|0|||
27906827|NCT01250119|54564157|FG001|Treatment Phase|Adverse Event|2|||
27906828|NCT01250119|54564156|FG000|Treatment Phase|Unknown reason|0|||
27906829|NCT01250119|54564157|FG001|Treatment Phase|Unknown reason|4|||
27906830|NCT01250002|54564166|FG000|Overall Study|Change to open surgical procedure|4|||
27906831|NCT01250002|54564167|FG001|Overall Study|Change to open surgical procedure|3|||
27906832|NCT01246960|54564175|FG000|Overall Study|Lost to Follow-up|3|||
27906833|NCT01246960|54564176|FG001|Overall Study|Lost to Follow-up|1|||
27906834|NCT01246960|54564175|FG000|Overall Study|Withdrawal (by participant or physician)|3|||
27906835|NCT01246960|54564176|FG001|Overall Study|Withdrawal (by participant or physician)|3|||
27906836|NCT01244620|54564182|FG000|Overall Study|Study terminated|4|||
27906837|NCT01244620|54564183|FG001|Overall Study|Study terminated|4|||
27906838|NCT01244620|54564184|FG002|Overall Study|Study terminated|4|||
27906839|NCT01244620|54564185|FG003|Overall Study|Study terminated|4|||
27906840|NCT01267201|54564195|FG000|First Intervention Period|Withdrawal by Subject|1|||
27906841|NCT01267201|54564196|FG001|First Intervention Period|Withdrawal by Subject|0|||
27906842|NCT01267201|54564197|FG002|First Intervention Period|Withdrawal by Subject|0|||
27906843|NCT01267201|54564198|FG003|First Intervention Period|Withdrawal by Subject|0|||
27906844|NCT01267201|54564199|FG004|First Intervention Period|Withdrawal by Subject|0|||
27906845|NCT01267201|54564200|FG005|First Intervention Period|Withdrawal by Subject|0|||
27906846|NCT01267201|54564195|FG000|Second Intervention Period|Withdrawal by Subject|0|||
27906847|NCT01267201|54564196|FG001|Second Intervention Period|Withdrawal by Subject|1|||
27906848|NCT01267201|54564197|FG002|Second Intervention Period|Withdrawal by Subject|0|||
27906849|NCT01267201|54564198|FG003|Second Intervention Period|Withdrawal by Subject|0|||
27906850|NCT01267201|54564199|FG004|Second Intervention Period|Withdrawal by Subject|0|||
27906851|NCT01267201|54564200|FG005|Second Intervention Period|Withdrawal by Subject|0|||
27906852|NCT01266967|54564210|FG000|Overall Study|Death|69|||
27906853|NCT01266967|54564211|FG001|Overall Study|Death|61|||
27906854|NCT01266967|54564210|FG000|Overall Study|Study Closed/Terminated|15|||
27906855|NCT01266967|54564211|FG001|Overall Study|Study Closed/Terminated|17|||
27906856|NCT01266967|54564210|FG000|Overall Study|Lost to Follow-up|2|||
27906857|NCT01266967|54564211|FG001|Overall Study|Lost to Follow-up|1|||
27906858|NCT01266967|54564210|FG000|Overall Study|Physician Decision|0|||
27906859|NCT01266967|54564211|FG001|Overall Study|Physician Decision|1|||
27906860|NCT01266967|54564210|FG000|Overall Study|Withdrawal by Subject|3|||
27906861|NCT01266967|54564211|FG001|Overall Study|Withdrawal by Subject|3|||
27906862|NCT01266850|54564225|FG000|Overall Study|Lost to Follow-up|19|||
27906863|NCT01266850|54564226|FG001|Overall Study|Lost to Follow-up|19|||
27906864|NCT01266850|54564227|FG002|Overall Study|Lost to Follow-up|13|||
27906865|NCT01266850|54564228|FG003|Overall Study|Lost to Follow-up|13|||
27906866|NCT01266850|54564229|FG004|Overall Study|Lost to Follow-up|12|||
27906867|NCT01266850|54564225|FG000|Overall Study|Withdrawal by Subject|8|||
27906868|NCT01266850|54564226|FG001|Overall Study|Withdrawal by Subject|9|||
27990354|NCT00603239|54649012|FG000|Overall Study|Loss of glucose control|3|||
27990355|NCT00603239|54649013|FG001|Overall Study|Loss of glucose control|0|||
27990356|NCT00603239|54649012|FG000|Overall Study|Lost to Follow-up|2|||
27990357|NCT00603239|54649013|FG001|Overall Study|Lost to Follow-up|1|||
27990358|NCT00603239|54649012|FG000|Overall Study|Physician Decision|2|||
27990359|NCT00603239|54649013|FG001|Overall Study|Physician Decision|0|||
27990360|NCT00603239|54649012|FG000|Overall Study|Protocol Violation|2|||
27990361|NCT00603239|54649013|FG001|Overall Study|Protocol Violation|0|||
27990362|NCT00603239|54649012|FG000|Overall Study|Subject decision|2|||
27990363|NCT00603239|54649013|FG001|Overall Study|Subject decision|1|||
27990364|NCT00852930|54649022|FG000|Overall Study|Withdrawal by Subject|1|||
27990365|NCT00852930|54649023|FG001|Overall Study|Withdrawal by Subject|1|||
27906869|NCT01266850|54564227|FG002|Overall Study|Withdrawal by Subject|6|||
27906870|NCT01266850|54564228|FG003|Overall Study|Withdrawal by Subject|9|||
27906871|NCT01266850|54564229|FG004|Overall Study|Withdrawal by Subject|12|||
27906872|NCT01266850|54564225|FG000|Overall Study|Physician Decision|3|||
27906873|NCT01266850|54564226|FG001|Overall Study|Physician Decision|6|||
27906874|NCT01266850|54564227|FG002|Overall Study|Physician Decision|4|||
27906875|NCT01266850|54564228|FG003|Overall Study|Physician Decision|4|||
27906876|NCT01266850|54564229|FG004|Overall Study|Physician Decision|3|||
27906877|NCT01266850|54564225|FG000|Overall Study|Protocol Violation|0|||
27990366|NCT00852930|54649024|FG002|Overall Study|Withdrawal by Subject|1|||
27990367|NCT00852930|54649022|FG000|Overall Study|Physician Decision|0|||
27906878|NCT01266850|54564226|FG001|Overall Study|Protocol Violation|1|||
27906879|NCT01266850|54564227|FG002|Overall Study|Protocol Violation|0|||
27906880|NCT01266850|54564228|FG003|Overall Study|Protocol Violation|1|||
27906881|NCT01266850|54564229|FG004|Overall Study|Protocol Violation|2|||
27906882|NCT01266850|54564225|FG000|Overall Study|Adverse Event|0|||
27906883|NCT01266850|54564226|FG001|Overall Study|Adverse Event|0|||
27906884|NCT01266850|54564227|FG002|Overall Study|Adverse Event|0|||
27906885|NCT01266850|54564228|FG003|Overall Study|Adverse Event|0|||
27906886|NCT01266850|54564229|FG004|Overall Study|Adverse Event|1|||
27906887|NCT01266850|54564225|FG000|Overall Study|Site Closure|0|||
27906888|NCT01266850|54564226|FG001|Overall Study|Site Closure|1|||
27906889|NCT01266850|54564227|FG002|Overall Study|Site Closure|1|||
27906890|NCT01266850|54564228|FG003|Overall Study|Site Closure|1|||
27906891|NCT01266850|54564229|FG004|Overall Study|Site Closure|0|||
27906892|NCT01266460|54564241|FG000|Overall Study|Adverse Event|3|||
27906893|NCT01266460|54564241|FG000|Overall Study|Withdrawal by Subject|5|||
27906894|NCT01266460|54564241|FG000|Overall Study|Disease Progression|18|||
27990368|NCT00852930|54649023|FG001|Overall Study|Physician Decision|0|||
27990369|NCT00852930|54649024|FG002|Overall Study|Physician Decision|1|||
27990370|NCT00852540|54649035|FG000|Overall Study|Adverse Event|10|||
27990371|NCT00852540|54649036|FG001|Overall Study|Adverse Event|3|||
27990372|NCT00852540|54649035|FG000|Overall Study|Lack of Efficacy|15|||
27990373|NCT00852540|54649036|FG001|Overall Study|Lack of Efficacy|3|||
27990374|NCT00852540|54649035|FG000|Overall Study|Protocol Violation|1|||
27990375|NCT00852540|54649036|FG001|Overall Study|Protocol Violation|2|||
27990376|NCT00852540|54649035|FG000|Overall Study|Lost to Follow-up|2|||
27990377|NCT00852540|54649036|FG001|Overall Study|Lost to Follow-up|3|||
27990378|NCT00852540|54649035|FG000|Overall Study|Investigator Discretion|2|||
27990379|NCT00852540|54649036|FG001|Overall Study|Investigator Discretion|3|||
27990380|NCT00852540|54649035|FG000|Overall Study|Withdrawal by Subject|3|||
27990381|NCT00852540|54649036|FG001|Overall Study|Withdrawal by Subject|1|||
27990382|NCT00852540|54649035|FG000|Overall Study|Did Not Receive Study Drug|3|||
27990383|NCT00852540|54649036|FG001|Overall Study|Did Not Receive Study Drug|3|||
27990384|NCT00861198|54649043|FG000|Overall Study|SpyGlass Failed|5|||
27990385|NCT00847704|54649047|FG000|Overall Study|Withdrawal by Subject|1|||
27990386|NCT00860574|54649051|FG000|Overall Study|Death|2|||
27990387|NCT00860574|54649051|FG000|Overall Study|Relapse|1|||
27990388|NCT00496015|54649060|FG000|Overall Study|Other|1|||
27990389|NCT00496015|54649061|FG001|Overall Study|Other|0|||
27990390|NCT00496015|54649062|FG002|Overall Study|Other|0|||
27990391|NCT00496015|54649063|FG003|Overall Study|Other|1|||
27990392|NCT00496015|54649064|FG004|Overall Study|Other|0|||
27990393|NCT00487825|54649086|FG000|Overall Study|Adverse Event|2|||
27990394|NCT00487825|54649087|FG001|Overall Study|Adverse Event|2|||
27990395|NCT00487825|54649086|FG000|Overall Study|Lack of Efficacy|1|||
27990396|NCT00487825|54649087|FG001|Overall Study|Lack of Efficacy|1|||
27990397|NCT00487825|54649086|FG000|Overall Study|Other|3|||
27990398|NCT00487825|54649087|FG001|Overall Study|Other|2|||
27990399|NCT00487747|54649093|FG000|Overall Study|Adverse Event|1|||
27990400|NCT00487747|54649093|FG000|Overall Study|Lost to Follow-up|9|||
27990401|NCT00487747|54649093|FG000|Overall Study|Lack of Efficacy|1|||
27990402|NCT00487435|54649097|FG000|Overall Study|Adverse Event|146|||
27990403|NCT00487435|54649097|FG000|Overall Study|Death|2|||
27990404|NCT00487435|54649097|FG000|Overall Study|Lack of Efficacy|33|||
27990405|NCT00487435|54649097|FG000|Overall Study|Lost to Follow-up|54|||
27990406|NCT00487435|54649097|FG000|Overall Study|Pregnancy|2|||
27990407|NCT00487435|54649097|FG000|Overall Study|Withdrawal by Subject|132|||
27990408|NCT00487435|54649097|FG000|Overall Study|Resolution Of Pain|1|||
27906895|NCT01266460|54564241|FG000|Overall Study|Not otherwise specified|8|||
27906896|NCT01266265|54564247|FG000|Overall Study|Death|95|||
27906897|NCT01266265|54564248|FG001|Overall Study|Death|73|||
27990409|NCT00487435|54649097|FG000|Overall Study|Study Medication Non-Compliant|32|||
27990410|NCT00487435|54649097|FG000|Overall Study|Other|83|||
27990411|NCT00487279|54649103|FG000|Overall Study|Death|1|||
27990412|NCT00487279|54649104|FG001|Overall Study|Death|0|||
27906898|NCT01266265|54564247|FG000|Overall Study|Lost to Follow-up|23|||
27906899|NCT01266265|54564248|FG001|Overall Study|Lost to Follow-up|28|||
27906900|NCT01266265|54564247|FG000|Overall Study|Withdrawal by Subject|13|||
27906901|NCT01266265|54564248|FG001|Overall Study|Withdrawal by Subject|11|||
27906902|NCT01266265|54564247|FG000|Overall Study|Respiratory-related adverse event|2|||
27906903|NCT01266265|54564248|FG001|Overall Study|Respiratory-related adverse event|1|||
27906904|NCT01266265|54564247|FG000|Overall Study|Transferred care to another provider|22|||
27906905|NCT01266265|54564248|FG001|Overall Study|Transferred care to another provider|28|||
27906906|NCT01266265|54564247|FG000|Overall Study|Stopped/changed PAH medication(s)|16|||
27925794|NCT01226745|54582371|FG004|Overall Study|Other|3|||
27990413|NCT00487279|54649103|FG000|Overall Study|Withdrawal by Subject|0|||
27990414|NCT00487279|54649104|FG001|Overall Study|Withdrawal by Subject|2|||
27990415|NCT00495625|54649110|FG000|Overall Study|Did not complete at least 1 42 day cycle|10|||
27990416|NCT00847626|54649125|FG000|Overall Study|Adverse Event|10|||
27990417|NCT00847626|54649126|FG001|Overall Study|Adverse Event|10|||
27990418|NCT00847626|54649127|FG002|Overall Study|Adverse Event|6|||
27990419|NCT00847626|54649128|FG003|Overall Study|Adverse Event|19|||
27990420|NCT00847626|54649129|FG004|Overall Study|Adverse Event|11|||
27990421|NCT00847626|54649130|FG005|Overall Study|Adverse Event|22|||
27990422|NCT00847626|54649131|FG006|Overall Study|Adverse Event|4|||
27990423|NCT00847626|54649132|FG007|Overall Study|Adverse Event|6|||
27990424|NCT00847626|54649133|FG008|Overall Study|Adverse Event|3|||
27990425|NCT00847626|54649134|FG009|Overall Study|Adverse Event|6|||
27990426|NCT00847626|54649135|FG010|Overall Study|Adverse Event|6|||
27990427|NCT00847626|54649125|FG000|Overall Study|Protocol Violation|2|||
27990428|NCT00847626|54649126|FG001|Overall Study|Protocol Violation|1|||
27990429|NCT00847626|54649127|FG002|Overall Study|Protocol Violation|2|||
27990430|NCT00847626|54649128|FG003|Overall Study|Protocol Violation|1|||
27990431|NCT00847626|54649129|FG004|Overall Study|Protocol Violation|1|||
27990432|NCT00847626|54649130|FG005|Overall Study|Protocol Violation|1|||
27990433|NCT00847626|54649131|FG006|Overall Study|Protocol Violation|1|||
27990434|NCT00847626|54649132|FG007|Overall Study|Protocol Violation|1|||
27990435|NCT00847626|54649133|FG008|Overall Study|Protocol Violation|0|||
27990436|NCT00847626|54649134|FG009|Overall Study|Protocol Violation|1|||
27990437|NCT00847626|54649135|FG010|Overall Study|Protocol Violation|1|||
27990438|NCT00847626|54649125|FG000|Overall Study|Lost to Follow-up|0|||
27990439|NCT00847626|54649126|FG001|Overall Study|Lost to Follow-up|1|||
27990440|NCT00847626|54649127|FG002|Overall Study|Lost to Follow-up|1|||
27990441|NCT00847626|54649128|FG003|Overall Study|Lost to Follow-up|1|||
27990442|NCT00847626|54649129|FG004|Overall Study|Lost to Follow-up|0|||
27990443|NCT00847626|54649130|FG005|Overall Study|Lost to Follow-up|3|||
27990444|NCT00847626|54649131|FG006|Overall Study|Lost to Follow-up|1|||
27990445|NCT00847626|54649132|FG007|Overall Study|Lost to Follow-up|3|||
27990446|NCT00847626|54649133|FG008|Overall Study|Lost to Follow-up|1|||
27990447|NCT00847626|54649134|FG009|Overall Study|Lost to Follow-up|0|||
27990448|NCT00847626|54649135|FG010|Overall Study|Lost to Follow-up|1|||
27990449|NCT00847626|54649125|FG000|Overall Study|Withdrawal by Subject|5|||
27990450|NCT00847626|54649126|FG001|Overall Study|Withdrawal by Subject|5|||
27990451|NCT00847626|54649127|FG002|Overall Study|Withdrawal by Subject|3|||
27990452|NCT00847626|54649128|FG003|Overall Study|Withdrawal by Subject|8|||
27990453|NCT00847626|54649129|FG004|Overall Study|Withdrawal by Subject|12|||
27990454|NCT00847626|54649130|FG005|Overall Study|Withdrawal by Subject|9|||
27990455|NCT00847626|54649131|FG006|Overall Study|Withdrawal by Subject|8|||
27990456|NCT00847626|54649132|FG007|Overall Study|Withdrawal by Subject|4|||
27990457|NCT00847626|54649133|FG008|Overall Study|Withdrawal by Subject|4|||
27990458|NCT00847626|54649134|FG009|Overall Study|Withdrawal by Subject|5|||
27990459|NCT00847626|54649135|FG010|Overall Study|Withdrawal by Subject|2|||
27990460|NCT00847626|54649125|FG000|Overall Study|Lack of Efficacy|3|||
27990461|NCT00847626|54649126|FG001|Overall Study|Lack of Efficacy|1|||
27990462|NCT00847626|54649127|FG002|Overall Study|Lack of Efficacy|0|||
27990463|NCT00847626|54649128|FG003|Overall Study|Lack of Efficacy|1|||
27990464|NCT00847626|54649129|FG004|Overall Study|Lack of Efficacy|2|||
27990465|NCT00847626|54649130|FG005|Overall Study|Lack of Efficacy|0|||
27990466|NCT00847626|54649131|FG006|Overall Study|Lack of Efficacy|6|||
27990467|NCT00847626|54649132|FG007|Overall Study|Lack of Efficacy|2|||
27990468|NCT00847626|54649133|FG008|Overall Study|Lack of Efficacy|5|||
27990469|NCT00847626|54649134|FG009|Overall Study|Lack of Efficacy|1|||
27990470|NCT00847626|54649135|FG010|Overall Study|Lack of Efficacy|7|||
27990471|NCT00847626|54649125|FG000|Overall Study|Other|1|||
27990472|NCT00847626|54649126|FG001|Overall Study|Other|5|||
27990473|NCT00847626|54649127|FG002|Overall Study|Other|4|||
27990474|NCT00847626|54649128|FG003|Overall Study|Other|1|||
27990475|NCT00847626|54649129|FG004|Overall Study|Other|2|||
28097676|NCT00090519|54753410|FG000|Overall Study|Withdrawal by Subject|28|||
28097677|NCT00090519|54753411|FG001|Overall Study|Withdrawal by Subject|29|||
27990476|NCT00847626|54649130|FG005|Overall Study|Other|2|||
27990477|NCT00847626|54649131|FG006|Overall Study|Other|2|||
27990478|NCT00847626|54649132|FG007|Overall Study|Other|3|||
28097678|NCT00090519|54753410|FG000|Overall Study|Physician Decision|2|||
28097679|NCT00090519|54753411|FG001|Overall Study|Physician Decision|3|||
27906907|NCT01266265|54564248|FG001|Overall Study|Stopped/changed PAH medication(s)|9|||
27906908|NCT01266265|54564247|FG000|Overall Study|Enrolled in another clinical study|15|||
27906909|NCT01266265|54564248|FG001|Overall Study|Enrolled in another clinical study|26|||
27906910|NCT01266265|54564247|FG000|Overall Study|Non-compliance|8|||
27906911|NCT01266265|54564248|FG001|Overall Study|Non-compliance|5|||
27906912|NCT01266265|54564247|FG000|Overall Study|Lung transplant|6|||
27906913|NCT01266265|54564248|FG001|Overall Study|Lung transplant|5|||
27906914|NCT01266265|54564247|FG000|Overall Study|Site closed early|4|||
27990479|NCT00847626|54649133|FG008|Overall Study|Other|1|||
27990480|NCT00847626|54649134|FG009|Overall Study|Other|1|||
27990481|NCT00847626|54649135|FG010|Overall Study|Other|3|||
27990482|NCT00851682|54649164|FG000|Overall Study|screen failure|5|||
27990483|NCT00851682|54649165|FG001|Overall Study|screen failure|0|||
27990484|NCT00860262|54649174|FG000|Overall Study|Adverse Event|9|||
27990485|NCT00860262|54649175|FG001|Overall Study|Adverse Event|6|||
27990486|NCT00860262|54649176|FG002|Overall Study|Adverse Event|7|||
27990487|NCT00860262|54649174|FG000|Overall Study|Protocol Violation|0|||
27990488|NCT00860262|54649175|FG001|Overall Study|Protocol Violation|1|||
27990489|NCT00860262|54649176|FG002|Overall Study|Protocol Violation|0|||
27990490|NCT00860262|54649174|FG000|Overall Study|Lost to Follow-up|2|||
27990491|NCT00860262|54649175|FG001|Overall Study|Lost to Follow-up|0|||
27990492|NCT00860262|54649176|FG002|Overall Study|Lost to Follow-up|1|||
27906915|NCT01266265|54564248|FG001|Overall Study|Site closed early|3|||
27906916|NCT01266265|54564247|FG000|Overall Study|Clinical worsening|1|||
27990493|NCT00860262|54649174|FG000|Overall Study|Withdrawal by Subject|4|||
27990494|NCT00860262|54649175|FG001|Overall Study|Withdrawal by Subject|8|||
27906917|NCT01266265|54564248|FG001|Overall Study|Clinical worsening|1|||
27906918|NCT01266148|54564273|FG000|Overall Study|Adverse Event|2|||
27906919|NCT01266148|54564274|FG001|Overall Study|Adverse Event|0|||
27906920|NCT01266148|54564273|FG000|Overall Study|Ongoing rejection|1|||
27906921|NCT01266148|54564274|FG001|Overall Study|Ongoing rejection|0|||
27906922|NCT01266148|54564273|FG000|Overall Study|2 2R rejections|1|||
27906923|NCT01266148|54564274|FG001|Overall Study|2 2R rejections|0|||
27906924|NCT01266148|54564273|FG000|Overall Study|Death|2|||
27906925|NCT01266148|54564274|FG001|Overall Study|Death|3|||
27906926|NCT01266148|54564273|FG000|Overall Study|missing mGFR value + AE|1|||
27906927|NCT01266148|54564274|FG001|Overall Study|missing mGFR value + AE|0|||
27906928|NCT01266070|54564280|FG000|Overall Study|Adverse Event|3|||
27906929|NCT01266070|54564280|FG000|Overall Study|Protocol Violation|1|||
27906930|NCT01265992|54564284|FG000|Overall Study|Lost to Follow-up|1|||
27906931|NCT01265992|54564284|FG000|Overall Study|Withdrawal by Subject|1|||
27906932|NCT01265992|54564284|FG000|Overall Study|Adverse Event|1|||
27906933|NCT01265992|54564284|FG000|Overall Study|Administrative reasons|2|||
27906934|NCT01265992|54564284|FG000|Overall Study|Stopped treatment|3|||
27906935|NCT01265992|54564284|FG000|Overall Study|Did not receive treatment|1|||
27906936|NCT01265953|54564290|FG000|Overall Study|Non compliance|5|||
27906937|NCT01265953|54564291|FG001|Overall Study|Non compliance|3|||
27906938|NCT01265875|54564297|FG000|Overall Study|Uncooperative/unreliable|1|||
27906939|NCT01265797|54564304|FG000|Run-in Month|Withdrawal by Subject|0|||
27906940|NCT01265797|54564305|FG001|Run-in Month|Withdrawal by Subject|4|||
27906941|NCT01265797|54564304|FG000|Run-in Month|1st seizure during run-in month|0|||
27906942|NCT01265797|54564305|FG001|Run-in Month|1st seizure during run-in month|1|||
27906943|NCT01265797|54564304|FG000|Blinded Month|Lack of Efficacy|5|||
27906944|NCT01265797|54564305|FG001|Blinded Month|Lack of Efficacy|0|||
27906945|NCT01265797|54564304|FG000|Blinded Month|Lost to Follow-up|1|||
27906946|NCT01265797|54564305|FG001|Blinded Month|Lost to Follow-up|0|||
27906947|NCT01265797|54564304|FG000|Blinded Month|Protocol Violation|2|||
27906948|NCT01265797|54564305|FG001|Blinded Month|Protocol Violation|1|||
27906949|NCT01265797|54564304|FG000|Blinded Month|Adverse Event|2|||
27990495|NCT00860262|54649176|FG002|Overall Study|Withdrawal by Subject|6|||
27990496|NCT00860262|54649174|FG000|Overall Study|Lack of Efficacy|0|||
27990497|NCT00860262|54649175|FG001|Overall Study|Lack of Efficacy|4|||
27990498|NCT00860262|54649176|FG002|Overall Study|Lack of Efficacy|3|||
27990499|NCT00860262|54649174|FG000|Overall Study|Other|5|||
27990500|NCT00860262|54649175|FG001|Overall Study|Other|3|||
28097680|NCT00090519|54753410|FG000|Overall Study|Sponsor Decision|3|||
28097681|NCT00090519|54753411|FG001|Overall Study|Sponsor Decision|1|||
28097682|NCT00096993|54753441|FG000|Overall Study|Death|1|||
28097683|NCT00096993|54753442|FG001|Overall Study|Death|0|||
28097684|NCT00096993|54753441|FG000|Overall Study|Disease progression|56|||
27906950|NCT01265797|54564305|FG001|Blinded Month|Adverse Event|0|||
27906951|NCT01265797|54564304|FG000|Blinded Month|Diary data incomplete|0|||
27906952|NCT01265797|54564305|FG001|Blinded Month|Diary data incomplete|1|||
27906953|NCT01265797|54564304|FG000|Open Label Month|Lost to Follow-up|0|||
27906954|NCT01265797|54564305|FG001|Open Label Month|Lost to Follow-up|1|||
27906955|NCT01265719|54564315|FG000|Overall Study|Does not meet entrance criteria|0|||
27906956|NCT01265719|54564316|FG001|Overall Study|Does not meet entrance criteria|3|||
27906957|NCT01265719|54564315|FG000|Overall Study|Other reasons|2|||
27906958|NCT01265719|54564316|FG001|Overall Study|Other reasons|0|||
27906959|NCT01265719|54564315|FG000|Overall Study|Withdrawal by Subject|8|||
27906960|NCT01265719|54564316|FG001|Overall Study|Withdrawal by Subject|3|||
27906961|NCT01265719|54564315|FG000|Overall Study|Lost to Follow-up|2|||
27906962|NCT01265719|54564316|FG001|Overall Study|Lost to Follow-up|7|||
27906963|NCT01265719|54564315|FG000|Overall Study|Adverse Event|2|||
27906964|NCT01265719|54564316|FG001|Overall Study|Adverse Event|0|||
27906965|NCT01265563|54564348|FG000|Overall Study|Withdrawal by Subject|0|||
27906966|NCT01265563|54564349|FG001|Overall Study|Withdrawal by Subject|1|||
27906967|NCT01265563|54564350|FG002|Overall Study|Withdrawal by Subject|1|||
27906968|NCT01265563|54564351|FG003|Overall Study|Withdrawal by Subject|0|||
27906969|NCT01265563|54564352|FG004|Overall Study|Withdrawal by Subject|2|||
27906970|NCT01265056|54564371|FG000|Initial Study Period|Withdrawal by Subject|1|||
27906971|NCT01265056|54564372|FG001|Initial Study Period|Withdrawal by Subject|1|||
27906972|NCT01265056|54564371|FG000|Initial Study Period|Withdrawal by Subject|1|||
27906973|NCT01265056|54564372|FG001|Initial Study Period|Withdrawal by Subject|1|||
27990501|NCT00860262|54649176|FG002|Overall Study|Other|1|||
27906974|NCT01265056|54564371|FG000|Follow up|Lost to Follow-up|7|||
27906975|NCT01265056|54564372|FG001|Follow up|Lost to Follow-up|3|||
27906976|NCT01264939|54564380|FG000|Overall Study|Adverse Event|1|||
27906977|NCT01264939|54564381|FG001|Overall Study|Adverse Event|3|||
27906978|NCT01264939|54564380|FG000|Overall Study|Lost to Follow-up|0|||
27990502|NCT00860028|54649188|FG000|Placebo Controlled Pretreatment Period|No longer interested in treatment|2|||
27990503|NCT00860028|54649189|FG001|Placebo Controlled Pretreatment Period|No longer interested in treatment|1|||
27990504|NCT00859638|54649199|FG000|Overall Study|Lost to Follow-up|6|||
27990505|NCT00859638|54649200|FG001|Overall Study|Lost to Follow-up|1|||
27990506|NCT00859638|54649199|FG000|Overall Study|Withdrawal by Subject|3|||
27990507|NCT00859638|54649200|FG001|Overall Study|Withdrawal by Subject|2|||
27990508|NCT00859638|54649199|FG000|Overall Study|Ill health|1|||
27990509|NCT00859638|54649200|FG001|Overall Study|Ill health|1|||
27990510|NCT00846846|54649206|FG000|Overall Study|Death|56|||
27990511|NCT00846846|54649206|FG000|Overall Study|Withdrawal by Subject|19|||
27906979|NCT01264939|54564381|FG001|Overall Study|Lost to Follow-up|3|||
27906980|NCT01264939|54564380|FG000|Overall Study|Physician Decision|1|||
27906981|NCT01264939|54564381|FG001|Overall Study|Physician Decision|1|||
27906982|NCT01264939|54564380|FG000|Overall Study|Patient/Guardian Decision|8|||
27906983|NCT01264939|54564381|FG001|Overall Study|Patient/Guardian Decision|10|||
27906984|NCT01264939|54564380|FG000|Overall Study|Disease Progression|8|||
27906985|NCT01264939|54564381|FG001|Overall Study|Disease Progression|11|||
27906986|NCT01264081|54564387|FG000|Participants Screened|Screening failures|30|||
27906987|NCT01264081|54564387|FG000|Started Treatment|Withdrawal by Subject|1|||
27906988|NCT01264081|54564387|FG000|Started Treatment|Not complete cycle 1 due to death|1|||
27906989|NCT01263925|54564393|FG000|Overall Study|Protocol Violation|1|||
27906990|NCT01263925|54564394|FG001|Overall Study|Protocol Violation|0|||
27906991|NCT01263925|54564393|FG000|Overall Study|Lack of Efficacy|0|||
27906992|NCT01263925|54564394|FG001|Overall Study|Lack of Efficacy|1|||
27906993|NCT01263925|54564393|FG000|Overall Study|Adverse Event|23|||
27906994|NCT01263925|54564394|FG001|Overall Study|Adverse Event|22|||
27906995|NCT01263925|54564393|FG000|Overall Study|Unsatisfactory Compliance of Subject|8|||
27906996|NCT01263925|54564394|FG001|Overall Study|Unsatisfactory Compliance of Subject|5|||
27906997|NCT01263925|54564393|FG000|Overall Study|Withdrawal by Subject|6|||
27906998|NCT01263925|54564394|FG001|Overall Study|Withdrawal by Subject|8|||
27906999|NCT01263925|54564393|FG000|Overall Study|Other|4|||
27907000|NCT01263925|54564394|FG001|Overall Study|Other|4|||
27907001|NCT01263925|54564393|FG000|Overall Study|Lost to Follow-up|3|||
27907002|NCT01263925|54564394|FG001|Overall Study|Lost to Follow-up|1|||
27907003|NCT01263925|54564393|FG000|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
27907004|NCT01263925|54564394|FG001|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
27907005|NCT01263925|54564393|FG000|Overall Study|AE/ Unsatisfactory Compliance|2|||
27907006|NCT01263925|54564394|FG001|Overall Study|AE/ Unsatisfactory Compliance|2|||
27907007|NCT01263925|54564393|FG000|Overall Study|AE/ Withdrawal|1|||
27907008|NCT01263925|54564394|FG001|Overall Study|AE/ Withdrawal|4|||
27907009|NCT01263925|54564393|FG000|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
27907010|NCT01263925|54564394|FG001|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
27907011|NCT01263925|54564393|FG000|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1|||
27907012|NCT01263925|54564394|FG001|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2|||
27907013|NCT01263925|54564393|FG000|Overall Study|Withdrawal/ Not specified|0|||
27907014|NCT01263925|54564394|FG001|Overall Study|Withdrawal/ Not specified|1|||
27907015|NCT01263769|54564400|FG000|Overall Study|Non-Compliant with treatment|1|||
27907016|NCT01263691|54564410|FG000|Overall Study|Lost to Follow-up|1|||
27907017|NCT01263691|54564411|FG001|Overall Study|Lost to Follow-up|0|||
27907018|NCT01263691|54564412|FG002|Overall Study|Lost to Follow-up|1|||
27907019|NCT01263691|54564413|FG003|Overall Study|Lost to Follow-up|1|||
27990512|NCT00846768|54649210|FG000|Overall Study|Adverse Event|0|||
27990513|NCT00846768|54649211|FG001|Overall Study|Adverse Event|1|||
27990514|NCT00846768|54649212|FG002|Overall Study|Adverse Event|0|||
27990515|NCT00846768|54649213|FG003|Overall Study|Adverse Event|0|||
27907020|NCT01263691|54564414|FG004|Overall Study|Lost to Follow-up|0|||
27907021|NCT01263691|54564415|FG005|Overall Study|Lost to Follow-up|0|||
27907022|NCT01263691|54564410|FG000|Overall Study|Withdrawal by Subject|1|||
27907023|NCT01263691|54564411|FG001|Overall Study|Withdrawal by Subject|0|||
27907024|NCT01263691|54564412|FG002|Overall Study|Withdrawal by Subject|0|||
27907025|NCT01263691|54564413|FG003|Overall Study|Withdrawal by Subject|0|||
27907026|NCT01263691|54564414|FG004|Overall Study|Withdrawal by Subject|0|||
27907027|NCT01263691|54564415|FG005|Overall Study|Withdrawal by Subject|0|||
27907028|NCT01263691|54564410|FG000|Overall Study|Adverse Event|1|||
27907029|NCT01263691|54564411|FG001|Overall Study|Adverse Event|0|||
27990516|NCT00863798|54649226|FG000|Overall Study|Adverse Event|5|||
27907030|NCT01263691|54564412|FG002|Overall Study|Adverse Event|0|||
27907031|NCT01263691|54564413|FG003|Overall Study|Adverse Event|0|||
27907032|NCT01263691|54564414|FG004|Overall Study|Adverse Event|0|||
27907033|NCT01263691|54564415|FG005|Overall Study|Adverse Event|0|||
27907034|NCT01263496|54564492|FG000|Enrolled - Long-Term Extension Study|Protocol Violation|1|||
27925795|NCT01226745|54582372|FG005|Overall Study|Other|1|||
27907035|NCT01263496|54564493|FG001|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
27907036|NCT01263496|54564494|FG002|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
27907037|NCT01263496|54564495|FG003|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
27907038|NCT01263496|54564496|FG004|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
27907039|NCT01263496|54564497|FG005|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
27907040|NCT01263496|54564498|FG006|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
27907041|NCT01263496|54564499|FG007|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
27907042|NCT01263496|54564500|FG008|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
27907043|NCT01263496|54564492|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
27907044|NCT01263496|54564493|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
27907045|NCT01263496|54564494|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
27907046|NCT01263496|54564495|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
27907047|NCT01263496|54564496|FG004|Enrolled - Long-Term Extension Study|Adverse Event|2|||
27907048|NCT01263496|54564497|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
27907049|NCT01263496|54564498|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
27907050|NCT01263496|54564499|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
27907051|NCT01263496|54564500|FG008|Enrolled - Long-Term Extension Study|Adverse Event|0|||
27907052|NCT01263496|54564492|FG000|Entered - Long-Term Extension Study|Adverse Event|0|||
27907053|NCT01263496|54564493|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
27907054|NCT01263496|54564494|FG002|Entered - Long-Term Extension Study|Adverse Event|6|||
27907055|NCT01263496|54564495|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
27907056|NCT01263496|54564496|FG004|Entered - Long-Term Extension Study|Adverse Event|1|||
27907057|NCT01263496|54564497|FG005|Entered - Long-Term Extension Study|Adverse Event|0|||
27907058|NCT01263496|54564498|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
27907059|NCT01263496|54564499|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
27907060|NCT01263496|54564500|FG008|Entered - Long-Term Extension Study|Adverse Event|1|||
27907061|NCT01263496|54564492|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
27907062|NCT01263496|54564493|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|2|||
27907063|NCT01263496|54564494|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
27907064|NCT01263496|54564495|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
27907065|NCT01263496|54564496|FG004|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
27907066|NCT01263496|54564497|FG005|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
27907067|NCT01263496|54564498|FG006|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
27907068|NCT01263496|54564499|FG007|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
27907069|NCT01263496|54564500|FG008|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
28097685|NCT00096993|54753442|FG001|Overall Study|Disease progression|53|||
28097686|NCT00096993|54753441|FG000|Overall Study|Adverse Event|2|||
28097687|NCT00096993|54753442|FG001|Overall Study|Adverse Event|8|||
28097688|NCT00096993|54753441|FG000|Overall Study|Subject's decision|3|||
28097689|NCT00096993|54753442|FG001|Overall Study|Subject's decision|1|||
28097690|NCT00096993|54753441|FG000|Overall Study|Physician Decision|2|||
28097691|NCT00096993|54753442|FG001|Overall Study|Physician Decision|1|||
28097692|NCT00096993|54753441|FG000|Overall Study|Non-compliance|0|||
28097693|NCT00096993|54753442|FG001|Overall Study|Non-compliance|1|||
28097694|NCT00096993|54753441|FG000|Overall Study|Other unspecified|1|||
28097695|NCT00096993|54753442|FG001|Overall Study|Other unspecified|1|||
28097696|NCT03040336|54753450|FG000|Overall Study|Death|1|||
28097697|NCT03040336|54753451|FG001|Overall Study|Death|0|||
28097698|NCT03040336|54753450|FG000|Overall Study|Withdrawal by Subject|2|||
28097699|NCT03040336|54753451|FG001|Overall Study|Withdrawal by Subject|3|||
28097700|NCT00072189|54753458|FG000|Overall Study|Withdrawal by Subject|1|||
28097701|NCT03040024|54753465|FG000|Overall Study|Adverse Event|0|||
28097702|NCT03040024|54753466|FG001|Overall Study|Adverse Event|1|||
28097703|NCT03040024|54753467|FG002|Overall Study|Adverse Event|0|||
28097704|NCT03040024|54753465|FG000|Overall Study|Death|0|||
28097705|NCT03040024|54753466|FG001|Overall Study|Death|1|||
28097706|NCT03040024|54753467|FG002|Overall Study|Death|0|||
28097707|NCT03040024|54753465|FG000|Overall Study|Physician Decision|0|||
28097708|NCT03040024|54753466|FG001|Overall Study|Physician Decision|0|||
27990517|NCT00863798|54649227|FG001|Overall Study|Adverse Event|2|||
27990518|NCT00863798|54649228|FG002|Overall Study|Adverse Event|4|||
27990519|NCT00863798|54649226|FG000|Overall Study|Participant failed to return|2|||
27990520|NCT00863798|54649227|FG001|Overall Study|Participant failed to return|1|||
28097709|NCT03040024|54753467|FG002|Overall Study|Physician Decision|1|||
28097710|NCT03039790|54753495|FG000|Overall Study|Lost to Follow-up|2|||
27990521|NCT00863798|54649228|FG002|Overall Study|Participant failed to return|0|||
28097711|NCT03039790|54753496|FG001|Overall Study|Lost to Follow-up|0|||
28097712|NCT03039790|54753497|FG002|Overall Study|Lost to Follow-up|1|||
28097713|NCT03039790|54753498|FG003|Overall Study|Lost to Follow-up|1|||
28097714|NCT03039790|54753499|FG004|Overall Study|Lost to Follow-up|0|||
28097715|NCT03039790|54753500|FG005|Overall Study|Lost to Follow-up|1|||
28097716|NCT03039790|54753501|FG006|Overall Study|Lost to Follow-up|1|||
28097717|NCT03039790|54753502|FG007|Overall Study|Lost to Follow-up|1|||
27990522|NCT00863798|54649226|FG000|Overall Study|Investigator request|1|||
27990523|NCT00863798|54649227|FG001|Overall Study|Investigator request|2|||
27990524|NCT00863798|54649228|FG002|Overall Study|Investigator request|1|||
27990525|NCT00863798|54649226|FG000|Overall Study|Lack of Efficacy|4|||
27990526|NCT00863798|54649227|FG001|Overall Study|Lack of Efficacy|3|||
27990527|NCT00863798|54649228|FG002|Overall Study|Lack of Efficacy|6|||
27990528|NCT00863798|54649226|FG000|Overall Study|Lost to Follow-up|6|||
27990529|NCT00863798|54649227|FG001|Overall Study|Lost to Follow-up|9|||
27990530|NCT00863798|54649228|FG002|Overall Study|Lost to Follow-up|5|||
27990531|NCT00863798|54649226|FG000|Overall Study|Other|2|||
27990532|NCT00863798|54649227|FG001|Overall Study|Other|3|||
27990533|NCT00863798|54649228|FG002|Overall Study|Other|1|||
27990534|NCT00863798|54649226|FG000|Overall Study|Protocol Violation|0|||
27990535|NCT00863798|54649227|FG001|Overall Study|Protocol Violation|1|||
27990536|NCT00863798|54649228|FG002|Overall Study|Protocol Violation|1|||
27990537|NCT00863798|54649226|FG000|Overall Study|Withdrawal by Subject|8|||
27990538|NCT00863798|54649227|FG001|Overall Study|Withdrawal by Subject|7|||
27990539|NCT00863798|54649228|FG002|Overall Study|Withdrawal by Subject|4|||
27990540|NCT00863798|54649226|FG000|Overall Study|Randomized not treated|4|||
27990541|NCT00863798|54649227|FG001|Overall Study|Randomized not treated|2|||
27990542|NCT00863798|54649228|FG002|Overall Study|Randomized not treated|3|||
27990543|NCT00859014|54649236|FG000|Overall Study|Death|4|||
27990544|NCT00859014|54649236|FG000|Overall Study|Lost to Follow-up|1|||
27990545|NCT00593606|54649240|FG000|Overall Study|Adverse Event|13|||
27990546|NCT00593606|54649240|FG000|Overall Study|Withdrawal by Subject|1|||
27990547|NCT00593606|54649240|FG000|Overall Study|Protocol Violation|3|||
27990548|NCT00593606|54649240|FG000|Overall Study|Lost to Follow-up|2|||
27990549|NCT00593606|54649240|FG000|Overall Study|Run-In Failure|5|||
27990550|NCT00593606|54649240|FG000|Overall Study|Screen Failure|3|||
27990551|NCT00870584|54649246|FG000|Overall Study|Adverse Event|3|||
27990552|NCT00870584|54649247|FG001|Overall Study|Adverse Event|3|||
27990553|NCT00870584|54649246|FG000|Overall Study|Withdrawal by Subject|6|||
27990554|NCT00870584|54649247|FG001|Overall Study|Withdrawal by Subject|7|||
27990555|NCT00870584|54649246|FG000|Overall Study|Lost to Follow-up|5|||
27990556|NCT00870584|54649247|FG001|Overall Study|Lost to Follow-up|1|||
27990557|NCT00870584|54649246|FG000|Overall Study|Protocol Deviation|2|||
27907070|NCT01263496|54564492|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
27907071|NCT01263496|54564493|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
27907072|NCT01263496|54564494|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
27907073|NCT01263496|54564495|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
27907074|NCT01263496|54564496|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|4|||
27907075|NCT01263496|54564497|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
27907076|NCT01263496|54564498|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
27907077|NCT01263496|54564499|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
27907078|NCT01263496|54564500|FG008|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
27907079|NCT01263496|54564492|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|8|||
27907080|NCT01263496|54564493|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
27907081|NCT01263496|54564494|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
27907082|NCT01263496|54564495|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
27907083|NCT01263496|54564496|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
27907084|NCT01263496|54564497|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
27907085|NCT01263496|54564498|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
27907086|NCT01263496|54564499|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
27907087|NCT01263496|54564500|FG008|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
27907088|NCT01263496|54564492|FG000|Entered - Long-Term Extension Study|Participant Unavailability|0|||
27907089|NCT01263496|54564493|FG001|Entered - Long-Term Extension Study|Participant Unavailability|0|||
27907090|NCT01263496|54564494|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
27907091|NCT01263496|54564495|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
27907092|NCT01263496|54564496|FG004|Entered - Long-Term Extension Study|Participant Unavailability|0|||
27907093|NCT01263496|54564497|FG005|Entered - Long-Term Extension Study|Participant Unavailability|0|||
27907094|NCT01263496|54564498|FG006|Entered - Long-Term Extension Study|Participant Unavailability|0|||
27907095|NCT01263496|54564499|FG007|Entered - Long-Term Extension Study|Participant Unavailability|1|||
27907096|NCT01263496|54564500|FG008|Entered - Long-Term Extension Study|Participant Unavailability|0|||
27907097|NCT01263223|54564512|FG000|Period 2|Withdrawal by Subject|0|||
27990558|NCT00870584|54649247|FG001|Overall Study|Protocol Deviation|2|||
27990559|NCT00870194|54649255|FG000|Overall Study|Adverse Event|10|||
27990560|NCT00870194|54649256|FG001|Overall Study|Adverse Event|5|||
27990561|NCT00870194|54649255|FG000|Overall Study|Lack of Efficacy|0|||
27990562|NCT00870194|54649256|FG001|Overall Study|Lack of Efficacy|1|||
27990563|NCT00870194|54649255|FG000|Overall Study|Lost to Follow-up|2|||
27990564|NCT00870194|54649256|FG001|Overall Study|Lost to Follow-up|0|||
27990565|NCT00870194|54649255|FG000|Overall Study|Physician Decision|3|||
27990566|NCT00870194|54649256|FG001|Overall Study|Physician Decision|1|||
27907098|NCT01263223|54564513|FG001|Period 2|Withdrawal by Subject|1|||
27907099|NCT01263223|54564512|FG000|7-day Follow-up|Withdrawal by Subject|0|||
27907100|NCT01263223|54564513|FG001|7-day Follow-up|Withdrawal by Subject|1|||
27907101|NCT01263223|54564512|FG000|7-day Follow-up|Lost to Follow-up|1|||
27907102|NCT01263223|54564513|FG001|7-day Follow-up|Lost to Follow-up|0|||
27907103|NCT01263106|54564522|FG000|Washout (at Least 7 Days)|Lost to Follow-up|1|||
27907104|NCT01263106|54564523|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
27907105|NCT01263028|54564532|FG000|Overall Study|Withdrawal by Subject|1|||
27907106|NCT01263028|54564532|FG000|Overall Study|Adverse Event|1|||
27907107|NCT01263028|54564532|FG000|Overall Study|Study terminated due to low enrollment.|4|||
27907108|NCT01262989|54564536|FG000|Period 1|Lost to Follow-up|1|||
27990567|NCT00870194|54649255|FG000|Overall Study|Protocol Violation|3|||
27990568|NCT00870194|54649256|FG001|Overall Study|Protocol Violation|3|||
27990569|NCT00870194|54649255|FG000|Overall Study|Entry Criteria Not Met|1|||
27990570|NCT00870194|54649256|FG001|Overall Study|Entry Criteria Not Met|2|||
27990571|NCT00870194|54649255|FG000|Overall Study|Subject Decision|7|||
27739617|NCT02224846|54189240|FG000|Period 1 (Month 3)|Protocol Violation|4|||
27739618|NCT02224846|54189241|FG001|Period 1 (Month 3)|Protocol Violation|8|||
27739619|NCT02224846|54189240|FG000|Period 1 (Month 3)|Withdrawal by Subject|8|||
27739620|NCT02224846|54189241|FG001|Period 1 (Month 3)|Withdrawal by Subject|18|||
27739621|NCT02224846|54189240|FG000|Period 1 (Month 3)|Sponsor Decision|2|||
27739622|NCT02224846|54189241|FG001|Period 1 (Month 3)|Sponsor Decision|1|||
27739623|NCT02224846|54189240|FG000|Period 2 (Month 3 to Month 12)|Adverse Event|1|||
27739624|NCT02224846|54189241|FG001|Period 2 (Month 3 to Month 12)|Adverse Event|2|||
27739625|NCT02224846|54189240|FG000|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3|||
27739626|NCT02224846|54189241|FG001|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5|||
27739627|NCT02224846|54189240|FG000|Period 2 (Month 3 to Month 12)|Protocol Violation|0|||
27739628|NCT02224846|54189241|FG001|Period 2 (Month 3 to Month 12)|Protocol Violation|3|||
27739629|NCT02224846|54189240|FG000|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15|||
27739630|NCT02224846|54189241|FG001|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19|||
27739631|NCT02224846|54189240|FG000|Period 2 (Month 3 to Month 12)|Physician Decision|0|||
27739632|NCT02224846|54189241|FG001|Period 2 (Month 3 to Month 12)|Physician Decision|2|||
27739633|NCT02224846|54189240|FG000|Period 2 (Month 12 to Month 24)|Adverse Event|3|||
27739634|NCT02224846|54189241|FG001|Period 2 (Month 12 to Month 24)|Adverse Event|4|||
27990572|NCT00870194|54649256|FG001|Overall Study|Subject Decision|2|||
27990573|NCT00690430|54649264|FG000|Core Phase|Abnormal Laboratory value|0|||
27990574|NCT00690430|54649265|FG001|Core Phase|Abnormal Laboratory value|1|||
27990575|NCT00690430|54649266|FG002|Core Phase|Abnormal Laboratory value|0|||
27990576|NCT00690430|54649264|FG000|Core Phase|Adverse Event|5|||
27990577|NCT00690430|54649265|FG001|Core Phase|Adverse Event|1|||
27990578|NCT00690430|54649266|FG002|Core Phase|Adverse Event|0|||
27990579|NCT00690430|54649264|FG000|Core Phase|Death|0|||
27990580|NCT00690430|54649265|FG001|Core Phase|Death|2|||
27990581|NCT00690430|54649266|FG002|Core Phase|Death|0|||
27990582|NCT00690430|54649264|FG000|Core Phase|Protocol Violation|1|||
27990583|NCT00690430|54649265|FG001|Core Phase|Protocol Violation|0|||
27990584|NCT00690430|54649266|FG002|Core Phase|Protocol Violation|0|||
27990585|NCT00690430|54649264|FG000|Core Phase|Withdrawal by Subject|3|||
27990586|NCT00690430|54649265|FG001|Core Phase|Withdrawal by Subject|3|||
27990587|NCT00690430|54649266|FG002|Core Phase|Withdrawal by Subject|0|||
27990588|NCT00690430|54649264|FG000|Core Phase|Subject no longer requires study drug|1|||
28097718|NCT03039790|54753503|FG008|Overall Study|Lost to Follow-up|0|||
27739635|NCT02224846|54189240|FG000|Period 2 (Month 12 to Month 24)|Death|1|||
27739636|NCT02224846|54189241|FG001|Period 2 (Month 12 to Month 24)|Death|0|||
27739637|NCT02224846|54189240|FG000|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7|||
27739638|NCT02224846|54189241|FG001|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13|||
27739639|NCT02224846|54189240|FG000|Period 2 (Month 12 to Month 24)|Protocol Violation|4|||
27739640|NCT02224846|54189241|FG001|Period 2 (Month 12 to Month 24)|Protocol Violation|11|||
27739641|NCT02224846|54189240|FG000|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25|||
27739642|NCT02224846|54189241|FG001|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43|||
27739643|NCT02224846|54189240|FG000|Period 2 (Month 12 to Month 24)|Physician Decision|0|||
27739644|NCT02224846|54189241|FG001|Period 2 (Month 12 to Month 24)|Physician Decision|2|||
27739645|NCT02224846|54189240|FG000|Period 2 (Month 12 to Month 24)|Sponsor Decision|2|||
27739646|NCT02224846|54189241|FG001|Period 2 (Month 12 to Month 24)|Sponsor Decision|1|||
27907109|NCT01262989|54564537|FG001|Period 1|Lost to Follow-up|1|||
27907110|NCT01262989|54564536|FG000|Period 1|Intercurrent disease|0|||
27907111|NCT01262989|54564537|FG001|Period 1|Intercurrent disease|1|||
27907112|NCT01262989|54564536|FG000|Period 1|Positive answer for exclusion criteria|0|||
27990589|NCT00690430|54649265|FG001|Core Phase|Subject no longer requires study drug|0|||
28097719|NCT03039790|54753504|FG009|Overall Study|Lost to Follow-up|1|||
27907113|NCT01262989|54564537|FG001|Period 1|Positive answer for exclusion criteria|1|||
27990590|NCT00690430|54649266|FG002|Core Phase|Subject no longer requires study drug|0|||
27990591|NCT00690430|54649264|FG000|Core Phase|Lack of Efficacy|8|||
27990592|NCT00690430|54649265|FG001|Core Phase|Lack of Efficacy|10|||
27990593|NCT00690430|54649266|FG002|Core Phase|Lack of Efficacy|0|||
27739647|NCT01632280|54189249|FG000|Overall Study|Withdrawal by Subject|1|||
27739648|NCT01632280|54189250|FG001|Overall Study|Withdrawal by Subject|0|||
27739649|NCT02224690|54189258|FG000|Overall Study|Adverse Event|8|||
27739650|NCT02224690|54189259|FG001|Overall Study|Adverse Event|1|||
27739651|NCT02224690|54189258|FG000|Overall Study|Met Withdrawal Criteria|4|||
27739652|NCT02224690|54189259|FG001|Overall Study|Met Withdrawal Criteria|0|||
27739653|NCT02224690|54189258|FG000|Overall Study|Use of G-tube|1|||
27907114|NCT01262989|54564536|FG000|Period 2|Intercurrent disease|0|||
27907115|NCT01262989|54564537|FG001|Period 2|Intercurrent disease|1|||
27907116|NCT01262872|54564551|FG000|Step 2|Death|0|||
27907117|NCT01262872|54564552|FG001|Step 2|Death|0|||
27907118|NCT01262872|54564553|FG002|Step 2|Death|0|||
27907119|NCT01262872|54564554|FG003|Step 2|Death|1|||
27907120|NCT01262872|54564555|FG004|Step 2|Death|0|||
27907121|NCT01262872|54564556|FG005|Step 2|Death|2|||
27907122|NCT01262872|54564557|FG006|Step 2|Death|2|||
27907123|NCT01262872|54564558|FG007|Step 2|Death|1|||
27907124|NCT01262872|54564551|FG000|Step 2|Protocol Violation|0|||
27907125|NCT01262872|54564552|FG001|Step 2|Protocol Violation|0|||
27907126|NCT01262872|54564553|FG002|Step 2|Protocol Violation|1|||
27907127|NCT01262872|54564554|FG003|Step 2|Protocol Violation|0|||
27907128|NCT01262872|54564555|FG004|Step 2|Protocol Violation|0|||
27907129|NCT01262872|54564556|FG005|Step 2|Protocol Violation|0|||
27907130|NCT01262872|54564557|FG006|Step 2|Protocol Violation|3|||
27907131|NCT01262872|54564558|FG007|Step 2|Protocol Violation|1|||
27907132|NCT01262872|54564551|FG000|Step 2|Withdrawal by Subject|0|||
27907133|NCT01262872|54564552|FG001|Step 2|Withdrawal by Subject|0|||
27907134|NCT01262872|54564553|FG002|Step 2|Withdrawal by Subject|4|||
27907135|NCT01262872|54564554|FG003|Step 2|Withdrawal by Subject|6|||
27907136|NCT01262872|54564555|FG004|Step 2|Withdrawal by Subject|3|||
27907137|NCT01262872|54564556|FG005|Step 2|Withdrawal by Subject|1|||
27907138|NCT01262872|54564557|FG006|Step 2|Withdrawal by Subject|2|||
27907139|NCT01262872|54564558|FG007|Step 2|Withdrawal by Subject|1|||
27907140|NCT01262872|54564551|FG000|Step 2|Migrated/moved from study area|0|||
27907141|NCT01262872|54564552|FG001|Step 2|Migrated/moved from study area|0|||
27907142|NCT01262872|54564553|FG002|Step 2|Migrated/moved from study area|4|||
27907143|NCT01262872|54564554|FG003|Step 2|Migrated/moved from study area|3|||
27907144|NCT01262872|54564555|FG004|Step 2|Migrated/moved from study area|2|||
27907145|NCT01262872|54564556|FG005|Step 2|Migrated/moved from study area|6|||
27907146|NCT01262872|54564557|FG006|Step 2|Migrated/moved from study area|2|||
27907147|NCT01262872|54564558|FG007|Step 2|Migrated/moved from study area|3|||
27907148|NCT01262677|54564595|FG000|Overall Study|Does not meet entrance criteria|0|||
27907149|NCT01262677|54564596|FG001|Overall Study|Does not meet entrance criteria|2|||
27907150|NCT01262677|54564597|FG002|Overall Study|Does not meet entrance criteria|0|||
27907151|NCT01262677|54564595|FG000|Overall Study|Insufficient clinical response|0|||
27907152|NCT01262677|54564596|FG001|Overall Study|Insufficient clinical response|0|||
27907153|NCT01262677|54564597|FG002|Overall Study|Insufficient clinical response|1|||
27907154|NCT01262677|54564595|FG000|Overall Study|Lost to Follow-up|1|||
27990594|NCT00690430|54649264|FG000|Core Phase|Administrative Problems|0|||
27990595|NCT00690430|54649265|FG001|Core Phase|Administrative Problems|1|||
27990596|NCT00690430|54649266|FG002|Core Phase|Administrative Problems|0|||
27990597|NCT00690430|54649264|FG000|Core Phase|Early Termination|0|||
27990598|NCT00690430|54649265|FG001|Core Phase|Early Termination|5|||
27990599|NCT00690430|54649266|FG002|Core Phase|Early Termination|0|||
27990600|NCT00690430|54649264|FG000|Extension Phase|Lack of Efficacy|3|||
27990601|NCT00690430|54649265|FG001|Extension Phase|Lack of Efficacy|1|||
27907155|NCT01262677|54564596|FG001|Overall Study|Lost to Follow-up|0|||
27907156|NCT01262677|54564597|FG002|Overall Study|Lost to Follow-up|2|||
27907157|NCT01262677|54564595|FG000|Overall Study|No longer willing to participate|3|||
27907158|NCT01262677|54564596|FG001|Overall Study|No longer willing to participate|3|||
27907159|NCT01262677|54564597|FG002|Overall Study|No longer willing to participate|2|||
27907160|NCT01262677|54564595|FG000|Overall Study|Reason not provided|2|||
27907161|NCT01262677|54564596|FG001|Overall Study|Reason not provided|1|||
27990602|NCT00690430|54649266|FG002|Extension Phase|Lack of Efficacy|4|||
27990603|NCT00690430|54649264|FG000|Extension Phase|Abnormal Lab Values|1|||
27990604|NCT00690430|54649265|FG001|Extension Phase|Abnormal Lab Values|0|||
27739654|NCT02224690|54189259|FG001|Overall Study|Use of G-tube|0|||
27739655|NCT02224690|54189258|FG000|Overall Study|Did not meet eligibility criteria|1|||
27907162|NCT01262677|54564597|FG002|Overall Study|Reason not provided|3|||
27907163|NCT01262677|54564595|FG000|Overall Study|Protocol Violation|0|||
27907164|NCT01262677|54564596|FG001|Overall Study|Protocol Violation|1|||
27907165|NCT01262677|54564597|FG002|Overall Study|Protocol Violation|1|||
27907166|NCT01262677|54564595|FG000|Overall Study|Adverse Event (AE) related to study drug|3|||
27907167|NCT01262677|54564596|FG001|Overall Study|Adverse Event (AE) related to study drug|8|||
27907168|NCT01262677|54564597|FG002|Overall Study|Adverse Event (AE) related to study drug|3|||
27990605|NCT00690430|54649266|FG002|Extension Phase|Abnormal Lab Values|0|||
27907169|NCT01262638|54564609|FG000|Overall Study|Adverse Event|3|||
27907170|NCT01262638|54564610|FG001|Overall Study|Adverse Event|4|||
27907171|NCT01262638|54564611|FG002|Overall Study|Adverse Event|3|||
27907172|NCT01262638|54564612|FG003|Overall Study|Adverse Event|4|||
27907173|NCT01262638|54564609|FG000|Overall Study|Protocol Violation|1|||
27907174|NCT01262638|54564610|FG001|Overall Study|Protocol Violation|0|||
27907175|NCT01262638|54564611|FG002|Overall Study|Protocol Violation|0|||
27907176|NCT01262638|54564612|FG003|Overall Study|Protocol Violation|1|||
27907177|NCT01262638|54564609|FG000|Overall Study|Withdrawal by Subject|2|||
27907178|NCT01262638|54564610|FG001|Overall Study|Withdrawal by Subject|1|||
27907179|NCT01262638|54564611|FG002|Overall Study|Withdrawal by Subject|0|||
27907180|NCT01262638|54564612|FG003|Overall Study|Withdrawal by Subject|1|||
27907181|NCT01262638|54564609|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
27907182|NCT01262638|54564610|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
27907183|NCT01262638|54564611|FG002|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
27907184|NCT01262638|54564612|FG003|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
27907185|NCT01262638|54564609|FG000|Overall Study|Lost to Follow-up|1|||
27907186|NCT01262638|54564610|FG001|Overall Study|Lost to Follow-up|1|||
27907187|NCT01262638|54564611|FG002|Overall Study|Lost to Follow-up|1|||
27907188|NCT01262638|54564612|FG003|Overall Study|Lost to Follow-up|1|||
27907189|NCT01262638|54564609|FG000|Overall Study|Participant Went Out of Town|0|||
27907190|NCT01262638|54564610|FG001|Overall Study|Participant Went Out of Town|0|||
27907191|NCT01262638|54564611|FG002|Overall Study|Participant Went Out of Town|1|||
27907192|NCT01262638|54564612|FG003|Overall Study|Participant Went Out of Town|0|||
27907193|NCT01262560|54564628|FG000|Overall Study|Protocol Violation|0|||
27907194|NCT01262560|54564629|FG001|Overall Study|Protocol Violation|1|||
27907195|NCT01262560|54564630|FG002|Overall Study|Protocol Violation|2|||
27907196|NCT01262365|54564641|FG000|Overall Study|Lack of Efficacy|35|||
27907197|NCT01262365|54564642|FG001|Overall Study|Lack of Efficacy|30|||
27907198|NCT01262365|54564643|FG002|Overall Study|Lack of Efficacy|47|||
27907199|NCT01262365|54564641|FG000|Overall Study|Protocol Violation|3|||
27907200|NCT01262365|54564642|FG001|Overall Study|Protocol Violation|1|||
27907201|NCT01262365|54564643|FG002|Overall Study|Protocol Violation|1|||
27907202|NCT01262365|54564641|FG000|Overall Study|Lost to Follow-up|3|||
27907203|NCT01262365|54564642|FG001|Overall Study|Lost to Follow-up|7|||
27907204|NCT01262365|54564643|FG002|Overall Study|Lost to Follow-up|6|||
27907205|NCT01262365|54564641|FG000|Overall Study|Withdrawal by Subject|17|||
27907206|NCT01262365|54564642|FG001|Overall Study|Withdrawal by Subject|22|||
27907207|NCT01262365|54564643|FG002|Overall Study|Withdrawal by Subject|22|||
27907208|NCT01262365|54564641|FG000|Overall Study|Death|1|||
27907209|NCT01262365|54564642|FG001|Overall Study|Death|2|||
27907210|NCT01262365|54564643|FG002|Overall Study|Death|1|||
27907211|NCT01262365|54564641|FG000|Overall Study|Adverse Event|26|||
27907212|NCT01262365|54564642|FG001|Overall Study|Adverse Event|16|||
27907213|NCT01262365|54564643|FG002|Overall Study|Adverse Event|11|||
27907214|NCT01262365|54564641|FG000|Overall Study|sponsor decision|1|||
27907215|NCT01262365|54564642|FG001|Overall Study|sponsor decision|1|||
27907216|NCT01262365|54564643|FG002|Overall Study|sponsor decision|0|||
27907217|NCT01262365|54564641|FG000|Overall Study|Randomization error|1|||
27907218|NCT01262365|54564642|FG001|Overall Study|Randomization error|0|||
27907219|NCT01262365|54564643|FG002|Overall Study|Randomization error|2|||
27907220|NCT01262365|54564641|FG000|Overall Study|Non-compliance|1|||
27907221|NCT01262365|54564642|FG001|Overall Study|Non-compliance|0|||
27907222|NCT01262365|54564643|FG002|Overall Study|Non-compliance|2|||
27907223|NCT01262365|54564641|FG000|Overall Study|Suspected pregnancy|1|||
27907224|NCT01262365|54564642|FG001|Overall Study|Suspected pregnancy|0|||
27907225|NCT01262365|54564643|FG002|Overall Study|Suspected pregnancy|0|||
27990606|NCT00690430|54649264|FG000|Extension Phase|Abnormal test procedure results|1|||
27990607|NCT00690430|54649265|FG001|Extension Phase|Abnormal test procedure results|0|||
27990608|NCT00690430|54649266|FG002|Extension Phase|Abnormal test procedure results|0|||
27990609|NCT00690430|54649264|FG000|Extension Phase|Administrative Problems|0|||
27990610|NCT00690430|54649265|FG001|Extension Phase|Administrative Problems|1|||
27990611|NCT00690430|54649266|FG002|Extension Phase|Administrative Problems|1|||
27990612|NCT00690430|54649264|FG000|Extension Phase|Adverse Event|2|||
27990613|NCT00690430|54649265|FG001|Extension Phase|Adverse Event|1|||
27990614|NCT00690430|54649266|FG002|Extension Phase|Adverse Event|2|||
27990615|NCT00690430|54649264|FG000|Extension Phase|Death|1|||
27907226|NCT01262365|54564641|FG000|Overall Study|Patient pregnant|1|||
27907227|NCT01262365|54564642|FG001|Overall Study|Patient pregnant|0|||
27907228|NCT01262365|54564643|FG002|Overall Study|Patient pregnant|1|||
27907229|NCT01262365|54564641|FG000|Overall Study|Toxicity related to study drug|0|||
27907230|NCT01262365|54564642|FG001|Overall Study|Toxicity related to study drug|1|||
27907231|NCT01262365|54564643|FG002|Overall Study|Toxicity related to study drug|0|||
27907232|NCT01262365|54564641|FG000|Overall Study|Cannot tolerate the protocol|0|||
27907233|NCT01262365|54564642|FG001|Overall Study|Cannot tolerate the protocol|1|||
27907234|NCT01262365|54564643|FG002|Overall Study|Cannot tolerate the protocol|0|||
27907235|NCT01262365|54564641|FG000|Overall Study|Patient unavailable|0|||
27907236|NCT01262365|54564642|FG001|Overall Study|Patient unavailable|0|||
27907237|NCT01262365|54564643|FG002|Overall Study|Patient unavailable|1|||
27907238|NCT03932812|54564653|FG000|Overall Study|Lost to Follow-up|12|||
27990616|NCT00690430|54649265|FG001|Extension Phase|Death|1|||
27990617|NCT00690430|54649266|FG002|Extension Phase|Death|1|||
27990618|NCT00690430|54649264|FG000|Extension Phase|Withdrawal by Subject|0|||
27990619|NCT00690430|54649265|FG001|Extension Phase|Withdrawal by Subject|0|||
27990620|NCT00690430|54649266|FG002|Extension Phase|Withdrawal by Subject|2|||
27990621|NCT00690430|54649264|FG000|Extension Phase|Early Termination|10|||
27990622|NCT00690430|54649265|FG001|Extension Phase|Early Termination|1|||
27990623|NCT00690430|54649266|FG002|Extension Phase|Early Termination|3|||
27990624|NCT00863330|54649275|FG000|Overall Study|study terminated early due to administra|6|||
27990625|NCT00688324|54649279|FG000|Overall Study|Withdrawal by Subject|2|||
27990626|NCT00688324|54649279|FG000|Overall Study|Physician Decision|5|||
27990627|NCT00688324|54649279|FG000|Overall Study|Lost to Follow-up|1|||
27990628|NCT00862940|54649286|FG000|Overall Study|Adverse Event|15|||
27990629|NCT00862940|54649287|FG001|Overall Study|Adverse Event|12|||
27990630|NCT00862940|54649286|FG000|Overall Study|Lack of Efficacy|1|||
27990631|NCT00862940|54649287|FG001|Overall Study|Lack of Efficacy|3|||
27990632|NCT00862940|54649286|FG000|Overall Study|Protocol Violation|2|||
27990633|NCT00862940|54649287|FG001|Overall Study|Protocol Violation|5|||
27990634|NCT00862940|54649286|FG000|Overall Study|Withdrawal by Subject|4|||
27990635|NCT00862940|54649287|FG001|Overall Study|Withdrawal by Subject|6|||
27907239|NCT03932812|54564654|FG001|Overall Study|Lost to Follow-up|14|||
27907240|NCT03932812|54564653|FG000|Overall Study|Death of care partner (person living with dementia)|5|||
27907241|NCT03932812|54564654|FG001|Overall Study|Death of care partner (person living with dementia)|1|||
27907242|NCT01262287|54564663|FG000|Overall Study|Lost to Follow-up|2|||
27907243|NCT01262287|54564664|FG001|Overall Study|Lost to Follow-up|1|||
27907244|NCT01262092|54564676|FG000|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2|||
27907245|NCT01262092|54564677|FG001|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1|||
27990636|NCT00862940|54649286|FG000|Overall Study|Non-compliance|4|||
27990637|NCT00862940|54649287|FG001|Overall Study|Non-compliance|0|||
27990638|NCT00862940|54649286|FG000|Overall Study|Lost to Follow-up|0|||
27990639|NCT00862940|54649287|FG001|Overall Study|Lost to Follow-up|1|||
27990640|NCT00862940|54649286|FG000|Overall Study|Administrative or other reason(s)|4|||
27907246|NCT01262092|54564676|FG000|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1|||
27907247|NCT01262092|54564677|FG001|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0|||
27907248|NCT01262092|54564676|FG000|Buprenorphine Taper|noncompliance - missed medication|1|||
27907249|NCT01262092|54564677|FG001|Buprenorphine Taper|noncompliance - missed medication|1|||
27907250|NCT01262092|54564676|FG000|Gabapentin Taper|noncompliance - missed medications|1|||
27907251|NCT01262092|54564677|FG001|Gabapentin Taper|noncompliance - missed medications|0|||
27907252|NCT01261975|54564683|FG000|Overall Study|Surgical complication|1|||
27907253|NCT01261780|54564692|FG000|Overall Study|Withdrawal by Subject|1|||
27907254|NCT01261780|54564693|FG001|Overall Study|Withdrawal by Subject|0|||
27907255|NCT01261780|54564692|FG000|Overall Study|Event not related to subject|1|||
27990641|NCT00862940|54649287|FG001|Overall Study|Administrative or other reason(s)|3|||
27990642|NCT00868166|54649295|FG000|Overall Study|Death|58|||
27990643|NCT00868166|54649296|FG001|Overall Study|Death|65|||
27990644|NCT00868166|54649295|FG000|Overall Study|Withdrawal by Subject|33|||
27990645|NCT00868166|54649296|FG001|Overall Study|Withdrawal by Subject|25|||
27990646|NCT00868166|54649295|FG000|Overall Study|Protocol Violation|1|||
27990647|NCT00868166|54649296|FG001|Overall Study|Protocol Violation|0|||
27990648|NCT00868166|54649295|FG000|Overall Study|Lost to Follow-up|1|||
27990649|NCT00868166|54649296|FG001|Overall Study|Lost to Follow-up|3|||
27990650|NCT00868166|54649295|FG000|Overall Study|Adverse Event|9|||
27990651|NCT00868166|54649296|FG001|Overall Study|Adverse Event|10|||
27990652|NCT00868166|54649295|FG000|Overall Study|Lack of efficacy, logistics, unwell|9|||
27990653|NCT00868166|54649296|FG001|Overall Study|Lack of efficacy, logistics, unwell|10|||
27990654|NCT00868166|54649295|FG000|Overall Study|Non-compliance with IMP|1|||
27990655|NCT00868166|54649296|FG001|Overall Study|Non-compliance with IMP|1|||
27990656|NCT00858780|54649302|FG000|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18|||
27990657|NCT00858780|54649303|FG001|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
27990658|NCT00858780|54649304|FG002|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
27990659|NCT00858780|54649305|FG003|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
27990660|NCT00858780|54649306|FG004|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
27990661|NCT00858780|54649302|FG000|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
27990662|NCT00858780|54649303|FG001|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
27990663|NCT00858780|54649304|FG002|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1|||
27990664|NCT00858780|54649305|FG003|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
27990665|NCT00858780|54649306|FG004|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
27990666|NCT00858780|54649302|FG000|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
27907256|NCT01261780|54564693|FG001|Overall Study|Event not related to subject|2|||
27907257|NCT01261624|54564701|FG000|Week 0 to Week 12|Disease Progression|1|||
27907258|NCT01261624|54564702|FG001|Week 0 to Week 12|Disease Progression|1|||
27907259|NCT01261624|54564701|FG000|Week 0 to Week 12|Insufficient Response|0|||
27990667|NCT00858780|54649303|FG001|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
27907260|NCT01261624|54564702|FG001|Week 0 to Week 12|Insufficient Response|2|||
27907261|NCT01261624|54564701|FG000|Week 13 to Week 24|Insufficient Response|0|||
28097720|NCT03039790|54753505|FG010|Overall Study|Lost to Follow-up|1|||
28097721|NCT03039790|54753506|FG011|Overall Study|Lost to Follow-up|0|||
28097722|NCT03039790|54753507|FG012|Overall Study|Lost to Follow-up|1|||
28097723|NCT03039790|54753508|FG013|Overall Study|Lost to Follow-up|0|||
28097724|NCT03039790|54753509|FG014|Overall Study|Lost to Follow-up|3|||
28097725|NCT03039790|54753510|FG015|Overall Study|Lost to Follow-up|1|||
28097726|NCT03039790|54753511|FG016|Overall Study|Lost to Follow-up|2|||
28097727|NCT03039790|54753512|FG017|Overall Study|Lost to Follow-up|2|||
28097728|NCT03039790|54753513|FG018|Overall Study|Lost to Follow-up|1|||
28097729|NCT03039790|54753514|FG019|Overall Study|Lost to Follow-up|3|||
28097730|NCT03039790|54753495|FG000|Overall Study|Withdrawal of Consent|1|||
28097731|NCT03039790|54753496|FG001|Overall Study|Withdrawal of Consent|0|||
28097732|NCT03039790|54753497|FG002|Overall Study|Withdrawal of Consent|0|||
28097733|NCT03039790|54753498|FG003|Overall Study|Withdrawal of Consent|1|||
27907262|NCT01261624|54564702|FG001|Week 13 to Week 24|Insufficient Response|1|||
27907263|NCT03694522|54564716|FG000|Overall Study|Withdrawal by Subject|8|||
27907264|NCT03694522|54564717|FG001|Overall Study|Withdrawal by Subject|10|||
27907265|NCT03694522|54564716|FG000|Overall Study|Physician Decision|53|||
27990668|NCT00858780|54649304|FG002|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
27990669|NCT00858780|54649305|FG003|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
27990670|NCT00858780|54649306|FG004|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
27990671|NCT00858780|54649302|FG000|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
27990672|NCT00858780|54649303|FG001|Double-Blind (Week 0 to Failure/Week 48)|Other|1|||
27990673|NCT00858780|54649304|FG002|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
27990674|NCT00858780|54649305|FG003|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
27990675|NCT00858780|54649306|FG004|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
27990676|NCT00858780|54649302|FG000|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
27990677|NCT00858780|54649303|FG001|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
27990678|NCT00858780|54649304|FG002|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
27990679|NCT00858780|54649305|FG003|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
27990680|NCT00858780|54649306|FG004|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1|||
27990681|NCT00858780|54649302|FG000|OL Re-Treatment (Failure to Week 48)|Other|0|||
27990682|NCT00858780|54649303|FG001|OL Re-Treatment (Failure to Week 48)|Other|0|||
27990683|NCT00858780|54649304|FG002|OL Re-Treatment (Failure to Week 48)|Other|0|||
27990684|NCT00858780|54649305|FG003|OL Re-Treatment (Failure to Week 48)|Other|0|||
27990685|NCT00858780|54649306|FG004|OL Re-Treatment (Failure to Week 48)|Other|1|||
27990686|NCT00850200|54649316|FG000|Overall Study|Physician Decision|2|||
27990687|NCT00850200|54649316|FG000|Overall Study|Did not recieve treatment|2|||
27990688|NCT00850200|54649316|FG000|Overall Study|Withdrawal by Subject|1|||
27990689|NCT00858234|54649323|FG000|Overall Study|Adverse Event|6|||
27990690|NCT00858234|54649323|FG000|Overall Study|Progressive disease|2|||
27990691|NCT00858234|54649323|FG000|Overall Study|Status unknown|1|||
27990692|NCT00862082|54649329|FG000|Overall Study|Sponsor decision to terminate the study|5|||
27990693|NCT00862082|54649330|FG001|Overall Study|Sponsor decision to terminate the study|0|||
27990694|NCT00862082|54649329|FG000|Overall Study|Withdrawal by Subject|0|||
27990695|NCT00862082|54649330|FG001|Overall Study|Withdrawal by Subject|1|||
27990696|NCT00849186|54649343|FG000|Overall Study|Adverse Event|2|||
27990697|NCT00849186|54649343|FG000|Overall Study|Withdrawal by Subject|1|||
27990698|NCT00849186|54649343|FG000|Overall Study|not treated|6|||
27990699|NCT00849186|54649343|FG000|Overall Study|Other|1|||
27990700|NCT00692770|54649350|FG000|Overall Study|Protocol Violation|2|||
27990701|NCT00692770|54649351|FG001|Overall Study|Protocol Violation|7|||
27990702|NCT00692770|54649350|FG000|Overall Study|Withdrawal by Subject|97|||
27990703|NCT00692770|54649351|FG001|Overall Study|Withdrawal by Subject|36|||
27990704|NCT00692770|54649350|FG000|Overall Study|Adverse Event|136|||
27990705|NCT00692770|54649351|FG001|Overall Study|Adverse Event|41|||
27990706|NCT00692770|54649350|FG000|Overall Study|Death|10|||
27990707|NCT00692770|54649351|FG001|Overall Study|Death|5|||
28097734|NCT03039790|54753499|FG004|Overall Study|Withdrawal of Consent|0|||
28097735|NCT03039790|54753500|FG005|Overall Study|Withdrawal of Consent|0|||
28097736|NCT03039790|54753501|FG006|Overall Study|Withdrawal of Consent|0|||
28097737|NCT03039790|54753502|FG007|Overall Study|Withdrawal of Consent|0|||
27739656|NCT02224690|54189259|FG001|Overall Study|Did not meet eligibility criteria|0|||
27739657|NCT01634152|54189268|FG000|Overall Study|Adverse Event|2|||
27907266|NCT03694522|54564717|FG001|Overall Study|Physician Decision|54|||
27907267|NCT03694522|54564716|FG000|Overall Study|Other|1|||
27990708|NCT00692770|54649350|FG000|Overall Study|Lost to Follow-up|7|||
27990709|NCT00692770|54649351|FG001|Overall Study|Lost to Follow-up|3|||
27990710|NCT00692770|54649350|FG000|Overall Study|Non-compliant with study medication|11|||
28097738|NCT03039790|54753503|FG008|Overall Study|Withdrawal of Consent|0|||
28097739|NCT03039790|54753504|FG009|Overall Study|Withdrawal of Consent|1|||
27990711|NCT00692770|54649351|FG001|Overall Study|Non-compliant with study medication|5|||
27990712|NCT00692770|54649350|FG000|Overall Study|Progression by clinical judgment|2|||
27990713|NCT00692770|54649351|FG001|Overall Study|Progression by clinical judgment|3|||
27990714|NCT00692770|54649350|FG000|Overall Study|Physician decision not protocol driven|10|||
27990715|NCT00692770|54649351|FG001|Overall Study|Physician decision not protocol driven|14|||
27990716|NCT00692770|54649350|FG000|Overall Study|Disease progression, recurrence/relapse|170|||
27990717|NCT00692770|54649351|FG001|Overall Study|Disease progression, recurrence/relapse|279|||
27990718|NCT00692770|54649350|FG000|Overall Study|Protocol driven decision point|3|||
27907268|NCT03694522|54564717|FG001|Overall Study|Other|1|||
27907269|NCT03694522|54564716|FG000|Overall Study|Lost to Follow-up|0|||
27990719|NCT00692770|54649351|FG001|Overall Study|Protocol driven decision point|7|||
27990720|NCT00692770|54649350|FG000|Overall Study|Completed all planned assessments|79|||
27990721|NCT00692770|54649351|FG001|Overall Study|Completed all planned assessments|101|||
27990722|NCT00692770|54649350|FG000|Overall Study|Radiological and clinical progression|8|||
27990723|NCT00692770|54649351|FG001|Overall Study|Radiological and clinical progression|8|||
27990724|NCT00692770|54649350|FG000|Overall Study|Clinical endpoint reached|16|||
27990725|NCT00692770|54649351|FG001|Overall Study|Clinical endpoint reached|43|||
27990726|NCT00692770|54649350|FG000|Overall Study|Study terminated by sponsor|2|||
27990727|NCT00692770|54649351|FG001|Overall Study|Study terminated by sponsor|2|||
27990728|NCT00692770|54649350|FG000|Overall Study|Randomized but not treated|3|||
27990729|NCT00692770|54649351|FG001|Overall Study|Randomized but not treated|4|||
27990730|NCT00849108|54649366|FG000|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1|||
27990731|NCT00849108|54649367|FG001|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0|||
27990732|NCT00849108|54649366|FG000|Cohort 2 Efficacy|Adverse Event|0|||
27990733|NCT00849108|54649367|FG001|Cohort 2 Efficacy|Adverse Event|1|||
27990734|NCT00849108|54649366|FG000|Cohort 2 Efficacy|Other|0|||
27990735|NCT00849108|54649367|FG001|Cohort 2 Efficacy|Other|9|||
27990736|NCT00867308|54649377|FG000|Overall Study|Death|1|||
27990737|NCT00867308|54649378|FG001|Overall Study|Death|0|||
27990738|NCT00867308|54649377|FG000|Overall Study|Adverse Event|1|||
27990739|NCT00867308|54649378|FG001|Overall Study|Adverse Event|4|||
27990740|NCT00867308|54649377|FG000|Overall Study|Lack of Efficacy|6|||
27990741|NCT00867308|54649378|FG001|Overall Study|Lack of Efficacy|12|||
27990742|NCT00867308|54649377|FG000|Overall Study|Withdrawal by Subject|1|||
27990743|NCT00867308|54649378|FG001|Overall Study|Withdrawal by Subject|2|||
27990744|NCT00866918|54649386|FG000|Overall Study|Death|1|||
27990745|NCT00866918|54649387|FG001|Overall Study|Death|5|||
27990746|NCT00866918|54649386|FG000|Overall Study|Lack of Efficacy|1|||
28097740|NCT03039790|54753505|FG010|Overall Study|Withdrawal of Consent|0|||
27739658|NCT01634152|54189269|FG001|Overall Study|Adverse Event|0|||
27907270|NCT03694522|54564717|FG001|Overall Study|Lost to Follow-up|1|||
27907271|NCT01261390|54564727|FG000|Overall Study|Significant Concurrent Illness|1|||
27907272|NCT01261390|54564728|FG001|Overall Study|Significant Concurrent Illness|0|||
27907273|NCT01261390|54564729|FG002|Overall Study|Significant Concurrent Illness|1|||
27907274|NCT01261390|54564730|FG003|Overall Study|Significant Concurrent Illness|0|||
27907275|NCT01261390|54564727|FG000|Overall Study|Dissatisfaction with Treatment|2|||
27907276|NCT01261390|54564728|FG001|Overall Study|Dissatisfaction with Treatment|1|||
27907277|NCT01261390|54564729|FG002|Overall Study|Dissatisfaction with Treatment|1|||
27907278|NCT01261390|54564730|FG003|Overall Study|Dissatisfaction with Treatment|2|||
27907279|NCT01261390|54564727|FG000|Overall Study|Relocation|0|||
27907280|NCT01261390|54564728|FG001|Overall Study|Relocation|1|||
27907281|NCT01261390|54564729|FG002|Overall Study|Relocation|0|||
27907282|NCT01261390|54564730|FG003|Overall Study|Relocation|0|||
27907283|NCT01261390|54564727|FG000|Overall Study|Loss of Interest in the Study|3|||
27907284|NCT01261390|54564728|FG001|Overall Study|Loss of Interest in the Study|1|||
27907285|NCT01261390|54564729|FG002|Overall Study|Loss of Interest in the Study|0|||
27907286|NCT01261390|54564730|FG003|Overall Study|Loss of Interest in the Study|0|||
27907287|NCT01261390|54564727|FG000|Overall Study|Lost to Follow-up|1|||
27907288|NCT01261390|54564728|FG001|Overall Study|Lost to Follow-up|6|||
27907289|NCT01261390|54564729|FG002|Overall Study|Lost to Follow-up|5|||
27907290|NCT01261390|54564730|FG003|Overall Study|Lost to Follow-up|6|||
27907291|NCT03391882|54564751|FG000|Study Overall|Adverse Event|3|||
27907292|NCT03391882|54564752|FG001|Study Overall|Adverse Event|6|||
27907293|NCT03391882|54564753|FG002|Study Overall|Adverse Event|1|||
27907294|NCT03391882|54564754|FG003|Study Overall|Adverse Event|1|||
27907295|NCT03391882|54564755|FG004|Study Overall|Adverse Event|3|||
27907296|NCT03391882|54564756|FG005|Study Overall|Adverse Event|1|||
27907297|NCT03391882|54564751|FG000|Study Overall|Lack of Efficacy|13|||
27990747|NCT00866918|54649387|FG001|Overall Study|Lack of Efficacy|1|||
27990748|NCT00866918|54649386|FG000|Overall Study|Physician Decision|10|||
27990749|NCT00866918|54649387|FG001|Overall Study|Physician Decision|2|||
27990750|NCT00866918|54649386|FG000|Overall Study|Ineligible|2|||
27990751|NCT00866918|54649387|FG001|Overall Study|Ineligible|4|||
27990752|NCT00866918|54649386|FG000|Overall Study|Inevaluable- RQPCR negative at diagnosi|1|||
27990753|NCT00866918|54649387|FG001|Overall Study|Inevaluable- RQPCR negative at diagnosi|0|||
27990754|NCT00866918|54649386|FG000|Overall Study|Secondary malignancy|1|||
27990755|NCT00866918|54649387|FG001|Overall Study|Secondary malignancy|0|||
27907298|NCT03391882|54564752|FG001|Study Overall|Lack of Efficacy|9|||
27907299|NCT03391882|54564753|FG002|Study Overall|Lack of Efficacy|0|||
27907300|NCT03391882|54564754|FG003|Study Overall|Lack of Efficacy|0|||
27907301|NCT03391882|54564755|FG004|Study Overall|Lack of Efficacy|0|||
27907302|NCT03391882|54564756|FG005|Study Overall|Lack of Efficacy|0|||
27907303|NCT03391882|54564751|FG000|Study Overall|Withdrawal by Subject|3|||
27907304|NCT03391882|54564752|FG001|Study Overall|Withdrawal by Subject|3|||
27907305|NCT03391882|54564753|FG002|Study Overall|Withdrawal by Subject|2|||
27907306|NCT03391882|54564754|FG003|Study Overall|Withdrawal by Subject|2|||
27907307|NCT03391882|54564755|FG004|Study Overall|Withdrawal by Subject|1|||
27907308|NCT03391882|54564756|FG005|Study Overall|Withdrawal by Subject|3|||
27907309|NCT03391882|54564751|FG000|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
27907310|NCT03391882|54564752|FG001|Study Overall|EARLY TERM AT SPONSOR REQUEST|1|||
27907311|NCT03391882|54564753|FG002|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
27907312|NCT03391882|54564754|FG003|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
27907313|NCT03391882|54564755|FG004|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
27907314|NCT03391882|54564756|FG005|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
27907315|NCT03391882|54564751|FG000|Study Overall|Protocol Violation|1|||
27907316|NCT03391882|54564752|FG001|Study Overall|Protocol Violation|0|||
27990756|NCT03158285|54649396|FG000|Placebo-controlled Period: Week 0 - 24|Adverse Event|4|||
27990757|NCT03158285|54649397|FG001|Placebo-controlled Period: Week 0 - 24|Adverse Event|2|||
27990758|NCT03158285|54649398|FG002|Placebo-controlled Period: Week 0 - 24|Adverse Event|6|||
27990759|NCT03158285|54649396|FG000|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0|||
27990760|NCT03158285|54649397|FG001|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
27990761|NCT03158285|54649398|FG002|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
27990762|NCT03158285|54649396|FG000|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
27990763|NCT03158285|54649397|FG001|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
27990764|NCT03158285|54649398|FG002|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
27990765|NCT03158285|54649396|FG000|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
27990766|NCT03158285|54649397|FG001|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1|||
27990767|NCT03158285|54649398|FG002|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
27990768|NCT03158285|54649396|FG000|Placebo-controlled Period: Week 0 - 24|Other|1|||
27990769|NCT03158285|54649397|FG001|Placebo-controlled Period: Week 0 - 24|Other|1|||
27990770|NCT03158285|54649398|FG002|Placebo-controlled Period: Week 0 - 24|Other|0|||
27990771|NCT03158285|54649396|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
27990772|NCT03158285|54649397|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
27990773|NCT03158285|54649398|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|1|||
27990774|NCT03158285|54649396|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5|||
27990775|NCT03158285|54649397|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
27990776|NCT03158285|54649398|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
27990777|NCT03158285|54649396|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
27990778|NCT03158285|54649397|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
27990779|NCT03158285|54649398|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
27990780|NCT03158285|54649396|FG000|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
27990781|NCT03158285|54649397|FG001|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
27990782|NCT03158285|54649398|FG002|Active Treatment Period: Week 24 - 52|Pregnancy|1|||
27990783|NCT03158285|54649396|FG000|Active Treatment Period: Week 24 - 52|Other|1|||
27990784|NCT03158285|54649397|FG001|Active Treatment Period: Week 24 - 52|Other|1|||
27990785|NCT03158285|54649398|FG002|Active Treatment Period: Week 24 - 52|Other|0|||
27990786|NCT03158285|54649396|FG000|Active Treatment Period: Week 52-100|Adverse Event|7|||
27990787|NCT03158285|54649397|FG001|Active Treatment Period: Week 52-100|Adverse Event|5|||
27990788|NCT03158285|54649398|FG002|Active Treatment Period: Week 52-100|Adverse Event|3|||
27990789|NCT03158285|54649396|FG000|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
27990790|NCT03158285|54649397|FG001|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
27990791|NCT03158285|54649398|FG002|Active Treatment Period: Week 52-100|Lack of Efficacy|3|||
27990792|NCT03158285|54649396|FG000|Active Treatment Period: Week 52-100|Withdrawal by Subject|5|||
27990793|NCT03158285|54649397|FG001|Active Treatment Period: Week 52-100|Withdrawal by Subject|2|||
27990794|NCT03158285|54649398|FG002|Active Treatment Period: Week 52-100|Withdrawal by Subject|1|||
27990795|NCT03158285|54649396|FG000|Active Treatment Period: Week 52-100|Pregnancy|0|||
27990796|NCT03158285|54649397|FG001|Active Treatment Period: Week 52-100|Pregnancy|0|||
27990797|NCT03158285|54649398|FG002|Active Treatment Period: Week 52-100|Pregnancy|1|||
27990798|NCT03158285|54649396|FG000|Active Treatment Period: Week 52-100|Death|1|||
27990799|NCT03158285|54649397|FG001|Active Treatment Period: Week 52-100|Death|0|||
28097741|NCT03039790|54753506|FG011|Overall Study|Withdrawal of Consent|0|||
27907317|NCT03391882|54564753|FG002|Study Overall|Protocol Violation|0|||
27907318|NCT03391882|54564754|FG003|Study Overall|Protocol Violation|0|||
27907319|NCT03391882|54564755|FG004|Study Overall|Protocol Violation|0|||
27990800|NCT03158285|54649398|FG002|Active Treatment Period: Week 52-100|Death|0|||
27907320|NCT03391882|54564756|FG005|Study Overall|Protocol Violation|0|||
27907321|NCT03391882|54564751|FG000|Part A - Titration Phase|Adverse Event|3|||
27990801|NCT03158285|54649396|FG000|Active Treatment Period: Week 52-100|Other|4|||
27990802|NCT03158285|54649397|FG001|Active Treatment Period: Week 52-100|Other|1|||
27990803|NCT03158285|54649398|FG002|Active Treatment Period: Week 52-100|Other|0|||
27990804|NCT00861692|54649411|FG000|Overall Study|Death|6|||
27990805|NCT00602927|54649417|FG000|Period 1: 13 Days|Protocol Violation|2|||
27990806|NCT00602927|54649418|FG001|Period 1: 13 Days|Protocol Violation|4|||
27990807|NCT00602927|54649417|FG000|Period 1: 13 Days|MRI scanner technical issue|1|||
27990808|NCT00602927|54649418|FG001|Period 1: 13 Days|MRI scanner technical issue|0|||
27990809|NCT00602927|54649417|FG000|Period 1: 13 Days|Time|1|||
27990810|NCT00602927|54649418|FG001|Period 1: 13 Days|Time|0|||
27990811|NCT00602927|54649417|FG000|Period 1: 13 Days|Claustrophobia|0|||
27990812|NCT00602927|54649418|FG001|Period 1: 13 Days|Claustrophobia|1|||
27990813|NCT00602927|54649417|FG000|Period 2: 14 Days|Protocol Violation|0|||
27907322|NCT03391882|54564752|FG001|Part A - Titration Phase|Adverse Event|6|||
27907323|NCT03391882|54564753|FG002|Part A - Titration Phase|Adverse Event|0|||
27907324|NCT03391882|54564754|FG003|Part A - Titration Phase|Adverse Event|0|||
27907325|NCT03391882|54564755|FG004|Part A - Titration Phase|Adverse Event|0|||
27907326|NCT03391882|54564756|FG005|Part A - Titration Phase|Adverse Event|0|||
27907327|NCT03391882|54564751|FG000|Part A - Titration Phase|Lack of Efficacy|12|||
27907328|NCT03391882|54564752|FG001|Part A - Titration Phase|Lack of Efficacy|6|||
27907329|NCT03391882|54564753|FG002|Part A - Titration Phase|Lack of Efficacy|0|||
27907330|NCT03391882|54564754|FG003|Part A - Titration Phase|Lack of Efficacy|0|||
27907331|NCT03391882|54564755|FG004|Part A - Titration Phase|Lack of Efficacy|0|||
27907332|NCT03391882|54564756|FG005|Part A - Titration Phase|Lack of Efficacy|0|||
27907333|NCT03391882|54564751|FG000|Part A - Titration Phase|Withdrawal by Subject|3|||
27907334|NCT03391882|54564752|FG001|Part A - Titration Phase|Withdrawal by Subject|3|||
27907335|NCT03391882|54564753|FG002|Part A - Titration Phase|Withdrawal by Subject|0|||
27907336|NCT03391882|54564754|FG003|Part A - Titration Phase|Withdrawal by Subject|0|||
27907337|NCT03391882|54564755|FG004|Part A - Titration Phase|Withdrawal by Subject|0|||
27907338|NCT03391882|54564756|FG005|Part A - Titration Phase|Withdrawal by Subject|0|||
27907339|NCT03391882|54564751|FG000|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
27907340|NCT03391882|54564752|FG001|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|1|||
27907341|NCT03391882|54564753|FG002|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
27907342|NCT03391882|54564754|FG003|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
27907343|NCT03391882|54564755|FG004|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
27907344|NCT03391882|54564756|FG005|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
27907345|NCT03391882|54564751|FG000|Post Part A / Pre Part B|Lack of Efficacy|1|||
27907346|NCT03391882|54564752|FG001|Post Part A / Pre Part B|Lack of Efficacy|3|||
27907347|NCT03391882|54564753|FG002|Post Part A / Pre Part B|Lack of Efficacy|0|||
27907348|NCT03391882|54564754|FG003|Post Part A / Pre Part B|Lack of Efficacy|0|||
27907349|NCT03391882|54564755|FG004|Post Part A / Pre Part B|Lack of Efficacy|0|||
27907350|NCT03391882|54564756|FG005|Post Part A / Pre Part B|Lack of Efficacy|0|||
27907351|NCT03391882|54564751|FG000|Post Part A / Pre Part B|Protocol Violation|1|||
27907352|NCT03391882|54564752|FG001|Post Part A / Pre Part B|Protocol Violation|0|||
27907353|NCT03391882|54564753|FG002|Post Part A / Pre Part B|Protocol Violation|0|||
27907354|NCT03391882|54564754|FG003|Post Part A / Pre Part B|Protocol Violation|0|||
27907355|NCT03391882|54564755|FG004|Post Part A / Pre Part B|Protocol Violation|0|||
27907356|NCT03391882|54564756|FG005|Post Part A / Pre Part B|Protocol Violation|0|||
27907357|NCT03391882|54564751|FG000|Part B - Treatment Phase|Adverse Event|0|||
27907358|NCT03391882|54564752|FG001|Part B - Treatment Phase|Adverse Event|0|||
27907359|NCT03391882|54564753|FG002|Part B - Treatment Phase|Adverse Event|1|||
27907360|NCT03391882|54564754|FG003|Part B - Treatment Phase|Adverse Event|1|||
27907361|NCT03391882|54564755|FG004|Part B - Treatment Phase|Adverse Event|3|||
27907362|NCT03391882|54564756|FG005|Part B - Treatment Phase|Adverse Event|1|||
27907363|NCT03391882|54564751|FG000|Part B - Treatment Phase|Withdrawal by Subject|0|||
27907364|NCT03391882|54564752|FG001|Part B - Treatment Phase|Withdrawal by Subject|0|||
27907365|NCT03391882|54564753|FG002|Part B - Treatment Phase|Withdrawal by Subject|2|||
27907366|NCT03391882|54564754|FG003|Part B - Treatment Phase|Withdrawal by Subject|2|||
27907367|NCT03391882|54564755|FG004|Part B - Treatment Phase|Withdrawal by Subject|1|||
27990814|NCT00602927|54649418|FG001|Period 2: 14 Days|Protocol Violation|2|||
27990815|NCT00602927|54649417|FG000|Period 3: 13 Days|Protocol Violation|0|||
27990816|NCT00602927|54649418|FG001|Period 3: 13 Days|Protocol Violation|1|||
27990817|NCT00602927|54649417|FG000|Period 3: 13 Days|MRI data quality|2|||
27990818|NCT00602927|54649418|FG001|Period 3: 13 Days|MRI data quality|2|||
27990819|NCT00602537|54649426|FG000|12 Week Double Blind Comparison|Adverse Event|2|||
27990820|NCT00602537|54649427|FG001|12 Week Double Blind Comparison|Adverse Event|5|||
27907368|NCT03391882|54564756|FG005|Part B - Treatment Phase|Withdrawal by Subject|3|||
27907369|NCT01261000|54564766|FG000|Overall Study|Screen failure|1|||
27907370|NCT01234402|54564799|FG000|Overall Study|Lost to Follow-up|0|||
27907371|NCT01234402|54564800|FG001|Overall Study|Lost to Follow-up|1|||
27907372|NCT01234402|54564801|FG002|Overall Study|Lost to Follow-up|3|||
27907373|NCT01234402|54564799|FG000|Overall Study|Withdrawal by Subject|1|||
27907374|NCT01234402|54564800|FG001|Overall Study|Withdrawal by Subject|3|||
27990821|NCT00602537|54649426|FG000|12 Week Double Blind Comparison|Lack of Efficacy|13|||
27990822|NCT00602537|54649427|FG001|12 Week Double Blind Comparison|Lack of Efficacy|23|||
27990823|NCT00602537|54649426|FG000|12 Week Double Blind Comparison|Lost to Follow-up|5|||
27990824|NCT00602537|54649427|FG001|12 Week Double Blind Comparison|Lost to Follow-up|6|||
27990825|NCT00602537|54649426|FG000|12 Week Double Blind Comparison|Withdrawal by Subject|3|||
27990826|NCT00602537|54649427|FG001|12 Week Double Blind Comparison|Withdrawal by Subject|13|||
27990827|NCT00602537|54649426|FG000|Follow Up Study Comparison|Adverse Event|1|||
27990828|NCT00602537|54649427|FG001|Follow Up Study Comparison|Adverse Event|0|||
27990829|NCT00602537|54649426|FG000|Follow Up Study Comparison|Lost to Follow-up|8|||
27990830|NCT00602537|54649427|FG001|Follow Up Study Comparison|Lost to Follow-up|1|||
27990831|NCT00602537|54649426|FG000|Follow Up Study Comparison|Withdrawal by Subject|2|||
27990832|NCT00602537|54649427|FG001|Follow Up Study Comparison|Withdrawal by Subject|2|||
27990833|NCT00861614|54649435|FG000|Overall Study|Disease Progression|182|||
27990834|NCT00861614|54649436|FG001|Overall Study|Disease Progression|263|||
27990835|NCT00861614|54649435|FG000|Overall Study|Study Drug Toxicity|79|||
27990836|NCT00861614|54649436|FG001|Overall Study|Study Drug Toxicity|6|||
27990837|NCT00861614|54649435|FG000|Overall Study|Death|32|||
27990838|NCT00861614|54649436|FG001|Overall Study|Death|19|||
27990839|NCT00861614|54649435|FG000|Overall Study|Adverse Event|27|||
27990840|NCT00861614|54649436|FG001|Overall Study|Adverse Event|23|||
27990841|NCT00861614|54649435|FG000|Overall Study|Withdrawal by Subject|34|||
27990842|NCT00861614|54649436|FG001|Overall Study|Withdrawal by Subject|35|||
27990843|NCT00861614|54649435|FG000|Overall Study|Other|17|||
27990844|NCT00861614|54649436|FG001|Overall Study|Other|22|||
27990845|NCT00485173|54649444|FG000|Overall Study|Death|4|||
27990846|NCT00485173|54649445|FG001|Overall Study|Death|3|||
27990847|NCT00485173|54649444|FG000|Overall Study|Lost to Follow-up|32|||
27990848|NCT00485173|54649445|FG001|Overall Study|Lost to Follow-up|61|||
27990849|NCT00495469|54649458|FG000|Overall Study|Adverse Event|0|||
27990850|NCT00495469|54649459|FG001|Overall Study|Adverse Event|1|||
27990851|NCT00495469|54649460|FG002|Overall Study|Adverse Event|3|||
27990852|NCT00495469|54649461|FG003|Overall Study|Adverse Event|0|||
27990853|NCT00495469|54649462|FG004|Overall Study|Adverse Event|1|||
27990854|NCT00495469|54649463|FG005|Overall Study|Adverse Event|1|||
27990855|NCT00495469|54649464|FG006|Overall Study|Adverse Event|1|||
27990856|NCT00495469|54649458|FG000|Overall Study|Lost to Follow-up|1|||
27990857|NCT00495469|54649459|FG001|Overall Study|Lost to Follow-up|1|||
27990858|NCT00495469|54649460|FG002|Overall Study|Lost to Follow-up|3|||
27990859|NCT00495469|54649461|FG003|Overall Study|Lost to Follow-up|1|||
27990860|NCT00495469|54649462|FG004|Overall Study|Lost to Follow-up|0|||
27990861|NCT00495469|54649463|FG005|Overall Study|Lost to Follow-up|0|||
27990862|NCT00495469|54649464|FG006|Overall Study|Lost to Follow-up|0|||
27990863|NCT00495469|54649458|FG000|Overall Study|Protocol Violation|0|||
27990864|NCT00495469|54649459|FG001|Overall Study|Protocol Violation|0|||
27990865|NCT00495469|54649460|FG002|Overall Study|Protocol Violation|0|||
27990866|NCT00495469|54649461|FG003|Overall Study|Protocol Violation|0|||
27990867|NCT00495469|54649462|FG004|Overall Study|Protocol Violation|1|||
27990868|NCT00495469|54649463|FG005|Overall Study|Protocol Violation|2|||
27990869|NCT00495469|54649464|FG006|Overall Study|Protocol Violation|0|||
27990870|NCT00495469|54649458|FG000|Overall Study|Withdrawal by Subject|5|||
27990871|NCT00495469|54649459|FG001|Overall Study|Withdrawal by Subject|3|||
27990872|NCT00495469|54649460|FG002|Overall Study|Withdrawal by Subject|1|||
27990873|NCT00495469|54649461|FG003|Overall Study|Withdrawal by Subject|3|||
27907375|NCT01234402|54564801|FG002|Overall Study|Withdrawal by Subject|4|||
27907376|NCT01234402|54564799|FG000|Overall Study|Never treated: Death|0|||
27907377|NCT01234402|54564800|FG001|Overall Study|Never treated: Death|0|||
27907378|NCT01234402|54564801|FG002|Overall Study|Never treated: Death|1|||
27907379|NCT01234402|54564799|FG000|Overall Study|Never treated: Withdrawal By Subject|0|||
27907380|NCT01234402|54564800|FG001|Overall Study|Never treated: Withdrawal By Subject|1|||
27907381|NCT01234402|54564801|FG002|Overall Study|Never treated: Withdrawal By Subject|0|||
27907382|NCT01234402|54564799|FG000|Overall Study|Never treated: Insurance Denied Xeloda|0|||
27907383|NCT01234402|54564800|FG001|Overall Study|Never treated: Insurance Denied Xeloda|1|||
27907384|NCT01234402|54564801|FG002|Overall Study|Never treated: Insurance Denied Xeloda|0|||
27990874|NCT00495469|54649462|FG004|Overall Study|Withdrawal by Subject|3|||
27990875|NCT00495469|54649463|FG005|Overall Study|Withdrawal by Subject|2|||
27739659|NCT01634152|54189270|FG002|Overall Study|Adverse Event|2|||
27990876|NCT00495469|54649464|FG006|Overall Study|Withdrawal by Subject|3|||
27990877|NCT00495469|54649458|FG000|Overall Study|Lack of Efficacy|0|||
27990878|NCT00495469|54649459|FG001|Overall Study|Lack of Efficacy|0|||
27990879|NCT00495469|54649460|FG002|Overall Study|Lack of Efficacy|0|||
27990880|NCT00495469|54649461|FG003|Overall Study|Lack of Efficacy|0|||
27990881|NCT00495469|54649462|FG004|Overall Study|Lack of Efficacy|0|||
27990882|NCT00495469|54649463|FG005|Overall Study|Lack of Efficacy|0|||
28097742|NCT03039790|54753507|FG012|Overall Study|Withdrawal of Consent|2|||
27907385|NCT01260922|54564813|FG000|First Intervention|Withdrawal by Subject|0|||
27990883|NCT00495469|54649464|FG006|Overall Study|Lack of Efficacy|1|||
27990884|NCT00495469|54649458|FG000|Overall Study|Liver function test abnormality|0|||
27990885|NCT00495469|54649459|FG001|Overall Study|Liver function test abnormality|1|||
27990886|NCT00495469|54649460|FG002|Overall Study|Liver function test abnormality|0|||
27990887|NCT00495469|54649461|FG003|Overall Study|Liver function test abnormality|0|||
27990888|NCT00495469|54649462|FG004|Overall Study|Liver function test abnormality|0|||
27990889|NCT00495469|54649463|FG005|Overall Study|Liver function test abnormality|0|||
27990890|NCT00495469|54649464|FG006|Overall Study|Liver function test abnormality|0|||
27990891|NCT00495469|54649458|FG000|Overall Study|ST depression at randomisation in ECG|0|||
27990892|NCT00495469|54649459|FG001|Overall Study|ST depression at randomisation in ECG|1|||
27990893|NCT00495469|54649460|FG002|Overall Study|ST depression at randomisation in ECG|0|||
27990894|NCT00495469|54649461|FG003|Overall Study|ST depression at randomisation in ECG|0|||
27990895|NCT00495469|54649462|FG004|Overall Study|ST depression at randomisation in ECG|0|||
27990896|NCT00495469|54649463|FG005|Overall Study|ST depression at randomisation in ECG|0|||
27990897|NCT00495469|54649464|FG006|Overall Study|ST depression at randomisation in ECG|0|||
27990898|NCT00861380|54649494|FG000|Overall Study|Withdrawal Information not recorded|8427|||
27990899|NCT00861380|54649495|FG001|Overall Study|Withdrawal Information not recorded|9112|||
27990900|NCT00861380|54649496|FG002|Overall Study|Withdrawal Information not recorded|8872|||
27990901|NCT00861380|54649497|FG003|Overall Study|Withdrawal Information not recorded|3689|||
27907386|NCT01260922|54564814|FG001|First Intervention|Withdrawal by Subject|1|||
27907387|NCT01260922|54564813|FG000|Washout of 28 Days|Withdrawal by Subject|4|||
27907388|NCT01260922|54564814|FG001|Washout of 28 Days|Withdrawal by Subject|2|||
27990902|NCT00861380|54649498|FG004|Overall Study|Withdrawal Information not recorded|1812|||
27990903|NCT00861380|54649499|FG005|Overall Study|Withdrawal Information not recorded|6249|||
27990904|NCT00861380|54649500|FG006|Overall Study|Withdrawal Information not recorded|3020|||
27990905|NCT00495391|54649535|FG000|Overall Study|Lack of Efficacy|34|||
27990906|NCT00495391|54649536|FG001|Overall Study|Lack of Efficacy|18|||
27990907|NCT00495391|54649535|FG000|Overall Study|Withdrawal by Subject|2|||
27990908|NCT00495391|54649536|FG001|Overall Study|Withdrawal by Subject|3|||
27990909|NCT00869960|54649542|FG000|Overall Study|Lost to Follow-up|2|||
27990910|NCT00494299|54649548|FG000|Overall Study|Adverse Event|93|||
27990911|NCT00494299|54649549|FG001|Overall Study|Adverse Event|13|||
27990912|NCT00494299|54649548|FG000|Overall Study|Lost to Follow-up|1|||
27990913|NCT00494299|54649549|FG001|Overall Study|Lost to Follow-up|0|||
27990914|NCT00494299|54649548|FG000|Overall Study|Physician Decision|0|||
27990915|NCT00494299|54649549|FG001|Overall Study|Physician Decision|2|||
27990916|NCT00494299|54649548|FG000|Overall Study|Protocol Violation|1|||
28097743|NCT03039790|54753508|FG013|Overall Study|Withdrawal of Consent|0|||
28097744|NCT03039790|54753509|FG014|Overall Study|Withdrawal of Consent|1|||
28097745|NCT03039790|54753510|FG015|Overall Study|Withdrawal of Consent|5|||
27907389|NCT01260922|54564813|FG000|Second Intervention|Emesis|0|||
27907390|NCT01260922|54564814|FG001|Second Intervention|Emesis|2|||
27907391|NCT01233817|54564820|FG000|Overall Study|Lost to Follow-up|1|||
27907392|NCT01233817|54564820|FG000|Overall Study|Withdrawal by Subject|2|||
27907393|NCT01233232|54564827|FG000|Overall Study|Voluntary Discontinuation by Subject|1|||
27907394|NCT01233232|54564828|FG001|Overall Study|Voluntary Discontinuation by Subject|0|||
27907395|NCT01233232|54564829|FG002|Overall Study|Voluntary Discontinuation by Subject|0|||
27907396|NCT01233076|54564839|FG000|Period 2, One Week|Lost to Follow-up|1|||
27907397|NCT01233076|54564840|FG001|Period 2, One Week|Lost to Follow-up|0|||
27907398|NCT01212094|54564849|FG000|Year 1: Baseline Monitoring|Study terminated|7|||
27907399|NCT01212094|54564850|FG001|Year 1: Baseline Monitoring|Study terminated|0|||
27907400|NCT01212094|54564851|FG002|Year 1: Baseline Monitoring|Study terminated|0|||
27907401|NCT01212094|54564849|FG000|Year 1: Baseline Monitoring|Withdrawal by Subject|7|||
27907402|NCT01212094|54564850|FG001|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
27907403|NCT01212094|54564851|FG002|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
27907404|NCT01212094|54564849|FG000|Year 1: Baseline Monitoring|Started on DMT|2|||
27907405|NCT01212094|54564850|FG001|Year 1: Baseline Monitoring|Started on DMT|0|||
27907406|NCT01212094|54564851|FG002|Year 1: Baseline Monitoring|Started on DMT|0|||
27907407|NCT01212094|54564849|FG000|Years 2 & 3: Treatment Randomization|Study terminated|0|||
27907408|NCT01212094|54564850|FG001|Years 2 & 3: Treatment Randomization|Study terminated|4|||
27907409|NCT01212094|54564851|FG002|Years 2 & 3: Treatment Randomization|Study terminated|7|||
27907410|NCT01212094|54564849|FG000|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
27907411|NCT01212094|54564850|FG001|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
27907412|NCT01212094|54564851|FG002|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3|||
27907413|NCT01212094|54564849|FG000|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
27990917|NCT00494299|54649549|FG001|Overall Study|Protocol Violation|2|||
27990918|NCT00494299|54649548|FG000|Overall Study|Withdrawal by Subject|8|||
28097746|NCT03039790|54753511|FG016|Overall Study|Withdrawal of Consent|3|||
27990919|NCT00494299|54649549|FG001|Overall Study|Withdrawal by Subject|3|||
27990920|NCT00494299|54649548|FG000|Overall Study|Disease Progression, Recurrence/Relapse|109|||
27907414|NCT01212094|54564850|FG001|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
27907415|NCT01212094|54564851|FG002|Years 2 & 3: Treatment Randomization|Adverse Event|1|||
27907416|NCT01232569|54564860|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
27907417|NCT01232569|54564861|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
27907418|NCT01232569|54564862|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
27907419|NCT01232569|54564863|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
27907420|NCT01232569|54564860|FG000|Double-blind Treatment Period|Escape|2|||
27907421|NCT01232569|54564861|FG001|Double-blind Treatment Period|Escape|2|||
27907422|NCT01232569|54564862|FG002|Double-blind Treatment Period|Escape|0|||
27907423|NCT01232569|54564863|FG003|Double-blind Treatment Period|Escape|0|||
27907424|NCT01232569|54564860|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
27907425|NCT01232569|54564861|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
27907426|NCT01232569|54564862|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
27907427|NCT01232569|54564863|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
27907428|NCT01232569|54564860|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
27907429|NCT01232569|54564861|FG001|Double-blind Treatment Period|Lack of Efficacy|2|||
27907430|NCT01232569|54564862|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
27907431|NCT01232569|54564863|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
27907432|NCT01232569|54564860|FG000|Double-blind Treatment Period|Physician Decision|1|||
27907433|NCT01232569|54564861|FG001|Double-blind Treatment Period|Physician Decision|0|||
27907434|NCT01232569|54564862|FG002|Double-blind Treatment Period|Physician Decision|0|||
27907435|NCT01232569|54564863|FG003|Double-blind Treatment Period|Physician Decision|0|||
27907436|NCT01232569|54564860|FG000|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9|||
27907437|NCT01232569|54564861|FG001|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3|||
27907438|NCT01232569|54564862|FG002|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
27907439|NCT01232569|54564863|FG003|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
27907440|NCT01232569|54564860|FG000|Double-blind Treatment Period|Death|2|||
27907441|NCT01232569|54564861|FG001|Double-blind Treatment Period|Death|0|||
27907442|NCT01232569|54564862|FG002|Double-blind Treatment Period|Death|0|||
27907443|NCT01232569|54564863|FG003|Double-blind Treatment Period|Death|0|||
27907444|NCT01211665|54564874|FG000|Overall Study|Withdrawal by Subject|1|||
27907445|NCT01211665|54564875|FG001|Overall Study|Withdrawal by Subject|0|||
27907446|NCT01211665|54564874|FG000|Overall Study|Death|1|||
27907447|NCT01211665|54564875|FG001|Overall Study|Death|0|||
27907448|NCT01232491|54564883|FG000|Overall Study|Adverse Event|13|||
27907449|NCT01232491|54564884|FG001|Overall Study|Adverse Event|8|||
27907450|NCT01232491|54564883|FG000|Overall Study|Lack of Efficacy|1|||
27907451|NCT01232491|54564884|FG001|Overall Study|Lack of Efficacy|5|||
27907452|NCT01232491|54564883|FG000|Overall Study|Protocol Violation|13|||
27907453|NCT01232491|54564884|FG001|Overall Study|Protocol Violation|11|||
27907454|NCT01232491|54564883|FG000|Overall Study|Withdrawal Criteria|12|||
27907455|NCT01232491|54564884|FG001|Overall Study|Withdrawal Criteria|21|||
27907456|NCT01232491|54564883|FG000|Overall Study|Other|21|||
27907457|NCT01232491|54564884|FG001|Overall Study|Other|18|||
27907458|NCT01232452|54564892|FG000|Overall Study|Adverse Event|17|||
27907459|NCT01232452|54564893|FG001|Overall Study|Adverse Event|15|||
27907460|NCT01232452|54564892|FG000|Overall Study|Withdrawal by Subject|11|||
27907461|NCT01232452|54564893|FG001|Overall Study|Withdrawal by Subject|8|||
27907462|NCT01232452|54564892|FG000|Overall Study|Physician Decision|8|||
27907463|NCT01232452|54564893|FG001|Overall Study|Physician Decision|12|||
27907464|NCT01232452|54564892|FG000|Overall Study|Protocol entry criterion not met|0|||
27907465|NCT01232452|54564893|FG001|Overall Study|Protocol entry criterion not met|2|||
27907466|NCT01232452|54564892|FG000|Overall Study|Sponsor Decision|3|||
27907467|NCT01232452|54564893|FG001|Overall Study|Sponsor Decision|1|||
27907468|NCT01232452|54564892|FG000|Overall Study|Protocol Violation|0|||
27907469|NCT01232452|54564893|FG001|Overall Study|Protocol Violation|1|||
27907470|NCT01211197|54564899|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
27907471|NCT01211197|54564900|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
27907472|NCT01211197|54564901|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
27907473|NCT01211197|54564902|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
27907474|NCT01211197|54564903|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
27907475|NCT01211197|54564904|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
27907476|NCT01211197|54564899|FG000|Washout Period 2 (7 Days)|Adverse Event|1|||
27907477|NCT01211197|54564900|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
27907478|NCT01211197|54564901|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
27907479|NCT01211197|54564902|FG003|Washout Period 2 (7 Days)|Adverse Event|0|||
27907480|NCT01211197|54564903|FG004|Washout Period 2 (7 Days)|Adverse Event|0|||
27907481|NCT01211197|54564904|FG005|Washout Period 2 (7 Days)|Adverse Event|0|||
27925796|NCT01226511|54582389|FG000|Acute Treatment Period|Adverse Event|7|||
27925797|NCT01226511|54582390|FG001|Acute Treatment Period|Adverse Event|6|||
27925798|NCT01226511|54582389|FG000|Acute Treatment Period|Lack of Efficacy|2|||
27925799|NCT01226511|54582390|FG001|Acute Treatment Period|Lack of Efficacy|1|||
27925800|NCT01226511|54582389|FG000|Acute Treatment Period|Lost to Follow-up|3|||
27925801|NCT01226511|54582390|FG001|Acute Treatment Period|Lost to Follow-up|6|||
27925802|NCT01226511|54582389|FG000|Acute Treatment Period|Parent/caregiver decision|5|||
27925803|NCT01226511|54582390|FG001|Acute Treatment Period|Parent/caregiver decision|7|||
27925804|NCT01226511|54582389|FG000|Acute Treatment Period|Protocol Violation|5|||
27907482|NCT01232296|54564914|FG000|Overall Study|Adverse Event|24|||
27907483|NCT01232296|54564915|FG001|Overall Study|Adverse Event|12|||
27907484|NCT01232296|54564914|FG000|Overall Study|Physician Decision|1|||
27907485|NCT01232296|54564915|FG001|Overall Study|Physician Decision|1|||
27907486|NCT01232296|54564914|FG000|Overall Study|Progressive disease|43|||
27907487|NCT01232296|54564915|FG001|Overall Study|Progressive disease|61|||
27907488|NCT01232296|54564914|FG000|Overall Study|Study terminated by sponsor|0|||
27907489|NCT01232296|54564915|FG001|Overall Study|Study terminated by sponsor|1|||
27907490|NCT01232296|54564914|FG000|Overall Study|Technical problems|3|||
27907491|NCT01232296|54564915|FG001|Overall Study|Technical problems|0|||
27907492|NCT01232296|54564914|FG000|Overall Study|Subject/guardian decision|10|||
27907493|NCT01232296|54564915|FG001|Overall Study|Subject/guardian decision|2|||
27907494|NCT01232296|54564914|FG000|Overall Study|Death|1|||
27907495|NCT01232296|54564915|FG001|Overall Study|Death|6|||
27907496|NCT01231984|54564923|FG000|Study Period 1|Withdrawal by Subject|0|||
27907497|NCT01231984|54564924|FG001|Study Period 1|Withdrawal by Subject|0|||
27907498|NCT01231984|54564925|FG002|Study Period 1|Withdrawal by Subject|0|||
27907499|NCT01231984|54564926|FG003|Study Period 1|Withdrawal by Subject|1|||
27907500|NCT01231984|54564923|FG000|Study Period 1|Lost to Follow-up|1|||
27907501|NCT01231984|54564924|FG001|Study Period 1|Lost to Follow-up|1|||
27907502|NCT01231984|54564925|FG002|Study Period 1|Lost to Follow-up|1|||
27907503|NCT01231984|54564926|FG003|Study Period 1|Lost to Follow-up|0|||
27907504|NCT01231984|54564923|FG000|Study Period 1|Did not continue to meet I/E Criteria|2|||
27907505|NCT01231984|54564924|FG001|Study Period 1|Did not continue to meet I/E Criteria|2|||
27907506|NCT01231984|54564925|FG002|Study Period 1|Did not continue to meet I/E Criteria|2|||
27907507|NCT01231984|54564926|FG003|Study Period 1|Did not continue to meet I/E Criteria|2|||
27907508|NCT01231984|54564923|FG000|Study Period 1|Screen Failure|0|||
27907509|NCT01231984|54564924|FG001|Study Period 1|Screen Failure|0|||
27907510|NCT01231984|54564925|FG002|Study Period 1|Screen Failure|0|||
27907511|NCT01231984|54564926|FG003|Study Period 1|Screen Failure|1|||
27907512|NCT01231984|54564923|FG000|Study Period 1|Non-compliance with study requirements|5|||
27907513|NCT01231984|54564924|FG001|Study Period 1|Non-compliance with study requirements|0|||
27907514|NCT01231984|54564925|FG002|Study Period 1|Non-compliance with study requirements|2|||
27907515|NCT01231984|54564926|FG003|Study Period 1|Non-compliance with study requirements|1|||
27907516|NCT01231984|54564923|FG000|Study Period 1|Protocol Violation|3|||
27907517|NCT01231984|54564924|FG001|Study Period 1|Protocol Violation|4|||
27907518|NCT01231984|54564925|FG002|Study Period 1|Protocol Violation|2|||
27907519|NCT01231984|54564926|FG003|Study Period 1|Protocol Violation|3|||
27907520|NCT01231984|54564923|FG000|Study Period 1|Adverse Event|1|||
27907521|NCT01231984|54564924|FG001|Study Period 1|Adverse Event|0|||
27907522|NCT01231984|54564925|FG002|Study Period 1|Adverse Event|0|||
27907523|NCT01231984|54564926|FG003|Study Period 1|Adverse Event|0|||
27990921|NCT00494299|54649549|FG001|Overall Study|Disease Progression, Recurrence/Relapse|185|||
27990922|NCT00494299|54649548|FG000|Overall Study|Participant Did Not Take Study Drug|0|||
27990923|NCT00494299|54649549|FG001|Overall Study|Participant Did Not Take Study Drug|2|||
27990924|NCT00494299|54649548|FG000|Overall Study|Site Closed by Sponsor|6|||
27990925|NCT00494299|54649549|FG001|Overall Study|Site Closed by Sponsor|0|||
27990926|NCT00494299|54649548|FG000|Overall Study|Protocol Driven Decision Point|11|||
27990927|NCT00494299|54649549|FG001|Overall Study|Protocol Driven Decision Point|22|||
27739660|NCT01634152|54189268|FG000|Overall Study|Consent withdrawn not due to AE|1|||
27739661|NCT01634152|54189269|FG001|Overall Study|Consent withdrawn not due to AE|0|||
27739662|NCT01634152|54189270|FG002|Overall Study|Consent withdrawn not due to AE|1|||
27739663|NCT01634152|54189268|FG000|Overall Study|Not treated|0|||
27907524|NCT01231984|54564923|FG000|Study Period 1|Other|0|||
27907525|NCT01231984|54564924|FG001|Study Period 1|Other|0|||
27907526|NCT01231984|54564925|FG002|Study Period 1|Other|0|||
27907527|NCT01231984|54564926|FG003|Study Period 1|Other|1|||
27907528|NCT01231984|54564923|FG000|Study Period 2|Withdrawal by Subject|1|||
27907529|NCT01231984|54564924|FG001|Study Period 2|Withdrawal by Subject|1|||
27907530|NCT01231984|54564925|FG002|Study Period 2|Withdrawal by Subject|0|||
27907531|NCT01231984|54564926|FG003|Study Period 2|Withdrawal by Subject|0|||
27907532|NCT01231984|54564923|FG000|Study Period 2|Lost to Follow-up|1|||
27907533|NCT01231984|54564924|FG001|Study Period 2|Lost to Follow-up|0|||
27907534|NCT01231984|54564925|FG002|Study Period 2|Lost to Follow-up|0|||
27907535|NCT01231984|54564926|FG003|Study Period 2|Lost to Follow-up|3|||
27907536|NCT01231984|54564923|FG000|Study Period 2|Did not continue to meet I/E Criteria|1|||
27907537|NCT01231984|54564924|FG001|Study Period 2|Did not continue to meet I/E Criteria|1|||
27907538|NCT01231984|54564925|FG002|Study Period 2|Did not continue to meet I/E Criteria|0|||
27907539|NCT01231984|54564926|FG003|Study Period 2|Did not continue to meet I/E Criteria|1|||
27907540|NCT01210807|54564946|FG000|Overall Study|Lost to Follow-up|1|||
27907541|NCT01210807|54564947|FG001|Overall Study|Lost to Follow-up|2|||
27907542|NCT01210807|54564946|FG000|Overall Study|Not implanted bilaterally|2|||
27907543|NCT01210807|54564947|FG001|Overall Study|Not implanted bilaterally|1|||
27907544|NCT01231555|54564956|FG000|Overall Study|Study terminated|8|||
27907545|NCT01231555|54564957|FG001|Overall Study|Study terminated|5|||
27907546|NCT01231555|54564958|FG002|Overall Study|Study terminated|8|||
27907547|NCT01231555|54564956|FG000|Overall Study|Withdrawal by Subject|0|||
27907548|NCT01231555|54564957|FG001|Overall Study|Withdrawal by Subject|2|||
27907549|NCT01231555|54564958|FG002|Overall Study|Withdrawal by Subject|0|||
27907550|NCT01210690|54564966|FG000|Overall Study|Adverse Event|7|||
27907551|NCT01210690|54564966|FG000|Overall Study|Lack of Efficacy|12|||
27907552|NCT01210690|54564966|FG000|Overall Study|Lost to Follow-up|3|||
27907553|NCT01210690|54564966|FG000|Overall Study|Disease Remission|1|||
27907554|NCT01210690|54564966|FG000|Overall Study|Withdrawal by Subject|1|||
27907555|NCT01210690|54564966|FG000|Overall Study|Patient refused to swallow|1|||
27907556|NCT01210690|54564966|FG000|Overall Study|Patient could not take glucose|1|||
27907557|NCT01210651|54564973|FG000|Overall Study|Lost to Follow-up|1|||
27907558|NCT01210651|54564974|FG001|Overall Study|Lost to Follow-up|1|||
27907559|NCT01210651|54564973|FG000|Overall Study|schedule conflicts|1|||
27907560|NCT01210651|54564974|FG001|Overall Study|schedule conflicts|5|||
27907561|NCT01210651|54564973|FG000|Overall Study|Withdrawn by PI for disruptive behavior|0|||
27907562|NCT01210651|54564974|FG001|Overall Study|Withdrawn by PI for disruptive behavior|1|||
27990928|NCT00593684|54649557|FG000|Overall Study|Death|2|||
27990929|NCT00593684|54649558|FG001|Overall Study|Death|1|||
27990930|NCT02963831|54649568|FG000|Overall Study|Progressive Disease|3|||
27990931|NCT02963831|54649569|FG001|Overall Study|Progressive Disease|3|||
27990932|NCT02963831|54649570|FG002|Overall Study|Progressive Disease|16|||
27990933|NCT02963831|54649571|FG003|Overall Study|Progressive Disease|27|||
27990934|NCT02963831|54649568|FG000|Overall Study|Withdrawal by Subject|1|||
27990935|NCT02963831|54649569|FG001|Overall Study|Withdrawal by Subject|0|||
27990936|NCT02963831|54649570|FG002|Overall Study|Withdrawal by Subject|2|||
27990937|NCT02963831|54649571|FG003|Overall Study|Withdrawal by Subject|4|||
27990938|NCT02963831|54649568|FG000|Overall Study|Adverse Event|0|||
27990939|NCT02963831|54649569|FG001|Overall Study|Adverse Event|1|||
27990940|NCT02963831|54649570|FG002|Overall Study|Adverse Event|1|||
27990941|NCT02963831|54649571|FG003|Overall Study|Adverse Event|2|||
27907563|NCT01210651|54564973|FG000|Overall Study|Withdrawal by Subject|1|||
27907564|NCT01210651|54564974|FG001|Overall Study|Withdrawal by Subject|1|||
27907565|NCT01210651|54564973|FG000|Overall Study|Injury outside study|2|||
27907566|NCT01210651|54564974|FG001|Overall Study|Injury outside study|0|||
27907567|NCT01210495|54565053|FG000|Overall Study|Participant Refused Further Follow-Up|1|||
27907568|NCT01210495|54565054|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
27907569|NCT01210495|54565055|FG002|Overall Study|Participant Refused Further Follow-Up|11|||
27907570|NCT01210495|54565056|FG003|Overall Study|Participant Refused Further Follow-Up|2|||
27907571|NCT01210495|54565053|FG000|Overall Study|Death|14|||
27907572|NCT01210495|54565054|FG001|Overall Study|Death|7|||
27907573|NCT01210495|54565055|FG002|Overall Study|Death|112|||
27907574|NCT01210495|54565056|FG003|Overall Study|Death|54|||
27907575|NCT01210495|54565053|FG000|Overall Study|Study Terminated by Sponsor|0|||
27907576|NCT01210495|54565054|FG001|Overall Study|Study Terminated by Sponsor|0|||
27907577|NCT01210495|54565055|FG002|Overall Study|Study Terminated by Sponsor|4|||
27907578|NCT01210495|54565056|FG003|Overall Study|Study Terminated by Sponsor|11|||
27907579|NCT01210495|54565053|FG000|Overall Study|Lost to Follow-up|0|||
27907580|NCT01210495|54565054|FG001|Overall Study|Lost to Follow-up|0|||
27907581|NCT01210495|54565055|FG002|Overall Study|Lost to Follow-up|1|||
27907582|NCT01210495|54565056|FG003|Overall Study|Lost to Follow-up|1|||
27907583|NCT01210495|54565053|FG000|Overall Study|Other unspecified|0|||
27907584|NCT01210495|54565054|FG001|Overall Study|Other unspecified|0|||
27907585|NCT01210495|54565055|FG002|Overall Study|Other unspecified|6|||
27907586|NCT01210495|54565056|FG003|Overall Study|Other unspecified|0|||
27907587|NCT01231516|54565068|FG000|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|4|||
27907588|NCT01231516|54565069|FG001|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|11|||
27907589|NCT01231516|54565068|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|20|||
27907590|NCT01231516|54565069|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|42|||
27907591|NCT01231516|54565068|FG000|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|9|||
27907592|NCT01231516|54565069|FG001|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|6|||
27907593|NCT01231516|54565068|FG000|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|5|||
27739664|NCT01634152|54189269|FG001|Overall Study|Not treated|1|||
27907594|NCT01231516|54565069|FG001|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|3|||
27907595|NCT01231516|54565068|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|5|||
27907596|NCT01231516|54565069|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|10|||
27907597|NCT01231516|54565068|FG000|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
27907598|NCT01231516|54565069|FG001|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
27907599|NCT01231516|54565068|FG000|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|11|||
27907600|NCT01231516|54565069|FG001|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|5|||
27990942|NCT02963831|54649568|FG000|Overall Study|Death|0|||
27990943|NCT02963831|54649569|FG001|Overall Study|Death|0|||
27990944|NCT02963831|54649570|FG002|Overall Study|Death|0|||
27990945|NCT02963831|54649571|FG003|Overall Study|Death|2|||
27990946|NCT00859898|54649586|FG000|Overall Study|Lack of Efficacy|0|||
27739665|NCT01634152|54189270|FG002|Overall Study|Not treated|0|||
27907601|NCT01231516|54565068|FG000|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|3|||
27907602|NCT01231516|54565069|FG001|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|1|||
27907603|NCT01231516|54565068|FG000|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|3|||
27907604|NCT01231516|54565069|FG001|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|2|||
27907605|NCT01231516|54565068|FG000|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|5|||
27907606|NCT01231516|54565069|FG001|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|0|||
27907607|NCT01231516|54565068|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|27|||
27907608|NCT01231516|54565069|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|11|||
27907609|NCT01231516|54565068|FG000|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|10|||
27907610|NCT01231516|54565069|FG001|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|0|||
27907611|NCT01231516|54565068|FG000|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|6|||
27907612|NCT01231516|54565069|FG001|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|3|||
27907613|NCT01231516|54565068|FG000|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|2|||
27907614|NCT01231516|54565069|FG001|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|0|||
27907615|NCT01231516|54565068|FG000|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|6|||
27907616|NCT01231516|54565069|FG001|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|1|||
27907617|NCT01231516|54565068|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|12|||
27907618|NCT01231516|54565069|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|2|||
27907619|NCT01231321|54565075|FG000|Overall Study|Adverse Event|3|||
27990947|NCT00859898|54649587|FG001|Overall Study|Lack of Efficacy|1|||
27990948|NCT00859898|54649588|FG002|Overall Study|Lack of Efficacy|1|||
27990949|NCT00859898|54649586|FG000|Overall Study|Adverse Event|4|||
27990950|NCT00859898|54649587|FG001|Overall Study|Adverse Event|9|||
27990951|NCT00859898|54649588|FG002|Overall Study|Adverse Event|8|||
27990952|NCT00859898|54649586|FG000|Overall Study|Withdrawal by Subject|11|||
27907620|NCT01231321|54565075|FG000|Overall Study|Lack of Efficacy|2|||
27990953|NCT00859898|54649587|FG001|Overall Study|Withdrawal by Subject|8|||
27990954|NCT00859898|54649588|FG002|Overall Study|Withdrawal by Subject|11|||
27990955|NCT00859898|54649586|FG000|Overall Study|Death|0|||
27990956|NCT00859898|54649587|FG001|Overall Study|Death|0|||
27990957|NCT00859898|54649588|FG002|Overall Study|Death|1|||
27990958|NCT00859898|54649586|FG000|Overall Study|Lost to Follow-up|10|||
27990959|NCT00859898|54649587|FG001|Overall Study|Lost to Follow-up|11|||
27990960|NCT00859898|54649588|FG002|Overall Study|Lost to Follow-up|5|||
27990961|NCT00859898|54649586|FG000|Overall Study|poor/non-compliance|2|||
27990962|NCT00859898|54649587|FG001|Overall Study|poor/non-compliance|0|||
27990963|NCT00859898|54649588|FG002|Overall Study|poor/non-compliance|0|||
28097747|NCT03039790|54753512|FG017|Overall Study|Withdrawal of Consent|0|||
28097748|NCT03039790|54753513|FG018|Overall Study|Withdrawal of Consent|2|||
28097749|NCT03039790|54753514|FG019|Overall Study|Withdrawal of Consent|5|||
27907621|NCT01210222|54565085|FG000|Overall Study|Ineligible|2|||
27907622|NCT01210222|54565085|FG000|Overall Study|Never treated|1|||
27907623|NCT01210144|54565097|FG000|Overall Study|Lack of ovarian response|1|||
27907624|NCT01210144|54565098|FG001|Overall Study|Lack of ovarian response|0|||
27907625|NCT01210144|54565097|FG000|Overall Study|No fertilization|1|||
27907626|NCT01210144|54565098|FG001|Overall Study|No fertilization|0|||
27907627|NCT01210144|54565097|FG000|Overall Study|No transfer|1|||
27907628|NCT01210144|54565098|FG001|Overall Study|No transfer|0|||
27907629|NCT01209949|54565105|FG000|Overall Study|Lost to Follow-up|3|||
27907630|NCT01209832|54565109|FG000|Period 1|Sponsor Decision and was not dosed|1|||
27907631|NCT01209832|54565109|FG000|Period 2|Sponsor Decision|1|||
27907632|NCT01230892|54565122|FG000|Overall Study|Withdrawal by Subject|1|||
27907633|NCT01230892|54565123|FG001|Overall Study|Withdrawal by Subject|1|||
27907634|NCT01230892|54565122|FG000|Overall Study|Lost to Follow-up|2|||
27907635|NCT01230892|54565123|FG001|Overall Study|Lost to Follow-up|0|||
27907636|NCT01230814|54565131|FG000|Overall Study|Lost to Follow-up|11|||
27907637|NCT01230814|54565132|FG001|Overall Study|Lost to Follow-up|3|||
27907638|NCT01230814|54565131|FG000|Overall Study|Discontinued (not due to adverse event)|2|||
27907639|NCT01230814|54565132|FG001|Overall Study|Discontinued (not due to adverse event)|1|||
27907640|NCT01230307|54565140|FG000|Overall Study|LVAD Placement|0|||
27907641|NCT01230307|54565141|FG001|Overall Study|LVAD Placement|2|||
27907642|NCT01209598|54565149|FG000|Overall Study|Withdrawal by Subject|1|||
27907643|NCT01209598|54565150|FG001|Overall Study|Withdrawal by Subject|0|||
27907644|NCT01209520|54565157|FG000|Overall Study|Withdrawal by Subject|3|||
27907645|NCT01209325|54565161|FG000|Overall Study|Lost to Follow-up|24|||
27907646|NCT01209325|54565161|FG000|Overall Study|Adverse Event|1|||
27907647|NCT01209325|54565161|FG000|Overall Study|Relocated|3|||
27990964|NCT00859898|54649586|FG000|Overall Study|No longer meets criteria|0|||
27990965|NCT00859898|54649587|FG001|Overall Study|No longer meets criteria|1|||
27990966|NCT00859898|54649588|FG002|Overall Study|No longer meets criteria|0|||
27990967|NCT00859898|54649586|FG000|Overall Study|non-specified|1|||
27990968|NCT00859898|54649587|FG001|Overall Study|non-specified|1|||
27990969|NCT00859898|54649588|FG002|Overall Study|non-specified|1|||
27990970|NCT00859586|54649597|FG000|Overall Study|Donors|4|||
27990971|NCT00494221|54649604|FG000|Overall Study|Death|15|||
27907648|NCT01209325|54565161|FG000|Overall Study|Refusal after starting therapy|8|||
27907649|NCT01209325|54565161|FG000|Overall Study|Protocol Violation|4|||
27907650|NCT01209325|54565161|FG000|Overall Study|Refusal prior to therapy|1|||
27907651|NCT01209325|54565161|FG000|Overall Study|Incarceration|2|||
27907652|NCT01209286|54565199|FG000|Overall Study|Adverse Event|4|||
27907653|NCT01209286|54565200|FG001|Overall Study|Adverse Event|3|||
27907654|NCT01209286|54565201|FG002|Overall Study|Adverse Event|1|||
27907655|NCT01209286|54565199|FG000|Overall Study|Hematological Relapse After Remission|0|||
27907656|NCT01209286|54565200|FG001|Overall Study|Hematological Relapse After Remission|1|||
27907657|NCT01209286|54565201|FG002|Overall Study|Hematological Relapse After Remission|1|||
27907658|NCT01209286|54565199|FG000|Overall Study|Remission Not Achieved in 2 Cycles|1|||
27907659|NCT01209286|54565200|FG001|Overall Study|Remission Not Achieved in 2 Cycles|3|||
27907660|NCT01209286|54565201|FG002|Overall Study|Remission Not Achieved in 2 Cycles|1|||
27907661|NCT01209286|54565199|FG000|Overall Study|Physician Decision|0|||
27907662|NCT01209286|54565200|FG001|Overall Study|Physician Decision|2|||
27907663|NCT01209286|54565201|FG002|Overall Study|Physician Decision|0|||
27907664|NCT01209286|54565199|FG000|Overall Study|Other|0|||
27990972|NCT00494221|54649605|FG001|Overall Study|Death|9|||
27990973|NCT00494221|54649606|FG002|Overall Study|Death|14|||
27990974|NCT00494221|54649604|FG000|Overall Study|Withdrawal by Subject|1|||
27990975|NCT00494221|54649605|FG001|Overall Study|Withdrawal by Subject|2|||
27990976|NCT00494221|54649606|FG002|Overall Study|Withdrawal by Subject|0|||
27990977|NCT00857948|54649618|FG000|Overall Study|Withdrawal by Subject|2|||
27990978|NCT00857948|54649619|FG001|Overall Study|Withdrawal by Subject|0|||
27990979|NCT00857948|54649620|FG002|Overall Study|Withdrawal by Subject|0|||
27907665|NCT01209286|54565200|FG001|Overall Study|Other|1|||
27907666|NCT01209286|54565201|FG002|Overall Study|Other|0|||
27907667|NCT01208233|54565224|FG000|Overall Study|Adverse Event|0|||
27907668|NCT01208233|54565225|FG001|Overall Study|Adverse Event|1|||
27907669|NCT01208233|54565226|FG002|Overall Study|Adverse Event|2|||
27907670|NCT01208233|54565227|FG003|Overall Study|Adverse Event|0|||
27907671|NCT01208233|54565228|FG004|Overall Study|Adverse Event|3|||
27907672|NCT01208233|54565229|FG005|Overall Study|Adverse Event|5|||
27907673|NCT01208233|54565224|FG000|Overall Study|Death|0|||
27907674|NCT01208233|54565225|FG001|Overall Study|Death|0|||
27907675|NCT01208233|54565226|FG002|Overall Study|Death|0|||
27907676|NCT01208233|54565227|FG003|Overall Study|Death|0|||
27907677|NCT01208233|54565228|FG004|Overall Study|Death|3|||
27907678|NCT01208233|54565229|FG005|Overall Study|Death|5|||
27907679|NCT01208233|54565224|FG000|Overall Study|Did not meet entrance criteria|2|||
27907680|NCT01208233|54565225|FG001|Overall Study|Did not meet entrance criteria|1|||
27907681|NCT01208233|54565226|FG002|Overall Study|Did not meet entrance criteria|1|||
27907682|NCT01208233|54565227|FG003|Overall Study|Did not meet entrance criteria|0|||
27907683|NCT01208233|54565228|FG004|Overall Study|Did not meet entrance criteria|1|||
27907684|NCT01208233|54565229|FG005|Overall Study|Did not meet entrance criteria|0|||
27907685|NCT01208233|54565224|FG000|Overall Study|Medication error without adverse event|0|||
27907686|NCT01208233|54565225|FG001|Overall Study|Medication error without adverse event|0|||
27907687|NCT01208233|54565226|FG002|Overall Study|Medication error without adverse event|0|||
27907688|NCT01208233|54565227|FG003|Overall Study|Medication error without adverse event|0|||
27907689|NCT01208233|54565228|FG004|Overall Study|Medication error without adverse event|0|||
27907690|NCT01208233|54565229|FG005|Overall Study|Medication error without adverse event|1|||
27907691|NCT01208233|54565224|FG000|Overall Study|Study terminated by sponsor|0|||
27907692|NCT01208233|54565225|FG001|Overall Study|Study terminated by sponsor|0|||
27907693|NCT01208233|54565226|FG002|Overall Study|Study terminated by sponsor|0|||
27907694|NCT01208233|54565227|FG003|Overall Study|Study terminated by sponsor|0|||
27907695|NCT01208233|54565228|FG004|Overall Study|Study terminated by sponsor|10|||
27907696|NCT01208233|54565229|FG005|Overall Study|Study terminated by sponsor|7|||
27907697|NCT01208233|54565224|FG000|Overall Study|Protocol Violation|0|||
27907698|NCT01208233|54565225|FG001|Overall Study|Protocol Violation|0|||
27990980|NCT00857948|54649621|FG003|Overall Study|Withdrawal by Subject|0|||
27990981|NCT00857948|54649618|FG000|Overall Study|Protocol Violation|1|||
27739666|NCT01634152|54189268|FG000|Overall Study|Other reason not defined above|1|||
27907699|NCT01208233|54565226|FG002|Overall Study|Protocol Violation|0|||
27907700|NCT01208233|54565227|FG003|Overall Study|Protocol Violation|0|||
27990982|NCT00857948|54649619|FG001|Overall Study|Protocol Violation|0|||
27990983|NCT00857948|54649620|FG002|Overall Study|Protocol Violation|1|||
27907701|NCT01208233|54565228|FG004|Overall Study|Protocol Violation|3|||
27907702|NCT01208233|54565229|FG005|Overall Study|Protocol Violation|0|||
27907703|NCT01208233|54565224|FG000|Overall Study|Other|2|||
27907704|NCT01208233|54565225|FG001|Overall Study|Other|1|||
27907705|NCT01208233|54565226|FG002|Overall Study|Other|0|||
27907706|NCT01208233|54565227|FG003|Overall Study|Other|0|||
27907707|NCT01208233|54565228|FG004|Overall Study|Other|0|||
27907708|NCT01208233|54565229|FG005|Overall Study|Other|1|||
27990984|NCT00857948|54649621|FG003|Overall Study|Protocol Violation|0|||
27990985|NCT00866606|54649631|FG000|Overall Study|Lost to Follow-up|3|||
27907709|NCT01208233|54565224|FG000|Overall Study|Withdrawal by Subject|1|||
27907710|NCT01208233|54565225|FG001|Overall Study|Withdrawal by Subject|0|||
27907711|NCT01208233|54565226|FG002|Overall Study|Withdrawal by Subject|1|||
27907712|NCT01208233|54565227|FG003|Overall Study|Withdrawal by Subject|1|||
27907713|NCT01208233|54565228|FG004|Overall Study|Withdrawal by Subject|4|||
27990986|NCT00866606|54649631|FG000|Overall Study|Adverse Event|1|||
27990987|NCT00857792|54649635|FG000|Overall Study|inadequate image quality for analysis|12|||
27907714|NCT01208233|54565229|FG005|Overall Study|Withdrawal by Subject|2|||
27990988|NCT00601835|54649641|FG000|Overall Study|Withdrawal by Subject|9|||
27990989|NCT00601835|54649642|FG001|Overall Study|Withdrawal by Subject|6|||
27990990|NCT00601835|54649641|FG000|Overall Study|Physician Decision|1|||
27990991|NCT00601835|54649642|FG001|Overall Study|Physician Decision|0|||
27907715|NCT01208038|54565249|FG000|Overall Study|Withdrawal by Subject|1|||
27907716|NCT01207687|54565253|FG000|Overall Study|Adverse Event|1|||
27907717|NCT01207687|54565253|FG000|Overall Study|Withdrawal by Subject|1|||
27907718|NCT01207453|54565265|FG000|First Intervention|Adverse Event|2|||
27907719|NCT01207453|54565266|FG001|First Intervention|Adverse Event|1|||
27907720|NCT01207453|54565265|FG000|Washout|Adverse Event|1|||
27990992|NCT00601835|54649641|FG000|Overall Study|Lost to Follow-up|37|||
27990993|NCT00601835|54649642|FG001|Overall Study|Lost to Follow-up|5|||
27990994|NCT00601835|54649641|FG000|Overall Study|Adverse Event|1|||
27990995|NCT00601835|54649642|FG001|Overall Study|Adverse Event|1|||
27990996|NCT00601835|54649641|FG000|Overall Study|Relocate|12|||
27990997|NCT00601835|54649642|FG001|Overall Study|Relocate|2|||
27990998|NCT00857246|54649648|FG000|Induction Regimen|Adverse Event|1|||
27990999|NCT00857246|54649648|FG000|Induction Regimen|disease-related complications|1|||
27991000|NCT00857246|54649648|FG000|Induction Regimen|Withdrawal by Subject|1|||
27991001|NCT00857246|54649648|FG000|Surgery (Curative)|disease progression|6|||
27991002|NCT00857246|54649648|FG000|ChemoRT|Withdrawal by Subject|1|||
27991003|NCT00857246|54649648|FG000|ChemoRT|Adverse Event|2|||
27907721|NCT01207453|54565266|FG001|Washout|Adverse Event|0|||
27907722|NCT01207453|54565265|FG000|Washout|Lost to Follow-up|1|||
27907723|NCT01207453|54565266|FG001|Washout|Lost to Follow-up|0|||
27907724|NCT01207453|54565265|FG000|2nd Intervention|Adverse Event|1|||
27907725|NCT01207453|54565266|FG001|2nd Intervention|Adverse Event|2|||
27907726|NCT01207453|54565265|FG000|2nd Intervention|Lost to Follow-up|1|||
27907727|NCT01207453|54565266|FG001|2nd Intervention|Lost to Follow-up|0|||
27907728|NCT01207414|54565277|FG000|Overall Study|Adverse Event|25|||
27907729|NCT01207414|54565278|FG001|Overall Study|Adverse Event|39|||
27907730|NCT01207414|54565277|FG000|Overall Study|Abnormal test procedure results|0|||
27907731|NCT01207414|54565278|FG001|Overall Study|Abnormal test procedure results|1|||
27907732|NCT01207414|54565277|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
27907733|NCT01207414|54565278|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
27907734|NCT01207414|54565277|FG000|Overall Study|Patient withdrew consent|14|||
27907735|NCT01207414|54565278|FG001|Overall Study|Patient withdrew consent|11|||
27907736|NCT01207414|54565277|FG000|Overall Study|Lost to Follow-up|15|||
27907737|NCT01207414|54565278|FG001|Overall Study|Lost to Follow-up|17|||
27907738|NCT01207414|54565277|FG000|Overall Study|Administrative problems|1|||
27907739|NCT01207414|54565278|FG001|Overall Study|Administrative problems|1|||
27907740|NCT01207414|54565277|FG000|Overall Study|Protocol deviation|12|||
27907741|NCT01207414|54565278|FG001|Overall Study|Protocol deviation|9|||
27907742|NCT01207414|54565277|FG000|Overall Study|Randomized in error|1|||
27907743|NCT01207414|54565278|FG001|Overall Study|Randomized in error|0|||
27907744|NCT01207219|54565287|FG000|Overall Study|changed diagnosis during study period|5|||
27907745|NCT01207219|54565288|FG001|Overall Study|changed diagnosis during study period|3|||
27907746|NCT01207219|54565289|FG002|Overall Study|changed diagnosis during study period|1|||
27907747|NCT01207219|54565287|FG000|Overall Study|Lost to Follow-up|6|||
27907748|NCT01207219|54565288|FG001|Overall Study|Lost to Follow-up|8|||
27907749|NCT01207219|54565289|FG002|Overall Study|Lost to Follow-up|6|||
27907750|NCT01206517|54565303|FG000|Overall Study|Withdrawal by Subject|0|||
27907751|NCT01206517|54565304|FG001|Overall Study|Withdrawal by Subject|0|||
27907752|NCT01206517|54565305|FG002|Overall Study|Withdrawal by Subject|2|||
27907753|NCT01206517|54565306|FG003|Overall Study|Withdrawal by Subject|0|||
27907754|NCT01206517|54565307|FG004|Overall Study|Withdrawal by Subject|1|||
27907755|NCT01206517|54565308|FG005|Overall Study|Withdrawal by Subject|0|||
27907756|NCT01206439|54565319|FG000|Overall Study|subject did not meet inclusion criteria|1|||
27907757|NCT01206322|54565325|FG000|Overall Study|Adverse Event|0|||
27907758|NCT01206322|54565326|FG001|Overall Study|Adverse Event|0|||
27907759|NCT01206322|54565327|FG002|Overall Study|Adverse Event|0|||
27907760|NCT01206322|54565328|FG003|Overall Study|Adverse Event|1|||
27907761|NCT01206166|54565340|FG000|Overall Study|No evaluable data|2|||
27991004|NCT00856856|54649655|FG000|2-year Clinical Follow-up|Lost to Follow-up|1|||
27991005|NCT00856856|54649655|FG000|4-year Clinical Follow-up|Missed visit|1|||
28097750|NCT03039790|54753495|FG000|Overall Study|Death|0|||
27907762|NCT01206166|54565341|FG001|Overall Study|No evaluable data|3|||
27991006|NCT00493285|54649670|FG000|Overall Study|Lost to Follow-up|0|||
27991007|NCT00493285|54649671|FG001|Overall Study|Lost to Follow-up|0|||
27991008|NCT00493285|54649672|FG002|Overall Study|Lost to Follow-up|0|||
27907763|NCT01207102|54565350|FG000|Overall Study|Withdrawal by Subject|5|||
27907764|NCT01207102|54565350|FG000|Overall Study|Adverse Event|2|||
27907765|NCT01207102|54565350|FG000|Overall Study|progression|2|||
27907766|NCT01207102|54565350|FG000|Overall Study|Withdrawal by Treating Physician|1|||
27907767|NCT01205776|54565366|FG000|Overall Study|Lost to Follow-up|53|||
27907768|NCT01205776|54565367|FG001|Overall Study|Lost to Follow-up|61|||
27991009|NCT00493285|54649673|FG003|Overall Study|Lost to Follow-up|0|||
27991010|NCT00493285|54649674|FG004|Overall Study|Lost to Follow-up|1|||
27991011|NCT00493285|54649675|FG005|Overall Study|Lost to Follow-up|0|||
27991012|NCT00856778|54649689|FG000|Overall Study|Adverse Event|7|||
27991013|NCT00856778|54649689|FG000|Overall Study|Withdrawal by Subject|10|||
27991014|NCT00856778|54649689|FG000|Overall Study|Study deviation|2|||
27991015|NCT00856778|54649689|FG000|Overall Study|Lost to Follow-up|5|||
27991016|NCT00603473|54649693|FG000|Overall Study|Adverse Event|4|||
27991017|NCT00603473|54649693|FG000|Overall Study|Lack of Efficacy|4|||
27991018|NCT00603473|54649693|FG000|Overall Study|Protocol Violation|1|||
27991019|NCT00486889|54649697|FG000|Overall Study|Death|3|||
27991020|NCT00486889|54649697|FG000|Overall Study|Non-compliant|2|||
27991021|NCT00486889|54649697|FG000|Overall Study|Withdrawal by Subject|6|||
27991022|NCT00486811|54649704|FG000|Overall Study|Adverse Event|28|||
27991023|NCT00486811|54649705|FG001|Overall Study|Adverse Event|60|||
27991024|NCT00486811|54649706|FG002|Overall Study|Adverse Event|135|||
27991025|NCT00486811|54649704|FG000|Overall Study|Lack of Efficacy|34|||
27991026|NCT00486811|54649705|FG001|Overall Study|Lack of Efficacy|14|||
27991027|NCT00486811|54649706|FG002|Overall Study|Lack of Efficacy|7|||
27991028|NCT00486811|54649704|FG000|Overall Study|Lost to Follow-up|4|||
27991029|NCT00486811|54649705|FG001|Overall Study|Lost to Follow-up|6|||
27991030|NCT00486811|54649706|FG002|Overall Study|Lost to Follow-up|4|||
27991031|NCT00486811|54649704|FG000|Overall Study|Withdrawal by Subject|33|||
27991032|NCT00486811|54649705|FG001|Overall Study|Withdrawal by Subject|44|||
27991033|NCT00486811|54649706|FG002|Overall Study|Withdrawal by Subject|58|||
27991034|NCT00486811|54649704|FG000|Overall Study|Study drug non-compliant|5|||
27991035|NCT00486811|54649705|FG001|Overall Study|Study drug non-compliant|6|||
27991036|NCT00486811|54649706|FG002|Overall Study|Study drug non-compliant|3|||
27991037|NCT00486811|54649704|FG000|Overall Study|All other|18|||
27991038|NCT00486811|54649705|FG001|Overall Study|All other|11|||
27991039|NCT00486811|54649706|FG002|Overall Study|All other|7|||
27991040|NCT00486265|54649714|FG000|Overall Study|Adverse Event|1|||
27991041|NCT00486265|54649714|FG000|Overall Study|Lack of Efficacy|8|||
27991042|NCT02151604|54649718|FG000|Overall Study|Lost to Follow-up|3|||
27991043|NCT02151604|54649718|FG000|Overall Study|Withdrawal by Subject|2|||
27991044|NCT02151604|54649718|FG000|Overall Study|Physician Decision|3|||
27991045|NCT02151604|54649718|FG000|Overall Study|Death|1|||
27991046|NCT00466921|54649723|FG000|First 3 Cycles of Treatment|Adverse Event|2|||
27991047|NCT00466921|54649723|FG000|First 3 Cycles of Treatment|Withdrawal by Subject|5|||
27991048|NCT00466921|54649723|FG000|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2|||
27991049|NCT00466921|54649723|FG000|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2|||
27991050|NCT00466921|54649723|FG000|Completed 4 Cycles/Reached 1st Response|Other|1|||
28097751|NCT03039790|54753496|FG001|Overall Study|Death|0|||
28097752|NCT03039790|54753497|FG002|Overall Study|Death|0|||
28097753|NCT03039790|54753498|FG003|Overall Study|Death|0|||
28097754|NCT03039790|54753499|FG004|Overall Study|Death|0|||
28097755|NCT03039790|54753500|FG005|Overall Study|Death|0|||
28097756|NCT03039790|54753501|FG006|Overall Study|Death|0|||
28097757|NCT03039790|54753502|FG007|Overall Study|Death|0|||
28097758|NCT03039790|54753503|FG008|Overall Study|Death|0|||
28097759|NCT03039790|54753504|FG009|Overall Study|Death|0|||
28097760|NCT03039790|54753505|FG010|Overall Study|Death|0|||
28172361|NCT02406742|54844034|FG001|Overall Study|Withdrawal by Participant|2|||
28172362|NCT02406742|54844035|FG002|Overall Study|Withdrawal by Participant|0|||
28172363|NCT02406742|54844033|FG000|Overall Study|Physician Decision|1|||
27739667|NCT01634152|54189269|FG001|Overall Study|Other reason not defined above|0|||
27739668|NCT01634152|54189270|FG002|Overall Study|Other reason not defined above|1|||
27739669|NCT03862807|54189278|FG000|Overall Study|Not Treated Due to Eligibility Criteria Failure|1|||
27907769|NCT01205776|54565366|FG000|Overall Study|Withdrawal by Subject|11|||
27907770|NCT01205776|54565367|FG001|Overall Study|Withdrawal by Subject|34|||
27991051|NCT00466921|54649723|FG000|Follow up for a Minimum of 1 Year|Death|6|||
27991052|NCT00601523|54649729|FG000|Overall Study|Adverse Event|42|||
27991053|NCT00601523|54649730|FG001|Overall Study|Adverse Event|14|||
28097761|NCT03039790|54753506|FG011|Overall Study|Death|0|||
28097762|NCT03039790|54753507|FG012|Overall Study|Death|0|||
28097763|NCT03039790|54753508|FG013|Overall Study|Death|0|||
27907771|NCT01205581|54565379|FG000|Overall Study|Withdrawal by Subject|1|||
27991054|NCT00601523|54649729|FG000|Overall Study|Lack of Efficacy|3|||
27991055|NCT00601523|54649730|FG001|Overall Study|Lack of Efficacy|0|||
27991056|NCT00601523|54649729|FG000|Overall Study|Protocol Violation|5|||
27991057|NCT00601523|54649730|FG001|Overall Study|Protocol Violation|1|||
27991058|NCT00601523|54649729|FG000|Overall Study|Lost to Follow-up|0|||
28097764|NCT03039790|54753509|FG014|Overall Study|Death|0|||
28172364|NCT02406742|54844034|FG001|Overall Study|Physician Decision|2|||
27991059|NCT00601523|54649730|FG001|Overall Study|Lost to Follow-up|1|||
27991060|NCT00601523|54649729|FG000|Overall Study|Withdrawal by Subject|18|||
27991061|NCT00601523|54649730|FG001|Overall Study|Withdrawal by Subject|9|||
27739670|NCT01378429|54189302|FG000|Overall Study|Noncompliance with study drug|1|||
27739671|NCT01378429|54189303|FG001|Overall Study|Noncompliance with study drug|0|||
27739672|NCT01599754|54189314|FG000|Overall Study|Anticancer therapy need not in protocol|5|||
27739673|NCT01599754|54189315|FG001|Overall Study|Anticancer therapy need not in protocol|2|||
27739674|NCT01599754|54189314|FG000|Overall Study|Participant noncompliance|4|||
27991062|NCT00601523|54649729|FG000|Overall Study|Other|9|||
27991063|NCT00601523|54649730|FG001|Overall Study|Other|1|||
27991064|NCT00466687|54649736|FG000|Overall Study|Adverse Event|1|||
27991065|NCT00466687|54649736|FG000|Overall Study|Other complicating illness|3|||
27991066|NCT00466687|54649736|FG000|Overall Study|Withdrawal by Subject|1|||
27991067|NCT00466687|54649736|FG000|Overall Study|Disease progression|29|||
27991068|NCT00465985|54649758|FG000|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4|||
27991069|NCT00465985|54649759|FG001|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
28097765|NCT03039790|54753510|FG015|Overall Study|Death|1|||
28097766|NCT03039790|54753511|FG016|Overall Study|Death|3|||
28097767|NCT03039790|54753512|FG017|Overall Study|Death|0|||
28097768|NCT03039790|54753513|FG018|Overall Study|Death|2|||
28097769|NCT03039790|54753514|FG019|Overall Study|Death|0|||
28097770|NCT03039790|54753495|FG000|Overall Study|Reason, not Specified|1|||
28097771|NCT03039790|54753496|FG001|Overall Study|Reason, not Specified|0|||
28097772|NCT03039790|54753497|FG002|Overall Study|Reason, not Specified|0|||
28097773|NCT03039790|54753498|FG003|Overall Study|Reason, not Specified|0|||
28097774|NCT03039790|54753499|FG004|Overall Study|Reason, not Specified|0|||
28097775|NCT03039790|54753500|FG005|Overall Study|Reason, not Specified|0|||
28097776|NCT03039790|54753501|FG006|Overall Study|Reason, not Specified|0|||
28097777|NCT03039790|54753502|FG007|Overall Study|Reason, not Specified|0|||
28097778|NCT03039790|54753503|FG008|Overall Study|Reason, not Specified|0|||
28097779|NCT03039790|54753504|FG009|Overall Study|Reason, not Specified|0|||
28097780|NCT03039790|54753505|FG010|Overall Study|Reason, not Specified|0|||
28097781|NCT03039790|54753506|FG011|Overall Study|Reason, not Specified|0|||
28097782|NCT03039790|54753507|FG012|Overall Study|Reason, not Specified|0|||
28097783|NCT03039790|54753508|FG013|Overall Study|Reason, not Specified|0|||
28097784|NCT03039790|54753509|FG014|Overall Study|Reason, not Specified|0|||
28097785|NCT03039790|54753510|FG015|Overall Study|Reason, not Specified|0|||
28097786|NCT03039790|54753511|FG016|Overall Study|Reason, not Specified|2|||
28097787|NCT03039790|54753512|FG017|Overall Study|Reason, not Specified|0|||
28097788|NCT03039790|54753513|FG018|Overall Study|Reason, not Specified|1|||
28097789|NCT03039790|54753514|FG019|Overall Study|Reason, not Specified|0|||
28097790|NCT03038620|54753587|FG000|Overall Study|Lost to Follow-up|18|||
28097791|NCT03038620|54753588|FG001|Overall Study|Lost to Follow-up|23|||
28097792|NCT03038620|54753587|FG000|Overall Study|Withdrawal by Subject|0|||
28097793|NCT03038620|54753588|FG001|Overall Study|Withdrawal by Subject|15|||
28097794|NCT03038620|54753587|FG000|Overall Study|Uninterpretable Outcome (Imaging)|1|||
28097795|NCT03038620|54753588|FG001|Overall Study|Uninterpretable Outcome (Imaging)|0|||
28097796|NCT01350934|54753609|FG000|Base Study|Adverse Event|6|||
28097797|NCT01350934|54753610|FG001|Base Study|Adverse Event|0|||
28097798|NCT01350934|54753609|FG000|Base Study|Lost to Follow-up|1|||
28097799|NCT01350934|54753610|FG001|Base Study|Lost to Follow-up|0|||
28097800|NCT01350934|54753609|FG000|Base Study|Protocol Violation|1|||
28097801|NCT01350934|54753610|FG001|Base Study|Protocol Violation|1|||
28097802|NCT01350934|54753609|FG000|Base Study|Withdrawal by Subject|1|||
28097803|NCT01350934|54753610|FG001|Base Study|Withdrawal by Subject|2|||
28097804|NCT01350934|54753609|FG000|Base Study|Non-Compliance With Study Drug|2|||
28097805|NCT01350934|54753610|FG001|Base Study|Non-Compliance With Study Drug|0|||
28097806|NCT01350934|54753609|FG000|Extension Study|Adverse Event|2|||
28097807|NCT01350934|54753610|FG001|Extension Study|Adverse Event|1|||
28097808|NCT01350934|54753609|FG000|Extension Study|Lost to Follow-up|2|||
28097809|NCT01350934|54753610|FG001|Extension Study|Lost to Follow-up|0|||
27739675|NCT01599754|54189315|FG001|Overall Study|Participant noncompliance|4|||
27907772|NCT01205581|54565380|FG001|Overall Study|Withdrawal by Subject|0|||
27907773|NCT01205581|54565381|FG002|Overall Study|Withdrawal by Subject|0|||
27907774|NCT01205581|54565382|FG003|Overall Study|Withdrawal by Subject|0|||
27907775|NCT01205581|54565383|FG004|Overall Study|Withdrawal by Subject|0|||
27907776|NCT01205581|54565384|FG005|Overall Study|Withdrawal by Subject|0|||
27907777|NCT01205269|54565415|FG000|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
27907778|NCT01205269|54565416|FG001|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
27907779|NCT01205269|54565417|FG002|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
27907780|NCT01205269|54565418|FG003|Period 4 - Washout|Eligibility criteria not fulfilled|1|||
27907781|NCT01205269|54565419|FG004|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
27907782|NCT01205269|54565420|FG005|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
28097810|NCT01350934|54753609|FG000|Extension Study|Protocol Violation|1|||
28097811|NCT01350934|54753610|FG001|Extension Study|Protocol Violation|1|||
28097812|NCT01350934|54753609|FG000|Extension Study|Lack of Efficacy|0|||
28172365|NCT02406742|54844035|FG002|Overall Study|Physician Decision|1|||
28172366|NCT02406742|54844033|FG000|Overall Study|Transition to other treatment|2|||
28172367|NCT02406742|54844034|FG001|Overall Study|Transition to other treatment|0|||
27991070|NCT00465985|54649758|FG000|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0|||
27991071|NCT00465985|54649759|FG001|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12|||
27991072|NCT00465985|54649758|FG000|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1|||
27991073|NCT00465985|54649759|FG001|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
27991074|NCT00465985|54649758|FG000|Part III - Open-label Treatment Period|Adverse Event|1|||
27991075|NCT00465985|54649759|FG001|Part III - Open-label Treatment Period|Adverse Event|0|||
27991076|NCT00454051|54649770|FG000|Overall Study|Adverse Event|1|||
27991077|NCT00454051|54649771|FG001|Overall Study|Adverse Event|2|||
27991078|NCT00454051|54649770|FG000|Overall Study|Withdrawal by Subject|1|||
27991079|NCT00454051|54649771|FG001|Overall Study|Withdrawal by Subject|0|||
27991080|NCT00454051|54649770|FG000|Overall Study|Protocol Violation|1|||
27991081|NCT00454051|54649771|FG001|Overall Study|Protocol Violation|1|||
27991082|NCT00484939|54649779|FG000|Overall Study|Death|9|||
27991083|NCT00484939|54649780|FG001|Overall Study|Death|13|||
27991084|NCT00484939|54649779|FG000|Overall Study|Adverse Event|22|||
27991085|NCT00484939|54649780|FG001|Overall Study|Adverse Event|12|||
27991086|NCT00484939|54649779|FG000|Overall Study|Patient Withdrew Consent|19|||
27991087|NCT00484939|54649780|FG001|Overall Study|Patient Withdrew Consent|10|||
27991088|NCT00484939|54649779|FG000|Overall Study|Protocol Violation|3|||
27991089|NCT00484939|54649780|FG001|Overall Study|Protocol Violation|3|||
27991090|NCT00484939|54649779|FG000|Overall Study|Lost to Follow-up|0|||
27991091|NCT00484939|54649780|FG001|Overall Study|Lost to Follow-up|3|||
27991092|NCT00484939|54649779|FG000|Overall Study|Discretion of Investigator or Sponsor|7|||
27991093|NCT00484939|54649780|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
27991094|NCT00484939|54649779|FG000|Overall Study|Disease progression|67|||
27991095|NCT00484939|54649780|FG001|Overall Study|Disease progression|88|||
27991096|NCT00484939|54649779|FG000|Overall Study|Screen Failure|2|||
27991097|NCT00484939|54649780|FG001|Overall Study|Screen Failure|2|||
27991098|NCT00484939|54649779|FG000|Overall Study|Reason Not Specified|11|||
27991099|NCT00484939|54649780|FG001|Overall Study|Reason Not Specified|6|||
27991100|NCT00453973|54649788|FG000|Overall Study|Adverse Event|4|||
27991101|NCT00453973|54649789|FG001|Overall Study|Adverse Event|9|||
27991102|NCT00453973|54649788|FG000|Overall Study|Withdrawal by Subject|7|||
27991103|NCT00453973|54649789|FG001|Overall Study|Withdrawal by Subject|6|||
27991104|NCT00453973|54649788|FG000|Overall Study|PI Decision|0|||
27991105|NCT00453973|54649789|FG001|Overall Study|PI Decision|2|||
27991106|NCT00453973|54649788|FG000|Overall Study|Relocation|1|||
27991107|NCT00453973|54649789|FG001|Overall Study|Relocation|0|||
27991108|NCT00453973|54649788|FG000|Overall Study|Renal transplant|1|||
27991109|NCT00453973|54649789|FG001|Overall Study|Renal transplant|1|||
27991110|NCT00453973|54649788|FG000|Overall Study|Site closed by sponsor|3|||
27991111|NCT00453973|54649789|FG001|Overall Study|Site closed by sponsor|0|||
27991112|NCT00453973|54649788|FG000|Overall Study|Sponsor Decision to Terminate Study|35|||
27991113|NCT00453973|54649789|FG001|Overall Study|Sponsor Decision to Terminate Study|30|||
27991114|NCT00465361|54649795|FG000|Baseline Assessment|Personal Issues/Scheduling|4|||
28097813|NCT01350934|54753610|FG001|Extension Study|Lack of Efficacy|1|||
28097814|NCT01350934|54753609|FG000|Extension Study|Withdrawal by Subject|0|||
28097815|NCT01350934|54753610|FG001|Extension Study|Withdrawal by Subject|1|||
28097816|NCT03622580|54753634|FG000|Overall Study|Death|16|||
28097817|NCT03622580|54753635|FG001|Overall Study|Death|21|||
28097818|NCT03622580|54753636|FG002|Overall Study|Death|13|||
28097819|NCT03622580|54753634|FG000|Overall Study|Adverse Event|6|||
28097820|NCT03622580|54753635|FG001|Overall Study|Adverse Event|6|||
27907783|NCT01240915|54565445|FG000|Overall Study|Adverse Event|0|||
27907784|NCT01240915|54565446|FG001|Overall Study|Adverse Event|0|||
27907785|NCT01240915|54565447|FG002|Overall Study|Adverse Event|0|||
27907786|NCT01240915|54565448|FG003|Overall Study|Adverse Event|1|||
27907787|NCT01240915|54565449|FG004|Overall Study|Adverse Event|0|||
27907788|NCT01240915|54565450|FG005|Overall Study|Adverse Event|2|||
27907789|NCT01240915|54565451|FG006|Overall Study|Adverse Event|0|||
27907790|NCT01240915|54565452|FG007|Overall Study|Adverse Event|0|||
27907791|NCT01240915|54565453|FG008|Overall Study|Adverse Event|1|||
27907792|NCT01240915|54565445|FG000|Overall Study|Lost to Follow-up|0|||
27907793|NCT01240915|54565446|FG001|Overall Study|Lost to Follow-up|0|||
27907794|NCT01240915|54565447|FG002|Overall Study|Lost to Follow-up|0|||
28097821|NCT03622580|54753636|FG002|Overall Study|Adverse Event|5|||
27991115|NCT00464815|54649801|FG000|Overall Study|Withdrawal by Subject|6|||
27991116|NCT00464815|54649802|FG001|Overall Study|Withdrawal by Subject|3|||
27991117|NCT00464737|54649811|FG000|Overall Study|Adverse Event|12|||
27991118|NCT00464737|54649812|FG001|Overall Study|Adverse Event|17|||
27991119|NCT00464737|54649813|FG002|Overall Study|Adverse Event|33|||
27991120|NCT00464737|54649811|FG000|Overall Study|Lack of Efficacy|7|||
27991121|NCT00464737|54649812|FG001|Overall Study|Lack of Efficacy|7|||
27991122|NCT00464737|54649813|FG002|Overall Study|Lack of Efficacy|4|||
27991123|NCT00464737|54649811|FG000|Overall Study|Withdrawal by Subject|5|||
27991124|NCT00464737|54649812|FG001|Overall Study|Withdrawal by Subject|3|||
27991125|NCT00464737|54649813|FG002|Overall Study|Withdrawal by Subject|5|||
27991126|NCT00464737|54649811|FG000|Overall Study|Protocol Violation|1|||
27991127|NCT00464737|54649812|FG001|Overall Study|Protocol Violation|1|||
27991128|NCT00464737|54649813|FG002|Overall Study|Protocol Violation|5|||
27991129|NCT00464737|54649811|FG000|Overall Study|Non-compliance|0|||
27991130|NCT00464737|54649812|FG001|Overall Study|Non-compliance|1|||
27991131|NCT00464737|54649813|FG002|Overall Study|Non-compliance|1|||
27991132|NCT00464737|54649811|FG000|Overall Study|Lost to Follow-up|5|||
28097822|NCT03622580|54753634|FG000|Overall Study|Withdrawal by Subject|12|||
28097823|NCT03622580|54753635|FG001|Overall Study|Withdrawal by Subject|7|||
28097824|NCT03622580|54753636|FG002|Overall Study|Withdrawal by Subject|19|||
28097825|NCT03622580|54753634|FG000|Overall Study|Lost to Follow-up|12|||
28172368|NCT02406742|54844035|FG002|Overall Study|Transition to other treatment|1|||
28172369|NCT02406742|54844033|FG000|Overall Study|Other Reasons|1|||
28172370|NCT02406742|54844034|FG001|Overall Study|Other Reasons|11|||
28172371|NCT02406742|54844035|FG002|Overall Study|Other Reasons|5|||
28172372|NCT02714595|54844045|FG000|Overall Study|Lost to Follow-up|1|||
28172373|NCT02714595|54844046|FG001|Overall Study|Lost to Follow-up|0|||
28172374|NCT02714595|54844045|FG000|Overall Study|Withdrawal by Subject|1|||
28172375|NCT02714595|54844046|FG001|Overall Study|Withdrawal by Subject|2|||
28172376|NCT02714595|54844045|FG000|Overall Study|Lack of Efficacy|0|||
28172377|NCT02714595|54844046|FG001|Overall Study|Lack of Efficacy|1|||
28172378|NCT02714595|54844045|FG000|Overall Study|Death|30|||
28172379|NCT02714595|54844046|FG001|Overall Study|Death|9|||
28172380|NCT02714595|54844045|FG000|Overall Study|Other-Miscellaneous|0|||
28097826|NCT03622580|54753635|FG001|Overall Study|Lost to Follow-up|9|||
28097827|NCT03622580|54753636|FG002|Overall Study|Lost to Follow-up|9|||
28097828|NCT03622580|54753634|FG000|Overall Study|Protocol Violation|1|||
28097829|NCT03622580|54753635|FG001|Overall Study|Protocol Violation|0|||
28097830|NCT03622580|54753636|FG002|Overall Study|Protocol Violation|1|||
28097831|NCT03622580|54753634|FG000|Overall Study|Physician Decision|3|||
28097832|NCT03622580|54753635|FG001|Overall Study|Physician Decision|0|||
28097833|NCT03622580|54753636|FG002|Overall Study|Physician Decision|1|||
28097834|NCT03622580|54753634|FG000|Overall Study|Pregnancy|0|||
28097835|NCT03622580|54753635|FG001|Overall Study|Pregnancy|1|||
28097836|NCT03622580|54753636|FG002|Overall Study|Pregnancy|0|||
28097837|NCT03622580|54753634|FG000|Overall Study|Lack of Efficacy|0|||
28097838|NCT03622580|54753635|FG001|Overall Study|Lack of Efficacy|0|||
28097839|NCT03622580|54753636|FG002|Overall Study|Lack of Efficacy|1|||
28097840|NCT03622580|54753634|FG000|Overall Study|Other|2|||
28097841|NCT03622580|54753635|FG001|Overall Study|Other|0|||
28097842|NCT03622580|54753636|FG002|Overall Study|Other|3|||
28097843|NCT00461032|54753647|FG000|Overall Study|Adverse Event|5|||
28097844|NCT00461032|54753648|FG001|Overall Study|Adverse Event|6|||
28097845|NCT00461032|54753647|FG000|Overall Study|Lack of Efficacy|5|||
28097846|NCT00461032|54753648|FG001|Overall Study|Lack of Efficacy|1|||
28097847|NCT00461032|54753647|FG000|Overall Study|Lost to Follow-up|7|||
28097848|NCT00461032|54753648|FG001|Overall Study|Lost to Follow-up|12|||
28097849|NCT00461032|54753647|FG000|Overall Study|Protocol Violation|4|||
28097850|NCT00461032|54753648|FG001|Overall Study|Protocol Violation|4|||
28097851|NCT00461032|54753647|FG000|Overall Study|Withdrawal by Subject|7|||
28097852|NCT00461032|54753648|FG001|Overall Study|Withdrawal by Subject|15|||
28172381|NCT02714595|54844046|FG001|Overall Study|Other-Miscellaneous|1|||
28172382|NCT02437162|54844073|FG000|Overall Study|Protocol Violation|0|||
28172383|NCT02437162|54844074|FG001|Overall Study|Protocol Violation|1|||
28172384|NCT02437162|54844075|FG002|Overall Study|Protocol Violation|0|||
28172385|NCT02437162|54844073|FG000|Overall Study|Randomized but not treated|0|||
28172386|NCT02437162|54844074|FG001|Overall Study|Randomized but not treated|0|||
28172387|NCT02437162|54844075|FG002|Overall Study|Randomized but not treated|1|||
28172388|NCT02437162|54844073|FG000|Overall Study|Study discontinued by Sponsor|93|||
28172389|NCT02437162|54844074|FG001|Overall Study|Study discontinued by Sponsor|98|||
28172390|NCT02437162|54844075|FG002|Overall Study|Study discontinued by Sponsor|97|||
28172391|NCT02437162|54844073|FG000|Overall Study|Withdrawal by Subject|13|||
28172392|NCT02437162|54844074|FG001|Overall Study|Withdrawal by Subject|7|||
27739676|NCT01599754|54189314|FG000|Overall Study|Lost to Follow-up|13|||
27991133|NCT00464737|54649812|FG001|Overall Study|Lost to Follow-up|2|||
28097853|NCT00461032|54753647|FG000|Overall Study|Patient Moved or Relocated|2|||
28097854|NCT00461032|54753648|FG001|Overall Study|Patient Moved or Relocated|1|||
28097855|NCT00461032|54753647|FG000|Overall Study|Other|7|||
28097856|NCT00461032|54753648|FG001|Overall Study|Other|5|||
28097857|NCT00090142|54753654|FG000|Treatment Period I|Lost to Follow-up|1|||
28097858|NCT00090142|54753655|FG001|Treatment Period I|Lost to Follow-up|2|||
28097859|NCT00090142|54753654|FG000|Treatment Period I|Protocol Violation|2|||
28172393|NCT02437162|54844075|FG002|Overall Study|Withdrawal by Subject|9|||
27991134|NCT00464737|54649813|FG002|Overall Study|Lost to Follow-up|5|||
28097860|NCT00090142|54753655|FG001|Treatment Period I|Protocol Violation|0|||
28172394|NCT02437162|54844073|FG000|Overall Study|Adverse Event|0|||
28172395|NCT02437162|54844074|FG001|Overall Study|Adverse Event|1|||
27991135|NCT00464737|54649811|FG000|Overall Study|Other: Subject's schedule doesn't permit|1|||
27991136|NCT00464737|54649812|FG001|Overall Study|Other: Subject's schedule doesn't permit|0|||
27991137|NCT00464737|54649813|FG002|Overall Study|Other: Subject's schedule doesn't permit|0|||
27991138|NCT00464737|54649811|FG000|Overall Study|Other: Subject left town; family illness|1|||
27991139|NCT00464737|54649812|FG001|Overall Study|Other: Subject left town; family illness|0|||
27991140|NCT00464737|54649813|FG002|Overall Study|Other: Subject left town; family illness|0|||
27991141|NCT00464737|54649811|FG000|Overall Study|Other: Study demands too great|0|||
27991142|NCT00464737|54649812|FG001|Overall Study|Other: Study demands too great|1|||
27991143|NCT00464737|54649813|FG002|Overall Study|Other: Study demands too great|0|||
27991144|NCT00464737|54649811|FG000|Overall Study|Other: Personal family reasons|0|||
27991145|NCT00464737|54649812|FG001|Overall Study|Other: Personal family reasons|0|||
27991146|NCT00464737|54649813|FG002|Overall Study|Other: Personal family reasons|1|||
27991147|NCT00464737|54649811|FG000|Overall Study|Other: Subject's disability per sponsor|0|||
27991148|NCT00464737|54649812|FG001|Overall Study|Other: Subject's disability per sponsor|0|||
27991149|NCT00464737|54649813|FG002|Overall Study|Other: Subject's disability per sponsor|1|||
27991150|NCT00453349|54649823|FG000|Randomized|Adverse Event|12|||
27991151|NCT00453349|54649824|FG001|Randomized|Adverse Event|11|||
27991152|NCT00453349|54649823|FG000|Randomized|Lack of Efficacy|2|||
27991153|NCT00453349|54649824|FG001|Randomized|Lack of Efficacy|1|||
28172396|NCT02437162|54844075|FG002|Overall Study|Adverse Event|0|||
28172397|NCT02437162|54844073|FG000|Overall Study|Lost to Follow-up|1|||
27991154|NCT00453349|54649823|FG000|Randomized|Lost to Follow-up|7|||
27991155|NCT00453349|54649824|FG001|Randomized|Lost to Follow-up|5|||
27991156|NCT00453349|54649823|FG000|Randomized|Protocol Violation|1|||
27991157|NCT00453349|54649824|FG001|Randomized|Protocol Violation|1|||
27991158|NCT00453349|54649823|FG000|Randomized|Withdrawal by Subject|3|||
27991159|NCT00453349|54649824|FG001|Randomized|Withdrawal by Subject|5|||
27991160|NCT00453349|54649823|FG000|Reaching of Primary Endpoint (TOC)|Missing information|10|||
27991161|NCT00453349|54649824|FG001|Reaching of Primary Endpoint (TOC)|Missing information|11|||
27991162|NCT00453349|54649823|FG000|Completed Study|Adverse Event|12|||
27991163|NCT00453349|54649824|FG001|Completed Study|Adverse Event|11|||
27991164|NCT00453349|54649823|FG000|Completed Study|Lack of Efficacy|2|||
27991165|NCT00453349|54649824|FG001|Completed Study|Lack of Efficacy|1|||
27991166|NCT00453349|54649823|FG000|Completed Study|Lost to Follow-up|7|||
28172398|NCT02437162|54844074|FG001|Overall Study|Lost to Follow-up|0|||
28172399|NCT02437162|54844075|FG002|Overall Study|Lost to Follow-up|1|||
28172400|NCT02437162|54844073|FG000|Overall Study|Death|0|||
28172401|NCT02437162|54844074|FG001|Overall Study|Death|1|||
28172402|NCT02437162|54844075|FG002|Overall Study|Death|0|||
28172403|NCT02437162|54844073|FG000|Overall Study|Other|0|||
28172404|NCT02437162|54844074|FG001|Overall Study|Other|0|||
28172405|NCT02437162|54844075|FG002|Overall Study|Other|1|||
28172406|NCT01368211|54844090|FG000|Second Platelets Transfusion|No need for additional transfusion|1|||
28172407|NCT01368211|54844091|FG001|Second Platelets Transfusion|No need for additional transfusion|2|||
27907795|NCT01240915|54565448|FG003|Overall Study|Lost to Follow-up|0|||
27907796|NCT01240915|54565449|FG004|Overall Study|Lost to Follow-up|1|||
27907797|NCT01240915|54565450|FG005|Overall Study|Lost to Follow-up|1|||
27907798|NCT01240915|54565451|FG006|Overall Study|Lost to Follow-up|0|||
27907799|NCT01240915|54565452|FG007|Overall Study|Lost to Follow-up|1|||
27907800|NCT01240915|54565453|FG008|Overall Study|Lost to Follow-up|1|||
27907801|NCT01240915|54565445|FG000|Overall Study|Withdrawal by Subject|2|||
27907802|NCT01240915|54565446|FG001|Overall Study|Withdrawal by Subject|1|||
27907803|NCT01240915|54565447|FG002|Overall Study|Withdrawal by Subject|0|||
27907804|NCT01240915|54565448|FG003|Overall Study|Withdrawal by Subject|2|||
27907805|NCT01240915|54565449|FG004|Overall Study|Withdrawal by Subject|0|||
27907806|NCT01240915|54565450|FG005|Overall Study|Withdrawal by Subject|4|||
27907807|NCT01240915|54565451|FG006|Overall Study|Withdrawal by Subject|2|||
27907808|NCT01240915|54565452|FG007|Overall Study|Withdrawal by Subject|3|||
27907809|NCT01240915|54565453|FG008|Overall Study|Withdrawal by Subject|3|||
27907810|NCT01240915|54565445|FG000|Overall Study|Other|0|||
27907811|NCT01240915|54565446|FG001|Overall Study|Other|0|||
27907812|NCT01240915|54565447|FG002|Overall Study|Other|0|||
27907813|NCT01240915|54565448|FG003|Overall Study|Other|0|||
27907814|NCT01240915|54565449|FG004|Overall Study|Other|2|||
27991167|NCT00453349|54649824|FG001|Completed Study|Lost to Follow-up|5|||
27991168|NCT00453349|54649823|FG000|Completed Study|Protocol Violation|1|||
27991169|NCT00453349|54649824|FG001|Completed Study|Protocol Violation|1|||
27991170|NCT00453349|54649823|FG000|Completed Study|Withdrawal by Subject|3|||
27907815|NCT01240915|54565450|FG005|Overall Study|Other|0|||
27907816|NCT01240915|54565451|FG006|Overall Study|Other|0|||
27991171|NCT00453349|54649824|FG001|Completed Study|Withdrawal by Subject|5|||
27991172|NCT00453349|54649823|FG000|Completed Study|Lost to follow up after study treatment|2|||
28172408|NCT02437084|54844097|FG000|Overall Study|Withdrawal by Subject|2|||
28172409|NCT02437084|54844097|FG000|Overall Study|Physician Decision|1|||
27907817|NCT01240915|54565452|FG007|Overall Study|Other|0|||
27907818|NCT01240915|54565453|FG008|Overall Study|Other|0|||
28172410|NCT02406586|54844104|FG000|Overall Study|Lost to Follow-up|0|||
27907819|NCT01240915|54565445|FG000|Overall Study|Insufficient Clinical Response|0|||
27907820|NCT01240915|54565446|FG001|Overall Study|Insufficient Clinical Response|0|||
27907821|NCT01240915|54565447|FG002|Overall Study|Insufficient Clinical Response|0|||
27907822|NCT01240915|54565448|FG003|Overall Study|Insufficient Clinical Response|0|||
27907823|NCT01240915|54565449|FG004|Overall Study|Insufficient Clinical Response|1|||
27907824|NCT01240915|54565450|FG005|Overall Study|Insufficient Clinical Response|3|||
27907825|NCT01240915|54565451|FG006|Overall Study|Insufficient Clinical Response|6|||
27907826|NCT01240915|54565452|FG007|Overall Study|Insufficient Clinical Response|0|||
27991173|NCT00453349|54649824|FG001|Completed Study|Lost to follow up after study treatment|11|||
27991174|NCT00464269|54649834|FG000|Overall Study|Lack of Efficacy|1|||
27991175|NCT00464269|54649835|FG001|Overall Study|Lack of Efficacy|0|||
27991176|NCT00464269|54649836|FG002|Overall Study|Lack of Efficacy|0|||
27991177|NCT00464269|54649837|FG003|Overall Study|Lack of Efficacy|0|||
27991178|NCT00464269|54649834|FG000|Overall Study|Lost to Follow-up|0|||
27991179|NCT00464269|54649835|FG001|Overall Study|Lost to Follow-up|4|||
27991180|NCT00464269|54649836|FG002|Overall Study|Lost to Follow-up|0|||
27991181|NCT00464269|54649837|FG003|Overall Study|Lost to Follow-up|1|||
27991182|NCT00464269|54649834|FG000|Overall Study|Withdrawal by Subject|0|||
27991183|NCT00464269|54649835|FG001|Overall Study|Withdrawal by Subject|2|||
27991184|NCT00464269|54649836|FG002|Overall Study|Withdrawal by Subject|1|||
27991185|NCT00464269|54649837|FG003|Overall Study|Withdrawal by Subject|1|||
27991186|NCT00464269|54649834|FG000|Overall Study|Other reason|3|||
27991187|NCT00464269|54649835|FG001|Overall Study|Other reason|3|||
27991188|NCT00464269|54649836|FG002|Overall Study|Other reason|1|||
27991189|NCT00464269|54649837|FG003|Overall Study|Other reason|1|||
27991190|NCT00464269|54649834|FG000|Overall Study|AE, serious fatal|0|||
27991191|NCT00464269|54649835|FG001|Overall Study|AE, serious fatal|0|||
27991192|NCT00464269|54649836|FG002|Overall Study|AE, serious fatal|1|||
27991193|NCT00464269|54649837|FG003|Overall Study|AE, serious fatal|1|||
27991194|NCT00464269|54649834|FG000|Overall Study|SAE, non-fatal|0|||
28097861|NCT00090142|54753654|FG000|Treatment Period I|Withdrawal by Subject|2|||
28097862|NCT00090142|54753655|FG001|Treatment Period I|Withdrawal by Subject|0|||
28097863|NCT00090142|54753654|FG000|Treatment Period I|Other|0|||
28097864|NCT00090142|54753655|FG001|Treatment Period I|Other|1|||
28097865|NCT00090142|54753654|FG000|Treatment Period II|Other|1|||
28097866|NCT00090142|54753655|FG001|Treatment Period II|Other|0|||
28097867|NCT03622112|54753672|FG000|Overall Study|Withdrawal by Subject|6|||
28097868|NCT03622112|54753673|FG001|Overall Study|Withdrawal by Subject|2|||
28097869|NCT03622112|54753674|FG002|Overall Study|Withdrawal by Subject|4|||
28097870|NCT03622112|54753675|FG003|Overall Study|Withdrawal by Subject|2|||
28097871|NCT03622112|54753676|FG004|Overall Study|Withdrawal by Subject|1|||
28097872|NCT03622112|54753677|FG005|Overall Study|Withdrawal by Subject|2|||
28097873|NCT03622112|54753678|FG006|Overall Study|Withdrawal by Subject|2|||
28097874|NCT03622112|54753672|FG000|Overall Study|Death|0|||
28097875|NCT03622112|54753673|FG001|Overall Study|Death|0|||
28097876|NCT03622112|54753674|FG002|Overall Study|Death|0|||
27907827|NCT01240915|54565453|FG008|Overall Study|Insufficient Clinical Response|3|||
27907828|NCT01239745|54565475|FG000|Overall Study|Study terminated by sponsor|45|||
27907829|NCT01239745|54565475|FG000|Overall Study|Adverse Event|1|||
27907830|NCT01239472|54565481|FG000|Overall Study|Withdrawal by Subject|5|||
27907831|NCT01239472|54565482|FG001|Overall Study|Withdrawal by Subject|1|||
27907832|NCT01239472|54565481|FG000|Overall Study|Adverse Event|0|||
27907833|NCT01239472|54565482|FG001|Overall Study|Adverse Event|1|||
27907834|NCT01239472|54565481|FG000|Overall Study|Lack of Efficacy|0|||
27907835|NCT01239472|54565482|FG001|Overall Study|Lack of Efficacy|1|||
27907836|NCT01229449|54565495|FG000|Overall Study|Withdrawal by Subject|0|||
27907837|NCT01229449|54565496|FG001|Overall Study|Withdrawal by Subject|3|||
27907838|NCT01229449|54565497|FG002|Overall Study|Withdrawal by Subject|0|||
27907839|NCT01229449|54565498|FG003|Overall Study|Withdrawal by Subject|1|||
27907840|NCT01229449|54565499|FG004|Overall Study|Withdrawal by Subject|1|||
27907841|NCT01229449|54565495|FG000|Overall Study|Lost to Follow-up|1|||
27907842|NCT01229449|54565496|FG001|Overall Study|Lost to Follow-up|1|||
27907843|NCT01229449|54565497|FG002|Overall Study|Lost to Follow-up|1|||
27991195|NCT00464269|54649835|FG001|Overall Study|SAE, non-fatal|0|||
27991196|NCT00464269|54649836|FG002|Overall Study|SAE, non-fatal|0|||
27991197|NCT00464269|54649837|FG003|Overall Study|SAE, non-fatal|1|||
28097877|NCT03622112|54753675|FG003|Overall Study|Death|1|||
27907844|NCT01229449|54565498|FG003|Overall Study|Lost to Follow-up|0|||
28097878|NCT03622112|54753676|FG004|Overall Study|Death|0|||
28097879|NCT03622112|54753677|FG005|Overall Study|Death|0|||
28097880|NCT03622112|54753678|FG006|Overall Study|Death|0|||
27907845|NCT01229449|54565499|FG004|Overall Study|Lost to Follow-up|0|||
27907846|NCT01229449|54565495|FG000|Overall Study|Physician Decision|0|||
27991198|NCT00464269|54649834|FG000|Overall Study|AE, non-serious non-fatal|2|||
27991199|NCT00464269|54649835|FG001|Overall Study|AE, non-serious non-fatal|8|||
27991200|NCT00464269|54649836|FG002|Overall Study|AE, non-serious non-fatal|3|||
27991201|NCT00464269|54649837|FG003|Overall Study|AE, non-serious non-fatal|4|||
28097881|NCT03622112|54753672|FG000|Overall Study|Lost to Follow-up|1|||
27907847|NCT01229449|54565496|FG001|Overall Study|Physician Decision|0|||
27907848|NCT01229449|54565497|FG002|Overall Study|Physician Decision|1|||
27907849|NCT01229449|54565498|FG003|Overall Study|Physician Decision|0|||
27907850|NCT01229449|54565499|FG004|Overall Study|Physician Decision|0|||
27907851|NCT01239316|54565511|FG000|Overall Study|Progression/Relapse|11|||
27907852|NCT01239316|54565511|FG000|Overall Study|Adverse Event|1|||
27907853|NCT01239160|54565517|FG000|Overall Study|Lost to Follow-up|3|||
27907854|NCT01239160|54565518|FG001|Overall Study|Lost to Follow-up|5|||
27907855|NCT01239160|54565519|FG002|Overall Study|Lost to Follow-up|0|||
27907856|NCT01239160|54565517|FG000|Overall Study|Withdrawal by Subject|17|||
27907857|NCT01239160|54565518|FG001|Overall Study|Withdrawal by Subject|6|||
27907858|NCT01239160|54565519|FG002|Overall Study|Withdrawal by Subject|2|||
27907859|NCT01239160|54565517|FG000|Overall Study|Physician Decision|5|||
27907860|NCT01239160|54565518|FG001|Overall Study|Physician Decision|7|||
27907861|NCT01239160|54565519|FG002|Overall Study|Physician Decision|2|||
27907862|NCT01239160|54565517|FG000|Overall Study|Early Termination Due to Study Closure|0|||
27907863|NCT01239160|54565518|FG001|Overall Study|Early Termination Due to Study Closure|1|||
27907864|NCT01239160|54565519|FG002|Overall Study|Early Termination Due to Study Closure|6|||
27907865|NCT01239121|54565528|FG000|Overall Study|Withdrawal by Subject|2|||
27907866|NCT01239121|54565529|FG001|Overall Study|Withdrawal by Subject|4|||
27907867|NCT01239121|54565530|FG002|Overall Study|Withdrawal by Subject|0|||
27907868|NCT01239043|54565540|FG000|Overall Study|Protocol Violation|2|||
27907869|NCT01239043|54565541|FG001|Overall Study|Protocol Violation|1|||
27907870|NCT01238848|54565549|FG000|Overall Study|Physician Decision|13|||
27907871|NCT01238848|54565550|FG001|Overall Study|Physician Decision|5|||
27907872|NCT01238575|54565558|FG000|Overall Study|Lack of Efficacy|2|||
27907873|NCT01238575|54565559|FG001|Overall Study|Lack of Efficacy|4|||
27907874|NCT01238575|54565558|FG000|Overall Study|Adverse Event|2|||
27907875|NCT01238575|54565559|FG001|Overall Study|Adverse Event|0|||
27907876|NCT01237951|54565565|FG000|Overall Study|Death|1|||
27907877|NCT01239394|54565569|FG000|Overall Study|Adverse Event|1|||
27907878|NCT01237678|54565576|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5|||
27907879|NCT01237678|54565577|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
27907880|NCT01237678|54565578|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
27907881|NCT01237678|54565576|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24|||
27907882|NCT01237678|54565577|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
27907883|NCT01237678|54565578|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
27991202|NCT00464269|54649834|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
27991203|NCT00464269|54649835|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
27991204|NCT00464269|54649836|FG002|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
27991205|NCT00464269|54649837|FG003|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
27991206|NCT00484315|54649851|FG000|12-Month Clinical Follow-up|Death|6|||
27991207|NCT00484315|54649852|FG001|12-Month Clinical Follow-up|Death|2|||
27991208|NCT00484315|54649851|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|4|||
27991209|NCT00484315|54649852|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|0|||
27991210|NCT00484315|54649851|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
27991211|NCT00484315|54649852|FG001|12-Month Clinical Follow-up|Lost to Follow-up|1|||
27991212|NCT00484315|54649851|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|13|||
27991213|NCT00484315|54649852|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|4|||
27991214|NCT00484315|54649851|FG000|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3|||
27991215|NCT00484315|54649852|FG001|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2|||
27991216|NCT00484315|54649851|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25|||
27991217|NCT00484315|54649852|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11|||
27991218|NCT00484315|54649851|FG000|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3|||
27991219|NCT00484315|54649852|FG001|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2|||
27991220|NCT00463801|54649858|FG000|Overall Study|Protocol Violation|1|||
27991221|NCT00463801|54649858|FG000|Overall Study|Lack of Efficacy|2|||
27991222|NCT00463801|54649858|FG000|Overall Study|Adverse Event|4|||
27991223|NCT00463801|54649858|FG000|Overall Study|Lost to Follow-up|5|||
27991224|NCT00463801|54649858|FG000|Overall Study|No longer require therapy|1|||
27991225|NCT00463567|54649869|FG000|Overall Study|Adverse Event|29|||
27907884|NCT01237678|54565576|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3|||
27991226|NCT00463567|54649870|FG001|Overall Study|Adverse Event|26|||
27991227|NCT00463567|54649871|FG002|Overall Study|Adverse Event|17|||
27991228|NCT00463567|54649872|FG003|Overall Study|Adverse Event|46|||
27991229|NCT00463567|54649873|FG004|Overall Study|Adverse Event|10|||
27991230|NCT00463567|54649874|FG005|Overall Study|Adverse Event|10|||
27907885|NCT01237678|54565577|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
27907886|NCT01237678|54565578|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
27907887|NCT01237678|54565576|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1|||
27907888|NCT01237678|54565577|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
27907889|NCT01237678|54565578|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
27907890|NCT01237678|54565576|FG000|Phase II|Adverse Event|0|||
27907891|NCT01237678|54565577|FG001|Phase II|Adverse Event|39|||
27907892|NCT01237678|54565578|FG002|Phase II|Adverse Event|9|||
27907893|NCT01237678|54565576|FG000|Phase II|Death|0|||
27907894|NCT01237678|54565577|FG001|Phase II|Death|0|||
27907895|NCT01237678|54565578|FG002|Phase II|Death|2|||
27907896|NCT01237678|54565576|FG000|Phase II|Lack of Efficacy|0|||
27907897|NCT01237678|54565577|FG001|Phase II|Lack of Efficacy|25|||
27907898|NCT01237678|54565578|FG002|Phase II|Lack of Efficacy|3|||
27907899|NCT01237678|54565576|FG000|Phase II|Withdrawal by Subject|0|||
27907900|NCT01237678|54565577|FG001|Phase II|Withdrawal by Subject|1|||
27907901|NCT01237678|54565578|FG002|Phase II|Withdrawal by Subject|5|||
27907902|NCT01237678|54565576|FG000|Phase II|Completed Cycles 4-6|0|||
27907903|NCT01237678|54565577|FG001|Phase II|Completed Cycles 4-6|11|||
27907904|NCT01237678|54565578|FG002|Phase II|Completed Cycles 4-6|21|||
27907905|NCT01237678|54565576|FG000|Phase II|Sponsor Decision/Study Closed|0|||
27907906|NCT01237678|54565577|FG001|Phase II|Sponsor Decision/Study Closed|18|||
27907907|NCT01237678|54565578|FG002|Phase II|Sponsor Decision/Study Closed|7|||
27907908|NCT01237678|54565576|FG000|Phase II|Randomized but were not treated|0|||
27907909|NCT01237678|54565577|FG001|Phase II|Randomized but were not treated|4|||
27907910|NCT01237678|54565578|FG002|Phase II|Randomized but were not treated|3|||
27907911|NCT01229371|54565601|FG000|Overall Study|Withdrawal by Subject|0|||
27907912|NCT01229371|54565602|FG001|Overall Study|Withdrawal by Subject|1|||
27907913|NCT01229371|54565603|FG002|Overall Study|Withdrawal by Subject|0|||
27907914|NCT01229371|54565604|FG003|Overall Study|Withdrawal by Subject|0|||
27907915|NCT01237327|54565616|FG000|Overall Study|Protocol Violation: Core Study|1|||
27907916|NCT01237327|54565617|FG001|Overall Study|Protocol Violation: Core Study|0|||
27907917|NCT01237327|54565616|FG000|Overall Study|Completed 26 weeks treatment:Core Study|3|||
27907918|NCT01237327|54565617|FG001|Overall Study|Completed 26 weeks treatment:Core Study|2|||
27907919|NCT01237327|54565616|FG000|Overall Study|Progression of Disease: Core Study|18|||
27907920|NCT01237327|54565617|FG001|Overall Study|Progression of Disease: Core Study|22|||
27907921|NCT01237327|54565616|FG000|Overall Study|Progression of Disease: Extension Study|15|||
27907922|NCT01237327|54565617|FG001|Overall Study|Progression of Disease: Extension Study|13|||
27907923|NCT01237327|54565616|FG000|Overall Study|Protocol Specific Withdrawal Criteria|1|||
27907924|NCT01237327|54565617|FG001|Overall Study|Protocol Specific Withdrawal Criteria|0|||
27907925|NCT01237327|54565616|FG000|Overall Study|Withdrawal by Subject|1|||
27907926|NCT01237327|54565617|FG001|Overall Study|Withdrawal by Subject|3|||
27907927|NCT01237327|54565616|FG000|Overall Study|Lost to Follow-up|3|||
27991231|NCT00463567|54649875|FG006|Overall Study|Adverse Event|4|||
27991232|NCT00463567|54649869|FG000|Overall Study|Withdrawal by Subject|29|||
27991233|NCT00463567|54649870|FG001|Overall Study|Withdrawal by Subject|22|||
27991234|NCT00463567|54649871|FG002|Overall Study|Withdrawal by Subject|20|||
27991235|NCT00463567|54649872|FG003|Overall Study|Withdrawal by Subject|37|||
27991236|NCT00463567|54649873|FG004|Overall Study|Withdrawal by Subject|6|||
27991237|NCT00463567|54649874|FG005|Overall Study|Withdrawal by Subject|5|||
28172411|NCT02406586|54844105|FG001|Overall Study|Lost to Follow-up|4|||
27907928|NCT01237327|54565617|FG001|Overall Study|Lost to Follow-up|0|||
27907929|NCT01237054|54565623|FG000|Overall Study|imaging 10C0096|1|||
27907930|NCT01236352|54565660|FG000|Overall Study|Death|0|||
27907931|NCT01236352|54565661|FG001|Overall Study|Death|0|||
27907932|NCT01236352|54565662|FG002|Overall Study|Death|0|||
27907933|NCT01236352|54565663|FG003|Overall Study|Death|0|||
27907934|NCT01236352|54565664|FG004|Overall Study|Death|0|||
27907935|NCT01236352|54565665|FG005|Overall Study|Death|0|||
27907936|NCT01236352|54565666|FG006|Overall Study|Death|0|||
27907937|NCT01236352|54565667|FG007|Overall Study|Death|1|||
27991238|NCT00463567|54649875|FG006|Overall Study|Withdrawal by Subject|1|||
27991239|NCT00463567|54649869|FG000|Overall Study|Protocol Deviation|13|||
27907938|NCT01236352|54565668|FG008|Overall Study|Death|0|||
27907939|NCT01236352|54565669|FG009|Overall Study|Death|0|||
27907940|NCT01236352|54565670|FG010|Overall Study|Death|0|||
27907941|NCT01236352|54565660|FG000|Overall Study|Withdrawal by Subject|0|||
27907942|NCT01236352|54565661|FG001|Overall Study|Withdrawal by Subject|0|||
27907943|NCT01236352|54565662|FG002|Overall Study|Withdrawal by Subject|0|||
27907944|NCT01236352|54565663|FG003|Overall Study|Withdrawal by Subject|0|||
27907945|NCT01236352|54565664|FG004|Overall Study|Withdrawal by Subject|0|||
27907946|NCT01236352|54565665|FG005|Overall Study|Withdrawal by Subject|0|||
27907947|NCT01236352|54565666|FG006|Overall Study|Withdrawal by Subject|0|||
27907948|NCT01236352|54565667|FG007|Overall Study|Withdrawal by Subject|0|||
27907949|NCT01236352|54565668|FG008|Overall Study|Withdrawal by Subject|0|||
27907950|NCT01236352|54565669|FG009|Overall Study|Withdrawal by Subject|2|||
27907951|NCT01236352|54565670|FG010|Overall Study|Withdrawal by Subject|1|||
27907952|NCT01236352|54565660|FG000|Overall Study|Adverse Event|0|||
27907953|NCT01236352|54565661|FG001|Overall Study|Adverse Event|0|||
27907954|NCT01236352|54565662|FG002|Overall Study|Adverse Event|0|||
27907955|NCT01236352|54565663|FG003|Overall Study|Adverse Event|0|||
27907956|NCT01236352|54565664|FG004|Overall Study|Adverse Event|0|||
27991240|NCT00463567|54649870|FG001|Overall Study|Protocol Deviation|9|||
28172412|NCT02406586|54844106|FG002|Overall Study|Lost to Follow-up|2|||
27907957|NCT01236352|54565665|FG005|Overall Study|Adverse Event|0|||
27907958|NCT01236352|54565666|FG006|Overall Study|Adverse Event|2|||
27907959|NCT01236352|54565667|FG007|Overall Study|Adverse Event|0|||
27907960|NCT01236352|54565668|FG008|Overall Study|Adverse Event|0|||
27907961|NCT01236352|54565669|FG009|Overall Study|Adverse Event|4|||
27907962|NCT01236352|54565670|FG010|Overall Study|Adverse Event|1|||
27907963|NCT01236352|54565660|FG000|Overall Study|Study drug toxicity|0|||
27907964|NCT01236352|54565661|FG001|Overall Study|Study drug toxicity|0|||
27907965|NCT01236352|54565662|FG002|Overall Study|Study drug toxicity|0|||
27907966|NCT01236352|54565663|FG003|Overall Study|Study drug toxicity|0|||
27907967|NCT01236352|54565664|FG004|Overall Study|Study drug toxicity|0|||
27907968|NCT01236352|54565665|FG005|Overall Study|Study drug toxicity|1|||
27907969|NCT01236352|54565666|FG006|Overall Study|Study drug toxicity|1|||
27907970|NCT01236352|54565667|FG007|Overall Study|Study drug toxicity|0|||
27907971|NCT01236352|54565668|FG008|Overall Study|Study drug toxicity|0|||
27907972|NCT01236352|54565669|FG009|Overall Study|Study drug toxicity|2|||
27907973|NCT01236352|54565670|FG010|Overall Study|Study drug toxicity|2|||
27907974|NCT01236352|54565660|FG000|Overall Study|Disease progression|1|||
27907975|NCT01236352|54565661|FG001|Overall Study|Disease progression|2|||
27907976|NCT01236352|54565662|FG002|Overall Study|Disease progression|1|||
27907977|NCT01236352|54565663|FG003|Overall Study|Disease progression|2|||
27907978|NCT01236352|54565664|FG004|Overall Study|Disease progression|2|||
27907979|NCT01236352|54565665|FG005|Overall Study|Disease progression|2|||
27907980|NCT01236352|54565666|FG006|Overall Study|Disease progression|1|||
27907981|NCT01236352|54565667|FG007|Overall Study|Disease progression|3|||
27907982|NCT01236352|54565668|FG008|Overall Study|Disease progression|2|||
27907983|NCT01236352|54565669|FG009|Overall Study|Disease progression|2|||
27991241|NCT00463567|54649871|FG002|Overall Study|Protocol Deviation|14|||
27991242|NCT00463567|54649872|FG003|Overall Study|Protocol Deviation|11|||
27991243|NCT00463567|54649873|FG004|Overall Study|Protocol Deviation|1|||
27991244|NCT00463567|54649874|FG005|Overall Study|Protocol Deviation|1|||
27991245|NCT00463567|54649875|FG006|Overall Study|Protocol Deviation|2|||
27991246|NCT00463567|54649869|FG000|Overall Study|Lost to Follow-up|12|||
27991247|NCT00463567|54649870|FG001|Overall Study|Lost to Follow-up|6|||
27991248|NCT00463567|54649871|FG002|Overall Study|Lost to Follow-up|13|||
27991249|NCT00463567|54649872|FG003|Overall Study|Lost to Follow-up|8|||
27991250|NCT00463567|54649873|FG004|Overall Study|Lost to Follow-up|1|||
27991251|NCT00463567|54649874|FG005|Overall Study|Lost to Follow-up|1|||
27991252|NCT00463567|54649875|FG006|Overall Study|Lost to Follow-up|1|||
27991253|NCT00463567|54649869|FG000|Overall Study|Administrative problems|5|||
27991254|NCT00463567|54649870|FG001|Overall Study|Administrative problems|3|||
27991255|NCT00463567|54649871|FG002|Overall Study|Administrative problems|6|||
27991256|NCT00463567|54649872|FG003|Overall Study|Administrative problems|9|||
27991257|NCT00463567|54649873|FG004|Overall Study|Administrative problems|3|||
27991258|NCT00463567|54649874|FG005|Overall Study|Administrative problems|2|||
27991259|NCT00463567|54649875|FG006|Overall Study|Administrative problems|2|||
27991260|NCT00463567|54649869|FG000|Overall Study|Lack of Efficacy|4|||
27991261|NCT00463567|54649870|FG001|Overall Study|Lack of Efficacy|9|||
27991262|NCT00463567|54649871|FG002|Overall Study|Lack of Efficacy|9|||
27991263|NCT00463567|54649872|FG003|Overall Study|Lack of Efficacy|17|||
27991264|NCT00463567|54649873|FG004|Overall Study|Lack of Efficacy|1|||
27991265|NCT00463567|54649874|FG005|Overall Study|Lack of Efficacy|0|||
27991266|NCT00463567|54649875|FG006|Overall Study|Lack of Efficacy|1|||
27991267|NCT00463567|54649869|FG000|Overall Study|Abnormal lab value(s)|1|||
27991268|NCT00463567|54649870|FG001|Overall Study|Abnormal lab value(s)|1|||
27991269|NCT00463567|54649871|FG002|Overall Study|Abnormal lab value(s)|2|||
27991270|NCT00463567|54649872|FG003|Overall Study|Abnormal lab value(s)|1|||
27991271|NCT00463567|54649873|FG004|Overall Study|Abnormal lab value(s)|1|||
27991272|NCT00463567|54649874|FG005|Overall Study|Abnormal lab value(s)|0|||
27991273|NCT00463567|54649875|FG006|Overall Study|Abnormal lab value(s)|0|||
27991274|NCT00463567|54649869|FG000|Overall Study|Abnormal test procedure result(s)|1|||
27991275|NCT00463567|54649870|FG001|Overall Study|Abnormal test procedure result(s)|1|||
27991276|NCT00463567|54649871|FG002|Overall Study|Abnormal test procedure result(s)|6|||
27991277|NCT00463567|54649872|FG003|Overall Study|Abnormal test procedure result(s)|2|||
27991278|NCT00463567|54649873|FG004|Overall Study|Abnormal test procedure result(s)|0|||
28097882|NCT03622112|54753673|FG001|Overall Study|Lost to Follow-up|1|||
27907984|NCT01236352|54565670|FG010|Overall Study|Disease progression|2|||
27991279|NCT00463567|54649874|FG005|Overall Study|Abnormal test procedure result(s)|2|||
27991280|NCT00463567|54649875|FG006|Overall Study|Abnormal test procedure result(s)|0|||
27991281|NCT00463567|54649869|FG000|Overall Study|Death|1|||
27991282|NCT00463567|54649870|FG001|Overall Study|Death|0|||
27907985|NCT01236352|54565660|FG000|Overall Study|Poor/Non-compliance|1|||
27907986|NCT01236352|54565661|FG001|Overall Study|Poor/Non-compliance|0|||
28097883|NCT03622112|54753674|FG002|Overall Study|Lost to Follow-up|0|||
28097884|NCT03622112|54753675|FG003|Overall Study|Lost to Follow-up|0|||
28097885|NCT03622112|54753676|FG004|Overall Study|Lost to Follow-up|0|||
27907987|NCT01236352|54565662|FG002|Overall Study|Poor/Non-compliance|0|||
27907988|NCT01236352|54565663|FG003|Overall Study|Poor/Non-compliance|0|||
27991283|NCT00463567|54649871|FG002|Overall Study|Death|2|||
28172413|NCT02406586|54844104|FG000|Overall Study|Withdrawal by Subject|1|||
28172414|NCT02406586|54844105|FG001|Overall Study|Withdrawal by Subject|0|||
28172415|NCT02406586|54844106|FG002|Overall Study|Withdrawal by Subject|0|||
28172416|NCT02460562|54844119|FG000|Overall Study|Lost to Follow-up|15|||
28172417|NCT02460562|54844120|FG001|Overall Study|Lost to Follow-up|16|||
28172418|NCT02788357|54844128|FG000|Overall Study|Lost to Follow-up|3|||
28172419|NCT02788357|54844129|FG001|Overall Study|Lost to Follow-up|0|||
28172420|NCT02457910|54844141|FG000|Overall Study|Withdrawal by Subject|0|||
28172421|NCT02457910|54844142|FG001|Overall Study|Withdrawal by Subject|0|||
28172422|NCT02457910|54844143|FG002|Overall Study|Withdrawal by Subject|0|||
28172423|NCT02457910|54844144|FG003|Overall Study|Withdrawal by Subject|0|||
28172424|NCT02457910|54844145|FG004|Overall Study|Withdrawal by Subject|0|||
28172425|NCT02457910|54844146|FG005|Overall Study|Withdrawal by Subject|1|||
28172426|NCT02457910|54844141|FG000|Overall Study|Adverse Event|0|||
28172427|NCT02457910|54844142|FG001|Overall Study|Adverse Event|2|||
28172428|NCT02457910|54844143|FG002|Overall Study|Adverse Event|1|||
28172429|NCT02457910|54844144|FG003|Overall Study|Adverse Event|1|||
28172430|NCT02457910|54844145|FG004|Overall Study|Adverse Event|1|||
28172431|NCT02457910|54844146|FG005|Overall Study|Adverse Event|3|||
28172432|NCT02457910|54844141|FG000|Overall Study|Disease progression|3|||
28097886|NCT03622112|54753677|FG005|Overall Study|Lost to Follow-up|0|||
28097887|NCT03622112|54753678|FG006|Overall Study|Lost to Follow-up|0|||
28097888|NCT03622112|54753672|FG000|Overall Study|Study-specific withdrawal criteria|10|||
28097889|NCT03622112|54753673|FG001|Overall Study|Study-specific withdrawal criteria|8|||
28097890|NCT03622112|54753674|FG002|Overall Study|Study-specific withdrawal criteria|7|||
28097891|NCT03622112|54753675|FG003|Overall Study|Study-specific withdrawal criteria|6|||
28097892|NCT03622112|54753676|FG004|Overall Study|Study-specific withdrawal criteria|4|||
28097893|NCT03622112|54753677|FG005|Overall Study|Study-specific withdrawal criteria|18|||
28097894|NCT03622112|54753678|FG006|Overall Study|Study-specific withdrawal criteria|4|||
28097895|NCT03622112|54753672|FG000|Overall Study|Protocol Violation|2|||
28097896|NCT03622112|54753673|FG001|Overall Study|Protocol Violation|0|||
28097897|NCT03622112|54753674|FG002|Overall Study|Protocol Violation|1|||
28097898|NCT03622112|54753675|FG003|Overall Study|Protocol Violation|1|||
28097899|NCT03622112|54753676|FG004|Overall Study|Protocol Violation|0|||
28097900|NCT03622112|54753677|FG005|Overall Study|Protocol Violation|0|||
28097901|NCT03622112|54753678|FG006|Overall Study|Protocol Violation|0|||
28097902|NCT03622112|54753672|FG000|Overall Study|Adverse Event|6|||
28097903|NCT03622112|54753673|FG001|Overall Study|Adverse Event|8|||
28097904|NCT03622112|54753674|FG002|Overall Study|Adverse Event|4|||
28097905|NCT03622112|54753675|FG003|Overall Study|Adverse Event|11|||
28097906|NCT03622112|54753676|FG004|Overall Study|Adverse Event|4|||
28097907|NCT03622112|54753677|FG005|Overall Study|Adverse Event|20|||
28097908|NCT03622112|54753678|FG006|Overall Study|Adverse Event|2|||
28097909|NCT03622112|54753672|FG000|Overall Study|Reason not specified|0|||
28097910|NCT03622112|54753673|FG001|Overall Study|Reason not specified|1|||
28097911|NCT03622112|54753674|FG002|Overall Study|Reason not specified|0|||
28097912|NCT03622112|54753675|FG003|Overall Study|Reason not specified|1|||
28097913|NCT03622112|54753676|FG004|Overall Study|Reason not specified|1|||
27907989|NCT01236352|54565664|FG004|Overall Study|Poor/Non-compliance|0|||
27907990|NCT01236352|54565665|FG005|Overall Study|Poor/Non-compliance|0|||
27907991|NCT01236352|54565666|FG006|Overall Study|Poor/Non-compliance|0|||
27907992|NCT01236352|54565667|FG007|Overall Study|Poor/Non-compliance|0|||
27907993|NCT01236352|54565668|FG008|Overall Study|Poor/Non-compliance|0|||
27907994|NCT01236352|54565669|FG009|Overall Study|Poor/Non-compliance|0|||
27907995|NCT01236352|54565670|FG010|Overall Study|Poor/Non-compliance|0|||
27907996|NCT01236352|54565660|FG000|Overall Study|Maximum clinical benefit|1|||
27907997|NCT01236352|54565661|FG001|Overall Study|Maximum clinical benefit|1|||
27907998|NCT01236352|54565662|FG002|Overall Study|Maximum clinical benefit|1|||
27907999|NCT01236352|54565663|FG003|Overall Study|Maximum clinical benefit|0|||
27908000|NCT01236352|54565664|FG004|Overall Study|Maximum clinical benefit|2|||
27908001|NCT01236352|54565665|FG005|Overall Study|Maximum clinical benefit|0|||
27908002|NCT01236352|54565666|FG006|Overall Study|Maximum clinical benefit|3|||
27908003|NCT01236352|54565667|FG007|Overall Study|Maximum clinical benefit|1|||
28097914|NCT03622112|54753677|FG005|Overall Study|Reason not specified|2|||
28097915|NCT03622112|54753678|FG006|Overall Study|Reason not specified|1|||
28097916|NCT04032158|54753696|FG000|Overall Study|Study Termination|2|||
28097917|NCT04032158|54753697|FG001|Overall Study|Study Termination|1|||
28097918|NCT03620708|54753706|FG000|Overall Study|Lost to Follow-up|1|||
28097919|NCT03620708|54753707|FG001|Overall Study|Lost to Follow-up|1|||
28097920|NCT03620708|54753708|FG002|Overall Study|Lost to Follow-up|2|||
27908004|NCT01236352|54565668|FG008|Overall Study|Maximum clinical benefit|1|||
27908005|NCT01236352|54565669|FG009|Overall Study|Maximum clinical benefit|4|||
27908006|NCT01236352|54565670|FG010|Overall Study|Maximum clinical benefit|2|||
27908007|NCT01236352|54565660|FG000|Overall Study|Subject request to discontinue treatment|0|||
28172433|NCT02457910|54844142|FG001|Overall Study|Disease progression|3|||
28172434|NCT02457910|54844143|FG002|Overall Study|Disease progression|1|||
28172435|NCT02457910|54844144|FG003|Overall Study|Disease progression|1|||
28172436|NCT02457910|54844145|FG004|Overall Study|Disease progression|4|||
27908008|NCT01236352|54565661|FG001|Overall Study|Subject request to discontinue treatment|0|||
27908009|NCT01236352|54565662|FG002|Overall Study|Subject request to discontinue treatment|1|||
27908010|NCT01236352|54565663|FG003|Overall Study|Subject request to discontinue treatment|1|||
27908011|NCT01236352|54565664|FG004|Overall Study|Subject request to discontinue treatment|0|||
27908012|NCT01236352|54565665|FG005|Overall Study|Subject request to discontinue treatment|1|||
27908013|NCT01236352|54565666|FG006|Overall Study|Subject request to discontinue treatment|0|||
27908014|NCT01236352|54565667|FG007|Overall Study|Subject request to discontinue treatment|0|||
27908015|NCT01236352|54565668|FG008|Overall Study|Subject request to discontinue treatment|0|||
27908016|NCT01236352|54565669|FG009|Overall Study|Subject request to discontinue treatment|1|||
27908017|NCT01236352|54565670|FG010|Overall Study|Subject request to discontinue treatment|4|||
27908018|NCT01236352|54565660|FG000|Overall Study|Subject to receive drug via EAP|1|||
27908019|NCT01236352|54565661|FG001|Overall Study|Subject to receive drug via EAP|1|||
27908020|NCT01236352|54565662|FG002|Overall Study|Subject to receive drug via EAP|1|||
27908021|NCT01236352|54565663|FG003|Overall Study|Subject to receive drug via EAP|0|||
27908022|NCT01236352|54565664|FG004|Overall Study|Subject to receive drug via EAP|0|||
27908023|NCT01236352|54565665|FG005|Overall Study|Subject to receive drug via EAP|0|||
28172437|NCT02457910|54844146|FG005|Overall Study|Disease progression|6|||
28172438|NCT02457910|54844141|FG000|Overall Study|Other complicating illness|0|||
28172439|NCT02457910|54844142|FG001|Overall Study|Other complicating illness|0|||
28172440|NCT02457910|54844143|FG002|Overall Study|Other complicating illness|0|||
28172441|NCT02457910|54844144|FG003|Overall Study|Other complicating illness|0|||
28172442|NCT02457910|54844145|FG004|Overall Study|Other complicating illness|0|||
28172443|NCT02457910|54844146|FG005|Overall Study|Other complicating illness|1|||
28172444|NCT02457910|54844141|FG000|Overall Study|Death|0|||
27991284|NCT00463567|54649872|FG003|Overall Study|Death|0|||
27991285|NCT00463567|54649873|FG004|Overall Study|Death|0|||
27991286|NCT00463567|54649874|FG005|Overall Study|Death|0|||
27991287|NCT00463567|54649875|FG006|Overall Study|Death|0|||
27991288|NCT00484159|54649900|FG000|Overall Study|Lost to Follow-up|1|||
27991289|NCT00484159|54649901|FG001|Overall Study|Lost to Follow-up|1|||
27991290|NCT00484159|54649902|FG002|Overall Study|Lost to Follow-up|0|||
27991291|NCT00462865|54649910|FG000|Overall Study|Adverse Event|1|||
27991292|NCT03839641|54649916|FG000|Overall Study|Withdrawal by Subject|1|||
27991293|NCT03839641|54649917|FG001|Overall Study|Withdrawal by Subject|1|||
27991294|NCT00462709|54649925|FG000|Overall Study|Transitioned to commercial C1INH-nf|40|||
27908024|NCT01236352|54565666|FG006|Overall Study|Subject to receive drug via EAP|0|||
27908025|NCT01236352|54565667|FG007|Overall Study|Subject to receive drug via EAP|2|||
27908026|NCT01236352|54565668|FG008|Overall Study|Subject to receive drug via EAP|0|||
27991295|NCT00462709|54649925|FG000|Overall Study|Lost to Follow-up|10|||
27991296|NCT00462709|54649925|FG000|Overall Study|Withdrawal by Subject|8|||
27991297|NCT00462709|54649925|FG000|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3|||
27991298|NCT00462709|54649925|FG000|Overall Study|Death|2|||
27991299|NCT00462709|54649925|FG000|Overall Study|Logistical reasons|2|||
27991300|NCT00462709|54649925|FG000|Overall Study|Physician Decision|1|||
27991301|NCT00462709|54649925|FG000|Overall Study|Withdrew to start treatment with Cetor|1|||
27991302|NCT00461305|54649931|FG000|Treatment|Adverse Event|26|||
27991303|NCT00461305|54649932|FG001|Treatment|Adverse Event|3|||
27991304|NCT00461305|54649931|FG000|Treatment|Lost to Follow-up|4|||
27991305|NCT00461305|54649932|FG001|Treatment|Lost to Follow-up|2|||
27991306|NCT00461305|54649931|FG000|Treatment|Protocol Violation|13|||
27991307|NCT00461305|54649932|FG001|Treatment|Protocol Violation|2|||
27991308|NCT00461305|54649931|FG000|Treatment|Withdrawal by Subject|48|||
27991309|NCT00461305|54649932|FG001|Treatment|Withdrawal by Subject|2|||
27991310|NCT00461305|54649931|FG000|Treatment|Never dispensed|5|||
27991311|NCT00461305|54649932|FG001|Treatment|Never dispensed|0|||
27991312|NCT00461305|54649931|FG000|Treatment|Study drug not taken|1|||
27991313|NCT00461305|54649932|FG001|Treatment|Study drug not taken|0|||
27991314|NCT00461305|54649931|FG000|Treatment|Partially missing diary|2|||
27991315|NCT00461305|54649932|FG001|Treatment|Partially missing diary|0|||
27908027|NCT01236352|54565669|FG009|Overall Study|Subject to receive drug via EAP|4|||
27908028|NCT01236352|54565670|FG010|Overall Study|Subject to receive drug via EAP|0|||
27908029|NCT01236352|54565660|FG000|Overall Study|Patient moving to allogeneic transplant|0|||
27991316|NCT00461305|54649931|FG000|Treatment|Other (missing drug etc)|2|||
27991317|NCT00461305|54649932|FG001|Treatment|Other (missing drug etc)|0|||
27991318|NCT00461305|54649931|FG000|Continued Treatment|Adverse Event|26|||
27991319|NCT00461305|54649932|FG001|Continued Treatment|Adverse Event|0|||
27991320|NCT00461305|54649931|FG000|Continued Treatment|Lost to Follow-up|4|||
27908030|NCT01236352|54565661|FG001|Overall Study|Patient moving to allogeneic transplant|0|||
27991321|NCT00461305|54649932|FG001|Continued Treatment|Lost to Follow-up|0|||
27991322|NCT00461305|54649931|FG000|Continued Treatment|Protocol Violation|13|||
27991323|NCT00461305|54649932|FG001|Continued Treatment|Protocol Violation|0|||
27991324|NCT00461305|54649931|FG000|Continued Treatment|Withdrawal by Subject|48|||
27991325|NCT00461305|54649932|FG001|Continued Treatment|Withdrawal by Subject|0|||
27991326|NCT00461305|54649931|FG000|Continued Treatment|Partially missing diary|2|||
28172445|NCT02457910|54844142|FG001|Overall Study|Death|0|||
27991327|NCT00461305|54649932|FG001|Continued Treatment|Partially missing diary|0|||
27991328|NCT00461305|54649931|FG000|Continued Treatment|Other (missing drug etc)|2|||
27991329|NCT00461305|54649932|FG001|Continued Treatment|Other (missing drug etc)|0|||
27991330|NCT00856544|54649943|FG000|Overall Study|Randomized but not treated|3|||
27991331|NCT00856544|54649944|FG001|Overall Study|Randomized but not treated|0|||
27991332|NCT00856544|54649945|FG002|Overall Study|Randomized but not treated|0|||
27991333|NCT00856544|54649946|FG003|Overall Study|Randomized but not treated|0|||
27991334|NCT00856544|54649943|FG000|Overall Study|Death|0|||
27991335|NCT00856544|54649944|FG001|Overall Study|Death|2|||
27991336|NCT00856544|54649945|FG002|Overall Study|Death|0|||
27991337|NCT00856544|54649946|FG003|Overall Study|Death|0|||
27991338|NCT00856544|54649943|FG000|Overall Study|Adverse Event|20|||
27991339|NCT00856544|54649944|FG001|Overall Study|Adverse Event|29|||
27991340|NCT00856544|54649945|FG002|Overall Study|Adverse Event|2|||
27991341|NCT00856544|54649946|FG003|Overall Study|Adverse Event|3|||
27991342|NCT00856544|54649943|FG000|Overall Study|Lack of Efficacy|16|||
27991343|NCT00856544|54649944|FG001|Overall Study|Lack of Efficacy|12|||
27908031|NCT01236352|54565662|FG002|Overall Study|Patient moving to allogeneic transplant|0|||
27908032|NCT01236352|54565663|FG003|Overall Study|Patient moving to allogeneic transplant|0|||
27991344|NCT00856544|54649945|FG002|Overall Study|Lack of Efficacy|3|||
27991345|NCT00856544|54649946|FG003|Overall Study|Lack of Efficacy|3|||
27991346|NCT00856544|54649943|FG000|Overall Study|Other|9|||
27991347|NCT00856544|54649944|FG001|Overall Study|Other|16|||
27991348|NCT00856544|54649945|FG002|Overall Study|Other|1|||
27991349|NCT00856544|54649946|FG003|Overall Study|Other|6|||
27991350|NCT00856544|54649943|FG000|Overall Study|Lost to Follow-up|1|||
27991351|NCT00856544|54649944|FG001|Overall Study|Lost to Follow-up|2|||
27991352|NCT00856544|54649945|FG002|Overall Study|Lost to Follow-up|2|||
27991353|NCT00856544|54649946|FG003|Overall Study|Lost to Follow-up|0|||
27908033|NCT01236352|54565664|FG004|Overall Study|Patient moving to allogeneic transplant|0|||
27908034|NCT01236352|54565665|FG005|Overall Study|Patient moving to allogeneic transplant|0|||
27908035|NCT01236352|54565666|FG006|Overall Study|Patient moving to allogeneic transplant|1|||
27908036|NCT01236352|54565667|FG007|Overall Study|Patient moving to allogeneic transplant|0|||
27908037|NCT01236352|54565668|FG008|Overall Study|Patient moving to allogeneic transplant|0|||
27908038|NCT01236352|54565669|FG009|Overall Study|Patient moving to allogeneic transplant|0|||
27991354|NCT00856544|54649943|FG000|Overall Study|Withdrawal by Subject|8|||
27991355|NCT00856544|54649944|FG001|Overall Study|Withdrawal by Subject|5|||
27991356|NCT00856544|54649945|FG002|Overall Study|Withdrawal by Subject|0|||
27991357|NCT00856544|54649946|FG003|Overall Study|Withdrawal by Subject|1|||
27991358|NCT00856388|54649968|FG000|Overall Study|Other|1|||
27991359|NCT00848354|54649975|FG000|Phase 1|Adverse Event|5|||
27991360|NCT00848354|54649976|FG001|Phase 1|Adverse Event|4|||
27991361|NCT00848354|54649975|FG000|Phase 1|Discontinuation of study by sponsor|2|||
27991362|NCT00848354|54649976|FG001|Phase 1|Discontinuation of study by sponsor|1|||
27991363|NCT00848354|54649975|FG000|Phase 1|Failed to return|0|||
27908039|NCT01236352|54565670|FG010|Overall Study|Patient moving to allogeneic transplant|0|||
27908040|NCT01236352|54565660|FG000|Overall Study|Relapse of Splenomegaly and symptoms|0|||
27908041|NCT01236352|54565661|FG001|Overall Study|Relapse of Splenomegaly and symptoms|0|||
27908042|NCT01236352|54565662|FG002|Overall Study|Relapse of Splenomegaly and symptoms|0|||
27908043|NCT01236352|54565663|FG003|Overall Study|Relapse of Splenomegaly and symptoms|0|||
27908044|NCT01236352|54565664|FG004|Overall Study|Relapse of Splenomegaly and symptoms|0|||
27908045|NCT01236352|54565665|FG005|Overall Study|Relapse of Splenomegaly and symptoms|0|||
27908046|NCT01236352|54565666|FG006|Overall Study|Relapse of Splenomegaly and symptoms|0|||
27908047|NCT01236352|54565667|FG007|Overall Study|Relapse of Splenomegaly and symptoms|0|||
27908048|NCT01236352|54565668|FG008|Overall Study|Relapse of Splenomegaly and symptoms|0|||
27908049|NCT01236352|54565669|FG009|Overall Study|Relapse of Splenomegaly and symptoms|0|||
27908050|NCT01236352|54565670|FG010|Overall Study|Relapse of Splenomegaly and symptoms|1|||
27908051|NCT01236352|54565660|FG000|Overall Study|Lack of response to drug|0|||
27908052|NCT01236352|54565661|FG001|Overall Study|Lack of response to drug|0|||
27908053|NCT01236352|54565662|FG002|Overall Study|Lack of response to drug|0|||
27908054|NCT01236352|54565663|FG003|Overall Study|Lack of response to drug|0|||
27908055|NCT01236352|54565664|FG004|Overall Study|Lack of response to drug|0|||
27908056|NCT01236352|54565665|FG005|Overall Study|Lack of response to drug|0|||
27991364|NCT00848354|54649976|FG001|Phase 1|Failed to return|1|||
27991365|NCT00848354|54649975|FG000|Phase 1|Lost to Follow-up|1|||
27991366|NCT00848354|54649976|FG001|Phase 1|Lost to Follow-up|1|||
27991367|NCT00848354|54649975|FG000|Phase 1|Unspecified Reason|1|||
27991368|NCT00848354|54649976|FG001|Phase 1|Unspecified Reason|1|||
27991369|NCT00848354|54649975|FG000|Phase 1|Protocol Violation|1|||
27991370|NCT00848354|54649976|FG001|Phase 1|Protocol Violation|1|||
27991371|NCT00848354|54649975|FG000|Phase 1|Withdrawal by Subject|2|||
27991372|NCT00848354|54649976|FG001|Phase 1|Withdrawal by Subject|4|||
27991373|NCT00848354|54649975|FG000|Phase 1|Lack of Efficacy|0|||
27991374|NCT00848354|54649976|FG001|Phase 1|Lack of Efficacy|1|||
27991375|NCT00848354|54649975|FG000|Phase 2 Year 1|Adverse Event|7|||
27991376|NCT00848354|54649976|FG001|Phase 2 Year 1|Adverse Event|2|||
27991377|NCT00848354|54649975|FG000|Phase 2 Year 1|Death|1|||
27991378|NCT00848354|54649976|FG001|Phase 2 Year 1|Death|0|||
27991379|NCT00848354|54649975|FG000|Phase 2 Year 1|Failed to Return|1|||
27991380|NCT00848354|54649976|FG001|Phase 2 Year 1|Failed to Return|1|||
27991381|NCT00848354|54649975|FG000|Phase 2 Year 1|Lost to Follow-up|1|||
27991382|NCT00848354|54649976|FG001|Phase 2 Year 1|Lost to Follow-up|0|||
27991383|NCT00848354|54649975|FG000|Phase 2 Year 1|Unspecified Reason|3|||
27991384|NCT00848354|54649976|FG001|Phase 2 Year 1|Unspecified Reason|0|||
27991385|NCT00848354|54649975|FG000|Phase 2 Year 1|Protocol Violation|4|||
27991386|NCT00848354|54649976|FG001|Phase 2 Year 1|Protocol Violation|1|||
27991387|NCT00848354|54649975|FG000|Phase 2 Year 1|Subject Request|1|||
27991388|NCT00848354|54649976|FG001|Phase 2 Year 1|Subject Request|2|||
27991389|NCT00848354|54649975|FG000|Phase 2 Year 2|Adverse Event|12|||
27991390|NCT00848354|54649976|FG001|Phase 2 Year 2|Adverse Event|2|||
27991391|NCT00848354|54649975|FG000|Phase 2 Year 2|Death|2|||
27991392|NCT00848354|54649976|FG001|Phase 2 Year 2|Death|0|||
27991393|NCT00848354|54649975|FG000|Phase 2 Year 2|Failed to return|3|||
27991394|NCT00848354|54649976|FG001|Phase 2 Year 2|Failed to return|0|||
27991395|NCT00848354|54649975|FG000|Phase 2 Year 2|Lost to Follow-up|1|||
27991396|NCT00848354|54649976|FG001|Phase 2 Year 2|Lost to Follow-up|3|||
27991397|NCT00848354|54649975|FG000|Phase 2 Year 2|Unspecified Reason|1|||
27991398|NCT00848354|54649976|FG001|Phase 2 Year 2|Unspecified Reason|0|||
27991399|NCT00848354|54649975|FG000|Phase 2 Year 2|Protocol Violation|1|||
27991400|NCT00848354|54649976|FG001|Phase 2 Year 2|Protocol Violation|1|||
27991401|NCT00848354|54649975|FG000|Phase 2 Year 2|Subject Request|1|||
27991402|NCT00848354|54649976|FG001|Phase 2 Year 2|Subject Request|1|||
27991403|NCT00848354|54649975|FG000|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2|||
27991404|NCT00848354|54649976|FG001|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0|||
27991405|NCT00848198|54649986|FG000|Overall Study|Incomplete Case Report Forms|15|||
27991406|NCT00848120|54649994|FG000|Overall Study|Adverse Event|1|||
27991407|NCT00600821|54650000|FG000|Overall Study|Death|45|||
27991408|NCT00600821|54650001|FG001|Overall Study|Death|46|||
27991409|NCT00600821|54650000|FG000|Overall Study|Lost to Follow-up|2|||
27991410|NCT00600821|54650001|FG001|Overall Study|Lost to Follow-up|2|||
27991411|NCT00600821|54650000|FG000|Overall Study|Withdrawal by Subject|1|||
27991412|NCT00600821|54650001|FG001|Overall Study|Withdrawal by Subject|1|||
27991413|NCT00600821|54650000|FG000|Overall Study|Terminated by sponsor|8|||
27991414|NCT00600821|54650001|FG001|Overall Study|Terminated by sponsor|6|||
27991415|NCT00600821|54650000|FG000|Overall Study|Objective progression or relapse|0|||
27991416|NCT00600821|54650001|FG001|Overall Study|Objective progression or relapse|1|||
27991417|NCT00600821|54650000|FG000|Overall Study|Randomized but not treated|0|||
27991418|NCT00600821|54650001|FG001|Overall Study|Randomized but not treated|1|||
27991419|NCT00600821|54650000|FG000|Overall Study|Other|2|||
27991420|NCT00600821|54650001|FG001|Overall Study|Other|3|||
27991421|NCT00592904|54650013|FG000|Overall Study|Adverse Event|15|||
27991422|NCT00592904|54650014|FG001|Overall Study|Adverse Event|25|||
27991423|NCT00592904|54650015|FG002|Overall Study|Adverse Event|13|||
27991424|NCT00592904|54650016|FG003|Overall Study|Adverse Event|5|||
27991425|NCT00592904|54650013|FG000|Overall Study|Protocol Violation|1|||
27991426|NCT00592904|54650014|FG001|Overall Study|Protocol Violation|1|||
27991427|NCT00592904|54650015|FG002|Overall Study|Protocol Violation|0|||
27991428|NCT00592904|54650016|FG003|Overall Study|Protocol Violation|1|||
27991429|NCT00592904|54650013|FG000|Overall Study|Withdrawal by Subject|4|||
27908057|NCT01236352|54565666|FG006|Overall Study|Lack of response to drug|0|||
27908058|NCT01236352|54565667|FG007|Overall Study|Lack of response to drug|0|||
27908059|NCT01236352|54565668|FG008|Overall Study|Lack of response to drug|0|||
27908060|NCT01236352|54565669|FG009|Overall Study|Lack of response to drug|1|||
27908061|NCT01236352|54565670|FG010|Overall Study|Lack of response to drug|1|||
27908062|NCT01236352|54565660|FG000|Overall Study|Patient transferred to IST|0|||
27908063|NCT01236352|54565661|FG001|Overall Study|Patient transferred to IST|0|||
27908064|NCT01236352|54565662|FG002|Overall Study|Patient transferred to IST|0|||
27908065|NCT01236352|54565663|FG003|Overall Study|Patient transferred to IST|0|||
27908066|NCT01236352|54565664|FG004|Overall Study|Patient transferred to IST|0|||
27908067|NCT01236352|54565665|FG005|Overall Study|Patient transferred to IST|0|||
27908068|NCT01236352|54565666|FG006|Overall Study|Patient transferred to IST|0|||
27908069|NCT01236352|54565667|FG007|Overall Study|Patient transferred to IST|0|||
27908070|NCT01236352|54565668|FG008|Overall Study|Patient transferred to IST|0|||
27908071|NCT01236352|54565669|FG009|Overall Study|Patient transferred to IST|2|||
27991430|NCT00592904|54650014|FG001|Overall Study|Withdrawal by Subject|16|||
27908072|NCT01236352|54565670|FG010|Overall Study|Patient transferred to IST|6|||
27908073|NCT01236118|54565697|FG000|Overall Study|Adverse Event|2|||
27908074|NCT01236118|54565698|FG001|Overall Study|Adverse Event|0|||
27991431|NCT00592904|54650015|FG002|Overall Study|Withdrawal by Subject|1|||
27991432|NCT00592904|54650016|FG003|Overall Study|Withdrawal by Subject|2|||
27991433|NCT00592904|54650013|FG000|Overall Study|Lack of Efficacy|2|||
27991434|NCT00592904|54650014|FG001|Overall Study|Lack of Efficacy|7|||
27991435|NCT00592904|54650015|FG002|Overall Study|Lack of Efficacy|2|||
27991436|NCT00592904|54650016|FG003|Overall Study|Lack of Efficacy|3|||
27991437|NCT00592904|54650013|FG000|Overall Study|Physician Decision|0|||
27908075|NCT01236118|54565699|FG002|Overall Study|Adverse Event|2|||
27908076|NCT01236118|54565697|FG000|Overall Study|Physician Decision|0|||
27908077|NCT01236118|54565698|FG001|Overall Study|Physician Decision|1|||
27908078|NCT01236118|54565699|FG002|Overall Study|Physician Decision|0|||
27991438|NCT00592904|54650014|FG001|Overall Study|Physician Decision|3|||
27991439|NCT00592904|54650015|FG002|Overall Study|Physician Decision|1|||
27991440|NCT00592904|54650016|FG003|Overall Study|Physician Decision|0|||
27991441|NCT00592904|54650013|FG000|Overall Study|Other|3|||
27908079|NCT01236118|54565697|FG000|Overall Study|Withdrawal by Subject|0|||
27908080|NCT01236118|54565698|FG001|Overall Study|Withdrawal by Subject|0|||
27908081|NCT01236118|54565699|FG002|Overall Study|Withdrawal by Subject|1|||
27908082|NCT01236001|54565709|FG000|Overall Study|Adverse Event|5|||
27908083|NCT01236001|54565710|FG001|Overall Study|Adverse Event|14|||
27908084|NCT01236001|54565709|FG000|Overall Study|Lack of Efficacy|6|||
27908085|NCT01236001|54565710|FG001|Overall Study|Lack of Efficacy|6|||
27908086|NCT01236001|54565709|FG000|Overall Study|Lost to Follow-up|6|||
27908087|NCT01236001|54565710|FG001|Overall Study|Lost to Follow-up|1|||
27908088|NCT01236001|54565709|FG000|Overall Study|Incompliance|1|||
27908089|NCT01236001|54565710|FG001|Overall Study|Incompliance|0|||
27908090|NCT01236001|54565709|FG000|Overall Study|Planned Visit After End of Study|0|||
27908091|NCT01236001|54565710|FG001|Overall Study|Planned Visit After End of Study|1|||
27908092|NCT01229254|54565720|FG000|Overall Study|Not Continuing Into Safety Extension|3|||
27908093|NCT01229254|54565721|FG001|Overall Study|Not Continuing Into Safety Extension|1|||
27908094|NCT01229254|54565722|FG002|Overall Study|Not Continuing Into Safety Extension|1|||
27991442|NCT00592904|54650014|FG001|Overall Study|Other|3|||
27991443|NCT00592904|54650015|FG002|Overall Study|Other|0|||
27991444|NCT00592904|54650016|FG003|Overall Study|Other|0|||
27991445|NCT00855920|54650029|FG000|Overall Study|Protocol Violation|0|||
27991446|NCT00855920|54650030|FG001|Overall Study|Protocol Violation|0|||
27991447|NCT00855920|54650031|FG002|Overall Study|Protocol Violation|2|||
27991448|NCT00855920|54650029|FG000|Overall Study|Adverse Event|2|||
27991449|NCT00855920|54650030|FG001|Overall Study|Adverse Event|1|||
27991450|NCT00855920|54650031|FG002|Overall Study|Adverse Event|1|||
27991451|NCT00855920|54650029|FG000|Overall Study|Lack of Efficacy|2|||
27991452|NCT00855920|54650030|FG001|Overall Study|Lack of Efficacy|2|||
27991453|NCT00855920|54650031|FG002|Overall Study|Lack of Efficacy|2|||
27991454|NCT00855920|54650029|FG000|Overall Study|Withdrawal by Subject|2|||
27991455|NCT00855920|54650030|FG001|Overall Study|Withdrawal by Subject|3|||
27908095|NCT01229254|54565720|FG000|Overall Study|Adverse Event|4|||
27908096|NCT01229254|54565721|FG001|Overall Study|Adverse Event|5|||
27908097|NCT01229254|54565722|FG002|Overall Study|Adverse Event|3|||
27908098|NCT01229254|54565720|FG000|Overall Study|Lost to Follow-up|3|||
27908099|NCT01229254|54565721|FG001|Overall Study|Lost to Follow-up|0|||
27908100|NCT01229254|54565722|FG002|Overall Study|Lost to Follow-up|1|||
27908101|NCT01229254|54565720|FG000|Overall Study|Physician Decision|0|||
27908102|NCT01229254|54565721|FG001|Overall Study|Physician Decision|3|||
27908103|NCT01229254|54565722|FG002|Overall Study|Physician Decision|0|||
27908104|NCT01229254|54565720|FG000|Overall Study|Protocol Violation|4|||
27908105|NCT01229254|54565721|FG001|Overall Study|Protocol Violation|6|||
27908106|NCT01229254|54565722|FG002|Overall Study|Protocol Violation|5|||
27908107|NCT01229254|54565720|FG000|Overall Study|Withdrawal by Subject|1|||
27908108|NCT01229254|54565721|FG001|Overall Study|Withdrawal by Subject|0|||
27908109|NCT01229254|54565722|FG002|Overall Study|Withdrawal by Subject|1|||
27908110|NCT01229254|54565720|FG000|Overall Study|Non-compliance with Study Drug|0|||
27908111|NCT01229254|54565721|FG001|Overall Study|Non-compliance with Study Drug|1|||
27908112|NCT01229254|54565722|FG002|Overall Study|Non-compliance with Study Drug|1|||
27908113|NCT01235728|54565731|FG000|Overall Study|Protocol Violation|0|||
27908114|NCT01235728|54565732|FG001|Overall Study|Protocol Violation|0|||
27908115|NCT01235728|54565733|FG002|Overall Study|Protocol Violation|0|||
27991456|NCT00855920|54650031|FG002|Overall Study|Withdrawal by Subject|2|||
27991457|NCT00855920|54650029|FG000|Overall Study|Lost to Follow-up|1|||
27991458|NCT00855920|54650030|FG001|Overall Study|Lost to Follow-up|0|||
27991459|NCT00855920|54650031|FG002|Overall Study|Lost to Follow-up|2|||
27991460|NCT00855920|54650029|FG000|Overall Study|Death|0|||
27991461|NCT00855920|54650030|FG001|Overall Study|Death|1|||
27991462|NCT00855920|54650031|FG002|Overall Study|Death|0|||
27991463|NCT00855920|54650029|FG000|Overall Study|Decision by the sponsor|0|||
27991464|NCT00855920|54650030|FG001|Overall Study|Decision by the sponsor|1|||
27991465|NCT00855920|54650031|FG002|Overall Study|Decision by the sponsor|1|||
27908116|NCT01235728|54565734|FG003|Overall Study|Protocol Violation|1|||
27908117|NCT01235728|54565735|FG004|Overall Study|Protocol Violation|0|||
27908118|NCT01235728|54565736|FG005|Overall Study|Protocol Violation|0|||
27908119|NCT01235728|54565737|FG006|Overall Study|Protocol Violation|0|||
27908120|NCT01235728|54565738|FG007|Overall Study|Protocol Violation|0|||
27908121|NCT01235689|54565748|FG000|Overall Study|Adverse Event|12|||
27908122|NCT01235689|54565749|FG001|Overall Study|Adverse Event|16|||
27908123|NCT01235689|54565748|FG000|Overall Study|Lack of Efficacy|12|||
27991466|NCT00855920|54650029|FG000|Overall Study|Other than specified above|1|||
27991467|NCT00855920|54650030|FG001|Overall Study|Other than specified above|1|||
27908124|NCT01235689|54565749|FG001|Overall Study|Lack of Efficacy|5|||
27908125|NCT01235689|54565748|FG000|Overall Study|Withdrawal by Subject|3|||
27908126|NCT01235689|54565749|FG001|Overall Study|Withdrawal by Subject|4|||
27908127|NCT01235689|54565748|FG000|Overall Study|Lost to Follow-up|1|||
27908128|NCT01235689|54565749|FG001|Overall Study|Lost to Follow-up|2|||
27908129|NCT01235689|54565748|FG000|Overall Study|Miscellaneous|1|||
27908130|NCT01235689|54565749|FG001|Overall Study|Miscellaneous|5|||
27908131|NCT01229176|54565763|FG000|Overall Study|Withdrawal by Subject|0|||
27908132|NCT01229176|54565764|FG001|Overall Study|Withdrawal by Subject|0|||
27991468|NCT00855920|54650031|FG002|Overall Study|Other than specified above|1|||
27991469|NCT00848042|54650042|FG000|Overall Study|Death|1|||
27991470|NCT00848042|54650043|FG001|Overall Study|Death|2|||
27991471|NCT00848042|54650044|FG002|Overall Study|Death|0|||
27991472|NCT00848042|54650042|FG000|Overall Study|Other Therapy|3|||
27991473|NCT00848042|54650043|FG001|Overall Study|Other Therapy|0|||
27991474|NCT00848042|54650044|FG002|Overall Study|Other Therapy|0|||
27991475|NCT00847886|54650054|FG000|Overall Study|Adverse Event|0|||
27991476|NCT00847886|54650055|FG001|Overall Study|Adverse Event|1|||
27991477|NCT00847808|54650061|FG000|Overall Study|Adverse Event|7|||
27991478|NCT00847808|54650061|FG000|Overall Study|Protocol Violation|1|||
27991479|NCT00847808|54650061|FG000|Overall Study|Lost to Follow-up|1|||
27991480|NCT00847808|54650061|FG000|Overall Study|Withdrawal by Subject|4|||
27991481|NCT00847808|54650061|FG000|Overall Study|Participant Reported Lack of Efficacy|1|||
27991482|NCT00847808|54650061|FG000|Overall Study|Participant Took Excluded Medication|1|||
27991483|NCT00600353|54650067|FG000|Overall Study|history of malignancy within 5 years|1|||
27991484|NCT00600353|54650068|FG001|Overall Study|history of malignancy within 5 years|0|||
27991485|NCT00600353|54650067|FG000|Overall Study|History of prepartive regimen|0|||
27991486|NCT00600353|54650068|FG001|Overall Study|History of prepartive regimen|1|||
27991487|NCT00691210|54650082|FG000|Overall Study|Progression of Disease|0|||
27991488|NCT00691210|54650083|FG001|Overall Study|Progression of Disease|0|||
27991489|NCT00691210|54650084|FG002|Overall Study|Progression of Disease|0|||
27991490|NCT00691210|54650085|FG003|Overall Study|Progression of Disease|2|||
27991491|NCT00691210|54650086|FG004|Overall Study|Progression of Disease|0|||
27991492|NCT00691210|54650087|FG005|Overall Study|Progression of Disease|0|||
27991493|NCT00691210|54650088|FG006|Overall Study|Progression of Disease|0|||
27991494|NCT00691210|54650089|FG007|Overall Study|Progression of Disease|0|||
27991495|NCT00691210|54650082|FG000|Overall Study|Lack of Efficacy|0|||
27991496|NCT00691210|54650083|FG001|Overall Study|Lack of Efficacy|0|||
27991497|NCT00691210|54650084|FG002|Overall Study|Lack of Efficacy|0|||
27991498|NCT00691210|54650085|FG003|Overall Study|Lack of Efficacy|1|||
27908133|NCT01229176|54565765|FG002|Overall Study|Withdrawal by Subject|0|||
27908134|NCT01229176|54565766|FG003|Overall Study|Withdrawal by Subject|1|||
27908135|NCT01229176|54565767|FG004|Overall Study|Withdrawal by Subject|1|||
27908136|NCT01229176|54565768|FG005|Overall Study|Withdrawal by Subject|1|||
27908137|NCT01229176|54565769|FG006|Overall Study|Withdrawal by Subject|0|||
27908138|NCT01229176|54565770|FG007|Overall Study|Withdrawal by Subject|1|||
27908139|NCT01229176|54565763|FG000|Overall Study|Lost to Follow-up|0|||
27908140|NCT01229176|54565764|FG001|Overall Study|Lost to Follow-up|3|||
27908141|NCT01229176|54565765|FG002|Overall Study|Lost to Follow-up|0|||
27908142|NCT01229176|54565766|FG003|Overall Study|Lost to Follow-up|0|||
27908143|NCT01229176|54565767|FG004|Overall Study|Lost to Follow-up|1|||
27908144|NCT01229176|54565768|FG005|Overall Study|Lost to Follow-up|1|||
27908145|NCT01229176|54565769|FG006|Overall Study|Lost to Follow-up|0|||
27908146|NCT01229176|54565770|FG007|Overall Study|Lost to Follow-up|2|||
27908147|NCT01228747|54565790|FG000|Overall Study|Adverse Event|8|||
27908148|NCT01228747|54565791|FG001|Overall Study|Adverse Event|4|||
27908149|NCT01228747|54565790|FG000|Overall Study|Lack of Efficacy|40|||
27908150|NCT01228747|54565791|FG001|Overall Study|Lack of Efficacy|27|||
27908151|NCT01228747|54565790|FG000|Overall Study|Protocol Violation|6|||
27908152|NCT01228747|54565791|FG001|Overall Study|Protocol Violation|5|||
27908153|NCT01228747|54565790|FG000|Overall Study|Lost to Follow-up|4|||
27908154|NCT01228747|54565791|FG001|Overall Study|Lost to Follow-up|3|||
27908155|NCT01228747|54565790|FG000|Overall Study|Withdrawal by Subject|5|||
27908156|NCT01228747|54565791|FG001|Overall Study|Withdrawal by Subject|1|||
27908157|NCT01228747|54565790|FG000|Overall Study|Other Reason|2|||
27991499|NCT00691210|54650086|FG004|Overall Study|Lack of Efficacy|0|||
27991500|NCT00691210|54650087|FG005|Overall Study|Lack of Efficacy|1|||
27991501|NCT00691210|54650088|FG006|Overall Study|Lack of Efficacy|0|||
27991502|NCT00691210|54650089|FG007|Overall Study|Lack of Efficacy|0|||
27991503|NCT00691132|54650109|FG000|Overall Study|Adverse Event|2|||
27991504|NCT00691132|54650110|FG001|Overall Study|Adverse Event|3|||
27991505|NCT00691132|54650109|FG000|Overall Study|Withdrawal by Subject|10|||
28172446|NCT02457910|54844143|FG002|Overall Study|Death|1|||
28172447|NCT02457910|54844144|FG003|Overall Study|Death|0|||
27908158|NCT01228747|54565791|FG001|Overall Study|Other Reason|5|||
27908159|NCT01228591|54565797|FG000|Baseline|Lack of Efficacy|1|||
27908160|NCT01228591|54565798|FG001|Baseline|Lack of Efficacy|2|||
27908161|NCT01235338|54565810|FG000|Overall Study|Adverse Event|3|||
27908162|NCT01235338|54565811|FG001|Overall Study|Adverse Event|2|||
27908163|NCT01235338|54565810|FG000|Overall Study|Protocol Violation|1|||
27908164|NCT01235338|54565811|FG001|Overall Study|Protocol Violation|1|||
27908165|NCT01235338|54565810|FG000|Overall Study|Withdrawal by Subject|5|||
27908166|NCT01235338|54565811|FG001|Overall Study|Withdrawal by Subject|0|||
27908167|NCT01235338|54565810|FG000|Overall Study|Exclusion criteria violations|1|||
27908168|NCT01235338|54565811|FG001|Overall Study|Exclusion criteria violations|1|||
27908169|NCT01235338|54565810|FG000|Overall Study|Positive drug screen|0|||
27908170|NCT01235338|54565811|FG001|Overall Study|Positive drug screen|1|||
27908171|NCT01235338|54565810|FG000|Overall Study|Prohibited meds|1|||
27908172|NCT01235338|54565811|FG001|Overall Study|Prohibited meds|0|||
27908173|NCT01234675|54565819|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
27908174|NCT01234675|54565820|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
27908175|NCT01234675|54565819|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
27908176|NCT01234675|54565820|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
27908177|NCT01228318|54565828|FG000|Overall Study|Clinic no show to receive intervention|1|||
27908178|NCT01228318|54565829|FG001|Overall Study|Clinic no show to receive intervention|0|||
27908179|NCT01228318|54565828|FG000|Overall Study|Unable to contact|2|||
27908180|NCT01228318|54565829|FG001|Overall Study|Unable to contact|5|||
27908181|NCT01228318|54565828|FG000|Overall Study|Moved|0|||
27908182|NCT01228318|54565829|FG001|Overall Study|Moved|2|||
27908183|NCT01228318|54565828|FG000|Overall Study|Incarcerated|1|||
27908184|NCT01228318|54565829|FG001|Overall Study|Incarcerated|0|||
27908185|NCT01227967|54565837|FG000|Overall Study|Protocol Violation|3|||
27908186|NCT01227967|54565838|FG001|Overall Study|Protocol Violation|1|||
27908187|NCT01227967|54565837|FG000|Overall Study|Death|0|||
27908188|NCT01227967|54565838|FG001|Overall Study|Death|1|||
27908189|NCT01227967|54565837|FG000|Overall Study|Lost to Follow-up|8|||
27908190|NCT01227967|54565838|FG001|Overall Study|Lost to Follow-up|3|||
27908191|NCT01227967|54565837|FG000|Overall Study|Withdrawal by Subject|4|||
27991506|NCT00691132|54650110|FG001|Overall Study|Withdrawal by Subject|10|||
27991507|NCT00855218|54650132|FG000|Overall Study|Adverse Event|43|||
27991508|NCT00855218|54650133|FG001|Overall Study|Adverse Event|27|||
27991509|NCT00855218|54650132|FG000|Overall Study|Withdrawal by Subject|10|||
27991510|NCT00855218|54650133|FG001|Overall Study|Withdrawal by Subject|6|||
27991511|NCT00855218|54650132|FG000|Overall Study|Physician Decision|18|||
27991512|NCT00855218|54650133|FG001|Overall Study|Physician Decision|11|||
28172448|NCT02457910|54844145|FG004|Overall Study|Death|0|||
28172449|NCT02457910|54844146|FG005|Overall Study|Death|0|||
28172450|NCT02405962|54844165|FG000|Overall Study|Lost to Follow-up|1|||
28172451|NCT02405962|54844166|FG001|Overall Study|Lost to Follow-up|4|||
28172452|NCT02405962|54844165|FG000|Overall Study|A participant has moved to another place|0|||
28172453|NCT02405962|54844166|FG001|Overall Study|A participant has moved to another place|1|||
28172454|NCT02436304|54844175|FG000|Overall Study|Lost to Follow-up|0|||
28172455|NCT02436304|54844176|FG001|Overall Study|Lost to Follow-up|1|||
28172456|NCT02436304|54844177|FG002|Overall Study|Lost to Follow-up|0|||
28172457|NCT02436304|54844175|FG000|Overall Study|Withdrawal by Subject|0|||
28172458|NCT02436304|54844176|FG001|Overall Study|Withdrawal by Subject|1|||
28172459|NCT02436304|54844177|FG002|Overall Study|Withdrawal by Subject|0|||
28172460|NCT02436304|54844175|FG000|Overall Study|Randomized in error didn't meet I/E crit|0|||
28172461|NCT02436304|54844176|FG001|Overall Study|Randomized in error didn't meet I/E crit|0|||
28172462|NCT02436304|54844177|FG002|Overall Study|Randomized in error didn't meet I/E crit|1|||
28172463|NCT02402218|54844189|FG000|Overall Study|Did not pickup study medication|12|||
28172464|NCT02402218|54844190|FG001|Overall Study|Did not pickup study medication|9|||
28172465|NCT02402218|54844191|FG002|Overall Study|Did not pickup study medication|13|||
28172466|NCT02402218|54844189|FG000|Overall Study|Lack of Efficacy|0|||
28172467|NCT02402218|54844190|FG001|Overall Study|Lack of Efficacy|1|||
28172468|NCT02402218|54844191|FG002|Overall Study|Lack of Efficacy|1|||
28172469|NCT02402218|54844189|FG000|Overall Study|Death|1|||
28172470|NCT02402218|54844190|FG001|Overall Study|Death|0|||
28172471|NCT02402218|54844191|FG002|Overall Study|Death|0|||
27991513|NCT00855218|54650132|FG000|Overall Study|Lost to Follow-up|0|||
27991514|NCT00855218|54650133|FG001|Overall Study|Lost to Follow-up|1|||
27991515|NCT00855218|54650132|FG000|Overall Study|Protocol Violation|5|||
27991516|NCT00855218|54650133|FG001|Overall Study|Protocol Violation|9|||
27991517|NCT00855218|54650132|FG000|Overall Study|non-compliant with study drug|3|||
28172472|NCT02402218|54844189|FG000|Overall Study|Reinfection|0|||
27908192|NCT01227967|54565838|FG001|Overall Study|Withdrawal by Subject|3|||
27908193|NCT01227967|54565837|FG000|Overall Study|Physician Decision|0|||
27908194|NCT01227967|54565838|FG001|Overall Study|Physician Decision|1|||
27908195|NCT01227967|54565837|FG000|Overall Study|Never Started Treatment|0|||
27908196|NCT01227967|54565838|FG001|Overall Study|Never Started Treatment|4|||
27908197|NCT01227967|54565837|FG000|Overall Study|Taking Additional Antiviral Drug|1|||
27908198|NCT01227967|54565838|FG001|Overall Study|Taking Additional Antiviral Drug|0|||
28172473|NCT02402218|54844190|FG001|Overall Study|Reinfection|0|||
28172474|NCT02402218|54844191|FG002|Overall Study|Reinfection|1|||
27739677|NCT01599754|54189315|FG001|Overall Study|Lost to Follow-up|6|||
28172475|NCT02402218|54844189|FG000|Overall Study|Adverse Event|0|||
27991518|NCT00855218|54650133|FG001|Overall Study|non-compliant with study drug|1|||
27991519|NCT00855218|54650132|FG000|Overall Study|patient convenience|2|||
27991520|NCT00855218|54650133|FG001|Overall Study|patient convenience|0|||
27991521|NCT00855218|54650132|FG000|Overall Study|technical problems|2|||
27991522|NCT00855218|54650133|FG001|Overall Study|technical problems|1|||
27991523|NCT00855218|54650132|FG000|Overall Study|Still treated with study medication|0|||
28172476|NCT02402218|54844190|FG001|Overall Study|Adverse Event|2|||
27908199|NCT01227928|54565846|FG000|Overall Study|Lost to Follow-up|4|||
27908200|NCT01227928|54565847|FG001|Overall Study|Lost to Follow-up|2|||
27991524|NCT00855218|54650133|FG001|Overall Study|Still treated with study medication|1|||
27991525|NCT00855218|54650132|FG000|Overall Study|Untreatable disease progression|54|||
27991526|NCT00855218|54650133|FG001|Overall Study|Untreatable disease progression|67|||
27991527|NCT00855218|54650132|FG000|Overall Study|Second malignancy|0|||
27991528|NCT00855218|54650133|FG001|Overall Study|Second malignancy|1|||
27991529|NCT00855218|54650132|FG000|Overall Study|Progression measurement proven|7|||
27991530|NCT00855218|54650133|FG001|Overall Study|Progression measurement proven|15|||
27991531|NCT00855218|54650132|FG000|Overall Study|Clinical endpoint reached|10|||
27991532|NCT00855218|54650133|FG001|Overall Study|Clinical endpoint reached|13|||
27991533|NCT01063348|54650141|FG000|Overall Study|Lost to Follow-up|3|||
27991534|NCT01063348|54650142|FG001|Overall Study|Lost to Follow-up|10|||
27991535|NCT00855062|54650150|FG000|Step1|Early Study Closure|5|||
27991536|NCT00855062|54650151|FG001|Step1|Early Study Closure|7|||
27991537|NCT00855062|54650150|FG000|Step1|Adverse Event|1|||
27991538|NCT00855062|54650151|FG001|Step1|Adverse Event|1|||
27991539|NCT00855062|54650150|FG000|Step1|Protocol Violation|1|||
27991540|NCT00855062|54650151|FG001|Step1|Protocol Violation|0|||
27991541|NCT00855062|54650150|FG000|Step1|Pregnancy|1|||
27991542|NCT00855062|54650151|FG001|Step1|Pregnancy|0|||
27991543|NCT00855062|54650150|FG000|Step1|Withdrawal by Subject|2|||
27991544|NCT00855062|54650151|FG001|Step1|Withdrawal by Subject|3|||
27991545|NCT00855062|54650150|FG000|Step2|Early Study Closure|6|||
27991546|NCT00855062|54650151|FG001|Step2|Early Study Closure|2|||
27991547|NCT00855062|54650150|FG000|Step2|Adverse Event|0|||
27991548|NCT00855062|54650151|FG001|Step2|Adverse Event|3|||
27991549|NCT00855062|54650150|FG000|Step2|Initiation of antiretroviral therapy/ART|0|||
27991550|NCT00855062|54650151|FG001|Step2|Initiation of antiretroviral therapy/ART|1|||
27991551|NCT00854906|54650157|FG000|Overall Study|One person had no ocular history|1|||
27991552|NCT00854828|54650168|FG000|Overall Study|Death|1|||
27991553|NCT00854828|54650169|FG001|Overall Study|Death|0|||
28097921|NCT03620708|54753706|FG000|Overall Study|Withdrawal by Subject|0|||
28097922|NCT03620708|54753707|FG001|Overall Study|Withdrawal by Subject|0|||
28097923|NCT03620708|54753708|FG002|Overall Study|Withdrawal by Subject|1|||
28097924|NCT03654326|54753718|FG000|Overall Study|Withdrawal by Subject|5|||
28097925|NCT03654326|54753719|FG001|Overall Study|Withdrawal by Subject|3|||
28097926|NCT03654326|54753718|FG000|Overall Study|Physician Decision|0|||
28097927|NCT03654326|54753719|FG001|Overall Study|Physician Decision|1|||
28097928|NCT03654326|54753718|FG000|Overall Study|Unable to adhere to study schedule|0|||
28097929|NCT03654326|54753719|FG001|Overall Study|Unable to adhere to study schedule|1|||
28097930|NCT03654326|54753718|FG000|Overall Study|Lost to Follow-up|1|||
28097931|NCT03654326|54753719|FG001|Overall Study|Lost to Follow-up|1|||
28097932|NCT04025684|54753729|FG000|Overall Study|Withdrawal by Subject|1|||
28097933|NCT04025684|54753730|FG001|Overall Study|Withdrawal by Subject|1|||
28097934|NCT04025684|54753731|FG002|Overall Study|Withdrawal by Subject|0|||
27908201|NCT01227928|54565846|FG000|Overall Study|Withdrawal by Subject|4|||
27908202|NCT01227928|54565847|FG001|Overall Study|Withdrawal by Subject|3|||
27908203|NCT01227928|54565846|FG000|Overall Study|Death|14|||
27908204|NCT01227928|54565847|FG001|Overall Study|Death|12|||
27908205|NCT01227889|54565855|FG000|Randomized Phase (RP)|Adverse Event|13|||
27908206|NCT01227889|54565856|FG001|Randomized Phase (RP)|Adverse Event|0|||
27908207|NCT01227889|54565855|FG000|Randomized Phase (RP)|Physician Decision|13|||
27908208|NCT01227889|54565856|FG001|Randomized Phase (RP)|Physician Decision|5|||
27908209|NCT01227889|54565855|FG000|Randomized Phase (RP)|Progressive Disease|135|||
27908210|NCT01227889|54565856|FG001|Randomized Phase (RP)|Progressive Disease|52|||
27908211|NCT01227889|54565855|FG000|Randomized Phase (RP)|Study terminated by sponsor|10|||
27908212|NCT01227889|54565856|FG001|Randomized Phase (RP)|Study terminated by sponsor|0|||
27908213|NCT01227889|54565855|FG000|Randomized Phase (RP)|Missing|1|||
27908214|NCT01227889|54565856|FG001|Randomized Phase (RP)|Missing|3|||
27908215|NCT01227889|54565855|FG000|Randomized Phase (RP)|Withdrawal by Subject|15|||
27908216|NCT01227889|54565856|FG001|Randomized Phase (RP)|Withdrawal by Subject|3|||
28097935|NCT04025684|54753732|FG003|Overall Study|Withdrawal by Subject|0|||
27908217|NCT01227889|54565855|FG000|Crossover Phase|Adverse Event|0|||
27908218|NCT01227889|54565856|FG001|Crossover Phase|Adverse Event|1|||
27908219|NCT01227889|54565855|FG000|Crossover Phase|Physician Decision|0|||
27908220|NCT01227889|54565856|FG001|Crossover Phase|Physician Decision|3|||
27991554|NCT00854828|54650170|FG002|Overall Study|Death|0|||
27991555|NCT00854828|54650171|FG003|Overall Study|Death|0|||
27991556|NCT00854828|54650168|FG000|Overall Study|Withdrawal by Subject|1|||
27991557|NCT00854828|54650169|FG001|Overall Study|Withdrawal by Subject|1|||
28172477|NCT02402218|54844191|FG002|Overall Study|Adverse Event|1|||
28172478|NCT02402218|54844189|FG000|Overall Study|Withdrawal by Subject|1|||
28172479|NCT02402218|54844190|FG001|Overall Study|Withdrawal by Subject|1|||
28172480|NCT02402218|54844191|FG002|Overall Study|Withdrawal by Subject|1|||
28172481|NCT02457520|54844199|FG000|Active Treatment Phase|Adverse Event|10|||
28172482|NCT02457520|54844199|FG000|Active Treatment Phase|Lost to Follow-up|8|||
28172483|NCT02457520|54844199|FG000|Active Treatment Phase|Non-compliance with Study Treatment|3|||
28172484|NCT02457520|54844199|FG000|Active Treatment Phase|other|4|||
28172485|NCT02457520|54844199|FG000|Active Treatment Phase|Physician Decision|1|||
28172486|NCT02457520|54844199|FG000|Active Treatment Phase|Protocol Violation|1|||
28172487|NCT02457520|54844199|FG000|Active Treatment Phase|Withdrawal by Subject|7|||
28172488|NCT02457520|54844199|FG000|Post-treatment Period|Other: Retreatment Required|7|||
28172489|NCT02457520|54844199|FG000|Post-treatment Period|Lost to Follow-up|23|||
28172490|NCT02457520|54844199|FG000|Post-treatment Period|Other|3|||
28172491|NCT02457520|54844199|FG000|Post-treatment Period|Physician Decision|1|||
28172492|NCT02457520|54844199|FG000|Post-treatment Period|Withdrawal by Subject|14|||
28172493|NCT02788279|54844232|FG000|Overall Study|Death|62|||
28172494|NCT02788279|54844233|FG001|Overall Study|Death|136|||
28172495|NCT02788279|54844234|FG002|Overall Study|Death|72|||
28172496|NCT02788279|54844232|FG000|Overall Study|Withdrawal by Subject|10|||
28172497|NCT02788279|54844233|FG001|Overall Study|Withdrawal by Subject|15|||
28172498|NCT02788279|54844234|FG002|Overall Study|Withdrawal by Subject|5|||
28172499|NCT02788279|54844232|FG000|Overall Study|Lost to Follow-up|0|||
28172500|NCT02788279|54844233|FG001|Overall Study|Lost to Follow-up|3|||
28172501|NCT02788279|54844234|FG002|Overall Study|Lost to Follow-up|2|||
28172502|NCT02788279|54844232|FG000|Overall Study|Sponsor decision|18|||
28172503|NCT02788279|54844233|FG001|Overall Study|Sponsor decision|29|||
28172504|NCT02788279|54844234|FG002|Overall Study|Sponsor decision|11|||
27991558|NCT00854828|54650170|FG002|Overall Study|Withdrawal by Subject|0|||
27991559|NCT00854828|54650171|FG003|Overall Study|Withdrawal by Subject|9|||
27991560|NCT00854828|54650168|FG000|Overall Study|Missed 24mo visit|1|||
27991561|NCT00854828|54650169|FG001|Overall Study|Missed 24mo visit|1|||
27991562|NCT00854828|54650170|FG002|Overall Study|Missed 24mo visit|8|||
27991563|NCT00854828|54650171|FG003|Overall Study|Missed 24mo visit|8|||
27991564|NCT00847730|54650181|FG000|Overall Study|Multiple interruptions in therapy|8|||
27991565|NCT00600119|54650191|FG000|Single-blind Placebo run-in Period|Other - Not specified|1|||
27991566|NCT00600119|54650192|FG001|Single-blind Placebo run-in Period|Other - Not specified|0|||
27991567|NCT00600119|54650193|FG002|Single-blind Placebo run-in Period|Other - Not specified|0|||
27991568|NCT00600119|54650194|FG003|Single-blind Placebo run-in Period|Other - Not specified|0|||
27991569|NCT00600119|54650195|FG004|Single-blind Placebo run-in Period|Other - Not specified|1|||
27991570|NCT00600119|54650196|FG005|Single-blind Placebo run-in Period|Other - Not specified|1|||
27991571|NCT00600119|54650191|FG000|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
27991572|NCT00600119|54650192|FG001|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
27991573|NCT00600119|54650193|FG002|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
27991574|NCT00600119|54650194|FG003|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
27991575|NCT00600119|54650195|FG004|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
27991576|NCT00600119|54650196|FG005|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
27991577|NCT00600119|54650191|FG000|Single-blind Placebo run-in Period|Sponsor Decision|0|||
27991578|NCT00600119|54650192|FG001|Single-blind Placebo run-in Period|Sponsor Decision|0|||
27991579|NCT00600119|54650193|FG002|Single-blind Placebo run-in Period|Sponsor Decision|1|||
27991580|NCT00600119|54650194|FG003|Single-blind Placebo run-in Period|Sponsor Decision|0|||
28097936|NCT04025684|54753729|FG000|Overall Study|Multiple reasons|1|||
28097937|NCT04025684|54753730|FG001|Overall Study|Multiple reasons|3|||
28097938|NCT04025684|54753731|FG002|Overall Study|Multiple reasons|0|||
27991581|NCT00600119|54650195|FG004|Single-blind Placebo run-in Period|Sponsor Decision|1|||
28097939|NCT04025684|54753732|FG003|Overall Study|Multiple reasons|1|||
28097940|NCT03617588|54753744|FG000|Overall Study|Withdrawal by Subject|1|||
28097941|NCT03617588|54753745|FG001|Overall Study|Withdrawal by Subject|0|||
28097942|NCT03616106|54753757|FG000|Overall Study|Removed by PI|6|||
28097943|NCT03616106|54753758|FG001|Overall Study|Removed by PI|0|||
28097944|NCT03616106|54753757|FG000|Overall Study|Withdrawal by Subject|1|||
28097945|NCT03616106|54753758|FG001|Overall Study|Withdrawal by Subject|1|||
28097946|NCT03616106|54753757|FG000|Overall Study|Lost to Follow-up|7|||
28097947|NCT03616106|54753758|FG001|Overall Study|Lost to Follow-up|0|||
27991582|NCT00600119|54650196|FG005|Single-blind Placebo run-in Period|Sponsor Decision|0|||
28097948|NCT04019054|54753765|FG000|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|0|||
28097949|NCT04019054|54753766|FG001|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|1|||
28172505|NCT02435992|54844250|FG000|Overall Study|non compliance with protocol|2|||
28172506|NCT02435992|54844251|FG001|Overall Study|non compliance with protocol|0|||
28172507|NCT02435992|54844252|FG002|Overall Study|non compliance with protocol|1|||
28172508|NCT02435992|54844253|FG003|Overall Study|non compliance with protocol|0|||
28172509|NCT02435992|54844254|FG004|Overall Study|non compliance with protocol|0|||
28172510|NCT02435992|54844250|FG000|Overall Study|Adverse Event|11|||
28172511|NCT02435992|54844251|FG001|Overall Study|Adverse Event|6|||
28172512|NCT02435992|54844252|FG002|Overall Study|Adverse Event|12|||
28172513|NCT02435992|54844253|FG003|Overall Study|Adverse Event|0|||
28172514|NCT02435992|54844254|FG004|Overall Study|Adverse Event|0|||
28172515|NCT02435992|54844250|FG000|Overall Study|Lack of Efficacy|4|||
28097950|NCT04019054|54753765|FG000|Overall Study|Withdrawal by Subject|3|||
27991583|NCT00600119|54650191|FG000|Single-blind Placebo run-in Period|Lost to Follow-up|1|||
27991584|NCT00600119|54650192|FG001|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
27991585|NCT00600119|54650193|FG002|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
27991586|NCT00600119|54650194|FG003|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
28097951|NCT04019054|54753766|FG001|Overall Study|Withdrawal by Subject|1|||
28097952|NCT00071799|54753774|FG000|Overall Study|Adverse Event|19|||
28097953|NCT00071799|54753775|FG001|Overall Study|Adverse Event|10|||
28097954|NCT00071799|54753774|FG000|Overall Study|Protocol Violation|1|||
28097955|NCT00071799|54753775|FG001|Overall Study|Protocol Violation|7|||
28097956|NCT00071799|54753774|FG000|Overall Study|Lost to Follow-up|1|||
28097957|NCT00071799|54753775|FG001|Overall Study|Lost to Follow-up|1|||
28097958|NCT00071799|54753774|FG000|Overall Study|Withdrawal by Subject|15|||
28097959|NCT00071799|54753775|FG001|Overall Study|Withdrawal by Subject|37|||
28172516|NCT02435992|54844251|FG001|Overall Study|Lack of Efficacy|10|||
28172517|NCT02435992|54844252|FG002|Overall Study|Lack of Efficacy|9|||
28172518|NCT02435992|54844253|FG003|Overall Study|Lack of Efficacy|0|||
28172519|NCT02435992|54844254|FG004|Overall Study|Lack of Efficacy|0|||
28172520|NCT02435992|54844250|FG000|Overall Study|Withdrawal by Subject|10|||
28172521|NCT02435992|54844251|FG001|Overall Study|Withdrawal by Subject|8|||
28172522|NCT02435992|54844252|FG002|Overall Study|Withdrawal by Subject|20|||
27991587|NCT00600119|54650195|FG004|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
27991588|NCT00600119|54650196|FG005|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
27991589|NCT00600119|54650191|FG000|Single-blind Placebo run-in Period|Adverse Event|0|||
27991590|NCT00600119|54650192|FG001|Single-blind Placebo run-in Period|Adverse Event|0|||
27991591|NCT00600119|54650193|FG002|Single-blind Placebo run-in Period|Adverse Event|0|||
27991592|NCT00600119|54650194|FG003|Single-blind Placebo run-in Period|Adverse Event|1|||
27991593|NCT00600119|54650195|FG004|Single-blind Placebo run-in Period|Adverse Event|0|||
27991594|NCT00600119|54650196|FG005|Single-blind Placebo run-in Period|Adverse Event|1|||
27991595|NCT00600119|54650191|FG000|Single-blind Placebo run-in Period|Withdrawal by Subject|2|||
28172523|NCT02435992|54844253|FG003|Overall Study|Withdrawal by Subject|0|||
28172524|NCT02435992|54844254|FG004|Overall Study|Withdrawal by Subject|0|||
28172525|NCT02435992|54844250|FG000|Overall Study|Other Reason|1|||
28172526|NCT02435992|54844251|FG001|Overall Study|Other Reason|0|||
28172527|NCT02435992|54844252|FG002|Overall Study|Other Reason|0|||
28172528|NCT02435992|54844253|FG003|Overall Study|Other Reason|0|||
27991596|NCT00600119|54650192|FG001|Single-blind Placebo run-in Period|Withdrawal by Subject|1|||
27991597|NCT00600119|54650193|FG002|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
27991598|NCT00600119|54650194|FG003|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
27991599|NCT00600119|54650195|FG004|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
27991600|NCT00600119|54650196|FG005|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
27991601|NCT00600119|54650191|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
27991602|NCT00600119|54650192|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
27991603|NCT00600119|54650193|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
27991604|NCT00600119|54650194|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
27991605|NCT00600119|54650195|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
27991606|NCT00600119|54650196|FG005|Double-blind Treatment Period|Withdrawal by Subject|3|||
27991607|NCT00600119|54650191|FG000|Double-blind Treatment Period|Other|0|||
27991608|NCT00600119|54650192|FG001|Double-blind Treatment Period|Other|0|||
27991609|NCT00600119|54650193|FG002|Double-blind Treatment Period|Other|0|||
27991610|NCT00600119|54650194|FG003|Double-blind Treatment Period|Other|0|||
27991611|NCT00600119|54650195|FG004|Double-blind Treatment Period|Other|2|||
27991612|NCT00600119|54650196|FG005|Double-blind Treatment Period|Other|1|||
27991613|NCT00600119|54650191|FG000|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
27991614|NCT00600119|54650192|FG001|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
27991615|NCT00600119|54650193|FG002|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
27991616|NCT00600119|54650194|FG003|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
27991617|NCT00600119|54650195|FG004|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
27991618|NCT00600119|54650196|FG005|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
28172529|NCT02435992|54844254|FG004|Overall Study|Other Reason|0|||
28172530|NCT02435992|54844250|FG000|Overall Study|Physician Decision|0|||
28172531|NCT02435992|54844251|FG001|Overall Study|Physician Decision|0|||
27991619|NCT00600119|54650191|FG000|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
28097960|NCT00071799|54753774|FG000|Overall Study|Physician Decision|0|||
28172532|NCT02435992|54844252|FG002|Overall Study|Physician Decision|1|||
28172533|NCT02435992|54844253|FG003|Overall Study|Physician Decision|0|||
28172534|NCT02435992|54844254|FG004|Overall Study|Physician Decision|0|||
28172535|NCT02788513|54844271|FG000|Overall Study|Withdrawal by Subject|3|||
28172536|NCT02788513|54844272|FG001|Overall Study|Withdrawal by Subject|0|||
28172537|NCT02788513|54844273|FG002|Overall Study|Withdrawal by Subject|2|||
28172538|NCT02788513|54844274|FG003|Overall Study|Withdrawal by Subject|3|||
28172539|NCT02788513|54844275|FG004|Overall Study|Withdrawal by Subject|1|||
28172540|NCT02788513|54844271|FG000|Overall Study|Lost to Follow-up|1|||
28172541|NCT02788513|54844272|FG001|Overall Study|Lost to Follow-up|0|||
28172542|NCT02788513|54844273|FG002|Overall Study|Lost to Follow-up|0|||
28172543|NCT02788513|54844274|FG003|Overall Study|Lost to Follow-up|0|||
28172544|NCT02788513|54844275|FG004|Overall Study|Lost to Follow-up|1|||
28172545|NCT02788513|54844271|FG000|Overall Study|Adverse Event|5|||
28172546|NCT02788513|54844272|FG001|Overall Study|Adverse Event|8|||
28172547|NCT02788513|54844273|FG002|Overall Study|Adverse Event|4|||
28172548|NCT02788513|54844274|FG003|Overall Study|Adverse Event|2|||
28172549|NCT02788513|54844275|FG004|Overall Study|Adverse Event|2|||
28172550|NCT02788513|54844271|FG000|Overall Study|Protocol Violation|0|||
28172551|NCT02788513|54844272|FG001|Overall Study|Protocol Violation|0|||
28172552|NCT02788513|54844273|FG002|Overall Study|Protocol Violation|1|||
28172553|NCT02788513|54844274|FG003|Overall Study|Protocol Violation|1|||
28172554|NCT02788513|54844275|FG004|Overall Study|Protocol Violation|0|||
27991620|NCT00600119|54650192|FG001|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1|||
27991621|NCT00600119|54650193|FG002|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
27991622|NCT00600119|54650194|FG003|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
27991623|NCT00600119|54650195|FG004|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
27991624|NCT00600119|54650196|FG005|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
27991625|NCT00600119|54650191|FG000|Double-blind Treatment Period|Sponsor Decision|0|||
27991626|NCT00600119|54650192|FG001|Double-blind Treatment Period|Sponsor Decision|1|||
27991627|NCT00600119|54650193|FG002|Double-blind Treatment Period|Sponsor Decision|0|||
27991628|NCT00600119|54650194|FG003|Double-blind Treatment Period|Sponsor Decision|0|||
27991629|NCT00600119|54650195|FG004|Double-blind Treatment Period|Sponsor Decision|1|||
27991630|NCT00600119|54650196|FG005|Double-blind Treatment Period|Sponsor Decision|0|||
27991631|NCT00600119|54650191|FG000|Double-blind Treatment Period|Physician Decision|2|||
27991632|NCT00600119|54650192|FG001|Double-blind Treatment Period|Physician Decision|0|||
27991633|NCT00600119|54650193|FG002|Double-blind Treatment Period|Physician Decision|0|||
27991634|NCT00600119|54650194|FG003|Double-blind Treatment Period|Physician Decision|0|||
27991635|NCT00600119|54650195|FG004|Double-blind Treatment Period|Physician Decision|0|||
27991636|NCT00600119|54650196|FG005|Double-blind Treatment Period|Physician Decision|0|||
27991637|NCT00600119|54650191|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
27991638|NCT00600119|54650192|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
27991639|NCT00600119|54650193|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
27991640|NCT00600119|54650194|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
27991641|NCT00600119|54650195|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
27991642|NCT00600119|54650196|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
27991643|NCT00600119|54650191|FG000|Double-blind Treatment Period|Adverse Event|1|||
27991644|NCT00600119|54650192|FG001|Double-blind Treatment Period|Adverse Event|1|||
27991645|NCT00600119|54650193|FG002|Double-blind Treatment Period|Adverse Event|0|||
27991646|NCT00600119|54650194|FG003|Double-blind Treatment Period|Adverse Event|1|||
27991647|NCT00600119|54650195|FG004|Double-blind Treatment Period|Adverse Event|2|||
27991648|NCT00600119|54650196|FG005|Double-blind Treatment Period|Adverse Event|10|||
27991649|NCT00600119|54650191|FG000|Follow-up Period|Adverse Event|0|||
27991650|NCT00600119|54650192|FG001|Follow-up Period|Adverse Event|0|||
27991651|NCT00600119|54650193|FG002|Follow-up Period|Adverse Event|0|||
27991652|NCT00600119|54650194|FG003|Follow-up Period|Adverse Event|0|||
27991653|NCT00600119|54650195|FG004|Follow-up Period|Adverse Event|0|||
27991654|NCT00600119|54650196|FG005|Follow-up Period|Adverse Event|1|||
27991655|NCT00600119|54650191|FG000|Follow-up Period|Other|1|||
27991656|NCT00600119|54650192|FG001|Follow-up Period|Other|0|||
27991657|NCT00600119|54650193|FG002|Follow-up Period|Other|0|||
27991658|NCT00600119|54650194|FG003|Follow-up Period|Other|0|||
27991659|NCT00600119|54650195|FG004|Follow-up Period|Other|0|||
27991660|NCT00600119|54650196|FG005|Follow-up Period|Other|0|||
28172555|NCT02788513|54844271|FG000|Overall Study|Subject decided to stop taking treatment|0|||
28172556|NCT02788513|54844272|FG001|Overall Study|Subject decided to stop taking treatment|0|||
28172557|NCT02788513|54844273|FG002|Overall Study|Subject decided to stop taking treatment|1|||
27991661|NCT00866294|54650213|FG000|Overall Study|Adverse Event|12|||
27991662|NCT00866294|54650214|FG001|Overall Study|Adverse Event|13|||
27991663|NCT00866294|54650215|FG002|Overall Study|Adverse Event|9|||
27991664|NCT00866294|54650213|FG000|Overall Study|Lack of Efficacy|7|||
27991665|NCT00866294|54650214|FG001|Overall Study|Lack of Efficacy|1|||
27991666|NCT00866294|54650215|FG002|Overall Study|Lack of Efficacy|0|||
27991667|NCT00866294|54650213|FG000|Overall Study|Protocol Violation|2|||
28172558|NCT02788513|54844274|FG003|Overall Study|Subject decided to stop taking treatment|0|||
28172559|NCT02788513|54844275|FG004|Overall Study|Subject decided to stop taking treatment|0|||
27991668|NCT00866294|54650214|FG001|Overall Study|Protocol Violation|0|||
27991669|NCT00866294|54650215|FG002|Overall Study|Protocol Violation|0|||
27991670|NCT00866294|54650213|FG000|Overall Study|Met Protocol-defined Stopping Criteria|5|||
27991671|NCT00866294|54650214|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
27991672|NCT00866294|54650215|FG002|Overall Study|Met Protocol-defined Stopping Criteria|1|||
27991673|NCT00866294|54650213|FG000|Overall Study|Lost to Follow-up|1|||
27991674|NCT00866294|54650214|FG001|Overall Study|Lost to Follow-up|3|||
27991675|NCT00866294|54650215|FG002|Overall Study|Lost to Follow-up|0|||
27991676|NCT00866294|54650213|FG000|Overall Study|Physician Decision|6|||
27991677|NCT00866294|54650214|FG001|Overall Study|Physician Decision|2|||
27991678|NCT00866294|54650215|FG002|Overall Study|Physician Decision|1|||
27991679|NCT00854360|54650235|FG000|Overall Study|Adverse Event|0|||
27991680|NCT00854360|54650236|FG001|Overall Study|Adverse Event|1|||
27991681|NCT00854360|54650237|FG002|Overall Study|Adverse Event|2|||
27991682|NCT00854360|54650238|FG003|Overall Study|Adverse Event|6|||
27991683|NCT00854360|54650235|FG000|Overall Study|Withdrawal by Subject|0|||
27991684|NCT00854360|54650236|FG001|Overall Study|Withdrawal by Subject|0|||
27991685|NCT00854360|54650237|FG002|Overall Study|Withdrawal by Subject|0|||
27991686|NCT00854360|54650238|FG003|Overall Study|Withdrawal by Subject|1|||
27991687|NCT00854360|54650235|FG000|Overall Study|Pregnancy|0|||
27991688|NCT00854360|54650236|FG001|Overall Study|Pregnancy|1|||
27991689|NCT00854360|54650237|FG002|Overall Study|Pregnancy|0|||
27991690|NCT00854360|54650238|FG003|Overall Study|Pregnancy|0|||
27991691|NCT00854360|54650235|FG000|Overall Study|Lack of Efficacy|2|||
27991692|NCT00854360|54650236|FG001|Overall Study|Lack of Efficacy|1|||
27991693|NCT00854360|54650237|FG002|Overall Study|Lack of Efficacy|0|||
27991694|NCT00854360|54650238|FG003|Overall Study|Lack of Efficacy|0|||
27991695|NCT00854360|54650235|FG000|Overall Study|Other|0|||
27991696|NCT00854360|54650236|FG001|Overall Study|Other|0|||
28097961|NCT00071799|54753775|FG001|Overall Study|Physician Decision|2|||
28097962|NCT00071799|54753774|FG000|Overall Study|Lack of Efficacy|11|||
28097963|NCT00071799|54753775|FG001|Overall Study|Lack of Efficacy|18|||
28097964|NCT00071799|54753774|FG000|Overall Study|Disease Progression|23|||
28097965|NCT00071799|54753775|FG001|Overall Study|Disease Progression|20|||
27991697|NCT00854360|54650237|FG002|Overall Study|Other|0|||
27991698|NCT00854360|54650238|FG003|Overall Study|Other|3|||
27991699|NCT00853970|54650250|FG000|Overall Study|Withdrawal by Subject|2|||
27991700|NCT00853970|54650251|FG001|Overall Study|Withdrawal by Subject|1|||
27991701|NCT00853970|54650250|FG000|Overall Study|Cancelled surgery|4|||
27991702|NCT00853970|54650251|FG001|Overall Study|Cancelled surgery|2|||
27991703|NCT00865904|54650279|FG000|Overall Study|Randomized but not Treated|2|||
27991704|NCT00865904|54650280|FG001|Overall Study|Randomized but not Treated|0|||
27991705|NCT00865904|54650281|FG002|Overall Study|Randomized but not Treated|0|||
27991706|NCT00865904|54650282|FG003|Overall Study|Randomized but not Treated|1|||
27991707|NCT00865904|54650283|FG004|Overall Study|Randomized but not Treated|1|||
27991708|NCT00599339|54650299|FG000|Overall Study|Adverse Event|79|||
27991709|NCT00599339|54650299|FG000|Overall Study|Withdrawal by Subject|137|||
27991710|NCT00599339|54650299|FG000|Overall Study|Other Reason|179|||
27991711|NCT00599339|54650299|FG000|Overall Study|Lost to Follow-up|221|||
27991712|NCT00599339|54650299|FG000|Overall Study|No valid data consent|36|||
27991713|NCT00599339|54650299|FG000|Overall Study|Study Termination Status Unknown|12|||
27991714|NCT00599027|54650323|FG000|Overall Study|Withdrawal by Subject|1|||
27991715|NCT00599027|54650324|FG001|Overall Study|Withdrawal by Subject|1|||
27991716|NCT00599027|54650323|FG000|Overall Study|Adverse Event|0|||
27991717|NCT00599027|54650324|FG001|Overall Study|Adverse Event|1|||
27991718|NCT00599027|54650323|FG000|Overall Study|Treatment Failure|0|||
27991719|NCT00599027|54650324|FG001|Overall Study|Treatment Failure|1|||
27991720|NCT02881151|54650339|FG000|Post-surgical Washout (65 to 93 Days)|Device explantation|1|||
27991721|NCT00689728|54650347|FG000|Double-Blind Treatment|Adverse Event|1|||
27991722|NCT00689728|54650348|FG001|Double-Blind Treatment|Adverse Event|0|||
27991723|NCT00689728|54650349|FG002|Double-Blind Treatment|Adverse Event|0|||
28097966|NCT00071799|54753774|FG000|Overall Study|Different Central+Local Pathology Review|0|||
28097967|NCT00071799|54753775|FG001|Overall Study|Different Central+Local Pathology Review|1|||
28097968|NCT00071799|54753774|FG000|Overall Study|Not Documented|0|||
28097969|NCT00071799|54753775|FG001|Overall Study|Not Documented|2|||
28097970|NCT03615482|54753789|FG000|Overall Study|Death|1|||
28097971|NCT03615482|54753790|FG001|Overall Study|Death|0|||
28097972|NCT03615482|54753789|FG000|Overall Study|Lost to Follow-up|7|||
28097973|NCT03615482|54753790|FG001|Overall Study|Lost to Follow-up|7|||
27991724|NCT00689728|54650347|FG000|Double-Blind Treatment|Protocol Violation|0|||
27991725|NCT00689728|54650348|FG001|Double-Blind Treatment|Protocol Violation|0|||
27991726|NCT00689728|54650349|FG002|Double-Blind Treatment|Protocol Violation|1|||
27991727|NCT00689728|54650347|FG000|Double-Blind Treatment|Withdrawal by Subject|3|||
27991728|NCT00689728|54650348|FG001|Double-Blind Treatment|Withdrawal by Subject|3|||
27991729|NCT00689728|54650349|FG002|Double-Blind Treatment|Withdrawal by Subject|2|||
27991730|NCT00689728|54650347|FG000|Double-Blind Treatment|Lack of Efficacy|0|||
27991731|NCT00689728|54650348|FG001|Double-Blind Treatment|Lack of Efficacy|1|||
28097974|NCT03615482|54753789|FG000|Overall Study|Physician Decision|2|||
27991732|NCT00689728|54650349|FG002|Double-Blind Treatment|Lack of Efficacy|2|||
27991733|NCT00689728|54650347|FG000|Rescue|Adverse Event|0|||
27991734|NCT00689728|54650348|FG001|Rescue|Adverse Event|1|||
27991735|NCT00689728|54650349|FG002|Rescue|Adverse Event|0|||
28172560|NCT02788513|54844271|FG000|Overall Study|Decision by the study team|0|||
28172561|NCT02788513|54844272|FG001|Overall Study|Decision by the study team|0|||
28172562|NCT02788513|54844273|FG002|Overall Study|Decision by the study team|0|||
28172563|NCT02788513|54844274|FG003|Overall Study|Decision by the study team|0|||
28172564|NCT02788513|54844275|FG004|Overall Study|Decision by the study team|1|||
28172565|NCT03077828|54844287|FG000|Treatment Cycles|Death|1|||
28172566|NCT03077828|54844287|FG000|Treatment Cycles|Withdrawal by Subject|1|||
28172567|NCT03077828|54844287|FG000|Treatment Cycles|Screen Fail|2|||
28172568|NCT03077828|54844287|FG000|Autologous Stem Cell Transplant|Adverse Event|1|||
27991736|NCT00689728|54650347|FG000|Rescue|Withdrawal by Subject|1|||
27991737|NCT00689728|54650348|FG001|Rescue|Withdrawal by Subject|1|||
27991738|NCT00689728|54650349|FG002|Rescue|Withdrawal by Subject|1|||
27991739|NCT00689728|54650347|FG000|Optional Follow-Up|Adverse Event|1|||
27991740|NCT00689728|54650348|FG001|Optional Follow-Up|Adverse Event|0|||
27991741|NCT00689728|54650349|FG002|Optional Follow-Up|Adverse Event|0|||
27991742|NCT00689728|54650347|FG000|Optional Follow-Up|Lack of Efficacy|0|||
27991743|NCT00689728|54650348|FG001|Optional Follow-Up|Lack of Efficacy|1|||
27991744|NCT00689728|54650349|FG002|Optional Follow-Up|Lack of Efficacy|1|||
27991745|NCT00689728|54650347|FG000|Optional Follow-Up|Lost to Follow-up|0|||
27991746|NCT00689728|54650348|FG001|Optional Follow-Up|Lost to Follow-up|1|||
27991747|NCT00689728|54650349|FG002|Optional Follow-Up|Lost to Follow-up|1|||
27991748|NCT00689728|54650347|FG000|Optional Follow-Up|Protocol Violation|0|||
27991749|NCT00689728|54650348|FG001|Optional Follow-Up|Protocol Violation|0|||
27991750|NCT00689728|54650349|FG002|Optional Follow-Up|Protocol Violation|1|||
27991751|NCT00689728|54650347|FG000|Optional Follow-Up|Withdrawal by Subject|2|||
27991752|NCT00689728|54650348|FG001|Optional Follow-Up|Withdrawal by Subject|4|||
27991753|NCT00689728|54650349|FG002|Optional Follow-Up|Withdrawal by Subject|3|||
27991754|NCT00691054|54650378|FG000|Overall Study|Withdrawal by Subject|1|||
27991755|NCT00598871|54650386|FG000|Overall Study|Adverse Event|0|||
27991756|NCT00598871|54650387|FG001|Overall Study|Adverse Event|1|||
27991757|NCT00690820|54650395|FG000|Period 1|Withdrawal by Subject|0|||
27991758|NCT00690820|54650396|FG001|Period 1|Withdrawal by Subject|1|||
27991759|NCT00689338|54650402|FG000|Overall Study|Death|65|||
27991760|NCT00689338|54650402|FG000|Overall Study|Adverse Event|13|||
27991761|NCT00689338|54650402|FG000|Overall Study|Insufficient Clinical Response|1|||
27991762|NCT00689338|54650402|FG000|Overall Study|Lack of Efficacy|6|||
27991763|NCT00689338|54650402|FG000|Overall Study|Other|8|||
27991764|NCT00689338|54650402|FG000|Overall Study|Did not Meet Entrance Criteria|27|||
27991765|NCT00689338|54650402|FG000|Overall Study|Lost to Follow-up|5|||
27991766|NCT00689338|54650402|FG000|Overall Study|Withdrawal by Subject|3|||
27991767|NCT00689338|54650402|FG000|Overall Study|Protocol Violation|15|||
27991768|NCT00686998|54650409|FG000|Overall Study|Adverse Event|3|||
27991769|NCT00686998|54650410|FG001|Overall Study|Adverse Event|2|||
27991770|NCT00686998|54650411|FG002|Overall Study|Adverse Event|1|||
27991771|NCT00686998|54650409|FG000|Overall Study|Withdrawal by Subject|2|||
27991772|NCT00686998|54650410|FG001|Overall Study|Withdrawal by Subject|1|||
27991773|NCT00686998|54650411|FG002|Overall Study|Withdrawal by Subject|2|||
27991774|NCT00686998|54650409|FG000|Overall Study|Lack of Efficacy|7|||
27991775|NCT00686998|54650410|FG001|Overall Study|Lack of Efficacy|5|||
27991776|NCT00686998|54650411|FG002|Overall Study|Lack of Efficacy|0|||
27991777|NCT00686998|54650409|FG000|Overall Study|Other|0|||
27991778|NCT00686998|54650410|FG001|Overall Study|Other|0|||
27991779|NCT00686998|54650411|FG002|Overall Study|Other|1|||
27991780|NCT00686998|54650409|FG000|Overall Study|Safety Reasons|1|||
27991781|NCT00686998|54650410|FG001|Overall Study|Safety Reasons|0|||
27991782|NCT00686998|54650411|FG002|Overall Study|Safety Reasons|0|||
27991783|NCT00848718|54650432|FG000|Overall Study|Adverse Event|2|||
27991784|NCT00848718|54650433|FG001|Overall Study|Adverse Event|2|||
27991785|NCT00848718|54650434|FG002|Overall Study|Adverse Event|1|||
27991786|NCT00848718|54650435|FG003|Overall Study|Adverse Event|1|||
27991787|NCT00848718|54650436|FG004|Overall Study|Adverse Event|1|||
28097975|NCT03615482|54753790|FG001|Overall Study|Physician Decision|3|||
28097976|NCT03615482|54753789|FG000|Overall Study|Withdrawal by Subject|7|||
28097977|NCT03615482|54753790|FG001|Overall Study|Withdrawal by Subject|7|||
28097978|NCT03688620|54753799|FG000|Overall Study|Other|0|||
28097979|NCT03688620|54753800|FG001|Overall Study|Other|0|||
28097980|NCT03688620|54753801|FG002|Overall Study|Other|1|||
28097981|NCT03688620|54753799|FG000|Overall Study|Unwilling to attend the scheduled visit|0|||
28097982|NCT03688620|54753800|FG001|Overall Study|Unwilling to attend the scheduled visit|1|||
28097983|NCT03688620|54753801|FG002|Overall Study|Unwilling to attend the scheduled visit|0|||
28097984|NCT03688620|54753799|FG000|Overall Study|Lost to Follow-up|16|||
28097985|NCT03688620|54753800|FG001|Overall Study|Lost to Follow-up|0|||
28172569|NCT03077828|54844287|FG000|Autologous Stem Cell Transplant|Withdrawal by Subject|2|||
27991788|NCT00848718|54650437|FG005|Overall Study|Adverse Event|0|||
27908221|NCT01227889|54565855|FG000|Crossover Phase|Progressive Disease|0|||
27908222|NCT01227889|54565856|FG001|Crossover Phase|Progressive Disease|31|||
28097986|NCT03688620|54753801|FG002|Overall Study|Lost to Follow-up|1|||
28097987|NCT03688620|54753799|FG000|Overall Study|Withdrawal by Subject|0|||
28097988|NCT03688620|54753800|FG001|Overall Study|Withdrawal by Subject|0|||
28097989|NCT03688620|54753801|FG002|Overall Study|Withdrawal by Subject|6|||
27908223|NCT01227889|54565855|FG000|Crossover Phase|Study Terminated By Sponsor|0|||
27908224|NCT01227889|54565856|FG001|Crossover Phase|Study Terminated By Sponsor|1|||
27908225|NCT01227889|54565855|FG000|Crossover Phase|Withdrawal by Subject|0|||
27908226|NCT01227889|54565856|FG001|Crossover Phase|Withdrawal by Subject|1|||
27908227|NCT01227577|54565870|FG000|Overall Study|Protocol deviation|3|||
27908228|NCT01227577|54565870|FG000|Overall Study|Death|3|||
27908229|NCT01227577|54565870|FG000|Overall Study|Administrative problems|2|||
27908230|NCT01227577|54565870|FG000|Overall Study|Lost to Follow-up|1|||
27908231|NCT01227577|54565870|FG000|Overall Study|Withdrawal by Subject|4|||
27908232|NCT01227577|54565870|FG000|Overall Study|Lack of Efficacy|5|||
27908233|NCT01227577|54565870|FG000|Overall Study|Adverse Event|17|||
27908234|NCT01227421|54565890|FG000|Overall Study|Lost to Follow-up|6|||
27908235|NCT01227421|54565891|FG001|Overall Study|Lost to Follow-up|7|||
27908236|NCT01227421|54565892|FG002|Overall Study|Lost to Follow-up|5|||
27908237|NCT01227421|54565890|FG000|Overall Study|Adverse Event|2|||
27908238|NCT01227421|54565891|FG001|Overall Study|Adverse Event|7|||
27908239|NCT01227421|54565892|FG002|Overall Study|Adverse Event|2|||
27908240|NCT01227421|54565890|FG000|Overall Study|Withdrawal by Subject|1|||
27908241|NCT01227421|54565891|FG001|Overall Study|Withdrawal by Subject|2|||
28097990|NCT00090363|54753814|FG000|Overall Study|Lost to Follow-up|1|||
28097991|NCT00090363|54753815|FG001|Overall Study|Lost to Follow-up|2|||
28097992|NCT00090363|54753816|FG002|Overall Study|Lost to Follow-up|1|||
28097993|NCT00090363|54753814|FG000|Overall Study|Withdrawal by Subject|7|||
28097994|NCT00090363|54753815|FG001|Overall Study|Withdrawal by Subject|7|||
28097995|NCT00090363|54753816|FG002|Overall Study|Withdrawal by Subject|6|||
27908242|NCT01227421|54565892|FG002|Overall Study|Withdrawal by Subject|1|||
27908243|NCT01227421|54565890|FG000|Overall Study|Protocol Violation|1|||
27908244|NCT01227421|54565891|FG001|Overall Study|Protocol Violation|1|||
27908245|NCT01227421|54565892|FG002|Overall Study|Protocol Violation|2|||
27908246|NCT01227421|54565890|FG000|Overall Study|Randomized in error|1|||
27908247|NCT01227421|54565891|FG001|Overall Study|Randomized in error|1|||
27908248|NCT01227421|54565892|FG002|Overall Study|Randomized in error|0|||
27908249|NCT01227265|54565903|FG000|Overall Study|Did Not Receive Treatment|1|||
27908250|NCT01227265|54565904|FG001|Overall Study|Did Not Receive Treatment|2|||
27908251|NCT01227265|54565905|FG002|Overall Study|Did Not Receive Treatment|0|||
27908252|NCT01227265|54565903|FG000|Overall Study|Administrative|1|||
27908253|NCT01227265|54565904|FG001|Overall Study|Administrative|0|||
27908254|NCT01227265|54565905|FG002|Overall Study|Administrative|2|||
27908255|NCT01227265|54565903|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
27908256|NCT01227265|54565904|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
27908257|NCT01227265|54565905|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
27908258|NCT01227265|54565903|FG000|Overall Study|Protocol Violation|2|||
27908259|NCT01227265|54565904|FG001|Overall Study|Protocol Violation|1|||
27908260|NCT01227265|54565905|FG002|Overall Study|Protocol Violation|0|||
27908261|NCT01227265|54565903|FG000|Overall Study|Withdrawal by Subject|7|||
27908262|NCT01227265|54565904|FG001|Overall Study|Withdrawal by Subject|7|||
27908263|NCT01227265|54565905|FG002|Overall Study|Withdrawal by Subject|3|||
27908264|NCT01227265|54565903|FG000|Overall Study|Lost to Follow-up|2|||
27908265|NCT01227265|54565904|FG001|Overall Study|Lost to Follow-up|0|||
27991789|NCT00848718|54650438|FG006|Overall Study|Adverse Event|0|||
27991790|NCT00848718|54650439|FG007|Overall Study|Adverse Event|1|||
27991791|NCT00848718|54650440|FG008|Overall Study|Adverse Event|1|||
27991792|NCT00848718|54650441|FG009|Overall Study|Adverse Event|0|||
27991793|NCT00848718|54650442|FG010|Overall Study|Adverse Event|0|||
27991794|NCT00848718|54650443|FG011|Overall Study|Adverse Event|0|||
27991795|NCT00848718|54650444|FG012|Overall Study|Adverse Event|2|||
28097996|NCT00090363|54753814|FG000|Overall Study|Study-specific discontinuation criteria|75|||
27908266|NCT01227265|54565905|FG002|Overall Study|Lost to Follow-up|3|||
27908267|NCT01227265|54565903|FG000|Overall Study|Adverse Event|6|||
27908268|NCT01227265|54565904|FG001|Overall Study|Adverse Event|10|||
28097997|NCT00090363|54753815|FG001|Overall Study|Study-specific discontinuation criteria|74|||
28097998|NCT00090363|54753816|FG002|Overall Study|Study-specific discontinuation criteria|62|||
27908269|NCT01227265|54565905|FG002|Overall Study|Adverse Event|5|||
27908270|NCT01226095|54565913|FG000|Overall Study|Poor compliance|1|||
27908271|NCT01225822|54565929|FG000|Overall Study|Adverse Event|13|||
27908272|NCT01225822|54565930|FG001|Overall Study|Adverse Event|31|||
28097999|NCT00090363|54753814|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
27991796|NCT00848718|54650432|FG000|Overall Study|Lack of Efficacy|0|||
27991797|NCT00848718|54650433|FG001|Overall Study|Lack of Efficacy|0|||
27908273|NCT01225822|54565931|FG002|Overall Study|Adverse Event|18|||
27908274|NCT01225822|54565932|FG003|Overall Study|Adverse Event|23|||
27908275|NCT01225822|54565933|FG004|Overall Study|Adverse Event|14|||
27908276|NCT01225822|54565929|FG000|Overall Study|Protocol Violation|6|||
27908277|NCT01225822|54565930|FG001|Overall Study|Protocol Violation|8|||
27908278|NCT01225822|54565931|FG002|Overall Study|Protocol Violation|6|||
27908279|NCT01225822|54565932|FG003|Overall Study|Protocol Violation|7|||
27908280|NCT01225822|54565933|FG004|Overall Study|Protocol Violation|4|||
27908281|NCT01225822|54565929|FG000|Overall Study|Lost to Follow-up|0|||
27908282|NCT01225822|54565930|FG001|Overall Study|Lost to Follow-up|0|||
27908283|NCT01225822|54565931|FG002|Overall Study|Lost to Follow-up|0|||
27908284|NCT01225822|54565932|FG003|Overall Study|Lost to Follow-up|1|||
27908285|NCT01225822|54565933|FG004|Overall Study|Lost to Follow-up|0|||
27908286|NCT01225822|54565929|FG000|Overall Study|Withdrawal by Subject|6|||
27908287|NCT01225822|54565930|FG001|Overall Study|Withdrawal by Subject|7|||
27908288|NCT01225822|54565931|FG002|Overall Study|Withdrawal by Subject|7|||
27908289|NCT01225822|54565932|FG003|Overall Study|Withdrawal by Subject|11|||
27908290|NCT01225822|54565933|FG004|Overall Study|Withdrawal by Subject|6|||
27908291|NCT01225822|54565929|FG000|Overall Study|Other|13|||
27908292|NCT01225822|54565930|FG001|Overall Study|Other|10|||
27908293|NCT01225822|54565931|FG002|Overall Study|Other|7|||
27908294|NCT01225822|54565932|FG003|Overall Study|Other|10|||
27908295|NCT01225822|54565933|FG004|Overall Study|Other|7|||
27908296|NCT01225549|54565948|FG000|Period 4 - Washout|Disallowed medication|0|||
27908297|NCT01225549|54565949|FG001|Period 4 - Washout|Disallowed medication|1|||
27908298|NCT01225549|54565950|FG002|Period 4 - Washout|Disallowed medication|0|||
27908299|NCT01225549|54565951|FG003|Period 4 - Washout|Disallowed medication|0|||
27908300|NCT01225549|54565952|FG004|Period 4 - Washout|Disallowed medication|0|||
27908301|NCT01225549|54565953|FG005|Period 4 - Washout|Disallowed medication|0|||
27908302|NCT01225549|54565954|FG006|Period 4 - Washout|Disallowed medication|0|||
27908303|NCT01225549|54565955|FG007|Period 4 - Washout|Disallowed medication|0|||
27908304|NCT01225549|54565956|FG008|Period 4 - Washout|Disallowed medication|0|||
27908305|NCT01225549|54565957|FG009|Period 4 - Washout|Disallowed medication|0|||
27908306|NCT01225549|54565948|FG000|Period 6 - Washout|Disallowed medication|0|||
27908307|NCT01225549|54565949|FG001|Period 6 - Washout|Disallowed medication|0|||
27908308|NCT01225549|54565950|FG002|Period 6 - Washout|Disallowed medication|0|||
27908309|NCT01225549|54565951|FG003|Period 6 - Washout|Disallowed medication|1|||
27908310|NCT01225549|54565952|FG004|Period 6 - Washout|Disallowed medication|0|||
27908311|NCT01225549|54565953|FG005|Period 6 - Washout|Disallowed medication|0|||
27908312|NCT01225549|54565954|FG006|Period 6 - Washout|Disallowed medication|0|||
27908313|NCT01225549|54565955|FG007|Period 6 - Washout|Disallowed medication|0|||
27908314|NCT01225549|54565956|FG008|Period 6 - Washout|Disallowed medication|0|||
27908315|NCT01225549|54565957|FG009|Period 6 - Washout|Disallowed medication|0|||
27908316|NCT01225159|54565969|FG000|Overall Study|Change operation|1|||
27908317|NCT01225159|54565970|FG001|Overall Study|Change operation|0|||
27908318|NCT01224925|54565978|FG000|Overall Study|Lost to Follow-up|3|||
27908319|NCT01224925|54565979|FG001|Overall Study|Lost to Follow-up|2|||
27908320|NCT01223404|54565987|FG000|First Intervention (1 Day)|Adverse Event|0|||
27908321|NCT01223404|54565988|FG001|First Intervention (1 Day)|Adverse Event|0|||
27908322|NCT01223404|54565989|FG002|First Intervention (1 Day)|Adverse Event|0|||
27908323|NCT01223404|54565990|FG003|First Intervention (1 Day)|Adverse Event|1|||
27908324|NCT01223404|54565991|FG004|First Intervention (1 Day)|Adverse Event|0|||
27908325|NCT01223404|54565992|FG005|First Intervention (1 Day)|Adverse Event|0|||
27991798|NCT00848718|54650434|FG002|Overall Study|Lack of Efficacy|1|||
27991799|NCT00848718|54650435|FG003|Overall Study|Lack of Efficacy|0|||
27991800|NCT00848718|54650436|FG004|Overall Study|Lack of Efficacy|0|||
27991801|NCT00848718|54650437|FG005|Overall Study|Lack of Efficacy|0|||
27991802|NCT00848718|54650438|FG006|Overall Study|Lack of Efficacy|1|||
27991803|NCT00848718|54650439|FG007|Overall Study|Lack of Efficacy|0|||
27991804|NCT00848718|54650440|FG008|Overall Study|Lack of Efficacy|0|||
27991805|NCT00848718|54650441|FG009|Overall Study|Lack of Efficacy|0|||
27991806|NCT00848718|54650442|FG010|Overall Study|Lack of Efficacy|0|||
27991807|NCT00848718|54650443|FG011|Overall Study|Lack of Efficacy|0|||
27991808|NCT00848718|54650444|FG012|Overall Study|Lack of Efficacy|0|||
27991809|NCT00848718|54650432|FG000|Overall Study|Physician Decision|0|||
27991810|NCT00848718|54650433|FG001|Overall Study|Physician Decision|1|||
27908326|NCT01223404|54565987|FG000|Second Intervention (1 Day)|Adverse Event|1|||
27908327|NCT01223404|54565988|FG001|Second Intervention (1 Day)|Adverse Event|0|||
27908328|NCT01223404|54565989|FG002|Second Intervention (1 Day)|Adverse Event|0|||
27991811|NCT00848718|54650434|FG002|Overall Study|Physician Decision|0|||
27991812|NCT00848718|54650435|FG003|Overall Study|Physician Decision|0|||
27991813|NCT00848718|54650436|FG004|Overall Study|Physician Decision|1|||
27908329|NCT01223404|54565990|FG003|Second Intervention (1 Day)|Adverse Event|0|||
27908330|NCT01223404|54565991|FG004|Second Intervention (1 Day)|Adverse Event|0|||
27908331|NCT01223404|54565992|FG005|Second Intervention (1 Day)|Adverse Event|0|||
27908332|NCT01223404|54565987|FG000|Third Intervention (1 Day)|Non-compliance (slept)|0|||
27908333|NCT01223404|54565988|FG001|Third Intervention (1 Day)|Non-compliance (slept)|0|||
27908334|NCT01223404|54565989|FG002|Third Intervention (1 Day)|Non-compliance (slept)|0|||
27908335|NCT01223404|54565990|FG003|Third Intervention (1 Day)|Non-compliance (slept)|1|||
27991814|NCT00848718|54650437|FG005|Overall Study|Physician Decision|1|||
27991815|NCT00848718|54650438|FG006|Overall Study|Physician Decision|0|||
27908336|NCT01223404|54565991|FG004|Third Intervention (1 Day)|Non-compliance (slept)|0|||
27908337|NCT01223404|54565992|FG005|Third Intervention (1 Day)|Non-compliance (slept)|0|||
27908338|NCT01223365|54566040|FG000|Open-label Titration Period|Enrolled but not treated|1|||
27908339|NCT01223365|54566040|FG000|Open-label Titration Period|Adverse Event|23|||
27908340|NCT01223365|54566040|FG000|Open-label Titration Period|Lack of Efficacy|3|||
27908341|NCT01223365|54566040|FG000|Open-label Titration Period|Withdrawal by Subject|5|||
27908342|NCT01223365|54566040|FG000|Open-label Titration Period|Protocol Violation|1|||
27908343|NCT01223365|54566040|FG000|Open-label Titration Period|Lost to Follow-up|2|||
27908344|NCT01223365|54566040|FG000|Open-label Titration Period|Noncompliance with study drug admin|1|||
27908345|NCT01223365|54566040|FG000|Open-label Titration Period|Noncompliance with study procedures|2|||
27908346|NCT01223365|54566040|FG000|Open-label Titration Period|Starting physical therapy|1|||
27908347|NCT01223365|54566040|FG000|Open-label Treatment Period|Adverse Event|39|||
27908348|NCT01223365|54566040|FG000|Open-label Treatment Period|Lack of Efficacy|2|||
27908349|NCT01223365|54566040|FG000|Open-label Treatment Period|Withdrawal by Subject|19|||
27908350|NCT01223365|54566040|FG000|Open-label Treatment Period|Protocol Violation|15|||
27908351|NCT01223365|54566040|FG000|Open-label Treatment Period|Lost to Follow-up|7|||
27908352|NCT01223365|54566040|FG000|Open-label Treatment Period|Noncompliance with study drug admin|7|||
27908353|NCT01223365|54566040|FG000|Open-label Treatment Period|Noncompliance with study procedures|6|||
27908354|NCT01223365|54566040|FG000|Open-label Treatment Period|Moved out of area|2|||
27908355|NCT01223365|54566040|FG000|Open-label Treatment Period|Negative urine drug screen when on treat|1|||
27908356|NCT01223365|54566040|FG000|Open-label Treatment Period|"Out of window"|1|||
27908357|NCT01223365|54566040|FG000|Open-label Treatment Period|Starting physical therapy|1|||
27908358|NCT01223365|54566040|FG000|Open-label Treatment Period|Physician Decision|2|||
27908359|NCT01222507|54566049|FG000|Overall Study|Physician Decision|1|||
27908360|NCT01222507|54566049|FG000|Overall Study|Withdrawal by Subject|1|||
27908361|NCT01222078|54566053|FG000|Overall Study|Early termination of the study|1|||
27908362|NCT01221727|54566060|FG000|Overall Study|Physician Decision|2|||
27991816|NCT00848718|54650439|FG007|Overall Study|Physician Decision|0|||
27991817|NCT00848718|54650440|FG008|Overall Study|Physician Decision|1|||
27991818|NCT00848718|54650441|FG009|Overall Study|Physician Decision|2|||
27991819|NCT00848718|54650442|FG010|Overall Study|Physician Decision|0|||
27991820|NCT00848718|54650443|FG011|Overall Study|Physician Decision|0|||
27991821|NCT00848718|54650444|FG012|Overall Study|Physician Decision|1|||
27991822|NCT00848718|54650432|FG000|Overall Study|Progressive disease before treatment|1|||
27991823|NCT00848718|54650433|FG001|Overall Study|Progressive disease before treatment|5|||
27991824|NCT00848718|54650434|FG002|Overall Study|Progressive disease before treatment|1|||
27991825|NCT00848718|54650435|FG003|Overall Study|Progressive disease before treatment|3|||
27991826|NCT00848718|54650436|FG004|Overall Study|Progressive disease before treatment|4|||
27991827|NCT00848718|54650437|FG005|Overall Study|Progressive disease before treatment|4|||
27991828|NCT00848718|54650438|FG006|Overall Study|Progressive disease before treatment|2|||
27991829|NCT00848718|54650439|FG007|Overall Study|Progressive disease before treatment|1|||
27991830|NCT00848718|54650440|FG008|Overall Study|Progressive disease before treatment|2|||
27991831|NCT00848718|54650441|FG009|Overall Study|Progressive disease before treatment|7|||
27991832|NCT00848718|54650442|FG010|Overall Study|Progressive disease before treatment|3|||
27991833|NCT00848718|54650443|FG011|Overall Study|Progressive disease before treatment|6|||
27991834|NCT00848718|54650444|FG012|Overall Study|Progressive disease before treatment|2|||
27991835|NCT00848718|54650432|FG000|Overall Study|Protocol Violation|0|||
27991836|NCT00848718|54650433|FG001|Overall Study|Protocol Violation|1|||
27991837|NCT00848718|54650434|FG002|Overall Study|Protocol Violation|0|||
27991838|NCT00848718|54650435|FG003|Overall Study|Protocol Violation|0|||
27991839|NCT00848718|54650436|FG004|Overall Study|Protocol Violation|0|||
27991840|NCT00848718|54650437|FG005|Overall Study|Protocol Violation|0|||
27991841|NCT00848718|54650438|FG006|Overall Study|Protocol Violation|0|||
27991842|NCT00848718|54650439|FG007|Overall Study|Protocol Violation|1|||
27908363|NCT01221727|54566061|FG001|Overall Study|Physician Decision|0|||
27908364|NCT01221727|54566060|FG000|Overall Study|Withdrawal by Subject|1|||
27908365|NCT01221727|54566061|FG001|Overall Study|Withdrawal by Subject|1|||
27908366|NCT01221181|54566073|FG000|Overall Study|Lost to Follow-up|1|||
27908367|NCT01220557|54566079|FG000|Overall Study|Lost to Follow-up|5|||
27908368|NCT01220557|54566080|FG001|Overall Study|Lost to Follow-up|3|||
27908369|NCT01220557|54566079|FG000|Overall Study|attended less than 6 lessons|1|||
27908370|NCT01220557|54566080|FG001|Overall Study|attended less than 6 lessons|2|||
27908371|NCT01220401|54566086|FG000|Overall Study|Withdrawal by Subject|2|||
27908372|NCT01220401|54566086|FG000|Overall Study|Protocol Violation|1|||
27908373|NCT01220167|54566093|FG000|Period 3|Urine positive for substance abuse|0|||
27908374|NCT01220167|54566094|FG001|Period 3|Urine positive for substance abuse|1|||
27991843|NCT00848718|54650440|FG008|Overall Study|Protocol Violation|0|||
27991844|NCT00848718|54650441|FG009|Overall Study|Protocol Violation|0|||
28098000|NCT00090363|54753815|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
27991845|NCT00848718|54650442|FG010|Overall Study|Protocol Violation|0|||
27991846|NCT00848718|54650443|FG011|Overall Study|Protocol Violation|0|||
27991847|NCT00848718|54650444|FG012|Overall Study|Protocol Violation|1|||
27908375|NCT01220167|54566095|FG002|Period 3|Urine positive for substance abuse|0|||
27908376|NCT01220128|54566108|FG000|Overall Study|Progressive disease|0|||
27908377|NCT01220128|54566109|FG001|Overall Study|Progressive disease|0|||
27908378|NCT01220128|54566110|FG002|Overall Study|Progressive disease|2|||
27908379|NCT01220128|54566111|FG003|Overall Study|Progressive disease|0|||
27908380|NCT01220128|54566112|FG004|Overall Study|Progressive disease|0|||
27908381|NCT01220128|54566113|FG005|Overall Study|Progressive disease|0|||
27908382|NCT01220128|54566114|FG006|Overall Study|Progressive disease|0|||
27908383|NCT01220128|54566108|FG000|Overall Study|Sponsor study termination|0|||
27908384|NCT01220128|54566109|FG001|Overall Study|Sponsor study termination|1|||
27908385|NCT01220128|54566110|FG002|Overall Study|Sponsor study termination|0|||
27908386|NCT01220128|54566111|FG003|Overall Study|Sponsor study termination|0|||
27908387|NCT01220128|54566112|FG004|Overall Study|Sponsor study termination|0|||
27908388|NCT01220128|54566113|FG005|Overall Study|Sponsor study termination|0|||
27908389|NCT01220128|54566114|FG006|Overall Study|Sponsor study termination|1|||
27991848|NCT00848718|54650432|FG000|Overall Study|Withdrawal by Subject|1|||
27991849|NCT00848718|54650433|FG001|Overall Study|Withdrawal by Subject|0|||
27991850|NCT00848718|54650434|FG002|Overall Study|Withdrawal by Subject|0|||
27991851|NCT00848718|54650435|FG003|Overall Study|Withdrawal by Subject|1|||
27991852|NCT00848718|54650436|FG004|Overall Study|Withdrawal by Subject|0|||
27991853|NCT00848718|54650437|FG005|Overall Study|Withdrawal by Subject|0|||
27991854|NCT00848718|54650438|FG006|Overall Study|Withdrawal by Subject|0|||
27991855|NCT00848718|54650439|FG007|Overall Study|Withdrawal by Subject|0|||
27991856|NCT00848718|54650440|FG008|Overall Study|Withdrawal by Subject|0|||
27991857|NCT00848718|54650441|FG009|Overall Study|Withdrawal by Subject|0|||
27991858|NCT00848718|54650442|FG010|Overall Study|Withdrawal by Subject|1|||
27991859|NCT00848718|54650443|FG011|Overall Study|Withdrawal by Subject|0|||
27991860|NCT00848718|54650444|FG012|Overall Study|Withdrawal by Subject|0|||
27991861|NCT00848718|54650432|FG000|Overall Study|Progressive disease during treatment|3|||
28098001|NCT00090363|54753816|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
28098002|NCT00090363|54753814|FG000|Overall Study|Consent expired|7|||
28098003|NCT00090363|54753815|FG001|Overall Study|Consent expired|10|||
28098004|NCT00090363|54753816|FG002|Overall Study|Consent expired|9|||
27991862|NCT00848718|54650433|FG001|Overall Study|Progressive disease during treatment|0|||
27991863|NCT00848718|54650434|FG002|Overall Study|Progressive disease during treatment|3|||
27991864|NCT00848718|54650435|FG003|Overall Study|Progressive disease during treatment|0|||
27991865|NCT00848718|54650436|FG004|Overall Study|Progressive disease during treatment|0|||
27991866|NCT00848718|54650437|FG005|Overall Study|Progressive disease during treatment|0|||
27991867|NCT00848718|54650438|FG006|Overall Study|Progressive disease during treatment|0|||
27991868|NCT00848718|54650439|FG007|Overall Study|Progressive disease during treatment|2|||
27991869|NCT00848718|54650440|FG008|Overall Study|Progressive disease during treatment|0|||
27991870|NCT00848718|54650441|FG009|Overall Study|Progressive disease during treatment|0|||
27991871|NCT00848718|54650442|FG010|Overall Study|Progressive disease during treatment|0|||
27991872|NCT00848718|54650443|FG011|Overall Study|Progressive disease during treatment|0|||
27991873|NCT00848718|54650444|FG012|Overall Study|Progressive disease during treatment|2|||
27991874|NCT00883337|54650481|FG000|Core Treatment Period|Adverse Event|9|||
27991875|NCT00883337|54650482|FG001|Core Treatment Period|Adverse Event|12|||
27991876|NCT00883337|54650483|FG002|Core Treatment Period|Adverse Event|22|||
27991877|NCT00883337|54650481|FG000|Core Treatment Period|Lack of Efficacy|7|||
27991878|NCT00883337|54650482|FG001|Core Treatment Period|Lack of Efficacy|4|||
27991879|NCT00883337|54650483|FG002|Core Treatment Period|Lack of Efficacy|2|||
27991880|NCT00883337|54650481|FG000|Core Treatment Period|Lost to Follow-up|1|||
27991881|NCT00883337|54650482|FG001|Core Treatment Period|Lost to Follow-up|1|||
27991882|NCT00883337|54650483|FG002|Core Treatment Period|Lost to Follow-up|0|||
27991883|NCT00883337|54650481|FG000|Core Treatment Period|Withdrawal by Subject|2|||
27991884|NCT00883337|54650482|FG001|Core Treatment Period|Withdrawal by Subject|2|||
27991885|NCT00883337|54650483|FG002|Core Treatment Period|Withdrawal by Subject|6|||
27991886|NCT00883337|54650481|FG000|Core Treatment Period|Wish to be pregnant|1|||
27991887|NCT00883337|54650482|FG001|Core Treatment Period|Wish to be pregnant|2|||
27991888|NCT00883337|54650483|FG002|Core Treatment Period|Wish to be pregnant|1|||
27991889|NCT00883337|54650481|FG000|Core Treatment Period|Poor compliance to protocol|0|||
28098005|NCT00090363|54753814|FG000|Overall Study|Reasons not specified|2|||
27908390|NCT01220128|54566108|FG000|Overall Study|Adverse event, serious fatal|2|||
27991890|NCT00883337|54650482|FG001|Core Treatment Period|Poor compliance to protocol|0|||
27991891|NCT00883337|54650483|FG002|Core Treatment Period|Poor compliance to protocol|1|||
27991892|NCT00883337|54650481|FG000|Core Treatment Period|Other than above|0|||
27991893|NCT00883337|54650482|FG001|Core Treatment Period|Other than above|1|||
27991894|NCT00883337|54650483|FG002|Core Treatment Period|Other than above|1|||
27991895|NCT00883337|54650481|FG000|Extension Treatment Period|Adverse Event|8|||
27991896|NCT00883337|54650482|FG001|Extension Treatment Period|Adverse Event|5|||
27908391|NCT01220128|54566109|FG001|Overall Study|Adverse event, serious fatal|0|||
27908392|NCT01220128|54566110|FG002|Overall Study|Adverse event, serious fatal|0|||
27908393|NCT01220128|54566111|FG003|Overall Study|Adverse event, serious fatal|0|||
27991897|NCT00883337|54650483|FG002|Extension Treatment Period|Adverse Event|5|||
27991898|NCT00883337|54650481|FG000|Extension Treatment Period|Lack of Efficacy|8|||
27991899|NCT00883337|54650482|FG001|Extension Treatment Period|Lack of Efficacy|8|||
27991900|NCT00883337|54650483|FG002|Extension Treatment Period|Lack of Efficacy|8|||
27991901|NCT00883337|54650481|FG000|Extension Treatment Period|Poor compliance to protocol|1|||
27991902|NCT00883337|54650482|FG001|Extension Treatment Period|Poor compliance to protocol|1|||
27991903|NCT00883337|54650483|FG002|Extension Treatment Period|Poor compliance to protocol|1|||
27991904|NCT00883337|54650481|FG000|Extension Treatment Period|Lost to Follow-up|1|||
27991905|NCT00883337|54650482|FG001|Extension Treatment Period|Lost to Follow-up|0|||
27991906|NCT00883337|54650483|FG002|Extension Treatment Period|Lost to Follow-up|0|||
27991907|NCT00883337|54650481|FG000|Extension Treatment Period|Other than above|10|||
27991908|NCT00883337|54650482|FG001|Extension Treatment Period|Other than above|9|||
27991909|NCT00883337|54650483|FG002|Extension Treatment Period|Other than above|5|||
27991910|NCT00838110|54650499|FG000|Overall Study|Death|0|||
27908394|NCT01220128|54566112|FG004|Overall Study|Adverse event, serious fatal|0|||
27908395|NCT01220128|54566113|FG005|Overall Study|Adverse event, serious fatal|0|||
27908396|NCT01220128|54566114|FG006|Overall Study|Adverse event, serious fatal|1|||
27908397|NCT01220128|54566108|FG000|Overall Study|Adverse event, non-fatal|1|||
27991911|NCT00838110|54650500|FG001|Overall Study|Death|0|||
27991912|NCT00838110|54650501|FG002|Overall Study|Death|1|||
27991913|NCT00838110|54650502|FG003|Overall Study|Death|2|||
27991914|NCT00838110|54650499|FG000|Overall Study|Adverse Event|11|||
27991915|NCT00838110|54650500|FG001|Overall Study|Adverse Event|10|||
27991916|NCT00838110|54650501|FG002|Overall Study|Adverse Event|8|||
27991917|NCT00838110|54650502|FG003|Overall Study|Adverse Event|7|||
27908398|NCT01220128|54566109|FG001|Overall Study|Adverse event, non-fatal|0|||
27908399|NCT01220128|54566110|FG002|Overall Study|Adverse event, non-fatal|0|||
27908400|NCT01220128|54566111|FG003|Overall Study|Adverse event, non-fatal|0|||
27908401|NCT01220128|54566112|FG004|Overall Study|Adverse event, non-fatal|0|||
27908402|NCT01220128|54566113|FG005|Overall Study|Adverse event, non-fatal|0|||
27908403|NCT01220128|54566114|FG006|Overall Study|Adverse event, non-fatal|3|||
27908404|NCT01220128|54566108|FG000|Overall Study|Other|0|||
27908405|NCT01220128|54566109|FG001|Overall Study|Other|0|||
27908406|NCT01220128|54566110|FG002|Overall Study|Other|1|||
27908407|NCT01220128|54566111|FG003|Overall Study|Other|0|||
27908408|NCT01220128|54566112|FG004|Overall Study|Other|0|||
27908409|NCT01220128|54566113|FG005|Overall Study|Other|0|||
27908410|NCT01220128|54566114|FG006|Overall Study|Other|0|||
27908411|NCT01220128|54566108|FG000|Overall Study|Consent withdrawn by subject|1|||
27908412|NCT01220128|54566109|FG001|Overall Study|Consent withdrawn by subject|0|||
27908413|NCT01220128|54566110|FG002|Overall Study|Consent withdrawn by subject|0|||
27908414|NCT01220128|54566111|FG003|Overall Study|Consent withdrawn by subject|0|||
27991918|NCT00838110|54650499|FG000|Overall Study|Withdrawal by Subject|5|||
27991919|NCT00838110|54650500|FG001|Overall Study|Withdrawal by Subject|6|||
27991920|NCT00838110|54650501|FG002|Overall Study|Withdrawal by Subject|3|||
27991921|NCT00838110|54650502|FG003|Overall Study|Withdrawal by Subject|4|||
27991922|NCT00838110|54650499|FG000|Overall Study|Other|3|||
27991923|NCT00838110|54650500|FG001|Overall Study|Other|3|||
27991924|NCT00838110|54650501|FG002|Overall Study|Other|3|||
27991925|NCT00838110|54650502|FG003|Overall Study|Other|2|||
27991926|NCT00838110|54650499|FG000|Overall Study|Protocol Violation|0|||
27991927|NCT00838110|54650500|FG001|Overall Study|Protocol Violation|2|||
27908415|NCT01220128|54566112|FG004|Overall Study|Consent withdrawn by subject|0|||
27991928|NCT00838110|54650501|FG002|Overall Study|Protocol Violation|1|||
27991929|NCT00838110|54650502|FG003|Overall Study|Protocol Violation|1|||
27991930|NCT00838110|54650499|FG000|Overall Study|Lost to Follow-up|3|||
27991931|NCT00838110|54650500|FG001|Overall Study|Lost to Follow-up|0|||
27991932|NCT00838110|54650501|FG002|Overall Study|Lost to Follow-up|0|||
27991933|NCT00838110|54650502|FG003|Overall Study|Lost to Follow-up|0|||
27991934|NCT00838110|54650499|FG000|Overall Study|Did not meet eligibility criteria|0|||
27991935|NCT00838110|54650500|FG001|Overall Study|Did not meet eligibility criteria|0|||
27991936|NCT00838110|54650501|FG002|Overall Study|Did not meet eligibility criteria|1|||
27991937|NCT00838110|54650502|FG003|Overall Study|Did not meet eligibility criteria|2|||
27991938|NCT00838110|54650499|FG000|Overall Study|Randomized but not treated|0|||
28098006|NCT00090363|54753815|FG001|Overall Study|Reasons not specified|1|||
28098007|NCT00090363|54753816|FG002|Overall Study|Reasons not specified|1|||
27908416|NCT01220128|54566113|FG005|Overall Study|Consent withdrawn by subject|0|||
28098008|NCT00090363|54753814|FG000|Overall Study|Continuing on study off treatment|14|||
27908417|NCT01220128|54566114|FG006|Overall Study|Consent withdrawn by subject|0|||
27908418|NCT01219933|54566131|FG000|Overall Study|Adverse Event|8|||
27991939|NCT00838110|54650500|FG001|Overall Study|Randomized but not treated|1|||
27991940|NCT00838110|54650501|FG002|Overall Study|Randomized but not treated|0|||
27991941|NCT00838110|54650502|FG003|Overall Study|Randomized but not treated|0|||
27991942|NCT00837876|54650512|FG000|Overall Study|Death|2|||
27991943|NCT00837876|54650512|FG000|Overall Study|Adverse Event|7|||
27908419|NCT01219933|54566131|FG000|Overall Study|No LDA reached|5|||
27908420|NCT01219933|54566131|FG000|Overall Study|No LDA maintained|7|||
27991944|NCT00837876|54650512|FG000|Overall Study|Physician Decision|1|||
27991945|NCT00837876|54650512|FG000|Overall Study|Withdrawal by Subject|3|||
27991946|NCT00837876|54650512|FG000|Overall Study|disease progression|24|||
27991947|NCT02637713|54650516|FG000|Overall Study|Screen Failure|2|||
27991948|NCT00686920|54650522|FG000|Overall Study|Death|45|||
27991949|NCT00686920|54650523|FG001|Overall Study|Death|14|||
27991950|NCT00686920|54650522|FG000|Overall Study|Liver Transplant|23|||
27991951|NCT00686920|54650523|FG001|Overall Study|Liver Transplant|8|||
27991952|NCT00686920|54650522|FG000|Overall Study|Recurrent Hepatic Encephalopathy Episode|1|||
27991953|NCT00686920|54650523|FG001|Overall Study|Recurrent Hepatic Encephalopathy Episode|2|||
27991954|NCT00686920|54650522|FG000|Overall Study|Withdrawal by Subject|23|||
27908421|NCT01219933|54566131|FG000|Overall Study|Lost to Follow-up|3|||
27908422|NCT01219933|54566131|FG000|Overall Study|GC free|1|||
27908423|NCT01219933|54566131|FG000|Overall Study|Withdrawal by Subject|5|||
27908424|NCT01219933|54566131|FG000|Overall Study|Protocol Violation|8|||
27908425|NCT01219933|54566131|FG000|Overall Study|Lack of Efficacy|1|||
27908426|NCT01218802|54566138|FG000|Overall Study|Lost to Follow-up|5|||
27908427|NCT01218802|54566139|FG001|Overall Study|Lost to Follow-up|6|||
27908428|NCT01218802|54566138|FG000|Overall Study|Withdrawal by Subject|3|||
27908429|NCT01218802|54566139|FG001|Overall Study|Withdrawal by Subject|10|||
27908430|NCT01218802|54566138|FG000|Overall Study|Adverse Event|0|||
27908431|NCT01218802|54566139|FG001|Overall Study|Adverse Event|2|||
27908432|NCT01218802|54566138|FG000|Overall Study|Incarcerated|2|||
27908433|NCT01218802|54566139|FG001|Overall Study|Incarcerated|0|||
27908434|NCT01218646|54566149|FG000|Overall Study|Adverse Event|0|||
27908435|NCT01218646|54566150|FG001|Overall Study|Adverse Event|0|||
27908436|NCT01218646|54566151|FG002|Overall Study|Adverse Event|1|||
27908437|NCT01218646|54566152|FG003|Overall Study|Adverse Event|0|||
27908438|NCT01218646|54566149|FG000|Overall Study|Lost to Follow-up|1|||
27908439|NCT01218646|54566150|FG001|Overall Study|Lost to Follow-up|0|||
27908440|NCT01218646|54566151|FG002|Overall Study|Lost to Follow-up|0|||
27908441|NCT01218646|54566152|FG003|Overall Study|Lost to Follow-up|0|||
27908442|NCT01218646|54566149|FG000|Overall Study|Protocol Violation|0|||
27908443|NCT01218646|54566150|FG001|Overall Study|Protocol Violation|0|||
27908444|NCT01218646|54566151|FG002|Overall Study|Protocol Violation|1|||
27908445|NCT01218646|54566152|FG003|Overall Study|Protocol Violation|1|||
27908446|NCT01188772|54566166|FG000|Overall Study|Randomized but Not Treated|0|||
27908447|NCT01188772|54566167|FG001|Overall Study|Randomized but Not Treated|1|||
27908448|NCT01188772|54566168|FG002|Overall Study|Randomized but Not Treated|0|||
27908449|NCT01188772|54566169|FG003|Overall Study|Randomized but Not Treated|0|||
27908450|NCT01188772|54566166|FG000|Overall Study|Adverse Event|0|||
27908451|NCT01188772|54566167|FG001|Overall Study|Adverse Event|1|||
27908452|NCT01188772|54566168|FG002|Overall Study|Adverse Event|2|||
27908453|NCT01188772|54566169|FG003|Overall Study|Adverse Event|0|||
27908454|NCT01188772|54566166|FG000|Overall Study|Lost to Follow-up|4|||
27908455|NCT01188772|54566167|FG001|Overall Study|Lost to Follow-up|1|||
27908456|NCT01188772|54566168|FG002|Overall Study|Lost to Follow-up|1|||
27908457|NCT01188772|54566169|FG003|Overall Study|Lost to Follow-up|1|||
27908458|NCT01188772|54566166|FG000|Overall Study|Non-responder|0|||
27908459|NCT01188772|54566167|FG001|Overall Study|Non-responder|0|||
27908460|NCT01188772|54566168|FG002|Overall Study|Non-responder|3|||
27908461|NCT01188772|54566169|FG003|Overall Study|Non-responder|0|||
27908462|NCT01188772|54566166|FG000|Overall Study|Physician Decision|0|||
27908463|NCT01188772|54566167|FG001|Overall Study|Physician Decision|0|||
27908464|NCT01188772|54566168|FG002|Overall Study|Physician Decision|1|||
27908465|NCT01188772|54566169|FG003|Overall Study|Physician Decision|0|||
27908466|NCT01188772|54566166|FG000|Overall Study|Terminated by Sponsor|0|||
27908467|NCT01188772|54566167|FG001|Overall Study|Terminated by Sponsor|0|||
27908468|NCT01188772|54566168|FG002|Overall Study|Terminated by Sponsor|1|||
27908469|NCT01188772|54566169|FG003|Overall Study|Terminated by Sponsor|0|||
27908470|NCT01188772|54566166|FG000|Overall Study|Treatment Failure|0|||
27991955|NCT00686920|54650523|FG001|Overall Study|Withdrawal by Subject|5|||
27991956|NCT00686920|54650522|FG000|Overall Study|Protocol Violation|2|||
27991957|NCT00686920|54650523|FG001|Overall Study|Protocol Violation|1|||
27908471|NCT01188772|54566167|FG001|Overall Study|Treatment Failure|0|||
27908472|NCT01188772|54566168|FG002|Overall Study|Treatment Failure|1|||
27908473|NCT01188772|54566169|FG003|Overall Study|Treatment Failure|0|||
27908474|NCT01188772|54566166|FG000|Overall Study|Virologic Failure|1|||
27908475|NCT01188772|54566167|FG001|Overall Study|Virologic Failure|0|||
27908476|NCT01188772|54566168|FG002|Overall Study|Virologic Failure|0|||
27908477|NCT01188772|54566169|FG003|Overall Study|Virologic Failure|0|||
27908478|NCT01188772|54566166|FG000|Overall Study|Withdrawal by Subject|0|||
27908479|NCT01188772|54566167|FG001|Overall Study|Withdrawal by Subject|0|||
27908480|NCT01188772|54566168|FG002|Overall Study|Withdrawal by Subject|2|||
27991958|NCT00686920|54650522|FG000|Overall Study|Adverse Event|10|||
27908481|NCT01188772|54566169|FG003|Overall Study|Withdrawal by Subject|0|||
27908482|NCT01188655|54566182|FG000|Overall Study|Lack of Efficacy|1|||
27908483|NCT01188655|54566182|FG000|Overall Study|Lost to Follow-up|1|||
27908484|NCT01188655|54566182|FG000|Overall Study|Other|11|||
27991959|NCT00686920|54650523|FG001|Overall Study|Adverse Event|2|||
27991960|NCT00686920|54650522|FG000|Overall Study|Personal Reason|0|||
27991961|NCT00686920|54650523|FG001|Overall Study|Personal Reason|1|||
27991962|NCT00686920|54650522|FG000|Overall Study|Lost to Follow-up|15|||
27991963|NCT00686920|54650523|FG001|Overall Study|Lost to Follow-up|3|||
27991964|NCT00686920|54650522|FG000|Overall Study|Moved to Another State|1|||
27991965|NCT00686920|54650523|FG001|Overall Study|Moved to Another State|0|||
27991966|NCT00686920|54650522|FG000|Overall Study|Transferred to Nursing Home|1|||
27991967|NCT00686920|54650523|FG001|Overall Study|Transferred to Nursing Home|0|||
27991968|NCT00686920|54650522|FG000|Overall Study|Noncompliance|9|||
27991969|NCT00686920|54650523|FG001|Overall Study|Noncompliance|0|||
27991970|NCT00686920|54650522|FG000|Overall Study|Principal Investigator Decision|2|||
27991971|NCT00686920|54650523|FG001|Overall Study|Principal Investigator Decision|0|||
27991972|NCT00845832|54650532|FG000|Treatment Period|Adverse Event|0|||
27991973|NCT00845832|54650533|FG001|Treatment Period|Adverse Event|2|||
27991974|NCT00845832|54650534|FG002|Treatment Period|Adverse Event|0|||
27991975|NCT00845832|54650532|FG000|Treatment Period|Protocol Violation|1|||
27991976|NCT00845832|54650533|FG001|Treatment Period|Protocol Violation|1|||
27991977|NCT00845832|54650534|FG002|Treatment Period|Protocol Violation|0|||
27991978|NCT00845832|54650532|FG000|Safety Follow-Up|Withdrawal by Subject|1|||
27991979|NCT00845832|54650533|FG001|Safety Follow-Up|Withdrawal by Subject|0|||
27991980|NCT00845832|54650534|FG002|Safety Follow-Up|Withdrawal by Subject|0|||
27991981|NCT00845832|54650532|FG000|Extended Safety Follow-Up|Withdrawal by Subject|0|||
27991982|NCT00845832|54650533|FG001|Extended Safety Follow-Up|Withdrawal by Subject|0|||
27991983|NCT00845832|54650534|FG002|Extended Safety Follow-Up|Withdrawal by Subject|7|||
27991984|NCT00591864|54650542|FG000|Overall Study|Incomplete Imaging|5|||
27991985|NCT00885755|54650550|FG000|Part I: Trastuzumab+Taxane|Adverse Event|1|||
27991986|NCT00885755|54650551|FG001|Part I: Trastuzumab+Taxane|Adverse Event|0|||
27991987|NCT00885755|54650552|FG002|Part I: Trastuzumab+Taxane|Adverse Event|0|||
27991988|NCT00885755|54650550|FG000|Part I: Trastuzumab+Taxane|Unknown Reason|16|||
27991989|NCT00885755|54650551|FG001|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
27991990|NCT00885755|54650552|FG002|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
27991991|NCT00885755|54650550|FG000|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1|||
27991992|NCT00885755|54650551|FG001|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
27991993|NCT00885755|54650552|FG002|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
27991994|NCT00885755|54650550|FG000|Part I: Trastuzumab+Taxane|Death|0|||
27991995|NCT00885755|54650551|FG001|Part I: Trastuzumab+Taxane|Death|0|||
27991996|NCT00885755|54650552|FG002|Part I: Trastuzumab+Taxane|Death|1|||
27991997|NCT00885755|54650550|FG000|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5|||
27991998|NCT00885755|54650551|FG001|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
27991999|NCT00885755|54650552|FG002|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
27992000|NCT00837486|54650562|FG000|Blinded-treatment Phase|Physician Decision|1|||
27992001|NCT00837486|54650563|FG001|Blinded-treatment Phase|Physician Decision|0|||
27992002|NCT00837486|54650562|FG000|Long-term Follow-up Phase - Open Label|Physician Decision|2|||
27992003|NCT00837486|54650563|FG001|Long-term Follow-up Phase - Open Label|Physician Decision|0|||
27992004|NCT00837486|54650562|FG000|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2|||
27992005|NCT00837486|54650563|FG001|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0|||
27992006|NCT00837486|54650562|FG000|Long-term Follow-up Phase - Open Label|Death|1|||
27908485|NCT01188538|54566188|FG000|Overall Study|Lost to Follow-up|0|||
27908486|NCT01188538|54566189|FG001|Overall Study|Lost to Follow-up|1|||
27908487|NCT01188343|54566200|FG000|Overall Study|Not vaccinated|0|||
27908488|NCT01188343|54566201|FG001|Overall Study|Not vaccinated|2|||
27908489|NCT01188343|54566202|FG002|Overall Study|Not vaccinated|1|||
27908490|NCT01188343|54566200|FG000|Overall Study|Withdrawal by Subject|1|||
27908491|NCT01188343|54566201|FG001|Overall Study|Withdrawal by Subject|24|||
27908492|NCT01188343|54566202|FG002|Overall Study|Withdrawal by Subject|0|||
27908493|NCT01188226|54566213|FG000|Overall Study|Withdrawal by Subject|4|||
27908494|NCT01218100|54566231|FG000|Overall Study|Did not meet InclusionExclusion criteria|1|||
27908495|NCT01218100|54566232|FG001|Overall Study|Did not meet InclusionExclusion criteria|1|||
27908496|NCT01218100|54566233|FG002|Overall Study|Did not meet InclusionExclusion criteria|1|||
27908497|NCT01218100|54566234|FG003|Overall Study|Did not meet InclusionExclusion criteria|2|||
27908498|NCT01218100|54566231|FG000|Overall Study|Adverse Event|4|||
27908499|NCT01218100|54566232|FG001|Overall Study|Adverse Event|6|||
27908500|NCT01218100|54566233|FG002|Overall Study|Adverse Event|6|||
27908501|NCT01218100|54566234|FG003|Overall Study|Adverse Event|7|||
27908502|NCT01218100|54566231|FG000|Overall Study|Lack of Efficacy|9|||
27992007|NCT00837486|54650563|FG001|Long-term Follow-up Phase - Open Label|Death|0|||
27992008|NCT00845676|54650571|FG000|Overall Study|Virologic breakthrough at week 20|1|||
27908503|NCT01218100|54566232|FG001|Overall Study|Lack of Efficacy|6|||
27908504|NCT01218100|54566233|FG002|Overall Study|Lack of Efficacy|5|||
27908505|NCT01218100|54566234|FG003|Overall Study|Lack of Efficacy|12|||
27992009|NCT00845676|54650571|FG000|Overall Study|Adverse Event|1|||
27992010|NCT00883181|54650576|FG000|Overall Study|Hematological Adverse Event|26|||
27992011|NCT00883181|54650576|FG000|Overall Study|Non-hematological Adverse Event|55|||
27992012|NCT00883181|54650576|FG000|Overall Study|Disease Progression|94|||
27992013|NCT00883181|54650576|FG000|Overall Study|Administrative Reason|24|||
27992014|NCT00883181|54650576|FG000|Overall Study|Withdrawal by Subject|4|||
27992015|NCT00883181|54650576|FG000|Overall Study|Death|31|||
27992016|NCT00883181|54650576|FG000|Overall Study|Other|38|||
27992017|NCT00883181|54650576|FG000|Overall Study|Protocol Deviation|3|||
27992018|NCT00883181|54650576|FG000|Overall Study|Noncompliance|3|||
27992019|NCT00845520|54650596|FG000|Overall Study|Death|1|||
27992020|NCT00845520|54650597|FG001|Overall Study|Death|2|||
27992021|NCT00845520|54650598|FG002|Overall Study|Death|0|||
27992022|NCT00845520|54650596|FG000|Overall Study|Lost to Follow-up|1|||
27992023|NCT00845520|54650597|FG001|Overall Study|Lost to Follow-up|0|||
27992024|NCT00845520|54650598|FG002|Overall Study|Lost to Follow-up|0|||
27992025|NCT00845520|54650596|FG000|Overall Study|Adverse Event|0|||
27992026|NCT00845520|54650597|FG001|Overall Study|Adverse Event|0|||
27992027|NCT00845520|54650598|FG002|Overall Study|Adverse Event|1|||
27992028|NCT00844896|54650614|FG000|Overall Study|Lost to Follow-up|12|||
27992029|NCT00844896|54650615|FG001|Overall Study|Lost to Follow-up|16|||
27992030|NCT00844896|54650614|FG000|Overall Study|Parents did not have time to complete|0|||
27992031|NCT00844896|54650615|FG001|Overall Study|Parents did not have time to complete|1|||
27992032|NCT00827502|54650622|FG000|Overall Study|randomized but not treated|11|||
27992033|NCT00827502|54650622|FG000|Overall Study|Adverse Event|1|||
27992034|NCT00827502|54650622|FG000|Overall Study|Lost to Follow-up|4|||
27992035|NCT00827502|54650622|FG000|Overall Study|Withdrawal by Subject|5|||
27992036|NCT00837330|54650628|FG000|Overall Study|Lost to Follow-up|1|||
27992037|NCT00837330|54650629|FG001|Overall Study|Lost to Follow-up|3|||
27992038|NCT00837096|54650637|FG000|Overall Study|Physician Decision|1|||
27992039|NCT00837096|54650638|FG001|Overall Study|Physician Decision|1|||
27992040|NCT00837096|54650637|FG000|Overall Study|Not reported|9|||
27992041|NCT00837096|54650638|FG001|Overall Study|Not reported|8|||
27992042|NCT00885677|54650646|FG000|Overall Study|Death|40|||
27992043|NCT00885677|54650647|FG001|Overall Study|Death|34|||
27992044|NCT00885677|54650646|FG000|Overall Study|Lost to Follow-up|15|||
27992045|NCT00885677|54650647|FG001|Overall Study|Lost to Follow-up|13|||
27992046|NCT00885677|54650646|FG000|Overall Study|Protocol Violation|54|||
27992047|NCT00885677|54650647|FG001|Overall Study|Protocol Violation|54|||
27992048|NCT00885677|54650646|FG000|Overall Study|premature study closure|41|||
27992049|NCT00885677|54650647|FG001|Overall Study|premature study closure|44|||
27992050|NCT00885677|54650646|FG000|Overall Study|device/lead revision or replacement|7|||
27992051|NCT00885677|54650647|FG001|Overall Study|device/lead revision or replacement|6|||
27992052|NCT00885677|54650646|FG000|Overall Study|Heart transplantation|1|||
27992053|NCT00885677|54650647|FG001|Overall Study|Heart transplantation|0|||
27992054|NCT00885677|54650646|FG000|Overall Study|Inclusion/exclusion not met|25|||
27992055|NCT00885677|54650647|FG001|Overall Study|Inclusion/exclusion not met|27|||
27992056|NCT00885365|54650655|FG000|4 Weeks ON Treatment|Adverse Event|2|||
27992057|NCT00885365|54650656|FG001|4 Weeks ON Treatment|Adverse Event|4|||
27992058|NCT00885365|54650655|FG000|4 Weeks ON Treatment|Protocol Violation|1|||
27992059|NCT00885365|54650656|FG001|4 Weeks ON Treatment|Protocol Violation|2|||
27992060|NCT00885365|54650655|FG000|4 Weeks ON Treatment|Withdrawal by Subject|1|||
27908506|NCT01218100|54566231|FG000|Overall Study|Protocol Violation|0|||
27908507|NCT01218100|54566232|FG001|Overall Study|Protocol Violation|0|||
27908508|NCT01218100|54566233|FG002|Overall Study|Protocol Violation|1|||
27908509|NCT01218100|54566234|FG003|Overall Study|Protocol Violation|1|||
27908510|NCT01218100|54566231|FG000|Overall Study|Withdrawal by Subject|5|||
27908511|NCT01218100|54566232|FG001|Overall Study|Withdrawal by Subject|2|||
27908512|NCT01218100|54566233|FG002|Overall Study|Withdrawal by Subject|6|||
27992061|NCT00885365|54650656|FG001|4 Weeks ON Treatment|Withdrawal by Subject|0|||
27992062|NCT00827112|54650664|FG000|Overall Study|Adverse Event|2|||
27992063|NCT00827112|54650665|FG001|Overall Study|Adverse Event|0|||
27992064|NCT00827112|54650664|FG000|Overall Study|Lack of Efficacy|2|||
27992065|NCT00827112|54650665|FG001|Overall Study|Lack of Efficacy|0|||
27992066|NCT00827112|54650664|FG000|Overall Study|Lost to Follow-up|3|||
27992067|NCT00827112|54650665|FG001|Overall Study|Lost to Follow-up|2|||
27992068|NCT00827112|54650664|FG000|Overall Study|Pregnancy|0|||
27908513|NCT01218100|54566234|FG003|Overall Study|Withdrawal by Subject|7|||
27908514|NCT01218100|54566231|FG000|Overall Study|Lost to Follow-up|3|||
27992069|NCT00827112|54650665|FG001|Overall Study|Pregnancy|1|||
27992070|NCT00827112|54650664|FG000|Overall Study|Protocol Violation|0|||
27992071|NCT00827112|54650665|FG001|Overall Study|Protocol Violation|2|||
27992072|NCT00827112|54650664|FG000|Overall Study|Withdrawal by Subject|2|||
27992073|NCT00827112|54650665|FG001|Overall Study|Withdrawal by Subject|1|||
27992074|NCT00827112|54650664|FG000|Overall Study|Randomized but not treated|5|||
27992075|NCT00827112|54650665|FG001|Overall Study|Randomized but not treated|3|||
27992076|NCT00827112|54650664|FG000|Overall Study|Other|1|||
27992077|NCT00827112|54650665|FG001|Overall Study|Other|3|||
27992078|NCT00689104|54650675|FG000|Overall Study|Eligibility criterion not met|5|||
27992079|NCT00689104|54650676|FG001|Overall Study|Eligibility criterion not met|8|||
27992080|NCT00689104|54650677|FG002|Overall Study|Eligibility criterion not met|0|||
27992081|NCT00689104|54650678|FG003|Overall Study|Eligibility criterion not met|4|||
27992082|NCT00689104|54650675|FG000|Overall Study|Adverse Event|13|||
27992083|NCT00689104|54650676|FG001|Overall Study|Adverse Event|25|||
27992084|NCT00689104|54650677|FG002|Overall Study|Adverse Event|16|||
27992085|NCT00689104|54650678|FG003|Overall Study|Adverse Event|24|||
27992086|NCT00689104|54650675|FG000|Overall Study|Lack of Efficacy|5|||
27992087|NCT00689104|54650676|FG001|Overall Study|Lack of Efficacy|6|||
27992088|NCT00689104|54650677|FG002|Overall Study|Lack of Efficacy|2|||
27992089|NCT00689104|54650678|FG003|Overall Study|Lack of Efficacy|3|||
27992090|NCT00689104|54650675|FG000|Overall Study|Withdrawal by Subject|12|||
27992091|NCT00689104|54650676|FG001|Overall Study|Withdrawal by Subject|11|||
27992092|NCT00689104|54650677|FG002|Overall Study|Withdrawal by Subject|18|||
27992093|NCT00689104|54650678|FG003|Overall Study|Withdrawal by Subject|11|||
27992094|NCT00689104|54650675|FG000|Overall Study|Lost to Follow-up|4|||
27992095|NCT00689104|54650676|FG001|Overall Study|Lost to Follow-up|3|||
27992096|NCT00689104|54650677|FG002|Overall Study|Lost to Follow-up|2|||
27992097|NCT00689104|54650678|FG003|Overall Study|Lost to Follow-up|5|||
27992098|NCT00689104|54650675|FG000|Overall Study|Protocol Violation|2|||
27992099|NCT00689104|54650676|FG001|Overall Study|Protocol Violation|3|||
27992100|NCT00689104|54650677|FG002|Overall Study|Protocol Violation|5|||
27992101|NCT00689104|54650678|FG003|Overall Study|Protocol Violation|3|||
27992102|NCT00689104|54650675|FG000|Overall Study|Randomized but never received study drug|2|||
27992103|NCT00689104|54650676|FG001|Overall Study|Randomized but never received study drug|1|||
27908515|NCT01218100|54566232|FG001|Overall Study|Lost to Follow-up|8|||
27908516|NCT01218100|54566233|FG002|Overall Study|Lost to Follow-up|2|||
27908517|NCT01218100|54566234|FG003|Overall Study|Lost to Follow-up|1|||
27908518|NCT01218100|54566231|FG000|Overall Study|Other Reason|2|||
27908519|NCT01218100|54566232|FG001|Overall Study|Other Reason|2|||
27908520|NCT01218100|54566233|FG002|Overall Study|Other Reason|6|||
27908521|NCT01218100|54566234|FG003|Overall Study|Other Reason|4|||
27908522|NCT01187953|54566280|FG000|Overall Study|Death|11|||
27992104|NCT00689104|54650677|FG002|Overall Study|Randomized but never received study drug|1|||
27992105|NCT00689104|54650678|FG003|Overall Study|Randomized but never received study drug|0|||
27992106|NCT00689104|54650675|FG000|Overall Study|Physician Decision|1|||
27992107|NCT00689104|54650676|FG001|Overall Study|Physician Decision|0|||
27992108|NCT00689104|54650677|FG002|Overall Study|Physician Decision|0|||
27992109|NCT00689104|54650678|FG003|Overall Study|Physician Decision|0|||
28098009|NCT00090363|54753815|FG001|Overall Study|Continuing on study off treatment|13|||
28098010|NCT00090363|54753816|FG002|Overall Study|Continuing on study off treatment|16|||
28098011|NCT03652610|54753826|FG000|Overall Study|Lost to Follow-up|1|||
28098012|NCT03652610|54753827|FG001|Overall Study|Lost to Follow-up|0|||
28098013|NCT03652610|54753826|FG000|Overall Study|Withdrawal by Subject|3|||
28098014|NCT03652610|54753827|FG001|Overall Study|Withdrawal by Subject|5|||
28098015|NCT03615404|54753833|FG000|Overall Study|Death|1|||
28098016|NCT03615404|54753833|FG000|Overall Study|vaccine did not pass quality assurance|1|||
28098017|NCT03614156|54753840|FG000|Open-Label Treatment Period|Protocol-specified withdrawal met|6|||
28098018|NCT03614156|54753841|FG001|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
28098019|NCT03614156|54753842|FG002|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
28098020|NCT03614156|54753843|FG003|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
28098021|NCT03614156|54753840|FG000|Open-Label Treatment Period|Adverse Event|7|||
28098022|NCT03614156|54753841|FG001|Open-Label Treatment Period|Adverse Event|0|||
27992110|NCT00689104|54650675|FG000|Overall Study|Non-compliance with study procedures|0|||
27992111|NCT00689104|54650676|FG001|Overall Study|Non-compliance with study procedures|0|||
27992112|NCT00689104|54650677|FG002|Overall Study|Non-compliance with study procedures|1|||
27992113|NCT00689104|54650678|FG003|Overall Study|Non-compliance with study procedures|0|||
27992114|NCT00689026|54650690|FG000|Overall Study|Withdrawal by Subject|13|||
27992115|NCT00689026|54650691|FG001|Overall Study|Withdrawal by Subject|6|||
27992116|NCT00598559|54650700|FG000|Overall Study|Adverse Event|11|||
27992117|NCT00598559|54650701|FG001|Overall Study|Adverse Event|7|||
27992118|NCT00598559|54650702|FG002|Overall Study|Adverse Event|0|||
27992119|NCT00598559|54650700|FG000|Overall Study|Withdrawal by Subject|2|||
27992120|NCT00598559|54650701|FG001|Overall Study|Withdrawal by Subject|2|||
27992121|NCT00598559|54650702|FG002|Overall Study|Withdrawal by Subject|0|||
27992122|NCT00598559|54650700|FG000|Overall Study|Protocol Non-compliance|1|||
28098023|NCT03614156|54753842|FG002|Open-Label Treatment Period|Adverse Event|0|||
28098024|NCT03614156|54753843|FG003|Open-Label Treatment Period|Adverse Event|0|||
28098025|NCT03614156|54753840|FG000|Open-Label Treatment Period|Lack of Efficacy|18|||
28098026|NCT03614156|54753841|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
27908523|NCT01187953|54566281|FG001|Overall Study|Death|13|||
27908524|NCT01187953|54566280|FG000|Overall Study|Adverse Event|1|||
27992123|NCT00598559|54650701|FG001|Overall Study|Protocol Non-compliance|0|||
27992124|NCT00598559|54650702|FG002|Overall Study|Protocol Non-compliance|0|||
27992125|NCT00598559|54650700|FG000|Overall Study|Early discharge from hospital|9|||
27992126|NCT00598559|54650701|FG001|Overall Study|Early discharge from hospital|12|||
27908525|NCT01187953|54566281|FG001|Overall Study|Adverse Event|2|||
27908526|NCT01187953|54566280|FG000|Overall Study|Lost to Follow-up|0|||
27908527|NCT01187953|54566281|FG001|Overall Study|Lost to Follow-up|3|||
27908528|NCT01187953|54566280|FG000|Overall Study|Withdrawal by Subject|3|||
27908529|NCT01187953|54566281|FG001|Overall Study|Withdrawal by Subject|3|||
27908530|NCT01217944|54566297|FG000|Overall Study|Protocol Violation|1|||
27908531|NCT01217944|54566298|FG001|Overall Study|Protocol Violation|1|||
27908532|NCT01217944|54566299|FG002|Overall Study|Protocol Violation|0|||
27908533|NCT01217944|54566297|FG000|Overall Study|Lost to Follow-up|3|||
27908534|NCT01217944|54566298|FG001|Overall Study|Lost to Follow-up|1|||
27908535|NCT01217944|54566299|FG002|Overall Study|Lost to Follow-up|0|||
27908536|NCT01217944|54566297|FG000|Overall Study|Withdrawal by Subject|1|||
27908537|NCT01217944|54566298|FG001|Overall Study|Withdrawal by Subject|2|||
27992127|NCT00598559|54650702|FG002|Overall Study|Early discharge from hospital|3|||
27992128|NCT00598559|54650700|FG000|Overall Study|Subject unable/unwilling to attend visit|4|||
27992129|NCT00598559|54650701|FG001|Overall Study|Subject unable/unwilling to attend visit|7|||
27992130|NCT00598559|54650702|FG002|Overall Study|Subject unable/unwilling to attend visit|0|||
27992131|NCT00686686|54650710|FG000|Overall Study|Non-compliance|1|||
27992132|NCT00686686|54650710|FG000|Overall Study|Adverse Event|2|||
27992133|NCT00686686|54650710|FG000|Overall Study|Lost to Follow-up|3|||
27992134|NCT04160195|54650716|FG000|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|1|||
27992135|NCT04160195|54650717|FG001|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|0|||
27992136|NCT00686374|54650725|FG000|Overall Study|Lack of Efficacy|10|||
27992137|NCT00686374|54650725|FG000|Overall Study|Adverse Event|8|||
27992138|NCT00686374|54650725|FG000|Overall Study|Withdrew consent|5|||
27992139|NCT00686374|54650725|FG000|Overall Study|Lost to Follow-up|1|||
27992140|NCT00686374|54650725|FG000|Overall Study|Missing reason|33|||
27992141|NCT00686374|54650725|FG000|Overall Study|Other, not specified|4|||
27992142|NCT00571948|54650731|FG000|Overall Study|Lost to Follow-up|2|||
27992143|NCT00571948|54650732|FG001|Overall Study|Lost to Follow-up|0|||
27992144|NCT00571948|54650731|FG000|Overall Study|Withdrawal by Subject|1|||
27992145|NCT00571948|54650732|FG001|Overall Study|Withdrawal by Subject|2|||
27992146|NCT00571948|54650731|FG000|Overall Study|Protocol Violation|3|||
27992147|NCT00571948|54650732|FG001|Overall Study|Protocol Violation|3|||
27992148|NCT00571948|54650731|FG000|Overall Study|infant refused study meal|3|||
27992149|NCT00571948|54650732|FG001|Overall Study|infant refused study meal|4|||
27992150|NCT00571948|54650731|FG000|Overall Study|Parent were afraid of blood colection|2|||
27992151|NCT00571948|54650732|FG001|Overall Study|Parent were afraid of blood colection|5|||
27992152|NCT00684424|54650738|FG000|Overall Study|Adverse Event|1|||
27992153|NCT00684424|54650738|FG000|Overall Study|Lost to Follow-up|2|||
27908538|NCT01217944|54566299|FG002|Overall Study|Withdrawal by Subject|0|||
27908539|NCT01217944|54566297|FG000|Overall Study|Lack of Efficacy|1|||
27908540|NCT01217944|54566298|FG001|Overall Study|Lack of Efficacy|0|||
27908541|NCT01217944|54566299|FG002|Overall Study|Lack of Efficacy|0|||
27908542|NCT01187446|54566311|FG000|Overall Study|Patient started non-protocol therapy|0|||
27908543|NCT01187446|54566312|FG001|Overall Study|Patient started non-protocol therapy|1|||
27992154|NCT00684424|54650738|FG000|Overall Study|Other|2|||
27992155|NCT00685750|54650750|FG000|Overall Study|Tumor sampling failure|0|||
27992156|NCT00685750|54650751|FG001|Overall Study|Tumor sampling failure|0|||
27992157|NCT00685750|54650752|FG002|Overall Study|Tumor sampling failure|1|||
27992158|NCT00685750|54650753|FG003|Overall Study|Tumor sampling failure|0|||
27992159|NCT00685750|54650754|FG004|Overall Study|Tumor sampling failure|0|||
27992160|NCT00685750|54650755|FG005|Overall Study|Tumor sampling failure|0|||
27992161|NCT00685750|54650756|FG006|Overall Study|Tumor sampling failure|0|||
27992162|NCT00685750|54650750|FG000|Overall Study|Patient didn't receive the treatment|0|||
27992163|NCT00685750|54650751|FG001|Overall Study|Patient didn't receive the treatment|0|||
27992164|NCT00685750|54650752|FG002|Overall Study|Patient didn't receive the treatment|0|||
27992165|NCT00685750|54650753|FG003|Overall Study|Patient didn't receive the treatment|0|||
27992166|NCT00685750|54650754|FG004|Overall Study|Patient didn't receive the treatment|0|||
27992167|NCT00685750|54650755|FG005|Overall Study|Patient didn't receive the treatment|0|||
27992168|NCT00685750|54650756|FG006|Overall Study|Patient didn't receive the treatment|1|||
27992169|NCT00685750|54650750|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
27992170|NCT00685750|54650751|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
27992171|NCT00685750|54650752|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
27992172|NCT00685750|54650753|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
27992173|NCT00685750|54650754|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
27992174|NCT00685750|54650755|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
27992175|NCT00685750|54650756|FG006|Overall Study|Eligibility criteria not fulfilled|0|||
28098027|NCT03614156|54753842|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
27908544|NCT01187407|54566322|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29|||
27908545|NCT01187407|54566323|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
27908546|NCT01187407|54566324|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
27992176|NCT00576628|54650776|FG000|Overall Study|Adverse Event|11|||
27992177|NCT00576628|54650776|FG000|Overall Study|Death|2|||
27992178|NCT00576628|54650776|FG000|Overall Study|Failure to return|1|||
27908547|NCT01187407|54566325|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
27908548|NCT01187407|54566326|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
27908549|NCT01187407|54566322|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4|||
27908550|NCT01187407|54566323|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
27908551|NCT01187407|54566324|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
27908552|NCT01187407|54566325|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
27908553|NCT01187407|54566326|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
27908554|NCT01187407|54566322|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9|||
27908555|NCT01187407|54566323|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
27992179|NCT00576628|54650776|FG000|Overall Study|Refused Treatment|8|||
27992180|NCT00576628|54650776|FG000|Overall Study|Pregnancy|1|||
27992181|NCT00576628|54650776|FG000|Overall Study|RBC transfusion|1|||
27992182|NCT00576628|54650776|FG000|Overall Study|Progression of Kidney Disease|1|||
27992183|NCT00576628|54650776|FG000|Overall Study|Progression of Renal Failure|1|||
27992184|NCT00576628|54650776|FG000|Overall Study|The patient move into other town|1|||
27992185|NCT00576628|54650776|FG000|Overall Study|Transplantation|1|||
27992186|NCT00576628|54650776|FG000|Overall Study|Dialysis|15|||
27992187|NCT00683878|54650784|FG000|Overall Study|Lack of Efficacy|3|||
27992188|NCT00683878|54650785|FG001|Overall Study|Lack of Efficacy|0|||
27992189|NCT00683878|54650786|FG002|Overall Study|Lack of Efficacy|1|||
27992190|NCT00683878|54650784|FG000|Overall Study|Adverse Event|4|||
27992191|NCT00683878|54650785|FG001|Overall Study|Adverse Event|3|||
27992192|NCT00683878|54650786|FG002|Overall Study|Adverse Event|3|||
27992193|NCT00683878|54650784|FG000|Overall Study|Withdrawal by Subject|9|||
27992194|NCT00683878|54650785|FG001|Overall Study|Withdrawal by Subject|8|||
27992195|NCT00683878|54650786|FG002|Overall Study|Withdrawal by Subject|6|||
27992196|NCT00683878|54650784|FG000|Overall Study|Death|0|||
27992197|NCT00683878|54650785|FG001|Overall Study|Death|1|||
27992198|NCT00683878|54650786|FG002|Overall Study|Death|0|||
27992199|NCT00683878|54650784|FG000|Overall Study|Lost to Follow-up|4|||
27992200|NCT00683878|54650785|FG001|Overall Study|Lost to Follow-up|2|||
27992201|NCT00683878|54650786|FG002|Overall Study|Lost to Follow-up|4|||
27992202|NCT00683878|54650784|FG000|Overall Study|Non-compliance, not met criteria etc.|3|||
27992203|NCT00683878|54650785|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
27992204|NCT00683878|54650786|FG002|Overall Study|Non-compliance, not met criteria etc.|0|||
27992205|NCT00884741|54650797|FG000|Step 1 Registration: Tissue Screening|Protocol Violation|157|||
27992206|NCT00884741|54650798|FG001|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
27992207|NCT00884741|54650799|FG002|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
27992208|NCT00884741|54650800|FG003|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
27992209|NCT00884741|54650797|FG000|Step 1 Registration: Tissue Screening|Death|3|||
27992210|NCT00884741|54650798|FG001|Step 1 Registration: Tissue Screening|Death|0|||
27992211|NCT00884741|54650799|FG002|Step 1 Registration: Tissue Screening|Death|0|||
27992212|NCT00884741|54650800|FG003|Step 1 Registration: Tissue Screening|Death|0|||
27992213|NCT00884741|54650797|FG000|Step 1 Registration: Tissue Screening|Physician Decision|3|||
27992214|NCT00884741|54650798|FG001|Step 1 Registration: Tissue Screening|Physician Decision|0|||
27992215|NCT00884741|54650799|FG002|Step 1 Registration: Tissue Screening|Physician Decision|0|||
27992216|NCT00884741|54650800|FG003|Step 1 Registration: Tissue Screening|Physician Decision|0|||
27992217|NCT00884741|54650797|FG000|Step 1 Registration: Tissue Screening|Insufficient tissue|105|||
27992218|NCT00884741|54650798|FG001|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
27992219|NCT00884741|54650799|FG002|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
27992220|NCT00884741|54650800|FG003|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
27992221|NCT00884741|54650797|FG000|Step 1 Registration: Tissue Screening|Disease progression|12|||
27992222|NCT00884741|54650798|FG001|Step 1 Registration: Tissue Screening|Disease progression|0|||
27992223|NCT00884741|54650799|FG002|Step 1 Registration: Tissue Screening|Disease progression|0|||
27992224|NCT00884741|54650800|FG003|Step 1 Registration: Tissue Screening|Disease progression|0|||
27992225|NCT00884741|54650797|FG000|Step 1 Registration: Tissue Screening|Patient refusal|32|||
27992226|NCT00884741|54650798|FG001|Step 1 Registration: Tissue Screening|Patient refusal|0|||
27992227|NCT00884741|54650799|FG002|Step 1 Registration: Tissue Screening|Patient refusal|0|||
27992228|NCT00884741|54650800|FG003|Step 1 Registration: Tissue Screening|Patient refusal|0|||
27992229|NCT00884741|54650797|FG000|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
27992230|NCT00884741|54650798|FG001|Step 2 Registration: Tissue Analysis|Protocol Violation|15|||
27992231|NCT00884741|54650799|FG002|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
27992232|NCT00884741|54650800|FG003|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
27992233|NCT00884741|54650797|FG000|Step 2 Registration: Tissue Analysis|Death|0|||
27992234|NCT00884741|54650798|FG001|Step 2 Registration: Tissue Analysis|Death|1|||
27992235|NCT00884741|54650799|FG002|Step 2 Registration: Tissue Analysis|Death|0|||
27992236|NCT00884741|54650800|FG003|Step 2 Registration: Tissue Analysis|Death|0|||
27992237|NCT00884741|54650797|FG000|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
27992238|NCT00884741|54650798|FG001|Step 2 Registration: Tissue Analysis|Adverse Event|2|||
27908556|NCT01187407|54566324|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
27992239|NCT00884741|54650799|FG002|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
27992240|NCT00884741|54650800|FG003|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
27992241|NCT00884741|54650797|FG000|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
27992242|NCT00884741|54650798|FG001|Step 2 Registration: Tissue Analysis|Patient refusal|7|||
27992243|NCT00884741|54650799|FG002|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
27992244|NCT00884741|54650800|FG003|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
27992245|NCT00884741|54650797|FG000|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
27992246|NCT00884741|54650798|FG001|Step 2 Registration: Tissue Analysis|Disease Progression|4|||
27992247|NCT00884741|54650799|FG002|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
27992248|NCT00884741|54650800|FG003|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
27992249|NCT00884741|54650797|FG000|Randomization|Protocol Violation|0|||
27992250|NCT00884741|54650798|FG001|Randomization|Protocol Violation|0|||
27992251|NCT00884741|54650799|FG002|Randomization|Protocol Violation|8|||
27992252|NCT00884741|54650800|FG003|Randomization|Protocol Violation|8|||
27992253|NCT00598481|54650807|FG000|Treatment|Physician Decision|1|||
27992254|NCT00880763|54650818|FG000|Extension Period (Part 2)|Adverse Event|0|||
27992255|NCT00880763|54650819|FG001|Extension Period (Part 2)|Adverse Event|0|||
27992256|NCT00880763|54650820|FG002|Extension Period (Part 2)|Adverse Event|1|||
27992257|NCT00880763|54650821|FG003|Extension Period (Part 2)|Adverse Event|1|||
27992258|NCT00880763|54650818|FG000|Extension Period (Part 2)|Withdrawal by Subject|0|||
27992259|NCT00880763|54650819|FG001|Extension Period (Part 2)|Withdrawal by Subject|2|||
27992260|NCT00880763|54650820|FG002|Extension Period (Part 2)|Withdrawal by Subject|1|||
27992261|NCT00880763|54650821|FG003|Extension Period (Part 2)|Withdrawal by Subject|1|||
27992262|NCT00880763|54650818|FG000|Extension Period (Part 2)|Physician Decision|0|||
28098028|NCT03614156|54753843|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
28098029|NCT03614156|54753840|FG000|Open-Label Treatment Period|Withdrawal by Subject|36|||
28098030|NCT03614156|54753841|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
28098031|NCT03614156|54753842|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
28098032|NCT03614156|54753843|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
28098033|NCT03614156|54753840|FG000|Open-Label Treatment Period|Lost to Follow-up|10|||
28098034|NCT03614156|54753841|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
28098035|NCT03614156|54753842|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
27908557|NCT01187407|54566325|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
27908558|NCT01187407|54566326|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
27908559|NCT01187407|54566322|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
27908560|NCT01187407|54566323|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
27908561|NCT01187407|54566324|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
27908562|NCT01187407|54566325|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
27908563|NCT01187407|54566326|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
27908564|NCT01187407|54566322|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13|||
27908565|NCT01187407|54566323|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
27908566|NCT01187407|54566324|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
27908567|NCT01187407|54566325|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
27908568|NCT01187407|54566326|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
27908569|NCT01187407|54566322|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29|||
27908570|NCT01187407|54566323|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
27908571|NCT01187407|54566324|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
27908572|NCT01187407|54566325|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
27908573|NCT01187407|54566326|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
27908574|NCT01187407|54566322|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4|||
27908575|NCT01187407|54566323|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
27908576|NCT01187407|54566324|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
27908577|NCT01187407|54566325|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
27908578|NCT01187407|54566326|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
27908579|NCT01187407|54566322|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
27908580|NCT01187407|54566323|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
27908581|NCT01187407|54566324|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6|||
27908582|NCT01187407|54566325|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5|||
27908583|NCT01187407|54566326|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12|||
27908584|NCT01187407|54566322|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
27908585|NCT01187407|54566323|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3|||
27908586|NCT01187407|54566324|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
27908587|NCT01187407|54566325|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5|||
27908588|NCT01187407|54566326|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13|||
27992263|NCT00880763|54650819|FG001|Extension Period (Part 2)|Physician Decision|1|||
28098036|NCT03614156|54753843|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
27908589|NCT01187407|54566322|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
27992264|NCT00880763|54650820|FG002|Extension Period (Part 2)|Physician Decision|1|||
27992265|NCT00880763|54650821|FG003|Extension Period (Part 2)|Physician Decision|0|||
27992266|NCT00880763|54650818|FG000|Extension Period (Part 2)|Lack of Efficacy|0|||
27992267|NCT00880763|54650819|FG001|Extension Period (Part 2)|Lack of Efficacy|0|||
27992268|NCT00880763|54650820|FG002|Extension Period (Part 2)|Lack of Efficacy|0|||
27992269|NCT00880763|54650821|FG003|Extension Period (Part 2)|Lack of Efficacy|1|||
27992270|NCT00884273|54650833|FG000|Overall Study|Adverse Event|0|||
27992271|NCT00884273|54650834|FG001|Overall Study|Adverse Event|2|||
27992272|NCT00884273|54650833|FG000|Overall Study|Protocol Violation|1|||
27992273|NCT00884273|54650834|FG001|Overall Study|Protocol Violation|3|||
27992274|NCT00884273|54650833|FG000|Overall Study|Practical reasons|1|||
27992275|NCT00884273|54650834|FG001|Overall Study|Practical reasons|0|||
27992276|NCT00884117|54650840|FG000|Overall Study|Adverse Event|2|||
27992277|NCT00884117|54650840|FG000|Overall Study|Withdrawal by Subject|89|||
27992278|NCT00884117|54650840|FG000|Overall Study|Death|3|||
27992279|NCT00884117|54650840|FG000|Overall Study|Lost to Follow-up|143|||
27992280|NCT00884117|54650840|FG000|Overall Study|Other|12|||
27992281|NCT00884039|54650859|FG000|Overall Study|Withdrawal by Subject|0|||
27992282|NCT00884039|54650860|FG001|Overall Study|Withdrawal by Subject|1|||
27992283|NCT00884039|54650859|FG000|Overall Study|Lack of Efficacy|2|||
27992284|NCT00884039|54650860|FG001|Overall Study|Lack of Efficacy|0|||
27992285|NCT00835770|54650868|FG000|Overall Study|MS Relapse|17|||
27992286|NCT00835770|54650869|FG001|Overall Study|MS Relapse|23|||
27992287|NCT00835770|54650868|FG000|Overall Study|MS Progression|14|||
27992288|NCT00835770|54650869|FG001|Overall Study|MS Progression|9|||
27992289|NCT00835770|54650868|FG000|Overall Study|Adverse Event|113|||
27992290|NCT00835770|54650869|FG001|Overall Study|Adverse Event|124|||
27992291|NCT00835770|54650868|FG000|Overall Study|Lost to Follow-up|22|||
27992292|NCT00835770|54650869|FG001|Overall Study|Lost to Follow-up|19|||
27992293|NCT00835770|54650868|FG000|Overall Study|Consent Withdrawn|144|||
27992294|NCT00835770|54650869|FG001|Overall Study|Consent Withdrawn|156|||
27992295|NCT00835770|54650868|FG000|Overall Study|Investigator Decision|42|||
27992296|NCT00835770|54650869|FG001|Overall Study|Investigator Decision|42|||
27992297|NCT00835770|54650868|FG000|Overall Study|Participant Non-Compliance|11|||
27992298|NCT00835770|54650869|FG001|Overall Study|Participant Non-Compliance|9|||
27992299|NCT00835770|54650868|FG000|Overall Study|Death|4|||
27992300|NCT00835770|54650869|FG001|Overall Study|Death|6|||
27992301|NCT00835770|54650868|FG000|Overall Study|Other|115|||
27992302|NCT00835770|54650869|FG001|Overall Study|Other|104|||
27992303|NCT00835770|54650868|FG000|Overall Study|Other|2|||
27992304|NCT00835770|54650869|FG001|Overall Study|Other|1|||
27992305|NCT00880685|54650881|FG000|Memantine 10mg|Lost to Follow-up|2|||
27992306|NCT00880685|54650881|FG000|Memantine 20mg|Withdrawal by Subject|1|||
27992307|NCT00835380|54650888|FG000|Overall Study|Withdrawal by Subject|2|||
27992308|NCT00880607|54650894|FG000|Overall Study|Physician Decision|2|||
27992309|NCT00880607|54650895|FG001|Overall Study|Physician Decision|2|||
27992310|NCT00880607|54650894|FG000|Overall Study|Protocol Violation|2|||
27992311|NCT00880607|54650895|FG001|Overall Study|Protocol Violation|1|||
27992312|NCT00880607|54650894|FG000|Overall Study|surgery did not extend past L1 level|3|||
27992313|NCT00880607|54650895|FG001|Overall Study|surgery did not extend past L1 level|0|||
27992314|NCT00835068|54650905|FG000|Overall Study|Death|1|||
27992315|NCT00835068|54650906|FG001|Overall Study|Death|0|||
27992316|NCT00835068|54650905|FG000|Overall Study|Adverse Event|0|||
27992317|NCT00835068|54650906|FG001|Overall Study|Adverse Event|1|||
27992318|NCT00835068|54650905|FG000|Overall Study|Other|8|||
27992319|NCT00835068|54650906|FG001|Overall Study|Other|0|||
27992320|NCT00835068|54650905|FG000|Overall Study|Withdrawal by Subject|1|||
27992321|NCT00835068|54650906|FG001|Overall Study|Withdrawal by Subject|0|||
27992322|NCT00834912|54650918|FG000|Treatment Period 1|Adverse Event|0|||
27992323|NCT00834912|54650919|FG001|Treatment Period 1|Adverse Event|1|||
27992324|NCT00834912|54650920|FG002|Treatment Period 1|Adverse Event|0|||
27992325|NCT00834912|54650921|FG003|Treatment Period 1|Adverse Event|1|||
27992326|NCT00834912|54650922|FG004|Treatment Period 1|Adverse Event|0|||
27992327|NCT00834912|54650923|FG005|Treatment Period 1|Adverse Event|0|||
27992328|NCT00834912|54650918|FG000|Treatment Period 2|Withdrawal by Subject|0|||
27992329|NCT00834912|54650919|FG001|Treatment Period 2|Withdrawal by Subject|0|||
27992330|NCT00834912|54650920|FG002|Treatment Period 2|Withdrawal by Subject|1|||
27992331|NCT00834912|54650921|FG003|Treatment Period 2|Withdrawal by Subject|0|||
27992332|NCT00834912|54650922|FG004|Treatment Period 2|Withdrawal by Subject|1|||
27992333|NCT00834912|54650923|FG005|Treatment Period 2|Withdrawal by Subject|0|||
27992334|NCT00883493|54650933|FG000|Overall Study|Adverse Event|11|||
27992335|NCT00883493|54650934|FG001|Overall Study|Adverse Event|12|||
27992336|NCT00883493|54650933|FG000|Overall Study|Lack of Efficacy|4|||
27992337|NCT00883493|54650934|FG001|Overall Study|Lack of Efficacy|3|||
27992338|NCT00883493|54650933|FG000|Overall Study|Lost to Follow-up|7|||
27992339|NCT00883493|54650934|FG001|Overall Study|Lost to Follow-up|6|||
27992340|NCT00883493|54650933|FG000|Overall Study|Withdrawal by Subject|11|||
27992341|NCT00883493|54650934|FG001|Overall Study|Withdrawal by Subject|20|||
27992342|NCT00883493|54650933|FG000|Overall Study|Eligibility Criteria not fullfilled|6|||
27992343|NCT00883493|54650934|FG001|Overall Study|Eligibility Criteria not fullfilled|6|||
27992344|NCT00883493|54650933|FG000|Overall Study|Study specific disc. criteria|2|||
27992345|NCT00883493|54650934|FG001|Overall Study|Study specific disc. criteria|0|||
27992346|NCT00883493|54650933|FG000|Overall Study|Other|5|||
27992347|NCT00883493|54650934|FG001|Overall Study|Other|3|||
27992348|NCT04887922|54650949|FG000|1st Randomization|Decided not to have surgery|0|||
27992349|NCT04887922|54650950|FG001|1st Randomization|Decided not to have surgery|1|||
27992350|NCT04887922|54650951|FG002|1st Randomization|Decided not to have surgery|0|||
27992351|NCT04887922|54650952|FG003|1st Randomization|Decided not to have surgery|0|||
27992352|NCT04887922|54650953|FG004|1st Randomization|Decided not to have surgery|0|||
27992353|NCT04771403|54650976|FG000|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|0|||
27992354|NCT04771403|54650977|FG001|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|1|||
27992355|NCT04771403|54650976|FG000|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|1|||
27992356|NCT04771403|54650977|FG001|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|0|||
27908590|NCT01187407|54566323|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
27908591|NCT01187407|54566324|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
27908592|NCT01187407|54566325|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
27992357|NCT04771403|54650976|FG000|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|1|||
27992358|NCT04771403|54650977|FG001|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|0|||
27992359|NCT04771403|54650976|FG000|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|1|||
27992360|NCT04771403|54650977|FG001|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|0|||
27992361|NCT04771403|54650976|FG000|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|1|||
27992362|NCT04771403|54650977|FG001|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|0|||
27992363|NCT04771403|54650976|FG000|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|0|||
27992364|NCT04771403|54650977|FG001|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|1|||
27992365|NCT04771403|54650976|FG000|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|1|||
27992366|NCT04771403|54650977|FG001|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|0|||
27992367|NCT04771403|54650976|FG000|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|1|||
27992368|NCT04771403|54650977|FG001|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|0|||
27992369|NCT04698525|54650986|FG000|Overall Study|Lost to Follow-up|1|||
27992370|NCT04698525|54650987|FG001|Overall Study|Lost to Follow-up|2|||
27992371|NCT04698525|54650986|FG000|Overall Study|Three suffered of Covid-19|2|||
27992372|NCT04698525|54650987|FG001|Overall Study|Three suffered of Covid-19|1|||
27992373|NCT04510675|54651001|FG000|Overall Study|Withdrawal by Subject|5|||
27992374|NCT04228783|54651023|FG000|Overall Study|Adverse Event|1|||
27908593|NCT01187407|54566326|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
27908594|NCT01187407|54566322|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
27908595|NCT01187407|54566323|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
27908596|NCT01187407|54566324|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
27908597|NCT01187407|54566325|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
27908598|NCT01187407|54566326|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
27908599|NCT01187407|54566322|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
27908600|NCT01187407|54566323|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6|||
27908601|NCT01187407|54566324|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
27908602|NCT01187407|54566325|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3|||
27908603|NCT01187407|54566326|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10|||
27908604|NCT01187407|54566322|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
27908605|NCT01187407|54566323|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
27908606|NCT01187407|54566324|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
27908607|NCT01187407|54566325|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11|||
27908608|NCT01187407|54566326|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22|||
27908609|NCT01187407|54566322|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
27908610|NCT01187407|54566323|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
27908611|NCT01187407|54566324|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
27908612|NCT01187407|54566325|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
27908613|NCT01187407|54566326|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
27992375|NCT04228783|54651024|FG001|Overall Study|Adverse Event|0|||
27992376|NCT04228783|54651025|FG002|Overall Study|Adverse Event|2|||
27992377|NCT04228783|54651026|FG003|Overall Study|Adverse Event|0|||
27992378|NCT04228783|54651027|FG004|Overall Study|Adverse Event|0|||
27992379|NCT04228783|54651028|FG005|Overall Study|Adverse Event|1|||
27992380|NCT04228783|54651023|FG000|Overall Study|Death|0|||
27992381|NCT04228783|54651024|FG001|Overall Study|Death|0|||
27992382|NCT04228783|54651025|FG002|Overall Study|Death|0|||
27992383|NCT04228783|54651026|FG003|Overall Study|Death|0|||
27992384|NCT04228783|54651027|FG004|Overall Study|Death|1|||
27992385|NCT04228783|54651028|FG005|Overall Study|Death|0|||
27992386|NCT04228783|54651023|FG000|Overall Study|Lost to Follow-up|36|||
27992387|NCT04228783|54651024|FG001|Overall Study|Lost to Follow-up|36|||
27992388|NCT04228783|54651025|FG002|Overall Study|Lost to Follow-up|28|||
27992389|NCT04228783|54651026|FG003|Overall Study|Lost to Follow-up|6|||
27992390|NCT04228783|54651027|FG004|Overall Study|Lost to Follow-up|14|||
27992391|NCT04228783|54651028|FG005|Overall Study|Lost to Follow-up|3|||
27992392|NCT04228783|54651023|FG000|Overall Study|Physician Decision|1|||
27992393|NCT04228783|54651024|FG001|Overall Study|Physician Decision|2|||
27992394|NCT04228783|54651025|FG002|Overall Study|Physician Decision|0|||
27992395|NCT04228783|54651026|FG003|Overall Study|Physician Decision|0|||
27992396|NCT04228783|54651027|FG004|Overall Study|Physician Decision|0|||
27992397|NCT04228783|54651028|FG005|Overall Study|Physician Decision|0|||
27992398|NCT04228783|54651023|FG000|Overall Study|Protocol Violation|0|||
27992399|NCT04228783|54651024|FG001|Overall Study|Protocol Violation|0|||
27992400|NCT04228783|54651025|FG002|Overall Study|Protocol Violation|0|||
27992401|NCT04228783|54651026|FG003|Overall Study|Protocol Violation|1|||
27992402|NCT04228783|54651027|FG004|Overall Study|Protocol Violation|0|||
27992403|NCT04228783|54651028|FG005|Overall Study|Protocol Violation|0|||
27992404|NCT04228783|54651023|FG000|Overall Study|Withdrawal by Subject|6|||
27992405|NCT04228783|54651024|FG001|Overall Study|Withdrawal by Subject|10|||
27992406|NCT04228783|54651025|FG002|Overall Study|Withdrawal by Subject|19|||
27992407|NCT04228783|54651026|FG003|Overall Study|Withdrawal by Subject|1|||
27992408|NCT04228783|54651027|FG004|Overall Study|Withdrawal by Subject|2|||
27992409|NCT04228783|54651028|FG005|Overall Study|Withdrawal by Subject|0|||
27992410|NCT04228783|54651023|FG000|Overall Study|Other|4|||
27992411|NCT04228783|54651024|FG001|Overall Study|Other|3|||
27992412|NCT04228783|54651025|FG002|Overall Study|Other|2|||
27992413|NCT04228783|54651026|FG003|Overall Study|Other|1|||
27992414|NCT04228783|54651027|FG004|Overall Study|Other|0|||
27992415|NCT04228783|54651028|FG005|Overall Study|Other|0|||
27992416|NCT03950674|54651044|FG000|Overall Study|Death|3|||
27992417|NCT03950674|54651045|FG001|Overall Study|Death|7|||
27992418|NCT03950674|54651044|FG000|Overall Study|Ongoing in Study|22|||
27992419|NCT03950674|54651045|FG001|Overall Study|Ongoing in Study|8|||
27992420|NCT03702621|54651054|FG000|Overall Study|Physician Decision|6|||
27992421|NCT03702621|54651055|FG001|Overall Study|Physician Decision|6|||
27992422|NCT03577990|54651063|FG000|Overall Study|Lost to Follow-up|4|||
27992423|NCT03577990|54651064|FG001|Overall Study|Lost to Follow-up|6|||
27992424|NCT03577990|54651063|FG000|Overall Study|Withdrawal by Subject|4|||
27992425|NCT03577990|54651064|FG001|Overall Study|Withdrawal by Subject|7|||
27992426|NCT03565497|54651074|FG000|Overall Study|COVID-19 halt to human subjects research|0|||
27992427|NCT03565497|54651075|FG001|Overall Study|COVID-19 halt to human subjects research|1|||
27992428|NCT03565497|54651076|FG002|Overall Study|COVID-19 halt to human subjects research|1|||
27992429|NCT03565497|54651074|FG000|Overall Study|Lost to Follow-up|1|||
27992430|NCT03565497|54651075|FG001|Overall Study|Lost to Follow-up|1|||
27992431|NCT03565497|54651076|FG002|Overall Study|Lost to Follow-up|2|||
27992432|NCT03565497|54651074|FG000|Overall Study|Withdrawal by Subject|1|||
27992433|NCT03565497|54651075|FG001|Overall Study|Withdrawal by Subject|1|||
27992434|NCT03565497|54651076|FG002|Overall Study|Withdrawal by Subject|1|||
27992435|NCT03362931|54651084|FG000|Overall Study|Adverse Event|1|||
27992436|NCT03362931|54651084|FG000|Overall Study|Death|2|||
27992437|NCT03360019|54651091|FG000|Overall Study|Withdrawal by Subject|2|||
27992438|NCT03360019|54651092|FG001|Overall Study|Withdrawal by Subject|0|||
27992439|NCT03360019|54651093|FG002|Overall Study|Withdrawal by Subject|0|||
27992440|NCT03360019|54651091|FG000|Overall Study|Pandemic caused suspension of study activities|6|||
27992441|NCT03360019|54651092|FG001|Overall Study|Pandemic caused suspension of study activities|0|||
27992442|NCT03360019|54651093|FG002|Overall Study|Pandemic caused suspension of study activities|0|||
27992443|NCT03260894|54651107|FG000|Overall Study|Death|6|||
27992444|NCT03260894|54651108|FG001|Overall Study|Death|8|||
27992445|NCT03260894|54651107|FG000|Overall Study|Withdrawal by Subject|4|||
27992446|NCT03260894|54651108|FG001|Overall Study|Withdrawal by Subject|11|||
27992447|NCT03260894|54651107|FG000|Overall Study|On-going at clinical cut off date|36|||
27992448|NCT03260894|54651108|FG001|Overall Study|On-going at clinical cut off date|31|||
27992449|NCT03245008|54651119|FG000|Overall Study|Adverse Event|15|||
27992450|NCT03245008|54651120|FG001|Overall Study|Adverse Event|18|||
27992451|NCT03245008|54651121|FG002|Overall Study|Adverse Event|15|||
27992452|NCT03245008|54651122|FG003|Overall Study|Adverse Event|0|||
27992453|NCT03245008|54651123|FG004|Overall Study|Adverse Event|1|||
27992454|NCT03245008|54651119|FG000|Overall Study|Lack of Efficacy|0|||
27992455|NCT03245008|54651120|FG001|Overall Study|Lack of Efficacy|1|||
27992456|NCT03245008|54651121|FG002|Overall Study|Lack of Efficacy|0|||
27992457|NCT03245008|54651122|FG003|Overall Study|Lack of Efficacy|0|||
27992458|NCT03245008|54651123|FG004|Overall Study|Lack of Efficacy|0|||
27992459|NCT03245008|54651119|FG000|Overall Study|Lost to Follow-up|4|||
27992460|NCT03245008|54651120|FG001|Overall Study|Lost to Follow-up|1|||
27992461|NCT03245008|54651121|FG002|Overall Study|Lost to Follow-up|0|||
27992462|NCT03245008|54651122|FG003|Overall Study|Lost to Follow-up|0|||
27992463|NCT03245008|54651123|FG004|Overall Study|Lost to Follow-up|1|||
27992464|NCT03245008|54651119|FG000|Overall Study|Physician Decision|1|||
27992465|NCT03245008|54651120|FG001|Overall Study|Physician Decision|3|||
27992466|NCT03245008|54651121|FG002|Overall Study|Physician Decision|4|||
27992467|NCT03245008|54651122|FG003|Overall Study|Physician Decision|0|||
27992468|NCT03245008|54651123|FG004|Overall Study|Physician Decision|0|||
27992469|NCT03245008|54651119|FG000|Overall Study|Protocol Violation|0|||
27992470|NCT03245008|54651120|FG001|Overall Study|Protocol Violation|1|||
27992471|NCT03245008|54651121|FG002|Overall Study|Protocol Violation|0|||
27992472|NCT03245008|54651122|FG003|Overall Study|Protocol Violation|0|||
27992473|NCT03245008|54651123|FG004|Overall Study|Protocol Violation|0|||
27992474|NCT03245008|54651119|FG000|Overall Study|Withdrawal by Subject|20|||
27992475|NCT03245008|54651120|FG001|Overall Study|Withdrawal by Subject|19|||
27992476|NCT03245008|54651121|FG002|Overall Study|Withdrawal by Subject|11|||
27992477|NCT03245008|54651122|FG003|Overall Study|Withdrawal by Subject|0|||
27992478|NCT03245008|54651123|FG004|Overall Study|Withdrawal by Subject|0|||
27992479|NCT03245008|54651119|FG000|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
27992480|NCT03245008|54651120|FG001|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
27992481|NCT03245008|54651121|FG002|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
27992482|NCT03245008|54651122|FG003|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
27992483|NCT03245008|54651123|FG004|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
27992484|NCT03245008|54651119|FG000|Overall Study|Failure to meet randomization criteria|0|||
27992485|NCT03245008|54651120|FG001|Overall Study|Failure to meet randomization criteria|1|||
27992486|NCT03245008|54651121|FG002|Overall Study|Failure to meet randomization criteria|0|||
27992487|NCT03245008|54651122|FG003|Overall Study|Failure to meet randomization criteria|1|||
27992488|NCT03245008|54651123|FG004|Overall Study|Failure to meet randomization criteria|0|||
27992489|NCT03203473|54651145|FG000|Induction Phase|Never started primary treatment|2|||
27992490|NCT03203473|54651146|FG001|Induction Phase|Never started primary treatment|0|||
27992491|NCT03203473|54651147|FG002|Induction Phase|Never started primary treatment|0|||
27992492|NCT03203473|54651145|FG000|Induction Phase|Withdrew from study due to progressive disease|7|||
27992493|NCT03203473|54651146|FG001|Induction Phase|Withdrew from study due to progressive disease|0|||
27992494|NCT03203473|54651147|FG002|Induction Phase|Withdrew from study due to progressive disease|0|||
27908614|NCT01186978|54566343|FG000|Overall Study|Withdrawal by Subject|1|||
27908615|NCT01186939|54566347|FG000|Overall Study|Death|7|||
27908616|NCT01186939|54566347|FG000|Overall Study|Withdrawal by Subject|2|||
27908617|NCT01186939|54566347|FG000|Overall Study|No longer receiving clinical benefit|17|||
27908618|NCT01186939|54566347|FG000|Overall Study|Program closed|5|||
27908619|NCT01186939|54566347|FG000|Overall Study|Sponsor decision|4|||
27908620|NCT01186939|54566347|FG000|Overall Study|Started additional treatment|1|||
27908621|NCT01186939|54566347|FG000|Overall Study|NCI CTC Grade 3 or 4 toxicity|1|||
27908622|NCT01186939|54566347|FG000|Overall Study|Myocardial infarction|1|||
27908623|NCT01186939|54566347|FG000|Overall Study|Bone marrow transplant|1|||
27908624|NCT01186939|54566347|FG000|Overall Study|Transformation to AML|1|||
27908625|NCT04938648|54566372|FG000|Overall Study|Patient admitted to SNF hospice/LTC|2|||
27908626|NCT04938648|54566373|FG001|Overall Study|Patient admitted to SNF hospice/LTC|1|||
27908627|NCT04938648|54566372|FG000|Overall Study|Patient too ill|0|||
27908628|NCT04938648|54566373|FG001|Overall Study|Patient too ill|1|||
27908629|NCT04938648|54566372|FG000|Overall Study|Patient in rehab at the time of intervention|1|||
27992495|NCT03203473|54651145|FG000|Induction Phase|Withdrew from study due to toxicity|7|||
27908630|NCT04938648|54566373|FG001|Overall Study|Patient in rehab at the time of intervention|0|||
27908631|NCT04938648|54566372|FG000|Overall Study|Patient did not have memory problems|1|||
27908632|NCT04938648|54566373|FG001|Overall Study|Patient did not have memory problems|1|||
27908633|NCT04938648|54566372|FG000|Overall Study|Intervention could not be scheduled within protocol window|1|||
27908634|NCT04938648|54566373|FG001|Overall Study|Intervention could not be scheduled within protocol window|0|||
27908635|NCT04938648|54566372|FG000|Overall Study|Care partner could not be reached|0|||
27908636|NCT04938648|54566373|FG001|Overall Study|Care partner could not be reached|1|||
27908637|NCT04938648|54566372|FG000|Overall Study|Patient no longer receiving care at an eligible clinic|0|||
27908638|NCT04938648|54566373|FG001|Overall Study|Patient no longer receiving care at an eligible clinic|2|||
27908639|NCT04938648|54566372|FG000|Overall Study|Withdrawal by Subject|2|||
27908640|NCT04938648|54566373|FG001|Overall Study|Withdrawal by Subject|1|||
27908641|NCT02128113|54566414|FG000|Overall Study|Withdrawal by Subject|3|||
27908642|NCT02128113|54566415|FG001|Overall Study|Withdrawal by Subject|1|||
27992496|NCT03203473|54651146|FG001|Induction Phase|Withdrew from study due to toxicity|0|||
27992497|NCT03203473|54651147|FG002|Induction Phase|Withdrew from study due to toxicity|0|||
27992498|NCT03203473|54651145|FG000|Arm Allocation Phase|Still on Arm A-observation|0|||
27992499|NCT03203473|54651146|FG001|Arm Allocation Phase|Still on Arm A-observation|7|||
27992500|NCT03203473|54651147|FG002|Arm Allocation Phase|Still on Arm A-observation|0|||
27992501|NCT03203473|54651145|FG000|Arm Allocation Phase|started salvage therapy|0|||
27992502|NCT03203473|54651146|FG001|Arm Allocation Phase|started salvage therapy|5|||
27908643|NCT02128113|54566416|FG002|Overall Study|Withdrawal by Subject|0|||
27908644|NCT02128113|54566414|FG000|Overall Study|Protocol Violation|0|||
27908645|NCT02128113|54566415|FG001|Overall Study|Protocol Violation|1|||
27908646|NCT02128113|54566416|FG002|Overall Study|Protocol Violation|0|||
27908647|NCT02128113|54566414|FG000|Overall Study|Surgery cancelled|0|||
27908648|NCT02128113|54566415|FG001|Overall Study|Surgery cancelled|1|||
27908649|NCT02128113|54566416|FG002|Overall Study|Surgery cancelled|0|||
27908650|NCT02128113|54566414|FG000|Overall Study|Adverse Event|0|||
27908651|NCT02128113|54566415|FG001|Overall Study|Adverse Event|0|||
27992503|NCT03203473|54651147|FG002|Arm Allocation Phase|started salvage therapy|0|||
27992504|NCT03203473|54651145|FG000|Arm Allocation Phase|Disease progression|0|||
27992505|NCT03203473|54651146|FG001|Arm Allocation Phase|Disease progression|0|||
27992506|NCT03203473|54651147|FG002|Arm Allocation Phase|Disease progression|37|||
27992507|NCT03203473|54651145|FG000|Arm Allocation Phase|Adverse Event|0|||
27992508|NCT03203473|54651146|FG001|Arm Allocation Phase|Adverse Event|0|||
27992509|NCT03203473|54651147|FG002|Arm Allocation Phase|Adverse Event|11|||
27992510|NCT03203473|54651145|FG000|Arm Allocation Phase|Physician Decision|0|||
27992511|NCT03203473|54651146|FG001|Arm Allocation Phase|Physician Decision|0|||
27992512|NCT03203473|54651147|FG002|Arm Allocation Phase|Physician Decision|3|||
27908652|NCT02128113|54566416|FG002|Overall Study|Adverse Event|1|||
27908653|NCT01658826|54566430|FG000|Period 1: First Intervention (28 Days)|Withdrawal by Subject|1|||
27908654|NCT01658826|54566431|FG001|Period 1: First Intervention (28 Days)|Withdrawal by Subject|0|||
27908655|NCT01658826|54566430|FG000|Period 1: First Intervention (28 Days)|Adverse Event|1|||
27908656|NCT01658826|54566431|FG001|Period 1: First Intervention (28 Days)|Adverse Event|2|||
27908657|NCT01658826|54566430|FG000|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|5|||
27908658|NCT01658826|54566431|FG001|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|6|||
27908659|NCT01658826|54566430|FG000|Period 1: First Intervention (28 Days)|Protocol Violation|0|||
27908660|NCT01658826|54566431|FG001|Period 1: First Intervention (28 Days)|Protocol Violation|1|||
27908661|NCT01658826|54566430|FG000|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|0|||
27908662|NCT01658826|54566431|FG001|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|1|||
27908663|NCT01658826|54566430|FG000|Washout Period: 28 Days|Withdrawal by Subject|1|||
27908664|NCT01658826|54566431|FG001|Washout Period: 28 Days|Withdrawal by Subject|1|||
27908665|NCT01658826|54566430|FG000|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|5|||
27992513|NCT03203473|54651145|FG000|Arm Allocation Phase|Death|0|||
27992514|NCT03203473|54651146|FG001|Arm Allocation Phase|Death|0|||
27992515|NCT03203473|54651147|FG002|Arm Allocation Phase|Death|1|||
27992516|NCT03203473|54651145|FG000|Arm Allocation Phase|Developed 2nd cancer|0|||
27992517|NCT03203473|54651146|FG001|Arm Allocation Phase|Developed 2nd cancer|0|||
27992518|NCT03203473|54651147|FG002|Arm Allocation Phase|Developed 2nd cancer|1|||
27992519|NCT03203473|54651145|FG000|Arm Allocation Phase|Intercurrent illness|0|||
27992520|NCT03203473|54651146|FG001|Arm Allocation Phase|Intercurrent illness|0|||
27992521|NCT03203473|54651147|FG002|Arm Allocation Phase|Intercurrent illness|1|||
27992522|NCT03203473|54651145|FG000|Arm Allocation Phase|Still on arm-B treatment|0|||
27992523|NCT03203473|54651146|FG001|Arm Allocation Phase|Still on arm-B treatment|0|||
27992524|NCT03203473|54651147|FG002|Arm Allocation Phase|Still on arm-B treatment|3|||
27992525|NCT03191786|54651160|FG000|Overall Study|Death|236|||
27908666|NCT01658826|54566431|FG001|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|3|||
27908667|NCT01658826|54566430|FG000|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|0|||
27908668|NCT01658826|54566431|FG001|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|1|||
27908669|NCT01658826|54566430|FG000|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|3|||
27908670|NCT01658826|54566431|FG001|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|4|||
27908671|NCT01186744|54566447|FG000|Overall Study|Lack of Efficacy|156|||
27908672|NCT01186744|54566448|FG001|Overall Study|Lack of Efficacy|99|||
27908673|NCT01186744|54566449|FG002|Overall Study|Lack of Efficacy|0|||
27908674|NCT01186744|54566450|FG003|Overall Study|Lack of Efficacy|2|||
27908675|NCT01186744|54566451|FG004|Overall Study|Lack of Efficacy|2|||
27908676|NCT01186744|54566452|FG005|Overall Study|Lack of Efficacy|5|||
27908677|NCT01186744|54566447|FG000|Overall Study|Protocol Violation|1|||
27908678|NCT01186744|54566448|FG001|Overall Study|Protocol Violation|2|||
27908679|NCT01186744|54566449|FG002|Overall Study|Protocol Violation|0|||
27908680|NCT01186744|54566450|FG003|Overall Study|Protocol Violation|1|||
27992526|NCT03191786|54651161|FG001|Overall Study|Death|127|||
27992527|NCT03191786|54651160|FG000|Overall Study|Lost to Follow-up|9|||
27992528|NCT03191786|54651161|FG001|Overall Study|Lost to Follow-up|3|||
27992529|NCT03191786|54651160|FG000|Overall Study|Physician Decision|1|||
27992530|NCT03191786|54651161|FG001|Overall Study|Physician Decision|0|||
27908681|NCT01186744|54566451|FG004|Overall Study|Protocol Violation|1|||
27992531|NCT03191786|54651160|FG000|Overall Study|Study Terminated By Sponsor|15|||
27992532|NCT03191786|54651161|FG001|Overall Study|Study Terminated By Sponsor|5|||
27992533|NCT03191786|54651160|FG000|Overall Study|Withdrawal by Subject|26|||
27992534|NCT03191786|54651161|FG001|Overall Study|Withdrawal by Subject|16|||
27992535|NCT03158051|54651169|FG000|Overall Study|Lost to Follow-up|41|||
27992536|NCT03158051|54651170|FG001|Overall Study|Lost to Follow-up|47|||
27992537|NCT03158051|54651169|FG000|Overall Study|Physician Decision|6|||
27992538|NCT03158051|54651170|FG001|Overall Study|Physician Decision|7|||
27992539|NCT03158051|54651169|FG000|Overall Study|Withdrawal by Subject|24|||
27992540|NCT03158051|54651170|FG001|Overall Study|Withdrawal by Subject|15|||
27992541|NCT03158051|54651169|FG000|Overall Study|Death|0|||
27992542|NCT03158051|54651170|FG001|Overall Study|Death|1|||
27992543|NCT03051659|54651187|FG000|Treatment Period|Withdrawal by Subject|0|||
27992544|NCT03051659|54651188|FG001|Treatment Period|Withdrawal by Subject|2|||
27992545|NCT03051659|54651187|FG000|Survival Follow-up|Lost to Follow-up|23|||
27992546|NCT03051659|54651188|FG001|Survival Follow-up|Lost to Follow-up|22|||
27992547|NCT02971761|54651194|FG000|Overall Study|GTx-024 drug supply was withdrawn|2|||
27992548|NCT02724878|54651198|FG000|Overall Study|Still on Active Therapy|15|||
27992549|NCT02724878|54651198|FG000|Overall Study|Disease Progression|31|||
27992550|NCT02724878|54651198|FG000|Overall Study|Toxicity|5|||
27992551|NCT02724878|54651198|FG000|Overall Study|Death|1|||
27992552|NCT02724878|54651198|FG000|Overall Study|Withdrawal by Subject|4|||
27992553|NCT02724878|54651198|FG000|Overall Study|Lost to Follow-up|2|||
27992554|NCT02724878|54651198|FG000|Overall Study|Protocol Violation|1|||
27992555|NCT02724878|54651198|FG000|Overall Study|Ineligible for Study Drug|5|||
27992556|NCT02724878|54651198|FG000|Overall Study|not started|1|||
27992557|NCT02600507|54651205|FG000|Overall Study|Adverse Event|3|||
27992558|NCT02600507|54651206|FG001|Overall Study|Adverse Event|15|||
27992559|NCT02600507|54651207|FG002|Overall Study|Adverse Event|5|||
27992560|NCT02600507|54651205|FG000|Overall Study|Lack of Efficacy|3|||
27992561|NCT02600507|54651206|FG001|Overall Study|Lack of Efficacy|8|||
27992562|NCT02600507|54651207|FG002|Overall Study|Lack of Efficacy|5|||
27992563|NCT02600507|54651205|FG000|Overall Study|Lost to Follow-up|3|||
27992564|NCT02600507|54651206|FG001|Overall Study|Lost to Follow-up|5|||
27992565|NCT02600507|54651207|FG002|Overall Study|Lost to Follow-up|2|||
27992566|NCT02600507|54651205|FG000|Overall Study|Protocol Violation|12|||
27992567|NCT02600507|54651206|FG001|Overall Study|Protocol Violation|4|||
27992568|NCT02600507|54651207|FG002|Overall Study|Protocol Violation|4|||
27992569|NCT02600507|54651205|FG000|Overall Study|Physician Decision|1|||
27992570|NCT02600507|54651206|FG001|Overall Study|Physician Decision|0|||
27992571|NCT02600507|54651207|FG002|Overall Study|Physician Decision|1|||
27992572|NCT02600507|54651205|FG000|Overall Study|Withdrawal by Subject|7|||
27992573|NCT02600507|54651206|FG001|Overall Study|Withdrawal by Subject|11|||
27992574|NCT02600507|54651207|FG002|Overall Study|Withdrawal by Subject|7|||
27992575|NCT02600507|54651205|FG000|Overall Study|Other|0|||
27908682|NCT01186744|54566452|FG005|Overall Study|Protocol Violation|2|||
27908683|NCT01186744|54566447|FG000|Overall Study|Lost to Follow-up|15|||
27908684|NCT01186744|54566448|FG001|Overall Study|Lost to Follow-up|16|||
27908685|NCT01186744|54566449|FG002|Overall Study|Lost to Follow-up|2|||
27908686|NCT01186744|54566450|FG003|Overall Study|Lost to Follow-up|1|||
27908687|NCT01186744|54566451|FG004|Overall Study|Lost to Follow-up|1|||
27908688|NCT01186744|54566452|FG005|Overall Study|Lost to Follow-up|4|||
27992576|NCT02600507|54651206|FG001|Overall Study|Other|1|||
27992577|NCT02600507|54651207|FG002|Overall Study|Other|1|||
27992578|NCT02578680|54651217|FG000|Overall Study|Death|124|||
27992579|NCT02578680|54651218|FG001|Overall Study|Death|104|||
27908689|NCT01186744|54566447|FG000|Overall Study|Screen failure|1|||
27908690|NCT01186744|54566448|FG001|Overall Study|Screen failure|1|||
27908691|NCT01186744|54566449|FG002|Overall Study|Screen failure|0|||
27908692|NCT01186744|54566450|FG003|Overall Study|Screen failure|1|||
27908693|NCT01186744|54566451|FG004|Overall Study|Screen failure|0|||
27908694|NCT01186744|54566452|FG005|Overall Study|Screen failure|0|||
27992580|NCT02578680|54651217|FG000|Overall Study|Protocol Violation|1|||
27992581|NCT02578680|54651218|FG001|Overall Study|Protocol Violation|1|||
27992582|NCT02578680|54651217|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
27992583|NCT02578680|54651218|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
27992584|NCT02578680|54651217|FG000|Overall Study|Withdrawal by Subject|8|||
27992585|NCT02578680|54651218|FG001|Overall Study|Withdrawal by Subject|5|||
27992586|NCT02578680|54651217|FG000|Overall Study|Ongoing in Study|276|||
27992587|NCT02578680|54651218|FG001|Overall Study|Ongoing in Study|96|||
27992588|NCT02385266|54651226|FG000|Overall Study|Withdrawal by Subject|1|||
27992589|NCT02385266|54651227|FG001|Overall Study|Withdrawal by Subject|3|||
27992590|NCT02379988|54651233|FG000|Overall Study|Not eligible|1|||
27992591|NCT02006069|54651248|FG000|Overall Study|MPP other programming|239|||
27992592|NCT02006069|54651249|FG001|Overall Study|MPP other programming|0|||
27908695|NCT01186744|54566447|FG000|Overall Study|Withdrawal by Subject|14|||
27908696|NCT01186744|54566448|FG001|Overall Study|Withdrawal by Subject|10|||
27908697|NCT01186744|54566449|FG002|Overall Study|Withdrawal by Subject|2|||
27908698|NCT01186744|54566450|FG003|Overall Study|Withdrawal by Subject|5|||
27992593|NCT02006069|54651248|FG000|Overall Study|RV only pacing|0|||
27992594|NCT02006069|54651249|FG001|Overall Study|RV only pacing|3|||
27992595|NCT01985867|54651257|FG000|Overall Study|Lost to Follow-up|3|||
27992596|NCT01985867|54651258|FG001|Overall Study|Lost to Follow-up|4|||
27992597|NCT01985867|54651257|FG000|Overall Study|Adverse Event|3|||
27992598|NCT01985867|54651258|FG001|Overall Study|Adverse Event|2|||
27992599|NCT01985867|54651257|FG000|Overall Study|Lack of Efficacy|1|||
27992600|NCT01985867|54651258|FG001|Overall Study|Lack of Efficacy|0|||
27992601|NCT01946139|54651264|FG000|Overall Study|Withdrawal by Subject|8|||
27992602|NCT01946139|54651264|FG000|Overall Study|ineligible|8|||
27992603|NCT01946139|54651264|FG000|Overall Study|Specimens not available|4|||
27992604|NCT01367002|54651270|FG000|Overall Study|Withdrawal by Subject|1|||
27992605|NCT01367002|54651271|FG001|Overall Study|Withdrawal by Subject|0|||
27992606|NCT01367002|54651270|FG000|Overall Study|Physician Decision|0|||
27992607|NCT01367002|54651271|FG001|Overall Study|Physician Decision|2|||
27992608|NCT00858273|54651279|FG000|Overall Study|Protocol Violation|3|||
27908699|NCT01186744|54566451|FG004|Overall Study|Withdrawal by Subject|0|||
27908700|NCT01186744|54566452|FG005|Overall Study|Withdrawal by Subject|6|||
27908701|NCT01186744|54566447|FG000|Overall Study|Study terminated by Sponsor|1|||
27992609|NCT00858273|54651280|FG001|Overall Study|Protocol Violation|5|||
27992610|NCT00844428|54651311|FG000|Screening Period|Screen Failure|3|||
27992611|NCT00844428|54651311|FG000|Extension Treatment Period|Death|1|||
27992612|NCT00844428|54651311|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
27908702|NCT01186744|54566448|FG001|Overall Study|Study terminated by Sponsor|0|||
27908703|NCT01186744|54566449|FG002|Overall Study|Study terminated by Sponsor|0|||
27908704|NCT01186744|54566450|FG003|Overall Study|Study terminated by Sponsor|0|||
27908705|NCT01186744|54566451|FG004|Overall Study|Study terminated by Sponsor|0|||
27908706|NCT01186744|54566452|FG005|Overall Study|Study terminated by Sponsor|0|||
27908707|NCT01186744|54566447|FG000|Overall Study|Other|9|||
27908708|NCT01186744|54566448|FG001|Overall Study|Other|10|||
27908709|NCT01186744|54566449|FG002|Overall Study|Other|1|||
27908710|NCT01186744|54566450|FG003|Overall Study|Other|2|||
27908711|NCT01186744|54566451|FG004|Overall Study|Other|1|||
27908712|NCT01186744|54566452|FG005|Overall Study|Other|5|||
27908713|NCT01186744|54566447|FG000|Overall Study|Adverse Event|10|||
27908714|NCT01186744|54566448|FG001|Overall Study|Adverse Event|14|||
27908715|NCT01186744|54566449|FG002|Overall Study|Adverse Event|1|||
27992613|NCT00834834|54651317|FG000|Overall Study|Withdrawal by Subject|4|||
27992614|NCT00834834|54651318|FG001|Overall Study|Withdrawal by Subject|3|||
27908716|NCT01186744|54566450|FG003|Overall Study|Adverse Event|0|||
27908717|NCT01186744|54566451|FG004|Overall Study|Adverse Event|1|||
27908718|NCT01186744|54566452|FG005|Overall Study|Adverse Event|4|||
27908719|NCT01186744|54566447|FG000|Overall Study|Death|1|||
27908720|NCT01186744|54566448|FG001|Overall Study|Death|0|||
27908721|NCT01186744|54566449|FG002|Overall Study|Death|0|||
27992615|NCT00834366|54651326|FG000|Treatment Period 1|Adverse Event|1|||
27992616|NCT00834366|54651327|FG001|Treatment Period 1|Adverse Event|1|||
27992617|NCT00844194|54651335|FG000|Overall Study|Adverse Event|17|||
27992618|NCT00844194|54651336|FG001|Overall Study|Adverse Event|5|||
27992619|NCT00844194|54651335|FG000|Overall Study|Protocol Violation|1|||
27992620|NCT00844194|54651336|FG001|Overall Study|Protocol Violation|1|||
27992621|NCT00844194|54651335|FG000|Overall Study|Lost to Follow-up|1|||
27992622|NCT00844194|54651336|FG001|Overall Study|Lost to Follow-up|1|||
27992623|NCT00844194|54651335|FG000|Overall Study|Withdrawal by Subject|2|||
27992624|NCT00844194|54651336|FG001|Overall Study|Withdrawal by Subject|1|||
27992625|NCT00844194|54651335|FG000|Overall Study|Lack of Efficacy|3|||
27992626|NCT00844194|54651336|FG001|Overall Study|Lack of Efficacy|0|||
27992627|NCT00844194|54651335|FG000|Overall Study|Other reason (not specified)|1|||
27908722|NCT01186744|54566450|FG003|Overall Study|Death|0|||
27908723|NCT01186744|54566451|FG004|Overall Study|Death|0|||
27992628|NCT00844194|54651336|FG001|Overall Study|Other reason (not specified)|0|||
27992629|NCT00826176|54651348|FG000|Overall Study|Lost to Follow-up|1|||
27992630|NCT00826176|54651349|FG001|Overall Study|Lost to Follow-up|0|||
27992631|NCT00826176|54651348|FG000|Overall Study|Subject Withdrew Consent|3|||
27992632|NCT00826176|54651349|FG001|Overall Study|Subject Withdrew Consent|0|||
27992633|NCT00826176|54651348|FG000|Overall Study|Administrative|9|||
27992634|NCT00826176|54651349|FG001|Overall Study|Administrative|0|||
27992635|NCT00878969|54651358|FG000|Overall Study|Physician Decision|5|||
27992636|NCT00878969|54651359|FG001|Overall Study|Physician Decision|3|||
27992637|NCT00878969|54651360|FG002|Overall Study|Physician Decision|2|||
27992638|NCT00878969|54651358|FG000|Overall Study|Withdrawal by Subject|1|||
28172570|NCT03077828|54844287|FG000|Autologous Stem Cell Transplant|Physician Decision|1|||
28172571|NCT03077828|54844287|FG000|Follow-up|Patients still in follow-up|15|||
27908724|NCT01186744|54566452|FG005|Overall Study|Death|0|||
27908725|NCT01185964|54566490|FG000|Phase 1b and Phase 2|Withdrawal by Subject|1|||
27908726|NCT01185964|54566491|FG001|Phase 1b and Phase 2|Withdrawal by Subject|6|||
27908727|NCT01185964|54566492|FG002|Phase 1b and Phase 2|Withdrawal by Subject|2|||
27908728|NCT01185964|54566493|FG003|Phase 1b and Phase 2|Withdrawal by Subject|0|||
27908729|NCT01185964|54566490|FG000|Phase 1b and Phase 2|Other Therapy Started|0|||
27992639|NCT00878969|54651359|FG001|Overall Study|Withdrawal by Subject|6|||
27992640|NCT00878969|54651360|FG002|Overall Study|Withdrawal by Subject|3|||
27992641|NCT00878969|54651358|FG000|Overall Study|kidney transplant|2|||
27992642|NCT00878969|54651359|FG001|Overall Study|kidney transplant|3|||
27992643|NCT00878969|54651360|FG002|Overall Study|kidney transplant|2|||
27992644|NCT00878969|54651358|FG000|Overall Study|Adverse Event|3|||
27992645|NCT00878969|54651359|FG001|Overall Study|Adverse Event|1|||
27992646|NCT00878969|54651360|FG002|Overall Study|Adverse Event|2|||
27992647|NCT00878969|54651358|FG000|Overall Study|Lost to Follow-up|2|||
27992648|NCT00878969|54651359|FG001|Overall Study|Lost to Follow-up|1|||
27992649|NCT00878969|54651360|FG002|Overall Study|Lost to Follow-up|0|||
27992650|NCT00878969|54651358|FG000|Overall Study|Protocol Violation|2|||
27992651|NCT00878969|54651359|FG001|Overall Study|Protocol Violation|0|||
27992652|NCT00878969|54651360|FG002|Overall Study|Protocol Violation|0|||
27992653|NCT00878969|54651358|FG000|Overall Study|Death|0|||
27992654|NCT00878969|54651359|FG001|Overall Study|Death|0|||
27992655|NCT00878969|54651360|FG002|Overall Study|Death|2|||
27992656|NCT00878969|54651358|FG000|Overall Study|Pregnancy|0|||
27992657|NCT00878969|54651359|FG001|Overall Study|Pregnancy|1|||
27992658|NCT00878969|54651360|FG002|Overall Study|Pregnancy|0|||
27992659|NCT00843726|54651374|FG000|Overall Study|Death|1|||
27992660|NCT00843726|54651375|FG001|Overall Study|Death|0|||
27992661|NCT00843726|54651374|FG000|Overall Study|Withdrawal by Subject|0|||
27992662|NCT00843726|54651375|FG001|Overall Study|Withdrawal by Subject|1|||
27992663|NCT00843492|54651384|FG000|Overall Study|Adverse Event|0|||
27992664|NCT00843492|54651385|FG001|Overall Study|Adverse Event|3|||
27992665|NCT00843492|54651384|FG000|Overall Study|Lost to Follow-up|4|||
27992666|NCT00843492|54651385|FG001|Overall Study|Lost to Follow-up|4|||
27992667|NCT00843492|54651384|FG000|Overall Study|Withdrawal by Subject|0|||
27992668|NCT00843492|54651385|FG001|Overall Study|Withdrawal by Subject|4|||
27992669|NCT00843492|54651384|FG000|Overall Study|Immobilization Stopped|1|||
27992670|NCT00843492|54651385|FG001|Overall Study|Immobilization Stopped|0|||
27992671|NCT00843492|54651384|FG000|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
27992672|NCT00843492|54651385|FG001|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
27992673|NCT00843492|54651384|FG000|Overall Study|Orthopedic Surgery|0|||
27992674|NCT00843492|54651385|FG001|Overall Study|Orthopedic Surgery|2|||
27992675|NCT00843492|54651384|FG000|Overall Study|Visit Not Performed|1|||
27992676|NCT00843492|54651385|FG001|Overall Study|Visit Not Performed|0|||
27992677|NCT00843492|54651384|FG000|Overall Study|Deep-vein Thrombosis|1|||
27992678|NCT00843492|54651385|FG001|Overall Study|Deep-vein Thrombosis|0|||
27992679|NCT00833976|54651391|FG000|Overall Study|Withdrawal by Subject|5|||
27992680|NCT00833976|54651391|FG000|Overall Study|Lost to Follow-up|4|||
27992681|NCT00833976|54651391|FG000|Overall Study|Did not meet eligibility criteria|41|||
27992682|NCT00833976|54651391|FG000|Overall Study|Physician Decision|1|||
27992683|NCT00833898|54651397|FG000|Overall Study|Withdrawal by Subject|33|||
27992684|NCT00833898|54651398|FG001|Overall Study|Withdrawal by Subject|27|||
27908730|NCT01185964|54566491|FG001|Phase 1b and Phase 2|Other Therapy Started|3|||
28098037|NCT03614156|54753840|FG000|Open-Label Treatment Period|Protocol Violation|2|||
27908731|NCT01185964|54566492|FG002|Phase 1b and Phase 2|Other Therapy Started|3|||
27908732|NCT01185964|54566493|FG003|Phase 1b and Phase 2|Other Therapy Started|0|||
27908733|NCT01185964|54566490|FG000|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
27908734|NCT01185964|54566491|FG001|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
27908735|NCT01185964|54566492|FG002|Phase 1b and Phase 2|Participant was beyond maximum weight|1|||
27908736|NCT01185964|54566493|FG003|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
27908737|NCT01185964|54566490|FG000|Phase 1b and Phase 2|Adverse Event|1|||
27908738|NCT01185964|54566491|FG001|Phase 1b and Phase 2|Adverse Event|0|||
27908739|NCT01185964|54566492|FG002|Phase 1b and Phase 2|Adverse Event|2|||
27908740|NCT01185964|54566493|FG003|Phase 1b and Phase 2|Adverse Event|0|||
27908741|NCT01185964|54566490|FG000|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
27908742|NCT01185964|54566491|FG001|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
27992685|NCT00833898|54651397|FG000|Overall Study|Lost to Follow-up|7|||
27992686|NCT00833898|54651398|FG001|Overall Study|Lost to Follow-up|7|||
27992687|NCT00833898|54651397|FG000|Overall Study|Patient did not receive transplant|0|||
27992688|NCT00833898|54651398|FG001|Overall Study|Patient did not receive transplant|2|||
27992689|NCT00825162|54651407|FG000|Overall Study|Withdrawal by Subject|11|||
28098038|NCT03614156|54753841|FG001|Open-Label Treatment Period|Protocol Violation|0|||
27908743|NCT01185964|54566492|FG002|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
27992690|NCT00825162|54651408|FG001|Overall Study|Withdrawal by Subject|13|||
27992691|NCT00825162|54651409|FG002|Overall Study|Withdrawal by Subject|3|||
27992692|NCT00825162|54651407|FG000|Overall Study|Lost to Follow-up|9|||
27992693|NCT00825162|54651408|FG001|Overall Study|Lost to Follow-up|6|||
27992694|NCT00825162|54651409|FG002|Overall Study|Lost to Follow-up|3|||
27992695|NCT00825162|54651407|FG000|Overall Study|Physician Decision|2|||
27992696|NCT00825162|54651408|FG001|Overall Study|Physician Decision|0|||
27992697|NCT00825162|54651409|FG002|Overall Study|Physician Decision|0|||
27992698|NCT00825162|54651407|FG000|Overall Study|Move away from the study area|1|||
27992699|NCT00825162|54651408|FG001|Overall Study|Move away from the study area|0|||
27992700|NCT00825162|54651409|FG002|Overall Study|Move away from the study area|0|||
27992701|NCT00825162|54651407|FG000|Overall Study|Unable to attend the study visit|5|||
27992702|NCT00825162|54651408|FG001|Overall Study|Unable to attend the study visit|2|||
27992703|NCT00825162|54651409|FG002|Overall Study|Unable to attend the study visit|0|||
27992704|NCT00824850|54651424|FG000|Overall Study|Withdrawal by Subject|0|||
27992705|NCT00824850|54651425|FG001|Overall Study|Withdrawal by Subject|1|||
27992706|NCT00596687|54651439|FG000|Overall Study|< 24 hours of insulin treatment|8|||
27992707|NCT00596687|54651440|FG001|Overall Study|< 24 hours of insulin treatment|6|||
27992708|NCT00596687|54651439|FG000|Overall Study|continuous insulin infusion during TPN|2|||
27992709|NCT00596687|54651440|FG001|Overall Study|continuous insulin infusion during TPN|1|||
27992710|NCT00596687|54651439|FG000|Overall Study|Withdrawal by Subject|3|||
27992711|NCT00596687|54651440|FG001|Overall Study|Withdrawal by Subject|1|||
27992712|NCT00596687|54651439|FG000|Overall Study|cancelled surgery|1|||
27992713|NCT00596687|54651440|FG001|Overall Study|cancelled surgery|1|||
27992714|NCT00824772|54651446|FG000|Overall Study|Withdrawal by Subject|8|||
27992715|NCT00824616|54651452|FG000|Overall Study|Adverse Event|2|||
27992716|NCT00824616|54651453|FG001|Overall Study|Adverse Event|1|||
27992717|NCT00824616|54651452|FG000|Overall Study|Creatinine/Creatinine Clearance|0|||
27992718|NCT00824616|54651453|FG001|Overall Study|Creatinine/Creatinine Clearance|2|||
27992719|NCT00824616|54651452|FG000|Overall Study|Hyperglycemia|1|||
27992720|NCT00824616|54651453|FG001|Overall Study|Hyperglycemia|1|||
27992721|NCT00824616|54651452|FG000|Overall Study|Lack of Efficacy|2|||
27992722|NCT00824616|54651453|FG001|Overall Study|Lack of Efficacy|1|||
27992723|NCT00824616|54651452|FG000|Overall Study|Lost to Follow-up|0|||
27992724|NCT00824616|54651453|FG001|Overall Study|Lost to Follow-up|1|||
27992725|NCT00824616|54651452|FG000|Overall Study|Withdrawal by Subject|1|||
27992726|NCT00824616|54651453|FG001|Overall Study|Withdrawal by Subject|1|||
27992727|NCT00824382|54651463|FG000|Overall Study|Adverse Event|4|||
27992728|NCT00824382|54651464|FG001|Overall Study|Adverse Event|1|||
27992729|NCT00824382|54651465|FG002|Overall Study|Adverse Event|1|||
27992730|NCT00824382|54651466|FG003|Overall Study|Adverse Event|4|||
27992731|NCT00824382|54651463|FG000|Overall Study|Protocol Violation|1|||
27908744|NCT01185964|54566493|FG003|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
27992732|NCT00824382|54651464|FG001|Overall Study|Protocol Violation|0|||
27992733|NCT00824382|54651465|FG002|Overall Study|Protocol Violation|0|||
27992734|NCT00824382|54651466|FG003|Overall Study|Protocol Violation|1|||
27992735|NCT00824382|54651463|FG000|Overall Study|Investigator's decision|0|||
27992736|NCT00824382|54651464|FG001|Overall Study|Investigator's decision|1|||
27992737|NCT00824382|54651465|FG002|Overall Study|Investigator's decision|2|||
27992738|NCT00824382|54651466|FG003|Overall Study|Investigator's decision|0|||
27992739|NCT00833040|54651478|FG000|Overall Study|Adverse Event|0|||
28098039|NCT03614156|54753842|FG002|Open-Label Treatment Period|Protocol Violation|0|||
28098040|NCT03614156|54753843|FG003|Open-Label Treatment Period|Protocol Violation|0|||
28098041|NCT03614156|54753840|FG000|Open-Label Treatment Period|Non-compliance with study drug|1|||
28098042|NCT03614156|54753841|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
27908745|NCT01185964|54566490|FG000|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
27908746|NCT01185964|54566491|FG001|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
27908747|NCT01185964|54566492|FG002|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
27908748|NCT01185964|54566493|FG003|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2|||
27908749|NCT01185964|54566490|FG000|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
27908750|NCT01185964|54566491|FG001|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
27908751|NCT01185964|54566492|FG002|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
27908752|NCT01185964|54566493|FG003|Optional Olaratumab Monotherapy on Dox|Adverse Event|1|||
27908753|NCT01185964|54566490|FG000|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
27908754|NCT01185964|54566491|FG001|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
27908755|NCT01185964|54566492|FG002|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
27908756|NCT01185964|54566493|FG003|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2|||
27908757|NCT01217476|54566511|FG000|Overall Study|Adverse Event|6|||
27908758|NCT01217476|54566512|FG001|Overall Study|Adverse Event|1|||
27908759|NCT01217476|54566511|FG000|Overall Study|Physician Decision|0|||
27908760|NCT01217476|54566512|FG001|Overall Study|Physician Decision|1|||
27908761|NCT01217476|54566511|FG000|Overall Study|Withdrawal by Subject|3|||
27908762|NCT01217476|54566512|FG001|Overall Study|Withdrawal by Subject|3|||
27908763|NCT01217476|54566511|FG000|Overall Study|Surgery on the Target Limb|0|||
27992740|NCT00833040|54651479|FG001|Overall Study|Adverse Event|0|||
27992741|NCT00833040|54651480|FG002|Overall Study|Adverse Event|0|||
27992742|NCT00833040|54651481|FG003|Overall Study|Adverse Event|0|||
27992743|NCT00833040|54651482|FG004|Overall Study|Adverse Event|0|||
27992744|NCT00833040|54651483|FG005|Overall Study|Adverse Event|1|||
27992745|NCT00843024|54651492|FG000|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79|||
27992746|NCT00843024|54651493|FG001|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74|||
28098043|NCT03614156|54753842|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
27908764|NCT01217476|54566512|FG001|Overall Study|Surgery on the Target Limb|2|||
27908765|NCT01217476|54566511|FG000|Overall Study|Protocol Deviation|1|||
27908766|NCT01217476|54566512|FG001|Overall Study|Protocol Deviation|0|||
27908767|NCT01217476|54566511|FG000|Overall Study|Other|2|||
27992747|NCT00843024|54651494|FG002|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
27992748|NCT00843024|54651495|FG003|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
27992749|NCT00843024|54651496|FG004|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
27992750|NCT00843024|54651497|FG005|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
27992751|NCT00843024|54651492|FG000|Single-blind Placebo Run-In Phase|Lost to Follow-up|36|||
27992752|NCT00843024|54651493|FG001|Single-blind Placebo Run-In Phase|Lost to Follow-up|31|||
27992753|NCT00843024|54651494|FG002|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
27992754|NCT00843024|54651495|FG003|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
27992755|NCT00843024|54651496|FG004|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
27992756|NCT00843024|54651497|FG005|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
27992757|NCT00843024|54651492|FG000|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19|||
27992758|NCT00843024|54651493|FG001|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18|||
27992759|NCT00843024|54651494|FG002|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
27992760|NCT00843024|54651495|FG003|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
27992761|NCT00843024|54651496|FG004|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
27992762|NCT00843024|54651497|FG005|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
27992763|NCT00843024|54651492|FG000|Single-blind Placebo Run-In Phase|Protocol Violation|4|||
27992764|NCT00843024|54651493|FG001|Single-blind Placebo Run-In Phase|Protocol Violation|5|||
27992765|NCT00843024|54651494|FG002|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
27992766|NCT00843024|54651495|FG003|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
27992767|NCT00843024|54651496|FG004|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
27992768|NCT00843024|54651497|FG005|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
27992769|NCT00843024|54651492|FG000|Single-blind Placebo Run-In Phase|Physician Decision|2|||
27992770|NCT00843024|54651493|FG001|Single-blind Placebo Run-In Phase|Physician Decision|6|||
27992771|NCT00843024|54651494|FG002|Single-blind Placebo Run-In Phase|Physician Decision|0|||
27992772|NCT00843024|54651495|FG003|Single-blind Placebo Run-In Phase|Physician Decision|0|||
27992773|NCT00843024|54651496|FG004|Single-blind Placebo Run-In Phase|Physician Decision|0|||
27992774|NCT00843024|54651497|FG005|Single-blind Placebo Run-In Phase|Physician Decision|0|||
27992775|NCT00843024|54651492|FG000|Single-blind Placebo Run-In Phase|Adverse Event|0|||
27992776|NCT00843024|54651493|FG001|Single-blind Placebo Run-In Phase|Adverse Event|1|||
27992777|NCT00843024|54651494|FG002|Single-blind Placebo Run-In Phase|Adverse Event|0|||
27992778|NCT00843024|54651495|FG003|Single-blind Placebo Run-In Phase|Adverse Event|0|||
27992779|NCT00843024|54651496|FG004|Single-blind Placebo Run-In Phase|Adverse Event|0|||
27992780|NCT00843024|54651497|FG005|Single-blind Placebo Run-In Phase|Adverse Event|0|||
27992781|NCT00843024|54651492|FG000|Single-blind Placebo Run-In Phase|Other|0|||
27992782|NCT00843024|54651493|FG001|Single-blind Placebo Run-In Phase|Other|1|||
27992783|NCT00843024|54651494|FG002|Single-blind Placebo Run-In Phase|Other|0|||
27992784|NCT00843024|54651495|FG003|Single-blind Placebo Run-In Phase|Other|0|||
27992785|NCT00843024|54651496|FG004|Single-blind Placebo Run-In Phase|Other|0|||
27992786|NCT00843024|54651497|FG005|Single-blind Placebo Run-In Phase|Other|0|||
27992787|NCT00843024|54651492|FG000|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
27992788|NCT00843024|54651493|FG001|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
27908768|NCT01217476|54566512|FG001|Overall Study|Other|0|||
27908769|NCT01217437|54566533|FG000|Overall Study|Adverse Event|0|||
27908770|NCT01217437|54566534|FG001|Overall Study|Adverse Event|8|||
27908771|NCT01217437|54566533|FG000|Overall Study|Death|5|||
27908772|NCT01217437|54566534|FG001|Overall Study|Death|0|||
27908773|NCT01217437|54566533|FG000|Overall Study|Lack of Efficacy|29|||
27908774|NCT01217437|54566534|FG001|Overall Study|Lack of Efficacy|25|||
27908775|NCT01217437|54566533|FG000|Overall Study|Physician Decision|8|||
27908776|NCT01217437|54566534|FG001|Overall Study|Physician Decision|5|||
27908777|NCT01217437|54566533|FG000|Overall Study|Withdrawal by Subject|0|||
27908778|NCT01217437|54566534|FG001|Overall Study|Withdrawal by Subject|2|||
27908779|NCT01217437|54566533|FG000|Overall Study|Ineligible|1|||
27908780|NCT01217437|54566534|FG001|Overall Study|Ineligible|1|||
27908781|NCT01217047|54566544|FG000|Overall Study|Lost to Follow-up|0|||
27908782|NCT01217047|54566545|FG001|Overall Study|Lost to Follow-up|1|||
27908783|NCT01217047|54566546|FG002|Overall Study|Lost to Follow-up|0|||
27908784|NCT01185340|54566558|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24|||
27908785|NCT01185340|54566559|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
27908786|NCT01185340|54566560|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
27992789|NCT00843024|54651494|FG002|Double-blind Treatment Phase|No opportunity to treat migraine|20|||
27992790|NCT00843024|54651495|FG003|Double-blind Treatment Phase|No opportunity to treat migraine|10|||
28098044|NCT03614156|54753843|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
28098045|NCT03614156|54753840|FG000|Open-Label Treatment Period|Study terminated by sponsor|74|||
28098046|NCT03614156|54753841|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
27992791|NCT00843024|54651496|FG004|Double-blind Treatment Phase|No opportunity to treat migraine|13|||
27992792|NCT00843024|54651497|FG005|Double-blind Treatment Phase|No opportunity to treat migraine|14|||
27992793|NCT00843024|54651492|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
27992794|NCT00843024|54651493|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
27992795|NCT00843024|54651494|FG002|Double-blind Treatment Phase|Lost to Follow-up|8|||
27992796|NCT00843024|54651495|FG003|Double-blind Treatment Phase|Lost to Follow-up|4|||
27992797|NCT00843024|54651496|FG004|Double-blind Treatment Phase|Lost to Follow-up|4|||
27992798|NCT00843024|54651497|FG005|Double-blind Treatment Phase|Lost to Follow-up|4|||
27992799|NCT00843024|54651492|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
27992800|NCT00843024|54651493|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
27992801|NCT00843024|54651494|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
27992802|NCT00843024|54651495|FG003|Double-blind Treatment Phase|Withdrawal by Subject|6|||
27992803|NCT00843024|54651496|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
27908787|NCT01185340|54566561|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
27908788|NCT01185340|54566558|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6|||
27908789|NCT01185340|54566559|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
27908790|NCT01185340|54566560|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
27908791|NCT01185340|54566561|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
27908792|NCT01185340|54566558|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5|||
27908793|NCT01185340|54566559|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
27992804|NCT00843024|54651497|FG005|Double-blind Treatment Phase|Withdrawal by Subject|2|||
27992805|NCT00843024|54651492|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
27992806|NCT00843024|54651493|FG001|Double-blind Treatment Phase|Protocol Violation|0|||
27992807|NCT00843024|54651494|FG002|Double-blind Treatment Phase|Protocol Violation|3|||
27992808|NCT00843024|54651495|FG003|Double-blind Treatment Phase|Protocol Violation|0|||
27992809|NCT00843024|54651496|FG004|Double-blind Treatment Phase|Protocol Violation|0|||
27992810|NCT00843024|54651497|FG005|Double-blind Treatment Phase|Protocol Violation|3|||
27992811|NCT00843024|54651492|FG000|Double-blind Treatment Phase|Physician Decision|0|||
27992812|NCT00843024|54651493|FG001|Double-blind Treatment Phase|Physician Decision|0|||
27992813|NCT00843024|54651494|FG002|Double-blind Treatment Phase|Physician Decision|0|||
27992814|NCT00843024|54651495|FG003|Double-blind Treatment Phase|Physician Decision|3|||
27992815|NCT00843024|54651496|FG004|Double-blind Treatment Phase|Physician Decision|1|||
27992816|NCT00843024|54651497|FG005|Double-blind Treatment Phase|Physician Decision|1|||
27992817|NCT00843024|54651492|FG000|Double-blind Treatment Phase|Adverse Event|0|||
27992818|NCT00843024|54651493|FG001|Double-blind Treatment Phase|Adverse Event|0|||
27992819|NCT00843024|54651494|FG002|Double-blind Treatment Phase|Adverse Event|0|||
27992820|NCT00843024|54651495|FG003|Double-blind Treatment Phase|Adverse Event|0|||
27992821|NCT00843024|54651496|FG004|Double-blind Treatment Phase|Adverse Event|1|||
27992822|NCT00843024|54651497|FG005|Double-blind Treatment Phase|Adverse Event|1|||
27992823|NCT00843024|54651492|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
27992824|NCT00843024|54651493|FG001|Double-blind Treatment Phase|Lack of Efficacy|0|||
27992825|NCT00843024|54651494|FG002|Double-blind Treatment Phase|Lack of Efficacy|0|||
27992826|NCT00843024|54651495|FG003|Double-blind Treatment Phase|Lack of Efficacy|0|||
27992827|NCT00843024|54651496|FG004|Double-blind Treatment Phase|Lack of Efficacy|1|||
27992828|NCT00843024|54651497|FG005|Double-blind Treatment Phase|Lack of Efficacy|0|||
28098047|NCT03614156|54753842|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
28098048|NCT03614156|54753843|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
28098049|NCT03614156|54753840|FG000|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
28098050|NCT03614156|54753841|FG001|Double-Blind Treatment Period (DBTP)|Adverse Event|2|||
28098051|NCT03614156|54753842|FG002|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
28098052|NCT03614156|54753843|FG003|Double-Blind Treatment Period (DBTP)|Adverse Event|1|||
28098053|NCT03614156|54753840|FG000|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
27908794|NCT01185340|54566560|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
27992829|NCT00832650|54651513|FG000|Overall Study|Randomized but not treated|0|||
27992830|NCT00832650|54651514|FG001|Overall Study|Randomized but not treated|0|||
27992831|NCT00832650|54651515|FG002|Overall Study|Randomized but not treated|1|||
27992832|NCT00595517|54651523|FG000|Overall Study|Adverse Event|6|||
27992833|NCT00595517|54651523|FG000|Overall Study|Withdrawal by Subject|4|||
27992834|NCT00595517|54651523|FG000|Overall Study|Protocol Violation|2|||
27992835|NCT00595517|54651523|FG000|Overall Study|Recurrence of ulcer|5|||
27992836|NCT00595517|54651523|FG000|Overall Study|usage of prohibited treatment|1|||
27992837|NCT00595517|54651523|FG000|Overall Study|No intention to attend regularly|1|||
28098054|NCT03614156|54753841|FG001|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4|||
28098055|NCT03614156|54753842|FG002|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
27992838|NCT00823836|54651529|FG000|NV and PR/XR Switching Phases|Adverse Event|22|||
27992839|NCT00823836|54651530|FG001|NV and PR/XR Switching Phases|Adverse Event|21|||
27992840|NCT00823836|54651529|FG000|NV and PR/XR Switching Phases|Protocol Violation|1|||
27992841|NCT00823836|54651530|FG001|NV and PR/XR Switching Phases|Protocol Violation|1|||
27992842|NCT00823836|54651529|FG000|NV and PR/XR Switching Phases|Physician Decision|5|||
27992843|NCT00823836|54651530|FG001|NV and PR/XR Switching Phases|Physician Decision|2|||
27992844|NCT00823836|54651529|FG000|NV and PR/XR Switching Phases|Withdrawal by Subject|4|||
27992845|NCT00823836|54651530|FG001|NV and PR/XR Switching Phases|Withdrawal by Subject|5|||
27992846|NCT00823836|54651529|FG000|Long-term Phase|Adverse Event|3|||
27992847|NCT00823836|54651530|FG001|Long-term Phase|Adverse Event|2|||
27992848|NCT00823836|54651529|FG000|Long-term Phase|Physician Decision|1|||
27992849|NCT00823836|54651530|FG001|Long-term Phase|Physician Decision|2|||
27992850|NCT00823836|54651529|FG000|Long-term Phase|Withdrawal by Subject|1|||
27992851|NCT00823836|54651530|FG001|Long-term Phase|Withdrawal by Subject|1|||
27992852|NCT00879437|54651539|FG000|Overall Study|Protocol Violation|0|||
27992853|NCT00879437|54651540|FG001|Overall Study|Protocol Violation|1|||
27992854|NCT00879437|54651539|FG000|Overall Study|Death|1|||
27992855|NCT00879437|54651540|FG001|Overall Study|Death|0|||
27992856|NCT00877799|54651553|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2|||
27992857|NCT00877799|54651554|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
27992858|NCT00877799|54651555|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
27992859|NCT00877799|54651556|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
27992860|NCT00877799|54651557|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
27992861|NCT00877799|54651553|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
27992862|NCT00877799|54651554|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
27992863|NCT00877799|54651555|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2|||
27992864|NCT00877799|54651556|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
27992865|NCT00877799|54651557|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
27992866|NCT00877799|54651553|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
27992867|NCT00877799|54651554|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3|||
27992868|NCT00877799|54651555|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
27992869|NCT00877799|54651556|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
27992870|NCT00877799|54651557|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
27992871|NCT00877799|54651553|FG000|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
27992872|NCT00877799|54651554|FG001|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
27992873|NCT00877799|54651555|FG002|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
27992874|NCT00877799|54651556|FG003|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1|||
27992875|NCT00877799|54651557|FG004|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
27992876|NCT00877799|54651553|FG000|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
27992877|NCT00877799|54651554|FG001|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
27992878|NCT00877799|54651555|FG002|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
27992879|NCT00877799|54651556|FG003|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
27992880|NCT00877799|54651557|FG004|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
27992881|NCT00595127|54651568|FG000|Overall Study|Death|6|||
27992882|NCT00595127|54651568|FG000|Overall Study|Relapsed|3|||
27992883|NCT00595127|54651568|FG000|Overall Study|joined another trial|1|||
27992884|NCT00877487|54651572|FG000|Open-label Treatment Phase|Adverse Event|1|||
27739678|NCT01599754|54189314|FG000|Overall Study|Death|31|||
27908795|NCT01185340|54566561|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
27908796|NCT01185340|54566558|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
27908797|NCT01185340|54566559|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
27908798|NCT01185340|54566560|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
27908799|NCT01185340|54566561|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
27908800|NCT01185340|54566558|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16|||
27908801|NCT01185340|54566559|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
27739679|NCT01599754|54189315|FG001|Overall Study|Death|33|||
27739680|NCT01599754|54189314|FG000|Overall Study|Adverse Event|3|||
27739681|NCT01599754|54189315|FG001|Overall Study|Adverse Event|2|||
27908802|NCT01185340|54566560|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
27908803|NCT01185340|54566561|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
27908804|NCT01185340|54566558|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32|||
27908805|NCT01185340|54566559|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
27908806|NCT01185340|54566560|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
27908807|NCT01185340|54566561|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
27908808|NCT01185340|54566558|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3|||
27908809|NCT01185340|54566559|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
27908810|NCT01185340|54566560|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
27908811|NCT01185340|54566561|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
27992885|NCT00877487|54651573|FG001|Open-label Treatment Phase|Adverse Event|0|||
27992886|NCT00877487|54651572|FG000|Open-label Treatment Phase|Protocol Violation|3|||
27992887|NCT00877487|54651573|FG001|Open-label Treatment Phase|Protocol Violation|0|||
27992888|NCT00877487|54651572|FG000|Open-label Treatment Phase|Withdrawal by Subject|1|||
27992889|NCT00877487|54651573|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
27739682|NCT01599754|54189314|FG000|Overall Study|Investigator decision|1|||
27992890|NCT00877487|54651572|FG000|Open-label Treatment Phase|Lost to Follow-up|1|||
27992891|NCT00877487|54651573|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
27992892|NCT00877487|54651572|FG000|Open-label Treatment Phase|Out of country for business|1|||
27992893|NCT00877487|54651573|FG001|Open-label Treatment Phase|Out of country for business|0|||
27992894|NCT00877487|54651572|FG000|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5|||
27992895|NCT00877487|54651573|FG001|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45|||
27992896|NCT00877487|54651572|FG000|Double-blind Randomized Withdrawal Phase|Adverse Event|0|||
27992897|NCT00877487|54651573|FG001|Double-blind Randomized Withdrawal Phase|Adverse Event|1|||
27992898|NCT00877487|54651572|FG000|Double-blind Randomized Withdrawal Phase|Protocol Violation|0|||
27992899|NCT00877487|54651573|FG001|Double-blind Randomized Withdrawal Phase|Protocol Violation|1|||
27992900|NCT00877487|54651572|FG000|Double-blind Randomized Withdrawal Phase|Moved out of state|1|||
27992901|NCT00877487|54651573|FG001|Double-blind Randomized Withdrawal Phase|Moved out of state|0|||
27992902|NCT00878501|54651582|FG000|Overall Study|Adverse Event|11|||
27992903|NCT00878501|54651583|FG001|Overall Study|Adverse Event|3|||
27992904|NCT00878501|54651584|FG002|Overall Study|Adverse Event|3|||
27992905|NCT00878501|54651582|FG000|Overall Study|Lack of Efficacy|2|||
27992906|NCT00878501|54651583|FG001|Overall Study|Lack of Efficacy|1|||
27992907|NCT00878501|54651584|FG002|Overall Study|Lack of Efficacy|0|||
27908812|NCT01185340|54566558|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
27908813|NCT01185340|54566559|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
27908814|NCT01185340|54566560|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8|||
27908815|NCT01185340|54566561|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
27908816|NCT01185340|54566558|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
27908817|NCT01185340|54566559|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
27908818|NCT01185340|54566560|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7|||
27908819|NCT01185340|54566561|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
27908820|NCT01185340|54566558|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
27908821|NCT01185340|54566559|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4|||
27908822|NCT01185340|54566560|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
27908823|NCT01185340|54566561|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7|||
27908824|NCT01185340|54566558|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
27908825|NCT01185340|54566559|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
27992908|NCT00878501|54651582|FG000|Overall Study|Withdrawal by Subject|2|||
27992909|NCT00878501|54651583|FG001|Overall Study|Withdrawal by Subject|1|||
27992910|NCT00878501|54651584|FG002|Overall Study|Withdrawal by Subject|2|||
27992911|NCT00878501|54651582|FG000|Overall Study|Protocol Violation|0|||
27992912|NCT00878501|54651583|FG001|Overall Study|Protocol Violation|0|||
27992913|NCT00878501|54651584|FG002|Overall Study|Protocol Violation|1|||
27992914|NCT00878501|54651582|FG000|Overall Study|Incorrect enrolment|1|||
27992915|NCT00878501|54651583|FG001|Overall Study|Incorrect enrolment|2|||
27992916|NCT00878501|54651584|FG002|Overall Study|Incorrect enrolment|0|||
27992917|NCT00878501|54651582|FG000|Overall Study|Intake of prohibited concom. medication|0|||
27992918|NCT00878501|54651583|FG001|Overall Study|Intake of prohibited concom. medication|0|||
27908826|NCT01185340|54566560|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
27908827|NCT01185340|54566561|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
27908828|NCT01185340|54566558|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
27908829|NCT01185340|54566559|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
27908830|NCT01185340|54566560|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2|||
27908831|NCT01185340|54566561|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
27908832|NCT01185340|54566558|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
27908833|NCT01185340|54566559|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
27908834|NCT01185340|54566560|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
27908835|NCT01185340|54566561|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
27908836|NCT01185340|54566558|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
27908837|NCT01185340|54566559|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
27908838|NCT01185340|54566560|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3|||
27908839|NCT01185340|54566561|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
27908840|NCT01216189|54566575|FG000|Overall Study|Lost to Follow-up|21|||
27908841|NCT01216189|54566576|FG001|Overall Study|Lost to Follow-up|3|||
27908842|NCT01216189|54566575|FG000|Overall Study|Death|4|||
27908843|NCT01216189|54566576|FG001|Overall Study|Death|2|||
27908844|NCT01185301|54566586|FG000|Overall Study|Adverse Event|3|||
27908845|NCT01185301|54566587|FG001|Overall Study|Adverse Event|0|||
27908846|NCT01185301|54566588|FG002|Overall Study|Adverse Event|2|||
27908847|NCT01185301|54566589|FG003|Overall Study|Adverse Event|3|||
27908848|NCT01185301|54566586|FG000|Overall Study|Withdrawal by Subject|7|||
27992919|NCT00878501|54651584|FG002|Overall Study|Intake of prohibited concom. medication|1|||
27992920|NCT00878501|54651582|FG000|Overall Study|Mis-randomisation of patient|1|||
27992921|NCT00878501|54651583|FG001|Overall Study|Mis-randomisation of patient|0|||
27992922|NCT00878501|54651584|FG002|Overall Study|Mis-randomisation of patient|0|||
27992923|NCT00878501|54651582|FG000|Overall Study|Administrative|0|||
27992924|NCT00878501|54651583|FG001|Overall Study|Administrative|0|||
27992925|NCT00878501|54651584|FG002|Overall Study|Administrative|1|||
27992926|NCT00882713|54651592|FG000|Overall Study|Adverse Event|2|||
27992927|NCT00882713|54651592|FG000|Overall Study|Death|3|||
27992928|NCT00882713|54651592|FG000|Overall Study|Administrative reasons|4|||
27992929|NCT00882713|54651592|FG000|Overall Study|refused treatment/withdrew consent|4|||
27992930|NCT00882713|54651592|FG000|Overall Study|Blood transfusion|2|||
27992931|NCT00882713|54651592|FG000|Overall Study|Insufficient therapeutic response|3|||
27992932|NCT00882713|54651592|FG000|Overall Study|Failure to return|2|||
27992933|NCT00882713|54651592|FG000|Overall Study|Other - Reasons|2|||
27992934|NCT00809133|54651611|FG000|Overall Study|Progressive disease|2|||
27992935|NCT00809133|54651612|FG001|Overall Study|Progressive disease|5|||
27992936|NCT00809133|54651613|FG002|Overall Study|Progressive disease|5|||
27992937|NCT00809133|54651614|FG003|Overall Study|Progressive disease|3|||
27992938|NCT00809133|54651615|FG004|Overall Study|Progressive disease|4|||
27992939|NCT00809133|54651616|FG005|Overall Study|Progressive disease|1|||
27992940|NCT00809133|54651617|FG006|Overall Study|Progressive disease|3|||
27992941|NCT00809133|54651618|FG007|Overall Study|Progressive disease|3|||
27992942|NCT00809133|54651619|FG008|Overall Study|Progressive disease|3|||
27992943|NCT00809133|54651620|FG009|Overall Study|Progressive disease|9|||
27992944|NCT00809133|54651621|FG010|Overall Study|Progressive disease|5|||
27992945|NCT00809133|54651622|FG011|Overall Study|Progressive disease|7|||
27992946|NCT00809133|54651623|FG012|Overall Study|Progressive disease|5|||
27908849|NCT01185301|54566587|FG001|Overall Study|Withdrawal by Subject|5|||
27908850|NCT01185301|54566588|FG002|Overall Study|Withdrawal by Subject|2|||
27908851|NCT01185301|54566589|FG003|Overall Study|Withdrawal by Subject|3|||
27908852|NCT01185301|54566586|FG000|Overall Study|Lost to Follow-up|2|||
27992947|NCT00809133|54651624|FG013|Overall Study|Progressive disease|4|||
27992948|NCT00809133|54651611|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
27992949|NCT00809133|54651612|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
27992950|NCT00809133|54651613|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
27992951|NCT00809133|54651614|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
27992952|NCT00809133|54651615|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
27908853|NCT01185301|54566587|FG001|Overall Study|Lost to Follow-up|0|||
27908854|NCT01185301|54566588|FG002|Overall Study|Lost to Follow-up|0|||
27908855|NCT01185301|54566589|FG003|Overall Study|Lost to Follow-up|1|||
27908856|NCT01185301|54566586|FG000|Overall Study|Other Reason|3|||
27908857|NCT01185301|54566587|FG001|Overall Study|Other Reason|2|||
27908858|NCT01185301|54566588|FG002|Overall Study|Other Reason|2|||
27908859|NCT01185301|54566589|FG003|Overall Study|Other Reason|2|||
27908860|NCT01216072|54566601|FG000|Open-Label Core Period ( 6 Months)|Adverse Event|40|||
27908861|NCT01216072|54566602|FG001|Open-Label Core Period ( 6 Months)|Adverse Event|4|||
27908862|NCT01216072|54566601|FG000|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2|||
27908863|NCT01216072|54566602|FG001|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0|||
27908864|NCT01216072|54566601|FG000|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3|||
27908865|NCT01216072|54566602|FG001|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0|||
27908866|NCT01216072|54566601|FG000|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3|||
27908867|NCT01216072|54566602|FG001|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4|||
27908868|NCT01216072|54566601|FG000|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12|||
27908869|NCT01216072|54566602|FG001|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22|||
27908870|NCT01216072|54566601|FG000|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5|||
27908871|NCT01216072|54566602|FG001|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0|||
27908872|NCT01216072|54566601|FG000|Open-Label Core Period ( 6 Months)|Protocol Deviation|11|||
27908873|NCT01216072|54566602|FG001|Open-Label Core Period ( 6 Months)|Protocol Deviation|4|||
27908874|NCT01216072|54566601|FG000|Open-Label Extension Period (3 Months)|Adverse Event|0|||
27908875|NCT01216072|54566602|FG001|Open-Label Extension Period (3 Months)|Adverse Event|10|||
27908876|NCT01216072|54566601|FG000|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0|||
27908877|NCT01216072|54566602|FG001|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1|||
27908878|NCT01216072|54566601|FG000|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0|||
27908879|NCT01216072|54566602|FG001|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3|||
27908880|NCT01184989|54566611|FG000|Overall Study|Adverse Event|11|||
27908881|NCT01184989|54566611|FG000|Overall Study|Withdrawal by Subject|1|||
27908882|NCT01215955|54566619|FG000|Overall Study|Adverse Event|1|||
27992953|NCT00809133|54651616|FG005|Overall Study|Dose Limiting Toxicity (DLT)|1|||
27992954|NCT00809133|54651617|FG006|Overall Study|Dose Limiting Toxicity (DLT)|1|||
27992955|NCT00809133|54651618|FG007|Overall Study|Dose Limiting Toxicity (DLT)|1|||
27992956|NCT00809133|54651619|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
27992957|NCT00809133|54651620|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
28172572|NCT02401672|54844293|FG000|Overall Study|Withdrawal by Subject|1|||
27992958|NCT00809133|54651621|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
27992959|NCT00809133|54651622|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
27908883|NCT01215955|54566620|FG001|Overall Study|Adverse Event|4|||
27908884|NCT01215955|54566621|FG002|Overall Study|Adverse Event|2|||
27908885|NCT01215955|54566622|FG003|Overall Study|Adverse Event|3|||
27908886|NCT01215955|54566619|FG000|Overall Study|Death|2|||
27908887|NCT01215955|54566620|FG001|Overall Study|Death|0|||
27908888|NCT01215955|54566621|FG002|Overall Study|Death|1|||
27908889|NCT01215955|54566622|FG003|Overall Study|Death|3|||
27908890|NCT01215955|54566619|FG000|Overall Study|Entry Criteria Not Met|1|||
27908891|NCT01215955|54566620|FG001|Overall Study|Entry Criteria Not Met|3|||
27908892|NCT01215955|54566621|FG002|Overall Study|Entry Criteria Not Met|4|||
27908893|NCT01215955|54566622|FG003|Overall Study|Entry Criteria Not Met|7|||
27908894|NCT01215955|54566619|FG000|Overall Study|Lack of Efficacy|1|||
27908895|NCT01215955|54566620|FG001|Overall Study|Lack of Efficacy|2|||
27908896|NCT01215955|54566621|FG002|Overall Study|Lack of Efficacy|1|||
27908897|NCT01215955|54566622|FG003|Overall Study|Lack of Efficacy|0|||
27908898|NCT01215955|54566619|FG000|Overall Study|Lost to Follow-up|4|||
27908899|NCT01215955|54566620|FG001|Overall Study|Lost to Follow-up|4|||
27908900|NCT01215955|54566621|FG002|Overall Study|Lost to Follow-up|8|||
27908901|NCT01215955|54566622|FG003|Overall Study|Lost to Follow-up|9|||
27908902|NCT01215955|54566619|FG000|Overall Study|Physician Decision|4|||
27908903|NCT01215955|54566620|FG001|Overall Study|Physician Decision|10|||
27908904|NCT01215955|54566621|FG002|Overall Study|Physician Decision|8|||
27908905|NCT01215955|54566622|FG003|Overall Study|Physician Decision|11|||
27908906|NCT01215955|54566619|FG000|Overall Study|Protocol Violation|17|||
27908907|NCT01215955|54566620|FG001|Overall Study|Protocol Violation|13|||
27908908|NCT01215955|54566621|FG002|Overall Study|Protocol Violation|8|||
27908909|NCT01215955|54566622|FG003|Overall Study|Protocol Violation|8|||
27908910|NCT01215955|54566619|FG000|Overall Study|Sponsor Decision|1|||
27908911|NCT01215955|54566620|FG001|Overall Study|Sponsor Decision|2|||
27908912|NCT01215955|54566621|FG002|Overall Study|Sponsor Decision|0|||
27908913|NCT01215955|54566622|FG003|Overall Study|Sponsor Decision|1|||
27908914|NCT01215955|54566619|FG000|Overall Study|Withdrawal by Subject|14|||
27908915|NCT01215955|54566620|FG001|Overall Study|Withdrawal by Subject|15|||
27908916|NCT01215955|54566621|FG002|Overall Study|Withdrawal by Subject|13|||
27908917|NCT01215955|54566622|FG003|Overall Study|Withdrawal by Subject|9|||
27908918|NCT01215955|54566619|FG000|Overall Study|Quality Issues|0|||
27908919|NCT01215955|54566620|FG001|Overall Study|Quality Issues|0|||
27908920|NCT01215955|54566621|FG002|Overall Study|Quality Issues|3|||
27908921|NCT01215955|54566622|FG003|Overall Study|Quality Issues|2|||
27908922|NCT01215916|54566661|FG000|Overall Study|Progressive Disease|0|||
27908923|NCT01215916|54566662|FG001|Overall Study|Progressive Disease|2|||
27908924|NCT01215916|54566663|FG002|Overall Study|Progressive Disease|1|||
27908925|NCT01215916|54566664|FG003|Overall Study|Progressive Disease|2|||
27908926|NCT01215916|54566665|FG004|Overall Study|Progressive Disease|5|||
27908927|NCT01215916|54566666|FG005|Overall Study|Progressive Disease|4|||
27908928|NCT01215916|54566667|FG006|Overall Study|Progressive Disease|5|||
27908929|NCT01215916|54566668|FG007|Overall Study|Progressive Disease|3|||
27908930|NCT01215916|54566669|FG008|Overall Study|Progressive Disease|1|||
27908931|NCT01215916|54566661|FG000|Overall Study|Adverse Event|1|||
27908932|NCT01215916|54566662|FG001|Overall Study|Adverse Event|1|||
27908933|NCT01215916|54566663|FG002|Overall Study|Adverse Event|0|||
27908934|NCT01215916|54566664|FG003|Overall Study|Adverse Event|1|||
27908935|NCT01215916|54566665|FG004|Overall Study|Adverse Event|0|||
27908936|NCT01215916|54566666|FG005|Overall Study|Adverse Event|0|||
27908937|NCT01215916|54566667|FG006|Overall Study|Adverse Event|3|||
27908938|NCT01215916|54566668|FG007|Overall Study|Adverse Event|0|||
27908939|NCT01215916|54566669|FG008|Overall Study|Adverse Event|0|||
27908940|NCT01215916|54566661|FG000|Overall Study|Withdrawal by Subject|0|||
27992960|NCT00809133|54651623|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
27992961|NCT00809133|54651624|FG013|Overall Study|Dose Limiting Toxicity (DLT)|2|||
27992962|NCT00809133|54651611|FG000|Overall Study|Other adverse event|1|||
27992963|NCT00809133|54651612|FG001|Overall Study|Other adverse event|1|||
28098056|NCT03614156|54753843|FG003|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
28098057|NCT03614156|54753840|FG000|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
27908941|NCT01215916|54566662|FG001|Overall Study|Withdrawal by Subject|1|||
27908942|NCT01215916|54566663|FG002|Overall Study|Withdrawal by Subject|1|||
27908943|NCT01215916|54566664|FG003|Overall Study|Withdrawal by Subject|2|||
27908944|NCT01215916|54566665|FG004|Overall Study|Withdrawal by Subject|0|||
27908945|NCT01215916|54566666|FG005|Overall Study|Withdrawal by Subject|0|||
27908946|NCT01215916|54566667|FG006|Overall Study|Withdrawal by Subject|1|||
27908947|NCT01215916|54566668|FG007|Overall Study|Withdrawal by Subject|0|||
27908948|NCT01215916|54566669|FG008|Overall Study|Withdrawal by Subject|0|||
27908949|NCT01215916|54566661|FG000|Overall Study|Death|0|||
27908950|NCT01215916|54566662|FG001|Overall Study|Death|1|||
27908951|NCT01215916|54566663|FG002|Overall Study|Death|0|||
27992964|NCT00809133|54651613|FG002|Overall Study|Other adverse event|1|||
27908952|NCT01215916|54566664|FG003|Overall Study|Death|0|||
27908953|NCT01215916|54566665|FG004|Overall Study|Death|1|||
27908954|NCT01215916|54566666|FG005|Overall Study|Death|0|||
27908955|NCT01215916|54566667|FG006|Overall Study|Death|0|||
27992965|NCT00809133|54651614|FG003|Overall Study|Other adverse event|0|||
27992966|NCT00809133|54651615|FG004|Overall Study|Other adverse event|0|||
27992967|NCT00809133|54651616|FG005|Overall Study|Other adverse event|3|||
27992968|NCT00809133|54651617|FG006|Overall Study|Other adverse event|2|||
27992969|NCT00809133|54651618|FG007|Overall Study|Other adverse event|4|||
27992970|NCT00809133|54651619|FG008|Overall Study|Other adverse event|0|||
27992971|NCT00809133|54651620|FG009|Overall Study|Other adverse event|0|||
27992972|NCT00809133|54651621|FG010|Overall Study|Other adverse event|1|||
27992973|NCT00809133|54651622|FG011|Overall Study|Other adverse event|1|||
27992974|NCT00809133|54651623|FG012|Overall Study|Other adverse event|0|||
27992975|NCT00809133|54651624|FG013|Overall Study|Other adverse event|1|||
27992976|NCT00809133|54651611|FG000|Overall Study|Lost to Follow-up|0|||
27992977|NCT00809133|54651612|FG001|Overall Study|Lost to Follow-up|0|||
27992978|NCT00809133|54651613|FG002|Overall Study|Lost to Follow-up|0|||
27992979|NCT00809133|54651614|FG003|Overall Study|Lost to Follow-up|0|||
27992980|NCT00809133|54651615|FG004|Overall Study|Lost to Follow-up|0|||
27992981|NCT00809133|54651616|FG005|Overall Study|Lost to Follow-up|1|||
27992982|NCT00809133|54651617|FG006|Overall Study|Lost to Follow-up|0|||
27992983|NCT00809133|54651618|FG007|Overall Study|Lost to Follow-up|0|||
27992984|NCT00809133|54651619|FG008|Overall Study|Lost to Follow-up|0|||
27992985|NCT00809133|54651620|FG009|Overall Study|Lost to Follow-up|0|||
27992986|NCT00809133|54651621|FG010|Overall Study|Lost to Follow-up|0|||
27992987|NCT00809133|54651622|FG011|Overall Study|Lost to Follow-up|0|||
27992988|NCT00809133|54651623|FG012|Overall Study|Lost to Follow-up|0|||
27992989|NCT00809133|54651624|FG013|Overall Study|Lost to Follow-up|0|||
27992990|NCT00809133|54651611|FG000|Overall Study|Consent withdrawn|0|||
27992991|NCT00809133|54651612|FG001|Overall Study|Consent withdrawn|0|||
27992992|NCT00809133|54651613|FG002|Overall Study|Consent withdrawn|0|||
27992993|NCT00809133|54651614|FG003|Overall Study|Consent withdrawn|0|||
27992994|NCT00809133|54651615|FG004|Overall Study|Consent withdrawn|1|||
27992995|NCT00809133|54651616|FG005|Overall Study|Consent withdrawn|0|||
28172573|NCT02401672|54844294|FG001|Overall Study|Withdrawal by Subject|3|||
27908956|NCT01215916|54566668|FG007|Overall Study|Death|0|||
27908957|NCT01215916|54566669|FG008|Overall Study|Death|1|||
27908958|NCT01215916|54566661|FG000|Overall Study|Physician Decision|0|||
27908959|NCT01215916|54566662|FG001|Overall Study|Physician Decision|0|||
27908960|NCT01215916|54566663|FG002|Overall Study|Physician Decision|1|||
27908961|NCT01215916|54566664|FG003|Overall Study|Physician Decision|1|||
27908962|NCT01215916|54566665|FG004|Overall Study|Physician Decision|0|||
27908963|NCT01215916|54566666|FG005|Overall Study|Physician Decision|0|||
27908964|NCT01215916|54566667|FG006|Overall Study|Physician Decision|0|||
27908965|NCT01215916|54566668|FG007|Overall Study|Physician Decision|0|||
27908966|NCT01215916|54566669|FG008|Overall Study|Physician Decision|0|||
27908967|NCT01184872|54566695|FG000|Overall Study|Adverse Event|3|||
27908968|NCT01184872|54566696|FG001|Overall Study|Adverse Event|4|||
27908969|NCT01184872|54566695|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
27908970|NCT01184872|54566696|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
27908971|NCT01184872|54566695|FG000|Overall Study|Withdrawal by Subject|2|||
27908972|NCT01184872|54566696|FG001|Overall Study|Withdrawal by Subject|0|||
27908973|NCT01184872|54566695|FG000|Overall Study|Lost to Follow-up|0|||
27908974|NCT01184872|54566696|FG001|Overall Study|Lost to Follow-up|1|||
27908975|NCT01184872|54566695|FG000|Overall Study|Administrative problems|1|||
27908976|NCT01184872|54566696|FG001|Overall Study|Administrative problems|1|||
27908977|NCT01184872|54566695|FG000|Overall Study|Protocol deviation|1|||
27908978|NCT01184872|54566696|FG001|Overall Study|Protocol deviation|0|||
27908979|NCT01215721|54566702|FG000|Overall Study|Adverse Event|2|||
27908980|NCT01184326|54566709|FG000|Overall Study|Adverse Event|1|||
27908981|NCT01184326|54566710|FG001|Overall Study|Adverse Event|2|||
27908982|NCT01184326|54566711|FG002|Overall Study|Adverse Event|0|||
27908983|NCT01184326|54566709|FG000|Overall Study|Death|0|||
27908984|NCT01184326|54566710|FG001|Overall Study|Death|0|||
27908985|NCT01184326|54566711|FG002|Overall Study|Death|1|||
27908986|NCT01184326|54566709|FG000|Overall Study|Withdrawal by Subject|0|||
27908987|NCT01184326|54566710|FG001|Overall Study|Withdrawal by Subject|0|||
27908988|NCT01184326|54566711|FG002|Overall Study|Withdrawal by Subject|1|||
27908989|NCT01184326|54566709|FG000|Overall Study|Physician Decision|1|||
27908990|NCT01184326|54566710|FG001|Overall Study|Physician Decision|1|||
27908991|NCT01184326|54566711|FG002|Overall Study|Physician Decision|0|||
27908992|NCT01184326|54566709|FG000|Overall Study|Disease Progression|1|||
27908993|NCT01184326|54566710|FG001|Overall Study|Disease Progression|3|||
27908994|NCT01184326|54566711|FG002|Overall Study|Disease Progression|12|||
27908995|NCT01215253|54566724|FG000|Overall Study|Withdrawal by Subject|57|||
27908996|NCT01215253|54566725|FG001|Overall Study|Withdrawal by Subject|35|||
27908997|NCT01215253|54566724|FG000|Overall Study|Physician Decision|9|||
27908998|NCT01215253|54566725|FG001|Overall Study|Physician Decision|12|||
27908999|NCT01215253|54566724|FG000|Overall Study|Lost to Follow-up|6|||
27909000|NCT01215253|54566725|FG001|Overall Study|Lost to Follow-up|4|||
27909001|NCT01215253|54566724|FG000|Overall Study|Other|14|||
27909002|NCT01215253|54566725|FG001|Overall Study|Other|12|||
27992996|NCT00809133|54651617|FG006|Overall Study|Consent withdrawn|0|||
27992997|NCT00809133|54651618|FG007|Overall Study|Consent withdrawn|0|||
27992998|NCT00809133|54651619|FG008|Overall Study|Consent withdrawn|0|||
27992999|NCT00809133|54651620|FG009|Overall Study|Consent withdrawn|0|||
27993000|NCT00809133|54651621|FG010|Overall Study|Consent withdrawn|0|||
27993001|NCT00809133|54651622|FG011|Overall Study|Consent withdrawn|0|||
27993002|NCT00809133|54651623|FG012|Overall Study|Consent withdrawn|0|||
27993003|NCT00809133|54651624|FG013|Overall Study|Consent withdrawn|0|||
27993004|NCT00809133|54651611|FG000|Overall Study|Other not mentioned above|0|||
27993005|NCT00809133|54651612|FG001|Overall Study|Other not mentioned above|1|||
27993006|NCT00809133|54651613|FG002|Overall Study|Other not mentioned above|0|||
27993007|NCT00809133|54651614|FG003|Overall Study|Other not mentioned above|0|||
27993008|NCT00809133|54651615|FG004|Overall Study|Other not mentioned above|0|||
27993009|NCT00809133|54651616|FG005|Overall Study|Other not mentioned above|1|||
27993010|NCT00809133|54651617|FG006|Overall Study|Other not mentioned above|0|||
27993011|NCT00809133|54651618|FG007|Overall Study|Other not mentioned above|0|||
27993012|NCT00809133|54651619|FG008|Overall Study|Other not mentioned above|0|||
27993013|NCT00809133|54651620|FG009|Overall Study|Other not mentioned above|0|||
27993014|NCT00809133|54651621|FG010|Overall Study|Other not mentioned above|0|||
27993015|NCT00809133|54651622|FG011|Overall Study|Other not mentioned above|0|||
27993016|NCT00809133|54651623|FG012|Overall Study|Other not mentioned above|0|||
27993017|NCT00809133|54651624|FG013|Overall Study|Other not mentioned above|0|||
27993018|NCT00882557|54651669|FG000|Overall Study|Withdrawal by Subject|1|||
27993019|NCT00882557|54651670|FG001|Overall Study|Withdrawal by Subject|0|||
27993020|NCT00882557|54651669|FG000|Overall Study|Trouble with Vein Access|1|||
27909003|NCT01184053|54566732|FG000|Overall Study|progression while on treatment|3|||
27909004|NCT01183975|54566737|FG000|Overall Study|Lost to Follow-up|73|||
27909005|NCT01183858|54566743|FG000|Overall Study|Death not related to Progressive Disease|5|||
27909006|NCT01183858|54566744|FG001|Overall Study|Death not related to Progressive Disease|6|||
27909007|NCT01183858|54566743|FG000|Overall Study|Adverse Event|14|||
27909008|NCT01183858|54566744|FG001|Overall Study|Adverse Event|11|||
27993021|NCT00882557|54651670|FG001|Overall Study|Trouble with Vein Access|0|||
27993022|NCT00882557|54651669|FG000|Overall Study|Randomized Not Treated|0|||
27993023|NCT00882557|54651670|FG001|Overall Study|Randomized Not Treated|1|||
27993024|NCT00808899|54651676|FG000|Overall Study|Death|1|||
27993025|NCT00808899|54651676|FG000|Overall Study|Physician Decision|3|||
27993026|NCT00808665|54651682|FG000|Overall Study|Withdrawal by Subject|1|||
27993027|NCT00808665|54651683|FG001|Overall Study|Withdrawal by Subject|0|||
27993028|NCT00808665|54651682|FG000|Overall Study|only required minimally invasive surgery|1|||
27993029|NCT00808665|54651683|FG001|Overall Study|only required minimally invasive surgery|0|||
27993030|NCT00808665|54651682|FG000|Overall Study|surgery cancelled|1|||
27993031|NCT00808665|54651683|FG001|Overall Study|surgery cancelled|0|||
27993032|NCT00808665|54651682|FG000|Overall Study|required an additional procedure|0|||
28098058|NCT03614156|54753841|FG001|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
28098059|NCT03614156|54753842|FG002|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3|||
28098060|NCT03614156|54753843|FG003|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4|||
28098061|NCT03614156|54753840|FG000|Double-Blind Treatment Period (DBTP)|Protocol Violation|0|||
28098062|NCT03614156|54753841|FG001|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
27909009|NCT01183858|54566743|FG000|Overall Study|Investigator's Decision|0|||
27909010|NCT01183858|54566744|FG001|Overall Study|Investigator's Decision|3|||
27909011|NCT01183858|54566743|FG000|Overall Study|Insufficient Therapeutic Response|2|||
27909012|NCT01183858|54566744|FG001|Overall Study|Insufficient Therapeutic Response|0|||
27909013|NCT01183858|54566743|FG000|Overall Study|Refused Treatment|1|||
27909014|NCT01183858|54566744|FG001|Overall Study|Refused Treatment|4|||
27909015|NCT01183858|54566743|FG000|Overall Study|Withdrew Consent|4|||
27909016|NCT01183858|54566744|FG001|Overall Study|Withdrew Consent|4|||
27909017|NCT01183858|54566743|FG000|Overall Study|Discontinued Smoking|3|||
27909018|NCT01183858|54566744|FG001|Overall Study|Discontinued Smoking|1|||
27909019|NCT01183858|54566743|FG000|Overall Study|Protocol Violation|1|||
27909020|NCT01183858|54566744|FG001|Overall Study|Protocol Violation|0|||
27909021|NCT01183858|54566743|FG000|Overall Study|Administrative/Other|6|||
27909022|NCT01183858|54566744|FG001|Overall Study|Administrative/Other|6|||
27909023|NCT01183858|54566743|FG000|Overall Study|Progressive Disease|112|||
27909024|NCT01183858|54566744|FG001|Overall Study|Progressive Disease|115|||
27909025|NCT01183858|54566743|FG000|Overall Study|Death related to Progressive Disease|4|||
27909026|NCT01183858|54566744|FG001|Overall Study|Death related to Progressive Disease|5|||
27909027|NCT01183858|54566743|FG000|Overall Study|Lost to Follow-up|1|||
27909028|NCT01183858|54566744|FG001|Overall Study|Lost to Follow-up|1|||
27909029|NCT01215175|54566755|FG000|Overall Study|Lost to Follow-up|0|||
27909030|NCT01215175|54566756|FG001|Overall Study|Lost to Follow-up|1|||
27909031|NCT01215175|54566757|FG002|Overall Study|Lost to Follow-up|0|||
27909032|NCT01215175|54566758|FG003|Overall Study|Lost to Follow-up|1|||
27909033|NCT01215175|54566759|FG004|Overall Study|Lost to Follow-up|0|||
27909034|NCT01215097|54566773|FG000|Overall Study|Adverse Event|1|||
27993033|NCT00808665|54651683|FG001|Overall Study|required an additional procedure|1|||
27993034|NCT00808665|54651682|FG000|Overall Study|Physician Decision|3|||
27909035|NCT01215097|54566774|FG001|Overall Study|Adverse Event|3|||
27909036|NCT01215097|54566773|FG000|Overall Study|Protocol Violation|0|||
27909037|NCT01215097|54566774|FG001|Overall Study|Protocol Violation|2|||
27909038|NCT01215097|54566773|FG000|Overall Study|Lost to Follow-up|2|||
27909039|NCT01215097|54566774|FG001|Overall Study|Lost to Follow-up|0|||
27909040|NCT01215097|54566773|FG000|Overall Study|Withdrawal by Subject|6|||
27909041|NCT01215097|54566774|FG001|Overall Study|Withdrawal by Subject|3|||
27909042|NCT01215097|54566773|FG000|Overall Study|Lack of Efficacy|0|||
27909043|NCT01215097|54566774|FG001|Overall Study|Lack of Efficacy|3|||
27909044|NCT01215097|54566773|FG000|Overall Study|patient's refusal to come|2|||
27909045|NCT01215097|54566774|FG001|Overall Study|patient's refusal to come|2|||
27909046|NCT01215097|54566773|FG000|Overall Study|patient's private reason|1|||
27909047|NCT01215097|54566774|FG001|Overall Study|patient's private reason|1|||
27909048|NCT03303339|54566792|FG000|Overall Study|Death|2|||
27909049|NCT03303339|54566793|FG001|Overall Study|Death|2|||
27909050|NCT03303339|54566794|FG002|Overall Study|Death|2|||
27909051|NCT03303339|54566795|FG003|Overall Study|Death|1|||
27909052|NCT03303339|54566796|FG004|Overall Study|Death|4|||
27909053|NCT03303339|54566797|FG005|Overall Study|Death|2|||
27909054|NCT03303339|54566798|FG006|Overall Study|Death|2|||
27909055|NCT03303339|54566799|FG007|Overall Study|Death|2|||
27909056|NCT03303339|54566800|FG008|Overall Study|Death|3|||
27909057|NCT03303339|54566801|FG009|Overall Study|Death|3|||
27909058|NCT03303339|54566802|FG010|Overall Study|Death|4|||
27909059|NCT03303339|54566803|FG011|Overall Study|Death|24|||
27993035|NCT00808665|54651683|FG001|Overall Study|Physician Decision|1|||
27993036|NCT00808665|54651682|FG000|Overall Study|Medication stopped by resident|0|||
27993037|NCT00808665|54651683|FG001|Overall Study|Medication stopped by resident|1|||
27993038|NCT00808509|54651691|FG000|Randomized Phase|Did not meet eligibility criteria|1|||
27993039|NCT00808509|54651692|FG001|Randomized Phase|Did not meet eligibility criteria|0|||
27993040|NCT00808509|54651691|FG000|Randomized Phase|Reduced methotrexate dose|1|||
27993041|NCT00808509|54651692|FG001|Randomized Phase|Reduced methotrexate dose|2|||
27993042|NCT00808509|54651691|FG000|Randomized Phase|Patient refused rescue therapy|0|||
27993043|NCT00808509|54651692|FG001|Randomized Phase|Patient refused rescue therapy|3|||
27993044|NCT00807885|54651709|FG000|Overall Study|Lost to Follow-up|0|||
28098063|NCT03614156|54753842|FG002|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
28098064|NCT03614156|54753843|FG003|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
28098065|NCT03614156|54753840|FG000|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0|||
28098066|NCT03614156|54753841|FG001|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22|||
28098067|NCT03614156|54753842|FG002|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26|||
28098068|NCT03614156|54753843|FG003|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38|||
28098069|NCT03614156|54753840|FG000|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
28098070|NCT03614156|54753841|FG001|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1|||
28098071|NCT03614156|54753842|FG002|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
28098072|NCT03614156|54753843|FG003|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
28098073|NCT03614156|54753840|FG000|Safety Follow-Up Period|Miscellaneous Reasons|2|||
28098074|NCT03614156|54753841|FG001|Safety Follow-Up Period|Miscellaneous Reasons|0|||
28098075|NCT03614156|54753842|FG002|Safety Follow-Up Period|Miscellaneous Reasons|0|||
28098076|NCT03614156|54753843|FG003|Safety Follow-Up Period|Miscellaneous Reasons|0|||
28098077|NCT03614156|54753840|FG000|Safety Follow-Up Period|Withdrawal by Subject|0|||
28098078|NCT03614156|54753841|FG001|Safety Follow-Up Period|Withdrawal by Subject|0|||
28098079|NCT03614156|54753842|FG002|Safety Follow-Up Period|Withdrawal by Subject|1|||
28098080|NCT03614156|54753843|FG003|Safety Follow-Up Period|Withdrawal by Subject|0|||
28098081|NCT03614156|54753840|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
28098082|NCT03614156|54753841|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
28098083|NCT03614156|54753842|FG002|Safety Follow-Up Period|Lost to Follow-up|0|||
28098084|NCT03614156|54753843|FG003|Safety Follow-Up Period|Lost to Follow-up|1|||
28098085|NCT03614078|54753855|FG000|Overall Study|Withdrawal by Subject|2|||
28098086|NCT03614078|54753856|FG001|Overall Study|Withdrawal by Subject|2|||
28098087|NCT03614078|54753857|FG002|Overall Study|Withdrawal by Subject|3|||
28098088|NCT03614078|54753855|FG000|Overall Study|Participant Did Not Return for Visit|0|||
28098089|NCT03614078|54753856|FG001|Overall Study|Participant Did Not Return for Visit|1|||
28098090|NCT03614078|54753857|FG002|Overall Study|Participant Did Not Return for Visit|0|||
28172574|NCT02435914|54844304|FG000|Overall Study|Ocular Adverse Event|1|||
28172575|NCT02435914|54844305|FG001|Overall Study|Ocular Adverse Event|0|||
27909060|NCT03303339|54566792|FG000|Overall Study|Study Terminated by Sponsor|0|||
28098091|NCT03614078|54753855|FG000|Overall Study|High Neutrophils|0|||
28098092|NCT03614078|54753856|FG001|Overall Study|High Neutrophils|0|||
28098093|NCT03614078|54753857|FG002|Overall Study|High Neutrophils|2|||
28172576|NCT02435914|54844306|FG002|Overall Study|Ocular Adverse Event|0|||
28172577|NCT02435914|54844307|FG003|Overall Study|Ocular Adverse Event|0|||
27909061|NCT03303339|54566793|FG001|Overall Study|Study Terminated by Sponsor|0|||
27909062|NCT03303339|54566794|FG002|Overall Study|Study Terminated by Sponsor|0|||
27909063|NCT03303339|54566795|FG003|Overall Study|Study Terminated by Sponsor|0|||
27993045|NCT00807885|54651710|FG001|Overall Study|Lost to Follow-up|0|||
27993046|NCT00807885|54651711|FG002|Overall Study|Lost to Follow-up|0|||
27993047|NCT00807885|54651712|FG003|Overall Study|Lost to Follow-up|0|||
27993048|NCT00807885|54651713|FG004|Overall Study|Lost to Follow-up|0|||
27993049|NCT00807885|54651714|FG005|Overall Study|Lost to Follow-up|1|||
27993050|NCT00807885|54651715|FG006|Overall Study|Lost to Follow-up|0|||
27993051|NCT00807885|54651716|FG007|Overall Study|Lost to Follow-up|0|||
27993052|NCT00807885|54651717|FG008|Overall Study|Lost to Follow-up|0|||
27993053|NCT00807573|54651737|FG000|Overall Study|Withdrawal by Subject|1|||
27993054|NCT00807573|54651737|FG000|Overall Study|Adverse Event|1|||
27993055|NCT00842712|54651748|FG000|Safety Run-in Part|Adverse Event|0|||
27993056|NCT00842712|54651749|FG001|Safety Run-in Part|Adverse Event|1|||
27993057|NCT00842712|54651750|FG002|Safety Run-in Part|Adverse Event|0|||
27993058|NCT00842712|54651751|FG003|Safety Run-in Part|Adverse Event|0|||
27993059|NCT00842712|54651752|FG004|Safety Run-in Part|Adverse Event|0|||
27993060|NCT00842712|54651753|FG005|Safety Run-in Part|Adverse Event|0|||
27993061|NCT00842712|54651754|FG006|Safety Run-in Part|Adverse Event|0|||
27909064|NCT03303339|54566796|FG004|Overall Study|Study Terminated by Sponsor|0|||
27909065|NCT03303339|54566797|FG005|Overall Study|Study Terminated by Sponsor|0|||
27909066|NCT03303339|54566798|FG006|Overall Study|Study Terminated by Sponsor|0|||
27909067|NCT03303339|54566799|FG007|Overall Study|Study Terminated by Sponsor|0|||
27993062|NCT00842712|54651748|FG000|Safety Run-in Part|Progressive disease|3|||
27993063|NCT00842712|54651749|FG001|Safety Run-in Part|Progressive disease|1|||
27993064|NCT00842712|54651750|FG002|Safety Run-in Part|Progressive disease|0|||
28098094|NCT03614078|54753855|FG000|Overall Study|Patient Did Not Meet Eligibility|1|||
28098095|NCT03614078|54753856|FG001|Overall Study|Patient Did Not Meet Eligibility|0|||
28098096|NCT03614078|54753857|FG002|Overall Study|Patient Did Not Meet Eligibility|0|||
28098097|NCT03614078|54753855|FG000|Overall Study|Exacerbation of Psoriasis|0|||
28098098|NCT03614078|54753856|FG001|Overall Study|Exacerbation of Psoriasis|1|||
28098099|NCT03614078|54753857|FG002|Overall Study|Exacerbation of Psoriasis|0|||
28098100|NCT03614078|54753855|FG000|Overall Study|Adverse Event|0|||
28098101|NCT03614078|54753856|FG001|Overall Study|Adverse Event|2|||
28098102|NCT03614078|54753857|FG002|Overall Study|Adverse Event|0|||
28098103|NCT03614078|54753855|FG000|Overall Study|Dizziness and Rash|0|||
28098104|NCT03614078|54753856|FG001|Overall Study|Dizziness and Rash|1|||
28098105|NCT03614078|54753857|FG002|Overall Study|Dizziness and Rash|0|||
28098106|NCT03613454|54753867|FG000|Overall Study|Protocol Violation|1|||
28098107|NCT03613454|54753868|FG001|Overall Study|Protocol Violation|0|||
28098108|NCT03613454|54753867|FG000|Overall Study|Protocol Violation|0|||
28098109|NCT03613454|54753868|FG001|Overall Study|Protocol Violation|1|||
28098110|NCT03581786|54753876|FG000|Overall Study|Death|17|||
28098111|NCT03581786|54753877|FG001|Overall Study|Death|12|||
28098112|NCT03581786|54753876|FG000|Overall Study|Withdrawal by Subject|2|||
28098113|NCT03581786|54753877|FG001|Overall Study|Withdrawal by Subject|4|||
28098114|NCT03581786|54753876|FG000|Overall Study|Lost to Follow-up|1|||
28098115|NCT03581786|54753877|FG001|Overall Study|Lost to Follow-up|0|||
28098116|NCT03581786|54753876|FG000|Overall Study|reason other than specified above|0|||
28098117|NCT03581786|54753877|FG001|Overall Study|reason other than specified above|1|||
28098118|NCT03581786|54753876|FG000|Overall Study|Ongoing in the study|123|||
28098119|NCT03581786|54753877|FG001|Overall Study|Ongoing in the study|129|||
28098120|NCT03580382|54753885|FG000|Overall Study|Early Termination of Study|0|||
28098121|NCT03580382|54753886|FG001|Overall Study|Early Termination of Study|3|||
28098122|NCT03579290|54753891|FG000|Overall Study|Lost to Follow-up|9|||
28098123|NCT03611582|54753897|FG000|Overall Study|Adverse Event|26|||
28098124|NCT03611582|54753898|FG001|Overall Study|Adverse Event|6|||
28098125|NCT03611582|54753897|FG000|Overall Study|Protocol Violation|0|||
28098126|NCT03611582|54753898|FG001|Overall Study|Protocol Violation|1|||
27909068|NCT03303339|54566800|FG008|Overall Study|Study Terminated by Sponsor|1|||
27909069|NCT03303339|54566801|FG009|Overall Study|Study Terminated by Sponsor|0|||
27909070|NCT03303339|54566802|FG010|Overall Study|Study Terminated by Sponsor|1|||
27909071|NCT03303339|54566803|FG011|Overall Study|Study Terminated by Sponsor|1|||
27909072|NCT03303339|54566792|FG000|Overall Study|Withdrawal by Subject|1|||
27909073|NCT03303339|54566793|FG001|Overall Study|Withdrawal by Subject|0|||
27909074|NCT03303339|54566794|FG002|Overall Study|Withdrawal by Subject|0|||
27909075|NCT03303339|54566795|FG003|Overall Study|Withdrawal by Subject|0|||
27993065|NCT00842712|54651751|FG003|Safety Run-in Part|Progressive disease|1|||
27993066|NCT00842712|54651752|FG004|Safety Run-in Part|Progressive disease|0|||
28098127|NCT03611582|54753897|FG000|Overall Study|Pregnancy|1|||
28098128|NCT03611582|54753898|FG001|Overall Study|Pregnancy|2|||
28098129|NCT03611582|54753897|FG000|Overall Study|Lack of Efficacy|0|||
28098130|NCT03611582|54753898|FG001|Overall Study|Lack of Efficacy|1|||
28098131|NCT03611582|54753897|FG000|Overall Study|At the discretion of the investigator|1|||
28098132|NCT03611582|54753898|FG001|Overall Study|At the discretion of the investigator|0|||
27909076|NCT03303339|54566796|FG004|Overall Study|Withdrawal by Subject|0|||
27993067|NCT00842712|54651753|FG005|Safety Run-in Part|Progressive disease|0|||
27993068|NCT00842712|54651754|FG006|Safety Run-in Part|Progressive disease|0|||
27993069|NCT00842712|54651748|FG000|Randomized Part|Randomized but not treated|0|||
27993070|NCT00842712|54651749|FG001|Randomized Part|Randomized but not treated|0|||
27993071|NCT00842712|54651750|FG002|Randomized Part|Randomized but not treated|0|||
27993072|NCT00842712|54651751|FG003|Randomized Part|Randomized but not treated|0|||
27993073|NCT00842712|54651752|FG004|Randomized Part|Randomized but not treated|0|||
27993074|NCT00842712|54651753|FG005|Randomized Part|Randomized but not treated|1|||
27993075|NCT00842712|54651754|FG006|Randomized Part|Randomized but not treated|4|||
27993076|NCT00842712|54651748|FG000|Randomized Part|Ongoing at cut-off date|0|||
27993077|NCT00842712|54651749|FG001|Randomized Part|Ongoing at cut-off date|0|||
27993078|NCT00842712|54651750|FG002|Randomized Part|Ongoing at cut-off date|0|||
27993079|NCT00842712|54651751|FG003|Randomized Part|Ongoing at cut-off date|0|||
27993080|NCT00842712|54651752|FG004|Randomized Part|Ongoing at cut-off date|0|||
27993081|NCT00842712|54651753|FG005|Randomized Part|Ongoing at cut-off date|0|||
27993082|NCT00842712|54651754|FG006|Randomized Part|Ongoing at cut-off date|2|||
27993083|NCT00842244|54651770|FG000|Overall Study|Death|3|||
27993084|NCT00842244|54651770|FG000|Overall Study|Withdrawal by Subject|1|||
27993085|NCT00842244|54651770|FG000|Overall Study|Other|17|||
27993086|NCT00832416|54651781|FG000|Overall Study|Lack of Efficacy|17|||
27993087|NCT00832416|54651782|FG001|Overall Study|Lack of Efficacy|15|||
27993088|NCT00832416|54651783|FG002|Overall Study|Lack of Efficacy|13|||
27993089|NCT00832416|54651784|FG003|Overall Study|Lack of Efficacy|52|||
27993090|NCT00832416|54651781|FG000|Overall Study|Withdrawal by Subject|5|||
27993091|NCT00832416|54651782|FG001|Overall Study|Withdrawal by Subject|7|||
27993092|NCT00832416|54651783|FG002|Overall Study|Withdrawal by Subject|2|||
27993093|NCT00832416|54651784|FG003|Overall Study|Withdrawal by Subject|10|||
27993094|NCT00832416|54651781|FG000|Overall Study|Physician Decision|2|||
27993095|NCT00832416|54651782|FG001|Overall Study|Physician Decision|12|||
27993096|NCT00832416|54651783|FG002|Overall Study|Physician Decision|5|||
27993097|NCT00832416|54651784|FG003|Overall Study|Physician Decision|10|||
27993098|NCT00832416|54651781|FG000|Overall Study|Administrative|0|||
27993099|NCT00832416|54651782|FG001|Overall Study|Administrative|0|||
27993100|NCT00832416|54651783|FG002|Overall Study|Administrative|0|||
27993101|NCT00832416|54651784|FG003|Overall Study|Administrative|1|||
27993102|NCT00832416|54651781|FG000|Overall Study|Adverse Event|21|||
27993103|NCT00832416|54651782|FG001|Overall Study|Adverse Event|19|||
27993104|NCT00832416|54651783|FG002|Overall Study|Adverse Event|41|||
27993105|NCT00832416|54651784|FG003|Overall Study|Adverse Event|10|||
27993106|NCT00832416|54651781|FG000|Overall Study|Death|1|||
27993107|NCT00832416|54651782|FG001|Overall Study|Death|0|||
27993108|NCT00832416|54651783|FG002|Overall Study|Death|0|||
27993109|NCT00832416|54651784|FG003|Overall Study|Death|0|||
27993110|NCT00841776|54651796|FG000|Overall Study|Lack of Efficacy|0|||
27993111|NCT00841776|54651797|FG001|Overall Study|Lack of Efficacy|1|||
27993112|NCT00841776|54651796|FG000|Overall Study|Lost to Follow-up|2|||
27993113|NCT00841776|54651797|FG001|Overall Study|Lost to Follow-up|1|||
27993114|NCT00841776|54651796|FG000|Overall Study|Withdrawal by Subject|0|||
27993115|NCT00841776|54651797|FG001|Overall Study|Withdrawal by Subject|1|||
27993116|NCT00683800|54651805|FG000|Overall Study|Adverse Event|195|||
27993117|NCT00683800|54651806|FG001|Overall Study|Adverse Event|102|||
27993118|NCT00683800|54651805|FG000|Overall Study|Death|0|||
27993119|NCT00683800|54651806|FG001|Overall Study|Death|1|||
27993120|NCT00683800|54651805|FG000|Overall Study|Lost to Follow-up|57|||
27993121|NCT00683800|54651806|FG001|Overall Study|Lost to Follow-up|44|||
27993122|NCT00683800|54651805|FG000|Overall Study|Other|5|||
27909077|NCT03303339|54566797|FG005|Overall Study|Withdrawal by Subject|1|||
27909078|NCT03303339|54566798|FG006|Overall Study|Withdrawal by Subject|1|||
27909079|NCT03303339|54566799|FG007|Overall Study|Withdrawal by Subject|0|||
27909080|NCT03303339|54566800|FG008|Overall Study|Withdrawal by Subject|0|||
27909081|NCT03303339|54566801|FG009|Overall Study|Withdrawal by Subject|0|||
27909082|NCT03303339|54566802|FG010|Overall Study|Withdrawal by Subject|0|||
27909083|NCT03303339|54566803|FG011|Overall Study|Withdrawal by Subject|2|||
27909084|NCT03303339|54566792|FG000|Overall Study|Physician Decision|0|||
27909085|NCT03303339|54566793|FG001|Overall Study|Physician Decision|0|||
27909086|NCT03303339|54566794|FG002|Overall Study|Physician Decision|0|||
27993123|NCT00683800|54651806|FG001|Overall Study|Other|2|||
27993124|NCT00683800|54651805|FG000|Overall Study|Protocol Violation|13|||
27993125|NCT00683800|54651806|FG001|Overall Study|Protocol Violation|16|||
27993126|NCT00683800|54651805|FG000|Overall Study|Withdrawal by Subject|66|||
27993127|NCT00683800|54651806|FG001|Overall Study|Withdrawal by Subject|64|||
27993128|NCT00683800|54651805|FG000|Overall Study|Lack of Efficacy|61|||
27993129|NCT00683800|54651806|FG001|Overall Study|Lack of Efficacy|104|||
27993130|NCT00683800|54651805|FG000|Overall Study|Randomized, not treated|35|||
27993131|NCT00683800|54651806|FG001|Overall Study|Randomized, not treated|33|||
27993132|NCT00683644|54651814|FG000|Overall Study|Withdrawal by Subject|4|||
27993133|NCT00683644|54651815|FG001|Overall Study|Withdrawal by Subject|2|||
27993134|NCT00683644|54651814|FG000|Overall Study|Lost to Follow-up|1|||
27993135|NCT00683644|54651815|FG001|Overall Study|Lost to Follow-up|4|||
27993136|NCT00683644|54651814|FG000|Overall Study|Adverse Event|1|||
27993137|NCT00683644|54651815|FG001|Overall Study|Adverse Event|2|||
27993138|NCT00683644|54651814|FG000|Overall Study|Low copper, other health problems,|7|||
27993139|NCT00683644|54651815|FG001|Overall Study|Low copper, other health problems,|6|||
27993140|NCT00685360|54651828|FG000|Overall Study|Lost to Follow-up|0|||
27993141|NCT00685360|54651829|FG001|Overall Study|Lost to Follow-up|1|||
27993142|NCT00685360|54651830|FG002|Overall Study|Lost to Follow-up|2|||
27993143|NCT00685360|54651828|FG000|Overall Study|Adverse Event|4|||
27993144|NCT00685360|54651829|FG001|Overall Study|Adverse Event|6|||
27993145|NCT00685360|54651830|FG002|Overall Study|Adverse Event|4|||
27993146|NCT00685360|54651828|FG000|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|1|||
27993147|NCT00685360|54651829|FG001|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|0|||
27993148|NCT00685360|54651830|FG002|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|2|||
27993149|NCT00685360|54651828|FG000|Overall Study|Subject was Withdrawn From Participation by the Investigator|0|||
27993150|NCT00685360|54651829|FG001|Overall Study|Subject was Withdrawn From Participation by the Investigator|4|||
27993151|NCT00685360|54651830|FG002|Overall Study|Subject was Withdrawn From Participation by the Investigator|1|||
27993152|NCT00685360|54651828|FG000|Overall Study|Subject Withdrew Consent to Participate|13|||
27993153|NCT00685360|54651829|FG001|Overall Study|Subject Withdrew Consent to Participate|2|||
28098133|NCT03611582|54753897|FG000|Overall Study|Safety concern as judged by the investigator|1|||
28098134|NCT03611582|54753898|FG001|Overall Study|Safety concern as judged by the investigator|2|||
28098135|NCT03611582|54753897|FG000|Overall Study|Withdrawal by Subject|4|||
27993154|NCT00685360|54651830|FG002|Overall Study|Subject Withdrew Consent to Participate|5|||
27993155|NCT00685360|54651828|FG000|Overall Study|Protocol Deviation|0|||
27993156|NCT00685360|54651829|FG001|Overall Study|Protocol Deviation|1|||
27993157|NCT00685360|54651830|FG002|Overall Study|Protocol Deviation|1|||
27993158|NCT00684814|54651838|FG000|Washout Period of 7 Days|Adverse Event|1|||
27993159|NCT00684814|54651839|FG001|Washout Period of 7 Days|Adverse Event|2|||
27993160|NCT00684814|54651838|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
27993161|NCT00684814|54651839|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
27993162|NCT00684814|54651838|FG000|Second Intervention|Adverse Event|1|||
27993163|NCT00684814|54651839|FG001|Second Intervention|Adverse Event|0|||
27993164|NCT00576472|54651860|FG000|MPH In-Lab Phase|Declined participation in medication pha|0|||
27993165|NCT00576472|54651861|FG001|MPH In-Lab Phase|Declined participation in medication pha|0|||
27993166|NCT00576472|54651862|FG002|MPH In-Lab Phase|Declined participation in medication pha|0|||
27993167|NCT00576472|54651863|FG003|MPH In-Lab Phase|Declined participation in medication pha|75|||
27993168|NCT00576472|54651864|FG004|MPH In-Lab Phase|Declined participation in medication pha|0|||
27993169|NCT00576472|54651865|FG005|MPH In-Lab Phase|Declined participation in medication pha|0|||
27993170|NCT00576472|54651866|FG006|MPH In-Lab Phase|Declined participation in medication pha|0|||
27993171|NCT00576472|54651867|FG007|MPH In-Lab Phase|Declined participation in medication pha|0|||
27993172|NCT00576472|54651868|FG008|MPH In-Lab Phase|Declined participation in medication pha|0|||
27993173|NCT00576472|54651869|FG009|MPH In-Lab Phase|Declined participation in medication pha|0|||
27993174|NCT00576472|54651870|FG010|MPH In-Lab Phase|Declined participation in medication pha|0|||
27993175|NCT00576472|54651871|FG011|MPH In-Lab Phase|Declined participation in medication pha|0|||
27993176|NCT00576472|54651872|FG012|MPH In-Lab Phase|Declined participation in medication pha|0|||
27993177|NCT00576472|54651873|FG013|MPH In-Lab Phase|Declined participation in medication pha|0|||
27993178|NCT00576472|54651874|FG014|MPH In-Lab Phase|Declined participation in medication pha|0|||
27993179|NCT00576472|54651860|FG000|MPH In-Lab Phase|Lost to Follow-up|0|||
27993180|NCT00576472|54651861|FG001|MPH In-Lab Phase|Lost to Follow-up|0|||
27993181|NCT00576472|54651862|FG002|MPH In-Lab Phase|Lost to Follow-up|0|||
27993182|NCT00576472|54651863|FG003|MPH In-Lab Phase|Lost to Follow-up|1|||
27909087|NCT03303339|54566795|FG003|Overall Study|Physician Decision|0|||
27909088|NCT03303339|54566796|FG004|Overall Study|Physician Decision|1|||
27909089|NCT03303339|54566797|FG005|Overall Study|Physician Decision|0|||
27909090|NCT03303339|54566798|FG006|Overall Study|Physician Decision|0|||
27909091|NCT03303339|54566799|FG007|Overall Study|Physician Decision|0|||
27909092|NCT03303339|54566800|FG008|Overall Study|Physician Decision|0|||
27909093|NCT03303339|54566801|FG009|Overall Study|Physician Decision|0|||
27909094|NCT03303339|54566802|FG010|Overall Study|Physician Decision|0|||
27909095|NCT03303339|54566803|FG011|Overall Study|Physician Decision|0|||
27909096|NCT03303339|54566792|FG000|Overall Study|Safety/Non-compliance|0|||
27909097|NCT03303339|54566793|FG001|Overall Study|Safety/Non-compliance|0|||
27909098|NCT03303339|54566794|FG002|Overall Study|Safety/Non-compliance|0|||
27909099|NCT03303339|54566795|FG003|Overall Study|Safety/Non-compliance|0|||
27909100|NCT03303339|54566796|FG004|Overall Study|Safety/Non-compliance|0|||
27909101|NCT03303339|54566797|FG005|Overall Study|Safety/Non-compliance|0|||
27909102|NCT03303339|54566798|FG006|Overall Study|Safety/Non-compliance|0|||
27909103|NCT03303339|54566799|FG007|Overall Study|Safety/Non-compliance|0|||
27993183|NCT00576472|54651864|FG004|MPH In-Lab Phase|Lost to Follow-up|0|||
27993184|NCT00576472|54651865|FG005|MPH In-Lab Phase|Lost to Follow-up|0|||
27993185|NCT00576472|54651866|FG006|MPH In-Lab Phase|Lost to Follow-up|0|||
27993186|NCT00576472|54651867|FG007|MPH In-Lab Phase|Lost to Follow-up|0|||
28098136|NCT03611582|54753898|FG001|Overall Study|Withdrawal by Subject|3|||
27909104|NCT03303339|54566800|FG008|Overall Study|Safety/Non-compliance|0|||
27909105|NCT03303339|54566801|FG009|Overall Study|Safety/Non-compliance|0|||
27993187|NCT00576472|54651868|FG008|MPH In-Lab Phase|Lost to Follow-up|0|||
27993188|NCT00576472|54651869|FG009|MPH In-Lab Phase|Lost to Follow-up|0|||
27993189|NCT00576472|54651870|FG010|MPH In-Lab Phase|Lost to Follow-up|0|||
27993190|NCT00576472|54651871|FG011|MPH In-Lab Phase|Lost to Follow-up|0|||
27993191|NCT00576472|54651872|FG012|MPH In-Lab Phase|Lost to Follow-up|0|||
27993192|NCT00576472|54651873|FG013|MPH In-Lab Phase|Lost to Follow-up|0|||
27993193|NCT00576472|54651874|FG014|MPH In-Lab Phase|Lost to Follow-up|0|||
27993194|NCT00576472|54651860|FG000|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
27993195|NCT00576472|54651861|FG001|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
27993196|NCT00576472|54651862|FG002|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
27993197|NCT00576472|54651863|FG003|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4|||
27993198|NCT00576472|54651864|FG004|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
27993199|NCT00576472|54651865|FG005|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
27993200|NCT00576472|54651866|FG006|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
27993201|NCT00576472|54651867|FG007|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
27993202|NCT00576472|54651868|FG008|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
27993203|NCT00576472|54651869|FG009|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
27993204|NCT00576472|54651870|FG010|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
27993205|NCT00576472|54651871|FG011|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
27993206|NCT00576472|54651872|FG012|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
27993207|NCT00576472|54651873|FG013|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
27993208|NCT00576472|54651874|FG014|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
27993209|NCT00576472|54651860|FG000|MPH In-Lab Phase|No attention/academic problems|0|||
27993210|NCT00576472|54651861|FG001|MPH In-Lab Phase|No attention/academic problems|0|||
27993211|NCT00576472|54651862|FG002|MPH In-Lab Phase|No attention/academic problems|0|||
27993212|NCT00576472|54651863|FG003|MPH In-Lab Phase|No attention/academic problems|245|||
27993213|NCT00576472|54651864|FG004|MPH In-Lab Phase|No attention/academic problems|0|||
27993214|NCT00576472|54651865|FG005|MPH In-Lab Phase|No attention/academic problems|0|||
27993215|NCT00576472|54651866|FG006|MPH In-Lab Phase|No attention/academic problems|0|||
27993216|NCT00576472|54651867|FG007|MPH In-Lab Phase|No attention/academic problems|0|||
27993217|NCT00576472|54651868|FG008|MPH In-Lab Phase|No attention/academic problems|0|||
27993218|NCT00576472|54651869|FG009|MPH In-Lab Phase|No attention/academic problems|0|||
27993219|NCT00576472|54651870|FG010|MPH In-Lab Phase|No attention/academic problems|0|||
27993220|NCT00576472|54651871|FG011|MPH In-Lab Phase|No attention/academic problems|0|||
27993221|NCT00576472|54651872|FG012|MPH In-Lab Phase|No attention/academic problems|0|||
27993222|NCT00576472|54651873|FG013|MPH In-Lab Phase|No attention/academic problems|0|||
27993223|NCT00576472|54651874|FG014|MPH In-Lab Phase|No attention/academic problems|0|||
27993224|NCT00576472|54651860|FG000|MPH In-Lab Phase|Psychiatric exclusion|0|||
27993225|NCT00576472|54651861|FG001|MPH In-Lab Phase|Psychiatric exclusion|0|||
27993226|NCT00576472|54651862|FG002|MPH In-Lab Phase|Psychiatric exclusion|0|||
27993227|NCT00576472|54651863|FG003|MPH In-Lab Phase|Psychiatric exclusion|10|||
27993228|NCT00576472|54651864|FG004|MPH In-Lab Phase|Psychiatric exclusion|0|||
27993229|NCT00576472|54651865|FG005|MPH In-Lab Phase|Psychiatric exclusion|0|||
27993230|NCT00576472|54651866|FG006|MPH In-Lab Phase|Psychiatric exclusion|0|||
27993231|NCT00576472|54651867|FG007|MPH In-Lab Phase|Psychiatric exclusion|0|||
27993232|NCT00576472|54651868|FG008|MPH In-Lab Phase|Psychiatric exclusion|0|||
27993233|NCT00576472|54651869|FG009|MPH In-Lab Phase|Psychiatric exclusion|0|||
27993234|NCT00576472|54651870|FG010|MPH In-Lab Phase|Psychiatric exclusion|0|||
27993235|NCT00576472|54651871|FG011|MPH In-Lab Phase|Psychiatric exclusion|0|||
27993236|NCT00576472|54651872|FG012|MPH In-Lab Phase|Psychiatric exclusion|0|||
27993237|NCT00576472|54651873|FG013|MPH In-Lab Phase|Psychiatric exclusion|0|||
27993238|NCT00576472|54651874|FG014|MPH In-Lab Phase|Psychiatric exclusion|0|||
28172578|NCT02435914|54844304|FG000|Overall Study|Withdrawal by Subject|0|||
28172579|NCT02435914|54844305|FG001|Overall Study|Withdrawal by Subject|1|||
28172580|NCT02435914|54844306|FG002|Overall Study|Withdrawal by Subject|0|||
28172581|NCT02435914|54844307|FG003|Overall Study|Withdrawal by Subject|0|||
28172582|NCT02435914|54844304|FG000|Overall Study|Other Miscellaneous Reason|0|||
27739683|NCT01599754|54189315|FG001|Overall Study|Investigator decision|3|||
27739684|NCT01599754|54189314|FG000|Overall Study|Withdrawal by Subject|24|||
27993239|NCT00576472|54651860|FG000|MPH Cross Over Phase|Withdrawal by Subject|0|||
27993240|NCT00576472|54651861|FG001|MPH Cross Over Phase|Withdrawal by Subject|0|||
27993241|NCT00576472|54651862|FG002|MPH Cross Over Phase|Withdrawal by Subject|0|||
27993242|NCT00576472|54651863|FG003|MPH Cross Over Phase|Withdrawal by Subject|0|||
27993243|NCT00576472|54651864|FG004|MPH Cross Over Phase|Withdrawal by Subject|0|||
27993244|NCT00576472|54651865|FG005|MPH Cross Over Phase|Withdrawal by Subject|0|||
27993245|NCT00576472|54651866|FG006|MPH Cross Over Phase|Withdrawal by Subject|6|||
27993246|NCT00576472|54651867|FG007|MPH Cross Over Phase|Withdrawal by Subject|0|||
27993247|NCT00576472|54651868|FG008|MPH Cross Over Phase|Withdrawal by Subject|0|||
27993248|NCT00576472|54651869|FG009|MPH Cross Over Phase|Withdrawal by Subject|0|||
27993249|NCT00576472|54651870|FG010|MPH Cross Over Phase|Withdrawal by Subject|0|||
27739685|NCT01599754|54189315|FG001|Overall Study|Withdrawal by Subject|25|||
27993250|NCT00576472|54651871|FG011|MPH Cross Over Phase|Withdrawal by Subject|0|||
27993251|NCT00576472|54651872|FG012|MPH Cross Over Phase|Withdrawal by Subject|0|||
27993252|NCT00576472|54651873|FG013|MPH Cross Over Phase|Withdrawal by Subject|0|||
27993253|NCT00576472|54651874|FG014|MPH Cross Over Phase|Withdrawal by Subject|0|||
27993254|NCT00576472|54651860|FG000|MPH Cross Over Phase|Ineligible due to disease|0|||
27993255|NCT00576472|54651861|FG001|MPH Cross Over Phase|Ineligible due to disease|0|||
27993256|NCT00576472|54651862|FG002|MPH Cross Over Phase|Ineligible due to disease|0|||
27993257|NCT00576472|54651863|FG003|MPH Cross Over Phase|Ineligible due to disease|0|||
27993258|NCT00576472|54651864|FG004|MPH Cross Over Phase|Ineligible due to disease|0|||
27993259|NCT00576472|54651865|FG005|MPH Cross Over Phase|Ineligible due to disease|0|||
27993260|NCT00576472|54651866|FG006|MPH Cross Over Phase|Ineligible due to disease|2|||
27993261|NCT00576472|54651867|FG007|MPH Cross Over Phase|Ineligible due to disease|0|||
27993262|NCT00576472|54651868|FG008|MPH Cross Over Phase|Ineligible due to disease|0|||
27993263|NCT00576472|54651869|FG009|MPH Cross Over Phase|Ineligible due to disease|0|||
27993264|NCT00576472|54651870|FG010|MPH Cross Over Phase|Ineligible due to disease|0|||
27993265|NCT00576472|54651871|FG011|MPH Cross Over Phase|Ineligible due to disease|0|||
27993266|NCT00576472|54651872|FG012|MPH Cross Over Phase|Ineligible due to disease|0|||
27993267|NCT00576472|54651873|FG013|MPH Cross Over Phase|Ineligible due to disease|0|||
27993268|NCT00576472|54651874|FG014|MPH Cross Over Phase|Ineligible due to disease|0|||
27993269|NCT00576472|54651860|FG000|MPH Cross Over Phase|Physician Decision|0|||
27993270|NCT00576472|54651861|FG001|MPH Cross Over Phase|Physician Decision|0|||
27993271|NCT00576472|54651862|FG002|MPH Cross Over Phase|Physician Decision|0|||
27993272|NCT00576472|54651863|FG003|MPH Cross Over Phase|Physician Decision|0|||
27993273|NCT00576472|54651864|FG004|MPH Cross Over Phase|Physician Decision|0|||
27993274|NCT00576472|54651865|FG005|MPH Cross Over Phase|Physician Decision|0|||
27993275|NCT00576472|54651866|FG006|MPH Cross Over Phase|Physician Decision|4|||
27993276|NCT00576472|54651867|FG007|MPH Cross Over Phase|Physician Decision|0|||
27993277|NCT00576472|54651868|FG008|MPH Cross Over Phase|Physician Decision|0|||
27993278|NCT00576472|54651869|FG009|MPH Cross Over Phase|Physician Decision|0|||
27993279|NCT00576472|54651870|FG010|MPH Cross Over Phase|Physician Decision|0|||
27993280|NCT00576472|54651871|FG011|MPH Cross Over Phase|Physician Decision|0|||
27993281|NCT00576472|54651872|FG012|MPH Cross Over Phase|Physician Decision|0|||
27993282|NCT00576472|54651873|FG013|MPH Cross Over Phase|Physician Decision|0|||
27993283|NCT00576472|54651874|FG014|MPH Cross Over Phase|Physician Decision|0|||
27993284|NCT00576472|54651860|FG000|MPH Cross Over Phase|Did not complete cross over phase|0|||
27993285|NCT00576472|54651861|FG001|MPH Cross Over Phase|Did not complete cross over phase|0|||
27993286|NCT00576472|54651862|FG002|MPH Cross Over Phase|Did not complete cross over phase|0|||
27993287|NCT00576472|54651863|FG003|MPH Cross Over Phase|Did not complete cross over phase|0|||
27993288|NCT00576472|54651864|FG004|MPH Cross Over Phase|Did not complete cross over phase|0|||
27993289|NCT00576472|54651865|FG005|MPH Cross Over Phase|Did not complete cross over phase|0|||
27993290|NCT00576472|54651866|FG006|MPH Cross Over Phase|Did not complete cross over phase|0|||
27993291|NCT00576472|54651867|FG007|MPH Cross Over Phase|Did not complete cross over phase|0|||
27993292|NCT00576472|54651868|FG008|MPH Cross Over Phase|Did not complete cross over phase|2|||
27993293|NCT00576472|54651869|FG009|MPH Cross Over Phase|Did not complete cross over phase|0|||
27993294|NCT00576472|54651870|FG010|MPH Cross Over Phase|Did not complete cross over phase|1|||
27993295|NCT00576472|54651871|FG011|MPH Cross Over Phase|Did not complete cross over phase|1|||
27993296|NCT00576472|54651872|FG012|MPH Cross Over Phase|Did not complete cross over phase|0|||
27993297|NCT00576472|54651873|FG013|MPH Cross Over Phase|Did not complete cross over phase|0|||
27993298|NCT00576472|54651874|FG014|MPH Cross Over Phase|Did not complete cross over phase|0|||
27993299|NCT00576472|54651860|FG000|MPH Home Maintenance Phase|Did not meet response criteria|0|||
27993300|NCT00576472|54651861|FG001|MPH Home Maintenance Phase|Did not meet response criteria|0|||
27993301|NCT00576472|54651862|FG002|MPH Home Maintenance Phase|Did not meet response criteria|0|||
27993302|NCT00576472|54651863|FG003|MPH Home Maintenance Phase|Did not meet response criteria|0|||
27993303|NCT00576472|54651864|FG004|MPH Home Maintenance Phase|Did not meet response criteria|0|||
27993304|NCT00576472|54651865|FG005|MPH Home Maintenance Phase|Did not meet response criteria|0|||
27993305|NCT00576472|54651866|FG006|MPH Home Maintenance Phase|Did not meet response criteria|0|||
27993306|NCT00576472|54651867|FG007|MPH Home Maintenance Phase|Did not meet response criteria|0|||
27993307|NCT00576472|54651868|FG008|MPH Home Maintenance Phase|Did not meet response criteria|0|||
27993308|NCT00576472|54651869|FG009|MPH Home Maintenance Phase|Did not meet response criteria|0|||
27993309|NCT00576472|54651870|FG010|MPH Home Maintenance Phase|Did not meet response criteria|0|||
27993310|NCT00576472|54651871|FG011|MPH Home Maintenance Phase|Did not meet response criteria|0|||
27993311|NCT00576472|54651872|FG012|MPH Home Maintenance Phase|Did not meet response criteria|0|||
27993312|NCT00576472|54651873|FG013|MPH Home Maintenance Phase|Did not meet response criteria|16|||
27993313|NCT00576472|54651874|FG014|MPH Home Maintenance Phase|Did not meet response criteria|0|||
27993314|NCT00576472|54651860|FG000|MPH Home Maintenance Phase|Declined to participate|0|||
27993315|NCT00576472|54651861|FG001|MPH Home Maintenance Phase|Declined to participate|0|||
27993316|NCT00576472|54651862|FG002|MPH Home Maintenance Phase|Declined to participate|0|||
28172583|NCT02435914|54844305|FG001|Overall Study|Other Miscellaneous Reason|0|||
28172584|NCT02435914|54844306|FG002|Overall Study|Other Miscellaneous Reason|1|||
27993317|NCT00576472|54651863|FG003|MPH Home Maintenance Phase|Declined to participate|0|||
27993318|NCT00576472|54651864|FG004|MPH Home Maintenance Phase|Declined to participate|0|||
27993319|NCT00576472|54651865|FG005|MPH Home Maintenance Phase|Declined to participate|0|||
27993320|NCT00576472|54651866|FG006|MPH Home Maintenance Phase|Declined to participate|0|||
27993321|NCT00576472|54651867|FG007|MPH Home Maintenance Phase|Declined to participate|0|||
27993322|NCT00576472|54651868|FG008|MPH Home Maintenance Phase|Declined to participate|0|||
27993323|NCT00576472|54651869|FG009|MPH Home Maintenance Phase|Declined to participate|0|||
27993324|NCT00576472|54651870|FG010|MPH Home Maintenance Phase|Declined to participate|0|||
27993325|NCT00576472|54651871|FG011|MPH Home Maintenance Phase|Declined to participate|0|||
27993326|NCT00576472|54651872|FG012|MPH Home Maintenance Phase|Declined to participate|0|||
27993327|NCT00576472|54651873|FG013|MPH Home Maintenance Phase|Declined to participate|7|||
27993328|NCT00576472|54651874|FG014|MPH Home Maintenance Phase|Declined to participate|0|||
27993329|NCT00576472|54651860|FG000|MPH Home Maintenance Phase|Insufficient data|0|||
27993330|NCT00576472|54651861|FG001|MPH Home Maintenance Phase|Insufficient data|0|||
27993331|NCT00576472|54651862|FG002|MPH Home Maintenance Phase|Insufficient data|0|||
27993332|NCT00576472|54651863|FG003|MPH Home Maintenance Phase|Insufficient data|0|||
27993333|NCT00576472|54651864|FG004|MPH Home Maintenance Phase|Insufficient data|0|||
27993334|NCT00576472|54651865|FG005|MPH Home Maintenance Phase|Insufficient data|0|||
27993335|NCT00576472|54651866|FG006|MPH Home Maintenance Phase|Insufficient data|0|||
27993336|NCT00576472|54651867|FG007|MPH Home Maintenance Phase|Insufficient data|0|||
27993337|NCT00576472|54651868|FG008|MPH Home Maintenance Phase|Insufficient data|0|||
27993338|NCT00576472|54651869|FG009|MPH Home Maintenance Phase|Insufficient data|0|||
27993339|NCT00576472|54651870|FG010|MPH Home Maintenance Phase|Insufficient data|0|||
27993340|NCT00576472|54651871|FG011|MPH Home Maintenance Phase|Insufficient data|0|||
27993341|NCT00576472|54651872|FG012|MPH Home Maintenance Phase|Insufficient data|0|||
27993342|NCT00576472|54651873|FG013|MPH Home Maintenance Phase|Insufficient data|4|||
27993343|NCT00576472|54651874|FG014|MPH Home Maintenance Phase|Insufficient data|0|||
27993344|NCT00576472|54651860|FG000|MPH Home Maintenance Phase|Side effects|0|||
27993345|NCT00576472|54651861|FG001|MPH Home Maintenance Phase|Side effects|0|||
27993346|NCT00576472|54651862|FG002|MPH Home Maintenance Phase|Side effects|0|||
27993347|NCT00576472|54651863|FG003|MPH Home Maintenance Phase|Side effects|0|||
27993348|NCT00576472|54651864|FG004|MPH Home Maintenance Phase|Side effects|0|||
27993349|NCT00576472|54651865|FG005|MPH Home Maintenance Phase|Side effects|0|||
27739686|NCT01599754|54189314|FG000|Overall Study|Study terminated by sponsor|282|||
27739687|NCT01599754|54189315|FG001|Overall Study|Study terminated by sponsor|285|||
27909106|NCT03303339|54566802|FG010|Overall Study|Safety/Non-compliance|0|||
27909107|NCT03303339|54566803|FG011|Overall Study|Safety/Non-compliance|1|||
27909108|NCT01183780|54566848|FG000|Overall Study|Withdrawal by Subject|25|||
27909109|NCT01183780|54566849|FG001|Overall Study|Withdrawal by Subject|14|||
27909110|NCT01183780|54566848|FG000|Overall Study|Lost to Follow-up|6|||
27909111|NCT01183780|54566849|FG001|Overall Study|Lost to Follow-up|11|||
27909112|NCT01183468|54566859|FG000|Overall Study|Lost to Follow-up|2|||
27909113|NCT01183468|54566860|FG001|Overall Study|Lost to Follow-up|1|||
27909114|NCT01183468|54566861|FG002|Overall Study|Lost to Follow-up|0|||
27909115|NCT01183468|54566862|FG003|Overall Study|Lost to Follow-up|0|||
27909116|NCT01183468|54566859|FG000|Overall Study|Physician Decision|1|||
27909117|NCT01183468|54566860|FG001|Overall Study|Physician Decision|0|||
27909118|NCT01183468|54566861|FG002|Overall Study|Physician Decision|0|||
27909119|NCT01183468|54566862|FG003|Overall Study|Physician Decision|0|||
27909120|NCT01183468|54566859|FG000|Overall Study|Withdrawal by Subject|0|||
27909121|NCT01183468|54566860|FG001|Overall Study|Withdrawal by Subject|1|||
27909122|NCT01183468|54566861|FG002|Overall Study|Withdrawal by Subject|0|||
27909123|NCT01183468|54566862|FG003|Overall Study|Withdrawal by Subject|0|||
27909124|NCT01183390|54566872|FG000|First Intervention|Adverse Event|0|||
27909125|NCT01183390|54566873|FG001|First Intervention|Adverse Event|1|||
27909126|NCT01214668|54566885|FG000|Overall Study|Adverse Event|0|||
27909127|NCT01214668|54566886|FG001|Overall Study|Adverse Event|1|||
27909128|NCT01214668|54566887|FG002|Overall Study|Adverse Event|0|||
27909129|NCT01214668|54566888|FG003|Overall Study|Adverse Event|2|||
27909130|NCT01214668|54566889|FG004|Overall Study|Adverse Event|1|||
27909131|NCT01214668|54566890|FG005|Overall Study|Adverse Event|1|||
27909132|NCT01214668|54566885|FG000|Overall Study|Death|0|||
27909133|NCT01214668|54566886|FG001|Overall Study|Death|0|||
27909134|NCT01214668|54566887|FG002|Overall Study|Death|1|||
27909135|NCT01214668|54566888|FG003|Overall Study|Death|0|||
27909136|NCT01214668|54566889|FG004|Overall Study|Death|0|||
27909137|NCT01214668|54566890|FG005|Overall Study|Death|0|||
27909138|NCT01214668|54566885|FG000|Overall Study|Progressive Disease|4|||
27909139|NCT01214668|54566886|FG001|Overall Study|Progressive Disease|2|||
27909140|NCT01214668|54566887|FG002|Overall Study|Progressive Disease|5|||
27993350|NCT00576472|54651866|FG006|MPH Home Maintenance Phase|Side effects|0|||
28098137|NCT03611582|54753897|FG000|Overall Study|Lost to Follow-up|18|||
27739688|NCT02138110|54189321|FG000|Enrolled for Scaffold Implantation|Physician Decision|1|||
27909141|NCT01214668|54566888|FG003|Overall Study|Progressive Disease|4|||
27993351|NCT00576472|54651867|FG007|MPH Home Maintenance Phase|Side effects|0|||
27909142|NCT01214668|54566889|FG004|Overall Study|Progressive Disease|4|||
27909143|NCT01214668|54566890|FG005|Overall Study|Progressive Disease|5|||
27909144|NCT01214668|54566885|FG000|Overall Study|Withdrawal by Subject|0|||
27909145|NCT01214668|54566886|FG001|Overall Study|Withdrawal by Subject|0|||
27909146|NCT01214668|54566887|FG002|Overall Study|Withdrawal by Subject|0|||
27909147|NCT01214668|54566888|FG003|Overall Study|Withdrawal by Subject|0|||
27909148|NCT01214668|54566889|FG004|Overall Study|Withdrawal by Subject|1|||
27909149|NCT01214668|54566890|FG005|Overall Study|Withdrawal by Subject|0|||
27909150|NCT01191268|54566908|FG000|Overall Study|Withdrawal by Subject|19|||
27909151|NCT01191268|54566909|FG001|Overall Study|Withdrawal by Subject|25|||
27909152|NCT01191268|54566910|FG002|Overall Study|Withdrawal by Subject|21|||
27909153|NCT01191268|54566908|FG000|Overall Study|Adverse Event|21|||
27909154|NCT01191268|54566909|FG001|Overall Study|Adverse Event|13|||
27909155|NCT01191268|54566910|FG002|Overall Study|Adverse Event|8|||
27909156|NCT01191268|54566908|FG000|Overall Study|Physician Decision|6|||
27909157|NCT01191268|54566909|FG001|Overall Study|Physician Decision|8|||
27909158|NCT01191268|54566910|FG002|Overall Study|Physician Decision|9|||
27909159|NCT01191268|54566908|FG000|Overall Study|Lost to Follow-up|8|||
27909160|NCT01191268|54566909|FG001|Overall Study|Lost to Follow-up|5|||
27909161|NCT01191268|54566910|FG002|Overall Study|Lost to Follow-up|9|||
27909162|NCT01191268|54566908|FG000|Overall Study|Entry Criteria Not Met|3|||
27993352|NCT00576472|54651868|FG008|MPH Home Maintenance Phase|Side effects|0|||
27993353|NCT00576472|54651869|FG009|MPH Home Maintenance Phase|Side effects|0|||
27993354|NCT00576472|54651870|FG010|MPH Home Maintenance Phase|Side effects|0|||
27993355|NCT00576472|54651871|FG011|MPH Home Maintenance Phase|Side effects|0|||
27993356|NCT00576472|54651872|FG012|MPH Home Maintenance Phase|Side effects|0|||
27993357|NCT00576472|54651873|FG013|MPH Home Maintenance Phase|Side effects|0|||
27993358|NCT00576472|54651874|FG014|MPH Home Maintenance Phase|Side effects|8|||
27993359|NCT00576472|54651860|FG000|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
27993360|NCT00576472|54651861|FG001|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
27993361|NCT00576472|54651862|FG002|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
27993362|NCT00576472|54651863|FG003|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
27993363|NCT00576472|54651864|FG004|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
27993364|NCT00576472|54651865|FG005|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
27993365|NCT00576472|54651866|FG006|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
27993366|NCT00576472|54651867|FG007|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
27993367|NCT00576472|54651868|FG008|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
27993368|NCT00576472|54651869|FG009|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
27993369|NCT00576472|54651870|FG010|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
27993370|NCT00576472|54651871|FG011|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
27993371|NCT00576472|54651872|FG012|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
27993372|NCT00576472|54651873|FG013|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
27993373|NCT00576472|54651874|FG014|MPH Home Maintenance Phase|Withdrawal by Subject|6|||
27993374|NCT00576472|54651860|FG000|MPH Home Maintenance Phase|Medical reasons|0|||
27993375|NCT00576472|54651861|FG001|MPH Home Maintenance Phase|Medical reasons|0|||
27993376|NCT00576472|54651862|FG002|MPH Home Maintenance Phase|Medical reasons|0|||
27993377|NCT00576472|54651863|FG003|MPH Home Maintenance Phase|Medical reasons|0|||
27993378|NCT00576472|54651864|FG004|MPH Home Maintenance Phase|Medical reasons|0|||
27993379|NCT00576472|54651865|FG005|MPH Home Maintenance Phase|Medical reasons|0|||
27993380|NCT00576472|54651866|FG006|MPH Home Maintenance Phase|Medical reasons|0|||
27993381|NCT00576472|54651867|FG007|MPH Home Maintenance Phase|Medical reasons|0|||
27993382|NCT00576472|54651868|FG008|MPH Home Maintenance Phase|Medical reasons|0|||
27993383|NCT00576472|54651869|FG009|MPH Home Maintenance Phase|Medical reasons|0|||
27993384|NCT00576472|54651870|FG010|MPH Home Maintenance Phase|Medical reasons|0|||
27993385|NCT00576472|54651871|FG011|MPH Home Maintenance Phase|Medical reasons|0|||
27993386|NCT00576472|54651872|FG012|MPH Home Maintenance Phase|Medical reasons|0|||
27993387|NCT00576472|54651873|FG013|MPH Home Maintenance Phase|Medical reasons|0|||
27993388|NCT00576472|54651874|FG014|MPH Home Maintenance Phase|Medical reasons|6|||
27993389|NCT00576472|54651860|FG000|MPH Home Maintenance Phase|Lost to Follow-up|0|||
27993390|NCT00576472|54651861|FG001|MPH Home Maintenance Phase|Lost to Follow-up|0|||
27993391|NCT00576472|54651862|FG002|MPH Home Maintenance Phase|Lost to Follow-up|0|||
27993392|NCT00576472|54651863|FG003|MPH Home Maintenance Phase|Lost to Follow-up|0|||
27993393|NCT00576472|54651864|FG004|MPH Home Maintenance Phase|Lost to Follow-up|0|||
27909163|NCT01191268|54566909|FG001|Overall Study|Entry Criteria Not Met|1|||
27909164|NCT01191268|54566910|FG002|Overall Study|Entry Criteria Not Met|1|||
27909165|NCT01191268|54566908|FG000|Overall Study|Death|0|||
27909166|NCT01191268|54566909|FG001|Overall Study|Death|1|||
27993394|NCT00576472|54651865|FG005|MPH Home Maintenance Phase|Lost to Follow-up|0|||
27993395|NCT00576472|54651866|FG006|MPH Home Maintenance Phase|Lost to Follow-up|0|||
27993396|NCT00576472|54651867|FG007|MPH Home Maintenance Phase|Lost to Follow-up|0|||
27993397|NCT00576472|54651868|FG008|MPH Home Maintenance Phase|Lost to Follow-up|0|||
28098138|NCT03611582|54753898|FG001|Overall Study|Lost to Follow-up|7|||
27909167|NCT01191268|54566910|FG002|Overall Study|Death|3|||
27909168|NCT01191268|54566908|FG000|Overall Study|Protocol Violation|1|||
27993398|NCT00576472|54651869|FG009|MPH Home Maintenance Phase|Lost to Follow-up|0|||
27993399|NCT00576472|54651870|FG010|MPH Home Maintenance Phase|Lost to Follow-up|0|||
27993400|NCT00576472|54651871|FG011|MPH Home Maintenance Phase|Lost to Follow-up|0|||
27993401|NCT00576472|54651872|FG012|MPH Home Maintenance Phase|Lost to Follow-up|0|||
27909169|NCT01191268|54566909|FG001|Overall Study|Protocol Violation|0|||
27909170|NCT01191268|54566910|FG002|Overall Study|Protocol Violation|1|||
27909171|NCT01191268|54566908|FG000|Overall Study|Sponsor Decision|0|||
27909172|NCT01191268|54566909|FG001|Overall Study|Sponsor Decision|2|||
27909173|NCT01191268|54566910|FG002|Overall Study|Sponsor Decision|0|||
27909174|NCT01191190|54566919|FG000|Overall Study|Withdrawal by Subject|1|||
27909175|NCT05751629|54566923|FG000|Overall Study|Withdrawal by Subject|6|||
27909176|NCT05751629|54566923|FG000|Overall Study|Death|25|||
27909177|NCT05751629|54566923|FG000|Overall Study|Study Site Closed|9|||
27909178|NCT05751629|54566923|FG000|Overall Study|Physician Decision|1|||
27909179|NCT05306977|54566927|FG000|Overall Study|Withdrawal by Subject|1|||
27909180|NCT05086276|54566933|FG000|Overall Study|Missed visit 5/Day 60 visit|1|||
27909181|NCT05086276|54566934|FG001|Overall Study|Missed visit 5/Day 60 visit|1|||
27909182|NCT04870710|54566940|FG000|Overall Study|Lost to Follow-up|3|||
27909183|NCT04858802|54566946|FG000|Overall Study|Lost to Follow-up|1|||
27909184|NCT04858802|54566947|FG001|Overall Study|Lost to Follow-up|1|||
27909185|NCT04858802|54566946|FG000|Overall Study|Withdrawal by Subject|1|||
27909186|NCT04858802|54566947|FG001|Overall Study|Withdrawal by Subject|1|||
27993402|NCT00576472|54651873|FG013|MPH Home Maintenance Phase|Lost to Follow-up|0|||
27993403|NCT00576472|54651874|FG014|MPH Home Maintenance Phase|Lost to Follow-up|3|||
27993404|NCT00823212|54651907|FG000|Overall Study|Death|8|||
27993405|NCT00823212|54651908|FG001|Overall Study|Death|10|||
27993406|NCT00823212|54651907|FG000|Overall Study|Withdrawal by Subject|6|||
27993407|NCT00823212|54651908|FG001|Overall Study|Withdrawal by Subject|1|||
27993408|NCT00823212|54651907|FG000|Overall Study|Incarcerated|0|||
27993409|NCT00823212|54651908|FG001|Overall Study|Incarcerated|1|||
27993410|NCT00823212|54651907|FG000|Overall Study|Missed 12-month visit|21|||
27993411|NCT00823212|54651908|FG001|Overall Study|Missed 12-month visit|21|||
27993412|NCT00807495|54651921|FG000|Overall Study|Adverse Event|6|||
27993413|NCT00807495|54651922|FG001|Overall Study|Adverse Event|3|||
27909187|NCT04562090|54566986|FG000|Overall Study|Withdrawal by Subject|3|||
27909188|NCT04562090|54566987|FG001|Overall Study|Withdrawal by Subject|4|||
27909189|NCT04562090|54566986|FG000|Overall Study|Protocol Violation|2|||
27909190|NCT04562090|54566987|FG001|Overall Study|Protocol Violation|0|||
27909191|NCT04562090|54566986|FG000|Overall Study|Lack of Efficacy|0|||
27909192|NCT04562090|54566987|FG001|Overall Study|Lack of Efficacy|1|||
27909193|NCT04562090|54566986|FG000|Overall Study|Adverse Event|1|||
27909194|NCT04562090|54566987|FG001|Overall Study|Adverse Event|4|||
27909195|NCT04562090|54566986|FG000|Overall Study|Miscellaneous|0|||
27909196|NCT04562090|54566987|FG001|Overall Study|Miscellaneous|3|||
27909197|NCT04557189|54566998|FG000|Overall Study|Adverse Event|0|||
27909198|NCT04557189|54566999|FG001|Overall Study|Adverse Event|1|||
27909199|NCT04557189|54566998|FG000|Overall Study|Lost to Follow-up|1|||
27909200|NCT04557189|54566999|FG001|Overall Study|Lost to Follow-up|1|||
27909201|NCT04557189|54566998|FG000|Overall Study|Withdrawal by Subject|2|||
27909202|NCT04557189|54566999|FG001|Overall Study|Withdrawal by Subject|1|||
27909203|NCT04557189|54566998|FG000|Overall Study|Reason not Specified|3|||
27909204|NCT04557189|54566999|FG001|Overall Study|Reason not Specified|6|||
27909205|NCT04530838|54567012|FG000|Overall Study|Other|2|||
27909206|NCT04530838|54567013|FG001|Overall Study|Other|1|||
27909207|NCT04530838|54567014|FG002|Overall Study|Other|0|||
27909208|NCT04530838|54567012|FG000|Overall Study|Physician Decision|0|||
27993414|NCT00807495|54651923|FG002|Overall Study|Adverse Event|1|||
27993415|NCT00807495|54651924|FG003|Overall Study|Adverse Event|1|||
27993416|NCT00807495|54651925|FG004|Overall Study|Adverse Event|2|||
27993417|NCT00807495|54651921|FG000|Overall Study|Withdrawal by Patient|2|||
27993418|NCT00807495|54651922|FG001|Overall Study|Withdrawal by Patient|0|||
27993419|NCT00807495|54651923|FG002|Overall Study|Withdrawal by Patient|1|||
27993420|NCT00807495|54651924|FG003|Overall Study|Withdrawal by Patient|0|||
27993421|NCT00807495|54651925|FG004|Overall Study|Withdrawal by Patient|0|||
27993422|NCT00807495|54651921|FG000|Overall Study|Reason Not Specified|0|||
27993423|NCT00807495|54651922|FG001|Overall Study|Reason Not Specified|3|||
27993424|NCT00807495|54651923|FG002|Overall Study|Reason Not Specified|2|||
27993425|NCT00807495|54651924|FG003|Overall Study|Reason Not Specified|0|||
27993426|NCT00807495|54651925|FG004|Overall Study|Reason Not Specified|3|||
27993427|NCT05074433|54651941|FG000|Overall Study|Adverse Event|0|||
27909209|NCT04530838|54567013|FG001|Overall Study|Physician Decision|0|||
27909210|NCT04530838|54567014|FG002|Overall Study|Physician Decision|1|||
27993428|NCT05074433|54651942|FG001|Overall Study|Adverse Event|2|||
27993429|NCT05074433|54651943|FG002|Overall Study|Adverse Event|0|||
28098139|NCT03611582|54753897|FG000|Overall Study|other|17|||
27909211|NCT04530838|54567012|FG000|Overall Study|Death|0|||
27909212|NCT04530838|54567013|FG001|Overall Study|Death|0|||
27909213|NCT04530838|54567014|FG002|Overall Study|Death|1|||
27993430|NCT05074433|54651944|FG003|Overall Study|Adverse Event|1|||
27993431|NCT05074433|54651941|FG000|Overall Study|Sponsor Request|0|||
27993432|NCT05074433|54651942|FG001|Overall Study|Sponsor Request|1|||
27993433|NCT05074433|54651943|FG002|Overall Study|Sponsor Request|1|||
27993434|NCT05074433|54651944|FG003|Overall Study|Sponsor Request|0|||
27993435|NCT05074433|54651941|FG000|Overall Study|Death|1|||
27993436|NCT05074433|54651942|FG001|Overall Study|Death|0|||
27993437|NCT05074433|54651943|FG002|Overall Study|Death|0|||
27993438|NCT05074433|54651944|FG003|Overall Study|Death|0|||
27993439|NCT05074433|54651941|FG000|Overall Study|Lost to Follow-up|0|||
27993440|NCT05074433|54651942|FG001|Overall Study|Lost to Follow-up|0|||
27993441|NCT05074433|54651943|FG002|Overall Study|Lost to Follow-up|2|||
27993442|NCT05074433|54651944|FG003|Overall Study|Lost to Follow-up|0|||
27993443|NCT05074433|54651941|FG000|Overall Study|Subject Decision|8|||
27993444|NCT05074433|54651942|FG001|Overall Study|Subject Decision|6|||
27993445|NCT05074433|54651943|FG002|Overall Study|Subject Decision|4|||
27993446|NCT05074433|54651944|FG003|Overall Study|Subject Decision|5|||
27993447|NCT04922021|54651968|FG000|Overall Study|Withdrawal by Subject|4|||
27993448|NCT04922021|54651969|FG001|Overall Study|Withdrawal by Subject|10|||
27993449|NCT04922021|54651968|FG000|Overall Study|Adverse Event|2|||
27993450|NCT04922021|54651969|FG001|Overall Study|Adverse Event|2|||
27993451|NCT04922021|54651968|FG000|Overall Study|Lack of Efficacy|0|||
27993452|NCT04922021|54651969|FG001|Overall Study|Lack of Efficacy|1|||
27993453|NCT04922021|54651968|FG000|Overall Study|Multiple reasons|1|||
27993454|NCT04922021|54651969|FG001|Overall Study|Multiple reasons|0|||
27993455|NCT04542057|54651985|FG000|Overall Study|Death|3|||
27993456|NCT04542057|54651986|FG001|Overall Study|Death|1|||
27993457|NCT04542057|54651985|FG000|Overall Study|COPD exacerbation withdrawal criteria|5|||
27993458|NCT04542057|54651986|FG001|Overall Study|COPD exacerbation withdrawal criteria|6|||
27993459|NCT04542057|54651985|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|10|||
27993460|NCT04542057|54651986|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
27993461|NCT04542057|54651985|FG000|Overall Study|Adverse Event|15|||
27993462|NCT04542057|54651986|FG001|Overall Study|Adverse Event|6|||
27993463|NCT04542057|54651985|FG000|Overall Study|COVID-19 adverse event|6|||
27993464|NCT04542057|54651986|FG001|Overall Study|COVID-19 adverse event|4|||
27909214|NCT04530838|54567012|FG000|Overall Study|Adverse Event|0|||
27909215|NCT04530838|54567013|FG001|Overall Study|Adverse Event|1|||
27909216|NCT04530838|54567014|FG002|Overall Study|Adverse Event|0|||
27993465|NCT04542057|54651985|FG000|Overall Study|Lack of Efficacy|2|||
27993466|NCT04542057|54651986|FG001|Overall Study|Lack of Efficacy|5|||
27993467|NCT04542057|54651985|FG000|Overall Study|Study terminated by sponsor|1|||
27993468|NCT04542057|54651986|FG001|Overall Study|Study terminated by sponsor|0|||
27993469|NCT04542057|54651985|FG000|Overall Study|Investigator discretion|2|||
27993470|NCT04542057|54651986|FG001|Overall Study|Investigator discretion|1|||
27993471|NCT04542057|54651985|FG000|Overall Study|Withdrawal by Subject|52|||
28098140|NCT03611582|54753898|FG001|Overall Study|other|16|||
28098141|NCT04015518|54753909|FG000|Overall Study|Adverse Event|6|||
28098142|NCT04015518|54753910|FG001|Overall Study|Adverse Event|1|||
28098143|NCT04015518|54753911|FG002|Overall Study|Adverse Event|1|||
28098144|NCT04015518|54753912|FG003|Overall Study|Adverse Event|3|||
28098145|NCT04015518|54753913|FG004|Overall Study|Adverse Event|3|||
28098146|NCT04015518|54753909|FG000|Overall Study|Lack of Efficacy|1|||
28098147|NCT04015518|54753910|FG001|Overall Study|Lack of Efficacy|0|||
28172585|NCT02435914|54844307|FG003|Overall Study|Other Miscellaneous Reason|0|||
27909217|NCT04530838|54567012|FG000|Overall Study|No longer meets eligibility criteria|1|||
27909218|NCT04530838|54567013|FG001|Overall Study|No longer meets eligibility criteria|0|||
27909219|NCT04530838|54567014|FG002|Overall Study|No longer meets eligibility criteria|2|||
27909220|NCT04530838|54567012|FG000|Overall Study|Withdrawal by parent/guardian|5|||
27909221|NCT04530838|54567013|FG001|Overall Study|Withdrawal by parent/guardian|2|||
27909222|NCT04530838|54567014|FG002|Overall Study|Withdrawal by parent/guardian|2|||
27909223|NCT04424901|54567028|FG000|Overall Study|patients were discharged prior to Hospital Day 9|17|||
27909224|NCT04424901|54567029|FG001|Overall Study|patients were discharged prior to Hospital Day 9|16|||
27909225|NCT04410445|54567037|FG000|Overall Study|Lost to Follow-up|3|||
27909226|NCT04410445|54567038|FG001|Overall Study|Lost to Follow-up|9|||
27909227|NCT04410445|54567037|FG000|Overall Study|Withdrawal by Subject|27|||
27909228|NCT04410445|54567038|FG001|Overall Study|Withdrawal by Subject|15|||
27909229|NCT04062448|54567062|FG000|Overall Study|Lost to Follow-up|1|||
27909230|NCT04062448|54567062|FG000|Overall Study|Withdrawal by Subject|1|||
27993472|NCT04542057|54651986|FG001|Overall Study|Withdrawal by Subject|30|||
27993473|NCT04542057|54651985|FG000|Overall Study|Lost to Follow-up|8|||
27993474|NCT04542057|54651986|FG001|Overall Study|Lost to Follow-up|11|||
27993475|NCT04542057|54651985|FG000|Overall Study|Other|2|||
27993476|NCT04542057|54651986|FG001|Overall Study|Other|2|||
27993477|NCT04233580|54652029|FG000|Overall Study|Adverse Event|3|||
27993478|NCT04233580|54652030|FG001|Overall Study|Adverse Event|3|||
27993479|NCT04233580|54652029|FG000|Overall Study|Withdrawal by Subject|2|||
27993480|NCT04233580|54652030|FG001|Overall Study|Withdrawal by Subject|1|||
27993481|NCT04016805|54652050|FG000|Overall Study|Sponsor's Discretion|30|||
28098148|NCT04015518|54753911|FG002|Overall Study|Lack of Efficacy|1|||
27993482|NCT04016805|54652051|FG001|Overall Study|Sponsor's Discretion|6|||
27993483|NCT04016805|54652052|FG002|Overall Study|Sponsor's Discretion|5|||
27993484|NCT03982199|54652062|FG000|Overall Study|Site terminated by sponsor|14|||
27993485|NCT03982199|54652063|FG001|Overall Study|Site terminated by sponsor|17|||
27993486|NCT03982199|54652062|FG000|Overall Study|Lost to Follow-up|137|||
27993487|NCT03982199|54652063|FG001|Overall Study|Lost to Follow-up|142|||
27993488|NCT03982199|54652062|FG000|Overall Study|Physician Decision|38|||
27993489|NCT03982199|54652063|FG001|Overall Study|Physician Decision|33|||
27993490|NCT03982199|54652062|FG000|Overall Study|Withdrawal by Subject|514|||
27993491|NCT03982199|54652063|FG001|Overall Study|Withdrawal by Subject|496|||
27993492|NCT03982199|54652062|FG000|Overall Study|Adverse Event|10|||
27993493|NCT03982199|54652063|FG001|Overall Study|Adverse Event|14|||
27993494|NCT03982199|54652062|FG000|Overall Study|Technical Problems|9|||
27993495|NCT03982199|54652063|FG001|Overall Study|Technical Problems|8|||
27993496|NCT03982199|54652062|FG000|Overall Study|Death|40|||
27993497|NCT03982199|54652063|FG001|Overall Study|Death|40|||
27993498|NCT03982199|54652062|FG000|Overall Study|Study terminated by sponsor|2|||
27993499|NCT03982199|54652063|FG001|Overall Study|Study terminated by sponsor|1|||
27993500|NCT03982199|54652062|FG000|Overall Study|Other|76|||
27993501|NCT03982199|54652063|FG001|Overall Study|Other|81|||
27993502|NCT03982199|54652062|FG000|Overall Study|Ongoing|743|||
27993503|NCT03982199|54652063|FG001|Overall Study|Ongoing|799|||
27993504|NCT03982199|54652062|FG000|Overall Study|Randomized but not vaccinated|18|||
27993505|NCT03982199|54652063|FG001|Overall Study|Randomized but not vaccinated|15|||
27993506|NCT03828448|54652069|FG000|Overall Study|Sponsor's Discretion|34|||
27993507|NCT03713593|54652079|FG000|Overall Study|Participants Ongoing|140|||
27993508|NCT03713593|54652080|FG001|Overall Study|Participants Ongoing|114|||
27993509|NCT03713593|54652079|FG000|Overall Study|Withdrawal by Subject|3|||
27993510|NCT03713593|54652080|FG001|Overall Study|Withdrawal by Subject|6|||
27993511|NCT03713593|54652079|FG000|Overall Study|Death|252|||
27993512|NCT03713593|54652080|FG001|Overall Study|Death|279|||
27993513|NCT03580369|54652090|FG000|Overall Study|No treatment due to mis-randomization|1|||
27993514|NCT03580369|54652091|FG001|Overall Study|No treatment due to mis-randomization|0|||
27993515|NCT03580369|54652092|FG002|Overall Study|No treatment due to mis-randomization|0|||
27993516|NCT03580369|54652093|FG003|Overall Study|No treatment due to mis-randomization|0|||
27993517|NCT03580369|54652094|FG004|Overall Study|No treatment due to mis-randomization|3|||
28098149|NCT04015518|54753912|FG003|Overall Study|Lack of Efficacy|0|||
28098150|NCT04015518|54753913|FG004|Overall Study|Lack of Efficacy|4|||
28098151|NCT04015518|54753909|FG000|Overall Study|Lost to Follow-up|0|||
28098152|NCT04015518|54753910|FG001|Overall Study|Lost to Follow-up|0|||
28098153|NCT04015518|54753911|FG002|Overall Study|Lost to Follow-up|0|||
28098154|NCT04015518|54753912|FG003|Overall Study|Lost to Follow-up|0|||
28098155|NCT04015518|54753913|FG004|Overall Study|Lost to Follow-up|1|||
28098156|NCT04015518|54753909|FG000|Overall Study|Withdrawal by Subject|0|||
28098157|NCT04015518|54753910|FG001|Overall Study|Withdrawal by Subject|1|||
28098158|NCT04015518|54753911|FG002|Overall Study|Withdrawal by Subject|0|||
28098159|NCT04015518|54753912|FG003|Overall Study|Withdrawal by Subject|1|||
28098160|NCT04015518|54753913|FG004|Overall Study|Withdrawal by Subject|1|||
28098161|NCT04015518|54753909|FG000|Overall Study|Patient did not come for consecutive visits|0|||
28098162|NCT04015518|54753910|FG001|Overall Study|Patient did not come for consecutive visits|1|||
28098163|NCT04015518|54753911|FG002|Overall Study|Patient did not come for consecutive visits|0|||
28098164|NCT04015518|54753912|FG003|Overall Study|Patient did not come for consecutive visits|0|||
28098165|NCT04015518|54753913|FG004|Overall Study|Patient did not come for consecutive visits|0|||
28098166|NCT04015518|54753909|FG000|Overall Study|not willing to travel due to Covid-19|0|||
28098167|NCT04015518|54753910|FG001|Overall Study|not willing to travel due to Covid-19|0|||
28098168|NCT04015518|54753911|FG002|Overall Study|not willing to travel due to Covid-19|1|||
28098169|NCT04015518|54753912|FG003|Overall Study|not willing to travel due to Covid-19|0|||
28098170|NCT04015518|54753913|FG004|Overall Study|not willing to travel due to Covid-19|0|||
28098171|NCT04015518|54753909|FG000|Overall Study|Patient wants to discontinue treatment|0|||
28098172|NCT04015518|54753910|FG001|Overall Study|Patient wants to discontinue treatment|0|||
28098173|NCT04015518|54753911|FG002|Overall Study|Patient wants to discontinue treatment|0|||
28098174|NCT04015518|54753912|FG003|Overall Study|Patient wants to discontinue treatment|1|||
28098175|NCT04015518|54753913|FG004|Overall Study|Patient wants to discontinue treatment|0|||
28098176|NCT04015518|54753909|FG000|Overall Study|Difficult for patient to come to the hospital|0|||
28098177|NCT04015518|54753910|FG001|Overall Study|Difficult for patient to come to the hospital|0|||
28098178|NCT04015518|54753911|FG002|Overall Study|Difficult for patient to come to the hospital|0|||
27993518|NCT03580369|54652095|FG005|Overall Study|No treatment due to mis-randomization|0|||
28098179|NCT04015518|54753912|FG003|Overall Study|Difficult for patient to come to the hospital|0|||
27993519|NCT03580369|54652096|FG006|Overall Study|No treatment due to mis-randomization|0|||
27993520|NCT03580369|54652097|FG007|Overall Study|No treatment due to mis-randomization|0|||
27993521|NCT03580369|54652090|FG000|Overall Study|Reason unknown|0|||
27993522|NCT03580369|54652091|FG001|Overall Study|Reason unknown|0|||
27993523|NCT03580369|54652092|FG002|Overall Study|Reason unknown|1|||
27993524|NCT03580369|54652093|FG003|Overall Study|Reason unknown|0|||
27993525|NCT03580369|54652094|FG004|Overall Study|Reason unknown|0|||
27993526|NCT03580369|54652095|FG005|Overall Study|Reason unknown|0|||
27993527|NCT03580369|54652096|FG006|Overall Study|Reason unknown|0|||
27993528|NCT03580369|54652097|FG007|Overall Study|Reason unknown|0|||
27993529|NCT03580369|54652090|FG000|Overall Study|Technical problems|0|||
27993530|NCT03580369|54652091|FG001|Overall Study|Technical problems|0|||
27993531|NCT03580369|54652092|FG002|Overall Study|Technical problems|0|||
27993532|NCT03580369|54652093|FG003|Overall Study|Technical problems|0|||
27993533|NCT03580369|54652094|FG004|Overall Study|Technical problems|1|||
27993534|NCT03580369|54652095|FG005|Overall Study|Technical problems|0|||
27993535|NCT03580369|54652096|FG006|Overall Study|Technical problems|2|||
27993536|NCT03580369|54652097|FG007|Overall Study|Technical problems|0|||
27993537|NCT03580369|54652090|FG000|Overall Study|Pregnancy|2|||
27993538|NCT03580369|54652091|FG001|Overall Study|Pregnancy|0|||
27993539|NCT03580369|54652092|FG002|Overall Study|Pregnancy|3|||
27993540|NCT03580369|54652093|FG003|Overall Study|Pregnancy|0|||
27993541|NCT03580369|54652094|FG004|Overall Study|Pregnancy|2|||
27993542|NCT03580369|54652095|FG005|Overall Study|Pregnancy|0|||
27993543|NCT03580369|54652096|FG006|Overall Study|Pregnancy|0|||
27993544|NCT03580369|54652097|FG007|Overall Study|Pregnancy|0|||
27993545|NCT03580369|54652090|FG000|Overall Study|Lost to Follow-up|2|||
27993546|NCT03580369|54652091|FG001|Overall Study|Lost to Follow-up|0|||
27993547|NCT03580369|54652092|FG002|Overall Study|Lost to Follow-up|2|||
27993548|NCT03580369|54652093|FG003|Overall Study|Lost to Follow-up|0|||
27993549|NCT03580369|54652094|FG004|Overall Study|Lost to Follow-up|3|||
27993550|NCT03580369|54652095|FG005|Overall Study|Lost to Follow-up|0|||
27993551|NCT03580369|54652096|FG006|Overall Study|Lost to Follow-up|1|||
27993552|NCT03580369|54652097|FG007|Overall Study|Lost to Follow-up|0|||
27993553|NCT03580369|54652090|FG000|Overall Study|Physician Decision|4|||
27993554|NCT03580369|54652091|FG001|Overall Study|Physician Decision|0|||
27993555|NCT03580369|54652092|FG002|Overall Study|Physician Decision|4|||
27993556|NCT03580369|54652093|FG003|Overall Study|Physician Decision|1|||
27993557|NCT03580369|54652094|FG004|Overall Study|Physician Decision|1|||
27993558|NCT03580369|54652095|FG005|Overall Study|Physician Decision|0|||
27993559|NCT03580369|54652096|FG006|Overall Study|Physician Decision|0|||
27993560|NCT03580369|54652097|FG007|Overall Study|Physician Decision|0|||
27993561|NCT03580369|54652090|FG000|Overall Study|Lack of Efficacy|3|||
27993562|NCT03580369|54652091|FG001|Overall Study|Lack of Efficacy|0|||
27993563|NCT03580369|54652092|FG002|Overall Study|Lack of Efficacy|7|||
27993564|NCT03580369|54652093|FG003|Overall Study|Lack of Efficacy|0|||
27993565|NCT03580369|54652094|FG004|Overall Study|Lack of Efficacy|2|||
27993566|NCT03580369|54652095|FG005|Overall Study|Lack of Efficacy|0|||
27909231|NCT04062448|54567062|FG000|Overall Study|Ongoing|14|||
27909232|NCT03970733|54567069|FG000|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
27909233|NCT03970733|54567070|FG001|Main Study Phase (18 Months)|Withdrawal by Subject|7|||
27909234|NCT03970733|54567071|FG002|Main Study Phase (18 Months)|Withdrawal by Subject|2|||
27909235|NCT03970733|54567072|FG003|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
27909236|NCT03970733|54567073|FG004|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
27909237|NCT03970733|54567069|FG000|Main Study Phase (18 Months)|Moved from study area|2|||
27909238|NCT03970733|54567070|FG001|Main Study Phase (18 Months)|Moved from study area|1|||
27909239|NCT03970733|54567071|FG002|Main Study Phase (18 Months)|Moved from study area|0|||
27909240|NCT03970733|54567072|FG003|Main Study Phase (18 Months)|Moved from study area|0|||
27909241|NCT03970733|54567073|FG004|Main Study Phase (18 Months)|Moved from study area|0|||
27909242|NCT03970733|54567069|FG000|Main Study Phase (18 Months)|Lost to Follow-up|5|||
27909243|NCT03970733|54567070|FG001|Main Study Phase (18 Months)|Lost to Follow-up|5|||
27909244|NCT03970733|54567071|FG002|Main Study Phase (18 Months)|Lost to Follow-up|3|||
27909245|NCT03970733|54567072|FG003|Main Study Phase (18 Months)|Lost to Follow-up|0|||
27909246|NCT03970733|54567073|FG004|Main Study Phase (18 Months)|Lost to Follow-up|0|||
27909247|NCT03970733|54567069|FG000|Main Study Phase (18 Months)|Other|1|||
27909248|NCT03970733|54567070|FG001|Main Study Phase (18 Months)|Other|1|||
27909249|NCT03970733|54567071|FG002|Main Study Phase (18 Months)|Other|0|||
27993567|NCT03580369|54652096|FG006|Overall Study|Lack of Efficacy|3|||
27993568|NCT03580369|54652097|FG007|Overall Study|Lack of Efficacy|0|||
27993569|NCT03580369|54652090|FG000|Overall Study|Protocol Violation|6|||
27993570|NCT03580369|54652091|FG001|Overall Study|Protocol Violation|0|||
27993571|NCT03580369|54652092|FG002|Overall Study|Protocol Violation|6|||
27993572|NCT03580369|54652093|FG003|Overall Study|Protocol Violation|1|||
27993573|NCT03580369|54652094|FG004|Overall Study|Protocol Violation|8|||
27993574|NCT03580369|54652095|FG005|Overall Study|Protocol Violation|2|||
27993575|NCT03580369|54652096|FG006|Overall Study|Protocol Violation|1|||
27993576|NCT03580369|54652097|FG007|Overall Study|Protocol Violation|0|||
27993577|NCT03580369|54652090|FG000|Overall Study|Adverse Event|7|||
27993578|NCT03580369|54652091|FG001|Overall Study|Adverse Event|0|||
27909250|NCT03970733|54567072|FG003|Main Study Phase (18 Months)|Other|0|||
27993579|NCT03580369|54652092|FG002|Overall Study|Adverse Event|14|||
27993580|NCT03580369|54652093|FG003|Overall Study|Adverse Event|1|||
27993581|NCT03580369|54652094|FG004|Overall Study|Adverse Event|6|||
27993582|NCT03580369|54652095|FG005|Overall Study|Adverse Event|0|||
27993583|NCT03580369|54652096|FG006|Overall Study|Adverse Event|1|||
27909251|NCT03970733|54567073|FG004|Main Study Phase (18 Months)|Other|0|||
27909252|NCT03970733|54567069|FG000|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
27909253|NCT03970733|54567070|FG001|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
27909254|NCT03970733|54567071|FG002|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
27909255|NCT03970733|54567072|FG003|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
27909256|NCT03970733|54567073|FG004|Booster Phase (Approx. 12 Months)|Lost to Follow-up|1|||
27909257|NCT03921411|54567085|FG000|Overall Study|Withdrawal by Subject|1|||
27909258|NCT03921411|54567085|FG000|Overall Study|Protocol Deviation|2|||
27909259|NCT03921411|54567085|FG000|Overall Study|Enrolled, but never treated|2|||
27909260|NCT03728582|54567089|FG000|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|0|||
27909261|NCT03728582|54567090|FG001|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|1|||
27909262|NCT03728582|54567089|FG000|Washout (8 Weeks)|Withdrawal by Subject|1|||
27909263|NCT03728582|54567090|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
27909264|NCT03416179|54567109|FG000|Overall Study|Death|90|||
28098180|NCT04015518|54753913|FG004|Overall Study|Difficult for patient to come to the hospital|1|||
28098181|NCT04015518|54753909|FG000|Overall Study|Pregnancy|0|||
28098182|NCT04015518|54753910|FG001|Overall Study|Pregnancy|0|||
28098183|NCT04015518|54753911|FG002|Overall Study|Pregnancy|0|||
28098184|NCT04015518|54753912|FG003|Overall Study|Pregnancy|0|||
28098185|NCT04015518|54753913|FG004|Overall Study|Pregnancy|1|||
28098186|NCT04015518|54753909|FG000|Overall Study|Personal reasons|1|||
28098187|NCT04015518|54753910|FG001|Overall Study|Personal reasons|0|||
28098188|NCT04015518|54753911|FG002|Overall Study|Personal reasons|0|||
27993584|NCT03580369|54652097|FG007|Overall Study|Adverse Event|0|||
27993585|NCT03580369|54652090|FG000|Overall Study|Withdrawal by Subject|19|||
27993586|NCT03580369|54652091|FG001|Overall Study|Withdrawal by Subject|0|||
27993587|NCT03580369|54652092|FG002|Overall Study|Withdrawal by Subject|17|||
27993588|NCT03580369|54652093|FG003|Overall Study|Withdrawal by Subject|0|||
27993589|NCT03580369|54652094|FG004|Overall Study|Withdrawal by Subject|16|||
27993590|NCT03580369|54652095|FG005|Overall Study|Withdrawal by Subject|1|||
27993591|NCT03580369|54652096|FG006|Overall Study|Withdrawal by Subject|7|||
27993592|NCT03580369|54652097|FG007|Overall Study|Withdrawal by Subject|0|||
27993593|NCT03412565|54652121|FG000|Overall Study|Other|0|||
27993594|NCT03412565|54652122|FG001|Overall Study|Other|0|||
28098189|NCT04015518|54753912|FG003|Overall Study|Personal reasons|0|||
28098190|NCT04015518|54753913|FG004|Overall Study|Personal reasons|1|||
28098191|NCT04015518|54753909|FG000|Overall Study|Withdrew consent|1|||
28098192|NCT04015518|54753910|FG001|Overall Study|Withdrew consent|0|||
28098193|NCT04015518|54753911|FG002|Overall Study|Withdrew consent|0|||
28098194|NCT04015518|54753912|FG003|Overall Study|Withdrew consent|0|||
28098195|NCT04015518|54753913|FG004|Overall Study|Withdrew consent|0|||
28098196|NCT04015518|54753909|FG000|Overall Study|Prostate carcinoma|1|||
28098197|NCT04015518|54753910|FG001|Overall Study|Prostate carcinoma|0|||
28098198|NCT04015518|54753911|FG002|Overall Study|Prostate carcinoma|0|||
28098199|NCT04015518|54753912|FG003|Overall Study|Prostate carcinoma|0|||
28098200|NCT04015518|54753913|FG004|Overall Study|Prostate carcinoma|0|||
28098201|NCT04015518|54753909|FG000|Overall Study|Could not keep appointments due to work|1|||
28098202|NCT04015518|54753910|FG001|Overall Study|Could not keep appointments due to work|0|||
28098203|NCT04015518|54753911|FG002|Overall Study|Could not keep appointments due to work|0|||
28098204|NCT04015518|54753912|FG003|Overall Study|Could not keep appointments due to work|0|||
28098205|NCT04015518|54753913|FG004|Overall Study|Could not keep appointments due to work|0|||
28098206|NCT03577730|54753930|FG000|Overall Study|Physician Decision|3|||
28098207|NCT03577730|54753931|FG001|Overall Study|Physician Decision|1|||
28098208|NCT03577730|54753930|FG000|Overall Study|Did not receive allocated intervention|1|||
28098209|NCT03577730|54753931|FG001|Overall Study|Did not receive allocated intervention|0|||
28098210|NCT03608774|54753939|FG000|Overall Study|Lost to Follow-up|5|||
28098211|NCT03608774|54753940|FG001|Overall Study|Lost to Follow-up|5|||
28098212|NCT03608774|54753939|FG000|Overall Study|Withdrawal by Subject|1|||
28098213|NCT03608774|54753940|FG001|Overall Study|Withdrawal by Subject|0|||
28098214|NCT03608774|54753939|FG000|Overall Study|Protocol Violation|1|||
28172586|NCT02786953|54844319|FG000|Overall Study|Withdrawal by Subject|3|||
27909265|NCT03416179|54567110|FG001|Overall Study|Death|87|||
27909266|NCT03416179|54567111|FG002|Overall Study|Death|117|||
27909267|NCT03416179|54567112|FG003|Overall Study|Death|113|||
27993595|NCT03412565|54652123|FG002|Overall Study|Other|0|||
27993596|NCT03412565|54652124|FG003|Overall Study|Other|3|||
27993597|NCT03412565|54652121|FG000|Overall Study|Withdrawal by Subject|0|||
27993598|NCT03412565|54652122|FG001|Overall Study|Withdrawal by Subject|0|||
27993599|NCT03412565|54652123|FG002|Overall Study|Withdrawal by Subject|1|||
28098215|NCT03608774|54753940|FG001|Overall Study|Protocol Violation|0|||
28098216|NCT03608774|54753939|FG000|Overall Study|Not eligible at enrollment|0|||
28098217|NCT03608774|54753940|FG001|Overall Study|Not eligible at enrollment|1|||
28098218|NCT03608774|54753939|FG000|Overall Study|Health related event|0|||
28098219|NCT03608774|54753940|FG001|Overall Study|Health related event|1|||
27909268|NCT03416179|54567109|FG000|Overall Study|Withdrawal by Subject|15|||
27909269|NCT03416179|54567110|FG001|Overall Study|Withdrawal by Subject|20|||
27909270|NCT03416179|54567111|FG002|Overall Study|Withdrawal by Subject|6|||
27909271|NCT03416179|54567112|FG003|Overall Study|Withdrawal by Subject|9|||
27909272|NCT03416179|54567109|FG000|Overall Study|Lost to Follow-up|1|||
27909273|NCT03416179|54567110|FG001|Overall Study|Lost to Follow-up|1|||
27909274|NCT03416179|54567111|FG002|Overall Study|Lost to Follow-up|0|||
27909275|NCT03416179|54567112|FG003|Overall Study|Lost to Follow-up|3|||
27909276|NCT03416179|54567109|FG000|Overall Study|Study participation terminated by Sponsor|93|||
27909277|NCT03416179|54567110|FG001|Overall Study|Study participation terminated by Sponsor|91|||
27909278|NCT03416179|54567111|FG002|Overall Study|Study participation terminated by Sponsor|26|||
27909279|NCT03416179|54567112|FG003|Overall Study|Study participation terminated by Sponsor|31|||
27909280|NCT03416179|54567109|FG000|Overall Study|Other|2|||
27909281|NCT03416179|54567110|FG001|Overall Study|Other|3|||
27909282|NCT03416179|54567111|FG002|Overall Study|Other|1|||
27909283|NCT03416179|54567112|FG003|Overall Study|Other|0|||
27909284|NCT03186638|54567124|FG000|Overall Study|Withdrawal by Subject|4|||
27909285|NCT03186638|54567125|FG001|Overall Study|Withdrawal by Subject|4|||
27909286|NCT03186638|54567124|FG000|Overall Study|Withdrawn due to medical problem|3|||
27909287|NCT03186638|54567125|FG001|Overall Study|Withdrawn due to medical problem|2|||
27909288|NCT03186638|54567124|FG000|Overall Study|Lost to Follow-up|1|||
27909289|NCT03186638|54567125|FG001|Overall Study|Lost to Follow-up|0|||
27909290|NCT02932332|54567148|FG000|Overall Study|Withdrawal by Subject|1|||
27909291|NCT02932332|54567149|FG001|Overall Study|Withdrawal by Subject|1|||
27909292|NCT02932332|54567150|FG002|Overall Study|Withdrawal by Subject|0|||
27909293|NCT02932332|54567151|FG003|Overall Study|Withdrawal by Subject|1|||
27909294|NCT02932332|54567148|FG000|Overall Study|Chest pain|0|||
27909295|NCT02932332|54567149|FG001|Overall Study|Chest pain|0|||
27909296|NCT02932332|54567150|FG002|Overall Study|Chest pain|0|||
27909297|NCT02932332|54567151|FG003|Overall Study|Chest pain|1|||
27909298|NCT02932332|54567148|FG000|Overall Study|Not Dyspneic cough|1|||
27909299|NCT02932332|54567149|FG001|Overall Study|Not Dyspneic cough|2|||
27909300|NCT02932332|54567150|FG002|Overall Study|Not Dyspneic cough|1|||
27909301|NCT02932332|54567151|FG003|Overall Study|Not Dyspneic cough|0|||
27909302|NCT02820623|54567185|FG000|Overall Study|Withdrawal by Subject|1|||
27993600|NCT03412565|54652124|FG003|Overall Study|Withdrawal by Subject|5|||
27993601|NCT03412565|54652121|FG000|Overall Study|Physician Decision|0|||
27993602|NCT03412565|54652122|FG001|Overall Study|Physician Decision|1|||
27993603|NCT03412565|54652123|FG002|Overall Study|Physician Decision|0|||
27993604|NCT03412565|54652124|FG003|Overall Study|Physician Decision|1|||
27993605|NCT03412565|54652121|FG000|Overall Study|Death|1|||
27993606|NCT03412565|54652122|FG001|Overall Study|Death|2|||
27993607|NCT03412565|54652123|FG002|Overall Study|Death|2|||
27993608|NCT03412565|54652124|FG003|Overall Study|Death|4|||
27993609|NCT03412565|54652121|FG000|Overall Study|Still ongoing|0|||
27993610|NCT03412565|54652122|FG001|Overall Study|Still ongoing|62|||
27993611|NCT03412565|54652123|FG002|Overall Study|Still ongoing|59|||
27993612|NCT03412565|54652124|FG003|Overall Study|Still ongoing|41|||
27993613|NCT03215810|54652165|FG000|Overall Study|Still responding to nivolumab|1|||
27993614|NCT03215810|54652165|FG000|Overall Study|Insufficient TIL growth|1|||
27993615|NCT03215810|54652165|FG000|Overall Study|Decline in performance status|1|||
27993616|NCT03215810|54652165|FG000|Overall Study|Withdrawal by Subject|1|||
28098220|NCT04021524|54753948|FG000|Overall Study|Change in surgical intervention|0|||
28098221|NCT04021524|54753949|FG001|Overall Study|Change in surgical intervention|1|||
28098222|NCT03607682|54753955|FG000|Overall Study|Withdrawal by Subject|1|||
28098223|NCT03607682|54753955|FG000|Overall Study|Disease progression|1|||
28098224|NCT03606668|54753959|FG000|Overall Study|Screen Failure|1|||
28098225|NCT03606668|54753959|FG000|Overall Study|Lost to Follow-up|1|||
28098226|NCT03601052|54753963|FG000|Overall Study|Lost to Follow-up|2|||
28098227|NCT03600740|54753972|FG000|Overall Study|Surgical plan was altered-subject not eligible|1|||
28098228|NCT03600428|54753978|FG000|Overall Study|Not eligible|0|||
28098229|NCT03600428|54753979|FG001|Overall Study|Not eligible|1|||
28172587|NCT02786953|54844320|FG001|Overall Study|Withdrawal by Subject|0|||
28172588|NCT02786953|54844319|FG000|Overall Study|Physician Decision|0|||
27909303|NCT02820623|54567186|FG001|Overall Study|Withdrawal by Subject|3|||
27909304|NCT02820623|54567187|FG002|Overall Study|Withdrawal by Subject|3|||
27909305|NCT02820623|54567185|FG000|Overall Study|Participation interrupted due to COVID-19|3|||
27909306|NCT02820623|54567186|FG001|Overall Study|Participation interrupted due to COVID-19|3|||
27909307|NCT02820623|54567187|FG002|Overall Study|Participation interrupted due to COVID-19|2|||
27909308|NCT02820623|54567185|FG000|Overall Study|Therapist unable to enroll clients|1|||
27909309|NCT02820623|54567186|FG001|Overall Study|Therapist unable to enroll clients|1|||
27909310|NCT02820623|54567187|FG002|Overall Study|Therapist unable to enroll clients|3|||
27993617|NCT02967692|54652186|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|3|||
27993618|NCT02967692|54652187|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|1|||
28098230|NCT03600428|54753978|FG000|Overall Study|Lost to Follow-up|5|||
28098231|NCT03600428|54753979|FG001|Overall Study|Lost to Follow-up|4|||
28098232|NCT03575702|54753987|FG000|Overall Study|Withdrawal by Subject|1|||
28098233|NCT03575702|54753988|FG001|Overall Study|Withdrawal by Subject|1|||
28098234|NCT03575702|54753987|FG000|Overall Study|Lost to Follow-up|1|||
28098235|NCT03575702|54753988|FG001|Overall Study|Lost to Follow-up|2|||
28098236|NCT03575702|54753987|FG000|Overall Study|Protocol Violation|0|||
28098237|NCT03575702|54753988|FG001|Overall Study|Protocol Violation|1|||
28098238|NCT03575702|54753987|FG000|Overall Study|Patient non compliance|4|||
28098239|NCT03575702|54753988|FG001|Overall Study|Patient non compliance|0|||
28098240|NCT03575468|54753996|FG000|Overall Study|Withdrawal by Subject|3|||
28098241|NCT03575468|54753997|FG001|Overall Study|Withdrawal by Subject|0|||
28098242|NCT03575468|54753996|FG000|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|10|||
28098243|NCT03575468|54753997|FG001|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|4|||
28098244|NCT03575468|54753996|FG000|Overall Study|Lost to Follow-up|13|||
28098245|NCT03575468|54753997|FG001|Overall Study|Lost to Follow-up|17|||
28098246|NCT03573908|54754005|FG000|Treatment Period|Adverse Event|4|||
28098247|NCT03573908|54754006|FG001|Treatment Period|Adverse Event|9|||
28098248|NCT03573908|54754007|FG002|Treatment Period|Adverse Event|0|||
28098249|NCT03573908|54754008|FG003|Treatment Period|Adverse Event|0|||
28098250|NCT03573908|54754009|FG004|Treatment Period|Adverse Event|0|||
28098251|NCT03573908|54754005|FG000|Treatment Period|Protocol Violation|1|||
28098252|NCT03573908|54754006|FG001|Treatment Period|Protocol Violation|0|||
28098253|NCT03573908|54754007|FG002|Treatment Period|Protocol Violation|0|||
28098254|NCT03573908|54754008|FG003|Treatment Period|Protocol Violation|0|||
27909311|NCT02820623|54567185|FG000|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
27909312|NCT02820623|54567186|FG001|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
27909313|NCT02820623|54567187|FG002|Overall Study|Clients declined, piloting condition, or only telehealth|3|||
27909314|NCT02774005|54567195|FG000|Overall Study|Adverse Event|8|||
27909315|NCT02774005|54567195|FG000|Overall Study|Withdrawal by Subject|23|||
27909316|NCT02774005|54567195|FG000|Overall Study|Lost to Follow-up|7|||
27909317|NCT02774005|54567195|FG000|Overall Study|Genetic diagnosis reveals that a patient does not harbour a LHON-specific mtDNA mutation|12|||
27909318|NCT02774005|54567195|FG000|Overall Study|Due to Covid-19 lockdown V9 was not completed|1|||
27909319|NCT02774005|54567195|FG000|Overall Study|Pt not willing to perform onsite V9,did not withdraw consent,not triggered by Covid19 situation|1|||
27909320|NCT02774005|54567195|FG000|Overall Study|Death|1|||
27909321|NCT02774005|54567195|FG000|Overall Study|Patient unable to return for visits. Sent medication back to site|1|||
27909322|NCT02774005|54567195|FG000|Overall Study|Lack of compliance with study medication|4|||
27909323|NCT02774005|54567195|FG000|Overall Study|subject is enrolling in a different LHON study that excludes use of idebenone|1|||
27909324|NCT02774005|54567195|FG000|Overall Study|another study|1|||
27909325|NCT02774005|54567195|FG000|Overall Study|cardiologist imposed travel restriction|1|||
27909326|NCT01975428|54567229|FG000|Overall Study|Lost to Follow-up|17|||
27909327|NCT01975428|54567230|FG001|Overall Study|Lost to Follow-up|4|||
27909328|NCT01975428|54567229|FG000|Overall Study|Withdrawal by Subject|3|||
27909329|NCT01975428|54567230|FG001|Overall Study|Withdrawal by Subject|10|||
27909330|NCT01047540|54567271|FG000|Overall Study|Protocol Violation|1|||
27909331|NCT01047540|54567272|FG001|Overall Study|Protocol Violation|0|||
27909332|NCT01047540|54567273|FG002|Overall Study|Protocol Violation|0|||
27909333|NCT01047540|54567274|FG003|Overall Study|Protocol Violation|0|||
27909334|NCT01047540|54567275|FG004|Overall Study|Protocol Violation|0|||
27909335|NCT01047540|54567271|FG000|Overall Study|Lost to Follow-up|1|||
27909336|NCT01047540|54567272|FG001|Overall Study|Lost to Follow-up|0|||
27909337|NCT01047540|54567273|FG002|Overall Study|Lost to Follow-up|0|||
27909338|NCT01047540|54567274|FG003|Overall Study|Lost to Follow-up|0|||
27909339|NCT01047540|54567275|FG004|Overall Study|Lost to Follow-up|0|||
27909340|NCT01047540|54567271|FG000|Overall Study|Withdrawal by Subject|1|||
27909341|NCT01047540|54567272|FG001|Overall Study|Withdrawal by Subject|0|||
27909342|NCT01047540|54567273|FG002|Overall Study|Withdrawal by Subject|3|||
27909343|NCT01047540|54567274|FG003|Overall Study|Withdrawal by Subject|0|||
27909344|NCT01047540|54567275|FG004|Overall Study|Withdrawal by Subject|1|||
27909345|NCT01047540|54567271|FG000|Overall Study|Pregnancy|1|||
27909346|NCT01047540|54567272|FG001|Overall Study|Pregnancy|0|||
27909347|NCT01047540|54567273|FG002|Overall Study|Pregnancy|0|||
27909348|NCT01047540|54567274|FG003|Overall Study|Pregnancy|0|||
27909349|NCT01047540|54567275|FG004|Overall Study|Pregnancy|0|||
27909350|NCT01047540|54567271|FG000|Overall Study|Adverse Event|1|||
27909351|NCT01047540|54567272|FG001|Overall Study|Adverse Event|0|||
27909352|NCT01047540|54567273|FG002|Overall Study|Adverse Event|0|||
27909353|NCT01047540|54567274|FG003|Overall Study|Adverse Event|0|||
27909354|NCT01047540|54567275|FG004|Overall Study|Adverse Event|0|||
27909355|NCT00521222|54567291|FG000|Overall Study|Lost to Follow-up|0|||
27909356|NCT00521222|54567292|FG001|Overall Study|Lost to Follow-up|0|||
28098255|NCT03573908|54754009|FG004|Treatment Period|Protocol Violation|0|||
28098256|NCT03573908|54754005|FG000|Treatment Period|Withdrawal by Subject|7|||
28098257|NCT03573908|54754006|FG001|Treatment Period|Withdrawal by Subject|5|||
28098258|NCT03573908|54754007|FG002|Treatment Period|Withdrawal by Subject|0|||
28098259|NCT03573908|54754008|FG003|Treatment Period|Withdrawal by Subject|0|||
27993619|NCT02967692|54652188|FG002|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|86|||
27993620|NCT02967692|54652189|FG003|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|82|||
27993621|NCT02967692|54652186|FG000|Overall Study|Progressive disease|3|||
27993622|NCT02967692|54652187|FG001|Overall Study|Progressive disease|15|||
27993623|NCT02967692|54652188|FG002|Overall Study|Progressive disease|99|||
27993624|NCT02967692|54652189|FG003|Overall Study|Progressive disease|128|||
27993625|NCT02967692|54652186|FG000|Overall Study|Subject/guardian decision|1|||
27993626|NCT02967692|54652187|FG001|Overall Study|Subject/guardian decision|1|||
27993627|NCT02967692|54652188|FG002|Overall Study|Subject/guardian decision|6|||
27993628|NCT02967692|54652189|FG003|Overall Study|Subject/guardian decision|13|||
27993629|NCT02967692|54652186|FG000|Overall Study|Death|0|||
27993630|NCT02967692|54652187|FG001|Overall Study|Death|1|||
27993631|NCT02967692|54652188|FG002|Overall Study|Death|10|||
27993632|NCT02967692|54652189|FG003|Overall Study|Death|9|||
27993633|NCT02967692|54652186|FG000|Overall Study|Protocol deviation|1|||
27993634|NCT02967692|54652187|FG001|Overall Study|Protocol deviation|0|||
27993635|NCT02967692|54652188|FG002|Overall Study|Protocol deviation|1|||
27993636|NCT02967692|54652189|FG003|Overall Study|Protocol deviation|1|||
27993637|NCT02967692|54652186|FG000|Overall Study|Lost to Follow-up|0|||
27993638|NCT02967692|54652187|FG001|Overall Study|Lost to Follow-up|0|||
27993639|NCT02967692|54652188|FG002|Overall Study|Lost to Follow-up|1|||
27993640|NCT02967692|54652189|FG003|Overall Study|Lost to Follow-up|0|||
27993641|NCT02967692|54652186|FG000|Overall Study|Physician Decision|0|||
27993642|NCT02967692|54652187|FG001|Overall Study|Physician Decision|0|||
27993643|NCT02967692|54652188|FG002|Overall Study|Physician Decision|13|||
27993644|NCT02967692|54652189|FG003|Overall Study|Physician Decision|9|||
27993645|NCT02967692|54652186|FG000|Overall Study|Adverse Event|1|||
27993646|NCT02967692|54652187|FG001|Overall Study|Adverse Event|9|||
27993647|NCT02967692|54652188|FG002|Overall Study|Adverse Event|51|||
27993648|NCT02967692|54652189|FG003|Overall Study|Adverse Event|23|||
27993649|NCT02677922|54652229|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
27993650|NCT02677922|54652230|FG001|Pre-Treatment Period|Withdrawal by Subject|0|||
27993651|NCT02677922|54652231|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
27993652|NCT02677922|54652232|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
27993653|NCT02677922|54652233|FG004|Pre-Treatment Period|Withdrawal by Subject|0|||
27993654|NCT02677922|54652234|FG005|Pre-Treatment Period|Withdrawal by Subject|1|||
27993655|NCT02677922|54652229|FG000|Treatment Period|Adverse Event|0|||
27993656|NCT02677922|54652230|FG001|Treatment Period|Adverse Event|0|||
27993657|NCT02677922|54652231|FG002|Treatment Period|Adverse Event|1|||
27993658|NCT02677922|54652232|FG003|Treatment Period|Adverse Event|3|||
27993659|NCT02677922|54652233|FG004|Treatment Period|Adverse Event|5|||
27993660|NCT02677922|54652234|FG005|Treatment Period|Adverse Event|2|||
27993661|NCT02677922|54652229|FG000|Treatment Period|Progressive Disease|1|||
27993662|NCT02677922|54652230|FG001|Treatment Period|Progressive Disease|1|||
27993663|NCT02677922|54652231|FG002|Treatment Period|Progressive Disease|0|||
27993664|NCT02677922|54652232|FG003|Treatment Period|Progressive Disease|0|||
27993665|NCT02677922|54652233|FG004|Treatment Period|Progressive Disease|8|||
27993666|NCT02677922|54652234|FG005|Treatment Period|Progressive Disease|7|||
27993667|NCT02677922|54652229|FG000|Treatment Period|Lack of Efficacy|0|||
27993668|NCT02677922|54652230|FG001|Treatment Period|Lack of Efficacy|0|||
27993669|NCT02677922|54652231|FG002|Treatment Period|Lack of Efficacy|0|||
27909357|NCT00521222|54567293|FG002|Overall Study|Lost to Follow-up|1|||
27909358|NCT00521222|54567294|FG003|Overall Study|Lost to Follow-up|1|||
27909359|NCT00521222|54567291|FG000|Overall Study|Withdrawal by Subject|0|||
27909360|NCT00521222|54567292|FG001|Overall Study|Withdrawal by Subject|0|||
27909361|NCT00521222|54567293|FG002|Overall Study|Withdrawal by Subject|2|||
27909362|NCT00521222|54567294|FG003|Overall Study|Withdrawal by Subject|0|||
27909363|NCT00521222|54567291|FG000|Overall Study|Physician Decision|0|||
27909364|NCT00521222|54567292|FG001|Overall Study|Physician Decision|1|||
27909365|NCT00521222|54567293|FG002|Overall Study|Physician Decision|0|||
27909366|NCT00521222|54567294|FG003|Overall Study|Physician Decision|1|||
27909367|NCT01214629|54567328|FG000|Overall Study|Progressive Disease|1|||
27909368|NCT01214629|54567329|FG001|Overall Study|Progressive Disease|1|||
27909369|NCT01214629|54567330|FG002|Overall Study|Progressive Disease|0|||
27909370|NCT01214629|54567331|FG003|Overall Study|Progressive Disease|1|||
27909371|NCT01214629|54567332|FG004|Overall Study|Progressive Disease|2|||
27909372|NCT01214629|54567333|FG005|Overall Study|Progressive Disease|3|||
27909373|NCT01214629|54567334|FG006|Overall Study|Progressive Disease|1|||
27993670|NCT02677922|54652232|FG003|Treatment Period|Lack of Efficacy|1|||
27993671|NCT02677922|54652233|FG004|Treatment Period|Lack of Efficacy|1|||
27993672|NCT02677922|54652234|FG005|Treatment Period|Lack of Efficacy|6|||
27909374|NCT01214629|54567335|FG007|Overall Study|Progressive Disease|1|||
27909375|NCT01214629|54567336|FG008|Overall Study|Progressive Disease|1|||
27993673|NCT02677922|54652229|FG000|Treatment Period|Withdrawal by Subject|0|||
27993674|NCT02677922|54652230|FG001|Treatment Period|Withdrawal by Subject|0|||
27993675|NCT02677922|54652231|FG002|Treatment Period|Withdrawal by Subject|1|||
27993676|NCT02677922|54652232|FG003|Treatment Period|Withdrawal by Subject|3|||
27993677|NCT02677922|54652233|FG004|Treatment Period|Withdrawal by Subject|5|||
27993678|NCT02677922|54652234|FG005|Treatment Period|Withdrawal by Subject|5|||
27993679|NCT02677922|54652229|FG000|Treatment Period|Transition to Commercially Available Treatment|0|||
27993680|NCT02677922|54652230|FG001|Treatment Period|Transition to Commercially Available Treatment|1|||
27993681|NCT02677922|54652231|FG002|Treatment Period|Transition to Commercially Available Treatment|1|||
27993682|NCT02677922|54652232|FG003|Treatment Period|Transition to Commercially Available Treatment|1|||
27909376|NCT01214629|54567337|FG009|Overall Study|Progressive Disease|5|||
27909377|NCT01214629|54567338|FG010|Overall Study|Progressive Disease|1|||
27909378|NCT01214629|54567328|FG000|Overall Study|Adverse Event|0|||
27909379|NCT01214629|54567329|FG001|Overall Study|Adverse Event|0|||
27909380|NCT01214629|54567330|FG002|Overall Study|Adverse Event|0|||
27909381|NCT01214629|54567331|FG003|Overall Study|Adverse Event|1|||
27909382|NCT01214629|54567332|FG004|Overall Study|Adverse Event|0|||
27909383|NCT01214629|54567333|FG005|Overall Study|Adverse Event|1|||
27909384|NCT01214629|54567334|FG006|Overall Study|Adverse Event|0|||
27909385|NCT01214629|54567335|FG007|Overall Study|Adverse Event|0|||
27909386|NCT01214629|54567336|FG008|Overall Study|Adverse Event|0|||
27909387|NCT01214629|54567337|FG009|Overall Study|Adverse Event|1|||
27909388|NCT01214629|54567338|FG010|Overall Study|Adverse Event|0|||
27909389|NCT01214629|54567328|FG000|Overall Study|Physician Decision|0|||
27909390|NCT01214629|54567329|FG001|Overall Study|Physician Decision|0|||
27909391|NCT01214629|54567330|FG002|Overall Study|Physician Decision|0|||
27909392|NCT01214629|54567331|FG003|Overall Study|Physician Decision|0|||
27909393|NCT01214629|54567332|FG004|Overall Study|Physician Decision|0|||
27993683|NCT02677922|54652233|FG004|Treatment Period|Transition to Commercially Available Treatment|1|||
27993684|NCT02677922|54652234|FG005|Treatment Period|Transition to Commercially Available Treatment|2|||
27993685|NCT02677922|54652229|FG000|Treatment Period|Disease Relapse|0|||
27993686|NCT02677922|54652230|FG001|Treatment Period|Disease Relapse|0|||
27993687|NCT02677922|54652231|FG002|Treatment Period|Disease Relapse|0|||
27993688|NCT02677922|54652232|FG003|Treatment Period|Disease Relapse|3|||
27993689|NCT02677922|54652233|FG004|Treatment Period|Disease Relapse|6|||
27993690|NCT02677922|54652234|FG005|Treatment Period|Disease Relapse|1|||
27993691|NCT02677922|54652229|FG000|Treatment Period|Allogeneic HSCT|1|||
27993692|NCT02677922|54652230|FG001|Treatment Period|Allogeneic HSCT|0|||
27993693|NCT02677922|54652231|FG002|Treatment Period|Allogeneic HSCT|0|||
27993694|NCT02677922|54652232|FG003|Treatment Period|Allogeneic HSCT|1|||
27993695|NCT02677922|54652233|FG004|Treatment Period|Allogeneic HSCT|4|||
27993696|NCT02677922|54652234|FG005|Treatment Period|Allogeneic HSCT|1|||
27993697|NCT02677922|54652229|FG000|Treatment Period|Other Reasons|0|||
27993698|NCT02677922|54652230|FG001|Treatment Period|Other Reasons|0|||
27993699|NCT02677922|54652231|FG002|Treatment Period|Other Reasons|0|||
27993700|NCT02677922|54652232|FG003|Treatment Period|Other Reasons|1|||
27993701|NCT02677922|54652233|FG004|Treatment Period|Other Reasons|3|||
27993702|NCT02677922|54652234|FG005|Treatment Period|Other Reasons|5|||
27993703|NCT02677922|54652229|FG000|Treatment Period|Death|0|||
27993704|NCT02677922|54652230|FG001|Treatment Period|Death|0|||
27993705|NCT02677922|54652231|FG002|Treatment Period|Death|0|||
27993706|NCT02677922|54652232|FG003|Treatment Period|Death|0|||
27993707|NCT02677922|54652233|FG004|Treatment Period|Death|12|||
27993708|NCT02677922|54652234|FG005|Treatment Period|Death|1|||
27993709|NCT02677922|54652229|FG000|Treatment Period|Non-compliance with Study Drug|0|||
27909394|NCT01214629|54567333|FG005|Overall Study|Physician Decision|0|||
28098260|NCT03573908|54754009|FG004|Treatment Period|Withdrawal by Subject|0|||
28098261|NCT03573908|54754005|FG000|Treatment Period|Lost to Follow-up|7|||
28098262|NCT03573908|54754006|FG001|Treatment Period|Lost to Follow-up|6|||
28098263|NCT03573908|54754007|FG002|Treatment Period|Lost to Follow-up|0|||
28098264|NCT03573908|54754008|FG003|Treatment Period|Lost to Follow-up|0|||
28098265|NCT03573908|54754009|FG004|Treatment Period|Lost to Follow-up|0|||
28098266|NCT03573908|54754005|FG000|Treatment Period|Pregnancy|1|||
27909395|NCT01214629|54567334|FG006|Overall Study|Physician Decision|0|||
27909396|NCT01214629|54567335|FG007|Overall Study|Physician Decision|0|||
27909397|NCT01214629|54567336|FG008|Overall Study|Physician Decision|0|||
27909398|NCT01214629|54567337|FG009|Overall Study|Physician Decision|0|||
27909399|NCT01214629|54567338|FG010|Overall Study|Physician Decision|1|||
27909400|NCT01214629|54567328|FG000|Overall Study|Withdrawal by Subject|0|||
27993710|NCT02677922|54652230|FG001|Treatment Period|Non-compliance with Study Drug|0|||
27993711|NCT02677922|54652231|FG002|Treatment Period|Non-compliance with Study Drug|0|||
27909401|NCT01214629|54567329|FG001|Overall Study|Withdrawal by Subject|0|||
27909402|NCT01214629|54567330|FG002|Overall Study|Withdrawal by Subject|0|||
27993712|NCT02677922|54652232|FG003|Treatment Period|Non-compliance with Study Drug|0|||
27993713|NCT02677922|54652233|FG004|Treatment Period|Non-compliance with Study Drug|1|||
27993714|NCT02677922|54652234|FG005|Treatment Period|Non-compliance with Study Drug|0|||
27993715|NCT02677922|54652229|FG000|Treatment Period|Physician Decision|0|||
27909403|NCT01214629|54567331|FG003|Overall Study|Withdrawal by Subject|0|||
27909404|NCT01214629|54567332|FG004|Overall Study|Withdrawal by Subject|0|||
27993716|NCT02677922|54652230|FG001|Treatment Period|Physician Decision|0|||
27909405|NCT01214629|54567333|FG005|Overall Study|Withdrawal by Subject|0|||
27909406|NCT01214629|54567334|FG006|Overall Study|Withdrawal by Subject|0|||
27993717|NCT02677922|54652231|FG002|Treatment Period|Physician Decision|0|||
27993718|NCT02677922|54652232|FG003|Treatment Period|Physician Decision|0|||
27993719|NCT02677922|54652233|FG004|Treatment Period|Physician Decision|0|||
27993720|NCT02677922|54652234|FG005|Treatment Period|Physician Decision|1|||
27993721|NCT02677922|54652229|FG000|Treatment Period|Symptomatic Deterioration|0|||
27993722|NCT02677922|54652230|FG001|Treatment Period|Symptomatic Deterioration|0|||
27993723|NCT02677922|54652231|FG002|Treatment Period|Symptomatic Deterioration|0|||
27993724|NCT02677922|54652232|FG003|Treatment Period|Symptomatic Deterioration|0|||
27993725|NCT02677922|54652233|FG004|Treatment Period|Symptomatic Deterioration|1|||
27993726|NCT02677922|54652234|FG005|Treatment Period|Symptomatic Deterioration|0|||
27993727|NCT02634710|54652267|FG000|Overall Study|Death|4|||
27993728|NCT02540993|54652282|FG000|Overall Study|Lost to Follow-up|5|||
27993729|NCT02540993|54652283|FG001|Overall Study|Lost to Follow-up|3|||
27993730|NCT02540993|54652282|FG000|Overall Study|Withdrawal by Subject|4|||
27993731|NCT02540993|54652283|FG001|Overall Study|Withdrawal by Subject|6|||
27993732|NCT02540993|54652282|FG000|Overall Study|GCP violations|33|||
27993733|NCT02540993|54652283|FG001|Overall Study|GCP violations|27|||
27993734|NCT02449239|54652318|FG000|Induction Phase|Lack of Efficacy|64|||
27993735|NCT02449239|54652318|FG000|Induction Phase|Adverse Event|1|||
27993736|NCT02449239|54652318|FG000|Induction Phase|Lost to Follow-up|1|||
27993737|NCT02449239|54652318|FG000|Induction Phase|Protocol Violation|1|||
27993738|NCT02449239|54652318|FG000|Induction Phase|Physician Decision|1|||
27993739|NCT02449239|54652318|FG000|Induction Phase|Patient was determined by the sponsor to be ineligible for enrollment|1|||
27993740|NCT02449239|54652318|FG000|Induction Phase|Withdrawal by Subject|1|||
27993741|NCT02449239|54652318|FG000|Maintenance Month 3|Lack of Efficacy|14|||
27993742|NCT02449239|54652318|FG000|Maintenance Month 6|Lack of Efficacy|10|||
27993743|NCT02449239|54652318|FG000|Maintenance Month 6|Adverse Event|2|||
27993744|NCT02449239|54652318|FG000|Maintenance Month 6|Physician Decision|1|||
27993745|NCT02449239|54652318|FG000|Maintenance Month 9|Lack of Efficacy|2|||
27993746|NCT02449239|54652318|FG000|Maintenance Month 9|Started ibrutinib for CLL|1|||
27993747|NCT02449239|54652318|FG000|Maintenance Month 12|Lack of Efficacy|5|||
27993748|NCT02449239|54652318|FG000|Maintenance Month 12|Withdrawal by Subject|1|||
27993749|NCT02449239|54652318|FG000|Maintenance Month 12|Subject moved from area|1|||
27993750|NCT02449239|54652318|FG000|Maintenance Month 15|Lack of Efficacy|1|||
27993751|NCT02449239|54652318|FG000|Maintenance Month 21|Lack of Efficacy|1|||
27993752|NCT02449239|54652318|FG000|Maintenance Month 21|Sponsor decision|1|||
27993753|NCT01292928|54652322|FG000|Overall Study|Death|8|||
27993754|NCT01292928|54652322|FG000|Overall Study|Withdrawal by Subject|8|||
27993755|NCT01292928|54652322|FG000|Overall Study|Lost to Follow-up|6|||
27993756|NCT01292928|54652322|FG000|Overall Study|Physician Decision|2|||
27993757|NCT01012817|54652368|FG000|Overall Study|Withdrawal by Subject|0|||
27993758|NCT01012817|54652369|FG001|Overall Study|Withdrawal by Subject|0|||
27993759|NCT01012817|54652370|FG002|Overall Study|Withdrawal by Subject|0|||
27993760|NCT01012817|54652371|FG003|Overall Study|Withdrawal by Subject|1|||
27993761|NCT01012817|54652372|FG004|Overall Study|Withdrawal by Subject|0|||
27993762|NCT01012817|54652373|FG005|Overall Study|Withdrawal by Subject|0|||
27993763|NCT01012817|54652374|FG006|Overall Study|Withdrawal by Subject|0|||
27993764|NCT01012817|54652375|FG007|Overall Study|Withdrawal by Subject|1|||
27993765|NCT01012817|54652376|FG008|Overall Study|Withdrawal by Subject|0|||
27993766|NCT01012817|54652377|FG009|Overall Study|Withdrawal by Subject|0|||
27993767|NCT01012817|54652378|FG010|Overall Study|Withdrawal by Subject|1|||
27993768|NCT01012817|54652379|FG011|Overall Study|Withdrawal by Subject|1|||
27993769|NCT01012817|54652380|FG012|Overall Study|Withdrawal by Subject|0|||
27909407|NCT01214629|54567335|FG007|Overall Study|Withdrawal by Subject|0|||
27909408|NCT01214629|54567336|FG008|Overall Study|Withdrawal by Subject|0|||
27909409|NCT01214629|54567337|FG009|Overall Study|Withdrawal by Subject|1|||
27909410|NCT01214629|54567338|FG010|Overall Study|Withdrawal by Subject|0|||
27909411|NCT01214434|54567378|FG000|Overall Study|Withdrawal by Subject|1|||
27909412|NCT01214434|54567379|FG001|Overall Study|Withdrawal by Subject|0|||
27909413|NCT01214434|54567378|FG000|Overall Study|Lost to Follow-up|2|||
27909414|NCT01214434|54567379|FG001|Overall Study|Lost to Follow-up|2|||
27909415|NCT01214434|54567378|FG000|Overall Study|Site error|1|||
27909416|NCT01214434|54567379|FG001|Overall Study|Site error|0|||
27909417|NCT01214395|54567385|FG000|Overall Study|All patients had infection|5|||
27909418|NCT01214239|54567392|FG000|Overall Study|Adverse Event|3|||
27993770|NCT01012817|54652381|FG013|Overall Study|Withdrawal by Subject|1|||
27993771|NCT01012817|54652368|FG000|Overall Study|Adverse Event|0|||
27993772|NCT01012817|54652369|FG001|Overall Study|Adverse Event|0|||
27993773|NCT01012817|54652370|FG002|Overall Study|Adverse Event|0|||
27993774|NCT01012817|54652371|FG003|Overall Study|Adverse Event|0|||
27993775|NCT01012817|54652372|FG004|Overall Study|Adverse Event|0|||
27993776|NCT01012817|54652373|FG005|Overall Study|Adverse Event|1|||
27993777|NCT01012817|54652374|FG006|Overall Study|Adverse Event|0|||
27909419|NCT01214239|54567393|FG001|Overall Study|Adverse Event|4|||
27909420|NCT01214239|54567392|FG000|Overall Study|Protocol Violation|2|||
27909421|NCT01214239|54567393|FG001|Overall Study|Protocol Violation|1|||
27993778|NCT01012817|54652375|FG007|Overall Study|Adverse Event|0|||
27993779|NCT01012817|54652376|FG008|Overall Study|Adverse Event|0|||
27993780|NCT01012817|54652377|FG009|Overall Study|Adverse Event|0|||
27993781|NCT01012817|54652378|FG010|Overall Study|Adverse Event|1|||
27993782|NCT01012817|54652379|FG011|Overall Study|Adverse Event|0|||
27993783|NCT01012817|54652380|FG012|Overall Study|Adverse Event|0|||
27993784|NCT01012817|54652381|FG013|Overall Study|Adverse Event|1|||
27993785|NCT00581828|54652411|FG000|Overall Study|Protocol Violation|1|||
27993786|NCT00220337|54652460|FG000|Overall Study|Adverse Event|70|||
27993787|NCT00220337|54652460|FG000|Overall Study|Lack of Efficacy|17|||
27993788|NCT00220337|54652460|FG000|Overall Study|Withdrawal by Subject|68|||
27993789|NCT00220337|54652460|FG000|Overall Study|Protocol Violation|2|||
27993790|NCT00220337|54652460|FG000|Overall Study|Lost to Follow-up|5|||
27993791|NCT00220337|54652460|FG000|Overall Study|Other|12|||
27993792|NCT00220337|54652460|FG000|Overall Study|Unsatisfactory compliance|5|||
27993793|NCT00576316|54652476|FG000|Overall Study|Adverse Event|9|||
27909422|NCT01214239|54567392|FG000|Overall Study|Lost to Follow-up|1|||
27909423|NCT01214239|54567393|FG001|Overall Study|Lost to Follow-up|1|||
27909424|NCT01214239|54567392|FG000|Overall Study|Withdrawal by Subject|4|||
27909425|NCT01214239|54567393|FG001|Overall Study|Withdrawal by Subject|9|||
27909426|NCT01214239|54567392|FG000|Overall Study|Lack of Efficacy|1|||
27993794|NCT00576316|54652476|FG000|Overall Study|Withdrawal by Subject|2|||
27993795|NCT00576316|54652476|FG000|Overall Study|Protocol Violation|9|||
27993796|NCT00823134|54652480|FG000|Overall Study|Invalid measurement|1|||
27993797|NCT00831792|54652485|FG000|Overall Study|Not Eligible|3|||
27993798|NCT00831792|54652485|FG000|Overall Study|Adverse Event|1|||
27993799|NCT00831792|54652485|FG000|Overall Study|Death|1|||
27993800|NCT00831792|54652485|FG000|Overall Study|Lack of Efficacy|1|||
27993801|NCT00575380|54652491|FG000|Overall Study|Withdrawal by Subject|1|||
27993802|NCT00575380|54652492|FG001|Overall Study|Withdrawal by Subject|0|||
27993803|NCT00575380|54652491|FG000|Overall Study|Adverse Event|0|||
27993804|NCT00575380|54652492|FG001|Overall Study|Adverse Event|1|||
27993805|NCT00575380|54652491|FG000|Overall Study|Various|0|||
27993806|NCT00575380|54652492|FG001|Overall Study|Various|2|||
27993807|NCT00840996|54652500|FG000|Overall Study|Withdrawal by Subject|1|||
27993808|NCT00840996|54652501|FG001|Overall Study|Withdrawal by Subject|0|||
27993809|NCT00680914|54652509|FG000|Overall Study|Consent withdrawal|6|||
27993810|NCT00680914|54652510|FG001|Overall Study|Consent withdrawal|3|||
27993811|NCT00680914|54652509|FG000|Overall Study|Lost to Follow-up|4|||
27993812|NCT00680914|54652510|FG001|Overall Study|Lost to Follow-up|0|||
27993813|NCT00680914|54652509|FG000|Overall Study|serious adverse event (SAE)|0|||
27993814|NCT00680914|54652510|FG001|Overall Study|serious adverse event (SAE)|1|||
27993815|NCT00680836|54652518|FG000|Overall Study|Withdrawal by Subject|3|||
27909427|NCT01214239|54567393|FG001|Overall Study|Lack of Efficacy|2|||
27993816|NCT00680836|54652519|FG001|Overall Study|Withdrawal by Subject|0|||
27993817|NCT00680836|54652518|FG000|Overall Study|Lost to Follow-up|3|||
27993818|NCT00680836|54652519|FG001|Overall Study|Lost to Follow-up|1|||
27993819|NCT00680836|54652518|FG000|Overall Study|Physician Decision|2|||
27993820|NCT00680836|54652519|FG001|Overall Study|Physician Decision|1|||
27993821|NCT00679432|54652530|FG000|Overall Study|Adverse Event|5|||
27993822|NCT00679432|54652531|FG001|Overall Study|Adverse Event|6|||
27909428|NCT01214239|54567392|FG000|Overall Study|patient's private reason|1|||
27909429|NCT01214239|54567393|FG001|Overall Study|patient's private reason|1|||
27909430|NCT01214200|54567399|FG000|Overall Study|Did not meet inclusion/exclusion|9|||
27909431|NCT01214200|54567399|FG000|Overall Study|Withdrawal by Subject|2|||
27909432|NCT01214044|54567405|FG000|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5|||
27909433|NCT01214044|54567405|FG000|Visit 1: Screening and Consent, Washout|Ineligible|3|||
27909434|NCT01214044|54567405|FG000|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4|||
27909435|NCT01214044|54567405|FG000|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3|||
27909436|NCT01214044|54567405|FG000|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3|||
27909437|NCT01214044|54567405|FG000|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1|||
27909438|NCT01213966|54567417|FG000|Overall Study|Protocol Violation|1|||
27909439|NCT01213966|54567418|FG001|Overall Study|Protocol Violation|0|||
27909440|NCT01213966|54567419|FG002|Overall Study|Protocol Violation|3|||
27993823|NCT00679432|54652532|FG002|Overall Study|Adverse Event|10|||
27993824|NCT00679432|54652533|FG003|Overall Study|Adverse Event|7|||
27993825|NCT00679432|54652530|FG000|Overall Study|Protocol Violation|1|||
27909441|NCT01213966|54567420|FG003|Overall Study|Protocol Violation|1|||
27993826|NCT00679432|54652531|FG001|Overall Study|Protocol Violation|1|||
27993827|NCT00679432|54652532|FG002|Overall Study|Protocol Violation|2|||
27993828|NCT00679432|54652533|FG003|Overall Study|Protocol Violation|1|||
27993829|NCT00679432|54652530|FG000|Overall Study|Withdrawal by Subject|8|||
27993830|NCT00679432|54652531|FG001|Overall Study|Withdrawal by Subject|11|||
27993831|NCT00679432|54652532|FG002|Overall Study|Withdrawal by Subject|10|||
27993832|NCT00679432|54652533|FG003|Overall Study|Withdrawal by Subject|9|||
27993833|NCT00679432|54652530|FG000|Overall Study|Lost to Follow-up|1|||
27993834|NCT00679432|54652531|FG001|Overall Study|Lost to Follow-up|5|||
27993835|NCT00679432|54652532|FG002|Overall Study|Lost to Follow-up|4|||
27909442|NCT01213264|54567433|FG000|Overall Study|Adverse Event|1|||
27909443|NCT01213264|54567434|FG001|Overall Study|Adverse Event|0|||
27909444|NCT01213264|54567435|FG002|Overall Study|Adverse Event|0|||
27909445|NCT01213264|54567433|FG000|Overall Study|Lost to Follow-up|1|||
27909446|NCT01213264|54567434|FG001|Overall Study|Lost to Follow-up|2|||
27909447|NCT01213264|54567435|FG002|Overall Study|Lost to Follow-up|6|||
27909448|NCT01212991|54567448|FG000|Double-blind|Lost to Follow-up|8|||
27993836|NCT00679432|54652533|FG003|Overall Study|Lost to Follow-up|2|||
27993837|NCT00679432|54652530|FG000|Overall Study|Physician Decision|3|||
27993838|NCT00679432|54652531|FG001|Overall Study|Physician Decision|2|||
27993839|NCT00679432|54652532|FG002|Overall Study|Physician Decision|2|||
27993840|NCT00679432|54652533|FG003|Overall Study|Physician Decision|2|||
27993841|NCT00679432|54652530|FG000|Overall Study|Sponsor decision|1|||
27993842|NCT00679432|54652531|FG001|Overall Study|Sponsor decision|0|||
27909449|NCT01212991|54567449|FG001|Double-blind|Lost to Follow-up|4|||
27909450|NCT01212991|54567450|FG002|Double-blind|Lost to Follow-up|0|||
27909451|NCT01212991|54567448|FG000|Double-blind|Death|699|||
27909452|NCT01212991|54567449|FG001|Double-blind|Death|550|||
27909453|NCT01212991|54567450|FG002|Double-blind|Death|0|||
27909454|NCT01212991|54567448|FG000|Double-blind|Withdrawal by Subject|16|||
27909455|NCT01212991|54567449|FG001|Double-blind|Withdrawal by Subject|19|||
27909456|NCT01212991|54567450|FG002|Double-blind|Withdrawal by Subject|0|||
27909457|NCT01212991|54567448|FG000|Double-blind|Other|7|||
27909458|NCT01212991|54567449|FG001|Double-blind|Other|0|||
27909459|NCT01212991|54567450|FG002|Double-blind|Other|0|||
27993843|NCT00679432|54652532|FG002|Overall Study|Sponsor decision|0|||
27993844|NCT00679432|54652533|FG003|Overall Study|Sponsor decision|0|||
27993845|NCT00679432|54652530|FG000|Overall Study|Lack of Efficacy|13|||
27993846|NCT00679432|54652531|FG001|Overall Study|Lack of Efficacy|9|||
27993847|NCT00679432|54652532|FG002|Overall Study|Lack of Efficacy|14|||
27993848|NCT00679432|54652533|FG003|Overall Study|Lack of Efficacy|8|||
27993849|NCT00679432|54652530|FG000|Overall Study|Infectious colitis, normal histology|5|||
27993850|NCT00679432|54652531|FG001|Overall Study|Infectious colitis, normal histology|4|||
27993851|NCT00679432|54652532|FG002|Overall Study|Infectious colitis, normal histology|8|||
27993852|NCT00679432|54652533|FG003|Overall Study|Infectious colitis, normal histology|3|||
27993853|NCT00679432|54652530|FG000|Overall Study|Randomization error, return to prior Rx|0|||
27993854|NCT00679432|54652531|FG001|Overall Study|Randomization error, return to prior Rx|0|||
27993855|NCT00679432|54652532|FG002|Overall Study|Randomization error, return to prior Rx|3|||
27993856|NCT00679432|54652533|FG003|Overall Study|Randomization error, return to prior Rx|0|||
27993857|NCT00679354|54652543|FG000|Overall Study|Death|3|||
27993858|NCT00679354|54652543|FG000|Overall Study|Lack of Efficacy|22|||
27993859|NCT00679354|54652543|FG000|Overall Study|Physician Decision|4|||
27993860|NCT00679354|54652543|FG000|Overall Study|Ineligible|1|||
27993861|NCT00822900|54652550|FG000|Overall Study|Withdrawal by Subject|14|||
27993862|NCT00822900|54652551|FG001|Overall Study|Withdrawal by Subject|14|||
27993863|NCT00822900|54652550|FG000|Overall Study|Lost to Follow-up|9|||
27993864|NCT00822900|54652551|FG001|Overall Study|Lost to Follow-up|9|||
27993865|NCT00822900|54652550|FG000|Overall Study|Death|83|||
27993866|NCT00822900|54652551|FG001|Overall Study|Death|69|||
27993867|NCT00822900|54652550|FG000|Overall Study|Became a ward of the state|2|||
27993868|NCT00822900|54652551|FG001|Overall Study|Became a ward of the state|1|||
27993869|NCT00682786|54652559|FG000|Overall Study|Withdrawal by Subject|2|||
27993870|NCT00682786|54652560|FG001|Overall Study|Withdrawal by Subject|2|||
27993871|NCT00682786|54652559|FG000|Overall Study|Did not receive irinotecan|0|||
27993872|NCT00682786|54652560|FG001|Overall Study|Did not receive irinotecan|1|||
27993873|NCT00840450|54652572|FG000|Overall Study|Adverse Event|1|||
27993874|NCT00840450|54652572|FG000|Overall Study|Lack of Efficacy|2|||
27993875|NCT00840294|54652578|FG000|Overall Study|Withdrawal by Subject|2|||
27993876|NCT00840294|54652579|FG001|Overall Study|Withdrawal by Subject|1|||
27993877|NCT00840294|54652578|FG000|Overall Study|Protocol Violation|1|||
27993878|NCT00840294|54652579|FG001|Overall Study|Protocol Violation|3|||
27993879|NCT00840294|54652578|FG000|Overall Study|Illness|0|||
27993880|NCT00840294|54652579|FG001|Overall Study|Illness|1|||
27909460|NCT01212991|54567448|FG000|Double-blind|Sponsor decision|142|||
27993881|NCT00679042|54652585|FG000|Transplant + 1 Year Follow Up|Withdrawal by Subject|2|||
27993882|NCT00679042|54652585|FG000|5-Year Follow Up|In follow-up (ongoing)|6|||
28098267|NCT03573908|54754006|FG001|Treatment Period|Pregnancy|0|||
28098268|NCT03573908|54754007|FG002|Treatment Period|Pregnancy|0|||
27993883|NCT00679042|54652585|FG000|5-Year Follow Up|Death|1|||
28098269|NCT03573908|54754008|FG003|Treatment Period|Pregnancy|0|||
27909461|NCT01212991|54567449|FG001|Double-blind|Sponsor decision|38|||
27909462|NCT01212991|54567450|FG002|Double-blind|Sponsor decision|0|||
27909463|NCT01212991|54567448|FG000|Open-label|Death|0|||
28098270|NCT03573908|54754009|FG004|Treatment Period|Pregnancy|0|||
27909464|NCT01212991|54567449|FG001|Open-label|Death|0|||
27909465|NCT01212991|54567450|FG002|Open-label|Death|166|||
27993884|NCT00679042|54652585|FG000|5-Year Follow Up|Did not consent to continue into 10-year follow up|7|||
27993885|NCT00679042|54652585|FG000|10-Year Follow Up|In follow-up (ongoing)|5|||
27993886|NCT00680368|54652589|FG000|Overall Study|not supervised, not eligible|15|||
27993887|NCT00680056|54652597|FG000|First Intervention|Mainly Exacerbation of COPD|1|||
27993888|NCT00680056|54652598|FG001|First Intervention|Mainly Exacerbation of COPD|2|||
27993889|NCT00680056|54652597|FG000|Second Intervention|Protocol Violation|3|||
27993890|NCT00680056|54652598|FG001|Second Intervention|Protocol Violation|1|||
27993891|NCT00680992|54652608|FG000|Overall Study|Complete Resection (as per protocol)|25|||
27993892|NCT00680992|54652609|FG001|Overall Study|Complete Resection (as per protocol)|121|||
27993893|NCT00680992|54652610|FG002|Overall Study|Complete Resection (as per protocol)|0|||
27993894|NCT00680992|54652608|FG000|Overall Study|Administrative Decision|83|||
27993895|NCT00680992|54652609|FG001|Overall Study|Administrative Decision|42|||
27993896|NCT00680992|54652610|FG002|Overall Study|Administrative Decision|5|||
27993897|NCT00680992|54652608|FG000|Overall Study|End of Trial|32|||
27993898|NCT00680992|54652609|FG001|Overall Study|End of Trial|12|||
27993899|NCT00680992|54652610|FG002|Overall Study|End of Trial|3|||
27993900|NCT00680992|54652608|FG000|Overall Study|Withdrawal by Subject|33|||
27993901|NCT00680992|54652609|FG001|Overall Study|Withdrawal by Subject|11|||
27909466|NCT01212991|54567448|FG000|Open-label|Lost to Follow-up|0|||
27909467|NCT01212991|54567449|FG001|Open-label|Lost to Follow-up|0|||
27909468|NCT01212991|54567450|FG002|Open-label|Lost to Follow-up|5|||
27909469|NCT01212991|54567448|FG000|Open-label|Withdrawal by Subject|0|||
27909470|NCT01212991|54567449|FG001|Open-label|Withdrawal by Subject|0|||
27909471|NCT01212991|54567450|FG002|Open-label|Withdrawal by Subject|7|||
27909472|NCT01212991|54567448|FG000|Open-label|Sponsor decision|0|||
27909473|NCT01212991|54567449|FG001|Open-label|Sponsor decision|0|||
27909474|NCT01212991|54567450|FG002|Open-label|Sponsor decision|53|||
27909475|NCT01212991|54567448|FG000|Open-label|Other|0|||
27909476|NCT01212991|54567449|FG001|Open-label|Other|0|||
27909477|NCT01212991|54567450|FG002|Open-label|Other|3|||
27909478|NCT01212757|54567461|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
27909479|NCT01212757|54567462|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
27909480|NCT01212757|54567463|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
27909481|NCT01212757|54567464|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
27909482|NCT01212757|54567465|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
27909483|NCT01212757|54567466|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
27909484|NCT01212757|54567467|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
27909485|NCT01212757|54567468|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
27909486|NCT01212757|54567469|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
27909487|NCT01212757|54567461|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
27909488|NCT01212757|54567462|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
27909489|NCT01212757|54567463|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
27909490|NCT01212757|54567464|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
27909491|NCT01212757|54567465|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
27909492|NCT01212757|54567466|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
27909493|NCT01212757|54567467|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
27909494|NCT01212757|54567468|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
27909495|NCT01212757|54567469|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
27909496|NCT01212757|54567461|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7|||
27909497|NCT01212757|54567462|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9|||
27909498|NCT01212757|54567463|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
27909499|NCT01212757|54567464|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
27909500|NCT01212757|54567465|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
27909501|NCT01212757|54567466|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
27909502|NCT01212757|54567467|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
27909503|NCT01212757|54567468|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
27909504|NCT01212757|54567469|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
27909505|NCT01212757|54567461|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3|||
27909506|NCT01212757|54567462|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
27909507|NCT01212757|54567463|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
27909508|NCT01212757|54567464|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
27909509|NCT01212757|54567465|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
27909510|NCT01212757|54567466|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
27909511|NCT01212757|54567467|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
27909512|NCT01212757|54567468|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
27909513|NCT01212757|54567469|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
27909514|NCT01212757|54567461|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
27993902|NCT00680992|54652610|FG002|Overall Study|Withdrawal by Subject|1|||
27909515|NCT01212757|54567462|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
27993903|NCT00680992|54652608|FG000|Overall Study|Adverse Event|21|||
27993904|NCT00680992|54652609|FG001|Overall Study|Adverse Event|19|||
27993905|NCT00680992|54652610|FG002|Overall Study|Adverse Event|1|||
27993906|NCT00680992|54652608|FG000|Overall Study|Other|19|||
27909516|NCT01212757|54567463|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
27909517|NCT01212757|54567464|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
27993907|NCT00680992|54652609|FG001|Overall Study|Other|14|||
27993908|NCT00680992|54652610|FG002|Overall Study|Other|1|||
27993909|NCT00680992|54652608|FG000|Overall Study|Disease Progression|21|||
27993910|NCT00680992|54652609|FG001|Overall Study|Disease Progression|9|||
27993911|NCT00680992|54652610|FG002|Overall Study|Disease Progression|0|||
27993912|NCT00680992|54652608|FG000|Overall Study|Lost to Follow-up|12|||
27993913|NCT00680992|54652609|FG001|Overall Study|Lost to Follow-up|14|||
27993914|NCT00680992|54652610|FG002|Overall Study|Lost to Follow-up|0|||
27993915|NCT00680992|54652608|FG000|Overall Study|Noncompliance|4|||
27993916|NCT00680992|54652609|FG001|Overall Study|Noncompliance|6|||
27993917|NCT00680992|54652610|FG002|Overall Study|Noncompliance|0|||
27993918|NCT00680992|54652608|FG000|Overall Study|Requirement for Alternative Therapy|8|||
27993919|NCT00680992|54652609|FG001|Overall Study|Requirement for Alternative Therapy|2|||
27993920|NCT00680992|54652610|FG002|Overall Study|Requirement for Alternative Therapy|0|||
27993921|NCT00680992|54652608|FG000|Overall Study|Pregnancy|5|||
27993922|NCT00680992|54652609|FG001|Overall Study|Pregnancy|0|||
27993923|NCT00680992|54652610|FG002|Overall Study|Pregnancy|1|||
27993924|NCT00680992|54652608|FG000|Overall Study|Death|5|||
27993925|NCT00680992|54652609|FG001|Overall Study|Death|1|||
27993926|NCT00680992|54652610|FG002|Overall Study|Death|0|||
27993927|NCT00680992|54652608|FG000|Overall Study|Ineligibility Determined|0|||
27993928|NCT00680992|54652609|FG001|Overall Study|Ineligibility Determined|1|||
27739689|NCT02138110|54189321|FG000|Overall Scaffold Implantation|Death|3|||
27739690|NCT02223754|54189327|FG000|Period 1|Adverse Event|1|||
27739691|NCT02223754|54189328|FG001|Period 1|Adverse Event|0|||
27739692|NCT02223754|54189327|FG000|Period 1|Lost to Follow-up|0|||
27739693|NCT02223754|54189328|FG001|Period 1|Lost to Follow-up|1|||
27739694|NCT02223754|54189327|FG000|Period 1|Protocol Violation|2|||
27739695|NCT02223754|54189328|FG001|Period 1|Protocol Violation|4|||
27739696|NCT02223754|54189327|FG000|Period 1|Withdrawal by Subject|0|||
27909518|NCT01212757|54567465|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
27909519|NCT01212757|54567466|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
27909520|NCT01212757|54567467|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
27909521|NCT01212757|54567468|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
27993929|NCT00680992|54652610|FG002|Overall Study|Ineligibility Determined|0|||
27993930|NCT00805389|54652624|FG000|Overall Study|Adverse Event|0|||
27993931|NCT00805389|54652625|FG001|Overall Study|Adverse Event|0|||
27993932|NCT00805389|54652626|FG002|Overall Study|Adverse Event|1|||
27993933|NCT00805389|54652627|FG003|Overall Study|Adverse Event|2|||
27993934|NCT00805389|54652628|FG004|Overall Study|Adverse Event|0|||
27993935|NCT00805389|54652624|FG000|Overall Study|Lost to Follow-up|4|||
27993936|NCT00805389|54652625|FG001|Overall Study|Lost to Follow-up|3|||
27993937|NCT00805389|54652626|FG002|Overall Study|Lost to Follow-up|6|||
27993938|NCT00805389|54652627|FG003|Overall Study|Lost to Follow-up|10|||
27993939|NCT00805389|54652628|FG004|Overall Study|Lost to Follow-up|9|||
27993940|NCT00805389|54652624|FG000|Overall Study|Protocol Violation|0|||
27993941|NCT00805389|54652625|FG001|Overall Study|Protocol Violation|0|||
27993942|NCT00805389|54652626|FG002|Overall Study|Protocol Violation|1|||
27993943|NCT00805389|54652627|FG003|Overall Study|Protocol Violation|0|||
27993944|NCT00805389|54652628|FG004|Overall Study|Protocol Violation|0|||
27993945|NCT00805389|54652624|FG000|Overall Study|Withdrawal by Subject|3|||
27993946|NCT00805389|54652625|FG001|Overall Study|Withdrawal by Subject|2|||
27993947|NCT00805389|54652626|FG002|Overall Study|Withdrawal by Subject|4|||
27993948|NCT00805389|54652627|FG003|Overall Study|Withdrawal by Subject|5|||
27993949|NCT00805389|54652628|FG004|Overall Study|Withdrawal by Subject|4|||
27993950|NCT00678886|54652652|FG000|Overall Study|Withdrawal by Subject|0|||
27993951|NCT00678886|54652653|FG001|Overall Study|Withdrawal by Subject|0|||
27909522|NCT01212757|54567469|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
27909523|NCT01212757|54567461|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
27909524|NCT01212757|54567462|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
27909525|NCT01212757|54567463|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
27993952|NCT00678886|54652654|FG002|Overall Study|Withdrawal by Subject|4|||
27993953|NCT00678886|54652655|FG003|Overall Study|Withdrawal by Subject|6|||
27993954|NCT00678886|54652652|FG000|Overall Study|Physician Decision|0|||
27993955|NCT00678886|54652653|FG001|Overall Study|Physician Decision|0|||
27993956|NCT00678886|54652654|FG002|Overall Study|Physician Decision|1|||
27993957|NCT00678886|54652655|FG003|Overall Study|Physician Decision|1|||
27993958|NCT00678886|54652652|FG000|Overall Study|Lost to Follow-up|0|||
27993959|NCT00678886|54652653|FG001|Overall Study|Lost to Follow-up|0|||
27993960|NCT00678886|54652654|FG002|Overall Study|Lost to Follow-up|3|||
27993961|NCT00678886|54652655|FG003|Overall Study|Lost to Follow-up|2|||
27993962|NCT00678886|54652652|FG000|Overall Study|Other|0|||
27739697|NCT02223754|54189328|FG001|Period 1|Withdrawal by Subject|4|||
27739698|NCT02223754|54189327|FG000|Period 1|Test Article No Longer Available|1|||
27739699|NCT02223754|54189328|FG001|Period 1|Test Article No Longer Available|5|||
27993963|NCT00678886|54652653|FG001|Overall Study|Other|0|||
27993964|NCT00678886|54652654|FG002|Overall Study|Other|1|||
27993965|NCT00678886|54652655|FG003|Overall Study|Other|0|||
27993966|NCT00804843|54652666|FG000|Overall Study|Protocol Violation|1|||
27993967|NCT00804843|54652667|FG001|Overall Study|Protocol Violation|0|||
27993968|NCT00804843|54652666|FG000|Overall Study|Adverse Event|8|||
27993969|NCT00804843|54652667|FG001|Overall Study|Adverse Event|5|||
27993970|NCT00804843|54652666|FG000|Overall Study|Withdrawal by Subject|1|||
27993971|NCT00804843|54652667|FG001|Overall Study|Withdrawal by Subject|2|||
27993972|NCT00822120|54652676|FG000|Initial Registration|Adverse Event|1|||
27993973|NCT00822120|54652677|FG001|Initial Registration|Adverse Event|0|||
27993974|NCT00822120|54652678|FG002|Initial Registration|Adverse Event|0|||
27993975|NCT00822120|54652679|FG003|Initial Registration|Adverse Event|0|||
27993976|NCT00822120|54652680|FG004|Initial Registration|Adverse Event|0|||
27993977|NCT00822120|54652681|FG005|Initial Registration|Adverse Event|0|||
27993978|NCT00822120|54652676|FG000|Initial Registration|Refusal Unrelated to Adverse Event|1|||
27993979|NCT00822120|54652677|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
27993980|NCT00822120|54652678|FG002|Initial Registration|Refusal Unrelated to Adverse Event|0|||
27993981|NCT00822120|54652679|FG003|Initial Registration|Refusal Unrelated to Adverse Event|0|||
27993982|NCT00822120|54652680|FG004|Initial Registration|Refusal Unrelated to Adverse Event|0|||
27993983|NCT00822120|54652681|FG005|Initial Registration|Refusal Unrelated to Adverse Event|0|||
27993984|NCT00822120|54652676|FG000|Initial Registration|Reasons not Protocol Specified|2|||
27993985|NCT00822120|54652677|FG001|Initial Registration|Reasons not Protocol Specified|0|||
27993986|NCT00822120|54652678|FG002|Initial Registration|Reasons not Protocol Specified|0|||
27993987|NCT00822120|54652679|FG003|Initial Registration|Reasons not Protocol Specified|0|||
27993988|NCT00822120|54652680|FG004|Initial Registration|Reasons not Protocol Specified|0|||
27993989|NCT00822120|54652681|FG005|Initial Registration|Reasons not Protocol Specified|0|||
27993990|NCT00822120|54652676|FG000|Initial Registration|Ineligible|22|||
27993991|NCT00822120|54652677|FG001|Initial Registration|Ineligible|1|||
27993992|NCT00822120|54652678|FG002|Initial Registration|Ineligible|0|||
27993993|NCT00822120|54652679|FG003|Initial Registration|Ineligible|0|||
27993994|NCT00822120|54652680|FG004|Initial Registration|Ineligible|0|||
27993995|NCT00822120|54652681|FG005|Initial Registration|Ineligible|0|||
27993996|NCT00822120|54652676|FG000|PET-directed Therapy|Adverse Event|0|||
27993997|NCT00822120|54652677|FG001|PET-directed Therapy|Adverse Event|0|||
27993998|NCT00822120|54652678|FG002|PET-directed Therapy|Adverse Event|0|||
27993999|NCT00822120|54652679|FG003|PET-directed Therapy|Adverse Event|1|||
27994000|NCT00822120|54652680|FG004|PET-directed Therapy|Adverse Event|0|||
27994001|NCT00822120|54652681|FG005|PET-directed Therapy|Adverse Event|0|||
27994002|NCT00822120|54652676|FG000|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
27994003|NCT00822120|54652677|FG001|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
27994004|NCT00822120|54652678|FG002|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
27994005|NCT00822120|54652679|FG003|PET-directed Therapy|Refusal Unrelated to Adverse Event|1|||
27994006|NCT00822120|54652680|FG004|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
27994007|NCT00822120|54652681|FG005|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
27994008|NCT00822120|54652676|FG000|PET-directed Therapy|Death|0|||
27994009|NCT00822120|54652677|FG001|PET-directed Therapy|Death|0|||
27994010|NCT00822120|54652678|FG002|PET-directed Therapy|Death|0|||
27994011|NCT00822120|54652679|FG003|PET-directed Therapy|Death|2|||
27994012|NCT00822120|54652680|FG004|PET-directed Therapy|Death|0|||
27994013|NCT00822120|54652681|FG005|PET-directed Therapy|Death|0|||
27994014|NCT00822120|54652676|FG000|PET-directed Therapy|Protocol Violation|0|||
27994015|NCT00822120|54652677|FG001|PET-directed Therapy|Protocol Violation|0|||
27994016|NCT00822120|54652678|FG002|PET-directed Therapy|Protocol Violation|0|||
27909526|NCT01212757|54567464|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
27909527|NCT01212757|54567465|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
27909528|NCT01212757|54567466|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
27909529|NCT01212757|54567467|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
27909530|NCT01212757|54567468|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
27909531|NCT01212757|54567469|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
27909532|NCT01212757|54567461|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
27909533|NCT01212757|54567462|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
27909534|NCT01212757|54567463|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
27909535|NCT01212757|54567464|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
27994017|NCT00822120|54652679|FG003|PET-directed Therapy|Protocol Violation|6|||
27909536|NCT01212757|54567465|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
27994018|NCT00822120|54652680|FG004|PET-directed Therapy|Protocol Violation|0|||
27994019|NCT00822120|54652681|FG005|PET-directed Therapy|Protocol Violation|0|||
27994020|NCT00804687|54652702|FG000|Period 3: Treatment Period|Positive Drug screen|0|||
27994021|NCT00804687|54652703|FG001|Period 3: Treatment Period|Positive Drug screen|0|||
27994022|NCT00804687|54652704|FG002|Period 3: Treatment Period|Positive Drug screen|0|||
27994023|NCT00804687|54652705|FG003|Period 3: Treatment Period|Positive Drug screen|1|||
27994024|NCT00804687|54652706|FG004|Period 3: Treatment Period|Positive Drug screen|0|||
27994025|NCT00804687|54652707|FG005|Period 3: Treatment Period|Positive Drug screen|0|||
27994026|NCT00804687|54652702|FG000|Period 5: Treatment Period|Withdrawal by Subject|0|||
27994027|NCT00804687|54652703|FG001|Period 5: Treatment Period|Withdrawal by Subject|0|||
27994028|NCT00804687|54652704|FG002|Period 5: Treatment Period|Withdrawal by Subject|0|||
27909537|NCT01212757|54567466|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
27909538|NCT01212757|54567467|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
27909539|NCT01212757|54567468|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
27909540|NCT01212757|54567469|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
27909541|NCT01212757|54567461|FG000|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
27909542|NCT01212757|54567462|FG001|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
27994029|NCT00804687|54652705|FG003|Period 5: Treatment Period|Withdrawal by Subject|0|||
27994030|NCT00804687|54652706|FG004|Period 5: Treatment Period|Withdrawal by Subject|1|||
27994031|NCT00804687|54652707|FG005|Period 5: Treatment Period|Withdrawal by Subject|0|||
27994032|NCT00804687|54652702|FG000|Period 5: Treatment Period|Positive drugs of abuse|0|||
27994033|NCT00804687|54652703|FG001|Period 5: Treatment Period|Positive drugs of abuse|0|||
27994034|NCT00804687|54652704|FG002|Period 5: Treatment Period|Positive drugs of abuse|1|||
27994035|NCT00804687|54652705|FG003|Period 5: Treatment Period|Positive drugs of abuse|0|||
27994036|NCT00804687|54652706|FG004|Period 5: Treatment Period|Positive drugs of abuse|0|||
27994037|NCT00804687|54652707|FG005|Period 5: Treatment Period|Positive drugs of abuse|0|||
27994038|NCT00804687|54652702|FG000|Period 5: Treatment Period|Positive drug test|1|||
27994039|NCT00804687|54652703|FG001|Period 5: Treatment Period|Positive drug test|0|||
27994040|NCT00804687|54652704|FG002|Period 5: Treatment Period|Positive drug test|0|||
27994041|NCT00804687|54652705|FG003|Period 5: Treatment Period|Positive drug test|0|||
27994042|NCT00804687|54652706|FG004|Period 5: Treatment Period|Positive drug test|0|||
27994043|NCT00804687|54652707|FG005|Period 5: Treatment Period|Positive drug test|0|||
27994044|NCT00678652|54652719|FG000|Overall Study|Protocol Violation|2|||
27994045|NCT00678652|54652720|FG001|Overall Study|Protocol Violation|0|||
27994046|NCT00678652|54652721|FG002|Overall Study|Protocol Violation|0|||
27994047|NCT00678652|54652722|FG003|Overall Study|Protocol Violation|0|||
27994048|NCT00678652|54652719|FG000|Overall Study|Pregnancy|0|||
27994049|NCT00678652|54652720|FG001|Overall Study|Pregnancy|0|||
27994050|NCT00678652|54652721|FG002|Overall Study|Pregnancy|1|||
27994051|NCT00678652|54652722|FG003|Overall Study|Pregnancy|0|||
27994052|NCT00678652|54652719|FG000|Overall Study|Relocation|1|||
27994053|NCT00678652|54652720|FG001|Overall Study|Relocation|0|||
27994054|NCT00678652|54652721|FG002|Overall Study|Relocation|0|||
27994055|NCT00678652|54652722|FG003|Overall Study|Relocation|0|||
27994056|NCT00840060|54652743|FG000|Overall Study|Withdrawal by Subject|1|||
27994057|NCT00840060|54652744|FG001|Overall Study|Withdrawal by Subject|0|||
27994058|NCT00840060|54652743|FG000|Overall Study|Change in emotional/behavioral status|0|||
27994059|NCT00840060|54652744|FG001|Overall Study|Change in emotional/behavioral status|1|||
27994060|NCT00574912|54652750|FG000|Overall Study|Could not place IV lines.|3|||
27994061|NCT00574912|54652750|FG000|Overall Study|scheduling conflicts|3|||
27994062|NCT00574912|54652750|FG000|Overall Study|Physician Decision|2|||
27994063|NCT00674128|54652764|FG000|Overall Study|Withdrawal by Subject|25|||
27994064|NCT00674128|54652765|FG001|Overall Study|Withdrawal by Subject|23|||
27994065|NCT00804141|54652771|FG000|Overall Study|Adverse Event|157|||
27994066|NCT00804141|54652771|FG000|Overall Study|Death|4|||
27994067|NCT00804141|54652771|FG000|Overall Study|Failed to return|96|||
27994068|NCT00804141|54652771|FG000|Overall Study|Investigator request|8|||
27994069|NCT00804141|54652771|FG000|Overall Study|Protocol Violation|85|||
27994070|NCT00804141|54652771|FG000|Overall Study|Withdrawal by Subject|131|||
27994071|NCT00804141|54652771|FG000|Overall Study|Lack of Efficacy|46|||
27994072|NCT00804141|54652771|FG000|Overall Study|Other than specified|30|||
27994073|NCT00804141|54652771|FG000|Overall Study|Enrolled but not treated|6|||
27994074|NCT00677092|54652775|FG000|Overall Study|Adverse Event|1|||
27994075|NCT00677092|54652775|FG000|Overall Study|Lost to Follow-up|1|||
27994076|NCT00677092|54652775|FG000|Overall Study|Withdrawal by Subject|3|||
27909543|NCT01212757|54567463|FG002|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3|||
27994077|NCT00677092|54652775|FG000|Overall Study|Death Prior to Receiving Treatment|1|||
27994078|NCT00677014|54652783|FG000|Overall Study|Lost to Follow-up|20|||
27994079|NCT00677014|54652784|FG001|Overall Study|Lost to Follow-up|12|||
27994080|NCT00677014|54652785|FG002|Overall Study|Lost to Follow-up|24|||
27994081|NCT00677014|54652783|FG000|Overall Study|Death|6|||
27909544|NCT01212757|54567464|FG003|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1|||
27909545|NCT01212757|54567465|FG004|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
27994082|NCT00677014|54652784|FG001|Overall Study|Death|15|||
27994083|NCT00677014|54652785|FG002|Overall Study|Death|7|||
27994084|NCT00677014|54652783|FG000|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
27994085|NCT00677014|54652784|FG001|Overall Study|Unavailable or unreadable 6 month LVESV|14|||
27994086|NCT00677014|54652785|FG002|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
27994087|NCT00839436|54652796|FG000|Overall Study|Developed exclusionary condition|1|||
27994088|NCT00839436|54652797|FG001|Overall Study|Developed exclusionary condition|0|||
27994089|NCT00839436|54652798|FG002|Overall Study|Developed exclusionary condition|0|||
27994090|NCT00839436|54652796|FG000|Overall Study|Withdrawal by Subject|0|||
27994091|NCT00839436|54652797|FG001|Overall Study|Withdrawal by Subject|1|||
27909546|NCT01212757|54567466|FG005|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
27909547|NCT01212757|54567467|FG006|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
27909548|NCT01212757|54567468|FG007|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
27909549|NCT01212757|54567469|FG008|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
27909550|NCT01212757|54567461|FG000|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
27909551|NCT01212757|54567462|FG001|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5|||
27909552|NCT01212757|54567463|FG002|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7|||
27909553|NCT01212757|54567464|FG003|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4|||
27909554|NCT01212757|54567465|FG004|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
27909555|NCT01212757|54567466|FG005|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2|||
27994092|NCT00839436|54652798|FG002|Overall Study|Withdrawal by Subject|0|||
27994093|NCT00839436|54652796|FG000|Overall Study|Study drug no longer available|0|||
27994094|NCT00839436|54652797|FG001|Overall Study|Study drug no longer available|0|||
27994095|NCT00839436|54652798|FG002|Overall Study|Study drug no longer available|1|||
27994096|NCT00675766|54652819|FG000|Overall Study|Lost to Follow-up|6|||
27994097|NCT00675766|54652820|FG001|Overall Study|Lost to Follow-up|5|||
27994098|NCT00675766|54652821|FG002|Overall Study|Lost to Follow-up|21|||
27994099|NCT00675766|54652822|FG003|Overall Study|Lost to Follow-up|26|||
27994100|NCT00673894|54652834|FG000|First Intervention 4 Weeks|Withdrawal by Subject|1|||
27994101|NCT00673894|54652835|FG001|First Intervention 4 Weeks|Withdrawal by Subject|0|||
27994102|NCT00673894|54652834|FG000|First Intervention 4 Weeks|Adverse Event|1|||
27994103|NCT00673894|54652835|FG001|First Intervention 4 Weeks|Adverse Event|0|||
27994104|NCT00674986|54652843|FG000|Overall Study|Adverse Event|2|||
27994105|NCT00674986|54652844|FG001|Overall Study|Adverse Event|1|||
27994106|NCT00674986|54652843|FG000|Overall Study|Subject withdrew consent|12|||
27994107|NCT00674986|54652844|FG001|Overall Study|Subject withdrew consent|19|||
27994108|NCT00674986|54652843|FG000|Overall Study|Lost to Follow-up|25|||
27994109|NCT00674986|54652844|FG001|Overall Study|Lost to Follow-up|53|||
27994110|NCT00674986|54652843|FG000|Overall Study|Other reasons|4|||
27994111|NCT00674986|54652844|FG001|Overall Study|Other reasons|8|||
27994112|NCT00673816|54652851|FG000|Overall Study|Adverse Event|1|||
27994113|NCT00673816|54652851|FG000|Overall Study|Withdrawal by Subject|1|||
27994114|NCT00673660|54652856|FG000|Overall Study|Lost to Follow-up|107|||
27994115|NCT00672958|54652867|FG000|Overall Study|Adverse Event|11|||
27994116|NCT00672958|54652868|FG001|Overall Study|Adverse Event|9|||
27994117|NCT00672958|54652867|FG000|Overall Study|Lack of Efficacy|6|||
27909556|NCT01212757|54567467|FG006|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
27909557|NCT01212757|54567468|FG007|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
27909558|NCT01212757|54567469|FG008|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
27909559|NCT01212757|54567461|FG000|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
27909560|NCT01212757|54567462|FG001|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
27909561|NCT01212757|54567463|FG002|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2|||
27909562|NCT01212757|54567464|FG003|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
27909563|NCT01212757|54567465|FG004|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
27909564|NCT01212757|54567466|FG005|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
27909565|NCT01212757|54567467|FG006|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
27909566|NCT01212757|54567468|FG007|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
27909567|NCT01212757|54567469|FG008|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
27909568|NCT01212757|54567461|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
27909569|NCT01212757|54567462|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
27909570|NCT01212757|54567463|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7|||
27909571|NCT01212757|54567464|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
27909572|NCT01212757|54567465|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1|||
27909573|NCT01212757|54567466|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
27909574|NCT01212757|54567467|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
27909575|NCT01212757|54567468|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
27909576|NCT01212757|54567469|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
27909577|NCT01212757|54567461|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
27909578|NCT01212757|54567462|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
27909579|NCT01212757|54567463|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
27909580|NCT01212757|54567464|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
27994118|NCT00672958|54652868|FG001|Overall Study|Lack of Efficacy|11|||
27994119|NCT00672958|54652867|FG000|Overall Study|Non-compliance with study drug|2|||
27994120|NCT00672958|54652868|FG001|Overall Study|Non-compliance with study drug|3|||
27994121|NCT00672958|54652867|FG000|Overall Study|Protocol deviations|11|||
27994122|NCT00672958|54652868|FG001|Overall Study|Protocol deviations|5|||
27994123|NCT00672958|54652867|FG000|Overall Study|Voluntary withdrawal|12|||
27909581|NCT01212757|54567465|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
27909582|NCT01212757|54567466|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
27909583|NCT01212757|54567467|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
27909584|NCT01212757|54567468|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
27909585|NCT01212757|54567469|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
27909586|NCT01212757|54567461|FG000|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
27909587|NCT01212757|54567462|FG001|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
27909588|NCT01212757|54567463|FG002|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
27909589|NCT01212757|54567464|FG003|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
27909590|NCT01212757|54567465|FG004|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
27909591|NCT01212757|54567466|FG005|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
27909592|NCT01212757|54567467|FG006|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
27909593|NCT01212757|54567468|FG007|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
27909594|NCT01212757|54567469|FG008|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
27909595|NCT01212757|54567461|FG000|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
27909596|NCT01212757|54567462|FG001|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
27994124|NCT00672958|54652868|FG001|Overall Study|Voluntary withdrawal|8|||
27994125|NCT00672958|54652867|FG000|Overall Study|Lost to Follow-up|22|||
27994126|NCT00672958|54652868|FG001|Overall Study|Lost to Follow-up|17|||
27994127|NCT00672958|54652867|FG000|Overall Study|Reason not specified|0|||
27994128|NCT00672958|54652868|FG001|Overall Study|Reason not specified|3|||
27994129|NCT00672646|54652877|FG000|Overall Study|Lost to Follow-up|0|||
27994130|NCT00672646|54652878|FG001|Overall Study|Lost to Follow-up|1|||
27994131|NCT00672646|54652879|FG002|Overall Study|Lost to Follow-up|2|||
27994132|NCT00672646|54652877|FG000|Overall Study|Withdrawal by Subject|0|||
27994133|NCT00672646|54652878|FG001|Overall Study|Withdrawal by Subject|0|||
27994134|NCT00672646|54652879|FG002|Overall Study|Withdrawal by Subject|1|||
27994135|NCT00672490|54652889|FG000|Overall Study|Withdrawal by Subject|8|||
27994136|NCT00672490|54652890|FG001|Overall Study|Withdrawal by Subject|8|||
27994137|NCT00672490|54652889|FG000|Overall Study|Lack of Compliance|2|||
27994138|NCT00672490|54652890|FG001|Overall Study|Lack of Compliance|7|||
27994139|NCT00672490|54652889|FG000|Overall Study|Mismatch Include/Exclude Criteria|1|||
27994140|NCT00672490|54652890|FG001|Overall Study|Mismatch Include/Exclude Criteria|0|||
27994141|NCT00672490|54652889|FG000|Overall Study|Adverse Event|5|||
27994142|NCT00672490|54652890|FG001|Overall Study|Adverse Event|8|||
28098271|NCT03573908|54754005|FG000|Treatment Period|Other, Not Specified|4|||
28098272|NCT03573908|54754006|FG001|Treatment Period|Other, Not Specified|6|||
28098273|NCT03573908|54754007|FG002|Treatment Period|Other, Not Specified|0|||
27909597|NCT01212757|54567463|FG002|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
27909598|NCT01212757|54567464|FG003|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
27909599|NCT01212757|54567465|FG004|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
27909600|NCT01212757|54567466|FG005|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
27909601|NCT01212757|54567467|FG006|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
27994143|NCT00672490|54652889|FG000|Overall Study|Violation of Concomitant Medicine|1|||
27994144|NCT00672490|54652890|FG001|Overall Study|Violation of Concomitant Medicine|0|||
27994145|NCT00672490|54652889|FG000|Overall Study|Intolerance|0|||
27994146|NCT00672490|54652890|FG001|Overall Study|Intolerance|2|||
27994147|NCT00672490|54652889|FG000|Overall Study|Lost to Follow-up|1|||
27994148|NCT00672490|54652890|FG001|Overall Study|Lost to Follow-up|5|||
27994149|NCT00672490|54652889|FG000|Overall Study|No reason was provided|6|||
27994150|NCT00672490|54652890|FG001|Overall Study|No reason was provided|2|||
27994151|NCT00670930|54652898|FG000|Overall Study|Adminstrative Problem|0|||
27994152|NCT00670930|54652899|FG001|Overall Study|Adminstrative Problem|1|||
27994153|NCT00670930|54652898|FG000|Overall Study|Lost to Follow-up|1|||
27994154|NCT00670930|54652899|FG001|Overall Study|Lost to Follow-up|0|||
27994155|NCT00670540|54652905|FG000|Overall Study|ineligible|17|||
27994156|NCT00670540|54652905|FG000|Overall Study|not living in France|348|||
27994157|NCT00670540|54652905|FG000|Overall Study|refused to participate|189|||
27994158|NCT00670540|54652905|FG000|Overall Study|controls randomised for no follow up|2770|||
27994159|NCT00670540|54652905|FG000|Overall Study|missing information inclusion criteria|1|||
27994160|NCT00591786|54652919|FG000|Overall Study|Withdrawal of Informed Consent|0|||
27994161|NCT00591786|54652920|FG001|Overall Study|Withdrawal of Informed Consent|0|||
27994162|NCT00591786|54652921|FG002|Overall Study|Withdrawal of Informed Consent|1|||
27994163|NCT00591786|54652922|FG003|Overall Study|Withdrawal of Informed Consent|0|||
27994164|NCT00591786|54652923|FG004|Overall Study|Withdrawal of Informed Consent|0|||
27994165|NCT00591786|54652924|FG005|Overall Study|Withdrawal of Informed Consent|0|||
27994166|NCT00591786|54652925|FG006|Overall Study|Withdrawal of Informed Consent|0|||
27994167|NCT00591786|54652926|FG007|Overall Study|Withdrawal of Informed Consent|0|||
27994168|NCT00591786|54652927|FG008|Overall Study|Withdrawal of Informed Consent|0|||
27994169|NCT00591786|54652928|FG009|Overall Study|Withdrawal of Informed Consent|0|||
27994170|NCT00674362|54652952|FG000|Double Blind|Adverse Event|6|||
27994171|NCT00674362|54652953|FG001|Double Blind|Adverse Event|6|||
28098274|NCT03573908|54754008|FG003|Treatment Period|Other, Not Specified|0|||
28172589|NCT02786953|54844320|FG001|Overall Study|Physician Decision|1|||
27909602|NCT01212757|54567468|FG007|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
27909603|NCT01212757|54567469|FG008|Long-Term Safety Phase (Year 2)|Miscellaneous|1|||
27909604|NCT01212757|54567461|FG000|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
27739700|NCT02223754|54189327|FG000|Period 1|Unsatisfactory Visual Response|0|||
27739701|NCT02223754|54189328|FG001|Period 1|Unsatisfactory Visual Response|1|||
27739702|NCT02223754|54189327|FG000|Period 2|Adverse Event|0|||
27739703|NCT02223754|54189328|FG001|Period 2|Adverse Event|1|||
27739704|NCT02223754|54189327|FG000|Period 2|Protocol Violation|1|||
27909605|NCT01212757|54567462|FG001|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
27909606|NCT01212757|54567463|FG002|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
27909607|NCT01212757|54567464|FG003|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
27909608|NCT01212757|54567465|FG004|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
27909609|NCT01212757|54567466|FG005|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
27909610|NCT01212757|54567467|FG006|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
27909611|NCT01212757|54567468|FG007|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
27909612|NCT01212757|54567469|FG008|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
27909613|NCT01212757|54567461|FG000|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
27909614|NCT01212757|54567462|FG001|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
27909615|NCT01212757|54567463|FG002|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2|||
27909616|NCT01212757|54567464|FG003|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
27909617|NCT01212757|54567465|FG004|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
27909618|NCT01212757|54567466|FG005|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
27909619|NCT01212757|54567467|FG006|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
27909620|NCT01212757|54567468|FG007|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
27909621|NCT01212757|54567469|FG008|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
27909622|NCT01212757|54567461|FG000|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
27909623|NCT01212757|54567462|FG001|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7|||
27909624|NCT01212757|54567463|FG002|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9|||
27909625|NCT01212757|54567464|FG003|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
27994172|NCT00674362|54652952|FG000|Double Blind|Lack of Efficacy|2|||
27994173|NCT00674362|54652953|FG001|Double Blind|Lack of Efficacy|6|||
27994174|NCT00674362|54652952|FG000|Double Blind|Loss of efficacy|0|||
27994175|NCT00674362|54652953|FG001|Double Blind|Loss of efficacy|1|||
27994176|NCT00674362|54652952|FG000|Double Blind|Withdrawal by Subject|4|||
27994177|NCT00674362|54652953|FG001|Double Blind|Withdrawal by Subject|3|||
27994178|NCT00674362|54652952|FG000|Double Blind|Other: Loss of Patient Compliance|0|||
27994179|NCT00674362|54652953|FG001|Double Blind|Other: Loss of Patient Compliance|1|||
27994180|NCT00674362|54652952|FG000|Double Blind|Other: Surgery|0|||
27994181|NCT00674362|54652953|FG001|Double Blind|Other: Surgery|1|||
27994182|NCT00674362|54652952|FG000|Open Label|Adverse Event|1|||
27994183|NCT00674362|54652953|FG001|Open Label|Adverse Event|0|||
27994184|NCT00674362|54652952|FG000|Open Label|Other: Subject moved to extension study|1|||
27994185|NCT00674362|54652953|FG001|Open Label|Other: Subject moved to extension study|0|||
27994186|NCT00820950|54652965|FG000|Overall Study|Scheduling Conflict|0|||
27994187|NCT00820950|54652966|FG001|Overall Study|Scheduling Conflict|0|||
27994188|NCT00820950|54652967|FG002|Overall Study|Scheduling Conflict|0|||
27994189|NCT00820950|54652968|FG003|Overall Study|Scheduling Conflict|0|||
27994190|NCT00820950|54652969|FG004|Overall Study|Scheduling Conflict|0|||
27994191|NCT00820950|54652970|FG005|Overall Study|Scheduling Conflict|0|||
27994192|NCT00820950|54652971|FG006|Overall Study|Scheduling Conflict|1|||
27994193|NCT00820950|54652972|FG007|Overall Study|Scheduling Conflict|1|||
27994194|NCT00820950|54652973|FG008|Overall Study|Scheduling Conflict|0|||
27994195|NCT00820950|54652974|FG009|Overall Study|Scheduling Conflict|0|||
27994196|NCT00820950|54652965|FG000|Overall Study|Protocol Violation|1|||
27994197|NCT00820950|54652966|FG001|Overall Study|Protocol Violation|1|||
27994198|NCT00820950|54652967|FG002|Overall Study|Protocol Violation|0|||
27994199|NCT00820950|54652968|FG003|Overall Study|Protocol Violation|0|||
27994200|NCT00820950|54652969|FG004|Overall Study|Protocol Violation|0|||
27994201|NCT00820950|54652970|FG005|Overall Study|Protocol Violation|0|||
27994202|NCT00820950|54652971|FG006|Overall Study|Protocol Violation|0|||
27994203|NCT00820950|54652972|FG007|Overall Study|Protocol Violation|0|||
27994204|NCT00820950|54652973|FG008|Overall Study|Protocol Violation|0|||
27994205|NCT00820950|54652974|FG009|Overall Study|Protocol Violation|0|||
27994206|NCT00670306|54653014|FG000|Overall Study|Adverse Event|8|||
27739705|NCT02223754|54189328|FG001|Period 2|Protocol Violation|0|||
27909626|NCT01212757|54567465|FG004|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
27909627|NCT01212757|54567466|FG005|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
27994207|NCT00670306|54653014|FG000|Overall Study|Lack of Efficacy|10|||
27994208|NCT00670306|54653014|FG000|Overall Study|Withdrawal by Subject|9|||
27994209|NCT00670306|54653014|FG000|Overall Study|Physician Decision|1|||
27994210|NCT00670306|54653014|FG000|Overall Study|Lost to Follow-up|8|||
27994211|NCT00670306|54653014|FG000|Overall Study|incl/excl criterias did not meet|19|||
27994212|NCT00672256|54653018|FG000|Overall Study|PI dropped, bad data|44|||
27994213|NCT00591630|54653026|FG000|Overall Study|Death|0|||
27994214|NCT00591630|54653027|FG001|Overall Study|Death|0|||
27994215|NCT00591630|54653028|FG002|Overall Study|Death|1|||
27994216|NCT00591630|54653029|FG003|Overall Study|Death|0|||
27994217|NCT00670228|54653041|FG000|Overall Study|Adverse Event|1|||
27994218|NCT00670228|54653042|FG001|Overall Study|Adverse Event|0|||
27994219|NCT00670228|54653041|FG000|Overall Study|Death or MACE|0|||
27994220|NCT00670228|54653042|FG001|Overall Study|Death or MACE|1|||
27994221|NCT00670228|54653041|FG000|Overall Study|Not treated|2|||
27994222|NCT00670228|54653042|FG001|Overall Study|Not treated|2|||
27994223|NCT00670228|54653041|FG000|Overall Study|Not meeting the selection criteria|2|||
27994224|NCT00670228|54653042|FG001|Overall Study|Not meeting the selection criteria|0|||
27994225|NCT00570778|54653048|FG000|Overall Study|Protocol deviation|2|||
27994226|NCT00570778|54653049|FG001|Overall Study|Protocol deviation|1|||
27994227|NCT00570778|54653050|FG002|Overall Study|Protocol deviation|2|||
27994228|NCT00570778|54653051|FG003|Overall Study|Protocol deviation|2|||
27994229|NCT00570778|54653048|FG000|Overall Study|Adverse Event|0|||
27994230|NCT00570778|54653049|FG001|Overall Study|Adverse Event|1|||
27994231|NCT00570778|54653050|FG002|Overall Study|Adverse Event|4|||
27994232|NCT00570778|54653051|FG003|Overall Study|Adverse Event|1|||
27994233|NCT00570778|54653048|FG000|Overall Study|Subject withdrew consent|0|||
27994234|NCT00570778|54653049|FG001|Overall Study|Subject withdrew consent|1|||
27994235|NCT00570778|54653050|FG002|Overall Study|Subject withdrew consent|0|||
27994236|NCT00570778|54653051|FG003|Overall Study|Subject withdrew consent|1|||
27994237|NCT00570778|54653048|FG000|Overall Study|Abnormal test procedure|1|||
27994238|NCT00570778|54653049|FG001|Overall Study|Abnormal test procedure|0|||
27994239|NCT00570778|54653050|FG002|Overall Study|Abnormal test procedure|0|||
27994240|NCT00570778|54653051|FG003|Overall Study|Abnormal test procedure|0|||
27994241|NCT00570778|54653048|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
27994242|NCT00570778|54653049|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
27994243|NCT00570778|54653050|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
27994244|NCT00570778|54653051|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
27994245|NCT00570778|54653048|FG000|Overall Study|Lost to Follow-up|0|||
27994246|NCT00570778|54653049|FG001|Overall Study|Lost to Follow-up|0|||
27994247|NCT00570778|54653050|FG002|Overall Study|Lost to Follow-up|1|||
27994248|NCT00570778|54653051|FG003|Overall Study|Lost to Follow-up|0|||
27994249|NCT00570778|54653048|FG000|Overall Study|Subject no longer requires study drug|0|||
27994250|NCT00570778|54653049|FG001|Overall Study|Subject no longer requires study drug|1|||
27994251|NCT00570778|54653050|FG002|Overall Study|Subject no longer requires study drug|0|||
27994252|NCT00570778|54653051|FG003|Overall Study|Subject no longer requires study drug|0|||
27994253|NCT00668746|54653063|FG000|Overall Study|Lost to Follow-up|2|||
27994254|NCT00668746|54653064|FG001|Overall Study|Lost to Follow-up|1|||
27994255|NCT00878189|54653082|FG000|Overall Study|Death|0|||
27994256|NCT00878189|54653083|FG001|Overall Study|Death|1|||
27994257|NCT00878189|54653084|FG002|Overall Study|Death|0|||
27994258|NCT00878189|54653085|FG003|Overall Study|Death|1|||
27994259|NCT00878189|54653086|FG004|Overall Study|Death|0|||
27994260|NCT00878189|54653087|FG005|Overall Study|Death|0|||
27994261|NCT00878189|54653088|FG006|Overall Study|Death|0|||
27994262|NCT00878189|54653089|FG007|Overall Study|Death|0|||
27994263|NCT00878189|54653090|FG008|Overall Study|Death|1|||
27994264|NCT00878189|54653082|FG000|Overall Study|Participant Refused to Follow-up|0|||
27994265|NCT00878189|54653083|FG001|Overall Study|Participant Refused to Follow-up|0|||
27994266|NCT00878189|54653084|FG002|Overall Study|Participant Refused to Follow-up|0|||
27994267|NCT00878189|54653085|FG003|Overall Study|Participant Refused to Follow-up|0|||
27994268|NCT00878189|54653086|FG004|Overall Study|Participant Refused to Follow-up|0|||
27994269|NCT00878189|54653087|FG005|Overall Study|Participant Refused to Follow-up|4|||
27994270|NCT00878189|54653088|FG006|Overall Study|Participant Refused to Follow-up|0|||
27739706|NCT02223754|54189327|FG000|Period 2|Lens Discomfort|1|||
27909628|NCT01212757|54567467|FG006|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
27909629|NCT01212757|54567468|FG007|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4|||
27909630|NCT01212757|54567469|FG008|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6|||
27909631|NCT01212757|54567461|FG000|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
27909632|NCT01212757|54567462|FG001|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
27909633|NCT01212757|54567463|FG002|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2|||
27909634|NCT01212757|54567464|FG003|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
27909635|NCT01212757|54567465|FG004|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
27909636|NCT01212757|54567466|FG005|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
27909637|NCT01212757|54567467|FG006|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
27909638|NCT01212757|54567468|FG007|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
27909639|NCT01212757|54567469|FG008|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
27909640|NCT01212757|54567461|FG000|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
27909641|NCT01212757|54567462|FG001|Long-Term Safety Phase (Year 3)|Adverse Event|4|||
27994271|NCT00878189|54653089|FG007|Overall Study|Participant Refused to Follow-up|0|||
27994272|NCT00878189|54653090|FG008|Overall Study|Participant Refused to Follow-up|0|||
27994273|NCT00878189|54653082|FG000|Overall Study|Other|3|||
27994274|NCT00878189|54653083|FG001|Overall Study|Other|2|||
27994275|NCT00878189|54653084|FG002|Overall Study|Other|4|||
27994276|NCT00878189|54653085|FG003|Overall Study|Other|7|||
27994277|NCT00878189|54653086|FG004|Overall Study|Other|4|||
27994278|NCT00878189|54653087|FG005|Overall Study|Other|18|||
27994279|NCT00878189|54653088|FG006|Overall Study|Other|15|||
27994280|NCT00878189|54653089|FG007|Overall Study|Other|3|||
27994281|NCT00878189|54653090|FG008|Overall Study|Other|4|||
27994282|NCT00878189|54653082|FG000|Overall Study|Lost to Follow-up|0|||
27994283|NCT00878189|54653083|FG001|Overall Study|Lost to Follow-up|0|||
27994284|NCT00878189|54653084|FG002|Overall Study|Lost to Follow-up|0|||
27994285|NCT00878189|54653085|FG003|Overall Study|Lost to Follow-up|0|||
27994286|NCT00878189|54653086|FG004|Overall Study|Lost to Follow-up|0|||
27994287|NCT00878189|54653087|FG005|Overall Study|Lost to Follow-up|1|||
27994288|NCT00878189|54653088|FG006|Overall Study|Lost to Follow-up|1|||
27994289|NCT00878189|54653089|FG007|Overall Study|Lost to Follow-up|0|||
27994290|NCT00878189|54653090|FG008|Overall Study|Lost to Follow-up|0|||
27994291|NCT00878189|54653082|FG000|Overall Study|Objection Progression or Relapse|0|||
27994292|NCT00878189|54653083|FG001|Overall Study|Objection Progression or Relapse|0|||
27994293|NCT00878189|54653084|FG002|Overall Study|Objection Progression or Relapse|0|||
27994294|NCT00878189|54653085|FG003|Overall Study|Objection Progression or Relapse|0|||
27994295|NCT00878189|54653086|FG004|Overall Study|Objection Progression or Relapse|0|||
27994296|NCT00878189|54653087|FG005|Overall Study|Objection Progression or Relapse|0|||
27994297|NCT00878189|54653088|FG006|Overall Study|Objection Progression or Relapse|0|||
27994298|NCT00878189|54653089|FG007|Overall Study|Objection Progression or Relapse|0|||
27994299|NCT00878189|54653090|FG008|Overall Study|Objection Progression or Relapse|3|||
27994300|NCT00668200|54653124|FG000|Overall Study|Withdrawal by Subject|2|||
27994301|NCT00668200|54653124|FG000|Overall Study|Lost to Follow-up|1|||
27994302|NCT00838578|54653128|FG000|Overall Study|Protocol Violation|2|||
27994303|NCT00829296|54653138|FG000|Overall Study|Adverse Event|5|||
27994304|NCT00829296|54653139|FG001|Overall Study|Adverse Event|4|||
27994305|NCT00881621|54653145|FG000|Overall Study|Physician Decision|34|||
27994306|NCT00818766|54653151|FG000|Overall Study|Could not be Contacted on Day 28|11|||
27994307|NCT00818766|54653152|FG001|Overall Study|Could not be Contacted on Day 28|10|||
27994308|NCT00818766|54653151|FG000|Overall Study|Death|1|||
27994309|NCT00818766|54653152|FG001|Overall Study|Death|0|||
27994310|NCT00818766|54653151|FG000|Overall Study|Did not Receive Allocated Intervention|3|||
27994311|NCT00818766|54653152|FG001|Overall Study|Did not Receive Allocated Intervention|0|||
27994312|NCT00667888|54653160|FG000|Overall Study|Death|1|||
27994313|NCT00667888|54653161|FG001|Overall Study|Death|1|||
27994314|NCT00667888|54653160|FG000|Overall Study|Withdrawal by Subject|6|||
27994315|NCT00667888|54653161|FG001|Overall Study|Withdrawal by Subject|3|||
27994316|NCT00667888|54653160|FG000|Overall Study|Proceed with other treatment|3|||
27994317|NCT00667888|54653161|FG001|Overall Study|Proceed with other treatment|3|||
27994318|NCT00667888|54653160|FG000|Overall Study|Ineligible after SIM|0|||
27994319|NCT00667888|54653161|FG001|Overall Study|Ineligible after SIM|2|||
27994320|NCT00594815|54653167|FG000|Overall Study|Never Treated|3|||
27994321|NCT00594815|54653167|FG000|Overall Study|Withdrawal by Subject|2|||
27994322|NCT00594815|54653167|FG000|Overall Study|Toxicity|4|||
27994323|NCT00820248|54653173|FG000|Overall Study|No treated|4|||
27994324|NCT00820248|54653174|FG001|Overall Study|No treated|1|||
27994325|NCT00820170|54653185|FG000|Overall Study|Adverse Event|0|||
27994326|NCT00820170|54653186|FG001|Overall Study|Adverse Event|0|||
27994327|NCT00820170|54653187|FG002|Overall Study|Adverse Event|0|||
27994328|NCT00820170|54653188|FG003|Overall Study|Adverse Event|0|||
27994329|NCT00820170|54653189|FG004|Overall Study|Adverse Event|2|||
27994330|NCT00820170|54653185|FG000|Overall Study|Progressive Disease|0|||
27994331|NCT00820170|54653186|FG001|Overall Study|Progressive Disease|0|||
27994332|NCT00820170|54653187|FG002|Overall Study|Progressive Disease|0|||
27994333|NCT00820170|54653188|FG003|Overall Study|Progressive Disease|0|||
27909642|NCT01212757|54567463|FG002|Long-Term Safety Phase (Year 3)|Adverse Event|1|||
27909643|NCT01212757|54567464|FG003|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
27909644|NCT01212757|54567465|FG004|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
27909645|NCT01212757|54567466|FG005|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
27909646|NCT01212757|54567467|FG006|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
27909647|NCT01212757|54567468|FG007|Long-Term Safety Phase (Year 3)|Adverse Event|2|||
27909648|NCT01212757|54567469|FG008|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
27909649|NCT01212757|54567461|FG000|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
27909650|NCT01212757|54567462|FG001|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8|||
27909651|NCT01212757|54567463|FG002|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5|||
27909652|NCT01212757|54567464|FG003|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
27994334|NCT00820170|54653189|FG004|Overall Study|Progressive Disease|2|||
27994335|NCT00818454|54653206|FG000|Treatment Period 1|Adverse Event|0|||
28172590|NCT02435836|54844326|FG000|Overall Study|Lost to Follow-up|21|||
27994336|NCT00818454|54653207|FG001|Treatment Period 1|Adverse Event|1|||
27994337|NCT00818454|54653208|FG002|Treatment Period 1|Adverse Event|0|||
27994338|NCT00818454|54653209|FG003|Treatment Period 1|Adverse Event|0|||
27994339|NCT00818454|54653206|FG000|Treatment Period 1|Other|3|||
27994340|NCT00818454|54653207|FG001|Treatment Period 1|Other|0|||
27994341|NCT00818454|54653208|FG002|Treatment Period 1|Other|0|||
27994342|NCT00818454|54653209|FG003|Treatment Period 1|Other|0|||
27909653|NCT01212757|54567465|FG004|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
27909654|NCT01212757|54567466|FG005|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
27909655|NCT01212757|54567467|FG006|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
27909656|NCT01212757|54567468|FG007|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3|||
27909657|NCT01212757|54567469|FG008|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1|||
27909658|NCT01212757|54567461|FG000|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
27909659|NCT01212757|54567462|FG001|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
27909660|NCT01212757|54567463|FG002|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1|||
27909661|NCT01212757|54567464|FG003|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
27909662|NCT01212757|54567465|FG004|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
27909663|NCT01212757|54567466|FG005|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
27909664|NCT01212757|54567467|FG006|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
27909665|NCT01212757|54567468|FG007|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
27909666|NCT01212757|54567469|FG008|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
27909667|NCT01212757|54567461|FG000|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
27909668|NCT01212757|54567462|FG001|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5|||
27909669|NCT01212757|54567463|FG002|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
27994343|NCT00818454|54653206|FG000|Washout Period of 1 Week|Adverse Event|1|||
27994344|NCT00818454|54653207|FG001|Washout Period of 1 Week|Adverse Event|1|||
27994345|NCT00818454|54653208|FG002|Washout Period of 1 Week|Adverse Event|0|||
27994346|NCT00818454|54653209|FG003|Washout Period of 1 Week|Adverse Event|0|||
27994347|NCT00818454|54653206|FG000|Washout Period of 1 Week|Protocol Violation|2|||
27994348|NCT00818454|54653207|FG001|Washout Period of 1 Week|Protocol Violation|0|||
27994349|NCT00818454|54653208|FG002|Washout Period of 1 Week|Protocol Violation|0|||
27994350|NCT00818454|54653209|FG003|Washout Period of 1 Week|Protocol Violation|0|||
28098275|NCT03573908|54754009|FG004|Treatment Period|Other, Not Specified|0|||
28098276|NCT03573908|54754005|FG000|Randomized Withdrawal Period|Adverse Event|0|||
28098277|NCT03573908|54754006|FG001|Randomized Withdrawal Period|Adverse Event|0|||
28098278|NCT03573908|54754007|FG002|Randomized Withdrawal Period|Adverse Event|3|||
28098279|NCT03573908|54754008|FG003|Randomized Withdrawal Period|Adverse Event|0|||
28098280|NCT03573908|54754009|FG004|Randomized Withdrawal Period|Adverse Event|0|||
28098281|NCT03573908|54754005|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
28098282|NCT03573908|54754006|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
28098283|NCT03573908|54754007|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
28098284|NCT03573908|54754008|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
28098285|NCT03573908|54754009|FG004|Randomized Withdrawal Period|Withdrawal by Subject|2|||
28098286|NCT03573908|54754005|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
28098287|NCT03573908|54754006|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
28098288|NCT03573908|54754007|FG002|Randomized Withdrawal Period|Lost to Follow-up|1|||
28098289|NCT03573908|54754008|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
28098290|NCT03573908|54754009|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
28098291|NCT03573908|54754005|FG000|Randomized Withdrawal Period|Other, Not Specified|0|||
27909670|NCT01212757|54567464|FG003|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
27994351|NCT00818454|54653206|FG000|Washout Period of 1 Week|Other|1|||
27994352|NCT00818454|54653207|FG001|Washout Period of 1 Week|Other|2|||
27994353|NCT00818454|54653208|FG002|Washout Period of 1 Week|Other|0|||
27994354|NCT00818454|54653209|FG003|Washout Period of 1 Week|Other|0|||
27994355|NCT00818454|54653206|FG000|Treatment Period 2|Other|2|||
27994356|NCT00818454|54653207|FG001|Treatment Period 2|Other|1|||
27994357|NCT00818454|54653208|FG002|Treatment Period 2|Other|0|||
27994358|NCT00818454|54653209|FG003|Treatment Period 2|Other|0|||
27994359|NCT00818454|54653206|FG000|Treatment Period 3|Adverse Event|0|||
27994360|NCT00818454|54653207|FG001|Treatment Period 3|Adverse Event|0|||
27994361|NCT00818454|54653208|FG002|Treatment Period 3|Adverse Event|0|||
27994362|NCT00818454|54653209|FG003|Treatment Period 3|Adverse Event|1|||
27994363|NCT00828984|54653222|FG000|Overall Study|Adverse Event|2|||
27994364|NCT00828984|54653223|FG001|Overall Study|Adverse Event|3|||
27994365|NCT00828984|54653224|FG002|Overall Study|Adverse Event|0|||
27994366|NCT00828984|54653222|FG000|Overall Study|Lost to Follow-up|5|||
27994367|NCT00828984|54653223|FG001|Overall Study|Lost to Follow-up|3|||
27994368|NCT00828984|54653224|FG002|Overall Study|Lost to Follow-up|1|||
27994369|NCT00828984|54653222|FG000|Overall Study|Withdrawal by Subject|4|||
27994370|NCT00828984|54653223|FG001|Overall Study|Withdrawal by Subject|4|||
27994371|NCT00828984|54653224|FG002|Overall Study|Withdrawal by Subject|4|||
27994372|NCT00828984|54653222|FG000|Overall Study|Ineligable|1|||
27994373|NCT00828984|54653223|FG001|Overall Study|Ineligable|2|||
27994374|NCT00828984|54653224|FG002|Overall Study|Ineligable|0|||
27994375|NCT00828984|54653222|FG000|Overall Study|Medical Contraindication|0|||
27994376|NCT00828984|54653223|FG001|Overall Study|Medical Contraindication|1|||
27994377|NCT00828984|54653224|FG002|Overall Study|Medical Contraindication|0|||
28098292|NCT03573908|54754006|FG001|Randomized Withdrawal Period|Other, Not Specified|0|||
28098293|NCT03573908|54754007|FG002|Randomized Withdrawal Period|Other, Not Specified|4|||
27909671|NCT01212757|54567465|FG004|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
27909672|NCT01212757|54567466|FG005|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
27909673|NCT01212757|54567467|FG006|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
27909674|NCT01212757|54567468|FG007|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
27909675|NCT01212757|54567469|FG008|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
27909676|NCT01212757|54567461|FG000|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
27909677|NCT01212757|54567462|FG001|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
27909678|NCT01212757|54567463|FG002|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
27909679|NCT01212757|54567464|FG003|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
27909680|NCT01212757|54567465|FG004|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
27909681|NCT01212757|54567466|FG005|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
27909682|NCT01212757|54567467|FG006|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
27909683|NCT01212757|54567468|FG007|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
27909684|NCT01212757|54567469|FG008|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1|||
27909685|NCT01212757|54567461|FG000|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
27909686|NCT01212757|54567462|FG001|Long-Term Safety Phase (Year 3)|Protocol Violation|1|||
27909687|NCT01212757|54567463|FG002|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
27909688|NCT01212757|54567464|FG003|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
27909689|NCT01212757|54567465|FG004|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
27909690|NCT01212757|54567466|FG005|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
27909691|NCT01212757|54567467|FG006|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
27909692|NCT01212757|54567468|FG007|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
27909693|NCT01212757|54567469|FG008|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
27909694|NCT01212757|54567461|FG000|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
27909695|NCT01212757|54567462|FG001|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
27909696|NCT01212757|54567463|FG002|Long-Term Safety Phase (Year 3)|Miscellaneous|3|||
27909697|NCT01212757|54567464|FG003|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
27909698|NCT01212757|54567465|FG004|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
27909699|NCT01212757|54567466|FG005|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
27909700|NCT01212757|54567467|FG006|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
27909701|NCT01212757|54567468|FG007|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
27909702|NCT01212757|54567469|FG008|Long-Term Safety Phase (Year 3)|Miscellaneous|2|||
27909703|NCT01212757|54567461|FG000|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
27909704|NCT01212757|54567462|FG001|Long-Term Safety Phase (Year 4)|Miscellaneous|2|||
27909705|NCT01212757|54567463|FG002|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
27909706|NCT01212757|54567464|FG003|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
27909707|NCT01212757|54567465|FG004|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
27909708|NCT01212757|54567466|FG005|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
27909709|NCT01212757|54567467|FG006|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
27909710|NCT01212757|54567468|FG007|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
27909711|NCT01212757|54567469|FG008|Long-Term Safety Phase (Year 4)|Miscellaneous|1|||
27739707|NCT02223754|54189328|FG001|Period 2|Lens Discomfort|1|||
27909712|NCT01212757|54567461|FG000|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
27909713|NCT01212757|54567462|FG001|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
27909714|NCT01212757|54567463|FG002|Long-Term Safety Phase (Year 4)|Adverse Event|2|||
27909715|NCT01212757|54567464|FG003|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
27909716|NCT01212757|54567465|FG004|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
27909717|NCT01212757|54567466|FG005|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
27909718|NCT01212757|54567467|FG006|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
27909719|NCT01212757|54567468|FG007|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
27909720|NCT01212757|54567469|FG008|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
27909721|NCT01212757|54567461|FG000|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
27909722|NCT01212757|54567462|FG001|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
27909723|NCT01212757|54567463|FG002|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
27909724|NCT01212757|54567464|FG003|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
27909725|NCT01212757|54567465|FG004|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
27909726|NCT01212757|54567466|FG005|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
27994378|NCT00828984|54653222|FG000|Overall Study|Noncompliant|1|||
27994379|NCT00828984|54653223|FG001|Overall Study|Noncompliant|2|||
27994380|NCT00828984|54653224|FG002|Overall Study|Noncompliant|3|||
27994381|NCT00828984|54653222|FG000|Overall Study|ConMed|1|||
27994382|NCT00828984|54653223|FG001|Overall Study|ConMed|1|||
27994383|NCT00828984|54653224|FG002|Overall Study|ConMed|1|||
27994384|NCT00828750|54653232|FG000|Overall Study|Lack of Efficacy|3|||
27994385|NCT00828750|54653232|FG000|Overall Study|Normal PC Remained While No Treatment|1|||
27994386|NCT00667810|54653241|FG000|Overall Study|Adverse Event|13|||
27994387|NCT00667810|54653242|FG001|Overall Study|Adverse Event|14|||
27994388|NCT00667810|54653243|FG002|Overall Study|Adverse Event|19|||
27994389|NCT00667810|54653244|FG003|Overall Study|Adverse Event|1|||
27994390|NCT00667810|54653241|FG000|Overall Study|Death|1|||
28098294|NCT03573908|54754008|FG003|Randomized Withdrawal Period|Other, Not Specified|2|||
27994391|NCT00667810|54653242|FG001|Overall Study|Death|1|||
27994392|NCT00667810|54653243|FG002|Overall Study|Death|3|||
27994393|NCT00667810|54653244|FG003|Overall Study|Death|0|||
27994394|NCT00667810|54653241|FG000|Overall Study|Lack of Efficacy|1|||
27994395|NCT00667810|54653242|FG001|Overall Study|Lack of Efficacy|0|||
27994396|NCT00667810|54653243|FG002|Overall Study|Lack of Efficacy|2|||
27994397|NCT00667810|54653244|FG003|Overall Study|Lack of Efficacy|0|||
27994398|NCT00667810|54653241|FG000|Overall Study|Lost to Follow-up|1|||
27994399|NCT00667810|54653242|FG001|Overall Study|Lost to Follow-up|4|||
27994400|NCT00667810|54653243|FG002|Overall Study|Lost to Follow-up|2|||
27994401|NCT00667810|54653244|FG003|Overall Study|Lost to Follow-up|0|||
27994402|NCT00667810|54653241|FG000|Overall Study|Physician Decision|1|||
27994403|NCT00667810|54653242|FG001|Overall Study|Physician Decision|1|||
27994404|NCT00667810|54653243|FG002|Overall Study|Physician Decision|2|||
27994405|NCT00667810|54653244|FG003|Overall Study|Physician Decision|0|||
27994406|NCT00667810|54653241|FG000|Overall Study|Protocol Violation|0|||
27994407|NCT00667810|54653242|FG001|Overall Study|Protocol Violation|2|||
27994408|NCT00667810|54653243|FG002|Overall Study|Protocol Violation|0|||
27994409|NCT00667810|54653244|FG003|Overall Study|Protocol Violation|0|||
27994410|NCT00667810|54653241|FG000|Overall Study|Withdrawal by Subject|14|||
27994411|NCT00667810|54653242|FG001|Overall Study|Withdrawal by Subject|20|||
27994412|NCT00667810|54653243|FG002|Overall Study|Withdrawal by Subject|29|||
27994413|NCT00667810|54653244|FG003|Overall Study|Withdrawal by Subject|1|||
27994414|NCT00667810|54653241|FG000|Overall Study|Discontinuation of Study by Sponsor|130|||
27994415|NCT00667810|54653242|FG001|Overall Study|Discontinuation of Study by Sponsor|118|||
27994416|NCT00667810|54653243|FG002|Overall Study|Discontinuation of Study by Sponsor|155|||
27994417|NCT00667810|54653244|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
27994418|NCT00667810|54653241|FG000|Overall Study|Failed to Return|0|||
27994419|NCT00667810|54653242|FG001|Overall Study|Failed to Return|0|||
27994420|NCT00667810|54653243|FG002|Overall Study|Failed to Return|2|||
27994421|NCT00667810|54653244|FG003|Overall Study|Failed to Return|0|||
27994422|NCT00667810|54653241|FG000|Overall Study|Loss of Caregiver|0|||
27994423|NCT00667810|54653242|FG001|Overall Study|Loss of Caregiver|1|||
27994424|NCT00667810|54653243|FG002|Overall Study|Loss of Caregiver|3|||
27994425|NCT00667810|54653244|FG003|Overall Study|Loss of Caregiver|0|||
27994426|NCT00667810|54653241|FG000|Overall Study|Vasogenic Edema Recurrence|0|||
27994427|NCT00667810|54653242|FG001|Overall Study|Vasogenic Edema Recurrence|3|||
27994428|NCT00667810|54653243|FG002|Overall Study|Vasogenic Edema Recurrence|0|||
27994429|NCT00667810|54653244|FG003|Overall Study|Vasogenic Edema Recurrence|0|||
27994430|NCT00667810|54653241|FG000|Overall Study|Other|6|||
27994431|NCT00667810|54653242|FG001|Overall Study|Other|6|||
27994432|NCT00667810|54653243|FG002|Overall Study|Other|5|||
27994433|NCT00667810|54653244|FG003|Overall Study|Other|0|||
27994434|NCT00819390|54653263|FG000|Overall Study|Lost to Follow-up|1|||
27994435|NCT00819390|54653264|FG001|Overall Study|Lost to Follow-up|1|||
27994436|NCT00819390|54653265|FG002|Overall Study|Lost to Follow-up|0|||
27994437|NCT00819390|54653266|FG003|Overall Study|Lost to Follow-up|0|||
27994438|NCT00819390|54653263|FG000|Overall Study|Withdrawal by Subject|2|||
27994439|NCT00819390|54653264|FG001|Overall Study|Withdrawal by Subject|0|||
27994440|NCT00819390|54653265|FG002|Overall Study|Withdrawal by Subject|0|||
27994441|NCT00819390|54653266|FG003|Overall Study|Withdrawal by Subject|0|||
27994442|NCT00819390|54653263|FG000|Overall Study|Adverse Event|0|||
27994443|NCT00819390|54653264|FG001|Overall Study|Adverse Event|0|||
27994444|NCT00819390|54653265|FG002|Overall Study|Adverse Event|1|||
27994445|NCT00819390|54653266|FG003|Overall Study|Adverse Event|0|||
27994446|NCT00876395|54653281|FG000|Overall Study|Untreated|8|||
27994447|NCT00876395|54653282|FG001|Overall Study|Untreated|1|||
27994448|NCT00876395|54653281|FG000|Overall Study|Adverse Event|63|||
27994449|NCT00876395|54653282|FG001|Overall Study|Adverse Event|11|||
27994450|NCT00876395|54653281|FG000|Overall Study|Abnormal test procedure result(s)|1|||
27994451|NCT00876395|54653282|FG001|Overall Study|Abnormal test procedure result(s)|0|||
27994452|NCT00876395|54653281|FG000|Overall Study|Disease progression|259|||
27994453|NCT00876395|54653282|FG001|Overall Study|Disease progression|162|||
27739708|NCT02223754|54189327|FG000|Period 2|Lost to Follow-up|1|||
27739709|NCT02223754|54189328|FG001|Period 2|Lost to Follow-up|0|||
27739710|NCT02223754|54189327|FG000|Period 2|Test Article No Longer Available|0|||
27994454|NCT00876395|54653281|FG000|Overall Study|New cancer therapy|25|||
27994455|NCT00876395|54653282|FG001|Overall Study|New cancer therapy|7|||
27994456|NCT00876395|54653281|FG000|Overall Study|Protocol Violation|5|||
27994457|NCT00876395|54653282|FG001|Overall Study|Protocol Violation|2|||
27994458|NCT00876395|54653281|FG000|Overall Study|Withdrawal by Subject|66|||
27994459|NCT00876395|54653282|FG001|Overall Study|Withdrawal by Subject|33|||
27994460|NCT00876395|54653281|FG000|Overall Study|Lost to Follow-up|2|||
27994461|NCT00876395|54653282|FG001|Overall Study|Lost to Follow-up|0|||
27994462|NCT00876395|54653281|FG000|Overall Study|Administrative problems|39|||
27994463|NCT00876395|54653282|FG001|Overall Study|Administrative problems|23|||
27994464|NCT00876395|54653281|FG000|Overall Study|Death|12|||
27994465|NCT00876395|54653282|FG001|Overall Study|Death|0|||
27994466|NCT00594659|54653296|FG000|Overall Study|Lost to Follow-up|13|||
27994467|NCT00594659|54653297|FG001|Overall Study|Lost to Follow-up|9|||
27994468|NCT00594659|54653298|FG002|Overall Study|Lost to Follow-up|7|||
27994469|NCT00667732|54653308|FG000|Run -In (8 Weeks)|Adverse Event|4|||
27994470|NCT00667732|54653309|FG001|Run -In (8 Weeks)|Adverse Event|0|||
27994471|NCT00667732|54653310|FG002|Run -In (8 Weeks)|Adverse Event|0|||
27994472|NCT00667732|54653308|FG000|Run -In (8 Weeks)|Withdrawal by Subject|3|||
27994473|NCT00667732|54653309|FG001|Run -In (8 Weeks)|Withdrawal by Subject|0|||
27909727|NCT01212757|54567467|FG006|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
27909728|NCT01212757|54567468|FG007|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
27909729|NCT01212757|54567469|FG008|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
27909730|NCT01212757|54567461|FG000|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
27994474|NCT00667732|54653310|FG002|Run -In (8 Weeks)|Withdrawal by Subject|0|||
27994475|NCT00667732|54653308|FG000|Randomization (24 Weeks)|Withdrawal by Subject|0|||
27994476|NCT00667732|54653309|FG001|Randomization (24 Weeks)|Withdrawal by Subject|1|||
27994477|NCT00667732|54653310|FG002|Randomization (24 Weeks)|Withdrawal by Subject|0|||
27994478|NCT00671788|54653320|FG000|Overall Study|Adverse Event|8|||
27994479|NCT00671788|54653320|FG000|Overall Study|Refused further treatment|3|||
27994480|NCT00671788|54653320|FG000|Overall Study|Ineligible|1|||
27994481|NCT00671788|54653320|FG000|Overall Study|MD Decision|1|||
27994482|NCT00671788|54653320|FG000|Overall Study|Other|1|||
27994483|NCT00875615|54653324|FG000|Overall Study|Withdrawal by Subject|1|||
27994484|NCT00597701|54653330|FG000|Overall Study|Withdrawal by Subject|5|||
27994485|NCT00597701|54653331|FG001|Overall Study|Withdrawal by Subject|5|||
27994486|NCT00597701|54653330|FG000|Overall Study|Death|0|||
27994487|NCT00597701|54653331|FG001|Overall Study|Death|1|||
27994488|NCT00597701|54653330|FG000|Overall Study|Physician Decision|2|||
27994489|NCT00597701|54653331|FG001|Overall Study|Physician Decision|0|||
27994490|NCT00597701|54653330|FG000|Overall Study|Did not start intervention (pharmacy er)|0|||
27994491|NCT00597701|54653331|FG001|Overall Study|Did not start intervention (pharmacy er)|2|||
27994492|NCT00671554|54653337|FG000|Overall Study|Disease progression|3|||
27994493|NCT00667576|54653347|FG000|Overall Study|Withdrawal by Subject|1|||
27994494|NCT00667576|54653348|FG001|Overall Study|Withdrawal by Subject|0|||
27994495|NCT00667576|54653349|FG002|Overall Study|Withdrawal by Subject|1|||
27994496|NCT00667576|54653350|FG003|Overall Study|Withdrawal by Subject|1|||
27994497|NCT00667576|54653351|FG004|Overall Study|Withdrawal by Subject|1|||
27994498|NCT00667576|54653347|FG000|Overall Study|Adverse Event|1|||
27994499|NCT00667576|54653348|FG001|Overall Study|Adverse Event|1|||
27994500|NCT00667576|54653349|FG002|Overall Study|Adverse Event|0|||
27994501|NCT00667576|54653350|FG003|Overall Study|Adverse Event|0|||
27994502|NCT00667576|54653351|FG004|Overall Study|Adverse Event|0|||
27994503|NCT00667576|54653347|FG000|Overall Study|Lost to Follow-up|0|||
27909731|NCT01212757|54567462|FG001|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4|||
27909732|NCT01212757|54567463|FG002|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2|||
27909733|NCT01212757|54567464|FG003|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
27909734|NCT01212757|54567465|FG004|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
27909735|NCT01212757|54567466|FG005|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
27909736|NCT01212757|54567467|FG006|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
27909737|NCT01212757|54567468|FG007|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1|||
27909738|NCT01212757|54567469|FG008|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3|||
27909739|NCT01212757|54567461|FG000|Long-Term Safety Phase (Year 4)|Death|0|||
27909740|NCT01212757|54567462|FG001|Long-Term Safety Phase (Year 4)|Death|0|||
27909741|NCT01212757|54567463|FG002|Long-Term Safety Phase (Year 4)|Death|1|||
27909742|NCT01212757|54567464|FG003|Long-Term Safety Phase (Year 4)|Death|0|||
27909743|NCT01212757|54567465|FG004|Long-Term Safety Phase (Year 4)|Death|0|||
27994504|NCT00667576|54653348|FG001|Overall Study|Lost to Follow-up|0|||
27994505|NCT00667576|54653349|FG002|Overall Study|Lost to Follow-up|1|||
27994506|NCT00667576|54653350|FG003|Overall Study|Lost to Follow-up|0|||
27994507|NCT00667576|54653351|FG004|Overall Study|Lost to Follow-up|0|||
27994508|NCT00667576|54653347|FG000|Overall Study|Protocol Violation|0|||
27994509|NCT00667576|54653348|FG001|Overall Study|Protocol Violation|0|||
27994510|NCT00667576|54653349|FG002|Overall Study|Protocol Violation|0|||
27909744|NCT01212757|54567466|FG005|Long-Term Safety Phase (Year 4)|Death|0|||
27909745|NCT01212757|54567467|FG006|Long-Term Safety Phase (Year 4)|Death|0|||
27994511|NCT00667576|54653350|FG003|Overall Study|Protocol Violation|1|||
27994512|NCT00667576|54653351|FG004|Overall Study|Protocol Violation|0|||
27994513|NCT00667576|54653347|FG000|Overall Study|Physician Decision|0|||
27994514|NCT00667576|54653348|FG001|Overall Study|Physician Decision|0|||
27994515|NCT00667576|54653349|FG002|Overall Study|Physician Decision|0|||
27994516|NCT00667576|54653350|FG003|Overall Study|Physician Decision|1|||
27994517|NCT00667576|54653351|FG004|Overall Study|Physician Decision|0|||
27994518|NCT00667576|54653347|FG000|Overall Study|Missed Visit|0|||
27994519|NCT00667576|54653348|FG001|Overall Study|Missed Visit|0|||
27909746|NCT01212757|54567468|FG007|Long-Term Safety Phase (Year 4)|Death|0|||
27909747|NCT01212757|54567469|FG008|Long-Term Safety Phase (Year 4)|Death|1|||
27994520|NCT00667576|54653349|FG002|Overall Study|Missed Visit|0|||
27994521|NCT00667576|54653350|FG003|Overall Study|Missed Visit|1|||
27994522|NCT00667576|54653351|FG004|Overall Study|Missed Visit|0|||
27909748|NCT01212757|54567461|FG000|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
27909749|NCT01212757|54567462|FG001|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
27909750|NCT01212757|54567463|FG002|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
27909751|NCT01212757|54567464|FG003|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
27909752|NCT01212757|54567465|FG004|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
27909753|NCT01212757|54567466|FG005|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
27909754|NCT01212757|54567467|FG006|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
27909755|NCT01212757|54567468|FG007|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1|||
27909756|NCT01212757|54567469|FG008|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
27909757|NCT01212757|54567461|FG000|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
27909758|NCT01212757|54567462|FG001|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
27909759|NCT01212757|54567463|FG002|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
27994523|NCT00666718|54653365|FG000|Overall Study|Adverse Event|0|||
27994524|NCT00666718|54653366|FG001|Overall Study|Adverse Event|1|||
27994525|NCT00666718|54653365|FG000|Overall Study|Death|1|||
27994526|NCT00666718|54653366|FG001|Overall Study|Death|0|||
27994527|NCT00666718|54653365|FG000|Overall Study|Lost to Follow-up|1|||
27994528|NCT00666718|54653366|FG001|Overall Study|Lost to Follow-up|0|||
27994529|NCT00666718|54653365|FG000|Overall Study|Entry Criteria Not Met|2|||
27994530|NCT00666718|54653366|FG001|Overall Study|Entry Criteria Not Met|0|||
27994531|NCT00666718|54653365|FG000|Overall Study|Protocol Violation|1|||
27994532|NCT00666718|54653366|FG001|Overall Study|Protocol Violation|3|||
27994533|NCT00666718|54653365|FG000|Overall Study|Withdrawal by Subject|7|||
27994534|NCT00666718|54653366|FG001|Overall Study|Withdrawal by Subject|12|||
27994535|NCT00666718|54653365|FG000|Overall Study|Physician Decision|0|||
27994536|NCT00666718|54653366|FG001|Overall Study|Physician Decision|2|||
27994537|NCT00667420|54653372|FG000|Overall Study|Adverse Event|2|||
27994538|NCT00667420|54653372|FG000|Overall Study|Lack of Efficacy|5|||
27994539|NCT00667420|54653372|FG000|Overall Study|Physician Decision|1|||
27994540|NCT00667420|54653372|FG000|Overall Study|Withdrawal by Subject|2|||
27994541|NCT00853658|54653380|FG000|Overall Study|Death|713|||
27994542|NCT00853658|54653381|FG001|Overall Study|Death|768|||
27994543|NCT00853658|54653382|FG002|Overall Study|Death|753|||
27994544|NCT00853658|54653380|FG000|Overall Study|Lost to Follow-up|11|||
27994545|NCT00853658|54653381|FG001|Overall Study|Lost to Follow-up|6|||
27994546|NCT00853658|54653382|FG002|Overall Study|Lost to Follow-up|11|||
27994547|NCT00853658|54653380|FG000|Overall Study|H.A. Request|26|||
27994548|NCT00853658|54653381|FG001|Overall Study|H.A. Request|23|||
27994549|NCT00853658|54653382|FG002|Overall Study|H.A. Request|19|||
27994550|NCT00853658|54653380|FG000|Overall Study|IRB request|0|||
27994551|NCT00853658|54653381|FG001|Overall Study|IRB request|0|||
27994552|NCT00853658|54653382|FG002|Overall Study|IRB request|2|||
27994553|NCT00853658|54653380|FG000|Overall Study|Vital Status known (alive) at study end|2|||
27994554|NCT00853658|54653381|FG001|Overall Study|Vital Status known (alive) at study end|3|||
27994555|NCT00853658|54653382|FG002|Overall Study|Vital Status known (alive) at study end|3|||
27994556|NCT00853658|54653380|FG000|Overall Study|Vital Status unknown at study end|1|||
27994557|NCT00853658|54653381|FG001|Overall Study|Vital Status unknown at study end|1|||
27994558|NCT00853658|54653382|FG002|Overall Study|Vital Status unknown at study end|0|||
27994559|NCT00853658|54653380|FG000|Overall Study|Vital Status at study end N/A|8|||
27994560|NCT00853658|54653381|FG001|Overall Study|Vital Status at study end N/A|10|||
27994561|NCT00853658|54653382|FG002|Overall Study|Vital Status at study end N/A|10|||
27994562|NCT00853658|54653380|FG000|Overall Study|Patient's request|21|||
27994563|NCT00853658|54653381|FG001|Overall Study|Patient's request|17|||
27994564|NCT00853658|54653382|FG002|Overall Study|Patient's request|11|||
27739711|NCT02223754|54189328|FG001|Period 2|Test Article No Longer Available|1|||
27739712|NCT02223364|54189338|FG000|Overall Study|Protocol Violation|3|||
27739713|NCT02223364|54189339|FG001|Overall Study|Protocol Violation|0|||
27739714|NCT02223364|54189340|FG002|Overall Study|Protocol Violation|3|||
27739715|NCT02223364|54189338|FG000|Overall Study|subject expired before surgery|1|||
27909760|NCT01212757|54567464|FG003|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
27909761|NCT01212757|54567465|FG004|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
27909762|NCT01212757|54567466|FG005|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
27994565|NCT00853658|54653380|FG000|Overall Study|Missing study completion information|5|||
27994566|NCT00853658|54653381|FG001|Overall Study|Missing study completion information|4|||
27994567|NCT00853658|54653382|FG002|Overall Study|Missing study completion information|6|||
27994568|NCT00666562|54653393|FG000|Overall Study|Withdrawal by Subject|0|||
27994569|NCT00666562|54653394|FG001|Overall Study|Withdrawal by Subject|1|||
27994570|NCT00666562|54653395|FG002|Overall Study|Withdrawal by Subject|0|||
27994571|NCT00666562|54653393|FG000|Overall Study|Concomitant Medication|0|||
27994572|NCT00666562|54653394|FG001|Overall Study|Concomitant Medication|1|||
27994573|NCT00666562|54653395|FG002|Overall Study|Concomitant Medication|0|||
27994574|NCT00666328|54653410|FG000|Overall Study|Death|2|||
27994575|NCT00666328|54653410|FG000|Overall Study|Lost to Follow-up|2|||
27739716|NCT02223364|54189339|FG001|Overall Study|subject expired before surgery|0|||
27909763|NCT01212757|54567467|FG006|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
27994576|NCT00666328|54653410|FG000|Overall Study|No longer met eligibility criteria|1|||
27994577|NCT00853580|54653418|FG000|Overall Study|Lost to Follow-up|3|||
27994578|NCT00853580|54653419|FG001|Overall Study|Lost to Follow-up|5|||
27994579|NCT00853580|54653418|FG000|Overall Study|Protocol Violation|2|||
27994580|NCT00853580|54653419|FG001|Overall Study|Protocol Violation|1|||
27994581|NCT00853580|54653418|FG000|Overall Study|Withdrawal by Subject|2|||
27909764|NCT01212757|54567468|FG007|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
27909765|NCT01212757|54567469|FG008|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
27909766|NCT01212757|54567461|FG000|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
27909767|NCT01212757|54567462|FG001|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
27909768|NCT01212757|54567463|FG002|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
27909769|NCT01212757|54567464|FG003|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
27909770|NCT01212757|54567465|FG004|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
27909771|NCT01212757|54567466|FG005|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
27909772|NCT01212757|54567467|FG006|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
27909773|NCT01212757|54567468|FG007|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
27909774|NCT01212757|54567469|FG008|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
27909775|NCT01212757|54567461|FG000|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
27909776|NCT01212757|54567462|FG001|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
27909777|NCT01212757|54567463|FG002|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
27909778|NCT01212757|54567464|FG003|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
27909779|NCT01212757|54567465|FG004|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
27909780|NCT01212757|54567466|FG005|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
27909781|NCT01212757|54567467|FG006|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
27909782|NCT01212757|54567468|FG007|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
27909783|NCT01212757|54567469|FG008|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
27909784|NCT01212757|54567461|FG000|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
27994582|NCT00853580|54653419|FG001|Overall Study|Withdrawal by Subject|8|||
27994583|NCT00853580|54653418|FG000|Overall Study|Commenced contraindicated therapy|0|||
27994584|NCT00853580|54653419|FG001|Overall Study|Commenced contraindicated therapy|2|||
27994585|NCT00865514|54653425|FG000|Overall Study|Infusion cost exceeded funding|2|||
27994586|NCT00865280|54653432|FG000|Overall Study|Withdrawal by Subject|4|||
27994587|NCT00865280|54653433|FG001|Overall Study|Withdrawal by Subject|1|||
27994588|NCT00865280|54653432|FG000|Overall Study|End of Treatment/Lost to Follow-up|0|||
27994589|NCT00865280|54653433|FG001|Overall Study|End of Treatment/Lost to Follow-up|1|||
27994590|NCT00865280|54653432|FG000|Overall Study|Adverse Event/Lost to Follow-up|1|||
27994591|NCT00865280|54653433|FG001|Overall Study|Adverse Event/Lost to Follow-up|0|||
27994592|NCT00865280|54653432|FG000|Overall Study|Exclusion Condition|1|||
27994593|NCT00865280|54653433|FG001|Overall Study|Exclusion Condition|0|||
27994594|NCT00865280|54653432|FG000|Overall Study|Adverse Event|0|||
27994595|NCT00865280|54653433|FG001|Overall Study|Adverse Event|1|||
27994596|NCT00865124|54653442|FG000|Overall Study|Physician Decision|2|||
27994597|NCT00865124|54653443|FG001|Overall Study|Physician Decision|1|||
27994598|NCT00865124|54653444|FG002|Overall Study|Physician Decision|0|||
27994599|NCT00865124|54653442|FG000|Overall Study|Withdrawn consent|2|||
27994600|NCT00865124|54653443|FG001|Overall Study|Withdrawn consent|0|||
27994601|NCT00865124|54653444|FG002|Overall Study|Withdrawn consent|0|||
27994602|NCT00871715|54653455|FG000|Overall Study|Withdrawal by Subject|6|||
27994603|NCT00871715|54653456|FG001|Overall Study|Withdrawal by Subject|10|||
27994604|NCT00871715|54653457|FG002|Overall Study|Withdrawal by Subject|15|||
27994605|NCT00871715|54653455|FG000|Overall Study|Physician Decision|6|||
27994606|NCT00871715|54653456|FG001|Overall Study|Physician Decision|0|||
27994607|NCT00871715|54653457|FG002|Overall Study|Physician Decision|2|||
27994608|NCT00871715|54653455|FG000|Overall Study|Lost to Follow-up|3|||
27994609|NCT00871715|54653456|FG001|Overall Study|Lost to Follow-up|6|||
27994610|NCT00871715|54653457|FG002|Overall Study|Lost to Follow-up|9|||
27994611|NCT00819234|54653466|FG000|Overall Study|Withdrawal by Subject|8|||
27994612|NCT00819234|54653467|FG001|Overall Study|Withdrawal by Subject|13|||
27994613|NCT00819234|54653468|FG002|Overall Study|Withdrawal by Subject|6|||
27994614|NCT00819234|54653469|FG003|Overall Study|Withdrawal by Subject|3|||
27994615|NCT00819234|54653470|FG004|Overall Study|Withdrawal by Subject|0|||
27909785|NCT01212757|54567462|FG001|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1|||
27994616|NCT00819234|54653471|FG005|Overall Study|Withdrawal by Subject|4|||
27994617|NCT00819234|54653472|FG006|Overall Study|Withdrawal by Subject|4|||
27994618|NCT00819234|54653473|FG007|Overall Study|Withdrawal by Subject|8|||
27994619|NCT00819234|54653474|FG008|Overall Study|Withdrawal by Subject|5|||
27994620|NCT00819234|54653475|FG009|Overall Study|Withdrawal by Subject|3|||
27994621|NCT00819234|54653466|FG000|Overall Study|Adverse Event|0|||
27994622|NCT00819234|54653467|FG001|Overall Study|Adverse Event|0|||
27994623|NCT00819234|54653468|FG002|Overall Study|Adverse Event|1|||
27994624|NCT00819234|54653469|FG003|Overall Study|Adverse Event|0|||
27994625|NCT00819234|54653470|FG004|Overall Study|Adverse Event|0|||
27994626|NCT00819234|54653471|FG005|Overall Study|Adverse Event|2|||
27994627|NCT00819234|54653472|FG006|Overall Study|Adverse Event|0|||
27994628|NCT00819234|54653473|FG007|Overall Study|Adverse Event|0|||
27909786|NCT01212757|54567463|FG002|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
27909787|NCT01212757|54567464|FG003|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
27994629|NCT00819234|54653474|FG008|Overall Study|Adverse Event|0|||
27994630|NCT00819234|54653475|FG009|Overall Study|Adverse Event|0|||
27994631|NCT00819234|54653466|FG000|Overall Study|Physician Decision|0|||
27994632|NCT00819234|54653467|FG001|Overall Study|Physician Decision|0|||
27994633|NCT00819234|54653468|FG002|Overall Study|Physician Decision|0|||
27994634|NCT00819234|54653469|FG003|Overall Study|Physician Decision|1|||
27994635|NCT00819234|54653470|FG004|Overall Study|Physician Decision|0|||
27994636|NCT00819234|54653471|FG005|Overall Study|Physician Decision|0|||
27994637|NCT00819234|54653472|FG006|Overall Study|Physician Decision|0|||
27994638|NCT00819234|54653473|FG007|Overall Study|Physician Decision|0|||
28098295|NCT03573908|54754009|FG004|Randomized Withdrawal Period|Other, Not Specified|0|||
28098296|NCT03573830|54754020|FG000|Overall Study|Dropped without completing treatment|0|||
28098297|NCT03573830|54754021|FG001|Overall Study|Dropped without completing treatment|7|||
28098298|NCT03573830|54754020|FG000|Overall Study|Lost to Follow-up|4|||
28098299|NCT03573830|54754021|FG001|Overall Study|Lost to Follow-up|0|||
28098300|NCT03595904|54754028|FG000|Overall Study|Protocol Violation|3|||
28098301|NCT03595904|54754029|FG001|Overall Study|Protocol Violation|1|||
28098302|NCT03595904|54754028|FG000|Overall Study|Deemed medically ineligible for direct access colonoscopy|4|||
28098303|NCT03595904|54754029|FG001|Overall Study|Deemed medically ineligible for direct access colonoscopy|3|||
28098304|NCT03595904|54754028|FG000|Overall Study|Insurance complications|1|||
28098305|NCT03595904|54754029|FG001|Overall Study|Insurance complications|0|||
28098306|NCT03595904|54754028|FG000|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|2|||
28098307|NCT03595904|54754029|FG001|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|1|||
28098308|NCT03595280|54754038|FG000|Overall Study|Lost to Follow-up|6|||
28098309|NCT03595280|54754039|FG001|Overall Study|Lost to Follow-up|9|||
28098310|NCT03595280|54754040|FG002|Overall Study|Lost to Follow-up|15|||
28098311|NCT03593876|54754048|FG000|Overall Study|Withdrawal by Subject|1|||
28098312|NCT03593876|54754048|FG000|Overall Study|Discharged home before intervention completion|2|||
27909788|NCT01212757|54567465|FG004|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
27909789|NCT01212757|54567466|FG005|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
27909790|NCT01212757|54567467|FG006|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
27909791|NCT01212757|54567468|FG007|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
28098313|NCT00071487|54754056|FG000|52-Week Double-Blind Period|Adverse Event|5|||
28098314|NCT00071487|54754057|FG001|52-Week Double-Blind Period|Adverse Event|8|||
28098315|NCT00071487|54754058|FG002|52-Week Double-Blind Period|Adverse Event|4|||
28098316|NCT00071487|54754059|FG003|52-Week Double-Blind Period|Adverse Event|8|||
28098317|NCT00071487|54754056|FG000|52-Week Double-Blind Period|Lack of Efficacy|1|||
28098318|NCT00071487|54754057|FG001|52-Week Double-Blind Period|Lack of Efficacy|2|||
28098319|NCT00071487|54754058|FG002|52-Week Double-Blind Period|Lack of Efficacy|0|||
28098320|NCT00071487|54754059|FG003|52-Week Double-Blind Period|Lack of Efficacy|1|||
28098321|NCT00071487|54754056|FG000|52-Week Double-Blind Period|Withdrawal by Subject|7|||
28098322|NCT00071487|54754057|FG001|52-Week Double-Blind Period|Withdrawal by Subject|11|||
28098323|NCT00071487|54754058|FG002|52-Week Double-Blind Period|Withdrawal by Subject|7|||
28098324|NCT00071487|54754059|FG003|52-Week Double-Blind Period|Withdrawal by Subject|7|||
28098325|NCT00071487|54754056|FG000|52-Week Double-Blind Period|Physician Decision|1|||
28098326|NCT00071487|54754057|FG001|52-Week Double-Blind Period|Physician Decision|0|||
27739717|NCT02223364|54189340|FG002|Overall Study|subject expired before surgery|0|||
27739718|NCT02223364|54189338|FG000|Overall Study|Physician Decision|1|||
27739719|NCT02223364|54189339|FG001|Overall Study|Physician Decision|0|||
27739720|NCT02223364|54189340|FG002|Overall Study|Physician Decision|0|||
27909792|NCT01212757|54567469|FG008|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
27909793|NCT01212757|54567461|FG000|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
27909794|NCT01212757|54567462|FG001|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
27909795|NCT01212757|54567463|FG002|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
27909796|NCT01212757|54567464|FG003|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
27909797|NCT01212757|54567465|FG004|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
27909798|NCT01212757|54567466|FG005|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
27909799|NCT01212757|54567467|FG006|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
27909800|NCT01212757|54567468|FG007|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
27909801|NCT01212757|54567469|FG008|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
27909802|NCT01190410|54567489|FG000|Overall Study|Adverse Event|0|||
27909803|NCT01190410|54567490|FG001|Overall Study|Adverse Event|3|||
27909804|NCT01190410|54567489|FG000|Overall Study|Lack of Efficacy|0|||
27909805|NCT01190410|54567490|FG001|Overall Study|Lack of Efficacy|2|||
27909806|NCT01190410|54567489|FG000|Overall Study|Withdrawal by Subject|0|||
27994639|NCT00819234|54653474|FG008|Overall Study|Physician Decision|0|||
27994640|NCT00819234|54653475|FG009|Overall Study|Physician Decision|2|||
27994641|NCT00819234|54653466|FG000|Overall Study|Protocol Violation|0|||
28098327|NCT00071487|54754058|FG002|52-Week Double-Blind Period|Physician Decision|0|||
28098328|NCT00071487|54754059|FG003|52-Week Double-Blind Period|Physician Decision|0|||
27909807|NCT01190410|54567490|FG001|Overall Study|Withdrawal by Subject|2|||
27909808|NCT01190410|54567489|FG000|Overall Study|Administrative decision|1|||
27909809|NCT01190410|54567490|FG001|Overall Study|Administrative decision|0|||
27909810|NCT01190410|54567489|FG000|Overall Study|PI discretion|0|||
27909811|NCT01190410|54567490|FG001|Overall Study|PI discretion|2|||
27909812|NCT01190254|54567505|FG000|Overall Study|Adverse Event|3|||
27909813|NCT01190254|54567506|FG001|Overall Study|Adverse Event|6|||
27909814|NCT01190254|54567507|FG002|Overall Study|Adverse Event|8|||
27994642|NCT00819234|54653467|FG001|Overall Study|Protocol Violation|0|||
27994643|NCT00819234|54653468|FG002|Overall Study|Protocol Violation|1|||
27994644|NCT00819234|54653469|FG003|Overall Study|Protocol Violation|0|||
27994645|NCT00819234|54653470|FG004|Overall Study|Protocol Violation|0|||
27994646|NCT00819234|54653471|FG005|Overall Study|Protocol Violation|0|||
27994647|NCT00819234|54653472|FG006|Overall Study|Protocol Violation|0|||
27994648|NCT00819234|54653473|FG007|Overall Study|Protocol Violation|0|||
27994649|NCT00819234|54653474|FG008|Overall Study|Protocol Violation|0|||
27994650|NCT00819234|54653475|FG009|Overall Study|Protocol Violation|0|||
27994651|NCT00819234|54653466|FG000|Overall Study|Lost to Follow-up|2|||
27994652|NCT00819234|54653467|FG001|Overall Study|Lost to Follow-up|2|||
27994653|NCT00819234|54653468|FG002|Overall Study|Lost to Follow-up|0|||
28098329|NCT00071487|54754056|FG000|52-Week Double-Blind Period|Lost to Follow-up|0|||
28098330|NCT00071487|54754057|FG001|52-Week Double-Blind Period|Lost to Follow-up|0|||
28098331|NCT00071487|54754058|FG002|52-Week Double-Blind Period|Lost to Follow-up|2|||
28098332|NCT00071487|54754059|FG003|52-Week Double-Blind Period|Lost to Follow-up|2|||
28098333|NCT00071487|54754056|FG000|52-Week Double-Blind Period|Pregnancy|0|||
28098334|NCT00071487|54754057|FG001|52-Week Double-Blind Period|Pregnancy|1|||
28098335|NCT00071487|54754058|FG002|52-Week Double-Blind Period|Pregnancy|0|||
28098336|NCT00071487|54754059|FG003|52-Week Double-Blind Period|Pregnancy|0|||
28098337|NCT00071487|54754056|FG000|52-Week Double-Blind Period|Protocol Violation|0|||
28098338|NCT00071487|54754057|FG001|52-Week Double-Blind Period|Protocol Violation|1|||
28098339|NCT00071487|54754058|FG002|52-Week Double-Blind Period|Protocol Violation|1|||
28098340|NCT00071487|54754059|FG003|52-Week Double-Blind Period|Protocol Violation|0|||
28098341|NCT00071487|54754056|FG000|52-Week Double-Blind Period|Death|0|||
28098342|NCT00071487|54754057|FG001|52-Week Double-Blind Period|Death|1|||
28098343|NCT00071487|54754058|FG002|52-Week Double-Blind Period|Death|0|||
28098344|NCT00071487|54754059|FG003|52-Week Double-Blind Period|Death|0|||
28098345|NCT00071487|54754056|FG000|52-Week Double-Blind Period|Lack of Compliance|6|||
28098346|NCT00071487|54754057|FG001|52-Week Double-Blind Period|Lack of Compliance|3|||
28098347|NCT00071487|54754058|FG002|52-Week Double-Blind Period|Lack of Compliance|3|||
28098348|NCT00071487|54754059|FG003|52-Week Double-Blind Period|Lack of Compliance|3|||
28098349|NCT00071487|54754056|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
28098350|NCT00071487|54754057|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
28098351|NCT00071487|54754058|FG002|24-Week Open-Label Extension Period|Adverse Event|1|||
28098352|NCT00071487|54754059|FG003|24-Week Open-Label Extension Period|Adverse Event|6|||
28098353|NCT00071487|54754056|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
28098354|NCT00071487|54754057|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
28098355|NCT00071487|54754058|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
28098356|NCT00071487|54754059|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|3|||
28098357|NCT00071487|54754056|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
28098358|NCT00071487|54754057|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
28098359|NCT00071487|54754058|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
28098360|NCT00071487|54754059|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|9|||
28098361|NCT00071487|54754056|FG000|24-Week Open-Label Extension Period|Pregnancy|0|||
28098362|NCT00071487|54754057|FG001|24-Week Open-Label Extension Period|Pregnancy|0|||
28098363|NCT00071487|54754058|FG002|24-Week Open-Label Extension Period|Pregnancy|0|||
28098364|NCT00071487|54754059|FG003|24-Week Open-Label Extension Period|Pregnancy|1|||
28098365|NCT00071487|54754056|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
28098366|NCT00071487|54754057|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
28098367|NCT00071487|54754058|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
28098368|NCT00071487|54754059|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
28098369|NCT00071487|54754056|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
28098370|NCT00071487|54754057|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
27909815|NCT01190254|54567505|FG000|Overall Study|Lack of Efficacy|7|||
27909816|NCT01190254|54567506|FG001|Overall Study|Lack of Efficacy|4|||
28098371|NCT00071487|54754058|FG002|24-Week Open-Label Extension Period|Lack of Compliance|0|||
28098372|NCT00071487|54754059|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
28098373|NCT03591146|54754076|FG000|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
27994654|NCT00819234|54653469|FG003|Overall Study|Lost to Follow-up|2|||
27994655|NCT00819234|54653470|FG004|Overall Study|Lost to Follow-up|1|||
27994656|NCT00819234|54653471|FG005|Overall Study|Lost to Follow-up|1|||
27994657|NCT00819234|54653472|FG006|Overall Study|Lost to Follow-up|1|||
28098374|NCT03591146|54754077|FG001|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
27909817|NCT01190254|54567507|FG002|Overall Study|Lack of Efficacy|5|||
27909818|NCT01190254|54567505|FG000|Overall Study|Lost to Follow-up|4|||
27909819|NCT01190254|54567506|FG001|Overall Study|Lost to Follow-up|2|||
27909820|NCT01190254|54567507|FG002|Overall Study|Lost to Follow-up|0|||
27909821|NCT01190254|54567505|FG000|Overall Study|Withdrawal by Subject|4|||
27909822|NCT01190254|54567506|FG001|Overall Study|Withdrawal by Subject|5|||
27994658|NCT00819234|54653473|FG007|Overall Study|Lost to Follow-up|1|||
27994659|NCT00819234|54653474|FG008|Overall Study|Lost to Follow-up|1|||
27994660|NCT00819234|54653475|FG009|Overall Study|Lost to Follow-up|2|||
27994661|NCT00667342|54653533|FG000|Overall Study|Protocol Violation|1|||
27994662|NCT00667342|54653534|FG001|Overall Study|Protocol Violation|0|||
27994663|NCT00667342|54653535|FG002|Overall Study|Protocol Violation|0|||
27994664|NCT00667342|54653533|FG000|Overall Study|Withdrawal by Subject|1|||
27994665|NCT00667342|54653534|FG001|Overall Study|Withdrawal by Subject|0|||
27909823|NCT01190254|54567507|FG002|Overall Study|Withdrawal by Subject|7|||
27909824|NCT01190254|54567505|FG000|Overall Study|Protocol Violation|2|||
27909825|NCT01190254|54567506|FG001|Overall Study|Protocol Violation|0|||
27909826|NCT01190254|54567507|FG002|Overall Study|Protocol Violation|2|||
27909827|NCT01190254|54567505|FG000|Overall Study|Did not meet protocol eligibility|1|||
27909828|NCT01190254|54567506|FG001|Overall Study|Did not meet protocol eligibility|0|||
27909829|NCT01190254|54567507|FG002|Overall Study|Did not meet protocol eligibility|0|||
27909830|NCT01190839|54567517|FG000|Overall Study|Adverse Event|32|||
27909831|NCT01190839|54567518|FG001|Overall Study|Adverse Event|41|||
27909832|NCT01190839|54567517|FG000|Overall Study|Protocol Violation|2|||
27909833|NCT01190839|54567518|FG001|Overall Study|Protocol Violation|2|||
27909834|NCT01190839|54567517|FG000|Overall Study|Lost to Follow-up|7|||
27909835|NCT01190839|54567518|FG001|Overall Study|Lost to Follow-up|1|||
27909836|NCT01190839|54567517|FG000|Overall Study|Death|1|||
27909837|NCT01190839|54567518|FG001|Overall Study|Death|0|||
27909838|NCT01190839|54567517|FG000|Overall Study|Trial stopped by Sponsor|71|||
27994666|NCT00667342|54653535|FG002|Overall Study|Withdrawal by Subject|0|||
27994667|NCT00667342|54653533|FG000|Overall Study|Physician Decision|3|||
27994668|NCT00667342|54653534|FG001|Overall Study|Physician Decision|0|||
27994669|NCT00667342|54653535|FG002|Overall Study|Physician Decision|0|||
27994670|NCT00667342|54653533|FG000|Overall Study|Relapse or tumor progression|9|||
27994671|NCT00667342|54653534|FG001|Overall Study|Relapse or tumor progression|0|||
27994672|NCT00667342|54653535|FG002|Overall Study|Relapse or tumor progression|7|||
27994673|NCT00667342|54653533|FG000|Overall Study|Adverse Event|0|||
27994674|NCT00667342|54653534|FG001|Overall Study|Adverse Event|0|||
27994675|NCT00667342|54653535|FG002|Overall Study|Adverse Event|1|||
28098375|NCT03591146|54754078|FG002|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
28098376|NCT03591146|54754079|FG003|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
28098377|NCT03591146|54754080|FG004|TLC590 190mg and Naropin 150mg|Lost to Follow-up|1|||
28098378|NCT03591146|54754076|FG000|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
28098379|NCT03591146|54754077|FG001|TLC590 380mg and Naropin 150mg|Lost to Follow-up|1|||
27909839|NCT01190839|54567518|FG001|Overall Study|Trial stopped by Sponsor|68|||
28098380|NCT03591146|54754078|FG002|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
28098381|NCT03591146|54754079|FG003|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
28098382|NCT03591146|54754080|FG004|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
28098383|NCT03591146|54754076|FG000|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
28098384|NCT03591146|54754077|FG001|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
28098385|NCT03591146|54754078|FG002|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
28098386|NCT03591146|54754079|FG003|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
28098387|NCT03591146|54754080|FG004|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|1|||
28098388|NCT03591146|54754076|FG000|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
28098389|NCT03591146|54754077|FG001|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
28098390|NCT03591146|54754078|FG002|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
28098391|NCT03591146|54754079|FG003|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
28098392|NCT03591146|54754080|FG004|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
28098393|NCT00096447|54754092|FG000|Overall Study|Never treated|1|||
28098394|NCT03590366|54754103|FG000|Overall Study|Adverse Event|0|||
28098395|NCT03590366|54754104|FG001|Overall Study|Adverse Event|3|||
28098396|NCT03590366|54754103|FG000|Overall Study|Lost to Follow-up|3|||
28098397|NCT03590366|54754104|FG001|Overall Study|Lost to Follow-up|3|||
28098398|NCT03590366|54754103|FG000|Overall Study|Withdrawal by Subject|0|||
28098399|NCT03590366|54754104|FG001|Overall Study|Withdrawal by Subject|2|||
27909840|NCT01190839|54567517|FG000|Overall Study|Undefined|35|||
27909841|NCT01190839|54567518|FG001|Overall Study|Undefined|31|||
27909842|NCT01190839|54567517|FG000|Overall Study|Randomized but not treated|2|||
27909843|NCT01190839|54567518|FG001|Overall Study|Randomized but not treated|4|||
27909844|NCT01190215|54567528|FG000|Up to Month 6|Lost to Follow-up|2|||
27994676|NCT00667342|54653533|FG000|Overall Study|Ineligible|0|||
27994677|NCT00667342|54653534|FG001|Overall Study|Ineligible|0|||
27994678|NCT00667342|54653535|FG002|Overall Study|Ineligible|1|||
27994679|NCT00871403|54653552|FG000|Combination Treatment Phase|Randomized but Not Treated|1|||
27994680|NCT00871403|54653553|FG001|Combination Treatment Phase|Randomized but Not Treated|1|||
27909845|NCT01190215|54567529|FG001|Up to Month 6|Lost to Follow-up|0|||
27909846|NCT01190449|54567537|FG000|Overall Study|Ineligible|0|||
27994681|NCT00871403|54653554|FG002|Combination Treatment Phase|Randomized but Not Treated|1|||
27994682|NCT00871403|54653552|FG000|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8|||
27994683|NCT00871403|54653553|FG001|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19|||
27994684|NCT00871403|54653554|FG002|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0|||
27909847|NCT01190449|54567538|FG001|Overall Study|Ineligible|4|||
27909848|NCT01190176|54567544|FG000|Overall Study|Withdrawal by Subject|1|||
27909849|NCT01190176|54567544|FG000|Overall Study|Lost to Follow-up|1|||
27909850|NCT01190098|54567550|FG000|Overall Study|Adverse Event|2|||
27909851|NCT01190098|54567551|FG001|Overall Study|Adverse Event|0|||
27909852|NCT01190098|54567550|FG000|Overall Study|Patient coomorbidity|0|||
27909853|NCT01190098|54567551|FG001|Overall Study|Patient coomorbidity|1|||
27994685|NCT00871403|54653552|FG000|Combination Treatment Phase|Adverse Event|0|||
27994686|NCT00871403|54653553|FG001|Combination Treatment Phase|Adverse Event|17|||
27994687|NCT00871403|54653554|FG002|Combination Treatment Phase|Adverse Event|2|||
27994688|NCT00871403|54653552|FG000|Combination Treatment Phase|Disease Progression|0|||
27994689|NCT00871403|54653553|FG001|Combination Treatment Phase|Disease Progression|8|||
27994690|NCT00871403|54653554|FG002|Combination Treatment Phase|Disease Progression|5|||
27909854|NCT01190098|54567550|FG000|Overall Study|Lack of transportation|1|||
27909855|NCT01190098|54567551|FG001|Overall Study|Lack of transportation|0|||
27994691|NCT00871403|54653552|FG000|Combination Treatment Phase|Withdrawal by Subject|0|||
27994692|NCT00871403|54653553|FG001|Combination Treatment Phase|Withdrawal by Subject|3|||
27994693|NCT00871403|54653554|FG002|Combination Treatment Phase|Withdrawal by Subject|1|||
27994694|NCT00871403|54653552|FG000|Combination Treatment Phase|Physician Decision|0|||
27994695|NCT00871403|54653553|FG001|Combination Treatment Phase|Physician Decision|1|||
27994696|NCT00871403|54653554|FG002|Combination Treatment Phase|Physician Decision|3|||
27994697|NCT00871403|54653552|FG000|Monotherapy Treatment Phase|Disease Progression|0|||
27994698|NCT00871403|54653553|FG001|Monotherapy Treatment Phase|Disease Progression|9|||
27994699|NCT00871403|54653554|FG002|Monotherapy Treatment Phase|Disease Progression|1|||
27994700|NCT00871403|54653552|FG000|Monotherapy Treatment Phase|Adverse Event|0|||
27994701|NCT00871403|54653553|FG001|Monotherapy Treatment Phase|Adverse Event|4|||
27909856|NCT01190098|54567550|FG000|Overall Study|Other|0|||
27909857|NCT01190098|54567551|FG001|Overall Study|Other|1|||
27994702|NCT00871403|54653554|FG002|Monotherapy Treatment Phase|Adverse Event|0|||
27994703|NCT00853112|54653568|FG000|Overall Study|Randomized but not treated|0|||
27994704|NCT00853112|54653569|FG001|Overall Study|Randomized but not treated|1|||
27994705|NCT00853112|54653570|FG002|Overall Study|Randomized but not treated|0|||
27994706|NCT00853112|54653571|FG003|Overall Study|Randomized but not treated|2|||
27994707|NCT00853112|54653572|FG004|Overall Study|Randomized but not treated|0|||
27994708|NCT00853112|54653573|FG005|Overall Study|Randomized but not treated|0|||
27994709|NCT00853112|54653574|FG006|Overall Study|Randomized but not treated|1|||
27994710|NCT00460603|54653602|FG000|Phase 1|Death|1|||
27994711|NCT00460603|54653603|FG001|Phase 1|Death|0|||
27994712|NCT00460603|54653604|FG002|Phase 1|Death|0|||
27994713|NCT00460603|54653605|FG003|Phase 1|Death|2|||
27994714|NCT00460603|54653606|FG004|Phase 1|Death|0|||
27994715|NCT00460603|54653607|FG005|Phase 1|Death|0|||
27994716|NCT00460603|54653608|FG006|Phase 1|Death|0|||
27994717|NCT00460603|54653609|FG007|Phase 1|Death|0|||
27994718|NCT00460603|54653610|FG008|Phase 1|Death|1|||
27994719|NCT00460603|54653611|FG009|Phase 1|Death|0|||
27994720|NCT00460603|54653612|FG010|Phase 1|Death|0|||
27994721|NCT00460603|54653613|FG011|Phase 1|Death|0|||
27994722|NCT00460603|54653602|FG000|Phase 1|Adverse Event|3|||
27994723|NCT00460603|54653603|FG001|Phase 1|Adverse Event|1|||
27994724|NCT00460603|54653604|FG002|Phase 1|Adverse Event|1|||
27994725|NCT00460603|54653605|FG003|Phase 1|Adverse Event|2|||
27994726|NCT00460603|54653606|FG004|Phase 1|Adverse Event|0|||
27994727|NCT00460603|54653607|FG005|Phase 1|Adverse Event|0|||
27994728|NCT00460603|54653608|FG006|Phase 1|Adverse Event|3|||
27994729|NCT00460603|54653609|FG007|Phase 1|Adverse Event|0|||
27994730|NCT00460603|54653610|FG008|Phase 1|Adverse Event|4|||
27994731|NCT00460603|54653611|FG009|Phase 1|Adverse Event|0|||
27994732|NCT00460603|54653612|FG010|Phase 1|Adverse Event|0|||
27909858|NCT01190020|54567559|FG000|Overall Study|Adverse Event|2|||
27994733|NCT00460603|54653613|FG011|Phase 1|Adverse Event|0|||
27994734|NCT00460603|54653602|FG000|Phase 1|Lack of Efficacy|1|||
27994735|NCT00460603|54653603|FG001|Phase 1|Lack of Efficacy|0|||
27994736|NCT00460603|54653604|FG002|Phase 1|Lack of Efficacy|1|||
27994737|NCT00460603|54653605|FG003|Phase 1|Lack of Efficacy|2|||
27909859|NCT01190020|54567560|FG001|Overall Study|Adverse Event|0|||
27909860|NCT01190020|54567559|FG000|Overall Study|Lost to Follow-up|2|||
27909861|NCT01190020|54567560|FG001|Overall Study|Lost to Follow-up|0|||
27994738|NCT00460603|54653606|FG004|Phase 1|Lack of Efficacy|2|||
27994739|NCT00460603|54653607|FG005|Phase 1|Lack of Efficacy|2|||
27994740|NCT00460603|54653608|FG006|Phase 1|Lack of Efficacy|2|||
27994741|NCT00460603|54653609|FG007|Phase 1|Lack of Efficacy|2|||
27994742|NCT00460603|54653610|FG008|Phase 1|Lack of Efficacy|11|||
27909862|NCT01190020|54567559|FG000|Overall Study|Withdrawal by Subject|3|||
27994743|NCT00460603|54653611|FG009|Phase 1|Lack of Efficacy|0|||
27994744|NCT00460603|54653612|FG010|Phase 1|Lack of Efficacy|0|||
27909863|NCT01190020|54567560|FG001|Overall Study|Withdrawal by Subject|0|||
27909864|NCT01189435|54567566|FG000|Overall Study|Withdrawal by Subject|1|||
27909865|NCT01189435|54567566|FG000|Overall Study|Physician Decision|1|||
27909866|NCT01165996|54567570|FG000|Overall Study|Death|1|||
27909867|NCT01165996|54567570|FG000|Overall Study|Physician Decision|1|||
27909868|NCT01165684|54567577|FG000|Overall Study|Adverse Event|1|||
27909869|NCT01165684|54567578|FG001|Overall Study|Adverse Event|1|||
27909870|NCT01165684|54567577|FG000|Overall Study|Lack of Efficacy|2|||
27909871|NCT01165684|54567578|FG001|Overall Study|Lack of Efficacy|1|||
27909872|NCT01165684|54567577|FG000|Overall Study|Protocol Violation|7|||
27909873|NCT01165684|54567578|FG001|Overall Study|Protocol Violation|15|||
27909874|NCT01165684|54567577|FG000|Overall Study|Withdrawal Criteria|2|||
27909875|NCT01165684|54567578|FG001|Overall Study|Withdrawal Criteria|13|||
27909876|NCT01165684|54567577|FG000|Overall Study|Unclassified|16|||
27909877|NCT01165684|54567578|FG001|Overall Study|Unclassified|22|||
27909878|NCT01189201|54567584|FG000|Overall Study|Adverse Event|1|||
27909879|NCT01188967|54567601|FG000|Overall Study|Withdrawal by Subject|1|||
27909880|NCT01188967|54567602|FG001|Overall Study|Withdrawal by Subject|1|||
27909881|NCT01188967|54567601|FG000|Overall Study|Physician Decision|1|||
27909882|NCT01188967|54567602|FG001|Overall Study|Physician Decision|1|||
27909883|NCT01188967|54567601|FG000|Overall Study|Lost to Follow-up|3|||
27909884|NCT01188967|54567602|FG001|Overall Study|Lost to Follow-up|2|||
27909885|NCT01188811|54567612|FG000|Overall Study|Withdrawal by Subject|0|||
27909886|NCT01188811|54567613|FG001|Overall Study|Withdrawal by Subject|2|||
27909887|NCT01188811|54567612|FG000|Overall Study|Adverse Event|6|||
27909888|NCT01188811|54567613|FG001|Overall Study|Adverse Event|0|||
27909889|NCT01183234|54567621|FG000|First Intervention|Adverse Event|1|||
27909890|NCT01183234|54567622|FG001|First Intervention|Adverse Event|0|||
27909891|NCT01165216|54567630|FG000|Overall Study|Adverse Event|6|||
27909892|NCT01165216|54567631|FG001|Overall Study|Adverse Event|3|||
27909893|NCT01165216|54567630|FG000|Overall Study|Withdrawal by Subject|1|||
27909894|NCT01165216|54567631|FG001|Overall Study|Withdrawal by Subject|1|||
27909895|NCT01165216|54567630|FG000|Overall Study|Disease progression|1|||
27909896|NCT01165216|54567631|FG001|Overall Study|Disease progression|3|||
27909897|NCT04545476|54567656|FG000|Overall Study|Lost to Follow-up|1|||
27909898|NCT04545476|54567657|FG001|Overall Study|Lost to Follow-up|1|||
27909899|NCT04545476|54567658|FG002|Overall Study|Lost to Follow-up|0|||
27909900|NCT04545476|54567659|FG003|Overall Study|Lost to Follow-up|0|||
27909901|NCT01969838|54567674|FG000|Double-blind Phase|Adverse Event|10|||
27909902|NCT01969838|54567675|FG001|Double-blind Phase|Adverse Event|4|||
27909903|NCT01969838|54567676|FG002|Double-blind Phase|Adverse Event|0|||
27909904|NCT01969838|54567677|FG003|Double-blind Phase|Adverse Event|0|||
27909905|NCT01969838|54567674|FG000|Double-blind Phase|Death|5|||
27909906|NCT01969838|54567675|FG001|Double-blind Phase|Death|2|||
27909907|NCT01969838|54567676|FG002|Double-blind Phase|Death|0|||
27909908|NCT01969838|54567677|FG003|Double-blind Phase|Death|0|||
27909909|NCT01969838|54567674|FG000|Double-blind Phase|Physician Decision|5|||
27909910|NCT01969838|54567675|FG001|Double-blind Phase|Physician Decision|1|||
27909911|NCT01969838|54567676|FG002|Double-blind Phase|Physician Decision|0|||
27909912|NCT01969838|54567677|FG003|Double-blind Phase|Physician Decision|0|||
27909913|NCT01969838|54567674|FG000|Double-blind Phase|Subject Decision|4|||
27909914|NCT01969838|54567675|FG001|Double-blind Phase|Subject Decision|2|||
27909915|NCT01969838|54567676|FG002|Double-blind Phase|Subject Decision|0|||
27909916|NCT01969838|54567677|FG003|Double-blind Phase|Subject Decision|0|||
27909917|NCT01969838|54567674|FG000|Double-blind Phase|Disease Progression|2|||
27909918|NCT01969838|54567675|FG001|Double-blind Phase|Disease Progression|0|||
27909919|NCT01969838|54567676|FG002|Double-blind Phase|Disease Progression|0|||
27909920|NCT01969838|54567677|FG003|Double-blind Phase|Disease Progression|0|||
27909921|NCT01969838|54567674|FG000|Double-blind Phase|Symptomatic Spleen Growth|1|||
27909922|NCT01969838|54567675|FG001|Double-blind Phase|Symptomatic Spleen Growth|0|||
27909923|NCT01969838|54567676|FG002|Double-blind Phase|Symptomatic Spleen Growth|0|||
27909924|NCT01969838|54567677|FG003|Double-blind Phase|Symptomatic Spleen Growth|0|||
27909925|NCT01969838|54567674|FG000|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
27909926|NCT01969838|54567675|FG001|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
27909927|NCT01969838|54567676|FG002|Open-label Phase|Transferred to study SRA-MMB-4365|52|||
27909928|NCT01969838|54567677|FG003|Open-label Phase|Transferred to study SRA-MMB-4365|62|||
27909929|NCT01969838|54567674|FG000|Open-label Phase|Adverse Event|0|||
27909930|NCT01969838|54567675|FG001|Open-label Phase|Adverse Event|0|||
27909931|NCT01969838|54567676|FG002|Open-label Phase|Adverse Event|37|||
27909932|NCT01969838|54567677|FG003|Open-label Phase|Adverse Event|49|||
27909933|NCT01969838|54567674|FG000|Open-label Phase|Disease Progression|0|||
27909934|NCT01969838|54567675|FG001|Open-label Phase|Disease Progression|0|||
27909935|NCT01969838|54567676|FG002|Open-label Phase|Disease Progression|26|||
27909936|NCT01969838|54567677|FG003|Open-label Phase|Disease Progression|27|||
27909937|NCT01969838|54567674|FG000|Open-label Phase|Lack of Efficacy|0|||
27909938|NCT01969838|54567675|FG001|Open-label Phase|Lack of Efficacy|0|||
27909939|NCT01969838|54567676|FG002|Open-label Phase|Lack of Efficacy|17|||
27909940|NCT01969838|54567677|FG003|Open-label Phase|Lack of Efficacy|19|||
27909941|NCT01969838|54567674|FG000|Open-label Phase|Subject Decision|0|||
27909942|NCT01969838|54567675|FG001|Open-label Phase|Subject Decision|0|||
27909943|NCT01969838|54567676|FG002|Open-label Phase|Subject Decision|14|||
27909944|NCT01969838|54567677|FG003|Open-label Phase|Subject Decision|15|||
27909945|NCT01969838|54567674|FG000|Open-label Phase|Death|0|||
27909946|NCT01969838|54567675|FG001|Open-label Phase|Death|0|||
27909947|NCT01969838|54567676|FG002|Open-label Phase|Death|13|||
27909948|NCT01969838|54567677|FG003|Open-label Phase|Death|11|||
27909949|NCT01969838|54567674|FG000|Open-label Phase|Physician Decision|0|||
27909950|NCT01969838|54567675|FG001|Open-label Phase|Physician Decision|0|||
27909951|NCT01969838|54567676|FG002|Open-label Phase|Physician Decision|9|||
27994745|NCT00460603|54653613|FG011|Phase 1|Lack of Efficacy|0|||
27994746|NCT00460603|54653602|FG000|Phase 1|Withdrawal by Subject|1|||
27994747|NCT00460603|54653603|FG001|Phase 1|Withdrawal by Subject|2|||
27994748|NCT00460603|54653604|FG002|Phase 1|Withdrawal by Subject|1|||
27994749|NCT00460603|54653605|FG003|Phase 1|Withdrawal by Subject|1|||
27994750|NCT00460603|54653606|FG004|Phase 1|Withdrawal by Subject|3|||
27994751|NCT00460603|54653607|FG005|Phase 1|Withdrawal by Subject|0|||
27994752|NCT00460603|54653608|FG006|Phase 1|Withdrawal by Subject|1|||
27994753|NCT00460603|54653609|FG007|Phase 1|Withdrawal by Subject|0|||
27994754|NCT00460603|54653610|FG008|Phase 1|Withdrawal by Subject|2|||
27994755|NCT00460603|54653611|FG009|Phase 1|Withdrawal by Subject|0|||
27994756|NCT00460603|54653612|FG010|Phase 1|Withdrawal by Subject|0|||
27994757|NCT00460603|54653613|FG011|Phase 1|Withdrawal by Subject|0|||
27994758|NCT00460603|54653602|FG000|Phase 1|Other|0|||
27994759|NCT00460603|54653603|FG001|Phase 1|Other|3|||
27994760|NCT00460603|54653604|FG002|Phase 1|Other|1|||
27994761|NCT00460603|54653605|FG003|Phase 1|Other|1|||
27994762|NCT00460603|54653606|FG004|Phase 1|Other|1|||
27994763|NCT00460603|54653607|FG005|Phase 1|Other|2|||
27994764|NCT00460603|54653608|FG006|Phase 1|Other|0|||
27994765|NCT00460603|54653609|FG007|Phase 1|Other|1|||
27994766|NCT00460603|54653610|FG008|Phase 1|Other|0|||
27994767|NCT00460603|54653611|FG009|Phase 1|Other|0|||
27994768|NCT00460603|54653612|FG010|Phase 1|Other|0|||
27994769|NCT00460603|54653613|FG011|Phase 1|Other|0|||
27994770|NCT00460603|54653602|FG000|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
27994771|NCT00460603|54653603|FG001|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
27994772|NCT00460603|54653604|FG002|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
27994773|NCT00460603|54653605|FG003|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
27994774|NCT00460603|54653606|FG004|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
27994775|NCT00460603|54653607|FG005|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
27994776|NCT00460603|54653608|FG006|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
27994777|NCT00460603|54653609|FG007|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
27994778|NCT00460603|54653610|FG008|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
27994779|NCT00460603|54653611|FG009|Phase 2|Ongoing in study A4061008 (NCT00828919)|1|||
27994780|NCT00460603|54653612|FG010|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
27994781|NCT00460603|54653613|FG011|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
27994782|NCT00460603|54653602|FG000|Phase 2|Adverse Event|0|||
27994783|NCT00460603|54653603|FG001|Phase 2|Adverse Event|0|||
27994784|NCT00460603|54653604|FG002|Phase 2|Adverse Event|0|||
27994785|NCT00460603|54653605|FG003|Phase 2|Adverse Event|0|||
27994786|NCT00460603|54653606|FG004|Phase 2|Adverse Event|0|||
27994787|NCT00460603|54653607|FG005|Phase 2|Adverse Event|0|||
27994788|NCT00460603|54653608|FG006|Phase 2|Adverse Event|0|||
27994789|NCT00460603|54653609|FG007|Phase 2|Adverse Event|0|||
27994790|NCT00460603|54653610|FG008|Phase 2|Adverse Event|0|||
27994791|NCT00460603|54653611|FG009|Phase 2|Adverse Event|12|||
27994792|NCT00460603|54653612|FG010|Phase 2|Adverse Event|9|||
28172591|NCT02435836|54844326|FG000|Overall Study|Lack of Efficacy|1|||
27909952|NCT01969838|54567677|FG003|Open-label Phase|Physician Decision|14|||
27909953|NCT01969838|54567674|FG000|Open-label Phase|Non-compliance with Study Drug|0|||
27909954|NCT01969838|54567675|FG001|Open-label Phase|Non-compliance with Study Drug|0|||
27909955|NCT01969838|54567676|FG002|Open-label Phase|Non-compliance with Study Drug|2|||
27909956|NCT01969838|54567677|FG003|Open-label Phase|Non-compliance with Study Drug|0|||
27909957|NCT01165177|54567688|FG000|Overall Study|Serious Adverse Event|227|||
27909958|NCT01165177|54567689|FG001|Overall Study|Serious Adverse Event|235|||
27909959|NCT01165177|54567688|FG000|Overall Study|Withdrawal by Subject|368|||
27909960|NCT01165177|54567689|FG001|Overall Study|Withdrawal by Subject|354|||
27909961|NCT01165177|54567688|FG000|Overall Study|Protocol Violation|19|||
27994793|NCT00460603|54653613|FG011|Phase 2|Adverse Event|10|||
27994794|NCT00460603|54653602|FG000|Phase 2|Death|0|||
27994795|NCT00460603|54653603|FG001|Phase 2|Death|0|||
27994796|NCT00460603|54653604|FG002|Phase 2|Death|0|||
27994797|NCT00460603|54653605|FG003|Phase 2|Death|0|||
27994798|NCT00460603|54653606|FG004|Phase 2|Death|0|||
27994799|NCT00460603|54653607|FG005|Phase 2|Death|0|||
27994800|NCT00460603|54653608|FG006|Phase 2|Death|0|||
27994801|NCT00460603|54653609|FG007|Phase 2|Death|0|||
27994802|NCT00460603|54653610|FG008|Phase 2|Death|0|||
27994803|NCT00460603|54653611|FG009|Phase 2|Death|4|||
27994804|NCT00460603|54653612|FG010|Phase 2|Death|2|||
27994805|NCT00460603|54653613|FG011|Phase 2|Death|2|||
27909962|NCT01165177|54567689|FG001|Overall Study|Protocol Violation|21|||
27909963|NCT01165177|54567688|FG000|Overall Study|Non-serious adverse event|30|||
27909964|NCT01165177|54567689|FG001|Overall Study|Non-serious adverse event|18|||
27909965|NCT01165177|54567688|FG000|Overall Study|Other unspecified reasons|47|||
27909966|NCT01165177|54567689|FG001|Overall Study|Other unspecified reasons|35|||
27909967|NCT01165177|54567688|FG000|Overall Study|Suspected HZ episode|0|||
27909968|NCT01165177|54567689|FG001|Overall Study|Suspected HZ episode|2|||
27909969|NCT01165177|54567688|FG000|Overall Study|Lost to Follow-up|183|||
27909970|NCT01165177|54567689|FG001|Overall Study|Lost to Follow-up|194|||
27909971|NCT01165177|54567688|FG000|Overall Study|Migrated/ moved from study area|48|||
27909972|NCT01165177|54567689|FG001|Overall Study|Migrated/ moved from study area|43|||
27909973|NCT01165138|54567706|FG000|Overall Study|Adverse Event|0|||
27909974|NCT01165138|54567707|FG001|Overall Study|Adverse Event|1|||
27909975|NCT01165138|54567708|FG002|Overall Study|Adverse Event|0|||
27909976|NCT01165138|54567709|FG003|Overall Study|Adverse Event|2|||
27909977|NCT01165138|54567706|FG000|Overall Study|Lack of Efficacy|0|||
27909978|NCT01165138|54567707|FG001|Overall Study|Lack of Efficacy|32|||
27909979|NCT01165138|54567708|FG002|Overall Study|Lack of Efficacy|6|||
27909980|NCT01165138|54567709|FG003|Overall Study|Lack of Efficacy|7|||
27909981|NCT01165138|54567706|FG000|Overall Study|Protocol Violation|0|||
27909982|NCT01165138|54567707|FG001|Overall Study|Protocol Violation|7|||
27909983|NCT01165138|54567708|FG002|Overall Study|Protocol Violation|0|||
27909984|NCT01165138|54567709|FG003|Overall Study|Protocol Violation|2|||
27994806|NCT00460603|54653602|FG000|Phase 2|Protocol Violation|0|||
27994807|NCT00460603|54653603|FG001|Phase 2|Protocol Violation|0|||
27994808|NCT00460603|54653604|FG002|Phase 2|Protocol Violation|0|||
27994809|NCT00460603|54653605|FG003|Phase 2|Protocol Violation|0|||
27994810|NCT00460603|54653606|FG004|Phase 2|Protocol Violation|0|||
27994811|NCT00460603|54653607|FG005|Phase 2|Protocol Violation|0|||
27994812|NCT00460603|54653608|FG006|Phase 2|Protocol Violation|0|||
27994813|NCT00460603|54653609|FG007|Phase 2|Protocol Violation|0|||
27994814|NCT00460603|54653610|FG008|Phase 2|Protocol Violation|0|||
27994815|NCT00460603|54653611|FG009|Phase 2|Protocol Violation|1|||
27994816|NCT00460603|54653612|FG010|Phase 2|Protocol Violation|1|||
27994817|NCT00460603|54653613|FG011|Phase 2|Protocol Violation|0|||
27994818|NCT00460603|54653602|FG000|Phase 2|Lost to Follow-up|0|||
27994819|NCT00460603|54653603|FG001|Phase 2|Lost to Follow-up|0|||
27994820|NCT00460603|54653604|FG002|Phase 2|Lost to Follow-up|0|||
27994821|NCT00460603|54653605|FG003|Phase 2|Lost to Follow-up|0|||
27994822|NCT00460603|54653606|FG004|Phase 2|Lost to Follow-up|0|||
27994823|NCT00460603|54653607|FG005|Phase 2|Lost to Follow-up|0|||
27994824|NCT00460603|54653608|FG006|Phase 2|Lost to Follow-up|0|||
27994825|NCT00460603|54653609|FG007|Phase 2|Lost to Follow-up|0|||
27994826|NCT00460603|54653610|FG008|Phase 2|Lost to Follow-up|0|||
27994827|NCT00460603|54653611|FG009|Phase 2|Lost to Follow-up|1|||
27994828|NCT00460603|54653612|FG010|Phase 2|Lost to Follow-up|0|||
27994829|NCT00460603|54653613|FG011|Phase 2|Lost to Follow-up|0|||
27994830|NCT00460603|54653602|FG000|Phase 2|Other|0|||
27994831|NCT00460603|54653603|FG001|Phase 2|Other|0|||
27994832|NCT00460603|54653604|FG002|Phase 2|Other|0|||
27994833|NCT00460603|54653605|FG003|Phase 2|Other|0|||
27994834|NCT00460603|54653606|FG004|Phase 2|Other|0|||
27994835|NCT00460603|54653607|FG005|Phase 2|Other|0|||
27994836|NCT00460603|54653608|FG006|Phase 2|Other|0|||
27994837|NCT00460603|54653609|FG007|Phase 2|Other|0|||
27994838|NCT00460603|54653610|FG008|Phase 2|Other|0|||
27994839|NCT00460603|54653611|FG009|Phase 2|Other|6|||
27994840|NCT00460603|54653612|FG010|Phase 2|Other|16|||
27994841|NCT00460603|54653613|FG011|Phase 2|Other|7|||
27909985|NCT01165138|54567706|FG000|Overall Study|Lost to Follow-up|0|||
27909986|NCT01165138|54567707|FG001|Overall Study|Lost to Follow-up|0|||
27994842|NCT00460603|54653602|FG000|Phase 2|Objective Progression or Relapse|0|||
27994843|NCT00460603|54653603|FG001|Phase 2|Objective Progression or Relapse|0|||
27909987|NCT01165138|54567708|FG002|Overall Study|Lost to Follow-up|1|||
27994844|NCT00460603|54653604|FG002|Phase 2|Objective Progression or Relapse|0|||
27994845|NCT00460603|54653605|FG003|Phase 2|Objective Progression or Relapse|0|||
27994846|NCT00460603|54653606|FG004|Phase 2|Objective Progression or Relapse|0|||
27994847|NCT00460603|54653607|FG005|Phase 2|Objective Progression or Relapse|0|||
27994848|NCT00460603|54653608|FG006|Phase 2|Objective Progression or Relapse|0|||
27994849|NCT00460603|54653609|FG007|Phase 2|Objective Progression or Relapse|0|||
27994850|NCT00460603|54653610|FG008|Phase 2|Objective Progression or Relapse|0|||
27909988|NCT01165138|54567709|FG003|Overall Study|Lost to Follow-up|2|||
27909989|NCT01165138|54567706|FG000|Overall Study|Physician Decision|0|||
27909990|NCT01165138|54567707|FG001|Overall Study|Physician Decision|6|||
27909991|NCT01165138|54567708|FG002|Overall Study|Physician Decision|7|||
27994851|NCT00460603|54653611|FG009|Phase 2|Objective Progression or Relapse|9|||
27994852|NCT00460603|54653612|FG010|Phase 2|Objective Progression or Relapse|10|||
27994853|NCT00460603|54653613|FG011|Phase 2|Objective Progression or Relapse|17|||
27994854|NCT00460603|54653602|FG000|Phase 2|Global Deterioration of Health Status|0|||
27994855|NCT00460603|54653603|FG001|Phase 2|Global Deterioration of Health Status|0|||
27994856|NCT00460603|54653604|FG002|Phase 2|Global Deterioration of Health Status|0|||
27994857|NCT00460603|54653605|FG003|Phase 2|Global Deterioration of Health Status|0|||
27994858|NCT00460603|54653606|FG004|Phase 2|Global Deterioration of Health Status|0|||
27994859|NCT00460603|54653607|FG005|Phase 2|Global Deterioration of Health Status|0|||
27994860|NCT00460603|54653608|FG006|Phase 2|Global Deterioration of Health Status|0|||
27994861|NCT00460603|54653609|FG007|Phase 2|Global Deterioration of Health Status|0|||
27994862|NCT00460603|54653610|FG008|Phase 2|Global Deterioration of Health Status|0|||
27994863|NCT00460603|54653611|FG009|Phase 2|Global Deterioration of Health Status|0|||
27994864|NCT00460603|54653612|FG010|Phase 2|Global Deterioration of Health Status|1|||
27994865|NCT00460603|54653613|FG011|Phase 2|Global Deterioration of Health Status|0|||
27994866|NCT00460603|54653602|FG000|Phase 2|Withdrawal by Subject|0|||
27994867|NCT00460603|54653603|FG001|Phase 2|Withdrawal by Subject|0|||
27994868|NCT00460603|54653604|FG002|Phase 2|Withdrawal by Subject|0|||
27994869|NCT00460603|54653605|FG003|Phase 2|Withdrawal by Subject|0|||
27994870|NCT00460603|54653606|FG004|Phase 2|Withdrawal by Subject|0|||
27994871|NCT00460603|54653607|FG005|Phase 2|Withdrawal by Subject|0|||
27994872|NCT00460603|54653608|FG006|Phase 2|Withdrawal by Subject|0|||
27994873|NCT00460603|54653609|FG007|Phase 2|Withdrawal by Subject|0|||
27994874|NCT00460603|54653610|FG008|Phase 2|Withdrawal by Subject|0|||
28098400|NCT03588572|54754112|FG000|Visitation 1|Lack of Efficacy|1|||
28098401|NCT03588572|54754113|FG001|Visitation 1|Lack of Efficacy|1|||
28098402|NCT03588572|54754112|FG000|Visitation 2|Lost to Follow-up|1|||
27909992|NCT01165138|54567709|FG003|Overall Study|Physician Decision|6|||
27909993|NCT01165138|54567706|FG000|Overall Study|Withdrawal by Subject|0|||
27909994|NCT01165138|54567707|FG001|Overall Study|Withdrawal by Subject|6|||
27909995|NCT01165138|54567708|FG002|Overall Study|Withdrawal by Subject|6|||
27909996|NCT01165138|54567709|FG003|Overall Study|Withdrawal by Subject|3|||
27909997|NCT01165021|54567717|FG000|Overall Study|Death|1|||
27909998|NCT01182844|54567723|FG000|Overall Study|Withdrawal by Subject|0|||
27909999|NCT01182844|54567724|FG001|Overall Study|Withdrawal by Subject|2|||
27910000|NCT01164865|54567732|FG000|Overall Study|Lost to Follow-up|2|||
27910001|NCT01164865|54567733|FG001|Overall Study|Lost to Follow-up|1|||
27910002|NCT01164475|54567741|FG000|Overall Study|Lack of Efficacy|1|||
27910003|NCT01164475|54567742|FG001|Overall Study|Lack of Efficacy|0|||
27910004|NCT01164475|54567741|FG000|Overall Study|Other|0|||
27910005|NCT01164475|54567742|FG001|Overall Study|Other|1|||
27910006|NCT01164475|54567741|FG000|Overall Study|Progressive disease|0|||
27910007|NCT01164475|54567742|FG001|Overall Study|Progressive disease|1|||
27910008|NCT01164475|54567741|FG000|Overall Study|Protocol Violation|1|||
27910009|NCT01164475|54567742|FG001|Overall Study|Protocol Violation|0|||
27910010|NCT01164007|54567748|FG000|Overall Study|Adverse Event|5|||
27910011|NCT01164007|54567748|FG000|Overall Study|Progression of Disease|30|||
27910012|NCT01164007|54567748|FG000|Overall Study|Protocol Violation|1|||
27910013|NCT01164007|54567748|FG000|Overall Study|Withdrawal by Subject|1|||
27910014|NCT01164007|54567748|FG000|Overall Study|Medical Decision|3|||
27910015|NCT01163851|54567754|FG000|Overall Study|Site Closure|0|||
27910016|NCT01163851|54567755|FG001|Overall Study|Site Closure|1|||
27910017|NCT01163851|54567754|FG000|Overall Study|Enrolled but not treated|1|||
27910018|NCT01163851|54567755|FG001|Overall Study|Enrolled but not treated|0|||
27910019|NCT01163617|54567761|FG000|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
27910020|NCT01163617|54567762|FG001|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1|||
27910021|NCT01163617|54567763|FG002|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
27910022|NCT01163617|54567764|FG003|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
27910023|NCT01163617|54567765|FG004|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
28098403|NCT03588572|54754113|FG001|Visitation 2|Lost to Follow-up|1|||
28098404|NCT03588572|54754112|FG000|Visitation 2|Lack of Efficacy|0|||
28098405|NCT03588572|54754113|FG001|Visitation 2|Lack of Efficacy|1|||
28098406|NCT03588572|54754112|FG000|Visitation 2|Withdrawal by Subject|1|||
28098407|NCT03588572|54754113|FG001|Visitation 2|Withdrawal by Subject|0|||
28098408|NCT03588572|54754112|FG000|Visitation 3|Lost to Follow-up|1|||
28098409|NCT03588572|54754113|FG001|Visitation 3|Lost to Follow-up|1|||
28098410|NCT03588572|54754112|FG000|Visitation 3|Physician Decision|1|||
28098411|NCT03588572|54754113|FG001|Visitation 3|Physician Decision|1|||
27739721|NCT01378975|54189350|FG000|Overall Study|Death|77|||
27910024|NCT01163617|54567766|FG005|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
27910025|NCT01163617|54567767|FG006|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
27910026|NCT01163617|54567768|FG007|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
27910027|NCT01163617|54567761|FG000|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
27910028|NCT01163617|54567762|FG001|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1|||
27910029|NCT01163617|54567763|FG002|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
27910030|NCT01163617|54567764|FG003|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
28098412|NCT03588572|54754112|FG000|Visitation 3|Withdrawal by Subject|1|||
27910031|NCT01163617|54567765|FG004|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
27994875|NCT00460603|54653611|FG009|Phase 2|Withdrawal by Subject|5|||
27994876|NCT00460603|54653612|FG010|Phase 2|Withdrawal by Subject|4|||
28098413|NCT03588572|54754113|FG001|Visitation 3|Withdrawal by Subject|0|||
28098414|NCT00090285|54754121|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|7|||
27910032|NCT01163617|54567766|FG005|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
27910033|NCT01163617|54567767|FG006|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
27910034|NCT01163617|54567768|FG007|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
27910035|NCT01163617|54567761|FG000|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
27910036|NCT01163617|54567762|FG001|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
27910037|NCT01163617|54567763|FG002|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1|||
27910038|NCT01163617|54567764|FG003|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
27910039|NCT01163617|54567765|FG004|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
27910040|NCT01163617|54567766|FG005|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
27910041|NCT01163617|54567767|FG006|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
27910042|NCT01163617|54567768|FG007|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
27910043|NCT01182337|54567790|FG000|Overall Study|Withdrawal by Subject|3|||
27910044|NCT01182337|54567791|FG001|Overall Study|Withdrawal by Subject|1|||
27910045|NCT01182337|54567790|FG000|Overall Study|Lost to Follow-up|0|||
27910046|NCT01182337|54567791|FG001|Overall Study|Lost to Follow-up|1|||
27910047|NCT01182298|54567798|FG000|Overall Study|Lack of Efficacy|4|||
27910048|NCT01182298|54567798|FG000|Overall Study|Withdrawal by Subject|2|||
27910049|NCT01163266|54567805|FG000|Overall Study|Pretreatment Event or Adverse Event|2|||
27910050|NCT01163266|54567806|FG001|Overall Study|Pretreatment Event or Adverse Event|9|||
27910051|NCT01163266|54567807|FG002|Overall Study|Pretreatment Event or Adverse Event|7|||
27910052|NCT01163266|54567805|FG000|Overall Study|Lack of Efficacy|1|||
27910053|NCT01163266|54567806|FG001|Overall Study|Lack of Efficacy|3|||
27910054|NCT01163266|54567807|FG002|Overall Study|Lack of Efficacy|1|||
27910055|NCT01163266|54567805|FG000|Overall Study|Noncompliance with Study Drug|0|||
27910056|NCT01163266|54567806|FG001|Overall Study|Noncompliance with Study Drug|2|||
27910057|NCT01163266|54567807|FG002|Overall Study|Noncompliance with Study Drug|0|||
27910058|NCT01163266|54567805|FG000|Overall Study|Protocol Deviations|2|||
27910059|NCT01163266|54567806|FG001|Overall Study|Protocol Deviations|2|||
27910060|NCT01163266|54567807|FG002|Overall Study|Protocol Deviations|5|||
27910061|NCT01163266|54567805|FG000|Overall Study|Withdrawal of Consent|5|||
27910062|NCT01163266|54567806|FG001|Overall Study|Withdrawal of Consent|7|||
27910063|NCT01163266|54567807|FG002|Overall Study|Withdrawal of Consent|3|||
27910064|NCT01163266|54567805|FG000|Overall Study|Lost to Follow-up|7|||
27910065|NCT01163266|54567806|FG001|Overall Study|Lost to Follow-up|7|||
27910066|NCT01163266|54567807|FG002|Overall Study|Lost to Follow-up|10|||
27910067|NCT01163266|54567805|FG000|Overall Study|Other|1|||
27910068|NCT01163266|54567806|FG001|Overall Study|Other|1|||
27910069|NCT01163266|54567807|FG002|Overall Study|Other|2|||
27910070|NCT01163149|54567865|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
27910071|NCT01163149|54567866|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
27910072|NCT01163149|54567867|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
27910073|NCT01163149|54567865|FG000|Extension Treatment Period|Adverse Event|0|||
27910074|NCT01163149|54567866|FG001|Extension Treatment Period|Adverse Event|1|||
27910075|NCT01163149|54567867|FG002|Extension Treatment Period|Adverse Event|0|||
27910076|NCT01163149|54567865|FG000|Extension Treatment Period|Noncompliance|0|||
27910077|NCT01163149|54567866|FG001|Extension Treatment Period|Noncompliance|0|||
27910078|NCT01163149|54567867|FG002|Extension Treatment Period|Noncompliance|1|||
27910079|NCT01163032|54567892|FG000|Randomization Phase|Withdrawal by Subject|2|||
27910080|NCT01163032|54567893|FG001|Randomization Phase|Withdrawal by Subject|3|||
27910081|NCT01163032|54567894|FG002|Randomization Phase|Withdrawal by Subject|0|||
27910082|NCT01163032|54567892|FG000|Randomization Phase|Adverse Event|3|||
27910083|NCT01163032|54567893|FG001|Randomization Phase|Adverse Event|3|||
27910084|NCT01163032|54567894|FG002|Randomization Phase|Adverse Event|0|||
27994877|NCT00460603|54653613|FG011|Phase 2|Withdrawal by Subject|5|||
27994878|NCT00460603|54653602|FG000|Phase 2|Randomized, but not treated|0|||
27994879|NCT00460603|54653603|FG001|Phase 2|Randomized, but not treated|0|||
27994880|NCT00460603|54653604|FG002|Phase 2|Randomized, but not treated|0|||
27994881|NCT00460603|54653605|FG003|Phase 2|Randomized, but not treated|0|||
27994882|NCT00460603|54653606|FG004|Phase 2|Randomized, but not treated|0|||
27994883|NCT00460603|54653607|FG005|Phase 2|Randomized, but not treated|0|||
27994884|NCT00460603|54653608|FG006|Phase 2|Randomized, but not treated|0|||
27994885|NCT00460603|54653609|FG007|Phase 2|Randomized, but not treated|0|||
27994886|NCT00460603|54653610|FG008|Phase 2|Randomized, but not treated|0|||
27994887|NCT00460603|54653611|FG009|Phase 2|Randomized, but not treated|3|||
27994888|NCT00460603|54653612|FG010|Phase 2|Randomized, but not treated|0|||
27994889|NCT00460603|54653613|FG011|Phase 2|Randomized, but not treated|0|||
27739722|NCT01378975|54189351|FG001|Overall Study|Death|46|||
27910085|NCT01163032|54567892|FG000|Randomization Phase|Protocol Violation|0|||
27910086|NCT01163032|54567893|FG001|Randomization Phase|Protocol Violation|1|||
27910087|NCT01163032|54567894|FG002|Randomization Phase|Protocol Violation|0|||
27910088|NCT01163032|54567892|FG000|Randomization Phase|Various*|5|||
27994890|NCT00662038|54653639|FG000|Overall Study|Reason not specified|3|||
27994891|NCT00662038|54653639|FG000|Overall Study|Withdrawn consent|22|||
27994892|NCT00662038|54653639|FG000|Overall Study|Withdrawal by Subject|83|||
27994893|NCT00662038|54653639|FG000|Overall Study|Sponsor decision|1|||
27994894|NCT00662038|54653639|FG000|Overall Study|Physician Decision|19|||
27994895|NCT00662038|54653639|FG000|Overall Study|Lung transplantation|44|||
27994896|NCT00662038|54653639|FG000|Overall Study|Lost to Follow-up|1|||
27994897|NCT00662038|54653639|FG000|Overall Study|Death|95|||
27994898|NCT00662038|54653639|FG000|Overall Study|Adverse Event|358|||
27910089|NCT01163032|54567893|FG001|Randomization Phase|Various*|4|||
27910090|NCT01163032|54567894|FG002|Randomization Phase|Various*|0|||
27910091|NCT01163032|54567892|FG000|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
27994899|NCT00662038|54653639|FG000|Overall Study|Continued treatment|5|||
27994900|NCT00819156|54653649|FG000|Overall Study|Adverse Event|1|||
27994901|NCT00819156|54653650|FG001|Overall Study|Adverse Event|4|||
27994902|NCT00819156|54653651|FG002|Overall Study|Adverse Event|2|||
27994903|NCT00819156|54653652|FG003|Overall Study|Adverse Event|1|||
27994904|NCT00819156|54653653|FG004|Overall Study|Adverse Event|2|||
27994905|NCT00819156|54653654|FG005|Overall Study|Adverse Event|3|||
27994906|NCT00819156|54653649|FG000|Overall Study|Withdrawal by Subject|0|||
27994907|NCT00819156|54653650|FG001|Overall Study|Withdrawal by Subject|3|||
27994908|NCT00819156|54653651|FG002|Overall Study|Withdrawal by Subject|2|||
27994909|NCT00819156|54653652|FG003|Overall Study|Withdrawal by Subject|0|||
27994910|NCT00819156|54653653|FG004|Overall Study|Withdrawal by Subject|1|||
27994911|NCT00819156|54653654|FG005|Overall Study|Withdrawal by Subject|0|||
27994912|NCT00819156|54653649|FG000|Overall Study|Protocol Violation|1|||
27994913|NCT00819156|54653650|FG001|Overall Study|Protocol Violation|0|||
27994914|NCT00819156|54653651|FG002|Overall Study|Protocol Violation|1|||
27994915|NCT00819156|54653652|FG003|Overall Study|Protocol Violation|0|||
27994916|NCT00819156|54653653|FG004|Overall Study|Protocol Violation|0|||
28098415|NCT00090285|54754122|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|3|||
28098416|NCT00090285|54754123|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
28098417|NCT00090285|54754124|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
28098418|NCT00090285|54754125|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
28098419|NCT00090285|54754126|FG005|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
28098420|NCT00090285|54754121|FG000|Base Study Vaccination Period|Adverse Event|2|||
27910092|NCT01163032|54567893|FG001|Randomization Phase|Unsatisfactory Therapeutic Effect|1|||
28098421|NCT00090285|54754122|FG001|Base Study Vaccination Period|Adverse Event|4|||
28098422|NCT00090285|54754123|FG002|Base Study Vaccination Period|Adverse Event|0|||
28098423|NCT00090285|54754124|FG003|Base Study Vaccination Period|Adverse Event|0|||
28098424|NCT00090285|54754125|FG004|Base Study Vaccination Period|Adverse Event|0|||
28098425|NCT00090285|54754126|FG005|Base Study Vaccination Period|Adverse Event|0|||
28098426|NCT00090285|54754121|FG000|Base Study Vaccination Period|Lost to Follow-up|111|||
28098427|NCT00090285|54754122|FG001|Base Study Vaccination Period|Lost to Follow-up|112|||
28098428|NCT00090285|54754123|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
28098429|NCT00090285|54754124|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
28098430|NCT00090285|54754125|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
28098431|NCT00090285|54754126|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
28098432|NCT00090285|54754121|FG000|Base Study Vaccination Period|Protocol Violation|2|||
28098433|NCT00090285|54754122|FG001|Base Study Vaccination Period|Protocol Violation|3|||
28098434|NCT00090285|54754123|FG002|Base Study Vaccination Period|Protocol Violation|0|||
28098435|NCT00090285|54754124|FG003|Base Study Vaccination Period|Protocol Violation|0|||
27910093|NCT01163032|54567894|FG002|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
27910094|NCT01163032|54567892|FG000|Open Label Extension Phase|Adverse Event|0|||
27910095|NCT01163032|54567893|FG001|Open Label Extension Phase|Adverse Event|0|||
27910096|NCT01163032|54567894|FG002|Open Label Extension Phase|Adverse Event|3|||
27910097|NCT01163032|54567892|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
27910098|NCT01163032|54567893|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
27910099|NCT01163032|54567894|FG002|Open Label Extension Phase|Withdrawal by Subject|3|||
27910100|NCT01163032|54567892|FG000|Open Label Extension Phase|Protocol Violation|0|||
27910101|NCT01163032|54567893|FG001|Open Label Extension Phase|Protocol Violation|0|||
27910102|NCT01163032|54567894|FG002|Open Label Extension Phase|Protocol Violation|1|||
27910103|NCT01163032|54567892|FG000|Open Label Extension Phase|Study Termination|0|||
27994917|NCT00819156|54653654|FG005|Overall Study|Protocol Violation|1|||
27994918|NCT00819156|54653649|FG000|Overall Study|Lost to Follow-up|0|||
27994919|NCT00819156|54653650|FG001|Overall Study|Lost to Follow-up|1|||
27994920|NCT00819156|54653651|FG002|Overall Study|Lost to Follow-up|0|||
28098436|NCT00090285|54754125|FG004|Base Study Vaccination Period|Protocol Violation|0|||
27994921|NCT00819156|54653652|FG003|Overall Study|Lost to Follow-up|0|||
27910104|NCT01163032|54567893|FG001|Open Label Extension Phase|Study Termination|0|||
27910105|NCT01163032|54567894|FG002|Open Label Extension Phase|Study Termination|7|||
27994922|NCT00819156|54653653|FG004|Overall Study|Lost to Follow-up|0|||
27994923|NCT00819156|54653654|FG005|Overall Study|Lost to Follow-up|2|||
27994924|NCT00819156|54653649|FG000|Overall Study|Testosterone >1ng/ml from Day 28+|5|||
27994925|NCT00819156|54653650|FG001|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
27910106|NCT01163032|54567892|FG000|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
27910107|NCT01163032|54567893|FG001|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
27910108|NCT01163032|54567894|FG002|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2|||
27910109|NCT01162486|54567907|FG000|Overall Study|low ANC|1|||
27910110|NCT01162486|54567908|FG001|Overall Study|low ANC|0|||
27910111|NCT01162486|54567909|FG002|Overall Study|low ANC|0|||
27910112|NCT01162486|54567910|FG003|Overall Study|low ANC|0|||
27910113|NCT01162486|54567911|FG004|Overall Study|low ANC|0|||
27910114|NCT01162486|54567907|FG000|Overall Study|vomited Rifampin/ gagged with midazolam|1|||
27910115|NCT01162486|54567908|FG001|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
27910116|NCT01162486|54567909|FG002|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
27910117|NCT01162486|54567910|FG003|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
27910118|NCT01162486|54567911|FG004|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
27910119|NCT01162486|54567907|FG000|Overall Study|elevated LFTs|0|||
27910120|NCT01162486|54567908|FG001|Overall Study|elevated LFTs|0|||
27910121|NCT01162486|54567909|FG002|Overall Study|elevated LFTs|1|||
27994926|NCT00819156|54653651|FG002|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
27994927|NCT00819156|54653652|FG003|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
27994928|NCT00819156|54653653|FG004|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
27994929|NCT00819156|54653654|FG005|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
27994930|NCT00819156|54653649|FG000|Overall Study|Testosterone >=.5ng/ml 2 visits|3|||
27994931|NCT00819156|54653650|FG001|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
27994932|NCT00819156|54653651|FG002|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
27994933|NCT00819156|54653652|FG003|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
27994934|NCT00819156|54653653|FG004|Overall Study|Testosterone >=.5ng/ml 2 visits|1|||
27994935|NCT00819156|54653654|FG005|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
27910122|NCT01162486|54567910|FG003|Overall Study|elevated LFTs|0|||
27910123|NCT01162486|54567911|FG004|Overall Study|elevated LFTs|0|||
27910124|NCT01162486|54567907|FG000|Overall Study|Pregnancy|0|||
27910125|NCT01162486|54567908|FG001|Overall Study|Pregnancy|0|||
27910126|NCT01162486|54567909|FG002|Overall Study|Pregnancy|0|||
27994936|NCT00819156|54653649|FG000|Overall Study|Prostate-specific antigen progression|0|||
27994937|NCT00819156|54653650|FG001|Overall Study|Prostate-specific antigen progression|0|||
27994938|NCT00819156|54653651|FG002|Overall Study|Prostate-specific antigen progression|0|||
27994939|NCT00819156|54653652|FG003|Overall Study|Prostate-specific antigen progression|0|||
27994940|NCT00819156|54653653|FG004|Overall Study|Prostate-specific antigen progression|1|||
27994941|NCT00819156|54653654|FG005|Overall Study|Prostate-specific antigen progression|0|||
27994942|NCT00459979|54653676|FG000|Overall Study|Withdrawal by Subject|1|||
27994943|NCT00459979|54653676|FG000|Overall Study|Protocol Violation|1|||
27994944|NCT00851786|54653682|FG000|Overall Study|Withdrawal by Subject|0|||
27994945|NCT00851786|54653683|FG001|Overall Study|Withdrawal by Subject|1|||
27994946|NCT00851786|54653682|FG000|Overall Study|Protocol Violation|0|||
27994947|NCT00851786|54653683|FG001|Overall Study|Protocol Violation|1|||
27994948|NCT00851786|54653682|FG000|Overall Study|Lost to Follow-up|1|||
27994949|NCT00851786|54653683|FG001|Overall Study|Lost to Follow-up|0|||
27994950|NCT00851786|54653682|FG000|Overall Study|Incarceration|1|||
27994951|NCT00851786|54653683|FG001|Overall Study|Incarceration|0|||
27994952|NCT00851786|54653682|FG000|Overall Study|Site Closure|1|||
27994953|NCT00851786|54653683|FG001|Overall Study|Site Closure|0|||
27994954|NCT00851786|54653682|FG000|Overall Study|Cannot Adhere to Protocol Requirement|2|||
28098437|NCT00090285|54754126|FG005|Base Study Vaccination Period|Protocol Violation|0|||
28098438|NCT00090285|54754121|FG000|Base Study Vaccination Period|Withdrawal by Subject|64|||
28098439|NCT00090285|54754122|FG001|Base Study Vaccination Period|Withdrawal by Subject|69|||
28098440|NCT00090285|54754123|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
28098441|NCT00090285|54754124|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
28098442|NCT00090285|54754125|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
28098443|NCT00090285|54754126|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
28098444|NCT00090285|54754121|FG000|Base Study Vaccination Period|Uncooperative|2|||
27910127|NCT01162486|54567910|FG003|Overall Study|Pregnancy|1|||
28098445|NCT00090285|54754122|FG001|Base Study Vaccination Period|Uncooperative|2|||
27910128|NCT01162486|54567911|FG004|Overall Study|Pregnancy|0|||
27910129|NCT01162135|54567927|FG000|Overall Study|Withdrawal by Subject|1|||
27910130|NCT01162135|54567927|FG000|Overall Study|Severe back pain|1|||
27910131|NCT01162135|54567927|FG000|Overall Study|Ineligible|1|||
27910132|NCT01161628|54567931|FG000|Overall Study|Death|6|||
28098446|NCT00090285|54754123|FG002|Base Study Vaccination Period|Uncooperative|0|||
28098447|NCT00090285|54754124|FG003|Base Study Vaccination Period|Uncooperative|0|||
28098448|NCT00090285|54754125|FG004|Base Study Vaccination Period|Uncooperative|0|||
28098449|NCT00090285|54754126|FG005|Base Study Vaccination Period|Uncooperative|0|||
28098450|NCT00090285|54754121|FG000|Base Study Vaccination Period|Moved|20|||
27910133|NCT01161628|54567931|FG000|Overall Study|Lack of Efficacy|2|||
27910134|NCT01161472|54567935|FG000|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1|||
27994955|NCT00851786|54653683|FG001|Overall Study|Cannot Adhere to Protocol Requirement|0|||
27910135|NCT01161472|54567936|FG001|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
27910136|NCT01161472|54567937|FG002|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
27910137|NCT01161472|54567938|FG003|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
27910138|NCT01161043|54567948|FG000|Overall Study|Withdrawal by Subject|3|||
27910139|NCT01160770|54567952|FG000|Overall Study|Adverse Event|10|||
27910140|NCT01160770|54567952|FG000|Overall Study|Protocol Violation|2|||
27910141|NCT01160770|54567952|FG000|Overall Study|Subject/parent/caregiver request|33|||
27910142|NCT01160770|54567952|FG000|Overall Study|Physician Decision|1|||
27910143|NCT01160770|54567952|FG000|Overall Study|Lost to Follow-up|7|||
27910144|NCT01160770|54567952|FG000|Overall Study|Study termination or sponsor request|1|||
27910145|NCT01160770|54567952|FG000|Overall Study|Death|9|||
27910146|NCT01160770|54567952|FG000|Overall Study|Lack of Efficacy|15|||
27994956|NCT00665626|54653691|FG000|Overall Study|Lack of Efficacy|8|||
27994957|NCT00665626|54653692|FG001|Overall Study|Lack of Efficacy|5|||
27994958|NCT00665626|54653691|FG000|Overall Study|Lost to Follow-up|0|||
27994959|NCT00665626|54653692|FG001|Overall Study|Lost to Follow-up|2|||
27910147|NCT01160770|54567952|FG000|Overall Study|Other Reasons|1|||
27910148|NCT01160614|54567958|FG000|Overall Study|Withdrawal by Subject|0|||
27910149|NCT01160614|54567959|FG001|Overall Study|Withdrawal by Subject|2|||
27994960|NCT00665626|54653691|FG000|Overall Study|Withdrawal by Subject|0|||
27994961|NCT00665626|54653692|FG001|Overall Study|Withdrawal by Subject|1|||
27910150|NCT01159912|54567986|FG000|Overall Study|Adverse Event|2|||
27910151|NCT01159912|54567987|FG001|Overall Study|Adverse Event|2|||
27910152|NCT01159912|54567988|FG002|Overall Study|Adverse Event|3|||
27910153|NCT01159912|54567986|FG000|Overall Study|Lack of Efficacy|23|||
27910154|NCT01159912|54567987|FG001|Overall Study|Lack of Efficacy|15|||
27910155|NCT01159912|54567988|FG002|Overall Study|Lack of Efficacy|14|||
27910156|NCT01159912|54567986|FG000|Overall Study|Protocol Violation|1|||
27910157|NCT01159912|54567987|FG001|Overall Study|Protocol Violation|2|||
27910158|NCT01159912|54567988|FG002|Overall Study|Protocol Violation|3|||
27910159|NCT01159912|54567986|FG000|Overall Study|Lost to Follow-up|4|||
27910160|NCT01159912|54567987|FG001|Overall Study|Lost to Follow-up|0|||
27910161|NCT01159912|54567988|FG002|Overall Study|Lost to Follow-up|0|||
27994962|NCT00665626|54653691|FG000|Overall Study|Protocol Violation|0|||
27994963|NCT00665626|54653692|FG001|Overall Study|Protocol Violation|2|||
27994964|NCT00665626|54653691|FG000|Overall Study|Adverse Event|1|||
27994965|NCT00665626|54653692|FG001|Overall Study|Adverse Event|9|||
27994966|NCT00665626|54653691|FG000|Overall Study|Due to exclusion criteria|0|||
27994967|NCT00665626|54653692|FG001|Overall Study|Due to exclusion criteria|1|||
27994968|NCT00665626|54653691|FG000|Overall Study|Did not fulfil inclusion criteria|0|||
27994969|NCT00665626|54653692|FG001|Overall Study|Did not fulfil inclusion criteria|1|||
27994970|NCT00665626|54653691|FG000|Overall Study|Unably to comply with dosing regimen|0|||
27994971|NCT00665626|54653692|FG001|Overall Study|Unably to comply with dosing regimen|1|||
27994972|NCT00665626|54653691|FG000|Overall Study|Death|1|||
27994973|NCT00665626|54653692|FG001|Overall Study|Death|0|||
27994974|NCT00828672|54653700|FG000|Study Treatment|Lost to Follow-up|1|||
27994975|NCT00828672|54653701|FG001|Study Treatment|Lost to Follow-up|0|||
27994976|NCT00828672|54653700|FG000|Study Treatment|Adverse Event|0|||
27994977|NCT00828672|54653701|FG001|Study Treatment|Adverse Event|1|||
27994978|NCT00828672|54653700|FG000|Study Treatment|Complete response, no surgery|1|||
27994979|NCT00828672|54653701|FG001|Study Treatment|Complete response, no surgery|1|||
27994980|NCT00828672|54653700|FG000|Post-surgery (<30 Days)|No central review materials|0|||
27994981|NCT00828672|54653701|FG001|Post-surgery (<30 Days)|No central review materials|1|||
27994982|NCT00873119|54653709|FG000|Overall Study|Patient request|4|||
27994983|NCT00873119|54653710|FG001|Overall Study|Patient request|2|||
27994984|NCT00873119|54653709|FG000|Overall Study|Adverse Event|8|||
27994985|NCT00873119|54653710|FG001|Overall Study|Adverse Event|0|||
27994986|NCT00873119|54653709|FG000|Overall Study|Progressive disease|26|||
27994987|NCT00873119|54653710|FG001|Overall Study|Progressive disease|18|||
27994988|NCT00873119|54653709|FG000|Overall Study|Death|2|||
27994989|NCT00873119|54653710|FG001|Overall Study|Death|1|||
27994990|NCT00873119|54653709|FG000|Overall Study|Other|2|||
28098451|NCT00090285|54754122|FG001|Base Study Vaccination Period|Moved|21|||
28098452|NCT00090285|54754123|FG002|Base Study Vaccination Period|Moved|0|||
27910162|NCT01159912|54567986|FG000|Overall Study|Physician Decision|0|||
27910163|NCT01159912|54567987|FG001|Overall Study|Physician Decision|0|||
28098453|NCT00090285|54754124|FG003|Base Study Vaccination Period|Moved|0|||
27910164|NCT01159912|54567988|FG002|Overall Study|Physician Decision|3|||
27910165|NCT01159912|54567986|FG000|Overall Study|Withdrawal by Subject|10|||
27910166|NCT01159912|54567987|FG001|Overall Study|Withdrawal by Subject|3|||
27994991|NCT00873119|54653710|FG001|Overall Study|Other|5|||
27994992|NCT00873119|54653709|FG000|Overall Study|Not treated|2|||
27910167|NCT01159912|54567988|FG002|Overall Study|Withdrawal by Subject|3|||
27910168|NCT01159600|54568004|FG000|Overall Study|Not treated|0|||
27910169|NCT01159600|54568005|FG001|Overall Study|Not treated|0|||
27994993|NCT00873119|54653710|FG001|Overall Study|Not treated|0|||
27910170|NCT01159600|54568006|FG002|Overall Study|Not treated|1|||
27994994|NCT00661726|54653716|FG000|Overall Study|Adverse Event|1|||
27994995|NCT00865046|54653723|FG000|Overall Study|Lost to Follow-up|1|||
27994996|NCT00865046|54653724|FG001|Overall Study|Lost to Follow-up|4|||
27994997|NCT00865046|54653725|FG002|Overall Study|Lost to Follow-up|0|||
27994998|NCT00865046|54653723|FG000|Overall Study|Death|0|||
27994999|NCT00865046|54653724|FG001|Overall Study|Death|1|||
27995000|NCT00865046|54653725|FG002|Overall Study|Death|1|||
27995001|NCT00865046|54653723|FG000|Overall Study|Withdrawal by Subject|5|||
27995002|NCT00865046|54653724|FG001|Overall Study|Withdrawal by Subject|0|||
27995003|NCT00865046|54653725|FG002|Overall Study|Withdrawal by Subject|0|||
27910171|NCT01159600|54568007|FG003|Overall Study|Not treated|0|||
27910172|NCT01159600|54568008|FG004|Overall Study|Not treated|0|||
27910173|NCT01159600|54568009|FG005|Overall Study|Not treated|1|||
27910174|NCT01159600|54568010|FG006|Overall Study|Not treated|2|||
27910175|NCT01159600|54568011|FG007|Overall Study|Not treated|2|||
27910176|NCT01159600|54568004|FG000|Overall Study|Adverse Event|7|||
27910177|NCT01159600|54568005|FG001|Overall Study|Adverse Event|2|||
27910178|NCT01159600|54568006|FG002|Overall Study|Adverse Event|5|||
27910179|NCT01159600|54568007|FG003|Overall Study|Adverse Event|1|||
27910180|NCT01159600|54568008|FG004|Overall Study|Adverse Event|8|||
27910181|NCT01159600|54568009|FG005|Overall Study|Adverse Event|6|||
27910182|NCT01159600|54568010|FG006|Overall Study|Adverse Event|7|||
27910183|NCT01159600|54568011|FG007|Overall Study|Adverse Event|5|||
27910184|NCT01159600|54568004|FG000|Overall Study|Lack of Efficacy|0|||
27910185|NCT01159600|54568005|FG001|Overall Study|Lack of Efficacy|0|||
27910186|NCT01159600|54568006|FG002|Overall Study|Lack of Efficacy|0|||
27910187|NCT01159600|54568007|FG003|Overall Study|Lack of Efficacy|0|||
27910188|NCT01159600|54568008|FG004|Overall Study|Lack of Efficacy|2|||
27995004|NCT00828516|54653733|FG000|Clinical Phase: Series 1|Withdrawal by Subject|2|||
27995005|NCT00665392|54653737|FG000|Overall Study|not treated|1|||
27995006|NCT00851630|54653744|FG000|Overall Study|Death|2|||
27995007|NCT00851630|54653745|FG001|Overall Study|Death|1|||
27995008|NCT00851630|54653744|FG000|Overall Study|Clinical failure|0|||
27995009|NCT00851630|54653745|FG001|Overall Study|Clinical failure|1|||
27995010|NCT00459667|54653754|FG000|Overall Study|Adverse Event|9|||
27995011|NCT00459667|54653755|FG001|Overall Study|Adverse Event|12|||
27910189|NCT01159600|54568009|FG005|Overall Study|Lack of Efficacy|0|||
27910190|NCT01159600|54568010|FG006|Overall Study|Lack of Efficacy|0|||
27910191|NCT01159600|54568011|FG007|Overall Study|Lack of Efficacy|1|||
27910192|NCT01159600|54568004|FG000|Overall Study|Non compliant with protocol|2|||
27910193|NCT01159600|54568005|FG001|Overall Study|Non compliant with protocol|1|||
27910194|NCT01159600|54568006|FG002|Overall Study|Non compliant with protocol|0|||
27910195|NCT01159600|54568007|FG003|Overall Study|Non compliant with protocol|0|||
27910196|NCT01159600|54568008|FG004|Overall Study|Non compliant with protocol|2|||
27910197|NCT01159600|54568009|FG005|Overall Study|Non compliant with protocol|0|||
27910198|NCT01159600|54568010|FG006|Overall Study|Non compliant with protocol|2|||
27910199|NCT01159600|54568011|FG007|Overall Study|Non compliant with protocol|0|||
27910200|NCT01159600|54568004|FG000|Overall Study|Lost to Follow-up|2|||
27910201|NCT01159600|54568005|FG001|Overall Study|Lost to Follow-up|3|||
27910202|NCT01159600|54568006|FG002|Overall Study|Lost to Follow-up|4|||
27910203|NCT01159600|54568007|FG003|Overall Study|Lost to Follow-up|3|||
27910204|NCT01159600|54568008|FG004|Overall Study|Lost to Follow-up|3|||
27910205|NCT01159600|54568009|FG005|Overall Study|Lost to Follow-up|0|||
27910206|NCT01159600|54568010|FG006|Overall Study|Lost to Follow-up|3|||
27995012|NCT00459667|54653756|FG002|Overall Study|Adverse Event|8|||
27995013|NCT00459667|54653754|FG000|Overall Study|Lost to Follow-up|5|||
27995014|NCT00459667|54653755|FG001|Overall Study|Lost to Follow-up|9|||
27995015|NCT00459667|54653756|FG002|Overall Study|Lost to Follow-up|3|||
27995016|NCT00459667|54653754|FG000|Overall Study|Pregnancy|1|||
27995017|NCT00459667|54653755|FG001|Overall Study|Pregnancy|1|||
27910207|NCT01159600|54568011|FG007|Overall Study|Lost to Follow-up|2|||
27910208|NCT01159600|54568004|FG000|Overall Study|Patient refusal to continue,not due toAE|7|||
27995018|NCT00459667|54653756|FG002|Overall Study|Pregnancy|1|||
27995019|NCT00459667|54653754|FG000|Overall Study|Protocol Violation|1|||
27995020|NCT00459667|54653755|FG001|Overall Study|Protocol Violation|0|||
27995021|NCT00459667|54653756|FG002|Overall Study|Protocol Violation|0|||
27995022|NCT00459667|54653754|FG000|Overall Study|Withdrawal by Subject|3|||
27995023|NCT00459667|54653755|FG001|Overall Study|Withdrawal by Subject|5|||
27995024|NCT00459667|54653756|FG002|Overall Study|Withdrawal by Subject|5|||
27995025|NCT00459667|54653754|FG000|Overall Study|Other disease modifying treatment|1|||
27995026|NCT00459667|54653755|FG001|Overall Study|Other disease modifying treatment|2|||
27910209|NCT01159600|54568005|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
27910210|NCT01159600|54568006|FG002|Overall Study|Patient refusal to continue,not due toAE|4|||
27995027|NCT00459667|54653756|FG002|Overall Study|Other disease modifying treatment|1|||
27910211|NCT01159600|54568007|FG003|Overall Study|Patient refusal to continue,not due toAE|5|||
27910212|NCT01159600|54568008|FG004|Overall Study|Patient refusal to continue,not due toAE|4|||
27910213|NCT01159600|54568009|FG005|Overall Study|Patient refusal to continue,not due toAE|4|||
27910214|NCT01159600|54568010|FG006|Overall Study|Patient refusal to continue,not due toAE|2|||
27910215|NCT01159600|54568011|FG007|Overall Study|Patient refusal to continue,not due toAE|5|||
27995028|NCT00459667|54653754|FG000|Overall Study|Other reason (incl. 2 missing subjects)|12|||
27995029|NCT00459667|54653755|FG001|Overall Study|Other reason (incl. 2 missing subjects)|15|||
27995030|NCT00459667|54653756|FG002|Overall Study|Other reason (incl. 2 missing subjects)|1|||
27995031|NCT00459667|54653754|FG000|Overall Study|No treatment administered|6|||
27995032|NCT00459667|54653755|FG001|Overall Study|No treatment administered|3|||
27995033|NCT00459667|54653756|FG002|Overall Study|No treatment administered|1|||
27995034|NCT00828204|54653766|FG000|Main Study: Prior to Study Suspension|Adverse Event|1|||
27995035|NCT00828204|54653767|FG001|Main Study: Prior to Study Suspension|Adverse Event|0|||
27995036|NCT00828204|54653766|FG000|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2|||
27995037|NCT00828204|54653767|FG001|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0|||
27995038|NCT00828204|54653766|FG000|Main Study: Prior to Study Suspension|Study Suspension|11|||
27995039|NCT00828204|54653767|FG001|Main Study: Prior to Study Suspension|Study Suspension|0|||
27995040|NCT00828204|54653766|FG000|Main Study: After Study Restart|Adverse Event|0|||
27995041|NCT00828204|54653767|FG001|Main Study: After Study Restart|Adverse Event|2|||
27995042|NCT00828204|54653766|FG000|Main Study: After Study Restart|Noncompliance|0|||
27995043|NCT00828204|54653767|FG001|Main Study: After Study Restart|Noncompliance|1|||
27995044|NCT00828204|54653766|FG000|Extension Study|Lost to Follow-up|0|||
27995045|NCT00828204|54653767|FG001|Extension Study|Lost to Follow-up|1|||
27995046|NCT00828204|54653766|FG000|Extension Study|Physician Decision|0|||
27995047|NCT00828204|54653767|FG001|Extension Study|Physician Decision|2|||
27910216|NCT01159600|54568004|FG000|Overall Study|Other reason not defined above|3|||
27910217|NCT01159600|54568005|FG001|Overall Study|Other reason not defined above|0|||
27995048|NCT00851552|54653774|FG000|Overall Study|Death|2|||
27995049|NCT00851552|54653774|FG000|Overall Study|Adverse Event|1|||
27910218|NCT01159600|54568006|FG002|Overall Study|Other reason not defined above|4|||
27910219|NCT01159600|54568007|FG003|Overall Study|Other reason not defined above|2|||
27910220|NCT01159600|54568008|FG004|Overall Study|Other reason not defined above|5|||
27910221|NCT01159600|54568009|FG005|Overall Study|Other reason not defined above|7|||
27910222|NCT01159600|54568010|FG006|Overall Study|Other reason not defined above|3|||
27910223|NCT01159600|54568011|FG007|Overall Study|Other reason not defined above|3|||
27910224|NCT01159171|54568030|FG000|Overall Study|Adverse Event|11|||
27910225|NCT01159171|54568030|FG000|Overall Study|Progression of Disease|28|||
27910226|NCT01159171|54568030|FG000|Overall Study|Protocol Violation|1|||
27910227|NCT01159171|54568030|FG000|Overall Study|Need for Surgery|5|||
27910228|NCT01159171|54568030|FG000|Overall Study|Medical Decision|4|||
27910229|NCT01159171|54568030|FG000|Overall Study|Death|1|||
27910230|NCT01158118|54568037|FG000|Overall Study|Screen failure|1|||
27910231|NCT01158118|54568038|FG001|Overall Study|Screen failure|0|||
27910232|NCT01158118|54568037|FG000|Overall Study|Donor match was a screen failure|0|||
27910233|NCT01158118|54568038|FG001|Overall Study|Donor match was a screen failure|1|||
27910234|NCT01158118|54568037|FG000|Overall Study|Suffered stroke prior to transplant|0|||
27910235|NCT01158118|54568038|FG001|Overall Study|Suffered stroke prior to transplant|1|||
27910236|NCT01158118|54568037|FG000|Overall Study|Death|0|||
27910237|NCT01158118|54568038|FG001|Overall Study|Death|1|||
27910238|NCT01157845|54568044|FG000|Overall Study|Lost to Follow-up|5|||
27910239|NCT01157845|54568044|FG000|Overall Study|Withdrawal by Subject|12|||
27910240|NCT01157845|54568044|FG000|Overall Study|Physician Decision|3|||
27910241|NCT01157845|54568044|FG000|Overall Study|Protocol Violation|13|||
27910242|NCT01157845|54568044|FG000|Overall Study|Study was ended|1|||
27910243|NCT01157845|54568044|FG000|Overall Study|Device malfunction|1|||
27910244|NCT01157377|54568055|FG000|Overall Study|Lost to Follow-up|0|||
27910245|NCT01157377|54568056|FG001|Overall Study|Lost to Follow-up|0|||
27910246|NCT01157377|54568057|FG002|Overall Study|Lost to Follow-up|1|||
27910247|NCT01157377|54568058|FG003|Overall Study|Lost to Follow-up|0|||
27910248|NCT01157377|54568059|FG004|Overall Study|Lost to Follow-up|1|||
27910249|NCT01157377|54568060|FG005|Overall Study|Lost to Follow-up|1|||
27910250|NCT01157377|54568061|FG006|Overall Study|Lost to Follow-up|0|||
27910251|NCT01157377|54568055|FG000|Overall Study|Personal Reasons|2|||
27910252|NCT01157377|54568056|FG001|Overall Study|Personal Reasons|1|||
27910253|NCT01157377|54568057|FG002|Overall Study|Personal Reasons|0|||
27995050|NCT00851552|54653774|FG000|Overall Study|Disease Progression|4|||
27995051|NCT00459355|54653780|FG000|Overall Study|Subject no longer met inc criteria|20|||
27995052|NCT00459355|54653781|FG001|Overall Study|Subject no longer met inc criteria|18|||
28098454|NCT00090285|54754125|FG004|Base Study Vaccination Period|Moved|0|||
27995053|NCT00459043|54653793|FG000|Overall Study|Withdrawal by Subject|1|||
27910254|NCT01157377|54568058|FG003|Overall Study|Personal Reasons|1|||
27910255|NCT01157377|54568059|FG004|Overall Study|Personal Reasons|0|||
27910256|NCT01157377|54568060|FG005|Overall Study|Personal Reasons|0|||
27910257|NCT01157377|54568061|FG006|Overall Study|Personal Reasons|0|||
27910258|NCT01157377|54568055|FG000|Overall Study|Protocol Violation|0|||
27910259|NCT01157377|54568056|FG001|Overall Study|Protocol Violation|0|||
27910260|NCT01157377|54568057|FG002|Overall Study|Protocol Violation|0|||
27910261|NCT01157377|54568058|FG003|Overall Study|Protocol Violation|0|||
27910262|NCT01157377|54568059|FG004|Overall Study|Protocol Violation|0|||
27910263|NCT01157377|54568060|FG005|Overall Study|Protocol Violation|1|||
27910264|NCT01157377|54568061|FG006|Overall Study|Protocol Violation|0|||
27910265|NCT01157377|54568055|FG000|Overall Study|Lack of Efficacy|0|||
27910266|NCT01157377|54568056|FG001|Overall Study|Lack of Efficacy|0|||
27910267|NCT01157377|54568057|FG002|Overall Study|Lack of Efficacy|0|||
27910268|NCT01157377|54568058|FG003|Overall Study|Lack of Efficacy|0|||
27910269|NCT01157377|54568059|FG004|Overall Study|Lack of Efficacy|0|||
27910270|NCT01157377|54568060|FG005|Overall Study|Lack of Efficacy|0|||
27910271|NCT01157377|54568061|FG006|Overall Study|Lack of Efficacy|1|||
27910272|NCT01157377|54568055|FG000|Overall Study|Other Miscellaneous Reasons|0|||
27910273|NCT01157377|54568056|FG001|Overall Study|Other Miscellaneous Reasons|2|||
27910274|NCT01157377|54568057|FG002|Overall Study|Other Miscellaneous Reasons|0|||
27910275|NCT01157377|54568058|FG003|Overall Study|Other Miscellaneous Reasons|0|||
27910276|NCT01157377|54568059|FG004|Overall Study|Other Miscellaneous Reasons|1|||
27910277|NCT01157377|54568060|FG005|Overall Study|Other Miscellaneous Reasons|1|||
27910278|NCT01157377|54568061|FG006|Overall Study|Other Miscellaneous Reasons|1|||
27910279|NCT01157182|54568079|FG000|Washout of 28 Days|Adverse Event|2|||
27910280|NCT01157182|54568080|FG001|Washout of 28 Days|Adverse Event|0|||
27910281|NCT01157065|54568088|FG000|Overall Study|Death|0|||
27910282|NCT01157065|54568089|FG001|Overall Study|Death|1|||
27995054|NCT00459043|54653794|FG001|Overall Study|Withdrawal by Subject|0|||
27995055|NCT00817206|54653802|FG000|Overall Study|Adverse Event|10|||
27995056|NCT00817206|54653803|FG001|Overall Study|Adverse Event|3|||
27995057|NCT00817206|54653802|FG000|Overall Study|Protocol Violation|0|||
27995058|NCT00817206|54653803|FG001|Overall Study|Protocol Violation|2|||
27995059|NCT00817206|54653802|FG000|Overall Study|Lost to Follow-up|0|||
27995060|NCT00817206|54653803|FG001|Overall Study|Lost to Follow-up|1|||
27995061|NCT00817206|54653802|FG000|Overall Study|Death|2|||
27995062|NCT00817206|54653803|FG001|Overall Study|Death|0|||
27995063|NCT00817206|54653802|FG000|Overall Study|Withdrawal by Subject|7|||
27995064|NCT00817206|54653803|FG001|Overall Study|Withdrawal by Subject|3|||
27995065|NCT00817206|54653802|FG000|Overall Study|Physician Decision|2|||
27995066|NCT00817206|54653803|FG001|Overall Study|Physician Decision|0|||
27995067|NCT00665002|54653809|FG000|Overall Study|Progression/relapse during treatment|11|||
27995068|NCT00665002|54653809|FG000|Overall Study|Cytogenetic resistance|1|||
27995069|NCT03847987|54653815|FG000|Overall Study|Lost to Follow-up|1|||
27995070|NCT03847987|54653816|FG001|Overall Study|Lost to Follow-up|0|||
27995071|NCT03847987|54653815|FG000|Overall Study|Adverse Event|2|||
27995072|NCT03847987|54653816|FG001|Overall Study|Adverse Event|0|||
27995073|NCT00660010|54653833|FG000|Overall Study|Withdrawal by Subject|2|||
27910283|NCT01156792|54568095|FG000|Overall Study|Adverse Event|1|||
27910284|NCT01156792|54568095|FG000|Overall Study|Lack of Efficacy|36|||
27910285|NCT01156792|54568095|FG000|Overall Study|Protocol Violation|6|||
27910286|NCT01156792|54568095|FG000|Overall Study|Lost to Follow-up|3|||
27910287|NCT01156792|54568095|FG000|Overall Study|Physician Decision|3|||
27995074|NCT00660010|54653833|FG000|Overall Study|Lost to Follow-up|3|||
27995075|NCT00660010|54653833|FG000|Overall Study|Adverse Event|1|||
27995076|NCT00660010|54653833|FG000|Overall Study|Noncompliance with visit schedule|3|||
27995077|NCT00873041|54653840|FG000|Core Study|Adverse Event|2|||
27995078|NCT00873041|54653841|FG001|Core Study|Adverse Event|3|||
28098455|NCT00090285|54754126|FG005|Base Study Vaccination Period|Moved|0|||
28098456|NCT00090285|54754121|FG000|Base Study Vaccination Period|Site Terminated|1|||
28098457|NCT00090285|54754122|FG001|Base Study Vaccination Period|Site Terminated|0|||
28098458|NCT00090285|54754123|FG002|Base Study Vaccination Period|Site Terminated|0|||
28098459|NCT00090285|54754124|FG003|Base Study Vaccination Period|Site Terminated|0|||
28098460|NCT00090285|54754125|FG004|Base Study Vaccination Period|Site Terminated|0|||
28098461|NCT00090285|54754126|FG005|Base Study Vaccination Period|Site Terminated|0|||
28098462|NCT00090285|54754121|FG000|Base Study Vaccination Period|Other|2|||
28098463|NCT00090285|54754122|FG001|Base Study Vaccination Period|Other|2|||
28098464|NCT00090285|54754123|FG002|Base Study Vaccination Period|Other|0|||
28098465|NCT00090285|54754124|FG003|Base Study Vaccination Period|Other|0|||
28098466|NCT00090285|54754125|FG004|Base Study Vaccination Period|Other|0|||
28098467|NCT00090285|54754126|FG005|Base Study Vaccination Period|Other|0|||
27995079|NCT00873041|54653842|FG002|Core Study|Adverse Event|1|||
27995080|NCT00873041|54653840|FG000|Core Study|Withdrawal by Subject|1|||
27995081|NCT00873041|54653841|FG001|Core Study|Withdrawal by Subject|2|||
27995082|NCT00873041|54653842|FG002|Core Study|Withdrawal by Subject|2|||
28098468|NCT00090285|54754121|FG000|Base Study Vaccination Period|Subject Incarcerated|2|||
28098469|NCT00090285|54754122|FG001|Base Study Vaccination Period|Subject Incarcerated|2|||
27910288|NCT01156792|54568095|FG000|Overall Study|Withdrawal by Subject|9|||
27910289|NCT01156792|54568095|FG000|Overall Study|other Sponsor Decision (Protocol Amendme|11|||
27910290|NCT01156714|54568113|FG000|Overall Study|Withdrawal by Subject|9|||
27910291|NCT01156714|54568114|FG001|Overall Study|Withdrawal by Subject|4|||
27995083|NCT00873041|54653840|FG000|Core Study|Lost to Follow-up|3|||
27995084|NCT00873041|54653841|FG001|Core Study|Lost to Follow-up|1|||
27995085|NCT00873041|54653842|FG002|Core Study|Lost to Follow-up|0|||
27995086|NCT00873041|54653840|FG000|Core Study|Abnormal laboratory value|0|||
27995087|NCT00873041|54653841|FG001|Core Study|Abnormal laboratory value|0|||
27995088|NCT00873041|54653842|FG002|Core Study|Abnormal laboratory value|1|||
27995089|NCT00873041|54653840|FG000|Core Study|Protocol deviation|1|||
27995090|NCT00873041|54653841|FG001|Core Study|Protocol deviation|0|||
27995091|NCT00873041|54653842|FG002|Core Study|Protocol deviation|1|||
27995092|NCT00873041|54653840|FG000|Extension Study|Adverse Event|1|||
27995093|NCT00873041|54653841|FG001|Extension Study|Adverse Event|0|||
28098470|NCT00090285|54754123|FG002|Base Study Vaccination Period|Subject Incarcerated|0|||
28098471|NCT00090285|54754124|FG003|Base Study Vaccination Period|Subject Incarcerated|0|||
28098472|NCT00090285|54754125|FG004|Base Study Vaccination Period|Subject Incarcerated|0|||
28098473|NCT00090285|54754126|FG005|Base Study Vaccination Period|Subject Incarcerated|0|||
28098474|NCT00090285|54754121|FG000|Base Study Vaccination Period|HIV positive|1|||
28098475|NCT00090285|54754122|FG001|Base Study Vaccination Period|HIV positive|1|||
28098476|NCT00090285|54754123|FG002|Base Study Vaccination Period|HIV positive|0|||
28098477|NCT00090285|54754124|FG003|Base Study Vaccination Period|HIV positive|0|||
28098478|NCT00090285|54754125|FG004|Base Study Vaccination Period|HIV positive|0|||
28098479|NCT00090285|54754126|FG005|Base Study Vaccination Period|HIV positive|0|||
28098480|NCT00090285|54754121|FG000|Base Study Follow-up Period|Adverse Event|3|||
28098481|NCT00090285|54754122|FG001|Base Study Follow-up Period|Adverse Event|10|||
28098482|NCT00090285|54754123|FG002|Base Study Follow-up Period|Adverse Event|0|||
28098483|NCT00090285|54754124|FG003|Base Study Follow-up Period|Adverse Event|0|||
28098484|NCT00090285|54754125|FG004|Base Study Follow-up Period|Adverse Event|0|||
28098485|NCT00090285|54754126|FG005|Base Study Follow-up Period|Adverse Event|0|||
27910292|NCT01156714|54568115|FG002|Overall Study|Withdrawal by Subject|3|||
27910293|NCT01156675|54568129|FG000|Overall Study|Death|5|||
27910294|NCT01156675|54568130|FG001|Overall Study|Death|3|||
27910295|NCT01156675|54568131|FG002|Overall Study|Death|0|||
27910296|NCT01156675|54568129|FG000|Overall Study|No data|29|||
27910297|NCT01156675|54568130|FG001|Overall Study|No data|22|||
27910298|NCT01156675|54568131|FG002|Overall Study|No data|2|||
27910299|NCT01156480|54568142|FG000|Overall Study|change in diagnosis|0|||
27910300|NCT01156480|54568143|FG001|Overall Study|change in diagnosis|1|||
27910301|NCT01156363|54568151|FG000|Overall Study|Adverse Event|6|||
27910302|NCT01156363|54568151|FG000|Overall Study|Insufficient Therapeutic Response|5|||
27910303|NCT01156363|54568151|FG000|Overall Study|Failure to Return|1|||
27910304|NCT01156363|54568151|FG000|Overall Study|Refused Treatment|4|||
27910305|NCT01156363|54568151|FG000|Overall Study|Other|6|||
27910306|NCT01156051|54568164|FG000|Overall Study|Lost to Follow-up|1|||
27910307|NCT01156051|54568165|FG001|Overall Study|Lost to Follow-up|0|||
27910308|NCT01156051|54568164|FG000|Overall Study|patient not compliant with protocol|0|||
27910309|NCT01156051|54568165|FG001|Overall Study|patient not compliant with protocol|1|||
27910310|NCT01156012|54568173|FG000|Overall Study|Adverse Event|3|||
27910311|NCT01156012|54568174|FG001|Overall Study|Adverse Event|1|||
27910312|NCT01156012|54568173|FG000|Overall Study|Lost to Follow-up|1|||
27910313|NCT01156012|54568174|FG001|Overall Study|Lost to Follow-up|0|||
27910314|NCT01156012|54568173|FG000|Overall Study|Withdrawal by Subject|1|||
27910315|NCT01156012|54568174|FG001|Overall Study|Withdrawal by Subject|0|||
27910316|NCT01156012|54568173|FG000|Overall Study|use of commercial drug instead of study|0|||
27910317|NCT01156012|54568174|FG001|Overall Study|use of commercial drug instead of study|1|||
27910318|NCT01156012|54568173|FG000|Overall Study|Non respect of one of inclusion criteria|2|||
27910319|NCT01156012|54568174|FG001|Overall Study|Non respect of one of inclusion criteria|1|||
27910320|NCT01155661|54568180|FG000|Overall Study|Adverse Event|101|||
27910321|NCT01155661|54568180|FG000|Overall Study|Death|1|||
27910322|NCT01155661|54568180|FG000|Overall Study|Lack of Efficacy|32|||
27910323|NCT01155661|54568180|FG000|Overall Study|Lost to Follow-up|22|||
27910324|NCT01155661|54568180|FG000|Overall Study|Physician Decision|3|||
27910325|NCT01155661|54568180|FG000|Overall Study|Protocol Violation|35|||
27910326|NCT01155661|54568180|FG000|Overall Study|Withdrawal by Subject|73|||
27910327|NCT01155661|54568180|FG000|Overall Study|Sponsor Decision|13|||
27910328|NCT01155583|54568195|FG000|Phase I|Screen failure - did not start treatment|0|||
28098486|NCT00090285|54754121|FG000|Base Study Follow-up Period|Lost to Follow-up|232|||
28098487|NCT00090285|54754122|FG001|Base Study Follow-up Period|Lost to Follow-up|226|||
28098488|NCT00090285|54754123|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
28098489|NCT00090285|54754124|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
28098490|NCT00090285|54754125|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
28098491|NCT00090285|54754126|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
27910329|NCT01155583|54568196|FG001|Phase I|Screen failure - did not start treatment|0|||
28098492|NCT00090285|54754121|FG000|Base Study Follow-up Period|Withdrawal by Subject|53|||
27910330|NCT01155583|54568197|FG002|Phase I|Screen failure - did not start treatment|0|||
27910331|NCT01155583|54568198|FG003|Phase I|Screen failure - did not start treatment|0|||
27910332|NCT01155583|54568199|FG004|Phase I|Screen failure - did not start treatment|1|||
27910333|NCT01155583|54568200|FG005|Phase I|Screen failure - did not start treatment|0|||
27910334|NCT01155583|54568201|FG006|Phase I|Screen failure - did not start treatment|0|||
27910335|NCT01155583|54568202|FG007|Phase I|Screen failure - did not start treatment|2|||
27910336|NCT01155583|54568203|FG008|Phase I|Screen failure - did not start treatment|0|||
27995094|NCT00873041|54653842|FG002|Extension Study|Adverse Event|1|||
27910337|NCT01155583|54568195|FG000|Phase I|Withdrawal by Subject|0|||
27910338|NCT01155583|54568196|FG001|Phase I|Withdrawal by Subject|0|||
27910339|NCT01155583|54568197|FG002|Phase I|Withdrawal by Subject|0|||
27910340|NCT01155583|54568198|FG003|Phase I|Withdrawal by Subject|0|||
27910341|NCT01155583|54568199|FG004|Phase I|Withdrawal by Subject|0|||
27910342|NCT01155583|54568200|FG005|Phase I|Withdrawal by Subject|0|||
27910343|NCT01155583|54568201|FG006|Phase I|Withdrawal by Subject|0|||
27910344|NCT01155583|54568202|FG007|Phase I|Withdrawal by Subject|1|||
27910345|NCT01155583|54568203|FG008|Phase I|Withdrawal by Subject|0|||
27910346|NCT01155466|54568224|FG000|Overall Study|Adverse Event|13|||
27910347|NCT01155466|54568225|FG001|Overall Study|Adverse Event|15|||
27910348|NCT01155466|54568226|FG002|Overall Study|Adverse Event|6|||
27910349|NCT01155466|54568227|FG003|Overall Study|Adverse Event|17|||
27910350|NCT01155466|54568228|FG004|Overall Study|Adverse Event|18|||
27910351|NCT01155466|54568224|FG000|Overall Study|Lost to Follow-up|0|||
27910352|NCT01155466|54568225|FG001|Overall Study|Lost to Follow-up|0|||
27910353|NCT01155466|54568226|FG002|Overall Study|Lost to Follow-up|0|||
27910354|NCT01155466|54568227|FG003|Overall Study|Lost to Follow-up|0|||
27910355|NCT01155466|54568228|FG004|Overall Study|Lost to Follow-up|2|||
27910356|NCT01155466|54568224|FG000|Overall Study|Withdrawal by Subject|7|||
27910357|NCT01155466|54568225|FG001|Overall Study|Withdrawal by Subject|5|||
27910358|NCT01155466|54568226|FG002|Overall Study|Withdrawal by Subject|9|||
27910359|NCT01155466|54568227|FG003|Overall Study|Withdrawal by Subject|4|||
27910360|NCT01155466|54568228|FG004|Overall Study|Withdrawal by Subject|4|||
27910361|NCT01155466|54568224|FG000|Overall Study|Protocol Violation|0|||
27910362|NCT01155466|54568225|FG001|Overall Study|Protocol Violation|0|||
27910363|NCT01155466|54568226|FG002|Overall Study|Protocol Violation|2|||
27910364|NCT01155466|54568227|FG003|Overall Study|Protocol Violation|0|||
27910365|NCT01155466|54568228|FG004|Overall Study|Protocol Violation|1|||
27910366|NCT01155466|54568224|FG000|Overall Study|Administrative|0|||
27910367|NCT01155466|54568225|FG001|Overall Study|Administrative|3|||
27910368|NCT01155466|54568226|FG002|Overall Study|Administrative|0|||
27910369|NCT01155466|54568227|FG003|Overall Study|Administrative|0|||
27910370|NCT01155466|54568228|FG004|Overall Study|Administrative|0|||
27910371|NCT01155466|54568224|FG000|Overall Study|Randomized not treated|2|||
27910372|NCT01155466|54568225|FG001|Overall Study|Randomized not treated|2|||
27910373|NCT01155466|54568226|FG002|Overall Study|Randomized not treated|3|||
27910374|NCT01155466|54568227|FG003|Overall Study|Randomized not treated|0|||
27910375|NCT01155466|54568228|FG004|Overall Study|Randomized not treated|2|||
27910376|NCT01155388|54568242|FG000|Overall Study|Adverse Event|1|||
27910377|NCT01155388|54568243|FG001|Overall Study|Adverse Event|0|||
27910378|NCT01154452|54568254|FG000|Phase Ib|Not Treated|1|||
28098493|NCT00090285|54754122|FG001|Base Study Follow-up Period|Withdrawal by Subject|64|||
28098494|NCT00090285|54754123|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
28098495|NCT00090285|54754124|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
28098496|NCT00090285|54754125|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
27995095|NCT00873041|54653840|FG000|Extension Study|Administrative reasons|0|||
28098497|NCT00090285|54754126|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
28098498|NCT00090285|54754121|FG000|Base Study Follow-up Period|Moved|41|||
27995096|NCT00873041|54653841|FG001|Extension Study|Administrative reasons|0|||
27995097|NCT00873041|54653842|FG002|Extension Study|Administrative reasons|1|||
27995098|NCT00458341|54653859|FG000|Cycle 1|Adverse Event|1|||
27995099|NCT00458341|54653860|FG001|Cycle 1|Adverse Event|0|||
27995100|NCT00816036|54653868|FG000|Overall Study|Death|47|||
27995101|NCT00816036|54653869|FG001|Overall Study|Death|28|||
27995102|NCT00816036|54653868|FG000|Overall Study|Lost to Follow-up|75|||
27995103|NCT00816036|54653869|FG001|Overall Study|Lost to Follow-up|57|||
27995104|NCT00816036|54653868|FG000|Overall Study|Withdrawal by Subject|54|||
27995105|NCT00816036|54653869|FG001|Overall Study|Withdrawal by Subject|23|||
27995106|NCT00664534|54653877|FG000|Overall Study|Adverse Event|2|||
27995107|NCT00664534|54653878|FG001|Overall Study|Adverse Event|3|||
27995108|NCT00664534|54653877|FG000|Overall Study|Lost to Follow-up|6|||
27995109|NCT00664534|54653878|FG001|Overall Study|Lost to Follow-up|10|||
28098499|NCT00090285|54754122|FG001|Base Study Follow-up Period|Moved|36|||
28098500|NCT00090285|54754123|FG002|Base Study Follow-up Period|Moved|0|||
27995110|NCT00664534|54653877|FG000|Overall Study|Protocol Violation|10|||
27995111|NCT00664534|54653878|FG001|Overall Study|Protocol Violation|8|||
28098501|NCT00090285|54754124|FG003|Base Study Follow-up Period|Moved|0|||
28098502|NCT00090285|54754125|FG004|Base Study Follow-up Period|Moved|0|||
27910379|NCT01154452|54568255|FG001|Phase Ib|Not Treated|0|||
27910380|NCT01154452|54568256|FG002|Phase Ib|Not Treated|0|||
27910381|NCT01154452|54568257|FG003|Phase Ib|Not Treated|0|||
27910382|NCT01154452|54568254|FG000|Phase Ib|Adverse Event|2|||
27910383|NCT01154452|54568255|FG001|Phase Ib|Adverse Event|1|||
27910384|NCT01154452|54568256|FG002|Phase Ib|Adverse Event|0|||
27995112|NCT00664534|54653877|FG000|Overall Study|Withdrawal by Subject|7|||
27995113|NCT00664534|54653878|FG001|Overall Study|Withdrawal by Subject|6|||
27910385|NCT01154452|54568257|FG003|Phase Ib|Adverse Event|0|||
27910386|NCT01154452|54568254|FG000|Phase II|Withdrawal by Subject|0|||
27995114|NCT00664534|54653877|FG000|Overall Study|Physician Decision|8|||
27910387|NCT01154452|54568255|FG001|Phase II|Withdrawal by Subject|0|||
27910388|NCT01154452|54568256|FG002|Phase II|Withdrawal by Subject|1|||
27910389|NCT01154452|54568257|FG003|Phase II|Withdrawal by Subject|2|||
27910390|NCT01154452|54568254|FG000|Phase II|Adverse Event|0|||
27910391|NCT01154452|54568255|FG001|Phase II|Adverse Event|0|||
27910392|NCT01154452|54568256|FG002|Phase II|Adverse Event|4|||
27910393|NCT01154452|54568257|FG003|Phase II|Adverse Event|4|||
27910394|NCT01154296|54568272|FG000|Randomization and Intervention|Decided to decline|1|||
27910395|NCT01154296|54568273|FG001|Randomization and Intervention|Decided to decline|1|||
27910396|NCT01154296|54568272|FG000|Randomization and Intervention|Declined by staff|1|||
27910397|NCT01154296|54568273|FG001|Randomization and Intervention|Declined by staff|0|||
27910398|NCT01154296|54568272|FG000|Randomization and Intervention|Did not return|1|||
27910399|NCT01154296|54568273|FG001|Randomization and Intervention|Did not return|0|||
27910400|NCT01154296|54568272|FG000|Randomization and Intervention|Left before test|0|||
27910401|NCT01154296|54568273|FG001|Randomization and Intervention|Left before test|1|||
27910402|NCT01154296|54568272|FG000|Randomization and Intervention|Left clinic early|2|||
27910403|NCT01154296|54568273|FG001|Randomization and Intervention|Left clinic early|0|||
27910404|NCT01154296|54568272|FG000|6-month Follow-up|Lost contact|269|||
27910405|NCT01154296|54568273|FG001|6-month Follow-up|Lost contact|275|||
27910406|NCT01154296|54568272|FG000|6-month Follow-up|Incarcerated|37|||
27910407|NCT01154296|54568273|FG001|6-month Follow-up|Incarcerated|32|||
27910408|NCT01154296|54568272|FG000|6-month Follow-up|Withdrew consent|14|||
27910409|NCT01154296|54568273|FG001|6-month Follow-up|Withdrew consent|15|||
27910410|NCT01154296|54568272|FG000|6-month Follow-up|Death|3|||
27910411|NCT01154296|54568273|FG001|6-month Follow-up|Death|2|||
27910412|NCT01154296|54568272|FG000|6-month Follow-up|Declined by Study Coordinator|5|||
27910413|NCT01154296|54568273|FG001|6-month Follow-up|Declined by Study Coordinator|4|||
27910414|NCT01154218|54568279|FG000|Third Intervention Period|Adverse Event|0|||
27910415|NCT01154218|54568280|FG001|Third Intervention Period|Adverse Event|1|||
27910416|NCT01154218|54568281|FG002|Third Intervention Period|Adverse Event|0|||
27910417|NCT01154218|54568282|FG003|Third Intervention Period|Adverse Event|0|||
27910418|NCT01154218|54568279|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
27910419|NCT01154218|54568280|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
27910420|NCT01154218|54568281|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
27910421|NCT01154218|54568282|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
27910422|NCT01154218|54568279|FG000|Fourth Intervention Period|Withdrawal by Subject|1|||
27910423|NCT01154218|54568280|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
27910424|NCT01154218|54568281|FG002|Fourth Intervention Period|Withdrawal by Subject|0|||
27910425|NCT01154218|54568282|FG003|Fourth Intervention Period|Withdrawal by Subject|0|||
27910426|NCT01154140|54568307|FG000|Overall Study|Death|71|||
27910427|NCT01154140|54568308|FG001|Overall Study|Death|81|||
27910428|NCT01154140|54568307|FG000|Overall Study|Lost to Follow-up|4|||
27910429|NCT01154140|54568308|FG001|Overall Study|Lost to Follow-up|5|||
27910430|NCT01154140|54568307|FG000|Overall Study|Withdrawal by Subject|12|||
27910431|NCT01154140|54568308|FG001|Overall Study|Withdrawal by Subject|13|||
27910432|NCT01154140|54568307|FG000|Overall Study|Other|3|||
27910433|NCT01154140|54568308|FG001|Overall Study|Other|1|||
27910434|NCT01154140|54568307|FG000|Overall Study|Randomized but not treated|1|||
27910435|NCT01154140|54568308|FG001|Overall Study|Randomized but not treated|2|||
27910436|NCT01154101|54568319|FG000|Overall Study|Adverse Event|0|||
28098503|NCT00090285|54754126|FG005|Base Study Follow-up Period|Moved|0|||
28098504|NCT00090285|54754121|FG000|Base Study Follow-up Period|Other|2|||
28098505|NCT00090285|54754122|FG001|Base Study Follow-up Period|Other|0|||
28098506|NCT00090285|54754123|FG002|Base Study Follow-up Period|Other|0|||
28098507|NCT00090285|54754124|FG003|Base Study Follow-up Period|Other|0|||
28098508|NCT00090285|54754125|FG004|Base Study Follow-up Period|Other|0|||
28098509|NCT00090285|54754126|FG005|Base Study Follow-up Period|Other|0|||
28098510|NCT00090285|54754121|FG000|Base Study Follow-up Period|Protocol Violation|1|||
28098511|NCT00090285|54754122|FG001|Base Study Follow-up Period|Protocol Violation|0|||
28098512|NCT00090285|54754123|FG002|Base Study Follow-up Period|Protocol Violation|0|||
28098513|NCT00090285|54754124|FG003|Base Study Follow-up Period|Protocol Violation|0|||
28098514|NCT00090285|54754125|FG004|Base Study Follow-up Period|Protocol Violation|0|||
28098515|NCT00090285|54754126|FG005|Base Study Follow-up Period|Protocol Violation|0|||
28098516|NCT00090285|54754121|FG000|Base Study Follow-up Period|Uncooperative|3|||
28098517|NCT00090285|54754122|FG001|Base Study Follow-up Period|Uncooperative|4|||
27910437|NCT01154101|54568320|FG001|Overall Study|Adverse Event|2|||
27910438|NCT01154101|54568321|FG002|Overall Study|Adverse Event|1|||
27910439|NCT01154101|54568322|FG003|Overall Study|Adverse Event|1|||
27910440|NCT01154101|54568323|FG004|Overall Study|Adverse Event|0|||
27910441|NCT01154101|54568319|FG000|Overall Study|Lost to Follow-up|0|||
27910442|NCT01154101|54568320|FG001|Overall Study|Lost to Follow-up|1|||
27910443|NCT01154101|54568321|FG002|Overall Study|Lost to Follow-up|0|||
27910444|NCT01154101|54568322|FG003|Overall Study|Lost to Follow-up|1|||
27995115|NCT00664534|54653878|FG001|Overall Study|Physician Decision|0|||
27910445|NCT01154101|54568323|FG004|Overall Study|Lost to Follow-up|0|||
27995116|NCT00664534|54653877|FG000|Overall Study|Sponsor decision|8|||
27995117|NCT00664534|54653878|FG001|Overall Study|Sponsor decision|6|||
27995118|NCT00594035|54653886|FG000|Overall Study|Lost to Follow-up|1|||
27995119|NCT00594035|54653887|FG001|Overall Study|Lost to Follow-up|1|||
27995120|NCT00594035|54653886|FG000|Overall Study|Withdrawal by Subject|1|||
27995121|NCT00594035|54653887|FG001|Overall Study|Withdrawal by Subject|0|||
27995122|NCT00594035|54653886|FG000|Overall Study|Subject transferred to nursing home|0|||
27995123|NCT00594035|54653887|FG001|Overall Study|Subject transferred to nursing home|1|||
27995124|NCT00594035|54653886|FG000|Overall Study|Subject couldn't return due to job|0|||
27995125|NCT00594035|54653887|FG001|Overall Study|Subject couldn't return due to job|1|||
27995126|NCT00570310|54653895|FG000|Overall Study|Adverse Event|1|||
27995127|NCT00570310|54653896|FG001|Overall Study|Adverse Event|2|||
27995128|NCT00570310|54653895|FG000|Overall Study|Lack of Efficacy|1|||
27995129|NCT00570310|54653896|FG001|Overall Study|Lack of Efficacy|4|||
27995130|NCT00664066|54653902|FG000|Overall Study|Study terminated|3|||
27995131|NCT00814710|54653908|FG000|Overall Study|Adverse Event|1|||
27995132|NCT00814710|54653909|FG001|Overall Study|Adverse Event|0|||
27910446|NCT01154101|54568319|FG000|Overall Study|Withdrawal by Subject|0|||
27910447|NCT01154101|54568320|FG001|Overall Study|Withdrawal by Subject|1|||
27910448|NCT01154101|54568321|FG002|Overall Study|Withdrawal by Subject|2|||
27910449|NCT01154101|54568322|FG003|Overall Study|Withdrawal by Subject|0|||
27910450|NCT01154101|54568323|FG004|Overall Study|Withdrawal by Subject|1|||
27910451|NCT01153984|54568340|FG000|Overall Study|Withdrawal by Subject|1|||
27910452|NCT01153984|54568340|FG000|Overall Study|Adverse Event|1|||
27910453|NCT01153633|54568346|FG000|Overall Study|Protocol Violation|1|||
27910454|NCT01153633|54568347|FG001|Overall Study|Protocol Violation|1|||
27995133|NCT00814710|54653908|FG000|Overall Study|Lost to Follow-up|7|||
27995134|NCT00814710|54653909|FG001|Overall Study|Lost to Follow-up|3|||
27995135|NCT00871169|54653915|FG000|Overall Study|Protocol Violation|1|||
27995136|NCT00871169|54653915|FG000|Overall Study|Patient did not receive study treatment|2|||
27995137|NCT00814632|54653919|FG000|Overall Study|Lack of Efficacy|2|||
27995138|NCT00851318|54653927|FG000|Overall Study|Withdrawal by Subject|7|||
27995139|NCT00851318|54653928|FG001|Overall Study|Withdrawal by Subject|1|||
27995140|NCT00851318|54653929|FG002|Overall Study|Withdrawal by Subject|5|||
27995141|NCT00851318|54653930|FG003|Overall Study|Withdrawal by Subject|3|||
27995142|NCT00851318|54653927|FG000|Overall Study|Adverse Event|13|||
27995143|NCT00851318|54653928|FG001|Overall Study|Adverse Event|2|||
27995144|NCT00851318|54653929|FG002|Overall Study|Adverse Event|9|||
27995145|NCT00851318|54653930|FG003|Overall Study|Adverse Event|12|||
27995146|NCT00851318|54653927|FG000|Overall Study|Pregnancy|0|||
27995147|NCT00851318|54653928|FG001|Overall Study|Pregnancy|0|||
27995148|NCT00851318|54653929|FG002|Overall Study|Pregnancy|1|||
27910455|NCT01153633|54568346|FG000|Overall Study|Therapeutic failure|3|||
27910456|NCT01153633|54568347|FG001|Overall Study|Therapeutic failure|3|||
27910457|NCT01153516|54568357|FG000|Overall Study|Both subjects refused surgery|2|||
27995149|NCT00851318|54653930|FG003|Overall Study|Pregnancy|1|||
27995150|NCT00851318|54653927|FG000|Overall Study|Lack of Efficacy|8|||
27995151|NCT00851318|54653928|FG001|Overall Study|Lack of Efficacy|2|||
27995152|NCT00851318|54653929|FG002|Overall Study|Lack of Efficacy|4|||
28098518|NCT00090285|54754123|FG002|Base Study Follow-up Period|Uncooperative|0|||
28098519|NCT00090285|54754124|FG003|Base Study Follow-up Period|Uncooperative|0|||
28098520|NCT00090285|54754125|FG004|Base Study Follow-up Period|Uncooperative|0|||
28098521|NCT00090285|54754126|FG005|Base Study Follow-up Period|Uncooperative|0|||
28098522|NCT00090285|54754121|FG000|Base Study Follow-up Period|Subject Incarcerated|0|||
28098523|NCT00090285|54754122|FG001|Base Study Follow-up Period|Subject Incarcerated|2|||
28098524|NCT00090285|54754123|FG002|Base Study Follow-up Period|Subject Incarcerated|0|||
28098525|NCT00090285|54754124|FG003|Base Study Follow-up Period|Subject Incarcerated|0|||
28098526|NCT00090285|54754125|FG004|Base Study Follow-up Period|Subject Incarcerated|0|||
28098527|NCT00090285|54754126|FG005|Base Study Follow-up Period|Subject Incarcerated|0|||
28098528|NCT00090285|54754121|FG000|Extension 1|Adverse Event|0|||
28098529|NCT00090285|54754122|FG001|Extension 1|Adverse Event|0|||
28098530|NCT00090285|54754123|FG002|Extension 1|Adverse Event|2|||
27910458|NCT01153516|54568358|FG001|Overall Study|Both subjects refused surgery|0|||
27995153|NCT00851318|54653930|FG003|Overall Study|Lack of Efficacy|2|||
27995154|NCT00851318|54653927|FG000|Overall Study|Non-compliance with Study Procedures|2|||
27995155|NCT00851318|54653928|FG001|Overall Study|Non-compliance with Study Procedures|0|||
28098531|NCT00090285|54754124|FG003|Extension 1|Adverse Event|0|||
28098532|NCT00090285|54754125|FG004|Extension 1|Adverse Event|0|||
27910459|NCT01153321|54568366|FG000|Overall Study|Development of study withdrawal criteria|0|||
27910460|NCT01153321|54568367|FG001|Overall Study|Development of study withdrawal criteria|1|||
27995156|NCT00851318|54653929|FG002|Overall Study|Non-compliance with Study Procedures|1|||
27995157|NCT00851318|54653930|FG003|Overall Study|Non-compliance with Study Procedures|0|||
27995158|NCT00851318|54653927|FG000|Overall Study|Physician Decision|0|||
27995159|NCT00851318|54653928|FG001|Overall Study|Physician Decision|0|||
27995160|NCT00851318|54653929|FG002|Overall Study|Physician Decision|1|||
27995161|NCT00851318|54653930|FG003|Overall Study|Physician Decision|1|||
27995162|NCT00593957|54653943|FG000|Overall Study|Physician Decision|0|||
27995163|NCT00593957|54653944|FG001|Overall Study|Physician Decision|1|||
27910461|NCT01153321|54568366|FG000|Overall Study|Withdrawal by Subject|0|||
27910462|NCT01153321|54568367|FG001|Overall Study|Withdrawal by Subject|1|||
27995164|NCT00593957|54653945|FG002|Overall Study|Physician Decision|2|||
27995165|NCT00870233|54653967|FG000|Overall Study|Withdrawal by Subject|18|||
27995166|NCT00870233|54653967|FG000|Overall Study|Did not undergo laparotomy|3|||
27995167|NCT00870233|54653967|FG000|Overall Study|Incompatible internet browser|2|||
27995168|NCT00870233|54653967|FG000|Overall Study|Death|1|||
27995169|NCT00851084|54653974|FG000|Overall Study|Randomized but not treated|1|||
27995170|NCT00851084|54653975|FG001|Overall Study|Randomized but not treated|0|||
27995171|NCT00851084|54653974|FG000|Overall Study|Adverse Event|26|||
27995172|NCT00851084|54653975|FG001|Overall Study|Adverse Event|36|||
27995173|NCT00851084|54653974|FG000|Overall Study|Disease progression|52|||
27995174|NCT00851084|54653975|FG001|Overall Study|Disease progression|47|||
27995175|NCT00851084|54653974|FG000|Overall Study|Poor compliance to protocol|1|||
27995176|NCT00851084|54653975|FG001|Overall Study|Poor compliance to protocol|1|||
27995177|NCT00851084|54653974|FG000|Overall Study|Physician Decision|13|||
27995178|NCT00851084|54653975|FG001|Overall Study|Physician Decision|14|||
27995179|NCT00851084|54653974|FG000|Overall Study|Consent withdrawn|0|||
27995180|NCT00851084|54653975|FG001|Overall Study|Consent withdrawn|2|||
27995181|NCT00851084|54653974|FG000|Overall Study|Withdrawal by Subject|11|||
27910463|NCT01153321|54568366|FG000|Overall Study|Adverse Event|1|||
27910464|NCT01153321|54568367|FG001|Overall Study|Adverse Event|1|||
27910465|NCT01153009|54568377|FG000|Overall Study|Adverse Event|4|||
27910466|NCT01153009|54568378|FG001|Overall Study|Adverse Event|14|||
27910467|NCT01153009|54568379|FG002|Overall Study|Adverse Event|14|||
27910468|NCT01153009|54568380|FG003|Overall Study|Adverse Event|10|||
27910469|NCT01153009|54568377|FG000|Overall Study|Lack of Efficacy|9|||
27910470|NCT01153009|54568378|FG001|Overall Study|Lack of Efficacy|0|||
27995182|NCT00851084|54653975|FG001|Overall Study|Withdrawal by Subject|12|||
27995183|NCT00851084|54653974|FG000|Overall Study|Metastatic surgery|6|||
27995184|NCT00851084|54653975|FG001|Overall Study|Metastatic surgery|6|||
27995185|NCT00851084|54653974|FG000|Overall Study|Other|7|||
27995186|NCT00851084|54653975|FG001|Overall Study|Other|1|||
27995187|NCT00845858|54653986|FG000|Overall Study|Withdrawal by Subject|5|||
27995188|NCT00845858|54653987|FG001|Overall Study|Withdrawal by Subject|1|||
27995189|NCT00845858|54653988|FG002|Overall Study|Withdrawal by Subject|1|||
27995190|NCT00845858|54653986|FG000|Overall Study|Adverse Event|3|||
27995191|NCT00845858|54653987|FG001|Overall Study|Adverse Event|8|||
27995192|NCT00845858|54653988|FG002|Overall Study|Adverse Event|4|||
27995193|NCT00845858|54653986|FG000|Overall Study|Protocol Violation|0|||
27995194|NCT00845858|54653987|FG001|Overall Study|Protocol Violation|0|||
27995195|NCT00845858|54653988|FG002|Overall Study|Protocol Violation|1|||
27995196|NCT00845858|54653986|FG000|Overall Study|not eligible|0|||
27995197|NCT00845858|54653987|FG001|Overall Study|not eligible|3|||
27995198|NCT00845858|54653988|FG002|Overall Study|not eligible|2|||
27910471|NCT01153009|54568379|FG002|Overall Study|Lack of Efficacy|2|||
27995199|NCT00850538|54653999|FG000|Overall Study|unable/unwilling to complete MRI|13|||
27910472|NCT01153009|54568380|FG003|Overall Study|Lack of Efficacy|1|||
27910473|NCT01153009|54568377|FG000|Overall Study|Noncompliance with Study Medication|1|||
27910474|NCT01153009|54568378|FG001|Overall Study|Noncompliance with Study Medication|3|||
27910475|NCT01153009|54568379|FG002|Overall Study|Noncompliance with Study Medication|4|||
27910476|NCT01153009|54568380|FG003|Overall Study|Noncompliance with Study Medication|1|||
27910477|NCT01153009|54568377|FG000|Overall Study|Protocol Deviations|4|||
27910478|NCT01153009|54568378|FG001|Overall Study|Protocol Deviations|3|||
27910479|NCT01153009|54568379|FG002|Overall Study|Protocol Deviations|3|||
27910480|NCT01153009|54568380|FG003|Overall Study|Protocol Deviations|2|||
27910481|NCT01153009|54568377|FG000|Overall Study|Withdrawal of Consent|5|||
27910482|NCT01153009|54568378|FG001|Overall Study|Withdrawal of Consent|5|||
27910483|NCT01153009|54568379|FG002|Overall Study|Withdrawal of Consent|4|||
27910484|NCT01153009|54568380|FG003|Overall Study|Withdrawal of Consent|6|||
27910485|NCT01153009|54568377|FG000|Overall Study|Lost to Follow-up|8|||
27910486|NCT01153009|54568378|FG001|Overall Study|Lost to Follow-up|8|||
27910487|NCT01153009|54568379|FG002|Overall Study|Lost to Follow-up|11|||
27995200|NCT00850538|54653999|FG000|Overall Study|specimen missed due to scheduling error|14|||
27995201|NCT00850538|54653999|FG000|Overall Study|specimen unusable|7|||
27995202|NCT00850538|54653999|FG000|Overall Study|Withdrawal by Subject|3|||
27995203|NCT00850538|54653999|FG000|Overall Study|radiology error|2|||
27995204|NCT00850538|54653999|FG000|Overall Study|Protocol Violation|2|||
27910488|NCT01153009|54568380|FG003|Overall Study|Lost to Follow-up|15|||
27995205|NCT00850460|54654005|FG000|Overall Study|Lost to Follow-up|4|||
27910489|NCT01153009|54568377|FG000|Overall Study|Other|1|||
27910490|NCT01153009|54568378|FG001|Overall Study|Other|1|||
27910491|NCT01153009|54568379|FG002|Overall Study|Other|3|||
27995206|NCT00850460|54654006|FG001|Overall Study|Lost to Follow-up|4|||
27995207|NCT00661492|54654014|FG000|Overall Study|Adverse Event|16|||
27995208|NCT00661492|54654015|FG001|Overall Study|Adverse Event|13|||
27995209|NCT00661492|54654014|FG000|Overall Study|Disease Progression|44|||
27995210|NCT00661492|54654015|FG001|Overall Study|Disease Progression|14|||
27995211|NCT00661492|54654014|FG000|Overall Study|Patient Request|6|||
27995212|NCT00661492|54654015|FG001|Overall Study|Patient Request|1|||
27995213|NCT00661492|54654014|FG000|Overall Study|Investigator Request|1|||
27995214|NCT00661492|54654015|FG001|Overall Study|Investigator Request|0|||
27995215|NCT00661492|54654014|FG000|Overall Study|Lost to Follow-up|0|||
27995216|NCT00661492|54654015|FG001|Overall Study|Lost to Follow-up|1|||
27995217|NCT00661492|54654014|FG000|Overall Study|Other|1|||
27995218|NCT00661492|54654015|FG001|Overall Study|Other|0|||
27995219|NCT00850070|54654023|FG000|Overall Study|Lack of Efficacy|1|||
27995220|NCT00850070|54654024|FG001|Overall Study|Lack of Efficacy|1|||
27995221|NCT00850070|54654023|FG000|Overall Study|Adverse Event|2|||
27995222|NCT00850070|54654024|FG001|Overall Study|Adverse Event|0|||
27995223|NCT00592358|54654035|FG000|Overall Study|Withdrawal by Subject|2|||
27995224|NCT00592358|54654035|FG000|Overall Study|Adverse Event|1|||
27995225|NCT00592358|54654035|FG000|Overall Study|Lack of Efficacy|2|||
27995226|NCT00592358|54654035|FG000|Overall Study|Inability to swallow pills|1|||
28098533|NCT00090285|54754126|FG005|Extension 1|Adverse Event|0|||
28098534|NCT00090285|54754121|FG000|Extension 1|Lost to Follow-up|0|||
28098535|NCT00090285|54754122|FG001|Extension 1|Lost to Follow-up|0|||
28098536|NCT00090285|54754123|FG002|Extension 1|Lost to Follow-up|35|||
28098537|NCT00090285|54754124|FG003|Extension 1|Lost to Follow-up|0|||
28098538|NCT00090285|54754125|FG004|Extension 1|Lost to Follow-up|0|||
28098539|NCT00090285|54754126|FG005|Extension 1|Lost to Follow-up|0|||
28098540|NCT00090285|54754121|FG000|Extension 1|Withdrawal by Subject|0|||
28098541|NCT00090285|54754122|FG001|Extension 1|Withdrawal by Subject|0|||
28098542|NCT00090285|54754123|FG002|Extension 1|Withdrawal by Subject|13|||
28172592|NCT02435836|54844326|FG000|Overall Study|Withdrawal by Subject|236|||
28172593|NCT02435836|54844326|FG000|Overall Study|Insufficient Clinical Response|26|||
28172594|NCT02435836|54844326|FG000|Overall Study|Adverse Event|44|||
28172595|NCT02435836|54844326|FG000|Overall Study|Sponsor discontinued trial|167|||
28172596|NCT02435836|54844326|FG000|Overall Study|Noncompliance|27|||
28172597|NCT02435836|54844326|FG000|Overall Study|Protocol Violation|6|||
28172598|NCT02435836|54844326|FG000|Overall Study|Met Withdrawal Criteria|7|||
28172599|NCT02435836|54844326|FG000|Overall Study|AE of Worsening Schizophrenia|96|||
28172600|NCT02788201|54844336|FG000|Overall Study|Death|1|||
28172601|NCT02788201|54844337|FG001|Overall Study|Death|1|||
28172602|NCT02788201|54844338|FG002|Overall Study|Death|1|||
28172603|NCT02788201|54844339|FG003|Overall Study|Death|1|||
28172604|NCT02788201|54844340|FG004|Overall Study|Death|0|||
28172605|NCT02788201|54844341|FG005|Overall Study|Death|1|||
28172606|NCT02788201|54844336|FG000|Overall Study|Ineligible|0|||
28172607|NCT02788201|54844337|FG001|Overall Study|Ineligible|0|||
28172608|NCT02788201|54844338|FG002|Overall Study|Ineligible|0|||
28172609|NCT02788201|54844339|FG003|Overall Study|Ineligible|0|||
28172610|NCT02788201|54844340|FG004|Overall Study|Ineligible|0|||
28172611|NCT02788201|54844341|FG005|Overall Study|Ineligible|1|||
28172612|NCT02788201|54844336|FG000|Overall Study|Withdrawal by Subject|0|||
27910492|NCT01153009|54568380|FG003|Overall Study|Other|2|||
27910493|NCT01152814|54568390|FG000|Overall Study|Lost to Follow-up|2|||
27910494|NCT01152580|54568396|FG000|Overall Study|Withdrawal by Subject|0|||
27910495|NCT01152580|54568397|FG001|Overall Study|Withdrawal by Subject|1|||
27910496|NCT01152385|54568407|FG000|Overall Study|Withdrawal by Subject|3|||
27910497|NCT01152385|54568408|FG001|Overall Study|Withdrawal by Subject|1|||
27910498|NCT01152385|54568409|FG002|Overall Study|Withdrawal by Subject|1|||
27910499|NCT01152385|54568410|FG003|Overall Study|Withdrawal by Subject|1|||
27910500|NCT01152385|54568407|FG000|Overall Study|Protocol Violation|0|||
27910501|NCT01152385|54568408|FG001|Overall Study|Protocol Violation|0|||
27910502|NCT01152385|54568409|FG002|Overall Study|Protocol Violation|0|||
27910503|NCT01152385|54568410|FG003|Overall Study|Protocol Violation|1|||
27910504|NCT01152385|54568407|FG000|Overall Study|Adverse Event|1|||
27910505|NCT01152385|54568408|FG001|Overall Study|Adverse Event|1|||
27910506|NCT01152385|54568409|FG002|Overall Study|Adverse Event|0|||
27910507|NCT01152385|54568410|FG003|Overall Study|Adverse Event|0|||
27910508|NCT01152385|54568407|FG000|Overall Study|Study-specific withdrawal criteria|1|||
27910509|NCT01152385|54568408|FG001|Overall Study|Study-specific withdrawal criteria|1|||
27910510|NCT01152385|54568409|FG002|Overall Study|Study-specific withdrawal criteria|2|||
27910511|NCT01152385|54568410|FG003|Overall Study|Study-specific withdrawal criteria|0|||
27910512|NCT01152385|54568407|FG000|Overall Study|Other|4|||
27910513|NCT01152385|54568408|FG001|Overall Study|Other|3|||
27910514|NCT01152385|54568409|FG002|Overall Study|Other|2|||
27910515|NCT01152385|54568410|FG003|Overall Study|Other|3|||
27910516|NCT01152190|54568426|FG000|Overall Study|Adverse Event|2|||
27995227|NCT00814320|54654041|FG000|Epoch 1 (IV Treatment)|Withdrawal by Subject|1|||
27995228|NCT00814320|54654042|FG001|Epoch 1 (IV Treatment)|Withdrawal by Subject|0|||
27995229|NCT00814320|54654041|FG000|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0|||
27995230|NCT00814320|54654042|FG001|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2|||
28098543|NCT00090285|54754124|FG003|Extension 1|Withdrawal by Subject|1|||
28098544|NCT00090285|54754125|FG004|Extension 1|Withdrawal by Subject|0|||
28098545|NCT00090285|54754126|FG005|Extension 1|Withdrawal by Subject|0|||
28172613|NCT02788201|54844337|FG001|Overall Study|Withdrawal by Subject|0|||
28172614|NCT02788201|54844338|FG002|Overall Study|Withdrawal by Subject|0|||
27995231|NCT00814320|54654041|FG000|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0|||
27995232|NCT00814320|54654042|FG001|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1|||
27995233|NCT00814320|54654041|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1|||
27995234|NCT00814320|54654042|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0|||
27995235|NCT00814320|54654041|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1|||
27910517|NCT01152190|54568427|FG001|Overall Study|Adverse Event|4|||
27910518|NCT01152190|54568426|FG000|Overall Study|Death|1|||
27910519|NCT01152190|54568427|FG001|Overall Study|Death|0|||
27910520|NCT01152190|54568426|FG000|Overall Study|Protocol Violation|1|||
27910521|NCT01152190|54568427|FG001|Overall Study|Protocol Violation|1|||
27910522|NCT01152190|54568426|FG000|Overall Study|Withdrawal by Subject|1|||
27910523|NCT01152190|54568427|FG001|Overall Study|Withdrawal by Subject|3|||
27910524|NCT01151410|54568435|FG000|Overall Study|Withdrawal by Subject|3|||
27910525|NCT01151410|54568436|FG001|Overall Study|Withdrawal by Subject|5|||
27910526|NCT01151410|54568435|FG000|Overall Study|Lost to Follow-up|3|||
27910527|NCT01151410|54568436|FG001|Overall Study|Lost to Follow-up|4|||
27995236|NCT00814320|54654042|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0|||
27995237|NCT00814320|54654041|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1|||
27995238|NCT00814320|54654042|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4|||
27995239|NCT00814320|54654041|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2|||
27995240|NCT00814320|54654042|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1|||
27995241|NCT00814320|54654041|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0|||
27995242|NCT00814320|54654042|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1|||
27995243|NCT00814320|54654041|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0|||
27995244|NCT00814320|54654042|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1|||
27995245|NCT00814320|54654041|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0|||
27995246|NCT00814320|54654042|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3|||
27995247|NCT00869999|54654065|FG000|Overall Study|Withdrawal by Subject|1|||
27995248|NCT00869999|54654065|FG000|Overall Study|removed prior to starting therapy|1|||
27995249|NCT00570232|54654069|FG000|Overall Study|Adverse Event|10|||
27995250|NCT00570232|54654069|FG000|Overall Study|discontinued due to medical condition|3|||
27995251|NCT00570232|54654069|FG000|Overall Study|discontinued due to recurrence|8|||
27995252|NCT00570232|54654069|FG000|Overall Study|discontinued due to noncompliance|2|||
27995253|NCT00809328|54654073|FG000|Overall Study|Lack of Efficacy|18|||
27995254|NCT00809328|54654073|FG000|Overall Study|Adverse Event|6|||
27995255|NCT00809328|54654073|FG000|Overall Study|Protocol Violation|3|||
27995256|NCT00809328|54654073|FG000|Overall Study|Withdrawal by Subject|2|||
27995257|NCT00868517|54654080|FG000|Overall Study|Withdrawal by Subject|3|||
27995258|NCT00868517|54654081|FG001|Overall Study|Withdrawal by Subject|3|||
27995259|NCT00868517|54654082|FG002|Overall Study|Withdrawal by Subject|2|||
27995260|NCT00868517|54654080|FG000|Overall Study|Protocol Violation|1|||
27995261|NCT00868517|54654081|FG001|Overall Study|Protocol Violation|1|||
27995262|NCT00868517|54654082|FG002|Overall Study|Protocol Violation|0|||
27995263|NCT00868439|54654092|FG000|Overall Study|Adverse Event|4|||
27995264|NCT00868439|54654093|FG001|Overall Study|Adverse Event|3|||
27995265|NCT00868439|54654092|FG000|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2|||
27995266|NCT00868439|54654093|FG001|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3|||
27995267|NCT00868439|54654092|FG000|Overall Study|Death|0|||
27995268|NCT00868439|54654093|FG001|Overall Study|Death|1|||
27995269|NCT00868439|54654092|FG000|Overall Study|Protocol Violation|1|||
27995270|NCT00868439|54654093|FG001|Overall Study|Protocol Violation|1|||
27995271|NCT00868439|54654092|FG000|Overall Study|Physician Decision|1|||
27995272|NCT00868439|54654093|FG001|Overall Study|Physician Decision|0|||
27995273|NCT00868439|54654092|FG000|Overall Study|Withdrawal by Subject|0|||
27995274|NCT00868439|54654093|FG001|Overall Study|Withdrawal by Subject|1|||
27995275|NCT00814164|54654099|FG000|Overall Study|Progression|7|||
27995276|NCT00814164|54654099|FG000|Overall Study|not stated|7|||
27995277|NCT00814164|54654099|FG000|Overall Study|Death|5|||
28172615|NCT02788201|54844339|FG003|Overall Study|Withdrawal by Subject|0|||
28172616|NCT02788201|54844340|FG004|Overall Study|Withdrawal by Subject|0|||
27995278|NCT00659230|54654105|FG000|Overall Study|Lost to Follow-up|2|||
27995279|NCT00659230|54654106|FG001|Overall Study|Lost to Follow-up|5|||
27995280|NCT00659230|54654105|FG000|Overall Study|Lost source documentation|5|||
27995281|NCT00659230|54654106|FG001|Overall Study|Lost source documentation|4|||
27995282|NCT00659230|54654105|FG000|Overall Study|Did not return post-randomization|2|||
27995283|NCT00659230|54654106|FG001|Overall Study|Did not return post-randomization|3|||
27995284|NCT00809094|54654114|FG000|Overall Study|Lost to Follow-up|0|||
27995285|NCT00809094|54654115|FG001|Overall Study|Lost to Follow-up|1|||
27995286|NCT00658996|54654121|FG000|First Intervention|Positive slit lamp finding|1|||
27995287|NCT00658996|54654122|FG001|First Intervention|Positive slit lamp finding|0|||
27910528|NCT01151410|54568435|FG000|Overall Study|Adverse Event|1|||
27910529|NCT01151410|54568436|FG001|Overall Study|Adverse Event|2|||
27910530|NCT01151410|54568435|FG000|Overall Study|Protocol deviation|2|||
27910531|NCT01151410|54568436|FG001|Overall Study|Protocol deviation|1|||
27995288|NCT00658996|54654121|FG000|First Intervention|Lack of lenses|0|||
27995289|NCT00658996|54654122|FG001|First Intervention|Lack of lenses|1|||
27995290|NCT00658996|54654121|FG000|Crossover Period|Physician Decision|1|||
27995291|NCT00658996|54654122|FG001|Crossover Period|Physician Decision|0|||
27995292|NCT00658996|54654121|FG000|Crossover Period|Ineligible|1|||
27995293|NCT00658996|54654122|FG001|Crossover Period|Ineligible|1|||
27995294|NCT00658996|54654121|FG000|Second Intervention|Developed a stye on upper lid|1|||
27995295|NCT00658996|54654122|FG001|Second Intervention|Developed a stye on upper lid|0|||
27995296|NCT00658996|54654121|FG000|Second Intervention|Positive slit lamp finding|0|||
27995297|NCT00658996|54654122|FG001|Second Intervention|Positive slit lamp finding|1|||
27995298|NCT00867815|54654128|FG000|Overall Study|Lost to Follow-up|1|||
27995299|NCT00452413|54654135|FG000|Overall Study|Progressive Disease|4|||
27995300|NCT00452413|54654136|FG001|Overall Study|Progressive Disease|11|||
27995301|NCT00452413|54654137|FG002|Overall Study|Progressive Disease|30|||
27995302|NCT00452413|54654135|FG000|Overall Study|Withdrawal by Subject|0|||
27995303|NCT00452413|54654136|FG001|Overall Study|Withdrawal by Subject|1|||
27910532|NCT01151410|54568435|FG000|Overall Study|Administrative problems|1|||
27910533|NCT01151410|54568436|FG001|Overall Study|Administrative problems|1|||
27910534|NCT01151410|54568435|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
27910535|NCT01151410|54568436|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
27910536|NCT01151410|54568435|FG000|Overall Study|Abnormal laboratory value(s)|0|||
27910537|NCT01151410|54568436|FG001|Overall Study|Abnormal laboratory value(s)|1|||
27910538|NCT01151215|54568445|FG000|Overall Study|Worsening of condition under study|1|||
27910539|NCT01151215|54568446|FG001|Overall Study|Worsening of condition under study|1|||
27910540|NCT01151215|54568447|FG002|Overall Study|Worsening of condition under study|1|||
27910541|NCT01151215|54568445|FG000|Overall Study|Death|16|||
27910542|NCT01151215|54568446|FG001|Overall Study|Death|20|||
27910543|NCT01151215|54568447|FG002|Overall Study|Death|11|||
27910544|NCT01151215|54568445|FG000|Overall Study|Lost to Follow-up|0|||
27910545|NCT01151215|54568446|FG001|Overall Study|Lost to Follow-up|0|||
27910546|NCT01151215|54568447|FG002|Overall Study|Lost to Follow-up|3|||
27910547|NCT01151215|54568445|FG000|Overall Study|Withdrawal by Subject|3|||
27910548|NCT01151215|54568446|FG001|Overall Study|Withdrawal by Subject|1|||
27910549|NCT01151215|54568447|FG002|Overall Study|Withdrawal by Subject|2|||
27910550|NCT01151215|54568445|FG000|Overall Study|Disease progression|0|||
27910551|NCT01151215|54568446|FG001|Overall Study|Disease progression|1|||
27910552|NCT01151215|54568447|FG002|Overall Study|Disease progression|1|||
27910553|NCT01151215|54568445|FG000|Overall Study|Safety as judged by the investigator|0|||
27910554|NCT01151215|54568446|FG001|Overall Study|Safety as judged by the investigator|0|||
27910555|NCT01151215|54568447|FG002|Overall Study|Safety as judged by the investigator|1|||
27910556|NCT01151137|54568457|FG000|Overall Study|Death|15|||
27910557|NCT01151137|54568458|FG001|Overall Study|Death|27|||
27910558|NCT01151137|54568457|FG000|Overall Study|Lost to Follow-up|1|||
27910559|NCT01151137|54568458|FG001|Overall Study|Lost to Follow-up|1|||
27995304|NCT00452413|54654137|FG002|Overall Study|Withdrawal by Subject|4|||
27995305|NCT00452413|54654135|FG000|Overall Study|Adverse Event|0|||
27995306|NCT00452413|54654136|FG001|Overall Study|Adverse Event|0|||
27995307|NCT00452413|54654137|FG002|Overall Study|Adverse Event|5|||
27995308|NCT00452413|54654135|FG000|Overall Study|Physician Decision|0|||
27995309|NCT00452413|54654136|FG001|Overall Study|Physician Decision|0|||
27995310|NCT00452413|54654137|FG002|Overall Study|Physician Decision|4|||
27995311|NCT00452413|54654135|FG000|Overall Study|Death due to study disease|0|||
27995312|NCT00452413|54654136|FG001|Overall Study|Death due to study disease|0|||
27995313|NCT00452413|54654137|FG002|Overall Study|Death due to study disease|2|||
27995314|NCT00452413|54654135|FG000|Overall Study|Death due to adverse event (AE)|0|||
27995315|NCT00452413|54654136|FG001|Overall Study|Death due to adverse event (AE)|0|||
27910560|NCT01151098|54568464|FG000|Overall Study|Adverse Event|82|||
27995316|NCT00452413|54654137|FG002|Overall Study|Death due to adverse event (AE)|1|||
27995317|NCT00452413|54654135|FG000|Overall Study|On treatment|0|||
27995318|NCT00452413|54654136|FG001|Overall Study|On treatment|0|||
27995319|NCT00452413|54654137|FG002|Overall Study|On treatment|3|||
27910561|NCT01151098|54568464|FG000|Overall Study|Lost to Follow-up|6|||
27910562|NCT01151098|54568464|FG000|Overall Study|Lack of Efficacy|15|||
27910563|NCT01151098|54568464|FG000|Overall Study|Protocol Violation|1|||
27910564|NCT01151098|54568464|FG000|Overall Study|Miscellaneous|13|||
27910565|NCT01151020|54568468|FG000|Overall Study|Death|25|||
27910566|NCT01151020|54568468|FG000|Overall Study|Conversion to open repair|1|||
27995320|NCT00867503|54654146|FG000|Overall Study|Withdrawal by Subject|1|||
27995321|NCT00867113|54654152|FG000|Treatment Period|Adverse Event|15|||
27910567|NCT01151020|54568468|FG000|Overall Study|Lost to Follow-up|4|||
27910568|NCT01151020|54568468|FG000|Overall Study|Withdrawal by Subject|22|||
27910569|NCT01151020|54568468|FG000|Overall Study|Patients did not receive the device|2|||
27910570|NCT01150474|54568474|FG000|Overall Study|Withdrawal by Subject|5|||
27995322|NCT00867113|54654152|FG000|Treatment Period|Death|2|||
27995323|NCT00867113|54654152|FG000|Treatment Period|Withdrawal by Subject|19|||
27995324|NCT00867113|54654152|FG000|Treatment Period|Lost to Follow-up|3|||
27995325|NCT00867113|54654152|FG000|Treatment Period|Administrative problems|1|||
27910571|NCT01150474|54568475|FG001|Overall Study|Withdrawal by Subject|2|||
27995326|NCT00867113|54654152|FG000|Treatment Period|Disease progression/relapse|1|||
27995327|NCT00867113|54654152|FG000|Treatment Period|Protocol Violation|4|||
27995328|NCT00867113|54654152|FG000|Post Treatment After Survival Follow-up|Death|1|||
27995329|NCT00867113|54654152|FG000|Post Treatment After Survival Follow-up|Withdrawal by Subject|1|||
27995330|NCT00867113|54654152|FG000|Post Treatment After Survival Follow-up|Lost to Follow-up|5|||
27995331|NCT00867113|54654152|FG000|Post Treatment After Survival Follow-up|Administrative problems|4|||
27995332|NCT00451555|54654159|FG000|Overall Study|Protocol Violation|2|||
27995333|NCT00451555|54654160|FG001|Overall Study|Protocol Violation|2|||
27910572|NCT01150474|54568474|FG000|Overall Study|Cancer found|1|||
27910573|NCT01150474|54568475|FG001|Overall Study|Cancer found|0|||
27910574|NCT01150474|54568474|FG000|Overall Study|Multiple Studies|0|||
27910575|NCT01150474|54568475|FG001|Overall Study|Multiple Studies|1|||
27910576|NCT01150474|54568474|FG000|Overall Study|Rectotomy|1|||
27910577|NCT01150474|54568475|FG001|Overall Study|Rectotomy|0|||
27910578|NCT01150474|54568474|FG000|Overall Study|Drug did not arrive in time|1|||
27910579|NCT01150474|54568475|FG001|Overall Study|Drug did not arrive in time|0|||
27910580|NCT01150474|54568474|FG000|Overall Study|Drug not administered|1|||
27995334|NCT00451555|54654159|FG000|Overall Study|Adverse Event|3|||
27995335|NCT00451555|54654160|FG001|Overall Study|Adverse Event|1|||
27995336|NCT00451555|54654159|FG000|Overall Study|Withdrawal by Subject|6|||
27995337|NCT00451555|54654160|FG001|Overall Study|Withdrawal by Subject|0|||
27995338|NCT00451555|54654159|FG000|Overall Study|Physician Decision|2|||
27995339|NCT00451555|54654160|FG001|Overall Study|Physician Decision|1|||
27995340|NCT00808236|54654177|FG000|Overall Study|Was not resuscitated|50|||
27995341|NCT00808236|54654178|FG001|Overall Study|Was not resuscitated|56|||
27995342|NCT00808236|54654177|FG000|Overall Study|Pre-defined exclusion|13|||
27995343|NCT00808236|54654178|FG001|Overall Study|Pre-defined exclusion|3|||
27995344|NCT00808236|54654177|FG000|Overall Study|Lost to Follow-up|1|||
27995345|NCT00808236|54654178|FG001|Overall Study|Lost to Follow-up|1|||
27995346|NCT00808236|54654177|FG000|Overall Study|Physician Decision|0|||
27995347|NCT00808236|54654178|FG001|Overall Study|Physician Decision|1|||
27995348|NCT00808236|54654177|FG000|Overall Study|Death|18|||
27995349|NCT00808236|54654178|FG001|Overall Study|Death|30|||
27995350|NCT00867035|54654186|FG000|Baseline to 1 Hour|Withdrawal by Subject|1|||
27995351|NCT00867035|54654187|FG001|Baseline to 1 Hour|Withdrawal by Subject|1|||
27995352|NCT00867035|54654186|FG000|Baseline to 1 Week|Withdrawal by Subject|1|||
27995353|NCT00867035|54654187|FG001|Baseline to 1 Week|Withdrawal by Subject|0|||
27995354|NCT00663208|54654200|FG000|Treatment Period|Lost to Follow-up|0|||
27995355|NCT00663208|54654201|FG001|Treatment Period|Lost to Follow-up|1|||
27910581|NCT01150474|54568475|FG001|Overall Study|Drug not administered|0|||
27910582|NCT01150474|54568474|FG000|Overall Study|Surgery Changed|1|||
27910583|NCT01150474|54568475|FG001|Overall Study|Surgery Changed|0|||
27910584|NCT01150357|54568484|FG000|Dose Response Phase (Phase 1)|Protocol Violation|0|||
27910585|NCT01150357|54568485|FG001|Dose Response Phase (Phase 1)|Protocol Violation|1|||
27995356|NCT00663208|54654202|FG002|Treatment Period|Lost to Follow-up|0|||
27995357|NCT00663208|54654203|FG003|Treatment Period|Lost to Follow-up|0|||
27995358|NCT00663208|54654204|FG004|Treatment Period|Lost to Follow-up|0|||
28098546|NCT00090285|54754121|FG000|Extension 1|Other|0|||
28098547|NCT00090285|54754122|FG001|Extension 1|Other|0|||
28098548|NCT00090285|54754123|FG002|Extension 1|Other|4|||
28098549|NCT00090285|54754124|FG003|Extension 1|Other|0|||
28098550|NCT00090285|54754125|FG004|Extension 1|Other|0|||
28098551|NCT00090285|54754126|FG005|Extension 1|Other|0|||
28098552|NCT00090285|54754121|FG000|Extension 1|Moved|0|||
28098553|NCT00090285|54754122|FG001|Extension 1|Moved|0|||
28098554|NCT00090285|54754123|FG002|Extension 1|Moved|3|||
28098555|NCT00090285|54754124|FG003|Extension 1|Moved|0|||
28098556|NCT00090285|54754125|FG004|Extension 1|Moved|0|||
28098557|NCT00090285|54754126|FG005|Extension 1|Moved|0|||
28098558|NCT00090285|54754121|FG000|Long-term Follow-up (EXT2)|Adverse Event|0|||
28098559|NCT00090285|54754122|FG001|Long-term Follow-up (EXT2)|Adverse Event|0|||
27910586|NCT01150357|54568486|FG002|Dose Response Phase (Phase 1)|Protocol Violation|1|||
27995359|NCT00663208|54654205|FG005|Treatment Period|Lost to Follow-up|0|||
27995360|NCT00663208|54654206|FG006|Treatment Period|Lost to Follow-up|0|||
27995361|NCT00663208|54654200|FG000|Follow-up Period|Lost to Follow-up|2|||
27995362|NCT00663208|54654201|FG001|Follow-up Period|Lost to Follow-up|0|||
27995363|NCT00663208|54654202|FG002|Follow-up Period|Lost to Follow-up|3|||
27995364|NCT00663208|54654203|FG003|Follow-up Period|Lost to Follow-up|2|||
27910587|NCT01150357|54568484|FG000|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1|||
27910588|NCT01150357|54568485|FG001|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
27995365|NCT00663208|54654204|FG004|Follow-up Period|Lost to Follow-up|0|||
27995366|NCT00663208|54654205|FG005|Follow-up Period|Lost to Follow-up|0|||
28098560|NCT00090285|54754123|FG002|Long-term Follow-up (EXT2)|Adverse Event|0|||
28098561|NCT00090285|54754124|FG003|Long-term Follow-up (EXT2)|Adverse Event|0|||
28098562|NCT00090285|54754125|FG004|Long-term Follow-up (EXT2)|Adverse Event|5|||
28098563|NCT00090285|54754126|FG005|Long-term Follow-up (EXT2)|Adverse Event|2|||
28098564|NCT00090285|54754121|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
28098565|NCT00090285|54754122|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
28098566|NCT00090285|54754123|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
28098567|NCT00090285|54754124|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
28098568|NCT00090285|54754125|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|156|||
28098569|NCT00090285|54754126|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|143|||
28098570|NCT00090285|54754121|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
28098571|NCT00090285|54754122|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
28098572|NCT00090285|54754123|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
28098573|NCT00090285|54754124|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
28098574|NCT00090285|54754125|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|60|||
27995367|NCT00663208|54654206|FG006|Follow-up Period|Lost to Follow-up|0|||
27995368|NCT00663208|54654200|FG000|Follow-up Period|Other reason|1|||
27995369|NCT00663208|54654201|FG001|Follow-up Period|Other reason|0|||
27995370|NCT00663208|54654202|FG002|Follow-up Period|Other reason|0|||
27995371|NCT00663208|54654203|FG003|Follow-up Period|Other reason|0|||
27995372|NCT00663208|54654204|FG004|Follow-up Period|Other reason|0|||
27995373|NCT00663208|54654205|FG005|Follow-up Period|Other reason|0|||
27995374|NCT00663208|54654206|FG006|Follow-up Period|Other reason|1|||
28098575|NCT00090285|54754126|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|53|||
28098576|NCT00090285|54754121|FG000|Long-term Follow-up (EXT2)|Physician Decision|0|||
27910589|NCT01150357|54568486|FG002|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
27910590|NCT01150357|54568484|FG000|Dose Response Phase (Phase 1)|Adverse Event|0|||
27910591|NCT01150357|54568485|FG001|Dose Response Phase (Phase 1)|Adverse Event|0|||
27910592|NCT01150357|54568486|FG002|Dose Response Phase (Phase 1)|Adverse Event|1|||
27910593|NCT01150357|54568484|FG000|Dose Response Phase (Phase 1)|Withdrawal by Participants|0|||
27910594|NCT01150357|54568485|FG001|Dose Response Phase (Phase 1)|Withdrawal by Participants|2|||
27910595|NCT01150357|54568486|FG002|Dose Response Phase (Phase 1)|Withdrawal by Participants|1|||
27910596|NCT01150357|54568484|FG000|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
27910597|NCT01150357|54568485|FG001|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
27910598|NCT01150357|54568486|FG002|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2|||
27910599|NCT01150357|54568484|FG000|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2|||
27910600|NCT01150357|54568485|FG001|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
27910601|NCT01150357|54568486|FG002|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
27910602|NCT01150357|54568484|FG000|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1|||
27910603|NCT01150357|54568485|FG001|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
27910604|NCT01150357|54568486|FG002|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
27910605|NCT01150123|54568536|FG000|Overall Study|Withdrawal by Subject|1|||
27910606|NCT01150123|54568537|FG001|Overall Study|Withdrawal by Subject|1|||
27910607|NCT01150123|54568538|FG002|Overall Study|Withdrawal by Subject|2|||
27910608|NCT01150123|54568539|FG003|Overall Study|Withdrawal by Subject|1|||
27910609|NCT01150123|54568540|FG004|Overall Study|Withdrawal by Subject|1|||
27910610|NCT01150123|54568541|FG005|Overall Study|Withdrawal by Subject|1|||
27910611|NCT01150123|54568542|FG006|Overall Study|Withdrawal by Subject|0|||
27910612|NCT01150123|54568543|FG007|Overall Study|Withdrawal by Subject|3|||
27910613|NCT01150123|54568544|FG008|Overall Study|Withdrawal by Subject|2|||
27910614|NCT01150123|54568545|FG009|Overall Study|Withdrawal by Subject|0|||
27910615|NCT01150123|54568546|FG010|Overall Study|Withdrawal by Subject|1|||
27910616|NCT01150123|54568547|FG011|Overall Study|Withdrawal by Subject|0|||
27910617|NCT01150123|54568548|FG012|Overall Study|Withdrawal by Subject|1|||
27910618|NCT01150123|54568549|FG013|Overall Study|Withdrawal by Subject|0|||
27995375|NCT00810810|54654228|FG000|Overall Study|Withdrawal by Subject|0|||
27995376|NCT00810810|54654229|FG001|Overall Study|Withdrawal by Subject|8|||
27995377|NCT00810810|54654230|FG002|Overall Study|Withdrawal by Subject|10|||
27995378|NCT00810810|54654231|FG003|Overall Study|Withdrawal by Subject|8|||
27995379|NCT00810810|54654228|FG000|Overall Study|Physician Decision|0|||
27995380|NCT00810810|54654229|FG001|Overall Study|Physician Decision|3|||
27995381|NCT00810810|54654230|FG002|Overall Study|Physician Decision|1|||
27995382|NCT00810810|54654231|FG003|Overall Study|Physician Decision|5|||
27995383|NCT00661258|54654243|FG000|Overall Study|Death|1|||
27995384|NCT00661258|54654244|FG001|Overall Study|Death|0|||
27995385|NCT00661258|54654243|FG000|Overall Study|caught by police and in detox center|2|||
27995386|NCT00661258|54654244|FG001|Overall Study|caught by police and in detox center|1|||
27995387|NCT00871871|54654252|FG000|Part I|Adverse Event|0|||
27995388|NCT00871871|54654253|FG001|Part I|Adverse Event|2|||
27995389|NCT00871871|54654254|FG002|Part I|Adverse Event|0|||
28098577|NCT00090285|54754122|FG001|Long-term Follow-up (EXT2)|Physician Decision|0|||
28098578|NCT00090285|54754123|FG002|Long-term Follow-up (EXT2)|Physician Decision|0|||
27995390|NCT00871871|54654255|FG003|Part I|Adverse Event|0|||
27995391|NCT00871871|54654252|FG000|Part I|Withdrawal by Subject|3|||
28098579|NCT00090285|54754124|FG003|Long-term Follow-up (EXT2)|Physician Decision|0|||
28172617|NCT02788201|54844341|FG005|Overall Study|Withdrawal by Subject|1|||
27995392|NCT00871871|54654253|FG001|Part I|Withdrawal by Subject|0|||
28098580|NCT00090285|54754125|FG004|Long-term Follow-up (EXT2)|Physician Decision|6|||
27910619|NCT01150123|54568550|FG014|Overall Study|Withdrawal by Subject|0|||
27910620|NCT01150123|54568551|FG015|Overall Study|Withdrawal by Subject|1|||
27910621|NCT01150123|54568552|FG016|Overall Study|Withdrawal by Subject|0|||
27910622|NCT01150123|54568553|FG017|Overall Study|Withdrawal by Subject|1|||
27910623|NCT01150123|54568536|FG000|Overall Study|Lost to Follow-up|2|||
27910624|NCT01150123|54568537|FG001|Overall Study|Lost to Follow-up|1|||
27995393|NCT00871871|54654254|FG002|Part I|Withdrawal by Subject|0|||
27995394|NCT00871871|54654255|FG003|Part I|Withdrawal by Subject|0|||
27995395|NCT00871871|54654252|FG000|Part I|Laboratory abnormality|0|||
27995396|NCT00871871|54654253|FG001|Part I|Laboratory abnormality|1|||
27995397|NCT00871871|54654254|FG002|Part I|Laboratory abnormality|0|||
27995398|NCT00871871|54654255|FG003|Part I|Laboratory abnormality|0|||
27910625|NCT01150123|54568538|FG002|Overall Study|Lost to Follow-up|2|||
27910626|NCT01150123|54568539|FG003|Overall Study|Lost to Follow-up|2|||
27910627|NCT01150123|54568540|FG004|Overall Study|Lost to Follow-up|2|||
27910628|NCT01150123|54568541|FG005|Overall Study|Lost to Follow-up|5|||
27910629|NCT01150123|54568542|FG006|Overall Study|Lost to Follow-up|0|||
27910630|NCT01150123|54568543|FG007|Overall Study|Lost to Follow-up|0|||
27910631|NCT01150123|54568544|FG008|Overall Study|Lost to Follow-up|3|||
27910632|NCT01150123|54568545|FG009|Overall Study|Lost to Follow-up|1|||
27910633|NCT01150123|54568546|FG010|Overall Study|Lost to Follow-up|1|||
27910634|NCT01150123|54568547|FG011|Overall Study|Lost to Follow-up|1|||
27910635|NCT01150123|54568548|FG012|Overall Study|Lost to Follow-up|2|||
27910636|NCT01150123|54568549|FG013|Overall Study|Lost to Follow-up|0|||
27910637|NCT01150123|54568550|FG014|Overall Study|Lost to Follow-up|0|||
27910638|NCT01150123|54568551|FG015|Overall Study|Lost to Follow-up|0|||
27910639|NCT01150123|54568552|FG016|Overall Study|Lost to Follow-up|0|||
27910640|NCT01150123|54568553|FG017|Overall Study|Lost to Follow-up|0|||
27910641|NCT01149655|54568612|FG000|Period 1 - Conversion Phase|Lost to Follow-up|1|||
27910642|NCT01149655|54568613|FG001|Period 1 - Conversion Phase|Lost to Follow-up|0|||
27910643|NCT01149655|54568614|FG002|Period 1 - Conversion Phase|Lost to Follow-up|0|||
27910644|NCT01149655|54568615|FG003|Period 1 - Conversion Phase|Lost to Follow-up|0|||
27910645|NCT01149655|54568612|FG000|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4|||
27910646|NCT01149655|54568613|FG001|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
27910647|NCT01149655|54568614|FG002|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
27910648|NCT01149655|54568615|FG003|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
27910649|NCT01149655|54568612|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
27910650|NCT01149655|54568613|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
27910651|NCT01149655|54568614|FG002|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
27910652|NCT01149655|54568615|FG003|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
27910653|NCT01149655|54568612|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
27910654|NCT01149655|54568613|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
27910655|NCT01149655|54568614|FG002|Period 1 - Conversion Phase|Physician Decision|0|||
27910656|NCT01149655|54568615|FG003|Period 1 - Conversion Phase|Physician Decision|0|||
27910657|NCT01149655|54568612|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
27910658|NCT01149655|54568613|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
27910659|NCT01149655|54568614|FG002|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
27910660|NCT01149655|54568615|FG003|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
27910661|NCT01149655|54568612|FG000|Period 1 - Conversion Phase|Adverse Event Without Relapse|3|||
27910662|NCT01149655|54568613|FG001|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
27910663|NCT01149655|54568614|FG002|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
27910664|NCT01149655|54568615|FG003|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
27910665|NCT01149655|54568612|FG000|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
27910666|NCT01149655|54568613|FG001|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16|||
27910667|NCT01149655|54568614|FG002|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
27910668|NCT01149655|54568615|FG003|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
27910669|NCT01149655|54568612|FG000|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
27910670|NCT01149655|54568613|FG001|Period 2-Stabilization Phase|Met Withdrawal Criteria|7|||
27910671|NCT01149655|54568614|FG002|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
27910672|NCT01149655|54568615|FG003|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
27910673|NCT01149655|54568612|FG000|Period 2-Stabilization Phase|Physician Decision|0|||
27910674|NCT01149655|54568613|FG001|Period 2-Stabilization Phase|Physician Decision|3|||
27910675|NCT01149655|54568614|FG002|Period 2-Stabilization Phase|Physician Decision|0|||
27910676|NCT01149655|54568615|FG003|Period 2-Stabilization Phase|Physician Decision|0|||
27910677|NCT01149655|54568612|FG000|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
27910678|NCT01149655|54568613|FG001|Period 2-Stabilization Phase|Withdrawal by Subject|5|||
27910679|NCT01149655|54568614|FG002|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
27910680|NCT01149655|54568615|FG003|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
28098581|NCT00090285|54754126|FG005|Long-term Follow-up (EXT2)|Physician Decision|5|||
28172618|NCT02456740|54844360|FG000|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
28098582|NCT00070941|54754144|FG000|Overall Study|Adverse Event|10|||
28172619|NCT02456740|54844361|FG001|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
27910681|NCT01149655|54568612|FG000|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
27910682|NCT01149655|54568613|FG001|Period 2-Stabilization Phase|Adverse Event Without Relapse|6|||
27910683|NCT01149655|54568614|FG002|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
27910684|NCT01149655|54568615|FG003|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
27910685|NCT01149655|54568612|FG000|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
27910686|NCT01149655|54568613|FG001|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
27910687|NCT01149655|54568614|FG002|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58|||
27910688|NCT01149655|54568615|FG003|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19|||
27910689|NCT01149655|54568612|FG000|Period 3-DB Maintenance Phase|Physician Decision|0|||
27910690|NCT01149655|54568613|FG001|Period 3-DB Maintenance Phase|Physician Decision|0|||
27910691|NCT01149655|54568614|FG002|Period 3-DB Maintenance Phase|Physician Decision|1|||
27910692|NCT01149655|54568615|FG003|Period 3-DB Maintenance Phase|Physician Decision|0|||
27910693|NCT01149655|54568612|FG000|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
27910694|NCT01149655|54568613|FG001|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
27910695|NCT01149655|54568614|FG002|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
27910696|NCT01149655|54568615|FG003|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
27995399|NCT00871871|54654252|FG000|Part II|Lack of Efficacy|0|||
27995400|NCT00871871|54654253|FG001|Part II|Lack of Efficacy|0|||
27995401|NCT00871871|54654254|FG002|Part II|Lack of Efficacy|1|||
27995402|NCT00871871|54654255|FG003|Part II|Lack of Efficacy|0|||
27995403|NCT00871871|54654252|FG000|Part II|Withdrawal by Subject|0|||
27995404|NCT00871871|54654253|FG001|Part II|Withdrawal by Subject|0|||
27995405|NCT00871871|54654254|FG002|Part II|Withdrawal by Subject|2|||
27995406|NCT00871871|54654255|FG003|Part II|Withdrawal by Subject|1|||
27995407|NCT00871871|54654252|FG000|Part II|Adverse Event|0|||
27995408|NCT00871871|54654253|FG001|Part II|Adverse Event|0|||
27995409|NCT00871871|54654254|FG002|Part II|Adverse Event|1|||
27995410|NCT00871871|54654255|FG003|Part II|Adverse Event|2|||
27995411|NCT00871871|54654252|FG000|Part II|Protocol Violation|0|||
27995412|NCT00871871|54654253|FG001|Part II|Protocol Violation|0|||
27995413|NCT00871871|54654254|FG002|Part II|Protocol Violation|0|||
27995414|NCT00871871|54654255|FG003|Part II|Protocol Violation|1|||
27995415|NCT00849680|54654273|FG000|Overall Study|Adverse Event|0|||
27995416|NCT00849680|54654274|FG001|Overall Study|Adverse Event|0|||
27995417|NCT00849680|54654275|FG002|Overall Study|Adverse Event|0|||
27910697|NCT01149655|54568612|FG000|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
27910698|NCT01149655|54568613|FG001|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
27910699|NCT01149655|54568614|FG002|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
27910700|NCT01149655|54568615|FG003|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
27910701|NCT01149655|54568612|FG000|Period 3-DB Maintenance Phase|Relapse With AE|0|||
27910702|NCT01149655|54568613|FG001|Period 3-DB Maintenance Phase|Relapse With AE|0|||
27910703|NCT01149655|54568614|FG002|Period 3-DB Maintenance Phase|Relapse With AE|19|||
27910704|NCT01149655|54568615|FG003|Period 3-DB Maintenance Phase|Relapse With AE|18|||
27910705|NCT01149538|54568625|FG000|Overall Study|Lost to Follow-up|0|||
27910706|NCT01149538|54568626|FG001|Overall Study|Lost to Follow-up|1|||
27910707|NCT01149538|54568625|FG000|Overall Study|Withdrawal by Subject|5|||
27910708|NCT01149538|54568626|FG001|Overall Study|Withdrawal by Subject|3|||
27910709|NCT01149460|54568634|FG000|Overall Study|Withdrawal by Subject|0|||
27910710|NCT01149460|54568635|FG001|Overall Study|Withdrawal by Subject|2|||
27910711|NCT01149421|54568644|FG000|Overall Study|Adverse Event|22|||
27910712|NCT01149421|54568645|FG001|Overall Study|Adverse Event|6|||
27910713|NCT01149421|54568646|FG002|Overall Study|Adverse Event|11|||
27910714|NCT01149421|54568644|FG000|Overall Study|Withdrawal by Subject|20|||
27910715|NCT01149421|54568645|FG001|Overall Study|Withdrawal by Subject|12|||
27910716|NCT01149421|54568646|FG002|Overall Study|Withdrawal by Subject|13|||
27910717|NCT01149421|54568644|FG000|Overall Study|Sponsor Decision|0|||
27995418|NCT00849680|54654276|FG003|Overall Study|Adverse Event|0|||
27995419|NCT00849680|54654277|FG004|Overall Study|Adverse Event|0|||
27995420|NCT00849680|54654278|FG005|Overall Study|Adverse Event|0|||
27995421|NCT00849680|54654279|FG006|Overall Study|Adverse Event|2|||
27995422|NCT00849680|54654280|FG007|Overall Study|Adverse Event|0|||
27995423|NCT00849680|54654273|FG000|Overall Study|Lost to Follow-up|7|||
27995424|NCT00849680|54654274|FG001|Overall Study|Lost to Follow-up|3|||
28098583|NCT00070941|54754145|FG001|Overall Study|Adverse Event|8|||
27995425|NCT00849680|54654275|FG002|Overall Study|Lost to Follow-up|12|||
27995426|NCT00849680|54654276|FG003|Overall Study|Lost to Follow-up|11|||
27995427|NCT00849680|54654277|FG004|Overall Study|Lost to Follow-up|8|||
27995428|NCT00849680|54654278|FG005|Overall Study|Lost to Follow-up|11|||
27995429|NCT00849680|54654279|FG006|Overall Study|Lost to Follow-up|12|||
27995430|NCT00849680|54654280|FG007|Overall Study|Lost to Follow-up|5|||
27995431|NCT00849680|54654273|FG000|Overall Study|Subject moved|1|||
27995432|NCT00849680|54654274|FG001|Overall Study|Subject moved|0|||
28098584|NCT00070941|54754146|FG002|Overall Study|Adverse Event|4|||
27995433|NCT00849680|54654275|FG002|Overall Study|Subject moved|3|||
28098585|NCT00070707|54754156|FG000|Overall Study|Adverse Event|1|||
28098586|NCT00070707|54754157|FG001|Overall Study|Adverse Event|2|||
27995434|NCT00849680|54654276|FG003|Overall Study|Subject moved|1|||
27995435|NCT00849680|54654277|FG004|Overall Study|Subject moved|0|||
27995436|NCT00849680|54654278|FG005|Overall Study|Subject moved|2|||
27995437|NCT00849680|54654279|FG006|Overall Study|Subject moved|2|||
27995438|NCT00849680|54654280|FG007|Overall Study|Subject moved|2|||
27995439|NCT00849680|54654273|FG000|Overall Study|Withdrawal by Subject|2|||
27910718|NCT01149421|54568645|FG001|Overall Study|Sponsor Decision|1|||
27910719|NCT01149421|54568646|FG002|Overall Study|Sponsor Decision|1|||
27910720|NCT01149421|54568644|FG000|Overall Study|Lost to Follow-up|2|||
27910721|NCT01149421|54568645|FG001|Overall Study|Lost to Follow-up|4|||
27910722|NCT01149421|54568646|FG002|Overall Study|Lost to Follow-up|5|||
27910723|NCT01149421|54568644|FG000|Overall Study|Physician Decision|5|||
27910724|NCT01149421|54568645|FG001|Overall Study|Physician Decision|3|||
27910725|NCT01149421|54568646|FG002|Overall Study|Physician Decision|6|||
27910726|NCT01149421|54568644|FG000|Overall Study|Entry Criteria Not Met|1|||
27910727|NCT01149421|54568645|FG001|Overall Study|Entry Criteria Not Met|1|||
27910728|NCT01149421|54568646|FG002|Overall Study|Entry Criteria Not Met|2|||
27910729|NCT01149421|54568644|FG000|Overall Study|Protocol Violation|2|||
27910730|NCT01149421|54568645|FG001|Overall Study|Protocol Violation|2|||
27910731|NCT01149421|54568646|FG002|Overall Study|Protocol Violation|6|||
27910732|NCT01149343|54568664|FG000|Overall Study|Withdrawal by Subject|1|||
27910733|NCT01149343|54568665|FG001|Overall Study|Withdrawal by Subject|1|||
27910734|NCT01149343|54568666|FG002|Overall Study|Withdrawal by Subject|1|||
27910735|NCT01149343|54568667|FG003|Overall Study|Withdrawal by Subject|5|||
27910736|NCT01149343|54568664|FG000|Overall Study|Death|10|||
27910737|NCT01149343|54568665|FG001|Overall Study|Death|13|||
27910738|NCT01149343|54568666|FG002|Overall Study|Death|18|||
27910739|NCT01149343|54568667|FG003|Overall Study|Death|18|||
27910740|NCT01149343|54568664|FG000|Overall Study|Lost to Follow-up|1|||
27910741|NCT01149343|54568665|FG001|Overall Study|Lost to Follow-up|0|||
27910742|NCT01149343|54568666|FG002|Overall Study|Lost to Follow-up|0|||
27910743|NCT01149343|54568667|FG003|Overall Study|Lost to Follow-up|1|||
27910744|NCT01149343|54568664|FG000|Overall Study|Other|8|||
27910745|NCT01149343|54568665|FG001|Overall Study|Other|10|||
27910746|NCT01149343|54568666|FG002|Overall Study|Other|2|||
27910747|NCT01149343|54568667|FG003|Overall Study|Other|14|||
27910748|NCT01149343|54568664|FG000|Overall Study|Sponsor study termination|0|||
27910749|NCT01149343|54568665|FG001|Overall Study|Sponsor study termination|0|||
27910750|NCT01149343|54568666|FG002|Overall Study|Sponsor study termination|0|||
27910751|NCT01149343|54568667|FG003|Overall Study|Sponsor study termination|2|||
27910752|NCT01149343|54568664|FG000|Overall Study|Recurrence / Progressive disease|0|||
27910753|NCT01149343|54568665|FG001|Overall Study|Recurrence / Progressive disease|0|||
27910754|NCT01149343|54568666|FG002|Overall Study|Recurrence / Progressive disease|1|||
27910755|NCT01149343|54568667|FG003|Overall Study|Recurrence / Progressive disease|0|||
27910756|NCT01149148|54568683|FG000|Overall Study|Lost to Follow-up|1|||
27910757|NCT01149148|54568684|FG001|Overall Study|Lost to Follow-up|2|||
27910758|NCT01149148|54568683|FG000|Overall Study|Death|1|||
27995440|NCT00849680|54654274|FG001|Overall Study|Withdrawal by Subject|0|||
27995441|NCT00849680|54654275|FG002|Overall Study|Withdrawal by Subject|0|||
27995442|NCT00849680|54654276|FG003|Overall Study|Withdrawal by Subject|2|||
27995443|NCT00849680|54654277|FG004|Overall Study|Withdrawal by Subject|2|||
27995444|NCT00849680|54654278|FG005|Overall Study|Withdrawal by Subject|2|||
27995445|NCT00849680|54654279|FG006|Overall Study|Withdrawal by Subject|1|||
27995446|NCT00849680|54654280|FG007|Overall Study|Withdrawal by Subject|1|||
27995447|NCT00849680|54654273|FG000|Overall Study|Subject unable to comply with protocol|1|||
27910759|NCT01149148|54568684|FG001|Overall Study|Death|0|||
27910760|NCT01148017|54568695|FG000|Overall Study|Withdrawal by Subject|31|||
27910761|NCT01148017|54568696|FG001|Overall Study|Withdrawal by Subject|14|||
27910762|NCT01148017|54568697|FG002|Overall Study|Withdrawal by Subject|0|||
27995448|NCT00849680|54654274|FG001|Overall Study|Subject unable to comply with protocol|0|||
27995449|NCT00849680|54654275|FG002|Overall Study|Subject unable to comply with protocol|0|||
27995450|NCT00849680|54654276|FG003|Overall Study|Subject unable to comply with protocol|0|||
27995451|NCT00849680|54654277|FG004|Overall Study|Subject unable to comply with protocol|0|||
28098587|NCT00070707|54754156|FG000|Overall Study|Lack of Efficacy|4|||
27910763|NCT01148017|54568698|FG003|Overall Study|Withdrawal by Subject|0|||
27995452|NCT00849680|54654278|FG005|Overall Study|Subject unable to comply with protocol|0|||
27995453|NCT00849680|54654279|FG006|Overall Study|Subject unable to comply with protocol|0|||
27995454|NCT00849680|54654280|FG007|Overall Study|Subject unable to comply with protocol|0|||
27910764|NCT01148017|54568695|FG000|Overall Study|Lost to Follow-up|23|||
27910765|NCT01148017|54568696|FG001|Overall Study|Lost to Follow-up|10|||
27910766|NCT01148017|54568697|FG002|Overall Study|Lost to Follow-up|0|||
27910767|NCT01148017|54568698|FG003|Overall Study|Lost to Follow-up|0|||
28098588|NCT00070707|54754157|FG001|Overall Study|Lack of Efficacy|1|||
27910768|NCT01148017|54568695|FG000|Overall Study|Inappropriate enrollment|1|||
27910769|NCT01148017|54568696|FG001|Overall Study|Inappropriate enrollment|0|||
27910770|NCT01148017|54568697|FG002|Overall Study|Inappropriate enrollment|0|||
27910771|NCT01148017|54568698|FG003|Overall Study|Inappropriate enrollment|0|||
27910772|NCT01148017|54568695|FG000|Overall Study|Administrative reason|22|||
27910773|NCT01148017|54568696|FG001|Overall Study|Administrative reason|9|||
27910774|NCT01148017|54568697|FG002|Overall Study|Administrative reason|0|||
27995455|NCT00810342|54654300|FG000|Month 1 Follow-up|Lost to Follow-up|4|||
27995456|NCT00810342|54654301|FG001|Month 1 Follow-up|Lost to Follow-up|2|||
27995457|NCT00810342|54654300|FG000|Month 1 Follow-up|Pregnancy|1|||
27995458|NCT00810342|54654301|FG001|Month 1 Follow-up|Pregnancy|0|||
27995459|NCT00810342|54654300|FG000|6-month Follow-up|Lost to Follow-up|18|||
27995460|NCT00810342|54654301|FG001|6-month Follow-up|Lost to Follow-up|6|||
27910775|NCT01148017|54568698|FG003|Overall Study|Administrative reason|0|||
27910776|NCT01148017|54568695|FG000|Overall Study|Unable to classify|3|||
27910777|NCT01148017|54568696|FG001|Overall Study|Unable to classify|1|||
27910778|NCT01148017|54568697|FG002|Overall Study|Unable to classify|0|||
27910779|NCT01148017|54568698|FG003|Overall Study|Unable to classify|0|||
27910780|NCT01147900|54568712|FG000|At Year 10|Lost to Follow-up|0|||
27910781|NCT01147900|54568713|FG001|At Year 10|Lost to Follow-up|1|||
27910782|NCT01147900|54568714|FG002|At Year 10|Lost to Follow-up|0|||
27910783|NCT01147744|54568729|FG000|Overall Study|Protocol Violation|1|||
27910784|NCT01147744|54568730|FG001|Overall Study|Protocol Violation|0|||
27910785|NCT01147744|54568731|FG002|Overall Study|Protocol Violation|1|||
27910786|NCT01147744|54568732|FG003|Overall Study|Protocol Violation|0|||
27910787|NCT01147744|54568733|FG004|Overall Study|Protocol Violation|1|||
27910788|NCT01147744|54568734|FG005|Overall Study|Protocol Violation|3|||
27910789|NCT01147744|54568735|FG006|Overall Study|Protocol Violation|1|||
27910790|NCT01147744|54568729|FG000|Overall Study|Physician Decision|0|||
27910791|NCT01147744|54568730|FG001|Overall Study|Physician Decision|1|||
27910792|NCT01147744|54568731|FG002|Overall Study|Physician Decision|1|||
27910793|NCT01147744|54568732|FG003|Overall Study|Physician Decision|0|||
27995461|NCT00810342|54654300|FG000|6-month Follow-up|Pregnancy|6|||
27995462|NCT00810342|54654301|FG001|6-month Follow-up|Pregnancy|2|||
27995463|NCT00810342|54654300|FG000|12-month Followup|Pregnancy|9|||
27995464|NCT00810342|54654301|FG001|12-month Followup|Pregnancy|10|||
27995465|NCT00810342|54654300|FG000|12-month Followup|Lost to Follow-up|3|||
27995466|NCT00810342|54654301|FG001|12-month Followup|Lost to Follow-up|1|||
27995467|NCT00849524|54654309|FG000|Overall Study|Lack of Efficacy|3|||
27995468|NCT00808080|54654313|FG000|Overall Study|Patients Became Ineligible for infusion|6|||
27995469|NCT00866723|54654318|FG000|Overall Study|Withdrawal by Subject|1|||
27995470|NCT00866723|54654318|FG000|Overall Study|Disease Progression|4|||
27995471|NCT00849290|54654322|FG000|Overall Study|Adverse Event|3|||
27995472|NCT00849290|54654322|FG000|Overall Study|Death|14|||
27995473|NCT00849290|54654322|FG000|Overall Study|Withdrawal by Subject|11|||
27995474|NCT00849290|54654322|FG000|Overall Study|Lost to Follow-up|2|||
27995475|NCT00849290|54654322|FG000|Overall Study|Protocol Violation|5|||
27995476|NCT00849290|54654322|FG000|Overall Study|Disease Progression|20|||
27995477|NCT00849212|54654326|FG000|Overall Study|Lack of Efficacy|1|||
27995478|NCT00849212|54654326|FG000|Overall Study|Withdrawal by Subject|3|||
27995479|NCT00849212|54654326|FG000|Overall Study|Adverse Event|2|||
27995480|NCT00849212|54654326|FG000|Overall Study|Miscellaneous|1|||
27995481|NCT00810264|54654330|FG000|Overall Study|Lost to Follow-up|191|||
27995482|NCT00810264|54654330|FG000|Overall Study|Withdrawal by subject or physician|721|||
27995483|NCT00810264|54654330|FG000|Overall Study|Death|641|||
27995484|NCT00849056|54654340|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|13|||
27995485|NCT00849056|54654341|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
27995486|NCT00849056|54654340|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|3|||
27995487|NCT00849056|54654341|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|6|||
27995488|NCT00849056|54654340|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
27995489|NCT00849056|54654341|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
27995490|NCT00849056|54654340|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
27995491|NCT00849056|54654341|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5|||
27995492|NCT00849056|54654340|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31|||
27995493|NCT00849056|54654341|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18|||
27995494|NCT00849056|54654340|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
27995495|NCT00849056|54654341|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
27995496|NCT00849056|54654340|FG000|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1|||
27995497|NCT00849056|54654341|FG001|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4|||
28098589|NCT00070707|54754156|FG000|Overall Study|Protocol Violation|8|||
27910794|NCT01147744|54568733|FG004|Overall Study|Physician Decision|0|||
27910795|NCT01147744|54568734|FG005|Overall Study|Physician Decision|0|||
27995498|NCT00849056|54654340|FG000|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1|||
27995499|NCT00849056|54654341|FG001|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0|||
27995500|NCT00849056|54654340|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
27995501|NCT00849056|54654341|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
27910796|NCT01147744|54568735|FG006|Overall Study|Physician Decision|1|||
27910797|NCT01147744|54568729|FG000|Overall Study|Lack of Efficacy|11|||
27910798|NCT01147744|54568730|FG001|Overall Study|Lack of Efficacy|11|||
27910799|NCT01147744|54568731|FG002|Overall Study|Lack of Efficacy|9|||
27995502|NCT00849056|54654340|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
27995503|NCT00849056|54654341|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3|||
27995504|NCT00849056|54654340|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
27995505|NCT00849056|54654341|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
27995506|NCT00849056|54654340|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14|||
27995507|NCT00849056|54654341|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9|||
27995508|NCT00849056|54654340|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9|||
27995509|NCT00849056|54654341|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7|||
27995510|NCT00849056|54654340|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
27995511|NCT00849056|54654341|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
27995512|NCT00849056|54654340|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1|||
27995513|NCT00849056|54654341|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4|||
27995514|NCT00849056|54654340|FG000|Follow-up Period (FUP) (8 Weeks)|Early Termination|1|||
27995515|NCT00849056|54654341|FG001|Follow-up Period (FUP) (8 Weeks)|Early Termination|0|||
27995516|NCT00837434|54654349|FG000|Overall Study|Physician Decision|3|||
27995517|NCT00837434|54654350|FG001|Overall Study|Physician Decision|0|||
27995518|NCT00837434|54654349|FG000|Overall Study|Lost to Follow-up|1|||
27995519|NCT00837434|54654350|FG001|Overall Study|Lost to Follow-up|1|||
27995520|NCT00837434|54654349|FG000|Overall Study|Withdrawn by sponsor/regulatory agency|1|||
27995521|NCT00837434|54654350|FG001|Overall Study|Withdrawn by sponsor/regulatory agency|0|||
27995522|NCT00837434|54654349|FG000|Overall Study|Noncompliant|2|||
27995523|NCT00837434|54654350|FG001|Overall Study|Noncompliant|0|||
27995524|NCT00837434|54654349|FG000|Overall Study|Baseline assessments not done in time|1|||
27995525|NCT00837434|54654350|FG001|Overall Study|Baseline assessments not done in time|0|||
27995526|NCT00837434|54654349|FG000|Overall Study|Unable to obtain study drug|1|||
27995527|NCT00837434|54654350|FG001|Overall Study|Unable to obtain study drug|0|||
27995528|NCT00827918|54654359|FG000|Overall Study|Adverse Event|4|||
27995529|NCT00827918|54654360|FG001|Overall Study|Adverse Event|0|||
27995530|NCT00827918|54654361|FG002|Overall Study|Adverse Event|0|||
27995531|NCT00827918|54654359|FG000|Overall Study|Lack of Efficacy|16|||
27995532|NCT00827918|54654360|FG001|Overall Study|Lack of Efficacy|4|||
27995533|NCT00827918|54654361|FG002|Overall Study|Lack of Efficacy|15|||
27995534|NCT00827918|54654359|FG000|Overall Study|Physician Decision|1|||
27995535|NCT00827918|54654360|FG001|Overall Study|Physician Decision|0|||
27995536|NCT00827918|54654361|FG002|Overall Study|Physician Decision|0|||
27995537|NCT00827918|54654359|FG000|Overall Study|Pregnancy|0|||
27995538|NCT00827918|54654360|FG001|Overall Study|Pregnancy|1|||
27995539|NCT00827918|54654361|FG002|Overall Study|Pregnancy|0|||
27995540|NCT00827918|54654359|FG000|Overall Study|Progressive Disease|1|||
27995541|NCT00827918|54654360|FG001|Overall Study|Progressive Disease|1|||
27995542|NCT00827918|54654361|FG002|Overall Study|Progressive Disease|0|||
27995543|NCT00827918|54654359|FG000|Overall Study|Protocol Violation|0|||
27995544|NCT00827918|54654360|FG001|Overall Study|Protocol Violation|1|||
27995545|NCT00827918|54654361|FG002|Overall Study|Protocol Violation|0|||
27995546|NCT00827918|54654359|FG000|Overall Study|Withdrawal by Subject|6|||
27995547|NCT00827918|54654360|FG001|Overall Study|Withdrawal by Subject|2|||
27995548|NCT00827918|54654361|FG002|Overall Study|Withdrawal by Subject|6|||
27995549|NCT00813150|54654371|FG000|Treatment Period|Adverse Event|16|||
27995550|NCT00813150|54654372|FG001|Treatment Period|Adverse Event|15|||
27995551|NCT00813150|54654371|FG000|Treatment Period|Death|2|||
27995552|NCT00813150|54654372|FG001|Treatment Period|Death|0|||
27995553|NCT00813150|54654371|FG000|Treatment Period|Progressive disease|1|||
27995554|NCT00813150|54654372|FG001|Treatment Period|Progressive disease|0|||
27995555|NCT00813150|54654371|FG000|Treatment Period|Complete response|0|||
27995556|NCT00813150|54654372|FG001|Treatment Period|Complete response|1|||
27995557|NCT00813150|54654371|FG000|Treatment Period|Stable disease|1|||
27995558|NCT00813150|54654372|FG001|Treatment Period|Stable disease|2|||
27995559|NCT00813150|54654371|FG000|Treatment Period|Protocol Violation|3|||
27995560|NCT00813150|54654372|FG001|Treatment Period|Protocol Violation|4|||
27995561|NCT00813150|54654371|FG000|Treatment Period|Withdrawal by Subject|5|||
28098590|NCT00070707|54754157|FG001|Overall Study|Protocol Violation|4|||
28098591|NCT00070707|54754156|FG000|Overall Study|Unrelated to Study Medication|1|||
27995562|NCT00813150|54654372|FG001|Treatment Period|Withdrawal by Subject|3|||
27995563|NCT00813150|54654371|FG000|Treatment Period|Non compliance|0|||
27995564|NCT00813150|54654372|FG001|Treatment Period|Non compliance|1|||
27995565|NCT00813150|54654371|FG000|Treatment Period|Reason not specified|3|||
27995566|NCT00813150|54654372|FG001|Treatment Period|Reason not specified|4|||
27995567|NCT00813150|54654371|FG000|Treatment Period|Data not available|1|||
27995568|NCT00813150|54654372|FG001|Treatment Period|Data not available|2|||
27995569|NCT00813150|54654371|FG000|Long Term Follow-up|Death|0|||
27995570|NCT00813150|54654372|FG001|Long Term Follow-up|Death|4|||
27995571|NCT00813150|54654371|FG000|Long Term Follow-up|Other|0|||
27995572|NCT00813150|54654372|FG001|Long Term Follow-up|Other|3|||
27995573|NCT00813150|54654371|FG000|Long Term Follow-up|Lost to Follow-up|2|||
28172620|NCT02456740|54844362|FG002|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
28098592|NCT00070707|54754157|FG001|Overall Study|Unrelated to Study Medication|0|||
27995574|NCT00813150|54654372|FG001|Long Term Follow-up|Lost to Follow-up|0|||
27995575|NCT00813150|54654371|FG000|Long Term Follow-up|Progression/Relapse|22|||
27995576|NCT00813150|54654372|FG001|Long Term Follow-up|Progression/Relapse|24|||
27995577|NCT00807846|54654380|FG000|Overall Study|Adverse Event|5|||
27995578|NCT00807846|54654381|FG001|Overall Study|Adverse Event|0|||
27995579|NCT00807846|54654380|FG000|Overall Study|Lack of Efficacy|2|||
27910800|NCT01147744|54568732|FG003|Overall Study|Lack of Efficacy|11|||
27910801|NCT01147744|54568733|FG004|Overall Study|Lack of Efficacy|13|||
27910802|NCT01147744|54568734|FG005|Overall Study|Lack of Efficacy|8|||
27910803|NCT01147744|54568735|FG006|Overall Study|Lack of Efficacy|7|||
27910804|NCT01147744|54568729|FG000|Overall Study|Adverse Event|1|||
27995580|NCT00807846|54654381|FG001|Overall Study|Lack of Efficacy|0|||
27995581|NCT00807846|54654380|FG000|Overall Study|Protocol Violation|2|||
27995582|NCT00807846|54654381|FG001|Overall Study|Protocol Violation|1|||
27995583|NCT00807846|54654380|FG000|Overall Study|Withdrawal by Subject|2|||
27995584|NCT00807846|54654381|FG001|Overall Study|Withdrawal by Subject|1|||
27995585|NCT00807846|54654380|FG000|Overall Study|Other|1|||
27910805|NCT01147744|54568730|FG001|Overall Study|Adverse Event|2|||
27910806|NCT01147744|54568731|FG002|Overall Study|Adverse Event|3|||
27910807|NCT01147744|54568732|FG003|Overall Study|Adverse Event|0|||
27910808|NCT01147744|54568733|FG004|Overall Study|Adverse Event|2|||
27910809|NCT01147744|54568734|FG005|Overall Study|Adverse Event|1|||
27910810|NCT01147744|54568735|FG006|Overall Study|Adverse Event|2|||
27910811|NCT01147744|54568729|FG000|Overall Study|Withdrawal by Subject|8|||
27910812|NCT01147744|54568730|FG001|Overall Study|Withdrawal by Subject|4|||
27995586|NCT00807846|54654381|FG001|Overall Study|Other|2|||
27995587|NCT00810108|54654389|FG000|Overall Study|Withdrawal by Subject|1|||
27995588|NCT00810108|54654390|FG001|Overall Study|Withdrawal by Subject|0|||
27995589|NCT00827606|54654397|FG000|Overall Study|Protocol Violation|4|||
27995590|NCT00827606|54654398|FG001|Overall Study|Protocol Violation|3|||
27995591|NCT00827606|54654397|FG000|Overall Study|Lost to Follow-up|3|||
27995592|NCT00827606|54654398|FG001|Overall Study|Lost to Follow-up|1|||
27995593|NCT00827606|54654397|FG000|Overall Study|Withdrawal by Subject|7|||
27995594|NCT00827606|54654398|FG001|Overall Study|Withdrawal by Subject|6|||
27995595|NCT00827606|54654397|FG000|Overall Study|Pregnancy|0|||
27995596|NCT00827606|54654398|FG001|Overall Study|Pregnancy|1|||
27995597|NCT00827606|54654397|FG000|Overall Study|Other|5|||
27995598|NCT00827606|54654398|FG001|Overall Study|Other|13|||
27995599|NCT00827606|54654397|FG000|Overall Study|LDL below 2.59 mmol/L|4|||
27995600|NCT00827606|54654398|FG001|Overall Study|LDL below 2.59 mmol/L|12|||
27995601|NCT00827606|54654397|FG000|Overall Study|Adverse Event|4|||
27995602|NCT00827606|54654398|FG001|Overall Study|Adverse Event|2|||
27995603|NCT00663052|54654412|FG000|Overall Study|Adverse Event|6|||
27995604|NCT00663052|54654413|FG001|Overall Study|Adverse Event|3|||
27995605|NCT00663052|54654412|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
27995606|NCT00663052|54654413|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
27995607|NCT00663052|54654412|FG000|Overall Study|Protocol Violation|1|||
27995608|NCT00663052|54654413|FG001|Overall Study|Protocol Violation|0|||
27995609|NCT00663052|54654412|FG000|Overall Study|Withdrawal by Subject|2|||
27995610|NCT00663052|54654413|FG001|Overall Study|Withdrawal by Subject|5|||
27995611|NCT00663052|54654412|FG000|Overall Study|Unsatisfactory Response - Efficacy|1|||
27995612|NCT00663052|54654413|FG001|Overall Study|Unsatisfactory Response - Efficacy|1|||
27995613|NCT00663052|54654412|FG000|Overall Study|Other|0|||
27995614|NCT00663052|54654413|FG001|Overall Study|Other|1|||
27995615|NCT00827372|54654419|FG000|Overall Study|Adverse Event|5|||
27739723|NCT01378975|54189350|FG000|Overall Study|Investigator Request|1|||
27910813|NCT01147744|54568731|FG002|Overall Study|Withdrawal by Subject|2|||
27910814|NCT01147744|54568732|FG003|Overall Study|Withdrawal by Subject|2|||
28098593|NCT03036124|54754165|FG000|Overall Study|Lost to Follow-up|0|||
28098594|NCT03036124|54754166|FG001|Overall Study|Lost to Follow-up|2|||
27910815|NCT01147744|54568733|FG004|Overall Study|Withdrawal by Subject|2|||
27995616|NCT00827372|54654419|FG000|Overall Study|Lack of Efficacy|3|||
27995617|NCT00826748|54654427|FG000|Overall Study|Withdrawal by Subject|0|||
27995618|NCT00826748|54654428|FG001|Overall Study|Withdrawal by Subject|0|||
28098595|NCT03036124|54754165|FG000|Overall Study|Withdrawal by Subject|5|||
28098596|NCT03036124|54754166|FG001|Overall Study|Withdrawal by Subject|4|||
27910816|NCT01147744|54568734|FG005|Overall Study|Withdrawal by Subject|5|||
27910817|NCT01147744|54568735|FG006|Overall Study|Withdrawal by Subject|2|||
27995619|NCT00826748|54654429|FG002|Overall Study|Withdrawal by Subject|2|||
27995620|NCT00826748|54654427|FG000|Overall Study|Physician Decision|0|||
27995621|NCT00826748|54654428|FG001|Overall Study|Physician Decision|0|||
27995622|NCT00826748|54654429|FG002|Overall Study|Physician Decision|1|||
27995623|NCT00826748|54654427|FG000|Overall Study|Samples Did Not pass QC|0|||
27995624|NCT00826748|54654428|FG001|Overall Study|Samples Did Not pass QC|0|||
27995625|NCT00826748|54654429|FG002|Overall Study|Samples Did Not pass QC|1|||
27995626|NCT00806988|54654439|FG000|Overall Study|Death|15|||
27995627|NCT00806988|54654440|FG001|Overall Study|Death|16|||
27739724|NCT01378975|54189351|FG001|Overall Study|Investigator Request|0|||
28098597|NCT00070317|54754172|FG000|Overall Study|Inevaluable (Never Treated)|1|||
27910818|NCT01147744|54568729|FG000|Overall Study|Lost to Follow-up|0|||
27910819|NCT01147744|54568730|FG001|Overall Study|Lost to Follow-up|1|||
27910820|NCT01147744|54568731|FG002|Overall Study|Lost to Follow-up|0|||
27910821|NCT01147744|54568732|FG003|Overall Study|Lost to Follow-up|0|||
27995628|NCT00806988|54654439|FG000|Overall Study|Withdrawal by Subject|8|||
27995629|NCT00806988|54654440|FG001|Overall Study|Withdrawal by Subject|8|||
27995630|NCT00806988|54654439|FG000|Overall Study|Lost to Follow-up|4|||
27995631|NCT00806988|54654440|FG001|Overall Study|Lost to Follow-up|19|||
27995632|NCT00807144|54654448|FG000|Overall Study|Lost to Follow-up|0|||
27995633|NCT00807144|54654449|FG001|Overall Study|Lost to Follow-up|1|||
28098598|NCT00070317|54754172|FG000|Overall Study|Ineligible Wrong Cell type/primary/stage|3|||
28098599|NCT00070317|54754172|FG000|Overall Study|Ineligible required test not done|1|||
27995634|NCT00591006|54654455|FG000|Overall Study|Withdrawal by Subject|0|||
27995635|NCT00591006|54654456|FG001|Overall Study|Withdrawal by Subject|0|||
27995636|NCT00591006|54654457|FG002|Overall Study|Withdrawal by Subject|0|||
27995637|NCT00591006|54654458|FG003|Overall Study|Withdrawal by Subject|0|||
27995638|NCT00591006|54654459|FG004|Overall Study|Withdrawal by Subject|0|||
27995639|NCT00591006|54654460|FG005|Overall Study|Withdrawal by Subject|0|||
27995640|NCT00591006|54654461|FG006|Overall Study|Withdrawal by Subject|0|||
27995641|NCT00591006|54654462|FG007|Overall Study|Withdrawal by Subject|0|||
27995642|NCT00591006|54654463|FG008|Overall Study|Withdrawal by Subject|0|||
27995643|NCT00591006|54654464|FG009|Overall Study|Withdrawal by Subject|0|||
27995644|NCT00591006|54654465|FG010|Overall Study|Withdrawal by Subject|0|||
27995645|NCT00591006|54654466|FG011|Overall Study|Withdrawal by Subject|0|||
27995646|NCT00591006|54654467|FG012|Overall Study|Withdrawal by Subject|0|||
27995647|NCT00591006|54654468|FG013|Overall Study|Withdrawal by Subject|0|||
27995648|NCT00591006|54654469|FG014|Overall Study|Withdrawal by Subject|0|||
27995649|NCT00591006|54654470|FG015|Overall Study|Withdrawal by Subject|1|||
27995650|NCT00591006|54654471|FG016|Overall Study|Withdrawal by Subject|0|||
27995651|NCT00591006|54654472|FG017|Overall Study|Withdrawal by Subject|0|||
27995652|NCT00591006|54654473|FG018|Overall Study|Withdrawal by Subject|0|||
27995653|NCT00591006|54654474|FG019|Overall Study|Withdrawal by Subject|0|||
27995654|NCT00591006|54654475|FG020|Overall Study|Withdrawal by Subject|0|||
28098600|NCT00070317|54754172|FG000|Overall Study|Ineligible-Improper prior treatment|2|||
28098601|NCT00070317|54754172|FG000|Overall Study|Ineligible-Inadequate pathology|6|||
28098602|NCT03649412|54754178|FG000|Part A, Washout Period 1 (7 Days)|Physician Decision|1|||
28098603|NCT03649412|54754179|FG001|Part A, Washout Period 1 (7 Days)|Physician Decision|0|||
28098604|NCT03649412|54754178|FG000|Part A, Washout Period 4 (7 Days)|Adverse Event|1|||
28098605|NCT03649412|54754179|FG001|Part A, Washout Period 4 (7 Days)|Adverse Event|0|||
28098606|NCT03649412|54754178|FG000|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
28098607|NCT03649412|54754179|FG001|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
28098608|NCT03649412|54754178|FG000|Part A, Washout Period 5 (7 Days)|Adverse Event|1|||
28098609|NCT03649412|54754179|FG001|Part A, Washout Period 5 (7 Days)|Adverse Event|0|||
28098610|NCT03649412|54754178|FG000|Part B, Washout Period 1 (7 Days)|Adverse Event|0|||
28098611|NCT03649412|54754179|FG001|Part B, Washout Period 1 (7 Days)|Adverse Event|1|||
28098612|NCT03649412|54754178|FG000|Part B, Washout Period 5 (7 Days)|Adverse Event|0|||
28098613|NCT03649412|54754179|FG001|Part B, Washout Period 5 (7 Days)|Adverse Event|1|||
28098614|NCT03587636|54754224|FG000|Overall Study|Lost to Follow-up|2|||
27910822|NCT01147744|54568733|FG004|Overall Study|Lost to Follow-up|0|||
27910823|NCT01147744|54568734|FG005|Overall Study|Lost to Follow-up|0|||
27910824|NCT01147744|54568735|FG006|Overall Study|Lost to Follow-up|0|||
27910825|NCT01147744|54568729|FG000|Overall Study|Sponsor decision to amend protocol|7|||
27910826|NCT01147744|54568730|FG001|Overall Study|Sponsor decision to amend protocol|4|||
27910827|NCT01147744|54568731|FG002|Overall Study|Sponsor decision to amend protocol|2|||
27910828|NCT01147744|54568732|FG003|Overall Study|Sponsor decision to amend protocol|5|||
27910829|NCT01147744|54568733|FG004|Overall Study|Sponsor decision to amend protocol|7|||
27910830|NCT01147744|54568734|FG005|Overall Study|Sponsor decision to amend protocol|2|||
27910831|NCT01147744|54568735|FG006|Overall Study|Sponsor decision to amend protocol|6|||
27910832|NCT01147744|54568729|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
27910833|NCT01147744|54568730|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
27910834|NCT01147744|54568731|FG002|Overall Study|Met Protocol-defined Stopping Criteria|0|||
27910835|NCT01147744|54568732|FG003|Overall Study|Met Protocol-defined Stopping Criteria|0|||
27910836|NCT01147744|54568733|FG004|Overall Study|Met Protocol-defined Stopping Criteria|0|||
27910837|NCT01147744|54568734|FG005|Overall Study|Met Protocol-defined Stopping Criteria|1|||
27995655|NCT00591006|54654476|FG021|Overall Study|Withdrawal by Subject|0|||
27995656|NCT00591006|54654477|FG022|Overall Study|Withdrawal by Subject|0|||
27995657|NCT00591006|54654478|FG023|Overall Study|Withdrawal by Subject|1|||
27995658|NCT00591006|54654455|FG000|Overall Study|Adverse Event|0|||
27995659|NCT00591006|54654456|FG001|Overall Study|Adverse Event|0|||
27995660|NCT00591006|54654457|FG002|Overall Study|Adverse Event|0|||
28098615|NCT03587636|54754225|FG001|Overall Study|Lost to Follow-up|5|||
28098616|NCT03586544|54754243|FG000|First Intervention|Adverse Event|0|||
28098617|NCT03586544|54754244|FG001|First Intervention|Adverse Event|1|||
28098618|NCT03586544|54754243|FG000|Second Intervention|Withdrawal by Subject|0|||
27995661|NCT00591006|54654458|FG003|Overall Study|Adverse Event|0|||
27995662|NCT00591006|54654459|FG004|Overall Study|Adverse Event|0|||
27995663|NCT00591006|54654460|FG005|Overall Study|Adverse Event|0|||
27995664|NCT00591006|54654461|FG006|Overall Study|Adverse Event|0|||
27995665|NCT00591006|54654462|FG007|Overall Study|Adverse Event|0|||
27995666|NCT00591006|54654463|FG008|Overall Study|Adverse Event|0|||
27995667|NCT00591006|54654464|FG009|Overall Study|Adverse Event|0|||
27995668|NCT00591006|54654465|FG010|Overall Study|Adverse Event|0|||
27995669|NCT00591006|54654466|FG011|Overall Study|Adverse Event|0|||
27995670|NCT00591006|54654467|FG012|Overall Study|Adverse Event|0|||
27995671|NCT00591006|54654468|FG013|Overall Study|Adverse Event|0|||
27995672|NCT00591006|54654469|FG014|Overall Study|Adverse Event|0|||
27995673|NCT00591006|54654470|FG015|Overall Study|Adverse Event|0|||
27995674|NCT00591006|54654471|FG016|Overall Study|Adverse Event|0|||
27995675|NCT00591006|54654472|FG017|Overall Study|Adverse Event|0|||
27995676|NCT00591006|54654473|FG018|Overall Study|Adverse Event|0|||
27995677|NCT00591006|54654474|FG019|Overall Study|Adverse Event|0|||
27995678|NCT00591006|54654475|FG020|Overall Study|Adverse Event|0|||
27995679|NCT00591006|54654476|FG021|Overall Study|Adverse Event|0|||
27995680|NCT00591006|54654477|FG022|Overall Study|Adverse Event|1|||
27995681|NCT00591006|54654478|FG023|Overall Study|Adverse Event|0|||
27995682|NCT00844844|54654495|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
27995683|NCT00844844|54654495|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
27995684|NCT00844844|54654495|FG000|Extension Treatment Period|Adverse Event|2|||
27995685|NCT00844844|54654495|FG000|Post Treatment Period|Withdrawal by Subject|1|||
27995686|NCT00660790|54654499|FG000|Baseline to 3 Months|Death|1|||
27995687|NCT00660790|54654499|FG000|Baseline to 3 Months|Withdrawal by Subject|2|||
27995688|NCT00660790|54654499|FG000|3 Months to 2 Years|Withdrawal by Subject|17|||
27995689|NCT00836810|54654505|FG000|Overall Study|New diagnosis|1|||
27995690|NCT00836810|54654506|FG001|Overall Study|New diagnosis|0|||
27995691|NCT00658684|54654515|FG000|Overall Study|Adverse Event|10|||
27995692|NCT00658684|54654516|FG001|Overall Study|Adverse Event|8|||
27995693|NCT00658684|54654517|FG002|Overall Study|Adverse Event|2|||
27995694|NCT00658684|54654518|FG003|Overall Study|Adverse Event|0|||
27995695|NCT00658684|54654515|FG000|Overall Study|Withdrawal by Subject|6|||
27995696|NCT00658684|54654516|FG001|Overall Study|Withdrawal by Subject|4|||
27995697|NCT00658684|54654517|FG002|Overall Study|Withdrawal by Subject|1|||
27995698|NCT00658684|54654518|FG003|Overall Study|Withdrawal by Subject|1|||
27995699|NCT00658684|54654515|FG000|Overall Study|Lack of Efficacy|1|||
27995700|NCT00658684|54654516|FG001|Overall Study|Lack of Efficacy|1|||
27995701|NCT00658684|54654517|FG002|Overall Study|Lack of Efficacy|0|||
27995702|NCT00658684|54654518|FG003|Overall Study|Lack of Efficacy|0|||
27995703|NCT00658684|54654515|FG000|Overall Study|Protocol Violation|1|||
27995704|NCT00658684|54654516|FG001|Overall Study|Protocol Violation|1|||
27995705|NCT00658684|54654517|FG002|Overall Study|Protocol Violation|0|||
27995706|NCT00658684|54654518|FG003|Overall Study|Protocol Violation|0|||
27995707|NCT00658684|54654515|FG000|Overall Study|Pregnancy|1|||
27995708|NCT00658684|54654516|FG001|Overall Study|Pregnancy|1|||
27995709|NCT00658684|54654517|FG002|Overall Study|Pregnancy|0|||
27995710|NCT00658684|54654518|FG003|Overall Study|Pregnancy|0|||
27995711|NCT00660400|54654528|FG000|Overall Study|Lack of insurance approval|1|||
27995712|NCT00660400|54654528|FG000|Overall Study|Suboptimal organ function|1|||
27995713|NCT00660400|54654528|FG000|Overall Study|Intracranial hemorrhage|1|||
27995714|NCT00660400|54654528|FG000|Overall Study|Withdrawal by Subject|1|||
27995715|NCT00826514|54654534|FG000|Overall Study|Adverse Event|1|||
27995716|NCT00826514|54654535|FG001|Overall Study|Adverse Event|1|||
27995717|NCT00826514|54654534|FG000|Overall Study|Lack of Efficacy|0|||
27995718|NCT00826514|54654535|FG001|Overall Study|Lack of Efficacy|1|||
27995719|NCT00826514|54654534|FG000|Overall Study|Withdrawal by Subject|2|||
27995720|NCT00826514|54654535|FG001|Overall Study|Withdrawal by Subject|3|||
27995721|NCT00826280|54654544|FG000|Overall Study|Randomized but drug not received|1|||
27995722|NCT00826280|54654545|FG001|Overall Study|Randomized but drug not received|0|||
27995723|NCT00826280|54654546|FG002|Overall Study|Randomized but drug not received|1|||
27995724|NCT00826280|54654544|FG000|Overall Study|Adverse Event|1|||
27995725|NCT00826280|54654545|FG001|Overall Study|Adverse Event|3|||
27995726|NCT00826280|54654546|FG002|Overall Study|Adverse Event|0|||
27995727|NCT00826280|54654544|FG000|Overall Study|Lost to Follow-up|0|||
27995728|NCT00826280|54654545|FG001|Overall Study|Lost to Follow-up|1|||
27995729|NCT00826280|54654546|FG002|Overall Study|Lost to Follow-up|0|||
27995730|NCT00826280|54654544|FG000|Overall Study|Sponsor discontinued subject or study|1|||
27995731|NCT00826280|54654545|FG001|Overall Study|Sponsor discontinued subject or study|0|||
27995732|NCT00826280|54654546|FG002|Overall Study|Sponsor discontinued subject or study|0|||
27995733|NCT00826280|54654544|FG000|Overall Study|Reversible ischemic defect not present|43|||
27995734|NCT00826280|54654545|FG001|Overall Study|Reversible ischemic defect not present|40|||
27995735|NCT00826280|54654546|FG002|Overall Study|Reversible ischemic defect not present|44|||
27995736|NCT00826280|54654544|FG000|Overall Study|Interpretation Failure|1|||
27995737|NCT00826280|54654545|FG001|Overall Study|Interpretation Failure|0|||
27995738|NCT00826280|54654546|FG002|Overall Study|Interpretation Failure|0|||
27995739|NCT00826280|54654544|FG000|Overall Study|Machine Failure|1|||
27910838|NCT01147744|54568735|FG006|Overall Study|Met Protocol-defined Stopping Criteria|0|||
27910839|NCT01147471|54568759|FG000|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0|||
27910840|NCT01147471|54568760|FG001|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1|||
27910841|NCT01147471|54568759|FG000|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0|||
27910842|NCT01147471|54568760|FG001|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1|||
27910843|NCT01147471|54568759|FG000|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0|||
27910844|NCT01147471|54568760|FG001|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1|||
27910845|NCT01147471|54568759|FG000|3 Month Follow Up|Lost to Follow-up|1|||
27910846|NCT01147471|54568760|FG001|3 Month Follow Up|Lost to Follow-up|1|||
27910847|NCT01147471|54568759|FG000|3 Month Follow Up|Physician Decision|0|||
27910848|NCT01147471|54568760|FG001|3 Month Follow Up|Physician Decision|1|||
27995740|NCT00826280|54654545|FG001|Overall Study|Machine Failure|1|||
27995741|NCT00826280|54654546|FG002|Overall Study|Machine Failure|0|||
27995742|NCT00826280|54654544|FG000|Overall Study|One or more non-interpretable scan|0|||
27995743|NCT00826280|54654545|FG001|Overall Study|One or more non-interpretable scan|1|||
27995744|NCT00826280|54654546|FG002|Overall Study|One or more non-interpretable scan|1|||
27995745|NCT00864851|54654557|FG000|Overall Study|Withdrawal by Subject|0|||
27995746|NCT00864851|54654558|FG001|Overall Study|Withdrawal by Subject|1|||
27995747|NCT00864851|54654559|FG002|Overall Study|Withdrawal by Subject|0|||
27995748|NCT00864851|54654557|FG000|Overall Study|Physician Decision|1|||
27995749|NCT00864851|54654558|FG001|Overall Study|Physician Decision|0|||
27995750|NCT00864851|54654559|FG002|Overall Study|Physician Decision|0|||
27995751|NCT00864851|54654557|FG000|Overall Study|Death|1|||
27995752|NCT00864851|54654558|FG001|Overall Study|Death|0|||
27995753|NCT00864851|54654559|FG002|Overall Study|Death|0|||
27995754|NCT00864851|54654557|FG000|Overall Study|Patient uncooperative|1|||
27995755|NCT00864851|54654558|FG001|Overall Study|Patient uncooperative|0|||
27995756|NCT00864851|54654559|FG002|Overall Study|Patient uncooperative|0|||
27995757|NCT00857207|54654571|FG000|Overall Study|Withdrawal by Subject|13|||
27995758|NCT00857207|54654572|FG001|Overall Study|Withdrawal by Subject|0|||
27995759|NCT00857207|54654571|FG000|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|18|||
27995760|NCT00857207|54654572|FG001|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|0|||
27995761|NCT00857207|54654571|FG000|Overall Study|Subject chose not to participate after signing consent|3|||
27995762|NCT00857207|54654572|FG001|Overall Study|Subject chose not to participate after signing consent|0|||
27995763|NCT00836498|54654581|FG000|Overall Study|Adverse Event|1|||
27995764|NCT00836498|54654582|FG001|Overall Study|Adverse Event|0|||
27995765|NCT00836498|54654581|FG000|Overall Study|Lost to Follow-up|1|||
27995766|NCT00836498|54654582|FG001|Overall Study|Lost to Follow-up|0|||
27995767|NCT00836498|54654581|FG000|Overall Study|Withdrawal by Subject|2|||
27995768|NCT00836498|54654582|FG001|Overall Study|Withdrawal by Subject|1|||
27995769|NCT00856973|54654592|FG000|Overall Study|Adverse Event|5|||
27995770|NCT00856973|54654593|FG001|Overall Study|Adverse Event|5|||
27995771|NCT00856973|54654594|FG002|Overall Study|Adverse Event|3|||
27995772|NCT00856973|54654592|FG000|Overall Study|Lost to Follow-up|6|||
27995773|NCT00856973|54654593|FG001|Overall Study|Lost to Follow-up|3|||
27995774|NCT00856973|54654594|FG002|Overall Study|Lost to Follow-up|5|||
27995775|NCT00856973|54654592|FG000|Overall Study|Physician Decision|0|||
27995776|NCT00856973|54654593|FG001|Overall Study|Physician Decision|3|||
27995777|NCT00856973|54654594|FG002|Overall Study|Physician Decision|1|||
27995778|NCT00856973|54654592|FG000|Overall Study|Protocol Violation|1|||
27995779|NCT00856973|54654593|FG001|Overall Study|Protocol Violation|2|||
27995780|NCT00856973|54654594|FG002|Overall Study|Protocol Violation|1|||
27995781|NCT00856973|54654592|FG000|Overall Study|Withdrawal by Subject|13|||
27995782|NCT00856973|54654593|FG001|Overall Study|Withdrawal by Subject|16|||
28098619|NCT03586544|54754244|FG001|Second Intervention|Withdrawal by Subject|1|||
28098620|NCT03585296|54754250|FG000|Overall Study|Adverse Event|1|||
27910849|NCT01147471|54568759|FG000|6 Month Follow Up|Lost to Follow-up|4|||
27995783|NCT00856973|54654594|FG002|Overall Study|Withdrawal by Subject|15|||
27910850|NCT01147471|54568760|FG001|6 Month Follow Up|Lost to Follow-up|2|||
27995784|NCT00856973|54654592|FG000|Overall Study|Other|11|||
27995785|NCT00856973|54654593|FG001|Overall Study|Other|12|||
27995786|NCT00856973|54654594|FG002|Overall Study|Other|13|||
27995787|NCT00844532|54654606|FG000|Overall Study|Death|16|||
27995788|NCT00844532|54654606|FG000|Overall Study|Withdrawal by Subject|16|||
27995789|NCT00844532|54654606|FG000|Overall Study|Lost to Follow-up|7|||
27995790|NCT00805194|54654612|FG000|Overall Study|Progressive disease (modified RECIST)|404|||
27995791|NCT00805194|54654613|FG001|Overall Study|Progressive disease (modified RECIST)|435|||
27995792|NCT00805194|54654612|FG000|Overall Study|Worsening or AE of underlying disease|64|||
28098621|NCT03585296|54754250|FG000|Overall Study|Lost to Follow-up|2|||
28098622|NCT03585296|54754250|FG000|Overall Study|Withdrawal by Subject|2|||
28098623|NCT03589768|54754258|FG000|Overall Study|Death|1|||
27995793|NCT00805194|54654613|FG001|Overall Study|Worsening or AE of underlying disease|70|||
28098624|NCT03589768|54754259|FG001|Overall Study|Death|0|||
27995794|NCT00805194|54654612|FG000|Overall Study|Other AE|84|||
27995795|NCT00805194|54654613|FG001|Overall Study|Other AE|73|||
27995796|NCT00805194|54654612|FG000|Overall Study|Protocol Violation|9|||
27995797|NCT00805194|54654613|FG001|Overall Study|Protocol Violation|9|||
27995798|NCT00805194|54654612|FG000|Overall Study|Lost to Follow-up|5|||
27995799|NCT00805194|54654613|FG001|Overall Study|Lost to Follow-up|5|||
27995800|NCT00805194|54654612|FG000|Overall Study|Withdrawal by Subject|60|||
27995801|NCT00805194|54654613|FG001|Overall Study|Withdrawal by Subject|42|||
27995802|NCT00805194|54654612|FG000|Overall Study|Not treated|3|||
27995803|NCT00805194|54654613|FG001|Overall Study|Not treated|4|||
27995804|NCT00805194|54654612|FG000|Overall Study|Reasons other than stated above|20|||
27995805|NCT00805194|54654613|FG001|Overall Study|Reasons other than stated above|16|||
27995806|NCT00836186|54654624|FG000|Overall Study|Blood could not be drawn|1|||
27995807|NCT00657046|54654632|FG000|Overall Study|Adverse Event|1|||
27995808|NCT00657046|54654633|FG001|Overall Study|Adverse Event|1|||
27995809|NCT00657046|54654634|FG002|Overall Study|Adverse Event|0|||
27995810|NCT00657046|54654632|FG000|Overall Study|Protocol Violation|2|||
27995811|NCT00657046|54654633|FG001|Overall Study|Protocol Violation|2|||
27995812|NCT00657046|54654634|FG002|Overall Study|Protocol Violation|0|||
28098625|NCT03589768|54754260|FG002|Overall Study|Death|8|||
28098626|NCT03589768|54754261|FG003|Overall Study|Death|3|||
28098627|NCT03589768|54754258|FG000|Overall Study|Withdrawal by Subject|2|||
28098628|NCT03589768|54754259|FG001|Overall Study|Withdrawal by Subject|0|||
28098629|NCT03589768|54754260|FG002|Overall Study|Withdrawal by Subject|0|||
28098630|NCT03589768|54754261|FG003|Overall Study|Withdrawal by Subject|0|||
27995813|NCT00657046|54654632|FG000|Overall Study|Withdrawal by Subject|1|||
27995814|NCT00657046|54654633|FG001|Overall Study|Withdrawal by Subject|0|||
27995815|NCT00657046|54654634|FG002|Overall Study|Withdrawal by Subject|0|||
27995816|NCT00657046|54654632|FG000|Overall Study|Death|0|||
27995817|NCT00657046|54654633|FG001|Overall Study|Death|0|||
27995818|NCT00657046|54654634|FG002|Overall Study|Death|1|||
27995819|NCT00657046|54654632|FG000|Overall Study|Surgery|0|||
27995820|NCT00657046|54654633|FG001|Overall Study|Surgery|0|||
27995821|NCT00657046|54654634|FG002|Overall Study|Surgery|1|||
27995822|NCT00856661|54654644|FG000|Overall Study|Death|15|||
27995823|NCT00856661|54654645|FG001|Overall Study|Death|18|||
27995824|NCT00856661|54654644|FG000|Overall Study|Protocol Violation|2|||
27995825|NCT00856661|54654645|FG001|Overall Study|Protocol Violation|1|||
27995826|NCT00856661|54654644|FG000|Overall Study|Withdrawal by Subject|1|||
27995827|NCT00856661|54654645|FG001|Overall Study|Withdrawal by Subject|2|||
27995828|NCT00856661|54654644|FG000|Overall Study|Lost to Follow-up|1|||
27995829|NCT00856661|54654645|FG001|Overall Study|Lost to Follow-up|3|||
27995830|NCT00856661|54654644|FG000|Overall Study|Physician Judgement|8|||
27995831|NCT00856661|54654645|FG001|Overall Study|Physician Judgement|5|||
27995832|NCT00844376|54654651|FG000|Period 1: First Intervention|Withdrawal by Subject|1|||
27995833|NCT00844376|54654652|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
27995834|NCT00658606|54654660|FG000|Overall Study|Adverse Event|2|||
27995835|NCT00658606|54654661|FG001|Overall Study|Adverse Event|1|||
27995836|NCT00658606|54654660|FG000|Overall Study|Lack of Efficacy|6|||
27995837|NCT00658606|54654661|FG001|Overall Study|Lack of Efficacy|3|||
27995838|NCT00658606|54654660|FG000|Overall Study|Lost to Follow-up|1|||
27995839|NCT00658606|54654661|FG001|Overall Study|Lost to Follow-up|0|||
28098631|NCT03589768|54754258|FG000|Overall Study|Protocol Violation|1|||
28098632|NCT03589768|54754259|FG001|Overall Study|Protocol Violation|0|||
28098633|NCT03589768|54754260|FG002|Overall Study|Protocol Violation|0|||
28098634|NCT03589768|54754261|FG003|Overall Study|Protocol Violation|0|||
28098635|NCT02892422|54754271|FG000|Overall Study|Enrolled not treated|4|||
28098636|NCT02892422|54754271|FG000|Overall Study|Adverse Event|38|||
28098637|NCT02892422|54754271|FG000|Overall Study|Lack of Efficacy|32|||
28098638|NCT02892422|54754271|FG000|Overall Study|Non-compliance with study drug|11|||
28098639|NCT02892422|54754271|FG000|Overall Study|Protocol Violation|4|||
28098640|NCT02892422|54754271|FG000|Overall Study|Withdrawal by Subject|56|||
28098641|NCT02892422|54754271|FG000|Overall Study|Lost to Follow-up|5|||
28098642|NCT02892422|54754271|FG000|Overall Study|sponsor information 16159A results|21|||
28098643|NCT02892422|54754271|FG000|Overall Study|withdrawal of consent|13|||
28098644|NCT02892422|54754271|FG000|Overall Study|exclusion criteria met|3|||
28098645|NCT02892422|54754271|FG000|Overall Study|moving elsewhere|4|||
28098646|NCT02892422|54754271|FG000|Overall Study|non-compliance|10|||
27739725|NCT01378975|54189350|FG000|Overall Study|Lost to Follow-up|4|||
27995840|NCT00658606|54654660|FG000|Overall Study|Withdrawal by Subject|7|||
27995841|NCT00658606|54654661|FG001|Overall Study|Withdrawal by Subject|16|||
27995842|NCT00658606|54654660|FG000|Overall Study|Lack of Compliance|0|||
27995843|NCT00658606|54654661|FG001|Overall Study|Lack of Compliance|3|||
27995844|NCT00589290|54654667|FG000|Overall Study|Withdrawal by Subject|1|||
27995845|NCT00843518|54654675|FG000|Period 2 (Double-blind Treatment)|Adverse Event|5|||
27739726|NCT01378975|54189351|FG001|Overall Study|Lost to Follow-up|1|||
27995846|NCT00843518|54654676|FG001|Period 2 (Double-blind Treatment)|Adverse Event|3|||
28098647|NCT02892422|54754271|FG000|Overall Study|patient legally incapable|1|||
27995847|NCT00843518|54654675|FG000|Period 2 (Double-blind Treatment)|Death|0|||
27995848|NCT00843518|54654676|FG001|Period 2 (Double-blind Treatment)|Death|1|||
27995849|NCT00843518|54654675|FG000|Period 2 (Double-blind Treatment)|Lost to Follow-up|2|||
27995850|NCT00843518|54654676|FG001|Period 2 (Double-blind Treatment)|Lost to Follow-up|3|||
27995851|NCT00843518|54654675|FG000|Period 2 (Double-blind Treatment)|Physician Decision|2|||
27995852|NCT00843518|54654676|FG001|Period 2 (Double-blind Treatment)|Physician Decision|1|||
27995853|NCT00843518|54654675|FG000|Period 2 (Double-blind Treatment)|Protocol Violation|2|||
27995854|NCT00843518|54654676|FG001|Period 2 (Double-blind Treatment)|Protocol Violation|5|||
27995855|NCT00843518|54654675|FG000|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2|||
27995856|NCT00843518|54654676|FG001|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0|||
27995857|NCT00843518|54654675|FG000|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
27995858|NCT00843518|54654676|FG001|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
27995859|NCT00843284|54654686|FG000|Overall Study|Adverse Event|39|||
27995860|NCT00843284|54654686|FG000|Overall Study|Lack of Efficacy|5|||
27995861|NCT00843284|54654686|FG000|Overall Study|Lost to Follow-up|11|||
27995862|NCT00843284|54654686|FG000|Overall Study|Other|10|||
27995863|NCT00843284|54654686|FG000|Overall Study|Withdrawal by Subject|4|||
27995864|NCT00843284|54654686|FG000|Overall Study|Death|3|||
27995865|NCT00652834|54654703|FG000|Overall Study|Withdrawal by Subject|3|||
27995866|NCT00652834|54654703|FG000|Overall Study|Lost to Follow-up|2|||
27995867|NCT00825812|54654711|FG000|Overall Study|Never entered follow up|0|||
27995868|NCT00825812|54654712|FG001|Overall Study|Never entered follow up|0|||
27995869|NCT00825812|54654713|FG002|Overall Study|Never entered follow up|0|||
27995870|NCT00825812|54654714|FG003|Overall Study|Never entered follow up|1|||
27995871|NCT00825812|54654711|FG000|Overall Study|Adverse Event|0|||
27995872|NCT00825812|54654712|FG001|Overall Study|Adverse Event|0|||
27995873|NCT00825812|54654713|FG002|Overall Study|Adverse Event|0|||
27995874|NCT00825812|54654714|FG003|Overall Study|Adverse Event|1|||
27995875|NCT00825812|54654711|FG000|Overall Study|Subject withdrew consent|0|||
27995876|NCT00825812|54654712|FG001|Overall Study|Subject withdrew consent|0|||
27995877|NCT00825812|54654713|FG002|Overall Study|Subject withdrew consent|3|||
27995878|NCT00825812|54654714|FG003|Overall Study|Subject withdrew consent|2|||
27995879|NCT00825812|54654711|FG000|Overall Study|Non-compliance with protocol|0|||
27995880|NCT00825812|54654712|FG001|Overall Study|Non-compliance with protocol|0|||
27995881|NCT00825812|54654713|FG002|Overall Study|Non-compliance with protocol|0|||
27995882|NCT00825812|54654714|FG003|Overall Study|Non-compliance with protocol|1|||
27995883|NCT00825812|54654711|FG000|Overall Study|Administrative|0|||
27995884|NCT00825812|54654712|FG001|Overall Study|Administrative|1|||
27995885|NCT00825812|54654713|FG002|Overall Study|Administrative|3|||
27995886|NCT00825812|54654714|FG003|Overall Study|Administrative|5|||
27995887|NCT00824720|54654727|FG000|Overall Study|failed plug insertion|3|||
27910851|NCT01147393|54568766|FG000|Dose Level 1|Dose limiting Toxicity|2|||
27910852|NCT01147393|54568766|FG000|Dose Level -1|Dose Limited Toxicity|1|||
27910853|NCT01146652|54568773|FG000|Overall Study|Adverse Event|506|||
27910854|NCT01146652|54568774|FG001|Overall Study|Adverse Event|15|||
27910855|NCT01146652|54568773|FG000|Overall Study|Lack of Efficacy|91|||
27910856|NCT01146652|54568774|FG001|Overall Study|Lack of Efficacy|7|||
27910857|NCT01146652|54568773|FG000|Overall Study|Poor compliance to protocol|38|||
27910858|NCT01146652|54568774|FG001|Overall Study|Poor compliance to protocol|1|||
27910859|NCT01146652|54568773|FG000|Overall Study|Other unspecified reasons|314|||
27910860|NCT01146652|54568774|FG001|Overall Study|Other unspecified reasons|22|||
27910861|NCT01146652|54568773|FG000|Overall Study|Enrolled but not treated|2|||
27910862|NCT01146652|54568774|FG001|Overall Study|Enrolled but not treated|0|||
27910863|NCT01146613|54568789|FG000|Overall Study|Lost to Follow-up|3|||
27910864|NCT01146613|54568790|FG001|Overall Study|Lost to Follow-up|8|||
27910865|NCT01146613|54568789|FG000|Overall Study|Lack of Efficacy|0|||
27910866|NCT01146613|54568790|FG001|Overall Study|Lack of Efficacy|1|||
27910867|NCT01146613|54568789|FG000|Overall Study|Death|1|||
27910868|NCT01146613|54568790|FG001|Overall Study|Death|0|||
27910869|NCT01146613|54568789|FG000|Overall Study|Physician Decision|1|||
27910870|NCT01146613|54568790|FG001|Overall Study|Physician Decision|0|||
27910871|NCT01146613|54568789|FG000|Overall Study|Withdrawal by Subject|0|||
27995888|NCT00824720|54654728|FG001|Overall Study|failed plug insertion|1|||
27995889|NCT00824720|54654729|FG002|Overall Study|failed plug insertion|0|||
27995890|NCT00824720|54654727|FG000|Overall Study|Protocol Violation|0|||
27995891|NCT00824720|54654728|FG001|Overall Study|Protocol Violation|0|||
27995892|NCT00824720|54654729|FG002|Overall Study|Protocol Violation|1|||
27995893|NCT03704064|54654739|FG000|Overall Study|Lost to Follow-up|8|||
27910872|NCT01146613|54568790|FG001|Overall Study|Withdrawal by Subject|3|||
27910873|NCT01146613|54568789|FG000|Overall Study|schedule conflict|1|||
27995894|NCT03704064|54654740|FG001|Overall Study|Lost to Follow-up|4|||
28172621|NCT02456740|54844363|FG003|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
27995895|NCT03704064|54654739|FG000|Overall Study|Withdrawal by Subject|1|||
27995896|NCT03704064|54654740|FG001|Overall Study|Withdrawal by Subject|1|||
27995897|NCT03704064|54654739|FG000|Overall Study|No longer available for study visits|0|||
27910874|NCT01146613|54568790|FG001|Overall Study|schedule conflict|0|||
27910875|NCT01146613|54568789|FG000|Overall Study|Outpatient detox|1|||
27910876|NCT01146613|54568790|FG001|Overall Study|Outpatient detox|0|||
27995898|NCT03704064|54654740|FG001|Overall Study|No longer available for study visits|1|||
27995899|NCT03704064|54654739|FG000|Overall Study|Censoring event|1|||
27995900|NCT03704064|54654740|FG001|Overall Study|Censoring event|0|||
27995901|NCT00824564|54654748|FG000|Overall Study|Lost to Follow-up|5|||
27995902|NCT00824564|54654749|FG001|Overall Study|Lost to Follow-up|7|||
27995903|NCT00824564|54654748|FG000|Overall Study|Withdrawal by Subject|1|||
27995904|NCT00824564|54654749|FG001|Overall Study|Withdrawal by Subject|1|||
27995905|NCT00824564|54654748|FG000|Overall Study|Other|1|||
27995906|NCT00824564|54654749|FG001|Overall Study|Other|2|||
27995907|NCT00824564|54654748|FG000|Overall Study|Randomized, but not treated|1|||
27995908|NCT00824564|54654749|FG001|Overall Study|Randomized, but not treated|0|||
27995909|NCT00658528|54654757|FG000|Overall Study|Adverse Event|5|||
27995910|NCT00658528|54654758|FG001|Overall Study|Adverse Event|7|||
27995911|NCT00658528|54654757|FG000|Overall Study|Lost to Follow-up|14|||
27995912|NCT00658528|54654758|FG001|Overall Study|Lost to Follow-up|22|||
27910877|NCT01145755|54568799|FG000|Overall Study|Adverse Event|2|||
27910878|NCT01145755|54568800|FG001|Overall Study|Adverse Event|4|||
27910879|NCT01145755|54568801|FG002|Overall Study|Adverse Event|2|||
27910880|NCT01145755|54568799|FG000|Overall Study|Withdrawal by Subject|2|||
27910881|NCT01145755|54568800|FG001|Overall Study|Withdrawal by Subject|2|||
27910882|NCT01145755|54568801|FG002|Overall Study|Withdrawal by Subject|2|||
27910883|NCT01145755|54568799|FG000|Overall Study|Lost to Follow-up|2|||
27910884|NCT01145755|54568800|FG001|Overall Study|Lost to Follow-up|3|||
27995913|NCT00658528|54654757|FG000|Overall Study|Withdrawal by Subject|8|||
27995914|NCT00658528|54654758|FG001|Overall Study|Withdrawal by Subject|6|||
27995915|NCT00658528|54654757|FG000|Overall Study|Withdrawal of consent|5|||
27995916|NCT00658528|54654758|FG001|Overall Study|Withdrawal of consent|6|||
27995917|NCT00658528|54654757|FG000|Overall Study|Other|8|||
27995918|NCT00658528|54654758|FG001|Overall Study|Other|4|||
27995919|NCT02864394|54654766|FG000|Overall Study|Death|135|||
27995920|NCT02864394|54654767|FG001|Overall Study|Death|150|||
27995921|NCT02864394|54654766|FG000|Overall Study|Withdrawal by Subject|1|||
27995922|NCT02864394|54654767|FG001|Overall Study|Withdrawal by Subject|9|||
27995923|NCT02864394|54654766|FG000|Overall Study|Ongoing In Study|77|||
27995924|NCT02864394|54654767|FG001|Overall Study|Ongoing In Study|53|||
27995925|NCT00856583|54654775|FG000|Overall Study|Lack of Efficacy|389|||
27995926|NCT00856583|54654776|FG001|Overall Study|Lack of Efficacy|377|||
27995927|NCT00856583|54654775|FG000|Overall Study|Serious Adverse Event (SAE)|99|||
27995928|NCT00856583|54654776|FG001|Overall Study|Serious Adverse Event (SAE)|65|||
27995929|NCT00856583|54654775|FG000|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393|||
27995930|NCT00856583|54654776|FG001|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179|||
27995931|NCT00856583|54654775|FG000|Overall Study|Non-compliance|305|||
27995932|NCT00856583|54654776|FG001|Overall Study|Non-compliance|262|||
27995933|NCT00856583|54654775|FG000|Overall Study|Withdrawal by Subject|1092|||
27995934|NCT00856583|54654776|FG001|Overall Study|Withdrawal by Subject|919|||
27995935|NCT00856583|54654775|FG000|Overall Study|Physician Decision|59|||
27995936|NCT00856583|54654776|FG001|Overall Study|Physician Decision|82|||
27995937|NCT00856583|54654775|FG000|Overall Study|Pregnancy|14|||
27995938|NCT00856583|54654776|FG001|Overall Study|Pregnancy|5|||
27995939|NCT00856583|54654775|FG000|Overall Study|Other|92|||
27995940|NCT00856583|54654776|FG001|Overall Study|Other|104|||
27995941|NCT00856583|54654775|FG000|Overall Study|Non-evaluable: Patient on Polytherapy|694|||
27995942|NCT00856583|54654776|FG001|Overall Study|Non-evaluable: Patient on Polytherapy|604|||
27995943|NCT00856349|54654782|FG000|Overall Study|Death|418|||
27995944|NCT00856349|54654782|FG000|Overall Study|Withdrawal by Subject|116|||
27995945|NCT00856349|54654782|FG000|Overall Study|Lost to Follow-up|91|||
27995946|NCT00856349|54654782|FG000|Overall Study|Protocol Violation|38|||
27995947|NCT00856349|54654782|FG000|Overall Study|Physician Decision|13|||
27995948|NCT00856349|54654782|FG000|Overall Study|Subject relocation|104|||
27995949|NCT00856349|54654782|FG000|Overall Study|Device explant|33|||
27995950|NCT00856349|54654782|FG000|Overall Study|Site closure|78|||
27995951|NCT00856349|54654782|FG000|Overall Study|Subject changed Dr, insurance issue, etc|130|||
27995952|NCT00803244|54654790|FG000|Overall Study|Adverse Event|1|||
27995953|NCT00803244|54654791|FG001|Overall Study|Adverse Event|2|||
27995954|NCT00803244|54654790|FG000|Overall Study|Withdrawal by Subject|2|||
27995955|NCT00803244|54654791|FG001|Overall Study|Withdrawal by Subject|3|||
27995956|NCT00803244|54654790|FG000|Overall Study|Any other reason not above-mentioned|4|||
27910885|NCT01145755|54568801|FG002|Overall Study|Lost to Follow-up|1|||
27910886|NCT01145755|54568799|FG000|Overall Study|Protocol Violation|0|||
27995957|NCT00803244|54654791|FG001|Overall Study|Any other reason not above-mentioned|10|||
27995958|NCT04060212|54654797|FG000|Overall Study|Withdrawal by Subject|7|||
27995959|NCT00804570|54654803|FG000|Overall Study|Adverse Event|14|||
27995960|NCT00804570|54654804|FG001|Overall Study|Adverse Event|7|||
27995961|NCT00804570|54654803|FG000|Overall Study|Lack of Efficacy|0|||
27995962|NCT00804570|54654804|FG001|Overall Study|Lack of Efficacy|1|||
27995963|NCT00804570|54654803|FG000|Overall Study|Lost to Follow-up|18|||
27995964|NCT00804570|54654804|FG001|Overall Study|Lost to Follow-up|21|||
27995965|NCT00804570|54654803|FG000|Overall Study|Entry criteria not met|5|||
28098648|NCT02892422|54754271|FG000|Overall Study|patient decision|7|||
27910887|NCT01145755|54568800|FG001|Overall Study|Protocol Violation|3|||
27910888|NCT01145755|54568801|FG002|Overall Study|Protocol Violation|1|||
27910889|NCT01145755|54568799|FG000|Overall Study|Study Closure|14|||
27910890|NCT01145755|54568800|FG001|Overall Study|Study Closure|14|||
27910891|NCT01145755|54568801|FG002|Overall Study|Study Closure|17|||
27910892|NCT01145755|54568799|FG000|Overall Study|Lack of Efficacy|0|||
27910893|NCT01145755|54568800|FG001|Overall Study|Lack of Efficacy|1|||
27910894|NCT01145755|54568801|FG002|Overall Study|Lack of Efficacy|0|||
27910895|NCT01145755|54568799|FG000|Overall Study|Patient could not swollow medication|0|||
27910896|NCT01145755|54568800|FG001|Overall Study|Patient could not swollow medication|0|||
27910897|NCT01145755|54568801|FG002|Overall Study|Patient could not swollow medication|1|||
27910898|NCT01145755|54568799|FG000|Overall Study|Withdrawal by Subject|0|||
27910899|NCT01145755|54568800|FG001|Overall Study|Withdrawal by Subject|0|||
27910900|NCT01145755|54568801|FG002|Overall Study|Withdrawal by Subject|1|||
27910901|NCT01145755|54568799|FG000|Overall Study|Positive urine ethanol|0|||
27910902|NCT01145755|54568800|FG001|Overall Study|Positive urine ethanol|1|||
27910903|NCT01145755|54568801|FG002|Overall Study|Positive urine ethanol|0|||
27910904|NCT01145560|54568812|FG000|Overall Study|Withdrawal by Subject|2|||
27910905|NCT01145560|54568813|FG001|Overall Study|Withdrawal by Subject|1|||
27910906|NCT01145560|54568814|FG002|Overall Study|Withdrawal by Subject|0|||
27910907|NCT01145560|54568812|FG000|Overall Study|Lost to Follow-up|1|||
27910908|NCT01145560|54568813|FG001|Overall Study|Lost to Follow-up|1|||
27910909|NCT01145560|54568814|FG002|Overall Study|Lost to Follow-up|1|||
27910910|NCT01145560|54568812|FG000|Overall Study|No study drug by 24h after organ failure|1|||
27910911|NCT01145560|54568813|FG001|Overall Study|No study drug by 24h after organ failure|0|||
27910912|NCT01145560|54568814|FG002|Overall Study|No study drug by 24h after organ failure|0|||
27910913|NCT01145560|54568812|FG000|Overall Study|Accidental unblinding of study treatment|0|||
27910914|NCT01145560|54568813|FG001|Overall Study|Accidental unblinding of study treatment|1|||
27910915|NCT01145560|54568814|FG002|Overall Study|Accidental unblinding of study treatment|0|||
27910916|NCT01145560|54568812|FG000|Overall Study|False insurance information|0|||
27910917|NCT01145560|54568813|FG001|Overall Study|False insurance information|1|||
27910918|NCT01145560|54568814|FG002|Overall Study|False insurance information|0|||
27910919|NCT01145560|54568812|FG000|Overall Study|Withdrawal of therapy|0|||
27910920|NCT01145560|54568813|FG001|Overall Study|Withdrawal of therapy|0|||
27910921|NCT01145560|54568814|FG002|Overall Study|Withdrawal of therapy|1|||
27910922|NCT01145482|54568824|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
27910923|NCT01145482|54568825|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
27910924|NCT01145053|54568831|FG000|Overall Study|Adverse Event|22|||
27910925|NCT01145053|54568831|FG000|Overall Study|Lost to Follow-up|28|||
27910926|NCT01145053|54568831|FG000|Overall Study|Withdrawal by Subject|25|||
27910927|NCT01145053|54568831|FG000|Overall Study|Other|18|||
27910928|NCT01144663|54568839|FG000|Primary Vaccination Phase|Serious adverse event, fatal|2|||
27910929|NCT01144663|54568840|FG001|Primary Vaccination Phase|Serious adverse event, fatal|0|||
27910930|NCT01144663|54568841|FG002|Primary Vaccination Phase|Serious adverse event, fatal|1|||
27910931|NCT01144663|54568842|FG003|Primary Vaccination Phase|Serious adverse event, fatal|0|||
27910932|NCT01144663|54568839|FG000|Primary Vaccination Phase|Adverse Event|1|||
27910933|NCT01144663|54568840|FG001|Primary Vaccination Phase|Adverse Event|0|||
27910934|NCT01144663|54568841|FG002|Primary Vaccination Phase|Adverse Event|0|||
27910935|NCT01144663|54568842|FG003|Primary Vaccination Phase|Adverse Event|1|||
27910936|NCT01144663|54568839|FG000|Primary Vaccination Phase|Protocol Violation|2|||
27910937|NCT01144663|54568840|FG001|Primary Vaccination Phase|Protocol Violation|0|||
27910938|NCT01144663|54568841|FG002|Primary Vaccination Phase|Protocol Violation|1|||
27910939|NCT01144663|54568842|FG003|Primary Vaccination Phase|Protocol Violation|0|||
27910940|NCT01144663|54568839|FG000|Primary Vaccination Phase|Withdrawal by Subject|9|||
27910941|NCT01144663|54568840|FG001|Primary Vaccination Phase|Withdrawal by Subject|5|||
27910942|NCT01144663|54568841|FG002|Primary Vaccination Phase|Withdrawal by Subject|3|||
27910943|NCT01144663|54568842|FG003|Primary Vaccination Phase|Withdrawal by Subject|10|||
27910944|NCT01144663|54568839|FG000|Primary Vaccination Phase|Migrated/moved from study area|4|||
27910945|NCT01144663|54568840|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
27910946|NCT01144663|54568841|FG002|Primary Vaccination Phase|Migrated/moved from study area|2|||
27910947|NCT01144663|54568842|FG003|Primary Vaccination Phase|Migrated/moved from study area|3|||
27910948|NCT01144663|54568839|FG000|Primary Vaccination Phase|Lost to Follow-up|2|||
27910949|NCT01144663|54568840|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
27910950|NCT01144663|54568841|FG002|Primary Vaccination Phase|Lost to Follow-up|1|||
27910951|NCT01144663|54568842|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
27910952|NCT01144663|54568839|FG000|Primary Vaccination Phase|Other|0|||
27910953|NCT01144663|54568840|FG001|Primary Vaccination Phase|Other|1|||
27910954|NCT01144663|54568841|FG002|Primary Vaccination Phase|Other|0|||
27910955|NCT01144663|54568842|FG003|Primary Vaccination Phase|Other|2|||
27910956|NCT01144663|54568839|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
27910957|NCT01144663|54568840|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
27910958|NCT01144663|54568841|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
27995966|NCT00804570|54654804|FG001|Overall Study|Entry criteria not met|5|||
27910959|NCT01144663|54568842|FG003|Booster Vaccination Phase|Withdrawal by Subject|1|||
27910960|NCT01144663|54568839|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
27910961|NCT01144663|54568840|FG001|Booster Vaccination Phase|Migrated/moved from study area|1|||
27910962|NCT01144663|54568841|FG002|Booster Vaccination Phase|Migrated/moved from study area|1|||
27910963|NCT01144663|54568842|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
27910964|NCT01144663|54568839|FG000|Booster Vaccination Phase|Lost to Follow-up|2|||
27910965|NCT01144663|54568840|FG001|Booster Vaccination Phase|Lost to Follow-up|1|||
27910966|NCT01144663|54568841|FG002|Booster Vaccination Phase|Lost to Follow-up|3|||
27910967|NCT01144663|54568842|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
27910968|NCT01144663|54568839|FG000|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
27910969|NCT01144663|54568840|FG001|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
27910970|NCT01144663|54568841|FG002|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
27910971|NCT01144663|54568842|FG003|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
27910972|NCT01144663|54568839|FG000|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
27910973|NCT01144663|54568840|FG001|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3|||
27910974|NCT01144663|54568841|FG002|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
27910975|NCT01144663|54568842|FG003|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0|||
27910976|NCT01144663|54568839|FG000|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4|||
27910977|NCT01144663|54568840|FG001|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6|||
27910978|NCT01144663|54568841|FG002|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5|||
27910979|NCT01144663|54568842|FG003|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0|||
27910980|NCT01143337|54568854|FG000|Overall Study|Adverse Event|3|||
27910981|NCT01143337|54568855|FG001|Overall Study|Adverse Event|9|||
27910982|NCT01143337|54568856|FG002|Overall Study|Adverse Event|5|||
27910983|NCT01143337|54568854|FG000|Overall Study|Lack of Efficacy|6|||
27910984|NCT01143337|54568855|FG001|Overall Study|Lack of Efficacy|2|||
27910985|NCT01143337|54568856|FG002|Overall Study|Lack of Efficacy|1|||
27910986|NCT01143337|54568854|FG000|Overall Study|Protocol Violation|1|||
27910987|NCT01143337|54568855|FG001|Overall Study|Protocol Violation|0|||
27910988|NCT01143337|54568856|FG002|Overall Study|Protocol Violation|0|||
27910989|NCT01143337|54568854|FG000|Overall Study|Withdrawal by Subject|0|||
27910990|NCT01143337|54568855|FG001|Overall Study|Withdrawal by Subject|0|||
27910991|NCT01143337|54568856|FG002|Overall Study|Withdrawal by Subject|1|||
27910992|NCT01143337|54568854|FG000|Overall Study|Other reason|0|||
27995967|NCT00804570|54654803|FG000|Overall Study|Protocol Violation|12|||
27995968|NCT00804570|54654804|FG001|Overall Study|Protocol Violation|16|||
27995969|NCT00804570|54654803|FG000|Overall Study|Physician Decision|1|||
27995970|NCT00804570|54654804|FG001|Overall Study|Physician Decision|2|||
27995971|NCT00804570|54654803|FG000|Overall Study|Sponsor decision|1|||
27995972|NCT00804570|54654804|FG001|Overall Study|Sponsor decision|4|||
27995973|NCT00804570|54654803|FG000|Overall Study|Withdrawal by Subject|21|||
27995974|NCT00804570|54654804|FG001|Overall Study|Withdrawal by Subject|38|||
27995975|NCT00824408|54654816|FG000|Run-in Phase|Progressive disease|4|||
27995976|NCT00824408|54654817|FG001|Run-in Phase|Progressive disease|4|||
27995977|NCT00824408|54654818|FG002|Run-in Phase|Progressive disease|0|||
27995978|NCT00824408|54654819|FG003|Run-in Phase|Progressive disease|0|||
27995979|NCT00824408|54654820|FG004|Run-in Phase|Progressive disease|0|||
27995980|NCT00824408|54654816|FG000|Run-in Phase|Adverse Event|1|||
27995981|NCT00824408|54654817|FG001|Run-in Phase|Adverse Event|1|||
27995982|NCT00824408|54654818|FG002|Run-in Phase|Adverse Event|0|||
27910993|NCT01143337|54568855|FG001|Overall Study|Other reason|0|||
27910994|NCT01143337|54568856|FG002|Overall Study|Other reason|5|||
27910995|NCT01143259|54568873|FG000|Overall Study|Withdrawal by Subject|3|||
27910996|NCT01143259|54568874|FG001|Overall Study|Withdrawal by Subject|2|||
27995983|NCT00824408|54654819|FG003|Run-in Phase|Adverse Event|0|||
27995984|NCT00824408|54654820|FG004|Run-in Phase|Adverse Event|0|||
27995985|NCT00824408|54654816|FG000|Run-in Phase|Refused to continue medication|1|||
27995986|NCT00824408|54654817|FG001|Run-in Phase|Refused to continue medication|0|||
27995987|NCT00824408|54654818|FG002|Run-in Phase|Refused to continue medication|0|||
27995988|NCT00824408|54654819|FG003|Run-in Phase|Refused to continue medication|0|||
27995989|NCT00824408|54654820|FG004|Run-in Phase|Refused to continue medication|0|||
27995990|NCT00824408|54654816|FG000|Run-in Phase|Other reason not defined above|0|||
27995991|NCT00824408|54654817|FG001|Run-in Phase|Other reason not defined above|1|||
27995992|NCT00824408|54654818|FG002|Run-in Phase|Other reason not defined above|0|||
27995993|NCT00824408|54654819|FG003|Run-in Phase|Other reason not defined above|0|||
27995994|NCT00824408|54654820|FG004|Run-in Phase|Other reason not defined above|0|||
27995995|NCT00824408|54654816|FG000|Randomized Phase|Not treated|0|||
27995996|NCT00824408|54654817|FG001|Randomized Phase|Not treated|0|||
28172622|NCT02456740|54844364|FG004|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
27910997|NCT01143259|54568873|FG000|Overall Study|Protocol Violation|13|||
27910998|NCT01143259|54568874|FG001|Overall Study|Protocol Violation|9|||
27910999|NCT01143259|54568873|FG000|Overall Study|Screen Failure|7|||
27995997|NCT00824408|54654818|FG002|Randomized Phase|Not treated|1|||
27911000|NCT01143259|54568874|FG001|Overall Study|Screen Failure|9|||
27911001|NCT01142791|54568880|FG000|Overall Study|Alternative Treatment|1|||
27911002|NCT01142791|54568881|FG001|Overall Study|Alternative Treatment|0|||
27911003|NCT01142791|54568880|FG000|Overall Study|Lost to Follow-up|1|||
27911004|NCT01142791|54568881|FG001|Overall Study|Lost to Follow-up|0|||
27911005|NCT01142791|54568880|FG000|Overall Study|Withdrawal by Subject|5|||
27911006|NCT01142791|54568881|FG001|Overall Study|Withdrawal by Subject|0|||
27911007|NCT01142791|54568880|FG000|Overall Study|Received only 1 sonication|0|||
27911008|NCT01142791|54568881|FG001|Overall Study|Received only 1 sonication|6|||
27911009|NCT01142596|54568887|FG000|Overall Study|Withdrawal by Subject|9|||
27911010|NCT01142596|54568888|FG001|Overall Study|Withdrawal by Subject|35|||
27911011|NCT01142596|54568887|FG000|Overall Study|Adverse Event|8|||
27911012|NCT01142596|54568888|FG001|Overall Study|Adverse Event|35|||
27911013|NCT01142596|54568887|FG000|Overall Study|Lack of Efficacy|5|||
27911014|NCT01142596|54568888|FG001|Overall Study|Lack of Efficacy|9|||
27911015|NCT01142596|54568887|FG000|Overall Study|Lost to Follow-up|2|||
27911016|NCT01142596|54568888|FG001|Overall Study|Lost to Follow-up|3|||
27911017|NCT01142596|54568887|FG000|Overall Study|Other reason (not specified)|5|||
27911018|NCT01142596|54568888|FG001|Overall Study|Other reason (not specified)|4|||
27911019|NCT01142128|54568898|FG000|Overall Study|Physician Decision|1|||
27911020|NCT01142128|54568898|FG000|Overall Study|Lost to Follow-up|1|||
27911021|NCT01142128|54568898|FG000|Overall Study|Withdrawal by Subject|2|||
27911022|NCT01142089|54568910|FG000|Overall Study|Physician Decision|1|||
27911023|NCT01142089|54568911|FG001|Overall Study|Physician Decision|0|||
27911024|NCT01142089|54568910|FG000|Overall Study|Withdrawal by Subject|1|||
27995998|NCT00824408|54654819|FG003|Randomized Phase|Not treated|1|||
27995999|NCT00824408|54654820|FG004|Randomized Phase|Not treated|1|||
27996000|NCT00824408|54654816|FG000|Randomized Phase|Progressive disease|0|||
27996001|NCT00824408|54654817|FG001|Randomized Phase|Progressive disease|0|||
27996002|NCT00824408|54654818|FG002|Randomized Phase|Progressive disease|25|||
27996003|NCT00824408|54654819|FG003|Randomized Phase|Progressive disease|36|||
27996004|NCT00824408|54654820|FG004|Randomized Phase|Progressive disease|34|||
27996005|NCT00824408|54654816|FG000|Randomized Phase|Adverse Event|0|||
27996006|NCT00824408|54654817|FG001|Randomized Phase|Adverse Event|0|||
27996007|NCT00824408|54654818|FG002|Randomized Phase|Adverse Event|4|||
27996008|NCT00824408|54654819|FG003|Randomized Phase|Adverse Event|5|||
27996009|NCT00824408|54654820|FG004|Randomized Phase|Adverse Event|5|||
27996010|NCT00824408|54654816|FG000|Randomized Phase|Refused to continue medication|0|||
27996011|NCT00824408|54654817|FG001|Randomized Phase|Refused to continue medication|0|||
27996012|NCT00824408|54654818|FG002|Randomized Phase|Refused to continue medication|2|||
27996013|NCT00824408|54654819|FG003|Randomized Phase|Refused to continue medication|2|||
27996014|NCT00824408|54654820|FG004|Randomized Phase|Refused to continue medication|2|||
27996015|NCT00824408|54654816|FG000|Randomized Phase|Other reason not defined above|0|||
27996016|NCT00824408|54654817|FG001|Randomized Phase|Other reason not defined above|0|||
27996017|NCT00824408|54654818|FG002|Randomized Phase|Other reason not defined above|4|||
27996018|NCT00824408|54654819|FG003|Randomized Phase|Other reason not defined above|2|||
28172623|NCT02456740|54844365|FG005|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
28172624|NCT02456740|54844366|FG006|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
27911025|NCT01142089|54568911|FG001|Overall Study|Withdrawal by Subject|2|||
27996019|NCT00824408|54654820|FG004|Randomized Phase|Other reason not defined above|4|||
27996020|NCT00866333|54654841|FG000|Overall Study|Withdrawal of consent|0|||
27996021|NCT00866333|54654842|FG001|Overall Study|Withdrawal of consent|1|||
28098649|NCT02892422|54754271|FG000|Overall Study|Investigator decision|1|||
28098650|NCT03571646|54754277|FG000|Overall Study|Adverse Event|1|||
28098651|NCT03571646|54754278|FG001|Overall Study|Adverse Event|0|||
28098652|NCT03571646|54754277|FG000|Overall Study|Withdrawal by Subject|1|||
28098653|NCT03571646|54754278|FG001|Overall Study|Withdrawal by Subject|1|||
28098654|NCT03645434|54754284|FG000|Period 1|Adverse Event|0|||
28098655|NCT03645434|54754285|FG001|Period 1|Adverse Event|0|||
28098656|NCT03645434|54754286|FG002|Period 1|Adverse Event|0|||
28098657|NCT03645434|54754287|FG003|Period 1|Adverse Event|1|||
28098658|NCT03645434|54754288|FG004|Period 1|Adverse Event|0|||
28098659|NCT03645434|54754289|FG005|Period 1|Adverse Event|0|||
28098660|NCT03645434|54754284|FG000|Period 1|COPD exacerbation|0|||
28098661|NCT03645434|54754285|FG001|Period 1|COPD exacerbation|0|||
28098662|NCT03645434|54754286|FG002|Period 1|COPD exacerbation|0|||
28098663|NCT03645434|54754287|FG003|Period 1|COPD exacerbation|0|||
28098664|NCT03645434|54754288|FG004|Period 1|COPD exacerbation|1|||
28172625|NCT02456740|54844367|FG007|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
27911026|NCT01142089|54568910|FG000|Overall Study|Use of prohibited medications|0|||
27911027|NCT01142089|54568911|FG001|Overall Study|Use of prohibited medications|1|||
27911028|NCT01142089|54568910|FG000|Overall Study|Noncompliance with study procedures|2|||
27996022|NCT00866333|54654843|FG002|Overall Study|Withdrawal of consent|2|||
27996023|NCT00866333|54654841|FG000|Overall Study|Reason not Specified|3|||
27996024|NCT00866333|54654842|FG001|Overall Study|Reason not Specified|1|||
27996025|NCT00866333|54654843|FG002|Overall Study|Reason not Specified|1|||
27996026|NCT00866333|54654841|FG000|Overall Study|Study Terminated by Sponsor|2|||
27996027|NCT00866333|54654842|FG001|Overall Study|Study Terminated by Sponsor|5|||
27996028|NCT00866333|54654843|FG002|Overall Study|Study Terminated by Sponsor|9|||
27996029|NCT00834080|54654851|FG000|Overall Study|Adverse Event|7|||
27996030|NCT00834080|54654851|FG000|Overall Study|Lost to Follow-up|7|||
27996031|NCT00834080|54654851|FG000|Overall Study|Withdrawal by Subject|5|||
27996032|NCT00834080|54654851|FG000|Overall Study|Other - Pregnancy|1|||
27996033|NCT00834080|54654851|FG000|Overall Study|Other - False positive tests of the UDS|1|||
27996034|NCT00834080|54654851|FG000|Overall Study|Physician Decision|1|||
27996035|NCT00834080|54654851|FG000|Overall Study|Subject Relocated|1|||
27996036|NCT00823472|54654857|FG000|Overall Study|Physician Decision|24|||
27996037|NCT00823472|54654858|FG001|Overall Study|Physician Decision|28|||
27996038|NCT00856193|54654864|FG000|Period 2|Abnormal test procedure results|0|||
27996039|NCT00856193|54654865|FG001|Period 2|Abnormal test procedure results|1|||
27996040|NCT00856193|54654864|FG000|Period 2|Lost to Follow-up|0|||
27996041|NCT00856193|54654865|FG001|Period 2|Lost to Follow-up|1|||
27996042|NCT00652366|54654876|FG000|Overall Study|Adverse Event|8|||
27996043|NCT00652366|54654877|FG001|Overall Study|Adverse Event|4|||
27996044|NCT00652366|54654878|FG002|Overall Study|Adverse Event|7|||
27996045|NCT00652366|54654879|FG003|Overall Study|Adverse Event|17|||
27996046|NCT00652366|54654880|FG004|Overall Study|Adverse Event|13|||
27996047|NCT00652366|54654876|FG000|Overall Study|Death|5|||
27996048|NCT00652366|54654877|FG001|Overall Study|Death|4|||
27996049|NCT00652366|54654878|FG002|Overall Study|Death|1|||
27996050|NCT00652366|54654879|FG003|Overall Study|Death|8|||
27996051|NCT00652366|54654880|FG004|Overall Study|Death|5|||
27996052|NCT00652366|54654876|FG000|Overall Study|Lack of Efficacy|84|||
27996053|NCT00652366|54654877|FG001|Overall Study|Lack of Efficacy|58|||
27996054|NCT00652366|54654878|FG002|Overall Study|Lack of Efficacy|53|||
27996055|NCT00652366|54654879|FG003|Overall Study|Lack of Efficacy|133|||
27996056|NCT00652366|54654880|FG004|Overall Study|Lack of Efficacy|13|||
27996057|NCT00652366|54654876|FG000|Overall Study|Violation of Selection Criteria|0|||
27996058|NCT00652366|54654877|FG001|Overall Study|Violation of Selection Criteria|0|||
27996059|NCT00652366|54654878|FG002|Overall Study|Violation of Selection Criteria|1|||
27996060|NCT00652366|54654879|FG003|Overall Study|Violation of Selection Criteria|0|||
27996061|NCT00652366|54654880|FG004|Overall Study|Violation of Selection Criteria|0|||
27996062|NCT00652366|54654876|FG000|Overall Study|Protocol Violation|1|||
27996063|NCT00652366|54654877|FG001|Overall Study|Protocol Violation|0|||
27996064|NCT00652366|54654878|FG002|Overall Study|Protocol Violation|0|||
27996065|NCT00652366|54654879|FG003|Overall Study|Protocol Violation|0|||
27996066|NCT00652366|54654880|FG004|Overall Study|Protocol Violation|0|||
27996067|NCT00652366|54654876|FG000|Overall Study|Refused treatment|3|||
27996068|NCT00652366|54654877|FG001|Overall Study|Refused treatment|7|||
27996069|NCT00652366|54654878|FG002|Overall Study|Refused treatment|6|||
27996070|NCT00652366|54654879|FG003|Overall Study|Refused treatment|17|||
27996071|NCT00652366|54654880|FG004|Overall Study|Refused treatment|5|||
27996072|NCT00652366|54654876|FG000|Overall Study|Other|5|||
27996073|NCT00652366|54654877|FG001|Overall Study|Other|2|||
27996074|NCT00652366|54654878|FG002|Overall Study|Other|3|||
27996075|NCT00652366|54654879|FG003|Overall Study|Other|4|||
27996076|NCT00652366|54654880|FG004|Overall Study|Other|0|||
27996077|NCT00841568|54654894|FG000|Overall Study|Adverse Event|1|||
27996078|NCT00841568|54654894|FG000|Overall Study|Death|1|||
27996079|NCT00841568|54654894|FG000|Overall Study|Withdrawal by Subject|2|||
27996080|NCT00841568|54654894|FG000|Overall Study|Creatinine over the withdrawal criteria|1|||
27996081|NCT00855959|54654902|FG000|Overall Study|Adverse Event|2|||
27996082|NCT00855959|54654902|FG000|Overall Study|Lost to Follow-up|2|||
27996083|NCT00855959|54654902|FG000|Overall Study|Withdrawal by Subject|3|||
27996084|NCT00855959|54654902|FG000|Overall Study|Pregnancy|1|||
27996085|NCT00855959|54654902|FG000|Overall Study|Incorrect enrolment|1|||
27996086|NCT00841100|54654906|FG000|Phase 1 (28 Days)|Adverse Event|1|||
27996087|NCT00841100|54654906|FG000|Phase 1 (28 Days)|Participant non-compliance|2|||
27996088|NCT00651820|54654910|FG000|Overall Study|Lost to Follow-up|2|||
27996089|NCT00866177|54654916|FG000|Overall Study|Withdrawal by Subject|1|||
27996090|NCT00866177|54654916|FG000|Overall Study|Not Treated|151|||
27996091|NCT00833924|54654920|FG000|Overall Study|Death|21|||
27996092|NCT00833924|54654920|FG000|Overall Study|Conversion|2|||
27996093|NCT00833924|54654920|FG000|Overall Study|Lost to Follow-up|2|||
27996094|NCT00833924|54654920|FG000|Overall Study|Withdrawal by Subject|13|||
27996095|NCT00833924|54654920|FG000|Overall Study|In study follow-up|71|||
27996096|NCT00840086|54654924|FG000|Overall Study|Adverse Event|1|||
27996097|NCT00840086|54654924|FG000|Overall Study|Protocol Violation|2|||
27996098|NCT00840086|54654924|FG000|Overall Study|Lost to Follow-up|1|||
27996099|NCT00822926|54654933|FG000|Second Injection Visit|Lost to Follow-up|1|||
27996100|NCT00822926|54654934|FG001|Second Injection Visit|Lost to Follow-up|0|||
27996101|NCT00822926|54654933|FG000|Second Injection Visit|Withdrawal by Subject|0|||
27996102|NCT00822926|54654934|FG001|Second Injection Visit|Withdrawal by Subject|1|||
27996103|NCT00822770|54654945|FG000|Overall Study|Not treated|1|||
27996104|NCT00822770|54654946|FG001|Overall Study|Not treated|0|||
27996105|NCT00822770|54654945|FG000|Overall Study|Complication/Incomplete treatment|1|||
27996106|NCT00822770|54654946|FG001|Overall Study|Complication/Incomplete treatment|0|||
27996107|NCT00822770|54654945|FG000|Overall Study|Death|1|||
27911029|NCT01142089|54568911|FG001|Overall Study|Noncompliance with study procedures|1|||
27911030|NCT01142089|54568910|FG000|Overall Study|Patient required rescue medication|8|||
27911031|NCT01142089|54568911|FG001|Overall Study|Patient required rescue medication|17|||
27911032|NCT01141660|54568919|FG000|Overall Study|Physician Decision|0|||
27911033|NCT01141660|54568920|FG001|Overall Study|Physician Decision|12|||
27911034|NCT01140880|54568928|FG000|Overall Study|Death|0|||
27911035|NCT01140880|54568929|FG001|Overall Study|Death|1|||
27911036|NCT01140880|54568928|FG000|Overall Study|Withdrawal by Subject|6|||
27911037|NCT01140880|54568929|FG001|Overall Study|Withdrawal by Subject|3|||
27911038|NCT01140880|54568928|FG000|Overall Study|Lost to Follow-up|8|||
27911039|NCT01140880|54568929|FG001|Overall Study|Lost to Follow-up|10|||
27911040|NCT01140880|54568928|FG000|Overall Study|Protocol Violation|0|||
27911041|NCT01140880|54568929|FG001|Overall Study|Protocol Violation|30|||
27911042|NCT01140646|54568935|FG000|Overall Study|Adverse Event|4|||
27996108|NCT00822770|54654946|FG001|Overall Study|Death|1|||
27996109|NCT02842086|54654954|FG000|Overall Study|Randomized but Never Treated|6|||
27996110|NCT02842086|54654955|FG001|Overall Study|Randomized but Never Treated|6|||
27996111|NCT02842086|54654954|FG000|Overall Study|Still in Double-Blind Phase|7|||
27996112|NCT02842086|54654955|FG001|Overall Study|Still in Double-Blind Phase|3|||
27996113|NCT02842086|54654954|FG000|Overall Study|Adverse Event|18|||
27996114|NCT02842086|54654955|FG001|Overall Study|Adverse Event|20|||
27996115|NCT02842086|54654954|FG000|Overall Study|Death|3|||
27996116|NCT02842086|54654955|FG001|Overall Study|Death|3|||
27996117|NCT02842086|54654954|FG000|Overall Study|Investigator's Discretion|9|||
27996118|NCT02842086|54654955|FG001|Overall Study|Investigator's Discretion|13|||
27996119|NCT02842086|54654954|FG000|Overall Study|Non-Compliance with Study Drug|9|||
27996120|NCT02842086|54654955|FG001|Overall Study|Non-Compliance with Study Drug|8|||
27996121|NCT02842086|54654954|FG000|Overall Study|Protocol Violation|8|||
27996122|NCT02842086|54654955|FG001|Overall Study|Protocol Violation|4|||
27996123|NCT02842086|54654954|FG000|Overall Study|Withdrew Consent|205|||
27996124|NCT02842086|54654955|FG001|Overall Study|Withdrew Consent|194|||
27996125|NCT02842086|54654954|FG000|Overall Study|Lost to Follow-up|274|||
27996126|NCT02842086|54654955|FG001|Overall Study|Lost to Follow-up|236|||
27996127|NCT02842086|54654954|FG000|Overall Study|HIV-1 Infection|5|||
27996128|NCT02842086|54654955|FG001|Overall Study|HIV-1 Infection|6|||
27996129|NCT00822692|54654963|FG000|Overall Study|Lost to Follow-up|17|||
27996130|NCT00822692|54654964|FG001|Overall Study|Lost to Follow-up|25|||
27996131|NCT00806442|54654970|FG000|Overall Study|Lost to Follow-up|3|||
28098665|NCT03645434|54754289|FG005|Period 1|COPD exacerbation|0|||
28098666|NCT00089505|54754301|FG000|Overall Study|Death|4|||
28098667|NCT00089505|54754302|FG001|Overall Study|Death|1|||
28098668|NCT00089505|54754303|FG002|Overall Study|Death|5|||
28098669|NCT00089505|54754304|FG003|Overall Study|Death|8|||
28098670|NCT00089505|54754301|FG000|Overall Study|Withdrawal by Subject|3|||
28098671|NCT00089505|54754302|FG001|Overall Study|Withdrawal by Subject|0|||
28098672|NCT00089505|54754303|FG002|Overall Study|Withdrawal by Subject|6|||
28098673|NCT00089505|54754304|FG003|Overall Study|Withdrawal by Subject|6|||
28098674|NCT00089505|54754301|FG000|Overall Study|Lost to Follow-up|1|||
28098675|NCT00089505|54754302|FG001|Overall Study|Lost to Follow-up|1|||
28098676|NCT00089505|54754303|FG002|Overall Study|Lost to Follow-up|9|||
27996132|NCT00806442|54654971|FG001|Overall Study|Lost to Follow-up|2|||
27996133|NCT00806442|54654970|FG000|Overall Study|Withdrawal by Subject|1|||
27996134|NCT00806442|54654971|FG001|Overall Study|Withdrawal by Subject|5|||
28098677|NCT00089505|54754304|FG003|Overall Study|Lost to Follow-up|7|||
28098678|NCT00089505|54754301|FG000|Overall Study|Physician Decision|1|||
28098679|NCT00089505|54754302|FG001|Overall Study|Physician Decision|0|||
28098680|NCT00089505|54754303|FG002|Overall Study|Physician Decision|0|||
28098681|NCT00089505|54754304|FG003|Overall Study|Physician Decision|0|||
28098682|NCT00089505|54754301|FG000|Overall Study|Protocol Violation|0|||
28172626|NCT02456740|54844368|FG008|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
27911043|NCT01140646|54568935|FG000|Overall Study|Refused Further Treatment|5|||
27911044|NCT01140568|54568939|FG000|Overall Study|disease progression|31|||
27911045|NCT01140568|54568939|FG000|Overall Study|Withdrawal by Subject|1|||
27911046|NCT01140568|54568939|FG000|Overall Study|Screen Fail|4|||
27911047|NCT01140451|54568945|FG000|Overall Study|Withdrawal by Subject|26|||
27911048|NCT01140451|54568946|FG001|Overall Study|Withdrawal by Subject|33|||
27911049|NCT01140451|54568945|FG000|Overall Study|Adverse Event|2|||
27996135|NCT00821678|54654981|FG000|Overall Study|Withdrawal by Subject|8|||
27996136|NCT00821678|54654982|FG001|Overall Study|Withdrawal by Subject|0|||
27996137|NCT00821678|54654981|FG000|Overall Study|Lost to Follow-up|13|||
27996138|NCT00821678|54654982|FG001|Overall Study|Lost to Follow-up|12|||
28098683|NCT00089505|54754302|FG001|Overall Study|Protocol Violation|0|||
28098684|NCT00089505|54754303|FG002|Overall Study|Protocol Violation|1|||
27996139|NCT00821678|54654981|FG000|Overall Study|Death|0|||
27996140|NCT00821678|54654982|FG001|Overall Study|Death|2|||
28098685|NCT00089505|54754304|FG003|Overall Study|Protocol Violation|0|||
28098686|NCT04009824|54754319|FG000|Overall Study|COVID-19 pandemic restriction/closure|2|||
27996141|NCT00839852|54654990|FG000|Overall Study|Adverse Event|10|||
27996142|NCT00839852|54654990|FG000|Overall Study|Insufficient Therapeutic Response|3|||
27996143|NCT00839852|54654990|FG000|Overall Study|Protocol Violation|9|||
27996144|NCT00839852|54654990|FG000|Overall Study|Withdrawal of Consent|16|||
27996145|NCT00839852|54654990|FG000|Overall Study|Lost to Follow-up|7|||
27996146|NCT00839852|54654990|FG000|Overall Study|Lack of Compliance While in Jail|1|||
27996147|NCT00839852|54654990|FG000|Overall Study|Pregnancy|1|||
27996148|NCT00833690|54654997|FG000|Overall Study|Withdrawal by Subject|1|||
27996149|NCT00833690|54654998|FG001|Overall Study|Withdrawal by Subject|0|||
27996150|NCT00833690|54654999|FG002|Overall Study|Withdrawal by Subject|0|||
27996151|NCT00833690|54654997|FG000|Overall Study|Discontinued study drug|3|||
27911050|NCT01140451|54568946|FG001|Overall Study|Adverse Event|6|||
27911051|NCT01140451|54568945|FG000|Overall Study|Physician Decision|5|||
27911052|NCT01140451|54568946|FG001|Overall Study|Physician Decision|3|||
27911053|NCT01140451|54568945|FG000|Overall Study|Lost to Follow-up|2|||
27911054|NCT01140451|54568946|FG001|Overall Study|Lost to Follow-up|0|||
27911055|NCT01140451|54568945|FG000|Overall Study|Participants Planning Pregnancy|3|||
27996152|NCT00833690|54654998|FG001|Overall Study|Discontinued study drug|2|||
27996153|NCT00833690|54654999|FG002|Overall Study|Discontinued study drug|0|||
27996154|NCT00820898|54655007|FG000|Overall Study|Inelgible - wrong primary site|1|||
27996155|NCT00865709|54655019|FG000|Treatment|Adverse Event|9|||
27996156|NCT00865709|54655020|FG001|Treatment|Adverse Event|6|||
27911056|NCT01140451|54568946|FG001|Overall Study|Participants Planning Pregnancy|0|||
27911057|NCT01140061|54568963|FG000|Part I|Adverse Event|1|||
27996157|NCT00865709|54655019|FG000|Treatment|Withdrawal by Subject|10|||
27996158|NCT00865709|54655020|FG001|Treatment|Withdrawal by Subject|7|||
27996159|NCT00865709|54655019|FG000|Treatment|Physician Decision|3|||
27996160|NCT00865709|54655020|FG001|Treatment|Physician Decision|2|||
27996161|NCT00865709|54655019|FG000|Treatment|Surgery|8|||
27996162|NCT00865709|54655020|FG001|Treatment|Surgery|3|||
27996163|NCT00839306|54655030|FG000|Overall Study|Adverse Event|3|||
27996164|NCT00839306|54655031|FG001|Overall Study|Adverse Event|5|||
27996165|NCT00839306|54655030|FG000|Overall Study|Lost to Follow-up|6|||
27996166|NCT00839306|54655031|FG001|Overall Study|Lost to Follow-up|9|||
27996167|NCT00839306|54655030|FG000|Overall Study|Withdrawal by Subject|5|||
27996168|NCT00839306|54655031|FG001|Overall Study|Withdrawal by Subject|7|||
27996169|NCT00839306|54655030|FG000|Overall Study|Lack of Efficacy|5|||
27996170|NCT00839306|54655031|FG001|Overall Study|Lack of Efficacy|4|||
27996171|NCT00839306|54655030|FG000|Overall Study|Other|6|||
27996172|NCT00839306|54655031|FG001|Overall Study|Other|18|||
27996173|NCT00839072|54655038|FG000|First Intervention Period|Withdrawal by Subject|1|||
27996174|NCT00839072|54655039|FG001|First Intervention Period|Withdrawal by Subject|0|||
27911058|NCT01140061|54568964|FG001|Part I|Adverse Event|0|||
27911059|NCT01140061|54568965|FG002|Part I|Adverse Event|0|||
27911060|NCT01140061|54568966|FG003|Part I|Adverse Event|0|||
27911061|NCT01140061|54568967|FG004|Part I|Adverse Event|0|||
27911062|NCT01140061|54568968|FG005|Part I|Adverse Event|0|||
27911063|NCT01140061|54568969|FG006|Part I|Adverse Event|0|||
27911064|NCT01140061|54568970|FG007|Part I|Adverse Event|0|||
27911065|NCT01140061|54568971|FG008|Part I|Adverse Event|0|||
27911066|NCT01140061|54568972|FG009|Part I|Adverse Event|0|||
27911067|NCT01140061|54568963|FG000|Extension|Laboratory Adverse Event|0|||
27996175|NCT00839072|54655038|FG000|First Intervention Period|Adverse Event|1|||
27996176|NCT00839072|54655039|FG001|First Intervention Period|Adverse Event|1|||
27996177|NCT00839072|54655038|FG000|Second Intervention Period|Withdrawal by Subject|1|||
27996178|NCT00839072|54655039|FG001|Second Intervention Period|Withdrawal by Subject|0|||
27996179|NCT00855803|54655045|FG000|Overall Study|Death|2|||
27996180|NCT00855803|54655045|FG000|Overall Study|Lost to Follow-up|2|||
27996181|NCT00855803|54655045|FG000|Overall Study|Technical inability to undergo procedure|2|||
27739727|NCT01378975|54189350|FG000|Overall Study|Withdrew Consent|4|||
27739728|NCT01378975|54189351|FG001|Overall Study|Withdrew Consent|3|||
27911068|NCT01140061|54568964|FG001|Extension|Laboratory Adverse Event|0|||
27911069|NCT01140061|54568965|FG002|Extension|Laboratory Adverse Event|0|||
27911070|NCT01140061|54568966|FG003|Extension|Laboratory Adverse Event|0|||
27911071|NCT01140061|54568967|FG004|Extension|Laboratory Adverse Event|0|||
27911072|NCT01140061|54568968|FG005|Extension|Laboratory Adverse Event|0|||
27911073|NCT01140061|54568969|FG006|Extension|Laboratory Adverse Event|0|||
27911074|NCT01140061|54568970|FG007|Extension|Laboratory Adverse Event|0|||
27911075|NCT01140061|54568971|FG008|Extension|Laboratory Adverse Event|0|||
27996182|NCT00855803|54655045|FG000|Overall Study|Not evaluable at 3 month timepoint|2|||
27996183|NCT00855803|54655045|FG000|Overall Study|Withdrawal by Subject|3|||
27996184|NCT00855803|54655045|FG000|Overall Study|Physician Decision|3|||
27996185|NCT03553836|54655051|FG000|Overall Study|Ongoing in Study|460|||
28098687|NCT04009824|54754320|FG001|Overall Study|COVID-19 pandemic restriction/closure|3|||
27996186|NCT03553836|54655052|FG001|Overall Study|Ongoing in Study|459|||
27996187|NCT03553836|54655051|FG000|Overall Study|Withdrawal by Subject|9|||
27911076|NCT01140061|54568972|FG009|Extension|Laboratory Adverse Event|1|||
27911077|NCT01139164|54568990|FG000|Overall Study|Withdrawn prior to study start|0|||
27996188|NCT03553836|54655052|FG001|Overall Study|Withdrawal by Subject|10|||
27996189|NCT03553836|54655051|FG000|Overall Study|Lost to Follow-up|1|||
27996190|NCT03553836|54655052|FG001|Overall Study|Lost to Follow-up|3|||
27996191|NCT03553836|54655051|FG000|Overall Study|Death|17|||
27996192|NCT03553836|54655052|FG001|Overall Study|Death|17|||
27996193|NCT00838916|54655061|FG000|Treatment Period (156 Weeks)|Adverse Event|50|||
27996194|NCT00838916|54655062|FG001|Treatment Period (156 Weeks)|Adverse Event|11|||
27996195|NCT00838916|54655061|FG000|Treatment Period (156 Weeks)|Protocol Violation|12|||
27996196|NCT00838916|54655062|FG001|Treatment Period (156 Weeks)|Protocol Violation|3|||
27996197|NCT00838916|54655061|FG000|Treatment Period (156 Weeks)|Noncompliance|21|||
27996198|NCT00838916|54655062|FG001|Treatment Period (156 Weeks)|Noncompliance|14|||
27996199|NCT00838916|54655061|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
27996200|NCT00838916|54655062|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
27996201|NCT00838916|54655061|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|19|||
27996202|NCT00838916|54655062|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|18|||
27996203|NCT00838916|54655061|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|81|||
27996204|NCT00838916|54655062|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|29|||
27996205|NCT00838916|54655061|FG000|Treatment Period (156 Weeks)|Physician Decision|6|||
27996206|NCT00838916|54655062|FG001|Treatment Period (156 Weeks)|Physician Decision|1|||
27911078|NCT01139164|54568991|FG001|Overall Study|Withdrawn prior to study start|2|||
27911079|NCT01139164|54568992|FG002|Overall Study|Withdrawn prior to study start|0|||
27911080|NCT01139125|54569000|FG000|Overall Study|Withdrawal by Subject|1|||
27996207|NCT00838916|54655061|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1|||
27996208|NCT00838916|54655062|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0|||
27996209|NCT00838916|54655061|FG000|Treatment Period (156 Weeks)|Missing|3|||
27996210|NCT00838916|54655062|FG001|Treatment Period (156 Weeks)|Missing|1|||
27996211|NCT00838916|54655061|FG000|Treatment Period (156 Weeks)|Pregnancy|2|||
27996212|NCT00838916|54655062|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
27996213|NCT00838916|54655061|FG000|Follow-up Period (8 Weeks)|Adverse Event|10|||
27996214|NCT00838916|54655062|FG001|Follow-up Period (8 Weeks)|Adverse Event|5|||
27996215|NCT00838916|54655061|FG000|Follow-up Period (8 Weeks)|Noncompliance|6|||
27996216|NCT00838916|54655062|FG001|Follow-up Period (8 Weeks)|Noncompliance|5|||
27996217|NCT00838916|54655061|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|38|||
27996218|NCT00838916|54655062|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
27996219|NCT00838916|54655061|FG000|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
27996220|NCT00838916|54655062|FG001|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
27996221|NCT00838916|54655061|FG000|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26|||
27996222|NCT00838916|54655062|FG001|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12|||
27996223|NCT00838916|54655061|FG000|Follow-up Period (8 Weeks)|Physician Decision|2|||
27996224|NCT00838916|54655062|FG001|Follow-up Period (8 Weeks)|Physician Decision|0|||
27996225|NCT00838916|54655061|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2|||
27996226|NCT00838916|54655062|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
27996227|NCT00838916|54655061|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
27996228|NCT00838916|54655062|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|0|||
27996229|NCT00838916|54655061|FG000|Follow-up Period (8 Weeks)|Missing|3|||
27996230|NCT00838916|54655062|FG001|Follow-up Period (8 Weeks)|Missing|0|||
27911081|NCT01139047|54569004|FG000|Overall Study|Withdrawal by Subject|1|||
27911082|NCT01139008|54569011|FG000|Overall Study|Withdrawal by Subject|5|||
28098688|NCT04009824|54754321|FG002|Overall Study|COVID-19 pandemic restriction/closure|5|||
27911083|NCT01139008|54569011|FG000|Overall Study|Non-compliant, lost product|1|||
27911084|NCT01138657|54569020|FG000|Overall Study|Adverse Event|3|||
27911085|NCT01138657|54569021|FG001|Overall Study|Adverse Event|10|||
27911086|NCT01138657|54569020|FG000|Overall Study|Lack of Efficacy|2|||
27911087|NCT01138657|54569021|FG001|Overall Study|Lack of Efficacy|1|||
27911088|NCT01138657|54569020|FG000|Overall Study|Lost to Follow-up|0|||
27911089|NCT01138657|54569021|FG001|Overall Study|Lost to Follow-up|3|||
27911090|NCT01138657|54569020|FG000|Overall Study|Miscellaneous Reasons|3|||
27911091|NCT01138657|54569021|FG001|Overall Study|Miscellaneous Reasons|4|||
27911092|NCT01138501|54569029|FG000|Overall Study|Protocol Violation|2|||
27911093|NCT01138501|54569029|FG000|Overall Study|Withdrawal by Subject|3|||
27911094|NCT01138150|54569035|FG000|Overall Study|blood unable to be processed|0|||
27911095|NCT01138150|54569036|FG001|Overall Study|blood unable to be processed|1|||
27911096|NCT01138150|54569035|FG000|Overall Study|Physician Decision|1|||
27911097|NCT01138150|54569036|FG001|Overall Study|Physician Decision|0|||
27911098|NCT01138111|54569052|FG000|Overall Study|Withdrawal by Subject|5|||
27911099|NCT01138111|54569052|FG000|Overall Study|Adverse Event|1|||
27911100|NCT01138111|54569052|FG000|Overall Study|Death|1|||
27996231|NCT00838682|54655070|FG000|Overall Study|Lost to Follow-up|21|||
27911101|NCT01138111|54569052|FG000|Overall Study|Lost to Follow-up|2|||
27911102|NCT01137955|54569083|FG000|Overall Study|Withdrawal by Subject|5|||
27996232|NCT00838682|54655071|FG001|Overall Study|Lost to Follow-up|14|||
27996233|NCT00838682|54655070|FG000|Overall Study|detection of exclusion criteria|4|||
27996234|NCT00838682|54655071|FG001|Overall Study|detection of exclusion criteria|3|||
27996235|NCT00838682|54655070|FG000|Overall Study|Protocol Violation|0|||
27996236|NCT00838682|54655071|FG001|Overall Study|Protocol Violation|1|||
27996237|NCT00838682|54655070|FG000|Overall Study|Withdrawal by Subject|0|||
27996238|NCT00838682|54655071|FG001|Overall Study|Withdrawal by Subject|1|||
27996239|NCT00820040|54655077|FG000|Overall Study|Death|1|||
27996240|NCT00820040|54655077|FG000|Overall Study|Sponsor terminated study|1|||
27996241|NCT00820040|54655077|FG000|Overall Study|Screen failure|1|||
27996242|NCT00803712|54655083|FG000|Overall Study|Noncompliance|3|||
27996243|NCT00803712|54655084|FG001|Overall Study|Noncompliance|0|||
27996244|NCT00803712|54655083|FG000|Overall Study|Adverse Event|5|||
27996245|NCT00803712|54655084|FG001|Overall Study|Adverse Event|0|||
27996246|NCT00803712|54655083|FG000|Overall Study|Death|8|||
27996247|NCT00803712|54655084|FG001|Overall Study|Death|7|||
27996248|NCT00803712|54655083|FG000|Overall Study|Lost to Follow-up|3|||
27996249|NCT00803712|54655084|FG001|Overall Study|Lost to Follow-up|1|||
27996250|NCT00803712|54655083|FG000|Overall Study|Withdrawal by Subject|2|||
27996251|NCT00803712|54655084|FG001|Overall Study|Withdrawal by Subject|4|||
27996252|NCT00803712|54655083|FG000|Overall Study|"Other in electronic Case Report Form"|0|||
27996253|NCT00803712|54655084|FG001|Overall Study|"Other in electronic Case Report Form"|1|||
27996254|NCT00803712|54655083|FG000|Overall Study|Protocol criteria (other)|0|||
27996255|NCT00803712|54655084|FG001|Overall Study|Protocol criteria (other)|2|||
27996256|NCT00803712|54655083|FG000|Overall Study|Protocol criteria (renal transplant)|12|||
27996257|NCT00803712|54655084|FG001|Overall Study|Protocol criteria (renal transplant)|8|||
27996258|NCT00803712|54655083|FG000|Overall Study|Administrative decision|2|||
27996259|NCT00803712|54655084|FG001|Overall Study|Administrative decision|3|||
27996260|NCT00803712|54655083|FG000|Overall Study|Protocol criteria (parathyroidectomy)|1|||
28098689|NCT04009824|54754322|FG003|Overall Study|COVID-19 pandemic restriction/closure|2|||
28098690|NCT04009824|54754323|FG004|Overall Study|COVID-19 pandemic restriction/closure|3|||
28098691|NCT03555890|54754339|FG000|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
28098692|NCT03555890|54754340|FG001|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
28098693|NCT03555890|54754341|FG002|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
28098694|NCT03555890|54754342|FG003|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
28098695|NCT03688074|54754354|FG000|Overall Study|Adverse Event|0|||
28098696|NCT03688074|54754355|FG001|Overall Study|Adverse Event|1|||
28098697|NCT03688074|54754354|FG000|Overall Study|Other|1|||
28098698|NCT03688074|54754355|FG001|Overall Study|Other|0|||
28098699|NCT03630120|54754365|FG000|Overall Study|Disease progression|0|||
28098700|NCT03630120|54754366|FG001|Overall Study|Disease progression|1|||
27911103|NCT01137955|54569084|FG001|Overall Study|Withdrawal by Subject|4|||
27911104|NCT01137682|54569094|FG000|Overall Study|Adverse Event-CORE|2|||
27911105|NCT01137682|54569095|FG001|Overall Study|Adverse Event-CORE|4|||
27911106|NCT01137682|54569096|FG002|Overall Study|Adverse Event-CORE|0|||
27911107|NCT01137682|54569094|FG000|Overall Study|Withdrawal by Subject-CORE|2|||
27911108|NCT01137682|54569095|FG001|Overall Study|Withdrawal by Subject-CORE|2|||
27911109|NCT01137682|54569096|FG002|Overall Study|Withdrawal by Subject-CORE|2|||
27911110|NCT01137682|54569094|FG000|Overall Study|Administrative problems-CORE|2|||
27911111|NCT01137682|54569095|FG001|Overall Study|Administrative problems-CORE|1|||
27911112|NCT01137682|54569096|FG002|Overall Study|Administrative problems-CORE|0|||
27911113|NCT01137682|54569094|FG000|Overall Study|Protocol Violation-CORE|0|||
27911114|NCT01137682|54569095|FG001|Overall Study|Protocol Violation-CORE|1|||
27911115|NCT01137682|54569096|FG002|Overall Study|Protocol Violation-CORE|1|||
27911116|NCT01137682|54569094|FG000|Overall Study|Adverse Event-Extension|4|||
27911117|NCT01137682|54569095|FG001|Overall Study|Adverse Event-Extension|8|||
27911118|NCT01137682|54569096|FG002|Overall Study|Adverse Event-Extension|7|||
27911119|NCT01137682|54569094|FG000|Overall Study|Lack of Efficacy-Extension|15|||
27911120|NCT01137682|54569095|FG001|Overall Study|Lack of Efficacy-Extension|9|||
27911121|NCT01137682|54569096|FG002|Overall Study|Lack of Efficacy-Extension|13|||
27911122|NCT01137682|54569094|FG000|Overall Study|Withdrawal by Subject-Extension|6|||
27911123|NCT01137682|54569095|FG001|Overall Study|Withdrawal by Subject-Extension|8|||
27911124|NCT01137682|54569096|FG002|Overall Study|Withdrawal by Subject-Extension|8|||
27911125|NCT01137682|54569094|FG000|Overall Study|Lost to Follow Up-Extension|0|||
27911126|NCT01137682|54569095|FG001|Overall Study|Lost to Follow Up-Extension|1|||
27911127|NCT01137682|54569096|FG002|Overall Study|Lost to Follow Up-Extension|0|||
27911128|NCT01137682|54569094|FG000|Overall Study|Administrative problems-Extension|0|||
27911129|NCT01137682|54569095|FG001|Overall Study|Administrative problems-Extension|2|||
27911130|NCT01137682|54569096|FG002|Overall Study|Administrative problems-Extension|0|||
27911131|NCT01137682|54569094|FG000|Overall Study|Death-Extension|2|||
27911132|NCT01137682|54569095|FG001|Overall Study|Death-Extension|0|||
27911133|NCT01137682|54569096|FG002|Overall Study|Death-Extension|0|||
27911134|NCT01137682|54569094|FG000|Overall Study|Protocol Violation-Extension|2|||
27911135|NCT01137682|54569095|FG001|Overall Study|Protocol Violation-Extension|1|||
27911136|NCT01137682|54569096|FG002|Overall Study|Protocol Violation-Extension|0|||
27996261|NCT00803712|54655084|FG001|Overall Study|Protocol criteria (parathyroidectomy)|1|||
27996262|NCT00591344|54655092|FG000|Overall Study|Transportation issues|1|||
27996263|NCT00591344|54655093|FG001|Overall Study|Transportation issues|0|||
27996264|NCT00591344|54655092|FG000|Overall Study|Moved out of state|1|||
27911137|NCT01137682|54569094|FG000|Overall Study|Did not enter extension|2|||
27911138|NCT01137682|54569095|FG001|Overall Study|Did not enter extension|3|||
27911139|NCT01137682|54569096|FG002|Overall Study|Did not enter extension|2|||
27911140|NCT01137682|54569094|FG000|Overall Study|Did not receive treatment in extension|0|||
27911141|NCT01137682|54569095|FG001|Overall Study|Did not receive treatment in extension|0|||
27911142|NCT01137682|54569096|FG002|Overall Study|Did not receive treatment in extension|1|||
27996265|NCT00591344|54655093|FG001|Overall Study|Moved out of state|0|||
27996266|NCT00591344|54655092|FG000|Overall Study|Medical complications|1|||
27996267|NCT00591344|54655093|FG001|Overall Study|Medical complications|3|||
27996268|NCT00591344|54655092|FG000|Overall Study|Underwent DBS|2|||
27996269|NCT00591344|54655093|FG001|Overall Study|Underwent DBS|2|||
27996270|NCT00591344|54655092|FG000|Overall Study|Death|0|||
27996271|NCT00591344|54655093|FG001|Overall Study|Death|1|||
27996272|NCT00591344|54655092|FG000|Overall Study|Lost to Follow-up|0|||
27996273|NCT00591344|54655093|FG001|Overall Study|Lost to Follow-up|1|||
27996274|NCT00591344|54655092|FG000|Overall Study|Did not want to come off medication|0|||
27996275|NCT00591344|54655093|FG001|Overall Study|Did not want to come off medication|1|||
27996276|NCT00803634|54655105|FG000|Overall Study|Withdrew Consent|1|||
27996277|NCT00803634|54655106|FG001|Overall Study|Withdrew Consent|0|||
27996278|NCT00803634|54655105|FG000|Overall Study|Lost to Follow-up|2|||
27996279|NCT00803634|54655106|FG001|Overall Study|Lost to Follow-up|3|||
27996280|NCT00803634|54655105|FG000|Overall Study|Death|3|||
27996281|NCT00803634|54655106|FG001|Overall Study|Death|2|||
27996282|NCT00838526|54655115|FG000|Overall Study|Adverse Event|3|||
27996283|NCT00838526|54655116|FG001|Overall Study|Adverse Event|12|||
27996284|NCT00838526|54655115|FG000|Overall Study|Lost to Follow-up|4|||
27996285|NCT00838526|54655116|FG001|Overall Study|Lost to Follow-up|12|||
27996286|NCT00838526|54655115|FG000|Overall Study|Withdrawal by Subject|4|||
27996287|NCT00838526|54655116|FG001|Overall Study|Withdrawal by Subject|5|||
27996288|NCT00838526|54655115|FG000|Overall Study|Lack of Efficacy|2|||
27996289|NCT00838526|54655116|FG001|Overall Study|Lack of Efficacy|3|||
27996290|NCT00838526|54655115|FG000|Overall Study|Other|11|||
27996291|NCT00838526|54655116|FG001|Overall Study|Other|7|||
27996292|NCT00818246|54655135|FG000|Overall Study|Impossible to match pictures|5|||
27996293|NCT00818168|54655139|FG000|Overall Study|Lack of Efficacy|18|||
27996294|NCT00818168|54655139|FG000|Overall Study|Pregnancy|2|||
27996295|NCT00818168|54655139|FG000|Overall Study|Withdrawal by Subject|16|||
27996296|NCT00818168|54655139|FG000|Overall Study|Lost to Follow-up|7|||
27996297|NCT00818168|54655139|FG000|Overall Study|Adverse Event|19|||
27996298|NCT00818168|54655139|FG000|Overall Study|Reason for Non-completion Not reported|6|||
27996299|NCT00818168|54655139|FG000|Overall Study|Participant Moved|2|||
27996300|NCT00817778|54655145|FG000|Overall Study|Adverse Event|1|||
27996301|NCT00817778|54655146|FG001|Overall Study|Adverse Event|0|||
27911143|NCT03452397|54569112|FG000|Overall Study|Adverse Event|1|||
27911144|NCT03452397|54569113|FG001|Overall Study|Adverse Event|0|||
27911145|NCT03452397|54569114|FG002|Overall Study|Adverse Event|0|||
27911146|NCT03452397|54569115|FG003|Overall Study|Adverse Event|0|||
27911147|NCT03452397|54569112|FG000|Overall Study|Administrative reason|0|||
27911148|NCT03452397|54569113|FG001|Overall Study|Administrative reason|0|||
27911149|NCT03452397|54569114|FG002|Overall Study|Administrative reason|1|||
27911150|NCT03452397|54569115|FG003|Overall Study|Administrative reason|1|||
27911151|NCT03452397|54569112|FG000|Overall Study|Withdrawal by Subject|0|||
27911152|NCT03452397|54569113|FG001|Overall Study|Withdrawal by Subject|0|||
27911153|NCT03452397|54569114|FG002|Overall Study|Withdrawal by Subject|1|||
27911154|NCT03452397|54569115|FG003|Overall Study|Withdrawal by Subject|0|||
27911155|NCT00199875|54569149|FG000|Overall Study|Withdrawal by Subject|0|||
27911156|NCT00199875|54569150|FG001|Overall Study|Withdrawal by Subject|0|||
27911157|NCT00199875|54569151|FG002|Overall Study|Withdrawal by Subject|0|||
27911158|NCT00199875|54569152|FG003|Overall Study|Withdrawal by Subject|0|||
27911159|NCT00199875|54569153|FG004|Overall Study|Withdrawal by Subject|1|||
27911160|NCT00199836|54569165|FG000|Overall Study|Progressive Disease|5|||
27911161|NCT00199836|54569165|FG000|Overall Study|Death|1|||
27911162|NCT00199797|54569170|FG000|Overall Study|Progressive Disease|1|||
27911163|NCT00199797|54569170|FG000|Overall Study|Adverse Event|1|||
27911164|NCT00199797|54569170|FG000|Overall Study|Physician Decision|1|||
27911165|NCT01137604|54569179|FG000|Overall Study|Adverse Event|3|||
27911166|NCT01137604|54569180|FG001|Overall Study|Adverse Event|6|||
27911167|NCT01137604|54569181|FG002|Overall Study|Adverse Event|9|||
27996302|NCT00817778|54655145|FG000|Overall Study|Withdrawal by Subject|1|||
27996303|NCT00817778|54655146|FG001|Overall Study|Withdrawal by Subject|1|||
27996304|NCT00817778|54655145|FG000|Overall Study|Protocol Violation|0|||
27996305|NCT00817778|54655146|FG001|Overall Study|Protocol Violation|1|||
27996306|NCT00817778|54655145|FG000|Overall Study|Study-specific discontinuation criteria|0|||
27911168|NCT01137604|54569182|FG003|Overall Study|Adverse Event|9|||
28098701|NCT03630120|54754367|FG002|Overall Study|Disease progression|1|||
27911169|NCT01137604|54569179|FG000|Overall Study|Participant Choice|0|||
27911170|NCT01137604|54569180|FG001|Overall Study|Participant Choice|2|||
27911171|NCT01137604|54569181|FG002|Overall Study|Participant Choice|2|||
27911172|NCT01137604|54569182|FG003|Overall Study|Participant Choice|0|||
27911173|NCT01137604|54569179|FG000|Overall Study|Withdrawal of consent|0|||
27911174|NCT01137604|54569180|FG001|Overall Study|Withdrawal of consent|0|||
27911175|NCT01137604|54569181|FG002|Overall Study|Withdrawal of consent|0|||
27911176|NCT01137604|54569182|FG003|Overall Study|Withdrawal of consent|2|||
27911177|NCT01137604|54569179|FG000|Overall Study|Clinical progression/deterioration|1|||
27911178|NCT01137604|54569180|FG001|Overall Study|Clinical progression/deterioration|2|||
27911179|NCT01137604|54569181|FG002|Overall Study|Clinical progression/deterioration|2|||
27911180|NCT01137604|54569182|FG003|Overall Study|Clinical progression/deterioration|0|||
27911181|NCT00198822|54569195|FG000|Overall Study|Lost to Follow-up|14|||
27911182|NCT00198822|54569196|FG001|Overall Study|Lost to Follow-up|20|||
27911183|NCT00198822|54569197|FG002|Overall Study|Lost to Follow-up|21|||
27911184|NCT01137292|54569205|FG000|Overall Study|Death|30|||
27911185|NCT01137292|54569205|FG000|Overall Study|Adverse Event|3|||
27996307|NCT00817778|54655146|FG001|Overall Study|Study-specific discontinuation criteria|1|||
27996308|NCT00817778|54655145|FG000|Overall Study|Poor venous access|1|||
27996309|NCT00817778|54655146|FG001|Overall Study|Poor venous access|0|||
27996310|NCT00813098|54655155|FG000|Overall Study|Adverse Event|2|||
27996311|NCT00813098|54655156|FG001|Overall Study|Adverse Event|4|||
27996312|NCT00813098|54655157|FG002|Overall Study|Adverse Event|1|||
27996313|NCT00813098|54655155|FG000|Overall Study|Withdrawal by Subject|0|||
27996314|NCT00813098|54655156|FG001|Overall Study|Withdrawal by Subject|1|||
27996315|NCT00813098|54655157|FG002|Overall Study|Withdrawal by Subject|0|||
27996316|NCT00813098|54655155|FG000|Overall Study|Inability to complete study procedures|1|||
27996317|NCT00813098|54655156|FG001|Overall Study|Inability to complete study procedures|0|||
27996318|NCT00813098|54655157|FG002|Overall Study|Inability to complete study procedures|0|||
27996319|NCT00813098|54655155|FG000|Overall Study|Lost to Follow-up|0|||
27996320|NCT00813098|54655156|FG001|Overall Study|Lost to Follow-up|1|||
27996321|NCT00813098|54655157|FG002|Overall Study|Lost to Follow-up|0|||
27996322|NCT00813098|54655155|FG000|Overall Study|Protocol Violation|0|||
27996323|NCT00813098|54655156|FG001|Overall Study|Protocol Violation|0|||
27996324|NCT00813098|54655157|FG002|Overall Study|Protocol Violation|1|||
27911186|NCT01137292|54569205|FG000|Overall Study|Lack of Efficacy|13|||
27996325|NCT00813098|54655155|FG000|Overall Study|Principal Investigator decision|0|||
27996326|NCT00813098|54655156|FG001|Overall Study|Principal Investigator decision|1|||
27996327|NCT00813098|54655157|FG002|Overall Study|Principal Investigator decision|0|||
27996328|NCT00813098|54655155|FG000|Overall Study|Withdrew Consent|0|||
27996329|NCT00813098|54655156|FG001|Overall Study|Withdrew Consent|1|||
27996330|NCT00813098|54655157|FG002|Overall Study|Withdrew Consent|0|||
27996331|NCT00796653|54655169|FG000|Overall Study|Adverse Event|19|||
27996332|NCT00796653|54655170|FG001|Overall Study|Adverse Event|16|||
27996333|NCT00796653|54655171|FG002|Overall Study|Adverse Event|16|||
27996334|NCT00796653|54655172|FG003|Overall Study|Adverse Event|16|||
27996335|NCT00796653|54655169|FG000|Overall Study|Lost to Follow-up|2|||
27996336|NCT00796653|54655170|FG001|Overall Study|Lost to Follow-up|1|||
27996337|NCT00796653|54655171|FG002|Overall Study|Lost to Follow-up|2|||
27996338|NCT00796653|54655172|FG003|Overall Study|Lost to Follow-up|3|||
27911187|NCT01137292|54569205|FG000|Overall Study|Lost to Follow-up|1|||
27911188|NCT01137292|54569205|FG000|Overall Study|Other|7|||
27911189|NCT00197496|54569211|FG000|Baseline to Discharge|not interested|1|||
27911190|NCT00197496|54569212|FG001|Baseline to Discharge|not interested|0|||
27911191|NCT00197496|54569211|FG000|Baseline to Discharge|MRSA|1|||
27911192|NCT00197496|54569212|FG001|Baseline to Discharge|MRSA|0|||
27911193|NCT00197496|54569211|FG000|Baseline to Discharge|Physician Decision|0|||
27911194|NCT00197496|54569212|FG001|Baseline to Discharge|Physician Decision|1|||
27911195|NCT00197496|54569211|FG000|Baseline to Discharge|Protocol Violation|0|||
27911196|NCT00197496|54569212|FG001|Baseline to Discharge|Protocol Violation|1|||
27911197|NCT00197496|54569211|FG000|Follow-up|Lost to Follow-up|2|||
27911198|NCT00197496|54569212|FG001|Follow-up|Lost to Follow-up|1|||
27911199|NCT00197145|54569220|FG000|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
27911200|NCT00197145|54569221|FG001|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
27911201|NCT00197145|54569220|FG000|Period 1: Randomized Treatment Phase|Sponsor terminated study|10|||
27911202|NCT00197145|54569221|FG001|Period 1: Randomized Treatment Phase|Sponsor terminated study|8|||
27911203|NCT00197145|54569220|FG000|Period 1: Randomized Treatment Phase|Other|2|||
27911204|NCT00197145|54569221|FG001|Period 1: Randomized Treatment Phase|Other|2|||
27996339|NCT00796653|54655169|FG000|Overall Study|Withdrawal by Subject|16|||
27996340|NCT00796653|54655170|FG001|Overall Study|Withdrawal by Subject|8|||
27996341|NCT00796653|54655171|FG002|Overall Study|Withdrawal by Subject|8|||
27996342|NCT00796653|54655172|FG003|Overall Study|Withdrawal by Subject|13|||
27996343|NCT00796653|54655169|FG000|Overall Study|Lack of Efficacy|8|||
27996344|NCT00796653|54655170|FG001|Overall Study|Lack of Efficacy|1|||
27996345|NCT00796653|54655171|FG002|Overall Study|Lack of Efficacy|3|||
28172627|NCT02456740|54844360|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27|||
27996346|NCT00796653|54655172|FG003|Overall Study|Lack of Efficacy|2|||
27996347|NCT00796653|54655169|FG000|Overall Study|Non compliance with protocol|2|||
27911205|NCT00197145|54569220|FG000|Period 2 : Open Label Phase|Insufficient viral load response|1|||
27911206|NCT00197145|54569221|FG001|Period 2 : Open Label Phase|Insufficient viral load response|0|||
27911207|NCT00197145|54569220|FG000|Period 2 : Open Label Phase|Protocol defined virological failure|3|||
27911208|NCT00197145|54569221|FG001|Period 2 : Open Label Phase|Protocol defined virological failure|0|||
27911209|NCT00197145|54569220|FG000|Period 2 : Open Label Phase|Availability of alternative ART|2|||
27911210|NCT00197145|54569221|FG001|Period 2 : Open Label Phase|Availability of alternative ART|0|||
27911211|NCT00197145|54569220|FG000|Period 2 : Open Label Phase|Were ongoing till data freeze|3|||
27911212|NCT00197145|54569221|FG001|Period 2 : Open Label Phase|Were ongoing till data freeze|0|||
27911213|NCT00197145|54569220|FG000|Period 2 : Open Label Phase|Other|1|||
27911214|NCT00197145|54569221|FG001|Period 2 : Open Label Phase|Other|0|||
27911215|NCT01136785|54569230|FG000|Overall Study|Protocol Violation|2|||
27911216|NCT01136785|54569231|FG001|Overall Study|Protocol Violation|1|||
27911217|NCT00197106|54569243|FG000|4-Week Run-In Period|Did not meet entry criteria|99|||
27911218|NCT00197106|54569244|FG001|4-Week Run-In Period|Did not meet entry criteria|0|||
27911219|NCT00197106|54569245|FG002|4-Week Run-In Period|Did not meet entry criteria|0|||
27911220|NCT00197106|54569243|FG000|Overall Treatment Period|Lack of Efficacy|0|||
27911221|NCT00197106|54569244|FG001|Overall Treatment Period|Lack of Efficacy|1|||
27911222|NCT00197106|54569245|FG002|Overall Treatment Period|Lack of Efficacy|0|||
27911223|NCT00197106|54569243|FG000|Overall Treatment Period|Lost to Follow-up|0|||
27996348|NCT00796653|54655170|FG001|Overall Study|Non compliance with protocol|2|||
27996349|NCT00796653|54655171|FG002|Overall Study|Non compliance with protocol|0|||
27996350|NCT00796653|54655172|FG003|Overall Study|Non compliance with protocol|2|||
27996351|NCT00796653|54655169|FG000|Overall Study|Other reason not described above|4|||
27996352|NCT00796653|54655170|FG001|Overall Study|Other reason not described above|9|||
27996353|NCT00796653|54655171|FG002|Overall Study|Other reason not described above|7|||
27996354|NCT00796653|54655172|FG003|Overall Study|Other reason not described above|4|||
27996355|NCT00806286|54655193|FG000|Overall Study|Adverse Event|5|||
27996356|NCT00806286|54655194|FG001|Overall Study|Adverse Event|2|||
27911224|NCT00197106|54569244|FG001|Overall Treatment Period|Lost to Follow-up|0|||
27911225|NCT00197106|54569245|FG002|Overall Treatment Period|Lost to Follow-up|2|||
27911226|NCT00197106|54569243|FG000|Overall Treatment Period|Protocol Violation|0|||
27911227|NCT00197106|54569244|FG001|Overall Treatment Period|Protocol Violation|0|||
27911228|NCT00197106|54569245|FG002|Overall Treatment Period|Protocol Violation|2|||
27911229|NCT00197106|54569243|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
27911230|NCT00197106|54569244|FG001|Overall Treatment Period|Withdrawal by Subject|0|||
27911231|NCT00197106|54569245|FG002|Overall Treatment Period|Withdrawal by Subject|2|||
27911232|NCT01136746|54569253|FG000|Overall Study|Lost to Follow-up|0|||
27911233|NCT01136746|54569254|FG001|Overall Study|Lost to Follow-up|2|||
27911234|NCT01136746|54569253|FG000|Overall Study|Protocol Violation|2|||
27911235|NCT01136746|54569254|FG001|Overall Study|Protocol Violation|1|||
27911236|NCT01136746|54569253|FG000|Overall Study|Death|1|||
27911237|NCT01136746|54569254|FG001|Overall Study|Death|0|||
27911238|NCT01136356|54569260|FG000|First 18-day Withdrawal|Withdrawal by Subject|3|||
27911239|NCT01136356|54569261|FG001|First 18-day Withdrawal|Withdrawal by Subject|0|||
27911240|NCT01136356|54569260|FG000|First 18-day Withdrawal|Physician Decision|1|||
27911241|NCT01136356|54569261|FG001|First 18-day Withdrawal|Physician Decision|0|||
27911242|NCT01136356|54569260|FG000|Second 18-day Withdrawal|Withdrawal by Subject|0|||
27911243|NCT01136356|54569261|FG001|Second 18-day Withdrawal|Withdrawal by Subject|1|||
27911244|NCT00196326|54569266|FG000|Overall Study|Did not meet protocol requirements|64|||
27911245|NCT00196326|54569266|FG000|Overall Study|Non-compliance with the protocol|81|||
27911246|NCT00196326|54569266|FG000|Overall Study|Physician Decision|3|||
27911247|NCT00196326|54569266|FG000|Overall Study|Withdrawal by Subject|225|||
27911248|NCT00196326|54569266|FG000|Overall Study|Adverse Event|253|||
27911249|NCT00196326|54569266|FG000|Overall Study|Pregnancy|34|||
27911250|NCT00196326|54569266|FG000|Overall Study|Lost to Follow-up|304|||
27911251|NCT00196326|54569266|FG000|Overall Study|Other|22|||
27911252|NCT00195663|54569273|FG000|2-year Double-blind Treatment Period|Adverse Event|21|||
27911253|NCT00195663|54569274|FG001|2-year Double-blind Treatment Period|Adverse Event|27|||
27911254|NCT00195663|54569275|FG002|2-year Double-blind Treatment Period|Adverse Event|32|||
27911255|NCT00195663|54569273|FG000|2-year Double-blind Treatment Period|Death|0|||
28098702|NCT03630120|54754368|FG003|Overall Study|Disease progression|1|||
27911256|NCT00195663|54569274|FG001|2-year Double-blind Treatment Period|Death|2|||
27911257|NCT00195663|54569275|FG002|2-year Double-blind Treatment Period|Death|0|||
27911258|NCT00195663|54569273|FG000|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
27911259|NCT00195663|54569274|FG001|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
27911260|NCT00195663|54569275|FG002|2-year Double-blind Treatment Period|Lost to Follow-up|1|||
28098703|NCT03555266|54754380|FG000|Overall Study|Protocol Violation|6|||
28098704|NCT03555266|54754381|FG001|Overall Study|Protocol Violation|4|||
28098705|NCT03629886|54754389|FG000|Overall Study|Migrated / moved from the study area|0|||
28098706|NCT03629886|54754390|FG001|Overall Study|Migrated / moved from the study area|55|||
27996357|NCT00806286|54655195|FG002|Overall Study|Adverse Event|0|||
27996358|NCT00806286|54655193|FG000|Overall Study|Disease progression|31|||
27996359|NCT00806286|54655194|FG001|Overall Study|Disease progression|38|||
27996360|NCT00806286|54655195|FG002|Overall Study|Disease progression|1|||
27996361|NCT00806286|54655193|FG000|Overall Study|Death|1|||
27996362|NCT00806286|54655194|FG001|Overall Study|Death|6|||
27996363|NCT00806286|54655195|FG002|Overall Study|Death|0|||
28098707|NCT03629886|54754389|FG000|Overall Study|Consent withdrawal, not due to an AE|0|||
28098708|NCT03629886|54754390|FG001|Overall Study|Consent withdrawal, not due to an AE|50|||
28098709|NCT03629886|54754389|FG000|Overall Study|Study vaccine not administrated|0|||
28098710|NCT03629886|54754390|FG001|Overall Study|Study vaccine not administrated|3|||
28098711|NCT03629886|54754389|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|0|||
28098712|NCT03629886|54754390|FG001|Overall Study|Didn't meet inclusion/exclusion criteria|28|||
28098713|NCT03629886|54754389|FG000|Overall Study|Refused vaccination step of the study|0|||
28098714|NCT03629886|54754390|FG001|Overall Study|Refused vaccination step of the study|44|||
28098715|NCT03656874|54754399|FG000|Overall Study|Lost to Follow-up|3|||
28098716|NCT03656874|54754400|FG001|Overall Study|Lost to Follow-up|17|||
28098717|NCT03554486|54754408|FG000|Run-in Period (2 Weeks)|Need for steroid injection|1|||
28098718|NCT03554486|54754409|FG001|Run-in Period (2 Weeks)|Need for steroid injection|0|||
28098719|NCT03554486|54754410|FG002|Run-in Period (2 Weeks)|Need for steroid injection|0|||
28098720|NCT03554486|54754408|FG000|Run-in Period (2 Weeks)|Lost to Follow-up|2|||
28098721|NCT03554486|54754409|FG001|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
28098722|NCT03554486|54754410|FG002|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
28098723|NCT03554486|54754408|FG000|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|0|||
28098724|NCT03554486|54754409|FG001|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
28098725|NCT03554486|54754410|FG002|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
28098726|NCT03554018|54754419|FG000|Overall Study|Lost to Follow-up|3|||
28098727|NCT03554018|54754420|FG001|Overall Study|Lost to Follow-up|7|||
28098728|NCT03571256|54754429|FG000|Overall Study|Adverse Event|3|||
28098729|NCT03571256|54754430|FG001|Overall Study|Adverse Event|0|||
28098730|NCT03571256|54754431|FG002|Overall Study|Adverse Event|1|||
28098731|NCT03571256|54754429|FG000|Overall Study|Withdrawal by Subject|3|||
28098732|NCT03571256|54754430|FG001|Overall Study|Withdrawal by Subject|1|||
28098733|NCT03571256|54754431|FG002|Overall Study|Withdrawal by Subject|1|||
27911261|NCT00195663|54569273|FG000|2-year Double-blind Treatment Period|Withdrawal by Subject|15|||
27911262|NCT00195663|54569274|FG001|2-year Double-blind Treatment Period|Withdrawal by Subject|18|||
27911263|NCT00195663|54569275|FG002|2-year Double-blind Treatment Period|Withdrawal by Subject|12|||
27911264|NCT00195663|54569273|FG000|2-year Double-blind Treatment Period|Lack of Efficacy|47|||
27911265|NCT00195663|54569274|FG001|2-year Double-blind Treatment Period|Lack of Efficacy|52|||
27911266|NCT00195663|54569275|FG002|2-year Double-blind Treatment Period|Lack of Efficacy|13|||
27911267|NCT00195663|54569273|FG000|2-year Double-blind Treatment Period|Protocol Violation|6|||
27911268|NCT00195663|54569274|FG001|2-year Double-blind Treatment Period|Protocol Violation|6|||
27911269|NCT00195663|54569275|FG002|2-year Double-blind Treatment Period|Protocol Violation|4|||
27911270|NCT00195663|54569273|FG000|2-year Double-blind Treatment Period|Planned selection criteria|0|||
28098734|NCT03571256|54754429|FG000|Overall Study|Other than specified|0|||
28098735|NCT03571256|54754430|FG001|Overall Study|Other than specified|1|||
28098736|NCT03571256|54754431|FG002|Overall Study|Other than specified|1|||
28098737|NCT03571256|54754429|FG000|Overall Study|Protocol Violation|0|||
28098738|NCT03571256|54754430|FG001|Overall Study|Protocol Violation|1|||
28098739|NCT03571256|54754431|FG002|Overall Study|Protocol Violation|1|||
28098740|NCT03570554|54754445|FG000|Overall Study|Non-compliance with study drug|0|||
28098741|NCT03570554|54754446|FG001|Overall Study|Non-compliance with study drug|0|||
28098742|NCT03570554|54754447|FG002|Overall Study|Non-compliance with study drug|1|||
28098743|NCT03570554|54754448|FG003|Overall Study|Non-compliance with study drug|0|||
28098744|NCT03570554|54754445|FG000|Overall Study|Adverse Event|0|||
28098745|NCT03570554|54754446|FG001|Overall Study|Adverse Event|0|||
28098746|NCT03570554|54754447|FG002|Overall Study|Adverse Event|0|||
28098747|NCT03570554|54754448|FG003|Overall Study|Adverse Event|1|||
28098748|NCT04004208|54754460|FG000|Overall Study|Withdrawal by parent/guardian|1|||
28098749|NCT04004208|54754461|FG001|Overall Study|Withdrawal by parent/guardian|1|||
28098750|NCT04004208|54754460|FG000|Overall Study|Death|3|||
28098751|NCT04004208|54754461|FG001|Overall Study|Death|0|||
28098752|NCT04004208|54754460|FG000|Overall Study|COVID-19 pandemic|1|||
27911271|NCT00195663|54569274|FG001|2-year Double-blind Treatment Period|Planned selection criteria|1|||
27911272|NCT00195663|54569275|FG002|2-year Double-blind Treatment Period|Planned selection criteria|0|||
28098753|NCT04004208|54754461|FG001|Overall Study|COVID-19 pandemic|0|||
28098754|NCT04004208|54754460|FG000|Overall Study|Physician Decision|1|||
28098755|NCT04004208|54754461|FG001|Overall Study|Physician Decision|0|||
28098756|NCT04004208|54754460|FG000|Overall Study|Adverse Event|1|||
28098757|NCT04004208|54754461|FG001|Overall Study|Adverse Event|1|||
28098758|NCT03643952|54754467|FG000|Overall Study|Lack of Efficacy|1|||
28098759|NCT03035032|54754479|FG000|Overall Study|Adverse Event|2|||
27739729|NCT02222896|54189358|FG000|Abdomen|Did not qualify|34|||
27996364|NCT00806286|54655193|FG000|Overall Study|Lost to Follow-up|0|||
27996365|NCT00806286|54655194|FG001|Overall Study|Lost to Follow-up|1|||
27996366|NCT00806286|54655195|FG002|Overall Study|Lost to Follow-up|0|||
27996367|NCT00806286|54655193|FG000|Overall Study|Withdrawal by Subject|8|||
27996368|NCT00806286|54655194|FG001|Overall Study|Withdrawal by Subject|3|||
27996369|NCT00806286|54655195|FG002|Overall Study|Withdrawal by Subject|1|||
27996370|NCT00806286|54655193|FG000|Overall Study|Physician Decision|2|||
27996371|NCT00806286|54655194|FG001|Overall Study|Physician Decision|2|||
27996372|NCT00806286|54655195|FG002|Overall Study|Physician Decision|0|||
27911273|NCT00195663|54569273|FG000|2-year Double-blind Treatment Period|Recovery|1|||
27911274|NCT00195663|54569274|FG001|2-year Double-blind Treatment Period|Recovery|0|||
27911275|NCT00195663|54569275|FG002|2-year Double-blind Treatment Period|Recovery|1|||
27911276|NCT00195663|54569273|FG000|2-year Double-blind Treatment Period|Administrative reasons|3|||
27911277|NCT00195663|54569274|FG001|2-year Double-blind Treatment Period|Administrative reasons|2|||
27911278|NCT00195663|54569275|FG002|2-year Double-blind Treatment Period|Administrative reasons|9|||
27911279|NCT00195663|54569273|FG000|Open-Label Extension Period|Adverse Event|21|||
27911280|NCT00195663|54569274|FG001|Open-Label Extension Period|Adverse Event|32|||
27911281|NCT00195663|54569275|FG002|Open-Label Extension Period|Adverse Event|36|||
27996373|NCT00806286|54655193|FG000|Overall Study|Due to a variety of reasons|7|||
28098760|NCT03035032|54754479|FG000|Overall Study|Death|9|||
28098761|NCT03035032|54754479|FG000|Overall Study|Lost to Follow-up|1|||
28098762|NCT03035032|54754479|FG000|Overall Study|Progressive Disease|22|||
28098763|NCT03035032|54754479|FG000|Overall Study|Protocol Violation|2|||
28098764|NCT03035032|54754479|FG000|Overall Study|Withdrawal by Subject|2|||
28098765|NCT03035032|54754479|FG000|Overall Study|Physician Decision|5|||
28098766|NCT03629184|54754485|FG000|Overall Study|Withdrawal by Subject|2|||
28098767|NCT03629184|54754486|FG001|Overall Study|Withdrawal by Subject|1|||
28098768|NCT03629184|54754485|FG000|Overall Study|Physician Decision|1|||
28098769|NCT03629184|54754486|FG001|Overall Study|Physician Decision|0|||
28098770|NCT03549338|54754504|FG000|Overall Study|Progressive Disease|1|||
28098771|NCT03549338|54754505|FG001|Overall Study|Progressive Disease|0|||
28098772|NCT03549338|54754506|FG002|Overall Study|Progressive Disease|0|||
28098773|NCT03549338|54754504|FG000|Overall Study|Clinical Progression|0|||
28098774|NCT03549338|54754505|FG001|Overall Study|Clinical Progression|1|||
28098775|NCT03549338|54754506|FG002|Overall Study|Clinical Progression|0|||
28098776|NCT03629028|54754514|FG000|Overall Study|Lost to Follow-up|26|||
28098777|NCT03629028|54754515|FG001|Overall Study|Lost to Follow-up|23|||
28098778|NCT03629028|54754514|FG000|Overall Study|Pregnancy|4|||
28098779|NCT03629028|54754515|FG001|Overall Study|Pregnancy|2|||
28098780|NCT03629028|54754514|FG000|Overall Study|intolerance to examination|2|||
28098781|NCT03629028|54754515|FG001|Overall Study|intolerance to examination|0|||
28098782|NCT03549104|54754533|FG000|Overall Study|Physician Decision|2|||
28098783|NCT03549104|54754534|FG001|Overall Study|Physician Decision|0|||
28098784|NCT03549104|54754533|FG000|Overall Study|Withdrawal by Subject|5|||
28098785|NCT03549104|54754534|FG001|Overall Study|Withdrawal by Subject|2|||
28098786|NCT03549104|54754533|FG000|Overall Study|Covid shelter in place|1|||
28098787|NCT03549104|54754534|FG001|Overall Study|Covid shelter in place|2|||
28098788|NCT02892344|54754542|FG000|Overall Study|Protocol deviation|3|||
28098789|NCT02892344|54754543|FG001|Overall Study|Protocol deviation|4|||
28098790|NCT02892344|54754542|FG000|Overall Study|Adverse Event|1|||
28098791|NCT02892344|54754543|FG001|Overall Study|Adverse Event|8|||
28098792|NCT02892344|54754542|FG000|Overall Study|Lost to Follow-up|0|||
28098793|NCT02892344|54754543|FG001|Overall Study|Lost to Follow-up|1|||
28098794|NCT02892344|54754542|FG000|Overall Study|Non-compliance with study treatment|0|||
28098795|NCT02892344|54754543|FG001|Overall Study|Non-compliance with study treatment|1|||
28098796|NCT02892344|54754542|FG000|Overall Study|Physician Decision|0|||
28098797|NCT02892344|54754543|FG001|Overall Study|Physician Decision|2|||
28098798|NCT02892344|54754542|FG000|Overall Study|Subject/guardian decision|0|||
28098799|NCT02892344|54754543|FG001|Overall Study|Subject/guardian decision|4|||
28098800|NCT02892344|54754542|FG000|Overall Study|Technical problems|0|||
28098801|NCT02892344|54754543|FG001|Overall Study|Technical problems|1|||
28098802|NCT03567980|54754549|FG000|Overall Study|Adverse Event|1|||
28098803|NCT02894840|54754557|FG000|Overall Study|Lost to Follow-up|1|||
28098804|NCT02894840|54754558|FG001|Overall Study|Lost to Follow-up|0|||
27911282|NCT00195663|54569273|FG000|Open-Label Extension Period|Lost to Follow-up|9|||
27911283|NCT00195663|54569274|FG001|Open-Label Extension Period|Lost to Follow-up|2|||
27911284|NCT00195663|54569275|FG002|Open-Label Extension Period|Lost to Follow-up|6|||
27996374|NCT00806286|54655194|FG001|Overall Study|Due to a variety of reasons|2|||
27996375|NCT00806286|54655195|FG002|Overall Study|Due to a variety of reasons|1|||
28098805|NCT02894840|54754559|FG002|Overall Study|Lost to Follow-up|3|||
28098806|NCT02894840|54754560|FG003|Overall Study|Lost to Follow-up|0|||
28098807|NCT03358030|54754579|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|2|||
28098808|NCT03358030|54754580|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
28098809|NCT03358030|54754581|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
28172628|NCT02456740|54844361|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28|||
28098810|NCT03358030|54754582|FG003|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
27911285|NCT00195663|54569273|FG000|Open-Label Extension Period|Recovery|0|||
27911286|NCT00195663|54569274|FG001|Open-Label Extension Period|Recovery|2|||
27911287|NCT00195663|54569275|FG002|Open-Label Extension Period|Recovery|2|||
27911288|NCT00195663|54569273|FG000|Open-Label Extension Period|Protocol Violation|3|||
27911289|NCT00195663|54569274|FG001|Open-Label Extension Period|Protocol Violation|4|||
27911290|NCT00195663|54569275|FG002|Open-Label Extension Period|Protocol Violation|4|||
27911291|NCT00195663|54569273|FG000|Open-Label Extension Period|Death|2|||
27911292|NCT00195663|54569274|FG001|Open-Label Extension Period|Death|2|||
27911293|NCT00195663|54569275|FG002|Open-Label Extension Period|Death|2|||
27911294|NCT00195663|54569273|FG000|Open-Label Extension Period|Withdrawal by Subject|16|||
27911295|NCT00195663|54569274|FG001|Open-Label Extension Period|Withdrawal by Subject|15|||
27911296|NCT00195663|54569275|FG002|Open-Label Extension Period|Withdrawal by Subject|22|||
27911297|NCT00195663|54569273|FG000|Open-Label Extension Period|Lack of Efficacy|14|||
27911298|NCT00195663|54569274|FG001|Open-Label Extension Period|Lack of Efficacy|6|||
27911299|NCT00195663|54569275|FG002|Open-Label Extension Period|Lack of Efficacy|12|||
27911300|NCT00195663|54569273|FG000|Open-Label Extension Period|Administrative reasons|11|||
27911301|NCT00195663|54569274|FG001|Open-Label Extension Period|Administrative reasons|11|||
27911302|NCT00195663|54569275|FG002|Open-Label Extension Period|Administrative reasons|13|||
27911303|NCT01135498|54569293|FG000|Overall Study|Adverse Event|20|||
27911304|NCT01135498|54569293|FG000|Overall Study|Progressive disease|38|||
27911305|NCT01135498|54569293|FG000|Overall Study|Investigator judgement|25|||
27911306|NCT01135498|54569293|FG000|Overall Study|Withdrawal by Subject|4|||
27911307|NCT01135498|54569293|FG000|Overall Study|Death|1|||
27911308|NCT01135498|54569293|FG000|Overall Study|Ongoing at time of analysis|2|||
27911309|NCT00195507|54569300|FG000|Overall Study|Adverse Event|24|||
27911310|NCT00195507|54569301|FG001|Overall Study|Adverse Event|13|||
27911311|NCT00195507|54569300|FG000|Overall Study|Death|0|||
27911312|NCT00195507|54569301|FG001|Overall Study|Death|1|||
27911313|NCT00195507|54569300|FG000|Overall Study|Failed to Return|4|||
28098811|NCT03358030|54754579|FG000|Overall Study|Ineligibility|0|||
28098812|NCT03358030|54754580|FG001|Overall Study|Ineligibility|0|||
28098813|NCT03358030|54754581|FG002|Overall Study|Ineligibility|0|||
28098814|NCT03358030|54754582|FG003|Overall Study|Ineligibility|2|||
28098815|NCT03358030|54754579|FG000|Overall Study|Voluntary Withdrawal|1|||
28098816|NCT03358030|54754580|FG001|Overall Study|Voluntary Withdrawal|1|||
28098817|NCT03358030|54754581|FG002|Overall Study|Voluntary Withdrawal|3|||
28098818|NCT03358030|54754582|FG003|Overall Study|Voluntary Withdrawal|1|||
28098819|NCT03358030|54754579|FG000|Overall Study|Other|0|||
28098820|NCT03358030|54754580|FG001|Overall Study|Other|0|||
28098821|NCT03358030|54754581|FG002|Overall Study|Other|1|||
28098822|NCT03358030|54754582|FG003|Overall Study|Other|0|||
28098823|NCT03566810|54754596|FG000|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
28098824|NCT03566810|54754597|FG001|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1|||
28098825|NCT03566810|54754598|FG002|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
28098826|NCT03566810|54754599|FG003|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
28098827|NCT03628716|54754622|FG000|Overall Study|Adverse Event|1|||
27996376|NCT00590538|54655203|FG000|Overall Study|Study terminated before completed|2|||
27996377|NCT00796419|54655209|FG000|Overall Study|Death|0|||
27996378|NCT00796419|54655210|FG001|Overall Study|Death|1|||
27996379|NCT00796107|54655216|FG000|Overall Study|Lack of Efficacy|1|||
27911314|NCT00195507|54569301|FG001|Overall Study|Failed to Return|3|||
27911315|NCT00195507|54569300|FG000|Overall Study|Physician Decision|1|||
27911316|NCT00195507|54569301|FG001|Overall Study|Physician Decision|2|||
27911317|NCT00195507|54569300|FG000|Overall Study|Lost to Follow-up|3|||
27996380|NCT00796107|54655216|FG000|Overall Study|Progressive Disease|5|||
27996381|NCT00795951|54655220|FG000|Overall Study|Lost to Follow-up|1|||
27996382|NCT00795951|54655220|FG000|Overall Study|Withdrawal by Subject|1|||
27996383|NCT00795717|54655227|FG000|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1|||
27996384|NCT00795717|54655228|FG001|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0|||
27996385|NCT00795717|54655227|FG000|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
27996386|NCT00795717|54655228|FG001|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
27996387|NCT00795717|54655227|FG000|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0|||
27996388|NCT00795717|54655228|FG001|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1|||
27996389|NCT00795717|54655227|FG000|Phase II|too busy|0|||
27996390|NCT00795717|54655228|FG001|Phase II|too busy|1|||
27996391|NCT00805740|54655237|FG000|Overall Study|Death|7|||
27911318|NCT00195507|54569301|FG001|Overall Study|Lost to Follow-up|2|||
27911319|NCT00195507|54569300|FG000|Overall Study|Protocol Violation|5|||
27996392|NCT00805740|54655238|FG001|Overall Study|Death|4|||
27911320|NCT00195507|54569301|FG001|Overall Study|Protocol Violation|4|||
27996393|NCT00805740|54655237|FG000|Overall Study|Withdrawal by Subject|1|||
27996394|NCT00805740|54655238|FG001|Overall Study|Withdrawal by Subject|0|||
28098828|NCT03628716|54754623|FG001|Overall Study|Adverse Event|1|||
28098829|NCT03628716|54754622|FG000|Overall Study|Death|1|||
27739730|NCT02222896|54189359|FG001|Abdomen|Did not qualify|10|||
27911321|NCT00195507|54569300|FG000|Overall Study|Lack of Efficacy|40|||
28098830|NCT03628716|54754623|FG001|Overall Study|Death|0|||
27911322|NCT00195507|54569301|FG001|Overall Study|Lack of Efficacy|67|||
27911323|NCT00195507|54569300|FG000|Overall Study|Withdrawal by Subject|16|||
27911324|NCT00195507|54569301|FG001|Overall Study|Withdrawal by Subject|23|||
27996395|NCT00805740|54655237|FG000|Overall Study|Lost to Follow-up|1|||
27996396|NCT00805740|54655238|FG001|Overall Study|Lost to Follow-up|0|||
27996397|NCT00805740|54655237|FG000|Overall Study|Randomized, but not treated|2|||
27996398|NCT00805740|54655238|FG001|Overall Study|Randomized, but not treated|0|||
27996399|NCT00795639|54655246|FG000|Overall Study|Death|1|||
27996400|NCT00795639|54655247|FG001|Overall Study|Death|6|||
28098831|NCT03628716|54754622|FG000|Overall Study|Lack of Efficacy|15|||
28098832|NCT03628716|54754623|FG001|Overall Study|Lack of Efficacy|20|||
28098833|NCT03628716|54754622|FG000|Overall Study|Withdrawal by Subject|1|||
28098834|NCT03628716|54754623|FG001|Overall Study|Withdrawal by Subject|2|||
28098835|NCT03628716|54754622|FG000|Overall Study|Study Terminated by Sponsor|1|||
28098836|NCT03628716|54754623|FG001|Overall Study|Study Terminated by Sponsor|0|||
28098837|NCT04002960|54754631|FG000|Overall Study|Withdrawn prior to Completion|2|||
28098838|NCT04002648|54754637|FG000|Overall Study|Lost to Follow-up|2|||
28098839|NCT04002648|54754638|FG001|Overall Study|Lost to Follow-up|0|||
28098840|NCT00088413|54754659|FG000|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
28098841|NCT00088413|54754660|FG001|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
28098842|NCT00088413|54754661|FG002|Overall Study|Limited supply of trmt drug (PANVAC-f)|1|||
28098843|NCT00088413|54754662|FG003|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
28098844|NCT00088413|54754659|FG000|Overall Study|Adverse Events/Side Effects|0|||
28098845|NCT00088413|54754660|FG001|Overall Study|Adverse Events/Side Effects|1|||
28098846|NCT00088413|54754661|FG002|Overall Study|Adverse Events/Side Effects|1|||
28098847|NCT00088413|54754662|FG003|Overall Study|Adverse Events/Side Effects|0|||
28098848|NCT00088413|54754659|FG000|Overall Study|Refused trmt Off-study per pt wishes|0|||
28098849|NCT00088413|54754660|FG001|Overall Study|Refused trmt Off-study per pt wishes|1|||
28098850|NCT00088413|54754661|FG002|Overall Study|Refused trmt Off-study per pt wishes|1|||
28098851|NCT00088413|54754662|FG003|Overall Study|Refused trmt Off-study per pt wishes|0|||
28098852|NCT00088413|54754659|FG000|Overall Study|Off study due to missing a vaccine dose|1|||
28098853|NCT00088413|54754660|FG001|Overall Study|Off study due to missing a vaccine dose|0|||
28098854|NCT00088413|54754661|FG002|Overall Study|Off study due to missing a vaccine dose|0|||
28098855|NCT00088413|54754662|FG003|Overall Study|Off study due to missing a vaccine dose|0|||
27911325|NCT00195507|54569300|FG000|Overall Study|Protocol Deviation|6|||
27911326|NCT00195507|54569301|FG001|Overall Study|Protocol Deviation|3|||
27911327|NCT01134562|54569312|FG000|Overall Study|Adverse Event|0|||
27911328|NCT01134562|54569313|FG001|Overall Study|Adverse Event|1|||
27911329|NCT01134562|54569314|FG002|Overall Study|Adverse Event|0|||
27911330|NCT01134562|54569315|FG003|Overall Study|Adverse Event|0|||
27911331|NCT01134562|54569316|FG004|Overall Study|Adverse Event|0|||
27911332|NCT00195429|54569343|FG000|Overall Study|Adverse Event|2|||
27911333|NCT00195429|54569344|FG001|Overall Study|Adverse Event|4|||
27911334|NCT00195429|54569343|FG000|Overall Study|Lack of Efficacy|2|||
27911335|NCT00195429|54569344|FG001|Overall Study|Lack of Efficacy|1|||
27911336|NCT00195429|54569343|FG000|Overall Study|Lost to Follow-up|1|||
27911337|NCT00195429|54569344|FG001|Overall Study|Lost to Follow-up|0|||
27911338|NCT00195351|54569352|FG000|Overall Study|Lost to Follow-up|9|||
27911339|NCT00195351|54569353|FG001|Overall Study|Lost to Follow-up|9|||
27911340|NCT00195351|54569352|FG000|Overall Study|Withdrawal by Subject|6|||
27911341|NCT00195351|54569353|FG001|Overall Study|Withdrawal by Subject|3|||
27911342|NCT00195351|54569352|FG000|Overall Study|Protocol Deviation|3|||
27911343|NCT00195351|54569353|FG001|Overall Study|Protocol Deviation|2|||
27996401|NCT00795639|54655246|FG000|Overall Study|Withdrawal by Subject|1|||
27996402|NCT00795639|54655247|FG001|Overall Study|Withdrawal by Subject|3|||
27996403|NCT00795639|54655246|FG000|Overall Study|Pregnancy|1|||
27996404|NCT00795639|54655247|FG001|Overall Study|Pregnancy|0|||
27996405|NCT00795639|54655246|FG000|Overall Study|Adverse Event|5|||
27996406|NCT00795639|54655247|FG001|Overall Study|Adverse Event|2|||
27996407|NCT00795639|54655246|FG000|Overall Study|Other|0|||
27996408|NCT00795639|54655247|FG001|Overall Study|Other|2|||
27996409|NCT00795639|54655246|FG000|Overall Study|Terminated by sponsor|13|||
27996410|NCT00795639|54655247|FG001|Overall Study|Terminated by sponsor|12|||
27996411|NCT00795639|54655246|FG000|Overall Study|Randomized and not treated|0|||
27996412|NCT00795639|54655247|FG001|Overall Study|Randomized and not treated|1|||
27996413|NCT00589602|54655253|FG000|Overall Study|Did not collect enough CD34+ cells|1|||
27911344|NCT00195351|54569352|FG000|Overall Study|Death|3|||
27911345|NCT00195351|54569353|FG001|Overall Study|Death|1|||
27996414|NCT00794157|54655262|FG000|Overall Study|Adverse Event|4|||
27911346|NCT00195351|54569352|FG000|Overall Study|Lack of Efficacy|0|||
27911347|NCT00195351|54569353|FG001|Overall Study|Lack of Efficacy|1|||
27911348|NCT00195273|54569361|FG000|Overall Study|Adverse Event|9|||
27911349|NCT00195273|54569362|FG001|Overall Study|Adverse Event|9|||
27911350|NCT00195273|54569361|FG000|Overall Study|Protocol deviation|0|||
27996415|NCT00794157|54655263|FG001|Overall Study|Adverse Event|1|||
27996416|NCT00794157|54655264|FG002|Overall Study|Adverse Event|8|||
28098856|NCT00088413|54754659|FG000|Overall Study|Death|0|||
27996417|NCT00794157|54655262|FG000|Overall Study|Subject withdrew consent|2|||
27996418|NCT00794157|54655263|FG001|Overall Study|Subject withdrew consent|0|||
27996419|NCT00794157|54655264|FG002|Overall Study|Subject withdrew consent|3|||
27996420|NCT00794157|54655262|FG000|Overall Study|Lost to Follow-up|2|||
27996421|NCT00794157|54655263|FG001|Overall Study|Lost to Follow-up|0|||
27996422|NCT00794157|54655264|FG002|Overall Study|Lost to Follow-up|1|||
27996423|NCT00794157|54655262|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
27996424|NCT00794157|54655263|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
27996425|NCT00794157|54655264|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
27996426|NCT00794157|54655262|FG000|Overall Study|Administrative problems|1|||
27996427|NCT00794157|54655263|FG001|Overall Study|Administrative problems|7|||
27996428|NCT00794157|54655264|FG002|Overall Study|Administrative problems|4|||
27996429|NCT00794157|54655262|FG000|Overall Study|Abnormal test procedure result(s)|0|||
27996430|NCT00794157|54655263|FG001|Overall Study|Abnormal test procedure result(s)|1|||
27911351|NCT00195273|54569362|FG001|Overall Study|Protocol deviation|1|||
27911352|NCT00195273|54569361|FG000|Overall Study|Lack of Efficacy|3|||
27911353|NCT00195273|54569362|FG001|Overall Study|Lack of Efficacy|1|||
27911354|NCT00195273|54569361|FG000|Overall Study|Procedural complications|9|||
27911355|NCT00195273|54569362|FG001|Overall Study|Procedural complications|3|||
27911356|NCT00193479|54569368|FG000|Induction Chemotherapy|Adverse Event|2|||
27996431|NCT00794157|54655264|FG002|Overall Study|Abnormal test procedure result(s)|0|||
27996432|NCT00794157|54655262|FG000|Overall Study|Protocol deviation|0|||
27996433|NCT00794157|54655263|FG001|Overall Study|Protocol deviation|1|||
27996434|NCT00794157|54655264|FG002|Overall Study|Protocol deviation|1|||
27996435|NCT00588237|54655272|FG000|Overall Study|Evaluable for toxicity only|3|||
27996436|NCT00588237|54655272|FG000|Overall Study|Patien not treated|1|||
27996437|NCT00790023|54655279|FG000|Overall Study|Adverse Event|2|||
27996438|NCT00790023|54655280|FG001|Overall Study|Adverse Event|1|||
27996439|NCT00790023|54655281|FG002|Overall Study|Adverse Event|4|||
27996440|NCT00790023|54655279|FG000|Overall Study|Protocol Violation|2|||
27996441|NCT00790023|54655280|FG001|Overall Study|Protocol Violation|4|||
27996442|NCT00790023|54655281|FG002|Overall Study|Protocol Violation|2|||
27996443|NCT00790023|54655279|FG000|Overall Study|Withdrawal by Subject|2|||
27911357|NCT00193479|54569368|FG000|Induction Chemotherapy|Disease Progression|1|||
27996444|NCT00790023|54655280|FG001|Overall Study|Withdrawal by Subject|0|||
27996445|NCT00790023|54655281|FG002|Overall Study|Withdrawal by Subject|6|||
27996446|NCT00790023|54655279|FG000|Overall Study|Lost to Follow-up|0|||
27996447|NCT00790023|54655280|FG001|Overall Study|Lost to Follow-up|0|||
27996448|NCT00790023|54655281|FG002|Overall Study|Lost to Follow-up|1|||
27996449|NCT00790023|54655279|FG000|Overall Study|Other|5|||
27996450|NCT00790023|54655280|FG001|Overall Study|Other|5|||
27996451|NCT00790023|54655281|FG002|Overall Study|Other|8|||
27996452|NCT00588822|54655290|FG000|Overall Study|progression of disease|8|||
27996453|NCT00589914|54655296|FG000|Overall Study|Adverse Event|19|||
27996454|NCT00589914|54655297|FG001|Overall Study|Adverse Event|10|||
27996455|NCT00589914|54655296|FG000|Overall Study|Death|2|||
27996456|NCT00589914|54655297|FG001|Overall Study|Death|0|||
27996457|NCT00589914|54655296|FG000|Overall Study|Lack of Efficacy|40|||
27996458|NCT00589914|54655297|FG001|Overall Study|Lack of Efficacy|43|||
27996459|NCT00589914|54655296|FG000|Overall Study|Lost to Follow-up|11|||
27996460|NCT00589914|54655297|FG001|Overall Study|Lost to Follow-up|18|||
27996461|NCT00589914|54655296|FG000|Overall Study|Pregnancy|1|||
27996462|NCT00589914|54655297|FG001|Overall Study|Pregnancy|0|||
27996463|NCT00589914|54655296|FG000|Overall Study|Withdrawal by Subject|55|||
27996464|NCT00589914|54655297|FG001|Overall Study|Withdrawal by Subject|49|||
27996465|NCT00589914|54655296|FG000|Overall Study|Other|22|||
27996466|NCT00589914|54655297|FG001|Overall Study|Other|17|||
27996467|NCT00789555|54655306|FG000|Overall Study|Protocol Amendment|78|||
27911358|NCT00193479|54569368|FG000|Maintenance Rituximab|Opted for full course rituximab/chemotherapy|2|||
27911359|NCT00193479|54569368|FG000|Maintenance Rituximab|Withdrawal by Subject|2|||
27996468|NCT00789555|54655307|FG001|Overall Study|Protocol Amendment|76|||
27996469|NCT00789555|54655308|FG002|Overall Study|Protocol Amendment|80|||
27996470|NCT00789555|54655306|FG000|Overall Study|Adverse Event|17|||
27996471|NCT00789555|54655307|FG001|Overall Study|Adverse Event|7|||
27996472|NCT00789555|54655308|FG002|Overall Study|Adverse Event|10|||
27996473|NCT00789555|54655306|FG000|Overall Study|Lost to Follow-up|9|||
27996474|NCT00789555|54655307|FG001|Overall Study|Lost to Follow-up|10|||
27996475|NCT00789555|54655308|FG002|Overall Study|Lost to Follow-up|18|||
27996476|NCT00789555|54655306|FG000|Overall Study|Patient decision unnrelated to adv event|38|||
27996477|NCT00789555|54655307|FG001|Overall Study|Patient decision unnrelated to adv event|29|||
27911360|NCT00193206|54569372|FG000|Preoperative Therapy|Lack of Efficacy|2|||
27911361|NCT00193206|54569372|FG000|Preoperative Therapy|Adverse Event|2|||
27911362|NCT00193206|54569372|FG000|Preoperative Therapy|Withdrawal by Subject|2|||
27996478|NCT00789555|54655308|FG002|Overall Study|Patient decision unnrelated to adv event|26|||
27996479|NCT00789555|54655306|FG000|Overall Study|Treatment failure|11|||
27996480|NCT00789555|54655307|FG001|Overall Study|Treatment failure|8|||
27996481|NCT00789555|54655308|FG002|Overall Study|Treatment failure|12|||
27996482|NCT00789555|54655306|FG000|Overall Study|Protocol Violation|6|||
27996483|NCT00789555|54655307|FG001|Overall Study|Protocol Violation|9|||
27996484|NCT00789555|54655308|FG002|Overall Study|Protocol Violation|13|||
27996485|NCT00451321|54655324|FG000|Overall Study|Lost to Follow-up|3|||
27996486|NCT00451321|54655325|FG001|Overall Study|Lost to Follow-up|3|||
27996487|NCT00451321|54655326|FG002|Overall Study|Lost to Follow-up|1|||
27996488|NCT00451321|54655327|FG003|Overall Study|Lost to Follow-up|3|||
27996489|NCT00451321|54655328|FG004|Overall Study|Lost to Follow-up|0|||
27996490|NCT00451321|54655329|FG005|Overall Study|Lost to Follow-up|1|||
27996491|NCT00451321|54655330|FG006|Overall Study|Lost to Follow-up|0|||
27996492|NCT00451321|54655331|FG007|Overall Study|Lost to Follow-up|0|||
27996493|NCT00451321|54655324|FG000|Overall Study|Withdrawal by Subject|3|||
27996494|NCT00451321|54655325|FG001|Overall Study|Withdrawal by Subject|1|||
27996495|NCT00451321|54655326|FG002|Overall Study|Withdrawal by Subject|0|||
27996496|NCT00451321|54655327|FG003|Overall Study|Withdrawal by Subject|4|||
27996497|NCT00451321|54655328|FG004|Overall Study|Withdrawal by Subject|0|||
27996498|NCT00451321|54655329|FG005|Overall Study|Withdrawal by Subject|0|||
27996499|NCT00451321|54655330|FG006|Overall Study|Withdrawal by Subject|0|||
27996500|NCT00451321|54655331|FG007|Overall Study|Withdrawal by Subject|0|||
27996501|NCT00451321|54655324|FG000|Overall Study|Study closed/terminated|1|||
27996502|NCT00451321|54655325|FG001|Overall Study|Study closed/terminated|1|||
27996503|NCT00451321|54655326|FG002|Overall Study|Study closed/terminated|17|||
27996504|NCT00451321|54655327|FG003|Overall Study|Study closed/terminated|5|||
27996505|NCT00451321|54655328|FG004|Overall Study|Study closed/terminated|7|||
27996506|NCT00451321|54655329|FG005|Overall Study|Study closed/terminated|7|||
27996507|NCT00451321|54655330|FG006|Overall Study|Study closed/terminated|5|||
27996508|NCT00451321|54655331|FG007|Overall Study|Study closed/terminated|3|||
27996509|NCT00451321|54655324|FG000|Overall Study|Sponsor decision to amend protocol|0|||
27996510|NCT00451321|54655325|FG001|Overall Study|Sponsor decision to amend protocol|0|||
27996511|NCT00451321|54655326|FG002|Overall Study|Sponsor decision to amend protocol|0|||
27996512|NCT00451321|54655327|FG003|Overall Study|Sponsor decision to amend protocol|0|||
27996513|NCT00451321|54655328|FG004|Overall Study|Sponsor decision to amend protocol|0|||
27996514|NCT00451321|54655329|FG005|Overall Study|Sponsor decision to amend protocol|1|||
27996515|NCT00451321|54655330|FG006|Overall Study|Sponsor decision to amend protocol|1|||
27996516|NCT00451321|54655331|FG007|Overall Study|Sponsor decision to amend protocol|3|||
27996517|NCT00802464|54655357|FG000|Month 0 - Month 8|Adverse Event|0|||
27996518|NCT00802464|54655358|FG001|Month 0 - Month 8|Adverse Event|1|||
27996519|NCT00802464|54655359|FG002|Month 0 - Month 8|Adverse Event|1|||
27996520|NCT00802464|54655360|FG003|Month 0 - Month 8|Adverse Event|2|||
27996521|NCT00802464|54655357|FG000|Month 0 - Month 8|Protocol Violation|0|||
27996522|NCT00802464|54655358|FG001|Month 0 - Month 8|Protocol Violation|0|||
27996523|NCT00802464|54655359|FG002|Month 0 - Month 8|Protocol Violation|1|||
27996524|NCT00802464|54655360|FG003|Month 0 - Month 8|Protocol Violation|0|||
27996525|NCT00802464|54655357|FG000|Month 0 - Month 8|Withdrawal by Subject|0|||
27996526|NCT00802464|54655358|FG001|Month 0 - Month 8|Withdrawal by Subject|1|||
27996527|NCT00802464|54655359|FG002|Month 0 - Month 8|Withdrawal by Subject|2|||
27996528|NCT00802464|54655360|FG003|Month 0 - Month 8|Withdrawal by Subject|5|||
27996529|NCT00802464|54655357|FG000|Month 0 - Month 8|Lost to Follow-up|0|||
27996530|NCT00802464|54655358|FG001|Month 0 - Month 8|Lost to Follow-up|1|||
27996531|NCT00802464|54655359|FG002|Month 0 - Month 8|Lost to Follow-up|2|||
27911363|NCT00193206|54569372|FG000|Preoperative Therapy|False Positive Pregnancy Test|1|||
27911364|NCT00193206|54569372|FG000|Postoperative Therapy|Withdrawal by Subject|7|||
27911365|NCT00193206|54569372|FG000|Postoperative Therapy|Physician Decision|3|||
27911366|NCT00193206|54569372|FG000|Postoperative Therapy|Intercurrent Illness|2|||
27911367|NCT00193206|54569372|FG000|Postoperative Therapy|Lack of Efficacy|1|||
27911368|NCT00193206|54569372|FG000|Postoperative Therapy|Protocol Violation|1|||
27996532|NCT00802464|54655360|FG003|Month 0 - Month 8|Lost to Follow-up|2|||
27996533|NCT00802464|54655357|FG000|Month 0 - Month 8|Other|0|||
27911369|NCT00193050|54569376|FG000|Neoadjuvant Treatment|Lack of Efficacy|2|||
27911370|NCT00193050|54569376|FG000|Neoadjuvant Treatment|Intercurrent Illness|3|||
27911371|NCT00193050|54569376|FG000|Neoadjuvant Treatment|Physician Decision|2|||
27911372|NCT00193050|54569376|FG000|Neoadjuvant Treatment|Adverse Event|2|||
27996534|NCT00802464|54655358|FG001|Month 0 - Month 8|Other|0|||
27996535|NCT00802464|54655359|FG002|Month 0 - Month 8|Other|1|||
27996536|NCT00802464|54655360|FG003|Month 0 - Month 8|Other|0|||
27996537|NCT00802464|54655357|FG000|Month 8 - Month 14|Adverse Event|0|||
27996538|NCT00802464|54655358|FG001|Month 8 - Month 14|Adverse Event|1|||
27996539|NCT00802464|54655359|FG002|Month 8 - Month 14|Adverse Event|0|||
27996540|NCT00802464|54655360|FG003|Month 8 - Month 14|Adverse Event|0|||
28098857|NCT00088413|54754660|FG001|Overall Study|Death|1|||
27911373|NCT00193050|54569376|FG000|Adjuvant|Physician Decision|5|||
27911374|NCT00193050|54569376|FG000|Adjuvant|Intercurrent Hospitalization|3|||
27911375|NCT00193050|54569376|FG000|Adjuvant|Lack of Efficacy|2|||
27911376|NCT00192504|54569385|FG000|Overall Study|Lost to Follow-up|1|||
27911377|NCT00192504|54569386|FG001|Overall Study|Lost to Follow-up|0|||
27911378|NCT00192504|54569387|FG002|Overall Study|Lost to Follow-up|0|||
27996541|NCT00802464|54655357|FG000|Month 8 - Month 14|Withdrawal by Subject|1|||
27996542|NCT00802464|54655358|FG001|Month 8 - Month 14|Withdrawal by Subject|1|||
27911379|NCT00192504|54569388|FG003|Overall Study|Lost to Follow-up|0|||
27911380|NCT00192504|54569385|FG000|Overall Study|Dosing window missed|0|||
27911381|NCT00192504|54569386|FG001|Overall Study|Dosing window missed|0|||
27911382|NCT00192504|54569387|FG002|Overall Study|Dosing window missed|1|||
27911383|NCT00192504|54569388|FG003|Overall Study|Dosing window missed|0|||
27911384|NCT00192114|54569398|FG000|Overall Study|Objective Tumor Progression|19|||
27911385|NCT00192114|54569398|FG000|Overall Study|Adverse Event|2|||
27996543|NCT00802464|54655359|FG002|Month 8 - Month 14|Withdrawal by Subject|0|||
27996544|NCT00802464|54655360|FG003|Month 8 - Month 14|Withdrawal by Subject|0|||
27996545|NCT00802464|54655357|FG000|Month 8 - Month 14|Lost to Follow-up|0|||
27996546|NCT00802464|54655358|FG001|Month 8 - Month 14|Lost to Follow-up|0|||
27996547|NCT00802464|54655359|FG002|Month 8 - Month 14|Lost to Follow-up|1|||
27996548|NCT00802464|54655360|FG003|Month 8 - Month 14|Lost to Follow-up|0|||
27996549|NCT00450619|54655374|FG000|Overall Study|refused treatment after randomization|2|||
27996550|NCT00450619|54655375|FG001|Overall Study|refused treatment after randomization|0|||
27996551|NCT00450619|54655374|FG000|Overall Study|did not progress; refused further trmt|1|||
27996552|NCT00450619|54655375|FG001|Overall Study|did not progress; refused further trmt|1|||
27996553|NCT00450619|54655374|FG000|Overall Study|Adverse Event|1|||
27996554|NCT00450619|54655375|FG001|Overall Study|Adverse Event|0|||
27996555|NCT00802074|54655388|FG000|Overall Study|Adverse Event|1|||
27996556|NCT00802074|54655389|FG001|Overall Study|Adverse Event|1|||
27996557|NCT00802074|54655390|FG002|Overall Study|Adverse Event|1|||
27996558|NCT00802074|54655391|FG003|Overall Study|Adverse Event|0|||
27996559|NCT00802074|54655392|FG004|Overall Study|Adverse Event|0|||
27996560|NCT00802074|54655393|FG005|Overall Study|Adverse Event|0|||
27996561|NCT00802074|54655388|FG000|Overall Study|Withdrawal by Subject|1|||
27996562|NCT00802074|54655389|FG001|Overall Study|Withdrawal by Subject|0|||
27996563|NCT00802074|54655390|FG002|Overall Study|Withdrawal by Subject|0|||
27996564|NCT00802074|54655391|FG003|Overall Study|Withdrawal by Subject|0|||
28098858|NCT00088413|54754661|FG002|Overall Study|Death|0|||
28098859|NCT00088413|54754662|FG003|Overall Study|Death|0|||
28098860|NCT00088413|54754659|FG000|Overall Study|Progressive disease|9|||
28098861|NCT00088413|54754660|FG001|Overall Study|Progressive disease|11|||
28098862|NCT00088413|54754661|FG002|Overall Study|Progressive disease|8|||
28098863|NCT00088413|54754662|FG003|Overall Study|Progressive disease|14|||
28098864|NCT00088413|54754659|FG000|Overall Study|Other|0|||
28098865|NCT00088413|54754660|FG001|Overall Study|Other|1|||
28098866|NCT00088413|54754661|FG002|Overall Study|Other|0|||
28098867|NCT00088413|54754662|FG003|Overall Study|Other|0|||
28098868|NCT00088413|54754659|FG000|Overall Study|Patient unevaluable due to adverse event|0|||
28098869|NCT00088413|54754660|FG001|Overall Study|Patient unevaluable due to adverse event|0|||
28098870|NCT00088413|54754661|FG002|Overall Study|Patient unevaluable due to adverse event|1|||
28098871|NCT00088413|54754662|FG003|Overall Study|Patient unevaluable due to adverse event|0|||
28098872|NCT03995784|54754674|FG000|Overall Study|One subject discontinued on Day 7 due to injection site reactions after Day 1, 2, and 3 doses|1|||
28098873|NCT00086385|54754689|FG000|Overall Study|Death|2|||
28098874|NCT00086385|54754690|FG001|Overall Study|Death|2|||
28098875|NCT00086385|54754691|FG002|Overall Study|Death|1|||
28098876|NCT00086385|54754692|FG003|Overall Study|Death|1|||
28098877|NCT03993288|54754704|FG000|Overall Study|Lost to Follow-up|2|||
28098878|NCT03993288|54754705|FG001|Overall Study|Lost to Follow-up|1|||
28098879|NCT03993288|54754704|FG000|Overall Study|non-compliance to the inclusion criteria|0|||
28098880|NCT03993288|54754705|FG001|Overall Study|non-compliance to the inclusion criteria|1|||
28098881|NCT03993288|54754704|FG000|Overall Study|wrong randomization|0|||
28098882|NCT03993288|54754705|FG001|Overall Study|wrong randomization|1|||
28098883|NCT03993288|54754704|FG000|Overall Study|improper enrollment|0|||
28098884|NCT03993288|54754705|FG001|Overall Study|improper enrollment|1|||
28098885|NCT03993288|54754704|FG000|Overall Study|prescribed with prohibited concomitant therapy|1|||
28098886|NCT03993288|54754705|FG001|Overall Study|prescribed with prohibited concomitant therapy|0|||
28098887|NCT03993288|54754704|FG000|Overall Study|developed SAE|2|||
28098888|NCT03993288|54754705|FG001|Overall Study|developed SAE|0|||
28098889|NCT03993288|54754704|FG000|Overall Study|consent withdrawal|1|||
28098890|NCT03993288|54754705|FG001|Overall Study|consent withdrawal|0|||
28098891|NCT03993288|54754704|FG000|Overall Study|did not follow the treatment schedule|1|||
27911386|NCT00192114|54569398|FG000|Overall Study|Clinical Progression|2|||
27911387|NCT00192114|54569398|FG000|Overall Study|Death|1|||
27911388|NCT00192075|54569404|FG000|Overall Study|Disease Progression|23|||
28098892|NCT03993288|54754705|FG001|Overall Study|did not follow the treatment schedule|0|||
27911389|NCT00192075|54569405|FG001|Overall Study|Disease Progression|6|||
27911390|NCT00192075|54569404|FG000|Overall Study|Adverse Event|1|||
27996565|NCT00802074|54655392|FG004|Overall Study|Withdrawal by Subject|0|||
27996566|NCT00802074|54655393|FG005|Overall Study|Withdrawal by Subject|0|||
27996567|NCT00450385|54655410|FG000|Overall Study|Death|3|||
27996568|NCT00450385|54655410|FG000|Overall Study|Protocol Violation|1|||
27996569|NCT00450385|54655410|FG000|Overall Study|Withdrawal by Subject|2|||
27996570|NCT00450385|54655410|FG000|Overall Study|Lack of Efficacy|2|||
28098893|NCT03993288|54754704|FG000|Overall Study|did not follow the treatment regimen|1|||
27996571|NCT00450385|54655410|FG000|Overall Study|Adverse Event|1|||
27996572|NCT00450385|54655410|FG000|Overall Study|Physician Decision|1|||
27996573|NCT00450385|54655410|FG000|Overall Study|Other|3|||
27996574|NCT00588354|54655417|FG000|Baseline to 2 Weeks|Adverse Event|1|||
27996575|NCT00588354|54655418|FG001|Baseline to 2 Weeks|Adverse Event|0|||
27996576|NCT00588354|54655417|FG000|Baseline to 2 Weeks|Lack of Efficacy|1|||
27996577|NCT00588354|54655418|FG001|Baseline to 2 Weeks|Lack of Efficacy|0|||
27996578|NCT00588354|54655417|FG000|Baseline to 4 Weeks|Lost to Follow-up|0|||
27996579|NCT00588354|54655418|FG001|Baseline to 4 Weeks|Lost to Follow-up|1|||
27996580|NCT00449761|54655425|FG000|Overall Study|Disease progression|12|||
27996581|NCT00449761|54655425|FG000|Overall Study|Death|5|||
27996582|NCT00449761|54655425|FG000|Overall Study|New cancer therapy|1|||
27996583|NCT00800982|54655432|FG000|Overall Study|Lost to Follow-up|1|||
27996584|NCT00800982|54655433|FG001|Overall Study|Lost to Follow-up|2|||
27996585|NCT00800982|54655432|FG000|Overall Study|Withdrawal by Subject|0|||
27996586|NCT00800982|54655433|FG001|Overall Study|Withdrawal by Subject|1|||
27996587|NCT00800982|54655432|FG000|Overall Study|Patient moved out of state|1|||
27996588|NCT00800982|54655433|FG001|Overall Study|Patient moved out of state|0|||
27996589|NCT00830960|54655445|FG000|Overall Study|Death|5|||
27996590|NCT00830960|54655446|FG001|Overall Study|Death|4|||
27996591|NCT00830960|54655447|FG002|Overall Study|Death|3|||
27996592|NCT00830960|54655448|FG003|Overall Study|Death|2|||
27996593|NCT00830960|54655449|FG004|Overall Study|Death|6|||
27996594|NCT00830960|54655450|FG005|Overall Study|Death|1|||
27996595|NCT00830960|54655445|FG000|Overall Study|Lost to Follow-up|1|||
27996596|NCT00830960|54655446|FG001|Overall Study|Lost to Follow-up|1|||
27996597|NCT00830960|54655447|FG002|Overall Study|Lost to Follow-up|1|||
27996598|NCT00830960|54655448|FG003|Overall Study|Lost to Follow-up|0|||
27996599|NCT00830960|54655449|FG004|Overall Study|Lost to Follow-up|0|||
27996600|NCT00830960|54655450|FG005|Overall Study|Lost to Follow-up|1|||
27996601|NCT00830960|54655445|FG000|Overall Study|Withdrawal by Subject|19|||
27996602|NCT00830960|54655446|FG001|Overall Study|Withdrawal by Subject|19|||
27996603|NCT00830960|54655447|FG002|Overall Study|Withdrawal by Subject|18|||
27996604|NCT00830960|54655448|FG003|Overall Study|Withdrawal by Subject|23|||
27996605|NCT00830960|54655449|FG004|Overall Study|Withdrawal by Subject|16|||
27996606|NCT00830960|54655450|FG005|Overall Study|Withdrawal by Subject|21|||
27996607|NCT00830960|54655445|FG000|Overall Study|Sponsor Decision|1|||
27996608|NCT00830960|54655446|FG001|Overall Study|Sponsor Decision|2|||
27996609|NCT00830960|54655447|FG002|Overall Study|Sponsor Decision|3|||
27996610|NCT00830960|54655448|FG003|Overall Study|Sponsor Decision|4|||
27996611|NCT00830960|54655449|FG004|Overall Study|Sponsor Decision|5|||
27996612|NCT00830960|54655450|FG005|Overall Study|Sponsor Decision|7|||
27996613|NCT00830960|54655445|FG000|Overall Study|No study drug received|7|||
27996614|NCT00830960|54655446|FG001|Overall Study|No study drug received|2|||
27996615|NCT00830960|54655447|FG002|Overall Study|No study drug received|4|||
27996616|NCT00830960|54655448|FG003|Overall Study|No study drug received|3|||
27996617|NCT00830960|54655449|FG004|Overall Study|No study drug received|5|||
27996618|NCT00830960|54655450|FG005|Overall Study|No study drug received|7|||
27996619|NCT00830804|54655487|FG000|Overall Study|Lost to Follow-up|4|||
27996620|NCT00830804|54655487|FG000|Overall Study|Death|1|||
27996621|NCT00830804|54655487|FG000|Overall Study|Unable to get to clinic|7|||
27996622|NCT00830804|54655487|FG000|Overall Study|Consent withdrawn|2|||
27996623|NCT00830804|54655487|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
27996624|NCT00789477|54655497|FG000|Overall Study|Withdrawal by Subject|2|||
27996625|NCT00789477|54655498|FG001|Overall Study|Withdrawal by Subject|1|||
27996626|NCT00789477|54655499|FG002|Overall Study|Withdrawal by Subject|3|||
27996627|NCT00789477|54655500|FG003|Overall Study|Withdrawal by Subject|2|||
27996628|NCT00789477|54655501|FG004|Overall Study|Withdrawal by Subject|3|||
27996629|NCT00789477|54655497|FG000|Overall Study|Protocol Violation|1|||
27996630|NCT00789477|54655498|FG001|Overall Study|Protocol Violation|0|||
27996631|NCT00789477|54655499|FG002|Overall Study|Protocol Violation|0|||
27996632|NCT00789477|54655500|FG003|Overall Study|Protocol Violation|1|||
27996633|NCT00789477|54655501|FG004|Overall Study|Protocol Violation|0|||
27996634|NCT00789477|54655497|FG000|Overall Study|Adverse Event|3|||
28172629|NCT02456740|54844362|FG002|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21|||
28172630|NCT02456740|54844363|FG003|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
27996635|NCT00789477|54655498|FG001|Overall Study|Adverse Event|3|||
27996636|NCT00789477|54655499|FG002|Overall Study|Adverse Event|1|||
27996637|NCT00789477|54655500|FG003|Overall Study|Adverse Event|0|||
27996638|NCT00789477|54655501|FG004|Overall Study|Adverse Event|0|||
27996639|NCT00789477|54655497|FG000|Overall Study|Death|1|||
27996640|NCT00789477|54655498|FG001|Overall Study|Death|1|||
27996641|NCT00789477|54655499|FG002|Overall Study|Death|2|||
27996642|NCT00789477|54655500|FG003|Overall Study|Death|2|||
27996643|NCT00789477|54655501|FG004|Overall Study|Death|0|||
27996644|NCT00789477|54655497|FG000|Overall Study|Lost to Follow-up|0|||
27996645|NCT00789477|54655498|FG001|Overall Study|Lost to Follow-up|1|||
27996646|NCT00789477|54655499|FG002|Overall Study|Lost to Follow-up|4|||
27996647|NCT00789477|54655500|FG003|Overall Study|Lost to Follow-up|2|||
27996648|NCT00789477|54655501|FG004|Overall Study|Lost to Follow-up|4|||
27996649|NCT00789477|54655497|FG000|Overall Study|Lack of Efficacy|2|||
27996650|NCT00789477|54655498|FG001|Overall Study|Lack of Efficacy|0|||
27996651|NCT00789477|54655499|FG002|Overall Study|Lack of Efficacy|0|||
27996652|NCT00789477|54655500|FG003|Overall Study|Lack of Efficacy|0|||
27996653|NCT00789477|54655501|FG004|Overall Study|Lack of Efficacy|0|||
27996654|NCT00789477|54655497|FG000|Overall Study|Other|2|||
27996655|NCT00789477|54655498|FG001|Overall Study|Other|0|||
27996656|NCT00789477|54655499|FG002|Overall Study|Other|1|||
27996657|NCT00789477|54655500|FG003|Overall Study|Other|3|||
27996658|NCT00789477|54655501|FG004|Overall Study|Other|0|||
27996659|NCT00796614|54655519|FG000|Overall Study|Adverse Event|1|||
27996660|NCT00796614|54655520|FG001|Overall Study|Adverse Event|2|||
27996661|NCT00796614|54655521|FG002|Overall Study|Adverse Event|0|||
27996662|NCT00796614|54655522|FG003|Overall Study|Adverse Event|0|||
27996663|NCT00796614|54655519|FG000|Overall Study|Protocol Violation|0|||
27996664|NCT00796614|54655520|FG001|Overall Study|Protocol Violation|0|||
27996665|NCT00796614|54655521|FG002|Overall Study|Protocol Violation|2|||
27996666|NCT00796614|54655522|FG003|Overall Study|Protocol Violation|0|||
27996667|NCT00796614|54655519|FG000|Overall Study|Lost to Follow-up|2|||
27996668|NCT00796614|54655520|FG001|Overall Study|Lost to Follow-up|2|||
27996669|NCT00796614|54655521|FG002|Overall Study|Lost to Follow-up|1|||
27996670|NCT00796614|54655522|FG003|Overall Study|Lost to Follow-up|0|||
27996671|NCT00796614|54655519|FG000|Overall Study|Withdrawal by Subject|1|||
27996672|NCT00796614|54655520|FG001|Overall Study|Withdrawal by Subject|0|||
27996673|NCT00796614|54655521|FG002|Overall Study|Withdrawal by Subject|0|||
27996674|NCT00796614|54655522|FG003|Overall Study|Withdrawal by Subject|1|||
27996675|NCT00796614|54655519|FG000|Overall Study|Other than stated|1|||
27996676|NCT00796614|54655520|FG001|Overall Study|Other than stated|0|||
27911391|NCT00192075|54569405|FG001|Overall Study|Adverse Event|3|||
27911392|NCT00192075|54569404|FG000|Overall Study|Death|0|||
27911393|NCT00192075|54569405|FG001|Overall Study|Death|1|||
27911394|NCT00192075|54569404|FG000|Overall Study|Lack of Efficacy|0|||
27911395|NCT00192075|54569405|FG001|Overall Study|Lack of Efficacy|0|||
27911396|NCT00192075|54569404|FG000|Overall Study|Physician Decision|3|||
27911397|NCT00192075|54569405|FG001|Overall Study|Physician Decision|0|||
27911398|NCT00192075|54569404|FG000|Overall Study|Withdrawal by Subject|5|||
27911399|NCT00192075|54569405|FG001|Overall Study|Withdrawal by Subject|5|||
27911400|NCT00192075|54569404|FG000|Overall Study|Patient Non-Compliance|0|||
27911401|NCT00192075|54569405|FG001|Overall Study|Patient Non-Compliance|1|||
27911402|NCT00192075|54569404|FG000|Overall Study|Unacceptable Toxicity Exhibited by Drug|2|||
27911403|NCT00192075|54569405|FG001|Overall Study|Unacceptable Toxicity Exhibited by Drug|1|||
27911404|NCT00192075|54569404|FG000|Overall Study|Other|5|||
27911405|NCT00192075|54569405|FG001|Overall Study|Other|2|||
27911406|NCT00192036|54569416|FG000|Overall Study|Protocol Violation|3|||
27911407|NCT00192036|54569416|FG000|Overall Study|Adverse Event|6|||
27911408|NCT00192036|54569416|FG000|Overall Study|Patient/Physician Perception|1|||
27911409|NCT00192036|54569416|FG000|Overall Study|Objective Tumor Progression|4|||
27911410|NCT00192036|54569416|FG000|Overall Study|Clinical Disease Progression|1|||
27911411|NCT00192036|54569416|FG000|Overall Study|Death|1|||
27911412|NCT00192036|54569416|FG000|Overall Study|Unknown or Not Specified|5|||
27911413|NCT00191724|54569425|FG000|Overall Study|Adverse Event|0|||
27911414|NCT00191724|54569426|FG001|Overall Study|Adverse Event|0|||
27911415|NCT00191724|54569427|FG002|Overall Study|Adverse Event|1|||
27911416|NCT00191724|54569428|FG003|Overall Study|Adverse Event|0|||
27996677|NCT00796614|54655521|FG002|Overall Study|Other than stated|0|||
27996678|NCT00796614|54655522|FG003|Overall Study|Other than stated|0|||
27996679|NCT00448747|54655534|FG000|Overall Study|collapsed veins|1|||
27996680|NCT00448747|54655535|FG001|Overall Study|collapsed veins|0|||
27996681|NCT00830180|54655551|FG000|Overall Study|Adverse Event|6|||
27996682|NCT00830180|54655551|FG000|Overall Study|Death|11|||
27911417|NCT00191724|54569429|FG004|Overall Study|Adverse Event|0|||
27911418|NCT00191724|54569425|FG000|Overall Study|Lost to Follow-up|1|||
27996683|NCT00830180|54655551|FG000|Overall Study|Insufficient clinical response|1|||
27996684|NCT00830180|54655551|FG000|Overall Study|Withdrawal by Subject|5|||
27996685|NCT00830180|54655551|FG000|Overall Study|Progressive disease|2|||
27911419|NCT00191724|54569426|FG001|Overall Study|Lost to Follow-up|1|||
27996686|NCT00830180|54655551|FG000|Overall Study|Other - Unspecified|1|||
27996687|NCT00863681|54655560|FG000|Overall Study|Other|2|||
27996688|NCT00863681|54655561|FG001|Overall Study|Other|0|||
27911420|NCT00191724|54569427|FG002|Overall Study|Lost to Follow-up|0|||
27996689|NCT00863681|54655562|FG002|Overall Study|Other|0|||
27996690|NCT00863681|54655560|FG000|Overall Study|Missing|1|||
27996691|NCT00863681|54655561|FG001|Overall Study|Missing|0|||
27911421|NCT00191724|54569428|FG003|Overall Study|Lost to Follow-up|2|||
27911422|NCT00191724|54569429|FG004|Overall Study|Lost to Follow-up|3|||
27911423|NCT00191724|54569425|FG000|Overall Study|Withdrawal by Subject|0|||
27911424|NCT00191724|54569426|FG001|Overall Study|Withdrawal by Subject|0|||
27996692|NCT00863681|54655562|FG002|Overall Study|Missing|0|||
27996693|NCT00863681|54655560|FG000|Overall Study|Death|40|||
27996694|NCT00863681|54655561|FG001|Overall Study|Death|23|||
27911425|NCT00191724|54569427|FG002|Overall Study|Withdrawal by Subject|0|||
27911426|NCT00191724|54569428|FG003|Overall Study|Withdrawal by Subject|1|||
27911427|NCT00191724|54569429|FG004|Overall Study|Withdrawal by Subject|0|||
27911428|NCT00191646|54569443|FG000|Overall Study|Toxicity|26|||
27911429|NCT00191646|54569444|FG001|Overall Study|Toxicity|37|||
27911430|NCT00191646|54569443|FG000|Overall Study|Disease Progression|5|||
27911431|NCT00191646|54569444|FG001|Overall Study|Disease Progression|6|||
27911432|NCT00191646|54569443|FG000|Overall Study|Physician Decision|20|||
27996695|NCT00863681|54655562|FG002|Overall Study|Death|6|||
27996696|NCT00863681|54655560|FG000|Overall Study|Withdrawal by Subject|12|||
27996697|NCT00863681|54655561|FG001|Overall Study|Withdrawal by Subject|5|||
27996698|NCT00863681|54655562|FG002|Overall Study|Withdrawal by Subject|2|||
27996699|NCT00863681|54655560|FG000|Overall Study|Protocol Violation|2|||
27996700|NCT00863681|54655561|FG001|Overall Study|Protocol Violation|0|||
27996701|NCT00863681|54655562|FG002|Overall Study|Protocol Violation|0|||
27996702|NCT00863681|54655560|FG000|Overall Study|Lost to Follow-up|3|||
27996703|NCT00863681|54655561|FG001|Overall Study|Lost to Follow-up|0|||
27996704|NCT00863681|54655562|FG002|Overall Study|Lost to Follow-up|3|||
27996705|NCT00863681|54655560|FG000|Overall Study|Adverse Event|28|||
27996706|NCT00863681|54655561|FG001|Overall Study|Adverse Event|10|||
27996707|NCT00863681|54655562|FG002|Overall Study|Adverse Event|6|||
27996708|NCT00863681|54655560|FG000|Overall Study|Lack of Efficacy|2|||
27996709|NCT00863681|54655561|FG001|Overall Study|Lack of Efficacy|2|||
27996710|NCT00863681|54655562|FG002|Overall Study|Lack of Efficacy|1|||
27996711|NCT00863681|54655560|FG000|Overall Study|Non-compliance with study drug|1|||
27996712|NCT00863681|54655561|FG001|Overall Study|Non-compliance with study drug|3|||
27996713|NCT00863681|54655562|FG002|Overall Study|Non-compliance with study drug|0|||
27996714|NCT00789321|54655572|FG000|Overall Study|Adverse Event|0|||
27996715|NCT00789321|54655573|FG001|Overall Study|Adverse Event|1|||
27996716|NCT00811928|54655581|FG000|Overall Study|AEs and SAEs Including Death|7|||
27996717|NCT00811928|54655582|FG001|Overall Study|AEs and SAEs Including Death|11|||
27996718|NCT00811928|54655581|FG000|Overall Study|Withdrawal by Subject|18|||
27996719|NCT00811928|54655582|FG001|Overall Study|Withdrawal by Subject|12|||
27996720|NCT00811928|54655581|FG000|Overall Study|Did Not Take Study Drug|3|||
27996721|NCT00811928|54655582|FG001|Overall Study|Did Not Take Study Drug|0|||
27996722|NCT00811928|54655581|FG000|Overall Study|Without Primary Efficacy Endpoint Data|7|||
27996723|NCT00811928|54655582|FG001|Overall Study|Without Primary Efficacy Endpoint Data|4|||
27996724|NCT00811928|54655581|FG000|Overall Study|Investigator Decision|2|||
27996725|NCT00811928|54655582|FG001|Overall Study|Investigator Decision|1|||
27996726|NCT00811928|54655581|FG000|Overall Study|Poor Compliance|2|||
27996727|NCT00811928|54655582|FG001|Overall Study|Poor Compliance|5|||
27996728|NCT00788775|54655590|FG000|Overall Study|Progressive Disease|8|||
27996729|NCT00788775|54655591|FG001|Overall Study|Progressive Disease|6|||
27996730|NCT00788775|54655590|FG000|Overall Study|Withdrawal by Subject|0|||
27996731|NCT00788775|54655591|FG001|Overall Study|Withdrawal by Subject|2|||
27996732|NCT00788775|54655590|FG000|Overall Study|Patient Non-Compliance|1|||
27996733|NCT00788775|54655591|FG001|Overall Study|Patient Non-Compliance|0|||
27996734|NCT00788775|54655590|FG000|Overall Study|Patient's measurable disease resected.|1|||
27996735|NCT00788775|54655591|FG001|Overall Study|Patient's measurable disease resected.|0|||
27996736|NCT00448669|54655599|FG000|Overall Study|Lost to Follow-up|52|||
27911433|NCT00191646|54569444|FG001|Overall Study|Physician Decision|11|||
27911434|NCT00191646|54569443|FG000|Overall Study|Withdrawal by Subject|58|||
27911435|NCT00191646|54569444|FG001|Overall Study|Withdrawal by Subject|39|||
27911436|NCT00191646|54569443|FG000|Overall Study|Protocol Violation|5|||
27911437|NCT00191646|54569444|FG001|Overall Study|Protocol Violation|7|||
27996737|NCT00448669|54655600|FG001|Overall Study|Lost to Follow-up|63|||
28098894|NCT03993288|54754705|FG001|Overall Study|did not follow the treatment regimen|0|||
28098895|NCT03993288|54754704|FG000|Overall Study|Adverse Event|1|||
28098896|NCT03993288|54754705|FG001|Overall Study|Adverse Event|0|||
28098897|NCT03993288|54754704|FG000|Overall Study|Withdrawal by Subject|1|||
28098898|NCT03993288|54754705|FG001|Overall Study|Withdrawal by Subject|1|||
28098899|NCT03991494|54754711|FG000|Overall Study|Progressive Disease|4|||
28098900|NCT00086307|54754720|FG000|Overall Study|Lack of Efficacy|1|||
28098901|NCT00086307|54754721|FG001|Overall Study|Lack of Efficacy|1|||
28098902|NCT00086307|54754722|FG002|Overall Study|Lack of Efficacy|2|||
28098903|NCT00086307|54754720|FG000|Overall Study|Shortness of breath and muscle spasms|1|||
28098904|NCT00086307|54754721|FG001|Overall Study|Shortness of breath and muscle spasms|0|||
28098905|NCT00086307|54754722|FG002|Overall Study|Shortness of breath and muscle spasms|0|||
28098906|NCT00086307|54754720|FG000|Overall Study|Nausea and headaches|0|||
28098907|NCT00086307|54754721|FG001|Overall Study|Nausea and headaches|0|||
28098908|NCT00086307|54754722|FG002|Overall Study|Nausea and headaches|1|||
28098909|NCT00086307|54754720|FG000|Overall Study|Constipation and sleepiness|0|||
27911438|NCT00191646|54569443|FG000|Overall Study|Death|6|||
27996738|NCT00448669|54655599|FG000|Overall Study|Withdrawal by Subject|90|||
27996739|NCT00448669|54655600|FG001|Overall Study|Withdrawal by Subject|74|||
27996740|NCT00448669|54655599|FG000|Overall Study|Relocated|49|||
28098910|NCT00086307|54754721|FG001|Overall Study|Constipation and sleepiness|0|||
28172631|NCT02456740|54844364|FG004|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
28172632|NCT02456740|54844365|FG005|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
28172633|NCT02456740|54844366|FG006|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
28172634|NCT02456740|54844367|FG007|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
28172635|NCT02456740|54844368|FG008|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
27911439|NCT00191646|54569444|FG001|Overall Study|Death|8|||
27911440|NCT00191646|54569443|FG000|Overall Study|Other|33|||
27911441|NCT00191646|54569444|FG001|Overall Study|Other|34|||
27911442|NCT00191646|54569443|FG000|Overall Study|Missing Data|18|||
27911443|NCT00191646|54569444|FG001|Overall Study|Missing Data|11|||
27911444|NCT00191451|54569461|FG000|Overall Study|Withdrawal by Subject|2|||
27911445|NCT00191451|54569462|FG001|Overall Study|Withdrawal by Subject|3|||
27911446|NCT00191451|54569463|FG002|Overall Study|Withdrawal by Subject|5|||
27911447|NCT00191451|54569461|FG000|Overall Study|Physician Decision|2|||
27911448|NCT00191451|54569462|FG001|Overall Study|Physician Decision|9|||
27911449|NCT00191451|54569463|FG002|Overall Study|Physician Decision|6|||
27911450|NCT00191451|54569461|FG000|Overall Study|Sponsor Decision|1|||
27911451|NCT00191451|54569462|FG001|Overall Study|Sponsor Decision|0|||
27911452|NCT00191451|54569463|FG002|Overall Study|Sponsor Decision|0|||
27911453|NCT00191451|54569461|FG000|Overall Study|Ineligible|0|||
27911454|NCT00191451|54569462|FG001|Overall Study|Ineligible|1|||
27911455|NCT00191451|54569463|FG002|Overall Study|Ineligible|0|||
27911456|NCT00191451|54569461|FG000|Overall Study|Reason Not Specified|2|||
27911457|NCT00191451|54569462|FG001|Overall Study|Reason Not Specified|1|||
27911458|NCT00191451|54569463|FG002|Overall Study|Reason Not Specified|3|||
27911459|NCT00191334|54569471|FG000|Overall Study|Adverse Event|4|||
27911460|NCT00191334|54569471|FG000|Overall Study|Disease Progression or Relapse|8|||
27911461|NCT00191334|54569471|FG000|Overall Study|Physician Decision|1|||
27911462|NCT00191334|54569471|FG000|Overall Study|Withdrawal by Subject|4|||
27911463|NCT00191139|54569477|FG000|Overall Study|Adverse Event|2|||
27911464|NCT00191139|54569478|FG001|Overall Study|Adverse Event|6|||
27911465|NCT00191139|54569477|FG000|Overall Study|Death|2|||
27911466|NCT00191139|54569478|FG001|Overall Study|Death|0|||
27911467|NCT00191139|54569477|FG000|Overall Study|Withdrawal by Subject|0|||
27911468|NCT00191139|54569478|FG001|Overall Study|Withdrawal by Subject|3|||
27911469|NCT00191139|54569477|FG000|Overall Study|Disease Progression|0|||
27911470|NCT00191139|54569478|FG001|Overall Study|Disease Progression|1|||
28098911|NCT00086307|54754722|FG002|Overall Study|Constipation and sleepiness|1|||
28098912|NCT00086307|54754720|FG000|Overall Study|Suicidal ideation|0|||
28098913|NCT00086307|54754721|FG001|Overall Study|Suicidal ideation|0|||
28098914|NCT00086307|54754722|FG002|Overall Study|Suicidal ideation|1|||
28098915|NCT00086307|54754720|FG000|Overall Study|Fatigue and difficulty falling asleep|0|||
28098916|NCT00086307|54754721|FG001|Overall Study|Fatigue and difficulty falling asleep|0|||
28098917|NCT00086307|54754722|FG002|Overall Study|Fatigue and difficulty falling asleep|1|||
28098918|NCT00086307|54754720|FG000|Overall Study|Withdrawal by Subject|0|||
28098919|NCT00086307|54754721|FG001|Overall Study|Withdrawal by Subject|0|||
28098920|NCT00086307|54754722|FG002|Overall Study|Withdrawal by Subject|2|||
28098921|NCT03624972|54754733|FG000|Overall Study|Lost to Follow-up|2|||
28098922|NCT03624972|54754734|FG001|Overall Study|Lost to Follow-up|0|||
28098923|NCT03624972|54754735|FG002|Overall Study|Lost to Follow-up|0|||
28098924|NCT03624972|54754733|FG000|Overall Study|Withdrawal by Subject|0|||
28098925|NCT03624972|54754734|FG001|Overall Study|Withdrawal by Subject|2|||
28098926|NCT03624972|54754735|FG002|Overall Study|Withdrawal by Subject|0|||
28098927|NCT03988842|54754744|FG000|Overall Study|Death|1|||
28098928|NCT02668822|54754751|FG000|Overall Study|Protocol Violation|2|||
28098929|NCT02668822|54754752|FG001|Overall Study|Protocol Violation|0|||
28098930|NCT02668822|54754751|FG000|Overall Study|Study Terminated by Sponsor|7|||
28098931|NCT02668822|54754752|FG001|Overall Study|Study Terminated by Sponsor|9|||
28172636|NCT02456740|54844360|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9|||
28172637|NCT02456740|54844361|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4|||
28172638|NCT02456740|54844362|FG002|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5|||
27911471|NCT00191139|54569477|FG000|Overall Study|Other|1|||
27911472|NCT00191139|54569478|FG001|Overall Study|Other|2|||
27911473|NCT00190983|54569484|FG000|Overall Study|Inevaluable (never treated)|2|||
27911474|NCT00190749|54569490|FG000|Overall Study|Lost to Follow-up|8|||
27911475|NCT00190749|54569491|FG001|Overall Study|Lost to Follow-up|11|||
27911476|NCT00190749|54569490|FG000|Overall Study|Withdrawal by Subject|10|||
27911477|NCT00190749|54569491|FG001|Overall Study|Withdrawal by Subject|6|||
27911478|NCT00190749|54569490|FG000|Overall Study|Protocol Violation|5|||
28098932|NCT02524288|54754758|FG000|Overall Study|Adverse Event|115|||
27911479|NCT00190749|54569491|FG001|Overall Study|Protocol Violation|4|||
27911480|NCT00190749|54569490|FG000|Overall Study|Adverse Event|0|||
27911481|NCT00190749|54569491|FG001|Overall Study|Adverse Event|5|||
27911482|NCT00190749|54569490|FG000|Overall Study|Lack of Efficacy|2|||
27996741|NCT00448669|54655600|FG001|Overall Study|Relocated|36|||
28098933|NCT02524288|54754758|FG000|Overall Study|Lost to Follow-up|216|||
28098934|NCT02524288|54754758|FG000|Overall Study|Non-Compliance With Protocol|32|||
27911483|NCT00190749|54569491|FG001|Overall Study|Lack of Efficacy|3|||
27911484|NCT00190749|54569490|FG000|Overall Study|Reason Not Specified|0|||
27911485|NCT00190749|54569491|FG001|Overall Study|Reason Not Specified|2|||
27911486|NCT00190749|54569490|FG000|Overall Study|Sponsor Decision|1|||
27911487|NCT00190749|54569491|FG001|Overall Study|Sponsor Decision|0|||
27911488|NCT00190671|54569499|FG000|Overall Study|Satisfactory Response|4|||
27911489|NCT00190671|54569500|FG001|Overall Study|Satisfactory Response|7|||
27911490|NCT00190671|54569499|FG000|Overall Study|Lack of Efficacy|19|||
27911491|NCT00190671|54569500|FG001|Overall Study|Lack of Efficacy|24|||
27911492|NCT00190671|54569499|FG000|Overall Study|Death from Study Disease|1|||
27911493|NCT00190671|54569500|FG001|Overall Study|Death from Study Disease|1|||
27911494|NCT00190671|54569499|FG000|Overall Study|Adverse Event|3|||
27911495|NCT00190671|54569500|FG001|Overall Study|Adverse Event|2|||
27911496|NCT00190671|54569499|FG000|Overall Study|Clinical Relapse|0|||
27911497|NCT00190671|54569500|FG001|Overall Study|Clinical Relapse|1|||
27911498|NCT00190671|54569499|FG000|Overall Study|Death from Study-Drug Toxicity|0|||
27911499|NCT00190671|54569500|FG001|Overall Study|Death from Study-Drug Toxicity|2|||
27911500|NCT00190671|54569499|FG000|Overall Study|Death from Other Causes|0|||
27911501|NCT00190671|54569500|FG001|Overall Study|Death from Other Causes|2|||
27911502|NCT00190671|54569499|FG000|Overall Study|Protocol Violation|0|||
27911503|NCT00190671|54569500|FG001|Overall Study|Protocol Violation|1|||
27911504|NCT00190671|54569499|FG000|Overall Study|Withdrawal by Subject|0|||
27911505|NCT00190671|54569500|FG001|Overall Study|Withdrawal by Subject|2|||
27911506|NCT00477165|54569522|FG000|Overall Study|Adverse Event|7|||
27911507|NCT00477165|54569523|FG001|Overall Study|Adverse Event|2|||
27911508|NCT00476229|54569529|FG000|Overall Study|Progressive shortness of breath|1|||
27911509|NCT00476151|54569535|FG000|Overall Study|Adverse Event|0|||
27911510|NCT00476151|54569536|FG001|Overall Study|Adverse Event|2|||
27911511|NCT00476151|54569535|FG000|Overall Study|Protocol Violation|1|||
27911512|NCT00476151|54569536|FG001|Overall Study|Protocol Violation|3|||
27911513|NCT00476151|54569535|FG000|Overall Study|Withdrawal by Subject|2|||
27911514|NCT00476151|54569536|FG001|Overall Study|Withdrawal by Subject|0|||
27911515|NCT00476151|54569535|FG000|Overall Study|Physician Decision|0|||
27911516|NCT00476151|54569536|FG001|Overall Study|Physician Decision|2|||
27911517|NCT00475644|54569542|FG000|Overall Study|Protocol Violation|13|||
27911518|NCT00474903|54569549|FG000|Overall Study|Protocol Violation|1|||
27911519|NCT00474903|54569550|FG001|Overall Study|Protocol Violation|5|||
27911520|NCT00474903|54569551|FG002|Overall Study|Protocol Violation|2|||
27911521|NCT01134055|54569566|FG000|Overall Study|Adverse Event|5|||
27911522|NCT01134055|54569567|FG001|Overall Study|Adverse Event|2|||
27911523|NCT01134055|54569568|FG002|Overall Study|Adverse Event|2|||
27911524|NCT01134055|54569569|FG003|Overall Study|Adverse Event|2|||
27911525|NCT01134055|54569570|FG004|Overall Study|Adverse Event|5|||
27911526|NCT01134055|54569571|FG005|Overall Study|Adverse Event|7|||
27911527|NCT01134055|54569572|FG006|Overall Study|Adverse Event|2|||
27911528|NCT01134055|54569566|FG000|Overall Study|Lost to Follow-up|0|||
27911529|NCT01134055|54569567|FG001|Overall Study|Lost to Follow-up|1|||
27911530|NCT01134055|54569568|FG002|Overall Study|Lost to Follow-up|0|||
27911531|NCT01134055|54569569|FG003|Overall Study|Lost to Follow-up|1|||
27911532|NCT01134055|54569570|FG004|Overall Study|Lost to Follow-up|0|||
27911533|NCT01134055|54569571|FG005|Overall Study|Lost to Follow-up|0|||
27911534|NCT01134055|54569572|FG006|Overall Study|Lost to Follow-up|0|||
27911535|NCT01134055|54569566|FG000|Overall Study|Withdrawal by Subject|3|||
27911536|NCT01134055|54569567|FG001|Overall Study|Withdrawal by Subject|3|||
27911537|NCT01134055|54569568|FG002|Overall Study|Withdrawal by Subject|1|||
27911538|NCT01134055|54569569|FG003|Overall Study|Withdrawal by Subject|2|||
27911539|NCT01134055|54569570|FG004|Overall Study|Withdrawal by Subject|0|||
27911540|NCT01134055|54569571|FG005|Overall Study|Withdrawal by Subject|0|||
27911541|NCT01134055|54569572|FG006|Overall Study|Withdrawal by Subject|8|||
27911542|NCT01134055|54569566|FG000|Overall Study|Protocol Violation|0|||
27911543|NCT01134055|54569567|FG001|Overall Study|Protocol Violation|0|||
27911544|NCT01134055|54569568|FG002|Overall Study|Protocol Violation|0|||
27911545|NCT01134055|54569569|FG003|Overall Study|Protocol Violation|1|||
27911546|NCT01134055|54569570|FG004|Overall Study|Protocol Violation|1|||
27911547|NCT01134055|54569571|FG005|Overall Study|Protocol Violation|0|||
27911548|NCT01134055|54569572|FG006|Overall Study|Protocol Violation|0|||
27911549|NCT01134055|54569566|FG000|Overall Study|Physician Decision|0|||
27911550|NCT01134055|54569567|FG001|Overall Study|Physician Decision|0|||
27911551|NCT01134055|54569568|FG002|Overall Study|Physician Decision|0|||
27911552|NCT01134055|54569569|FG003|Overall Study|Physician Decision|0|||
27911553|NCT01134055|54569570|FG004|Overall Study|Physician Decision|0|||
27911554|NCT01134055|54569571|FG005|Overall Study|Physician Decision|0|||
27911555|NCT01134055|54569572|FG006|Overall Study|Physician Decision|1|||
27911556|NCT00474708|54569596|FG000|Overall Study|Lack of Efficacy|11|||
27911557|NCT00474708|54569597|FG001|Overall Study|Lack of Efficacy|5|||
27911558|NCT00474708|54569596|FG000|Overall Study|Suicide ideation/behavior|0|||
27911559|NCT00474708|54569597|FG001|Overall Study|Suicide ideation/behavior|1|||
27911560|NCT00474708|54569596|FG000|Overall Study|Withdrawal by Subject|7|||
27911561|NCT00474708|54569597|FG001|Overall Study|Withdrawal by Subject|0|||
27911562|NCT00474708|54569596|FG000|Overall Study|Lack of compliance|12|||
27911563|NCT00474708|54569597|FG001|Overall Study|Lack of compliance|4|||
27911564|NCT00474708|54569596|FG000|Overall Study|Lost to Follow-up|18|||
27911565|NCT00474708|54569597|FG001|Overall Study|Lost to Follow-up|9|||
27911566|NCT00474708|54569596|FG000|Overall Study|Physician Decision|9|||
27911567|NCT00474708|54569597|FG001|Overall Study|Physician Decision|6|||
27911568|NCT00474240|54569609|FG000|Overall Study|Withdrawal by Subject|1|||
27911569|NCT00474240|54569610|FG001|Overall Study|Withdrawal by Subject|1|||
27911570|NCT00474240|54569611|FG002|Overall Study|Withdrawal by Subject|0|||
27911571|NCT00474240|54569612|FG003|Overall Study|Withdrawal by Subject|2|||
27911572|NCT00474240|54569613|FG004|Overall Study|Withdrawal by Subject|3|||
27911573|NCT00474240|54569614|FG005|Overall Study|Withdrawal by Subject|1|||
27911574|NCT00474240|54569609|FG000|Overall Study|Adverse Event|0|||
27911575|NCT00474240|54569610|FG001|Overall Study|Adverse Event|0|||
27911576|NCT00474240|54569611|FG002|Overall Study|Adverse Event|9|||
27911577|NCT00474240|54569612|FG003|Overall Study|Adverse Event|14|||
27911578|NCT00474240|54569613|FG004|Overall Study|Adverse Event|5|||
27911579|NCT00474240|54569614|FG005|Overall Study|Adverse Event|16|||
27911580|NCT00474240|54569609|FG000|Overall Study|Removed due to lab value|0|||
27911581|NCT00474240|54569610|FG001|Overall Study|Removed due to lab value|0|||
27911582|NCT00474240|54569611|FG002|Overall Study|Removed due to lab value|0|||
27911583|NCT00474240|54569612|FG003|Overall Study|Removed due to lab value|0|||
27911584|NCT00474240|54569613|FG004|Overall Study|Removed due to lab value|0|||
27911585|NCT00474240|54569614|FG005|Overall Study|Removed due to lab value|1|||
27911586|NCT00473889|54569630|FG000|Overall Study|Did not receive study medication|1|||
27911587|NCT00473889|54569631|FG001|Overall Study|Did not receive study medication|4|||
27911588|NCT00473889|54569630|FG000|Overall Study|Adverse Event|30|||
27911589|NCT00473889|54569631|FG001|Overall Study|Adverse Event|17|||
27911590|NCT00473889|54569630|FG000|Overall Study|Protocol Violation|4|||
27911591|NCT00473889|54569631|FG001|Overall Study|Protocol Violation|2|||
27911592|NCT00473889|54569630|FG000|Overall Study|Lack of Efficacy|28|||
27911593|NCT00473889|54569631|FG001|Overall Study|Lack of Efficacy|29|||
27911594|NCT00473889|54569630|FG000|Overall Study|Lost to Follow-up|2|||
27911595|NCT00473889|54569631|FG001|Overall Study|Lost to Follow-up|1|||
27911596|NCT00473889|54569630|FG000|Overall Study|Physician Decision|10|||
27911597|NCT00473889|54569631|FG001|Overall Study|Physician Decision|5|||
27911598|NCT00473889|54569630|FG000|Overall Study|Trial Terminated|3|||
27911599|NCT00473889|54569631|FG001|Overall Study|Trial Terminated|6|||
27911600|NCT00473889|54569630|FG000|Overall Study|Withdrawal by Subject|5|||
27911601|NCT00473889|54569631|FG001|Overall Study|Withdrawal by Subject|0|||
27911602|NCT00473694|54569641|FG000|Overall Study|Adverse Event|0|||
27911603|NCT00473694|54569642|FG001|Overall Study|Adverse Event|1|||
27911604|NCT00473694|54569643|FG002|Overall Study|Adverse Event|0|||
27911605|NCT00473694|54569644|FG003|Overall Study|Adverse Event|0|||
27911606|NCT00473694|54569641|FG000|Overall Study|Participants did not receive treatment|11|||
27911607|NCT00473694|54569642|FG001|Overall Study|Participants did not receive treatment|3|||
27911608|NCT00473694|54569643|FG002|Overall Study|Participants did not receive treatment|5|||
27911609|NCT00473694|54569644|FG003|Overall Study|Participants did not receive treatment|6|||
27911610|NCT00473694|54569641|FG000|Overall Study|Lost to Follow-up|0|||
27911611|NCT00473694|54569642|FG001|Overall Study|Lost to Follow-up|0|||
27911612|NCT00473694|54569643|FG002|Overall Study|Lost to Follow-up|0|||
27911613|NCT00473694|54569644|FG003|Overall Study|Lost to Follow-up|1|||
27911614|NCT00473655|54569660|FG000|Overall Study|Lost to Follow-up|9|||
27911615|NCT00473655|54569661|FG001|Overall Study|Lost to Follow-up|5|||
27911616|NCT00473655|54569662|FG002|Overall Study|Lost to Follow-up|8|||
27911617|NCT00473382|54569673|FG000|Core Study|Adverse Event|3|||
27911618|NCT00473382|54569674|FG001|Core Study|Adverse Event|1|||
27911619|NCT00473382|54569675|FG002|Core Study|Adverse Event|1|||
27911620|NCT00473382|54569673|FG000|Core Study|Death|3|||
27911621|NCT00473382|54569674|FG001|Core Study|Death|5|||
27911622|NCT00473382|54569675|FG002|Core Study|Death|10|||
27911623|NCT00473382|54569673|FG000|Core Study|Lost to Follow-up|3|||
27911624|NCT00473382|54569674|FG001|Core Study|Lost to Follow-up|3|||
27911625|NCT00473382|54569675|FG002|Core Study|Lost to Follow-up|3|||
27911626|NCT00473382|54569673|FG000|Core Study|Physician Decision|1|||
27911627|NCT00473382|54569674|FG001|Core Study|Physician Decision|2|||
27911628|NCT00473382|54569675|FG002|Core Study|Physician Decision|2|||
27911629|NCT00473382|54569673|FG000|Core Study|Subject non-compliance|5|||
27911630|NCT00473382|54569674|FG001|Core Study|Subject non-compliance|2|||
27911631|NCT00473382|54569675|FG002|Core Study|Subject non-compliance|1|||
27911632|NCT00473382|54569673|FG000|Core Study|Subject needed other treatment|1|||
27911633|NCT00473382|54569674|FG001|Core Study|Subject needed other treatment|3|||
27911634|NCT00473382|54569675|FG002|Core Study|Subject needed other treatment|2|||
27911635|NCT00473382|54569673|FG000|Core Study|Subject's decision|12|||
27911636|NCT00473382|54569674|FG001|Core Study|Subject's decision|11|||
27911637|NCT00473382|54569675|FG002|Core Study|Subject's decision|10|||
27911638|NCT00473382|54569673|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
27911639|NCT00473382|54569674|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
27911640|NCT00473382|54569675|FG002|Open-label Extension Through Month 48|Adverse Event|1|||
27911641|NCT00473382|54569673|FG000|Open-label Extension Through Month 48|Death|1|||
27911642|NCT00473382|54569674|FG001|Open-label Extension Through Month 48|Death|3|||
27911643|NCT00473382|54569675|FG002|Open-label Extension Through Month 48|Death|3|||
27911644|NCT00473382|54569673|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
27911645|NCT00473382|54569674|FG001|Open-label Extension Through Month 48|Lost to Follow-up|2|||
27911646|NCT00473382|54569675|FG002|Open-label Extension Through Month 48|Lost to Follow-up|1|||
27911647|NCT00473382|54569673|FG000|Open-label Extension Through Month 48|Subject's Decision|5|||
27911648|NCT00473382|54569674|FG001|Open-label Extension Through Month 48|Subject's Decision|1|||
27911649|NCT00473382|54569675|FG002|Open-label Extension Through Month 48|Subject's Decision|6|||
27911650|NCT00473382|54569673|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41|||
27911651|NCT00473382|54569674|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34|||
27911652|NCT00473382|54569675|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36|||
27911653|NCT00473382|54569673|FG000|Open-label Extension Through Month 48|Subject Required Other Intervention|2|||
27911654|NCT00473382|54569674|FG001|Open-label Extension Through Month 48|Subject Required Other Intervention|1|||
27911655|NCT00473382|54569675|FG002|Open-label Extension Through Month 48|Subject Required Other Intervention|0|||
27911656|NCT00473382|54569673|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
27911657|NCT00473382|54569674|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
27911658|NCT00473382|54569675|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
27911659|NCT00473382|54569673|FG000|Open-label Extension Through Month 60|Death|1|||
27911660|NCT00473382|54569674|FG001|Open-label Extension Through Month 60|Death|7|||
27911661|NCT00473382|54569675|FG002|Open-label Extension Through Month 60|Death|4|||
27911662|NCT00473382|54569673|FG000|Open-label Extension Through Month 60|Lost to Follow-up|1|||
27911663|NCT00473382|54569674|FG001|Open-label Extension Through Month 60|Lost to Follow-up|3|||
27911664|NCT00473382|54569675|FG002|Open-label Extension Through Month 60|Lost to Follow-up|1|||
27911665|NCT00473382|54569673|FG000|Open-label Extension Through Month 60|Subject's Decision|7|||
27911666|NCT00473382|54569674|FG001|Open-label Extension Through Month 60|Subject's Decision|1|||
27911667|NCT00473382|54569675|FG002|Open-label Extension Through Month 60|Subject's Decision|6|||
27911668|NCT00473382|54569673|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75|||
27911669|NCT00473382|54569674|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70|||
27911670|NCT00473382|54569675|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69|||
27911671|NCT00473382|54569673|FG000|Open-label Extension Through Month 60|Subject Required Other Intervention|2|||
27911672|NCT00473382|54569674|FG001|Open-label Extension Through Month 60|Subject Required Other Intervention|1|||
27911673|NCT00473382|54569675|FG002|Open-label Extension Through Month 60|Subject Required Other Intervention|0|||
27911674|NCT00473265|54569701|FG000|Overall Study|Unrelated adverse event|5|||
27911675|NCT00473265|54569701|FG000|Overall Study|Off treatment early|15|||
27911676|NCT00472641|54569705|FG000|Overall Study|Lack of Efficacy|3|||
27911677|NCT00472641|54569705|FG000|Overall Study|Adverse Event|3|||
27911678|NCT00472641|54569705|FG000|Overall Study|Lost to Follow-up|1|||
27911679|NCT01133977|54569714|FG000|Overall Study|Adverse Event|0|||
27911680|NCT01133977|54569715|FG001|Overall Study|Adverse Event|0|||
27911681|NCT01133977|54569716|FG002|Overall Study|Adverse Event|1|||
27911682|NCT01133977|54569717|FG003|Overall Study|Adverse Event|0|||
27911683|NCT01133977|54569718|FG004|Overall Study|Adverse Event|0|||
27911684|NCT01133977|54569714|FG000|Overall Study|Death|1|||
27911685|NCT01133977|54569715|FG001|Overall Study|Death|1|||
27911686|NCT01133977|54569716|FG002|Overall Study|Death|1|||
27911687|NCT01133977|54569717|FG003|Overall Study|Death|7|||
27911688|NCT01133977|54569718|FG004|Overall Study|Death|3|||
27911689|NCT01133977|54569714|FG000|Overall Study|Started a New Line of Therapy|2|||
27911690|NCT01133977|54569715|FG001|Overall Study|Started a New Line of Therapy|6|||
27911691|NCT01133977|54569716|FG002|Overall Study|Started a New Line of Therapy|4|||
27911692|NCT01133977|54569717|FG003|Overall Study|Started a New Line of Therapy|25|||
27911693|NCT01133977|54569718|FG004|Overall Study|Started a New Line of Therapy|33|||
27911694|NCT01133977|54569714|FG000|Overall Study|Lost to Follow-up|0|||
27911695|NCT01133977|54569715|FG001|Overall Study|Lost to Follow-up|0|||
27911696|NCT01133977|54569716|FG002|Overall Study|Lost to Follow-up|0|||
27911697|NCT01133977|54569717|FG003|Overall Study|Lost to Follow-up|2|||
27911698|NCT01133977|54569718|FG004|Overall Study|Lost to Follow-up|1|||
27911699|NCT01133977|54569714|FG000|Overall Study|Withdrawal by Subject|0|||
27911700|NCT01133977|54569715|FG001|Overall Study|Withdrawal by Subject|0|||
27911701|NCT01133977|54569716|FG002|Overall Study|Withdrawal by Subject|0|||
27911702|NCT01133977|54569717|FG003|Overall Study|Withdrawal by Subject|5|||
27911703|NCT01133977|54569718|FG004|Overall Study|Withdrawal by Subject|1|||
27911704|NCT01133821|54569735|FG000|Overall Study|Lost to Follow-up|8|||
27911705|NCT01133821|54569736|FG001|Overall Study|Lost to Follow-up|11|||
27911706|NCT01133821|54569735|FG000|Overall Study|Withdrawal by Subject|8|||
27911707|NCT01133821|54569736|FG001|Overall Study|Withdrawal by Subject|3|||
27911708|NCT01133821|54569735|FG000|Overall Study|preferred other treatment|1|||
27911709|NCT01133821|54569736|FG001|Overall Study|preferred other treatment|1|||
27911710|NCT01133821|54569735|FG000|Overall Study|Protocol Violation|0|||
27911711|NCT01133821|54569736|FG001|Overall Study|Protocol Violation|1|||
27911712|NCT01133821|54569735|FG000|Overall Study|Refused participation|1|||
27911713|NCT01133821|54569736|FG001|Overall Study|Refused participation|3|||
27911714|NCT00472446|54569746|FG000|Overall Study|Protocol Violation|0|||
27911715|NCT00472446|54569747|FG001|Overall Study|Protocol Violation|0|||
27911716|NCT00472446|54569748|FG002|Overall Study|Protocol Violation|0|||
27911717|NCT00472446|54569749|FG003|Overall Study|Protocol Violation|1|||
27911718|NCT00472446|54569746|FG000|Overall Study|Reintervention|0|||
27911719|NCT00472446|54569747|FG001|Overall Study|Reintervention|0|||
27911720|NCT00472446|54569748|FG002|Overall Study|Reintervention|1|||
27911721|NCT00472446|54569749|FG003|Overall Study|Reintervention|1|||
27911722|NCT00472446|54569746|FG000|Overall Study|Questionnaires not returned|5|||
27911723|NCT00472446|54569747|FG001|Overall Study|Questionnaires not returned|6|||
27911724|NCT00472446|54569748|FG002|Overall Study|Questionnaires not returned|6|||
27911725|NCT00472446|54569749|FG003|Overall Study|Questionnaires not returned|4|||
27911726|NCT00472290|54569759|FG000|Overall Study|Progression of Therapy-Related MDS|1|||
27911727|NCT00472290|54569759|FG000|Overall Study|Protocol Specified Criteria|7|||
27911728|NCT00472290|54569759|FG000|Overall Study|Administrative Decision|37|||
27911729|NCT00472290|54569759|FG000|Overall Study|Death|3|||
27911730|NCT00472290|54569759|FG000|Overall Study|Lost to Follow-up|1|||
27911731|NCT00472290|54569759|FG000|Overall Study|Lack of Efficacy|1|||
27911732|NCT00472290|54569759|FG000|Overall Study|Disease Progression|4|||
27911733|NCT00472290|54569759|FG000|Overall Study|Withdrawal by Subject|5|||
27911734|NCT00472290|54569759|FG000|Overall Study|Adverse Event|6|||
27911735|NCT00472290|54569759|FG000|Overall Study|Requirement for alternative therapy|7|||
27911736|NCT01133704|54569765|FG000|Overall Study|Death|44|||
27911737|NCT01133704|54569766|FG001|Overall Study|Death|26|||
27911738|NCT01133704|54569765|FG000|Overall Study|Patient refused to continue|4|||
27911739|NCT01133704|54569766|FG001|Overall Study|Patient refused to continue|0|||
27911740|NCT01133704|54569765|FG000|Overall Study|Study Closure|1|||
27911741|NCT01133704|54569766|FG001|Overall Study|Study Closure|0|||
27911742|NCT01133665|54569772|FG000|Overall Study|Physician Decision|2|||
27911743|NCT01133626|54569779|FG000|Overall Study|Adverse Event|0|||
27911744|NCT01133626|54569780|FG001|Overall Study|Adverse Event|1|||
27911745|NCT01133626|54569781|FG002|Overall Study|Adverse Event|0|||
27911746|NCT01133626|54569779|FG000|Overall Study|Withdrawal by Subject|1|||
27911747|NCT01133626|54569780|FG001|Overall Study|Withdrawal by Subject|2|||
27911748|NCT01133626|54569781|FG002|Overall Study|Withdrawal by Subject|2|||
27911749|NCT01133626|54569779|FG000|Overall Study|Other|0|||
27911750|NCT01133626|54569780|FG001|Overall Study|Other|2|||
27911751|NCT01133626|54569781|FG002|Overall Study|Other|0|||
27911752|NCT01133392|54569791|FG000|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0|||
27911753|NCT01133392|54569792|FG001|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1|||
27911754|NCT01133392|54569791|FG000|Interval Between Dosing (4-7 Days)|Protocol Violation|0|||
27911755|NCT01133392|54569792|FG001|Interval Between Dosing (4-7 Days)|Protocol Violation|1|||
27911756|NCT00471354|54569798|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
27911757|NCT00471354|54569798|FG000|Overall Study|Adverse Event|13|||
27911758|NCT00471354|54569798|FG000|Overall Study|Protocol Violation|12|||
27911759|NCT00471354|54569798|FG000|Overall Study|Withdrawal by Subject|1|||
27911760|NCT00471354|54569798|FG000|Overall Study|Physician Decision|4|||
27911761|NCT00471354|54569798|FG000|Overall Study|Sponsor Decision|1|||
27911762|NCT00471354|54569798|FG000|Overall Study|Lost to Follow-up|3|||
27911763|NCT00471354|54569798|FG000|Overall Study|Lack of Efficacy|5|||
27911764|NCT00471354|54569798|FG000|Overall Study|Patient/Caregiver Decision|12|||
27911765|NCT00471315|54569802|FG000|Overall Study|Adverse Event|7|||
27911766|NCT00471315|54569802|FG000|Overall Study|Withdrawal by Subject|1|||
27911767|NCT00471237|54569813|FG000|Overall Study|Adverse Event|6|||
27911768|NCT00471237|54569814|FG001|Overall Study|Adverse Event|5|||
27911769|NCT00471237|54569815|FG002|Overall Study|Adverse Event|4|||
27911770|NCT00471237|54569816|FG003|Overall Study|Adverse Event|8|||
27911771|NCT00471237|54569817|FG004|Overall Study|Adverse Event|7|||
27911772|NCT00471237|54569818|FG005|Overall Study|Adverse Event|5|||
27911773|NCT00471237|54569819|FG006|Overall Study|Adverse Event|0|||
27911774|NCT00471237|54569813|FG000|Overall Study|Lost to Follow-up|1|||
27911775|NCT00471237|54569814|FG001|Overall Study|Lost to Follow-up|1|||
27911776|NCT00471237|54569815|FG002|Overall Study|Lost to Follow-up|0|||
27911777|NCT00471237|54569816|FG003|Overall Study|Lost to Follow-up|2|||
27911778|NCT00471237|54569817|FG004|Overall Study|Lost to Follow-up|3|||
27911779|NCT00471237|54569818|FG005|Overall Study|Lost to Follow-up|0|||
27911780|NCT00471237|54569819|FG006|Overall Study|Lost to Follow-up|0|||
27911781|NCT00471237|54569813|FG000|Overall Study|Protocol Violation|3|||
27911782|NCT00471237|54569814|FG001|Overall Study|Protocol Violation|6|||
27911783|NCT00471237|54569815|FG002|Overall Study|Protocol Violation|3|||
27911784|NCT00471237|54569816|FG003|Overall Study|Protocol Violation|2|||
27911785|NCT00471237|54569817|FG004|Overall Study|Protocol Violation|2|||
27911786|NCT00471237|54569818|FG005|Overall Study|Protocol Violation|4|||
27911787|NCT00471237|54569819|FG006|Overall Study|Protocol Violation|1|||
27911788|NCT00471237|54569813|FG000|Overall Study|Withdrawal by Subject|8|||
27911789|NCT00471237|54569814|FG001|Overall Study|Withdrawal by Subject|6|||
27911790|NCT00471237|54569815|FG002|Overall Study|Withdrawal by Subject|5|||
27911791|NCT00471237|54569816|FG003|Overall Study|Withdrawal by Subject|8|||
27911792|NCT00471237|54569817|FG004|Overall Study|Withdrawal by Subject|7|||
27911793|NCT00471237|54569818|FG005|Overall Study|Withdrawal by Subject|4|||
27911794|NCT00471237|54569819|FG006|Overall Study|Withdrawal by Subject|2|||
27911795|NCT00471237|54569813|FG000|Overall Study|Sponsor terminated study|20|||
27911796|NCT00471237|54569814|FG001|Overall Study|Sponsor terminated study|23|||
27911797|NCT00471237|54569815|FG002|Overall Study|Sponsor terminated study|19|||
27911798|NCT00471237|54569816|FG003|Overall Study|Sponsor terminated study|22|||
27911799|NCT00471237|54569817|FG004|Overall Study|Sponsor terminated study|18|||
27911800|NCT00471237|54569818|FG005|Overall Study|Sponsor terminated study|24|||
27911801|NCT00471237|54569819|FG006|Overall Study|Sponsor terminated study|0|||
27911802|NCT00471237|54569813|FG000|Overall Study|Non-compliance|0|||
27911803|NCT00471237|54569814|FG001|Overall Study|Non-compliance|1|||
27911804|NCT00471237|54569815|FG002|Overall Study|Non-compliance|0|||
27911805|NCT00471237|54569816|FG003|Overall Study|Non-compliance|1|||
27911806|NCT00471237|54569817|FG004|Overall Study|Non-compliance|0|||
27911807|NCT00471237|54569818|FG005|Overall Study|Non-compliance|0|||
27911808|NCT00471237|54569819|FG006|Overall Study|Non-compliance|0|||
27911809|NCT00471237|54569813|FG000|Overall Study|Met serum creatinine withdrawal criteria|1|||
27911810|NCT00471237|54569814|FG001|Overall Study|Met serum creatinine withdrawal criteria|0|||
27911811|NCT00471237|54569815|FG002|Overall Study|Met serum creatinine withdrawal criteria|2|||
27911812|NCT00471237|54569816|FG003|Overall Study|Met serum creatinine withdrawal criteria|2|||
27911813|NCT00471237|54569817|FG004|Overall Study|Met serum creatinine withdrawal criteria|0|||
27911814|NCT00471237|54569818|FG005|Overall Study|Met serum creatinine withdrawal criteria|0|||
27911815|NCT00471237|54569819|FG006|Overall Study|Met serum creatinine withdrawal criteria|0|||
27911816|NCT00471237|54569813|FG000|Overall Study|Early stopping due to non-efficacy|1|||
27911817|NCT00471237|54569814|FG001|Overall Study|Early stopping due to non-efficacy|0|||
27911818|NCT00471237|54569815|FG002|Overall Study|Early stopping due to non-efficacy|0|||
27911819|NCT00471237|54569816|FG003|Overall Study|Early stopping due to non-efficacy|0|||
27911820|NCT00471237|54569817|FG004|Overall Study|Early stopping due to non-efficacy|1|||
27911821|NCT00471237|54569818|FG005|Overall Study|Early stopping due to non-efficacy|0|||
27911822|NCT00471237|54569819|FG006|Overall Study|Early stopping due to non-efficacy|0|||
27911823|NCT00471237|54569813|FG000|Overall Study|Participant planned to travel to abraod|1|||
27911824|NCT00471237|54569814|FG001|Overall Study|Participant planned to travel to abraod|0|||
27911825|NCT00471237|54569815|FG002|Overall Study|Participant planned to travel to abraod|0|||
27911826|NCT00471237|54569816|FG003|Overall Study|Participant planned to travel to abraod|0|||
27911827|NCT00471237|54569817|FG004|Overall Study|Participant planned to travel to abraod|0|||
27911828|NCT00471237|54569818|FG005|Overall Study|Participant planned to travel to abraod|1|||
27911829|NCT00471237|54569819|FG006|Overall Study|Participant planned to travel to abraod|0|||
27911830|NCT00471237|54569813|FG000|Overall Study|High parathyroid hormone|0|||
27911831|NCT00471237|54569814|FG001|Overall Study|High parathyroid hormone|0|||
27911832|NCT00471237|54569815|FG002|Overall Study|High parathyroid hormone|1|||
27911833|NCT00471237|54569816|FG003|Overall Study|High parathyroid hormone|0|||
27911834|NCT00471237|54569817|FG004|Overall Study|High parathyroid hormone|0|||
27911835|NCT00471237|54569818|FG005|Overall Study|High parathyroid hormone|0|||
27911836|NCT00471237|54569819|FG006|Overall Study|High parathyroid hormone|0|||
27911837|NCT00471237|54569813|FG000|Overall Study|Participant lost medication|0|||
27996742|NCT00448669|54655599|FG000|Overall Study|Were withdrawn by investigator|10|||
27996743|NCT00448669|54655600|FG001|Overall Study|Were withdrawn by investigator|6|||
27996744|NCT00448669|54655599|FG000|Overall Study|Death|2|||
27996745|NCT00448669|54655600|FG001|Overall Study|Death|4|||
27996746|NCT00448669|54655599|FG000|Overall Study|Had other reasons|5|||
27996747|NCT00448669|54655600|FG001|Overall Study|Had other reasons|6|||
27996748|NCT00448669|54655599|FG000|Overall Study|HIV-infected at enrollment|1|||
27996749|NCT00448669|54655600|FG001|Overall Study|HIV-infected at enrollment|2|||
27996750|NCT00448669|54655599|FG000|Overall Study|Never started drug|9|||
27996751|NCT00448669|54655600|FG001|Overall Study|Never started drug|7|||
27996752|NCT00591734|54655608|FG000|Overall Study|Lack of Efficacy|35|||
27996753|NCT00591734|54655608|FG000|Overall Study|Adverse Event|5|||
27996754|NCT00591734|54655608|FG000|Overall Study|Physician Decision|5|||
27996755|NCT00591734|54655608|FG000|Overall Study|Intercurrent Illness|8|||
27996756|NCT00788697|54655612|FG000|Overall Study|No study drug administered|12|||
27911838|NCT00471237|54569814|FG001|Overall Study|Participant lost medication|0|||
27996757|NCT00788697|54655612|FG000|Overall Study|Training Patients|74|||
27911839|NCT00471237|54569815|FG002|Overall Study|Participant lost medication|0|||
27996758|NCT00788697|54655612|FG000|Overall Study|no truth standard procedure available|5|||
27996759|NCT00788697|54655612|FG000|Overall Study|Technically inadequate truth standard|1|||
27996760|NCT00788697|54655612|FG000|Overall Study|Indeterminate diagnosis from truth stand|17|||
28098935|NCT02524288|54754758|FG000|Overall Study|Non-Compliance With Study Drug|14|||
27911840|NCT00471237|54569816|FG003|Overall Study|Participant lost medication|0|||
27996761|NCT00848549|54655626|FG000|E2090-E044-310 (Base Study) Disposition|Adverse Event|31|||
27996762|NCT00848549|54655627|FG001|E2090-E044-310 (Base Study) Disposition|Adverse Event|35|||
27996763|NCT00848549|54655626|FG000|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35|||
27996764|NCT00848549|54655627|FG001|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24|||
27996765|NCT00848549|54655626|FG000|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
27996766|NCT00848549|54655627|FG001|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
27996767|NCT00848549|54655626|FG000|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3|||
27996768|NCT00848549|54655627|FG001|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8|||
27996769|NCT00848549|54655626|FG000|E2090-E044-310 (Base Study) Disposition|Physician Decision|4|||
27996770|NCT00848549|54655627|FG001|E2090-E044-310 (Base Study) Disposition|Physician Decision|5|||
27996771|NCT00848549|54655626|FG000|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21|||
27996772|NCT00848549|54655627|FG001|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11|||
27996773|NCT00848549|54655626|FG000|E2090-E044-310 (Base Study) Disposition|Other|4|||
27996774|NCT00848549|54655627|FG001|E2090-E044-310 (Base Study) Disposition|Other|3|||
27996775|NCT00848549|54655626|FG000|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24|||
27996776|NCT00848549|54655627|FG001|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34|||
27996777|NCT00848549|54655626|FG000|E2090-E044-314 (Extension Study)|Adverse Event|2|||
27996778|NCT00848549|54655627|FG001|E2090-E044-314 (Extension Study)|Adverse Event|1|||
27996779|NCT00848549|54655626|FG000|E2090-E044-314 (Extension Study)|Protocol Violation|1|||
27911841|NCT00471237|54569817|FG004|Overall Study|Participant lost medication|1|||
27911842|NCT00471237|54569818|FG005|Overall Study|Participant lost medication|0|||
27911843|NCT00471237|54569819|FG006|Overall Study|Participant lost medication|0|||
27911844|NCT00471237|54569813|FG000|Overall Study|Administration of prohibited medicine|0|||
27911845|NCT00471237|54569814|FG001|Overall Study|Administration of prohibited medicine|0|||
27911846|NCT00471237|54569815|FG002|Overall Study|Administration of prohibited medicine|0|||
27911847|NCT00471237|54569816|FG003|Overall Study|Administration of prohibited medicine|0|||
27911848|NCT00471237|54569817|FG004|Overall Study|Administration of prohibited medicine|1|||
27911849|NCT00471237|54569818|FG005|Overall Study|Administration of prohibited medicine|0|||
27911850|NCT00471237|54569819|FG006|Overall Study|Administration of prohibited medicine|0|||
27911851|NCT00471237|54569813|FG000|Overall Study|Participant shifted residence|0|||
27911852|NCT00471237|54569814|FG001|Overall Study|Participant shifted residence|0|||
27911853|NCT00471237|54569815|FG002|Overall Study|Participant shifted residence|0|||
27911854|NCT00471237|54569816|FG003|Overall Study|Participant shifted residence|0|||
27911855|NCT00471237|54569817|FG004|Overall Study|Participant shifted residence|1|||
27911856|NCT00471237|54569818|FG005|Overall Study|Participant shifted residence|0|||
27911857|NCT00471237|54569819|FG006|Overall Study|Participant shifted residence|0|||
27911858|NCT00471237|54569813|FG000|Overall Study|Participant's decision|0|||
27911859|NCT00471237|54569814|FG001|Overall Study|Participant's decision|0|||
27911860|NCT00471237|54569815|FG002|Overall Study|Participant's decision|0|||
27911861|NCT00471237|54569816|FG003|Overall Study|Participant's decision|0|||
27911862|NCT00471237|54569817|FG004|Overall Study|Participant's decision|0|||
27911863|NCT00471237|54569818|FG005|Overall Study|Participant's decision|1|||
27911864|NCT00471237|54569819|FG006|Overall Study|Participant's decision|0|||
27911865|NCT00471081|54569841|FG000|Active Phase|Protocol Violation|1|||
27911866|NCT00471081|54569842|FG001|Active Phase|Protocol Violation|1|||
27911867|NCT00471081|54569841|FG000|Active Phase|Withdrawal by Subject|0|||
27911868|NCT00471081|54569842|FG001|Active Phase|Withdrawal by Subject|3|||
27911869|NCT00471081|54569841|FG000|Active Phase|Lost to Follow-up|0|||
27911870|NCT00471081|54569842|FG001|Active Phase|Lost to Follow-up|1|||
27911871|NCT00471081|54569841|FG000|Active Phase|Lost health plan/insurance|1|||
27911872|NCT00471081|54569842|FG001|Active Phase|Lost health plan/insurance|8|||
27911873|NCT00471081|54569841|FG000|Extended Safety Follow-Up|Withdrawal by Subject|1|||
27911874|NCT00471081|54569842|FG001|Extended Safety Follow-Up|Withdrawal by Subject|4|||
27911875|NCT00471081|54569841|FG000|Extended Safety Follow-Up|Lost to Follow-up|1|||
27911876|NCT00471081|54569842|FG001|Extended Safety Follow-Up|Lost to Follow-up|8|||
27911877|NCT00471081|54569841|FG000|Extended Safety Follow-Up|Missing confirmed|0|||
27911878|NCT00471081|54569842|FG001|Extended Safety Follow-Up|Missing confirmed|1|||
27911879|NCT00470847|54569849|FG000|Overall Study|Pt still receiving treatment|1|||
27911880|NCT00470535|54569855|FG000|Overall Study|Disease Progression|13|||
27911881|NCT00470535|54569855|FG000|Overall Study|Withdrawal by Subject|1|||
27911882|NCT00470535|54569855|FG000|Overall Study|Adverse Event|1|||
27911883|NCT00470535|54569855|FG000|Overall Study|Death|1|||
27911884|NCT00470535|54569855|FG000|Overall Study|Other|2|||
27911885|NCT00470418|54569861|FG000|Overall Study|Withdrawal by Subject|1|||
27911886|NCT00470418|54569862|FG001|Overall Study|Withdrawal by Subject|0|||
27911887|NCT01133275|54569868|FG000|Overall Study|Withdrawal by Subject|1|||
27996780|NCT00848549|54655627|FG001|E2090-E044-314 (Extension Study)|Protocol Violation|2|||
27996781|NCT00848549|54655626|FG000|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8|||
27996782|NCT00848549|54655627|FG001|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12|||
27996783|NCT00848549|54655626|FG000|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
27739731|NCT02222896|54189360|FG002|Abdomen|Did not qualify|32|||
27911888|NCT01133275|54569868|FG000|Overall Study|Cerebrovascular accident (CVA)|1|||
27911889|NCT00470184|54569872|FG000|Overall Study|Not Treated(became ineligible)|4|||
27911890|NCT00470184|54569872|FG000|Overall Study|Not treated (other)|1|||
27911891|NCT00470184|54569872|FG000|Overall Study|disease Progression|4|||
27911892|NCT00470184|54569872|FG000|Overall Study|Adverse Event|3|||
27911893|NCT00470184|54569872|FG000|Overall Study|Withdrawal by Subject|4|||
27911894|NCT00470184|54569872|FG000|Overall Study|other|5|||
27996784|NCT00848549|54655627|FG001|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
27996785|NCT00848549|54655626|FG000|E2090-E044-314 (Extension Study)|Physician Decision|0|||
27996786|NCT00848549|54655627|FG001|E2090-E044-314 (Extension Study)|Physician Decision|2|||
27996787|NCT00848549|54655626|FG000|E2090-E044-314 (Extension Study)|Other|5|||
27996788|NCT00848549|54655627|FG001|E2090-E044-314 (Extension Study)|Other|6|||
27996789|NCT00788151|54655637|FG000|Overall Study|Other adverse event|0|||
27996790|NCT00788151|54655638|FG001|Overall Study|Other adverse event|2|||
27996791|NCT00788151|54655637|FG000|Overall Study|Protocol Violation|0|||
27996792|NCT00788151|54655638|FG001|Overall Study|Protocol Violation|1|||
27996793|NCT00788151|54655637|FG000|Overall Study|Withdrawal by Subject|13|||
27996794|NCT00788151|54655638|FG001|Overall Study|Withdrawal by Subject|6|||
27996795|NCT00788151|54655637|FG000|Overall Study|Enrolled but not treated|1|||
27996796|NCT00788151|54655638|FG001|Overall Study|Enrolled but not treated|1|||
27996797|NCT00788073|54655646|FG000|STX209 Then Placebo|Adverse Event|1|||
27996798|NCT00788073|54655647|FG001|STX209 Then Placebo|Adverse Event|0|||
27996799|NCT00788073|54655646|FG000|STX209 Then Placebo|Lost to Follow-up|0|||
27996800|NCT00788073|54655647|FG001|STX209 Then Placebo|Lost to Follow-up|1|||
27996801|NCT00788073|54655646|FG000|STX209 Then Placebo|Withdrawal by Subject|0|||
27996802|NCT00788073|54655647|FG001|STX209 Then Placebo|Withdrawal by Subject|1|||
27996803|NCT00788073|54655646|FG000|STX209 Then Placebo|unable to return due to travel|0|||
27996804|NCT00788073|54655647|FG001|STX209 Then Placebo|unable to return due to travel|1|||
27996805|NCT00788073|54655646|FG000|Placebo Then STX209|Adverse Event|2|||
27996806|NCT00788073|54655647|FG001|Placebo Then STX209|Adverse Event|0|||
27996807|NCT00788073|54655646|FG000|Placebo Then STX209|Protocol Violation|0|||
27996808|NCT00788073|54655647|FG001|Placebo Then STX209|Protocol Violation|1|||
27996809|NCT00848393|54655656|FG000|Overall Study|Protocol Violation|0|||
27996810|NCT00848393|54655657|FG001|Overall Study|Protocol Violation|0|||
27996811|NCT00848393|54655658|FG002|Overall Study|Protocol Violation|1|||
27996812|NCT00848393|54655656|FG000|Overall Study|surgical complications unrelated to stud|0|||
27996813|NCT00848393|54655657|FG001|Overall Study|surgical complications unrelated to stud|0|||
27996814|NCT00848393|54655658|FG002|Overall Study|surgical complications unrelated to stud|2|||
27996815|NCT00815516|54655672|FG000|Overall Study|Death|3|||
27996816|NCT00815516|54655673|FG001|Overall Study|Death|1|||
27996817|NCT00815516|54655672|FG000|Overall Study|Physician Decision|1|||
27996818|NCT00815516|54655673|FG001|Overall Study|Physician Decision|0|||
27996819|NCT00787917|54655681|FG000|Blinded Treatment|Adverse Event|1|||
27911895|NCT00470184|54569872|FG000|Overall Study|recurrence|1|||
27911896|NCT00470067|54569877|FG000|Overall Study|Death|1|||
27911897|NCT00470067|54569877|FG000|Overall Study|Disease Progression|6|||
27911898|NCT00475020|54569881|FG000|Overall Study|Physician Decision|3|||
27911899|NCT00475020|54569881|FG000|Overall Study|Insurance Denial|1|||
27911900|NCT00475020|54569881|FG000|Overall Study|Donor not able to donate the last minute|1|||
27911901|NCT02484456|54569887|FG000|Washout Period|Withdrawal by Subject|0|||
27911902|NCT02484456|54569888|FG001|Washout Period|Withdrawal by Subject|1|||
27911903|NCT02484456|54569887|FG000|Second Treatment Period: Week 1|Adverse Event|1|||
27911904|NCT02484456|54569888|FG001|Second Treatment Period: Week 1|Adverse Event|0|||
27911905|NCT02484456|54569887|FG000|Second Treatment Period: Week 1|Withdrawal by Subject|0|||
27911906|NCT02484456|54569888|FG001|Second Treatment Period: Week 1|Withdrawal by Subject|1|||
27911907|NCT02484456|54569887|FG000|Second Treatment Period: Week 2|Adverse Event|0|||
27911908|NCT02484456|54569888|FG001|Second Treatment Period: Week 2|Adverse Event|1|||
27911909|NCT01132807|54569895|FG000|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|9|||
27911910|NCT01132807|54569896|FG001|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
27911911|NCT01132807|54569897|FG002|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
27911912|NCT01132807|54569895|FG000|Initial ABVD Treatment (2 Cycles)|Ineligible|6|||
27911913|NCT01132807|54569896|FG001|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
27996820|NCT00787917|54655682|FG001|Blinded Treatment|Adverse Event|0|||
28098936|NCT02524288|54754758|FG000|Overall Study|Pregnancy Wish|6|||
27911914|NCT01132807|54569897|FG002|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
27911915|NCT01132651|54569907|FG000|Overall Study|Lost to Follow-up|1|||
27911916|NCT01132651|54569908|FG001|Overall Study|Lost to Follow-up|1|||
27911917|NCT01089543|54569918|FG000|Overall Study|Withdrawal by Subject|2|||
27996821|NCT00787917|54655681|FG000|Blinded Treatment|Lack of Efficacy|1|||
27996822|NCT00787917|54655682|FG001|Blinded Treatment|Lack of Efficacy|0|||
27996823|NCT00787917|54655681|FG000|Blinded Treatment|Administrative problems|3|||
27996824|NCT00787917|54655682|FG001|Blinded Treatment|Administrative problems|2|||
27996825|NCT00787917|54655681|FG000|Open Label|Unsatisfactory therapeutic effect|1|||
27996826|NCT00787917|54655682|FG001|Open Label|Unsatisfactory therapeutic effect|0|||
27996827|NCT00787917|54655681|FG000|Open Label|Administrative problems|3|||
27996828|NCT00787917|54655682|FG001|Open Label|Administrative problems|0|||
27911918|NCT01089543|54569919|FG001|Overall Study|Withdrawal by Subject|3|||
27911919|NCT01089543|54569920|FG002|Overall Study|Withdrawal by Subject|3|||
27911920|NCT01089543|54569921|FG003|Overall Study|Withdrawal by Subject|1|||
27911921|NCT01089543|54569918|FG000|Overall Study|Physician Decision|1|||
27911922|NCT01089543|54569919|FG001|Overall Study|Physician Decision|0|||
27911923|NCT01089543|54569920|FG002|Overall Study|Physician Decision|0|||
27911924|NCT01089543|54569921|FG003|Overall Study|Physician Decision|1|||
27911925|NCT01089543|54569918|FG000|Overall Study|Adverse Event|0|||
27911926|NCT01089543|54569919|FG001|Overall Study|Adverse Event|1|||
27911927|NCT01089543|54569920|FG002|Overall Study|Adverse Event|0|||
27911928|NCT01089543|54569921|FG003|Overall Study|Adverse Event|0|||
27911929|NCT01089504|54569933|FG000|Overall Study|Lost to Follow-up|1|||
27911930|NCT01089504|54569934|FG001|Overall Study|Lost to Follow-up|1|||
27911931|NCT01089504|54569933|FG000|Overall Study|Withdrawal by Subject|2|||
27911932|NCT01089504|54569934|FG001|Overall Study|Withdrawal by Subject|0|||
27911933|NCT01088997|54569942|FG000|Overall Study|Physician Decision|1|||
27911934|NCT01088997|54569943|FG001|Overall Study|Physician Decision|1|||
27911935|NCT01088997|54569942|FG000|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
27911936|NCT01088997|54569943|FG001|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
27911937|NCT01088997|54569942|FG000|Overall Study|Excluded prior to receiving drug|1|||
27911938|NCT01088997|54569943|FG001|Overall Study|Excluded prior to receiving drug|1|||
27911939|NCT01088529|54569954|FG000|Overall Study|Did not receive study treatment|0|||
27996829|NCT00814892|54655690|FG000|Overall Study|Disease Progression|1|||
27996830|NCT00814892|54655690|FG000|Overall Study|Study Termination|1|||
27996831|NCT00787839|54655694|FG000|Overall Study|Failure to have the OGTT was most common|404|||
27996832|NCT00829244|54655717|FG000|Overall Study|Adverse Event|1|||
27996833|NCT00829244|54655718|FG001|Overall Study|Adverse Event|3|||
27996834|NCT00829244|54655717|FG000|Overall Study|Protocol Violation|1|||
27996835|NCT00829244|54655718|FG001|Overall Study|Protocol Violation|0|||
27996836|NCT00829244|54655717|FG000|Overall Study|Lack of ovarian response to stimulation|9|||
27996837|NCT00829244|54655718|FG001|Overall Study|Lack of ovarian response to stimulation|5|||
27996838|NCT00829244|54655717|FG000|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1|||
27996839|NCT00829244|54655718|FG001|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6|||
27996840|NCT00829244|54655717|FG000|Overall Study|No fertilization|2|||
27996841|NCT00829244|54655718|FG001|Overall Study|No fertilization|2|||
27996842|NCT00829244|54655717|FG000|Overall Study|All embryos discarded|0|||
27996843|NCT00829244|54655718|FG001|Overall Study|All embryos discarded|3|||
27996844|NCT00829244|54655717|FG000|Overall Study|No embryo cleavage|0|||
27996845|NCT00829244|54655718|FG001|Overall Study|No embryo cleavage|2|||
27996846|NCT00787605|54655726|FG000|Overall Study|Administrative Problems|3|||
27996847|NCT00787605|54655727|FG001|Overall Study|Administrative Problems|0|||
27996848|NCT00787605|54655726|FG000|Overall Study|Adverse Event|14|||
27996849|NCT00787605|54655727|FG001|Overall Study|Adverse Event|25|||
27996850|NCT00787605|54655726|FG000|Overall Study|Lost to Follow-up|3|||
27996851|NCT00787605|54655727|FG001|Overall Study|Lost to Follow-up|6|||
27996852|NCT00787605|54655726|FG000|Overall Study|Protocol Violation|7|||
27996853|NCT00787605|54655727|FG001|Overall Study|Protocol Violation|3|||
27996854|NCT00787605|54655726|FG000|Overall Study|Withdrawal by Subject|6|||
27996855|NCT00787605|54655727|FG001|Overall Study|Withdrawal by Subject|13|||
27996856|NCT00787605|54655726|FG000|Overall Study|Lack of Efficacy|13|||
27996857|NCT00787605|54655727|FG001|Overall Study|Lack of Efficacy|9|||
27996858|NCT00448591|54655733|FG000|Overall Study|Withdrawal by Subject|178|||
27996859|NCT00448591|54655733|FG000|Overall Study|Progressive Disease|1382|||
27996860|NCT00448591|54655733|FG000|Overall Study|Adverse Event|382|||
27996861|NCT00448591|54655733|FG000|Overall Study|Protocol Violation|41|||
27996862|NCT00448591|54655733|FG000|Overall Study|Lost to Follow-up|19|||
27996863|NCT00448591|54655733|FG000|Overall Study|Treatment Regimen Completed|70|||
27996864|NCT00448591|54655733|FG000|Overall Study|Other|154|||
27911940|NCT01088529|54569955|FG001|Overall Study|Did not receive study treatment|1|||
27911941|NCT01087944|54569961|FG000|Period 1 (Week 1-3)|Adverse Event|1|||
27911942|NCT01087944|54569962|FG001|Period 1 (Week 1-3)|Adverse Event|0|||
27911943|NCT01087944|54569961|FG000|Period 2 (Week 4-6)|Adverse Event|0|||
27911944|NCT01087944|54569962|FG001|Period 2 (Week 4-6)|Adverse Event|2|||
27996865|NCT00448591|54655733|FG000|Overall Study|Termination of Study|70|||
27996866|NCT00651664|54655749|FG000|Overall Study|Occurrence of Adverse Event(s)|0|||
27996867|NCT00651664|54655750|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
27996868|NCT00651664|54655751|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
27996869|NCT00651664|54655752|FG003|Overall Study|Occurrence of Adverse Event(s)|0|||
27911945|NCT01132612|54569971|FG000|Overall Study|Death|0|||
27996870|NCT00651664|54655753|FG004|Overall Study|Occurrence of Adverse Event(s)|0|||
27996871|NCT00651664|54655754|FG005|Overall Study|Occurrence of Adverse Event(s)|0|||
27996872|NCT00651664|54655755|FG006|Overall Study|Occurrence of Adverse Event(s)|1|||
27996873|NCT00651664|54655756|FG007|Overall Study|Occurrence of Adverse Event(s)|0|||
27911946|NCT01132612|54569972|FG001|Overall Study|Death|0|||
27911947|NCT01132612|54569973|FG002|Overall Study|Death|1|||
27911948|NCT01132612|54569971|FG000|Overall Study|Protocol deviation|0|||
27911949|NCT01132612|54569972|FG001|Overall Study|Protocol deviation|0|||
27911950|NCT01132612|54569973|FG002|Overall Study|Protocol deviation|3|||
27911951|NCT01132612|54569971|FG000|Overall Study|Lost to Follow-up|2|||
27911952|NCT01132612|54569972|FG001|Overall Study|Lost to Follow-up|2|||
27911953|NCT01132612|54569973|FG002|Overall Study|Lost to Follow-up|7|||
27911954|NCT01132612|54569971|FG000|Overall Study|Adverse Event|5|||
27911955|NCT01132612|54569972|FG001|Overall Study|Adverse Event|2|||
27911956|NCT01132612|54569973|FG002|Overall Study|Adverse Event|15|||
27911957|NCT01132612|54569971|FG000|Overall Study|Withdrawal by Subject|5|||
27911958|NCT01132612|54569972|FG001|Overall Study|Withdrawal by Subject|8|||
27911959|NCT01132612|54569973|FG002|Overall Study|Withdrawal by Subject|19|||
27911960|NCT01132612|54569971|FG000|Overall Study|Administrative problems|5|||
27911961|NCT01132612|54569972|FG001|Overall Study|Administrative problems|1|||
27911962|NCT01132612|54569973|FG002|Overall Study|Administrative problems|52|||
27911963|NCT01132612|54569971|FG000|Overall Study|Lack of Efficacy|23|||
27911964|NCT01132612|54569972|FG001|Overall Study|Lack of Efficacy|22|||
27911965|NCT01132612|54569973|FG002|Overall Study|Lack of Efficacy|73|||
27911966|NCT01132495|54569985|FG000|Overall Study|Various reasons|40|||
27911967|NCT01132495|54569986|FG001|Overall Study|Various reasons|38|||
27911968|NCT01132495|54569987|FG002|Overall Study|Various reasons|20|||
27911969|NCT01132495|54569988|FG003|Overall Study|Various reasons|12|||
27911970|NCT01087905|54570007|FG000|Overall Study|Lost to Follow-up|24|||
27911971|NCT01087905|54570008|FG001|Overall Study|Lost to Follow-up|28|||
27911972|NCT01087905|54570009|FG002|Overall Study|Lost to Follow-up|18|||
27911973|NCT01087905|54570010|FG003|Overall Study|Lost to Follow-up|31|||
27911974|NCT01087905|54570011|FG004|Overall Study|Lost to Follow-up|27|||
27911975|NCT01087905|54570012|FG005|Overall Study|Lost to Follow-up|25|||
27996874|NCT00651664|54655757|FG008|Overall Study|Occurrence of Adverse Event(s)|1|||
27996875|NCT00651664|54655758|FG009|Overall Study|Occurrence of Adverse Event(s)|0|||
27996876|NCT00651664|54655749|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
27996877|NCT00651664|54655750|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
27996878|NCT00651664|54655751|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
27996879|NCT00651664|54655752|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
27996880|NCT00651664|54655753|FG004|Overall Study|Unsatisfactory Therapeutic Response|1|||
27996881|NCT00651664|54655754|FG005|Overall Study|Unsatisfactory Therapeutic Response|1|||
27996882|NCT00651664|54655755|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
27996883|NCT00651664|54655756|FG007|Overall Study|Unsatisfactory Therapeutic Response|1|||
27996884|NCT00651664|54655757|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
27996885|NCT00651664|54655758|FG009|Overall Study|Unsatisfactory Therapeutic Response|1|||
27996886|NCT00651664|54655749|FG000|Overall Study|Progressive Disease|3|||
27996887|NCT00651664|54655750|FG001|Overall Study|Progressive Disease|3|||
27996888|NCT00651664|54655751|FG002|Overall Study|Progressive Disease|3|||
27996889|NCT00651664|54655752|FG003|Overall Study|Progressive Disease|12|||
27996890|NCT00651664|54655753|FG004|Overall Study|Progressive Disease|4|||
27996891|NCT00651664|54655754|FG005|Overall Study|Progressive Disease|1|||
27996892|NCT00651664|54655755|FG006|Overall Study|Progressive Disease|3|||
27996893|NCT00651664|54655756|FG007|Overall Study|Progressive Disease|6|||
27996894|NCT00651664|54655757|FG008|Overall Study|Progressive Disease|5|||
27996895|NCT00651664|54655758|FG009|Overall Study|Progressive Disease|5|||
27996896|NCT00651664|54655749|FG000|Overall Study|Patient Declined Further Treatment|0|||
27996897|NCT00651664|54655750|FG001|Overall Study|Patient Declined Further Treatment|0|||
27996898|NCT00651664|54655751|FG002|Overall Study|Patient Declined Further Treatment|0|||
27996899|NCT00651664|54655752|FG003|Overall Study|Patient Declined Further Treatment|1|||
27996900|NCT00651664|54655753|FG004|Overall Study|Patient Declined Further Treatment|1|||
27996901|NCT00651664|54655754|FG005|Overall Study|Patient Declined Further Treatment|1|||
27996902|NCT00651664|54655755|FG006|Overall Study|Patient Declined Further Treatment|0|||
27996903|NCT00651664|54655756|FG007|Overall Study|Patient Declined Further Treatment|0|||
27996904|NCT00651664|54655757|FG008|Overall Study|Patient Declined Further Treatment|0|||
27996905|NCT00651664|54655758|FG009|Overall Study|Patient Declined Further Treatment|1|||
27996906|NCT00651664|54655749|FG000|Overall Study|Symptomatic Deterioration|0|||
27996907|NCT00651664|54655750|FG001|Overall Study|Symptomatic Deterioration|0|||
27996908|NCT00651664|54655751|FG002|Overall Study|Symptomatic Deterioration|0|||
27996909|NCT00651664|54655752|FG003|Overall Study|Symptomatic Deterioration|1|||
27996910|NCT00651664|54655753|FG004|Overall Study|Symptomatic Deterioration|0|||
27996911|NCT00651664|54655754|FG005|Overall Study|Symptomatic Deterioration|0|||
28172639|NCT02456740|54844363|FG003|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
27911976|NCT01087905|54570013|FG006|Overall Study|Lost to Follow-up|20|||
27911977|NCT01087905|54570014|FG007|Overall Study|Lost to Follow-up|24|||
27911978|NCT01087905|54570007|FG000|Overall Study|Withdrawal by Subject|5|||
27911979|NCT01087905|54570008|FG001|Overall Study|Withdrawal by Subject|4|||
27996912|NCT00651664|54655755|FG006|Overall Study|Symptomatic Deterioration|1|||
27996913|NCT00651664|54655756|FG007|Overall Study|Symptomatic Deterioration|0|||
27911980|NCT01087905|54570009|FG002|Overall Study|Withdrawal by Subject|4|||
27996914|NCT00651664|54655757|FG008|Overall Study|Symptomatic Deterioration|1|||
27911981|NCT01087905|54570010|FG003|Overall Study|Withdrawal by Subject|5|||
27911982|NCT01087905|54570011|FG004|Overall Study|Withdrawal by Subject|4|||
27996915|NCT00651664|54655758|FG009|Overall Study|Symptomatic Deterioration|0|||
27996916|NCT00651664|54655749|FG000|Overall Study|Reason not Specified|0|||
27996917|NCT00651664|54655750|FG001|Overall Study|Reason not Specified|0|||
27996918|NCT00651664|54655751|FG002|Overall Study|Reason not Specified|0|||
27996919|NCT00651664|54655752|FG003|Overall Study|Reason not Specified|0|||
27996920|NCT00651664|54655753|FG004|Overall Study|Reason not Specified|0|||
27996921|NCT00651664|54655754|FG005|Overall Study|Reason not Specified|0|||
27996922|NCT00651664|54655755|FG006|Overall Study|Reason not Specified|1|||
27996923|NCT00651664|54655756|FG007|Overall Study|Reason not Specified|0|||
27996924|NCT00651664|54655757|FG008|Overall Study|Reason not Specified|0|||
27996925|NCT00651664|54655758|FG009|Overall Study|Reason not Specified|0|||
27996926|NCT00787527|54655784|FG000|Overall Study|Toxicity|3|||
27996927|NCT00787137|54655795|FG000|Overall Study|Study Termination|0|||
27911983|NCT01087905|54570012|FG005|Overall Study|Withdrawal by Subject|3|||
27911984|NCT01087905|54570013|FG006|Overall Study|Withdrawal by Subject|3|||
27996928|NCT00787137|54655796|FG001|Overall Study|Study Termination|0|||
27996929|NCT00787137|54655797|FG002|Overall Study|Study Termination|1|||
27996930|NCT00448435|54655805|FG000|Washout Period - 2 Weeks|Withdrawal by Subject|1|||
27996931|NCT00448435|54655806|FG001|Washout Period - 2 Weeks|Withdrawal by Subject|0|||
27996932|NCT00448279|54655817|FG000|Overall Study|Lost to Follow-up|2|||
27996933|NCT00448279|54655818|FG001|Overall Study|Lost to Follow-up|2|||
27996934|NCT00448279|54655817|FG000|Overall Study|Adverse Event|1|||
27996935|NCT00448279|54655818|FG001|Overall Study|Adverse Event|1|||
27996936|NCT00448279|54655817|FG000|Overall Study|Disease progression|16|||
27996937|NCT00448279|54655818|FG001|Overall Study|Disease progression|18|||
27996938|NCT00448279|54655817|FG000|Overall Study|Withdrawal by Subject|4|||
27996939|NCT00448279|54655818|FG001|Overall Study|Withdrawal by Subject|3|||
27996940|NCT00448279|54655817|FG000|Overall Study|Other|6|||
27996941|NCT00448279|54655818|FG001|Overall Study|Other|4|||
27996942|NCT00448279|54655817|FG000|Overall Study|Protocol Violation|0|||
27996943|NCT00448279|54655818|FG001|Overall Study|Protocol Violation|1|||
27996944|NCT00448123|54655826|FG000|Overall Study|Lost to Follow-up|9|||
27996945|NCT00448123|54655827|FG001|Overall Study|Lost to Follow-up|6|||
27996946|NCT00448123|54655826|FG000|Overall Study|Physician Decision|6|||
27996947|NCT00448123|54655827|FG001|Overall Study|Physician Decision|6|||
28098937|NCT02524288|54754758|FG000|Overall Study|Protocol Violation|6|||
28098938|NCT02524288|54754758|FG000|Overall Study|Screen Failure|2|||
28098939|NCT02524288|54754758|FG000|Overall Study|Site Discontinued Study Participation|1|||
28098940|NCT02524288|54754758|FG000|Overall Study|Study Terminated By Sponsor|1417|||
28098941|NCT02524288|54754758|FG000|Overall Study|Subject Moved|32|||
28098942|NCT02524288|54754758|FG000|Overall Study|Withdrawal by Subject|76|||
28098943|NCT02524288|54754758|FG000|Overall Study|Pregnancy|22|||
28098944|NCT02524288|54754758|FG000|Overall Study|Physician Decision|2|||
28098945|NCT03624504|54754762|FG000|Overall Study|Unsuccessful Implant|1|||
28098946|NCT02954952|54754769|FG000|Overall Study|Withdrawal by Subject|1|||
28098947|NCT02954952|54754770|FG001|Overall Study|Withdrawal by Subject|0|||
28098948|NCT02954952|54754771|FG002|Overall Study|Withdrawal by Subject|0|||
28098949|NCT02954952|54754769|FG000|Overall Study|No data collected|0|||
28098950|NCT02954952|54754770|FG001|Overall Study|No data collected|1|||
28098951|NCT02954952|54754771|FG002|Overall Study|No data collected|0|||
28098952|NCT03547154|54754781|FG000|Overall Study|Disease Progression/Recurrence|6|||
28098953|NCT03547154|54754782|FG001|Overall Study|Disease Progression/Recurrence|14|||
28098954|NCT03547154|54754781|FG000|Overall Study|Adverse Event|26|||
28098955|NCT03547154|54754782|FG001|Overall Study|Adverse Event|31|||
28098956|NCT03547154|54754781|FG000|Overall Study|Protocol Violation|6|||
28098957|NCT03547154|54754782|FG001|Overall Study|Protocol Violation|1|||
28098958|NCT03547154|54754781|FG000|Overall Study|Physician Decision|4|||
28098959|NCT03547154|54754782|FG001|Overall Study|Physician Decision|3|||
27911985|NCT01087905|54570014|FG007|Overall Study|Withdrawal by Subject|5|||
27911986|NCT01087788|54570033|FG000|24-weeks Double-blind Period|Lack of Efficacy|2|||
27911987|NCT01087788|54570034|FG001|24-weeks Double-blind Period|Lack of Efficacy|0|||
27911988|NCT01087788|54570035|FG002|24-weeks Double-blind Period|Lack of Efficacy|1|||
27911989|NCT01087788|54570033|FG000|24-weeks Double-blind Period|Protocol Violation|0|||
27911990|NCT01087788|54570034|FG001|24-weeks Double-blind Period|Protocol Violation|1|||
28098960|NCT03547154|54754781|FG000|Overall Study|Insufficient Therapeutic Response|13|||
28098961|NCT03547154|54754782|FG001|Overall Study|Insufficient Therapeutic Response|10|||
28098962|NCT03547154|54754781|FG000|Overall Study|Withdrawal by Subject|10|||
28098963|NCT03547154|54754782|FG001|Overall Study|Withdrawal by Subject|6|||
28098964|NCT03547154|54754781|FG000|Overall Study|Not Selected|0|||
27911991|NCT01087788|54570035|FG002|24-weeks Double-blind Period|Protocol Violation|0|||
28098965|NCT03547154|54754782|FG001|Overall Study|Not Selected|1|||
28098966|NCT03547154|54754781|FG000|Overall Study|Continued treatment beyond 12 mo.|58|||
28098967|NCT03547154|54754782|FG001|Overall Study|Continued treatment beyond 12 mo.|50|||
28098968|NCT02275546|54754788|FG000|Treatment Period 2|Withdrawal by Subject|2|||
28098969|NCT02275546|54754789|FG001|Treatment Period 2|Withdrawal by Subject|1|||
28098970|NCT02275546|54754788|FG000|Treatment Period 2|Protocol Violation|0|||
28098971|NCT02275546|54754789|FG001|Treatment Period 2|Protocol Violation|1|||
28098972|NCT03624192|54754795|FG000|Overall Study|Lost to Follow-up|1|||
27996948|NCT00447499|54655836|FG000|Overall Study|Adverse Event|1|||
27996949|NCT00447499|54655836|FG000|Overall Study|Patient Decision|4|||
27996950|NCT00447499|54655836|FG000|Overall Study|Sponsor Decision|1|||
27996951|NCT00447499|54655836|FG000|Overall Study|Physician Decision|1|||
27996952|NCT00800436|54655849|FG000|Overall Study|Withdrawal by Subject|0|||
27996953|NCT00800436|54655850|FG001|Overall Study|Withdrawal by Subject|0|||
27996954|NCT00800436|54655851|FG002|Overall Study|Withdrawal by Subject|1|||
27911992|NCT01087788|54570033|FG000|24-weeks Double-blind Period|Lost to Follow-up|4|||
27911993|NCT01087788|54570034|FG001|24-weeks Double-blind Period|Lost to Follow-up|1|||
27911994|NCT01087788|54570035|FG002|24-weeks Double-blind Period|Lost to Follow-up|1|||
27911995|NCT01087788|54570033|FG000|24-weeks Double-blind Period|Withdrawal by Subject|7|||
27911996|NCT01087788|54570034|FG001|24-weeks Double-blind Period|Withdrawal by Subject|2|||
27911997|NCT01087788|54570035|FG002|24-weeks Double-blind Period|Withdrawal by Subject|5|||
27911998|NCT01087788|54570033|FG000|24-weeks Double-blind Period|AE, serious fatal|0|||
27911999|NCT01087788|54570034|FG001|24-weeks Double-blind Period|AE, serious fatal|1|||
27912000|NCT01087788|54570035|FG002|24-weeks Double-blind Period|AE, serious fatal|1|||
27912001|NCT01087788|54570033|FG000|24-weeks Double-blind Period|AE, serious non-fatal|0|||
27912002|NCT01087788|54570034|FG001|24-weeks Double-blind Period|AE, serious non-fatal|2|||
27912003|NCT01087788|54570035|FG002|24-weeks Double-blind Period|AE, serious non-fatal|3|||
27996955|NCT00800436|54655852|FG003|Overall Study|Withdrawal by Subject|1|||
27996956|NCT00800436|54655853|FG004|Overall Study|Withdrawal by Subject|0|||
27996957|NCT00800436|54655854|FG005|Overall Study|Withdrawal by Subject|0|||
27996958|NCT00800436|54655855|FG006|Overall Study|Withdrawal by Subject|0|||
27996959|NCT00655564|54655871|FG000|Overall Study|Adverse Event|1|||
27996960|NCT00655564|54655871|FG000|Overall Study|Lost to Follow-up|1|||
27996961|NCT00655564|54655871|FG000|Overall Study|Desired Alternate Therapy|1|||
27996962|NCT00447421|54655876|FG000|Overall Study|Lack of Efficacy|1|||
27996963|NCT00447421|54655876|FG000|Overall Study|Adverse Event|3|||
27996964|NCT00447421|54655876|FG000|Overall Study|Sponsor Decision|2|||
27996965|NCT00651118|54655884|FG000|Overall Study|Adverse Event|4|||
27996966|NCT00651118|54655885|FG001|Overall Study|Adverse Event|0|||
27996967|NCT00651118|54655886|FG002|Overall Study|Adverse Event|1|||
27996968|NCT00651118|54655887|FG003|Overall Study|Adverse Event|1|||
27996969|NCT00651118|54655884|FG000|Overall Study|Protocol Violation|2|||
27996970|NCT00651118|54655885|FG001|Overall Study|Protocol Violation|2|||
27996971|NCT00651118|54655886|FG002|Overall Study|Protocol Violation|6|||
27996972|NCT00651118|54655887|FG003|Overall Study|Protocol Violation|2|||
27912004|NCT01087788|54570033|FG000|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
27912005|NCT01087788|54570034|FG001|24-weeks Double-blind Period|AE, non-serious non-fatal|1|||
27996973|NCT00651118|54655884|FG000|Overall Study|Lost to Follow-up|2|||
27996974|NCT00651118|54655885|FG001|Overall Study|Lost to Follow-up|0|||
27996975|NCT00651118|54655886|FG002|Overall Study|Lost to Follow-up|1|||
27996976|NCT00651118|54655887|FG003|Overall Study|Lost to Follow-up|2|||
27996977|NCT00651118|54655884|FG000|Overall Study|administrative|1|||
27996978|NCT00651118|54655885|FG001|Overall Study|administrative|4|||
27996979|NCT00651118|54655886|FG002|Overall Study|administrative|2|||
27996980|NCT00651118|54655887|FG003|Overall Study|administrative|1|||
27996981|NCT00651118|54655884|FG000|Overall Study|Withdrawal by Subject|0|||
27996982|NCT00651118|54655885|FG001|Overall Study|Withdrawal by Subject|1|||
27996983|NCT00651118|54655886|FG002|Overall Study|Withdrawal by Subject|1|||
27996984|NCT00651118|54655887|FG003|Overall Study|Withdrawal by Subject|1|||
27996985|NCT00447265|54655900|FG000|Overall Study|Physician Decision|1|||
27996986|NCT00447265|54655901|FG001|Overall Study|Physician Decision|0|||
27996987|NCT00657358|54655905|FG000|Overall Study|Lack of Efficacy|6|||
28098973|NCT03624192|54754796|FG001|Overall Study|Lost to Follow-up|1|||
27912006|NCT01087788|54570035|FG002|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
27912007|NCT01087788|54570033|FG000|24-weeks Double-blind Period|AE, unknown type|0|||
27912008|NCT01087788|54570034|FG001|24-weeks Double-blind Period|AE, unknown type|0|||
27912009|NCT01087788|54570035|FG002|24-weeks Double-blind Period|AE, unknown type|1|||
27912010|NCT01087788|54570033|FG000|24-weeks Double-blind Period|Patient (P) does not want to attend|1|||
27912011|NCT01087788|54570034|FG001|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
27912012|NCT01087788|54570035|FG002|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
27912013|NCT01087788|54570033|FG000|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
27912014|NCT01087788|54570034|FG001|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1|||
27912015|NCT01087788|54570035|FG002|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
27996988|NCT00457639|54655910|FG000|Intervention 1 (6 Months)|Lost to Follow-up|3|||
28098974|NCT03034954|54754806|FG000|Overall Study|Machine malfunction; did not reach 3 mA|1|||
28098975|NCT03034954|54754807|FG001|Overall Study|Machine malfunction; did not reach 3 mA|0|||
27996989|NCT00457639|54655911|FG001|Intervention 1 (6 Months)|Lost to Follow-up|0|||
27996990|NCT00457639|54655910|FG000|Intervention 1 (6 Months)|unrelated illness|0|||
27996991|NCT00457639|54655911|FG001|Intervention 1 (6 Months)|unrelated illness|2|||
27996992|NCT00457639|54655910|FG000|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0|||
28098976|NCT03546842|54754813|FG000|Overall Study|Protocol Violation|1|||
27912016|NCT01087788|54570033|FG000|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
27912017|NCT01087788|54570034|FG001|24-weeks Double-blind Period|Exclusion criteria were not met|1|||
27912018|NCT01087788|54570035|FG002|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
27912019|NCT01087788|54570033|FG000|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
27996993|NCT00457639|54655911|FG001|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1|||
27996994|NCT00800202|54655919|FG000|Overall Study|Adverse Event|7|||
27996995|NCT00800202|54655920|FG001|Overall Study|Adverse Event|6|||
27996996|NCT00800202|54655919|FG000|Overall Study|Death|1|||
27996997|NCT00800202|54655920|FG001|Overall Study|Death|0|||
27996998|NCT00800202|54655919|FG000|Overall Study|Other|5|||
27996999|NCT00800202|54655920|FG001|Overall Study|Other|0|||
27997000|NCT00800202|54655919|FG000|Overall Study|Disease Progression|54|||
27997001|NCT00800202|54655920|FG001|Overall Study|Disease Progression|18|||
27997002|NCT00655486|54655926|FG000|Overall Study|Adverse Event|10|||
27997003|NCT00655486|54655926|FG000|Overall Study|Lack of Efficacy|8|||
27997004|NCT00655486|54655926|FG000|Overall Study|Withdrawal by Subject|4|||
27997005|NCT00655486|54655926|FG000|Overall Study|Protocol Violation|1|||
27997006|NCT00655486|54655926|FG000|Overall Study|Unsatisfactory compliance|2|||
27997007|NCT00655486|54655926|FG000|Overall Study|Other: Pregnancy|1|||
27997008|NCT00655486|54655926|FG000|Overall Study|Other: Could not tolerate BID dosing|1|||
27997009|NCT00655486|54655926|FG000|Overall Study|Other: Abnormal electrocardiogram (ECG)|1|||
27912020|NCT01087788|54570034|FG001|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
27912021|NCT01087788|54570035|FG002|24-weeks Double-blind Period|P cannot comply with scheduled visits|1|||
27912022|NCT01087788|54570033|FG000|24-weeks Dose-blind Period|Lack of Efficacy|0|||
27912023|NCT01087788|54570034|FG001|24-weeks Dose-blind Period|Lack of Efficacy|2|||
27997010|NCT00457249|54655932|FG000|Overall Study|Lost to Follow-up|3|||
27997011|NCT00457249|54655933|FG001|Overall Study|Lost to Follow-up|0|||
27997012|NCT00457249|54655932|FG000|Overall Study|Protocol Violation|4|||
27997013|NCT00457249|54655933|FG001|Overall Study|Protocol Violation|1|||
27997014|NCT00457249|54655932|FG000|Overall Study|Withdrawal by Subject|3|||
27997015|NCT00457249|54655933|FG001|Overall Study|Withdrawal by Subject|1|||
27997016|NCT00457249|54655932|FG000|Overall Study|Serious Adverse Events|2|||
27997017|NCT00457249|54655933|FG001|Overall Study|Serious Adverse Events|0|||
27997018|NCT00457015|54655943|FG000|Overall Study|Left study site against medical advice|0|||
27997019|NCT00457015|54655944|FG001|Overall Study|Left study site against medical advice|1|||
27997020|NCT00654940|54655952|FG000|Period 1|Adverse Event|0|||
27997021|NCT00654940|54655953|FG001|Period 1|Adverse Event|1|||
27997022|NCT00654940|54655952|FG000|Period 1|Intolerable Pain Level|1|||
27997023|NCT00654940|54655953|FG001|Period 1|Intolerable Pain Level|0|||
27997024|NCT00588666|54655965|FG000|Overall Study|Adverse Event|4|||
27997025|NCT00793182|54655980|FG000|Overall Study|Adverse Event|0|||
27997026|NCT00793182|54655981|FG001|Overall Study|Adverse Event|1|||
27997027|NCT00793104|54655987|FG000|Overall Study|Lost to Follow-up|1|||
27997028|NCT00446797|54655993|FG000|Overall Study|Lack of Efficacy|0|||
27997029|NCT00446797|54655994|FG001|Overall Study|Lack of Efficacy|2|||
27912024|NCT01087788|54570035|FG002|24-weeks Dose-blind Period|Lack of Efficacy|1|||
27912025|NCT01087788|54570033|FG000|24-weeks Dose-blind Period|Lost to Follow-up|1|||
27912026|NCT01087788|54570034|FG001|24-weeks Dose-blind Period|Lost to Follow-up|0|||
27912027|NCT01087788|54570035|FG002|24-weeks Dose-blind Period|Lost to Follow-up|1|||
27912028|NCT01087788|54570033|FG000|24-weeks Dose-blind Period|Withdrawal by Subject|1|||
27912029|NCT01087788|54570034|FG001|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
27912030|NCT01087788|54570035|FG002|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
27912031|NCT01087788|54570033|FG000|24-weeks Dose-blind Period|AE, serious fatal|0|||
27912032|NCT01087788|54570034|FG001|24-weeks Dose-blind Period|AE, serious fatal|1|||
27912033|NCT01087788|54570035|FG002|24-weeks Dose-blind Period|AE, serious fatal|0|||
27912034|NCT01087788|54570033|FG000|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
27912035|NCT01087788|54570034|FG001|24-weeks Dose-blind Period|AE, serious non-fatal|1|||
27912036|NCT01087788|54570035|FG002|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
27912037|NCT01087788|54570033|FG000|24-weeks Dose-blind Period|AE, non-serious non-fatal|2|||
27912038|NCT01087788|54570034|FG001|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
27912039|NCT01087788|54570035|FG002|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
27912040|NCT01087788|54570033|FG000|24-weeks Dose-blind Period|Sponsor decision following missed visits|1|||
27912041|NCT01087788|54570034|FG001|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
27912042|NCT01087788|54570035|FG002|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
27997030|NCT00446797|54655993|FG000|Overall Study|Lost to Follow-up|5|||
27997031|NCT00446797|54655994|FG001|Overall Study|Lost to Follow-up|3|||
27997032|NCT00446797|54655993|FG000|Overall Study|Withdrawal by Subject|2|||
27997033|NCT00446797|54655994|FG001|Overall Study|Withdrawal by Subject|2|||
27997034|NCT00446797|54655993|FG000|Overall Study|Protocol Violation|1|||
27997035|NCT00446797|54655994|FG001|Overall Study|Protocol Violation|3|||
27997036|NCT00446797|54655993|FG000|Overall Study|subject entered at another site|0|||
27997037|NCT00446797|54655994|FG001|Overall Study|subject entered at another site|1|||
27997038|NCT00446797|54655993|FG000|Overall Study|did not meet entrance criteria|0|||
27912043|NCT01087788|54570033|FG000|24-weeks Dose-blind Period|Patient moved|0|||
27912044|NCT01087788|54570034|FG001|24-weeks Dose-blind Period|Patient moved|0|||
27912045|NCT01087788|54570035|FG002|24-weeks Dose-blind Period|Patient moved|1|||
27912046|NCT01087788|54570033|FG000|Open-Label Period (OL-P)|Lack of Efficacy|4|||
27912047|NCT01087788|54570034|FG001|Open-Label Period (OL-P)|Lack of Efficacy|2|||
27912048|NCT01087788|54570035|FG002|Open-Label Period (OL-P)|Lack of Efficacy|3|||
27912049|NCT01087788|54570033|FG000|Open-Label Period (OL-P)|Protocol Violation|2|||
27912050|NCT01087788|54570034|FG001|Open-Label Period (OL-P)|Protocol Violation|1|||
27912051|NCT01087788|54570035|FG002|Open-Label Period (OL-P)|Protocol Violation|0|||
27912052|NCT01087788|54570033|FG000|Open-Label Period (OL-P)|Lost to Follow-up|0|||
27912053|NCT01087788|54570034|FG001|Open-Label Period (OL-P)|Lost to Follow-up|4|||
27912054|NCT01087788|54570035|FG002|Open-Label Period (OL-P)|Lost to Follow-up|2|||
27912055|NCT01087788|54570033|FG000|Open-Label Period (OL-P)|Withdrawal by Subject|13|||
27912056|NCT01087788|54570034|FG001|Open-Label Period (OL-P)|Withdrawal by Subject|8|||
27912057|NCT01087788|54570035|FG002|Open-Label Period (OL-P)|Withdrawal by Subject|10|||
27912058|NCT01087788|54570033|FG000|Open-Label Period (OL-P)|AE, serious fatal|2|||
27912059|NCT01087788|54570034|FG001|Open-Label Period (OL-P)|AE, serious fatal|0|||
27997039|NCT00446797|54655994|FG001|Overall Study|did not meet entrance criteria|1|||
27997040|NCT00855335|54656005|FG000|Overall Study|Lost to Follow-up|0|||
27997041|NCT00855335|54656006|FG001|Overall Study|Lost to Follow-up|0|||
27997042|NCT00855335|54656007|FG002|Overall Study|Lost to Follow-up|3|||
27997043|NCT00855335|54656008|FG003|Overall Study|Lost to Follow-up|1|||
27997044|NCT00855335|54656009|FG004|Overall Study|Lost to Follow-up|0|||
27912060|NCT01087788|54570035|FG002|Open-Label Period (OL-P)|AE, serious fatal|1|||
27912061|NCT01087788|54570033|FG000|Open-Label Period (OL-P)|AE, serious non-fatal|1|||
27997045|NCT00855335|54656005|FG000|Overall Study|Withdrawal by Subject|0|||
27997046|NCT00855335|54656006|FG001|Overall Study|Withdrawal by Subject|0|||
27997047|NCT00855335|54656007|FG002|Overall Study|Withdrawal by Subject|0|||
27997048|NCT00855335|54656008|FG003|Overall Study|Withdrawal by Subject|1|||
27997049|NCT00855335|54656009|FG004|Overall Study|Withdrawal by Subject|0|||
27997050|NCT00855335|54656005|FG000|Overall Study|Adverse Event|2|||
27997051|NCT00855335|54656006|FG001|Overall Study|Adverse Event|0|||
27997052|NCT00855335|54656007|FG002|Overall Study|Adverse Event|0|||
27997053|NCT00855335|54656008|FG003|Overall Study|Adverse Event|0|||
27997054|NCT00855335|54656009|FG004|Overall Study|Adverse Event|0|||
27997055|NCT00855335|54656005|FG000|Overall Study|Physician Decision|1|||
27997056|NCT00855335|54656006|FG001|Overall Study|Physician Decision|1|||
27997057|NCT00855335|54656007|FG002|Overall Study|Physician Decision|0|||
27997058|NCT00855335|54656008|FG003|Overall Study|Physician Decision|0|||
27912062|NCT01087788|54570034|FG001|Open-Label Period (OL-P)|AE, serious non-fatal|3|||
27912063|NCT01087788|54570035|FG002|Open-Label Period (OL-P)|AE, serious non-fatal|4|||
27912064|NCT01087788|54570033|FG000|Open-Label Period (OL-P)|AE, non-serious non-fatal|6|||
27912065|NCT01087788|54570034|FG001|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
27912066|NCT01087788|54570035|FG002|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
27912067|NCT01087788|54570033|FG000|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
27912068|NCT01087788|54570034|FG001|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1|||
27912069|NCT01087788|54570035|FG002|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
27912070|NCT01087788|54570033|FG000|Open-Label Period (OL-P)|AE, non-serious unknown|1|||
27912071|NCT01087788|54570034|FG001|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
27912072|NCT01087788|54570035|FG002|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
27912073|NCT01087788|54570033|FG000|Open-Label Period (OL-P)|Sponsor request|1|||
27912074|NCT01087788|54570034|FG001|Open-Label Period (OL-P)|Sponsor request|0|||
27912075|NCT01087788|54570035|FG002|Open-Label Period (OL-P)|Sponsor request|0|||
27912076|NCT01087788|54570033|FG000|Open-Label Period (OL-P)|Principal investigator decision|0|||
27912077|NCT01087788|54570034|FG001|Open-Label Period (OL-P)|Principal investigator decision|1|||
27912078|NCT01087788|54570035|FG002|Open-Label Period (OL-P)|Principal investigator decision|2|||
27912079|NCT01087788|54570033|FG000|Open-Label Period (OL-P)|No participation in study extension|0|||
27912080|NCT01087788|54570034|FG001|Open-Label Period (OL-P)|No participation in study extension|0|||
27912081|NCT01087788|54570035|FG002|Open-Label Period (OL-P)|No participation in study extension|1|||
27912082|NCT01087788|54570033|FG000|Open-Label Period (OL-P)|Personal reasons|0|||
27912083|NCT01087788|54570034|FG001|Open-Label Period (OL-P)|Personal reasons|0|||
27912084|NCT01087788|54570035|FG002|Open-Label Period (OL-P)|Personal reasons|1|||
27912085|NCT01086969|54570047|FG000|Overall Study|Withdrawal by Subject|1|||
27912086|NCT01086969|54570048|FG001|Overall Study|Withdrawal by Subject|2|||
27912087|NCT01086969|54570049|FG002|Overall Study|Withdrawal by Subject|0|||
27912088|NCT01086423|54570060|FG000|Overall Study|Protocol Violation|0|||
27912089|NCT01086423|54570061|FG001|Overall Study|Protocol Violation|0|||
27912090|NCT01086423|54570062|FG002|Overall Study|Protocol Violation|1|||
27997059|NCT00855335|54656009|FG004|Overall Study|Physician Decision|0|||
27739732|NCT02222896|54189358|FG000|Groin|Did not qualify|43|||
27912091|NCT01086423|54570060|FG000|Overall Study|Migrated/moved from study area|2|||
27997060|NCT00855335|54656005|FG000|Overall Study|Other|2|||
27997061|NCT00855335|54656006|FG001|Overall Study|Other|1|||
27997062|NCT00855335|54656007|FG002|Overall Study|Other|2|||
27997063|NCT00855335|54656008|FG003|Overall Study|Other|5|||
27997064|NCT00855335|54656009|FG004|Overall Study|Other|1|||
27997065|NCT00799422|54656034|FG000|First Week of Wear|Lost to Follow-up|0|||
27997066|NCT00799422|54656035|FG001|First Week of Wear|Lost to Follow-up|0|||
27997067|NCT00799422|54656036|FG002|First Week of Wear|Lost to Follow-up|1|||
27997068|NCT00799422|54656037|FG003|First Week of Wear|Lost to Follow-up|0|||
27912092|NCT01086423|54570061|FG001|Overall Study|Migrated/moved from study area|0|||
27912093|NCT01086423|54570062|FG002|Overall Study|Migrated/moved from study area|4|||
27997069|NCT00799422|54656038|FG004|First Week of Wear|Lost to Follow-up|0|||
27997070|NCT00799422|54656039|FG005|First Week of Wear|Lost to Follow-up|0|||
27997071|NCT00799422|54656034|FG000|First Week of Wear|Adverse Event|0|||
27997072|NCT00799422|54656035|FG001|First Week of Wear|Adverse Event|0|||
27997073|NCT00799422|54656036|FG002|First Week of Wear|Adverse Event|0|||
27997074|NCT00799422|54656037|FG003|First Week of Wear|Adverse Event|1|||
27912094|NCT01086423|54570060|FG000|Overall Study|Adverse event, fatal|1|||
27912095|NCT01086423|54570061|FG001|Overall Study|Adverse event, fatal|1|||
27912096|NCT01086423|54570062|FG002|Overall Study|Adverse event, fatal|0|||
27912097|NCT01086423|54570060|FG000|Overall Study|Adverse event, non-fatal|2|||
27912098|NCT01086423|54570061|FG001|Overall Study|Adverse event, non-fatal|1|||
27912099|NCT01086423|54570062|FG002|Overall Study|Adverse event, non-fatal|0|||
27912100|NCT01086423|54570060|FG000|Overall Study|Withdrawal by Subject|5|||
27912101|NCT01086423|54570061|FG001|Overall Study|Withdrawal by Subject|1|||
27912102|NCT01086423|54570062|FG002|Overall Study|Withdrawal by Subject|3|||
27912103|NCT01086423|54570060|FG000|Overall Study|Lost to Follow-up|0|||
27912104|NCT01086423|54570061|FG001|Overall Study|Lost to Follow-up|0|||
27912105|NCT01086423|54570062|FG002|Overall Study|Lost to Follow-up|1|||
27912106|NCT01086150|54570073|FG000|Overall Study|Withdrawal by Subject|0|||
27912107|NCT01086150|54570074|FG001|Overall Study|Withdrawal by Subject|4|||
27912108|NCT01086150|54570075|FG002|Overall Study|Withdrawal by Subject|1|||
27912109|NCT01086150|54570073|FG000|Overall Study|Lost to Follow-up|0|||
27912110|NCT01086150|54570074|FG001|Overall Study|Lost to Follow-up|1|||
27912111|NCT01086150|54570075|FG002|Overall Study|Lost to Follow-up|0|||
27912112|NCT01086150|54570073|FG000|Overall Study|Screen Failure|0|||
27912113|NCT01086150|54570074|FG001|Overall Study|Screen Failure|1|||
27912114|NCT01086150|54570075|FG002|Overall Study|Screen Failure|0|||
27912115|NCT01086033|54570083|FG000|Overall Study|Lack of efficacy/Exacerbation of RA|86|||
27912116|NCT01086033|54570083|FG000|Overall Study|Lost to Follow-up|86|||
27912117|NCT01086033|54570083|FG000|Overall Study|Adverse Event|42|||
27912118|NCT01086033|54570083|FG000|Overall Study|Withdrawal by Subject|41|||
27912119|NCT01086033|54570083|FG000|Overall Study|Other|14|||
27912120|NCT01086033|54570083|FG000|Overall Study|Other|13|||
27912121|NCT01086033|54570083|FG000|Overall Study|AE and Withdrew Consent|5|||
27912122|NCT01086033|54570083|FG000|Overall Study|Withdrew Consent and Lack of Efficacy|5|||
27912123|NCT01086033|54570083|FG000|Overall Study|Withdrew consent and Other Reason|4|||
27912124|NCT01086033|54570083|FG000|Overall Study|AE and Lack of Efficacy|4|||
27912125|NCT01086033|54570083|FG000|Overall Study|Death|1|||
27912126|NCT01086033|54570083|FG000|Overall Study|AE and Lost to Follow-up|1|||
27997075|NCT00799422|54656038|FG004|First Week of Wear|Adverse Event|0|||
27997076|NCT00799422|54656039|FG005|First Week of Wear|Adverse Event|0|||
27997077|NCT00593489|54656049|FG000|Allocation|did not attend workshop; allocation not|2|||
27997078|NCT00593489|54656050|FG001|Allocation|did not attend workshop; allocation not|1|||
27997079|NCT00446641|54656060|FG000|Overall Study|Withdrawal by Subject|8|||
27997080|NCT00446641|54656061|FG001|Overall Study|Withdrawal by Subject|3|||
27997081|NCT00446641|54656060|FG000|Overall Study|poor compliance|8|||
27997082|NCT00446641|54656061|FG001|Overall Study|poor compliance|6|||
27997083|NCT00446641|54656060|FG000|Overall Study|Lost to Follow-up|1|||
27997084|NCT00446641|54656061|FG001|Overall Study|Lost to Follow-up|1|||
27997085|NCT00646282|54656069|FG000|Overall Study|Protocol terminated|4|||
27997086|NCT00646282|54656070|FG001|Overall Study|Protocol terminated|4|||
27997087|NCT00792636|54656079|FG000|Overall Study|Protocol Violation|17|||
27997088|NCT00792636|54656080|FG001|Overall Study|Protocol Violation|23|||
28098977|NCT03546842|54754813|FG000|Overall Study|Withdrawal by Subject|2|||
28098978|NCT03640052|54754817|FG000|Overall Study|Lost to Follow-up|0|||
28098979|NCT03640052|54754818|FG001|Overall Study|Lost to Follow-up|1|||
27997089|NCT00792636|54656081|FG002|Overall Study|Protocol Violation|20|||
27997090|NCT00792636|54656079|FG000|Overall Study|Met Protocol-defined Stopping Criteria|19|||
27912127|NCT01086033|54570083|FG000|Overall Study|AE and Other Reason|1|||
27997091|NCT00792636|54656080|FG001|Overall Study|Met Protocol-defined Stopping Criteria|20|||
27997092|NCT00792636|54656081|FG002|Overall Study|Met Protocol-defined Stopping Criteria|20|||
28098980|NCT03640052|54754819|FG002|Overall Study|Lost to Follow-up|0|||
27912128|NCT01086033|54570083|FG000|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1|||
27912129|NCT01085682|54570092|FG000|Overall Study|Withdrawal by Subject|25|||
27912130|NCT01085682|54570093|FG001|Overall Study|Withdrawal by Subject|25|||
27912131|NCT01085214|54570099|FG000|Overall Study|Alternate treatment required|1|||
27912132|NCT01085136|54570103|FG000|Part A|Other Adverse event|223|||
27912133|NCT01085136|54570104|FG001|Part A|Other Adverse event|0|||
27912134|NCT01085136|54570105|FG002|Part A|Other Adverse event|0|||
27912135|NCT01085136|54570103|FG000|Part A|Protocol Violation|3|||
27912136|NCT01085136|54570104|FG001|Part A|Protocol Violation|0|||
27912137|NCT01085136|54570105|FG002|Part A|Protocol Violation|0|||
27912138|NCT01085136|54570103|FG000|Part A|Lost to Follow-up|3|||
27912139|NCT01085136|54570104|FG001|Part A|Lost to Follow-up|0|||
27997093|NCT00792636|54656079|FG000|Overall Study|Lost to Follow-up|13|||
27997094|NCT00792636|54656080|FG001|Overall Study|Lost to Follow-up|19|||
27997095|NCT00792636|54656081|FG002|Overall Study|Lost to Follow-up|14|||
27997096|NCT00792636|54656079|FG000|Overall Study|Withdrew Consent|10|||
27912140|NCT01085136|54570105|FG002|Part A|Lost to Follow-up|0|||
27912141|NCT01085136|54570103|FG000|Part A|Refusal to continue trial medication|64|||
27912142|NCT01085136|54570104|FG001|Part A|Refusal to continue trial medication|0|||
27997097|NCT00792636|54656080|FG001|Overall Study|Withdrew Consent|13|||
27997098|NCT00792636|54656081|FG002|Overall Study|Withdrew Consent|9|||
27997099|NCT00792636|54656079|FG000|Overall Study|Lack of Efficacy|3|||
27997100|NCT00792636|54656080|FG001|Overall Study|Lack of Efficacy|4|||
27997101|NCT00792636|54656081|FG002|Overall Study|Lack of Efficacy|13|||
27997102|NCT00792636|54656079|FG000|Overall Study|Adverse Event|4|||
27997103|NCT00792636|54656080|FG001|Overall Study|Adverse Event|2|||
27997104|NCT00792636|54656081|FG002|Overall Study|Adverse Event|3|||
27997105|NCT00792636|54656079|FG000|Overall Study|Investigator Discretion|2|||
27997106|NCT00792636|54656080|FG001|Overall Study|Investigator Discretion|0|||
27997107|NCT00792636|54656081|FG002|Overall Study|Investigator Discretion|2|||
27997108|NCT00446563|54656093|FG000|Overall Study|Adverse Event|4|||
27997109|NCT00446563|54656094|FG001|Overall Study|Adverse Event|3|||
27997110|NCT00446563|54656093|FG000|Overall Study|Abnormal laboratory value(s)|0|||
27997111|NCT00446563|54656094|FG001|Overall Study|Abnormal laboratory value(s)|1|||
27997112|NCT00446563|54656093|FG000|Overall Study|Abnormal test procedure result(s)|1|||
27997113|NCT00446563|54656094|FG001|Overall Study|Abnormal test procedure result(s)|0|||
27997114|NCT00446563|54656093|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
27997115|NCT00446563|54656094|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
27997116|NCT00446563|54656093|FG000|Overall Study|Withdrawal by Subject|2|||
27997117|NCT00446563|54656094|FG001|Overall Study|Withdrawal by Subject|1|||
27997118|NCT00446563|54656093|FG000|Overall Study|Administrative problems|0|||
27997119|NCT00446563|54656094|FG001|Overall Study|Administrative problems|1|||
27997120|NCT00650806|54656104|FG000|Overall Study|Adverse Event|0|||
27997121|NCT00650806|54656105|FG001|Overall Study|Adverse Event|5|||
27997122|NCT00650806|54656106|FG002|Overall Study|Adverse Event|3|||
27997123|NCT00650806|54656107|FG003|Overall Study|Adverse Event|4|||
27997124|NCT00650806|54656104|FG000|Overall Study|Lost to Follow-up|7|||
27997125|NCT00650806|54656105|FG001|Overall Study|Lost to Follow-up|6|||
27997126|NCT00650806|54656106|FG002|Overall Study|Lost to Follow-up|11|||
27997127|NCT00650806|54656107|FG003|Overall Study|Lost to Follow-up|10|||
27997128|NCT00650806|54656104|FG000|Overall Study|Protocol Violation|0|||
27997129|NCT00650806|54656105|FG001|Overall Study|Protocol Violation|0|||
27997130|NCT00650806|54656106|FG002|Overall Study|Protocol Violation|0|||
27997131|NCT00650806|54656107|FG003|Overall Study|Protocol Violation|1|||
27997132|NCT00650806|54656104|FG000|Overall Study|Pregnancy|0|||
27997133|NCT00650806|54656105|FG001|Overall Study|Pregnancy|0|||
27997134|NCT00650806|54656106|FG002|Overall Study|Pregnancy|0|||
27997135|NCT00650806|54656107|FG003|Overall Study|Pregnancy|1|||
27997136|NCT00650806|54656104|FG000|Overall Study|Withdrawal by Subject|7|||
27997137|NCT00650806|54656105|FG001|Overall Study|Withdrawal by Subject|5|||
27997138|NCT00650806|54656106|FG002|Overall Study|Withdrawal by Subject|8|||
27997139|NCT00650806|54656107|FG003|Overall Study|Withdrawal by Subject|6|||
27997140|NCT00650806|54656104|FG000|Overall Study|Noncompliance with study drug regimen|1|||
27997141|NCT00650806|54656105|FG001|Overall Study|Noncompliance with study drug regimen|1|||
27997142|NCT00650806|54656106|FG002|Overall Study|Noncompliance with study drug regimen|0|||
27997143|NCT00650806|54656107|FG003|Overall Study|Noncompliance with study drug regimen|0|||
27997144|NCT00650806|54656104|FG000|Overall Study|Study terminated by sponsor|2|||
27997145|NCT00650806|54656105|FG001|Overall Study|Study terminated by sponsor|3|||
27997146|NCT00650806|54656106|FG002|Overall Study|Study terminated by sponsor|5|||
27997147|NCT00650806|54656107|FG003|Overall Study|Study terminated by sponsor|4|||
27997148|NCT00650806|54656104|FG000|Overall Study|Other|1|||
27997149|NCT00650806|54656105|FG001|Overall Study|Other|1|||
27997150|NCT00650806|54656106|FG002|Overall Study|Other|2|||
27912143|NCT01085136|54570105|FG002|Part A|Refusal to continue trial medication|0|||
27997151|NCT00650806|54656107|FG003|Overall Study|Other|0|||
27997152|NCT00863057|54656123|FG000|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
27997153|NCT00863057|54656124|FG001|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
27912144|NCT01085136|54570103|FG000|Part A|Other reason not defined above|30|||
27997154|NCT00863057|54656125|FG002|Milestones Period 1 (Weeks 0-5)|Adverse Event|0|||
27997155|NCT00863057|54656126|FG003|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
27912145|NCT01085136|54570104|FG001|Part A|Other reason not defined above|0|||
27997156|NCT00863057|54656123|FG000|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
27912146|NCT01085136|54570105|FG002|Part A|Other reason not defined above|0|||
27912147|NCT01085136|54570103|FG000|Part B|Other AE|0|||
27912148|NCT01085136|54570104|FG001|Part B|Other AE|29|||
27997157|NCT00863057|54656124|FG001|Milestones Period 1 (Weeks 0-5)|Physician Decision|1|||
27997158|NCT00863057|54656125|FG002|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
27997159|NCT00863057|54656126|FG003|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
27997160|NCT00863057|54656123|FG000|Period 2 (Weeks 6-10)|Adverse Event|0|||
27997161|NCT00863057|54656124|FG001|Period 2 (Weeks 6-10)|Adverse Event|1|||
27997162|NCT00863057|54656125|FG002|Period 2 (Weeks 6-10)|Adverse Event|1|||
27997163|NCT00863057|54656126|FG003|Period 2 (Weeks 6-10)|Adverse Event|0|||
27997164|NCT00863057|54656123|FG000|Period 2 (Weeks 6-10)|Physician Decision|0|||
27997165|NCT00863057|54656124|FG001|Period 2 (Weeks 6-10)|Physician Decision|0|||
27997166|NCT00863057|54656125|FG002|Period 2 (Weeks 6-10)|Physician Decision|0|||
27997167|NCT00863057|54656126|FG003|Period 2 (Weeks 6-10)|Physician Decision|1|||
27997168|NCT00829166|54656144|FG000|Overall Study|Death|305|||
27997169|NCT00829166|54656145|FG001|Overall Study|Death|333|||
27997170|NCT00829166|54656144|FG000|Overall Study|Lost to Follow-up|5|||
27997171|NCT00829166|54656145|FG001|Overall Study|Lost to Follow-up|4|||
27997172|NCT00829166|54656144|FG000|Overall Study|Physician's Decision|4|||
27997173|NCT00829166|54656145|FG001|Overall Study|Physician's Decision|3|||
27997174|NCT00829166|54656144|FG000|Overall Study|Subject's Decision|41|||
27997175|NCT00829166|54656145|FG001|Overall Study|Subject's Decision|55|||
27997176|NCT00829166|54656144|FG000|Overall Study|Sponsor's Decision|137|||
27997177|NCT00829166|54656145|FG001|Overall Study|Sponsor's Decision|98|||
27997178|NCT00829166|54656144|FG000|Overall Study|Reason Not Specified|3|||
27997179|NCT00829166|54656145|FG001|Overall Study|Reason Not Specified|3|||
27997180|NCT00799266|54656154|FG000|Overall Study|Adverse Event|0|||
27997181|NCT00799266|54656155|FG001|Overall Study|Adverse Event|1|||
27997182|NCT00799266|54656154|FG000|Overall Study|Subject withdrew consent|3|||
27997183|NCT00799266|54656155|FG001|Overall Study|Subject withdrew consent|0|||
27997184|NCT00650104|54656161|FG000|Overall Study|Adverse Event|17|||
27997185|NCT00650104|54656161|FG000|Overall Study|Death|2|||
27997186|NCT00650104|54656161|FG000|Overall Study|Withdrawal by Subject|11|||
27997187|NCT00650104|54656161|FG000|Overall Study|Physician Decision|7|||
27997188|NCT00650104|54656161|FG000|Overall Study|Lost to Follow-up|1|||
27997189|NCT00650104|54656161|FG000|Overall Study|Non-compliance|2|||
27997190|NCT00650104|54656161|FG000|Overall Study|Sponsor Terminated Dosing|1|||
27997191|NCT00654238|54656165|FG000|Overall Study|Screen Failures|4|||
27997192|NCT00862979|54656172|FG000|Overall Study|Adverse Event|6|||
27997193|NCT00862979|54656173|FG001|Overall Study|Adverse Event|3|||
27997194|NCT00862979|54656172|FG000|Overall Study|Protocol Violation|0|||
27997195|NCT00862979|54656173|FG001|Overall Study|Protocol Violation|1|||
27997196|NCT00862979|54656172|FG000|Overall Study|Patient withdrew consent|2|||
27997197|NCT00862979|54656173|FG001|Overall Study|Patient withdrew consent|1|||
27997198|NCT00862979|54656172|FG000|Overall Study|Administrative problems|0|||
28098981|NCT03640052|54754820|FG003|Overall Study|Lost to Follow-up|0|||
28098982|NCT03640052|54754821|FG004|Overall Study|Lost to Follow-up|0|||
27739733|NCT02222896|54189359|FG001|Groin|Did not qualify|9|||
27739734|NCT02222896|54189360|FG002|Groin|Did not qualify|40|||
27912149|NCT01085136|54570105|FG002|Part B|Other AE|8|||
27912150|NCT01085136|54570103|FG000|Part B|Refusal to continue trial medication|0|||
27912151|NCT01085136|54570104|FG001|Part B|Refusal to continue trial medication|12|||
27912152|NCT01085136|54570105|FG002|Part B|Refusal to continue trial medication|7|||
27912153|NCT01085136|54570103|FG000|Part B|Not treated|0|||
27912154|NCT01085136|54570104|FG001|Part B|Not treated|4|||
27912155|NCT01085136|54570105|FG002|Part B|Not treated|8|||
27912156|NCT01085136|54570103|FG000|Part B|Other reason not defined above|0|||
27912157|NCT01085136|54570104|FG001|Part B|Other reason not defined above|6|||
27912158|NCT01085136|54570105|FG002|Part B|Other reason not defined above|3|||
27912159|NCT01084707|54570115|FG000|Overall Study|Withdrawal by Subject|6|||
27912160|NCT01084668|54570127|FG000|Overall Study|Lack of Efficacy|5|||
27912161|NCT01084668|54570127|FG000|Overall Study|Withdrawal by Subject|2|||
27912162|NCT01084668|54570127|FG000|Overall Study|Pregnancy|1|||
27912163|NCT01084668|54570127|FG000|Overall Study|Non-compliance|1|||
27912164|NCT01084551|54570136|FG000|Overall Study|Adverse Event|2|||
27912165|NCT01084551|54570137|FG001|Overall Study|Adverse Event|9|||
27912166|NCT01084551|54570138|FG002|Overall Study|Adverse Event|4|||
27912167|NCT01084551|54570136|FG000|Overall Study|Lack of Efficacy|2|||
27912168|NCT01084551|54570137|FG001|Overall Study|Lack of Efficacy|0|||
27912169|NCT01084551|54570138|FG002|Overall Study|Lack of Efficacy|1|||
27912170|NCT01084551|54570136|FG000|Overall Study|Withdrawal by Subject|2|||
27912171|NCT01084551|54570137|FG001|Overall Study|Withdrawal by Subject|1|||
27912172|NCT01084551|54570138|FG002|Overall Study|Withdrawal by Subject|0|||
27912173|NCT01084551|54570136|FG000|Overall Study|Protocol Violation|2|||
27997199|NCT00862979|54656173|FG001|Overall Study|Administrative problems|1|||
27997200|NCT00862979|54656172|FG000|Overall Study|Death|0|||
27997201|NCT00862979|54656173|FG001|Overall Study|Death|1|||
27997202|NCT00483379|54656181|FG000|Treatment Period|Adverse Event|1|||
27997203|NCT00483379|54656182|FG001|Treatment Period|Adverse Event|0|||
28098983|NCT00068601|54754835|FG000|Overall Study|Ineligible|11|||
27997204|NCT00483379|54656181|FG000|Treatment Period|Withdrawal by Subject|1|||
27997205|NCT00483379|54656182|FG001|Treatment Period|Withdrawal by Subject|0|||
27997206|NCT00446251|54656190|FG000|Overall Study|On-study Transplants|2|||
27997207|NCT00446251|54656190|FG000|Overall Study|Rituximab Infusion Reaction|2|||
27997208|NCT00446251|54656190|FG000|Overall Study|Lost to Follow-up|1|||
27997209|NCT00796224|54656196|FG000|Overall Study|Adverse Event|1|||
27997210|NCT00796224|54656197|FG001|Overall Study|Adverse Event|0|||
27997211|NCT00796224|54656196|FG000|Overall Study|Protocol Violation|0|||
27997212|NCT00796224|54656197|FG001|Overall Study|Protocol Violation|1|||
27997213|NCT00791934|54656205|FG000|Overall Study|Withdrawal by Subject|2|||
27997214|NCT00791934|54656205|FG000|Overall Study|Did not consent for extended follow-up|13|||
27997215|NCT00848081|54656211|FG000|Overall Study|Adverse Event|6|||
27997216|NCT00848081|54656212|FG001|Overall Study|Adverse Event|7|||
27997217|NCT00848081|54656211|FG000|Overall Study|Protocol Violation|8|||
27997218|NCT00848081|54656212|FG001|Overall Study|Protocol Violation|5|||
27997219|NCT00848081|54656211|FG000|Overall Study|Lost to Follow-up|1|||
27997220|NCT00848081|54656212|FG001|Overall Study|Lost to Follow-up|0|||
27997221|NCT00848081|54656211|FG000|Overall Study|Physician Decision|0|||
27997222|NCT00848081|54656212|FG001|Overall Study|Physician Decision|3|||
27997223|NCT00848081|54656211|FG000|Overall Study|Withdrawal by Subject|5|||
27997224|NCT00848081|54656212|FG001|Overall Study|Withdrawal by Subject|3|||
27997225|NCT00654004|54656220|FG000|Overall Study|Lost to Follow-up|1|||
27997226|NCT00654004|54656221|FG001|Overall Study|Lost to Follow-up|0|||
27997227|NCT00791778|54656229|FG000|Double-blind Treatment|Adverse Event|49|||
27997228|NCT00791778|54656230|FG001|Double-blind Treatment|Adverse Event|9|||
27912174|NCT01084551|54570137|FG001|Overall Study|Protocol Violation|4|||
27912175|NCT01084551|54570138|FG002|Overall Study|Protocol Violation|0|||
27912176|NCT01084551|54570136|FG000|Overall Study|Lost to Follow-up|0|||
27912177|NCT01084551|54570137|FG001|Overall Study|Lost to Follow-up|0|||
27912178|NCT01084551|54570138|FG002|Overall Study|Lost to Follow-up|3|||
27912179|NCT01084551|54570136|FG000|Overall Study|Physician Decision|1|||
27912180|NCT01084551|54570137|FG001|Overall Study|Physician Decision|0|||
27997229|NCT00791778|54656229|FG000|Double-blind Treatment|Physician Decision|6|||
27997230|NCT00791778|54656230|FG001|Double-blind Treatment|Physician Decision|26|||
27997231|NCT00791778|54656229|FG000|Double-blind Treatment|Protocol Violation|0|||
27997232|NCT00791778|54656230|FG001|Double-blind Treatment|Protocol Violation|4|||
27997233|NCT00791778|54656229|FG000|Double-blind Treatment|Withdrawal by Subject|20|||
27997234|NCT00791778|54656230|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
28098984|NCT00068601|54754836|FG001|Overall Study|Ineligible|13|||
28098985|NCT00068601|54754835|FG000|Overall Study|Not evaluable: withdrew consent|5|||
28098986|NCT00068601|54754836|FG001|Overall Study|Not evaluable: withdrew consent|4|||
28098987|NCT00068601|54754835|FG000|Overall Study|Not evaluable: hysterectomy/oophorectomy|2|||
28098988|NCT00068601|54754836|FG001|Overall Study|Not evaluable: hysterectomy/oophorectomy|4|||
28098989|NCT00068601|54754835|FG000|Overall Study|Death|11|||
28098990|NCT00068601|54754836|FG001|Overall Study|Death|3|||
28098991|NCT00068601|54754835|FG000|Overall Study|Lost to Follow-up|3|||
28098992|NCT00068601|54754836|FG001|Overall Study|Lost to Follow-up|2|||
28098993|NCT00068601|54754835|FG000|Overall Study|Missing primary outcome data|30|||
28098994|NCT00068601|54754836|FG001|Overall Study|Missing primary outcome data|34|||
28098995|NCT03638258|54754845|FG000|Overall Study|Adverse Event|1|||
28098996|NCT03638258|54754846|FG001|Overall Study|Adverse Event|0|||
28098997|NCT03638258|54754847|FG002|Overall Study|Adverse Event|2|||
28098998|NCT03638258|54754845|FG000|Overall Study|Lost to Follow-up|2|||
28098999|NCT03638258|54754846|FG001|Overall Study|Lost to Follow-up|4|||
28099000|NCT03638258|54754847|FG002|Overall Study|Lost to Follow-up|5|||
28099001|NCT03638258|54754845|FG000|Overall Study|Pregnancy|0|||
28099002|NCT03638258|54754846|FG001|Overall Study|Pregnancy|0|||
28099003|NCT03638258|54754847|FG002|Overall Study|Pregnancy|1|||
28099004|NCT03638258|54754845|FG000|Overall Study|Protocol Violation|0|||
28099005|NCT03638258|54754846|FG001|Overall Study|Protocol Violation|0|||
28099006|NCT03638258|54754847|FG002|Overall Study|Protocol Violation|1|||
28099007|NCT03638258|54754845|FG000|Overall Study|Withdrawal by Subject|4|||
28099008|NCT03638258|54754846|FG001|Overall Study|Withdrawal by Subject|5|||
28099009|NCT03638258|54754847|FG002|Overall Study|Withdrawal by Subject|12|||
28099010|NCT03638258|54754845|FG000|Overall Study|Lack of Efficacy|0|||
27912181|NCT01084551|54570138|FG002|Overall Study|Physician Decision|0|||
27912182|NCT01084005|54570148|FG000|Overall Study|Adverse Event|1|||
28099011|NCT03638258|54754846|FG001|Overall Study|Lack of Efficacy|0|||
28099012|NCT03638258|54754847|FG002|Overall Study|Lack of Efficacy|2|||
28099013|NCT01670656|54754861|FG000|Overall Study|Non-compliance with study drug|0|||
28099014|NCT01670656|54754862|FG001|Overall Study|Non-compliance with study drug|0|||
27912183|NCT01084005|54570149|FG001|Overall Study|Adverse Event|8|||
27912184|NCT01084005|54570148|FG000|Overall Study|Protocol Violation|3|||
27997235|NCT00791778|54656229|FG000|Double-blind Treatment|Non-compliant with study medication|2|||
28099015|NCT01670656|54754863|FG002|Overall Study|Non-compliance with study drug|3|||
28099016|NCT01670656|54754864|FG003|Overall Study|Non-compliance with study drug|0|||
28099017|NCT01670656|54754865|FG004|Overall Study|Non-compliance with study drug|1|||
28099018|NCT01670656|54754861|FG000|Overall Study|Pregnancy|0|||
27997236|NCT00791778|54656230|FG001|Double-blind Treatment|Non-compliant with study medication|0|||
27997237|NCT00791778|54656229|FG000|Follow-up|Withdrawal by Subject|3|||
27997238|NCT00791778|54656230|FG001|Follow-up|Withdrawal by Subject|0|||
27997239|NCT00791778|54656229|FG000|Follow-up|Lost to Follow-up|2|||
27997240|NCT00791778|54656230|FG001|Follow-up|Lost to Follow-up|1|||
27997241|NCT00798174|54656236|FG000|Overall Study|inability to implant azygos coil|3|||
27997242|NCT00798174|54656237|FG001|Overall Study|inability to implant azygos coil|3|||
27997243|NCT00798174|54656236|FG000|Overall Study|Inability to sedate for DFT testing|1|||
27997244|NCT00798174|54656237|FG001|Overall Study|Inability to sedate for DFT testing|0|||
27997245|NCT00798096|54656241|FG000|Overall Study|Ongoing|2|||
27997246|NCT00795600|54656247|FG000|Overall Study|Adverse Event|1|||
27912185|NCT01084005|54570149|FG001|Overall Study|Protocol Violation|7|||
27912186|NCT01084005|54570148|FG000|Overall Study|Withdrawal by Subject|1|||
27912187|NCT01084005|54570149|FG001|Overall Study|Withdrawal by Subject|1|||
27912188|NCT01083810|54570158|FG000|Overall Study|Lost to Follow-up|23|||
27912189|NCT01083810|54570159|FG001|Overall Study|Lost to Follow-up|11|||
27912190|NCT01083810|54570160|FG002|Overall Study|Lost to Follow-up|4|||
27912191|NCT01083810|54570158|FG000|Overall Study|Adverse Event|15|||
27912192|NCT01083810|54570159|FG001|Overall Study|Adverse Event|11|||
27912193|NCT01083810|54570160|FG002|Overall Study|Adverse Event|4|||
27912194|NCT01083810|54570158|FG000|Overall Study|Withdrawal by Subject|7|||
27997247|NCT00795600|54656248|FG001|Overall Study|Adverse Event|1|||
27997248|NCT00795600|54656247|FG000|Overall Study|Protocol Violation|1|||
27997249|NCT00795600|54656248|FG001|Overall Study|Protocol Violation|2|||
27912195|NCT01083810|54570159|FG001|Overall Study|Withdrawal by Subject|2|||
27997250|NCT00795600|54656247|FG000|Overall Study|Withdrawal by Subject|1|||
27997251|NCT00795600|54656248|FG001|Overall Study|Withdrawal by Subject|0|||
27997252|NCT00795600|54656247|FG000|Overall Study|Unclassified|1|||
27997253|NCT00795600|54656248|FG001|Overall Study|Unclassified|1|||
27997254|NCT00795132|54656254|FG000|Overall Study|Death|1|||
27997255|NCT00795132|54656254|FG000|Overall Study|Relapse|2|||
27997256|NCT00647296|54656270|FG000|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
27997257|NCT00647296|54656271|FG001|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
27997258|NCT00647296|54656272|FG002|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
27997259|NCT00647296|54656273|FG003|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|1|||
27997260|NCT00647296|54656270|FG000|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
27997261|NCT00647296|54656271|FG001|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
27997262|NCT00647296|54656272|FG002|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
27997263|NCT00647296|54656273|FG003|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
27997264|NCT00647296|54656270|FG000|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
27997265|NCT00647296|54656271|FG001|Part 1: 12-week Double-Blind Treatment|Physician Decision|1|||
27997266|NCT00647296|54656272|FG002|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
27997267|NCT00647296|54656273|FG003|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
27997268|NCT00647296|54656270|FG000|Part 2: 4-week Placebo Washout|Withdrawal by Subject|1|||
27997269|NCT00647296|54656271|FG001|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
27997270|NCT00647296|54656272|FG002|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
27997271|NCT00647296|54656273|FG003|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
27997272|NCT00647296|54656270|FG000|Part 2: 4-week Placebo Washout|Lost to Follow-up|1|||
27997273|NCT00647296|54656271|FG001|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
27997274|NCT00647296|54656272|FG002|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
27997275|NCT00647296|54656273|FG003|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
27997276|NCT00647296|54656270|FG000|Part 2: 4-week Placebo Washout|Death|3|||
27997277|NCT00647296|54656271|FG001|Part 2: 4-week Placebo Washout|Death|0|||
27997278|NCT00647296|54656272|FG002|Part 2: 4-week Placebo Washout|Death|0|||
27997279|NCT00647296|54656273|FG003|Part 2: 4-week Placebo Washout|Death|0|||
27997280|NCT00647296|54656270|FG000|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
27997281|NCT00647296|54656271|FG001|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|5|||
27997282|NCT00647296|54656272|FG002|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
27997283|NCT00647296|54656273|FG003|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|4|||
27997284|NCT00647296|54656270|FG000|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
27997285|NCT00647296|54656271|FG001|Part 2: 76-week Double-Blind Treatment|Adverse Event|1|||
27997286|NCT00647296|54656272|FG002|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
27997287|NCT00647296|54656273|FG003|Part 2: 76-week Double-Blind Treatment|Adverse Event|4|||
27997288|NCT00647296|54656270|FG000|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
27997289|NCT00647296|54656271|FG001|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|1|||
27997290|NCT00647296|54656272|FG002|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
27997291|NCT00647296|54656273|FG003|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
27912196|NCT01083810|54570160|FG002|Overall Study|Withdrawal by Subject|4|||
27912197|NCT01083810|54570158|FG000|Overall Study|Reason not reported|6|||
27912198|NCT01083810|54570159|FG001|Overall Study|Reason not reported|1|||
27912199|NCT01083810|54570160|FG002|Overall Study|Reason not reported|1|||
27997292|NCT00647296|54656270|FG000|Part 2: 76-week Double-Blind Treatment|Death|0|||
27997293|NCT00647296|54656271|FG001|Part 2: 76-week Double-Blind Treatment|Death|7|||
27997294|NCT00647296|54656272|FG002|Part 2: 76-week Double-Blind Treatment|Death|0|||
27997295|NCT00647296|54656273|FG003|Part 2: 76-week Double-Blind Treatment|Death|5|||
27997296|NCT00647296|54656270|FG000|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
27997297|NCT00647296|54656271|FG001|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
27997298|NCT00647296|54656272|FG002|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
27997299|NCT00647296|54656273|FG003|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
27912200|NCT01083810|54570158|FG000|Overall Study|Non-compliance|4|||
27912201|NCT01083810|54570159|FG001|Overall Study|Non-compliance|7|||
27912202|NCT01083810|54570160|FG002|Overall Study|Non-compliance|2|||
27912203|NCT01083810|54570158|FG000|Overall Study|Simplification|4|||
27997300|NCT00644878|54656295|FG000|Overall Study|Adverse Event|2|||
27912204|NCT01083810|54570159|FG001|Overall Study|Simplification|1|||
27912205|NCT01083810|54570160|FG002|Overall Study|Simplification|0|||
27912206|NCT01083810|54570158|FG000|Overall Study|Death|2|||
27997301|NCT00644878|54656295|FG000|Overall Study|Abnormal laboratory value|3|||
27997302|NCT00644878|54656295|FG000|Overall Study|Protocol deviation|2|||
27997303|NCT00644878|54656295|FG000|Overall Study|Treatment duration completed as per protocol|11|||
27997304|NCT00646906|54656303|FG000|Crossover Period 1|Withdrawal by Subject|1|||
27997305|NCT00646906|54656304|FG001|Crossover Period 1|Withdrawal by Subject|0|||
27997306|NCT00646906|54656305|FG002|Crossover Period 1|Withdrawal by Subject|0|||
27997307|NCT00646906|54656306|FG003|Crossover Period 1|Withdrawal by Subject|0|||
27997308|NCT00646906|54656307|FG004|Crossover Period 1|Withdrawal by Subject|0|||
27997309|NCT00646906|54656308|FG005|Crossover Period 1|Withdrawal by Subject|1|||
27997310|NCT00646906|54656309|FG006|Crossover Period 1|Withdrawal by Subject|0|||
27997311|NCT00646906|54656303|FG000|Crossover Period 2|Withdrawal by Subject|0|||
27997312|NCT00646906|54656304|FG001|Crossover Period 2|Withdrawal by Subject|1|||
27997313|NCT00646906|54656305|FG002|Crossover Period 2|Withdrawal by Subject|2|||
27997314|NCT00646906|54656306|FG003|Crossover Period 2|Withdrawal by Subject|1|||
27997315|NCT00646906|54656307|FG004|Crossover Period 2|Withdrawal by Subject|0|||
27997316|NCT00646906|54656308|FG005|Crossover Period 2|Withdrawal by Subject|0|||
27997317|NCT00646906|54656309|FG006|Crossover Period 2|Withdrawal by Subject|0|||
27997318|NCT00646906|54656303|FG000|Crossover Period 2|Physician Decision|0|||
27997319|NCT00646906|54656304|FG001|Crossover Period 2|Physician Decision|0|||
27997320|NCT00646906|54656305|FG002|Crossover Period 2|Physician Decision|0|||
27997321|NCT00646906|54656306|FG003|Crossover Period 2|Physician Decision|0|||
27997322|NCT00646906|54656307|FG004|Crossover Period 2|Physician Decision|0|||
27997323|NCT00646906|54656308|FG005|Crossover Period 2|Physician Decision|0|||
27997324|NCT00646906|54656309|FG006|Crossover Period 2|Physician Decision|1|||
27997325|NCT00642772|54656322|FG000|Overall Study|Lost to Follow-up|3|||
27997326|NCT00642772|54656322|FG000|Overall Study|Withdrawal by Subject|7|||
27997327|NCT00446095|54656331|FG000|Phase II (8 Weeks)|Lost to Follow-up|1|||
27997328|NCT00446095|54656332|FG001|Phase II (8 Weeks)|Lost to Follow-up|0|||
27997329|NCT00446095|54656333|FG002|Phase II (8 Weeks)|Lost to Follow-up|0|||
27997330|NCT00446095|54656334|FG003|Phase II (8 Weeks)|Lost to Follow-up|0|||
27997331|NCT00446095|54656335|FG004|Phase II (8 Weeks)|Lost to Follow-up|0|||
27997332|NCT00446095|54656331|FG000|Phase II (8 Weeks)|Adverse Event|0|||
27997333|NCT00446095|54656332|FG001|Phase II (8 Weeks)|Adverse Event|1|||
27997334|NCT00446095|54656333|FG002|Phase II (8 Weeks)|Adverse Event|1|||
27997335|NCT00446095|54656334|FG003|Phase II (8 Weeks)|Adverse Event|0|||
27997336|NCT00446095|54656335|FG004|Phase II (8 Weeks)|Adverse Event|0|||
27997337|NCT00446095|54656331|FG000|Phase II (8 Weeks)|Withdrawal by Subject|1|||
27997338|NCT00446095|54656332|FG001|Phase II (8 Weeks)|Withdrawal by Subject|0|||
27997339|NCT00446095|54656333|FG002|Phase II (8 Weeks)|Withdrawal by Subject|0|||
27997340|NCT00446095|54656334|FG003|Phase II (8 Weeks)|Withdrawal by Subject|0|||
27997341|NCT00446095|54656335|FG004|Phase II (8 Weeks)|Withdrawal by Subject|0|||
27997342|NCT00446095|54656331|FG000|Phase II (8 Weeks)|Physician Decision|1|||
27997343|NCT00446095|54656332|FG001|Phase II (8 Weeks)|Physician Decision|0|||
27997344|NCT00446095|54656333|FG002|Phase II (8 Weeks)|Physician Decision|0|||
27997345|NCT00446095|54656334|FG003|Phase II (8 Weeks)|Physician Decision|0|||
27912207|NCT01083810|54570159|FG001|Overall Study|Death|2|||
27997346|NCT00446095|54656335|FG004|Phase II (8 Weeks)|Physician Decision|0|||
27997347|NCT00446095|54656331|FG000|Phase II (8 Weeks)|Lack of Efficacy|9|||
27997348|NCT00446095|54656332|FG001|Phase II (8 Weeks)|Lack of Efficacy|2|||
27997349|NCT00446095|54656333|FG002|Phase II (8 Weeks)|Lack of Efficacy|1|||
27912208|NCT01083810|54570160|FG002|Overall Study|Death|3|||
27912209|NCT01083810|54570158|FG000|Overall Study|Co-morbidities|1|||
27997350|NCT00446095|54656334|FG003|Phase II (8 Weeks)|Lack of Efficacy|0|||
27997351|NCT00446095|54656335|FG004|Phase II (8 Weeks)|Lack of Efficacy|0|||
27997352|NCT00446095|54656331|FG000|Phase II (8 Weeks)|Ongoing|0|||
27997353|NCT00446095|54656332|FG001|Phase II (8 Weeks)|Ongoing|0|||
27997354|NCT00446095|54656333|FG002|Phase II (8 Weeks)|Ongoing|1|||
27912210|NCT01083810|54570159|FG001|Overall Study|Co-morbidities|0|||
27912211|NCT01083810|54570160|FG002|Overall Study|Co-morbidities|0|||
27912212|NCT01083810|54570158|FG000|Overall Study|Participation in study|1|||
27912213|NCT01083810|54570159|FG001|Overall Study|Participation in study|0|||
27912214|NCT01083810|54570160|FG002|Overall Study|Participation in study|0|||
27912215|NCT01083810|54570158|FG000|Overall Study|Therapy break|1|||
27912216|NCT01083810|54570159|FG001|Overall Study|Therapy break|2|||
27912217|NCT01083810|54570160|FG002|Overall Study|Therapy break|2|||
27912218|NCT01083810|54570158|FG000|Overall Study|Virologic failure|1|||
27912219|NCT01083810|54570159|FG001|Overall Study|Virologic failure|8|||
27912220|NCT01083810|54570160|FG002|Overall Study|Virologic failure|0|||
27912221|NCT01083771|54570166|FG000|Overall Study|non-compliant|2|||
27912222|NCT01083771|54570166|FG000|Overall Study|Withdrawal by Subject|3|||
27912223|NCT01083693|54570173|FG000|Overall Study|Adverse Event|1|||
27912224|NCT01083693|54570174|FG001|Overall Study|Adverse Event|1|||
27997355|NCT00446095|54656334|FG003|Phase II (8 Weeks)|Ongoing|0|||
27997356|NCT00446095|54656335|FG004|Phase II (8 Weeks)|Ongoing|0|||
27997357|NCT00446095|54656331|FG000|Phase I (28 Days)|Adverse Event|0|||
27997358|NCT00446095|54656332|FG001|Phase I (28 Days)|Adverse Event|0|||
27997359|NCT00446095|54656333|FG002|Phase I (28 Days)|Adverse Event|0|||
27997360|NCT00446095|54656334|FG003|Phase I (28 Days)|Adverse Event|1|||
27997361|NCT00446095|54656335|FG004|Phase I (28 Days)|Adverse Event|0|||
27997362|NCT00446095|54656331|FG000|Phase I (28 Days)|Lack of Efficacy|0|||
27912225|NCT01083693|54570175|FG002|Overall Study|Adverse Event|0|||
27912226|NCT01083693|54570173|FG000|Overall Study|Lost to Follow-up|2|||
27912227|NCT01083693|54570174|FG001|Overall Study|Lost to Follow-up|0|||
27912228|NCT01083693|54570175|FG002|Overall Study|Lost to Follow-up|2|||
27912229|NCT01083693|54570173|FG000|Overall Study|Lack of effectiveness|13|||
27912230|NCT01083693|54570174|FG001|Overall Study|Lack of effectiveness|2|||
27912231|NCT01083693|54570175|FG002|Overall Study|Lack of effectiveness|2|||
27912232|NCT01083693|54570173|FG000|Overall Study|Patient Moved|0|||
27912233|NCT01083693|54570174|FG001|Overall Study|Patient Moved|1|||
27912234|NCT01083693|54570175|FG002|Overall Study|Patient Moved|0|||
27912235|NCT01083693|54570173|FG000|Overall Study|Complete remission|0|||
27912236|NCT01083693|54570174|FG001|Overall Study|Complete remission|1|||
27912237|NCT01083693|54570175|FG002|Overall Study|Complete remission|0|||
27912238|NCT01083693|54570173|FG000|Overall Study|Other medical condition/surgery|1|||
27912239|NCT01083693|54570174|FG001|Overall Study|Other medical condition/surgery|1|||
27912240|NCT01083693|54570175|FG002|Overall Study|Other medical condition/surgery|0|||
27997363|NCT00446095|54656332|FG001|Phase I (28 Days)|Lack of Efficacy|0|||
27997364|NCT00446095|54656333|FG002|Phase I (28 Days)|Lack of Efficacy|0|||
27912241|NCT01083693|54570173|FG000|Overall Study|Withdrawal by Subject|3|||
27912242|NCT01083693|54570174|FG001|Overall Study|Withdrawal by Subject|0|||
27912243|NCT01083693|54570175|FG002|Overall Study|Withdrawal by Subject|2|||
27912244|NCT01083693|54570173|FG000|Overall Study|Reason unknown|0|||
27912245|NCT01083693|54570174|FG001|Overall Study|Reason unknown|0|||
27997365|NCT00446095|54656334|FG003|Phase I (28 Days)|Lack of Efficacy|0|||
27997366|NCT00446095|54656335|FG004|Phase I (28 Days)|Lack of Efficacy|3|||
27997367|NCT00829010|54656351|FG000|Overall Study|Adverse Event|1|||
27997368|NCT00829010|54656352|FG001|Overall Study|Adverse Event|0|||
27912246|NCT01083693|54570175|FG002|Overall Study|Reason unknown|1|||
27997369|NCT00829010|54656353|FG002|Overall Study|Adverse Event|0|||
27997370|NCT00829010|54656354|FG003|Overall Study|Adverse Event|0|||
27997371|NCT00829010|54656355|FG004|Overall Study|Adverse Event|0|||
27997372|NCT00829010|54656351|FG000|Overall Study|Withdrawal by Subject|0|||
27997373|NCT00829010|54656352|FG001|Overall Study|Withdrawal by Subject|1|||
27997374|NCT00829010|54656353|FG002|Overall Study|Withdrawal by Subject|1|||
27997375|NCT00829010|54656354|FG003|Overall Study|Withdrawal by Subject|0|||
27997376|NCT00829010|54656355|FG004|Overall Study|Withdrawal by Subject|2|||
27997377|NCT00829010|54656351|FG000|Overall Study|Lost to Follow-up|1|||
27997378|NCT00829010|54656352|FG001|Overall Study|Lost to Follow-up|0|||
27997379|NCT00829010|54656353|FG002|Overall Study|Lost to Follow-up|2|||
27997380|NCT00829010|54656354|FG003|Overall Study|Lost to Follow-up|0|||
27997381|NCT00829010|54656355|FG004|Overall Study|Lost to Follow-up|0|||
27997382|NCT00829010|54656351|FG000|Overall Study|Fatality|5|||
27997383|NCT00829010|54656352|FG001|Overall Study|Fatality|4|||
27912247|NCT01083576|54570189|FG000|Overall Study|Treatment Failure|6|||
27912248|NCT01083576|54570190|FG001|Overall Study|Treatment Failure|1|||
27912249|NCT01083186|54570197|FG000|Overall Study|Lost to Follow-up|48|||
27912250|NCT01083186|54570197|FG000|Overall Study|Consent Withdrawal|7|||
27997384|NCT00829010|54656353|FG002|Overall Study|Fatality|0|||
27997385|NCT00829010|54656354|FG003|Overall Study|Fatality|3|||
27997386|NCT00829010|54656355|FG004|Overall Study|Fatality|0|||
27997387|NCT00829010|54656351|FG000|Overall Study|Migrated/Moved from study area|3|||
27997388|NCT00829010|54656352|FG001|Overall Study|Migrated/Moved from study area|4|||
28099019|NCT01670656|54754862|FG001|Overall Study|Pregnancy|0|||
27912251|NCT01083186|54570197|FG000|Overall Study|Death|3|||
27912252|NCT01083186|54570197|FG000|Overall Study|Adverse Event|3|||
27997389|NCT00829010|54656353|FG002|Overall Study|Migrated/Moved from study area|0|||
27997390|NCT00829010|54656354|FG003|Overall Study|Migrated/Moved from study area|5|||
27997391|NCT00829010|54656355|FG004|Overall Study|Migrated/Moved from study area|0|||
27997392|NCT00644332|54656367|FG000|Overall Study|Adverse Event|11|||
27997393|NCT00644332|54656367|FG000|Overall Study|Withdrawal by Subject|6|||
27997394|NCT00644332|54656367|FG000|Overall Study|Completion Status Unknown|2|||
27997395|NCT00644332|54656367|FG000|Overall Study|Did Not Meet Eligibility Requirements|1|||
27997396|NCT00644332|54656367|FG000|Overall Study|Could Not Attend Scheduled Visits|1|||
27997397|NCT00445939|54656374|FG000|Period A - Week 0 - Week 4|Adverse Event|1|||
27997398|NCT00445939|54656375|FG001|Period A - Week 0 - Week 4|Adverse Event|2|||
27997399|NCT00445939|54656376|FG002|Period A - Week 0 - Week 4|Adverse Event|0|||
27997400|NCT00445939|54656377|FG003|Period A - Week 0 - Week 4|Adverse Event|0|||
27997401|NCT00445939|54656374|FG000|Period B - Week 4 - Week 8|Adverse Event|2|||
27997402|NCT00445939|54656375|FG001|Period B - Week 4 - Week 8|Adverse Event|0|||
27997403|NCT00445939|54656376|FG002|Period B - Week 4 - Week 8|Adverse Event|0|||
27997404|NCT00445939|54656377|FG003|Period B - Week 4 - Week 8|Adverse Event|1|||
27997405|NCT00482053|54656397|FG000|Inter-treatment Period|Disease progression|1|||
27997406|NCT00455923|54656403|FG000|Overall Study|Pregnancy|0|||
27997407|NCT00455923|54656404|FG001|Overall Study|Pregnancy|2|||
27997408|NCT00455923|54656403|FG000|Overall Study|Other|3|||
27997409|NCT00455923|54656404|FG001|Overall Study|Other|1|||
27997410|NCT00642616|54656414|FG000|Overall Study|Adverse Event|2|||
27997411|NCT00642616|54656415|FG001|Overall Study|Adverse Event|0|||
27997412|NCT00642616|54656416|FG002|Overall Study|Adverse Event|1|||
27997413|NCT00642616|54656417|FG003|Overall Study|Adverse Event|0|||
27997414|NCT00642616|54656414|FG000|Overall Study|Study Terminated by Sponsor|7|||
27997415|NCT00642616|54656415|FG001|Overall Study|Study Terminated by Sponsor|6|||
27997416|NCT00642616|54656416|FG002|Overall Study|Study Terminated by Sponsor|4|||
27997417|NCT00642616|54656417|FG003|Overall Study|Study Terminated by Sponsor|5|||
27997418|NCT00642616|54656414|FG000|Overall Study|Withdrawal by Subject|0|||
27997419|NCT00642616|54656415|FG001|Overall Study|Withdrawal by Subject|1|||
27997420|NCT00642616|54656416|FG002|Overall Study|Withdrawal by Subject|1|||
27997421|NCT00642616|54656417|FG003|Overall Study|Withdrawal by Subject|1|||
27997422|NCT00642616|54656414|FG000|Overall Study|Protocol Violation|0|||
27997423|NCT00642616|54656415|FG001|Overall Study|Protocol Violation|0|||
27997424|NCT00642616|54656416|FG002|Overall Study|Protocol Violation|2|||
27997425|NCT00642616|54656417|FG003|Overall Study|Protocol Violation|0|||
27997426|NCT00642616|54656414|FG000|Overall Study|Physician Decision|0|||
27997427|NCT00642616|54656415|FG001|Overall Study|Physician Decision|0|||
27997428|NCT00642616|54656416|FG002|Overall Study|Physician Decision|1|||
27997429|NCT00642616|54656417|FG003|Overall Study|Physician Decision|1|||
27997430|NCT03844945|54656433|FG000|Overall Study|Adverse Event|1|||
27997431|NCT03844945|54656434|FG001|Overall Study|Adverse Event|1|||
27997432|NCT03844945|54656435|FG002|Overall Study|Adverse Event|4|||
27997433|NCT03844945|54656436|FG003|Overall Study|Adverse Event|0|||
27997434|NCT03844945|54656433|FG000|Overall Study|Withdrawal by Subject|0|||
27997435|NCT03844945|54656434|FG001|Overall Study|Withdrawal by Subject|0|||
27997436|NCT03844945|54656435|FG002|Overall Study|Withdrawal by Subject|1|||
27997437|NCT03844945|54656436|FG003|Overall Study|Withdrawal by Subject|0|||
27997438|NCT03844945|54656433|FG000|Overall Study|Lack of Efficacy|0|||
27997439|NCT03844945|54656434|FG001|Overall Study|Lack of Efficacy|0|||
27997440|NCT03844945|54656435|FG002|Overall Study|Lack of Efficacy|0|||
27997441|NCT03844945|54656436|FG003|Overall Study|Lack of Efficacy|1|||
27997442|NCT00445549|54656446|FG000|Overall Study|progressive disease|12|||
27997443|NCT00445003|54656453|FG000|Overall Study|Death|1|||
27912253|NCT01083186|54570197|FG000|Overall Study|Lack of Efficacy|2|||
27912254|NCT01083186|54570197|FG000|Overall Study|Hemodialysis Initiation|28|||
27912255|NCT01083186|54570197|FG000|Overall Study|Administrative Reasons|2|||
27912256|NCT01083186|54570197|FG000|Overall Study|Non-compliance to Study Treatment|1|||
27912257|NCT01082640|54570224|FG000|Overall Study|Adverse Event|9|||
27912258|NCT01082640|54570225|FG001|Overall Study|Adverse Event|5|||
27912259|NCT01082640|54570226|FG002|Overall Study|Adverse Event|3|||
27912260|NCT01082640|54570224|FG000|Overall Study|Withdrawal by Subject|3|||
27912261|NCT01082640|54570225|FG001|Overall Study|Withdrawal by Subject|3|||
27912262|NCT01082640|54570226|FG002|Overall Study|Withdrawal by Subject|2|||
27912263|NCT01082640|54570224|FG000|Overall Study|Major protocol deviation|3|||
27912264|NCT01082640|54570225|FG001|Overall Study|Major protocol deviation|3|||
27997444|NCT00445003|54656454|FG001|Overall Study|Death|2|||
27997445|NCT00445003|54656455|FG002|Overall Study|Death|1|||
27997446|NCT00445003|54656453|FG000|Overall Study|Missed Visit|3|||
27997447|NCT00445003|54656454|FG001|Overall Study|Missed Visit|5|||
27912265|NCT01082640|54570226|FG002|Overall Study|Major protocol deviation|0|||
28099020|NCT01670656|54754863|FG002|Overall Study|Pregnancy|0|||
27912266|NCT01082640|54570224|FG000|Overall Study|Lost to Follow-up|0|||
27997448|NCT00445003|54656455|FG002|Overall Study|Missed Visit|1|||
27997449|NCT00445003|54656453|FG000|Overall Study|Dropped|1|||
27997450|NCT00445003|54656454|FG001|Overall Study|Dropped|3|||
27997451|NCT00445003|54656455|FG002|Overall Study|Dropped|2|||
27997452|NCT00811070|54656469|FG000|Overall Study|Death|0|||
27997453|NCT00811070|54656470|FG001|Overall Study|Death|0|||
27997454|NCT00811070|54656471|FG002|Overall Study|Death|0|||
27997455|NCT00811070|54656472|FG003|Overall Study|Death|2|||
27912267|NCT01082640|54570225|FG001|Overall Study|Lost to Follow-up|3|||
27912268|NCT01082640|54570226|FG002|Overall Study|Lost to Follow-up|0|||
27912269|NCT01082640|54570224|FG000|Overall Study|Other|2|||
27912270|NCT01082640|54570225|FG001|Overall Study|Other|1|||
27912271|NCT01082640|54570226|FG002|Overall Study|Other|3|||
27912272|NCT01082367|54570239|FG000|Double-blind Period|Administrative problems|0|||
27912273|NCT01082367|54570240|FG001|Double-blind Period|Administrative problems|1|||
27912274|NCT01082367|54570239|FG000|Double-blind Period|Lack of Efficacy|5|||
27912275|NCT01082367|54570240|FG001|Double-blind Period|Lack of Efficacy|11|||
27912276|NCT01082367|54570239|FG000|Double-blind Period|Adverse Event|0|||
27912277|NCT01082367|54570240|FG001|Double-blind Period|Adverse Event|1|||
27912278|NCT01082367|54570239|FG000|Follow-up (F-U) Period|Administrative problems|1|||
27912279|NCT01082367|54570240|FG001|Follow-up (F-U) Period|Administrative problems|0|||
27912280|NCT01082367|54570239|FG000|Follow-up (F-U) Period|Abnormal lab values|1|||
27912281|NCT01082367|54570240|FG001|Follow-up (F-U) Period|Abnormal lab values|0|||
27912282|NCT01082367|54570239|FG000|Follow-up (F-U) Period|Adverse Event|0|||
27912283|NCT01082367|54570240|FG001|Follow-up (F-U) Period|Adverse Event|1|||
27912284|NCT01082211|54570250|FG000|Overall Study|Protocol Violation|4|||
27912285|NCT01082211|54570250|FG000|Overall Study|No protocol treatment received|3|||
27997456|NCT00811070|54656473|FG004|Overall Study|Death|5|||
27997457|NCT00811070|54656474|FG005|Overall Study|Death|0|||
27997458|NCT00811070|54656469|FG000|Overall Study|Other|1|||
27997459|NCT00811070|54656470|FG001|Overall Study|Other|0|||
27997460|NCT00811070|54656471|FG002|Overall Study|Other|0|||
27997461|NCT00811070|54656472|FG003|Overall Study|Other|0|||
27997462|NCT00811070|54656473|FG004|Overall Study|Other|0|||
27997463|NCT00811070|54656474|FG005|Overall Study|Other|0|||
27997464|NCT00811070|54656469|FG000|Overall Study|Withdrawal by Subject|0|||
27997465|NCT00811070|54656470|FG001|Overall Study|Withdrawal by Subject|1|||
27997466|NCT00811070|54656471|FG002|Overall Study|Withdrawal by Subject|0|||
27997467|NCT00811070|54656472|FG003|Overall Study|Withdrawal by Subject|0|||
27997468|NCT00811070|54656473|FG004|Overall Study|Withdrawal by Subject|0|||
27997469|NCT00811070|54656474|FG005|Overall Study|Withdrawal by Subject|0|||
27912286|NCT01081665|54570257|FG000|Overall Study|Death|41|||
27912287|NCT01081665|54570257|FG000|Overall Study|Lost to Follow-up|18|||
27912288|NCT01081665|54570257|FG000|Overall Study|Withdrawal by Subject|17|||
27912289|NCT01081665|54570257|FG000|Overall Study|Change of dialysis unit|10|||
27912290|NCT01081665|54570257|FG000|Overall Study|Regulation of iPTH|5|||
27912291|NCT01081665|54570257|FG000|Overall Study|Change in renal replacement therapy|2|||
27997470|NCT00811070|54656469|FG000|Overall Study|Physician Decision|0|||
27997471|NCT00811070|54656470|FG001|Overall Study|Physician Decision|0|||
27997472|NCT00811070|54656471|FG002|Overall Study|Physician Decision|0|||
27997473|NCT00811070|54656472|FG003|Overall Study|Physician Decision|0|||
27997474|NCT00811070|54656473|FG004|Overall Study|Physician Decision|0|||
27997475|NCT00811070|54656474|FG005|Overall Study|Physician Decision|1|||
27997476|NCT00642460|54656492|FG000|Part I: 12 Week Double-Blind|Adverse Event|0|||
27997477|NCT00642460|54656493|FG001|Part I: 12 Week Double-Blind|Adverse Event|1|||
27997478|NCT00642460|54656494|FG002|Part I: 12 Week Double-Blind|Adverse Event|1|||
27997479|NCT00642460|54656495|FG003|Part I: 12 Week Double-Blind|Adverse Event|0|||
27997480|NCT00642460|54656496|FG004|Part I: 12 Week Double-Blind|Adverse Event|0|||
27997481|NCT00642460|54656497|FG005|Part I: 12 Week Double-Blind|Adverse Event|0|||
27997482|NCT00642460|54656492|FG000|Part I: 12 Week Double-Blind|Refused Treatment|1|||
27997483|NCT00642460|54656493|FG001|Part I: 12 Week Double-Blind|Refused Treatment|0|||
27997484|NCT00642460|54656494|FG002|Part I: 12 Week Double-Blind|Refused Treatment|0|||
27997485|NCT00642460|54656495|FG003|Part I: 12 Week Double-Blind|Refused Treatment|0|||
27997486|NCT00642460|54656496|FG004|Part I: 12 Week Double-Blind|Refused Treatment|0|||
27997487|NCT00642460|54656497|FG005|Part I: 12 Week Double-Blind|Refused Treatment|0|||
27997488|NCT00642460|54656492|FG000|Part II: Open-Label Up to Week 92|Adverse Event|4|||
27997489|NCT00642460|54656493|FG001|Part II: Open-Label Up to Week 92|Adverse Event|2|||
27912292|NCT01081665|54570257|FG000|Overall Study|Adverse Event|1|||
27912293|NCT01081665|54570257|FG000|Overall Study|Lack of Efficacy|1|||
27912294|NCT01081626|54570263|FG000|Overall Study|Dosing error|1|||
27912295|NCT01081626|54570264|FG001|Overall Study|Dosing error|1|||
27912296|NCT01081626|54570263|FG000|Overall Study|Missing Estradiol|25|||
27912297|NCT01081626|54570264|FG001|Overall Study|Missing Estradiol|28|||
27997490|NCT00642460|54656494|FG002|Part II: Open-Label Up to Week 92|Adverse Event|0|||
27997491|NCT00642460|54656495|FG003|Part II: Open-Label Up to Week 92|Adverse Event|0|||
27997492|NCT00642460|54656496|FG004|Part II: Open-Label Up to Week 92|Adverse Event|0|||
27912298|NCT01081626|54570263|FG000|Overall Study|Low antral follicle count|1|||
27912299|NCT01081626|54570264|FG001|Overall Study|Low antral follicle count|0|||
27912300|NCT01081626|54570263|FG000|Overall Study|Overstimulation|0|||
27912301|NCT01081626|54570264|FG001|Overall Study|Overstimulation|1|||
27997493|NCT00642460|54656497|FG005|Part II: Open-Label Up to Week 92|Adverse Event|0|||
27997494|NCT00642460|54656492|FG000|Part II: Open-Label Up to Week 92|Death|0|||
27997495|NCT00642460|54656493|FG001|Part II: Open-Label Up to Week 92|Death|1|||
27997496|NCT00642460|54656494|FG002|Part II: Open-Label Up to Week 92|Death|0|||
27997497|NCT00642460|54656495|FG003|Part II: Open-Label Up to Week 92|Death|2|||
27912302|NCT01081626|54570263|FG000|Overall Study|Lost to Follow-up|0|||
27912303|NCT01081626|54570264|FG001|Overall Study|Lost to Follow-up|1|||
27912304|NCT01081626|54570263|FG000|Overall Study|Other|33|||
27912305|NCT01081626|54570264|FG001|Overall Study|Other|30|||
27912306|NCT01080768|54570272|FG000|Overall Study|Protocol Deviation|2|||
27912307|NCT01080768|54570273|FG001|Overall Study|Protocol Deviation|1|||
27912308|NCT01080300|54570281|FG000|Overall Study|Adverse Event|49|||
27912309|NCT01080300|54570282|FG001|Overall Study|Adverse Event|35|||
27912310|NCT01080300|54570281|FG000|Overall Study|Lack of Efficacy|12|||
27997498|NCT00642460|54656496|FG004|Part II: Open-Label Up to Week 92|Death|0|||
27997499|NCT00642460|54656497|FG005|Part II: Open-Label Up to Week 92|Death|0|||
27997500|NCT00642460|54656492|FG000|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2|||
27997501|NCT00642460|54656493|FG001|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3|||
27997502|NCT00642460|54656494|FG002|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
27997503|NCT00642460|54656495|FG003|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
27997504|NCT00642460|54656496|FG004|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
27997505|NCT00642460|54656497|FG005|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
27997506|NCT00642460|54656492|FG000|Part II: Open-Label Up to Week 92|Refused treatment|3|||
27997507|NCT00642460|54656493|FG001|Part II: Open-Label Up to Week 92|Refused treatment|1|||
27997508|NCT00642460|54656494|FG002|Part II: Open-Label Up to Week 92|Refused treatment|0|||
27997509|NCT00642460|54656495|FG003|Part II: Open-Label Up to Week 92|Refused treatment|0|||
27997510|NCT00642460|54656496|FG004|Part II: Open-Label Up to Week 92|Refused treatment|0|||
27997511|NCT00642460|54656497|FG005|Part II: Open-Label Up to Week 92|Refused treatment|0|||
27997512|NCT00642460|54656492|FG000|Part II: Open-Label Up to Week 92|Failure to return|0|||
27997513|NCT00642460|54656493|FG001|Part II: Open-Label Up to Week 92|Failure to return|1|||
27997514|NCT00642460|54656494|FG002|Part II: Open-Label Up to Week 92|Failure to return|0|||
27997515|NCT00642460|54656495|FG003|Part II: Open-Label Up to Week 92|Failure to return|0|||
27997516|NCT00642460|54656496|FG004|Part II: Open-Label Up to Week 92|Failure to return|0|||
27997517|NCT00642460|54656497|FG005|Part II: Open-Label Up to Week 92|Failure to return|0|||
27997518|NCT00642460|54656492|FG000|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
27997519|NCT00642460|54656493|FG001|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
27997520|NCT00642460|54656494|FG002|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
27997521|NCT00642460|54656495|FG003|Part II: Open-Label Up to Week 92|Administrative reasons|1|||
27997522|NCT00642460|54656496|FG004|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
27997523|NCT00642460|54656497|FG005|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
27997524|NCT00642460|54656492|FG000|Part III: Open-Label Up to Week 260|Adverse Event|0|||
27997525|NCT00642460|54656493|FG001|Part III: Open-Label Up to Week 260|Adverse Event|0|||
27997526|NCT00642460|54656494|FG002|Part III: Open-Label Up to Week 260|Adverse Event|0|||
27997527|NCT00642460|54656495|FG003|Part III: Open-Label Up to Week 260|Adverse Event|0|||
27997528|NCT00642460|54656496|FG004|Part III: Open-Label Up to Week 260|Adverse Event|7|||
27997529|NCT00642460|54656497|FG005|Part III: Open-Label Up to Week 260|Adverse Event|6|||
27997530|NCT00642460|54656492|FG000|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
27997531|NCT00642460|54656493|FG001|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
27997532|NCT00642460|54656494|FG002|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
27997533|NCT00642460|54656495|FG003|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
27997534|NCT00642460|54656496|FG004|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3|||
27997535|NCT00642460|54656497|FG005|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4|||
27997536|NCT00642460|54656492|FG000|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
27997537|NCT00642460|54656493|FG001|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
27997538|NCT00642460|54656494|FG002|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
27997539|NCT00642460|54656495|FG003|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
27997540|NCT00642460|54656496|FG004|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4|||
27997541|NCT00642460|54656497|FG005|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1|||
27997542|NCT00642460|54656492|FG000|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
27997543|NCT00642460|54656493|FG001|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
27997544|NCT00642460|54656494|FG002|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
27997545|NCT00642460|54656495|FG003|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
27997546|NCT00642460|54656496|FG004|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
27997547|NCT00642460|54656497|FG005|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
27997548|NCT00642460|54656492|FG000|Part III: Open-Label Up to Week 260|Other|0|||
27997549|NCT00642460|54656493|FG001|Part III: Open-Label Up to Week 260|Other|0|||
27997550|NCT00642460|54656494|FG002|Part III: Open-Label Up to Week 260|Other|0|||
27997551|NCT00642460|54656495|FG003|Part III: Open-Label Up to Week 260|Other|0|||
27997552|NCT00642460|54656496|FG004|Part III: Open-Label Up to Week 260|Other|2|||
27997553|NCT00642460|54656497|FG005|Part III: Open-Label Up to Week 260|Other|2|||
27912311|NCT01080300|54570282|FG001|Overall Study|Lack of Efficacy|15|||
27912312|NCT01080300|54570281|FG000|Overall Study|Protocol Violation|7|||
27997554|NCT00642460|54656492|FG000|Part III: Open-Label Up to Week 260|Death|0|||
27997555|NCT00642460|54656493|FG001|Part III: Open-Label Up to Week 260|Death|0|||
27997556|NCT00642460|54656494|FG002|Part III: Open-Label Up to Week 260|Death|0|||
27997557|NCT00642460|54656495|FG003|Part III: Open-Label Up to Week 260|Death|0|||
27997558|NCT00642460|54656496|FG004|Part III: Open-Label Up to Week 260|Death|0|||
27997559|NCT00642460|54656497|FG005|Part III: Open-Label Up to Week 260|Death|3|||
27997560|NCT00642460|54656492|FG000|Part III: Open-Label Up to Week 260|Administrative reason|0|||
27997561|NCT00642460|54656493|FG001|Part III: Open-Label Up to Week 260|Administrative reason|0|||
27997562|NCT00642460|54656494|FG002|Part III: Open-Label Up to Week 260|Administrative reason|0|||
27997563|NCT00642460|54656495|FG003|Part III: Open-Label Up to Week 260|Administrative reason|0|||
27997564|NCT00642460|54656496|FG004|Part III: Open-Label Up to Week 260|Administrative reason|0|||
27997565|NCT00642460|54656497|FG005|Part III: Open-Label Up to Week 260|Administrative reason|1|||
27997566|NCT00642460|54656492|FG000|Part III: Open-Label Up to Week 260|Refused treatment|0|||
27997567|NCT00642460|54656493|FG001|Part III: Open-Label Up to Week 260|Refused treatment|0|||
27997568|NCT00642460|54656494|FG002|Part III: Open-Label Up to Week 260|Refused treatment|0|||
27997569|NCT00642460|54656495|FG003|Part III: Open-Label Up to Week 260|Refused treatment|0|||
27997570|NCT00642460|54656496|FG004|Part III: Open-Label Up to Week 260|Refused treatment|8|||
27997571|NCT00642460|54656497|FG005|Part III: Open-Label Up to Week 260|Refused treatment|3|||
27997572|NCT00814658|54656509|FG000|Overall Study|Lost to Follow-up|0|||
27997573|NCT00814658|54656510|FG001|Overall Study|Lost to Follow-up|1|||
27997574|NCT00814658|54656509|FG000|Overall Study|Physician Decision|1|||
27997575|NCT00814658|54656510|FG001|Overall Study|Physician Decision|0|||
27997576|NCT00814658|54656509|FG000|Overall Study|Adverse Event|3|||
27997577|NCT00814658|54656510|FG001|Overall Study|Adverse Event|3|||
27997578|NCT00642304|54656526|FG000|Overall Study|Adverse Event|1|||
27997579|NCT00642304|54656526|FG000|Overall Study|Death|1|||
27997580|NCT00642304|54656526|FG000|Overall Study|Blood transfusion|2|||
27997581|NCT00642304|54656526|FG000|Overall Study|Erythropoiesis Stimulating Agent Use.|1|||
27997582|NCT00642304|54656526|FG000|Overall Study|Transplantation|1|||
27912313|NCT01080300|54570282|FG001|Overall Study|Protocol Violation|13|||
27912314|NCT01080300|54570281|FG000|Overall Study|Lost to Follow-up|10|||
27912315|NCT01080300|54570282|FG001|Overall Study|Lost to Follow-up|6|||
27912316|NCT01080300|54570281|FG000|Overall Study|Death|0|||
27997583|NCT00814580|54656532|FG000|Overall Study|Adverse Event|6|||
27997584|NCT00814580|54656533|FG001|Overall Study|Adverse Event|15|||
27997585|NCT00814580|54656532|FG000|Overall Study|Lack of Efficacy|18|||
27912317|NCT01080300|54570282|FG001|Overall Study|Death|1|||
27912318|NCT01080300|54570281|FG000|Overall Study|Withdrawal by Subject|12|||
27912319|NCT01080300|54570282|FG001|Overall Study|Withdrawal by Subject|28|||
27912320|NCT01080300|54570281|FG000|Overall Study|Reasons not specified|4|||
27912321|NCT01080300|54570282|FG001|Overall Study|Reasons not specified|6|||
27912322|NCT01085097|54570293|FG000|Overall Study|Adverse Event|0|||
27912323|NCT01085097|54570294|FG001|Overall Study|Adverse Event|0|||
27912324|NCT01085097|54570295|FG002|Overall Study|Adverse Event|2|||
27912325|NCT01085097|54570293|FG000|Overall Study|Treatment failure|2|||
27912326|NCT01085097|54570294|FG001|Overall Study|Treatment failure|0|||
27912327|NCT01085097|54570295|FG002|Overall Study|Treatment failure|0|||
27912328|NCT03450629|54570309|FG000|Overall Study|Adverse Event|15|||
27912329|NCT03450629|54570310|FG001|Overall Study|Adverse Event|14|||
27912330|NCT03450629|54570309|FG000|Overall Study|Physician Decision|2|||
27912331|NCT03450629|54570310|FG001|Overall Study|Physician Decision|2|||
27912332|NCT03450629|54570309|FG000|Overall Study|Lack of Efficacy|2|||
27912333|NCT03450629|54570310|FG001|Overall Study|Lack of Efficacy|0|||
27912334|NCT03450629|54570309|FG000|Overall Study|Lost to Follow-up|4|||
27912335|NCT03450629|54570310|FG001|Overall Study|Lost to Follow-up|2|||
27912336|NCT03450629|54570309|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
27912337|NCT03450629|54570310|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
27912338|NCT03450629|54570309|FG000|Overall Study|Non-Compliance With Study Drug|2|||
27912339|NCT03450629|54570310|FG001|Overall Study|Non-Compliance With Study Drug|1|||
27912340|NCT03450629|54570309|FG000|Overall Study|Protocol Violation|11|||
27912341|NCT03450629|54570310|FG001|Overall Study|Protocol Violation|8|||
27912342|NCT03450629|54570309|FG000|Overall Study|Withdrawal by Subject|12|||
27997586|NCT00814580|54656533|FG001|Overall Study|Lack of Efficacy|25|||
27997587|NCT00814580|54656532|FG000|Overall Study|Protocol Violation|2|||
27997588|NCT00814580|54656533|FG001|Overall Study|Protocol Violation|0|||
27997589|NCT00814580|54656532|FG000|Overall Study|Withdrawal by Subject|2|||
27997590|NCT00814580|54656533|FG001|Overall Study|Withdrawal by Subject|2|||
27997591|NCT00814580|54656532|FG000|Overall Study|Other|1|||
27997592|NCT00814580|54656533|FG001|Overall Study|Other|3|||
27997593|NCT00814580|54656532|FG000|Overall Study|Did Not Take Drug|2|||
27912343|NCT03450629|54570310|FG001|Overall Study|Withdrawal by Subject|6|||
27912344|NCT00198029|54570316|FG000|Overall Study|Withdrawal by Subject|4|||
27912345|NCT00197054|54570323|FG000|Overall Study|Withdrawal by Subject|9|||
27912346|NCT00197054|54570324|FG001|Overall Study|Withdrawal by Subject|3|||
27912347|NCT00197054|54570325|FG002|Overall Study|Withdrawal by Subject|3|||
27912348|NCT00197054|54570323|FG000|Overall Study|Moved from area|7|||
27997594|NCT00814580|54656533|FG001|Overall Study|Did Not Take Drug|2|||
27997595|NCT00643162|54656553|FG000|Overall Study|Withdrawal by Subject|1|||
27997596|NCT00643162|54656554|FG001|Overall Study|Withdrawal by Subject|1|||
27997597|NCT00643006|54656562|FG000|Overall Study|Lost to Follow-up|5|||
27997598|NCT00643006|54656563|FG001|Overall Study|Lost to Follow-up|4|||
27997599|NCT00814502|54656573|FG000|Overall Study|Adverse Event|1|||
27997600|NCT00814502|54656574|FG001|Overall Study|Adverse Event|0|||
27997601|NCT00814502|54656573|FG000|Overall Study|Withdrawal by Subject|0|||
27997602|NCT00814502|54656574|FG001|Overall Study|Withdrawal by Subject|2|||
27997603|NCT00653224|54656584|FG000|Overall Study|Adverse Event|2|||
27997604|NCT00653224|54656585|FG001|Overall Study|Adverse Event|1|||
27997605|NCT00653224|54656584|FG000|Overall Study|Lack of Efficacy|1|||
27997606|NCT00653224|54656585|FG001|Overall Study|Lack of Efficacy|2|||
27997607|NCT00653224|54656584|FG000|Overall Study|Loss of efficacy|1|||
27997608|NCT00653224|54656585|FG001|Overall Study|Loss of efficacy|0|||
27997609|NCT00653224|54656584|FG000|Overall Study|Lost to Follow-up|1|||
27997610|NCT00653224|54656585|FG001|Overall Study|Lost to Follow-up|0|||
27997611|NCT00653224|54656584|FG000|Overall Study|Other|2|||
27997612|NCT00653224|54656585|FG001|Overall Study|Other|4|||
27997613|NCT00444925|54656594|FG000|Randomized to Double-blind Treatment|Never returned after randomization|3|||
27997614|NCT00444925|54656595|FG001|Randomized to Double-blind Treatment|Never returned after randomization|6|||
27997615|NCT00444925|54656596|FG002|Randomized to Double-blind Treatment|Never returned after randomization|6|||
27997616|NCT00444925|54656594|FG000|Double-blind Treatment Period|Death|2|||
27997617|NCT00444925|54656595|FG001|Double-blind Treatment Period|Death|0|||
27997618|NCT00444925|54656596|FG002|Double-blind Treatment Period|Death|0|||
27997619|NCT00444925|54656594|FG000|Double-blind Treatment Period|Adverse Event|6|||
27997620|NCT00444925|54656595|FG001|Double-blind Treatment Period|Adverse Event|28|||
27997621|NCT00444925|54656596|FG002|Double-blind Treatment Period|Adverse Event|44|||
27997622|NCT00444925|54656594|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
27997623|NCT00444925|54656595|FG001|Double-blind Treatment Period|Lack of Efficacy|5|||
27997624|NCT00444925|54656596|FG002|Double-blind Treatment Period|Lack of Efficacy|13|||
27997625|NCT00444925|54656594|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
28099021|NCT01670656|54754864|FG003|Overall Study|Pregnancy|0|||
28099022|NCT01670656|54754865|FG004|Overall Study|Pregnancy|1|||
28099023|NCT01670656|54754861|FG000|Overall Study|Withdrawal by Subject|1|||
28099024|NCT01670656|54754862|FG001|Overall Study|Withdrawal by Subject|1|||
28099025|NCT01670656|54754863|FG002|Overall Study|Withdrawal by Subject|0|||
28099026|NCT01670656|54754864|FG003|Overall Study|Withdrawal by Subject|0|||
28099027|NCT01670656|54754865|FG004|Overall Study|Withdrawal by Subject|0|||
28099028|NCT01670656|54754861|FG000|Overall Study|Non-compliance with protocol|0|||
27912349|NCT00197054|54570324|FG001|Overall Study|Moved from area|14|||
27912350|NCT00197054|54570325|FG002|Overall Study|Moved from area|9|||
27912351|NCT00197054|54570323|FG000|Overall Study|Lost to Follow-up|1|||
27912352|NCT00197054|54570324|FG001|Overall Study|Lost to Follow-up|4|||
27912353|NCT00197054|54570325|FG002|Overall Study|Lost to Follow-up|0|||
27912354|NCT00197015|54570346|FG000|Overall Study|Adverse Event|3|||
27912355|NCT00197015|54570347|FG001|Overall Study|Adverse Event|0|||
27912356|NCT00197015|54570348|FG002|Overall Study|Adverse Event|1|||
27912357|NCT00197015|54570346|FG000|Overall Study|Protocol Violation|0|||
27912358|NCT00197015|54570347|FG001|Overall Study|Protocol Violation|3|||
27912359|NCT00197015|54570348|FG002|Overall Study|Protocol Violation|3|||
27912360|NCT00197015|54570346|FG000|Overall Study|Withdrawal by Subject|17|||
27912361|NCT00197015|54570347|FG001|Overall Study|Withdrawal by Subject|37|||
27912362|NCT00197015|54570348|FG002|Overall Study|Withdrawal by Subject|34|||
27912363|NCT00197015|54570346|FG000|Overall Study|Lost to Follow-up|28|||
27912364|NCT00197015|54570347|FG001|Overall Study|Lost to Follow-up|46|||
27912365|NCT00197015|54570348|FG002|Overall Study|Lost to Follow-up|37|||
27912366|NCT00197015|54570346|FG000|Overall Study|Other|2|||
27912367|NCT00197015|54570347|FG001|Overall Study|Other|3|||
27912368|NCT00197015|54570348|FG002|Overall Study|Other|2|||
27912369|NCT00196976|54570370|FG000|Primary Study|Migrated from study area|0|||
27912370|NCT00196976|54570371|FG001|Primary Study|Migrated from study area|0|||
27912371|NCT00196976|54570372|FG002|Primary Study|Migrated from study area|0|||
27912372|NCT00196976|54570373|FG003|Primary Study|Migrated from study area|0|||
27912373|NCT00196976|54570374|FG004|Primary Study|Migrated from study area|0|||
27997626|NCT00444925|54656595|FG001|Double-blind Treatment Period|Lost to Follow-up|8|||
27997627|NCT00444925|54656596|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
27997628|NCT00444925|54656594|FG000|Double-blind Treatment Period|Withdrawal by Subject|6|||
27912374|NCT00196976|54570375|FG005|Primary Study|Migrated from study area|0|||
27997629|NCT00444925|54656595|FG001|Double-blind Treatment Period|Withdrawal by Subject|8|||
27997630|NCT00444925|54656596|FG002|Double-blind Treatment Period|Withdrawal by Subject|7|||
27912375|NCT00196976|54570376|FG006|Primary Study|Migrated from study area|0|||
27912376|NCT00196976|54570377|FG007|Primary Study|Migrated from study area|1|||
27912377|NCT00196976|54570378|FG008|Primary Study|Migrated from study area|0|||
27912378|NCT00196976|54570379|FG009|Primary Study|Migrated from study area|0|||
28099029|NCT01670656|54754862|FG001|Overall Study|Non-compliance with protocol|3|||
27912379|NCT00196976|54570380|FG010|Primary Study|Migrated from study area|0|||
27912380|NCT00196976|54570381|FG011|Primary Study|Migrated from study area|0|||
27912381|NCT00196976|54570382|FG012|Primary Study|Migrated from study area|0|||
27912382|NCT00196976|54570383|FG013|Primary Study|Migrated from study area|0|||
27912383|NCT00196976|54570370|FG000|Primary Study|Protocol Violation|0|||
27912384|NCT00196976|54570371|FG001|Primary Study|Protocol Violation|1|||
27912385|NCT00196976|54570372|FG002|Primary Study|Protocol Violation|1|||
27912386|NCT00196976|54570373|FG003|Primary Study|Protocol Violation|0|||
27912387|NCT00196976|54570374|FG004|Primary Study|Protocol Violation|0|||
27912388|NCT00196976|54570375|FG005|Primary Study|Protocol Violation|0|||
27912389|NCT00196976|54570376|FG006|Primary Study|Protocol Violation|0|||
27912390|NCT00196976|54570377|FG007|Primary Study|Protocol Violation|0|||
27912391|NCT00196976|54570378|FG008|Primary Study|Protocol Violation|0|||
27912392|NCT00196976|54570379|FG009|Primary Study|Protocol Violation|0|||
27912393|NCT00196976|54570380|FG010|Primary Study|Protocol Violation|0|||
27912394|NCT00196976|54570381|FG011|Primary Study|Protocol Violation|0|||
27912395|NCT00196976|54570382|FG012|Primary Study|Protocol Violation|0|||
27912396|NCT00196976|54570383|FG013|Primary Study|Protocol Violation|0|||
27912397|NCT00196976|54570370|FG000|Primary Study|Withdrawal by Subject|1|||
27912398|NCT00196976|54570371|FG001|Primary Study|Withdrawal by Subject|0|||
27912399|NCT00196976|54570372|FG002|Primary Study|Withdrawal by Subject|1|||
27912400|NCT00196976|54570373|FG003|Primary Study|Withdrawal by Subject|1|||
27912401|NCT00196976|54570374|FG004|Primary Study|Withdrawal by Subject|2|||
27912402|NCT00196976|54570375|FG005|Primary Study|Withdrawal by Subject|1|||
27912403|NCT00196976|54570376|FG006|Primary Study|Withdrawal by Subject|0|||
27912404|NCT00196976|54570377|FG007|Primary Study|Withdrawal by Subject|0|||
27912405|NCT00196976|54570378|FG008|Primary Study|Withdrawal by Subject|0|||
27912406|NCT00196976|54570379|FG009|Primary Study|Withdrawal by Subject|1|||
27912407|NCT00196976|54570380|FG010|Primary Study|Withdrawal by Subject|0|||
27912408|NCT00196976|54570381|FG011|Primary Study|Withdrawal by Subject|0|||
27912409|NCT00196976|54570382|FG012|Primary Study|Withdrawal by Subject|0|||
27912410|NCT00196976|54570383|FG013|Primary Study|Withdrawal by Subject|0|||
27912411|NCT00196976|54570370|FG000|Primary Study|Lost to Follow-up|0|||
27912412|NCT00196976|54570371|FG001|Primary Study|Lost to Follow-up|0|||
27912413|NCT00196976|54570372|FG002|Primary Study|Lost to Follow-up|0|||
27912414|NCT00196976|54570373|FG003|Primary Study|Lost to Follow-up|0|||
27912415|NCT00196976|54570374|FG004|Primary Study|Lost to Follow-up|1|||
27912416|NCT00196976|54570375|FG005|Primary Study|Lost to Follow-up|1|||
27912417|NCT00196976|54570376|FG006|Primary Study|Lost to Follow-up|0|||
27912418|NCT00196976|54570377|FG007|Primary Study|Lost to Follow-up|2|||
27912419|NCT00196976|54570378|FG008|Primary Study|Lost to Follow-up|0|||
27912420|NCT00196976|54570379|FG009|Primary Study|Lost to Follow-up|0|||
27912421|NCT00196976|54570380|FG010|Primary Study|Lost to Follow-up|0|||
27912422|NCT00196976|54570381|FG011|Primary Study|Lost to Follow-up|0|||
27997631|NCT00444925|54656594|FG000|Double-blind Treatment Period|Other|7|||
27997632|NCT00444925|54656595|FG001|Double-blind Treatment Period|Other|7|||
27997633|NCT00444925|54656596|FG002|Double-blind Treatment Period|Other|12|||
27997634|NCT00641056|54656606|FG000|Overall Study|Adverse Event|12|||
27997635|NCT00641056|54656607|FG001|Overall Study|Adverse Event|2|||
27997636|NCT00641056|54656606|FG000|Overall Study|Lost to Follow-up|2|||
27997637|NCT00641056|54656607|FG001|Overall Study|Lost to Follow-up|1|||
27997638|NCT00641056|54656606|FG000|Overall Study|Physician Decision|3|||
27997639|NCT00641056|54656607|FG001|Overall Study|Physician Decision|1|||
27997640|NCT00641056|54656606|FG000|Overall Study|Protocol Violation|2|||
27997641|NCT00641056|54656607|FG001|Overall Study|Protocol Violation|0|||
27997642|NCT00641056|54656606|FG000|Overall Study|Entry Criteria Not Met|3|||
27997643|NCT00641056|54656607|FG001|Overall Study|Entry Criteria Not Met|0|||
27997644|NCT00641056|54656606|FG000|Overall Study|Subject Decision|6|||
27997645|NCT00641056|54656607|FG001|Overall Study|Subject Decision|19|||
28172640|NCT02456740|54844364|FG004|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
28172641|NCT02456740|54844365|FG005|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
28172642|NCT02456740|54844366|FG006|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
27912423|NCT00196976|54570382|FG012|Primary Study|Lost to Follow-up|0|||
27912424|NCT00196976|54570383|FG013|Primary Study|Lost to Follow-up|0|||
27912425|NCT00196976|54570370|FG000|Primary Study|Other|0|||
27912426|NCT00196976|54570371|FG001|Primary Study|Other|0|||
27912427|NCT00196976|54570372|FG002|Primary Study|Other|2|||
27912428|NCT00196976|54570373|FG003|Primary Study|Other|0|||
27912429|NCT00196976|54570374|FG004|Primary Study|Other|0|||
27912430|NCT00196976|54570375|FG005|Primary Study|Other|0|||
27912431|NCT00196976|54570376|FG006|Primary Study|Other|0|||
27997646|NCT00641056|54656606|FG000|Overall Study|Sponsor Decision|1|||
28172643|NCT02456740|54844367|FG007|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
28172644|NCT02456740|54844368|FG008|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
27912432|NCT00196976|54570377|FG007|Primary Study|Other|0|||
27912433|NCT00196976|54570378|FG008|Primary Study|Other|0|||
27912434|NCT00196976|54570379|FG009|Primary Study|Other|0|||
27912435|NCT00196976|54570380|FG010|Primary Study|Other|0|||
27912436|NCT00196976|54570381|FG011|Primary Study|Other|0|||
27912437|NCT00196976|54570382|FG012|Primary Study|Other|0|||
27912438|NCT00196976|54570383|FG013|Primary Study|Other|0|||
27997647|NCT00641056|54656607|FG001|Overall Study|Sponsor Decision|2|||
27997648|NCT00814346|54656619|FG000|Double-blind Phase (4 Weeks)|Adverse Event|0|||
27997649|NCT00814346|54656620|FG001|Double-blind Phase (4 Weeks)|Adverse Event|1|||
27997650|NCT00814346|54656619|FG000|Double-blind Phase (4 Weeks)|Not otherwise specified|0|||
27997651|NCT00814346|54656620|FG001|Double-blind Phase (4 Weeks)|Not otherwise specified|2|||
27997652|NCT00814346|54656619|FG000|Open Phase (17 Months)|Adverse Event|5|||
27997653|NCT00814346|54656620|FG001|Open Phase (17 Months)|Adverse Event|0|||
27997654|NCT00814346|54656619|FG000|Open Phase (17 Months)|Consent|2|||
27997655|NCT00814346|54656620|FG001|Open Phase (17 Months)|Consent|0|||
27997656|NCT00814346|54656619|FG000|Open Phase (17 Months)|Lost to Follow-up|2|||
27997657|NCT00814346|54656620|FG001|Open Phase (17 Months)|Lost to Follow-up|0|||
27997658|NCT00814346|54656619|FG000|Open Phase (17 Months)|Not otherwise specified|1|||
27997659|NCT00814346|54656620|FG001|Open Phase (17 Months)|Not otherwise specified|0|||
27997660|NCT00569374|54656639|FG000|Overall Study|Withdrawal by Subject|4|||
27997661|NCT00828464|54656643|FG000|Overall Study|Withdrawal by Subject|1|||
27997662|NCT00810602|54656647|FG000|Overall Study|Withdrawal by Subject|8|||
27997663|NCT00810602|54656648|FG001|Overall Study|Withdrawal by Subject|3|||
27997664|NCT00791700|54656656|FG000|Overall Study|Insufficient clinical response|1|||
27997665|NCT00791700|54656657|FG001|Overall Study|Insufficient clinical response|4|||
27997666|NCT00791700|54656658|FG002|Overall Study|Insufficient clinical response|1|||
27997667|NCT00791700|54656659|FG003|Overall Study|Insufficient clinical response|8|||
27997668|NCT00791700|54656656|FG000|Overall Study|No longer willing to participate|1|||
27997669|NCT00791700|54656657|FG001|Overall Study|No longer willing to participate|1|||
27997670|NCT00791700|54656658|FG002|Overall Study|No longer willing to participate|0|||
27997671|NCT00791700|54656659|FG003|Overall Study|No longer willing to participate|8|||
27997672|NCT00791700|54656656|FG000|Overall Study|Non-compliance with study treatment|0|||
27997673|NCT00791700|54656657|FG001|Overall Study|Non-compliance with study treatment|2|||
27997674|NCT00791700|54656658|FG002|Overall Study|Non-compliance with study treatment|0|||
27997675|NCT00791700|54656659|FG003|Overall Study|Non-compliance with study treatment|4|||
27997676|NCT00791700|54656656|FG000|Overall Study|Withdrawn due to pregnancy|0|||
27997677|NCT00791700|54656657|FG001|Overall Study|Withdrawn due to pregnancy|0|||
27997678|NCT00791700|54656658|FG002|Overall Study|Withdrawn due to pregnancy|0|||
27997679|NCT00791700|54656659|FG003|Overall Study|Withdrawn due to pregnancy|1|||
27997680|NCT00791700|54656656|FG000|Overall Study|Other|0|||
27997681|NCT00791700|54656657|FG001|Overall Study|Other|1|||
27997682|NCT00791700|54656658|FG002|Overall Study|Other|0|||
27997683|NCT00791700|54656659|FG003|Overall Study|Other|1|||
27997684|NCT00791700|54656656|FG000|Overall Study|Death|0|||
27997685|NCT00791700|54656657|FG001|Overall Study|Death|0|||
27997686|NCT00791700|54656658|FG002|Overall Study|Death|0|||
27997687|NCT00791700|54656659|FG003|Overall Study|Death|1|||
27997688|NCT00791700|54656656|FG000|Overall Study|Lost to Follow-up|4|||
27997689|NCT00791700|54656657|FG001|Overall Study|Lost to Follow-up|3|||
27997690|NCT00791700|54656658|FG002|Overall Study|Lost to Follow-up|4|||
27997691|NCT00791700|54656659|FG003|Overall Study|Lost to Follow-up|6|||
27997692|NCT00791700|54656656|FG000|Overall Study|Adverse Event|0|||
27997693|NCT00791700|54656657|FG001|Overall Study|Adverse Event|0|||
27997694|NCT00791700|54656658|FG002|Overall Study|Adverse Event|1|||
27997695|NCT00791700|54656659|FG003|Overall Study|Adverse Event|1|||
27912439|NCT00196976|54570370|FG000|Booster Study|Withdrawal by Subject|0|||
27912440|NCT00196976|54570371|FG001|Booster Study|Withdrawal by Subject|0|||
27912441|NCT00196976|54570372|FG002|Booster Study|Withdrawal by Subject|0|||
27912442|NCT00196976|54570373|FG003|Booster Study|Withdrawal by Subject|0|||
27912443|NCT00196976|54570374|FG004|Booster Study|Withdrawal by Subject|0|||
27912444|NCT00196976|54570375|FG005|Booster Study|Withdrawal by Subject|0|||
27912445|NCT00196976|54570376|FG006|Booster Study|Withdrawal by Subject|0|||
27912446|NCT00196976|54570377|FG007|Booster Study|Withdrawal by Subject|0|||
27912447|NCT00196976|54570378|FG008|Booster Study|Withdrawal by Subject|0|||
27912448|NCT00196976|54570379|FG009|Booster Study|Withdrawal by Subject|0|||
27912449|NCT00196976|54570380|FG010|Booster Study|Withdrawal by Subject|1|||
27912450|NCT00196976|54570381|FG011|Booster Study|Withdrawal by Subject|0|||
27912451|NCT00196976|54570382|FG012|Booster Study|Withdrawal by Subject|0|||
27912452|NCT00196976|54570383|FG013|Booster Study|Withdrawal by Subject|0|||
27912453|NCT00196976|54570370|FG000|Booster Study|Lost to Follow-up|0|||
27912454|NCT00196976|54570371|FG001|Booster Study|Lost to Follow-up|0|||
27997696|NCT00810368|54656682|FG000|Overall Study|Lost to Follow-up|4|||
27997697|NCT00810368|54656683|FG001|Overall Study|Lost to Follow-up|2|||
27997698|NCT00810368|54656682|FG000|Overall Study|Lack of Efficacy|2|||
27997699|NCT00810368|54656683|FG001|Overall Study|Lack of Efficacy|0|||
27997700|NCT00628108|54656693|FG000|Overall Study|Adverse Event|0|||
27997701|NCT00628108|54656694|FG001|Overall Study|Adverse Event|3|||
27997702|NCT00628108|54656693|FG000|Overall Study|Withdrawal by Subject|1|||
27997703|NCT00628108|54656694|FG001|Overall Study|Withdrawal by Subject|0|||
27997704|NCT00628030|54656702|FG000|Baseline to Post-Assessment|Lost to Follow-up|28|||
27912455|NCT00196976|54570372|FG002|Booster Study|Lost to Follow-up|0|||
27997705|NCT00628030|54656703|FG001|Baseline to Post-Assessment|Lost to Follow-up|29|||
27997706|NCT00628030|54656702|FG000|Baseline to Post-Assessment|Withdrawal by Subject|5|||
27997707|NCT00628030|54656703|FG001|Baseline to Post-Assessment|Withdrawal by Subject|0|||
27997708|NCT00628030|54656702|FG000|Post to 6 Month Follow-up|Lost to Follow-up|32|||
27997709|NCT00628030|54656703|FG001|Post to 6 Month Follow-up|Lost to Follow-up|30|||
27997710|NCT00591578|54656712|FG000|Double-Blind Treatment Phase|Adverse Event|20|||
27997711|NCT00591578|54656713|FG001|Double-Blind Treatment Phase|Adverse Event|26|||
27997712|NCT00591578|54656714|FG002|Double-Blind Treatment Phase|Adverse Event|19|||
27997713|NCT00591578|54656712|FG000|Double-Blind Treatment Phase|Protocol Violation|3|||
27997714|NCT00591578|54656713|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
27997715|NCT00591578|54656714|FG002|Double-Blind Treatment Phase|Protocol Violation|3|||
27997716|NCT00591578|54656712|FG000|Double-Blind Treatment Phase|Lost to Follow-up|12|||
27997717|NCT00591578|54656713|FG001|Double-Blind Treatment Phase|Lost to Follow-up|12|||
27997718|NCT00591578|54656714|FG002|Double-Blind Treatment Phase|Lost to Follow-up|11|||
27997719|NCT00591578|54656712|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
27997720|NCT00591578|54656713|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
27997721|NCT00591578|54656714|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
27997722|NCT00591578|54656712|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
27997723|NCT00591578|54656713|FG001|Double-Blind Treatment Phase|Pregnancy|0|||
27997724|NCT00591578|54656714|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
27997725|NCT00591578|54656712|FG000|Double-Blind Treatment Phase|Lack of Efficacy|16|||
27997726|NCT00591578|54656713|FG001|Double-Blind Treatment Phase|Lack of Efficacy|9|||
27997727|NCT00591578|54656714|FG002|Double-Blind Treatment Phase|Lack of Efficacy|25|||
27997728|NCT00591578|54656712|FG000|Double-Blind Treatment Phase|Other|4|||
27997729|NCT00591578|54656713|FG001|Double-Blind Treatment Phase|Other|9|||
27997730|NCT00591578|54656714|FG002|Double-Blind Treatment Phase|Other|4|||
27997731|NCT00591578|54656712|FG000|Open-Label Extension Phase|Adverse Event|3|||
27997732|NCT00591578|54656713|FG001|Open-Label Extension Phase|Adverse Event|5|||
27997733|NCT00591578|54656714|FG002|Open-Label Extension Phase|Adverse Event|0|||
27912456|NCT00196976|54570373|FG003|Booster Study|Lost to Follow-up|0|||
27912457|NCT00196976|54570374|FG004|Booster Study|Lost to Follow-up|0|||
27912458|NCT00196976|54570375|FG005|Booster Study|Lost to Follow-up|0|||
27912459|NCT00196976|54570376|FG006|Booster Study|Lost to Follow-up|0|||
27912460|NCT00196976|54570377|FG007|Booster Study|Lost to Follow-up|0|||
27912461|NCT00196976|54570378|FG008|Booster Study|Lost to Follow-up|0|||
27912462|NCT00196976|54570379|FG009|Booster Study|Lost to Follow-up|0|||
27912463|NCT00196976|54570380|FG010|Booster Study|Lost to Follow-up|1|||
27912464|NCT00196976|54570381|FG011|Booster Study|Lost to Follow-up|2|||
27912465|NCT00196976|54570382|FG012|Booster Study|Lost to Follow-up|0|||
27912466|NCT00196976|54570383|FG013|Booster Study|Lost to Follow-up|0|||
27912467|NCT00196313|54570425|FG000|Overall Study|Protocol Violation|2|||
27912468|NCT00196313|54570426|FG001|Overall Study|Protocol Violation|3|||
27912469|NCT00196313|54570425|FG000|Overall Study|Withdrawal by Subject|3|||
27912470|NCT00196313|54570426|FG001|Overall Study|Withdrawal by Subject|1|||
27912471|NCT00196313|54570425|FG000|Overall Study|Adverse Event|3|||
27912472|NCT00196313|54570426|FG001|Overall Study|Adverse Event|1|||
27912473|NCT00196313|54570425|FG000|Overall Study|Subject Pregnant|1|||
27912474|NCT00196313|54570426|FG001|Overall Study|Subject Pregnant|1|||
27912475|NCT00196313|54570425|FG000|Overall Study|Lost to Follow-up|2|||
27997734|NCT00591578|54656712|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
27997735|NCT00591578|54656713|FG001|Open-Label Extension Phase|Lost to Follow-up|4|||
27997736|NCT00591578|54656714|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
27997737|NCT00591578|54656712|FG000|Open-Label Extension Phase|Withdrawal by Subject|1|||
27997738|NCT00591578|54656713|FG001|Open-Label Extension Phase|Withdrawal by Subject|1|||
27997739|NCT00591578|54656714|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
27997740|NCT00591578|54656712|FG000|Open-Label Extension Phase|Other|1|||
28099030|NCT01670656|54754863|FG002|Overall Study|Non-compliance with protocol|1|||
28099031|NCT01670656|54754864|FG003|Overall Study|Non-compliance with protocol|1|||
28099032|NCT01670656|54754865|FG004|Overall Study|Non-compliance with protocol|2|||
27912476|NCT00196313|54570426|FG001|Overall Study|Lost to Follow-up|2|||
27912477|NCT00196196|54570433|FG000|Overall Study|Withdrawal by Subject|2|||
27912478|NCT00196196|54570433|FG000|Overall Study|Did not have required condition (hydroce|5|||
27912479|NCT00195650|54570437|FG000|Overall Study|Adverse Event|194|||
27912480|NCT00195650|54570437|FG000|Overall Study|Lack of Efficacy|99|||
27997741|NCT00591578|54656713|FG001|Open-Label Extension Phase|Other|0|||
27997742|NCT00591578|54656714|FG002|Open-Label Extension Phase|Other|0|||
27997743|NCT00797862|54656726|FG000|Overall Study|Adverse Event|86|||
27912481|NCT00195650|54570437|FG000|Overall Study|Withdrawal by Subject|67|||
27912482|NCT00195650|54570437|FG000|Overall Study|Lost to Follow-up|44|||
27912483|NCT00195650|54570437|FG000|Overall Study|Death|23|||
27997744|NCT00797862|54656727|FG001|Overall Study|Adverse Event|44|||
27997745|NCT00797862|54656728|FG002|Overall Study|Adverse Event|58|||
28099033|NCT01670656|54754861|FG000|Overall Study|Adverse Event|2|||
27912484|NCT00195650|54570437|FG000|Overall Study|Protocol Violation|15|||
27912485|NCT00195650|54570437|FG000|Overall Study|Administrative reasons|83|||
27912486|NCT00195494|54570443|FG000|Year 1|Adverse Event|0|||
27912487|NCT00195494|54570444|FG001|Year 1|Adverse Event|0|||
27912488|NCT00195494|54570445|FG002|Year 1|Adverse Event|0|||
27912489|NCT00195494|54570446|FG003|Year 1|Adverse Event|0|||
27912490|NCT00195494|54570447|FG004|Year 1|Adverse Event|34|||
27912491|NCT00195494|54570448|FG005|Year 1|Adverse Event|27|||
27912492|NCT00195494|54570443|FG000|Year 1|System Toxicity|0|||
27912493|NCT00195494|54570444|FG001|Year 1|System Toxicity|0|||
27912494|NCT00195494|54570445|FG002|Year 1|System Toxicity|0|||
27912495|NCT00195494|54570446|FG003|Year 1|System Toxicity|0|||
27912496|NCT00195494|54570447|FG004|Year 1|System Toxicity|0|||
27912497|NCT00195494|54570448|FG005|Year 1|System Toxicity|1|||
27997746|NCT00797862|54656726|FG000|Overall Study|Abnormal Test Procedure Result|0|||
27997747|NCT00797862|54656727|FG001|Overall Study|Abnormal Test Procedure Result|1|||
27997748|NCT00797862|54656728|FG002|Overall Study|Abnormal Test Procedure Result|1|||
27997749|NCT00797862|54656726|FG000|Overall Study|Lack of Efficacy|1|||
27997750|NCT00797862|54656727|FG001|Overall Study|Lack of Efficacy|7|||
27997751|NCT00797862|54656728|FG002|Overall Study|Lack of Efficacy|6|||
27997752|NCT00797862|54656726|FG000|Overall Study|No longer required study medication|1|||
27997753|NCT00797862|54656727|FG001|Overall Study|No longer required study medication|0|||
27997754|NCT00797862|54656728|FG002|Overall Study|No longer required study medication|0|||
27997755|NCT00797862|54656726|FG000|Overall Study|Withdrawal by Subject|14|||
27997756|NCT00797862|54656727|FG001|Overall Study|Withdrawal by Subject|7|||
27997757|NCT00797862|54656728|FG002|Overall Study|Withdrawal by Subject|7|||
27997758|NCT00797862|54656726|FG000|Overall Study|Lost to Follow-up|11|||
27997759|NCT00797862|54656727|FG001|Overall Study|Lost to Follow-up|0|||
27997760|NCT00797862|54656728|FG002|Overall Study|Lost to Follow-up|5|||
27997761|NCT00797862|54656726|FG000|Overall Study|Administrative Problem|4|||
27997762|NCT00797862|54656727|FG001|Overall Study|Administrative Problem|0|||
27997763|NCT00797862|54656728|FG002|Overall Study|Administrative Problem|0|||
27997764|NCT00797862|54656726|FG000|Overall Study|Protocol Violation|4|||
27997765|NCT00797862|54656727|FG001|Overall Study|Protocol Violation|6|||
27997766|NCT00797862|54656728|FG002|Overall Study|Protocol Violation|8|||
27997767|NCT00797862|54656726|FG000|Overall Study|Mis-randomized|3|||
27997768|NCT00797862|54656727|FG001|Overall Study|Mis-randomized|3|||
27997769|NCT00797862|54656728|FG002|Overall Study|Mis-randomized|1|||
27997770|NCT00794820|54656736|FG000|Overall Study|Adverse Event|11|||
27997771|NCT00794820|54656736|FG000|Overall Study|Secondary Malignancies|2|||
27997772|NCT00794820|54656736|FG000|Overall Study|Resistant Disease|2|||
27997773|NCT00794820|54656736|FG000|Overall Study|Ineligible/Screen Failure|1|||
27997774|NCT00455533|54656742|FG000|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1|||
27997775|NCT00455533|54656743|FG001|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
27997776|NCT00455533|54656744|FG002|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
27997777|NCT00455533|54656742|FG000|Period One: Initial Chemotherapy|Disease Progression|5|||
27997778|NCT00455533|54656743|FG001|Period One: Initial Chemotherapy|Disease Progression|0|||
27997779|NCT00455533|54656744|FG002|Period One: Initial Chemotherapy|Disease Progression|0|||
27997780|NCT00455533|54656742|FG000|Period One: Initial Chemotherapy|Lost to Follow-up|2|||
27997781|NCT00455533|54656743|FG001|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
27912498|NCT00195494|54570443|FG000|Year 1|Lack of Efficacy|0|||
27912499|NCT00195494|54570444|FG001|Year 1|Lack of Efficacy|0|||
27912500|NCT00195494|54570445|FG002|Year 1|Lack of Efficacy|0|||
27912501|NCT00195494|54570446|FG003|Year 1|Lack of Efficacy|0|||
27912502|NCT00195494|54570447|FG004|Year 1|Lack of Efficacy|24|||
27912503|NCT00195494|54570448|FG005|Year 1|Lack of Efficacy|9|||
27912504|NCT00195494|54570443|FG000|Year 1|Compliance|0|||
27912505|NCT00195494|54570444|FG001|Year 1|Compliance|0|||
27997782|NCT00455533|54656744|FG002|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
27997783|NCT00455533|54656742|FG000|Period One: Initial Chemotherapy|Not Reported|1|||
27997784|NCT00455533|54656743|FG001|Period One: Initial Chemotherapy|Not Reported|0|||
27997785|NCT00455533|54656744|FG002|Period One: Initial Chemotherapy|Not Reported|0|||
27997786|NCT00455533|54656742|FG000|Period One: Initial Chemotherapy|Other--Need Reasons|2|||
27997787|NCT00455533|54656743|FG001|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
27997788|NCT00455533|54656744|FG002|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
27912506|NCT00195494|54570445|FG002|Year 1|Compliance|0|||
27912507|NCT00195494|54570446|FG003|Year 1|Compliance|0|||
27912508|NCT00195494|54570447|FG004|Year 1|Compliance|5|||
27912509|NCT00195494|54570448|FG005|Year 1|Compliance|1|||
27912510|NCT00195494|54570443|FG000|Year 1|Lost to Follow-up|0|||
27912511|NCT00195494|54570444|FG001|Year 1|Lost to Follow-up|0|||
27912512|NCT00195494|54570445|FG002|Year 1|Lost to Follow-up|0|||
27912513|NCT00195494|54570446|FG003|Year 1|Lost to Follow-up|0|||
27912514|NCT00195494|54570447|FG004|Year 1|Lost to Follow-up|1|||
27912515|NCT00195494|54570448|FG005|Year 1|Lost to Follow-up|0|||
27912516|NCT00195494|54570443|FG000|Year 1|Missed >4 consecutive doses|0|||
27912517|NCT00195494|54570444|FG001|Year 1|Missed >4 consecutive doses|0|||
27912518|NCT00195494|54570445|FG002|Year 1|Missed >4 consecutive doses|0|||
27997789|NCT00455533|54656742|FG000|Period One: Initial Chemotherapy|Study Drug Toxicity|2|||
27997790|NCT00455533|54656743|FG001|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
27912519|NCT00195494|54570446|FG003|Year 1|Missed >4 consecutive doses|0|||
27912520|NCT00195494|54570447|FG004|Year 1|Missed >4 consecutive doses|3|||
27912521|NCT00195494|54570448|FG005|Year 1|Missed >4 consecutive doses|2|||
27912522|NCT00195494|54570443|FG000|Year 1|Protocol deviation|0|||
27912523|NCT00195494|54570444|FG001|Year 1|Protocol deviation|0|||
27912524|NCT00195494|54570445|FG002|Year 1|Protocol deviation|0|||
27912525|NCT00195494|54570446|FG003|Year 1|Protocol deviation|0|||
27912526|NCT00195494|54570447|FG004|Year 1|Protocol deviation|2|||
27912527|NCT00195494|54570448|FG005|Year 1|Protocol deviation|3|||
27912528|NCT00195494|54570443|FG000|Year 1|Physician Decision|0|||
27912529|NCT00195494|54570444|FG001|Year 1|Physician Decision|0|||
27912530|NCT00195494|54570445|FG002|Year 1|Physician Decision|0|||
27912531|NCT00195494|54570446|FG003|Year 1|Physician Decision|0|||
27997791|NCT00455533|54656744|FG002|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
27997792|NCT00455533|54656742|FG000|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1|||
27997793|NCT00455533|54656743|FG001|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
27912532|NCT00195494|54570447|FG004|Year 1|Physician Decision|1|||
27912533|NCT00195494|54570448|FG005|Year 1|Physician Decision|0|||
27912534|NCT00195494|54570443|FG000|Year 1|Withdrawal by Subject|0|||
27912535|NCT00195494|54570444|FG001|Year 1|Withdrawal by Subject|0|||
27912536|NCT00195494|54570445|FG002|Year 1|Withdrawal by Subject|0|||
27912537|NCT00195494|54570446|FG003|Year 1|Withdrawal by Subject|0|||
27912538|NCT00195494|54570447|FG004|Year 1|Withdrawal by Subject|8|||
27912539|NCT00195494|54570448|FG005|Year 1|Withdrawal by Subject|9|||
27997794|NCT00455533|54656744|FG002|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
28172645|NCT02456740|54844360|FG000|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
28172646|NCT02456740|54844361|FG001|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
28172647|NCT02456740|54844362|FG002|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
27739735|NCT02222818|54189373|FG000|Period 1|Eligibility criteria not met|0|||
27739736|NCT02222818|54189374|FG001|Period 1|Eligibility criteria not met|3|||
27739737|NCT01378195|54189385|FG000|Overall Study|Lost to Follow-up|29|||
28099034|NCT01670656|54754862|FG001|Overall Study|Adverse Event|2|||
28099035|NCT01670656|54754863|FG002|Overall Study|Adverse Event|2|||
28099036|NCT01670656|54754864|FG003|Overall Study|Adverse Event|3|||
28099037|NCT01670656|54754865|FG004|Overall Study|Adverse Event|3|||
28099038|NCT01670656|54754861|FG000|Overall Study|Subject withdrew consent|0|||
27739738|NCT01378195|54189386|FG001|Overall Study|Lost to Follow-up|18|||
27739739|NCT01378117|54189395|FG000|Overall Study|withdrawal|2|||
27739740|NCT01378117|54189396|FG001|Overall Study|withdrawal|1|||
27739741|NCT01378117|54189397|FG002|Overall Study|withdrawal|2|||
27739742|NCT01378117|54189395|FG000|Overall Study|discharged before med given|2|||
27739743|NCT01378117|54189396|FG001|Overall Study|discharged before med given|0|||
27739744|NCT01378117|54189397|FG002|Overall Study|discharged before med given|1|||
27739745|NCT04254809|54189432|FG000|Overall Study|Lost to Follow-up|5|||
27739746|NCT04254809|54189433|FG001|Overall Study|Lost to Follow-up|10|||
27739747|NCT02736409|54189443|FG000|Overall Study|Withdrawal by Subject|4|||
27739748|NCT02736409|54189444|FG001|Overall Study|Withdrawal by Subject|2|||
27739749|NCT02736409|54189445|FG002|Overall Study|Withdrawal by Subject|17|||
27739750|NCT02736409|54189446|FG003|Overall Study|Withdrawal by Subject|3|||
27739751|NCT02736409|54189443|FG000|Overall Study|Non-Compliance with Study Drug|0|||
27997795|NCT00455533|54656742|FG000|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2|||
28099039|NCT01670656|54754862|FG001|Overall Study|Subject withdrew consent|1|||
28099040|NCT01670656|54754863|FG002|Overall Study|Subject withdrew consent|2|||
28099041|NCT01670656|54754864|FG003|Overall Study|Subject withdrew consent|1|||
28099042|NCT01670656|54754865|FG004|Overall Study|Subject withdrew consent|1|||
28099043|NCT01670656|54754861|FG000|Overall Study|Lost to Follow-up|0|||
28099044|NCT01670656|54754862|FG001|Overall Study|Lost to Follow-up|0|||
28099045|NCT01670656|54754863|FG002|Overall Study|Lost to Follow-up|0|||
28099046|NCT01670656|54754864|FG003|Overall Study|Lost to Follow-up|0|||
28099047|NCT01670656|54754865|FG004|Overall Study|Lost to Follow-up|3|||
28099048|NCT01670656|54754861|FG000|Overall Study|Subject moved|0|||
27739752|NCT02736409|54189444|FG001|Overall Study|Non-Compliance with Study Drug|0|||
27739753|NCT02736409|54189445|FG002|Overall Study|Non-Compliance with Study Drug|0|||
27739754|NCT02736409|54189446|FG003|Overall Study|Non-Compliance with Study Drug|1|||
27739755|NCT02736409|54189443|FG000|Overall Study|Adverse Event|0|||
27739756|NCT02736409|54189444|FG001|Overall Study|Adverse Event|1|||
27739757|NCT02736409|54189445|FG002|Overall Study|Adverse Event|5|||
27739758|NCT02736409|54189446|FG003|Overall Study|Adverse Event|4|||
28099049|NCT01670656|54754862|FG001|Overall Study|Subject moved|0|||
28099050|NCT01670656|54754863|FG002|Overall Study|Subject moved|0|||
27912540|NCT00195494|54570443|FG000|Year 1|Protocol Violation|0|||
27912541|NCT00195494|54570444|FG001|Year 1|Protocol Violation|0|||
27912542|NCT00195494|54570445|FG002|Year 1|Protocol Violation|0|||
27912543|NCT00195494|54570446|FG003|Year 1|Protocol Violation|0|||
27912544|NCT00195494|54570447|FG004|Year 1|Protocol Violation|1|||
27912545|NCT00195494|54570448|FG005|Year 1|Protocol Violation|1|||
28099051|NCT01670656|54754864|FG003|Overall Study|Subject moved|1|||
27912546|NCT00195494|54570443|FG000|Year 2|Adverse Event|3|||
27912547|NCT00195494|54570444|FG001|Year 2|Adverse Event|7|||
27912548|NCT00195494|54570445|FG002|Year 2|Adverse Event|5|||
27912549|NCT00195494|54570446|FG003|Year 2|Adverse Event|9|||
27912550|NCT00195494|54570447|FG004|Year 2|Adverse Event|0|||
27912551|NCT00195494|54570448|FG005|Year 2|Adverse Event|0|||
27912552|NCT00195494|54570443|FG000|Year 2|Lack of Efficacy|0|||
27912553|NCT00195494|54570444|FG001|Year 2|Lack of Efficacy|1|||
27912554|NCT00195494|54570445|FG002|Year 2|Lack of Efficacy|7|||
27912555|NCT00195494|54570446|FG003|Year 2|Lack of Efficacy|7|||
27912556|NCT00195494|54570447|FG004|Year 2|Lack of Efficacy|0|||
27912557|NCT00195494|54570448|FG005|Year 2|Lack of Efficacy|0|||
27912558|NCT00195494|54570443|FG000|Year 2|Compliance|1|||
27912559|NCT00195494|54570444|FG001|Year 2|Compliance|0|||
27912560|NCT00195494|54570445|FG002|Year 2|Compliance|0|||
27912561|NCT00195494|54570446|FG003|Year 2|Compliance|2|||
27912562|NCT00195494|54570447|FG004|Year 2|Compliance|0|||
27912563|NCT00195494|54570448|FG005|Year 2|Compliance|0|||
27912564|NCT00195494|54570443|FG000|Year 2|Lost to Follow-up|0|||
27912565|NCT00195494|54570444|FG001|Year 2|Lost to Follow-up|0|||
27912566|NCT00195494|54570445|FG002|Year 2|Lost to Follow-up|1|||
27912567|NCT00195494|54570446|FG003|Year 2|Lost to Follow-up|1|||
27912568|NCT00195494|54570447|FG004|Year 2|Lost to Follow-up|0|||
27912569|NCT00195494|54570448|FG005|Year 2|Lost to Follow-up|0|||
27912570|NCT00195494|54570443|FG000|Year 2|Missed >4 consecutive doses|1|||
27912571|NCT00195494|54570444|FG001|Year 2|Missed >4 consecutive doses|1|||
27912572|NCT00195494|54570445|FG002|Year 2|Missed >4 consecutive doses|1|||
27912573|NCT00195494|54570446|FG003|Year 2|Missed >4 consecutive doses|0|||
27912574|NCT00195494|54570447|FG004|Year 2|Missed >4 consecutive doses|0|||
27912575|NCT00195494|54570448|FG005|Year 2|Missed >4 consecutive doses|0|||
27912576|NCT00195494|54570443|FG000|Year 2|Protocol deviation|0|||
27912577|NCT00195494|54570444|FG001|Year 2|Protocol deviation|1|||
27912578|NCT00195494|54570445|FG002|Year 2|Protocol deviation|0|||
27912579|NCT00195494|54570446|FG003|Year 2|Protocol deviation|0|||
27912580|NCT00195494|54570447|FG004|Year 2|Protocol deviation|0|||
27912581|NCT00195494|54570448|FG005|Year 2|Protocol deviation|0|||
27912582|NCT00195494|54570443|FG000|Year 2|Physician Decision|1|||
27912583|NCT00195494|54570444|FG001|Year 2|Physician Decision|1|||
27912584|NCT00195494|54570445|FG002|Year 2|Physician Decision|0|||
27912585|NCT00195494|54570446|FG003|Year 2|Physician Decision|0|||
27912586|NCT00195494|54570447|FG004|Year 2|Physician Decision|0|||
27912587|NCT00195494|54570448|FG005|Year 2|Physician Decision|0|||
27912588|NCT00195494|54570443|FG000|Year 2|Withdrawal by Subject|1|||
27912589|NCT00195494|54570444|FG001|Year 2|Withdrawal by Subject|5|||
27912590|NCT00195494|54570445|FG002|Year 2|Withdrawal by Subject|4|||
27912591|NCT00195494|54570446|FG003|Year 2|Withdrawal by Subject|3|||
27912592|NCT00195494|54570447|FG004|Year 2|Withdrawal by Subject|0|||
27912593|NCT00195494|54570448|FG005|Year 2|Withdrawal by Subject|0|||
27912594|NCT00195494|54570443|FG000|Year 2|System toxicity|0|||
27912595|NCT00195494|54570444|FG001|Year 2|System toxicity|0|||
27912596|NCT00195494|54570445|FG002|Year 2|System toxicity|0|||
27912597|NCT00195494|54570446|FG003|Year 2|System toxicity|1|||
27912598|NCT00195494|54570447|FG004|Year 2|System toxicity|0|||
27912599|NCT00195494|54570448|FG005|Year 2|System toxicity|0|||
27912600|NCT00194987|54570466|FG000|Overall Study|Withdrawal by Subject|0|||
27912601|NCT00194987|54570467|FG001|Overall Study|Withdrawal by Subject|3|||
27912602|NCT00194792|54570475|FG000|Overall Study|Withdrawal by Subject|1|||
27912603|NCT00194675|54570490|FG000|Overall Study|Lost to Follow-up|1|||
28099052|NCT01670656|54754865|FG004|Overall Study|Subject moved|0|||
28172648|NCT02456740|54844363|FG003|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1|||
27739759|NCT02736409|54189443|FG000|Overall Study|Other|0|||
27912604|NCT00194675|54570491|FG001|Overall Study|Lost to Follow-up|1|||
27912605|NCT00194675|54570490|FG000|Overall Study|lack of interest|1|||
27912606|NCT00194675|54570491|FG001|Overall Study|lack of interest|1|||
27912607|NCT00194675|54570490|FG000|Overall Study|"withdrew due to edgy feeling"|1|||
27912608|NCT00194675|54570491|FG001|Overall Study|"withdrew due to edgy feeling"|0|||
27912609|NCT00194675|54570490|FG000|Overall Study|Protocol Violation|1|||
27912610|NCT00194675|54570491|FG001|Overall Study|Protocol Violation|0|||
27912611|NCT00194675|54570490|FG000|Overall Study|Death|1|||
27912612|NCT00194675|54570491|FG001|Overall Study|Death|0|||
27912613|NCT00194012|54570501|FG000|Randomized Phase|Lack of Efficacy|8|||
27912614|NCT00194012|54570502|FG001|Randomized Phase|Lack of Efficacy|18|||
27912615|NCT00194012|54570501|FG000|Randomized Phase|Study nonadherence|2|||
27912616|NCT00194012|54570502|FG001|Randomized Phase|Study nonadherence|1|||
27912617|NCT00194012|54570501|FG000|Randomized Phase|Withdrawal by Subject|3|||
27912618|NCT00194012|54570502|FG001|Randomized Phase|Withdrawal by Subject|3|||
27912619|NCT00194012|54570501|FG000|Randomized Phase|Adverse Event|2|||
27912620|NCT00194012|54570502|FG001|Randomized Phase|Adverse Event|1|||
27912621|NCT00194012|54570501|FG000|Randomized Phase|Participant reported having a rash|1|||
27912622|NCT00194012|54570502|FG001|Randomized Phase|Participant reported having a rash|0|||
27912623|NCT00194012|54570501|FG000|Randomized Phase|Emesis and enuresis|0|||
27912624|NCT00194012|54570502|FG001|Randomized Phase|Emesis and enuresis|1|||
27912625|NCT00194012|54570501|FG000|Randomized Phase|Oral/nasal twitching|0|||
27912626|NCT00194012|54570502|FG001|Randomized Phase|Oral/nasal twitching|1|||
27912627|NCT00194012|54570501|FG000|Open Label Extension (OLE)|Weight Gain|1|||
27912628|NCT00194012|54570502|FG001|Open Label Extension (OLE)|Weight Gain|0|||
27912629|NCT00194012|54570501|FG000|Open Label Extension (OLE)|Drowsiness; Jittery|0|||
27912630|NCT00194012|54570502|FG001|Open Label Extension (OLE)|Drowsiness; Jittery|1|||
27912631|NCT00194012|54570501|FG000|Open Label Extension (OLE)|Lost to Follow-up|3|||
27912632|NCT00194012|54570502|FG001|Open Label Extension (OLE)|Lost to Follow-up|5|||
27912633|NCT00194012|54570501|FG000|Open Label Extension (OLE)|Lack of Efficacy|1|||
27912634|NCT00194012|54570502|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
27912635|NCT00192647|54570516|FG000|Overall Study|Death|1|||
27912636|NCT00192647|54570517|FG001|Overall Study|Death|1|||
27912637|NCT00192647|54570516|FG000|Overall Study|Adverse Event|35|||
27997796|NCT00455533|54656743|FG001|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
27912638|NCT00192647|54570517|FG001|Overall Study|Adverse Event|29|||
27912639|NCT00192647|54570516|FG000|Overall Study|Laboratory Test Abnormality|4|||
27912640|NCT00192647|54570517|FG001|Overall Study|Laboratory Test Abnormality|2|||
27912641|NCT00192647|54570516|FG000|Overall Study|Insufficient Therapeutic Response|53|||
27997797|NCT00455533|54656744|FG002|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
27997798|NCT00455533|54656742|FG000|Period One: Initial Chemotherapy|Subject Withdrew Consent|2|||
27997799|NCT00455533|54656743|FG001|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
27997800|NCT00455533|54656744|FG002|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
27997801|NCT00455533|54656742|FG000|Period Two: Randomized Period|Death|0|||
27997802|NCT00455533|54656743|FG001|Period Two: Randomized Period|Death|0|||
27997803|NCT00455533|54656744|FG002|Period Two: Randomized Period|Death|3|||
27997804|NCT00455533|54656742|FG000|Period Two: Randomized Period|Disease Progression|0|||
27912642|NCT00192647|54570517|FG001|Overall Study|Insufficient Therapeutic Response|83|||
27912643|NCT00192647|54570516|FG000|Overall Study|Entry Criteria Violation|6|||
27912644|NCT00192647|54570517|FG001|Overall Study|Entry Criteria Violation|6|||
27912645|NCT00192647|54570516|FG000|Overall Study|Protocol Violation|3|||
27912646|NCT00192647|54570517|FG001|Overall Study|Protocol Violation|1|||
27912647|NCT00192647|54570516|FG000|Overall Study|Refused Treatment/Did not Cooperate|10|||
27912648|NCT00192647|54570517|FG001|Overall Study|Refused Treatment/Did not Cooperate|8|||
27912649|NCT00192647|54570516|FG000|Overall Study|Failure to Return|11|||
27912650|NCT00192647|54570517|FG001|Overall Study|Failure to Return|13|||
27912651|NCT00192647|54570516|FG000|Overall Study|Other/Administrative|5|||
27912652|NCT00192647|54570517|FG001|Overall Study|Other/Administrative|3|||
27912653|NCT00192296|54570527|FG000|Overall Study|Withdrawal by Subject|0|||
27912654|NCT00192296|54570528|FG001|Overall Study|Withdrawal by Subject|1|||
27912655|NCT00192296|54570529|FG002|Overall Study|Withdrawal by Subject|0|||
27912656|NCT00192296|54570530|FG003|Overall Study|Withdrawal by Subject|0|||
27912657|NCT00192023|54570542|FG000|Period III - Double-Blind|Adverse Event|3|||
27912658|NCT00192023|54570543|FG001|Period III - Double-Blind|Adverse Event|0|||
27997805|NCT00455533|54656743|FG001|Period Two: Randomized Period|Disease Progression|1|||
27997806|NCT00455533|54656744|FG002|Period Two: Randomized Period|Disease Progression|1|||
27997807|NCT00455533|54656742|FG000|Period Two: Randomized Period|Lost to Follow-up|0|||
27997808|NCT00455533|54656743|FG001|Period Two: Randomized Period|Lost to Follow-up|0|||
27997809|NCT00455533|54656744|FG002|Period Two: Randomized Period|Lost to Follow-up|1|||
27997810|NCT00455533|54656742|FG000|Period Two: Randomized Period|Other - need reasons|0|||
27997811|NCT00455533|54656743|FG001|Period Two: Randomized Period|Other - need reasons|1|||
27997812|NCT00455533|54656744|FG002|Period Two: Randomized Period|Other - need reasons|0|||
27912659|NCT00192023|54570542|FG000|Period III - Double-Blind|Physician Decision|2|||
27912660|NCT00192023|54570543|FG001|Period III - Double-Blind|Physician Decision|0|||
27912661|NCT00192023|54570542|FG000|Period III - Double-Blind|Parent/Caregiver Decision|2|||
27912662|NCT00192023|54570543|FG001|Period III - Double-Blind|Parent/Caregiver Decision|0|||
27912663|NCT00192023|54570542|FG000|Period IV - Optional Open-Label|Adverse Event|6|||
27912664|NCT00192023|54570543|FG001|Period IV - Optional Open-Label|Adverse Event|0|||
27912665|NCT00192023|54570542|FG000|Period IV - Optional Open-Label|Lack of Efficacy|7|||
27912666|NCT00192023|54570543|FG001|Period IV - Optional Open-Label|Lack of Efficacy|0|||
27912667|NCT00192023|54570542|FG000|Period IV - Optional Open-Label|Patient/Caregiver Decision|46|||
27912668|NCT00192023|54570543|FG001|Period IV - Optional Open-Label|Patient/Caregiver Decision|0|||
27912669|NCT00192023|54570542|FG000|Period IV - Optional Open-Label|Lost to Follow-up|2|||
27912670|NCT00192023|54570543|FG001|Period IV - Optional Open-Label|Lost to Follow-up|0|||
27912671|NCT00192023|54570542|FG000|Period IV - Optional Open-Label|Protocol Violation|1|||
27912672|NCT00192023|54570543|FG001|Period IV - Optional Open-Label|Protocol Violation|0|||
27912673|NCT00192023|54570542|FG000|Period IV - Optional Open-Label|Withdrawal by Subject|4|||
27912674|NCT00192023|54570543|FG001|Period IV - Optional Open-Label|Withdrawal by Subject|0|||
27912675|NCT00192023|54570542|FG000|Period IV - Optional Open-Label|Physician Decision|9|||
27912676|NCT00192023|54570543|FG001|Period IV - Optional Open-Label|Physician Decision|0|||
27912677|NCT00191984|54570549|FG000|Overall Study|Disease Progression|21|||
27912678|NCT00191984|54570549|FG000|Overall Study|Adverse Event|4|||
27912679|NCT00191984|54570549|FG000|Overall Study|Death|2|||
27912680|NCT00191984|54570549|FG000|Overall Study|Entry Criteria Exclusion|1|||
27912681|NCT00191984|54570549|FG000|Overall Study|Withdrawal by Subject|7|||
27912682|NCT00191984|54570549|FG000|Overall Study|Physician Decision|4|||
27912683|NCT00191906|54570557|FG000|Study Period II|Adverse Event|0|||
27912684|NCT00191906|54570558|FG001|Study Period II|Adverse Event|1|||
27912685|NCT00191906|54570559|FG002|Study Period II|Adverse Event|0|||
27912686|NCT00191906|54570560|FG003|Study Period II|Adverse Event|0|||
27912687|NCT00191906|54570557|FG000|Study Period II|Withdrawal by Subject|0|||
27912688|NCT00191906|54570558|FG001|Study Period II|Withdrawal by Subject|3|||
27912689|NCT00191906|54570559|FG002|Study Period II|Withdrawal by Subject|0|||
27912690|NCT00191906|54570560|FG003|Study Period II|Withdrawal by Subject|0|||
27912691|NCT00191906|54570557|FG000|Study Period II|Parent/Caregiver Decision|0|||
27912692|NCT00191906|54570558|FG001|Study Period II|Parent/Caregiver Decision|1|||
27912693|NCT00191906|54570559|FG002|Study Period II|Parent/Caregiver Decision|0|||
27912694|NCT00191906|54570560|FG003|Study Period II|Parent/Caregiver Decision|0|||
27912695|NCT00191906|54570557|FG000|Study Period II|Entry Criteria Exclusion|0|||
27912696|NCT00191906|54570558|FG001|Study Period II|Entry Criteria Exclusion|0|||
27912697|NCT00191906|54570559|FG002|Study Period II|Entry Criteria Exclusion|1|||
27912698|NCT00191906|54570560|FG003|Study Period II|Entry Criteria Exclusion|0|||
27912699|NCT00191906|54570557|FG000|Study Period III|Adverse Event|1|||
27912700|NCT00191906|54570558|FG001|Study Period III|Adverse Event|0|||
27912701|NCT00191906|54570559|FG002|Study Period III|Adverse Event|0|||
27912702|NCT00191906|54570560|FG003|Study Period III|Adverse Event|0|||
27912703|NCT00191906|54570557|FG000|Study Period III|Lost to Follow-up|0|||
27912704|NCT00191906|54570558|FG001|Study Period III|Lost to Follow-up|1|||
27912705|NCT00191906|54570559|FG002|Study Period III|Lost to Follow-up|0|||
27912706|NCT00191906|54570560|FG003|Study Period III|Lost to Follow-up|0|||
27912707|NCT00191906|54570557|FG000|Study Period III|Parent/Caregiver Decision|1|||
27912708|NCT00191906|54570558|FG001|Study Period III|Parent/Caregiver Decision|0|||
27912709|NCT00191906|54570559|FG002|Study Period III|Parent/Caregiver Decision|0|||
27912710|NCT00191906|54570560|FG003|Study Period III|Parent/Caregiver Decision|0|||
27912711|NCT00191906|54570557|FG000|Study Period III|Lack of Efficacy|3|||
27912712|NCT00191906|54570558|FG001|Study Period III|Lack of Efficacy|3|||
27997813|NCT00455533|54656742|FG000|Period Two: Randomized Period|Study Drug Toxicity|0|||
27997814|NCT00455533|54656743|FG001|Period Two: Randomized Period|Study Drug Toxicity|2|||
27997815|NCT00455533|54656744|FG002|Period Two: Randomized Period|Study Drug Toxicity|0|||
27997816|NCT00455533|54656742|FG000|Period Two: Randomized Period|Subject Withdrew Consent|0|||
27912713|NCT00191906|54570559|FG002|Study Period III|Lack of Efficacy|0|||
27912714|NCT00191906|54570560|FG003|Study Period III|Lack of Efficacy|0|||
27912715|NCT00191789|54570576|FG000|Overall Study|Adverse Event|5|||
27997817|NCT00455533|54656743|FG001|Period Two: Randomized Period|Subject Withdrew Consent|2|||
27997818|NCT00455533|54656744|FG002|Period Two: Randomized Period|Subject Withdrew Consent|1|||
27997819|NCT00627094|54656754|FG000|Overall Study|Adverse Event|8|||
27997820|NCT00627094|54656755|FG001|Overall Study|Adverse Event|7|||
27997821|NCT00627094|54656754|FG000|Overall Study|Lost to Follow-up|1|||
27997822|NCT00627094|54656755|FG001|Overall Study|Lost to Follow-up|0|||
27997823|NCT00627094|54656754|FG000|Overall Study|Withdrawal by Subject|1|||
27997824|NCT00627094|54656755|FG001|Overall Study|Withdrawal by Subject|1|||
27997825|NCT00627094|54656754|FG000|Overall Study|ulcer healed|1|||
27997826|NCT00627094|54656755|FG001|Overall Study|ulcer healed|7|||
27997827|NCT00627094|54656754|FG000|Overall Study|Other reason|1|||
27997828|NCT00627094|54656755|FG001|Overall Study|Other reason|0|||
27997829|NCT00642850|54656763|FG000|Overall Study|Death|7|||
27997830|NCT00642850|54656763|FG000|Overall Study|Adverse Event|2|||
27997831|NCT00642850|54656763|FG000|Overall Study|Lack of Efficacy|1|||
27997832|NCT00642850|54656763|FG000|Overall Study|Protocol Violation|2|||
27997833|NCT00642850|54656763|FG000|Overall Study|Kidney transplantation|8|||
27997834|NCT00642850|54656763|FG000|Overall Study|Blood transfusion|6|||
27997835|NCT00642850|54656763|FG000|Overall Study|Other reasons|7|||
27997836|NCT00455455|54656767|FG000|Washout|Withdrawal by Subject|0|||
27997837|NCT00455455|54656768|FG001|Washout|Withdrawal by Subject|1|||
27997838|NCT00455455|54656767|FG000|Washout|Withdrawal by Subject|1|||
27997839|NCT00455455|54656768|FG001|Washout|Withdrawal by Subject|0|||
27997840|NCT03840811|54656780|FG000|Overall Study|Lost to Follow-up|0|||
27912716|NCT00191789|54570576|FG000|Overall Study|Patient: Satisfactory Response|5|||
27912717|NCT00191789|54570576|FG000|Overall Study|Patient/Physician: Satisfactory Response|4|||
27997841|NCT03840811|54656781|FG001|Overall Study|Lost to Follow-up|0|||
27997842|NCT03840811|54656782|FG002|Overall Study|Lost to Follow-up|1|||
27912718|NCT00191789|54570576|FG000|Overall Study|Withdrawal by Subject|4|||
27912719|NCT00191789|54570576|FG000|Overall Study|Death - Possibly Study Drug Related|4|||
27912720|NCT00191789|54570576|FG000|Overall Study|Progressive Disease/Lack of Efficacy|2|||
27912721|NCT00191789|54570576|FG000|Overall Study|Death - Not Study-Drug Related|1|||
27997843|NCT00640510|54656792|FG000|Overall Study|Lack of Efficacy|0|||
27997844|NCT00640510|54656793|FG001|Overall Study|Lack of Efficacy|1|||
27997845|NCT00640510|54656792|FG000|Overall Study|Protocol Violation|1|||
27997846|NCT00640510|54656793|FG001|Overall Study|Protocol Violation|0|||
27912722|NCT00191282|54570582|FG000|Overall Study|Adverse Event|5|||
27912723|NCT00191282|54570583|FG001|Overall Study|Adverse Event|6|||
27997847|NCT00640510|54656792|FG000|Overall Study|Physician Decision|0|||
27997848|NCT00640510|54656793|FG001|Overall Study|Physician Decision|1|||
27997849|NCT00813800|54656799|FG000|Overall Study|Screen Failure after Consent|2|||
27997850|NCT00813800|54656799|FG000|Overall Study|Adverse Event|1|||
27997851|NCT00813800|54656799|FG000|Overall Study|Worsening of depression|2|||
27997852|NCT00813800|54656799|FG000|Overall Study|Physician Decision|1|||
27997853|NCT00627016|54656805|FG000|Overall Study|Adverse Event|1|||
27997854|NCT00627016|54656806|FG001|Overall Study|Adverse Event|1|||
27997855|NCT00627016|54656805|FG000|Overall Study|Protocol Violation|0|||
27997856|NCT00627016|54656806|FG001|Overall Study|Protocol Violation|2|||
27997857|NCT00627016|54656805|FG000|Overall Study|Lost to Follow-up|0|||
27997858|NCT00627016|54656806|FG001|Overall Study|Lost to Follow-up|1|||
27997859|NCT00627016|54656805|FG000|Overall Study|Withdrawal by Subject|2|||
27997860|NCT00627016|54656806|FG001|Overall Study|Withdrawal by Subject|1|||
27997861|NCT00627016|54656805|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
27997862|NCT00627016|54656806|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
27997863|NCT00627016|54656805|FG000|Overall Study|Lack of Efficacy|1|||
27997864|NCT00627016|54656806|FG001|Overall Study|Lack of Efficacy|0|||
27997865|NCT00627016|54656805|FG000|Overall Study|Placed on Excluded Drugs|1|||
27997866|NCT00627016|54656806|FG001|Overall Study|Placed on Excluded Drugs|0|||
27997867|NCT00627016|54656805|FG000|Overall Study|Pregnancy|1|||
27997868|NCT00627016|54656806|FG001|Overall Study|Pregnancy|0|||
27997869|NCT00794664|54656814|FG000|Treatment Period|Withdrawal by Subject|0|||
27997870|NCT00794664|54656815|FG001|Treatment Period|Withdrawal by Subject|2|||
27912724|NCT00191282|54570582|FG000|Overall Study|Death|51|||
27912725|NCT00191282|54570583|FG001|Overall Study|Death|51|||
27912726|NCT00191282|54570582|FG000|Overall Study|Lack of Efficacy|11|||
27912727|NCT00191282|54570583|FG001|Overall Study|Lack of Efficacy|6|||
27912728|NCT00191282|54570582|FG000|Overall Study|Noncompliance|14|||
27912729|NCT00191282|54570583|FG001|Overall Study|Noncompliance|17|||
27912730|NCT00191282|54570582|FG000|Overall Study|Patient moved|11|||
27912731|NCT00191282|54570583|FG001|Overall Study|Patient moved|14|||
27912732|NCT00191282|54570582|FG000|Overall Study|Withdrawal by Subject|59|||
27912733|NCT00191282|54570583|FG001|Overall Study|Withdrawal by Subject|44|||
27912734|NCT00191282|54570582|FG000|Overall Study|Physician Decision|18|||
27912735|NCT00191282|54570583|FG001|Overall Study|Physician Decision|15|||
27912736|NCT00191282|54570582|FG000|Overall Study|Protocol entry criteria not met|14|||
27912737|NCT00191282|54570583|FG001|Overall Study|Protocol entry criteria not met|9|||
27912738|NCT00191282|54570582|FG000|Overall Study|Protocol Violation|9|||
27912739|NCT00191282|54570583|FG001|Overall Study|Protocol Violation|12|||
27912740|NCT00191282|54570582|FG000|Overall Study|Severity of outcome|2|||
27912741|NCT00191282|54570583|FG001|Overall Study|Severity of outcome|5|||
27912742|NCT00191282|54570582|FG000|Overall Study|Sponsor's decision|2|||
27912743|NCT00191282|54570583|FG001|Overall Study|Sponsor's decision|2|||
27912744|NCT00191282|54570582|FG000|Overall Study|Lost to Follow-up|24|||
27912745|NCT00191282|54570583|FG001|Overall Study|Lost to Follow-up|31|||
27912746|NCT00191165|54570591|FG000|Overall Study|Adverse Event|2|||
27912747|NCT00191165|54570592|FG001|Overall Study|Adverse Event|0|||
27912748|NCT00191165|54570591|FG000|Overall Study|Protocol Violation|0|||
27912749|NCT00191165|54570592|FG001|Overall Study|Protocol Violation|1|||
27912750|NCT00191165|54570591|FG000|Overall Study|Participant Moved Away|0|||
27912751|NCT00191165|54570592|FG001|Overall Study|Participant Moved Away|1|||
27912752|NCT00190775|54570600|FG000|Overall Study|Adverse Event|57|||
27912753|NCT00190775|54570601|FG001|Overall Study|Adverse Event|22|||
27912754|NCT00190775|54570600|FG000|Overall Study|Satisfactory Response|1|||
27912755|NCT00190775|54570601|FG001|Overall Study|Satisfactory Response|0|||
27912756|NCT00190775|54570600|FG000|Overall Study|Lack of Efficacy|28|||
27912757|NCT00190775|54570601|FG001|Overall Study|Lack of Efficacy|32|||
27912758|NCT00190775|54570600|FG000|Overall Study|Lost to Follow-up|31|||
27912759|NCT00190775|54570601|FG001|Overall Study|Lost to Follow-up|23|||
27912760|NCT00190775|54570600|FG000|Overall Study|Participant Moved|0|||
27912761|NCT00190775|54570601|FG001|Overall Study|Participant Moved|1|||
27912762|NCT00190775|54570600|FG000|Overall Study|Withdrawal by Subject|24|||
27912763|NCT00190775|54570601|FG001|Overall Study|Withdrawal by Subject|13|||
27912764|NCT00190775|54570600|FG000|Overall Study|Sponsor Decision|1|||
27912765|NCT00190775|54570601|FG001|Overall Study|Sponsor Decision|0|||
27912766|NCT00190775|54570600|FG000|Overall Study|Physician Decision|3|||
27912767|NCT00190775|54570601|FG001|Overall Study|Physician Decision|0|||
27912768|NCT00190775|54570600|FG000|Overall Study|Noncompliance|3|||
27912769|NCT00190775|54570601|FG001|Overall Study|Noncompliance|5|||
27912770|NCT00190775|54570600|FG000|Overall Study|Protocol Violation|0|||
27912771|NCT00190775|54570601|FG001|Overall Study|Protocol Violation|1|||
27997871|NCT00794664|54656814|FG000|Treatment Period|Protocol non-compliance|0|||
27997872|NCT00794664|54656815|FG001|Treatment Period|Protocol non-compliance|1|||
27997873|NCT00794664|54656814|FG000|Treatment Period|Other|0|||
27997874|NCT00794664|54656815|FG001|Treatment Period|Other|1|||
27997875|NCT00794664|54656814|FG000|Treatment Period|Adverse Event|1|||
27997876|NCT00794664|54656815|FG001|Treatment Period|Adverse Event|8|||
27997877|NCT00794664|54656814|FG000|Follow-up Period|Other|1|||
27997878|NCT00794664|54656815|FG001|Follow-up Period|Other|2|||
27997879|NCT00794664|54656814|FG000|Follow-up Period|Withdrawal by Subject|0|||
27997880|NCT00794664|54656815|FG001|Follow-up Period|Withdrawal by Subject|2|||
27997881|NCT00794664|54656814|FG000|Follow-up Period|Protocol non-compliance|0|||
27997882|NCT00794664|54656815|FG001|Follow-up Period|Protocol non-compliance|1|||
27997883|NCT00444535|54656821|FG000|Overall Study|Withdrawal by Subject|5|||
27912772|NCT00190775|54570600|FG000|Overall Study|Exclusion Criteria Met|1|||
27912773|NCT00190775|54570601|FG001|Overall Study|Exclusion Criteria Met|3|||
27912774|NCT00199901|54570616|FG000|Overall Study|Protocol Violation|2|||
27912775|NCT00199901|54570617|FG001|Overall Study|Protocol Violation|0|||
27912776|NCT00199901|54570616|FG000|Overall Study|Withdrawal by Subject|1|||
27912777|NCT00199901|54570617|FG001|Overall Study|Withdrawal by Subject|0|||
27912778|NCT00199901|54570616|FG000|Overall Study|Progressive Disease|24|||
27912779|NCT00199901|54570617|FG001|Overall Study|Progressive Disease|24|||
27912780|NCT00198107|54570627|FG000|Double-Blind Period|Adverse Event|1|||
27912781|NCT00198107|54570628|FG001|Double-Blind Period|Adverse Event|1|||
27912782|NCT00198107|54570629|FG002|Double-Blind Period|Adverse Event|0|||
27912783|NCT00198107|54570627|FG000|Double-Blind Period|Lack of Efficacy|2|||
27912784|NCT00198107|54570628|FG001|Double-Blind Period|Lack of Efficacy|0|||
27912785|NCT00198107|54570629|FG002|Double-Blind Period|Lack of Efficacy|0|||
27912786|NCT00198107|54570627|FG000|Double-Blind Period|Lost to Follow-up|2|||
27912787|NCT00198107|54570628|FG001|Double-Blind Period|Lost to Follow-up|1|||
27912788|NCT00198107|54570629|FG002|Double-Blind Period|Lost to Follow-up|0|||
27912789|NCT00198107|54570627|FG000|Double-Blind Period|Physician Decision|1|||
27912790|NCT00198107|54570628|FG001|Double-Blind Period|Physician Decision|0|||
27912791|NCT00198107|54570629|FG002|Double-Blind Period|Physician Decision|0|||
27912792|NCT00198107|54570627|FG000|Double-Blind Period|Withdrawal by Subject|0|||
27912793|NCT00198107|54570628|FG001|Double-Blind Period|Withdrawal by Subject|1|||
27912794|NCT00198107|54570629|FG002|Double-Blind Period|Withdrawal by Subject|0|||
27912795|NCT00198107|54570627|FG000|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
27912796|NCT00198107|54570628|FG001|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
27997884|NCT00444535|54656821|FG000|Overall Study|Physician Decision|5|||
27997885|NCT00444535|54656821|FG000|Overall Study|progressive disease|1|||
27997886|NCT00444535|54656821|FG000|Overall Study|Adverse Event|2|||
27997887|NCT00847613|54656829|FG000|Overall Study|Ongoing at cut-off date|250|||
27997888|NCT00847613|54656830|FG001|Overall Study|Ongoing at cut-off date|265|||
27997889|NCT00847613|54656831|FG002|Overall Study|Ongoing at cut-off date|64|||
28099053|NCT03621696|54754881|FG000|Overall Study|Not eligible|0|||
28099054|NCT03621696|54754882|FG001|Overall Study|Not eligible|0|||
28099055|NCT03621696|54754883|FG002|Overall Study|Not eligible|0|||
28099056|NCT03621696|54754884|FG003|Overall Study|Not eligible|5|||
28099057|NCT03621696|54754881|FG000|Overall Study|Withdrawal by Subject|1|||
28099058|NCT03621696|54754882|FG001|Overall Study|Withdrawal by Subject|1|||
28099059|NCT03621696|54754883|FG002|Overall Study|Withdrawal by Subject|1|||
28099060|NCT03621696|54754884|FG003|Overall Study|Withdrawal by Subject|0|||
28099061|NCT03621696|54754881|FG000|Overall Study|Physician Decision|0|||
28099062|NCT03621696|54754882|FG001|Overall Study|Physician Decision|0|||
28099063|NCT03621696|54754883|FG002|Overall Study|Physician Decision|1|||
28099064|NCT03621696|54754884|FG003|Overall Study|Physician Decision|0|||
28099065|NCT00068445|54754894|FG000|Randomization|Cancel|1|||
28099066|NCT00068445|54754895|FG001|Randomization|Cancel|3|||
28099067|NCT00068445|54754894|FG000|Randomization|Ineligible|1|||
28099068|NCT00068445|54754895|FG001|Randomization|Ineligible|1|||
28099069|NCT00068445|54754894|FG000|Treatment|Refused Further Treatment|13|||
28099070|NCT00068445|54754895|FG001|Treatment|Refused Further Treatment|10|||
28099071|NCT00068445|54754894|FG000|Treatment|Adverse Event|7|||
28099072|NCT00068445|54754895|FG001|Treatment|Adverse Event|1|||
28099073|NCT00068445|54754894|FG000|Treatment|Other (Specifics not available)|9|||
28099074|NCT00068445|54754895|FG001|Treatment|Other (Specifics not available)|5|||
28099075|NCT03653208|54754910|FG000|Overall Study|Withdrawal by Subject|0|||
28099076|NCT03653208|54754911|FG001|Overall Study|Withdrawal by Subject|0|||
28099077|NCT03653208|54754912|FG002|Overall Study|Withdrawal by Subject|0|||
28099078|NCT03653208|54754913|FG003|Overall Study|Withdrawal by Subject|0|||
28099079|NCT03653208|54754914|FG004|Overall Study|Withdrawal by Subject|1|||
27912797|NCT00198107|54570629|FG002|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2|||
27912798|NCT00179660|54570637|FG000|Overall Study|Adverse Event|7|||
27912799|NCT00179660|54570637|FG000|Overall Study|Lack of therapeutic effect|28|||
27912800|NCT00179660|54570637|FG000|Overall Study|Withdrawal by Subject|2|||
27912801|NCT00179660|54570637|FG000|Overall Study|Lost to Follow-up|1|||
27997890|NCT00847613|54656832|FG003|Overall Study|Ongoing at cut-off date|64|||
27997891|NCT00847613|54656829|FG000|Overall Study|Death|1|||
27997892|NCT00847613|54656830|FG001|Overall Study|Death|1|||
28099080|NCT03653208|54754915|FG005|Overall Study|Withdrawal by Subject|0|||
28099081|NCT03653208|54754916|FG006|Overall Study|Withdrawal by Subject|0|||
28099082|NCT03653208|54754917|FG007|Overall Study|Withdrawal by Subject|1|||
28099083|NCT03653208|54754918|FG008|Overall Study|Withdrawal by Subject|1|||
28099084|NCT03545984|54754940|FG000|Overall Study|CSF cases not present during rotation|11|||
27912802|NCT00179660|54570637|FG000|Overall Study|Death|3|||
27912803|NCT00179660|54570637|FG000|Overall Study|Other - Unspecified|9|||
27912804|NCT00178256|54570641|FG000|Overall Study|Adverse Event|2|||
27912805|NCT00178256|54570642|FG001|Overall Study|Adverse Event|0|||
27912806|NCT00178256|54570643|FG002|Overall Study|Adverse Event|0|||
27912807|NCT00178256|54570644|FG003|Overall Study|Adverse Event|0|||
27912808|NCT00178256|54570641|FG000|Overall Study|Death|0|||
27912809|NCT00178256|54570642|FG001|Overall Study|Death|1|||
27912810|NCT00178256|54570643|FG002|Overall Study|Death|0|||
27912811|NCT00178256|54570644|FG003|Overall Study|Death|1|||
27997893|NCT00847613|54656831|FG002|Overall Study|Death|0|||
27997894|NCT00847613|54656832|FG003|Overall Study|Death|0|||
27997895|NCT00847613|54656829|FG000|Overall Study|Adverse Event|36|||
27997896|NCT00847613|54656830|FG001|Overall Study|Adverse Event|26|||
27997897|NCT00847613|54656831|FG002|Overall Study|Adverse Event|5|||
27997898|NCT00847613|54656832|FG003|Overall Study|Adverse Event|6|||
27997899|NCT00847613|54656829|FG000|Overall Study|Lack of Efficacy|7|||
27997900|NCT00847613|54656830|FG001|Overall Study|Lack of Efficacy|3|||
27997901|NCT00847613|54656831|FG002|Overall Study|Lack of Efficacy|3|||
27997902|NCT00847613|54656832|FG003|Overall Study|Lack of Efficacy|1|||
27997903|NCT00847613|54656829|FG000|Overall Study|Study terminated by Sponsor|1|||
27997904|NCT00847613|54656830|FG001|Overall Study|Study terminated by Sponsor|0|||
27997905|NCT00847613|54656831|FG002|Overall Study|Study terminated by Sponsor|2|||
27997906|NCT00847613|54656832|FG003|Overall Study|Study terminated by Sponsor|1|||
27997907|NCT00847613|54656829|FG000|Overall Study|Lost to Follow-up|5|||
27997908|NCT00847613|54656830|FG001|Overall Study|Lost to Follow-up|0|||
27997909|NCT00847613|54656831|FG002|Overall Study|Lost to Follow-up|0|||
27997910|NCT00847613|54656832|FG003|Overall Study|Lost to Follow-up|3|||
27997911|NCT00847613|54656829|FG000|Overall Study|Protocol Violation|6|||
27997912|NCT00847613|54656830|FG001|Overall Study|Protocol Violation|6|||
27997913|NCT00847613|54656831|FG002|Overall Study|Protocol Violation|3|||
27997914|NCT00847613|54656832|FG003|Overall Study|Protocol Violation|1|||
27997915|NCT00847613|54656829|FG000|Overall Study|Pregnancy|1|||
27997916|NCT00847613|54656830|FG001|Overall Study|Pregnancy|1|||
27997917|NCT00847613|54656831|FG002|Overall Study|Pregnancy|0|||
27997918|NCT00847613|54656832|FG003|Overall Study|Pregnancy|0|||
27997919|NCT00847613|54656829|FG000|Overall Study|Site closure|1|||
27997920|NCT00847613|54656830|FG001|Overall Study|Site closure|0|||
27997921|NCT00847613|54656831|FG002|Overall Study|Site closure|0|||
27997922|NCT00847613|54656832|FG003|Overall Study|Site closure|1|||
27997923|NCT00847613|54656829|FG000|Overall Study|Withdrawal by Subject|8|||
27912812|NCT00178256|54570641|FG000|Overall Study|Cancer progression|2|||
27997924|NCT00847613|54656830|FG001|Overall Study|Withdrawal by Subject|11|||
27997925|NCT00847613|54656831|FG002|Overall Study|Withdrawal by Subject|2|||
27997926|NCT00847613|54656832|FG003|Overall Study|Withdrawal by Subject|2|||
27997927|NCT00847613|54656829|FG000|Overall Study|Participant moved|4|||
27997928|NCT00847613|54656830|FG001|Overall Study|Participant moved|1|||
27997929|NCT00847613|54656831|FG002|Overall Study|Participant moved|0|||
27912813|NCT00178256|54570642|FG001|Overall Study|Cancer progression|0|||
27912814|NCT00178256|54570643|FG002|Overall Study|Cancer progression|0|||
27997930|NCT00847613|54656832|FG003|Overall Study|Participant moved|0|||
27997931|NCT00847613|54656829|FG000|Overall Study|Sponsor request|0|||
27997932|NCT00847613|54656830|FG001|Overall Study|Sponsor request|1|||
27997933|NCT00847613|54656831|FG002|Overall Study|Sponsor request|0|||
27997934|NCT00847613|54656832|FG003|Overall Study|Sponsor request|0|||
27997935|NCT00847613|54656829|FG000|Overall Study|Randomized, but not treated|0|||
27997936|NCT00847613|54656830|FG001|Overall Study|Randomized, but not treated|3|||
27997937|NCT00847613|54656831|FG002|Overall Study|Randomized, but not treated|0|||
27997938|NCT00847613|54656832|FG003|Overall Study|Randomized, but not treated|0|||
27997939|NCT00847613|54656829|FG000|Overall Study|Other|1|||
27997940|NCT00847613|54656830|FG001|Overall Study|Other|1|||
27997941|NCT00847613|54656831|FG002|Overall Study|Other|2|||
27997942|NCT00847613|54656832|FG003|Overall Study|Other|0|||
27997943|NCT00794196|54656851|FG000|Overall Study|Lost to Follow-up|5|||
27997944|NCT00794196|54656852|FG001|Overall Study|Lost to Follow-up|23|||
27912815|NCT00178256|54570644|FG003|Overall Study|Cancer progression|1|||
27912816|NCT00177164|54570653|FG000|Overall Study|Protocol Violation|0|||
27912817|NCT00177164|54570654|FG001|Overall Study|Protocol Violation|7|||
27912818|NCT00177164|54570653|FG000|Overall Study|Lost to Follow-up|4|||
27912819|NCT00177164|54570654|FG001|Overall Study|Lost to Follow-up|5|||
27912820|NCT00177164|54570653|FG000|Overall Study|increase in alcohol and drug use|1|||
27912821|NCT00177164|54570654|FG001|Overall Study|increase in alcohol and drug use|2|||
27997945|NCT00807092|54656860|FG000|Overall Study|Adverse Event|0|||
27997946|NCT00807092|54656861|FG001|Overall Study|Adverse Event|1|||
27997947|NCT00807092|54656860|FG000|Overall Study|Protocol Violation|0|||
27997948|NCT00807092|54656861|FG001|Overall Study|Protocol Violation|2|||
27739760|NCT02736409|54189444|FG001|Overall Study|Other|0|||
27997949|NCT00807092|54656860|FG000|Overall Study|Withdrawal by Subject|1|||
27997950|NCT00807092|54656861|FG001|Overall Study|Withdrawal by Subject|0|||
27997951|NCT00807092|54656860|FG000|Overall Study|CGMS data collection failed|0|||
27997952|NCT00807092|54656861|FG001|Overall Study|CGMS data collection failed|1|||
27997953|NCT00794118|54656867|FG000|Overall Study|Lost to Follow-up|16|||
27997954|NCT00794118|54656867|FG000|Overall Study|Withdrawal by Subject|9|||
27997955|NCT00794118|54656867|FG000|Overall Study|Changed hospital center|2|||
27997956|NCT00640042|54656871|FG000|Enrollment|Did not receive study drug|83|||
27997957|NCT00807014|54656877|FG000|Overall Study|Participant Considered Disease Cured|13|||
27997958|NCT00807014|54656878|FG001|Overall Study|Participant Considered Disease Cured|2|||
27997959|NCT00807014|54656877|FG000|Overall Study|Participant Considered Disease Not Cured|2|||
27997960|NCT00807014|54656878|FG001|Overall Study|Participant Considered Disease Not Cured|7|||
27997961|NCT00807014|54656877|FG000|Overall Study|Protocol Violation|2|||
27997962|NCT00807014|54656878|FG001|Overall Study|Protocol Violation|8|||
27997963|NCT00807014|54656877|FG000|Overall Study|Adverse Event|0|||
27997964|NCT00807014|54656878|FG001|Overall Study|Adverse Event|2|||
27997965|NCT00807014|54656877|FG000|Overall Study|Lost to Follow-up|9|||
27912822|NCT00177164|54570653|FG000|Overall Study|Adverse Event|1|||
27912823|NCT00177164|54570654|FG001|Overall Study|Adverse Event|0|||
27997966|NCT00807014|54656878|FG001|Overall Study|Lost to Follow-up|7|||
27997967|NCT00807014|54656877|FG000|Overall Study|Recovery|1|||
27997968|NCT00807014|54656878|FG001|Overall Study|Recovery|0|||
27997969|NCT00807014|54656877|FG000|Overall Study|Missed Visit 2 Due to Personal Reasons|0|||
27997970|NCT00807014|54656878|FG001|Overall Study|Missed Visit 2 Due to Personal Reasons|1|||
27997971|NCT00847535|54656884|FG000|Overall Study|Withdrawal by Subject|2|||
27912824|NCT00177164|54570653|FG000|Overall Study|discharge from hospital|1|||
27912825|NCT00177164|54570654|FG001|Overall Study|discharge from hospital|0|||
27912826|NCT00177164|54570653|FG000|Overall Study|Lack of Efficacy|2|||
27912827|NCT00177164|54570654|FG001|Overall Study|Lack of Efficacy|1|||
27912828|NCT00177164|54570653|FG000|Overall Study|Pregnancy|0|||
27912829|NCT00177164|54570654|FG001|Overall Study|Pregnancy|1|||
27912830|NCT02489942|54570677|FG000|Overall Study|Request by patient|602|||
27997972|NCT00847535|54656885|FG001|Overall Study|Withdrawal by Subject|1|||
27997973|NCT00847535|54656886|FG002|Overall Study|Withdrawal by Subject|1|||
27912831|NCT02489942|54570677|FG000|Overall Study|Improvement/remission|157|||
27912832|NCT02489942|54570677|FG000|Overall Study|No change/Progressive disease|263|||
27912833|NCT02489942|54570677|FG000|Overall Study|Adverse Event|522|||
27912834|NCT02489942|54570677|FG000|Overall Study|Other personal reasons|1218|||
27912835|NCT02489942|54570677|FG000|Overall Study|Lost to Follow-up|456|||
27912836|NCT02489942|54570677|FG000|Overall Study|Not continuously investigated|7|||
27912837|NCT02489942|54570677|FG000|Overall Study|Patient started jardiance treatment out of registration period|1|||
27912838|NCT02489942|54570677|FG000|Overall Study|Multiple registration|1|||
27912839|NCT02489942|54570677|FG000|Overall Study|No patient visit after entry|100|||
27912840|NCT02489942|54570677|FG000|Overall Study|No treatment with Jardiance|2|||
27912841|NCT02489942|54570677|FG000|Overall Study|Patient received Jardiance before registration|1|||
27912842|NCT02489942|54570677|FG000|Overall Study|No CRF collected|86|||
27997974|NCT00847535|54656884|FG000|Overall Study|Lost to Follow-up|0|||
27997975|NCT00847535|54656885|FG001|Overall Study|Lost to Follow-up|1|||
27997976|NCT00847535|54656886|FG002|Overall Study|Lost to Follow-up|0|||
27997977|NCT00592631|54656893|FG000|Overall Study|Lost to Follow-up|0|||
27997978|NCT00592631|54656894|FG001|Overall Study|Lost to Follow-up|2|||
27997979|NCT00791388|54656905|FG000|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
27997980|NCT00791388|54656906|FG001|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1|||
27997981|NCT00791388|54656907|FG002|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
27997982|NCT00791388|54656908|FG003|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
27997983|NCT00791388|54656909|FG004|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
27997984|NCT00791388|54656905|FG000|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1|||
27997985|NCT00791388|54656906|FG001|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
27997986|NCT00791388|54656907|FG002|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
27997987|NCT00791388|54656908|FG003|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
27997988|NCT00791388|54656909|FG004|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
27997989|NCT00791388|54656905|FG000|Period 4 - 400 mg Dose Group|Adverse Event|0|||
27997990|NCT00791388|54656906|FG001|Period 4 - 400 mg Dose Group|Adverse Event|0|||
27997991|NCT00791388|54656907|FG002|Period 4 - 400 mg Dose Group|Adverse Event|0|||
27997992|NCT00791388|54656908|FG003|Period 4 - 400 mg Dose Group|Adverse Event|0|||
27997993|NCT00791388|54656909|FG004|Period 4 - 400 mg Dose Group|Adverse Event|4|||
27997994|NCT00794040|54656923|FG000|Overall Study|Withdrawal by Subject|3|||
27912843|NCT00176462|54570683|FG000|Induction (4 Weeks)|Withdrawal by Subject|0|||
27912844|NCT00176462|54570684|FG001|Induction (4 Weeks)|Withdrawal by Subject|2|||
27912845|NCT00176462|54570683|FG000|Induction (4 Weeks)|Death|1|||
27912846|NCT00176462|54570684|FG001|Induction (4 Weeks)|Death|2|||
27912847|NCT00176462|54570683|FG000|Induction (4 Weeks)|Lack of Efficacy|0|||
27997995|NCT00794040|54656924|FG001|Overall Study|Withdrawal by Subject|4|||
27997996|NCT00794040|54656923|FG000|Overall Study|Physician Decision|0|||
27997997|NCT00794040|54656924|FG001|Overall Study|Physician Decision|1|||
27997998|NCT00813488|54656930|FG000|Titration Period 1|Adverse Event|6|||
27997999|NCT00813488|54656931|FG001|Titration Period 1|Adverse Event|1|||
27998000|NCT00813488|54656930|FG000|Titration Period 1|Lack of Efficacy|9|||
27998001|NCT00813488|54656931|FG001|Titration Period 1|Lack of Efficacy|7|||
27998002|NCT00813488|54656930|FG000|Titration Period 1|Withdrawal by Subject|2|||
27998003|NCT00813488|54656931|FG001|Titration Period 1|Withdrawal by Subject|2|||
27998004|NCT00813488|54656930|FG000|Titration Period 1|Protocol Violation|4|||
27998005|NCT00813488|54656931|FG001|Titration Period 1|Protocol Violation|3|||
27998006|NCT00813488|54656930|FG000|Titration Period 1|Non-compliance to study medication|4|||
27998007|NCT00813488|54656931|FG001|Titration Period 1|Non-compliance to study medication|1|||
27998008|NCT00813488|54656930|FG000|Titration Period 1|Non-compliance to study procedures|2|||
27998009|NCT00813488|54656931|FG001|Titration Period 1|Non-compliance to study procedures|2|||
27998010|NCT00813488|54656930|FG000|Titration Period 1|Technical Difficulties|0|||
27998011|NCT00813488|54656931|FG001|Titration Period 1|Technical Difficulties|1|||
27998012|NCT00813488|54656930|FG000|Titration Period 2|Adverse Event|2|||
27998013|NCT00813488|54656931|FG001|Titration Period 2|Adverse Event|3|||
27998014|NCT00813488|54656930|FG000|Titration Period 2|Lack of Efficacy|8|||
27998015|NCT00813488|54656931|FG001|Titration Period 2|Lack of Efficacy|4|||
27998016|NCT00813488|54656930|FG000|Titration Period 2|Protocol Violation|3|||
27998017|NCT00813488|54656931|FG001|Titration Period 2|Protocol Violation|2|||
27998018|NCT00813488|54656930|FG000|Titration Period 2|Lost to Follow-up|1|||
27998019|NCT00813488|54656931|FG001|Titration Period 2|Lost to Follow-up|0|||
27998020|NCT00813488|54656930|FG000|Titration Period 2|Non-compliance with study procedures|2|||
27998021|NCT00813488|54656931|FG001|Titration Period 2|Non-compliance with study procedures|1|||
27998022|NCT00813488|54656930|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
27998023|NCT00813488|54656931|FG001|Double-blind Treatment Period 1|Adverse Event|1|||
28099085|NCT03545984|54754941|FG001|Overall Study|CSF cases not present during rotation|9|||
28099086|NCT03033784|54754949|FG000|Overall Study|Anxiety related to MRI scanner|0|||
28099087|NCT03033784|54754950|FG001|Overall Study|Anxiety related to MRI scanner|1|||
28099088|NCT03033784|54754951|FG002|Overall Study|Anxiety related to MRI scanner|0|||
28099089|NCT03033784|54754952|FG003|Overall Study|Anxiety related to MRI scanner|0|||
28099090|NCT03033784|54754953|FG004|Overall Study|Anxiety related to MRI scanner|0|||
28099091|NCT03033784|54754954|FG005|Overall Study|Anxiety related to MRI scanner|0|||
28099092|NCT03033784|54754955|FG006|Overall Study|Anxiety related to MRI scanner|0|||
28099093|NCT03033784|54754956|FG007|Overall Study|Anxiety related to MRI scanner|0|||
28099094|NCT03033784|54754957|FG008|Overall Study|Anxiety related to MRI scanner|0|||
28099095|NCT03033784|54754958|FG009|Overall Study|Anxiety related to MRI scanner|0|||
28099096|NCT03033784|54754959|FG010|Overall Study|Anxiety related to MRI scanner|0|||
28099097|NCT03033784|54754960|FG011|Overall Study|Anxiety related to MRI scanner|0|||
28099098|NCT03033784|54754961|FG012|Overall Study|Anxiety related to MRI scanner|0|||
28099099|NCT03033784|54754949|FG000|Overall Study|Withdrawal by Subject|0|||
28099100|NCT03033784|54754950|FG001|Overall Study|Withdrawal by Subject|0|||
28099101|NCT03033784|54754951|FG002|Overall Study|Withdrawal by Subject|0|||
28099102|NCT03033784|54754952|FG003|Overall Study|Withdrawal by Subject|0|||
27739761|NCT02736409|54189445|FG002|Overall Study|Other|1|||
27912848|NCT00176462|54570684|FG001|Induction (4 Weeks)|Lack of Efficacy|1|||
27912849|NCT00176462|54570683|FG000|Consolidation (12 Weeks)|Patient moved to another state|0|||
27912850|NCT00176462|54570684|FG001|Consolidation (12 Weeks)|Patient moved to another state|1|||
27912851|NCT00176462|54570683|FG000|Consolidation (12 Weeks)|Adverse Event|0|||
27912852|NCT00176462|54570684|FG001|Consolidation (12 Weeks)|Adverse Event|1|||
27912853|NCT00176462|54570683|FG000|Consolidation (12 Weeks)|Lack of Efficacy|0|||
27912854|NCT00176462|54570684|FG001|Consolidation (12 Weeks)|Lack of Efficacy|2|||
27912855|NCT00176462|54570683|FG000|Consolidation (12 Weeks)|Not documented|0|||
27912856|NCT00176462|54570684|FG001|Consolidation (12 Weeks)|Not documented|1|||
27912857|NCT00176462|54570683|FG000|Intensive Continuation (8X8-week Cycles)|Death|1|||
27912858|NCT00176462|54570684|FG001|Intensive Continuation (8X8-week Cycles)|Death|0|||
27912859|NCT00176462|54570683|FG000|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0|||
27912860|NCT00176462|54570684|FG001|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3|||
27912861|NCT00175019|54570694|FG000|Overall Study|Adverse Event|54|||
27912862|NCT00175019|54570695|FG001|Overall Study|Adverse Event|22|||
27912863|NCT00175019|54570696|FG002|Overall Study|Adverse Event|2|||
27912864|NCT00175019|54570694|FG000|Overall Study|Protocol Violation|6|||
27912865|NCT00175019|54570695|FG001|Overall Study|Protocol Violation|3|||
27912866|NCT00175019|54570696|FG002|Overall Study|Protocol Violation|3|||
27912867|NCT00175019|54570694|FG000|Overall Study|Lost to Follow-up|42|||
27912868|NCT00175019|54570695|FG001|Overall Study|Lost to Follow-up|39|||
27912869|NCT00175019|54570696|FG002|Overall Study|Lost to Follow-up|9|||
27912870|NCT00175019|54570694|FG000|Overall Study|Did not continue under Amendment 4|1|||
27912871|NCT00175019|54570695|FG001|Overall Study|Did not continue under Amendment 4|1|||
27912872|NCT00175019|54570696|FG002|Overall Study|Did not continue under Amendment 4|2|||
27998024|NCT00813488|54656930|FG000|Double-blind Treatment Period 1|Withdrawal by Subject|0|||
27998025|NCT00813488|54656931|FG001|Double-blind Treatment Period 1|Withdrawal by Subject|1|||
27998026|NCT00813488|54656930|FG000|Double-blind Treatment Period 1|Protocol Violation|0|||
27998027|NCT00813488|54656931|FG001|Double-blind Treatment Period 1|Protocol Violation|2|||
28099103|NCT03033784|54754953|FG004|Overall Study|Withdrawal by Subject|0|||
27998028|NCT00813488|54656930|FG000|Double-blind Treatment Period 1|Lost to Follow-up|0|||
27998029|NCT00813488|54656931|FG001|Double-blind Treatment Period 1|Lost to Follow-up|1|||
27998030|NCT00813488|54656930|FG000|Double-blind Treatment Period 2|Adverse Event|1|||
27998031|NCT00813488|54656931|FG001|Double-blind Treatment Period 2|Adverse Event|0|||
27998032|NCT00813488|54656930|FG000|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
27998033|NCT00813488|54656931|FG001|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
27998034|NCT00813488|54656930|FG000|Double-blind Treatment Period 2|Protocol Violation|2|||
27998035|NCT00813488|54656931|FG001|Double-blind Treatment Period 2|Protocol Violation|0|||
27998036|NCT00813488|54656930|FG000|Double-blind Treatment Period 2|Other|1|||
27998037|NCT00813488|54656931|FG001|Double-blind Treatment Period 2|Other|0|||
27998038|NCT00813488|54656930|FG000|Open-label Extension|Adverse Event|1|||
27998039|NCT00813488|54656931|FG001|Open-label Extension|Adverse Event|2|||
27998040|NCT00813488|54656930|FG000|Open-label Extension|Lack of Efficacy|3|||
27998041|NCT00813488|54656931|FG001|Open-label Extension|Lack of Efficacy|0|||
27998042|NCT00813488|54656930|FG000|Open-label Extension|Withdrawal by Subject|0|||
27998043|NCT00813488|54656931|FG001|Open-label Extension|Withdrawal by Subject|2|||
27998044|NCT00813488|54656930|FG000|Open-label Extension|Protocol Violation|1|||
27998045|NCT00813488|54656931|FG001|Open-label Extension|Protocol Violation|2|||
27998046|NCT00813488|54656930|FG000|Open-label Extension|Non-compliance study medication|4|||
27998047|NCT00813488|54656931|FG001|Open-label Extension|Non-compliance study medication|0|||
27998048|NCT00813488|54656930|FG000|Open-label Extension|Non-compliance study procedures|2|||
27998049|NCT00813488|54656931|FG001|Open-label Extension|Non-compliance study procedures|1|||
27998050|NCT00813488|54656930|FG000|Open-label Extension|Other|1|||
27998051|NCT00813488|54656931|FG001|Open-label Extension|Other|0|||
27998052|NCT00797316|54656943|FG000|Overall Study|Administrative problems|1|||
27998053|NCT00797316|54656944|FG001|Overall Study|Administrative problems|0|||
27998054|NCT00797316|54656943|FG000|Overall Study|Adverse Event|5|||
27998055|NCT00797316|54656944|FG001|Overall Study|Adverse Event|3|||
27998056|NCT00797316|54656943|FG000|Overall Study|Lost to Follow-up|4|||
27998057|NCT00797316|54656944|FG001|Overall Study|Lost to Follow-up|8|||
27998058|NCT00797316|54656943|FG000|Overall Study|Protocol Deviation|1|||
27998059|NCT00797316|54656944|FG001|Overall Study|Protocol Deviation|2|||
27998060|NCT00797316|54656943|FG000|Overall Study|Patient withdrew consent|12|||
27998061|NCT00797316|54656944|FG001|Overall Study|Patient withdrew consent|6|||
27998062|NCT00797316|54656943|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
27998063|NCT00797316|54656944|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
27998064|NCT00587964|54656950|FG000|Overall Study|Withdrawal by Subject|1|||
27998065|NCT00587964|54656950|FG000|Overall Study|Lost to Follow-up|1|||
27998066|NCT00587964|54656950|FG000|Overall Study|Patient found to be ineligible|1|||
27998067|NCT00587964|54656950|FG000|Overall Study|Patient did not receive intervention|5|||
27998068|NCT00587964|54656950|FG000|Overall Study|Progression of Disease|4|||
27998069|NCT00590954|54656954|FG000|Overall Study|Inevaluable|2|||
27912873|NCT00175019|54570694|FG000|Overall Study|Personal Reason(s)|39|||
27912874|NCT00175019|54570695|FG001|Overall Study|Personal Reason(s)|31|||
27912875|NCT00175019|54570696|FG002|Overall Study|Personal Reason(s)|8|||
27912876|NCT00175019|54570694|FG000|Overall Study|Therapeutic Failure|10|||
27912877|NCT00175019|54570695|FG001|Overall Study|Therapeutic Failure|38|||
27912878|NCT00175019|54570696|FG002|Overall Study|Therapeutic Failure|22|||
27912879|NCT00175019|54570694|FG000|Overall Study|Gout Flare|2|||
27912880|NCT00175019|54570695|FG001|Overall Study|Gout Flare|3|||
27912881|NCT00175019|54570696|FG002|Overall Study|Gout Flare|0|||
27912882|NCT00175019|54570694|FG000|Overall Study|Reason Not Specified|40|||
27998070|NCT00791076|54656960|FG000|Overall Study|Study was terminated,PI left institution|8|||
27998071|NCT00590720|54656968|FG000|Overall Study|Lost to Follow-up|1|||
27998072|NCT00590720|54656969|FG001|Overall Study|Lost to Follow-up|0|||
27998073|NCT00590720|54656968|FG000|Overall Study|Withdrawal by Subject|0|||
27998074|NCT00590720|54656969|FG001|Overall Study|Withdrawal by Subject|1|||
27998075|NCT00625378|54656977|FG000|Overall Study|Adverse Event|22|||
27998076|NCT00625378|54656978|FG001|Overall Study|Adverse Event|0|||
27998077|NCT00625378|54656977|FG000|Overall Study|Withdrawal by Subject|16|||
28099104|NCT03033784|54754954|FG005|Overall Study|Withdrawal by Subject|0|||
28099105|NCT03033784|54754955|FG006|Overall Study|Withdrawal by Subject|0|||
27912883|NCT00175019|54570695|FG001|Overall Study|Reason Not Specified|34|||
27912884|NCT00175019|54570696|FG002|Overall Study|Reason Not Specified|11|||
27912885|NCT00174941|54570707|FG000|Overall Study|Adverse Event|1|||
27998078|NCT00625378|54656978|FG001|Overall Study|Withdrawal by Subject|0|||
27998079|NCT00625378|54656977|FG000|Overall Study|Death|38|||
27998080|NCT00625378|54656978|FG001|Overall Study|Death|0|||
28099106|NCT03033784|54754956|FG007|Overall Study|Withdrawal by Subject|0|||
27912886|NCT00174941|54570708|FG001|Overall Study|Adverse Event|10|||
27912887|NCT00174941|54570709|FG002|Overall Study|Adverse Event|2|||
27912888|NCT00174941|54570710|FG003|Overall Study|Adverse Event|13|||
27912889|NCT00174941|54570707|FG000|Overall Study|Protocol Violation|0|||
27912890|NCT00174941|54570708|FG001|Overall Study|Protocol Violation|1|||
27912891|NCT00174941|54570709|FG002|Overall Study|Protocol Violation|0|||
27912892|NCT00174941|54570710|FG003|Overall Study|Protocol Violation|1|||
27912893|NCT00174941|54570707|FG000|Overall Study|Lost to Follow-up|0|||
27912894|NCT00174941|54570708|FG001|Overall Study|Lost to Follow-up|3|||
27912895|NCT00174941|54570709|FG002|Overall Study|Lost to Follow-up|2|||
27912896|NCT00174941|54570710|FG003|Overall Study|Lost to Follow-up|5|||
27912897|NCT00174941|54570707|FG000|Overall Study|Personal Reason(s)|0|||
27912898|NCT00174941|54570708|FG001|Overall Study|Personal Reason(s)|14|||
27912899|NCT00174941|54570709|FG002|Overall Study|Personal Reason(s)|8|||
27912900|NCT00174941|54570710|FG003|Overall Study|Personal Reason(s)|22|||
27912901|NCT00174941|54570707|FG000|Overall Study|Gout Flare|0|||
27912902|NCT00174941|54570708|FG001|Overall Study|Gout Flare|4|||
27912903|NCT00174941|54570709|FG002|Overall Study|Gout Flare|4|||
27912904|NCT00174941|54570710|FG003|Overall Study|Gout Flare|8|||
27912905|NCT00174941|54570707|FG000|Overall Study|Reason Not Specified|1|||
27912906|NCT00174941|54570708|FG001|Overall Study|Reason Not Specified|6|||
27912907|NCT00174941|54570709|FG002|Overall Study|Reason Not Specified|2|||
27912908|NCT00174941|54570710|FG003|Overall Study|Reason Not Specified|9|||
27912909|NCT00171704|54570722|FG000|Overall Study|Adverse Event|24|||
27912910|NCT00171704|54570723|FG001|Overall Study|Adverse Event|33|||
27912911|NCT00171704|54570722|FG000|Overall Study|Disease Progression|14|||
27912912|NCT00171704|54570723|FG001|Overall Study|Disease Progression|9|||
27912913|NCT00171704|54570722|FG000|Overall Study|New therapy for 2nd non-breast prim canc|1|||
27912914|NCT00171704|54570723|FG001|Overall Study|New therapy for 2nd non-breast prim canc|0|||
27912915|NCT00171704|54570722|FG000|Overall Study|Administrative Problems|2|||
27912916|NCT00171704|54570723|FG001|Overall Study|Administrative Problems|1|||
27912917|NCT00171704|54570722|FG000|Overall Study|Death|2|||
27912918|NCT00171704|54570723|FG001|Overall Study|Death|2|||
27912919|NCT00171704|54570722|FG000|Overall Study|Withdrawal by Subject|1|||
27912920|NCT00171704|54570723|FG001|Overall Study|Withdrawal by Subject|3|||
27912921|NCT00171704|54570722|FG000|Overall Study|Protocol Violation|0|||
27912922|NCT00171704|54570723|FG001|Overall Study|Protocol Violation|1|||
27912923|NCT00171314|54570731|FG000|Overall Study|Adverse Event|44|||
27998081|NCT00625378|54656977|FG000|Overall Study|Disease progression, recurrence or relapse|88|||
27998082|NCT00625378|54656978|FG001|Overall Study|Disease progression, recurrence or relapse|0|||
27998083|NCT00625378|54656977|FG000|Overall Study|Lost to Follow-up|17|||
27998084|NCT00625378|54656978|FG001|Overall Study|Lost to Follow-up|0|||
27998085|NCT00625378|54656977|FG000|Overall Study|Non-compliant with study medication|3|||
27998086|NCT00625378|54656978|FG001|Overall Study|Non-compliant with study medication|0|||
27998087|NCT00625378|54656977|FG000|Overall Study|Investigator's judgement (no need to continue treatment)|1|||
27998088|NCT00625378|54656978|FG001|Overall Study|Investigator's judgement (no need to continue treatment)|0|||
27998089|NCT00625378|54656977|FG000|Overall Study|Medical decision|1|||
27998090|NCT00625378|54656978|FG001|Overall Study|Medical decision|0|||
27998091|NCT00625378|54656977|FG000|Overall Study|Multiple toxicities|1|||
27998092|NCT00625378|54656978|FG001|Overall Study|Multiple toxicities|0|||
27998093|NCT00625378|54656977|FG000|Overall Study|New cancer|1|||
28099107|NCT03033784|54754957|FG008|Overall Study|Withdrawal by Subject|0|||
28099108|NCT03033784|54754958|FG009|Overall Study|Withdrawal by Subject|0|||
28099109|NCT03033784|54754959|FG010|Overall Study|Withdrawal by Subject|0|||
28099110|NCT03033784|54754960|FG011|Overall Study|Withdrawal by Subject|0|||
28099111|NCT03033784|54754961|FG012|Overall Study|Withdrawal by Subject|2|||
28099112|NCT00038649|54754972|FG000|Overall Study|Adverse Event|9|||
28099113|NCT03544268|54754978|FG000|Overall Study|Did not meet full criteria for inclusion after enrollment|2|||
28099114|NCT03544268|54754979|FG001|Overall Study|Did not meet full criteria for inclusion after enrollment|0|||
28099115|NCT03652818|54754990|FG000|Overall Study|Adverse Event|1|||
28099116|NCT03652818|54754991|FG001|Overall Study|Adverse Event|0|||
28099117|NCT03652818|54754992|FG002|Overall Study|Adverse Event|0|||
28099118|NCT03652818|54754993|FG003|Overall Study|Adverse Event|0|||
28099119|NCT03652818|54754994|FG004|Overall Study|Adverse Event|0|||
28099120|NCT03652818|54754990|FG000|Overall Study|Physician Decision|1|||
28099121|NCT03652818|54754991|FG001|Overall Study|Physician Decision|0|||
28099122|NCT03652818|54754992|FG002|Overall Study|Physician Decision|0|||
28099123|NCT03652818|54754993|FG003|Overall Study|Physician Decision|0|||
27912924|NCT00171314|54570732|FG001|Overall Study|Adverse Event|41|||
27912925|NCT00171314|54570731|FG000|Overall Study|Lack of Efficacy|19|||
27912926|NCT00171314|54570732|FG001|Overall Study|Lack of Efficacy|14|||
27912927|NCT00171314|54570731|FG000|Overall Study|Withdrawal by Subject|9|||
27912928|NCT00171314|54570732|FG001|Overall Study|Withdrawal by Subject|6|||
27912929|NCT00171314|54570731|FG000|Overall Study|Abnormal Test Procedure Results|9|||
27912930|NCT00171314|54570732|FG001|Overall Study|Abnormal Test Procedure Results|3|||
27912931|NCT00171314|54570731|FG000|Overall Study|Protocol Violation|3|||
27998094|NCT00625378|54656978|FG001|Overall Study|New cancer|0|||
27998095|NCT00625378|54656977|FG000|Overall Study|PTA program|2|||
27912932|NCT00171314|54570732|FG001|Overall Study|Protocol Violation|7|||
27998096|NCT00625378|54656978|FG001|Overall Study|PTA program|0|||
28099124|NCT03652818|54754994|FG004|Overall Study|Physician Decision|0|||
28099125|NCT03652818|54754990|FG000|Overall Study|Lost to Follow-up|0|||
28099126|NCT03652818|54754991|FG001|Overall Study|Lost to Follow-up|1|||
28099127|NCT03652818|54754992|FG002|Overall Study|Lost to Follow-up|2|||
27912933|NCT00171314|54570731|FG000|Overall Study|Administrative Problems|4|||
27912934|NCT00171314|54570732|FG001|Overall Study|Administrative Problems|3|||
27912935|NCT00171314|54570731|FG000|Overall Study|Lost to Follow-up|1|||
27912936|NCT00171314|54570732|FG001|Overall Study|Lost to Follow-up|3|||
28099128|NCT03652818|54754993|FG003|Overall Study|Lost to Follow-up|1|||
28099129|NCT03652818|54754994|FG004|Overall Study|Lost to Follow-up|1|||
28099130|NCT03619902|54755006|FG000|Overall Study|Termination of Study by Investigator|1|||
28099131|NCT03619902|54755006|FG000|Overall Study|Use of Excluded/Prohibited Medication|1|||
28099132|NCT00620464|54755012|FG000|Overall Study|Adverse Event|15|||
28099133|NCT00620464|54755013|FG001|Overall Study|Adverse Event|17|||
28099134|NCT00620464|54755012|FG000|Overall Study|Lost to Follow-up|1|||
28099135|NCT00620464|54755013|FG001|Overall Study|Lost to Follow-up|1|||
28099136|NCT00620464|54755012|FG000|Overall Study|Planning Pregnancy|1|||
28099137|NCT00620464|54755013|FG001|Overall Study|Planning Pregnancy|4|||
28099138|NCT00620464|54755012|FG000|Overall Study|Personal|2|||
28099139|NCT00620464|54755013|FG001|Overall Study|Personal|2|||
28099140|NCT00620464|54755012|FG000|Overall Study|Used prohibited medication|1|||
28099141|NCT00620464|54755013|FG001|Overall Study|Used prohibited medication|0|||
28099142|NCT03652662|54755021|FG000|Overall Study|Withdrawal by Subject|2|||
28099143|NCT03652662|54755022|FG001|Overall Study|Withdrawal by Subject|1|||
28099144|NCT03652662|54755021|FG000|Overall Study|Lost to Follow-up|1|||
28099145|NCT03652662|54755022|FG001|Overall Study|Lost to Follow-up|0|||
28099146|NCT03560258|54755031|FG000|Overall Study|Lost to Follow-up|3|||
28099147|NCT03560258|54755032|FG001|Overall Study|Lost to Follow-up|0|||
28099148|NCT03560258|54755033|FG002|Overall Study|Lost to Follow-up|0|||
28099149|NCT03560258|54755031|FG000|Overall Study|Protocol Violation|0|||
28099150|NCT03560258|54755032|FG001|Overall Study|Protocol Violation|1|||
28099151|NCT03560258|54755033|FG002|Overall Study|Protocol Violation|0|||
28099152|NCT03560258|54755031|FG000|Overall Study|Withdrawal by Subject|0|||
28099153|NCT03560258|54755032|FG001|Overall Study|Withdrawal by Subject|0|||
28099154|NCT03560258|54755033|FG002|Overall Study|Withdrawal by Subject|1|||
28099155|NCT02768662|54755041|FG000|Overall Study|Adverse Event|1|||
28099156|NCT02768662|54755041|FG000|Overall Study|Lost to Follow-up|4|||
28099157|NCT02768662|54755041|FG000|Overall Study|Withdrawal by Subject|3|||
28099158|NCT02768662|54755041|FG000|Overall Study|Study terminated by Sponsor|78|||
28099159|NCT03539432|54755047|FG000|Overall Study|Lost to Follow-up|0|||
28099160|NCT03539432|54755048|FG001|Overall Study|Lost to Follow-up|1|||
28099161|NCT03615924|54755056|FG000|Overall Study|Withdrawal by Subject|2|||
28099162|NCT03615924|54755057|FG001|Overall Study|Withdrawal by Subject|5|||
28099163|NCT03615924|54755056|FG000|Overall Study|Death|3|||
28099164|NCT03615924|54755057|FG001|Overall Study|Death|1|||
27912937|NCT00171314|54570731|FG000|Overall Study|Death|2|||
27912938|NCT00171314|54570732|FG001|Overall Study|Death|1|||
27912939|NCT00171158|54570738|FG000|Core Study|Death|27|||
27912940|NCT00171158|54570738|FG000|Core Study|Unsatisfactory therapeutic effect|163|||
27912941|NCT00171158|54570738|FG000|Core Study|Protocol Violation|4|||
27912942|NCT00171158|54570738|FG000|Core Study|Administrative problems|1|||
27912943|NCT00171158|54570738|FG000|Core Study|Adverse event, non-fatal|21|||
27912944|NCT00171158|54570738|FG000|Core Study|Consent withdrawn by subject|6|||
27998097|NCT00625378|54656977|FG000|Overall Study|Recurrent rise in amylase and lipase|1|||
27998098|NCT00625378|54656978|FG001|Overall Study|Recurrent rise in amylase and lipase|0|||
27998099|NCT00625378|54656977|FG000|Overall Study|Sponsor decision|1|||
27998100|NCT00625378|54656978|FG001|Overall Study|Sponsor decision|0|||
27998101|NCT00625378|54656977|FG000|Overall Study|Sponsor's decision to stop the trial|1|||
27998102|NCT00625378|54656978|FG001|Overall Study|Sponsor's decision to stop the trial|0|||
27912945|NCT00171158|54570738|FG000|Core Study|No longer required drug (BMT)|14|||
27998103|NCT00625378|54656977|FG000|Overall Study|Switch to commercial drug|6|||
27998104|NCT00625378|54656978|FG001|Overall Study|Switch to commercial drug|1|||
27998105|NCT00625378|54656977|FG000|Overall Study|Missing|2|||
27998106|NCT00625378|54656978|FG001|Overall Study|Missing|0|||
28099165|NCT03615924|54755056|FG000|Overall Study|Lost to Follow-up|1|||
28099166|NCT03615924|54755057|FG001|Overall Study|Lost to Follow-up|0|||
28099167|NCT03615924|54755056|FG000|Overall Study|Randomized in error|1|||
28099168|NCT03615924|54755057|FG001|Overall Study|Randomized in error|0|||
28099169|NCT03615924|54755056|FG000|Overall Study|Study termination by Sponsor|94|||
28099170|NCT03615924|54755057|FG001|Overall Study|Study termination by Sponsor|86|||
28099171|NCT03535844|54755065|FG000|Overall Study|Withdrawal by Subject|0|||
28099172|NCT03535844|54755066|FG001|Overall Study|Withdrawal by Subject|1|||
27912946|NCT00171158|54570738|FG000|Core Study|Abnormal Laboratory Values|2|||
27912947|NCT00171158|54570738|FG000|Core Study|Lost to Follow-up|1|||
27912948|NCT00171158|54570738|FG000|E2 Extension|Other|7|||
27912949|NCT00170846|54570745|FG000|Overall Study|Subject withdrew Informed Consent|5|||
27912950|NCT00170846|54570746|FG001|Overall Study|Subject withdrew Informed Consent|12|||
28099173|NCT03533114|54755083|FG000|Overall|Adverse Event|16|||
28099174|NCT03533114|54755084|FG001|Overall|Adverse Event|11|||
28099175|NCT03533114|54755083|FG000|Overall|Consent Withdrawal by Participant|7|||
28099176|NCT03533114|54755084|FG001|Overall|Consent Withdrawal by Participant|6|||
28099177|NCT03533114|54755083|FG000|Overall|Lack of Efficacy|5|||
27998107|NCT00625378|54656977|FG000|Overall Study|End of treatment not available|2|||
27998108|NCT00625378|54656978|FG001|Overall Study|End of treatment not available|0|||
27998109|NCT00625378|54656977|FG000|Overall Study|Never treated|2|||
27998110|NCT00625378|54656978|FG001|Overall Study|Never treated|0|||
27998111|NCT00806624|54656987|FG000|Overall Study|Adverse Event|2|||
27998112|NCT00806624|54656988|FG001|Overall Study|Adverse Event|8|||
27998113|NCT00806624|54656989|FG002|Overall Study|Adverse Event|0|||
27998114|NCT00806624|54656987|FG000|Overall Study|Death|0|||
27998115|NCT00806624|54656988|FG001|Overall Study|Death|1|||
27998116|NCT00806624|54656989|FG002|Overall Study|Death|1|||
27998117|NCT00806624|54656987|FG000|Overall Study|Lost to Follow-up|1|||
27998118|NCT00806624|54656988|FG001|Overall Study|Lost to Follow-up|0|||
27998119|NCT00806624|54656989|FG002|Overall Study|Lost to Follow-up|1|||
27998120|NCT00806624|54656987|FG000|Overall Study|Withdrawal by Subject|6|||
27998121|NCT00806624|54656988|FG001|Overall Study|Withdrawal by Subject|3|||
27998122|NCT00806624|54656989|FG002|Overall Study|Withdrawal by Subject|3|||
27998123|NCT00806624|54656987|FG000|Overall Study|discontinued before start of treatment|0|||
27998124|NCT00806624|54656988|FG001|Overall Study|discontinued before start of treatment|0|||
27998125|NCT00806624|54656989|FG002|Overall Study|discontinued before start of treatment|1|||
27998126|NCT00806546|54656997|FG000|Overall Study|Enrolled, not treated|35|||
27998127|NCT00806546|54656997|FG000|Overall Study|Lost to Follow-up|32|||
27998128|NCT00806546|54656997|FG000|Overall Study|Adverse Event|74|||
27998129|NCT00806546|54656997|FG000|Overall Study|Withdrawal by Subject|75|||
27998130|NCT00806546|54656997|FG000|Overall Study|Protocol Violation|49|||
27998131|NCT00806546|54656997|FG000|Overall Study|Various|42|||
27998132|NCT00624832|54657005|FG000|Overall Study|Adverse Event|0|||
27998133|NCT00624832|54657006|FG001|Overall Study|Adverse Event|1|||
27998134|NCT00624832|54657007|FG002|Overall Study|Adverse Event|0|||
27998135|NCT00624832|54657008|FG003|Overall Study|Adverse Event|1|||
27998136|NCT00624832|54657005|FG000|Overall Study|Abnormal Laboratory Value|2|||
27998137|NCT00624832|54657006|FG001|Overall Study|Abnormal Laboratory Value|0|||
27998138|NCT00624832|54657007|FG002|Overall Study|Abnormal Laboratory Value|0|||
27998139|NCT00624832|54657008|FG003|Overall Study|Abnormal Laboratory Value|0|||
27912951|NCT00170846|54570747|FG002|Overall Study|Subject withdrew Informed Consent|8|||
27912952|NCT00170846|54570745|FG000|Overall Study|Lost to Follow-up|6|||
27912953|NCT00170846|54570746|FG001|Overall Study|Lost to Follow-up|3|||
27912954|NCT00170846|54570747|FG002|Overall Study|Lost to Follow-up|2|||
27998140|NCT00633880|54657020|FG000|Open Label Titration|Lack of Efficacy|1|||
27998141|NCT00633880|54657021|FG001|Open Label Titration|Lack of Efficacy|0|||
27912955|NCT00170846|54570745|FG000|Overall Study|Death|0|||
27912956|NCT00170846|54570746|FG001|Overall Study|Death|3|||
27912957|NCT00170846|54570747|FG002|Overall Study|Death|3|||
27912958|NCT00170846|54570745|FG000|Overall Study|Reason Missing|0|||
27912959|NCT00170846|54570746|FG001|Overall Study|Reason Missing|1|||
27912960|NCT00170846|54570747|FG002|Overall Study|Reason Missing|0|||
27912961|NCT00479882|54570759|FG000|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96|||
27912962|NCT00479882|54570760|FG001|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99|||
27912963|NCT00479882|54570761|FG002|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98|||
27998142|NCT00633880|54657022|FG002|Open Label Titration|Lack of Efficacy|0|||
27998143|NCT00633880|54657020|FG000|Open Label Titration|Adverse Event|13|||
27912964|NCT00479882|54570762|FG003|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87|||
27912965|NCT00479882|54570759|FG000|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0|||
27912966|NCT00479882|54570760|FG001|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
27998144|NCT00633880|54657021|FG001|Open Label Titration|Adverse Event|0|||
27998145|NCT00633880|54657022|FG002|Open Label Titration|Adverse Event|0|||
27998146|NCT00633880|54657020|FG000|Open Label Titration|Treatment Failure|55|||
27998147|NCT00633880|54657021|FG001|Open Label Titration|Treatment Failure|0|||
27998148|NCT00633880|54657022|FG002|Open Label Titration|Treatment Failure|0|||
27998149|NCT00633880|54657020|FG000|Open Label Titration|Protocol Violation|6|||
27998150|NCT00633880|54657021|FG001|Open Label Titration|Protocol Violation|0|||
27998151|NCT00633880|54657022|FG002|Open Label Titration|Protocol Violation|0|||
27998152|NCT00633880|54657020|FG000|Open Label Titration|Physician Decision|1|||
27998153|NCT00633880|54657021|FG001|Open Label Titration|Physician Decision|0|||
27998154|NCT00633880|54657022|FG002|Open Label Titration|Physician Decision|0|||
27998155|NCT00633880|54657020|FG000|Open Label Titration|Withdrawal by Subject|4|||
27912967|NCT00479882|54570761|FG002|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
27998156|NCT00633880|54657021|FG001|Open Label Titration|Withdrawal by Subject|0|||
27998157|NCT00633880|54657022|FG002|Open Label Titration|Withdrawal by Subject|0|||
27912968|NCT00479882|54570762|FG003|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
27912969|NCT00479882|54570759|FG000|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12|||
27998158|NCT00590564|54657029|FG000|Overall Study|Withdrawal by Subject|4|||
27998159|NCT00590564|54657029|FG000|Overall Study|Lost to Follow-up|6|||
27998160|NCT00590564|54657029|FG000|Overall Study|Protocol Violation|1|||
27998161|NCT00590564|54657029|FG000|Overall Study|Patient Found to be Ineligible|1|||
27998162|NCT00590564|54657029|FG000|Overall Study|Patient Non-compliance|6|||
27912970|NCT00479882|54570760|FG001|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
27912971|NCT00479882|54570761|FG002|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
27912972|NCT00479882|54570762|FG003|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11|||
27912973|NCT00479882|54570759|FG000|Precrossover: Periods I/II (Weeks 1-12)|Other|4|||
27912974|NCT00479882|54570760|FG001|Precrossover: Periods I/II (Weeks 1-12)|Other|6|||
27912975|NCT00479882|54570761|FG002|Precrossover: Periods I/II (Weeks 1-12)|Other|9|||
27912976|NCT00479882|54570762|FG003|Precrossover: Periods I/II (Weeks 1-12)|Other|5|||
27912977|NCT00479882|54570759|FG000|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0|||
27912978|NCT00479882|54570760|FG001|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4|||
27912979|NCT00479882|54570761|FG002|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2|||
27912980|NCT00479882|54570762|FG003|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1|||
27912981|NCT00479882|54570759|FG000|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24|||
27998163|NCT00631696|54657035|FG000|Overall Study|Entered, not randomized to treatment|1|||
27998164|NCT00631696|54657036|FG001|Overall Study|Entered, not randomized to treatment|1|||
27998165|NCT00631696|54657035|FG000|Overall Study|Discontinued after database release date|1|||
27998166|NCT00631696|54657036|FG001|Overall Study|Discontinued after database release date|0|||
27998167|NCT00631696|54657035|FG000|Overall Study|Follow up after database release date|1|||
27998168|NCT00631696|54657036|FG001|Overall Study|Follow up after database release date|0|||
27998169|NCT00631696|54657035|FG000|Overall Study|Lost to Follow-up|7|||
27998170|NCT00631696|54657036|FG001|Overall Study|Lost to Follow-up|10|||
27998171|NCT00631696|54657035|FG000|Overall Study|Withdrawal by Subject|2|||
27998172|NCT00631696|54657036|FG001|Overall Study|Withdrawal by Subject|9|||
27998173|NCT00631696|54657035|FG000|Overall Study|Other|8|||
27998174|NCT00631696|54657036|FG001|Overall Study|Other|8|||
27998175|NCT00631696|54657035|FG000|Overall Study|Protocol Violation|9|||
27998176|NCT00631696|54657036|FG001|Overall Study|Protocol Violation|9|||
27912982|NCT00479882|54570760|FG001|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33|||
27998177|NCT00631696|54657035|FG000|Overall Study|Study terminated by sponsor|3|||
27912983|NCT00479882|54570761|FG002|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30|||
27912984|NCT00479882|54570762|FG003|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25|||
27998178|NCT00631696|54657036|FG001|Overall Study|Study terminated by sponsor|3|||
27998179|NCT00631696|54657035|FG000|Overall Study|Adverse Event|5|||
27998180|NCT00631696|54657036|FG001|Overall Study|Adverse Event|0|||
27998181|NCT00631540|54657042|FG000|Overall Study|Withdrawal by Subject|5|||
27998182|NCT00631540|54657042|FG000|Overall Study|Death|4|||
27998183|NCT00631540|54657042|FG000|Overall Study|Lost to Follow-up|2|||
27998184|NCT00631540|54657042|FG000|Overall Study|Core Lab Data Unavailable|3|||
27998185|NCT00630916|54657046|FG000|Overall Study|Death|110|||
27998186|NCT00630916|54657046|FG000|Overall Study|Explant|8|||
27998187|NCT00630916|54657046|FG000|Overall Study|Lost to Follow-up|5|||
27998188|NCT00630916|54657046|FG000|Overall Study|Withdrawal by Subject|30|||
27998189|NCT00630916|54657046|FG000|Overall Study|Protocol Violation|7|||
27998190|NCT00630916|54657046|FG000|Overall Study|Physician Decision|47|||
27998191|NCT00630916|54657046|FG000|Overall Study|Lack of Efficacy|3|||
27998192|NCT00630292|54657050|FG000|Overall Study|Withdrawal by Subject|1|||
27998193|NCT00626548|54657056|FG000|Overall Study|Adverse Event|164|||
27998194|NCT00626548|54657057|FG001|Overall Study|Adverse Event|44|||
27998195|NCT00626548|54657056|FG000|Overall Study|Withdrawal by Subject|42|||
27998196|NCT00626548|54657057|FG001|Overall Study|Withdrawal by Subject|46|||
27998197|NCT00626548|54657056|FG000|Overall Study|Protocol Violation|4|||
27998198|NCT00626548|54657057|FG001|Overall Study|Protocol Violation|11|||
27998199|NCT00626548|54657056|FG000|Overall Study|Lost to Follow-up|2|||
27998200|NCT00626548|54657057|FG001|Overall Study|Lost to Follow-up|2|||
27998201|NCT00626548|54657056|FG000|Overall Study|Other termination reason|493|||
27998202|NCT00626548|54657057|FG001|Overall Study|Other termination reason|613|||
27998203|NCT00847379|54657066|FG000|Overall Study|Study terminated by Sponsor|59|||
27998204|NCT00847379|54657067|FG001|Overall Study|Study terminated by Sponsor|57|||
27998205|NCT00847379|54657068|FG002|Overall Study|Study terminated by Sponsor|57|||
27998206|NCT00847301|54657078|FG000|Overall Study|Adverse Event|35|||
27998207|NCT00847301|54657078|FG000|Overall Study|Switch to other anticoagulants|16|||
27998208|NCT00847301|54657078|FG000|Overall Study|Lost to Follow-up|1|||
27998209|NCT00847301|54657078|FG000|Overall Study|No prescription after hospital discharge|1|||
27998210|NCT00847301|54657078|FG000|Overall Study|Other reason not defined above|1|||
27998211|NCT00624520|54657084|FG000|Overall Study|Withdrawal by Subject|12|||
27998212|NCT00624520|54657085|FG001|Overall Study|Withdrawal by Subject|7|||
27998213|NCT00624520|54657084|FG000|Overall Study|Death|0|||
27998214|NCT00624520|54657085|FG001|Overall Study|Death|1|||
27998215|NCT00847145|54657099|FG000|Overall Study|AE or Death|0|||
27998216|NCT00847145|54657100|FG001|Overall Study|AE or Death|1|||
27998217|NCT00847145|54657101|FG002|Overall Study|AE or Death|1|||
27998218|NCT00847145|54657102|FG003|Overall Study|AE or Death|0|||
27998219|NCT00847145|54657103|FG004|Overall Study|AE or Death|0|||
27998220|NCT00847145|54657104|FG005|Overall Study|AE or Death|0|||
27998221|NCT00847145|54657105|FG006|Overall Study|AE or Death|0|||
27998222|NCT00847145|54657106|FG007|Overall Study|AE or Death|0|||
27998223|NCT00847145|54657099|FG000|Overall Study|Withdrawal by Subject|3|||
28099178|NCT03533114|54755084|FG001|Overall|Lack of Efficacy|3|||
28099179|NCT03533114|54755083|FG000|Overall|Lost to Follow-up|1|||
28099180|NCT03533114|54755084|FG001|Overall|Lost to Follow-up|1|||
28099181|NCT03533114|54755083|FG000|Overall|Physician Decision|0|||
28099182|NCT03533114|54755084|FG001|Overall|Physician Decision|2|||
28099183|NCT03533114|54755083|FG000|Overall|Protocol deviation|1|||
28099184|NCT03533114|54755084|FG001|Overall|Protocol deviation|1|||
28099185|NCT03533114|54755083|FG000|Overall|Failure to meet randomization criteria|1|||
28099186|NCT03533114|54755084|FG001|Overall|Failure to meet randomization criteria|2|||
28099187|NCT03533114|54755083|FG000|Overall|Non-Compliance with study drug|0|||
28099188|NCT03533114|54755084|FG001|Overall|Non-Compliance with study drug|1|||
28099189|NCT03533114|54755083|FG000|Overall|Other|0|||
28099190|NCT03533114|54755084|FG001|Overall|Other|1|||
28099191|NCT03533114|54755083|FG000|Open Label Titration and Optimization|Adverse Event|11|||
28099192|NCT03533114|54755084|FG001|Open Label Titration and Optimization|Adverse Event|8|||
28099193|NCT03533114|54755083|FG000|Open Label Titration and Optimization|Consent Withdrawal by Participant|2|||
28099194|NCT03533114|54755084|FG001|Open Label Titration and Optimization|Consent Withdrawal by Participant|1|||
28099195|NCT03533114|54755083|FG000|Open Label Titration and Optimization|Lack of Efficacy|3|||
28099196|NCT03533114|54755084|FG001|Open Label Titration and Optimization|Lack of Efficacy|1|||
28099197|NCT03533114|54755083|FG000|Open Label Titration and Optimization|Lost to Follow-up|0|||
28099198|NCT03533114|54755084|FG001|Open Label Titration and Optimization|Lost to Follow-up|1|||
28099199|NCT03533114|54755083|FG000|Open Label Titration and Optimization|Protocol Deviation|0|||
28099200|NCT03533114|54755084|FG001|Open Label Titration and Optimization|Protocol Deviation|1|||
28099201|NCT03533114|54755083|FG000|Open Label Titration and Optimization|Non-Compliance with Study Drug|0|||
28099202|NCT03533114|54755084|FG001|Open Label Titration and Optimization|Non-Compliance with Study Drug|1|||
28099203|NCT03533114|54755083|FG000|Stable Dose|Adverse Event|0|||
28099204|NCT03533114|54755084|FG001|Stable Dose|Adverse Event|2|||
28099205|NCT03533114|54755083|FG000|Stable Dose|Consent Withdrawal by Participant|1|||
28099206|NCT03533114|54755084|FG001|Stable Dose|Consent Withdrawal by Participant|0|||
28099207|NCT03533114|54755083|FG000|Stable Dose|Lack of Efficacy|1|||
28099208|NCT03533114|54755084|FG001|Stable Dose|Lack of Efficacy|0|||
28099209|NCT03533114|54755083|FG000|Double Blind Randomized-Withdrawal|Adverse Event|1|||
28099210|NCT03533114|54755084|FG001|Double Blind Randomized-Withdrawal|Adverse Event|1|||
28099211|NCT03533114|54755083|FG000|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|1|||
28099212|NCT03533114|54755084|FG001|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|0|||
28099213|NCT03533114|54755083|FG000|Open-Label Safety Extension|Adverse Event|3|||
28099214|NCT03533114|54755084|FG001|Open-Label Safety Extension|Adverse Event|0|||
28099215|NCT03533114|54755083|FG000|Open-Label Safety Extension|Consent Withdrawal by Participant|2|||
28099216|NCT03533114|54755084|FG001|Open-Label Safety Extension|Consent Withdrawal by Participant|3|||
28099217|NCT03533114|54755083|FG000|Open-Label Safety Extension|Lack of Efficacy|1|||
28099218|NCT03533114|54755084|FG001|Open-Label Safety Extension|Lack of Efficacy|0|||
28099219|NCT03533114|54755083|FG000|Open-Label Safety Extension|Lost to Follow-up|1|||
28099220|NCT03533114|54755084|FG001|Open-Label Safety Extension|Lost to Follow-up|0|||
28099221|NCT03533114|54755083|FG000|Open-Label Safety Extension|Protocol Deviation|1|||
28099222|NCT03533114|54755084|FG001|Open-Label Safety Extension|Protocol Deviation|0|||
28099223|NCT03033394|54755092|FG000|Completed Pharmacokinetic Analysis|Missing data|1|||
28099224|NCT03033394|54755092|FG000|Completed Pharmacokinetic Analysis|Oral dosing not incorporated into pharmacokinetic model|3|||
28099225|NCT03033394|54755092|FG000|Completed Pharmacokinetic Analysis|Level taken at incorrect time|1|||
28099226|NCT03033394|54755092|FG000|Completed Pharmacokinetic Analysis|Pharmacokinetic soffware unable to generate predicted values|1|||
28099227|NCT03033394|54755092|FG000|Completed Final Analysis|1 participant excluded from final analysis as an outlier (>1.5 x interquartile range)|1|||
28099228|NCT03981822|54755109|FG000|Overall Study|Lost to Follow-up|0|||
28099229|NCT03981822|54755110|FG001|Overall Study|Lost to Follow-up|1|||
27912985|NCT00479882|54570759|FG000|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2|||
27912986|NCT00479882|54570760|FG001|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
27912987|NCT00479882|54570761|FG002|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5|||
27912988|NCT00479882|54570762|FG003|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
27912989|NCT00479882|54570759|FG000|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
27912990|NCT00479882|54570760|FG001|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13|||
27912991|NCT00479882|54570761|FG002|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
27912992|NCT00479882|54570762|FG003|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10|||
27912993|NCT00479882|54570759|FG000|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3|||
27912994|NCT00479882|54570760|FG001|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1|||
27912995|NCT00479882|54570761|FG002|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
27912996|NCT00479882|54570762|FG003|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
28099230|NCT03981822|54755111|FG002|Overall Study|Lost to Follow-up|1|||
28099231|NCT03981822|54755112|FG003|Overall Study|Lost to Follow-up|0|||
28099232|NCT03981822|54755113|FG004|Overall Study|Lost to Follow-up|6|||
27998224|NCT00847145|54657100|FG001|Overall Study|Withdrawal by Subject|4|||
27998225|NCT00847145|54657101|FG002|Overall Study|Withdrawal by Subject|6|||
27998226|NCT00847145|54657102|FG003|Overall Study|Withdrawal by Subject|1|||
27998227|NCT00847145|54657103|FG004|Overall Study|Withdrawal by Subject|0|||
27998228|NCT00847145|54657104|FG005|Overall Study|Withdrawal by Subject|0|||
27998229|NCT00847145|54657105|FG006|Overall Study|Withdrawal by Subject|1|||
27998230|NCT00847145|54657106|FG007|Overall Study|Withdrawal by Subject|1|||
27998231|NCT00847145|54657099|FG000|Overall Study|Lost to Follow-up|3|||
28099233|NCT03981822|54755114|FG005|Overall Study|Lost to Follow-up|4|||
28099234|NCT03981822|54755115|FG006|Overall Study|Lost to Follow-up|4|||
28099235|NCT03981822|54755116|FG007|Overall Study|Lost to Follow-up|2|||
28099236|NCT03981822|54755109|FG000|Overall Study|Withdrawal by Subject|0|||
28099237|NCT03981822|54755110|FG001|Overall Study|Withdrawal by Subject|1|||
28099238|NCT03981822|54755111|FG002|Overall Study|Withdrawal by Subject|0|||
28099239|NCT03981822|54755112|FG003|Overall Study|Withdrawal by Subject|0|||
28099240|NCT03981822|54755113|FG004|Overall Study|Withdrawal by Subject|0|||
28099241|NCT03981822|54755114|FG005|Overall Study|Withdrawal by Subject|1|||
28099242|NCT03981822|54755115|FG006|Overall Study|Withdrawal by Subject|0|||
28099243|NCT03981822|54755116|FG007|Overall Study|Withdrawal by Subject|2|||
28099244|NCT03981822|54755109|FG000|Overall Study|COVID-19 Related|0|||
28172649|NCT02456740|54844364|FG004|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4|||
28172650|NCT02456740|54844365|FG005|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
28172651|NCT02456740|54844366|FG006|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
28172652|NCT02456740|54844367|FG007|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
28172653|NCT02456740|54844368|FG008|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5|||
28172654|NCT02456740|54844360|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
28172655|NCT02456740|54844361|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
28172656|NCT02456740|54844362|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
28172657|NCT02456740|54844363|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10|||
28172658|NCT02456740|54844364|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11|||
28172659|NCT02456740|54844365|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
28172660|NCT02456740|54844366|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
28172661|NCT02456740|54844367|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
28172662|NCT02456740|54844368|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
28172663|NCT02456740|54844360|FG000|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
28172664|NCT02456740|54844361|FG001|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
28172665|NCT02456740|54844362|FG002|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
28172666|NCT02456740|54844363|FG003|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
28172667|NCT02456740|54844364|FG004|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
28172668|NCT02456740|54844365|FG005|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
28172669|NCT02456740|54844366|FG006|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
28172670|NCT02456740|54844367|FG007|Active Treatment Phase (Weeks 24 - 52)|Death|1|||
28172671|NCT02456740|54844368|FG008|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
28172672|NCT02456740|54844360|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
28172673|NCT02456740|54844361|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
28172674|NCT02456740|54844362|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
28172675|NCT02456740|54844363|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
28172676|NCT02456740|54844364|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2|||
28172677|NCT02456740|54844365|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
28172678|NCT02456740|54844366|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
28172679|NCT02456740|54844367|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
28172680|NCT02456740|54844368|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
28172681|NCT02400580|54844380|FG000|Overall Study|Withdrawal by Subject|1|||
28172682|NCT02400580|54844381|FG001|Overall Study|Withdrawal by Subject|1|||
28172683|NCT02400580|54844380|FG000|Overall Study|Adverse Event|1|||
28172684|NCT02400580|54844381|FG001|Overall Study|Adverse Event|0|||
28172685|NCT01367119|54844389|FG000|Overall Study|Adverse Event|1|||
28172686|NCT01367119|54844390|FG001|Overall Study|Adverse Event|0|||
28172687|NCT01367119|54844389|FG000|Overall Study|Withdrawal by Subject|1|||
27739762|NCT02736409|54189446|FG003|Overall Study|Other|1|||
27739763|NCT02736409|54189443|FG000|Overall Study|Pregnancy|0|||
28172688|NCT01367119|54844390|FG001|Overall Study|Withdrawal by Subject|1|||
28172689|NCT02635724|54844399|FG000|Overall Study|Withdrawal by Subject|0|||
28172690|NCT02635724|54844400|FG001|Overall Study|Withdrawal by Subject|1|||
28172691|NCT02635724|54844401|FG002|Overall Study|Withdrawal by Subject|0|||
28172692|NCT02635646|54844411|FG000|Overall Study|Lost to Follow-up|24|||
28099245|NCT03981822|54755110|FG001|Overall Study|COVID-19 Related|0|||
27739764|NCT02736409|54189444|FG001|Overall Study|Pregnancy|0|||
28099246|NCT03981822|54755111|FG002|Overall Study|COVID-19 Related|0|||
28099247|NCT03981822|54755112|FG003|Overall Study|COVID-19 Related|0|||
28099248|NCT03981822|54755113|FG004|Overall Study|COVID-19 Related|2|||
27998232|NCT00847145|54657100|FG001|Overall Study|Lost to Follow-up|1|||
27998233|NCT00847145|54657101|FG002|Overall Study|Lost to Follow-up|1|||
27998234|NCT00847145|54657102|FG003|Overall Study|Lost to Follow-up|0|||
27998235|NCT00847145|54657103|FG004|Overall Study|Lost to Follow-up|4|||
27998236|NCT00847145|54657104|FG005|Overall Study|Lost to Follow-up|4|||
27998237|NCT00847145|54657105|FG006|Overall Study|Lost to Follow-up|8|||
27998238|NCT00847145|54657106|FG007|Overall Study|Lost to Follow-up|2|||
27998239|NCT00847145|54657099|FG000|Overall Study|Inappropriate enrollment|0|||
27998240|NCT00847145|54657100|FG001|Overall Study|Inappropriate enrollment|0|||
27998241|NCT00847145|54657101|FG002|Overall Study|Inappropriate enrollment|0|||
27998242|NCT00847145|54657102|FG003|Overall Study|Inappropriate enrollment|0|||
27998243|NCT00847145|54657103|FG004|Overall Study|Inappropriate enrollment|1|||
27998244|NCT00847145|54657104|FG005|Overall Study|Inappropriate enrollment|0|||
27998245|NCT00847145|54657105|FG006|Overall Study|Inappropriate enrollment|0|||
27998246|NCT00847145|54657106|FG007|Overall Study|Inappropriate enrollment|0|||
27998247|NCT00847145|54657099|FG000|Overall Study|Protocol Violation|0|||
27998248|NCT00847145|54657100|FG001|Overall Study|Protocol Violation|0|||
27998249|NCT00847145|54657101|FG002|Overall Study|Protocol Violation|3|||
27998250|NCT00847145|54657102|FG003|Overall Study|Protocol Violation|0|||
27998251|NCT00847145|54657103|FG004|Overall Study|Protocol Violation|1|||
27998252|NCT00847145|54657104|FG005|Overall Study|Protocol Violation|0|||
27998253|NCT00847145|54657105|FG006|Overall Study|Protocol Violation|0|||
27998254|NCT00847145|54657106|FG007|Overall Study|Protocol Violation|1|||
27998255|NCT00846521|54657133|FG000|Overall Study|Withdrawal by Subject|5|||
27998256|NCT00846521|54657133|FG000|Overall Study|Did not meet OGTT/ CGMS criteria|5|||
27998257|NCT00846521|54657133|FG000|Overall Study|Protocol Violation|1|||
27998258|NCT00862823|54657137|FG000|First Intervention|Withdrawal by Subject|1|||
27998259|NCT00862823|54657138|FG001|First Intervention|Withdrawal by Subject|1|||
27998260|NCT00790842|54657146|FG000|Dose Level 1|Adverse Event|1|||
27998261|NCT00790842|54657147|FG001|Dose Level 1|Adverse Event|0|||
27998262|NCT00790842|54657148|FG002|Dose Level 1|Adverse Event|0|||
27998263|NCT00790842|54657149|FG003|Dose Level 1|Adverse Event|2|||
27998264|NCT00790842|54657150|FG004|Dose Level 1|Adverse Event|0|||
27998265|NCT00790842|54657151|FG005|Dose Level 1|Adverse Event|0|||
27998266|NCT00790842|54657152|FG006|Dose Level 1|Adverse Event|0|||
27998267|NCT00790842|54657153|FG007|Dose Level 1|Adverse Event|1|||
27998268|NCT00790842|54657154|FG008|Dose Level 1|Adverse Event|0|||
27998269|NCT00790842|54657155|FG009|Dose Level 1|Adverse Event|0|||
27998270|NCT00790842|54657156|FG010|Dose Level 1|Adverse Event|0|||
27998271|NCT00790842|54657146|FG000|Dose Level 1|Physician Decision|1|||
27998272|NCT00790842|54657147|FG001|Dose Level 1|Physician Decision|0|||
27998273|NCT00790842|54657148|FG002|Dose Level 1|Physician Decision|0|||
27998274|NCT00790842|54657149|FG003|Dose Level 1|Physician Decision|0|||
27998275|NCT00790842|54657150|FG004|Dose Level 1|Physician Decision|0|||
27998276|NCT00790842|54657151|FG005|Dose Level 1|Physician Decision|0|||
27998277|NCT00790842|54657152|FG006|Dose Level 1|Physician Decision|0|||
27998278|NCT00790842|54657153|FG007|Dose Level 1|Physician Decision|1|||
27998279|NCT00790842|54657154|FG008|Dose Level 1|Physician Decision|0|||
27998280|NCT00790842|54657155|FG009|Dose Level 1|Physician Decision|0|||
27998281|NCT00790842|54657156|FG010|Dose Level 1|Physician Decision|0|||
27998282|NCT00790842|54657146|FG000|Dose Level 1|Withdrawal by Subject|1|||
27998283|NCT00790842|54657147|FG001|Dose Level 1|Withdrawal by Subject|0|||
27998284|NCT00790842|54657148|FG002|Dose Level 1|Withdrawal by Subject|0|||
27998285|NCT00790842|54657149|FG003|Dose Level 1|Withdrawal by Subject|0|||
27998286|NCT00790842|54657150|FG004|Dose Level 1|Withdrawal by Subject|0|||
27998287|NCT00790842|54657151|FG005|Dose Level 1|Withdrawal by Subject|0|||
27998288|NCT00790842|54657152|FG006|Dose Level 1|Withdrawal by Subject|0|||
27998289|NCT00790842|54657153|FG007|Dose Level 1|Withdrawal by Subject|0|||
27998290|NCT00790842|54657154|FG008|Dose Level 1|Withdrawal by Subject|0|||
27998291|NCT00790842|54657155|FG009|Dose Level 1|Withdrawal by Subject|0|||
27998292|NCT00790842|54657156|FG010|Dose Level 1|Withdrawal by Subject|0|||
27998293|NCT00790842|54657146|FG000|Dose Level 2|Death|0|||
27998294|NCT00790842|54657147|FG001|Dose Level 2|Death|1|||
27998295|NCT00790842|54657148|FG002|Dose Level 2|Death|0|||
27998296|NCT00790842|54657149|FG003|Dose Level 2|Death|0|||
27998297|NCT00790842|54657150|FG004|Dose Level 2|Death|1|||
27998298|NCT00790842|54657151|FG005|Dose Level 2|Death|0|||
27998299|NCT00790842|54657152|FG006|Dose Level 2|Death|0|||
27998300|NCT00790842|54657153|FG007|Dose Level 2|Death|0|||
27998301|NCT00790842|54657154|FG008|Dose Level 2|Death|0|||
27998302|NCT00790842|54657155|FG009|Dose Level 2|Death|0|||
27998303|NCT00790842|54657156|FG010|Dose Level 2|Death|0|||
27998304|NCT00790842|54657146|FG000|Dose Level 2|Physician Decision|0|||
27998305|NCT00790842|54657147|FG001|Dose Level 2|Physician Decision|1|||
27998306|NCT00790842|54657148|FG002|Dose Level 2|Physician Decision|0|||
27998307|NCT00790842|54657149|FG003|Dose Level 2|Physician Decision|0|||
27998308|NCT00790842|54657150|FG004|Dose Level 2|Physician Decision|0|||
27998309|NCT00790842|54657151|FG005|Dose Level 2|Physician Decision|0|||
27998310|NCT00790842|54657152|FG006|Dose Level 2|Physician Decision|0|||
27998311|NCT00790842|54657153|FG007|Dose Level 2|Physician Decision|0|||
27998312|NCT00790842|54657154|FG008|Dose Level 2|Physician Decision|0|||
27998313|NCT00790842|54657155|FG009|Dose Level 2|Physician Decision|0|||
27998314|NCT00790842|54657156|FG010|Dose Level 2|Physician Decision|0|||
27998315|NCT00790842|54657146|FG000|Dose Level 2|Withdrawal by Subject|0|||
27998316|NCT00790842|54657147|FG001|Dose Level 2|Withdrawal by Subject|1|||
27998317|NCT00790842|54657148|FG002|Dose Level 2|Withdrawal by Subject|0|||
27998318|NCT00790842|54657149|FG003|Dose Level 2|Withdrawal by Subject|0|||
27998319|NCT00790842|54657150|FG004|Dose Level 2|Withdrawal by Subject|0|||
27998320|NCT00790842|54657151|FG005|Dose Level 2|Withdrawal by Subject|0|||
27998321|NCT00790842|54657152|FG006|Dose Level 2|Withdrawal by Subject|0|||
27998322|NCT00790842|54657153|FG007|Dose Level 2|Withdrawal by Subject|0|||
27998323|NCT00790842|54657154|FG008|Dose Level 2|Withdrawal by Subject|0|||
27998324|NCT00790842|54657155|FG009|Dose Level 2|Withdrawal by Subject|0|||
27998325|NCT00790842|54657156|FG010|Dose Level 2|Withdrawal by Subject|0|||
27998326|NCT00790842|54657146|FG000|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
27998327|NCT00790842|54657147|FG001|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
27998328|NCT00790842|54657148|FG002|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
27998329|NCT00790842|54657149|FG003|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
27998330|NCT00790842|54657150|FG004|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
27998331|NCT00790842|54657151|FG005|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
27998332|NCT00790842|54657152|FG006|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
27998333|NCT00790842|54657153|FG007|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
27998334|NCT00790842|54657154|FG008|Dose Level 2|Intercurrent Illness/Other Treatment|2|||
27998335|NCT00790842|54657155|FG009|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
27998336|NCT00790842|54657156|FG010|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
27998337|NCT00790842|54657146|FG000|Dose Level 3|Adverse Event|0|||
27998338|NCT00790842|54657147|FG001|Dose Level 3|Adverse Event|0|||
28099249|NCT03981822|54755114|FG005|Overall Study|COVID-19 Related|1|||
28099250|NCT03981822|54755115|FG006|Overall Study|COVID-19 Related|2|||
28099251|NCT03981822|54755116|FG007|Overall Study|COVID-19 Related|1|||
28099252|NCT03650556|54755128|FG000|Overall Study|Death|2|||
28099253|NCT03650556|54755128|FG000|Overall Study|Withdrawal by Subject|20|||
28099254|NCT03650556|54755128|FG000|Overall Study|Physician Decision|2|||
28099255|NCT03650556|54755128|FG000|Overall Study|Lost to Follow-up|8|||
28099256|NCT03650556|54755128|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|4|||
28099257|NCT03650556|54755128|FG000|Overall Study|Enrolled, but no ablation performed-investigational catheter was not inserted|1|||
28099258|NCT03531632|54755136|FG000|Overall Study|Adverse Event|0|||
28099259|NCT03531632|54755137|FG001|Overall Study|Adverse Event|0|||
28099260|NCT03531632|54755138|FG002|Overall Study|Adverse Event|1|||
28099261|NCT03531632|54755136|FG000|Overall Study|Death|4|||
28099262|NCT03531632|54755137|FG001|Overall Study|Death|0|||
28099263|NCT03531632|54755138|FG002|Overall Study|Death|14|||
28099264|NCT03531632|54755136|FG000|Overall Study|Study Terminated|1|||
28099265|NCT03531632|54755137|FG001|Overall Study|Study Terminated|3|||
28099266|NCT03531632|54755138|FG002|Overall Study|Study Terminated|11|||
28099267|NCT03979638|54755149|FG000|Period 1|Physician Decision|1|||
28099268|NCT03979638|54755150|FG001|Period 1|Physician Decision|1|||
28099269|NCT03979638|54755149|FG000|Period 1|Withdrawal by Subject|4|||
28099270|NCT03979638|54755150|FG001|Period 1|Withdrawal by Subject|3|||
28099271|NCT03979638|54755149|FG000|Period 1|Study terminated by Sponsor|1|||
28099272|NCT03979638|54755150|FG001|Period 1|Study terminated by Sponsor|3|||
28099273|NCT03979638|54755149|FG000|Period 1|Protocol Violation|1|||
28099274|NCT03979638|54755150|FG001|Period 1|Protocol Violation|0|||
28099275|NCT03979638|54755149|FG000|Period 2|Study terminated by Sponsor|1|||
28099276|NCT03979638|54755150|FG001|Period 2|Study terminated by Sponsor|1|||
28099277|NCT03655054|54755165|FG000|Overall Study|Lost to Follow-up|1|||
28099278|NCT03615144|54755171|FG000|Overall Study|Participant no longer eligible for this protocol|1|||
28099279|NCT03615144|54755172|FG001|Overall Study|Participant no longer eligible for this protocol|0|||
28099280|NCT03682302|54755182|FG000|Overall Study|Lost to Follow-up|1|||
28099281|NCT03682302|54755183|FG001|Overall Study|Lost to Follow-up|2|||
28099282|NCT03682302|54755184|FG002|Overall Study|Lost to Follow-up|0|||
27998339|NCT00790842|54657148|FG002|Dose Level 3|Adverse Event|1|||
28099283|NCT03682302|54755185|FG003|Overall Study|Lost to Follow-up|1|||
27998340|NCT00790842|54657149|FG003|Dose Level 3|Adverse Event|0|||
27998341|NCT00790842|54657150|FG004|Dose Level 3|Adverse Event|0|||
27998342|NCT00790842|54657151|FG005|Dose Level 3|Adverse Event|0|||
27998343|NCT00790842|54657152|FG006|Dose Level 3|Adverse Event|0|||
28099284|NCT03682302|54755182|FG000|Overall Study|Study drug was not administered|0|||
28099285|NCT03682302|54755183|FG001|Overall Study|Study drug was not administered|0|||
28099286|NCT03682302|54755184|FG002|Overall Study|Study drug was not administered|1|||
28099287|NCT03682302|54755185|FG003|Overall Study|Study drug was not administered|1|||
28099288|NCT03522506|54755199|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
28099289|NCT03522506|54755200|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
28099290|NCT03522506|54755201|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
28099291|NCT03522506|54755202|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
27998344|NCT00790842|54657153|FG007|Dose Level 3|Adverse Event|0|||
27998345|NCT00790842|54657154|FG008|Dose Level 3|Adverse Event|0|||
27998346|NCT00790842|54657155|FG009|Dose Level 3|Adverse Event|0|||
27998347|NCT00790842|54657156|FG010|Dose Level 3|Adverse Event|0|||
27998348|NCT00790842|54657146|FG000|Dose Level 3|Withdrawal by Subject|0|||
27998349|NCT00790842|54657147|FG001|Dose Level 3|Withdrawal by Subject|0|||
27998350|NCT00790842|54657148|FG002|Dose Level 3|Withdrawal by Subject|3|||
27998351|NCT00790842|54657149|FG003|Dose Level 3|Withdrawal by Subject|0|||
27998352|NCT00790842|54657150|FG004|Dose Level 3|Withdrawal by Subject|0|||
27998353|NCT00790842|54657151|FG005|Dose Level 3|Withdrawal by Subject|0|||
27998354|NCT00790842|54657152|FG006|Dose Level 3|Withdrawal by Subject|0|||
27998355|NCT00790842|54657153|FG007|Dose Level 3|Withdrawal by Subject|0|||
27998356|NCT00790842|54657154|FG008|Dose Level 3|Withdrawal by Subject|0|||
27998357|NCT00790842|54657155|FG009|Dose Level 3|Withdrawal by Subject|2|||
27998358|NCT00790842|54657156|FG010|Dose Level 3|Withdrawal by Subject|0|||
27998359|NCT00790842|54657146|FG000|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
27998360|NCT00790842|54657147|FG001|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
27998361|NCT00790842|54657148|FG002|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
27998362|NCT00790842|54657149|FG003|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
27998363|NCT00790842|54657150|FG004|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
27998364|NCT00790842|54657151|FG005|Dose Level 3|Intercurrent Illness/Alternative Therapy|1|||
27998365|NCT00790842|54657152|FG006|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
27998366|NCT00790842|54657153|FG007|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
27998367|NCT00790842|54657154|FG008|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
27998368|NCT00790842|54657155|FG009|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
27998369|NCT00790842|54657156|FG010|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
27998370|NCT00790842|54657146|FG000|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
27998371|NCT00790842|54657147|FG001|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
27998372|NCT00790842|54657148|FG002|Dose Level 3|Ineligible/Withdrew before Treatment|1|||
28099292|NCT03522506|54755199|FG000|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
27912997|NCT00479882|54570759|FG000|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
27912998|NCT00479882|54570760|FG001|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2|||
27912999|NCT00479882|54570761|FG002|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
27913000|NCT00479882|54570762|FG003|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
27913001|NCT00479882|54570759|FG000|Crossover: Period III (Weeks 13-20)|Other|5|||
27913002|NCT00479882|54570760|FG001|Crossover: Period III (Weeks 13-20)|Other|0|||
27913003|NCT00479882|54570761|FG002|Crossover: Period III (Weeks 13-20)|Other|2|||
27913004|NCT00479882|54570762|FG003|Crossover: Period III (Weeks 13-20)|Other|2|||
28099293|NCT03522506|54755200|FG001|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
28099294|NCT03522506|54755201|FG002|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
28099295|NCT03522506|54755202|FG003|Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
28099296|NCT02892734|54755233|FG000|Treatment on Study|Progressive Disease|2|||
28099297|NCT02892734|54755233|FG000|Follow up for 2 Years|Death|2|||
28099298|NCT02892734|54755233|FG000|Follow up for 2 Years|Study closed early|1|||
28099299|NCT00055497|54755241|FG000|Overall Study|Adverse Event|1|||
28099300|NCT00055497|54755242|FG001|Overall Study|Adverse Event|1|||
28099301|NCT00055497|54755243|FG002|Overall Study|Adverse Event|1|||
28099302|NCT00055497|54755244|FG003|Overall Study|Adverse Event|28|||
28099303|NCT00055497|54755241|FG000|Overall Study|Withdrawal by Subject|3|||
28099304|NCT00055497|54755242|FG001|Overall Study|Withdrawal by Subject|1|||
28099305|NCT00055497|54755243|FG002|Overall Study|Withdrawal by Subject|1|||
28099306|NCT00055497|54755244|FG003|Overall Study|Withdrawal by Subject|15|||
28099307|NCT00055497|54755241|FG000|Overall Study|Lost to Follow-up|0|||
28099308|NCT00055497|54755242|FG001|Overall Study|Lost to Follow-up|1|||
28099309|NCT00055497|54755243|FG002|Overall Study|Lost to Follow-up|0|||
28099310|NCT00055497|54755244|FG003|Overall Study|Lost to Follow-up|5|||
28099311|NCT00055497|54755241|FG000|Overall Study|Protocol Violation|0|||
28099312|NCT00055497|54755242|FG001|Overall Study|Protocol Violation|0|||
28099313|NCT00055497|54755243|FG002|Overall Study|Protocol Violation|0|||
28099314|NCT00055497|54755244|FG003|Overall Study|Protocol Violation|3|||
28099315|NCT00055497|54755241|FG000|Overall Study|Lack of Efficacy|1|||
28099316|NCT00055497|54755242|FG001|Overall Study|Lack of Efficacy|0|||
28099317|NCT00055497|54755243|FG002|Overall Study|Lack of Efficacy|0|||
28099318|NCT00055497|54755244|FG003|Overall Study|Lack of Efficacy|27|||
28099319|NCT00055497|54755241|FG000|Overall Study|Administrative Reasons|0|||
28099320|NCT00055497|54755242|FG001|Overall Study|Administrative Reasons|0|||
28099321|NCT00055497|54755243|FG002|Overall Study|Administrative Reasons|0|||
27998373|NCT00790842|54657149|FG003|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
27913005|NCT00479882|54570759|FG000|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
27998374|NCT00790842|54657150|FG004|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
28099322|NCT00055497|54755244|FG003|Overall Study|Administrative Reasons|1|||
28099323|NCT00055497|54755241|FG000|Overall Study|Other|0|||
28099324|NCT00055497|54755242|FG001|Overall Study|Other|0|||
28099325|NCT00055497|54755243|FG002|Overall Study|Other|0|||
27913006|NCT00479882|54570760|FG001|Crossover: Period III (Weeks 13-20)|Participant moved|2|||
27913007|NCT00479882|54570761|FG002|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
27913008|NCT00479882|54570762|FG003|Crossover: Period III (Weeks 13-20)|Participant moved|0|||
27998375|NCT00790842|54657151|FG005|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
27998376|NCT00790842|54657152|FG006|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
27998377|NCT00790842|54657153|FG007|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
27998378|NCT00790842|54657154|FG008|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
27998379|NCT00790842|54657155|FG009|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
27998380|NCT00790842|54657156|FG010|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
27998381|NCT00790842|54657146|FG000|Dose Level 4|Adverse Event|0|||
27998382|NCT00790842|54657147|FG001|Dose Level 4|Adverse Event|0|||
27998383|NCT00790842|54657148|FG002|Dose Level 4|Adverse Event|0|||
27998384|NCT00790842|54657149|FG003|Dose Level 4|Adverse Event|0|||
27913009|NCT00479882|54570759|FG000|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
27913010|NCT00479882|54570760|FG001|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
27913011|NCT00479882|54570761|FG002|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1|||
27913012|NCT00479882|54570762|FG003|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
27913013|NCT00479882|54570759|FG000|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
27913014|NCT00479882|54570760|FG001|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
27913015|NCT00479882|54570761|FG002|Crossover: Period III (Weeks 13-20)|Protocol Violation|1|||
27913016|NCT00479882|54570762|FG003|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
27913017|NCT00479765|54570788|FG000|Overall Study|study terminated|4|||
27913018|NCT00479687|54570794|FG000|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
27998385|NCT00790842|54657150|FG004|Dose Level 4|Adverse Event|0|||
27998386|NCT00790842|54657151|FG005|Dose Level 4|Adverse Event|0|||
27998387|NCT00790842|54657152|FG006|Dose Level 4|Adverse Event|1|||
27998388|NCT00790842|54657153|FG007|Dose Level 4|Adverse Event|0|||
27998389|NCT00790842|54657154|FG008|Dose Level 4|Adverse Event|0|||
27998390|NCT00790842|54657155|FG009|Dose Level 4|Adverse Event|0|||
27998391|NCT00790842|54657156|FG010|Dose Level 4|Adverse Event|0|||
27998392|NCT00790842|54657146|FG000|Dose Level 4|Physician Decision|0|||
27998393|NCT00790842|54657147|FG001|Dose Level 4|Physician Decision|0|||
27998394|NCT00790842|54657148|FG002|Dose Level 4|Physician Decision|0|||
28099326|NCT00055497|54755244|FG003|Overall Study|Other|11|||
28099327|NCT03520400|54755261|FG000|Overall Study|Physician Decision|15|||
28099328|NCT03520400|54755262|FG001|Overall Study|Physician Decision|7|||
27913019|NCT00479687|54570795|FG001|Ph 1: Blinded, Randomized, Controlled|Adverse Event|2|||
27913020|NCT00479687|54570796|FG002|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
27913021|NCT00479687|54570794|FG000|Ph 1: Blinded, Randomized, Controlled|Death|0|||
27913022|NCT00479687|54570795|FG001|Ph 1: Blinded, Randomized, Controlled|Death|1|||
27998395|NCT00790842|54657149|FG003|Dose Level 4|Physician Decision|0|||
28099329|NCT03615066|54755271|FG000|Main Study|Withdrew Consent|0|||
28099330|NCT03615066|54755272|FG001|Main Study|Withdrew Consent|1|||
28099331|NCT03615066|54755273|FG002|Main Study|Withdrew Consent|1|||
28099332|NCT03615066|54755271|FG000|Main Study|Lost to Follow-up|0|||
28099333|NCT03615066|54755272|FG001|Main Study|Lost to Follow-up|0|||
28099334|NCT03615066|54755273|FG002|Main Study|Lost to Follow-up|1|||
28099335|NCT03615066|54755271|FG000|Treatment-free Follow-up (TFFU) Phase|Adverse Event|1|||
28099336|NCT03615066|54755272|FG001|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
28099337|NCT03615066|54755273|FG002|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
28099338|NCT03615066|54755271|FG000|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|1|||
28099339|NCT03615066|54755272|FG001|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
28099340|NCT03615066|54755273|FG002|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
28099341|NCT03615066|54755271|FG000|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
28099342|NCT03615066|54755272|FG001|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|1|||
28099343|NCT03615066|54755273|FG002|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
28099344|NCT03527966|54755287|FG000|Overall Study|Lost to Follow-up|3|||
28099345|NCT03527966|54755288|FG001|Overall Study|Lost to Follow-up|0|||
28099346|NCT03808545|54755296|FG000|Overall Study|Withdrawal by Subject|1|||
28099347|NCT03808545|54755297|FG001|Overall Study|Withdrawal by Subject|1|||
28099348|NCT03807843|54755306|FG000|Overall Study|Lost to Follow-up|1|||
28099349|NCT03807843|54755307|FG001|Overall Study|Lost to Follow-up|0|||
28099350|NCT03519932|54755313|FG000|First Intervention|Adverse Event|1|||
28099351|NCT03519932|54755314|FG001|First Intervention|Adverse Event|3|||
28099352|NCT03806127|54755327|FG000|Overall Study|Withdrawal by Subject|4|||
28099353|NCT03806127|54755328|FG001|Overall Study|Withdrawal by Subject|5|||
28099354|NCT03806127|54755327|FG000|Overall Study|Protocol Violation|3|||
28099355|NCT03806127|54755328|FG001|Overall Study|Protocol Violation|1|||
28172693|NCT02635646|54844412|FG001|Overall Study|Lost to Follow-up|25|||
27998396|NCT00790842|54657150|FG004|Dose Level 4|Physician Decision|0|||
27998397|NCT00790842|54657151|FG005|Dose Level 4|Physician Decision|0|||
28099356|NCT03806127|54755327|FG000|Overall Study|Adverse Event|3|||
28099357|NCT03806127|54755328|FG001|Overall Study|Adverse Event|0|||
27998398|NCT00790842|54657152|FG006|Dose Level 4|Physician Decision|1|||
27913023|NCT00479687|54570796|FG002|Ph 1: Blinded, Randomized, Controlled|Death|0|||
27913024|NCT00479687|54570794|FG000|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|4|||
27913025|NCT00479687|54570795|FG001|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|5|||
27913026|NCT00479687|54570796|FG002|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|0|||
27913027|NCT00479687|54570794|FG000|Ph 1: Blinded, Randomized, Controlled|Physician Decision|2|||
27913028|NCT00479687|54570795|FG001|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
27913029|NCT00479687|54570796|FG002|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
27913030|NCT00479687|54570794|FG000|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|19|||
27913031|NCT00479687|54570795|FG001|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|11|||
27913032|NCT00479687|54570796|FG002|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|0|||
27998399|NCT00790842|54657153|FG007|Dose Level 4|Physician Decision|0|||
27998400|NCT00790842|54657154|FG008|Dose Level 4|Physician Decision|0|||
27998401|NCT00790842|54657155|FG009|Dose Level 4|Physician Decision|0|||
27998402|NCT00790842|54657156|FG010|Dose Level 4|Physician Decision|1|||
27998403|NCT00790842|54657146|FG000|Dose Level 4|Withdrawal by Subject|0|||
27998404|NCT00790842|54657147|FG001|Dose Level 4|Withdrawal by Subject|0|||
27998405|NCT00790842|54657148|FG002|Dose Level 4|Withdrawal by Subject|0|||
27998406|NCT00790842|54657149|FG003|Dose Level 4|Withdrawal by Subject|0|||
27998407|NCT00790842|54657150|FG004|Dose Level 4|Withdrawal by Subject|0|||
27998408|NCT00790842|54657151|FG005|Dose Level 4|Withdrawal by Subject|0|||
27998409|NCT00790842|54657152|FG006|Dose Level 4|Withdrawal by Subject|0|||
27998410|NCT00790842|54657153|FG007|Dose Level 4|Withdrawal by Subject|0|||
27998411|NCT00790842|54657154|FG008|Dose Level 4|Withdrawal by Subject|0|||
27998412|NCT00790842|54657155|FG009|Dose Level 4|Withdrawal by Subject|0|||
27998413|NCT00790842|54657156|FG010|Dose Level 4|Withdrawal by Subject|1|||
27998414|NCT00790842|54657146|FG000|Expansion Cohort|Adverse Event|0|||
27998415|NCT00790842|54657147|FG001|Expansion Cohort|Adverse Event|0|||
27998416|NCT00790842|54657148|FG002|Expansion Cohort|Adverse Event|0|||
27998417|NCT00790842|54657149|FG003|Expansion Cohort|Adverse Event|0|||
27998418|NCT00790842|54657150|FG004|Expansion Cohort|Adverse Event|0|||
27998419|NCT00790842|54657151|FG005|Expansion Cohort|Adverse Event|0|||
27998420|NCT00790842|54657152|FG006|Expansion Cohort|Adverse Event|1|||
27998421|NCT00790842|54657153|FG007|Expansion Cohort|Adverse Event|0|||
27998422|NCT00790842|54657154|FG008|Expansion Cohort|Adverse Event|0|||
27998423|NCT00790842|54657155|FG009|Expansion Cohort|Adverse Event|0|||
27998424|NCT00790842|54657156|FG010|Expansion Cohort|Adverse Event|0|||
27998425|NCT00790842|54657146|FG000|Expansion Cohort|Death|0|||
27998426|NCT00790842|54657147|FG001|Expansion Cohort|Death|0|||
27998427|NCT00790842|54657148|FG002|Expansion Cohort|Death|2|||
27998428|NCT00790842|54657149|FG003|Expansion Cohort|Death|0|||
27998429|NCT00790842|54657150|FG004|Expansion Cohort|Death|0|||
27998430|NCT00790842|54657151|FG005|Expansion Cohort|Death|0|||
27998431|NCT00790842|54657152|FG006|Expansion Cohort|Death|0|||
27998432|NCT00790842|54657153|FG007|Expansion Cohort|Death|0|||
27998433|NCT00790842|54657154|FG008|Expansion Cohort|Death|0|||
27998434|NCT00790842|54657155|FG009|Expansion Cohort|Death|0|||
27998435|NCT00790842|54657156|FG010|Expansion Cohort|Death|0|||
27998436|NCT00790842|54657146|FG000|Expansion Cohort|Physician Decision|0|||
27998437|NCT00790842|54657147|FG001|Expansion Cohort|Physician Decision|0|||
27998438|NCT00790842|54657148|FG002|Expansion Cohort|Physician Decision|1|||
27913033|NCT00479687|54570794|FG000|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
27913034|NCT00479687|54570795|FG001|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
27913035|NCT00479687|54570796|FG002|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|4|||
27913036|NCT00479687|54570794|FG000|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
27913037|NCT00479687|54570795|FG001|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
27913038|NCT00479687|54570796|FG002|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|3|||
27913039|NCT00479687|54570794|FG000|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
27913040|NCT00479687|54570795|FG001|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
27913041|NCT00479687|54570796|FG002|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|1|||
27913042|NCT00479687|54570794|FG000|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
27913043|NCT00479687|54570795|FG001|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
27913044|NCT00479687|54570796|FG002|Ph 2: Open Label, Single (Supartz) Arm|Death|1|||
27913045|NCT00479336|54570807|FG000|Overall Study|Adverse Event|1|||
27913046|NCT00479336|54570808|FG001|Overall Study|Adverse Event|1|||
27913047|NCT00479336|54570809|FG002|Overall Study|Adverse Event|1|||
27913048|NCT00479336|54570810|FG003|Overall Study|Adverse Event|3|||
27998439|NCT00790842|54657149|FG003|Expansion Cohort|Physician Decision|0|||
27913049|NCT00479336|54570807|FG000|Overall Study|Lack of Efficacy|1|||
27913050|NCT00479336|54570808|FG001|Overall Study|Lack of Efficacy|0|||
27998440|NCT00790842|54657150|FG004|Expansion Cohort|Physician Decision|0|||
27998441|NCT00790842|54657151|FG005|Expansion Cohort|Physician Decision|0|||
27998442|NCT00790842|54657152|FG006|Expansion Cohort|Physician Decision|0|||
27998443|NCT00790842|54657153|FG007|Expansion Cohort|Physician Decision|0|||
27998444|NCT00790842|54657154|FG008|Expansion Cohort|Physician Decision|0|||
27998445|NCT00790842|54657155|FG009|Expansion Cohort|Physician Decision|0|||
27998446|NCT00790842|54657156|FG010|Expansion Cohort|Physician Decision|0|||
27998447|NCT00790842|54657146|FG000|Expansion Cohort|Withdrawal by Subject|0|||
27998448|NCT00790842|54657147|FG001|Expansion Cohort|Withdrawal by Subject|0|||
27998449|NCT00790842|54657148|FG002|Expansion Cohort|Withdrawal by Subject|3|||
27998450|NCT00790842|54657149|FG003|Expansion Cohort|Withdrawal by Subject|0|||
27998451|NCT00790842|54657150|FG004|Expansion Cohort|Withdrawal by Subject|0|||
27998452|NCT00790842|54657151|FG005|Expansion Cohort|Withdrawal by Subject|0|||
27998453|NCT00790842|54657152|FG006|Expansion Cohort|Withdrawal by Subject|0|||
27998454|NCT00790842|54657153|FG007|Expansion Cohort|Withdrawal by Subject|0|||
27998455|NCT00790842|54657154|FG008|Expansion Cohort|Withdrawal by Subject|0|||
27913051|NCT00479336|54570809|FG002|Overall Study|Lack of Efficacy|0|||
27913052|NCT00479336|54570810|FG003|Overall Study|Lack of Efficacy|0|||
27913053|NCT00479336|54570807|FG000|Overall Study|Protocol Violation|0|||
27913054|NCT00479336|54570808|FG001|Overall Study|Protocol Violation|1|||
27913055|NCT00479336|54570809|FG002|Overall Study|Protocol Violation|0|||
27913056|NCT00479336|54570810|FG003|Overall Study|Protocol Violation|0|||
27913057|NCT00479336|54570807|FG000|Overall Study|Withdrawal by Subject|1|||
27913058|NCT00479336|54570808|FG001|Overall Study|Withdrawal by Subject|2|||
27998456|NCT00790842|54657155|FG009|Expansion Cohort|Withdrawal by Subject|0|||
27998457|NCT00790842|54657156|FG010|Expansion Cohort|Withdrawal by Subject|0|||
27998458|NCT00790842|54657146|FG000|Expansion Cohort|Study Closure|0|||
27998459|NCT00790842|54657147|FG001|Expansion Cohort|Study Closure|0|||
27998460|NCT00790842|54657148|FG002|Expansion Cohort|Study Closure|1|||
27998461|NCT00790842|54657149|FG003|Expansion Cohort|Study Closure|0|||
27998462|NCT00790842|54657150|FG004|Expansion Cohort|Study Closure|0|||
27998463|NCT00790842|54657151|FG005|Expansion Cohort|Study Closure|0|||
27998464|NCT00790842|54657152|FG006|Expansion Cohort|Study Closure|0|||
27998465|NCT00790842|54657153|FG007|Expansion Cohort|Study Closure|0|||
27998466|NCT00790842|54657154|FG008|Expansion Cohort|Study Closure|0|||
27998467|NCT00790842|54657155|FG009|Expansion Cohort|Study Closure|0|||
27998468|NCT00790842|54657156|FG010|Expansion Cohort|Study Closure|0|||
27998469|NCT00574288|54657211|FG000|Overall Study|Adverse Event|2|||
27998470|NCT00574288|54657212|FG001|Overall Study|Adverse Event|0|||
27998471|NCT00574288|54657213|FG002|Overall Study|Adverse Event|0|||
27998472|NCT00574288|54657214|FG003|Overall Study|Adverse Event|0|||
27998473|NCT00574288|54657215|FG004|Overall Study|Adverse Event|1|||
27998474|NCT00574288|54657216|FG005|Overall Study|Adverse Event|0|||
27998475|NCT00574288|54657217|FG006|Overall Study|Adverse Event|0|||
27998476|NCT00574288|54657211|FG000|Overall Study|Death|0|||
27998477|NCT00574288|54657212|FG001|Overall Study|Death|0|||
27998478|NCT00574288|54657213|FG002|Overall Study|Death|0|||
27998479|NCT00574288|54657214|FG003|Overall Study|Death|0|||
27998480|NCT00574288|54657215|FG004|Overall Study|Death|0|||
27998481|NCT00574288|54657216|FG005|Overall Study|Death|25|||
27913059|NCT00479336|54570809|FG002|Overall Study|Withdrawal by Subject|0|||
27913060|NCT00479336|54570810|FG003|Overall Study|Withdrawal by Subject|0|||
27913061|NCT00479336|54570807|FG000|Overall Study|Physician Decision|0|||
27913062|NCT00479336|54570808|FG001|Overall Study|Physician Decision|1|||
27913063|NCT00479336|54570809|FG002|Overall Study|Physician Decision|0|||
27913064|NCT00479336|54570810|FG003|Overall Study|Physician Decision|2|||
27913065|NCT00479336|54570807|FG000|Overall Study|Resolution of all hepatic edema findings|1|||
27913066|NCT00479336|54570808|FG001|Overall Study|Resolution of all hepatic edema findings|1|||
27913067|NCT00479336|54570809|FG002|Overall Study|Resolution of all hepatic edema findings|0|||
27913068|NCT00479336|54570810|FG003|Overall Study|Resolution of all hepatic edema findings|0|||
27913069|NCT00478244|54570820|FG000|Overall Study|Did not receive transplant|1|||
27913070|NCT00478205|54570826|FG000|Overall Study|Adverse Event|182|||
27913071|NCT00478205|54570827|FG001|Overall Study|Adverse Event|39|||
27913072|NCT00478205|54570826|FG000|Overall Study|Medication Non-compliance|9|||
27913073|NCT00478205|54570827|FG001|Overall Study|Medication Non-compliance|4|||
27913074|NCT00478205|54570826|FG000|Overall Study|Protocol Violation|15|||
27913075|NCT00478205|54570827|FG001|Overall Study|Protocol Violation|5|||
27913076|NCT00478205|54570826|FG000|Overall Study|Request of Investigator or Sponsor|4|||
27913077|NCT00478205|54570827|FG001|Overall Study|Request of Investigator or Sponsor|5|||
27913078|NCT00478205|54570826|FG000|Overall Study|Withdrawal by Subject|61|||
27913079|NCT00478205|54570827|FG001|Overall Study|Withdrawal by Subject|22|||
27913080|NCT00478205|54570826|FG000|Overall Study|Lack of Efficacy|1|||
27913081|NCT00478205|54570827|FG001|Overall Study|Lack of Efficacy|0|||
27913082|NCT00478205|54570826|FG000|Overall Study|Other|24|||
27913083|NCT00478205|54570827|FG001|Overall Study|Other|12|||
27998482|NCT00574288|54657217|FG006|Overall Study|Death|21|||
27998483|NCT00574288|54657211|FG000|Overall Study|Lost to Follow-up|0|||
27998484|NCT00574288|54657212|FG001|Overall Study|Lost to Follow-up|0|||
27998485|NCT00574288|54657213|FG002|Overall Study|Lost to Follow-up|0|||
27998486|NCT00574288|54657214|FG003|Overall Study|Lost to Follow-up|0|||
27998487|NCT00574288|54657215|FG004|Overall Study|Lost to Follow-up|0|||
28099358|NCT03806127|54755327|FG000|Overall Study|Unable to Complete Procedures|0|||
27913084|NCT00477971|54570835|FG000|Overall Study|Disease progression|6|||
27998488|NCT00574288|54657216|FG005|Overall Study|Lost to Follow-up|1|||
27998489|NCT00574288|54657217|FG006|Overall Study|Lost to Follow-up|2|||
27998490|NCT00574288|54657211|FG000|Overall Study|Study Terminated By Sponsor|0|||
27998491|NCT00574288|54657212|FG001|Overall Study|Study Terminated By Sponsor|0|||
27998492|NCT00574288|54657213|FG002|Overall Study|Study Terminated By Sponsor|0|||
27998493|NCT00574288|54657214|FG003|Overall Study|Study Terminated By Sponsor|0|||
27998494|NCT00574288|54657215|FG004|Overall Study|Study Terminated By Sponsor|0|||
27998495|NCT00574288|54657216|FG005|Overall Study|Study Terminated By Sponsor|0|||
27998496|NCT00574288|54657217|FG006|Overall Study|Study Terminated By Sponsor|5|||
27998497|NCT00574288|54657211|FG000|Overall Study|Progressive Disease|17|||
27998498|NCT00574288|54657212|FG001|Overall Study|Progressive Disease|2|||
27998499|NCT00574288|54657213|FG002|Overall Study|Progressive Disease|3|||
27998500|NCT00574288|54657214|FG003|Overall Study|Progressive Disease|2|||
27998501|NCT00574288|54657215|FG004|Overall Study|Progressive Disease|1|||
27998502|NCT00574288|54657216|FG005|Overall Study|Progressive Disease|0|||
27998503|NCT00574288|54657217|FG006|Overall Study|Progressive Disease|0|||
27998504|NCT00574288|54657211|FG000|Overall Study|Other|1|||
27998505|NCT00574288|54657212|FG001|Overall Study|Other|1|||
28099359|NCT03806127|54755328|FG001|Overall Study|Unable to Complete Procedures|1|||
28099360|NCT03806127|54755327|FG000|Overall Study|Pregnancy|0|||
27739765|NCT02736409|54189445|FG002|Overall Study|Pregnancy|1|||
27739766|NCT02736409|54189446|FG003|Overall Study|Pregnancy|0|||
27739767|NCT02736409|54189443|FG000|Overall Study|Lost to Follow-up|0|||
27739768|NCT02736409|54189444|FG001|Overall Study|Lost to Follow-up|0|||
27739769|NCT02736409|54189445|FG002|Overall Study|Lost to Follow-up|2|||
27739770|NCT02736409|54189446|FG003|Overall Study|Lost to Follow-up|1|||
27913085|NCT00477971|54570836|FG001|Overall Study|Disease progression|0|||
27913086|NCT00477971|54570835|FG000|Overall Study|Withdrawal by Subject|3|||
27913087|NCT00477971|54570836|FG001|Overall Study|Withdrawal by Subject|1|||
27913088|NCT00477971|54570835|FG000|Overall Study|Adverse Event|3|||
27913089|NCT00477971|54570836|FG001|Overall Study|Adverse Event|0|||
27913090|NCT00477971|54570835|FG000|Overall Study|Death|2|||
27913091|NCT00477971|54570836|FG001|Overall Study|Death|4|||
27913092|NCT00477971|54570835|FG000|Overall Study|Alternative treatment|3|||
27913093|NCT00477971|54570836|FG001|Overall Study|Alternative treatment|1|||
27913094|NCT00477464|54570842|FG000|Overall Study|Lost to Follow-up|1|||
27913095|NCT00477464|54570842|FG000|Overall Study|Death|36|||
27913096|NCT00477464|54570842|FG000|Overall Study|Completion of protocol-defined follow-up|14|||
27913097|NCT00477386|54570850|FG000|Overall Study|Adverse Event|4|||
27913098|NCT00477386|54570851|FG001|Overall Study|Adverse Event|8|||
27913099|NCT00477386|54570850|FG000|Overall Study|Disease progression, relapse|3|||
27913100|NCT00477386|54570851|FG001|Overall Study|Disease progression, relapse|4|||
27913101|NCT00477386|54570850|FG000|Overall Study|Disease progression, refractory|1|||
27913102|NCT00477386|54570851|FG001|Overall Study|Disease progression, refractory|3|||
27913103|NCT00477386|54570850|FG000|Overall Study|Other|1|||
27913104|NCT00477386|54570851|FG001|Overall Study|Other|2|||
27913105|NCT00477386|54570850|FG000|Overall Study|Physician Decision|1|||
27913106|NCT00477386|54570851|FG001|Overall Study|Physician Decision|0|||
27913107|NCT00477386|54570850|FG000|Overall Study|Withdrawal by Subject|1|||
27913108|NCT00477386|54570851|FG001|Overall Study|Withdrawal by Subject|0|||
27913109|NCT00477269|54570859|FG000|Core Study|Adverse Event|6|||
27913110|NCT00477269|54570860|FG001|Core Study|Adverse Event|4|||
27913111|NCT00477269|54570861|FG002|Core Study|Adverse Event|0|||
27913112|NCT00477269|54570859|FG000|Core Study|Death|3|||
27913113|NCT00477269|54570860|FG001|Core Study|Death|3|||
27913114|NCT00477269|54570861|FG002|Core Study|Death|0|||
27913115|NCT00477269|54570859|FG000|Core Study|Withdrawn Consent|0|||
27913116|NCT00477269|54570860|FG001|Core Study|Withdrawn Consent|1|||
27913117|NCT00477269|54570861|FG002|Core Study|Withdrawn Consent|0|||
27913118|NCT00477269|54570859|FG000|Open Label Extension|Adverse Event|0|||
27913119|NCT00477269|54570860|FG001|Open Label Extension|Adverse Event|0|||
27913120|NCT00477269|54570861|FG002|Open Label Extension|Adverse Event|4|||
27998506|NCT00574288|54657213|FG002|Overall Study|Other|0|||
27998507|NCT00574288|54657214|FG003|Overall Study|Other|0|||
27998508|NCT00574288|54657215|FG004|Overall Study|Other|0|||
27998509|NCT00574288|54657216|FG005|Overall Study|Other|0|||
27913121|NCT00477269|54570859|FG000|Open Label Extension|Abnormal laboratory values|0|||
27913122|NCT00477269|54570860|FG001|Open Label Extension|Abnormal laboratory values|0|||
27998510|NCT00574288|54657217|FG006|Overall Study|Other|0|||
28099361|NCT03806127|54755328|FG001|Overall Study|Pregnancy|1|||
27739771|NCT02736409|54189443|FG000|Overall Study|Physician Decision|0|||
27913123|NCT00477269|54570861|FG002|Open Label Extension|Abnormal laboratory values|1|||
27913124|NCT00477269|54570859|FG000|Open Label Extension|unsatisfactory therapeutic effects|0|||
27913125|NCT00477269|54570860|FG001|Open Label Extension|unsatisfactory therapeutic effects|0|||
27913126|NCT00477269|54570861|FG002|Open Label Extension|unsatisfactory therapeutic effects|2|||
27913127|NCT00477269|54570859|FG000|Open Label Extension|Adminiatrative problems|0|||
27913128|NCT00477269|54570860|FG001|Open Label Extension|Adminiatrative problems|0|||
27913129|NCT00477269|54570861|FG002|Open Label Extension|Adminiatrative problems|2|||
28099362|NCT03806127|54755327|FG000|Overall Study|Lost to Follow-up|5|||
27739772|NCT02736409|54189444|FG001|Overall Study|Physician Decision|0|||
27998511|NCT00790452|54657245|FG000|Overall Study|Drug supply issue|1|||
27739773|NCT02736409|54189445|FG002|Overall Study|Physician Decision|0|||
27739774|NCT02736409|54189446|FG003|Overall Study|Physician Decision|2|||
27739775|NCT03099707|54189459|FG000|Overall Study|Withdrawal by Subject|0|||
27739776|NCT03099707|54189460|FG001|Overall Study|Withdrawal by Subject|3|||
27739777|NCT03099707|54189459|FG000|Overall Study|Lost to Follow-up|0|||
27739778|NCT03099707|54189460|FG001|Overall Study|Lost to Follow-up|1|||
27739779|NCT02906033|54189468|FG000|Baseline|Protocol Violation|37|||
27739780|NCT02906033|54189469|FG001|Baseline|Protocol Violation|33|||
27739781|NCT02906033|54189468|FG000|Follow-up|Lost to Follow-up|46|||
27739782|NCT02906033|54189469|FG001|Follow-up|Lost to Follow-up|62|||
27739783|NCT02221882|54189481|FG000|Overall Study|Withdrawal by Subject|0|||
27739784|NCT02221882|54189482|FG001|Overall Study|Withdrawal by Subject|0|||
27739785|NCT02221882|54189483|FG002|Overall Study|Withdrawal by Subject|4|||
27739786|NCT02221882|54189484|FG003|Overall Study|Withdrawal by Subject|2|||
27913130|NCT00477269|54570859|FG000|Open Label Extension|Death|0|||
27913131|NCT00477269|54570860|FG001|Open Label Extension|Death|0|||
27913132|NCT00477269|54570861|FG002|Open Label Extension|Death|4|||
27913133|NCT00477152|54570869|FG000|Overall Study|Parent withdrew consent|2|||
27913134|NCT00477152|54570869|FG000|Overall Study|Adverse Event|1|||
27913135|NCT00476996|54570876|FG000|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12|||
27739787|NCT02221882|54189485|FG004|Overall Study|Withdrawal by Subject|2|||
27739788|NCT02221882|54189486|FG005|Overall Study|Withdrawal by Subject|2|||
27739789|NCT02221882|54189481|FG000|Overall Study|Death|0|||
27739790|NCT02221882|54189482|FG001|Overall Study|Death|1|||
27739791|NCT02221882|54189483|FG002|Overall Study|Death|0|||
27739792|NCT02221882|54189484|FG003|Overall Study|Death|0|||
27739793|NCT02221882|54189485|FG004|Overall Study|Death|0|||
27739794|NCT02221882|54189486|FG005|Overall Study|Death|0|||
27739795|NCT02837783|54189507|FG000|Overall Study|Adverse Event|1|||
27913136|NCT00476996|54570877|FG001|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
27913137|NCT00476996|54570878|FG002|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
27913138|NCT00476996|54570879|FG003|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0|||
27998512|NCT00790452|54657246|FG001|Overall Study|Drug supply issue|0|||
27998513|NCT00626392|54657258|FG000|Run-in Period|Adverse Event|0|||
27998514|NCT00626392|54657259|FG001|Run-in Period|Adverse Event|0|||
27998515|NCT00626392|54657260|FG002|Run-in Period|Adverse Event|1|||
27998516|NCT00626392|54657261|FG003|Run-in Period|Adverse Event|0|||
27998517|NCT00626392|54657262|FG004|Run-in Period|Adverse Event|1|||
27998518|NCT00626392|54657263|FG005|Run-in Period|Adverse Event|0|||
27998519|NCT00626392|54657258|FG000|Run-in Period|Withdrawal by Subject|0|||
27998520|NCT00626392|54657259|FG001|Run-in Period|Withdrawal by Subject|1|||
27998521|NCT00626392|54657260|FG002|Run-in Period|Withdrawal by Subject|1|||
27998522|NCT00626392|54657261|FG003|Run-in Period|Withdrawal by Subject|1|||
27998523|NCT00626392|54657262|FG004|Run-in Period|Withdrawal by Subject|3|||
27998524|NCT00626392|54657263|FG005|Run-in Period|Withdrawal by Subject|1|||
27998525|NCT00626392|54657258|FG000|Run-in Period|Noncompliance|1|||
27998526|NCT00626392|54657259|FG001|Run-in Period|Noncompliance|0|||
27998527|NCT00626392|54657260|FG002|Run-in Period|Noncompliance|1|||
27998528|NCT00626392|54657261|FG003|Run-in Period|Noncompliance|0|||
27998529|NCT00626392|54657262|FG004|Run-in Period|Noncompliance|0|||
27998530|NCT00626392|54657263|FG005|Run-in Period|Noncompliance|0|||
27998531|NCT00626392|54657258|FG000|Coadministration Period|Adverse Event|3|||
27998532|NCT00626392|54657259|FG001|Coadministration Period|Adverse Event|1|||
27998533|NCT00626392|54657260|FG002|Coadministration Period|Adverse Event|7|||
27998534|NCT00626392|54657261|FG003|Coadministration Period|Adverse Event|4|||
27998535|NCT00626392|54657262|FG004|Coadministration Period|Adverse Event|3|||
27998536|NCT00626392|54657263|FG005|Coadministration Period|Adverse Event|4|||
27998537|NCT00626392|54657258|FG000|Coadministration Period|Withdrawal by Subject|1|||
27998538|NCT00626392|54657259|FG001|Coadministration Period|Withdrawal by Subject|1|||
27739796|NCT02837783|54189508|FG001|Overall Study|Adverse Event|0|||
27998539|NCT00626392|54657260|FG002|Coadministration Period|Withdrawal by Subject|0|||
27998540|NCT00626392|54657261|FG003|Coadministration Period|Withdrawal by Subject|1|||
27998541|NCT00626392|54657262|FG004|Coadministration Period|Withdrawal by Subject|0|||
27998542|NCT00626392|54657263|FG005|Coadministration Period|Withdrawal by Subject|1|||
27739797|NCT02837783|54189507|FG000|Overall Study|Other, Not Specified|1|||
27913139|NCT00476996|54570876|FG000|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1|||
27739798|NCT02837783|54189508|FG001|Overall Study|Other, Not Specified|2|||
27913140|NCT00476996|54570877|FG001|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3|||
27998543|NCT00626392|54657258|FG000|Coadministration Period|Protocol Violation|0|||
27998544|NCT00626392|54657259|FG001|Coadministration Period|Protocol Violation|1|||
27998545|NCT00626392|54657260|FG002|Coadministration Period|Protocol Violation|0|||
27998546|NCT00626392|54657261|FG003|Coadministration Period|Protocol Violation|1|||
27739799|NCT02221648|54189516|FG000|Overall Study|Withdrawal by Subject|3|||
27739800|NCT02221648|54189517|FG001|Overall Study|Withdrawal by Subject|3|||
27739801|NCT02220712|54189527|FG000|Overall Study|Adverse Event|1|||
27739802|NCT02220712|54189527|FG000|Overall Study|Withdrawal by Subject|2|||
27998547|NCT00626392|54657262|FG004|Coadministration Period|Protocol Violation|1|||
27998548|NCT00626392|54657263|FG005|Coadministration Period|Protocol Violation|0|||
27998549|NCT00626392|54657258|FG000|Coadministration Period|Other|0|||
27998550|NCT00626392|54657259|FG001|Coadministration Period|Other|2|||
27998551|NCT00626392|54657260|FG002|Coadministration Period|Other|3|||
27998552|NCT00626392|54657261|FG003|Coadministration Period|Other|1|||
27998553|NCT00626392|54657262|FG004|Coadministration Period|Other|1|||
27998554|NCT00626392|54657263|FG005|Coadministration Period|Other|1|||
27998555|NCT00624286|54657271|FG000|Overall Study|Protocol Deviation|7|||
27998556|NCT00624286|54657272|FG001|Overall Study|Protocol Deviation|9|||
27998557|NCT00624286|54657271|FG000|Overall Study|Adverse Event|6|||
27998558|NCT00624286|54657272|FG001|Overall Study|Adverse Event|3|||
27998559|NCT00624286|54657271|FG000|Overall Study|Withdrawal by Subject|5|||
27998560|NCT00624286|54657272|FG001|Overall Study|Withdrawal by Subject|4|||
27998561|NCT00624286|54657271|FG000|Overall Study|Lost to Follow-up|3|||
27998562|NCT00624286|54657272|FG001|Overall Study|Lost to Follow-up|2|||
27998563|NCT00624286|54657271|FG000|Overall Study|Administrative problems|3|||
27998564|NCT00624286|54657272|FG001|Overall Study|Administrative problems|0|||
27739803|NCT02220712|54189527|FG000|Overall Study|Exacerbation of symptoms of an underlying disease|1|||
27739804|NCT02219932|54189537|FG000|Overall Study|Other|5|||
27739805|NCT02219932|54189538|FG001|Overall Study|Other|11|||
27739806|NCT02219932|54189537|FG000|Overall Study|Death|1|||
27739807|NCT02219932|54189538|FG001|Overall Study|Death|1|||
27739808|NCT02219932|54189537|FG000|Overall Study|Investigator Decision|0|||
27739809|NCT02219932|54189538|FG001|Overall Study|Investigator Decision|1|||
27739810|NCT02219932|54189537|FG000|Overall Study|Consent Withdrawn|11|||
27739811|NCT02219932|54189538|FG001|Overall Study|Consent Withdrawn|7|||
27739812|NCT02219932|54189537|FG000|Overall Study|Lack of Efficacy (Subject Perception)|10|||
27739813|NCT02219932|54189538|FG001|Overall Study|Lack of Efficacy (Subject Perception)|2|||
27913141|NCT00476996|54570878|FG002|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
27913142|NCT00476996|54570879|FG003|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
27913143|NCT00476996|54570876|FG000|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24|||
27913144|NCT00476996|54570877|FG001|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20|||
27913145|NCT00476996|54570878|FG002|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21|||
27913146|NCT00476996|54570879|FG003|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0|||
27913147|NCT00476996|54570876|FG000|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
27913148|NCT00476996|54570877|FG001|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2|||
27913149|NCT00476996|54570878|FG002|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
27913150|NCT00476996|54570879|FG003|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
27913151|NCT00476996|54570876|FG000|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
27913152|NCT00476996|54570877|FG001|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4|||
27913153|NCT00476996|54570878|FG002|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3|||
27913154|NCT00476996|54570879|FG003|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
27913155|NCT00476996|54570876|FG000|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22|||
27913156|NCT00476996|54570877|FG001|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5|||
27913157|NCT00476996|54570878|FG002|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6|||
27913158|NCT00476996|54570879|FG003|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0|||
27913159|NCT00476996|54570876|FG000|Blinded Treatment Phase (up to Week 48)|Death|2|||
27913160|NCT00476996|54570877|FG001|Blinded Treatment Phase (up to Week 48)|Death|1|||
27913161|NCT00476996|54570878|FG002|Blinded Treatment Phase (up to Week 48)|Death|1|||
27913162|NCT00476996|54570879|FG003|Blinded Treatment Phase (up to Week 48)|Death|0|||
27913163|NCT00476996|54570876|FG000|Blinded Treatment Phase (up to Week 48)|Adverse Event|11|||
27913164|NCT00476996|54570877|FG001|Blinded Treatment Phase (up to Week 48)|Adverse Event|13|||
27913165|NCT00476996|54570878|FG002|Blinded Treatment Phase (up to Week 48)|Adverse Event|7|||
27913166|NCT00476996|54570879|FG003|Blinded Treatment Phase (up to Week 48)|Adverse Event|0|||
27913167|NCT00476996|54570876|FG000|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
27913168|NCT00476996|54570877|FG001|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
27913169|NCT00476996|54570878|FG002|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
27913170|NCT00476996|54570879|FG003|OLE Phase (From Week 48)|Withdrawal by Subject|50|||
27913171|NCT00476996|54570876|FG000|OLE Phase (From Week 48)|Adverse Event|0|||
27913172|NCT00476996|54570877|FG001|OLE Phase (From Week 48)|Adverse Event|0|||
27913173|NCT00476996|54570878|FG002|OLE Phase (From Week 48)|Adverse Event|0|||
27913174|NCT00476996|54570879|FG003|OLE Phase (From Week 48)|Adverse Event|8|||
27998565|NCT00624286|54657271|FG000|Overall Study|Lack of Efficacy|1|||
27998566|NCT00624286|54657272|FG001|Overall Study|Lack of Efficacy|6|||
27998567|NCT00624286|54657271|FG000|Overall Study|Not stated|0|||
27998568|NCT00624286|54657272|FG001|Overall Study|Not stated|1|||
27998569|NCT00624286|54657271|FG000|Overall Study|Abnormal test procedure result(s)|0|||
27998570|NCT00624286|54657272|FG001|Overall Study|Abnormal test procedure result(s)|1|||
27998571|NCT00624286|54657271|FG000|Overall Study|Death|0|||
27739814|NCT02219932|54189537|FG000|Overall Study|Protocol Violation|10|||
27913175|NCT00476996|54570876|FG000|OLE Phase (From Week 48)|Death|0|||
27913176|NCT00476996|54570877|FG001|OLE Phase (From Week 48)|Death|0|||
27913177|NCT00476996|54570878|FG002|OLE Phase (From Week 48)|Death|0|||
27913178|NCT00476996|54570879|FG003|OLE Phase (From Week 48)|Death|7|||
27913179|NCT00476996|54570876|FG000|OLE Phase (From Week 48)|Lack of Efficacy|0|||
27913180|NCT00476996|54570877|FG001|OLE Phase (From Week 48)|Lack of Efficacy|0|||
27913181|NCT00476996|54570878|FG002|OLE Phase (From Week 48)|Lack of Efficacy|0|||
27913182|NCT00476996|54570879|FG003|OLE Phase (From Week 48)|Lack of Efficacy|13|||
27998572|NCT00624286|54657272|FG001|Overall Study|Death|1|||
27998573|NCT00624052|54657282|FG000|Overall Study|Adverse Event|7|||
27998574|NCT00624052|54657283|FG001|Overall Study|Adverse Event|6|||
27998575|NCT00624052|54657284|FG002|Overall Study|Adverse Event|0|||
27998576|NCT00624052|54657285|FG003|Overall Study|Adverse Event|3|||
27998577|NCT00624052|54657282|FG000|Overall Study|Lack of Efficacy|1|||
27998578|NCT00624052|54657283|FG001|Overall Study|Lack of Efficacy|1|||
27998579|NCT00624052|54657284|FG002|Overall Study|Lack of Efficacy|0|||
27998580|NCT00624052|54657285|FG003|Overall Study|Lack of Efficacy|0|||
27998581|NCT00624052|54657282|FG000|Overall Study|Lost to Follow-up|2|||
27998582|NCT00624052|54657283|FG001|Overall Study|Lost to Follow-up|3|||
27998583|NCT00624052|54657284|FG002|Overall Study|Lost to Follow-up|1|||
27998584|NCT00624052|54657285|FG003|Overall Study|Lost to Follow-up|0|||
27913183|NCT00476996|54570876|FG000|OLE Phase (From Week 48)|Lost to Follow-up|0|||
27913184|NCT00476996|54570877|FG001|OLE Phase (From Week 48)|Lost to Follow-up|0|||
27913185|NCT00476996|54570878|FG002|OLE Phase (From Week 48)|Lost to Follow-up|0|||
27913186|NCT00476996|54570879|FG003|OLE Phase (From Week 48)|Lost to Follow-up|4|||
27998585|NCT00624052|54657282|FG000|Overall Study|Non compliant with the protocol|2|||
27998586|NCT00624052|54657283|FG001|Overall Study|Non compliant with the protocol|1|||
27998587|NCT00624052|54657284|FG002|Overall Study|Non compliant with the protocol|1|||
27998588|NCT00624052|54657285|FG003|Overall Study|Non compliant with the protocol|1|||
27998589|NCT00624052|54657282|FG000|Overall Study|Consent withdrawn|3|||
27998590|NCT00624052|54657283|FG001|Overall Study|Consent withdrawn|1|||
27998591|NCT00624052|54657284|FG002|Overall Study|Consent withdrawn|1|||
27998592|NCT00624052|54657285|FG003|Overall Study|Consent withdrawn|0|||
27998593|NCT00624052|54657282|FG000|Overall Study|Changed job/ran out if meds|0|||
27998594|NCT00624052|54657283|FG001|Overall Study|Changed job/ran out if meds|2|||
27998595|NCT00624052|54657284|FG002|Overall Study|Changed job/ran out if meds|0|||
27998596|NCT00624052|54657285|FG003|Overall Study|Changed job/ran out if meds|0|||
27998597|NCT00785577|54657304|FG000|Study Period 2: Therapy Phase|Adverse Event|5|||
27913187|NCT00476996|54570876|FG000|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
27913188|NCT00476996|54570877|FG001|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
27913189|NCT00476996|54570878|FG002|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
27913190|NCT00476996|54570879|FG003|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4|||
27913191|NCT00476996|54570876|FG000|OLE Phase (From Week 48)|Early termination of the study|0|||
27913192|NCT00476996|54570877|FG001|OLE Phase (From Week 48)|Early termination of the study|0|||
28099363|NCT03806127|54755328|FG001|Overall Study|Lost to Follow-up|1|||
28099364|NCT03806127|54755327|FG000|Overall Study|Physician Decision|1|||
28099365|NCT03806127|54755328|FG001|Overall Study|Physician Decision|1|||
27913193|NCT00476996|54570878|FG002|OLE Phase (From Week 48)|Early termination of the study|0|||
27913194|NCT00476996|54570879|FG003|OLE Phase (From Week 48)|Early termination of the study|578|||
27913195|NCT00476957|54570890|FG000|Overall Study|Lost to Follow-up|176|||
27913196|NCT00476957|54570891|FG001|Overall Study|Lost to Follow-up|193|||
27913197|NCT00475865|54570900|FG000|Overall Study|Adverse Event|0|||
27998598|NCT00785577|54657305|FG001|Study Period 2: Therapy Phase|Adverse Event|7|||
27998599|NCT00785577|54657306|FG002|Study Period 2: Therapy Phase|Adverse Event|14|||
27998600|NCT00785577|54657307|FG003|Study Period 2: Therapy Phase|Adverse Event|10|||
27998601|NCT00785577|54657308|FG004|Study Period 2: Therapy Phase|Adverse Event|17|||
27998602|NCT00785577|54657304|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
28099366|NCT03806127|54755327|FG000|Overall Study|Could Not Come Due to Covid|1|||
28099367|NCT03806127|54755328|FG001|Overall Study|Could Not Come Due to Covid|0|||
27998603|NCT00785577|54657305|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
27998604|NCT00785577|54657306|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
28099368|NCT03806127|54755327|FG000|Overall Study|Prescribed Exclusionary Medication (Med)|1|||
28099369|NCT03806127|54755328|FG001|Overall Study|Prescribed Exclusionary Medication (Med)|0|||
28099370|NCT03806127|54755327|FG000|Overall Study|Ran Out of Study Meds (Covid Quarantine)|1|||
27913198|NCT00475865|54570901|FG001|Overall Study|Adverse Event|3|||
27913199|NCT00475865|54570902|FG002|Overall Study|Adverse Event|4|||
27913200|NCT00475865|54570900|FG000|Overall Study|Lack of Efficacy|1|||
27913201|NCT00475865|54570901|FG001|Overall Study|Lack of Efficacy|0|||
27998605|NCT00785577|54657307|FG003|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
27998606|NCT00785577|54657308|FG004|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
27998607|NCT00785577|54657304|FG000|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
27998608|NCT00785577|54657305|FG001|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
27998609|NCT00785577|54657306|FG002|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
27998610|NCT00785577|54657307|FG003|Study Period 2: Therapy Phase|Lost to Follow-up|1|||
27913202|NCT00475865|54570902|FG002|Overall Study|Lack of Efficacy|0|||
27913203|NCT00475865|54570900|FG000|Overall Study|Progressive disease|0|||
27913204|NCT00475865|54570901|FG001|Overall Study|Progressive disease|1|||
27998611|NCT00785577|54657308|FG004|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
27998612|NCT00785577|54657304|FG000|Study Period 2: Therapy Phase|Physician Decision|1|||
27998613|NCT00785577|54657305|FG001|Study Period 2: Therapy Phase|Physician Decision|0|||
27998614|NCT00785577|54657306|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
27913205|NCT00475865|54570902|FG002|Overall Study|Progressive disease|2|||
27913206|NCT00475865|54570900|FG000|Overall Study|Participant did not wish to continue|1|||
27913207|NCT00475865|54570901|FG001|Overall Study|Participant did not wish to continue|0|||
27913208|NCT00475865|54570902|FG002|Overall Study|Participant did not wish to continue|0|||
27913209|NCT00475865|54570900|FG000|Overall Study|Other than above|0|||
27913210|NCT00475865|54570901|FG001|Overall Study|Other than above|1|||
27913211|NCT00475865|54570902|FG002|Overall Study|Other than above|0|||
27913212|NCT00475709|54570912|FG000|Overall Study|Did not meet eligibility criteria|8|||
27913213|NCT00475709|54570912|FG000|Overall Study|Death|41|||
27913214|NCT00475709|54570912|FG000|Overall Study|Device Explant|6|||
27913215|NCT00475709|54570912|FG000|Overall Study|Lost to Follow-up|21|||
27913216|NCT00475670|54570918|FG000|Overall Study|Death|0|||
27913217|NCT00475670|54570919|FG001|Overall Study|Death|1|||
27998615|NCT00785577|54657307|FG003|Study Period 2: Therapy Phase|Physician Decision|0|||
27998616|NCT00785577|54657308|FG004|Study Period 2: Therapy Phase|Physician Decision|0|||
27998617|NCT00785577|54657304|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
27913218|NCT00475670|54570918|FG000|Overall Study|Lack of Efficacy|3|||
27913219|NCT00475670|54570919|FG001|Overall Study|Lack of Efficacy|34|||
27913220|NCT00475670|54570918|FG000|Overall Study|Refused treatment|0|||
27913221|NCT00475670|54570919|FG001|Overall Study|Refused treatment|2|||
27913222|NCT00475670|54570918|FG000|Overall Study|Failure to Return|0|||
27913223|NCT00475670|54570919|FG001|Overall Study|Failure to Return|1|||
27913224|NCT00475670|54570918|FG000|Overall Study|Other|0|||
27913225|NCT00475670|54570919|FG001|Overall Study|Other|3|||
27913226|NCT00474968|54570927|FG000|Overall Study|Withdrawal by Subject|8|||
27913227|NCT00474968|54570928|FG001|Overall Study|Withdrawal by Subject|7|||
27913228|NCT00474968|54570927|FG000|Overall Study|Protocol Violation|9|||
27913229|NCT00474968|54570928|FG001|Overall Study|Protocol Violation|8|||
27998618|NCT00785577|54657305|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
27913230|NCT00474968|54570927|FG000|Overall Study|Sample not collected|1|||
27913231|NCT00474968|54570928|FG001|Overall Study|Sample not collected|1|||
27913232|NCT00474929|54570939|FG000|Overall Study|Withdrawal by Subject|0|||
27913233|NCT00474929|54570940|FG001|Overall Study|Withdrawal by Subject|1|||
27913234|NCT00474929|54570941|FG002|Overall Study|Withdrawal by Subject|0|||
27913235|NCT00474929|54570942|FG003|Overall Study|Withdrawal by Subject|0|||
27913236|NCT00474929|54570943|FG004|Overall Study|Withdrawal by Subject|0|||
27913237|NCT00474929|54570939|FG000|Overall Study|Unrelated medical condition|0|||
27998619|NCT00785577|54657306|FG002|Study Period 2: Therapy Phase|Protocol Violation|1|||
28099371|NCT03806127|54755328|FG001|Overall Study|Ran Out of Study Meds (Covid Quarantine)|0|||
28099372|NCT03806127|54755327|FG000|Overall Study|Covid 19 Restrictions|2|||
27913238|NCT00474929|54570940|FG001|Overall Study|Unrelated medical condition|0|||
27913239|NCT00474929|54570941|FG002|Overall Study|Unrelated medical condition|1|||
27913240|NCT00474929|54570942|FG003|Overall Study|Unrelated medical condition|0|||
27913241|NCT00474929|54570943|FG004|Overall Study|Unrelated medical condition|0|||
27913242|NCT00474929|54570939|FG000|Overall Study|Physician Decision|0|||
27913243|NCT00474929|54570940|FG001|Overall Study|Physician Decision|0|||
27913244|NCT00474929|54570941|FG002|Overall Study|Physician Decision|1|||
27913245|NCT00474929|54570942|FG003|Overall Study|Physician Decision|2|||
27913246|NCT00474929|54570943|FG004|Overall Study|Physician Decision|0|||
27913247|NCT00474812|54570956|FG000|Overall Study|Withdrawal by Subject|5|||
27913248|NCT00474812|54570956|FG000|Overall Study|No Initiation of treatment|2|||
27913249|NCT00474383|54570960|FG000|Main Study|Adverse Event|11|||
27913250|NCT00474383|54570961|FG001|Main Study|Adverse Event|0|||
27998620|NCT00785577|54657307|FG003|Study Period 2: Therapy Phase|Protocol Violation|0|||
27739815|NCT02219932|54189538|FG001|Overall Study|Protocol Violation|6|||
27739816|NCT02219932|54189537|FG000|Overall Study|Pregnancy|1|||
27913251|NCT00474383|54570960|FG000|Main Study|Symptomatic Deterioration|1|||
27913252|NCT00474383|54570961|FG001|Main Study|Symptomatic Deterioration|0|||
27913253|NCT00474383|54570960|FG000|Main Study|Progressive Disease|23|||
27913254|NCT00474383|54570961|FG001|Main Study|Progressive Disease|0|||
27913255|NCT00474383|54570960|FG000|Main Study|Other|1|||
27913256|NCT00474383|54570961|FG001|Main Study|Other|0|||
27913257|NCT00474383|54570960|FG000|Between Main Study and Extension|Did Not Enter Extension Phase|6|||
27913258|NCT00474383|54570961|FG001|Between Main Study and Extension|Did Not Enter Extension Phase|0|||
27913259|NCT00474383|54570960|FG000|Extension|Progressive Disease|0|||
27913260|NCT00474383|54570961|FG001|Extension|Progressive Disease|5|||
27913261|NCT00474266|54570969|FG000|Overall Study|Withdrawal by Subject|7|||
27913262|NCT00474266|54570970|FG001|Overall Study|Withdrawal by Subject|20|||
27998621|NCT00785577|54657308|FG004|Study Period 2: Therapy Phase|Protocol Violation|1|||
27998622|NCT00785577|54657304|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
27998623|NCT00785577|54657305|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
27998624|NCT00785577|54657306|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
27998625|NCT00785577|54657307|FG003|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
27998626|NCT00785577|54657308|FG004|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
27998627|NCT00785577|54657304|FG000|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
27998628|NCT00785577|54657305|FG001|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
27998629|NCT00785577|54657306|FG002|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
27998630|NCT00785577|54657307|FG003|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
27913263|NCT00474266|54570971|FG002|Overall Study|Withdrawal by Subject|4|||
27913264|NCT00474266|54570972|FG003|Overall Study|Withdrawal by Subject|7|||
27913265|NCT00473564|54570985|FG000|Overall Study|robot surgery aborted in OR|23|||
27913266|NCT00472199|54570991|FG000|Overall Study|Adverse Event|19|||
27913267|NCT00472199|54570992|FG001|Overall Study|Adverse Event|23|||
27913268|NCT00472199|54570991|FG000|Overall Study|Lack of Efficacy|4|||
27913269|NCT00472199|54570992|FG001|Overall Study|Lack of Efficacy|25|||
27913270|NCT00472199|54570991|FG000|Overall Study|Lost to Follow-up|2|||
27913271|NCT00472199|54570992|FG001|Overall Study|Lost to Follow-up|4|||
27913272|NCT00472199|54570991|FG000|Overall Study|Protocol Violation|3|||
27913273|NCT00472199|54570992|FG001|Overall Study|Protocol Violation|2|||
27913274|NCT00472199|54570991|FG000|Overall Study|Withdrawal by Subject|6|||
27913275|NCT00472199|54570992|FG001|Overall Study|Withdrawal by Subject|5|||
27998631|NCT00785577|54657308|FG004|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
27998632|NCT00785577|54657304|FG000|Study Period 2: Therapy Phase|Sponsor Decision|1|||
27998633|NCT00785577|54657305|FG001|Study Period 2: Therapy Phase|Sponsor Decision|0|||
27998634|NCT00785577|54657306|FG002|Study Period 2: Therapy Phase|Sponsor Decision|1|||
27998635|NCT00785577|54657307|FG003|Study Period 2: Therapy Phase|Sponsor Decision|1|||
27998636|NCT00785577|54657308|FG004|Study Period 2: Therapy Phase|Sponsor Decision|0|||
27998637|NCT00785577|54657304|FG000|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
27998638|NCT00785577|54657305|FG001|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
27998639|NCT00785577|54657306|FG002|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
27998640|NCT00785577|54657307|FG003|Study Period 3: 1-Week Washout Phase|Adverse Event|1|||
27998641|NCT00785577|54657308|FG004|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
27998642|NCT00785577|54657304|FG000|Study Period 3: 1-Week Washout Phase|Death|0|||
27998643|NCT00785577|54657305|FG001|Study Period 3: 1-Week Washout Phase|Death|0|||
27998644|NCT00785577|54657306|FG002|Study Period 3: 1-Week Washout Phase|Death|0|||
27998645|NCT00785577|54657307|FG003|Study Period 3: 1-Week Washout Phase|Death|0|||
27998646|NCT00785577|54657308|FG004|Study Period 3: 1-Week Washout Phase|Death|1|||
27998647|NCT00789828|54657332|FG000|Core Period (48 Weeks)|Administrative problems|0|||
27998648|NCT00789828|54657333|FG001|Core Period (48 Weeks)|Administrative problems|1|||
27998649|NCT00789828|54657332|FG000|Core Period (48 Weeks)|Withdrawal by Subject|0|||
27998650|NCT00789828|54657333|FG001|Core Period (48 Weeks)|Withdrawal by Subject|4|||
27998651|NCT00789828|54657332|FG000|Core Period (48 Weeks)|Lost to Follow-up|0|||
27998652|NCT00789828|54657333|FG001|Core Period (48 Weeks)|Lost to Follow-up|1|||
27998653|NCT00789828|54657332|FG000|Open-label Extension Period (4 Years)|Adverse Event|10|||
27998654|NCT00789828|54657333|FG001|Open-label Extension Period (4 Years)|Adverse Event|0|||
27998655|NCT00789828|54657332|FG000|Open-label Extension Period (4 Years)|Withdrawal by Subject|6|||
27998656|NCT00789828|54657333|FG001|Open-label Extension Period (4 Years)|Withdrawal by Subject|0|||
27998657|NCT00789828|54657332|FG000|Open-label Extension Period (4 Years)|Lost to Follow-up|3|||
27998658|NCT00789828|54657333|FG001|Open-label Extension Period (4 Years)|Lost to Follow-up|0|||
27998659|NCT00789828|54657332|FG000|Open-label Extension Period (4 Years)|Administrative problems|7|||
27998660|NCT00789828|54657333|FG001|Open-label Extension Period (4 Years)|Administrative problems|0|||
27998661|NCT00789828|54657332|FG000|Open-label Extension Period (4 Years)|Death|1|||
27998662|NCT00789828|54657333|FG001|Open-label Extension Period (4 Years)|Death|0|||
27998663|NCT00789828|54657332|FG000|Open-label Extension Period (4 Years)|Disease progression|1|||
27998664|NCT00789828|54657333|FG001|Open-label Extension Period (4 Years)|Disease progression|0|||
27998665|NCT00789828|54657332|FG000|Open-label Extension Period (4 Years)|New treatment for indication under study|1|||
27998666|NCT00789828|54657333|FG001|Open-label Extension Period (4 Years)|New treatment for indication under study|0|||
27998667|NCT00790296|54657344|FG000|Overall Study|Did not meet study eligibility criteria|1|||
27998668|NCT00790296|54657345|FG001|Overall Study|Did not meet study eligibility criteria|1|||
27998669|NCT00790296|54657344|FG000|Overall Study|Adverse Event|0|||
27998670|NCT00790296|54657345|FG001|Overall Study|Adverse Event|1|||
27998671|NCT00623194|54657351|FG000|Overall Study|Lack of Efficacy|1|||
27998672|NCT00623194|54657351|FG000|Overall Study|Protocol Violation|3|||
28099373|NCT03806127|54755328|FG001|Overall Study|Covid 19 Restrictions|0|||
28099374|NCT03806127|54755327|FG000|Overall Study|Withdrawn Due to Work/School Schedule|0|||
27913276|NCT00472199|54570991|FG000|Overall Study|personal reason|0|||
27998673|NCT00623194|54657351|FG000|Overall Study|Unclassified|1|||
27998674|NCT00784368|54657358|FG000|Overall Study|Physician Decision|0|||
27998675|NCT00784368|54657359|FG001|Overall Study|Physician Decision|0|||
27913277|NCT00472199|54570992|FG001|Overall Study|personal reason|1|||
27998676|NCT00784368|54657360|FG002|Overall Study|Physician Decision|6|||
27998677|NCT00784368|54657358|FG000|Overall Study|Lack of Efficacy|2|||
27998678|NCT00784368|54657359|FG001|Overall Study|Lack of Efficacy|0|||
27913278|NCT00472199|54570991|FG000|Overall Study|patient was asymptomatic|1|||
27913279|NCT00472199|54570992|FG001|Overall Study|patient was asymptomatic|0|||
27998679|NCT00784368|54657360|FG002|Overall Study|Lack of Efficacy|1|||
27913280|NCT00472082|54570998|FG000|Overall Study|Study prematurely terminated|5|||
27913281|NCT00471887|54571002|FG000|Overall Study|Adverse Event|9|||
27913282|NCT00471536|54571006|FG000|Overall Study|Withdrawal by Subject|1|||
27913283|NCT00470834|54571012|FG000|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16|||
27913284|NCT00470834|54571013|FG001|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14|||
27913285|NCT00470834|54571012|FG000|Treatment Period (18 Months)|Adverse Event|7|||
27913286|NCT00470834|54571013|FG001|Treatment Period (18 Months)|Adverse Event|6|||
27998680|NCT00784368|54657358|FG000|Overall Study|Adverse Event|6|||
28099375|NCT03806127|54755328|FG001|Overall Study|Withdrawn Due to Work/School Schedule|1|||
27913287|NCT00470834|54571012|FG000|Treatment Period (18 Months)|Withdrawal by Subject|4|||
27913288|NCT00470834|54571013|FG001|Treatment Period (18 Months)|Withdrawal by Subject|5|||
27913289|NCT00470834|54571012|FG000|Treatment Period (18 Months)|Physician Decision|4|||
27913290|NCT00470834|54571013|FG001|Treatment Period (18 Months)|Physician Decision|4|||
27913291|NCT00470834|54571012|FG000|Treatment Period (18 Months)|Protocol Violation|3|||
27913292|NCT00470834|54571013|FG001|Treatment Period (18 Months)|Protocol Violation|1|||
27913293|NCT00470834|54571012|FG000|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
27913294|NCT00470834|54571013|FG001|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
27913295|NCT00470834|54571012|FG000|Treatment Period (18 Months)|Lost to Follow-up|1|||
27913296|NCT00470834|54571013|FG001|Treatment Period (18 Months)|Lost to Follow-up|0|||
27913297|NCT00470834|54571012|FG000|Treatment Period (18 Months)|Non-compliance|1|||
27913298|NCT00470834|54571013|FG001|Treatment Period (18 Months)|Non-compliance|0|||
27913299|NCT00470834|54571012|FG000|Treatment Period (18 Months)|Lack of Efficacy|1|||
27913300|NCT00470834|54571013|FG001|Treatment Period (18 Months)|Lack of Efficacy|0|||
27913301|NCT00470834|54571012|FG000|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6|||
27913302|NCT00470834|54571013|FG001|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7|||
27913303|NCT00470834|54571012|FG000|Extension Period (24 Months)|Adverse Event|3|||
28099376|NCT03806127|54755327|FG000|Overall Study|Covid 19 Concern; Possible Site Closure|0|||
28099377|NCT03806127|54755328|FG001|Overall Study|Covid 19 Concern; Possible Site Closure|1|||
28099378|NCT02843074|54755334|FG000|Overall Study|Withdrawal by Subject|5|||
28099379|NCT02843074|54755334|FG000|Overall Study|Progressive disease|1|||
28099380|NCT02843074|54755334|FG000|Overall Study|Physician Decision|1|||
28099381|NCT02843074|54755334|FG000|Overall Study|Lost to Follow-up|1|||
28099382|NCT02843074|54755334|FG000|Overall Study|Death|9|||
28099383|NCT03650400|54755340|FG000|Overall Study|Study terminated by sponsor|0|||
28099384|NCT03650400|54755341|FG001|Overall Study|Study terminated by sponsor|5|||
28099385|NCT00038103|54755349|FG000|Overall Study|Adverse Event|5|||
28099386|NCT00038103|54755350|FG001|Overall Study|Adverse Event|6|||
28099387|NCT00038103|54755349|FG000|Overall Study|Lack of Efficacy|48|||
28099388|NCT00038103|54755350|FG001|Overall Study|Lack of Efficacy|41|||
28099389|NCT00038103|54755349|FG000|Overall Study|Withdrawal by Subject|0|||
28099390|NCT00038103|54755350|FG001|Overall Study|Withdrawal by Subject|3|||
28099391|NCT00038103|54755349|FG000|Overall Study|Lost to Follow-up|0|||
28099392|NCT00038103|54755350|FG001|Overall Study|Lost to Follow-up|3|||
28099393|NCT00038103|54755349|FG000|Overall Study|Protocol Violation|0|||
28099394|NCT00038103|54755350|FG001|Overall Study|Protocol Violation|2|||
28099395|NCT00038103|54755349|FG000|Overall Study|Sponsor Decision|0|||
28099396|NCT00038103|54755350|FG001|Overall Study|Sponsor Decision|1|||
28099397|NCT00038103|54755349|FG000|Overall Study|Randomized/never treated|2|||
28099398|NCT00038103|54755350|FG001|Overall Study|Randomized/never treated|0|||
28099399|NCT03680742|54755356|FG000|Overall Study|Unsuccessful Implant Attempt|2|||
28099400|NCT03678870|54755362|FG000|Overall Study|prescribed non- protocol medications|10|||
28099401|NCT03678870|54755363|FG001|Overall Study|prescribed non- protocol medications|6|||
28099402|NCT03678870|54755362|FG000|Overall Study|Lost to Follow-up|3|||
28099403|NCT03678870|54755363|FG001|Overall Study|Lost to Follow-up|2|||
28099404|NCT03805971|54755369|FG000|Overall Study|Withdrawal by Subject|1|||
27739817|NCT02219932|54189538|FG001|Overall Study|Pregnancy|0|||
27739818|NCT02219932|54189537|FG000|Overall Study|Lost to Follow-up|4|||
27913304|NCT00470834|54571013|FG001|Extension Period (24 Months)|Adverse Event|4|||
27913305|NCT00470834|54571012|FG000|Extension Period (24 Months)|Withdrawal by Subject|2|||
27998681|NCT00784368|54657359|FG001|Overall Study|Adverse Event|9|||
27998682|NCT00784368|54657360|FG002|Overall Study|Adverse Event|2|||
27998683|NCT00784368|54657358|FG000|Overall Study|Diagnosis of fever|0|||
27998684|NCT00784368|54657359|FG001|Overall Study|Diagnosis of fever|0|||
27998685|NCT00784368|54657360|FG002|Overall Study|Diagnosis of fever|1|||
28099405|NCT03805971|54755369|FG000|Overall Study|Protocol Violation|2|||
28099406|NCT03032380|54755376|FG000|Overall Study|Adverse Event|0|||
28099407|NCT03032380|54755377|FG001|Overall Study|Adverse Event|1|||
28099408|NCT03032380|54755376|FG000|Overall Study|Lack of Efficacy|1|||
27998686|NCT00784368|54657358|FG000|Overall Study|Worsening of complications|0|||
27913306|NCT00470834|54571013|FG001|Extension Period (24 Months)|Withdrawal by Subject|5|||
27913307|NCT00470834|54571012|FG000|Extension Period (24 Months)|Physician Decision|4|||
27913308|NCT00470834|54571013|FG001|Extension Period (24 Months)|Physician Decision|3|||
27913309|NCT00470834|54571012|FG000|Extension Period (24 Months)|Sponsor Terminated Study|0|||
27998687|NCT00784368|54657359|FG001|Overall Study|Worsening of complications|0|||
27998688|NCT00784368|54657360|FG002|Overall Study|Worsening of complications|1|||
27998689|NCT00784368|54657358|FG000|Overall Study|Worsening of symptoms|0|||
27998690|NCT00784368|54657359|FG001|Overall Study|Worsening of symptoms|1|||
27998691|NCT00784368|54657360|FG002|Overall Study|Worsening of symptoms|0|||
27998692|NCT00784368|54657358|FG000|Overall Study|Withdrawal of informed consent|0|||
27998693|NCT00784368|54657359|FG001|Overall Study|Withdrawal of informed consent|1|||
27998694|NCT00784368|54657360|FG002|Overall Study|Withdrawal of informed consent|0|||
27998695|NCT00622726|54657373|FG000|March, 2008 to August, 2010|Death|5|||
27998696|NCT00622726|54657374|FG001|March, 2008 to August, 2010|Death|2|||
27998697|NCT00622726|54657373|FG000|August, 2010 to April, 2013|Death|1|||
27998698|NCT00622726|54657374|FG001|August, 2010 to April, 2013|Death|5|||
27998699|NCT00623428|54657386|FG000|Treatment Period|Adverse event/intercurrent illness|0|||
27998700|NCT00623428|54657387|FG001|Treatment Period|Adverse event/intercurrent illness|9|||
27998701|NCT00623428|54657386|FG000|Treatment Period|Death|0|||
27998702|NCT00623428|54657387|FG001|Treatment Period|Death|1|||
27998703|NCT00623428|54657386|FG000|Treatment Period|Did not cooperate / refused treatment|0|||
27998704|NCT00623428|54657387|FG001|Treatment Period|Did not cooperate / refused treatment|13|||
27998705|NCT00623428|54657386|FG000|Treatment Period|Insufficient therapeutic response|0|||
27998706|NCT00623428|54657387|FG001|Treatment Period|Insufficient therapeutic response|2|||
27998707|NCT00623428|54657386|FG000|Treatment Period|Other|0|||
27998708|NCT00623428|54657387|FG001|Treatment Period|Other|1|||
27998709|NCT00623428|54657386|FG000|Treatment Period|Withdrawal by Subject|0|||
27998710|NCT00623428|54657387|FG001|Treatment Period|Withdrawal by Subject|1|||
27998711|NCT00623428|54657386|FG000|Follow-up Period|Relapse post-treatment|11|||
27998712|NCT00623428|54657387|FG001|Follow-up Period|Relapse post-treatment|3|||
27998713|NCT00623428|54657386|FG000|Follow-up Period|Failure to return|10|||
27998714|NCT00623428|54657387|FG001|Follow-up Period|Failure to return|2|||
27998715|NCT00623428|54657386|FG000|Follow-up Period|Patient withdrew consent|5|||
27998716|NCT00623428|54657387|FG001|Follow-up Period|Patient withdrew consent|4|||
27998717|NCT00623428|54657386|FG000|Follow-up Period|HCV-RNA detectable at end of treatment|2|||
27998718|NCT00623428|54657387|FG001|Follow-up Period|HCV-RNA detectable at end of treatment|1|||
27998719|NCT00623428|54657386|FG000|Follow-up Period|Did not cooperate|0|||
27998720|NCT00623428|54657387|FG001|Follow-up Period|Did not cooperate|3|||
27998721|NCT00623428|54657386|FG000|Follow-up Period|Reason not specified|1|||
27998722|NCT00623428|54657387|FG001|Follow-up Period|Reason not specified|1|||
27998723|NCT00623428|54657386|FG000|Follow-up Period|Death|0|||
27998724|NCT00623428|54657387|FG001|Follow-up Period|Death|1|||
27998725|NCT00784134|54657395|FG000|Overall Study|Lost to Follow-up|3|||
27998726|NCT00784134|54657396|FG001|Overall Study|Lost to Follow-up|6|||
27998727|NCT00776100|54657404|FG000|Overall Study|Disease Progression|1|||
27998728|NCT00776100|54657405|FG001|Overall Study|Disease Progression|0|||
27998729|NCT00783432|54657413|FG000|Overall Study|Adverse Event|22|||
27913310|NCT00470834|54571013|FG001|Extension Period (24 Months)|Sponsor Terminated Study|1|||
27913311|NCT00470834|54571012|FG000|Extension Period (24 Months)|Lost to Follow-up|0|||
27913312|NCT00470834|54571013|FG001|Extension Period (24 Months)|Lost to Follow-up|1|||
27913313|NCT00470834|54571012|FG000|Extension Period (24 Months)|Non-compliance|0|||
27913314|NCT00470834|54571013|FG001|Extension Period (24 Months)|Non-compliance|1|||
27913315|NCT00470834|54571012|FG000|Extension Period (24 Months)|Disease Progression|0|||
27913316|NCT00470834|54571013|FG001|Extension Period (24 Months)|Disease Progression|1|||
27913317|NCT00470366|54571019|FG000|Overall Study|Adverse Event|3|||
27913318|NCT00470366|54571019|FG000|Overall Study|Poor compliance|1|||
27913319|NCT00470093|54571023|FG000|Overall Study|Adverse Event|2|||
27913320|NCT00470054|54571027|FG000|Overall Study|Ineligible|1|||
27998730|NCT00783432|54657414|FG001|Overall Study|Adverse Event|17|||
27998731|NCT00783432|54657413|FG000|Overall Study|Lack of Efficacy|20|||
27998732|NCT00783432|54657414|FG001|Overall Study|Lack of Efficacy|21|||
27998733|NCT00783432|54657413|FG000|Overall Study|Lost to Follow-up|11|||
27998734|NCT00783432|54657414|FG001|Overall Study|Lost to Follow-up|6|||
27913321|NCT00474188|54571031|FG000|Overall Study|Withdrawal by Subject|1|||
27913322|NCT00474188|54571031|FG000|Overall Study|Study discontinued by sponsor|5|||
27998735|NCT00783432|54657413|FG000|Overall Study|Withdrawal by Subject|23|||
27998736|NCT00783432|54657414|FG001|Overall Study|Withdrawal by Subject|20|||
27998737|NCT00783432|54657413|FG000|Overall Study|subject moved|3|||
27913323|NCT00475982|54571036|FG000|Overall Study|surgery rescheduled|7|||
27913324|NCT00475982|54571037|FG001|Overall Study|surgery rescheduled|3|||
27913325|NCT01089647|54571045|FG000|Overall Study|Lost to Follow-up|2|||
27998738|NCT00783432|54657414|FG001|Overall Study|subject moved|5|||
27998739|NCT00783432|54657413|FG000|Overall Study|Protocol Violation|6|||
27998740|NCT00783432|54657414|FG001|Overall Study|Protocol Violation|9|||
27998741|NCT00783198|54657423|FG000|Overall Study|Adverse Event|15|||
27913326|NCT01089647|54571046|FG001|Overall Study|Lost to Follow-up|2|||
27913327|NCT01089647|54571045|FG000|Overall Study|Withdrawal by Subject|2|||
27913328|NCT01089647|54571046|FG001|Overall Study|Withdrawal by Subject|1|||
27913329|NCT01089647|54571045|FG000|Overall Study|Adverse Event|0|||
27913330|NCT01089647|54571046|FG001|Overall Study|Adverse Event|1|||
27913331|NCT01089608|54571054|FG000|Overall Study|Adverse Event|0|||
27913332|NCT01089608|54571055|FG001|Overall Study|Adverse Event|4|||
27913333|NCT01089608|54571054|FG000|Overall Study|Lost to Follow-up|0|||
27913334|NCT01089608|54571055|FG001|Overall Study|Lost to Follow-up|2|||
27913335|NCT01089413|54571064|FG000|Overall Study|Lost to Follow-up|1|||
27998742|NCT00783198|54657424|FG001|Overall Study|Adverse Event|19|||
27998743|NCT00783198|54657425|FG002|Overall Study|Adverse Event|3|||
27998744|NCT00783198|54657423|FG000|Overall Study|Lost to Follow-up|11|||
27998745|NCT00783198|54657424|FG001|Overall Study|Lost to Follow-up|1|||
27998746|NCT00783198|54657425|FG002|Overall Study|Lost to Follow-up|7|||
27998747|NCT00783198|54657423|FG000|Overall Study|Withdrawal by Subject|22|||
27998748|NCT00783198|54657424|FG001|Overall Study|Withdrawal by Subject|14|||
27998749|NCT00783198|54657425|FG002|Overall Study|Withdrawal by Subject|20|||
27998750|NCT00783198|54657423|FG000|Overall Study|Noncompliance with protocol|7|||
27998751|NCT00783198|54657424|FG001|Overall Study|Noncompliance with protocol|7|||
27998752|NCT00783198|54657425|FG002|Overall Study|Noncompliance with protocol|10|||
27998753|NCT00783198|54657423|FG000|Overall Study|Did not meet protocol eligibility|0|||
27998754|NCT00783198|54657424|FG001|Overall Study|Did not meet protocol eligibility|1|||
27998755|NCT00783198|54657425|FG002|Overall Study|Did not meet protocol eligibility|0|||
27998756|NCT00783198|54657423|FG000|Overall Study|Administrative|2|||
27998757|NCT00783198|54657424|FG001|Overall Study|Administrative|1|||
27998758|NCT00783198|54657425|FG002|Overall Study|Administrative|2|||
27998759|NCT00789360|54657435|FG000|Overall Study|Protocol Violation|3|||
27998760|NCT00789360|54657436|FG001|Overall Study|Protocol Violation|1|||
27998761|NCT00782496|54657445|FG000|Overall Study|Lost to Follow-up|14|||
27998762|NCT00782496|54657446|FG001|Overall Study|Lost to Follow-up|15|||
27998763|NCT00782418|54657453|FG000|Period 1 Procedure/Treatment Groups|Adverse Event|1|||
27998764|NCT00782418|54657454|FG001|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
27998765|NCT00782418|54657455|FG002|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
27998766|NCT00782418|54657456|FG003|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
27998767|NCT00782418|54657457|FG004|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
27998768|NCT00782418|54657458|FG005|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
27998769|NCT00782418|54657459|FG006|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
27998770|NCT00782418|54657453|FG000|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
27998771|NCT00782418|54657454|FG001|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
27998772|NCT00782418|54657455|FG002|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
27998773|NCT00782418|54657456|FG003|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
27998774|NCT00782418|54657457|FG004|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
27998775|NCT00782418|54657458|FG005|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
27998776|NCT00782418|54657459|FG006|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
27998777|NCT00782340|54657476|FG000|Open Label Titration|Adverse Event|12|||
27998778|NCT00782340|54657477|FG001|Open Label Titration|Adverse Event|0|||
27998779|NCT00782340|54657478|FG002|Open Label Titration|Adverse Event|0|||
27998780|NCT00782340|54657476|FG000|Open Label Titration|Treatment failure|50|||
27998781|NCT00782340|54657477|FG001|Open Label Titration|Treatment failure|0|||
27998782|NCT00782340|54657478|FG002|Open Label Titration|Treatment failure|0|||
27998783|NCT00782340|54657476|FG000|Open Label Titration|Protocol Violation|5|||
27998784|NCT00782340|54657477|FG001|Open Label Titration|Protocol Violation|0|||
27998785|NCT00782340|54657478|FG002|Open Label Titration|Protocol Violation|0|||
27998786|NCT00782340|54657476|FG000|Open Label Titration|Withdrawal by Subject|5|||
27998787|NCT00782340|54657477|FG001|Open Label Titration|Withdrawal by Subject|0|||
27998788|NCT00782340|54657478|FG002|Open Label Titration|Withdrawal by Subject|0|||
27998789|NCT00782340|54657476|FG000|Open Label Titration|Enrollment capped|16|||
27998790|NCT00782340|54657477|FG001|Open Label Titration|Enrollment capped|0|||
27998791|NCT00782340|54657478|FG002|Open Label Titration|Enrollment capped|0|||
27998792|NCT00782340|54657476|FG000|Open Label Titration|Did not meet responder criteria|2|||
27998793|NCT00782340|54657477|FG001|Open Label Titration|Did not meet responder criteria|0|||
27998794|NCT00782340|54657478|FG002|Open Label Titration|Did not meet responder criteria|0|||
28099409|NCT03032380|54755377|FG001|Overall Study|Lack of Efficacy|0|||
27913336|NCT01089413|54571064|FG000|Overall Study|Progressive Disease|93|||
27913337|NCT01089413|54571064|FG000|Overall Study|Participant Withdrew Consent|1|||
27913338|NCT01089413|54571064|FG000|Overall Study|Unacceptable Toxicity|12|||
27913339|NCT01089413|54571064|FG000|Overall Study|Death|10|||
27998795|NCT00782340|54657476|FG000|Open Label Titration|Lost to Follow-up|5|||
27998796|NCT00782340|54657477|FG001|Open Label Titration|Lost to Follow-up|0|||
27998797|NCT00782340|54657478|FG002|Open Label Titration|Lost to Follow-up|0|||
27998798|NCT00782340|54657476|FG000|Open Label Titration|Randomized in error|6|||
27913340|NCT01089413|54571064|FG000|Overall Study|Metastasectomy|13|||
27998799|NCT00782340|54657477|FG001|Open Label Titration|Randomized in error|0|||
27998800|NCT00782340|54657478|FG002|Open Label Titration|Randomized in error|0|||
27998801|NCT00774852|54657487|FG000|Overall Study|Adverse Event|9|||
27998802|NCT00774852|54657488|FG001|Overall Study|Adverse Event|6|||
27998803|NCT00774852|54657487|FG000|Overall Study|Death|2|||
27998804|NCT00774852|54657488|FG001|Overall Study|Death|1|||
27998805|NCT00774852|54657487|FG000|Overall Study|Lack of Efficacy|3|||
27998806|NCT00774852|54657488|FG001|Overall Study|Lack of Efficacy|7|||
27998807|NCT00774852|54657487|FG000|Overall Study|Lost to Follow-up|9|||
27998808|NCT00774852|54657488|FG001|Overall Study|Lost to Follow-up|5|||
27998809|NCT00774852|54657487|FG000|Overall Study|Physician Decision|2|||
27998810|NCT00774852|54657488|FG001|Overall Study|Physician Decision|6|||
27998811|NCT00774852|54657487|FG000|Overall Study|Pregnancy|1|||
27998812|NCT00774852|54657488|FG001|Overall Study|Pregnancy|2|||
27998813|NCT00774852|54657487|FG000|Overall Study|Withdrawal by Subject|2|||
27998814|NCT00774852|54657488|FG001|Overall Study|Withdrawal by Subject|2|||
27998815|NCT00774852|54657487|FG000|Overall Study|Non-responder|15|||
27998816|NCT00774852|54657488|FG001|Overall Study|Non-responder|11|||
27998817|NCT00774852|54657487|FG000|Overall Study|Subject non-compliance|0|||
27998818|NCT00774852|54657488|FG001|Overall Study|Subject non-compliance|1|||
27998819|NCT00774852|54657487|FG000|Overall Study|Protocol Violation|1|||
27998820|NCT00774852|54657488|FG001|Overall Study|Protocol Violation|0|||
27998821|NCT00774852|54657487|FG000|Overall Study|Subject received prohibited medication|1|||
27998822|NCT00774852|54657488|FG001|Overall Study|Subject received prohibited medication|0|||
27998823|NCT00774306|54657508|FG000|Overall Study|Adverse Event|3|||
27998824|NCT00774306|54657509|FG001|Overall Study|Adverse Event|0|||
27998825|NCT00774306|54657510|FG002|Overall Study|Adverse Event|0|||
27998826|NCT00774306|54657511|FG003|Overall Study|Adverse Event|0|||
27998827|NCT00774306|54657508|FG000|Overall Study|Protocol Violation|2|||
27998828|NCT00774306|54657509|FG001|Overall Study|Protocol Violation|0|||
27998829|NCT00774306|54657510|FG002|Overall Study|Protocol Violation|3|||
27998830|NCT00774306|54657511|FG003|Overall Study|Protocol Violation|0|||
27998831|NCT00774306|54657508|FG000|Overall Study|Withdrawal by Subject|6|||
27998832|NCT00774306|54657509|FG001|Overall Study|Withdrawal by Subject|1|||
27998833|NCT00774306|54657510|FG002|Overall Study|Withdrawal by Subject|1|||
27998834|NCT00774306|54657511|FG003|Overall Study|Withdrawal by Subject|0|||
27998835|NCT00774306|54657508|FG000|Overall Study|Lost to Follow-up|6|||
27998836|NCT00774306|54657509|FG001|Overall Study|Lost to Follow-up|0|||
27998837|NCT00774306|54657510|FG002|Overall Study|Lost to Follow-up|4|||
27998838|NCT00774306|54657511|FG003|Overall Study|Lost to Follow-up|5|||
27998839|NCT00774306|54657508|FG000|Overall Study|Death|1|||
27998840|NCT00774306|54657509|FG001|Overall Study|Death|1|||
27998841|NCT00774306|54657510|FG002|Overall Study|Death|0|||
27998842|NCT00774306|54657511|FG003|Overall Study|Death|0|||
27998843|NCT00781326|54657521|FG000|Phase I|Adverse Event|1|||
27998844|NCT00781326|54657521|FG000|Phase I|Withdrawal by Subject|1|||
27998845|NCT00781326|54657521|FG000|Phase I|Physician Decision|2|||
27998846|NCT00787800|54657527|FG000|Overall Study|Withdrawal by Subject|3|||
27998847|NCT00787800|54657528|FG001|Overall Study|Withdrawal by Subject|5|||
27998848|NCT00787800|54657527|FG000|Overall Study|Death|0|||
27998849|NCT00787800|54657528|FG001|Overall Study|Death|2|||
27998850|NCT00773838|54657535|FG000|Overall Study|Adverse Event|29|||
27998851|NCT00773838|54657535|FG000|Overall Study|Lost to Follow-up|1|||
27998852|NCT00773838|54657535|FG000|Overall Study|Physician Decision|8|||
27998853|NCT00773838|54657535|FG000|Overall Study|Progressive Disease|82|||
27998854|NCT00773838|54657535|FG000|Overall Study|Protocol Violation|2|||
27998855|NCT00773838|54657535|FG000|Overall Study|Withdrawal by Subject|21|||
27998856|NCT00787644|54657541|FG000|Overall Study|Lost to Follow-up|1|||
27998857|NCT00787644|54657542|FG001|Overall Study|Lost to Follow-up|1|||
27998858|NCT00787644|54657541|FG000|Overall Study|Withdrawal by Subject|1|||
28172694|NCT02635646|54844411|FG000|Overall Study|Pregnancy|1|||
27998859|NCT00787644|54657542|FG001|Overall Study|Withdrawal by Subject|1|||
27998860|NCT00787566|54657551|FG000|Overall Study|AE related to chemotherapy|0|||
27998861|NCT00787566|54657552|FG001|Overall Study|AE related to chemotherapy|1|||
27998862|NCT00787566|54657553|FG002|Overall Study|AE related to chemotherapy|0|||
27998863|NCT00787254|54657563|FG000|Overall Study|Adverse Event|24|||
27998864|NCT00787254|54657564|FG001|Overall Study|Adverse Event|23|||
27998865|NCT00787254|54657563|FG000|Overall Study|Protocol Violation|26|||
27998866|NCT00787254|54657564|FG001|Overall Study|Protocol Violation|23|||
27998867|NCT00787254|54657563|FG000|Overall Study|Withdrawal by Subject|16|||
27998868|NCT00787254|54657564|FG001|Overall Study|Withdrawal by Subject|11|||
27998869|NCT00787254|54657563|FG000|Overall Study|Lack of Efficacy|4|||
27998870|NCT00787254|54657564|FG001|Overall Study|Lack of Efficacy|15|||
27998871|NCT00787254|54657563|FG000|Overall Study|NSAIDs discontinuation|1|||
27998872|NCT00787254|54657564|FG001|Overall Study|NSAIDs discontinuation|2|||
27998873|NCT00787254|54657563|FG000|Overall Study|Institution closed|1|||
27998874|NCT00787254|54657564|FG001|Overall Study|Institution closed|0|||
27998875|NCT00787254|54657563|FG000|Overall Study|Physician Decision|4|||
27998876|NCT00787254|54657564|FG001|Overall Study|Physician Decision|8|||
27998877|NCT00625846|54657574|FG000|Overall Study|Withdrawal by Subject|2|||
27998878|NCT00625846|54657575|FG001|Overall Study|Withdrawal by Subject|0|||
27998879|NCT00625846|54657576|FG002|Overall Study|Withdrawal by Subject|1|||
27998880|NCT00625846|54657577|FG003|Overall Study|Withdrawal by Subject|2|||
27998881|NCT00773292|54657591|FG000|Treatment 48 Weeks|Adverse Event|1|||
27998882|NCT00773292|54657591|FG000|Treatment 48 Weeks|Lack of Efficacy|1|||
27998883|NCT00786864|54657597|FG000|Overall Study|Lost to Follow-up|0|||
27998884|NCT00786864|54657598|FG001|Overall Study|Lost to Follow-up|1|||
27998885|NCT00786864|54657597|FG000|Overall Study|Sustained serious back injury|1|||
27998886|NCT00786864|54657598|FG001|Overall Study|Sustained serious back injury|0|||
27998887|NCT00621322|54657610|FG000|Overall Study|Lost to Follow-up|0|||
27998888|NCT00621322|54657611|FG001|Overall Study|Lost to Follow-up|0|||
27998889|NCT00621322|54657612|FG002|Overall Study|Lost to Follow-up|0|||
27998890|NCT00621322|54657613|FG003|Overall Study|Lost to Follow-up|0|||
27998891|NCT00621322|54657614|FG004|Overall Study|Lost to Follow-up|1|||
27998892|NCT00621322|54657615|FG005|Overall Study|Lost to Follow-up|0|||
27998893|NCT00621322|54657610|FG000|Overall Study|Physician Decision|0|||
27913341|NCT01089413|54571064|FG000|Overall Study|Other|71|||
27998894|NCT00621322|54657611|FG001|Overall Study|Physician Decision|0|||
27998895|NCT00621322|54657612|FG002|Overall Study|Physician Decision|1|||
27998896|NCT00621322|54657613|FG003|Overall Study|Physician Decision|1|||
27998897|NCT00621322|54657614|FG004|Overall Study|Physician Decision|0|||
27998898|NCT00621322|54657615|FG005|Overall Study|Physician Decision|0|||
27998899|NCT00621322|54657610|FG000|Overall Study|Withdrawal by Subject|0|||
27998900|NCT00621322|54657611|FG001|Overall Study|Withdrawal by Subject|0|||
27913342|NCT01089023|54571074|FG000|Overall Study|Lost to Follow-up|3|||
27913343|NCT01089023|54571074|FG000|Overall Study|Adverse Event|1|||
27913344|NCT01089023|54571074|FG000|Overall Study|Withdrawal by Subject|1|||
27913345|NCT01089023|54571074|FG000|Overall Study|Protocol Violation|1|||
27913346|NCT01089023|54571074|FG000|Overall Study|Lack of Efficacy|1|||
27913347|NCT01088984|54571080|FG000|Phase 1|Death|2|||
27998901|NCT00621322|54657612|FG002|Overall Study|Withdrawal by Subject|0|||
27998902|NCT00621322|54657613|FG003|Overall Study|Withdrawal by Subject|1|||
27998903|NCT00621322|54657614|FG004|Overall Study|Withdrawal by Subject|0|||
27998904|NCT00621322|54657615|FG005|Overall Study|Withdrawal by Subject|2|||
27998905|NCT00621322|54657610|FG000|Overall Study|Migrated/moved from study area|1|||
27998906|NCT00621322|54657611|FG001|Overall Study|Migrated/moved from study area|0|||
27998907|NCT00621322|54657612|FG002|Overall Study|Migrated/moved from study area|1|||
27998908|NCT00621322|54657613|FG003|Overall Study|Migrated/moved from study area|1|||
27998909|NCT00621322|54657614|FG004|Overall Study|Migrated/moved from study area|0|||
27998910|NCT00621322|54657615|FG005|Overall Study|Migrated/moved from study area|2|||
27998911|NCT00853385|54657634|FG000|Overall Study|Death|0|||
27998912|NCT00853385|54657635|FG001|Overall Study|Death|0|||
27998913|NCT00853385|54657636|FG002|Overall Study|Death|0|||
27998914|NCT00853385|54657637|FG003|Overall Study|Death|0|||
27998915|NCT00853385|54657638|FG004|Overall Study|Death|1|||
27998916|NCT00853385|54657634|FG000|Overall Study|Adverse Event|24|||
27998917|NCT00853385|54657635|FG001|Overall Study|Adverse Event|24|||
27998918|NCT00853385|54657636|FG002|Overall Study|Adverse Event|2|||
27998919|NCT00853385|54657637|FG003|Overall Study|Adverse Event|5|||
27998920|NCT00853385|54657638|FG004|Overall Study|Adverse Event|22|||
27998921|NCT00853385|54657634|FG000|Overall Study|Lack of Efficacy|6|||
27998922|NCT00853385|54657635|FG001|Overall Study|Lack of Efficacy|7|||
27998923|NCT00853385|54657636|FG002|Overall Study|Lack of Efficacy|3|||
27998924|NCT00853385|54657637|FG003|Overall Study|Lack of Efficacy|3|||
27998925|NCT00853385|54657638|FG004|Overall Study|Lack of Efficacy|6|||
27998926|NCT00853385|54657634|FG000|Overall Study|Lost to Follow-up|2|||
27998927|NCT00853385|54657635|FG001|Overall Study|Lost to Follow-up|1|||
27998928|NCT00853385|54657636|FG002|Overall Study|Lost to Follow-up|0|||
28099410|NCT03032380|54755376|FG000|Overall Study|Withdrawal by Subject|2|||
27913348|NCT01088984|54571081|FG001|Phase 1|Death|1|||
28099411|NCT03032380|54755377|FG001|Overall Study|Withdrawal by Subject|3|||
28099412|NCT03032380|54755376|FG000|Overall Study|Recovery|0|||
27998929|NCT00853385|54657637|FG003|Overall Study|Lost to Follow-up|0|||
27998930|NCT00853385|54657638|FG004|Overall Study|Lost to Follow-up|0|||
27998931|NCT00853385|54657634|FG000|Overall Study|Withdrawal by Subject|4|||
27998932|NCT00853385|54657635|FG001|Overall Study|Withdrawal by Subject|2|||
27998933|NCT00853385|54657636|FG002|Overall Study|Withdrawal by Subject|0|||
27998934|NCT00853385|54657637|FG003|Overall Study|Withdrawal by Subject|1|||
27998935|NCT00853385|54657638|FG004|Overall Study|Withdrawal by Subject|1|||
27998936|NCT00853385|54657634|FG000|Overall Study|Other|18|||
27998937|NCT00853385|54657635|FG001|Overall Study|Other|9|||
27998938|NCT00853385|54657636|FG002|Overall Study|Other|4|||
27998939|NCT00853385|54657637|FG003|Overall Study|Other|4|||
27998940|NCT00853385|54657638|FG004|Overall Study|Other|12|||
27913349|NCT01088984|54571080|FG000|Phase 1|Disease Progression|2|||
27998941|NCT00622336|54657660|FG000|Treatment Phase|Progression of Disease|181|||
27998942|NCT00622336|54657660|FG000|Treatment Phase|Adverse Event|46|||
27998943|NCT00622336|54657660|FG000|Treatment Phase|Other|40|||
27998944|NCT00622336|54657660|FG000|Treatment Phase|Death|14|||
28099413|NCT03032380|54755377|FG001|Overall Study|Recovery|1|||
27913350|NCT01088984|54571081|FG001|Phase 1|Disease Progression|4|||
27913351|NCT01088984|54571080|FG000|Phase 1|Other|1|||
27913352|NCT01088984|54571081|FG001|Phase 1|Other|1|||
27913353|NCT01088984|54571080|FG000|Phase 2|Death|0|||
27913354|NCT01088984|54571081|FG001|Phase 2|Death|5|||
27913355|NCT01088984|54571080|FG000|Phase 2|Withdrawal by Subject|0|||
27913356|NCT01088984|54571081|FG001|Phase 2|Withdrawal by Subject|1|||
27913357|NCT01088984|54571080|FG000|Phase 2|DIsease Progression|0|||
27998945|NCT00622336|54657660|FG000|Treatment Phase|Lack of therapeutic effect|13|||
27998946|NCT00622336|54657660|FG000|Treatment Phase|Withdrawal by Subject|13|||
27998947|NCT00622336|54657660|FG000|Treatment Phase|Lost to Follow-up|2|||
27998948|NCT00622336|54657660|FG000|Extension Phase|Adverse Event|2|||
27998949|NCT00622336|54657660|FG000|Extension Phase|Progressive Disease|6|||
27998950|NCT00622336|54657660|FG000|Extension Phase|Lack of therapeutic effect|2|||
27998951|NCT00622336|54657660|FG000|Extension Phase|Withdrawal by Subject|1|||
27998952|NCT00622336|54657660|FG000|Extension Phase|Lost to Follow-up|1|||
27998953|NCT00622336|54657660|FG000|Extension Phase|Other|9|||
27998954|NCT00779766|54657668|FG000|Month 24|Serious Adverse Event|2|||
27998955|NCT00779766|54657669|FG001|Month 24|Serious Adverse Event|3|||
27998956|NCT00779766|54657668|FG000|Month 24|Adverse Event|3|||
27998957|NCT00779766|54657669|FG001|Month 24|Adverse Event|3|||
27998958|NCT00779766|54657668|FG000|Month 24|Protocol Violation|3|||
27913358|NCT01088984|54571081|FG001|Phase 2|DIsease Progression|25|||
27913359|NCT01088984|54571080|FG000|Phase 2|Other|0|||
27998959|NCT00779766|54657669|FG001|Month 24|Protocol Violation|1|||
27998960|NCT00779766|54657668|FG000|Month 24|Withdrawal by Subject|159|||
27998961|NCT00779766|54657669|FG001|Month 24|Withdrawal by Subject|127|||
27998962|NCT00779766|54657668|FG000|Month 24|Migrated/moved from study area|138|||
27998963|NCT00779766|54657669|FG001|Month 24|Migrated/moved from study area|162|||
27998964|NCT00779766|54657668|FG000|Month 24|Lost to Follow-up|9|||
27998965|NCT00779766|54657669|FG001|Month 24|Lost to Follow-up|9|||
27998966|NCT00779766|54657668|FG000|Month 24|Other|18|||
27998967|NCT00779766|54657669|FG001|Month 24|Other|27|||
27998968|NCT00779766|54657668|FG000|Month 48|Withdrawal by Subject|68|||
27998969|NCT00779766|54657669|FG001|Month 48|Withdrawal by Subject|63|||
27998970|NCT00779766|54657668|FG000|Month 48|Migrated/moved from study area|76|||
27998971|NCT00779766|54657669|FG001|Month 48|Migrated/moved from study area|75|||
27998972|NCT00779766|54657668|FG000|Month 48|Lost to Follow-up|29|||
27998973|NCT00779766|54657669|FG001|Month 48|Lost to Follow-up|30|||
27998974|NCT00779766|54657668|FG000|Month 48|Other|1|||
27998975|NCT00779766|54657669|FG001|Month 48|Other|0|||
27998976|NCT00779766|54657668|FG000|Month 72|Withdrawal by Subject|55|||
27998977|NCT00779766|54657669|FG001|Month 72|Withdrawal by Subject|71|||
27998978|NCT00779766|54657668|FG000|Month 72|Migrated/moved from study area|124|||
27998979|NCT00779766|54657669|FG001|Month 72|Migrated/moved from study area|109|||
27998980|NCT00779766|54657668|FG000|Month 72|Lost to Follow-up|6|||
27998981|NCT00779766|54657669|FG001|Month 72|Lost to Follow-up|8|||
27998982|NCT00779766|54657668|FG000|Month 72|Other|0|||
27998983|NCT00779766|54657669|FG001|Month 72|Other|1|||
27998984|NCT00846365|54657679|FG000|Overall Study|Adverse Event|20|||
27998985|NCT00846365|54657680|FG001|Overall Study|Adverse Event|30|||
27998986|NCT00846365|54657681|FG002|Overall Study|Adverse Event|11|||
27998987|NCT00846365|54657679|FG000|Overall Study|Protocol Violation|5|||
27998988|NCT00846365|54657680|FG001|Overall Study|Protocol Violation|4|||
27998989|NCT00846365|54657681|FG002|Overall Study|Protocol Violation|0|||
27998990|NCT00846365|54657679|FG000|Overall Study|Lost to Follow-up|8|||
27998991|NCT00846365|54657680|FG001|Overall Study|Lost to Follow-up|2|||
27998992|NCT00846365|54657681|FG002|Overall Study|Lost to Follow-up|5|||
27998993|NCT00846365|54657679|FG000|Overall Study|Withdrawal by Subject|11|||
27998994|NCT00846365|54657680|FG001|Overall Study|Withdrawal by Subject|11|||
27998995|NCT00846365|54657681|FG002|Overall Study|Withdrawal by Subject|9|||
27998996|NCT00846365|54657679|FG000|Overall Study|Pregnancy|1|||
27998997|NCT00846365|54657680|FG001|Overall Study|Pregnancy|0|||
28099414|NCT03032380|54755376|FG000|Overall Study|Death|39|||
28099415|NCT03032380|54755377|FG001|Overall Study|Death|34|||
28099416|NCT03032380|54755376|FG000|Overall Study|Other - Miscellaneous|0|||
27913360|NCT01088984|54571081|FG001|Phase 2|Other|1|||
27913361|NCT01088438|54571092|FG000|Overall Study|Withdrawal by Subject|11|||
27913362|NCT01088438|54571093|FG001|Overall Study|Withdrawal by Subject|6|||
27998998|NCT00846365|54657681|FG002|Overall Study|Pregnancy|0|||
27998999|NCT00846365|54657679|FG000|Overall Study|Lack of Efficacy|1|||
27999000|NCT00846365|54657680|FG001|Overall Study|Lack of Efficacy|1|||
27999001|NCT00846365|54657681|FG002|Overall Study|Lack of Efficacy|2|||
27999002|NCT00846365|54657679|FG000|Overall Study|Other|9|||
27999003|NCT00846365|54657680|FG001|Overall Study|Other|1|||
27999004|NCT00846365|54657681|FG002|Overall Study|Other|6|||
27999005|NCT00779142|54657689|FG000|Overall Study|Screen Failures|3|||
27999006|NCT00622180|54657694|FG000|Overall Study|Lost to Follow-up|1|||
27999007|NCT00622180|54657695|FG001|Overall Study|Lost to Follow-up|2|||
27999008|NCT00773136|54657701|FG000|Overall Study|Physician Decision|2|||
27999009|NCT00853307|54657708|FG000|Overall Study|Adverse Event|1|||
27999010|NCT00853307|54657709|FG001|Overall Study|Adverse Event|2|||
27999011|NCT00853307|54657708|FG000|Overall Study|Withdrawal by Subject|1|||
27999012|NCT00853307|54657709|FG001|Overall Study|Withdrawal by Subject|2|||
27999013|NCT00853307|54657708|FG000|Overall Study|Reason Not Specified|0|||
27999014|NCT00853307|54657709|FG001|Overall Study|Reason Not Specified|1|||
27999015|NCT00778830|54657717|FG000|Overall Study|Ongoing at data cut-off|0|||
27999016|NCT00778830|54657718|FG001|Overall Study|Ongoing at data cut-off|1|||
27999017|NCT00772668|54657724|FG000|Overall Study|Physician Decision|3|||
27999018|NCT00786474|54657731|FG000|Overall Study|Death|5|||
27999019|NCT00786474|54657732|FG001|Overall Study|Death|4|||
27999020|NCT00786474|54657731|FG000|Overall Study|Withdrawal by Subject|23|||
27999021|NCT00786474|54657732|FG001|Overall Study|Withdrawal by Subject|31|||
27999022|NCT00786474|54657731|FG000|Overall Study|Lost to Follow-up|3|||
27999023|NCT00786474|54657732|FG001|Overall Study|Lost to Follow-up|3|||
27999024|NCT00786474|54657731|FG000|Overall Study|Physician Decision|2|||
27999025|NCT00786474|54657732|FG001|Overall Study|Physician Decision|1|||
27999026|NCT00786474|54657731|FG000|Overall Study|Other|4|||
27999027|NCT00786474|54657732|FG001|Overall Study|Other|4|||
27999028|NCT00784875|54657742|FG000|Period A - Baseline|Entry Criteria Not Met|0|||
27999029|NCT00784875|54657743|FG001|Period A - Baseline|Entry Criteria Not Met|0|||
27999030|NCT00784875|54657744|FG002|Period A - Baseline|Entry Criteria Not Met|0|||
27913363|NCT01088438|54571092|FG000|Overall Study|Lost to Follow-up|18|||
27913364|NCT01088438|54571093|FG001|Overall Study|Lost to Follow-up|30|||
27913365|NCT01088243|54571101|FG000|Overall Study|Adverse Event|1|||
27913366|NCT01088243|54571102|FG001|Overall Study|Adverse Event|0|||
27913367|NCT01088048|54571118|FG000|Overall Study|Adverse Event|7|||
27913368|NCT01088048|54571119|FG001|Overall Study|Adverse Event|9|||
27913369|NCT01088048|54571120|FG002|Overall Study|Adverse Event|7|||
27999031|NCT00784875|54657745|FG003|Period A - Baseline|Entry Criteria Not Met|5|||
27999032|NCT00784875|54657742|FG000|Period A - Baseline|Adverse Event|0|||
27999033|NCT00784875|54657743|FG001|Period A - Baseline|Adverse Event|0|||
27999034|NCT00784875|54657744|FG002|Period A - Baseline|Adverse Event|0|||
27999035|NCT00784875|54657745|FG003|Period A - Baseline|Adverse Event|8|||
27999036|NCT00784875|54657742|FG000|Period A - Baseline|Protocol Violation|0|||
27999037|NCT00784875|54657743|FG001|Period A - Baseline|Protocol Violation|0|||
27999038|NCT00784875|54657744|FG002|Period A - Baseline|Protocol Violation|0|||
27999039|NCT00784875|54657745|FG003|Period A - Baseline|Protocol Violation|25|||
27999040|NCT00784875|54657742|FG000|Period A - Baseline|Withdrawal by Subject|0|||
27999041|NCT00784875|54657743|FG001|Period A - Baseline|Withdrawal by Subject|0|||
27999042|NCT00784875|54657744|FG002|Period A - Baseline|Withdrawal by Subject|0|||
27999043|NCT00784875|54657745|FG003|Period A - Baseline|Withdrawal by Subject|27|||
27999044|NCT00784875|54657742|FG000|Period A - Baseline|Physician Decision|0|||
27999045|NCT00784875|54657743|FG001|Period A - Baseline|Physician Decision|0|||
27999046|NCT00784875|54657744|FG002|Period A - Baseline|Physician Decision|0|||
27999047|NCT00784875|54657745|FG003|Period A - Baseline|Physician Decision|2|||
27999048|NCT00784875|54657742|FG000|Period A - Baseline|Sponsor Decision|0|||
27999049|NCT00784875|54657743|FG001|Period A - Baseline|Sponsor Decision|0|||
27999050|NCT00784875|54657744|FG002|Period A - Baseline|Sponsor Decision|0|||
27999051|NCT00784875|54657745|FG003|Period A - Baseline|Sponsor Decision|113|||
27739819|NCT02219932|54189538|FG001|Overall Study|Lost to Follow-up|2|||
27999052|NCT00784875|54657742|FG000|Period A - Baseline|Lost to Follow-up|0|||
27999053|NCT00784875|54657743|FG001|Period A - Baseline|Lost to Follow-up|0|||
27999054|NCT00784875|54657744|FG002|Period A - Baseline|Lost to Follow-up|0|||
27999055|NCT00784875|54657745|FG003|Period A - Baseline|Lost to Follow-up|2|||
27999056|NCT00784875|54657742|FG000|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
27999057|NCT00784875|54657743|FG001|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
27999058|NCT00784875|54657744|FG002|Period B - Efficacy Endpoint|Entry Criteria Not Met|2|||
27999059|NCT00784875|54657745|FG003|Period B - Efficacy Endpoint|Entry Criteria Not Met|1|||
28099417|NCT03032380|54755377|FG001|Overall Study|Other - Miscellaneous|1|||
28099418|NCT03519854|54755401|FG000|Overall Study|Technical Error|0|||
28099419|NCT03519854|54755402|FG001|Overall Study|Technical Error|0|||
28099420|NCT03519854|54755403|FG002|Overall Study|Technical Error|1|||
28099421|NCT03519854|54755404|FG003|Overall Study|Technical Error|0|||
28099422|NCT03519854|54755405|FG004|Overall Study|Technical Error|0|||
28099423|NCT03519854|54755406|FG005|Overall Study|Technical Error|0|||
27913370|NCT01088048|54571121|FG003|Overall Study|Adverse Event|5|||
27913371|NCT01088048|54571122|FG004|Overall Study|Adverse Event|6|||
27913372|NCT01088048|54571123|FG005|Overall Study|Adverse Event|3|||
27913373|NCT01088048|54571124|FG006|Overall Study|Adverse Event|3|||
27913374|NCT01088048|54571125|FG007|Overall Study|Adverse Event|0|||
27999060|NCT00784875|54657742|FG000|Period B - Efficacy Endpoint|Adverse Event|0|||
27999061|NCT00784875|54657743|FG001|Period B - Efficacy Endpoint|Adverse Event|3|||
27999062|NCT00784875|54657744|FG002|Period B - Efficacy Endpoint|Adverse Event|2|||
27999063|NCT00784875|54657745|FG003|Period B - Efficacy Endpoint|Adverse Event|1|||
27999064|NCT00784875|54657742|FG000|Period B - Efficacy Endpoint|Protocol Violation|1|||
27999065|NCT00784875|54657743|FG001|Period B - Efficacy Endpoint|Protocol Violation|1|||
28099424|NCT03519854|54755407|FG006|Overall Study|Technical Error|0|||
28099425|NCT03519854|54755408|FG007|Overall Study|Technical Error|0|||
27999066|NCT00784875|54657744|FG002|Period B - Efficacy Endpoint|Protocol Violation|2|||
27999067|NCT00784875|54657745|FG003|Period B - Efficacy Endpoint|Protocol Violation|3|||
27999068|NCT00784875|54657742|FG000|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
27999069|NCT00784875|54657743|FG001|Period B - Efficacy Endpoint|Lack of Efficacy|1|||
27999070|NCT00784875|54657744|FG002|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
27999071|NCT00784875|54657745|FG003|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
27999072|NCT00784875|54657742|FG000|Period B - Efficacy Endpoint|Withdrawal by Subject|4|||
27999073|NCT00784875|54657743|FG001|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
27999074|NCT00784875|54657744|FG002|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
27999075|NCT00784875|54657745|FG003|Period B - Efficacy Endpoint|Withdrawal by Subject|2|||
27999076|NCT00784875|54657742|FG000|Period B - Efficacy Endpoint|Physician Decision|0|||
27999077|NCT00784875|54657743|FG001|Period B - Efficacy Endpoint|Physician Decision|0|||
27999078|NCT00784875|54657744|FG002|Period B - Efficacy Endpoint|Physician Decision|1|||
27999079|NCT00784875|54657745|FG003|Period B - Efficacy Endpoint|Physician Decision|0|||
27999080|NCT00784875|54657742|FG000|Period B - Efficacy Endpoint|Sponsor Decision|9|||
27999081|NCT00784875|54657743|FG001|Period B - Efficacy Endpoint|Sponsor Decision|6|||
27913375|NCT01088048|54571126|FG008|Overall Study|Adverse Event|2|||
27913376|NCT01088048|54571127|FG009|Overall Study|Adverse Event|2|||
27913377|NCT01088048|54571118|FG000|Overall Study|Withdrew Consent|1|||
27913378|NCT01088048|54571119|FG001|Overall Study|Withdrew Consent|1|||
27913379|NCT01088048|54571120|FG002|Overall Study|Withdrew Consent|1|||
27913380|NCT01088048|54571121|FG003|Overall Study|Withdrew Consent|1|||
27999082|NCT00784875|54657744|FG002|Period B - Efficacy Endpoint|Sponsor Decision|12|||
27999083|NCT00784875|54657745|FG003|Period B - Efficacy Endpoint|Sponsor Decision|12|||
27999084|NCT00784875|54657742|FG000|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
27999085|NCT00784875|54657743|FG001|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
27999086|NCT00784875|54657744|FG002|Period B - Efficacy Endpoint|Lost to Follow-up|1|||
27999087|NCT00784875|54657745|FG003|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
27999088|NCT00784875|54657742|FG000|Period C|Adverse Event|1|||
27999089|NCT00784875|54657743|FG001|Period C|Adverse Event|0|||
27913381|NCT01088048|54571122|FG004|Overall Study|Withdrew Consent|2|||
27913382|NCT01088048|54571123|FG005|Overall Study|Withdrew Consent|1|||
27913383|NCT01088048|54571124|FG006|Overall Study|Withdrew Consent|0|||
27913384|NCT01088048|54571125|FG007|Overall Study|Withdrew Consent|2|||
27913385|NCT01088048|54571126|FG008|Overall Study|Withdrew Consent|2|||
27913386|NCT01088048|54571127|FG009|Overall Study|Withdrew Consent|1|||
27913387|NCT01088048|54571118|FG000|Overall Study|Concomitant Medication Prohibited|1|||
27913388|NCT01088048|54571119|FG001|Overall Study|Concomitant Medication Prohibited|0|||
27913389|NCT01088048|54571120|FG002|Overall Study|Concomitant Medication Prohibited|0|||
27913390|NCT01088048|54571121|FG003|Overall Study|Concomitant Medication Prohibited|0|||
27913391|NCT01088048|54571122|FG004|Overall Study|Concomitant Medication Prohibited|0|||
27913392|NCT01088048|54571123|FG005|Overall Study|Concomitant Medication Prohibited|0|||
27999090|NCT00784875|54657744|FG002|Period C|Adverse Event|4|||
27999091|NCT00784875|54657745|FG003|Period C|Adverse Event|2|||
27999092|NCT00784875|54657742|FG000|Period C|Protocol Violation|0|||
27999093|NCT00784875|54657743|FG001|Period C|Protocol Violation|0|||
27913393|NCT01088048|54571124|FG006|Overall Study|Concomitant Medication Prohibited|0|||
27913394|NCT01088048|54571125|FG007|Overall Study|Concomitant Medication Prohibited|0|||
27913395|NCT01088048|54571126|FG008|Overall Study|Concomitant Medication Prohibited|0|||
27913396|NCT01088048|54571127|FG009|Overall Study|Concomitant Medication Prohibited|0|||
27913397|NCT01088048|54571118|FG000|Overall Study|Investigator Request|2|||
27913398|NCT01088048|54571119|FG001|Overall Study|Investigator Request|2|||
27913399|NCT01088048|54571120|FG002|Overall Study|Investigator Request|0|||
27913400|NCT01088048|54571121|FG003|Overall Study|Investigator Request|0|||
27913401|NCT01088048|54571122|FG004|Overall Study|Investigator Request|3|||
27913402|NCT01088048|54571123|FG005|Overall Study|Investigator Request|1|||
27913403|NCT01088048|54571124|FG006|Overall Study|Investigator Request|1|||
27913404|NCT01088048|54571125|FG007|Overall Study|Investigator Request|0|||
27999094|NCT00784875|54657744|FG002|Period C|Protocol Violation|1|||
27999095|NCT00784875|54657745|FG003|Period C|Protocol Violation|2|||
27999096|NCT00784875|54657742|FG000|Period C|Lack of Efficacy|0|||
27999097|NCT00784875|54657743|FG001|Period C|Lack of Efficacy|0|||
27999098|NCT00784875|54657744|FG002|Period C|Lack of Efficacy|1|||
27999099|NCT00784875|54657745|FG003|Period C|Lack of Efficacy|0|||
27999100|NCT00784875|54657742|FG000|Period C|Withdrawal by Subject|1|||
27999101|NCT00784875|54657743|FG001|Period C|Withdrawal by Subject|1|||
27999102|NCT00784875|54657744|FG002|Period C|Withdrawal by Subject|2|||
27999103|NCT00784875|54657745|FG003|Period C|Withdrawal by Subject|0|||
27999104|NCT00784875|54657742|FG000|Period C|Physician Decision|0|||
27999105|NCT00784875|54657743|FG001|Period C|Physician Decision|0|||
27999106|NCT00784875|54657744|FG002|Period C|Physician Decision|1|||
27999107|NCT00784875|54657745|FG003|Period C|Physician Decision|1|||
27913405|NCT01088048|54571126|FG008|Overall Study|Investigator Request|0|||
27913406|NCT01088048|54571127|FG009|Overall Study|Investigator Request|0|||
27913407|NCT01088048|54571118|FG000|Overall Study|Patient Non-compliance|0|||
27999108|NCT00784875|54657742|FG000|Period C|Sponsor Decision|5|||
27913408|NCT01088048|54571119|FG001|Overall Study|Patient Non-compliance|1|||
27913409|NCT01088048|54571120|FG002|Overall Study|Patient Non-compliance|0|||
27913410|NCT01088048|54571121|FG003|Overall Study|Patient Non-compliance|0|||
27913411|NCT01088048|54571122|FG004|Overall Study|Patient Non-compliance|0|||
27913412|NCT01088048|54571123|FG005|Overall Study|Patient Non-compliance|0|||
27913413|NCT01088048|54571124|FG006|Overall Study|Patient Non-compliance|0|||
27913414|NCT01088048|54571125|FG007|Overall Study|Patient Non-compliance|0|||
27913415|NCT01088048|54571126|FG008|Overall Study|Patient Non-compliance|0|||
27913416|NCT01088048|54571127|FG009|Overall Study|Patient Non-compliance|0|||
27913417|NCT01088048|54571118|FG000|Overall Study|Disease Progression|7|||
27999109|NCT00784875|54657743|FG001|Period C|Sponsor Decision|5|||
27999110|NCT00784875|54657744|FG002|Period C|Sponsor Decision|4|||
27999111|NCT00784875|54657745|FG003|Period C|Sponsor Decision|2|||
27999112|NCT00784875|54657742|FG000|Period D|Adverse Event|0|||
27999113|NCT00784875|54657743|FG001|Period D|Adverse Event|2|||
27999114|NCT00784875|54657744|FG002|Period D|Adverse Event|2|||
27999115|NCT00784875|54657745|FG003|Period D|Adverse Event|0|||
27999116|NCT00784875|54657742|FG000|Period D|Protocol Violation|1|||
27999117|NCT00784875|54657743|FG001|Period D|Protocol Violation|0|||
27999118|NCT00784875|54657744|FG002|Period D|Protocol Violation|0|||
27999119|NCT00784875|54657745|FG003|Period D|Protocol Violation|0|||
27999120|NCT00784875|54657742|FG000|Period D|Withdrawal by Subject|2|||
27999121|NCT00784875|54657743|FG001|Period D|Withdrawal by Subject|0|||
27999122|NCT00784875|54657744|FG002|Period D|Withdrawal by Subject|2|||
27999123|NCT00784875|54657745|FG003|Period D|Withdrawal by Subject|0|||
27999124|NCT00784875|54657742|FG000|Period D|Physician Decision|0|||
27999125|NCT00784875|54657743|FG001|Period D|Physician Decision|1|||
28099426|NCT03519854|54755409|FG008|Overall Study|Technical Error|0|||
27913418|NCT01088048|54571119|FG001|Overall Study|Disease Progression|4|||
27913419|NCT01088048|54571120|FG002|Overall Study|Disease Progression|3|||
27913420|NCT01088048|54571121|FG003|Overall Study|Disease Progression|5|||
27913421|NCT01088048|54571122|FG004|Overall Study|Disease Progression|3|||
27913422|NCT01088048|54571123|FG005|Overall Study|Disease Progression|3|||
27913423|NCT01088048|54571124|FG006|Overall Study|Disease Progression|2|||
27913424|NCT01088048|54571125|FG007|Overall Study|Disease Progression|1|||
27913425|NCT01088048|54571126|FG008|Overall Study|Disease Progression|0|||
27913426|NCT01088048|54571127|FG009|Overall Study|Disease Progression|0|||
27913427|NCT01088048|54571118|FG000|Overall Study|Death|1|||
27913428|NCT01088048|54571119|FG001|Overall Study|Death|5|||
27913429|NCT01088048|54571120|FG002|Overall Study|Death|3|||
27913430|NCT01088048|54571121|FG003|Overall Study|Death|3|||
27913431|NCT01088048|54571122|FG004|Overall Study|Death|1|||
27913432|NCT01088048|54571123|FG005|Overall Study|Death|3|||
27913433|NCT01088048|54571124|FG006|Overall Study|Death|0|||
27913434|NCT01088048|54571125|FG007|Overall Study|Death|0|||
27913435|NCT01088048|54571126|FG008|Overall Study|Death|3|||
27913436|NCT01088048|54571127|FG009|Overall Study|Death|1|||
27913437|NCT01088048|54571118|FG000|Overall Study|Other|3|||
27913438|NCT01088048|54571119|FG001|Overall Study|Other|5|||
27913439|NCT01088048|54571120|FG002|Overall Study|Other|0|||
27913440|NCT01088048|54571121|FG003|Overall Study|Other|0|||
27913441|NCT01088048|54571122|FG004|Overall Study|Other|2|||
27913442|NCT01088048|54571123|FG005|Overall Study|Other|0|||
27913443|NCT01088048|54571124|FG006|Overall Study|Other|0|||
27913444|NCT01088048|54571125|FG007|Overall Study|Other|2|||
27913445|NCT01088048|54571126|FG008|Overall Study|Other|0|||
27913446|NCT01088048|54571127|FG009|Overall Study|Other|0|||
27913447|NCT01087970|54571160|FG000|Overall Study|Protocol Violation|2|||
27913448|NCT01087814|54571167|FG000|First Intervention (5 Days)|Withdrawal by Subject|3|||
27913449|NCT01087814|54571168|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
27913450|NCT01087814|54571167|FG000|Second Intervention (5 Days)|Physician Decision|1|||
27913451|NCT01087814|54571168|FG001|Second Intervention (5 Days)|Physician Decision|0|||
28099427|NCT03519854|54755410|FG009|Overall Study|Technical Error|0|||
28099428|NCT03519854|54755411|FG010|Overall Study|Technical Error|0|||
27913452|NCT01087775|54571174|FG000|Overall Study|failed inclusion criteria|2|||
27913453|NCT01087502|54571181|FG000|Up to Interim Analysis (Week 12)|Adverse Event|5|||
27913454|NCT01087502|54571182|FG001|Up to Interim Analysis (Week 12)|Adverse Event|4|||
27913455|NCT01087502|54571181|FG000|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
27913456|NCT01087502|54571182|FG001|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
27999126|NCT00784875|54657744|FG002|Period D|Physician Decision|0|||
27999127|NCT00784875|54657745|FG003|Period D|Physician Decision|0|||
27999128|NCT00784875|54657742|FG000|Period D|Sponsor Decision|1|||
27999129|NCT00784875|54657743|FG001|Period D|Sponsor Decision|1|||
27913457|NCT01087502|54571181|FG000|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
27913458|NCT01087502|54571182|FG001|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
27913459|NCT01087502|54571181|FG000|Up to Interim Analysis (Week 12)|Lack of Efficacy|1|||
27913460|NCT01087502|54571182|FG001|Up to Interim Analysis (Week 12)|Lack of Efficacy|0|||
27913461|NCT01087502|54571181|FG000|Up to Interim Analysis (Week 12)|Other reason not described above|1|||
27999130|NCT00784875|54657744|FG002|Period D|Sponsor Decision|1|||
27999131|NCT00784875|54657745|FG003|Period D|Sponsor Decision|0|||
27913462|NCT01087502|54571182|FG001|Up to Interim Analysis (Week 12)|Other reason not described above|2|||
27913463|NCT01087502|54571181|FG000|Up to Final Analysis (Week 52)|Adverse Event|17|||
27913464|NCT01087502|54571182|FG001|Up to Final Analysis (Week 52)|Adverse Event|10|||
27913465|NCT01087502|54571181|FG000|Up to Final Analysis (Week 52)|Lack of Efficacy|1|||
27913466|NCT01087502|54571182|FG001|Up to Final Analysis (Week 52)|Lack of Efficacy|2|||
27913467|NCT01087502|54571181|FG000|Up to Final Analysis (Week 52)|Protocol Violation|4|||
27913468|NCT01087502|54571182|FG001|Up to Final Analysis (Week 52)|Protocol Violation|0|||
27913469|NCT01087502|54571181|FG000|Up to Final Analysis (Week 52)|Lost to Follow-up|2|||
27913470|NCT01087502|54571182|FG001|Up to Final Analysis (Week 52)|Lost to Follow-up|0|||
27913471|NCT01087502|54571181|FG000|Up to Final Analysis (Week 52)|Withdrawal by Subject|3|||
27913472|NCT01087502|54571182|FG001|Up to Final Analysis (Week 52)|Withdrawal by Subject|2|||
27913473|NCT01087502|54571181|FG000|Up to Final Analysis (Week 52)|Study site excluded from analysis|1|||
27913474|NCT01087502|54571182|FG001|Up to Final Analysis (Week 52)|Study site excluded from analysis|5|||
27999132|NCT00784875|54657742|FG000|Period D|Lost to Follow-up|1|||
27999133|NCT00784875|54657743|FG001|Period D|Lost to Follow-up|0|||
27999134|NCT00784875|54657744|FG002|Period D|Lost to Follow-up|1|||
27999135|NCT00784875|54657745|FG003|Period D|Lost to Follow-up|1|||
27999136|NCT00592553|54657771|FG000|Overall Study|Protocol Noncompliance|1|||
27999137|NCT00592553|54657772|FG001|Overall Study|Protocol Noncompliance|0|||
27999138|NCT00592553|54657773|FG002|Overall Study|Protocol Noncompliance|0|||
27999139|NCT00853229|54657783|FG000|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
27999140|NCT00853229|54657784|FG001|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
27999141|NCT00853151|54657796|FG000|Overall Study|Adverse Event|1|||
27999142|NCT00853151|54657797|FG001|Overall Study|Adverse Event|4|||
27999143|NCT00853151|54657798|FG002|Overall Study|Adverse Event|2|||
27999144|NCT00853151|54657799|FG003|Overall Study|Adverse Event|0|||
27999145|NCT00853151|54657796|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
27999146|NCT00853151|54657797|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
27999147|NCT00853151|54657798|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
27999148|NCT00853151|54657799|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
27999149|NCT00853151|54657796|FG000|Overall Study|Lost to Follow-up|2|||
27999150|NCT00853151|54657797|FG001|Overall Study|Lost to Follow-up|0|||
27999151|NCT00853151|54657798|FG002|Overall Study|Lost to Follow-up|3|||
27999152|NCT00853151|54657799|FG003|Overall Study|Lost to Follow-up|0|||
27999153|NCT00853151|54657796|FG000|Overall Study|Death|1|||
27999154|NCT00853151|54657797|FG001|Overall Study|Death|0|||
27999155|NCT00853151|54657798|FG002|Overall Study|Death|0|||
27999156|NCT00853151|54657799|FG003|Overall Study|Death|1|||
27999157|NCT00853151|54657796|FG000|Overall Study|Protocol Violation|0|||
27999158|NCT00853151|54657797|FG001|Overall Study|Protocol Violation|0|||
27999159|NCT00853151|54657798|FG002|Overall Study|Protocol Violation|0|||
27999160|NCT00853151|54657799|FG003|Overall Study|Protocol Violation|1|||
27999161|NCT00853151|54657796|FG000|Overall Study|Withdrawal by Subject|5|||
27999162|NCT00853151|54657797|FG001|Overall Study|Withdrawal by Subject|4|||
27999163|NCT00853151|54657798|FG002|Overall Study|Withdrawal by Subject|2|||
27999164|NCT00853151|54657799|FG003|Overall Study|Withdrawal by Subject|1|||
27999165|NCT00853151|54657796|FG000|Overall Study|Physician Decision|0|||
27999166|NCT00853151|54657797|FG001|Overall Study|Physician Decision|2|||
27999167|NCT00853151|54657798|FG002|Overall Study|Physician Decision|1|||
27999168|NCT00853151|54657799|FG003|Overall Study|Physician Decision|0|||
27999169|NCT00853151|54657796|FG000|Overall Study|Sponsor Decision|0|||
27999170|NCT00853151|54657797|FG001|Overall Study|Sponsor Decision|3|||
27999171|NCT00853151|54657798|FG002|Overall Study|Sponsor Decision|0|||
27999172|NCT00853151|54657799|FG003|Overall Study|Sponsor Decision|0|||
27999173|NCT00853073|54657814|FG000|Overall Study|Withdrawal by Subject|3|||
27999174|NCT00853073|54657815|FG001|Overall Study|Withdrawal by Subject|2|||
27999175|NCT00846053|54657823|FG000|Overall Study|Physician Decision|3|||
27999176|NCT00846053|54657824|FG001|Overall Study|Physician Decision|0|||
27999177|NCT00845897|54657835|FG000|Overall Study|Lost to Follow-up|1|||
27999178|NCT00845897|54657836|FG001|Overall Study|Lost to Follow-up|1|||
27999179|NCT00845897|54657837|FG002|Overall Study|Lost to Follow-up|0|||
27999180|NCT00845897|54657835|FG000|Overall Study|Withdrawal by Subject|0|||
27999181|NCT00845897|54657836|FG001|Overall Study|Withdrawal by Subject|3|||
27739820|NCT02219932|54189537|FG000|Overall Study|Adverse Event|23|||
27739821|NCT02219932|54189538|FG001|Overall Study|Adverse Event|21|||
27739822|NCT02219464|54189546|FG000|Overall Study|Withdrawal by Subject|1|||
27913475|NCT01087502|54571181|FG000|Up to Final Analysis (Week 52)|Other reason not described above|5|||
27913476|NCT01087502|54571182|FG001|Up to Final Analysis (Week 52)|Other reason not described above|4|||
27913477|NCT01086410|54571194|FG000|Overall Study|Adverse Event|1|||
27913478|NCT01086410|54571195|FG001|Overall Study|Adverse Event|0|||
27999182|NCT00845897|54657837|FG002|Overall Study|Withdrawal by Subject|2|||
27999183|NCT00845897|54657835|FG000|Overall Study|Ulcer did not heal|1|||
27999184|NCT00845897|54657836|FG001|Overall Study|Ulcer did not heal|0|||
27999185|NCT00845897|54657837|FG002|Overall Study|Ulcer did not heal|1|||
27999186|NCT00845897|54657835|FG000|Overall Study|Too ill to participate|0|||
27999187|NCT00845897|54657836|FG001|Overall Study|Too ill to participate|1|||
27913479|NCT01086410|54571196|FG002|Overall Study|Adverse Event|0|||
27913480|NCT01086410|54571197|FG003|Overall Study|Adverse Event|2|||
27913481|NCT01086410|54571194|FG000|Overall Study|Lack of Efficacy|1|||
27913482|NCT01086410|54571195|FG001|Overall Study|Lack of Efficacy|1|||
27913483|NCT01086410|54571196|FG002|Overall Study|Lack of Efficacy|0|||
27913484|NCT01086410|54571197|FG003|Overall Study|Lack of Efficacy|0|||
27913485|NCT01086410|54571194|FG000|Overall Study|Protocol Violation|1|||
27913486|NCT01086410|54571195|FG001|Overall Study|Protocol Violation|1|||
27913487|NCT01086410|54571196|FG002|Overall Study|Protocol Violation|0|||
27913488|NCT01086410|54571197|FG003|Overall Study|Protocol Violation|0|||
27999188|NCT00845897|54657837|FG002|Overall Study|Too ill to participate|0|||
27999189|NCT00862277|54657848|FG000|Overall Study|Protocol Violation|1|||
27999190|NCT00862277|54657849|FG001|Overall Study|Protocol Violation|2|||
27999191|NCT00862277|54657850|FG002|Overall Study|Protocol Violation|5|||
27999192|NCT00852995|54657863|FG000|Overall Study|Adverse Event|1|||
27999193|NCT00852995|54657864|FG001|Overall Study|Adverse Event|0|||
27999194|NCT00852995|54657865|FG002|Overall Study|Adverse Event|4|||
27999195|NCT00852995|54657866|FG003|Overall Study|Adverse Event|0|||
27999196|NCT00852995|54657867|FG004|Overall Study|Adverse Event|0|||
27999197|NCT00852995|54657863|FG000|Overall Study|Lost to Follow-up|0|||
27999198|NCT00852995|54657864|FG001|Overall Study|Lost to Follow-up|1|||
27999199|NCT00852995|54657865|FG002|Overall Study|Lost to Follow-up|1|||
27999200|NCT00852995|54657866|FG003|Overall Study|Lost to Follow-up|0|||
27999201|NCT00852995|54657867|FG004|Overall Study|Lost to Follow-up|0|||
27999202|NCT00852995|54657863|FG000|Overall Study|Withdrawal by Subject|4|||
27999203|NCT00852995|54657864|FG001|Overall Study|Withdrawal by Subject|0|||
27999204|NCT00852995|54657865|FG002|Overall Study|Withdrawal by Subject|0|||
27999205|NCT00852995|54657866|FG003|Overall Study|Withdrawal by Subject|1|||
27999206|NCT00852995|54657867|FG004|Overall Study|Withdrawal by Subject|2|||
27999207|NCT00852995|54657863|FG000|Overall Study|Non-Compliance|0|||
27999208|NCT00852995|54657864|FG001|Overall Study|Non-Compliance|0|||
27999209|NCT00852995|54657865|FG002|Overall Study|Non-Compliance|0|||
27999210|NCT00852995|54657866|FG003|Overall Study|Non-Compliance|2|||
27999211|NCT00852995|54657867|FG004|Overall Study|Non-Compliance|0|||
27999212|NCT00852995|54657863|FG000|Overall Study|Progressive Disease|1|||
27999213|NCT00852995|54657864|FG001|Overall Study|Progressive Disease|0|||
27999214|NCT00852995|54657865|FG002|Overall Study|Progressive Disease|0|||
27999215|NCT00852995|54657866|FG003|Overall Study|Progressive Disease|2|||
27999216|NCT00852995|54657867|FG004|Overall Study|Progressive Disease|1|||
27999217|NCT00852995|54657863|FG000|Overall Study|Physician Decision|1|||
27913489|NCT01086410|54571194|FG000|Overall Study|Lost to Follow-up|0|||
27913490|NCT01086410|54571195|FG001|Overall Study|Lost to Follow-up|0|||
27913491|NCT01086410|54571196|FG002|Overall Study|Lost to Follow-up|1|||
27913492|NCT01086410|54571197|FG003|Overall Study|Lost to Follow-up|0|||
27913493|NCT04553679|54571209|FG000|Overall Study|Withdrawal by Subject|2|||
27913494|NCT04553679|54571210|FG001|Overall Study|Withdrawal by Subject|0|||
27913495|NCT04553679|54571209|FG000|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|0|||
27913496|NCT04553679|54571210|FG001|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|1|||
27913497|NCT01086215|54571224|FG000|Overall Study|Death|14|||
27913498|NCT01086215|54571225|FG001|Overall Study|Death|8|||
27913499|NCT01086215|54571226|FG002|Overall Study|Death|8|||
27913500|NCT01086215|54571227|FG003|Overall Study|Death|1|||
27913501|NCT01086215|54571224|FG000|Overall Study|Lost to Follow-up|22|||
27913502|NCT01086215|54571225|FG001|Overall Study|Lost to Follow-up|39|||
27913503|NCT01086215|54571226|FG002|Overall Study|Lost to Follow-up|18|||
27913504|NCT01086215|54571227|FG003|Overall Study|Lost to Follow-up|2|||
27913505|NCT01085591|54571240|FG000|Overall Study|Adverse Event|0|||
27913506|NCT01085591|54571241|FG001|Overall Study|Adverse Event|1|||
27913507|NCT01085591|54571242|FG002|Overall Study|Adverse Event|3|||
27913508|NCT01085591|54571240|FG000|Overall Study|Physician Decision|1|||
27913509|NCT01085591|54571241|FG001|Overall Study|Physician Decision|0|||
27999218|NCT00852995|54657864|FG001|Overall Study|Physician Decision|0|||
27999219|NCT00852995|54657865|FG002|Overall Study|Physician Decision|0|||
27913510|NCT01085591|54571242|FG002|Overall Study|Physician Decision|1|||
27913511|NCT01085591|54571240|FG000|Overall Study|Withdrawal by Subject|0|||
27913512|NCT01085591|54571241|FG001|Overall Study|Withdrawal by Subject|2|||
27913513|NCT01085591|54571242|FG002|Overall Study|Withdrawal by Subject|1|||
27913514|NCT01085591|54571240|FG000|Overall Study|Lost to Follow-up|0|||
27913515|NCT01085591|54571241|FG001|Overall Study|Lost to Follow-up|1|||
27913516|NCT01085591|54571242|FG002|Overall Study|Lost to Follow-up|1|||
27913517|NCT01085591|54571240|FG000|Overall Study|Protocol Violation|1|||
27913518|NCT01085591|54571241|FG001|Overall Study|Protocol Violation|1|||
27999220|NCT00852995|54657866|FG003|Overall Study|Physician Decision|0|||
27999221|NCT00852995|54657867|FG004|Overall Study|Physician Decision|0|||
27999222|NCT00852995|54657863|FG000|Overall Study|Protocol Violation|0|||
27999223|NCT00852995|54657864|FG001|Overall Study|Protocol Violation|0|||
27999224|NCT00852995|54657865|FG002|Overall Study|Protocol Violation|0|||
27999225|NCT00852995|54657866|FG003|Overall Study|Protocol Violation|0|||
27913519|NCT01085591|54571242|FG002|Overall Study|Protocol Violation|1|||
27913520|NCT01085591|54571240|FG000|Overall Study|Other|0|||
27913521|NCT01085591|54571241|FG001|Overall Study|Other|1|||
27913522|NCT01085591|54571242|FG002|Overall Study|Other|0|||
27913523|NCT01085591|54571240|FG000|Overall Study|Not Properly Consented|1|||
27913524|NCT01085591|54571241|FG001|Overall Study|Not Properly Consented|0|||
27913525|NCT01085591|54571242|FG002|Overall Study|Not Properly Consented|0|||
27913526|NCT01085357|54571253|FG000|Overall Study|Adverse Event|1|||
27913527|NCT01085357|54571254|FG001|Overall Study|Adverse Event|1|||
27913528|NCT01085357|54571253|FG000|Overall Study|Subject Decision|4|||
27913529|NCT01085357|54571254|FG001|Overall Study|Subject Decision|3|||
27913530|NCT01085357|54571253|FG000|Overall Study|Investigator Decision|1|||
27913531|NCT01085357|54571254|FG001|Overall Study|Investigator Decision|1|||
27913532|NCT01085357|54571253|FG000|Overall Study|Death|11|||
27913533|NCT01085357|54571254|FG001|Overall Study|Death|1|||
27913534|NCT01085357|54571253|FG000|Overall Study|Lost to Follow-up|2|||
27913535|NCT01085357|54571254|FG001|Overall Study|Lost to Follow-up|0|||
27913536|NCT01085201|54571265|FG000|Overall Study|Scheduling conflict|1|||
27913537|NCT01085201|54571266|FG001|Overall Study|Scheduling conflict|0|||
27913538|NCT01085201|54571267|FG002|Overall Study|Scheduling conflict|1|||
27913539|NCT01085201|54571268|FG003|Overall Study|Scheduling conflict|0|||
27913540|NCT01085201|54571269|FG004|Overall Study|Scheduling conflict|0|||
27913541|NCT01085201|54571265|FG000|Overall Study|Unknown- no study drug|2|||
27913542|NCT01085201|54571266|FG001|Overall Study|Unknown- no study drug|0|||
27913543|NCT01085201|54571267|FG002|Overall Study|Unknown- no study drug|0|||
27913544|NCT01085201|54571268|FG003|Overall Study|Unknown- no study drug|0|||
27913545|NCT01085201|54571269|FG004|Overall Study|Unknown- no study drug|0|||
27913546|NCT01085201|54571265|FG000|Overall Study|Fond ineligible after consent|0|||
27913547|NCT01085201|54571266|FG001|Overall Study|Fond ineligible after consent|1|||
27913548|NCT01085201|54571267|FG002|Overall Study|Fond ineligible after consent|1|||
27913549|NCT01085201|54571268|FG003|Overall Study|Fond ineligible after consent|0|||
27913550|NCT01085201|54571269|FG004|Overall Study|Fond ineligible after consent|0|||
27913551|NCT01085084|54571289|FG000|Overall Study|Withdrawal by Subject|1|||
27913552|NCT01085084|54571290|FG001|Overall Study|Withdrawal by Subject|0|||
27913553|NCT01085084|54571291|FG002|Overall Study|Withdrawal by Subject|0|||
27913554|NCT01085084|54571289|FG000|Overall Study|Lost to Follow-up|2|||
27913555|NCT01085084|54571290|FG001|Overall Study|Lost to Follow-up|1|||
27913556|NCT01085084|54571291|FG002|Overall Study|Lost to Follow-up|1|||
27913557|NCT01085084|54571289|FG000|Overall Study|Adverse Event|4|||
27913558|NCT01085084|54571290|FG001|Overall Study|Adverse Event|3|||
27913559|NCT01085084|54571291|FG002|Overall Study|Adverse Event|6|||
27913560|NCT01085084|54571289|FG000|Overall Study|Treatment Failure|0|||
27913561|NCT01085084|54571290|FG001|Overall Study|Treatment Failure|1|||
27913562|NCT01085084|54571291|FG002|Overall Study|Treatment Failure|2|||
27913563|NCT01085045|54571299|FG000|Part A|Withdrawal by Subject|4|||
27913564|NCT01085045|54571299|FG000|Part A|Adverse Event|6|||
27913565|NCT01085045|54571299|FG000|Part A|Protocol Violation|1|||
27913566|NCT01085045|54571299|FG000|Part A|Protocol Specified Criteria|7|||
27913567|NCT01085045|54571299|FG000|Part B|Withdrawal by Subject|2|||
27913568|NCT01085045|54571299|FG000|Part B|Protocol Specified Criteria|6|||
27913569|NCT01085045|54571299|FG000|Part B|Lost to Follow-up|1|||
27913570|NCT01085045|54571299|FG000|Part B|Adverse Event|6|||
27913571|NCT01084772|54571321|FG000|Baseline|Withdrawal by Subject|7|||
27913572|NCT01084772|54571322|FG001|Baseline|Withdrawal by Subject|6|||
27913573|NCT01084772|54571321|FG000|3 Months|Death|1|||
27913574|NCT01084772|54571322|FG001|3 Months|Death|0|||
27913575|NCT01084772|54571321|FG000|3 Months|Study Termination|2|||
27913576|NCT01084772|54571322|FG001|3 Months|Study Termination|2|||
27913577|NCT01084772|54571321|FG000|1 Year|Withdrawal by Subject|0|||
27913578|NCT01084772|54571322|FG001|1 Year|Withdrawal by Subject|1|||
27913579|NCT01084772|54571321|FG000|1 Year|Lost to Follow-up|3|||
27913580|NCT01084772|54571322|FG001|1 Year|Lost to Follow-up|0|||
27913581|NCT01084772|54571321|FG000|1 Year|Study Termination|0|||
27913582|NCT01084772|54571322|FG001|1 Year|Study Termination|7|||
27913583|NCT01084772|54571321|FG000|2 Years|Withdrawal by Subject|1|||
27913584|NCT01084772|54571322|FG001|2 Years|Withdrawal by Subject|0|||
27913585|NCT01084772|54571321|FG000|2 Years|Lost to Follow-up|5|||
27913586|NCT01084772|54571322|FG001|2 Years|Lost to Follow-up|2|||
27913587|NCT01084772|54571321|FG000|2 Years|Study Termination|3|||
27913588|NCT01084772|54571322|FG001|2 Years|Study Termination|2|||
27913589|NCT00179673|54571328|FG000|Overall Study|Adverse Event|7|||
27913590|NCT00179673|54571328|FG000|Overall Study|Lack of Efficacy|15|||
27913591|NCT00179673|54571328|FG000|Overall Study|Withdrawal by Subject|3|||
27913592|NCT00179673|54571328|FG000|Overall Study|Death|4|||
27913593|NCT00179673|54571328|FG000|Overall Study|Other Observations and options|14|||
27913594|NCT01084655|54571335|FG000|Overall Study|Radiographic disease progression|3|||
27913595|NCT01084655|54571336|FG001|Overall Study|Radiographic disease progression|2|||
27913596|NCT01084655|54571337|FG002|Overall Study|Radiographic disease progression|8|||
27913597|NCT01084655|54571335|FG000|Overall Study|Withdrawal by Subject|1|||
27913598|NCT01084655|54571336|FG001|Overall Study|Withdrawal by Subject|0|||
27913599|NCT01084655|54571337|FG002|Overall Study|Withdrawal by Subject|4|||
27913600|NCT01084655|54571335|FG000|Overall Study|Adverse Event|2|||
27999226|NCT00852995|54657867|FG004|Overall Study|Protocol Violation|1|||
27999227|NCT00852995|54657863|FG000|Overall Study|Moved Out of Area|1|||
27999228|NCT00852995|54657864|FG001|Overall Study|Moved Out of Area|0|||
27999229|NCT00852995|54657865|FG002|Overall Study|Moved Out of Area|0|||
27999230|NCT00852995|54657866|FG003|Overall Study|Moved Out of Area|0|||
27999231|NCT00852995|54657867|FG004|Overall Study|Moved Out of Area|0|||
27999232|NCT00592319|54657886|FG000|Overall Study|Lost to Follow-up|0|||
27999233|NCT00592319|54657887|FG001|Overall Study|Lost to Follow-up|3|||
27999234|NCT00862121|54657897|FG000|Overall Study|Adverse Event|1|||
27999235|NCT00862121|54657898|FG001|Overall Study|Adverse Event|2|||
27999236|NCT00862121|54657897|FG000|Overall Study|Lack of Efficacy|0|||
27999237|NCT00862121|54657898|FG001|Overall Study|Lack of Efficacy|3|||
27999238|NCT00862121|54657897|FG000|Overall Study|Protocol Violation|0|||
27999239|NCT00862121|54657898|FG001|Overall Study|Protocol Violation|1|||
27999240|NCT00862121|54657897|FG000|Overall Study|Exclusion criterion violation|0|||
27999241|NCT00862121|54657898|FG001|Overall Study|Exclusion criterion violation|1|||
27999242|NCT00862121|54657897|FG000|Overall Study|Incorrect randomisation|0|||
27999243|NCT00862121|54657898|FG001|Overall Study|Incorrect randomisation|1|||
27999244|NCT00784719|54657911|FG000|Overall Study|Adverse Event|0|||
27999245|NCT00784719|54657912|FG001|Overall Study|Adverse Event|2|||
27999246|NCT00784719|54657913|FG002|Overall Study|Adverse Event|0|||
27999247|NCT00784719|54657914|FG003|Overall Study|Adverse Event|0|||
27999248|NCT00784719|54657915|FG004|Overall Study|Adverse Event|1|||
27999249|NCT00784719|54657916|FG005|Overall Study|Adverse Event|1|||
27999250|NCT00784719|54657917|FG006|Overall Study|Adverse Event|1|||
27999251|NCT00784719|54657911|FG000|Overall Study|Lost to Follow-up|0|||
27999252|NCT00784719|54657912|FG001|Overall Study|Lost to Follow-up|0|||
27999253|NCT00784719|54657913|FG002|Overall Study|Lost to Follow-up|0|||
27999254|NCT00784719|54657914|FG003|Overall Study|Lost to Follow-up|0|||
27999255|NCT00784719|54657915|FG004|Overall Study|Lost to Follow-up|1|||
27999256|NCT00784719|54657916|FG005|Overall Study|Lost to Follow-up|1|||
27999257|NCT00784719|54657917|FG006|Overall Study|Lost to Follow-up|0|||
27999258|NCT00784719|54657911|FG000|Overall Study|Other|2|||
27999259|NCT00784719|54657912|FG001|Overall Study|Other|1|||
27999260|NCT00784719|54657913|FG002|Overall Study|Other|1|||
27999261|NCT00784719|54657914|FG003|Overall Study|Other|0|||
27999262|NCT00784719|54657915|FG004|Overall Study|Other|2|||
27999263|NCT00784719|54657916|FG005|Overall Study|Other|1|||
27999264|NCT00784719|54657917|FG006|Overall Study|Other|3|||
27999265|NCT00784719|54657911|FG000|Overall Study|Withdrawal by Subject|1|||
27999266|NCT00784719|54657912|FG001|Overall Study|Withdrawal by Subject|0|||
27999267|NCT00784719|54657913|FG002|Overall Study|Withdrawal by Subject|0|||
27999268|NCT00784719|54657914|FG003|Overall Study|Withdrawal by Subject|0|||
27999269|NCT00784719|54657915|FG004|Overall Study|Withdrawal by Subject|2|||
27999270|NCT00784719|54657916|FG005|Overall Study|Withdrawal by Subject|0|||
27999271|NCT00784719|54657917|FG006|Overall Study|Withdrawal by Subject|1|||
27999272|NCT00852917|54657937|FG000|Overall Study|Adverse Event|13|||
27999273|NCT00852917|54657938|FG001|Overall Study|Adverse Event|20|||
27999274|NCT00852917|54657939|FG002|Overall Study|Adverse Event|35|||
27999275|NCT00852917|54657940|FG003|Overall Study|Adverse Event|17|||
27999276|NCT00852917|54657937|FG000|Overall Study|Lack of Efficacy|21|||
27999277|NCT00852917|54657938|FG001|Overall Study|Lack of Efficacy|11|||
28099429|NCT03519854|54755412|FG011|Overall Study|Technical Error|0|||
27913601|NCT01084655|54571336|FG001|Overall Study|Adverse Event|1|||
27913602|NCT01084655|54571337|FG002|Overall Study|Adverse Event|2|||
27913603|NCT01084655|54571335|FG000|Overall Study|Other|0|||
27913604|NCT01084655|54571336|FG001|Overall Study|Other|3|||
27913605|NCT01084655|54571337|FG002|Overall Study|Other|2|||
27913606|NCT01084655|54571335|FG000|Overall Study|Symptomatic deterioration|0|||
27913607|NCT01084655|54571336|FG001|Overall Study|Symptomatic deterioration|0|||
27999278|NCT00852917|54657939|FG002|Overall Study|Lack of Efficacy|11|||
27999279|NCT00852917|54657940|FG003|Overall Study|Lack of Efficacy|47|||
27999280|NCT00852917|54657937|FG000|Overall Study|Withdrawal by Subject|4|||
27999281|NCT00852917|54657938|FG001|Overall Study|Withdrawal by Subject|8|||
27999282|NCT00852917|54657939|FG002|Overall Study|Withdrawal by Subject|10|||
28099430|NCT03519854|54755413|FG012|Overall Study|Technical Error|0|||
27913608|NCT01084655|54571337|FG002|Overall Study|Symptomatic deterioration|2|||
27913609|NCT01084655|54571335|FG000|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
27999283|NCT00852917|54657940|FG003|Overall Study|Withdrawal by Subject|9|||
27999284|NCT00852917|54657937|FG000|Overall Study|Physician Decision|6|||
27999285|NCT00852917|54657938|FG001|Overall Study|Physician Decision|7|||
27999286|NCT00852917|54657939|FG002|Overall Study|Physician Decision|2|||
27999287|NCT00852917|54657940|FG003|Overall Study|Physician Decision|19|||
27999288|NCT00852917|54657937|FG000|Overall Study|Death|0|||
27999289|NCT00852917|54657938|FG001|Overall Study|Death|0|||
27999290|NCT00852917|54657939|FG002|Overall Study|Death|0|||
27999291|NCT00852917|54657940|FG003|Overall Study|Death|1|||
27999292|NCT00845429|54657953|FG000|Overall Study|Protocol Violation|5|||
27913610|NCT01084655|54571336|FG001|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
27913611|NCT01084655|54571337|FG002|Overall Study|Prostate-specificAntigen(PSA)progression|1|||
27913612|NCT01084538|54571349|FG000|Overall Study|Drug not available|30|||
27913613|NCT01084538|54571349|FG000|Overall Study|Adverse Event|9|||
27913614|NCT01084538|54571349|FG000|Overall Study|Kidney transplant|6|||
27913615|NCT01084538|54571349|FG000|Overall Study|Serious Adverse Event|3|||
27913616|NCT01084538|54571349|FG000|Overall Study|Lack of effectiveness|2|||
27913617|NCT01084538|54571349|FG000|Overall Study|Patient noncompliance|2|||
27913618|NCT01084538|54571349|FG000|Overall Study|Hyperphosphatemia|2|||
27913619|NCT01084538|54571349|FG000|Overall Study|Nodular hyperplasia of parathyroid gland|2|||
27913620|NCT01084538|54571349|FG000|Overall Study|Change of residence|2|||
27913621|NCT01084538|54571349|FG000|Overall Study|Over-suppression of parathyroid gland|2|||
27913622|NCT01084538|54571349|FG000|Overall Study|Reason unknown|8|||
27913623|NCT01083680|54571353|FG000|Overall Study|Lost to Follow-up|2758|||
27913624|NCT01083680|54571353|FG000|Overall Study|Withdrawal by Subject|1086|||
27913625|NCT00179517|54571359|FG000|Overall Study|Withdrawal by Subject|2|||
27913626|NCT00179517|54571360|FG001|Overall Study|Withdrawal by Subject|1|||
27913627|NCT01083641|54571366|FG000|Overall Study|Withdrawal by Subject|2|||
27913628|NCT00179010|54571372|FG000|Overall Study|Muscle probe defective|1|||
27913629|NCT00179010|54571373|FG001|Overall Study|Muscle probe defective|1|||
27913630|NCT00179010|54571372|FG000|Overall Study|Failure to place arterial line|0|||
27913631|NCT00179010|54571373|FG001|Overall Study|Failure to place arterial line|1|||
27913632|NCT01083602|54571380|FG000|Overall Study|Adverse Event|11|||
27913633|NCT01083602|54571380|FG000|Overall Study|New Cancer Therapy|2|||
27913634|NCT01083602|54571380|FG000|Overall Study|Death|1|||
27913635|NCT01083602|54571380|FG000|Overall Study|Withdrawal by Subject|5|||
27913636|NCT01083602|54571380|FG000|Overall Study|Lack of Efficacy|36|||
27913637|NCT00178464|54571384|FG000|Overall Study|Withdrawal by Subject|1|||
27913638|NCT00178464|54571384|FG000|Overall Study|Physician Decision|1|||
27913639|NCT01083485|54571390|FG000|Overall Study|Adverse Event|0|||
27913640|NCT01083485|54571391|FG001|Overall Study|Adverse Event|1|||
27913641|NCT01083485|54571390|FG000|Overall Study|Protocol Violation|1|||
27913642|NCT01083485|54571391|FG001|Overall Study|Protocol Violation|0|||
27913643|NCT01083485|54571390|FG000|Overall Study|Withdrawal by Subject|5|||
27913644|NCT01083485|54571391|FG001|Overall Study|Withdrawal by Subject|2|||
27913645|NCT01083485|54571390|FG000|Overall Study|Other|1|||
27913646|NCT01083485|54571391|FG001|Overall Study|Other|0|||
27913647|NCT01083173|54571399|FG000|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
27913648|NCT01083173|54571400|FG001|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
27913649|NCT01083173|54571399|FG000|Main Surveillance: Safety Group|Violation of the use/dosage|1|||
27913650|NCT01083173|54571400|FG001|Main Surveillance: Safety Group|Violation of the use/dosage|0|||
27913651|NCT01083173|54571399|FG000|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201|||
27913652|NCT01083173|54571400|FG001|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0|||
27913653|NCT01083173|54571399|FG000|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168|||
27913654|NCT01083173|54571400|FG001|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0|||
27913655|NCT01083173|54571399|FG000|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13|||
27913656|NCT01083173|54571400|FG001|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0|||
27913657|NCT01083173|54571399|FG000|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
27913658|NCT01083173|54571400|FG001|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
27913659|NCT01083173|54571399|FG000|Long-term Surveillance: Safety Group|Violation of the dosage|0|||
27913660|NCT01083173|54571400|FG001|Long-term Surveillance: Safety Group|Violation of the dosage|1|||
27913661|NCT01083173|54571399|FG000|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0|||
27913662|NCT01083173|54571400|FG001|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101|||
27913663|NCT01083173|54571399|FG000|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0|||
27913664|NCT01083173|54571400|FG001|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195|||
27913665|NCT01083173|54571399|FG000|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0|||
27913666|NCT01083173|54571400|FG001|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136|||
27913667|NCT01083173|54571399|FG000|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0|||
27913668|NCT01083173|54571400|FG001|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46|||
27913669|NCT00177294|54571411|FG000|Overall Study|Withdrawal by Subject|7|||
27913670|NCT00177294|54571412|FG001|Overall Study|Withdrawal by Subject|5|||
27913671|NCT01082081|54571421|FG000|Overall Study|Lost to Follow-up|0|||
27913672|NCT01082081|54571422|FG001|Overall Study|Lost to Follow-up|0|||
27913673|NCT01082081|54571423|FG002|Overall Study|Lost to Follow-up|1|||
27913674|NCT01082081|54571421|FG000|Overall Study|Withdrawal by Subject|0|||
27913675|NCT01082081|54571422|FG001|Overall Study|Withdrawal by Subject|0|||
27913676|NCT01082081|54571423|FG002|Overall Study|Withdrawal by Subject|1|||
27913677|NCT01082081|54571421|FG000|Overall Study|Other Reason|0|||
28099431|NCT03519854|54755414|FG013|Overall Study|Technical Error|0|||
28099432|NCT03519854|54755415|FG014|Overall Study|Technical Error|0|||
27913678|NCT01082081|54571422|FG001|Overall Study|Other Reason|1|||
27999293|NCT00845429|54657954|FG001|Overall Study|Protocol Violation|4|||
27999294|NCT00845429|54657955|FG002|Overall Study|Protocol Violation|7|||
27999295|NCT00845429|54657953|FG000|Overall Study|Lost to Follow-up|7|||
27999296|NCT00845429|54657954|FG001|Overall Study|Lost to Follow-up|9|||
27999297|NCT00845429|54657955|FG002|Overall Study|Lost to Follow-up|10|||
27999298|NCT00845429|54657953|FG000|Overall Study|Withdrawal by Subject|2|||
27999299|NCT00845429|54657954|FG001|Overall Study|Withdrawal by Subject|2|||
27913679|NCT01082081|54571423|FG002|Overall Study|Other Reason|0|||
27913680|NCT00177216|54571434|FG000|Overall Study|Withdrawal by Subject|6|||
27913681|NCT00177216|54571435|FG001|Overall Study|Withdrawal by Subject|3|||
27913682|NCT00177216|54571436|FG002|Overall Study|Withdrawal by Subject|1|||
27913683|NCT01081886|54571450|FG000|Overall Study|Study termination|11|||
27913684|NCT01081886|54571451|FG001|Overall Study|Study termination|13|||
27913685|NCT01081769|54571459|FG000|Whole Intent-to-Treat|Missing Responder Assessment|10|||
27999300|NCT00845429|54657955|FG002|Overall Study|Withdrawal by Subject|2|||
27999301|NCT00845429|54657953|FG000|Overall Study|Serious adverse event|0|||
27913686|NCT01081769|54571460|FG001|Whole Intent-to-Treat|Missing Responder Assessment|12|||
27913687|NCT01081769|54571459|FG000|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
27999302|NCT00845429|54657954|FG001|Overall Study|Serious adverse event|0|||
27999303|NCT00845429|54657955|FG002|Overall Study|Serious adverse event|1|||
27999304|NCT00593333|54657965|FG000|Overall Study|Lost to Follow-up|10|||
27999305|NCT00593333|54657966|FG001|Overall Study|Lost to Follow-up|11|||
27999306|NCT00844883|54657972|FG000|Overall Study|Bridged to liver transplant|3|||
27999307|NCT00844883|54657972|FG000|Overall Study|Bridged to resection|1|||
27999308|NCT00851903|54657976|FG000|Overall Study|Withdrawal by Subject|2|||
27999309|NCT00587457|54657983|FG000|Overall Study|Adverse Event|1|||
27999310|NCT00587457|54657984|FG001|Overall Study|Adverse Event|2|||
27999311|NCT00587457|54657985|FG002|Overall Study|Adverse Event|1|||
27999312|NCT00587457|54657983|FG000|Overall Study|Disease progression|2|||
27999313|NCT00587457|54657984|FG001|Overall Study|Disease progression|0|||
27999314|NCT00587457|54657985|FG002|Overall Study|Disease progression|2|||
27999315|NCT00587457|54657983|FG000|Overall Study|Initiation of alternative therapy|0|||
27999316|NCT00587457|54657984|FG001|Overall Study|Initiation of alternative therapy|1|||
27999317|NCT00587457|54657985|FG002|Overall Study|Initiation of alternative therapy|0|||
27999318|NCT00587457|54657983|FG000|Overall Study|Undefined|0|||
27999319|NCT00587457|54657984|FG001|Overall Study|Undefined|0|||
27999320|NCT00587457|54657985|FG002|Overall Study|Undefined|1|||
27999321|NCT00587457|54657983|FG000|Overall Study|Development of neutralizing Abs|0|||
27999322|NCT00587457|54657984|FG001|Overall Study|Development of neutralizing Abs|0|||
27999323|NCT00587457|54657985|FG002|Overall Study|Development of neutralizing Abs|1|||
27999324|NCT00851747|54657996|FG000|Overall Study|Physician Decision|6|||
27999325|NCT00851747|54657997|FG001|Overall Study|Physician Decision|6|||
27999326|NCT00851747|54657998|FG002|Overall Study|Physician Decision|6|||
28099433|NCT03519854|54755416|FG015|Overall Study|Technical Error|0|||
28099434|NCT03519854|54755417|FG016|Overall Study|Technical Error|0|||
28099435|NCT03519854|54755418|FG017|Overall Study|Technical Error|0|||
28099436|NCT03479216|54755458|FG000|Overall Study|Withdrawal by Subject|3|||
28099437|NCT03479216|54755459|FG001|Overall Study|Withdrawal by Subject|2|||
28099438|NCT03479216|54755458|FG000|Overall Study|Physician Decision|2|||
28099439|NCT03479216|54755459|FG001|Overall Study|Physician Decision|3|||
28099440|NCT03518840|54755465|FG000|Overall Study|Lost to Follow-up|6|||
28099441|NCT03436082|54755474|FG000|Overall Study|Did not undergo procedure|1|||
28099442|NCT03436082|54755475|FG001|Overall Study|Did not undergo procedure|0|||
28099443|NCT03677934|54755483|FG000|Overall Study|Adverse Event|1|||
27913688|NCT01081769|54571460|FG001|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
27913689|NCT01081769|54571459|FG000|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6|||
27913690|NCT01081769|54571460|FG001|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7|||
27913691|NCT01081769|54571459|FG000|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2|||
27913692|NCT01081769|54571460|FG001|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0|||
27913693|NCT01081769|54571459|FG000|CORE Intent-To-Treat|Adverse Event|14|||
27913694|NCT01081769|54571460|FG001|CORE Intent-To-Treat|Adverse Event|11|||
27913695|NCT01081769|54571459|FG000|CORE Intent-To-Treat|Death|1|||
27999327|NCT00767325|54658005|FG000|Overall Study|Lack of Efficacy|2|||
27999328|NCT00767325|54658005|FG000|Overall Study|Adverse Event|7|||
27999329|NCT00767325|54658005|FG000|Overall Study|Lost to Follow-up|3|||
27999330|NCT00767325|54658005|FG000|Overall Study|No longer met study criteria|2|||
27999331|NCT00767325|54658005|FG000|Overall Study|Missed visit due to family reasons|1|||
27999332|NCT00851591|54658011|FG000|Overall Study|Withdrawal by Subject|2|||
27999333|NCT00851591|54658012|FG001|Overall Study|Withdrawal by Subject|0|||
27999334|NCT00861341|54658018|FG000|Overall Study|Withdrawal by Subject|2|||
28099444|NCT03677934|54755484|FG001|Overall Study|Adverse Event|1|||
28099445|NCT03677934|54755483|FG000|Overall Study|Death|8|||
27999335|NCT00766467|54658024|FG000|Overall Study|Withdrawal by Subject|7|||
27999336|NCT00766467|54658025|FG001|Overall Study|Withdrawal by Subject|2|||
28099446|NCT03677934|54755484|FG001|Overall Study|Death|4|||
27913696|NCT01081769|54571460|FG001|CORE Intent-To-Treat|Death|1|||
27913697|NCT01081769|54571459|FG000|CORE Intent-To-Treat|Lack of Efficacy|2|||
27913698|NCT01081769|54571460|FG001|CORE Intent-To-Treat|Lack of Efficacy|6|||
27913699|NCT01081769|54571459|FG000|CORE Intent-To-Treat|Lost to Follow-up|4|||
27913700|NCT01081769|54571460|FG001|CORE Intent-To-Treat|Lost to Follow-up|5|||
27913701|NCT01081769|54571459|FG000|CORE Intent-To-Treat|Pregnancy|1|||
27913702|NCT01081769|54571460|FG001|CORE Intent-To-Treat|Pregnancy|0|||
27913703|NCT01081769|54571459|FG000|CORE Intent-To-Treat|Withdrawal by Subject|52|||
27913704|NCT01081769|54571460|FG001|CORE Intent-To-Treat|Withdrawal by Subject|60|||
27913705|NCT01081769|54571459|FG000|CORE Intent-To-Treat|Noncompliance With Study Drug|0|||
27913706|NCT01081769|54571460|FG001|CORE Intent-To-Treat|Noncompliance With Study Drug|5|||
27913707|NCT01081769|54571459|FG000|CORE Intent-To-Treat|Other|0|||
27913708|NCT01081769|54571460|FG001|CORE Intent-To-Treat|Other|1|||
27913709|NCT01081769|54571459|FG000|CORE Intent-To-Treat|Ineligibility|3|||
27913710|NCT01081769|54571460|FG001|CORE Intent-To-Treat|Ineligibility|4|||
27913711|NCT01081769|54571459|FG000|CORE Intent-To-Treat|Visit Schedule Issues|1|||
27913712|NCT01081769|54571460|FG001|CORE Intent-To-Treat|Visit Schedule Issues|2|||
27913713|NCT01081769|54571459|FG000|CORE Intent-To-Treat|Patient Moved|2|||
27913714|NCT01081769|54571460|FG001|CORE Intent-To-Treat|Patient Moved|2|||
27913715|NCT01081301|54571466|FG000|Overall Study|Bereaved|3|||
27913716|NCT01081301|54571466|FG000|Overall Study|Too busy|5|||
27913717|NCT01081301|54571466|FG000|Overall Study|Patient too ill|2|||
27913718|NCT01081301|54571466|FG000|Overall Study|Lost to Follow-up|4|||
27913719|NCT00174954|54571487|FG000|Overall Study|Adverse Event|2|||
27913720|NCT00174954|54571487|FG000|Overall Study|No tophi found in MRI|1|||
27913721|NCT00174954|54571487|FG000|Overall Study|Physician Decision|1|||
27913722|NCT01081145|54571491|FG000|Open-Label Phase|Lack of Efficacy|56|||
27913723|NCT01081145|54571492|FG001|Open-Label Phase|Lack of Efficacy|0|||
27913724|NCT01081145|54571491|FG000|Open-Label Phase|Response criteria not met|46|||
27913725|NCT01081145|54571492|FG001|Open-Label Phase|Response criteria not met|0|||
27913726|NCT01081145|54571491|FG000|Open-Label Phase|Adverse Event|42|||
27913727|NCT01081145|54571492|FG001|Open-Label Phase|Adverse Event|0|||
27913728|NCT01081145|54571491|FG000|Open-Label Phase|Withdrawal by Subject|41|||
27913729|NCT01081145|54571492|FG001|Open-Label Phase|Withdrawal by Subject|0|||
27913730|NCT01081145|54571491|FG000|Open-Label Phase|Other|12|||
27913731|NCT01081145|54571492|FG001|Open-Label Phase|Other|0|||
27913732|NCT01081145|54571491|FG000|Open-Label Phase|Lost to Follow-up|11|||
27913733|NCT01081145|54571492|FG001|Open-Label Phase|Lost to Follow-up|0|||
27913734|NCT01081145|54571491|FG000|Open-Label Phase|Protocol Violation|4|||
27913735|NCT01081145|54571492|FG001|Open-Label Phase|Protocol Violation|0|||
27913736|NCT01081145|54571491|FG000|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3|||
27913737|NCT01081145|54571492|FG001|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2|||
27913738|NCT01081145|54571491|FG000|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1|||
27913739|NCT01081145|54571492|FG001|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0|||
27999337|NCT00766467|54658024|FG000|Overall Study|Adverse Event|1|||
27999338|NCT00766467|54658025|FG001|Overall Study|Adverse Event|1|||
27999339|NCT00766467|54658024|FG000|Overall Study|Protocol Violation|2|||
27999340|NCT00766467|54658025|FG001|Overall Study|Protocol Violation|4|||
27999341|NCT00766467|54658024|FG000|Overall Study|Tumor Progression on Study|0|||
27999342|NCT00766467|54658025|FG001|Overall Study|Tumor Progression on Study|1|||
28099447|NCT03677934|54755483|FG000|Overall Study|Lost to Follow-up|3|||
28099448|NCT03677934|54755484|FG001|Overall Study|Lost to Follow-up|0|||
28099449|NCT03677934|54755483|FG000|Overall Study|Non-Compliance With Study Drug|1|||
28099450|NCT03677934|54755484|FG001|Overall Study|Non-Compliance With Study Drug|0|||
28099451|NCT03677934|54755483|FG000|Overall Study|Physician Decision|0|||
28099452|NCT03677934|54755484|FG001|Overall Study|Physician Decision|1|||
28099453|NCT03677934|54755483|FG000|Overall Study|Withdrawal by Subject|1|||
28099454|NCT03677934|54755484|FG001|Overall Study|Withdrawal by Subject|7|||
28099455|NCT03435692|54755496|FG000|Overall Study|Lack of Efficacy|2|||
28099456|NCT03435692|54755497|FG001|Overall Study|Lack of Efficacy|2|||
28099457|NCT03435692|54755498|FG002|Overall Study|Lack of Efficacy|0|||
28099458|NCT03475316|54755512|FG000|6 Month Intervention|Adverse Event|2|||
28099459|NCT03475316|54755513|FG001|6 Month Intervention|Adverse Event|1|||
27913740|NCT01081145|54571491|FG000|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10|||
27913741|NCT01081145|54571492|FG001|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8|||
27913742|NCT01081145|54571491|FG000|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3|||
27913743|NCT01081145|54571492|FG001|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2|||
27913744|NCT01081145|54571491|FG000|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13|||
27913745|NCT01081145|54571492|FG001|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20|||
27913746|NCT01081145|54571491|FG000|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47|||
27999343|NCT00766467|54658024|FG000|Overall Study|Physician Decision|1|||
27999344|NCT00766467|54658025|FG001|Overall Study|Physician Decision|0|||
27999345|NCT00850499|54658033|FG000|Overall Study|Adverse Event|3|||
28099460|NCT03475316|54755512|FG000|6 Month Intervention|Withdrawal by Subject|2|||
28172695|NCT02635646|54844412|FG001|Overall Study|Pregnancy|1|||
27999346|NCT00850499|54658034|FG001|Overall Study|Adverse Event|1|||
27999347|NCT00850499|54658033|FG000|Overall Study|Lack of Efficacy|0|||
27999348|NCT00850499|54658034|FG001|Overall Study|Lack of Efficacy|1|||
27999349|NCT00860951|54658040|FG000|Overall Study|Withdrawal by Subject|2|||
27999350|NCT00860951|54658040|FG000|Overall Study|Lost to Follow-up|5|||
27999351|NCT00844805|54658058|FG000|Treatment Phase|Adverse Event|5|||
27999352|NCT00844805|54658059|FG001|Treatment Phase|Adverse Event|1|||
27999353|NCT00844805|54658060|FG002|Treatment Phase|Adverse Event|0|||
27999354|NCT00844805|54658061|FG003|Treatment Phase|Adverse Event|0|||
27999355|NCT00844805|54658058|FG000|Treatment Phase|Withdrawal by Subject|3|||
27999356|NCT00844805|54658059|FG001|Treatment Phase|Withdrawal by Subject|4|||
27999357|NCT00844805|54658060|FG002|Treatment Phase|Withdrawal by Subject|0|||
27999358|NCT00844805|54658061|FG003|Treatment Phase|Withdrawal by Subject|0|||
27999359|NCT00844805|54658058|FG000|Treatment Phase|Noncompliance With Protocol|1|||
27999360|NCT00844805|54658059|FG001|Treatment Phase|Noncompliance With Protocol|0|||
27999361|NCT00844805|54658060|FG002|Treatment Phase|Noncompliance With Protocol|0|||
27999362|NCT00844805|54658061|FG003|Treatment Phase|Noncompliance With Protocol|0|||
27999363|NCT00844805|54658058|FG000|Treatment Phase|Did Not Meet Protocol Eligibility|1|||
27999364|NCT00844805|54658059|FG001|Treatment Phase|Did Not Meet Protocol Eligibility|2|||
27999365|NCT00844805|54658060|FG002|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
27999366|NCT00844805|54658061|FG003|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
27999367|NCT00844805|54658058|FG000|Follow-Up Phase|Adverse Event|0|||
27999368|NCT00844805|54658059|FG001|Follow-Up Phase|Adverse Event|0|||
27999369|NCT00844805|54658060|FG002|Follow-Up Phase|Adverse Event|1|||
27999370|NCT00844805|54658061|FG003|Follow-Up Phase|Adverse Event|0|||
27999371|NCT00844805|54658058|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
27999372|NCT00844805|54658059|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
27999373|NCT00844805|54658060|FG002|Follow-Up Phase|Withdrawal by Subject|6|||
27999374|NCT00844805|54658061|FG003|Follow-Up Phase|Withdrawal by Subject|3|||
27999375|NCT00844805|54658058|FG000|Follow-Up Phase|Noncompliance With Protocol|0|||
27999376|NCT00844805|54658059|FG001|Follow-Up Phase|Noncompliance With Protocol|0|||
27999377|NCT00844805|54658060|FG002|Follow-Up Phase|Noncompliance With Protocol|0|||
27999378|NCT00844805|54658061|FG003|Follow-Up Phase|Noncompliance With Protocol|1|||
27913747|NCT01081145|54571492|FG001|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71|||
27913748|NCT01081145|54571491|FG000|Double-Blind Randomized-Withdrawal Phase|Other|4|||
27913749|NCT01081145|54571492|FG001|Double-Blind Randomized-Withdrawal Phase|Other|3|||
27913750|NCT00174915|54571505|FG000|Overall Study|Lost to Follow-up|19|||
27999379|NCT00844805|54658058|FG000|Follow-Up Phase|Relapse/Recurrence|0|||
27999380|NCT00844805|54658059|FG001|Follow-Up Phase|Relapse/Recurrence|0|||
27999381|NCT00844805|54658060|FG002|Follow-Up Phase|Relapse/Recurrence|2|||
27999382|NCT00844805|54658061|FG003|Follow-Up Phase|Relapse/Recurrence|4|||
28099461|NCT03475316|54755513|FG001|6 Month Intervention|Withdrawal by Subject|0|||
28099462|NCT03475316|54755512|FG000|6 Month Intervention|Study stopped due to COVID pandemic|1|||
28099463|NCT03475316|54755513|FG001|6 Month Intervention|Study stopped due to COVID pandemic|3|||
28099464|NCT03475316|54755512|FG000|9 Months|Study stopped due to COVID pandemic|3|||
28099465|NCT03475316|54755513|FG001|9 Months|Study stopped due to COVID pandemic|4|||
28099466|NCT03673956|54755523|FG000|Overall Study|Lost to Follow-up|1|||
28099467|NCT03673956|54755524|FG001|Overall Study|Lost to Follow-up|0|||
28099468|NCT03673956|54755525|FG002|Overall Study|Lost to Follow-up|0|||
28099469|NCT03673956|54755526|FG003|Overall Study|Lost to Follow-up|0|||
28099470|NCT03673956|54755523|FG000|Overall Study|Did not use the prescribed topical antibiotics as directed|1|||
28099471|NCT03673956|54755524|FG001|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
28099472|NCT03673956|54755525|FG002|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
27913751|NCT00174915|54571506|FG001|Overall Study|Lost to Follow-up|17|||
27913752|NCT00174915|54571507|FG002|Overall Study|Lost to Follow-up|9|||
27913753|NCT00174915|54571508|FG003|Overall Study|Lost to Follow-up|17|||
27913754|NCT00174915|54571509|FG004|Overall Study|Lost to Follow-up|10|||
27913755|NCT00174915|54571505|FG000|Overall Study|Adverse Event|18|||
27913756|NCT00174915|54571506|FG001|Overall Study|Adverse Event|16|||
27913757|NCT00174915|54571507|FG002|Overall Study|Adverse Event|11|||
27913758|NCT00174915|54571508|FG003|Overall Study|Adverse Event|18|||
27913759|NCT00174915|54571509|FG004|Overall Study|Adverse Event|5|||
27913760|NCT00174915|54571505|FG000|Overall Study|Personal Reason(s)|16|||
27999383|NCT00844805|54658058|FG000|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
27999384|NCT00844805|54658059|FG001|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
27999385|NCT00844805|54658060|FG002|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
27999386|NCT00844805|54658061|FG003|Follow-Up Phase|Did Not Meet Protocol Eligibility|1|||
27999387|NCT00765999|54658072|FG000|Overall Study|Adverse Event|203|||
27999388|NCT00765999|54658072|FG000|Overall Study|Insufficient Therapeutic Response|100|||
27999389|NCT00765999|54658072|FG000|Overall Study|Protocol Violation|95|||
27999390|NCT00765999|54658072|FG000|Overall Study|Consent Withdrawn|202|||
27999391|NCT00765999|54658072|FG000|Overall Study|Lost to Follow-up|131|||
28099473|NCT03673956|54755526|FG003|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
28099474|NCT03517436|54755536|FG000|Overall Study|Death|3|||
27999392|NCT00765999|54658072|FG000|Overall Study|Study Terminated by Sponsor|2|||
27913761|NCT00174915|54571506|FG001|Overall Study|Personal Reason(s)|16|||
27913762|NCT00174915|54571507|FG002|Overall Study|Personal Reason(s)|9|||
27913763|NCT00174915|54571508|FG003|Overall Study|Personal Reason(s)|9|||
27913764|NCT00174915|54571509|FG004|Overall Study|Personal Reason(s)|9|||
27913765|NCT00174915|54571505|FG000|Overall Study|Other|15|||
27913766|NCT00174915|54571506|FG001|Overall Study|Other|8|||
27913767|NCT00174915|54571507|FG002|Overall Study|Other|6|||
27913768|NCT00174915|54571508|FG003|Overall Study|Other|5|||
27913769|NCT00174915|54571509|FG004|Overall Study|Other|3|||
27913770|NCT00174915|54571505|FG000|Overall Study|Gout Flare|13|||
27999393|NCT00765999|54658072|FG000|Overall Study|Other Miscellaneous Reasons|51|||
27999394|NCT00765843|54658081|FG000|Overall Study|Lost to Follow-up|1|||
27999395|NCT00765843|54658082|FG001|Overall Study|Lost to Follow-up|3|||
27999396|NCT00765843|54658083|FG002|Overall Study|Lost to Follow-up|2|||
27999397|NCT00765843|54658081|FG000|Overall Study|did not return to receive intervention|0|||
27999398|NCT00765843|54658082|FG001|Overall Study|did not return to receive intervention|1|||
27999399|NCT00765843|54658083|FG002|Overall Study|did not return to receive intervention|0|||
27999400|NCT00765843|54658081|FG000|Overall Study|Adverse Event|0|||
27999401|NCT00765843|54658082|FG001|Overall Study|Adverse Event|0|||
27999402|NCT00765843|54658083|FG002|Overall Study|Adverse Event|1|||
27999403|NCT00765063|54658091|FG000|Overall Study|Lack of Efficacy|5|||
27999404|NCT00765063|54658091|FG000|Overall Study|Withdrawal by Subject|1|||
27999405|NCT00765063|54658091|FG000|Overall Study|Other|16|||
27999406|NCT00765063|54658091|FG000|Overall Study|Protocol Violation|6|||
27999407|NCT00765063|54658091|FG000|Overall Study|Adverse Event|4|||
27999408|NCT00764751|54658097|FG000|Overall Study|Adverse Event|1|||
27999409|NCT00764751|54658098|FG001|Overall Study|Adverse Event|1|||
27999410|NCT00764751|54658097|FG000|Overall Study|Psoriasis flare up on the scalp|1|||
27999411|NCT00764751|54658098|FG001|Overall Study|Psoriasis flare up on the scalp|0|||
27999412|NCT00764673|54658109|FG000|Overall Study|Death|1|||
27999413|NCT00764673|54658109|FG000|Overall Study|Lost to Follow-up|3|||
27999414|NCT00764673|54658109|FG000|Overall Study|Withdrawal by Subject|6|||
27999415|NCT00764673|54658109|FG000|Overall Study|Revision of Device|2|||
27999416|NCT00764517|54658115|FG000|Overall Study|Adverse Event|9|||
27999417|NCT00764517|54658116|FG001|Overall Study|Adverse Event|3|||
27999418|NCT00764517|54658115|FG000|Overall Study|Death|3|||
27999419|NCT00764517|54658116|FG001|Overall Study|Death|11|||
27999420|NCT00764517|54658115|FG000|Overall Study|Physician Decision|3|||
27999421|NCT00764517|54658116|FG001|Overall Study|Physician Decision|0|||
27999422|NCT00764361|54658124|FG000|Overall Study|Withdrawal by Subject|2|||
27999423|NCT00764361|54658125|FG001|Overall Study|Withdrawal by Subject|3|||
27999424|NCT00764361|54658124|FG000|Overall Study|Adverse Event|0|||
27999425|NCT00764361|54658125|FG001|Overall Study|Adverse Event|1|||
27999426|NCT00763971|54658134|FG000|Overall Study|Adverse Event|5|||
27999427|NCT00763971|54658135|FG001|Overall Study|Adverse Event|2|||
27999428|NCT00763971|54658136|FG002|Overall Study|Adverse Event|4|||
27913771|NCT00174915|54571506|FG001|Overall Study|Gout Flare|6|||
27999429|NCT00763971|54658134|FG000|Overall Study|Protocol Violation|3|||
27999430|NCT00763971|54658135|FG001|Overall Study|Protocol Violation|3|||
27999431|NCT00763971|54658136|FG002|Overall Study|Protocol Violation|2|||
27999432|NCT00763971|54658134|FG000|Overall Study|Withdrawal by Subject|4|||
27999433|NCT00763971|54658135|FG001|Overall Study|Withdrawal by Subject|5|||
27999434|NCT00763971|54658136|FG002|Overall Study|Withdrawal by Subject|5|||
27999435|NCT00763971|54658134|FG000|Overall Study|Lost to Follow-up|0|||
27999436|NCT00763971|54658135|FG001|Overall Study|Lost to Follow-up|1|||
27999437|NCT00763971|54658136|FG002|Overall Study|Lost to Follow-up|0|||
27999438|NCT00763971|54658134|FG000|Overall Study|Lack of Efficacy|11|||
27913772|NCT00174915|54571507|FG002|Overall Study|Gout Flare|8|||
27913773|NCT00174915|54571508|FG003|Overall Study|Gout Flare|1|||
27913774|NCT00174915|54571509|FG004|Overall Study|Gout Flare|0|||
27999439|NCT00763971|54658135|FG001|Overall Study|Lack of Efficacy|22|||
27913775|NCT00174915|54571505|FG000|Overall Study|Protocol Violation|6|||
27913776|NCT00174915|54571506|FG001|Overall Study|Protocol Violation|3|||
27999440|NCT00763971|54658136|FG002|Overall Study|Lack of Efficacy|54|||
27913777|NCT00174915|54571507|FG002|Overall Study|Protocol Violation|3|||
27913778|NCT00174915|54571508|FG003|Overall Study|Protocol Violation|6|||
27913779|NCT00174915|54571509|FG004|Overall Study|Protocol Violation|3|||
27999441|NCT00763971|54658134|FG000|Overall Study|Unable to swallow capsule|2|||
27999442|NCT00763971|54658135|FG001|Overall Study|Unable to swallow capsule|1|||
27999443|NCT00763971|54658136|FG002|Overall Study|Unable to swallow capsule|1|||
27999444|NCT00763971|54658134|FG000|Overall Study|Personal reason|3|||
27999445|NCT00763971|54658135|FG001|Overall Study|Personal reason|0|||
27999446|NCT00763971|54658136|FG002|Overall Study|Personal reason|0|||
27999447|NCT00763971|54658134|FG000|Overall Study|Exclusion criteria met|1|||
27999448|NCT00763971|54658135|FG001|Overall Study|Exclusion criteria met|0|||
27999449|NCT00763971|54658136|FG002|Overall Study|Exclusion criteria met|0|||
27999450|NCT00763971|54658134|FG000|Overall Study|Sponsor decision|1|||
27999451|NCT00763971|54658135|FG001|Overall Study|Sponsor decision|0|||
27913780|NCT00174915|54571505|FG000|Overall Study|Therapeutic Failure|6|||
27913781|NCT00174915|54571506|FG001|Overall Study|Therapeutic Failure|3|||
27999452|NCT00763971|54658136|FG002|Overall Study|Sponsor decision|0|||
27999453|NCT00763971|54658134|FG000|Overall Study|Due to holiday season|2|||
27999454|NCT00763971|54658135|FG001|Overall Study|Due to holiday season|0|||
27999455|NCT00763971|54658136|FG002|Overall Study|Due to holiday season|1|||
27999456|NCT00763971|54658134|FG000|Overall Study|Randomization error|0|||
27999457|NCT00763971|54658135|FG001|Overall Study|Randomization error|0|||
27913782|NCT00174915|54571507|FG002|Overall Study|Therapeutic Failure|2|||
27913783|NCT00174915|54571508|FG003|Overall Study|Therapeutic Failure|1|||
27913784|NCT00174915|54571509|FG004|Overall Study|Therapeutic Failure|3|||
27913785|NCT01080716|54571525|FG000|Part 1|Physician Decision|1|||
27913786|NCT01080716|54571526|FG001|Part 1|Physician Decision|0|||
27913787|NCT01080716|54571527|FG002|Part 1|Physician Decision|0|||
27913788|NCT01080716|54571528|FG003|Part 1|Physician Decision|0|||
27913789|NCT00172185|54571546|FG000|Overall Study|Adverse Event|0|||
27913790|NCT00172185|54571547|FG001|Overall Study|Adverse Event|1|||
27913791|NCT00172185|54571548|FG002|Overall Study|Adverse Event|3|||
27999458|NCT00763971|54658136|FG002|Overall Study|Randomization error|1|||
27999459|NCT00763971|54658134|FG000|Overall Study|Medical monitor decision|0|||
27999460|NCT00763971|54658135|FG001|Overall Study|Medical monitor decision|0|||
27999461|NCT00763971|54658136|FG002|Overall Study|Medical monitor decision|1|||
27999462|NCT00763971|54658134|FG000|Overall Study|Moved to another country|0|||
27999463|NCT00763971|54658135|FG001|Overall Study|Moved to another country|1|||
27999464|NCT00763971|54658136|FG002|Overall Study|Moved to another country|0|||
27999465|NCT00763971|54658134|FG000|Overall Study|Subject wanted dose reduction|0|||
27999466|NCT00763971|54658135|FG001|Overall Study|Subject wanted dose reduction|1|||
27999467|NCT00763971|54658136|FG002|Overall Study|Subject wanted dose reduction|0|||
27999468|NCT00763971|54658134|FG000|Overall Study|Lack of availability|0|||
27999469|NCT00763971|54658135|FG001|Overall Study|Lack of availability|1|||
27999470|NCT00763971|54658136|FG002|Overall Study|Lack of availability|0|||
27913792|NCT00172185|54571549|FG003|Overall Study|Adverse Event|4|||
27913793|NCT00172185|54571546|FG000|Overall Study|Physician Decision|0|||
27913794|NCT00172185|54571547|FG001|Overall Study|Physician Decision|0|||
27913795|NCT00172185|54571548|FG002|Overall Study|Physician Decision|1|||
27913796|NCT00172185|54571549|FG003|Overall Study|Physician Decision|0|||
27913797|NCT00172185|54571546|FG000|Overall Study|SPONSOR Decision|0|||
27913798|NCT00172185|54571547|FG001|Overall Study|SPONSOR Decision|1|||
27913799|NCT00172185|54571548|FG002|Overall Study|SPONSOR Decision|0|||
27913800|NCT00172185|54571549|FG003|Overall Study|SPONSOR Decision|0|||
27913801|NCT00172185|54571546|FG000|Overall Study|Withdrawal by Subject|0|||
27913802|NCT00172185|54571547|FG001|Overall Study|Withdrawal by Subject|0|||
27913803|NCT00172185|54571548|FG002|Overall Study|Withdrawal by Subject|1|||
27913804|NCT00172185|54571549|FG003|Overall Study|Withdrawal by Subject|0|||
27913805|NCT01080326|54571563|FG000|Overall Study|Patient deterioration prior to procedure|3|||
27999471|NCT00763971|54658134|FG000|Overall Study|Performed final visit on phone|0|||
27999472|NCT00763971|54658135|FG001|Overall Study|Performed final visit on phone|1|||
27999473|NCT00763971|54658136|FG002|Overall Study|Performed final visit on phone|0|||
27999474|NCT00763971|54658134|FG000|Overall Study|Participation in 489-326 required|1|||
27999475|NCT00763971|54658135|FG001|Overall Study|Participation in 489-326 required|0|||
27999476|NCT00763971|54658136|FG002|Overall Study|Participation in 489-326 required|0|||
27999477|NCT00763815|54658146|FG000|Overall Study|Adverse Event|14|||
27913806|NCT01080326|54571563|FG000|Overall Study|Surgeon decision|1|||
27999478|NCT00763815|54658147|FG001|Overall Study|Adverse Event|29|||
27999479|NCT00763815|54658146|FG000|Overall Study|Lack of Efficacy|10|||
27999480|NCT00763815|54658147|FG001|Overall Study|Lack of Efficacy|11|||
27999481|NCT00763815|54658146|FG000|Overall Study|Poor Compliance to Protocol|6|||
27999482|NCT00763815|54658147|FG001|Overall Study|Poor Compliance to Protocol|6|||
27999483|NCT00763815|54658146|FG000|Overall Study|Lost to Follow-up|2|||
27999484|NCT00763815|54658147|FG001|Overall Study|Lost to Follow-up|4|||
27999485|NCT00763815|54658146|FG000|Overall Study|Early Termination|1|||
27999486|NCT00763815|54658147|FG001|Overall Study|Early Termination|0|||
27999487|NCT00763815|54658146|FG000|Overall Study|Familial and Personal Reasons|9|||
27999488|NCT00763815|54658147|FG001|Overall Study|Familial and Personal Reasons|16|||
27999489|NCT00763815|54658146|FG000|Overall Study|Physician Decision|1|||
27999490|NCT00763815|54658147|FG001|Overall Study|Physician Decision|0|||
27913807|NCT00171951|54571567|FG000|Overall Study|Adverse Event|1|||
28099475|NCT03517436|54755536|FG000|Overall Study|Withdrawal by Subject|4|||
27913808|NCT00171951|54571567|FG000|Overall Study|Abnormal Laboratory Values|2|||
27913809|NCT00171951|54571567|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
27913810|NCT00171951|54571567|FG000|Overall Study|Participants Withdrew Consent|3|||
27999491|NCT00763815|54658146|FG000|Overall Study|Withdrawal by Subject|7|||
27999492|NCT00763815|54658147|FG001|Overall Study|Withdrawal by Subject|12|||
27913811|NCT00171951|54571567|FG000|Overall Study|New Cancer Therapy|5|||
27913812|NCT00171951|54571567|FG000|Overall Study|Reason not Specified|2|||
27913813|NCT01080131|54571576|FG000|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
27913814|NCT01080131|54571577|FG001|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
27999493|NCT00763815|54658146|FG000|Overall Study|Protocol Violation|2|||
27999494|NCT00763815|54658147|FG001|Overall Study|Protocol Violation|5|||
27999495|NCT00763815|54658146|FG000|Overall Study|Sponsor's Decision|0|||
27999496|NCT00763815|54658147|FG001|Overall Study|Sponsor's Decision|1|||
27999497|NCT00763269|54658155|FG000|Overall Study|Lost to Follow-up|12|||
27999498|NCT00763269|54658156|FG001|Overall Study|Lost to Follow-up|13|||
27999499|NCT00763035|54658162|FG000|First Intervention|Did not meeting inclusion/exclusion|1|||
27999500|NCT00763035|54658163|FG001|First Intervention|Did not meeting inclusion/exclusion|0|||
27999501|NCT00763035|54658162|FG000|First Intervention|Adverse Event|0|||
27999502|NCT00763035|54658163|FG001|First Intervention|Adverse Event|1|||
27999503|NCT00763035|54658162|FG000|Second Intervention|Adverse Event|1|||
27999504|NCT00763035|54658163|FG001|Second Intervention|Adverse Event|0|||
27999505|NCT00763035|54658162|FG000|Second Intervention|Physician Decision|2|||
27999506|NCT00763035|54658163|FG001|Second Intervention|Physician Decision|0|||
27999507|NCT00844649|54658171|FG000|Overall Study|Progressive Disease|196|||
27999508|NCT00844649|54658172|FG001|Overall Study|Progressive Disease|245|||
27999509|NCT00844649|54658171|FG000|Overall Study|Adverse Event|128|||
27999510|NCT00844649|54658172|FG001|Overall Study|Adverse Event|73|||
27999511|NCT00844649|54658171|FG000|Overall Study|Physician Decision|25|||
27999512|NCT00844649|54658172|FG001|Overall Study|Physician Decision|18|||
27999513|NCT00844649|54658171|FG000|Overall Study|Protocol Violation|10|||
27999514|NCT00844649|54658172|FG001|Overall Study|Protocol Violation|6|||
27999515|NCT00844649|54658171|FG000|Overall Study|Withdrawal by Subject|28|||
27999516|NCT00844649|54658172|FG001|Overall Study|Withdrawal by Subject|39|||
27999517|NCT00844649|54658171|FG000|Overall Study|Other|7|||
27999518|NCT00844649|54658172|FG001|Overall Study|Other|10|||
27999519|NCT00844649|54658171|FG000|Overall Study|Withdrew prior to starting treatment|11|||
27999520|NCT00844649|54658172|FG001|Overall Study|Withdrew prior to starting treatment|27|||
27999521|NCT00762723|54658183|FG000|Overall Study|Study Terminated slow enrollement|5|||
27999522|NCT00762723|54658184|FG001|Overall Study|Study Terminated slow enrollement|5|||
27999523|NCT00762723|54658185|FG002|Overall Study|Study Terminated slow enrollement|3|||
27999524|NCT00850343|54658197|FG000|Overall Study|Withdrawal by Subject|11|||
27999525|NCT00850343|54658198|FG001|Overall Study|Withdrawal by Subject|0|||
27999526|NCT00850343|54658199|FG002|Overall Study|Withdrawal by Subject|3|||
27999527|NCT00850343|54658200|FG003|Overall Study|Withdrawal by Subject|2|||
27999528|NCT00850343|54658197|FG000|Overall Study|Adverse Event|15|||
27999529|NCT00850343|54658198|FG001|Overall Study|Adverse Event|2|||
27999530|NCT00850343|54658199|FG002|Overall Study|Adverse Event|6|||
27999531|NCT00850343|54658200|FG003|Overall Study|Adverse Event|6|||
27913815|NCT01080131|54571576|FG000|Core Study (0- 12 Weeks)|Patient withdrew consent|6|||
27913816|NCT01080131|54571577|FG001|Core Study (0- 12 Weeks)|Patient withdrew consent|4|||
27913817|NCT01080131|54571576|FG000|Core Study (0- 12 Weeks)|Lost to Follow-up|5|||
27913818|NCT01080131|54571577|FG001|Core Study (0- 12 Weeks)|Lost to Follow-up|3|||
27913819|NCT01080131|54571576|FG000|Core Study (0- 12 Weeks)|Administrative problems|0|||
27913820|NCT01080131|54571577|FG001|Core Study (0- 12 Weeks)|Administrative problems|1|||
27913821|NCT01080131|54571576|FG000|Core Study (0- 12 Weeks)|Death|1|||
27999532|NCT00850343|54658197|FG000|Overall Study|Pregnancy|0|||
27999533|NCT00850343|54658198|FG001|Overall Study|Pregnancy|0|||
27999534|NCT00850343|54658199|FG002|Overall Study|Pregnancy|0|||
27999535|NCT00850343|54658200|FG003|Overall Study|Pregnancy|1|||
27999536|NCT00850343|54658197|FG000|Overall Study|Lack of Efficacy|17|||
27999537|NCT00850343|54658198|FG001|Overall Study|Lack of Efficacy|0|||
27999538|NCT00850343|54658199|FG002|Overall Study|Lack of Efficacy|3|||
27999539|NCT00850343|54658200|FG003|Overall Study|Lack of Efficacy|2|||
27999540|NCT00850343|54658197|FG000|Overall Study|Non-compliance with Study Procedures|1|||
27999541|NCT00850343|54658198|FG001|Overall Study|Non-compliance with Study Procedures|0|||
27999542|NCT00850343|54658199|FG002|Overall Study|Non-compliance with Study Procedures|1|||
27999543|NCT00850343|54658200|FG003|Overall Study|Non-compliance with Study Procedures|1|||
27999544|NCT00850343|54658197|FG000|Overall Study|Physician Decision|2|||
27999545|NCT00850343|54658198|FG001|Overall Study|Physician Decision|1|||
27999546|NCT00850343|54658199|FG002|Overall Study|Physician Decision|1|||
27999547|NCT00850343|54658200|FG003|Overall Study|Physician Decision|1|||
27999548|NCT00849875|54658213|FG000|Overall Study|Death|28|||
27999549|NCT00849875|54658213|FG000|Overall Study|Ongoing (unknown completion status)|11|||
27999550|NCT00849875|54658213|FG000|Overall Study|Others|6|||
27913822|NCT01080131|54571577|FG001|Core Study (0- 12 Weeks)|Death|0|||
27913823|NCT01080131|54571576|FG000|Core Study (0- 12 Weeks)|Protocol deviation|0|||
27999551|NCT00849875|54658213|FG000|Overall Study|Lost to Follow-up|2|||
27999552|NCT00844415|54658224|FG000|Overall Study|Withdrawal by Subject|1|||
27999553|NCT00843635|54658232|FG000|Overall Study|Adverse Event|2|||
27999554|NCT00843635|54658233|FG001|Overall Study|Adverse Event|2|||
27999555|NCT00843635|54658234|FG002|Overall Study|Adverse Event|0|||
27999556|NCT00843167|54658248|FG000|Treatment Period|Adverse Event|1|||
27999557|NCT00843167|54658249|FG001|Treatment Period|Adverse Event|5|||
27999558|NCT00843167|54658248|FG000|Treatment Period|Withdrawal by Subject|2|||
27913824|NCT01080131|54571577|FG001|Core Study (0- 12 Weeks)|Protocol deviation|2|||
27913825|NCT01080131|54571576|FG000|Extension Study 1 (12 -24 Weeks)|Adverse Event|1|||
27913826|NCT01080131|54571577|FG001|Extension Study 1 (12 -24 Weeks)|Adverse Event|0|||
27999559|NCT00843167|54658249|FG001|Treatment Period|Withdrawal by Subject|3|||
27999560|NCT00849017|54658262|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
27913827|NCT01080131|54571576|FG000|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0|||
27913828|NCT01080131|54571577|FG001|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1|||
27913829|NCT01080131|54571576|FG000|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4|||
27913830|NCT01080131|54571577|FG001|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3|||
27913831|NCT01080131|54571576|FG000|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1|||
27913832|NCT01080131|54571577|FG001|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0|||
27913833|NCT01080131|54571576|FG000|Extension Study 2 (25-72 Weeks)|Adverse Event|1|||
27913834|NCT01080131|54571577|FG001|Extension Study 2 (25-72 Weeks)|Adverse Event|2|||
27913835|NCT01080131|54571576|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3|||
27913836|NCT01080131|54571577|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4|||
27999561|NCT00849017|54658263|FG001|Treatment Period (156 Weeks)|Adverse Event|6|||
27999562|NCT00849017|54658264|FG002|Treatment Period (156 Weeks)|Adverse Event|15|||
28099476|NCT03517436|54755536|FG000|Overall Study|Did not receive study valve.|1|||
28099477|NCT03673098|54755542|FG000|Overall Study|Lost to Follow-up|2|||
28099478|NCT03673098|54755543|FG001|Overall Study|Lost to Follow-up|3|||
28099479|NCT03673098|54755542|FG000|Overall Study|Withdrawal by Subject|6|||
28099480|NCT03673098|54755543|FG001|Overall Study|Withdrawal by Subject|1|||
28099481|NCT03673098|54755542|FG000|Overall Study|Could not participate due to scheduling conflicts or health issues|2|||
28099482|NCT03673098|54755543|FG001|Overall Study|Could not participate due to scheduling conflicts or health issues|0|||
28099483|NCT03435224|54755556|FG000|Overall Study|Unable to achieve a minimum desaturation level|4|||
28099484|NCT03672396|54755560|FG000|Overall Study|Withdrawal by Subject|4|||
28099485|NCT03672396|54755560|FG000|Overall Study|Physician Decision|1|||
28099486|NCT03672396|54755560|FG000|Overall Study|Adverse Event|1|||
28099487|NCT03434834|54755564|FG000|Overall Study|unable to swallow OCT probe|16|||
28099488|NCT03605862|54755570|FG000|Overall Study|Withdrawal by Subject|12|||
28099489|NCT03605862|54755571|FG001|Overall Study|Withdrawal by Subject|9|||
28099490|NCT03605862|54755570|FG000|Overall Study|Adverse Event|2|||
28099491|NCT03605862|54755571|FG001|Overall Study|Adverse Event|1|||
28099492|NCT03605862|54755570|FG000|Overall Study|Physician Decision|3|||
28099493|NCT03605862|54755571|FG001|Overall Study|Physician Decision|1|||
28099494|NCT03605862|54755570|FG000|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|11|||
28099495|NCT03605862|54755571|FG001|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|15|||
28099496|NCT03672006|54755580|FG000|Overall Study|exclusion criteria met|0|||
28099497|NCT03672006|54755581|FG001|Overall Study|exclusion criteria met|1|||
28099498|NCT03512288|54755591|FG000|Overall Study|Adverse Event|1|||
28099499|NCT03512288|54755592|FG001|Overall Study|Adverse Event|0|||
28099500|NCT03512288|54755591|FG000|Overall Study|Lost to Follow-up|12|||
28099501|NCT03512288|54755592|FG001|Overall Study|Lost to Follow-up|15|||
28099502|NCT03512288|54755591|FG000|Overall Study|Physician Decision|0|||
28099503|NCT03512288|54755592|FG001|Overall Study|Physician Decision|2|||
28099504|NCT03512288|54755591|FG000|Overall Study|Protocol Violation|6|||
28099505|NCT03512288|54755592|FG001|Overall Study|Protocol Violation|4|||
28099506|NCT03512288|54755591|FG000|Overall Study|Medication error without associated adverse event|1|||
28099507|NCT03512288|54755592|FG001|Overall Study|Medication error without associated adverse event|0|||
28099508|NCT03512288|54755591|FG000|Overall Study|No longer met eligibility criteria|5|||
28099509|NCT03512288|54755592|FG001|Overall Study|No longer met eligibility criteria|2|||
28099510|NCT03512288|54755591|FG000|Overall Study|Withdrawal by parent/guardian|14|||
28099511|NCT03512288|54755592|FG001|Overall Study|Withdrawal by parent/guardian|18|||
28099512|NCT03512288|54755591|FG000|Overall Study|Other|1|||
28099513|NCT03512288|54755592|FG001|Overall Study|Other|1|||
28099514|NCT03512288|54755591|FG000|Overall Study|Randomized but not treated|1|||
28099515|NCT03512288|54755592|FG001|Overall Study|Randomized but not treated|1|||
28099516|NCT03031678|54755598|FG000|Overall Study|Study closed prior to completion|1|||
28099517|NCT03669588|54755608|FG000|Overall Study|Adverse Event|1|||
27999563|NCT00849017|54658262|FG000|Treatment Period (156 Weeks)|Noncompliance|3|||
27999564|NCT00849017|54658263|FG001|Treatment Period (156 Weeks)|Noncompliance|3|||
27999565|NCT00849017|54658264|FG002|Treatment Period (156 Weeks)|Noncompliance|4|||
27999566|NCT00849017|54658262|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|10|||
27999567|NCT00849017|54658263|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|7|||
27999568|NCT00849017|54658264|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|8|||
27999569|NCT00849017|54658262|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|18|||
27913837|NCT01080131|54571576|FG000|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4|||
27913838|NCT01080131|54571577|FG001|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5|||
28099518|NCT03669588|54755609|FG001|Overall Study|Adverse Event|0|||
28099519|NCT03669588|54755608|FG000|Overall Study|Physician Decision|0|||
28099520|NCT03669588|54755609|FG001|Overall Study|Physician Decision|1|||
28099521|NCT03669588|54755608|FG000|Overall Study|Protocol Violation|1|||
28099522|NCT03669588|54755609|FG001|Overall Study|Protocol Violation|0|||
28099523|NCT03669588|54755608|FG000|Overall Study|Sponsor Decision|1|||
28099524|NCT03669588|54755609|FG001|Overall Study|Sponsor Decision|1|||
27913839|NCT00171873|54571603|FG000|Overall Study|Withdrawal by Subject|4|||
27999570|NCT00849017|54658263|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|14|||
27999571|NCT00849017|54658264|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|11|||
27999572|NCT00849017|54658262|FG000|Treatment Period (156 Weeks)|Physician Decision|0|||
27999573|NCT00849017|54658263|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
27999574|NCT00849017|54658264|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
27999575|NCT00849017|54658262|FG000|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3|||
27999576|NCT00849017|54658263|FG001|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
27999577|NCT00849017|54658264|FG002|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
27999578|NCT00849017|54658262|FG000|Treatment Period (156 Weeks)|Increased Calcitonin|1|||
27999579|NCT00849017|54658263|FG001|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
27999580|NCT00849017|54658264|FG002|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
27999581|NCT00849017|54658262|FG000|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1|||
27999582|NCT00849017|54658263|FG001|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
27999583|NCT00849017|54658264|FG002|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
27999584|NCT00849017|54658262|FG000|Treatment Period (156 Weeks)|Participant Moved to Africa|1|||
27913840|NCT00171873|54571604|FG001|Overall Study|Withdrawal by Subject|2|||
27913841|NCT00171873|54571603|FG000|Overall Study|Adverse Event|5|||
27913842|NCT00171873|54571604|FG001|Overall Study|Adverse Event|0|||
27913843|NCT00171873|54571603|FG000|Overall Study|Switched to Octreotide|0|||
27913844|NCT00171873|54571604|FG001|Overall Study|Switched to Octreotide|1|||
27913845|NCT00171834|54571617|FG000|Overall Study|Adverse Event|2|||
27913846|NCT00171834|54571618|FG001|Overall Study|Adverse Event|1|||
27913847|NCT00171834|54571619|FG002|Overall Study|Adverse Event|3|||
27913848|NCT00171834|54571620|FG003|Overall Study|Adverse Event|2|||
27913849|NCT00171834|54571621|FG004|Overall Study|Adverse Event|2|||
27913850|NCT00171834|54571622|FG005|Overall Study|Adverse Event|15|||
27913851|NCT00171834|54571623|FG006|Overall Study|Adverse Event|1|||
27999585|NCT00849017|54658263|FG001|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
27999586|NCT00849017|54658264|FG002|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
27999587|NCT00849017|54658262|FG000|Treatment Period (156 Weeks)|Pregnancy|1|||
27999588|NCT00849017|54658263|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
27999589|NCT00849017|54658264|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
27999590|NCT00849017|54658262|FG000|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
27999591|NCT00849017|54658263|FG001|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
27999592|NCT00849017|54658264|FG002|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1|||
27999593|NCT00849017|54658262|FG000|Follow-up Period (8 Weeks)|Adverse Event|1|||
27999594|NCT00849017|54658263|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
27999595|NCT00849017|54658264|FG002|Follow-up Period (8 Weeks)|Adverse Event|0|||
27999596|NCT00849017|54658262|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
27999597|NCT00849017|54658263|FG001|Follow-up Period (8 Weeks)|Noncompliance|1|||
27999598|NCT00849017|54658264|FG002|Follow-up Period (8 Weeks)|Noncompliance|0|||
27999599|NCT00849017|54658262|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|13|||
27999600|NCT00849017|54658263|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
27999601|NCT00849017|54658264|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|16|||
27999602|NCT00849017|54658262|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
27999603|NCT00849017|54658263|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
27913852|NCT00171834|54571617|FG000|Overall Study|Withdrawal by Subject|0|||
27913853|NCT00171834|54571618|FG001|Overall Study|Withdrawal by Subject|2|||
27913854|NCT00171834|54571619|FG002|Overall Study|Withdrawal by Subject|0|||
27913855|NCT00171834|54571620|FG003|Overall Study|Withdrawal by Subject|1|||
27913856|NCT00171834|54571621|FG004|Overall Study|Withdrawal by Subject|1|||
27913857|NCT00171834|54571622|FG005|Overall Study|Withdrawal by Subject|1|||
27913858|NCT00171834|54571623|FG006|Overall Study|Withdrawal by Subject|0|||
27913859|NCT00171834|54571617|FG000|Overall Study|Death from study indication|0|||
27913860|NCT00171834|54571618|FG001|Overall Study|Death from study indication|1|||
27999604|NCT00849017|54658264|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4|||
27999605|NCT00849017|54658262|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
27999606|NCT00849017|54658263|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
27999607|NCT00849017|54658264|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
27999608|NCT00849017|54658262|FG000|Follow-up Period (8 Weeks)|Physician Decision|0|||
27999609|NCT00849017|54658263|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
27913861|NCT00171834|54571619|FG002|Overall Study|Death from study indication|0|||
27913862|NCT00171834|54571620|FG003|Overall Study|Death from study indication|0|||
27913863|NCT00171834|54571621|FG004|Overall Study|Death from study indication|1|||
27913864|NCT00171834|54571622|FG005|Overall Study|Death from study indication|0|||
27999610|NCT00849017|54658264|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
27999611|NCT00849017|54658262|FG000|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3|||
27913865|NCT00171834|54571623|FG006|Overall Study|Death from study indication|0|||
27913866|NCT00171834|54571617|FG000|Overall Study|Disease Progression|4|||
27913867|NCT00171834|54571618|FG001|Overall Study|Disease Progression|8|||
27913868|NCT00171834|54571619|FG002|Overall Study|Disease Progression|8|||
27913869|NCT00171834|54571620|FG003|Overall Study|Disease Progression|9|||
28099525|NCT03669588|54755608|FG000|Overall Study|Withdrawal by Subject|1|||
28099526|NCT03669588|54755609|FG001|Overall Study|Withdrawal by Subject|4|||
28099527|NCT03669588|54755608|FG000|Overall Study|Rescue Therapy Needed|0|||
27999612|NCT00849017|54658263|FG001|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
27999613|NCT00849017|54658264|FG002|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
27999614|NCT00849017|54658262|FG000|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1|||
27999615|NCT00849017|54658263|FG001|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
27999616|NCT00849017|54658264|FG002|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
27999617|NCT00842543|54658280|FG000|Overall Study|Withdrawal by Subject|2|||
27999618|NCT00842543|54658281|FG001|Overall Study|Withdrawal by Subject|0|||
27999619|NCT00842543|54658282|FG002|Overall Study|Withdrawal by Subject|3|||
27999620|NCT00842543|54658283|FG003|Overall Study|Withdrawal by Subject|4|||
27999621|NCT00785928|54658302|FG000|Treatment Phase|Adverse Event|1|||
27999622|NCT00785928|54658303|FG001|Treatment Phase|Adverse Event|1|||
27999623|NCT00785928|54658304|FG002|Treatment Phase|Adverse Event|2|||
28099528|NCT03669588|54755609|FG001|Overall Study|Rescue Therapy Needed|1|||
28099529|NCT03598140|54755617|FG000|Overall Study|enrolled but didn't start|1|||
28099530|NCT03598140|54755618|FG001|Overall Study|enrolled but didn't start|0|||
28099531|NCT03644550|54755624|FG000|Overall Study|Withdrawal by Subject|3|||
28099532|NCT03644550|54755624|FG000|Overall Study|Progressive disease|15|||
28099533|NCT03511664|54755631|FG000|Overall Study|Treatment ongoing|49|||
28099534|NCT03511664|54755632|FG001|Overall Study|Treatment ongoing|5|||
28099535|NCT03511664|54755631|FG000|Overall Study|Entered long-term follow-up|140|||
28099536|NCT03511664|54755632|FG001|Overall Study|Entered long-term follow-up|50|||
28099537|NCT03511664|54755631|FG000|Overall Study|Withdrawal by Subject|29|||
28099538|NCT03511664|54755632|FG001|Overall Study|Withdrawal by Subject|53|||
27913870|NCT00171834|54571621|FG004|Overall Study|Disease Progression|2|||
27913871|NCT00171834|54571622|FG005|Overall Study|Disease Progression|18|||
27913872|NCT00171834|54571623|FG006|Overall Study|Disease Progression|3|||
27913873|NCT00171834|54571617|FG000|Overall Study|Treatment Duration Completed|0|||
27913874|NCT00171834|54571618|FG001|Overall Study|Treatment Duration Completed|0|||
27913875|NCT00171834|54571619|FG002|Overall Study|Treatment Duration Completed|1|||
27913876|NCT00171834|54571620|FG003|Overall Study|Treatment Duration Completed|0|||
27913877|NCT00171834|54571621|FG004|Overall Study|Treatment Duration Completed|2|||
27913878|NCT00171834|54571622|FG005|Overall Study|Treatment Duration Completed|1|||
27913879|NCT00171834|54571623|FG006|Overall Study|Treatment Duration Completed|0|||
27913880|NCT00171249|54571653|FG000|Overall Study|Withdrawal by Subject|2|||
27913881|NCT00171249|54571654|FG001|Overall Study|Withdrawal by Subject|0|||
27913882|NCT00171249|54571655|FG002|Overall Study|Withdrawal by Subject|0|||
27913883|NCT00171249|54571656|FG003|Overall Study|Withdrawal by Subject|6|||
27913884|NCT00171249|54571657|FG004|Overall Study|Withdrawal by Subject|0|||
27913885|NCT00171249|54571658|FG005|Overall Study|Withdrawal by Subject|0|||
27913886|NCT00171249|54571659|FG006|Overall Study|Withdrawal by Subject|0|||
27913887|NCT00171249|54571653|FG000|Overall Study|Unsatisfactory Therapeutic Effect|44|||
27913888|NCT00171249|54571654|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
27913889|NCT00171249|54571655|FG002|Overall Study|Unsatisfactory Therapeutic Effect|5|||
27913890|NCT00171249|54571656|FG003|Overall Study|Unsatisfactory Therapeutic Effect|70|||
27913891|NCT00171249|54571657|FG004|Overall Study|Unsatisfactory Therapeutic Effect|3|||
27913892|NCT00171249|54571658|FG005|Overall Study|Unsatisfactory Therapeutic Effect|31|||
27913893|NCT00171249|54571659|FG006|Overall Study|Unsatisfactory Therapeutic Effect|1|||
27913894|NCT00171249|54571653|FG000|Overall Study|Death|7|||
27913895|NCT00171249|54571654|FG001|Overall Study|Death|1|||
27913896|NCT00171249|54571655|FG002|Overall Study|Death|0|||
27913897|NCT00171249|54571656|FG003|Overall Study|Death|4|||
27913898|NCT00171249|54571657|FG004|Overall Study|Death|0|||
27913899|NCT00171249|54571658|FG005|Overall Study|Death|3|||
27913900|NCT00171249|54571659|FG006|Overall Study|Death|1|||
27913901|NCT00171249|54571653|FG000|Overall Study|Other|10|||
27913902|NCT00171249|54571654|FG001|Overall Study|Other|0|||
27913903|NCT00171249|54571655|FG002|Overall Study|Other|0|||
27913904|NCT00171249|54571656|FG003|Overall Study|Other|43|||
28099539|NCT03511664|54755631|FG000|Overall Study|Lost to Follow-up|4|||
27913905|NCT00171249|54571657|FG004|Overall Study|Other|0|||
28099540|NCT03511664|54755632|FG001|Overall Study|Lost to Follow-up|4|||
28099541|NCT03511664|54755631|FG000|Overall Study|Physician Decision|0|||
28099542|NCT03511664|54755632|FG001|Overall Study|Physician Decision|1|||
27913906|NCT00171249|54571658|FG005|Overall Study|Other|2|||
27913907|NCT00171249|54571659|FG006|Overall Study|Other|0|||
27913908|NCT00171249|54571653|FG000|Overall Study|No Longer Requires Study Drug|4|||
27913909|NCT00171249|54571654|FG001|Overall Study|No Longer Requires Study Drug|0|||
27913910|NCT00171249|54571655|FG002|Overall Study|No Longer Requires Study Drug|0|||
27913911|NCT00171249|54571656|FG003|Overall Study|No Longer Requires Study Drug|3|||
27913912|NCT00171249|54571657|FG004|Overall Study|No Longer Requires Study Drug|0|||
27999624|NCT00785928|54658305|FG003|Treatment Phase|Adverse Event|0|||
27999625|NCT00785928|54658306|FG004|Treatment Phase|Adverse Event|0|||
27999626|NCT00785928|54658307|FG005|Treatment Phase|Adverse Event|0|||
27999627|NCT00785928|54658308|FG006|Treatment Phase|Adverse Event|2|||
27999628|NCT00785928|54658302|FG000|Treatment Phase|Inadequate Response|0|||
27999629|NCT00785928|54658303|FG001|Treatment Phase|Inadequate Response|1|||
27999630|NCT00785928|54658304|FG002|Treatment Phase|Inadequate Response|0|||
27999631|NCT00785928|54658305|FG003|Treatment Phase|Inadequate Response|0|||
27999632|NCT00785928|54658306|FG004|Treatment Phase|Inadequate Response|0|||
27999633|NCT00785928|54658307|FG005|Treatment Phase|Inadequate Response|0|||
27999634|NCT00785928|54658308|FG006|Treatment Phase|Inadequate Response|0|||
27999635|NCT00785928|54658302|FG000|Treatment Phase|Lack of Efficacy|0|||
27999636|NCT00785928|54658303|FG001|Treatment Phase|Lack of Efficacy|1|||
27999637|NCT00785928|54658304|FG002|Treatment Phase|Lack of Efficacy|1|||
27999638|NCT00785928|54658305|FG003|Treatment Phase|Lack of Efficacy|0|||
27913913|NCT00171249|54571658|FG005|Overall Study|No Longer Requires Study Drug|5|||
27913914|NCT00171249|54571659|FG006|Overall Study|No Longer Requires Study Drug|0|||
27913915|NCT00171249|54571653|FG000|Overall Study|Administrative Problems|1|||
27913916|NCT00171249|54571654|FG001|Overall Study|Administrative Problems|0|||
27913917|NCT00171249|54571655|FG002|Overall Study|Administrative Problems|0|||
27913918|NCT00171249|54571656|FG003|Overall Study|Administrative Problems|2|||
27999639|NCT00785928|54658306|FG004|Treatment Phase|Lack of Efficacy|0|||
27999640|NCT00785928|54658307|FG005|Treatment Phase|Lack of Efficacy|0|||
27999641|NCT00785928|54658308|FG006|Treatment Phase|Lack of Efficacy|0|||
27999642|NCT00785928|54658302|FG000|Treatment Phase|Physician Decision|0|||
27999643|NCT00785928|54658303|FG001|Treatment Phase|Physician Decision|0|||
27999644|NCT00785928|54658304|FG002|Treatment Phase|Physician Decision|0|||
27999645|NCT00785928|54658305|FG003|Treatment Phase|Physician Decision|0|||
27999646|NCT00785928|54658306|FG004|Treatment Phase|Physician Decision|1|||
27999647|NCT00785928|54658307|FG005|Treatment Phase|Physician Decision|0|||
27999648|NCT00785928|54658308|FG006|Treatment Phase|Physician Decision|0|||
27999649|NCT00785928|54658302|FG000|Treatment Phase|Sponsor Decision|1|||
27999650|NCT00785928|54658303|FG001|Treatment Phase|Sponsor Decision|0|||
27999651|NCT00785928|54658304|FG002|Treatment Phase|Sponsor Decision|0|||
27999652|NCT00785928|54658305|FG003|Treatment Phase|Sponsor Decision|0|||
27913919|NCT00171249|54571657|FG004|Overall Study|Administrative Problems|0|||
27913920|NCT00171249|54571658|FG005|Overall Study|Administrative Problems|0|||
27913921|NCT00171249|54571659|FG006|Overall Study|Administrative Problems|0|||
27913922|NCT00171249|54571653|FG000|Overall Study|Adverse Event|3|||
27913923|NCT00171249|54571654|FG001|Overall Study|Adverse Event|1|||
27913924|NCT00171249|54571655|FG002|Overall Study|Adverse Event|0|||
27913925|NCT00171249|54571656|FG003|Overall Study|Adverse Event|15|||
27913926|NCT00171249|54571657|FG004|Overall Study|Adverse Event|0|||
27913927|NCT00171249|54571658|FG005|Overall Study|Adverse Event|2|||
27913928|NCT00171249|54571659|FG006|Overall Study|Adverse Event|0|||
27913929|NCT00171249|54571653|FG000|Overall Study|Lost to Follow-up|5|||
27913930|NCT00171249|54571654|FG001|Overall Study|Lost to Follow-up|0|||
27913931|NCT00171249|54571655|FG002|Overall Study|Lost to Follow-up|0|||
27913932|NCT00171249|54571656|FG003|Overall Study|Lost to Follow-up|9|||
27913933|NCT00171249|54571657|FG004|Overall Study|Lost to Follow-up|0|||
27913934|NCT00171249|54571658|FG005|Overall Study|Lost to Follow-up|0|||
27913935|NCT00171249|54571659|FG006|Overall Study|Lost to Follow-up|0|||
27913936|NCT01085630|54571670|FG000|Overall Study|Insufficient data|1|||
27913937|NCT01085630|54571671|FG001|Overall Study|Insufficient data|0|||
27913938|NCT01085630|54571670|FG000|Overall Study|Ineligible|3|||
27913939|NCT01085630|54571671|FG001|Overall Study|Ineligible|0|||
27913940|NCT00171210|54571679|FG000|Overall Study|Adverse Event|16|||
27913941|NCT00171210|54571680|FG001|Overall Study|Adverse Event|27|||
27913942|NCT00171210|54571679|FG000|Overall Study|Abnormal laboratory value(s)|6|||
27913943|NCT00171210|54571680|FG001|Overall Study|Abnormal laboratory value(s)|3|||
27913944|NCT00171210|54571679|FG000|Overall Study|Abnormal test procedure result(s)|0|||
27913945|NCT00171210|54571680|FG001|Overall Study|Abnormal test procedure result(s)|1|||
27913946|NCT00171210|54571679|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
27913947|NCT00171210|54571680|FG001|Overall Study|Unsatisfactory therapeutic effect|15|||
27913948|NCT00171210|54571679|FG000|Overall Study|Protocol Violation|0|||
27913949|NCT00171210|54571680|FG001|Overall Study|Protocol Violation|2|||
27913950|NCT00171210|54571679|FG000|Overall Study|Withdrawal by Subject|32|||
27913951|NCT00171210|54571680|FG001|Overall Study|Withdrawal by Subject|30|||
27913952|NCT00171210|54571679|FG000|Overall Study|Lost to Follow-up|1|||
27913953|NCT00171210|54571680|FG001|Overall Study|Lost to Follow-up|0|||
27913954|NCT00171210|54571679|FG000|Overall Study|Administrative problems|1|||
27999653|NCT00785928|54658306|FG004|Treatment Phase|Sponsor Decision|0|||
27913955|NCT00171210|54571680|FG001|Overall Study|Administrative problems|1|||
27913956|NCT00171210|54571679|FG000|Overall Study|Death|2|||
27913957|NCT00171210|54571680|FG001|Overall Study|Death|3|||
27913958|NCT00171210|54571679|FG000|Overall Study|Stopped at end of core|0|||
27999654|NCT00785928|54658307|FG005|Treatment Phase|Sponsor Decision|0|||
27999655|NCT00785928|54658308|FG006|Treatment Phase|Sponsor Decision|1|||
27999656|NCT00785928|54658302|FG000|Treatment Phase|Withdrawal by Subject|1|||
27913959|NCT00171210|54571680|FG001|Overall Study|Stopped at end of core|32|||
27913960|NCT00171210|54571679|FG000|Overall Study|Stopped at end of extension 1|0|||
27913961|NCT00171210|54571680|FG001|Overall Study|Stopped at end of extension 1|1|||
27913962|NCT00171054|54571688|FG000|Overall Study|Protocol Violation|1|||
27913963|NCT00171054|54571689|FG001|Overall Study|Protocol Violation|2|||
27913964|NCT00171054|54571688|FG000|Overall Study|Patient withdrew consent|1|||
27913965|NCT00171054|54571689|FG001|Overall Study|Patient withdrew consent|0|||
27913966|NCT00171054|54571688|FG000|Overall Study|Lost to Follow-up|0|||
27913967|NCT00171054|54571689|FG001|Overall Study|Lost to Follow-up|1|||
27913968|NCT00171054|54571688|FG000|Overall Study|Adverse Event|8|||
27913969|NCT00171054|54571689|FG001|Overall Study|Adverse Event|8|||
27913970|NCT00171054|54571688|FG000|Overall Study|Condition no longer required study drug|0|||
27913971|NCT00171054|54571689|FG001|Overall Study|Condition no longer required study drug|1|||
27913972|NCT01084694|54571697|FG000|Overall Study|Withdrawal by Subject|2|||
27913973|NCT01084694|54571698|FG001|Overall Study|Withdrawal by Subject|1|||
27913974|NCT01084694|54571697|FG000|Overall Study|Death|2|||
27913975|NCT01084694|54571698|FG001|Overall Study|Death|12|||
27913976|NCT01084694|54571697|FG000|Overall Study|eligibility not maintained|2|||
27913977|NCT01084694|54571698|FG001|Overall Study|eligibility not maintained|7|||
27913978|NCT00479856|54571712|FG000|Overall Study|Adverse Event|1|||
27913979|NCT00479856|54571712|FG000|Overall Study|Withdrawal by Subject|1|||
27913980|NCT00479856|54571712|FG000|Overall Study|Physician Decision|1|||
27913981|NCT00479466|54571722|FG000|Overall Study|Adverse Event|5|||
27913982|NCT00479466|54571723|FG001|Overall Study|Adverse Event|1|||
27913983|NCT00479466|54571724|FG002|Overall Study|Adverse Event|0|||
27913984|NCT00479466|54571725|FG003|Overall Study|Adverse Event|1|||
27913985|NCT00479466|54571726|FG004|Overall Study|Adverse Event|2|||
27913986|NCT00479466|54571727|FG005|Overall Study|Adverse Event|0|||
27913987|NCT00479466|54571722|FG000|Overall Study|Hyperglycemia|0|||
27913988|NCT00479466|54571723|FG001|Overall Study|Hyperglycemia|0|||
27913989|NCT00479466|54571724|FG002|Overall Study|Hyperglycemia|0|||
27913990|NCT00479466|54571725|FG003|Overall Study|Hyperglycemia|0|||
27913991|NCT00479466|54571726|FG004|Overall Study|Hyperglycemia|0|||
27913992|NCT00479466|54571727|FG005|Overall Study|Hyperglycemia|1|||
27913993|NCT00479466|54571722|FG000|Overall Study|Lack of Efficacy|2|||
27913994|NCT00479466|54571723|FG001|Overall Study|Lack of Efficacy|0|||
27913995|NCT00479466|54571724|FG002|Overall Study|Lack of Efficacy|1|||
27913996|NCT00479466|54571725|FG003|Overall Study|Lack of Efficacy|0|||
27913997|NCT00479466|54571726|FG004|Overall Study|Lack of Efficacy|0|||
27913998|NCT00479466|54571727|FG005|Overall Study|Lack of Efficacy|0|||
27913999|NCT00479466|54571722|FG000|Overall Study|Lost to Follow-up|0|||
27914000|NCT00479466|54571723|FG001|Overall Study|Lost to Follow-up|1|||
27914001|NCT00479466|54571724|FG002|Overall Study|Lost to Follow-up|1|||
27914002|NCT00479466|54571725|FG003|Overall Study|Lost to Follow-up|0|||
27914003|NCT00479466|54571726|FG004|Overall Study|Lost to Follow-up|2|||
27914004|NCT00479466|54571727|FG005|Overall Study|Lost to Follow-up|2|||
27914005|NCT00479466|54571722|FG000|Overall Study|Physician Decision|2|||
27914006|NCT00479466|54571723|FG001|Overall Study|Physician Decision|1|||
27914007|NCT00479466|54571724|FG002|Overall Study|Physician Decision|1|||
27914008|NCT00479466|54571725|FG003|Overall Study|Physician Decision|0|||
27914009|NCT00479466|54571726|FG004|Overall Study|Physician Decision|0|||
27914010|NCT00479466|54571727|FG005|Overall Study|Physician Decision|0|||
27914011|NCT00479466|54571722|FG000|Overall Study|Pregnancy|0|||
27914012|NCT00479466|54571723|FG001|Overall Study|Pregnancy|0|||
27914013|NCT00479466|54571724|FG002|Overall Study|Pregnancy|0|||
27914014|NCT00479466|54571725|FG003|Overall Study|Pregnancy|0|||
27914015|NCT00479466|54571726|FG004|Overall Study|Pregnancy|1|||
27914016|NCT00479466|54571727|FG005|Overall Study|Pregnancy|0|||
27914017|NCT00479466|54571722|FG000|Overall Study|Protocol Violation|1|||
27914018|NCT00479466|54571723|FG001|Overall Study|Protocol Violation|0|||
27914019|NCT00479466|54571724|FG002|Overall Study|Protocol Violation|0|||
27914020|NCT00479466|54571725|FG003|Overall Study|Protocol Violation|0|||
27914021|NCT00479466|54571726|FG004|Overall Study|Protocol Violation|0|||
27999657|NCT00785928|54658303|FG001|Treatment Phase|Withdrawal by Subject|2|||
27999658|NCT00785928|54658304|FG002|Treatment Phase|Withdrawal by Subject|0|||
27914022|NCT00479466|54571727|FG005|Overall Study|Protocol Violation|0|||
27914023|NCT00479466|54571722|FG000|Overall Study|Withdrawal by Subject|3|||
27914024|NCT00479466|54571723|FG001|Overall Study|Withdrawal by Subject|5|||
27914025|NCT00479466|54571724|FG002|Overall Study|Withdrawal by Subject|0|||
27914026|NCT00479466|54571725|FG003|Overall Study|Withdrawal by Subject|2|||
27914027|NCT00479466|54571726|FG004|Overall Study|Withdrawal by Subject|3|||
27914028|NCT00479466|54571727|FG005|Overall Study|Withdrawal by Subject|1|||
27914029|NCT00479388|54571743|FG000|Overall Study|Adverse Event|90|||
27914030|NCT00479388|54571744|FG001|Overall Study|Adverse Event|45|||
27914031|NCT00479388|54571743|FG000|Overall Study|Lost to Follow-up|0|||
27914032|NCT00479388|54571744|FG001|Overall Study|Lost to Follow-up|2|||
27914033|NCT00479388|54571743|FG000|Overall Study|Protocol Violation|10|||
27914034|NCT00479388|54571744|FG001|Overall Study|Protocol Violation|9|||
27914035|NCT00479388|54571743|FG000|Overall Study|Withdrawal by Subject|32|||
27999659|NCT00785928|54658305|FG003|Treatment Phase|Withdrawal by Subject|0|||
27914036|NCT00479388|54571744|FG001|Overall Study|Withdrawal by Subject|17|||
27914037|NCT00479232|54571752|FG000|Overall Study|Adverse Event|0|||
27914038|NCT00479232|54571753|FG001|Overall Study|Adverse Event|0|||
27999660|NCT00785928|54658306|FG004|Treatment Phase|Withdrawal by Subject|1|||
27999661|NCT00785928|54658307|FG005|Treatment Phase|Withdrawal by Subject|0|||
27999662|NCT00785928|54658308|FG006|Treatment Phase|Withdrawal by Subject|0|||
27999663|NCT00842309|54658348|FG000|Overall Study|Withdrawal by Subject|3|||
27999664|NCT00842309|54658349|FG001|Overall Study|Withdrawal by Subject|1|||
27999665|NCT00842153|54658357|FG000|Overall Study|Adverse Event|0|||
27999666|NCT00842153|54658358|FG001|Overall Study|Adverse Event|1|||
27999667|NCT00842153|54658357|FG000|Overall Study|Lost to Follow-up|1|||
27999668|NCT00842153|54658358|FG001|Overall Study|Lost to Follow-up|2|||
27999669|NCT00762411|54658366|FG000|Initial Treatment|Death|7|||
27999670|NCT00762411|54658367|FG001|Initial Treatment|Death|6|||
27999671|NCT00762411|54658366|FG000|Initial Treatment|Adverse Event|132|||
27999672|NCT00762411|54658367|FG001|Initial Treatment|Adverse Event|40|||
27999673|NCT00762411|54658366|FG000|Initial Treatment|Protocol Violation|4|||
27999674|NCT00762411|54658367|FG001|Initial Treatment|Protocol Violation|1|||
27999675|NCT00762411|54658366|FG000|Initial Treatment|Withdrawal by Subject|65|||
27999676|NCT00762411|54658367|FG001|Initial Treatment|Withdrawal by Subject|52|||
27999677|NCT00762411|54658366|FG000|Initial Treatment|Physician Decision|1|||
27999678|NCT00762411|54658367|FG001|Initial Treatment|Physician Decision|0|||
27999679|NCT00762411|54658366|FG000|Initial Treatment|Sponsor Decision|293|||
27999680|NCT00762411|54658367|FG001|Initial Treatment|Sponsor Decision|401|||
27999681|NCT00762411|54658366|FG000|Initial Treatment|Lost to Follow-up|5|||
27999682|NCT00762411|54658367|FG001|Initial Treatment|Lost to Follow-up|0|||
27999683|NCT00762411|54658366|FG000|Initial Treatment|Caregiver Decision|21|||
27999684|NCT00762411|54658367|FG001|Initial Treatment|Caregiver Decision|16|||
27999685|NCT00762411|54658366|FG000|Initial Treatment|Abnormal Lab/ECG Result|6|||
27999686|NCT00762411|54658367|FG001|Initial Treatment|Abnormal Lab/ECG Result|4|||
27999687|NCT00762411|54658366|FG000|Initial Treatment|Entry Criteria Exclusion|0|||
27999688|NCT00762411|54658367|FG001|Initial Treatment|Entry Criteria Exclusion|1|||
27999689|NCT00762411|54658366|FG000|Delayed Start|Adverse Event|0|||
27999690|NCT00762411|54658367|FG001|Delayed Start|Adverse Event|4|||
27999691|NCT00762411|54658366|FG000|Delayed Start|Protocol Violation|0|||
27999692|NCT00762411|54658367|FG001|Delayed Start|Protocol Violation|1|||
27999693|NCT00762411|54658366|FG000|Delayed Start|Sponsor Decision|16|||
27999694|NCT00762411|54658367|FG001|Delayed Start|Sponsor Decision|20|||
27999695|NCT00762411|54658366|FG000|Delayed Start|Caregiver Decision|1|||
27999696|NCT00762411|54658367|FG001|Delayed Start|Caregiver Decision|1|||
27999697|NCT00762411|54658366|FG000|Safety Follow Up (SFU)-Optional|Death|1|||
27999698|NCT00762411|54658367|FG001|Safety Follow Up (SFU)-Optional|Death|8|||
27999699|NCT00762411|54658366|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
27999700|NCT00762411|54658367|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|1|||
27999701|NCT00762411|54658366|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21|||
27999702|NCT00762411|54658367|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46|||
27999703|NCT00762411|54658366|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6|||
27999704|NCT00762411|54658367|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
27999705|NCT00762411|54658366|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
27999706|NCT00762411|54658367|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
27999707|NCT00762411|54658366|FG000|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48|||
27999708|NCT00762411|54658367|FG001|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54|||
27999709|NCT00761865|54658379|FG000|Overall Study|Lost to Follow-up|8|||
27999710|NCT00761865|54658380|FG001|Overall Study|Lost to Follow-up|7|||
27999711|NCT00841763|54658388|FG000|Overall Study|Withdrawal by Subject|60|||
28099543|NCT00054717|54755640|FG000|Overall Study|Randomized but not treated|2|||
27914039|NCT00479232|54571754|FG002|Overall Study|Adverse Event|5|||
27914040|NCT00479232|54571755|FG003|Overall Study|Adverse Event|0|||
27914041|NCT00479232|54571756|FG004|Overall Study|Adverse Event|0|||
27914042|NCT00479232|54571757|FG005|Overall Study|Adverse Event|10|||
27914043|NCT00479232|54571752|FG000|Overall Study|Deviation from Protocol|0|||
27914044|NCT00479232|54571753|FG001|Overall Study|Deviation from Protocol|0|||
27914045|NCT00479232|54571754|FG002|Overall Study|Deviation from Protocol|1|||
27914046|NCT00479232|54571755|FG003|Overall Study|Deviation from Protocol|0|||
27914047|NCT00479232|54571756|FG004|Overall Study|Deviation from Protocol|0|||
27999712|NCT00841763|54658389|FG001|Overall Study|Withdrawal by Subject|17|||
27999713|NCT00841763|54658390|FG002|Overall Study|Withdrawal by Subject|4|||
27999714|NCT00841763|54658391|FG003|Overall Study|Withdrawal by Subject|1|||
27999715|NCT00841763|54658388|FG000|Overall Study|Adverse Event|9|||
27999716|NCT00841763|54658389|FG001|Overall Study|Adverse Event|10|||
27999717|NCT00841763|54658390|FG002|Overall Study|Adverse Event|3|||
28099544|NCT00054717|54755641|FG001|Overall Study|Randomized but not treated|8|||
27999718|NCT00841763|54658391|FG003|Overall Study|Adverse Event|2|||
28099545|NCT00054717|54755640|FG000|Overall Study|Adverse Event|70|||
27914048|NCT00479232|54571757|FG005|Overall Study|Deviation from Protocol|0|||
27999719|NCT00841763|54658388|FG000|Overall Study|Lost to Follow-up|63|||
27999720|NCT00841763|54658389|FG001|Overall Study|Lost to Follow-up|25|||
27999721|NCT00841763|54658390|FG002|Overall Study|Lost to Follow-up|0|||
27999722|NCT00841763|54658391|FG003|Overall Study|Lost to Follow-up|0|||
27999723|NCT00841763|54658388|FG000|Overall Study|Protocol Violation|20|||
27999724|NCT00841763|54658389|FG001|Overall Study|Protocol Violation|3|||
27914049|NCT00479232|54571752|FG000|Overall Study|Lack of Efficacy|0|||
27914050|NCT00479232|54571753|FG001|Overall Study|Lack of Efficacy|0|||
27914051|NCT00479232|54571754|FG002|Overall Study|Lack of Efficacy|2|||
27914052|NCT00479232|54571755|FG003|Overall Study|Lack of Efficacy|0|||
27914053|NCT00479232|54571756|FG004|Overall Study|Lack of Efficacy|0|||
27914054|NCT00479232|54571757|FG005|Overall Study|Lack of Efficacy|4|||
27914055|NCT00479232|54571752|FG000|Overall Study|Physician Decision|0|||
27914056|NCT00479232|54571753|FG001|Overall Study|Physician Decision|0|||
27914057|NCT00479232|54571754|FG002|Overall Study|Physician Decision|2|||
27914058|NCT00479232|54571755|FG003|Overall Study|Physician Decision|0|||
27914059|NCT00479232|54571756|FG004|Overall Study|Physician Decision|0|||
27914060|NCT00479232|54571757|FG005|Overall Study|Physician Decision|1|||
27914061|NCT00479232|54571752|FG000|Overall Study|Progressive Disease|3|||
27914062|NCT00479232|54571753|FG001|Overall Study|Progressive Disease|1|||
27914063|NCT00479232|54571754|FG002|Overall Study|Progressive Disease|12|||
27914064|NCT00479232|54571755|FG003|Overall Study|Progressive Disease|3|||
27914065|NCT00479232|54571756|FG004|Overall Study|Progressive Disease|3|||
27914066|NCT00479232|54571757|FG005|Overall Study|Progressive Disease|12|||
27914067|NCT00479232|54571752|FG000|Overall Study|Withdrew Consent|0|||
27914068|NCT00479232|54571753|FG001|Overall Study|Withdrew Consent|2|||
27914069|NCT00479232|54571754|FG002|Overall Study|Withdrew Consent|6|||
27914070|NCT00479232|54571755|FG003|Overall Study|Withdrew Consent|0|||
27914071|NCT00479232|54571756|FG004|Overall Study|Withdrew Consent|1|||
27914072|NCT00479232|54571757|FG005|Overall Study|Withdrew Consent|3|||
27914073|NCT00478881|54571777|FG000|Overall Study|Adverse Event|31|||
27914074|NCT00478881|54571778|FG001|Overall Study|Adverse Event|12|||
28099546|NCT00054717|54755641|FG001|Overall Study|Adverse Event|22|||
28099547|NCT00054717|54755640|FG000|Overall Study|Protocol Violation|18|||
27914075|NCT00478881|54571777|FG000|Overall Study|Lack of Efficacy|0|||
27914076|NCT00478881|54571778|FG001|Overall Study|Lack of Efficacy|3|||
27914077|NCT00478881|54571777|FG000|Overall Study|Lost to Follow-up|0|||
27914078|NCT00478881|54571778|FG001|Overall Study|Lost to Follow-up|1|||
27914079|NCT00478881|54571777|FG000|Overall Study|Protocol Violation|2|||
27914080|NCT00478881|54571778|FG001|Overall Study|Protocol Violation|2|||
27914081|NCT00478881|54571777|FG000|Overall Study|Withdrawal by Subject|6|||
27914082|NCT00478881|54571778|FG001|Overall Study|Withdrawal by Subject|2|||
27914083|NCT00478881|54571777|FG000|Overall Study|Non-Compliance with Study Medication|0|||
27914084|NCT00478881|54571778|FG001|Overall Study|Non-Compliance with Study Medication|2|||
27914085|NCT00478647|54571784|FG000|Overall Study|Adverse Event|1|||
27914086|NCT00478647|54571784|FG000|Overall Study|Withdrawal by Subject|1|||
27914087|NCT00478608|54571788|FG000|Overall Study|Adverse Event|1|||
27999725|NCT00841763|54658390|FG002|Overall Study|Protocol Violation|1|||
27999726|NCT00841763|54658391|FG003|Overall Study|Protocol Violation|0|||
27999727|NCT00841763|54658388|FG000|Overall Study|Administrative Reasons|3|||
27999728|NCT00841763|54658389|FG001|Overall Study|Administrative Reasons|1|||
27999729|NCT00841763|54658390|FG002|Overall Study|Administrative Reasons|0|||
27999730|NCT00841763|54658391|FG003|Overall Study|Administrative Reasons|0|||
27999731|NCT00841763|54658388|FG000|Overall Study|Unable to Classify|7|||
27999732|NCT00841763|54658389|FG001|Overall Study|Unable to Classify|1|||
27999733|NCT00841763|54658390|FG002|Overall Study|Unable to Classify|0|||
27999734|NCT00841763|54658391|FG003|Overall Study|Unable to Classify|0|||
27999735|NCT00838331|54658436|FG000|Aged Blood Transfusion|Withdrawal by Subject|9|||
27999736|NCT00785538|54658444|FG000|Treatment Period|Adverse Event|1|||
27999737|NCT00785538|54658445|FG001|Treatment Period|Adverse Event|2|||
27999738|NCT00785538|54658446|FG002|Treatment Period|Adverse Event|2|||
27999739|NCT00785538|54658447|FG003|Treatment Period|Adverse Event|0|||
27999740|NCT00785538|54658444|FG000|Treatment Period|Withdrawal by Subject|0|||
27999741|NCT00785538|54658445|FG001|Treatment Period|Withdrawal by Subject|0|||
27999742|NCT00785538|54658446|FG002|Treatment Period|Withdrawal by Subject|0|||
27999743|NCT00785538|54658447|FG003|Treatment Period|Withdrawal by Subject|1|||
28099548|NCT00054717|54755641|FG001|Overall Study|Protocol Violation|19|||
27914088|NCT00478608|54571788|FG000|Overall Study|Serious Adverse Event|14|||
27914089|NCT00478608|54571788|FG000|Overall Study|Withdrawal by Subject|2|||
27914090|NCT00478608|54571788|FG000|Overall Study|Protocol Violation|3|||
27999744|NCT00860405|54658460|FG000|Overall Study|Main reason: Follow-up data not complete|5|||
27999745|NCT00860405|54658461|FG001|Overall Study|Main reason: Follow-up data not complete|4|||
27999746|NCT00838097|54658467|FG000|Overall Study|Ineligibility determined|6|||
27914091|NCT00478257|54571794|FG000|Overall Study|Withdrawal by Subject|8|||
27914092|NCT00478257|54571795|FG001|Overall Study|Withdrawal by Subject|3|||
27914093|NCT00478140|54571801|FG000|Overall Study|Clinical Disease Progression|1|||
27914094|NCT00478023|54571810|FG000|Overall Study|Adverse Event|11|||
27999747|NCT00838097|54658467|FG000|Overall Study|Adverse Event|2|||
27999748|NCT00838097|54658467|FG000|Overall Study|Withdrawal by Subject|3|||
28099549|NCT00054717|54755640|FG000|Overall Study|Lost to Follow-up|23|||
27999749|NCT00838097|54658467|FG000|Overall Study|Requirement for alternative therapy|2|||
27999750|NCT00838097|54658467|FG000|Overall Study|Physician Decision|4|||
27999751|NCT00838097|54658467|FG000|Overall Study|Lost to Follow-up|11|||
27999752|NCT00838097|54658467|FG000|Overall Study|Death|6|||
27999753|NCT00838097|54658467|FG000|Overall Study|Protocol-specified criteria|142|||
27999754|NCT00840827|54658471|FG000|Overall Study|Adverse Event|1|||
27999755|NCT00840827|54658471|FG000|Overall Study|Lack of Efficacy|4|||
27999756|NCT00840827|54658471|FG000|Overall Study|Physician Decision|1|||
27999757|NCT00860249|54658478|FG000|Overall Study|trial was terminated prior to completion|21|||
27999758|NCT00860249|54658479|FG001|Overall Study|trial was terminated prior to completion|18|||
27999759|NCT00860249|54658480|FG002|Overall Study|trial was terminated prior to completion|21|||
27999760|NCT00840749|54658490|FG000|Overall Study|Death|1|||
27999761|NCT00840749|54658491|FG001|Overall Study|Death|2|||
27999762|NCT00840749|54658490|FG000|Overall Study|not treated on study arm|11|||
27999763|NCT00840749|54658491|FG001|Overall Study|not treated on study arm|11|||
27999764|NCT00840749|54658490|FG000|Overall Study|study closed|19|||
27999765|NCT00840749|54658491|FG001|Overall Study|study closed|14|||
27999766|NCT00859937|54658499|FG000|Overall Study|Protocol Violation|1|||
27999767|NCT00859937|54658500|FG001|Overall Study|Protocol Violation|0|||
27999768|NCT00592007|54658506|FG000|Overall Study|Withdrawal by Subject|1|||
27999769|NCT00592007|54658506|FG000|Overall Study|patient ineligible (out of lab range)|1|||
27999770|NCT00591851|54658510|FG000|Overall Study|Withdrawal by Subject|3|||
27999771|NCT00591851|54658510|FG000|Overall Study|Adverse Event|2|||
27999772|NCT00591851|54658510|FG000|Overall Study|Progressive Disease|1|||
27999773|NCT00837473|54658514|FG000|Overall Study|Lost to Follow-up|1|||
27999774|NCT00837473|54658514|FG000|Overall Study|Withdrawal by Subject|2|||
27999775|NCT00839423|54658522|FG000|Overall Study|Adverse Event|4|||
27999776|NCT00839423|54658523|FG001|Overall Study|Adverse Event|3|||
27999777|NCT00839423|54658524|FG002|Overall Study|Adverse Event|7|||
27999778|NCT00839423|54658525|FG003|Overall Study|Adverse Event|16|||
27999779|NCT00839423|54658522|FG000|Overall Study|Lack of Efficacy|6|||
27999780|NCT00839423|54658523|FG001|Overall Study|Lack of Efficacy|6|||
27999781|NCT00839423|54658524|FG002|Overall Study|Lack of Efficacy|3|||
27999782|NCT00839423|54658525|FG003|Overall Study|Lack of Efficacy|2|||
27999783|NCT00839423|54658522|FG000|Overall Study|Non-compliance|0|||
27999784|NCT00839423|54658523|FG001|Overall Study|Non-compliance|0|||
27999785|NCT00839423|54658524|FG002|Overall Study|Non-compliance|0|||
27999786|NCT00839423|54658525|FG003|Overall Study|Non-compliance|1|||
27999787|NCT00839423|54658522|FG000|Overall Study|Protocol Violation|0|||
27999788|NCT00839423|54658523|FG001|Overall Study|Protocol Violation|1|||
27999789|NCT00839423|54658524|FG002|Overall Study|Protocol Violation|2|||
27999790|NCT00839423|54658525|FG003|Overall Study|Protocol Violation|0|||
27999791|NCT00839423|54658522|FG000|Overall Study|Withdrawal of consent|4|||
27999792|NCT00839423|54658523|FG001|Overall Study|Withdrawal of consent|0|||
27914095|NCT00478023|54571811|FG001|Overall Study|Adverse Event|7|||
27914096|NCT00478023|54571812|FG002|Overall Study|Adverse Event|8|||
27914097|NCT00478023|54571813|FG003|Overall Study|Adverse Event|14|||
27914098|NCT00478023|54571814|FG004|Overall Study|Adverse Event|6|||
27914099|NCT00478023|54571810|FG000|Overall Study|Death|1|||
27914100|NCT00478023|54571811|FG001|Overall Study|Death|0|||
27914101|NCT00478023|54571812|FG002|Overall Study|Death|0|||
27914102|NCT00478023|54571813|FG003|Overall Study|Death|0|||
27914103|NCT00478023|54571814|FG004|Overall Study|Death|0|||
27914104|NCT00478023|54571810|FG000|Overall Study|Lack of Efficacy|11|||
27914105|NCT00478023|54571811|FG001|Overall Study|Lack of Efficacy|10|||
27914106|NCT00478023|54571812|FG002|Overall Study|Lack of Efficacy|4|||
27914107|NCT00478023|54571813|FG003|Overall Study|Lack of Efficacy|5|||
27914108|NCT00478023|54571814|FG004|Overall Study|Lack of Efficacy|41|||
27914109|NCT00478023|54571810|FG000|Overall Study|Lost to Follow-up|3|||
27914110|NCT00478023|54571811|FG001|Overall Study|Lost to Follow-up|1|||
27914111|NCT00478023|54571812|FG002|Overall Study|Lost to Follow-up|1|||
27914112|NCT00478023|54571813|FG003|Overall Study|Lost to Follow-up|1|||
27914113|NCT00478023|54571814|FG004|Overall Study|Lost to Follow-up|0|||
27914114|NCT00478023|54571810|FG000|Overall Study|Withdrawal by Subject|2|||
27914115|NCT00478023|54571811|FG001|Overall Study|Withdrawal by Subject|3|||
27914116|NCT00478023|54571812|FG002|Overall Study|Withdrawal by Subject|2|||
27914117|NCT00478023|54571813|FG003|Overall Study|Withdrawal by Subject|4|||
27999793|NCT00839423|54658524|FG002|Overall Study|Withdrawal of consent|4|||
27999794|NCT00839423|54658525|FG003|Overall Study|Withdrawal of consent|1|||
27999795|NCT00839423|54658522|FG000|Overall Study|Lost to Follow-up|1|||
27999796|NCT00839423|54658523|FG001|Overall Study|Lost to Follow-up|0|||
27999797|NCT00839423|54658524|FG002|Overall Study|Lost to Follow-up|1|||
27999798|NCT00839423|54658525|FG003|Overall Study|Lost to Follow-up|0|||
27999799|NCT00839423|54658522|FG000|Overall Study|Administrative or other reasons|3|||
27999800|NCT00839423|54658523|FG001|Overall Study|Administrative or other reasons|0|||
27999801|NCT00839423|54658524|FG002|Overall Study|Administrative or other reasons|1|||
27999802|NCT00839423|54658525|FG003|Overall Study|Administrative or other reasons|0|||
27914118|NCT00478023|54571814|FG004|Overall Study|Withdrawal by Subject|5|||
27914119|NCT00478023|54571810|FG000|Overall Study|Lack of pain, Technical difficulties|7|||
27914120|NCT00478023|54571811|FG001|Overall Study|Lack of pain, Technical difficulties|3|||
27914121|NCT00478023|54571812|FG002|Overall Study|Lack of pain, Technical difficulties|5|||
27914122|NCT00478023|54571813|FG003|Overall Study|Lack of pain, Technical difficulties|6|||
27914123|NCT00478023|54571814|FG004|Overall Study|Lack of pain, Technical difficulties|3|||
27914124|NCT00477750|54571826|FG000|Overall Study|Currently Receiving Treatment|11|||
27914125|NCT00477672|54571835|FG000|Overall Study|Adverse Event|3|||
27914126|NCT00477672|54571836|FG001|Overall Study|Adverse Event|5|||
27914127|NCT00477672|54571837|FG002|Overall Study|Adverse Event|6|||
27914128|NCT00477672|54571835|FG000|Overall Study|Death|0|||
27914129|NCT00477672|54571836|FG001|Overall Study|Death|1|||
27914130|NCT00477672|54571837|FG002|Overall Study|Death|0|||
27914131|NCT00477672|54571835|FG000|Overall Study|Disease progression|0|||
27914132|NCT00477672|54571836|FG001|Overall Study|Disease progression|1|||
27914133|NCT00477672|54571837|FG002|Overall Study|Disease progression|0|||
27914134|NCT00477672|54571835|FG000|Overall Study|Physician Decision|1|||
27914135|NCT00477672|54571836|FG001|Overall Study|Physician Decision|0|||
27914136|NCT00477672|54571837|FG002|Overall Study|Physician Decision|0|||
27914137|NCT00477672|54571835|FG000|Overall Study|Protocol noncompliance|0|||
27914138|NCT00477672|54571836|FG001|Overall Study|Protocol noncompliance|2|||
27914139|NCT00477672|54571837|FG002|Overall Study|Protocol noncompliance|0|||
27999803|NCT00837161|54658535|FG000|Overall Study|refused hysterectomy|2|||
27999804|NCT00859547|54658539|FG000|Overall Study|Lost to Follow-up|1|||
27999805|NCT00859547|54658539|FG000|Overall Study|Parent withdrew consent|1|||
27999806|NCT00859469|54658543|FG000|Overall Study|Adverse Event|2|||
27999807|NCT00859469|54658543|FG000|Overall Study|Lack of Efficacy|9|||
27999808|NCT00859469|54658543|FG000|Overall Study|Withdrawal by Subject|1|||
27999809|NCT00859469|54658543|FG000|Overall Study|Death|16|||
27999810|NCT00859313|54658547|FG000|Overall Study|Lack of Efficacy|2|||
27999811|NCT00859313|54658547|FG000|Overall Study|Adverse Event|1|||
27999812|NCT00859313|54658547|FG000|Overall Study|staff error|1|||
27999813|NCT00771810|54658554|FG000|Overall Study|Adverse Event|3|||
27999814|NCT00771810|54658555|FG001|Overall Study|Adverse Event|0|||
27999815|NCT00771810|54658556|FG002|Overall Study|Adverse Event|2|||
27999816|NCT00771810|54658554|FG000|Overall Study|Lost to Follow-up|0|||
27999817|NCT00771810|54658555|FG001|Overall Study|Lost to Follow-up|0|||
27999818|NCT00771810|54658556|FG002|Overall Study|Lost to Follow-up|1|||
27999819|NCT00771810|54658554|FG000|Overall Study|Physician Decision|1|||
27999820|NCT00771810|54658555|FG001|Overall Study|Physician Decision|2|||
27999821|NCT00771810|54658556|FG002|Overall Study|Physician Decision|2|||
27999822|NCT00771810|54658554|FG000|Overall Study|Protocol Violation|0|||
27999823|NCT00771810|54658555|FG001|Overall Study|Protocol Violation|1|||
27999824|NCT00771810|54658556|FG002|Overall Study|Protocol Violation|1|||
27999825|NCT00771810|54658554|FG000|Overall Study|Withdrawal by Subject|1|||
27999826|NCT00771810|54658555|FG001|Overall Study|Withdrawal by Subject|2|||
27999827|NCT00771810|54658556|FG002|Overall Study|Withdrawal by Subject|0|||
27999828|NCT00771810|54658554|FG000|Overall Study|Other|0|||
27999829|NCT00771810|54658555|FG001|Overall Study|Other|0|||
27914140|NCT00477672|54571835|FG000|Overall Study|Consent withdrawn|2|||
27914141|NCT00477672|54571836|FG001|Overall Study|Consent withdrawn|5|||
27914142|NCT00477672|54571837|FG002|Overall Study|Consent withdrawn|10|||
27914143|NCT00477672|54571835|FG000|Overall Study|Discretion of Sponsor|1|||
27999830|NCT00771810|54658556|FG002|Overall Study|Other|1|||
27999831|NCT00836927|54658570|FG000|Overall Study|Progressive disease|2|||
27999832|NCT00836927|54658571|FG001|Overall Study|Progressive disease|0|||
27999833|NCT00836927|54658572|FG002|Overall Study|Progressive disease|0|||
27999834|NCT00836927|54658573|FG003|Overall Study|Progressive disease|1|||
27999835|NCT00836927|54658574|FG004|Overall Study|Progressive disease|1|||
27999836|NCT00836927|54658570|FG000|Overall Study|Withdrawal by Subject|1|||
27914144|NCT00477672|54571836|FG001|Overall Study|Discretion of Sponsor|2|||
27914145|NCT00477672|54571837|FG002|Overall Study|Discretion of Sponsor|0|||
27914146|NCT00477633|54571845|FG000|Overall Study|Did not receive treatment|23|||
27914147|NCT00477633|54571845|FG000|Overall Study|Adverse Event|143|||
27914148|NCT00477633|54571845|FG000|Overall Study|Pregnancy|23|||
27999837|NCT00836927|54658571|FG001|Overall Study|Withdrawal by Subject|0|||
27999838|NCT00836927|54658572|FG002|Overall Study|Withdrawal by Subject|0|||
27999839|NCT00836927|54658573|FG003|Overall Study|Withdrawal by Subject|0|||
27999840|NCT00836927|54658574|FG004|Overall Study|Withdrawal by Subject|0|||
27999841|NCT00771030|54658595|FG000|Overall Study|Adverse Event|0|||
27999842|NCT00771030|54658596|FG001|Overall Study|Adverse Event|1|||
28099550|NCT00054717|54755641|FG001|Overall Study|Lost to Follow-up|13|||
27914149|NCT00477633|54571845|FG000|Overall Study|Lost to Follow-up|271|||
27999843|NCT00771030|54658597|FG002|Overall Study|Adverse Event|0|||
27999844|NCT00771030|54658598|FG003|Overall Study|Adverse Event|0|||
27999845|NCT00771030|54658599|FG004|Overall Study|Adverse Event|0|||
27999846|NCT00771030|54658600|FG005|Overall Study|Adverse Event|0|||
27914150|NCT00477633|54571845|FG000|Overall Study|Withdrawal by Subject|149|||
27914151|NCT00477633|54571845|FG000|Overall Study|Protocol Violation|25|||
27999847|NCT00771030|54658601|FG006|Overall Study|Adverse Event|0|||
27999848|NCT00768300|54658624|FG000|Overall Study|Randomized but not treated|1|||
27999849|NCT00768300|54658625|FG001|Overall Study|Randomized but not treated|1|||
27999850|NCT00768300|54658624|FG000|Overall Study|Adverse Event|10|||
27999851|NCT00768300|54658625|FG001|Overall Study|Adverse Event|2|||
27999852|NCT00768300|54658624|FG000|Overall Study|Protocol Violation|6|||
27999853|NCT00768300|54658625|FG001|Overall Study|Protocol Violation|1|||
27914152|NCT00477633|54571845|FG000|Overall Study|Various (Moving, Enrollment closed)|75|||
27914153|NCT01131676|54571861|FG000|Discontinuation From Treatment|Study drug stopped, reason missing|5|||
27914154|NCT01131676|54571862|FG001|Discontinuation From Treatment|Study drug stopped, reason missing|3|||
27914155|NCT01131676|54571863|FG002|Discontinuation From Treatment|Study drug stopped, reason missing|4|||
27914156|NCT01131676|54571861|FG000|Discontinuation From Treatment|Not treated|4|||
27999854|NCT00768300|54658624|FG000|Overall Study|Withdrawal by Subject|13|||
27999855|NCT00768300|54658625|FG001|Overall Study|Withdrawal by Subject|7|||
27999856|NCT00768300|54658624|FG000|Overall Study|Physician Decision|2|||
27999857|NCT00768300|54658625|FG001|Overall Study|Physician Decision|3|||
27999858|NCT00768300|54658624|FG000|Overall Study|Study discontinued by Sponsor|271|||
27999859|NCT00768300|54658625|FG001|Overall Study|Study discontinued by Sponsor|140|||
27999860|NCT00768300|54658624|FG000|Overall Study|Death|21|||
27999861|NCT00768300|54658625|FG001|Overall Study|Death|5|||
27999862|NCT00768300|54658624|FG000|Overall Study|Subject moved to pursue lung transplant|1|||
27999863|NCT00768300|54658625|FG001|Overall Study|Subject moved to pursue lung transplant|1|||
27999864|NCT00768300|54658624|FG000|Overall Study|Screen failure following randomization|1|||
27999865|NCT00768300|54658625|FG001|Overall Study|Screen failure following randomization|0|||
27999866|NCT00768300|54658624|FG000|Overall Study|Received lung transplant|1|||
27999867|NCT00768300|54658625|FG001|Overall Study|Received lung transplant|1|||
27999868|NCT00768300|54658624|FG000|Overall Study|Lost to Follow-up|0|||
27999869|NCT00768300|54658625|FG001|Overall Study|Lost to Follow-up|1|||
27999870|NCT00768300|54658624|FG000|Overall Study|Began prohibited concomitant medication|0|||
27999871|NCT00768300|54658625|FG001|Overall Study|Began prohibited concomitant medication|1|||
27999872|NCT00768300|54658624|FG000|Overall Study|Treated but never dosed with Study drug|1|||
27999873|NCT00768300|54658625|FG001|Overall Study|Treated but never dosed with Study drug|0|||
27999874|NCT00768300|54658624|FG000|Overall Study|Missing data|1|||
27999875|NCT00768300|54658625|FG001|Overall Study|Missing data|0|||
27999876|NCT00768222|54658633|FG000|Overall Study|Lost to Follow-up|1|||
27999877|NCT00768222|54658634|FG001|Overall Study|Lost to Follow-up|1|||
27999878|NCT00768222|54658633|FG000|Overall Study|Withdrawal by Subject|3|||
27999879|NCT00768222|54658634|FG001|Overall Study|Withdrawal by Subject|1|||
27999880|NCT00768222|54658633|FG000|Overall Study|Protocol Violation|0|||
27999881|NCT00768222|54658634|FG001|Overall Study|Protocol Violation|2|||
27999882|NCT00768144|54658640|FG000|Overall Study|Adverse Event|13|||
27999883|NCT00768144|54658640|FG000|Overall Study|Progressive Disease|21|||
27999884|NCT00768144|54658640|FG000|Overall Study|Patient or MD Decision to End Treatment|1|||
27999885|NCT00768144|54658640|FG000|Overall Study|Pt Withdrew Consent|1|||
27999886|NCT00784836|54658644|FG000|Overall Study|Early Study Termination|3|||
27999887|NCT00784758|54658650|FG000|Overall Study|Withdrawal by Subject|3|||
27999888|NCT00784758|54658651|FG001|Overall Study|Withdrawal by Subject|0|||
27999889|NCT00784758|54658650|FG000|Overall Study|Adverse Event|1|||
27999890|NCT00784758|54658651|FG001|Overall Study|Adverse Event|0|||
27999891|NCT00768066|54658662|FG000|Overall Study|Did not receive study product injection.|3|||
27999892|NCT00768066|54658663|FG001|Overall Study|Did not receive study product injection.|3|||
27999893|NCT00768066|54658664|FG002|Overall Study|Did not receive study product injection.|0|||
27999894|NCT00767676|54658672|FG000|Overall Study|Investigator error|54|||
27914157|NCT01131676|54571862|FG001|Discontinuation From Treatment|Not treated|2|||
27914158|NCT01131676|54571863|FG002|Discontinuation From Treatment|Not treated|2|||
27999895|NCT00767520|54658678|FG000|Overall Study|Participants still on treatment|11|||
27999896|NCT00767520|54658679|FG001|Overall Study|Participants still on treatment|15|||
27999897|NCT00767520|54658678|FG000|Overall Study|Randomized in error and Never treated|0|||
27999898|NCT00767520|54658679|FG001|Overall Study|Randomized in error and Never treated|2|||
27999899|NCT00838565|54658691|FG000|Overall Study|Withdrawal by Subject|0|||
27999900|NCT00838565|54658692|FG001|Overall Study|Withdrawal by Subject|0|||
27999901|NCT00838565|54658693|FG002|Overall Study|Withdrawal by Subject|1|||
27999902|NCT00838565|54658694|FG003|Overall Study|Withdrawal by Subject|0|||
27999903|NCT00838565|54658695|FG004|Overall Study|Withdrawal by Subject|0|||
27999904|NCT00838565|54658696|FG005|Overall Study|Withdrawal by Subject|2|||
27999905|NCT00838565|54658691|FG000|Overall Study|Other|0|||
27999906|NCT00838565|54658692|FG001|Overall Study|Other|2|||
28172696|NCT02634788|54844428|FG000|Overall Study|Adverse Event|0|||
27999907|NCT00838565|54658693|FG002|Overall Study|Other|0|||
27999908|NCT00838565|54658694|FG003|Overall Study|Other|0|||
27999909|NCT00838565|54658695|FG004|Overall Study|Other|0|||
27999910|NCT00838565|54658696|FG005|Overall Study|Other|0|||
27999911|NCT00838565|54658691|FG000|Overall Study|Randomized but not Treated|0|||
27999912|NCT00838565|54658692|FG001|Overall Study|Randomized but not Treated|1|||
27999913|NCT00838565|54658693|FG002|Overall Study|Randomized but not Treated|0|||
27999914|NCT00838565|54658694|FG003|Overall Study|Randomized but not Treated|0|||
28172697|NCT02634788|54844429|FG001|Overall Study|Adverse Event|8|||
27999915|NCT00838565|54658695|FG004|Overall Study|Randomized but not Treated|0|||
27999916|NCT00838565|54658696|FG005|Overall Study|Randomized but not Treated|0|||
27999917|NCT00858845|54658717|FG000|Overall Study|Patient underwent heart transplant.|0|||
27999918|NCT00858845|54658718|FG001|Overall Study|Patient underwent heart transplant.|1|||
27999919|NCT00770562|54658726|FG000|Overall Study|Did not take treatment|1|||
27999920|NCT00770562|54658727|FG001|Overall Study|Did not take treatment|1|||
27999921|NCT00836693|54658736|FG000|Overall Study|Adverse Event|4|||
27999922|NCT00836693|54658737|FG001|Overall Study|Adverse Event|1|||
27999923|NCT00836693|54658736|FG000|Overall Study|Sponsor Decision|0|||
27999924|NCT00836693|54658737|FG001|Overall Study|Sponsor Decision|1|||
27914159|NCT01131676|54571861|FG000|Discontinuation From Treatment|Lack of Efficacy|11|||
27914160|NCT01131676|54571862|FG001|Discontinuation From Treatment|Lack of Efficacy|1|||
27914161|NCT01131676|54571863|FG002|Discontinuation From Treatment|Lack of Efficacy|0|||
27914162|NCT01131676|54571861|FG000|Discontinuation From Treatment|Non compliant with protocol|15|||
27914163|NCT01131676|54571862|FG001|Discontinuation From Treatment|Non compliant with protocol|15|||
27914164|NCT01131676|54571863|FG002|Discontinuation From Treatment|Non compliant with protocol|12|||
27914165|NCT01131676|54571861|FG000|Discontinuation From Treatment|Lost to Follow-up|15|||
27999925|NCT00836693|54658736|FG000|Overall Study|Physician Decision|2|||
27999926|NCT00836693|54658737|FG001|Overall Study|Physician Decision|0|||
27999927|NCT00836693|54658736|FG000|Overall Study|Withdrawal by Subject|9|||
27999928|NCT00836693|54658737|FG001|Overall Study|Withdrawal by Subject|4|||
27999929|NCT00836693|54658736|FG000|Overall Study|Protocol Violation|1|||
27999930|NCT00836693|54658737|FG001|Overall Study|Protocol Violation|0|||
28099551|NCT00054717|54755640|FG000|Overall Study|Withdrawal by Subject|32|||
28099552|NCT00054717|54755641|FG001|Overall Study|Withdrawal by Subject|20|||
28099553|NCT00054717|54755640|FG000|Overall Study|Other reason not defined above|117|||
28099554|NCT00054717|54755641|FG001|Overall Study|Other reason not defined above|217|||
28099555|NCT03430856|54755650|FG000|Overall Study|Adverse Event|0|||
28099556|NCT03430856|54755651|FG001|Overall Study|Adverse Event|1|||
28099557|NCT03430856|54755652|FG002|Overall Study|Adverse Event|0|||
28099558|NCT03430856|54755650|FG000|Overall Study|Rescue criteria|1|||
28099559|NCT03430856|54755651|FG001|Overall Study|Rescue criteria|1|||
28099560|NCT03430856|54755652|FG002|Overall Study|Rescue criteria|0|||
28099561|NCT03430856|54755650|FG000|Overall Study|Voluntary withdrawal of consent|1|||
28099562|NCT03430856|54755651|FG001|Overall Study|Voluntary withdrawal of consent|1|||
28099563|NCT03430856|54755652|FG002|Overall Study|Voluntary withdrawal of consent|1|||
28099564|NCT03731364|54755668|FG000|Overall Study|Adverse Event|0|||
28099565|NCT03731364|54755669|FG001|Overall Study|Adverse Event|0|||
28099566|NCT03731364|54755670|FG002|Overall Study|Adverse Event|1|||
28099567|NCT03731364|54755671|FG003|Overall Study|Adverse Event|2|||
28099568|NCT03731364|54755672|FG004|Overall Study|Adverse Event|1|||
28099569|NCT03510182|54755684|FG000|Overall Study|Withdrawal by Subject|2|||
28099570|NCT00066807|54755690|FG000|Overall Study|Study was terminated early|14|||
28099571|NCT00066807|54755691|FG001|Overall Study|Study was terminated early|15|||
28099572|NCT03428750|54755699|FG000|Overall Study|Withdrawal by Subject|11|||
28099573|NCT03428750|54755700|FG001|Overall Study|Withdrawal by Subject|10|||
28099574|NCT03428750|54755699|FG000|Overall Study|Lost to Follow-up|3|||
28099575|NCT03428750|54755700|FG001|Overall Study|Lost to Follow-up|9|||
28099576|NCT03428750|54755699|FG000|Overall Study|Adverse Event|9|||
28099577|NCT03428750|54755700|FG001|Overall Study|Adverse Event|1|||
28099578|NCT03428750|54755699|FG000|Overall Study|Protocol Violation|1|||
28099579|NCT03428750|54755700|FG001|Overall Study|Protocol Violation|0|||
28099580|NCT03428750|54755699|FG000|Overall Study|Administrative|0|||
28099581|NCT03428750|54755700|FG001|Overall Study|Administrative|1|||
28099582|NCT03666858|54755729|FG000|Cohort 1|Adverse Event|1|||
28099583|NCT03666858|54755730|FG001|Cohort 1|Adverse Event|0|||
28099584|NCT03666858|54755729|FG000|Cohort 2|Adverse Event|0|||
28099585|NCT03666858|54755730|FG001|Cohort 2|Adverse Event|1|||
28099586|NCT00054639|54755736|FG000|Overall Study|Lack of Efficacy|1|||
28099587|NCT00054639|54755736|FG000|Overall Study|Physician Decision|1|||
28099588|NCT03428360|54755740|FG000|Overall Study|Informed consent withdrawn|5|||
28099589|NCT03428360|54755740|FG000|Overall Study|Withdrawal by Subject|4|||
28099590|NCT03428360|54755740|FG000|Overall Study|Lost to Follow-up|5|||
28099591|NCT03428360|54755740|FG000|Overall Study|Physician Decision|2|||
28172698|NCT02634788|54844430|FG002|Overall Study|Adverse Event|3|||
28099592|NCT03428360|54755740|FG000|Overall Study|Informed consent withdrawn|5|||
27914166|NCT01131676|54571862|FG001|Discontinuation From Treatment|Lost to Follow-up|9|||
27914167|NCT01131676|54571863|FG002|Discontinuation From Treatment|Lost to Follow-up|6|||
27914168|NCT01131676|54571861|FG000|Discontinuation From Treatment|Refusal to continue, not due to AE|172|||
27999931|NCT00836693|54658736|FG000|Overall Study|Lost to Follow-up|1|||
27999932|NCT00836693|54658737|FG001|Overall Study|Lost to Follow-up|0|||
27999933|NCT00770484|54658745|FG000|Overall Study|Withdrawal by Subject|1|||
28099593|NCT03428360|54755740|FG000|Overall Study|Study terminated by sponsor|10|||
28099594|NCT03428360|54755740|FG000|Overall Study|Non-compliant with study|1|||
27999934|NCT00770484|54658746|FG001|Overall Study|Withdrawal by Subject|0|||
27999935|NCT00835679|54658756|FG000|Overall Study|Withdrawal by Subject|1|||
27914169|NCT01131676|54571862|FG001|Discontinuation From Treatment|Refusal to continue, not due to AE|118|||
27914170|NCT01131676|54571863|FG002|Discontinuation From Treatment|Refusal to continue, not due to AE|122|||
27999936|NCT00835679|54658757|FG001|Overall Study|Withdrawal by Subject|0|||
27999937|NCT00835679|54658758|FG002|Overall Study|Withdrawal by Subject|0|||
27999938|NCT00835679|54658759|FG003|Overall Study|Withdrawal by Subject|0|||
27999939|NCT00766506|54658775|FG000|Overall Study|Use rescue medication after 3 hours|3|||
27999940|NCT00766506|54658776|FG001|Overall Study|Use rescue medication after 3 hours|0|||
27999941|NCT00766506|54658775|FG000|Overall Study|Other|2|||
27999942|NCT00766506|54658776|FG001|Overall Study|Other|2|||
27999943|NCT00770328|54658784|FG000|Overall Study|Adverse Event|11|||
28099595|NCT03428360|54755740|FG000|Overall Study|Non-compliant with study drug|3|||
28099596|NCT03428360|54755740|FG000|Overall Study|Death|3|||
28099597|NCT03428360|54755740|FG000|Overall Study|Adverse Event|1|||
28099598|NCT03428360|54755740|FG000|Overall Study|Not on antiepileptic drug|1|||
28099599|NCT03427892|54755748|FG000|Overall Study|Lost to Follow-up|2|||
28099600|NCT03595332|54755754|FG000|Overall Study|Lost to Follow-up|16|||
28099601|NCT03595332|54755755|FG001|Overall Study|Lost to Follow-up|22|||
28099602|NCT03595332|54755754|FG000|Overall Study|Unable to retrieve ID from school|0|||
28099603|NCT03595332|54755755|FG001|Overall Study|Unable to retrieve ID from school|2|||
28099604|NCT03427268|54755764|FG000|Overall Study|Progressive disease|25|||
28099605|NCT03427268|54755764|FG000|Overall Study|Never treated|2|||
28099606|NCT03427268|54755764|FG000|Overall Study|Compassionate use|1|||
28099607|NCT03427268|54755764|FG000|Overall Study|Withdrawal by Subject|1|||
28099608|NCT03427268|54755764|FG000|Overall Study|Adverse Event|3|||
28099609|NCT03509948|54755768|FG000|Overall Study|Protocol Violation|0|||
28099610|NCT03509948|54755769|FG001|Overall Study|Protocol Violation|1|||
28099611|NCT03466658|54755775|FG000|Overall Study|Withdrawal by Subject|3|||
28099612|NCT03425396|54755786|FG000|Overall Study|Lost to Follow-up|2|||
28099613|NCT03425396|54755787|FG001|Overall Study|Lost to Follow-up|5|||
28099614|NCT03425396|54755788|FG002|Overall Study|Lost to Follow-up|2|||
28099615|NCT03425396|54755789|FG003|Overall Study|Lost to Follow-up|0|||
28099616|NCT03425396|54755790|FG004|Overall Study|Lost to Follow-up|0|||
28099617|NCT03425396|54755786|FG000|Overall Study|Withdrawal by Subject|0|||
28099618|NCT03425396|54755787|FG001|Overall Study|Withdrawal by Subject|1|||
28099619|NCT03425396|54755788|FG002|Overall Study|Withdrawal by Subject|0|||
28099620|NCT03425396|54755789|FG003|Overall Study|Withdrawal by Subject|1|||
28099621|NCT03425396|54755790|FG004|Overall Study|Withdrawal by Subject|0|||
28099622|NCT03425396|54755786|FG000|Overall Study|Other|0|||
28099623|NCT03425396|54755787|FG001|Overall Study|Other|1|||
28099624|NCT03425396|54755788|FG002|Overall Study|Other|1|||
28099625|NCT03425396|54755789|FG003|Overall Study|Other|0|||
28099626|NCT03425396|54755790|FG004|Overall Study|Other|1|||
28099627|NCT00066729|54755802|FG000|Overall Study|Lost to Follow-up|1|||
28099628|NCT00066729|54755802|FG000|Overall Study|Disease progression|1|||
28099629|NCT00032487|54755808|FG000|Overall Study|Withdrawal by Subject|67|||
28099630|NCT00032487|54755809|FG001|Overall Study|Withdrawal by Subject|43|||
28099631|NCT00032487|54755808|FG000|Overall Study|Adverse Event|3|||
27999944|NCT00770328|54658785|FG001|Overall Study|Adverse Event|2|||
27999945|NCT00770328|54658784|FG000|Overall Study|Lost to Follow-up|2|||
28099632|NCT00032487|54755809|FG001|Overall Study|Adverse Event|7|||
28099633|NCT00032487|54755808|FG000|Overall Study|Lost to Follow-up|57|||
28099634|NCT00032487|54755809|FG001|Overall Study|Lost to Follow-up|58|||
28099635|NCT00032487|54755808|FG000|Overall Study|Had other reason|12|||
28099636|NCT00032487|54755809|FG001|Overall Study|Had other reason|12|||
28099637|NCT03641508|54755817|FG000|First Injection|Lost to Follow-up|2|||
28172699|NCT02634788|54844431|FG003|Overall Study|Adverse Event|1|||
27914171|NCT01131676|54571861|FG000|Discontinuation From Treatment|Other than those specified|162|||
27914172|NCT01131676|54571862|FG001|Discontinuation From Treatment|Other than those specified|142|||
27914173|NCT01131676|54571863|FG002|Discontinuation From Treatment|Other than those specified|125|||
27914174|NCT01131676|54571861|FG000|Discontinuation From Treatment|Adverse Event|303|||
27914175|NCT01131676|54571862|FG001|Discontinuation From Treatment|Adverse Event|267|||
27914176|NCT01131676|54571863|FG002|Discontinuation From Treatment|Adverse Event|273|||
27914177|NCT01131676|54571861|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23|||
27999946|NCT00770328|54658785|FG001|Overall Study|Lost to Follow-up|2|||
27999947|NCT00766038|54658793|FG000|Overall Study|Lost to Follow-up|15|||
28099638|NCT03641508|54755818|FG001|First Injection|Lost to Follow-up|0|||
28099639|NCT00066573|54755826|FG000|Overall Study|Did not received protocol treatment|28|||
27999948|NCT00766038|54658794|FG001|Overall Study|Lost to Follow-up|14|||
28099640|NCT00066573|54755827|FG001|Overall Study|Did not received protocol treatment|28|||
28099641|NCT03465878|54755835|FG000|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
28099642|NCT03465878|54755836|FG001|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1|||
28099643|NCT03465878|54755837|FG002|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
28172700|NCT02634788|54844428|FG000|Overall Study|Lack of Efficacy|4|||
27999949|NCT00765882|54658805|FG000|Overall Study|Adverse Event|10|||
28099644|NCT03465878|54755838|FG003|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
28172701|NCT02634788|54844429|FG001|Overall Study|Lack of Efficacy|0|||
27999950|NCT00765882|54658806|FG001|Overall Study|Adverse Event|21|||
27999951|NCT00765882|54658807|FG002|Overall Study|Adverse Event|20|||
27999952|NCT00765882|54658805|FG000|Overall Study|Lack of Efficacy|4|||
27999953|NCT00765882|54658806|FG001|Overall Study|Lack of Efficacy|0|||
27999954|NCT00765882|54658807|FG002|Overall Study|Lack of Efficacy|1|||
27999955|NCT00765882|54658805|FG000|Overall Study|Protocol Violation|4|||
27999956|NCT00765882|54658806|FG001|Overall Study|Protocol Violation|3|||
27999957|NCT00765882|54658807|FG002|Overall Study|Protocol Violation|1|||
27999958|NCT00765882|54658805|FG000|Overall Study|Withdrawal by Subject|2|||
27999959|NCT00765882|54658806|FG001|Overall Study|Withdrawal by Subject|6|||
27999960|NCT00765882|54658807|FG002|Overall Study|Withdrawal by Subject|6|||
27914178|NCT01131676|54571862|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35|||
27914179|NCT01131676|54571863|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25|||
27914180|NCT01131676|54571861|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8|||
27914181|NCT01131676|54571862|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6|||
27914182|NCT01131676|54571863|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5|||
27914183|NCT01131676|54571861|FG000|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20|||
27914184|NCT01131676|54571862|FG001|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21|||
27914185|NCT01131676|54571863|FG002|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19|||
27914186|NCT01131676|54571861|FG000|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5|||
27914187|NCT01131676|54571862|FG001|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9|||
27914188|NCT01131676|54571863|FG002|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7|||
27914189|NCT01131676|54571861|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7|||
27914190|NCT01131676|54571862|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6|||
27914191|NCT01131676|54571863|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5|||
27999961|NCT00765882|54658805|FG000|Overall Study|Lost to Follow-up|1|||
27999962|NCT00765882|54658806|FG001|Overall Study|Lost to Follow-up|9|||
27999963|NCT00765882|54658807|FG002|Overall Study|Lost to Follow-up|6|||
27999964|NCT00765882|54658805|FG000|Overall Study|Other Reason|3|||
27999965|NCT00765882|54658806|FG001|Overall Study|Other Reason|1|||
27999966|NCT00765882|54658807|FG002|Overall Study|Other Reason|2|||
27999967|NCT00769860|54658817|FG000|Overall Study|Withdrawal by Subject|2|||
27999968|NCT00769860|54658818|FG001|Overall Study|Withdrawal by Subject|0|||
27999969|NCT00858143|54658824|FG000|Overall Study|Adverse Event|16|||
27999970|NCT00858143|54658824|FG000|Overall Study|Lack of Efficacy|4|||
27999971|NCT00858143|54658824|FG000|Overall Study|Death|7|||
27999972|NCT00858143|54658824|FG000|Overall Study|Other|23|||
27999973|NCT00828113|54658830|FG000|Overall Study|Withdrawal by Subject|27|||
27999974|NCT00828113|54658831|FG001|Overall Study|Withdrawal by Subject|26|||
27999975|NCT00828113|54658830|FG000|Overall Study|Lost to Follow-up|3|||
27999976|NCT00828113|54658831|FG001|Overall Study|Lost to Follow-up|5|||
27999977|NCT00769704|54658839|FG000|Overall Study|Lost to Follow-up|3|||
27999978|NCT00769704|54658840|FG001|Overall Study|Lost to Follow-up|2|||
27999979|NCT00769704|54658839|FG000|Overall Study|Death|95|||
27999980|NCT00769704|54658840|FG001|Overall Study|Death|190|||
27999981|NCT00769704|54658839|FG000|Overall Study|Withdrawal by Subject|12|||
27999982|NCT00769704|54658840|FG001|Overall Study|Withdrawal by Subject|5|||
27999983|NCT00769704|54658839|FG000|Overall Study|Other|1|||
27999984|NCT00769704|54658840|FG001|Overall Study|Other|2|||
27999985|NCT00818753|54658850|FG000|Overall Study|Protocol Violation|1|||
27999986|NCT00818753|54658851|FG001|Overall Study|Protocol Violation|0|||
27999987|NCT00818753|54658852|FG002|Overall Study|Protocol Violation|0|||
27999988|NCT00818753|54658850|FG000|Overall Study|Other reason (not specified)|0|||
27999989|NCT00818753|54658851|FG001|Overall Study|Other reason (not specified)|0|||
27999990|NCT00818753|54658852|FG002|Overall Study|Other reason (not specified)|1|||
28172702|NCT02634788|54844430|FG002|Overall Study|Lack of Efficacy|1|||
27914192|NCT01131676|54571861|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
27914193|NCT01131676|54571862|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
27914194|NCT01131676|54571863|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2|||
27914195|NCT01131520|54571885|FG000|Overall Study|Computer problem|1|||
27914196|NCT01131520|54571886|FG001|Overall Study|Computer problem|0|||
27914197|NCT01131520|54571885|FG000|Overall Study|Counselor not available|0|||
27999991|NCT00818753|54658850|FG000|Overall Study|Randomised and not treated|2|||
27999992|NCT00818753|54658851|FG001|Overall Study|Randomised and not treated|0|||
27999993|NCT00818753|54658852|FG002|Overall Study|Randomised and not treated|0|||
27999994|NCT00765726|54658860|FG000|Overall Study|Withdrawal by Subject|1|||
27999995|NCT00765726|54658860|FG000|Overall Study|Discontinuation of study by sponsor|8|||
27999996|NCT00765336|54658866|FG000|Overall Study|Protocol Violation|4|||
27999997|NCT00765336|54658867|FG001|Overall Study|Protocol Violation|2|||
27999998|NCT00765336|54658866|FG000|Overall Study|Withdrawal by Subject|6|||
27999999|NCT00765336|54658867|FG001|Overall Study|Withdrawal by Subject|4|||
28000000|NCT00765336|54658866|FG000|Overall Study|Lost to Follow-up|7|||
27914198|NCT01131520|54571886|FG001|Overall Study|Counselor not available|3|||
27914199|NCT01131520|54571885|FG000|Overall Study|Subject changed history after enrollment|0|||
27914200|NCT01131520|54571886|FG001|Overall Study|Subject changed history after enrollment|1|||
28000001|NCT00765336|54658867|FG001|Overall Study|Lost to Follow-up|9|||
28000002|NCT00765336|54658866|FG000|Overall Study|Adverse Event|2|||
28000003|NCT00765336|54658867|FG001|Overall Study|Adverse Event|1|||
28000004|NCT00818519|54658875|FG000|Overall Study|Adverse Event|2|||
28000005|NCT00818519|54658876|FG001|Overall Study|Adverse Event|2|||
28000006|NCT00818519|54658875|FG000|Overall Study|Lost to Follow-up|4|||
28000007|NCT00818519|54658876|FG001|Overall Study|Lost to Follow-up|6|||
28000008|NCT00818519|54658875|FG000|Overall Study|Protocol Violation|2|||
28000009|NCT00818519|54658876|FG001|Overall Study|Protocol Violation|1|||
28000010|NCT00818519|54658875|FG000|Overall Study|Pregnancy|0|||
28000011|NCT00818519|54658876|FG001|Overall Study|Pregnancy|1|||
28000012|NCT00818519|54658875|FG000|Overall Study|Withdrawal by Subject|4|||
28000013|NCT00818519|54658876|FG001|Overall Study|Withdrawal by Subject|9|||
28000014|NCT00818519|54658875|FG000|Overall Study|participant recovered completely|1|||
28000015|NCT00818519|54658876|FG001|Overall Study|participant recovered completely|0|||
28000016|NCT00818519|54658875|FG000|Overall Study|participant will leave for long tme|1|||
28000017|NCT00818519|54658876|FG001|Overall Study|participant will leave for long tme|0|||
28000018|NCT00827567|54658882|FG000|Overall Study|Progression of Disease/Screen Failure|4|||
28000019|NCT00765102|54658886|FG000|Overall Study|Progressive disease|18|||
28000020|NCT00765102|54658886|FG000|Overall Study|Adverse Event|6|||
28000021|NCT00765102|54658886|FG000|Overall Study|Physician Decision|4|||
28000022|NCT00765102|54658886|FG000|Overall Study|Withdrawal by Subject|2|||
28000023|NCT00765102|54658886|FG000|Overall Study|Protocol Violation|1|||
28000024|NCT00809354|54658902|FG000|Overall Study|Adverse Event|32|||
28000025|NCT00809354|54658903|FG001|Overall Study|Adverse Event|45|||
28000026|NCT00809354|54658904|FG002|Overall Study|Adverse Event|37|||
27914201|NCT01131325|54571892|FG000|Overall Study|Adverse Event|1|||
27914202|NCT01131325|54571892|FG000|Overall Study|The participants discontinued the study as the study got terminated|2|||
27914203|NCT01131130|54571896|FG000|Period 1 - Baseline|Pregnancy|1|||
27914204|NCT01131130|54571896|FG000|Period 3- Crossover|+ Slit lamp finding|1|||
27914205|NCT01130974|54571906|FG000|Overall Study|Protocol Violation|10|||
27914206|NCT01130974|54571907|FG001|Overall Study|Protocol Violation|10|||
27914207|NCT01130974|54571906|FG000|Overall Study|Withdrawal by Subject|0|||
27914208|NCT01130974|54571907|FG001|Overall Study|Withdrawal by Subject|1|||
27914209|NCT01130974|54571906|FG000|Overall Study|Ineligibility criteria|5|||
27914210|NCT01130974|54571907|FG001|Overall Study|Ineligibility criteria|2|||
27914211|NCT01130272|54571919|FG000|Overall Study|Adverse Event|2|||
27914212|NCT01130272|54571920|FG001|Overall Study|Adverse Event|5|||
27914213|NCT01130272|54571921|FG002|Overall Study|Adverse Event|6|||
27914214|NCT01130272|54571922|FG003|Overall Study|Adverse Event|22|||
27914215|NCT01130272|54571923|FG004|Overall Study|Adverse Event|7|||
27914216|NCT01130272|54571919|FG000|Overall Study|IVRS-confirmed constipation|0|||
28000027|NCT00809354|54658905|FG003|Overall Study|Adverse Event|53|||
28000028|NCT00809354|54658906|FG004|Overall Study|Adverse Event|26|||
28000029|NCT00809354|54658907|FG005|Overall Study|Adverse Event|33|||
28000030|NCT00809354|54658908|FG006|Overall Study|Adverse Event|44|||
28000031|NCT00809354|54658909|FG007|Overall Study|Adverse Event|40|||
28000032|NCT00809354|54658910|FG008|Overall Study|Adverse Event|46|||
28000033|NCT00809354|54658911|FG009|Overall Study|Adverse Event|26|||
28000034|NCT00809354|54658902|FG000|Overall Study|Lack of Efficacy|23|||
28000035|NCT00809354|54658903|FG001|Overall Study|Lack of Efficacy|23|||
27914217|NCT01130272|54571920|FG001|Overall Study|IVRS-confirmed constipation|1|||
27914218|NCT01130272|54571921|FG002|Overall Study|IVRS-confirmed constipation|1|||
27914219|NCT01130272|54571922|FG003|Overall Study|IVRS-confirmed constipation|2|||
27914220|NCT01130272|54571923|FG004|Overall Study|IVRS-confirmed constipation|0|||
27914221|NCT01130272|54571919|FG000|Overall Study|Rescue medications due to diarrhea|3|||
27914222|NCT01130272|54571920|FG001|Overall Study|Rescue medications due to diarrhea|5|||
27914223|NCT01130272|54571921|FG002|Overall Study|Rescue medications due to diarrhea|8|||
27914224|NCT01130272|54571922|FG003|Overall Study|Rescue medications due to diarrhea|8|||
27914225|NCT01130272|54571923|FG004|Overall Study|Rescue medications due to diarrhea|6|||
27914226|NCT01130272|54571919|FG000|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
27914227|NCT01130272|54571920|FG001|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
27914228|NCT01130272|54571921|FG002|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
27914229|NCT01130272|54571922|FG003|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
28000036|NCT00809354|54658904|FG002|Overall Study|Lack of Efficacy|22|||
28000037|NCT00809354|54658905|FG003|Overall Study|Lack of Efficacy|15|||
28000038|NCT00809354|54658906|FG004|Overall Study|Lack of Efficacy|40|||
28000039|NCT00809354|54658907|FG005|Overall Study|Lack of Efficacy|19|||
28000040|NCT00809354|54658908|FG006|Overall Study|Lack of Efficacy|21|||
28000041|NCT00809354|54658909|FG007|Overall Study|Lack of Efficacy|15|||
28000042|NCT00809354|54658910|FG008|Overall Study|Lack of Efficacy|18|||
28000043|NCT00809354|54658911|FG009|Overall Study|Lack of Efficacy|38|||
28000044|NCT00809354|54658902|FG000|Overall Study|Lost to Follow-up|10|||
28000045|NCT00809354|54658903|FG001|Overall Study|Lost to Follow-up|11|||
28000046|NCT00809354|54658904|FG002|Overall Study|Lost to Follow-up|8|||
28000047|NCT00809354|54658905|FG003|Overall Study|Lost to Follow-up|13|||
28000048|NCT00809354|54658906|FG004|Overall Study|Lost to Follow-up|6|||
28000049|NCT00809354|54658907|FG005|Overall Study|Lost to Follow-up|2|||
28000050|NCT00809354|54658908|FG006|Overall Study|Lost to Follow-up|0|||
28000051|NCT00809354|54658909|FG007|Overall Study|Lost to Follow-up|5|||
28000052|NCT00809354|54658910|FG008|Overall Study|Lost to Follow-up|4|||
28000053|NCT00809354|54658911|FG009|Overall Study|Lost to Follow-up|0|||
28000054|NCT00809354|54658902|FG000|Overall Study|Protocol Violation|7|||
28000055|NCT00809354|54658903|FG001|Overall Study|Protocol Violation|14|||
28000056|NCT00809354|54658904|FG002|Overall Study|Protocol Violation|14|||
28000057|NCT00809354|54658905|FG003|Overall Study|Protocol Violation|12|||
28000058|NCT00809354|54658906|FG004|Overall Study|Protocol Violation|14|||
28000059|NCT00809354|54658907|FG005|Overall Study|Protocol Violation|6|||
28000060|NCT00809354|54658908|FG006|Overall Study|Protocol Violation|4|||
28000061|NCT00809354|54658909|FG007|Overall Study|Protocol Violation|6|||
28000062|NCT00809354|54658910|FG008|Overall Study|Protocol Violation|9|||
28000063|NCT00809354|54658911|FG009|Overall Study|Protocol Violation|3|||
28000064|NCT00809354|54658902|FG000|Overall Study|Withdrawal by Subject|32|||
28000065|NCT00809354|54658903|FG001|Overall Study|Withdrawal by Subject|27|||
28000066|NCT00809354|54658904|FG002|Overall Study|Withdrawal by Subject|31|||
28000067|NCT00809354|54658905|FG003|Overall Study|Withdrawal by Subject|33|||
28000068|NCT00809354|54658906|FG004|Overall Study|Withdrawal by Subject|34|||
28000069|NCT00809354|54658907|FG005|Overall Study|Withdrawal by Subject|29|||
28000070|NCT00809354|54658908|FG006|Overall Study|Withdrawal by Subject|27|||
28000071|NCT00809354|54658909|FG007|Overall Study|Withdrawal by Subject|19|||
28000072|NCT00809354|54658910|FG008|Overall Study|Withdrawal by Subject|18|||
28000073|NCT00809354|54658911|FG009|Overall Study|Withdrawal by Subject|20|||
28000074|NCT00809354|54658902|FG000|Overall Study|Other|10|||
28000075|NCT00809354|54658903|FG001|Overall Study|Other|2|||
28000076|NCT00809354|54658904|FG002|Overall Study|Other|7|||
28000077|NCT00809354|54658905|FG003|Overall Study|Other|10|||
28000078|NCT00809354|54658906|FG004|Overall Study|Other|5|||
28000079|NCT00809354|54658907|FG005|Overall Study|Other|3|||
28000080|NCT00809354|54658908|FG006|Overall Study|Other|2|||
28000081|NCT00809354|54658909|FG007|Overall Study|Other|3|||
28000082|NCT00809354|54658910|FG008|Overall Study|Other|4|||
28000083|NCT00809354|54658911|FG009|Overall Study|Other|3|||
28000084|NCT00809354|54658902|FG000|Overall Study|Study terminated by sponsor|138|||
28000085|NCT00809354|54658903|FG001|Overall Study|Study terminated by sponsor|134|||
28000086|NCT00809354|54658904|FG002|Overall Study|Study terminated by sponsor|129|||
28000087|NCT00809354|54658905|FG003|Overall Study|Study terminated by sponsor|120|||
28000088|NCT00809354|54658906|FG004|Overall Study|Study terminated by sponsor|126|||
28000089|NCT00809354|54658907|FG005|Overall Study|Study terminated by sponsor|133|||
28000090|NCT00809354|54658908|FG006|Overall Study|Study terminated by sponsor|124|||
28000091|NCT00809354|54658909|FG007|Overall Study|Study terminated by sponsor|148|||
28000092|NCT00809354|54658910|FG008|Overall Study|Study terminated by sponsor|127|||
28000093|NCT00809354|54658911|FG009|Overall Study|Study terminated by sponsor|135|||
28000094|NCT00809354|54658902|FG000|Overall Study|Withdrawn due to pregnancy|0|||
28000095|NCT00809354|54658903|FG001|Overall Study|Withdrawn due to pregnancy|1|||
28000096|NCT00809354|54658904|FG002|Overall Study|Withdrawn due to pregnancy|0|||
28000097|NCT00809354|54658905|FG003|Overall Study|Withdrawn due to pregnancy|0|||
28000098|NCT00809354|54658906|FG004|Overall Study|Withdrawn due to pregnancy|0|||
28000099|NCT00809354|54658907|FG005|Overall Study|Withdrawn due to pregnancy|0|||
28000100|NCT00809354|54658908|FG006|Overall Study|Withdrawn due to pregnancy|0|||
28000101|NCT00809354|54658909|FG007|Overall Study|Withdrawn due to pregnancy|0|||
28000102|NCT00809354|54658910|FG008|Overall Study|Withdrawn due to pregnancy|0|||
28000103|NCT00809354|54658911|FG009|Overall Study|Withdrawn due to pregnancy|0|||
28000104|NCT00809354|54658902|FG000|Overall Study|Randomized but not Treated|3|||
28000105|NCT00809354|54658903|FG001|Overall Study|Randomized but not Treated|1|||
28000106|NCT00809354|54658904|FG002|Overall Study|Randomized but not Treated|6|||
28000107|NCT00809354|54658905|FG003|Overall Study|Randomized but not Treated|0|||
28000108|NCT00809354|54658906|FG004|Overall Study|Randomized but not Treated|5|||
28000109|NCT00809354|54658907|FG005|Overall Study|Randomized but not Treated|0|||
28000110|NCT00809354|54658908|FG006|Overall Study|Randomized but not Treated|1|||
28000111|NCT00809354|54658909|FG007|Overall Study|Randomized but not Treated|1|||
28000112|NCT00809354|54658910|FG008|Overall Study|Randomized but not Treated|2|||
28000113|NCT00809354|54658911|FG009|Overall Study|Randomized but not Treated|1|||
28000114|NCT00809354|54658902|FG000|Overall Study|Death|0|||
28000115|NCT00809354|54658903|FG001|Overall Study|Death|0|||
28000116|NCT00809354|54658904|FG002|Overall Study|Death|0|||
28000117|NCT00809354|54658905|FG003|Overall Study|Death|0|||
28000118|NCT00809354|54658906|FG004|Overall Study|Death|0|||
28000119|NCT00809354|54658907|FG005|Overall Study|Death|0|||
28000120|NCT00809354|54658908|FG006|Overall Study|Death|0|||
28000121|NCT00809354|54658909|FG007|Overall Study|Death|1|||
28000122|NCT00809354|54658910|FG008|Overall Study|Death|0|||
28000123|NCT00809354|54658911|FG009|Overall Study|Death|0|||
28000124|NCT00834899|54658940|FG000|Overall Study|Withdrawal by Subject|1|||
28000125|NCT00834899|54658941|FG001|Overall Study|Withdrawal by Subject|1|||
28000126|NCT00764946|54658950|FG000|Overall Study|Lack of Efficacy|1|||
28000127|NCT00764946|54658951|FG001|Overall Study|Lack of Efficacy|0|||
28000128|NCT00764946|54658952|FG002|Overall Study|Lack of Efficacy|0|||
28000129|NCT00764946|54658950|FG000|Overall Study|Lost to Follow-up|3|||
28000130|NCT00764946|54658951|FG001|Overall Study|Lost to Follow-up|4|||
28000131|NCT00764946|54658952|FG002|Overall Study|Lost to Follow-up|0|||
28000132|NCT00764946|54658950|FG000|Overall Study|Physician Decision|2|||
28000133|NCT00764946|54658951|FG001|Overall Study|Physician Decision|4|||
28000134|NCT00764946|54658952|FG002|Overall Study|Physician Decision|0|||
28000135|NCT00764946|54658950|FG000|Overall Study|Adverse Event|3|||
28000136|NCT00764946|54658951|FG001|Overall Study|Adverse Event|2|||
28000137|NCT00764946|54658952|FG002|Overall Study|Adverse Event|1|||
28000138|NCT00764946|54658950|FG000|Overall Study|Withdrawal by Subject|3|||
28000139|NCT00764946|54658951|FG001|Overall Study|Withdrawal by Subject|6|||
28000140|NCT00764946|54658952|FG002|Overall Study|Withdrawal by Subject|2|||
28000141|NCT00764946|54658950|FG000|Overall Study|Never Treated|1|||
28000142|NCT00764946|54658951|FG001|Overall Study|Never Treated|1|||
28000143|NCT00764946|54658952|FG002|Overall Study|Never Treated|1|||
28000144|NCT00764868|54658966|FG000|Overall Study|Adverse Event|18|||
28000145|NCT00764868|54658966|FG000|Overall Study|Withdrawal by Subject|31|||
28000146|NCT00764868|54658966|FG000|Overall Study|Non-compliance|16|||
28000147|NCT00764868|54658966|FG000|Overall Study|Lost to Follow-up|25|||
28000148|NCT00764868|54658966|FG000|Overall Study|Lack of Efficacy|5|||
28000149|NCT00764868|54658966|FG000|Overall Study|Subject moved|7|||
28000150|NCT00764868|54658966|FG000|Overall Study|Pregnancy|3|||
28000151|NCT00764868|54658966|FG000|Overall Study|Prohibited medication|1|||
28000152|NCT00764868|54658966|FG000|Overall Study|Out of town|1|||
28000153|NCT00764868|54658966|FG000|Overall Study|Misuse and compliance of study drug|1|||
28000154|NCT00764868|54658966|FG000|Overall Study|Subject sent to boarding school|1|||
28000155|NCT00764868|54658966|FG000|Overall Study|Met an exclusion criteria|1|||
28000156|NCT00764868|54658966|FG000|Overall Study|Positive drug screen|2|||
28000157|NCT00764868|54658966|FG000|Overall Study|Sponsor requested withdrawal|1|||
28000158|NCT00764790|54658973|FG000|Overall Study|Protocol Violation|0|||
28000159|NCT00764790|54658974|FG001|Overall Study|Protocol Violation|0|||
28000160|NCT00764790|54658975|FG002|Overall Study|Protocol Violation|1|||
28000161|NCT00764790|54658973|FG000|Overall Study|Withdrawal by Subject|10|||
28000162|NCT00764790|54658974|FG001|Overall Study|Withdrawal by Subject|12|||
28000163|NCT00764790|54658975|FG002|Overall Study|Withdrawal by Subject|6|||
28000164|NCT00764790|54658973|FG000|Overall Study|Lost to Follow-up|28|||
28000165|NCT00764790|54658974|FG001|Overall Study|Lost to Follow-up|29|||
28000166|NCT00764790|54658975|FG002|Overall Study|Lost to Follow-up|23|||
28000167|NCT00756444|54658985|FG000|Overall Study|Adverse Event|1|||
28000168|NCT00756444|54658986|FG001|Overall Study|Adverse Event|1|||
28000169|NCT00756444|54658985|FG000|Overall Study|Withdrawal by Subject|6|||
28000170|NCT00756444|54658986|FG001|Overall Study|Withdrawal by Subject|8|||
28000171|NCT00756444|54658985|FG000|Overall Study|Lost to Follow-up|0|||
28000172|NCT00756444|54658986|FG001|Overall Study|Lost to Follow-up|1|||
28000173|NCT00756444|54658985|FG000|Overall Study|Death|5|||
28000174|NCT00756444|54658986|FG001|Overall Study|Death|4|||
28000175|NCT00756444|54658985|FG000|Overall Study|Disease Progression|2|||
28000176|NCT00756444|54658986|FG001|Overall Study|Disease Progression|7|||
28000177|NCT00756444|54658985|FG000|Overall Study|Ineligibility Determined|1|||
28000178|NCT00756444|54658986|FG001|Overall Study|Ineligibility Determined|0|||
28000179|NCT00769002|54658997|FG000|Overall Study|Study was not completed, no data|9|||
28000180|NCT00769002|54658998|FG001|Overall Study|Study was not completed, no data|9|||
28000181|NCT00753012|54659005|FG000|Overall Study|Ineligible, abnormal cardiac histo|1|||
28000182|NCT00753012|54659006|FG001|Overall Study|Ineligible, abnormal cardiac histo|0|||
28000183|NCT00753012|54659005|FG000|Overall Study|Adverse Event|2|||
28000184|NCT00753012|54659006|FG001|Overall Study|Adverse Event|0|||
27914230|NCT01130272|54571923|FG004|Overall Study|Lack of efficacy- uncontrolled diarrhea|2|||
27914231|NCT01130272|54571919|FG000|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
27914232|NCT01130272|54571920|FG001|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
27914233|NCT01130272|54571921|FG002|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
27914234|NCT01130272|54571922|FG003|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1|||
27914235|NCT01130272|54571923|FG004|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
27914236|NCT01130272|54571919|FG000|Overall Study|Protocol Violation|0|||
28000185|NCT00753012|54659005|FG000|Overall Study|Withdrawal by Subject|0|||
28099645|NCT03465878|54755835|FG000|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
28000186|NCT00753012|54659006|FG001|Overall Study|Withdrawal by Subject|1|||
28000187|NCT00753012|54659005|FG000|Overall Study|Lost to Follow-up|4|||
28000188|NCT00753012|54659006|FG001|Overall Study|Lost to Follow-up|0|||
28000189|NCT00753012|54659005|FG000|Overall Study|Confounded endpoint data|1|||
28000190|NCT00753012|54659006|FG001|Overall Study|Confounded endpoint data|0|||
28000191|NCT00806156|54659015|FG000|Overall Study|Death|35|||
28000192|NCT00806156|54659016|FG001|Overall Study|Death|95|||
28000193|NCT00806156|54659015|FG000|Overall Study|Did not meet eligibility criteria|1|||
28000194|NCT00806156|54659016|FG001|Overall Study|Did not meet eligibility criteria|0|||
28000195|NCT00806156|54659015|FG000|Overall Study|Study terminated by Sponsor|2|||
28172703|NCT02634788|54844431|FG003|Overall Study|Lack of Efficacy|4|||
28000196|NCT00806156|54659016|FG001|Overall Study|Study terminated by Sponsor|40|||
28000197|NCT00806156|54659015|FG000|Overall Study|Consent withdrawn by subject|1|||
28000198|NCT00806156|54659016|FG001|Overall Study|Consent withdrawn by subject|3|||
28000199|NCT00806156|54659015|FG000|Overall Study|Lost to Follow-up|0|||
28000200|NCT00806156|54659016|FG001|Overall Study|Lost to Follow-up|1|||
28000201|NCT00764478|54659037|FG000|Overall Study|Adverse Event|1|||
28000202|NCT00764478|54659038|FG001|Overall Study|Adverse Event|1|||
28000203|NCT00764478|54659039|FG002|Overall Study|Adverse Event|1|||
28000204|NCT00764478|54659037|FG000|Overall Study|Withdrawal by Subject|7|||
28000205|NCT00764478|54659038|FG001|Overall Study|Withdrawal by Subject|12|||
28000206|NCT00764478|54659039|FG002|Overall Study|Withdrawal by Subject|1|||
28000207|NCT00764478|54659037|FG000|Overall Study|Lost to Follow-up|7|||
28000208|NCT00764478|54659038|FG001|Overall Study|Lost to Follow-up|8|||
28000209|NCT00764478|54659039|FG002|Overall Study|Lost to Follow-up|5|||
28000210|NCT00764478|54659037|FG000|Overall Study|Protocol Violation|0|||
28000211|NCT00764478|54659038|FG001|Overall Study|Protocol Violation|1|||
28000212|NCT00764478|54659039|FG002|Overall Study|Protocol Violation|1|||
28000213|NCT00805766|54659047|FG000|Screening Period|Adverse Event|1|||
28000214|NCT00805766|54659047|FG000|Screening Period|Lack of Efficacy|2|||
28000215|NCT00805766|54659047|FG000|Screening Period|Pregnancy|1|||
28000216|NCT00805766|54659047|FG000|Screening Period|Responder|2|||
28000217|NCT00805766|54659047|FG000|Increased Dose Period|Adverse Event|4|||
28000218|NCT00805766|54659047|FG000|Increased Dose Period|Lack of Efficacy|7|||
28000219|NCT00805766|54659047|FG000|Increased Dose Period|Pregnancy|1|||
28000220|NCT00805766|54659047|FG000|Increased Dose Period|Withdrawal by Subject|1|||
28000221|NCT00805532|54659057|FG000|Overall Study|invalid data|0|||
28000222|NCT00805532|54659058|FG001|Overall Study|invalid data|1|||
28000223|NCT00764322|54659068|FG000|Overall Study|Withdrawal by Subject|11|||
28000224|NCT00764322|54659068|FG000|Overall Study|No CYP2D6 genotyping|9|||
28000225|NCT00752856|54659087|FG000|Overall Study|randomized but did not do viral kinetics|0|||
28000226|NCT00752856|54659088|FG001|Overall Study|randomized but did not do viral kinetics|1|||
28000227|NCT00755196|54659094|FG000|Overall Study|Lost to Follow-up|1|||
28000228|NCT00755196|54659094|FG000|Overall Study|Lack of Efficiency|1|||
28000229|NCT00805142|54659101|FG000|Titration Period|Adverse Event|3|||
28000230|NCT00805142|54659102|FG001|Titration Period|Adverse Event|3|||
28000231|NCT00805142|54659101|FG000|Titration Period|Lack of Efficacy|1|||
28000232|NCT00805142|54659102|FG001|Titration Period|Lack of Efficacy|1|||
28000233|NCT00805142|54659101|FG000|Titration Period|Lost to Follow-up|0|||
28000234|NCT00805142|54659102|FG001|Titration Period|Lost to Follow-up|1|||
28000235|NCT00805142|54659101|FG000|Titration Period|Disease Progression|2|||
28000236|NCT00805142|54659102|FG001|Titration Period|Disease Progression|1|||
28000237|NCT00805142|54659101|FG000|Titration Period|Withdrawal of consent|0|||
28000238|NCT00805142|54659102|FG001|Titration Period|Withdrawal of consent|1|||
28000239|NCT00805142|54659101|FG000|Titration Period|Other|0|||
28000240|NCT00805142|54659102|FG001|Titration Period|Other|3|||
28000241|NCT00805142|54659101|FG000|Maintenance Period|Adverse Event|0|||
28000242|NCT00805142|54659102|FG001|Maintenance Period|Adverse Event|1|||
28000243|NCT00805142|54659101|FG000|Maintenance Period|Other|0|||
28000244|NCT00805142|54659102|FG001|Maintenance Period|Other|1|||
28000245|NCT00761631|54659119|FG000|Overall Study|Parent/legal guardian request|8|||
28000246|NCT00761631|54659120|FG001|Overall Study|Parent/legal guardian request|3|||
28000247|NCT00761631|54659121|FG002|Overall Study|Parent/legal guardian request|8|||
28000248|NCT00761631|54659122|FG003|Overall Study|Parent/legal guardian request|0|||
28000249|NCT00761631|54659123|FG004|Overall Study|Parent/legal guardian request|5|||
28000250|NCT00761631|54659124|FG005|Overall Study|Parent/legal guardian request|0|||
28000251|NCT00761631|54659119|FG000|Overall Study|Lost to Follow-up|2|||
28000252|NCT00761631|54659120|FG001|Overall Study|Lost to Follow-up|4|||
28000253|NCT00761631|54659121|FG002|Overall Study|Lost to Follow-up|7|||
28000254|NCT00761631|54659122|FG003|Overall Study|Lost to Follow-up|1|||
28000255|NCT00761631|54659123|FG004|Overall Study|Lost to Follow-up|6|||
28000256|NCT00761631|54659124|FG005|Overall Study|Lost to Follow-up|1|||
28000257|NCT00761631|54659119|FG000|Overall Study|Protocol Violation|2|||
28000258|NCT00761631|54659120|FG001|Overall Study|Protocol Violation|0|||
27739823|NCT02219464|54189547|FG001|Overall Study|Withdrawal by Subject|0|||
28000259|NCT00761631|54659121|FG002|Overall Study|Protocol Violation|0|||
28172704|NCT02634788|54844428|FG000|Overall Study|Lost to Follow-up|0|||
28000260|NCT00761631|54659122|FG003|Overall Study|Protocol Violation|1|||
28000261|NCT00761631|54659123|FG004|Overall Study|Protocol Violation|5|||
28000262|NCT00761631|54659124|FG005|Overall Study|Protocol Violation|1|||
28000263|NCT00761631|54659119|FG000|Overall Study|Randomized, not treated|1|||
28000264|NCT00761631|54659120|FG001|Overall Study|Randomized, not treated|0|||
28000265|NCT00761631|54659121|FG002|Overall Study|Randomized, not treated|0|||
28000266|NCT00761631|54659122|FG003|Overall Study|Randomized, not treated|0|||
28000267|NCT00761631|54659123|FG004|Overall Study|Randomized, not treated|0|||
28172705|NCT02634788|54844429|FG001|Overall Study|Lost to Follow-up|1|||
28000268|NCT00761631|54659124|FG005|Overall Study|Randomized, not treated|0|||
28000269|NCT00761631|54659119|FG000|Overall Study|Failed to return|1|||
28000270|NCT00761631|54659120|FG001|Overall Study|Failed to return|0|||
28000271|NCT00761631|54659121|FG002|Overall Study|Failed to return|1|||
28000272|NCT00761631|54659122|FG003|Overall Study|Failed to return|1|||
28000273|NCT00761631|54659123|FG004|Overall Study|Failed to return|5|||
28000274|NCT00761631|54659124|FG005|Overall Study|Failed to return|2|||
28000275|NCT00761631|54659119|FG000|Overall Study|Physician Decision|1|||
28000276|NCT00761631|54659120|FG001|Overall Study|Physician Decision|0|||
28000277|NCT00761631|54659121|FG002|Overall Study|Physician Decision|0|||
28000278|NCT00761631|54659122|FG003|Overall Study|Physician Decision|0|||
28000279|NCT00761631|54659123|FG004|Overall Study|Physician Decision|0|||
28000280|NCT00761631|54659124|FG005|Overall Study|Physician Decision|0|||
28000281|NCT00761631|54659119|FG000|Overall Study|Other|0|||
28099646|NCT03465878|54755836|FG001|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
28099647|NCT03465878|54755837|FG002|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
28099648|NCT03465878|54755838|FG003|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1|||
28099649|NCT03465878|54755835|FG000|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
28099650|NCT03465878|54755836|FG001|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
28099651|NCT03465878|54755837|FG002|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
28099652|NCT03465878|54755838|FG003|Period 1-Part B First Intervention Day 1|Physician Decision|1|||
28099653|NCT03637374|54755866|FG000|Overall Study|Death|2|||
28099654|NCT03637374|54755867|FG001|Overall Study|Death|0|||
28099655|NCT03421730|54755873|FG000|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
28099656|NCT03421730|54755874|FG001|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2|||
28099657|NCT03421730|54755875|FG002|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
28099658|NCT03421730|54755876|FG003|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
28099659|NCT03421730|54755877|FG004|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
28099660|NCT03421730|54755878|FG005|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
28099661|NCT03421730|54755879|FG006|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
28099662|NCT03421730|54755880|FG007|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
28099663|NCT03421730|54755881|FG008|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
28099664|NCT03421730|54755882|FG009|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
28099665|NCT03421730|54755883|FG010|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
28099666|NCT03421730|54755884|FG011|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
28099667|NCT03421730|54755873|FG000|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
28099668|NCT03421730|54755874|FG001|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
28099669|NCT03421730|54755875|FG002|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
28099670|NCT03421730|54755876|FG003|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
28099671|NCT03421730|54755877|FG004|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2|||
28099672|NCT03421730|54755878|FG005|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
28099673|NCT03421730|54755879|FG006|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
28099674|NCT03421730|54755880|FG007|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
28099675|NCT03421730|54755881|FG008|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
28172706|NCT02634788|54844430|FG002|Overall Study|Lost to Follow-up|0|||
27914237|NCT01130272|54571920|FG001|Overall Study|Protocol Violation|0|||
27914238|NCT01130272|54571921|FG002|Overall Study|Protocol Violation|3|||
27914239|NCT01130272|54571922|FG003|Overall Study|Protocol Violation|5|||
27914240|NCT01130272|54571923|FG004|Overall Study|Protocol Violation|5|||
27914241|NCT01130272|54571919|FG000|Overall Study|Lost to Follow-up|4|||
27914242|NCT01130272|54571920|FG001|Overall Study|Lost to Follow-up|3|||
27914243|NCT01130272|54571921|FG002|Overall Study|Lost to Follow-up|4|||
27914244|NCT01130272|54571922|FG003|Overall Study|Lost to Follow-up|7|||
27914245|NCT01130272|54571923|FG004|Overall Study|Lost to Follow-up|6|||
27914246|NCT01130272|54571919|FG000|Overall Study|Withdrawal by Subject|4|||
27914247|NCT01130272|54571920|FG001|Overall Study|Withdrawal by Subject|11|||
27914248|NCT01130272|54571921|FG002|Overall Study|Withdrawal by Subject|10|||
27914249|NCT01130272|54571922|FG003|Overall Study|Withdrawal by Subject|9|||
27914250|NCT01130272|54571923|FG004|Overall Study|Withdrawal by Subject|8|||
27914251|NCT01130272|54571919|FG000|Overall Study|Physician Decision|1|||
27914252|NCT01130272|54571920|FG001|Overall Study|Physician Decision|1|||
28000282|NCT00761631|54659120|FG001|Overall Study|Other|0|||
28000283|NCT00761631|54659121|FG002|Overall Study|Other|0|||
28000284|NCT00761631|54659122|FG003|Overall Study|Other|0|||
28000285|NCT00761631|54659123|FG004|Overall Study|Other|1|||
28000286|NCT00761631|54659124|FG005|Overall Study|Other|1|||
28000287|NCT00763698|54659147|FG000|Overall Study|Unsuccessful Implant|5|||
27914253|NCT01130272|54571921|FG002|Overall Study|Physician Decision|0|||
27914254|NCT01130272|54571922|FG003|Overall Study|Physician Decision|1|||
28000288|NCT00763698|54659147|FG000|Overall Study|Death|4|||
28000289|NCT00763698|54659147|FG000|Overall Study|Withdrawal by Subject|1|||
27914255|NCT01130272|54571923|FG004|Overall Study|Physician Decision|2|||
27914256|NCT01130272|54571919|FG000|Overall Study|Sponsor decision|6|||
28000290|NCT00763386|54659154|FG000|Overall Study|Adverse Event|43|||
27914257|NCT01130272|54571920|FG001|Overall Study|Sponsor decision|15|||
27914258|NCT01130272|54571921|FG002|Overall Study|Sponsor decision|16|||
27914259|NCT01130272|54571922|FG003|Overall Study|Sponsor decision|13|||
27914260|NCT01130272|54571923|FG004|Overall Study|Sponsor decision|16|||
27914261|NCT01130272|54571919|FG000|Overall Study|Study arm discontinued|38|||
27914262|NCT01130272|54571920|FG001|Overall Study|Study arm discontinued|0|||
27914263|NCT01130272|54571921|FG002|Overall Study|Study arm discontinued|0|||
28000291|NCT00763386|54659155|FG001|Overall Study|Adverse Event|33|||
28000292|NCT00763386|54659154|FG000|Overall Study|Death|1|||
28000293|NCT00763386|54659155|FG001|Overall Study|Death|2|||
28000294|NCT00763386|54659154|FG000|Overall Study|Lost to Follow-up|3|||
28000295|NCT00763386|54659155|FG001|Overall Study|Lost to Follow-up|3|||
28000296|NCT00763386|54659154|FG000|Overall Study|Withdrawal by Subject|0|||
28000297|NCT00763386|54659155|FG001|Overall Study|Withdrawal by Subject|1|||
28000298|NCT00763386|54659154|FG000|Overall Study|CRF missing|0|||
28000299|NCT00763386|54659155|FG001|Overall Study|CRF missing|1|||
28000300|NCT00763386|54659154|FG000|Overall Study|Study Prosthesis Removed|1|||
28000301|NCT00763386|54659155|FG001|Overall Study|Study Prosthesis Removed|0|||
28000302|NCT00761319|54659163|FG000|Overall Study|Protocol Violation|21|||
28000303|NCT00761319|54659164|FG001|Overall Study|Protocol Violation|14|||
28000304|NCT00761319|54659163|FG000|Overall Study|Adverse Event|11|||
28000305|NCT00761319|54659164|FG001|Overall Study|Adverse Event|7|||
28000306|NCT00761319|54659163|FG000|Overall Study|Withdrawal by Subject|8|||
28000307|NCT00761319|54659164|FG001|Overall Study|Withdrawal by Subject|7|||
28000308|NCT00761319|54659163|FG000|Overall Study|Noncompliance|4|||
28000309|NCT00761319|54659164|FG001|Overall Study|Noncompliance|3|||
28000310|NCT00761319|54659163|FG000|Overall Study|Lost to Follow-up|1|||
28000311|NCT00761319|54659164|FG001|Overall Study|Lost to Follow-up|1|||
28000312|NCT00761319|54659163|FG000|Overall Study|Nonspecified|2|||
28000313|NCT00761319|54659164|FG001|Overall Study|Nonspecified|2|||
27914264|NCT01130272|54571922|FG003|Overall Study|Study arm discontinued|0|||
27914265|NCT01130272|54571923|FG004|Overall Study|Study arm discontinued|0|||
27914266|NCT01129960|54571939|FG000|Overall Study|Withdrawal by Subject|3|||
27914267|NCT01129960|54571940|FG001|Overall Study|Withdrawal by Subject|0|||
27914268|NCT01129960|54571941|FG002|Overall Study|Withdrawal by Subject|3|||
27914269|NCT01129960|54571942|FG003|Overall Study|Withdrawal by Subject|2|||
27914270|NCT01129960|54571939|FG000|Overall Study|Lack of Efficacy|1|||
27914271|NCT01129960|54571940|FG001|Overall Study|Lack of Efficacy|1|||
27914272|NCT01129960|54571941|FG002|Overall Study|Lack of Efficacy|1|||
27914273|NCT01129960|54571942|FG003|Overall Study|Lack of Efficacy|1|||
27914274|NCT01129960|54571939|FG000|Overall Study|Adverse Event|23|||
27914275|NCT01129960|54571940|FG001|Overall Study|Adverse Event|16|||
27914276|NCT01129960|54571941|FG002|Overall Study|Adverse Event|16|||
27914277|NCT01129960|54571942|FG003|Overall Study|Adverse Event|7|||
27914278|NCT01129960|54571939|FG000|Overall Study|Protocol Violation|1|||
27914279|NCT01129960|54571940|FG001|Overall Study|Protocol Violation|2|||
27914280|NCT01129960|54571941|FG002|Overall Study|Protocol Violation|3|||
27914281|NCT01129960|54571942|FG003|Overall Study|Protocol Violation|0|||
27914282|NCT01129960|54571939|FG000|Overall Study|Lost to Follow-up|0|||
27914283|NCT01129960|54571940|FG001|Overall Study|Lost to Follow-up|2|||
27914284|NCT01129960|54571941|FG002|Overall Study|Lost to Follow-up|3|||
27914285|NCT01129960|54571942|FG003|Overall Study|Lost to Follow-up|3|||
27914286|NCT01129960|54571939|FG000|Overall Study|Discontinuation of the study by Sponsor|0|||
27914287|NCT01129960|54571940|FG001|Overall Study|Discontinuation of the study by Sponsor|1|||
27914288|NCT01129960|54571941|FG002|Overall Study|Discontinuation of the study by Sponsor|0|||
27914289|NCT01129960|54571942|FG003|Overall Study|Discontinuation of the study by Sponsor|0|||
27914290|NCT01129960|54571939|FG000|Overall Study|Physician Decision|1|||
27914291|NCT01129960|54571940|FG001|Overall Study|Physician Decision|0|||
27914292|NCT01129960|54571941|FG002|Overall Study|Physician Decision|0|||
27914293|NCT01129960|54571942|FG003|Overall Study|Physician Decision|0|||
27914294|NCT01129960|54571939|FG000|Overall Study|Pregnancy|1|||
27914295|NCT01129960|54571940|FG001|Overall Study|Pregnancy|0|||
27914296|NCT01129960|54571941|FG002|Overall Study|Pregnancy|0|||
28000314|NCT00761319|54659163|FG000|Overall Study|Missing|1|||
28000315|NCT00761319|54659164|FG001|Overall Study|Missing|0|||
28000316|NCT00762996|54659170|FG000|Period One|Protocol Violation|0|||
28000317|NCT00762996|54659171|FG001|Period One|Protocol Violation|0|||
27914297|NCT01129960|54571942|FG003|Overall Study|Pregnancy|0|||
27914298|NCT01129921|54571954|FG000|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2|||
27914299|NCT01129921|54571955|FG001|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1|||
27914300|NCT01129921|54571954|FG000|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0|||
27914301|NCT01129921|54571955|FG001|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1|||
28000318|NCT00762996|54659172|FG002|Period One|Protocol Violation|1|||
28000319|NCT00762996|54659173|FG003|Period One|Protocol Violation|0|||
28000320|NCT00762996|54659170|FG000|Period One|ineligible|0|||
27914302|NCT01129921|54571954|FG000|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0|||
27914303|NCT01129921|54571955|FG001|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4|||
27914304|NCT01129921|54571954|FG000|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0|||
27914305|NCT01129921|54571955|FG001|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1|||
27914306|NCT01129882|54571974|FG000|Overall Study|Adverse Event|39|||
27914307|NCT01129882|54571974|FG000|Overall Study|Death|6|||
27914308|NCT01129882|54571974|FG000|Overall Study|Lack of Efficacy|5|||
27914309|NCT01129882|54571974|FG000|Overall Study|Lost to Follow-up|13|||
27914310|NCT01129882|54571974|FG000|Overall Study|Physician Decision|27|||
27914311|NCT01129882|54571974|FG000|Overall Study|Protocol Deviation|3|||
27914312|NCT01129882|54571974|FG000|Overall Study|Withdrawal Criteria Met|19|||
27914313|NCT01129882|54571974|FG000|Overall Study|Trial Termination by Sponsor|6|||
27914314|NCT01129882|54571974|FG000|Overall Study|Withdrawal by Subject|160|||
27914315|NCT01129102|54571981|FG000|Overall Study|No study drug treatment|2|||
27914316|NCT01129102|54571982|FG001|Overall Study|No study drug treatment|3|||
27914317|NCT01129102|54571983|FG002|Overall Study|No study drug treatment|1|||
27914318|NCT01129102|54571981|FG000|Overall Study|Withdrawal by Subject|2|||
27914319|NCT01129102|54571982|FG001|Overall Study|Withdrawal by Subject|0|||
27914320|NCT01129102|54571983|FG002|Overall Study|Withdrawal by Subject|3|||
27914321|NCT01129102|54571981|FG000|Overall Study|Protocol Violation|0|||
27914322|NCT01129102|54571982|FG001|Overall Study|Protocol Violation|1|||
27914323|NCT01129102|54571983|FG002|Overall Study|Protocol Violation|1|||
27914324|NCT01129102|54571981|FG000|Overall Study|Pregnancy|0|||
27914325|NCT01129102|54571982|FG001|Overall Study|Pregnancy|0|||
27914326|NCT01129102|54571983|FG002|Overall Study|Pregnancy|1|||
27914327|NCT01129102|54571981|FG000|Overall Study|Adverse Event|2|||
27914328|NCT01129102|54571982|FG001|Overall Study|Adverse Event|2|||
27914329|NCT01129102|54571983|FG002|Overall Study|Adverse Event|1|||
27914330|NCT01129102|54571981|FG000|Overall Study|Lost to Follow-up|2|||
27914331|NCT01129102|54571982|FG001|Overall Study|Lost to Follow-up|0|||
27914332|NCT01129102|54571983|FG002|Overall Study|Lost to Follow-up|0|||
27914333|NCT01129024|54571990|FG000|Overall Study|Physician Decision|5|||
27914334|NCT01129024|54571990|FG000|Overall Study|Study Terminated by Sponsor|8|||
27914335|NCT01129024|54571990|FG000|Overall Study|Withdrawal by Subject|2|||
27914336|NCT01129024|54571990|FG000|Overall Study|Lack of Efficacy|3|||
27914337|NCT01129024|54571990|FG000|Overall Study|Needed a Platelet Transfusion|1|||
27914338|NCT01128946|54571994|FG000|Period I|Protocol Violation|0|||
27914339|NCT01128946|54571995|FG001|Period I|Protocol Violation|1|||
27914340|NCT01128946|54571996|FG002|Period I|Protocol Violation|0|||
27914341|NCT01128946|54571997|FG003|Period I|Protocol Violation|0|||
27914342|NCT01128946|54571994|FG000|Period I|Withdrawal by Subject|0|||
27914343|NCT01128946|54571995|FG001|Period I|Withdrawal by Subject|0|||
27914344|NCT01128946|54571996|FG002|Period I|Withdrawal by Subject|1|||
27914345|NCT01128946|54571997|FG003|Period I|Withdrawal by Subject|1|||
27914346|NCT01128946|54571994|FG000|Period II|Protocol Violation|0|||
27914347|NCT01128946|54571995|FG001|Period II|Protocol Violation|1|||
27914348|NCT01128946|54571996|FG002|Period II|Protocol Violation|0|||
27914349|NCT01128946|54571997|FG003|Period II|Protocol Violation|0|||
27914350|NCT01128946|54571994|FG000|Period II|Withdrawal by Subject|0|||
27914351|NCT01128946|54571995|FG001|Period II|Withdrawal by Subject|0|||
28000321|NCT00762996|54659171|FG001|Period One|ineligible|0|||
28000322|NCT00762996|54659172|FG002|Period One|ineligible|1|||
28000323|NCT00762996|54659173|FG003|Period One|ineligible|1|||
28000324|NCT00762996|54659170|FG000|Period One|Adverse Event|0|||
28000325|NCT00762996|54659171|FG001|Period One|Adverse Event|0|||
28000326|NCT00762996|54659172|FG002|Period One|Adverse Event|1|||
28000327|NCT00762996|54659173|FG003|Period One|Adverse Event|0|||
28000328|NCT00762996|54659170|FG000|Period One|Withdrawal by Subject|0|||
28000329|NCT00762996|54659171|FG001|Period One|Withdrawal by Subject|0|||
28000330|NCT00762996|54659172|FG002|Period One|Withdrawal by Subject|1|||
28000331|NCT00762996|54659173|FG003|Period One|Withdrawal by Subject|0|||
28000332|NCT00762606|54659183|FG000|Overall Study|Lost to Follow-up|18|||
28000333|NCT00762606|54659184|FG001|Overall Study|Lost to Follow-up|13|||
28000334|NCT00818441|54659192|FG000|Overall Study|Death|69|||
27914352|NCT01128946|54571996|FG002|Period II|Withdrawal by Subject|0|||
27914353|NCT01128946|54571997|FG003|Period II|Withdrawal by Subject|1|||
28000335|NCT00818441|54659193|FG001|Overall Study|Death|26|||
28000336|NCT00818441|54659192|FG000|Overall Study|Other|5|||
28000337|NCT00818441|54659193|FG001|Overall Study|Other|0|||
27914354|NCT01128946|54571994|FG000|Period III|Protocol Violation|1|||
27914355|NCT01128946|54571995|FG001|Period III|Protocol Violation|0|||
27914356|NCT01128946|54571996|FG002|Period III|Protocol Violation|0|||
27914357|NCT01128946|54571997|FG003|Period III|Protocol Violation|0|||
27914358|NCT01128595|54572008|FG000|Treatment Period 3|Withdrawal by Subject|0|||
28000338|NCT00818441|54659192|FG000|Overall Study|Lost to Follow-up|2|||
28000339|NCT00818441|54659193|FG001|Overall Study|Lost to Follow-up|1|||
27914359|NCT01128595|54572009|FG001|Treatment Period 3|Withdrawal by Subject|1|||
28000340|NCT00818441|54659192|FG000|Overall Study|Withdrawal by Subject|2|||
28000341|NCT00818441|54659193|FG001|Overall Study|Withdrawal by Subject|0|||
28000342|NCT00818441|54659192|FG000|Overall Study|Adverse Event|0|||
28000343|NCT00818441|54659193|FG001|Overall Study|Adverse Event|1|||
28000344|NCT00818441|54659192|FG000|Overall Study|Study terminated by sponsor|11|||
28000345|NCT00818441|54659193|FG001|Overall Study|Study terminated by sponsor|2|||
28000346|NCT00826943|54659200|FG000|Overall Study|Withdrawal by Subject|0|||
28000347|NCT00826943|54659201|FG001|Overall Study|Withdrawal by Subject|0|||
28000348|NCT00826943|54659202|FG002|Overall Study|Withdrawal by Subject|0|||
28000349|NCT00826943|54659203|FG003|Overall Study|Withdrawal by Subject|0|||
28000350|NCT00826943|54659204|FG004|Overall Study|Withdrawal by Subject|1|||
28000351|NCT00826943|54659205|FG005|Overall Study|Withdrawal by Subject|0|||
28000352|NCT00834041|54659215|FG000|Overall Study|Withdrawal by Subject|1|||
28000353|NCT00834041|54659216|FG001|Overall Study|Withdrawal by Subject|0|||
28000354|NCT00834041|54659215|FG000|Overall Study|Lost to Follow-up|0|||
27914360|NCT01128595|54572010|FG002|Treatment Period 3|Withdrawal by Subject|0|||
28000355|NCT00834041|54659216|FG001|Overall Study|Lost to Follow-up|1|||
28000356|NCT00760929|54659226|FG000|Overall Study|Adverse Event|2|||
28000357|NCT00760929|54659227|FG001|Overall Study|Adverse Event|0|||
28000358|NCT00760929|54659228|FG002|Overall Study|Adverse Event|6|||
28000359|NCT00760929|54659229|FG003|Overall Study|Adverse Event|10|||
28000360|NCT00760929|54659226|FG000|Overall Study|Lack of Efficacy|0|||
28000361|NCT00760929|54659227|FG001|Overall Study|Lack of Efficacy|2|||
28000362|NCT00760929|54659228|FG002|Overall Study|Lack of Efficacy|1|||
28000363|NCT00760929|54659229|FG003|Overall Study|Lack of Efficacy|0|||
28000364|NCT00760929|54659226|FG000|Overall Study|Withdrawal by Subject|1|||
28099676|NCT03421730|54755882|FG009|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
28099677|NCT03421730|54755883|FG010|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
28099678|NCT03421730|54755884|FG011|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
28099679|NCT00054327|54755904|FG000|Overall Study|Engraftment failure|1|||
28099680|NCT00054327|54755905|FG001|Overall Study|Engraftment failure|0|||
28099681|NCT00054327|54755906|FG002|Overall Study|Engraftment failure|0|||
28099682|NCT00054327|54755907|FG003|Overall Study|Engraftment failure|0|||
28099683|NCT00054327|54755908|FG004|Overall Study|Engraftment failure|0|||
28099684|NCT00054327|54755909|FG005|Overall Study|Engraftment failure|0|||
28099685|NCT03503162|54755923|FG000|Overall Study|did not meet eligibility|1|||
28099686|NCT03029650|54755927|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
28099687|NCT03029650|54755928|FG001|Washout (1 Week)|Withdrawal by Subject|1|||
28099688|NCT03029650|54755927|FG000|Washout (1 Week)|Physician Decision|0|||
28099689|NCT03029650|54755928|FG001|Washout (1 Week)|Physician Decision|1|||
28099690|NCT03462680|54755940|FG000|Overall Study|Withdrawal by Subject|3|||
28099691|NCT03462680|54755941|FG001|Overall Study|Withdrawal by Subject|5|||
28099692|NCT03636906|54755950|FG000|Overall Study|Adverse Event|0|||
28099693|NCT03636906|54755951|FG001|Overall Study|Adverse Event|0|||
28099694|NCT03636906|54755952|FG002|Overall Study|Adverse Event|1|||
28099695|NCT03636906|54755950|FG000|Overall Study|Lost to Follow-up|1|||
28099696|NCT03636906|54755951|FG001|Overall Study|Lost to Follow-up|0|||
28099697|NCT03636906|54755952|FG002|Overall Study|Lost to Follow-up|0|||
28099698|NCT03636906|54755950|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|2|||
28099699|NCT03636906|54755951|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|0|||
28099700|NCT03636906|54755952|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|1|||
28099701|NCT03636906|54755950|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
28099702|NCT03636906|54755951|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
28099703|NCT03636906|54755952|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|2|||
28099704|NCT03636906|54755950|FG000|Overall Study|Other|0|||
27914361|NCT01128595|54572011|FG003|Treatment Period 3|Withdrawal by Subject|0|||
27914362|NCT01129336|54572024|FG000|Overall Study|Protocol Violation|1|||
27914363|NCT01129336|54572025|FG001|Overall Study|Protocol Violation|0|||
27914364|NCT01129336|54572024|FG000|Overall Study|Disease Progression|1|||
27914365|NCT01129336|54572025|FG001|Overall Study|Disease Progression|4|||
27914366|NCT01129336|54572024|FG000|Overall Study|Lost to Follow-up|1|||
27914367|NCT01129336|54572025|FG001|Overall Study|Lost to Follow-up|0|||
27914368|NCT01129336|54572024|FG000|Overall Study|Withdrawal by Subject|7|||
27914369|NCT01129336|54572025|FG001|Overall Study|Withdrawal by Subject|4|||
27914370|NCT01129336|54572024|FG000|Overall Study|Adverse Event|0|||
28000365|NCT00760929|54659227|FG001|Overall Study|Withdrawal by Subject|0|||
28000366|NCT00760929|54659228|FG002|Overall Study|Withdrawal by Subject|9|||
28000367|NCT00760929|54659229|FG003|Overall Study|Withdrawal by Subject|1|||
28000368|NCT00760929|54659226|FG000|Overall Study|Lost to Follow-up|0|||
28099705|NCT03636906|54755951|FG001|Overall Study|Other|0|||
28099706|NCT03636906|54755952|FG002|Overall Study|Other|1|||
27914371|NCT01129336|54572025|FG001|Overall Study|Adverse Event|1|||
27914372|NCT01129336|54572024|FG000|Overall Study|Missing Study Completion Status|2|||
28000369|NCT00760929|54659227|FG001|Overall Study|Lost to Follow-up|0|||
28000370|NCT00760929|54659228|FG002|Overall Study|Lost to Follow-up|1|||
28000371|NCT00760929|54659229|FG003|Overall Study|Lost to Follow-up|0|||
28099707|NCT03028870|54755970|FG000|Overall Study|Adverse Event|7|||
28099708|NCT03028870|54755971|FG001|Overall Study|Adverse Event|4|||
28099709|NCT03028870|54755972|FG002|Overall Study|Adverse Event|3|||
27914373|NCT01129336|54572025|FG001|Overall Study|Missing Study Completion Status|3|||
27914374|NCT01129336|54572024|FG000|Overall Study|Death|0|||
27914375|NCT01129336|54572025|FG001|Overall Study|Death|4|||
27914376|NCT01128400|54572034|FG000|Overall Study|Lost to Follow-up|1|||
27914377|NCT01128400|54572035|FG001|Overall Study|Lost to Follow-up|0|||
27914378|NCT01128400|54572036|FG002|Overall Study|Lost to Follow-up|1|||
27914379|NCT01128400|54572034|FG000|Overall Study|Screening failure|1|||
27914380|NCT01128400|54572035|FG001|Overall Study|Screening failure|0|||
27914381|NCT01128400|54572036|FG002|Overall Study|Screening failure|0|||
27914382|NCT01128400|54572034|FG000|Overall Study|were not invited to participate on taste|0|||
27914383|NCT01128400|54572035|FG001|Overall Study|were not invited to participate on taste|0|||
27914384|NCT01128400|54572036|FG002|Overall Study|were not invited to participate on taste|15|||
27914385|NCT01128400|54572034|FG000|Overall Study|Excluded due to sinus problems|0|||
27914386|NCT01128400|54572035|FG001|Overall Study|Excluded due to sinus problems|1|||
27914387|NCT01128400|54572036|FG002|Overall Study|Excluded due to sinus problems|0|||
27914388|NCT01128361|54572046|FG000|Overall Study|Lost to Follow-up|0|||
27914389|NCT01128361|54572047|FG001|Overall Study|Lost to Follow-up|1|||
27914390|NCT01128361|54572046|FG000|Overall Study|Withdrawal by Subject|5|||
27914391|NCT01128361|54572047|FG001|Overall Study|Withdrawal by Subject|2|||
27914392|NCT01128244|54572053|FG000|Overall Study|Adverse Event|1|||
27914393|NCT01128244|54572053|FG000|Overall Study|Scheduling conflict|2|||
27914394|NCT01127893|54572061|FG000|Overall Study|Study Termination by the Sponsor|1|||
27914395|NCT01126879|54572067|FG000|Overall Study|Progressive Disease|3|||
27914396|NCT01126879|54572068|FG001|Overall Study|Progressive Disease|1|||
27914397|NCT01126879|54572067|FG000|Overall Study|Withdrawal by Subject|1|||
27914398|NCT01126879|54572068|FG001|Overall Study|Withdrawal by Subject|0|||
27914399|NCT01126879|54572067|FG000|Overall Study|Adverse Event|0|||
27914400|NCT01126879|54572068|FG001|Overall Study|Adverse Event|1|||
27914401|NCT01126879|54572067|FG000|Overall Study|Physician Decision|1|||
27914402|NCT01126879|54572068|FG001|Overall Study|Physician Decision|0|||
27914403|NCT01126060|54572076|FG000|Overall Study|Protocol Violation|0|||
28000372|NCT00760929|54659226|FG000|Overall Study|Progression of Disease|21|||
28000373|NCT00760929|54659227|FG001|Overall Study|Progression of Disease|26|||
28000374|NCT00760929|54659228|FG002|Overall Study|Progression of Disease|38|||
28000375|NCT00760929|54659229|FG003|Overall Study|Progression of Disease|42|||
28000376|NCT00760929|54659226|FG000|Overall Study|Other|2|||
28000377|NCT00760929|54659227|FG001|Overall Study|Other|0|||
28000378|NCT00760929|54659228|FG002|Overall Study|Other|2|||
27914404|NCT01126060|54572077|FG001|Overall Study|Protocol Violation|2|||
27914405|NCT01125748|54572085|FG000|Overall Study|Adverse Event|0|||
27914406|NCT01125748|54572086|FG001|Overall Study|Adverse Event|2|||
27914407|NCT01125748|54572085|FG000|Overall Study|Lost to Follow-up|0|||
27914408|NCT01125748|54572086|FG001|Overall Study|Lost to Follow-up|1|||
27914409|NCT01125748|54572085|FG000|Overall Study|Physician Decision|8|||
27914410|NCT01125748|54572086|FG001|Overall Study|Physician Decision|7|||
28000379|NCT00760929|54659229|FG003|Overall Study|Other|1|||
28000380|NCT00760929|54659226|FG000|Overall Study|Death|0|||
28000381|NCT00760929|54659227|FG001|Overall Study|Death|0|||
28000382|NCT00760929|54659228|FG002|Overall Study|Death|1|||
28000383|NCT00760929|54659229|FG003|Overall Study|Death|0|||
28000384|NCT00760929|54659226|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
28000385|NCT00760929|54659227|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
28000386|NCT00760929|54659228|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
28000387|NCT00760929|54659229|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
28000388|NCT00818207|54659240|FG000|Overall Study|Adverse Event|6|||
28000389|NCT00818207|54659241|FG001|Overall Study|Adverse Event|0|||
27914411|NCT01125748|54572085|FG000|Overall Study|Patient Decision to Withdraw|2|||
27914412|NCT01125748|54572086|FG001|Overall Study|Patient Decision to Withdraw|4|||
27914413|NCT01125514|54572092|FG000|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1|||
27914414|NCT01125514|54572092|FG000|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1|||
27914415|NCT01125514|54572092|FG000|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3|||
27914416|NCT01125514|54572092|FG000|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2|||
27914417|NCT01125514|54572092|FG000|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1|||
27914418|NCT01125514|54572092|FG000|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1|||
28000390|NCT00818207|54659240|FG000|Overall Study|Lost to Follow-up|160|||
28000391|NCT00818207|54659241|FG001|Overall Study|Lost to Follow-up|146|||
28000392|NCT00818207|54659240|FG000|Overall Study|Multiple reasons|11|||
28000393|NCT00818207|54659241|FG001|Overall Study|Multiple reasons|12|||
28000394|NCT00818207|54659240|FG000|Overall Study|Withdrawal by Subject|42|||
28172707|NCT02634788|54844431|FG003|Overall Study|Lost to Follow-up|0|||
27914419|NCT01125358|54572110|FG000|Overall Study|Adverse Event|3|||
27914420|NCT01125358|54572111|FG001|Overall Study|Adverse Event|0|||
27914421|NCT01125358|54572112|FG002|Overall Study|Adverse Event|0|||
27914422|NCT01125358|54572113|FG003|Overall Study|Adverse Event|2|||
27914423|NCT01125358|54572110|FG000|Overall Study|Perceived Lack of Efficacy|6|||
28000395|NCT00818207|54659241|FG001|Overall Study|Withdrawal by Subject|104|||
28000396|NCT00818207|54659240|FG000|Overall Study|Death|3|||
28000397|NCT00818207|54659241|FG001|Overall Study|Death|5|||
28000398|NCT00760617|54659250|FG000|Overall Study|Adverse Event|5|||
28000399|NCT00760617|54659251|FG001|Overall Study|Adverse Event|2|||
28000400|NCT00760617|54659252|FG002|Overall Study|Adverse Event|0|||
28000401|NCT00760617|54659250|FG000|Overall Study|Lost to Follow-up|0|||
28099710|NCT03028870|54755973|FG003|Overall Study|Adverse Event|3|||
28099711|NCT03028870|54755970|FG000|Overall Study|Withdrawal by Subject|1|||
28099712|NCT03028870|54755971|FG001|Overall Study|Withdrawal by Subject|1|||
28099713|NCT03028870|54755972|FG002|Overall Study|Withdrawal by Subject|1|||
28099714|NCT03028870|54755973|FG003|Overall Study|Withdrawal by Subject|2|||
28099715|NCT03028870|54755970|FG000|Overall Study|Lost to Follow-up|1|||
28099716|NCT03028870|54755971|FG001|Overall Study|Lost to Follow-up|0|||
28099717|NCT03028870|54755972|FG002|Overall Study|Lost to Follow-up|0|||
28099718|NCT03028870|54755973|FG003|Overall Study|Lost to Follow-up|0|||
28099719|NCT03028870|54755970|FG000|Overall Study|Lack of Efficacy|3|||
28099720|NCT03028870|54755971|FG001|Overall Study|Lack of Efficacy|0|||
28099721|NCT03028870|54755972|FG002|Overall Study|Lack of Efficacy|0|||
28099722|NCT03028870|54755973|FG003|Overall Study|Lack of Efficacy|0|||
27914424|NCT01125358|54572111|FG001|Overall Study|Perceived Lack of Efficacy|3|||
27914425|NCT01125358|54572112|FG002|Overall Study|Perceived Lack of Efficacy|7|||
27914426|NCT01125358|54572113|FG003|Overall Study|Perceived Lack of Efficacy|4|||
27914427|NCT01125358|54572110|FG000|Overall Study|Protocol Violation|1|||
27914428|NCT01125358|54572111|FG001|Overall Study|Protocol Violation|0|||
27914429|NCT01125358|54572112|FG002|Overall Study|Protocol Violation|0|||
28099723|NCT03028870|54755970|FG000|Overall Study|Administrative|5|||
28099724|NCT03028870|54755971|FG001|Overall Study|Administrative|5|||
28099725|NCT03028870|54755972|FG002|Overall Study|Administrative|12|||
28099726|NCT03028870|54755973|FG003|Overall Study|Administrative|4|||
28099727|NCT03663582|54755983|FG000|Overall Study|Physician Decision|1|||
28099728|NCT03502616|54755989|FG000|Up to Week 16|Withdrawal by Subject|1|||
28099729|NCT03502616|54755990|FG001|Up to Week 16|Withdrawal by Subject|2|||
28099730|NCT03502616|54755989|FG000|Up to Week 16|Lost to Follow-up|0|||
28099731|NCT03502616|54755990|FG001|Up to Week 16|Lost to Follow-up|1|||
28099732|NCT03502616|54755989|FG000|Up to Week 16|Randomized, but not treated|1|||
28099733|NCT03502616|54755990|FG001|Up to Week 16|Randomized, but not treated|0|||
28099734|NCT03502616|54755989|FG000|Week 16 to Week 48|Withdrawal by Subject|6|||
28099735|NCT03502616|54755990|FG001|Week 16 to Week 48|Withdrawal by Subject|6|||
28099736|NCT03502616|54755989|FG000|Week 16 to Week 48|Lost to Follow-up|1|||
28099737|NCT03502616|54755990|FG001|Week 16 to Week 48|Lost to Follow-up|0|||
28099738|NCT03028012|54756011|FG000|Overall Study|Lost to Follow-up|2|||
28099739|NCT03028012|54756012|FG001|Overall Study|Lost to Follow-up|3|||
28099740|NCT03028012|54756013|FG002|Overall Study|Lost to Follow-up|3|||
28099741|NCT03635190|54756022|FG000|Overall Study|Lost to Follow-up|4|||
28099742|NCT03635190|54756022|FG000|Overall Study|Death|3|||
27914430|NCT01125358|54572113|FG003|Overall Study|Protocol Violation|0|||
27914431|NCT01125358|54572110|FG000|Overall Study|Sponsor Decision|0|||
27914432|NCT01125358|54572111|FG001|Overall Study|Sponsor Decision|0|||
27914433|NCT01125358|54572112|FG002|Overall Study|Sponsor Decision|1|||
27914434|NCT01125358|54572113|FG003|Overall Study|Sponsor Decision|1|||
27914435|NCT01125358|54572110|FG000|Overall Study|Withdrawal by Subject|2|||
27914436|NCT01125358|54572111|FG001|Overall Study|Withdrawal by Subject|1|||
27914437|NCT01125358|54572112|FG002|Overall Study|Withdrawal by Subject|1|||
27914438|NCT01125358|54572113|FG003|Overall Study|Withdrawal by Subject|1|||
27914439|NCT01125046|54572123|FG000|First 6 Months of Treatment|Death|1|||
27914440|NCT01125046|54572123|FG000|First 6 Months of Treatment|Withdrawal by Subject|2|||
28099743|NCT03635190|54756022|FG000|Overall Study|Withdrawal by Subject|1|||
28099744|NCT03635190|54756022|FG000|Overall Study|Patient moved and did not return for follow up|1|||
28099745|NCT03634800|54756029|FG000|Overall Study|Adverse Event|1|||
28099746|NCT03634800|54756029|FG000|Overall Study|Disease Progression|4|||
28099747|NCT03634800|54756029|FG000|Overall Study|Withdrawal by Subject|1|||
28099748|NCT03027466|54756037|FG000|Overall Study|Opting out of the app|1869|||
28099749|NCT03027466|54756038|FG001|Overall Study|Opting out of the app|1819|||
28099750|NCT03027466|54756039|FG002|Overall Study|Opting out of the app|1743|||
28099751|NCT03027466|54756040|FG003|Overall Study|Opting out of the app|1821|||
28099752|NCT03662334|54756052|FG000|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1|||
28099753|NCT03662334|54756053|FG001|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0|||
28099754|NCT02955186|54756061|FG000|Overall Study|Withdrawal by Subject|6|||
28000402|NCT00760617|54659251|FG001|Overall Study|Lost to Follow-up|0|||
28000403|NCT00760617|54659252|FG002|Overall Study|Lost to Follow-up|5|||
28099755|NCT02955186|54756062|FG001|Overall Study|Withdrawal by Subject|2|||
27739824|NCT02219464|54189546|FG000|Overall Study|case cancelled|1|||
27914441|NCT01125046|54572123|FG000|First 6 Months of Treatment|Non-compliance|1|||
28000404|NCT00760383|54659262|FG000|Overall Study|moved away; withdrew; medical reasons|5|||
28000405|NCT00760383|54659263|FG001|Overall Study|moved away; withdrew; medical reasons|7|||
28099756|NCT02955186|54756061|FG000|Overall Study|Protocol Violation|1|||
28099757|NCT02955186|54756062|FG001|Overall Study|Protocol Violation|0|||
28099758|NCT03502070|54756068|FG000|Overall Study|Withdrawal by Subject|1|||
28000406|NCT00759915|54659271|FG000|Overall Study|Withdrawal by Subject|1|||
28000407|NCT00759915|54659272|FG001|Overall Study|Withdrawal by Subject|0|||
28000408|NCT00759915|54659271|FG000|Overall Study|Adverse Event|0|||
28000409|NCT00759915|54659272|FG001|Overall Study|Adverse Event|1|||
28000410|NCT00759759|54659280|FG000|Overall Study|didn't return for period 2|1|||
28000411|NCT00759759|54659281|FG001|Overall Study|didn't return for period 2|0|||
28000412|NCT00759759|54659280|FG000|Overall Study|Didn't receive drug in period 2|1|||
28000413|NCT00759759|54659281|FG001|Overall Study|Didn't receive drug in period 2|0|||
28000414|NCT00759759|54659280|FG000|Overall Study|Withdrawal by Subject|2|||
28000415|NCT00759759|54659281|FG001|Overall Study|Withdrawal by Subject|1|||
28000416|NCT00759681|54659289|FG000|Overall Study|Death|2|||
27914442|NCT01125046|54572123|FG000|First 6 Months of Treatment|Surgery|1|||
27914443|NCT01125046|54572123|FG000|First 6 Months of Treatment|Progressive Disease|7|||
28000417|NCT00759681|54659290|FG001|Overall Study|Death|5|||
28000418|NCT00759681|54659289|FG000|Overall Study|Lost to Follow-up|8|||
28000419|NCT00759681|54659290|FG001|Overall Study|Lost to Follow-up|5|||
28000420|NCT00826241|54659297|FG000|Overall Study|Withdrawal from Follow-up|1|||
28000421|NCT00826241|54659297|FG000|Overall Study|Withdrew consent|2|||
28000422|NCT00826241|54659297|FG000|Overall Study|Death|4|||
27914444|NCT01125046|54572123|FG000|First 6 Months of Treatment|Adverse Event|2|||
27914445|NCT01125046|54572123|FG000|Continued Treatment After 6 Months|Progressive Disease|2|||
27914446|NCT01125046|54572123|FG000|Continued Treatment After 6 Months|Adverse Event|1|||
27914447|NCT01125046|54572123|FG000|Follow-up/Data Cut Off Point|Death|29|||
27914448|NCT01125046|54572123|FG000|Follow-up/Data Cut Off Point|Lost to Follow-up|4|||
27914449|NCT01124734|54572127|FG000|Overall Study|Disease progression|13|||
27914450|NCT01124734|54572127|FG000|Overall Study|Adverse Event|1|||
27914451|NCT01124734|54572127|FG000|Overall Study|Withdrawal by Subject|1|||
27914452|NCT01124734|54572127|FG000|Overall Study|Elected for alternative treatment|2|||
27914453|NCT01124617|54572138|FG000|Overall Study|Adverse Event|5|||
27914454|NCT01124617|54572139|FG001|Overall Study|Adverse Event|2|||
27914455|NCT01124617|54572138|FG000|Overall Study|Lack of Efficacy|2|||
27914456|NCT01124617|54572139|FG001|Overall Study|Lack of Efficacy|1|||
27914457|NCT01124617|54572138|FG000|Overall Study|Protocol Violation|1|||
27914458|NCT01124617|54572139|FG001|Overall Study|Protocol Violation|1|||
27914459|NCT01124617|54572138|FG000|Overall Study|Withdrawal by Subject|9|||
27914460|NCT01124617|54572139|FG001|Overall Study|Withdrawal by Subject|1|||
27914461|NCT01124617|54572138|FG000|Overall Study|Other|2|||
27914462|NCT01124617|54572139|FG001|Overall Study|Other|1|||
27914463|NCT01124422|54572147|FG000|4-Week Open-label Run-in Phase|Withdrawal by Subject|5|||
27914464|NCT01124422|54572148|FG001|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
27914465|NCT01124422|54572149|FG002|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
27914466|NCT01124422|54572147|FG000|4-Week Open-label Run-in Phase|Adverse Event|7|||
27914467|NCT01124422|54572148|FG001|4-Week Open-label Run-in Phase|Adverse Event|0|||
28000423|NCT00826241|54659297|FG000|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1|||
28000424|NCT00826241|54659297|FG000|Overall Study|Non-compliance|1|||
28000425|NCT00826241|54659297|FG000|Overall Study|Progression of disease|1|||
28000426|NCT00826241|54659297|FG000|Overall Study|Patient refused follow-up|3|||
28000427|NCT00826241|54659297|FG000|Overall Study|Lost to Follow-up|9|||
28000428|NCT00826241|54659297|FG000|Overall Study|Could not obtain records|1|||
28000429|NCT00826241|54659297|FG000|Overall Study|Screen failure|2|||
28000430|NCT00826241|54659297|FG000|Overall Study|Pt unable to proceed to registration|1|||
28000431|NCT00826241|54659297|FG000|Overall Study|Pt opt not to proceed w/trmt|1|||
28000432|NCT00758589|54659305|FG000|Overall Study|Adverse Event|3|||
28000433|NCT00758589|54659306|FG001|Overall Study|Adverse Event|2|||
28000434|NCT00758589|54659307|FG002|Overall Study|Adverse Event|5|||
28000435|NCT00758589|54659308|FG003|Overall Study|Adverse Event|4|||
28000436|NCT00758589|54659305|FG000|Overall Study|Withdrawal by Subject|0|||
28000437|NCT00758589|54659306|FG001|Overall Study|Withdrawal by Subject|1|||
28000438|NCT00758589|54659307|FG002|Overall Study|Withdrawal by Subject|1|||
28000439|NCT00758589|54659308|FG003|Overall Study|Withdrawal by Subject|1|||
28000440|NCT00758589|54659305|FG000|Overall Study|Palm stopped to work|0|||
28000441|NCT00758589|54659306|FG001|Overall Study|Palm stopped to work|0|||
28000442|NCT00758589|54659307|FG002|Overall Study|Palm stopped to work|0|||
28000443|NCT00758589|54659308|FG003|Overall Study|Palm stopped to work|1|||
28000444|NCT00833417|54659320|FG000|Overall Study|Adverse Event|5|||
28000445|NCT00833417|54659321|FG001|Overall Study|Adverse Event|16|||
27914468|NCT01124422|54572149|FG002|4-Week Open-label Run-in Phase|Adverse Event|0|||
27914469|NCT01124422|54572147|FG000|4-Week Open-label Run-in Phase|Physician Decision|4|||
27914470|NCT01124422|54572148|FG001|4-Week Open-label Run-in Phase|Physician Decision|0|||
27914471|NCT01124422|54572149|FG002|4-Week Open-label Run-in Phase|Physician Decision|0|||
28000446|NCT00833417|54659320|FG000|Overall Study|Death|1|||
28000447|NCT00833417|54659321|FG001|Overall Study|Death|3|||
28000448|NCT00833417|54659320|FG000|Overall Study|Lost to Follow-up|1|||
28000449|NCT00833417|54659321|FG001|Overall Study|Lost to Follow-up|2|||
28000450|NCT00833417|54659320|FG000|Overall Study|Physician Decision to Withdraw Patient|3|||
28000451|NCT00833417|54659321|FG001|Overall Study|Physician Decision to Withdraw Patient|7|||
28000452|NCT00833417|54659320|FG000|Overall Study|Patient Decision to Withdraw|4|||
28000453|NCT00833417|54659321|FG001|Overall Study|Patient Decision to Withdraw|23|||
28000454|NCT00833417|54659320|FG000|Overall Study|Sponsor Decision to Terminate Study|1|||
28000455|NCT00833417|54659321|FG001|Overall Study|Sponsor Decision to Terminate Study|2|||
28000456|NCT00833417|54659320|FG000|Overall Study|Disease Progression|18|||
28000457|NCT00833417|54659321|FG001|Overall Study|Disease Progression|17|||
28000458|NCT00833417|54659320|FG000|Overall Study|Reason Not Specified|0|||
28000459|NCT00833417|54659321|FG001|Overall Study|Reason Not Specified|1|||
28000460|NCT00762372|54659331|FG000|Overall Study|Adverse Event|1|||
28000461|NCT00762372|54659332|FG001|Overall Study|Adverse Event|0|||
28000462|NCT00762372|54659333|FG002|Overall Study|Adverse Event|0|||
28000463|NCT00833261|54659347|FG000|Overall Study|Withdrawal by Subject|4|||
28000464|NCT00833105|54659351|FG000|Overall Study|Withdrawal by Subject|1|||
28000465|NCT00833105|54659351|FG000|Overall Study|Adverse Event|2|||
28000466|NCT00833027|54659357|FG000|Overall Study|Adverse Event|33|||
28000467|NCT00833027|54659357|FG000|Overall Study|Death|1|||
28000468|NCT00833027|54659357|FG000|Overall Study|Lack of Efficacy|12|||
28000469|NCT00833027|54659357|FG000|Overall Study|Lost to Follow-up|24|||
28000470|NCT00833027|54659357|FG000|Overall Study|Protocol Violation|115|||
28000471|NCT00833027|54659357|FG000|Overall Study|Withdrawal by Subject|16|||
27914472|NCT01124422|54572147|FG000|4-Week Open-label Run-in Phase|Lost to Follow-up|1|||
27914473|NCT01124422|54572148|FG001|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
27914474|NCT01124422|54572149|FG002|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
27914475|NCT01124422|54572147|FG000|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61|||
27914476|NCT01124422|54572148|FG001|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
27914477|NCT01124422|54572149|FG002|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
27914478|NCT01124422|54572147|FG000|4-Week Open-label Run-in Phase|Protocol Violation|5|||
27914479|NCT01124422|54572148|FG001|4-Week Open-label Run-in Phase|Protocol Violation|0|||
27914480|NCT01124422|54572149|FG002|4-Week Open-label Run-in Phase|Protocol Violation|0|||
27914481|NCT01124422|54572147|FG000|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
27914482|NCT01124422|54572148|FG001|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
27914483|NCT01124422|54572149|FG002|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3|||
27914484|NCT01124422|54572147|FG000|4-Week Double-blind Treatment Phase|Adverse Event|0|||
28000472|NCT00833027|54659357|FG000|Overall Study|Missing|10|||
28000473|NCT00752622|54659361|FG000|Induction Phase|Adverse Event|3|||
28000474|NCT00752622|54659361|FG000|Induction Phase|Other|3|||
28000475|NCT00752622|54659361|FG000|Induction Phase|Non-responder|14|||
28000476|NCT00752622|54659361|FG000|Induction Phase|Withdrawal by Subject|1|||
28000477|NCT00752622|54659361|FG000|Induction Phase|Premature study termination|14|||
28000478|NCT00752622|54659361|FG000|Observational Phase|Premature Study Termination|36|||
28000479|NCT00752622|54659361|FG000|Observational Phase|Non-responder|2|||
28000480|NCT00752622|54659361|FG000|Observational Phase|Withdrawal by Subject|2|||
28000481|NCT00752622|54659361|FG000|Observational Phase|Adverse Event|1|||
28000482|NCT00752622|54659361|FG000|Observational Phase|Other|2|||
28000483|NCT00752622|54659361|FG000|Interventional Phase|Non-responder|2|||
28000484|NCT00752622|54659361|FG000|Interventional Phase|Physician Decision|1|||
28000485|NCT00752622|54659361|FG000|Interventional Phase|Premature Study Termination|5|||
28000486|NCT00754650|54659366|FG000|Overall Study|Disease Progression|2|||
28000487|NCT00761748|54659370|FG000|First Intervention (21 +/- 3 Days)|Adverse Event|3|||
28000488|NCT00761748|54659371|FG001|First Intervention (21 +/- 3 Days)|Adverse Event|0|||
28000489|NCT00761748|54659370|FG000|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0|||
28000490|NCT00761748|54659371|FG001|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3|||
28000491|NCT00825305|54659379|FG000|Overall Study|Adverse Event|1|||
28000492|NCT00825305|54659380|FG001|Overall Study|Adverse Event|1|||
28000493|NCT00825305|54659379|FG000|Overall Study|Withdrawal by Subject|6|||
28000494|NCT00825305|54659380|FG001|Overall Study|Withdrawal by Subject|12|||
28000495|NCT00825305|54659379|FG000|Overall Study|Inappropriate inclusion|1|||
28000496|NCT00825305|54659380|FG001|Overall Study|Inappropriate inclusion|0|||
28000497|NCT00825305|54659379|FG000|Overall Study|Protocol Violation|9|||
28000498|NCT00825305|54659380|FG001|Overall Study|Protocol Violation|9|||
28000499|NCT00825305|54659379|FG000|Overall Study|Can not be classified|0|||
28000500|NCT00825305|54659380|FG001|Overall Study|Can not be classified|1|||
28000501|NCT00754572|54659386|FG000|Overall Study|Adverse Event|19|||
28000502|NCT00754572|54659386|FG000|Overall Study|Other|39|||
28000503|NCT00754572|54659386|FG000|Overall Study|Protocol Violation|3|||
28000504|NCT00754572|54659386|FG000|Overall Study|Withdrawal by Subject|3|||
28000505|NCT00754572|54659386|FG000|Overall Study|Lack of Efficacy|2|||
28000506|NCT00754572|54659386|FG000|Overall Study|Death|1|||
28099759|NCT03502070|54756068|FG000|Overall Study|Screen Failure|1|||
28000507|NCT00754572|54659386|FG000|Overall Study|Administrative Reason|3|||
28000508|NCT00754572|54659386|FG000|Overall Study|Lost to Follow-up|1|||
28000509|NCT00824993|54659392|FG000|Overall Study|Withdrawal by Subject|1|||
28000510|NCT00824993|54659393|FG001|Overall Study|Withdrawal by Subject|1|||
28000511|NCT00824993|54659392|FG000|Overall Study|Malignancy Relapse|9|||
28000512|NCT00824993|54659393|FG001|Overall Study|Malignancy Relapse|10|||
28000513|NCT00824993|54659392|FG000|Overall Study|Rapid Bone Loss|0|||
28000514|NCT00824993|54659393|FG001|Overall Study|Rapid Bone Loss|1|||
28000515|NCT00824993|54659392|FG000|Overall Study|Non-Compliant|2|||
27914485|NCT01124422|54572148|FG001|4-Week Double-blind Treatment Phase|Adverse Event|6|||
27914486|NCT01124422|54572149|FG002|4-Week Double-blind Treatment Phase|Adverse Event|3|||
27914487|NCT01124422|54572147|FG000|4-Week Double-blind Treatment Phase|Physician Decision|0|||
28000516|NCT00824993|54659393|FG001|Overall Study|Non-Compliant|1|||
28000517|NCT00824993|54659392|FG000|Overall Study|Insurance Issue|2|||
28000518|NCT00824993|54659393|FG001|Overall Study|Insurance Issue|1|||
28000519|NCT00824993|54659392|FG000|Overall Study|Death|0|||
28000520|NCT00824993|54659393|FG001|Overall Study|Death|3|||
28000521|NCT00832091|54659401|FG000|Overall Study|Adverse Event|1|||
28000522|NCT00832091|54659402|FG001|Overall Study|Adverse Event|1|||
28000523|NCT00832091|54659401|FG000|Overall Study|Protocol Violation|1|||
28000524|NCT00832091|54659402|FG001|Overall Study|Protocol Violation|0|||
28000525|NCT00832091|54659401|FG000|Overall Study|Withdrawal by Subject|2|||
28000526|NCT00832091|54659402|FG001|Overall Study|Withdrawal by Subject|1|||
28000527|NCT00832091|54659401|FG000|Overall Study|Prohibited Medication|1|||
28000528|NCT00832091|54659402|FG001|Overall Study|Prohibited Medication|0|||
28000529|NCT00754338|54659412|FG000|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
28000530|NCT00754338|54659413|FG001|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
28000531|NCT00754338|54659414|FG002|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
28000532|NCT00754338|54659415|FG003|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
28000533|NCT00754338|54659412|FG000|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
28000534|NCT00754338|54659413|FG001|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
28000535|NCT00754338|54659414|FG002|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
28000536|NCT00754338|54659415|FG003|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
28000537|NCT00761514|54659427|FG000|Overall Study|Adverse Event|1|||
28000538|NCT00761514|54659427|FG000|Overall Study|Withdrawal by Subject|2|||
28000539|NCT00761514|54659427|FG000|Overall Study|Lost to Follow-up|1|||
28000540|NCT00761514|54659427|FG000|Overall Study|Health insurance didn't cover study drug|1|||
28000541|NCT00761514|54659427|FG000|Overall Study|Problem complying with study visit|1|||
28000542|NCT00761514|54659427|FG000|Overall Study|Unable to pay for medications|1|||
28000543|NCT00831779|54659433|FG000|Overall Study|Lost to Follow-up|1|||
28000544|NCT00831779|54659434|FG001|Overall Study|Lost to Follow-up|0|||
28000545|NCT00831779|54659433|FG000|Overall Study|No longer met criteria|0|||
28000546|NCT00831779|54659434|FG001|Overall Study|No longer met criteria|1|||
28000547|NCT00758043|54659444|FG000|Overall Study|Adverse Event|1|||
28000548|NCT00758043|54659445|FG001|Overall Study|Adverse Event|20|||
28000549|NCT00758043|54659446|FG002|Overall Study|Adverse Event|12|||
28099760|NCT03586830|54756076|FG000|Overall Study|Site terminated by Sponsor|1|||
28099761|NCT03586830|54756077|FG001|Overall Study|Site terminated by Sponsor|4|||
28099762|NCT03586830|54756078|FG002|Overall Study|Site terminated by Sponsor|3|||
28099763|NCT03586830|54756079|FG003|Overall Study|Site terminated by Sponsor|3|||
28099764|NCT03586830|54756076|FG000|Overall Study|Lost to Follow-up|0|||
27914488|NCT01124422|54572148|FG001|4-Week Double-blind Treatment Phase|Physician Decision|5|||
27914489|NCT01124422|54572149|FG002|4-Week Double-blind Treatment Phase|Physician Decision|2|||
28099765|NCT03586830|54756077|FG001|Overall Study|Lost to Follow-up|2|||
28099766|NCT03586830|54756078|FG002|Overall Study|Lost to Follow-up|2|||
28099767|NCT03586830|54756079|FG003|Overall Study|Lost to Follow-up|1|||
28099768|NCT03586830|54756076|FG000|Overall Study|Withdrawal by Subject|1|||
28099769|NCT03586830|54756077|FG001|Overall Study|Withdrawal by Subject|0|||
28099770|NCT03586830|54756078|FG002|Overall Study|Withdrawal by Subject|3|||
28099771|NCT03586830|54756079|FG003|Overall Study|Withdrawal by Subject|1|||
28099772|NCT03026530|54756091|FG000|Overall Study|Lost to Follow-up|19|||
28099773|NCT03026530|54756092|FG001|Overall Study|Lost to Follow-up|24|||
28099774|NCT03026530|54756091|FG000|Overall Study|Protocol Violation|2|||
28099775|NCT03026530|54756092|FG001|Overall Study|Protocol Violation|5|||
28099776|NCT03418376|54756102|FG000|Overall Study|Musculoskeletal injury|1|||
28099777|NCT03418376|54756103|FG001|Overall Study|Musculoskeletal injury|2|||
28099778|NCT03418376|54756104|FG002|Overall Study|Musculoskeletal injury|1|||
28099779|NCT03418376|54756105|FG003|Overall Study|Musculoskeletal injury|0|||
27914490|NCT01124422|54572147|FG000|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
27914491|NCT01124422|54572148|FG001|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
27914492|NCT01124422|54572149|FG002|4-Week Double-blind Treatment Phase|Lost to Follow-up|1|||
28000550|NCT00758043|54659447|FG003|Overall Study|Adverse Event|62|||
28000551|NCT00758043|54659444|FG000|Overall Study|Lack of Efficacy|0|||
28000552|NCT00758043|54659445|FG001|Overall Study|Lack of Efficacy|6|||
28099780|NCT03418376|54756102|FG000|Overall Study|Personal reasons|0|||
28099781|NCT03418376|54756103|FG001|Overall Study|Personal reasons|2|||
28000553|NCT00758043|54659446|FG002|Overall Study|Lack of Efficacy|18|||
28000554|NCT00758043|54659447|FG003|Overall Study|Lack of Efficacy|12|||
28000555|NCT00758043|54659444|FG000|Overall Study|Refused Further Treatment|0|||
28099782|NCT03418376|54756104|FG002|Overall Study|Personal reasons|2|||
28099783|NCT03418376|54756105|FG003|Overall Study|Personal reasons|1|||
28000556|NCT00758043|54659445|FG001|Overall Study|Refused Further Treatment|11|||
28000557|NCT00758043|54659446|FG002|Overall Study|Refused Further Treatment|5|||
28000558|NCT00758043|54659447|FG003|Overall Study|Refused Further Treatment|8|||
28000559|NCT00758043|54659444|FG000|Overall Study|Lost to Follow-up|0|||
28000560|NCT00758043|54659445|FG001|Overall Study|Lost to Follow-up|2|||
28000561|NCT00758043|54659446|FG002|Overall Study|Lost to Follow-up|2|||
28000562|NCT00758043|54659447|FG003|Overall Study|Lost to Follow-up|5|||
28000563|NCT00758043|54659444|FG000|Overall Study|Withdrawal by Subject|0|||
28000564|NCT00758043|54659445|FG001|Overall Study|Withdrawal by Subject|1|||
28000565|NCT00758043|54659446|FG002|Overall Study|Withdrawal by Subject|1|||
28000566|NCT00758043|54659447|FG003|Overall Study|Withdrawal by Subject|4|||
28000567|NCT00758043|54659444|FG000|Overall Study|Required Prohibited Medication|0|||
28000568|NCT00758043|54659445|FG001|Overall Study|Required Prohibited Medication|0|||
28000569|NCT00758043|54659446|FG002|Overall Study|Required Prohibited Medication|1|||
28099784|NCT03418376|54756102|FG000|Overall Study|Exacerbation|0|||
28099785|NCT03418376|54756103|FG001|Overall Study|Exacerbation|1|||
28099786|NCT03418376|54756104|FG002|Overall Study|Exacerbation|0|||
28099787|NCT03418376|54756105|FG003|Overall Study|Exacerbation|0|||
28099788|NCT03585504|54756117|FG000|Overall Study|Lost to Follow-up|26|||
28099789|NCT03585504|54756118|FG001|Overall Study|Lost to Follow-up|29|||
28099790|NCT03417830|54756126|FG000|Part A (up to 26 Days)|Study Closed/Terminated|1|||
28099791|NCT03417830|54756127|FG001|Part A (up to 26 Days)|Study Closed/Terminated|0|||
28099792|NCT03576768|54756138|FG000|Overall Study|Lost to Follow-up|3|||
28099793|NCT03576768|54756139|FG001|Overall Study|Lost to Follow-up|3|||
28099794|NCT03576768|54756140|FG002|Overall Study|Lost to Follow-up|0|||
28099795|NCT03576768|54756141|FG003|Overall Study|Lost to Follow-up|0|||
28099796|NCT03576066|54756153|FG000|Overall Study|Noncompliance with study drug|0|||
28099797|NCT03576066|54756154|FG001|Overall Study|Noncompliance with study drug|1|||
28099798|NCT03557034|54756166|FG000|Overall Study|Withdrawal by Subject|1|||
28099799|NCT03557034|54756167|FG001|Overall Study|Withdrawal by Subject|0|||
28099800|NCT03583554|54756173|FG000|Period 2|Did not receive treatment due to loss of contact|1|||
28099801|NCT03583554|54756174|FG001|Period 2|Did not receive treatment due to loss of contact|0|||
28099802|NCT03583554|54756175|FG002|Period 2|Did not receive treatment due to loss of contact|1|||
28099803|NCT03948178|54756186|FG000|Overall Study|Protocol Violation|1|||
28099804|NCT03948178|54756186|FG000|Overall Study|Lost to Follow-up|2|||
28099805|NCT03948178|54756186|FG000|Overall Study|Withdrawal by Subject|2|||
28099806|NCT03948178|54756186|FG000|Overall Study|Reason not known|2|||
28099807|NCT03948178|54756186|FG000|Overall Study|Personal reason|14|||
28099808|NCT03948178|54756186|FG000|Overall Study|Disease progression|30|||
28099809|NCT03948178|54756186|FG000|Overall Study|Adverse Event|12|||
28099810|NCT03948178|54756186|FG000|Overall Study|Sponsor terminated study|164|||
28099811|NCT03520920|54756193|FG000|Overall Study|Death|13|||
28099812|NCT03520920|54756194|FG001|Overall Study|Death|1|||
28099813|NCT03520920|54756195|FG002|Overall Study|Death|0|||
28099814|NCT03520920|54756193|FG000|Overall Study|Withdrawal by Subject|2|||
28099815|NCT03520920|54756194|FG001|Overall Study|Withdrawal by Subject|1|||
28099816|NCT03520920|54756195|FG002|Overall Study|Withdrawal by Subject|0|||
28099817|NCT03520920|54756193|FG000|Overall Study|Study Terminated by the Sponsor|5|||
28099818|NCT03520920|54756194|FG001|Overall Study|Study Terminated by the Sponsor|14|||
28099819|NCT03520920|54756195|FG002|Overall Study|Study Terminated by the Sponsor|5|||
28099820|NCT02953340|54756211|FG000|Overall Study|Death|0|||
28099821|NCT02953340|54756212|FG001|Overall Study|Death|1|||
28099822|NCT02953340|54756211|FG000|Overall Study|Investigator Decision|3|||
28099823|NCT02953340|54756212|FG001|Overall Study|Investigator Decision|3|||
27739825|NCT02219464|54189547|FG001|Overall Study|case cancelled|0|||
27739826|NCT02219464|54189546|FG000|Overall Study|catheter malfunction|1|||
27914493|NCT01124149|54572156|FG000|Acute Phase|Withdrawal by Subject|22|||
27914494|NCT01124149|54572156|FG000|Acute Phase|Adverse Event|21|||
27914495|NCT01124149|54572156|FG000|Acute Phase|Lack of Efficacy|17|||
27914496|NCT01124149|54572156|FG000|Acute Phase|Protocol Violation|14|||
27914497|NCT01124149|54572156|FG000|Acute Phase|Lost to Follow-up|2|||
27914498|NCT01124149|54572156|FG000|Acute Phase|Prolonged antibiotic therapy|1|||
27914499|NCT01124149|54572156|FG000|Acute Phase|Sponsor request|1|||
27914500|NCT01124149|54572156|FG000|Acute Phase|UC symptoms not ameliorated|1|||
27914501|NCT01124149|54572156|FG000|Acute Phase|Non-compliance|1|||
28000570|NCT00758043|54659447|FG003|Overall Study|Required Prohibited Medication|3|||
28000571|NCT00758043|54659444|FG000|Overall Study|Non-Compliant With study Drug|0|||
28099824|NCT02953340|54756211|FG000|Overall Study|Initiated Non-Protocol Therapy|5|||
28099825|NCT02953340|54756212|FG001|Overall Study|Initiated Non-Protocol Therapy|14|||
28099826|NCT02953340|54756211|FG000|Overall Study|Myeloid Growth Factors Treatment|0|||
28099827|NCT02953340|54756212|FG001|Overall Study|Myeloid Growth Factors Treatment|1|||
28099828|NCT02953340|54756211|FG000|Overall Study|Withdrawal by Subject|9|||
28099829|NCT02953340|54756212|FG001|Overall Study|Withdrawal by Subject|9|||
28099830|NCT02953340|54756211|FG000|Overall Study|Sponsor decision|0|||
28099831|NCT02953340|54756212|FG001|Overall Study|Sponsor decision|2|||
27914502|NCT01124149|54572156|FG000|Acute Phase|Low hemoglobin|1|||
28099832|NCT02953340|54756211|FG000|Overall Study|Lost to Follow-up|3|||
28000572|NCT00758043|54659445|FG001|Overall Study|Non-Compliant With study Drug|0|||
28000573|NCT00758043|54659446|FG002|Overall Study|Non-Compliant With study Drug|0|||
28000574|NCT00758043|54659447|FG003|Overall Study|Non-Compliant With study Drug|1|||
28000575|NCT00758043|54659444|FG000|Overall Study|Other Reasons|0|||
28000576|NCT00758043|54659445|FG001|Overall Study|Other Reasons|1|||
28000577|NCT00758043|54659446|FG002|Overall Study|Other Reasons|0|||
28000578|NCT00758043|54659447|FG003|Overall Study|Other Reasons|5|||
28000579|NCT00831701|54659465|FG000|Overall Study|Withdrawal by Subject|2|||
28000580|NCT00831701|54659466|FG001|Overall Study|Withdrawal by Subject|0|||
28000581|NCT00831701|54659465|FG000|Overall Study|Stone expulsion before first medication|2|||
28000582|NCT00831701|54659466|FG001|Overall Study|Stone expulsion before first medication|2|||
28000583|NCT00831701|54659465|FG000|Overall Study|Lost to Follow-up|1|||
28000584|NCT00831701|54659466|FG001|Overall Study|Lost to Follow-up|3|||
28000585|NCT00752895|54659474|FG000|Overall Study|Withdrawal by Subject|8|||
28000586|NCT00752895|54659475|FG001|Overall Study|Withdrawal by Subject|3|||
28000587|NCT00831389|54659483|FG000|Overall Study|Withdrawal by Subject|0|||
28000588|NCT00831389|54659484|FG001|Overall Study|Withdrawal by Subject|1|||
28000589|NCT00831311|54659492|FG000|Overall Study|Definitive Contraindication|3|||
28000590|NCT00831311|54659493|FG001|Overall Study|Definitive Contraindication|3|||
28000591|NCT00831311|54659492|FG000|Overall Study|Lost to Follow-up|3|||
28000592|NCT00831311|54659493|FG001|Overall Study|Lost to Follow-up|0|||
28000593|NCT00831311|54659492|FG000|Overall Study|Physician Decision|0|||
28000594|NCT00831311|54659493|FG001|Overall Study|Physician Decision|1|||
28000595|NCT00831311|54659492|FG000|Overall Study|Withdrawal by Subject|6|||
28000596|NCT00831311|54659493|FG001|Overall Study|Withdrawal by Subject|4|||
28000597|NCT00831233|54659502|FG000|Overall Study|Adverse Event|0|||
28000598|NCT00831233|54659503|FG001|Overall Study|Adverse Event|1|||
28000599|NCT00831233|54659502|FG000|Overall Study|Protocol Violation|1|||
28000600|NCT00831233|54659503|FG001|Overall Study|Protocol Violation|0|||
28000601|NCT00831233|54659502|FG000|Overall Study|Selection Criteria Not Met|2|||
28000602|NCT00831233|54659503|FG001|Overall Study|Selection Criteria Not Met|0|||
28000603|NCT00761280|54659520|FG000|Randomization to First Dose|Withdrawal by Subject|0|||
28000604|NCT00761280|54659521|FG001|Randomization to First Dose|Withdrawal by Subject|2|||
28000605|NCT00761280|54659520|FG000|Randomization to First Dose|Sponsor decision|1|||
28000606|NCT00761280|54659521|FG001|Randomization to First Dose|Sponsor decision|0|||
28000607|NCT00761280|54659520|FG000|Randomization to First Dose|Other|1|||
28000608|NCT00761280|54659521|FG001|Randomization to First Dose|Other|0|||
28000609|NCT00761280|54659520|FG000|First Dose to End of Study|End of trial|5|||
28000610|NCT00761280|54659521|FG001|First Dose to End of Study|End of trial|5|||
28000611|NCT00761280|54659520|FG000|First Dose to End of Study|Progressive disease|5|||
28000612|NCT00761280|54659521|FG001|First Dose to End of Study|Progressive disease|3|||
28099833|NCT02953340|54756212|FG001|Overall Study|Lost to Follow-up|2|||
28099834|NCT02953340|54756211|FG000|Overall Study|Reason not specified|2|||
28099835|NCT02953340|54756212|FG001|Overall Study|Reason not specified|2|||
28099836|NCT03554772|54756228|FG000|Overall Study|Lost to Follow-up|0|||
28099837|NCT03554772|54756229|FG001|Overall Study|Lost to Follow-up|0|||
28099838|NCT03554772|54756230|FG002|Overall Study|Lost to Follow-up|0|||
28099839|NCT03554772|54756231|FG003|Overall Study|Lost to Follow-up|2|||
28099840|NCT03573804|54756241|FG000|Overall Study|claustrophobia or MRI table problems|10|||
28099841|NCT03417440|54756259|FG000|Overall Study|Lost to Follow-up|0|||
28099842|NCT03417440|54756260|FG001|Overall Study|Lost to Follow-up|1|||
28099843|NCT03417440|54756261|FG002|Overall Study|Lost to Follow-up|0|||
28099844|NCT03417440|54756262|FG003|Overall Study|Lost to Follow-up|0|||
28099845|NCT03417440|54756263|FG004|Overall Study|Lost to Follow-up|1|||
28172708|NCT02634788|54844428|FG000|Overall Study|Withdrawal by Subject|0|||
27914503|NCT01124149|54572156|FG000|Acute Phase|Travelling to another country|1|||
27914504|NCT01124149|54572156|FG000|Acute Phase|Sponsor decision|1|||
27914505|NCT01124149|54572156|FG000|Maintenance Phase|Lack of Efficacy|40|||
27914506|NCT01124149|54572156|FG000|Maintenance Phase|Adverse Event|24|||
27914507|NCT01124149|54572156|FG000|Maintenance Phase|Lost to Follow-up|15|||
27914508|NCT01124149|54572156|FG000|Maintenance Phase|Withdrawal by Subject|10|||
27914509|NCT01124149|54572156|FG000|Maintenance Phase|Protocol Violation|5|||
27914510|NCT01124149|54572156|FG000|Maintenance Phase|Coordinator error|1|||
27914511|NCT01124149|54572156|FG000|Maintenance Phase|Non-compliance|1|||
28000613|NCT00761280|54659520|FG000|First Dose to End of Study|Sponsor decision|1|||
28000614|NCT00761280|54659521|FG001|First Dose to End of Study|Sponsor decision|2|||
28000615|NCT00761280|54659520|FG000|First Dose to End of Study|Death|1|||
28000616|NCT00761280|54659521|FG001|First Dose to End of Study|Death|0|||
28000617|NCT00761280|54659520|FG000|First Dose to End of Study|Lost to Follow-up|0|||
28000618|NCT00761280|54659521|FG001|First Dose to End of Study|Lost to Follow-up|1|||
28000619|NCT00824369|54659533|FG000|Overall Study|Nolonger willing to participate in study|1|||
28000620|NCT00824369|54659534|FG001|Overall Study|Nolonger willing to participate in study|0|||
28000621|NCT00824369|54659535|FG002|Overall Study|Nolonger willing to participate in study|1|||
28000622|NCT00824369|54659536|FG003|Overall Study|Nolonger willing to participate in study|2|||
27914512|NCT01123642|54572163|FG000|Overall Study|Lost to Follow-up|23|||
28172709|NCT02634788|54844429|FG001|Overall Study|Withdrawal by Subject|1|||
27914513|NCT01123642|54572163|FG000|Overall Study|Withdrawal by Subject|9|||
27914514|NCT01123642|54572163|FG000|Overall Study|ineligible at baseline assessment|36|||
28000623|NCT00824369|54659537|FG004|Overall Study|Nolonger willing to participate in study|0|||
28000624|NCT00824369|54659538|FG005|Overall Study|Nolonger willing to participate in study|1|||
28000625|NCT00824369|54659533|FG000|Overall Study|Lost to Follow-up|0|||
27914515|NCT01122862|54572168|FG000|Period 1|Protocol Violation|0|||
27914516|NCT01122862|54572169|FG001|Period 1|Protocol Violation|1|||
27914517|NCT01122862|54572170|FG002|Period 1|Protocol Violation|0|||
27914518|NCT01122862|54572168|FG000|Period 2|Adverse Event|0|||
27914519|NCT01122862|54572169|FG001|Period 2|Adverse Event|0|||
27914520|NCT01122862|54572170|FG002|Period 2|Adverse Event|1|||
27914521|NCT01122394|54572181|FG000|Overall Study|Withdrawal by Subject|1|||
27914522|NCT01122394|54572182|FG001|Overall Study|Withdrawal by Subject|1|||
27914523|NCT01122394|54572181|FG000|Overall Study|Lost to Follow-up|2|||
27914524|NCT01122394|54572182|FG001|Overall Study|Lost to Follow-up|2|||
27914525|NCT01122394|54572181|FG000|Overall Study|Adverse Event|0|||
27914526|NCT01122394|54572182|FG001|Overall Study|Adverse Event|1|||
27914527|NCT01121926|54572190|FG000|First Intervention Period|Adverse Event|1|||
27914528|NCT01121926|54572191|FG001|First Intervention Period|Adverse Event|0|||
27914529|NCT01121926|54572190|FG000|Washout Period|Adverse Event|0|||
27914530|NCT01121926|54572191|FG001|Washout Period|Adverse Event|1|||
27914531|NCT01121926|54572190|FG000|Washout Period|Positive pregnancy test|0|||
27914532|NCT01121926|54572191|FG001|Washout Period|Positive pregnancy test|1|||
27914533|NCT01121575|54572203|FG000|Overall Study|Participant Refused Further Follow-Up|0|||
27914534|NCT01121575|54572204|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
27914535|NCT01121575|54572205|FG002|Overall Study|Participant Refused Further Follow-Up|0|||
27914536|NCT01121575|54572206|FG003|Overall Study|Participant Refused Further Follow-Up|0|||
27914537|NCT01121575|54572207|FG004|Overall Study|Participant Refused Further Follow-Up|5|||
27914538|NCT01121575|54572208|FG005|Overall Study|Participant Refused Further Follow-Up|1|||
28000626|NCT00824369|54659534|FG001|Overall Study|Lost to Follow-up|0|||
28000627|NCT00824369|54659535|FG002|Overall Study|Lost to Follow-up|0|||
28000628|NCT00824369|54659536|FG003|Overall Study|Lost to Follow-up|0|||
28000629|NCT00824369|54659537|FG004|Overall Study|Lost to Follow-up|1|||
27914539|NCT01121575|54572203|FG000|Overall Study|Unspecified Reasons|8|||
27914540|NCT01121575|54572204|FG001|Overall Study|Unspecified Reasons|6|||
27914541|NCT01121575|54572205|FG002|Overall Study|Unspecified Reasons|7|||
27914542|NCT01121575|54572206|FG003|Overall Study|Unspecified Reasons|5|||
28000630|NCT00824369|54659538|FG005|Overall Study|Lost to Follow-up|0|||
28000631|NCT00824291|54659554|FG000|Overall Study|Adverse Event|15|||
28000632|NCT00824291|54659555|FG001|Overall Study|Adverse Event|6|||
28000633|NCT00824291|54659554|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
28000634|NCT00824291|54659555|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
28000635|NCT00824291|54659554|FG000|Overall Study|Lost to Follow-up|11|||
28000636|NCT00824291|54659555|FG001|Overall Study|Lost to Follow-up|9|||
28000637|NCT00824291|54659554|FG000|Overall Study|Non-compliance|1|||
28000638|NCT00824291|54659555|FG001|Overall Study|Non-compliance|1|||
28000639|NCT00824291|54659554|FG000|Overall Study|Protocol Violation|4|||
28000640|NCT00824291|54659555|FG001|Overall Study|Protocol Violation|1|||
28000641|NCT00824291|54659554|FG000|Overall Study|Withdrawal by Subject|14|||
28000642|NCT00824291|54659555|FG001|Overall Study|Withdrawal by Subject|8|||
28000643|NCT00824291|54659554|FG000|Overall Study|Lack of Efficacy|7|||
28000644|NCT00824291|54659555|FG001|Overall Study|Lack of Efficacy|8|||
28099846|NCT03417440|54756264|FG005|Overall Study|Lost to Follow-up|0|||
28099847|NCT03417440|54756265|FG006|Overall Study|Lost to Follow-up|0|||
28099848|NCT03417440|54756266|FG007|Overall Study|Lost to Follow-up|0|||
27914543|NCT01121575|54572207|FG004|Overall Study|Unspecified Reasons|13|||
28000645|NCT00824291|54659554|FG000|Overall Study|Participant on prohibited medication|1|||
28099849|NCT03417440|54756259|FG000|Overall Study|Withdrawal by Subject|2|||
28099850|NCT03417440|54756260|FG001|Overall Study|Withdrawal by Subject|0|||
28099851|NCT03417440|54756261|FG002|Overall Study|Withdrawal by Subject|2|||
28099852|NCT03417440|54756262|FG003|Overall Study|Withdrawal by Subject|1|||
28099853|NCT03417440|54756263|FG004|Overall Study|Withdrawal by Subject|1|||
28099854|NCT03417440|54756264|FG005|Overall Study|Withdrawal by Subject|0|||
28099855|NCT03417440|54756265|FG006|Overall Study|Withdrawal by Subject|0|||
28099856|NCT03417440|54756266|FG007|Overall Study|Withdrawal by Subject|1|||
28099857|NCT03458702|54756289|FG000|Study Condition A (Yoga or Rest)|Lost to Follow-up|4|||
27914544|NCT01121575|54572208|FG005|Overall Study|Unspecified Reasons|10|||
27914545|NCT01121575|54572203|FG000|Overall Study|Death|6|||
28000646|NCT00824291|54659555|FG001|Overall Study|Participant on prohibited medication|0|||
28000647|NCT00804986|54659567|FG000|Overall Study|Adverse Event|0|||
28000648|NCT00804986|54659568|FG001|Overall Study|Adverse Event|1|||
28000649|NCT00804986|54659569|FG002|Overall Study|Adverse Event|2|||
27914546|NCT01121575|54572204|FG001|Overall Study|Death|0|||
27914547|NCT01121575|54572205|FG002|Overall Study|Death|0|||
27914548|NCT01121575|54572206|FG003|Overall Study|Death|1|||
27914549|NCT01121575|54572207|FG004|Overall Study|Death|7|||
28000650|NCT00804986|54659570|FG003|Overall Study|Adverse Event|1|||
27914550|NCT01121575|54572208|FG005|Overall Study|Death|1|||
27914551|NCT01121536|54572231|FG000|Overall Study|Adverse Event|63|||
27914552|NCT01121536|54572231|FG000|Overall Study|Lack of Efficacy|35|||
27914553|NCT01121536|54572231|FG000|Overall Study|Withdrawal by Subject|65|||
27914554|NCT01121536|54572231|FG000|Overall Study|Protocol Violation|20|||
27914555|NCT01121536|54572231|FG000|Overall Study|Noncompliance with study medication|12|||
27914556|NCT01121536|54572231|FG000|Overall Study|Noncompliance with study procedures|9|||
27914557|NCT01121536|54572231|FG000|Overall Study|Lost to Follow-up|39|||
27914558|NCT01121536|54572231|FG000|Overall Study|Other|118|||
27914559|NCT01121263|54572237|FG000|Overall Study|Death|3|||
27914560|NCT01121263|54572238|FG001|Overall Study|Death|2|||
27914561|NCT01121263|54572237|FG000|Overall Study|Lost to Follow-up|22|||
27914562|NCT01121263|54572238|FG001|Overall Study|Lost to Follow-up|12|||
27914563|NCT01121263|54572237|FG000|Overall Study|Withdrawal by Subject|0|||
27914564|NCT01121263|54572238|FG001|Overall Study|Withdrawal by Subject|1|||
27914565|NCT01121185|54572248|FG000|Overall Study|Not infused|0|||
27914566|NCT01121185|54572249|FG001|Overall Study|Not infused|1|||
27914567|NCT01121185|54572248|FG000|Overall Study|Not transplanted|1|||
27914568|NCT01121185|54572249|FG001|Overall Study|Not transplanted|0|||
27914569|NCT01121146|54572257|FG000|Overall Study|Death|17|||
27914570|NCT01121146|54572258|FG001|Overall Study|Death|15|||
27914571|NCT01121146|54572257|FG000|Overall Study|Adverse Event|2|||
27914572|NCT01121146|54572258|FG001|Overall Study|Adverse Event|11|||
27914573|NCT01121146|54572257|FG000|Overall Study|Lost to Follow-up|7|||
27914574|NCT01121146|54572258|FG001|Overall Study|Lost to Follow-up|16|||
27914575|NCT01120756|54572267|FG000|Overall Study|Withdrawal by Subject|1|||
27914576|NCT01120756|54572268|FG001|Overall Study|Withdrawal by Subject|1|||
27914577|NCT01120717|54572276|FG000|Overall Study|Withdrawal by Subject|11|||
27914578|NCT01120717|54572277|FG001|Overall Study|Withdrawal by Subject|6|||
27914579|NCT01120717|54572276|FG000|Overall Study|Adverse Event|10|||
27914580|NCT01120717|54572277|FG001|Overall Study|Adverse Event|6|||
27914581|NCT01120717|54572276|FG000|Overall Study|Protocol Deviation|2|||
27914582|NCT01120717|54572277|FG001|Overall Study|Protocol Deviation|5|||
27914583|NCT01120717|54572276|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
27914584|NCT01120717|54572277|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
27914585|NCT01120717|54572276|FG000|Overall Study|Lost to Follow-up|2|||
27914586|NCT01120717|54572277|FG001|Overall Study|Lost to Follow-up|3|||
27914587|NCT01120717|54572276|FG000|Overall Study|Death|3|||
27914588|NCT01120717|54572277|FG001|Overall Study|Death|1|||
27914589|NCT01120717|54572276|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
27914590|NCT01120717|54572277|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
27914591|NCT01120600|54572285|FG000|Overall Study|Adverse Event|7|||
27914592|NCT01120600|54572286|FG001|Overall Study|Adverse Event|7|||
27914593|NCT01120600|54572285|FG000|Overall Study|Excessive Bone Loss|0|||
27914594|NCT01120600|54572286|FG001|Overall Study|Excessive Bone Loss|4|||
27914595|NCT01120600|54572285|FG000|Overall Study|Lost to Follow-up|1|||
27914596|NCT01120600|54572286|FG001|Overall Study|Lost to Follow-up|3|||
27914597|NCT01120600|54572285|FG000|Overall Study|Physician Decision|1|||
27914598|NCT01120600|54572286|FG001|Overall Study|Physician Decision|3|||
27914599|NCT01120600|54572285|FG000|Overall Study|Protocol Violation|0|||
27914600|NCT01120600|54572286|FG001|Overall Study|Protocol Violation|4|||
27914601|NCT01120600|54572285|FG000|Overall Study|Withdrawal by Subject|10|||
27914602|NCT01120600|54572286|FG001|Overall Study|Withdrawal by Subject|11|||
27914603|NCT01120210|54572294|FG000|MAIN INFUSION|Adverse Event|1|||
27914604|NCT01120210|54572295|FG001|MAIN INFUSION|Adverse Event|0|||
27914605|NCT01120210|54572294|FG000|MAIN INFUSION|Withdrawal by Subject|0|||
27914606|NCT01120210|54572295|FG001|MAIN INFUSION|Withdrawal by Subject|1|||
27914607|NCT01120093|54572301|FG000|Treatment Period 1|Adverse Event|0|||
28099858|NCT03458702|54756290|FG001|Study Condition A (Yoga or Rest)|Lost to Follow-up|6|||
28099859|NCT03458702|54756289|FG000|Study Condition B (Yoga or Rest)|Lost to Follow-up|4|||
27914608|NCT01120093|54572302|FG001|Treatment Period 1|Adverse Event|0|||
27914609|NCT01120093|54572303|FG002|Treatment Period 1|Adverse Event|1|||
27914610|NCT01120093|54572304|FG003|Treatment Period 1|Adverse Event|0|||
27914611|NCT01120093|54572305|FG004|Treatment Period 1|Adverse Event|1|||
27914612|NCT01120093|54572301|FG000|Treatment Period 1|Withdrawal by Subject|0|||
27914613|NCT01120093|54572302|FG001|Treatment Period 1|Withdrawal by Subject|1|||
27914614|NCT01120093|54572303|FG002|Treatment Period 1|Withdrawal by Subject|0|||
27914615|NCT01120093|54572304|FG003|Treatment Period 1|Withdrawal by Subject|0|||
27914616|NCT01120093|54572305|FG004|Treatment Period 1|Withdrawal by Subject|0|||
27914617|NCT01120093|54572301|FG000|Treatment Period 2|Adverse Event|0|||
27914618|NCT01120093|54572302|FG001|Treatment Period 2|Adverse Event|0|||
27914619|NCT01120093|54572303|FG002|Treatment Period 2|Adverse Event|0|||
27914620|NCT01120093|54572304|FG003|Treatment Period 2|Adverse Event|1|||
27914621|NCT01120093|54572305|FG004|Treatment Period 2|Adverse Event|0|||
27914622|NCT01120093|54572301|FG000|Treatment Period 2|Withdrawal by Subject|0|||
27914623|NCT01120093|54572302|FG001|Treatment Period 2|Withdrawal by Subject|0|||
27914624|NCT01120093|54572303|FG002|Treatment Period 2|Withdrawal by Subject|0|||
27914625|NCT01120093|54572304|FG003|Treatment Period 2|Withdrawal by Subject|0|||
28000651|NCT00804986|54659571|FG004|Overall Study|Adverse Event|3|||
27914626|NCT01120093|54572305|FG004|Treatment Period 2|Withdrawal by Subject|1|||
27914627|NCT01120093|54572301|FG000|Treatment Period 3|Lack of Efficacy|0|||
27914628|NCT01120093|54572302|FG001|Treatment Period 3|Lack of Efficacy|0|||
27914629|NCT01120093|54572303|FG002|Treatment Period 3|Lack of Efficacy|0|||
27914630|NCT01120093|54572304|FG003|Treatment Period 3|Lack of Efficacy|1|||
27914631|NCT01120093|54572305|FG004|Treatment Period 3|Lack of Efficacy|0|||
27914632|NCT01120093|54572301|FG000|Treatment Period 3|Adverse Event|0|||
27914633|NCT01120093|54572302|FG001|Treatment Period 3|Adverse Event|0|||
27914634|NCT01120093|54572303|FG002|Treatment Period 3|Adverse Event|0|||
27914635|NCT01120093|54572304|FG003|Treatment Period 3|Adverse Event|0|||
27914636|NCT01120093|54572305|FG004|Treatment Period 3|Adverse Event|1|||
27914637|NCT01120093|54572301|FG000|Treatment Period 3|Withdrawal by Subject|0|||
27914638|NCT01120093|54572302|FG001|Treatment Period 3|Withdrawal by Subject|0|||
27914639|NCT01120093|54572303|FG002|Treatment Period 3|Withdrawal by Subject|1|||
27914640|NCT01120093|54572304|FG003|Treatment Period 3|Withdrawal by Subject|0|||
27914641|NCT01120093|54572305|FG004|Treatment Period 3|Withdrawal by Subject|0|||
27914642|NCT01120093|54572301|FG000|Treatment Period 4|Adverse Event|1|||
27914643|NCT01120093|54572302|FG001|Treatment Period 4|Adverse Event|0|||
27914644|NCT01120093|54572303|FG002|Treatment Period 4|Adverse Event|0|||
27914645|NCT01120093|54572304|FG003|Treatment Period 4|Adverse Event|0|||
27914646|NCT01120093|54572305|FG004|Treatment Period 4|Adverse Event|0|||
27914647|NCT01120093|54572301|FG000|Treatment Period 5|Adverse Event|0|||
27914648|NCT01120093|54572302|FG001|Treatment Period 5|Adverse Event|1|||
28000652|NCT00804986|54659572|FG005|Overall Study|Adverse Event|0|||
28000653|NCT00804986|54659567|FG000|Overall Study|Lack of Efficacy|0|||
28000654|NCT00804986|54659568|FG001|Overall Study|Lack of Efficacy|0|||
28000655|NCT00804986|54659569|FG002|Overall Study|Lack of Efficacy|0|||
28000656|NCT00804986|54659570|FG003|Overall Study|Lack of Efficacy|1|||
28000657|NCT00804986|54659571|FG004|Overall Study|Lack of Efficacy|0|||
28000658|NCT00804986|54659572|FG005|Overall Study|Lack of Efficacy|3|||
28000659|NCT00804986|54659567|FG000|Overall Study|Lost to Follow-up|0|||
28000660|NCT00804986|54659568|FG001|Overall Study|Lost to Follow-up|0|||
28000661|NCT00804986|54659569|FG002|Overall Study|Lost to Follow-up|0|||
27914649|NCT01120093|54572303|FG002|Treatment Period 5|Adverse Event|0|||
27914650|NCT01120093|54572304|FG003|Treatment Period 5|Adverse Event|1|||
27914651|NCT01120093|54572305|FG004|Treatment Period 5|Adverse Event|0|||
27914652|NCT01119937|54572319|FG000|Overall Study|Adverse Event|11|||
27914653|NCT01119937|54572320|FG001|Overall Study|Adverse Event|5|||
27914654|NCT01119937|54572319|FG000|Overall Study|Protocol deviation|3|||
27914655|NCT01119937|54572320|FG001|Overall Study|Protocol deviation|1|||
27914656|NCT01119937|54572319|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
27914657|NCT01119937|54572320|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
27914658|NCT01119937|54572319|FG000|Overall Study|Withdrawal by Subject|2|||
27914659|NCT01119937|54572320|FG001|Overall Study|Withdrawal by Subject|1|||
27914660|NCT01119898|54572328|FG000|Overall Study|Adverse Event|4|||
28000662|NCT00804986|54659570|FG003|Overall Study|Lost to Follow-up|1|||
28000663|NCT00804986|54659571|FG004|Overall Study|Lost to Follow-up|1|||
28000664|NCT00804986|54659572|FG005|Overall Study|Lost to Follow-up|3|||
28000665|NCT00804986|54659567|FG000|Overall Study|Protocol Violation|0|||
28000666|NCT00804986|54659568|FG001|Overall Study|Protocol Violation|1|||
28000667|NCT00804986|54659569|FG002|Overall Study|Protocol Violation|0|||
28000668|NCT00804986|54659570|FG003|Overall Study|Protocol Violation|1|||
28000669|NCT00804986|54659571|FG004|Overall Study|Protocol Violation|0|||
28000670|NCT00804986|54659572|FG005|Overall Study|Protocol Violation|0|||
28000671|NCT00804986|54659567|FG000|Overall Study|Withdrawal by Subject|0|||
28000672|NCT00804986|54659568|FG001|Overall Study|Withdrawal by Subject|3|||
28000673|NCT00804986|54659569|FG002|Overall Study|Withdrawal by Subject|0|||
28000674|NCT00804986|54659570|FG003|Overall Study|Withdrawal by Subject|3|||
28000675|NCT00804986|54659571|FG004|Overall Study|Withdrawal by Subject|5|||
28000676|NCT00804986|54659572|FG005|Overall Study|Withdrawal by Subject|3|||
28000677|NCT00804986|54659567|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
28000678|NCT00804986|54659568|FG001|Overall Study|Inclusion/Exclusion criteria not met|2|||
28000679|NCT00804986|54659569|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
28000680|NCT00804986|54659570|FG003|Overall Study|Inclusion/Exclusion criteria not met|1|||
27914661|NCT01119898|54572329|FG001|Overall Study|Adverse Event|5|||
27914662|NCT01119898|54572328|FG000|Overall Study|Withdrawal by Subject|1|||
28000681|NCT00804986|54659571|FG004|Overall Study|Inclusion/Exclusion criteria not met|0|||
27914663|NCT01119898|54572329|FG001|Overall Study|Withdrawal by Subject|4|||
27914664|NCT01119898|54572328|FG000|Overall Study|Lack of Efficacy|0|||
28000682|NCT00804986|54659572|FG005|Overall Study|Inclusion/Exclusion criteria not met|1|||
28000683|NCT00804986|54659567|FG000|Overall Study|Sponsor Decision|0|||
28000684|NCT00804986|54659568|FG001|Overall Study|Sponsor Decision|1|||
28000685|NCT00804986|54659569|FG002|Overall Study|Sponsor Decision|0|||
28000686|NCT00804986|54659570|FG003|Overall Study|Sponsor Decision|0|||
27914665|NCT01119898|54572329|FG001|Overall Study|Lack of Efficacy|2|||
27914666|NCT01119898|54572328|FG000|Overall Study|Protocol Violation|1|||
27914667|NCT01119898|54572329|FG001|Overall Study|Protocol Violation|1|||
28000687|NCT00804986|54659571|FG004|Overall Study|Sponsor Decision|0|||
28000688|NCT00804986|54659572|FG005|Overall Study|Sponsor Decision|0|||
28000689|NCT00804986|54659567|FG000|Overall Study|Physician Decision|1|||
28000690|NCT00804986|54659568|FG001|Overall Study|Physician Decision|0|||
28000691|NCT00804986|54659569|FG002|Overall Study|Physician Decision|0|||
28000692|NCT00804986|54659570|FG003|Overall Study|Physician Decision|0|||
28000693|NCT00804986|54659571|FG004|Overall Study|Physician Decision|0|||
28000694|NCT00804986|54659572|FG005|Overall Study|Physician Decision|0|||
28000695|NCT00752232|54659593|FG000|Overall Study|Protocol Violation|0|||
28000696|NCT00752232|54659594|FG001|Overall Study|Protocol Violation|0|||
28000697|NCT00752232|54659595|FG002|Overall Study|Protocol Violation|0|||
28000698|NCT00752232|54659596|FG003|Overall Study|Protocol Violation|0|||
28000699|NCT00752232|54659597|FG004|Overall Study|Protocol Violation|0|||
28000700|NCT00752232|54659598|FG005|Overall Study|Protocol Violation|1|||
28000701|NCT00752232|54659599|FG006|Overall Study|Protocol Violation|0|||
28000702|NCT00752232|54659593|FG000|Overall Study|Caregiver request|2|||
28000703|NCT00752232|54659594|FG001|Overall Study|Caregiver request|0|||
28000704|NCT00752232|54659595|FG002|Overall Study|Caregiver request|0|||
28000705|NCT00752232|54659596|FG003|Overall Study|Caregiver request|0|||
28000706|NCT00752232|54659597|FG004|Overall Study|Caregiver request|1|||
28000707|NCT00752232|54659598|FG005|Overall Study|Caregiver request|0|||
28000708|NCT00752232|54659599|FG006|Overall Study|Caregiver request|0|||
28000709|NCT00752232|54659593|FG000|Overall Study|Investigator request|0|||
28000710|NCT00752232|54659594|FG001|Overall Study|Investigator request|0|||
28000711|NCT00752232|54659595|FG002|Overall Study|Investigator request|0|||
28000712|NCT00752232|54659596|FG003|Overall Study|Investigator request|0|||
28000713|NCT00752232|54659597|FG004|Overall Study|Investigator request|1|||
28000714|NCT00752232|54659598|FG005|Overall Study|Investigator request|0|||
28000715|NCT00752232|54659599|FG006|Overall Study|Investigator request|0|||
28000716|NCT00752232|54659593|FG000|Overall Study|Subject request|0|||
28000717|NCT00752232|54659594|FG001|Overall Study|Subject request|0|||
28000718|NCT00752232|54659595|FG002|Overall Study|Subject request|1|||
28000719|NCT00752232|54659596|FG003|Overall Study|Subject request|0|||
28000720|NCT00752232|54659597|FG004|Overall Study|Subject request|0|||
28000721|NCT00752232|54659598|FG005|Overall Study|Subject request|0|||
28000722|NCT00752232|54659599|FG006|Overall Study|Subject request|0|||
28000723|NCT00752232|54659593|FG000|Overall Study|Group home admission|0|||
28000724|NCT00752232|54659594|FG001|Overall Study|Group home admission|0|||
28000725|NCT00752232|54659595|FG002|Overall Study|Group home admission|0|||
28000726|NCT00752232|54659596|FG003|Overall Study|Group home admission|1|||
28000727|NCT00752232|54659597|FG004|Overall Study|Group home admission|0|||
28000728|NCT00752232|54659598|FG005|Overall Study|Group home admission|0|||
28000729|NCT00752232|54659599|FG006|Overall Study|Group home admission|0|||
28000730|NCT00752232|54659593|FG000|Overall Study|Caregiver could not attend the subject|0|||
28000731|NCT00752232|54659594|FG001|Overall Study|Caregiver could not attend the subject|0|||
28000732|NCT00752232|54659595|FG002|Overall Study|Caregiver could not attend the subject|0|||
28000733|NCT00752232|54659596|FG003|Overall Study|Caregiver could not attend the subject|0|||
28000734|NCT00752232|54659597|FG004|Overall Study|Caregiver could not attend the subject|1|||
28000735|NCT00752232|54659598|FG005|Overall Study|Caregiver could not attend the subject|0|||
28000736|NCT00752232|54659599|FG006|Overall Study|Caregiver could not attend the subject|0|||
28000737|NCT00760266|54659618|FG000|Overall Study|Adverse Event|13|||
28000738|NCT00760266|54659619|FG001|Overall Study|Adverse Event|7|||
28000739|NCT00760266|54659618|FG000|Overall Study|Abnormal laboratory value(s)|1|||
28000740|NCT00760266|54659619|FG001|Overall Study|Abnormal laboratory value(s)|0|||
28000741|NCT00760266|54659618|FG000|Overall Study|Abnormal test procedure result(s)|1|||
28000742|NCT00760266|54659619|FG001|Overall Study|Abnormal test procedure result(s)|0|||
28000743|NCT00760266|54659618|FG000|Overall Study|Lack of Efficacy|2|||
28000744|NCT00760266|54659619|FG001|Overall Study|Lack of Efficacy|2|||
28000745|NCT00760266|54659618|FG000|Overall Study|Protocol deviation|2|||
28000746|NCT00760266|54659619|FG001|Overall Study|Protocol deviation|4|||
28000747|NCT00760266|54659618|FG000|Overall Study|Patient withdrew consent|3|||
28000748|NCT00760266|54659619|FG001|Overall Study|Patient withdrew consent|3|||
28000749|NCT00760266|54659618|FG000|Overall Study|Lost to Follow-up|2|||
28000750|NCT00760266|54659619|FG001|Overall Study|Lost to Follow-up|1|||
28000751|NCT00760266|54659618|FG000|Overall Study|Administrative Problems|0|||
28000752|NCT00760266|54659619|FG001|Overall Study|Administrative Problems|1|||
28000753|NCT00753714|54659627|FG000|Overall Study|Lack of Efficacy|21|||
28000754|NCT00753714|54659628|FG001|Overall Study|Lack of Efficacy|34|||
28000755|NCT00753714|54659627|FG000|Overall Study|Adverse Event|26|||
28000756|NCT00753714|54659628|FG001|Overall Study|Adverse Event|18|||
28000757|NCT00753714|54659627|FG000|Overall Study|Protocol Violation|1|||
28000758|NCT00753714|54659628|FG001|Overall Study|Protocol Violation|0|||
28000759|NCT00753714|54659627|FG000|Overall Study|Lost to Follow-up|0|||
28000760|NCT00753714|54659628|FG001|Overall Study|Lost to Follow-up|1|||
28000761|NCT00753714|54659627|FG000|Overall Study|Withdrawal by Subject|2|||
28000762|NCT00753714|54659628|FG001|Overall Study|Withdrawal by Subject|1|||
28000763|NCT00753714|54659627|FG000|Overall Study|Death|3|||
28000764|NCT00753714|54659628|FG001|Overall Study|Death|3|||
28000765|NCT00753714|54659627|FG000|Overall Study|Other|7|||
28000766|NCT00753714|54659628|FG001|Overall Study|Other|5|||
28000767|NCT00759954|54659639|FG000|Overall Study|Personal reason|1|||
28000768|NCT00759954|54659640|FG001|Overall Study|Personal reason|0|||
28000769|NCT00759954|54659639|FG000|Overall Study|Adverse Event|1|||
28000770|NCT00759954|54659640|FG001|Overall Study|Adverse Event|2|||
28000771|NCT00804908|54659649|FG000|Overall Study|Other|115|||
28000772|NCT00804908|54659650|FG001|Overall Study|Other|116|||
28000773|NCT00804908|54659651|FG002|Overall Study|Other|114|||
28000774|NCT00808808|54659662|FG000|Overall Study|Vaccinated; survey not completed|131|||
28000775|NCT00808808|54659663|FG001|Overall Study|Vaccinated; survey not completed|169|||
28000776|NCT00808808|54659664|FG002|Overall Study|Vaccinated; survey not completed|302|||
28000777|NCT00808808|54659662|FG000|Overall Study|Employee was not vaccinated.|2686|||
28000778|NCT00808808|54659663|FG001|Overall Study|Employee was not vaccinated.|2268|||
28000779|NCT00808808|54659664|FG002|Overall Study|Employee was not vaccinated.|2255|||
28000780|NCT00589784|54659680|FG000|Overall Study|Withdrawal by Subject|0|||
28000781|NCT00589784|54659681|FG001|Overall Study|Withdrawal by Subject|6|||
28000782|NCT00589784|54659680|FG000|Overall Study|Patient inevaluable|1|||
28000783|NCT00589784|54659681|FG001|Overall Study|Patient inevaluable|0|||
28000784|NCT00589784|54659680|FG000|Overall Study|Adverse Event|0|||
28000785|NCT00589784|54659681|FG001|Overall Study|Adverse Event|4|||
28000786|NCT00759876|54659686|FG000|Overall Study|Sponsor terminated study early|36|||
28000787|NCT00823979|54659693|FG000|Overall Study|Lack of Efficacy|13|||
28000788|NCT00823979|54659694|FG001|Overall Study|Lack of Efficacy|16|||
28000789|NCT00823979|54659695|FG002|Overall Study|Lack of Efficacy|9|||
28000790|NCT00823979|54659693|FG000|Overall Study|Lost to Follow-up|2|||
28000791|NCT00823979|54659694|FG001|Overall Study|Lost to Follow-up|1|||
28000792|NCT00823979|54659695|FG002|Overall Study|Lost to Follow-up|0|||
28000793|NCT00823979|54659693|FG000|Overall Study|Withdrawal by Subject|2|||
28000794|NCT00823979|54659694|FG001|Overall Study|Withdrawal by Subject|3|||
28000795|NCT00823979|54659695|FG002|Overall Study|Withdrawal by Subject|2|||
28000796|NCT00823979|54659693|FG000|Overall Study|Protocol Violation|1|||
28000797|NCT00823979|54659694|FG001|Overall Study|Protocol Violation|1|||
28000798|NCT00823979|54659695|FG002|Overall Study|Protocol Violation|0|||
28000799|NCT00823979|54659693|FG000|Overall Study|Pregnancy|0|||
28000800|NCT00823979|54659694|FG001|Overall Study|Pregnancy|1|||
28000801|NCT00823979|54659695|FG002|Overall Study|Pregnancy|0|||
28000802|NCT00823979|54659693|FG000|Overall Study|Adverse Event|0|||
28000803|NCT00823979|54659694|FG001|Overall Study|Adverse Event|2|||
28000804|NCT00823979|54659695|FG002|Overall Study|Adverse Event|4|||
28000805|NCT00823979|54659693|FG000|Overall Study|Other|2|||
28000806|NCT00823979|54659694|FG001|Overall Study|Other|0|||
28000807|NCT00823979|54659695|FG002|Overall Study|Other|1|||
28000808|NCT00823979|54659693|FG000|Overall Study|Randomized but not Treated|4|||
28000809|NCT00823979|54659694|FG001|Overall Study|Randomized but not Treated|3|||
28000810|NCT00823979|54659695|FG002|Overall Study|Randomized but not Treated|1|||
28000811|NCT00823979|54659693|FG000|Overall Study|Study Terminated by Sponsor|5|||
28000812|NCT00823979|54659694|FG001|Overall Study|Study Terminated by Sponsor|5|||
28000813|NCT00823979|54659695|FG002|Overall Study|Study Terminated by Sponsor|7|||
28000814|NCT00823901|54659705|FG000|Overall Study|Adverse Event|1|||
27914668|NCT01119898|54572328|FG000|Overall Study|Medical procedure|1|||
27914669|NCT01119898|54572329|FG001|Overall Study|Medical procedure|0|||
27914670|NCT01119898|54572328|FG000|Overall Study|Randomized in error did not participate|1|||
27914671|NCT01119898|54572329|FG001|Overall Study|Randomized in error did not participate|0|||
27914672|NCT01119859|54572337|FG000|Overall Study|Adverse Event|9|||
27914673|NCT01119859|54572338|FG001|Overall Study|Adverse Event|10|||
27914674|NCT01119859|54572337|FG000|Overall Study|Death|2|||
27914675|NCT01119859|54572338|FG001|Overall Study|Death|0|||
27914676|NCT01119859|54572337|FG000|Overall Study|Insufficient therapeutic response|7|||
27914677|NCT01119859|54572338|FG001|Overall Study|Insufficient therapeutic response|14|||
27914678|NCT01119859|54572337|FG000|Overall Study|Refused treatment|3|||
27914679|NCT01119859|54572338|FG001|Overall Study|Refused treatment|6|||
27914680|NCT01119859|54572337|FG000|Overall Study|Failure to return|3|||
27914681|NCT01119859|54572338|FG001|Overall Study|Failure to return|0|||
27914682|NCT01119703|54572346|FG000|Overall Study|Adverse Event|0|||
27914683|NCT01119703|54572347|FG001|Overall Study|Adverse Event|1|||
27914684|NCT01119625|54572354|FG000|Overall Study|Lost to Follow-up|1|||
28000815|NCT00823901|54659706|FG001|Overall Study|Adverse Event|1|||
28000816|NCT00823901|54659705|FG000|Overall Study|Lack of Efficacy|1|||
28000817|NCT00823901|54659706|FG001|Overall Study|Lack of Efficacy|0|||
28000818|NCT00823901|54659705|FG000|Overall Study|Lost to Follow-up|2|||
28000819|NCT00823901|54659706|FG001|Overall Study|Lost to Follow-up|1|||
28000820|NCT00823823|54659714|FG000|Overall Study|Lost to Follow-up|3|||
28000821|NCT00823823|54659715|FG001|Overall Study|Lost to Follow-up|1|||
28000822|NCT00823823|54659714|FG000|Overall Study|Protocol Violation|5|||
27914685|NCT01119625|54572355|FG001|Overall Study|Lost to Follow-up|2|||
27914686|NCT01119625|54572354|FG000|Overall Study|Withdrawal by Subject|2|||
27914687|NCT01119625|54572355|FG001|Overall Study|Withdrawal by Subject|1|||
27914688|NCT01119625|54572354|FG000|Overall Study|Other|0|||
28000823|NCT00823823|54659715|FG001|Overall Study|Protocol Violation|5|||
28000824|NCT00759564|54659735|FG000|Washout Period (at Least 14 Days)|Adverse Event|0|||
28000825|NCT00759564|54659736|FG001|Washout Period (at Least 14 Days)|Adverse Event|0|||
28000826|NCT00759564|54659737|FG002|Washout Period (at Least 14 Days)|Adverse Event|0|||
28000827|NCT00759564|54659738|FG003|Washout Period (at Least 14 Days)|Adverse Event|0|||
28000828|NCT00759564|54659739|FG004|Washout Period (at Least 14 Days)|Adverse Event|1|||
28000829|NCT00816023|54659775|FG000|Overall Study|Lost to Follow-up|1|||
28000830|NCT00816023|54659776|FG001|Overall Study|Lost to Follow-up|1|||
27914689|NCT01119625|54572355|FG001|Overall Study|Other|1|||
27914690|NCT01119118|54572361|FG000|Overall Study|Adverse Event|1|||
27914691|NCT01119001|54572365|FG000|Overall Study|Withdrawal by Subject|2|||
27914692|NCT01118962|54572371|FG000|Overall Study|Adverse Event|2|||
27914693|NCT01118962|54572371|FG000|Overall Study|Lack of Efficacy|1|||
28000831|NCT00816023|54659777|FG002|Overall Study|Lost to Follow-up|0|||
28000832|NCT00816023|54659778|FG003|Overall Study|Lost to Follow-up|0|||
28000833|NCT00816023|54659775|FG000|Overall Study|Withdrawal by Subject|1|||
28000834|NCT00816023|54659776|FG001|Overall Study|Withdrawal by Subject|0|||
28000835|NCT00816023|54659777|FG002|Overall Study|Withdrawal by Subject|0|||
28000836|NCT00816023|54659778|FG003|Overall Study|Withdrawal by Subject|0|||
28000837|NCT00816023|54659775|FG000|Overall Study|Physician Decision|0|||
28000838|NCT00816023|54659776|FG001|Overall Study|Physician Decision|0|||
28000839|NCT00816023|54659777|FG002|Overall Study|Physician Decision|1|||
28000840|NCT00816023|54659778|FG003|Overall Study|Physician Decision|0|||
28000841|NCT00816023|54659775|FG000|Overall Study|assessments complete prior to window|1|||
28000842|NCT00816023|54659776|FG001|Overall Study|assessments complete prior to window|1|||
28000843|NCT00816023|54659777|FG002|Overall Study|assessments complete prior to window|2|||
28000844|NCT00816023|54659778|FG003|Overall Study|assessments complete prior to window|1|||
27914694|NCT01118962|54572371|FG000|Overall Study|Protocol Violation|1|||
27914695|NCT01118962|54572371|FG000|Overall Study|Withdrawal by Subject|4|||
27914696|NCT01118962|54572371|FG000|Overall Study|Pregnancy|1|||
28000845|NCT00816023|54659775|FG000|Overall Study|Randomized Not Treated|6|||
28000846|NCT00816023|54659776|FG001|Overall Study|Randomized Not Treated|4|||
28000847|NCT00816023|54659777|FG002|Overall Study|Randomized Not Treated|6|||
28000848|NCT00816023|54659778|FG003|Overall Study|Randomized Not Treated|11|||
28000849|NCT00759174|54659790|FG000|Overall Study|Other|0|||
28000850|NCT00759174|54659791|FG001|Overall Study|Other|2|||
28000851|NCT00815633|54659798|FG000|Overall Study|study terminated|1|||
28000852|NCT00830765|54659804|FG000|Overall Study|Protocol Violation|3|||
28000853|NCT00830765|54659805|FG001|Overall Study|Protocol Violation|2|||
28000854|NCT00830375|54659811|FG000|Overall Study|Lost to Follow-up|1|||
28000855|NCT00803270|54659817|FG000|Overall Study|Lost to Follow-up|1|||
28000856|NCT00803270|54659818|FG001|Overall Study|Lost to Follow-up|2|||
28000857|NCT00751998|54659824|FG000|Overall Study|Lost to Follow-up|7|||
28000858|NCT00751998|54659824|FG000|Overall Study|Death|11|||
28000859|NCT00751998|54659824|FG000|Overall Study|Withdrawal by Subject|2|||
28000860|NCT00803738|54659830|FG000|Overall Study|Adverse Event|3|||
28000861|NCT00803738|54659831|FG001|Overall Study|Adverse Event|5|||
28000862|NCT00803738|54659830|FG000|Overall Study|Lost to Follow-up|4|||
28000863|NCT00803738|54659831|FG001|Overall Study|Lost to Follow-up|4|||
28000864|NCT00803738|54659830|FG000|Overall Study|Protocol Violation|18|||
28000865|NCT00803738|54659831|FG001|Overall Study|Protocol Violation|10|||
28000866|NCT00803738|54659830|FG000|Overall Study|Withdrawal by Subject|1|||
28000867|NCT00803738|54659831|FG001|Overall Study|Withdrawal by Subject|4|||
28000868|NCT00803738|54659830|FG000|Overall Study|Lack of Efficacy|10|||
28000869|NCT00803738|54659831|FG001|Overall Study|Lack of Efficacy|16|||
28000870|NCT00803738|54659830|FG000|Overall Study|Negative Baseline Culture of Candida|56|||
28000871|NCT00803738|54659831|FG001|Overall Study|Negative Baseline Culture of Candida|63|||
28000872|NCT00803738|54659830|FG000|Overall Study|Positive Results for STD or abnormal PAP|2|||
28000873|NCT00803738|54659831|FG001|Overall Study|Positive Results for STD or abnormal PAP|8|||
28000874|NCT00758706|54659839|FG000|Overall Study|Adverse Event|4|||
28099860|NCT03458702|54756290|FG001|Study Condition B (Yoga or Rest)|Lost to Follow-up|2|||
28099861|NCT03454412|54756296|FG000|Baseline Assesment|Physician Decision|12|||
28099862|NCT03452540|54756300|FG000|Overall Study|Adverse Event|1|||
28099863|NCT03452540|54756300|FG000|Overall Study|Withdrawal by Subject|1|||
28099864|NCT03452540|54756300|FG000|Overall Study|Other SAE and AE|2|||
28099865|NCT03573336|54756307|FG000|Overall Study|Study terminated|2|||
27914697|NCT01118962|54572371|FG000|Overall Study|Non-compliance with Medicinal Product|1|||
28000875|NCT00758706|54659840|FG001|Overall Study|Adverse Event|4|||
28000876|NCT00591266|54659849|FG000|Overall Study|Adverse Event|2|||
28000877|NCT00591266|54659850|FG001|Overall Study|Adverse Event|2|||
28000878|NCT00591266|54659851|FG002|Overall Study|Adverse Event|3|||
28099866|NCT03573336|54756308|FG001|Overall Study|Study terminated|4|||
27914698|NCT01118728|54572375|FG000|Overall Study|Adverse Event|17|||
28000879|NCT00591266|54659849|FG000|Overall Study|Lost to Follow-up|0|||
28099867|NCT03573336|54756309|FG002|Overall Study|Study terminated|2|||
27914699|NCT01118728|54572375|FG000|Overall Study|Lack of Efficacy|27|||
27914700|NCT01118728|54572375|FG000|Overall Study|Sponsor's decision to discontinue study|172|||
27914701|NCT01118728|54572375|FG000|Overall Study|Withdrawal by Subject|3|||
28000880|NCT00591266|54659850|FG001|Overall Study|Lost to Follow-up|1|||
28000881|NCT00591266|54659851|FG002|Overall Study|Lost to Follow-up|0|||
28000882|NCT00591266|54659849|FG000|Overall Study|Protocol Violation|0|||
28000883|NCT00591266|54659850|FG001|Overall Study|Protocol Violation|0|||
28000884|NCT00591266|54659851|FG002|Overall Study|Protocol Violation|1|||
28000885|NCT00591266|54659849|FG000|Overall Study|Withdrawal by Subject|6|||
28000886|NCT00591266|54659850|FG001|Overall Study|Withdrawal by Subject|2|||
28000887|NCT00591266|54659851|FG002|Overall Study|Withdrawal by Subject|5|||
28000888|NCT00591266|54659849|FG000|Overall Study|Lack of Efficacy|0|||
28000889|NCT00591266|54659850|FG001|Overall Study|Lack of Efficacy|2|||
28000890|NCT00591266|54659851|FG002|Overall Study|Lack of Efficacy|0|||
28000891|NCT00591266|54659849|FG000|Overall Study|Other|1|||
28000892|NCT00591266|54659850|FG001|Overall Study|Other|4|||
28000893|NCT00591266|54659851|FG002|Overall Study|Other|5|||
28000894|NCT00758394|54659863|FG000|2nd Intervention Order|Lost to Follow-up|0|||
28000895|NCT00758394|54659864|FG001|2nd Intervention Order|Lost to Follow-up|1|||
28000896|NCT00758394|54659865|FG002|2nd Intervention Order|Lost to Follow-up|0|||
28000897|NCT00758394|54659866|FG003|2nd Intervention Order|Lost to Follow-up|0|||
28000898|NCT00758394|54659863|FG000|3rd Intervention|Lost to Follow-up|1|||
28000899|NCT00758394|54659864|FG001|3rd Intervention|Lost to Follow-up|0|||
28000900|NCT00758394|54659865|FG002|3rd Intervention|Lost to Follow-up|0|||
28000901|NCT00758394|54659866|FG003|3rd Intervention|Lost to Follow-up|1|||
28000902|NCT04450394|54659879|FG000|Overall Study|Adverse Event|2|||
28000903|NCT04450394|54659880|FG001|Overall Study|Adverse Event|0|||
28000904|NCT04450394|54659881|FG002|Overall Study|Adverse Event|0|||
28000905|NCT04450394|54659879|FG000|Overall Study|Death|0|||
28000906|NCT04450394|54659880|FG001|Overall Study|Death|1|||
28000907|NCT04450394|54659881|FG002|Overall Study|Death|0|||
28000908|NCT04450394|54659879|FG000|Overall Study|Lost to Follow-up|0|||
28000909|NCT04450394|54659880|FG001|Overall Study|Lost to Follow-up|3|||
28000910|NCT04450394|54659881|FG002|Overall Study|Lost to Follow-up|0|||
28000911|NCT04450394|54659879|FG000|Overall Study|Physician Decision|0|||
28000912|NCT04450394|54659880|FG001|Overall Study|Physician Decision|1|||
28000913|NCT04450394|54659881|FG002|Overall Study|Physician Decision|0|||
28000914|NCT04450394|54659879|FG000|Overall Study|Protocol Violation|2|||
28000915|NCT04450394|54659880|FG001|Overall Study|Protocol Violation|0|||
28000916|NCT04450394|54659881|FG002|Overall Study|Protocol Violation|0|||
28000917|NCT04450394|54659879|FG000|Overall Study|Withdrawal by Subject|6|||
28000918|NCT04450394|54659880|FG001|Overall Study|Withdrawal by Subject|9|||
28000919|NCT04450394|54659881|FG002|Overall Study|Withdrawal by Subject|0|||
28000920|NCT00758160|54659888|FG000|Overall Study|No Longer Requires Study Medication|4|||
28000921|NCT00758160|54659888|FG000|Overall Study|Administration Problems|3|||
28000922|NCT00758160|54659888|FG000|Overall Study|Adverse Event|15|||
28000923|NCT00758160|54659888|FG000|Overall Study|Lack of Efficacy|10|||
28000924|NCT00758160|54659888|FG000|Overall Study|Lost to Follow-up|14|||
28000925|NCT00758160|54659888|FG000|Overall Study|Protocol Violation|12|||
28000926|NCT00758160|54659888|FG000|Overall Study|Withdrawal by Subject|8|||
28000927|NCT00757848|54659898|FG000|Overall Study|Voluntary discontinuation|1|||
28000928|NCT00757848|54659899|FG001|Overall Study|Voluntary discontinuation|0|||
28000929|NCT00757848|54659898|FG000|Overall Study|Adverse Event|1|||
28000930|NCT00757848|54659899|FG001|Overall Study|Adverse Event|2|||
28000931|NCT00757848|54659898|FG000|Overall Study|Incorrect enrolment|1|||
28000932|NCT00757848|54659899|FG001|Overall Study|Incorrect enrolment|0|||
28000933|NCT00751296|54659905|FG000|Overall Study|Adverse Event|2|||
28000934|NCT00751140|54659909|FG000|Overall Study|benign angioma excluded from analysis|1|||
28000935|NCT00751881|54659920|FG000|Core Treatment Period|Not treated|1|||
28000936|NCT00751881|54659921|FG001|Core Treatment Period|Not treated|1|||
28000937|NCT00751881|54659922|FG002|Core Treatment Period|Not treated|2|||
28099868|NCT03500198|54756319|FG000|Overall Study|Lost to Follow-up|0|||
27914702|NCT01118728|54572375|FG000|Overall Study|Lost to Follow-up|4|||
27914703|NCT01118455|54572381|FG000|Baseline [Visits 1 & 2]|Adverse Event|1|||
27914704|NCT01118455|54572382|FG001|Baseline [Visits 1 & 2]|Adverse Event|0|||
27914705|NCT01118377|54572396|FG000|Overall Study|Did Not Receive Study Medication|1|||
27914706|NCT01118377|54572396|FG000|Overall Study|Death|38|||
27914707|NCT01118377|54572396|FG000|Overall Study|Failure to Return|3|||
27914708|NCT01118299|54572402|FG000|Overall Study|Death|7|||
27914709|NCT01118299|54572403|FG001|Overall Study|Death|5|||
27914710|NCT01118299|54572402|FG000|Overall Study|Withdrawal by Subject|8|||
27914711|NCT01118299|54572403|FG001|Overall Study|Withdrawal by Subject|8|||
27914712|NCT01118299|54572402|FG000|Overall Study|Lost to Follow-up|2|||
27914713|NCT01118299|54572403|FG001|Overall Study|Lost to Follow-up|1|||
27914714|NCT01118299|54572402|FG000|Overall Study|Enrollment Closure, Protocol Amendment|6|||
27914715|NCT01118299|54572403|FG001|Overall Study|Enrollment Closure, Protocol Amendment|15|||
27914716|NCT01118143|54572410|FG000|Overall Study|Withdrawal by Subject|2|||
27914717|NCT01118143|54572411|FG001|Overall Study|Withdrawal by Subject|5|||
27914718|NCT01117987|54572421|FG000|Overall Study|Protocol deviation|0|||
27914719|NCT01117987|54572422|FG001|Overall Study|Protocol deviation|1|||
27914720|NCT01117987|54572421|FG000|Overall Study|Subject no longer requires study drug|1|||
28000938|NCT00751881|54659920|FG000|Core Treatment Period|Adverse Event|26|||
28000939|NCT00751881|54659921|FG001|Core Treatment Period|Adverse Event|54|||
28000940|NCT00751881|54659922|FG002|Core Treatment Period|Adverse Event|58|||
28000941|NCT00751881|54659920|FG000|Core Treatment Period|Lack of Efficacy|37|||
28000942|NCT00751881|54659921|FG001|Core Treatment Period|Lack of Efficacy|30|||
28099869|NCT03500198|54756320|FG001|Overall Study|Lost to Follow-up|1|||
28099870|NCT03553758|54756328|FG000|Overall Study|Lost to Follow-up|1|||
28099871|NCT03552198|54756338|FG000|Overall Study|Lost to Follow-up|42|||
28099872|NCT03552198|54756339|FG001|Overall Study|Lost to Follow-up|48|||
28099873|NCT03552198|54756340|FG002|Overall Study|Lost to Follow-up|15|||
28099874|NCT03552198|54756341|FG003|Overall Study|Lost to Follow-up|19|||
28099875|NCT03552198|54756338|FG000|Overall Study|Incomplete/unmatched questionnaire|6|||
28099876|NCT03552198|54756339|FG001|Overall Study|Incomplete/unmatched questionnaire|7|||
28099877|NCT03552198|54756340|FG002|Overall Study|Incomplete/unmatched questionnaire|2|||
28099878|NCT03552198|54756341|FG003|Overall Study|Incomplete/unmatched questionnaire|2|||
28099879|NCT03552198|54756338|FG000|Overall Study|Did not receive air alerts|1|||
28099880|NCT03552198|54756339|FG001|Overall Study|Did not receive air alerts|0|||
28099881|NCT03552198|54756340|FG002|Overall Study|Did not receive air alerts|0|||
28099882|NCT03552198|54756341|FG003|Overall Study|Did not receive air alerts|1|||
27914721|NCT01117987|54572422|FG001|Overall Study|Subject no longer requires study drug|0|||
27914722|NCT01117987|54572421|FG000|Overall Study|Lost to Follow-up|1|||
27914723|NCT01117987|54572422|FG001|Overall Study|Lost to Follow-up|1|||
28099883|NCT02954354|54756354|FG000|Overall Study|Adverse Event|2|||
28099884|NCT02954354|54756355|FG001|Overall Study|Adverse Event|2|||
28099885|NCT02954354|54756356|FG002|Overall Study|Adverse Event|4|||
28099886|NCT02954354|54756354|FG000|Overall Study|Failure to Meet Eligibility Criteria|1|||
28099887|NCT02954354|54756355|FG001|Overall Study|Failure to Meet Eligibility Criteria|0|||
28099888|NCT02954354|54756356|FG002|Overall Study|Failure to Meet Eligibility Criteria|0|||
28099889|NCT02954354|54756354|FG000|Overall Study|Lack of Efficacy|0|||
28099890|NCT02954354|54756355|FG001|Overall Study|Lack of Efficacy|2|||
28099891|NCT02954354|54756356|FG002|Overall Study|Lack of Efficacy|0|||
28099892|NCT02954354|54756354|FG000|Overall Study|Withdrawal by Subject|17|||
28099893|NCT02954354|54756355|FG001|Overall Study|Withdrawal by Subject|9|||
28099894|NCT02954354|54756356|FG002|Overall Study|Withdrawal by Subject|11|||
28099895|NCT02954354|54756354|FG000|Overall Study|Lost to Follow-up|12|||
28099896|NCT02954354|54756355|FG001|Overall Study|Lost to Follow-up|5|||
28099897|NCT02954354|54756356|FG002|Overall Study|Lost to Follow-up|0|||
28099898|NCT02954354|54756354|FG000|Overall Study|Miscellaneous|2|||
28099899|NCT02954354|54756355|FG001|Overall Study|Miscellaneous|2|||
28099900|NCT02954354|54756356|FG002|Overall Study|Miscellaneous|1|||
28099901|NCT03519516|54756368|FG000|Overall Study|Adverse Event|0|||
28099902|NCT03519516|54756369|FG001|Overall Study|Adverse Event|1|||
27739827|NCT02219464|54189547|FG001|Overall Study|catheter malfunction|0|||
27914724|NCT01117987|54572421|FG000|Overall Study|Abnormal test procedure result|2|||
27914725|NCT01117987|54572422|FG001|Overall Study|Abnormal test procedure result|0|||
27914726|NCT01117987|54572421|FG000|Overall Study|Lack of Efficacy|3|||
27914727|NCT01117987|54572422|FG001|Overall Study|Lack of Efficacy|4|||
27914728|NCT01117987|54572421|FG000|Overall Study|Death|5|||
27914729|NCT01117987|54572422|FG001|Overall Study|Death|10|||
27914730|NCT01117987|54572421|FG000|Overall Study|Withdrawal by Subject|5|||
27914731|NCT01117987|54572422|FG001|Overall Study|Withdrawal by Subject|10|||
27914732|NCT01117987|54572421|FG000|Overall Study|Adverse Event|19|||
27914733|NCT01117987|54572422|FG001|Overall Study|Adverse Event|26|||
27914734|NCT01117987|54572421|FG000|Overall Study|Administrative problems|25|||
27914735|NCT01117987|54572422|FG001|Overall Study|Administrative problems|22|||
27914736|NCT01117870|54572430|FG000|Overall Study|Inability to place needle|1|||
27914737|NCT01117870|54572431|FG001|Overall Study|Inability to place needle|0|||
27914738|NCT01117792|54572441|FG000|Overall Study|Death|1|||
27914739|NCT01117792|54572441|FG000|Overall Study|Adverse Event|3|||
27914740|NCT02219490|54572445|FG000|Overall Study|Adverse Event|24|||
28000943|NCT00751881|54659922|FG002|Core Treatment Period|Lack of Efficacy|20|||
28000944|NCT00751881|54659920|FG000|Core Treatment Period|Poor compliance to protocol|15|||
28000945|NCT00751881|54659921|FG001|Core Treatment Period|Poor compliance to protocol|3|||
28000946|NCT00751881|54659922|FG002|Core Treatment Period|Poor compliance to protocol|4|||
28000947|NCT00751881|54659920|FG000|Core Treatment Period|Lost to Follow-up|6|||
28099903|NCT03519204|54756377|FG000|Overall Study|Lost to Follow-up|3|||
27914741|NCT02219490|54572445|FG000|Overall Study|Withdrew consent|96|||
27914742|NCT02219490|54572445|FG000|Overall Study|Lost to Follow-up|126|||
27914743|NCT02219490|54572445|FG000|Overall Study|COVID-19 infection|2|||
27914744|NCT02219490|54572445|FG000|Overall Study|COVID-19 logistical restrictions|33|||
28000948|NCT00751881|54659921|FG001|Core Treatment Period|Lost to Follow-up|4|||
28099904|NCT03519204|54756378|FG001|Overall Study|Lost to Follow-up|8|||
28099905|NCT03519204|54756377|FG000|Overall Study|Withdrawal by Subject|9|||
28099906|NCT03519204|54756378|FG001|Overall Study|Withdrawal by Subject|7|||
28099907|NCT03519204|54756377|FG000|Overall Study|Other Miscellaneous Reasons|1|||
27914745|NCT02219490|54572445|FG000|Overall Study|Other, not specified|57|||
28099908|NCT03519204|54756378|FG001|Overall Study|Other Miscellaneous Reasons|0|||
28000949|NCT00751881|54659922|FG002|Core Treatment Period|Lost to Follow-up|3|||
28000950|NCT00751881|54659920|FG000|Core Treatment Period|Other: protocol deviation|3|||
28000951|NCT00751881|54659921|FG001|Core Treatment Period|Other: protocol deviation|3|||
28000952|NCT00751881|54659922|FG002|Core Treatment Period|Other: protocol deviation|7|||
28000953|NCT00751881|54659920|FG000|Core Treatment Period|Other: wish to parent|5|||
28000954|NCT00751881|54659921|FG001|Core Treatment Period|Other: wish to parent|7|||
28000955|NCT00751881|54659922|FG002|Core Treatment Period|Other: wish to parent|4|||
28000956|NCT00751881|54659920|FG000|Core Treatment Period|Other: personal/family constraints|6|||
28000957|NCT00751881|54659921|FG001|Core Treatment Period|Other: personal/family constraints|7|||
28000958|NCT00751881|54659922|FG002|Core Treatment Period|Other: personal/family constraints|10|||
28000959|NCT00751881|54659920|FG000|Core Treatment Period|Other: MS treatment change|6|||
28000960|NCT00751881|54659921|FG001|Core Treatment Period|Other: MS treatment change|4|||
28000961|NCT00751881|54659922|FG002|Core Treatment Period|Other: MS treatment change|4|||
28000962|NCT00751881|54659920|FG000|Core Treatment Period|Other: tolerability complaints|2|||
28000963|NCT00751881|54659921|FG001|Core Treatment Period|Other: tolerability complaints|0|||
28000964|NCT00751881|54659922|FG002|Core Treatment Period|Other: tolerability complaints|0|||
28000965|NCT00751881|54659920|FG000|Core Treatment Period|Other:participant's decision/unspecified|19|||
28000966|NCT00751881|54659921|FG001|Core Treatment Period|Other:participant's decision/unspecified|22|||
28000967|NCT00751881|54659922|FG002|Core Treatment Period|Other:participant's decision/unspecified|16|||
28000968|NCT00751881|54659920|FG000|Extension Study Period|Adverse Event|18|||
28000969|NCT00751881|54659921|FG001|Extension Study Period|Adverse Event|20|||
28000970|NCT00751881|54659922|FG002|Extension Study Period|Adverse Event|21|||
28000971|NCT00751881|54659920|FG000|Extension Study Period|Lack of Efficacy|14|||
28000972|NCT00751881|54659921|FG001|Extension Study Period|Lack of Efficacy|10|||
28000973|NCT00751881|54659922|FG002|Extension Study Period|Lack of Efficacy|20|||
28000974|NCT00751881|54659920|FG000|Extension Study Period|Lost to Follow-up|4|||
28000975|NCT00751881|54659921|FG001|Extension Study Period|Lost to Follow-up|9|||
28000976|NCT00751881|54659922|FG002|Extension Study Period|Lost to Follow-up|6|||
28000977|NCT00751881|54659920|FG000|Extension Study Period|Poor Compliance to Protocol|3|||
28000978|NCT00751881|54659921|FG001|Extension Study Period|Poor Compliance to Protocol|2|||
28000979|NCT00751881|54659922|FG002|Extension Study Period|Poor Compliance to Protocol|1|||
28000980|NCT00751881|54659920|FG000|Extension Study Period|Other than specified above|26|||
28000981|NCT00751881|54659921|FG001|Extension Study Period|Other than specified above|30|||
28000982|NCT00751881|54659922|FG002|Extension Study Period|Other than specified above|18|||
28000983|NCT00747474|54659936|FG000|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
28000984|NCT00747474|54659937|FG001|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
28000985|NCT00747474|54659938|FG002|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
27914746|NCT01117480|54572453|FG000|Overall Study|Protocol Violation|8|||
27914747|NCT01117480|54572453|FG000|Overall Study|Did Not Start Adalimumab Therapy|20|||
27914748|NCT01117051|54572459|FG000|Overall Study|Withdrawal by Subject|5|||
27914749|NCT01117051|54572460|FG001|Overall Study|Withdrawal by Subject|3|||
27914750|NCT01117051|54572459|FG000|Overall Study|Adverse Event|4|||
27914751|NCT01117051|54572460|FG001|Overall Study|Adverse Event|3|||
27914752|NCT01117051|54572459|FG000|Overall Study|Lost to Follow-up|0|||
27914753|NCT01117051|54572460|FG001|Overall Study|Lost to Follow-up|1|||
27914754|NCT01117051|54572459|FG000|Overall Study|Did not meet in-/exclusion criteria|0|||
27914755|NCT01117051|54572460|FG001|Overall Study|Did not meet in-/exclusion criteria|1|||
27914756|NCT01117051|54572459|FG000|Overall Study|Sponsor's decision|3|||
27914757|NCT01117051|54572460|FG001|Overall Study|Sponsor's decision|1|||
27914758|NCT01117051|54572459|FG000|Overall Study|Surgical procedure|0|||
27914759|NCT01117051|54572460|FG001|Overall Study|Surgical procedure|1|||
27914760|NCT01117051|54572459|FG000|Overall Study|Randomized by mistake|0|||
27914761|NCT01117051|54572460|FG001|Overall Study|Randomized by mistake|1|||
27914762|NCT01117051|54572459|FG000|Overall Study|Convenience issue|1|||
28000986|NCT00747474|54659939|FG003|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
28000987|NCT00747474|54659940|FG004|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
28000988|NCT00747474|54659941|FG005|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
28000989|NCT00747474|54659942|FG006|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
28000990|NCT00747474|54659943|FG007|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1|||
28000991|NCT00747474|54659944|FG008|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
28000992|NCT00747474|54659945|FG009|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
28000993|NCT00747474|54659946|FG010|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
28000994|NCT00747474|54659947|FG011|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
28000995|NCT00830063|54659956|FG000|Overall Study|Adverse Event|7|||
28000996|NCT00830063|54659957|FG001|Overall Study|Adverse Event|13|||
28000997|NCT00830063|54659958|FG002|Overall Study|Adverse Event|16|||
27914763|NCT01117051|54572460|FG001|Overall Study|Convenience issue|0|||
28000998|NCT00830063|54659959|FG003|Overall Study|Adverse Event|13|||
27914764|NCT02211417|54572469|FG000|Overall Study|Withdrawal by Subject|11|||
27914765|NCT02211417|54572470|FG001|Overall Study|Withdrawal by Subject|8|||
28000999|NCT00830063|54659956|FG000|Overall Study|Death|1|||
28001000|NCT00830063|54659957|FG001|Overall Study|Death|0|||
28001001|NCT00830063|54659958|FG002|Overall Study|Death|0|||
28001002|NCT00830063|54659959|FG003|Overall Study|Death|0|||
28001003|NCT00830063|54659956|FG000|Overall Study|Lost to Follow-up|0|||
28001004|NCT00830063|54659957|FG001|Overall Study|Lost to Follow-up|0|||
28001005|NCT00830063|54659958|FG002|Overall Study|Lost to Follow-up|3|||
28001006|NCT00830063|54659959|FG003|Overall Study|Lost to Follow-up|1|||
28001007|NCT00830063|54659956|FG000|Overall Study|Preferred Time Entry in Extension Study|119|||
28001008|NCT00830063|54659957|FG001|Overall Study|Preferred Time Entry in Extension Study|139|||
28001009|NCT00830063|54659958|FG002|Overall Study|Preferred Time Entry in Extension Study|127|||
28001010|NCT00830063|54659959|FG003|Overall Study|Preferred Time Entry in Extension Study|126|||
28001011|NCT00830063|54659956|FG000|Overall Study|Lack of Efficacy|51|||
28001012|NCT00830063|54659957|FG001|Overall Study|Lack of Efficacy|23|||
28001013|NCT00830063|54659958|FG002|Overall Study|Lack of Efficacy|25|||
28001014|NCT00830063|54659959|FG003|Overall Study|Lack of Efficacy|32|||
28001015|NCT00830063|54659956|FG000|Overall Study|Other|5|||
28001016|NCT00830063|54659957|FG001|Overall Study|Other|5|||
28001017|NCT00830063|54659958|FG002|Overall Study|Other|8|||
28001018|NCT00830063|54659959|FG003|Overall Study|Other|6|||
28001019|NCT00830063|54659956|FG000|Overall Study|Withdrawal by Subject|16|||
28001020|NCT00830063|54659957|FG001|Overall Study|Withdrawal by Subject|10|||
28001021|NCT00830063|54659958|FG002|Overall Study|Withdrawal by Subject|16|||
28001022|NCT00830063|54659959|FG003|Overall Study|Withdrawal by Subject|13|||
28001023|NCT00830063|54659956|FG000|Overall Study|Protocol Violation|1|||
28001024|NCT00830063|54659957|FG001|Overall Study|Protocol Violation|0|||
28001025|NCT00830063|54659958|FG002|Overall Study|Protocol Violation|3|||
28001026|NCT00830063|54659959|FG003|Overall Study|Protocol Violation|2|||
28001027|NCT00830063|54659956|FG000|Overall Study|Randomized But Not Treated|0|||
28001028|NCT00830063|54659957|FG001|Overall Study|Randomized But Not Treated|2|||
28001029|NCT00830063|54659958|FG002|Overall Study|Randomized But Not Treated|0|||
28001030|NCT00830063|54659959|FG003|Overall Study|Randomized But Not Treated|2|||
28001031|NCT00750438|54659973|FG000|Overall Study|Protocol Violation|4|||
28001032|NCT00750438|54659974|FG001|Overall Study|Protocol Violation|1|||
27914766|NCT02211417|54572469|FG000|Overall Study|Protocol Violation|1|||
27914767|NCT02211417|54572470|FG001|Overall Study|Protocol Violation|0|||
27914768|NCT02211417|54572469|FG000|Overall Study|Pregnancy|0|||
27914769|NCT02211417|54572470|FG001|Overall Study|Pregnancy|1|||
27914770|NCT02211417|54572469|FG000|Overall Study|Lost to Follow-up|2|||
27914771|NCT02211417|54572470|FG001|Overall Study|Lost to Follow-up|3|||
27914772|NCT02211417|54572469|FG000|Overall Study|Adverse Event|1|||
27914773|NCT02211417|54572470|FG001|Overall Study|Adverse Event|4|||
27914774|NCT01117012|54572483|FG000|Overall Study|Adverse Event|0|||
27914775|NCT01117012|54572484|FG001|Overall Study|Adverse Event|1|||
27914776|NCT01117012|54572483|FG000|Overall Study|Death|1|||
28001033|NCT00750438|54659973|FG000|Overall Study|Physician Decision|2|||
28001034|NCT00750438|54659974|FG001|Overall Study|Physician Decision|2|||
28001035|NCT00750438|54659973|FG000|Overall Study|Withdrawal by Subject|1|||
28001036|NCT00750438|54659974|FG001|Overall Study|Withdrawal by Subject|1|||
28001037|NCT00586326|54659980|FG000|Enrollment to Device Placement-Enrolled|Skin Distance|6|||
28001038|NCT00586326|54659980|FG000|Enrollment to Device Placement-Enrolled|Cavity Conformance|4|||
28099909|NCT03518658|54756390|FG000|Overall Study|Other|51|||
28099910|NCT03518658|54756391|FG001|Overall Study|Other|0|||
28099911|NCT03518112|54756399|FG000|Overall Study|Withdrawal by Subject|1|||
27914777|NCT01117012|54572484|FG001|Overall Study|Death|1|||
27914778|NCT01117012|54572483|FG000|Overall Study|Withdrawal by Subject|3|||
27914779|NCT01117012|54572484|FG001|Overall Study|Withdrawal by Subject|0|||
27914780|NCT01117012|54572483|FG000|Overall Study|Undefined|4|||
27914781|NCT01117012|54572484|FG001|Overall Study|Undefined|3|||
27914782|NCT01116739|54572492|FG000|Overall Study|Child had 2 years of HS|110|||
27914783|NCT01116739|54572493|FG001|Overall Study|Child had 2 years of HS|128|||
27914784|NCT01116739|54572492|FG000|Overall Study|Withdrawal by Subject|6|||
27914785|NCT01116739|54572493|FG001|Overall Study|Withdrawal by Subject|0|||
27914786|NCT01116739|54572492|FG000|Overall Study|child too young|2|||
27914787|NCT01116739|54572493|FG001|Overall Study|child too young|6|||
28001039|NCT00586326|54659980|FG000|Enrollment to Device Placement-Enrolled|Microinvasion|2|||
28001040|NCT00586326|54659980|FG000|Enrollment to Device Placement-Enrolled|Physician Decision|1|||
28001041|NCT00586326|54659980|FG000|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1|||
28099912|NCT03706456|54756403|FG000|Overall Study|Lack of Efficacy|1|||
28099913|NCT03706456|54756403|FG000|Overall Study|Ongoing|21|||
28099914|NCT03517566|54756412|FG000|Overall Study|Adverse Event|5|||
27914788|NCT01116739|54572492|FG000|Overall Study|child not enrolled in head start|10|||
28001042|NCT00586326|54659980|FG000|Enrollment to Device Placement-Enrolled|Other|1|||
27914789|NCT01116739|54572493|FG001|Overall Study|child not enrolled in head start|2|||
27914790|NCT01116739|54572492|FG000|Overall Study|enrolled caregiver not legal guardian|2|||
27914791|NCT01116739|54572493|FG001|Overall Study|enrolled caregiver not legal guardian|0|||
28001043|NCT00586326|54659980|FG000|Device Placed toTreatment-ITT|Skin Distance|7|||
28099915|NCT03517566|54756413|FG001|Overall Study|Adverse Event|2|||
27914792|NCT01116544|54572501|FG000|Overall Study|Protocol Violation|1|||
27914793|NCT01116544|54572502|FG001|Overall Study|Protocol Violation|0|||
27914794|NCT01116544|54572501|FG000|Overall Study|Withdrawal by Subject|1|||
27914795|NCT01116544|54572502|FG001|Overall Study|Withdrawal by Subject|1|||
27914796|NCT01116427|54572510|FG000|Core Phase|Adverse Event|0|||
27914797|NCT01116427|54572511|FG001|Core Phase|Adverse Event|1|||
27914798|NCT01116427|54572510|FG000|Core Phase|Lost to Follow-up|1|||
27914799|NCT01116427|54572511|FG001|Core Phase|Lost to Follow-up|0|||
27914800|NCT01116427|54572510|FG000|Core Phase|Withdrawal by Subject|3|||
27914801|NCT01116427|54572511|FG001|Core Phase|Withdrawal by Subject|0|||
27914802|NCT01116427|54572510|FG000|Core Phase|Worsening Multiple Sclerosis|1|||
27914803|NCT01116427|54572511|FG001|Core Phase|Worsening Multiple Sclerosis|0|||
27914804|NCT01116427|54572510|FG000|Extension Phase|Adverse Event|1|||
27914805|NCT01116427|54572511|FG001|Extension Phase|Adverse Event|1|||
27914806|NCT01116427|54572510|FG000|Extension Phase|Lost to Follow-up|2|||
27914807|NCT01116427|54572511|FG001|Extension Phase|Lost to Follow-up|0|||
27914808|NCT01116427|54572510|FG000|Extension Phase|Withdrawal by Subject|5|||
27914809|NCT01116427|54572511|FG001|Extension Phase|Withdrawal by Subject|1|||
28001044|NCT00586326|54659980|FG000|Device Placed toTreatment-ITT|Cavity Conformance|6|||
28001045|NCT00586326|54659980|FG000|Device Placed toTreatment-ITT|Microinvasion|1|||
28001046|NCT00586326|54659980|FG000|Device Placed toTreatment-ITT|Positive Margins|3|||
28001047|NCT00586326|54659980|FG000|Device Placed toTreatment-ITT|Physician Decision|1|||
28001048|NCT00586326|54659980|FG000|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1|||
28001049|NCT00586326|54659980|FG000|Treated Through 5-yr Follow Up-Treated|Death|2|||
28001050|NCT00586326|54659980|FG000|Treated Through 5-yr Follow Up-Treated|Medical Reason|2|||
28001051|NCT00586326|54659980|FG000|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5|||
27914810|NCT01116427|54572510|FG000|Extension Phase|Not using appropriate birth control|1|||
28001052|NCT00586326|54659980|FG000|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14|||
28001053|NCT00586326|54659980|FG000|Treated Through 5-yr Follow Up-Treated|Other|2|||
28001054|NCT00751101|54659990|FG000|Overall Study|Withdrawal by Subject|1|||
28001055|NCT00751101|54659991|FG001|Overall Study|Withdrawal by Subject|0|||
28001056|NCT00751101|54659990|FG000|Overall Study|No HFS / Never Started Patch/|0|||
28001057|NCT00751101|54659991|FG001|Overall Study|No HFS / Never Started Patch/|4|||
28001058|NCT00751101|54659990|FG000|Overall Study|Never began capecitabine|1|||
28001059|NCT00751101|54659991|FG001|Overall Study|Never began capecitabine|0|||
28001060|NCT00751101|54659990|FG000|Overall Study|Physician Decision|0|||
28001061|NCT00751101|54659991|FG001|Overall Study|Physician Decision|1|||
28001062|NCT00750204|54660003|FG000|Overall Study|study halted prematurely|1|||
28001063|NCT00750204|54660004|FG001|Overall Study|study halted prematurely|1|||
27914811|NCT01116427|54572511|FG001|Extension Phase|Not using appropriate birth control|0|||
27914812|NCT01116232|54572521|FG000|Overall Study|Progressive diease|4|||
27914813|NCT01115998|54572530|FG000|Overall Study|Lost to Follow-up|6|||
27914814|NCT01115998|54572531|FG001|Overall Study|Lost to Follow-up|6|||
27914815|NCT01205230|54572539|FG000|Overall Study|Adverse Event|4|||
27914816|NCT01205230|54572540|FG001|Overall Study|Adverse Event|0|||
27914817|NCT01205230|54572539|FG000|Overall Study|Physician Decision|1|||
28001064|NCT00751023|54660012|FG000|Overall Study|Lost to Follow-up|11|||
28001065|NCT00751023|54660013|FG001|Overall Study|Lost to Follow-up|7|||
28001066|NCT00591773|54660022|FG000|Overall Study|Adverse Event|9|||
28001067|NCT00591773|54660023|FG001|Overall Study|Adverse Event|9|||
28001068|NCT00591773|54660024|FG002|Overall Study|Adverse Event|6|||
28001069|NCT00591773|54660022|FG000|Overall Study|Protocol Violation|2|||
28001070|NCT00591773|54660023|FG001|Overall Study|Protocol Violation|3|||
28001071|NCT00591773|54660024|FG002|Overall Study|Protocol Violation|0|||
28001072|NCT00591773|54660022|FG000|Overall Study|Lost to Follow-up|1|||
28001073|NCT00591773|54660023|FG001|Overall Study|Lost to Follow-up|4|||
28001074|NCT00591773|54660024|FG002|Overall Study|Lost to Follow-up|1|||
28001075|NCT00591773|54660022|FG000|Overall Study|Withdrawal by Subject|2|||
28001076|NCT00591773|54660023|FG001|Overall Study|Withdrawal by Subject|5|||
28001077|NCT00591773|54660024|FG002|Overall Study|Withdrawal by Subject|3|||
28001078|NCT00591773|54660022|FG000|Overall Study|Lack of Efficacy|1|||
28001079|NCT00591773|54660023|FG001|Overall Study|Lack of Efficacy|2|||
28099916|NCT03517566|54756414|FG002|Overall Study|Adverse Event|2|||
27914818|NCT01205230|54572540|FG001|Overall Study|Physician Decision|0|||
28001080|NCT00591773|54660024|FG002|Overall Study|Lack of Efficacy|2|||
28001081|NCT00591773|54660022|FG000|Overall Study|Other|1|||
28001082|NCT00591773|54660023|FG001|Overall Study|Other|1|||
28001083|NCT00591773|54660024|FG002|Overall Study|Other|4|||
28001084|NCT00750867|54660032|FG000|Overall Study|Adverse Event|2|||
28001085|NCT00744042|54660036|FG000|Overall Study|Withdrawal by Subject|1|||
27914819|NCT01205152|54572551|FG000|Overall Study|Death|1|||
27914820|NCT01205035|54572559|FG000|Overall Study|Withdrawal by Subject|1|||
27914821|NCT01205035|54572560|FG001|Overall Study|Withdrawal by Subject|0|||
27914822|NCT01205035|54572559|FG000|Overall Study|Physician Decision|1|||
27914823|NCT01205035|54572560|FG001|Overall Study|Physician Decision|0|||
27914824|NCT01204918|54572569|FG000|Overall Study|Withdrawal by Subject|4|||
28001086|NCT00829829|54660049|FG000|Overall Study|Protocol Violation|0|||
28001087|NCT00829829|54660050|FG001|Overall Study|Protocol Violation|3|||
28001088|NCT00829829|54660051|FG002|Overall Study|Protocol Violation|0|||
28001089|NCT00829829|54660049|FG000|Overall Study|Adverse Event|4|||
28001090|NCT00829829|54660050|FG001|Overall Study|Adverse Event|4|||
28001091|NCT00829829|54660051|FG002|Overall Study|Adverse Event|3|||
28001092|NCT00829829|54660049|FG000|Overall Study|Withdrawal by Subject|8|||
28001093|NCT00829829|54660050|FG001|Overall Study|Withdrawal by Subject|4|||
28001094|NCT00829829|54660051|FG002|Overall Study|Withdrawal by Subject|2|||
28001095|NCT00829829|54660049|FG000|Overall Study|Decision by the Sponsor|1|||
28001096|NCT00829829|54660050|FG001|Overall Study|Decision by the Sponsor|0|||
28001097|NCT00829829|54660051|FG002|Overall Study|Decision by the Sponsor|2|||
28001098|NCT00829829|54660049|FG000|Overall Study|Lost to Follow-up|7|||
28001099|NCT00829829|54660050|FG001|Overall Study|Lost to Follow-up|3|||
28001100|NCT00829829|54660051|FG002|Overall Study|Lost to Follow-up|3|||
28001101|NCT00829829|54660049|FG000|Overall Study|Other than specified above|2|||
28001102|NCT00829829|54660050|FG001|Overall Study|Other than specified above|2|||
28001103|NCT00829829|54660051|FG002|Overall Study|Other than specified above|1|||
28001104|NCT00823199|54660060|FG000|Overall Study|Withdrawal by Subject|2|||
28001105|NCT00829439|54660065|FG000|Overall Study|Adverse Event|0|||
28001106|NCT00829439|54660066|FG001|Overall Study|Adverse Event|0|||
28001107|NCT00829439|54660067|FG002|Overall Study|Adverse Event|1|||
28001108|NCT00829439|54660068|FG003|Overall Study|Adverse Event|0|||
28001109|NCT00749775|54660072|FG000|Overall Study|Protocol Violation|24|||
28001110|NCT00749775|54660072|FG000|Overall Study|Lost to Follow-up|36|||
28001111|NCT00749775|54660072|FG000|Overall Study|No visit after first day of treatment|44|||
28099917|NCT03517566|54756415|FG003|Overall Study|Adverse Event|8|||
28099918|NCT03517566|54756416|FG004|Overall Study|Adverse Event|7|||
28099919|NCT03517566|54756412|FG000|Overall Study|Lack of Efficacy|3|||
28099920|NCT03517566|54756413|FG001|Overall Study|Lack of Efficacy|2|||
28099921|NCT03517566|54756414|FG002|Overall Study|Lack of Efficacy|1|||
28099922|NCT03517566|54756415|FG003|Overall Study|Lack of Efficacy|1|||
28099923|NCT03517566|54756416|FG004|Overall Study|Lack of Efficacy|4|||
28099924|NCT03517566|54756412|FG000|Overall Study|Lost to Follow-up|3|||
28099925|NCT03517566|54756413|FG001|Overall Study|Lost to Follow-up|1|||
28099926|NCT03517566|54756414|FG002|Overall Study|Lost to Follow-up|1|||
28099927|NCT03517566|54756415|FG003|Overall Study|Lost to Follow-up|1|||
28099928|NCT03517566|54756416|FG004|Overall Study|Lost to Follow-up|0|||
28099929|NCT03517566|54756412|FG000|Overall Study|Physician Decision|1|||
28099930|NCT03517566|54756413|FG001|Overall Study|Physician Decision|1|||
28099931|NCT03517566|54756414|FG002|Overall Study|Physician Decision|0|||
28099932|NCT03517566|54756415|FG003|Overall Study|Physician Decision|1|||
28099933|NCT03517566|54756416|FG004|Overall Study|Physician Decision|0|||
28099934|NCT03517566|54756412|FG000|Overall Study|Pregnancy|0|||
28099935|NCT03517566|54756413|FG001|Overall Study|Pregnancy|1|||
28099936|NCT03517566|54756414|FG002|Overall Study|Pregnancy|0|||
28099937|NCT03517566|54756415|FG003|Overall Study|Pregnancy|0|||
28099938|NCT03517566|54756416|FG004|Overall Study|Pregnancy|0|||
28099939|NCT03517566|54756412|FG000|Overall Study|Protocol Deviation|0|||
28099940|NCT03517566|54756413|FG001|Overall Study|Protocol Deviation|1|||
28099941|NCT03517566|54756414|FG002|Overall Study|Protocol Deviation|0|||
28099942|NCT03517566|54756415|FG003|Overall Study|Protocol Deviation|1|||
28099943|NCT03517566|54756416|FG004|Overall Study|Protocol Deviation|1|||
28099944|NCT03517566|54756412|FG000|Overall Study|Study terminated by Sponsor|11|||
28099945|NCT03517566|54756413|FG001|Overall Study|Study terminated by Sponsor|5|||
28099946|NCT03517566|54756414|FG002|Overall Study|Study terminated by Sponsor|6|||
28099947|NCT03517566|54756415|FG003|Overall Study|Study terminated by Sponsor|14|||
28099948|NCT03517566|54756416|FG004|Overall Study|Study terminated by Sponsor|12|||
27914825|NCT01204918|54572570|FG001|Overall Study|Withdrawal by Subject|10|||
27914826|NCT01204918|54572571|FG002|Overall Study|Withdrawal by Subject|5|||
27914827|NCT01204294|54572586|FG000|Overall Study|Adverse Event|2|||
27914828|NCT01204294|54572587|FG001|Overall Study|Adverse Event|6|||
27914829|NCT01204294|54572588|FG002|Overall Study|Adverse Event|0|||
27914830|NCT01204294|54572589|FG003|Overall Study|Adverse Event|7|||
27914831|NCT01204294|54572590|FG004|Overall Study|Adverse Event|1|||
27914832|NCT01204294|54572591|FG005|Overall Study|Adverse Event|4|||
27914833|NCT01204294|54572592|FG006|Overall Study|Adverse Event|0|||
27914834|NCT01204294|54572586|FG000|Overall Study|Protocol Violation|1|||
28099949|NCT03517566|54756412|FG000|Overall Study|Subject Decision /Guardian Decision|9|||
28099950|NCT03517566|54756413|FG001|Overall Study|Subject Decision /Guardian Decision|8|||
28099951|NCT03517566|54756414|FG002|Overall Study|Subject Decision /Guardian Decision|5|||
28099952|NCT03517566|54756415|FG003|Overall Study|Subject Decision /Guardian Decision|8|||
27914835|NCT01204294|54572587|FG001|Overall Study|Protocol Violation|0|||
27914836|NCT01204294|54572588|FG002|Overall Study|Protocol Violation|2|||
27914837|NCT01204294|54572589|FG003|Overall Study|Protocol Violation|1|||
28001112|NCT00749775|54660072|FG000|Overall Study|No drug administration|3|||
28001113|NCT00829283|54660088|FG000|Overall Study|Lost to Follow-up|7|||
28001114|NCT00829283|54660089|FG001|Overall Study|Lost to Follow-up|25|||
28099953|NCT03517566|54756416|FG004|Overall Study|Subject Decision /Guardian Decision|8|||
28099954|NCT03916744|54756432|FG000|Overall Study|Withdrawal by Subject|0|||
28001115|NCT00821873|54660095|FG000|Overall Study|Lost to Follow-up|4|||
28001116|NCT00749463|54660102|FG000|Overall Study|Adverse Event|0|||
28001117|NCT00749463|54660103|FG001|Overall Study|Adverse Event|4|||
28001118|NCT00749463|54660104|FG002|Overall Study|Adverse Event|1|||
28001119|NCT00749463|54660102|FG000|Overall Study|Withdrawal by Subject|1|||
28001120|NCT00749463|54660103|FG001|Overall Study|Withdrawal by Subject|0|||
28001121|NCT00749463|54660104|FG002|Overall Study|Withdrawal by Subject|0|||
28001122|NCT00821327|54660112|FG000|Overall Study|Adverse Event|13|||
27914838|NCT01204294|54572590|FG004|Overall Study|Protocol Violation|0|||
27914839|NCT01204294|54572591|FG005|Overall Study|Protocol Violation|0|||
27914840|NCT01204294|54572592|FG006|Overall Study|Protocol Violation|0|||
27914841|NCT01204294|54572586|FG000|Overall Study|Withdrawal by Subject|0|||
27914842|NCT01204294|54572587|FG001|Overall Study|Withdrawal by Subject|2|||
27914843|NCT01204294|54572588|FG002|Overall Study|Withdrawal by Subject|2|||
27914844|NCT01204294|54572589|FG003|Overall Study|Withdrawal by Subject|1|||
27914845|NCT01204294|54572590|FG004|Overall Study|Withdrawal by Subject|1|||
27914846|NCT01204294|54572591|FG005|Overall Study|Withdrawal by Subject|1|||
27914847|NCT01204294|54572592|FG006|Overall Study|Withdrawal by Subject|2|||
27914848|NCT01204294|54572586|FG000|Overall Study|Lack of Efficacy|0|||
27914849|NCT01204294|54572587|FG001|Overall Study|Lack of Efficacy|0|||
27914850|NCT01204294|54572588|FG002|Overall Study|Lack of Efficacy|0|||
27914851|NCT01204294|54572589|FG003|Overall Study|Lack of Efficacy|2|||
27914852|NCT01204294|54572590|FG004|Overall Study|Lack of Efficacy|0|||
27914853|NCT01204294|54572591|FG005|Overall Study|Lack of Efficacy|0|||
27914854|NCT01204294|54572592|FG006|Overall Study|Lack of Efficacy|0|||
27914855|NCT01204294|54572586|FG000|Overall Study|Other (house moving)|0|||
27914856|NCT01204294|54572587|FG001|Overall Study|Other (house moving)|0|||
27914857|NCT01204294|54572588|FG002|Overall Study|Other (house moving)|1|||
27914858|NCT01204294|54572589|FG003|Overall Study|Other (house moving)|0|||
27914859|NCT01204294|54572590|FG004|Overall Study|Other (house moving)|0|||
27914860|NCT01204294|54572591|FG005|Overall Study|Other (house moving)|0|||
27914861|NCT01204294|54572592|FG006|Overall Study|Other (house moving)|0|||
27914862|NCT01182181|54572610|FG000|First Intervention|Adverse Event|1|||
27914863|NCT01182181|54572611|FG001|First Intervention|Adverse Event|0|||
27914864|NCT01182181|54572610|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
27914865|NCT01182181|54572611|FG001|Washout of 21 Days|Withdrawal by Subject|1|||
27914866|NCT01181986|54572619|FG000|Phase 1|Lost to Follow-up|0|||
27914867|NCT01181986|54572620|FG001|Phase 1|Lost to Follow-up|1|||
27914868|NCT01181986|54572621|FG002|Phase 1|Lost to Follow-up|1|||
27914869|NCT01181986|54572619|FG000|Phase 1|Adverse Event|0|||
27914870|NCT01181986|54572620|FG001|Phase 1|Adverse Event|0|||
27914871|NCT01181986|54572621|FG002|Phase 1|Adverse Event|1|||
27914872|NCT01181986|54572619|FG000|Phase 1|Protocol Violation|1|||
27914873|NCT01181986|54572620|FG001|Phase 1|Protocol Violation|0|||
27914874|NCT01181986|54572621|FG002|Phase 1|Protocol Violation|0|||
27914875|NCT01181986|54572619|FG000|Phase 2|Adverse Event|0|||
27914876|NCT01181986|54572620|FG001|Phase 2|Adverse Event|3|||
27914877|NCT01181986|54572621|FG002|Phase 2|Adverse Event|0|||
27914878|NCT01181986|54572619|FG000|Phase 2|Medical condition|0|||
27914879|NCT01181986|54572620|FG001|Phase 2|Medical condition|1|||
27914880|NCT01181986|54572621|FG002|Phase 2|Medical condition|0|||
27914881|NCT01181167|54572637|FG000|Overall Study|Adverse Event|11|||
27914882|NCT01181167|54572638|FG001|Overall Study|Adverse Event|21|||
27914883|NCT01181167|54572637|FG000|Overall Study|Lost to Follow-up|1|||
28001123|NCT00821327|54660112|FG000|Overall Study|Patient Request|1|||
28001124|NCT00821327|54660112|FG000|Overall Study|Investigator Request|2|||
28001125|NCT00821327|54660112|FG000|Overall Study|Sponsor Request|1|||
28001126|NCT00821327|54660112|FG000|Overall Study|Disease Progression|13|||
28001127|NCT00821327|54660112|FG000|Overall Study|Other/Unknown|5|||
28001128|NCT00821093|54660118|FG000|Overall Study|Adverse Event|20|||
28001129|NCT00821093|54660119|FG001|Overall Study|Adverse Event|12|||
27914884|NCT01181167|54572638|FG001|Overall Study|Lost to Follow-up|0|||
27914885|NCT01181167|54572637|FG000|Overall Study|Physician Decision|2|||
27914886|NCT01181167|54572638|FG001|Overall Study|Physician Decision|3|||
28001130|NCT00821093|54660118|FG000|Overall Study|Withdrawal by Subject|9|||
28001131|NCT00821093|54660119|FG001|Overall Study|Withdrawal by Subject|13|||
28001132|NCT00821093|54660118|FG000|Overall Study|Lost to Follow-up|9|||
27914887|NCT01181167|54572637|FG000|Overall Study|Protocol Violation|3|||
27914888|NCT01181167|54572638|FG001|Overall Study|Protocol Violation|0|||
27914889|NCT01181167|54572637|FG000|Overall Study|Withdrawal by Subject|6|||
27914890|NCT01181167|54572638|FG001|Overall Study|Withdrawal by Subject|8|||
27914891|NCT01181128|54572647|FG000|Overall Study|Withdrawal by Subject|2|||
27914892|NCT01181128|54572648|FG001|Overall Study|Withdrawal by Subject|2|||
27914893|NCT01181128|54572649|FG002|Overall Study|Withdrawal by Subject|0|||
27914894|NCT01181128|54572647|FG000|Overall Study|Death|1|||
27914895|NCT01181128|54572648|FG001|Overall Study|Death|0|||
27914896|NCT01181128|54572649|FG002|Overall Study|Death|0|||
28001133|NCT00821093|54660119|FG001|Overall Study|Lost to Follow-up|3|||
28001134|NCT00821093|54660118|FG000|Overall Study|Protocol deviation|3|||
28001135|NCT00821093|54660119|FG001|Overall Study|Protocol deviation|6|||
27914897|NCT01181128|54572647|FG000|Overall Study|Physician Decision|2|||
27914898|NCT01181128|54572648|FG001|Overall Study|Physician Decision|0|||
27914899|NCT01181128|54572649|FG002|Overall Study|Physician Decision|0|||
27914900|NCT01181128|54572647|FG000|Overall Study|Adverse Event|0|||
27914901|NCT01181128|54572648|FG001|Overall Study|Adverse Event|2|||
27914902|NCT01181128|54572649|FG002|Overall Study|Adverse Event|0|||
27914903|NCT01181128|54572647|FG000|Overall Study|Other|1|||
27914904|NCT01181128|54572648|FG001|Overall Study|Other|1|||
27914905|NCT01181128|54572649|FG002|Overall Study|Other|1|||
28001136|NCT00821093|54660118|FG000|Overall Study|Abnormal laboratory value(s)|2|||
28001137|NCT00821093|54660119|FG001|Overall Study|Abnormal laboratory value(s)|0|||
28001138|NCT00821093|54660118|FG000|Overall Study|Lack of Efficacy|2|||
28001139|NCT00821093|54660119|FG001|Overall Study|Lack of Efficacy|2|||
28001140|NCT00821093|54660118|FG000|Overall Study|Death|2|||
28001141|NCT00821093|54660119|FG001|Overall Study|Death|1|||
28001142|NCT00821093|54660118|FG000|Overall Study|Abnormal test procedure result(s)|1|||
28099955|NCT03916744|54756433|FG001|Overall Study|Withdrawal by Subject|1|||
28099956|NCT03916744|54756434|FG002|Overall Study|Withdrawal by Subject|2|||
28099957|NCT03639610|54756449|FG000|Overall Study|Adverse Event|7|||
28099958|NCT03639610|54756450|FG001|Overall Study|Adverse Event|1|||
28099959|NCT03639610|54756451|FG002|Overall Study|Adverse Event|0|||
28099960|NCT03639610|54756449|FG000|Overall Study|Physician Decision|3|||
28099961|NCT03639610|54756450|FG001|Overall Study|Physician Decision|1|||
28099962|NCT03639610|54756451|FG002|Overall Study|Physician Decision|0|||
28099963|NCT03639610|54756449|FG000|Overall Study|Disease progression|8|||
28099964|NCT03639610|54756450|FG001|Overall Study|Disease progression|5|||
28099965|NCT03639610|54756451|FG002|Overall Study|Disease progression|3|||
28099966|NCT03639610|54756449|FG000|Overall Study|Study terminated by sponsor|2|||
28099967|NCT03639610|54756450|FG001|Overall Study|Study terminated by sponsor|1|||
28099968|NCT03639610|54756451|FG002|Overall Study|Study terminated by sponsor|1|||
28099969|NCT03639610|54756449|FG000|Overall Study|Patient request to stop treatment|1|||
28099970|NCT03639610|54756450|FG001|Overall Study|Patient request to stop treatment|2|||
28099971|NCT03639610|54756451|FG002|Overall Study|Patient request to stop treatment|0|||
28099972|NCT02954406|54756469|FG000|Overall Study|Adverse Event|0|||
28099973|NCT02954406|54756470|FG001|Overall Study|Adverse Event|1|||
28099974|NCT02954406|54756471|FG002|Overall Study|Adverse Event|0|||
28099975|NCT02954406|54756472|FG003|Overall Study|Adverse Event|0|||
28099976|NCT02954406|54756473|FG004|Overall Study|Adverse Event|1|||
28099977|NCT02954406|54756474|FG005|Overall Study|Adverse Event|0|||
28099978|NCT02954406|54756475|FG006|Overall Study|Adverse Event|0|||
28099979|NCT02954406|54756476|FG007|Overall Study|Adverse Event|0|||
28099980|NCT02954406|54756477|FG008|Overall Study|Adverse Event|1|||
28099981|NCT02954406|54756478|FG009|Overall Study|Adverse Event|1|||
28099982|NCT02954406|54756479|FG010|Overall Study|Adverse Event|0|||
28099983|NCT02954406|54756469|FG000|Overall Study|Progressive Disease|3|||
28099984|NCT02954406|54756470|FG001|Overall Study|Progressive Disease|4|||
28099985|NCT02954406|54756471|FG002|Overall Study|Progressive Disease|3|||
28099986|NCT02954406|54756472|FG003|Overall Study|Progressive Disease|4|||
27914906|NCT01203787|54572671|FG000|Overall Study|Death|12|||
27914907|NCT01203787|54572672|FG001|Overall Study|Death|10|||
27914908|NCT01203787|54572671|FG000|Overall Study|Withdrawal by Subject|6|||
27914909|NCT01203787|54572672|FG001|Overall Study|Withdrawal by Subject|2|||
27914910|NCT01203787|54572671|FG000|Overall Study|Lost to Follow-up|2|||
27914911|NCT01203787|54572672|FG001|Overall Study|Lost to Follow-up|0|||
27914912|NCT01203787|54572671|FG000|Overall Study|Adverse Event|11|||
27914913|NCT01203787|54572672|FG001|Overall Study|Adverse Event|15|||
27914914|NCT01181011|54572680|FG000|Overall Study|Adverse Event|2|||
27914915|NCT01181011|54572680|FG000|Overall Study|Lost to Follow-up|1|||
27914916|NCT01180777|54572689|FG000|Overall Study|Protocol Violation|6|||
27914917|NCT01180777|54572689|FG000|Overall Study|Poor lens fit|4|||
27914918|NCT01180777|54572689|FG000|Overall Study|Lost to Follow-up|1|||
27914919|NCT01180777|54572689|FG000|Overall Study|Adverse Event|1|||
27914920|NCT01648023|54572697|FG000|Overall Study|Screen Fail Post Randomization|1|||
27914921|NCT01648023|54572698|FG001|Overall Study|Screen Fail Post Randomization|2|||
27914922|NCT02756208|54572712|FG000|Overall Study|Withdrawal by Subject|1|||
27914923|NCT02756208|54572713|FG001|Overall Study|Withdrawal by Subject|0|||
28001143|NCT00821093|54660119|FG001|Overall Study|Abnormal test procedure result(s)|1|||
28099987|NCT02954406|54756473|FG004|Overall Study|Progressive Disease|3|||
28099988|NCT02954406|54756474|FG005|Overall Study|Progressive Disease|3|||
28099989|NCT02954406|54756475|FG006|Overall Study|Progressive Disease|2|||
28099990|NCT02954406|54756476|FG007|Overall Study|Progressive Disease|2|||
28099991|NCT02954406|54756477|FG008|Overall Study|Progressive Disease|1|||
28099992|NCT02954406|54756478|FG009|Overall Study|Progressive Disease|1|||
28099993|NCT02954406|54756479|FG010|Overall Study|Progressive Disease|0|||
27914924|NCT02756208|54572714|FG002|Overall Study|Withdrawal by Subject|1|||
27914925|NCT02756208|54572715|FG003|Overall Study|Withdrawal by Subject|3|||
27914926|NCT02756208|54572712|FG000|Overall Study|Lost to Follow-up|3|||
27914927|NCT02756208|54572713|FG001|Overall Study|Lost to Follow-up|1|||
28001144|NCT00821093|54660118|FG000|Overall Study|Administrative problems|1|||
27914928|NCT02756208|54572714|FG002|Overall Study|Lost to Follow-up|1|||
27914929|NCT02756208|54572715|FG003|Overall Study|Lost to Follow-up|1|||
27914930|NCT02756208|54572712|FG000|Overall Study|Physician Decision|1|||
27914931|NCT02756208|54572713|FG001|Overall Study|Physician Decision|0|||
27914932|NCT02756208|54572714|FG002|Overall Study|Physician Decision|0|||
27914933|NCT02756208|54572715|FG003|Overall Study|Physician Decision|0|||
27914934|NCT02756208|54572712|FG000|Overall Study|Protocol Violation|0|||
27914935|NCT02756208|54572713|FG001|Overall Study|Protocol Violation|1|||
27914936|NCT02756208|54572714|FG002|Overall Study|Protocol Violation|0|||
27914937|NCT02756208|54572715|FG003|Overall Study|Protocol Violation|0|||
27914938|NCT02756013|54572725|FG000|Overall Study|Adverse Event|1|||
27914939|NCT02756013|54572725|FG000|Overall Study|Hypersensitivity|1|||
27914940|NCT01202773|54572732|FG000|Overall Study|Adverse Event|4|||
27914941|NCT01202773|54572733|FG001|Overall Study|Adverse Event|5|||
27914942|NCT01202773|54572734|FG002|Overall Study|Adverse Event|5|||
27914943|NCT01202773|54572732|FG000|Overall Study|Lack of Efficacy|5|||
27914944|NCT01202773|54572733|FG001|Overall Study|Lack of Efficacy|4|||
28001145|NCT00821093|54660119|FG001|Overall Study|Administrative problems|2|||
28001146|NCT00821015|54660125|FG000|Overall Study|Lost to Follow-up|12|||
28001147|NCT00814463|54660129|FG000|Overall Study|Lost to Follow-up|1|||
28001148|NCT00743652|54660139|FG000|Overall Study|Parent/Legal Guardian Request|3|||
28001149|NCT00743652|54660140|FG001|Overall Study|Parent/Legal Guardian Request|2|||
28001150|NCT00743652|54660141|FG002|Overall Study|Parent/Legal Guardian Request|2|||
27914945|NCT01202773|54572734|FG002|Overall Study|Lack of Efficacy|9|||
27914946|NCT01202773|54572732|FG000|Overall Study|Entry Criteria Not Met|2|||
27914947|NCT01202773|54572733|FG001|Overall Study|Entry Criteria Not Met|0|||
27914948|NCT01202773|54572734|FG002|Overall Study|Entry Criteria Not Met|1|||
27914949|NCT01202773|54572732|FG000|Overall Study|Lost to Follow-up|1|||
27914950|NCT01202773|54572733|FG001|Overall Study|Lost to Follow-up|2|||
27914951|NCT01202773|54572734|FG002|Overall Study|Lost to Follow-up|2|||
27914952|NCT01202773|54572732|FG000|Overall Study|Withdrawal by Subject|13|||
27914953|NCT01202773|54572733|FG001|Overall Study|Withdrawal by Subject|6|||
27914954|NCT01202773|54572734|FG002|Overall Study|Withdrawal by Subject|5|||
27914955|NCT01202773|54572732|FG000|Overall Study|Physician Decision|2|||
27914956|NCT01202773|54572733|FG001|Overall Study|Physician Decision|0|||
27914957|NCT01202773|54572734|FG002|Overall Study|Physician Decision|0|||
28001151|NCT00743652|54660142|FG003|Overall Study|Parent/Legal Guardian Request|2|||
28001152|NCT00743652|54660143|FG004|Overall Study|Parent/Legal Guardian Request|0|||
28001153|NCT00743652|54660139|FG000|Overall Study|Adverse Event|3|||
28001154|NCT00743652|54660140|FG001|Overall Study|Adverse Event|0|||
28001155|NCT00743652|54660141|FG002|Overall Study|Adverse Event|0|||
28001156|NCT00743652|54660142|FG003|Overall Study|Adverse Event|0|||
28001157|NCT00743652|54660143|FG004|Overall Study|Adverse Event|0|||
28001158|NCT00743652|54660139|FG000|Overall Study|Death|2|||
28001159|NCT00743652|54660140|FG001|Overall Study|Death|0|||
28099994|NCT02954406|54756469|FG000|Overall Study|Symptomatic Deterioration|0|||
28099995|NCT02954406|54756470|FG001|Overall Study|Symptomatic Deterioration|1|||
28099996|NCT02954406|54756471|FG002|Overall Study|Symptomatic Deterioration|0|||
28001160|NCT00743652|54660141|FG002|Overall Study|Death|0|||
28001161|NCT00743652|54660142|FG003|Overall Study|Death|0|||
28001162|NCT00743652|54660143|FG004|Overall Study|Death|0|||
28001163|NCT00743652|54660139|FG000|Overall Study|Investigator Request|0|||
28001164|NCT00743652|54660140|FG001|Overall Study|Investigator Request|0|||
28001165|NCT00743652|54660141|FG002|Overall Study|Investigator Request|0|||
28001166|NCT00743652|54660142|FG003|Overall Study|Investigator Request|2|||
28001167|NCT00743652|54660143|FG004|Overall Study|Investigator Request|0|||
28001168|NCT00743652|54660139|FG000|Overall Study|Other|1|||
28001169|NCT00743652|54660140|FG001|Overall Study|Other|1|||
28099997|NCT02954406|54756472|FG003|Overall Study|Symptomatic Deterioration|0|||
28099998|NCT02954406|54756473|FG004|Overall Study|Symptomatic Deterioration|0|||
28099999|NCT02954406|54756474|FG005|Overall Study|Symptomatic Deterioration|0|||
28100000|NCT02954406|54756475|FG006|Overall Study|Symptomatic Deterioration|0|||
28100001|NCT02954406|54756476|FG007|Overall Study|Symptomatic Deterioration|0|||
28100002|NCT02954406|54756477|FG008|Overall Study|Symptomatic Deterioration|0|||
28100003|NCT02954406|54756478|FG009|Overall Study|Symptomatic Deterioration|0|||
28100004|NCT02954406|54756479|FG010|Overall Study|Symptomatic Deterioration|0|||
28100005|NCT02954406|54756469|FG000|Overall Study|Death|0|||
28100006|NCT02954406|54756470|FG001|Overall Study|Death|0|||
27914958|NCT01202773|54572732|FG000|Overall Study|Protocol Violation|11|||
27914959|NCT01202773|54572733|FG001|Overall Study|Protocol Violation|6|||
27914960|NCT01202773|54572734|FG002|Overall Study|Protocol Violation|10|||
27914961|NCT01202773|54572732|FG000|Overall Study|Sponsor Decision|19|||
27914962|NCT01202773|54572733|FG001|Overall Study|Sponsor Decision|20|||
27914963|NCT01202773|54572734|FG002|Overall Study|Sponsor Decision|23|||
27914964|NCT01180660|54572754|FG000|Overall Study|Changed to open surgery|1|||
28001170|NCT00743652|54660141|FG002|Overall Study|Other|0|||
28001171|NCT00743652|54660142|FG003|Overall Study|Other|0|||
28001172|NCT00743652|54660143|FG004|Overall Study|Other|0|||
28001173|NCT00743652|54660139|FG000|Overall Study|Lost to Follow-up|1|||
27914965|NCT01180660|54572755|FG001|Overall Study|Changed to open surgery|0|||
27914966|NCT01202227|54572761|FG000|Overall Study|Adverse Event|16|||
27914967|NCT01202227|54572761|FG000|Overall Study|Withdrawal by Subject|2|||
27914968|NCT01202227|54572761|FG000|Overall Study|Lack of Efficacy|1|||
27914969|NCT01202188|54572770|FG000|Overall Study|Protocol deviation|14|||
27914970|NCT01202188|54572771|FG001|Overall Study|Protocol deviation|8|||
27914971|NCT01202188|54572772|FG002|Overall Study|Protocol deviation|12|||
28100007|NCT02954406|54756471|FG002|Overall Study|Death|0|||
28100008|NCT02954406|54756472|FG003|Overall Study|Death|0|||
28100009|NCT02954406|54756473|FG004|Overall Study|Death|1|||
28100010|NCT02954406|54756474|FG005|Overall Study|Death|0|||
28100011|NCT02954406|54756475|FG006|Overall Study|Death|0|||
28100012|NCT02954406|54756476|FG007|Overall Study|Death|0|||
28100013|NCT02954406|54756477|FG008|Overall Study|Death|1|||
28100014|NCT02954406|54756478|FG009|Overall Study|Death|1|||
28100015|NCT02954406|54756479|FG010|Overall Study|Death|0|||
28100016|NCT02954406|54756469|FG000|Overall Study|Reason Not Specified|0|||
28100017|NCT02954406|54756470|FG001|Overall Study|Reason Not Specified|0|||
28100018|NCT02954406|54756471|FG002|Overall Study|Reason Not Specified|3|||
28100019|NCT02954406|54756472|FG003|Overall Study|Reason Not Specified|2|||
28100020|NCT02954406|54756473|FG004|Overall Study|Reason Not Specified|2|||
28100021|NCT02954406|54756474|FG005|Overall Study|Reason Not Specified|0|||
28100022|NCT02954406|54756475|FG006|Overall Study|Reason Not Specified|1|||
28001174|NCT00743652|54660140|FG001|Overall Study|Lost to Follow-up|0|||
28001175|NCT00743652|54660141|FG002|Overall Study|Lost to Follow-up|0|||
28001176|NCT00743652|54660142|FG003|Overall Study|Lost to Follow-up|0|||
28001177|NCT00743652|54660143|FG004|Overall Study|Lost to Follow-up|0|||
28001178|NCT00748215|54660161|FG000|Overall Study|Withdrawal by Subject|7|||
28001179|NCT00748215|54660162|FG001|Overall Study|Withdrawal by Subject|7|||
28001180|NCT00748215|54660161|FG000|Overall Study|Treatment change|2|||
28001181|NCT00748215|54660162|FG001|Overall Study|Treatment change|1|||
28001182|NCT00748215|54660161|FG000|Overall Study|Change in patient condition|0|||
28001183|NCT00748215|54660162|FG001|Overall Study|Change in patient condition|3|||
28001184|NCT00748215|54660161|FG000|Overall Study|Non-compliant|0|||
28001185|NCT00748215|54660162|FG001|Overall Study|Non-compliant|2|||
28001186|NCT00748215|54660161|FG000|Overall Study|Adverse Event|0|||
28001187|NCT00748215|54660162|FG001|Overall Study|Adverse Event|5|||
28001188|NCT00749892|54660168|FG000|Overall Study|Withdrawal by Subject|3|||
28001189|NCT00749580|54660174|FG000|Overall Study|Lost to Follow-up|4|||
28001190|NCT00749580|54660175|FG001|Overall Study|Lost to Follow-up|8|||
28001191|NCT00749580|54660174|FG000|Overall Study|Adverse Event|0|||
28001192|NCT00749580|54660175|FG001|Overall Study|Adverse Event|1|||
28001193|NCT00747006|54660184|FG000|Overall Study|Adverse Event|1|||
28001194|NCT00747006|54660185|FG001|Overall Study|Adverse Event|0|||
28001195|NCT00747006|54660186|FG002|Overall Study|Adverse Event|0|||
28001196|NCT00747006|54660184|FG000|Overall Study|Lost to Follow-up|0|||
28001197|NCT00747006|54660185|FG001|Overall Study|Lost to Follow-up|1|||
28001198|NCT00747006|54660186|FG002|Overall Study|Lost to Follow-up|0|||
28001199|NCT00747006|54660184|FG000|Overall Study|Physician Decision|2|||
28001200|NCT00747006|54660185|FG001|Overall Study|Physician Decision|0|||
28001201|NCT00747006|54660186|FG002|Overall Study|Physician Decision|1|||
28001202|NCT00743340|54660197|FG000|Overall Study|Study medication non-compliance|1|||
28001203|NCT00743340|54660197|FG000|Overall Study|Lost to Follow-up|1|||
28001204|NCT00743340|54660197|FG000|Overall Study|Withdrawal from the Study|5|||
28001205|NCT00743340|54660197|FG000|Overall Study|Protocol Violation|1|||
28001206|NCT00743340|54660197|FG000|Overall Study|Virologic failure|8|||
28001207|NCT00743340|54660197|FG000|Overall Study|Pregnancy|1|||
28001208|NCT00743340|54660197|FG000|Overall Study|Rolled over to other Gilead Study|23|||
28001209|NCT00743340|54660197|FG000|Overall Study|Participant Relocated|1|||
28001210|NCT00749190|54660208|FG000|Overall Study|Adverse Event|0|||
28001211|NCT00749190|54660209|FG001|Overall Study|Adverse Event|2|||
28001212|NCT00749190|54660210|FG002|Overall Study|Adverse Event|0|||
28001213|NCT00749190|54660211|FG003|Overall Study|Adverse Event|4|||
28100023|NCT02954406|54756476|FG007|Overall Study|Reason Not Specified|0|||
28100024|NCT02954406|54756477|FG008|Overall Study|Reason Not Specified|1|||
28100025|NCT02954406|54756478|FG009|Overall Study|Reason Not Specified|0|||
28001214|NCT00749190|54660212|FG004|Overall Study|Adverse Event|0|||
28001215|NCT00749190|54660213|FG005|Overall Study|Adverse Event|3|||
28001216|NCT00749190|54660214|FG006|Overall Study|Adverse Event|0|||
28001217|NCT00749190|54660208|FG000|Overall Study|Lack of Efficacy|3|||
28001218|NCT00749190|54660209|FG001|Overall Study|Lack of Efficacy|1|||
28001219|NCT00749190|54660210|FG002|Overall Study|Lack of Efficacy|1|||
28001220|NCT00749190|54660211|FG003|Overall Study|Lack of Efficacy|0|||
28001221|NCT00749190|54660212|FG004|Overall Study|Lack of Efficacy|0|||
28001222|NCT00749190|54660213|FG005|Overall Study|Lack of Efficacy|1|||
28001223|NCT00749190|54660214|FG006|Overall Study|Lack of Efficacy|0|||
28001224|NCT00749190|54660208|FG000|Overall Study|Withdrawal by Subject|2|||
28100026|NCT02954406|54756479|FG010|Overall Study|Reason Not Specified|0|||
27914972|NCT01202188|54572773|FG003|Overall Study|Protocol deviation|10|||
28100027|NCT03514914|54756509|FG000|Overall Study|Death|3|||
27914973|NCT01202188|54572774|FG004|Overall Study|Protocol deviation|11|||
27914974|NCT01202188|54572770|FG000|Overall Study|Subject withdrew consent|12|||
27914975|NCT01202188|54572771|FG001|Overall Study|Subject withdrew consent|13|||
27914976|NCT01202188|54572772|FG002|Overall Study|Subject withdrew consent|22|||
27914977|NCT01202188|54572773|FG003|Overall Study|Subject withdrew consent|11|||
27914978|NCT01202188|54572774|FG004|Overall Study|Subject withdrew consent|13|||
27914979|NCT01202188|54572770|FG000|Overall Study|Adverse Event|5|||
27914980|NCT01202188|54572771|FG001|Overall Study|Adverse Event|23|||
27914981|NCT01202188|54572772|FG002|Overall Study|Adverse Event|13|||
28001225|NCT00749190|54660209|FG001|Overall Study|Withdrawal by Subject|1|||
28001226|NCT00749190|54660210|FG002|Overall Study|Withdrawal by Subject|0|||
28001227|NCT00749190|54660211|FG003|Overall Study|Withdrawal by Subject|0|||
28001228|NCT00749190|54660212|FG004|Overall Study|Withdrawal by Subject|0|||
28001229|NCT00749190|54660213|FG005|Overall Study|Withdrawal by Subject|1|||
28001230|NCT00749190|54660214|FG006|Overall Study|Withdrawal by Subject|0|||
28001231|NCT00749190|54660208|FG000|Overall Study|Protocol Violation|0|||
28001232|NCT00749190|54660209|FG001|Overall Study|Protocol Violation|1|||
28001233|NCT00749190|54660210|FG002|Overall Study|Protocol Violation|0|||
28001234|NCT00749190|54660211|FG003|Overall Study|Protocol Violation|0|||
28001235|NCT00749190|54660212|FG004|Overall Study|Protocol Violation|0|||
28001236|NCT00749190|54660213|FG005|Overall Study|Protocol Violation|0|||
28001237|NCT00749190|54660214|FG006|Overall Study|Protocol Violation|1|||
28001238|NCT00749190|54660208|FG000|Overall Study|Other reason not defined above|0|||
28001239|NCT00749190|54660209|FG001|Overall Study|Other reason not defined above|0|||
28001240|NCT00749190|54660210|FG002|Overall Study|Other reason not defined above|0|||
28001241|NCT00749190|54660211|FG003|Overall Study|Other reason not defined above|1|||
28001242|NCT00749190|54660212|FG004|Overall Study|Other reason not defined above|0|||
28001243|NCT00749190|54660213|FG005|Overall Study|Other reason not defined above|0|||
28001244|NCT00749190|54660214|FG006|Overall Study|Other reason not defined above|0|||
28001245|NCT00748566|54660235|FG000|Overall Study|Adverse Event|49|||
28001246|NCT00748566|54660235|FG000|Overall Study|Death|1|||
28001247|NCT00748566|54660235|FG000|Overall Study|Lack of Efficacy|12|||
28001248|NCT00748566|54660235|FG000|Overall Study|Lost to Follow-up|1|||
28001249|NCT00748566|54660235|FG000|Overall Study|Protocol Violation|13|||
28001250|NCT00748566|54660235|FG000|Overall Study|Withdrawal by Subject|22|||
28001251|NCT00748566|54660235|FG000|Overall Study|Study terminated by sponsor|5|||
28001252|NCT00748566|54660235|FG000|Overall Study|Other|9|||
28001253|NCT00743106|54660241|FG000|Overall Study|Met intraoperative exclusion criterion|8|||
28001254|NCT00743106|54660242|FG001|Overall Study|Met intraoperative exclusion criterion|5|||
28001255|NCT00738699|54660250|FG000|Overall Study|Withdrawal by Subject|5|||
28001256|NCT00738699|54660251|FG001|Overall Study|Withdrawal by Subject|0|||
28001257|NCT00738699|54660250|FG000|Overall Study|Lost to Follow-up|1|||
28001258|NCT00738699|54660251|FG001|Overall Study|Lost to Follow-up|0|||
28001259|NCT00738699|54660250|FG000|Overall Study|Death|144|||
28001260|NCT00738699|54660251|FG001|Overall Study|Death|68|||
28001261|NCT00738699|54660250|FG000|Overall Study|Discontinuation of study by Sponsor|123|||
28001262|NCT00738699|54660251|FG001|Overall Study|Discontinuation of study by Sponsor|72|||
28001263|NCT00738699|54660250|FG000|Overall Study|Other|2|||
28001264|NCT00738699|54660251|FG001|Overall Study|Other|0|||
28001265|NCT00814307|54660261|FG000|Overall Study|Randomized but not treated|1|||
28001266|NCT00814307|54660262|FG001|Overall Study|Randomized but not treated|0|||
28001267|NCT00814307|54660263|FG002|Overall Study|Randomized but not treated|0|||
28001268|NCT00814307|54660264|FG003|Overall Study|Randomized but not treated|0|||
28001269|NCT00814307|54660261|FG000|Overall Study|Adverse Event|3|||
28001270|NCT00814307|54660262|FG001|Overall Study|Adverse Event|9|||
28001271|NCT00814307|54660263|FG002|Overall Study|Adverse Event|3|||
28001272|NCT00814307|54660264|FG003|Overall Study|Adverse Event|2|||
28001273|NCT00814307|54660261|FG000|Overall Study|Lack of Efficacy|1|||
28001274|NCT00814307|54660262|FG001|Overall Study|Lack of Efficacy|1|||
28001275|NCT00814307|54660263|FG002|Overall Study|Lack of Efficacy|3|||
28001276|NCT00814307|54660264|FG003|Overall Study|Lack of Efficacy|4|||
28001277|NCT00814307|54660261|FG000|Overall Study|Other|1|||
28001278|NCT00814307|54660262|FG001|Overall Study|Other|2|||
28001279|NCT00814307|54660263|FG002|Overall Study|Other|0|||
28001280|NCT00814307|54660264|FG003|Overall Study|Other|1|||
28001281|NCT00814307|54660261|FG000|Overall Study|Protocol Violation|2|||
28001282|NCT00814307|54660262|FG001|Overall Study|Protocol Violation|8|||
28001283|NCT00814307|54660263|FG002|Overall Study|Protocol Violation|1|||
28100028|NCT03514914|54756510|FG001|Overall Study|Death|3|||
28001284|NCT00814307|54660264|FG003|Overall Study|Protocol Violation|1|||
28001285|NCT00814307|54660261|FG000|Overall Study|Withdrawal by Subject|4|||
28001286|NCT00814307|54660262|FG001|Overall Study|Withdrawal by Subject|6|||
28001287|NCT00814307|54660263|FG002|Overall Study|Withdrawal by Subject|0|||
28001288|NCT00814307|54660264|FG003|Overall Study|Withdrawal by Subject|2|||
28001289|NCT00814307|54660261|FG000|Overall Study|Death|0|||
28001290|NCT00814307|54660262|FG001|Overall Study|Death|1|||
27739828|NCT02219308|54189555|FG000|Overall Study|Withdrawal by Subject|1|||
27914982|NCT01202188|54572773|FG003|Overall Study|Adverse Event|10|||
27914983|NCT01202188|54572774|FG004|Overall Study|Adverse Event|10|||
27914984|NCT01202188|54572770|FG000|Overall Study|Administrative problems|3|||
27914985|NCT01202188|54572771|FG001|Overall Study|Administrative problems|2|||
27914986|NCT01202188|54572772|FG002|Overall Study|Administrative problems|1|||
27914987|NCT01202188|54572773|FG003|Overall Study|Administrative problems|1|||
27914988|NCT01202188|54572774|FG004|Overall Study|Administrative problems|2|||
27914989|NCT01202188|54572770|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
27914990|NCT01202188|54572771|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
27914991|NCT01202188|54572772|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
27914992|NCT01202188|54572773|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
27914993|NCT01202188|54572774|FG004|Overall Study|Unsatisfactory therapeutic effect|8|||
27914994|NCT01202188|54572770|FG000|Overall Study|Lost to Follow-up|1|||
27914995|NCT01202188|54572771|FG001|Overall Study|Lost to Follow-up|1|||
27914996|NCT01202188|54572772|FG002|Overall Study|Lost to Follow-up|0|||
27914997|NCT01202188|54572773|FG003|Overall Study|Lost to Follow-up|4|||
28001291|NCT00814307|54660263|FG002|Overall Study|Death|0|||
28001292|NCT00814307|54660264|FG003|Overall Study|Death|0|||
28001293|NCT00748098|54660276|FG000|First Treatment Intervention Period|Adverse Event|1|||
28001294|NCT00748098|54660277|FG001|First Treatment Intervention Period|Adverse Event|1|||
28001295|NCT00748098|54660276|FG000|First Treatment Intervention Period|Protocol Violation|1|||
28001296|NCT00748098|54660277|FG001|First Treatment Intervention Period|Protocol Violation|0|||
28001297|NCT00748098|54660276|FG000|First Treatment Intervention Period|Lost to Follow-up|1|||
28001298|NCT00748098|54660277|FG001|First Treatment Intervention Period|Lost to Follow-up|0|||
28001299|NCT00748098|54660276|FG000|First Treatment Intervention Period|Withdrawal by Subject|2|||
28001300|NCT00748098|54660277|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
28001301|NCT00748098|54660276|FG000|First Taper Period|Protocol Violation|1|||
28001302|NCT00748098|54660277|FG001|First Taper Period|Protocol Violation|0|||
28001303|NCT00748098|54660276|FG000|First Taper Period|Withdrawal by Subject|2|||
28001304|NCT00748098|54660277|FG001|First Taper Period|Withdrawal by Subject|0|||
28001305|NCT00748098|54660276|FG000|First Taper Period|Protocol Stopping Criteria Met|0|||
28001306|NCT00748098|54660277|FG001|First Taper Period|Protocol Stopping Criteria Met|1|||
28001307|NCT00748098|54660276|FG000|1-Week Washout Period|Adverse Event|0|||
28001308|NCT00748098|54660277|FG001|1-Week Washout Period|Adverse Event|1|||
28001309|NCT00748098|54660276|FG000|1-Week Washout Period|Withdrawal by Subject|2|||
28001310|NCT00748098|54660277|FG001|1-Week Washout Period|Withdrawal by Subject|0|||
28001311|NCT00748098|54660276|FG000|Second Treatment Intervention Period|Adverse Event|4|||
28001312|NCT00748098|54660277|FG001|Second Treatment Intervention Period|Adverse Event|1|||
28001313|NCT00748098|54660276|FG000|Second Treatment Intervention Period|Lost to Follow-up|1|||
28001314|NCT00748098|54660277|FG001|Second Treatment Intervention Period|Lost to Follow-up|1|||
28001315|NCT00748098|54660276|FG000|Second Treatment Intervention Period|Withdrawal by Subject|1|||
28001316|NCT00748098|54660277|FG001|Second Treatment Intervention Period|Withdrawal by Subject|1|||
28001317|NCT00813995|54660286|FG000|Overall Study|Clinical adverse event|9|||
28001318|NCT00813995|54660287|FG001|Overall Study|Clinical adverse event|3|||
28001319|NCT00813995|54660286|FG000|Overall Study|Laboratory adverse event|0|||
28001320|NCT00813995|54660287|FG001|Overall Study|Laboratory adverse event|2|||
28001321|NCT00813995|54660286|FG000|Overall Study|Lack of Efficacy|1|||
28001322|NCT00813995|54660287|FG001|Overall Study|Lack of Efficacy|0|||
28001323|NCT00813995|54660286|FG000|Overall Study|Lost to Follow-up|4|||
28001324|NCT00813995|54660287|FG001|Overall Study|Lost to Follow-up|2|||
28001325|NCT00813995|54660286|FG000|Overall Study|Other reason|2|||
28001326|NCT00813995|54660287|FG001|Overall Study|Other reason|2|||
28001327|NCT00813995|54660286|FG000|Overall Study|Protocol Violation|3|||
28001328|NCT00813995|54660287|FG001|Overall Study|Protocol Violation|2|||
28001329|NCT00813995|54660286|FG000|Overall Study|Subject moved|4|||
28001330|NCT00813995|54660287|FG001|Overall Study|Subject moved|0|||
28001331|NCT00813995|54660286|FG000|Overall Study|Withdrawal by Subject|0|||
28001332|NCT00813995|54660287|FG001|Overall Study|Withdrawal by Subject|5|||
28001333|NCT00737529|54660297|FG000|Overall Study|Disease Progression|95|||
28001334|NCT00737529|54660297|FG000|Overall Study|Adverse Event|24|||
28001335|NCT00737529|54660297|FG000|Overall Study|Withdrawal by Subject|5|||
28001336|NCT00737529|54660297|FG000|Overall Study|Death|4|||
28001337|NCT00737529|54660297|FG000|Overall Study|Protocol Violation|1|||
28001338|NCT00737529|54660297|FG000|Overall Study|Other|4|||
28001339|NCT00813917|54660303|FG000|Overall Study|Adverse Event|0|||
27914998|NCT01202188|54572774|FG004|Overall Study|Lost to Follow-up|1|||
28001340|NCT00813917|54660304|FG001|Overall Study|Adverse Event|1|||
28001341|NCT00813917|54660303|FG000|Overall Study|Withdrawal by Subject|3|||
28001342|NCT00813917|54660304|FG001|Overall Study|Withdrawal by Subject|4|||
28001343|NCT00813917|54660303|FG000|Overall Study|Lost to Follow-up|3|||
28001344|NCT00813917|54660304|FG001|Overall Study|Lost to Follow-up|1|||
28001345|NCT00737061|54660310|FG000|Waiting Period|Lost to Follow-up|6|||
28001346|NCT00737061|54660310|FG000|Waiting Period|Withdrawal by Subject|1|||
27914999|NCT01202188|54572770|FG000|Overall Study|Death|1|||
27915000|NCT01202188|54572771|FG001|Overall Study|Death|1|||
27915001|NCT01202188|54572772|FG002|Overall Study|Death|1|||
28001347|NCT00737061|54660310|FG000|Waiting Period|Bilateral placement failure|34|||
28001348|NCT00737061|54660310|FG000|Waiting Period|Deemed patent following HSG|26|||
27915002|NCT01202188|54572773|FG003|Overall Study|Death|1|||
27915003|NCT01202188|54572774|FG004|Overall Study|Death|0|||
27915004|NCT01202188|54572770|FG000|Overall Study|Abnormal test procedure result (s)|0|||
27915005|NCT01202188|54572771|FG001|Overall Study|Abnormal test procedure result (s)|0|||
27915006|NCT01202188|54572772|FG002|Overall Study|Abnormal test procedure result (s)|2|||
27915007|NCT01202188|54572773|FG003|Overall Study|Abnormal test procedure result (s)|0|||
27915008|NCT01202188|54572774|FG004|Overall Study|Abnormal test procedure result (s)|0|||
27915009|NCT01201915|54572795|FG000|Overall Study|Adverse Event|2|||
27915010|NCT01201915|54572796|FG001|Overall Study|Adverse Event|1|||
28001349|NCT00737061|54660310|FG000|Waiting Period|Alternative contraception failure|3|||
28001350|NCT00737061|54660310|FG000|Waiting Period|Elected surgical tubal ligation|5|||
28001351|NCT00737061|54660310|FG000|1 Year Wearing Period|Lost to Follow-up|11|||
28001352|NCT00737061|54660310|FG000|1 Year Wearing Period|Withdrawal by Subject|2|||
28001353|NCT00737061|54660310|FG000|1 Year Wearing Period|Discontinued reilance|3|||
28001354|NCT00737061|54660310|FG000|1 Year Wearing Period|Terminated for protocol non-compliance|1|||
28001355|NCT00585975|54660316|FG000|Overall Study|Withdrawal by Subject|3|||
28001356|NCT00585975|54660317|FG001|Overall Study|Withdrawal by Subject|3|||
28001357|NCT00585975|54660316|FG000|Overall Study|Lost to Follow-up|2|||
28001358|NCT00585975|54660317|FG001|Overall Study|Lost to Follow-up|1|||
28001359|NCT00585975|54660316|FG000|Overall Study|Enrollment met/over-enrolled|10|||
28001360|NCT00585975|54660317|FG001|Overall Study|Enrollment met/over-enrolled|9|||
28001361|NCT00585585|54660323|FG000|Overall Study|Adverse Event|1|||
28001362|NCT00734097|54660327|FG000|Screening|Protocol Violation|12|||
28001363|NCT00734097|54660327|FG000|Screening|Withdrawal by Subject|5|||
28001364|NCT00734097|54660327|FG000|Screening|Lost to Follow-up|2|||
28001365|NCT00734097|54660327|FG000|Screening|Unconfirmed pregnancy|1|||
28001366|NCT00734097|54660327|FG000|Open Label|Lost to Follow-up|7|||
28001367|NCT00734097|54660327|FG000|Open Label|Withdrawal by Subject|5|||
28001368|NCT00734097|54660327|FG000|Open Label|Protocol Violation|4|||
28001369|NCT00819767|54660333|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
28001370|NCT00819767|54660334|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
28001371|NCT00733005|54660342|FG000|Overall Study|Adverse Event|0|||
28001372|NCT00733005|54660343|FG001|Overall Study|Adverse Event|1|||
28001373|NCT00733005|54660342|FG000|Overall Study|Treatment Failure|0|||
28001374|NCT00733005|54660343|FG001|Overall Study|Treatment Failure|1|||
28001375|NCT00733005|54660342|FG000|Overall Study|Withdrawal by Subject|0|||
28001376|NCT00733005|54660343|FG001|Overall Study|Withdrawal by Subject|1|||
28001377|NCT00733005|54660342|FG000|Overall Study|Protocol Violation|2|||
28001378|NCT00733005|54660343|FG001|Overall Study|Protocol Violation|0|||
28001379|NCT00812981|54660351|FG000|Overall Study|Other|0|||
28001380|NCT00812981|54660352|FG001|Overall Study|Other|1|||
27915011|NCT01201915|54572797|FG002|Overall Study|Adverse Event|1|||
27915012|NCT01201915|54572795|FG000|Overall Study|Lost to Follow-up|0|||
27915013|NCT01201915|54572796|FG001|Overall Study|Lost to Follow-up|4|||
27915014|NCT01201915|54572797|FG002|Overall Study|Lost to Follow-up|0|||
27915015|NCT01201915|54572795|FG000|Overall Study|Physician Decision|3|||
27915016|NCT01201915|54572796|FG001|Overall Study|Physician Decision|0|||
27915017|NCT01201915|54572797|FG002|Overall Study|Physician Decision|0|||
27915018|NCT01201915|54572795|FG000|Overall Study|Subject Decision|3|||
27915019|NCT01201915|54572796|FG001|Overall Study|Subject Decision|3|||
27915020|NCT01201915|54572797|FG002|Overall Study|Subject Decision|5|||
27915021|NCT01201915|54572795|FG000|Overall Study|Target Lesion Progression|0|||
27915022|NCT01201915|54572796|FG001|Overall Study|Target Lesion Progression|3|||
27915023|NCT01201915|54572797|FG002|Overall Study|Target Lesion Progression|0|||
27915024|NCT01179919|54572805|FG000|Overall Study|Protocol Violation|1|||
27915025|NCT01179919|54572805|FG000|Overall Study|Adverse Event|1|||
27915026|NCT01201798|54572811|FG000|Overall Study|Adverse Event|2|||
27915027|NCT01201798|54572812|FG001|Overall Study|Adverse Event|0|||
27915028|NCT01201798|54572811|FG000|Overall Study|Lost to Follow-up|3|||
27915029|NCT01201798|54572812|FG001|Overall Study|Lost to Follow-up|5|||
27915030|NCT01201798|54572811|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
27915031|NCT01201798|54572812|FG001|Overall Study|Decision Unrelated to an Adverse Event|1|||
27915032|NCT01201798|54572811|FG000|Overall Study|Noncompliance|1|||
27915033|NCT01201798|54572812|FG001|Overall Study|Noncompliance|0|||
28001381|NCT00732615|54660360|FG000|Overall Study|Withdrawal by Subject|3|||
28001382|NCT00732615|54660361|FG001|Overall Study|Withdrawal by Subject|1|||
28100029|NCT03514914|54756509|FG000|Overall Study|Lost to Follow-up|117|||
28100030|NCT03514914|54756510|FG001|Overall Study|Lost to Follow-up|89|||
27915034|NCT01201798|54572811|FG000|Overall Study|Protocol Violation|1|||
27915035|NCT01201798|54572812|FG001|Overall Study|Protocol Violation|1|||
27915036|NCT01201798|54572811|FG000|Overall Study|Treatment Failure|1|||
27915037|NCT01201798|54572812|FG001|Overall Study|Treatment Failure|8|||
27915038|NCT01201759|54572820|FG000|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2|||
27915039|NCT01201759|54572821|FG001|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1|||
28001383|NCT00732615|54660360|FG000|Overall Study|Lost to Follow-up|0|||
28001384|NCT00732615|54660361|FG001|Overall Study|Lost to Follow-up|1|||
28001385|NCT00732615|54660360|FG000|Overall Study|Adverse Event|0|||
28001386|NCT00732615|54660361|FG001|Overall Study|Adverse Event|2|||
28001387|NCT00732615|54660360|FG000|Overall Study|Physician Decision|3|||
28001388|NCT00732615|54660361|FG001|Overall Study|Physician Decision|0|||
28001389|NCT00732615|54660360|FG000|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
28001390|NCT00732615|54660361|FG001|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
28100031|NCT03513588|54756519|FG000|Overall Study|Lost to Follow-up|0|||
28100032|NCT03513588|54756520|FG001|Overall Study|Lost to Follow-up|1|||
28100033|NCT03513588|54756521|FG002|Overall Study|Lost to Follow-up|1|||
28100034|NCT03513588|54756519|FG000|Overall Study|Study dosing paused by sponsor|1|||
28100035|NCT03513588|54756520|FG001|Overall Study|Study dosing paused by sponsor|1|||
28100036|NCT03513588|54756521|FG002|Overall Study|Study dosing paused by sponsor|0|||
28100037|NCT03513588|54756519|FG000|Overall Study|Death|0|||
28100038|NCT03513588|54756520|FG001|Overall Study|Death|0|||
28100039|NCT03513588|54756521|FG002|Overall Study|Death|1|||
28100040|NCT03512028|54756533|FG000|Overall Study|Withdrawal by Subject|2|||
28100041|NCT03512028|54756534|FG001|Overall Study|Withdrawal by Subject|0|||
28100042|NCT03512028|54756533|FG000|Overall Study|Protocol Violation|2|||
28100043|NCT03512028|54756534|FG001|Overall Study|Protocol Violation|0|||
28100044|NCT03511326|54756540|FG000|Overall Study|Withdrawal by Subject|1|||
28100045|NCT03508830|54756546|FG000|Overall Study|Withdrawal by Subject|3|||
28100046|NCT03508830|54756547|FG001|Overall Study|Withdrawal by Subject|4|||
28100047|NCT03508830|54756546|FG000|Overall Study|Physician Decision|2|||
28100048|NCT03508830|54756547|FG001|Overall Study|Physician Decision|2|||
28100049|NCT03508050|54756555|FG000|Overall Study|Pleural adhesions|1|||
28100050|NCT03508050|54756556|FG001|Overall Study|Pleural adhesions|0|||
28100051|NCT03508050|54756555|FG000|Overall Study|Mucus plug|1|||
28100052|NCT03508050|54756556|FG001|Overall Study|Mucus plug|0|||
28100053|NCT03508050|54756555|FG000|Overall Study|Negative biopsy, surgery cancelled|3|||
28100054|NCT03508050|54756556|FG001|Overall Study|Negative biopsy, surgery cancelled|1|||
28100055|NCT03508050|54756555|FG000|Overall Study|Sustained desaturation|0|||
28100056|NCT03508050|54756556|FG001|Overall Study|Sustained desaturation|1|||
28100057|NCT03569202|54756565|FG000|Part 3|Physician Decision|1|||
28100058|NCT03569202|54756566|FG001|Part 3|Physician Decision|0|||
28100059|NCT03569202|54756565|FG000|Part 3|Other|1|||
28100060|NCT03569202|54756566|FG001|Part 3|Other|1|||
28100061|NCT03568500|54756575|FG000|Overall Study|Lost to Follow-up|1|||
28100062|NCT03568500|54756576|FG001|Overall Study|Lost to Follow-up|1|||
28100063|NCT03568500|54756577|FG002|Overall Study|Lost to Follow-up|2|||
28100064|NCT03568500|54756575|FG000|Overall Study|Adverse Event|1|||
28100065|NCT03568500|54756576|FG001|Overall Study|Adverse Event|1|||
28100066|NCT03568500|54756577|FG002|Overall Study|Adverse Event|2|||
28100067|NCT03568500|54756575|FG000|Overall Study|Physician Decision|1|||
28100068|NCT03568500|54756576|FG001|Overall Study|Physician Decision|0|||
28100069|NCT03568500|54756577|FG002|Overall Study|Physician Decision|0|||
28100070|NCT03568500|54756575|FG000|Overall Study|Withdrawal by Subject|4|||
28100071|NCT03568500|54756576|FG001|Overall Study|Withdrawal by Subject|2|||
28100072|NCT03568500|54756577|FG002|Overall Study|Withdrawal by Subject|0|||
28100073|NCT03568500|54756575|FG000|Overall Study|Technical Problems|2|||
28100074|NCT03568500|54756576|FG001|Overall Study|Technical Problems|1|||
28100075|NCT03568500|54756577|FG002|Overall Study|Technical Problems|0|||
28100076|NCT03568500|54756575|FG000|Overall Study|Participant Noncompliance|1|||
28100077|NCT03568500|54756576|FG001|Overall Study|Participant Noncompliance|1|||
28100078|NCT03568500|54756577|FG002|Overall Study|Participant Noncompliance|0|||
28100079|NCT03504852|54756602|FG000|Overall Study|Withdrawal of informed consent|2|||
28100080|NCT03504852|54756603|FG001|Overall Study|Withdrawal of informed consent|1|||
28100081|NCT03504852|54756604|FG002|Overall Study|Withdrawal of informed consent|0|||
28100082|NCT03504852|54756602|FG000|Overall Study|Withdrawal by Subject|5|||
28100083|NCT03504852|54756603|FG001|Overall Study|Withdrawal by Subject|5|||
28100084|NCT03504852|54756604|FG002|Overall Study|Withdrawal by Subject|1|||
27915040|NCT01201759|54572820|FG000|Visit 3 - Washout|Adverse Event|0|||
27915041|NCT01201759|54572821|FG001|Visit 3 - Washout|Adverse Event|3|||
27915042|NCT01201759|54572820|FG000|Visit 3 - Washout|Lost to Follow-up|1|||
27915043|NCT01201759|54572821|FG001|Visit 3 - Washout|Lost to Follow-up|0|||
27915044|NCT01201759|54572820|FG000|Visit 4 Crossover|Lost to Follow-up|0|||
27915045|NCT01201759|54572821|FG001|Visit 4 Crossover|Lost to Follow-up|1|||
27915046|NCT01200589|54572831|FG000|Overall Study|Withdrawal by Subject|13|||
27915047|NCT01200589|54572832|FG001|Overall Study|Withdrawal by Subject|11|||
27915048|NCT01200589|54572831|FG000|Overall Study|Physician Decision|2|||
27915049|NCT01200589|54572832|FG001|Overall Study|Physician Decision|2|||
28100085|NCT03504852|54756602|FG000|Overall Study|Lost to Follow-up|4|||
28100086|NCT03504852|54756603|FG001|Overall Study|Lost to Follow-up|1|||
27915050|NCT01200589|54572831|FG000|Overall Study|Lost to Follow-up|5|||
28100087|NCT03504852|54756604|FG002|Overall Study|Lost to Follow-up|0|||
27915051|NCT01200589|54572832|FG001|Overall Study|Lost to Follow-up|4|||
27915052|NCT01200589|54572831|FG000|Overall Study|Study terminated|170|||
28001391|NCT00732381|54660370|FG000|Overall Study|Adverse Event|1|||
28001392|NCT00732381|54660371|FG001|Overall Study|Adverse Event|0|||
28001393|NCT00732381|54660370|FG000|Overall Study|Treatment Failure|1|||
28001394|NCT00732381|54660371|FG001|Overall Study|Treatment Failure|1|||
28001395|NCT00732303|54660377|FG000|Overall Study|Study Terminated|2|||
28001396|NCT00813761|54660383|FG000|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2|||
28001397|NCT00813761|54660384|FG001|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
28001398|NCT00813761|54660385|FG002|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
28001399|NCT00813761|54660386|FG003|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
28001400|NCT00813761|54660383|FG000|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
28001401|NCT00813761|54660384|FG001|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
28001402|NCT00813761|54660385|FG002|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3|||
28001403|NCT00813761|54660386|FG003|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1|||
28001404|NCT00813761|54660383|FG000|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
28001405|NCT00813761|54660384|FG001|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
28001406|NCT00813761|54660385|FG002|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
28001407|NCT00813761|54660386|FG003|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0|||
28001408|NCT00813761|54660383|FG000|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
28001409|NCT00813761|54660384|FG001|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
28001410|NCT00813761|54660385|FG002|Phase 1 (Baseline to 4 Weeks)|poor vision|3|||
28001411|NCT00813761|54660386|FG003|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
28001412|NCT00813761|54660383|FG000|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
28001413|NCT00813761|54660384|FG001|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
28001414|NCT00813761|54660385|FG002|Phase 1 (Baseline to 4 Weeks)|poor comfort|5|||
28001415|NCT00813761|54660386|FG003|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
28001416|NCT00813761|54660383|FG000|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
28001417|NCT00813761|54660384|FG001|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1|||
28001418|NCT00813761|54660385|FG002|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
28001419|NCT00813761|54660386|FG003|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
28001420|NCT00813761|54660383|FG000|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2|||
28001421|NCT00813761|54660384|FG001|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3|||
28001422|NCT00813761|54660385|FG002|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
28001423|NCT00813761|54660386|FG003|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
28001424|NCT00813761|54660383|FG000|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3|||
28001425|NCT00813761|54660384|FG001|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0|||
28001426|NCT00813761|54660385|FG002|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2|||
28001427|NCT00813761|54660386|FG003|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1|||
28001428|NCT00813761|54660383|FG000|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
28001429|NCT00813761|54660384|FG001|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
27915053|NCT01200589|54572832|FG001|Overall Study|Study terminated|172|||
27915054|NCT01200511|54572838|FG000|Overall Study|Lost to Follow-up|3|||
27915055|NCT01200511|54572838|FG000|Overall Study|Withdrawal by Subject|1|||
28001430|NCT00813761|54660385|FG002|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
28001431|NCT00813761|54660386|FG003|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
28001432|NCT00813761|54660383|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
28001433|NCT00813761|54660384|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
28001434|NCT00813761|54660385|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
28001435|NCT00813761|54660386|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0|||
28001436|NCT00813761|54660383|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1|||
28001437|NCT00813761|54660384|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4|||
28001438|NCT00813761|54660385|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0|||
28001439|NCT00813761|54660386|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3|||
28001440|NCT00813761|54660383|FG000|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9|||
28001441|NCT00813761|54660384|FG001|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
28001442|NCT00813761|54660385|FG002|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6|||
28001443|NCT00813761|54660386|FG003|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
28001444|NCT00732069|54660402|FG000|Washout After First Study Drug|Adverse Event|1|||
28001445|NCT00732069|54660403|FG001|Washout After First Study Drug|Adverse Event|0|||
28001446|NCT00732069|54660404|FG002|Washout After First Study Drug|Adverse Event|0|||
28001447|NCT00732069|54660405|FG003|Washout After First Study Drug|Adverse Event|0|||
28001448|NCT00732069|54660406|FG004|Washout After First Study Drug|Adverse Event|0|||
27915056|NCT01200511|54572838|FG000|Overall Study|Adverse Event|1|||
27915057|NCT01179334|54572846|FG000|Treatment Period|Adverse Event|1|||
27915058|NCT01179334|54572847|FG001|Treatment Period|Adverse Event|0|||
27915059|NCT01179334|54572846|FG000|Long-term Extension (LTE) Period|Study terminated by sponsor|6|||
27915060|NCT01179334|54572847|FG001|Long-term Extension (LTE) Period|Study terminated by sponsor|2|||
27915061|NCT01179334|54572846|FG000|Long-term Extension (LTE) Period|Death|3|||
27915062|NCT01179334|54572847|FG001|Long-term Extension (LTE) Period|Death|0|||
28001449|NCT00732069|54660407|FG005|Washout After First Study Drug|Adverse Event|0|||
28001450|NCT00731679|54660417|FG000|Overall Study|Adverse Event|7|||
28001451|NCT00731679|54660418|FG001|Overall Study|Adverse Event|8|||
27915063|NCT01179334|54572846|FG000|Long-term Extension (LTE) Period|Adverse Event|2|||
28001452|NCT00731679|54660417|FG000|Overall Study|Withdrawal by Subject|8|||
27915064|NCT01179334|54572847|FG001|Long-term Extension (LTE) Period|Adverse Event|4|||
27915065|NCT01178671|54572855|FG000|Overall Study|Adverse Event|4|||
27915066|NCT01178671|54572856|FG001|Overall Study|Adverse Event|6|||
27915067|NCT01178671|54572855|FG000|Overall Study|Protocol Violation|1|||
27915068|NCT01178671|54572856|FG001|Overall Study|Protocol Violation|1|||
27915069|NCT01178671|54572855|FG000|Overall Study|Lack of Efficacy|0|||
27915070|NCT01178671|54572856|FG001|Overall Study|Lack of Efficacy|1|||
27915071|NCT01178671|54572855|FG000|Overall Study|Lost to Follow-up|3|||
27915072|NCT01178671|54572856|FG001|Overall Study|Lost to Follow-up|1|||
27915073|NCT01178671|54572855|FG000|Overall Study|Physician Decision|4|||
27915074|NCT01178671|54572856|FG001|Overall Study|Physician Decision|6|||
27915075|NCT01178125|54572862|FG000|Overall Study|Lost to Follow-up|397|||
27915076|NCT01178125|54572862|FG000|Overall Study|Adverse Event|244|||
27915077|NCT01178125|54572862|FG000|Overall Study|Withdrawal by Subject|209|||
27915078|NCT01178125|54572862|FG000|Overall Study|Noncompliance|184|||
27915079|NCT01178125|54572862|FG000|Overall Study|Pregnancy|55|||
27915080|NCT01178125|54572862|FG000|Overall Study|Other Reason|39|||
27915081|NCT01178125|54572862|FG000|Overall Study|Sponsor Decision|28|||
27915082|NCT01178125|54572862|FG000|Overall Study|Protocol Violation|17|||
27915083|NCT01178125|54572862|FG000|Overall Study|Investigator Decision|5|||
27915084|NCT01178086|54572884|FG000|Overall Study|Participant refusal|7|||
27915085|NCT01178086|54572884|FG000|Overall Study|Physician Decision|44|||
27915086|NCT01178086|54572884|FG000|Overall Study|Switch to other CLL therapy|113|||
27915087|NCT01178086|54572884|FG000|Overall Study|Death|59|||
27915088|NCT01178086|54572884|FG000|Overall Study|Other unspecified|89|||
27915089|NCT01178086|54572884|FG000|Overall Study|Excluded from EAS|20|||
27915090|NCT01177969|54572892|FG000|Overall Study|Protocol Violation|2|||
27915091|NCT01177969|54572893|FG001|Overall Study|Protocol Violation|1|||
27915092|NCT01177969|54572892|FG000|Overall Study|Withdrawal by Subject|1|||
27915093|NCT01177969|54572893|FG001|Overall Study|Withdrawal by Subject|2|||
27915094|NCT01177813|54572904|FG000|Overall Study|Adverse Event|8|||
27915095|NCT01177813|54572905|FG001|Overall Study|Adverse Event|2|||
27915096|NCT01177813|54572906|FG002|Overall Study|Adverse Event|4|||
27915097|NCT01177813|54572907|FG003|Overall Study|Adverse Event|6|||
27915098|NCT01177813|54572908|FG004|Overall Study|Adverse Event|3|||
27915099|NCT01177813|54572904|FG000|Overall Study|Lack of Efficacy|1|||
27915100|NCT01177813|54572905|FG001|Overall Study|Lack of Efficacy|0|||
27915101|NCT01177813|54572906|FG002|Overall Study|Lack of Efficacy|0|||
27915102|NCT01177813|54572907|FG003|Overall Study|Lack of Efficacy|0|||
27915103|NCT01177813|54572908|FG004|Overall Study|Lack of Efficacy|0|||
27915104|NCT01177813|54572904|FG000|Overall Study|Protocol Violation|3|||
27915105|NCT01177813|54572905|FG001|Overall Study|Protocol Violation|2|||
27915106|NCT01177813|54572906|FG002|Overall Study|Protocol Violation|2|||
27915107|NCT01177813|54572907|FG003|Overall Study|Protocol Violation|0|||
27915108|NCT01177813|54572908|FG004|Overall Study|Protocol Violation|1|||
27915109|NCT01177813|54572904|FG000|Overall Study|Lost to Follow-up|12|||
27915110|NCT01177813|54572905|FG001|Overall Study|Lost to Follow-up|5|||
27915111|NCT01177813|54572906|FG002|Overall Study|Lost to Follow-up|6|||
27915112|NCT01177813|54572907|FG003|Overall Study|Lost to Follow-up|3|||
27915113|NCT01177813|54572908|FG004|Overall Study|Lost to Follow-up|0|||
27915114|NCT01177813|54572904|FG000|Overall Study|Withdrawal by Subject|12|||
27915115|NCT01177813|54572905|FG001|Overall Study|Withdrawal by Subject|7|||
27915116|NCT01177813|54572906|FG002|Overall Study|Withdrawal by Subject|6|||
27915117|NCT01177813|54572907|FG003|Overall Study|Withdrawal by Subject|5|||
27915118|NCT01177813|54572908|FG004|Overall Study|Withdrawal by Subject|3|||
27915119|NCT01177813|54572904|FG000|Overall Study|Other reason not defined above|5|||
27915120|NCT01177813|54572905|FG001|Overall Study|Other reason not defined above|2|||
27915121|NCT01177813|54572906|FG002|Overall Study|Other reason not defined above|2|||
27915122|NCT01177813|54572907|FG003|Overall Study|Other reason not defined above|3|||
27915123|NCT01177813|54572908|FG004|Overall Study|Other reason not defined above|2|||
27915124|NCT01200394|54572922|FG000|Overall Study|Adverse Event|0|||
27915125|NCT01200394|54572923|FG001|Overall Study|Adverse Event|14|||
27915126|NCT01200394|54572922|FG000|Overall Study|Death|1|||
27915127|NCT01200394|54572923|FG001|Overall Study|Death|0|||
27915128|NCT01200394|54572922|FG000|Overall Study|Lost to Follow-up|0|||
27915129|NCT01200394|54572923|FG001|Overall Study|Lost to Follow-up|1|||
27915130|NCT01200394|54572922|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
27915131|NCT01200394|54572923|FG001|Overall Study|Did Not Meet Entrance Criteria|4|||
27915132|NCT01200394|54572922|FG000|Overall Study|Protocol Violation|0|||
27915133|NCT01200394|54572923|FG001|Overall Study|Protocol Violation|3|||
27915134|NCT01200394|54572922|FG000|Overall Study|Withdrawal by Subject|0|||
27915135|NCT01200394|54572923|FG001|Overall Study|Withdrawal by Subject|5|||
27915136|NCT01200394|54572922|FG000|Overall Study|Other|0|||
27915137|NCT01200394|54572923|FG001|Overall Study|Other|1|||
27915138|NCT01200355|54572932|FG000|Overall Study|Death|7|||
27915139|NCT01200355|54572933|FG001|Overall Study|Death|2|||
27915140|NCT01200238|54572941|FG000|Overall Study|Adverse Event|2|||
27915141|NCT01200238|54572942|FG001|Overall Study|Adverse Event|1|||
27915142|NCT01200238|54572941|FG000|Overall Study|Progressive Disease|5|||
27915143|NCT01200238|54572942|FG001|Overall Study|Progressive Disease|8|||
27915144|NCT01200238|54572941|FG000|Overall Study|Withdrawal by Subject|0|||
27915145|NCT01200238|54572942|FG001|Overall Study|Withdrawal by Subject|1|||
27915146|NCT01199731|54572951|FG000|Overall Study|Adverse Event|0|||
27915147|NCT01199731|54572952|FG001|Overall Study|Adverse Event|1|||
27915148|NCT01199731|54572953|FG002|Overall Study|Adverse Event|0|||
27915149|NCT01199731|54572951|FG000|Overall Study|Study closed/terminated|7|||
27915150|NCT01199731|54572952|FG001|Overall Study|Study closed/terminated|9|||
27915151|NCT01199731|54572953|FG002|Overall Study|Study closed/terminated|7|||
27915152|NCT01199731|54572951|FG000|Overall Study|Lost to Follow-up|0|||
27915153|NCT01199731|54572952|FG001|Overall Study|Lost to Follow-up|0|||
27915154|NCT01199731|54572953|FG002|Overall Study|Lost to Follow-up|2|||
27915155|NCT01199731|54572951|FG000|Overall Study|Physician Decision|0|||
27915156|NCT01199731|54572952|FG001|Overall Study|Physician Decision|1|||
27915157|NCT01199731|54572953|FG002|Overall Study|Physician Decision|1|||
27915158|NCT01199731|54572951|FG000|Overall Study|Withdrawal by Subject|2|||
27915159|NCT01199731|54572952|FG001|Overall Study|Withdrawal by Subject|0|||
28001453|NCT00731679|54660418|FG001|Overall Study|Withdrawal by Subject|8|||
28001454|NCT00731679|54660417|FG000|Overall Study|Lost to Follow-up|7|||
28001455|NCT00731679|54660418|FG001|Overall Study|Lost to Follow-up|8|||
28001456|NCT00731679|54660417|FG000|Overall Study|Noncompliance|0|||
28001457|NCT00731679|54660418|FG001|Overall Study|Noncompliance|1|||
28001458|NCT00731679|54660417|FG000|Overall Study|Pregnancy|0|||
28001459|NCT00731679|54660418|FG001|Overall Study|Pregnancy|1|||
28001460|NCT00731133|54660424|FG000|Overall Study|Withdrawal by Subject|10|||
28001461|NCT00730275|54660432|FG000|Overall Study|Withdrawal by Subject|0|||
28001462|NCT00730275|54660433|FG001|Overall Study|Withdrawal by Subject|0|||
28001463|NCT00730275|54660434|FG002|Overall Study|Withdrawal by Subject|0|||
28001464|NCT00730275|54660435|FG003|Overall Study|Withdrawal by Subject|1|||
27915160|NCT01199731|54572953|FG002|Overall Study|Withdrawal by Subject|0|||
27915161|NCT01199263|54572963|FG000|Overall Study|Ineligible|0|||
27915162|NCT01199263|54572964|FG001|Overall Study|Ineligible|2|||
27915163|NCT01199263|54572963|FG000|Overall Study|Never Treated|6|||
28001465|NCT00730041|54660453|FG000|Overall Study|Lost to Follow-up|0|||
28001466|NCT00730041|54660454|FG001|Overall Study|Lost to Follow-up|2|||
28001467|NCT00729651|54660462|FG000|Overall Study|Withdrawal by Subject|5|||
28001468|NCT00729651|54660463|FG001|Overall Study|Withdrawal by Subject|6|||
28001469|NCT00729651|54660462|FG000|Overall Study|Lost to Follow-up|5|||
28001470|NCT00729651|54660463|FG001|Overall Study|Lost to Follow-up|4|||
28001471|NCT00729651|54660462|FG000|Overall Study|Protocol Violation|0|||
28001472|NCT00729651|54660463|FG001|Overall Study|Protocol Violation|1|||
28001473|NCT00729651|54660462|FG000|Overall Study|Adverse Event|7|||
28001474|NCT00729651|54660463|FG001|Overall Study|Adverse Event|3|||
28001475|NCT00729651|54660462|FG000|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0|||
28001476|NCT00729651|54660463|FG001|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4|||
28001477|NCT00729651|54660462|FG000|Overall Study|Subject's private reason|2|||
28001478|NCT00729651|54660463|FG001|Overall Study|Subject's private reason|0|||
28001479|NCT00729183|54660471|FG000|Overall Study|Adverse Event|11|||
27915164|NCT01199263|54572964|FG001|Overall Study|Never Treated|0|||
27915165|NCT01199068|54572975|FG000|Overall Study|Unacceptable toxicity|0|||
27915166|NCT01199068|54572976|FG001|Overall Study|Unacceptable toxicity|0|||
27915167|NCT01199068|54572977|FG002|Overall Study|Unacceptable toxicity|2|||
27915168|NCT01199068|54572975|FG000|Overall Study|Progressive disease|3|||
27915169|NCT01199068|54572976|FG001|Overall Study|Progressive disease|3|||
27915170|NCT01199068|54572977|FG002|Overall Study|Progressive disease|6|||
28001480|NCT00729183|54660472|FG001|Overall Study|Adverse Event|5|||
28001481|NCT00729183|54660471|FG000|Overall Study|Lack of Efficacy|0|||
28001482|NCT00729183|54660472|FG001|Overall Study|Lack of Efficacy|1|||
28001483|NCT00729183|54660471|FG000|Overall Study|Lost to Follow-up|3|||
28001484|NCT00729183|54660472|FG001|Overall Study|Lost to Follow-up|1|||
28001485|NCT00729183|54660471|FG000|Overall Study|Physician Decision|1|||
28001486|NCT00729183|54660472|FG001|Overall Study|Physician Decision|1|||
28001487|NCT00729183|54660471|FG000|Overall Study|Protocol Violation|1|||
28001488|NCT00729183|54660472|FG001|Overall Study|Protocol Violation|0|||
28001489|NCT00729183|54660471|FG000|Overall Study|Withdrawal by Subject|9|||
28001490|NCT00729183|54660472|FG001|Overall Study|Withdrawal by Subject|7|||
28001491|NCT00811733|54660480|FG000|Overall Study|Investigator Discretion|10|||
28001492|NCT00811733|54660481|FG001|Overall Study|Investigator Discretion|8|||
27915171|NCT01199068|54572975|FG000|Overall Study|Withdrawal by Subject|0|||
28001493|NCT00811733|54660480|FG000|Overall Study|Withdrawal by Subject|1|||
27915172|NCT01199068|54572976|FG001|Overall Study|Withdrawal by Subject|0|||
28001494|NCT00811733|54660481|FG001|Overall Study|Withdrawal by Subject|2|||
28001495|NCT00728949|54660489|FG000|Overall Study|Adverse Event|8|||
27915173|NCT01199068|54572977|FG002|Overall Study|Withdrawal by Subject|1|||
27915174|NCT01198873|54572994|FG000|Overall Study|Adverse Event|4|||
27915175|NCT01198873|54572995|FG001|Overall Study|Adverse Event|7|||
27915176|NCT01198873|54572994|FG000|Overall Study|Study closure|29|||
27915177|NCT01198873|54572995|FG001|Overall Study|Study closure|23|||
28001496|NCT00728949|54660490|FG001|Overall Study|Adverse Event|0|||
28001497|NCT00728949|54660489|FG000|Overall Study|Withdrawal by Subject|2|||
28001498|NCT00728949|54660490|FG001|Overall Study|Withdrawal by Subject|2|||
28001499|NCT00728949|54660489|FG000|Overall Study|Abnormal Lab Results|0|||
28001500|NCT00728949|54660490|FG001|Overall Study|Abnormal Lab Results|2|||
28001501|NCT00728949|54660489|FG000|Overall Study|On treatment at cutoff date|1|||
28001502|NCT00728949|54660490|FG001|Overall Study|On treatment at cutoff date|0|||
28001503|NCT00728481|54660498|FG000|Overall Study|Withdrawal by Subject|0|||
28001504|NCT00728481|54660499|FG001|Overall Study|Withdrawal by Subject|1|||
28001505|NCT00728481|54660498|FG000|Overall Study|Adverse Event|0|||
28001506|NCT00728481|54660499|FG001|Overall Study|Adverse Event|1|||
28001507|NCT00728481|54660498|FG000|Overall Study|Study medication non-compliance|0|||
28001508|NCT00728481|54660499|FG001|Overall Study|Study medication non-compliance|2|||
28001509|NCT00728481|54660498|FG000|Overall Study|Incorrectly assigned to opposite arm|1|||
28001510|NCT00728481|54660499|FG001|Overall Study|Incorrectly assigned to opposite arm|0|||
28001511|NCT00811655|54660505|FG000|Overall Study|Physician Decision|1|||
28001512|NCT00727311|54660509|FG000|Overall Study|Did not receive drug|316|||
28001513|NCT00727311|54660509|FG000|Overall Study|Missing end of therapy data|205|||
28001514|NCT00727311|54660509|FG000|Overall Study|Adverse Event|58|||
28001515|NCT00727311|54660509|FG000|Overall Study|Lack of Efficacy|242|||
28001516|NCT00727311|54660509|FG000|Overall Study|Lost to Follow-up|73|||
28001517|NCT00727311|54660509|FG000|Overall Study|Withdrawal by Subject|77|||
28001518|NCT00727311|54660509|FG000|Overall Study|Other|97|||
28001519|NCT00727311|54660509|FG000|Overall Study|Multiple reasons|39|||
28001520|NCT00726999|54660515|FG000|Overall Study|Physician Decision|0|||
28001521|NCT00726999|54660516|FG001|Overall Study|Physician Decision|1|||
28001522|NCT00726999|54660515|FG000|Overall Study|Withdrawal by Subject|2|||
28001523|NCT00726999|54660516|FG001|Overall Study|Withdrawal by Subject|0|||
28001524|NCT00726999|54660515|FG000|Overall Study|Protocol Violation|1|||
28001525|NCT00726999|54660516|FG001|Overall Study|Protocol Violation|0|||
28001526|NCT00585351|54660530|FG000|Notification Period (Informed Consent)|Physician Decision|0|||
28001527|NCT00585351|54660531|FG001|Notification Period (Informed Consent)|Physician Decision|2|||
28001528|NCT00585351|54660532|FG002|Notification Period (Informed Consent)|Physician Decision|0|||
28001529|NCT00585351|54660533|FG003|Notification Period (Informed Consent)|Physician Decision|0|||
28001530|NCT00585351|54660534|FG004|Notification Period (Informed Consent)|Physician Decision|0|||
28001531|NCT00585351|54660535|FG005|Notification Period (Informed Consent)|Physician Decision|0|||
28001532|NCT00585351|54660536|FG006|Notification Period (Informed Consent)|Physician Decision|0|||
28100088|NCT03504852|54756602|FG000|Overall Study|New therapy for study indication|1|||
27915178|NCT01198873|54572994|FG000|Overall Study|Other than above|4|||
27915179|NCT01198873|54572995|FG001|Overall Study|Other than above|2|||
27915180|NCT01198795|54573001|FG000|Overall Study|Did not meet InclusionExclusion criteria|30|||
27915181|NCT01198795|54573001|FG000|Overall Study|Withdrawal by Subject|17|||
27915182|NCT01198795|54573001|FG000|Overall Study|Lost to Follow-up|15|||
27915183|NCT01198795|54573001|FG000|Overall Study|Adverse Event|9|||
27915184|NCT01198795|54573001|FG000|Overall Study|Lack of Efficacy|5|||
27915185|NCT01198795|54573001|FG000|Overall Study|Protocol Violation|2|||
27915186|NCT01198795|54573001|FG000|Overall Study|Other Reason|4|||
27915187|NCT01198756|54573009|FG000|Overall Study|Adverse Event|0|||
27915188|NCT01198756|54573010|FG001|Overall Study|Adverse Event|0|||
27915189|NCT01198756|54573011|FG002|Overall Study|Adverse Event|0|||
27915190|NCT01198756|54573012|FG003|Overall Study|Adverse Event|1|||
27915191|NCT01198756|54573009|FG000|Overall Study|Protocol Violation|0|||
27915192|NCT01198756|54573010|FG001|Overall Study|Protocol Violation|0|||
27915193|NCT01198756|54573011|FG002|Overall Study|Protocol Violation|0|||
27915194|NCT01198756|54573012|FG003|Overall Study|Protocol Violation|2|||
27915195|NCT01198756|54573009|FG000|Overall Study|Withdrawal by Subject|9|||
27915196|NCT01198756|54573010|FG001|Overall Study|Withdrawal by Subject|4|||
27915197|NCT01198756|54573011|FG002|Overall Study|Withdrawal by Subject|7|||
27915198|NCT01198756|54573012|FG003|Overall Study|Withdrawal by Subject|5|||
27915199|NCT01198756|54573009|FG000|Overall Study|Lost to Follow-up|29|||
27915200|NCT01198756|54573010|FG001|Overall Study|Lost to Follow-up|36|||
27915201|NCT01198756|54573011|FG002|Overall Study|Lost to Follow-up|23|||
27915202|NCT01198756|54573012|FG003|Overall Study|Lost to Follow-up|18|||
27915203|NCT01198600|54573029|FG000|Phase 1: Period One, 30 Days of Wear|Inconvenience|1|||
28001533|NCT00585351|54660537|FG007|Notification Period (Informed Consent)|Physician Decision|0|||
28001534|NCT00585351|54660530|FG000|Notification Period (Informed Consent)|Flight aborted|2|||
28001535|NCT00585351|54660531|FG001|Notification Period (Informed Consent)|Flight aborted|1|||
28001536|NCT00585351|54660532|FG002|Notification Period (Informed Consent)|Flight aborted|0|||
28100089|NCT03504852|54756603|FG001|Overall Study|New therapy for study indication|0|||
27915204|NCT01198600|54573030|FG001|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
27915205|NCT01198600|54573031|FG002|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
27915206|NCT01198600|54573032|FG003|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
27915207|NCT01198600|54573029|FG000|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1|||
27915208|NCT01198600|54573030|FG001|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
27915209|NCT01198600|54573031|FG002|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
28001537|NCT00585351|54660533|FG003|Notification Period (Informed Consent)|Flight aborted|0|||
28001538|NCT00585351|54660534|FG004|Notification Period (Informed Consent)|Flight aborted|0|||
28001539|NCT00585351|54660535|FG005|Notification Period (Informed Consent)|Flight aborted|0|||
28001540|NCT00585351|54660536|FG006|Notification Period (Informed Consent)|Flight aborted|0|||
28001541|NCT00585351|54660537|FG007|Notification Period (Informed Consent)|Flight aborted|0|||
28001542|NCT00585351|54660530|FG000|Notification Period (Informed Consent)|No study medication on flight|0|||
28001543|NCT00585351|54660531|FG001|Notification Period (Informed Consent)|No study medication on flight|1|||
28001544|NCT00585351|54660532|FG002|Notification Period (Informed Consent)|No study medication on flight|0|||
28001545|NCT00585351|54660533|FG003|Notification Period (Informed Consent)|No study medication on flight|0|||
28001546|NCT00585351|54660534|FG004|Notification Period (Informed Consent)|No study medication on flight|0|||
28001547|NCT00585351|54660535|FG005|Notification Period (Informed Consent)|No study medication on flight|0|||
28001548|NCT00585351|54660536|FG006|Notification Period (Informed Consent)|No study medication on flight|0|||
28001549|NCT00585351|54660537|FG007|Notification Period (Informed Consent)|No study medication on flight|0|||
28001550|NCT00585351|54660530|FG000|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
28001551|NCT00585351|54660531|FG001|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
28001552|NCT00585351|54660532|FG002|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
28001553|NCT00585351|54660533|FG003|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
28001554|NCT00585351|54660534|FG004|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
28001555|NCT00585351|54660535|FG005|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
28001556|NCT00585351|54660536|FG006|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
28001557|NCT00585351|54660537|FG007|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
27915210|NCT01198600|54573032|FG003|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
27915211|NCT01198600|54573029|FG000|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
27915212|NCT01198600|54573030|FG001|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1|||
27915213|NCT01198600|54573031|FG002|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
27915214|NCT01198600|54573032|FG003|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
27915215|NCT01198600|54573029|FG000|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
27915216|NCT01198600|54573030|FG001|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1|||
27915217|NCT01198600|54573031|FG002|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
28001558|NCT00585351|54660530|FG000|Enrollment Period (Intervention)|Lost to Follow-up|0|||
28001559|NCT00585351|54660531|FG001|Enrollment Period (Intervention)|Lost to Follow-up|0|||
28001560|NCT00585351|54660532|FG002|Enrollment Period (Intervention)|Lost to Follow-up|0|||
28001561|NCT00585351|54660533|FG003|Enrollment Period (Intervention)|Lost to Follow-up|0|||
28001562|NCT00585351|54660534|FG004|Enrollment Period (Intervention)|Lost to Follow-up|0|||
28001563|NCT00585351|54660535|FG005|Enrollment Period (Intervention)|Lost to Follow-up|0|||
28001564|NCT00585351|54660536|FG006|Enrollment Period (Intervention)|Lost to Follow-up|1|||
28001565|NCT00585351|54660537|FG007|Enrollment Period (Intervention)|Lost to Follow-up|1|||
28001566|NCT00585351|54660530|FG000|Enrollment Period (Intervention)|Death|0|||
28001567|NCT00585351|54660531|FG001|Enrollment Period (Intervention)|Death|0|||
27915218|NCT01198600|54573032|FG003|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
27915219|NCT01198600|54573029|FG000|Phase 2: 56 Days of Wear|Inconvenience|0|||
27915220|NCT01198600|54573030|FG001|Phase 2: 56 Days of Wear|Inconvenience|0|||
27915221|NCT01198600|54573031|FG002|Phase 2: 56 Days of Wear|Inconvenience|2|||
27915222|NCT01198600|54573032|FG003|Phase 2: 56 Days of Wear|Inconvenience|0|||
27915223|NCT01198600|54573029|FG000|Phase 2: 56 Days of Wear|Relocation|0|||
27915224|NCT01198600|54573030|FG001|Phase 2: 56 Days of Wear|Relocation|0|||
28001568|NCT00585351|54660532|FG002|Enrollment Period (Intervention)|Death|0|||
28001569|NCT00585351|54660533|FG003|Enrollment Period (Intervention)|Death|0|||
28001570|NCT00585351|54660534|FG004|Enrollment Period (Intervention)|Death|1|||
28001571|NCT00585351|54660535|FG005|Enrollment Period (Intervention)|Death|0|||
28001572|NCT00585351|54660536|FG006|Enrollment Period (Intervention)|Death|1|||
28001573|NCT00585351|54660537|FG007|Enrollment Period (Intervention)|Death|0|||
28001574|NCT00585351|54660530|FG000|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
28001575|NCT00585351|54660531|FG001|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
28001576|NCT00585351|54660532|FG002|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
28001577|NCT00585351|54660533|FG003|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
28001578|NCT00585351|54660534|FG004|Enrollment Period (Intervention)|Unknown if alive or deceased|1|||
27739829|NCT02219308|54189556|FG001|Overall Study|Withdrawal by Subject|2|||
28001579|NCT00585351|54660535|FG005|Enrollment Period (Intervention)|Unknown if alive or deceased|2|||
28001580|NCT00585351|54660536|FG006|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
28001581|NCT00585351|54660537|FG007|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
28001582|NCT00726609|54660551|FG000|Overall Study|Adverse Event|10|||
27915225|NCT01198600|54573031|FG002|Phase 2: 56 Days of Wear|Relocation|2|||
27915226|NCT01198600|54573032|FG003|Phase 2: 56 Days of Wear|Relocation|0|||
27915227|NCT01198600|54573029|FG000|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
27915228|NCT01198600|54573030|FG001|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
27915229|NCT01198600|54573031|FG002|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1|||
27915230|NCT01198600|54573032|FG003|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
27915231|NCT01198132|54573042|FG000|Overall Study|Withdrawal by Subject|4|||
27915232|NCT01198132|54573043|FG001|Overall Study|Withdrawal by Subject|5|||
27915233|NCT01198132|54573042|FG000|Overall Study|Physician Decision|5|||
27915234|NCT01198132|54573043|FG001|Overall Study|Physician Decision|4|||
27915235|NCT01198132|54573042|FG000|Overall Study|Other Unspecified|3|||
27915236|NCT01198132|54573043|FG001|Overall Study|Other Unspecified|6|||
27915237|NCT01198132|54573042|FG000|Overall Study|Lack of Efficacy|2|||
27915238|NCT01198132|54573043|FG001|Overall Study|Lack of Efficacy|3|||
27915239|NCT01198132|54573042|FG000|Overall Study|Sign/symptoms of underlying disease|2|||
27915240|NCT01198132|54573043|FG001|Overall Study|Sign/symptoms of underlying disease|1|||
27915241|NCT01198132|54573042|FG000|Overall Study|Abnormal/clinically significant biologic|1|||
27915242|NCT01198132|54573043|FG001|Overall Study|Abnormal/clinically significant biologic|1|||
27915243|NCT01198132|54573042|FG000|Overall Study|Adverse Event|0|||
27915244|NCT01198132|54573043|FG001|Overall Study|Adverse Event|1|||
27915245|NCT01198132|54573042|FG000|Overall Study|Protocol Violation|1|||
28001583|NCT00726609|54660551|FG000|Overall Study|Withdrawal by Subject|2|||
28001584|NCT00726609|54660551|FG000|Overall Study|Lack of Efficacy|25|||
28001585|NCT00726609|54660551|FG000|Overall Study|Other|16|||
28001586|NCT00726609|54660551|FG000|Overall Study|Missing|42|||
28001587|NCT00726609|54660551|FG000|Overall Study|Other|3|||
28001588|NCT00726453|54660557|FG000|Primary Enrollment Group|Death|18|||
28001589|NCT00726453|54660558|FG001|Primary Enrollment Group|Death|0|||
28001590|NCT00726453|54660557|FG000|Primary Enrollment Group|Withdrawal by Subject|13|||
28001591|NCT00726453|54660558|FG001|Primary Enrollment Group|Withdrawal by Subject|0|||
28001592|NCT00726453|54660557|FG000|38 mm Length Group|Death|0|||
28001593|NCT00726453|54660558|FG001|38 mm Length Group|Death|3|||
28001594|NCT00726063|54660565|FG000|Overall Study|Adverse Event|9|||
28001595|NCT00726063|54660566|FG001|Overall Study|Adverse Event|7|||
28001596|NCT00808028|54660576|FG000|Stage 1 (6 Months)|Withdrawal by Subject|3|||
28001597|NCT00808028|54660577|FG001|Stage 1 (6 Months)|Withdrawal by Subject|0|||
28001598|NCT00808028|54660578|FG002|Stage 1 (6 Months)|Withdrawal by Subject|2|||
28001599|NCT00808028|54660579|FG003|Stage 1 (6 Months)|Withdrawal by Subject|5|||
28001600|NCT00808028|54660576|FG000|Stage 1 (6 Months)|Other|1|||
28001601|NCT00808028|54660577|FG001|Stage 1 (6 Months)|Other|0|||
28001602|NCT00808028|54660578|FG002|Stage 1 (6 Months)|Other|2|||
28001603|NCT00808028|54660579|FG003|Stage 1 (6 Months)|Other|4|||
28001604|NCT00808028|54660576|FG000|Stage 1 (6 Months)|Parent/legal guardian request|0|||
28001605|NCT00808028|54660577|FG001|Stage 1 (6 Months)|Parent/legal guardian request|1|||
28001606|NCT00808028|54660578|FG002|Stage 1 (6 Months)|Parent/legal guardian request|1|||
28001607|NCT00808028|54660579|FG003|Stage 1 (6 Months)|Parent/legal guardian request|3|||
28001608|NCT00808028|54660576|FG000|Stage 1 (6 Months)|Adverse Event|0|||
28001609|NCT00808028|54660577|FG001|Stage 1 (6 Months)|Adverse Event|0|||
28001610|NCT00808028|54660578|FG002|Stage 1 (6 Months)|Adverse Event|1|||
28001611|NCT00808028|54660579|FG003|Stage 1 (6 Months)|Adverse Event|2|||
28001612|NCT00808028|54660576|FG000|Stage 1 (6 Months)|Lost to Follow-up|1|||
28001613|NCT00808028|54660577|FG001|Stage 1 (6 Months)|Lost to Follow-up|0|||
28001614|NCT00808028|54660578|FG002|Stage 1 (6 Months)|Lost to Follow-up|1|||
28001615|NCT00808028|54660579|FG003|Stage 1 (6 Months)|Lost to Follow-up|0|||
28001616|NCT00808028|54660576|FG000|Stage 1 (6 Months)|Protocol Violation|0|||
28001617|NCT00808028|54660577|FG001|Stage 1 (6 Months)|Protocol Violation|0|||
28001618|NCT00808028|54660578|FG002|Stage 1 (6 Months)|Protocol Violation|0|||
28001619|NCT00808028|54660579|FG003|Stage 1 (6 Months)|Protocol Violation|1|||
28001620|NCT00808028|54660576|FG000|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6|||
28001621|NCT00808028|54660577|FG001|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0|||
28001622|NCT00808028|54660578|FG002|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9|||
28001623|NCT00808028|54660579|FG003|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11|||
28001624|NCT00808028|54660576|FG000|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
28001625|NCT00808028|54660577|FG001|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
28001626|NCT00808028|54660578|FG002|Stage 2 (Followed up to 48 Months )|Protocol Violation|1|||
28001627|NCT00808028|54660579|FG003|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
28001628|NCT00808028|54660576|FG000|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2|||
27915246|NCT01198132|54573043|FG001|Overall Study|Protocol Violation|0|||
27915247|NCT01197508|54573055|FG000|Overall Study|Withdrawal by Subject|8|||
27915248|NCT01197508|54573056|FG001|Overall Study|Withdrawal by Subject|7|||
28001629|NCT00808028|54660577|FG001|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0|||
28001630|NCT00808028|54660578|FG002|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8|||
28001631|NCT00808028|54660579|FG003|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7|||
28001632|NCT00808028|54660576|FG000|Stage 2 (Followed up to 48 Months )|Failed to return|2|||
28001633|NCT00808028|54660577|FG001|Stage 2 (Followed up to 48 Months )|Failed to return|0|||
28001634|NCT00808028|54660578|FG002|Stage 2 (Followed up to 48 Months )|Failed to return|5|||
28001635|NCT00808028|54660579|FG003|Stage 2 (Followed up to 48 Months )|Failed to return|4|||
28001636|NCT00808028|54660576|FG000|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
28001637|NCT00808028|54660577|FG001|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
28001638|NCT00808028|54660578|FG002|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
28001639|NCT00808028|54660579|FG003|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
28001640|NCT00808028|54660576|FG000|Stage 2 (Followed up to 48 Months )|Other|0|||
28001641|NCT00808028|54660577|FG001|Stage 2 (Followed up to 48 Months )|Other|0|||
28001642|NCT00808028|54660578|FG002|Stage 2 (Followed up to 48 Months )|Other|1|||
28001643|NCT00808028|54660579|FG003|Stage 2 (Followed up to 48 Months )|Other|1|||
28001644|NCT00808028|54660576|FG000|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
27915249|NCT01197508|54573057|FG002|Overall Study|Withdrawal by Subject|15|||
27915250|NCT01197508|54573058|FG003|Overall Study|Withdrawal by Subject|4|||
28001645|NCT00808028|54660577|FG001|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
28001646|NCT00808028|54660578|FG002|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2|||
28001647|NCT00808028|54660579|FG003|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
28001648|NCT00808028|54660576|FG000|Stage 2 (Followed up to 48 Months )|Death|0|||
28001649|NCT00808028|54660577|FG001|Stage 2 (Followed up to 48 Months )|Death|0|||
28001650|NCT00808028|54660578|FG002|Stage 2 (Followed up to 48 Months )|Death|1|||
28001651|NCT00808028|54660579|FG003|Stage 2 (Followed up to 48 Months )|Death|0|||
28001652|NCT00808028|54660576|FG000|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
28001653|NCT00808028|54660577|FG001|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
28001654|NCT00808028|54660578|FG002|Stage 2 (Followed up to 48 Months )|Non-compliance|1|||
28001655|NCT00808028|54660579|FG003|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
28001656|NCT00809783|54660602|FG000|Overall Study|Death|1|||
28001657|NCT00809783|54660603|FG001|Overall Study|Death|0|||
28001658|NCT00809783|54660604|FG002|Overall Study|Death|0|||
27915251|NCT01197508|54573055|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
27915252|NCT01197508|54573056|FG001|Overall Study|Eligiblity criteria not fulfilled|0|||
27915253|NCT01197508|54573057|FG002|Overall Study|Eligiblity criteria not fulfilled|2|||
27915254|NCT01197508|54573058|FG003|Overall Study|Eligiblity criteria not fulfilled|0|||
27915255|NCT01197508|54573055|FG000|Overall Study|Adverse Event|10|||
27915256|NCT01197508|54573056|FG001|Overall Study|Adverse Event|13|||
27915257|NCT01197508|54573057|FG002|Overall Study|Adverse Event|23|||
27915258|NCT01197508|54573058|FG003|Overall Study|Adverse Event|3|||
27915259|NCT01197508|54573055|FG000|Overall Study|Severe non-compliance to protocol|0|||
27915260|NCT01197508|54573056|FG001|Overall Study|Severe non-compliance to protocol|3|||
27915261|NCT01197508|54573057|FG002|Overall Study|Severe non-compliance to protocol|1|||
27915262|NCT01197508|54573058|FG003|Overall Study|Severe non-compliance to protocol|3|||
27915263|NCT01197508|54573055|FG000|Overall Study|Condition under investigation worsened|1|||
27915264|NCT01197508|54573056|FG001|Overall Study|Condition under investigation worsened|1|||
27915265|NCT01197508|54573057|FG002|Overall Study|Condition under investigation worsened|1|||
27915266|NCT01197508|54573058|FG003|Overall Study|Condition under investigation worsened|1|||
27915267|NCT01197508|54573055|FG000|Overall Study|Lack of Efficacy|1|||
27915268|NCT01197508|54573056|FG001|Overall Study|Lack of Efficacy|2|||
27915269|NCT01197508|54573057|FG002|Overall Study|Lack of Efficacy|2|||
27915270|NCT01197508|54573058|FG003|Overall Study|Lack of Efficacy|1|||
27915271|NCT01197508|54573055|FG000|Overall Study|Study-specific withdrawal criteria|0|||
27915272|NCT01197508|54573056|FG001|Overall Study|Study-specific withdrawal criteria|0|||
27915273|NCT01197508|54573057|FG002|Overall Study|Study-specific withdrawal criteria|1|||
27915274|NCT01197508|54573058|FG003|Overall Study|Study-specific withdrawal criteria|2|||
27915275|NCT01197508|54573055|FG000|Overall Study|Lost to Follow-up|1|||
27915276|NCT01197508|54573056|FG001|Overall Study|Lost to Follow-up|1|||
27915277|NCT01197508|54573057|FG002|Overall Study|Lost to Follow-up|2|||
27915278|NCT01197508|54573058|FG003|Overall Study|Lost to Follow-up|0|||
27915279|NCT01197508|54573055|FG000|Overall Study|Other|2|||
27915280|NCT01197508|54573056|FG001|Overall Study|Other|3|||
27915281|NCT01197508|54573057|FG002|Overall Study|Other|2|||
27915282|NCT01197508|54573058|FG003|Overall Study|Other|2|||
27915283|NCT01196416|54573075|FG000|Overall Study|Withdrawal by Subject|2|||
27915284|NCT01196104|54573081|FG000|Overall Study|Lost to Follow-up|1|||
28001659|NCT00809783|54660602|FG000|Overall Study|Adverse Event|34|||
28001660|NCT00809783|54660603|FG001|Overall Study|Adverse Event|52|||
28001661|NCT00809783|54660604|FG002|Overall Study|Adverse Event|71|||
28001662|NCT00809783|54660602|FG000|Overall Study|Lack of Efficacy|39|||
27915285|NCT01196104|54573082|FG001|Overall Study|Lost to Follow-up|0|||
27915286|NCT01196104|54573081|FG000|Overall Study|Physician Decision|0|||
27915287|NCT01196104|54573082|FG001|Overall Study|Physician Decision|1|||
27915288|NCT01196104|54573081|FG000|Overall Study|Withdrawal by Subject|3|||
27915289|NCT01196104|54573082|FG001|Overall Study|Withdrawal by Subject|3|||
27915290|NCT01196104|54573081|FG000|Overall Study|Various|0|||
28001663|NCT00809783|54660603|FG001|Overall Study|Lack of Efficacy|52|||
28001664|NCT00809783|54660604|FG002|Overall Study|Lack of Efficacy|63|||
27915291|NCT01196104|54573082|FG001|Overall Study|Various|1|||
27915292|NCT01196026|54573100|FG000|Overall Study|Withdrawal by Subject|1|||
27915293|NCT01196026|54573101|FG001|Overall Study|Withdrawal by Subject|4|||
28001665|NCT00809783|54660602|FG000|Overall Study|Lost to Follow-up|0|||
28001666|NCT00809783|54660603|FG001|Overall Study|Lost to Follow-up|3|||
28001667|NCT00809783|54660604|FG002|Overall Study|Lost to Follow-up|4|||
28001668|NCT00809783|54660602|FG000|Overall Study|Withdrawal by Subject|47|||
28001669|NCT00809783|54660603|FG001|Overall Study|Withdrawal by Subject|72|||
28001670|NCT00809783|54660604|FG002|Overall Study|Withdrawal by Subject|64|||
28001671|NCT00809783|54660602|FG000|Overall Study|Protocol Violation|2|||
28001672|NCT00809783|54660603|FG001|Overall Study|Protocol Violation|6|||
28001673|NCT00809783|54660604|FG002|Overall Study|Protocol Violation|5|||
28001674|NCT00809783|54660602|FG000|Overall Study|Randomized, but not treated|3|||
28001675|NCT00809783|54660603|FG001|Overall Study|Randomized, but not treated|0|||
28001676|NCT00809783|54660604|FG002|Overall Study|Randomized, but not treated|2|||
28001677|NCT00809783|54660602|FG000|Overall Study|Study Terminated by Sponsor|378|||
28001678|NCT00809783|54660603|FG001|Overall Study|Study Terminated by Sponsor|626|||
28001679|NCT00809783|54660604|FG002|Overall Study|Study Terminated by Sponsor|565|||
28001680|NCT00809783|54660602|FG000|Overall Study|Other|21|||
27915294|NCT01196026|54573102|FG002|Overall Study|Withdrawal by Subject|0|||
27915295|NCT01196026|54573103|FG003|Overall Study|Withdrawal by Subject|0|||
27915296|NCT01196026|54573104|FG004|Overall Study|Withdrawal by Subject|0|||
27915297|NCT01196026|54573105|FG005|Overall Study|Withdrawal by Subject|0|||
28001681|NCT00809783|54660603|FG001|Overall Study|Other|21|||
28001682|NCT00809783|54660604|FG002|Overall Study|Other|16|||
28001683|NCT00809471|54660615|FG000|Overall Study|Protocol non-compliance|15|||
28001684|NCT00809471|54660616|FG001|Overall Study|Protocol non-compliance|15|||
28001685|NCT00809471|54660617|FG002|Overall Study|Protocol non-compliance|6|||
28001686|NCT00809471|54660615|FG000|Overall Study|Lost to Follow-up|4|||
28001687|NCT00809471|54660616|FG001|Overall Study|Lost to Follow-up|2|||
28001688|NCT00809471|54660617|FG002|Overall Study|Lost to Follow-up|9|||
28001689|NCT00809471|54660615|FG000|Overall Study|Adverse Event|0|||
28001690|NCT00809471|54660616|FG001|Overall Study|Adverse Event|2|||
28001691|NCT00809471|54660617|FG002|Overall Study|Adverse Event|2|||
28001692|NCT00809471|54660615|FG000|Overall Study|Requirement for restricted medication|1|||
28001693|NCT00809471|54660616|FG001|Overall Study|Requirement for restricted medication|1|||
28001694|NCT00809471|54660617|FG002|Overall Study|Requirement for restricted medication|0|||
28001695|NCT00807248|54660629|FG000|Overall Study|Adverse Event|1|||
28100090|NCT03504852|54756604|FG002|Overall Study|New therapy for study indication|0|||
28100091|NCT03504852|54756602|FG000|Overall Study|Lack of Efficacy|1|||
27739830|NCT02218372|54189564|FG000|Overall Study|Adverse Event|1|||
27739831|NCT02218372|54189565|FG001|Overall Study|Adverse Event|1|||
27739832|NCT02218372|54189564|FG000|Overall Study|Miscellaneous|2|||
27739833|NCT02218372|54189565|FG001|Overall Study|Miscellaneous|1|||
27739834|NCT02218372|54189564|FG000|Overall Study|Randomized but did not receive treatment|2|||
27739835|NCT02218372|54189565|FG001|Overall Study|Randomized but did not receive treatment|3|||
27739836|NCT02218372|54189564|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
27739837|NCT02218372|54189565|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
27739838|NCT02218216|54189578|FG000|Overall Study|Study terminated before completed|6|||
27739839|NCT02218216|54189579|FG001|Overall Study|Study terminated before completed|0|||
27739840|NCT02218216|54189580|FG002|Overall Study|Study terminated before completed|0|||
27739841|NCT02217982|54189590|FG000|Overall Study|Trial discontinued|1|||
27739842|NCT02217982|54189591|FG001|Overall Study|Trial discontinued|0|||
27739843|NCT02217982|54189590|FG000|Overall Study|Adverse Event|0|||
27739844|NCT02217982|54189591|FG001|Overall Study|Adverse Event|1|||
27739845|NCT02254408|54189599|FG000|Overall Study|Randomized But Not Treated|1|||
27739846|NCT02254408|54189600|FG001|Overall Study|Randomized But Not Treated|3|||
27739847|NCT02254408|54189599|FG000|Overall Study|Adverse Event|1|||
27739848|NCT02254408|54189600|FG001|Overall Study|Adverse Event|0|||
27739849|NCT02254408|54189599|FG000|Overall Study|Death|2|||
27739850|NCT02254408|54189600|FG001|Overall Study|Death|3|||
27739851|NCT02254408|54189599|FG000|Overall Study|Investigator's Discretion|0|||
27915298|NCT01196026|54573100|FG000|Overall Study|Lost to Follow-up|0|||
27915299|NCT01196026|54573101|FG001|Overall Study|Lost to Follow-up|3|||
27915300|NCT01196026|54573102|FG002|Overall Study|Lost to Follow-up|0|||
27739852|NCT02254408|54189600|FG001|Overall Study|Investigator's Discretion|1|||
27739853|NCT02254408|54189599|FG000|Overall Study|Withdrawal by Subject|3|||
27915301|NCT01196026|54573103|FG003|Overall Study|Lost to Follow-up|0|||
27915302|NCT01196026|54573104|FG004|Overall Study|Lost to Follow-up|1|||
27915303|NCT01196026|54573105|FG005|Overall Study|Lost to Follow-up|0|||
27915304|NCT01196026|54573100|FG000|Overall Study|Other|0|||
27915305|NCT01196026|54573101|FG001|Overall Study|Other|1|||
27915306|NCT01196026|54573102|FG002|Overall Study|Other|0|||
27915307|NCT01196026|54573103|FG003|Overall Study|Other|0|||
27915308|NCT01196026|54573104|FG004|Overall Study|Other|0|||
28001696|NCT00807248|54660630|FG001|Overall Study|Adverse Event|2|||
28001697|NCT00807248|54660631|FG002|Overall Study|Adverse Event|2|||
27915309|NCT01196026|54573105|FG005|Overall Study|Other|0|||
27915310|NCT01195948|54573124|FG000|Overall Study|Lost to Follow-up|0|||
28001698|NCT00807248|54660632|FG003|Overall Study|Adverse Event|6|||
28001699|NCT00807248|54660629|FG000|Overall Study|Lack of Efficacy|14|||
27915311|NCT01195948|54573125|FG001|Overall Study|Lost to Follow-up|1|||
27915312|NCT01195948|54573126|FG002|Overall Study|Lost to Follow-up|2|||
27915313|NCT01195831|54573139|FG000|Overall Study|Lost to Follow-up|2|||
27915314|NCT01195831|54573140|FG001|Overall Study|Lost to Follow-up|4|||
27915315|NCT01195831|54573139|FG000|Overall Study|Withdrawal by Subject|2|||
27915316|NCT01195831|54573140|FG001|Overall Study|Withdrawal by Subject|2|||
27915317|NCT01195831|54573139|FG000|Overall Study|Adverse Event|4|||
27915318|NCT01195831|54573140|FG001|Overall Study|Adverse Event|2|||
27915319|NCT01195831|54573139|FG000|Overall Study|Protocol Violation|0|||
27915320|NCT01195831|54573140|FG001|Overall Study|Protocol Violation|2|||
27915321|NCT01195675|54573146|FG000|Overall Study|Adverse Event|1|||
27915322|NCT01195675|54573146|FG000|Overall Study|Withdrawal by Subject|2|||
27915323|NCT01195636|54573163|FG000|First Intervention (3 Weeks)|Adverse Event|2|||
27915324|NCT01195636|54573164|FG001|First Intervention (3 Weeks)|Adverse Event|3|||
27915325|NCT01195636|54573163|FG000|First Intervention (3 Weeks)|Protocol Violation|1|||
27915326|NCT01195636|54573164|FG001|First Intervention (3 Weeks)|Protocol Violation|0|||
28001700|NCT00807248|54660630|FG001|Overall Study|Lack of Efficacy|4|||
28001701|NCT00807248|54660631|FG002|Overall Study|Lack of Efficacy|8|||
28001702|NCT00807248|54660632|FG003|Overall Study|Lack of Efficacy|3|||
28001703|NCT00807248|54660629|FG000|Overall Study|Protocol Violation|0|||
28001704|NCT00807248|54660630|FG001|Overall Study|Protocol Violation|1|||
28100092|NCT03504852|54756603|FG001|Overall Study|Lack of Efficacy|2|||
28100093|NCT03504852|54756604|FG002|Overall Study|Lack of Efficacy|0|||
28100094|NCT03504852|54756602|FG000|Overall Study|Death|0|||
28100095|NCT03504852|54756603|FG001|Overall Study|Death|1|||
28100096|NCT03504852|54756604|FG002|Overall Study|Death|0|||
28100097|NCT03504852|54756602|FG000|Overall Study|Adverse Event|4|||
28100098|NCT03504852|54756603|FG001|Overall Study|Adverse Event|8|||
28100099|NCT03504852|54756604|FG002|Overall Study|Adverse Event|2|||
28100100|NCT03025828|54756614|FG000|Overall Study|Lost to Follow-up|1|||
28100101|NCT03546816|54756620|FG000|Overall Study|Adverse Event|5|||
28001705|NCT00807248|54660631|FG002|Overall Study|Protocol Violation|1|||
28001706|NCT00807248|54660632|FG003|Overall Study|Protocol Violation|0|||
28001707|NCT00807248|54660629|FG000|Overall Study|Withdrawal of Consent|5|||
28001708|NCT00807248|54660630|FG001|Overall Study|Withdrawal of Consent|5|||
28001709|NCT00807248|54660631|FG002|Overall Study|Withdrawal of Consent|5|||
28001710|NCT00807248|54660632|FG003|Overall Study|Withdrawal of Consent|5|||
28001711|NCT00807248|54660629|FG000|Overall Study|Lost to Follow-up|1|||
28001712|NCT00807248|54660630|FG001|Overall Study|Lost to Follow-up|0|||
28001713|NCT00807248|54660631|FG002|Overall Study|Lost to Follow-up|0|||
28001714|NCT00807248|54660632|FG003|Overall Study|Lost to Follow-up|0|||
28001715|NCT00807248|54660629|FG000|Overall Study|Other Reason|0|||
28001716|NCT00807248|54660630|FG001|Overall Study|Other Reason|0|||
28100102|NCT03546816|54756621|FG001|Overall Study|Adverse Event|3|||
28100103|NCT03546816|54756620|FG000|Overall Study|Lack of Efficacy|2|||
28100104|NCT03546816|54756621|FG001|Overall Study|Lack of Efficacy|4|||
28100105|NCT03546816|54756620|FG000|Overall Study|Pregnancy|1|||
28100106|NCT03546816|54756621|FG001|Overall Study|Pregnancy|0|||
28100107|NCT03546816|54756620|FG000|Overall Study|Physician Decision|2|||
28100108|NCT03546816|54756621|FG001|Overall Study|Physician Decision|0|||
28100109|NCT03546816|54756620|FG000|Overall Study|Withdrawal by Subject|8|||
28100110|NCT03546816|54756621|FG001|Overall Study|Withdrawal by Subject|10|||
28100111|NCT03546816|54756620|FG000|Overall Study|Lost to Follow-up|3|||
28100112|NCT03546816|54756621|FG001|Overall Study|Lost to Follow-up|2|||
28100113|NCT03024970|54756629|FG000|First Intervention|Adverse Event|1|||
28100114|NCT03024970|54756630|FG001|First Intervention|Adverse Event|0|||
28100115|NCT03024970|54756629|FG000|Second Intervention|Lost to Follow-up|1|||
28100116|NCT03024970|54756630|FG001|Second Intervention|Lost to Follow-up|0|||
28100117|NCT03500094|54756636|FG000|Overall Study|Withdrawal by Subject|1|||
28100118|NCT03500094|54756636|FG000|Overall Study|Withdrawal by Parent or Legally-authorized Representative|1|||
28100119|NCT03500094|54756636|FG000|Overall Study|Lost to Follow-up|1|||
28100120|NCT03566550|54756644|FG000|Overall Study|Withdrawal by Subject|0|||
28100121|NCT03566550|54756645|FG001|Overall Study|Withdrawal by Subject|1|||
28100122|NCT03566238|54756654|FG000|Overall Study|Adverse Event|0|||
28100123|NCT03566238|54756655|FG001|Overall Study|Adverse Event|1|||
28100124|NCT03566238|54756656|FG002|Overall Study|Adverse Event|0|||
28100125|NCT03566238|54756654|FG000|Overall Study|Lack of Efficacy|4|||
28100126|NCT03566238|54756655|FG001|Overall Study|Lack of Efficacy|2|||
27739854|NCT02254408|54189600|FG001|Overall Study|Withdrawal by Subject|3|||
27915327|NCT01195636|54573163|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
27915328|NCT01195636|54573164|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
28001717|NCT00807248|54660631|FG002|Overall Study|Other Reason|2|||
27739855|NCT02254408|54189599|FG000|Overall Study|Lost to Follow-up|1|||
27739856|NCT02254408|54189600|FG001|Overall Study|Lost to Follow-up|0|||
28001718|NCT00807248|54660632|FG003|Overall Study|Other Reason|0|||
28001719|NCT00589628|54660644|FG000|Overall Study|Lost to Follow-up|0|||
28100127|NCT03566238|54756656|FG002|Overall Study|Lack of Efficacy|5|||
28100128|NCT03566238|54756654|FG000|Overall Study|Other|1|||
28100129|NCT03566238|54756655|FG001|Overall Study|Other|0|||
28001720|NCT00589628|54660645|FG001|Overall Study|Lost to Follow-up|1|||
28001721|NCT00588848|54660653|FG000|Overall Study|Physician Decision|0|||
28001722|NCT00588848|54660654|FG001|Overall Study|Physician Decision|3|||
28001723|NCT00797108|54660665|FG000|Overall Study|Adverse Event|1|||
28001724|NCT00797108|54660666|FG001|Overall Study|Adverse Event|0|||
28001725|NCT00797108|54660667|FG002|Overall Study|Adverse Event|3|||
28001726|NCT00797108|54660665|FG000|Overall Study|Did Not Meet Entrance Criteria|0|||
28001727|NCT00797108|54660666|FG001|Overall Study|Did Not Meet Entrance Criteria|1|||
28001728|NCT00797108|54660667|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
28001729|NCT00797108|54660665|FG000|Overall Study|Global Deterioration of Health Status|0|||
28001730|NCT00797108|54660666|FG001|Overall Study|Global Deterioration of Health Status|1|||
28001731|NCT00797108|54660667|FG002|Overall Study|Global Deterioration of Health Status|0|||
28100130|NCT03566238|54756656|FG002|Overall Study|Other|0|||
28100131|NCT02894502|54756667|FG000|Baseline|Withdrawal by Subject|24|||
28100132|NCT02894502|54756668|FG001|Baseline|Withdrawal by Subject|31|||
27739857|NCT02207608|54189608|FG000|Overall Study|Adverse Event|1|||
27739858|NCT02207608|54189609|FG001|Overall Study|Adverse Event|0|||
27739859|NCT03530995|54189617|FG000|Part 1 Period 3|Withdrawal by Subject|2|||
27739860|NCT03530995|54189618|FG001|Part 1 Period 3|Withdrawal by Subject|0|||
27739861|NCT03530995|54189617|FG000|Part 1 Period 3|Protocol Violation|1|||
27739862|NCT03530995|54189618|FG001|Part 1 Period 3|Protocol Violation|0|||
27739863|NCT03530995|54189617|FG000|Part 1 Period 4|Physician Decision|1|||
27739864|NCT03530995|54189618|FG001|Part 1 Period 4|Physician Decision|0|||
27739865|NCT03530995|54189617|FG000|Part 1 Period 4|Withdrawal by Subject|1|||
27739866|NCT03530995|54189618|FG001|Part 1 Period 4|Withdrawal by Subject|0|||
27739867|NCT02217436|54189642|FG000|Overall Study|Protocol Violation|1|||
27739868|NCT02217436|54189643|FG001|Overall Study|Protocol Violation|1|||
27739869|NCT02217436|54189642|FG000|Overall Study|Incomplete data|0|||
27739870|NCT02217436|54189643|FG001|Overall Study|Incomplete data|1|||
27739871|NCT02207530|54189649|FG000|Overall Study|Worsening condition under investigation|78|||
27739872|NCT02207530|54189649|FG000|Overall Study|Patient decision to stop study treatment|5|||
27739873|NCT02207530|54189649|FG000|Overall Study|Adverse Event|8|||
27739874|NCT02207374|54189656|FG000|Overall Study|Withdrawal by Subject|5|||
27739875|NCT02207374|54189657|FG001|Overall Study|Withdrawal by Subject|9|||
27739876|NCT02207374|54189658|FG002|Overall Study|Withdrawal by Subject|4|||
27739877|NCT02207374|54189656|FG000|Overall Study|Death|1|||
28100133|NCT02894502|54756669|FG002|Baseline|Withdrawal by Subject|36|||
28100134|NCT02894502|54756667|FG000|Baseline|Death|3|||
28100135|NCT02894502|54756668|FG001|Baseline|Death|1|||
28100136|NCT02894502|54756669|FG002|Baseline|Death|9|||
28100137|NCT02894502|54756667|FG000|First Follow up|Withdrawal by Subject|32|||
28100138|NCT02894502|54756668|FG001|First Follow up|Withdrawal by Subject|29|||
28100139|NCT02894502|54756669|FG002|First Follow up|Withdrawal by Subject|37|||
28100140|NCT02894502|54756667|FG000|First Follow up|Death|2|||
28100141|NCT02894502|54756668|FG001|First Follow up|Death|2|||
28100142|NCT02894502|54756669|FG002|First Follow up|Death|3|||
28100143|NCT02894502|54756667|FG000|Second Follow up|Withdrawal by Subject|13|||
27739878|NCT02207374|54189657|FG001|Overall Study|Death|0|||
27915329|NCT01195636|54573163|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
27915330|NCT01195636|54573164|FG001|First Intervention (3 Weeks)|Lost to Follow-up|0|||
27915331|NCT01195636|54573163|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
27915332|NCT01195636|54573164|FG001|Washout Period (2 Weeks)|Adverse Event|1|||
27915333|NCT01195636|54573163|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
27915334|NCT01195636|54573164|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
27915335|NCT01195636|54573163|FG000|Second Intervention (3 Weeks)|Adverse Event|1|||
27915336|NCT01195636|54573164|FG001|Second Intervention (3 Weeks)|Adverse Event|1|||
27915337|NCT01195636|54573163|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
27915338|NCT01195636|54573164|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
27915339|NCT01195363|54573172|FG000|Overall Study|Lost to Follow-up|7|||
27915340|NCT01195363|54573173|FG001|Overall Study|Lost to Follow-up|4|||
27915341|NCT01195363|54573172|FG000|Overall Study|Adverse Event|3|||
27915342|NCT01195363|54573173|FG001|Overall Study|Adverse Event|1|||
27915343|NCT01195363|54573172|FG000|Overall Study|Lack of Efficacy|0|||
27915344|NCT01195363|54573173|FG001|Overall Study|Lack of Efficacy|4|||
27915345|NCT01195363|54573172|FG000|Overall Study|incarceration|1|||
27915346|NCT01195363|54573173|FG001|Overall Study|incarceration|0|||
27915347|NCT01195090|54573181|FG000|Overall Study|Adverse Event|1|||
27915348|NCT01195090|54573182|FG001|Overall Study|Adverse Event|2|||
27915349|NCT01195090|54573181|FG000|Overall Study|Lost to Follow-up|2|||
27915350|NCT01195090|54573182|FG001|Overall Study|Lost to Follow-up|2|||
27915351|NCT01195090|54573181|FG000|Overall Study|Protocol Violation|3|||
28001732|NCT00797108|54660665|FG000|Overall Study|Lack of Efficacy|1|||
27739879|NCT02207374|54189658|FG002|Overall Study|Death|1|||
27739880|NCT02207374|54189656|FG000|Overall Study|Missing follow-up information|0|||
28001733|NCT00797108|54660666|FG001|Overall Study|Lack of Efficacy|0|||
28001734|NCT00797108|54660667|FG002|Overall Study|Lack of Efficacy|1|||
28100144|NCT02894502|54756668|FG001|Second Follow up|Withdrawal by Subject|15|||
27739881|NCT02207374|54189657|FG001|Overall Study|Missing follow-up information|1|||
27739882|NCT02207374|54189658|FG002|Overall Study|Missing follow-up information|1|||
27739883|NCT02217280|54189666|FG000|Overall Study|Withdrawal by Subject|2|||
27739884|NCT02217280|54189666|FG000|Overall Study|Post-consent sceen fail|2|||
27739885|NCT02786537|54189677|FG000|As Randomized|Adverse Event|0|||
27739886|NCT02786537|54189678|FG001|As Randomized|Adverse Event|11|||
27739887|NCT02786537|54189679|FG002|As Randomized|Adverse Event|0|||
27739888|NCT02786537|54189680|FG003|As Randomized|Adverse Event|4|||
27739889|NCT02786537|54189681|FG004|As Randomized|Adverse Event|6|||
28001735|NCT00797108|54660665|FG000|Overall Study|Other|0|||
28001736|NCT00797108|54660666|FG001|Overall Study|Other|0|||
28001737|NCT00797108|54660667|FG002|Overall Study|Other|2|||
28001738|NCT00797108|54660665|FG000|Overall Study|Randomized but not Treated|2|||
28001739|NCT00797108|54660666|FG001|Overall Study|Randomized but not Treated|0|||
28001740|NCT00797108|54660667|FG002|Overall Study|Randomized but not Treated|0|||
28001741|NCT00742560|54660680|FG000|Overall Study|Adverse Event|0|||
28001742|NCT00742560|54660681|FG001|Overall Study|Adverse Event|0|||
28001743|NCT00742560|54660682|FG002|Overall Study|Adverse Event|1|||
28001744|NCT00742560|54660683|FG003|Overall Study|Adverse Event|1|||
27915352|NCT01195090|54573182|FG001|Overall Study|Protocol Violation|4|||
27915353|NCT01194973|54573188|FG000|Screening Period|Screen Failure|3|||
27915354|NCT01194973|54573188|FG000|26 Week Treatment Period|Adverse Event|1|||
27915355|NCT01194973|54573188|FG000|26 Week Treatment Period|Lack of Efficacy|1|||
27915356|NCT01194973|54573188|FG000|26 Week Treatment Period|Pregnancy|1|||
27915357|NCT02218697|54573194|FG000|Overall Study|Adverse Event|0|||
28001745|NCT00742560|54660684|FG004|Overall Study|Adverse Event|1|||
28001746|NCT00742560|54660680|FG000|Overall Study|Death|0|||
28001747|NCT00742560|54660681|FG001|Overall Study|Death|2|||
28001748|NCT00742560|54660682|FG002|Overall Study|Death|0|||
28001749|NCT00742560|54660683|FG003|Overall Study|Death|2|||
27915358|NCT02218697|54573195|FG001|Overall Study|Adverse Event|2|||
27915359|NCT02218697|54573194|FG000|Overall Study|Unwilling to be vaccinated in left arm|0|||
27915360|NCT02218697|54573195|FG001|Overall Study|Unwilling to be vaccinated in left arm|1|||
27915361|NCT02218697|54573194|FG000|Overall Study|Withdrawal by Subject|2|||
27915362|NCT02218697|54573195|FG001|Overall Study|Withdrawal by Subject|3|||
27915363|NCT01177540|54573203|FG000|Overall Study|Adverse Event|1|||
27915364|NCT01177540|54573204|FG001|Overall Study|Adverse Event|0|||
27915365|NCT01177384|54573212|FG000|Overall Study|Adverse Event|6|||
27915366|NCT01177384|54573213|FG001|Overall Study|Adverse Event|4|||
27915367|NCT01177384|54573212|FG000|Overall Study|Lack of Efficacy|0|||
27915368|NCT01177384|54573213|FG001|Overall Study|Lack of Efficacy|1|||
27915369|NCT01177384|54573212|FG000|Overall Study|Lost to Follow-up|3|||
27915370|NCT01177384|54573213|FG001|Overall Study|Lost to Follow-up|4|||
27915371|NCT01177384|54573212|FG000|Overall Study|Physician Decision|0|||
28001750|NCT00742560|54660684|FG004|Overall Study|Death|3|||
28001751|NCT00742560|54660680|FG000|Overall Study|Subject's Decision|1|||
28001752|NCT00742560|54660681|FG001|Overall Study|Subject's Decision|0|||
28001753|NCT00742560|54660682|FG002|Overall Study|Subject's Decision|2|||
28001754|NCT00742560|54660683|FG003|Overall Study|Subject's Decision|3|||
28001755|NCT00742560|54660684|FG004|Overall Study|Subject's Decision|3|||
28001756|NCT00742560|54660680|FG000|Overall Study|Investigator's Decision|0|||
28001757|NCT00742560|54660681|FG001|Overall Study|Investigator's Decision|0|||
28001758|NCT00742560|54660682|FG002|Overall Study|Investigator's Decision|4|||
28001759|NCT00742560|54660683|FG003|Overall Study|Investigator's Decision|1|||
28001760|NCT00742560|54660684|FG004|Overall Study|Investigator's Decision|0|||
28001761|NCT00742560|54660680|FG000|Overall Study|Disease Progression|1|||
28001762|NCT00742560|54660681|FG001|Overall Study|Disease Progression|0|||
28001763|NCT00742560|54660682|FG002|Overall Study|Disease Progression|5|||
28001764|NCT00742560|54660683|FG003|Overall Study|Disease Progression|17|||
28001765|NCT00742560|54660684|FG004|Overall Study|Disease Progression|16|||
28001766|NCT00742560|54660680|FG000|Overall Study|New Multiple Myeloma Therapy|1|||
28001767|NCT00742560|54660681|FG001|Overall Study|New Multiple Myeloma Therapy|0|||
27739890|NCT02786537|54189682|FG005|As Randomized|Adverse Event|2|||
27915372|NCT01177384|54573213|FG001|Overall Study|Physician Decision|3|||
27915373|NCT01177384|54573212|FG000|Overall Study|Protocol Violation|0|||
28001768|NCT00742560|54660682|FG002|Overall Study|New Multiple Myeloma Therapy|2|||
28001769|NCT00742560|54660683|FG003|Overall Study|New Multiple Myeloma Therapy|3|||
28001770|NCT00742560|54660684|FG004|Overall Study|New Multiple Myeloma Therapy|4|||
28001771|NCT00742560|54660680|FG000|Overall Study|Other|0|||
28001772|NCT00742560|54660681|FG001|Overall Study|Other|1|||
28100145|NCT02894502|54756669|FG002|Second Follow up|Withdrawal by Subject|13|||
28100146|NCT02894502|54756667|FG000|Second Follow up|Death|2|||
27739891|NCT02786537|54189677|FG000|As Randomized|Lack of Efficacy|0|||
27915374|NCT01177384|54573213|FG001|Overall Study|Protocol Violation|2|||
27915375|NCT01177384|54573212|FG000|Overall Study|Withdrawal by Subject|5|||
28001773|NCT00742560|54660682|FG002|Overall Study|Other|8|||
28001774|NCT00742560|54660683|FG003|Overall Study|Other|9|||
28001775|NCT00742560|54660684|FG004|Overall Study|Other|9|||
28001776|NCT00742560|54660680|FG000|Overall Study|MIssing|0|||
28100147|NCT02894502|54756668|FG001|Second Follow up|Death|3|||
28001777|NCT00742560|54660681|FG001|Overall Study|MIssing|0|||
28001778|NCT00742560|54660682|FG002|Overall Study|MIssing|0|||
28001779|NCT00742560|54660683|FG003|Overall Study|MIssing|0|||
28001780|NCT00742560|54660684|FG004|Overall Study|MIssing|1|||
28001781|NCT00740220|54660715|FG000|Overall Study|screen failures (non-COPD patients)|9|||
28001782|NCT00796718|54660719|FG000|Overall Study|Adverse Event|2|||
28001783|NCT00796718|54660719|FG000|Overall Study|Exclusion Criteria|1|||
28001784|NCT00796718|54660719|FG000|Overall Study|Lost to Follow-up|5|||
28001785|NCT00796718|54660719|FG000|Overall Study|Withdrawal by Informed Consent|1|||
28001786|NCT00809159|54660727|FG000|Part 1|Adverse Event|1|||
28001787|NCT00809159|54660728|FG001|Part 1|Adverse Event|1|||
28001788|NCT00809159|54660729|FG002|Part 1|Adverse Event|0|||
28001789|NCT00809159|54660730|FG003|Part 1|Adverse Event|0|||
28001790|NCT00809159|54660731|FG004|Part 1|Adverse Event|0|||
28001791|NCT00809159|54660732|FG005|Part 1|Adverse Event|0|||
28001792|NCT00809159|54660727|FG000|Part 1|Lost to Follow-up|1|||
28001793|NCT00809159|54660728|FG001|Part 1|Lost to Follow-up|0|||
28001794|NCT00809159|54660729|FG002|Part 1|Lost to Follow-up|0|||
28001795|NCT00809159|54660730|FG003|Part 1|Lost to Follow-up|0|||
28001796|NCT00809159|54660731|FG004|Part 1|Lost to Follow-up|0|||
28001797|NCT00809159|54660732|FG005|Part 1|Lost to Follow-up|0|||
28001798|NCT00809159|54660727|FG000|Part 1|Withdrawal by Subject|3|||
28001799|NCT00809159|54660728|FG001|Part 1|Withdrawal by Subject|1|||
28001800|NCT00809159|54660729|FG002|Part 1|Withdrawal by Subject|0|||
28001801|NCT00809159|54660730|FG003|Part 1|Withdrawal by Subject|0|||
28001802|NCT00809159|54660731|FG004|Part 1|Withdrawal by Subject|0|||
28001803|NCT00809159|54660732|FG005|Part 1|Withdrawal by Subject|0|||
28001804|NCT00809159|54660727|FG000|Part 1|Unsatisfactory therapeutic effect|3|||
28100148|NCT02894502|54756669|FG002|Second Follow up|Death|1|||
28100149|NCT02894502|54756667|FG000|Third Follow up|Withdrawal by Subject|5|||
28100150|NCT02894502|54756668|FG001|Third Follow up|Withdrawal by Subject|6|||
28100151|NCT02894502|54756669|FG002|Third Follow up|Withdrawal by Subject|3|||
28100152|NCT02894502|54756667|FG000|Third Follow up|Death|1|||
28100153|NCT02894502|54756668|FG001|Third Follow up|Death|1|||
28100154|NCT02894502|54756669|FG002|Third Follow up|Death|0|||
28100155|NCT03449030|54756690|FG000|Overall Study|Withdrawal by Subject|0|||
28100156|NCT03449030|54756691|FG001|Overall Study|Withdrawal by Subject|0|||
28100157|NCT03449030|54756692|FG002|Overall Study|Withdrawal by Subject|0|||
28100158|NCT03449030|54756693|FG003|Overall Study|Withdrawal by Subject|1|||
28100159|NCT03449030|54756694|FG004|Overall Study|Withdrawal by Subject|1|||
28100160|NCT03449030|54756695|FG005|Overall Study|Withdrawal by Subject|1|||
28100161|NCT03449030|54756696|FG006|Overall Study|Withdrawal by Subject|1|||
28100162|NCT03449030|54756697|FG007|Overall Study|Withdrawal by Subject|2|||
28100163|NCT03449030|54756698|FG008|Overall Study|Withdrawal by Subject|0|||
28100164|NCT03449030|54756699|FG009|Overall Study|Withdrawal by Subject|0|||
28100165|NCT03449030|54756690|FG000|Overall Study|Symptomatic Deterioration|0|||
28100166|NCT03449030|54756691|FG001|Overall Study|Symptomatic Deterioration|1|||
28100167|NCT03449030|54756692|FG002|Overall Study|Symptomatic Deterioration|0|||
28001805|NCT00809159|54660728|FG001|Part 1|Unsatisfactory therapeutic effect|1|||
28100168|NCT03449030|54756693|FG003|Overall Study|Symptomatic Deterioration|0|||
28100169|NCT03449030|54756694|FG004|Overall Study|Symptomatic Deterioration|0|||
28100170|NCT03449030|54756695|FG005|Overall Study|Symptomatic Deterioration|1|||
28100171|NCT03449030|54756696|FG006|Overall Study|Symptomatic Deterioration|1|||
28100172|NCT03449030|54756697|FG007|Overall Study|Symptomatic Deterioration|0|||
28100173|NCT03449030|54756698|FG008|Overall Study|Symptomatic Deterioration|2|||
28100174|NCT03449030|54756699|FG009|Overall Study|Symptomatic Deterioration|0|||
28100175|NCT03449030|54756690|FG000|Overall Study|Progressive Disease|1|||
28100176|NCT03449030|54756691|FG001|Overall Study|Progressive Disease|0|||
28100177|NCT03449030|54756692|FG002|Overall Study|Progressive Disease|1|||
28100178|NCT03449030|54756693|FG003|Overall Study|Progressive Disease|4|||
28100179|NCT03449030|54756694|FG004|Overall Study|Progressive Disease|5|||
28100180|NCT03449030|54756695|FG005|Overall Study|Progressive Disease|3|||
28100181|NCT03449030|54756696|FG006|Overall Study|Progressive Disease|0|||
28100182|NCT03449030|54756697|FG007|Overall Study|Progressive Disease|1|||
28100183|NCT03449030|54756698|FG008|Overall Study|Progressive Disease|1|||
28100184|NCT03449030|54756699|FG009|Overall Study|Progressive Disease|1|||
28100185|NCT03449030|54756690|FG000|Overall Study|Adverse Event|0|||
28100186|NCT03449030|54756691|FG001|Overall Study|Adverse Event|0|||
28100187|NCT03449030|54756692|FG002|Overall Study|Adverse Event|0|||
28100188|NCT03449030|54756693|FG003|Overall Study|Adverse Event|0|||
28100189|NCT03449030|54756694|FG004|Overall Study|Adverse Event|0|||
28001806|NCT00809159|54660729|FG002|Part 1|Unsatisfactory therapeutic effect|0|||
28001807|NCT00809159|54660730|FG003|Part 1|Unsatisfactory therapeutic effect|0|||
28001808|NCT00809159|54660731|FG004|Part 1|Unsatisfactory therapeutic effect|0|||
28100190|NCT03449030|54756695|FG005|Overall Study|Adverse Event|2|||
28100191|NCT03449030|54756696|FG006|Overall Study|Adverse Event|0|||
28001809|NCT00809159|54660732|FG005|Part 1|Unsatisfactory therapeutic effect|0|||
28001810|NCT00809159|54660727|FG000|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
28001811|NCT00809159|54660728|FG001|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
28100192|NCT03449030|54756697|FG007|Overall Study|Adverse Event|0|||
28001812|NCT00809159|54660729|FG002|Part 1 and 2|Unsatisfactory therapeutic effect|4|||
28001813|NCT00809159|54660730|FG003|Part 1 and 2|Unsatisfactory therapeutic effect|3|||
28001814|NCT00809159|54660731|FG004|Part 1 and 2|Unsatisfactory therapeutic effect|5|||
28001815|NCT00809159|54660732|FG005|Part 1 and 2|Unsatisfactory therapeutic effect|1|||
28001816|NCT00809159|54660727|FG000|Part 1 and 2|Administrative problems|0|||
28001817|NCT00809159|54660728|FG001|Part 1 and 2|Administrative problems|0|||
28001818|NCT00809159|54660729|FG002|Part 1 and 2|Administrative problems|0|||
28001819|NCT00809159|54660730|FG003|Part 1 and 2|Administrative problems|1|||
28001820|NCT00809159|54660731|FG004|Part 1 and 2|Administrative problems|0|||
28001821|NCT00809159|54660732|FG005|Part 1 and 2|Administrative problems|0|||
28001822|NCT00809159|54660727|FG000|Part 1 and 2|Adverse Event|0|||
28100193|NCT03449030|54756698|FG008|Overall Study|Adverse Event|0|||
28100194|NCT03449030|54756699|FG009|Overall Study|Adverse Event|0|||
28100195|NCT03449030|54756690|FG000|Overall Study|Death|0|||
28100196|NCT03449030|54756691|FG001|Overall Study|Death|0|||
28100197|NCT03449030|54756692|FG002|Overall Study|Death|0|||
28100198|NCT03449030|54756693|FG003|Overall Study|Death|0|||
28100199|NCT03449030|54756694|FG004|Overall Study|Death|1|||
28100200|NCT03449030|54756695|FG005|Overall Study|Death|0|||
28100201|NCT03449030|54756696|FG006|Overall Study|Death|0|||
28100202|NCT03449030|54756697|FG007|Overall Study|Death|0|||
28100203|NCT03449030|54756698|FG008|Overall Study|Death|0|||
28100204|NCT03449030|54756699|FG009|Overall Study|Death|0|||
28100205|NCT03448406|54756724|FG000|Overall Study|Noncompliance of scheduled visits|1|||
28100206|NCT03448406|54756725|FG001|Overall Study|Noncompliance of scheduled visits|2|||
28100207|NCT03448406|54756724|FG000|Overall Study|Withdrawal by Subject|1|||
28100208|NCT03448406|54756725|FG001|Overall Study|Withdrawal by Subject|2|||
28100209|NCT03448406|54756724|FG000|Overall Study|Protocol Violation|1|||
28100210|NCT03448406|54756725|FG001|Overall Study|Protocol Violation|0|||
28100211|NCT03448406|54756724|FG000|Overall Study|Adverse Event|8|||
28100212|NCT03448406|54756725|FG001|Overall Study|Adverse Event|9|||
28100213|NCT03499028|54756733|FG000|Overall Study|Lost to Follow-up|12|||
28100214|NCT03499028|54756734|FG001|Overall Study|Lost to Follow-up|9|||
28100215|NCT03499028|54756733|FG000|Overall Study|Withdrawal by Subject|5|||
28100216|NCT03499028|54756734|FG001|Overall Study|Withdrawal by Subject|8|||
28100217|NCT03499028|54756733|FG000|Overall Study|Unplanned SNF discharge|5|||
28100218|NCT03499028|54756734|FG001|Overall Study|Unplanned SNF discharge|8|||
28100219|NCT03498560|54756742|FG000|Overall Study|Found Ineligible|2|||
28100220|NCT03498560|54756742|FG000|Overall Study|Withdrawal by Subject|14|||
28100221|NCT03498560|54756742|FG000|Overall Study|Lost to Follow-up|4|||
28100222|NCT03498560|54756742|FG000|Overall Study|Death|1|||
28100223|NCT00064701|54756750|FG000|One Year Post-transplant|Did not receive study drug|7|||
28100224|NCT00064701|54756751|FG001|One Year Post-transplant|Did not receive study drug|12|||
28100225|NCT00064701|54756752|FG002|One Year Post-transplant|Did not receive study drug|11|||
28100226|NCT00064701|54756750|FG000|One Year Post-transplant|Adverse Event|23|||
28100227|NCT00064701|54756751|FG001|One Year Post-transplant|Adverse Event|19|||
28100228|NCT00064701|54756752|FG002|One Year Post-transplant|Adverse Event|37|||
28100229|NCT00064701|54756750|FG000|One Year Post-transplant|Rejection|0|||
28100230|NCT00064701|54756751|FG001|One Year Post-transplant|Rejection|1|||
28100231|NCT00064701|54756752|FG002|One Year Post-transplant|Rejection|16|||
28100232|NCT00064701|54756750|FG000|One Year Post-transplant|Non-compliance|4|||
28100233|NCT00064701|54756751|FG001|One Year Post-transplant|Non-compliance|2|||
28172710|NCT02634788|54844430|FG002|Overall Study|Withdrawal by Subject|1|||
27739892|NCT02786537|54189678|FG001|As Randomized|Lack of Efficacy|0|||
28001823|NCT00809159|54660728|FG001|Part 1 and 2|Adverse Event|0|||
28001824|NCT00809159|54660729|FG002|Part 1 and 2|Adverse Event|1|||
28001825|NCT00809159|54660730|FG003|Part 1 and 2|Adverse Event|0|||
28001826|NCT00809159|54660731|FG004|Part 1 and 2|Adverse Event|1|||
28001827|NCT00809159|54660732|FG005|Part 1 and 2|Adverse Event|1|||
28001828|NCT00809159|54660727|FG000|Part 1 and 2|Lost to Follow-up|0|||
28001829|NCT00809159|54660728|FG001|Part 1 and 2|Lost to Follow-up|0|||
28001830|NCT00809159|54660729|FG002|Part 1 and 2|Lost to Follow-up|1|||
28001831|NCT00809159|54660730|FG003|Part 1 and 2|Lost to Follow-up|1|||
28001832|NCT00809159|54660731|FG004|Part 1 and 2|Lost to Follow-up|0|||
28001833|NCT00809159|54660732|FG005|Part 1 and 2|Lost to Follow-up|0|||
28001834|NCT00809159|54660727|FG000|Part 1 and 2|Withdrawal by Subject|0|||
28100234|NCT00064701|54756752|FG002|One Year Post-transplant|Non-compliance|5|||
28100235|NCT00064701|54756750|FG000|One Year Post-transplant|Graft Failure|3|||
28100236|NCT00064701|54756751|FG001|One Year Post-transplant|Graft Failure|2|||
28100237|NCT00064701|54756752|FG002|One Year Post-transplant|Graft Failure|1|||
28100238|NCT00064701|54756750|FG000|One Year Post-transplant|Withdrawal by Subject|0|||
28100239|NCT00064701|54756751|FG001|One Year Post-transplant|Withdrawal by Subject|4|||
28100240|NCT00064701|54756752|FG002|One Year Post-transplant|Withdrawal by Subject|1|||
28100241|NCT00064701|54756750|FG000|One Year Post-transplant|Lost to Follow-up|1|||
28100242|NCT00064701|54756751|FG001|One Year Post-transplant|Lost to Follow-up|0|||
28100243|NCT00064701|54756752|FG002|One Year Post-transplant|Lost to Follow-up|0|||
28100244|NCT00064701|54756750|FG000|One Year Post-transplant|Converted to rapamycin|1|||
28001835|NCT00809159|54660728|FG001|Part 1 and 2|Withdrawal by Subject|0|||
28001836|NCT00809159|54660729|FG002|Part 1 and 2|Withdrawal by Subject|4|||
28001837|NCT00809159|54660730|FG003|Part 1 and 2|Withdrawal by Subject|0|||
28001838|NCT00809159|54660731|FG004|Part 1 and 2|Withdrawal by Subject|0|||
28001839|NCT00809159|54660732|FG005|Part 1 and 2|Withdrawal by Subject|1|||
28001840|NCT00745368|54660746|FG000|Overall Study|Unable to provide sample|3|||
28001841|NCT00589472|54660750|FG000|Overall Study|Adverse Event|1|||
28001842|NCT00811577|54660756|FG000|Overall Study|Lost to Follow-up|7|||
28001843|NCT00811577|54660757|FG001|Overall Study|Lost to Follow-up|1|||
28001844|NCT00811577|54660756|FG000|Overall Study|Withdrawal by Subject|3|||
28001845|NCT00811577|54660757|FG001|Overall Study|Withdrawal by Subject|0|||
28001846|NCT00802178|54660806|FG000|Overall Study|Lack of Efficacy|36|||
28001847|NCT00802178|54660806|FG000|Overall Study|Insufficient tolerability (IT)|17|||
28001848|NCT00802178|54660806|FG000|Overall Study|Withdrawal by Subject|18|||
28001849|NCT00802178|54660806|FG000|Overall Study|Other|32|||
28001850|NCT00802178|54660806|FG000|Overall Study|Lack of efficacy and patient wish|1|||
28001851|NCT00802178|54660806|FG000|Overall Study|IT and patient wish|8|||
28001852|NCT00802178|54660806|FG000|Overall Study|Patients wish and other reason|1|||
28001853|NCT00744978|54660812|FG000|Period 1|Lost to Follow-up|1|||
28001854|NCT00744978|54660813|FG001|Period 1|Lost to Follow-up|0|||
28001855|NCT00744978|54660812|FG000|Period 1|Withdrawal by Subject|0|||
28001856|NCT00744978|54660813|FG001|Period 1|Withdrawal by Subject|2|||
28001857|NCT00744978|54660812|FG000|Period 1|Other|0|||
28001858|NCT00744978|54660813|FG001|Period 1|Other|2|||
28001859|NCT00744978|54660812|FG000|Period 1|Adverse Event|4|||
28001860|NCT00744978|54660813|FG001|Period 1|Adverse Event|0|||
28001861|NCT00744978|54660812|FG000|Period 1|Randomized but not Treated|1|||
28001862|NCT00744978|54660813|FG001|Period 1|Randomized but not Treated|1|||
28001863|NCT00744978|54660812|FG000|Period 2|Adverse Event|0|||
28001864|NCT00744978|54660813|FG001|Period 2|Adverse Event|1|||
28001865|NCT00739908|54660821|FG000|Overall Study|Adverse Event|5|||
28001866|NCT00739908|54660822|FG001|Overall Study|Adverse Event|6|||
28001867|NCT00739908|54660821|FG000|Overall Study|Withdrawal by Subject|4|||
28001868|NCT00739908|54660822|FG001|Overall Study|Withdrawal by Subject|2|||
28001869|NCT00739908|54660821|FG000|Overall Study|Lost to Follow-up|14|||
28001870|NCT00739908|54660822|FG001|Overall Study|Lost to Follow-up|9|||
28001871|NCT00739908|54660821|FG000|Overall Study|Non-Compliance With Study Procedures|2|||
28001872|NCT00739908|54660822|FG001|Overall Study|Non-Compliance With Study Procedures|3|||
28001873|NCT00739908|54660821|FG000|Overall Study|Non-Compliance With Study Medication|0|||
28001874|NCT00739908|54660822|FG001|Overall Study|Non-Compliance With Study Medication|3|||
28001875|NCT00739908|54660821|FG000|Overall Study|Lack of Efficacy|0|||
28001876|NCT00739908|54660822|FG001|Overall Study|Lack of Efficacy|1|||
28001877|NCT00739908|54660821|FG000|Overall Study|Relocation|0|||
28001878|NCT00739908|54660822|FG001|Overall Study|Relocation|1|||
28001879|NCT00739596|54660832|FG000|Overall Study|Adverse Event|12|||
28001880|NCT00739596|54660833|FG001|Overall Study|Adverse Event|6|||
28001881|NCT00739596|54660832|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
28001882|NCT00739596|54660833|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
28001883|NCT00739596|54660832|FG000|Overall Study|Patient Withdrew Consent|8|||
28001884|NCT00739596|54660833|FG001|Overall Study|Patient Withdrew Consent|8|||
28001885|NCT00739596|54660832|FG000|Overall Study|Lost to Follow-up|0|||
28001886|NCT00739596|54660833|FG001|Overall Study|Lost to Follow-up|2|||
28001887|NCT00739596|54660832|FG000|Overall Study|Protocol Deviation|1|||
28001888|NCT00739596|54660833|FG001|Overall Study|Protocol Deviation|1|||
28001889|NCT00742326|54660841|FG000|Overall Study|Physician Decision|0|||
28001890|NCT00742326|54660842|FG001|Overall Study|Physician Decision|1|||
28001891|NCT00741936|54660850|FG000|Overall Study|Lost to Follow-up|1|||
27739893|NCT02786537|54189679|FG002|As Randomized|Lack of Efficacy|0|||
27915376|NCT01177384|54573213|FG001|Overall Study|Withdrawal by Subject|12|||
27915377|NCT01194154|54573221|FG000|Overall Study|Adverse Event|12|||
27915378|NCT01194154|54573222|FG001|Overall Study|Adverse Event|7|||
27915379|NCT01194154|54573221|FG000|Overall Study|Lost to Follow-up|2|||
27915380|NCT01194154|54573222|FG001|Overall Study|Lost to Follow-up|3|||
27915381|NCT01194154|54573221|FG000|Overall Study|Protocol Violation|0|||
27915382|NCT01194154|54573222|FG001|Overall Study|Protocol Violation|1|||
28001892|NCT00741936|54660851|FG001|Overall Study|Lost to Follow-up|1|||
28001893|NCT00741936|54660850|FG000|Overall Study|Adverse Event|3|||
28001894|NCT00741936|54660851|FG001|Overall Study|Adverse Event|4|||
28001895|NCT00741936|54660850|FG000|Overall Study|Pregnancy|0|||
28001896|NCT00741936|54660851|FG001|Overall Study|Pregnancy|1|||
28001897|NCT00741936|54660850|FG000|Overall Study|Protocol Violation|2|||
28001898|NCT00741936|54660851|FG001|Overall Study|Protocol Violation|0|||
28001899|NCT00741936|54660850|FG000|Overall Study|Lack of Efficacy|0|||
28001900|NCT00741936|54660851|FG001|Overall Study|Lack of Efficacy|2|||
28001901|NCT00741936|54660850|FG000|Overall Study|Low compliance|3|||
28001902|NCT00741936|54660851|FG001|Overall Study|Low compliance|0|||
28001903|NCT00811187|54660859|FG000|Overall Study|Unable to place device / procedure abort|3|||
27915383|NCT01194154|54573221|FG000|Overall Study|Withdrawal by Subject|5|||
27915384|NCT01194154|54573222|FG001|Overall Study|Withdrawal by Subject|6|||
27915385|NCT01194154|54573221|FG000|Overall Study|Blood pressure increase|5|||
27915386|NCT01194154|54573222|FG001|Overall Study|Blood pressure increase|3|||
27915387|NCT01194154|54573221|FG000|Overall Study|Hemoglobin decrease|0|||
27915388|NCT01194154|54573222|FG001|Overall Study|Hemoglobin decrease|1|||
27915389|NCT01194154|54573221|FG000|Overall Study|Hemoglobin increase|12|||
27915390|NCT01194154|54573222|FG001|Overall Study|Hemoglobin increase|3|||
27915391|NCT01194154|54573221|FG000|Overall Study|Skipping of CERA treatment at two visits|3|||
27915392|NCT01194154|54573222|FG001|Overall Study|Skipping of CERA treatment at two visits|0|||
27915393|NCT01194154|54573221|FG000|Overall Study|Treatment with prohibited medication|4|||
27915394|NCT01194154|54573222|FG001|Overall Study|Treatment with prohibited medication|5|||
27915395|NCT01194154|54573221|FG000|Overall Study|Other|4|||
27915396|NCT01194154|54573222|FG001|Overall Study|Other|0|||
27915397|NCT01194154|54573221|FG000|Overall Study|Did not receive study medication|2|||
28001904|NCT00811187|54660860|FG001|Overall Study|Unable to place device / procedure abort|3|||
28001905|NCT00591149|54660866|FG000|Overall Study|Adverse Event|4|||
28001906|NCT00591149|54660866|FG000|Overall Study|Withdrawal by Subject|1|||
28001907|NCT00735072|54660872|FG000|Overall Study|interrupted study med during ARV change|1|||
28001908|NCT00735072|54660873|FG001|Overall Study|interrupted study med during ARV change|0|||
28001909|NCT00735072|54660872|FG000|Overall Study|Subject interrupted ARVs (non-adherence)|0|||
28001910|NCT00735072|54660873|FG001|Overall Study|Subject interrupted ARVs (non-adherence)|1|||
28001911|NCT00810641|54660884|FG000|Overall Study|Withdrawal by Subject|0|||
28001912|NCT00810641|54660885|FG001|Overall Study|Withdrawal by Subject|1|||
28001913|NCT00810641|54660886|FG002|Overall Study|Withdrawal by Subject|2|||
28001914|NCT00793598|54660899|FG000|Overall Study|Patient Request|0|||
28001915|NCT00793598|54660900|FG001|Overall Study|Patient Request|1|||
28001916|NCT00793598|54660901|FG002|Overall Study|Patient Request|0|||
28001917|NCT00793598|54660902|FG003|Overall Study|Patient Request|0|||
28001918|NCT00793598|54660903|FG004|Overall Study|Patient Request|0|||
28001919|NCT00793598|54660904|FG005|Overall Study|Patient Request|0|||
28001920|NCT00793598|54660905|FG006|Overall Study|Patient Request|0|||
28001921|NCT00793598|54660906|FG007|Overall Study|Patient Request|0|||
28001922|NCT00793598|54660899|FG000|Overall Study|Protocol Violation|0|||
28001923|NCT00793598|54660900|FG001|Overall Study|Protocol Violation|0|||
28001924|NCT00793598|54660901|FG002|Overall Study|Protocol Violation|0|||
28001925|NCT00793598|54660902|FG003|Overall Study|Protocol Violation|0|||
28001926|NCT00793598|54660903|FG004|Overall Study|Protocol Violation|0|||
28001927|NCT00793598|54660904|FG005|Overall Study|Protocol Violation|0|||
28001928|NCT00793598|54660905|FG006|Overall Study|Protocol Violation|0|||
28001929|NCT00793598|54660906|FG007|Overall Study|Protocol Violation|1|||
28001930|NCT00793598|54660899|FG000|Overall Study|Subject not dosed|0|||
28001931|NCT00793598|54660900|FG001|Overall Study|Subject not dosed|0|||
28001932|NCT00793598|54660901|FG002|Overall Study|Subject not dosed|0|||
28001933|NCT00793598|54660902|FG003|Overall Study|Subject not dosed|0|||
28001934|NCT00793598|54660903|FG004|Overall Study|Subject not dosed|0|||
28001935|NCT00793598|54660904|FG005|Overall Study|Subject not dosed|1|||
28001936|NCT00793598|54660905|FG006|Overall Study|Subject not dosed|0|||
27915398|NCT01194154|54573222|FG001|Overall Study|Did not receive study medication|4|||
27915399|NCT01193920|54573249|FG000|Overall Study|Withdrawal by Subject|1|||
28001937|NCT00793598|54660906|FG007|Overall Study|Subject not dosed|0|||
28001938|NCT00796562|54660928|FG000|Overall Study|Death|49|||
28001939|NCT00801632|54660932|FG000|Overall Study|Re-transplant|1|||
28001940|NCT00806819|54660938|FG000|Overall Study|progressive disease (modified RECIST )|217|||
28001941|NCT00806819|54660939|FG001|Overall Study|progressive disease (modified RECIST )|216|||
28001942|NCT00806819|54660938|FG000|Overall Study|Worsening or AE of underlying disease|18|||
28001943|NCT00806819|54660939|FG001|Overall Study|Worsening or AE of underlying disease|25|||
28001944|NCT00806819|54660938|FG000|Overall Study|Other AE|38|||
28100245|NCT00064701|54756751|FG001|One Year Post-transplant|Converted to rapamycin|0|||
28100246|NCT00064701|54756752|FG002|One Year Post-transplant|Converted to rapamycin|0|||
28100247|NCT00064701|54756750|FG000|One Year Post-transplant|Acute tubular necrosis|1|||
27739894|NCT02786537|54189680|FG003|As Randomized|Lack of Efficacy|1|||
27915400|NCT01193920|54573250|FG001|Overall Study|Withdrawal by Subject|0|||
27915401|NCT01193920|54573251|FG002|Overall Study|Withdrawal by Subject|5|||
27915402|NCT01193920|54573252|FG003|Overall Study|Withdrawal by Subject|1|||
27915403|NCT01193920|54573253|FG004|Overall Study|Withdrawal by Subject|3|||
27915404|NCT01193920|54573254|FG005|Overall Study|Withdrawal by Subject|1|||
27915405|NCT01193920|54573255|FG006|Overall Study|Withdrawal by Subject|3|||
27915406|NCT01193920|54573256|FG007|Overall Study|Withdrawal by Subject|0|||
27915407|NCT01193920|54573257|FG008|Overall Study|Withdrawal by Subject|1|||
28001945|NCT00806819|54660939|FG001|Overall Study|Other AE|40|||
28001946|NCT00806819|54660938|FG000|Overall Study|Protocol Violation|9|||
28001947|NCT00806819|54660939|FG001|Overall Study|Protocol Violation|4|||
28001948|NCT00806819|54660938|FG000|Overall Study|Lost to Follow-up|1|||
28001949|NCT00806819|54660939|FG001|Overall Study|Lost to Follow-up|0|||
28001950|NCT00806819|54660938|FG000|Overall Study|Withdrawal by Subject|32|||
28001951|NCT00806819|54660939|FG001|Overall Study|Withdrawal by Subject|29|||
28001952|NCT00806819|54660938|FG000|Overall Study|Not treated|6|||
28001953|NCT00806819|54660939|FG001|Overall Study|Not treated|3|||
28001954|NCT00806819|54660938|FG000|Overall Study|Reasons other than stated above|25|||
28001955|NCT00806819|54660939|FG001|Overall Study|Reasons other than stated above|41|||
28001956|NCT00801242|54660946|FG000|Overall Study|Adverse Event|10|||
28001957|NCT00801242|54660946|FG000|Overall Study|Withdrawal by Subject|13|||
28001958|NCT00801242|54660946|FG000|Overall Study|Protocol Violation|5|||
28001959|NCT00801242|54660946|FG000|Overall Study|Physician Decision|3|||
28001960|NCT00801242|54660946|FG000|Overall Study|Lost to Follow-up|1|||
28001961|NCT00801242|54660946|FG000|Overall Study|Miscellaneous reasons|20|||
28001962|NCT00800540|54660959|FG000|Period One: 6 Weeks|Noncompliance|1|||
28001963|NCT00800540|54660960|FG001|Period One: 6 Weeks|Noncompliance|0|||
28001964|NCT00800540|54660959|FG000|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0|||
28001965|NCT00800540|54660960|FG001|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1|||
28001966|NCT00800540|54660959|FG000|Period 2: 6 Weeks|Adverse Event|0|||
28001967|NCT00800540|54660960|FG001|Period 2: 6 Weeks|Adverse Event|1|||
27915408|NCT01193920|54573258|FG009|Overall Study|Withdrawal by Subject|0|||
27915409|NCT01193920|54573249|FG000|Overall Study|Lost to Follow-up|1|||
27915410|NCT01193920|54573250|FG001|Overall Study|Lost to Follow-up|0|||
27915411|NCT01193920|54573251|FG002|Overall Study|Lost to Follow-up|1|||
27915412|NCT01193920|54573252|FG003|Overall Study|Lost to Follow-up|1|||
27915413|NCT01193920|54573253|FG004|Overall Study|Lost to Follow-up|3|||
27915414|NCT01193920|54573254|FG005|Overall Study|Lost to Follow-up|3|||
27915415|NCT01193920|54573255|FG006|Overall Study|Lost to Follow-up|1|||
27915416|NCT01193920|54573256|FG007|Overall Study|Lost to Follow-up|0|||
27915417|NCT01193920|54573257|FG008|Overall Study|Lost to Follow-up|2|||
27915418|NCT01193920|54573258|FG009|Overall Study|Lost to Follow-up|3|||
27915419|NCT01193920|54573249|FG000|Overall Study|Protocol Violation|1|||
28001968|NCT00800384|54660968|FG000|Overall Study|Withdrawal by Subject|24|||
28001969|NCT00800384|54660969|FG001|Overall Study|Withdrawal by Subject|17|||
28001970|NCT00800384|54660968|FG000|Overall Study|Lost to Follow-up|17|||
28001971|NCT00800384|54660969|FG001|Overall Study|Lost to Follow-up|26|||
28001972|NCT00796328|54660976|FG000|Overall Study|experienced hypotension requiring tx|6|||
28001973|NCT00588692|54660982|FG000|Overall Study|Withdrawal by Subject|4|||
28001974|NCT00588692|54660983|FG001|Overall Study|Withdrawal by Subject|2|||
28001975|NCT00588692|54660982|FG000|Overall Study|Hip Surgery|0|||
28001976|NCT00588692|54660983|FG001|Overall Study|Hip Surgery|1|||
28001977|NCT00588692|54660982|FG000|Overall Study|Severe Peptic Ulcer Disease|1|||
28001978|NCT00588692|54660983|FG001|Overall Study|Severe Peptic Ulcer Disease|0|||
28001979|NCT00588692|54660982|FG000|Overall Study|Cancer|1|||
28001980|NCT00588692|54660983|FG001|Overall Study|Cancer|0|||
28001981|NCT00588692|54660982|FG000|Overall Study|Death|1|||
28001982|NCT00588692|54660983|FG001|Overall Study|Death|0|||
28001983|NCT00588146|54660991|FG000|First Intervention (Baseline to 6 mo)|Adverse Event|4|||
28001984|NCT00588146|54660992|FG001|First Intervention (Baseline to 6 mo)|Adverse Event|3|||
28001985|NCT00795704|54661000|FG000|Overall Study|Withdrawal by Subject|3|||
27915420|NCT01193920|54573250|FG001|Overall Study|Protocol Violation|0|||
27915421|NCT01193920|54573251|FG002|Overall Study|Protocol Violation|0|||
27915422|NCT01193920|54573252|FG003|Overall Study|Protocol Violation|0|||
27915423|NCT01193920|54573253|FG004|Overall Study|Protocol Violation|0|||
27915424|NCT01193920|54573254|FG005|Overall Study|Protocol Violation|0|||
27915425|NCT01193920|54573255|FG006|Overall Study|Protocol Violation|0|||
27915426|NCT01193920|54573256|FG007|Overall Study|Protocol Violation|0|||
27915427|NCT01193920|54573257|FG008|Overall Study|Protocol Violation|0|||
27915428|NCT01193920|54573258|FG009|Overall Study|Protocol Violation|0|||
27915429|NCT01193920|54573249|FG000|Overall Study|Death|0|||
28001986|NCT00795704|54661001|FG001|Overall Study|Withdrawal by Subject|2|||
28001987|NCT00795704|54661000|FG000|Overall Study|Adverse Event|1|||
28001988|NCT00795704|54661001|FG001|Overall Study|Adverse Event|1|||
28001989|NCT00444457|54661011|FG000|Infant Series|Other|0|||
28001990|NCT00444457|54661012|FG001|Infant Series|Other|1|||
28001991|NCT00444457|54661013|FG002|Infant Series|Other|0|||
28001992|NCT00444457|54661014|FG003|Infant Series|Other|0|||
28001993|NCT00444457|54661011|FG000|Infant Series|Parent or legal guardian request|18|||
28001994|NCT00444457|54661012|FG001|Infant Series|Parent or legal guardian request|29|||
28001995|NCT00444457|54661013|FG002|Infant Series|Parent or legal guardian request|34|||
28001996|NCT00444457|54661014|FG003|Infant Series|Parent or legal guardian request|14|||
28001997|NCT00444457|54661011|FG000|Infant Series|Lost to Follow-up|10|||
28001998|NCT00444457|54661012|FG001|Infant Series|Lost to Follow-up|11|||
28001999|NCT00444457|54661013|FG002|Infant Series|Lost to Follow-up|7|||
28002000|NCT00444457|54661014|FG003|Infant Series|Lost to Follow-up|6|||
28002001|NCT00444457|54661011|FG000|Infant Series|Protocol Violation|16|||
28100248|NCT00064701|54756751|FG001|One Year Post-transplant|Acute tubular necrosis|0|||
27915430|NCT01193920|54573250|FG001|Overall Study|Death|0|||
28002002|NCT00444457|54661012|FG001|Infant Series|Protocol Violation|8|||
28002003|NCT00444457|54661013|FG002|Infant Series|Protocol Violation|6|||
27915431|NCT01193920|54573251|FG002|Overall Study|Death|0|||
27915432|NCT01193920|54573252|FG003|Overall Study|Death|1|||
27915433|NCT01193920|54573253|FG004|Overall Study|Death|0|||
27915434|NCT01193920|54573254|FG005|Overall Study|Death|0|||
28002004|NCT00444457|54661014|FG003|Infant Series|Protocol Violation|3|||
28002005|NCT00444457|54661011|FG000|Infant Series|Failed to return|5|||
28002006|NCT00444457|54661012|FG001|Infant Series|Failed to return|4|||
28002007|NCT00444457|54661013|FG002|Infant Series|Failed to return|4|||
28002008|NCT00444457|54661014|FG003|Infant Series|Failed to return|2|||
28002009|NCT00444457|54661011|FG000|Infant Series|Investigator request|4|||
28002010|NCT00444457|54661012|FG001|Infant Series|Investigator request|3|||
28002011|NCT00444457|54661013|FG002|Infant Series|Investigator request|3|||
28002012|NCT00444457|54661014|FG003|Infant Series|Investigator request|2|||
28002013|NCT00444457|54661011|FG000|Infant Series|Other|0|||
28002014|NCT00444457|54661012|FG001|Infant Series|Other|2|||
28002015|NCT00444457|54661013|FG002|Infant Series|Other|4|||
28002016|NCT00444457|54661014|FG003|Infant Series|Other|0|||
28002017|NCT00444457|54661011|FG000|Infant Series|Adverse Event|1|||
28002018|NCT00444457|54661012|FG001|Infant Series|Adverse Event|2|||
28002019|NCT00444457|54661013|FG002|Infant Series|Adverse Event|2|||
28002020|NCT00444457|54661014|FG003|Infant Series|Adverse Event|0|||
28002021|NCT00444457|54661011|FG000|Infant Series|Death|0|||
28002022|NCT00444457|54661012|FG001|Infant Series|Death|1|||
28002023|NCT00444457|54661013|FG002|Infant Series|Death|1|||
28002024|NCT00444457|54661014|FG003|Infant Series|Death|1|||
28002025|NCT00444457|54661011|FG000|After Infant Series|Other|0|||
28002026|NCT00444457|54661012|FG001|After Infant Series|Other|1|||
28002027|NCT00444457|54661013|FG002|After Infant Series|Other|1|||
28002028|NCT00444457|54661014|FG003|After Infant Series|Other|1|||
28002029|NCT00444457|54661011|FG000|After Infant Series|Parent or legal guardian request|4|||
28002030|NCT00444457|54661012|FG001|After Infant Series|Parent or legal guardian request|11|||
28002031|NCT00444457|54661013|FG002|After Infant Series|Parent or legal guardian request|6|||
28002032|NCT00444457|54661014|FG003|After Infant Series|Parent or legal guardian request|3|||
28002033|NCT00444457|54661011|FG000|After Infant Series|Failed to return|7|||
28002034|NCT00444457|54661012|FG001|After Infant Series|Failed to return|6|||
28002035|NCT00444457|54661013|FG002|After Infant Series|Failed to return|5|||
28002036|NCT00444457|54661014|FG003|After Infant Series|Failed to return|1|||
28002037|NCT00444457|54661011|FG000|After Infant Series|Lost to Follow-up|5|||
28002038|NCT00444457|54661012|FG001|After Infant Series|Lost to Follow-up|5|||
28002039|NCT00444457|54661013|FG002|After Infant Series|Lost to Follow-up|5|||
28002040|NCT00444457|54661014|FG003|After Infant Series|Lost to Follow-up|2|||
28002041|NCT00444457|54661011|FG000|After Infant Series|Protocol Violation|2|||
28002042|NCT00444457|54661012|FG001|After Infant Series|Protocol Violation|4|||
28002043|NCT00444457|54661013|FG002|After Infant Series|Protocol Violation|2|||
28002044|NCT00444457|54661014|FG003|After Infant Series|Protocol Violation|2|||
28002045|NCT00444457|54661011|FG000|After Infant Series|Adverse Event|2|||
28002046|NCT00444457|54661012|FG001|After Infant Series|Adverse Event|2|||
28002047|NCT00444457|54661013|FG002|After Infant Series|Adverse Event|0|||
28002048|NCT00444457|54661014|FG003|After Infant Series|Adverse Event|0|||
28002049|NCT00444457|54661011|FG000|After Infant Series|Investigator request|0|||
28002050|NCT00444457|54661012|FG001|After Infant Series|Investigator request|0|||
28002051|NCT00444457|54661013|FG002|After Infant Series|Investigator request|0|||
28002052|NCT00444457|54661014|FG003|After Infant Series|Investigator request|1|||
28002053|NCT00444457|54661011|FG000|After Infant Series|Other|0|||
28002054|NCT00444457|54661012|FG001|After Infant Series|Other|1|||
28002055|NCT00444457|54661013|FG002|After Infant Series|Other|0|||
28002056|NCT00444457|54661014|FG003|After Infant Series|Other|0|||
28002057|NCT00444457|54661011|FG000|Toddler Dose|Lost to Follow-up|4|||
28002058|NCT00444457|54661012|FG001|Toddler Dose|Lost to Follow-up|1|||
28002059|NCT00444457|54661013|FG002|Toddler Dose|Lost to Follow-up|1|||
28002060|NCT00444457|54661014|FG003|Toddler Dose|Lost to Follow-up|3|||
28002061|NCT00444457|54661011|FG000|Toddler Dose|Failed to return|2|||
28002062|NCT00444457|54661012|FG001|Toddler Dose|Failed to return|2|||
27915435|NCT01193920|54573255|FG006|Overall Study|Death|2|||
27915436|NCT01193920|54573256|FG007|Overall Study|Death|3|||
27915437|NCT01193920|54573257|FG008|Overall Study|Death|2|||
27915438|NCT01193920|54573258|FG009|Overall Study|Death|4|||
27915439|NCT01193920|54573249|FG000|Overall Study|Unable to classify|0|||
27915440|NCT01193920|54573250|FG001|Overall Study|Unable to classify|0|||
27915441|NCT01193920|54573251|FG002|Overall Study|Unable to classify|0|||
28172711|NCT02634788|54844431|FG003|Overall Study|Withdrawal by Subject|0|||
27915442|NCT01193920|54573252|FG003|Overall Study|Unable to classify|1|||
27915443|NCT01193920|54573253|FG004|Overall Study|Unable to classify|0|||
28002063|NCT00444457|54661013|FG002|Toddler Dose|Failed to return|1|||
28002064|NCT00444457|54661014|FG003|Toddler Dose|Failed to return|3|||
28002065|NCT00444457|54661011|FG000|Toddler Dose|Parent or legal guardian request|0|||
28002066|NCT00444457|54661012|FG001|Toddler Dose|Parent or legal guardian request|3|||
27915444|NCT01193920|54573254|FG005|Overall Study|Unable to classify|0|||
27915445|NCT01193920|54573255|FG006|Overall Study|Unable to classify|0|||
28002067|NCT00444457|54661013|FG002|Toddler Dose|Parent or legal guardian request|2|||
28002068|NCT00444457|54661014|FG003|Toddler Dose|Parent or legal guardian request|1|||
28002069|NCT00444457|54661011|FG000|Toddler Dose|Protocol Violation|1|||
28002070|NCT00444457|54661012|FG001|Toddler Dose|Protocol Violation|0|||
28172712|NCT02785939|54844443|FG000|Overall Study|Progression|25|||
27915446|NCT01193920|54573256|FG007|Overall Study|Unable to classify|1|||
27915447|NCT01193920|54573257|FG008|Overall Study|Unable to classify|0|||
27915448|NCT01193920|54573258|FG009|Overall Study|Unable to classify|0|||
27915449|NCT01193686|54573283|FG000|Overall Study|Withdrawal by Subject|4|||
27915450|NCT01193686|54573284|FG001|Overall Study|Withdrawal by Subject|1|||
27915451|NCT01193686|54573283|FG000|Overall Study|Removed by Investigators; unable to matc|3|||
27915452|NCT01193686|54573284|FG001|Overall Study|Removed by Investigators; unable to matc|0|||
27915453|NCT01193608|54573297|FG000|Overall Study|Other|0|||
28002071|NCT00444457|54661013|FG002|Toddler Dose|Protocol Violation|0|||
28002072|NCT00444457|54661014|FG003|Toddler Dose|Protocol Violation|1|||
28002073|NCT00799058|54661038|FG000|Overall Study|Withdrawal by Subject|2|||
28002074|NCT00799058|54661039|FG001|Overall Study|Withdrawal by Subject|2|||
28002075|NCT00799058|54661040|FG002|Overall Study|Withdrawal by Subject|2|||
28002076|NCT00799058|54661038|FG000|Overall Study|Lost to Follow-up|1|||
28002077|NCT00799058|54661039|FG001|Overall Study|Lost to Follow-up|2|||
28002078|NCT00799058|54661040|FG002|Overall Study|Lost to Follow-up|1|||
28002079|NCT00799058|54661038|FG000|Overall Study|Adverse Event|0|||
28002080|NCT00799058|54661039|FG001|Overall Study|Adverse Event|2|||
28002081|NCT00799058|54661040|FG002|Overall Study|Adverse Event|0|||
28002082|NCT00799058|54661038|FG000|Overall Study|Pregnancy|1|||
28002083|NCT00799058|54661039|FG001|Overall Study|Pregnancy|0|||
28002084|NCT00799058|54661040|FG002|Overall Study|Pregnancy|0|||
28002085|NCT00799058|54661038|FG000|Overall Study|Not adherent|3|||
28002086|NCT00799058|54661039|FG001|Overall Study|Not adherent|2|||
28002087|NCT00799058|54661040|FG002|Overall Study|Not adherent|1|||
28002088|NCT00799058|54661038|FG000|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
28002089|NCT00799058|54661039|FG001|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
28002090|NCT00799058|54661040|FG002|Overall Study|discontinued use of IP due to AE, but completed visits|1|||
28002091|NCT00799058|54661038|FG000|Overall Study|IP dispensing error|1|||
28002092|NCT00799058|54661039|FG001|Overall Study|IP dispensing error|0|||
28002093|NCT00799058|54661040|FG002|Overall Study|IP dispensing error|0|||
28002094|NCT00799058|54661038|FG000|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
28002095|NCT00799058|54661039|FG001|Overall Study|not enough IP to complete trial due to IP dispending error|1|||
28002096|NCT00799058|54661040|FG002|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
28002097|NCT00799058|54661038|FG000|Overall Study|IP discontinued too long during BV treatment|1|||
28002098|NCT00799058|54661039|FG001|Overall Study|IP discontinued too long during BV treatment|0|||
28002099|NCT00799058|54661040|FG002|Overall Study|IP discontinued too long during BV treatment|0|||
28002100|NCT00799058|54661038|FG000|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
28002101|NCT00799058|54661039|FG001|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
28002102|NCT00799058|54661040|FG002|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|1|||
28002103|NCT00799058|54661038|FG000|Overall Study|participant did not attend clinic visit 6 (final visit)|1|||
28002104|NCT00799058|54661039|FG001|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
28002105|NCT00799058|54661040|FG002|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
28002106|NCT00725985|54661053|FG000|ITP- Treatment Disposition|Adverse Event|20|||
27915454|NCT01193608|54573298|FG001|Overall Study|Other|1|||
27915455|NCT01193608|54573299|FG002|Overall Study|Other|0|||
27915456|NCT01193608|54573300|FG003|Overall Study|Other|0|||
27915457|NCT01193608|54573301|FG004|Overall Study|Other|0|||
27915458|NCT01193608|54573302|FG005|Overall Study|Other|0|||
27915459|NCT01193608|54573297|FG000|Overall Study|Withdrawal by Subject|0|||
27915460|NCT01193608|54573298|FG001|Overall Study|Withdrawal by Subject|1|||
27915461|NCT01193608|54573299|FG002|Overall Study|Withdrawal by Subject|2|||
27915462|NCT01193608|54573300|FG003|Overall Study|Withdrawal by Subject|3|||
27915463|NCT01193608|54573301|FG004|Overall Study|Withdrawal by Subject|3|||
27915464|NCT01193608|54573302|FG005|Overall Study|Withdrawal by Subject|0|||
27915465|NCT01193608|54573297|FG000|Overall Study|Lost to Follow-up|0|||
27915466|NCT01193608|54573298|FG001|Overall Study|Lost to Follow-up|0|||
27915467|NCT01193608|54573299|FG002|Overall Study|Lost to Follow-up|0|||
27915468|NCT01193608|54573300|FG003|Overall Study|Lost to Follow-up|0|||
28002107|NCT00725985|54661054|FG001|ITP- Treatment Disposition|Adverse Event|10|||
28002108|NCT00725985|54661055|FG002|ITP- Treatment Disposition|Adverse Event|5|||
28002109|NCT00725985|54661056|FG003|ITP- Treatment Disposition|Adverse Event|0|||
28002110|NCT00725985|54661057|FG004|ITP- Treatment Disposition|Adverse Event|0|||
28002111|NCT00725985|54661058|FG005|ITP- Treatment Disposition|Adverse Event|0|||
28002112|NCT00725985|54661059|FG006|ITP- Treatment Disposition|Adverse Event|0|||
28002113|NCT00725985|54661060|FG007|ITP- Treatment Disposition|Adverse Event|0|||
28002114|NCT00725985|54661061|FG008|ITP- Treatment Disposition|Adverse Event|0|||
28002115|NCT00725985|54661062|FG009|ITP- Treatment Disposition|Adverse Event|0|||
28002116|NCT00725985|54661063|FG010|ITP- Treatment Disposition|Adverse Event|0|||
27915469|NCT01193608|54573301|FG004|Overall Study|Lost to Follow-up|1|||
27915470|NCT01193608|54573302|FG005|Overall Study|Lost to Follow-up|2|||
27915471|NCT01193608|54573297|FG000|Overall Study|Adverse Event|0|||
27915472|NCT01193608|54573298|FG001|Overall Study|Adverse Event|0|||
27915473|NCT01193608|54573299|FG002|Overall Study|Adverse Event|0|||
28002117|NCT00725985|54661064|FG011|ITP- Treatment Disposition|Adverse Event|0|||
28002118|NCT00725985|54661053|FG000|ITP- Treatment Disposition|Lost to Follow-up|0|||
28002119|NCT00725985|54661054|FG001|ITP- Treatment Disposition|Lost to Follow-up|0|||
28002120|NCT00725985|54661055|FG002|ITP- Treatment Disposition|Lost to Follow-up|2|||
28002121|NCT00725985|54661056|FG003|ITP- Treatment Disposition|Lost to Follow-up|0|||
28002122|NCT00725985|54661057|FG004|ITP- Treatment Disposition|Lost to Follow-up|0|||
28002123|NCT00725985|54661058|FG005|ITP- Treatment Disposition|Lost to Follow-up|0|||
28002124|NCT00725985|54661059|FG006|ITP- Treatment Disposition|Lost to Follow-up|0|||
28002125|NCT00725985|54661060|FG007|ITP- Treatment Disposition|Lost to Follow-up|0|||
28002126|NCT00725985|54661061|FG008|ITP- Treatment Disposition|Lost to Follow-up|0|||
28002127|NCT00725985|54661062|FG009|ITP- Treatment Disposition|Lost to Follow-up|0|||
28002128|NCT00725985|54661063|FG010|ITP- Treatment Disposition|Lost to Follow-up|0|||
28002129|NCT00725985|54661064|FG011|ITP- Treatment Disposition|Lost to Follow-up|0|||
28002130|NCT00725985|54661053|FG000|ITP- Treatment Disposition|Randomized but not treated|1|||
28002131|NCT00725985|54661054|FG001|ITP- Treatment Disposition|Randomized but not treated|0|||
28002132|NCT00725985|54661055|FG002|ITP- Treatment Disposition|Randomized but not treated|0|||
28002133|NCT00725985|54661056|FG003|ITP- Treatment Disposition|Randomized but not treated|0|||
28002134|NCT00725985|54661057|FG004|ITP- Treatment Disposition|Randomized but not treated|0|||
28002135|NCT00725985|54661058|FG005|ITP- Treatment Disposition|Randomized but not treated|0|||
28002136|NCT00725985|54661059|FG006|ITP- Treatment Disposition|Randomized but not treated|0|||
28002137|NCT00725985|54661060|FG007|ITP- Treatment Disposition|Randomized but not treated|0|||
28002138|NCT00725985|54661061|FG008|ITP- Treatment Disposition|Randomized but not treated|0|||
28002139|NCT00725985|54661062|FG009|ITP- Treatment Disposition|Randomized but not treated|0|||
28002140|NCT00725985|54661063|FG010|ITP- Treatment Disposition|Randomized but not treated|0|||
28002141|NCT00725985|54661064|FG011|ITP- Treatment Disposition|Randomized but not treated|0|||
28002142|NCT00725985|54661053|FG000|ITP- Treatment Disposition|Converted to CDMS|30|||
28002143|NCT00725985|54661054|FG001|ITP- Treatment Disposition|Converted to CDMS|27|||
28002144|NCT00725985|54661055|FG002|ITP- Treatment Disposition|Converted to CDMS|71|||
28002145|NCT00725985|54661056|FG003|ITP- Treatment Disposition|Converted to CDMS|0|||
28002146|NCT00725985|54661057|FG004|ITP- Treatment Disposition|Converted to CDMS|0|||
28002147|NCT00725985|54661058|FG005|ITP- Treatment Disposition|Converted to CDMS|0|||
28002148|NCT00725985|54661059|FG006|ITP- Treatment Disposition|Converted to CDMS|0|||
27915474|NCT01193608|54573300|FG003|Overall Study|Adverse Event|0|||
27915475|NCT01193608|54573301|FG004|Overall Study|Adverse Event|1|||
27915476|NCT01193608|54573302|FG005|Overall Study|Adverse Event|0|||
28002149|NCT00725985|54661060|FG007|ITP- Treatment Disposition|Converted to CDMS|0|||
28002150|NCT00725985|54661061|FG008|ITP- Treatment Disposition|Converted to CDMS|0|||
28002151|NCT00725985|54661062|FG009|ITP- Treatment Disposition|Converted to CDMS|0|||
28002152|NCT00725985|54661063|FG010|ITP- Treatment Disposition|Converted to CDMS|0|||
28002153|NCT00725985|54661064|FG011|ITP- Treatment Disposition|Converted to CDMS|0|||
28002154|NCT00725985|54661053|FG000|ITP- Treatment Disposition|Other|50|||
28002155|NCT00725985|54661054|FG001|ITP- Treatment Disposition|Other|38|||
28002156|NCT00725985|54661055|FG002|ITP- Treatment Disposition|Other|24|||
28002157|NCT00725985|54661056|FG003|ITP- Treatment Disposition|Other|0|||
28002158|NCT00725985|54661057|FG004|ITP- Treatment Disposition|Other|0|||
28002159|NCT00725985|54661058|FG005|ITP- Treatment Disposition|Other|0|||
28002160|NCT00725985|54661059|FG006|ITP- Treatment Disposition|Other|0|||
28002161|NCT00725985|54661060|FG007|ITP- Treatment Disposition|Other|0|||
28002162|NCT00725985|54661061|FG008|ITP- Treatment Disposition|Other|0|||
28002163|NCT00725985|54661062|FG009|ITP- Treatment Disposition|Other|0|||
28002164|NCT00725985|54661063|FG010|ITP- Treatment Disposition|Other|0|||
28002165|NCT00725985|54661064|FG011|ITP- Treatment Disposition|Other|0|||
28002166|NCT00725985|54661053|FG000|OLMP (Up to 96 Weeks)|Adverse Event|0|||
28100249|NCT00064701|54756752|FG002|One Year Post-transplant|Acute tubular necrosis|0|||
28100250|NCT00064701|54756750|FG000|One Year Post-transplant|Incorrect study drug dispensed|0|||
28100251|NCT00064701|54756751|FG001|One Year Post-transplant|Incorrect study drug dispensed|1|||
28100252|NCT00064701|54756752|FG002|One Year Post-transplant|Incorrect study drug dispensed|0|||
27915477|NCT01177228|54573325|FG000|Overall Study|Positive tuberculosis test|0|||
27915478|NCT01177228|54573326|FG001|Overall Study|Positive tuberculosis test|1|||
27915479|NCT01177228|54573327|FG002|Overall Study|Positive tuberculosis test|0|||
27915480|NCT01177228|54573328|FG003|Overall Study|Positive tuberculosis test|0|||
27915481|NCT01177228|54573325|FG000|Overall Study|Worsening disease activity|1|||
28002167|NCT00725985|54661054|FG001|OLMP (Up to 96 Weeks)|Adverse Event|0|||
28002168|NCT00725985|54661055|FG002|OLMP (Up to 96 Weeks)|Adverse Event|0|||
28002169|NCT00725985|54661056|FG003|OLMP (Up to 96 Weeks)|Adverse Event|2|||
28002170|NCT00725985|54661057|FG004|OLMP (Up to 96 Weeks)|Adverse Event|2|||
28002171|NCT00725985|54661058|FG005|OLMP (Up to 96 Weeks)|Adverse Event|5|||
28002172|NCT00725985|54661059|FG006|OLMP (Up to 96 Weeks)|Adverse Event|0|||
28100253|NCT00064701|54756750|FG000|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
28100254|NCT00064701|54756751|FG001|One Year Post-transplant|Crossover secondary to possible toxicity|1|||
27915482|NCT01177228|54573326|FG001|Overall Study|Worsening disease activity|0|||
27915483|NCT01177228|54573327|FG002|Overall Study|Worsening disease activity|0|||
27915484|NCT01177228|54573328|FG003|Overall Study|Worsening disease activity|0|||
27915485|NCT01177228|54573325|FG000|Overall Study|Withdrawal by Subject|0|||
27915486|NCT01177228|54573326|FG001|Overall Study|Withdrawal by Subject|1|||
27915487|NCT01177228|54573327|FG002|Overall Study|Withdrawal by Subject|0|||
27915488|NCT01177228|54573328|FG003|Overall Study|Withdrawal by Subject|0|||
27915489|NCT01193530|54573345|FG000|Overall Study|Withdrawal by Subject|2|||
27915490|NCT01193530|54573346|FG001|Overall Study|Withdrawal by Subject|2|||
28002173|NCT00725985|54661060|FG007|OLMP (Up to 96 Weeks)|Adverse Event|0|||
28002174|NCT00725985|54661061|FG008|OLMP (Up to 96 Weeks)|Adverse Event|0|||
28002175|NCT00725985|54661062|FG009|OLMP (Up to 96 Weeks)|Adverse Event|0|||
28002176|NCT00725985|54661063|FG010|OLMP (Up to 96 Weeks)|Adverse Event|0|||
28002177|NCT00725985|54661064|FG011|OLMP (Up to 96 Weeks)|Adverse Event|0|||
28002178|NCT00725985|54661053|FG000|OLMP (Up to 96 Weeks)|Death|0|||
28002179|NCT00725985|54661054|FG001|OLMP (Up to 96 Weeks)|Death|0|||
28002180|NCT00725985|54661055|FG002|OLMP (Up to 96 Weeks)|Death|0|||
28002181|NCT00725985|54661056|FG003|OLMP (Up to 96 Weeks)|Death|0|||
28002182|NCT00725985|54661057|FG004|OLMP (Up to 96 Weeks)|Death|1|||
28002183|NCT00725985|54661058|FG005|OLMP (Up to 96 Weeks)|Death|0|||
28002184|NCT00725985|54661059|FG006|OLMP (Up to 96 Weeks)|Death|0|||
28002185|NCT00725985|54661060|FG007|OLMP (Up to 96 Weeks)|Death|0|||
28002186|NCT00725985|54661061|FG008|OLMP (Up to 96 Weeks)|Death|0|||
28002187|NCT00725985|54661062|FG009|OLMP (Up to 96 Weeks)|Death|0|||
28002188|NCT00725985|54661063|FG010|OLMP (Up to 96 Weeks)|Death|0|||
28002189|NCT00725985|54661064|FG011|OLMP (Up to 96 Weeks)|Death|0|||
28002190|NCT00725985|54661053|FG000|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
28002191|NCT00725985|54661054|FG001|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
28002192|NCT00725985|54661055|FG002|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
28002193|NCT00725985|54661056|FG003|OLMP (Up to 96 Weeks)|Lost to Follow-up|1|||
28100255|NCT00064701|54756752|FG002|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
28100256|NCT00064701|54756750|FG000|One Year Post-transplant|Poor absorption|0|||
28100257|NCT00064701|54756751|FG001|One Year Post-transplant|Poor absorption|1|||
28100258|NCT00064701|54756752|FG002|One Year Post-transplant|Poor absorption|0|||
28100259|NCT00064701|54756750|FG000|One Year Post-transplant|Pancreas transplant|0|||
28100260|NCT00064701|54756751|FG001|One Year Post-transplant|Pancreas transplant|0|||
28100261|NCT00064701|54756752|FG002|One Year Post-transplant|Pancreas transplant|1|||
27915491|NCT01193530|54573345|FG000|Overall Study|Began Contraindicated Therapy|1|||
27915492|NCT01193530|54573346|FG001|Overall Study|Began Contraindicated Therapy|0|||
28100262|NCT00064701|54756750|FG000|Clinical Continuation Phase|Adverse Event|12|||
28100263|NCT00064701|54756751|FG001|Clinical Continuation Phase|Adverse Event|21|||
28100264|NCT00064701|54756752|FG002|Clinical Continuation Phase|Adverse Event|14|||
28100265|NCT00064701|54756750|FG000|Clinical Continuation Phase|Non-compliance|8|||
28100266|NCT00064701|54756751|FG001|Clinical Continuation Phase|Non-compliance|6|||
28100267|NCT00064701|54756752|FG002|Clinical Continuation Phase|Non-compliance|7|||
28100268|NCT00064701|54756750|FG000|Clinical Continuation Phase|Withdrawal by Subject|22|||
28100269|NCT00064701|54756751|FG001|Clinical Continuation Phase|Withdrawal by Subject|3|||
28100270|NCT00064701|54756752|FG002|Clinical Continuation Phase|Withdrawal by Subject|22|||
28100271|NCT00064701|54756750|FG000|Clinical Continuation Phase|Lost to Follow-up|6|||
28100272|NCT00064701|54756751|FG001|Clinical Continuation Phase|Lost to Follow-up|3|||
28100273|NCT00064701|54756752|FG002|Clinical Continuation Phase|Lost to Follow-up|6|||
28100274|NCT00064701|54756750|FG000|Clinical Continuation Phase|Graft Failure|5|||
28100275|NCT00064701|54756751|FG001|Clinical Continuation Phase|Graft Failure|5|||
28100276|NCT00064701|54756752|FG002|Clinical Continuation Phase|Graft Failure|2|||
28100277|NCT00064701|54756750|FG000|Clinical Continuation Phase|Rejection|1|||
28100278|NCT00064701|54756751|FG001|Clinical Continuation Phase|Rejection|2|||
28100279|NCT00064701|54756752|FG002|Clinical Continuation Phase|Rejection|2|||
28100280|NCT00064701|54756750|FG000|Clinical Continuation Phase|Sponsor discontinued study|113|||
27915493|NCT01193530|54573345|FG000|Overall Study|Lost Light Box|0|||
28002194|NCT00725985|54661057|FG004|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
28002195|NCT00725985|54661058|FG005|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
28002196|NCT00725985|54661059|FG006|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
28002197|NCT00725985|54661060|FG007|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
28002198|NCT00725985|54661061|FG008|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
28100281|NCT00064701|54756751|FG001|Clinical Continuation Phase|Sponsor discontinued study|129|||
28100282|NCT00064701|54756752|FG002|Clinical Continuation Phase|Sponsor discontinued study|79|||
28100283|NCT00064701|54756750|FG000|Clinical Continuation Phase|Immunosuppressive treatment crossover|0|||
28100284|NCT00064701|54756751|FG001|Clinical Continuation Phase|Immunosuppressive treatment crossover|3|||
28002199|NCT00725985|54661062|FG009|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
28002200|NCT00725985|54661063|FG010|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
28100285|NCT00064701|54756752|FG002|Clinical Continuation Phase|Immunosuppressive treatment crossover|6|||
28100286|NCT00064701|54756750|FG000|Clinical Continuation Phase|Physician Decision|1|||
28100287|NCT00064701|54756751|FG001|Clinical Continuation Phase|Physician Decision|3|||
27915494|NCT01193530|54573346|FG001|Overall Study|Lost Light Box|1|||
28002201|NCT00725985|54661064|FG011|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
28002202|NCT00725985|54661053|FG000|OLMP (Up to 96 Weeks)|Disease progression|0|||
27915495|NCT01193530|54573345|FG000|Overall Study|Returned home - out of state|0|||
27915496|NCT01193530|54573346|FG001|Overall Study|Returned home - out of state|1|||
28100288|NCT00064701|54756752|FG002|Clinical Continuation Phase|Physician Decision|0|||
28100289|NCT00064701|54756750|FG000|Clinical Continuation Phase|Unable to return to site for study visit|1|||
28172713|NCT02785939|54844444|FG001|Overall Study|Progression|8|||
28172714|NCT02785939|54844443|FG000|Overall Study|Adverse Event|3|||
28172715|NCT02785939|54844444|FG001|Overall Study|Adverse Event|1|||
28172716|NCT02785939|54844443|FG000|Overall Study|Death|1|||
28172717|NCT02785939|54844444|FG001|Overall Study|Death|0|||
28172718|NCT02785939|54844443|FG000|Overall Study|Refusal|1|||
28172719|NCT02785939|54844444|FG001|Overall Study|Refusal|0|||
28172720|NCT02785939|54844443|FG000|Overall Study|Deteriorating health|1|||
28172721|NCT02785939|54844444|FG001|Overall Study|Deteriorating health|0|||
28172722|NCT02785939|54844443|FG000|Overall Study|Not protocol specified|0|||
28172723|NCT02785939|54844444|FG001|Overall Study|Not protocol specified|1|||
28172724|NCT02634320|54844458|FG000|Overall Study|Adverse Event|2|||
28172725|NCT02634320|54844458|FG000|Overall Study|Lost to Follow-up|3|||
28172726|NCT02634320|54844458|FG000|Overall Study|Moved out of area|2|||
28172727|NCT02634320|54844458|FG000|Overall Study|Out of window for study visits|1|||
28172728|NCT02634320|54844458|FG000|Overall Study|Protocol Violation|1|||
28172729|NCT02634320|54844458|FG000|Overall Study|Withdrawal by Subject|5|||
28172730|NCT02634320|54844458|FG000|Overall Study|Lack of Efficacy|2|||
28172731|NCT02435680|54844465|FG000|Overall Study|Physician Decision|3|||
28172732|NCT02435680|54844466|FG001|Overall Study|Physician Decision|0|||
28172733|NCT02435680|54844467|FG002|Overall Study|Physician Decision|0|||
28172734|NCT02435680|54844465|FG000|Overall Study|subject / guardian decision|0|||
28172735|NCT02435680|54844466|FG001|Overall Study|subject / guardian decision|3|||
28172736|NCT02435680|54844467|FG002|Overall Study|subject / guardian decision|2|||
28172737|NCT02435680|54844465|FG000|Overall Study|Adverse Event|8|||
28172738|NCT02435680|54844466|FG001|Overall Study|Adverse Event|3|||
28172739|NCT02435680|54844467|FG002|Overall Study|Adverse Event|2|||
27915497|NCT01193530|54573345|FG000|Overall Study|Non-Compliance|0|||
27915498|NCT01193530|54573346|FG001|Overall Study|Non-Compliance|1|||
27915499|NCT00107172|54573354|FG000|Overall Study|Withdrawal by Subject|1|||
28100290|NCT00064701|54756751|FG001|Clinical Continuation Phase|Unable to return to site for study visit|0|||
28100291|NCT00064701|54756752|FG002|Clinical Continuation Phase|Unable to return to site for study visit|1|||
28100292|NCT00064701|54756750|FG000|Clinical Continuation Phase|Pancreas transplant|1|||
28100293|NCT00064701|54756751|FG001|Clinical Continuation Phase|Pancreas transplant|0|||
27915500|NCT00107172|54573355|FG001|Overall Study|Withdrawal by Subject|0|||
27915501|NCT00107172|54573354|FG000|Overall Study|Death|0|||
27915502|NCT00107172|54573355|FG001|Overall Study|Death|2|||
27915503|NCT00107172|54573354|FG000|Overall Study|Other Reason|4|||
27915504|NCT00107172|54573355|FG001|Overall Study|Other Reason|3|||
27915505|NCT01680965|54573369|FG000|Overall Study|Death|0|||
27915506|NCT01680965|54573370|FG001|Overall Study|Death|0|||
27915507|NCT01680965|54573371|FG002|Overall Study|Death|0|||
27915508|NCT01680965|54573372|FG003|Overall Study|Death|6|||
27915509|NCT01339923|54573387|FG000|Overall Study|Adverse Event|1|||
27915510|NCT01339923|54573388|FG001|Overall Study|Adverse Event|1|||
27915511|NCT01339923|54573389|FG002|Overall Study|Adverse Event|1|||
27915512|NCT01339923|54573390|FG003|Overall Study|Adverse Event|0|||
28002203|NCT00725985|54661054|FG001|OLMP (Up to 96 Weeks)|Disease progression|0|||
28002204|NCT00725985|54661055|FG002|OLMP (Up to 96 Weeks)|Disease progression|0|||
28002205|NCT00725985|54661056|FG003|OLMP (Up to 96 Weeks)|Disease progression|0|||
28002206|NCT00725985|54661057|FG004|OLMP (Up to 96 Weeks)|Disease progression|0|||
28002207|NCT00725985|54661058|FG005|OLMP (Up to 96 Weeks)|Disease progression|4|||
28002208|NCT00725985|54661059|FG006|OLMP (Up to 96 Weeks)|Disease progression|0|||
28002209|NCT00725985|54661060|FG007|OLMP (Up to 96 Weeks)|Disease progression|0|||
28100294|NCT00064701|54756752|FG002|Clinical Continuation Phase|Pancreas transplant|0|||
28100295|NCT00064701|54756750|FG000|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
28100296|NCT00064701|54756751|FG001|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1|||
28100297|NCT00064701|54756752|FG002|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
28100298|NCT00064701|54756750|FG000|Clinical Continuation Phase|Discharged to nursing home|0|||
28100299|NCT00064701|54756751|FG001|Clinical Continuation Phase|Discharged to nursing home|1|||
28100300|NCT00064701|54756752|FG002|Clinical Continuation Phase|Discharged to nursing home|0|||
28172740|NCT02435680|54844465|FG000|Overall Study|progressive disease|10|||
27915513|NCT01339923|54573391|FG004|Overall Study|Adverse Event|0|||
27915514|NCT01339923|54573392|FG005|Overall Study|Adverse Event|0|||
27915515|NCT01339923|54573393|FG006|Overall Study|Adverse Event|1|||
27915516|NCT01339923|54573387|FG000|Overall Study|Inappropriate Enrollment|1|||
27915517|NCT01339923|54573388|FG001|Overall Study|Inappropriate Enrollment|0|||
28172741|NCT02435680|54844466|FG001|Overall Study|progressive disease|7|||
28172742|NCT02435680|54844467|FG002|Overall Study|progressive disease|11|||
28172743|NCT02435680|54844465|FG000|Overall Study|not treated|0|||
28172744|NCT02435680|54844466|FG001|Overall Study|not treated|0|||
28172745|NCT02435680|54844467|FG002|Overall Study|not treated|1|||
27915518|NCT01339923|54573389|FG002|Overall Study|Inappropriate Enrollment|0|||
28002210|NCT00725985|54661061|FG008|OLMP (Up to 96 Weeks)|Disease progression|0|||
28002211|NCT00725985|54661062|FG009|OLMP (Up to 96 Weeks)|Disease progression|0|||
28002212|NCT00725985|54661063|FG010|OLMP (Up to 96 Weeks)|Disease progression|0|||
28002213|NCT00725985|54661064|FG011|OLMP (Up to 96 Weeks)|Disease progression|0|||
28002214|NCT00725985|54661053|FG000|OLMP (Up to 96 Weeks)|Other|0|||
28002215|NCT00725985|54661054|FG001|OLMP (Up to 96 Weeks)|Other|0|||
28002216|NCT00725985|54661055|FG002|OLMP (Up to 96 Weeks)|Other|0|||
28002217|NCT00725985|54661056|FG003|OLMP (Up to 96 Weeks)|Other|15|||
28002218|NCT00725985|54661057|FG004|OLMP (Up to 96 Weeks)|Other|20|||
28002219|NCT00725985|54661058|FG005|OLMP (Up to 96 Weeks)|Other|44|||
28002220|NCT00725985|54661059|FG006|OLMP (Up to 96 Weeks)|Other|0|||
28002221|NCT00725985|54661060|FG007|OLMP (Up to 96 Weeks)|Other|0|||
28002222|NCT00725985|54661061|FG008|OLMP (Up to 96 Weeks)|Other|0|||
28002223|NCT00725985|54661062|FG009|OLMP (Up to 96 Weeks)|Other|0|||
28002224|NCT00725985|54661063|FG010|OLMP (Up to 96 Weeks)|Other|0|||
28002225|NCT00725985|54661064|FG011|OLMP (Up to 96 Weeks)|Other|0|||
28002226|NCT00725985|54661053|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
28002227|NCT00725985|54661054|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
28002228|NCT00725985|54661055|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
28002229|NCT00725985|54661056|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
28002230|NCT00725985|54661057|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
28002231|NCT00725985|54661058|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
28002232|NCT00725985|54661059|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
28002233|NCT00725985|54661060|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|1|||
28002234|NCT00725985|54661061|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
28002235|NCT00725985|54661062|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
28002236|NCT00725985|54661063|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
28002237|NCT00725985|54661064|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
28002238|NCT00725985|54661053|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
28002239|NCT00725985|54661054|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
28002240|NCT00725985|54661055|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
28002241|NCT00725985|54661056|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
28002242|NCT00725985|54661057|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
28002243|NCT00725985|54661058|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
28002244|NCT00725985|54661059|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
28002245|NCT00725985|54661060|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
28002246|NCT00725985|54661061|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|1|||
28002247|NCT00725985|54661062|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
28002248|NCT00725985|54661063|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
27739895|NCT02786537|54189681|FG004|As Randomized|Lack of Efficacy|0|||
27915519|NCT01339923|54573390|FG003|Overall Study|Inappropriate Enrollment|0|||
27915520|NCT01339923|54573391|FG004|Overall Study|Inappropriate Enrollment|0|||
27915521|NCT01339923|54573392|FG005|Overall Study|Inappropriate Enrollment|1|||
27915522|NCT01339923|54573393|FG006|Overall Study|Inappropriate Enrollment|0|||
27915523|NCT01339923|54573387|FG000|Overall Study|Lost to Follow-up|4|||
27915524|NCT01339923|54573388|FG001|Overall Study|Lost to Follow-up|4|||
27915525|NCT01339923|54573389|FG002|Overall Study|Lost to Follow-up|0|||
27915526|NCT01339923|54573390|FG003|Overall Study|Lost to Follow-up|3|||
27915527|NCT01339923|54573391|FG004|Overall Study|Lost to Follow-up|1|||
27915528|NCT01339923|54573392|FG005|Overall Study|Lost to Follow-up|1|||
27915529|NCT01339923|54573393|FG006|Overall Study|Lost to Follow-up|5|||
27915530|NCT01339923|54573387|FG000|Overall Study|Protocol Violation|0|||
27915531|NCT01339923|54573388|FG001|Overall Study|Protocol Violation|0|||
27915532|NCT01339923|54573389|FG002|Overall Study|Protocol Violation|0|||
27915533|NCT01339923|54573390|FG003|Overall Study|Protocol Violation|0|||
27915534|NCT01339923|54573391|FG004|Overall Study|Protocol Violation|0|||
27915535|NCT01339923|54573392|FG005|Overall Study|Protocol Violation|3|||
27915536|NCT01339923|54573393|FG006|Overall Study|Protocol Violation|1|||
27915537|NCT01339923|54573387|FG000|Overall Study|Unable to Classify|1|||
27915538|NCT01339923|54573388|FG001|Overall Study|Unable to Classify|0|||
27915539|NCT01339923|54573389|FG002|Overall Study|Unable to Classify|1|||
27915540|NCT01339923|54573390|FG003|Overall Study|Unable to Classify|0|||
27915541|NCT01339923|54573391|FG004|Overall Study|Unable to Classify|0|||
28002249|NCT00725985|54661064|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
27739896|NCT02786537|54189682|FG005|As Randomized|Lack of Efficacy|0|||
27915542|NCT01339923|54573392|FG005|Overall Study|Unable to Classify|1|||
28002250|NCT00725985|54661053|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
28002251|NCT00725985|54661054|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
28002252|NCT00725985|54661055|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
27915543|NCT01339923|54573393|FG006|Overall Study|Unable to Classify|5|||
27915544|NCT01339923|54573387|FG000|Overall Study|Withdrawal by Subject|7|||
27915545|NCT01339923|54573388|FG001|Overall Study|Withdrawal by Subject|11|||
27915546|NCT01339923|54573389|FG002|Overall Study|Withdrawal by Subject|6|||
28002253|NCT00725985|54661056|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
28002254|NCT00725985|54661057|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
28002255|NCT00725985|54661058|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
28002256|NCT00725985|54661059|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Other|9|||
28002257|NCT00725985|54661060|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Other|8|||
28002258|NCT00725985|54661061|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Other|16|||
28002259|NCT00725985|54661062|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
28002260|NCT00725985|54661063|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
28002261|NCT00725985|54661064|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
28002262|NCT00725985|54661053|FG000|LTFU (No Cladribine) (48 Weeks)|Other|0|||
28002263|NCT00725985|54661054|FG001|LTFU (No Cladribine) (48 Weeks)|Other|0|||
28002264|NCT00725985|54661055|FG002|LTFU (No Cladribine) (48 Weeks)|Other|0|||
28002265|NCT00725985|54661056|FG003|LTFU (No Cladribine) (48 Weeks)|Other|0|||
28002266|NCT00725985|54661057|FG004|LTFU (No Cladribine) (48 Weeks)|Other|0|||
28002267|NCT00725985|54661058|FG005|LTFU (No Cladribine) (48 Weeks)|Other|0|||
28002268|NCT00725985|54661059|FG006|LTFU (No Cladribine) (48 Weeks)|Other|0|||
28002269|NCT00725985|54661060|FG007|LTFU (No Cladribine) (48 Weeks)|Other|0|||
28002270|NCT00725985|54661061|FG008|LTFU (No Cladribine) (48 Weeks)|Other|0|||
28002271|NCT00725985|54661062|FG009|LTFU (No Cladribine) (48 Weeks)|Other|34|||
28002272|NCT00725985|54661063|FG010|LTFU (No Cladribine) (48 Weeks)|Other|36|||
28002273|NCT00725985|54661064|FG011|LTFU (No Cladribine) (48 Weeks)|Other|14|||
28002274|NCT00793910|54661092|FG000|Overall Study|discarded study pills|0|||
28002275|NCT00793910|54661093|FG001|Overall Study|discarded study pills|1|||
28002276|NCT00793910|54661092|FG000|Overall Study|did not pick up medications|1|||
28002277|NCT00793910|54661093|FG001|Overall Study|did not pick up medications|1|||
28002278|NCT00793910|54661092|FG000|Overall Study|ineligible based on entry criteria|2|||
28002279|NCT00793910|54661093|FG001|Overall Study|ineligible based on entry criteria|3|||
28002280|NCT00793910|54661092|FG000|Overall Study|decided to undergo LASIK instead of PRK|2|||
28002281|NCT00793910|54661093|FG001|Overall Study|decided to undergo LASIK instead of PRK|1|||
28002282|NCT00793910|54661092|FG000|Overall Study|Withdrawal by Subject|0|||
28002283|NCT00793910|54661093|FG001|Overall Study|Withdrawal by Subject|1|||
28002284|NCT00444145|54661099|FG000|Overall Study|Withdrawal by Subject|2|||
28002285|NCT00444145|54661099|FG000|Overall Study|Lost to Follow-up|1|||
28002286|NCT00444145|54661099|FG000|Overall Study|non-compliant|11|||
28002287|NCT00444145|54661099|FG000|Overall Study|Screen Failures|5|||
28002288|NCT00725283|54661103|FG000|Overall Study|Missing Code|3|||
28002289|NCT00725283|54661103|FG000|Overall Study|Death|5|||
28002290|NCT00725283|54661103|FG000|Overall Study|Other|6|||
28002291|NCT00725283|54661103|FG000|Overall Study|Withdrawal by Subject|10|||
28002292|NCT00444067|54661109|FG000|Overall Study|Lost to Follow-up|0|||
28002293|NCT00444067|54661110|FG001|Overall Study|Lost to Follow-up|1|||
28002294|NCT00789854|54661119|FG000|Overall Study|Adverse Event|28|||
28002295|NCT00789854|54661120|FG001|Overall Study|Adverse Event|23|||
28002296|NCT00789854|54661121|FG002|Overall Study|Adverse Event|18|||
28002297|NCT00789854|54661119|FG000|Overall Study|Lost to Follow-up|1|||
28002298|NCT00789854|54661120|FG001|Overall Study|Lost to Follow-up|1|||
28002299|NCT00789854|54661121|FG002|Overall Study|Lost to Follow-up|4|||
28002300|NCT00789854|54661119|FG000|Overall Study|Withdrawal by Subject|9|||
28002301|NCT00789854|54661120|FG001|Overall Study|Withdrawal by Subject|6|||
28002302|NCT00789854|54661121|FG002|Overall Study|Withdrawal by Subject|17|||
28002303|NCT00789854|54661119|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
28002304|NCT00789854|54661120|FG001|Overall Study|Eligibility criteria not fulfilled|5|||
28002305|NCT00789854|54661121|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
28002306|NCT00789854|54661119|FG000|Overall Study|Severe non-compliance to the protocol|3|||
28002307|NCT00789854|54661120|FG001|Overall Study|Severe non-compliance to the protocol|0|||
28002308|NCT00789854|54661121|FG002|Overall Study|Severe non-compliance to the protocol|0|||
28002309|NCT00789854|54661119|FG000|Overall Study|Safety reasons|0|||
28002310|NCT00789854|54661120|FG001|Overall Study|Safety reasons|0|||
28002311|NCT00789854|54661121|FG002|Overall Study|Safety reasons|2|||
28002312|NCT00789854|54661119|FG000|Overall Study|Other|6|||
28002313|NCT00789854|54661120|FG001|Overall Study|Other|0|||
28002314|NCT00789854|54661121|FG002|Overall Study|Other|5|||
28002315|NCT00725205|54661129|FG000|Overall Study|Adverse Event|22|||
28002316|NCT00725205|54661129|FG000|Overall Study|Investigator Discontinued|1|||
28002317|NCT00725205|54661129|FG000|Overall Study|Non-compliance With Protocol|14|||
28002318|NCT00725205|54661129|FG000|Overall Study|Other|8|||
28002319|NCT00725205|54661129|FG000|Overall Study|Protocol Defined Clinical Event|1|||
28172746|NCT03371732|54844481|FG000|Overall Study|Withdrawal by Subject|9|||
28172747|NCT03371732|54844482|FG001|Overall Study|Withdrawal by Subject|3|||
28002320|NCT00725205|54661129|FG000|Overall Study|Treatment Failure|41|||
28002321|NCT00443755|54661135|FG000|Overall Study|Withdrawal by Subject|2|||
28002322|NCT00443755|54661136|FG001|Overall Study|Withdrawal by Subject|1|||
28002323|NCT00724971|54661142|FG000|Overall Study|Adverse Event|5|||
28002324|NCT00724971|54661142|FG000|Overall Study|Withdrawal by Subject|1|||
28002325|NCT00443599|54661148|FG000|Overall Study|Physician Decision|2|||
28172748|NCT03371732|54844481|FG000|Overall Study|Refusal to continue|3|||
28002326|NCT00443599|54661149|FG001|Overall Study|Physician Decision|1|||
28002327|NCT00443599|54661148|FG000|Overall Study|Death|1|||
28002328|NCT00443599|54661149|FG001|Overall Study|Death|1|||
28002329|NCT00443599|54661148|FG000|Overall Study|Cardiopulmonary bypass canceled|3|||
28002330|NCT00443599|54661149|FG001|Overall Study|Cardiopulmonary bypass canceled|1|||
28002331|NCT00455143|54661155|FG000|Overall Study|Physician Decision|1|||
28002332|NCT00455143|54661155|FG000|Overall Study|Withdrawal by Subject|1|||
28002333|NCT00455143|54661155|FG000|Overall Study|Staff was not avail to follow patient|2|||
28002334|NCT00455143|54661155|FG000|Overall Study|No longer met Inclusion Criteria|1|||
28002335|NCT00455143|54661155|FG000|Overall Study|Surgical time, staff not available|1|||
28002336|NCT00454987|54661163|FG000|Booster Period (NCT00258700)|Adverse Event|1|||
28002337|NCT00454987|54661164|FG001|Booster Period (NCT00258700)|Adverse Event|0|||
28002338|NCT00454987|54661165|FG002|Booster Period (NCT00258700)|Adverse Event|0|||
28002339|NCT00454987|54661163|FG000|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
28002340|NCT00454987|54661164|FG001|Booster Period (NCT00258700)|Withdrawal by Subject|1|||
28002341|NCT00454987|54661165|FG002|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
28002342|NCT00454987|54661163|FG000|Booster Period (NCT00258700)|Lost to Follow-up|1|||
28002343|NCT00454987|54661164|FG001|Booster Period (NCT00258700)|Lost to Follow-up|0|||
28002344|NCT00454987|54661165|FG002|Booster Period (NCT00258700)|Lost to Follow-up|0|||
28002345|NCT00724893|54661176|FG000|Overall Study|Adverse Event|76|||
28002346|NCT00724893|54661177|FG001|Overall Study|Adverse Event|142|||
28002347|NCT00724893|54661176|FG000|Overall Study|Withdrawal by Subject|0|||
28002348|NCT00724893|54661177|FG001|Overall Study|Withdrawal by Subject|1|||
28002349|NCT00724893|54661176|FG000|Overall Study|Lack of virologic response|94|||
28002350|NCT00724893|54661177|FG001|Overall Study|Lack of virologic response|202|||
28002351|NCT00724893|54661176|FG000|Overall Study|Reason not specified|193|||
28002352|NCT00724893|54661177|FG001|Overall Study|Reason not specified|7|||
28002353|NCT00724893|54661176|FG000|Overall Study|Patient choice|0|||
28002354|NCT00724893|54661177|FG001|Overall Study|Patient choice|26|||
28002355|NCT00724893|54661176|FG000|Overall Study|Geographic reasons|0|||
28002356|NCT00724893|54661177|FG001|Overall Study|Geographic reasons|11|||
28002357|NCT00724893|54661176|FG000|Overall Study|Incarceration|0|||
28002358|NCT00724893|54661177|FG001|Overall Study|Incarceration|9|||
28002359|NCT00724893|54661176|FG000|Overall Study|Substance abuse|0|||
28002360|NCT00724893|54661177|FG001|Overall Study|Substance abuse|3|||
28002361|NCT00724893|54661176|FG000|Overall Study|Financial reasons|0|||
28002362|NCT00724893|54661177|FG001|Overall Study|Financial reasons|2|||
28002363|NCT00724893|54661176|FG000|Overall Study|Assigned shorter treatment|0|||
28002364|NCT00724893|54661177|FG001|Overall Study|Assigned shorter treatment|2|||
28002365|NCT00724893|54661176|FG000|Overall Study|Lost to Follow-up|0|||
28002366|NCT00724893|54661177|FG001|Overall Study|Lost to Follow-up|52|||
28002367|NCT00724893|54661176|FG000|Overall Study|Unknown, missing data|1|||
28002368|NCT00724893|54661177|FG001|Overall Study|Unknown, missing data|1|||
27915547|NCT01339923|54573390|FG003|Overall Study|Withdrawal by Subject|1|||
27915548|NCT01339923|54573391|FG004|Overall Study|Withdrawal by Subject|4|||
27915549|NCT01339923|54573392|FG005|Overall Study|Withdrawal by Subject|3|||
27915550|NCT01339923|54573393|FG006|Overall Study|Withdrawal by Subject|2|||
28002369|NCT00789698|54661202|FG000|Overall Study|Lack of Efficacy|10|||
28002370|NCT00789698|54661203|FG001|Overall Study|Lack of Efficacy|4|||
28002371|NCT00789698|54661204|FG002|Overall Study|Lack of Efficacy|5|||
28002372|NCT00789698|54661205|FG003|Overall Study|Lack of Efficacy|18|||
28002373|NCT00789698|54661202|FG000|Overall Study|Adverse Event|5|||
28002374|NCT00789698|54661203|FG001|Overall Study|Adverse Event|5|||
28002375|NCT00789698|54661204|FG002|Overall Study|Adverse Event|3|||
28002376|NCT00789698|54661205|FG003|Overall Study|Adverse Event|4|||
28100301|NCT00064701|54756750|FG000|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
27915551|NCT01380093|54573426|FG000|Naloxone Challenge Phase|Screen failures|21|||
27915552|NCT01380093|54573427|FG001|Naloxone Challenge Phase|Screen failures|0|||
27915553|NCT01380093|54573428|FG002|Naloxone Challenge Phase|Screen failures|0|||
27915554|NCT01380093|54573429|FG003|Naloxone Challenge Phase|Screen failures|0|||
27915555|NCT01380093|54573430|FG004|Naloxone Challenge Phase|Screen failures|0|||
27915556|NCT01380093|54573431|FG005|Naloxone Challenge Phase|Screen failures|0|||
27915557|NCT01380093|54573432|FG006|Naloxone Challenge Phase|Screen failures|0|||
27915558|NCT01380093|54573433|FG007|Naloxone Challenge Phase|Screen failures|0|||
28002377|NCT00789698|54661202|FG000|Overall Study|Lost to Follow-up|5|||
28002378|NCT00789698|54661203|FG001|Overall Study|Lost to Follow-up|5|||
28002379|NCT00789698|54661204|FG002|Overall Study|Lost to Follow-up|2|||
28002380|NCT00789698|54661205|FG003|Overall Study|Lost to Follow-up|9|||
28002381|NCT00789698|54661202|FG000|Overall Study|Protocol Violation|6|||
28002382|NCT00789698|54661203|FG001|Overall Study|Protocol Violation|1|||
28100302|NCT00064701|54756751|FG001|Clinical Continuation Phase|Incorrect study drug dispensed|1|||
27915559|NCT01380093|54573434|FG008|Naloxone Challenge Phase|Screen failures|0|||
28002383|NCT00789698|54661204|FG002|Overall Study|Protocol Violation|2|||
28002384|NCT00789698|54661205|FG003|Overall Study|Protocol Violation|1|||
27915560|NCT01380093|54573426|FG000|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
28002385|NCT00789698|54661202|FG000|Overall Study|Withdrawal by Subject|14|||
28002386|NCT00789698|54661203|FG001|Overall Study|Withdrawal by Subject|15|||
28002387|NCT00789698|54661204|FG002|Overall Study|Withdrawal by Subject|12|||
28002388|NCT00789698|54661205|FG003|Overall Study|Withdrawal by Subject|19|||
28002389|NCT00789698|54661202|FG000|Overall Study|Administrative|0|||
28002390|NCT00789698|54661203|FG001|Overall Study|Administrative|3|||
28002391|NCT00789698|54661204|FG002|Overall Study|Administrative|3|||
28002392|NCT00789698|54661205|FG003|Overall Study|Administrative|1|||
28002393|NCT00724815|54661216|FG000|Overall Study|Randomized, not treated|31|||
28002394|NCT00724815|54661217|FG001|Overall Study|Randomized, not treated|30|||
28002395|NCT00724815|54661216|FG000|Overall Study|Adverse Event|5|||
28002396|NCT00724815|54661217|FG001|Overall Study|Adverse Event|3|||
28002397|NCT00724815|54661216|FG000|Overall Study|Lost to Follow-up|4|||
28002398|NCT00724815|54661217|FG001|Overall Study|Lost to Follow-up|1|||
28002399|NCT00724815|54661216|FG000|Overall Study|Other Various|3|||
28002400|NCT00724815|54661217|FG001|Overall Study|Other Various|5|||
28002401|NCT00454909|54661226|FG000|Overall Study|Withdrawal by Subject|1|||
28002402|NCT00454909|54661227|FG001|Overall Study|Withdrawal by Subject|0|||
28002403|NCT00454909|54661228|FG002|Overall Study|Withdrawal by Subject|0|||
28002404|NCT00454909|54661226|FG000|Overall Study|Migrated/moved from study area|0|||
28002405|NCT00454909|54661227|FG001|Overall Study|Migrated/moved from study area|0|||
28002406|NCT00454909|54661228|FG002|Overall Study|Migrated/moved from study area|1|||
28002407|NCT00454909|54661226|FG000|Overall Study|Lost to follow-up (complete vaccination)|5|||
28002408|NCT00454909|54661227|FG001|Overall Study|Lost to follow-up (complete vaccination)|3|||
28002409|NCT00454909|54661228|FG002|Overall Study|Lost to follow-up (complete vaccination)|1|||
28002410|NCT00454909|54661226|FG000|Overall Study|Others|1|||
28002411|NCT00454909|54661227|FG001|Overall Study|Others|0|||
28002412|NCT00454909|54661228|FG002|Overall Study|Others|0|||
28002413|NCT00798590|54661239|FG000|Overall Study|P.I, Left institution. Study terminated|11|||
28002414|NCT00798590|54661240|FG001|Overall Study|P.I, Left institution. Study terminated|8|||
28002415|NCT00481195|54661248|FG000|Overall Study|Adverse Event|16|||
28002416|NCT00481195|54661249|FG001|Overall Study|Adverse Event|11|||
28002417|NCT00481195|54661248|FG000|Overall Study|Lack of Efficacy|1|||
28002418|NCT00481195|54661249|FG001|Overall Study|Lack of Efficacy|3|||
28002419|NCT00481195|54661248|FG000|Overall Study|Lost to Follow-up|4|||
28002420|NCT00481195|54661249|FG001|Overall Study|Lost to Follow-up|6|||
28002421|NCT00481195|54661248|FG000|Overall Study|Physician Decision|3|||
28002422|NCT00481195|54661249|FG001|Overall Study|Physician Decision|1|||
28002423|NCT00481195|54661248|FG000|Overall Study|Protocol Violation|10|||
27915561|NCT01380093|54573427|FG001|Drug Discrimination Phase: Day 1|Discrimination failure|1|||
27915562|NCT01380093|54573428|FG002|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
27915563|NCT01380093|54573429|FG003|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
27915564|NCT01380093|54573430|FG004|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
27915565|NCT01380093|54573431|FG005|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
27915566|NCT01380093|54573432|FG006|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
27915567|NCT01380093|54573433|FG007|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
27915568|NCT01380093|54573434|FG008|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
27915569|NCT01380093|54573426|FG000|Drug Discrimination Phase: Day 2|Physician Decision|0|||
27915570|NCT01380093|54573427|FG001|Drug Discrimination Phase: Day 2|Physician Decision|3|||
27915571|NCT01380093|54573428|FG002|Drug Discrimination Phase: Day 2|Physician Decision|1|||
27915572|NCT01380093|54573429|FG003|Drug Discrimination Phase: Day 2|Physician Decision|0|||
27915573|NCT01380093|54573430|FG004|Drug Discrimination Phase: Day 2|Physician Decision|0|||
27915574|NCT01380093|54573431|FG005|Drug Discrimination Phase: Day 2|Physician Decision|0|||
27915575|NCT01380093|54573432|FG006|Drug Discrimination Phase: Day 2|Physician Decision|0|||
27915576|NCT01380093|54573433|FG007|Drug Discrimination Phase: Day 2|Physician Decision|0|||
27915577|NCT01380093|54573434|FG008|Drug Discrimination Phase: Day 2|Physician Decision|0|||
28002424|NCT00481195|54661249|FG001|Overall Study|Protocol Violation|7|||
28002425|NCT00481195|54661248|FG000|Overall Study|Withdrawal by Subject|3|||
28002426|NCT00481195|54661249|FG001|Overall Study|Withdrawal by Subject|9|||
28002427|NCT00481195|54661248|FG000|Overall Study|Miscellaneous|2|||
28002428|NCT00481195|54661249|FG001|Overall Study|Miscellaneous|2|||
28002429|NCT00454363|54661266|FG000|Overall Study|Adverse Event|1|||
28002430|NCT00454363|54661267|FG001|Overall Study|Adverse Event|2|||
28002431|NCT00454363|54661266|FG000|Overall Study|Withdrawal prior to 12 weeks treatment|4|||
28002432|NCT00454363|54661267|FG001|Overall Study|Withdrawal prior to 12 weeks treatment|0|||
28002433|NCT00454207|54661274|FG000|Overall Study|Adverse Event|3|||
27915578|NCT01380093|54573426|FG000|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
27915579|NCT01380093|54573427|FG001|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1|||
28002434|NCT00454207|54661275|FG001|Overall Study|Adverse Event|1|||
28002435|NCT00454207|54661274|FG000|Overall Study|Lack of Efficacy|1|||
28002436|NCT00454207|54661275|FG001|Overall Study|Lack of Efficacy|0|||
28002437|NCT00454207|54661274|FG000|Overall Study|Protocol Violation|0|||
28002438|NCT00454207|54661275|FG001|Overall Study|Protocol Violation|1|||
28002439|NCT00738894|54661295|FG000|Overall Study|Lost to Follow-up|23|||
27915580|NCT01380093|54573428|FG002|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
28002440|NCT00738894|54661296|FG001|Overall Study|Lost to Follow-up|13|||
28002441|NCT00738894|54661295|FG000|Overall Study|Withdrawal by Subject|10|||
28002442|NCT00738894|54661296|FG001|Overall Study|Withdrawal by Subject|15|||
28002443|NCT00738894|54661295|FG000|Overall Study|Physician Decision|4|||
28002444|NCT00738894|54661296|FG001|Overall Study|Physician Decision|5|||
28002445|NCT00738894|54661295|FG000|Overall Study|Death|2|||
28002446|NCT00738894|54661296|FG001|Overall Study|Death|0|||
28002447|NCT00480493|54661304|FG000|Overall Study|moved|2|||
28002448|NCT00480493|54661305|FG001|Overall Study|moved|7|||
28002449|NCT00734994|54661313|FG000|Overall Study|Withdrawal by Subject|1|||
28002450|NCT00798434|54661320|FG000|Double-Blind|Adverse Event|22|||
28002451|NCT00798434|54661321|FG001|Double-Blind|Adverse Event|46|||
28002452|NCT00798434|54661320|FG000|Double-Blind|Death|0|||
28002453|NCT00798434|54661321|FG001|Double-Blind|Death|1|||
28002454|NCT00798434|54661320|FG000|Double-Blind|Lost to Follow-up|1|||
28002455|NCT00798434|54661321|FG001|Double-Blind|Lost to Follow-up|0|||
27915581|NCT01380093|54573429|FG003|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
27915582|NCT01380093|54573430|FG004|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
27915583|NCT01380093|54573431|FG005|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
27915584|NCT01380093|54573432|FG006|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
27915585|NCT01380093|54573433|FG007|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
28002456|NCT00798434|54661320|FG000|Double-Blind|Lack of Efficacy|8|||
28002457|NCT00798434|54661321|FG001|Double-Blind|Lack of Efficacy|12|||
28002458|NCT00798434|54661320|FG000|Double-Blind|Withdrawal by Subject|17|||
27915586|NCT01380093|54573434|FG008|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
27915587|NCT01380093|54573426|FG000|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
27915588|NCT01380093|54573427|FG001|Drug Discrimination Phase: Day 2|Discrimination failure|4|||
27915589|NCT01380093|54573428|FG002|Drug Discrimination Phase: Day 2|Discrimination failure|9|||
27915590|NCT01380093|54573429|FG003|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
27915591|NCT01380093|54573430|FG004|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
27915592|NCT01380093|54573431|FG005|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
27915593|NCT01380093|54573432|FG006|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
27915594|NCT01380093|54573433|FG007|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
27915595|NCT01380093|54573434|FG008|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
27915596|NCT01380093|54573426|FG000|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
27915597|NCT01380093|54573427|FG001|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
27915598|NCT01380093|54573428|FG002|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
27915599|NCT01380093|54573429|FG003|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
27915600|NCT01380093|54573430|FG004|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
28002459|NCT00798434|54661321|FG001|Double-Blind|Withdrawal by Subject|14|||
28002460|NCT00798434|54661320|FG000|Double-Blind|Protocol Violation|1|||
28002461|NCT00798434|54661321|FG001|Double-Blind|Protocol Violation|4|||
28002462|NCT00798434|54661320|FG000|Double-Blind|Did Not Meet Entrance Criteria|2|||
28002463|NCT00798434|54661321|FG001|Double-Blind|Did Not Meet Entrance Criteria|1|||
28002464|NCT00798434|54661320|FG000|Double-Blind|Other|1|||
28002465|NCT00798434|54661321|FG001|Double-Blind|Other|0|||
28002466|NCT00798434|54661320|FG000|Double-Blind|Not Treated|3|||
28002467|NCT00798434|54661321|FG001|Double-Blind|Not Treated|6|||
28002468|NCT00798434|54661320|FG000|Open-Label|Adverse Event|33|||
28002469|NCT00798434|54661321|FG001|Open-Label|Adverse Event|11|||
28002470|NCT00798434|54661320|FG000|Open-Label|Lack of Efficacy|5|||
28002471|NCT00798434|54661321|FG001|Open-Label|Lack of Efficacy|11|||
28002472|NCT00798434|54661320|FG000|Open-Label|Withdrawal by Subject|2|||
28002473|NCT00798434|54661321|FG001|Open-Label|Withdrawal by Subject|7|||
28002474|NCT00798434|54661320|FG000|Open-Label|Protocol Violation|1|||
28002475|NCT00798434|54661321|FG001|Open-Label|Protocol Violation|0|||
28002476|NCT00798434|54661320|FG000|Open-Label|Other|1|||
28002477|NCT00798434|54661321|FG001|Open-Label|Other|2|||
27915601|NCT01380093|54573431|FG005|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
28002478|NCT00798434|54661320|FG000|Open-Label|Not Treated|0|||
28002479|NCT00798434|54661321|FG001|Open-Label|Not Treated|1|||
28002480|NCT00724503|54661334|FG000|Overall Study|Lost to Follow-up|4|||
28002481|NCT00724503|54661335|FG001|Overall Study|Lost to Follow-up|8|||
28002482|NCT00724503|54661334|FG000|Overall Study|Withdrawal by Subject|11|||
28002483|NCT00724503|54661335|FG001|Overall Study|Withdrawal by Subject|23|||
28002484|NCT00724503|54661334|FG000|Overall Study|Death|190|||
28002485|NCT00724503|54661335|FG001|Overall Study|Death|182|||
28002486|NCT00724503|54661334|FG000|Overall Study|Adverse Event|1|||
28002487|NCT00724503|54661335|FG001|Overall Study|Adverse Event|0|||
28002488|NCT00724503|54661334|FG000|Overall Study|Not otherwise specified|4|||
28002489|NCT00724503|54661335|FG001|Overall Study|Not otherwise specified|7|||
28002490|NCT00791648|54661345|FG000|Overall Study|Physician Decision|0|||
28002491|NCT00791648|54661346|FG001|Overall Study|Physician Decision|1|||
28002492|NCT00791648|54661345|FG000|Overall Study|Withdrawal by Subject|0|||
28002493|NCT00791648|54661346|FG001|Overall Study|Withdrawal by Subject|1|||
28002494|NCT00791492|54661354|FG000|Overall Study|Withdrawal by Subject|1|||
27915602|NCT01380093|54573432|FG006|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
27915603|NCT01380093|54573433|FG007|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
27915604|NCT01380093|54573434|FG008|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
28100303|NCT00064701|54756752|FG002|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
28100304|NCT00064701|54756750|FG000|Clinical Continuation Phase|Patient opted out|0|||
28100305|NCT00064701|54756751|FG001|Clinical Continuation Phase|Patient opted out|0|||
28100306|NCT00064701|54756752|FG002|Clinical Continuation Phase|Patient opted out|1|||
28100307|NCT00064077|54756764|FG000|Overall Study|Improper prior treatment|1|||
28100308|NCT00064077|54756765|FG001|Overall Study|Improper prior treatment|0|||
28100309|NCT00064077|54756766|FG002|Overall Study|Improper prior treatment|0|||
28100310|NCT00064077|54756767|FG003|Overall Study|Improper prior treatment|0|||
28100311|NCT00064077|54756764|FG000|Overall Study|Poor risk|2|||
28100312|NCT00064077|54756765|FG001|Overall Study|Poor risk|0|||
28100313|NCT00064077|54756766|FG002|Overall Study|Poor risk|1|||
28100314|NCT00064077|54756767|FG003|Overall Study|Poor risk|1|||
28100315|NCT00064077|54756764|FG000|Overall Study|Pathology|10|||
28100316|NCT00064077|54756765|FG001|Overall Study|Pathology|7|||
28100317|NCT00064077|54756766|FG002|Overall Study|Pathology|3|||
28100318|NCT00064077|54756767|FG003|Overall Study|Pathology|4|||
28100319|NCT00064077|54756764|FG000|Overall Study|No surgery|0|||
28100320|NCT00064077|54756765|FG001|Overall Study|No surgery|0|||
28100321|NCT00064077|54756766|FG002|Overall Study|No surgery|1|||
28100322|NCT00064077|54756767|FG003|Overall Study|No surgery|0|||
28100323|NCT00064077|54756764|FG000|Overall Study|No tumor|0|||
28100324|NCT00064077|54756765|FG001|Overall Study|No tumor|0|||
28100325|NCT00064077|54756766|FG002|Overall Study|No tumor|1|||
28100326|NCT00064077|54756767|FG003|Overall Study|No tumor|0|||
28100327|NCT00064077|54756764|FG000|Overall Study|Other reasons|2|||
28100328|NCT00064077|54756765|FG001|Overall Study|Other reasons|2|||
28100329|NCT00064077|54756766|FG002|Overall Study|Other reasons|1|||
27739897|NCT02786537|54189677|FG000|As Randomized|Withdrawal by Subject|1|||
27915605|NCT01380093|54573426|FG000|Drug Discrimination Phase: Day 2|Backup participant|0|||
27915606|NCT01380093|54573427|FG001|Drug Discrimination Phase: Day 2|Backup participant|0|||
27915607|NCT01380093|54573428|FG002|Drug Discrimination Phase: Day 2|Backup participant|1|||
27915608|NCT01380093|54573429|FG003|Drug Discrimination Phase: Day 2|Backup participant|0|||
27915609|NCT01380093|54573430|FG004|Drug Discrimination Phase: Day 2|Backup participant|0|||
27915610|NCT01380093|54573431|FG005|Drug Discrimination Phase: Day 2|Backup participant|0|||
27915611|NCT01380093|54573432|FG006|Drug Discrimination Phase: Day 2|Backup participant|0|||
27915612|NCT01380093|54573433|FG007|Drug Discrimination Phase: Day 2|Backup participant|0|||
27915613|NCT01380093|54573434|FG008|Drug Discrimination Phase: Day 2|Backup participant|0|||
27915614|NCT01380093|54573426|FG000|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
27915615|NCT01380093|54573427|FG001|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
28002495|NCT00791492|54661355|FG001|Overall Study|Withdrawal by Subject|2|||
28002496|NCT00791492|54661354|FG000|Overall Study|Liver transplantation|5|||
28002497|NCT00791492|54661355|FG001|Overall Study|Liver transplantation|1|||
28002498|NCT00723957|54661363|FG000|Overall Study|Adverse event unrelated to study drug|1|||
28002499|NCT00723957|54661364|FG001|Overall Study|Adverse event unrelated to study drug|4|||
28002500|NCT00723957|54661363|FG000|Overall Study|Death|3|||
28002501|NCT00723957|54661364|FG001|Overall Study|Death|4|||
28002502|NCT00723957|54661363|FG000|Overall Study|Disease progression|27|||
28002503|NCT00723957|54661364|FG001|Overall Study|Disease progression|25|||
28002504|NCT00723957|54661363|FG000|Overall Study|Maximum clinical benefit|4|||
28002505|NCT00723957|54661364|FG001|Overall Study|Maximum clinical benefit|5|||
28002506|NCT00723957|54661363|FG000|Overall Study|Investigator decision|1|||
28002507|NCT00723957|54661364|FG001|Overall Study|Investigator decision|1|||
28002508|NCT00723957|54661363|FG000|Overall Study|Study drug toxicity|4|||
28100330|NCT00064077|54756767|FG003|Overall Study|Other reasons|2|||
28100331|NCT00063999|54756779|FG000|Overall Study|Withdrawal by Subject|1|||
28100332|NCT00063999|54756780|FG001|Overall Study|Withdrawal by Subject|0|||
28100333|NCT00063999|54756779|FG000|Overall Study|Ineligible|44|||
28100334|NCT00063999|54756780|FG001|Overall Study|Ineligible|24|||
28100335|NCT03131440|54756825|FG000|Overall Study|Withdrawal by Subject|1|||
28100336|NCT03131440|54756826|FG001|Overall Study|Withdrawal by Subject|3|||
28100337|NCT03131440|54756827|FG002|Overall Study|Withdrawal by Subject|0|||
28100338|NCT03131440|54756828|FG003|Overall Study|Withdrawal by Subject|0|||
28100339|NCT03131440|54756829|FG004|Overall Study|Withdrawal by Subject|1|||
28100340|NCT03131440|54756830|FG005|Overall Study|Withdrawal by Subject|0|||
28100341|NCT03131440|54756831|FG006|Overall Study|Withdrawal by Subject|0|||
28100342|NCT03131440|54756832|FG007|Overall Study|Withdrawal by Subject|1|||
28100343|NCT03131440|54756833|FG008|Overall Study|Withdrawal by Subject|1|||
28100344|NCT03131440|54756834|FG009|Overall Study|Withdrawal by Subject|1|||
28100345|NCT03131440|54756835|FG010|Overall Study|Withdrawal by Subject|0|||
28100346|NCT03131440|54756836|FG011|Overall Study|Withdrawal by Subject|1|||
28100347|NCT03131440|54756837|FG012|Overall Study|Withdrawal by Subject|1|||
28100348|NCT03131440|54756838|FG013|Overall Study|Withdrawal by Subject|0|||
28100349|NCT03131440|54756839|FG014|Overall Study|Withdrawal by Subject|1|||
27915616|NCT01380093|54573428|FG002|Drug Discrimination Phase: Day 2|Sponsor decision|1|||
27915617|NCT01380093|54573429|FG003|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
27915618|NCT01380093|54573430|FG004|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
27915619|NCT01380093|54573431|FG005|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
27915620|NCT01380093|54573432|FG006|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
27915621|NCT01380093|54573433|FG007|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
27915622|NCT01380093|54573434|FG008|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
27915623|NCT01380093|54573426|FG000|Treatment Phase: Second Intervention|Other|0|||
27915624|NCT01380093|54573427|FG001|Treatment Phase: Second Intervention|Other|0|||
27915625|NCT01380093|54573428|FG002|Treatment Phase: Second Intervention|Other|0|||
27915626|NCT01380093|54573429|FG003|Treatment Phase: Second Intervention|Other|1|||
27915627|NCT01380093|54573430|FG004|Treatment Phase: Second Intervention|Other|0|||
27915628|NCT01380093|54573431|FG005|Treatment Phase: Second Intervention|Other|0|||
27915629|NCT01380093|54573432|FG006|Treatment Phase: Second Intervention|Other|0|||
27915630|NCT01380093|54573433|FG007|Treatment Phase: Second Intervention|Other|0|||
28002509|NCT00723957|54661364|FG001|Overall Study|Study drug toxicity|6|||
28002510|NCT00723957|54661363|FG000|Overall Study|Withdrawal by Subject|7|||
28002511|NCT00723957|54661364|FG001|Overall Study|Withdrawal by Subject|5|||
28002512|NCT00723957|54661363|FG000|Overall Study|Reason not analyzed|1|||
28002513|NCT00723957|54661364|FG001|Overall Study|Reason not analyzed|0|||
28002514|NCT00723957|54661363|FG000|Overall Study|Never received treatment|3|||
28002515|NCT00723957|54661364|FG001|Overall Study|Never received treatment|3|||
28002516|NCT00723801|54661372|FG000|Overall Study|Lost to Follow-up|1|||
28002517|NCT00723801|54661373|FG001|Overall Study|Lost to Follow-up|2|||
28002518|NCT00723801|54661372|FG000|Overall Study|Protocol Violation|2|||
28002519|NCT00723801|54661373|FG001|Overall Study|Protocol Violation|1|||
28002520|NCT00797966|54661383|FG000|Phase A|Lost to Follow-up|0|||
28002521|NCT00797966|54661384|FG001|Phase A|Lost to Follow-up|0|||
28002522|NCT00797966|54661385|FG002|Phase A|Lost to Follow-up|0|||
28002523|NCT00797966|54661386|FG003|Phase A|Lost to Follow-up|0|||
28002524|NCT00797966|54661387|FG004|Phase A|Lost to Follow-up|33|||
28002525|NCT00797966|54661388|FG005|Phase A|Lost to Follow-up|0|||
28002526|NCT00797966|54661383|FG000|Phase A|Adverse Event|0|||
28002527|NCT00797966|54661384|FG001|Phase A|Adverse Event|0|||
27915631|NCT01380093|54573434|FG008|Treatment Phase: Second Intervention|Other|0|||
27915632|NCT01380093|54573426|FG000|Treatment Phase: Third Intervention|Non-compliance|0|||
27915633|NCT01380093|54573427|FG001|Treatment Phase: Third Intervention|Non-compliance|0|||
27915634|NCT01380093|54573428|FG002|Treatment Phase: Third Intervention|Non-compliance|0|||
27915635|NCT01380093|54573429|FG003|Treatment Phase: Third Intervention|Non-compliance|0|||
27915636|NCT01380093|54573430|FG004|Treatment Phase: Third Intervention|Non-compliance|0|||
27915637|NCT01380093|54573431|FG005|Treatment Phase: Third Intervention|Non-compliance|0|||
27915638|NCT01380093|54573432|FG006|Treatment Phase: Third Intervention|Non-compliance|0|||
28002528|NCT00797966|54661385|FG002|Phase A|Adverse Event|0|||
28002529|NCT00797966|54661386|FG003|Phase A|Adverse Event|0|||
28002530|NCT00797966|54661387|FG004|Phase A|Adverse Event|46|||
28002531|NCT00797966|54661388|FG005|Phase A|Adverse Event|0|||
28002532|NCT00797966|54661383|FG000|Phase A|Met withdrawal criteria|0|||
28002533|NCT00797966|54661384|FG001|Phase A|Met withdrawal criteria|0|||
28002534|NCT00797966|54661385|FG002|Phase A|Met withdrawal criteria|0|||
28002535|NCT00797966|54661386|FG003|Phase A|Met withdrawal criteria|0|||
28002536|NCT00797966|54661387|FG004|Phase A|Met withdrawal criteria|4|||
28002537|NCT00797966|54661388|FG005|Phase A|Met withdrawal criteria|0|||
28002538|NCT00797966|54661383|FG000|Phase A|Physician Decision|0|||
28002539|NCT00797966|54661384|FG001|Phase A|Physician Decision|0|||
28002540|NCT00797966|54661385|FG002|Phase A|Physician Decision|0|||
28002541|NCT00797966|54661386|FG003|Phase A|Physician Decision|0|||
28002542|NCT00797966|54661387|FG004|Phase A|Physician Decision|13|||
28002543|NCT00797966|54661388|FG005|Phase A|Physician Decision|0|||
28002544|NCT00797966|54661383|FG000|Phase A|Withdrawal by Subject|0|||
28002545|NCT00797966|54661384|FG001|Phase A|Withdrawal by Subject|0|||
28002546|NCT00797966|54661385|FG002|Phase A|Withdrawal by Subject|0|||
28002547|NCT00797966|54661386|FG003|Phase A|Withdrawal by Subject|0|||
28002548|NCT00797966|54661387|FG004|Phase A|Withdrawal by Subject|33|||
28002549|NCT00797966|54661388|FG005|Phase A|Withdrawal by Subject|0|||
28002550|NCT00797966|54661383|FG000|Phase A|Protocol deviation|0|||
28002551|NCT00797966|54661384|FG001|Phase A|Protocol deviation|0|||
28002552|NCT00797966|54661385|FG002|Phase A|Protocol deviation|0|||
28100350|NCT03131440|54756840|FG015|Overall Study|Withdrawal by Subject|0|||
28002553|NCT00797966|54661386|FG003|Phase A|Protocol deviation|0|||
28002554|NCT00797966|54661387|FG004|Phase A|Protocol deviation|56|||
28002555|NCT00797966|54661388|FG005|Phase A|Protocol deviation|0|||
28002556|NCT00797966|54661383|FG000|Phase B|Lost to Follow-up|0|||
28002557|NCT00797966|54661384|FG001|Phase B|Lost to Follow-up|1|||
28002558|NCT00797966|54661385|FG002|Phase B|Lost to Follow-up|3|||
28002559|NCT00797966|54661386|FG003|Phase B|Lost to Follow-up|0|||
28002560|NCT00797966|54661387|FG004|Phase B|Lost to Follow-up|0|||
28002561|NCT00797966|54661388|FG005|Phase B|Lost to Follow-up|0|||
28002562|NCT00797966|54661383|FG000|Phase B|Adverse Event|2|||
28002563|NCT00797966|54661384|FG001|Phase B|Adverse Event|1|||
28002564|NCT00797966|54661385|FG002|Phase B|Adverse Event|3|||
28002565|NCT00797966|54661386|FG003|Phase B|Adverse Event|1|||
28002566|NCT00797966|54661387|FG004|Phase B|Adverse Event|0|||
28002567|NCT00797966|54661388|FG005|Phase B|Adverse Event|0|||
28002568|NCT00797966|54661383|FG000|Phase B|Met Withdrawal Criteria|3|||
28002569|NCT00797966|54661384|FG001|Phase B|Met Withdrawal Criteria|3|||
28002570|NCT00797966|54661385|FG002|Phase B|Met Withdrawal Criteria|6|||
28002571|NCT00797966|54661386|FG003|Phase B|Met Withdrawal Criteria|1|||
28002572|NCT00797966|54661387|FG004|Phase B|Met Withdrawal Criteria|0|||
28002573|NCT00797966|54661388|FG005|Phase B|Met Withdrawal Criteria|0|||
28002574|NCT00797966|54661383|FG000|Phase B|Physician Decision|1|||
28002575|NCT00797966|54661384|FG001|Phase B|Physician Decision|0|||
28002576|NCT00797966|54661385|FG002|Phase B|Physician Decision|3|||
28002577|NCT00797966|54661386|FG003|Phase B|Physician Decision|1|||
28002578|NCT00797966|54661387|FG004|Phase B|Physician Decision|0|||
28002579|NCT00797966|54661388|FG005|Phase B|Physician Decision|0|||
28002580|NCT00797966|54661383|FG000|Phase B|Withdrawal by Subject|1|||
28002581|NCT00797966|54661384|FG001|Phase B|Withdrawal by Subject|4|||
28002582|NCT00797966|54661385|FG002|Phase B|Withdrawal by Subject|3|||
28002583|NCT00797966|54661386|FG003|Phase B|Withdrawal by Subject|3|||
28002584|NCT00797966|54661387|FG004|Phase B|Withdrawal by Subject|0|||
28002585|NCT00797966|54661388|FG005|Phase B|Withdrawal by Subject|0|||
28002586|NCT00797966|54661383|FG000|Phase B|Protocol Deviation|4|||
28002587|NCT00797966|54661384|FG001|Phase B|Protocol Deviation|8|||
28002588|NCT00797966|54661385|FG002|Phase B|Protocol Deviation|2|||
28002589|NCT00797966|54661386|FG003|Phase B|Protocol Deviation|6|||
28002590|NCT00797966|54661387|FG004|Phase B|Protocol Deviation|0|||
28100351|NCT03131440|54756841|FG016|Overall Study|Withdrawal by Subject|0|||
28100352|NCT03131440|54756842|FG017|Overall Study|Withdrawal by Subject|0|||
28100353|NCT03131440|54756843|FG018|Overall Study|Withdrawal by Subject|1|||
28100354|NCT03131440|54756844|FG019|Overall Study|Withdrawal by Subject|0|||
28100355|NCT03131440|54756845|FG020|Overall Study|Withdrawal by Subject|1|||
28100356|NCT03131440|54756846|FG021|Overall Study|Withdrawal by Subject|1|||
28100357|NCT03131440|54756847|FG022|Overall Study|Withdrawal by Subject|1|||
28100358|NCT03131440|54756848|FG023|Overall Study|Withdrawal by Subject|0|||
28100359|NCT03131440|54756849|FG024|Overall Study|Withdrawal by Subject|0|||
28100360|NCT03131440|54756850|FG025|Overall Study|Withdrawal by Subject|0|||
28100361|NCT03131440|54756851|FG026|Overall Study|Withdrawal by Subject|0|||
28100362|NCT03131440|54756852|FG027|Overall Study|Withdrawal by Subject|0|||
28100363|NCT03131440|54756853|FG028|Overall Study|Withdrawal by Subject|0|||
28100364|NCT03131440|54756854|FG029|Overall Study|Withdrawal by Subject|0|||
28100365|NCT03131440|54756855|FG030|Overall Study|Withdrawal by Subject|1|||
28100366|NCT03131440|54756856|FG031|Overall Study|Withdrawal by Subject|0|||
28100367|NCT03131440|54756825|FG000|Overall Study|Lost to Follow-up|0|||
28100368|NCT03131440|54756826|FG001|Overall Study|Lost to Follow-up|0|||
28100369|NCT03131440|54756827|FG002|Overall Study|Lost to Follow-up|0|||
28100370|NCT03131440|54756828|FG003|Overall Study|Lost to Follow-up|0|||
28100371|NCT03131440|54756829|FG004|Overall Study|Lost to Follow-up|0|||
28002591|NCT00797966|54661388|FG005|Phase B|Protocol Deviation|0|||
28002592|NCT00797966|54661383|FG000|Phase B|Lack of Efficacy|0|||
28002593|NCT00797966|54661384|FG001|Phase B|Lack of Efficacy|1|||
28100372|NCT03131440|54756830|FG005|Overall Study|Lost to Follow-up|1|||
28100373|NCT03131440|54756831|FG006|Overall Study|Lost to Follow-up|0|||
28100374|NCT03131440|54756832|FG007|Overall Study|Lost to Follow-up|0|||
28100375|NCT03131440|54756833|FG008|Overall Study|Lost to Follow-up|0|||
28100376|NCT03131440|54756834|FG009|Overall Study|Lost to Follow-up|0|||
28100377|NCT03131440|54756835|FG010|Overall Study|Lost to Follow-up|0|||
27915639|NCT01380093|54573433|FG007|Treatment Phase: Third Intervention|Non-compliance|0|||
27915640|NCT01380093|54573434|FG008|Treatment Phase: Third Intervention|Non-compliance|1|||
27915641|NCT01380093|54573426|FG000|Treatment Phase: Third Intervention|Other|0|||
27915642|NCT01380093|54573427|FG001|Treatment Phase: Third Intervention|Other|0|||
27915643|NCT01380093|54573428|FG002|Treatment Phase: Third Intervention|Other|0|||
27915644|NCT01380093|54573429|FG003|Treatment Phase: Third Intervention|Other|0|||
27915645|NCT01380093|54573430|FG004|Treatment Phase: Third Intervention|Other|0|||
27915646|NCT01380093|54573431|FG005|Treatment Phase: Third Intervention|Other|0|||
27915647|NCT01380093|54573432|FG006|Treatment Phase: Third Intervention|Other|0|||
27915648|NCT01380093|54573433|FG007|Treatment Phase: Third Intervention|Other|0|||
28002594|NCT00797966|54661385|FG002|Phase B|Lack of Efficacy|1|||
28002595|NCT00797966|54661386|FG003|Phase B|Lack of Efficacy|4|||
28002596|NCT00797966|54661387|FG004|Phase B|Lack of Efficacy|0|||
28002597|NCT00797966|54661388|FG005|Phase B|Lack of Efficacy|0|||
28002598|NCT00797966|54661383|FG000|Phase A+|Lost to Follow-up|0|||
28002599|NCT00797966|54661384|FG001|Phase A+|Lost to Follow-up|0|||
28002600|NCT00797966|54661385|FG002|Phase A+|Lost to Follow-up|0|||
28100378|NCT03131440|54756836|FG011|Overall Study|Lost to Follow-up|0|||
28100379|NCT03131440|54756837|FG012|Overall Study|Lost to Follow-up|0|||
28002601|NCT00797966|54661386|FG003|Phase A+|Lost to Follow-up|0|||
28002602|NCT00797966|54661387|FG004|Phase A+|Lost to Follow-up|0|||
28002603|NCT00797966|54661388|FG005|Phase A+|Lost to Follow-up|9|||
27915649|NCT01380093|54573434|FG008|Treatment Phase: Third Intervention|Other|1|||
28002604|NCT00797966|54661383|FG000|Phase A+|Met withdrawal criteria|0|||
28002605|NCT00797966|54661384|FG001|Phase A+|Met withdrawal criteria|0|||
28002606|NCT00797966|54661385|FG002|Phase A+|Met withdrawal criteria|0|||
28002607|NCT00797966|54661386|FG003|Phase A+|Met withdrawal criteria|0|||
28002608|NCT00797966|54661387|FG004|Phase A+|Met withdrawal criteria|0|||
28002609|NCT00797966|54661388|FG005|Phase A+|Met withdrawal criteria|5|||
28002610|NCT00797966|54661383|FG000|Phase A+|Withdrawal by Subject|0|||
28002611|NCT00797966|54661384|FG001|Phase A+|Withdrawal by Subject|0|||
28002612|NCT00797966|54661385|FG002|Phase A+|Withdrawal by Subject|0|||
28002613|NCT00797966|54661386|FG003|Phase A+|Withdrawal by Subject|0|||
28002614|NCT00797966|54661387|FG004|Phase A+|Withdrawal by Subject|0|||
28002615|NCT00797966|54661388|FG005|Phase A+|Withdrawal by Subject|6|||
28002616|NCT00797966|54661383|FG000|Phase A+|Adverse Event|0|||
28002617|NCT00797966|54661384|FG001|Phase A+|Adverse Event|0|||
28002618|NCT00797966|54661385|FG002|Phase A+|Adverse Event|0|||
28002619|NCT00797966|54661386|FG003|Phase A+|Adverse Event|0|||
28002620|NCT00797966|54661387|FG004|Phase A+|Adverse Event|0|||
28002621|NCT00797966|54661388|FG005|Phase A+|Adverse Event|4|||
28002622|NCT00797966|54661383|FG000|Phase A+|Protocol deviation|0|||
28002623|NCT00797966|54661384|FG001|Phase A+|Protocol deviation|0|||
28002624|NCT00797966|54661385|FG002|Phase A+|Protocol deviation|0|||
28002625|NCT00797966|54661386|FG003|Phase A+|Protocol deviation|0|||
28002626|NCT00797966|54661387|FG004|Phase A+|Protocol deviation|0|||
28002627|NCT00797966|54661388|FG005|Phase A+|Protocol deviation|4|||
28002628|NCT00723489|54661404|FG000|Overall Study|Physician Decision|0|||
28002629|NCT00723489|54661405|FG001|Overall Study|Physician Decision|1|||
28002630|NCT00723489|54661406|FG002|Overall Study|Physician Decision|0|||
28002631|NCT00723489|54661407|FG003|Overall Study|Physician Decision|0|||
28002632|NCT00723489|54661404|FG000|Overall Study|Pregnancy|0|||
28002633|NCT00723489|54661405|FG001|Overall Study|Pregnancy|0|||
28002634|NCT00723489|54661406|FG002|Overall Study|Pregnancy|0|||
27915650|NCT01379937|54573452|FG000|Overall Study|Protocol Violation|0|||
27915651|NCT01379937|54573453|FG001|Overall Study|Protocol Violation|0|||
27915652|NCT01379937|54573454|FG002|Overall Study|Protocol Violation|0|||
27915653|NCT01379937|54573455|FG003|Overall Study|Protocol Violation|1|||
27915654|NCT01379937|54573452|FG000|Overall Study|Consent withdrawal|0|||
27915655|NCT01379937|54573453|FG001|Overall Study|Consent withdrawal|1|||
27915656|NCT01379937|54573454|FG002|Overall Study|Consent withdrawal|0|||
27915657|NCT01379937|54573455|FG003|Overall Study|Consent withdrawal|0|||
27915658|NCT01379937|54573452|FG000|Overall Study|Lost to Follow-up|1|||
27915659|NCT01379937|54573453|FG001|Overall Study|Lost to Follow-up|2|||
27915660|NCT01379937|54573454|FG002|Overall Study|Lost to Follow-up|2|||
27915661|NCT01379937|54573455|FG003|Overall Study|Lost to Follow-up|0|||
27915662|NCT01379781|54573481|FG000|Overall Study|Lost to Follow-up|11|||
27915663|NCT01379781|54573482|FG001|Overall Study|Lost to Follow-up|8|||
27915664|NCT01379703|54573488|FG000|Study Start Through 9 Months|Lost to Follow-up|2|||
27915665|NCT01379703|54573489|FG001|Study Start Through 9 Months|Lost to Follow-up|61|||
27915666|NCT01379703|54573490|FG002|Study Start Through 9 Months|Lost to Follow-up|104|||
27915667|NCT01379703|54573488|FG000|Study Start Through 9 Months|Adverse Event|0|||
27915668|NCT01379703|54573489|FG001|Study Start Through 9 Months|Adverse Event|14|||
27915669|NCT01379703|54573490|FG002|Study Start Through 9 Months|Adverse Event|10|||
27915670|NCT01379703|54573488|FG000|Study Start Through 9 Months|Withdrawal by Subject|0|||
27915671|NCT01379703|54573489|FG001|Study Start Through 9 Months|Withdrawal by Subject|6|||
27915672|NCT01379703|54573490|FG002|Study Start Through 9 Months|Withdrawal by Subject|1|||
27915673|NCT01379703|54573488|FG000|Study Start Through 9 Months|Treatment Failure|0|||
27915674|NCT01379703|54573489|FG001|Study Start Through 9 Months|Treatment Failure|2|||
27915675|NCT01379703|54573490|FG002|Study Start Through 9 Months|Treatment Failure|2|||
27915676|NCT01379703|54573488|FG000|Study Start Through 9 Months|Patient Noncompliance|0|||
27915677|NCT01379703|54573489|FG001|Study Start Through 9 Months|Patient Noncompliance|0|||
27915678|NCT01379703|54573490|FG002|Study Start Through 9 Months|Patient Noncompliance|1|||
27915679|NCT01379703|54573488|FG000|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
27915680|NCT01379703|54573489|FG001|Study Start Through 9 Months|Tuberculosis/TB treatment|4|||
27915681|NCT01379703|54573490|FG002|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
27915682|NCT01379703|54573488|FG000|Study Start Through 9 Months|Medication not available|0|||
27915683|NCT01379703|54573489|FG001|Study Start Through 9 Months|Medication not available|2|||
27915684|NCT01379703|54573490|FG002|Study Start Through 9 Months|Medication not available|1|||
28002635|NCT00723489|54661407|FG003|Overall Study|Pregnancy|1|||
28002636|NCT00723489|54661404|FG000|Overall Study|Withdrawal by Subject|0|||
28002637|NCT00723489|54661405|FG001|Overall Study|Withdrawal by Subject|0|||
28002638|NCT00723489|54661406|FG002|Overall Study|Withdrawal by Subject|0|||
28002639|NCT00723489|54661407|FG003|Overall Study|Withdrawal by Subject|1|||
28002640|NCT00723489|54661404|FG000|Overall Study|Seropositive at baseline|1|||
28002641|NCT00723489|54661405|FG001|Overall Study|Seropositive at baseline|0|||
28002642|NCT00723489|54661406|FG002|Overall Study|Seropositive at baseline|0|||
28002643|NCT00723489|54661407|FG003|Overall Study|Seropositive at baseline|0|||
28002644|NCT00723489|54661404|FG000|Overall Study|Prohibited Medication|0|||
27915685|NCT01379703|54573488|FG000|Study Start Through 9 Months|Poor general condition|0|||
27915686|NCT01379703|54573489|FG001|Study Start Through 9 Months|Poor general condition|1|||
27915687|NCT01379703|54573490|FG002|Study Start Through 9 Months|Poor general condition|0|||
27915688|NCT01379703|54573488|FG000|Study Start Through 9 Months|Increased triglycerides|0|||
27915689|NCT01379703|54573489|FG001|Study Start Through 9 Months|Increased triglycerides|1|||
27915690|NCT01379703|54573490|FG002|Study Start Through 9 Months|Increased triglycerides|0|||
27915691|NCT01379703|54573488|FG000|Study Start Through 9 Months|Reason unknown|2|||
27915692|NCT01379703|54573489|FG001|Study Start Through 9 Months|Reason unknown|31|||
27915693|NCT01379703|54573490|FG002|Study Start Through 9 Months|Reason unknown|24|||
28002645|NCT00723489|54661405|FG001|Overall Study|Prohibited Medication|0|||
28002646|NCT00723489|54661406|FG002|Overall Study|Prohibited Medication|0|||
28002647|NCT00723489|54661407|FG003|Overall Study|Prohibited Medication|1|||
28002648|NCT00723489|54661404|FG000|Overall Study|Samples Collected Out of Window|0|||
28002649|NCT00723489|54661405|FG001|Overall Study|Samples Collected Out of Window|3|||
28002650|NCT00723489|54661406|FG002|Overall Study|Samples Collected Out of Window|0|||
28002651|NCT00723489|54661407|FG003|Overall Study|Samples Collected Out of Window|0|||
28002652|NCT00587990|54661420|FG000|Overall Study|Death|0|||
28002653|NCT00587990|54661421|FG001|Overall Study|Death|0|||
28002654|NCT00587990|54661422|FG002|Overall Study|Death|1|||
28002655|NCT00723255|54661430|FG000|Overall Study|Ineligible: Inadequate pathology|1|||
28002656|NCT00723255|54661430|FG000|Overall Study|Ineligible: Second primary|1|||
28002657|NCT00723255|54661430|FG000|Overall Study|Ineligible: Wrong Primary|2|||
28002658|NCT00791258|54661446|FG000|Overall Study|Adverse Event|87|||
28002659|NCT00791258|54661446|FG000|Overall Study|Lost to Follow-up|18|||
28002660|NCT00791258|54661446|FG000|Overall Study|Protocol Violation|109|||
28002661|NCT00791258|54661446|FG000|Overall Study|Withdrawal by Subject|40|||
28002662|NCT00791258|54661446|FG000|Overall Study|Did not take medication for >3 days|1|||
28002663|NCT00791258|54661446|FG000|Overall Study|subject left area|2|||
28002664|NCT00791258|54661446|FG000|Overall Study|non-compliance|3|||
28002665|NCT00791258|54661446|FG000|Overall Study|Subject incarcerated|1|||
28002666|NCT00791258|54661446|FG000|Overall Study|Subject required restricted medication|1|||
28002667|NCT00791258|54661446|FG000|Overall Study|Lack of Efficacy|1|||
28002668|NCT00808067|54661452|FG000|Overall Study|Major/minor bleed|30|||
28002669|NCT00808067|54661453|FG001|Overall Study|Major/minor bleed|44|||
28002670|NCT00808067|54661452|FG000|Overall Study|Outcome event - other|33|||
28002671|NCT00808067|54661453|FG001|Overall Study|Outcome event - other|25|||
28002672|NCT00808067|54661452|FG000|Overall Study|Adverse Event|111|||
28002673|NCT00808067|54661453|FG001|Overall Study|Adverse Event|121|||
28002674|NCT00808067|54661452|FG000|Overall Study|Hospitalization (not including surgery)|18|||
28002675|NCT00808067|54661453|FG001|Overall Study|Hospitalization (not including surgery)|17|||
28002676|NCT00808067|54661452|FG000|Overall Study|Hospitalization due to surgery|37|||
28002677|NCT00808067|54661453|FG001|Overall Study|Hospitalization due to surgery|40|||
28002678|NCT00808067|54661452|FG000|Overall Study|Reduced creatinine clearance|53|||
28002679|NCT00808067|54661453|FG001|Overall Study|Reduced creatinine clearance|55|||
28002680|NCT00808067|54661452|FG000|Overall Study|Elevated LFT results|7|||
28002681|NCT00808067|54661453|FG001|Overall Study|Elevated LFT results|3|||
28002682|NCT00808067|54661452|FG000|Overall Study|Patient refused to take study medication|65|||
28002683|NCT00808067|54661453|FG001|Overall Study|Patient refused to take study medication|76|||
28002684|NCT00808067|54661452|FG000|Overall Study|Missing|1|||
28002685|NCT00808067|54661453|FG001|Overall Study|Missing|0|||
28002686|NCT00808067|54661452|FG000|Overall Study|Death|1|||
28002687|NCT00808067|54661453|FG001|Overall Study|Death|1|||
28002688|NCT00808067|54661452|FG000|Overall Study|Procedure|6|||
28002689|NCT00808067|54661453|FG001|Overall Study|Procedure|7|||
28002690|NCT00808067|54661452|FG000|Overall Study|Withdrawal by Subject|21|||
28002691|NCT00808067|54661453|FG001|Overall Study|Withdrawal by Subject|25|||
28002692|NCT00808067|54661452|FG000|Overall Study|Site closed|4|||
28002693|NCT00808067|54661453|FG001|Overall Study|Site closed|3|||
28002694|NCT00808067|54661452|FG000|Overall Study|Physician Decision|47|||
28002695|NCT00808067|54661453|FG001|Overall Study|Physician Decision|38|||
28002696|NCT00808067|54661452|FG000|Overall Study|Protocol Violation|3|||
28002697|NCT00808067|54661453|FG001|Overall Study|Protocol Violation|11|||
28002698|NCT00808067|54661452|FG000|Overall Study|Patient elected|7|||
28002699|NCT00808067|54661453|FG001|Overall Study|Patient elected|9|||
28002700|NCT00808067|54661452|FG000|Overall Study|Site closed for cause|19|||
27915694|NCT01379703|54573488|FG000|9 Months Through 18 Months|Lost to Follow-up|0|||
27915695|NCT01379703|54573489|FG001|9 Months Through 18 Months|Lost to Follow-up|178|||
28002701|NCT00808067|54661453|FG001|Overall Study|Site closed for cause|19|||
28002702|NCT00808067|54661452|FG000|Overall Study|Other reason not defined above|5|||
28002703|NCT00808067|54661453|FG001|Overall Study|Other reason not defined above|5|||
28002704|NCT00808067|54661452|FG000|Overall Study|Excluded from analysis|13|||
28002705|NCT00808067|54661453|FG001|Overall Study|Excluded from analysis|19|||
28002706|NCT00723021|54661459|FG000|Intervention Period 4|Adverse Event|0|||
28002707|NCT00723021|54661460|FG001|Intervention Period 4|Adverse Event|0|||
28002708|NCT00723021|54661461|FG002|Intervention Period 4|Adverse Event|0|||
28002709|NCT00723021|54661462|FG003|Intervention Period 4|Adverse Event|0|||
28002710|NCT00723021|54661463|FG004|Intervention Period 4|Adverse Event|1|||
28002711|NCT00721227|54661484|FG000|Overall Study|Lost to Follow-up|3|||
28002712|NCT00721227|54661485|FG001|Overall Study|Lost to Follow-up|0|||
28002713|NCT00721227|54661484|FG000|Overall Study|Noncompliance with scheduled visits.|1|||
28002714|NCT00721227|54661485|FG001|Overall Study|Noncompliance with scheduled visits.|0|||
28002715|NCT00807599|54661493|FG000|Overall Study|Not treated on protocol study|0|||
28002716|NCT00807599|54661494|FG001|Overall Study|Not treated on protocol study|0|||
28002717|NCT00807599|54661495|FG002|Overall Study|Not treated on protocol study|2|||
28002718|NCT00807599|54661493|FG000|Overall Study|Adverse Event|0|||
28002719|NCT00807599|54661494|FG001|Overall Study|Adverse Event|0|||
28002720|NCT00807599|54661495|FG002|Overall Study|Adverse Event|5|||
28002721|NCT00807599|54661493|FG000|Overall Study|Inadequate response to induction|0|||
28002722|NCT00807599|54661494|FG001|Overall Study|Inadequate response to induction|0|||
28002723|NCT00807599|54661495|FG002|Overall Study|Inadequate response to induction|9|||
28002724|NCT00807599|54661493|FG000|Overall Study|Withdrawal by Subject|0|||
28002725|NCT00807599|54661494|FG001|Overall Study|Withdrawal by Subject|0|||
28002726|NCT00807599|54661495|FG002|Overall Study|Withdrawal by Subject|1|||
28002727|NCT00721149|54661501|FG000|Overall Study|Physician Decision|1|||
28100380|NCT03131440|54756838|FG013|Overall Study|Lost to Follow-up|0|||
28100381|NCT03131440|54756839|FG014|Overall Study|Lost to Follow-up|0|||
28100382|NCT03131440|54756840|FG015|Overall Study|Lost to Follow-up|0|||
28100383|NCT03131440|54756841|FG016|Overall Study|Lost to Follow-up|0|||
28100384|NCT03131440|54756842|FG017|Overall Study|Lost to Follow-up|0|||
28100385|NCT03131440|54756843|FG018|Overall Study|Lost to Follow-up|0|||
28100386|NCT03131440|54756844|FG019|Overall Study|Lost to Follow-up|2|||
28100387|NCT03131440|54756845|FG020|Overall Study|Lost to Follow-up|1|||
28100388|NCT03131440|54756846|FG021|Overall Study|Lost to Follow-up|0|||
28100389|NCT03131440|54756847|FG022|Overall Study|Lost to Follow-up|1|||
27915696|NCT01379703|54573490|FG002|9 Months Through 18 Months|Lost to Follow-up|0|||
27915697|NCT01379703|54573488|FG000|9 Months Through 18 Months|Withdrawal by Subject|0|||
27915698|NCT01379703|54573489|FG001|9 Months Through 18 Months|Withdrawal by Subject|11|||
27915699|NCT01379703|54573490|FG002|9 Months Through 18 Months|Withdrawal by Subject|0|||
27915700|NCT01379703|54573488|FG000|9 Months Through 18 Months|Adverse Event|0|||
27915701|NCT01379703|54573489|FG001|9 Months Through 18 Months|Adverse Event|6|||
28100390|NCT03131440|54756848|FG023|Overall Study|Lost to Follow-up|0|||
28100391|NCT03131440|54756849|FG024|Overall Study|Lost to Follow-up|1|||
28100392|NCT03131440|54756850|FG025|Overall Study|Lost to Follow-up|0|||
28100393|NCT03131440|54756851|FG026|Overall Study|Lost to Follow-up|0|||
28100394|NCT03131440|54756852|FG027|Overall Study|Lost to Follow-up|2|||
28100395|NCT03131440|54756853|FG028|Overall Study|Lost to Follow-up|0|||
28100396|NCT03131440|54756854|FG029|Overall Study|Lost to Follow-up|2|||
27915702|NCT01379703|54573490|FG002|9 Months Through 18 Months|Adverse Event|0|||
27915703|NCT01379703|54573488|FG000|9 Months Through 18 Months|Treatment failure|0|||
27915704|NCT01379703|54573489|FG001|9 Months Through 18 Months|Treatment failure|5|||
27915705|NCT01379703|54573490|FG002|9 Months Through 18 Months|Treatment failure|0|||
27915706|NCT01379703|54573488|FG000|9 Months Through 18 Months|Patient Noncompliance|0|||
27915707|NCT01379703|54573489|FG001|9 Months Through 18 Months|Patient Noncompliance|4|||
27915708|NCT01379703|54573490|FG002|9 Months Through 18 Months|Patient Noncompliance|0|||
27915709|NCT01379703|54573488|FG000|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
27915710|NCT01379703|54573489|FG001|9 Months Through 18 Months|Tuberculosis/TB treatment|2|||
27915711|NCT01379703|54573490|FG002|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
27915712|NCT01379703|54573488|FG000|9 Months Through 18 Months|Fatigue|0|||
27915713|NCT01379703|54573489|FG001|9 Months Through 18 Months|Fatigue|1|||
27915714|NCT01379703|54573490|FG002|9 Months Through 18 Months|Fatigue|0|||
27915715|NCT01379703|54573488|FG000|9 Months Through 18 Months|Reason Unknown|0|||
27915716|NCT01379703|54573489|FG001|9 Months Through 18 Months|Reason Unknown|23|||
27915717|NCT01379703|54573490|FG002|9 Months Through 18 Months|Reason Unknown|0|||
27915718|NCT01335477|54573501|FG000|Overall Study|Adverse Event|30|||
27915719|NCT01335477|54573502|FG001|Overall Study|Adverse Event|42|||
27915720|NCT01335477|54573501|FG000|Overall Study|Non compliant with protocol|0|||
27915721|NCT01335477|54573502|FG001|Overall Study|Non compliant with protocol|2|||
27915722|NCT01335477|54573501|FG000|Overall Study|Lost to Follow-up|1|||
27915723|NCT01335477|54573502|FG001|Overall Study|Lost to Follow-up|2|||
28002728|NCT00788372|54661505|FG000|Period 1 (up to 4 Weeks)|Adverse Event|18|||
28100397|NCT03131440|54756855|FG030|Overall Study|Lost to Follow-up|0|||
27915724|NCT01335477|54573501|FG000|Overall Study|Consent withdrawn, not due to AE|7|||
27915725|NCT01335477|54573502|FG001|Overall Study|Consent withdrawn, not due to AE|9|||
27915726|NCT01335477|54573501|FG000|Overall Study|Not treated|1|||
28002729|NCT00788372|54661505|FG000|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9|||
28002730|NCT00788372|54661505|FG000|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4|||
28100398|NCT03131440|54756856|FG031|Overall Study|Lost to Follow-up|0|||
28100399|NCT03131440|54756825|FG000|Overall Study|Death|0|||
28100400|NCT03131440|54756826|FG001|Overall Study|Death|0|||
28100401|NCT03131440|54756827|FG002|Overall Study|Death|0|||
28100402|NCT03131440|54756828|FG003|Overall Study|Death|0|||
28002731|NCT00788372|54661505|FG000|Period 2 (Week 4 to Week 52)|Adverse Event|13|||
28002732|NCT00788372|54661505|FG000|Period 2 (Week 4 to Week 52)|Physician Decision|9|||
28002733|NCT00788372|54661505|FG000|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9|||
28002734|NCT00788372|54661505|FG000|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1|||
27915727|NCT01335477|54573502|FG001|Overall Study|Not treated|2|||
27915728|NCT01335477|54573501|FG000|Overall Study|Reason other than those stated above|2|||
27915729|NCT01335477|54573502|FG001|Overall Study|Reason other than those stated above|2|||
27915730|NCT01371825|54573508|FG000|Overall Study|Death|4|||
27915731|NCT01371747|54573518|FG000|Overall Study|Adverse Event|4|||
27915732|NCT01371747|54573519|FG001|Overall Study|Adverse Event|2|||
27915733|NCT01371747|54573520|FG002|Overall Study|Adverse Event|7|||
27915734|NCT01371747|54573521|FG003|Overall Study|Adverse Event|2|||
27915735|NCT01371747|54573522|FG004|Overall Study|Adverse Event|2|||
28002735|NCT00738582|54661509|FG000|Combination Therapy|Completed Combination Therapy|1|||
28002736|NCT00738582|54661510|FG001|Combination Therapy|Completed Combination Therapy|0|||
28002737|NCT00738582|54661509|FG000|Combination Therapy|Physician Decision|1|||
28002738|NCT00738582|54661510|FG001|Combination Therapy|Physician Decision|0|||
28002739|NCT00738582|54661509|FG000|Combination Therapy|Toxicity to Chemotherapy|1|||
28002740|NCT00738582|54661510|FG001|Combination Therapy|Toxicity to Chemotherapy|0|||
28002741|NCT00738582|54661509|FG000|Combination Therapy|Other|5|||
28002742|NCT00738582|54661510|FG001|Combination Therapy|Other|0|||
28002743|NCT00738582|54661509|FG000|Combination Therapy|Adverse Event|16|||
28002744|NCT00738582|54661510|FG001|Combination Therapy|Adverse Event|0|||
28002745|NCT00738582|54661509|FG000|Combination Therapy|Progressive Disease|9|||
28002746|NCT00738582|54661510|FG001|Combination Therapy|Progressive Disease|0|||
28002747|NCT00738582|54661509|FG000|Maintenance Therapy|Other|0|||
28002748|NCT00738582|54661510|FG001|Maintenance Therapy|Other|2|||
28002749|NCT00738582|54661509|FG000|Maintenance Therapy|Adverse Event|0|||
28002750|NCT00738582|54661510|FG001|Maintenance Therapy|Adverse Event|6|||
28002751|NCT00738582|54661509|FG000|Maintenance Therapy|Progressive Disease|0|||
28002752|NCT00738582|54661510|FG001|Maintenance Therapy|Progressive Disease|47|||
28002753|NCT00738582|54661509|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
28002754|NCT00738582|54661510|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
28002755|NCT00720759|54661521|FG000|Overall Study|Lost to Follow-up|0|||
28002756|NCT00720759|54661522|FG001|Overall Study|Lost to Follow-up|1|||
28002757|NCT00720759|54661523|FG002|Overall Study|Lost to Follow-up|1|||
28002758|NCT00720759|54661524|FG003|Overall Study|Lost to Follow-up|0|||
28002759|NCT00720213|54661534|FG000|Screening Phase With Diagnostic PSG|Screen Failure|7|||
28002760|NCT00720213|54661535|FG001|Screening Phase With Diagnostic PSG|Screen Failure|0|||
28002761|NCT00720213|54661536|FG002|Screening Phase With Diagnostic PSG|Screen Failure|0|||
28002762|NCT00810407|54661544|FG000|Overall Study|Protocol Violation|3|||
28002763|NCT00810407|54661544|FG000|Overall Study|No Visit After First Day of Treatment|3|||
28002764|NCT00720057|54661550|FG000|Overall Study|Lost to Follow-up|0|||
28002765|NCT00720057|54661551|FG001|Overall Study|Lost to Follow-up|2|||
28002766|NCT00720057|54661550|FG000|Overall Study|Protocol Violation|1|||
28002767|NCT00720057|54661551|FG001|Overall Study|Protocol Violation|0|||
28002768|NCT00720057|54661550|FG000|Overall Study|Withdrawal by Subject|0|||
28002769|NCT00720057|54661551|FG001|Overall Study|Withdrawal by Subject|1|||
28002770|NCT00790868|54661559|FG000|Overall Study|Withdrawal by Subject|4|||
28002771|NCT00790868|54661560|FG001|Overall Study|Withdrawal by Subject|5|||
28002772|NCT00790868|54661559|FG000|Overall Study|Lost to Follow-up|2|||
28002773|NCT00790868|54661560|FG001|Overall Study|Lost to Follow-up|12|||
28002774|NCT00719901|54661568|FG000|Overall Study|Adverse Event|5|||
28002775|NCT00719901|54661568|FG000|Overall Study|Withdrawal by Subject|1|||
28002776|NCT00719901|54661568|FG000|Overall Study|Alternate Treatment|1|||
27915736|NCT01371747|54573523|FG005|Overall Study|Adverse Event|2|||
27915737|NCT01371747|54573518|FG000|Overall Study|Death|1|||
27915738|NCT01371747|54573519|FG001|Overall Study|Death|0|||
27915739|NCT01371747|54573520|FG002|Overall Study|Death|4|||
27915740|NCT01371747|54573521|FG003|Overall Study|Death|1|||
27915741|NCT01371747|54573522|FG004|Overall Study|Death|2|||
27915742|NCT01371747|54573523|FG005|Overall Study|Death|0|||
27915743|NCT01371747|54573518|FG000|Overall Study|Abnormal Renal Function|0|||
27915744|NCT01371747|54573519|FG001|Overall Study|Abnormal Renal Function|2|||
27915745|NCT01371747|54573520|FG002|Overall Study|Abnormal Renal Function|0|||
27915746|NCT01371747|54573521|FG003|Overall Study|Abnormal Renal Function|1|||
27915747|NCT01371747|54573522|FG004|Overall Study|Abnormal Renal Function|0|||
28002777|NCT00719901|54661568|FG000|Overall Study|Disease Progression|3|||
28002778|NCT00719901|54661568|FG000|Overall Study|Availability of Study Drug|1|||
28002779|NCT00807365|54661572|FG000|Overall Study|Study Terminated|5|||
28002780|NCT00719355|54661578|FG000|Overall Study|Death|0|||
28002781|NCT00719355|54661579|FG001|Overall Study|Death|1|||
28002782|NCT00719355|54661578|FG000|Overall Study|Medical|14|||
28002783|NCT00719355|54661579|FG001|Overall Study|Medical|5|||
28002784|NCT00719355|54661578|FG000|Overall Study|Compliance|4|||
27915748|NCT01371747|54573523|FG005|Overall Study|Abnormal Renal Function|1|||
27915749|NCT01371747|54573518|FG000|Overall Study|High Serum Potassium Results|1|||
27915750|NCT01371747|54573519|FG001|Overall Study|High Serum Potassium Results|1|||
28002785|NCT00719355|54661579|FG001|Overall Study|Compliance|6|||
28002786|NCT00719355|54661578|FG000|Overall Study|Moved|0|||
28002787|NCT00719355|54661579|FG001|Overall Study|Moved|1|||
28002788|NCT00590759|54661585|FG000|Overall Study|Death|52|||
28002789|NCT00590759|54661585|FG000|Overall Study|Lost to Follow-up|28|||
28002790|NCT00734604|54661595|FG000|Overall Study|Adverse Event|0|||
27915751|NCT01371747|54573520|FG002|Overall Study|High Serum Potassium Results|1|||
27915752|NCT01371747|54573521|FG003|Overall Study|High Serum Potassium Results|2|||
27915753|NCT01371747|54573522|FG004|Overall Study|High Serum Potassium Results|0|||
27915754|NCT01371747|54573523|FG005|Overall Study|High Serum Potassium Results|2|||
27915755|NCT01371747|54573518|FG000|Overall Study|Low Serum Potassium Results|1|||
27915756|NCT01371747|54573519|FG001|Overall Study|Low Serum Potassium Results|1|||
27915757|NCT01371747|54573520|FG002|Overall Study|Low Serum Potassium Results|1|||
27915758|NCT01371747|54573521|FG003|Overall Study|Low Serum Potassium Results|1|||
27915759|NCT01371747|54573522|FG004|Overall Study|Low Serum Potassium Results|0|||
27915760|NCT01371747|54573523|FG005|Overall Study|Low Serum Potassium Results|3|||
28002791|NCT00734604|54661596|FG001|Overall Study|Adverse Event|2|||
28002792|NCT00734604|54661597|FG002|Overall Study|Adverse Event|0|||
28002793|NCT00734604|54661598|FG003|Overall Study|Adverse Event|2|||
28002794|NCT00734604|54661599|FG004|Overall Study|Adverse Event|1|||
28002795|NCT00734604|54661600|FG005|Overall Study|Adverse Event|1|||
28002796|NCT00734604|54661595|FG000|Overall Study|Serious Adverse Event|1|||
28002797|NCT00734604|54661596|FG001|Overall Study|Serious Adverse Event|0|||
28002798|NCT00734604|54661597|FG002|Overall Study|Serious Adverse Event|1|||
28002799|NCT00734604|54661598|FG003|Overall Study|Serious Adverse Event|2|||
28002800|NCT00734604|54661599|FG004|Overall Study|Serious Adverse Event|0|||
28002801|NCT00734604|54661600|FG005|Overall Study|Serious Adverse Event|1|||
28002802|NCT00734604|54661595|FG000|Overall Study|Lost to Follow-up|1|||
28002803|NCT00734604|54661596|FG001|Overall Study|Lost to Follow-up|2|||
28002804|NCT00734604|54661597|FG002|Overall Study|Lost to Follow-up|2|||
28002805|NCT00734604|54661598|FG003|Overall Study|Lost to Follow-up|4|||
28002806|NCT00734604|54661599|FG004|Overall Study|Lost to Follow-up|2|||
28002807|NCT00734604|54661600|FG005|Overall Study|Lost to Follow-up|3|||
28002808|NCT00734604|54661595|FG000|Overall Study|Physician Decision|0|||
28002809|NCT00734604|54661596|FG001|Overall Study|Physician Decision|1|||
28002810|NCT00734604|54661597|FG002|Overall Study|Physician Decision|1|||
28002811|NCT00734604|54661598|FG003|Overall Study|Physician Decision|0|||
28002812|NCT00734604|54661599|FG004|Overall Study|Physician Decision|0|||
28002813|NCT00734604|54661600|FG005|Overall Study|Physician Decision|0|||
28002814|NCT00734604|54661595|FG000|Overall Study|Protocol Violation|0|||
28002815|NCT00734604|54661596|FG001|Overall Study|Protocol Violation|2|||
28002816|NCT00734604|54661597|FG002|Overall Study|Protocol Violation|0|||
28002817|NCT00734604|54661598|FG003|Overall Study|Protocol Violation|0|||
28002818|NCT00734604|54661599|FG004|Overall Study|Protocol Violation|1|||
28002819|NCT00734604|54661600|FG005|Overall Study|Protocol Violation|0|||
28002820|NCT00734604|54661595|FG000|Overall Study|Sponsor Decision|1|||
28002821|NCT00734604|54661596|FG001|Overall Study|Sponsor Decision|2|||
28002822|NCT00734604|54661597|FG002|Overall Study|Sponsor Decision|1|||
28002823|NCT00734604|54661598|FG003|Overall Study|Sponsor Decision|0|||
28002824|NCT00734604|54661599|FG004|Overall Study|Sponsor Decision|2|||
28002825|NCT00734604|54661600|FG005|Overall Study|Sponsor Decision|0|||
28002826|NCT00734604|54661595|FG000|Overall Study|Withdrawal by Subject|0|||
28002827|NCT00734604|54661596|FG001|Overall Study|Withdrawal by Subject|2|||
28002828|NCT00734604|54661597|FG002|Overall Study|Withdrawal by Subject|0|||
28002829|NCT00734604|54661598|FG003|Overall Study|Withdrawal by Subject|1|||
28002830|NCT00734604|54661599|FG004|Overall Study|Withdrawal by Subject|2|||
28002831|NCT00734604|54661600|FG005|Overall Study|Withdrawal by Subject|1|||
28002832|NCT00734604|54661595|FG000|Overall Study|Lack of Efficacy|0|||
28002833|NCT00734604|54661596|FG001|Overall Study|Lack of Efficacy|1|||
28002834|NCT00734604|54661597|FG002|Overall Study|Lack of Efficacy|1|||
28002835|NCT00734604|54661598|FG003|Overall Study|Lack of Efficacy|0|||
28002836|NCT00734604|54661599|FG004|Overall Study|Lack of Efficacy|0|||
28002837|NCT00734604|54661600|FG005|Overall Study|Lack of Efficacy|0|||
28002838|NCT00590681|54661611|FG000|Overall Study|Withdrawal by Subject|7|||
28002839|NCT00590681|54661611|FG000|Overall Study|Adverse Event|8|||
28002840|NCT00590681|54661611|FG000|Overall Study|Death|3|||
28002841|NCT00590681|54661611|FG000|Overall Study|Lost to Follow-up|1|||
28002842|NCT00590681|54661611|FG000|Overall Study|disease progression|1|||
28172749|NCT03371732|54844482|FG001|Overall Study|Refusal to continue|4|||
28002843|NCT00727272|54661615|FG000|Washout Period A|Adverse Event|0|||
28002844|NCT00727272|54661616|FG001|Washout Period A|Adverse Event|0|||
28002845|NCT00727272|54661617|FG002|Washout Period A|Adverse Event|1|||
28002846|NCT00727272|54661615|FG000|Washout Period B|Withdrawal by Subject|0|||
28002847|NCT00727272|54661616|FG001|Washout Period B|Withdrawal by Subject|0|||
28002848|NCT00727272|54661617|FG002|Washout Period B|Withdrawal by Subject|1|||
28002849|NCT00805025|54661627|FG000|Overall Study|Screened but not enrolled/treated|42|||
28002850|NCT00805025|54661627|FG000|Overall Study|Adverse Event|4|||
28002851|NCT00805025|54661627|FG000|Overall Study|Withdrawal by Subject|2|||
28002852|NCT00805025|54661627|FG000|Overall Study|Physician Decision|1|||
28002853|NCT00734214|54661633|FG000|Overall Study|Withdrawal by Subject|3|||
28002854|NCT00734214|54661634|FG001|Overall Study|Withdrawal by Subject|4|||
28002855|NCT00734214|54661633|FG000|Overall Study|MD withdrawal|1|||
28002856|NCT00734214|54661634|FG001|Overall Study|MD withdrawal|0|||
28002857|NCT00787202|54661645|FG000|Overall Study|Adverse Event|3|||
28002858|NCT00787202|54661646|FG001|Overall Study|Adverse Event|2|||
28002859|NCT00787202|54661647|FG002|Overall Study|Adverse Event|0|||
28002860|NCT00787202|54661648|FG003|Overall Study|Adverse Event|0|||
28002861|NCT00787202|54661649|FG004|Overall Study|Adverse Event|2|||
28002862|NCT00787202|54661645|FG000|Overall Study|Lack of Efficacy|5|||
28002863|NCT00787202|54661646|FG001|Overall Study|Lack of Efficacy|6|||
28002864|NCT00787202|54661647|FG002|Overall Study|Lack of Efficacy|5|||
28002865|NCT00787202|54661648|FG003|Overall Study|Lack of Efficacy|2|||
28002866|NCT00787202|54661649|FG004|Overall Study|Lack of Efficacy|1|||
28002867|NCT00787202|54661645|FG000|Overall Study|Lost to Follow-up|1|||
28002868|NCT00787202|54661646|FG001|Overall Study|Lost to Follow-up|0|||
28002869|NCT00787202|54661647|FG002|Overall Study|Lost to Follow-up|0|||
28002870|NCT00787202|54661648|FG003|Overall Study|Lost to Follow-up|0|||
28002871|NCT00787202|54661649|FG004|Overall Study|Lost to Follow-up|0|||
28002872|NCT00787202|54661645|FG000|Overall Study|Withdrawal by Subject|2|||
28002873|NCT00787202|54661646|FG001|Overall Study|Withdrawal by Subject|2|||
28002874|NCT00787202|54661647|FG002|Overall Study|Withdrawal by Subject|2|||
28002875|NCT00787202|54661648|FG003|Overall Study|Withdrawal by Subject|0|||
28002876|NCT00787202|54661649|FG004|Overall Study|Withdrawal by Subject|0|||
28002877|NCT00787202|54661645|FG000|Overall Study|Protocol Violation|2|||
28002878|NCT00787202|54661646|FG001|Overall Study|Protocol Violation|1|||
28002879|NCT00787202|54661647|FG002|Overall Study|Protocol Violation|0|||
28002880|NCT00787202|54661648|FG003|Overall Study|Protocol Violation|0|||
28002881|NCT00787202|54661649|FG004|Overall Study|Protocol Violation|1|||
28002882|NCT00787202|54661645|FG000|Overall Study|Randomized, not treated|1|||
28002883|NCT00787202|54661646|FG001|Overall Study|Randomized, not treated|0|||
27915761|NCT01371747|54573518|FG000|Overall Study|Protocol Violation|0|||
27915762|NCT01371747|54573519|FG001|Overall Study|Protocol Violation|0|||
27915763|NCT01371747|54573520|FG002|Overall Study|Protocol Violation|1|||
27915764|NCT01371747|54573521|FG003|Overall Study|Protocol Violation|0|||
28002884|NCT00787202|54661647|FG002|Overall Study|Randomized, not treated|0|||
27915765|NCT01371747|54573522|FG004|Overall Study|Protocol Violation|0|||
27915766|NCT01371747|54573523|FG005|Overall Study|Protocol Violation|0|||
27915767|NCT01371747|54573518|FG000|Overall Study|Non-Compliance|3|||
27915768|NCT01371747|54573519|FG001|Overall Study|Non-Compliance|4|||
27915769|NCT01371747|54573520|FG002|Overall Study|Non-Compliance|3|||
27915770|NCT01371747|54573521|FG003|Overall Study|Non-Compliance|0|||
28002885|NCT00787202|54661648|FG003|Overall Study|Randomized, not treated|0|||
28002886|NCT00787202|54661649|FG004|Overall Study|Randomized, not treated|0|||
28002887|NCT04033367|54661667|FG000|DB Period (Up to Week 12)|Adverse Event|1|||
28002888|NCT04033367|54661668|FG001|DB Period (Up to Week 12)|Adverse Event|1|||
28002889|NCT04033367|54661667|FG000|DB Period (Up to Week 12)|Withdrawal by Subject|4|||
28002890|NCT04033367|54661668|FG001|DB Period (Up to Week 12)|Withdrawal by Subject|0|||
28002891|NCT04033367|54661667|FG000|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|4|||
28002892|NCT04033367|54661668|FG001|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|1|||
28002893|NCT04033367|54661667|FG000|OLE Period (Week 12 to Week 24)|Other-unspecified|1|||
28002894|NCT04033367|54661668|FG001|OLE Period (Week 12 to Week 24)|Other-unspecified|0|||
28002895|NCT00733980|54661680|FG000|Overall Study|Adverse Event|5|||
28002896|NCT00733980|54661681|FG001|Overall Study|Adverse Event|2|||
28002897|NCT00733980|54661680|FG000|Overall Study|Lack of Efficacy|0|||
28100403|NCT03131440|54756829|FG004|Overall Study|Death|0|||
28100404|NCT03131440|54756830|FG005|Overall Study|Death|0|||
28100405|NCT03131440|54756831|FG006|Overall Study|Death|0|||
28100406|NCT03131440|54756832|FG007|Overall Study|Death|0|||
28100407|NCT03131440|54756833|FG008|Overall Study|Death|0|||
28100408|NCT03131440|54756834|FG009|Overall Study|Death|0|||
27915771|NCT01371747|54573522|FG004|Overall Study|Non-Compliance|0|||
28002898|NCT00733980|54661681|FG001|Overall Study|Lack of Efficacy|1|||
28002899|NCT00733980|54661680|FG000|Overall Study|Protocol Violation|2|||
28002900|NCT00733980|54661681|FG001|Overall Study|Protocol Violation|1|||
28002901|NCT00733980|54661680|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
28002902|NCT00733980|54661681|FG001|Overall Study|Protocol defined stopping criteria reach|1|||
28002903|NCT00733980|54661680|FG000|Overall Study|Lost to Follow-up|6|||
28002904|NCT00733980|54661681|FG001|Overall Study|Lost to Follow-up|11|||
28002905|NCT00733980|54661680|FG000|Overall Study|Physician Decision|2|||
28002906|NCT00733980|54661681|FG001|Overall Study|Physician Decision|3|||
28002907|NCT00733980|54661680|FG000|Overall Study|Withdrawal by Subject|6|||
28002908|NCT00733980|54661681|FG001|Overall Study|Withdrawal by Subject|2|||
28002909|NCT00806585|54661693|FG000|Overall Study|Study terminated by Sponsor|0|||
28002910|NCT00806585|54661694|FG001|Overall Study|Study terminated by Sponsor|0|||
28100409|NCT03131440|54756835|FG010|Overall Study|Death|0|||
28100410|NCT03131440|54756836|FG011|Overall Study|Death|0|||
27915772|NCT01371747|54573523|FG005|Overall Study|Non-Compliance|1|||
27915773|NCT01371747|54573518|FG000|Overall Study|Physician Decision|0|||
28002911|NCT00806585|54661695|FG002|Overall Study|Study terminated by Sponsor|1|||
28002912|NCT00806585|54661696|FG003|Overall Study|Study terminated by Sponsor|2|||
28002913|NCT00806585|54661697|FG004|Overall Study|Study terminated by Sponsor|0|||
28002914|NCT00806585|54661693|FG000|Overall Study|Protocol Violation|3|||
28002915|NCT00806585|54661694|FG001|Overall Study|Protocol Violation|1|||
28002916|NCT00806585|54661695|FG002|Overall Study|Protocol Violation|2|||
28002917|NCT00806585|54661696|FG003|Overall Study|Protocol Violation|0|||
28002918|NCT00806585|54661697|FG004|Overall Study|Protocol Violation|0|||
28002919|NCT00806585|54661693|FG000|Overall Study|Physician Decision|0|||
28002920|NCT00806585|54661694|FG001|Overall Study|Physician Decision|2|||
28002921|NCT00806585|54661695|FG002|Overall Study|Physician Decision|3|||
28002922|NCT00806585|54661696|FG003|Overall Study|Physician Decision|0|||
28002923|NCT00806585|54661697|FG004|Overall Study|Physician Decision|1|||
28002924|NCT00806585|54661693|FG000|Overall Study|Lost to Follow-up|2|||
28002925|NCT00806585|54661694|FG001|Overall Study|Lost to Follow-up|1|||
28002926|NCT00806585|54661695|FG002|Overall Study|Lost to Follow-up|2|||
28002927|NCT00806585|54661696|FG003|Overall Study|Lost to Follow-up|2|||
28002928|NCT00806585|54661697|FG004|Overall Study|Lost to Follow-up|5|||
28002929|NCT00806585|54661693|FG000|Overall Study|Lack of Efficacy|1|||
28002930|NCT00806585|54661694|FG001|Overall Study|Lack of Efficacy|0|||
28002931|NCT00806585|54661695|FG002|Overall Study|Lack of Efficacy|0|||
28002932|NCT00806585|54661696|FG003|Overall Study|Lack of Efficacy|0|||
28002933|NCT00806585|54661697|FG004|Overall Study|Lack of Efficacy|0|||
28002934|NCT00806585|54661693|FG000|Overall Study|Adverse Event|1|||
28002935|NCT00806585|54661694|FG001|Overall Study|Adverse Event|5|||
28002936|NCT00806585|54661695|FG002|Overall Study|Adverse Event|3|||
28002937|NCT00806585|54661696|FG003|Overall Study|Adverse Event|4|||
28002938|NCT00806585|54661697|FG004|Overall Study|Adverse Event|2|||
28002939|NCT00806585|54661693|FG000|Overall Study|Withdrawal by Subject|10|||
28002940|NCT00806585|54661694|FG001|Overall Study|Withdrawal by Subject|8|||
28002941|NCT00806585|54661695|FG002|Overall Study|Withdrawal by Subject|9|||
28002942|NCT00806585|54661696|FG003|Overall Study|Withdrawal by Subject|3|||
28002943|NCT00806585|54661697|FG004|Overall Study|Withdrawal by Subject|11|||
28002944|NCT00806585|54661693|FG000|Overall Study|Completion status unknown|15|||
28002945|NCT00806585|54661694|FG001|Overall Study|Completion status unknown|14|||
28002946|NCT00806585|54661695|FG002|Overall Study|Completion status unknown|12|||
28002947|NCT00806585|54661696|FG003|Overall Study|Completion status unknown|4|||
28002948|NCT00806585|54661697|FG004|Overall Study|Completion status unknown|12|||
28002949|NCT00480025|54661711|FG000|Overall Study|Protocol Violation|12|||
28002950|NCT00480025|54661712|FG001|Overall Study|Protocol Violation|7|||
28002951|NCT00480025|54661711|FG000|Overall Study|Patients remaining ongoing at Data Lock|101|||
28002952|NCT00480025|54661712|FG001|Overall Study|Patients remaining ongoing at Data Lock|55|||
28002953|NCT00480025|54661711|FG000|Overall Study|Disease Progression / Recurrence|449|||
28002954|NCT00480025|54661712|FG001|Overall Study|Disease Progression / Recurrence|224|||
27915774|NCT01371747|54573519|FG001|Overall Study|Physician Decision|0|||
27915775|NCT01371747|54573520|FG002|Overall Study|Physician Decision|0|||
27915776|NCT01371747|54573521|FG003|Overall Study|Physician Decision|0|||
27915777|NCT01371747|54573522|FG004|Overall Study|Physician Decision|1|||
27915778|NCT01371747|54573523|FG005|Overall Study|Physician Decision|0|||
27915779|NCT01371747|54573518|FG000|Overall Study|Withdrawal by Subject|6|||
27915780|NCT01371747|54573519|FG001|Overall Study|Withdrawal by Subject|12|||
27915781|NCT01371747|54573520|FG002|Overall Study|Withdrawal by Subject|5|||
27915782|NCT01371747|54573521|FG003|Overall Study|Withdrawal by Subject|2|||
27915783|NCT01371747|54573522|FG004|Overall Study|Withdrawal by Subject|2|||
27915784|NCT01371747|54573523|FG005|Overall Study|Withdrawal by Subject|4|||
27915785|NCT01371747|54573518|FG000|Overall Study|Other Reasons|2|||
27915786|NCT01371747|54573519|FG001|Overall Study|Other Reasons|1|||
27915787|NCT01371747|54573520|FG002|Overall Study|Other Reasons|2|||
27915788|NCT01371747|54573521|FG003|Overall Study|Other Reasons|0|||
27915789|NCT01371747|54573522|FG004|Overall Study|Other Reasons|0|||
27915790|NCT01371747|54573523|FG005|Overall Study|Other Reasons|1|||
27915791|NCT01371708|54573558|FG000|Overall Study|Insufficient clinical response|3|||
27915792|NCT01371708|54573559|FG001|Overall Study|Insufficient clinical response|2|||
28002955|NCT00480025|54661711|FG000|Overall Study|Adverse Event|44|||
28002956|NCT00480025|54661712|FG001|Overall Study|Adverse Event|12|||
27915793|NCT01371708|54573560|FG002|Overall Study|Insufficient clinical response|0|||
27915794|NCT01371708|54573558|FG000|Overall Study|Lost to Follow-up|5|||
27915795|NCT01371708|54573559|FG001|Overall Study|Lost to Follow-up|9|||
28002957|NCT00480025|54661711|FG000|Overall Study|Other|70|||
28002958|NCT00480025|54661712|FG001|Overall Study|Other|29|||
28002959|NCT00480025|54661711|FG000|Overall Study|SAE including intercurrent illness|76|||
28002960|NCT00480025|54661712|FG001|Overall Study|SAE including intercurrent illness|42|||
28002961|NCT00806351|54661726|FG000|Overall Study|Death|5|||
28002962|NCT00806351|54661727|FG001|Overall Study|Death|4|||
28002963|NCT00733902|54661737|FG000|Overall Study|Death|0|||
28002964|NCT00733902|54661738|FG001|Overall Study|Death|0|||
28002965|NCT00733902|54661739|FG002|Overall Study|Death|0|||
28002966|NCT00733902|54661740|FG003|Overall Study|Death|1|||
28002967|NCT00733902|54661737|FG000|Overall Study|Adverse Event|3|||
28002968|NCT00733902|54661738|FG001|Overall Study|Adverse Event|4|||
28002969|NCT00733902|54661739|FG002|Overall Study|Adverse Event|7|||
28002970|NCT00733902|54661740|FG003|Overall Study|Adverse Event|11|||
28002971|NCT00733902|54661737|FG000|Overall Study|Lack of Efficacy|56|||
28002972|NCT00733902|54661738|FG001|Overall Study|Lack of Efficacy|21|||
28002973|NCT00733902|54661739|FG002|Overall Study|Lack of Efficacy|34|||
27915796|NCT01371708|54573560|FG002|Overall Study|Lost to Follow-up|7|||
27915797|NCT01371708|54573558|FG000|Overall Study|Protocol Violation|2|||
27915798|NCT01371708|54573559|FG001|Overall Study|Protocol Violation|1|||
27915799|NCT01371708|54573560|FG002|Overall Study|Protocol Violation|2|||
27915800|NCT01371708|54573558|FG000|Overall Study|No longer willing to participate|7|||
27915801|NCT01371708|54573559|FG001|Overall Study|No longer willing to participate|7|||
27915802|NCT01371708|54573560|FG002|Overall Study|No longer willing to participate|13|||
28100411|NCT03131440|54756837|FG012|Overall Study|Death|0|||
28100412|NCT03131440|54756838|FG013|Overall Study|Death|0|||
27915803|NCT01371708|54573558|FG000|Overall Study|Medication error/not related to AE|0|||
27915804|NCT01371708|54573559|FG001|Overall Study|Medication error/not related to AE|1|||
27915805|NCT01371708|54573560|FG002|Overall Study|Medication error/not related to AE|0|||
27915806|NCT01371708|54573558|FG000|Overall Study|Other|3|||
27915807|NCT01371708|54573559|FG001|Overall Study|Other|2|||
27915808|NCT01371708|54573560|FG002|Overall Study|Other|4|||
27915809|NCT01371708|54573558|FG000|Overall Study|Adverse Event|5|||
27915810|NCT01371708|54573559|FG001|Overall Study|Adverse Event|8|||
27915811|NCT01371708|54573560|FG002|Overall Study|Adverse Event|12|||
27915812|NCT01371708|54573558|FG000|Overall Study|Started but did not receive treatment|1|||
27915813|NCT01371708|54573559|FG001|Overall Study|Started but did not receive treatment|0|||
28002974|NCT00733902|54661740|FG003|Overall Study|Lack of Efficacy|23|||
28002975|NCT00733902|54661737|FG000|Overall Study|Protocol Violation|4|||
28002976|NCT00733902|54661738|FG001|Overall Study|Protocol Violation|6|||
28002977|NCT00733902|54661739|FG002|Overall Study|Protocol Violation|3|||
28002978|NCT00733902|54661740|FG003|Overall Study|Protocol Violation|3|||
28002979|NCT00733902|54661737|FG000|Overall Study|Withdrawal by Subject|10|||
28002980|NCT00733902|54661738|FG001|Overall Study|Withdrawal by Subject|5|||
28002981|NCT00733902|54661739|FG002|Overall Study|Withdrawal by Subject|4|||
27915814|NCT01371708|54573560|FG002|Overall Study|Started but did not receive treatment|1|||
27915815|NCT01335399|54573572|FG000|Pre-treatment Period|No longer meeting study criteria|0|||
27915816|NCT01335399|54573573|FG001|Pre-treatment Period|No longer meeting study criteria|1|||
27915817|NCT01335399|54573572|FG000|Pre-treatment Period|Participant request to discontinue|0|||
27915818|NCT01335399|54573573|FG001|Pre-treatment Period|Participant request to discontinue|1|||
27915819|NCT01335399|54573572|FG000|Pre-treatment Period|Adverse event unrelated to study drug|0|||
27915820|NCT01335399|54573573|FG001|Pre-treatment Period|Adverse event unrelated to study drug|1|||
27915821|NCT01335399|54573572|FG000|Pre-treatment Period|Consent withdrawal|3|||
27915822|NCT01335399|54573573|FG001|Pre-treatment Period|Consent withdrawal|0|||
27915823|NCT01335399|54573572|FG000|Treatment Period|Disease progression|117|||
27915824|NCT01335399|54573573|FG001|Treatment Period|Disease progression|145|||
27915825|NCT01335399|54573572|FG000|Treatment Period|Adverse event unrelated to study drug|110|||
27915826|NCT01335399|54573573|FG001|Treatment Period|Adverse event unrelated to study drug|73|||
27915827|NCT01335399|54573572|FG000|Treatment Period|Study drug toxicity|52|||
27915828|NCT01335399|54573573|FG001|Treatment Period|Study drug toxicity|64|||
27915829|NCT01335399|54573572|FG000|Treatment Period|Participant request to discontinue|30|||
27915830|NCT01335399|54573573|FG001|Treatment Period|Participant request to discontinue|22|||
27915831|NCT01335399|54573572|FG000|Treatment Period|Other reasons|30|||
27915832|NCT01335399|54573573|FG001|Treatment Period|Other reasons|30|||
27915833|NCT01335399|54573572|FG000|Treatment Period|Consent withdrawal|10|||
27915834|NCT01335399|54573573|FG001|Treatment Period|Consent withdrawal|7|||
27915835|NCT01335399|54573572|FG000|Treatment Period|Death|7|||
27915836|NCT01335399|54573573|FG001|Treatment Period|Death|6|||
27915837|NCT01335399|54573572|FG000|Treatment Period|Poor/Non-compliance|3|||
27915838|NCT01335399|54573573|FG001|Treatment Period|Poor/Non-compliance|4|||
27915839|NCT01335399|54573572|FG000|Treatment Period|Lost to Follow-up|2|||
27915840|NCT01335399|54573573|FG001|Treatment Period|Lost to Follow-up|2|||
27915841|NCT01335399|54573572|FG000|Treatment Period|Maximum clinical benefit|1|||
27915842|NCT01335399|54573573|FG001|Treatment Period|Maximum clinical benefit|1|||
27915843|NCT01335399|54573572|FG000|Treatment Period|No longer meet study criteria|1|||
28002982|NCT00733902|54661740|FG003|Overall Study|Withdrawal by Subject|16|||
28002983|NCT00733902|54661737|FG000|Overall Study|Entered extension study|89|||
28002984|NCT00733902|54661738|FG001|Overall Study|Entered extension study|124|||
28172750|NCT02745119|54844494|FG000|Overall Study|Adverse Event|1|||
27915844|NCT01335399|54573573|FG001|Treatment Period|No longer meet study criteria|1|||
27915845|NCT01335399|54573572|FG000|Treatment Period|Administrative reasons by Sponsor|8|||
27915846|NCT01335399|54573573|FG001|Treatment Period|Administrative reasons by Sponsor|16|||
27915847|NCT01366521|54573583|FG000|Overall Study|Adverse Event|1|||
27915848|NCT01366521|54573584|FG001|Overall Study|Adverse Event|0|||
27915849|NCT01366521|54573585|FG002|Overall Study|Adverse Event|0|||
27915850|NCT01366521|54573586|FG003|Overall Study|Adverse Event|0|||
28002985|NCT00733902|54661739|FG002|Overall Study|Entered extension study|111|||
28002986|NCT00733902|54661740|FG003|Overall Study|Entered extension study|109|||
28002987|NCT00733902|54661737|FG000|Overall Study|Randomized but not treated|2|||
28002988|NCT00733902|54661738|FG001|Overall Study|Randomized but not treated|2|||
28002989|NCT00733902|54661739|FG002|Overall Study|Randomized but not treated|2|||
28002990|NCT00733902|54661740|FG003|Overall Study|Randomized but not treated|1|||
28002991|NCT00790790|54661753|FG000|Study Period 2: Therapy Phase|Adverse Event|3|||
28002992|NCT00790790|54661754|FG001|Study Period 2: Therapy Phase|Adverse Event|16|||
28002993|NCT00790790|54661755|FG002|Study Period 2: Therapy Phase|Adverse Event|16|||
28002994|NCT00790790|54661753|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
28002995|NCT00790790|54661754|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
28002996|NCT00790790|54661755|FG002|Study Period 2: Therapy Phase|Protocol Violation|0|||
28002997|NCT00790790|54661753|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|7|||
28002998|NCT00790790|54661754|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
28002999|NCT00790790|54661755|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
28003000|NCT00790790|54661753|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
28003001|NCT00790790|54661754|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
28003002|NCT00790790|54661755|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|3|||
28003003|NCT00790790|54661753|FG000|Study Period 2: Therapy Phase|Physician Decision|0|||
28003004|NCT00790790|54661754|FG001|Study Period 2: Therapy Phase|Physician Decision|1|||
28003005|NCT00790790|54661755|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
28003006|NCT00719043|54661775|FG000|Overall Study|Adverse Event|5|||
28003007|NCT00719043|54661776|FG001|Overall Study|Adverse Event|1|||
28003008|NCT00719043|54661777|FG002|Overall Study|Adverse Event|2|||
28003009|NCT00719043|54661778|FG003|Overall Study|Adverse Event|2|||
28003010|NCT00719043|54661779|FG004|Overall Study|Adverse Event|1|||
28003011|NCT00719043|54661780|FG005|Overall Study|Adverse Event|4|||
28003012|NCT00719043|54661781|FG006|Overall Study|Adverse Event|4|||
28003013|NCT00719043|54661775|FG000|Overall Study|Lost to Follow-up|14|||
28003014|NCT00719043|54661776|FG001|Overall Study|Lost to Follow-up|10|||
28003015|NCT00719043|54661777|FG002|Overall Study|Lost to Follow-up|8|||
28003016|NCT00719043|54661778|FG003|Overall Study|Lost to Follow-up|9|||
28003017|NCT00719043|54661779|FG004|Overall Study|Lost to Follow-up|10|||
28003018|NCT00719043|54661780|FG005|Overall Study|Lost to Follow-up|9|||
28003019|NCT00719043|54661781|FG006|Overall Study|Lost to Follow-up|9|||
27915851|NCT01366521|54573583|FG000|Overall Study|Protocol Violation|0|||
27915852|NCT01366521|54573584|FG001|Overall Study|Protocol Violation|0|||
27915853|NCT01366521|54573585|FG002|Overall Study|Protocol Violation|1|||
27915854|NCT01366521|54573586|FG003|Overall Study|Protocol Violation|0|||
27915855|NCT01366521|54573583|FG000|Overall Study|Physician Decision|0|||
27915856|NCT01366521|54573584|FG001|Overall Study|Physician Decision|0|||
27915857|NCT01366521|54573585|FG002|Overall Study|Physician Decision|1|||
28003020|NCT00719043|54661775|FG000|Overall Study|Protocol Violation|0|||
28003021|NCT00719043|54661776|FG001|Overall Study|Protocol Violation|0|||
28003022|NCT00719043|54661777|FG002|Overall Study|Protocol Violation|0|||
28003023|NCT00719043|54661778|FG003|Overall Study|Protocol Violation|0|||
28003024|NCT00719043|54661779|FG004|Overall Study|Protocol Violation|0|||
28003025|NCT00719043|54661780|FG005|Overall Study|Protocol Violation|1|||
28003026|NCT00719043|54661781|FG006|Overall Study|Protocol Violation|0|||
28003027|NCT00719043|54661775|FG000|Overall Study|Other|1|||
28003028|NCT00719043|54661776|FG001|Overall Study|Other|0|||
28003029|NCT00719043|54661777|FG002|Overall Study|Other|1|||
28003030|NCT00719043|54661778|FG003|Overall Study|Other|2|||
28003031|NCT00719043|54661779|FG004|Overall Study|Other|0|||
28003032|NCT00719043|54661780|FG005|Overall Study|Other|2|||
28003033|NCT00719043|54661781|FG006|Overall Study|Other|1|||
28003034|NCT00719043|54661775|FG000|Overall Study|Withdrawal by Subject|12|||
28003035|NCT00719043|54661776|FG001|Overall Study|Withdrawal by Subject|14|||
28003036|NCT00719043|54661777|FG002|Overall Study|Withdrawal by Subject|9|||
28003037|NCT00719043|54661778|FG003|Overall Study|Withdrawal by Subject|10|||
28003038|NCT00719043|54661779|FG004|Overall Study|Withdrawal by Subject|16|||
28003039|NCT00719043|54661780|FG005|Overall Study|Withdrawal by Subject|18|||
27915858|NCT01366521|54573586|FG003|Overall Study|Physician Decision|0|||
27915859|NCT01366521|54573583|FG000|Overall Study|Withdrawal by Subject|0|||
27915860|NCT01366521|54573584|FG001|Overall Study|Withdrawal by Subject|1|||
28003040|NCT00719043|54661781|FG006|Overall Study|Withdrawal by Subject|14|||
28003041|NCT00786422|54661809|FG000|Rivaroxaban Treatment|Death|2|||
28003042|NCT00786422|54661809|FG000|Rivaroxaban Treatment|Final visit earlier than planned|3|||
28003043|NCT00786422|54661809|FG000|Rivaroxaban Treatment|Lack of Efficacy|1|||
28003044|NCT00786422|54661809|FG000|Rivaroxaban Treatment|Physician Decision|1|||
28003045|NCT00786422|54661809|FG000|Rivaroxaban Treatment|Withdrawal by Subject|1|||
28003046|NCT00786422|54661809|FG000|Rivaroxaban Treatment|Non-compliance with study drug treatment|1|||
28003047|NCT00786422|54661809|FG000|Rivaroxaban Treatment|Adverse Event|2|||
28003048|NCT00786422|54661809|FG000|Follow-up Period|Death|1|||
27915861|NCT01366521|54573585|FG002|Overall Study|Withdrawal by Subject|0|||
28003049|NCT00786422|54661809|FG000|Follow-up Period|End-of-study done up to 4 days early|2|||
28003050|NCT00718887|54661817|FG000|Overall Study|Withdrawal by Subject|3|||
28003051|NCT00718887|54661818|FG001|Overall Study|Withdrawal by Subject|2|||
28003052|NCT00718887|54661817|FG000|Overall Study|Not identified|2|||
28003053|NCT00718887|54661818|FG001|Overall Study|Not identified|7|||
27915862|NCT01366521|54573586|FG003|Overall Study|Withdrawal by Subject|0|||
27915863|NCT01335009|54573600|FG000|Overall Study|Too ill to travel to study sites|1|||
27915864|NCT01335009|54573601|FG001|Overall Study|Too ill to travel to study sites|0|||
27915865|NCT01335009|54573600|FG000|Overall Study|Death|28|||
27915866|NCT01335009|54573601|FG001|Overall Study|Death|32|||
27915867|NCT01335009|54573600|FG000|Overall Study|Withdrawal by Subject|1|||
27915868|NCT01335009|54573601|FG001|Overall Study|Withdrawal by Subject|1|||
27915869|NCT01335009|54573600|FG000|Overall Study|Lost to Follow-up|1|||
28003054|NCT00786188|54661832|FG000|Overall Study|Adverse Event|3|||
28003055|NCT00786188|54661833|FG001|Overall Study|Adverse Event|1|||
28003056|NCT00786188|54661832|FG000|Overall Study|Withdrawal by Subject|2|||
28003057|NCT00786188|54661833|FG001|Overall Study|Withdrawal by Subject|0|||
28003058|NCT00790556|54661841|FG000|Treatment Period 1|Physician Decision|1|||
28003059|NCT00790556|54661842|FG001|Treatment Period 1|Physician Decision|0|||
28003060|NCT00790556|54661841|FG000|Treatment Period 1|Withdrawal by Subject|1|||
28003061|NCT00790556|54661842|FG001|Treatment Period 1|Withdrawal by Subject|0|||
28003062|NCT00733824|54661853|FG000|Phase I|Withdrawal by Subject|1|||
28003063|NCT00733824|54661854|FG001|Phase I|Withdrawal by Subject|0|||
28003064|NCT00733824|54661855|FG002|Phase I|Withdrawal by Subject|0|||
28003065|NCT00733824|54661856|FG003|Phase I|Withdrawal by Subject|0|||
28003066|NCT00733824|54661857|FG004|Phase I|Withdrawal by Subject|0|||
28003067|NCT00718809|54661873|FG000|Overall Study|Disease progression|9|||
28003068|NCT00718809|54661874|FG001|Overall Study|Disease progression|7|||
28003069|NCT00718809|54661873|FG000|Overall Study|Adverse Event|1|||
28003070|NCT00718809|54661874|FG001|Overall Study|Adverse Event|1|||
28003071|NCT00718809|54661873|FG000|Overall Study|Withdrawal by Subject|0|||
28003072|NCT00718809|54661874|FG001|Overall Study|Withdrawal by Subject|1|||
28003073|NCT00718809|54661873|FG000|Overall Study|Lost to Follow-up|1|||
28003074|NCT00718809|54661874|FG001|Overall Study|Lost to Follow-up|0|||
28003075|NCT00718809|54661873|FG000|Overall Study|Noncompliance|1|||
28003076|NCT00718809|54661874|FG001|Overall Study|Noncompliance|0|||
28003077|NCT00585039|54661882|FG000|Overall Study|medication spilled|2|||
28003078|NCT00585039|54661883|FG001|Overall Study|medication spilled|0|||
28003079|NCT00806195|54661895|FG000|Overall Study|Death|6|||
28003080|NCT00806195|54661896|FG001|Overall Study|Death|0|||
28003081|NCT00806195|54661897|FG002|Overall Study|Death|1|||
28003082|NCT00806195|54661898|FG003|Overall Study|Death|0|||
28003083|NCT00806195|54661895|FG000|Overall Study|Adverse Event|25|||
28003084|NCT00806195|54661896|FG001|Overall Study|Adverse Event|5|||
28003085|NCT00806195|54661897|FG002|Overall Study|Adverse Event|11|||
28003086|NCT00806195|54661898|FG003|Overall Study|Adverse Event|2|||
28003087|NCT00806195|54661895|FG000|Overall Study|Withdrawal by Subject|119|||
28003088|NCT00806195|54661896|FG001|Overall Study|Withdrawal by Subject|31|||
28003089|NCT00806195|54661897|FG002|Overall Study|Withdrawal by Subject|76|||
28003090|NCT00806195|54661898|FG003|Overall Study|Withdrawal by Subject|35|||
28003091|NCT00806195|54661895|FG000|Overall Study|Lost to Follow-up|217|||
28003092|NCT00806195|54661896|FG001|Overall Study|Lost to Follow-up|66|||
28003093|NCT00806195|54661897|FG002|Overall Study|Lost to Follow-up|90|||
27915870|NCT01335009|54573601|FG001|Overall Study|Lost to Follow-up|0|||
27915871|NCT01366443|54573616|FG000|Overall Study|Lost to Follow-up|2|||
27915872|NCT01366443|54573616|FG000|Overall Study|Under 18 yo|1|||
27915873|NCT01332630|54573621|FG000|Overall Study|Withdrawal by Subject|3|||
27915874|NCT01366209|54573627|FG000|Overall Study|Adverse Event|6|||
27915875|NCT01366209|54573628|FG001|Overall Study|Adverse Event|7|||
27915876|NCT01366209|54573627|FG000|Overall Study|Withdrawal by Subject|4|||
27915877|NCT01366209|54573628|FG001|Overall Study|Withdrawal by Subject|4|||
27915878|NCT01366209|54573627|FG000|Overall Study|Death|12|||
27915879|NCT01366209|54573628|FG001|Overall Study|Death|19|||
28003094|NCT00806195|54661898|FG003|Overall Study|Lost to Follow-up|34|||
28003095|NCT00806195|54661895|FG000|Overall Study|Inappropriate Enrollment|0|||
28003096|NCT00806195|54661896|FG001|Overall Study|Inappropriate Enrollment|1|||
28003097|NCT00806195|54661897|FG002|Overall Study|Inappropriate Enrollment|0|||
27915880|NCT01366209|54573627|FG000|Overall Study|Lung transplantation|6|||
27915881|NCT01366209|54573628|FG001|Overall Study|Lung transplantation|1|||
28003098|NCT00806195|54661898|FG003|Overall Study|Inappropriate Enrollment|0|||
28003099|NCT00806195|54661895|FG000|Overall Study|Administrative Reason|113|||
28003100|NCT00806195|54661896|FG001|Overall Study|Administrative Reason|35|||
28003101|NCT00806195|54661897|FG002|Overall Study|Administrative Reason|66|||
28003102|NCT00806195|54661898|FG003|Overall Study|Administrative Reason|26|||
28003103|NCT00806195|54661895|FG000|Overall Study|Protocol Violation|34|||
28003104|NCT00806195|54661896|FG001|Overall Study|Protocol Violation|24|||
28003105|NCT00806195|54661897|FG002|Overall Study|Protocol Violation|26|||
28003106|NCT00806195|54661898|FG003|Overall Study|Protocol Violation|9|||
28003107|NCT00733746|54661910|FG000|Overall Study|Ineligible|5|||
28003108|NCT00718419|54661916|FG000|Overall Study|Adverse Event|2|||
28003109|NCT00718419|54661917|FG001|Overall Study|Adverse Event|1|||
27915882|NCT01366209|54573627|FG000|Overall Study|Lost to Follow-up|2|||
27915883|NCT01366209|54573628|FG001|Overall Study|Lost to Follow-up|1|||
27915884|NCT01366209|54573627|FG000|Overall Study|Physician Decision|1|||
27915885|NCT01366209|54573628|FG001|Overall Study|Physician Decision|0|||
27915886|NCT01366209|54573627|FG000|Overall Study|Sponsors decision|0|||
27915887|NCT01366209|54573628|FG001|Overall Study|Sponsors decision|1|||
27915888|NCT01366209|54573627|FG000|Overall Study|Withdrew consent|4|||
27915889|NCT01366209|54573628|FG001|Overall Study|Withdrew consent|3|||
27915890|NCT01365546|54573634|FG000|Overall Study|Withdrawal by Subject|1|||
27915891|NCT01365546|54573634|FG000|Overall Study|Screen failure|9|||
28003110|NCT00718419|54661916|FG000|Overall Study|Physician Decision|1|||
28003111|NCT00718419|54661917|FG001|Overall Study|Physician Decision|6|||
28003112|NCT00718419|54661916|FG000|Overall Study|Sponsor decision|0|||
28003113|NCT00718419|54661917|FG001|Overall Study|Sponsor decision|1|||
28003114|NCT00718419|54661916|FG000|Overall Study|Withdrawal by Subject|0|||
28003115|NCT00718419|54661917|FG001|Overall Study|Withdrawal by Subject|5|||
28003116|NCT00718419|54661916|FG000|Overall Study|Progressive Disease|7|||
28003117|NCT00718419|54661917|FG001|Overall Study|Progressive Disease|25|||
28003118|NCT00718419|54661916|FG000|Overall Study|Death Due to Progressive Disease|2|||
28003119|NCT00718419|54661917|FG001|Overall Study|Death Due to Progressive Disease|0|||
28003120|NCT00718419|54661916|FG000|Overall Study|Death Due to Study Drug Related|0|||
28003121|NCT00718419|54661917|FG001|Overall Study|Death Due to Study Drug Related|1|||
28003122|NCT00718419|54661916|FG000|Overall Study|Death Due to Adverse Events|1|||
28003123|NCT00718419|54661917|FG001|Overall Study|Death Due to Adverse Events|0|||
28003124|NCT00717249|54661925|FG000|Overall Study|Lens Discomfort|4|||
28003125|NCT00717249|54661926|FG001|Overall Study|Lens Discomfort|1|||
27915892|NCT01365546|54573634|FG000|Overall Study|Study termination|1|||
27915893|NCT01365507|54573644|FG000|Overall Study|Withdrawal Criteria|8|||
27915894|NCT01365507|54573645|FG001|Overall Study|Withdrawal Criteria|5|||
27915895|NCT01365507|54573644|FG000|Overall Study|Unclassified|1|||
27915896|NCT01365507|54573645|FG001|Overall Study|Unclassified|4|||
27915897|NCT01365468|54573669|FG000|Overall Study|Physician Decision|1|||
28003126|NCT00717249|54661925|FG000|Overall Study|Unsatisfactory visual Response|0|||
28003127|NCT00717249|54661926|FG001|Overall Study|Unsatisfactory visual Response|2|||
28003128|NCT00717249|54661925|FG000|Overall Study|Adverse Event|4|||
28003129|NCT00717249|54661926|FG001|Overall Study|Adverse Event|2|||
28003130|NCT00717249|54661925|FG000|Overall Study|Lost to Follow-up|2|||
28003131|NCT00717249|54661926|FG001|Overall Study|Lost to Follow-up|0|||
28003132|NCT00717249|54661925|FG000|Overall Study|Withdrawal by Subject|1|||
28003133|NCT00717249|54661926|FG001|Overall Study|Withdrawal by Subject|2|||
28003134|NCT00717249|54661925|FG000|Overall Study|Pregnancy|6|||
28003135|NCT00717249|54661926|FG001|Overall Study|Pregnancy|3|||
28003136|NCT00717249|54661925|FG000|Overall Study|Protocol Violation|0|||
28003137|NCT00717249|54661926|FG001|Overall Study|Protocol Violation|2|||
28003138|NCT00717249|54661925|FG000|Overall Study|Subject became Ineligible|1|||
28003139|NCT00717249|54661926|FG001|Overall Study|Subject became Ineligible|1|||
28003140|NCT00717249|54661925|FG000|Overall Study|Unsatisfactory Physiological Response|0|||
28100413|NCT03131440|54756839|FG014|Overall Study|Death|0|||
28100414|NCT03131440|54756840|FG015|Overall Study|Death|0|||
27915898|NCT01365468|54573670|FG001|Overall Study|Physician Decision|0|||
27915899|NCT01365468|54573669|FG000|Overall Study|Disease progression|1|||
27915900|NCT01365468|54573670|FG001|Overall Study|Disease progression|0|||
27915901|NCT01365468|54573669|FG000|Overall Study|Lost to Follow-up|2|||
27915902|NCT01365468|54573670|FG001|Overall Study|Lost to Follow-up|0|||
27915903|NCT01357980|54573681|FG000|Overall Study|Lack of Efficacy|0|||
27915904|NCT01357980|54573682|FG001|Overall Study|Lack of Efficacy|1|||
27915905|NCT01357980|54573683|FG002|Overall Study|Lack of Efficacy|0|||
27915906|NCT01357980|54573684|FG003|Overall Study|Lack of Efficacy|0|||
27915907|NCT01357980|54573681|FG000|Overall Study|Consent withdrawn|0|||
27915908|NCT01357980|54573682|FG001|Overall Study|Consent withdrawn|0|||
27915909|NCT01357980|54573683|FG002|Overall Study|Consent withdrawn|1|||
27915910|NCT01357980|54573684|FG003|Overall Study|Consent withdrawn|0|||
28003141|NCT00717249|54661926|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
28003142|NCT00717249|54661925|FG000|Overall Study|Gastric Surgery|0|||
28003143|NCT00717249|54661926|FG001|Overall Study|Gastric Surgery|1|||
28003144|NCT00717249|54661925|FG000|Overall Study|Diagnosed with Diabetes|1|||
28003145|NCT00717249|54661926|FG001|Overall Study|Diagnosed with Diabetes|0|||
28003146|NCT00717249|54661925|FG000|Overall Study|Diagnosed with Multiple Scletosis|1|||
28003147|NCT00717249|54661926|FG001|Overall Study|Diagnosed with Multiple Scletosis|0|||
27915911|NCT01332318|54573698|FG000|Overall Study|Adverse Event|0|||
27915912|NCT01332318|54573699|FG001|Overall Study|Adverse Event|3|||
27915913|NCT01332318|54573700|FG002|Overall Study|Adverse Event|0|||
27915914|NCT01332318|54573701|FG003|Overall Study|Adverse Event|0|||
27915915|NCT01332318|54573698|FG000|Overall Study|Withdrawal by Subject|1|||
27915916|NCT01332318|54573699|FG001|Overall Study|Withdrawal by Subject|1|||
27915917|NCT01332318|54573700|FG002|Overall Study|Withdrawal by Subject|0|||
28003148|NCT00717249|54661925|FG000|Overall Study|Subject relocated|1|||
28003149|NCT00717249|54661926|FG001|Overall Study|Subject relocated|0|||
28100415|NCT03131440|54756841|FG016|Overall Study|Death|0|||
27915918|NCT01332318|54573701|FG003|Overall Study|Withdrawal by Subject|1|||
27915919|NCT01332318|54573698|FG000|Overall Study|Protocol Violation|1|||
27915920|NCT01332318|54573699|FG001|Overall Study|Protocol Violation|0|||
27915921|NCT01332318|54573700|FG002|Overall Study|Protocol Violation|1|||
27915922|NCT01332318|54573701|FG003|Overall Study|Protocol Violation|1|||
27915923|NCT01331109|54573716|FG000|Overall Study|Adverse Event|6|||
27915924|NCT01331109|54573716|FG000|Overall Study|Lack of Efficacy|2|||
27915925|NCT01331109|54573716|FG000|Overall Study|Protocol Violation|3|||
27915926|NCT01331109|54573716|FG000|Overall Study|Withdrawal by Subject|7|||
28003150|NCT00717249|54661925|FG000|Overall Study|Headaches|1|||
28003151|NCT00717249|54661926|FG001|Overall Study|Headaches|0|||
28003152|NCT00727194|54661932|FG000|Screening Period|Low QMG scores|0|||
28003153|NCT00727194|54661933|FG001|Screening Period|Low QMG scores|0|||
28003154|NCT00727194|54661934|FG002|Screening Period|Low QMG scores|6|||
28003155|NCT00727194|54661932|FG000|Screening Period|Lacked AChR antibodies|0|||
28003156|NCT00727194|54661933|FG001|Screening Period|Lacked AChR antibodies|0|||
28003157|NCT00727194|54661934|FG002|Screening Period|Lacked AChR antibodies|5|||
28003158|NCT00727194|54661932|FG000|Screening Period|Not stable on concomitant MG therapy|0|||
28003159|NCT00727194|54661933|FG001|Screening Period|Not stable on concomitant MG therapy|0|||
28003160|NCT00727194|54661934|FG002|Screening Period|Not stable on concomitant MG therapy|2|||
28003161|NCT00727194|54661932|FG000|Screening Period|Severe infections|0|||
28003162|NCT00727194|54661933|FG001|Screening Period|Severe infections|0|||
28003163|NCT00727194|54661934|FG002|Screening Period|Severe infections|2|||
28003164|NCT00727194|54661932|FG000|Screening Period|History of thymoma|0|||
28003165|NCT00727194|54661933|FG001|Screening Period|History of thymoma|0|||
28003166|NCT00727194|54661934|FG002|Screening Period|History of thymoma|1|||
28003167|NCT00727194|54661932|FG000|Treatment Period 2|Lack of Efficacy|0|||
28003168|NCT00727194|54661933|FG001|Treatment Period 2|Lack of Efficacy|1|||
27915927|NCT01331109|54573716|FG000|Overall Study|Lost to Follow-up|1|||
27915928|NCT01331109|54573716|FG000|Overall Study|Study Terminated by Sponsor|38|||
28003169|NCT00727194|54661934|FG002|Treatment Period 2|Lack of Efficacy|0|||
28003170|NCT00717093|54661950|FG000|Overall Study|Adverse Event|19|||
28003171|NCT00717093|54661951|FG001|Overall Study|Adverse Event|9|||
28003172|NCT00717093|54661950|FG000|Overall Study|Lack of Efficacy|3|||
28003173|NCT00717093|54661951|FG001|Overall Study|Lack of Efficacy|13|||
28003174|NCT00717093|54661950|FG000|Overall Study|Lost to Follow-up|9|||
28003175|NCT00717093|54661951|FG001|Overall Study|Lost to Follow-up|6|||
28003176|NCT00717093|54661950|FG000|Overall Study|Withdrawal by Subject|12|||
28003177|NCT00717093|54661951|FG001|Overall Study|Withdrawal by Subject|19|||
28003178|NCT00717093|54661950|FG000|Overall Study|Other|0|||
28003179|NCT00717093|54661951|FG001|Overall Study|Other|1|||
28003180|NCT00717093|54661950|FG000|Overall Study|Randomized but not treated|1|||
28003181|NCT00717093|54661951|FG001|Overall Study|Randomized but not treated|0|||
28003182|NCT00716859|54661959|FG000|Overall Study|Adverse Event|4|||
28003183|NCT00716859|54661960|FG001|Overall Study|Adverse Event|1|||
28003184|NCT00716859|54661959|FG000|Overall Study|Lack of Efficacy|3|||
28003185|NCT00716859|54661960|FG001|Overall Study|Lack of Efficacy|0|||
28003186|NCT00716859|54661959|FG000|Overall Study|Withdrawal by Subject|1|||
28003187|NCT00716859|54661960|FG001|Overall Study|Withdrawal by Subject|3|||
28003188|NCT00716859|54661959|FG000|Overall Study|Not treated|1|||
28003189|NCT00716859|54661960|FG001|Overall Study|Not treated|1|||
27915929|NCT01357551|54573722|FG000|Overall Study|Withdrawal by Subject|6|||
27915930|NCT01357551|54573723|FG001|Overall Study|Withdrawal by Subject|4|||
27915931|NCT01357551|54573722|FG000|Overall Study|Death|0|||
27915932|NCT01357551|54573723|FG001|Overall Study|Death|1|||
27915933|NCT01357551|54573722|FG000|Overall Study|Lost to Follow-up|16|||
27915934|NCT01357551|54573723|FG001|Overall Study|Lost to Follow-up|6|||
27915935|NCT01357239|54573736|FG000|Stratum: All Patients|Adverse Event|0|||
27915936|NCT01357239|54573737|FG001|Stratum: All Patients|Adverse Event|0|||
27915937|NCT01357239|54573738|FG002|Stratum: All Patients|Adverse Event|1|||
27915938|NCT01357239|54573739|FG003|Stratum: All Patients|Adverse Event|1|||
28003190|NCT00589121|54661968|FG000|Overall Study|Protocol Violation|2|||
28003191|NCT00589121|54661969|FG001|Overall Study|Protocol Violation|6|||
28003192|NCT00589121|54661968|FG000|Overall Study|No protocol treatment received|0|||
28003193|NCT00589121|54661969|FG001|Overall Study|No protocol treatment received|1|||
28003194|NCT00590135|54661978|FG000|Overall Study|Primary endpoint measure not obtainable|59|||
28003195|NCT00589667|54661983|FG000|Overall Study|Adverse Event|2|||
28003196|NCT00589667|54661983|FG000|Overall Study|Withdrawal by Subject|1|||
28003197|NCT00737568|54661989|FG000|Treatment Period Through Week 240|Investigator's Discretion|6|||
28003198|NCT00737568|54661990|FG001|Treatment Period Through Week 240|Investigator's Discretion|5|||
28003199|NCT00737568|54661989|FG000|Treatment Period Through Week 240|Withdrew Consent|5|||
28003200|NCT00737568|54661990|FG001|Treatment Period Through Week 240|Withdrew Consent|6|||
28003201|NCT00737568|54661989|FG000|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3|||
27915939|NCT01357239|54573736|FG000|Stratum: All Patients|Subject withdrew consent|0|||
27915940|NCT01357239|54573737|FG001|Stratum: All Patients|Subject withdrew consent|0|||
27915941|NCT01357239|54573738|FG002|Stratum: All Patients|Subject withdrew consent|1|||
28003202|NCT00737568|54661990|FG001|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4|||
28003203|NCT00737568|54661989|FG000|Treatment Period Through Week 240|Lost to Follow-up|3|||
28003204|NCT00737568|54661990|FG001|Treatment Period Through Week 240|Lost to Follow-up|3|||
28003205|NCT00737568|54661989|FG000|Treatment Period Through Week 240|Protocol Violation|2|||
28003206|NCT00737568|54661990|FG001|Treatment Period Through Week 240|Protocol Violation|3|||
28003207|NCT00737568|54661989|FG000|Treatment Period Through Week 240|Study Discontinued by Sponsor|1|||
28003208|NCT00737568|54661990|FG001|Treatment Period Through Week 240|Study Discontinued by Sponsor|0|||
28003209|NCT00737568|54661989|FG000|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25|||
28003210|NCT00737568|54661990|FG001|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17|||
28003211|NCT00737568|54661989|FG000|Treatment-Free Follow-up (TFFU) Period|Death|0|||
28003212|NCT00737568|54661990|FG001|Treatment-Free Follow-up (TFFU) Period|Death|1|||
28003213|NCT00737568|54661989|FG000|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1|||
28003214|NCT00737568|54661990|FG001|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0|||
28003215|NCT00737100|54661999|FG000|Overall Study|Adverse Event|6|||
28003216|NCT00737100|54662000|FG001|Overall Study|Adverse Event|5|||
27915942|NCT01357239|54573739|FG003|Stratum: All Patients|Subject withdrew consent|1|||
27915943|NCT01357239|54573736|FG000|Stratum I: Fully-Methylated|Adverse Event|0|||
27915944|NCT01357239|54573737|FG001|Stratum I: Fully-Methylated|Adverse Event|0|||
28003217|NCT00737100|54662001|FG002|Overall Study|Adverse Event|3|||
28003218|NCT00737100|54661999|FG000|Overall Study|Lost to Follow-up|0|||
28003219|NCT00737100|54662000|FG001|Overall Study|Lost to Follow-up|1|||
28003220|NCT00737100|54662001|FG002|Overall Study|Lost to Follow-up|0|||
28003221|NCT00737100|54661999|FG000|Overall Study|Withdrawal by Subject|0|||
28003222|NCT00737100|54662000|FG001|Overall Study|Withdrawal by Subject|0|||
28003223|NCT00737100|54662001|FG002|Overall Study|Withdrawal by Subject|3|||
28003224|NCT00737100|54661999|FG000|Overall Study|Reason discontinued not explained above|1|||
28003225|NCT00737100|54662000|FG001|Overall Study|Reason discontinued not explained above|1|||
28003226|NCT00737100|54662001|FG002|Overall Study|Reason discontinued not explained above|1|||
28003227|NCT00732498|54662011|FG000|Overall Study|Ineligible|1|||
28003228|NCT00732498|54662011|FG000|Overall Study|Adverse Event|2|||
28003229|NCT00732498|54662011|FG000|Overall Study|Physician Decision|3|||
28003230|NCT00726882|54662015|FG000|Overall Study|Withdrawal by Subject|5|||
28003231|NCT00726882|54662015|FG000|Overall Study|Lost to Follow-up|7|||
28003232|NCT00726882|54662015|FG000|Overall Study|Other|10|||
28003233|NCT00790400|54662023|FG000|Double-blind Period (Core Phase)|Protocol Violation|1|||
28003234|NCT00790400|54662024|FG001|Double-blind Period (Core Phase)|Protocol Violation|0|||
28003235|NCT00790400|54662023|FG000|Double-blind Period (Core Phase)|Progressive disease|0|||
28003236|NCT00790400|54662024|FG001|Double-blind Period (Core Phase)|Progressive disease|9|||
28003237|NCT00790400|54662023|FG000|Double-blind Period (Core Phase)|Adverse Event|2|||
28003238|NCT00790400|54662024|FG001|Double-blind Period (Core Phase)|Adverse Event|4|||
28003239|NCT00790400|54662023|FG000|Double-blind Period (Core Phase)|Abnormal lab value (s)|1|||
28003240|NCT00790400|54662024|FG001|Double-blind Period (Core Phase)|Abnormal lab value (s)|0|||
28003241|NCT00790400|54662023|FG000|Double-blind Period (Core Phase)|Withdrawal by Subject|1|||
28003242|NCT00790400|54662024|FG001|Double-blind Period (Core Phase)|Withdrawal by Subject|0|||
28003243|NCT00790400|54662023|FG000|Double-blind Period (Core Phase)|Administrative problems|1|||
28003244|NCT00790400|54662024|FG001|Double-blind Period (Core Phase)|Administrative problems|0|||
28003245|NCT00790400|54662023|FG000|Double-blind Period (Core Phase)|Death|1|||
28003246|NCT00790400|54662024|FG001|Double-blind Period (Core Phase)|Death|0|||
28003247|NCT00790400|54662023|FG000|Everolimus Period (Core or Extension)|Adverse Event|9|||
28003248|NCT00790400|54662024|FG001|Everolimus Period (Core or Extension)|Adverse Event|0|||
28003249|NCT00790400|54662023|FG000|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1|||
27915945|NCT01357239|54573738|FG002|Stratum I: Fully-Methylated|Adverse Event|1|||
28003250|NCT00790400|54662024|FG001|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0|||
28003251|NCT00790400|54662023|FG000|Everolimus Period (Core or Extension)|Withdrawal by Subject|7|||
28003252|NCT00790400|54662024|FG001|Everolimus Period (Core or Extension)|Withdrawal by Subject|0|||
28172751|NCT02745119|54844495|FG001|Overall Study|Adverse Event|0|||
27915946|NCT01357239|54573739|FG003|Stratum I: Fully-Methylated|Adverse Event|0|||
27915947|NCT01357239|54573736|FG000|Stratum II: Partially-Methylated|Adverse Event|0|||
27915948|NCT01357239|54573737|FG001|Stratum II: Partially-Methylated|Adverse Event|0|||
27915949|NCT01357239|54573738|FG002|Stratum II: Partially-Methylated|Adverse Event|0|||
27915950|NCT01357239|54573739|FG003|Stratum II: Partially-Methylated|Adverse Event|1|||
27915951|NCT01357239|54573736|FG000|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
27915952|NCT01357239|54573737|FG001|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
27915953|NCT01357239|54573738|FG002|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
27915954|NCT01357239|54573739|FG003|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
27915955|NCT01357161|54573755|FG000|Part 1 (Open Label Run-in)|Death|5|||
27915956|NCT01357161|54573756|FG001|Part 1 (Open Label Run-in)|Death|0|||
28003253|NCT00790400|54662023|FG000|Everolimus Period (Core or Extension)|Lost to Follow-up|1|||
28003254|NCT00790400|54662024|FG001|Everolimus Period (Core or Extension)|Lost to Follow-up|0|||
28100416|NCT03131440|54756842|FG017|Overall Study|Death|0|||
28003255|NCT00790400|54662023|FG000|Everolimus Period (Core or Extension)|Administrative problems|2|||
28003256|NCT00790400|54662024|FG001|Everolimus Period (Core or Extension)|Administrative problems|0|||
28003257|NCT00790400|54662023|FG000|Everolimus Period (Core or Extension)|Death|1|||
28003258|NCT00790400|54662024|FG001|Everolimus Period (Core or Extension)|Death|0|||
28003259|NCT00790400|54662023|FG000|Everolimus Period (Core or Extension)|Disease progression|5|||
27739898|NCT02786537|54189678|FG001|As Randomized|Withdrawal by Subject|2|||
27739899|NCT02786537|54189679|FG002|As Randomized|Withdrawal by Subject|0|||
27739900|NCT02786537|54189680|FG003|As Randomized|Withdrawal by Subject|1|||
27739901|NCT02786537|54189681|FG004|As Randomized|Withdrawal by Subject|1|||
27739902|NCT02786537|54189682|FG005|As Randomized|Withdrawal by Subject|0|||
27739903|NCT02786537|54189677|FG000|As Randomized|Death|0|||
27915957|NCT01357161|54573757|FG002|Part 1 (Open Label Run-in)|Death|0|||
27915958|NCT01357161|54573755|FG000|Part 1 (Open Label Run-in)|Lost to Follow-up|3|||
27915959|NCT01357161|54573756|FG001|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
27915960|NCT01357161|54573757|FG002|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
27915961|NCT01357161|54573755|FG000|Part 1 (Open Label Run-in)|Physician Decision|1|||
27915962|NCT01357161|54573756|FG001|Part 1 (Open Label Run-in)|Physician Decision|0|||
27915963|NCT01357161|54573757|FG002|Part 1 (Open Label Run-in)|Physician Decision|0|||
27915964|NCT01357161|54573755|FG000|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5|||
27915965|NCT01357161|54573756|FG001|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
27915966|NCT01357161|54573757|FG002|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
27915967|NCT01357161|54573755|FG000|Part 1 (Open Label Run-in)|Withdrawal by Subject|1|||
27915968|NCT01357161|54573756|FG001|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
27915969|NCT01357161|54573757|FG002|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
27915970|NCT01357161|54573755|FG000|Part 2 (Double-Blind Comparison)|Death|0|||
27915971|NCT01357161|54573756|FG001|Part 2 (Double-Blind Comparison)|Death|22|||
27915972|NCT01357161|54573757|FG002|Part 2 (Double-Blind Comparison)|Death|19|||
27915973|NCT01357161|54573755|FG000|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0|||
27915974|NCT01357161|54573756|FG001|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1|||
27915975|NCT01357161|54573757|FG002|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6|||
27915976|NCT01357161|54573755|FG000|Part 2 (Double-Blind Comparison)|Physician Decision|0|||
27915977|NCT01357161|54573756|FG001|Part 2 (Double-Blind Comparison)|Physician Decision|1|||
27915978|NCT01357161|54573757|FG002|Part 2 (Double-Blind Comparison)|Physician Decision|4|||
27915979|NCT01357161|54573755|FG000|Part 2 (Double-Blind Comparison)|Progressive Disease|0|||
27915980|NCT01357161|54573756|FG001|Part 2 (Double-Blind Comparison)|Progressive Disease|1|||
27915981|NCT01357161|54573757|FG002|Part 2 (Double-Blind Comparison)|Progressive Disease|3|||
27915982|NCT01357161|54573755|FG000|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0|||
27915983|NCT01357161|54573756|FG001|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29|||
27915984|NCT01357161|54573757|FG002|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26|||
27915985|NCT01357161|54573755|FG000|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0|||
27915986|NCT01357161|54573756|FG001|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5|||
27915987|NCT01357161|54573757|FG002|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4|||
27915988|NCT01351350|54573770|FG000|Overall Study|Disease Progression|5|||
27915989|NCT01351350|54573771|FG001|Overall Study|Disease Progression|13|||
27915990|NCT01351350|54573772|FG002|Overall Study|Disease Progression|6|||
27915991|NCT01351350|54573773|FG003|Overall Study|Disease Progression|8|||
27915992|NCT01351350|54573774|FG004|Overall Study|Disease Progression|5|||
27915993|NCT01351350|54573770|FG000|Overall Study|Adverse Event|1|||
27915994|NCT01351350|54573771|FG001|Overall Study|Adverse Event|10|||
27915995|NCT01351350|54573772|FG002|Overall Study|Adverse Event|1|||
27915996|NCT01351350|54573773|FG003|Overall Study|Adverse Event|2|||
27915997|NCT01351350|54573774|FG004|Overall Study|Adverse Event|0|||
27915998|NCT01351350|54573770|FG000|Overall Study|Participant Decision|2|||
27915999|NCT01351350|54573771|FG001|Overall Study|Participant Decision|6|||
27916000|NCT01351350|54573772|FG002|Overall Study|Participant Decision|3|||
27916001|NCT01351350|54573773|FG003|Overall Study|Participant Decision|3|||
27916002|NCT01351350|54573774|FG004|Overall Study|Participant Decision|2|||
27916003|NCT01351350|54573770|FG000|Overall Study|Enrolled but not Treated|0|||
27916004|NCT01351350|54573771|FG001|Overall Study|Enrolled but not Treated|0|||
27916005|NCT01351350|54573772|FG002|Overall Study|Enrolled but not Treated|1|||
27916006|NCT01351350|54573773|FG003|Overall Study|Enrolled but not Treated|0|||
27916007|NCT01351350|54573774|FG004|Overall Study|Enrolled but not Treated|0|||
27916008|NCT01350999|54573802|FG000|Overall Study|Adverse Event|4|||
27916009|NCT01350999|54573803|FG001|Overall Study|Adverse Event|9|||
27916010|NCT01350999|54573804|FG002|Overall Study|Adverse Event|10|||
28003260|NCT00790400|54662024|FG001|Everolimus Period (Core or Extension)|Disease progression|0|||
27739904|NCT02786537|54189678|FG001|As Randomized|Death|2|||
27739905|NCT02786537|54189679|FG002|As Randomized|Death|0|||
27916011|NCT01350999|54573802|FG000|Overall Study|Voluntary withdrawal|3|||
27916012|NCT01350999|54573803|FG001|Overall Study|Voluntary withdrawal|4|||
27916013|NCT01350999|54573804|FG002|Overall Study|Voluntary withdrawal|6|||
27916014|NCT01350999|54573802|FG000|Overall Study|Difficulty Making it to Study Visit|1|||
27916015|NCT01350999|54573803|FG001|Overall Study|Difficulty Making it to Study Visit|1|||
27916016|NCT01350999|54573804|FG002|Overall Study|Difficulty Making it to Study Visit|5|||
27916017|NCT01330914|54573823|FG000|Overall Study|Withdrawal by Subject|4|||
27916018|NCT01330914|54573823|FG000|Overall Study|No longer eligible (sleeve gastrectomy)|3|||
27916019|NCT01350804|54573831|FG000|Core Study|Withdrawal by Subject|11|||
27916020|NCT01350804|54573832|FG001|Core Study|Withdrawal by Subject|17|||
27916021|NCT01350804|54573833|FG002|Core Study|Withdrawal by Subject|16|||
27916022|NCT01350804|54573834|FG003|Core Study|Withdrawal by Subject|7|||
27916023|NCT01350804|54573831|FG000|Core Study|Study terminated by Sponsor|0|||
27916024|NCT01350804|54573832|FG001|Core Study|Study terminated by Sponsor|0|||
27916025|NCT01350804|54573833|FG002|Core Study|Study terminated by Sponsor|0|||
27916026|NCT01350804|54573834|FG003|Core Study|Study terminated by Sponsor|2|||
27916027|NCT01350804|54573831|FG000|Core Study|Protocol deviation|1|||
27916028|NCT01350804|54573832|FG001|Core Study|Protocol deviation|0|||
27916029|NCT01350804|54573833|FG002|Core Study|Protocol deviation|1|||
27916030|NCT01350804|54573834|FG003|Core Study|Protocol deviation|0|||
27916031|NCT01350804|54573831|FG000|Core Study|Physician Decision|1|||
27916032|NCT01350804|54573832|FG001|Core Study|Physician Decision|0|||
27916033|NCT01350804|54573833|FG002|Core Study|Physician Decision|1|||
27916034|NCT01350804|54573834|FG003|Core Study|Physician Decision|3|||
27916035|NCT01350804|54573831|FG000|Core Study|Lost to Follow-up|3|||
27916036|NCT01350804|54573832|FG001|Core Study|Lost to Follow-up|0|||
27916037|NCT01350804|54573833|FG002|Core Study|Lost to Follow-up|2|||
27916038|NCT01350804|54573834|FG003|Core Study|Lost to Follow-up|1|||
27916039|NCT01350804|54573831|FG000|Core Study|Lack of Efficacy|16|||
27916040|NCT01350804|54573832|FG001|Core Study|Lack of Efficacy|19|||
27916041|NCT01350804|54573833|FG002|Core Study|Lack of Efficacy|18|||
27916042|NCT01350804|54573834|FG003|Core Study|Lack of Efficacy|5|||
27916043|NCT01350804|54573831|FG000|Core Study|Death|1|||
27916044|NCT01350804|54573832|FG001|Core Study|Death|1|||
27916045|NCT01350804|54573833|FG002|Core Study|Death|1|||
27916046|NCT01350804|54573834|FG003|Core Study|Death|0|||
27916047|NCT01350804|54573831|FG000|Core Study|Adverse Event|8|||
27916048|NCT01350804|54573832|FG001|Core Study|Adverse Event|10|||
27916049|NCT01350804|54573833|FG002|Core Study|Adverse Event|8|||
27916050|NCT01350804|54573834|FG003|Core Study|Adverse Event|8|||
27916051|NCT01350804|54573831|FG000|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5|||
27916052|NCT01350804|54573832|FG001|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6|||
27916053|NCT01350804|54573833|FG002|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4|||
27916054|NCT01350804|54573834|FG003|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3|||
27916055|NCT01350804|54573831|FG000|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
27916056|NCT01350804|54573832|FG001|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
27916057|NCT01350804|54573833|FG002|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64|||
27916058|NCT01350804|54573834|FG003|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16|||
27916059|NCT01350804|54573831|FG000|Extension Study, Weeks 52 - 260|Physician Decision|1|||
27916060|NCT01350804|54573832|FG001|Extension Study, Weeks 52 - 260|Physician Decision|0|||
27916061|NCT01350804|54573833|FG002|Extension Study, Weeks 52 - 260|Physician Decision|2|||
27916062|NCT01350804|54573834|FG003|Extension Study, Weeks 52 - 260|Physician Decision|0|||
27916063|NCT01350804|54573831|FG000|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
27916064|NCT01350804|54573832|FG001|Extension Study, Weeks 52 - 260|Lost to Follow-up|1|||
27916065|NCT01350804|54573833|FG002|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
27916066|NCT01350804|54573834|FG003|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
27916067|NCT01350804|54573831|FG000|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
27916068|NCT01350804|54573832|FG001|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
28003261|NCT00790400|54662023|FG000|Everolimus Period (Core or Extension)|Protocol Violation|1|||
28003262|NCT00790400|54662024|FG001|Everolimus Period (Core or Extension)|Protocol Violation|0|||
28003263|NCT00790400|54662023|FG000|Everolimus Period (Core or Extension)|New treatment|2|||
28003264|NCT00790400|54662024|FG001|Everolimus Period (Core or Extension)|New treatment|0|||
28003265|NCT00786032|54662033|FG000|Overall Study|Death|4|||
28003266|NCT00786032|54662033|FG000|Overall Study|Withdrawal by Subject|14|||
28003267|NCT00786032|54662033|FG000|Overall Study|Did not complete in the timeframe|6|||
28003268|NCT00785486|54662039|FG000|Midazolam Alone|Withdrawal by Subject|1|||
28003269|NCT00589979|54662062|FG000|Run-In Period|Adverse Event|5|||
28003270|NCT00589979|54662063|FG001|Run-In Period|Adverse Event|0|||
28003271|NCT00589979|54662064|FG002|Run-In Period|Adverse Event|0|||
28100417|NCT03131440|54756843|FG018|Overall Study|Death|0|||
28100418|NCT03131440|54756844|FG019|Overall Study|Death|0|||
27916069|NCT01350804|54573833|FG002|Extension Study, Weeks 52 - 260|Lack of Efficacy|0|||
27916070|NCT01350804|54573834|FG003|Extension Study, Weeks 52 - 260|Lack of Efficacy|1|||
27916071|NCT01350804|54573831|FG000|Extension Study, Weeks 52 - 260|Adverse Event|3|||
27916072|NCT01350804|54573832|FG001|Extension Study, Weeks 52 - 260|Adverse Event|1|||
27916073|NCT01350804|54573833|FG002|Extension Study, Weeks 52 - 260|Adverse Event|2|||
27916074|NCT01350804|54573834|FG003|Extension Study, Weeks 52 - 260|Adverse Event|3|||
28003272|NCT00589979|54662062|FG000|Run-In Period|Protocol Violation|3|||
27916075|NCT01350492|54573856|FG000|Intervention|Lost to Follow-up|2|||
27916076|NCT01350492|54573857|FG001|Intervention|Lost to Follow-up|5|||
27916077|NCT01350492|54573856|FG000|Intervention|Withdrawal by Subject|3|||
27916078|NCT01350492|54573857|FG001|Intervention|Withdrawal by Subject|1|||
27916079|NCT01350492|54573856|FG000|Post Intervention Follow-Up|Lost to Follow-up|6|||
27916080|NCT01350492|54573857|FG001|Post Intervention Follow-Up|Lost to Follow-up|1|||
27916081|NCT01350492|54573856|FG000|Post Intervention Follow-Up|Withdrawal by Subject|0|||
27916082|NCT01350492|54573857|FG001|Post Intervention Follow-Up|Withdrawal by Subject|1|||
27916083|NCT02270957|54573865|FG000|Overall Study|Lack of Efficacy|2|||
27916084|NCT02270957|54573866|FG001|Overall Study|Lack of Efficacy|4|||
27916085|NCT02270957|54573865|FG000|Overall Study|Adverse Event|2|||
27916086|NCT02270957|54573866|FG001|Overall Study|Adverse Event|0|||
27916087|NCT01350414|54573873|FG000|Overall Study|Lost to Follow-up|13|||
27916088|NCT01350414|54573873|FG000|Overall Study|Withdrawal by Subject|4|||
27916089|NCT01350414|54573873|FG000|Overall Study|Physician Decision|2|||
27916090|NCT01350336|54573883|FG000|Overall Study|Lost to Follow-up|31|||
27916091|NCT01350336|54573883|FG000|Overall Study|Withdrawal by Subject|14|||
27916092|NCT01350336|54573883|FG000|Overall Study|Physician Decision|8|||
27916093|NCT01350336|54573883|FG000|Overall Study|Death|4|||
27916094|NCT01349049|54573941|FG000|Overall Study|Disease progression|3|||
27916095|NCT01349049|54573942|FG001|Overall Study|Disease progression|5|||
27916096|NCT01349049|54573943|FG002|Overall Study|Disease progression|3|||
27916097|NCT01349049|54573944|FG003|Overall Study|Disease progression|2|||
27916098|NCT01349049|54573945|FG004|Overall Study|Disease progression|2|||
27916099|NCT01349049|54573946|FG005|Overall Study|Disease progression|2|||
27916100|NCT01349049|54573947|FG006|Overall Study|Disease progression|3|||
27916101|NCT01349049|54573948|FG007|Overall Study|Disease progression|2|||
27916102|NCT01349049|54573949|FG008|Overall Study|Disease progression|33|||
27916103|NCT01349049|54573941|FG000|Overall Study|Adverse Event|0|||
27916104|NCT01349049|54573942|FG001|Overall Study|Adverse Event|1|||
27916105|NCT01349049|54573943|FG002|Overall Study|Adverse Event|0|||
27916106|NCT01349049|54573944|FG003|Overall Study|Adverse Event|0|||
27916107|NCT01349049|54573945|FG004|Overall Study|Adverse Event|0|||
27916108|NCT01349049|54573946|FG005|Overall Study|Adverse Event|3|||
27916109|NCT01349049|54573947|FG006|Overall Study|Adverse Event|1|||
27916110|NCT01349049|54573948|FG007|Overall Study|Adverse Event|0|||
27916111|NCT01349049|54573949|FG008|Overall Study|Adverse Event|4|||
27916112|NCT01349049|54573941|FG000|Overall Study|Physician Decision|0|||
27916113|NCT01349049|54573942|FG001|Overall Study|Physician Decision|1|||
27916114|NCT01349049|54573943|FG002|Overall Study|Physician Decision|0|||
27916115|NCT01349049|54573944|FG003|Overall Study|Physician Decision|0|||
27916116|NCT01349049|54573945|FG004|Overall Study|Physician Decision|0|||
27916117|NCT01349049|54573946|FG005|Overall Study|Physician Decision|0|||
27916118|NCT01349049|54573947|FG006|Overall Study|Physician Decision|0|||
27916119|NCT01349049|54573948|FG007|Overall Study|Physician Decision|0|||
27916120|NCT01349049|54573949|FG008|Overall Study|Physician Decision|2|||
27916121|NCT01349049|54573941|FG000|Overall Study|Protocol Violation|0|||
27916122|NCT01349049|54573942|FG001|Overall Study|Protocol Violation|0|||
28003273|NCT00589979|54662063|FG001|Run-In Period|Protocol Violation|0|||
28003274|NCT00589979|54662064|FG002|Run-In Period|Protocol Violation|0|||
28003275|NCT00589979|54662062|FG000|Run-In Period|Did not qualify for randomization|54|||
28003276|NCT00589979|54662063|FG001|Run-In Period|Did not qualify for randomization|0|||
28003277|NCT00589979|54662064|FG002|Run-In Period|Did not qualify for randomization|0|||
28003278|NCT00589979|54662062|FG000|Run-In Period|Withdrawal by Subject|10|||
28003279|NCT00589979|54662063|FG001|Run-In Period|Withdrawal by Subject|0|||
28003280|NCT00589979|54662064|FG002|Run-In Period|Withdrawal by Subject|0|||
28003281|NCT00589979|54662062|FG000|Run-In Period|Informed Consent Withdrawn|4|||
28003282|NCT00589979|54662063|FG001|Run-In Period|Informed Consent Withdrawn|0|||
28003283|NCT00589979|54662064|FG002|Run-In Period|Informed Consent Withdrawn|0|||
28003284|NCT00589979|54662062|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
28003285|NCT00589979|54662063|FG001|Double-Blind Treatment Period 1|Adverse Event|1|||
28003286|NCT00589979|54662064|FG002|Double-Blind Treatment Period 1|Adverse Event|0|||
28003287|NCT00589979|54662062|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
28003288|NCT00589979|54662063|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
28003289|NCT00589979|54662064|FG002|Double-Blind Treatment Period 1|Protocol Violation|1|||
28003290|NCT00589979|54662062|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
28003291|NCT00589979|54662063|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
28003292|NCT00589979|54662064|FG002|Double-Blind Treatment Period 1|Withdrawal by Subject|1|||
28003293|NCT00589979|54662062|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
27916123|NCT01349049|54573943|FG002|Overall Study|Protocol Violation|0|||
27916124|NCT01349049|54573944|FG003|Overall Study|Protocol Violation|0|||
27916125|NCT01349049|54573945|FG004|Overall Study|Protocol Violation|0|||
27916126|NCT01349049|54573946|FG005|Overall Study|Protocol Violation|0|||
27916127|NCT01349049|54573947|FG006|Overall Study|Protocol Violation|0|||
28003294|NCT00589979|54662063|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
27916128|NCT01349049|54573948|FG007|Overall Study|Protocol Violation|0|||
27916129|NCT01349049|54573949|FG008|Overall Study|Protocol Violation|1|||
27916130|NCT01349049|54573941|FG000|Overall Study|Hematopoietic stem cell transplant|0|||
28003295|NCT00589979|54662064|FG002|Double-Blind Treatment Period 2|Adverse Event|0|||
28003296|NCT00589979|54662062|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
28003297|NCT00589979|54662063|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
28003298|NCT00589979|54662064|FG002|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
28003299|NCT00589979|54662062|FG000|Double-Blind Treatment Period 2|Other|0|||
28003300|NCT00589979|54662063|FG001|Double-Blind Treatment Period 2|Other|0|||
28003301|NCT00589979|54662064|FG002|Double-Blind Treatment Period 2|Other|1|||
28003302|NCT00589979|54662062|FG000|Double-Blind Treatment Period 3|Protocol Violation|0|||
28003303|NCT00589979|54662063|FG001|Double-Blind Treatment Period 3|Protocol Violation|1|||
28003304|NCT00589979|54662064|FG002|Double-Blind Treatment Period 3|Protocol Violation|0|||
28003305|NCT00589979|54662062|FG000|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
28003306|NCT00589979|54662063|FG001|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
28003307|NCT00589979|54662064|FG002|Double-Blind Treatment Period 3|Withdrawal by Subject|1|||
28003308|NCT00797732|54662078|FG000|Overall Study|Withdrawal by Subject|3|||
28003309|NCT00797732|54662079|FG001|Overall Study|Withdrawal by Subject|3|||
28003310|NCT00797732|54662080|FG002|Overall Study|Withdrawal by Subject|0|||
28003311|NCT00797732|54662078|FG000|Overall Study|Lost to Follow-up|1|||
28003312|NCT00797732|54662079|FG001|Overall Study|Lost to Follow-up|0|||
28003313|NCT00797732|54662080|FG002|Overall Study|Lost to Follow-up|0|||
28003314|NCT00797732|54662078|FG000|Overall Study|Death|1|||
28003315|NCT00797732|54662079|FG001|Overall Study|Death|0|||
28003316|NCT00797732|54662080|FG002|Overall Study|Death|0|||
28003317|NCT00797732|54662078|FG000|Overall Study|Not meet inclusion criteria|0|||
28003318|NCT00797732|54662079|FG001|Overall Study|Not meet inclusion criteria|0|||
28003319|NCT00797732|54662080|FG002|Overall Study|Not meet inclusion criteria|7|||
28003320|NCT00797732|54662078|FG000|Overall Study|Excluded due to time constraints|0|||
28003321|NCT00797732|54662079|FG001|Overall Study|Excluded due to time constraints|0|||
28003322|NCT00797732|54662080|FG002|Overall Study|Excluded due to time constraints|24|||
28003323|NCT00797732|54662078|FG000|Overall Study|Refused to Participate|0|||
28003324|NCT00797732|54662079|FG001|Overall Study|Refused to Participate|0|||
28003325|NCT00797732|54662080|FG002|Overall Study|Refused to Participate|123|||
28003326|NCT00790088|54662086|FG000|Overall Study|Protocol Violation|11|||
28003327|NCT00790088|54662086|FG000|Overall Study|Withdrawal by Subject|17|||
28003328|NCT00790088|54662086|FG000|Overall Study|Lost to Follow-up|7|||
28003329|NCT00790088|54662086|FG000|Overall Study|Physician Decision|4|||
28003330|NCT00736944|54662092|FG000|Induction|Death|1|||
28003331|NCT00736944|54662092|FG000|Definitive Treatment|Physician Decision|1|||
28003332|NCT00736476|54662101|FG000|Overall Study|Adverse Event|1|||
28003333|NCT00736476|54662102|FG001|Overall Study|Adverse Event|0|||
28003334|NCT00715299|54662114|FG000|Overall Study|Withdrawal by Subject|1|||
28003335|NCT00715299|54662114|FG000|Overall Study|Adverse Event|3|||
28003336|NCT00715299|54662114|FG000|Overall Study|failed the pre-screen exercise test|2|||
28003337|NCT00730236|54662118|FG000|Overall Study|Adverse Event|4|||
28003338|NCT00730236|54662118|FG000|Overall Study|Withdrawal by Subject|1|||
28003339|NCT00730236|54662118|FG000|Overall Study|Non-compliance|1|||
28003340|NCT00714285|54662126|FG000|Overall Study|Lost to Follow-up|0|||
28003341|NCT00714285|54662127|FG001|Overall Study|Lost to Follow-up|2|||
28003342|NCT00714285|54662128|FG002|Overall Study|Lost to Follow-up|0|||
28003343|NCT00714285|54662129|FG003|Overall Study|Lost to Follow-up|1|||
28003344|NCT00714285|54662126|FG000|Overall Study|Migrated/moved from study area|0|||
28003345|NCT00714285|54662127|FG001|Overall Study|Migrated/moved from study area|1|||
28003346|NCT00714285|54662128|FG002|Overall Study|Migrated/moved from study area|0|||
28003347|NCT00714285|54662129|FG003|Overall Study|Migrated/moved from study area|0|||
28003348|NCT00776984|54662143|FG000|Overall Study|Adverse Event|8|||
28003349|NCT00776984|54662144|FG001|Overall Study|Adverse Event|2|||
28003350|NCT00776984|54662143|FG000|Overall Study|Protocol Violation|4|||
28003351|NCT00776984|54662144|FG001|Overall Study|Protocol Violation|2|||
28003352|NCT00776984|54662143|FG000|Overall Study|Lost to Follow-up|2|||
28003353|NCT00776984|54662144|FG001|Overall Study|Lost to Follow-up|0|||
28003354|NCT00776984|54662143|FG000|Overall Study|Withdrawal by Subject|12|||
28003355|NCT00776984|54662144|FG001|Overall Study|Withdrawal by Subject|7|||
28003356|NCT00776984|54662143|FG000|Overall Study|Lack of Efficacy|0|||
28003357|NCT00776984|54662144|FG001|Overall Study|Lack of Efficacy|1|||
28003358|NCT00776984|54662143|FG000|Overall Study|Other|5|||
28003359|NCT00776984|54662144|FG001|Overall Study|Other|9|||
28003360|NCT00714051|54662152|FG000|Overall Study|Withdrawal by Subject|1|||
28003361|NCT00714051|54662153|FG001|Overall Study|Withdrawal by Subject|0|||
28003362|NCT00714051|54662152|FG000|Overall Study|Death|0|||
28003363|NCT00714051|54662153|FG001|Overall Study|Death|1|||
28003364|NCT00784784|54662161|FG000|Overall Study|Withdrawal by Subject|2|||
28003365|NCT00784784|54662162|FG001|Overall Study|Withdrawal by Subject|2|||
28003366|NCT00801983|54662170|FG000|Period 1|Lost to Follow-up|2|||
28003367|NCT00801983|54662171|FG001|Period 1|Lost to Follow-up|0|||
28003368|NCT00801983|54662170|FG000|Period 1|Withdrawal by Subject|2|||
28003369|NCT00801983|54662171|FG001|Period 1|Withdrawal by Subject|8|||
28003370|NCT00801983|54662170|FG000|Period 2|Withdrawal by Subject|2|||
28003371|NCT00801983|54662171|FG001|Period 2|Withdrawal by Subject|1|||
28003372|NCT00587288|54662179|FG000|Overall Study|Adverse Event|0|||
28003373|NCT00587288|54662180|FG001|Overall Study|Adverse Event|1|||
28003374|NCT00587288|54662179|FG000|Overall Study|Lack of Efficacy|2|||
28003375|NCT00587288|54662180|FG001|Overall Study|Lack of Efficacy|8|||
28003376|NCT00587288|54662179|FG000|Overall Study|Protocol Violation|1|||
28003377|NCT00587288|54662180|FG001|Overall Study|Protocol Violation|0|||
28003378|NCT00800735|54662188|FG000|Overall Study|Administrative/Other|2|||
28003379|NCT00800735|54662188|FG000|Overall Study|Insufficient Therapeutic Response|2|||
28003380|NCT00800735|54662188|FG000|Overall Study|Violation of Selection Criteria at Entry|7|||
28003381|NCT00800735|54662188|FG000|Overall Study|Withdrew Consent|3|||
28003382|NCT00730158|54662194|FG000|Overall Study|Withdrawal by Subject|1|||
28003383|NCT00730158|54662195|FG001|Overall Study|Withdrawal by Subject|1|||
28003384|NCT00784550|54662207|FG000|Overall Study|Adverse Event|12|||
28003385|NCT00784550|54662208|FG001|Overall Study|Adverse Event|10|||
28003386|NCT00784550|54662207|FG000|Overall Study|Lack of Efficacy|0|||
28003387|NCT00784550|54662208|FG001|Overall Study|Lack of Efficacy|1|||
28003388|NCT00784550|54662207|FG000|Overall Study|Protocol Violation|10|||
28003389|NCT00784550|54662208|FG001|Overall Study|Protocol Violation|10|||
27916131|NCT01349049|54573942|FG001|Overall Study|Hematopoietic stem cell transplant|0|||
27916132|NCT01349049|54573943|FG002|Overall Study|Hematopoietic stem cell transplant|0|||
27916133|NCT01349049|54573944|FG003|Overall Study|Hematopoietic stem cell transplant|0|||
27916134|NCT01349049|54573945|FG004|Overall Study|Hematopoietic stem cell transplant|1|||
27916135|NCT01349049|54573946|FG005|Overall Study|Hematopoietic stem cell transplant|0|||
27916136|NCT01349049|54573947|FG006|Overall Study|Hematopoietic stem cell transplant|1|||
27916137|NCT01349049|54573948|FG007|Overall Study|Hematopoietic stem cell transplant|1|||
27916138|NCT01349049|54573949|FG008|Overall Study|Hematopoietic stem cell transplant|0|||
27916139|NCT01349049|54573941|FG000|Overall Study|Other|0|||
27916140|NCT01349049|54573942|FG001|Overall Study|Other|0|||
27916141|NCT01349049|54573943|FG002|Overall Study|Other|0|||
27916142|NCT01349049|54573944|FG003|Overall Study|Other|0|||
27916143|NCT01349049|54573945|FG004|Overall Study|Other|0|||
27916144|NCT01349049|54573946|FG005|Overall Study|Other|1|||
27916145|NCT01349049|54573947|FG006|Overall Study|Other|0|||
27916146|NCT01349049|54573948|FG007|Overall Study|Other|0|||
27916147|NCT01349049|54573949|FG008|Overall Study|Other|4|||
27916148|NCT01349049|54573941|FG000|Overall Study|Death|0|||
27916149|NCT01349049|54573942|FG001|Overall Study|Death|0|||
27916150|NCT01349049|54573943|FG002|Overall Study|Death|0|||
27916151|NCT01349049|54573944|FG003|Overall Study|Death|0|||
27916152|NCT01349049|54573945|FG004|Overall Study|Death|0|||
27916153|NCT01349049|54573946|FG005|Overall Study|Death|0|||
27916154|NCT01349049|54573947|FG006|Overall Study|Death|0|||
27916155|NCT01349049|54573948|FG007|Overall Study|Death|1|||
27916156|NCT01349049|54573949|FG008|Overall Study|Death|5|||
27916157|NCT01349049|54573941|FG000|Overall Study|Non-compliance|0|||
27916158|NCT01349049|54573942|FG001|Overall Study|Non-compliance|0|||
27916159|NCT01349049|54573943|FG002|Overall Study|Non-compliance|0|||
27916160|NCT01349049|54573944|FG003|Overall Study|Non-compliance|1|||
28003390|NCT00784550|54662207|FG000|Overall Study|Lost to Follow-up|8|||
28003391|NCT00784550|54662208|FG001|Overall Study|Lost to Follow-up|5|||
28003392|NCT00784550|54662207|FG000|Overall Study|Physician Decision|2|||
28003393|NCT00784550|54662208|FG001|Overall Study|Physician Decision|3|||
28003394|NCT00784550|54662207|FG000|Overall Study|Withdrawal by Subject|4|||
28003395|NCT00784550|54662208|FG001|Overall Study|Withdrawal by Subject|13|||
28003396|NCT00729690|54662217|FG000|Overall Study|IT Catheter Malfunction|0|||
28003397|NCT00729690|54662218|FG001|Overall Study|IT Catheter Malfunction|2|||
28003398|NCT00729690|54662219|FG002|Overall Study|IT Catheter Malfunction|2|||
28003399|NCT00784238|54662227|FG000|Overall Study|Adverse Event|14|||
28003400|NCT00784238|54662227|FG000|Overall Study|Death|2|||
28003401|NCT00784238|54662227|FG000|Overall Study|Lack of Efficacy|33|||
28003402|NCT00784238|54662227|FG000|Overall Study|Lost to Follow-up|29|||
28003403|NCT00784238|54662227|FG000|Overall Study|Pregnancy|1|||
27739906|NCT02786537|54189680|FG003|As Randomized|Death|3|||
27916161|NCT01349049|54573945|FG004|Overall Study|Non-compliance|0|||
27916162|NCT01349049|54573946|FG005|Overall Study|Non-compliance|0|||
27916163|NCT01349049|54573947|FG006|Overall Study|Non-compliance|0|||
27916164|NCT01349049|54573948|FG007|Overall Study|Non-compliance|0|||
27916165|NCT01349049|54573949|FG008|Overall Study|Non-compliance|0|||
27916166|NCT01349049|54573941|FG000|Overall Study|Withdrawal by Subject|0|||
27916167|NCT01349049|54573942|FG001|Overall Study|Withdrawal by Subject|0|||
28003404|NCT00784238|54662227|FG000|Overall Study|Withdrawal by Subject|26|||
28003405|NCT00784238|54662227|FG000|Overall Study|Other|14|||
28003406|NCT00729612|54662234|FG000|Overall Study|Non evaluable for response|10|||
28003407|NCT00585546|54662238|FG000|Clenbuterol Treatment - up to 12 Months|Death|1|||
27916168|NCT01349049|54573943|FG002|Overall Study|Withdrawal by Subject|0|||
27916169|NCT01349049|54573944|FG003|Overall Study|Withdrawal by Subject|0|||
27916170|NCT01349049|54573945|FG004|Overall Study|Withdrawal by Subject|0|||
27916171|NCT01349049|54573946|FG005|Overall Study|Withdrawal by Subject|0|||
27916172|NCT01349049|54573947|FG006|Overall Study|Withdrawal by Subject|0|||
28003408|NCT00585546|54662238|FG000|Clenbuterol Treatment - up to 12 Months|Adverse Event|3|||
28003409|NCT00768248|54662244|FG000|Overall Study|Research coordinator didn't collect data|1|||
28003410|NCT00768248|54662245|FG001|Overall Study|Research coordinator didn't collect data|1|||
28003411|NCT00775268|54662253|FG000|Baseline|Drug not synthesize dose|1|||
28003412|NCT00775268|54662254|FG001|Baseline|Drug not synthesize dose|0|||
28003413|NCT00775268|54662253|FG000|Baseline|Not treated-ineligible per CT|0|||
28003414|NCT00775268|54662254|FG001|Baseline|Not treated-ineligible per CT|1|||
28003415|NCT00775268|54662253|FG000|After 2 Cycles|Participant refused to be scanned further|1|||
28003416|NCT00775268|54662254|FG001|After 2 Cycles|Participant refused to be scanned further|0|||
28003417|NCT00775268|54662253|FG000|After Completion|Participant missed scan appointment|1|||
28003418|NCT00775268|54662254|FG001|After Completion|Participant missed scan appointment|0|||
28003419|NCT00775190|54662273|FG000|Overall Study|Lost to Follow-up|2|||
28003420|NCT00775190|54662274|FG001|Overall Study|Lost to Follow-up|3|||
28003421|NCT00775190|54662273|FG000|Overall Study|Withdrawal by Subject|1|||
28003422|NCT00775190|54662274|FG001|Overall Study|Withdrawal by Subject|2|||
28003423|NCT00775190|54662273|FG000|Overall Study|Protocol Violation|1|||
28003424|NCT00775190|54662274|FG001|Overall Study|Protocol Violation|0|||
28003425|NCT00479557|54662287|FG000|Overall Study|Death|0|||
28003426|NCT00479557|54662288|FG001|Overall Study|Death|0|||
28003427|NCT00479557|54662289|FG002|Overall Study|Death|0|||
28003428|NCT00479557|54662290|FG003|Overall Study|Death|0|||
28003429|NCT00479557|54662291|FG004|Overall Study|Death|0|||
28003430|NCT00479557|54662292|FG005|Overall Study|Death|1|||
28003431|NCT00479557|54662293|FG006|Overall Study|Death|0|||
28003432|NCT00479557|54662287|FG000|Overall Study|Lack of Efficacy|1|||
27916173|NCT01349049|54573948|FG007|Overall Study|Withdrawal by Subject|0|||
27916174|NCT01349049|54573949|FG008|Overall Study|Withdrawal by Subject|6|||
27916175|NCT01348854|54573983|FG000|Overall Study|Lost to Follow-up|2|||
27916176|NCT01348854|54573984|FG001|Overall Study|Lost to Follow-up|1|||
27916177|NCT01348854|54573983|FG000|Overall Study|Withdrawal by Subject|1|||
27916178|NCT01348854|54573984|FG001|Overall Study|Withdrawal by Subject|0|||
28003433|NCT00479557|54662288|FG001|Overall Study|Lack of Efficacy|0|||
28003434|NCT00479557|54662289|FG002|Overall Study|Lack of Efficacy|0|||
28003435|NCT00479557|54662290|FG003|Overall Study|Lack of Efficacy|0|||
28003436|NCT00479557|54662291|FG004|Overall Study|Lack of Efficacy|0|||
28003437|NCT00479557|54662292|FG005|Overall Study|Lack of Efficacy|0|||
28003438|NCT00479557|54662293|FG006|Overall Study|Lack of Efficacy|0|||
28003439|NCT00479557|54662287|FG000|Overall Study|Lost to Follow-up|0|||
28003440|NCT00479557|54662288|FG001|Overall Study|Lost to Follow-up|2|||
27739907|NCT02786537|54189681|FG004|As Randomized|Death|1|||
27739908|NCT02786537|54189682|FG005|As Randomized|Death|0|||
27739909|NCT02786537|54189677|FG000|As Randomized|Non-compliance with study drug|1|||
27739910|NCT02786537|54189678|FG001|As Randomized|Non-compliance with study drug|11|||
27916179|NCT01348776|54573990|FG000|Overall Study|Lost to Follow-up|3|||
27916180|NCT01348698|54574003|FG000|Overall Study|Does not meet lesion size criteria|1|||
27916181|NCT01348698|54574003|FG000|Overall Study|Death|3|||
27916182|NCT01348698|54574003|FG000|Overall Study|PI decision to close study|68|||
28003441|NCT00479557|54662289|FG002|Overall Study|Lost to Follow-up|0|||
28003442|NCT00479557|54662290|FG003|Overall Study|Lost to Follow-up|2|||
28003443|NCT00479557|54662291|FG004|Overall Study|Lost to Follow-up|0|||
28003444|NCT00479557|54662292|FG005|Overall Study|Lost to Follow-up|0|||
27916183|NCT01348542|54574009|FG000|Overall Study|Withdrawal by Subject|3|||
28003445|NCT00479557|54662293|FG006|Overall Study|Lost to Follow-up|0|||
28003446|NCT00479557|54662287|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
28003447|NCT00479557|54662288|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
28003448|NCT00479557|54662289|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
28100419|NCT03131440|54756845|FG020|Overall Study|Death|0|||
27739911|NCT02786537|54189679|FG002|As Randomized|Non-compliance with study drug|0|||
27916184|NCT01348542|54574010|FG001|Overall Study|Withdrawal by Subject|0|||
27916185|NCT01346709|54574016|FG000|Overall Study|Protocol Violation|35|||
27916186|NCT01346709|54574016|FG000|Overall Study|Lost to Follow-up|31|||
27916187|NCT01346709|54574016|FG000|Overall Study|Missing data in candidate risk factor|285|||
27916188|NCT01346592|54574023|FG000|Overall Study|Lost to Follow-up|62|||
27916189|NCT01346592|54574024|FG001|Overall Study|Lost to Follow-up|29|||
27916190|NCT01346592|54574025|FG002|Overall Study|Lost to Follow-up|29|||
27916191|NCT01346592|54574023|FG000|Overall Study|Protocol Violation|2|||
27916192|NCT01346592|54574024|FG001|Overall Study|Protocol Violation|1|||
27916193|NCT01346592|54574025|FG002|Overall Study|Protocol Violation|0|||
27916194|NCT01346592|54574023|FG000|Overall Study|Death|1|||
27916195|NCT01346592|54574024|FG001|Overall Study|Death|3|||
27916196|NCT01346592|54574025|FG002|Overall Study|Death|4|||
27916197|NCT01346592|54574023|FG000|Overall Study|Adverse Event|0|||
27916198|NCT01346592|54574024|FG001|Overall Study|Adverse Event|1|||
28003449|NCT00479557|54662290|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
28003450|NCT00479557|54662291|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
28003451|NCT00479557|54662292|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
28003452|NCT00479557|54662293|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
28003453|NCT00479557|54662287|FG000|Overall Study|AE not related to Study Drug|1|||
28003454|NCT00479557|54662288|FG001|Overall Study|AE not related to Study Drug|3|||
28003455|NCT00479557|54662289|FG002|Overall Study|AE not related to Study Drug|0|||
28003456|NCT00479557|54662290|FG003|Overall Study|AE not related to Study Drug|0|||
28003457|NCT00479557|54662291|FG004|Overall Study|AE not related to Study Drug|2|||
28003458|NCT00479557|54662292|FG005|Overall Study|AE not related to Study Drug|2|||
28003459|NCT00479557|54662293|FG006|Overall Study|AE not related to Study Drug|1|||
28003460|NCT00479557|54662287|FG000|Overall Study|Caregiver Request|2|||
28003461|NCT00479557|54662288|FG001|Overall Study|Caregiver Request|2|||
28003462|NCT00479557|54662289|FG002|Overall Study|Caregiver Request|2|||
28003463|NCT00479557|54662290|FG003|Overall Study|Caregiver Request|0|||
28003464|NCT00479557|54662291|FG004|Overall Study|Caregiver Request|1|||
28003465|NCT00479557|54662292|FG005|Overall Study|Caregiver Request|2|||
28003466|NCT00479557|54662293|FG006|Overall Study|Caregiver Request|0|||
28003467|NCT00479557|54662287|FG000|Overall Study|Investigator Request|0|||
28003468|NCT00479557|54662288|FG001|Overall Study|Investigator Request|0|||
28003469|NCT00479557|54662289|FG002|Overall Study|Investigator Request|1|||
28003470|NCT00479557|54662290|FG003|Overall Study|Investigator Request|0|||
28003471|NCT00479557|54662291|FG004|Overall Study|Investigator Request|0|||
27916199|NCT01346592|54574025|FG002|Overall Study|Adverse Event|0|||
27916200|NCT01346592|54574023|FG000|Overall Study|Withdrawal by Subject|77|||
27916201|NCT01346592|54574024|FG001|Overall Study|Withdrawal by Subject|51|||
27916202|NCT01346592|54574025|FG002|Overall Study|Withdrawal by Subject|38|||
27916203|NCT01346592|54574023|FG000|Overall Study|Inappropriate enrollment|3|||
27916204|NCT01346592|54574024|FG001|Overall Study|Inappropriate enrollment|1|||
27916205|NCT01346592|54574025|FG002|Overall Study|Inappropriate enrollment|1|||
27916206|NCT01346592|54574023|FG000|Overall Study|Administrative reason|1|||
27916207|NCT01346592|54574024|FG001|Overall Study|Administrative reason|0|||
27916208|NCT01346592|54574025|FG002|Overall Study|Administrative reason|0|||
27916209|NCT01346592|54574023|FG000|Overall Study|Unable to Classify|7|||
27916210|NCT01346592|54574024|FG001|Overall Study|Unable to Classify|3|||
27916211|NCT01346592|54574025|FG002|Overall Study|Unable to Classify|6|||
27916212|NCT01346514|54574052|FG000|Overall Study|Lost to Follow-up|19|||
27916213|NCT01346514|54574053|FG001|Overall Study|Lost to Follow-up|30|||
27916214|NCT01346514|54574052|FG000|Overall Study|Withdrawal by Subject|7|||
27916215|NCT01346514|54574053|FG001|Overall Study|Withdrawal by Subject|3|||
27916216|NCT01346514|54574052|FG000|Overall Study|Death|3|||
27916217|NCT01346514|54574053|FG001|Overall Study|Death|4|||
27916218|NCT01193335|54574063|FG000|After Infant Series|Lost to Follow-up|1|||
27916219|NCT01193335|54574064|FG001|After Infant Series|Lost to Follow-up|2|||
27916220|NCT01193335|54574063|FG000|After Infant Series|No Longer Met Eligibility Criteria|0|||
27916221|NCT01193335|54574064|FG001|After Infant Series|No Longer Met Eligibility Criteria|1|||
27916222|NCT01193335|54574063|FG000|1-Year Follow-up|No Longer Willing to Participate|7|||
27916223|NCT01193335|54574064|FG001|1-Year Follow-up|No Longer Willing to Participate|9|||
27916224|NCT01193335|54574063|FG000|1-Year Follow-up|Lost to Follow-up|4|||
27916225|NCT01193335|54574064|FG001|1-Year Follow-up|Lost to Follow-up|0|||
27916226|NCT01193335|54574063|FG000|2-Year Follow-up|No Longer Willing to Participate|5|||
27916227|NCT01193335|54574064|FG001|2-Year Follow-up|No Longer Willing to Participate|6|||
27916228|NCT01193335|54574063|FG000|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
27916229|NCT01193335|54574064|FG001|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
27916230|NCT01342887|54574086|FG000|Overall Study|Death|2|||
27916231|NCT01342341|54574092|FG000|Overall Study|Lost to Follow-up|4|||
27916232|NCT01342341|54574093|FG001|Overall Study|Lost to Follow-up|4|||
27916233|NCT01340664|54574102|FG000|Overall Study|Adverse Event|0|||
27916234|NCT01340664|54574103|FG001|Overall Study|Adverse Event|1|||
27916235|NCT01340664|54574104|FG002|Overall Study|Adverse Event|7|||
27916236|NCT01340664|54574102|FG000|Overall Study|Lost to Follow-up|2|||
28003472|NCT00479557|54662292|FG005|Overall Study|Investigator Request|0|||
27916237|NCT01340664|54574103|FG001|Overall Study|Lost to Follow-up|0|||
27916238|NCT01340664|54574104|FG002|Overall Study|Lost to Follow-up|2|||
27916239|NCT01340664|54574102|FG000|Overall Study|Withdrawal by Subject|2|||
27916240|NCT01340664|54574103|FG001|Overall Study|Withdrawal by Subject|4|||
27916241|NCT01340664|54574104|FG002|Overall Study|Withdrawal by Subject|0|||
27916242|NCT01340664|54574102|FG000|Overall Study|Glycemic withdrawal criteria|2|||
27916243|NCT01340664|54574103|FG001|Overall Study|Glycemic withdrawal criteria|0|||
27916244|NCT01340664|54574104|FG002|Overall Study|Glycemic withdrawal criteria|0|||
27916245|NCT01340664|54574102|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|0|||
27916246|NCT01340664|54574103|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|1|||
27916247|NCT01340664|54574104|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|2|||
27916248|NCT01340664|54574102|FG000|Overall Study|Other|1|||
27916249|NCT01340664|54574103|FG001|Overall Study|Other|2|||
27916250|NCT01340664|54574104|FG002|Overall Study|Other|2|||
27916251|NCT01340625|54574114|FG000|First Intervention|Adverse Event|1|||
28003473|NCT00479557|54662293|FG006|Overall Study|Investigator Request|0|||
28003474|NCT00479557|54662287|FG000|Overall Study|Subject Request|3|||
28003475|NCT00479557|54662288|FG001|Overall Study|Subject Request|0|||
28003476|NCT00479557|54662289|FG002|Overall Study|Subject Request|1|||
28003477|NCT00479557|54662290|FG003|Overall Study|Subject Request|1|||
28003478|NCT00479557|54662291|FG004|Overall Study|Subject Request|1|||
28003479|NCT00479557|54662292|FG005|Overall Study|Subject Request|4|||
28003480|NCT00479557|54662293|FG006|Overall Study|Subject Request|1|||
28003481|NCT00479557|54662287|FG000|Overall Study|Other|2|||
28003482|NCT00479557|54662288|FG001|Overall Study|Other|3|||
28003483|NCT00479557|54662289|FG002|Overall Study|Other|1|||
28003484|NCT00479557|54662290|FG003|Overall Study|Other|0|||
28003485|NCT00479557|54662291|FG004|Overall Study|Other|0|||
28003486|NCT00479557|54662292|FG005|Overall Study|Other|3|||
28003487|NCT00479557|54662293|FG006|Overall Study|Other|0|||
27916252|NCT01340625|54574115|FG001|First Intervention|Adverse Event|0|||
27916253|NCT01340625|54574114|FG000|Washout Period of 28 Days|Withdrawal by Subject|1|||
27916254|NCT01340625|54574115|FG001|Washout Period of 28 Days|Withdrawal by Subject|0|||
27916255|NCT01340196|54574121|FG000|Treat. Period 3 (Faldaprevir)|Adverse Event|2|||
27916256|NCT01327599|54574130|FG000|Overall Study|Adverse Event|1|||
28003488|NCT00774800|54662315|FG000|Intervention 4|Withdrawal by Subject|1|||
28003489|NCT00439309|54662327|FG000|Follow-Up|Death|1|||
27916257|NCT01327599|54574130|FG000|Overall Study|Could Not Attend Visit|1|||
27916258|NCT01327599|54574130|FG000|Overall Study|Withdrawal of Consent|1|||
28003490|NCT00439309|54662328|FG001|Follow-Up|Death|0|||
28003491|NCT00439309|54662327|FG000|Follow-Up|Lost to Follow-up|2|||
28003492|NCT00439309|54662328|FG001|Follow-Up|Lost to Follow-up|0|||
28003493|NCT00439309|54662327|FG000|Follow-Up|Withdrawal by Subject|0|||
28003494|NCT00439309|54662328|FG001|Follow-Up|Withdrawal by Subject|1|||
28003495|NCT00439309|54662327|FG000|Follow-Up|Late response by subject|0|||
28003496|NCT00439309|54662328|FG001|Follow-Up|Late response by subject|1|||
28003497|NCT00479167|54662334|FG000|Overall Study|Withdrawal by Subject|1|||
28003498|NCT00725712|54662341|FG000|Overall Study|Withdrawal by Subject|2|||
28003499|NCT00725712|54662342|FG001|Overall Study|Withdrawal by Subject|1|||
28003500|NCT00725712|54662341|FG000|Overall Study|Protocol Violation|1|||
28003501|NCT00725712|54662342|FG001|Overall Study|Protocol Violation|0|||
28003502|NCT00725712|54662341|FG000|Overall Study|Progressive disease|37|||
28003503|NCT00725712|54662342|FG001|Overall Study|Progressive disease|16|||
28003504|NCT00725712|54662341|FG000|Overall Study|Clinical progression not based on RECIST|0|||
27916259|NCT01193257|54574136|FG000|Overall Study|Death|202|||
28003505|NCT00725712|54662342|FG001|Overall Study|Clinical progression not based on RECIST|3|||
28003506|NCT00725712|54662341|FG000|Overall Study|Adverse Event|5|||
28003507|NCT00725712|54662342|FG001|Overall Study|Adverse Event|5|||
28003508|NCT00725712|54662341|FG000|Overall Study|Death|2|||
28003509|NCT00725712|54662342|FG001|Overall Study|Death|0|||
28003510|NCT00725712|54662341|FG000|Overall Study|Other: Death|1|||
28003511|NCT00725712|54662342|FG001|Overall Study|Other: Death|0|||
28003512|NCT00725712|54662341|FG000|Overall Study|Hospitalized, unable to continue|0|||
28003513|NCT00725712|54662342|FG001|Overall Study|Hospitalized, unable to continue|1|||
28003514|NCT00729378|54662354|FG000|Baseline|Did not complete study measurements|72|||
28003515|NCT00729378|54662355|FG001|Baseline|Did not complete study measurements|33|||
28003516|NCT00729378|54662354|FG000|Baseline|Withdrawal by Subject|66|||
28003517|NCT00729378|54662355|FG001|Baseline|Withdrawal by Subject|59|||
28003518|NCT00729378|54662354|FG000|12-months|Lost to Follow-up|100|||
28003519|NCT00729378|54662355|FG001|12-months|Lost to Follow-up|65|||
28003520|NCT00729378|54662354|FG000|24-months|Lost to Follow-up|72|||
28003521|NCT00729378|54662355|FG001|24-months|Lost to Follow-up|51|||
28003522|NCT00729378|54662354|FG000|36-months|Lost to Follow-up|15|||
28003523|NCT00729378|54662355|FG001|36-months|Lost to Follow-up|6|||
28003524|NCT00478933|54662364|FG000|Overall Study|Protocol Violation|22|||
28003525|NCT00478933|54662364|FG000|Overall Study|Informed consent not verified|3|||
28003526|NCT00478933|54662364|FG000|Overall Study|Inadequate data available|53|||
28003527|NCT00725322|54662390|FG000|Washout (28 Days)|Withdrawal by Subject|2|||
28003528|NCT00725322|54662391|FG001|Washout (28 Days)|Withdrawal by Subject|0|||
28003529|NCT00725322|54662390|FG000|Washout (28 Days)|Protocol Violation|0|||
27916260|NCT01193257|54574137|FG001|Overall Study|Death|391|||
28003530|NCT00725322|54662391|FG001|Washout (28 Days)|Protocol Violation|1|||
28003531|NCT00725010|54662397|FG000|Overall Study|Toxicity|9|||
28003532|NCT00725010|54662397|FG000|Overall Study|Tumor Progression|7|||
28003533|NCT00725010|54662397|FG000|Overall Study|Withdrawal by Subject|2|||
28003534|NCT00725010|54662397|FG000|Overall Study|Death|1|||
27916261|NCT01193257|54574136|FG000|Overall Study|Study termination by sponsor|0|||
28003535|NCT00725010|54662397|FG000|Overall Study|Lost to Follow-up|1|||
28003536|NCT00725010|54662397|FG000|Overall Study|Hepatopathy probably not Temodal-related|1|||
27916262|NCT01193257|54574137|FG001|Overall Study|Study termination by sponsor|3|||
28003537|NCT00725010|54662397|FG000|Overall Study|Suspect lymph nodes neck thorax abdomen|1|||
28003538|NCT00725010|54662397|FG000|Overall Study|No further documentation|1|||
28003539|NCT00725010|54662397|FG000|Overall Study|Intensified treatment scheme: 3 on 1 off|2|||
28003540|NCT00767000|54662408|FG000|54-week Study|Adverse Event|4|||
28003541|NCT00767000|54662409|FG001|54-week Study|Adverse Event|6|||
28003542|NCT00767000|54662410|FG002|54-week Study|Adverse Event|6|||
28003543|NCT00767000|54662411|FG003|54-week Study|Adverse Event|8|||
28003544|NCT00767000|54662412|FG004|54-week Study|Adverse Event|4|||
28003545|NCT00767000|54662408|FG000|54-week Study|Creaninine/creatinine clearance|2|||
28003546|NCT00767000|54662409|FG001|54-week Study|Creaninine/creatinine clearance|1|||
27916263|NCT01193257|54574136|FG000|Overall Study|Withdrawal by Subject|26|||
27916264|NCT01193257|54574137|FG001|Overall Study|Withdrawal by Subject|86|||
28003547|NCT00767000|54662410|FG002|54-week Study|Creaninine/creatinine clearance|2|||
28003548|NCT00767000|54662411|FG003|54-week Study|Creaninine/creatinine clearance|2|||
28003549|NCT00767000|54662412|FG004|54-week Study|Creaninine/creatinine clearance|4|||
28003550|NCT00767000|54662408|FG000|54-week Study|Hyperglycemia|0|||
28003551|NCT00767000|54662409|FG001|54-week Study|Hyperglycemia|0|||
28003552|NCT00767000|54662410|FG002|54-week Study|Hyperglycemia|1|||
28003553|NCT00767000|54662411|FG003|54-week Study|Hyperglycemia|0|||
28003554|NCT00767000|54662412|FG004|54-week Study|Hyperglycemia|1|||
28003555|NCT00767000|54662408|FG000|54-week Study|Hypoglycemia|0|||
28003556|NCT00767000|54662409|FG001|54-week Study|Hypoglycemia|1|||
28003557|NCT00767000|54662410|FG002|54-week Study|Hypoglycemia|0|||
28003558|NCT00767000|54662411|FG003|54-week Study|Hypoglycemia|0|||
28003559|NCT00767000|54662412|FG004|54-week Study|Hypoglycemia|0|||
27916265|NCT01193257|54574136|FG000|Overall Study|Lost to Follow-up|2|||
27916266|NCT01193257|54574137|FG001|Overall Study|Lost to Follow-up|3|||
27916267|NCT01193257|54574136|FG000|Overall Study|Unblinded due to futility|135|||
27916268|NCT01193257|54574137|FG001|Overall Study|Unblinded due to futility|251|||
27916269|NCT01193218|54574148|FG000|0-12 Weeks|Adverse Event|6|||
27916270|NCT01193218|54574149|FG001|0-12 Weeks|Adverse Event|0|||
28003560|NCT00767000|54662408|FG000|54-week Study|Interruption of study medication|0|||
28003561|NCT00767000|54662409|FG001|54-week Study|Interruption of study medication|0|||
28003562|NCT00767000|54662410|FG002|54-week Study|Interruption of study medication|1|||
28003563|NCT00767000|54662411|FG003|54-week Study|Interruption of study medication|0|||
28003564|NCT00767000|54662412|FG004|54-week Study|Interruption of study medication|0|||
28003565|NCT00767000|54662408|FG000|54-week Study|Lack of Efficacy|2|||
28003566|NCT00767000|54662409|FG001|54-week Study|Lack of Efficacy|0|||
28003567|NCT00767000|54662410|FG002|54-week Study|Lack of Efficacy|1|||
28003568|NCT00767000|54662411|FG003|54-week Study|Lack of Efficacy|0|||
28003569|NCT00767000|54662412|FG004|54-week Study|Lack of Efficacy|5|||
28003570|NCT00767000|54662408|FG000|54-week Study|Lost to Follow-up|4|||
28003571|NCT00767000|54662409|FG001|54-week Study|Lost to Follow-up|0|||
28003572|NCT00767000|54662410|FG002|54-week Study|Lost to Follow-up|1|||
28003573|NCT00767000|54662411|FG003|54-week Study|Lost to Follow-up|4|||
27916271|NCT01193218|54574150|FG002|0-12 Weeks|Adverse Event|1|||
27916272|NCT01193218|54574151|FG003|0-12 Weeks|Adverse Event|0|||
28003574|NCT00767000|54662412|FG004|54-week Study|Lost to Follow-up|2|||
28003575|NCT00767000|54662408|FG000|54-week Study|Physician Decision|4|||
28003576|NCT00767000|54662409|FG001|54-week Study|Physician Decision|0|||
28003577|NCT00767000|54662410|FG002|54-week Study|Physician Decision|1|||
28003578|NCT00767000|54662411|FG003|54-week Study|Physician Decision|1|||
28003579|NCT00767000|54662412|FG004|54-week Study|Physician Decision|1|||
28003580|NCT00767000|54662408|FG000|54-week Study|Progressive disease|0|||
28003581|NCT00767000|54662409|FG001|54-week Study|Progressive disease|0|||
28003582|NCT00767000|54662410|FG002|54-week Study|Progressive disease|1|||
28003583|NCT00767000|54662411|FG003|54-week Study|Progressive disease|0|||
28003584|NCT00767000|54662412|FG004|54-week Study|Progressive disease|0|||
28003585|NCT00767000|54662408|FG000|54-week Study|Protocol Violation|0|||
28003586|NCT00767000|54662409|FG001|54-week Study|Protocol Violation|0|||
28003587|NCT00767000|54662410|FG002|54-week Study|Protocol Violation|1|||
28003588|NCT00767000|54662411|FG003|54-week Study|Protocol Violation|2|||
28003589|NCT00767000|54662412|FG004|54-week Study|Protocol Violation|0|||
28003590|NCT00767000|54662408|FG000|54-week Study|Withdrawal by Subject|2|||
28003591|NCT00767000|54662409|FG001|54-week Study|Withdrawal by Subject|3|||
28003592|NCT00767000|54662410|FG002|54-week Study|Withdrawal by Subject|5|||
28003593|NCT00767000|54662411|FG003|54-week Study|Withdrawal by Subject|11|||
28003594|NCT00767000|54662412|FG004|54-week Study|Withdrawal by Subject|13|||
28003595|NCT00767000|54662408|FG000|54-week Study|Study terminated by sponsor|90|||
28003596|NCT00767000|54662409|FG001|54-week Study|Study terminated by sponsor|102|||
28003597|NCT00767000|54662410|FG002|54-week Study|Study terminated by sponsor|89|||
28003598|NCT00767000|54662411|FG003|54-week Study|Study terminated by sponsor|196|||
28003599|NCT00767000|54662412|FG004|54-week Study|Study terminated by sponsor|194|||
28003600|NCT00767000|54662408|FG000|54-week Study|Reason not reported|0|||
28003601|NCT00767000|54662409|FG001|54-week Study|Reason not reported|0|||
27739912|NCT02786537|54189680|FG003|As Randomized|Non-compliance with study drug|1|||
27739913|NCT02786537|54189681|FG004|As Randomized|Non-compliance with study drug|0|||
27916273|NCT01193218|54574152|FG004|0-12 Weeks|Adverse Event|0|||
27916274|NCT01193218|54574153|FG005|0-12 Weeks|Adverse Event|2|||
27916275|NCT01193218|54574154|FG006|0-12 Weeks|Adverse Event|2|||
27916276|NCT01193218|54574155|FG007|0-12 Weeks|Adverse Event|0|||
27916277|NCT01193218|54574148|FG000|0-12 Weeks|Protocol Violation|0|||
28003602|NCT00767000|54662410|FG002|54-week Study|Reason not reported|0|||
28003603|NCT00767000|54662411|FG003|54-week Study|Reason not reported|1|||
28003604|NCT00767000|54662412|FG004|54-week Study|Reason not reported|0|||
27916278|NCT01193218|54574149|FG001|0-12 Weeks|Protocol Violation|0|||
27916279|NCT01193218|54574150|FG002|0-12 Weeks|Protocol Violation|0|||
28003605|NCT00767000|54662408|FG000|Optional 104-week Extension|Study terminated by sponsor|7|||
28003606|NCT00767000|54662409|FG001|Optional 104-week Extension|Study terminated by sponsor|3|||
28003607|NCT00767000|54662410|FG002|Optional 104-week Extension|Study terminated by sponsor|7|||
28003608|NCT00767000|54662411|FG003|Optional 104-week Extension|Study terminated by sponsor|2|||
28003609|NCT00767000|54662412|FG004|Optional 104-week Extension|Study terminated by sponsor|4|||
28003610|NCT00724932|54662426|FG000|Overall Study|Lost to Follow-up|1|||
28003611|NCT00724932|54662427|FG001|Overall Study|Lost to Follow-up|0|||
28003612|NCT00724932|54662426|FG000|Overall Study|Not treated|4|||
28003613|NCT00724932|54662427|FG001|Overall Study|Not treated|3|||
28003614|NCT00766532|54662435|FG000|Overall Study|Protocol Violation|2|||
28003615|NCT00774566|54662441|FG000|Overall Study|Protocol Violation|18|||
28003616|NCT00774566|54662442|FG001|Overall Study|Protocol Violation|15|||
28003617|NCT00766376|54662448|FG000|Overall Study|Withdrawal by Subject|27|||
28003618|NCT00587054|54662452|FG000|Overall Study|Patient not treated|9|||
28003619|NCT00766142|54662456|FG000|Overall Study|Protocol Violation|4|||
28003620|NCT00724854|54662462|FG000|Overall Study|Lack of Efficacy|187|||
28003621|NCT00724854|54662463|FG001|Overall Study|Lack of Efficacy|13|||
28003622|NCT00724854|54662462|FG000|Overall Study|Lost to Follow-up|87|||
28003623|NCT00724854|54662463|FG001|Overall Study|Lost to Follow-up|10|||
28003624|NCT00724854|54662462|FG000|Overall Study|Adverse Event|62|||
28003625|NCT00724854|54662463|FG001|Overall Study|Adverse Event|4|||
28003626|NCT00724854|54662462|FG000|Overall Study|Other|42|||
28003627|NCT00724854|54662463|FG001|Overall Study|Other|3|||
28003628|NCT00724854|54662462|FG000|Overall Study|Death|11|||
28003629|NCT00724854|54662463|FG001|Overall Study|Death|0|||
28003630|NCT00724854|54662462|FG000|Overall Study|Change of treatment|7|||
28003631|NCT00724854|54662463|FG001|Overall Study|Change of treatment|0|||
28003632|NCT00724854|54662462|FG000|Overall Study|Withdrawal by Subject|5|||
28003633|NCT00724854|54662463|FG001|Overall Study|Withdrawal by Subject|0|||
28003634|NCT00724854|54662462|FG000|Overall Study|Adverse event + lack of efficacy|2|||
28003635|NCT00724854|54662463|FG001|Overall Study|Adverse event + lack of efficacy|1|||
28003636|NCT00728988|54662472|FG000|Overall Study|Not Treated|2|||
28003637|NCT00728988|54662473|FG001|Overall Study|Not Treated|2|||
28003638|NCT00728988|54662472|FG000|Overall Study|Death|1|||
28003639|NCT00728988|54662473|FG001|Overall Study|Death|1|||
28003640|NCT00728988|54662472|FG000|Overall Study|Adverse Event|3|||
28003641|NCT00728988|54662473|FG001|Overall Study|Adverse Event|2|||
28003642|NCT00728988|54662472|FG000|Overall Study|Other|85|||
28003643|NCT00728988|54662473|FG001|Overall Study|Other|77|||
28003644|NCT00728988|54662472|FG000|Overall Study|Withdrawal by Subject|2|||
28003645|NCT00728988|54662473|FG001|Overall Study|Withdrawal by Subject|6|||
28003646|NCT00728754|54662482|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
28003647|NCT00728754|54662483|FG001|Permanent Prosthesis Placement|Adverse Event|1|||
28003648|NCT00728754|54662482|FG000|Permanent Prosthesis Placement|Lost to Follow-up|3|||
28003649|NCT00728754|54662483|FG001|Permanent Prosthesis Placement|Lost to Follow-up|3|||
28003650|NCT00728754|54662482|FG000|One Year Post Placement Follow-up|Adverse Event|1|||
28003651|NCT00728754|54662483|FG001|One Year Post Placement Follow-up|Adverse Event|0|||
28003652|NCT00728130|54662489|FG000|Overall Study|Withdrawal by Subject|1|||
28003653|NCT00728130|54662489|FG000|Overall Study|Paperwork not completed in time|1|||
28100420|NCT03131440|54756846|FG021|Overall Study|Death|0|||
28100421|NCT03131440|54756847|FG022|Overall Study|Death|0|||
28100422|NCT03131440|54756848|FG023|Overall Study|Death|0|||
28100423|NCT03131440|54756849|FG024|Overall Study|Death|0|||
28003654|NCT00728130|54662489|FG000|Overall Study|Physician Decision|1|||
28003655|NCT00735696|54662493|FG000|Overall Study|Withdrawal by Subject|1|||
28003656|NCT00735696|54662493|FG000|Overall Study|Enrolled but never Treated|1|||
28003657|NCT00478231|54662502|FG000|Overall Study|Death|7|||
28003658|NCT00478231|54662502|FG000|Overall Study|Lack of Efficacy|47|||
28003659|NCT00478231|54662502|FG000|Overall Study|Lost to Follow-up|7|||
28003660|NCT00478231|54662502|FG000|Overall Study|Withdrawal by Subject|6|||
28003661|NCT00478231|54662502|FG000|Overall Study|Other|9|||
28003662|NCT00478231|54662502|FG000|Overall Study|Adverse Event|5|||
28003663|NCT00478231|54662502|FG000|Overall Study|Randomized, not treated|3|||
28003664|NCT00474175|54662509|FG000|Overall Study|Lack of Efficacy|0|||
28003665|NCT00474175|54662510|FG001|Overall Study|Lack of Efficacy|0|||
28003666|NCT00474175|54662511|FG002|Overall Study|Lack of Efficacy|1|||
28100424|NCT03131440|54756850|FG025|Overall Study|Death|1|||
28100425|NCT03131440|54756851|FG026|Overall Study|Death|0|||
28100426|NCT03131440|54756852|FG027|Overall Study|Death|0|||
28003667|NCT00474175|54662509|FG000|Overall Study|Withdrawal by Subject|0|||
28003668|NCT00474175|54662510|FG001|Overall Study|Withdrawal by Subject|1|||
28003669|NCT00474175|54662511|FG002|Overall Study|Withdrawal by Subject|1|||
28003670|NCT00474175|54662509|FG000|Overall Study|Ineligible|1|||
28003671|NCT00474175|54662510|FG001|Overall Study|Ineligible|3|||
28003672|NCT00474175|54662511|FG002|Overall Study|Ineligible|1|||
28003673|NCT00474175|54662509|FG000|Overall Study|Protocol Violation|0|||
28003674|NCT00474175|54662510|FG001|Overall Study|Protocol Violation|2|||
28003675|NCT00474175|54662511|FG002|Overall Study|Protocol Violation|1|||
28003676|NCT00474175|54662509|FG000|Overall Study|Administrative|0|||
28100427|NCT03131440|54756853|FG028|Overall Study|Death|0|||
28003677|NCT00474175|54662510|FG001|Overall Study|Administrative|1|||
28003678|NCT00474175|54662511|FG002|Overall Study|Administrative|0|||
28003679|NCT00443209|54662542|FG000|Months 1 to 12 Treatment Period|Adverse Event|22|||
28003680|NCT00443209|54662543|FG001|Months 1 to 12 Treatment Period|Adverse Event|11|||
28003681|NCT00443209|54662542|FG000|Months 1 to 12 Treatment Period|Protocol Violation|14|||
28003682|NCT00443209|54662543|FG001|Months 1 to 12 Treatment Period|Protocol Violation|7|||
28003683|NCT00443209|54662542|FG000|Months 1 to 12 Treatment Period|Lack of Efficacy|50|||
28003684|NCT00443209|54662543|FG001|Months 1 to 12 Treatment Period|Lack of Efficacy|11|||
28003685|NCT00443209|54662542|FG000|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
28003686|NCT00443209|54662543|FG001|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
28003687|NCT00443209|54662542|FG000|Months 1 to 12 Treatment Period|Lost to Follow-up|36|||
28003688|NCT00443209|54662543|FG001|Months 1 to 12 Treatment Period|Lost to Follow-up|15|||
28003689|NCT00443209|54662542|FG000|Months 1 to 12 Treatment Period|Physician Decision|8|||
28003690|NCT00443209|54662543|FG001|Months 1 to 12 Treatment Period|Physician Decision|4|||
28003691|NCT00443209|54662542|FG000|Months 1 to 12 Treatment Period|Pregnancy|3|||
28003692|NCT00443209|54662543|FG001|Months 1 to 12 Treatment Period|Pregnancy|4|||
28003693|NCT00443209|54662542|FG000|Months 1 to 12 Treatment Period|Trial Terminated|43|||
28003694|NCT00443209|54662543|FG001|Months 1 to 12 Treatment Period|Trial Terminated|23|||
28003695|NCT00443209|54662542|FG000|Months 1 to 12 Treatment Period|Withdrawal by Subject|95|||
28003696|NCT00443209|54662543|FG001|Months 1 to 12 Treatment Period|Withdrawal by Subject|34|||
28003697|NCT00443209|54662542|FG000|Months 1 to 12 Treatment Period|Missing|2|||
28003698|NCT00443209|54662543|FG001|Months 1 to 12 Treatment Period|Missing|1|||
28003699|NCT00443209|54662542|FG000|Months 1 to 12 Treatment Period|Not Treated|71|||
28003700|NCT00443209|54662543|FG001|Months 1 to 12 Treatment Period|Not Treated|43|||
28003701|NCT00443209|54662542|FG000|Months 13 to 18 Treatment Period|Adverse Event|1|||
27916280|NCT01193218|54574151|FG003|0-12 Weeks|Protocol Violation|0|||
27916281|NCT01193218|54574152|FG004|0-12 Weeks|Protocol Violation|1|||
27916282|NCT01193218|54574153|FG005|0-12 Weeks|Protocol Violation|1|||
27916283|NCT01193218|54574154|FG006|0-12 Weeks|Protocol Violation|0|||
27916284|NCT01193218|54574155|FG007|0-12 Weeks|Protocol Violation|0|||
27916285|NCT01193218|54574148|FG000|0-12 Weeks|Withdrawal by Subject|3|||
28003702|NCT00443209|54662543|FG001|Months 13 to 18 Treatment Period|Adverse Event|0|||
28003703|NCT00443209|54662542|FG000|Months 13 to 18 Treatment Period|Protocol Violation|1|||
28003704|NCT00443209|54662543|FG001|Months 13 to 18 Treatment Period|Protocol Violation|0|||
28003705|NCT00443209|54662542|FG000|Months 13 to 18 Treatment Period|Lack of Efficacy|1|||
28003706|NCT00443209|54662543|FG001|Months 13 to 18 Treatment Period|Lack of Efficacy|0|||
28003707|NCT00443209|54662542|FG000|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
28003708|NCT00443209|54662543|FG001|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
28003709|NCT00443209|54662542|FG000|Months 13 to 18 Treatment Period|Trial Terminated|87|||
28003710|NCT00443209|54662543|FG001|Months 13 to 18 Treatment Period|Trial Terminated|43|||
28003711|NCT00443209|54662542|FG000|Months 13 to 18 Treatment Period|Withdrawal by Subject|7|||
28003712|NCT00443209|54662543|FG001|Months 13 to 18 Treatment Period|Withdrawal by Subject|2|||
28003713|NCT00439231|54662549|FG000|Overall Study|Lack of Efficacy|28|||
28003714|NCT00437983|54662555|FG000|Overall Study|Adverse Event|6|||
28003715|NCT00437983|54662556|FG001|Overall Study|Adverse Event|6|||
28003716|NCT00437983|54662555|FG000|Overall Study|Protocol Violation|2|||
28003717|NCT00437983|54662556|FG001|Overall Study|Protocol Violation|1|||
28003718|NCT00437983|54662555|FG000|Overall Study|Withdrawal by Subject|5|||
27916286|NCT01193218|54574149|FG001|0-12 Weeks|Withdrawal by Subject|0|||
27916287|NCT01193218|54574150|FG002|0-12 Weeks|Withdrawal by Subject|2|||
27916288|NCT01193218|54574151|FG003|0-12 Weeks|Withdrawal by Subject|0|||
27916289|NCT01193218|54574152|FG004|0-12 Weeks|Withdrawal by Subject|0|||
27916290|NCT01193218|54574153|FG005|0-12 Weeks|Withdrawal by Subject|0|||
27916291|NCT01193218|54574154|FG006|0-12 Weeks|Withdrawal by Subject|1|||
27916292|NCT01193218|54574155|FG007|0-12 Weeks|Withdrawal by Subject|0|||
27916293|NCT01193218|54574148|FG000|12-52 Weeks|Adverse Event|1|||
27916294|NCT01193218|54574149|FG001|12-52 Weeks|Adverse Event|0|||
27916295|NCT01193218|54574150|FG002|12-52 Weeks|Adverse Event|1|||
27916296|NCT01193218|54574151|FG003|12-52 Weeks|Adverse Event|2|||
27916297|NCT01193218|54574152|FG004|12-52 Weeks|Adverse Event|3|||
27916298|NCT01193218|54574153|FG005|12-52 Weeks|Adverse Event|3|||
27916299|NCT01193218|54574154|FG006|12-52 Weeks|Adverse Event|1|||
27916300|NCT01193218|54574155|FG007|12-52 Weeks|Adverse Event|2|||
27916301|NCT01193218|54574148|FG000|12-52 Weeks|Lack of Efficacy|0|||
28003719|NCT00437983|54662556|FG001|Overall Study|Withdrawal by Subject|6|||
28100428|NCT03131440|54756854|FG029|Overall Study|Death|0|||
27916302|NCT01193218|54574149|FG001|12-52 Weeks|Lack of Efficacy|0|||
27916303|NCT01193218|54574150|FG002|12-52 Weeks|Lack of Efficacy|0|||
27916304|NCT01193218|54574151|FG003|12-52 Weeks|Lack of Efficacy|0|||
27916305|NCT01193218|54574152|FG004|12-52 Weeks|Lack of Efficacy|0|||
28003720|NCT00783692|54662565|FG000|Induction Phase|Adverse Event|7|||
28003721|NCT00783692|54662566|FG001|Induction Phase|Adverse Event|9|||
28100429|NCT03131440|54756855|FG030|Overall Study|Death|0|||
27916306|NCT01193218|54574153|FG005|12-52 Weeks|Lack of Efficacy|0|||
27916307|NCT01193218|54574154|FG006|12-52 Weeks|Lack of Efficacy|1|||
27916308|NCT01193218|54574155|FG007|12-52 Weeks|Lack of Efficacy|0|||
27916309|NCT01193218|54574148|FG000|12-52 Weeks|Withdrawal by Subject|3|||
27916310|NCT01193218|54574149|FG001|12-52 Weeks|Withdrawal by Subject|0|||
27916311|NCT01193218|54574150|FG002|12-52 Weeks|Withdrawal by Subject|3|||
27916312|NCT01193218|54574151|FG003|12-52 Weeks|Withdrawal by Subject|0|||
27916313|NCT01193218|54574152|FG004|12-52 Weeks|Withdrawal by Subject|0|||
27916314|NCT01193218|54574153|FG005|12-52 Weeks|Withdrawal by Subject|2|||
28003722|NCT00783692|54662567|FG002|Induction Phase|Adverse Event|24|||
28003723|NCT00783692|54662568|FG003|Induction Phase|Adverse Event|0|||
27916315|NCT01193218|54574154|FG006|12-52 Weeks|Withdrawal by Subject|1|||
27916316|NCT01193218|54574155|FG007|12-52 Weeks|Withdrawal by Subject|2|||
27916317|NCT01193218|54574148|FG000|12-52 Weeks|Other reason than above|1|||
27916318|NCT01193218|54574149|FG001|12-52 Weeks|Other reason than above|0|||
27916319|NCT01193218|54574150|FG002|12-52 Weeks|Other reason than above|0|||
27916320|NCT01193218|54574151|FG003|12-52 Weeks|Other reason than above|1|||
27916321|NCT01193218|54574152|FG004|12-52 Weeks|Other reason than above|1|||
27916322|NCT01193218|54574153|FG005|12-52 Weeks|Other reason than above|0|||
27916323|NCT01193218|54574154|FG006|12-52 Weeks|Other reason than above|0|||
27916324|NCT01193218|54574155|FG007|12-52 Weeks|Other reason than above|0|||
27916325|NCT01193101|54574175|FG000|Overall Study|Adverse Event|0|||
27916326|NCT01193101|54574176|FG001|Overall Study|Adverse Event|1|||
27916327|NCT01193101|54574177|FG002|Overall Study|Adverse Event|1|||
27916328|NCT01193101|54574178|FG003|Overall Study|Adverse Event|3|||
27916329|NCT01193101|54574175|FG000|Overall Study|Lack of Efficacy|3|||
27916330|NCT01193101|54574176|FG001|Overall Study|Lack of Efficacy|1|||
27916331|NCT01193101|54574177|FG002|Overall Study|Lack of Efficacy|0|||
27916332|NCT01193101|54574178|FG003|Overall Study|Lack of Efficacy|8|||
27916333|NCT01193101|54574175|FG000|Overall Study|Withdrawal by Subject|2|||
27916334|NCT01193101|54574176|FG001|Overall Study|Withdrawal by Subject|4|||
27916335|NCT01193101|54574177|FG002|Overall Study|Withdrawal by Subject|1|||
27916336|NCT01193101|54574178|FG003|Overall Study|Withdrawal by Subject|1|||
27916337|NCT01193101|54574175|FG000|Overall Study|Administrative problems|0|||
27916338|NCT01193101|54574176|FG001|Overall Study|Administrative problems|0|||
27916339|NCT01193101|54574177|FG002|Overall Study|Administrative problems|1|||
27916340|NCT01193101|54574178|FG003|Overall Study|Administrative problems|0|||
27916341|NCT01193101|54574175|FG000|Overall Study|Abnormal test procedure results|0|||
27916342|NCT01193101|54574176|FG001|Overall Study|Abnormal test procedure results|1|||
27916343|NCT01193101|54574177|FG002|Overall Study|Abnormal test procedure results|0|||
27916344|NCT01193101|54574178|FG003|Overall Study|Abnormal test procedure results|0|||
27916345|NCT01192516|54574191|FG000|Overall Study|Lost to Follow-up|7|||
27916346|NCT01192516|54574192|FG001|Overall Study|Lost to Follow-up|10|||
27916347|NCT01192516|54574193|FG002|Overall Study|Lost to Follow-up|7|||
27916348|NCT01192516|54574191|FG000|Overall Study|Withdrawal by Subject|4|||
27916349|NCT01192516|54574192|FG001|Overall Study|Withdrawal by Subject|4|||
27916350|NCT01192516|54574193|FG002|Overall Study|Withdrawal by Subject|1|||
27916351|NCT01192516|54574191|FG000|Overall Study|started new treatment|5|||
28003724|NCT00783692|54662569|FG004|Induction Phase|Adverse Event|0|||
28003725|NCT00783692|54662570|FG005|Induction Phase|Adverse Event|0|||
28003726|NCT00783692|54662571|FG006|Induction Phase|Adverse Event|0|||
28003727|NCT00783692|54662565|FG000|Induction Phase|Protocol Violation|0|||
28003728|NCT00783692|54662566|FG001|Induction Phase|Protocol Violation|0|||
28003729|NCT00783692|54662567|FG002|Induction Phase|Protocol Violation|1|||
28003730|NCT00783692|54662568|FG003|Induction Phase|Protocol Violation|0|||
28003731|NCT00783692|54662569|FG004|Induction Phase|Protocol Violation|0|||
28003732|NCT00783692|54662570|FG005|Induction Phase|Protocol Violation|0|||
28003733|NCT00783692|54662571|FG006|Induction Phase|Protocol Violation|0|||
28003734|NCT00783692|54662565|FG000|Induction Phase|Lack of Efficacy|1|||
28003735|NCT00783692|54662566|FG001|Induction Phase|Lack of Efficacy|3|||
28003736|NCT00783692|54662567|FG002|Induction Phase|Lack of Efficacy|28|||
28003737|NCT00783692|54662568|FG003|Induction Phase|Lack of Efficacy|0|||
28003738|NCT00783692|54662569|FG004|Induction Phase|Lack of Efficacy|0|||
28003739|NCT00783692|54662570|FG005|Induction Phase|Lack of Efficacy|0|||
27916352|NCT01192516|54574192|FG001|Overall Study|started new treatment|1|||
27916353|NCT01192516|54574193|FG002|Overall Study|started new treatment|0|||
27916354|NCT01192516|54574191|FG000|Overall Study|Unable to follow Actiwatch instructions|4|||
27916355|NCT01192516|54574192|FG001|Overall Study|Unable to follow Actiwatch instructions|2|||
27916356|NCT01192516|54574193|FG002|Overall Study|Unable to follow Actiwatch instructions|0|||
27916357|NCT01192399|54574205|FG000|Overall Study|Lack of Efficacy|2|||
27916358|NCT01176916|54574209|FG000|Overall Study|Adverse Event|61|||
28003740|NCT00783692|54662571|FG006|Induction Phase|Lack of Efficacy|0|||
27916359|NCT01176916|54574209|FG000|Overall Study|Death|1|||
27916360|NCT01176916|54574209|FG000|Overall Study|Lost to Follow-up|15|||
28003741|NCT00783692|54662565|FG000|Induction Phase|Withdrawal by Subject|3|||
28003742|NCT00783692|54662566|FG001|Induction Phase|Withdrawal by Subject|9|||
28003743|NCT00783692|54662567|FG002|Induction Phase|Withdrawal by Subject|16|||
27916361|NCT01176916|54574209|FG000|Overall Study|Objective progression or relapse|17|||
27916362|NCT01176916|54574209|FG000|Overall Study|Protocol Violation|24|||
28003744|NCT00783692|54662568|FG003|Induction Phase|Withdrawal by Subject|0|||
28003745|NCT00783692|54662569|FG004|Induction Phase|Withdrawal by Subject|0|||
28003746|NCT00783692|54662570|FG005|Induction Phase|Withdrawal by Subject|0|||
28003747|NCT00783692|54662571|FG006|Induction Phase|Withdrawal by Subject|0|||
28003748|NCT00783692|54662565|FG000|Induction Phase|Lost to Follow-up|0|||
28003749|NCT00783692|54662566|FG001|Induction Phase|Lost to Follow-up|0|||
28003750|NCT00783692|54662567|FG002|Induction Phase|Lost to Follow-up|3|||
28003751|NCT00783692|54662568|FG003|Induction Phase|Lost to Follow-up|0|||
28003752|NCT00783692|54662569|FG004|Induction Phase|Lost to Follow-up|0|||
28003753|NCT00783692|54662570|FG005|Induction Phase|Lost to Follow-up|0|||
28003754|NCT00783692|54662571|FG006|Induction Phase|Lost to Follow-up|0|||
28003755|NCT00783692|54662565|FG000|Induction Phase|Other|0|||
28003756|NCT00783692|54662566|FG001|Induction Phase|Other|0|||
28003757|NCT00783692|54662567|FG002|Induction Phase|Other|2|||
28003758|NCT00783692|54662568|FG003|Induction Phase|Other|0|||
28003759|NCT00783692|54662569|FG004|Induction Phase|Other|0|||
28003760|NCT00783692|54662570|FG005|Induction Phase|Other|0|||
28003761|NCT00783692|54662571|FG006|Induction Phase|Other|0|||
28003762|NCT00783692|54662565|FG000|Maintenance Phase|Adverse Event|7|||
28003763|NCT00783692|54662566|FG001|Maintenance Phase|Adverse Event|0|||
28003764|NCT00783692|54662567|FG002|Maintenance Phase|Adverse Event|0|||
28003765|NCT00783692|54662568|FG003|Maintenance Phase|Adverse Event|15|||
28003766|NCT00783692|54662569|FG004|Maintenance Phase|Adverse Event|12|||
28003767|NCT00783692|54662570|FG005|Maintenance Phase|Adverse Event|9|||
28003768|NCT00783692|54662571|FG006|Maintenance Phase|Adverse Event|38|||
28003769|NCT00783692|54662565|FG000|Maintenance Phase|Protocol Violation|0|||
28003770|NCT00783692|54662566|FG001|Maintenance Phase|Protocol Violation|0|||
28003771|NCT00783692|54662567|FG002|Maintenance Phase|Protocol Violation|0|||
28003772|NCT00783692|54662568|FG003|Maintenance Phase|Protocol Violation|1|||
28003773|NCT00783692|54662569|FG004|Maintenance Phase|Protocol Violation|2|||
28003774|NCT00783692|54662570|FG005|Maintenance Phase|Protocol Violation|3|||
28003775|NCT00783692|54662571|FG006|Maintenance Phase|Protocol Violation|4|||
28003776|NCT00783692|54662565|FG000|Maintenance Phase|Lack of Efficacy|79|||
28003777|NCT00783692|54662566|FG001|Maintenance Phase|Lack of Efficacy|0|||
28003778|NCT00783692|54662567|FG002|Maintenance Phase|Lack of Efficacy|0|||
28003779|NCT00783692|54662568|FG003|Maintenance Phase|Lack of Efficacy|64|||
28003780|NCT00783692|54662569|FG004|Maintenance Phase|Lack of Efficacy|58|||
28003781|NCT00783692|54662570|FG005|Maintenance Phase|Lack of Efficacy|48|||
28003782|NCT00783692|54662571|FG006|Maintenance Phase|Lack of Efficacy|177|||
28003783|NCT00783692|54662565|FG000|Maintenance Phase|Withdrawal by Subject|7|||
28003784|NCT00783692|54662566|FG001|Maintenance Phase|Withdrawal by Subject|0|||
28003785|NCT00783692|54662567|FG002|Maintenance Phase|Withdrawal by Subject|0|||
28003786|NCT00783692|54662568|FG003|Maintenance Phase|Withdrawal by Subject|7|||
28003787|NCT00783692|54662569|FG004|Maintenance Phase|Withdrawal by Subject|6|||
28003788|NCT00783692|54662570|FG005|Maintenance Phase|Withdrawal by Subject|9|||
28003789|NCT00783692|54662571|FG006|Maintenance Phase|Withdrawal by Subject|24|||
28003790|NCT00783692|54662565|FG000|Maintenance Phase|Lost to Follow-up|2|||
28003791|NCT00783692|54662566|FG001|Maintenance Phase|Lost to Follow-up|0|||
28003792|NCT00783692|54662567|FG002|Maintenance Phase|Lost to Follow-up|0|||
28003793|NCT00783692|54662568|FG003|Maintenance Phase|Lost to Follow-up|1|||
28003794|NCT00783692|54662569|FG004|Maintenance Phase|Lost to Follow-up|3|||
28003795|NCT00783692|54662570|FG005|Maintenance Phase|Lost to Follow-up|2|||
28003796|NCT00783692|54662571|FG006|Maintenance Phase|Lost to Follow-up|5|||
28003797|NCT00783692|54662565|FG000|Maintenance Phase|Other|0|||
28003798|NCT00783692|54662566|FG001|Maintenance Phase|Other|0|||
28003799|NCT00783692|54662567|FG002|Maintenance Phase|Other|0|||
28003800|NCT00783692|54662568|FG003|Maintenance Phase|Other|1|||
28003801|NCT00783692|54662569|FG004|Maintenance Phase|Other|0|||
28003802|NCT00783692|54662570|FG005|Maintenance Phase|Other|1|||
27916363|NCT01176916|54574209|FG000|Overall Study|Withdrawal by Subject|37|||
27916364|NCT01176916|54574209|FG000|Overall Study|Other|6|||
27916365|NCT01176916|54574209|FG000|Overall Study|Withdrawal prior to Treatment|6|||
27916366|NCT01192204|54574215|FG000|Overall Study|could not keep recall appointments|1|||
27916367|NCT01192204|54574216|FG001|Overall Study|could not keep recall appointments|0|||
27916368|NCT01192126|54574223|FG000|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1|||
27916369|NCT01192126|54574224|FG001|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0|||
27916370|NCT01192126|54574223|FG000|First Intervention (1 Week)|Lost to Follow-up|1|||
27916371|NCT01192126|54574224|FG001|First Intervention (1 Week)|Lost to Follow-up|1|||
27916372|NCT01327482|54574230|FG000|Overall Study|Adverse Event|1|||
27916373|NCT01176565|54574236|FG000|Overall Study|Lost to Follow-up|12|||
27916374|NCT01176565|54574237|FG001|Overall Study|Lost to Follow-up|16|||
27916375|NCT01176565|54574236|FG000|Overall Study|Withdrawal by Subject|7|||
28003803|NCT00783692|54662571|FG006|Maintenance Phase|Other|1|||
28003804|NCT04992273|54662586|FG000|Overall Study|Lost to Follow-up|0|||
28003805|NCT04992273|54662587|FG001|Overall Study|Lost to Follow-up|1|||
28003806|NCT00783302|54662594|FG000|Overall Study|Lost to Follow-up|17|||
28003807|NCT00783302|54662594|FG000|Overall Study|Technical Problems|11|||
28003808|NCT00783302|54662594|FG000|Overall Study|Protocol Violation|3|||
28003809|NCT00783302|54662594|FG000|Overall Study|Physician Decision|1|||
27916376|NCT01176565|54574237|FG001|Overall Study|Withdrawal by Subject|1|||
28003810|NCT00783302|54662594|FG000|Overall Study|Withdrawal by Subject|3|||
28003811|NCT00783224|54662616|FG000|Overall Study|Adverse Event|0|||
28003812|NCT00783224|54662617|FG001|Overall Study|Adverse Event|0|||
28003813|NCT00783224|54662618|FG002|Overall Study|Adverse Event|1|||
28003814|NCT00783224|54662619|FG003|Overall Study|Adverse Event|0|||
28003815|NCT00783224|54662616|FG000|Overall Study|Discarded the Investigational Drug Used|0|||
28003816|NCT00783224|54662617|FG001|Overall Study|Discarded the Investigational Drug Used|0|||
28003817|NCT00783224|54662618|FG002|Overall Study|Discarded the Investigational Drug Used|0|||
28003818|NCT00783224|54662619|FG003|Overall Study|Discarded the Investigational Drug Used|1|||
28003819|NCT00783224|54662616|FG000|Overall Study|Inappropriate as a study subject|0|||
28003820|NCT00783224|54662617|FG001|Overall Study|Inappropriate as a study subject|0|||
28003821|NCT00783224|54662618|FG002|Overall Study|Inappropriate as a study subject|0|||
28003822|NCT00783224|54662619|FG003|Overall Study|Inappropriate as a study subject|1|||
28003823|NCT00782834|54662628|FG000|Treatment Phase|fibrous tumor not GIST|1|||
28003824|NCT00584805|54662632|FG000|Overall Study|No longer at risk of exposure|39|||
28100430|NCT03131440|54756856|FG031|Overall Study|Death|0|||
28100431|NCT02915302|54756901|FG000|Overall Study|Adverse Event|3|||
28100432|NCT02915302|54756902|FG001|Overall Study|Adverse Event|0|||
28100433|NCT02915302|54756901|FG000|Overall Study|Protocol Violation|20|||
28100434|NCT02915302|54756902|FG001|Overall Study|Protocol Violation|27|||
28100435|NCT02915302|54756901|FG000|Overall Study|Lost to Follow-up|19|||
28100436|NCT02915302|54756902|FG001|Overall Study|Lost to Follow-up|22|||
28100437|NCT02915302|54756901|FG000|Overall Study|Withdrawal by Subject|22|||
28100438|NCT02915302|54756902|FG001|Overall Study|Withdrawal by Subject|29|||
28100439|NCT02915302|54756901|FG000|Overall Study|Other|1|||
28100440|NCT02915302|54756902|FG001|Overall Study|Other|0|||
28100441|NCT03023878|54756908|FG000|Pre-Study Run-In Period|Protocol-specified criteria|11|||
28100442|NCT03023878|54756908|FG000|Pre-Study Run-In Period|Death|1|||
28100443|NCT03023878|54756908|FG000|Pre-Study Run-In Period|Withdrawal by Subject|5|||
28100444|NCT03023878|54756908|FG000|Between Run-In and Treatment Periods|Protocol-specified criteria|2|||
28100445|NCT03023878|54756908|FG000|Treatment Period|Disease Progression|1|||
28100446|NCT03023878|54756908|FG000|Treatment Period|Withdrawal by Subject|1|||
28100447|NCT03023878|54756908|FG000|Treatment Period|Adverse Event|1|||
28100448|NCT03023878|54756908|FG000|Long Term Follow-Up Period|Death|2|||
28100449|NCT03022630|54756914|FG000|Overall Study|Death|9|||
28100450|NCT03022630|54756915|FG001|Overall Study|Death|7|||
28100451|NCT03022630|54756914|FG000|Overall Study|Withdrawal by Subject|0|||
28100452|NCT03022630|54756915|FG001|Overall Study|Withdrawal by Subject|5|||
28100453|NCT03023722|54756926|FG000|Overall Study|No follow-up assessment|4|||
28100454|NCT03022084|54756932|FG000|Overall Study|Lost to Follow-up|2|||
28100455|NCT03022084|54756933|FG001|Overall Study|Lost to Follow-up|3|||
28100456|NCT03021304|54756939|FG000|Overall Study|Lack of Efficacy|1|||
27916377|NCT01176565|54574236|FG000|Overall Study|Not Analyzed (any other reason)|1|||
27916378|NCT01176565|54574237|FG001|Overall Study|Not Analyzed (any other reason)|2|||
27916379|NCT01176292|54574245|FG000|Overall Study|Lost to Follow-up|2|||
27916380|NCT01176292|54574246|FG001|Overall Study|Lost to Follow-up|4|||
27916381|NCT01176292|54574245|FG000|Overall Study|Adverse Event|1|||
27916382|NCT01176292|54574246|FG001|Overall Study|Adverse Event|1|||
27916383|NCT01176292|54574245|FG000|Overall Study|Physician Decision|0|||
27916384|NCT01176292|54574246|FG001|Overall Study|Physician Decision|2|||
27916385|NCT01176292|54574245|FG000|Overall Study|Has not scheduled one-year visit yet|2|||
27916386|NCT01176292|54574246|FG001|Overall Study|Has not scheduled one-year visit yet|2|||
27916387|NCT01113541|54574252|FG000|Overall Study|Withdrawal by Subject|1|||
27916388|NCT01113541|54574252|FG000|Overall Study|Protocol Violation|1|||
27916389|NCT01113541|54574252|FG000|Overall Study|Study Terminated by Sponsor|7|||
27916390|NCT01113541|54574252|FG000|Overall Study|Adverse Event|4|||
27916391|NCT01113502|54574265|FG000|Overall Study|Withdrawal by Subject|1|||
27916392|NCT01113502|54574266|FG001|Overall Study|Withdrawal by Subject|0|||
27916393|NCT01113502|54574267|FG002|Overall Study|Withdrawal by Subject|1|||
27916394|NCT01113502|54574268|FG003|Overall Study|Withdrawal by Subject|1|||
27916395|NCT01113502|54574269|FG004|Overall Study|Withdrawal by Subject|0|||
27916396|NCT01113502|54574265|FG000|Overall Study|Adverse Event|0|||
28003825|NCT00584805|54662632|FG000|Overall Study|Relocation|36|||
28003826|NCT00584805|54662632|FG000|Overall Study|Withdrawal by Subject|18|||
28100457|NCT01979536|54756945|FG000|Overall Study|Physician Decision|2|||
28100458|NCT01979536|54756946|FG001|Overall Study|Physician Decision|3|||
28100459|NCT01979536|54756945|FG000|Overall Study|Withdrawal by Subject|0|||
28100460|NCT01979536|54756946|FG001|Overall Study|Withdrawal by Subject|1|||
28100461|NCT01979536|54756945|FG000|Overall Study|Refusal|0|||
28100462|NCT01979536|54756946|FG001|Overall Study|Refusal|1|||
28100463|NCT01979536|54756945|FG000|Overall Study|Relapse|0|||
28100464|NCT01979536|54756946|FG001|Overall Study|Relapse|1|||
27916397|NCT01113502|54574266|FG001|Overall Study|Adverse Event|0|||
28100465|NCT01979536|54756945|FG000|Overall Study|Study terminated by Sponsor|0|||
28100466|NCT01979536|54756946|FG001|Overall Study|Study terminated by Sponsor|1|||
28003827|NCT00584805|54662632|FG000|Overall Study|Non-compliance|1|||
28003828|NCT00584805|54662632|FG000|Overall Study|Lost to follow up|3|||
27916398|NCT01113502|54574267|FG002|Overall Study|Adverse Event|3|||
27916399|NCT01113502|54574268|FG003|Overall Study|Adverse Event|2|||
28003829|NCT00584805|54662632|FG000|Overall Study|Screen failures|2|||
28003830|NCT00765674|54662642|FG000|Overall Study|Adverse Event|7|||
28003831|NCT00765674|54662643|FG001|Overall Study|Adverse Event|2|||
28003832|NCT00765674|54662644|FG002|Overall Study|Adverse Event|8|||
28003833|NCT00765674|54662645|FG003|Overall Study|Adverse Event|11|||
28003834|NCT00765674|54662642|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
28003835|NCT00765674|54662643|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
28003836|NCT00765674|54662644|FG002|Overall Study|Abnormal Laboratory Value(s)|1|||
28003837|NCT00765674|54662645|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
28003838|NCT00765674|54662642|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
28003839|NCT00765674|54662643|FG001|Overall Study|Abnormal Test Procedure Result(s)|3|||
28003840|NCT00765674|54662644|FG002|Overall Study|Abnormal Test Procedure Result(s)|1|||
28003841|NCT00765674|54662645|FG003|Overall Study|Abnormal Test Procedure Result(s)|2|||
28003842|NCT00765674|54662642|FG000|Overall Study|Lack of Efficacy|2|||
28003843|NCT00765674|54662643|FG001|Overall Study|Lack of Efficacy|3|||
28003844|NCT00765674|54662644|FG002|Overall Study|Lack of Efficacy|1|||
28003845|NCT00765674|54662645|FG003|Overall Study|Lack of Efficacy|2|||
28003846|NCT00765674|54662642|FG000|Overall Study|Protocol Violation|2|||
27739914|NCT02786537|54189682|FG005|As Randomized|Non-compliance with study drug|1|||
27739915|NCT02786537|54189677|FG000|As Randomized|Lost to treatment follow-up|4|||
27739916|NCT02786537|54189678|FG001|As Randomized|Lost to treatment follow-up|32|||
27739917|NCT02786537|54189679|FG002|As Randomized|Lost to treatment follow-up|0|||
27739918|NCT02786537|54189680|FG003|As Randomized|Lost to treatment follow-up|24|||
27739919|NCT02786537|54189681|FG004|As Randomized|Lost to treatment follow-up|4|||
27739920|NCT02786537|54189682|FG005|As Randomized|Lost to treatment follow-up|4|||
27739921|NCT02786537|54189677|FG000|As Randomized|Incarceration|0|||
27739922|NCT02786537|54189678|FG001|As Randomized|Incarceration|1|||
27739923|NCT02786537|54189679|FG002|As Randomized|Incarceration|0|||
27739924|NCT02786537|54189680|FG003|As Randomized|Incarceration|0|||
27916400|NCT01113502|54574269|FG004|Overall Study|Adverse Event|0|||
28003847|NCT00765674|54662643|FG001|Overall Study|Protocol Violation|0|||
28003848|NCT00765674|54662644|FG002|Overall Study|Protocol Violation|1|||
28003849|NCT00765674|54662645|FG003|Overall Study|Protocol Violation|0|||
28003850|NCT00765674|54662642|FG000|Overall Study|Withdrawal by Subject|5|||
28003851|NCT00765674|54662643|FG001|Overall Study|Withdrawal by Subject|7|||
28003852|NCT00765674|54662644|FG002|Overall Study|Withdrawal by Subject|3|||
28003853|NCT00765674|54662645|FG003|Overall Study|Withdrawal by Subject|8|||
28003854|NCT00765674|54662642|FG000|Overall Study|Lost to Follow-up|4|||
28003855|NCT00765674|54662643|FG001|Overall Study|Lost to Follow-up|6|||
28100467|NCT01979536|54756945|FG000|Overall Study|Did not start treatment|0|||
28100468|NCT01979536|54756946|FG001|Overall Study|Did not start treatment|1|||
28100469|NCT03496298|54756963|FG000|Overall Study|Adverse Event|49|||
28100470|NCT03496298|54756964|FG001|Overall Study|Adverse Event|68|||
28100471|NCT03496298|54756965|FG002|Overall Study|Adverse Event|79|||
28100472|NCT03496298|54756963|FG000|Overall Study|Study terminated by Sponsor|1050|||
28100473|NCT03496298|54756964|FG001|Overall Study|Study terminated by Sponsor|1063|||
28100474|NCT03496298|54756965|FG002|Overall Study|Study terminated by Sponsor|1071|||
28100475|NCT03496298|54756963|FG000|Overall Study|Physician decision (other than Adverse event)|12|||
28100476|NCT03496298|54756964|FG001|Overall Study|Physician decision (other than Adverse event)|17|||
28100477|NCT03496298|54756965|FG002|Overall Study|Physician decision (other than Adverse event)|10|||
28100478|NCT03496298|54756963|FG000|Overall Study|Withdrawal by Subject|176|||
28100479|NCT03496298|54756964|FG001|Overall Study|Withdrawal by Subject|154|||
28100480|NCT03496298|54756965|FG002|Overall Study|Withdrawal by Subject|151|||
28100481|NCT03496298|54756963|FG000|Overall Study|Other|29|||
28100482|NCT03496298|54756964|FG001|Overall Study|Other|20|||
27916401|NCT01113463|54574282|FG000|Overall Study|Physician Decision|5|||
28100483|NCT03496298|54756965|FG002|Overall Study|Other|23|||
27916402|NCT01112917|54574286|FG000|Overall Study|Death|2|||
27916403|NCT01112917|54574287|FG001|Overall Study|Death|11|||
27916404|NCT01112917|54574286|FG000|Overall Study|Lost to Follow-up|1|||
27916405|NCT01112917|54574287|FG001|Overall Study|Lost to Follow-up|1|||
27916406|NCT01112917|54574286|FG000|Overall Study|Withdrawal by Subject|1|||
27916407|NCT01112917|54574287|FG001|Overall Study|Withdrawal by Subject|3|||
27916408|NCT01112917|54574286|FG000|Overall Study|Unable to Convert Filter|3|||
27739925|NCT02786537|54189681|FG004|As Randomized|Incarceration|0|||
27739926|NCT02786537|54189682|FG005|As Randomized|Incarceration|0|||
27916409|NCT01112917|54574287|FG001|Overall Study|Unable to Convert Filter|0|||
27916410|NCT01176058|54574293|FG000|Overall Study|Adverse Event|1|||
27916411|NCT01176058|54574294|FG001|Overall Study|Adverse Event|0|||
28003856|NCT00765674|54662644|FG002|Overall Study|Lost to Follow-up|2|||
28003857|NCT00765674|54662645|FG003|Overall Study|Lost to Follow-up|1|||
28003858|NCT00765674|54662642|FG000|Overall Study|Randomized in Error - No Study Drug|0|||
28003859|NCT00765674|54662643|FG001|Overall Study|Randomized in Error - No Study Drug|1|||
28003860|NCT00765674|54662644|FG002|Overall Study|Randomized in Error - No Study Drug|0|||
28003861|NCT00765674|54662645|FG003|Overall Study|Randomized in Error - No Study Drug|1|||
28003862|NCT00765362|54662655|FG000|Overall Study|Death|9|||
28003863|NCT00765362|54662655|FG000|Overall Study|Adverse Event|2|||
28003864|NCT00765362|54662655|FG000|Overall Study|Protocol Violation|18|||
28003865|NCT00765362|54662655|FG000|Overall Study|Withdrawal by Subject|13|||
28003866|NCT00765362|54662655|FG000|Overall Study|Lost to Follow-up|95|||
28003867|NCT00586898|54662659|FG000|Overall Study|Adverse Event|1|||
28003868|NCT00586898|54662659|FG000|Overall Study|Patiemt Non-compliance|1|||
28003869|NCT00586898|54662659|FG000|Overall Study|Evaluable for Toxicity Only|5|||
28003870|NCT04912245|54662663|FG000|Overall Study|Withdrawal by Subject|21|||
28003871|NCT04912245|54662664|FG001|Overall Study|Withdrawal by Subject|4|||
27916412|NCT01176058|54574293|FG000|Overall Study|Insufficient clinical response|2|||
27916413|NCT01176058|54574294|FG001|Overall Study|Insufficient clinical response|2|||
27916414|NCT01176058|54574293|FG000|Overall Study|Insufficient mycological response|0|||
27916415|NCT01176058|54574294|FG001|Overall Study|Insufficient mycological response|1|||
27916416|NCT01176058|54574293|FG000|Overall Study|Withdrawal by Subject|1|||
27916417|NCT01176058|54574294|FG001|Overall Study|Withdrawal by Subject|0|||
27916418|NCT01175824|54574302|FG000|Overall Study|Adverse Event|2|||
27916419|NCT01175824|54574303|FG001|Overall Study|Adverse Event|1|||
27916420|NCT01175824|54574302|FG000|Overall Study|Lack of Efficacy|2|||
27916421|NCT01175824|54574303|FG001|Overall Study|Lack of Efficacy|0|||
27916422|NCT01175824|54574302|FG000|Overall Study|Lost to Follow-up|0|||
27916423|NCT01175824|54574303|FG001|Overall Study|Lost to Follow-up|1|||
27916424|NCT01175824|54574302|FG000|Overall Study|Physician Decision|0|||
27916425|NCT01175824|54574303|FG001|Overall Study|Physician Decision|4|||
27916426|NCT01175824|54574302|FG000|Overall Study|Protocol Violation|2|||
27916427|NCT01175824|54574303|FG001|Overall Study|Protocol Violation|5|||
27916428|NCT01175824|54574302|FG000|Overall Study|Withdrawal by Subject|3|||
27916429|NCT01175824|54574303|FG001|Overall Study|Withdrawal by Subject|7|||
27916430|NCT01175824|54574302|FG000|Overall Study|Sponsor Decision|1|||
27916431|NCT01175824|54574303|FG001|Overall Study|Sponsor Decision|0|||
27916432|NCT01175824|54574302|FG000|Overall Study|Entry Criteria Not Met|6|||
27916433|NCT01175824|54574303|FG001|Overall Study|Entry Criteria Not Met|4|||
27916434|NCT01175707|54574311|FG000|Overall Study|Adverse Event|4|||
27916435|NCT01175707|54574312|FG001|Overall Study|Adverse Event|6|||
27916436|NCT01112059|54574321|FG000|Overall Study|Withdrawal by Subject|1|||
27916437|NCT01112059|54574322|FG001|Overall Study|Withdrawal by Subject|0|||
27916438|NCT01175668|54574333|FG000|Overall Study|Withdrawal by Subject|2|||
27916439|NCT01175668|54574334|FG001|Overall Study|Withdrawal by Subject|0|||
27916440|NCT01111825|54574344|FG000|Overall Study|Withdrawal by Subject|0|||
27916441|NCT01111825|54574345|FG001|Overall Study|Withdrawal by Subject|0|||
27916442|NCT01111825|54574346|FG002|Overall Study|Withdrawal by Subject|1|||
27916443|NCT01111825|54574347|FG003|Overall Study|Withdrawal by Subject|0|||
27916444|NCT01111825|54574344|FG000|Overall Study|Lost to Follow-up|0|||
27916445|NCT01111825|54574345|FG001|Overall Study|Lost to Follow-up|0|||
27916446|NCT01111825|54574346|FG002|Overall Study|Lost to Follow-up|3|||
27916447|NCT01111825|54574347|FG003|Overall Study|Lost to Follow-up|1|||
27916448|NCT01111825|54574344|FG000|Overall Study|Adverse Event|2|||
28003872|NCT04912245|54662663|FG000|Overall Study|Lost to Follow-up|5|||
28100484|NCT03496298|54756963|FG000|Overall Study|Randomized and not treated|1|||
28100485|NCT03496298|54756964|FG001|Overall Study|Randomized and not treated|1|||
28100486|NCT03496298|54756965|FG002|Overall Study|Randomized and not treated|1|||
28100487|NCT02914522|54756978|FG000|Induction Study: Up to Week 11|Adverse Event|5|||
28100488|NCT02914522|54756979|FG001|Induction Study: Up to Week 11|Adverse Event|6|||
28100489|NCT02914522|54756980|FG002|Induction Study: Up to Week 11|Adverse Event|4|||
28100490|NCT02914522|54756981|FG003|Induction Study: Up to Week 11|Adverse Event|18|||
28100491|NCT02914522|54756982|FG004|Induction Study: Up to Week 11|Adverse Event|14|||
28100492|NCT02914522|54756983|FG005|Induction Study: Up to Week 11|Adverse Event|10|||
28100493|NCT02914522|54756984|FG006|Induction Study: Up to Week 11|Adverse Event|0|||
28100494|NCT02914522|54756985|FG007|Induction Study: Up to Week 11|Adverse Event|0|||
27916449|NCT01111825|54574345|FG001|Overall Study|Adverse Event|1|||
27916450|NCT01111825|54574346|FG002|Overall Study|Adverse Event|4|||
27916451|NCT01111825|54574347|FG003|Overall Study|Adverse Event|0|||
27916452|NCT01111825|54574344|FG000|Overall Study|Disease Progression|1|||
27916453|NCT01111825|54574345|FG001|Overall Study|Disease Progression|0|||
27916454|NCT01111825|54574346|FG002|Overall Study|Disease Progression|0|||
28003873|NCT04912245|54662664|FG001|Overall Study|Lost to Follow-up|11|||
28003874|NCT00796991|54662671|FG000|Overall Study|Adverse Event|0|||
28003875|NCT00796991|54662672|FG001|Overall Study|Adverse Event|0|||
28100495|NCT02914522|54756986|FG008|Induction Study: Up to Week 11|Adverse Event|0|||
28100496|NCT02914522|54756987|FG009|Induction Study: Up to Week 11|Adverse Event|0|||
27916455|NCT01111825|54574347|FG003|Overall Study|Disease Progression|0|||
28003876|NCT00796991|54662673|FG002|Overall Study|Adverse Event|1|||
28003877|NCT00796991|54662671|FG000|Overall Study|Death|2|||
28003878|NCT00796991|54662672|FG001|Overall Study|Death|0|||
28100497|NCT02914522|54756988|FG010|Induction Study: Up to Week 11|Adverse Event|0|||
28003879|NCT00796991|54662673|FG002|Overall Study|Death|0|||
28003880|NCT00796991|54662671|FG000|Overall Study|Disease Progression|10|||
28003881|NCT00796991|54662672|FG001|Overall Study|Disease Progression|9|||
28003882|NCT00796991|54662673|FG002|Overall Study|Disease Progression|7|||
28003883|NCT00796991|54662671|FG000|Overall Study|Study Drug Toxicity|3|||
28003884|NCT00796991|54662672|FG001|Overall Study|Study Drug Toxicity|3|||
28003885|NCT00796991|54662673|FG002|Overall Study|Study Drug Toxicity|5|||
28003886|NCT00796991|54662671|FG000|Overall Study|Withdrawal by Subject|0|||
28003887|NCT00796991|54662672|FG001|Overall Study|Withdrawal by Subject|0|||
28003888|NCT00796991|54662673|FG002|Overall Study|Withdrawal by Subject|1|||
28003889|NCT00799487|54662684|FG000|Dose Adjustment Period|Lost to Follow-up|1|||
28003890|NCT00799487|54662685|FG001|Dose Adjustment Period|Lost to Follow-up|0|||
28003891|NCT00799487|54662686|FG002|Dose Adjustment Period|Lost to Follow-up|0|||
28003892|NCT00799487|54662684|FG000|Dose Adjustment Period|Adverse Event|2|||
28003893|NCT00799487|54662685|FG001|Dose Adjustment Period|Adverse Event|0|||
28003894|NCT00799487|54662686|FG002|Dose Adjustment Period|Adverse Event|0|||
28003895|NCT00799487|54662684|FG000|Dose Adjustment Period|Optimal Dose Not Achieved|8|||
28003896|NCT00799487|54662685|FG001|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
28003897|NCT00799487|54662686|FG002|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
28003898|NCT00799487|54662684|FG000|Dose Adjustment Period|Investigator Discretion|2|||
28003899|NCT00799487|54662685|FG001|Dose Adjustment Period|Investigator Discretion|0|||
28003900|NCT00799487|54662686|FG002|Dose Adjustment Period|Investigator Discretion|0|||
28003901|NCT00799487|54662684|FG000|Dose Adjustment Period|Withdrawal by Subject|3|||
28003902|NCT00799487|54662685|FG001|Dose Adjustment Period|Withdrawal by Subject|0|||
28003903|NCT00799487|54662686|FG002|Dose Adjustment Period|Withdrawal by Subject|0|||
28003904|NCT00799487|54662684|FG000|Dose Adjustment Period|Parent to home school child (exclusion)|1|||
28003905|NCT00799487|54662685|FG001|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
28003906|NCT00799487|54662686|FG002|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
28003907|NCT00799487|54662684|FG000|Dose Adjustment Period|Child too young (exclusion)|1|||
28003908|NCT00799487|54662685|FG001|Dose Adjustment Period|Child too young (exclusion)|0|||
27916456|NCT01111825|54574344|FG000|Overall Study|Discontinuation by Sponsor|0|||
27916457|NCT01111825|54574345|FG001|Overall Study|Discontinuation by Sponsor|0|||
27916458|NCT01111825|54574346|FG002|Overall Study|Discontinuation by Sponsor|0|||
27916459|NCT01111825|54574347|FG003|Overall Study|Discontinuation by Sponsor|20|||
27916460|NCT01175590|54574359|FG000|Overall Study|Lost to Follow-up|1|||
27916461|NCT01175590|54574360|FG001|Overall Study|Lost to Follow-up|0|||
27916462|NCT01175590|54574359|FG000|Overall Study|Withdrawal by Subject|0|||
27916463|NCT01175590|54574360|FG001|Overall Study|Withdrawal by Subject|2|||
28003909|NCT00799487|54662686|FG002|Dose Adjustment Period|Child too young (exclusion)|0|||
28003910|NCT00799487|54662684|FG000|Dose Adjustment Period|Missed laboratory day 1|1|||
28003911|NCT00799487|54662685|FG001|Dose Adjustment Period|Missed laboratory day 1|0|||
28003912|NCT00799487|54662686|FG002|Dose Adjustment Period|Missed laboratory day 1|0|||
28003913|NCT00799487|54662684|FG000|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2|||
28003914|NCT00799487|54662685|FG001|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
28003915|NCT00799487|54662686|FG002|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
28003916|NCT00799487|54662684|FG000|Double-Blind Assessment Period|Lost to Follow-up|0|||
28003917|NCT00799487|54662685|FG001|Double-Blind Assessment Period|Lost to Follow-up|0|||
28003918|NCT00799487|54662686|FG002|Double-Blind Assessment Period|Lost to Follow-up|1|||
28003919|NCT00799487|54662684|FG000|Double-Blind Assessment Period|Subject was out of the state|0|||
28003920|NCT00799487|54662685|FG001|Double-Blind Assessment Period|Subject was out of the state|0|||
28003921|NCT00799487|54662686|FG002|Double-Blind Assessment Period|Subject was out of the state|1|||
28003922|NCT00799487|54662684|FG000|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
27916464|NCT01175590|54574359|FG000|Overall Study|Adverse Event|4|||
27916465|NCT01175590|54574360|FG001|Overall Study|Adverse Event|0|||
27916466|NCT01175590|54574359|FG000|Overall Study|Physician Decision|1|||
27916467|NCT01175590|54574360|FG001|Overall Study|Physician Decision|4|||
27916468|NCT01175590|54574359|FG000|Overall Study|Lack of Efficacy|1|||
27916469|NCT01175590|54574360|FG001|Overall Study|Lack of Efficacy|1|||
27916470|NCT01175590|54574359|FG000|Overall Study|Residual Bacterial Conjunctivitis|1|||
27916471|NCT01175590|54574360|FG001|Overall Study|Residual Bacterial Conjunctivitis|0|||
28003923|NCT00799487|54662685|FG001|Double-Blind Assessment Period|Overslept and missed lab day 2|1|||
28003924|NCT00799487|54662686|FG002|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
28003925|NCT00584727|54662697|FG000|First Intervention|Discontinuation|0|||
28003926|NCT00584727|54662698|FG001|First Intervention|Discontinuation|0|||
27916472|NCT01175590|54574359|FG000|Overall Study|Treated not as randomized|3|||
27916473|NCT01175590|54574360|FG001|Overall Study|Treated not as randomized|2|||
27916474|NCT01175590|54574359|FG000|Overall Study|Herpes Simplex Dermatitis|1|||
27916475|NCT01175590|54574360|FG001|Overall Study|Herpes Simplex Dermatitis|0|||
28003927|NCT00584727|54662699|FG002|First Intervention|Discontinuation|1|||
28003928|NCT00584727|54662700|FG003|First Intervention|Discontinuation|0|||
28003929|NCT00584727|54662701|FG004|First Intervention|Discontinuation|0|||
28003930|NCT00584727|54662702|FG005|First Intervention|Discontinuation|0|||
27916476|NCT01175590|54574359|FG000|Overall Study|Protocol Violation|0|||
28003931|NCT00584727|54662697|FG000|Third Intervention|Protocol Violation|0|||
28003932|NCT00584727|54662698|FG001|Third Intervention|Protocol Violation|0|||
28003933|NCT00584727|54662699|FG002|Third Intervention|Protocol Violation|1|||
28003934|NCT00584727|54662700|FG003|Third Intervention|Protocol Violation|0|||
28003935|NCT00584727|54662701|FG004|Third Intervention|Protocol Violation|4|||
28003936|NCT00584727|54662702|FG005|Third Intervention|Protocol Violation|2|||
28003937|NCT00799409|54662716|FG000|Overall Study|Withdrawal by Subject|1|||
28003938|NCT00799409|54662717|FG001|Overall Study|Withdrawal by Subject|0|||
28003939|NCT00799409|54662718|FG002|Overall Study|Withdrawal by Subject|0|||
28003940|NCT00799409|54662716|FG000|Overall Study|Lost to Follow-up|1|||
28003941|NCT00799409|54662717|FG001|Overall Study|Lost to Follow-up|0|||
28003942|NCT00799409|54662718|FG002|Overall Study|Lost to Follow-up|0|||
28003943|NCT00799409|54662716|FG000|Overall Study|Optimal Dose Not Achieved|2|||
28003944|NCT00799409|54662717|FG001|Overall Study|Optimal Dose Not Achieved|0|||
28003945|NCT00799409|54662718|FG002|Overall Study|Optimal Dose Not Achieved|0|||
28003946|NCT00799409|54662716|FG000|Overall Study|Failure to follow study protocol)|1|||
28003947|NCT00799409|54662717|FG001|Overall Study|Failure to follow study protocol)|0|||
27739927|NCT02786537|54189677|FG000|As Randomized|Opiate Dependency Relapse|0|||
27739928|NCT02786537|54189678|FG001|As Randomized|Opiate Dependency Relapse|1|||
28003948|NCT00799409|54662718|FG002|Overall Study|Failure to follow study protocol)|0|||
28003949|NCT00799409|54662716|FG000|Overall Study|Did not attend lab school day 1|1|||
28003950|NCT00799409|54662717|FG001|Overall Study|Did not attend lab school day 1|0|||
28003951|NCT00799409|54662718|FG002|Overall Study|Did not attend lab school day 1|0|||
28003952|NCT00799409|54662716|FG000|Overall Study|medication compliance|1|||
28003953|NCT00799409|54662717|FG001|Overall Study|medication compliance|0|||
28003954|NCT00799409|54662718|FG002|Overall Study|medication compliance|0|||
28003955|NCT00782210|54662729|FG000|Overall Study|Adverse Event|21|||
28003956|NCT00782210|54662730|FG001|Overall Study|Adverse Event|17|||
28003957|NCT00782210|54662731|FG002|Overall Study|Adverse Event|16|||
28003958|NCT00782210|54662729|FG000|Overall Study|Lost to Follow-up|2|||
28003959|NCT00782210|54662730|FG001|Overall Study|Lost to Follow-up|1|||
28003960|NCT00782210|54662731|FG002|Overall Study|Lost to Follow-up|2|||
28003961|NCT00782210|54662729|FG000|Overall Study|Withdrawal by Subject|11|||
28003962|NCT00782210|54662730|FG001|Overall Study|Withdrawal by Subject|8|||
28003963|NCT00782210|54662731|FG002|Overall Study|Withdrawal by Subject|11|||
28003964|NCT00782210|54662729|FG000|Overall Study|Non compliance with protocol|0|||
28003965|NCT00782210|54662730|FG001|Overall Study|Non compliance with protocol|3|||
28003966|NCT00782210|54662731|FG002|Overall Study|Non compliance with protocol|2|||
28003967|NCT00782210|54662729|FG000|Overall Study|Lack of Efficacy|13|||
28003968|NCT00782210|54662730|FG001|Overall Study|Lack of Efficacy|4|||
28003969|NCT00782210|54662731|FG002|Overall Study|Lack of Efficacy|1|||
28003970|NCT00782210|54662729|FG000|Overall Study|Other reason not described above|3|||
28003971|NCT00782210|54662730|FG001|Overall Study|Other reason not described above|2|||
28003972|NCT00782210|54662731|FG002|Overall Study|Other reason not described above|3|||
28003973|NCT01558115|54662748|FG000|Overall Study|Withdrawal by Subject|3|||
28003974|NCT01558115|54662748|FG000|Overall Study|Study closed due to poor enrollment|4|||
28003975|NCT00764660|54662771|FG000|Overall Study|Adverse Event|6|||
28003976|NCT00764660|54662772|FG001|Overall Study|Adverse Event|3|||
28003977|NCT00764660|54662771|FG000|Overall Study|Lost to Follow-up|3|||
28003978|NCT00764660|54662772|FG001|Overall Study|Lost to Follow-up|4|||
28003979|NCT00764660|54662771|FG000|Overall Study|Withdrawal by Subject|7|||
28003980|NCT00764660|54662772|FG001|Overall Study|Withdrawal by Subject|3|||
27916477|NCT01175590|54574360|FG001|Overall Study|Protocol Violation|1|||
27916478|NCT01175473|54574369|FG000|Overall Study|Adverse Event|2|||
27916479|NCT01175473|54574370|FG001|Overall Study|Adverse Event|2|||
27916480|NCT01111552|54574376|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|9|||
27916481|NCT01111552|54574377|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
27916482|NCT01111552|54574378|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
27916483|NCT01111552|54574379|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
27916484|NCT01111552|54574380|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
27916485|NCT01111552|54574376|FG000|Phase B (Day 1 to Week 8)|Adverse Event|4|||
27916486|NCT01111552|54574377|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
28003981|NCT00764660|54662771|FG000|Overall Study|Noncompliance With Protocol|5|||
28003982|NCT00764660|54662772|FG001|Overall Study|Noncompliance With Protocol|1|||
28003983|NCT00764660|54662771|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
28003984|NCT00764660|54662772|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
28172752|NCT02745119|54844496|FG002|Overall Study|Adverse Event|1|||
28003985|NCT00584415|54662778|FG000|Overall Study|Adverse Event|7|||
28003986|NCT00764504|54662786|FG000|Overall Study|Death|12|||
28003987|NCT00764504|54662787|FG001|Overall Study|Death|6|||
28003988|NCT00764504|54662788|FG002|Overall Study|Death|13|||
28003989|NCT00764504|54662786|FG000|Overall Study|Revision of Device|12|||
28003990|NCT00764504|54662787|FG001|Overall Study|Revision of Device|23|||
28003991|NCT00764504|54662788|FG002|Overall Study|Revision of Device|14|||
28003992|NCT00764504|54662786|FG000|Overall Study|Physician Decision|1|||
28003993|NCT00764504|54662787|FG001|Overall Study|Physician Decision|0|||
28003994|NCT00764504|54662788|FG002|Overall Study|Physician Decision|0|||
28003995|NCT00764504|54662786|FG000|Overall Study|Withdrawal by Subject|1|||
28003996|NCT00764504|54662787|FG001|Overall Study|Withdrawal by Subject|7|||
28003997|NCT00764504|54662788|FG002|Overall Study|Withdrawal by Subject|4|||
28003998|NCT00764504|54662786|FG000|Overall Study|Lost to Follow-up|40|||
28003999|NCT00764504|54662787|FG001|Overall Study|Lost to Follow-up|34|||
28004000|NCT00764504|54662788|FG002|Overall Study|Lost to Follow-up|72|||
28004001|NCT00763958|54662798|FG000|Overall Study|did not meet final criteria|4|||
28004002|NCT00763958|54662799|FG001|Overall Study|did not meet final criteria|4|||
28004003|NCT00763958|54662798|FG000|Overall Study|Lost to Follow-up|10|||
28004004|NCT00763958|54662799|FG001|Overall Study|Lost to Follow-up|2|||
28004005|NCT00763958|54662798|FG000|Overall Study|Believed they were receiving placebo|0|||
28004006|NCT00763958|54662799|FG001|Overall Study|Believed they were receiving placebo|5|||
28004007|NCT00763256|54662808|FG000|Overall Study|Didn't return for appointments|7|||
28004008|NCT00763256|54662809|FG001|Overall Study|Didn't return for appointments|10|||
28004009|NCT00762788|54662821|FG000|Overall Study|Lost to Follow-up|26|||
28004010|NCT00762788|54662822|FG001|Overall Study|Lost to Follow-up|37|||
28004011|NCT00762788|54662823|FG002|Overall Study|Lost to Follow-up|21|||
28004012|NCT00762788|54662824|FG003|Overall Study|Lost to Follow-up|26|||
28004013|NCT00762788|54662825|FG004|Overall Study|Lost to Follow-up|13|||
28004014|NCT00762788|54662826|FG005|Overall Study|Lost to Follow-up|21|||
28004015|NCT00583947|54662842|FG000|Cross-over Period|Adverse Event|2|||
28004016|NCT00583947|54662843|FG001|Cross-over Period|Adverse Event|0|||
28004017|NCT00583947|54662842|FG000|Cross-over Period|Withdrawal by Subject|2|||
28004018|NCT00583947|54662843|FG001|Cross-over Period|Withdrawal by Subject|0|||
28004019|NCT00583947|54662842|FG000|Cross-over Period|Did not meet-no longer met entry criteri|0|||
28004020|NCT00583947|54662843|FG001|Cross-over Period|Did not meet-no longer met entry criteri|1|||
28004021|NCT00583947|54662842|FG000|Cross-over Period|Other|1|||
28004022|NCT00583947|54662843|FG001|Cross-over Period|Other|1|||
28004023|NCT00772928|54662853|FG000|Overall Study|Lost to Follow-up|9|||
28004024|NCT00772928|54662854|FG001|Overall Study|Lost to Follow-up|6|||
28004025|NCT00772928|54662853|FG000|Overall Study|Protocol Violation|10|||
28004026|NCT00772928|54662854|FG001|Overall Study|Protocol Violation|12|||
28004027|NCT00772928|54662853|FG000|Overall Study|Withdrawal by Subject|25|||
28004028|NCT00772928|54662854|FG001|Overall Study|Withdrawal by Subject|22|||
28004029|NCT00772928|54662853|FG000|Overall Study|Did not receive vaccine|0|||
28004030|NCT00772928|54662854|FG001|Overall Study|Did not receive vaccine|1|||
28004031|NCT00762476|54662862|FG000|Overall Study|Adverse Event|7|||
28004032|NCT00762476|54662863|FG001|Overall Study|Adverse Event|1|||
28004033|NCT00762476|54662862|FG000|Overall Study|Lost to Follow-up|2|||
28004034|NCT00762476|54662863|FG001|Overall Study|Lost to Follow-up|0|||
28004035|NCT00762476|54662862|FG000|Overall Study|Protocol Violation|5|||
28004036|NCT00762476|54662863|FG001|Overall Study|Protocol Violation|6|||
28004037|NCT00762476|54662862|FG000|Overall Study|Physician Decision|2|||
28004038|NCT00762476|54662863|FG001|Overall Study|Physician Decision|14|||
28004039|NCT00762476|54662862|FG000|Overall Study|Withdrawal by Subject|6|||
28004040|NCT00762476|54662863|FG001|Overall Study|Withdrawal by Subject|12|||
28004041|NCT00762476|54662862|FG000|Overall Study|antibiotic use|0|||
28004042|NCT00762476|54662863|FG001|Overall Study|antibiotic use|1|||
28004043|NCT00762476|54662862|FG000|Overall Study|non-compliance with study visits|0|||
28004044|NCT00762476|54662863|FG001|Overall Study|non-compliance with study visits|2|||
28004045|NCT00762476|54662862|FG000|Overall Study|Seasonal allergies|1|||
28004046|NCT00762476|54662863|FG001|Overall Study|Seasonal allergies|0|||
28004047|NCT00762164|54662872|FG000|Overall Study|Lost to Follow-up|1|||
28004048|NCT00762164|54662873|FG001|Overall Study|Lost to Follow-up|1|||
28004049|NCT00762164|54662872|FG000|Overall Study|Discontinued medication|2|||
28004050|NCT00762164|54662873|FG001|Overall Study|Discontinued medication|0|||
28004051|NCT00762164|54662872|FG000|Overall Study|Withdrawal by Subject|0|||
28004052|NCT00762164|54662873|FG001|Overall Study|Withdrawal by Subject|1|||
28100498|NCT02914522|54756978|FG000|Induction Study: Up to Week 11|Withdrew Consent|4|||
28100499|NCT02914522|54756979|FG001|Induction Study: Up to Week 11|Withdrew Consent|11|||
28100500|NCT02914522|54756980|FG002|Induction Study: Up to Week 11|Withdrew Consent|4|||
28100501|NCT02914522|54756981|FG003|Induction Study: Up to Week 11|Withdrew Consent|6|||
28100502|NCT02914522|54756982|FG004|Induction Study: Up to Week 11|Withdrew Consent|3|||
28004053|NCT00762086|54662881|FG000|Overall Study|Adverse Event|2|||
28004054|NCT00762086|54662882|FG001|Overall Study|Adverse Event|0|||
28004055|NCT00762086|54662881|FG000|Overall Study|Lost to Follow-up|0|||
28004056|NCT00762086|54662882|FG001|Overall Study|Lost to Follow-up|2|||
28004057|NCT00762086|54662881|FG000|Overall Study|Non compliance|1|||
28004058|NCT00762086|54662882|FG001|Overall Study|Non compliance|0|||
28004059|NCT00762086|54662881|FG000|Overall Study|Withdrawal by Subject|2|||
28004060|NCT00762086|54662882|FG001|Overall Study|Withdrawal by Subject|2|||
28100503|NCT02914522|54756983|FG005|Induction Study: Up to Week 11|Withdrew Consent|3|||
28100504|NCT02914522|54756984|FG006|Induction Study: Up to Week 11|Withdrew Consent|0|||
28172753|NCT02745119|54844497|FG003|Overall Study|Adverse Event|3|||
28004061|NCT00762086|54662881|FG000|Overall Study|Ineligible to participate in the study|1|||
28004062|NCT00762086|54662882|FG001|Overall Study|Ineligible to participate in the study|0|||
28004063|NCT00761774|54662888|FG000|Overall Study|Adverse Event|17|||
28004064|NCT00761774|54662888|FG000|Overall Study|Lack of Efficacy|37|||
28004065|NCT00761774|54662888|FG000|Overall Study|Lost to Follow-up|2|||
28004066|NCT00761774|54662888|FG000|Overall Study|Withdrawal by Subject|9|||
28004067|NCT00761774|54662888|FG000|Overall Study|Non-compliance|4|||
28004068|NCT00761774|54662888|FG000|Overall Study|End of study|2|||
28004069|NCT00761774|54662888|FG000|Overall Study|Reclassification of seizures|1|||
28004070|NCT00761774|54662888|FG000|Overall Study|Medical decision to read SUSAR reports|1|||
28100505|NCT02914522|54756985|FG007|Induction Study: Up to Week 11|Withdrew Consent|0|||
28100506|NCT02914522|54756986|FG008|Induction Study: Up to Week 11|Withdrew Consent|0|||
28100507|NCT02914522|54756987|FG009|Induction Study: Up to Week 11|Withdrew Consent|0|||
28100508|NCT02914522|54756988|FG010|Induction Study: Up to Week 11|Withdrew Consent|0|||
28100509|NCT02914522|54756978|FG000|Induction Study: Up to Week 11|Protocol Violation|0|||
28100510|NCT02914522|54756979|FG001|Induction Study: Up to Week 11|Protocol Violation|2|||
28100511|NCT02914522|54756980|FG002|Induction Study: Up to Week 11|Protocol Violation|1|||
28100512|NCT02914522|54756981|FG003|Induction Study: Up to Week 11|Protocol Violation|3|||
28100513|NCT02914522|54756982|FG004|Induction Study: Up to Week 11|Protocol Violation|4|||
28100514|NCT02914522|54756983|FG005|Induction Study: Up to Week 11|Protocol Violation|2|||
28100515|NCT02914522|54756984|FG006|Induction Study: Up to Week 11|Protocol Violation|0|||
28100516|NCT02914522|54756985|FG007|Induction Study: Up to Week 11|Protocol Violation|0|||
28100517|NCT02914522|54756986|FG008|Induction Study: Up to Week 11|Protocol Violation|0|||
28100518|NCT02914522|54756987|FG009|Induction Study: Up to Week 11|Protocol Violation|0|||
28100519|NCT02914522|54756988|FG010|Induction Study: Up to Week 11|Protocol Violation|0|||
28100520|NCT02914522|54756978|FG000|Induction Study: Up to Week 11|Lost to Follow-up|0|||
28100521|NCT02914522|54756979|FG001|Induction Study: Up to Week 11|Lost to Follow-up|2|||
28100522|NCT02914522|54756980|FG002|Induction Study: Up to Week 11|Lost to Follow-up|1|||
28100523|NCT02914522|54756981|FG003|Induction Study: Up to Week 11|Lost to Follow-up|1|||
28100524|NCT02914522|54756982|FG004|Induction Study: Up to Week 11|Lost to Follow-up|0|||
28100525|NCT02914522|54756983|FG005|Induction Study: Up to Week 11|Lost to Follow-up|0|||
28100526|NCT02914522|54756984|FG006|Induction Study: Up to Week 11|Lost to Follow-up|0|||
28100527|NCT02914522|54756985|FG007|Induction Study: Up to Week 11|Lost to Follow-up|0|||
28100528|NCT02914522|54756986|FG008|Induction Study: Up to Week 11|Lost to Follow-up|0|||
28100529|NCT02914522|54756987|FG009|Induction Study: Up to Week 11|Lost to Follow-up|0|||
28100530|NCT02914522|54756988|FG010|Induction Study: Up to Week 11|Lost to Follow-up|0|||
28100531|NCT02914522|54756978|FG000|Induction Study: Up to Week 11|Investigator's Discretion|0|||
28100532|NCT02914522|54756979|FG001|Induction Study: Up to Week 11|Investigator's Discretion|0|||
28100533|NCT02914522|54756980|FG002|Induction Study: Up to Week 11|Investigator's Discretion|0|||
28100534|NCT02914522|54756981|FG003|Induction Study: Up to Week 11|Investigator's Discretion|0|||
28100535|NCT02914522|54756982|FG004|Induction Study: Up to Week 11|Investigator's Discretion|1|||
28100536|NCT02914522|54756983|FG005|Induction Study: Up to Week 11|Investigator's Discretion|0|||
28100537|NCT02914522|54756984|FG006|Induction Study: Up to Week 11|Investigator's Discretion|0|||
28100538|NCT02914522|54756985|FG007|Induction Study: Up to Week 11|Investigator's Discretion|0|||
28100539|NCT02914522|54756986|FG008|Induction Study: Up to Week 11|Investigator's Discretion|0|||
28100540|NCT02914522|54756987|FG009|Induction Study: Up to Week 11|Investigator's Discretion|0|||
28100541|NCT02914522|54756988|FG010|Induction Study: Up to Week 11|Investigator's Discretion|0|||
28100542|NCT02914522|54756978|FG000|Induction Study: Up to Week 11|Non-compliance With Study Drug|1|||
28100543|NCT02914522|54756979|FG001|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
28100544|NCT02914522|54756980|FG002|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
28100545|NCT02914522|54756981|FG003|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
28100546|NCT02914522|54756982|FG004|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
28172754|NCT02745119|54844494|FG000|Overall Study|Death|3|||
28172755|NCT02745119|54844495|FG001|Overall Study|Death|3|||
28172756|NCT02745119|54844496|FG002|Overall Study|Death|0|||
28172757|NCT02745119|54844497|FG003|Overall Study|Death|4|||
28172758|NCT02745119|54844494|FG000|Overall Study|Lost to Follow-up|0|||
28172759|NCT02745119|54844495|FG001|Overall Study|Lost to Follow-up|0|||
28172760|NCT02745119|54844496|FG002|Overall Study|Lost to Follow-up|0|||
28172761|NCT02745119|54844497|FG003|Overall Study|Lost to Follow-up|1|||
28004071|NCT00761774|54662888|FG000|Overall Study|Sponsor decision|1|||
28004072|NCT00761774|54662888|FG000|Overall Study|Investigator clinical judgement|1|||
28004073|NCT00761774|54662888|FG000|Overall Study|Patient moved out of study area|1|||
28100547|NCT02914522|54756983|FG005|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
28100548|NCT02914522|54756984|FG006|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
28100549|NCT02914522|54756985|FG007|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
28100550|NCT02914522|54756986|FG008|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
28100551|NCT02914522|54756987|FG009|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
28100552|NCT02914522|54756988|FG010|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
28172762|NCT02745119|54844494|FG000|Overall Study|Protocol Deviation|0|||
28172763|NCT02745119|54844495|FG001|Overall Study|Protocol Deviation|0|||
28004074|NCT00761774|54662888|FG000|Overall Study|Coordinator leaving site|1|||
28004075|NCT00761774|54662888|FG000|Overall Study|Subject IP non-compliance|1|||
28004076|NCT00761774|54662888|FG000|Overall Study|IP stopped by hospital physician|1|||
28004077|NCT00583791|54662894|FG000|Overall Study|Other|67|||
28004078|NCT00583791|54662894|FG000|Overall Study|Death|6|||
28004079|NCT00781274|54662898|FG000|Overall Study|Withdrawal by Subject|2|||
28004080|NCT00780416|54662904|FG000|Overall Study|Physician Decision|3|||
28004081|NCT00780416|54662905|FG001|Overall Study|Physician Decision|3|||
28004082|NCT00780416|54662904|FG000|Overall Study|Protocol Violation|1|||
28004083|NCT00780416|54662905|FG001|Overall Study|Protocol Violation|0|||
28004084|NCT00780416|54662904|FG000|Overall Study|Withdrawal by Subject|8|||
28004085|NCT00780416|54662905|FG001|Overall Study|Withdrawal by Subject|6|||
28004086|NCT00761462|54662913|FG000|Treatment|Subjects never received study medication|23|||
28004087|NCT00761462|54662914|FG001|Treatment|Subjects never received study medication|12|||
28004088|NCT00761462|54662913|FG000|2 or 5 Years Long-term Safety Follow-up|Death|4|||
28004089|NCT00761462|54662914|FG001|2 or 5 Years Long-term Safety Follow-up|Death|0|||
28004090|NCT00761462|54662913|FG000|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75|||
28004091|NCT00761462|54662914|FG001|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30|||
28004092|NCT00761462|54662913|FG000|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75|||
28100553|NCT02914522|54756978|FG000|Induction Study: Up to Week 11|Pregnancy|0|||
28100554|NCT02914522|54756979|FG001|Induction Study: Up to Week 11|Pregnancy|0|||
28100555|NCT02914522|54756980|FG002|Induction Study: Up to Week 11|Pregnancy|0|||
28100556|NCT02914522|54756981|FG003|Induction Study: Up to Week 11|Pregnancy|0|||
28100557|NCT02914522|54756982|FG004|Induction Study: Up to Week 11|Pregnancy|1|||
28100558|NCT02914522|54756983|FG005|Induction Study: Up to Week 11|Pregnancy|0|||
28100559|NCT02914522|54756984|FG006|Induction Study: Up to Week 11|Pregnancy|0|||
28100560|NCT02914522|54756985|FG007|Induction Study: Up to Week 11|Pregnancy|0|||
28100561|NCT02914522|54756986|FG008|Induction Study: Up to Week 11|Pregnancy|0|||
28100562|NCT02914522|54756987|FG009|Induction Study: Up to Week 11|Pregnancy|0|||
28100563|NCT02914522|54756988|FG010|Induction Study: Up to Week 11|Pregnancy|0|||
28100564|NCT02914522|54756978|FG000|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
28100565|NCT02914522|54756979|FG001|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
28100566|NCT02914522|54756980|FG002|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
28100567|NCT02914522|54756981|FG003|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
28100568|NCT02914522|54756982|FG004|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
28100569|NCT02914522|54756983|FG005|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
28100570|NCT02914522|54756984|FG006|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
28100571|NCT02914522|54756985|FG007|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
28100572|NCT02914522|54756986|FG008|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
28100573|NCT02914522|54756987|FG009|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
28100574|NCT02914522|54756988|FG010|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
28100575|NCT02914522|54756978|FG000|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
28100576|NCT02914522|54756979|FG001|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
28100577|NCT02914522|54756980|FG002|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
28100578|NCT02914522|54756981|FG003|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
28100579|NCT02914522|54756982|FG004|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
28100580|NCT02914522|54756983|FG005|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
28100581|NCT02914522|54756984|FG006|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|34|||
28100582|NCT02914522|54756985|FG007|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|49|||
28100583|NCT02914522|54756986|FG008|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|53|||
28100584|NCT02914522|54756987|FG009|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|39|||
28100585|NCT02914522|54756988|FG010|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|21|||
28100586|NCT02914522|54756978|FG000|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
28100587|NCT02914522|54756979|FG001|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
28100588|NCT02914522|54756980|FG002|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
28100589|NCT02914522|54756981|FG003|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
28100590|NCT02914522|54756982|FG004|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
28100591|NCT02914522|54756983|FG005|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
28100592|NCT02914522|54756984|FG006|Maintenance Study: Week 11 to Week 58|Adverse Event|7|||
28100593|NCT02914522|54756985|FG007|Maintenance Study: Week 11 to Week 58|Adverse Event|2|||
28100594|NCT02914522|54756986|FG008|Maintenance Study: Week 11 to Week 58|Adverse Event|10|||
28100595|NCT02914522|54756987|FG009|Maintenance Study: Week 11 to Week 58|Adverse Event|4|||
28100596|NCT02914522|54756988|FG010|Maintenance Study: Week 11 to Week 58|Adverse Event|3|||
28004093|NCT00761462|54662914|FG001|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21|||
28004094|NCT00761306|54662920|FG000|Overall Study|Adverse Event|5|||
28004095|NCT00761306|54662920|FG000|Overall Study|Lack of Efficacy|4|||
28004096|NCT00761306|54662920|FG000|Overall Study|Protocol Violation|2|||
28004097|NCT00761306|54662920|FG000|Overall Study|Withdrawal of Consent|3|||
28004098|NCT00761306|54662920|FG000|Overall Study|Lost to Follow-up|1|||
28004099|NCT00761306|54662920|FG000|Overall Study|Administrative or Other Reasons|5|||
28004100|NCT00772538|54662926|FG000|Overall Study|Adverse Event|6|||
28004101|NCT00772538|54662927|FG001|Overall Study|Adverse Event|6|||
28004102|NCT00772538|54662926|FG000|Overall Study|Protocol Violation|3|||
28004103|NCT00772538|54662927|FG001|Overall Study|Protocol Violation|3|||
28004104|NCT00772538|54662926|FG000|Overall Study|Lost to Follow-up|1|||
28004105|NCT00772538|54662927|FG001|Overall Study|Lost to Follow-up|1|||
28004106|NCT00772538|54662926|FG000|Overall Study|Withdrawal by Subject|3|||
28004107|NCT00772538|54662927|FG001|Overall Study|Withdrawal by Subject|8|||
28004108|NCT00772538|54662926|FG000|Overall Study|Lack of Efficacy|0|||
28004109|NCT00772538|54662927|FG001|Overall Study|Lack of Efficacy|1|||
28004110|NCT00772538|54662926|FG000|Overall Study|Other|7|||
28004111|NCT00772538|54662927|FG001|Overall Study|Other|7|||
28004112|NCT00761150|54662936|FG000|Open-label Period|Adverse Event|36|||
28004113|NCT00761150|54662937|FG001|Open-label Period|Adverse Event|0|||
28004114|NCT00761150|54662938|FG002|Open-label Period|Adverse Event|0|||
28004115|NCT00761150|54662936|FG000|Open-label Period|Did not meet DB randomization criteria|11|||
28004116|NCT00761150|54662937|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
28004117|NCT00761150|54662938|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
28004118|NCT00761150|54662936|FG000|Open-label Period|Lost to Follow-up|7|||
28004119|NCT00761150|54662937|FG001|Open-label Period|Lost to Follow-up|0|||
28004120|NCT00761150|54662938|FG002|Open-label Period|Lost to Follow-up|0|||
28004121|NCT00761150|54662936|FG000|Open-label Period|Lack of Efficacy|4|||
28004122|NCT00761150|54662937|FG001|Open-label Period|Lack of Efficacy|0|||
28004123|NCT00761150|54662938|FG002|Open-label Period|Lack of Efficacy|0|||
28004124|NCT00761150|54662936|FG000|Open-label Period|Withdrawal by Subject|5|||
28004125|NCT00761150|54662937|FG001|Open-label Period|Withdrawal by Subject|0|||
28004126|NCT00761150|54662938|FG002|Open-label Period|Withdrawal by Subject|0|||
28004127|NCT00761150|54662936|FG000|Open-label Period|Noncompliance|2|||
28004128|NCT00761150|54662937|FG001|Open-label Period|Noncompliance|0|||
28004129|NCT00761150|54662938|FG002|Open-label Period|Noncompliance|0|||
28004130|NCT00761150|54662936|FG000|Open-label Period|Other|5|||
27916487|NCT01111552|54574378|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
27916488|NCT01111552|54574379|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
27916489|NCT01111552|54574380|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
28004131|NCT00761150|54662937|FG001|Open-label Period|Other|0|||
28004132|NCT00761150|54662938|FG002|Open-label Period|Other|0|||
28004133|NCT00761150|54662936|FG000|Double-blind Period|Lack of Efficacy|0|||
28004134|NCT00761150|54662937|FG001|Double-blind Period|Lack of Efficacy|2|||
28100597|NCT02914522|54756978|FG000|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
27916490|NCT01111552|54574376|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|89|||
27916491|NCT01111552|54574377|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
27916492|NCT01111552|54574378|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
27916493|NCT01111552|54574379|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
27916494|NCT01111552|54574380|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
27916495|NCT01111552|54574376|FG000|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|3|||
27916496|NCT01111552|54574377|FG001|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
27916497|NCT01111552|54574378|FG002|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
27916498|NCT01111552|54574379|FG003|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
27916499|NCT01111552|54574380|FG004|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
27916500|NCT01111552|54574376|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|3|||
27916501|NCT01111552|54574377|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
27916502|NCT01111552|54574378|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
27916503|NCT01111552|54574379|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
27916504|NCT01111552|54574380|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
27916505|NCT01111552|54574376|FG000|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|7|||
27916506|NCT01111552|54574377|FG001|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
27916507|NCT01111552|54574378|FG002|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
27916508|NCT01111552|54574379|FG003|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
27916509|NCT01111552|54574380|FG004|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
27916510|NCT01111552|54574376|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|1|||
28004135|NCT00761150|54662938|FG002|Double-blind Period|Lack of Efficacy|19|||
28004136|NCT00761150|54662936|FG000|Double-blind Period|Adverse Event|0|||
28004137|NCT00761150|54662937|FG001|Double-blind Period|Adverse Event|3|||
28004138|NCT00761150|54662938|FG002|Double-blind Period|Adverse Event|3|||
28004139|NCT00761150|54662936|FG000|Double-blind Period|Withdrawal by Subject|0|||
28100598|NCT02914522|54756979|FG001|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
28004140|NCT00761150|54662937|FG001|Double-blind Period|Withdrawal by Subject|3|||
28004141|NCT00761150|54662938|FG002|Double-blind Period|Withdrawal by Subject|2|||
28004142|NCT00761150|54662936|FG000|Double-blind Period|Lost to Follow-up|0|||
28004143|NCT00761150|54662937|FG001|Double-blind Period|Lost to Follow-up|2|||
28004144|NCT00761150|54662938|FG002|Double-blind Period|Lost to Follow-up|1|||
28004145|NCT00761150|54662936|FG000|Double-blind Period|Did not meet DB randomization criteria|0|||
28004146|NCT00761150|54662937|FG001|Double-blind Period|Did not meet DB randomization criteria|0|||
28004147|NCT00761150|54662938|FG002|Double-blind Period|Did not meet DB randomization criteria|1|||
28004148|NCT00761150|54662936|FG000|Double-blind Period|Noncompliance|0|||
28004149|NCT00761150|54662937|FG001|Double-blind Period|Noncompliance|1|||
28004150|NCT00761150|54662938|FG002|Double-blind Period|Noncompliance|0|||
28004151|NCT00761150|54662936|FG000|Double-blind Period|Other|0|||
28004152|NCT00761150|54662937|FG001|Double-blind Period|Other|3|||
28004153|NCT00761150|54662938|FG002|Double-blind Period|Other|3|||
28004154|NCT00760994|54662948|FG000|Overall Study|Lost to Follow-up|4|||
28004155|NCT00760994|54662949|FG001|Overall Study|Lost to Follow-up|4|||
28004156|NCT00760994|54662950|FG002|Overall Study|Lost to Follow-up|3|||
28004157|NCT00583557|54662960|FG000|Overall Study|Withdrawal by Subject|18|||
28004158|NCT00583557|54662960|FG000|Overall Study|Adverse Event|9|||
28004159|NCT00583557|54662960|FG000|Overall Study|Lack of Efficacy|31|||
28004160|NCT00583557|54662960|FG000|Overall Study|Lack of Compliance|5|||
28004161|NCT00583557|54662960|FG000|Overall Study|Other|5|||
28004162|NCT00583557|54662960|FG000|Overall Study|Did not receive belimumab in LBRA99|2|||
28004163|NCT00586820|54662966|FG000|Overall Study|Unsuccessful PCI|1|||
28004164|NCT00586820|54662967|FG001|Overall Study|Unsuccessful PCI|0|||
28004165|NCT00760838|54662975|FG000|Overall Study|Adverse Event|1|||
28004166|NCT00760838|54662976|FG001|Overall Study|Adverse Event|1|||
28004167|NCT00760838|54662975|FG000|Overall Study|Lack of Efficacy|1|||
28004168|NCT00760838|54662976|FG001|Overall Study|Lack of Efficacy|0|||
28004169|NCT00760838|54662975|FG000|Overall Study|Lost to Follow-up|2|||
28004170|NCT00760838|54662976|FG001|Overall Study|Lost to Follow-up|0|||
28004171|NCT00760838|54662975|FG000|Overall Study|Withdrawal by Subject|1|||
28004172|NCT00760838|54662976|FG001|Overall Study|Withdrawal by Subject|1|||
28004173|NCT00586664|54662985|FG000|Overall Study|Withdrawal by Subject|3|||
28004174|NCT00586664|54662986|FG001|Overall Study|Withdrawal by Subject|7|||
28004175|NCT00586664|54662987|FG002|Overall Study|Withdrawal by Subject|1|||
28004176|NCT00586664|54662985|FG000|Overall Study|Exclusion criteria met|2|||
28004177|NCT00586664|54662986|FG001|Overall Study|Exclusion criteria met|0|||
28004178|NCT00586664|54662987|FG002|Overall Study|Exclusion criteria met|0|||
28004179|NCT00437281|54663015|FG000|Overall Study|Adverse Event|0|||
28004180|NCT00437281|54663016|FG001|Overall Study|Adverse Event|0|||
28004181|NCT00437281|54663017|FG002|Overall Study|Adverse Event|0|||
28100599|NCT02914522|54756980|FG002|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
28100600|NCT02914522|54756981|FG003|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
28100601|NCT02914522|54756982|FG004|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
28100602|NCT02914522|54756983|FG005|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
28100603|NCT02914522|54756984|FG006|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
28100604|NCT02914522|54756985|FG007|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
28100605|NCT02914522|54756986|FG008|Maintenance Study: Week 11 to Week 58|Protocol Violation|3|||
28100606|NCT02914522|54756987|FG009|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
28100607|NCT02914522|54756988|FG010|Maintenance Study: Week 11 to Week 58|Protocol Violation|1|||
28100608|NCT02914522|54756978|FG000|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
28100609|NCT02914522|54756979|FG001|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
28100610|NCT02914522|54756980|FG002|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
28100611|NCT02914522|54756981|FG003|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
28100612|NCT02914522|54756982|FG004|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
28100613|NCT02914522|54756983|FG005|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
28100614|NCT02914522|54756984|FG006|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
28100615|NCT02914522|54756985|FG007|Maintenance Study: Week 11 to Week 58|Withdrew Consent|1|||
28100616|NCT02914522|54756986|FG008|Maintenance Study: Week 11 to Week 58|Withdrew Consent|6|||
28100617|NCT02914522|54756987|FG009|Maintenance Study: Week 11 to Week 58|Withdrew Consent|3|||
28100618|NCT02914522|54756988|FG010|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
28100619|NCT02914522|54756978|FG000|Maintenance Study: Week 11 to Week 58|Death|0|||
28100620|NCT02914522|54756979|FG001|Maintenance Study: Week 11 to Week 58|Death|0|||
28004182|NCT00437281|54663018|FG003|Overall Study|Adverse Event|1|||
28004183|NCT00437281|54663019|FG004|Overall Study|Adverse Event|0|||
28004184|NCT00437281|54663020|FG005|Overall Study|Adverse Event|1|||
28004185|NCT00437281|54663021|FG006|Overall Study|Adverse Event|0|||
28004186|NCT00437281|54663022|FG007|Overall Study|Adverse Event|0|||
28004187|NCT00437281|54663023|FG008|Overall Study|Adverse Event|0|||
28004188|NCT00437281|54663024|FG009|Overall Study|Adverse Event|1|||
28004189|NCT00437281|54663025|FG010|Overall Study|Adverse Event|0|||
28004190|NCT00437281|54663026|FG011|Overall Study|Adverse Event|0|||
28004191|NCT00437281|54663027|FG012|Overall Study|Adverse Event|0|||
28004192|NCT00437281|54663028|FG013|Overall Study|Adverse Event|1|||
28004193|NCT00437281|54663029|FG014|Overall Study|Adverse Event|1|||
28004194|NCT00437281|54663030|FG015|Overall Study|Adverse Event|0|||
28004195|NCT00437281|54663031|FG016|Overall Study|Adverse Event|0|||
28004196|NCT00437281|54663032|FG017|Overall Study|Adverse Event|0|||
28004197|NCT00437281|54663033|FG018|Overall Study|Adverse Event|1|||
28004198|NCT00437281|54663034|FG019|Overall Study|Adverse Event|0|||
28004199|NCT00437281|54663015|FG000|Overall Study|Lost to Follow-up|0|||
28004200|NCT00437281|54663016|FG001|Overall Study|Lost to Follow-up|0|||
28004201|NCT00437281|54663017|FG002|Overall Study|Lost to Follow-up|0|||
28004202|NCT00437281|54663018|FG003|Overall Study|Lost to Follow-up|0|||
28004203|NCT00437281|54663019|FG004|Overall Study|Lost to Follow-up|0|||
28004204|NCT00437281|54663020|FG005|Overall Study|Lost to Follow-up|0|||
28004205|NCT00437281|54663021|FG006|Overall Study|Lost to Follow-up|0|||
28004206|NCT00437281|54663022|FG007|Overall Study|Lost to Follow-up|0|||
28004207|NCT00437281|54663023|FG008|Overall Study|Lost to Follow-up|0|||
28004208|NCT00437281|54663024|FG009|Overall Study|Lost to Follow-up|0|||
28004209|NCT00437281|54663025|FG010|Overall Study|Lost to Follow-up|0|||
28004210|NCT00437281|54663026|FG011|Overall Study|Lost to Follow-up|0|||
28004211|NCT00437281|54663027|FG012|Overall Study|Lost to Follow-up|0|||
28004212|NCT00437281|54663028|FG013|Overall Study|Lost to Follow-up|0|||
28004213|NCT00437281|54663029|FG014|Overall Study|Lost to Follow-up|0|||
28004214|NCT00437281|54663030|FG015|Overall Study|Lost to Follow-up|0|||
28004215|NCT00437281|54663031|FG016|Overall Study|Lost to Follow-up|0|||
28004216|NCT00437281|54663032|FG017|Overall Study|Lost to Follow-up|0|||
28004217|NCT00437281|54663033|FG018|Overall Study|Lost to Follow-up|0|||
28004218|NCT00437281|54663034|FG019|Overall Study|Lost to Follow-up|1|||
28004219|NCT00741039|54663108|FG000|Overall Study|Patient non-compliance|2|||
28004220|NCT00741039|54663109|FG001|Overall Study|Patient non-compliance|0|||
28004221|NCT00772382|54663115|FG000|Overall Study|Adverse Event|19|||
28004222|NCT00772382|54663115|FG000|Overall Study|Death|6|||
28004223|NCT00772382|54663115|FG000|Overall Study|Lack of Efficacy|4|||
28004224|NCT00772382|54663115|FG000|Overall Study|Physician Decision|5|||
28004225|NCT00772382|54663115|FG000|Overall Study|Protocol Violation|1|||
28004226|NCT00772382|54663115|FG000|Overall Study|Withdrawal by Subject|10|||
28004227|NCT00772382|54663115|FG000|Overall Study|Other Reasons|10|||
28004228|NCT00798707|54663122|FG000|Overall Study|Adverse Event|6|||
28004229|NCT00798707|54663123|FG001|Overall Study|Adverse Event|8|||
28004230|NCT00798707|54663124|FG002|Overall Study|Adverse Event|8|||
28004231|NCT00798707|54663122|FG000|Overall Study|Failed to return|2|||
28004232|NCT00798707|54663123|FG001|Overall Study|Failed to return|2|||
28004233|NCT00798707|54663124|FG002|Overall Study|Failed to return|0|||
28004234|NCT00798707|54663122|FG000|Overall Study|Investigator|0|||
28004235|NCT00798707|54663123|FG001|Overall Study|Investigator|1|||
28004236|NCT00798707|54663124|FG002|Overall Study|Investigator|2|||
28004237|NCT00798707|54663122|FG000|Overall Study|Lack of Efficacy|2|||
28004238|NCT00798707|54663123|FG001|Overall Study|Lack of Efficacy|2|||
28004239|NCT00798707|54663124|FG002|Overall Study|Lack of Efficacy|1|||
28100621|NCT02914522|54756980|FG002|Maintenance Study: Week 11 to Week 58|Death|0|||
28100622|NCT02914522|54756981|FG003|Maintenance Study: Week 11 to Week 58|Death|0|||
28100623|NCT02914522|54756982|FG004|Maintenance Study: Week 11 to Week 58|Death|0|||
28100624|NCT02914522|54756983|FG005|Maintenance Study: Week 11 to Week 58|Death|0|||
28100625|NCT02914522|54756984|FG006|Maintenance Study: Week 11 to Week 58|Death|2|||
28100626|NCT02914522|54756985|FG007|Maintenance Study: Week 11 to Week 58|Death|0|||
28100627|NCT02914522|54756986|FG008|Maintenance Study: Week 11 to Week 58|Death|0|||
28100628|NCT02914522|54756987|FG009|Maintenance Study: Week 11 to Week 58|Death|0|||
28100629|NCT02914522|54756988|FG010|Maintenance Study: Week 11 to Week 58|Death|0|||
28100630|NCT02914522|54756978|FG000|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
28100631|NCT02914522|54756979|FG001|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
28100632|NCT02914522|54756980|FG002|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
28100633|NCT02914522|54756981|FG003|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
28100634|NCT02914522|54756982|FG004|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
28100635|NCT02914522|54756983|FG005|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
28100636|NCT02914522|54756984|FG006|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
28100637|NCT02914522|54756985|FG007|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|1|||
28100638|NCT02914522|54756986|FG008|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|2|||
28100639|NCT02914522|54756987|FG009|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
28100640|NCT02914522|54756988|FG010|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
28100641|NCT02914522|54756978|FG000|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
28100642|NCT02914522|54756979|FG001|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
28004240|NCT00798707|54663122|FG000|Overall Study|Lost to Follow-up|5|||
28004241|NCT00798707|54663123|FG001|Overall Study|Lost to Follow-up|6|||
28004242|NCT00798707|54663124|FG002|Overall Study|Lost to Follow-up|6|||
28004243|NCT00798707|54663122|FG000|Overall Study|Other|0|||
28004244|NCT00798707|54663123|FG001|Overall Study|Other|1|||
28004245|NCT00798707|54663124|FG002|Overall Study|Other|0|||
28004246|NCT00798707|54663122|FG000|Overall Study|Protocol Violation|4|||
28004247|NCT00798707|54663123|FG001|Overall Study|Protocol Violation|0|||
28004248|NCT00798707|54663124|FG002|Overall Study|Protocol Violation|2|||
28004249|NCT00798707|54663122|FG000|Overall Study|Withdrawal by Subject|3|||
28004250|NCT00798707|54663123|FG001|Overall Study|Withdrawal by Subject|8|||
28004251|NCT00798707|54663124|FG002|Overall Study|Withdrawal by Subject|2|||
28004252|NCT00798707|54663122|FG000|Overall Study|Randomized not treated|4|||
28004253|NCT00798707|54663123|FG001|Overall Study|Randomized not treated|5|||
28004254|NCT00798707|54663124|FG002|Overall Study|Randomized not treated|1|||
28004255|NCT00760214|54663135|FG000|Overall Study|Adverse Event|8|||
28004256|NCT00760214|54663136|FG001|Overall Study|Adverse Event|9|||
28004257|NCT00760214|54663137|FG002|Overall Study|Adverse Event|12|||
28004258|NCT00760214|54663135|FG000|Overall Study|Protocol Violation|3|||
28004259|NCT00760214|54663136|FG001|Overall Study|Protocol Violation|0|||
28004260|NCT00760214|54663137|FG002|Overall Study|Protocol Violation|3|||
28004261|NCT00760214|54663135|FG000|Overall Study|Lost to Follow-up|0|||
28004262|NCT00760214|54663136|FG001|Overall Study|Lost to Follow-up|0|||
28004263|NCT00760214|54663137|FG002|Overall Study|Lost to Follow-up|1|||
28004264|NCT00760214|54663135|FG000|Overall Study|Withdrawal by Subject|12|||
28004265|NCT00760214|54663136|FG001|Overall Study|Withdrawal by Subject|14|||
28004266|NCT00760214|54663137|FG002|Overall Study|Withdrawal by Subject|13|||
28004267|NCT00760214|54663135|FG000|Overall Study|Lack of Efficacy|3|||
28004268|NCT00760214|54663136|FG001|Overall Study|Lack of Efficacy|2|||
28004269|NCT00760214|54663137|FG002|Overall Study|Lack of Efficacy|4|||
28004270|NCT00760214|54663135|FG000|Overall Study|Pregnancy|0|||
28004271|NCT00760214|54663136|FG001|Overall Study|Pregnancy|0|||
28004272|NCT00760214|54663137|FG002|Overall Study|Pregnancy|1|||
28004273|NCT00760214|54663135|FG000|Overall Study|Physician Decision|1|||
28004274|NCT00760214|54663136|FG001|Overall Study|Physician Decision|1|||
28004275|NCT00760214|54663137|FG002|Overall Study|Physician Decision|1|||
28004276|NCT00760214|54663135|FG000|Overall Study|Other|3|||
28004277|NCT00760214|54663136|FG001|Overall Study|Other|4|||
28004278|NCT00760214|54663137|FG002|Overall Study|Other|6|||
28004279|NCT00802841|54663147|FG000|Overall Study|Administrative problems|1|||
27916511|NCT01111552|54574377|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
27916512|NCT01111552|54574378|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
27916513|NCT01111552|54574379|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
27916514|NCT01111552|54574380|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
27916515|NCT01111552|54574376|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|1|||
27916516|NCT01111552|54574377|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
28004280|NCT00802841|54663148|FG001|Overall Study|Administrative problems|0|||
28004281|NCT00802841|54663147|FG000|Overall Study|Lost to Follow-up|2|||
28004282|NCT00802841|54663148|FG001|Overall Study|Lost to Follow-up|1|||
28004283|NCT00802841|54663147|FG000|Overall Study|Death|1|||
28004284|NCT00802841|54663148|FG001|Overall Study|Death|2|||
28004285|NCT00802841|54663147|FG000|Overall Study|Adverse Event|8|||
28004286|NCT00802841|54663148|FG001|Overall Study|Adverse Event|2|||
28004287|NCT00802841|54663147|FG000|Overall Study|Disease progression|7|||
28004288|NCT00802841|54663148|FG001|Overall Study|Disease progression|3|||
28004289|NCT00802841|54663147|FG000|Overall Study|Withdrawal by Subject|9|||
28004290|NCT00802841|54663148|FG001|Overall Study|Withdrawal by Subject|5|||
28004291|NCT00802841|54663147|FG000|Overall Study|Protocol deviation|2|||
28004292|NCT00802841|54663148|FG001|Overall Study|Protocol deviation|6|||
28004293|NCT00802841|54663147|FG000|Overall Study|Treatment duration completed|66|||
28004294|NCT00802841|54663148|FG001|Overall Study|Treatment duration completed|76|||
28004295|NCT00772148|54663158|FG000|Pharmacokinetic Phase (14 Days)|Adverse Event|3|||
28004296|NCT00772148|54663159|FG001|Pharmacokinetic Phase (14 Days)|Adverse Event|1|||
28004297|NCT00772148|54663158|FG000|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3|||
28004298|NCT00772148|54663159|FG001|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5|||
28004299|NCT00772148|54663158|FG000|Pharmacokinetic Phase (14 Days)|Administrative/other|2|||
28004300|NCT00772148|54663159|FG001|Pharmacokinetic Phase (14 Days)|Administrative/other|0|||
28004301|NCT00772148|54663158|FG000|Maintenance Phase (Week 52)|Death|2|||
28004302|NCT00772148|54663159|FG001|Maintenance Phase (Week 52)|Death|2|||
28004303|NCT00772148|54663158|FG000|Maintenance Phase (Week 52)|Adverse Event|1|||
28004304|NCT00772148|54663159|FG001|Maintenance Phase (Week 52)|Adverse Event|0|||
28004305|NCT00772148|54663158|FG000|Maintenance Phase (Week 52)|Withdrawal by Subject|0|||
28004306|NCT00772148|54663159|FG001|Maintenance Phase (Week 52)|Withdrawal by Subject|1|||
28004307|NCT00772148|54663158|FG000|Maintenance Phase (Week 52)|Administrative/other|1|||
28004308|NCT00772148|54663159|FG001|Maintenance Phase (Week 52)|Administrative/other|2|||
27916517|NCT01111552|54574378|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
28004309|NCT00759902|54663167|FG000|Overall Study|Adverse Event|0|||
28004310|NCT00759902|54663168|FG001|Overall Study|Adverse Event|1|||
28004311|NCT00772070|54663176|FG000|Overall Study|Lost to Follow-up|0|||
28004312|NCT00772070|54663177|FG001|Overall Study|Lost to Follow-up|8|||
28004313|NCT00772070|54663176|FG000|Overall Study|Withdrawal by Subject|0|||
28004314|NCT00772070|54663177|FG001|Overall Study|Withdrawal by Subject|2|||
28004315|NCT00772070|54663176|FG000|Overall Study|Vaccination error-wrong dose/expired lot|2|||
28004316|NCT00772070|54663177|FG001|Overall Study|Vaccination error-wrong dose/expired lot|0|||
28004317|NCT00796757|54663183|FG000|Overall Study|Withdrawal by Subject|14|||
28004318|NCT00796757|54663183|FG000|Overall Study|Death|61|||
28004319|NCT00796757|54663183|FG000|Overall Study|Protocol Violation|1|||
28004320|NCT00796757|54663183|FG000|Overall Study|Participant noncompliance|1|||
28004321|NCT00796757|54663183|FG000|Overall Study|Investigator's decision|2|||
28004322|NCT00796757|54663183|FG000|Overall Study|Other|7|||
28004323|NCT00759356|54663189|FG000|Overall Study|Adverse Event|0|||
28004324|NCT00759356|54663190|FG001|Overall Study|Adverse Event|1|||
28004325|NCT00759356|54663189|FG000|Overall Study|Withdrawal by Subject|0|||
28004326|NCT00759356|54663190|FG001|Overall Study|Withdrawal by Subject|2|||
28004327|NCT00759356|54663189|FG000|Overall Study|Subject was unable to return|1|||
28004328|NCT00759356|54663190|FG001|Overall Study|Subject was unable to return|0|||
28004329|NCT00721734|54663201|FG000|Overall Study|Progressive Disease|3|||
28004330|NCT00721734|54663202|FG001|Overall Study|Progressive Disease|10|||
28004331|NCT00721734|54663203|FG002|Overall Study|Progressive Disease|4|||
28004332|NCT00721734|54663204|FG003|Overall Study|Progressive Disease|5|||
28004333|NCT00721734|54663205|FG004|Overall Study|Progressive Disease|2|||
28004334|NCT00721734|54663201|FG000|Overall Study|Adverse Event|3|||
28004335|NCT00721734|54663202|FG001|Overall Study|Adverse Event|1|||
28004336|NCT00721734|54663203|FG002|Overall Study|Adverse Event|4|||
28004337|NCT00721734|54663204|FG003|Overall Study|Adverse Event|0|||
28004338|NCT00721734|54663205|FG004|Overall Study|Adverse Event|3|||
28004339|NCT00721734|54663201|FG000|Overall Study|Withdrawal by Subject|2|||
28004340|NCT00721734|54663202|FG001|Overall Study|Withdrawal by Subject|1|||
28004341|NCT00721734|54663203|FG002|Overall Study|Withdrawal by Subject|0|||
28004342|NCT00721734|54663204|FG003|Overall Study|Withdrawal by Subject|0|||
28004343|NCT00721734|54663205|FG004|Overall Study|Withdrawal by Subject|1|||
28004344|NCT00721734|54663201|FG000|Overall Study|Other|0|||
28004345|NCT00721734|54663202|FG001|Overall Study|Other|0|||
28004346|NCT00721734|54663203|FG002|Overall Study|Other|0|||
28004347|NCT00721734|54663204|FG003|Overall Study|Other|1|||
28004348|NCT00721734|54663205|FG004|Overall Study|Other|0|||
27916518|NCT01111552|54574379|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
27916519|NCT01111552|54574380|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
27916520|NCT01111552|54574376|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
27916521|NCT01111552|54574377|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
27916522|NCT01111552|54574378|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
27916523|NCT01111552|54574379|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
28004349|NCT00798317|54663219|FG000|Overall Study|Physician Decision|0|||
28004350|NCT00798317|54663220|FG001|Overall Study|Physician Decision|1|||
28004351|NCT00798317|54663219|FG000|Overall Study|Withdrawal by Subject|5|||
28004352|NCT00798317|54663220|FG001|Overall Study|Withdrawal by Subject|4|||
28004353|NCT00798317|54663219|FG000|Overall Study|Lost to Follow-up|2|||
28004354|NCT00798317|54663220|FG001|Overall Study|Lost to Follow-up|2|||
28004355|NCT00798317|54663219|FG000|Overall Study|Adverse Event|2|||
28004356|NCT00798317|54663220|FG001|Overall Study|Adverse Event|0|||
28004357|NCT00798317|54663219|FG000|Overall Study|Death|1|||
28004358|NCT00798317|54663220|FG001|Overall Study|Death|0|||
28004359|NCT00779402|54663228|FG000|Treatment Phase 1|Disease Progression|1|||
28004360|NCT00779402|54663229|FG001|Treatment Phase 1|Disease Progression|0|||
28004361|NCT00779402|54663228|FG000|Treatment Phase 1|Adverse Event|2|||
28004362|NCT00779402|54663229|FG001|Treatment Phase 1|Adverse Event|0|||
27916524|NCT01111552|54574380|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
27916525|NCT01111552|54574376|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
27916526|NCT01111552|54574377|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
27916527|NCT01111552|54574378|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
27916528|NCT01111552|54574379|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
27916529|NCT01111552|54574380|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
27916530|NCT01111552|54574376|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
27916531|NCT01111552|54574377|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|2|||
27916532|NCT01111552|54574378|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
27916533|NCT01111552|54574379|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
27916534|NCT01111552|54574380|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
27916535|NCT01111552|54574376|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
28004363|NCT00779402|54663228|FG000|Treatment Phase 1|Protocol Violation|1|||
28004364|NCT00779402|54663229|FG001|Treatment Phase 1|Protocol Violation|0|||
28004365|NCT00779402|54663228|FG000|Treatment Phase 1|Patient Refused to Continue|17|||
28004366|NCT00779402|54663229|FG001|Treatment Phase 1|Patient Refused to Continue|2|||
28004367|NCT00779402|54663228|FG000|Treatment Phase 1|Lost to Follow-up|0|||
28100643|NCT02914522|54756980|FG002|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
27916536|NCT01111552|54574377|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|1|||
27916537|NCT01111552|54574378|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
28004368|NCT00779402|54663229|FG001|Treatment Phase 1|Lost to Follow-up|1|||
28004369|NCT00779402|54663228|FG000|Treatment Phase 1|Death|0|||
28004370|NCT00779402|54663229|FG001|Treatment Phase 1|Death|1|||
28004371|NCT00779402|54663228|FG000|Treatment Phase 1|Intercurrent Illness|1|||
28004372|NCT00779402|54663229|FG001|Treatment Phase 1|Intercurrent Illness|1|||
28004373|NCT00779402|54663228|FG000|Treatment Phase 1|Withdrawal by Subject|1|||
28004374|NCT00779402|54663229|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
28004375|NCT00779402|54663228|FG000|Treatment Phase 1|Other|4|||
28004376|NCT00779402|54663229|FG001|Treatment Phase 1|Other|2|||
28004377|NCT00779402|54663228|FG000|Treatment Phase 1|Closure of Study|3|||
28004378|NCT00779402|54663229|FG001|Treatment Phase 1|Closure of Study|2|||
28004379|NCT00779402|54663228|FG000|Treatment Phase 1|Completed Protocol Visits|3|||
28004380|NCT00779402|54663229|FG001|Treatment Phase 1|Completed Protocol Visits|6|||
28004381|NCT00779402|54663228|FG000|Surveillance Phase|Protocol Violation|0|||
28004382|NCT00779402|54663229|FG001|Surveillance Phase|Protocol Violation|1|||
28004383|NCT00779402|54663228|FG000|Surveillance Phase|Patient refused to continue|22|||
28004384|NCT00779402|54663229|FG001|Surveillance Phase|Patient refused to continue|14|||
28004385|NCT00779402|54663228|FG000|Surveillance Phase|Lost to Follow-up|2|||
28004386|NCT00779402|54663229|FG001|Surveillance Phase|Lost to Follow-up|1|||
28004387|NCT00779402|54663228|FG000|Surveillance Phase|Death|0|||
28004388|NCT00779402|54663229|FG001|Surveillance Phase|Death|1|||
28004389|NCT00779402|54663228|FG000|Surveillance Phase|Intercurrent Illness|2|||
28004390|NCT00779402|54663229|FG001|Surveillance Phase|Intercurrent Illness|0|||
28004391|NCT00779402|54663228|FG000|Surveillance Phase|Other|5|||
28004392|NCT00779402|54663229|FG001|Surveillance Phase|Other|5|||
28004393|NCT00779402|54663228|FG000|Surveillance Phase|Withdrawal by Subject|4|||
28004394|NCT00779402|54663229|FG001|Surveillance Phase|Withdrawal by Subject|1|||
28004395|NCT00779402|54663228|FG000|Surveillance Phase|Closure of study|5|||
28004396|NCT00779402|54663229|FG001|Surveillance Phase|Closure of study|6|||
28004397|NCT00779402|54663228|FG000|Surveillance Phase|Completed Protocol Visits|3|||
28004398|NCT00779402|54663229|FG001|Surveillance Phase|Completed Protocol Visits|2|||
28004399|NCT00779402|54663228|FG000|Long-term Follow-up|Patient refused to continue|2|||
28004400|NCT00779402|54663229|FG001|Long-term Follow-up|Patient refused to continue|0|||
28004401|NCT00779402|54663228|FG000|Long-term Follow-up|Other|5|||
28004402|NCT00779402|54663229|FG001|Long-term Follow-up|Other|0|||
28004403|NCT00779402|54663228|FG000|Long-term Follow-up|Closure of Study|8|||
28004404|NCT00779402|54663229|FG001|Long-term Follow-up|Closure of Study|4|||
28004405|NCT00779402|54663228|FG000|Long-term Follow-up|Completed Protocol Visits|6|||
28004406|NCT00779402|54663229|FG001|Long-term Follow-up|Completed Protocol Visits|2|||
28004407|NCT00771914|54663239|FG000|Overall Study|Physician Decision|0|||
28004408|NCT00771914|54663240|FG001|Overall Study|Physician Decision|0|||
28004409|NCT00771914|54663241|FG002|Overall Study|Physician Decision|0|||
28004410|NCT00771914|54663242|FG003|Overall Study|Physician Decision|1|||
28004411|NCT00771914|54663239|FG000|Overall Study|Lost to Follow-up|0|||
28004412|NCT00771914|54663240|FG001|Overall Study|Lost to Follow-up|0|||
28004413|NCT00771914|54663241|FG002|Overall Study|Lost to Follow-up|0|||
28004414|NCT00771914|54663242|FG003|Overall Study|Lost to Follow-up|1|||
28004415|NCT00779324|54663254|FG000|Overall Study|Lost to Follow-up|2|||
28004416|NCT00779324|54663255|FG001|Overall Study|Lost to Follow-up|1|||
28004417|NCT00779324|54663254|FG000|Overall Study|Withdrawal by Subject|4|||
28004418|NCT00779324|54663255|FG001|Overall Study|Withdrawal by Subject|2|||
28004419|NCT00779324|54663254|FG000|Overall Study|Missed visit|1|||
28004420|NCT00779324|54663255|FG001|Overall Study|Missed visit|1|||
28004421|NCT00779246|54663263|FG000|Overall Study|Missing sufficient data for analysis|33|||
28004422|NCT00779246|54663264|FG001|Overall Study|Missing sufficient data for analysis|53|||
28004423|NCT00771758|54663273|FG000|Overall Study|Adverse Event|2|||
28004424|NCT00771758|54663274|FG001|Overall Study|Adverse Event|8|||
28004425|NCT00771758|54663275|FG002|Overall Study|Adverse Event|1|||
28004426|NCT00771758|54663273|FG000|Overall Study|Lack of Efficacy|0|||
28004427|NCT00771758|54663274|FG001|Overall Study|Lack of Efficacy|2|||
28004428|NCT00771758|54663275|FG002|Overall Study|Lack of Efficacy|1|||
28004429|NCT00771758|54663273|FG000|Overall Study|Lost to Follow-up|1|||
28004430|NCT00771758|54663274|FG001|Overall Study|Lost to Follow-up|0|||
28004431|NCT00771758|54663275|FG002|Overall Study|Lost to Follow-up|0|||
28004432|NCT00771758|54663273|FG000|Overall Study|Protocol Violation|1|||
28004433|NCT00771758|54663274|FG001|Overall Study|Protocol Violation|0|||
28004434|NCT00771758|54663275|FG002|Overall Study|Protocol Violation|0|||
28004435|NCT00771758|54663273|FG000|Overall Study|Withdrawal by Subject|1|||
28004436|NCT00771758|54663274|FG001|Overall Study|Withdrawal by Subject|0|||
28004437|NCT00771758|54663275|FG002|Overall Study|Withdrawal by Subject|0|||
28004438|NCT00771758|54663273|FG000|Overall Study|Other|3|||
28004439|NCT00771758|54663274|FG001|Overall Study|Other|2|||
28004440|NCT00771758|54663275|FG002|Overall Study|Other|0|||
28004441|NCT00758498|54663303|FG000|Overall Study|Adverse Event|2|||
28004442|NCT00758498|54663304|FG001|Overall Study|Adverse Event|2|||
28172764|NCT02745119|54844496|FG002|Overall Study|Protocol Deviation|0|||
28004443|NCT00758498|54663305|FG002|Overall Study|Adverse Event|3|||
28004444|NCT00758498|54663303|FG000|Overall Study|Subject legally detained out of state|1|||
28004445|NCT00758498|54663304|FG001|Overall Study|Subject legally detained out of state|0|||
28004446|NCT00758498|54663305|FG002|Overall Study|Subject legally detained out of state|0|||
28004447|NCT00758498|54663303|FG000|Overall Study|Withdrawal by Subject|0|||
28004448|NCT00758498|54663304|FG001|Overall Study|Withdrawal by Subject|0|||
28004449|NCT00758498|54663305|FG002|Overall Study|Withdrawal by Subject|1|||
28004450|NCT00758498|54663303|FG000|Overall Study|Noncompliance to study procedures|0|||
28004451|NCT00758498|54663304|FG001|Overall Study|Noncompliance to study procedures|0|||
28004452|NCT00758498|54663305|FG002|Overall Study|Noncompliance to study procedures|1|||
28004453|NCT00798161|54663320|FG000|Overall Study|Adverse Event|3|||
28004454|NCT00798161|54663321|FG001|Overall Study|Adverse Event|4|||
28004455|NCT00798161|54663322|FG002|Overall Study|Adverse Event|6|||
28004456|NCT00798161|54663323|FG003|Overall Study|Adverse Event|6|||
28004457|NCT00798161|54663324|FG004|Overall Study|Adverse Event|5|||
28004458|NCT00798161|54663325|FG005|Overall Study|Adverse Event|2|||
28004459|NCT00798161|54663326|FG006|Overall Study|Adverse Event|4|||
28004460|NCT00798161|54663320|FG000|Overall Study|Protocol Violation|2|||
28004461|NCT00798161|54663321|FG001|Overall Study|Protocol Violation|1|||
28004462|NCT00798161|54663322|FG002|Overall Study|Protocol Violation|3|||
28004463|NCT00798161|54663323|FG003|Overall Study|Protocol Violation|3|||
28004464|NCT00798161|54663324|FG004|Overall Study|Protocol Violation|3|||
28004465|NCT00798161|54663325|FG005|Overall Study|Protocol Violation|2|||
28004466|NCT00798161|54663326|FG006|Overall Study|Protocol Violation|0|||
28004467|NCT00798161|54663320|FG000|Overall Study|Lost to Follow-up|1|||
28004468|NCT00798161|54663321|FG001|Overall Study|Lost to Follow-up|3|||
28004469|NCT00798161|54663322|FG002|Overall Study|Lost to Follow-up|4|||
28004470|NCT00798161|54663323|FG003|Overall Study|Lost to Follow-up|3|||
28004471|NCT00798161|54663324|FG004|Overall Study|Lost to Follow-up|4|||
28004472|NCT00798161|54663325|FG005|Overall Study|Lost to Follow-up|0|||
28004473|NCT00798161|54663326|FG006|Overall Study|Lost to Follow-up|0|||
28004474|NCT00798161|54663320|FG000|Overall Study|Withdrawal by Subject|5|||
28004475|NCT00798161|54663321|FG001|Overall Study|Withdrawal by Subject|4|||
28004476|NCT00798161|54663322|FG002|Overall Study|Withdrawal by Subject|5|||
28004477|NCT00798161|54663323|FG003|Overall Study|Withdrawal by Subject|4|||
28004478|NCT00798161|54663324|FG004|Overall Study|Withdrawal by Subject|2|||
28004479|NCT00798161|54663325|FG005|Overall Study|Withdrawal by Subject|3|||
28004480|NCT00798161|54663326|FG006|Overall Study|Withdrawal by Subject|1|||
28004481|NCT00798161|54663320|FG000|Overall Study|Other reason (incl. lack of efficacy)|7|||
28004482|NCT00798161|54663321|FG001|Overall Study|Other reason (incl. lack of efficacy)|5|||
28004483|NCT00798161|54663322|FG002|Overall Study|Other reason (incl. lack of efficacy)|3|||
28004484|NCT00798161|54663323|FG003|Overall Study|Other reason (incl. lack of efficacy)|5|||
28004485|NCT00798161|54663324|FG004|Overall Study|Other reason (incl. lack of efficacy)|2|||
27916538|NCT01111552|54574379|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
27916539|NCT01111552|54574380|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
27916540|NCT01111552|54574376|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
27916541|NCT01111552|54574377|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|1|||
27916542|NCT01111552|54574378|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
27916543|NCT01111552|54574379|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
27916544|NCT01111552|54574380|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
27916545|NCT01111552|54574376|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
27916546|NCT01111552|54574377|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
27916547|NCT01111552|54574378|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
27916548|NCT01111552|54574379|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
27916549|NCT01111552|54574380|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
27916550|NCT01175083|54574396|FG000|Primary Epoch|Withdrawal by Subject|0|||
27916551|NCT01175083|54574397|FG001|Primary Epoch|Withdrawal by Subject|0|||
27916552|NCT01175083|54574398|FG002|Primary Epoch|Withdrawal by Subject|0|||
27916553|NCT01175083|54574399|FG003|Primary Epoch|Withdrawal by Subject|0|||
27916554|NCT01175083|54574400|FG004|Primary Epoch|Withdrawal by Subject|0|||
27916555|NCT01175083|54574401|FG005|Primary Epoch|Withdrawal by Subject|2|||
28004486|NCT00798161|54663325|FG005|Overall Study|Other reason (incl. lack of efficacy)|4|||
28004487|NCT00798161|54663326|FG006|Overall Study|Other reason (incl. lack of efficacy)|5|||
28004488|NCT00588341|54663342|FG000|Overall Study|Withdrawal by Subject|3|||
28004489|NCT00588341|54663342|FG000|Overall Study|Not treated due to metastatic disease|1|||
28004490|NCT00588341|54663342|FG000|Overall Study|Patient ineligible|1|||
28004491|NCT00802529|54663348|FG000|Overall Study|Lost to Follow-up|0|||
28004492|NCT00802529|54663349|FG001|Overall Study|Lost to Follow-up|1|||
28004493|NCT00758264|54663358|FG000|Active Phase|Withdrawal by Subject|0|||
28004494|NCT00758264|54663359|FG001|Active Phase|Withdrawal by Subject|0|||
28004495|NCT00758264|54663360|FG002|Active Phase|Withdrawal by Subject|1|||
28004496|NCT00758264|54663358|FG000|Active Phase|Lost to Follow-up|1|||
28004497|NCT00758264|54663359|FG001|Active Phase|Lost to Follow-up|0|||
27916556|NCT01175083|54574396|FG000|Primary Epoch|Lost to Follow-up|0|||
27916557|NCT01175083|54574397|FG001|Primary Epoch|Lost to Follow-up|0|||
27916558|NCT01175083|54574398|FG002|Primary Epoch|Lost to Follow-up|0|||
27916559|NCT01175083|54574399|FG003|Primary Epoch|Lost to Follow-up|0|||
27916560|NCT01175083|54574400|FG004|Primary Epoch|Lost to Follow-up|0|||
28004498|NCT00758264|54663360|FG002|Active Phase|Lost to Follow-up|0|||
28004499|NCT00758264|54663358|FG000|Active Phase|Other|0|||
28004500|NCT00758264|54663359|FG001|Active Phase|Other|0|||
28004501|NCT00758264|54663360|FG002|Active Phase|Other|4|||
28004502|NCT00588731|54663370|FG000|Overall Study|Withdrawal by Subject|3|||
28004503|NCT00588731|54663371|FG001|Overall Study|Withdrawal by Subject|2|||
28004504|NCT00757172|54663377|FG000|Overall Study|Withdrawal by Subject|4|||
28004505|NCT00757172|54663377|FG000|Overall Study|Physician Decision|3|||
28004506|NCT00757172|54663377|FG000|Overall Study|Progression|4|||
28004507|NCT00797225|54663385|FG000|Weeks 1 to 12|Adverse Event|0|||
28004508|NCT00797225|54663386|FG001|Weeks 1 to 12|Adverse Event|0|||
28004509|NCT00797225|54663387|FG002|Weeks 1 to 12|Adverse Event|1|||
28004510|NCT00797225|54663388|FG003|Weeks 1 to 12|Adverse Event|0|||
28004511|NCT00797225|54663389|FG004|Weeks 1 to 12|Adverse Event|0|||
28004512|NCT00797225|54663390|FG005|Weeks 1 to 12|Adverse Event|0|||
28100644|NCT02914522|54756981|FG003|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
28100645|NCT02914522|54756982|FG004|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
28100646|NCT02914522|54756983|FG005|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
28100647|NCT02914522|54756984|FG006|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
28100648|NCT02914522|54756985|FG007|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
28100649|NCT02914522|54756986|FG008|Maintenance Study: Week 11 to Week 58|Pregnancy|1|||
28100650|NCT02914522|54756987|FG009|Maintenance Study: Week 11 to Week 58|Pregnancy|2|||
28100651|NCT02914522|54756988|FG010|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
27916561|NCT01175083|54574401|FG005|Primary Epoch|Lost to Follow-up|1|||
27916562|NCT01175083|54574396|FG000|Booster Epoch|Death|0|||
27916563|NCT01175083|54574397|FG001|Booster Epoch|Death|0|||
27916564|NCT01175083|54574398|FG002|Booster Epoch|Death|1|||
27916565|NCT01175083|54574399|FG003|Booster Epoch|Death|0|||
27916566|NCT01175083|54574400|FG004|Booster Epoch|Death|0|||
27916567|NCT01175083|54574401|FG005|Booster Epoch|Death|0|||
27916568|NCT01175083|54574396|FG000|Booster Epoch|Withdrawal by Subject|0|||
27916569|NCT01175083|54574397|FG001|Booster Epoch|Withdrawal by Subject|0|||
27916570|NCT01175083|54574398|FG002|Booster Epoch|Withdrawal by Subject|0|||
27916571|NCT01175083|54574399|FG003|Booster Epoch|Withdrawal by Subject|1|||
27916572|NCT01175083|54574400|FG004|Booster Epoch|Withdrawal by Subject|0|||
27916573|NCT01175083|54574401|FG005|Booster Epoch|Withdrawal by Subject|0|||
27916574|NCT01174459|54574419|FG000|Overall Study|case report form (CRF) not collected|5|||
27916575|NCT01174342|54574423|FG000|Overall Study|Conversion to cesarean section|4|||
27916576|NCT01111474|54574427|FG000|Overall Study|Lost to Follow-up|12|||
27916577|NCT01174264|54574436|FG000|Single Dose Pharmacokinetics|Early progressive disease|1|||
27916578|NCT01174264|54574437|FG001|Single Dose Pharmacokinetics|Early progressive disease|0|||
27916579|NCT01174264|54574438|FG002|Single Dose Pharmacokinetics|Early progressive disease|1|||
27916580|NCT01174264|54574436|FG000|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
27916581|NCT01174264|54574437|FG001|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
27916582|NCT01174264|54574438|FG002|Single Dose Pharmacokinetics|Patient entered hospice care|1|||
27916583|NCT01174264|54574436|FG000|Steady-state Pharmacokinetics|Not evaluable|6|||
27916584|NCT01174264|54574437|FG001|Steady-state Pharmacokinetics|Not evaluable|0|||
27916585|NCT01174264|54574438|FG002|Steady-state Pharmacokinetics|Not evaluable|2|||
27916586|NCT01174186|54574448|FG000|Overall Study|Lost to Follow-up|0|||
27916587|NCT01174186|54574449|FG001|Overall Study|Lost to Follow-up|1|||
28004513|NCT00797225|54663391|FG006|Weeks 1 to 12|Adverse Event|0|||
28004514|NCT00797225|54663392|FG007|Weeks 1 to 12|Adverse Event|0|||
28004515|NCT00797225|54663385|FG000|Weeks 1 to 12|Non-compliance|0|||
28004516|NCT00797225|54663386|FG001|Weeks 1 to 12|Non-compliance|1|||
28004517|NCT00797225|54663387|FG002|Weeks 1 to 12|Non-compliance|0|||
28004518|NCT00797225|54663388|FG003|Weeks 1 to 12|Non-compliance|0|||
28004519|NCT00797225|54663389|FG004|Weeks 1 to 12|Non-compliance|0|||
28004520|NCT00797225|54663390|FG005|Weeks 1 to 12|Non-compliance|0|||
27916588|NCT01174186|54574448|FG000|Overall Study|Withdrawal by Subject|0|||
27916589|NCT01174186|54574449|FG001|Overall Study|Withdrawal by Subject|2|||
27916590|NCT01173718|54574455|FG000|Overall Study|Death|17|||
27916591|NCT01173718|54574455|FG000|Overall Study|Abandonment of study graft|27|||
27916592|NCT01111240|54574459|FG000|Overall Study|Adverse Event|190|||
27916593|NCT01111240|54574459|FG000|Overall Study|Lack of Efficacy|545|||
27916594|NCT01111240|54574459|FG000|Overall Study|Lack of Efficacy and Adverse Event|19|||
27916595|NCT01111240|54574459|FG000|Overall Study|Other|312|||
27916596|NCT01111123|54574465|FG000|Open- Label Phase|Failed to be clear or almost cleared|14|||
27916597|NCT01111123|54574466|FG001|Open- Label Phase|Failed to be clear or almost cleared|0|||
27916598|NCT01111123|54574465|FG000|Maintenance Phase|Lost to Follow-up|0|||
27916599|NCT01111123|54574466|FG001|Maintenance Phase|Lost to Follow-up|2|||
28172765|NCT02745119|54844497|FG003|Overall Study|Protocol Deviation|1|||
27916600|NCT01173679|54574474|FG000|Overall Study|Death|1|||
27916601|NCT01110382|54574481|FG000|Overall Study|Withdrawal by Subject|0|||
27916602|NCT01110382|54574482|FG001|Overall Study|Withdrawal by Subject|1|||
27916603|NCT01110382|54574481|FG000|Overall Study|Protocol Violation|0|||
27916604|NCT01110382|54574482|FG001|Overall Study|Protocol Violation|1|||
27916605|NCT01173601|54574492|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23|||
28004521|NCT00797225|54663391|FG006|Weeks 1 to 12|Non-compliance|0|||
28004522|NCT00797225|54663392|FG007|Weeks 1 to 12|Non-compliance|0|||
28004523|NCT00797225|54663385|FG000|Weeks 1 to 12|Lack of Efficacy|1|||
28004524|NCT00797225|54663386|FG001|Weeks 1 to 12|Lack of Efficacy|0|||
27916606|NCT01173601|54574493|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
27916607|NCT01173601|54574494|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
27916608|NCT01173601|54574495|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
27916609|NCT01173601|54574496|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
27916610|NCT01173601|54574492|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9|||
27916611|NCT01173601|54574493|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
27916612|NCT01173601|54574494|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
27916613|NCT01173601|54574495|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
27916614|NCT01173601|54574496|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
27916615|NCT01173601|54574492|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7|||
27916616|NCT01173601|54574493|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
27916617|NCT01173601|54574494|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
27916618|NCT01173601|54574495|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
27916619|NCT01173601|54574496|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
27916620|NCT01173601|54574492|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3|||
27916621|NCT01173601|54574493|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
27916622|NCT01173601|54574494|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
27916623|NCT01173601|54574495|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
27916624|NCT01173601|54574496|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
27916625|NCT01173601|54574492|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15|||
27916626|NCT01173601|54574493|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
27916627|NCT01173601|54574494|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
27916628|NCT01173601|54574495|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
27916629|NCT01173601|54574496|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
27916630|NCT01173601|54574492|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25|||
27916631|NCT01173601|54574493|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
27916632|NCT01173601|54574494|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
27916633|NCT01173601|54574495|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
27916634|NCT01173601|54574496|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
27916635|NCT01173601|54574492|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6|||
27916636|NCT01173601|54574493|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
27916637|NCT01173601|54574494|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
27916638|NCT01173601|54574495|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
27916639|NCT01173601|54574496|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
28004525|NCT00797225|54663387|FG002|Weeks 1 to 12|Lack of Efficacy|0|||
28004526|NCT00797225|54663388|FG003|Weeks 1 to 12|Lack of Efficacy|0|||
28004527|NCT00797225|54663389|FG004|Weeks 1 to 12|Lack of Efficacy|0|||
28004528|NCT00797225|54663390|FG005|Weeks 1 to 12|Lack of Efficacy|0|||
28004529|NCT00797225|54663391|FG006|Weeks 1 to 12|Lack of Efficacy|0|||
28004530|NCT00797225|54663392|FG007|Weeks 1 to 12|Lack of Efficacy|0|||
28004531|NCT00797225|54663385|FG000|Weeks 1 to 12|Sponsor Decision|1|||
28004532|NCT00797225|54663386|FG001|Weeks 1 to 12|Sponsor Decision|0|||
28004533|NCT00797225|54663387|FG002|Weeks 1 to 12|Sponsor Decision|0|||
28004534|NCT00797225|54663388|FG003|Weeks 1 to 12|Sponsor Decision|0|||
28004535|NCT00797225|54663389|FG004|Weeks 1 to 12|Sponsor Decision|0|||
28004536|NCT00797225|54663390|FG005|Weeks 1 to 12|Sponsor Decision|0|||
28004537|NCT00797225|54663391|FG006|Weeks 1 to 12|Sponsor Decision|0|||
28004538|NCT00797225|54663392|FG007|Weeks 1 to 12|Sponsor Decision|0|||
28004539|NCT00797225|54663385|FG000|Weeks 13 to 24|Non-compliance|0|||
28004540|NCT00797225|54663386|FG001|Weeks 13 to 24|Non-compliance|2|||
28004541|NCT00797225|54663387|FG002|Weeks 13 to 24|Non-compliance|0|||
28004542|NCT00797225|54663388|FG003|Weeks 13 to 24|Non-compliance|0|||
28004543|NCT00797225|54663389|FG004|Weeks 13 to 24|Non-compliance|0|||
28004544|NCT00797225|54663390|FG005|Weeks 13 to 24|Non-compliance|0|||
28004545|NCT00797225|54663391|FG006|Weeks 13 to 24|Non-compliance|0|||
28004546|NCT00797225|54663392|FG007|Weeks 13 to 24|Non-compliance|0|||
28004547|NCT00797225|54663385|FG000|Weeks 13 to 24|Withdrawal by Subject|0|||
28004548|NCT00797225|54663386|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
28004549|NCT00797225|54663387|FG002|Weeks 13 to 24|Withdrawal by Subject|1|||
28004550|NCT00797225|54663388|FG003|Weeks 13 to 24|Withdrawal by Subject|0|||
28004551|NCT00797225|54663389|FG004|Weeks 13 to 24|Withdrawal by Subject|0|||
28004552|NCT00797225|54663390|FG005|Weeks 13 to 24|Withdrawal by Subject|0|||
28004553|NCT00797225|54663391|FG006|Weeks 13 to 24|Withdrawal by Subject|0|||
28004554|NCT00797225|54663392|FG007|Weeks 13 to 24|Withdrawal by Subject|0|||
27739929|NCT02786537|54189679|FG002|As Randomized|Opiate Dependency Relapse|0|||
27916640|NCT01173601|54574492|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
27916641|NCT01173601|54574493|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10|||
28004555|NCT00797225|54663385|FG000|Weeks 13 to 24|Lost to Follow-up|0|||
27916642|NCT01173601|54574494|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15|||
28004556|NCT00797225|54663386|FG001|Weeks 13 to 24|Lost to Follow-up|0|||
28004557|NCT00797225|54663387|FG002|Weeks 13 to 24|Lost to Follow-up|1|||
28004558|NCT00797225|54663388|FG003|Weeks 13 to 24|Lost to Follow-up|0|||
28004559|NCT00797225|54663389|FG004|Weeks 13 to 24|Lost to Follow-up|1|||
28004560|NCT00797225|54663390|FG005|Weeks 13 to 24|Lost to Follow-up|0|||
28004561|NCT00797225|54663391|FG006|Weeks 13 to 24|Lost to Follow-up|0|||
28004562|NCT00797225|54663392|FG007|Weeks 13 to 24|Lost to Follow-up|0|||
28004563|NCT00797225|54663385|FG000|Weeks 13 to 24|Adverse Event|0|||
28004564|NCT00797225|54663386|FG001|Weeks 13 to 24|Adverse Event|1|||
28004565|NCT00797225|54663387|FG002|Weeks 13 to 24|Adverse Event|0|||
28004566|NCT00797225|54663388|FG003|Weeks 13 to 24|Adverse Event|0|||
28004567|NCT00797225|54663389|FG004|Weeks 13 to 24|Adverse Event|0|||
28004568|NCT00797225|54663390|FG005|Weeks 13 to 24|Adverse Event|0|||
28004569|NCT00797225|54663391|FG006|Weeks 13 to 24|Adverse Event|1|||
28004570|NCT00797225|54663392|FG007|Weeks 13 to 24|Adverse Event|0|||
28004571|NCT00797225|54663385|FG000|Weeks 13 to 24|Sponsor Decision|0|||
28004572|NCT00797225|54663386|FG001|Weeks 13 to 24|Sponsor Decision|0|||
28004573|NCT00797225|54663387|FG002|Weeks 13 to 24|Sponsor Decision|0|||
28004574|NCT00797225|54663388|FG003|Weeks 13 to 24|Sponsor Decision|0|||
28004575|NCT00797225|54663389|FG004|Weeks 13 to 24|Sponsor Decision|0|||
28004576|NCT00797225|54663390|FG005|Weeks 13 to 24|Sponsor Decision|0|||
28004577|NCT00797225|54663391|FG006|Weeks 13 to 24|Sponsor Decision|1|||
28004578|NCT00797225|54663392|FG007|Weeks 13 to 24|Sponsor Decision|0|||
28004579|NCT00778700|54663412|FG000|Overall Study|Adverse Event|6|||
28004580|NCT00778700|54663413|FG001|Overall Study|Adverse Event|1|||
28004581|NCT00778700|54663414|FG002|Overall Study|Adverse Event|3|||
28004582|NCT00778700|54663415|FG003|Overall Study|Adverse Event|5|||
28004583|NCT00778700|54663412|FG000|Overall Study|Protocol Violation|1|||
28004584|NCT00778700|54663413|FG001|Overall Study|Protocol Violation|1|||
28004585|NCT00778700|54663414|FG002|Overall Study|Protocol Violation|0|||
28004586|NCT00778700|54663415|FG003|Overall Study|Protocol Violation|0|||
28004587|NCT00778700|54663412|FG000|Overall Study|Subject Withdrew Consent|6|||
28004588|NCT00778700|54663413|FG001|Overall Study|Subject Withdrew Consent|4|||
28004589|NCT00778700|54663414|FG002|Overall Study|Subject Withdrew Consent|1|||
28004590|NCT00778700|54663415|FG003|Overall Study|Subject Withdrew Consent|4|||
28004591|NCT00778700|54663412|FG000|Overall Study|Lost to Follow-up|3|||
28004592|NCT00778700|54663413|FG001|Overall Study|Lost to Follow-up|1|||
28004593|NCT00778700|54663414|FG002|Overall Study|Lost to Follow-up|0|||
27916643|NCT01173601|54574495|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7|||
27916644|NCT01173601|54574496|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14|||
27916645|NCT01173601|54574492|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
27916646|NCT01173601|54574493|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10|||
27916647|NCT01173601|54574494|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6|||
27916648|NCT01173601|54574495|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
27916649|NCT01173601|54574496|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9|||
27916650|NCT01173601|54574492|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
27916651|NCT01173601|54574493|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
27916652|NCT01173601|54574494|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
27916653|NCT01173601|54574495|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
27916654|NCT01173601|54574496|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
27916655|NCT01173601|54574492|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
27916656|NCT01173601|54574493|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
27916657|NCT01173601|54574494|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
27916658|NCT01173601|54574495|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
27916659|NCT01173601|54574496|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
27916660|NCT01173601|54574492|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
27916661|NCT01173601|54574493|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1|||
27916662|NCT01173601|54574494|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
27916663|NCT01173601|54574495|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4|||
27916664|NCT01173601|54574496|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
27916665|NCT01173601|54574492|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
27916666|NCT01173601|54574493|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
27916667|NCT01173601|54574494|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7|||
28004594|NCT00778700|54663415|FG003|Overall Study|Lost to Follow-up|1|||
28004595|NCT00778700|54663412|FG000|Overall Study|Reason not Specified|2|||
28004596|NCT00778700|54663413|FG001|Overall Study|Reason not Specified|0|||
28004597|NCT00778700|54663414|FG002|Overall Study|Reason not Specified|1|||
28004598|NCT00778700|54663415|FG003|Overall Study|Reason not Specified|3|||
28004599|NCT00778700|54663412|FG000|Overall Study|Other|0|||
28004600|NCT00778700|54663413|FG001|Overall Study|Other|0|||
28004601|NCT00778700|54663414|FG002|Overall Study|Other|1|||
28004602|NCT00778700|54663415|FG003|Overall Study|Other|0|||
28004603|NCT00793403|54663429|FG000|Overall Study|Other|73|||
28004604|NCT00793325|54663433|FG000|Overall Study|Protocol Violation|18|||
28004605|NCT00793325|54663433|FG000|Overall Study|Lost to Follow-up|1|||
27916668|NCT01173601|54574495|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5|||
27916669|NCT01173601|54574496|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
27916670|NCT01173601|54574492|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
27916671|NCT01173601|54574493|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
27916672|NCT01173601|54574494|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
27916673|NCT01173601|54574495|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
27916674|NCT01173601|54574496|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6|||
28004606|NCT00778622|54663459|FG000|Overall Study|Adverse Event|5|||
28004607|NCT00778622|54663460|FG001|Overall Study|Adverse Event|4|||
28004608|NCT00778622|54663461|FG002|Overall Study|Adverse Event|7|||
28004609|NCT00778622|54663459|FG000|Overall Study|Withdrawal by Subject|4|||
28004610|NCT00778622|54663460|FG001|Overall Study|Withdrawal by Subject|5|||
28004611|NCT00778622|54663461|FG002|Overall Study|Withdrawal by Subject|5|||
28004612|NCT00778622|54663459|FG000|Overall Study|Lost to Follow-up|3|||
28004613|NCT00778622|54663460|FG001|Overall Study|Lost to Follow-up|3|||
28004614|NCT00778622|54663461|FG002|Overall Study|Lost to Follow-up|2|||
28004615|NCT00778622|54663459|FG000|Overall Study|Protocol Violation|0|||
28004616|NCT00778622|54663460|FG001|Overall Study|Protocol Violation|3|||
28004617|NCT00778622|54663461|FG002|Overall Study|Protocol Violation|0|||
28004618|NCT00778622|54663459|FG000|Overall Study|Lack of Efficacy|2|||
28004619|NCT00778622|54663460|FG001|Overall Study|Lack of Efficacy|0|||
28004620|NCT00778622|54663461|FG002|Overall Study|Lack of Efficacy|0|||
28004621|NCT00778622|54663459|FG000|Overall Study|immigration|1|||
28004622|NCT00778622|54663460|FG001|Overall Study|immigration|0|||
28004623|NCT00778622|54663461|FG002|Overall Study|immigration|0|||
28004624|NCT00778622|54663459|FG000|Overall Study|Other|1|||
28004625|NCT00778622|54663460|FG001|Overall Study|Other|0|||
28004626|NCT00778622|54663461|FG002|Overall Study|Other|1|||
28004627|NCT00777920|54663473|FG000|Overall Study|Adverse Event|39|||
28004628|NCT00777920|54663473|FG000|Overall Study|Withdrawal of Consent|4|||
28004629|NCT00777920|54663473|FG000|Overall Study|Lost to Follow-up|1|||
28004630|NCT00777920|54663473|FG000|Overall Study|Investigator's discretion|1|||
28004631|NCT00777920|54663473|FG000|Overall Study|Clinical status did not improve|1|||
28004632|NCT00777920|54663473|FG000|Overall Study|Other, not specified|4|||
28004633|NCT04236141|54663479|FG000|Overall Study|Death|18|||
28004634|NCT04236141|54663480|FG001|Overall Study|Death|10|||
28004635|NCT04236141|54663479|FG000|Overall Study|Withdrawal by Participant|1|||
28004636|NCT04236141|54663480|FG001|Overall Study|Withdrawal by Participant|0|||
28004637|NCT04236141|54663479|FG000|Overall Study|Reason not Specified|1|||
28004638|NCT04236141|54663480|FG001|Overall Study|Reason not Specified|0|||
28004639|NCT04236141|54663479|FG000|Overall Study|Study terminated by Sponsor|8|||
28004640|NCT04236141|54663480|FG001|Overall Study|Study terminated by Sponsor|4|||
28004641|NCT00796445|54663488|FG000|Overall Study|Protocol Violation|5|||
28004642|NCT00796445|54663489|FG001|Overall Study|Protocol Violation|3|||
28004643|NCT00796445|54663488|FG000|Overall Study|Adverse event, serious fatal|10|||
28004644|NCT00796445|54663489|FG001|Overall Study|Adverse event, serious fatal|5|||
28004645|NCT00796445|54663488|FG000|Overall Study|Adverse event, non-fatal|4|||
28004646|NCT00796445|54663489|FG001|Overall Study|Adverse event, non-fatal|0|||
28004647|NCT00796445|54663488|FG000|Overall Study|Disease progression/recurrence|537|||
28004648|NCT00796445|54663489|FG001|Overall Study|Disease progression/recurrence|268|||
28004649|NCT00796445|54663488|FG000|Overall Study|Other|10|||
28004650|NCT00796445|54663489|FG001|Overall Study|Other|7|||
28004651|NCT00796445|54663488|FG000|Overall Study|Withdrawal by Subject|18|||
28004652|NCT00796445|54663489|FG001|Overall Study|Withdrawal by Subject|9|||
28004653|NCT00796445|54663488|FG000|Overall Study|Invalid Informed Consent Form|1|||
28004654|NCT00796445|54663489|FG001|Overall Study|Invalid Informed Consent Form|0|||
28004655|NCT03939819|54663505|FG000|Overall Study|Death|2|||
28004656|NCT03939819|54663506|FG001|Overall Study|Death|0|||
28004657|NCT00756938|54663515|FG000|12-week Base Study|Protocol-specific Criteria Met|1|||
28004658|NCT00756938|54663516|FG001|12-week Base Study|Protocol-specific Criteria Met|0|||
28004659|NCT00756938|54663517|FG002|12-week Base Study|Protocol-specific Criteria Met|1|||
28004660|NCT00756938|54663518|FG003|12-week Base Study|Protocol-specific Criteria Met|0|||
27916675|NCT01173523|54574516|FG000|Overall Study|Clinical Progression|1|||
27916676|NCT01173523|54574517|FG001|Overall Study|Clinical Progression|1|||
27916677|NCT01173523|54574516|FG000|Overall Study|Progressive Disease|10|||
27916678|NCT01173523|54574517|FG001|Overall Study|Progressive Disease|8|||
27916679|NCT01173523|54574516|FG000|Overall Study|Other|2|||
28004661|NCT00756938|54663515|FG000|12-week Base Study|Protocol Violation|0|||
28004662|NCT00756938|54663516|FG001|12-week Base Study|Protocol Violation|0|||
28004663|NCT00756938|54663517|FG002|12-week Base Study|Protocol Violation|1|||
28004664|NCT00756938|54663518|FG003|12-week Base Study|Protocol Violation|0|||
28004665|NCT00756938|54663515|FG000|12-week Base Study|Lost to Follow-up|1|||
28004666|NCT00756938|54663516|FG001|12-week Base Study|Lost to Follow-up|0|||
28004667|NCT00756938|54663517|FG002|12-week Base Study|Lost to Follow-up|0|||
28004668|NCT00756938|54663518|FG003|12-week Base Study|Lost to Follow-up|0|||
28004669|NCT00756938|54663515|FG000|Optional Extension|Lack of Efficacy|0|||
28004670|NCT00756938|54663516|FG001|Optional Extension|Lack of Efficacy|0|||
28004671|NCT00756938|54663517|FG002|Optional Extension|Lack of Efficacy|0|||
28004672|NCT00756938|54663518|FG003|Optional Extension|Lack of Efficacy|1|||
28004673|NCT00756938|54663515|FG000|Optional Extension|End of Study|0|||
28004674|NCT00756938|54663516|FG001|Optional Extension|End of Study|0|||
28004675|NCT00756938|54663517|FG002|Optional Extension|End of Study|0|||
28004676|NCT00756938|54663518|FG003|Optional Extension|End of Study|11|||
28004677|NCT00756938|54663515|FG000|Optional Extension|Protocol-specific criteria met|0|||
28004678|NCT00756938|54663516|FG001|Optional Extension|Protocol-specific criteria met|0|||
28004679|NCT00756938|54663517|FG002|Optional Extension|Protocol-specific criteria met|0|||
28004680|NCT00756938|54663518|FG003|Optional Extension|Protocol-specific criteria met|9|||
28004681|NCT00756938|54663515|FG000|Optional Extension|Physician Decision|0|||
28004682|NCT00756938|54663516|FG001|Optional Extension|Physician Decision|0|||
28004683|NCT00756938|54663517|FG002|Optional Extension|Physician Decision|0|||
28004684|NCT00756938|54663518|FG003|Optional Extension|Physician Decision|3|||
28004685|NCT00756938|54663515|FG000|Optional Extension|Lost to Follow-up|0|||
28004686|NCT00756938|54663516|FG001|Optional Extension|Lost to Follow-up|0|||
28004687|NCT00756938|54663517|FG002|Optional Extension|Lost to Follow-up|0|||
28004688|NCT00756938|54663518|FG003|Optional Extension|Lost to Follow-up|1|||
28004689|NCT00756938|54663515|FG000|Optional Extension|Protocol Violation|0|||
28004690|NCT00756938|54663516|FG001|Optional Extension|Protocol Violation|0|||
27916680|NCT01173523|54574517|FG001|Overall Study|Other|3|||
27916681|NCT01173055|54574525|FG000|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
27916682|NCT01173055|54574526|FG001|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
27916683|NCT01173055|54574525|FG000|Period 2 - Day 64 to 112|Adverse Event|0|||
27916684|NCT01173055|54574526|FG001|Period 2 - Day 64 to 112|Adverse Event|1|||
27916685|NCT01172938|54574535|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|11|||
27916686|NCT01172938|54574536|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|8|||
27916687|NCT01172938|54574537|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|10|||
27916688|NCT01172938|54574538|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
27916689|NCT01172938|54574539|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
27916690|NCT01172938|54574540|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
27916691|NCT01172938|54574541|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
27916692|NCT01172938|54574542|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
27916693|NCT01172938|54574543|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
28004691|NCT00756938|54663517|FG002|Optional Extension|Protocol Violation|0|||
28004692|NCT00756938|54663518|FG003|Optional Extension|Protocol Violation|1|||
28004693|NCT00756938|54663515|FG000|Optional Extension|Withdrawal by Subject|0|||
28004694|NCT00756938|54663516|FG001|Optional Extension|Withdrawal by Subject|0|||
28004695|NCT00756938|54663517|FG002|Optional Extension|Withdrawal by Subject|0|||
28004696|NCT00756938|54663518|FG003|Optional Extension|Withdrawal by Subject|10|||
28004697|NCT00756938|54663515|FG000|Optional Extension|Adverse Event|0|||
28004698|NCT00756938|54663516|FG001|Optional Extension|Adverse Event|0|||
28004699|NCT00756938|54663517|FG002|Optional Extension|Adverse Event|0|||
28004700|NCT00756938|54663518|FG003|Optional Extension|Adverse Event|1|||
28004701|NCT00796367|54663539|FG000|Overall Study|Adverse Event|6|||
28004702|NCT00796367|54663540|FG001|Overall Study|Adverse Event|4|||
28004703|NCT00796367|54663541|FG002|Overall Study|Adverse Event|7|||
28004704|NCT00796367|54663539|FG000|Overall Study|Lost to Follow-up|5|||
28004705|NCT00796367|54663540|FG001|Overall Study|Lost to Follow-up|4|||
28004706|NCT00796367|54663541|FG002|Overall Study|Lost to Follow-up|21|||
28004707|NCT00796367|54663539|FG000|Overall Study|Withdrawal by Subject|9|||
28004708|NCT00796367|54663540|FG001|Overall Study|Withdrawal by Subject|11|||
28004709|NCT00796367|54663541|FG002|Overall Study|Withdrawal by Subject|12|||
28004710|NCT00796367|54663539|FG000|Overall Study|Lack of Efficacy|2|||
28004711|NCT00796367|54663540|FG001|Overall Study|Lack of Efficacy|1|||
28004712|NCT00796367|54663541|FG002|Overall Study|Lack of Efficacy|0|||
28004713|NCT00796367|54663539|FG000|Overall Study|non compliance|3|||
28004714|NCT00796367|54663540|FG001|Overall Study|non compliance|1|||
27916694|NCT01172938|54574535|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
27916695|NCT01172938|54574536|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
27916696|NCT01172938|54574537|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
27916697|NCT01172938|54574538|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
27916698|NCT01172938|54574539|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
27916699|NCT01172938|54574540|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
28004715|NCT00796367|54663541|FG002|Overall Study|non compliance|1|||
28004716|NCT00796367|54663539|FG000|Overall Study|Pregnancy|1|||
28004717|NCT00796367|54663540|FG001|Overall Study|Pregnancy|0|||
28004718|NCT00796367|54663541|FG002|Overall Study|Pregnancy|1|||
28004719|NCT00796367|54663539|FG000|Overall Study|Requirement for restricted medication|2|||
28004720|NCT00796367|54663540|FG001|Overall Study|Requirement for restricted medication|0|||
28004721|NCT00796367|54663541|FG002|Overall Study|Requirement for restricted medication|2|||
28004722|NCT00796367|54663539|FG000|Overall Study|other|2|||
28004723|NCT00796367|54663540|FG001|Overall Study|other|4|||
28004724|NCT00796367|54663541|FG002|Overall Study|other|3|||
28004725|NCT00770588|54663551|FG000|Overall Study|Adverse Event|9|||
28004726|NCT00770588|54663552|FG001|Overall Study|Adverse Event|2|||
28004727|NCT00770588|54663551|FG000|Overall Study|Death caused by progression of disease|70|||
28004728|NCT00770588|54663552|FG001|Overall Study|Death caused by progression of disease|91|||
28004729|NCT00770588|54663551|FG000|Overall Study|Lost to Follow-up|1|||
28004730|NCT00770588|54663552|FG001|Overall Study|Lost to Follow-up|1|||
28004731|NCT00770588|54663551|FG000|Overall Study|Withdrawal by Subject|1|||
28004732|NCT00770588|54663552|FG001|Overall Study|Withdrawal by Subject|1|||
28004733|NCT00777608|54663561|FG000|Overall Study|Lost to Follow-up|1|||
28004734|NCT00777608|54663562|FG001|Overall Study|Lost to Follow-up|1|||
28004735|NCT00777608|54663561|FG000|Overall Study|Withdrawal by Subject|1|||
28004736|NCT00777608|54663562|FG001|Overall Study|Withdrawal by Subject|3|||
28004737|NCT00777608|54663561|FG000|Overall Study|Protocol Violation|1|||
28004738|NCT00777608|54663562|FG001|Overall Study|Protocol Violation|0|||
28004739|NCT00777608|54663561|FG000|Overall Study|Investigator Decision|1|||
28004740|NCT00777608|54663562|FG001|Overall Study|Investigator Decision|2|||
28004741|NCT00792935|54663570|FG000|Overall Study|Adverse Event|2|||
28004742|NCT00792935|54663571|FG001|Overall Study|Adverse Event|1|||
28004743|NCT00792935|54663570|FG000|Overall Study|Lost to Follow-up|0|||
28004744|NCT00792935|54663571|FG001|Overall Study|Lost to Follow-up|1|||
28004745|NCT00792935|54663570|FG000|Overall Study|Protocol Violation|2|||
28004746|NCT00792935|54663571|FG001|Overall Study|Protocol Violation|0|||
28004747|NCT00792935|54663570|FG000|Overall Study|Withdrawal by Subject|0|||
28004748|NCT00792935|54663571|FG001|Overall Study|Withdrawal by Subject|1|||
28004749|NCT00770510|54663577|FG000|Overall Study|Lost to Follow-up|2|||
28004750|NCT00770510|54663577|FG000|Overall Study|Pregnancy|1|||
28004751|NCT00770510|54663577|FG000|Overall Study|Withdrawal by Subject|2|||
28004752|NCT00770432|54663591|FG000|Overall Study|Other|4|||
28004753|NCT00770432|54663592|FG001|Overall Study|Other|6|||
28004754|NCT00770432|54663591|FG000|Overall Study|Non-compliance|0|||
28004755|NCT00770432|54663592|FG001|Overall Study|Non-compliance|1|||
28004756|NCT00792701|54663600|FG000|Overall Study|Adverse Event|0|||
28004757|NCT00792701|54663601|FG001|Overall Study|Adverse Event|22|||
28004758|NCT00792701|54663600|FG000|Overall Study|Ineligible|1|||
28004759|NCT00792701|54663601|FG001|Overall Study|Ineligible|3|||
28004760|NCT00792701|54663600|FG000|Overall Study|Withdrawal by Subject|1|||
28004761|NCT00792701|54663601|FG001|Overall Study|Withdrawal by Subject|19|||
28004762|NCT00792701|54663600|FG000|Overall Study|Not protocol specified|17|||
28004763|NCT00792701|54663601|FG001|Overall Study|Not protocol specified|0|||
28004764|NCT00777296|54663613|FG000|Overall Study|Adverse Event|0|||
28004765|NCT00777296|54663614|FG001|Overall Study|Adverse Event|1|||
28004766|NCT00777296|54663615|FG002|Overall Study|Adverse Event|0|||
28004767|NCT00777296|54663616|FG003|Overall Study|Adverse Event|1|||
28004768|NCT00777296|54663613|FG000|Overall Study|Withdrawal by Subject|1|||
28004769|NCT00777296|54663614|FG001|Overall Study|Withdrawal by Subject|0|||
28004770|NCT00777296|54663615|FG002|Overall Study|Withdrawal by Subject|0|||
28004771|NCT00777296|54663616|FG003|Overall Study|Withdrawal by Subject|0|||
28004772|NCT00777296|54663613|FG000|Overall Study|CRF form not completed|0|||
28004773|NCT00777296|54663614|FG001|Overall Study|CRF form not completed|0|||
28004774|NCT00777296|54663615|FG002|Overall Study|CRF form not completed|2|||
28004775|NCT00777296|54663616|FG003|Overall Study|CRF form not completed|0|||
28004776|NCT00756470|54663638|FG000|Overall Study|Withdrawal by Subject|1|||
28004777|NCT00756470|54663638|FG000|Overall Study|Adverse Event|4|||
28004778|NCT00792623|54663642|FG000|Overall Study|Adverse Event|2|||
28004779|NCT00792623|54663642|FG000|Overall Study|Withdrawal by Subject|5|||
28004780|NCT00756314|54663649|FG000|Overall Study|Lost to Follow-up|2|||
28004781|NCT00756314|54663650|FG001|Overall Study|Lost to Follow-up|59|||
28004782|NCT00727506|54663662|FG000|Overall Study|Adverse Event|0|||
28004783|NCT00727506|54663663|FG001|Overall Study|Adverse Event|0|||
28004784|NCT00727506|54663664|FG002|Overall Study|Adverse Event|4|||
28004785|NCT00727506|54663665|FG003|Overall Study|Adverse Event|4|||
28004786|NCT00727506|54663666|FG004|Overall Study|Adverse Event|1|||
27916700|NCT01172938|54574541|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
27916701|NCT01172938|54574542|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
27916702|NCT01172938|54574543|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
27916703|NCT01172938|54574535|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
27916704|NCT01172938|54574536|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
27916705|NCT01172938|54574537|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2|||
27916706|NCT01172938|54574538|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
27916707|NCT01172938|54574539|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
28004787|NCT00727506|54663667|FG005|Overall Study|Adverse Event|8|||
28004788|NCT00727506|54663662|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
28004789|NCT00727506|54663663|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
28004790|NCT00727506|54663664|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
28004791|NCT00727506|54663665|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
28004792|NCT00727506|54663666|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
28004793|NCT00727506|54663667|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
28004794|NCT00727506|54663662|FG000|Overall Study|Progressive disease|4|||
28004795|NCT00727506|54663663|FG001|Overall Study|Progressive disease|7|||
28004796|NCT00727506|54663664|FG002|Overall Study|Progressive disease|9|||
28004797|NCT00727506|54663665|FG003|Overall Study|Progressive disease|28|||
28004798|NCT00727506|54663666|FG004|Overall Study|Progressive disease|38|||
28004799|NCT00727506|54663667|FG005|Overall Study|Progressive disease|28|||
28004800|NCT00727506|54663662|FG000|Overall Study|Refused to continue medication|0|||
28004801|NCT00727506|54663663|FG001|Overall Study|Refused to continue medication|1|||
28004802|NCT00727506|54663664|FG002|Overall Study|Refused to continue medication|2|||
28004803|NCT00727506|54663665|FG003|Overall Study|Refused to continue medication|3|||
28004804|NCT00727506|54663666|FG004|Overall Study|Refused to continue medication|1|||
28004805|NCT00727506|54663667|FG005|Overall Study|Refused to continue medication|2|||
28004806|NCT00727506|54663662|FG000|Overall Study|Other reason not described above|0|||
28004807|NCT00727506|54663663|FG001|Overall Study|Other reason not described above|0|||
28004808|NCT00727506|54663664|FG002|Overall Study|Other reason not described above|1|||
27916708|NCT01172938|54574540|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
27916709|NCT01172938|54574541|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
27916710|NCT01172938|54574542|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
28004809|NCT00727506|54663665|FG003|Overall Study|Other reason not described above|4|||
28004810|NCT00727506|54663666|FG004|Overall Study|Other reason not described above|1|||
28004811|NCT00727506|54663667|FG005|Overall Study|Other reason not described above|1|||
28004812|NCT00789815|54663689|FG000|Overall Study|Protocol Violation|6|||
28004813|NCT00789815|54663690|FG001|Overall Study|Protocol Violation|1|||
28004814|NCT00789815|54663689|FG000|Overall Study|Intubation due to massive bleeding|1|||
28004815|NCT00789815|54663690|FG001|Overall Study|Intubation due to massive bleeding|0|||
28004816|NCT00721578|54663696|FG000|Overall Study|Death|1|||
28004817|NCT00721578|54663697|FG001|Overall Study|Death|1|||
28004818|NCT00721578|54663696|FG000|Overall Study|Withdrawal by Subject|1|||
28004819|NCT00721578|54663697|FG001|Overall Study|Withdrawal by Subject|1|||
28004820|NCT00789737|54663705|FG000|Overall Study|Withdrawal by Subject|13|||
28004821|NCT00789737|54663706|FG001|Overall Study|Withdrawal by Subject|22|||
28004822|NCT00789737|54663705|FG000|Overall Study|Lost to Follow-up|10|||
27916711|NCT01172938|54574543|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
27916712|NCT01172938|54574535|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2|||
27916713|NCT01172938|54574536|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
28004823|NCT00789737|54663706|FG001|Overall Study|Lost to Follow-up|14|||
28004824|NCT00789737|54663705|FG000|Overall Study|Adverse Event|8|||
28004825|NCT00789737|54663706|FG001|Overall Study|Adverse Event|8|||
28004826|NCT00789737|54663705|FG000|Overall Study|Protocol Violation|3|||
28004827|NCT00789737|54663706|FG001|Overall Study|Protocol Violation|0|||
28004828|NCT00789737|54663705|FG000|Overall Study|Lack of Efficacy|3|||
28004829|NCT00789737|54663706|FG001|Overall Study|Lack of Efficacy|0|||
28004830|NCT00789737|54663705|FG000|Overall Study|hyperglycemia that met protocol-specifie|0|||
28004831|NCT00789737|54663706|FG001|Overall Study|hyperglycemia that met protocol-specifie|4|||
28100652|NCT02914522|54756978|FG000|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
28100653|NCT02914522|54756979|FG001|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
28100654|NCT02914522|54756980|FG002|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
27916714|NCT01172938|54574537|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
27916715|NCT01172938|54574538|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
27916716|NCT01172938|54574539|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
27916717|NCT01172938|54574540|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
27916718|NCT01172938|54574541|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
27916719|NCT01172938|54574542|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
27916720|NCT01172938|54574543|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
27916721|NCT01172938|54574535|FG000|Placebo-controlled Phase (Week 0-24)|Death|0|||
27916722|NCT01172938|54574536|FG001|Placebo-controlled Phase (Week 0-24)|Death|1|||
27916723|NCT01172938|54574537|FG002|Placebo-controlled Phase (Week 0-24)|Death|0|||
27916724|NCT01172938|54574538|FG003|Placebo-controlled Phase (Week 0-24)|Death|0|||
27916725|NCT01172938|54574539|FG004|Placebo-controlled Phase (Week 0-24)|Death|0|||
27916726|NCT01172938|54574540|FG005|Placebo-controlled Phase (Week 0-24)|Death|0|||
28004832|NCT00789737|54663705|FG000|Overall Study|Other|11|||
28004833|NCT00789737|54663706|FG001|Overall Study|Other|7|||
28004834|NCT00792467|54663712|FG000|Overall Study|progression of disease|17|||
28004835|NCT00792467|54663712|FG000|Overall Study|Adverse Event|1|||
28004836|NCT00792467|54663712|FG000|Overall Study|patient request|1|||
28004837|NCT00792467|54663712|FG000|Overall Study|Lost to Follow-up|1|||
28004838|NCT00792467|54663712|FG000|Overall Study|Patient achieved a PR and allogenic transplant was performed|1|||
28004839|NCT00792467|54663712|FG000|Overall Study|Patient in CR and HLA-matched donor available. Allogenic SCT performed|1|||
28004840|NCT00585468|54663717|FG000|First Intervention|Withdrawal by Subject|1|||
28004841|NCT00585468|54663718|FG001|First Intervention|Withdrawal by Subject|1|||
28004842|NCT00724152|54663731|FG000|Two-arm Study Period|Withdrawal by Subject|3|||
28004843|NCT00724152|54663732|FG001|Two-arm Study Period|Withdrawal by Subject|2|||
28004844|NCT00724152|54663733|FG002|Two-arm Study Period|Withdrawal by Subject|0|||
28004845|NCT00724152|54663731|FG000|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
28004846|NCT00724152|54663732|FG001|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2|||
28004847|NCT00724152|54663733|FG002|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
28004848|NCT00721110|54663747|FG000|Overall Study|Ultram use|1|||
28004849|NCT00721110|54663748|FG001|Overall Study|Ultram use|0|||
28004850|NCT00721110|54663749|FG002|Overall Study|Ultram use|0|||
28172766|NCT02745119|54844494|FG000|Overall Study|Withdrawal by Subject|7|||
28172767|NCT02745119|54844495|FG001|Overall Study|Withdrawal by Subject|15|||
28172768|NCT02745119|54844496|FG002|Overall Study|Withdrawal by Subject|8|||
28172769|NCT02745119|54844497|FG003|Overall Study|Withdrawal by Subject|14|||
28172770|NCT02745119|54844494|FG000|Overall Study|Study Terminated by Sponsor|134|||
28172771|NCT02745119|54844495|FG001|Overall Study|Study Terminated by Sponsor|252|||
28172772|NCT02745119|54844496|FG002|Overall Study|Study Terminated by Sponsor|135|||
27916727|NCT01172938|54574541|FG006|Placebo-controlled Phase (Week 0-24)|Death|0|||
27916728|NCT01172938|54574542|FG007|Placebo-controlled Phase (Week 0-24)|Death|0|||
28004851|NCT00721110|54663750|FG003|Overall Study|Ultram use|0|||
28004852|NCT00721110|54663747|FG000|Overall Study|vertical incision|0|||
28004853|NCT00721110|54663748|FG001|Overall Study|vertical incision|0|||
28004854|NCT00721110|54663749|FG002|Overall Study|vertical incision|1|||
28004855|NCT00721110|54663750|FG003|Overall Study|vertical incision|0|||
28004856|NCT00791999|54663764|FG000|Overall Study|Protocol planed withdrawal|14|||
28004857|NCT00791999|54663765|FG001|Overall Study|Protocol planed withdrawal|11|||
28004858|NCT00791999|54663766|FG002|Overall Study|Protocol planed withdrawal|11|||
28004859|NCT00791999|54663767|FG003|Overall Study|Protocol planed withdrawal|45|||
28004860|NCT00791999|54663764|FG000|Overall Study|Withdrawal by Subject|0|||
28004861|NCT00791999|54663765|FG001|Overall Study|Withdrawal by Subject|1|||
28004862|NCT00791999|54663766|FG002|Overall Study|Withdrawal by Subject|0|||
28004863|NCT00791999|54663767|FG003|Overall Study|Withdrawal by Subject|2|||
28004864|NCT00791999|54663764|FG000|Overall Study|Protocol Violation|3|||
28004865|NCT00791999|54663765|FG001|Overall Study|Protocol Violation|0|||
28004866|NCT00791999|54663766|FG002|Overall Study|Protocol Violation|1|||
28004867|NCT00791999|54663767|FG003|Overall Study|Protocol Violation|0|||
28004868|NCT00791999|54663764|FG000|Overall Study|Adverse Event|3|||
28004869|NCT00791999|54663765|FG001|Overall Study|Adverse Event|3|||
28004870|NCT00791999|54663766|FG002|Overall Study|Adverse Event|7|||
28004871|NCT00791999|54663767|FG003|Overall Study|Adverse Event|3|||
28004872|NCT00791999|54663764|FG000|Overall Study|Lack of Efficacy|0|||
28004873|NCT00791999|54663765|FG001|Overall Study|Lack of Efficacy|1|||
28004874|NCT00791999|54663766|FG002|Overall Study|Lack of Efficacy|0|||
28004875|NCT00791999|54663767|FG003|Overall Study|Lack of Efficacy|2|||
28004876|NCT00791999|54663764|FG000|Overall Study|Reason other than those above|1|||
27916729|NCT01172938|54574543|FG008|Placebo-controlled Phase (Week 0-24)|Death|0|||
27916730|NCT01172938|54574535|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1|||
27916731|NCT01172938|54574536|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
27916732|NCT01172938|54574537|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
27916733|NCT01172938|54574538|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
27916734|NCT01172938|54574539|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
27916735|NCT01172938|54574540|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
27916736|NCT01172938|54574541|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
27916737|NCT01172938|54574542|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
27916738|NCT01172938|54574543|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
27916739|NCT01172938|54574535|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
27916740|NCT01172938|54574536|FG001|Placebo-controlled Phase (Week 0-24)|Other|2|||
27916741|NCT01172938|54574537|FG002|Placebo-controlled Phase (Week 0-24)|Other|1|||
28004877|NCT00791999|54663765|FG001|Overall Study|Reason other than those above|0|||
28004878|NCT00791999|54663766|FG002|Overall Study|Reason other than those above|1|||
28004879|NCT00791999|54663767|FG003|Overall Study|Reason other than those above|0|||
28004880|NCT00585078|54663781|FG000|Overall Study|Withdrawal by Subject|4|||
28004881|NCT00585078|54663781|FG000|Overall Study|Poor performance status|1|||
28004882|NCT00585078|54663781|FG000|Overall Study|Disease Progression|24|||
28004883|NCT00585078|54663781|FG000|Overall Study|Adverse Event|10|||
28004884|NCT00585078|54663781|FG000|Overall Study|Death|1|||
28004885|NCT00720876|54663785|FG000|Overall Study|found to be ineligible after starting tx|2|||
28004886|NCT00723840|54663789|FG000|Overall Study|Lost to Follow-up|2|||
28004887|NCT00723840|54663789|FG000|Overall Study|Failure to return|18|||
28004888|NCT00723840|54663789|FG000|Overall Study|Withdrawal by Subject|55|||
28004889|NCT00723840|54663789|FG000|Overall Study|Serious Adverse Events|3|||
28172773|NCT02745119|54844497|FG003|Overall Study|Study Terminated by Sponsor|251|||
27916742|NCT01172938|54574538|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
27916743|NCT01172938|54574539|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
27916744|NCT01172938|54574540|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
27916745|NCT01172938|54574541|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
27916746|NCT01172938|54574542|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
27916747|NCT01172938|54574543|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
27916748|NCT01172938|54574535|FG000|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
27916749|NCT01172938|54574536|FG001|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
27916750|NCT01172938|54574537|FG002|Active Treatment Phase (Weeks 25-52)|Adverse Event|5|||
27916751|NCT01172938|54574538|FG003|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
28004890|NCT00723840|54663789|FG000|Overall Study|Other Medical Event|2|||
28004891|NCT00723840|54663789|FG000|Overall Study|Unspecified reason|2|||
27916752|NCT01172938|54574539|FG004|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
27916753|NCT01172938|54574540|FG005|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
28004892|NCT00789581|54663802|FG000|AC Therapy|Adverse Event|2|||
28004893|NCT00789581|54663803|FG001|AC Therapy|Adverse Event|3|||
28004894|NCT00789581|54663802|FG000|AC Therapy|Withdrawal by Subject|4|||
28004895|NCT00789581|54663803|FG001|AC Therapy|Withdrawal by Subject|7|||
28004896|NCT00789581|54663802|FG000|AC Therapy|Disease recurrence|3|||
28004897|NCT00789581|54663803|FG001|AC Therapy|Disease recurrence|1|||
28004898|NCT00789581|54663802|FG000|AC Therapy|Intercurrent Illness|1|||
28004899|NCT00789581|54663803|FG001|AC Therapy|Intercurrent Illness|0|||
28004900|NCT00789581|54663802|FG000|AC Therapy|Never Treated|1|||
28004901|NCT00789581|54663803|FG001|AC Therapy|Never Treated|4|||
28004902|NCT00789581|54663802|FG000|AC Therapy|Other|0|||
28004903|NCT00789581|54663803|FG001|AC Therapy|Other|2|||
28004904|NCT00789581|54663802|FG000|Adjuvant Therapy|Never treated|2|||
28004905|NCT00789581|54663803|FG001|Adjuvant Therapy|Never treated|2|||
28004906|NCT00789581|54663802|FG000|Adjuvant Therapy|Adverse Event|20|||
28100655|NCT02914522|54756981|FG003|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
28100656|NCT02914522|54756982|FG004|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
28100657|NCT02914522|54756983|FG005|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
28100658|NCT02914522|54756984|FG006|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
28100659|NCT02914522|54756985|FG007|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
28100660|NCT02914522|54756986|FG008|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
28100661|NCT02914522|54756987|FG009|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|1|||
28100662|NCT02914522|54756988|FG010|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
28100663|NCT02924428|54757017|FG000|Overall Study|Adverse Event|1|||
28100664|NCT02924428|54757018|FG001|Overall Study|Adverse Event|0|||
28100665|NCT02924428|54757017|FG000|Overall Study|Physician Decision|1|||
28100666|NCT02924428|54757018|FG001|Overall Study|Physician Decision|0|||
28100667|NCT02924428|54757017|FG000|Overall Study|Lost to Follow-up|2|||
28100668|NCT02924428|54757018|FG001|Overall Study|Lost to Follow-up|4|||
28100669|NCT02924428|54757017|FG000|Overall Study|Pregnancy|0|||
28100670|NCT02924428|54757018|FG001|Overall Study|Pregnancy|1|||
28100671|NCT00062751|54757029|FG000|Overall Study|Disease progression|24|||
28100672|NCT00062751|54757030|FG001|Overall Study|Disease progression|17|||
28100673|NCT00062751|54757031|FG002|Overall Study|Disease progression|24|||
28100674|NCT00062751|54757032|FG003|Overall Study|Disease progression|2|||
28100675|NCT00062751|54757033|FG004|Overall Study|Disease progression|2|||
28100676|NCT00062751|54757029|FG000|Overall Study|Adverse Event|4|||
28100677|NCT00062751|54757030|FG001|Overall Study|Adverse Event|7|||
28100678|NCT00062751|54757031|FG002|Overall Study|Adverse Event|2|||
28100679|NCT00062751|54757032|FG003|Overall Study|Adverse Event|2|||
28100680|NCT00062751|54757033|FG004|Overall Study|Adverse Event|2|||
28100681|NCT00062751|54757029|FG000|Overall Study|Other|2|||
28100682|NCT00062751|54757030|FG001|Overall Study|Other|3|||
28100683|NCT00062751|54757031|FG002|Overall Study|Other|1|||
28100684|NCT00062751|54757032|FG003|Overall Study|Other|0|||
28100685|NCT00062751|54757033|FG004|Overall Study|Other|1|||
28100686|NCT00062751|54757029|FG000|Overall Study|Withdrawal by Subject|1|||
28100687|NCT00062751|54757030|FG001|Overall Study|Withdrawal by Subject|2|||
28100688|NCT00062751|54757031|FG002|Overall Study|Withdrawal by Subject|2|||
28100689|NCT00062751|54757032|FG003|Overall Study|Withdrawal by Subject|1|||
28100690|NCT00062751|54757033|FG004|Overall Study|Withdrawal by Subject|0|||
27916754|NCT01172938|54574541|FG006|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
28004907|NCT00789581|54663803|FG001|Adjuvant Therapy|Adverse Event|44|||
28004908|NCT00789581|54663802|FG000|Adjuvant Therapy|Withdrawal by Subject|14|||
28004909|NCT00789581|54663803|FG001|Adjuvant Therapy|Withdrawal by Subject|5|||
28004910|NCT00789581|54663802|FG000|Adjuvant Therapy|Disease recurrence|2|||
28100691|NCT00062751|54757029|FG000|Overall Study|Symptomatic deterioration|1|||
28100692|NCT00062751|54757030|FG001|Overall Study|Symptomatic deterioration|1|||
28004911|NCT00789581|54663803|FG001|Adjuvant Therapy|Disease recurrence|1|||
28004912|NCT00789581|54663802|FG000|Adjuvant Therapy|Intercurrent Illness|1|||
28004913|NCT00789581|54663803|FG001|Adjuvant Therapy|Intercurrent Illness|3|||
27916755|NCT01172938|54574542|FG007|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
27916756|NCT01172938|54574543|FG008|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
27916757|NCT01172938|54574535|FG000|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
27916758|NCT01172938|54574536|FG001|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4|||
27916759|NCT01172938|54574537|FG002|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7|||
27916760|NCT01172938|54574538|FG003|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
27916761|NCT01172938|54574539|FG004|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1|||
27916762|NCT01172938|54574540|FG005|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
27916763|NCT01172938|54574541|FG006|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
27916764|NCT01172938|54574542|FG007|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
27916765|NCT01172938|54574543|FG008|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
27916766|NCT01172938|54574535|FG000|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
27916767|NCT01172938|54574536|FG001|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
27916768|NCT01172938|54574537|FG002|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1|||
27916769|NCT01172938|54574538|FG003|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
27916770|NCT01172938|54574539|FG004|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
27916771|NCT01172938|54574540|FG005|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
28004914|NCT00789581|54663802|FG000|Adjuvant Therapy|Protocol Violation|1|||
28004915|NCT00789581|54663803|FG001|Adjuvant Therapy|Protocol Violation|1|||
28004916|NCT00789581|54663802|FG000|Adjuvant Therapy|Other|0|||
28004917|NCT00789581|54663803|FG001|Adjuvant Therapy|Other|1|||
28004918|NCT00717756|54663810|FG000|Overall Study|Withdrawal by Subject|1|||
28004919|NCT00717522|54663814|FG000|Overall Study|Disease Progression|5|||
28004920|NCT00717522|54663814|FG000|Overall Study|Adverse Event|1|||
28004921|NCT00717522|54663814|FG000|Overall Study|Death|1|||
28004922|NCT00791921|54663820|FG000|Overall Study|Protocol planed|24|||
28004923|NCT00791921|54663821|FG001|Overall Study|Protocol planed|88|||
28004924|NCT00791921|54663820|FG000|Overall Study|Withdrawal by Subject|1|||
28004925|NCT00791921|54663821|FG001|Overall Study|Withdrawal by Subject|2|||
28004926|NCT00791921|54663820|FG000|Overall Study|Adverse Event|8|||
28004927|NCT00791921|54663821|FG001|Overall Study|Adverse Event|2|||
28004928|NCT00791921|54663820|FG000|Overall Study|Lack of Efficacy|0|||
28004929|NCT00791921|54663821|FG001|Overall Study|Lack of Efficacy|2|||
28004930|NCT00791921|54663820|FG000|Overall Study|Lack of study drug administration|1|||
28004931|NCT00791921|54663821|FG001|Overall Study|Lack of study drug administration|1|||
28004932|NCT00791921|54663820|FG000|Overall Study|Reason other than those above|0|||
28004933|NCT00791921|54663821|FG001|Overall Study|Reason other than those above|1|||
28004934|NCT00582933|54663827|FG000|Overall Study|Physician Decision|3|||
28004935|NCT00791765|54663833|FG000|Weeks 1 to 12|Adverse Event|0|||
28004936|NCT00791765|54663834|FG001|Weeks 1 to 12|Adverse Event|1|||
28004937|NCT00791765|54663833|FG000|Weeks 1 to 12|Lost to Follow-up|1|||
28004938|NCT00791765|54663834|FG001|Weeks 1 to 12|Lost to Follow-up|0|||
28004939|NCT00791765|54663833|FG000|Weeks 1 to 12|Withdrawal by Subject|3|||
28004940|NCT00791765|54663834|FG001|Weeks 1 to 12|Withdrawal by Subject|0|||
28004941|NCT00791765|54663833|FG000|Weeks 1 to 12|Physician Decision|1|||
28100693|NCT00062751|54757031|FG002|Overall Study|Symptomatic deterioration|0|||
28100694|NCT00062751|54757032|FG003|Overall Study|Symptomatic deterioration|0|||
28100695|NCT00062751|54757033|FG004|Overall Study|Symptomatic deterioration|1|||
28100696|NCT00062751|54757029|FG000|Overall Study|Death|1|||
28100697|NCT00062751|54757030|FG001|Overall Study|Death|0|||
28100698|NCT00062751|54757031|FG002|Overall Study|Death|1|||
28100699|NCT00062751|54757032|FG003|Overall Study|Death|0|||
28100700|NCT00062751|54757033|FG004|Overall Study|Death|0|||
28100701|NCT00062439|54757050|FG000|Induction Chemotherapy + Radiotherapy|Ineligible|1|||
28100702|NCT00062439|54757050|FG000|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1|||
28100703|NCT00062439|54757050|FG000|Induction Chemotherapy + Radiotherapy|Adverse Event|3|||
28100704|NCT00062439|54757050|FG000|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3|||
28100705|NCT00062439|54757050|FG000|Post Chemoradiation Assessment|Death|1|||
28100706|NCT00062439|54757050|FG000|Post Chemoradiation Assessment|Disease progression|2|||
28100707|NCT00062439|54757050|FG000|Post Chemoradiation Assessment|Withdrawal by Subject|1|||
28172774|NCT02745119|54844494|FG000|Overall Study|Physician Decision|0|||
28172775|NCT02745119|54844495|FG001|Overall Study|Physician Decision|2|||
27739930|NCT02786537|54189680|FG003|As Randomized|Opiate Dependency Relapse|0|||
27739931|NCT02786537|54189681|FG004|As Randomized|Opiate Dependency Relapse|0|||
27916772|NCT01172938|54574541|FG006|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
28004942|NCT00791765|54663834|FG001|Weeks 1 to 12|Physician Decision|0|||
28004943|NCT00791765|54663833|FG000|Weeks 1 to 12|Disease progression|3|||
28004944|NCT00791765|54663834|FG001|Weeks 1 to 12|Disease progression|0|||
28004945|NCT00791765|54663833|FG000|Weeks 1 to 12|Ineligibility determined|0|||
28004946|NCT00791765|54663834|FG001|Weeks 1 to 12|Ineligibility determined|3|||
28004947|NCT00791765|54663833|FG000|Weeks 13 to 24|Protocol deviation|2|||
28004948|NCT00791765|54663834|FG001|Weeks 13 to 24|Protocol deviation|0|||
28004949|NCT00791765|54663833|FG000|Weeks 13 to 24|Adverse Event|0|||
27916773|NCT01172938|54574542|FG007|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
27916774|NCT01172938|54574543|FG008|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
27916775|NCT01172938|54574535|FG000|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
27916776|NCT01172938|54574536|FG001|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5|||
27916777|NCT01172938|54574537|FG002|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
27916778|NCT01172938|54574538|FG003|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
27916779|NCT01172938|54574539|FG004|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
27916780|NCT01172938|54574540|FG005|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9|||
28004950|NCT00791765|54663834|FG001|Weeks 13 to 24|Adverse Event|3|||
28004951|NCT00791765|54663833|FG000|Weeks 13 to 24|Withdrawal by Subject|2|||
28004952|NCT00791765|54663834|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
28004953|NCT00791765|54663833|FG000|Weeks 13 to 24|Disease progression|0|||
28004954|NCT00791765|54663834|FG001|Weeks 13 to 24|Disease progression|1|||
28004955|NCT00791765|54663833|FG000|Weeks 13 to 24|Lost to Follow-up|1|||
27916781|NCT01172938|54574541|FG006|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
27916782|NCT01172938|54574542|FG007|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
27916783|NCT01172938|54574543|FG008|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
27916784|NCT01172938|54574535|FG000|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
27916785|NCT01172938|54574536|FG001|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
27916786|NCT01172938|54574537|FG002|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
27916787|NCT01172938|54574538|FG003|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
27916788|NCT01172938|54574539|FG004|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
27916789|NCT01172938|54574540|FG005|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
27916790|NCT01172938|54574541|FG006|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
27916791|NCT01172938|54574542|FG007|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
27916792|NCT01172938|54574543|FG008|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
27916793|NCT01172938|54574535|FG000|Active Treatment Phase (Weeks 25-52)|Other|0|||
28004956|NCT00791765|54663834|FG001|Weeks 13 to 24|Lost to Follow-up|2|||
28004957|NCT00791765|54663833|FG000|Weeks 13 to 24|Other|0|||
28004958|NCT00791765|54663834|FG001|Weeks 13 to 24|Other|1|||
28100708|NCT00062439|54757050|FG000|Post Chemoradiation Assessment|Physician Decision|1|||
28100709|NCT00062439|54757050|FG000|Post Chemoradiation Assessment|Not eligible to continue to surgery|4|||
28100710|NCT00062439|54757050|FG000|Surgery|Physician Decision|4|||
28100711|NCT00062439|54757050|FG000|Surgery|Death|1|||
28100712|NCT00062439|54757050|FG000|Surgery|Adverse Event|2|||
28100713|NCT00062439|54757050|FG000|Consolidation Chemotherapy|Adverse Event|2|||
28100714|NCT00051363|54757061|FG000|Overall Study|Dropped Post-Rand for Any Reason|102|||
28100715|NCT00051363|54757062|FG001|Overall Study|Dropped Post-Rand for Any Reason|126|||
28100716|NCT00051363|54757061|FG000|Overall Study|Disqualified Post-Rand for Any Reason|9|||
28100717|NCT00051363|54757062|FG001|Overall Study|Disqualified Post-Rand for Any Reason|11|||
28100718|NCT00051363|54757061|FG000|Overall Study|Death|2|||
28100719|NCT00051363|54757062|FG001|Overall Study|Death|2|||
28100720|NCT00051363|54757061|FG000|Overall Study|Excluded Pre-Randomization|2|||
28100721|NCT00051363|54757062|FG001|Overall Study|Excluded Pre-Randomization|5|||
28100722|NCT00031551|54757070|FG000|Overall Study|Withdrew due to chemotherapy effects|2|||
28100723|NCT00031551|54757071|FG001|Overall Study|Withdrew due to chemotherapy effects|0|||
28100724|NCT00049257|54757081|FG000|Carboplatin, Paclitaxel|Withdrawal by Subject|10|||
28100725|NCT00049257|54757081|FG000|Carboplatin, Paclitaxel|Lost to Follow-up|1|||
28100726|NCT00049257|54757081|FG000|Carboplatin, Paclitaxel|Death|2|||
28100727|NCT00049257|54757081|FG000|Follow-up Period for Survival Status|Lost to Follow-up|4|||
28100728|NCT03020992|54757085|FG000|Overall Study|Adverse Event|5|||
28100729|NCT03020992|54757085|FG000|Overall Study|Withdrawal by Subject|1|||
28100730|NCT03020914|54757092|FG000|Overall Study|Surgery Cancelled|1|||
28100731|NCT03020914|54757093|FG001|Overall Study|Surgery Cancelled|0|||
28100732|NCT03018340|54757101|FG000|Overall Study|Adverse Event|1|||
28100733|NCT03018340|54757102|FG001|Overall Study|Adverse Event|2|||
28100734|NCT03018340|54757101|FG000|Overall Study|Withdrawal by Subject|0|||
28100735|NCT03018340|54757102|FG001|Overall Study|Withdrawal by Subject|8|||
28100736|NCT03018340|54757101|FG000|Overall Study|Lack of Efficacy|0|||
28100737|NCT03018340|54757102|FG001|Overall Study|Lack of Efficacy|1|||
28100738|NCT03018340|54757101|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
28100739|NCT03018340|54757102|FG001|Overall Study|Non-compliance with study drug/procedure|4|||
28100740|NCT03018340|54757101|FG000|Overall Study|Lost to Follow-up|1|||
28100741|NCT03018340|54757102|FG001|Overall Study|Lost to Follow-up|7|||
28100742|NCT03018340|54757101|FG000|Overall Study|Protocol Violation|3|||
28100743|NCT03018340|54757102|FG001|Overall Study|Protocol Violation|7|||
28100744|NCT03018340|54757101|FG000|Overall Study|Not further specified|0|||
28100745|NCT03018340|54757102|FG001|Overall Study|Not further specified|1|||
28100746|NCT03016078|54757112|FG000|Overall Study|Protocol Violation|1|||
28100747|NCT03016078|54757112|FG000|Overall Study|Protocol Violation|1|||
28100748|NCT00048165|54757118|FG000|Completed 6 Months Study|Administration/Other|8|||
28100749|NCT00048165|54757119|FG001|Completed 6 Months Study|Administration/Other|8|||
28004959|NCT00789191|54663842|FG000|Overall Study|Adverse Event|2|||
28004960|NCT00789191|54663843|FG001|Overall Study|Adverse Event|4|||
28004961|NCT00789191|54663842|FG000|Overall Study|Lack of Efficacy|0|||
28004962|NCT00789191|54663843|FG001|Overall Study|Lack of Efficacy|5|||
28004963|NCT00789191|54663842|FG000|Overall Study|Protocol Violation|5|||
28004964|NCT00789191|54663843|FG001|Overall Study|Protocol Violation|3|||
28004965|NCT00789191|54663842|FG000|Overall Study|Withdrawal Criteria|2|||
28004966|NCT00789191|54663843|FG001|Overall Study|Withdrawal Criteria|4|||
28004967|NCT00789191|54663842|FG000|Overall Study|Unclassified|5|||
28004968|NCT00789191|54663843|FG001|Overall Study|Unclassified|3|||
28004969|NCT00789035|54663854|FG000|Overall Study|Adverse Event|0|||
28004970|NCT00789035|54663855|FG001|Overall Study|Adverse Event|2|||
28004971|NCT00789035|54663856|FG002|Overall Study|Adverse Event|0|||
28004972|NCT00789035|54663857|FG003|Overall Study|Adverse Event|1|||
28004973|NCT00789035|54663858|FG004|Overall Study|Adverse Event|3|||
28004974|NCT00789035|54663854|FG000|Overall Study|Lack of Efficacy|3|||
28004975|NCT00789035|54663855|FG001|Overall Study|Lack of Efficacy|0|||
28004976|NCT00789035|54663856|FG002|Overall Study|Lack of Efficacy|0|||
28004977|NCT00789035|54663857|FG003|Overall Study|Lack of Efficacy|0|||
28004978|NCT00789035|54663858|FG004|Overall Study|Lack of Efficacy|2|||
28004979|NCT00789035|54663854|FG000|Overall Study|Protocol Violation|1|||
28004980|NCT00789035|54663855|FG001|Overall Study|Protocol Violation|0|||
28004981|NCT00789035|54663856|FG002|Overall Study|Protocol Violation|0|||
28004982|NCT00789035|54663857|FG003|Overall Study|Protocol Violation|0|||
28004983|NCT00789035|54663858|FG004|Overall Study|Protocol Violation|0|||
28004984|NCT00789035|54663854|FG000|Overall Study|Withdrawal by Subject|0|||
28004985|NCT00789035|54663855|FG001|Overall Study|Withdrawal by Subject|2|||
28004986|NCT00789035|54663856|FG002|Overall Study|Withdrawal by Subject|0|||
28004987|NCT00789035|54663857|FG003|Overall Study|Withdrawal by Subject|0|||
28004988|NCT00789035|54663858|FG004|Overall Study|Withdrawal by Subject|0|||
28004989|NCT00789035|54663854|FG000|Overall Study|Other reason not defined above|2|||
28004990|NCT00789035|54663855|FG001|Overall Study|Other reason not defined above|3|||
28004991|NCT00789035|54663856|FG002|Overall Study|Other reason not defined above|1|||
28004992|NCT00789035|54663857|FG003|Overall Study|Other reason not defined above|0|||
28004993|NCT00789035|54663858|FG004|Overall Study|Other reason not defined above|1|||
28004994|NCT03326193|54663882|FG000|Overall Study|Treatment ongoing at the time of analysis|26|||
28004995|NCT03326193|54663882|FG000|Overall Study|Death|19|||
28004996|NCT03326193|54663882|FG000|Overall Study|Withdrawal by Subject|8|||
28004997|NCT00437203|54663905|FG000|Overall Study|Death|0|||
28004998|NCT00437203|54663906|FG001|Overall Study|Death|0|||
28004999|NCT00437203|54663907|FG002|Overall Study|Death|1|||
28005000|NCT00437203|54663908|FG003|Overall Study|Death|0|||
28100750|NCT00048165|54757118|FG000|Completed 6 Months Study|Abnormality of laboratory test|1|||
27916794|NCT01172938|54574536|FG001|Active Treatment Phase (Weeks 25-52)|Other|0|||
27916795|NCT01172938|54574537|FG002|Active Treatment Phase (Weeks 25-52)|Other|0|||
27916796|NCT01172938|54574538|FG003|Active Treatment Phase (Weeks 25-52)|Other|0|||
27916797|NCT01172938|54574539|FG004|Active Treatment Phase (Weeks 25-52)|Other|0|||
27916798|NCT01172938|54574540|FG005|Active Treatment Phase (Weeks 25-52)|Other|1|||
27916799|NCT01172938|54574541|FG006|Active Treatment Phase (Weeks 25-52)|Other|1|||
27916800|NCT01172938|54574542|FG007|Active Treatment Phase (Weeks 25-52)|Other|0|||
27916801|NCT01172938|54574543|FG008|Active Treatment Phase (Weeks 25-52)|Other|0|||
27916802|NCT01172938|54574535|FG000|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
27916803|NCT01172938|54574536|FG001|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2|||
27916804|NCT01172938|54574537|FG002|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
27916805|NCT01172938|54574538|FG003|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
27916806|NCT01172938|54574539|FG004|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
27916807|NCT01172938|54574540|FG005|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
27916808|NCT01172938|54574541|FG006|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
27916809|NCT01172938|54574542|FG007|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3|||
27916810|NCT01172938|54574543|FG008|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
27916811|NCT01172938|54574535|FG000|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
27916812|NCT01172938|54574536|FG001|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7|||
27916813|NCT01172938|54574537|FG002|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8|||
27916814|NCT01172938|54574538|FG003|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
28005001|NCT00437203|54663909|FG004|Overall Study|Death|0|||
28005002|NCT00437203|54663910|FG005|Overall Study|Death|0|||
28172776|NCT02745119|54844496|FG002|Overall Study|Physician Decision|2|||
28005003|NCT00437203|54663911|FG006|Overall Study|Death|0|||
28005004|NCT00437203|54663912|FG007|Overall Study|Death|1|||
27916815|NCT01172938|54574539|FG004|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
28005005|NCT00437203|54663913|FG008|Overall Study|Death|0|||
28005006|NCT00437203|54663914|FG009|Overall Study|Death|1|||
28005007|NCT00437203|54663905|FG000|Overall Study|Adverse Event|1|||
28005008|NCT00437203|54663906|FG001|Overall Study|Adverse Event|1|||
28005009|NCT00437203|54663907|FG002|Overall Study|Adverse Event|0|||
28005010|NCT00437203|54663908|FG003|Overall Study|Adverse Event|0|||
28005011|NCT00437203|54663909|FG004|Overall Study|Adverse Event|0|||
28005012|NCT00437203|54663910|FG005|Overall Study|Adverse Event|0|||
28100751|NCT00048165|54757119|FG001|Completed 6 Months Study|Abnormality of laboratory test|0|||
28100752|NCT00048165|54757118|FG000|Completed 6 Months Study|Adverse event/intermittent illness|14|||
28100753|NCT00048165|54757119|FG001|Completed 6 Months Study|Adverse event/intermittent illness|11|||
28100754|NCT00048165|54757118|FG000|Completed 6 Months Study|Death|12|||
28100755|NCT00048165|54757119|FG001|Completed 6 Months Study|Death|6|||
28100756|NCT00048165|54757118|FG000|Completed 6 Months Study|Insufficient therapy|1|||
28100757|NCT00048165|54757119|FG001|Completed 6 Months Study|Insufficient therapy|4|||
28100758|NCT00048165|54757118|FG000|Completed 6 Months Study|Other violation|4|||
28100759|NCT00048165|54757119|FG001|Completed 6 Months Study|Other violation|6|||
28100760|NCT00048165|54757118|FG000|Completed 6 Months Study|Refused treatment|5|||
28100761|NCT00048165|54757119|FG001|Completed 6 Months Study|Refused treatment|5|||
28100762|NCT00048165|54757118|FG000|Completed 6 Months Study|Violation criteria|0|||
28100763|NCT00048165|54757119|FG001|Completed 6 Months Study|Violation criteria|2|||
28100764|NCT00048165|54757118|FG000|Completed 6 Months Study|Did not receive study drug|6|||
28100765|NCT00048165|54757119|FG001|Completed 6 Months Study|Did not receive study drug|6|||
28100766|NCT00048165|54757118|FG000|Completed 12 Months Study|Administration/Other|0|||
28100767|NCT00048165|54757119|FG001|Completed 12 Months Study|Administration/Other|2|||
28100768|NCT00048165|54757118|FG000|Completed 12 Months Study|Death|2|||
28100769|NCT00048165|54757119|FG001|Completed 12 Months Study|Death|1|||
28100770|NCT00048165|54757118|FG000|Completed 12 Months Study|Did not co-operate/Withdrew|1|||
28100771|NCT00048165|54757119|FG001|Completed 12 Months Study|Did not co-operate/Withdrew|0|||
28100772|NCT00059787|54757127|FG000|Overall Study|Adverse Event|13|||
28100773|NCT00059787|54757127|FG000|Overall Study|disease progression|2|||
28100774|NCT00059787|54757127|FG000|Overall Study|ineligible|1|||
28100775|NCT00059787|54757127|FG000|Overall Study|Other|4|||
28100776|NCT00058539|54757132|FG000|Overall Study|Disease progression|24|||
28100777|NCT00058539|54757132|FG000|Overall Study|Adverse Event|3|||
28100778|NCT00058539|54757132|FG000|Overall Study|Withdrawal by Subject|5|||
28100779|NCT00058539|54757132|FG000|Overall Study|Physician Decision|9|||
28100780|NCT00058539|54757132|FG000|Overall Study|Death|1|||
28100781|NCT03015532|54757144|FG000|Overall Study|Adverse Event|0|||
28100782|NCT03015532|54757145|FG001|Overall Study|Adverse Event|0|||
28100783|NCT03015532|54757146|FG002|Overall Study|Adverse Event|0|||
28100784|NCT03015532|54757147|FG003|Overall Study|Adverse Event|0|||
28100785|NCT03015532|54757148|FG004|Overall Study|Adverse Event|0|||
28100786|NCT03015532|54757149|FG005|Overall Study|Adverse Event|2|||
28100787|NCT03015532|54757150|FG006|Overall Study|Adverse Event|1|||
28100788|NCT03015532|54757151|FG007|Overall Study|Adverse Event|0|||
28100789|NCT03015532|54757144|FG000|Overall Study|Withdrawal by Subject|0|||
28100790|NCT03015532|54757145|FG001|Overall Study|Withdrawal by Subject|0|||
28100791|NCT03015532|54757146|FG002|Overall Study|Withdrawal by Subject|0|||
28100792|NCT03015532|54757147|FG003|Overall Study|Withdrawal by Subject|0|||
28100793|NCT03015532|54757148|FG004|Overall Study|Withdrawal by Subject|0|||
28100794|NCT03015532|54757149|FG005|Overall Study|Withdrawal by Subject|0|||
28100795|NCT03015532|54757150|FG006|Overall Study|Withdrawal by Subject|1|||
28100796|NCT03015532|54757151|FG007|Overall Study|Withdrawal by Subject|0|||
28100797|NCT00047463|54757173|FG000|Overall Study|Withdrawal by Subject|0|||
28100798|NCT00047463|54757174|FG001|Overall Study|Withdrawal by Subject|3|||
28100799|NCT03015220|54757187|FG000|Overall Study|Withdrawal by Subject|3|||
28100800|NCT03015220|54757188|FG001|Overall Study|Withdrawal by Subject|2|||
28100801|NCT03015220|54757189|FG002|Overall Study|Withdrawal by Subject|2|||
28100802|NCT03015220|54757190|FG003|Overall Study|Withdrawal by Subject|2|||
27916816|NCT01172938|54574540|FG005|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
27916817|NCT01172938|54574541|FG006|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
27916818|NCT01172938|54574542|FG007|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4|||
27916819|NCT01172938|54574543|FG008|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
27916820|NCT01172938|54574535|FG000|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
27916821|NCT01172938|54574536|FG001|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
28100803|NCT03015220|54757187|FG000|Overall Study|Lost to Follow-up|0|||
27916822|NCT01172938|54574537|FG002|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2|||
27916823|NCT01172938|54574538|FG003|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
28005013|NCT00437203|54663911|FG006|Overall Study|Adverse Event|0|||
28100804|NCT03015220|54757188|FG001|Overall Study|Lost to Follow-up|0|||
28100805|NCT03015220|54757189|FG002|Overall Study|Lost to Follow-up|1|||
28100806|NCT03015220|54757190|FG003|Overall Study|Lost to Follow-up|0|||
28100807|NCT00022659|54757200|FG000|Overall Study|Ineligible: wrong primary|1|||
28005014|NCT00437203|54663912|FG007|Overall Study|Adverse Event|1|||
28100808|NCT00022659|54757200|FG000|Overall Study|Never treated|1|||
28100809|NCT03014674|54757211|FG000|Overall Study|Withdrawal by Subject|1|||
28100810|NCT03014674|54757212|FG001|Overall Study|Withdrawal by Subject|0|||
28100811|NCT03014674|54757213|FG002|Overall Study|Withdrawal by Subject|0|||
28100812|NCT03018106|54757223|FG000|Overall Study|Lost to Follow-up|0|||
28005015|NCT00437203|54663913|FG008|Overall Study|Adverse Event|0|||
28005016|NCT00437203|54663914|FG009|Overall Study|Adverse Event|1|||
28005017|NCT00437203|54663905|FG000|Overall Study|Study terminated by sponsor|0|||
28005018|NCT00437203|54663906|FG001|Overall Study|Study terminated by sponsor|0|||
28005019|NCT00437203|54663907|FG002|Overall Study|Study terminated by sponsor|0|||
28005020|NCT00437203|54663908|FG003|Overall Study|Study terminated by sponsor|0|||
28005021|NCT00437203|54663909|FG004|Overall Study|Study terminated by sponsor|0|||
28005022|NCT00437203|54663910|FG005|Overall Study|Study terminated by sponsor|0|||
28005023|NCT00437203|54663911|FG006|Overall Study|Study terminated by sponsor|0|||
28005024|NCT00437203|54663912|FG007|Overall Study|Study terminated by sponsor|0|||
28005025|NCT00437203|54663913|FG008|Overall Study|Study terminated by sponsor|1|||
28005026|NCT00437203|54663914|FG009|Overall Study|Study terminated by sponsor|0|||
28005027|NCT00437203|54663905|FG000|Overall Study|Objective progression or relapse|5|||
28005028|NCT00437203|54663906|FG001|Overall Study|Objective progression or relapse|6|||
28005029|NCT00437203|54663907|FG002|Overall Study|Objective progression or relapse|2|||
28005030|NCT00437203|54663908|FG003|Overall Study|Objective progression or relapse|3|||
28005031|NCT00437203|54663909|FG004|Overall Study|Objective progression or relapse|3|||
28005032|NCT00437203|54663910|FG005|Overall Study|Objective progression or relapse|3|||
28005033|NCT00437203|54663911|FG006|Overall Study|Objective progression or relapse|6|||
28005034|NCT00437203|54663912|FG007|Overall Study|Objective progression or relapse|1|||
28005035|NCT00437203|54663913|FG008|Overall Study|Objective progression or relapse|2|||
28005036|NCT00437203|54663914|FG009|Overall Study|Objective progression or relapse|2|||
28005037|NCT00437203|54663905|FG000|Overall Study|Other|0|||
28005038|NCT00437203|54663906|FG001|Overall Study|Other|1|||
28005039|NCT00437203|54663907|FG002|Overall Study|Other|0|||
28005040|NCT00437203|54663908|FG003|Overall Study|Other|0|||
28005041|NCT00437203|54663909|FG004|Overall Study|Other|0|||
28005042|NCT00437203|54663910|FG005|Overall Study|Other|0|||
28005043|NCT00437203|54663911|FG006|Overall Study|Other|1|||
28005044|NCT00437203|54663912|FG007|Overall Study|Other|0|||
28005045|NCT00437203|54663913|FG008|Overall Study|Other|0|||
28005046|NCT00437203|54663914|FG009|Overall Study|Other|0|||
28005047|NCT00753272|54663947|FG000|Overall Study|Adverse Event|878|||
28005048|NCT00753272|54663948|FG001|Overall Study|Adverse Event|869|||
28005049|NCT00753272|54663947|FG000|Overall Study|Protocol Violation|28|||
28005050|NCT00753272|54663948|FG001|Overall Study|Protocol Violation|46|||
28005051|NCT00753272|54663947|FG000|Overall Study|Withdrawal by Subject|2481|||
28005052|NCT00753272|54663948|FG001|Overall Study|Withdrawal by Subject|2407|||
28005053|NCT00753272|54663947|FG000|Overall Study|Lost to Follow-up|491|||
28005054|NCT00753272|54663948|FG001|Overall Study|Lost to Follow-up|497|||
28005055|NCT00753272|54663947|FG000|Overall Study|Other|1104|||
28005056|NCT00753272|54663948|FG001|Overall Study|Other|1088|||
28005057|NCT00437125|54663957|FG000|Overall Study|Adverse Event|12|||
28005058|NCT00437125|54663957|FG000|Overall Study|Death|1|||
28005059|NCT00437125|54663957|FG000|Overall Study|Clinical Relapse|1|||
28005060|NCT00437125|54663957|FG000|Overall Study|Lack of Efficacy|1|||
28005061|NCT00437125|54663957|FG000|Overall Study|Lost to Follow-up|1|||
28005062|NCT00437125|54663957|FG000|Overall Study|Withdrawal by Subject|13|||
28005063|NCT00437125|54663957|FG000|Overall Study|Withdrawal by Caregiver|2|||
28005064|NCT00437125|54663957|FG000|Overall Study|Physician Decision|1|||
28005065|NCT00582309|54663973|FG000|Overall Study|Protocol Violation|0|||
28005066|NCT00582309|54663974|FG001|Overall Study|Protocol Violation|0|||
28005067|NCT00582309|54663975|FG002|Overall Study|Protocol Violation|2|||
27916824|NCT01172938|54574539|FG004|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
27916825|NCT01172938|54574540|FG005|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
27916826|NCT01172938|54574541|FG006|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
27916827|NCT01172938|54574542|FG007|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
27916828|NCT01172938|54574543|FG008|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
27916829|NCT01172938|54574535|FG000|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
27916830|NCT01172938|54574536|FG001|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10|||
27916831|NCT01172938|54574537|FG002|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8|||
27916832|NCT01172938|54574538|FG003|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
27916833|NCT01172938|54574539|FG004|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
28005068|NCT00443053|54663985|FG000|Overall Study|Adverse Event|2|||
28005069|NCT00443053|54663986|FG001|Overall Study|Adverse Event|1|||
28005070|NCT00443053|54663985|FG000|Overall Study|Withdrawal by Subject|9|||
28005071|NCT00443053|54663986|FG001|Overall Study|Withdrawal by Subject|18|||
28005072|NCT00443053|54663985|FG000|Overall Study|Lost to Follow-up|4|||
28005073|NCT00443053|54663986|FG001|Overall Study|Lost to Follow-up|5|||
28005074|NCT00443053|54663985|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
28005075|NCT00443053|54663986|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
28005076|NCT00443053|54663985|FG000|Overall Study|Noncompliance|2|||
28005077|NCT00443053|54663986|FG001|Overall Study|Noncompliance|1|||
28005078|NCT00443053|54663985|FG000|Overall Study|Other|3|||
28005079|NCT00443053|54663986|FG001|Overall Study|Other|4|||
28005080|NCT00443053|54663985|FG000|Overall Study|Physician Decision|0|||
27916834|NCT01172938|54574540|FG005|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
27916835|NCT01172938|54574541|FG006|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
28005081|NCT00443053|54663986|FG001|Overall Study|Physician Decision|4|||
28005082|NCT00720798|54663992|FG000|Overall Study|Adverse Event|304|||
28005083|NCT00720798|54663992|FG000|Overall Study|Death|39|||
28005084|NCT00720798|54663992|FG000|Overall Study|Insufficient Therapeutic Response|129|||
28005085|NCT00720798|54663992|FG000|Overall Study|Protocol Violation|4|||
28005086|NCT00720798|54663992|FG000|Overall Study|Refused Treatment|151|||
28005087|NCT00720798|54663992|FG000|Overall Study|Failure to Return|46|||
28005088|NCT00720798|54663992|FG000|Overall Study|Reason not Specified|83|||
28005089|NCT00756002|54664002|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
28005090|NCT00756002|54664003|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
28005091|NCT00756002|54664002|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
28005092|NCT00756002|54664003|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
28005093|NCT00756002|54664002|FG000|Double-Blind Treatment Period|Withdrawal by Subject|6|||
28005094|NCT00756002|54664003|FG001|Double-Blind Treatment Period|Withdrawal by Subject|6|||
28005095|NCT00756002|54664002|FG000|Double-Blind Treatment Period|Protocol Violation|6|||
28005096|NCT00756002|54664003|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
28005097|NCT00756002|54664002|FG000|Double-Blind Treatment Period|Other|2|||
28005098|NCT00756002|54664003|FG001|Double-Blind Treatment Period|Other|2|||
28005099|NCT00717366|54664011|FG000|Core Study Period (20 Weeks)|Renal transplant|4|||
28005100|NCT00717366|54664012|FG001|Core Study Period (20 Weeks)|Renal transplant|9|||
28005101|NCT00717366|54664011|FG000|Core Study Period (20 Weeks)|Admin/Other than specified|0|||
28005102|NCT00717366|54664012|FG001|Core Study Period (20 Weeks)|Admin/Other than specified|2|||
28005103|NCT00717366|54664011|FG000|Core Study Period (20 Weeks)|Death|0|||
28005104|NCT00717366|54664012|FG001|Core Study Period (20 Weeks)|Death|1|||
28005105|NCT00717366|54664011|FG000|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0|||
28005106|NCT00717366|54664012|FG001|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1|||
28005107|NCT00717366|54664011|FG000|Extension Period (52 Weeks)|Renal transplant|3|||
28005108|NCT00717366|54664012|FG001|Extension Period (52 Weeks)|Renal transplant|13|||
28005109|NCT00717366|54664011|FG000|Extension Period (52 Weeks)|Admin/Other than specified|0|||
28005110|NCT00717366|54664012|FG001|Extension Period (52 Weeks)|Admin/Other than specified|2|||
28005111|NCT00717366|54664011|FG000|Extension Period (52 Weeks)|Withdrew consent|1|||
28005112|NCT00717366|54664012|FG001|Extension Period (52 Weeks)|Withdrew consent|1|||
28005113|NCT00723606|54664031|FG000|Overall Study|Adverse Event|2|||
28005114|NCT00723606|54664032|FG001|Overall Study|Adverse Event|5|||
28005115|NCT00723606|54664031|FG000|Overall Study|Other|2|||
28005116|NCT00723606|54664032|FG001|Overall Study|Other|0|||
28005117|NCT00723606|54664031|FG000|Overall Study|Withdrawal by Subject|0|||
28005118|NCT00723606|54664032|FG001|Overall Study|Withdrawal by Subject|2|||
28005119|NCT00442351|54664040|FG000|Overall Study|Administrative|6|||
28005120|NCT00442351|54664041|FG001|Overall Study|Administrative|5|||
28005121|NCT00442351|54664040|FG000|Overall Study|Did not meet protocol eligibility|1|||
28005122|NCT00442351|54664041|FG001|Overall Study|Did not meet protocol eligibility|0|||
28005123|NCT00442351|54664040|FG000|Overall Study|Other|0|||
28005124|NCT00442351|54664041|FG001|Overall Study|Other|1|||
27916836|NCT01172938|54574542|FG007|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5|||
27916837|NCT01172938|54574543|FG008|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2|||
27916838|NCT01172938|54574535|FG000|Active-Treatment Phase (Weeks 52-104)|Death|0|||
27916839|NCT01172938|54574536|FG001|Active-Treatment Phase (Weeks 52-104)|Death|0|||
27916840|NCT01172938|54574537|FG002|Active-Treatment Phase (Weeks 52-104)|Death|1|||
27916841|NCT01172938|54574538|FG003|Active-Treatment Phase (Weeks 52-104)|Death|0|||
27916842|NCT01172938|54574539|FG004|Active-Treatment Phase (Weeks 52-104)|Death|0|||
27916843|NCT01172938|54574540|FG005|Active-Treatment Phase (Weeks 52-104)|Death|0|||
27916844|NCT01172938|54574541|FG006|Active-Treatment Phase (Weeks 52-104)|Death|0|||
27916845|NCT01172938|54574542|FG007|Active-Treatment Phase (Weeks 52-104)|Death|0|||
27916846|NCT01172938|54574543|FG008|Active-Treatment Phase (Weeks 52-104)|Death|0|||
27916847|NCT01172938|54574535|FG000|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
27916848|NCT01172938|54574536|FG001|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
27916849|NCT01172938|54574537|FG002|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
27916850|NCT01172938|54574538|FG003|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
27916851|NCT01172938|54574539|FG004|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
27916852|NCT01172938|54574540|FG005|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
27916853|NCT01172938|54574541|FG006|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
27916854|NCT01172938|54574542|FG007|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3|||
27916855|NCT01172938|54574543|FG008|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
27916856|NCT01172938|54574535|FG000|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
27916857|NCT01172938|54574536|FG001|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2|||
28005125|NCT00436501|54664049|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0|||
28005126|NCT00436501|54664050|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2|||
28100813|NCT03018106|54757224|FG001|Overall Study|Lost to Follow-up|1|||
28100814|NCT03018028|54757233|FG000|Overall Study|Withdrawal by Subject|3|||
28100815|NCT03018028|54757234|FG001|Overall Study|Withdrawal by Subject|0|||
28100816|NCT03018028|54757235|FG002|Overall Study|Withdrawal by Subject|1|||
28100817|NCT03018028|54757236|FG003|Overall Study|Withdrawal by Subject|2|||
28100818|NCT03018028|54757237|FG004|Overall Study|Withdrawal by Subject|0|||
28100819|NCT03014206|54757249|FG000|Overall Study|Registration Violation|12|||
28100820|NCT03010462|54757255|FG000|Overall Study|Withdrawal by Subject|3|||
28100821|NCT03010462|54757256|FG001|Overall Study|Withdrawal by Subject|1|||
28100822|NCT00021255|54757265|FG000|Overall Study|Death|1|||
28100823|NCT00021255|54757266|FG001|Overall Study|Death|0|||
28100824|NCT00021255|54757267|FG002|Overall Study|Death|2|||
28005127|NCT00436501|54664049|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0|||
28005128|NCT00436501|54664050|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1|||
28100825|NCT00021255|54757265|FG000|Overall Study|Breast cancer relapse|5|||
28100826|NCT00021255|54757266|FG001|Overall Study|Breast cancer relapse|18|||
28100827|NCT00021255|54757267|FG002|Overall Study|Breast cancer relapse|11|||
28005129|NCT00755846|54664063|FG000|Overall Study|Adverse Event|0|||
28005130|NCT00755846|54664064|FG001|Overall Study|Adverse Event|0|||
28100828|NCT00021255|54757265|FG000|Overall Study|Second primary malignancy|0|||
28100829|NCT00021255|54757266|FG001|Overall Study|Second primary malignancy|4|||
28100830|NCT00021255|54757267|FG002|Overall Study|Second primary malignancy|1|||
28100831|NCT00021255|54757265|FG000|Overall Study|Withdrawal by Subject|41|||
28100832|NCT00021255|54757266|FG001|Overall Study|Withdrawal by Subject|64|||
28100833|NCT00021255|54757267|FG002|Overall Study|Withdrawal by Subject|26|||
28100834|NCT00021255|54757265|FG000|Overall Study|Lost to Follow-up|0|||
28100835|NCT00021255|54757266|FG001|Overall Study|Lost to Follow-up|2|||
28100836|NCT00021255|54757267|FG002|Overall Study|Lost to Follow-up|3|||
28100837|NCT00021255|54757265|FG000|Overall Study|Cardiac toxicity|0|||
28100838|NCT00021255|54757266|FG001|Overall Study|Cardiac toxicity|61|||
28100839|NCT00021255|54757267|FG002|Overall Study|Cardiac toxicity|32|||
28100840|NCT00021255|54757265|FG000|Overall Study|Herceptin toxicity|0|||
28100841|NCT00021255|54757266|FG001|Overall Study|Herceptin toxicity|22|||
28100842|NCT00021255|54757267|FG002|Overall Study|Herceptin toxicity|6|||
28100843|NCT00021255|54757265|FG000|Overall Study|Adverse Event|46|||
28100844|NCT00021255|54757266|FG001|Overall Study|Adverse Event|30|||
28100845|NCT00021255|54757267|FG002|Overall Study|Adverse Event|18|||
28005131|NCT00755846|54664065|FG002|Overall Study|Adverse Event|0|||
28100846|NCT00021255|54757265|FG000|Overall Study|Protocol Violation|0|||
28100847|NCT00021255|54757266|FG001|Overall Study|Protocol Violation|2|||
28100848|NCT00021255|54757267|FG002|Overall Study|Protocol Violation|0|||
28100849|NCT00021255|54757265|FG000|Overall Study|Other than specified above|0|||
28100850|NCT00021255|54757266|FG001|Overall Study|Other than specified above|38|||
28100851|NCT00021255|54757267|FG002|Overall Study|Other than specified above|19|||
28100852|NCT00021255|54757265|FG000|Overall Study|Missing|0|||
28100853|NCT00021255|54757266|FG001|Overall Study|Missing|27|||
28100854|NCT00021255|54757267|FG002|Overall Study|Missing|13|||
28100855|NCT00021255|54757265|FG000|Overall Study|Randomized but not treated|28|||
28100856|NCT00021255|54757266|FG001|Overall Study|Randomized but not treated|2|||
28100857|NCT00021255|54757267|FG002|Overall Study|Randomized but not treated|18|||
28100858|NCT03012334|54757285|FG000|Period 1|Withdrawal by Subject|0|||
28100859|NCT03012334|54757286|FG001|Period 1|Withdrawal by Subject|0|||
28100860|NCT03012334|54757287|FG002|Period 1|Withdrawal by Subject|0|||
28100861|NCT03012334|54757288|FG003|Period 1|Withdrawal by Subject|0|||
28100862|NCT03012334|54757289|FG004|Period 1|Withdrawal by Subject|0|||
28100863|NCT03012334|54757290|FG005|Period 1|Withdrawal by Subject|0|||
28100864|NCT03012334|54757291|FG006|Period 1|Withdrawal by Subject|0|||
28100865|NCT03012334|54757292|FG007|Period 1|Withdrawal by Subject|0|||
28100866|NCT03012334|54757293|FG008|Period 1|Withdrawal by Subject|0|||
28100867|NCT03012334|54757294|FG009|Period 1|Withdrawal by Subject|1|||
28100868|NCT03012334|54757285|FG000|Period 2|Withdrawal by Subject|0|||
28172777|NCT02745119|54844497|FG003|Overall Study|Physician Decision|2|||
28172778|NCT02745119|54844494|FG000|Overall Study|Reason Not Specified|0|||
28100869|NCT03012334|54757286|FG001|Period 2|Withdrawal by Subject|1|||
28100870|NCT03012334|54757287|FG002|Period 2|Withdrawal by Subject|0|||
28100871|NCT03012334|54757288|FG003|Period 2|Withdrawal by Subject|0|||
27916858|NCT01172938|54574537|FG002|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
27916859|NCT01172938|54574538|FG003|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
27916860|NCT01172938|54574539|FG004|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
27916861|NCT01172938|54574540|FG005|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
27916862|NCT01172938|54574541|FG006|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
27916863|NCT01172938|54574542|FG007|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
27916864|NCT01172938|54574543|FG008|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1|||
27916865|NCT01172938|54574535|FG000|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
27916866|NCT01172938|54574536|FG001|Active-Treatment Phase (Weeks 52-104)|Missing|1|||
28100872|NCT03012334|54757289|FG004|Period 2|Withdrawal by Subject|0|||
28100873|NCT03012334|54757290|FG005|Period 2|Withdrawal by Subject|0|||
28100874|NCT03012334|54757291|FG006|Period 2|Withdrawal by Subject|0|||
28100875|NCT03012334|54757292|FG007|Period 2|Withdrawal by Subject|0|||
28100876|NCT03012334|54757293|FG008|Period 2|Withdrawal by Subject|0|||
28100877|NCT03012334|54757294|FG009|Period 2|Withdrawal by Subject|0|||
28100878|NCT03012334|54757285|FG000|Period 2|Protocol Violation|0|||
28100879|NCT03012334|54757286|FG001|Period 2|Protocol Violation|0|||
28100880|NCT03012334|54757287|FG002|Period 2|Protocol Violation|1|||
28100881|NCT03012334|54757288|FG003|Period 2|Protocol Violation|0|||
28100882|NCT03012334|54757289|FG004|Period 2|Protocol Violation|0|||
28100883|NCT03012334|54757290|FG005|Period 2|Protocol Violation|0|||
28100884|NCT03012334|54757291|FG006|Period 2|Protocol Violation|0|||
28100885|NCT03012334|54757292|FG007|Period 2|Protocol Violation|1|||
28100886|NCT03012334|54757293|FG008|Period 2|Protocol Violation|0|||
28100887|NCT03012334|54757294|FG009|Period 2|Protocol Violation|0|||
28100888|NCT03012334|54757285|FG000|Period 4|Non-Compliance|0|||
28100889|NCT03012334|54757286|FG001|Period 4|Non-Compliance|0|||
28100890|NCT03012334|54757287|FG002|Period 4|Non-Compliance|0|||
28100891|NCT03012334|54757288|FG003|Period 4|Non-Compliance|0|||
28100892|NCT03012334|54757289|FG004|Period 4|Non-Compliance|0|||
28100893|NCT03012334|54757290|FG005|Period 4|Non-Compliance|0|||
28100894|NCT03012334|54757291|FG006|Period 4|Non-Compliance|1|||
28100895|NCT03012334|54757292|FG007|Period 4|Non-Compliance|0|||
28100896|NCT03012334|54757293|FG008|Period 4|Non-Compliance|0|||
28100897|NCT03012334|54757294|FG009|Period 4|Non-Compliance|0|||
28100898|NCT03012334|54757285|FG000|Period 4|Adverse Event|0|||
28100899|NCT03012334|54757286|FG001|Period 4|Adverse Event|0|||
28100900|NCT03012334|54757287|FG002|Period 4|Adverse Event|0|||
28100901|NCT03012334|54757288|FG003|Period 4|Adverse Event|0|||
28100902|NCT03012334|54757289|FG004|Period 4|Adverse Event|0|||
28100903|NCT03012334|54757290|FG005|Period 4|Adverse Event|0|||
28100904|NCT03012334|54757291|FG006|Period 4|Adverse Event|0|||
28100905|NCT03012334|54757292|FG007|Period 4|Adverse Event|0|||
28100906|NCT03012334|54757293|FG008|Period 4|Adverse Event|1|||
28100907|NCT03012334|54757294|FG009|Period 4|Adverse Event|0|||
28100908|NCT03565068|54757316|FG000|Overall Study|Protocol Violation|0|||
28100909|NCT03565068|54757317|FG001|Overall Study|Protocol Violation|0|||
28100910|NCT03565068|54757318|FG002|Overall Study|Protocol Violation|0|||
28100911|NCT03565068|54757319|FG003|Overall Study|Protocol Violation|0|||
28100912|NCT03565068|54757320|FG004|Overall Study|Protocol Violation|1|||
28100913|NCT03565068|54757321|FG005|Overall Study|Protocol Violation|0|||
28100914|NCT03565068|54757322|FG006|Overall Study|Protocol Violation|0|||
28100915|NCT03565068|54757323|FG007|Overall Study|Protocol Violation|1|||
28100916|NCT03565068|54757324|FG008|Overall Study|Protocol Violation|0|||
28100917|NCT03565068|54757316|FG000|Overall Study|Sponsor decision|0|||
28100918|NCT03565068|54757317|FG001|Overall Study|Sponsor decision|0|||
28100919|NCT03565068|54757318|FG002|Overall Study|Sponsor decision|0|||
28100920|NCT03565068|54757319|FG003|Overall Study|Sponsor decision|0|||
28100921|NCT03565068|54757320|FG004|Overall Study|Sponsor decision|1|||
28100922|NCT03565068|54757321|FG005|Overall Study|Sponsor decision|1|||
28100923|NCT03565068|54757322|FG006|Overall Study|Sponsor decision|0|||
28100924|NCT03565068|54757323|FG007|Overall Study|Sponsor decision|0|||
28100925|NCT03565068|54757324|FG008|Overall Study|Sponsor decision|0|||
28100926|NCT03565068|54757316|FG000|Overall Study|Withdrawal by Subject|0|||
28100927|NCT03565068|54757317|FG001|Overall Study|Withdrawal by Subject|0|||
28100928|NCT03565068|54757318|FG002|Overall Study|Withdrawal by Subject|1|||
28100929|NCT03565068|54757319|FG003|Overall Study|Withdrawal by Subject|0|||
28100930|NCT03565068|54757320|FG004|Overall Study|Withdrawal by Subject|2|||
28100931|NCT03565068|54757321|FG005|Overall Study|Withdrawal by Subject|0|||
28100932|NCT03565068|54757322|FG006|Overall Study|Withdrawal by Subject|1|||
28100933|NCT03565068|54757323|FG007|Overall Study|Withdrawal by Subject|5|||
28100934|NCT03565068|54757324|FG008|Overall Study|Withdrawal by Subject|1|||
28100935|NCT03565068|54757316|FG000|Overall Study|Physician Decision|0|||
28100936|NCT03565068|54757317|FG001|Overall Study|Physician Decision|0|||
28100937|NCT03565068|54757318|FG002|Overall Study|Physician Decision|0|||
28100938|NCT03565068|54757319|FG003|Overall Study|Physician Decision|0|||
28100939|NCT03565068|54757320|FG004|Overall Study|Physician Decision|0|||
28100940|NCT03565068|54757321|FG005|Overall Study|Physician Decision|0|||
28100941|NCT03565068|54757322|FG006|Overall Study|Physician Decision|0|||
28100942|NCT03565068|54757323|FG007|Overall Study|Physician Decision|1|||
28100943|NCT03565068|54757324|FG008|Overall Study|Physician Decision|0|||
28100944|NCT03565068|54757316|FG000|Overall Study|Lost to Follow-up|0|||
28100945|NCT03565068|54757317|FG001|Overall Study|Lost to Follow-up|0|||
28100946|NCT03565068|54757318|FG002|Overall Study|Lost to Follow-up|0|||
28100947|NCT03565068|54757319|FG003|Overall Study|Lost to Follow-up|0|||
28100948|NCT03565068|54757320|FG004|Overall Study|Lost to Follow-up|0|||
28100949|NCT03565068|54757321|FG005|Overall Study|Lost to Follow-up|0|||
28100950|NCT03565068|54757322|FG006|Overall Study|Lost to Follow-up|0|||
28100951|NCT03565068|54757323|FG007|Overall Study|Lost to Follow-up|1|||
28100952|NCT03565068|54757324|FG008|Overall Study|Lost to Follow-up|0|||
28100953|NCT00010803|54757383|FG000|Overall Study|Withdrawal by Subject|97|||
28100954|NCT00010803|54757384|FG001|Overall Study|Withdrawal by Subject|98|||
28100955|NCT02914834|54757392|FG000|Overall Study|Study halted due to COVID|1|||
28100956|NCT02914834|54757393|FG001|Overall Study|Study halted due to COVID|1|||
28100957|NCT02914834|54757392|FG000|Overall Study|1 subject withdrew|0|||
28100958|NCT02914834|54757393|FG001|Overall Study|1 subject withdrew|1|||
28100959|NCT03497130|54757401|FG000|Overall Study|Lost to Follow-up|1|||
28100960|NCT03497130|54757402|FG001|Overall Study|Lost to Follow-up|1|||
28100961|NCT03006562|54757410|FG000|Overall Study|Lost to Follow-up|0|||
27916867|NCT01172938|54574537|FG002|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
27916868|NCT01172938|54574538|FG003|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
27916869|NCT01172938|54574539|FG004|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
27916870|NCT01172938|54574540|FG005|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
27916871|NCT01172938|54574541|FG006|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
28005132|NCT00755846|54664066|FG003|Overall Study|Adverse Event|1|||
28005133|NCT00755846|54664067|FG004|Overall Study|Adverse Event|3|||
28005134|NCT00755846|54664068|FG005|Overall Study|Adverse Event|2|||
28005135|NCT00755846|54664063|FG000|Overall Study|Protocol Violation|1|||
28005136|NCT00755846|54664064|FG001|Overall Study|Protocol Violation|1|||
28005137|NCT00755846|54664065|FG002|Overall Study|Protocol Violation|1|||
28005138|NCT00755846|54664066|FG003|Overall Study|Protocol Violation|1|||
28005139|NCT00755846|54664067|FG004|Overall Study|Protocol Violation|1|||
28005140|NCT00755846|54664068|FG005|Overall Study|Protocol Violation|1|||
28005141|NCT00755846|54664063|FG000|Overall Study|Lost to Follow-up|0|||
28005142|NCT00755846|54664064|FG001|Overall Study|Lost to Follow-up|2|||
28005143|NCT00755846|54664065|FG002|Overall Study|Lost to Follow-up|1|||
28005144|NCT00755846|54664066|FG003|Overall Study|Lost to Follow-up|0|||
28005145|NCT00755846|54664067|FG004|Overall Study|Lost to Follow-up|4|||
28005146|NCT00755846|54664068|FG005|Overall Study|Lost to Follow-up|2|||
28005147|NCT00755846|54664063|FG000|Overall Study|Withdrawal by Subject|2|||
28005148|NCT00755846|54664064|FG001|Overall Study|Withdrawal by Subject|3|||
28005149|NCT00755846|54664065|FG002|Overall Study|Withdrawal by Subject|5|||
28005150|NCT00755846|54664066|FG003|Overall Study|Withdrawal by Subject|2|||
28005151|NCT00755846|54664067|FG004|Overall Study|Withdrawal by Subject|0|||
28005152|NCT00755846|54664068|FG005|Overall Study|Withdrawal by Subject|1|||
28005153|NCT00755846|54664063|FG000|Overall Study|Hyperglycemic Rescue|21|||
28005154|NCT00755846|54664064|FG001|Overall Study|Hyperglycemic Rescue|7|||
28005155|NCT00755846|54664065|FG002|Overall Study|Hyperglycemic Rescue|5|||
28005156|NCT00755846|54664066|FG003|Overall Study|Hyperglycemic Rescue|8|||
28005157|NCT00755846|54664067|FG004|Overall Study|Hyperglycemic Rescue|8|||
28005158|NCT00755846|54664068|FG005|Overall Study|Hyperglycemic Rescue|7|||
28005159|NCT00755846|54664063|FG000|Overall Study|Physician Decision|1|||
28005160|NCT00755846|54664064|FG001|Overall Study|Physician Decision|3|||
28005161|NCT00755846|54664065|FG002|Overall Study|Physician Decision|0|||
28005162|NCT00755846|54664066|FG003|Overall Study|Physician Decision|1|||
28005163|NCT00755846|54664067|FG004|Overall Study|Physician Decision|0|||
28005164|NCT00755846|54664068|FG005|Overall Study|Physician Decision|1|||
28005165|NCT00755846|54664063|FG000|Overall Study|Administrative Error|0|||
28005166|NCT00755846|54664064|FG001|Overall Study|Administrative Error|1|||
28005167|NCT00755846|54664065|FG002|Overall Study|Administrative Error|0|||
28005168|NCT00755846|54664066|FG003|Overall Study|Administrative Error|0|||
28005169|NCT00755846|54664067|FG004|Overall Study|Administrative Error|0|||
28005170|NCT00755846|54664068|FG005|Overall Study|Administrative Error|0|||
28005171|NCT00755846|54664063|FG000|Overall Study|Participant Non-compliance|0|||
28005172|NCT00755846|54664064|FG001|Overall Study|Participant Non-compliance|0|||
28005173|NCT00755846|54664065|FG002|Overall Study|Participant Non-compliance|0|||
28005174|NCT00755846|54664066|FG003|Overall Study|Participant Non-compliance|0|||
28005175|NCT00755846|54664067|FG004|Overall Study|Participant Non-compliance|1|||
28005176|NCT00755846|54664068|FG005|Overall Study|Participant Non-compliance|0|||
28005177|NCT03850093|54664085|FG000|Overall Study|Withdrawal by Subject|1|||
28005178|NCT03850093|54664086|FG001|Overall Study|Withdrawal by Subject|0|||
28005179|NCT03850093|54664087|FG002|Overall Study|Withdrawal by Subject|2|||
28005180|NCT00442117|54664097|FG000|Overall Study|Adverse Event|3|||
28005181|NCT00442117|54664098|FG001|Overall Study|Adverse Event|2|||
28005182|NCT00442117|54664097|FG000|Overall Study|Lack of Efficacy|2|||
27916872|NCT01172938|54574542|FG007|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
28005183|NCT00442117|54664098|FG001|Overall Study|Lack of Efficacy|6|||
28005184|NCT00442117|54664097|FG000|Overall Study|Lost to Follow-up|1|||
28005185|NCT00442117|54664098|FG001|Overall Study|Lost to Follow-up|2|||
28005186|NCT00442117|54664097|FG000|Overall Study|Withdrawal by Subject|2|||
27916873|NCT01172938|54574543|FG008|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
27916874|NCT01172938|54574535|FG000|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
27916875|NCT01172938|54574536|FG001|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
28005187|NCT00442117|54664098|FG001|Overall Study|Withdrawal by Subject|2|||
28005188|NCT00442117|54664097|FG000|Overall Study|Major Deviation|25|||
28005189|NCT00442117|54664098|FG001|Overall Study|Major Deviation|20|||
27916876|NCT01172938|54574537|FG002|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
27916877|NCT01172938|54574538|FG003|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
27916878|NCT01172938|54574539|FG004|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
28100962|NCT03006562|54757411|FG001|Overall Study|Lost to Follow-up|1|||
27916879|NCT01172938|54574540|FG005|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
27916880|NCT01172938|54574541|FG006|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
27916881|NCT01172938|54574542|FG007|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
27916882|NCT01172938|54574543|FG008|Active-Treatment Phase Weeks (104-156)|Adverse Event|1|||
27916883|NCT01172938|54574535|FG000|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
28100963|NCT03007966|54757419|FG000|Overall Study|Did not meeting inclusion/exclusion|1|||
28100964|NCT03007966|54757420|FG001|Overall Study|Did not meeting inclusion/exclusion|0|||
28100965|NCT03007888|54757427|FG000|First Intervention (14 Days)|Adverse Event|1|||
28100966|NCT03007888|54757428|FG001|First Intervention (14 Days)|Adverse Event|0|||
28100967|NCT03541044|54757437|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
28100968|NCT03541044|54757438|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
28100969|NCT03541044|54757437|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
28100970|NCT03541044|54757438|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
28100971|NCT00009945|54757448|FG000|Overall Study|no follow up data|7|||
28100972|NCT00009945|54757449|FG001|Overall Study|no follow up data|5|||
28100973|NCT03540030|54757457|FG000|Overall Study|Withdrawal by Subject|2|||
28100974|NCT03540030|54757458|FG001|Overall Study|Withdrawal by Subject|1|||
28100975|NCT03540030|54757457|FG000|Overall Study|screen fail|7|||
28100976|NCT03540030|54757458|FG001|Overall Study|screen fail|1|||
28100977|NCT03540030|54757457|FG000|Overall Study|never had surgery after signing consent|9|||
28100978|NCT03540030|54757458|FG001|Overall Study|never had surgery after signing consent|1|||
28100979|NCT03003676|54757466|FG000|Overall Study|Lack of Efficacy|5|||
28100980|NCT03003676|54757467|FG001|Overall Study|Lack of Efficacy|7|||
28100981|NCT03003676|54757466|FG000|Overall Study|Withdrawal by Subject|0|||
28100982|NCT03003676|54757467|FG001|Overall Study|Withdrawal by Subject|1|||
28100983|NCT03003676|54757466|FG000|Overall Study|Hepatitis B infection|1|||
28100984|NCT03003676|54757467|FG001|Overall Study|Hepatitis B infection|0|||
28100985|NCT00047385|54757477|FG000|Overall Study|Death before any screening|2|||
28100986|NCT00047385|54757478|FG001|Overall Study|Death before any screening|5|||
28100987|NCT00047385|54757477|FG000|Overall Study|Lung Cancer diagnosed before screening|5|||
28100988|NCT00047385|54757478|FG001|Overall Study|Lung Cancer diagnosed before screening|3|||
28100989|NCT00047385|54757477|FG000|Overall Study|Eligible for screening but had no screen|260|||
28100990|NCT00047385|54757478|FG001|Overall Study|Eligible for screening but had no screen|492|||
28100991|NCT03002818|54757484|FG000|Overall Study|Decision of the investigator|1|||
28100992|NCT03002194|54757488|FG000|Overall Study|Lost to Follow-up|6|||
28100993|NCT03002194|54757488|FG000|Overall Study|Adverse Event|1|||
28100994|NCT03002194|54757488|FG000|Overall Study|Lack of Efficacy|1|||
28100995|NCT03002194|54757488|FG000|Overall Study|Withdrawal by Subject|2|||
28100996|NCT02912650|54757496|FG000|Overall Study|Withdrawal by Subject|1|||
28100997|NCT02912650|54757497|FG001|Overall Study|Withdrawal by Subject|0|||
28100998|NCT02912650|54757498|FG002|Overall Study|Withdrawal by Subject|1|||
28100999|NCT02912650|54757499|FG003|Overall Study|Withdrawal by Subject|5|||
28101000|NCT02912650|54757496|FG000|Overall Study|Adverse Event|0|||
28101001|NCT02912650|54757497|FG001|Overall Study|Adverse Event|0|||
28101002|NCT02912650|54757498|FG002|Overall Study|Adverse Event|1|||
28101003|NCT02912650|54757499|FG003|Overall Study|Adverse Event|0|||
28101004|NCT03004924|54757512|FG000|Overall Study|Adverse Event|6|||
28101005|NCT03004924|54757513|FG001|Overall Study|Adverse Event|5|||
28101006|NCT03004924|54757514|FG002|Overall Study|Adverse Event|10|||
28101007|NCT03004924|54757512|FG000|Overall Study|Protocol Violation|4|||
28101008|NCT03004924|54757513|FG001|Overall Study|Protocol Violation|0|||
28101009|NCT03004924|54757514|FG002|Overall Study|Protocol Violation|1|||
28101010|NCT03004924|54757512|FG000|Overall Study|Withdrawal by Subject|5|||
28101011|NCT03004924|54757513|FG001|Overall Study|Withdrawal by Subject|3|||
28101012|NCT03004924|54757514|FG002|Overall Study|Withdrawal by Subject|5|||
28101013|NCT03004924|54757512|FG000|Overall Study|Lost to Follow-up|6|||
28101014|NCT03004924|54757513|FG001|Overall Study|Lost to Follow-up|1|||
28101015|NCT03004924|54757514|FG002|Overall Study|Lost to Follow-up|4|||
28101016|NCT03004924|54757512|FG000|Overall Study|Lack of Efficacy|2|||
28101017|NCT03004924|54757513|FG001|Overall Study|Lack of Efficacy|4|||
28101018|NCT03004924|54757514|FG002|Overall Study|Lack of Efficacy|2|||
28101019|NCT03004924|54757512|FG000|Overall Study|Physician Decision|1|||
28101020|NCT03004924|54757513|FG001|Overall Study|Physician Decision|0|||
28101021|NCT03004924|54757514|FG002|Overall Study|Physician Decision|1|||
28101022|NCT03004924|54757512|FG000|Overall Study|Withdrawal by parent/guardian|1|||
28101023|NCT03004924|54757513|FG001|Overall Study|Withdrawal by parent/guardian|0|||
28101024|NCT03004924|54757514|FG002|Overall Study|Withdrawal by parent/guardian|2|||
28101025|NCT03004924|54757512|FG000|Overall Study|Screen Failure|1|||
28101026|NCT03004924|54757513|FG001|Overall Study|Screen Failure|0|||
28101027|NCT03004924|54757514|FG002|Overall Study|Screen Failure|0|||
28101028|NCT03004924|54757512|FG000|Overall Study|Pregnancy|0|||
28101029|NCT03004924|54757513|FG001|Overall Study|Pregnancy|1|||
28101030|NCT03004924|54757514|FG002|Overall Study|Pregnancy|0|||
28101031|NCT03004924|54757512|FG000|Overall Study|Terminated by Sponsor|0|||
28101032|NCT03004924|54757513|FG001|Overall Study|Terminated by Sponsor|0|||
28101033|NCT03004924|54757514|FG002|Overall Study|Terminated by Sponsor|1|||
28101034|NCT03004924|54757512|FG000|Overall Study|Missed Study Visit|0|||
28172779|NCT02745119|54844495|FG001|Overall Study|Reason Not Specified|2|||
28101035|NCT03004924|54757513|FG001|Overall Study|Missed Study Visit|0|||
28101036|NCT03004924|54757514|FG002|Overall Study|Missed Study Visit|2|||
28101037|NCT03004924|54757512|FG000|Overall Study|HSV1 Positive|1|||
28101038|NCT03004924|54757513|FG001|Overall Study|HSV1 Positive|0|||
28101039|NCT03004924|54757514|FG002|Overall Study|HSV1 Positive|0|||
28101040|NCT03002038|54757525|FG000|Overall Study|Adverse Event|3|||
28101041|NCT03002038|54757526|FG001|Overall Study|Adverse Event|1|||
28101042|NCT03002038|54757525|FG000|Overall Study|Withdrawal by Subject|8|||
28101043|NCT03002038|54757526|FG001|Overall Study|Withdrawal by Subject|4|||
28101044|NCT03002038|54757525|FG000|Overall Study|Immigration to another region|0|||
28101045|NCT03002038|54757526|FG001|Overall Study|Immigration to another region|2|||
28101046|NCT02911948|54757534|FG000|Overall Study|Protocol Violation|0|||
28101047|NCT02911948|54757535|FG001|Overall Study|Protocol Violation|1|||
28101048|NCT02911948|54757534|FG000|Overall Study|Withdrawal by Subject|0|||
28101049|NCT02911948|54757535|FG001|Overall Study|Withdrawal by Subject|2|||
28101050|NCT02911948|54757534|FG000|Overall Study|Lack of Efficacy|0|||
28101051|NCT02911948|54757535|FG001|Overall Study|Lack of Efficacy|1|||
28101052|NCT02911948|54757534|FG000|Overall Study|Unclassified|0|||
28101053|NCT02911948|54757535|FG001|Overall Study|Unclassified|3|||
28101054|NCT02996968|54757543|FG000|Overall Study|Withdrawal by Subject|1|||
28101055|NCT02996968|54757544|FG001|Overall Study|Withdrawal by Subject|0|||
28101056|NCT00027027|54757555|FG000|Overall Study|Adverse Event|0|||
28172780|NCT02745119|54844496|FG002|Overall Study|Reason Not Specified|0|||
28172781|NCT02745119|54844497|FG003|Overall Study|Reason Not Specified|1|||
27739932|NCT02786537|54189682|FG005|As Randomized|Opiate Dependency Relapse|0|||
28101057|NCT00027027|54757556|FG001|Overall Study|Adverse Event|0|||
28101058|NCT00027027|54757557|FG002|Overall Study|Adverse Event|1|||
28101059|NCT00027027|54757558|FG003|Overall Study|Adverse Event|0|||
28101060|NCT00027027|54757559|FG004|Overall Study|Adverse Event|1|||
28101061|NCT00027027|54757555|FG000|Overall Study|Admitted for Signs of PD|0|||
28101062|NCT00027027|54757556|FG001|Overall Study|Admitted for Signs of PD|0|||
28101063|NCT00027027|54757557|FG002|Overall Study|Admitted for Signs of PD|0|||
28101064|NCT00027027|54757558|FG003|Overall Study|Admitted for Signs of PD|0|||
28101065|NCT00027027|54757559|FG004|Overall Study|Admitted for Signs of PD|1|||
28101066|NCT00027027|54757555|FG000|Overall Study|Clinical Symptoms Progression not PD|1|||
28101067|NCT00027027|54757556|FG001|Overall Study|Clinical Symptoms Progression not PD|0|||
28101068|NCT00027027|54757557|FG002|Overall Study|Clinical Symptoms Progression not PD|0|||
28101069|NCT00027027|54757558|FG003|Overall Study|Clinical Symptoms Progression not PD|0|||
28101070|NCT00027027|54757559|FG004|Overall Study|Clinical Symptoms Progression not PD|0|||
28101071|NCT00027027|54757555|FG000|Overall Study|PD Requiring Surgery|0|||
28101072|NCT00027027|54757556|FG001|Overall Study|PD Requiring Surgery|0|||
28101073|NCT00027027|54757557|FG002|Overall Study|PD Requiring Surgery|1|||
28101074|NCT00027027|54757558|FG003|Overall Study|PD Requiring Surgery|0|||
28101075|NCT00027027|54757559|FG004|Overall Study|PD Requiring Surgery|0|||
28101076|NCT00027027|54757555|FG000|Overall Study|Physician Decision Due To PD|2|||
28101077|NCT00027027|54757556|FG001|Overall Study|Physician Decision Due To PD|3|||
28101078|NCT00027027|54757557|FG002|Overall Study|Physician Decision Due To PD|2|||
28101079|NCT00027027|54757558|FG003|Overall Study|Physician Decision Due To PD|3|||
28101080|NCT00027027|54757559|FG004|Overall Study|Physician Decision Due To PD|5|||
28101081|NCT00027027|54757555|FG000|Overall Study|Withdrawal by Subject|0|||
28101082|NCT00027027|54757556|FG001|Overall Study|Withdrawal by Subject|0|||
28101083|NCT00027027|54757557|FG002|Overall Study|Withdrawal by Subject|0|||
28101084|NCT00027027|54757558|FG003|Overall Study|Withdrawal by Subject|0|||
28101085|NCT00027027|54757559|FG004|Overall Study|Withdrawal by Subject|1|||
28101086|NCT00046839|54757577|FG000|Overall Study|Ineligible / No protocol treatment|0|||
28101087|NCT00046839|54757578|FG001|Overall Study|Ineligible / No protocol treatment|2|||
28101088|NCT00046839|54757577|FG000|Overall Study|Withdrawal of consent|1|||
28101089|NCT00046839|54757578|FG001|Overall Study|Withdrawal of consent|0|||
28101090|NCT00006903|54757587|FG000|Overall Study|Still receiving treatment|0|||
28101091|NCT00006903|54757588|FG001|Overall Study|Still receiving treatment|0|||
28101092|NCT00006903|54757589|FG002|Overall Study|Still receiving treatment|1|||
28101093|NCT00006903|54757587|FG000|Overall Study|Refused further treatment|0|||
28101094|NCT00006903|54757588|FG001|Overall Study|Refused further treatment|2|||
27739933|NCT02786537|54189677|FG000|As Randomized|HCV drugs stolen from pt|0|||
28101095|NCT00006903|54757589|FG002|Overall Study|Refused further treatment|1|||
28101096|NCT00006903|54757587|FG000|Overall Study|Adverse Event|0|||
28101097|NCT00006903|54757588|FG001|Overall Study|Adverse Event|0|||
28101098|NCT00006903|54757589|FG002|Overall Study|Adverse Event|1|||
28101099|NCT00006903|54757587|FG000|Overall Study|Death|0|||
28101100|NCT00006903|54757588|FG001|Overall Study|Death|1|||
28101101|NCT00006903|54757589|FG002|Overall Study|Death|0|||
28101102|NCT00006903|54757587|FG000|Overall Study|Patient never treated|0|||
28101103|NCT00006903|54757588|FG001|Overall Study|Patient never treated|0|||
28172782|NCT01367665|54844511|FG000|Overall Study|Death|102|||
28101104|NCT00006903|54757589|FG002|Overall Study|Patient never treated|1|||
28101105|NCT00006903|54757587|FG000|Overall Study|Ineligible|10|||
28101106|NCT00006903|54757588|FG001|Overall Study|Ineligible|1|||
28101107|NCT00006903|54757589|FG002|Overall Study|Ineligible|2|||
28101108|NCT00026793|54757597|FG000|Overall Study|Death on study due to underlying disease|4|||
28101109|NCT00026793|54757597|FG000|Overall Study|Physician Decision|2|||
28101110|NCT00026793|54757597|FG000|Overall Study|Off study|2|||
28101111|NCT03539484|54757608|FG000|Overall Study|Death|1|||
28101112|NCT03539484|54757609|FG001|Overall Study|Death|0|||
28101113|NCT03539484|54757610|FG002|Overall Study|Death|0|||
28101114|NCT03539484|54757611|FG003|Overall Study|Death|2|||
28101115|NCT03539484|54757612|FG004|Overall Study|Death|8|||
28101116|NCT03539484|54757613|FG005|Overall Study|Death|3|||
28101117|NCT03539484|54757614|FG006|Overall Study|Death|0|||
28101118|NCT03539484|54757608|FG000|Overall Study|Lost to Follow-up|0|||
28101119|NCT03539484|54757609|FG001|Overall Study|Lost to Follow-up|1|||
28101120|NCT03539484|54757610|FG002|Overall Study|Lost to Follow-up|0|||
28101121|NCT03539484|54757611|FG003|Overall Study|Lost to Follow-up|0|||
28101122|NCT03539484|54757612|FG004|Overall Study|Lost to Follow-up|1|||
28101123|NCT03539484|54757613|FG005|Overall Study|Lost to Follow-up|0|||
28101124|NCT03539484|54757614|FG006|Overall Study|Lost to Follow-up|0|||
28101125|NCT03539484|54757608|FG000|Overall Study|Withdrawal by Subject|0|||
28101126|NCT03539484|54757609|FG001|Overall Study|Withdrawal by Subject|0|||
28101127|NCT03539484|54757610|FG002|Overall Study|Withdrawal by Subject|0|||
28101128|NCT03539484|54757611|FG003|Overall Study|Withdrawal by Subject|0|||
28101129|NCT03539484|54757612|FG004|Overall Study|Withdrawal by Subject|2|||
28101130|NCT03539484|54757613|FG005|Overall Study|Withdrawal by Subject|0|||
28101131|NCT03539484|54757614|FG006|Overall Study|Withdrawal by Subject|1|||
28101132|NCT03539484|54757608|FG000|Overall Study|Study Terminated by Sponsor|0|||
28101133|NCT03539484|54757609|FG001|Overall Study|Study Terminated by Sponsor|0|||
28101134|NCT03539484|54757610|FG002|Overall Study|Study Terminated by Sponsor|1|||
28101135|NCT03539484|54757611|FG003|Overall Study|Study Terminated by Sponsor|1|||
28101136|NCT03539484|54757612|FG004|Overall Study|Study Terminated by Sponsor|2|||
28101137|NCT03539484|54757613|FG005|Overall Study|Study Terminated by Sponsor|2|||
28101138|NCT03539484|54757614|FG006|Overall Study|Study Terminated by Sponsor|1|||
28101139|NCT03561090|54757637|FG000|Overall Study|Adverse Event|11|||
28101140|NCT03561090|54757638|FG001|Overall Study|Adverse Event|7|||
28101141|NCT03561090|54757637|FG000|Overall Study|Non-Compliance With Study Drug|2|||
28101142|NCT03561090|54757638|FG001|Overall Study|Non-Compliance With Study Drug|0|||
28101143|NCT03561090|54757637|FG000|Overall Study|Protocol Violation|2|||
28101144|NCT03561090|54757638|FG001|Overall Study|Protocol Violation|2|||
28005190|NCT00442117|54664097|FG000|Overall Study|Non compliance with protocol|3|||
28005191|NCT00442117|54664098|FG001|Overall Study|Non compliance with protocol|5|||
28005192|NCT00442117|54664097|FG000|Overall Study|Met Withdrawal Criteria|2|||
28005193|NCT00442117|54664098|FG001|Overall Study|Met Withdrawal Criteria|1|||
28005194|NCT00752726|54664106|FG000|Overall Study|Lost to Follow-up|2|||
28005195|NCT00752726|54664107|FG001|Overall Study|Lost to Follow-up|1|||
28005196|NCT00752726|54664106|FG000|Overall Study|Adverse Event|3|||
28005197|NCT00752726|54664107|FG001|Overall Study|Adverse Event|0|||
28005198|NCT00752726|54664106|FG000|Overall Study|Withdrawal by Subject|5|||
28005199|NCT00752726|54664107|FG001|Overall Study|Withdrawal by Subject|10|||
28005200|NCT00752726|54664106|FG000|Overall Study|Other Reason|1|||
28005201|NCT00752726|54664107|FG001|Overall Study|Other Reason|2|||
28005202|NCT00755222|54664115|FG000|Overall Study|Withdrawal by Subject|4|||
28005203|NCT00755222|54664116|FG001|Overall Study|Withdrawal by Subject|2|||
28005204|NCT00755222|54664115|FG000|Overall Study|Adverse Event|2|||
28005205|NCT00755222|54664116|FG001|Overall Study|Adverse Event|0|||
28005206|NCT00755222|54664115|FG000|Overall Study|Protocol Violation|2|||
28005207|NCT00755222|54664116|FG001|Overall Study|Protocol Violation|0|||
28005208|NCT00441727|54664125|FG000|Overall Study|Protocol Violation|19|||
28005209|NCT00441727|54664126|FG001|Overall Study|Protocol Violation|28|||
28005210|NCT00441727|54664127|FG002|Overall Study|Protocol Violation|32|||
28005211|NCT00441727|54664125|FG000|Overall Study|Adverse Event|26|||
28005212|NCT00441727|54664126|FG001|Overall Study|Adverse Event|33|||
28005213|NCT00441727|54664127|FG002|Overall Study|Adverse Event|28|||
28101145|NCT03561090|54757637|FG000|Overall Study|Withdrawal by Subject|7|||
28101146|NCT03561090|54757638|FG001|Overall Study|Withdrawal by Subject|7|||
28101147|NCT03561090|54757637|FG000|Overall Study|Lost to Follow-up|7|||
28101148|NCT03561090|54757638|FG001|Overall Study|Lost to Follow-up|2|||
28101149|NCT03561090|54757637|FG000|Overall Study|Study Terminated by Sponsor|10|||
28101150|NCT03561090|54757638|FG001|Overall Study|Study Terminated by Sponsor|15|||
28101151|NCT03561090|54757637|FG000|Overall Study|Randomized by Mistake|1|||
28005214|NCT00441727|54664125|FG000|Overall Study|Lack of Efficacy|7|||
28005215|NCT00441727|54664126|FG001|Overall Study|Lack of Efficacy|8|||
28005216|NCT00441727|54664127|FG002|Overall Study|Lack of Efficacy|48|||
28005217|NCT00441727|54664125|FG000|Overall Study|Withdrawal by Subject|40|||
28005218|NCT00441727|54664126|FG001|Overall Study|Withdrawal by Subject|34|||
28101152|NCT03561090|54757638|FG001|Overall Study|Randomized by Mistake|1|||
28101153|NCT03561090|54757637|FG000|Overall Study|Other Not Specified|0|||
28005219|NCT00441727|54664127|FG002|Overall Study|Withdrawal by Subject|47|||
28005220|NCT00441727|54664125|FG000|Overall Study|Lost to Follow-up|5|||
28005221|NCT00441727|54664126|FG001|Overall Study|Lost to Follow-up|6|||
28005222|NCT00441727|54664127|FG002|Overall Study|Lost to Follow-up|5|||
28005223|NCT00441727|54664125|FG000|Overall Study|Safety Reasons|3|||
28005224|NCT00441727|54664126|FG001|Overall Study|Safety Reasons|1|||
28005225|NCT00441727|54664127|FG002|Overall Study|Safety Reasons|3|||
28005226|NCT00441727|54664125|FG000|Overall Study|Various reason specified|6|||
28005227|NCT00441727|54664126|FG001|Overall Study|Various reason specified|8|||
28005228|NCT00441727|54664127|FG002|Overall Study|Various reason specified|5|||
28005229|NCT00770120|54664149|FG000|Overall Study|Progression|31|||
28005230|NCT00770120|54664149|FG000|Overall Study|Adverse Event|11|||
28005231|NCT00770120|54664149|FG000|Overall Study|Not Protocol Specified|11|||
28005232|NCT00770120|54664149|FG000|Overall Study|Death|3|||
28005233|NCT00770120|54664149|FG000|Overall Study|Withdrawal by Subject|2|||
28005234|NCT00770120|54664149|FG000|Overall Study|Ineligible|1|||
28005235|NCT00770120|54664149|FG000|Overall Study|Never Received Treatment/Not Analyzable|1|||
28005236|NCT00770120|54664149|FG000|Overall Study|Reason under Review|1|||
28005237|NCT00436345|54664156|FG000|Overall Study|ICU resident beyond follow-up period|3|||
28005238|NCT00436345|54664157|FG001|Overall Study|ICU resident beyond follow-up period|0|||
28005239|NCT00769184|54664164|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1|||
28005240|NCT00769184|54664165|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0|||
28005241|NCT00769184|54664164|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0|||
28005242|NCT00769184|54664165|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1|||
28005243|NCT00769184|54664164|FG000|No Treatment (6 Weeks)|Adverse Event|1|||
28005244|NCT00769184|54664165|FG001|No Treatment (6 Weeks)|Adverse Event|1|||
28005245|NCT00768560|54664179|FG000|Intervention Set 1|Adverse Event|0|||
28005246|NCT00768560|54664180|FG001|Intervention Set 1|Adverse Event|1|||
28005247|NCT00768560|54664181|FG002|Intervention Set 1|Adverse Event|0|||
28005248|NCT00768560|54664182|FG003|Intervention Set 1|Adverse Event|0|||
28005249|NCT00768560|54664183|FG004|Intervention Set 1|Adverse Event|0|||
28005250|NCT00768560|54664184|FG005|Intervention Set 1|Adverse Event|0|||
28005251|NCT00468559|54664194|FG000|Open-label Treatment Phase|Adverse Event|5|||
28005252|NCT00468559|54664195|FG001|Open-label Treatment Phase|Adverse Event|0|||
28005253|NCT00468559|54664196|FG002|Open-label Treatment Phase|Adverse Event|0|||
28005254|NCT00468559|54664194|FG000|Open-label Treatment Phase|Lack of Efficacy|9|||
28005255|NCT00468559|54664195|FG001|Open-label Treatment Phase|Lack of Efficacy|0|||
28005256|NCT00468559|54664196|FG002|Open-label Treatment Phase|Lack of Efficacy|0|||
28005257|NCT00468559|54664194|FG000|Open-label Treatment Phase|Withdrawal by Subject|4|||
28005258|NCT00468559|54664195|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
28005259|NCT00468559|54664196|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
28005260|NCT00468559|54664194|FG000|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0|||
28005261|NCT00468559|54664195|FG001|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8|||
28005262|NCT00468559|54664196|FG002|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17|||
28005263|NCT00468559|54664194|FG000|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
28005264|NCT00468559|54664195|FG001|Double-blind, Treatment-withdrawal Phase|Adverse Event|2|||
28005265|NCT00468559|54664196|FG002|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
28005266|NCT00754442|54664206|FG000|Overall Study|Withdrawal by Subject|5|||
28005267|NCT00754442|54664207|FG001|Overall Study|Withdrawal by Subject|3|||
28005268|NCT00754052|54664216|FG000|Overall Study|Study terminated by Sponsor|5|||
28005269|NCT00754052|54664217|FG001|Overall Study|Study terminated by Sponsor|3|||
28005270|NCT00747812|54664225|FG000|Overall Study|Research Site Staff Relocation|5|||
28005271|NCT00747812|54664226|FG001|Overall Study|Research Site Staff Relocation|3|||
28005272|NCT02927067|54664234|FG000|Overall Study|Withdrawn Consent|20|||
28005273|NCT02927067|54664235|FG001|Overall Study|Withdrawn Consent|12|||
28005274|NCT02927067|54664234|FG000|Overall Study|Death|18|||
28005275|NCT02927067|54664235|FG001|Overall Study|Death|31|||
28101154|NCT03561090|54757638|FG001|Overall Study|Other Not Specified|2|||
28101155|NCT02996500|54757652|FG000|Overall Study|Adverse Event|1|||
28101156|NCT02996500|54757653|FG001|Overall Study|Adverse Event|1|||
28101157|NCT02996500|54757654|FG002|Overall Study|Adverse Event|4|||
28101158|NCT02996500|54757655|FG003|Overall Study|Adverse Event|3|||
28101159|NCT02996500|54757656|FG004|Overall Study|Adverse Event|1|||
28101160|NCT02996500|54757657|FG005|Overall Study|Adverse Event|2|||
28005276|NCT02927067|54664234|FG000|Overall Study|Adverse Event|13|||
28101161|NCT02996500|54757652|FG000|Overall Study|Lack of Efficacy|0|||
28101162|NCT02996500|54757653|FG001|Overall Study|Lack of Efficacy|0|||
28101163|NCT02996500|54757654|FG002|Overall Study|Lack of Efficacy|0|||
28101164|NCT02996500|54757655|FG003|Overall Study|Lack of Efficacy|0|||
28101165|NCT02996500|54757656|FG004|Overall Study|Lack of Efficacy|2|||
28101166|NCT02996500|54757657|FG005|Overall Study|Lack of Efficacy|0|||
28005277|NCT02927067|54664235|FG001|Overall Study|Adverse Event|10|||
28005278|NCT02927067|54664234|FG000|Overall Study|Noncompliance|5|||
28101167|NCT02996500|54757652|FG000|Overall Study|Lost to Follow-up|1|||
28101168|NCT02996500|54757653|FG001|Overall Study|Lost to Follow-up|0|||
28101169|NCT02996500|54757654|FG002|Overall Study|Lost to Follow-up|0|||
28005279|NCT02927067|54664235|FG001|Overall Study|Noncompliance|2|||
28005280|NCT02927067|54664234|FG000|Overall Study|Reason not Specified|4|||
28005281|NCT02927067|54664235|FG001|Overall Study|Reason not Specified|6|||
28005282|NCT01771107|54664245|FG000|Overall Study|Adverse Event|1|||
28005283|NCT01771107|54664246|FG001|Overall Study|Adverse Event|3|||
28005284|NCT01771107|54664245|FG000|Overall Study|Withdrawal by Subject|0|||
28005285|NCT01771107|54664246|FG001|Overall Study|Withdrawal by Subject|2|||
28005286|NCT01771107|54664245|FG000|Overall Study|Lost to Follow-up|0|||
28005287|NCT01771107|54664246|FG001|Overall Study|Lost to Follow-up|1|||
28005288|NCT01771107|54664245|FG000|Overall Study|participant moved|0|||
28005289|NCT01771107|54664246|FG001|Overall Study|participant moved|1|||
28005290|NCT01771107|54664245|FG000|Overall Study|Other|0|||
28005291|NCT01771107|54664246|FG001|Overall Study|Other|1|||
28005292|NCT01751685|54664256|FG000|6-mo Followup|Missed study visit|1|||
28005293|NCT01751685|54664257|FG001|6-mo Followup|Missed study visit|0|||
28005294|NCT01751685|54664256|FG000|6-mo Followup|Withdrawal by Subject|2|||
28005295|NCT01751685|54664257|FG001|6-mo Followup|Withdrawal by Subject|2|||
28005296|NCT01751685|54664256|FG000|6-mo Followup|Lost to Follow-up|0|||
28005297|NCT01751685|54664257|FG001|6-mo Followup|Lost to Follow-up|1|||
28005298|NCT01751685|54664256|FG000|12-mo Followup|Lost to Follow-up|5|||
28005299|NCT01751685|54664257|FG001|12-mo Followup|Lost to Follow-up|0|||
28005300|NCT00586508|54664265|FG000|Overall Study|Progressive disease|52|||
28005301|NCT00586508|54664266|FG001|Overall Study|Progressive disease|8|||
28005302|NCT00586508|54664265|FG000|Overall Study|Death|0|||
28005303|NCT00586508|54664266|FG001|Overall Study|Death|1|||
28005304|NCT00586508|54664265|FG000|Overall Study|Adverse Event|12|||
28005305|NCT00586508|54664266|FG001|Overall Study|Adverse Event|4|||
28005306|NCT00586508|54664265|FG000|Overall Study|Withdrawal by Subject|4|||
28005307|NCT00586508|54664266|FG001|Overall Study|Withdrawal by Subject|0|||
28005308|NCT00581919|54664272|FG000|Overall Study|Adverse Event|8|||
28005309|NCT00581919|54664272|FG000|Overall Study|Death|1|||
28005310|NCT00581919|54664272|FG000|Overall Study|Disease Progression|10|||
28005311|NCT00581919|54664272|FG000|Overall Study|Physician Decision|1|||
28005312|NCT00581919|54664272|FG000|Overall Study|Other Complicating Disease|1|||
28005313|NCT00581919|54664272|FG000|Overall Study|Started Non-Protocol Therapy|2|||
28005314|NCT00581919|54664272|FG000|Overall Study|Withdrawal by Subject|1|||
28101170|NCT02996500|54757655|FG003|Overall Study|Lost to Follow-up|0|||
28101171|NCT02996500|54757656|FG004|Overall Study|Lost to Follow-up|0|||
28101172|NCT02996500|54757657|FG005|Overall Study|Lost to Follow-up|1|||
28101173|NCT02996500|54757652|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
28101174|NCT02996500|54757653|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
28101175|NCT02996500|54757654|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
28101176|NCT02996500|54757655|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
28101177|NCT02996500|54757656|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
28101178|NCT02996500|54757657|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
28101179|NCT02996500|54757652|FG000|Overall Study|Non-Compliance With Study Drug|0|||
28101180|NCT02996500|54757653|FG001|Overall Study|Non-Compliance With Study Drug|0|||
28101181|NCT02996500|54757654|FG002|Overall Study|Non-Compliance With Study Drug|0|||
28101182|NCT02996500|54757655|FG003|Overall Study|Non-Compliance With Study Drug|0|||
28101183|NCT02996500|54757656|FG004|Overall Study|Non-Compliance With Study Drug|0|||
28101184|NCT02996500|54757657|FG005|Overall Study|Non-Compliance With Study Drug|1|||
28101185|NCT02996500|54757652|FG000|Overall Study|Progressive Disease|1|||
28101186|NCT02996500|54757653|FG001|Overall Study|Progressive Disease|0|||
28101187|NCT02996500|54757654|FG002|Overall Study|Progressive Disease|0|||
28101188|NCT02996500|54757655|FG003|Overall Study|Progressive Disease|0|||
28101189|NCT02996500|54757656|FG004|Overall Study|Progressive Disease|0|||
28101190|NCT02996500|54757657|FG005|Overall Study|Progressive Disease|0|||
28101191|NCT02996500|54757652|FG000|Overall Study|Other|2|||
28101192|NCT02996500|54757653|FG001|Overall Study|Other|0|||
28101193|NCT02996500|54757654|FG002|Overall Study|Other|2|||
28101194|NCT02996500|54757655|FG003|Overall Study|Other|0|||
28101195|NCT02996500|54757656|FG004|Overall Study|Other|0|||
28101196|NCT02996500|54757657|FG005|Overall Study|Other|0|||
28101197|NCT02996500|54757652|FG000|Overall Study|Protocol Violation|0|||
28172783|NCT01367665|54844512|FG001|Overall Study|Death|19|||
28005315|NCT00723528|54664280|FG000|Period 1: Controlled Period (CP)|Adverse Event|0|||
28005316|NCT00723528|54664281|FG001|Period 1: Controlled Period (CP)|Adverse Event|0|||
28005317|NCT00723528|54664282|FG002|Period 1: Controlled Period (CP)|Adverse Event|1|||
28005318|NCT00723528|54664283|FG003|Period 1: Controlled Period (CP)|Adverse Event|0|||
28005319|NCT00723528|54664284|FG004|Period 1: Controlled Period (CP)|Adverse Event|0|||
28005320|NCT00723528|54664285|FG005|Period 1: Controlled Period (CP)|Adverse Event|0|||
28172784|NCT01367665|54844511|FG000|Overall Study|Lost to Follow-up|222|||
28005321|NCT00723528|54664286|FG006|Period 1: Controlled Period (CP)|Adverse Event|0|||
28005322|NCT00723528|54664280|FG000|Period 1: Controlled Period (CP)|Withdrawal by Subject|2|||
28005323|NCT00723528|54664281|FG001|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
28005324|NCT00723528|54664282|FG002|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
28172785|NCT01367665|54844512|FG001|Overall Study|Lost to Follow-up|22|||
28101198|NCT02996500|54757653|FG001|Overall Study|Protocol Violation|0|||
28101199|NCT02996500|54757654|FG002|Overall Study|Protocol Violation|0|||
28101200|NCT02996500|54757655|FG003|Overall Study|Protocol Violation|1|||
28101201|NCT02996500|54757656|FG004|Overall Study|Protocol Violation|0|||
28101202|NCT02996500|54757657|FG005|Overall Study|Protocol Violation|0|||
28101203|NCT02996500|54757652|FG000|Overall Study|Withdrawal by Subject|3|||
28101204|NCT02996500|54757653|FG001|Overall Study|Withdrawal by Subject|0|||
28101205|NCT02996500|54757654|FG002|Overall Study|Withdrawal by Subject|3|||
28101206|NCT02996500|54757655|FG003|Overall Study|Withdrawal by Subject|0|||
28101207|NCT02996500|54757656|FG004|Overall Study|Withdrawal by Subject|2|||
28101208|NCT02996500|54757657|FG005|Overall Study|Withdrawal by Subject|0|||
28101209|NCT00006489|54757679|FG000|Overall Study|Adverse Event|3|||
28101210|NCT00006489|54757680|FG001|Overall Study|Adverse Event|2|||
28101211|NCT00006489|54757681|FG002|Overall Study|Adverse Event|4|||
28101212|NCT00006489|54757682|FG003|Overall Study|Adverse Event|3|||
28101213|NCT00006489|54757679|FG000|Overall Study|Withdrawal by Subject|10|||
28101214|NCT00006489|54757680|FG001|Overall Study|Withdrawal by Subject|9|||
28101215|NCT00006489|54757681|FG002|Overall Study|Withdrawal by Subject|9|||
28101216|NCT00006489|54757682|FG003|Overall Study|Withdrawal by Subject|6|||
28101217|NCT00006489|54757679|FG000|Overall Study|Scheduling Conflict|0|||
28101218|NCT00006489|54757680|FG001|Overall Study|Scheduling Conflict|3|||
28101219|NCT00006489|54757681|FG002|Overall Study|Scheduling Conflict|2|||
28101220|NCT00006489|54757682|FG003|Overall Study|Scheduling Conflict|1|||
28101221|NCT00006489|54757679|FG000|Overall Study|Death|0|||
28101222|NCT00006489|54757680|FG001|Overall Study|Death|0|||
28101223|NCT00006489|54757681|FG002|Overall Study|Death|0|||
28101224|NCT00006489|54757682|FG003|Overall Study|Death|1|||
28101225|NCT03535974|54757695|FG000|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
28101226|NCT03535974|54757696|FG001|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1|||
28101227|NCT03535974|54757697|FG002|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
28101228|NCT03535974|54757695|FG000|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2|||
28101229|NCT03535974|54757696|FG001|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1|||
27916884|NCT01172938|54574536|FG001|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4|||
28005325|NCT00723528|54664283|FG003|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
28005326|NCT00723528|54664284|FG004|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
28005327|NCT00723528|54664285|FG005|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
28005328|NCT00723528|54664286|FG006|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
28005329|NCT00723528|54664280|FG000|Period 1: Controlled Period (CP)|Physician Decision|0|||
28005330|NCT00723528|54664281|FG001|Period 1: Controlled Period (CP)|Physician Decision|0|||
28005331|NCT00723528|54664282|FG002|Period 1: Controlled Period (CP)|Physician Decision|1|||
28005332|NCT00723528|54664283|FG003|Period 1: Controlled Period (CP)|Physician Decision|0|||
28005333|NCT00723528|54664284|FG004|Period 1: Controlled Period (CP)|Physician Decision|0|||
28005334|NCT00723528|54664285|FG005|Period 1: Controlled Period (CP)|Physician Decision|0|||
28005335|NCT00723528|54664286|FG006|Period 1: Controlled Period (CP)|Physician Decision|0|||
28005336|NCT00723528|54664280|FG000|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
28005337|NCT00723528|54664281|FG001|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
28005338|NCT00723528|54664282|FG002|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1|||
28005339|NCT00723528|54664283|FG003|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
28005340|NCT00723528|54664284|FG004|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
28005341|NCT00723528|54664285|FG005|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
28005342|NCT00723528|54664286|FG006|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
28005343|NCT00723528|54664280|FG000|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2|||
28005344|NCT00723528|54664281|FG001|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
28005345|NCT00723528|54664282|FG002|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1|||
28005346|NCT00723528|54664283|FG003|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
28005347|NCT00723528|54664284|FG004|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
28101230|NCT03535974|54757697|FG002|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0|||
28101231|NCT00025233|54757705|FG000|Overall Study|Ineligible: wrong cell type|1|||
27916885|NCT01172938|54574537|FG002|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
27916886|NCT01172938|54574538|FG003|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
27916887|NCT01172938|54574539|FG004|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
27916888|NCT01172938|54574540|FG005|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
27916889|NCT01172938|54574541|FG006|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
27916890|NCT01172938|54574542|FG007|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
27916891|NCT01172938|54574543|FG008|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
27916892|NCT01172938|54574535|FG000|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
28101232|NCT00025233|54757705|FG000|Overall Study|Ineligible: wrong primary|1|||
28101233|NCT00025233|54757705|FG000|Overall Study|Ineligible: improper prior treatment|1|||
28101234|NCT00025233|54757705|FG000|Overall Study|Never treated|1|||
28172786|NCT01367665|54844511|FG000|Overall Study|Not Done|118|||
28101235|NCT03535740|54757715|FG000|Overall Study|Ongoing at Data Cut-off Date: 30 September 2020|55|||
28101236|NCT03535740|54757715|FG000|Overall Study|Death|34|||
28101237|NCT03535740|54757715|FG000|Overall Study|Lost to Follow-up|1|||
28101238|NCT03535740|54757715|FG000|Overall Study|Withdrawal by Subject|13|||
28101239|NCT00025155|54757720|FG000|Overall Study|Ineligible: Wrong primary cancer site|1|||
28101240|NCT00025155|54757720|FG000|Overall Study|Ineligible: Second primary cancer site|1|||
28101241|NCT02998996|54757735|FG000|Overall Study|Lost to Follow-up|0|||
28101242|NCT02998996|54757736|FG001|Overall Study|Lost to Follow-up|0|||
28101243|NCT02998996|54757737|FG002|Overall Study|Lost to Follow-up|1|||
28101244|NCT02998996|54757738|FG003|Overall Study|Lost to Follow-up|0|||
28101245|NCT02998996|54757739|FG004|Overall Study|Lost to Follow-up|0|||
28101246|NCT02998996|54757740|FG005|Overall Study|Lost to Follow-up|0|||
28101247|NCT02998996|54757735|FG000|Overall Study|Pregnancy|0|||
28101248|NCT02998996|54757736|FG001|Overall Study|Pregnancy|1|||
28101249|NCT02998996|54757737|FG002|Overall Study|Pregnancy|0|||
28101250|NCT02998996|54757738|FG003|Overall Study|Pregnancy|0|||
28101251|NCT02998996|54757739|FG004|Overall Study|Pregnancy|0|||
28101252|NCT02998996|54757740|FG005|Overall Study|Pregnancy|0|||
28101253|NCT02998996|54757735|FG000|Overall Study|Family reasons|0|||
28101254|NCT02998996|54757736|FG001|Overall Study|Family reasons|0|||
28101255|NCT02998996|54757737|FG002|Overall Study|Family reasons|0|||
28101256|NCT02998996|54757738|FG003|Overall Study|Family reasons|0|||
28101257|NCT02998996|54757739|FG004|Overall Study|Family reasons|1|||
28101258|NCT02998996|54757740|FG005|Overall Study|Family reasons|0|||
28101259|NCT02994940|54757756|FG000|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6|||
28101260|NCT02994940|54757757|FG001|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0|||
28101261|NCT02994940|54757756|FG000|Overall Study|Did not receive study medications: vomited after ingestion|1|||
28101262|NCT02994940|54757757|FG001|Overall Study|Did not receive study medications: vomited after ingestion|0|||
28101263|NCT02994940|54757756|FG000|Overall Study|Did not receive study medications: red dye allergy|0|||
28101264|NCT02994940|54757757|FG001|Overall Study|Did not receive study medications: red dye allergy|1|||
28101265|NCT02994394|54757765|FG000|Period 1 (Days 1 to 3)|Adverse Event|0|||
28101266|NCT02994394|54757766|FG001|Period 1 (Days 1 to 3)|Adverse Event|0|||
28101267|NCT02994394|54757767|FG002|Period 1 (Days 1 to 3)|Adverse Event|1|||
28101268|NCT02994394|54757768|FG003|Period 1 (Days 1 to 3)|Adverse Event|0|||
28101269|NCT02994394|54757769|FG004|Period 1 (Days 1 to 3)|Adverse Event|0|||
28101270|NCT02994394|54757770|FG005|Period 1 (Days 1 to 3)|Adverse Event|0|||
28101271|NCT02994394|54757765|FG000|Period 2 (Days 4 to 6)|Adverse Event|0|||
28101272|NCT02994394|54757766|FG001|Period 2 (Days 4 to 6)|Adverse Event|1|||
28101273|NCT02994394|54757767|FG002|Period 2 (Days 4 to 6)|Adverse Event|0|||
28005348|NCT00723528|54664285|FG005|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
28005349|NCT00723528|54664286|FG006|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
28005350|NCT00723528|54664280|FG000|Period 2: After Controlled Period|Withdrawal by Subject|0|||
28005351|NCT00723528|54664281|FG001|Period 2: After Controlled Period|Withdrawal by Subject|0|||
28005352|NCT00723528|54664282|FG002|Period 2: After Controlled Period|Withdrawal by Subject|0|||
28005353|NCT00723528|54664283|FG003|Period 2: After Controlled Period|Withdrawal by Subject|1|||
28005354|NCT00723528|54664284|FG004|Period 2: After Controlled Period|Withdrawal by Subject|0|||
28005355|NCT00723528|54664285|FG005|Period 2: After Controlled Period|Withdrawal by Subject|1|||
28005356|NCT00723528|54664286|FG006|Period 2: After Controlled Period|Withdrawal by Subject|1|||
28101274|NCT02994394|54757768|FG003|Period 2 (Days 4 to 6)|Adverse Event|0|||
28101275|NCT02994394|54757769|FG004|Period 2 (Days 4 to 6)|Adverse Event|1|||
28101276|NCT02994394|54757770|FG005|Period 2 (Days 4 to 6)|Adverse Event|0|||
28101277|NCT02998840|54757788|FG000|Overall Study|Lost to Follow-up|1|||
28101278|NCT02998840|54757789|FG001|Overall Study|Lost to Follow-up|1|||
28101279|NCT02998840|54757790|FG002|Overall Study|Lost to Follow-up|2|||
28101280|NCT02998840|54757791|FG003|Overall Study|Lost to Follow-up|3|||
28101281|NCT02998840|54757788|FG000|Overall Study|Withdrawal by Subject|1|||
28101282|NCT02998840|54757789|FG001|Overall Study|Withdrawal by Subject|1|||
28101283|NCT02998840|54757790|FG002|Overall Study|Withdrawal by Subject|0|||
28101284|NCT02998840|54757791|FG003|Overall Study|Withdrawal by Subject|1|||
28101285|NCT02998840|54757788|FG000|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|2|||
28101286|NCT02998840|54757789|FG001|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
28101287|NCT02998840|54757790|FG002|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|0|||
28172787|NCT01367665|54844512|FG001|Overall Study|Not Done|14|||
28172788|NCT02576847|54844519|FG000|Overall Study|Adverse Event|27|||
28005357|NCT00723528|54664280|FG000|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
28101288|NCT02998840|54757791|FG003|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
28101289|NCT00023673|54757802|FG000|Overall Study|Ineligible / no protocol treatment|0|||
28101290|NCT00023673|54757803|FG001|Overall Study|Ineligible / no protocol treatment|0|||
28101291|NCT00023673|54757804|FG002|Overall Study|Ineligible / no protocol treatment|0|||
28101292|NCT00023673|54757805|FG003|Overall Study|Ineligible / no protocol treatment|1|||
28101293|NCT00023673|54757802|FG000|Overall Study|Patient withdrew consent|0|||
28101294|NCT00023673|54757803|FG001|Overall Study|Patient withdrew consent|0|||
28101295|NCT00023673|54757804|FG002|Overall Study|Patient withdrew consent|0|||
28101296|NCT00023673|54757805|FG003|Overall Study|Patient withdrew consent|1|||
28101297|NCT01069900|54757817|FG000|Overall Study|Technical problems|0|||
28101298|NCT01069900|54757818|FG001|Overall Study|Technical problems|1|||
28101299|NCT01069900|54757817|FG000|Overall Study|Lost to Follow-up|7|||
28101300|NCT01069900|54757818|FG001|Overall Study|Lost to Follow-up|1|||
28101301|NCT01069900|54757817|FG000|Overall Study|Withdrawal by Subject|6|||
28101302|NCT01069900|54757818|FG001|Overall Study|Withdrawal by Subject|1|||
28101303|NCT01069900|54757817|FG000|Overall Study|Protocol Violation|4|||
28101304|NCT01069900|54757818|FG001|Overall Study|Protocol Violation|1|||
28101305|NCT01069900|54757817|FG000|Overall Study|Insufficient Therapeutic effect|1|||
28101306|NCT01069900|54757818|FG001|Overall Study|Insufficient Therapeutic effect|0|||
28101307|NCT01069120|54757826|FG000|Overall Study|Study prematurely terminated|27|||
28101308|NCT00006237|54757834|FG000|Overall Study|Adverse Event|39|||
28101309|NCT00006237|54757835|FG001|Overall Study|Adverse Event|29|||
28101310|NCT00006237|54757834|FG000|Overall Study|Death|1|||
28101311|NCT00006237|54757835|FG001|Overall Study|Death|0|||
28101312|NCT00006237|54757834|FG000|Overall Study|Refusal unrelated to adverse effects|8|||
28101313|NCT00006237|54757835|FG001|Overall Study|Refusal unrelated to adverse effects|4|||
28101314|NCT00006237|54757834|FG000|Overall Study|Progression/relapse|54|||
28101315|NCT00006237|54757835|FG001|Overall Study|Progression/relapse|2|||
28101316|NCT00006237|54757834|FG000|Overall Study|Not eligible|9|||
28101317|NCT00006237|54757835|FG001|Overall Study|Not eligible|20|||
28101318|NCT00006237|54757834|FG000|Overall Study|Withdrawal by Subject|0|||
27916893|NCT01172938|54574536|FG001|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6|||
27916894|NCT01172938|54574537|FG002|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3|||
27916895|NCT01172938|54574538|FG003|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
27916896|NCT01172938|54574539|FG004|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
27916897|NCT01172938|54574540|FG005|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
27916898|NCT01172938|54574541|FG006|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
28005358|NCT00723528|54664281|FG001|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
28005359|NCT00723528|54664282|FG002|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
28005360|NCT00723528|54664283|FG003|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
28005361|NCT00723528|54664284|FG004|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
28005362|NCT00723528|54664285|FG005|Period 2: After Controlled Period|Onset of tuberculosis infection|1|||
28005363|NCT00723528|54664286|FG006|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
28005364|NCT00723528|54664280|FG000|Period 2: After Controlled Period|Other|0|||
28005365|NCT00723528|54664281|FG001|Period 2: After Controlled Period|Other|0|||
28005366|NCT00723528|54664282|FG002|Period 2: After Controlled Period|Other|0|||
28005367|NCT00723528|54664283|FG003|Period 2: After Controlled Period|Other|0|||
28005368|NCT00723528|54664284|FG004|Period 2: After Controlled Period|Other|1|||
28005369|NCT00723528|54664285|FG005|Period 2: After Controlled Period|Other|4|||
28005370|NCT00723528|54664286|FG006|Period 2: After Controlled Period|Other|0|||
28005371|NCT00723528|54664280|FG000|Period 2: After Controlled Period|Adverse Event|0|||
28005372|NCT00723528|54664281|FG001|Period 2: After Controlled Period|Adverse Event|0|||
28005373|NCT00723528|54664282|FG002|Period 2: After Controlled Period|Adverse Event|0|||
28005374|NCT00723528|54664283|FG003|Period 2: After Controlled Period|Adverse Event|0|||
28005375|NCT00723528|54664284|FG004|Period 2: After Controlled Period|Adverse Event|1|||
28005376|NCT00723528|54664285|FG005|Period 2: After Controlled Period|Adverse Event|0|||
28005377|NCT00723528|54664286|FG006|Period 2: After Controlled Period|Adverse Event|1|||
28005378|NCT00723528|54664280|FG000|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
28005379|NCT00723528|54664281|FG001|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
28005380|NCT00723528|54664282|FG002|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
28005381|NCT00723528|54664283|FG003|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
28005382|NCT00723528|54664284|FG004|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
28005383|NCT00723528|54664285|FG005|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
28005384|NCT00723528|54664286|FG006|Period 2: After Controlled Period|Use of prohibited concomitant medication|1|||
28005385|NCT00723528|54664280|FG000|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
28005386|NCT00723528|54664281|FG001|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
28101319|NCT00006237|54757835|FG001|Overall Study|Withdrawal by Subject|1|||
28101320|NCT00006237|54757834|FG000|Overall Study|Not protocol specified|14|||
28101321|NCT00006237|54757835|FG001|Overall Study|Not protocol specified|5|||
28101322|NCT02993926|54757844|FG000|Enantone Treatment Phase|Adverse Event|1|||
28101323|NCT02993926|54757845|FG001|Enantone Treatment Phase|Adverse Event|0|||
28101324|NCT02993926|54757846|FG002|Enantone Treatment Phase|Adverse Event|0|||
27916899|NCT01172938|54574542|FG007|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2|||
27916900|NCT01172938|54574543|FG008|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1|||
27916901|NCT01172938|54574535|FG000|Active-Treatment Phase Weeks (104-156)|Death|0|||
28101325|NCT02993926|54757844|FG000|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26|||
28101326|NCT02993926|54757845|FG001|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
28101327|NCT02993926|54757846|FG002|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
28101328|NCT02993926|54757844|FG000|Enantone Treatment Phase|Investigator Judgment|1|||
28101329|NCT02993926|54757845|FG001|Enantone Treatment Phase|Investigator Judgment|0|||
28101330|NCT02993926|54757846|FG002|Enantone Treatment Phase|Investigator Judgment|0|||
28101331|NCT02993926|54757844|FG000|Enantone Treatment Phase|Reason Not Specified|4|||
28101332|NCT02993926|54757845|FG001|Enantone Treatment Phase|Reason Not Specified|0|||
28101333|NCT02993926|54757846|FG002|Enantone Treatment Phase|Reason Not Specified|0|||
28101334|NCT02993224|54757856|FG000|Core Phase - Period 1|Adverse Event|4|||
28101335|NCT02993224|54757856|FG000|Core Phase - Period 1|Withdrawal by Subject|1|||
28101336|NCT02993224|54757856|FG000|Core Phase - Period 1|Lost to Follow-up|3|||
28101337|NCT02993224|54757856|FG000|Core Phase- Period 2|Adverse Event|1|||
28101338|NCT02993224|54757856|FG000|Core Phase- Period 2|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|2|||
28101339|NCT02993224|54757856|FG000|Core Phase- Period 2|Allogenic stem cell transplantation|1|||
28101340|NCT02993224|54757856|FG000|Extension Phase|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|1|||
28101341|NCT02993224|54757856|FG000|Extension Phase|Adverse Event|3|||
28101342|NCT02993224|54757856|FG000|Extension Phase|Withdrawal by Subject|3|||
28101343|NCT02993224|54757856|FG000|Extension Phase|Lost to Follow-up|2|||
28101344|NCT02993224|54757856|FG000|Extension Phase|Deferasirox FCT locally reimbursed|27|||
28005387|NCT00723528|54664282|FG002|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
28005388|NCT00723528|54664283|FG003|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
28101345|NCT03495908|54757864|FG000|Overall Study|Withdrawal by Subject|3|||
28005389|NCT00723528|54664284|FG004|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
28101346|NCT03495908|54757865|FG001|Overall Study|Withdrawal by Subject|1|||
28101347|NCT03495908|54757864|FG000|Overall Study|Lost to Follow-up|1|||
28101348|NCT03495908|54757865|FG001|Overall Study|Lost to Follow-up|4|||
28101349|NCT03495908|54757864|FG000|Overall Study|Adverse Event|0|||
28101350|NCT03495908|54757865|FG001|Overall Study|Adverse Event|2|||
28101351|NCT03495908|54757864|FG000|Overall Study|Death|1|||
28101352|NCT03495908|54757865|FG001|Overall Study|Death|0|||
28101353|NCT03495908|54757864|FG000|Overall Study|Physician Decision|5|||
28101354|NCT03495908|54757865|FG001|Overall Study|Physician Decision|4|||
28101355|NCT03495908|54757864|FG000|Overall Study|No documented reason|0|||
28101356|NCT03495908|54757865|FG001|Overall Study|No documented reason|2|||
28101357|NCT02992288|54757877|FG000|Overall Study|Adverse Event|8|||
28101358|NCT02992288|54757878|FG001|Overall Study|Adverse Event|2|||
28101359|NCT02992288|54757879|FG002|Overall Study|Adverse Event|2|||
28101360|NCT02992288|54757880|FG003|Overall Study|Adverse Event|2|||
28101361|NCT02992288|54757881|FG004|Overall Study|Adverse Event|2|||
28101362|NCT02992288|54757882|FG005|Overall Study|Adverse Event|7|||
28101363|NCT02992288|54757877|FG000|Overall Study|Non-compliance with study drug|0|||
28101364|NCT02992288|54757878|FG001|Overall Study|Non-compliance with study drug|1|||
28101365|NCT02992288|54757879|FG002|Overall Study|Non-compliance with study drug|1|||
28101366|NCT02992288|54757880|FG003|Overall Study|Non-compliance with study drug|0|||
28101367|NCT02992288|54757881|FG004|Overall Study|Non-compliance with study drug|1|||
28101368|NCT02992288|54757882|FG005|Overall Study|Non-compliance with study drug|0|||
28101369|NCT02992288|54757877|FG000|Overall Study|Physician Decision|3|||
28101370|NCT02992288|54757878|FG001|Overall Study|Physician Decision|0|||
28101371|NCT02992288|54757879|FG002|Overall Study|Physician Decision|1|||
28101372|NCT02992288|54757880|FG003|Overall Study|Physician Decision|0|||
28172789|NCT02576847|54844519|FG000|Overall Study|Lost to Follow-up|22|||
28005390|NCT00723528|54664285|FG005|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
28005391|NCT00723528|54664286|FG006|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1|||
28005392|NCT00751790|54664302|FG000|Overall Study|Lost to Follow-up|1|||
28005393|NCT00751790|54664302|FG000|Overall Study|Death|3|||
28005394|NCT00751790|54664302|FG000|Overall Study|Withdrawal by Subject|1|||
28005395|NCT00723450|54664308|FG000|Open-Label Phase|Adverse Event|26|||
28005396|NCT00723450|54664309|FG001|Open-Label Phase|Adverse Event|0|||
28005397|NCT00723450|54664310|FG002|Open-Label Phase|Adverse Event|0|||
28005398|NCT00723450|54664308|FG000|Open-Label Phase|Lack of Efficacy|18|||
28005399|NCT00723450|54664309|FG001|Open-Label Phase|Lack of Efficacy|0|||
28005400|NCT00723450|54664310|FG002|Open-Label Phase|Lack of Efficacy|0|||
28005401|NCT00723450|54664308|FG000|Open-Label Phase|Protocol Violation|35|||
28005402|NCT00723450|54664309|FG001|Open-Label Phase|Protocol Violation|0|||
28005403|NCT00723450|54664310|FG002|Open-Label Phase|Protocol Violation|0|||
28005404|NCT00723450|54664308|FG000|Open-Label Phase|Lost to Follow-up|7|||
28005405|NCT00723450|54664309|FG001|Open-Label Phase|Lost to Follow-up|0|||
28101373|NCT02992288|54757881|FG004|Overall Study|Physician Decision|0|||
28101374|NCT02992288|54757882|FG005|Overall Study|Physician Decision|1|||
28101375|NCT02992288|54757877|FG000|Overall Study|Death|2|||
28101376|NCT02992288|54757878|FG001|Overall Study|Death|0|||
28101377|NCT02992288|54757879|FG002|Overall Study|Death|2|||
28172790|NCT02576847|54844519|FG000|Overall Study|Physician Decision|1|||
28005406|NCT00723450|54664310|FG002|Open-Label Phase|Lost to Follow-up|0|||
28005407|NCT00723450|54664308|FG000|Open-Label Phase|Physician Decision|2|||
28005408|NCT00723450|54664309|FG001|Open-Label Phase|Physician Decision|0|||
28005409|NCT00723450|54664310|FG002|Open-Label Phase|Physician Decision|0|||
28005410|NCT00723450|54664308|FG000|Open-Label Phase|Withdrawal by Subject|37|||
28005411|NCT00723450|54664309|FG001|Open-Label Phase|Withdrawal by Subject|0|||
28005412|NCT00723450|54664310|FG002|Open-Label Phase|Withdrawal by Subject|0|||
28005413|NCT00723450|54664308|FG000|Randomized Phase|Adverse Event|0|||
28005414|NCT00723450|54664309|FG001|Randomized Phase|Adverse Event|26|||
28005415|NCT00723450|54664310|FG002|Randomized Phase|Adverse Event|17|||
28101378|NCT02992288|54757880|FG003|Overall Study|Death|1|||
28101379|NCT02992288|54757881|FG004|Overall Study|Death|2|||
28101380|NCT02992288|54757882|FG005|Overall Study|Death|0|||
28101381|NCT02992288|54757877|FG000|Overall Study|Lost to Follow-up|0|||
28101382|NCT02992288|54757878|FG001|Overall Study|Lost to Follow-up|0|||
28101383|NCT02992288|54757879|FG002|Overall Study|Lost to Follow-up|0|||
28101384|NCT02992288|54757880|FG003|Overall Study|Lost to Follow-up|1|||
28101385|NCT02992288|54757881|FG004|Overall Study|Lost to Follow-up|0|||
28101386|NCT02992288|54757882|FG005|Overall Study|Lost to Follow-up|0|||
28101387|NCT02992288|54757877|FG000|Overall Study|Protocol Violation|0|||
28101388|NCT02992288|54757878|FG001|Overall Study|Protocol Violation|0|||
28101389|NCT02992288|54757879|FG002|Overall Study|Protocol Violation|0|||
28101390|NCT02992288|54757880|FG003|Overall Study|Protocol Violation|0|||
28101391|NCT02992288|54757881|FG004|Overall Study|Protocol Violation|0|||
28101392|NCT02992288|54757882|FG005|Overall Study|Protocol Violation|1|||
28101393|NCT02992288|54757877|FG000|Overall Study|Withdrawal by Subject|4|||
28101394|NCT02992288|54757878|FG001|Overall Study|Withdrawal by Subject|2|||
28101395|NCT02992288|54757879|FG002|Overall Study|Withdrawal by Subject|1|||
28101396|NCT02992288|54757880|FG003|Overall Study|Withdrawal by Subject|5|||
28101397|NCT02992288|54757881|FG004|Overall Study|Withdrawal by Subject|3|||
28101398|NCT02992288|54757882|FG005|Overall Study|Withdrawal by Subject|4|||
28101399|NCT02953262|54757900|FG000|Overall Study|Used portal during 6 months prior to randomization|3|||
27916902|NCT01172938|54574536|FG001|Active-Treatment Phase Weeks (104-156)|Death|0|||
27916903|NCT01172938|54574537|FG002|Active-Treatment Phase Weeks (104-156)|Death|0|||
27916904|NCT01172938|54574538|FG003|Active-Treatment Phase Weeks (104-156)|Death|0|||
27916905|NCT01172938|54574539|FG004|Active-Treatment Phase Weeks (104-156)|Death|0|||
27916906|NCT01172938|54574540|FG005|Active-Treatment Phase Weeks (104-156)|Death|0|||
27916907|NCT01172938|54574541|FG006|Active-Treatment Phase Weeks (104-156)|Death|0|||
27916908|NCT01172938|54574542|FG007|Active-Treatment Phase Weeks (104-156)|Death|1|||
28005416|NCT00723450|54664308|FG000|Randomized Phase|Lack of Efficacy|0|||
28005417|NCT00723450|54664309|FG001|Randomized Phase|Lack of Efficacy|11|||
28005418|NCT00723450|54664310|FG002|Randomized Phase|Lack of Efficacy|11|||
28005419|NCT00723450|54664308|FG000|Randomized Phase|Protocol Violation|0|||
28005420|NCT00723450|54664309|FG001|Randomized Phase|Protocol Violation|9|||
28005421|NCT00723450|54664310|FG002|Randomized Phase|Protocol Violation|13|||
28005422|NCT00723450|54664308|FG000|Randomized Phase|Lost to Follow-up|0|||
28101400|NCT02953262|54757901|FG001|Overall Study|Used portal during 6 months prior to randomization|6|||
28101401|NCT02953262|54757902|FG002|Overall Study|Used portal during 6 months prior to randomization|3|||
28101402|NCT02953262|54757903|FG003|Overall Study|Used portal during 6 months prior to randomization|3|||
28101403|NCT02992132|54757920|FG000|Overall Study|Adverse Event|4|||
28101404|NCT02992132|54757921|FG001|Overall Study|Adverse Event|1|||
28101405|NCT02992132|54757922|FG002|Overall Study|Adverse Event|3|||
28101406|NCT02992132|54757920|FG000|Overall Study|Lack of Efficacy|2|||
27916909|NCT01172938|54574543|FG008|Active-Treatment Phase Weeks (104-156)|Death|0|||
27916910|NCT01172938|54574535|FG000|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
27916911|NCT01172938|54574536|FG001|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1|||
27916912|NCT01172938|54574537|FG002|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
27916913|NCT01172938|54574538|FG003|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
27916914|NCT01172938|54574539|FG004|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
27916915|NCT01172938|54574540|FG005|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
27916916|NCT01172938|54574541|FG006|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
27916917|NCT01172938|54574542|FG007|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
27916918|NCT01172938|54574543|FG008|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
27916919|NCT01172938|54574535|FG000|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
27916920|NCT01172938|54574536|FG001|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
27916921|NCT01172938|54574537|FG002|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2|||
27916922|NCT01172938|54574538|FG003|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
27916923|NCT01172938|54574539|FG004|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
28005423|NCT00723450|54664309|FG001|Randomized Phase|Lost to Follow-up|2|||
28005424|NCT00723450|54664310|FG002|Randomized Phase|Lost to Follow-up|3|||
28005425|NCT00723450|54664308|FG000|Randomized Phase|Physician Decision|0|||
28005426|NCT00723450|54664309|FG001|Randomized Phase|Physician Decision|3|||
28005427|NCT00723450|54664310|FG002|Randomized Phase|Physician Decision|1|||
28101407|NCT02992132|54757921|FG001|Overall Study|Lack of Efficacy|0|||
28101408|NCT02992132|54757922|FG002|Overall Study|Lack of Efficacy|0|||
28101409|NCT02992132|54757920|FG000|Overall Study|Non-compliance with study drug|2|||
28101410|NCT02992132|54757921|FG001|Overall Study|Non-compliance with study drug|0|||
28101411|NCT02992132|54757922|FG002|Overall Study|Non-compliance with study drug|0|||
28101412|NCT02992132|54757920|FG000|Overall Study|Progressive disease|1|||
28101413|NCT02992132|54757921|FG001|Overall Study|Progressive disease|0|||
28101414|NCT02992132|54757922|FG002|Overall Study|Progressive disease|0|||
28101415|NCT02992132|54757920|FG000|Overall Study|Protocol Violation|2|||
28101416|NCT02992132|54757921|FG001|Overall Study|Protocol Violation|2|||
28101417|NCT02992132|54757922|FG002|Overall Study|Protocol Violation|0|||
28101418|NCT02992132|54757920|FG000|Overall Study|Caregiver withdrew consent|2|||
28101419|NCT02992132|54757921|FG001|Overall Study|Caregiver withdrew consent|3|||
28101420|NCT02992132|54757922|FG002|Overall Study|Caregiver withdrew consent|2|||
28101421|NCT02992132|54757920|FG000|Overall Study|Withdrawal by Subject|0|||
28101422|NCT02992132|54757921|FG001|Overall Study|Withdrawal by Subject|2|||
28101423|NCT02992132|54757922|FG002|Overall Study|Withdrawal by Subject|1|||
28101424|NCT02992132|54757920|FG000|Overall Study|Physician Decision|0|||
28101425|NCT02992132|54757921|FG001|Overall Study|Physician Decision|0|||
28101426|NCT02992132|54757922|FG002|Overall Study|Physician Decision|1|||
28101427|NCT03444584|54757932|FG000|Overall Study|Withdrawal by Subject|0|||
28101428|NCT03444584|54757933|FG001|Overall Study|Withdrawal by Subject|1|||
28101429|NCT03444584|54757932|FG000|Overall Study|Other|0|||
28101430|NCT03444584|54757933|FG001|Overall Study|Other|1|||
28101431|NCT02989168|54757942|FG000|Overall Study|Withdrawal by Subject|2|||
28101432|NCT02989168|54757943|FG001|Overall Study|Withdrawal by Subject|0|||
28101433|NCT02989168|54757942|FG000|Overall Study|Physician Decision|0|||
28101434|NCT02989168|54757943|FG001|Overall Study|Physician Decision|1|||
28101435|NCT02989168|54757942|FG000|Overall Study|Adverse Event|1|||
28101436|NCT02989168|54757943|FG001|Overall Study|Adverse Event|2|||
28101437|NCT02989168|54757942|FG000|Overall Study|Sponsor stopped study.|1|||
28101438|NCT02989168|54757943|FG001|Overall Study|Sponsor stopped study.|0|||
28101439|NCT02988622|54757951|FG000|Overall Study|Lost to Follow-up|17|||
28101440|NCT03412604|54757957|FG000|Overall Study|Withdrawal by Subject|1|||
28101441|NCT02991430|54757964|FG000|Treatment Period 1|Adverse Event|1|||
28101442|NCT02991430|54757965|FG001|Treatment Period 1|Adverse Event|0|||
28101443|NCT02991430|54757966|FG002|Treatment Period 1|Adverse Event|2|||
28101444|NCT02991430|54757964|FG000|Treatment Period 1|Withdrawal by Subject|0|||
28101445|NCT02991430|54757965|FG001|Treatment Period 1|Withdrawal by Subject|4|||
28101446|NCT02991430|54757966|FG002|Treatment Period 1|Withdrawal by Subject|0|||
28101447|NCT02991430|54757964|FG000|Treatment Period 2|Study Termination|6|||
28101448|NCT02991430|54757965|FG001|Treatment Period 2|Study Termination|3|||
28101449|NCT02991430|54757966|FG002|Treatment Period 2|Study Termination|3|||
28101450|NCT02991430|54757964|FG000|Treatment Period 2|Lost to Follow-up|0|||
28101451|NCT02991430|54757965|FG001|Treatment Period 2|Lost to Follow-up|0|||
28172791|NCT02576847|54844519|FG000|Overall Study|Pregnancy|1|||
28172792|NCT02576847|54844519|FG000|Overall Study|Protocol Violation|3|||
28172793|NCT02576847|54844519|FG000|Overall Study|Withdrawal by Subject|78|||
28172794|NCT02576847|54844519|FG000|Overall Study|Other|5|||
28172795|NCT02135029|54844535|FG000|Overall Study|Adverse Event|2|||
28172796|NCT02135029|54844536|FG001|Overall Study|Adverse Event|2|||
28172797|NCT02135029|54844537|FG002|Overall Study|Adverse Event|2|||
28172798|NCT02135029|54844535|FG000|Overall Study|Lost to Follow-up|0|||
28172799|NCT02135029|54844536|FG001|Overall Study|Lost to Follow-up|1|||
28172800|NCT02135029|54844537|FG002|Overall Study|Lost to Follow-up|0|||
28172801|NCT02135029|54844535|FG000|Overall Study|Withdrawal by Subject|2|||
28172802|NCT02135029|54844536|FG001|Overall Study|Withdrawal by Subject|0|||
28172803|NCT02135029|54844537|FG002|Overall Study|Withdrawal by Subject|1|||
28172804|NCT02135029|54844535|FG000|Overall Study|Other|0|||
28172805|NCT02135029|54844536|FG001|Overall Study|Other|1|||
28172806|NCT02135029|54844537|FG002|Overall Study|Other|0|||
28172807|NCT02135029|54844535|FG000|Overall Study|Death|0|||
27739934|NCT02786537|54189678|FG001|As Randomized|HCV drugs stolen from pt|1|||
27916924|NCT01172938|54574540|FG005|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
28101452|NCT02991430|54757966|FG002|Treatment Period 2|Lost to Follow-up|1|||
28101453|NCT02991430|54757964|FG000|Post-treatment Observation Period|Study Termination|3|||
28101454|NCT02991430|54757965|FG001|Post-treatment Observation Period|Study Termination|6|||
28101455|NCT02991430|54757966|FG002|Post-treatment Observation Period|Study Termination|5|||
28101456|NCT03411902|54757976|FG000|Overall Study|Lost to Follow-up|3|||
28101457|NCT03411902|54757977|FG001|Overall Study|Lost to Follow-up|0|||
28101458|NCT03494816|54757983|FG000|Overall Study|Protocol Violation|2|||
28101459|NCT03494816|54757983|FG000|Overall Study|Physician Decision|2|||
28101460|NCT03494816|54757983|FG000|Overall Study|Did not start trial treatment|1|||
28172808|NCT02135029|54844536|FG001|Overall Study|Death|1|||
28172809|NCT02135029|54844537|FG002|Overall Study|Death|0|||
28172810|NCT02842151|54844546|FG000|Overall Study|Adverse Event|1|||
28172811|NCT02842151|54844546|FG000|Overall Study|Subject moved too far away|1|||
28172812|NCT02842073|54844552|FG000|Overall Study|Withdrawal by Subject|1|||
28172813|NCT02784535|54844556|FG000|Overall Study|Adverse Event|1|||
28101461|NCT03494816|54757983|FG000|Overall Study|Adverse Event|1|||
28101462|NCT03492554|54757993|FG000|Overall Study|Protocol Violation|0|||
28101463|NCT03492554|54757994|FG001|Overall Study|Protocol Violation|14|||
28101464|NCT03443414|54758006|FG000|Overall Study|Adverse Event|6|||
28101465|NCT03443414|54758007|FG001|Overall Study|Adverse Event|0|||
28101466|NCT03443414|54758008|FG002|Overall Study|Adverse Event|4|||
28101467|NCT03443414|54758009|FG003|Overall Study|Adverse Event|2|||
28101468|NCT03443414|54758010|FG004|Overall Study|Adverse Event|3|||
28101469|NCT03443414|54758006|FG000|Overall Study|Withdrawal by Subject|3|||
28101470|NCT03443414|54758007|FG001|Overall Study|Withdrawal by Subject|2|||
28101471|NCT03443414|54758008|FG002|Overall Study|Withdrawal by Subject|2|||
28101472|NCT03443414|54758009|FG003|Overall Study|Withdrawal by Subject|2|||
28101473|NCT03443414|54758010|FG004|Overall Study|Withdrawal by Subject|1|||
28101474|NCT03443414|54758006|FG000|Overall Study|Death|0|||
28101475|NCT03443414|54758007|FG001|Overall Study|Death|1|||
28101476|NCT03443414|54758008|FG002|Overall Study|Death|0|||
28101477|NCT03443414|54758009|FG003|Overall Study|Death|1|||
28101478|NCT03443414|54758010|FG004|Overall Study|Death|0|||
28101479|NCT03443414|54758006|FG000|Overall Study|Reason not specified|2|||
28101480|NCT03443414|54758007|FG001|Overall Study|Reason not specified|0|||
28101481|NCT03443414|54758008|FG002|Overall Study|Reason not specified|0|||
28101482|NCT03443414|54758009|FG003|Overall Study|Reason not specified|0|||
28101483|NCT03443414|54758010|FG004|Overall Study|Reason not specified|1|||
28101484|NCT02991118|54758024|FG000|Overall Study|Death|3|||
28101485|NCT02991118|54758025|FG001|Overall Study|Death|8|||
28101486|NCT02991118|54758024|FG000|Overall Study|Protocol Violation|0|||
28101487|NCT02991118|54758025|FG001|Overall Study|Protocol Violation|3|||
28101488|NCT02991118|54758024|FG000|Overall Study|Physician Decision|0|||
28101489|NCT02991118|54758025|FG001|Overall Study|Physician Decision|1|||
28101490|NCT02991118|54758024|FG000|Overall Study|Moved out of the country|0|||
28101491|NCT02991118|54758025|FG001|Overall Study|Moved out of the country|1|||
28101492|NCT02991118|54758024|FG000|Overall Study|Adverse Event|2|||
28101493|NCT02991118|54758025|FG001|Overall Study|Adverse Event|2|||
28101494|NCT02991118|54758024|FG000|Overall Study|Withdrawal by Subject|1|||
28101495|NCT02991118|54758025|FG001|Overall Study|Withdrawal by Subject|7|||
28101496|NCT02991118|54758024|FG000|Overall Study|Could not attend study visits|0|||
28101497|NCT02991118|54758025|FG001|Overall Study|Could not attend study visits|1|||
28101498|NCT02991118|54758024|FG000|Overall Study|Lost to Follow-up|1|||
28101499|NCT02991118|54758025|FG001|Overall Study|Lost to Follow-up|9|||
28101500|NCT03491150|54758033|FG000|Overall Study|Adverse Event|1|||
28101501|NCT03491150|54758034|FG001|Overall Study|Adverse Event|0|||
28101502|NCT03491150|54758033|FG000|Overall Study|Study Terminated by Sponsor|74|||
28101503|NCT03491150|54758034|FG001|Overall Study|Study Terminated by Sponsor|70|||
28101504|NCT03491150|54758033|FG000|Overall Study|Other|0|||
28101505|NCT03491150|54758034|FG001|Overall Study|Other|1|||
28101506|NCT03491150|54758033|FG000|Overall Study|Withdrawal by Subject|1|||
28101507|NCT03491150|54758034|FG001|Overall Study|Withdrawal by Subject|2|||
28101508|NCT02991040|54758040|FG000|Overall Study|Withdrawal by Subject|2|||
28101509|NCT02991040|54758040|FG000|Overall Study|Lost to Follow-up|2|||
28101510|NCT02910466|54758046|FG000|Overall Study|Adverse Event|1|||
28101511|NCT02910466|54758046|FG000|Overall Study|Withdrawal by Subject|3|||
28101512|NCT02910466|54758046|FG000|Overall Study|Lost to Follow-up|5|||
28101513|NCT02910466|54758046|FG000|Overall Study|Due to Food and Drug Administration (FDA) recall|29|||
28101514|NCT02910466|54758046|FG000|Overall Study|Participant didn't meet inclusion criteria|1|||
28101515|NCT03415178|54758052|FG000|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0|||
28101516|NCT03415178|54758053|FG001|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2|||
28101517|NCT03415178|54758052|FG000|Single Arm Period (up to Week 16)|Adverse Event|0|||
28101518|NCT03415178|54758053|FG001|Single Arm Period (up to Week 16)|Adverse Event|1|||
28101519|NCT01068730|54758063|FG000|Period 3|Personal reason|1|||
28101520|NCT01068730|54758064|FG001|Period 3|Personal reason|0|||
28101521|NCT01068730|54758065|FG002|Period 3|Personal reason|0|||
28101522|NCT01068730|54758066|FG003|Period 3|Personal reason|0|||
28101523|NCT01068730|54758063|FG000|Period 4|Family emergency|0|||
28101524|NCT01068730|54758064|FG001|Period 4|Family emergency|1|||
28101525|NCT01068730|54758065|FG002|Period 4|Family emergency|0|||
28101526|NCT01068730|54758066|FG003|Period 4|Family emergency|0|||
28101527|NCT01068652|54758085|FG000|Overall Study|Adverse Event|4|||
28101528|NCT01068652|54758086|FG001|Overall Study|Adverse Event|0|||
27916925|NCT01172938|54574541|FG006|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
28101529|NCT01068652|54758085|FG000|Overall Study|Lack of Efficacy|0|||
28101530|NCT01068652|54758086|FG001|Overall Study|Lack of Efficacy|2|||
28101531|NCT01068652|54758085|FG000|Overall Study|Lost to Follow-up|2|||
28101532|NCT01068652|54758086|FG001|Overall Study|Lost to Follow-up|1|||
28101533|NCT01068652|54758085|FG000|Overall Study|Protocol Violation|3|||
28101534|NCT01068652|54758086|FG001|Overall Study|Protocol Violation|6|||
28101535|NCT01068652|54758085|FG000|Overall Study|Withdrawal criteria|1|||
28101536|NCT01068652|54758086|FG001|Overall Study|Withdrawal criteria|2|||
28101537|NCT01068652|54758085|FG000|Overall Study|Patient was not eligible|1|||
28101538|NCT01068652|54758086|FG001|Overall Study|Patient was not eligible|0|||
27916926|NCT01172938|54574542|FG007|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
27916927|NCT01172938|54574543|FG008|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
27916928|NCT01172938|54574535|FG000|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
28005428|NCT00723450|54664308|FG000|Randomized Phase|Withdrawal by Subject|0|||
28005429|NCT00723450|54664309|FG001|Randomized Phase|Withdrawal by Subject|14|||
28005430|NCT00723450|54664310|FG002|Randomized Phase|Withdrawal by Subject|22|||
28005431|NCT00751400|54664319|FG000|Overall Study|Lost to Follow-up|10|||
28005432|NCT00585312|54664325|FG000|Overall Study|Adverse Event|3|||
28005433|NCT00585312|54664326|FG001|Overall Study|Adverse Event|0|||
28005434|NCT00585312|54664325|FG000|Overall Study|Lack of Efficacy|6|||
28005435|NCT00585312|54664326|FG001|Overall Study|Lack of Efficacy|11|||
28005436|NCT00585312|54664325|FG000|Overall Study|Lost to Follow-up|1|||
28005437|NCT00585312|54664326|FG001|Overall Study|Lost to Follow-up|1|||
28005438|NCT00585312|54664325|FG000|Overall Study|Reason not specified|2|||
28005439|NCT00585312|54664326|FG001|Overall Study|Reason not specified|0|||
28005440|NCT00585312|54664325|FG000|Overall Study|Withdrawal by Subject|5|||
28005441|NCT00585312|54664326|FG001|Overall Study|Withdrawal by Subject|1|||
28005442|NCT00585312|54664325|FG000|Overall Study|Study terminated by the sponsor|34|||
28005443|NCT00585312|54664326|FG001|Overall Study|Study terminated by the sponsor|31|||
28005444|NCT00753506|54664334|FG000|Overall Study|Withdrawal by Subject|4|||
28005445|NCT00753506|54664335|FG001|Overall Study|Withdrawal by Subject|1|||
28005446|NCT00753506|54664334|FG000|Overall Study|Lost to Follow-up|2|||
28005447|NCT00753506|54664335|FG001|Overall Study|Lost to Follow-up|0|||
28005448|NCT00753506|54664334|FG000|Overall Study|Other reason|1|||
28005449|NCT00753506|54664335|FG001|Overall Study|Other reason|1|||
28005450|NCT00720096|54664343|FG000|Overall Study|Withdrawal by Subject|0|||
28005451|NCT00720096|54664344|FG001|Overall Study|Withdrawal by Subject|2|||
28005452|NCT00723294|54664350|FG000|Overall Study|Lobular histology|2|||
28005453|NCT00723294|54664350|FG000|Overall Study|>25% intraductal component|1|||
28005454|NCT00723294|54664350|FG000|Overall Study|No MRI tumor enhancement|1|||
28005455|NCT00723294|54664350|FG000|Overall Study|1.0-Tesla MRI|1|||
28005456|NCT00723294|54664350|FG000|Overall Study|No cryoabalation|2|||
28005457|NCT00723294|54664350|FG000|Overall Study|Did not undergo surgery|1|||
28005458|NCT00723294|54664350|FG000|Overall Study|Treated prior to registration|1|||
28005459|NCT00723294|54664350|FG000|Overall Study|Treated by non-credentialed surgeon|1|||
28005460|NCT00723294|54664350|FG000|Overall Study|Benign lesion|1|||
28005461|NCT00723294|54664350|FG000|Overall Study|Withdrawal by Subject|1|||
28005462|NCT00723294|54664350|FG000|Overall Study|No treatment due to probe failure|1|||
28005463|NCT00747344|54664356|FG000|Controlled Period|Adverse Event|3|||
28005464|NCT00747344|54664357|FG001|Controlled Period|Adverse Event|0|||
28005465|NCT00747344|54664358|FG002|Controlled Period|Adverse Event|0|||
28005466|NCT00747344|54664359|FG003|Controlled Period|Adverse Event|0|||
28005467|NCT00747344|54664356|FG000|Controlled Period|Lack of Efficacy|2|||
28005468|NCT00747344|54664357|FG001|Controlled Period|Lack of Efficacy|1|||
28005469|NCT00747344|54664358|FG002|Controlled Period|Lack of Efficacy|0|||
28005470|NCT00747344|54664359|FG003|Controlled Period|Lack of Efficacy|0|||
28005471|NCT00747344|54664356|FG000|Controlled Period|Other|0|||
28005472|NCT00747344|54664357|FG001|Controlled Period|Other|3|||
28005473|NCT00747344|54664358|FG002|Controlled Period|Other|0|||
28005474|NCT00747344|54664359|FG003|Controlled Period|Other|0|||
28005475|NCT00747344|54664356|FG000|After Controlled Period|Adverse Event|0|||
28005476|NCT00747344|54664357|FG001|After Controlled Period|Adverse Event|0|||
28005477|NCT00747344|54664358|FG002|After Controlled Period|Adverse Event|0|||
28005478|NCT00747344|54664359|FG003|After Controlled Period|Adverse Event|1|||
27916929|NCT01172938|54574536|FG001|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4|||
27916930|NCT01172938|54574537|FG002|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1|||
27916931|NCT01172938|54574538|FG003|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
27916932|NCT01172938|54574539|FG004|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
27916933|NCT01172938|54574540|FG005|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
28005479|NCT00580983|54664367|FG000|Overall Study|Did not complete 12 mon post RT studies|7|||
28005480|NCT00753896|54664371|FG000|Overall Study|Adverse Event|4|||
28005481|NCT00753896|54664371|FG000|Overall Study|Death|1|||
28005482|NCT00753896|54664371|FG000|Overall Study|Lost to Follow-up|2|||
28005483|NCT00753896|54664371|FG000|Overall Study|Protocol Violation|1|||
28005484|NCT00753896|54664371|FG000|Overall Study|Withdrawal by Subject|4|||
28005485|NCT00753896|54664371|FG000|Overall Study|Entry Criteria Not Met|4|||
28005486|NCT00716976|54664377|FG000|Overall Study|Adverse Event|2|||
28005487|NCT00716976|54664378|FG001|Overall Study|Adverse Event|0|||
28005488|NCT00716976|54664377|FG000|Overall Study|Death|1|||
28005489|NCT00716976|54664378|FG001|Overall Study|Death|0|||
28005490|NCT00716976|54664377|FG000|Overall Study|Physician Decision|2|||
28005491|NCT00716976|54664378|FG001|Overall Study|Physician Decision|2|||
28005492|NCT00716976|54664377|FG000|Overall Study|Withdrawal by Subject|5|||
28005493|NCT00716976|54664378|FG001|Overall Study|Withdrawal by Subject|1|||
28005494|NCT00716976|54664377|FG000|Overall Study|Premature discontinuation cisplatin|5|||
28005495|NCT00716976|54664378|FG001|Overall Study|Premature discontinuation cisplatin|4|||
28101539|NCT01068652|54758085|FG000|Overall Study|Unclassified|7|||
28101540|NCT01068652|54758086|FG001|Overall Study|Unclassified|4|||
28101541|NCT02921776|54758098|FG000|Overall Study|patient deterioration, fatigue|2|||
28101542|NCT02921776|54758099|FG001|Overall Study|patient deterioration, fatigue|6|||
28101543|NCT02921776|54758100|FG002|Overall Study|patient deterioration, fatigue|0|||
28101544|NCT02921776|54758101|FG003|Overall Study|patient deterioration, fatigue|0|||
28172814|NCT02784535|54844557|FG001|Overall Study|Adverse Event|0|||
28172815|NCT02784535|54844556|FG000|Overall Study|Withdrawal by Subject|0|||
28172816|NCT02784535|54844557|FG001|Overall Study|Withdrawal by Subject|1|||
28172817|NCT02784535|54844556|FG000|Overall Study|Physician Decision|0|||
28005496|NCT00716976|54664377|FG000|Overall Study|Radiation during protocol|1|||
28005497|NCT00716976|54664378|FG001|Overall Study|Radiation during protocol|0|||
28005498|NCT00716976|54664377|FG000|Overall Study|Ineligibles|4|||
28005499|NCT00716976|54664378|FG001|Overall Study|Ineligibles|2|||
28005500|NCT00743444|54664386|FG000|First Intervention|Catheter placement problems|0|||
28005501|NCT00743444|54664387|FG001|First Intervention|Catheter placement problems|1|||
28005502|NCT00743444|54664386|FG000|Washout Period|Adverse Event|0|||
28005503|NCT00743444|54664387|FG001|Washout Period|Adverse Event|1|||
28005504|NCT00743366|54664393|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
28005505|NCT00743366|54664394|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
28005506|NCT00721968|54664402|FG000|Overall Study|Lost to Follow-up|2|||
28005507|NCT00721968|54664403|FG001|Overall Study|Lost to Follow-up|0|||
28005508|NCT00743288|54664409|FG000|Overall Study|Adverse Event|1|||
28005509|NCT00743288|54664410|FG001|Overall Study|Adverse Event|1|||
28005510|NCT00743288|54664411|FG002|Overall Study|Adverse Event|2|||
28005511|NCT00743288|54664412|FG003|Overall Study|Adverse Event|2|||
28005512|NCT00743288|54664413|FG004|Overall Study|Adverse Event|1|||
28005513|NCT00743288|54664414|FG005|Overall Study|Adverse Event|1|||
28005514|NCT00743288|54664415|FG006|Overall Study|Adverse Event|2|||
28005515|NCT00743288|54664409|FG000|Overall Study|Withdrawal by Subject|0|||
28005516|NCT00743288|54664410|FG001|Overall Study|Withdrawal by Subject|0|||
28005517|NCT00743288|54664411|FG002|Overall Study|Withdrawal by Subject|1|||
28005518|NCT00743288|54664412|FG003|Overall Study|Withdrawal by Subject|0|||
28005519|NCT00743288|54664413|FG004|Overall Study|Withdrawal by Subject|0|||
28005520|NCT00743288|54664414|FG005|Overall Study|Withdrawal by Subject|1|||
28005521|NCT00743288|54664415|FG006|Overall Study|Withdrawal by Subject|1|||
28005522|NCT00743288|54664409|FG000|Overall Study|Progressive disease (PD)|2|||
28005523|NCT00743288|54664410|FG001|Overall Study|Progressive disease (PD)|0|||
28005524|NCT00743288|54664411|FG002|Overall Study|Progressive disease (PD)|1|||
28005525|NCT00743288|54664412|FG003|Overall Study|Progressive disease (PD)|4|||
28005526|NCT00743288|54664413|FG004|Overall Study|Progressive disease (PD)|5|||
28005527|NCT00743288|54664414|FG005|Overall Study|Progressive disease (PD)|3|||
28005528|NCT00743288|54664415|FG006|Overall Study|Progressive disease (PD)|6|||
28005529|NCT00743288|54664409|FG000|Overall Study|Worsening of condition (Not PD)|0|||
28005530|NCT00743288|54664410|FG001|Overall Study|Worsening of condition (Not PD)|2|||
28005531|NCT00743288|54664411|FG002|Overall Study|Worsening of condition (Not PD)|1|||
28005532|NCT00743288|54664412|FG003|Overall Study|Worsening of condition (Not PD)|1|||
28005533|NCT00743288|54664413|FG004|Overall Study|Worsening of condition (Not PD)|0|||
28005534|NCT00743288|54664414|FG005|Overall Study|Worsening of condition (Not PD)|0|||
28005535|NCT00743288|54664415|FG006|Overall Study|Worsening of condition (Not PD)|0|||
28005536|NCT00750308|54664426|FG000|First Treatment|Adverse Event|0|||
28005537|NCT00750308|54664427|FG001|First Treatment|Adverse Event|1|||
28005538|NCT00750308|54664428|FG002|First Treatment|Adverse Event|0|||
28005539|NCT00750308|54664429|FG003|First Treatment|Adverse Event|0|||
28005540|NCT00750308|54664430|FG004|First Treatment|Adverse Event|0|||
28005541|NCT00750308|54664431|FG005|First Treatment|Adverse Event|0|||
28005542|NCT00750308|54664432|FG006|First Treatment|Adverse Event|0|||
28005543|NCT00750308|54664433|FG007|First Treatment|Adverse Event|0|||
28005544|NCT00750308|54664434|FG008|First Treatment|Adverse Event|0|||
28005545|NCT00750308|54664435|FG009|First Treatment|Adverse Event|0|||
28005546|NCT00750308|54664436|FG010|First Treatment|Adverse Event|1|||
28005547|NCT00750308|54664437|FG011|First Treatment|Adverse Event|1|||
28101545|NCT02921776|54758102|FG004|Overall Study|patient deterioration, fatigue|0|||
28101546|NCT02921776|54758103|FG005|Overall Study|patient deterioration, fatigue|0|||
28101547|NCT02921776|54758104|FG006|Overall Study|patient deterioration, fatigue|0|||
28172818|NCT02784535|54844557|FG001|Overall Study|Physician Decision|1|||
28172819|NCT01367275|54844566|FG000|Overall Study|Ineligible|1|||
27916934|NCT01172938|54574541|FG006|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
27916935|NCT01172938|54574542|FG007|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3|||
27916936|NCT01172938|54574543|FG008|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
27916937|NCT01172938|54574535|FG000|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
27916938|NCT01172938|54574536|FG001|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
27916939|NCT01172938|54574537|FG002|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
27916940|NCT01172938|54574538|FG003|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
27916941|NCT01172938|54574539|FG004|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
28005548|NCT00750308|54664426|FG000|First Treatment|Withdrawal by Subject|0|||
28005549|NCT00750308|54664427|FG001|First Treatment|Withdrawal by Subject|0|||
28005550|NCT00750308|54664428|FG002|First Treatment|Withdrawal by Subject|0|||
28005551|NCT00750308|54664429|FG003|First Treatment|Withdrawal by Subject|1|||
28005552|NCT00750308|54664430|FG004|First Treatment|Withdrawal by Subject|0|||
28005553|NCT00750308|54664431|FG005|First Treatment|Withdrawal by Subject|0|||
28005554|NCT00750308|54664432|FG006|First Treatment|Withdrawal by Subject|0|||
28005555|NCT00750308|54664433|FG007|First Treatment|Withdrawal by Subject|1|||
28005556|NCT00750308|54664434|FG008|First Treatment|Withdrawal by Subject|0|||
28005557|NCT00750308|54664435|FG009|First Treatment|Withdrawal by Subject|0|||
28005558|NCT00750308|54664436|FG010|First Treatment|Withdrawal by Subject|0|||
28005559|NCT00750308|54664437|FG011|First Treatment|Withdrawal by Subject|0|||
28005560|NCT00750308|54664426|FG000|Second Treatment|Adverse Event|0|||
28005561|NCT00750308|54664427|FG001|Second Treatment|Adverse Event|0|||
28005562|NCT00750308|54664428|FG002|Second Treatment|Adverse Event|0|||
28005563|NCT00750308|54664429|FG003|Second Treatment|Adverse Event|0|||
28005564|NCT00750308|54664430|FG004|Second Treatment|Adverse Event|0|||
28005565|NCT00750308|54664431|FG005|Second Treatment|Adverse Event|1|||
28005566|NCT00750308|54664432|FG006|Second Treatment|Adverse Event|0|||
28005567|NCT00750308|54664433|FG007|Second Treatment|Adverse Event|0|||
28005568|NCT00750308|54664434|FG008|Second Treatment|Adverse Event|1|||
28005569|NCT00750308|54664435|FG009|Second Treatment|Adverse Event|0|||
28005570|NCT00750308|54664436|FG010|Second Treatment|Adverse Event|0|||
28005571|NCT00750308|54664437|FG011|Second Treatment|Adverse Event|0|||
28005572|NCT00750308|54664426|FG000|Second Treatment|Withdrawal by Subject|0|||
28005573|NCT00750308|54664427|FG001|Second Treatment|Withdrawal by Subject|0|||
28005574|NCT00750308|54664428|FG002|Second Treatment|Withdrawal by Subject|0|||
28005575|NCT00750308|54664429|FG003|Second Treatment|Withdrawal by Subject|0|||
28005576|NCT00750308|54664430|FG004|Second Treatment|Withdrawal by Subject|1|||
28005577|NCT00750308|54664431|FG005|Second Treatment|Withdrawal by Subject|0|||
28005578|NCT00750308|54664432|FG006|Second Treatment|Withdrawal by Subject|0|||
28005579|NCT00750308|54664433|FG007|Second Treatment|Withdrawal by Subject|0|||
28005580|NCT00750308|54664434|FG008|Second Treatment|Withdrawal by Subject|0|||
28005581|NCT00750308|54664435|FG009|Second Treatment|Withdrawal by Subject|0|||
28005582|NCT00750308|54664436|FG010|Second Treatment|Withdrawal by Subject|0|||
28005583|NCT00750308|54664437|FG011|Second Treatment|Withdrawal by Subject|0|||
28005584|NCT00750308|54664426|FG000|Third Treatment|Withdrawal by Subject|0|||
28005585|NCT00750308|54664427|FG001|Third Treatment|Withdrawal by Subject|1|||
28005586|NCT00750308|54664428|FG002|Third Treatment|Withdrawal by Subject|0|||
28005587|NCT00750308|54664429|FG003|Third Treatment|Withdrawal by Subject|0|||
28005588|NCT00750308|54664430|FG004|Third Treatment|Withdrawal by Subject|0|||
28005589|NCT00750308|54664431|FG005|Third Treatment|Withdrawal by Subject|0|||
28005590|NCT00750308|54664432|FG006|Third Treatment|Withdrawal by Subject|0|||
28005591|NCT00750308|54664433|FG007|Third Treatment|Withdrawal by Subject|0|||
28005592|NCT00750308|54664434|FG008|Third Treatment|Withdrawal by Subject|0|||
28005593|NCT00750308|54664435|FG009|Third Treatment|Withdrawal by Subject|0|||
28005594|NCT00750308|54664436|FG010|Third Treatment|Withdrawal by Subject|0|||
28005595|NCT00750308|54664437|FG011|Third Treatment|Withdrawal by Subject|0|||
28005596|NCT00750152|54664453|FG000|Overall Study|Adverse Event|2|||
28005597|NCT00750152|54664454|FG001|Overall Study|Adverse Event|1|||
28005598|NCT00750152|54664453|FG000|Overall Study|Lost to Follow-up|8|||
28005599|NCT00750152|54664454|FG001|Overall Study|Lost to Follow-up|13|||
28005600|NCT00750152|54664453|FG000|Overall Study|Withdrawal by Subject|3|||
28005601|NCT00750152|54664454|FG001|Overall Study|Withdrawal by Subject|3|||
28005602|NCT00750152|54664453|FG000|Overall Study|Physician Decision|1|||
28005603|NCT00750152|54664454|FG001|Overall Study|Physician Decision|1|||
28005604|NCT00750152|54664453|FG000|Overall Study|Non-compliance|0|||
28101548|NCT02921776|54758105|FG007|Overall Study|patient deterioration, fatigue|0|||
27916942|NCT01172938|54574540|FG005|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
27916943|NCT01172938|54574541|FG006|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
27916944|NCT01172938|54574542|FG007|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3|||
27916945|NCT01172938|54574543|FG008|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2|||
27916946|NCT01172938|54574535|FG000|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
27916947|NCT01172938|54574536|FG001|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
27916948|NCT01172938|54574537|FG002|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
28101549|NCT02921776|54758098|FG000|Overall Study|Withdrawal by Subject|0|||
28005605|NCT00750152|54664454|FG001|Overall Study|Non-compliance|1|||
28005606|NCT00750152|54664453|FG000|Overall Study|Termination by sponsor|1|||
28005607|NCT00750152|54664454|FG001|Overall Study|Termination by sponsor|0|||
28005608|NCT00750152|54664453|FG000|Overall Study|Other|7|||
28005609|NCT00750152|54664454|FG001|Overall Study|Other|8|||
28005610|NCT00749996|54664462|FG000|Overall Study|Lost to Follow-up|7|||
28005611|NCT00749996|54664463|FG001|Overall Study|Lost to Follow-up|4|||
28005612|NCT00749996|54664462|FG000|Overall Study|Withdrawal by Subject|5|||
28005613|NCT00749996|54664463|FG001|Overall Study|Withdrawal by Subject|4|||
28005614|NCT00749996|54664462|FG000|Overall Study|Protocol Violation|2|||
28005615|NCT00749996|54664463|FG001|Overall Study|Protocol Violation|3|||
28005616|NCT00749996|54664462|FG000|Overall Study|Physician Decision|2|||
28005617|NCT00749996|54664463|FG001|Overall Study|Physician Decision|0|||
28005618|NCT00749996|54664462|FG000|Overall Study|Pregnancy|0|||
28005619|NCT00749996|54664463|FG001|Overall Study|Pregnancy|2|||
28005620|NCT00749996|54664462|FG000|Overall Study|Adverse Event|1|||
28005621|NCT00749996|54664463|FG001|Overall Study|Adverse Event|0|||
28005622|NCT00749996|54664462|FG000|Overall Study|Death|1|||
28005623|NCT00749996|54664463|FG001|Overall Study|Death|0|||
28005624|NCT00749684|54664469|FG000|Overall Study|Death|1|||
28005625|NCT00749684|54664469|FG000|Overall Study|Adverse Event|27|||
28005626|NCT00749684|54664469|FG000|Overall Study|Participant's Wish|10|||
28005627|NCT00749684|54664469|FG000|Overall Study|Not Documented|1|||
28005628|NCT00749684|54664469|FG000|Overall Study|Progressive Desease|31|||
28005629|NCT00749684|54664469|FG000|Overall Study|Therapy according to protocol + AE|2|||
28005630|NCT00749684|54664469|FG000|Overall Study|AE+discontinuation on participants wish|1|||
28005631|NCT00749684|54664469|FG000|Overall Study|Missing|9|||
28005632|NCT00746798|54664477|FG000|Overall Study|Protocol Violation|0|||
28005633|NCT00746798|54664478|FG001|Overall Study|Protocol Violation|1|||
28005634|NCT00746798|54664479|FG002|Overall Study|Protocol Violation|0|||
28005635|NCT00746798|54664480|FG003|Overall Study|Protocol Violation|0|||
28005636|NCT00746798|54664477|FG000|Overall Study|Withdrawal by Subject|0|||
28005637|NCT00746798|54664478|FG001|Overall Study|Withdrawal by Subject|1|||
28005638|NCT00746798|54664479|FG002|Overall Study|Withdrawal by Subject|1|||
28005639|NCT00746798|54664480|FG003|Overall Study|Withdrawal by Subject|0|||
28005640|NCT00746798|54664477|FG000|Overall Study|Death|0|||
28005641|NCT00746798|54664478|FG001|Overall Study|Death|0|||
28005642|NCT00746798|54664479|FG002|Overall Study|Death|2|||
28005643|NCT00746798|54664480|FG003|Overall Study|Death|0|||
28005644|NCT00746798|54664477|FG000|Overall Study|Participant unable to return for visit|1|||
28005645|NCT00746798|54664478|FG001|Overall Study|Participant unable to return for visit|0|||
28005646|NCT00746798|54664479|FG002|Overall Study|Participant unable to return for visit|0|||
28005647|NCT00746798|54664480|FG003|Overall Study|Participant unable to return for visit|0|||
28005648|NCT00716274|54664493|FG000|Study Period II (16-Weeks)|Entry Criteria Not Met|2|||
28005649|NCT00716274|54664494|FG001|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
28005650|NCT00716274|54664495|FG002|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
28005651|NCT00716274|54664496|FG003|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
28005652|NCT00716274|54664497|FG004|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
28005653|NCT00716274|54664498|FG005|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
28005654|NCT00716274|54664493|FG000|Study Period II (16-Weeks)|Protocol Violation|0|||
28005655|NCT00716274|54664494|FG001|Study Period II (16-Weeks)|Protocol Violation|3|||
28005656|NCT00716274|54664495|FG002|Study Period II (16-Weeks)|Protocol Violation|0|||
28005657|NCT00716274|54664496|FG003|Study Period II (16-Weeks)|Protocol Violation|0|||
28005658|NCT00716274|54664497|FG004|Study Period II (16-Weeks)|Protocol Violation|0|||
28005659|NCT00716274|54664498|FG005|Study Period II (16-Weeks)|Protocol Violation|1|||
28005660|NCT00716274|54664493|FG000|Study Period II (16-Weeks)|Withdrawal by Subject|1|||
28005661|NCT00716274|54664494|FG001|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
28005662|NCT00716274|54664495|FG002|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
28005663|NCT00716274|54664496|FG003|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
28005664|NCT00716274|54664497|FG004|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
28005665|NCT00716274|54664498|FG005|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
28005666|NCT00716274|54664493|FG000|Study Period II (16-Weeks)|Physician Decision|3|||
28005667|NCT00716274|54664494|FG001|Study Period II (16-Weeks)|Physician Decision|1|||
28005668|NCT00716274|54664495|FG002|Study Period II (16-Weeks)|Physician Decision|0|||
28005669|NCT00716274|54664496|FG003|Study Period II (16-Weeks)|Physician Decision|0|||
28005670|NCT00716274|54664497|FG004|Study Period II (16-Weeks)|Physician Decision|0|||
28005671|NCT00716274|54664498|FG005|Study Period II (16-Weeks)|Physician Decision|1|||
28005672|NCT00716274|54664493|FG000|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
28005673|NCT00716274|54664494|FG001|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
28005674|NCT00716274|54664495|FG002|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
28005675|NCT00716274|54664496|FG003|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
28005676|NCT00716274|54664497|FG004|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
28101550|NCT02921776|54758099|FG001|Overall Study|Withdrawal by Subject|2|||
28101551|NCT02921776|54758100|FG002|Overall Study|Withdrawal by Subject|0|||
28005677|NCT00716274|54664498|FG005|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
28005678|NCT00716274|54664493|FG000|Study Period II (16-Weeks)|Lost to Follow-up|0|||
28005679|NCT00716274|54664494|FG001|Study Period II (16-Weeks)|Lost to Follow-up|2|||
28005680|NCT00716274|54664495|FG002|Study Period II (16-Weeks)|Lost to Follow-up|0|||
28005681|NCT00716274|54664496|FG003|Study Period II (16-Weeks)|Lost to Follow-up|0|||
28005682|NCT00716274|54664497|FG004|Study Period II (16-Weeks)|Lost to Follow-up|0|||
28005683|NCT00716274|54664498|FG005|Study Period II (16-Weeks)|Lost to Follow-up|0|||
28005684|NCT00716274|54664493|FG000|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
28172820|NCT01367275|54844566|FG000|Overall Study|Disease Progression|2|||
28005685|NCT00716274|54664494|FG001|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
28005686|NCT00716274|54664495|FG002|Study Period III (16-Weeks)|Withdrawal by Subject|2|||
28005687|NCT00716274|54664496|FG003|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
28005688|NCT00716274|54664497|FG004|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
28005689|NCT00716274|54664498|FG005|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
28005690|NCT00716274|54664493|FG000|Study Period III (16-Weeks)|Physician Decision|0|||
28005691|NCT00716274|54664494|FG001|Study Period III (16-Weeks)|Physician Decision|0|||
28005692|NCT00716274|54664495|FG002|Study Period III (16-Weeks)|Physician Decision|0|||
28005693|NCT00716274|54664496|FG003|Study Period III (16-Weeks)|Physician Decision|0|||
28005694|NCT00716274|54664497|FG004|Study Period III (16-Weeks)|Physician Decision|1|||
28005695|NCT00716274|54664498|FG005|Study Period III (16-Weeks)|Physician Decision|0|||
28005696|NCT00716274|54664493|FG000|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
28005697|NCT00716274|54664494|FG001|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
28005698|NCT00716274|54664495|FG002|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
28005699|NCT00716274|54664496|FG003|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
28005700|NCT00716274|54664497|FG004|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
28005701|NCT00716274|54664498|FG005|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
28005702|NCT00716274|54664493|FG000|Study Period III (16-Weeks)|Adverse Event|0|||
28005703|NCT00716274|54664494|FG001|Study Period III (16-Weeks)|Adverse Event|0|||
28005704|NCT00716274|54664495|FG002|Study Period III (16-Weeks)|Adverse Event|0|||
28005705|NCT00716274|54664496|FG003|Study Period III (16-Weeks)|Adverse Event|0|||
28005706|NCT00716274|54664497|FG004|Study Period III (16-Weeks)|Adverse Event|1|||
28005707|NCT00716274|54664498|FG005|Study Period III (16-Weeks)|Adverse Event|0|||
28005708|NCT00746564|54664515|FG000|Overall Study|Required Pacemaker/ICD Implant|2|||
28005709|NCT01298193|54664521|FG000|Observational Phase (First Cycle)|Withdrawal by Subject|2|||
28005710|NCT01298193|54664521|FG000|Observational Phase (First Cycle)|Received TC at a different dose|16|||
28005711|NCT01298193|54664521|FG000|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9|||
28005712|NCT01298193|54664521|FG000|Efficacy Phase (Second Cycle)|Death|1|||
28005713|NCT00719862|54664530|FG000|Overall Study|Adverse Event|1|||
28005714|NCT00719862|54664531|FG001|Overall Study|Adverse Event|2|||
28005715|NCT00719862|54664530|FG000|Overall Study|Lack of Efficacy|3|||
28005716|NCT00719862|54664531|FG001|Overall Study|Lack of Efficacy|0|||
28005717|NCT00719862|54664530|FG000|Overall Study|Non-Compliance|1|||
28005718|NCT00719862|54664531|FG001|Overall Study|Non-Compliance|0|||
28005719|NCT00719862|54664530|FG000|Overall Study|Withdrawal by Subject|1|||
28005720|NCT00719862|54664531|FG001|Overall Study|Withdrawal by Subject|0|||
28005721|NCT00719862|54664530|FG000|Overall Study|Lost to Follow-up|0|||
28005722|NCT00719862|54664531|FG001|Overall Study|Lost to Follow-up|1|||
28005723|NCT00719862|54664530|FG000|Overall Study|Other|2|||
28005724|NCT00719862|54664531|FG001|Overall Study|Other|3|||
28005725|NCT00742508|54664539|FG000|8-Week Primary Evaluation Period|Adverse Event|2|||
28005726|NCT00742508|54664540|FG001|8-Week Primary Evaluation Period|Adverse Event|4|||
28005727|NCT00742508|54664539|FG000|8-Week Primary Evaluation Period|Protocol Violation|1|||
28005728|NCT00742508|54664540|FG001|8-Week Primary Evaluation Period|Protocol Violation|0|||
28005729|NCT00742508|54664539|FG000|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8|||
28005730|NCT00742508|54664540|FG001|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5|||
28005731|NCT00742508|54664539|FG000|8-Week Primary Evaluation Period|Withdrawal by Subject|0|||
28005732|NCT00742508|54664540|FG001|8-Week Primary Evaluation Period|Withdrawal by Subject|2|||
28005733|NCT00742508|54664539|FG000|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0|||
28005734|NCT00742508|54664540|FG001|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1|||
28005735|NCT00719706|54664548|FG000|Overall Study|Adverse Event|5|||
28005736|NCT00719706|54664549|FG001|Overall Study|Adverse Event|4|||
28005737|NCT00719706|54664548|FG000|Overall Study|Withdrawal by Subject|1|||
28005738|NCT00719706|54664549|FG001|Overall Study|Withdrawal by Subject|2|||
28005739|NCT00719706|54664548|FG000|Overall Study|Protocol Violation|3|||
28005740|NCT00719706|54664549|FG001|Overall Study|Protocol Violation|0|||
28005741|NCT00742274|54664557|FG000|Overall Study|Death|1|||
28005742|NCT00742274|54664558|FG001|Overall Study|Death|0|||
28005743|NCT00742274|54664557|FG000|Overall Study|Withdrawal by Subject|1|||
28005744|NCT00742274|54664558|FG001|Overall Study|Withdrawal by Subject|2|||
28005745|NCT00742274|54664557|FG000|Overall Study|Removed for medical reasons|1|||
28005746|NCT00742274|54664558|FG001|Overall Study|Removed for medical reasons|1|||
28005747|NCT00719472|54664564|FG000|Enrolled in Study|Physician decision to withdraw patient|1|||
28005748|NCT00719472|54664564|FG000|Enrolled in Study|Subject decision to withdraw|8|||
28005749|NCT00719472|54664564|FG000|Enrolled in Study|Various Reasons|17|||
28005750|NCT00719472|54664564|FG000|Received Cycle 1 Treatment|Adverse Event|8|||
28005751|NCT00719472|54664564|FG000|Received Cycle 1 Treatment|Death|5|||
28005752|NCT00719472|54664564|FG000|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11|||
28005753|NCT00719472|54664564|FG000|Received Cycle 1 Treatment|Physician decision to withdraw patient|7|||
28005754|NCT00719472|54664564|FG000|Received Cycle 1 Treatment|Subject decision to withdraw|9|||
28005755|NCT00719472|54664564|FG000|Received Cycle 1 Treatment|Various Reasons|13|||
28005756|NCT00719472|54664564|FG000|Received Cycle 2 Treatment|Adverse Event|12|||
28005757|NCT00719472|54664564|FG000|Received Cycle 2 Treatment|Death|6|||
28005758|NCT00719472|54664564|FG000|Received Cycle 2 Treatment|Disease progression|3|||
28005759|NCT00719472|54664564|FG000|Received Cycle 2 Treatment|Lost to Follow-up|3|||
28005760|NCT00719472|54664564|FG000|Received Cycle 2 Treatment|Physician decision to withdraw patient|13|||
28005761|NCT00719472|54664564|FG000|Received Cycle 2 Treatment|Subject decision to withdraw|6|||
28005762|NCT00719472|54664564|FG000|Received Cycle 2 Treatment|Various Reasons|25|||
28005763|NCT00579501|54664568|FG000|Overall Study|Death|1|||
28005764|NCT00579501|54664568|FG000|Overall Study|End of neoadjuvant therapy|25|||
28005765|NCT00579501|54664568|FG000|Overall Study|toxicity|1|||
28005766|NCT00579501|54664568|FG000|Overall Study|Secondary lesion|1|||
28005767|NCT00579501|54664568|FG000|Overall Study|Radiation therapy before surgery|1|||
28005768|NCT00741338|54664574|FG000|Overall Study|Adverse Event|0|||
28005769|NCT00741338|54664575|FG001|Overall Study|Adverse Event|1|||
28005770|NCT00746330|54664585|FG000|Period 1|Abnormal test procedure result|0|||
28005771|NCT00746330|54664586|FG001|Period 1|Abnormal test procedure result|0|||
28005772|NCT00746330|54664587|FG002|Period 1|Abnormal test procedure result|1|||
28005773|NCT00746330|54664588|FG003|Period 1|Abnormal test procedure result|0|||
28005774|NCT00746252|54664601|FG000|Overall Study|weight gain >7.5 %|1|||
28005775|NCT00746252|54664602|FG001|Overall Study|weight gain >7.5 %|2|||
28005776|NCT00718770|54664608|FG000|Overall Study|Adverse Event|1|||
28005777|NCT00718770|54664608|FG000|Overall Study|Lack of Efficacy|1|||
28005778|NCT00718770|54664608|FG000|Overall Study|Lack of Efficacy|1|||
28005779|NCT00718770|54664608|FG000|Overall Study|Adverse Event|1|||
28005780|NCT00718770|54664608|FG000|Overall Study|Lack of Efficacy|1|||
28005781|NCT00718770|54664608|FG000|Overall Study|Adverse Event|1|||
28005782|NCT00718770|54664608|FG000|Overall Study|Lack of Efficacy|1|||
28005783|NCT00718770|54664608|FG000|Overall Study|Adverse Event|1|||
28005784|NCT00746096|54664614|FG000|Overall Study|Adverse Event|1|||
28005785|NCT00746096|54664615|FG001|Overall Study|Adverse Event|0|||
28005786|NCT00746096|54664614|FG000|Overall Study|Withdrawal by Subject|5|||
28005787|NCT00746096|54664615|FG001|Overall Study|Withdrawal by Subject|1|||
28005788|NCT00746096|54664614|FG000|Overall Study|Lost to Follow-up|2|||
28005789|NCT00746096|54664615|FG001|Overall Study|Lost to Follow-up|1|||
28005790|NCT00746096|54664614|FG000|Overall Study|Protocol Violation|1|||
28005791|NCT00746096|54664615|FG001|Overall Study|Protocol Violation|0|||
28005792|NCT00746096|54664614|FG000|Overall Study|No study drug treatment|1|||
28005793|NCT00746096|54664615|FG001|Overall Study|No study drug treatment|1|||
28005794|NCT00715026|54664621|FG000|Overall Study|Withdrawal by Subject|5|||
28005795|NCT00715026|54664621|FG000|Overall Study|Lost to Follow-up|3|||
28005796|NCT00715026|54664621|FG000|Overall Study|Protocol Violation|1|||
28005797|NCT00715026|54664621|FG000|Overall Study|Surgery done on non-study consented hip|1|||
28005798|NCT00714948|54664625|FG000|Overall Study|Adverse Event|2|||
28005799|NCT00714870|54664631|FG000|Overall Study|Lost to Follow-up|22|||
28005800|NCT00714870|54664632|FG001|Overall Study|Lost to Follow-up|5|||
28005801|NCT00714870|54664631|FG000|Overall Study|patient unable to come b/c back pain|1|||
28005802|NCT00714870|54664632|FG001|Overall Study|patient unable to come b/c back pain|0|||
28005803|NCT00714870|54664631|FG000|Overall Study|did not attend minimum of 4 sessions|4|||
28005804|NCT00714870|54664632|FG001|Overall Study|did not attend minimum of 4 sessions|0|||
28005805|NCT00714714|54664638|FG000|Overall Study|Adverse Event|1|||
28005806|NCT00441337|54664648|FG000|Overall Study|Disease Progression|6|||
28005807|NCT00441337|54664649|FG001|Overall Study|Disease Progression|6|||
28005808|NCT00441337|54664650|FG002|Overall Study|Disease Progression|4|||
28005809|NCT00441337|54664651|FG003|Overall Study|Disease Progression|18|||
28005810|NCT00441337|54664648|FG000|Overall Study|Lost to Follow-up|0|||
28101552|NCT02921776|54758101|FG003|Overall Study|Withdrawal by Subject|1|||
28101553|NCT02921776|54758102|FG004|Overall Study|Withdrawal by Subject|1|||
28101554|NCT02921776|54758103|FG005|Overall Study|Withdrawal by Subject|0|||
28101555|NCT02921776|54758104|FG006|Overall Study|Withdrawal by Subject|8|||
28101556|NCT02921776|54758105|FG007|Overall Study|Withdrawal by Subject|1|||
28101557|NCT02921776|54758098|FG000|Overall Study|Death|0|||
28101558|NCT02921776|54758099|FG001|Overall Study|Death|0|||
27916949|NCT01172938|54574538|FG003|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
27916950|NCT01172938|54574539|FG004|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
27916951|NCT01172938|54574540|FG005|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
27916952|NCT01172938|54574541|FG006|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
27916953|NCT01172938|54574542|FG007|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
27916954|NCT01172938|54574543|FG008|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
27916955|NCT01172938|54574535|FG000|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
27916956|NCT01172938|54574536|FG001|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
27916957|NCT01172938|54574537|FG002|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
28005811|NCT00441337|54664649|FG001|Overall Study|Lost to Follow-up|0|||
28005812|NCT00441337|54664650|FG002|Overall Study|Lost to Follow-up|0|||
28101559|NCT02921776|54758100|FG002|Overall Study|Death|0|||
28101560|NCT02921776|54758101|FG003|Overall Study|Death|2|||
28101561|NCT02921776|54758102|FG004|Overall Study|Death|0|||
28101562|NCT02921776|54758103|FG005|Overall Study|Death|0|||
28101563|NCT02921776|54758104|FG006|Overall Study|Death|0|||
28101564|NCT02921776|54758105|FG007|Overall Study|Death|0|||
28101565|NCT02921776|54758098|FG000|Overall Study|extubation or early discharge|0|||
28101566|NCT02921776|54758099|FG001|Overall Study|extubation or early discharge|0|||
28101567|NCT02921776|54758100|FG002|Overall Study|extubation or early discharge|0|||
28101568|NCT02921776|54758101|FG003|Overall Study|extubation or early discharge|5|||
28101569|NCT02921776|54758102|FG004|Overall Study|extubation or early discharge|5|||
28101570|NCT02921776|54758103|FG005|Overall Study|extubation or early discharge|0|||
28101571|NCT02921776|54758104|FG006|Overall Study|extubation or early discharge|0|||
28101572|NCT02921776|54758105|FG007|Overall Study|extubation or early discharge|0|||
28101573|NCT02921776|54758098|FG000|Overall Study|Lost to Follow-up|0|||
28101574|NCT02921776|54758099|FG001|Overall Study|Lost to Follow-up|0|||
28101575|NCT02921776|54758100|FG002|Overall Study|Lost to Follow-up|0|||
28101576|NCT02921776|54758101|FG003|Overall Study|Lost to Follow-up|0|||
28101577|NCT02921776|54758102|FG004|Overall Study|Lost to Follow-up|0|||
28101578|NCT02921776|54758103|FG005|Overall Study|Lost to Follow-up|2|||
28101579|NCT02921776|54758104|FG006|Overall Study|Lost to Follow-up|3|||
28101580|NCT02921776|54758105|FG007|Overall Study|Lost to Follow-up|6|||
28101581|NCT02922634|54758129|FG000|Overall Study|Withdrawal by Subject|5|||
28101582|NCT02922634|54758129|FG000|Overall Study|Did not have their surgery|5|||
28101583|NCT00023595|54758145|FG000|5 Year Follow up|Lost to Follow-up|2|||
28101584|NCT00023595|54758146|FG001|5 Year Follow up|Lost to Follow-up|2|||
28101585|NCT00023595|54758147|FG002|5 Year Follow up|Lost to Follow-up|1|||
28101586|NCT00023595|54758148|FG003|5 Year Follow up|Lost to Follow-up|7|||
28101587|NCT00023595|54758149|FG004|5 Year Follow up|Lost to Follow-up|3|||
28101588|NCT00023595|54758145|FG000|10 Year Follow up|Lost to Follow-up|12|||
28101589|NCT00023595|54758146|FG001|10 Year Follow up|Lost to Follow-up|10|||
28101590|NCT00023595|54758147|FG002|10 Year Follow up|Lost to Follow-up|3|||
28101591|NCT00023595|54758148|FG003|10 Year Follow up|Lost to Follow-up|0|||
28101592|NCT00023595|54758149|FG004|10 Year Follow up|Lost to Follow-up|0|||
28101593|NCT02920528|54758175|FG000|Overall Study|Incomplete Data|1|||
28101594|NCT02920528|54758176|FG001|Overall Study|Incomplete Data|1|||
28101595|NCT02920528|54758177|FG002|Overall Study|Incomplete Data|1|||
28101596|NCT02920528|54758175|FG000|Overall Study|Adverse Event|0|||
28101597|NCT02920528|54758176|FG001|Overall Study|Adverse Event|0|||
28101598|NCT02920528|54758177|FG002|Overall Study|Adverse Event|3|||
28172821|NCT02842853|54844574|FG000|Overall Study|Non-compliance with the protocol|3|||
28172822|NCT02842853|54844575|FG001|Overall Study|Non-compliance with the protocol|7|||
28172823|NCT02842853|54844576|FG002|Overall Study|Non-compliance with the protocol|2|||
28172824|NCT02842853|54844577|FG003|Overall Study|Non-compliance with the protocol|5|||
28172825|NCT02842853|54844574|FG000|Overall Study|Subject met exclusion criteria|0|||
28172826|NCT02842853|54844575|FG001|Overall Study|Subject met exclusion criteria|1|||
28172827|NCT02842853|54844576|FG002|Overall Study|Subject met exclusion criteria|0|||
28172828|NCT02842853|54844577|FG003|Overall Study|Subject met exclusion criteria|0|||
28172829|NCT02842853|54844574|FG000|Overall Study|Withdrawal by Subject|11|||
28172830|NCT02842853|54844575|FG001|Overall Study|Withdrawal by Subject|13|||
28172831|NCT02842853|54844576|FG002|Overall Study|Withdrawal by Subject|9|||
28172832|NCT02842853|54844577|FG003|Overall Study|Withdrawal by Subject|8|||
28172833|NCT02842853|54844574|FG000|Overall Study|Lost to Follow-up|9|||
28172834|NCT02842853|54844575|FG001|Overall Study|Lost to Follow-up|13|||
28172835|NCT02842853|54844576|FG002|Overall Study|Lost to Follow-up|10|||
28172836|NCT02842853|54844577|FG003|Overall Study|Lost to Follow-up|11|||
28172837|NCT02433340|54844593|FG000|Overall Study|Adverse Event|0|||
28172838|NCT02433340|54844594|FG001|Overall Study|Adverse Event|0|||
28172839|NCT02433340|54844595|FG002|Overall Study|Adverse Event|1|||
28172840|NCT02433340|54844596|FG003|Overall Study|Adverse Event|0|||
28172841|NCT02433340|54844593|FG000|Overall Study|Withdrawal by Subject|1|||
28172842|NCT02433340|54844594|FG001|Overall Study|Withdrawal by Subject|0|||
28172843|NCT02433340|54844595|FG002|Overall Study|Withdrawal by Subject|1|||
28172844|NCT02433340|54844596|FG003|Overall Study|Withdrawal by Subject|2|||
28172845|NCT02433340|54844593|FG000|Overall Study|Lost to Follow-up|0|||
28172846|NCT02433340|54844594|FG001|Overall Study|Lost to Follow-up|1|||
28172847|NCT02433340|54844595|FG002|Overall Study|Lost to Follow-up|0|||
28172848|NCT02433340|54844596|FG003|Overall Study|Lost to Follow-up|0|||
28172849|NCT02433340|54844593|FG000|Overall Study|Required Alternative/Prohibited Therapy|1|||
28172850|NCT02433340|54844594|FG001|Overall Study|Required Alternative/Prohibited Therapy|0|||
28172851|NCT02433340|54844595|FG002|Overall Study|Required Alternative/Prohibited Therapy|0|||
28172852|NCT02433340|54844596|FG003|Overall Study|Required Alternative/Prohibited Therapy|0|||
28172853|NCT02433340|54844593|FG000|Overall Study|Other|0|||
28172854|NCT02433340|54844594|FG001|Overall Study|Other|1|||
28101599|NCT02920528|54758175|FG000|Overall Study|Did not meet inclusion criteria|2|||
28101600|NCT02920528|54758176|FG001|Overall Study|Did not meet inclusion criteria|0|||
28101601|NCT02920528|54758177|FG002|Overall Study|Did not meet inclusion criteria|1|||
28101602|NCT01068418|54758185|FG000|Overall Study|Physician Decision|12|||
28101603|NCT01068262|54758193|FG000|Overall Study|Adverse Event|2|||
28101604|NCT01068262|54758194|FG001|Overall Study|Adverse Event|0|||
28101605|NCT01068262|54758195|FG002|Overall Study|Adverse Event|1|||
28101606|NCT01068262|54758196|FG003|Overall Study|Adverse Event|0|||
28101607|NCT01068262|54758193|FG000|Overall Study|Protocol Violation|1|||
28101608|NCT01068262|54758194|FG001|Overall Study|Protocol Violation|0|||
28101609|NCT01068262|54758195|FG002|Overall Study|Protocol Violation|0|||
28101610|NCT01068262|54758196|FG003|Overall Study|Protocol Violation|0|||
28101611|NCT01068262|54758193|FG000|Overall Study|Withdrawal by Subject|0|||
28101612|NCT01068262|54758194|FG001|Overall Study|Withdrawal by Subject|1|||
28101613|NCT01068262|54758195|FG002|Overall Study|Withdrawal by Subject|0|||
28101614|NCT01068262|54758196|FG003|Overall Study|Withdrawal by Subject|0|||
28101615|NCT02920450|54758209|FG000|Overall Study|Death|1|||
28101616|NCT02920450|54758210|FG001|Overall Study|Death|0|||
28101617|NCT02920450|54758211|FG002|Overall Study|Death|0|||
28101618|NCT02920450|54758212|FG003|Overall Study|Death|0|||
28101619|NCT02920450|54758209|FG000|Overall Study|Withdrawal by Subject|1|||
28101620|NCT02920450|54758210|FG001|Overall Study|Withdrawal by Subject|0|||
28101621|NCT02920450|54758211|FG002|Overall Study|Withdrawal by Subject|0|||
28101622|NCT02920450|54758212|FG003|Overall Study|Withdrawal by Subject|0|||
28101623|NCT01066936|54758223|FG000|Overall Study|Death|2|||
28101624|NCT01066936|54758223|FG000|Overall Study|Device revised/removed|1|||
28101625|NCT01066936|54758223|FG000|Overall Study|Lost to Follow-up|3|||
28172855|NCT02433340|54844595|FG002|Overall Study|Other|0|||
28005813|NCT00441337|54664651|FG003|Overall Study|Lost to Follow-up|1|||
28005814|NCT00441337|54664648|FG000|Overall Study|Sponsor Decision|0|||
28005815|NCT00441337|54664649|FG001|Overall Study|Sponsor Decision|0|||
28005816|NCT00441337|54664650|FG002|Overall Study|Sponsor Decision|1|||
28005817|NCT00441337|54664651|FG003|Overall Study|Sponsor Decision|2|||
28005818|NCT00441337|54664648|FG000|Overall Study|Did not meet inclusion criteria|0|||
28005819|NCT00441337|54664649|FG001|Overall Study|Did not meet inclusion criteria|0|||
28005820|NCT00441337|54664650|FG002|Overall Study|Did not meet inclusion criteria|1|||
28005821|NCT00441337|54664651|FG003|Overall Study|Did not meet inclusion criteria|0|||
28005822|NCT00578877|54664671|FG000|Overall Study|Lost to Follow-up|8|||
28005823|NCT00578877|54664672|FG001|Overall Study|Lost to Follow-up|10|||
28005824|NCT00578877|54664671|FG000|Overall Study|early discontinue|61|||
28005825|NCT00578877|54664672|FG001|Overall Study|early discontinue|101|||
28005826|NCT00578877|54664671|FG000|Overall Study|did not provide follow-up data|12|||
28005827|NCT00578877|54664672|FG001|Overall Study|did not provide follow-up data|17|||
28005828|NCT00468481|54664680|FG000|Overall Study|Adverse Event|13|||
28005829|NCT00468481|54664681|FG001|Overall Study|Adverse Event|3|||
28005830|NCT00468481|54664680|FG000|Overall Study|Lost to Follow-up|25|||
28005831|NCT00468481|54664681|FG001|Overall Study|Lost to Follow-up|8|||
28005832|NCT00468481|54664680|FG000|Overall Study|Pregnancy|2|||
28005833|NCT00468481|54664681|FG001|Overall Study|Pregnancy|0|||
28005834|NCT00468481|54664680|FG000|Overall Study|Protocol Violation|18|||
28005835|NCT00468481|54664681|FG001|Overall Study|Protocol Violation|8|||
28005836|NCT00468481|54664680|FG000|Overall Study|Withdrawal by Subject|12|||
28005837|NCT00468481|54664681|FG001|Overall Study|Withdrawal by Subject|3|||
28101626|NCT01066936|54758223|FG000|Overall Study|Withdrawal by Subject|4|||
28101627|NCT02919436|54758231|FG000|Overall Study|Did not undergo surgery|16|||
28101628|NCT02919436|54758232|FG001|Overall Study|Did not undergo surgery|20|||
28172856|NCT02433340|54844596|FG003|Overall Study|Other|0|||
28172857|NCT02400346|54844608|FG000|Overall Study|Adverse Event|24|||
28172858|NCT02400346|54844608|FG000|Overall Study|Lack of Efficacy|9|||
27916958|NCT01172938|54574538|FG003|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
27916959|NCT01172938|54574539|FG004|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
27916960|NCT01172938|54574540|FG005|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
28172859|NCT02400346|54844608|FG000|Overall Study|Non-compliance with IMP|1|||
28172860|NCT02400346|54844608|FG000|Overall Study|Withdrawal by Subject|7|||
27916961|NCT01172938|54574541|FG006|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
27916962|NCT01172938|54574542|FG007|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
27916963|NCT01172938|54574543|FG008|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
27916964|NCT01172938|54574535|FG000|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
27916965|NCT01172938|54574536|FG001|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
27916966|NCT01172938|54574537|FG002|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
27916967|NCT01172938|54574538|FG003|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
27916968|NCT01172938|54574539|FG004|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
27916969|NCT01172938|54574540|FG005|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
27916970|NCT01172938|54574541|FG006|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
28005838|NCT00468481|54664680|FG000|Overall Study|susp/diag malignant/premalignant disease|1|||
28005839|NCT00468481|54664681|FG001|Overall Study|susp/diag malignant/premalignant disease|0|||
28005840|NCT00468481|54664680|FG000|Overall Study|Prohibited Medication|1|||
28005841|NCT00468481|54664681|FG001|Overall Study|Prohibited Medication|1|||
28101629|NCT02919436|54758231|FG000|Overall Study|Enrolled before trial registration|44|||
28101630|NCT02919436|54758232|FG001|Overall Study|Enrolled before trial registration|33|||
28101631|NCT03804879|54758242|FG000|Overall Study|Adverse Event|3|||
28101632|NCT03804879|54758243|FG001|Overall Study|Adverse Event|0|||
28101633|NCT03804879|54758242|FG000|Overall Study|Study Terminated By Sponsor|10|||
28101634|NCT03804879|54758243|FG001|Overall Study|Study Terminated By Sponsor|12|||
28101635|NCT03804879|54758242|FG000|Overall Study|Withdrawal by Subject|3|||
28101636|NCT03804879|54758243|FG001|Overall Study|Withdrawal by Subject|1|||
28101637|NCT03803475|54758250|FG000|Overall Study|Physician Decision|1|||
28101638|NCT00005937|54758254|FG000|Overall Study|Lack of Efficacy|5|||
28101639|NCT03443024|54758262|FG000|Overall Study|Adverse Event|2|||
28101640|NCT03443024|54758263|FG001|Overall Study|Adverse Event|4|||
28101641|NCT03443024|54758264|FG002|Overall Study|Adverse Event|3|||
28101642|NCT03443024|54758265|FG003|Overall Study|Adverse Event|1|||
28101643|NCT03443024|54758262|FG000|Overall Study|Lost to Follow-up|9|||
28101644|NCT03443024|54758263|FG001|Overall Study|Lost to Follow-up|9|||
28101645|NCT03443024|54758264|FG002|Overall Study|Lost to Follow-up|7|||
28101646|NCT03443024|54758265|FG003|Overall Study|Lost to Follow-up|5|||
28101647|NCT03443024|54758262|FG000|Overall Study|Withdrawal by Subject|8|||
28101648|NCT03443024|54758263|FG001|Overall Study|Withdrawal by Subject|15|||
28172861|NCT02400346|54844608|FG000|Overall Study|Administrative or other reason(s)|2|||
28172862|NCT02400346|54844608|FG000|Overall Study|Lost to Follow-up|1|||
28005842|NCT00468481|54664680|FG000|Overall Study|Egg Donor|1|||
28005843|NCT00468481|54664681|FG001|Overall Study|Egg Donor|0|||
28005844|NCT00468481|54664680|FG000|Overall Study|Moved out of area|4|||
28005845|NCT00468481|54664681|FG001|Overall Study|Moved out of area|1|||
28005846|NCT00468481|54664680|FG000|Overall Study|Non-Compliance|5|||
28005847|NCT00468481|54664681|FG001|Overall Study|Non-Compliance|0|||
28005848|NCT00468481|54664680|FG000|Overall Study|Other|6|||
28005849|NCT00468481|54664681|FG001|Overall Study|Other|0|||
28005850|NCT00714168|54664689|FG000|Overall Study|Pregnancy|5|||
28005851|NCT00714168|54664690|FG001|Overall Study|Pregnancy|4|||
28005852|NCT00714168|54664689|FG000|Overall Study|Lost to Follow-up|32|||
28005853|NCT00714168|54664690|FG001|Overall Study|Lost to Follow-up|50|||
28005854|NCT00714168|54664689|FG000|Overall Study|Relocation|4|||
28005855|NCT00714168|54664690|FG001|Overall Study|Relocation|3|||
28005856|NCT00714168|54664689|FG000|Overall Study|Non-study medical condition|3|||
28005857|NCT00714168|54664690|FG001|Overall Study|Non-study medical condition|2|||
28005858|NCT00713700|54664696|FG000|Overall Study|Lost to Follow-up|3|||
28005859|NCT00713700|54664696|FG000|Overall Study|Withdrawal by Subject|1|||
28005860|NCT00468169|54664702|FG000|Overall Study|Withdrawal by Subject|1|||
28005861|NCT00468169|54664703|FG001|Overall Study|Withdrawal by Subject|0|||
28005862|NCT00435487|54664713|FG000|Overall Study|Death|3|||
28005863|NCT00435487|54664714|FG001|Overall Study|Death|4|||
28005864|NCT00435487|54664713|FG000|Overall Study|Adverse Event|0|||
28005865|NCT00435487|54664714|FG001|Overall Study|Adverse Event|3|||
28005866|NCT00435487|54664713|FG000|Overall Study|Lost to Follow-up|2|||
28005867|NCT00435487|54664714|FG001|Overall Study|Lost to Follow-up|2|||
28005868|NCT00435487|54664713|FG000|Overall Study|Other|5|||
28005869|NCT00435487|54664714|FG001|Overall Study|Other|2|||
28005870|NCT00435487|54664713|FG000|Overall Study|Withdrawal by Subject|2|||
28005871|NCT00435487|54664714|FG001|Overall Study|Withdrawal by Subject|1|||
28005872|NCT00435487|54664713|FG000|Overall Study|Withdrawal by Subject Prior to Treatment|0|||
28005873|NCT00435487|54664714|FG001|Overall Study|Withdrawal by Subject Prior to Treatment|2|||
28005874|NCT00435487|54664713|FG000|Overall Study|Received Drug in Other Treatment Group|0|||
28005875|NCT00435487|54664714|FG001|Overall Study|Received Drug in Other Treatment Group|1|||
28005876|NCT00579345|54664728|FG000|Overall Study|Withdrawal by Subject|2|||
28005877|NCT00579345|54664729|FG001|Overall Study|Withdrawal by Subject|0|||
28005878|NCT00579345|54664730|FG002|Overall Study|Withdrawal by Subject|0|||
28005879|NCT00579345|54664731|FG003|Overall Study|Withdrawal by Subject|0|||
28005880|NCT00579345|54664732|FG004|Overall Study|Withdrawal by Subject|0|||
28005881|NCT00579345|54664733|FG005|Overall Study|Withdrawal by Subject|0|||
28005882|NCT00579345|54664734|FG006|Overall Study|Withdrawal by Subject|0|||
28005883|NCT00579345|54664735|FG007|Overall Study|Withdrawal by Subject|1|||
28005884|NCT00579345|54664728|FG000|Overall Study|Lost to Follow-up|1|||
28005885|NCT00579345|54664729|FG001|Overall Study|Lost to Follow-up|0|||
28005886|NCT00579345|54664730|FG002|Overall Study|Lost to Follow-up|0|||
28005887|NCT00579345|54664731|FG003|Overall Study|Lost to Follow-up|0|||
28005888|NCT00579345|54664732|FG004|Overall Study|Lost to Follow-up|0|||
28005889|NCT00579345|54664733|FG005|Overall Study|Lost to Follow-up|0|||
28005890|NCT00579345|54664734|FG006|Overall Study|Lost to Follow-up|0|||
28005891|NCT00579345|54664735|FG007|Overall Study|Lost to Follow-up|0|||
28005892|NCT00579345|54664728|FG000|Overall Study|Adverse Event|0|||
28101649|NCT03443024|54758264|FG002|Overall Study|Withdrawal by Subject|9|||
28101650|NCT03443024|54758265|FG003|Overall Study|Withdrawal by Subject|23|||
28101651|NCT03443024|54758262|FG000|Overall Study|Physician Decision|1|||
28101652|NCT03443024|54758263|FG001|Overall Study|Physician Decision|2|||
28101653|NCT03443024|54758264|FG002|Overall Study|Physician Decision|0|||
28005893|NCT00579345|54664729|FG001|Overall Study|Adverse Event|0|||
28005894|NCT00579345|54664730|FG002|Overall Study|Adverse Event|1|||
28101654|NCT03443024|54758265|FG003|Overall Study|Physician Decision|1|||
28005895|NCT00579345|54664731|FG003|Overall Study|Adverse Event|0|||
28005896|NCT00579345|54664732|FG004|Overall Study|Adverse Event|0|||
28005897|NCT00579345|54664733|FG005|Overall Study|Adverse Event|0|||
28101655|NCT03443024|54758262|FG000|Overall Study|Sponsor Decision|1|||
28101656|NCT03443024|54758263|FG001|Overall Study|Sponsor Decision|1|||
28101657|NCT03443024|54758264|FG002|Overall Study|Sponsor Decision|0|||
28101658|NCT03443024|54758265|FG003|Overall Study|Sponsor Decision|0|||
28101659|NCT03443024|54758262|FG000|Overall Study|Protocol Deviation|0|||
28101660|NCT03443024|54758263|FG001|Overall Study|Protocol Deviation|0|||
28101661|NCT03443024|54758264|FG002|Overall Study|Protocol Deviation|0|||
28101662|NCT03443024|54758265|FG003|Overall Study|Protocol Deviation|2|||
28101663|NCT02908516|54758277|FG000|Overall Study|Study Terminated|3|||
28101664|NCT02908516|54758278|FG001|Overall Study|Study Terminated|3|||
28101665|NCT02907892|54758286|FG000|Overall Study|Lost to Follow-up|27|||
28172863|NCT02399254|54844612|FG000|Overall Study|Physician Decision|2|||
28172864|NCT02456662|54844619|FG000|Overall Study|Lost to Follow-up|2|||
28172865|NCT02456662|54844620|FG001|Overall Study|Lost to Follow-up|1|||
28172866|NCT01653262|54844626|FG000|Overall Study|Lack of Efficacy|1|||
28172867|NCT01653262|54844626|FG000|Overall Study|SAE, non-fatal|1|||
28172868|NCT01653262|54844626|FG000|Overall Study|AE, non-serious non-fatal|1|||
28172869|NCT02455336|54844632|FG000|Overall Study|Withdrawal by Subject|0|||
28172870|NCT02455336|54844633|FG001|Overall Study|Withdrawal by Subject|2|||
27916971|NCT01172938|54574542|FG007|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1|||
28101666|NCT02907892|54758287|FG001|Overall Study|Lost to Follow-up|40|||
28101667|NCT02906644|54758295|FG000|First 2 Weeks|Withdrawal by Subject|0|||
28101668|NCT02906644|54758296|FG001|First 2 Weeks|Withdrawal by Subject|2|||
28101669|NCT02906644|54758295|FG000|First 2 Weeks|Physician Decision|1|||
28101670|NCT02906644|54758296|FG001|First 2 Weeks|Physician Decision|1|||
28101671|NCT02906644|54758295|FG000|Weeks 3 to 14|Withdrawal by Subject|13|||
28101672|NCT02906644|54758296|FG001|Weeks 3 to 14|Withdrawal by Subject|7|||
28101673|NCT02906644|54758295|FG000|Weeks 3 to 14|Lost to Follow-up|3|||
28101674|NCT02906644|54758296|FG001|Weeks 3 to 14|Lost to Follow-up|4|||
28101675|NCT03410108|54758303|FG000|Overall Study|Ongoing|41|||
28101676|NCT03410108|54758303|FG000|Overall Study|Adverse Event|4|||
28101677|NCT03410108|54758303|FG000|Overall Study|Progressive Disease|58|||
28101678|NCT03410108|54758303|FG000|Overall Study|Withdrawal by Subject|1|||
28101679|NCT02982772|54758312|FG000|Intervention|Lost to Follow-up|19|||
28101680|NCT02982772|54758313|FG001|Intervention|Lost to Follow-up|13|||
28101681|NCT02982772|54758312|FG000|1M Follow-Up|Lost to Follow-up|21|||
28101682|NCT02982772|54758313|FG001|1M Follow-Up|Lost to Follow-up|18|||
28101683|NCT02982772|54758312|FG000|3M Follow-Up|Lost to Follow-up|17|||
28101684|NCT02982772|54758313|FG001|3M Follow-Up|Lost to Follow-up|11|||
28101685|NCT02982772|54758312|FG000|6M Follow-Up|Lost to Follow-up|11|||
28101686|NCT02982772|54758313|FG001|6M Follow-Up|Lost to Follow-up|9|||
28101687|NCT02982772|54758312|FG000|12M Follow-Up|Lost to Follow-up|11|||
28101688|NCT02982772|54758313|FG001|12M Follow-Up|Lost to Follow-up|5|||
28101689|NCT03488108|54758323|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
28101690|NCT03488108|54758324|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
28101691|NCT03488108|54758323|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
28101692|NCT03488108|54758324|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
28101693|NCT03440918|54758334|FG000|Overall Study|Protocol Violation|0|||
28101694|NCT03440918|54758335|FG001|Overall Study|Protocol Violation|16|||
28101695|NCT03486392|54758346|FG000|Overall Study|Lost to Follow-up|0|||
28101696|NCT03486392|54758347|FG001|Overall Study|Lost to Follow-up|0|||
28101697|NCT03486392|54758348|FG002|Overall Study|Lost to Follow-up|8|||
28101698|NCT03486392|54758349|FG003|Overall Study|Lost to Follow-up|5|||
28101699|NCT03486392|54758350|FG004|Overall Study|Lost to Follow-up|2|||
28101700|NCT03486392|54758346|FG000|Overall Study|Withdrawal by Subject|3|||
28101701|NCT03486392|54758347|FG001|Overall Study|Withdrawal by Subject|0|||
28101702|NCT03486392|54758348|FG002|Overall Study|Withdrawal by Subject|6|||
27916972|NCT01172938|54574543|FG008|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
27916973|NCT01172938|54574535|FG000|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
27916974|NCT01172938|54574536|FG001|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
28101703|NCT03486392|54758349|FG003|Overall Study|Withdrawal by Subject|4|||
28101704|NCT03486392|54758350|FG004|Overall Study|Withdrawal by Subject|1|||
28101705|NCT03486392|54758346|FG000|Overall Study|Death|0|||
28172871|NCT02455336|54844632|FG000|Overall Study|Adverse Event|3|||
27916975|NCT01172938|54574537|FG002|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
27916976|NCT01172938|54574538|FG003|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
27916977|NCT01172938|54574539|FG004|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
27916978|NCT01172938|54574540|FG005|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
27916979|NCT01172938|54574541|FG006|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
27916980|NCT01172938|54574542|FG007|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
27916981|NCT01172938|54574543|FG008|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
28172872|NCT02455336|54844633|FG001|Overall Study|Adverse Event|0|||
28172873|NCT02455336|54844632|FG000|Overall Study|Non-responder to treatment|2|||
28101706|NCT03486392|54758347|FG001|Overall Study|Death|0|||
28172874|NCT02455336|54844633|FG001|Overall Study|Non-responder to treatment|0|||
28005898|NCT00579345|54664734|FG006|Overall Study|Adverse Event|0|||
28005899|NCT00579345|54664735|FG007|Overall Study|Adverse Event|0|||
28005900|NCT00579345|54664728|FG000|Overall Study|Protocol Violation|1|||
28101707|NCT03486392|54758348|FG002|Overall Study|Death|0|||
28101708|NCT03486392|54758349|FG003|Overall Study|Death|0|||
28101709|NCT03486392|54758350|FG004|Overall Study|Death|1|||
28101710|NCT02981602|54758367|FG000|Overall Study|Adverse Event|0|||
28101711|NCT02981602|54758368|FG001|Overall Study|Adverse Event|0|||
28101712|NCT02981602|54758369|FG002|Overall Study|Adverse Event|0|||
28101713|NCT02981602|54758370|FG003|Overall Study|Adverse Event|1|||
28101714|NCT02981602|54758371|FG004|Overall Study|Adverse Event|0|||
28101715|NCT02981524|54758384|FG000|Overall Study|Progressive Disease|14|||
28101716|NCT02981524|54758384|FG000|Overall Study|Death (unrelated)|1|||
28101717|NCT02981524|54758384|FG000|Overall Study|Treatment Related Toxicity|1|||
28101718|NCT02981524|54758384|FG000|Overall Study|Withdrawal by Subject|1|||
28101719|NCT03486314|54758388|FG000|Part A|Adverse Event|1|||
28101720|NCT03486314|54758389|FG001|Part A|Adverse Event|0|||
28101721|NCT03486314|54758390|FG002|Part A|Adverse Event|0|||
28101722|NCT03486314|54758388|FG000|Part A|Symptomatic Deterioration|2|||
28101723|NCT03486314|54758389|FG001|Part A|Symptomatic Deterioration|0|||
28101724|NCT03486314|54758390|FG002|Part A|Symptomatic Deterioration|0|||
28101725|NCT02905006|54758404|FG000|Overall Study|Adverse Event|1|||
28101726|NCT02905006|54758405|FG001|Overall Study|Adverse Event|1|||
28005901|NCT00579345|54664729|FG001|Overall Study|Protocol Violation|0|||
28005902|NCT00579345|54664730|FG002|Overall Study|Protocol Violation|0|||
28005903|NCT00579345|54664731|FG003|Overall Study|Protocol Violation|0|||
28005904|NCT00579345|54664732|FG004|Overall Study|Protocol Violation|0|||
28005905|NCT00579345|54664733|FG005|Overall Study|Protocol Violation|0|||
28005906|NCT00579345|54664734|FG006|Overall Study|Protocol Violation|0|||
28005907|NCT00579345|54664735|FG007|Overall Study|Protocol Violation|1|||
28005908|NCT00579345|54664728|FG000|Overall Study|Death|1|||
28005909|NCT00579345|54664729|FG001|Overall Study|Death|1|||
28005910|NCT00579345|54664730|FG002|Overall Study|Death|1|||
28005911|NCT00579345|54664731|FG003|Overall Study|Death|1|||
28005912|NCT00579345|54664732|FG004|Overall Study|Death|0|||
27916982|NCT01172938|54574535|FG000|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
27916983|NCT01172938|54574536|FG001|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
27916984|NCT01172938|54574537|FG002|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2|||
27916985|NCT01172938|54574538|FG003|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
27916986|NCT01172938|54574539|FG004|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
27916987|NCT01172938|54574540|FG005|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
27916988|NCT01172938|54574541|FG006|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
27916989|NCT01172938|54574542|FG007|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
27916990|NCT01172938|54574543|FG008|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
27916991|NCT01172938|54574535|FG000|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
27916992|NCT01172938|54574536|FG001|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
27916993|NCT01172938|54574537|FG002|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
27916994|NCT01172938|54574538|FG003|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
27916995|NCT01172938|54574539|FG004|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
27916996|NCT01172938|54574540|FG005|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
27916997|NCT01172938|54574541|FG006|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
27916998|NCT01172938|54574542|FG007|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
27916999|NCT01172938|54574543|FG008|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
27917000|NCT01172938|54574535|FG000|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
27917001|NCT01172938|54574536|FG001|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2|||
27917002|NCT01172938|54574537|FG002|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3|||
27917003|NCT01172938|54574538|FG003|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
27917004|NCT01172938|54574539|FG004|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
27917005|NCT01172938|54574540|FG005|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
28005913|NCT00579345|54664733|FG005|Overall Study|Death|0|||
28005914|NCT00579345|54664734|FG006|Overall Study|Death|0|||
28005915|NCT00579345|54664735|FG007|Overall Study|Death|0|||
28005916|NCT00795821|54664783|FG000|Acute Treatment Phase|Adverse Event|23|||
28005917|NCT00795821|54664784|FG001|Acute Treatment Phase|Adverse Event|4|||
28005918|NCT00795821|54664783|FG000|Acute Treatment Phase|Death|1|||
28005919|NCT00795821|54664784|FG001|Acute Treatment Phase|Death|0|||
28101727|NCT02905006|54758406|FG002|Overall Study|Adverse Event|1|||
28101728|NCT02905006|54758407|FG003|Overall Study|Adverse Event|1|||
28101729|NCT02905006|54758408|FG004|Overall Study|Adverse Event|0|||
28101730|NCT02905006|54758409|FG005|Overall Study|Adverse Event|1|||
28101731|NCT02905006|54758404|FG000|Overall Study|Lack of Efficacy|1|||
28101732|NCT02905006|54758405|FG001|Overall Study|Lack of Efficacy|0|||
28101733|NCT02905006|54758406|FG002|Overall Study|Lack of Efficacy|0|||
28101734|NCT02905006|54758407|FG003|Overall Study|Lack of Efficacy|0|||
28101735|NCT02905006|54758408|FG004|Overall Study|Lack of Efficacy|0|||
28101736|NCT02905006|54758409|FG005|Overall Study|Lack of Efficacy|0|||
28101737|NCT02905006|54758404|FG000|Overall Study|Protocol Violation|2|||
28101738|NCT02905006|54758405|FG001|Overall Study|Protocol Violation|0|||
28101739|NCT02905006|54758406|FG002|Overall Study|Protocol Violation|0|||
28101740|NCT02905006|54758407|FG003|Overall Study|Protocol Violation|0|||
28101741|NCT02905006|54758408|FG004|Overall Study|Protocol Violation|0|||
28101742|NCT02905006|54758409|FG005|Overall Study|Protocol Violation|0|||
28101743|NCT02905006|54758404|FG000|Overall Study|Lost to Follow-up|0|||
28101744|NCT02905006|54758405|FG001|Overall Study|Lost to Follow-up|0|||
28101745|NCT02905006|54758406|FG002|Overall Study|Lost to Follow-up|0|||
28101746|NCT02905006|54758407|FG003|Overall Study|Lost to Follow-up|1|||
28101747|NCT02905006|54758408|FG004|Overall Study|Lost to Follow-up|1|||
28101748|NCT02905006|54758409|FG005|Overall Study|Lost to Follow-up|0|||
28101749|NCT02905006|54758404|FG000|Overall Study|Withdrawal by Subject|0|||
28101750|NCT02905006|54758405|FG001|Overall Study|Withdrawal by Subject|0|||
28101751|NCT02905006|54758406|FG002|Overall Study|Withdrawal by Subject|1|||
28101752|NCT02905006|54758407|FG003|Overall Study|Withdrawal by Subject|1|||
28101753|NCT02905006|54758408|FG004|Overall Study|Withdrawal by Subject|0|||
28101754|NCT02905006|54758409|FG005|Overall Study|Withdrawal by Subject|1|||
28101755|NCT02905006|54758404|FG000|Overall Study|Screening exclusion criteria met|1|||
28101756|NCT02905006|54758405|FG001|Overall Study|Screening exclusion criteria met|0|||
28101757|NCT02905006|54758406|FG002|Overall Study|Screening exclusion criteria met|0|||
28101758|NCT02905006|54758407|FG003|Overall Study|Screening exclusion criteria met|0|||
28101759|NCT02905006|54758408|FG004|Overall Study|Screening exclusion criteria met|0|||
28101760|NCT02905006|54758409|FG005|Overall Study|Screening exclusion criteria met|0|||
28101761|NCT02905006|54758404|FG000|Overall Study|Lab withdrawal criterion met|0|||
28101762|NCT02905006|54758405|FG001|Overall Study|Lab withdrawal criterion met|1|||
28101763|NCT02905006|54758406|FG002|Overall Study|Lab withdrawal criterion met|2|||
28101764|NCT02905006|54758407|FG003|Overall Study|Lab withdrawal criterion met|2|||
28101765|NCT02905006|54758408|FG004|Overall Study|Lab withdrawal criterion met|2|||
28101766|NCT02905006|54758409|FG005|Overall Study|Lab withdrawal criterion met|1|||
28101767|NCT02905006|54758404|FG000|Overall Study|Positive for Tuberculosis|0|||
28101768|NCT02905006|54758405|FG001|Overall Study|Positive for Tuberculosis|1|||
28101769|NCT02905006|54758406|FG002|Overall Study|Positive for Tuberculosis|0|||
28101770|NCT02905006|54758407|FG003|Overall Study|Positive for Tuberculosis|0|||
28101771|NCT02905006|54758408|FG004|Overall Study|Positive for Tuberculosis|0|||
28101772|NCT02905006|54758409|FG005|Overall Study|Positive for Tuberculosis|0|||
28101773|NCT02905006|54758404|FG000|Overall Study|Subject positive for Hep B|0|||
28101774|NCT02905006|54758405|FG001|Overall Study|Subject positive for Hep B|0|||
28101775|NCT02905006|54758406|FG002|Overall Study|Subject positive for Hep B|1|||
28101776|NCT02905006|54758407|FG003|Overall Study|Subject positive for Hep B|0|||
28101777|NCT02905006|54758408|FG004|Overall Study|Subject positive for Hep B|0|||
28101778|NCT02905006|54758409|FG005|Overall Study|Subject positive for Hep B|0|||
28101779|NCT02905006|54758404|FG000|Overall Study|Patient moved abroad|0|||
28101780|NCT02905006|54758405|FG001|Overall Study|Patient moved abroad|0|||
28101781|NCT02905006|54758406|FG002|Overall Study|Patient moved abroad|0|||
28101782|NCT02905006|54758407|FG003|Overall Study|Patient moved abroad|1|||
28101783|NCT02905006|54758408|FG004|Overall Study|Patient moved abroad|0|||
28101784|NCT02905006|54758409|FG005|Overall Study|Patient moved abroad|0|||
28101785|NCT02905006|54758404|FG000|Overall Study|Patient randomized by mistake|0|||
28101786|NCT02905006|54758405|FG001|Overall Study|Patient randomized by mistake|0|||
28172875|NCT04525703|54844660|FG000|Overall Study|Lost to Follow-up|6|||
28172876|NCT04525703|54844661|FG001|Overall Study|Lost to Follow-up|15|||
28172877|NCT04525703|54844662|FG002|Overall Study|Lost to Follow-up|8|||
28172878|NCT04509076|54844675|FG000|Overall Study|Withdrawal by Subject|1|||
28172879|NCT04509076|54844676|FG001|Overall Study|Withdrawal by Subject|2|||
28172880|NCT04509076|54844675|FG000|Overall Study|Lost to Follow-up|1|||
28172881|NCT04509076|54844676|FG001|Overall Study|Lost to Follow-up|2|||
28172882|NCT04267614|54844690|FG000|Overall Study|Participants did not meet inclusion criteria|132|||
28172883|NCT04267614|54844690|FG000|Overall Study|Lost to Follow-up|115|||
28172884|NCT03946670|54844697|FG000|Overall Study|Progressive Disease|26|||
28172885|NCT03946670|54844698|FG001|Overall Study|Progressive Disease|23|||
28172886|NCT03946670|54844697|FG000|Overall Study|Adverse Event|7|||
28172887|NCT03946670|54844698|FG001|Overall Study|Adverse Event|9|||
27739935|NCT02786537|54189679|FG002|As Randomized|HCV drugs stolen from pt|0|||
27739936|NCT02786537|54189680|FG003|As Randomized|HCV drugs stolen from pt|0|||
27739937|NCT02786537|54189681|FG004|As Randomized|HCV drugs stolen from pt|0|||
27739938|NCT02786537|54189682|FG005|As Randomized|HCV drugs stolen from pt|0|||
27739939|NCT02786537|54189677|FG000|As Randomized|Advised to stop after lapse in dosing|0|||
27739940|NCT02786537|54189678|FG001|As Randomized|Advised to stop after lapse in dosing|1|||
27739941|NCT02786537|54189679|FG002|As Randomized|Advised to stop after lapse in dosing|0|||
27739942|NCT02786537|54189680|FG003|As Randomized|Advised to stop after lapse in dosing|0|||
27739943|NCT02786537|54189681|FG004|As Randomized|Advised to stop after lapse in dosing|0|||
27739944|NCT02786537|54189682|FG005|As Randomized|Advised to stop after lapse in dosing|0|||
28101787|NCT02905006|54758406|FG002|Overall Study|Patient randomized by mistake|0|||
28101788|NCT02905006|54758407|FG003|Overall Study|Patient randomized by mistake|0|||
28101789|NCT02905006|54758408|FG004|Overall Study|Patient randomized by mistake|0|||
28101790|NCT02905006|54758409|FG005|Overall Study|Patient randomized by mistake|1|||
28101791|NCT01066780|54758447|FG000|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
28101792|NCT01066780|54758448|FG001|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
28101793|NCT02975206|54758455|FG000|Overall Study|Withdrawal by Subject|14|||
28101794|NCT02975206|54758456|FG001|Overall Study|Withdrawal by Subject|11|||
28101795|NCT02975206|54758457|FG002|Overall Study|Withdrawal by Subject|11|||
28101796|NCT02975206|54758455|FG000|Overall Study|Other (e.g., lost to follow up)|13|||
28101797|NCT02975206|54758456|FG001|Overall Study|Other (e.g., lost to follow up)|6|||
28101798|NCT02975206|54758457|FG002|Overall Study|Other (e.g., lost to follow up)|6|||
28101799|NCT01066156|54758465|FG000|Overall Study|ineligible|2|||
27739945|NCT02786537|54189677|FG000|As Randomized|Subject lost insurance|0|||
27917006|NCT01172938|54574541|FG006|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
27917007|NCT01172938|54574542|FG007|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1|||
27917008|NCT01172938|54574543|FG008|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
27917009|NCT01172938|54574535|FG000|Active-Treatment Phase (Weeks 208-260)|Death|0|||
28005920|NCT00795821|54664783|FG000|Acute Treatment Phase|Lack of Efficacy|5|||
28005921|NCT00795821|54664784|FG001|Acute Treatment Phase|Lack of Efficacy|2|||
27917010|NCT01172938|54574536|FG001|Active-Treatment Phase (Weeks 208-260)|Death|0|||
27917011|NCT01172938|54574537|FG002|Active-Treatment Phase (Weeks 208-260)|Death|1|||
27917012|NCT01172938|54574538|FG003|Active-Treatment Phase (Weeks 208-260)|Death|0|||
27917013|NCT01172938|54574539|FG004|Active-Treatment Phase (Weeks 208-260)|Death|0|||
27917014|NCT01172938|54574540|FG005|Active-Treatment Phase (Weeks 208-260)|Death|0|||
27917015|NCT01172938|54574541|FG006|Active-Treatment Phase (Weeks 208-260)|Death|0|||
27917016|NCT01172938|54574542|FG007|Active-Treatment Phase (Weeks 208-260)|Death|0|||
27917017|NCT01172938|54574543|FG008|Active-Treatment Phase (Weeks 208-260)|Death|0|||
27917018|NCT01172938|54574535|FG000|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
27917019|NCT01172938|54574536|FG001|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
27917020|NCT01172938|54574537|FG002|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1|||
27917021|NCT01172938|54574538|FG003|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
27917022|NCT01172938|54574539|FG004|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
27917023|NCT01172938|54574540|FG005|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
27917024|NCT01172938|54574541|FG006|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
27917025|NCT01172938|54574542|FG007|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
27917026|NCT01172938|54574543|FG008|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
27917027|NCT01172938|54574535|FG000|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
27917028|NCT01172938|54574536|FG001|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
27917029|NCT01172938|54574537|FG002|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
27917030|NCT01172938|54574538|FG003|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
27917031|NCT01172938|54574539|FG004|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
27917032|NCT01172938|54574540|FG005|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
27917033|NCT01172938|54574541|FG006|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
27917034|NCT01172938|54574542|FG007|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
27917035|NCT01172938|54574543|FG008|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1|||
27917036|NCT01109992|54574563|FG000|Overall Study|Withdrawal by Subject|0|||
27917037|NCT01109992|54574564|FG001|Overall Study|Withdrawal by Subject|1|||
27917038|NCT01109992|54574563|FG000|Overall Study|Movement during rest scan.|0|||
27917039|NCT01109992|54574564|FG001|Overall Study|Movement during rest scan.|1|||
27917040|NCT01109524|54574573|FG000|Overall Study|Disease Progression|29|||
27917041|NCT01109524|54574573|FG000|Overall Study|Study Drug toxicity|6|||
27917042|NCT01109524|54574573|FG000|Overall Study|Adverse Event|4|||
27917043|NCT01109524|54574573|FG000|Overall Study|Withdrawal by Subject|2|||
27917044|NCT01109524|54574573|FG000|Overall Study|Maximum clinical benefit|3|||
28005922|NCT00795821|54664783|FG000|Acute Treatment Phase|Lost to Follow-up|9|||
28005923|NCT00795821|54664784|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
28005924|NCT00795821|54664783|FG000|Acute Treatment Phase|Physician Decision|1|||
28005925|NCT00795821|54664784|FG001|Acute Treatment Phase|Physician Decision|1|||
28005926|NCT00795821|54664783|FG000|Acute Treatment Phase|Protocol Violation|1|||
28005927|NCT00795821|54664784|FG001|Acute Treatment Phase|Protocol Violation|2|||
28005928|NCT00795821|54664783|FG000|Acute Treatment Phase|Withdrawal by Subject|16|||
28005929|NCT00795821|54664784|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
28005930|NCT00795821|54664783|FG000|Long-term Extension Phase|Adverse Event|25|||
28005931|NCT00795821|54664784|FG001|Long-term Extension Phase|Adverse Event|32|||
28005932|NCT00795821|54664783|FG000|Long-term Extension Phase|Lack of Efficacy|16|||
28101800|NCT01066156|54758465|FG000|Overall Study|Lost to Follow-up|7|||
28101801|NCT01066156|54758465|FG000|Overall Study|Withdrawal by Subject|1|||
27739946|NCT02786537|54189678|FG001|As Randomized|Subject lost insurance|0|||
27739947|NCT02786537|54189679|FG002|As Randomized|Subject lost insurance|0|||
28101802|NCT02980042|54758471|FG000|Overall Study|Lost to Follow-up|5|||
28101803|NCT02980042|54758472|FG001|Overall Study|Lost to Follow-up|0|||
28101804|NCT02980042|54758471|FG000|Overall Study|Insurance issues/treatment plan changes|2|||
28101805|NCT02980042|54758472|FG001|Overall Study|Insurance issues/treatment plan changes|0|||
28101806|NCT01066000|54758490|FG000|Overall Study|Protocol Violation|4|||
28101807|NCT01066000|54758490|FG000|Overall Study|Death|3|||
28101808|NCT01066000|54758490|FG000|Overall Study|Withdrawal by Subject|1|||
28101809|NCT01066000|54758490|FG000|Overall Study|Adverse Event|1|||
28101810|NCT01065844|54758494|FG000|Overall Study|Adverse Event|5|||
28101811|NCT00004635|54758500|FG000|Period One|refused|2|||
28101812|NCT00004635|54758501|FG001|Period One|refused|1|||
28101813|NCT00004635|54758500|FG000|Period One|Withdrawal by Subject|1|||
28101814|NCT00004635|54758501|FG001|Period One|Withdrawal by Subject|1|||
28101815|NCT00004635|54758500|FG000|Period One|Protocol Violation|1|||
28101816|NCT00004635|54758501|FG001|Period One|Protocol Violation|0|||
28005933|NCT00795821|54664784|FG001|Long-term Extension Phase|Lack of Efficacy|12|||
28005934|NCT00795821|54664783|FG000|Long-term Extension Phase|Lost to Follow-up|20|||
28005935|NCT00795821|54664784|FG001|Long-term Extension Phase|Lost to Follow-up|16|||
28005936|NCT00795821|54664783|FG000|Long-term Extension Phase|Physician Decision|1|||
28005937|NCT00795821|54664784|FG001|Long-term Extension Phase|Physician Decision|2|||
28005938|NCT00795821|54664783|FG000|Long-term Extension Phase|Protocol Violation|3|||
28005939|NCT00795821|54664784|FG001|Long-term Extension Phase|Protocol Violation|5|||
28005940|NCT00795821|54664783|FG000|Long-term Extension Phase|Withdrawal by Subject|25|||
28005941|NCT00795821|54664784|FG001|Long-term Extension Phase|Withdrawal by Subject|25|||
28005942|NCT00795821|54664783|FG000|Taper Phase|Adverse Event|2|||
28005943|NCT00795821|54664784|FG001|Taper Phase|Adverse Event|0|||
28005944|NCT00795821|54664783|FG000|Taper Phase|Lost to Follow-up|1|||
28005945|NCT00795821|54664784|FG001|Taper Phase|Lost to Follow-up|0|||
28005946|NCT00795821|54664783|FG000|Taper Phase|Physician Decision|2|||
28005947|NCT00795821|54664784|FG001|Taper Phase|Physician Decision|0|||
28005948|NCT00795821|54664783|FG000|Taper Phase|Withdrawal by Subject|4|||
28005949|NCT00795821|54664784|FG001|Taper Phase|Withdrawal by Subject|0|||
28005950|NCT00578643|54664800|FG000|Overall Study|Death|1|||
28005951|NCT00578643|54664800|FG000|Overall Study|Lost to Follow-up|1|||
28101817|NCT00004635|54758500|FG000|Period One|PSA did not go <5 ng/mL|1|||
28101818|NCT00004635|54758501|FG001|Period One|PSA did not go <5 ng/mL|0|||
28101819|NCT00004635|54758500|FG000|Period One|second malignancy|1|||
28101820|NCT00004635|54758501|FG001|Period One|second malignancy|0|||
28101821|NCT00004635|54758500|FG000|Period One|progressed|0|||
28101822|NCT00004635|54758501|FG001|Period One|progressed|2|||
28101823|NCT00004635|54758500|FG000|Period One|health problem|0|||
28101824|NCT00004635|54758501|FG001|Period One|health problem|1|||
28101825|NCT00004635|54758500|FG000|Period One|discrepancy in data entry|0|||
28101826|NCT00004635|54758501|FG001|Period One|discrepancy in data entry|1|||
28101827|NCT00004635|54758500|FG000|Period Two|progression|2|||
28172888|NCT03946670|54844697|FG000|Overall Study|Death|5|||
28172889|NCT03946670|54844698|FG001|Overall Study|Death|6|||
28172890|NCT03946670|54844697|FG000|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|5|||
28172891|NCT03946670|54844698|FG001|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|6|||
28172892|NCT03946670|54844697|FG000|Overall Study|Subject Decision|4|||
28172893|NCT03946670|54844698|FG001|Overall Study|Subject Decision|4|||
28172894|NCT03946670|54844697|FG000|Overall Study|Physician Decision|3|||
28172895|NCT03946670|54844698|FG001|Overall Study|Physician Decision|3|||
28172896|NCT03946670|54844697|FG000|Overall Study|New Therapy for Study Indication|1|||
28172897|NCT03946670|54844698|FG001|Overall Study|New Therapy for Study Indication|0|||
28172898|NCT03946670|54844697|FG000|Overall Study|Not treated|1|||
28172899|NCT03946670|54844698|FG001|Overall Study|Not treated|1|||
28172900|NCT03735680|54844710|FG000|Overall Study|Withdrawal by Subject|0|||
28172901|NCT03735680|54844711|FG001|Overall Study|Withdrawal by Subject|1|||
28172902|NCT03735680|54844712|FG002|Overall Study|Withdrawal by Subject|0|||
28172903|NCT03735680|54844713|FG003|Overall Study|Withdrawal by Subject|0|||
28172904|NCT03735680|54844714|FG004|Overall Study|Withdrawal by Subject|0|||
28172905|NCT03735680|54844715|FG005|Overall Study|Withdrawal by Subject|1|||
28172906|NCT03735680|54844710|FG000|Overall Study|Patient unable or unwilling to continue|0|||
28005952|NCT00578565|54664804|FG000|Overall Study|Adverse Event|3|||
28005953|NCT00741260|54664816|FG000|Overall Study|Disease Progression|3|||
28005954|NCT00741260|54664817|FG001|Overall Study|Disease Progression|5|||
28101828|NCT00004635|54758501|FG001|Period Two|progression|3|||
28101829|NCT00004635|54758500|FG000|Period Two|Adverse Event|1|||
28101830|NCT00004635|54758501|FG001|Period Two|Adverse Event|0|||
28101831|NCT00004635|54758500|FG000|Period Two|refused|0|||
28172907|NCT03735680|54844711|FG001|Overall Study|Patient unable or unwilling to continue|0|||
28101832|NCT00004635|54758501|FG001|Period Two|refused|2|||
28172908|NCT03735680|54844712|FG002|Overall Study|Patient unable or unwilling to continue|1|||
28172909|NCT03735680|54844713|FG003|Overall Study|Patient unable or unwilling to continue|0|||
28101833|NCT00004635|54758500|FG000|Period Two|health problem|1|||
28101834|NCT00004635|54758501|FG001|Period Two|health problem|1|||
28101835|NCT00004635|54758500|FG000|Period Two|travel issues|0|||
28101836|NCT00004635|54758501|FG001|Period Two|travel issues|1|||
28101837|NCT00004635|54758500|FG000|Period Two|secondary malignancy|1|||
28101838|NCT00004635|54758501|FG001|Period Two|secondary malignancy|1|||
28101839|NCT00004635|54758500|FG000|Period Two|Lost to Follow-up|1|||
28101840|NCT00004635|54758501|FG001|Period Two|Lost to Follow-up|0|||
28101841|NCT00004635|54758500|FG000|Period Two|discrepancy in data entry|0|||
28101842|NCT00004635|54758501|FG001|Period Two|discrepancy in data entry|1|||
28101843|NCT00004563|54758512|FG000|Overall Study|Withdrawal by Subject|20|||
28101844|NCT00004563|54758513|FG001|Overall Study|Withdrawal by Subject|16|||
28101845|NCT00004563|54758512|FG000|Overall Study|Lack of Efficacy|3|||
28101846|NCT00004563|54758513|FG001|Overall Study|Lack of Efficacy|5|||
28101847|NCT00004563|54758512|FG000|Overall Study|Death|2|||
28101848|NCT00004563|54758513|FG001|Overall Study|Death|3|||
28101849|NCT00003645|54758521|FG000|Overall Study|Death|4|||
28101850|NCT00003645|54758522|FG001|Overall Study|Death|1|||
28101851|NCT00003645|54758521|FG000|Overall Study|Lost to Follow-up|7|||
28101852|NCT00003645|54758522|FG001|Overall Study|Lost to Follow-up|8|||
28101853|NCT00003645|54758521|FG000|Overall Study|Withdrawal by Subject|1|||
28101854|NCT00003645|54758522|FG001|Overall Study|Withdrawal by Subject|3|||
28101855|NCT00003537|54758530|FG000|Overall Study|Not evalauable|1|||
28101856|NCT00003531|54758534|FG000|Overall Study|Not evaluable|10|||
28101857|NCT02918968|54758540|FG000|1st Line AAT|Progressive disease|9|||
28101858|NCT02918968|54758541|FG001|1st Line AAT|Progressive disease|4|||
28101859|NCT02918968|54758540|FG000|1st Line AAT|Adverse Event|12|||
28101860|NCT02918968|54758541|FG001|1st Line AAT|Adverse Event|3|||
28101861|NCT02918968|54758540|FG000|1st Line AAT|Physician Decision|4|||
28101862|NCT02918968|54758541|FG001|1st Line AAT|Physician Decision|2|||
28101863|NCT02918968|54758540|FG000|1st Line AAT|Withdrawal by Subject|2|||
28101864|NCT02918968|54758541|FG001|1st Line AAT|Withdrawal by Subject|1|||
28101865|NCT02918968|54758540|FG000|1st Line AAT|Lost to Follow-up|0|||
28101866|NCT02918968|54758541|FG001|1st Line AAT|Lost to Follow-up|1|||
28101867|NCT02918968|54758540|FG000|1st Line AAT|Death|1|||
28101868|NCT02918968|54758541|FG001|1st Line AAT|Death|0|||
28101869|NCT02918968|54758540|FG000|1st Line AAT|Miscellaneous|1|||
28101870|NCT02918968|54758541|FG001|1st Line AAT|Miscellaneous|0|||
28101871|NCT02918968|54758540|FG000|2nd Line AAT|Progressive disease|21|||
28101872|NCT02918968|54758541|FG001|2nd Line AAT|Progressive disease|3|||
28101873|NCT02918968|54758540|FG000|2nd Line AAT|Adverse Event|2|||
28101874|NCT02918968|54758541|FG001|2nd Line AAT|Adverse Event|5|||
28101875|NCT02918968|54758540|FG000|2nd Line AAT|Physician Decision|0|||
28005955|NCT00741260|54664818|FG002|Overall Study|Disease Progression|3|||
28005956|NCT00741260|54664819|FG003|Overall Study|Disease Progression|3|||
28005957|NCT00741260|54664820|FG004|Overall Study|Disease Progression|5|||
28005958|NCT00741260|54664821|FG005|Overall Study|Disease Progression|37|||
28005959|NCT00741260|54664822|FG006|Overall Study|Disease Progression|4|||
28005960|NCT00741260|54664816|FG000|Overall Study|Death|0|||
27917045|NCT01109524|54574573|FG000|Overall Study|Death|2|||
27917046|NCT01109524|54574573|FG000|Overall Study|No longer meets criteria|2|||
27917047|NCT01109524|54574573|FG000|Overall Study|Participant requested to end treatment|4|||
27917048|NCT01109524|54574573|FG000|Overall Study|Other|5|||
27917049|NCT01109173|54574588|FG000|Overall Study|Adverse Event|15|||
27917050|NCT01109173|54574589|FG001|Overall Study|Adverse Event|17|||
27917051|NCT01109173|54574590|FG002|Overall Study|Adverse Event|9|||
28101876|NCT02918968|54758541|FG001|2nd Line AAT|Physician Decision|1|||
28101877|NCT02918968|54758540|FG000|2nd Line AAT|Withdrawal by Subject|2|||
28101878|NCT02918968|54758541|FG001|2nd Line AAT|Withdrawal by Subject|2|||
28101879|NCT02918968|54758540|FG000|2nd Line AAT|Death|0|||
28101880|NCT02918968|54758541|FG001|2nd Line AAT|Death|1|||
28101881|NCT01065766|54758549|FG000|Overall Study|Assessed before the contracted date|1|||
27917052|NCT01109173|54574591|FG003|Overall Study|Adverse Event|6|||
27917053|NCT01109173|54574588|FG000|Overall Study|Lost to Follow-up|0|||
27917054|NCT01109173|54574589|FG001|Overall Study|Lost to Follow-up|1|||
27917055|NCT01109173|54574590|FG002|Overall Study|Lost to Follow-up|0|||
27917056|NCT01109173|54574591|FG003|Overall Study|Lost to Follow-up|0|||
27917057|NCT01109173|54574588|FG000|Overall Study|Patient Decision Unrelated to Advrs Evnt|5|||
28005961|NCT00741260|54664817|FG001|Overall Study|Death|1|||
27917058|NCT01109173|54574589|FG001|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
28101882|NCT01065766|54758549|FG000|Overall Study|Contraindication to administration|6|||
28101883|NCT01065766|54758549|FG000|Overall Study|Violated dosage/administration|25|||
28101884|NCT01063972|54758555|FG000|Overall Study|Death|12|||
28101885|NCT01063972|54758556|FG001|Overall Study|Death|11|||
28101886|NCT01063972|54758555|FG000|Overall Study|Incarcerated|2|||
28101887|NCT01063972|54758556|FG001|Overall Study|Incarcerated|1|||
28101888|NCT00003483|54758562|FG000|Overall Study|Not evaluable|1|||
28172910|NCT03735680|54844714|FG004|Overall Study|Patient unable or unwilling to continue|0|||
28101889|NCT00003477|54758566|FG000|Overall Study|Not evalauable|4|||
28101890|NCT00003471|54758570|FG000|Overall Study|Not evaluable|4|||
27917059|NCT01109173|54574590|FG002|Overall Study|Patient Decision Unrelated to Advrs Evnt|2|||
28101891|NCT04185220|54758576|FG000|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|0|||
28172911|NCT03735680|54844715|FG005|Overall Study|Patient unable or unwilling to continue|0|||
28005962|NCT00741260|54664818|FG002|Overall Study|Death|0|||
28005963|NCT00741260|54664819|FG003|Overall Study|Death|1|||
28005964|NCT00741260|54664820|FG004|Overall Study|Death|2|||
28005965|NCT00741260|54664821|FG005|Overall Study|Death|2|||
28005966|NCT00741260|54664822|FG006|Overall Study|Death|1|||
28005967|NCT00741260|54664816|FG000|Overall Study|Withdrawal by Subject|0|||
28005968|NCT00741260|54664817|FG001|Overall Study|Withdrawal by Subject|0|||
28005969|NCT00741260|54664818|FG002|Overall Study|Withdrawal by Subject|0|||
28005970|NCT00741260|54664819|FG003|Overall Study|Withdrawal by Subject|0|||
28005971|NCT00741260|54664820|FG004|Overall Study|Withdrawal by Subject|1|||
28005972|NCT00741260|54664821|FG005|Overall Study|Withdrawal by Subject|3|||
28005973|NCT00741260|54664822|FG006|Overall Study|Withdrawal by Subject|1|||
28101892|NCT04185220|54758577|FG001|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|1|||
28101893|NCT04185220|54758576|FG000|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|0|||
28101894|NCT04185220|54758577|FG001|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|1|||
28101895|NCT00002931|54758584|FG000|Overall Study|rapidly progressing disease during|2|||
28101896|NCT02918266|54758599|FG000|Part 2: Intervention Period 1 (2 Days)|Study termination|0|||
28101897|NCT02918266|54758600|FG001|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
28101898|NCT02918266|54758601|FG002|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
28101899|NCT02918266|54758602|FG003|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
28101900|NCT02918266|54758603|FG004|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
28101901|NCT02918266|54758604|FG005|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
28101902|NCT02918266|54758605|FG006|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
28101903|NCT02918266|54758606|FG007|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
28101904|NCT02918266|54758607|FG008|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
28101905|NCT02918266|54758608|FG009|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
28101906|NCT02918266|54758609|FG010|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
28101907|NCT00041067|54758629|FG000|Overall Study|Adverse Event|20|||
28101908|NCT00041067|54758629|FG000|Overall Study|Progression|19|||
28101909|NCT00041067|54758629|FG000|Overall Study|Patient refusal|12|||
28101910|NCT00041067|54758629|FG000|Overall Study|Other reasons|23|||
28101911|NCT00041067|54758629|FG000|Overall Study|Ineligible|2|||
28101912|NCT01063036|54758634|FG000|Participants Treated With Study Drug|Adverse Event|1|||
28101913|NCT01063036|54758634|FG000|Participants Treated With Study Drug|Protocol Violation|1|||
28101914|NCT01063036|54758634|FG000|Participants Treated With Study Drug|Withdrawal by Subject|2|||
28101915|NCT01063036|54758634|FG000|Participants Treated With Study Drug|Lost to Follow-up|1|||
28101916|NCT01063036|54758634|FG000|Participants Treated With Study Drug|Pregnancy|1|||
28101917|NCT01063036|54758634|FG000|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1|||
28101918|NCT01063036|54758634|FG000|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6|||
28101919|NCT01063036|54758634|FG000|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32|||
28101920|NCT00040365|54758638|FG000|Overall Study|Death|1|||
28101921|NCT00040365|54758638|FG000|Overall Study|Progressive disease|7|||
28101922|NCT00040365|54758638|FG000|Overall Study|Lost to Follow-up|3|||
28101923|NCT02974114|54758645|FG000|Overall Study|Other (Not specified)|0|||
28101924|NCT02974114|54758646|FG001|Overall Study|Other (Not specified)|1|||
28101925|NCT02974114|54758647|FG002|Overall Study|Other (Not specified)|2|||
28101926|NCT00001959|54758657|FG000|Overall Study|newly diagnosed colon cancer|1|||
28101927|NCT00001959|54758657|FG000|Overall Study|disabling sedation|1|||
28101928|NCT00001959|54758657|FG000|Overall Study|non-compliance|1|||
28101929|NCT00001941|54758661|FG000|Overall Study|not treated- rapidly progressing disease|0|||
28005974|NCT00741260|54664816|FG000|Overall Study|Physician Decision|1|||
28005975|NCT00741260|54664817|FG001|Overall Study|Physician Decision|1|||
28005976|NCT00741260|54664818|FG002|Overall Study|Physician Decision|0|||
28005977|NCT00741260|54664819|FG003|Overall Study|Physician Decision|0|||
28005978|NCT00741260|54664820|FG004|Overall Study|Physician Decision|0|||
28005979|NCT00741260|54664821|FG005|Overall Study|Physician Decision|0|||
28005980|NCT00741260|54664822|FG006|Overall Study|Physician Decision|0|||
28005981|NCT00741260|54664816|FG000|Overall Study|Other|2|||
28005982|NCT00741260|54664817|FG001|Overall Study|Other|1|||
28005983|NCT00741260|54664818|FG002|Overall Study|Other|1|||
28005984|NCT00741260|54664819|FG003|Overall Study|Other|2|||
28101930|NCT00001941|54758662|FG001|Overall Study|not treated- rapidly progressing disease|0|||
28101931|NCT00001941|54758663|FG002|Overall Study|not treated- rapidly progressing disease|0|||
28101932|NCT00001941|54758664|FG003|Overall Study|not treated- rapidly progressing disease|0|||
28172912|NCT03726658|54844751|FG000|Overall Study|Lost to Follow-up|0|||
28172913|NCT03726658|54844752|FG001|Overall Study|Lost to Follow-up|0|||
28005985|NCT00741260|54664820|FG004|Overall Study|Other|1|||
28005986|NCT00741260|54664821|FG005|Overall Study|Other|3|||
28005987|NCT00741260|54664822|FG006|Overall Study|Other|1|||
28005988|NCT00740870|54664843|FG000|Overall Study|Not Catheterized|4|||
28005989|NCT00740870|54664843|FG000|Overall Study|Further testing contraindicated implant|17|||
28005990|NCT00740792|54664854|FG000|Overall Study|Adverse Event|3|||
28005991|NCT00740792|54664855|FG001|Overall Study|Adverse Event|1|||
28101933|NCT00001941|54758665|FG004|Overall Study|not treated- rapidly progressing disease|1|||
28101934|NCT02978326|54758673|FG000|Part B (Up to 45 Days)|Adverse Event|0|||
28101935|NCT02978326|54758674|FG001|Part B (Up to 45 Days)|Adverse Event|0|||
28101936|NCT02978326|54758675|FG002|Part B (Up to 45 Days)|Adverse Event|1|||
28101937|NCT02978326|54758673|FG000|Part B (Up to 45 Days)|Lost to Follow-up|0|||
28101938|NCT02978326|54758674|FG001|Part B (Up to 45 Days)|Lost to Follow-up|3|||
28101939|NCT02978326|54758675|FG002|Part B (Up to 45 Days)|Lost to Follow-up|0|||
28101940|NCT02978326|54758673|FG000|Part B (Up to 45 Days)|Non-compliance|0|||
28101941|NCT02978326|54758674|FG001|Part B (Up to 45 Days)|Non-compliance|2|||
28101942|NCT02978326|54758675|FG002|Part B (Up to 45 Days)|Non-compliance|0|||
28101943|NCT02978326|54758673|FG000|Part B (Up to 45 Days)|Withdrawal by Subject|0|||
28101944|NCT02978326|54758674|FG001|Part B (Up to 45 Days)|Withdrawal by Subject|2|||
28101945|NCT02978326|54758675|FG002|Part B (Up to 45 Days)|Withdrawal by Subject|3|||
28101946|NCT01061866|54758685|FG000|Overall Study|Adverse Event|2|||
28101947|NCT01061008|54758691|FG000|Overall Study|Badiocephalic fistula failed|3|||
28172914|NCT03726658|54844753|FG002|Overall Study|Lost to Follow-up|2|||
28172915|NCT03726658|54844754|FG003|Overall Study|Lost to Follow-up|0|||
28172916|NCT03726658|54844755|FG004|Overall Study|Lost to Follow-up|0|||
28172917|NCT03726658|54844756|FG005|Overall Study|Lost to Follow-up|1|||
28172918|NCT03726658|54844757|FG006|Overall Study|Lost to Follow-up|1|||
28172919|NCT03726658|54844751|FG000|Overall Study|Withdrawal by Subject|1|||
28172920|NCT03726658|54844752|FG001|Overall Study|Withdrawal by Subject|0|||
28005992|NCT00740792|54664856|FG002|Overall Study|Adverse Event|1|||
28005993|NCT00740792|54664857|FG003|Overall Study|Adverse Event|3|||
28005994|NCT00740792|54664854|FG000|Overall Study|Lack of Efficacy|1|||
28005995|NCT00740792|54664855|FG001|Overall Study|Lack of Efficacy|1|||
28005996|NCT00740792|54664856|FG002|Overall Study|Lack of Efficacy|0|||
28005997|NCT00740792|54664857|FG003|Overall Study|Lack of Efficacy|3|||
28005998|NCT00740792|54664854|FG000|Overall Study|Lost to Follow-up|2|||
28005999|NCT00740792|54664855|FG001|Overall Study|Lost to Follow-up|1|||
28006000|NCT00740792|54664856|FG002|Overall Study|Lost to Follow-up|0|||
28006001|NCT00740792|54664857|FG003|Overall Study|Lost to Follow-up|0|||
28006002|NCT00740792|54664854|FG000|Overall Study|Protocol Violation|0|||
28006003|NCT00740792|54664855|FG001|Overall Study|Protocol Violation|1|||
28006004|NCT00740792|54664856|FG002|Overall Study|Protocol Violation|0|||
28006005|NCT00740792|54664857|FG003|Overall Study|Protocol Violation|2|||
28006006|NCT00740792|54664854|FG000|Overall Study|Withdrawal by Subject|1|||
28006007|NCT00740792|54664855|FG001|Overall Study|Withdrawal by Subject|1|||
28006008|NCT00740792|54664856|FG002|Overall Study|Withdrawal by Subject|0|||
28006009|NCT00740792|54664857|FG003|Overall Study|Withdrawal by Subject|0|||
28006010|NCT00740792|54664854|FG000|Overall Study|administrative|3|||
28006011|NCT00740792|54664855|FG001|Overall Study|administrative|3|||
28006012|NCT00740792|54664856|FG002|Overall Study|administrative|8|||
28006013|NCT00740792|54664857|FG003|Overall Study|administrative|2|||
28006014|NCT00740714|54664870|FG000|Overall Study|Withdrawal by Subject|17|||
28006015|NCT00740714|54664871|FG001|Overall Study|Withdrawal by Subject|19|||
28006016|NCT00740714|54664872|FG002|Overall Study|Withdrawal by Subject|29|||
28006017|NCT00788957|54664884|FG000|Part 1|Death|8|||
28006018|NCT00788957|54664885|FG001|Part 1|Death|0|||
28006019|NCT00788957|54664886|FG002|Part 1|Death|0|||
28006020|NCT00788957|54664887|FG003|Part 1|Death|0|||
28006021|NCT00788957|54664888|FG004|Part 1|Death|0|||
28006022|NCT00788957|54664889|FG005|Part 1|Death|0|||
28006023|NCT00788957|54664884|FG000|Part 1|Lost to Follow-up|1|||
28006024|NCT00788957|54664885|FG001|Part 1|Lost to Follow-up|0|||
28006025|NCT00788957|54664886|FG002|Part 1|Lost to Follow-up|0|||
28006026|NCT00788957|54664887|FG003|Part 1|Lost to Follow-up|0|||
28006027|NCT00788957|54664888|FG004|Part 1|Lost to Follow-up|0|||
28006028|NCT00788957|54664889|FG005|Part 1|Lost to Follow-up|0|||
28006029|NCT00788957|54664884|FG000|Part 2|Withdrawal by Subject|0|||
28006030|NCT00788957|54664885|FG001|Part 2|Withdrawal by Subject|9|||
28006031|NCT00788957|54664886|FG002|Part 2|Withdrawal by Subject|5|||
28006032|NCT00788957|54664887|FG003|Part 2|Withdrawal by Subject|3|||
28006033|NCT00788957|54664888|FG004|Part 2|Withdrawal by Subject|0|||
28172921|NCT03726658|54844753|FG002|Overall Study|Withdrawal by Subject|0|||
28006034|NCT00788957|54664889|FG005|Part 2|Withdrawal by Subject|0|||
28006035|NCT00788957|54664884|FG000|Part 2|Death|0|||
28006036|NCT00788957|54664885|FG001|Part 2|Death|32|||
28006037|NCT00788957|54664886|FG002|Part 2|Death|35|||
28101948|NCT01061008|54758692|FG001|Overall Study|Badiocephalic fistula failed|2|||
28172922|NCT03726658|54844754|FG003|Overall Study|Withdrawal by Subject|0|||
28172923|NCT03726658|54844755|FG004|Overall Study|Withdrawal by Subject|6|||
28172924|NCT03726658|54844756|FG005|Overall Study|Withdrawal by Subject|4|||
28101949|NCT01061008|54758691|FG000|Overall Study|Death|1|||
28101950|NCT01061008|54758692|FG001|Overall Study|Death|0|||
28006038|NCT00788957|54664887|FG003|Part 2|Death|37|||
28006039|NCT00788957|54664888|FG004|Part 2|Death|0|||
28006040|NCT00788957|54664889|FG005|Part 2|Death|0|||
28006041|NCT00788957|54664884|FG000|Part 2|Lost to Follow-up|0|||
28006042|NCT00788957|54664885|FG001|Part 2|Lost to Follow-up|0|||
28006043|NCT00788957|54664886|FG002|Part 2|Lost to Follow-up|3|||
28101951|NCT01061008|54758691|FG000|Overall Study|Withdrawal by Subject|1|||
28101952|NCT01061008|54758692|FG001|Overall Study|Withdrawal by Subject|3|||
28101953|NCT01061008|54758691|FG000|Overall Study|Unable to exercise following surgery|1|||
28101954|NCT01061008|54758692|FG001|Overall Study|Unable to exercise following surgery|0|||
28101955|NCT01061008|54758691|FG000|Overall Study|Adverse Event|0|||
28101956|NCT01061008|54758692|FG001|Overall Study|Adverse Event|1|||
28101957|NCT00039741|54758702|FG000|Overall Study|Death|0|||
28101958|NCT00039741|54758703|FG001|Overall Study|Death|1|||
28101959|NCT00039741|54758704|FG002|Overall Study|Death|0|||
28101960|NCT00039741|54758705|FG003|Overall Study|Death|0|||
28101961|NCT00039741|54758702|FG000|Overall Study|Lost to Follow-up|3|||
28101962|NCT00039741|54758703|FG001|Overall Study|Lost to Follow-up|1|||
28101963|NCT00039741|54758704|FG002|Overall Study|Lost to Follow-up|5|||
28101964|NCT00039741|54758705|FG003|Overall Study|Lost to Follow-up|2|||
28101965|NCT00039741|54758702|FG000|Overall Study|Confounding medical condition|1|||
28101966|NCT00039741|54758703|FG001|Overall Study|Confounding medical condition|0|||
28101967|NCT00039741|54758704|FG002|Overall Study|Confounding medical condition|0|||
28101968|NCT00039741|54758705|FG003|Overall Study|Confounding medical condition|0|||
28101969|NCT00039741|54758702|FG000|Overall Study|Not able to get to clinic|5|||
28101970|NCT00039741|54758703|FG001|Overall Study|Not able to get to clinic|2|||
28101971|NCT00039741|54758704|FG002|Overall Study|Not able to get to clinic|0|||
28101972|NCT00039741|54758705|FG003|Overall Study|Not able to get to clinic|3|||
28101973|NCT00039741|54758702|FG000|Overall Study|Moved|3|||
28101974|NCT00039741|54758703|FG001|Overall Study|Moved|2|||
28101975|NCT00039741|54758704|FG002|Overall Study|Moved|3|||
28101976|NCT00039741|54758705|FG003|Overall Study|Moved|6|||
28101977|NCT00039741|54758702|FG000|Overall Study|Non-compliance with protocol|1|||
28101978|NCT00039741|54758703|FG001|Overall Study|Non-compliance with protocol|0|||
28101979|NCT00039741|54758704|FG002|Overall Study|Non-compliance with protocol|1|||
28101980|NCT00039741|54758705|FG003|Overall Study|Non-compliance with protocol|0|||
28101981|NCT00039741|54758702|FG000|Overall Study|Withdrew consent|0|||
28101982|NCT00039741|54758703|FG001|Overall Study|Withdrew consent|5|||
28101983|NCT00039741|54758704|FG002|Overall Study|Withdrew consent|0|||
28101984|NCT00039741|54758705|FG003|Overall Study|Withdrew consent|1|||
28101985|NCT00039741|54758702|FG000|Overall Study|Missed final visit|2|||
28101986|NCT00039741|54758703|FG001|Overall Study|Missed final visit|1|||
28101987|NCT00039741|54758704|FG002|Overall Study|Missed final visit|2|||
28101988|NCT00039741|54758705|FG003|Overall Study|Missed final visit|2|||
28101989|NCT02973802|54758715|FG000|Overall Study|Lost to Follow-up|1|||
28101990|NCT02973802|54758715|FG000|Overall Study|Withdrawal by Subject|1|||
28101991|NCT02973100|54758724|FG000|Overall Study|Adverse Event|1|||
28101992|NCT02973100|54758725|FG001|Overall Study|Adverse Event|2|||
28006044|NCT00788957|54664887|FG003|Part 2|Lost to Follow-up|0|||
28006045|NCT00788957|54664888|FG004|Part 2|Lost to Follow-up|0|||
28006046|NCT00788957|54664889|FG005|Part 2|Lost to Follow-up|0|||
28006047|NCT00788957|54664884|FG000|Part 2|On-study at time of data cut-off|0|||
28006048|NCT00788957|54664885|FG001|Part 2|On-study at time of data cut-off|1|||
28006049|NCT00788957|54664886|FG002|Part 2|On-study at time of data cut-off|1|||
28006050|NCT00788957|54664887|FG003|Part 2|On-study at time of data cut-off|1|||
28006051|NCT00788957|54664888|FG004|Part 2|On-study at time of data cut-off|0|||
28006052|NCT00788957|54664889|FG005|Part 2|On-study at time of data cut-off|0|||
28006053|NCT00788957|54664884|FG000|Part 3|Withdrawal by Subject|0|||
28006054|NCT00788957|54664885|FG001|Part 3|Withdrawal by Subject|0|||
28006055|NCT00788957|54664886|FG002|Part 3|Withdrawal by Subject|0|||
28006056|NCT00788957|54664887|FG003|Part 3|Withdrawal by Subject|0|||
28006057|NCT00788957|54664888|FG004|Part 3|Withdrawal by Subject|0|||
28006058|NCT00788957|54664889|FG005|Part 3|Withdrawal by Subject|2|||
28006059|NCT00788957|54664884|FG000|Part 3|Death|0|||
28006060|NCT00788957|54664885|FG001|Part 3|Death|0|||
28006061|NCT00788957|54664886|FG002|Part 3|Death|0|||
28006062|NCT00788957|54664887|FG003|Part 3|Death|0|||
28006063|NCT00788957|54664888|FG004|Part 3|Death|8|||
28006064|NCT00788957|54664889|FG005|Part 3|Death|9|||
28101993|NCT02973100|54758726|FG002|Overall Study|Adverse Event|1|||
28101994|NCT02973100|54758727|FG003|Overall Study|Adverse Event|2|||
28101995|NCT02973100|54758724|FG000|Overall Study|Lost to Follow-up|3|||
28101996|NCT02973100|54758725|FG001|Overall Study|Lost to Follow-up|1|||
28101997|NCT02973100|54758726|FG002|Overall Study|Lost to Follow-up|1|||
28101998|NCT02973100|54758727|FG003|Overall Study|Lost to Follow-up|0|||
28101999|NCT02973100|54758724|FG000|Overall Study|Withdrawal by Subject|3|||
28102000|NCT02973100|54758725|FG001|Overall Study|Withdrawal by Subject|5|||
28102001|NCT02973100|54758726|FG002|Overall Study|Withdrawal by Subject|1|||
28102002|NCT02973100|54758727|FG003|Overall Study|Withdrawal by Subject|4|||
28006065|NCT00788957|54664884|FG000|Part 3|On-study at time of data cut-off|0|||
28006066|NCT00788957|54664885|FG001|Part 3|On-study at time of data cut-off|0|||
28006067|NCT00788957|54664886|FG002|Part 3|On-study at time of data cut-off|0|||
28006068|NCT00788957|54664887|FG003|Part 3|On-study at time of data cut-off|0|||
28006069|NCT00788957|54664888|FG004|Part 3|On-study at time of data cut-off|1|||
28102003|NCT02973100|54758724|FG000|Overall Study|Notification of change in address|0|||
28006070|NCT00788957|54664889|FG005|Part 3|On-study at time of data cut-off|0|||
28006071|NCT00740636|54664908|FG000|Overall Study|Adverse Event|0|||
28006072|NCT00740636|54664909|FG001|Overall Study|Adverse Event|2|||
28006073|NCT00740636|54664908|FG000|Overall Study|Patient Ineligible|0|||
28006074|NCT00740636|54664909|FG001|Overall Study|Patient Ineligible|1|||
28006075|NCT00740636|54664908|FG000|Overall Study|Patient Not Treated|0|||
28006076|NCT00740636|54664909|FG001|Overall Study|Patient Not Treated|1|||
28006077|NCT00740636|54664908|FG000|Overall Study|Progressive Disease|1|||
28006078|NCT00740636|54664909|FG001|Overall Study|Progressive Disease|0|||
28006079|NCT00740636|54664908|FG000|Overall Study|Death|1|||
28006080|NCT00740636|54664909|FG001|Overall Study|Death|0|||
28006081|NCT00735254|54664919|FG000|Overall Study|Protocol Violation|1|||
28006082|NCT00735254|54664920|FG001|Overall Study|Protocol Violation|1|||
28102004|NCT02973100|54758725|FG001|Overall Study|Notification of change in address|0|||
28102005|NCT02973100|54758726|FG002|Overall Study|Notification of change in address|0|||
28102006|NCT02973100|54758727|FG003|Overall Study|Notification of change in address|1|||
28102007|NCT02973100|54758724|FG000|Overall Study|Failed to attend Safety followup period|0|||
28102008|NCT02973100|54758725|FG001|Overall Study|Failed to attend Safety followup period|0|||
28102009|NCT02973100|54758726|FG002|Overall Study|Failed to attend Safety followup period|1|||
28102010|NCT02973100|54758727|FG003|Overall Study|Failed to attend Safety followup period|0|||
28006083|NCT00735254|54664921|FG002|Overall Study|Protocol Violation|1|||
28006084|NCT00735254|54664922|FG003|Overall Study|Protocol Violation|0|||
28006085|NCT00795509|54664932|FG000|Overall Study|Protocol Violation|31|||
28006086|NCT00787787|54664936|FG000|Overall Study|Lack of Efficacy|4|||
28006087|NCT00787787|54664936|FG000|Overall Study|Adverse Event|3|||
28006088|NCT00787319|54664940|FG000|Overall Study|Lost to Follow-up|2|||
28006089|NCT00787319|54664940|FG000|Overall Study|Withdrawal by Subject|15|||
28006090|NCT00787319|54664940|FG000|Overall Study|Adverse Event|3|||
28102011|NCT01060540|54758742|FG000|Overall Study|Withdrawal by Subject|10|||
28102012|NCT01060540|54758743|FG001|Overall Study|Withdrawal by Subject|20|||
28102013|NCT01060540|54758742|FG000|Overall Study|Lost to Follow-up|52|||
28102014|NCT01060540|54758743|FG001|Overall Study|Lost to Follow-up|43|||
28102015|NCT01060540|54758742|FG000|Overall Study|Death|2|||
28102016|NCT01060540|54758743|FG001|Overall Study|Death|1|||
28102017|NCT01060540|54758742|FG000|Overall Study|Physician Decision|0|||
28102018|NCT01060540|54758743|FG001|Overall Study|Physician Decision|1|||
28102019|NCT02972632|54758768|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
28102020|NCT02972632|54758768|FG000|Overall Study|Lost to Follow-up|4|||
28102021|NCT02972632|54758768|FG000|Overall Study|Voluntary Withdrawal|10|||
28102022|NCT01060384|54758772|FG000|Overall Study|Withdrawal by Subject|0|||
28102023|NCT01060384|54758773|FG001|Overall Study|Withdrawal by Subject|1|||
28102024|NCT01060384|54758774|FG002|Overall Study|Withdrawal by Subject|0|||
28102025|NCT01060384|54758775|FG003|Overall Study|Withdrawal by Subject|0|||
27917060|NCT01109173|54574591|FG003|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
27917061|NCT01109173|54574588|FG000|Overall Study|Noncompliance|0|||
27917062|NCT01109173|54574589|FG001|Overall Study|Noncompliance|1|||
28102026|NCT01060384|54758776|FG004|Overall Study|Withdrawal by Subject|0|||
28102027|NCT01060384|54758772|FG000|Overall Study|Death|0|||
28102028|NCT01060384|54758773|FG001|Overall Study|Death|0|||
28102029|NCT01060384|54758774|FG002|Overall Study|Death|0|||
28102030|NCT01060384|54758775|FG003|Overall Study|Death|0|||
27917063|NCT01109173|54574590|FG002|Overall Study|Noncompliance|0|||
27917064|NCT01109173|54574591|FG003|Overall Study|Noncompliance|0|||
27917065|NCT01109173|54574588|FG000|Overall Study|Treatment Failure|25|||
27917066|NCT01109173|54574589|FG001|Overall Study|Treatment Failure|32|||
27917067|NCT01109173|54574590|FG002|Overall Study|Treatment Failure|69|||
27917068|NCT01109173|54574591|FG003|Overall Study|Treatment Failure|64|||
27917069|NCT01109173|54574588|FG000|Overall Study|Protocol Violation|4|||
27917070|NCT01109173|54574589|FG001|Overall Study|Protocol Violation|5|||
27917071|NCT01109173|54574590|FG002|Overall Study|Protocol Violation|1|||
27917072|NCT01109173|54574591|FG003|Overall Study|Protocol Violation|2|||
27917073|NCT01109173|54574588|FG000|Overall Study|Patient Did Not Use Study Medication|34|||
27917074|NCT01109173|54574589|FG001|Overall Study|Patient Did Not Use Study Medication|26|||
27917075|NCT01109173|54574590|FG002|Overall Study|Patient Did Not Use Study Medication|11|||
27917076|NCT01109173|54574591|FG003|Overall Study|Patient Did Not Use Study Medication|7|||
27917077|NCT01109173|54574588|FG000|Overall Study|Not Specifiied|5|||
27917078|NCT01109173|54574589|FG001|Overall Study|Not Specifiied|4|||
27917079|NCT01109173|54574590|FG002|Overall Study|Not Specifiied|9|||
28006091|NCT00787319|54664940|FG000|Overall Study|Objective progression or relapse|30|||
28006092|NCT00787319|54664940|FG000|Overall Study|Lack of Efficacy|1|||
28006093|NCT00787319|54664940|FG000|Overall Study|Budget exhausted/exceeded|1|||
28006094|NCT00787319|54664940|FG000|Overall Study|Unresponsiveness to visit invitation|1|||
28006095|NCT00787319|54664940|FG000|Overall Study|No health insurance reimbursement|2|||
28102031|NCT01060384|54758776|FG004|Overall Study|Death|1|||
28102032|NCT01060384|54758772|FG000|Overall Study|Intercurrent illness|0|||
28102033|NCT01060384|54758773|FG001|Overall Study|Intercurrent illness|0|||
28102034|NCT01060384|54758774|FG002|Overall Study|Intercurrent illness|0|||
28102035|NCT01060384|54758775|FG003|Overall Study|Intercurrent illness|0|||
28102036|NCT01060384|54758776|FG004|Overall Study|Intercurrent illness|1|||
28102037|NCT01060150|54758785|FG000|Overall Study|Adverse Event|6|||
28102038|NCT01060150|54758785|FG000|Overall Study|Lost to Follow-up|1|||
28102039|NCT01060150|54758785|FG000|Overall Study|Protocol Violation|6|||
28102040|NCT01060150|54758785|FG000|Overall Study|Withdrawal by Subject|8|||
28102041|NCT01060150|54758785|FG000|Overall Study|Enrolled, but not treated|2|||
28102042|NCT02972242|54758791|FG000|Overall Study|Withdrawal by Subject|1|||
28102043|NCT02972242|54758792|FG001|Overall Study|Withdrawal by Subject|0|||
28102044|NCT02970292|54758800|FG000|Overall Study|Physician Decision|1|||
28102045|NCT02970292|54758801|FG001|Overall Study|Physician Decision|1|||
28102046|NCT02970292|54758800|FG000|Overall Study|Withdrawal by Subject|11|||
28102047|NCT02970292|54758801|FG001|Overall Study|Withdrawal by Subject|5|||
28102048|NCT02970292|54758800|FG000|Overall Study|Noncompliance with study drug|2|||
28102049|NCT02970292|54758801|FG001|Overall Study|Noncompliance with study drug|2|||
28102050|NCT02970292|54758800|FG000|Overall Study|Adverse Event|5|||
28102051|NCT02970292|54758801|FG001|Overall Study|Adverse Event|0|||
28102052|NCT02970292|54758800|FG000|Overall Study|Lack of Efficacy|1|||
28102053|NCT02970292|54758801|FG001|Overall Study|Lack of Efficacy|0|||
28102054|NCT02970292|54758800|FG000|Overall Study|Lost to Follow-up|1|||
28102055|NCT02970292|54758801|FG001|Overall Study|Lost to Follow-up|0|||
28102056|NCT02970292|54758800|FG000|Overall Study|Protocol Violation|2|||
28102057|NCT02970292|54758801|FG001|Overall Study|Protocol Violation|0|||
28102058|NCT02970292|54758800|FG000|Overall Study|Other|1|||
28102059|NCT02970292|54758801|FG001|Overall Study|Other|0|||
28102060|NCT02971228|54758807|FG000|Overall Study|Withdrawal by Subject|1|||
28102061|NCT02971228|54758808|FG001|Overall Study|Withdrawal by Subject|1|||
28102062|NCT02971228|54758809|FG002|Overall Study|Withdrawal by Subject|0|||
28102063|NCT02971228|54758810|FG003|Overall Study|Withdrawal by Subject|0|||
28102064|NCT02971228|54758811|FG004|Overall Study|Withdrawal by Subject|0|||
28102065|NCT02971228|54758807|FG000|Overall Study|Logistical challenges|0|||
28102066|NCT02971228|54758808|FG001|Overall Study|Logistical challenges|1|||
28102067|NCT02971228|54758809|FG002|Overall Study|Logistical challenges|0|||
28102068|NCT02971228|54758810|FG003|Overall Study|Logistical challenges|0|||
28102069|NCT02971228|54758811|FG004|Overall Study|Logistical challenges|0|||
28102070|NCT01060072|54758824|FG000|Overall Study|Adverse Event|1|||
28102071|NCT01060072|54758825|FG001|Overall Study|Adverse Event|1|||
28102072|NCT01060072|54758824|FG000|Overall Study|Physician Decision|0|||
28102073|NCT01060072|54758825|FG001|Overall Study|Physician Decision|2|||
28102074|NCT01060072|54758824|FG000|Overall Study|Protocol Violation|0|||
28102075|NCT01060072|54758825|FG001|Overall Study|Protocol Violation|1|||
28102076|NCT01060072|54758824|FG000|Overall Study|Acute cholecystitis|1|||
28102077|NCT01060072|54758825|FG001|Overall Study|Acute cholecystitis|0|||
28102078|NCT01060072|54758824|FG000|Overall Study|Excluded Medications|0|||
28102079|NCT01060072|54758825|FG001|Overall Study|Excluded Medications|1|||
28102080|NCT02969590|54758833|FG000|Screening Period|Hormones not suppressed post Lupron|1|||
28102081|NCT02969590|54758834|FG001|Screening Period|Hormones not suppressed post Lupron|0|||
28102082|NCT02969590|54758835|FG002|Screening Period|Hormones not suppressed post Lupron|0|||
28102083|NCT03345849|54758847|FG000|Part 1: Induction Period (Weeks 1-12)|Adverse Event|8|||
28006096|NCT00787319|54664940|FG000|Overall Study|Stabilized disease findings|3|||
28006097|NCT00787319|54664940|FG000|Overall Study|Inactive disease|5|||
28006098|NCT00794963|54664946|FG000|Overall Study|Withdrawal by Subject|1|||
28006099|NCT00794963|54664947|FG001|Overall Study|Withdrawal by Subject|4|||
28006100|NCT00794573|54664955|FG000|Overall Study|Death|3|||
28006101|NCT00794573|54664956|FG001|Overall Study|Death|0|||
28006102|NCT00794573|54664955|FG000|Overall Study|Withdrawal by Subject|9|||
28006103|NCT00794573|54664956|FG001|Overall Study|Withdrawal by Subject|12|||
28006104|NCT00794573|54664955|FG000|Overall Study|Lost to Follow-up|26|||
28006105|NCT00794573|54664956|FG001|Overall Study|Lost to Follow-up|33|||
28006106|NCT00584844|54664962|FG000|Overall Study|Withdrawal by Subject|59|||
28006107|NCT00584844|54664962|FG000|Overall Study|Screen Failure|20|||
28102084|NCT03345849|54758848|FG001|Part 1: Induction Period (Weeks 1-12)|Adverse Event|12|||
28102085|NCT03345849|54758849|FG002|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
28102086|NCT03345849|54758850|FG003|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
28102087|NCT03345849|54758847|FG000|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|6|||
28102088|NCT03345849|54758848|FG001|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|3|||
28102089|NCT03345849|54758849|FG002|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
28102090|NCT03345849|54758850|FG003|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
28102091|NCT03345849|54758847|FG000|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
28102092|NCT03345849|54758848|FG001|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|1|||
28102093|NCT03345849|54758849|FG002|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
28102094|NCT03345849|54758850|FG003|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
28006108|NCT00739934|54664970|FG000|Voriconazole IV|Adverse Event|6|||
28006109|NCT00739934|54664970|FG000|Voriconazole Oral|Other|3|||
28006110|NCT00739310|54664979|FG000|Overall Study|Poor adherance to prescribed therapy|4|||
28102095|NCT03345849|54758847|FG000|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|8|||
28102096|NCT03345849|54758848|FG001|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|3|||
28102097|NCT03345849|54758849|FG002|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
28102098|NCT03345849|54758850|FG003|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
28102099|NCT03345849|54758847|FG000|Part 1: Induction Period (Weeks 1-12)|Other|0|||
28102100|NCT03345849|54758848|FG001|Part 1: Induction Period (Weeks 1-12)|Other|1|||
28102101|NCT03345849|54758849|FG002|Part 1: Induction Period (Weeks 1-12)|Other|0|||
28102102|NCT03345849|54758850|FG003|Part 1: Induction Period (Weeks 1-12)|Other|0|||
28102103|NCT03345849|54758847|FG000|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
28102104|NCT03345849|54758848|FG001|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
28102105|NCT03345849|54758849|FG002|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
28102106|NCT03345849|54758850|FG003|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
28102107|NCT03345849|54758847|FG000|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
28102108|NCT03345849|54758848|FG001|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
28102109|NCT03345849|54758849|FG002|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|3|||
28102110|NCT03345849|54758850|FG003|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|1|||
28102111|NCT03345849|54758847|FG000|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
28102112|NCT03345849|54758848|FG001|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
28102113|NCT03345849|54758849|FG002|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|1|||
28102114|NCT03345849|54758850|FG003|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|5|||
28102115|NCT03345849|54758847|FG000|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
28102116|NCT03345849|54758848|FG001|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
28102117|NCT03345849|54758849|FG002|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
28102118|NCT03345849|54758850|FG003|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|1|||
28102119|NCT03345849|54758847|FG000|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
28102120|NCT03345849|54758848|FG001|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
28102121|NCT03345849|54758849|FG002|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|1|||
28102122|NCT03345849|54758850|FG003|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
28102123|NCT03345849|54758847|FG000|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
28102124|NCT03345849|54758848|FG001|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
28102125|NCT03345849|54758849|FG002|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
28102126|NCT03345849|54758850|FG003|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
28102127|NCT03011307|54758860|FG000|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|3|||
28102128|NCT03011307|54758861|FG001|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|2|||
28102129|NCT03011307|54758860|FG000|Overall Study|Did not receive study drug: unable to place spinal needle|2|||
28102130|NCT03011307|54758861|FG001|Overall Study|Did not receive study drug: unable to place spinal needle|0|||
28102131|NCT03011307|54758860|FG000|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|1|||
28102132|NCT03011307|54758861|FG001|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|0|||
27739948|NCT02786537|54189680|FG003|As Randomized|Subject lost insurance|1|||
27739949|NCT02786537|54189681|FG004|As Randomized|Subject lost insurance|0|||
27739950|NCT02786537|54189682|FG005|As Randomized|Subject lost insurance|0|||
27739951|NCT02786537|54189677|FG000|As Treated|Adverse Event|0|||
27739952|NCT02786537|54189678|FG001|As Treated|Adverse Event|11|||
27739953|NCT02786537|54189679|FG002|As Treated|Adverse Event|0|||
27739954|NCT02786537|54189680|FG003|As Treated|Adverse Event|4|||
27739955|NCT02786537|54189681|FG004|As Treated|Adverse Event|6|||
27739956|NCT02786537|54189682|FG005|As Treated|Adverse Event|2|||
27739957|NCT02786537|54189677|FG000|As Treated|Death|0|||
27739958|NCT02786537|54189678|FG001|As Treated|Death|2|||
27739959|NCT02786537|54189679|FG002|As Treated|Death|0|||
27739960|NCT02786537|54189680|FG003|As Treated|Death|3|||
27739961|NCT02786537|54189681|FG004|As Treated|Death|1|||
27739962|NCT02786537|54189682|FG005|As Treated|Death|0|||
27739963|NCT02786537|54189677|FG000|As Treated|Lack of Efficacy|0|||
27739964|NCT02786537|54189678|FG001|As Treated|Lack of Efficacy|0|||
27739965|NCT02786537|54189679|FG002|As Treated|Lack of Efficacy|0|||
27739966|NCT02786537|54189680|FG003|As Treated|Lack of Efficacy|1|||
27739967|NCT02786537|54189681|FG004|As Treated|Lack of Efficacy|0|||
27739968|NCT02786537|54189682|FG005|As Treated|Lack of Efficacy|0|||
28006111|NCT00739310|54664979|FG000|Overall Study|Withdrawal by Subject|1|||
28102133|NCT03798717|54758873|FG000|Overall Study|Failed Screening|0|||
28102134|NCT03798717|54758874|FG001|Overall Study|Failed Screening|0|||
27739969|NCT02786537|54189677|FG000|As Treated|Lost to Follow-up|4|||
27739970|NCT02786537|54189678|FG001|As Treated|Lost to Follow-up|32|||
27739971|NCT02786537|54189679|FG002|As Treated|Lost to Follow-up|0|||
27739972|NCT02786537|54189680|FG003|As Treated|Lost to Follow-up|25|||
27739973|NCT02786537|54189681|FG004|As Treated|Lost to Follow-up|4|||
27739974|NCT02786537|54189682|FG005|As Treated|Lost to Follow-up|4|||
27739975|NCT02786537|54189677|FG000|As Treated|Non-compliance with study drug|1|||
28102135|NCT03798717|54758875|FG002|Overall Study|Failed Screening|0|||
28102136|NCT03798717|54758876|FG003|Overall Study|Failed Screening|0|||
28102137|NCT03798717|54758877|FG004|Overall Study|Failed Screening|0|||
28102138|NCT03798717|54758878|FG005|Overall Study|Failed Screening|1|||
28102139|NCT03798717|54758873|FG000|Overall Study|Physician Decision|1|||
28102140|NCT03798717|54758874|FG001|Overall Study|Physician Decision|0|||
28102141|NCT03798717|54758875|FG002|Overall Study|Physician Decision|1|||
28102142|NCT03798717|54758876|FG003|Overall Study|Physician Decision|0|||
28102143|NCT03798717|54758877|FG004|Overall Study|Physician Decision|0|||
28102144|NCT03798717|54758878|FG005|Overall Study|Physician Decision|0|||
28102145|NCT03798717|54758873|FG000|Overall Study|Withdrawal by Subject|0|||
28102146|NCT03798717|54758874|FG001|Overall Study|Withdrawal by Subject|0|||
28102147|NCT03798717|54758875|FG002|Overall Study|Withdrawal by Subject|0|||
28102148|NCT03798717|54758876|FG003|Overall Study|Withdrawal by Subject|1|||
28102149|NCT03798717|54758877|FG004|Overall Study|Withdrawal by Subject|0|||
28102150|NCT03798717|54758878|FG005|Overall Study|Withdrawal by Subject|0|||
28102151|NCT03798717|54758873|FG000|Overall Study|Lost to Follow-up|1|||
28102152|NCT03798717|54758874|FG001|Overall Study|Lost to Follow-up|0|||
28102153|NCT03798717|54758875|FG002|Overall Study|Lost to Follow-up|0|||
28102154|NCT03798717|54758876|FG003|Overall Study|Lost to Follow-up|1|||
28102155|NCT03798717|54758877|FG004|Overall Study|Lost to Follow-up|0|||
28102156|NCT03798717|54758878|FG005|Overall Study|Lost to Follow-up|0|||
28102157|NCT03798717|54758873|FG000|Overall Study|Adverse Event|0|||
28102158|NCT03798717|54758874|FG001|Overall Study|Adverse Event|1|||
28102159|NCT03798717|54758875|FG002|Overall Study|Adverse Event|0|||
28102160|NCT03798717|54758876|FG003|Overall Study|Adverse Event|0|||
28102161|NCT03798717|54758877|FG004|Overall Study|Adverse Event|0|||
28102162|NCT03798717|54758878|FG005|Overall Study|Adverse Event|0|||
28102163|NCT03798717|54758873|FG000|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
28102164|NCT03798717|54758874|FG001|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
28102165|NCT03798717|54758875|FG002|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
28102166|NCT03798717|54758876|FG003|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
28102167|NCT03798717|54758877|FG004|Overall Study|COVID-19 (coronavirus disease) Lockdown|1|||
28102168|NCT03798717|54758878|FG005|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
28102169|NCT03798483|54758887|FG000|Overall Study|Lost to Follow-up|2|||
28102170|NCT03792477|54758900|FG000|Overall Study|Adverse Event|0|||
28006112|NCT00739310|54664979|FG000|Overall Study|Lost to Follow-up|2|||
28006113|NCT00734630|54664986|FG000|Overall Study|Lack of Efficacy|4|||
28006114|NCT00734630|54664987|FG001|Overall Study|Lack of Efficacy|4|||
28006115|NCT00734630|54664986|FG000|Overall Study|Withdrawal by Subject|7|||
28006116|NCT00734630|54664987|FG001|Overall Study|Withdrawal by Subject|9|||
28006117|NCT00734630|54664986|FG000|Overall Study|Lost to Follow-up|13|||
27739976|NCT02786537|54189678|FG001|As Treated|Non-compliance with study drug|11|||
27739977|NCT02786537|54189679|FG002|As Treated|Non-compliance with study drug|0|||
27739978|NCT02786537|54189680|FG003|As Treated|Non-compliance with study drug|1|||
27739979|NCT02786537|54189681|FG004|As Treated|Non-compliance with study drug|0|||
27739980|NCT02786537|54189682|FG005|As Treated|Non-compliance with study drug|1|||
27739981|NCT02786537|54189677|FG000|As Treated|Lost insurance|0|||
27739982|NCT02786537|54189678|FG001|As Treated|Lost insurance|0|||
27739983|NCT02786537|54189679|FG002|As Treated|Lost insurance|0|||
27739984|NCT02786537|54189680|FG003|As Treated|Lost insurance|1|||
27739985|NCT02786537|54189681|FG004|As Treated|Lost insurance|0|||
27739986|NCT02786537|54189682|FG005|As Treated|Lost insurance|0|||
27739987|NCT02786537|54189677|FG000|As Treated|Withdrawal by Subject|1|||
27739988|NCT02786537|54189678|FG001|As Treated|Withdrawal by Subject|2|||
27739989|NCT02786537|54189679|FG002|As Treated|Withdrawal by Subject|0|||
27739990|NCT02786537|54189680|FG003|As Treated|Withdrawal by Subject|0|||
27739991|NCT02786537|54189681|FG004|As Treated|Withdrawal by Subject|1|||
27739992|NCT02786537|54189682|FG005|As Treated|Withdrawal by Subject|0|||
28102171|NCT03792477|54758901|FG001|Overall Study|Adverse Event|0|||
28102172|NCT03792477|54758902|FG002|Overall Study|Adverse Event|0|||
28102173|NCT03792477|54758903|FG003|Overall Study|Adverse Event|1|||
28102174|NCT03792477|54758904|FG004|Overall Study|Adverse Event|0|||
28102175|NCT03792477|54758900|FG000|Overall Study|Lost to Follow-up|0|||
28102176|NCT03792477|54758901|FG001|Overall Study|Lost to Follow-up|0|||
28102177|NCT03792477|54758902|FG002|Overall Study|Lost to Follow-up|2|||
28102178|NCT03792477|54758903|FG003|Overall Study|Lost to Follow-up|0|||
27739993|NCT02786537|54189677|FG000|As Treated|Incarceration|0|||
27739994|NCT02786537|54189678|FG001|As Treated|Incarceration|1|||
27739995|NCT02786537|54189679|FG002|As Treated|Incarceration|0|||
27917080|NCT01109173|54574591|FG003|Overall Study|Not Specifiied|14|||
27917081|NCT01172821|54574605|FG000|Overall Study|Adverse Event|5|||
27917082|NCT01172821|54574606|FG001|Overall Study|Adverse Event|2|||
27917083|NCT01172821|54574607|FG002|Overall Study|Adverse Event|2|||
27739996|NCT02786537|54189680|FG003|As Treated|Incarceration|0|||
27739997|NCT02786537|54189681|FG004|As Treated|Incarceration|0|||
28006118|NCT00734630|54664987|FG001|Overall Study|Lost to Follow-up|7|||
28102179|NCT03792477|54758904|FG004|Overall Study|Lost to Follow-up|0|||
28102180|NCT03792477|54758900|FG000|Overall Study|Other|0|||
28102181|NCT03792477|54758901|FG001|Overall Study|Other|0|||
28102182|NCT03792477|54758902|FG002|Overall Study|Other|0|||
28006119|NCT00734630|54664986|FG000|Overall Study|Protocol Violation|0|||
28006120|NCT00734630|54664987|FG001|Overall Study|Protocol Violation|3|||
28006121|NCT00734630|54664986|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
28006122|NCT00734630|54664987|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
28006123|NCT00734630|54664986|FG000|Overall Study|Adverse Event|3|||
28006124|NCT00734630|54664987|FG001|Overall Study|Adverse Event|6|||
28006125|NCT00734630|54664986|FG000|Overall Study|Randomized in Error|0|||
28006126|NCT00734630|54664987|FG001|Overall Study|Randomized in Error|1|||
28006127|NCT00734630|54664986|FG000|Overall Study|Tested Positive for Illegal Drug Use|1|||
28006128|NCT00734630|54664987|FG001|Overall Study|Tested Positive for Illegal Drug Use|1|||
28006129|NCT00734630|54664986|FG000|Overall Study|Poor Compliance|1|||
28006130|NCT00734630|54664987|FG001|Overall Study|Poor Compliance|1|||
28006131|NCT00584454|54664993|FG000|Overall Study|Adverse Event|1|||
28006132|NCT00584454|54664993|FG000|Overall Study|Relocation|1|||
28006133|NCT00584454|54664993|FG000|Overall Study|Clinical Hold|2|||
28006134|NCT00578175|54665000|FG000|Overall Study|Adverse Event|0|||
28006135|NCT00578175|54665001|FG001|Overall Study|Adverse Event|1|||
28006136|NCT00578175|54665002|FG002|Overall Study|Adverse Event|1|||
28006137|NCT00578175|54665000|FG000|Overall Study|Other reasons|70|||
28006138|NCT00578175|54665001|FG001|Overall Study|Other reasons|42|||
28006139|NCT00578175|54665002|FG002|Overall Study|Other reasons|23|||
28006140|NCT00435409|54665014|FG000|Overall Study|Protocol Violation|1|||
28006141|NCT00435409|54665015|FG001|Overall Study|Protocol Violation|2|||
27917084|NCT01172821|54574608|FG003|Overall Study|Adverse Event|7|||
28172925|NCT03726658|54844757|FG006|Overall Study|Withdrawal by Subject|2|||
28172926|NCT03726658|54844751|FG000|Overall Study|Pregnancy|0|||
28172927|NCT03726658|54844752|FG001|Overall Study|Pregnancy|0|||
27917085|NCT01172821|54574605|FG000|Overall Study|Protocol Violation|0|||
27917086|NCT01172821|54574606|FG001|Overall Study|Protocol Violation|2|||
28006142|NCT00435409|54665016|FG002|Overall Study|Protocol Violation|0|||
28006143|NCT00435409|54665014|FG000|Overall Study|Lost to Follow-up|1|||
28006144|NCT00435409|54665015|FG001|Overall Study|Lost to Follow-up|2|||
28006145|NCT00435409|54665016|FG002|Overall Study|Lost to Follow-up|0|||
28006146|NCT00435409|54665014|FG000|Overall Study|Death|8|||
28006147|NCT00435409|54665015|FG001|Overall Study|Death|6|||
28006148|NCT00435409|54665016|FG002|Overall Study|Death|6|||
28006149|NCT00435409|54665014|FG000|Overall Study|Objective progression or relapse|158|||
28006150|NCT00435409|54665015|FG001|Overall Study|Objective progression or relapse|93|||
28006151|NCT00435409|54665016|FG002|Overall Study|Objective progression or relapse|58|||
28006152|NCT00435409|54665014|FG000|Overall Study|Global deterioration of health status|0|||
28006153|NCT00435409|54665015|FG001|Overall Study|Global deterioration of health status|0|||
28006154|NCT00435409|54665016|FG002|Overall Study|Global deterioration of health status|4|||
28006155|NCT00435409|54665014|FG000|Overall Study|Withdrawal by Subject|8|||
28006156|NCT00435409|54665015|FG001|Overall Study|Withdrawal by Subject|7|||
28006157|NCT00435409|54665016|FG002|Overall Study|Withdrawal by Subject|1|||
28006158|NCT00435409|54665014|FG000|Overall Study|Other|45|||
28006159|NCT00435409|54665015|FG001|Overall Study|Other|30|||
28102183|NCT03792477|54758903|FG003|Overall Study|Other|0|||
28102184|NCT03792477|54758904|FG004|Overall Study|Other|1|||
28102185|NCT03790917|54758910|FG000|Overall Study|Death|1|||
28102186|NCT03788967|54758917|FG000|Overall Study|Lost to Follow-up|14|||
28102187|NCT03788967|54758918|FG001|Overall Study|Lost to Follow-up|10|||
28102188|NCT03788967|54758917|FG000|Overall Study|Participant Non-Compliance/Uncooperativeness|3|||
28102189|NCT03788967|54758918|FG001|Overall Study|Participant Non-Compliance/Uncooperativeness|6|||
28102190|NCT03788967|54758917|FG000|Overall Study|Participant Withdrawal of Consent|13|||
28102191|NCT03788967|54758918|FG001|Overall Study|Participant Withdrawal of Consent|5|||
28172928|NCT03726658|54844753|FG002|Overall Study|Pregnancy|0|||
28172929|NCT03726658|54844754|FG003|Overall Study|Pregnancy|0|||
28172930|NCT03726658|54844755|FG004|Overall Study|Pregnancy|0|||
28172931|NCT03726658|54844756|FG005|Overall Study|Pregnancy|0|||
28172932|NCT03726658|54844757|FG006|Overall Study|Pregnancy|1|||
27917087|NCT01172821|54574607|FG002|Overall Study|Protocol Violation|1|||
27917088|NCT01172821|54574608|FG003|Overall Study|Protocol Violation|2|||
27917089|NCT01172821|54574605|FG000|Overall Study|Lost to Follow-up|4|||
27917090|NCT01172821|54574606|FG001|Overall Study|Lost to Follow-up|1|||
27917091|NCT01172821|54574607|FG002|Overall Study|Lost to Follow-up|2|||
28006160|NCT00435409|54665016|FG002|Overall Study|Other|1|||
28006161|NCT00435409|54665014|FG000|Overall Study|Adverse Event|0|||
28006162|NCT00435409|54665015|FG001|Overall Study|Adverse Event|0|||
28006163|NCT00435409|54665016|FG002|Overall Study|Adverse Event|8|||
28006164|NCT00435409|54665014|FG000|Overall Study|Sponsor decision|0|||
28006165|NCT00435409|54665015|FG001|Overall Study|Sponsor decision|3|||
27917092|NCT01172821|54574608|FG003|Overall Study|Lost to Follow-up|2|||
28006166|NCT00435409|54665016|FG002|Overall Study|Sponsor decision|0|||
28006167|NCT00467857|54665033|FG000|Overall Study|Adverse Event|1|||
28006168|NCT00467857|54665034|FG001|Overall Study|Adverse Event|0|||
28006169|NCT00467857|54665033|FG000|Overall Study|Withdrew consent|2|||
28172933|NCT03726658|54844751|FG000|Overall Study|Not Reported|0|||
28102192|NCT03788967|54758917|FG000|Overall Study|Adverse Event|1|||
28102193|NCT03788967|54758918|FG001|Overall Study|Adverse Event|1|||
28102194|NCT03788967|54758917|FG000|Overall Study|COVID-19|1|||
28102195|NCT03788967|54758918|FG001|Overall Study|COVID-19|2|||
28102196|NCT03782571|54758926|FG000|Period 1|Withdrawal by Subject|1|||
28102197|NCT03782571|54758927|FG001|Period 1|Withdrawal by Subject|0|||
28102198|NCT03782571|54758928|FG002|Period 1|Withdrawal by Subject|0|||
28102199|NCT03782571|54758929|FG003|Period 1|Withdrawal by Subject|0|||
28102200|NCT03782571|54758926|FG000|Period 3|Subject Unable to Attend V5|1|||
28102201|NCT03782571|54758927|FG001|Period 3|Subject Unable to Attend V5|0|||
28102202|NCT03782571|54758928|FG002|Period 3|Subject Unable to Attend V5|0|||
28102203|NCT03782571|54758929|FG003|Period 3|Subject Unable to Attend V5|0|||
28102204|NCT03782571|54758926|FG000|Period 3|Adverse Event|1|||
28102205|NCT03782571|54758927|FG001|Period 3|Adverse Event|0|||
28102206|NCT03782571|54758928|FG002|Period 3|Adverse Event|0|||
28102207|NCT03782571|54758929|FG003|Period 3|Adverse Event|0|||
28102208|NCT03783039|54758943|FG000|Overall Study|Death|2|||
28102209|NCT03783039|54758944|FG001|Overall Study|Death|1|||
28102210|NCT03776175|54758954|FG000|Treatment Period (42 Days)|Adverse Event|0|||
28102211|NCT03776175|54758955|FG001|Treatment Period (42 Days)|Adverse Event|1|||
28102212|NCT03776175|54758956|FG002|Treatment Period (42 Days)|Adverse Event|1|||
28102213|NCT03776175|54758957|FG003|Treatment Period (42 Days)|Adverse Event|0|||
28102214|NCT03776175|54758954|FG000|Treatment Period (42 Days)|Lost to Follow-up|0|||
28102215|NCT03776175|54758955|FG001|Treatment Period (42 Days)|Lost to Follow-up|0|||
28102216|NCT03776175|54758956|FG002|Treatment Period (42 Days)|Lost to Follow-up|0|||
28102217|NCT03776175|54758957|FG003|Treatment Period (42 Days)|Lost to Follow-up|2|||
28102218|NCT03776175|54758954|FG000|Treatment Period (42 Days)|Participants screened at other site|0|||
28102219|NCT03776175|54758955|FG001|Treatment Period (42 Days)|Participants screened at other site|2|||
28102220|NCT03776175|54758956|FG002|Treatment Period (42 Days)|Participants screened at other site|0|||
28102221|NCT03776175|54758957|FG003|Treatment Period (42 Days)|Participants screened at other site|0|||
28102222|NCT03776175|54758954|FG000|Treatment Period (42 Days)|Withdrawal by Subject|1|||
28102223|NCT03776175|54758955|FG001|Treatment Period (42 Days)|Withdrawal by Subject|2|||
28102224|NCT03776175|54758956|FG002|Treatment Period (42 Days)|Withdrawal by Subject|3|||
28102225|NCT03776175|54758957|FG003|Treatment Period (42 Days)|Withdrawal by Subject|0|||
28102226|NCT03776175|54758954|FG000|Treatment Period (42 Days)|Unable to attend study visits|0|||
28102227|NCT03776175|54758955|FG001|Treatment Period (42 Days)|Unable to attend study visits|2|||
28102228|NCT03776175|54758956|FG002|Treatment Period (42 Days)|Unable to attend study visits|0|||
28102229|NCT03776175|54758957|FG003|Treatment Period (42 Days)|Unable to attend study visits|0|||
28102230|NCT03776175|54758954|FG000|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
28102231|NCT03776175|54758955|FG001|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
28102232|NCT03776175|54758956|FG002|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
28102233|NCT03776175|54758957|FG003|Follow-Up Period (35 Days)|Lost to Follow-up|2|||
28102234|NCT02903914|54758975|FG000|Overall Study|Adverse Event|0|||
28102235|NCT02903914|54758976|FG001|Overall Study|Adverse Event|0|||
28102236|NCT02903914|54758977|FG002|Overall Study|Adverse Event|1|||
28102237|NCT02903914|54758978|FG003|Overall Study|Adverse Event|0|||
28102238|NCT02903914|54758979|FG004|Overall Study|Adverse Event|0|||
28102239|NCT02903914|54758980|FG005|Overall Study|Adverse Event|1|||
28102240|NCT02903914|54758981|FG006|Overall Study|Adverse Event|2|||
28102241|NCT02903914|54758982|FG007|Overall Study|Adverse Event|1|||
28102242|NCT02903914|54758975|FG000|Overall Study|Withdrawal by Subject|3|||
28102243|NCT02903914|54758976|FG001|Overall Study|Withdrawal by Subject|1|||
28102244|NCT02903914|54758977|FG002|Overall Study|Withdrawal by Subject|28|||
28102245|NCT02903914|54758978|FG003|Overall Study|Withdrawal by Subject|0|||
28102246|NCT02903914|54758979|FG004|Overall Study|Withdrawal by Subject|1|||
28102247|NCT02903914|54758980|FG005|Overall Study|Withdrawal by Subject|1|||
28102248|NCT02903914|54758981|FG006|Overall Study|Withdrawal by Subject|12|||
28102249|NCT02903914|54758982|FG007|Overall Study|Withdrawal by Subject|0|||
28102250|NCT02903914|54758975|FG000|Overall Study|Progressive Disease|1|||
28102251|NCT02903914|54758976|FG001|Overall Study|Progressive Disease|0|||
28102252|NCT02903914|54758977|FG002|Overall Study|Progressive Disease|4|||
28102253|NCT02903914|54758978|FG003|Overall Study|Progressive Disease|0|||
28102254|NCT02903914|54758979|FG004|Overall Study|Progressive Disease|0|||
28102255|NCT02903914|54758980|FG005|Overall Study|Progressive Disease|0|||
28102256|NCT02903914|54758981|FG006|Overall Study|Progressive Disease|2|||
28172934|NCT03726658|54844752|FG001|Overall Study|Not Reported|0|||
28102257|NCT02903914|54758982|FG007|Overall Study|Progressive Disease|4|||
28102258|NCT02903914|54758975|FG000|Overall Study|Death|0|||
28102259|NCT02903914|54758976|FG001|Overall Study|Death|0|||
28102260|NCT02903914|54758977|FG002|Overall Study|Death|9|||
28102261|NCT02903914|54758978|FG003|Overall Study|Death|0|||
28102262|NCT02903914|54758979|FG004|Overall Study|Death|1|||
28102263|NCT02903914|54758980|FG005|Overall Study|Death|3|||
28102264|NCT02903914|54758981|FG006|Overall Study|Death|24|||
28102265|NCT02903914|54758982|FG007|Overall Study|Death|0|||
28102266|NCT02903914|54758975|FG000|Overall Study|Lost to Follow-up|0|||
28102267|NCT02903914|54758976|FG001|Overall Study|Lost to Follow-up|1|||
28102268|NCT02903914|54758977|FG002|Overall Study|Lost to Follow-up|0|||
28102269|NCT02903914|54758978|FG003|Overall Study|Lost to Follow-up|0|||
28102270|NCT02903914|54758979|FG004|Overall Study|Lost to Follow-up|2|||
28102271|NCT02903914|54758980|FG005|Overall Study|Lost to Follow-up|0|||
28102272|NCT02903914|54758981|FG006|Overall Study|Lost to Follow-up|1|||
28102273|NCT02903914|54758982|FG007|Overall Study|Lost to Follow-up|0|||
28102274|NCT02903914|54758975|FG000|Overall Study|Physician Decision|0|||
28102275|NCT02903914|54758976|FG001|Overall Study|Physician Decision|0|||
28102276|NCT02903914|54758977|FG002|Overall Study|Physician Decision|1|||
28102277|NCT02903914|54758978|FG003|Overall Study|Physician Decision|0|||
28102278|NCT02903914|54758979|FG004|Overall Study|Physician Decision|0|||
28102279|NCT02903914|54758980|FG005|Overall Study|Physician Decision|0|||
28102280|NCT02903914|54758981|FG006|Overall Study|Physician Decision|1|||
28102281|NCT02903914|54758982|FG007|Overall Study|Physician Decision|0|||
28102282|NCT02903914|54758975|FG000|Overall Study|Symptomatic Deterioration|0|||
28102283|NCT02903914|54758976|FG001|Overall Study|Symptomatic Deterioration|0|||
28102284|NCT02903914|54758977|FG002|Overall Study|Symptomatic Deterioration|1|||
28102285|NCT02903914|54758978|FG003|Overall Study|Symptomatic Deterioration|0|||
28102286|NCT02903914|54758979|FG004|Overall Study|Symptomatic Deterioration|0|||
28102287|NCT02903914|54758980|FG005|Overall Study|Symptomatic Deterioration|0|||
28102288|NCT02903914|54758981|FG006|Overall Study|Symptomatic Deterioration|0|||
28102289|NCT02903914|54758982|FG007|Overall Study|Symptomatic Deterioration|0|||
28102290|NCT02903914|54758975|FG000|Overall Study|New Cancer Therapy|2|||
28102291|NCT02903914|54758976|FG001|Overall Study|New Cancer Therapy|2|||
28102292|NCT02903914|54758977|FG002|Overall Study|New Cancer Therapy|21|||
28102293|NCT02903914|54758978|FG003|Overall Study|New Cancer Therapy|4|||
28102294|NCT02903914|54758979|FG004|Overall Study|New Cancer Therapy|3|||
28102295|NCT02903914|54758980|FG005|Overall Study|New Cancer Therapy|6|||
28102296|NCT02903914|54758981|FG006|Overall Study|New Cancer Therapy|55|||
28102297|NCT02903914|54758982|FG007|Overall Study|New Cancer Therapy|0|||
28102298|NCT02903914|54758975|FG000|Overall Study|Reasoning not specified|2|||
28102299|NCT02903914|54758976|FG001|Overall Study|Reasoning not specified|3|||
28102300|NCT02903914|54758977|FG002|Overall Study|Reasoning not specified|20|||
28102301|NCT02903914|54758978|FG003|Overall Study|Reasoning not specified|3|||
28102302|NCT02903914|54758979|FG004|Overall Study|Reasoning not specified|3|||
28102303|NCT02903914|54758980|FG005|Overall Study|Reasoning not specified|3|||
28102304|NCT02903914|54758981|FG006|Overall Study|Reasoning not specified|20|||
28102305|NCT02903914|54758982|FG007|Overall Study|Reasoning not specified|0|||
28102306|NCT02969044|54759004|FG000|Overall Study|Withdrawal by Subject|2|||
28102307|NCT02969044|54759005|FG001|Overall Study|Withdrawal by Subject|6|||
28102308|NCT02969044|54759004|FG000|Overall Study|Adverse Event|3|||
28102309|NCT02969044|54759005|FG001|Overall Study|Adverse Event|0|||
28102310|NCT02967562|54759013|FG000|Overall Study|Consent not obtained|1|||
28102311|NCT02967562|54759014|FG001|Overall Study|Consent not obtained|0|||
28102312|NCT02967562|54759013|FG000|Overall Study|High leak precluding analysis|1|||
28102313|NCT02967562|54759014|FG001|Overall Study|High leak precluding analysis|1|||
28102314|NCT02968576|54759020|FG000|Overall Study|Pregnancy|0|||
28102315|NCT02968576|54759021|FG001|Overall Study|Pregnancy|1|||
28102316|NCT02966002|54759025|FG000|Overall Study|Withdrawal by Subject|2|||
28102317|NCT02966002|54759025|FG000|Overall Study|Adverse Event|1|||
28102318|NCT02966002|54759025|FG000|Overall Study|Lost to Follow-up|1|||
28102319|NCT02965846|54759032|FG000|Overall Study|Lost to Follow-up|1|||
28102320|NCT02965846|54759033|FG001|Overall Study|Lost to Follow-up|0|||
28102321|NCT02965846|54759034|FG002|Overall Study|Lost to Follow-up|0|||
28102322|NCT02965846|54759032|FG000|Overall Study|Withdrawal by Subject|0|||
28102323|NCT02965846|54759033|FG001|Overall Study|Withdrawal by Subject|1|||
28102324|NCT02965846|54759034|FG002|Overall Study|Withdrawal by Subject|0|||
28102325|NCT02965846|54759032|FG000|Overall Study|Study Terminated By Sponsor|4|||
28102326|NCT02965846|54759033|FG001|Overall Study|Study Terminated By Sponsor|4|||
28102327|NCT02965846|54759034|FG002|Overall Study|Study Terminated By Sponsor|0|||
28102328|NCT02965846|54759032|FG000|Overall Study|Participants not randomized|0|||
28102329|NCT02965846|54759033|FG001|Overall Study|Participants not randomized|0|||
28102330|NCT02965846|54759034|FG002|Overall Study|Participants not randomized|33|||
28102331|NCT02900170|54759040|FG000|Overall Study|Lost to Follow-up|8|||
28102332|NCT02900092|54759044|FG000|Overall Study|Adverse Event|1|||
28102333|NCT02902120|54759052|FG000|Overall Study|Lack of Efficacy|1|||
28102334|NCT02965456|54759058|FG000|Overall Study|Lost to Follow-up|40|||
28102335|NCT02965456|54759059|FG001|Overall Study|Lost to Follow-up|18|||
28102336|NCT02965456|54759058|FG000|Overall Study|Subject Request|22|||
28102337|NCT02965456|54759059|FG001|Overall Study|Subject Request|13|||
28102338|NCT02965456|54759058|FG000|Overall Study|Withdrawal by Parent or Guardian|3|||
28102339|NCT02965456|54759059|FG001|Overall Study|Withdrawal by Parent or Guardian|6|||
28102340|NCT02965456|54759058|FG000|Overall Study|Adverse Event|3|||
28102341|NCT02965456|54759059|FG001|Overall Study|Adverse Event|0|||
28102342|NCT02965456|54759058|FG000|Overall Study|Noncompliance with Study Drug|1|||
28102343|NCT02965456|54759059|FG001|Overall Study|Noncompliance with Study Drug|1|||
28102344|NCT02965456|54759058|FG000|Overall Study|Worsening Condition|0|||
28102345|NCT02965456|54759059|FG001|Overall Study|Worsening Condition|2|||
28102346|NCT02965456|54759058|FG000|Overall Study|Lack of Efficacy|1|||
28102347|NCT02965456|54759059|FG001|Overall Study|Lack of Efficacy|0|||
28102348|NCT02965456|54759058|FG000|Overall Study|Physician Decision|0|||
28102349|NCT02965456|54759059|FG001|Overall Study|Physician Decision|1|||
28102350|NCT02965456|54759058|FG000|Overall Study|Pregnancy|1|||
28102351|NCT02965456|54759059|FG001|Overall Study|Pregnancy|0|||
28102352|NCT02965456|54759058|FG000|Overall Study|Protocol Violation|0|||
28102353|NCT02965456|54759059|FG001|Overall Study|Protocol Violation|1|||
28102354|NCT02965456|54759058|FG000|Overall Study|Participant ran out of study drug|0|||
28102355|NCT02965456|54759059|FG001|Overall Study|Participant ran out of study drug|1|||
28102356|NCT02965378|54759067|FG000|Overall Study|Progression|16|||
28102357|NCT02965378|54759068|FG001|Overall Study|Progression|4|||
28102358|NCT02965378|54759067|FG000|Overall Study|Adverse Event|5|||
28102359|NCT02965378|54759068|FG001|Overall Study|Adverse Event|2|||
28102360|NCT02965378|54759067|FG000|Overall Study|Death|2|||
28102361|NCT02965378|54759068|FG001|Overall Study|Death|0|||
28102362|NCT02965378|54759067|FG000|Overall Study|Refusal|2|||
28102363|NCT02965378|54759068|FG001|Overall Study|Refusal|1|||
28102364|NCT02965378|54759067|FG000|Overall Study|Not protocol specified|0|||
28102365|NCT02965378|54759068|FG001|Overall Study|Not protocol specified|2|||
28102366|NCT03772041|54759076|FG000|Overall Study|Adverse Event|8|||
28102367|NCT03772041|54759077|FG001|Overall Study|Adverse Event|3|||
28102368|NCT03772041|54759076|FG000|Overall Study|Withdrawal by Subject|0|||
28102369|NCT03772041|54759077|FG001|Overall Study|Withdrawal by Subject|2|||
28102370|NCT03772041|54759076|FG000|Overall Study|Protocol Violation|4|||
28102371|NCT03772041|54759077|FG001|Overall Study|Protocol Violation|2|||
28102372|NCT03772041|54759076|FG000|Overall Study|Physician Decision|2|||
28102373|NCT03772041|54759077|FG001|Overall Study|Physician Decision|3|||
28102374|NCT02899156|54759085|FG000|Overall Study|Death|1|||
28102375|NCT02899156|54759086|FG001|Overall Study|Death|0|||
28102376|NCT02899156|54759085|FG000|Overall Study|Physician Decision|0|||
28102377|NCT02899156|54759086|FG001|Overall Study|Physician Decision|1|||
28102378|NCT03773133|54759092|FG000|Overall Study|Screen Failure|8|||
28102379|NCT02969356|54759097|FG000|Overall Study|Adverse Event|7|||
28102380|NCT02969356|54759097|FG000|Overall Study|Consent withdrawn|2|||
28102381|NCT02969356|54759097|FG000|Overall Study|Lost to Follow-up|3|||
28102382|NCT02969356|54759097|FG000|Overall Study|Did not need to be reinjected|6|||
28102383|NCT02969356|54759097|FG000|Overall Study|Personal reasons|5|||
28102384|NCT02898454|54759104|FG000|Overall Study|Adverse Event|4|||
28102385|NCT02898454|54759105|FG001|Overall Study|Adverse Event|1|||
28102386|NCT02898454|54759106|FG002|Overall Study|Adverse Event|2|||
28102387|NCT02898454|54759104|FG000|Overall Study|Protocol Violation|1|||
28102388|NCT02898454|54759105|FG001|Overall Study|Protocol Violation|0|||
28102389|NCT02898454|54759106|FG002|Overall Study|Protocol Violation|1|||
28102390|NCT02898454|54759104|FG000|Overall Study|Lack of Efficacy|4|||
28102391|NCT02898454|54759105|FG001|Overall Study|Lack of Efficacy|1|||
28102392|NCT02898454|54759106|FG002|Overall Study|Lack of Efficacy|0|||
28102393|NCT02898454|54759104|FG000|Overall Study|Withdrawal by Subject|6|||
28102394|NCT02898454|54759105|FG001|Overall Study|Withdrawal by Subject|3|||
28102395|NCT02898454|54759106|FG002|Overall Study|Withdrawal by Subject|3|||
28102396|NCT02898454|54759104|FG000|Overall Study|Lost to Follow-up|1|||
28102397|NCT02898454|54759105|FG001|Overall Study|Lost to Follow-up|0|||
28102398|NCT02898454|54759106|FG002|Overall Study|Lost to Follow-up|0|||
28102399|NCT02898454|54759104|FG000|Overall Study|Did Not Met Eligibility Criteria|1|||
28102400|NCT02898454|54759105|FG001|Overall Study|Did Not Met Eligibility Criteria|0|||
28102401|NCT02898454|54759106|FG002|Overall Study|Did Not Met Eligibility Criteria|0|||
28102402|NCT03772587|54759124|FG000|Overall Study|COVID-19|0|||
28102403|NCT03772587|54759125|FG001|Overall Study|COVID-19|0|||
28102404|NCT03772587|54759126|FG002|Overall Study|COVID-19|1|||
28102405|NCT03772587|54759127|FG003|Overall Study|COVID-19|1|||
28102406|NCT03772587|54759128|FG004|Overall Study|COVID-19|0|||
28102407|NCT03772587|54759124|FG000|Overall Study|Withdrawal by Subject|1|||
28102408|NCT03772587|54759125|FG001|Overall Study|Withdrawal by Subject|0|||
28102409|NCT03772587|54759126|FG002|Overall Study|Withdrawal by Subject|0|||
28102410|NCT03772587|54759127|FG003|Overall Study|Withdrawal by Subject|0|||
28102411|NCT03772587|54759128|FG004|Overall Study|Withdrawal by Subject|0|||
28102412|NCT02963506|54759155|FG000|Double-Blind Period|Adverse Event|0|||
28102413|NCT02963506|54759156|FG001|Double-Blind Period|Adverse Event|0|||
27739998|NCT02786537|54189682|FG005|As Treated|Incarceration|0|||
28102414|NCT02963506|54759157|FG002|Double-Blind Period|Adverse Event|1|||
27739999|NCT02786537|54189677|FG000|As Treated|Opiate dependency relapse|0|||
27917093|NCT01172821|54574605|FG000|Overall Study|Withdrawal by Subject|2|||
28102415|NCT02963506|54759158|FG003|Double-Blind Period|Adverse Event|0|||
28102416|NCT02963506|54759159|FG004|Double-Blind Period|Adverse Event|0|||
28102417|NCT02963506|54759160|FG005|Double-Blind Period|Adverse Event|0|||
28102418|NCT02963506|54759161|FG006|Double-Blind Period|Adverse Event|0|||
28102419|NCT02963506|54759162|FG007|Double-Blind Period|Adverse Event|0|||
28102420|NCT02963506|54759163|FG008|Double-Blind Period|Adverse Event|0|||
28102421|NCT02963506|54759164|FG009|Double-Blind Period|Adverse Event|0|||
28102422|NCT02963506|54759165|FG010|Double-Blind Period|Adverse Event|0|||
28102423|NCT02963506|54759166|FG011|Double-Blind Period|Adverse Event|0|||
28102424|NCT02963506|54759167|FG012|Double-Blind Period|Adverse Event|0|||
28102425|NCT02963506|54759155|FG000|Double-Blind Period|Death|0|||
28102426|NCT02963506|54759156|FG001|Double-Blind Period|Death|0|||
28102427|NCT02963506|54759157|FG002|Double-Blind Period|Death|0|||
28102428|NCT02963506|54759158|FG003|Double-Blind Period|Death|1|||
28102429|NCT02963506|54759159|FG004|Double-Blind Period|Death|0|||
28102430|NCT02963506|54759160|FG005|Double-Blind Period|Death|0|||
28102431|NCT02963506|54759161|FG006|Double-Blind Period|Death|0|||
28102432|NCT02963506|54759162|FG007|Double-Blind Period|Death|0|||
28102433|NCT02963506|54759163|FG008|Double-Blind Period|Death|0|||
28102434|NCT02963506|54759164|FG009|Double-Blind Period|Death|0|||
28102435|NCT02963506|54759165|FG010|Double-Blind Period|Death|0|||
28102436|NCT02963506|54759166|FG011|Double-Blind Period|Death|0|||
28102437|NCT02963506|54759167|FG012|Double-Blind Period|Death|0|||
28102438|NCT02963506|54759155|FG000|Double-Blind Period|Lost to Follow-up|0|||
28102439|NCT02963506|54759156|FG001|Double-Blind Period|Lost to Follow-up|1|||
28102440|NCT02963506|54759157|FG002|Double-Blind Period|Lost to Follow-up|0|||
28102441|NCT02963506|54759158|FG003|Double-Blind Period|Lost to Follow-up|0|||
28102442|NCT02963506|54759159|FG004|Double-Blind Period|Lost to Follow-up|0|||
28102443|NCT02963506|54759160|FG005|Double-Blind Period|Lost to Follow-up|0|||
28102444|NCT02963506|54759161|FG006|Double-Blind Period|Lost to Follow-up|0|||
28102445|NCT02963506|54759162|FG007|Double-Blind Period|Lost to Follow-up|0|||
28102446|NCT02963506|54759163|FG008|Double-Blind Period|Lost to Follow-up|0|||
28102447|NCT02963506|54759164|FG009|Double-Blind Period|Lost to Follow-up|0|||
28006170|NCT00467857|54665034|FG001|Overall Study|Withdrew consent|0|||
28006171|NCT00467857|54665033|FG000|Overall Study|Death|0|||
28102448|NCT02963506|54759165|FG010|Double-Blind Period|Lost to Follow-up|0|||
28102449|NCT02963506|54759166|FG011|Double-Blind Period|Lost to Follow-up|0|||
28102450|NCT02963506|54759167|FG012|Double-Blind Period|Lost to Follow-up|0|||
28102451|NCT02963506|54759155|FG000|Double-Blind Period|Withdrawal by Subject|0|||
28102452|NCT02963506|54759156|FG001|Double-Blind Period|Withdrawal by Subject|0|||
28102453|NCT02963506|54759157|FG002|Double-Blind Period|Withdrawal by Subject|1|||
28102454|NCT02963506|54759158|FG003|Double-Blind Period|Withdrawal by Subject|1|||
28102455|NCT02963506|54759159|FG004|Double-Blind Period|Withdrawal by Subject|0|||
28102456|NCT02963506|54759160|FG005|Double-Blind Period|Withdrawal by Subject|0|||
28102457|NCT02963506|54759161|FG006|Double-Blind Period|Withdrawal by Subject|0|||
28102458|NCT02963506|54759162|FG007|Double-Blind Period|Withdrawal by Subject|0|||
28102459|NCT02963506|54759163|FG008|Double-Blind Period|Withdrawal by Subject|0|||
28102460|NCT02963506|54759164|FG009|Double-Blind Period|Withdrawal by Subject|0|||
28102461|NCT02963506|54759165|FG010|Double-Blind Period|Withdrawal by Subject|0|||
28102462|NCT02963506|54759166|FG011|Double-Blind Period|Withdrawal by Subject|0|||
28102463|NCT02963506|54759167|FG012|Double-Blind Period|Withdrawal by Subject|0|||
28172935|NCT03726658|54844753|FG002|Overall Study|Not Reported|0|||
28172936|NCT03726658|54844754|FG003|Overall Study|Not Reported|0|||
28172937|NCT03726658|54844755|FG004|Overall Study|Not Reported|0|||
28172938|NCT03726658|54844756|FG005|Overall Study|Not Reported|0|||
28172939|NCT03726658|54844757|FG006|Overall Study|Not Reported|1|||
28172940|NCT03106779|54844817|FG000|Overall Study|Lack of Efficacy|33|||
28172941|NCT03106779|54844818|FG001|Overall Study|Lack of Efficacy|24|||
28172942|NCT03106779|54844817|FG000|Overall Study|Adverse Event|8|||
28172943|NCT03106779|54844818|FG001|Overall Study|Adverse Event|16|||
28172944|NCT03106779|54844817|FG000|Overall Study|Physician Decision|10|||
28172945|NCT03106779|54844818|FG001|Overall Study|Physician Decision|6|||
28172946|NCT03106779|54844817|FG000|Overall Study|Patient/guardian decision|4|||
28172947|NCT03106779|54844818|FG001|Overall Study|Patient/guardian decision|3|||
28102464|NCT02963506|54759155|FG000|Double-Blind Period|No compliance|0|||
28102465|NCT02963506|54759156|FG001|Double-Blind Period|No compliance|1|||
28102466|NCT02963506|54759157|FG002|Double-Blind Period|No compliance|0|||
28102467|NCT02963506|54759158|FG003|Double-Blind Period|No compliance|0|||
28102468|NCT02963506|54759159|FG004|Double-Blind Period|No compliance|0|||
28102469|NCT02963506|54759160|FG005|Double-Blind Period|No compliance|0|||
28172948|NCT03106779|54844817|FG000|Overall Study|Progressive disease|1|||
28172949|NCT03106779|54844818|FG001|Overall Study|Progressive disease|3|||
28172950|NCT03106779|54844817|FG000|Overall Study|Lost to Follow-up|1|||
28172951|NCT03106779|54844818|FG001|Overall Study|Lost to Follow-up|2|||
28172952|NCT03106779|54844817|FG000|Overall Study|Death|1|||
28006172|NCT00467857|54665034|FG001|Overall Study|Death|1|||
28102470|NCT02963506|54759161|FG006|Double-Blind Period|No compliance|0|||
28102471|NCT02963506|54759162|FG007|Double-Blind Period|No compliance|0|||
28102472|NCT02963506|54759163|FG008|Double-Blind Period|No compliance|0|||
28102473|NCT02963506|54759164|FG009|Double-Blind Period|No compliance|0|||
28102474|NCT02963506|54759165|FG010|Double-Blind Period|No compliance|0|||
28102475|NCT02963506|54759166|FG011|Double-Blind Period|No compliance|0|||
28102476|NCT02963506|54759167|FG012|Double-Blind Period|No compliance|0|||
28102477|NCT02963506|54759155|FG000|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
28102478|NCT02963506|54759156|FG001|Double-Blind Period|Adverse event, non fatal after Wk12|1|||
28172953|NCT03106779|54844818|FG001|Overall Study|Death|0|||
28172954|NCT03106779|54844817|FG000|Overall Study|Protocol Violation|1|||
28172955|NCT03106779|54844818|FG001|Overall Study|Protocol Violation|0|||
28102479|NCT02963506|54759157|FG002|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
28102480|NCT02963506|54759158|FG003|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
28102481|NCT02963506|54759159|FG004|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
28102482|NCT02963506|54759160|FG005|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
28102483|NCT02963506|54759161|FG006|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
28102484|NCT02963506|54759162|FG007|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
28102485|NCT02963506|54759163|FG008|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
28102486|NCT02963506|54759164|FG009|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
28102487|NCT02963506|54759165|FG010|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
28102488|NCT02963506|54759166|FG011|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
28102489|NCT02963506|54759167|FG012|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
28102490|NCT02963506|54759155|FG000|Dose-Blind Period|Adverse Event|0|||
28102491|NCT02963506|54759156|FG001|Dose-Blind Period|Adverse Event|0|||
28102492|NCT02963506|54759157|FG002|Dose-Blind Period|Adverse Event|0|||
28102493|NCT02963506|54759158|FG003|Dose-Blind Period|Adverse Event|0|||
28102494|NCT02963506|54759159|FG004|Dose-Blind Period|Adverse Event|0|||
28102495|NCT02963506|54759160|FG005|Dose-Blind Period|Adverse Event|1|||
28102496|NCT02963506|54759161|FG006|Dose-Blind Period|Adverse Event|3|||
28102497|NCT02963506|54759162|FG007|Dose-Blind Period|Adverse Event|2|||
28102498|NCT02963506|54759163|FG008|Dose-Blind Period|Adverse Event|2|||
28102499|NCT02963506|54759164|FG009|Dose-Blind Period|Adverse Event|2|||
28172956|NCT03106779|54844817|FG000|Overall Study|Not treated|1|||
28172957|NCT03106779|54844818|FG001|Overall Study|Not treated|0|||
28172958|NCT03062358|54844835|FG000|Overall Study|Death|220|||
28172959|NCT03062358|54844836|FG001|Overall Study|Death|127|||
28172960|NCT03062358|54844835|FG000|Overall Study|Withdrawal by Subject|2|||
28172961|NCT03062358|54844836|FG001|Overall Study|Withdrawal by Subject|1|||
28172962|NCT03062358|54844835|FG000|Overall Study|Ongoing in Trial|78|||
28172963|NCT03062358|54844836|FG001|Overall Study|Ongoing in Trial|25|||
28172964|NCT02706873|54844847|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|15|||
28172965|NCT02706873|54844848|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|3|||
28172966|NCT02706873|54844849|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|18|||
28172967|NCT02706873|54844850|FG003|Period 1 (Weeks 1 to 48)|Adverse Event|11|||
28172968|NCT02706873|54844847|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|22|||
28172969|NCT02706873|54844848|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|0|||
28172970|NCT02706873|54844849|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|12|||
28172971|NCT02706873|54844850|FG003|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|20|||
28172972|NCT02706873|54844847|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|4|||
28172973|NCT02706873|54844848|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
28172974|NCT02706873|54844849|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|6|||
28172975|NCT02706873|54844850|FG003|Period 1 (Weeks 1 to 48)|Lost to Follow-up|5|||
28172976|NCT02706873|54844847|FG000|Period 1 (Weeks 1 to 48)|Lack of Efficacy|12|||
28172977|NCT02706873|54844848|FG001|Period 1 (Weeks 1 to 48)|Lack of Efficacy|0|||
28172978|NCT02706873|54844849|FG002|Period 1 (Weeks 1 to 48)|Lack of Efficacy|2|||
28172979|NCT02706873|54844850|FG003|Period 1 (Weeks 1 to 48)|Lack of Efficacy|4|||
28172980|NCT02706873|54844847|FG000|Period 1 (Weeks 1 to 48)|Other|5|||
28172981|NCT02706873|54844848|FG001|Period 1 (Weeks 1 to 48)|Other|1|||
28172982|NCT02706873|54844849|FG002|Period 1 (Weeks 1 to 48)|Other|2|||
28172983|NCT02706873|54844850|FG003|Period 1 (Weeks 1 to 48)|Other|3|||
28172984|NCT02706873|54844847|FG000|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
28172985|NCT02706873|54844848|FG001|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
28172986|NCT02706873|54844849|FG002|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
28172987|NCT02706873|54844850|FG003|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
28172988|NCT02706873|54844847|FG000|Period 2 (Weeks 48 to 260)|Adverse Event|16|||
28172989|NCT02706873|54844848|FG001|Period 2 (Weeks 48 to 260)|Adverse Event|4|||
28172990|NCT02706873|54844849|FG002|Period 2 (Weeks 48 to 260)|Adverse Event|11|||
28172991|NCT02706873|54844850|FG003|Period 2 (Weeks 48 to 260)|Adverse Event|26|||
28172992|NCT02706873|54844847|FG000|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|32|||
28172993|NCT02706873|54844848|FG001|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|5|||
28172994|NCT02706873|54844849|FG002|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|23|||
28172995|NCT02706873|54844850|FG003|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|27|||
28172996|NCT02706873|54844847|FG000|Period 2 (Weeks 48 to 260)|Lost to Follow-up|17|||
28172997|NCT02706873|54844848|FG001|Period 2 (Weeks 48 to 260)|Lost to Follow-up|0|||
28172998|NCT02706873|54844849|FG002|Period 2 (Weeks 48 to 260)|Lost to Follow-up|10|||
28172999|NCT02706873|54844850|FG003|Period 2 (Weeks 48 to 260)|Lost to Follow-up|6|||
28173000|NCT02706873|54844847|FG000|Period 2 (Weeks 48 to 260)|Lack of Efficacy|11|||
28173001|NCT02706873|54844848|FG001|Period 2 (Weeks 48 to 260)|Lack of Efficacy|0|||
28173002|NCT02706873|54844849|FG002|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
28173003|NCT02706873|54844850|FG003|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
28173004|NCT02706873|54844847|FG000|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
28173005|NCT02706873|54844848|FG001|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
28173006|NCT02706873|54844849|FG002|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
28102500|NCT02963506|54759165|FG010|Dose-Blind Period|Adverse Event|1|||
28102501|NCT02963506|54759166|FG011|Dose-Blind Period|Adverse Event|1|||
28102502|NCT02963506|54759167|FG012|Dose-Blind Period|Adverse Event|6|||
28102503|NCT02963506|54759155|FG000|Dose-Blind Period|Lack of Efficacy|0|||
28102504|NCT02963506|54759156|FG001|Dose-Blind Period|Lack of Efficacy|0|||
28102505|NCT02963506|54759157|FG002|Dose-Blind Period|Lack of Efficacy|0|||
28102506|NCT02963506|54759158|FG003|Dose-Blind Period|Lack of Efficacy|0|||
28102507|NCT02963506|54759159|FG004|Dose-Blind Period|Lack of Efficacy|0|||
28102508|NCT02963506|54759160|FG005|Dose-Blind Period|Lack of Efficacy|0|||
28102509|NCT02963506|54759161|FG006|Dose-Blind Period|Lack of Efficacy|0|||
28102510|NCT02963506|54759162|FG007|Dose-Blind Period|Lack of Efficacy|1|||
28102511|NCT02963506|54759163|FG008|Dose-Blind Period|Lack of Efficacy|0|||
28102512|NCT02963506|54759164|FG009|Dose-Blind Period|Lack of Efficacy|1|||
28102513|NCT02963506|54759165|FG010|Dose-Blind Period|Lack of Efficacy|0|||
28102514|NCT02963506|54759166|FG011|Dose-Blind Period|Lack of Efficacy|0|||
28102515|NCT02963506|54759167|FG012|Dose-Blind Period|Lack of Efficacy|0|||
28102516|NCT02963506|54759155|FG000|Dose-Blind Period|Lost to Follow-up|0|||
28102517|NCT02963506|54759156|FG001|Dose-Blind Period|Lost to Follow-up|0|||
28102518|NCT02963506|54759157|FG002|Dose-Blind Period|Lost to Follow-up|0|||
28102519|NCT02963506|54759158|FG003|Dose-Blind Period|Lost to Follow-up|0|||
28102520|NCT02963506|54759159|FG004|Dose-Blind Period|Lost to Follow-up|0|||
28102521|NCT02963506|54759160|FG005|Dose-Blind Period|Lost to Follow-up|1|||
28102522|NCT02963506|54759161|FG006|Dose-Blind Period|Lost to Follow-up|0|||
28102523|NCT02963506|54759162|FG007|Dose-Blind Period|Lost to Follow-up|0|||
28102524|NCT02963506|54759163|FG008|Dose-Blind Period|Lost to Follow-up|1|||
28102525|NCT02963506|54759164|FG009|Dose-Blind Period|Lost to Follow-up|0|||
28102526|NCT02963506|54759165|FG010|Dose-Blind Period|Lost to Follow-up|0|||
28102527|NCT02963506|54759166|FG011|Dose-Blind Period|Lost to Follow-up|1|||
28173007|NCT02706873|54844850|FG003|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|3|||
28173008|NCT02706873|54844847|FG000|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
28173009|NCT02706873|54844848|FG001|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
28173010|NCT02706873|54844849|FG002|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|2|||
28173011|NCT02706873|54844850|FG003|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|1|||
28173012|NCT02706873|54844847|FG000|Period 2 (Weeks 48 to 260)|Other|14|||
28173013|NCT02706873|54844848|FG001|Period 2 (Weeks 48 to 260)|Other|1|||
28173014|NCT02706873|54844849|FG002|Period 2 (Weeks 48 to 260)|Other|11|||
28173015|NCT02706873|54844850|FG003|Period 2 (Weeks 48 to 260)|Other|17|||
28173016|NCT02584634|54844873|FG000|Overall Study|Adverse Event|3|||
28173017|NCT02584634|54844874|FG001|Overall Study|Adverse Event|5|||
28173018|NCT02584634|54844873|FG000|Overall Study|Death|0|||
28173019|NCT02584634|54844874|FG001|Overall Study|Death|1|||
28173020|NCT02584634|54844873|FG000|Overall Study|Lost to Follow-up|0|||
28173021|NCT02584634|54844874|FG001|Overall Study|Lost to Follow-up|1|||
28173022|NCT02584634|54844873|FG000|Overall Study|Physician Decision|1|||
28173023|NCT02584634|54844874|FG001|Overall Study|Physician Decision|2|||
28173024|NCT02584634|54844873|FG000|Overall Study|Progressive disease|7|||
28173025|NCT02584634|54844874|FG001|Overall Study|Progressive disease|15|||
28173026|NCT02584634|54844873|FG000|Overall Study|Withdrawal by Subject|1|||
28173027|NCT02584634|54844874|FG001|Overall Study|Withdrawal by Subject|1|||
28173028|NCT02584634|54844873|FG000|Overall Study|Other|0|||
28102528|NCT02963506|54759167|FG012|Dose-Blind Period|Lost to Follow-up|0|||
28102529|NCT02963506|54759155|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
28102530|NCT02963506|54759156|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
28102531|NCT02963506|54759157|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
28102532|NCT02963506|54759158|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
28102533|NCT02963506|54759159|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
28102534|NCT02963506|54759160|FG005|Dose-Blind Period|Withdrawal by Subject|1|||
28102535|NCT02963506|54759161|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
28102536|NCT02963506|54759162|FG007|Dose-Blind Period|Withdrawal by Subject|2|||
28102537|NCT02963506|54759163|FG008|Dose-Blind Period|Withdrawal by Subject|0|||
28102538|NCT02963506|54759164|FG009|Dose-Blind Period|Withdrawal by Subject|1|||
28102539|NCT02963506|54759165|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
28102540|NCT02963506|54759166|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
28102541|NCT02963506|54759167|FG012|Dose-Blind Period|Withdrawal by Subject|0|||
28102542|NCT02963506|54759155|FG000|Dose-Blind Period|Sponsor decision|0|||
27740000|NCT02786537|54189678|FG001|As Treated|Opiate dependency relapse|1|||
27740001|NCT02786537|54189679|FG002|As Treated|Opiate dependency relapse|0|||
28102543|NCT02963506|54759156|FG001|Dose-Blind Period|Sponsor decision|0|||
28102544|NCT02963506|54759157|FG002|Dose-Blind Period|Sponsor decision|0|||
28102545|NCT02963506|54759158|FG003|Dose-Blind Period|Sponsor decision|0|||
28102546|NCT02963506|54759159|FG004|Dose-Blind Period|Sponsor decision|0|||
28102547|NCT02963506|54759160|FG005|Dose-Blind Period|Sponsor decision|1|||
28173029|NCT02584634|54844874|FG001|Overall Study|Other|6|||
28173030|NCT02091960|54844882|FG000|Overall Study|Death|7|||
28173031|NCT02091960|54844882|FG000|Overall Study|Withdrawal by Subject|1|||
28173032|NCT02091960|54844882|FG000|Overall Study|Miscellaneous Reasons|31|||
28102548|NCT02963506|54759161|FG006|Dose-Blind Period|Sponsor decision|0|||
28102549|NCT02963506|54759162|FG007|Dose-Blind Period|Sponsor decision|0|||
28102550|NCT02963506|54759163|FG008|Dose-Blind Period|Sponsor decision|0|||
28102551|NCT02963506|54759164|FG009|Dose-Blind Period|Sponsor decision|0|||
28102552|NCT02963506|54759165|FG010|Dose-Blind Period|Sponsor decision|0|||
28102553|NCT02963506|54759166|FG011|Dose-Blind Period|Sponsor decision|0|||
28102554|NCT02963506|54759167|FG012|Dose-Blind Period|Sponsor decision|0|||
28102555|NCT02963506|54759155|FG000|Dose-Blind Period|Meeting exclusion criteria 9|0|||
28102556|NCT02963506|54759156|FG001|Dose-Blind Period|Meeting exclusion criteria 9|0|||
28102557|NCT02963506|54759157|FG002|Dose-Blind Period|Meeting exclusion criteria 9|0|||
28102558|NCT02963506|54759158|FG003|Dose-Blind Period|Meeting exclusion criteria 9|0|||
28102559|NCT02963506|54759159|FG004|Dose-Blind Period|Meeting exclusion criteria 9|0|||
28102560|NCT02963506|54759160|FG005|Dose-Blind Period|Meeting exclusion criteria 9|0|||
28102561|NCT02963506|54759161|FG006|Dose-Blind Period|Meeting exclusion criteria 9|0|||
28102562|NCT02963506|54759162|FG007|Dose-Blind Period|Meeting exclusion criteria 9|0|||
28102563|NCT02963506|54759163|FG008|Dose-Blind Period|Meeting exclusion criteria 9|0|||
28102564|NCT02963506|54759164|FG009|Dose-Blind Period|Meeting exclusion criteria 9|0|||
28102565|NCT02963506|54759165|FG010|Dose-Blind Period|Meeting exclusion criteria 9|0|||
28102566|NCT02963506|54759166|FG011|Dose-Blind Period|Meeting exclusion criteria 9|0|||
28102567|NCT02963506|54759167|FG012|Dose-Blind Period|Meeting exclusion criteria 9|1|||
28102568|NCT01345162|54759186|FG000|Overall Study|Protocol Violation|2|||
28102569|NCT01345162|54759187|FG001|Overall Study|Protocol Violation|4|||
28102570|NCT01345318|54759193|FG000|Overall Study|Adverse Event|16|||
28102571|NCT01345318|54759193|FG000|Overall Study|Lack of Efficacy|17|||
28102572|NCT01345318|54759193|FG000|Overall Study|Lost to Follow-up|2|||
28102573|NCT01345318|54759193|FG000|Overall Study|Protocol Violation|1|||
28102574|NCT01345318|54759193|FG000|Overall Study|Withdrawal by Subject|41|||
28102575|NCT01345318|54759193|FG000|Overall Study|Other|3|||
28102576|NCT02961244|54759200|FG000|Overall Study|Protocol Violation|0|||
28102577|NCT02961244|54759201|FG001|Overall Study|Protocol Violation|1|||
28102578|NCT02961244|54759200|FG000|Overall Study|Withdrawal by Subject|1|||
28102579|NCT02961244|54759201|FG001|Overall Study|Withdrawal by Subject|2|||
28102580|NCT02961244|54759200|FG000|Overall Study|Surgery plan change after study approval|0|||
28102581|NCT02961244|54759201|FG001|Overall Study|Surgery plan change after study approval|2|||
28102582|NCT02961244|54759200|FG000|Overall Study|Lost to Follow-up|0|||
28102583|NCT02961244|54759201|FG001|Overall Study|Lost to Follow-up|2|||
28102584|NCT02961244|54759200|FG000|Overall Study|İnadequate data|0|||
28102585|NCT02961244|54759201|FG001|Overall Study|İnadequate data|2|||
28102586|NCT03771963|54759207|FG000|Overall Study|Lost to Follow-up|22|||
28006173|NCT00467857|54665033|FG000|Overall Study|Discharged from court service|0|||
28006174|NCT00467857|54665034|FG001|Overall Study|Discharged from court service|1|||
28006175|NCT00467857|54665033|FG000|Overall Study|Emergency care required|0|||
28006176|NCT00467857|54665034|FG001|Overall Study|Emergency care required|1|||
28006177|NCT00467857|54665033|FG000|Overall Study|Did not meet inclusion/exclusion criteri|0|||
28006178|NCT00467857|54665034|FG001|Overall Study|Did not meet inclusion/exclusion criteri|2|||
28102587|NCT03771963|54759207|FG000|Overall Study|Withdrawal of Consent|10|||
28102588|NCT02962648|54759211|FG000|Overall Study|Withdrawal by Subject|3|||
28102589|NCT02962648|54759211|FG000|Overall Study|Lost to Follow-up|3|||
28102590|NCT02962648|54759211|FG000|Overall Study|Physician Decision|1|||
28102591|NCT02962648|54759211|FG000|Overall Study|Subject had problems with transportation|2|||
28102592|NCT02962882|54759215|FG000|Overall Study|Adverse Event|2|||
28006179|NCT00467857|54665033|FG000|Overall Study|Discontinuation reason missing|0|||
28006180|NCT00467857|54665034|FG001|Overall Study|Discontinuation reason missing|3|||
28006181|NCT00435019|54665042|FG000|Overall Study|Adverse Event|1|||
28006182|NCT00435019|54665043|FG001|Overall Study|Adverse Event|0|||
28006183|NCT00435019|54665042|FG000|Overall Study|Lack of Efficacy|1|||
28006184|NCT00435019|54665043|FG001|Overall Study|Lack of Efficacy|2|||
28006185|NCT00435019|54665042|FG000|Overall Study|Protocol Violation|3|||
28006186|NCT00435019|54665043|FG001|Overall Study|Protocol Violation|1|||
28006187|NCT00435019|54665042|FG000|Overall Study|Personal reasons for withdrawal|8|||
28006188|NCT00435019|54665043|FG001|Overall Study|Personal reasons for withdrawal|7|||
28006189|NCT00577863|54665051|FG000|Overall Study|Adverse Event|4|||
28006190|NCT00577863|54665052|FG001|Overall Study|Adverse Event|2|||
28006191|NCT00577863|54665051|FG000|Overall Study|Death|1|||
28006192|NCT00577863|54665052|FG001|Overall Study|Death|0|||
28006193|NCT00577863|54665051|FG000|Overall Study|Lost to Follow-up|2|||
28006194|NCT00577863|54665052|FG001|Overall Study|Lost to Follow-up|2|||
28006195|NCT00577863|54665051|FG000|Overall Study|Entry Criteria Exclusion|1|||
28102593|NCT02962882|54759215|FG000|Overall Study|Withdrawal by Subject|2|||
28102594|NCT02962882|54759215|FG000|Overall Study|Transfer from ICU|32|||
28102595|NCT02961790|54759224|FG000|Overall Study|Canceled|4|||
28102596|NCT02961790|54759225|FG001|Overall Study|Canceled|5|||
28006196|NCT00577863|54665052|FG001|Overall Study|Entry Criteria Exclusion|0|||
28006197|NCT00577863|54665051|FG000|Overall Study|Withdrawal by Subject|0|||
28006198|NCT00577863|54665052|FG001|Overall Study|Withdrawal by Subject|2|||
28006199|NCT00577863|54665051|FG000|Overall Study|Sponsor Decision|2|||
28102597|NCT02961790|54759226|FG002|Overall Study|Canceled|1|||
28102598|NCT02961790|54759227|FG003|Overall Study|Canceled|4|||
28102599|NCT02961790|54759224|FG000|Overall Study|without baseline data|4|||
28102600|NCT02961790|54759225|FG001|Overall Study|without baseline data|0|||
28102601|NCT02961790|54759226|FG002|Overall Study|without baseline data|1|||
28102602|NCT02961790|54759227|FG003|Overall Study|without baseline data|0|||
28102603|NCT02961790|54759224|FG000|Overall Study|without post baseline data|7|||
28102604|NCT02961790|54759225|FG001|Overall Study|without post baseline data|6|||
28102605|NCT02961790|54759226|FG002|Overall Study|without post baseline data|4|||
28102606|NCT02961790|54759227|FG003|Overall Study|without post baseline data|1|||
28102607|NCT02960854|54759249|FG000|Overall Study|Not Disclosed|2|||
28173033|NCT02091960|54844882|FG000|Overall Study|On Study at Data Cut-off|12|||
28173034|NCT02000622|54844888|FG000|Overall Study|Withdrawal by Subject|5|||
28173035|NCT02000622|54844889|FG001|Overall Study|Withdrawal by Subject|7|||
28173036|NCT02000622|54844888|FG000|Overall Study|Lost to Follow-up|4|||
28173037|NCT02000622|54844889|FG001|Overall Study|Lost to Follow-up|0|||
28173038|NCT02000622|54844888|FG000|Overall Study|Death|159|||
28173039|NCT02000622|54844889|FG001|Overall Study|Death|73|||
28173040|NCT02000622|54844888|FG000|Overall Study|Withdrawn due to site closure|1|||
28173041|NCT02000622|54844889|FG001|Overall Study|Withdrawn due to site closure|0|||
28173042|NCT01275729|54844955|FG000|Overall Study|Death|3|||
28173043|NCT01275729|54844955|FG000|Overall Study|Withdrawal by Subject|1|||
28173044|NCT01107626|54844963|FG000|Step 1: Induction Therapy|Lack of Efficacy|167|||
28173045|NCT01107626|54844964|FG001|Step 1: Induction Therapy|Lack of Efficacy|0|||
28173046|NCT01107626|54844965|FG002|Step 1: Induction Therapy|Lack of Efficacy|0|||
28173047|NCT01107626|54844966|FG003|Step 1: Induction Therapy|Lack of Efficacy|0|||
28173048|NCT01107626|54844963|FG000|Step 1: Induction Therapy|Adverse Event|198|||
28173049|NCT01107626|54844964|FG001|Step 1: Induction Therapy|Adverse Event|0|||
28173050|NCT01107626|54844965|FG002|Step 1: Induction Therapy|Adverse Event|0|||
28173051|NCT01107626|54844966|FG003|Step 1: Induction Therapy|Adverse Event|0|||
28173052|NCT01107626|54844963|FG000|Step 1: Induction Therapy|Death|62|||
28173053|NCT01107626|54844964|FG001|Step 1: Induction Therapy|Death|0|||
28173054|NCT01107626|54844965|FG002|Step 1: Induction Therapy|Death|0|||
28173055|NCT01107626|54844966|FG003|Step 1: Induction Therapy|Death|0|||
28173056|NCT01107626|54844963|FG000|Step 1: Induction Therapy|Withdrawal by Subject|54|||
28173057|NCT01107626|54844964|FG001|Step 1: Induction Therapy|Withdrawal by Subject|0|||
28173058|NCT01107626|54844965|FG002|Step 1: Induction Therapy|Withdrawal by Subject|0|||
28173059|NCT01107626|54844966|FG003|Step 1: Induction Therapy|Withdrawal by Subject|0|||
28173060|NCT01107626|54844963|FG000|Step 1: Induction Therapy|Complicating disease|13|||
28173061|NCT01107626|54844964|FG001|Step 1: Induction Therapy|Complicating disease|0|||
28173062|NCT01107626|54844965|FG002|Step 1: Induction Therapy|Complicating disease|0|||
28173063|NCT01107626|54844966|FG003|Step 1: Induction Therapy|Complicating disease|0|||
28173064|NCT01107626|54844963|FG000|Step 1: Induction Therapy|Alternative therapy|12|||
28173065|NCT01107626|54844964|FG001|Step 1: Induction Therapy|Alternative therapy|0|||
28173066|NCT01107626|54844965|FG002|Step 1: Induction Therapy|Alternative therapy|0|||
28173067|NCT01107626|54844966|FG003|Step 1: Induction Therapy|Alternative therapy|0|||
28173068|NCT01107626|54844963|FG000|Step 1: Induction Therapy|Symptomatic deterioration|10|||
28173069|NCT01107626|54844964|FG001|Step 1: Induction Therapy|Symptomatic deterioration|0|||
28173070|NCT01107626|54844965|FG002|Step 1: Induction Therapy|Symptomatic deterioration|0|||
28173071|NCT01107626|54844966|FG003|Step 1: Induction Therapy|Symptomatic deterioration|0|||
28173072|NCT01107626|54844963|FG000|Step 1: Induction Therapy|Non-compliance|4|||
28102608|NCT02960854|54759250|FG001|Overall Study|Not Disclosed|2|||
28102609|NCT02960854|54759249|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
28102610|NCT02960854|54759250|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
28102611|NCT02960854|54759249|FG000|Overall Study|Subject Withdrew Consent|0|||
28102612|NCT02960854|54759250|FG001|Overall Study|Subject Withdrew Consent|1|||
28102613|NCT02960854|54759249|FG000|Overall Study|Death|4|||
28102614|NCT02960854|54759250|FG001|Overall Study|Death|6|||
28102615|NCT01344538|54759258|FG000|Overall Study|Adverse Event|1|||
28102616|NCT01344538|54759259|FG001|Overall Study|Adverse Event|1|||
28102617|NCT01344538|54759258|FG000|Overall Study|Lost to Follow-up|1|||
28102618|NCT01344538|54759259|FG001|Overall Study|Lost to Follow-up|0|||
28102619|NCT01344460|54759265|FG000|Overall Study|Withdrawal by Subject|1|||
28173073|NCT01107626|54844964|FG001|Step 1: Induction Therapy|Non-compliance|0|||
28173074|NCT01107626|54844965|FG002|Step 1: Induction Therapy|Non-compliance|0|||
28173075|NCT01107626|54844966|FG003|Step 1: Induction Therapy|Non-compliance|0|||
28173076|NCT01107626|54844963|FG000|Step 1: Induction Therapy|Pain|4|||
27740002|NCT02786537|54189680|FG003|As Treated|Opiate dependency relapse|0|||
27740003|NCT02786537|54189681|FG004|As Treated|Opiate dependency relapse|0|||
28173077|NCT01107626|54844964|FG001|Step 1: Induction Therapy|Pain|0|||
28173078|NCT01107626|54844965|FG002|Step 1: Induction Therapy|Pain|0|||
27740004|NCT02786537|54189682|FG005|As Treated|Opiate dependency relapse|0|||
28102620|NCT01344460|54759265|FG000|Overall Study|Lost to Follow-up|2|||
28102621|NCT03764631|54759275|FG000|Overall Study|Personal Reasons|3|||
28173079|NCT01107626|54844966|FG003|Step 1: Induction Therapy|Pain|0|||
28102622|NCT03764631|54759276|FG001|Overall Study|Personal Reasons|2|||
28102623|NCT03764631|54759275|FG000|Overall Study|Switching Therapy|3|||
28102624|NCT03764631|54759276|FG001|Overall Study|Switching Therapy|3|||
28102625|NCT03764631|54759275|FG000|Overall Study|Adverse Event|0|||
28102626|NCT03764631|54759276|FG001|Overall Study|Adverse Event|1|||
28102627|NCT03764631|54759275|FG000|Overall Study|Lost to Follow-up|33|||
28102628|NCT03764631|54759276|FG001|Overall Study|Lost to Follow-up|41|||
28102629|NCT03764631|54759275|FG000|Overall Study|No data as study site was closed|2|||
28102630|NCT03764631|54759276|FG001|Overall Study|No data as study site was closed|6|||
28102631|NCT02956486|54759295|FG000|Core Phase|Adverse Event|51|||
28102632|NCT02956486|54759296|FG001|Core Phase|Adverse Event|88|||
28102633|NCT02956486|54759297|FG002|Core Phase|Adverse Event|0|||
28173080|NCT01107626|54844963|FG000|Step 1: Induction Therapy|Protocol Violation|1|||
28173081|NCT01107626|54844964|FG001|Step 1: Induction Therapy|Protocol Violation|0|||
28173082|NCT01107626|54844965|FG002|Step 1: Induction Therapy|Protocol Violation|0|||
28173083|NCT01107626|54844966|FG003|Step 1: Induction Therapy|Protocol Violation|0|||
28173084|NCT01107626|54844963|FG000|Step 1: Induction Therapy|Hospice care|1|||
28173085|NCT01107626|54844964|FG001|Step 1: Induction Therapy|Hospice care|0|||
28173086|NCT01107626|54844965|FG002|Step 1: Induction Therapy|Hospice care|0|||
28173087|NCT01107626|54844966|FG003|Step 1: Induction Therapy|Hospice care|0|||
28173088|NCT01107626|54844963|FG000|Step 1: Induction Therapy|Physician Decision|1|||
28173089|NCT01107626|54844964|FG001|Step 1: Induction Therapy|Physician Decision|0|||
28102634|NCT02956486|54759295|FG000|Core Phase|Lost to Follow-up|8|||
28102635|NCT02956486|54759296|FG001|Core Phase|Lost to Follow-up|6|||
28102636|NCT02956486|54759297|FG002|Core Phase|Lost to Follow-up|0|||
28102637|NCT02956486|54759295|FG000|Core Phase|Inadequate therapeutic effect|4|||
28102638|NCT02956486|54759296|FG001|Core Phase|Inadequate therapeutic effect|5|||
28102639|NCT02956486|54759297|FG002|Core Phase|Inadequate therapeutic effect|0|||
28102640|NCT02956486|54759295|FG000|Core Phase|Withdrawal by Subject|101|||
28102641|NCT02956486|54759296|FG001|Core Phase|Withdrawal by Subject|104|||
28102642|NCT02956486|54759297|FG002|Core Phase|Withdrawal by Subject|0|||
28102643|NCT02956486|54759295|FG000|Core Phase|Study terminated by sponsor|888|||
28102644|NCT02956486|54759296|FG001|Core Phase|Study terminated by sponsor|848|||
28102645|NCT02956486|54759297|FG002|Core Phase|Study terminated by sponsor|0|||
28102646|NCT02956486|54759295|FG000|Core Phase|Other|27|||
28102647|NCT02956486|54759296|FG001|Core Phase|Other|18|||
28102648|NCT02956486|54759297|FG002|Core Phase|Other|0|||
28102649|NCT02956486|54759295|FG000|Core Phase|Not treated|0|||
28102650|NCT02956486|54759296|FG001|Core Phase|Not treated|3|||
28102651|NCT02956486|54759297|FG002|Core Phase|Not treated|0|||
28102652|NCT02956486|54759295|FG000|Extension Phase|Adverse Event|0|||
28102653|NCT02956486|54759296|FG001|Extension Phase|Adverse Event|0|||
28102654|NCT02956486|54759297|FG002|Extension Phase|Adverse Event|2|||
28102655|NCT02956486|54759295|FG000|Extension Phase|Study terminated by sponsor|0|||
28102656|NCT02956486|54759296|FG001|Extension Phase|Study terminated by sponsor|0|||
28102657|NCT02956486|54759297|FG002|Extension Phase|Study terminated by sponsor|16|||
28102658|NCT02956486|54759295|FG000|Extension Phase|Not Treated|0|||
28102659|NCT02956486|54759296|FG001|Extension Phase|Not Treated|0|||
28173090|NCT01107626|54844965|FG002|Step 1: Induction Therapy|Physician Decision|0|||
28173091|NCT01107626|54844966|FG003|Step 1: Induction Therapy|Physician Decision|0|||
28173092|NCT01107626|54844963|FG000|Step 1: Induction Therapy|Off treatment reason not reported|50|||
28173093|NCT01107626|54844964|FG001|Step 1: Induction Therapy|Off treatment reason not reported|0|||
28173094|NCT01107626|54844965|FG002|Step 1: Induction Therapy|Off treatment reason not reported|0|||
28173095|NCT01107626|54844966|FG003|Step 1: Induction Therapy|Off treatment reason not reported|0|||
28173096|NCT01107626|54844963|FG000|Step 2: Maintenance Therapy|Lack of Efficacy|0|||
28173097|NCT01107626|54844964|FG001|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
27917094|NCT01172821|54574606|FG001|Overall Study|Withdrawal by Subject|3|||
27917095|NCT01172821|54574607|FG002|Overall Study|Withdrawal by Subject|3|||
27917096|NCT01172821|54574608|FG003|Overall Study|Withdrawal by Subject|3|||
27917097|NCT01172821|54574605|FG000|Overall Study|Other|3|||
28102660|NCT02956486|54759297|FG002|Extension Phase|Not Treated|1|||
28102661|NCT03445533|54759312|FG000|Overall Study|Progressive Disease|48|||
28102662|NCT03445533|54759313|FG001|Overall Study|Progressive Disease|81|||
28102663|NCT03445533|54759312|FG000|Overall Study|Adverse Event|60|||
28102664|NCT03445533|54759313|FG001|Overall Study|Adverse Event|64|||
28102665|NCT03445533|54759312|FG000|Overall Study|Death|9|||
28102666|NCT03445533|54759313|FG001|Overall Study|Death|19|||
28102667|NCT03445533|54759312|FG000|Overall Study|Miscellaneous|0|||
28102668|NCT03445533|54759313|FG001|Overall Study|Miscellaneous|16|||
28102669|NCT03445533|54759312|FG000|Overall Study|Withdrawal by Subject|3|||
28102670|NCT03445533|54759313|FG001|Overall Study|Withdrawal by Subject|4|||
28173098|NCT01107626|54844965|FG002|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
28173099|NCT01107626|54844966|FG003|Step 2: Maintenance Therapy|Lack of Efficacy|170|||
28173100|NCT01107626|54844963|FG000|Step 2: Maintenance Therapy|Adverse Event|0|||
28173101|NCT01107626|54844964|FG001|Step 2: Maintenance Therapy|Adverse Event|32|||
28173102|NCT01107626|54844965|FG002|Step 2: Maintenance Therapy|Adverse Event|29|||
28173103|NCT01107626|54844966|FG003|Step 2: Maintenance Therapy|Adverse Event|46|||
28102671|NCT03445533|54759312|FG000|Overall Study|Physician Decision|1|||
28102672|NCT03445533|54759313|FG001|Overall Study|Physician Decision|3|||
28102673|NCT03445533|54759312|FG000|Overall Study|Sponsor Decision|0|||
28102674|NCT03445533|54759313|FG001|Overall Study|Sponsor Decision|1|||
28102675|NCT03445533|54759312|FG000|Overall Study|Lost to Follow-up|0|||
28102676|NCT03445533|54759313|FG001|Overall Study|Lost to Follow-up|1|||
28102677|NCT03445533|54759312|FG000|Overall Study|Never Received any Study Treatment|7|||
28102678|NCT03445533|54759313|FG001|Overall Study|Never Received any Study Treatment|4|||
28102679|NCT01337050|54759322|FG000|Overall Study|Death|0|||
28102680|NCT01337050|54759323|FG001|Overall Study|Death|0|||
28102681|NCT01337050|54759324|FG002|Overall Study|Death|4|||
28102682|NCT01337050|54759322|FG000|Overall Study|Other|4|||
28102683|NCT01337050|54759323|FG001|Overall Study|Other|6|||
28102684|NCT01337050|54759324|FG002|Overall Study|Other|8|||
28102685|NCT01337050|54759322|FG000|Overall Study|Participants refused further follow-up|0|||
28102686|NCT01337050|54759323|FG001|Overall Study|Participants refused further follow-up|7|||
28102687|NCT01337050|54759324|FG002|Overall Study|Participants refused further follow-up|7|||
28102688|NCT01336972|54759336|FG000|Overall Study|Adverse Event|1|||
28102689|NCT01336972|54759337|FG001|Overall Study|Adverse Event|1|||
28102690|NCT01336972|54759338|FG002|Overall Study|Adverse Event|0|||
28102691|NCT03762681|54759355|FG000|Part 1|Withdrawal by Subject|0|||
28102692|NCT03762681|54759356|FG001|Part 1|Withdrawal by Subject|0|||
28102693|NCT03762681|54759357|FG002|Part 1|Withdrawal by Subject|0|||
28102694|NCT03762681|54759358|FG003|Part 1|Withdrawal by Subject|1|||
28102695|NCT03762681|54759359|FG004|Part 1|Withdrawal by Subject|0|||
28102696|NCT03762681|54759360|FG005|Part 1|Withdrawal by Subject|0|||
28102697|NCT03762681|54759361|FG006|Part 1|Withdrawal by Subject|0|||
28102698|NCT03762681|54759362|FG007|Part 1|Withdrawal by Subject|0|||
28102699|NCT03762681|54759355|FG000|Part 2a|Pandemic Travel Restrictions|0|||
28102700|NCT03762681|54759356|FG001|Part 2a|Pandemic Travel Restrictions|0|||
28102701|NCT03762681|54759357|FG002|Part 2a|Pandemic Travel Restrictions|0|||
28102702|NCT03762681|54759358|FG003|Part 2a|Pandemic Travel Restrictions|0|||
28173104|NCT01107626|54844963|FG000|Step 2: Maintenance Therapy|Death|0|||
28173105|NCT01107626|54844964|FG001|Step 2: Maintenance Therapy|Death|8|||
27917098|NCT01172821|54574606|FG001|Overall Study|Other|4|||
28173106|NCT01107626|54844965|FG002|Step 2: Maintenance Therapy|Death|2|||
28173107|NCT01107626|54844966|FG003|Step 2: Maintenance Therapy|Death|13|||
28173108|NCT01107626|54844963|FG000|Step 2: Maintenance Therapy|Withdrawal by Subject|0|||
28173109|NCT01107626|54844964|FG001|Step 2: Maintenance Therapy|Withdrawal by Subject|11|||
28173110|NCT01107626|54844965|FG002|Step 2: Maintenance Therapy|Withdrawal by Subject|21|||
28173111|NCT01107626|54844966|FG003|Step 2: Maintenance Therapy|Withdrawal by Subject|27|||
28173112|NCT01107626|54844963|FG000|Step 2: Maintenance Therapy|Alternative therapy|0|||
28173113|NCT01107626|54844964|FG001|Step 2: Maintenance Therapy|Alternative therapy|2|||
28173114|NCT01107626|54844965|FG002|Step 2: Maintenance Therapy|Alternative therapy|4|||
28173115|NCT01107626|54844966|FG003|Step 2: Maintenance Therapy|Alternative therapy|5|||
28173116|NCT01107626|54844963|FG000|Step 2: Maintenance Therapy|Other complicating disease|0|||
28173117|NCT01107626|54844964|FG001|Step 2: Maintenance Therapy|Other complicating disease|2|||
28173118|NCT01107626|54844965|FG002|Step 2: Maintenance Therapy|Other complicating disease|5|||
28173119|NCT01107626|54844966|FG003|Step 2: Maintenance Therapy|Other complicating disease|9|||
28173120|NCT01107626|54844963|FG000|Step 2: Maintenance Therapy|Symptomatic deterioration|0|||
28173121|NCT01107626|54844964|FG001|Step 2: Maintenance Therapy|Symptomatic deterioration|2|||
28173122|NCT01107626|54844965|FG002|Step 2: Maintenance Therapy|Symptomatic deterioration|4|||
28173123|NCT01107626|54844966|FG003|Step 2: Maintenance Therapy|Symptomatic deterioration|3|||
28173124|NCT01107626|54844963|FG000|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0|||
28173125|NCT01107626|54844964|FG001|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
28173126|NCT01107626|54844965|FG002|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
28173127|NCT01107626|54844966|FG003|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3|||
28173128|NCT01107626|54844963|FG000|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
28173129|NCT01107626|54844964|FG001|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
27917099|NCT01172821|54574607|FG002|Overall Study|Other|5|||
27917100|NCT01172821|54574608|FG003|Overall Study|Other|3|||
27917101|NCT01172275|54574620|FG000|Overall Study|Lost to Follow-up|1|||
28173130|NCT01107626|54844965|FG002|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
27917102|NCT01172275|54574621|FG001|Overall Study|Lost to Follow-up|0|||
27917103|NCT01172275|54574620|FG000|Overall Study|Protocol Violation|1|||
27917104|NCT01172275|54574621|FG001|Overall Study|Protocol Violation|0|||
27917105|NCT01108510|54574629|FG000|Overall Study|Randomized but Not Treated|5|||
27917106|NCT01108510|54574630|FG001|Overall Study|Randomized but Not Treated|1|||
27917107|NCT01108510|54574629|FG000|Overall Study|Joined Another Gilead-sponsored Study|186|||
28102703|NCT03762681|54759359|FG004|Part 2a|Pandemic Travel Restrictions|0|||
28102704|NCT03762681|54759360|FG005|Part 2a|Pandemic Travel Restrictions|0|||
28102705|NCT03762681|54759361|FG006|Part 2a|Pandemic Travel Restrictions|0|||
28102706|NCT03762681|54759362|FG007|Part 2a|Pandemic Travel Restrictions|1|||
28102707|NCT03764475|54759391|FG000|Overall Study|Adverse Event|11|||
28006200|NCT00577863|54665052|FG001|Overall Study|Sponsor Decision|7|||
28006201|NCT00577863|54665051|FG000|Overall Study|Did Not Receive at Least One Injection|0|||
28006202|NCT00577863|54665052|FG001|Overall Study|Did Not Receive at Least One Injection|1|||
28102708|NCT03764475|54759392|FG001|Overall Study|Adverse Event|2|||
28102709|NCT03764475|54759391|FG000|Overall Study|Lost to Follow-up|24|||
28102710|NCT03764475|54759392|FG001|Overall Study|Lost to Follow-up|10|||
28102711|NCT03764475|54759391|FG000|Overall Study|Withdrawal by Subject|26|||
28102712|NCT03764475|54759392|FG001|Overall Study|Withdrawal by Subject|10|||
28102713|NCT03764475|54759391|FG000|Overall Study|Lack of Efficacy|3|||
28102714|NCT03764475|54759392|FG001|Overall Study|Lack of Efficacy|0|||
27917108|NCT01108510|54574630|FG001|Overall Study|Joined Another Gilead-sponsored Study|195|||
27917109|NCT01108510|54574629|FG000|Overall Study|Adverse Event|26|||
27917110|NCT01108510|54574630|FG001|Overall Study|Adverse Event|19|||
27917111|NCT01108510|54574629|FG000|Overall Study|Lost to Follow-up|20|||
27917112|NCT01108510|54574630|FG001|Overall Study|Lost to Follow-up|17|||
28102715|NCT03764475|54759391|FG000|Overall Study|COVID-19 Disruption|2|||
28102716|NCT03764475|54759392|FG001|Overall Study|COVID-19 Disruption|0|||
28102717|NCT02873338|54759405|FG000|Overall Study|Adverse Event|0|||
28102718|NCT02873338|54759406|FG001|Overall Study|Adverse Event|2|||
28102719|NCT02873338|54759407|FG002|Overall Study|Adverse Event|1|||
28102720|NCT02873338|54759405|FG000|Overall Study|Death|2|||
28102721|NCT02873338|54759406|FG001|Overall Study|Death|1|||
28102722|NCT02873338|54759407|FG002|Overall Study|Death|1|||
28173131|NCT01107626|54844966|FG003|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
27917113|NCT01108510|54574629|FG000|Overall Study|Withdrew Consent|21|||
27917114|NCT01108510|54574630|FG001|Overall Study|Withdrew Consent|15|||
27917115|NCT01108510|54574629|FG000|Overall Study|Investigator's Discretion|12|||
27917116|NCT01108510|54574630|FG001|Overall Study|Investigator's Discretion|10|||
28006203|NCT00794417|54665062|FG000|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
28006204|NCT00794417|54665063|FG001|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
28006205|NCT00794417|54665064|FG002|Phase 1: Baseline (Day 1) up to Day 751|Death|2|||
28006206|NCT00794417|54665065|FG003|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
28006207|NCT00794417|54665062|FG000|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
28006208|NCT00794417|54665063|FG001|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
28006209|NCT00794417|54665064|FG002|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1|||
28006210|NCT00794417|54665065|FG003|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0|||
28006211|NCT00794417|54665062|FG000|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
28006212|NCT00794417|54665063|FG001|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
28006213|NCT00794417|54665064|FG002|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
28006214|NCT00794417|54665065|FG003|Phase 2: Baseline (Day 421) to Day 972|Death|7|||
28006215|NCT00794417|54665062|FG000|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
28006216|NCT00794417|54665063|FG001|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
28006217|NCT00794417|54665064|FG002|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
28006218|NCT00794417|54665065|FG003|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11|||
28006219|NCT00794417|54665062|FG000|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
28006220|NCT00794417|54665063|FG001|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
28006221|NCT00794417|54665064|FG002|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
28006222|NCT00794417|54665065|FG003|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4|||
28006223|NCT00794417|54665062|FG000|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
28006224|NCT00794417|54665063|FG001|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
28006225|NCT00794417|54665064|FG002|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
28006226|NCT00794417|54665065|FG003|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13|||
28006227|NCT00794339|54665077|FG000|Overall Study|Withdrawal by Subject|3|||
28006228|NCT00794339|54665077|FG000|Overall Study|Ineligible|4|||
28006229|NCT00794339|54665077|FG000|Overall Study|Tx prior to ATSM|3|||
28006230|NCT00794339|54665077|FG000|Overall Study|ATSM imaging not complete or inadequate|3|||
28006231|NCT00794339|54665077|FG000|Overall Study|Tx not per protocol|1|||
28006232|NCT00790907|54665101|FG000|Overall Study|Adverse Event|9|||
28006233|NCT00790907|54665102|FG001|Overall Study|Adverse Event|7|||
28006234|NCT00790907|54665103|FG002|Overall Study|Adverse Event|6|||
28006235|NCT00790907|54665101|FG000|Overall Study|Physician Decision|304|||
28006236|NCT00790907|54665102|FG001|Overall Study|Physician Decision|271|||
28006237|NCT00790907|54665103|FG002|Overall Study|Physician Decision|255|||
27917117|NCT01108510|54574629|FG000|Overall Study|Participant Noncompliance|5|||
28006238|NCT00790907|54665101|FG000|Overall Study|Withdrawal by Subject|1|||
28006239|NCT00790907|54665102|FG001|Overall Study|Withdrawal by Subject|7|||
28006240|NCT00790907|54665103|FG002|Overall Study|Withdrawal by Subject|5|||
28102723|NCT02873338|54759405|FG000|Overall Study|Withdrawal by Subject|2|||
28102724|NCT02873338|54759406|FG001|Overall Study|Withdrawal by Subject|1|||
28102725|NCT02873338|54759407|FG002|Overall Study|Withdrawal by Subject|3|||
28102726|NCT02873338|54759405|FG000|Overall Study|Lack of Efficacy|0|||
28102727|NCT02873338|54759406|FG001|Overall Study|Lack of Efficacy|2|||
27917118|NCT01108510|54574630|FG001|Overall Study|Participant Noncompliance|7|||
28102728|NCT02873338|54759407|FG002|Overall Study|Lack of Efficacy|0|||
28102729|NCT02873338|54759405|FG000|Overall Study|Other or Missing|14|||
28102730|NCT02873338|54759406|FG001|Overall Study|Other or Missing|15|||
28102731|NCT02873338|54759407|FG002|Overall Study|Other or Missing|13|||
28102732|NCT02872012|54759420|FG000|Overall Study|Withdrawal by Subject|1|||
28102733|NCT02872012|54759421|FG001|Overall Study|Withdrawal by Subject|0|||
28102734|NCT02872012|54759422|FG002|Overall Study|Withdrawal by Subject|0|||
28102735|NCT02872012|54759423|FG003|Overall Study|Withdrawal by Subject|0|||
28102736|NCT02872012|54759424|FG004|Overall Study|Withdrawal by Subject|0|||
28102737|NCT02959138|54759441|FG000|Overall Study|Enrolled but Never Treated|0|||
28102738|NCT02959138|54759442|FG001|Overall Study|Enrolled but Never Treated|1|||
28102739|NCT02959138|54759443|FG002|Overall Study|Enrolled but Never Treated|0|||
28102740|NCT01344226|54759455|FG000|Overall Study|Protocol Violation|2|||
28102741|NCT01344226|54759455|FG000|Overall Study|Withdrawal by Subject|3|||
28102742|NCT01344226|54759455|FG000|Overall Study|Lack of Efficacy|3|||
28102743|NCT02869438|54759461|FG000|Overall Study|Lost to Follow-up|1|||
28102744|NCT02869438|54759462|FG001|Overall Study|Lost to Follow-up|0|||
28102745|NCT02869438|54759461|FG000|Overall Study|Adverse Event|1|||
28102746|NCT02869438|54759462|FG001|Overall Study|Adverse Event|0|||
28102747|NCT02869438|54759461|FG000|Overall Study|Withdrawal by Subject|1|||
28102748|NCT02869438|54759462|FG001|Overall Study|Withdrawal by Subject|2|||
28102749|NCT02868892|54759468|FG000|Overall Study|Investigator left site and no follow-up|6|||
28102750|NCT03352557|54759477|FG000|PC Period: Day 1 to Week 78|Death|1|||
28102751|NCT03352557|54759478|FG001|PC Period: Day 1 to Week 78|Death|1|||
28102752|NCT03352557|54759479|FG002|PC Period: Day 1 to Week 78|Death|0|||
28102753|NCT03352557|54759480|FG003|PC Period: Day 1 to Week 78|Death|0|||
28102754|NCT03352557|54759481|FG004|PC Period: Day 1 to Week 78|Death|1|||
28102755|NCT03352557|54759482|FG005|PC Period: Day 1 to Week 78|Death|0|||
28102756|NCT03352557|54759483|FG006|PC Period: Day 1 to Week 78|Death|0|||
28102757|NCT03352557|54759484|FG007|PC Period: Day 1 to Week 78|Death|0|||
28102758|NCT03352557|54759485|FG008|PC Period: Day 1 to Week 78|Death|0|||
28102759|NCT03352557|54759486|FG009|PC Period: Day 1 to Week 78|Death|0|||
28102760|NCT03352557|54759477|FG000|PC Period: Day 1 to Week 78|Adverse Event|10|||
28102761|NCT03352557|54759478|FG001|PC Period: Day 1 to Week 78|Adverse Event|1|||
28102762|NCT03352557|54759479|FG002|PC Period: Day 1 to Week 78|Adverse Event|1|||
28102763|NCT03352557|54759480|FG003|PC Period: Day 1 to Week 78|Adverse Event|0|||
28102764|NCT03352557|54759481|FG004|PC Period: Day 1 to Week 78|Adverse Event|5|||
28102765|NCT03352557|54759482|FG005|PC Period: Day 1 to Week 78|Adverse Event|0|||
28102766|NCT03352557|54759483|FG006|PC Period: Day 1 to Week 78|Adverse Event|0|||
28102767|NCT03352557|54759484|FG007|PC Period: Day 1 to Week 78|Adverse Event|0|||
28102768|NCT03352557|54759485|FG008|PC Period: Day 1 to Week 78|Adverse Event|0|||
28006241|NCT00790907|54665101|FG000|Overall Study|Bleeding Event|11|||
28006242|NCT00790907|54665102|FG001|Overall Study|Bleeding Event|16|||
28006243|NCT00790907|54665103|FG002|Overall Study|Bleeding Event|21|||
28006244|NCT00790907|54665101|FG000|Overall Study|Required Protocol-prohibited Therapy|17|||
28006245|NCT00790907|54665102|FG001|Overall Study|Required Protocol-prohibited Therapy|5|||
28006246|NCT00790907|54665103|FG002|Overall Study|Required Protocol-prohibited Therapy|7|||
28006247|NCT00790907|54665101|FG000|Overall Study|Qualifying Condition Not Present|29|||
28006248|NCT00790907|54665102|FG001|Overall Study|Qualifying Condition Not Present|14|||
28006249|NCT00790907|54665103|FG002|Overall Study|Qualifying Condition Not Present|16|||
28102769|NCT03352557|54759486|FG009|PC Period: Day 1 to Week 78|Adverse Event|0|||
28102770|NCT03352557|54759477|FG000|PC Period: Day 1 to Week 78|Progressive Disease|0|||
28102771|NCT03352557|54759478|FG001|PC Period: Day 1 to Week 78|Progressive Disease|0|||
28102772|NCT03352557|54759479|FG002|PC Period: Day 1 to Week 78|Progressive Disease|0|||
28102773|NCT03352557|54759480|FG003|PC Period: Day 1 to Week 78|Progressive Disease|0|||
28102774|NCT03352557|54759481|FG004|PC Period: Day 1 to Week 78|Progressive Disease|1|||
28102775|NCT03352557|54759482|FG005|PC Period: Day 1 to Week 78|Progressive Disease|0|||
28102776|NCT03352557|54759483|FG006|PC Period: Day 1 to Week 78|Progressive Disease|0|||
28102777|NCT03352557|54759484|FG007|PC Period: Day 1 to Week 78|Progressive Disease|0|||
28102778|NCT03352557|54759485|FG008|PC Period: Day 1 to Week 78|Progressive Disease|0|||
28102779|NCT03352557|54759486|FG009|PC Period: Day 1 to Week 78|Progressive Disease|0|||
28102780|NCT03352557|54759477|FG000|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|1|||
27740005|NCT02786537|54189677|FG000|As Treated|Drugs stolen from patient|0|||
27740006|NCT02786537|54189678|FG001|As Treated|Drugs stolen from patient|1|||
28006250|NCT00790907|54665101|FG000|Overall Study|Verbatim Reason on the Case Report Form|74|||
28102781|NCT03352557|54759478|FG001|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
28102782|NCT03352557|54759479|FG002|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
28102783|NCT03352557|54759480|FG003|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
28102784|NCT03352557|54759481|FG004|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
28102785|NCT03352557|54759482|FG005|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
28102786|NCT03352557|54759483|FG006|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
28102787|NCT03352557|54759484|FG007|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
28102788|NCT03352557|54759485|FG008|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
28102789|NCT03352557|54759486|FG009|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
28102790|NCT03352557|54759477|FG000|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
28102791|NCT03352557|54759478|FG001|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
28102792|NCT03352557|54759479|FG002|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
28102793|NCT03352557|54759480|FG003|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
28102794|NCT03352557|54759481|FG004|PC Period: Day 1 to Week 78|Protocol Deviation|2|||
28102795|NCT03352557|54759482|FG005|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
28102796|NCT03352557|54759483|FG006|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
28102797|NCT03352557|54759484|FG007|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
28102798|NCT03352557|54759485|FG008|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
28102799|NCT03352557|54759486|FG009|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
28102800|NCT03352557|54759477|FG000|PC Period: Day 1 to Week 78|Randomized by Mistake|2|||
28102801|NCT03352557|54759478|FG001|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
28102802|NCT03352557|54759479|FG002|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
28102803|NCT03352557|54759480|FG003|PC Period: Day 1 to Week 78|Randomized by Mistake|1|||
28102804|NCT03352557|54759481|FG004|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
28102805|NCT03352557|54759482|FG005|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
28102806|NCT03352557|54759483|FG006|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
28102807|NCT03352557|54759484|FG007|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
28102808|NCT03352557|54759485|FG008|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
28102809|NCT03352557|54759486|FG009|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
28102810|NCT03352557|54759477|FG000|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
28102811|NCT03352557|54759478|FG001|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
28102812|NCT03352557|54759479|FG002|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
28102813|NCT03352557|54759480|FG003|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
28102814|NCT03352557|54759481|FG004|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
28102815|NCT03352557|54759482|FG005|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
28102816|NCT03352557|54759483|FG006|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
28102817|NCT03352557|54759484|FG007|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
28102818|NCT03352557|54759485|FG008|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
28102819|NCT03352557|54759486|FG009|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
28102820|NCT03352557|54759477|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|7|||
28102821|NCT03352557|54759478|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
28102822|NCT03352557|54759479|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
28102823|NCT03352557|54759480|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
28102824|NCT03352557|54759481|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
28102825|NCT03352557|54759482|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
28102826|NCT03352557|54759483|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
28102827|NCT03352557|54759484|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
28006251|NCT00790907|54665102|FG001|Overall Study|Verbatim Reason on the Case Report Form|20|||
28006252|NCT00790907|54665103|FG002|Overall Study|Verbatim Reason on the Case Report Form|29|||
28006253|NCT00790907|54665101|FG000|Overall Study|Did Not Receive Study Drug|10|||
28006254|NCT00790907|54665102|FG001|Overall Study|Did Not Receive Study Drug|0|||
28006255|NCT00790907|54665103|FG002|Overall Study|Did Not Receive Study Drug|0|||
28006256|NCT00793871|54665121|FG000|Overall Study|Death|50|||
28006257|NCT00793871|54665121|FG000|Overall Study|Lost to Follow-up|3|||
28006258|NCT00793871|54665121|FG000|Overall Study|Study terminated by the Sponsor|7|||
28006259|NCT00577707|54665129|FG000|Overall Study|Withdrawal by Subject|3|||
28006260|NCT00713349|54665133|FG000|Overall Study|Protocol Violation|1|||
28102828|NCT03352557|54759485|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
28102829|NCT03352557|54759486|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
28173132|NCT01107626|54844963|FG000|Step 2: Maintenance Therapy|Financial reason|0|||
28173133|NCT01107626|54844964|FG001|Step 2: Maintenance Therapy|Financial reason|2|||
28173134|NCT01107626|54844965|FG002|Step 2: Maintenance Therapy|Financial reason|0|||
28173135|NCT01107626|54844966|FG003|Step 2: Maintenance Therapy|Financial reason|0|||
28173136|NCT01107626|54844963|FG000|Step 2: Maintenance Therapy|Physician Decision|0|||
27917119|NCT01108510|54574629|FG000|Overall Study|Lack of Efficacy|3|||
27917120|NCT01108510|54574630|FG001|Overall Study|Lack of Efficacy|0|||
27917121|NCT01108510|54574629|FG000|Overall Study|Pregnancy|0|||
27917122|NCT01108510|54574630|FG001|Overall Study|Pregnancy|3|||
27917123|NCT01108510|54574629|FG000|Overall Study|Death|1|||
27917124|NCT01108510|54574630|FG001|Overall Study|Death|1|||
27917125|NCT01108237|54574638|FG000|Overall Study|No alignment data|2|||
27917126|NCT01108237|54574639|FG001|Overall Study|No alignment data|17|||
28006261|NCT00712959|54665141|FG000|Overall Study|Protocol Violation|3|||
27917127|NCT01108237|54574638|FG000|Overall Study|Did not meet criteria for analysis|7|||
27917128|NCT01108237|54574639|FG001|Overall Study|Did not meet criteria for analysis|0|||
28006262|NCT00712959|54665142|FG001|Overall Study|Protocol Violation|1|||
28006263|NCT00712959|54665141|FG000|Overall Study|Lost to Follow-up|13|||
28006264|NCT00712959|54665142|FG001|Overall Study|Lost to Follow-up|2|||
28102830|NCT03352557|54759477|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
28102831|NCT03352557|54759478|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
28102832|NCT03352557|54759479|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
28102833|NCT03352557|54759480|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
28102834|NCT03352557|54759481|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|2|||
28102835|NCT03352557|54759482|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
28102836|NCT03352557|54759483|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
28102837|NCT03352557|54759484|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
28006265|NCT00712959|54665141|FG000|Overall Study|Withdrawal by Subject|3|||
28006266|NCT00712959|54665142|FG001|Overall Study|Withdrawal by Subject|0|||
28006267|NCT00712725|54665156|FG000|Overall Study|Adverse Event|1|||
28006268|NCT00712725|54665157|FG001|Overall Study|Adverse Event|0|||
28102838|NCT03352557|54759485|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
28102839|NCT03352557|54759486|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
28102840|NCT03352557|54759477|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
28102841|NCT03352557|54759478|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
28102842|NCT03352557|54759479|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
28102843|NCT03352557|54759480|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
28102844|NCT03352557|54759481|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
28102845|NCT03352557|54759482|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
28102846|NCT03352557|54759483|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
28102847|NCT03352557|54759484|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
28102848|NCT03352557|54759485|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
28102849|NCT03352557|54759486|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
28102850|NCT03352557|54759477|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
28102851|NCT03352557|54759478|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
28102852|NCT03352557|54759479|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
28102853|NCT03352557|54759480|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
28102854|NCT03352557|54759481|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
28006269|NCT00712725|54665158|FG002|Overall Study|Adverse Event|0|||
28006270|NCT00712725|54665159|FG003|Overall Study|Adverse Event|1|||
28006271|NCT00712725|54665160|FG004|Overall Study|Adverse Event|0|||
28006272|NCT00712725|54665161|FG005|Overall Study|Adverse Event|0|||
28006273|NCT00712725|54665162|FG006|Overall Study|Adverse Event|0|||
28006274|NCT00712725|54665163|FG007|Overall Study|Adverse Event|0|||
28006275|NCT00712725|54665156|FG000|Overall Study|Lost to Follow-up|3|||
28006276|NCT00712725|54665157|FG001|Overall Study|Lost to Follow-up|2|||
28006277|NCT00712725|54665158|FG002|Overall Study|Lost to Follow-up|1|||
28006278|NCT00712725|54665159|FG003|Overall Study|Lost to Follow-up|1|||
28006279|NCT00712725|54665160|FG004|Overall Study|Lost to Follow-up|2|||
28006280|NCT00712725|54665161|FG005|Overall Study|Lost to Follow-up|2|||
28006281|NCT00712725|54665162|FG006|Overall Study|Lost to Follow-up|3|||
28006282|NCT00712725|54665163|FG007|Overall Study|Lost to Follow-up|1|||
28006283|NCT00712725|54665156|FG000|Overall Study|Physician Decision|2|||
28006284|NCT00712725|54665157|FG001|Overall Study|Physician Decision|0|||
28006285|NCT00712725|54665158|FG002|Overall Study|Physician Decision|0|||
28006286|NCT00712725|54665159|FG003|Overall Study|Physician Decision|0|||
28006287|NCT00712725|54665160|FG004|Overall Study|Physician Decision|1|||
28006288|NCT00712725|54665161|FG005|Overall Study|Physician Decision|0|||
28006289|NCT00712725|54665162|FG006|Overall Study|Physician Decision|2|||
28006290|NCT00712725|54665163|FG007|Overall Study|Physician Decision|0|||
28006291|NCT00712725|54665156|FG000|Overall Study|Pregnancy|0|||
28006292|NCT00712725|54665157|FG001|Overall Study|Pregnancy|1|||
28006293|NCT00712725|54665158|FG002|Overall Study|Pregnancy|0|||
28006294|NCT00712725|54665159|FG003|Overall Study|Pregnancy|0|||
28006295|NCT00712725|54665160|FG004|Overall Study|Pregnancy|1|||
28006296|NCT00712725|54665161|FG005|Overall Study|Pregnancy|0|||
28006297|NCT00712725|54665162|FG006|Overall Study|Pregnancy|2|||
28006298|NCT00712725|54665163|FG007|Overall Study|Pregnancy|0|||
28006299|NCT00712725|54665156|FG000|Overall Study|Protocol Violation|2|||
28006300|NCT00712725|54665157|FG001|Overall Study|Protocol Violation|0|||
28006301|NCT00712725|54665158|FG002|Overall Study|Protocol Violation|1|||
28006302|NCT00712725|54665159|FG003|Overall Study|Protocol Violation|3|||
28006303|NCT00712725|54665160|FG004|Overall Study|Protocol Violation|2|||
28102855|NCT03352557|54759482|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
28102856|NCT03352557|54759483|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
28006304|NCT00712725|54665161|FG005|Overall Study|Protocol Violation|0|||
28006305|NCT00712725|54665162|FG006|Overall Study|Protocol Violation|1|||
28006306|NCT00712725|54665163|FG007|Overall Study|Protocol Violation|1|||
28006307|NCT00712725|54665156|FG000|Overall Study|Withdrawal by Subject|2|||
28006308|NCT00712725|54665157|FG001|Overall Study|Withdrawal by Subject|1|||
28006309|NCT00712725|54665158|FG002|Overall Study|Withdrawal by Subject|1|||
28006310|NCT00712725|54665159|FG003|Overall Study|Withdrawal by Subject|2|||
28006311|NCT00712725|54665160|FG004|Overall Study|Withdrawal by Subject|1|||
28006312|NCT00712725|54665161|FG005|Overall Study|Withdrawal by Subject|1|||
28006313|NCT00712725|54665162|FG006|Overall Study|Withdrawal by Subject|1|||
28006314|NCT00712725|54665163|FG007|Overall Study|Withdrawal by Subject|2|||
28006315|NCT00712725|54665156|FG000|Overall Study|Lack of Qualifying Event|16|||
28006316|NCT00712725|54665157|FG001|Overall Study|Lack of Qualifying Event|2|||
28102857|NCT03352557|54759484|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
28102858|NCT03352557|54759485|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
28102859|NCT03352557|54759486|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
28102860|NCT03352557|54759477|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|6|||
28102861|NCT03352557|54759478|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
28102862|NCT03352557|54759479|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
28102863|NCT03352557|54759480|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|5|||
28102864|NCT03352557|54759481|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|7|||
28102865|NCT03352557|54759482|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
28102866|NCT03352557|54759483|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
28102867|NCT03352557|54759484|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
28102868|NCT03352557|54759485|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
28102869|NCT03352557|54759486|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
28102870|NCT03352557|54759477|FG000|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
28102871|NCT03352557|54759478|FG001|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
28102872|NCT03352557|54759479|FG002|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
28102873|NCT03352557|54759480|FG003|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
28102874|NCT03352557|54759481|FG004|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|3|||
28102875|NCT03352557|54759482|FG005|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
28102876|NCT03352557|54759483|FG006|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
28102877|NCT03352557|54759484|FG007|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
28102878|NCT03352557|54759485|FG008|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
28102879|NCT03352557|54759486|FG009|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
28102880|NCT03352557|54759477|FG000|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
28102881|NCT03352557|54759478|FG001|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
28102882|NCT03352557|54759479|FG002|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
28102883|NCT03352557|54759480|FG003|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
28102884|NCT03352557|54759481|FG004|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
28102885|NCT03352557|54759482|FG005|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
28102886|NCT03352557|54759483|FG006|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
28102887|NCT03352557|54759484|FG007|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
28102888|NCT03352557|54759485|FG008|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
28102889|NCT03352557|54759486|FG009|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
27917129|NCT01340027|54574657|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
27917130|NCT01340027|54574658|FG001|Overall Study|Randomized but Never Received Study Drug|0|||
27917131|NCT01340027|54574659|FG002|Overall Study|Randomized but Never Received Study Drug|1|||
27917132|NCT01340027|54574660|FG003|Overall Study|Randomized but Never Received Study Drug|0|||
27917133|NCT01340027|54574661|FG004|Overall Study|Randomized but Never Received Study Drug|0|||
27917134|NCT01340027|54574662|FG005|Overall Study|Randomized but Never Received Study Drug|0|||
27917135|NCT01340027|54574663|FG006|Overall Study|Randomized but Never Received Study Drug|0|||
27917136|NCT01340027|54574664|FG007|Overall Study|Randomized but Never Received Study Drug|0|||
27917137|NCT01340027|54574665|FG008|Overall Study|Randomized but Never Received Study Drug|0|||
28006317|NCT00712725|54665158|FG002|Overall Study|Lack of Qualifying Event|6|||
28006318|NCT00712725|54665159|FG003|Overall Study|Lack of Qualifying Event|8|||
28102890|NCT03352557|54759477|FG000|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
28102891|NCT03352557|54759478|FG001|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
28102892|NCT03352557|54759479|FG002|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
28102893|NCT03352557|54759480|FG003|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
28102894|NCT03352557|54759481|FG004|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
28102895|NCT03352557|54759482|FG005|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
28102896|NCT03352557|54759483|FG006|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
28102897|NCT03352557|54759484|FG007|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
28102898|NCT03352557|54759485|FG008|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
28102899|NCT03352557|54759486|FG009|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
28102900|NCT03352557|54759477|FG000|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
28102901|NCT03352557|54759478|FG001|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
28102902|NCT03352557|54759479|FG002|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
28102903|NCT03352557|54759480|FG003|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
28102904|NCT03352557|54759481|FG004|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
28102905|NCT03352557|54759482|FG005|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
28102906|NCT03352557|54759483|FG006|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
28102907|NCT03352557|54759484|FG007|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
28102908|NCT03352557|54759485|FG008|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
28102909|NCT03352557|54759486|FG009|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
28102910|NCT03352557|54759477|FG000|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
28102911|NCT03352557|54759478|FG001|PC Period: Day 1 to Week 78|WBP/G-Other|2|||
28102912|NCT03352557|54759479|FG002|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
28102913|NCT03352557|54759480|FG003|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
28102914|NCT03352557|54759481|FG004|PC Period: Day 1 to Week 78|WBP/G-Other|3|||
28102915|NCT03352557|54759482|FG005|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
28102916|NCT03352557|54759483|FG006|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
28102917|NCT03352557|54759484|FG007|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
28102918|NCT03352557|54759485|FG008|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
28102919|NCT03352557|54759486|FG009|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
28102920|NCT03352557|54759477|FG000|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|2|||
28102921|NCT03352557|54759478|FG001|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
28006319|NCT00712725|54665160|FG004|Overall Study|Lack of Qualifying Event|11|||
28006320|NCT00712725|54665161|FG005|Overall Study|Lack of Qualifying Event|13|||
28102922|NCT03352557|54759479|FG002|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
28006321|NCT00712725|54665162|FG006|Overall Study|Lack of Qualifying Event|11|||
28006322|NCT00712725|54665163|FG007|Overall Study|Lack of Qualifying Event|6|||
28102923|NCT03352557|54759480|FG003|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
28102924|NCT03352557|54759481|FG004|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|1|||
28102925|NCT03352557|54759482|FG005|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
28102926|NCT03352557|54759483|FG006|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
28102927|NCT03352557|54759484|FG007|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
28102928|NCT03352557|54759485|FG008|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
28102929|NCT03352557|54759486|FG009|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
28102930|NCT03352557|54759477|FG000|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
28102931|NCT03352557|54759478|FG001|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
28102932|NCT03352557|54759479|FG002|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
28102933|NCT03352557|54759480|FG003|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
28102934|NCT03352557|54759481|FG004|PC Period: Day 1 to Week 78|Lost to Follow-up|2|||
28102935|NCT03352557|54759482|FG005|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
28102936|NCT03352557|54759483|FG006|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
28102937|NCT03352557|54759484|FG007|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
28102938|NCT03352557|54759485|FG008|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
27740007|NCT02786537|54189679|FG002|As Treated|Drugs stolen from patient|0|||
27740008|NCT02786537|54189680|FG003|As Treated|Drugs stolen from patient|0|||
27917138|NCT01340027|54574666|FG009|Overall Study|Randomized but Never Received Study Drug|0|||
27917139|NCT01340027|54574667|FG010|Overall Study|Randomized but Never Received Study Drug|0|||
27917140|NCT01340027|54574668|FG011|Overall Study|Randomized but Never Received Study Drug|0|||
27917141|NCT01340027|54574657|FG000|Overall Study|Adverse Event|0|||
28102939|NCT03352557|54759486|FG009|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
28102940|NCT03352557|54759477|FG000|PC Period: Day 1 to Week 78|Other|5|||
28102941|NCT03352557|54759478|FG001|PC Period: Day 1 to Week 78|Other|1|||
28102942|NCT03352557|54759479|FG002|PC Period: Day 1 to Week 78|Other|0|||
28102943|NCT03352557|54759480|FG003|PC Period: Day 1 to Week 78|Other|3|||
28102944|NCT03352557|54759481|FG004|PC Period: Day 1 to Week 78|Other|0|||
28102945|NCT03352557|54759482|FG005|PC Period: Day 1 to Week 78|Other|0|||
28102946|NCT03352557|54759483|FG006|PC Period: Day 1 to Week 78|Other|0|||
28102947|NCT03352557|54759484|FG007|PC Period: Day 1 to Week 78|Other|0|||
28102948|NCT03352557|54759485|FG008|PC Period: Day 1 to Week 78|Other|0|||
28102949|NCT03352557|54759486|FG009|PC Period: Day 1 to Week 78|Other|0|||
28102950|NCT03352557|54759477|FG000|PC Period: Day 1 to Week 78|Not Dosed|0|||
28102951|NCT03352557|54759478|FG001|PC Period: Day 1 to Week 78|Not Dosed|0|||
28102952|NCT03352557|54759479|FG002|PC Period: Day 1 to Week 78|Not Dosed|0|||
28102953|NCT03352557|54759480|FG003|PC Period: Day 1 to Week 78|Not Dosed|0|||
28102954|NCT03352557|54759481|FG004|PC Period: Day 1 to Week 78|Not Dosed|4|||
28102955|NCT03352557|54759482|FG005|PC Period: Day 1 to Week 78|Not Dosed|0|||
28102956|NCT03352557|54759483|FG006|PC Period: Day 1 to Week 78|Not Dosed|0|||
28102957|NCT03352557|54759484|FG007|PC Period: Day 1 to Week 78|Not Dosed|0|||
28173137|NCT01107626|54844964|FG001|Step 2: Maintenance Therapy|Physician Decision|2|||
28173138|NCT01107626|54844965|FG002|Step 2: Maintenance Therapy|Physician Decision|3|||
28173139|NCT01107626|54844966|FG003|Step 2: Maintenance Therapy|Physician Decision|3|||
28173140|NCT01107626|54844963|FG000|Step 2: Maintenance Therapy|Hospice care|0|||
28173141|NCT01107626|54844964|FG001|Step 2: Maintenance Therapy|Hospice care|1|||
28173142|NCT01107626|54844965|FG002|Step 2: Maintenance Therapy|Hospice care|2|||
28173143|NCT01107626|54844966|FG003|Step 2: Maintenance Therapy|Hospice care|0|||
28173144|NCT01107626|54844963|FG000|Step 2: Maintenance Therapy|Non-compliance|0|||
28102958|NCT03352557|54759485|FG008|PC Period: Day 1 to Week 78|Not Dosed|0|||
28102959|NCT03352557|54759486|FG009|PC Period: Day 1 to Week 78|Not Dosed|0|||
28102960|NCT03352557|54759477|FG000|LTE Period: Week 80 to Week 173|Death|0|||
28102961|NCT03352557|54759478|FG001|LTE Period: Week 80 to Week 173|Death|0|||
28102962|NCT03352557|54759479|FG002|LTE Period: Week 80 to Week 173|Death|0|||
28102963|NCT03352557|54759480|FG003|LTE Period: Week 80 to Week 173|Death|0|||
28102964|NCT03352557|54759481|FG004|LTE Period: Week 80 to Week 173|Death|0|||
28102965|NCT03352557|54759482|FG005|LTE Period: Week 80 to Week 173|Death|1|||
28102966|NCT03352557|54759483|FG006|LTE Period: Week 80 to Week 173|Death|0|||
28102967|NCT03352557|54759484|FG007|LTE Period: Week 80 to Week 173|Death|1|||
28102968|NCT03352557|54759485|FG008|LTE Period: Week 80 to Week 173|Death|1|||
28102969|NCT03352557|54759486|FG009|LTE Period: Week 80 to Week 173|Death|1|||
28102970|NCT03352557|54759477|FG000|LTE Period: Week 80 to Week 173|Adverse Event|0|||
28102971|NCT03352557|54759478|FG001|LTE Period: Week 80 to Week 173|Adverse Event|0|||
28102972|NCT03352557|54759479|FG002|LTE Period: Week 80 to Week 173|Adverse Event|0|||
28102973|NCT03352557|54759480|FG003|LTE Period: Week 80 to Week 173|Adverse Event|0|||
28102974|NCT03352557|54759481|FG004|LTE Period: Week 80 to Week 173|Adverse Event|0|||
28102975|NCT03352557|54759482|FG005|LTE Period: Week 80 to Week 173|Adverse Event|3|||
28102976|NCT03352557|54759483|FG006|LTE Period: Week 80 to Week 173|Adverse Event|0|||
28102977|NCT03352557|54759484|FG007|LTE Period: Week 80 to Week 173|Adverse Event|0|||
28102978|NCT03352557|54759485|FG008|LTE Period: Week 80 to Week 173|Adverse Event|0|||
28102979|NCT03352557|54759486|FG009|LTE Period: Week 80 to Week 173|Adverse Event|0|||
28102980|NCT03352557|54759477|FG000|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
28173145|NCT01107626|54844964|FG001|Step 2: Maintenance Therapy|Non-compliance|0|||
28173146|NCT01107626|54844965|FG002|Step 2: Maintenance Therapy|Non-compliance|0|||
28173147|NCT01107626|54844966|FG003|Step 2: Maintenance Therapy|Non-compliance|2|||
28173148|NCT01107626|54844963|FG000|Step 2: Maintenance Therapy|Pain|0|||
28173149|NCT01107626|54844964|FG001|Step 2: Maintenance Therapy|Pain|0|||
28173150|NCT01107626|54844965|FG002|Step 2: Maintenance Therapy|Pain|0|||
28173151|NCT01107626|54844966|FG003|Step 2: Maintenance Therapy|Pain|1|||
28173152|NCT01107626|54844963|FG000|Step 2: Maintenance Therapy|Off treatment reason not reported|0|||
28173153|NCT01107626|54844964|FG001|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
28173154|NCT01107626|54844965|FG002|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
28173155|NCT01107626|54844966|FG003|Step 2: Maintenance Therapy|Off treatment reason not reported|10|||
28173156|NCT00828009|54844975|FG000|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10|||
28173157|NCT00828009|54844975|FG000|Step 1 - Chemo RT/Consolidation Chemo|Death|2|||
28102981|NCT03352557|54759478|FG001|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
28102982|NCT03352557|54759479|FG002|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
28102983|NCT03352557|54759480|FG003|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
28102984|NCT03352557|54759481|FG004|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
28173158|NCT00828009|54844975|FG000|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3|||
28102985|NCT03352557|54759482|FG005|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
28102986|NCT03352557|54759483|FG006|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
28102987|NCT03352557|54759484|FG007|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
28102988|NCT03352557|54759485|FG008|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|2|||
28102989|NCT03352557|54759486|FG009|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
28102990|NCT03352557|54759477|FG000|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
28102991|NCT03352557|54759478|FG001|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
28102992|NCT03352557|54759479|FG002|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
28102993|NCT03352557|54759480|FG003|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
28102994|NCT03352557|54759481|FG004|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
28006323|NCT00712725|54665156|FG000|Overall Study|Protocol Specified Criteria|3|||
28006324|NCT00712725|54665157|FG001|Overall Study|Protocol Specified Criteria|0|||
28006325|NCT00712725|54665158|FG002|Overall Study|Protocol Specified Criteria|1|||
28006326|NCT00712725|54665159|FG003|Overall Study|Protocol Specified Criteria|2|||
28006327|NCT00712725|54665160|FG004|Overall Study|Protocol Specified Criteria|1|||
28006328|NCT00712725|54665161|FG005|Overall Study|Protocol Specified Criteria|0|||
28006329|NCT00712725|54665162|FG006|Overall Study|Protocol Specified Criteria|2|||
28006330|NCT00712725|54665163|FG007|Overall Study|Protocol Specified Criteria|1|||
28102995|NCT03352557|54759482|FG005|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|38|||
27917142|NCT01340027|54574658|FG001|Overall Study|Adverse Event|1|||
27917143|NCT01340027|54574659|FG002|Overall Study|Adverse Event|2|||
27917144|NCT01340027|54574660|FG003|Overall Study|Adverse Event|0|||
27917145|NCT01340027|54574661|FG004|Overall Study|Adverse Event|1|||
27917146|NCT01340027|54574662|FG005|Overall Study|Adverse Event|2|||
27917147|NCT01340027|54574663|FG006|Overall Study|Adverse Event|2|||
27917148|NCT01340027|54574664|FG007|Overall Study|Adverse Event|1|||
27917149|NCT01340027|54574665|FG008|Overall Study|Adverse Event|4|||
27917150|NCT01340027|54574666|FG009|Overall Study|Adverse Event|1|||
27917151|NCT01340027|54574667|FG010|Overall Study|Adverse Event|1|||
27917152|NCT01340027|54574668|FG011|Overall Study|Adverse Event|3|||
27917153|NCT01340027|54574657|FG000|Overall Study|Lack of Efficacy|0|||
27917154|NCT01340027|54574658|FG001|Overall Study|Lack of Efficacy|0|||
27917155|NCT01340027|54574659|FG002|Overall Study|Lack of Efficacy|0|||
27917156|NCT01340027|54574660|FG003|Overall Study|Lack of Efficacy|0|||
27917157|NCT01340027|54574661|FG004|Overall Study|Lack of Efficacy|0|||
27917158|NCT01340027|54574662|FG005|Overall Study|Lack of Efficacy|0|||
27917159|NCT01340027|54574663|FG006|Overall Study|Lack of Efficacy|1|||
27917160|NCT01340027|54574664|FG007|Overall Study|Lack of Efficacy|1|||
27917161|NCT01340027|54574665|FG008|Overall Study|Lack of Efficacy|1|||
27917162|NCT01340027|54574666|FG009|Overall Study|Lack of Efficacy|0|||
27917163|NCT01340027|54574667|FG010|Overall Study|Lack of Efficacy|0|||
27917164|NCT01340027|54574668|FG011|Overall Study|Lack of Efficacy|0|||
27917165|NCT01340027|54574657|FG000|Overall Study|Lost to Follow-up|0|||
27917166|NCT01340027|54574658|FG001|Overall Study|Lost to Follow-up|1|||
27917167|NCT01340027|54574659|FG002|Overall Study|Lost to Follow-up|0|||
27917168|NCT01340027|54574660|FG003|Overall Study|Lost to Follow-up|0|||
27917169|NCT01340027|54574661|FG004|Overall Study|Lost to Follow-up|0|||
27917170|NCT01340027|54574662|FG005|Overall Study|Lost to Follow-up|0|||
27917171|NCT01340027|54574663|FG006|Overall Study|Lost to Follow-up|1|||
27917172|NCT01340027|54574664|FG007|Overall Study|Lost to Follow-up|0|||
27917173|NCT01340027|54574665|FG008|Overall Study|Lost to Follow-up|0|||
27917174|NCT01340027|54574666|FG009|Overall Study|Lost to Follow-up|1|||
27917175|NCT01340027|54574667|FG010|Overall Study|Lost to Follow-up|0|||
27917176|NCT01340027|54574668|FG011|Overall Study|Lost to Follow-up|0|||
27917177|NCT01340027|54574657|FG000|Overall Study|Protocol Violation|1|||
27917178|NCT01340027|54574658|FG001|Overall Study|Protocol Violation|2|||
27917179|NCT01340027|54574659|FG002|Overall Study|Protocol Violation|0|||
27917180|NCT01340027|54574660|FG003|Overall Study|Protocol Violation|0|||
27917181|NCT01340027|54574661|FG004|Overall Study|Protocol Violation|6|||
27917182|NCT01340027|54574662|FG005|Overall Study|Protocol Violation|0|||
27917183|NCT01340027|54574663|FG006|Overall Study|Protocol Violation|0|||
27917184|NCT01340027|54574664|FG007|Overall Study|Protocol Violation|1|||
28006331|NCT00712335|54665186|FG000|Overall Study|Withdrawal by Subject|0|||
28006332|NCT00712335|54665187|FG001|Overall Study|Withdrawal by Subject|7|||
28006333|NCT00712335|54665188|FG002|Overall Study|Withdrawal by Subject|2|||
27917185|NCT01340027|54574665|FG008|Overall Study|Protocol Violation|2|||
27917186|NCT01340027|54574666|FG009|Overall Study|Protocol Violation|2|||
27917187|NCT01340027|54574667|FG010|Overall Study|Protocol Violation|0|||
27917188|NCT01340027|54574668|FG011|Overall Study|Protocol Violation|0|||
27917189|NCT01340027|54574657|FG000|Overall Study|Withdrawal by Subject|4|||
27917190|NCT01340027|54574658|FG001|Overall Study|Withdrawal by Subject|3|||
28006334|NCT00712335|54665189|FG003|Overall Study|Withdrawal by Subject|3|||
27917191|NCT01340027|54574659|FG002|Overall Study|Withdrawal by Subject|1|||
27917192|NCT01340027|54574660|FG003|Overall Study|Withdrawal by Subject|3|||
27917193|NCT01340027|54574661|FG004|Overall Study|Withdrawal by Subject|3|||
28006335|NCT00712335|54665190|FG004|Overall Study|Withdrawal by Subject|0|||
27917194|NCT01340027|54574662|FG005|Overall Study|Withdrawal by Subject|2|||
27917195|NCT01340027|54574663|FG006|Overall Study|Withdrawal by Subject|3|||
27917196|NCT01340027|54574664|FG007|Overall Study|Withdrawal by Subject|4|||
28006336|NCT00712335|54665186|FG000|Overall Study|Lost to Follow-up|2|||
28006337|NCT00712335|54665187|FG001|Overall Study|Lost to Follow-up|5|||
28006338|NCT00712335|54665188|FG002|Overall Study|Lost to Follow-up|0|||
28006339|NCT00712335|54665189|FG003|Overall Study|Lost to Follow-up|1|||
28006340|NCT00712335|54665190|FG004|Overall Study|Lost to Follow-up|0|||
28102996|NCT03352557|54759483|FG006|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|49|||
28102997|NCT03352557|54759484|FG007|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|75|||
28102998|NCT03352557|54759485|FG008|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|151|||
28102999|NCT03352557|54759486|FG009|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|154|||
28006341|NCT00712335|54665186|FG000|Overall Study|Protocol Violation|1|||
28006342|NCT00712335|54665187|FG001|Overall Study|Protocol Violation|2|||
28006343|NCT00712335|54665188|FG002|Overall Study|Protocol Violation|1|||
28103000|NCT03352557|54759477|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
28103001|NCT03352557|54759478|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
28103002|NCT03352557|54759479|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
28103003|NCT03352557|54759480|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
28103004|NCT03352557|54759481|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
28103005|NCT03352557|54759482|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
28103006|NCT03352557|54759483|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
28103007|NCT03352557|54759484|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
28103008|NCT03352557|54759485|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
28103009|NCT03352557|54759486|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
28103010|NCT03352557|54759477|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
28103011|NCT03352557|54759478|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
28103012|NCT03352557|54759479|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
28103013|NCT03352557|54759480|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
28103014|NCT03352557|54759481|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
28103015|NCT03352557|54759482|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
28103016|NCT03352557|54759483|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
28103017|NCT03352557|54759484|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
28103018|NCT03352557|54759485|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
28103019|NCT03352557|54759486|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
28103020|NCT03352557|54759477|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
28103021|NCT03352557|54759478|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
28103022|NCT03352557|54759479|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
28103023|NCT03352557|54759480|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
28103024|NCT03352557|54759481|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
28103025|NCT03352557|54759482|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
28103026|NCT03352557|54759483|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
28103027|NCT03352557|54759484|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
28103028|NCT03352557|54759485|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
28103029|NCT03352557|54759486|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|4|||
28103030|NCT03352557|54759477|FG000|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
28103031|NCT03352557|54759478|FG001|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
28103032|NCT03352557|54759479|FG002|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
28103033|NCT03352557|54759480|FG003|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
28103034|NCT03352557|54759481|FG004|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
28103035|NCT03352557|54759482|FG005|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
28103036|NCT03352557|54759483|FG006|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
28103037|NCT03352557|54759484|FG007|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
28103038|NCT03352557|54759485|FG008|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|2|||
28103039|NCT03352557|54759486|FG009|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
28103040|NCT03352557|54759477|FG000|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
28103041|NCT03352557|54759478|FG001|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
28103042|NCT03352557|54759479|FG002|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
28006344|NCT00712335|54665189|FG003|Overall Study|Protocol Violation|0|||
28006345|NCT00712335|54665190|FG004|Overall Study|Protocol Violation|0|||
28103043|NCT03352557|54759480|FG003|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
28103044|NCT03352557|54759481|FG004|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
28103045|NCT03352557|54759482|FG005|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
28103046|NCT03352557|54759483|FG006|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
28103047|NCT03352557|54759484|FG007|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
28103048|NCT03352557|54759485|FG008|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
28103049|NCT03352557|54759486|FG009|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
28103050|NCT03352557|54759477|FG000|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
28103051|NCT03352557|54759478|FG001|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
28103052|NCT03352557|54759479|FG002|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
28103053|NCT03352557|54759480|FG003|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
28103054|NCT03352557|54759481|FG004|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
28103055|NCT03352557|54759482|FG005|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
28103056|NCT03352557|54759483|FG006|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
28103057|NCT03352557|54759484|FG007|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|2|||
28103058|NCT03352557|54759485|FG008|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
28103059|NCT03352557|54759486|FG009|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
28103060|NCT03352557|54759477|FG000|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
28103061|NCT03352557|54759478|FG001|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
28103062|NCT03352557|54759479|FG002|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
28103063|NCT03352557|54759480|FG003|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
28103064|NCT03352557|54759481|FG004|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
28103065|NCT03352557|54759482|FG005|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
28103066|NCT03352557|54759483|FG006|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
28103067|NCT03352557|54759484|FG007|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|2|||
28103068|NCT03352557|54759485|FG008|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
28103069|NCT03352557|54759486|FG009|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
28103070|NCT03352557|54759477|FG000|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
28103071|NCT03352557|54759478|FG001|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
28103072|NCT03352557|54759479|FG002|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
28103073|NCT03352557|54759480|FG003|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
28103074|NCT03352557|54759481|FG004|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
28103075|NCT03352557|54759482|FG005|LTE Period: Week 80 to Week 173|WBP/G-Other|1|||
28103076|NCT03352557|54759483|FG006|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
28103077|NCT03352557|54759484|FG007|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
28103078|NCT03352557|54759485|FG008|LTE Period: Week 80 to Week 173|WBP/G-Other|2|||
28103079|NCT03352557|54759486|FG009|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
28103080|NCT03352557|54759477|FG000|LTE Period: Week 80 to Week 173|Physician Decision|0|||
28103081|NCT03352557|54759478|FG001|LTE Period: Week 80 to Week 173|Physician Decision|0|||
28103082|NCT03352557|54759479|FG002|LTE Period: Week 80 to Week 173|Physician Decision|0|||
28103083|NCT03352557|54759480|FG003|LTE Period: Week 80 to Week 173|Physician Decision|0|||
28103084|NCT03352557|54759481|FG004|LTE Period: Week 80 to Week 173|Physician Decision|0|||
28103085|NCT03352557|54759482|FG005|LTE Period: Week 80 to Week 173|Physician Decision|0|||
28103086|NCT03352557|54759483|FG006|LTE Period: Week 80 to Week 173|Physician Decision|0|||
28103087|NCT03352557|54759484|FG007|LTE Period: Week 80 to Week 173|Physician Decision|0|||
28103088|NCT03352557|54759485|FG008|LTE Period: Week 80 to Week 173|Physician Decision|0|||
28103089|NCT03352557|54759486|FG009|LTE Period: Week 80 to Week 173|Physician Decision|3|||
28103090|NCT03352557|54759477|FG000|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
28103091|NCT03352557|54759478|FG001|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
28103092|NCT03352557|54759479|FG002|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
28103093|NCT03352557|54759480|FG003|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
28103094|NCT03352557|54759481|FG004|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
28103095|NCT03352557|54759482|FG005|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
28103096|NCT03352557|54759483|FG006|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
28103097|NCT03352557|54759484|FG007|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
28173159|NCT00828009|54844975|FG000|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11|||
28173160|NCT00828009|54844975|FG000|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1|||
28173161|NCT00828009|54844975|FG000|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2|||
28103098|NCT03352557|54759485|FG008|LTE Period: Week 80 to Week 173|Lost to Follow-up|3|||
28103099|NCT03352557|54759486|FG009|LTE Period: Week 80 to Week 173|Lost to Follow-up|1|||
28103100|NCT03352557|54759477|FG000|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
28103101|NCT03352557|54759478|FG001|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
28103102|NCT03352557|54759479|FG002|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
28103103|NCT03352557|54759480|FG003|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
28103104|NCT03352557|54759481|FG004|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
28103105|NCT03352557|54759482|FG005|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
28103106|NCT03352557|54759483|FG006|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
28103107|NCT03352557|54759484|FG007|LTE Period: Week 80 to Week 173|Progressive Disease|1|||
28103108|NCT03352557|54759485|FG008|LTE Period: Week 80 to Week 173|Progressive Disease|2|||
28103109|NCT03352557|54759486|FG009|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
28103110|NCT03352557|54759477|FG000|LTE Period: Week 80 to Week 173|Other|0|||
28103111|NCT03352557|54759478|FG001|LTE Period: Week 80 to Week 173|Other|0|||
28103112|NCT03352557|54759479|FG002|LTE Period: Week 80 to Week 173|Other|0|||
28103113|NCT03352557|54759480|FG003|LTE Period: Week 80 to Week 173|Other|0|||
28103114|NCT03352557|54759481|FG004|LTE Period: Week 80 to Week 173|Other|0|||
28103115|NCT03352557|54759482|FG005|LTE Period: Week 80 to Week 173|Other|0|||
28103116|NCT03352557|54759483|FG006|LTE Period: Week 80 to Week 173|Other|0|||
28103117|NCT03352557|54759484|FG007|LTE Period: Week 80 to Week 173|Other|1|||
28103118|NCT03352557|54759485|FG008|LTE Period: Week 80 to Week 173|Other|0|||
28103119|NCT03352557|54759486|FG009|LTE Period: Week 80 to Week 173|Other|0|||
28103120|NCT02866942|54759511|FG000|Overall Study|Invalid consent|1|||
28103121|NCT02908672|54759565|FG000|Overall Study|Death|112|||
28103122|NCT02908672|54759566|FG001|Overall Study|Death|93|||
28103123|NCT02908672|54759565|FG000|Overall Study|Lost to Follow-up|3|||
28103124|NCT02908672|54759566|FG001|Overall Study|Lost to Follow-up|3|||
28103125|NCT02908672|54759565|FG000|Overall Study|Other|2|||
28103126|NCT02908672|54759566|FG001|Overall Study|Other|0|||
28103127|NCT02908672|54759565|FG000|Overall Study|Protocol Violation|1|||
28103128|NCT02908672|54759566|FG001|Overall Study|Protocol Violation|1|||
28103129|NCT02908672|54759565|FG000|Overall Study|Withdrawal by Subject|13|||
28103130|NCT02908672|54759566|FG001|Overall Study|Withdrawal by Subject|18|||
28103131|NCT02908672|54759565|FG000|Overall Study|Study is ongoing|124|||
28103132|NCT02908672|54759566|FG001|Overall Study|Study is ongoing|141|||
28103133|NCT02908672|54759565|FG000|Overall Study|Discontinued the study during run-in|3|||
28103134|NCT02908672|54759566|FG001|Overall Study|Discontinued the study during run-in|0|||
28103135|NCT01336894|54759574|FG000|Follow-up|Study terminated prematurely|2|||
28103136|NCT01336894|54759575|FG001|Follow-up|Study terminated prematurely|7|||
28103137|NCT02572167|54759584|FG000|Overall Study|Withdrawal by Subject|0|||
28103138|NCT02572167|54759585|FG001|Overall Study|Withdrawal by Subject|3|||
28103139|NCT02572167|54759586|FG002|Overall Study|Withdrawal by Subject|0|||
28103140|NCT02572167|54759584|FG000|Overall Study|Lost to Follow-up|2|||
28103141|NCT02572167|54759585|FG001|Overall Study|Lost to Follow-up|5|||
28103142|NCT02572167|54759586|FG002|Overall Study|Lost to Follow-up|3|||
28103143|NCT02572167|54759584|FG000|Overall Study|Death|0|||
28103144|NCT02572167|54759585|FG001|Overall Study|Death|8|||
28103145|NCT02572167|54759586|FG002|Overall Study|Death|3|||
28103146|NCT02572167|54759584|FG000|Overall Study|Did not meet inclusion criteria|0|||
28103147|NCT02572167|54759585|FG001|Overall Study|Did not meet inclusion criteria|0|||
28103148|NCT02572167|54759586|FG002|Overall Study|Did not meet inclusion criteria|1|||
27917197|NCT01340027|54574665|FG008|Overall Study|Withdrawal by Subject|1|||
27917198|NCT01340027|54574666|FG009|Overall Study|Withdrawal by Subject|2|||
27917199|NCT01340027|54574667|FG010|Overall Study|Withdrawal by Subject|0|||
27917200|NCT01340027|54574668|FG011|Overall Study|Withdrawal by Subject|1|||
27917201|NCT01340027|54574657|FG000|Overall Study|Miscellaneous|0|||
28173162|NCT00828009|54844975|FG000|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2|||
27917202|NCT01340027|54574658|FG001|Overall Study|Miscellaneous|0|||
27917203|NCT01340027|54574659|FG002|Overall Study|Miscellaneous|0|||
27917204|NCT01340027|54574660|FG003|Overall Study|Miscellaneous|1|||
27917205|NCT01340027|54574661|FG004|Overall Study|Miscellaneous|0|||
27917206|NCT01340027|54574662|FG005|Overall Study|Miscellaneous|0|||
27917207|NCT01340027|54574663|FG006|Overall Study|Miscellaneous|0|||
27917208|NCT01340027|54574664|FG007|Overall Study|Miscellaneous|0|||
28103149|NCT02572167|54759584|FG000|Overall Study|Study closure by Sponsor|4|||
28103150|NCT02572167|54759585|FG001|Overall Study|Study closure by Sponsor|40|||
27917209|NCT01340027|54574665|FG008|Overall Study|Miscellaneous|0|||
28173163|NCT00828009|54844975|FG000|Step 2 - Maintenance Therapy|Progressive disease|12|||
27740009|NCT02786537|54189681|FG004|As Treated|Drugs stolen from patient|0|||
27917210|NCT01340027|54574666|FG009|Overall Study|Miscellaneous|0|||
28103151|NCT02572167|54759586|FG002|Overall Study|Study closure by Sponsor|24|||
28103152|NCT01336738|54759600|FG000|Overall Study|Adverse Event|0|||
28103153|NCT01336738|54759601|FG001|Overall Study|Adverse Event|3|||
28103154|NCT01336738|54759602|FG002|Overall Study|Adverse Event|2|||
28103155|NCT01336738|54759603|FG003|Overall Study|Adverse Event|1|||
28103156|NCT01336738|54759604|FG004|Overall Study|Adverse Event|3|||
28103157|NCT01336738|54759600|FG000|Overall Study|Lost to Follow-up|2|||
28103158|NCT01336738|54759601|FG001|Overall Study|Lost to Follow-up|1|||
28103159|NCT01336738|54759602|FG002|Overall Study|Lost to Follow-up|2|||
28103160|NCT01336738|54759603|FG003|Overall Study|Lost to Follow-up|2|||
28103161|NCT01336738|54759604|FG004|Overall Study|Lost to Follow-up|2|||
28103162|NCT01336738|54759600|FG000|Overall Study|Did not meet entrance criteria|0|||
28103163|NCT01336738|54759601|FG001|Overall Study|Did not meet entrance criteria|1|||
28103164|NCT01336738|54759602|FG002|Overall Study|Did not meet entrance criteria|0|||
28103165|NCT01336738|54759603|FG003|Overall Study|Did not meet entrance criteria|0|||
28103166|NCT01336738|54759604|FG004|Overall Study|Did not meet entrance criteria|0|||
28103167|NCT01336738|54759600|FG000|Overall Study|Protocol Violation|0|||
28006346|NCT00712335|54665186|FG000|Overall Study|Lack of Efficacy|0|||
28006347|NCT00712335|54665187|FG001|Overall Study|Lack of Efficacy|0|||
28006348|NCT00712335|54665188|FG002|Overall Study|Lack of Efficacy|1|||
28006349|NCT00712335|54665189|FG003|Overall Study|Lack of Efficacy|1|||
28006350|NCT00712335|54665190|FG004|Overall Study|Lack of Efficacy|0|||
28006351|NCT00712335|54665186|FG000|Overall Study|Other Reason|0|||
28006352|NCT00712335|54665187|FG001|Overall Study|Other Reason|3|||
28006353|NCT00712335|54665188|FG002|Overall Study|Other Reason|1|||
28006354|NCT00712335|54665189|FG003|Overall Study|Other Reason|0|||
28006355|NCT00712335|54665190|FG004|Overall Study|Other Reason|0|||
28006356|NCT00577629|54665202|FG000|Treatment Period|Death|1|||
28006357|NCT00577629|54665202|FG000|Long Term Follow-Up|Death|15|||
28006358|NCT00577629|54665202|FG000|Long Term Follow-Up|Lost to Follow-up|5|||
28006359|NCT00577629|54665202|FG000|Long Term Follow-Up|Withdrawal by Subject|4|||
28006360|NCT00577629|54665202|FG000|Long Term Follow-Up|Physician Decision|1|||
28006361|NCT00710385|54665208|FG000|Overall Study|Did not qualify|1|||
28006362|NCT00710385|54665208|FG000|Overall Study|Withdrawal by Subject|1|||
28006363|NCT00710385|54665208|FG000|Overall Study|Undisclosed back pain|1|||
28006364|NCT00710385|54665208|FG000|Overall Study|Physician Decision|1|||
28006365|NCT00710385|54665208|FG000|Overall Study|Undisclosed excessive methadone use|1|||
28006366|NCT00701415|54665220|FG000|Overall Study|Adverse Event|0|||
28006367|NCT00701415|54665221|FG001|Overall Study|Adverse Event|1|||
28006368|NCT00701415|54665220|FG000|Overall Study|Social/family issues and needle phobia|1|||
28006369|NCT00701415|54665221|FG001|Overall Study|Social/family issues and needle phobia|0|||
28006370|NCT00700011|54665229|FG000|Overall Study|Death|0|||
28006371|NCT00700011|54665230|FG001|Overall Study|Death|1|||
28006372|NCT00707031|54665238|FG000|Overall Study|Adverse Event|45|||
28006373|NCT00707031|54665239|FG001|Overall Study|Adverse Event|45|||
28006374|NCT00707031|54665238|FG000|Overall Study|Lack of Efficacy|19|||
28006375|NCT00707031|54665239|FG001|Overall Study|Lack of Efficacy|6|||
28006376|NCT00707031|54665238|FG000|Overall Study|Lost to Follow-up|2|||
28006377|NCT00707031|54665239|FG001|Overall Study|Lost to Follow-up|1|||
28006378|NCT00707031|54665238|FG000|Overall Study|Protocol Violation|1|||
28006379|NCT00707031|54665239|FG001|Overall Study|Protocol Violation|0|||
28006380|NCT00707031|54665238|FG000|Overall Study|Withdrawal by Subject|7|||
28006381|NCT00707031|54665239|FG001|Overall Study|Withdrawal by Subject|8|||
28006382|NCT00707031|54665238|FG000|Overall Study|Poor Compliance to Protocol|7|||
28006383|NCT00707031|54665239|FG001|Overall Study|Poor Compliance to Protocol|13|||
28006384|NCT00707031|54665238|FG000|Overall Study|Familial or Personal Reasons|12|||
28006385|NCT00707031|54665239|FG001|Overall Study|Familial or Personal Reasons|15|||
28006386|NCT00707031|54665238|FG000|Overall Study|Serious Noncompliance|2|||
28006387|NCT00707031|54665239|FG001|Overall Study|Serious Noncompliance|3|||
28006388|NCT00707031|54665238|FG000|Overall Study|Sponsor Decision|9|||
28006389|NCT00707031|54665239|FG001|Overall Study|Sponsor Decision|8|||
28006390|NCT00711477|54665248|FG000|Overall Study|Adverse Event|3|||
28006391|NCT00711477|54665249|FG001|Overall Study|Adverse Event|1|||
28006392|NCT00711477|54665248|FG000|Overall Study|Lost to Follow-up|0|||
28006393|NCT00711477|54665249|FG001|Overall Study|Lost to Follow-up|1|||
28006394|NCT00711477|54665248|FG000|Overall Study|Noncompliance|0|||
28006395|NCT00711477|54665249|FG001|Overall Study|Noncompliance|1|||
28006396|NCT00699699|54665257|FG000|Overall Study|Adverse Event|36|||
28006397|NCT00699699|54665257|FG000|Overall Study|Individual different reasons|21|||
28006398|NCT00734474|54665270|FG000|Overall Study|Entry Criteria Not Met|0|||
28006399|NCT00734474|54665271|FG001|Overall Study|Entry Criteria Not Met|0|||
28006400|NCT00734474|54665272|FG002|Overall Study|Entry Criteria Not Met|5|||
28103168|NCT01336738|54759601|FG001|Overall Study|Protocol Violation|1|||
28103169|NCT01336738|54759602|FG002|Overall Study|Protocol Violation|0|||
28103170|NCT01336738|54759603|FG003|Overall Study|Protocol Violation|0|||
28006401|NCT00734474|54665273|FG003|Overall Study|Entry Criteria Not Met|0|||
28006402|NCT00734474|54665274|FG004|Overall Study|Entry Criteria Not Met|3|||
28006403|NCT00734474|54665275|FG005|Overall Study|Entry Criteria Not Met|1|||
28103171|NCT01336738|54759604|FG004|Overall Study|Protocol Violation|0|||
28103172|NCT01336738|54759600|FG000|Overall Study|Withdrawal by Subject|2|||
28006404|NCT00734474|54665276|FG006|Overall Study|Entry Criteria Not Met|0|||
28006405|NCT00734474|54665277|FG007|Overall Study|Entry Criteria Not Met|1|||
28006406|NCT00734474|54665278|FG008|Overall Study|Entry Criteria Not Met|1|||
28006407|NCT00734474|54665270|FG000|Overall Study|Lost to Follow-up|1|||
28006408|NCT00734474|54665271|FG001|Overall Study|Lost to Follow-up|0|||
28006409|NCT00734474|54665272|FG002|Overall Study|Lost to Follow-up|13|||
28006410|NCT00734474|54665273|FG003|Overall Study|Lost to Follow-up|0|||
28006411|NCT00734474|54665274|FG004|Overall Study|Lost to Follow-up|11|||
28006412|NCT00734474|54665275|FG005|Overall Study|Lost to Follow-up|1|||
28006413|NCT00734474|54665276|FG006|Overall Study|Lost to Follow-up|0|||
28006414|NCT00734474|54665277|FG007|Overall Study|Lost to Follow-up|9|||
28006415|NCT00734474|54665278|FG008|Overall Study|Lost to Follow-up|4|||
28006416|NCT00734474|54665270|FG000|Overall Study|Withdrawal by Subject|2|||
28006417|NCT00734474|54665271|FG001|Overall Study|Withdrawal by Subject|1|||
28103173|NCT01336738|54759601|FG001|Overall Study|Withdrawal by Subject|0|||
28173164|NCT00828009|54844975|FG000|Step 2 - Maintenance Therapy|Adverse Event|13|||
28173165|NCT00828009|54844975|FG000|Step 2 - Maintenance Therapy|Death|1|||
28173166|NCT00828009|54844975|FG000|Step 2 - Maintenance Therapy|Withdrawal by Subject|4|||
28173167|NCT00828009|54844975|FG000|Step 2 - Maintenance Therapy|Complicating disease|2|||
28173168|NCT00828009|54844975|FG000|Step 2 - Maintenance Therapy|Other|1|||
28173169|NCT00539591|54844987|FG000|Overall Study|Toxicity|3|||
28173170|NCT00539591|54844988|FG001|Overall Study|Toxicity|0|||
28173171|NCT00539591|54844989|FG002|Overall Study|Toxicity|0|||
28173172|NCT00539591|54844987|FG000|Overall Study|Disease progression|2|||
28173173|NCT00539591|54844988|FG001|Overall Study|Disease progression|2|||
28173174|NCT00539591|54844989|FG002|Overall Study|Disease progression|3|||
28173175|NCT00068393|54845036|FG000|Overall Study|Adverse Event|2|||
28173176|NCT00068393|54845036|FG000|Overall Study|Death|3|||
28173177|NCT00068393|54845036|FG000|Overall Study|Withdrawal by Subject|3|||
28173178|NCT00068393|54845036|FG000|Overall Study|Alternative treatment|1|||
28173179|NCT00068393|54845036|FG000|Overall Study|Quality of life worsening|1|||
28173180|NCT00062010|54845040|FG000|Overall Study|Ineligible|3|||
28173181|NCT00047008|54845046|FG000|Overall Study|Withdrawn consent|2|||
28173182|NCT00047008|54845047|FG001|Overall Study|Withdrawn consent|3|||
28173183|NCT00047008|54845046|FG000|Overall Study|Ineligible|9|||
28173184|NCT00047008|54845047|FG001|Overall Study|Ineligible|8|||
28173185|NCT02397694|54845055|FG000|Double-Blinded Phase|Adverse Event|1|||
28173186|NCT02397694|54845056|FG001|Double-Blinded Phase|Adverse Event|0|||
28173187|NCT02397694|54845055|FG000|Double-Blinded Phase|Non-compliance with study drug|0|||
28173188|NCT02397694|54845056|FG001|Double-Blinded Phase|Non-compliance with study drug|2|||
28173189|NCT02397694|54845055|FG000|Double-Blinded Phase|Withdrawal by Subject|1|||
28173190|NCT02397694|54845056|FG001|Double-Blinded Phase|Withdrawal by Subject|0|||
28173191|NCT02397694|54845055|FG000|Double-Blinded Phase|Lost to Follow-up|1|||
28173192|NCT02397694|54845056|FG001|Double-Blinded Phase|Lost to Follow-up|1|||
28173193|NCT02397694|54845055|FG000|Open Label Extension Phase|Protocol Violation|1|||
28173194|NCT02397694|54845056|FG001|Open Label Extension Phase|Protocol Violation|0|||
28103174|NCT01336738|54759602|FG002|Overall Study|Withdrawal by Subject|2|||
28103175|NCT01336738|54759603|FG003|Overall Study|Withdrawal by Subject|1|||
28103176|NCT01336738|54759604|FG004|Overall Study|Withdrawal by Subject|1|||
28103177|NCT01336738|54759600|FG000|Overall Study|Other|3|||
28103178|NCT01336738|54759601|FG001|Overall Study|Other|3|||
28103179|NCT01336738|54759602|FG002|Overall Study|Other|2|||
28103180|NCT01336738|54759603|FG003|Overall Study|Other|3|||
28103181|NCT01336738|54759604|FG004|Overall Study|Other|4|||
28103182|NCT02258451|54759618|FG000|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|88|||
28103183|NCT02258451|54759619|FG001|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|95|||
28103184|NCT02258451|54759618|FG000|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|6|||
28103185|NCT02258451|54759619|FG001|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
28103186|NCT02258451|54759618|FG000|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|8|||
28103187|NCT02258451|54759619|FG001|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|1|||
28103188|NCT02258451|54759618|FG000|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|8|||
28103189|NCT02258451|54759619|FG001|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|6|||
28103190|NCT02258451|54759618|FG000|Overall Study|Death|4|||
28103191|NCT02258451|54759619|FG001|Overall Study|Death|3|||
28103192|NCT02258451|54759618|FG000|Overall Study|Withdrawal by Subject|21|||
28103193|NCT02258451|54759619|FG001|Overall Study|Withdrawal by Subject|12|||
28103194|NCT02258451|54759618|FG000|Overall Study|Discontinuation all treatment due to TS-1 started|1|||
28173195|NCT02397694|54845055|FG000|Open Label Extension Phase|Withdrew Consent|3|||
28173196|NCT02397694|54845056|FG001|Open Label Extension Phase|Withdrew Consent|1|||
28173197|NCT02397694|54845055|FG000|Open Label Extension Phase|Lost to Follow-up|4|||
28173198|NCT02397694|54845056|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
27740010|NCT02786537|54189682|FG005|As Treated|Drugs stolen from patient|0|||
28006418|NCT00734474|54665272|FG002|Overall Study|Withdrawal by Subject|18|||
28006419|NCT00734474|54665273|FG003|Overall Study|Withdrawal by Subject|0|||
28006420|NCT00734474|54665274|FG004|Overall Study|Withdrawal by Subject|24|||
28173199|NCT02783599|54845066|FG000|Overall Study|Progressive disease|23|||
28006421|NCT00734474|54665275|FG005|Overall Study|Withdrawal by Subject|2|||
28006422|NCT00734474|54665276|FG006|Overall Study|Withdrawal by Subject|0|||
28006423|NCT00734474|54665277|FG007|Overall Study|Withdrawal by Subject|36|||
28006424|NCT00734474|54665278|FG008|Overall Study|Withdrawal by Subject|21|||
28006425|NCT00734474|54665270|FG000|Overall Study|Physician Decision|0|||
28006426|NCT00734474|54665271|FG001|Overall Study|Physician Decision|0|||
28006427|NCT00734474|54665272|FG002|Overall Study|Physician Decision|4|||
28006428|NCT00734474|54665273|FG003|Overall Study|Physician Decision|1|||
28006429|NCT00734474|54665274|FG004|Overall Study|Physician Decision|11|||
28006430|NCT00734474|54665275|FG005|Overall Study|Physician Decision|0|||
28006431|NCT00734474|54665276|FG006|Overall Study|Physician Decision|0|||
28006432|NCT00734474|54665277|FG007|Overall Study|Physician Decision|9|||
28006433|NCT00734474|54665278|FG008|Overall Study|Physician Decision|9|||
28006434|NCT00734474|54665270|FG000|Overall Study|Adverse Event|4|||
28006435|NCT00734474|54665271|FG001|Overall Study|Adverse Event|4|||
28006436|NCT00734474|54665272|FG002|Overall Study|Adverse Event|63|||
28006437|NCT00734474|54665273|FG003|Overall Study|Adverse Event|1|||
28006438|NCT00734474|54665274|FG004|Overall Study|Adverse Event|64|||
28006439|NCT00734474|54665275|FG005|Overall Study|Adverse Event|0|||
28006440|NCT00734474|54665276|FG006|Overall Study|Adverse Event|1|||
28006441|NCT00734474|54665277|FG007|Overall Study|Adverse Event|65|||
28006442|NCT00734474|54665278|FG008|Overall Study|Adverse Event|39|||
28006443|NCT00734474|54665270|FG000|Overall Study|Protocol Violation|0|||
28006444|NCT00734474|54665271|FG001|Overall Study|Protocol Violation|0|||
28006445|NCT00734474|54665272|FG002|Overall Study|Protocol Violation|4|||
28006446|NCT00734474|54665273|FG003|Overall Study|Protocol Violation|0|||
28006447|NCT00734474|54665274|FG004|Overall Study|Protocol Violation|3|||
28006448|NCT00734474|54665275|FG005|Overall Study|Protocol Violation|0|||
28006449|NCT00734474|54665276|FG006|Overall Study|Protocol Violation|0|||
28006450|NCT00734474|54665277|FG007|Overall Study|Protocol Violation|3|||
28006451|NCT00734474|54665278|FG008|Overall Study|Protocol Violation|1|||
28006452|NCT00734474|54665270|FG000|Overall Study|Sponsor Decision, Arm Discontinued|8|||
28006453|NCT00734474|54665271|FG001|Overall Study|Sponsor Decision, Arm Discontinued|25|||
28006454|NCT00734474|54665272|FG002|Overall Study|Sponsor Decision, Arm Discontinued|0|||
28006455|NCT00734474|54665273|FG003|Overall Study|Sponsor Decision, Arm Discontinued|8|||
28006456|NCT00734474|54665274|FG004|Overall Study|Sponsor Decision, Arm Discontinued|0|||
28006457|NCT00734474|54665275|FG005|Overall Study|Sponsor Decision, Arm Discontinued|21|||
28006458|NCT00734474|54665276|FG006|Overall Study|Sponsor Decision, Arm Discontinued|23|||
28006459|NCT00734474|54665277|FG007|Overall Study|Sponsor Decision, Arm Discontinued|0|||
28006460|NCT00734474|54665278|FG008|Overall Study|Sponsor Decision, Arm Discontinued|0|||
28006461|NCT00734474|54665270|FG000|Overall Study|Sponsor Decision|0|||
28006462|NCT00734474|54665271|FG001|Overall Study|Sponsor Decision|0|||
28006463|NCT00734474|54665272|FG002|Overall Study|Sponsor Decision|0|||
28006464|NCT00734474|54665273|FG003|Overall Study|Sponsor Decision|0|||
28006465|NCT00734474|54665274|FG004|Overall Study|Sponsor Decision|2|||
28006466|NCT00734474|54665275|FG005|Overall Study|Sponsor Decision|0|||
28006467|NCT00734474|54665276|FG006|Overall Study|Sponsor Decision|0|||
28006468|NCT00734474|54665277|FG007|Overall Study|Sponsor Decision|0|||
28006469|NCT00734474|54665278|FG008|Overall Study|Sponsor Decision|0|||
28006470|NCT00734474|54665270|FG000|Overall Study|Death|0|||
28006471|NCT00734474|54665271|FG001|Overall Study|Death|0|||
28006472|NCT00734474|54665272|FG002|Overall Study|Death|1|||
28006473|NCT00734474|54665273|FG003|Overall Study|Death|0|||
28006474|NCT00734474|54665274|FG004|Overall Study|Death|0|||
28006475|NCT00734474|54665275|FG005|Overall Study|Death|0|||
28006476|NCT00734474|54665276|FG006|Overall Study|Death|0|||
28006477|NCT00734474|54665277|FG007|Overall Study|Death|2|||
28006478|NCT00734474|54665278|FG008|Overall Study|Death|1|||
28006479|NCT00734474|54665270|FG000|Overall Study|Lack of Efficacy|0|||
28006480|NCT00734474|54665271|FG001|Overall Study|Lack of Efficacy|0|||
28006481|NCT00734474|54665272|FG002|Overall Study|Lack of Efficacy|4|||
28006482|NCT00734474|54665273|FG003|Overall Study|Lack of Efficacy|0|||
28006483|NCT00734474|54665274|FG004|Overall Study|Lack of Efficacy|0|||
28006484|NCT00734474|54665275|FG005|Overall Study|Lack of Efficacy|0|||
28006485|NCT00734474|54665276|FG006|Overall Study|Lack of Efficacy|0|||
28006486|NCT00734474|54665277|FG007|Overall Study|Lack of Efficacy|4|||
28006487|NCT00734474|54665278|FG008|Overall Study|Lack of Efficacy|6|||
28006488|NCT00583362|54665304|FG000|Overall Study|Adverse Event|44|||
28006489|NCT00583362|54665304|FG000|Overall Study|Lack of Efficacy|22|||
28006490|NCT00583362|54665304|FG000|Overall Study|Lost to Follow-up|4|||
28006491|NCT00583362|54665304|FG000|Overall Study|Non-compliance with study drug|28|||
28006492|NCT00583362|54665304|FG000|Overall Study|Pregnancy|7|||
28006493|NCT00583362|54665304|FG000|Overall Study|Miscommunication of visit window|5|||
28006494|NCT00583362|54665304|FG000|Overall Study|Current site closed|7|||
28006495|NCT00583362|54665304|FG000|Overall Study|Subject not dosed in LBSL99|1|||
28006496|NCT00583362|54665304|FG000|Overall Study|Subject moved out of the country/state|2|||
28006497|NCT00583362|54665304|FG000|Overall Study|Missed visits due to staff changes|1|||
28006498|NCT00583362|54665304|FG000|Overall Study|Misunderstanding of protocol|1|||
28006499|NCT00583362|54665304|FG000|Overall Study|Behavioral problems and non-compliance|1|||
28006500|NCT00583362|54665304|FG000|Overall Study|Sponsor request due to missed doses|1|||
28006501|NCT00583362|54665304|FG000|Overall Study|Physician Decision|19|||
28103195|NCT02258451|54759619|FG001|Overall Study|Discontinuation all treatment due to TS-1 started|0|||
28103196|NCT02258451|54759618|FG000|Overall Study|Discontinuation all treatment due to event point reached|1|||
28103197|NCT02258451|54759619|FG001|Overall Study|Discontinuation all treatment due to event point reached|1|||
28103198|NCT02258451|54759618|FG000|Overall Study|Physician Decision|0|||
28103199|NCT02258451|54759619|FG001|Overall Study|Physician Decision|2|||
28103200|NCT02258451|54759618|FG000|Overall Study|Never treated|2|||
28173200|NCT02783599|54845066|FG000|Overall Study|Surgical Resection|10|||
28173201|NCT02783599|54845066|FG000|Overall Study|Adverse Event|4|||
28173202|NCT02783599|54845066|FG000|Overall Study|Physician Decision|2|||
28173203|NCT02783599|54845066|FG000|Overall Study|Death|1|||
28173204|NCT02838017|54845079|FG000|Overall Study|Lost to Follow-up|14|||
28173205|NCT02838017|54845080|FG001|Overall Study|Lost to Follow-up|11|||
28173206|NCT03188666|54845088|FG000|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
28173207|NCT03188666|54845089|FG001|Period 1 (28 Weeks Double-blind)|Adverse Event|1|||
28103201|NCT02258451|54759619|FG001|Overall Study|Never treated|3|||
28103202|NCT02258451|54759618|FG000|Overall Study|Ongoing with any Treatment of radium 223 or placebo, exemestane, or everolimus|3|||
28103203|NCT02258451|54759619|FG001|Overall Study|Ongoing with any Treatment of radium 223 or placebo, exemestane, or everolimus|11|||
28173208|NCT03188666|54845090|FG002|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
28173209|NCT03188666|54845091|FG003|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
28173210|NCT03188666|54845088|FG000|Period 2 (28 Weeks Open-label)|Death|0|||
27740011|NCT02786537|54189677|FG000|As Treated|Advised to stop tx after loss of meds|0|||
28006502|NCT00583362|54665304|FG000|Overall Study|Protocol Violation|2|||
28006503|NCT00583362|54665304|FG000|Overall Study|Withdrawal by Subject|57|||
28006504|NCT00577473|54665310|FG000|Overall Study|Protocol Violation|1|||
28006505|NCT00577473|54665311|FG001|Overall Study|Protocol Violation|4|||
28103204|NCT02865538|54759632|FG000|Overall Study|Withdrawal by Subject|0|||
28103205|NCT02865538|54759633|FG001|Overall Study|Withdrawal by Subject|0|||
28103206|NCT02865538|54759634|FG002|Overall Study|Withdrawal by Subject|1|||
28103207|NCT02865538|54759635|FG003|Overall Study|Withdrawal by Subject|0|||
28103208|NCT02865538|54759636|FG004|Overall Study|Withdrawal by Subject|0|||
28103209|NCT02865538|54759632|FG000|Overall Study|Lost to Follow-up|1|||
28103210|NCT02865538|54759633|FG001|Overall Study|Lost to Follow-up|0|||
28103211|NCT02865538|54759634|FG002|Overall Study|Lost to Follow-up|0|||
28103212|NCT02865538|54759635|FG003|Overall Study|Lost to Follow-up|0|||
28103213|NCT02865538|54759636|FG004|Overall Study|Lost to Follow-up|0|||
28103214|NCT02860546|54759648|FG000|Overall Study|Clinical Progression|6|||
28103215|NCT02860546|54759648|FG000|Overall Study|Radiological Progression|12|||
28103216|NCT01982955|54759657|FG000|Overall Study|Randomized but not treated|0|||
28103217|NCT01982955|54759658|FG001|Overall Study|Randomized but not treated|0|||
28103218|NCT01982955|54759659|FG002|Overall Study|Randomized but not treated|0|||
28103219|NCT01982955|54759660|FG003|Overall Study|Randomized but not treated|1|||
28103220|NCT01982955|54759661|FG004|Overall Study|Randomized but not treated|0|||
28103221|NCT00396279|54759674|FG000|Overall Study|Ongoing in study|26|||
28103222|NCT00396279|54759674|FG000|Overall Study|Disease progression|2|||
28103223|NCT00396279|54759674|FG000|Overall Study|Withdrawal by Subject|1|||
28103224|NCT00396279|54759674|FG000|Overall Study|Physician Decision|1|||
28103225|NCT01347866|54759695|FG000|Overall Study|Death|0|||
28103226|NCT01347866|54759696|FG001|Overall Study|Death|0|||
28103227|NCT01347866|54759697|FG002|Overall Study|Death|0|||
28103228|NCT01347866|54759698|FG003|Overall Study|Death|1|||
28103229|NCT01347866|54759699|FG004|Overall Study|Death|2|||
28103230|NCT01347866|54759700|FG005|Overall Study|Death|2|||
28103231|NCT01347866|54759701|FG006|Overall Study|Death|1|||
28103232|NCT01347866|54759702|FG007|Overall Study|Death|0|||
28103233|NCT01347866|54759703|FG008|Overall Study|Death|4|||
28103234|NCT01347866|54759704|FG009|Overall Study|Death|1|||
28103235|NCT01347866|54759705|FG010|Overall Study|Death|3|||
28103236|NCT01347866|54759706|FG011|Overall Study|Death|1|||
28006506|NCT00577473|54665310|FG000|Overall Study|Adverse Event|8|||
28006507|NCT00577473|54665311|FG001|Overall Study|Adverse Event|5|||
28006508|NCT00577473|54665310|FG000|Overall Study|Withdrawal by Subject|2|||
28006509|NCT00577473|54665311|FG001|Overall Study|Withdrawal by Subject|6|||
28006510|NCT00577473|54665310|FG000|Overall Study|Physician Decision|2|||
28103237|NCT01347866|54759707|FG012|Overall Study|Death|2|||
28103238|NCT01347866|54759708|FG013|Overall Study|Death|0|||
28103239|NCT01347866|54759709|FG014|Overall Study|Death|0|||
28103240|NCT01347866|54759710|FG015|Overall Study|Death|1|||
28103241|NCT01347866|54759711|FG016|Overall Study|Death|0|||
28103242|NCT01347866|54759695|FG000|Overall Study|Lost to Follow-up|0|||
28173211|NCT03188666|54845089|FG001|Period 2 (28 Weeks Open-label)|Death|0|||
28173212|NCT03188666|54845090|FG002|Period 2 (28 Weeks Open-label)|Death|0|||
28173213|NCT03188666|54845091|FG003|Period 2 (28 Weeks Open-label)|Death|1|||
28173214|NCT03188666|54845088|FG000|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
27917211|NCT01340027|54574667|FG010|Overall Study|Miscellaneous|1|||
28103243|NCT01347866|54759696|FG001|Overall Study|Lost to Follow-up|0|||
28103244|NCT01347866|54759697|FG002|Overall Study|Lost to Follow-up|0|||
28103245|NCT01347866|54759698|FG003|Overall Study|Lost to Follow-up|0|||
28103246|NCT01347866|54759699|FG004|Overall Study|Lost to Follow-up|0|||
28103247|NCT01347866|54759700|FG005|Overall Study|Lost to Follow-up|0|||
28103248|NCT01347866|54759701|FG006|Overall Study|Lost to Follow-up|0|||
28103249|NCT01347866|54759702|FG007|Overall Study|Lost to Follow-up|1|||
28103250|NCT01347866|54759703|FG008|Overall Study|Lost to Follow-up|1|||
28103251|NCT01347866|54759704|FG009|Overall Study|Lost to Follow-up|0|||
28103252|NCT01347866|54759705|FG010|Overall Study|Lost to Follow-up|0|||
28103253|NCT01347866|54759706|FG011|Overall Study|Lost to Follow-up|0|||
28103254|NCT01347866|54759707|FG012|Overall Study|Lost to Follow-up|0|||
28103255|NCT01347866|54759708|FG013|Overall Study|Lost to Follow-up|0|||
28103256|NCT01347866|54759709|FG014|Overall Study|Lost to Follow-up|0|||
28103257|NCT01347866|54759710|FG015|Overall Study|Lost to Follow-up|0|||
28103258|NCT01347866|54759711|FG016|Overall Study|Lost to Follow-up|0|||
28103259|NCT01347866|54759695|FG000|Overall Study|Other|3|||
28103260|NCT01347866|54759696|FG001|Overall Study|Other|1|||
28103261|NCT01347866|54759697|FG002|Overall Study|Other|1|||
28103262|NCT01347866|54759698|FG003|Overall Study|Other|4|||
28103263|NCT01347866|54759699|FG004|Overall Study|Other|5|||
28103264|NCT01347866|54759700|FG005|Overall Study|Other|0|||
28103265|NCT01347866|54759701|FG006|Overall Study|Other|5|||
28103266|NCT01347866|54759702|FG007|Overall Study|Other|3|||
28103267|NCT01347866|54759703|FG008|Overall Study|Other|22|||
28103268|NCT01347866|54759704|FG009|Overall Study|Other|5|||
28006511|NCT00577473|54665311|FG001|Overall Study|Physician Decision|2|||
28006512|NCT00577473|54665310|FG000|Overall Study|Lack of Efficacy|8|||
28006513|NCT00577473|54665311|FG001|Overall Study|Lack of Efficacy|7|||
28006514|NCT00785291|54665320|FG000|Overall Study|Never began treatment|8|||
28006515|NCT00785291|54665321|FG001|Overall Study|Never began treatment|4|||
28006516|NCT00785291|54665322|FG002|Overall Study|Never began treatment|4|||
28103269|NCT01347866|54759705|FG010|Overall Study|Other|0|||
28103270|NCT01347866|54759706|FG011|Overall Study|Other|3|||
28103271|NCT01347866|54759707|FG012|Overall Study|Other|4|||
28103272|NCT01347866|54759708|FG013|Overall Study|Other|4|||
28103273|NCT01347866|54759709|FG014|Overall Study|Other|2|||
28103274|NCT01347866|54759710|FG015|Overall Study|Other|3|||
28103275|NCT01347866|54759711|FG016|Overall Study|Other|0|||
28006517|NCT00785291|54665320|FG000|Overall Study|Adverse Event|39|||
28006518|NCT00785291|54665321|FG001|Overall Study|Adverse Event|70|||
28006519|NCT00785291|54665322|FG002|Overall Study|Adverse Event|56|||
28006520|NCT00785291|54665320|FG000|Overall Study|Death|7|||
28006521|NCT00785291|54665321|FG001|Overall Study|Death|4|||
28006522|NCT00785291|54665322|FG002|Overall Study|Death|3|||
28006523|NCT00785291|54665320|FG000|Overall Study|Withdrawal by Subject|35|||
28006524|NCT00785291|54665321|FG001|Overall Study|Withdrawal by Subject|36|||
28006525|NCT00785291|54665322|FG002|Overall Study|Withdrawal by Subject|17|||
28006526|NCT00785291|54665320|FG000|Overall Study|Alternative Therapy|12|||
28006527|NCT00785291|54665321|FG001|Overall Study|Alternative Therapy|6|||
28006528|NCT00785291|54665322|FG002|Overall Study|Alternative Therapy|7|||
28006529|NCT00785291|54665320|FG000|Overall Study|Complicating illness|6|||
28006530|NCT00785291|54665321|FG001|Overall Study|Complicating illness|4|||
28006531|NCT00785291|54665322|FG002|Overall Study|Complicating illness|4|||
28006532|NCT00785291|54665320|FG000|Overall Study|Other Medical Reasons|29|||
28006533|NCT00785291|54665321|FG001|Overall Study|Other Medical Reasons|25|||
28006534|NCT00785291|54665322|FG002|Overall Study|Other Medical Reasons|15|||
28006535|NCT00705939|54665333|FG000|Overall Study|Protocol Violation|0|||
28103276|NCT01347866|54759695|FG000|Overall Study|Subject refused further follow-up|2|||
28103277|NCT01347866|54759696|FG001|Overall Study|Subject refused further follow-up|0|||
28103278|NCT01347866|54759697|FG002|Overall Study|Subject refused further follow-up|0|||
28103279|NCT01347866|54759698|FG003|Overall Study|Subject refused further follow-up|2|||
28103280|NCT01347866|54759699|FG004|Overall Study|Subject refused further follow-up|0|||
28103281|NCT01347866|54759700|FG005|Overall Study|Subject refused further follow-up|1|||
28103282|NCT01347866|54759701|FG006|Overall Study|Subject refused further follow-up|0|||
28103283|NCT01347866|54759702|FG007|Overall Study|Subject refused further follow-up|0|||
28103284|NCT01347866|54759703|FG008|Overall Study|Subject refused further follow-up|4|||
28103285|NCT01347866|54759704|FG009|Overall Study|Subject refused further follow-up|1|||
28006536|NCT00705939|54665334|FG001|Overall Study|Protocol Violation|0|||
28006537|NCT00705939|54665335|FG002|Overall Study|Protocol Violation|1|||
28006538|NCT00705939|54665333|FG000|Overall Study|Withdrawal by Subject|0|||
28006539|NCT00705939|54665334|FG001|Overall Study|Withdrawal by Subject|1|||
28103286|NCT01347866|54759705|FG010|Overall Study|Subject refused further follow-up|0|||
28103287|NCT01347866|54759706|FG011|Overall Study|Subject refused further follow-up|0|||
28006540|NCT00705939|54665335|FG002|Overall Study|Withdrawal by Subject|3|||
28006541|NCT00705939|54665333|FG000|Overall Study|Physician Decision|0|||
28006542|NCT00705939|54665334|FG001|Overall Study|Physician Decision|1|||
28006543|NCT00705939|54665335|FG002|Overall Study|Physician Decision|0|||
28103288|NCT01347866|54759707|FG012|Overall Study|Subject refused further follow-up|1|||
28103289|NCT01347866|54759708|FG013|Overall Study|Subject refused further follow-up|3|||
28006544|NCT00785213|54665344|FG000|Quinine Sulfate Alone|Adverse Event|4|||
28006545|NCT00785213|54665344|FG000|Rosiglitazone With Quinine Sulfate|Adverse Event|1|||
28006546|NCT00577317|54665353|FG000|Overall Study|Study Terminated|0|||
28006547|NCT00577317|54665354|FG001|Overall Study|Study Terminated|2|||
28006548|NCT00734162|54665364|FG000|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
28006549|NCT00734162|54665365|FG001|Randomized Phase (Through Week 72)|Investigator's Discretion|1|||
28006550|NCT00734162|54665366|FG002|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
28103290|NCT01347866|54759709|FG014|Overall Study|Subject refused further follow-up|1|||
28103291|NCT01347866|54759710|FG015|Overall Study|Subject refused further follow-up|0|||
28103292|NCT01347866|54759711|FG016|Overall Study|Subject refused further follow-up|2|||
28103293|NCT01347710|54759782|FG000|Overall Study|Withdrawal by Subject|2|||
28103294|NCT01347710|54759782|FG000|Overall Study|Adverse Event|4|||
28103295|NCT01347710|54759782|FG000|Overall Study|Angio or SPECT not completed|18|||
28103296|NCT01347710|54759782|FG000|Overall Study|issue with vitals prior to dosing|1|||
28103297|NCT01347710|54759782|FG000|Overall Study|Lost to Follow-up|1|||
28103298|NCT01347710|54759782|FG000|Overall Study|Physician Decision|2|||
28103299|NCT01347710|54759782|FG000|Overall Study|Other|3|||
28103300|NCT03485222|54759792|FG000|Overall Study|Death|0|||
28103301|NCT03485222|54759793|FG001|Overall Study|Death|1|||
28103302|NCT03485222|54759792|FG000|Overall Study|Lost to Follow-up|2|||
28103303|NCT03485222|54759793|FG001|Overall Study|Lost to Follow-up|1|||
28103304|NCT01347554|54759801|FG000|Overall Study|Lack of Efficacy|7|||
28103305|NCT01347554|54759802|FG001|Overall Study|Lack of Efficacy|11|||
28103306|NCT03482882|54759808|FG000|Overall Study|Adverse Event|3|||
28103307|NCT03482882|54759808|FG000|Overall Study|Lost to Follow-up|1|||
28103308|NCT03482882|54759808|FG000|Overall Study|Protocol Violation|2|||
28103309|NCT03482882|54759808|FG000|Overall Study|Not further specified|1|||
28006551|NCT00734162|54665367|FG003|Randomized Phase (Through Week 72)|Investigator's Discretion|2|||
28103310|NCT03480932|54759815|FG000|Overall Study|Death|1|||
28103311|NCT03480932|54759816|FG001|Overall Study|Death|1|||
28103312|NCT03480932|54759817|FG002|Overall Study|Death|0|||
28103313|NCT03480932|54759815|FG000|Overall Study|Lost to Follow-up|0|||
28103314|NCT03480932|54759816|FG001|Overall Study|Lost to Follow-up|2|||
28103315|NCT03480932|54759817|FG002|Overall Study|Lost to Follow-up|3|||
28103316|NCT03480932|54759815|FG000|Overall Study|Incarcerated|2|||
28103317|NCT03480932|54759816|FG001|Overall Study|Incarcerated|2|||
28103318|NCT03480932|54759817|FG002|Overall Study|Incarcerated|2|||
28103319|NCT03387020|54759828|FG000|Overall Study|Adverse Event|0|||
28103320|NCT03387020|54759829|FG001|Overall Study|Adverse Event|2|||
28103321|NCT03387020|54759830|FG002|Overall Study|Adverse Event|0|||
28103322|NCT03387020|54759828|FG000|Overall Study|Withdrawal by Subject|2|||
28103323|NCT03387020|54759829|FG001|Overall Study|Withdrawal by Subject|0|||
28103324|NCT03387020|54759830|FG002|Overall Study|Withdrawal by Subject|0|||
28103325|NCT03386474|54759850|FG000|Overall Study|Death|1|||
28103326|NCT03386474|54759851|FG001|Overall Study|Death|0|||
28103327|NCT03386474|54759850|FG000|Overall Study|Adverse Event|0|||
28103328|NCT03386474|54759851|FG001|Overall Study|Adverse Event|1|||
28103329|NCT03405818|54759862|FG000|Overall Study|Withdrawal by Subject|4|||
28103330|NCT03405818|54759862|FG000|Overall Study|Lost to Follow-up|4|||
28103331|NCT03403634|54759866|FG000|Overall Study|Disease progression|3|||
28103332|NCT03403634|54759866|FG000|Overall Study|Did not meet eligibility criteria|4|||
28103333|NCT03403400|54759873|FG000|Overall Study|Lost to Follow-up|1|||
28103334|NCT03403400|54759874|FG001|Overall Study|Lost to Follow-up|0|||
28103335|NCT03403400|54759875|FG002|Overall Study|Lost to Follow-up|1|||
28103336|NCT03403400|54759873|FG000|Overall Study|Hospitalization|1|||
28103337|NCT03403400|54759874|FG001|Overall Study|Hospitalization|0|||
28103338|NCT03403400|54759875|FG002|Overall Study|Hospitalization|0|||
28103339|NCT03403400|54759873|FG000|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
28103340|NCT03403400|54759874|FG001|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
28103341|NCT03403400|54759875|FG002|Overall Study|Benign Paroxysmal Positional Vertigo|1|||
28103342|NCT02863354|54759900|FG000|Year 1|Lost to Follow-up|1|||
28173215|NCT03188666|54845089|FG001|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
28173216|NCT03188666|54845090|FG002|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|2|||
28173217|NCT03188666|54845091|FG003|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
28173218|NCT03188666|54845088|FG000|Period 3 (20 Weeks Follow-up)|Death|0|||
28006552|NCT00734162|54665364|FG000|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
28103343|NCT02863354|54759901|FG001|Year 1|Lost to Follow-up|1|||
28103344|NCT02863354|54759900|FG000|Year 1|Withdrawal by Subject|3|||
28103345|NCT02863354|54759901|FG001|Year 1|Withdrawal by Subject|0|||
28103346|NCT02863354|54759900|FG000|Year 1|Death|0|||
28103347|NCT02863354|54759901|FG001|Year 1|Death|1|||
28103348|NCT02863354|54759900|FG000|Year 2|Lost to Follow-up|2|||
28006553|NCT00734162|54665365|FG001|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
27917212|NCT01340027|54574668|FG011|Overall Study|Miscellaneous|0|||
28103349|NCT02863354|54759901|FG001|Year 2|Lost to Follow-up|2|||
28103350|NCT03480152|54759909|FG000|Phase I|Signed consent. Died before treatment.|1|||
28103351|NCT03480152|54759910|FG001|Phase I|Signed consent. Died before treatment.|0|||
28103352|NCT03480152|54759911|FG002|Phase I|Signed consent. Died before treatment.|0|||
28103353|NCT02859454|54759919|FG000|Overall Study|PI discretion/off study prior to trtmt|1|||
28103354|NCT02862730|54759926|FG000|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
28103355|NCT02862730|54759927|FG001|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
28103356|NCT02862730|54759928|FG002|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1|||
28103357|NCT02862730|54759929|FG003|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
28103358|NCT02862730|54759930|FG004|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
28103359|NCT02862730|54759931|FG005|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
28103360|NCT02862730|54759932|FG006|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
28103361|NCT02862730|54759926|FG000|Second Intervention (84 Hours)|Withdrawal by Subject|1|||
28103362|NCT02862730|54759927|FG001|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
28103363|NCT02862730|54759928|FG002|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
28103364|NCT02862730|54759929|FG003|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
28103365|NCT02862730|54759930|FG004|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
28103366|NCT02862730|54759931|FG005|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
28103367|NCT02862730|54759932|FG006|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
28103368|NCT02862730|54759926|FG000|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
28103369|NCT02862730|54759927|FG001|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
28103370|NCT02862730|54759928|FG002|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
28103371|NCT02862730|54759929|FG003|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
28103372|NCT02862730|54759930|FG004|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
28103373|NCT02862730|54759931|FG005|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
28103374|NCT02862730|54759932|FG006|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
28103375|NCT02862730|54759926|FG000|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
28103376|NCT02862730|54759927|FG001|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
28103377|NCT02862730|54759928|FG002|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
28103378|NCT02862730|54759929|FG003|Third Intervention (84 Hours)|diagnosis of gastroparesis|1|||
28103379|NCT02862730|54759930|FG004|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
28103380|NCT02862730|54759931|FG005|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
28103381|NCT02862730|54759932|FG006|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
28103382|NCT03402386|54759947|FG000|Overall Study|Adverse Event|3|||
28103383|NCT03402386|54759947|FG000|Overall Study|Physician Decision|1|||
28103384|NCT03402386|54759947|FG000|Overall Study|Difficult to control Hb|2|||
28103385|NCT03353792|54759953|FG000|Overall Study|Lost to Follow-up|1|||
28103386|NCT03353792|54759954|FG001|Overall Study|Lost to Follow-up|0|||
28103387|NCT03353792|54759953|FG000|Overall Study|Participant Unable to Manage Device|1|||
28103388|NCT03353792|54759954|FG001|Overall Study|Participant Unable to Manage Device|0|||
28103389|NCT02862574|54759963|FG000|Double-Blind Treatment Period|Adverse Event|0|||
28103390|NCT02862574|54759964|FG001|Double-Blind Treatment Period|Adverse Event|1|||
28103391|NCT02862574|54759965|FG002|Double-Blind Treatment Period|Adverse Event|0|||
28103392|NCT02862574|54759963|FG000|Double-Blind Treatment Period|Study Terminated by Sponsor|3|||
28103393|NCT02862574|54759964|FG001|Double-Blind Treatment Period|Study Terminated by Sponsor|1|||
28103394|NCT02862574|54759965|FG002|Double-Blind Treatment Period|Study Terminated by Sponsor|4|||
28103395|NCT02862574|54759963|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
28103396|NCT02862574|54759964|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|3|||
28103397|NCT02862574|54759965|FG002|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
28103398|NCT02862106|54759980|FG000|Overall Study|Adverse Event|4|||
28103399|NCT02862106|54759981|FG001|Overall Study|Adverse Event|0|||
28103400|NCT02862106|54759980|FG000|Overall Study|Protocol Violation|16|||
28103401|NCT02862106|54759981|FG001|Overall Study|Protocol Violation|1|||
28103402|NCT02862106|54759980|FG000|Overall Study|Lost to Follow-up|15|||
28103403|NCT02862106|54759981|FG001|Overall Study|Lost to Follow-up|5|||
28103404|NCT02862106|54759980|FG000|Overall Study|Withdrawal by Subject|2|||
28103405|NCT02862106|54759981|FG001|Overall Study|Withdrawal by Subject|0|||
28103406|NCT02862106|54759980|FG000|Overall Study|Subjects moved to other city|1|||
28103407|NCT02862106|54759981|FG001|Overall Study|Subjects moved to other city|0|||
28103408|NCT04157296|54759996|FG000|Overall Study|Withdrawal by Subject|0|||
28103409|NCT04157296|54759997|FG001|Overall Study|Withdrawal by Subject|1|||
28103410|NCT04157296|54759996|FG000|Overall Study|Did not obtain second fMRI.|0|||
28103411|NCT04157296|54759997|FG001|Overall Study|Did not obtain second fMRI.|1|||
28103412|NCT04157296|54759996|FG000|Overall Study|MRI failed/no second fMRI|0|||
28103413|NCT04157296|54759997|FG001|Overall Study|MRI failed/no second fMRI|1|||
28103414|NCT02859142|54760005|FG000|Overall Study|Adverse Event|1|||
28103415|NCT02859142|54760006|FG001|Overall Study|Adverse Event|2|||
28103416|NCT02859142|54760005|FG000|Overall Study|Lost to Follow-up|1|||
28103417|NCT02859142|54760006|FG001|Overall Study|Lost to Follow-up|4|||
28103418|NCT02859142|54760005|FG000|Overall Study|Withdrawal by Subject|2|||
28103419|NCT02859142|54760006|FG001|Overall Study|Withdrawal by Subject|0|||
28103420|NCT02859142|54760005|FG000|Overall Study|Scheduling difficulties|0|||
28103421|NCT02859142|54760006|FG001|Overall Study|Scheduling difficulties|3|||
28103422|NCT03351608|54760017|FG000|Overall Study|Lost to Follow-up|0|||
28103423|NCT03351608|54760018|FG001|Overall Study|Lost to Follow-up|1|||
28103424|NCT03351608|54760019|FG002|Overall Study|Lost to Follow-up|1|||
28103425|NCT03351608|54760020|FG003|Overall Study|Lost to Follow-up|1|||
28103426|NCT03351608|54760021|FG004|Overall Study|Lost to Follow-up|1|||
28103427|NCT03351608|54760017|FG000|Overall Study|Physician Decision|1|||
28103428|NCT03351608|54760018|FG001|Overall Study|Physician Decision|0|||
28103429|NCT03351608|54760019|FG002|Overall Study|Physician Decision|0|||
28006554|NCT00734162|54665366|FG002|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
28006555|NCT00734162|54665367|FG003|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2|||
28006556|NCT00734162|54665364|FG000|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1|||
28006557|NCT00734162|54665365|FG001|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
28006558|NCT00734162|54665366|FG002|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
28006559|NCT00734162|54665367|FG003|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
28006560|NCT00734162|54665364|FG000|Open-Label Phase|Withdrew Consent|1|||
28006561|NCT00734162|54665365|FG001|Open-Label Phase|Withdrew Consent|0|||
28006562|NCT00734162|54665366|FG002|Open-Label Phase|Withdrew Consent|1|||
28006563|NCT00734162|54665367|FG003|Open-Label Phase|Withdrew Consent|1|||
28006564|NCT00734162|54665364|FG000|Open-Label Phase|Lost to Follow-up|1|||
28006565|NCT00734162|54665365|FG001|Open-Label Phase|Lost to Follow-up|2|||
28006566|NCT00734162|54665366|FG002|Open-Label Phase|Lost to Follow-up|0|||
28006567|NCT00734162|54665367|FG003|Open-Label Phase|Lost to Follow-up|1|||
28006568|NCT00734162|54665364|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
28006569|NCT00734162|54665365|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
28006570|NCT00734162|54665366|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
28103430|NCT03351608|54760020|FG003|Overall Study|Physician Decision|2|||
28103431|NCT03351608|54760021|FG004|Overall Study|Physician Decision|1|||
28103432|NCT03351608|54760017|FG000|Overall Study|Randomized by mistake, no treatment given|0|||
28103433|NCT03351608|54760018|FG001|Overall Study|Randomized by mistake, no treatment given|0|||
28103434|NCT03351608|54760019|FG002|Overall Study|Randomized by mistake, no treatment given|0|||
28103435|NCT03351608|54760020|FG003|Overall Study|Randomized by mistake, no treatment given|1|||
28103436|NCT03351608|54760021|FG004|Overall Study|Randomized by mistake, no treatment given|0|||
28103437|NCT03351608|54760017|FG000|Overall Study|Withdrawal by parent/guardian|0|||
28103438|NCT03351608|54760018|FG001|Overall Study|Withdrawal by parent/guardian|0|||
28103439|NCT03351608|54760019|FG002|Overall Study|Withdrawal by parent/guardian|1|||
28103440|NCT03351608|54760020|FG003|Overall Study|Withdrawal by parent/guardian|1|||
28103441|NCT03351608|54760021|FG004|Overall Study|Withdrawal by parent/guardian|0|||
28103442|NCT03351608|54760017|FG000|Overall Study|Other|0|||
28103443|NCT03351608|54760018|FG001|Overall Study|Other|1|||
28103444|NCT03351608|54760019|FG002|Overall Study|Other|1|||
28103445|NCT03351608|54760020|FG003|Overall Study|Other|3|||
28103446|NCT03351608|54760021|FG004|Overall Study|Other|0|||
28103447|NCT02857816|54760044|FG000|Overall Study|Screen Failure|33|||
28103448|NCT02857816|54760044|FG000|Overall Study|Withdrawal by Subject|4|||
28173219|NCT03188666|54845089|FG001|Period 3 (20 Weeks Follow-up)|Death|0|||
28173220|NCT03188666|54845090|FG002|Period 3 (20 Weeks Follow-up)|Death|1|||
28173221|NCT03188666|54845091|FG003|Period 3 (20 Weeks Follow-up)|Death|2|||
28173222|NCT02836769|54845105|FG000|Overall Study|Lost to Follow-up|10|||
27917213|NCT01327053|54574696|FG000|Overall Study|Adverse Event|23|||
27917214|NCT01327053|54574697|FG001|Overall Study|Adverse Event|57|||
27917215|NCT01327053|54574696|FG000|Overall Study|Patient/guardian decision|11|||
27917216|NCT01327053|54574697|FG001|Overall Study|Patient/guardian decision|35|||
27917217|NCT01327053|54574696|FG000|Overall Study|Physician Decision|10|||
27917218|NCT01327053|54574697|FG001|Overall Study|Physician Decision|14|||
27917219|NCT01327053|54574696|FG000|Overall Study|Death|1|||
27917220|NCT01327053|54574697|FG001|Overall Study|Death|5|||
27917221|NCT01327053|54574696|FG000|Overall Study|Lost to Follow-up|2|||
27917222|NCT01327053|54574697|FG001|Overall Study|Lost to Follow-up|4|||
27917223|NCT01327053|54574696|FG000|Overall Study|Non-compliance with study treatment|0|||
27917224|NCT01327053|54574697|FG001|Overall Study|Non-compliance with study treatment|5|||
27917225|NCT01327053|54574696|FG000|Overall Study|Study terminated by Sponsor|1|||
27917226|NCT01327053|54574697|FG001|Overall Study|Study terminated by Sponsor|3|||
27917227|NCT01327053|54574696|FG000|Overall Study|Progressive disease|31|||
27917228|NCT01327053|54574697|FG001|Overall Study|Progressive disease|26|||
28006571|NCT00734162|54665367|FG003|Open-Label Phase|Did Not Meet Entrance Criteria|1|||
28173223|NCT02836769|54845105|FG000|Overall Study|Medical withdrawal|2|||
28173224|NCT02836769|54845105|FG000|Overall Study|Withdrawal by Subject|3|||
28173225|NCT02836613|54845111|FG000|Overall Study|Accidental drowning|1|||
27740012|NCT02786537|54189678|FG001|As Treated|Advised to stop tx after loss of meds|1|||
27917229|NCT01327053|54574696|FG000|Overall Study|Protocol Violation|0|||
28006572|NCT00790751|54665385|FG000|Overall Study|Protocol non-compliance|16|||
28006573|NCT00790751|54665386|FG001|Overall Study|Protocol non-compliance|16|||
27917230|NCT01327053|54574697|FG001|Overall Study|Protocol Violation|1|||
27917231|NCT01327053|54574696|FG000|Overall Study|Untreated|0|||
28103449|NCT02857816|54760044|FG000|Overall Study|Lost to Follow-up|1|||
28173226|NCT02836613|54845112|FG001|Overall Study|Accidental drowning|0|||
28173227|NCT02836613|54845111|FG000|Overall Study|Lost to Follow-up|0|||
28173228|NCT02836613|54845112|FG001|Overall Study|Lost to Follow-up|1|||
28173229|NCT02836613|54845111|FG000|Overall Study|Withdrawal by Subject|0|||
28173230|NCT02836613|54845112|FG001|Overall Study|Withdrawal by Subject|2|||
28173231|NCT02397460|54845126|FG000|Treatment Period 2|Adverse Event|0|||
28173232|NCT02397460|54845127|FG001|Treatment Period 2|Adverse Event|0|||
28173233|NCT02397460|54845128|FG002|Treatment Period 2|Adverse Event|0|||
28173234|NCT02397460|54845129|FG003|Treatment Period 2|Adverse Event|0|||
28173235|NCT02397460|54845130|FG004|Treatment Period 2|Adverse Event|0|||
28173236|NCT02397460|54845131|FG005|Treatment Period 2|Adverse Event|0|||
28173237|NCT02397460|54845132|FG006|Treatment Period 2|Adverse Event|0|||
28173238|NCT02397460|54845133|FG007|Treatment Period 2|Adverse Event|1|||
28173239|NCT02397460|54845126|FG000|Treatment Period 4|Adverse Event|0|||
28173240|NCT02397460|54845127|FG001|Treatment Period 4|Adverse Event|1|||
28173241|NCT02397460|54845128|FG002|Treatment Period 4|Adverse Event|0|||
28173242|NCT02397460|54845129|FG003|Treatment Period 4|Adverse Event|0|||
28173243|NCT02397460|54845130|FG004|Treatment Period 4|Adverse Event|0|||
28173244|NCT02397460|54845131|FG005|Treatment Period 4|Adverse Event|0|||
28173245|NCT02397460|54845132|FG006|Treatment Period 4|Adverse Event|0|||
28173246|NCT02397460|54845133|FG007|Treatment Period 4|Adverse Event|0|||
28173247|NCT02397460|54845126|FG000|Treatment Period 4|Physician Decision|0|||
28173248|NCT02397460|54845127|FG001|Treatment Period 4|Physician Decision|0|||
28173249|NCT02397460|54845128|FG002|Treatment Period 4|Physician Decision|0|||
28173250|NCT02397460|54845129|FG003|Treatment Period 4|Physician Decision|0|||
28173251|NCT02397460|54845130|FG004|Treatment Period 4|Physician Decision|1|||
28173252|NCT02397460|54845131|FG005|Treatment Period 4|Physician Decision|0|||
28173253|NCT02397460|54845132|FG006|Treatment Period 4|Physician Decision|0|||
28173254|NCT02397460|54845133|FG007|Treatment Period 4|Physician Decision|0|||
28173255|NCT02834819|54845209|FG000|Overall Study|Did not complete 7 day follow up call.|5|||
28173256|NCT02834819|54845210|FG001|Overall Study|Did not complete 7 day follow up call.|0|||
28173257|NCT02454478|54845216|FG000|Overall Study|Incomplete DLT Evaluation|1|||
28173258|NCT01341587|54845222|FG000|Overall Study|Lost to Follow-up|2|||
28173259|NCT01341587|54845223|FG001|Overall Study|Lost to Follow-up|0|||
28173260|NCT01341587|54845222|FG000|Overall Study|stopped using the meters|2|||
28173261|NCT01341587|54845223|FG001|Overall Study|stopped using the meters|10|||
28173262|NCT01358825|54845231|FG000|Overall Study|Blood sample not drawn|0|||
28173263|NCT01358825|54845232|FG001|Overall Study|Blood sample not drawn|1|||
28173264|NCT02453386|54845241|FG000|Overall Study|Adverse Event|22|||
28173265|NCT02453386|54845242|FG001|Overall Study|Adverse Event|30|||
28173266|NCT02453386|54845243|FG002|Overall Study|Adverse Event|15|||
28173267|NCT02453386|54845241|FG000|Overall Study|Protocol Violation|1|||
28173268|NCT02453386|54845242|FG001|Overall Study|Protocol Violation|0|||
28173269|NCT02453386|54845243|FG002|Overall Study|Protocol Violation|1|||
28173270|NCT02453386|54845241|FG000|Overall Study|Withdrawal by Subject|10|||
28173271|NCT02453386|54845242|FG001|Overall Study|Withdrawal by Subject|9|||
28173272|NCT02453386|54845243|FG002|Overall Study|Withdrawal by Subject|9|||
28173273|NCT02453386|54845241|FG000|Overall Study|Sponsor Terminated Study|14|||
28173274|NCT02453386|54845242|FG001|Overall Study|Sponsor Terminated Study|8|||
28173275|NCT02453386|54845243|FG002|Overall Study|Sponsor Terminated Study|11|||
28173276|NCT02453386|54845241|FG000|Overall Study|Subject Terminated by Sponsor|1|||
28173277|NCT02453386|54845242|FG001|Overall Study|Subject Terminated by Sponsor|1|||
28173278|NCT02453386|54845243|FG002|Overall Study|Subject Terminated by Sponsor|1|||
28173279|NCT02453386|54845241|FG000|Overall Study|Sponsor Terminated by Investigator|0|||
28173280|NCT02453386|54845242|FG001|Overall Study|Sponsor Terminated by Investigator|1|||
28173281|NCT02453386|54845243|FG002|Overall Study|Sponsor Terminated by Investigator|2|||
28173282|NCT02453386|54845241|FG000|Overall Study|Lost to Follow-up|0|||
28173283|NCT02453386|54845242|FG001|Overall Study|Lost to Follow-up|0|||
28173284|NCT02453386|54845243|FG002|Overall Study|Lost to Follow-up|1|||
28173285|NCT02453386|54845241|FG000|Overall Study|Other|1|||
28173286|NCT02453386|54845242|FG001|Overall Study|Other|0|||
28173287|NCT02453386|54845243|FG002|Overall Study|Other|1|||
27917232|NCT01327053|54574697|FG001|Overall Study|Untreated|1|||
27917233|NCT01107925|54574711|FG000|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
27917234|NCT01107925|54574712|FG001|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
27917235|NCT01107925|54574713|FG002|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
27917236|NCT01107925|54574714|FG003|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
27917237|NCT01107925|54574715|FG004|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
28173288|NCT02431468|54845261|FG000|Overall Study|Adverse Event|2|||
28173289|NCT02431468|54845262|FG001|Overall Study|Adverse Event|4|||
28173290|NCT02431468|54845263|FG002|Overall Study|Adverse Event|5|||
28173291|NCT02431468|54845261|FG000|Overall Study|Withdrawal by Subject|4|||
28173292|NCT02431468|54845262|FG001|Overall Study|Withdrawal by Subject|12|||
28173293|NCT02431468|54845263|FG002|Overall Study|Withdrawal by Subject|2|||
28173294|NCT02431468|54845261|FG000|Overall Study|noncompliance, investigator termination,|2|||
28173295|NCT02431468|54845262|FG001|Overall Study|noncompliance, investigator termination,|2|||
28173296|NCT02431468|54845263|FG002|Overall Study|noncompliance, investigator termination,|2|||
28173297|NCT02452762|54845279|FG000|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|4|||
28173298|NCT02452762|54845280|FG001|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|3|||
28173299|NCT02452762|54845279|FG000|Overall Study|Withdrawal by Subject|1|||
28173300|NCT02452762|54845280|FG001|Overall Study|Withdrawal by Subject|0|||
28173301|NCT02631746|54845287|FG000|Overall Study|Lack of Efficacy|3|||
28173302|NCT02633306|54845291|FG000|Overall Study|Withdrawal by Subject|3|||
28173303|NCT02396758|54845300|FG000|Overall Study|Withdrawal by Subject|2|||
28173304|NCT02396758|54845301|FG001|Overall Study|Withdrawal by Subject|0|||
28173305|NCT02396758|54845302|FG002|Overall Study|Withdrawal by Subject|0|||
28173306|NCT02396758|54845303|FG003|Overall Study|Withdrawal by Subject|1|||
28173307|NCT02396758|54845300|FG000|Overall Study|Lost to Follow-up|8|||
28173308|NCT02396758|54845301|FG001|Overall Study|Lost to Follow-up|5|||
28173309|NCT02396758|54845302|FG002|Overall Study|Lost to Follow-up|3|||
28173310|NCT02396758|54845303|FG003|Overall Study|Lost to Follow-up|3|||
28173311|NCT02396758|54845300|FG000|Overall Study|Death|1|||
28173312|NCT02396758|54845301|FG001|Overall Study|Death|1|||
28173313|NCT02396758|54845302|FG002|Overall Study|Death|0|||
28173314|NCT02396758|54845303|FG003|Overall Study|Death|1|||
28173315|NCT02396758|54845300|FG000|Overall Study|Randomized but not treated|1|||
28173316|NCT02396758|54845301|FG001|Overall Study|Randomized but not treated|0|||
28173317|NCT02396758|54845302|FG002|Overall Study|Randomized but not treated|1|||
28173318|NCT02396758|54845303|FG003|Overall Study|Randomized but not treated|0|||
28173319|NCT02632838|54845315|FG000|Overall Study|Withdrawal by Subject|3|||
28173320|NCT02632838|54845316|FG001|Overall Study|Withdrawal by Subject|0|||
28173321|NCT02632838|54845315|FG000|Overall Study|Lost to Follow-up|0|||
28173322|NCT02632838|54845316|FG001|Overall Study|Lost to Follow-up|2|||
28173323|NCT02396212|54845326|FG000|Overall Study|Adverse Event|1|||
28173324|NCT02396212|54845326|FG000|Overall Study|Lack of Efficacy|2|||
28173325|NCT02395822|54845330|FG000|Overall Study|Withdrawal by Subject|1|||
28173326|NCT02395822|54845330|FG000|Overall Study|Death|1|||
28173327|NCT01651936|54845336|FG000|Base Study|Adverse Event|3|||
28173328|NCT01651936|54845337|FG001|Base Study|Adverse Event|0|||
28173329|NCT01651936|54845338|FG002|Base Study|Adverse Event|0|||
28173330|NCT01651936|54845336|FG000|Base Study|Withdrawal by Subject|1|||
28173331|NCT01651936|54845337|FG001|Base Study|Withdrawal by Subject|1|||
28173332|NCT01651936|54845338|FG002|Base Study|Withdrawal by Subject|0|||
28173333|NCT01651936|54845336|FG000|Base Study|Early Escape|2|||
28173334|NCT01651936|54845337|FG001|Base Study|Early Escape|8|||
28173335|NCT01651936|54845338|FG002|Base Study|Early Escape|0|||
28173336|NCT01651936|54845336|FG000|Base Study|Study terminated by sponsor|21|||
28173337|NCT01651936|54845337|FG001|Base Study|Study terminated by sponsor|16|||
28173338|NCT01651936|54845338|FG002|Base Study|Study terminated by sponsor|0|||
28173339|NCT01651936|54845336|FG000|Extension Study|Lack of Efficacy|0|||
28173340|NCT01651936|54845337|FG001|Extension Study|Lack of Efficacy|0|||
28173341|NCT01651936|54845338|FG002|Extension Study|Lack of Efficacy|1|||
28173342|NCT01651936|54845336|FG000|Extension Study|Study terminated by sponsor|0|||
27917238|NCT01107925|54574716|FG005|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
27917239|NCT01107925|54574711|FG000|Period 2|Withdrawal by Subject|0|||
27917240|NCT01107925|54574712|FG001|Period 2|Withdrawal by Subject|1|||
27917241|NCT01107925|54574713|FG002|Period 2|Withdrawal by Subject|0|||
27917242|NCT01107925|54574714|FG003|Period 2|Withdrawal by Subject|0|||
27917243|NCT01107925|54574715|FG004|Period 2|Withdrawal by Subject|0|||
27917244|NCT01107925|54574716|FG005|Period 2|Withdrawal by Subject|1|||
27917245|NCT01339832|54574744|FG000|Overall Study|Lost to Follow-up|3|||
27917246|NCT01339832|54574744|FG000|Overall Study|Death|11|||
27917247|NCT01339559|54574748|FG000|Overall Study|Adverse Event|92|||
28006574|NCT00790751|54665387|FG002|Overall Study|Protocol non-compliance|10|||
28006575|NCT00790751|54665388|FG003|Overall Study|Protocol non-compliance|11|||
28006576|NCT00790751|54665385|FG000|Overall Study|Lost to Follow-up|4|||
28006577|NCT00790751|54665386|FG001|Overall Study|Lost to Follow-up|9|||
28006578|NCT00790751|54665387|FG002|Overall Study|Lost to Follow-up|4|||
28006579|NCT00790751|54665388|FG003|Overall Study|Lost to Follow-up|5|||
28006580|NCT00790751|54665385|FG000|Overall Study|Adverse Event|5|||
28006581|NCT00790751|54665386|FG001|Overall Study|Adverse Event|3|||
28006582|NCT00790751|54665387|FG002|Overall Study|Adverse Event|5|||
28173343|NCT01651936|54845337|FG001|Extension Study|Study terminated by sponsor|0|||
28173344|NCT01651936|54845338|FG002|Extension Study|Study terminated by sponsor|13|||
28173345|NCT02395042|54845348|FG000|Treatment 1 Period|Adverse Event|1|||
28173346|NCT02395042|54845349|FG001|Treatment 1 Period|Adverse Event|3|||
28173347|NCT02395042|54845350|FG002|Treatment 1 Period|Adverse Event|1|||
28173348|NCT02395042|54845348|FG000|Treatment 1 Period|Lack of Efficacy|1|||
28173349|NCT02395042|54845349|FG001|Treatment 1 Period|Lack of Efficacy|1|||
28173350|NCT02395042|54845350|FG002|Treatment 1 Period|Lack of Efficacy|0|||
28173351|NCT02395042|54845348|FG000|Treatment 1 Period|Lost to Follow-up|1|||
27917248|NCT01339559|54574748|FG000|Overall Study|Death|5|||
28006583|NCT00790751|54665388|FG003|Overall Study|Adverse Event|4|||
28173352|NCT02395042|54845349|FG001|Treatment 1 Period|Lost to Follow-up|0|||
28173353|NCT02395042|54845350|FG002|Treatment 1 Period|Lost to Follow-up|0|||
28173354|NCT02395042|54845348|FG000|Treatment 1 Period|Other Miscellaneous Reasons|0|||
28173355|NCT02395042|54845349|FG001|Treatment 1 Period|Other Miscellaneous Reasons|2|||
28173356|NCT02395042|54845350|FG002|Treatment 1 Period|Other Miscellaneous Reasons|1|||
28173357|NCT02395042|54845348|FG000|Treatment 2 Period|Lack of Efficacy|1|||
28173358|NCT02395042|54845349|FG001|Treatment 2 Period|Lack of Efficacy|1|||
28173359|NCT02395042|54845350|FG002|Treatment 2 Period|Lack of Efficacy|0|||
28173360|NCT02394808|54845361|FG000|Period 1|Unsatisfactory lens fitting|0|||
28173361|NCT02394808|54845362|FG001|Period 1|Unsatisfactory lens fitting|1|||
28173362|NCT02394808|54845361|FG000|Period 2|Lost to Follow-up|1|||
28173363|NCT02394808|54845362|FG001|Period 2|Lost to Follow-up|0|||
28173364|NCT02630966|54845370|FG000|Overall Study|Adverse Event|1|||
28173365|NCT02630966|54845371|FG001|Overall Study|Adverse Event|3|||
28173366|NCT02630966|54845370|FG000|Overall Study|Significant Protocol Deviation|0|||
28173367|NCT02630966|54845371|FG001|Overall Study|Significant Protocol Deviation|2|||
28173368|NCT02630966|54845370|FG000|Overall Study|Voluntary Withdrawal|1|||
28173369|NCT02630966|54845371|FG001|Overall Study|Voluntary Withdrawal|1|||
28173370|NCT02630966|54845370|FG000|Overall Study|Lack of Efficacy|0|||
28173371|NCT02630966|54845371|FG001|Overall Study|Lack of Efficacy|2|||
28173372|NCT01651780|54845379|FG000|Overall Study|Physician decision: No 30-day visit|2|||
28173373|NCT01651780|54845380|FG001|Overall Study|Physician decision: No 30-day visit|1|||
28173374|NCT01651780|54845379|FG000|Overall Study|Reason Not Specified: No 30-day visit|2|||
28173375|NCT01651780|54845380|FG001|Overall Study|Reason Not Specified: No 30-day visit|2|||
28173376|NCT01651780|54845379|FG000|Overall Study|Withdrawal by Subject|2|||
28173377|NCT01651780|54845380|FG001|Overall Study|Withdrawal by Subject|0|||
28173378|NCT01651780|54845379|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
28173379|NCT01651780|54845380|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
28173380|NCT01651780|54845379|FG000|Overall Study|Lost to Follow-up|1|||
28173381|NCT01651780|54845380|FG001|Overall Study|Lost to Follow-up|2|||
28173382|NCT01651780|54845379|FG000|Overall Study|Physician decision: Day 30 visit <23 day|1|||
27917249|NCT01339559|54574748|FG000|Overall Study|Lack of Efficacy|164|||
27917250|NCT01339559|54574748|FG000|Overall Study|Lost to Follow-up|22|||
27917251|NCT01339559|54574748|FG000|Overall Study|Subject choice|89|||
27917252|NCT01339559|54574748|FG000|Overall Study|Protocol Violation|15|||
27917253|NCT01339559|54574748|FG000|Overall Study|Study closure at site|1|||
27917254|NCT01339559|54574748|FG000|Overall Study|Incarcerated|2|||
27917255|NCT01339559|54574748|FG000|Overall Study|Epilepsy surgery|1|||
27917256|NCT01339559|54574748|FG000|Overall Study|Pregnancy planned|2|||
27917257|NCT01339559|54574748|FG000|Overall Study|Left the country|1|||
27917258|NCT01339559|54574748|FG000|Overall Study|Investigator decision|2|||
27917259|NCT01339559|54574748|FG000|Overall Study|Patient didn't wish to continue|1|||
28006584|NCT00790751|54665385|FG000|Overall Study|Requirement for restricted medication|0|||
28006585|NCT00790751|54665386|FG001|Overall Study|Requirement for restricted medication|2|||
28006586|NCT00790751|54665387|FG002|Overall Study|Requirement for restricted medication|0|||
28006587|NCT00790751|54665388|FG003|Overall Study|Requirement for restricted medication|0|||
28006588|NCT00790751|54665385|FG000|Overall Study|Death|0|||
28006589|NCT00790751|54665386|FG001|Overall Study|Death|0|||
28006590|NCT00790751|54665387|FG002|Overall Study|Death|1|||
28006591|NCT00790751|54665388|FG003|Overall Study|Death|0|||
28006592|NCT00790751|54665385|FG000|Overall Study|Physician Decision|0|||
28006593|NCT00790751|54665386|FG001|Overall Study|Physician Decision|0|||
28006594|NCT00790751|54665387|FG002|Overall Study|Physician Decision|0|||
28006595|NCT00790751|54665388|FG003|Overall Study|Physician Decision|1|||
28006596|NCT00784979|54665398|FG000|Overall Study|incomplete data|6|||
28006597|NCT00738920|54665405|FG000|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
28006598|NCT00738920|54665406|FG001|Baseline to 2-Week Follow-Up|Lost to Follow-up|9|||
28006599|NCT00738920|54665407|FG002|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
28006600|NCT00738920|54665405|FG000|Baseline to 2-Week Follow-Up|Withdrawal by Subject|8|||
28006601|NCT00738920|54665406|FG001|Baseline to 2-Week Follow-Up|Withdrawal by Subject|14|||
28006602|NCT00738920|54665407|FG002|Baseline to 2-Week Follow-Up|Withdrawal by Subject|7|||
28006603|NCT00738920|54665405|FG000|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|3|||
28006604|NCT00738920|54665406|FG001|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|5|||
28006605|NCT00738920|54665407|FG002|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|6|||
28006606|NCT00738920|54665405|FG000|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|5|||
28006607|NCT00738920|54665406|FG001|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|7|||
28006608|NCT00738920|54665407|FG002|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|6|||
27917260|NCT01339559|54574748|FG000|Overall Study|PI decision|1|||
28006609|NCT00738920|54665405|FG000|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|3|||
28006610|NCT00738920|54665406|FG001|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|0|||
28006611|NCT00738920|54665407|FG002|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|2|||
28006612|NCT00738920|54665405|FG000|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
28173383|NCT01651780|54845380|FG001|Overall Study|Physician decision: Day 30 visit <23 day|5|||
27917261|NCT00107900|54574759|FG000|Overall Study|Adverse Event|3|||
27917262|NCT00107900|54574760|FG001|Overall Study|Adverse Event|2|||
28173384|NCT02394730|54845392|FG000|Overall Study|Lost to Follow-up|1|||
28173385|NCT02394730|54845393|FG001|Overall Study|Lost to Follow-up|0|||
28173386|NCT02394730|54845392|FG000|Overall Study|Withdrawal by Subject|0|||
28173387|NCT02394730|54845393|FG001|Overall Study|Withdrawal by Subject|1|||
28173388|NCT02430532|54845401|FG000|Overall Study|Sponsor Decision to Stop Study Early|30|||
28173389|NCT02430532|54845402|FG001|Overall Study|Sponsor Decision to Stop Study Early|25|||
28173390|NCT02430532|54845401|FG000|Overall Study|Consent Withdrawn|0|||
28173391|NCT02430532|54845402|FG001|Overall Study|Consent Withdrawn|2|||
28173392|NCT02430532|54845401|FG000|Overall Study|Adverse Event|0|||
28173393|NCT02430532|54845402|FG001|Overall Study|Adverse Event|1|||
28173394|NCT02394340|54845410|FG000|Overall Study|Failed drug screen test|1|||
28173395|NCT02394340|54845410|FG000|Overall Study|Adverse Event|1|||
28173396|NCT01672736|54845414|FG000|Overall Study|Available drug expired on 31 May 16|3|||
28173397|NCT01560637|54845418|FG000|Overall Study|Adverse Event|63|||
28173398|NCT01560637|54845418|FG000|Overall Study|Death|69|||
28173399|NCT01560637|54845418|FG000|Overall Study|Lost to Follow-up|8|||
28173400|NCT01560637|54845418|FG000|Overall Study|Protocol Violation|8|||
28173401|NCT01560637|54845418|FG000|Overall Study|Withdrawal by Subject|24|||
28173402|NCT01560637|54845418|FG000|Overall Study|Progressive Disease|20|||
28173403|NCT01560637|54845418|FG000|Overall Study|Other Reason Not Specified|6|||
28173404|NCT01353911|54845430|FG000|Overall Study|Lost to Follow-up|2|||
28173405|NCT01353911|54845431|FG001|Overall Study|Lost to Follow-up|6|||
28173406|NCT01353911|54845432|FG002|Overall Study|Lost to Follow-up|4|||
28173407|NCT01353911|54845433|FG003|Overall Study|Lost to Follow-up|0|||
28173408|NCT01353911|54845434|FG004|Overall Study|Lost to Follow-up|4|||
28173409|NCT01353911|54845435|FG005|Overall Study|Lost to Follow-up|4|||
28173410|NCT01353911|54845436|FG006|Overall Study|Lost to Follow-up|3|||
28173411|NCT01353911|54845437|FG007|Overall Study|Lost to Follow-up|6|||
28173412|NCT01353911|54845430|FG000|Overall Study|Withdrawal by Subject|2|||
28173413|NCT01353911|54845431|FG001|Overall Study|Withdrawal by Subject|3|||
28173414|NCT01353911|54845432|FG002|Overall Study|Withdrawal by Subject|4|||
28173415|NCT01353911|54845433|FG003|Overall Study|Withdrawal by Subject|2|||
28173416|NCT01353911|54845434|FG004|Overall Study|Withdrawal by Subject|2|||
28173417|NCT01353911|54845435|FG005|Overall Study|Withdrawal by Subject|3|||
28173418|NCT01353911|54845436|FG006|Overall Study|Withdrawal by Subject|3|||
28173419|NCT01353911|54845437|FG007|Overall Study|Withdrawal by Subject|9|||
28173420|NCT01353911|54845430|FG000|Overall Study|Status Not Recorded|4|||
28173421|NCT01353911|54845431|FG001|Overall Study|Status Not Recorded|0|||
28173422|NCT01353911|54845432|FG002|Overall Study|Status Not Recorded|1|||
28173423|NCT01353911|54845433|FG003|Overall Study|Status Not Recorded|0|||
28173424|NCT01353911|54845434|FG004|Overall Study|Status Not Recorded|0|||
28173425|NCT01353911|54845435|FG005|Overall Study|Status Not Recorded|0|||
28173426|NCT01353911|54845436|FG006|Overall Study|Status Not Recorded|0|||
28173427|NCT01353911|54845437|FG007|Overall Study|Status Not Recorded|0|||
28173428|NCT01671488|54845455|FG000|Overall Study|Withdrawal by Subject|1|||
28173429|NCT02783911|54845461|FG000|Overall Study|Lost to Follow-up|3|||
27917263|NCT00107900|54574761|FG002|Overall Study|Adverse Event|10|||
27917264|NCT00107900|54574762|FG003|Overall Study|Adverse Event|3|||
28173430|NCT02783911|54845462|FG001|Overall Study|Lost to Follow-up|32|||
27917265|NCT00107900|54574763|FG004|Overall Study|Adverse Event|5|||
27917266|NCT00107900|54574764|FG005|Overall Study|Adverse Event|3|||
27917267|NCT00107900|54574759|FG000|Overall Study|Death|0|||
27917268|NCT00107900|54574760|FG001|Overall Study|Death|0|||
27917269|NCT00107900|54574761|FG002|Overall Study|Death|0|||
27917270|NCT00107900|54574762|FG003|Overall Study|Death|0|||
27917271|NCT00107900|54574763|FG004|Overall Study|Death|1|||
27917272|NCT00107900|54574764|FG005|Overall Study|Death|0|||
28103450|NCT02858440|54760049|FG000|Overall Study|Lost to Follow-up|3|||
28173431|NCT01358357|54845470|FG000|Open Label Phase|Adverse Event|0|||
28173432|NCT01358357|54845471|FG001|Open Label Phase|Adverse Event|0|||
28173433|NCT01358357|54845472|FG002|Open Label Phase|Adverse Event|59|||
28173434|NCT01358357|54845470|FG000|Open Label Phase|Lack of Efficacy|0|||
28173435|NCT01358357|54845471|FG001|Open Label Phase|Lack of Efficacy|0|||
28173436|NCT01358357|54845472|FG002|Open Label Phase|Lack of Efficacy|107|||
28173437|NCT01358357|54845470|FG000|Open Label Phase|Lost to Follow-up|0|||
28173438|NCT01358357|54845471|FG001|Open Label Phase|Lost to Follow-up|0|||
28173439|NCT01358357|54845472|FG002|Open Label Phase|Lost to Follow-up|76|||
27917273|NCT00107900|54574759|FG000|Overall Study|Lost to Follow-up|4|||
27917274|NCT00107900|54574760|FG001|Overall Study|Lost to Follow-up|1|||
27917275|NCT00107900|54574761|FG002|Overall Study|Lost to Follow-up|3|||
28103451|NCT02858440|54760049|FG000|Overall Study|Protocol Violation|2|||
28103452|NCT02858440|54760049|FG000|Overall Study|Consent withdrawal|3|||
28103453|NCT02858440|54760049|FG000|Overall Study|Migrated/moved from study area|4|||
28103454|NCT03382418|54760056|FG000|Overall Study|Withdrawal by Subject|1|||
28103455|NCT03382418|54760057|FG001|Overall Study|Withdrawal by Subject|0|||
28103456|NCT03382418|54760058|FG002|Overall Study|Withdrawal by Subject|0|||
28103457|NCT03382418|54760056|FG000|Overall Study|Lost to Follow-up|2|||
28103458|NCT03382418|54760057|FG001|Overall Study|Lost to Follow-up|3|||
28103459|NCT03382418|54760058|FG002|Overall Study|Lost to Follow-up|0|||
28173440|NCT01358357|54845470|FG000|Open Label Phase|Protocol Violation|0|||
28173441|NCT01358357|54845471|FG001|Open Label Phase|Protocol Violation|0|||
28173442|NCT01358357|54845472|FG002|Open Label Phase|Protocol Violation|45|||
28173443|NCT01358357|54845470|FG000|Open Label Phase|Withdrawal by Subject|0|||
28173444|NCT01358357|54845471|FG001|Open Label Phase|Withdrawal by Subject|0|||
28173445|NCT01358357|54845472|FG002|Open Label Phase|Withdrawal by Subject|112|||
28173446|NCT01358357|54845470|FG000|Open Label Phase|Did not meet criteria for DB phase|0|||
28173447|NCT01358357|54845471|FG001|Open Label Phase|Did not meet criteria for DB phase|0|||
28173448|NCT01358357|54845472|FG002|Open Label Phase|Did not meet criteria for DB phase|16|||
28173449|NCT01358357|54845470|FG000|Open Label Phase|Terminated at study completion|0|||
28173450|NCT01358357|54845471|FG001|Open Label Phase|Terminated at study completion|0|||
28173451|NCT01358357|54845472|FG002|Open Label Phase|Terminated at study completion|5|||
28173452|NCT01358357|54845470|FG000|Open Label Phase|Mood episode|0|||
28173453|NCT01358357|54845471|FG001|Open Label Phase|Mood episode|0|||
28173454|NCT01358357|54845472|FG002|Open Label Phase|Mood episode|42|||
28173455|NCT01358357|54845470|FG000|Double-Blind Phase|Adverse Event|8|||
28173456|NCT01358357|54845471|FG001|Double-Blind Phase|Adverse Event|5|||
28173457|NCT01358357|54845472|FG002|Double-Blind Phase|Adverse Event|0|||
28173458|NCT01358357|54845470|FG000|Double-Blind Phase|Lost to Follow-up|5|||
28173459|NCT01358357|54845471|FG001|Double-Blind Phase|Lost to Follow-up|7|||
28173460|NCT01358357|54845472|FG002|Double-Blind Phase|Lost to Follow-up|0|||
28173461|NCT01358357|54845470|FG000|Double-Blind Phase|Protocol Violation|1|||
28173462|NCT01358357|54845471|FG001|Double-Blind Phase|Protocol Violation|11|||
28173463|NCT01358357|54845472|FG002|Double-Blind Phase|Protocol Violation|0|||
28173464|NCT01358357|54845470|FG000|Double-Blind Phase|Protocol Violation|16|||
28173465|NCT01358357|54845471|FG001|Double-Blind Phase|Protocol Violation|12|||
28173466|NCT01358357|54845472|FG002|Double-Blind Phase|Protocol Violation|0|||
28173467|NCT01358357|54845470|FG000|Double-Blind Phase|Terminated at study completion|2|||
28173468|NCT01358357|54845471|FG001|Double-Blind Phase|Terminated at study completion|0|||
28173469|NCT01358357|54845472|FG002|Double-Blind Phase|Terminated at study completion|0|||
28173470|NCT01358357|54845470|FG000|Double-Blind Phase|Recurrence of mood event|48|||
28173471|NCT01358357|54845471|FG001|Double-Blind Phase|Recurrence of mood event|64|||
28173472|NCT01358357|54845472|FG002|Double-Blind Phase|Recurrence of mood event|0|||
28173473|NCT01358357|54845470|FG000|Double-Blind Phase|Administrative|0|||
28173474|NCT01358357|54845471|FG001|Double-Blind Phase|Administrative|1|||
28173475|NCT01358357|54845472|FG002|Double-Blind Phase|Administrative|0|||
28173476|NCT02831387|54845481|FG000|Overall Study|Withdrawal by Subject|1|||
28173477|NCT02831387|54845482|FG001|Overall Study|Withdrawal by Subject|1|||
28173478|NCT02831387|54845481|FG000|Overall Study|Discontinued due to stock recovery|0|||
28173479|NCT02831387|54845482|FG001|Overall Study|Discontinued due to stock recovery|1|||
28173480|NCT02831855|54845488|FG000|Open Label Phase (24 Weeks)|Adverse Event|39|||
28173481|NCT02831855|54845489|FG001|Open Label Phase (24 Weeks)|Adverse Event|0|||
28173482|NCT02831855|54845490|FG002|Open Label Phase (24 Weeks)|Adverse Event|0|||
28173483|NCT02831855|54845488|FG000|Open Label Phase (24 Weeks)|Lost to Follow-up|8|||
28173484|NCT02831855|54845489|FG001|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
28173485|NCT02831855|54845490|FG002|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
28173486|NCT02831855|54845488|FG000|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7|||
28173487|NCT02831855|54845489|FG001|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
28173488|NCT02831855|54845490|FG002|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
28173489|NCT02831855|54845488|FG000|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2|||
28173490|NCT02831855|54845489|FG001|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
28173491|NCT02831855|54845490|FG002|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
28173492|NCT02831855|54845488|FG000|Open Label Phase (24 Weeks)|Protocol Violation|5|||
28173493|NCT02831855|54845489|FG001|Open Label Phase (24 Weeks)|Protocol Violation|0|||
28173494|NCT02831855|54845490|FG002|Open Label Phase (24 Weeks)|Protocol Violation|0|||
28173495|NCT02831855|54845488|FG000|Open Label Phase (24 Weeks)|Withdrawal by Subject|6|||
28173496|NCT02831855|54845489|FG001|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
28173497|NCT02831855|54845490|FG002|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
28173498|NCT02831855|54845488|FG000|Open Label Phase (24 Weeks)|Other|4|||
28173499|NCT02831855|54845489|FG001|Open Label Phase (24 Weeks)|Other|0|||
28173500|NCT02831855|54845490|FG002|Open Label Phase (24 Weeks)|Other|0|||
28173501|NCT02831855|54845488|FG000|Double Blind Phase (24 Weeks)|Adverse Event|0|||
28173502|NCT02831855|54845489|FG001|Double Blind Phase (24 Weeks)|Adverse Event|6|||
28173503|NCT02831855|54845490|FG002|Double Blind Phase (24 Weeks)|Adverse Event|6|||
28173504|NCT02831855|54845488|FG000|Double Blind Phase (24 Weeks)|Death|0|||
28173505|NCT02831855|54845489|FG001|Double Blind Phase (24 Weeks)|Death|0|||
28173506|NCT02831855|54845490|FG002|Double Blind Phase (24 Weeks)|Death|2|||
28173507|NCT02831855|54845488|FG000|Double Blind Phase (24 Weeks)|Lost to Follow-up|0|||
28173508|NCT02831855|54845489|FG001|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
28173509|NCT02831855|54845490|FG002|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
28173510|NCT02831855|54845488|FG000|Double Blind Phase (24 Weeks)|Screen Failure|0|||
27917276|NCT00107900|54574762|FG003|Overall Study|Lost to Follow-up|2|||
28173511|NCT02831855|54845489|FG001|Double Blind Phase (24 Weeks)|Screen Failure|1|||
28173512|NCT02831855|54845490|FG002|Double Blind Phase (24 Weeks)|Screen Failure|0|||
28173513|NCT02831855|54845488|FG000|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0|||
28173514|NCT02831855|54845489|FG001|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5|||
28173515|NCT02831855|54845490|FG002|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2|||
28173516|NCT02831855|54845488|FG000|Double Blind Phase (24 Weeks)|Other|0|||
28173517|NCT02831855|54845489|FG001|Double Blind Phase (24 Weeks)|Other|2|||
28173518|NCT02831855|54845490|FG002|Double Blind Phase (24 Weeks)|Other|5|||
28173519|NCT02831855|54845488|FG000|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0|||
28173520|NCT02831855|54845489|FG001|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6|||
28173521|NCT02831855|54845490|FG002|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1|||
28173522|NCT02831855|54845488|FG000|Double Blind Phase (24 Weeks)|Protocol Violation|0|||
28173523|NCT02831855|54845489|FG001|Double Blind Phase (24 Weeks)|Protocol Violation|5|||
28173524|NCT02831855|54845490|FG002|Double Blind Phase (24 Weeks)|Protocol Violation|2|||
28173525|NCT02831855|54845488|FG000|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
27917277|NCT00107900|54574763|FG004|Overall Study|Lost to Follow-up|5|||
28173526|NCT02831855|54845489|FG001|Double Blind Phase (24 Weeks)|Randomized but not Treated|3|||
28173527|NCT02831855|54845490|FG002|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
28173528|NCT02628938|54845503|FG000|Overall Study|Did not attend the follow up recall|2|||
28173529|NCT02628938|54845504|FG001|Overall Study|Did not attend the follow up recall|2|||
28173530|NCT02628938|54845505|FG002|Overall Study|Did not attend the follow up recall|1|||
28173531|NCT02628938|54845503|FG000|Overall Study|Failure to comply with the instructions|3|||
28173532|NCT02628938|54845504|FG001|Overall Study|Failure to comply with the instructions|0|||
28173533|NCT02628938|54845505|FG002|Overall Study|Failure to comply with the instructions|3|||
28173534|NCT01356407|54845519|FG000|Overall Study|Lost to Follow-up|2|||
28173535|NCT01356407|54845520|FG001|Overall Study|Lost to Follow-up|0|||
28173536|NCT01356407|54845519|FG000|Overall Study|Patient Withdrew Consent|2|||
28173537|NCT01356407|54845520|FG001|Overall Study|Patient Withdrew Consent|1|||
28173538|NCT01356407|54845519|FG000|Overall Study|Could not afford IMP administration|0|||
28173539|NCT01356407|54845520|FG001|Overall Study|Could not afford IMP administration|1|||
28173540|NCT01356407|54845519|FG000|Overall Study|Not complete Endoscopy|2|||
28173541|NCT01356407|54845520|FG001|Overall Study|Not complete Endoscopy|2|||
28173542|NCT00109837|54845526|FG000|Overall Study|Adverse Event|2|||
28173543|NCT00109837|54845526|FG000|Overall Study|Refusal unrelated to adverse effects|1|||
28173544|NCT00109837|54845526|FG000|Overall Study|Death|1|||
28173545|NCT00109837|54845526|FG000|Overall Study|BCR/ABL+ or Ph+|17|||
28173546|NCT00109837|54845526|FG000|Overall Study|Not treated|1|||
28173547|NCT00109837|54845526|FG000|Overall Study|Ineligible|1|||
28173548|NCT02828111|54845539|FG000|Overall Study|Withdrawal by Subject|0|||
28173549|NCT02828111|54845540|FG001|Overall Study|Withdrawal by Subject|0|||
28173550|NCT02828111|54845541|FG002|Overall Study|Withdrawal by Subject|2|||
28173551|NCT02828111|54845542|FG003|Overall Study|Withdrawal by Subject|0|||
28173552|NCT02828111|54845543|FG004|Overall Study|Withdrawal by Subject|0|||
28173553|NCT02828111|54845539|FG000|Overall Study|Lost to Follow-up|0|||
28173554|NCT02828111|54845540|FG001|Overall Study|Lost to Follow-up|0|||
28173555|NCT02828111|54845541|FG002|Overall Study|Lost to Follow-up|0|||
28173556|NCT02828111|54845542|FG003|Overall Study|Lost to Follow-up|1|||
28173557|NCT02828111|54845543|FG004|Overall Study|Lost to Follow-up|1|||
28173558|NCT01671332|54845566|FG000|Overall Study|Withdrawal by Subject|1|||
27917278|NCT00107900|54574764|FG005|Overall Study|Lost to Follow-up|5|||
27917279|NCT00107900|54574759|FG000|Overall Study|Protocol Violation|1|||
27917280|NCT00107900|54574760|FG001|Overall Study|Protocol Violation|0|||
28006613|NCT00738920|54665406|FG001|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|0|||
28006614|NCT00738920|54665407|FG002|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
28006615|NCT00738920|54665405|FG000|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|2|||
28006616|NCT00738920|54665406|FG001|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|4|||
28173559|NCT01671332|54845567|FG001|Overall Study|Withdrawal by Subject|1|||
28173560|NCT01355627|54845575|FG000|Overall Study|Request By the Patient to Discontinue|5|||
28173561|NCT01355627|54845576|FG001|Overall Study|Request By the Patient to Discontinue|7|||
27917281|NCT00107900|54574761|FG002|Overall Study|Protocol Violation|5|||
27917282|NCT00107900|54574762|FG003|Overall Study|Protocol Violation|5|||
27917283|NCT00107900|54574763|FG004|Overall Study|Protocol Violation|7|||
27917284|NCT00107900|54574764|FG005|Overall Study|Protocol Violation|0|||
27917285|NCT00107900|54574759|FG000|Overall Study|Withdrawal by Subject|1|||
27917286|NCT00107900|54574760|FG001|Overall Study|Withdrawal by Subject|0|||
27917287|NCT00107900|54574761|FG002|Overall Study|Withdrawal by Subject|5|||
28173562|NCT01355627|54845575|FG000|Overall Study|Lost to Follow-up|8|||
28173563|NCT01355627|54845576|FG001|Overall Study|Lost to Follow-up|7|||
28173564|NCT01355627|54845575|FG000|Overall Study|Fatal Adverse Event|19|||
28173565|NCT01355627|54845576|FG001|Overall Study|Fatal Adverse Event|23|||
27917288|NCT00107900|54574762|FG003|Overall Study|Withdrawal by Subject|0|||
27917289|NCT00107900|54574763|FG004|Overall Study|Withdrawal by Subject|1|||
27917290|NCT00107900|54574764|FG005|Overall Study|Withdrawal by Subject|1|||
28173566|NCT01355627|54845575|FG000|Overall Study|Other|1|||
28173567|NCT01355627|54845576|FG001|Overall Study|Other|1|||
28173568|NCT00100802|54845582|FG000|Overall Study|Adverse Event|9|||
28173569|NCT00100802|54845582|FG000|Overall Study|Death|1|||
28006617|NCT00738920|54665407|FG002|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|7|||
28173570|NCT00100802|54845582|FG000|Overall Study|Lack of Efficacy|47|||
28173571|NCT00100802|54845582|FG000|Overall Study|Physician Decision|5|||
28006618|NCT00738920|54665405|FG000|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|2|||
28006619|NCT00738920|54665406|FG001|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|3|||
28006620|NCT00738920|54665407|FG002|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|5|||
28006621|NCT00738920|54665405|FG000|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
28006622|NCT00738920|54665406|FG001|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|0|||
28006623|NCT00738920|54665407|FG002|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
28006624|NCT00738920|54665405|FG000|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
28006625|NCT00738920|54665406|FG001|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|1|||
28173572|NCT00100802|54845582|FG000|Overall Study|Protocol Violation|1|||
28173573|NCT00100802|54845582|FG000|Overall Study|Withdrawal by Subject|5|||
28006626|NCT00738920|54665407|FG002|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
28006627|NCT00582972|54665415|FG000|Overall Study|Protocol Violation|2|||
28006628|NCT04319718|54665422|FG000|Overall Study|Adverse Event|0|||
28006629|NCT04319718|54665423|FG001|Overall Study|Adverse Event|2|||
28006630|NCT04319718|54665422|FG000|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|1|||
28006631|NCT04319718|54665423|FG001|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|0|||
28006632|NCT04372602|54665431|FG000|Overall Study|Withdrawal by Subject|1|||
28006633|NCT04372602|54665432|FG001|Overall Study|Withdrawal by Subject|1|||
28006634|NCT04372602|54665431|FG000|Overall Study|Adverse Event|0|||
28173574|NCT00100802|54845582|FG000|Overall Study|Ineligible|12|||
28173575|NCT01355159|54845588|FG000|Overall Study|Withdrew consent|39|||
28173576|NCT01355159|54845589|FG001|Overall Study|Withdrew consent|47|||
28173577|NCT01355159|54845588|FG000|Overall Study|No primary outcome data|17|||
28173578|NCT01355159|54845589|FG001|Overall Study|No primary outcome data|11|||
28173579|NCT01355159|54845588|FG000|Overall Study|Spontaneous abortion (<20 weeks)|22|||
28173580|NCT01355159|54845589|FG001|Overall Study|Spontaneous abortion (<20 weeks)|15|||
28173581|NCT01355159|54845588|FG000|Overall Study|Early intrauterine fetal death|6|||
28173582|NCT01355159|54845589|FG001|Overall Study|Early intrauterine fetal death|6|||
28173583|NCT02630186|54845595|FG000|Overall Study|Withdrawal by Subject|1|||
28173584|NCT01669928|54845601|FG000|First Intervention|Withdrawal by Subject|3|||
28173585|NCT01669928|54845602|FG001|First Intervention|Withdrawal by Subject|5|||
28173586|NCT01355081|54845613|FG000|Overall Study|Pretreatment Event or Adverse Event|3|||
28173587|NCT01355081|54845614|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
28173588|NCT01355081|54845615|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
28173589|NCT01355081|54845613|FG000|Overall Study|Major Protocol Deviation|0|||
28173590|NCT01355081|54845614|FG001|Overall Study|Major Protocol Deviation|1|||
28173591|NCT01355081|54845615|FG002|Overall Study|Major Protocol Deviation|0|||
28173592|NCT01355081|54845613|FG000|Overall Study|Lost to Follow-up|0|||
28173593|NCT01355081|54845614|FG001|Overall Study|Lost to Follow-up|0|||
28173594|NCT01355081|54845615|FG002|Overall Study|Lost to Follow-up|1|||
28173595|NCT01355081|54845613|FG000|Overall Study|Withdrawal of Consent|2|||
28173596|NCT01355081|54845614|FG001|Overall Study|Withdrawal of Consent|3|||
28173597|NCT01355081|54845615|FG002|Overall Study|Withdrawal of Consent|3|||
28173598|NCT01355081|54845613|FG000|Overall Study|Lack of Efficacy|2|||
28173599|NCT01355081|54845614|FG001|Overall Study|Lack of Efficacy|1|||
28173600|NCT01355081|54845615|FG002|Overall Study|Lack of Efficacy|1|||
28173601|NCT01355081|54845613|FG000|Overall Study|Non Compliance with Study Medication|0|||
28173602|NCT01355081|54845614|FG001|Overall Study|Non Compliance with Study Medication|1|||
28173603|NCT01355081|54845615|FG002|Overall Study|Non Compliance with Study Medication|0|||
28173604|NCT01354223|54845625|FG000|Overall Study|Withdrawal by Subject|3|||
27917291|NCT00107900|54574759|FG000|Overall Study|Administrative Reasons|1|||
27917292|NCT00107900|54574760|FG001|Overall Study|Administrative Reasons|0|||
27917293|NCT00107900|54574761|FG002|Overall Study|Administrative Reasons|2|||
27917294|NCT00107900|54574762|FG003|Overall Study|Administrative Reasons|2|||
27917295|NCT00107900|54574763|FG004|Overall Study|Administrative Reasons|2|||
27917296|NCT00107900|54574764|FG005|Overall Study|Administrative Reasons|0|||
27917297|NCT01339052|54574780|FG000|Overall Study|Disease progression|13|||
28173605|NCT01354223|54845626|FG001|Overall Study|Withdrawal by Subject|1|||
28173606|NCT04043455|54845636|FG000|Main Study Double-Blind Treatment Period|Adverse Event|2|||
28173607|NCT04043455|54845637|FG001|Main Study Double-Blind Treatment Period|Adverse Event|3|||
28173608|NCT04043455|54845638|FG002|Main Study Double-Blind Treatment Period|Adverse Event|2|||
28173609|NCT04043455|54845639|FG003|Main Study Double-Blind Treatment Period|Adverse Event|3|||
27917298|NCT01339052|54574781|FG001|Overall Study|Disease progression|46|||
27917299|NCT01339052|54574780|FG000|Overall Study|Adverse Event|1|||
27917300|NCT01339052|54574781|FG001|Overall Study|Adverse Event|1|||
28006635|NCT04372602|54665432|FG001|Overall Study|Adverse Event|1|||
28173610|NCT04043455|54845640|FG004|Main Study Double-Blind Treatment Period|Adverse Event|0|||
28173611|NCT04043455|54845641|FG005|Main Study Double-Blind Treatment Period|Adverse Event|0|||
28173612|NCT04043455|54845636|FG000|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
28173613|NCT04043455|54845637|FG001|Main Study Double-Blind Treatment Period|Withdrawal by Subject|5|||
28006636|NCT04372602|54665431|FG000|Overall Study|Transitioned to comfort care|0|||
28006637|NCT04372602|54665432|FG001|Overall Study|Transitioned to comfort care|1|||
28006638|NCT00733304|54665441|FG000|Overall Study|Adverse Event|3|||
28006639|NCT00733304|54665442|FG001|Overall Study|Adverse Event|0|||
28006640|NCT00733304|54665443|FG002|Overall Study|Adverse Event|0|||
28006641|NCT00733304|54665441|FG000|Overall Study|Lack of Efficacy|0|||
28006642|NCT00733304|54665442|FG001|Overall Study|Lack of Efficacy|0|||
28006643|NCT00733304|54665443|FG002|Overall Study|Lack of Efficacy|2|||
28006644|NCT00733304|54665441|FG000|Overall Study|Lost to Follow-up|0|||
28006645|NCT00733304|54665442|FG001|Overall Study|Lost to Follow-up|1|||
28006646|NCT00733304|54665443|FG002|Overall Study|Lost to Follow-up|0|||
28006647|NCT00733304|54665441|FG000|Overall Study|Physician Decision|3|||
28006648|NCT00733304|54665442|FG001|Overall Study|Physician Decision|1|||
28006649|NCT00733304|54665443|FG002|Overall Study|Physician Decision|3|||
28006650|NCT00733304|54665441|FG000|Overall Study|Withdrawal by Subject|1|||
28006651|NCT00733304|54665442|FG001|Overall Study|Withdrawal by Subject|1|||
28006652|NCT00733304|54665443|FG002|Overall Study|Withdrawal by Subject|0|||
28006653|NCT00711243|54665457|FG000|Registed and Started Treatment|Withdrawal by Subject|0|||
28006654|NCT00711243|54665458|FG001|Registed and Started Treatment|Withdrawal by Subject|0|||
28006655|NCT00711243|54665459|FG002|Registed and Started Treatment|Withdrawal by Subject|0|||
28006656|NCT00711243|54665460|FG003|Registed and Started Treatment|Withdrawal by Subject|0|||
28006657|NCT00711243|54665461|FG004|Registed and Started Treatment|Withdrawal by Subject|0|||
28006658|NCT00711243|54665462|FG005|Registed and Started Treatment|Withdrawal by Subject|1|||
28006659|NCT00711243|54665457|FG000|Reached First Response/4 Cycles|Death|0|||
28006660|NCT00711243|54665458|FG001|Reached First Response/4 Cycles|Death|0|||
28006661|NCT00711243|54665459|FG002|Reached First Response/4 Cycles|Death|0|||
28006662|NCT00711243|54665460|FG003|Reached First Response/4 Cycles|Death|0|||
28006663|NCT00711243|54665461|FG004|Reached First Response/4 Cycles|Death|0|||
28006664|NCT00711243|54665462|FG005|Reached First Response/4 Cycles|Death|2|||
28006665|NCT00711243|54665457|FG000|Reached First Response/4 Cycles|Progressive disease|0|||
28006666|NCT00711243|54665458|FG001|Reached First Response/4 Cycles|Progressive disease|0|||
28006667|NCT00711243|54665459|FG002|Reached First Response/4 Cycles|Progressive disease|0|||
28173614|NCT04043455|54845638|FG002|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
28173615|NCT04043455|54845639|FG003|Main Study Double-Blind Treatment Period|Withdrawal by Subject|9|||
28173616|NCT04043455|54845640|FG004|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
28173617|NCT04043455|54845641|FG005|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
28173618|NCT04043455|54845636|FG000|Main Study Double-Blind Treatment Period|Physician Decision|0|||
28173619|NCT04043455|54845637|FG001|Main Study Double-Blind Treatment Period|Physician Decision|2|||
28006668|NCT00711243|54665460|FG003|Reached First Response/4 Cycles|Progressive disease|1|||
28006669|NCT00711243|54665461|FG004|Reached First Response/4 Cycles|Progressive disease|0|||
28006670|NCT00711243|54665462|FG005|Reached First Response/4 Cycles|Progressive disease|0|||
28006671|NCT00711243|54665457|FG000|Treated Cycle 5 After First Response|Progressive disease|1|||
28006672|NCT00711243|54665458|FG001|Treated Cycle 5 After First Response|Progressive disease|2|||
28006673|NCT00711243|54665459|FG002|Treated Cycle 5 After First Response|Progressive disease|0|||
28006674|NCT00711243|54665460|FG003|Treated Cycle 5 After First Response|Progressive disease|0|||
28006675|NCT00711243|54665461|FG004|Treated Cycle 5 After First Response|Progressive disease|1|||
28006676|NCT00711243|54665462|FG005|Treated Cycle 5 After First Response|Progressive disease|1|||
28006677|NCT00711243|54665457|FG000|Treated Cycle 5 After First Response|Death|0|||
28006678|NCT00711243|54665458|FG001|Treated Cycle 5 After First Response|Death|0|||
28006679|NCT00711243|54665459|FG002|Treated Cycle 5 After First Response|Death|0|||
28006680|NCT00711243|54665460|FG003|Treated Cycle 5 After First Response|Death|0|||
28006681|NCT00711243|54665461|FG004|Treated Cycle 5 After First Response|Death|0|||
28006682|NCT00711243|54665462|FG005|Treated Cycle 5 After First Response|Death|2|||
28006683|NCT00711243|54665457|FG000|Treated Cycle 5 After First Response|Decline in performance status|0|||
28173620|NCT04043455|54845638|FG002|Main Study Double-Blind Treatment Period|Physician Decision|1|||
28173621|NCT04043455|54845639|FG003|Main Study Double-Blind Treatment Period|Physician Decision|0|||
28173622|NCT04043455|54845640|FG004|Main Study Double-Blind Treatment Period|Physician Decision|0|||
28173623|NCT04043455|54845641|FG005|Main Study Double-Blind Treatment Period|Physician Decision|0|||
28006684|NCT00711243|54665458|FG001|Treated Cycle 5 After First Response|Decline in performance status|0|||
28006685|NCT00711243|54665459|FG002|Treated Cycle 5 After First Response|Decline in performance status|0|||
28006686|NCT00711243|54665460|FG003|Treated Cycle 5 After First Response|Decline in performance status|0|||
28006687|NCT00711243|54665461|FG004|Treated Cycle 5 After First Response|Decline in performance status|0|||
28006688|NCT00711243|54665462|FG005|Treated Cycle 5 After First Response|Decline in performance status|1|||
28173624|NCT04043455|54845636|FG000|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
28006689|NCT00711243|54665457|FG000|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
28006690|NCT00711243|54665458|FG001|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
28173625|NCT04043455|54845637|FG001|Main Study Double-Blind Treatment Period|Lost to Follow-up|2|||
28173626|NCT04043455|54845638|FG002|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
28173627|NCT04043455|54845639|FG003|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
28173628|NCT04043455|54845640|FG004|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
28173629|NCT04043455|54845641|FG005|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
28173630|NCT04043455|54845636|FG000|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
28173631|NCT04043455|54845637|FG001|Main Study Double-Blind Treatment Period|Protocol Violation|1|||
28173632|NCT04043455|54845638|FG002|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
28173633|NCT04043455|54845639|FG003|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
28173634|NCT04043455|54845640|FG004|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
28173635|NCT04043455|54845641|FG005|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
28173636|NCT04043455|54845636|FG000|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|1|||
28173637|NCT04043455|54845637|FG001|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
28173638|NCT04043455|54845638|FG002|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
28173639|NCT04043455|54845639|FG003|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
28173640|NCT04043455|54845640|FG004|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
28173641|NCT04043455|54845641|FG005|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
28173642|NCT04043455|54845636|FG000|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
28173643|NCT04043455|54845637|FG001|Main Study Double-Blind Treatment Period|Did not receive treatment|1|||
28173644|NCT04043455|54845638|FG002|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
28173645|NCT04043455|54845639|FG003|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
28173646|NCT04043455|54845640|FG004|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
28173647|NCT04043455|54845641|FG005|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
28173648|NCT04043455|54845636|FG000|Double-Blind LTE Treatment Period|Adverse Event|0|||
28173649|NCT04043455|54845637|FG001|Double-Blind LTE Treatment Period|Adverse Event|0|||
28173650|NCT04043455|54845638|FG002|Double-Blind LTE Treatment Period|Adverse Event|0|||
28173651|NCT04043455|54845639|FG003|Double-Blind LTE Treatment Period|Adverse Event|0|||
28173652|NCT04043455|54845640|FG004|Double-Blind LTE Treatment Period|Adverse Event|0|||
28173653|NCT04043455|54845641|FG005|Double-Blind LTE Treatment Period|Adverse Event|2|||
28006691|NCT00711243|54665459|FG002|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
28006692|NCT00711243|54665460|FG003|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
28006693|NCT00711243|54665461|FG004|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
28006694|NCT00711243|54665462|FG005|Follow up Every 3 Months Until Death|Lost to Follow-up|2|||
28006695|NCT00733226|54665480|FG000|Overall Study|Withdrawal by Subject|1|||
28006696|NCT00733226|54665481|FG001|Overall Study|Withdrawal by Subject|0|||
28006697|NCT00733226|54665480|FG000|Overall Study|Lost to Follow-up|2|||
28006698|NCT00733226|54665481|FG001|Overall Study|Lost to Follow-up|0|||
28006699|NCT00733226|54665480|FG000|Overall Study|moved to another place|2|||
28006700|NCT00733226|54665481|FG001|Overall Study|moved to another place|0|||
28006701|NCT00732992|54665489|FG000|Overall Study|Adverse Event|1|||
28006702|NCT00732992|54665490|FG001|Overall Study|Adverse Event|1|||
28006703|NCT00732992|54665489|FG000|Overall Study|Objective Progression or Relapse|3|||
28006704|NCT00732992|54665490|FG001|Overall Study|Objective Progression or Relapse|5|||
28006705|NCT00732992|54665489|FG000|Overall Study|Global Deterioration of Health Status|1|||
28006706|NCT00732992|54665490|FG001|Overall Study|Global Deterioration of Health Status|0|||
28006707|NCT00732992|54665489|FG000|Overall Study|Withdrawal by Subject|1|||
28006708|NCT00732992|54665490|FG001|Overall Study|Withdrawal by Subject|0|||
28006709|NCT00732758|54665499|FG000|Overall Study|Lost to Follow-up|8|||
28006710|NCT00732758|54665500|FG001|Overall Study|Lost to Follow-up|16|||
28173654|NCT04043455|54845636|FG000|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
28173655|NCT04043455|54845637|FG001|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
28173656|NCT04043455|54845638|FG002|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
28173657|NCT04043455|54845639|FG003|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
28173658|NCT04043455|54845640|FG004|Double-Blind LTE Treatment Period|Withdrawal by Subject|5|||
28173659|NCT04043455|54845641|FG005|Double-Blind LTE Treatment Period|Withdrawal by Subject|6|||
28006711|NCT00699153|54665508|FG000|Overall Study|Lost to Follow-up|1|||
28006712|NCT00699153|54665509|FG001|Overall Study|Lost to Follow-up|0|||
28173660|NCT04043455|54845636|FG000|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
28173661|NCT04043455|54845637|FG001|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
28173662|NCT04043455|54845638|FG002|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
28173663|NCT04043455|54845639|FG003|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
28006713|NCT00699153|54665508|FG000|Overall Study|Adverse Event|0|||
28173664|NCT04043455|54845640|FG004|Double-Blind LTE Treatment Period|Lost to Follow-up|1|||
28173665|NCT04043455|54845641|FG005|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
28173666|NCT04043455|54845636|FG000|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
28173667|NCT04043455|54845637|FG001|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
28173668|NCT04043455|54845638|FG002|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
28173669|NCT04043455|54845639|FG003|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
28173670|NCT04043455|54845640|FG004|Double-Blind LTE Treatment Period|Study termination by Sponsor|47|||
28006714|NCT00699153|54665509|FG001|Overall Study|Adverse Event|2|||
28006715|NCT00699153|54665508|FG000|Overall Study|Protocol Violation|1|||
28006716|NCT00699153|54665509|FG001|Overall Study|Protocol Violation|0|||
28006717|NCT00699153|54665508|FG000|Overall Study|Travel Problem|1|||
28006718|NCT00699153|54665509|FG001|Overall Study|Travel Problem|0|||
28006719|NCT00698997|54665517|FG000|Overall Study|Lost to Follow-up|3|||
28006720|NCT00698997|54665518|FG001|Overall Study|Lost to Follow-up|0|||
28006721|NCT00698997|54665517|FG000|Overall Study|Withdrawal by Subject|7|||
28173671|NCT04043455|54845641|FG005|Double-Blind LTE Treatment Period|Study termination by Sponsor|44|||
28173672|NCT02627144|54845659|FG000|Overall Study|Serious adverse event|32|||
28173673|NCT02627144|54845659|FG000|Overall Study|Cancer progression|171|||
28173674|NCT02627144|54845659|FG000|Overall Study|Death from cancer|20|||
28173675|NCT02627144|54845659|FG000|Overall Study|Death from other cause|8|||
28173676|NCT02627144|54845659|FG000|Overall Study|Refusal of treatment / poor cooperation|38|||
28173677|NCT02627144|54845659|FG000|Overall Study|Administrative reasons|65|||
28173678|NCT02627144|54845659|FG000|Overall Study|Lost to Follow-up|8|||
28173679|NCT02627144|54845659|FG000|Overall Study|Enrolled, not treated|6|||
28173680|NCT02627144|54845659|FG000|Overall Study|Other|17|||
28173681|NCT02626520|54845665|FG000|Overall Study|Physician Decision|1|||
28173682|NCT02626520|54845666|FG001|Overall Study|Physician Decision|1|||
28173683|NCT02626520|54845665|FG000|Overall Study|Adverse Event|0|||
28173684|NCT02626520|54845666|FG001|Overall Study|Adverse Event|4|||
28173685|NCT02626520|54845665|FG000|Overall Study|Lack of Efficacy|0|||
28173686|NCT02626520|54845666|FG001|Overall Study|Lack of Efficacy|2|||
28173687|NCT02626520|54845665|FG000|Overall Study|Did not start protocol therapy|0|||
28173688|NCT02626520|54845666|FG001|Overall Study|Did not start protocol therapy|2|||
28173689|NCT02626520|54845665|FG000|Overall Study|Study terminated|0|||
28173690|NCT02626520|54845666|FG001|Overall Study|Study terminated|1|||
28173691|NCT04522141|54845674|FG000|Overall Study|Withdrawal by Subject|1|||
28173692|NCT04522141|54845675|FG001|Overall Study|Withdrawal by Subject|0|||
28173693|NCT01329029|54845698|FG000|Overall Study|Withdrawal by Subject|117|||
28173694|NCT01329029|54845699|FG001|Overall Study|Withdrawal by Subject|87|||
28173695|NCT01329029|54845698|FG000|Overall Study|Adverse Event|82|||
28173696|NCT01329029|54845699|FG001|Overall Study|Adverse Event|29|||
28173697|NCT01329029|54845698|FG000|Overall Study|Death|16|||
28173698|NCT01329029|54845699|FG001|Overall Study|Death|19|||
28173699|NCT01329029|54845698|FG000|Overall Study|Other|14|||
28173700|NCT01329029|54845699|FG001|Overall Study|Other|20|||
28173701|NCT01329029|54845698|FG000|Overall Study|COPD Exacerbation|11|||
28173702|NCT01329029|54845699|FG001|Overall Study|COPD Exacerbation|18|||
28173703|NCT01329029|54845698|FG000|Overall Study|Physician Decision|16|||
28173704|NCT01329029|54845699|FG001|Overall Study|Physician Decision|13|||
28173705|NCT01329029|54845698|FG000|Overall Study|Lost to Follow-up|8|||
28173706|NCT01329029|54845699|FG001|Overall Study|Lost to Follow-up|5|||
28173707|NCT01329029|54845698|FG000|Overall Study|Met Pre-defined Discontinuation Criteria|5|||
28173708|NCT01329029|54845699|FG001|Overall Study|Met Pre-defined Discontinuation Criteria|1|||
28173709|NCT01372085|54845715|FG000|Washout Period 2|Physician Decision|0|||
28173710|NCT01372085|54845716|FG001|Washout Period 2|Physician Decision|0|||
28173711|NCT01372085|54845717|FG002|Washout Period 2|Physician Decision|0|||
28173712|NCT01372085|54845718|FG003|Washout Period 2|Physician Decision|0|||
28173713|NCT01372085|54845719|FG004|Washout Period 2|Physician Decision|1|||
28173714|NCT01372085|54845720|FG005|Washout Period 2|Physician Decision|0|||
28173715|NCT01372085|54845721|FG006|Washout Period 2|Physician Decision|0|||
28173716|NCT01372085|54845722|FG007|Washout Period 2|Physician Decision|0|||
28173717|NCT01372085|54845723|FG008|Washout Period 2|Physician Decision|0|||
28173718|NCT01372085|54845724|FG009|Washout Period 2|Physician Decision|0|||
28173719|NCT01372085|54845715|FG000|Washout Period 3|Withdrawal by Subject|0|||
27740013|NCT02786537|54189679|FG002|As Treated|Advised to stop tx after loss of meds|0|||
28006722|NCT00698997|54665518|FG001|Overall Study|Withdrawal by Subject|27|||
28173720|NCT01372085|54845716|FG001|Washout Period 3|Withdrawal by Subject|0|||
28173721|NCT01372085|54845717|FG002|Washout Period 3|Withdrawal by Subject|0|||
28173722|NCT01372085|54845718|FG003|Washout Period 3|Withdrawal by Subject|0|||
28173723|NCT01372085|54845719|FG004|Washout Period 3|Withdrawal by Subject|0|||
28173724|NCT01372085|54845720|FG005|Washout Period 3|Withdrawal by Subject|2|||
28173725|NCT01372085|54845721|FG006|Washout Period 3|Withdrawal by Subject|0|||
28173726|NCT01372085|54845722|FG007|Washout Period 3|Withdrawal by Subject|0|||
28173727|NCT01372085|54845723|FG008|Washout Period 3|Withdrawal by Subject|0|||
28173728|NCT01372085|54845724|FG009|Washout Period 3|Withdrawal by Subject|0|||
28173729|NCT04012853|54845750|FG000|Overall Study|Withdrawal by Subject|1|||
28173730|NCT04012853|54845751|FG001|Overall Study|Withdrawal by Subject|1|||
28173731|NCT04012853|54845750|FG000|Overall Study|Protocol Violation|1|||
28173732|NCT04012853|54845751|FG001|Overall Study|Protocol Violation|0|||
28173733|NCT04012853|54845750|FG000|Overall Study|Unable to tolerate target tDCS intensity|1|||
28173734|NCT04012853|54845751|FG001|Overall Study|Unable to tolerate target tDCS intensity|0|||
28173735|NCT02941549|54845760|FG000|Overall Study|Adverse Event|1|||
28173736|NCT02941549|54845761|FG001|Overall Study|Adverse Event|0|||
28173737|NCT02941549|54845762|FG002|Overall Study|Adverse Event|0|||
28173738|NCT02941549|54845760|FG000|Overall Study|Withdrawal by Subject|2|||
28173739|NCT02941549|54845761|FG001|Overall Study|Withdrawal by Subject|1|||
28173740|NCT02941549|54845762|FG002|Overall Study|Withdrawal by Subject|2|||
28173741|NCT02394028|54845784|FG000|Induction Phase|Adverse Event|2|||
28173742|NCT02394028|54845785|FG001|Induction Phase|Adverse Event|4|||
28006723|NCT00711087|54665527|FG000|Overall Study|Lost to Follow-up|1|||
28006724|NCT00711087|54665528|FG001|Overall Study|Lost to Follow-up|0|||
28006725|NCT00738530|54665536|FG000|Overall Study|Death|220|||
28006726|NCT00738530|54665537|FG001|Overall Study|Death|224|||
28006727|NCT00738530|54665536|FG000|Overall Study|Lost to Follow-up|8|||
28006728|NCT00738530|54665537|FG001|Overall Study|Lost to Follow-up|6|||
28006729|NCT00738530|54665536|FG000|Overall Study|Withdrawal by Subject|6|||
28006730|NCT00738530|54665537|FG001|Overall Study|Withdrawal by Subject|8|||
28006731|NCT00711009|54665545|FG000|Overall Study|Adverse Event/HIV-Related Event|4|||
28173743|NCT02394028|54845786|FG002|Induction Phase|Adverse Event|1|||
28173744|NCT02394028|54845787|FG003|Induction Phase|Adverse Event|2|||
28173745|NCT02394028|54845788|FG004|Induction Phase|Adverse Event|5|||
28173746|NCT02394028|54845789|FG005|Induction Phase|Adverse Event|2|||
28173747|NCT02394028|54845790|FG006|Induction Phase|Adverse Event|0|||
28173748|NCT02394028|54845791|FG007|Induction Phase|Adverse Event|0|||
27740014|NCT02786537|54189680|FG003|As Treated|Advised to stop tx after loss of meds|0|||
27917301|NCT01339052|54574780|FG000|Overall Study|Withdrawal by Subject|0|||
27917302|NCT01339052|54574781|FG001|Overall Study|Withdrawal by Subject|3|||
27917303|NCT01339052|54574780|FG000|Overall Study|Physician Decision|1|||
27917304|NCT01339052|54574781|FG001|Overall Study|Physician Decision|0|||
27917305|NCT00107315|54574790|FG000|Overall Study|Disease Progression|9|||
27917306|NCT00107315|54574790|FG000|Overall Study|Adverse Event|4|||
27917307|NCT00107315|54574790|FG000|Overall Study|Withdrawal by Subject|2|||
27917308|NCT01335971|54574797|FG000|Overall Study|Withdrawal by Subject|1|||
27917309|NCT01335971|54574798|FG001|Overall Study|Withdrawal by Subject|0|||
27917310|NCT01335971|54574799|FG002|Overall Study|Withdrawal by Subject|0|||
27917311|NCT01335971|54574797|FG000|Overall Study|Did not complete bronchoscopy|1|||
28006732|NCT00711009|54665546|FG001|Overall Study|Adverse Event/HIV-Related Event|5|||
28006733|NCT00711009|54665545|FG000|Overall Study|Withdrawal by Subject|4|||
27917312|NCT01335971|54574798|FG001|Overall Study|Did not complete bronchoscopy|1|||
27917313|NCT01335971|54574799|FG002|Overall Study|Did not complete bronchoscopy|1|||
27917314|NCT00107276|54574807|FG000|Overall Study|Progression|46|||
27917315|NCT00107276|54574807|FG000|Overall Study|Adverse Event|6|||
27917316|NCT00107276|54574807|FG000|Overall Study|M.D. decision|2|||
27917317|NCT00107276|54574807|FG000|Overall Study|Patient refusal|1|||
27917318|NCT00107276|54574807|FG000|Overall Study|Death|1|||
27917319|NCT00107276|54574807|FG000|Overall Study|Ineligible|16|||
27917320|NCT01335698|54574817|FG000|Treatment Stage 1|Lack of Efficacy|3|||
27917321|NCT01335698|54574818|FG001|Treatment Stage 1|Lack of Efficacy|1|||
27917322|NCT01335698|54574819|FG002|Treatment Stage 1|Lack of Efficacy|3|||
27917323|NCT01335698|54574820|FG003|Treatment Stage 1|Lack of Efficacy|3|||
27917324|NCT01335698|54574821|FG004|Treatment Stage 1|Lack of Efficacy|1|||
27917325|NCT01335698|54574817|FG000|Treatment Stage 1|Adverse Event|1|||
27917326|NCT01335698|54574818|FG001|Treatment Stage 1|Adverse Event|2|||
27917327|NCT01335698|54574819|FG002|Treatment Stage 1|Adverse Event|2|||
27917328|NCT01335698|54574820|FG003|Treatment Stage 1|Adverse Event|1|||
27917329|NCT01335698|54574821|FG004|Treatment Stage 1|Adverse Event|1|||
27917330|NCT01335698|54574817|FG000|Treatment Stage 1|Withdrawal by Subject|1|||
27917331|NCT01335698|54574818|FG001|Treatment Stage 1|Withdrawal by Subject|2|||
27917332|NCT01335698|54574819|FG002|Treatment Stage 1|Withdrawal by Subject|0|||
28006734|NCT00711009|54665546|FG001|Overall Study|Withdrawal by Subject|2|||
28006735|NCT00711009|54665545|FG000|Overall Study|Lost to Follow-up|3|||
28006736|NCT00711009|54665546|FG001|Overall Study|Lost to Follow-up|9|||
28173749|NCT02394028|54845792|FG008|Induction Phase|Adverse Event|0|||
28173750|NCT02394028|54845793|FG009|Induction Phase|Adverse Event|0|||
28173751|NCT02394028|54845794|FG010|Induction Phase|Adverse Event|0|||
28173752|NCT02394028|54845784|FG000|Induction Phase|Lack of Efficacy|3|||
28173753|NCT02394028|54845785|FG001|Induction Phase|Lack of Efficacy|6|||
28173754|NCT02394028|54845786|FG002|Induction Phase|Lack of Efficacy|2|||
28173755|NCT02394028|54845787|FG003|Induction Phase|Lack of Efficacy|17|||
28173756|NCT02394028|54845788|FG004|Induction Phase|Lack of Efficacy|14|||
28173757|NCT02394028|54845789|FG005|Induction Phase|Lack of Efficacy|8|||
28173758|NCT02394028|54845790|FG006|Induction Phase|Lack of Efficacy|17|||
28173759|NCT02394028|54845791|FG007|Induction Phase|Lack of Efficacy|23|||
28173760|NCT02394028|54845792|FG008|Induction Phase|Lack of Efficacy|0|||
28173761|NCT02394028|54845793|FG009|Induction Phase|Lack of Efficacy|0|||
28173762|NCT02394028|54845794|FG010|Induction Phase|Lack of Efficacy|0|||
28173763|NCT02394028|54845784|FG000|Induction Phase|Lost to Follow-up|1|||
28173764|NCT02394028|54845785|FG001|Induction Phase|Lost to Follow-up|0|||
28173765|NCT02394028|54845786|FG002|Induction Phase|Lost to Follow-up|0|||
28173766|NCT02394028|54845787|FG003|Induction Phase|Lost to Follow-up|1|||
28173767|NCT02394028|54845788|FG004|Induction Phase|Lost to Follow-up|0|||
28173768|NCT02394028|54845789|FG005|Induction Phase|Lost to Follow-up|0|||
28173769|NCT02394028|54845790|FG006|Induction Phase|Lost to Follow-up|1|||
28173770|NCT02394028|54845791|FG007|Induction Phase|Lost to Follow-up|0|||
28173771|NCT02394028|54845792|FG008|Induction Phase|Lost to Follow-up|0|||
28173772|NCT02394028|54845793|FG009|Induction Phase|Lost to Follow-up|0|||
28173773|NCT02394028|54845794|FG010|Induction Phase|Lost to Follow-up|0|||
28173774|NCT02394028|54845784|FG000|Induction Phase|Non-compliance|0|||
28173775|NCT02394028|54845785|FG001|Induction Phase|Non-compliance|1|||
28173776|NCT02394028|54845786|FG002|Induction Phase|Non-compliance|3|||
28173777|NCT02394028|54845787|FG003|Induction Phase|Non-compliance|1|||
28173778|NCT02394028|54845788|FG004|Induction Phase|Non-compliance|3|||
28173779|NCT02394028|54845789|FG005|Induction Phase|Non-compliance|0|||
28173780|NCT02394028|54845790|FG006|Induction Phase|Non-compliance|1|||
28173781|NCT02394028|54845791|FG007|Induction Phase|Non-compliance|1|||
28173782|NCT02394028|54845792|FG008|Induction Phase|Non-compliance|0|||
28173783|NCT02394028|54845793|FG009|Induction Phase|Non-compliance|0|||
28173784|NCT02394028|54845794|FG010|Induction Phase|Non-compliance|0|||
28173785|NCT02394028|54845784|FG000|Induction Phase|Physician Decision|0|||
28173786|NCT02394028|54845785|FG001|Induction Phase|Physician Decision|0|||
28173787|NCT02394028|54845786|FG002|Induction Phase|Physician Decision|1|||
28173788|NCT02394028|54845787|FG003|Induction Phase|Physician Decision|4|||
28173789|NCT02394028|54845788|FG004|Induction Phase|Physician Decision|0|||
28173790|NCT02394028|54845789|FG005|Induction Phase|Physician Decision|2|||
28173791|NCT02394028|54845790|FG006|Induction Phase|Physician Decision|1|||
28173792|NCT02394028|54845791|FG007|Induction Phase|Physician Decision|0|||
28173793|NCT02394028|54845792|FG008|Induction Phase|Physician Decision|0|||
28173794|NCT02394028|54845793|FG009|Induction Phase|Physician Decision|0|||
28173795|NCT02394028|54845794|FG010|Induction Phase|Physician Decision|0|||
28173796|NCT02394028|54845784|FG000|Induction Phase|Protocol Violation|0|||
28173797|NCT02394028|54845785|FG001|Induction Phase|Protocol Violation|2|||
28173798|NCT02394028|54845786|FG002|Induction Phase|Protocol Violation|0|||
28173799|NCT02394028|54845787|FG003|Induction Phase|Protocol Violation|3|||
28173800|NCT02394028|54845788|FG004|Induction Phase|Protocol Violation|0|||
28173801|NCT02394028|54845789|FG005|Induction Phase|Protocol Violation|1|||
28173802|NCT02394028|54845790|FG006|Induction Phase|Protocol Violation|1|||
28173803|NCT02394028|54845791|FG007|Induction Phase|Protocol Violation|0|||
28173804|NCT02394028|54845792|FG008|Induction Phase|Protocol Violation|0|||
28173805|NCT02394028|54845793|FG009|Induction Phase|Protocol Violation|0|||
28173806|NCT02394028|54845794|FG010|Induction Phase|Protocol Violation|0|||
28173807|NCT02394028|54845784|FG000|Induction Phase|Withdrawal by Subject|1|||
28173808|NCT02394028|54845785|FG001|Induction Phase|Withdrawal by Subject|2|||
28173809|NCT02394028|54845786|FG002|Induction Phase|Withdrawal by Subject|4|||
28173810|NCT02394028|54845787|FG003|Induction Phase|Withdrawal by Subject|6|||
28173811|NCT02394028|54845788|FG004|Induction Phase|Withdrawal by Subject|7|||
28173812|NCT02394028|54845789|FG005|Induction Phase|Withdrawal by Subject|4|||
27740015|NCT02786537|54189681|FG004|As Treated|Advised to stop tx after loss of meds|0|||
27740016|NCT02786537|54189682|FG005|As Treated|Advised to stop tx after loss of meds|0|||
27917333|NCT01335698|54574820|FG003|Treatment Stage 1|Withdrawal by Subject|1|||
27917334|NCT01335698|54574821|FG004|Treatment Stage 1|Withdrawal by Subject|0|||
27917335|NCT01335698|54574817|FG000|Treatment Stage 1|Lost to Follow-up|1|||
27917336|NCT01335698|54574818|FG001|Treatment Stage 1|Lost to Follow-up|1|||
27917337|NCT01335698|54574819|FG002|Treatment Stage 1|Lost to Follow-up|0|||
27917338|NCT01335698|54574820|FG003|Treatment Stage 1|Lost to Follow-up|0|||
27917339|NCT01335698|54574821|FG004|Treatment Stage 1|Lost to Follow-up|0|||
27917340|NCT01335698|54574817|FG000|Treatment Stage 1|Poor compliance/noncompliance|0|||
27917341|NCT01335698|54574818|FG001|Treatment Stage 1|Poor compliance/noncompliance|1|||
27917342|NCT01335698|54574819|FG002|Treatment Stage 1|Poor compliance/noncompliance|0|||
27917343|NCT01335698|54574820|FG003|Treatment Stage 1|Poor compliance/noncompliance|2|||
27917344|NCT01335698|54574821|FG004|Treatment Stage 1|Poor compliance/noncompliance|0|||
27917345|NCT01335698|54574817|FG000|Treatment Stage 1|No longer meets study criteria|1|||
27917346|NCT01335698|54574818|FG001|Treatment Stage 1|No longer meets study criteria|1|||
28173813|NCT02394028|54845790|FG006|Induction Phase|Withdrawal by Subject|3|||
28173814|NCT02394028|54845791|FG007|Induction Phase|Withdrawal by Subject|6|||
28173815|NCT02394028|54845792|FG008|Induction Phase|Withdrawal by Subject|0|||
28173816|NCT02394028|54845793|FG009|Induction Phase|Withdrawal by Subject|0|||
28173817|NCT02394028|54845794|FG010|Induction Phase|Withdrawal by Subject|0|||
28173818|NCT02394028|54845784|FG000|Induction Phase|Early withdrawal and roll over to a different study|0|||
28173819|NCT02394028|54845785|FG001|Induction Phase|Early withdrawal and roll over to a different study|0|||
28173820|NCT02394028|54845786|FG002|Induction Phase|Early withdrawal and roll over to a different study|0|||
28173821|NCT02394028|54845787|FG003|Induction Phase|Early withdrawal and roll over to a different study|0|||
28173822|NCT02394028|54845788|FG004|Induction Phase|Early withdrawal and roll over to a different study|0|||
28173823|NCT02394028|54845789|FG005|Induction Phase|Early withdrawal and roll over to a different study|0|||
28173824|NCT02394028|54845790|FG006|Induction Phase|Early withdrawal and roll over to a different study|1|||
28173825|NCT02394028|54845791|FG007|Induction Phase|Early withdrawal and roll over to a different study|0|||
28173826|NCT02394028|54845792|FG008|Induction Phase|Early withdrawal and roll over to a different study|0|||
28173827|NCT02394028|54845793|FG009|Induction Phase|Early withdrawal and roll over to a different study|0|||
28173828|NCT02394028|54845794|FG010|Induction Phase|Early withdrawal and roll over to a different study|0|||
28173829|NCT02394028|54845784|FG000|Induction Phase|Sponsor decision|0|||
28173830|NCT02394028|54845785|FG001|Induction Phase|Sponsor decision|1|||
28173831|NCT02394028|54845786|FG002|Induction Phase|Sponsor decision|2|||
28173832|NCT02394028|54845787|FG003|Induction Phase|Sponsor decision|0|||
28173833|NCT02394028|54845788|FG004|Induction Phase|Sponsor decision|0|||
28173834|NCT02394028|54845789|FG005|Induction Phase|Sponsor decision|0|||
28173835|NCT02394028|54845790|FG006|Induction Phase|Sponsor decision|0|||
28173836|NCT02394028|54845791|FG007|Induction Phase|Sponsor decision|0|||
28173837|NCT02394028|54845792|FG008|Induction Phase|Sponsor decision|0|||
28173838|NCT02394028|54845793|FG009|Induction Phase|Sponsor decision|0|||
28173839|NCT02394028|54845794|FG010|Induction Phase|Sponsor decision|0|||
28173840|NCT02394028|54845784|FG000|Induction Phase|Technical reason|0|||
28173841|NCT02394028|54845785|FG001|Induction Phase|Technical reason|0|||
28173842|NCT02394028|54845786|FG002|Induction Phase|Technical reason|0|||
28173843|NCT02394028|54845787|FG003|Induction Phase|Technical reason|1|||
28173844|NCT02394028|54845788|FG004|Induction Phase|Technical reason|0|||
28173845|NCT02394028|54845789|FG005|Induction Phase|Technical reason|0|||
28173846|NCT02394028|54845790|FG006|Induction Phase|Technical reason|0|||
28173847|NCT02394028|54845791|FG007|Induction Phase|Technical reason|0|||
28173848|NCT02394028|54845792|FG008|Induction Phase|Technical reason|0|||
28173849|NCT02394028|54845793|FG009|Induction Phase|Technical reason|0|||
28173850|NCT02394028|54845794|FG010|Induction Phase|Technical reason|0|||
28173851|NCT02394028|54845784|FG000|Induction Phase|:ack of calculation|0|||
28173852|NCT02394028|54845785|FG001|Induction Phase|:ack of calculation|0|||
28173853|NCT02394028|54845786|FG002|Induction Phase|:ack of calculation|0|||
28173854|NCT02394028|54845787|FG003|Induction Phase|:ack of calculation|0|||
28173855|NCT02394028|54845788|FG004|Induction Phase|:ack of calculation|0|||
28173856|NCT02394028|54845789|FG005|Induction Phase|:ack of calculation|0|||
28173857|NCT02394028|54845790|FG006|Induction Phase|:ack of calculation|0|||
28173858|NCT02394028|54845791|FG007|Induction Phase|:ack of calculation|1|||
28006737|NCT00711009|54665545|FG000|Overall Study|Participant Noncompliant|0|||
28006738|NCT00711009|54665546|FG001|Overall Study|Participant Noncompliant|1|||
28006739|NCT00711009|54665545|FG000|Overall Study|Virologic Failure|2|||
28006740|NCT00711009|54665546|FG001|Overall Study|Virologic Failure|1|||
28006741|NCT00711009|54665545|FG000|Overall Study|Pregnancy|1|||
28006742|NCT00711009|54665546|FG001|Overall Study|Pregnancy|0|||
28006743|NCT00711009|54665545|FG000|Overall Study|Site closing|0|||
28006744|NCT00711009|54665546|FG001|Overall Study|Site closing|1|||
28006745|NCT00711009|54665545|FG000|Overall Study|Dose adjustment|1|||
28006746|NCT00711009|54665546|FG001|Overall Study|Dose adjustment|0|||
28006747|NCT00577005|54665554|FG000|Overall Study|Lost to Follow-up|3|||
28006748|NCT00577005|54665555|FG001|Overall Study|Lost to Follow-up|2|||
28006749|NCT00577005|54665554|FG000|Overall Study|Withdrawal by Subject|2|||
28006750|NCT00577005|54665555|FG001|Overall Study|Withdrawal by Subject|1|||
28006751|NCT00576927|54665566|FG000|Clinical Assessment|Lack of Efficacy|24|||
28006752|NCT00576927|54665566|FG000|Clinical Assessment|Death|1|||
28006753|NCT00576927|54665566|FG000|Clinical Assessment|Withdrawal by Subject|10|||
28006754|NCT00576927|54665566|FG000|Clinical Assessment|Physician Decision|1|||
28006755|NCT00576927|54665566|FG000|Baseline|Physician Decision|9|||
28006756|NCT00576927|54665566|FG000|Baseline|Medication Change by PCP of subject|1|||
28006757|NCT00576927|54665566|FG000|Baseline|Withdrawal by Subject|3|||
28173859|NCT02394028|54845792|FG008|Induction Phase|:ack of calculation|0|||
28173860|NCT02394028|54845793|FG009|Induction Phase|:ack of calculation|0|||
28173861|NCT02394028|54845794|FG010|Induction Phase|:ack of calculation|0|||
28173862|NCT02394028|54845784|FG000|Maintenance Phase|Protocol Violation|0|||
28173863|NCT02394028|54845785|FG001|Maintenance Phase|Protocol Violation|0|||
28173864|NCT02394028|54845786|FG002|Maintenance Phase|Protocol Violation|0|||
28173865|NCT02394028|54845787|FG003|Maintenance Phase|Protocol Violation|0|||
28173866|NCT02394028|54845788|FG004|Maintenance Phase|Protocol Violation|0|||
28173867|NCT02394028|54845789|FG005|Maintenance Phase|Protocol Violation|0|||
28006758|NCT00576927|54665566|FG000|Sleep Hygiene Behavioral Intervention|Responded to intervention|4|||
28006759|NCT00576927|54665566|FG000|Sleep Hygiene Behavioral Intervention|Death|1|||
28006760|NCT00576927|54665566|FG000|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1|||
28006761|NCT00576927|54665566|FG000|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1|||
28006762|NCT00576927|54665566|FG000|Sleep Hygiene With the Placebo|Withdrawal by Subject|1|||
28006763|NCT00698841|54665572|FG000|Overall Study|Withdrawal by Subject|2|||
28006764|NCT00698841|54665572|FG000|Overall Study|Adverse Event|3|||
28006765|NCT00698841|54665572|FG000|Overall Study|Disease progression|7|||
28006766|NCT00698841|54665572|FG000|Overall Study|Failure to meet eligibility criteria|2|||
28006767|NCT00698841|54665572|FG000|Overall Study|Study drug toxicity|2|||
28173868|NCT02394028|54845790|FG006|Maintenance Phase|Protocol Violation|0|||
28173869|NCT02394028|54845791|FG007|Maintenance Phase|Protocol Violation|0|||
28173870|NCT02394028|54845792|FG008|Maintenance Phase|Protocol Violation|0|||
28173871|NCT02394028|54845793|FG009|Maintenance Phase|Protocol Violation|0|||
28173872|NCT02394028|54845794|FG010|Maintenance Phase|Protocol Violation|1|||
28173873|NCT02394028|54845784|FG000|Maintenance Phase|Physician Decision|0|||
28173874|NCT02394028|54845785|FG001|Maintenance Phase|Physician Decision|0|||
28173875|NCT02394028|54845786|FG002|Maintenance Phase|Physician Decision|0|||
28173876|NCT02394028|54845787|FG003|Maintenance Phase|Physician Decision|0|||
28173877|NCT02394028|54845788|FG004|Maintenance Phase|Physician Decision|0|||
28173878|NCT02394028|54845789|FG005|Maintenance Phase|Physician Decision|0|||
28173879|NCT02394028|54845790|FG006|Maintenance Phase|Physician Decision|0|||
28173880|NCT02394028|54845791|FG007|Maintenance Phase|Physician Decision|0|||
28173881|NCT02394028|54845792|FG008|Maintenance Phase|Physician Decision|1|||
28173882|NCT02394028|54845793|FG009|Maintenance Phase|Physician Decision|3|||
28173883|NCT02394028|54845794|FG010|Maintenance Phase|Physician Decision|2|||
28173884|NCT02394028|54845784|FG000|Maintenance Phase|Lack of Efficacy|0|||
28173885|NCT02394028|54845785|FG001|Maintenance Phase|Lack of Efficacy|0|||
28173886|NCT02394028|54845786|FG002|Maintenance Phase|Lack of Efficacy|0|||
28173887|NCT02394028|54845787|FG003|Maintenance Phase|Lack of Efficacy|0|||
28173888|NCT02394028|54845788|FG004|Maintenance Phase|Lack of Efficacy|0|||
28173889|NCT02394028|54845789|FG005|Maintenance Phase|Lack of Efficacy|0|||
28173890|NCT02394028|54845790|FG006|Maintenance Phase|Lack of Efficacy|0|||
28173891|NCT02394028|54845791|FG007|Maintenance Phase|Lack of Efficacy|0|||
28173892|NCT02394028|54845792|FG008|Maintenance Phase|Lack of Efficacy|7|||
28173893|NCT02394028|54845793|FG009|Maintenance Phase|Lack of Efficacy|25|||
28173894|NCT02394028|54845794|FG010|Maintenance Phase|Lack of Efficacy|33|||
28173895|NCT02394028|54845784|FG000|Maintenance Phase|Death|0|||
28173896|NCT02394028|54845785|FG001|Maintenance Phase|Death|0|||
28173897|NCT02394028|54845786|FG002|Maintenance Phase|Death|0|||
28173898|NCT02394028|54845787|FG003|Maintenance Phase|Death|0|||
28173899|NCT02394028|54845788|FG004|Maintenance Phase|Death|0|||
28173900|NCT02394028|54845789|FG005|Maintenance Phase|Death|0|||
28173901|NCT02394028|54845790|FG006|Maintenance Phase|Death|0|||
28173902|NCT02394028|54845791|FG007|Maintenance Phase|Death|0|||
28173903|NCT02394028|54845792|FG008|Maintenance Phase|Death|0|||
28173904|NCT02394028|54845793|FG009|Maintenance Phase|Death|0|||
28173905|NCT02394028|54845794|FG010|Maintenance Phase|Death|1|||
28173906|NCT02394028|54845784|FG000|Maintenance Phase|Adverse Event|0|||
28173907|NCT02394028|54845785|FG001|Maintenance Phase|Adverse Event|0|||
28173908|NCT02394028|54845786|FG002|Maintenance Phase|Adverse Event|0|||
28173909|NCT02394028|54845787|FG003|Maintenance Phase|Adverse Event|0|||
28173910|NCT02394028|54845788|FG004|Maintenance Phase|Adverse Event|0|||
28006768|NCT00698841|54665572|FG000|Overall Study|Other|2|||
28006769|NCT00577395|54665578|FG000|Overall Study|Study was terminated early by Sponsor|7|||
28006770|NCT00577395|54665579|FG001|Overall Study|Study was terminated early by Sponsor|6|||
28006771|NCT00738374|54665588|FG000|Induction Treatment Phase|Adverse Event|14|||
28006772|NCT00738374|54665589|FG001|Induction Treatment Phase|Adverse Event|0|||
28006773|NCT00738374|54665590|FG002|Induction Treatment Phase|Adverse Event|0|||
28006774|NCT00738374|54665591|FG003|Induction Treatment Phase|Adverse Event|0|||
28173911|NCT02394028|54845789|FG005|Maintenance Phase|Adverse Event|0|||
28173912|NCT02394028|54845790|FG006|Maintenance Phase|Adverse Event|0|||
28173913|NCT02394028|54845791|FG007|Maintenance Phase|Adverse Event|0|||
28173914|NCT02394028|54845792|FG008|Maintenance Phase|Adverse Event|1|||
28173915|NCT02394028|54845793|FG009|Maintenance Phase|Adverse Event|1|||
28173916|NCT02394028|54845794|FG010|Maintenance Phase|Adverse Event|3|||
28173917|NCT02394028|54845784|FG000|Maintenance Phase|Site closure|0|||
28173918|NCT02394028|54845785|FG001|Maintenance Phase|Site closure|0|||
28173919|NCT02394028|54845786|FG002|Maintenance Phase|Site closure|0|||
28173920|NCT02394028|54845787|FG003|Maintenance Phase|Site closure|0|||
28006775|NCT00738374|54665588|FG000|Induction Treatment Phase|Disease progression/relapse/stable|4|||
27740017|NCT02216812|54189790|FG000|Overall Study|Lost to Follow-up|10|||
28006776|NCT00738374|54665589|FG001|Induction Treatment Phase|Disease progression/relapse/stable|0|||
28006777|NCT00738374|54665590|FG002|Induction Treatment Phase|Disease progression/relapse/stable|0|||
28103460|NCT02858362|54760070|FG000|Overall Study|Protocol Violation|0|||
28103461|NCT02858362|54760071|FG001|Overall Study|Protocol Violation|1|||
28103462|NCT02858362|54760072|FG002|Overall Study|Protocol Violation|0|||
28103463|NCT02858362|54760070|FG000|Overall Study|Withdrawal by Subject|1|||
28103464|NCT02858362|54760071|FG001|Overall Study|Withdrawal by Subject|0|||
28103465|NCT02858362|54760072|FG002|Overall Study|Withdrawal by Subject|0|||
28103466|NCT02858362|54760070|FG000|Overall Study|Early Study Termination|0|||
28103467|NCT02858362|54760071|FG001|Overall Study|Early Study Termination|0|||
28173921|NCT02394028|54845788|FG004|Maintenance Phase|Site closure|0|||
28173922|NCT02394028|54845789|FG005|Maintenance Phase|Site closure|0|||
28173923|NCT02394028|54845790|FG006|Maintenance Phase|Site closure|0|||
28173924|NCT02394028|54845791|FG007|Maintenance Phase|Site closure|0|||
28173925|NCT02394028|54845792|FG008|Maintenance Phase|Site closure|0|||
28173926|NCT02394028|54845793|FG009|Maintenance Phase|Site closure|1|||
28173927|NCT02394028|54845794|FG010|Maintenance Phase|Site closure|0|||
28173928|NCT02394028|54845784|FG000|Maintenance Phase|Withdrawal by Subject|0|||
28173929|NCT02394028|54845785|FG001|Maintenance Phase|Withdrawal by Subject|0|||
28173930|NCT02394028|54845786|FG002|Maintenance Phase|Withdrawal by Subject|0|||
28173931|NCT02394028|54845787|FG003|Maintenance Phase|Withdrawal by Subject|0|||
28173932|NCT02394028|54845788|FG004|Maintenance Phase|Withdrawal by Subject|0|||
28173933|NCT02394028|54845789|FG005|Maintenance Phase|Withdrawal by Subject|0|||
28173934|NCT02394028|54845790|FG006|Maintenance Phase|Withdrawal by Subject|0|||
28173935|NCT02394028|54845791|FG007|Maintenance Phase|Withdrawal by Subject|0|||
28173936|NCT02394028|54845792|FG008|Maintenance Phase|Withdrawal by Subject|3|||
28173937|NCT02394028|54845793|FG009|Maintenance Phase|Withdrawal by Subject|12|||
28173938|NCT02394028|54845794|FG010|Maintenance Phase|Withdrawal by Subject|12|||
28173939|NCT01371539|54845848|FG000|Period One: One Week|Lost to Follow-up|0|||
28173940|NCT01371539|54845849|FG001|Period One: One Week|Lost to Follow-up|1|||
28173941|NCT01371539|54845848|FG000|Period Two: One Week|Lost to Follow-up|0|||
28173942|NCT01371539|54845849|FG001|Period Two: One Week|Lost to Follow-up|1|||
28173943|NCT01371539|54845848|FG000|Period Two: One Week|Unacceptable Objective Visual Acuity|0|||
28173944|NCT01371539|54845849|FG001|Period Two: One Week|Unacceptable Objective Visual Acuity|1|||
28173945|NCT01371539|54845848|FG000|Period Two: One Week|Time/job conflict|0|||
28173946|NCT01371539|54845849|FG001|Period Two: One Week|Time/job conflict|1|||
28173947|NCT03320330|54845858|FG000|Overall Study|Lack of Efficacy|5|||
28173948|NCT03320330|54845859|FG001|Overall Study|Lack of Efficacy|5|||
28173949|NCT03320330|54845860|FG002|Overall Study|Lack of Efficacy|14|||
28173950|NCT03320330|54845858|FG000|Overall Study|Physician Decision|1|||
28173951|NCT03320330|54845859|FG001|Overall Study|Physician Decision|0|||
28173952|NCT03320330|54845860|FG002|Overall Study|Physician Decision|0|||
28173953|NCT02819297|54845871|FG000|Overall Study|Withdrawal by Subject|25|||
28173954|NCT02819297|54845872|FG001|Overall Study|Withdrawal by Subject|13|||
28173955|NCT02819297|54845871|FG000|Overall Study|Lost to Follow-up|12|||
28173956|NCT02819297|54845872|FG001|Overall Study|Lost to Follow-up|14|||
28173957|NCT02819297|54845871|FG000|Overall Study|Adverse Event|12|||
28173958|NCT02819297|54845872|FG001|Overall Study|Adverse Event|10|||
28173959|NCT02819297|54845871|FG000|Overall Study|Physician Decision|5|||
28173960|NCT02819297|54845872|FG001|Overall Study|Physician Decision|5|||
28173961|NCT02819297|54845871|FG000|Overall Study|Lack of Efficacy|5|||
28173962|NCT02819297|54845872|FG001|Overall Study|Lack of Efficacy|8|||
28173963|NCT02819297|54845871|FG000|Overall Study|Protocol Violation|1|||
28173964|NCT02819297|54845872|FG001|Overall Study|Protocol Violation|2|||
28173965|NCT02429830|54845878|FG000|Overall Study|Lost to Follow-up|1|||
28173966|NCT02429830|54845878|FG000|Overall Study|Device Explant|2|||
28173967|NCT02821715|54845882|FG000|Overall Study|Protocol Violation|1|||
28173968|NCT02821715|54845883|FG001|Overall Study|Protocol Violation|0|||
28173969|NCT02821715|54845884|FG002|Overall Study|Protocol Violation|0|||
28173970|NCT02821715|54845885|FG003|Overall Study|Protocol Violation|0|||
28173971|NCT02821715|54845886|FG004|Overall Study|Protocol Violation|0|||
28173972|NCT02821715|54845887|FG005|Overall Study|Protocol Violation|0|||
28173973|NCT02813681|54845898|FG000|Overall Study|Physician Decision|5|||
28173974|NCT02813681|54845899|FG001|Overall Study|Physician Decision|5|||
28173975|NCT02813681|54845900|FG002|Overall Study|Physician Decision|0|||
28173976|NCT02813681|54845898|FG000|Overall Study|Lost to Follow-up|0|||
28173977|NCT02813681|54845899|FG001|Overall Study|Lost to Follow-up|1|||
28173978|NCT02813681|54845900|FG002|Overall Study|Lost to Follow-up|0|||
28173979|NCT02393950|54845912|FG000|Overall Study|Adverse Event|1|||
28173980|NCT02393950|54845913|FG001|Overall Study|Adverse Event|0|||
28173981|NCT02393950|54845912|FG000|Overall Study|Withdrawal by Subject|0|||
28173982|NCT02393950|54845913|FG001|Overall Study|Withdrawal by Subject|1|||
28173983|NCT02815397|54845948|FG000|Overall Study|Physician Decision|2|||
28173984|NCT02427958|54845952|FG000|Overall Study|Pretreatment Event (PTE) or AE|3|||
28173985|NCT02427958|54845952|FG000|Overall Study|Lost to Follow-up|6|||
28173986|NCT02427958|54845952|FG000|Overall Study|Withdrawal by Subject|14|||
28173987|NCT02427958|54845952|FG000|Overall Study|Lack of Efficacy|1|||
28173988|NCT02392624|54845959|FG000|Overall Study|Withdrawal by Subject|15|||
28173989|NCT02392624|54845960|FG001|Overall Study|Withdrawal by Subject|12|||
28173990|NCT02392624|54845961|FG002|Overall Study|Withdrawal by Subject|9|||
28173991|NCT02392624|54845959|FG000|Overall Study|Adverse Event|4|||
28173992|NCT02392624|54845960|FG001|Overall Study|Adverse Event|1|||
28173993|NCT02392624|54845961|FG002|Overall Study|Adverse Event|2|||
28173994|NCT02392624|54845959|FG000|Overall Study|Pregnancy|1|||
28173995|NCT02392624|54845960|FG001|Overall Study|Pregnancy|0|||
28173996|NCT02392624|54845961|FG002|Overall Study|Pregnancy|0|||
28173997|NCT02392624|54845959|FG000|Overall Study|Protocol Violation|0|||
28173998|NCT02392624|54845960|FG001|Overall Study|Protocol Violation|0|||
28173999|NCT02392624|54845961|FG002|Overall Study|Protocol Violation|1|||
28174000|NCT02392624|54845959|FG000|Overall Study|Sponsor/Investigator Decision|2|||
28006778|NCT00738374|54665591|FG003|Induction Treatment Phase|Disease progression/relapse/stable|0|||
28006779|NCT00738374|54665588|FG000|Induction Treatment Phase|Physician Decision|2|||
28006780|NCT00738374|54665589|FG001|Induction Treatment Phase|Physician Decision|0|||
28006781|NCT00738374|54665590|FG002|Induction Treatment Phase|Physician Decision|0|||
28006782|NCT00738374|54665591|FG003|Induction Treatment Phase|Physician Decision|0|||
28006783|NCT00738374|54665588|FG000|Induction Treatment Phase|Protocol Violation|2|||
28006784|NCT00738374|54665589|FG001|Induction Treatment Phase|Protocol Violation|0|||
28006785|NCT00738374|54665590|FG002|Induction Treatment Phase|Protocol Violation|0|||
28006786|NCT00738374|54665591|FG003|Induction Treatment Phase|Protocol Violation|0|||
28006787|NCT00738374|54665588|FG000|Induction Treatment Phase|Non-compliance|1|||
28006788|NCT00738374|54665589|FG001|Induction Treatment Phase|Non-compliance|0|||
28006789|NCT00738374|54665590|FG002|Induction Treatment Phase|Non-compliance|0|||
28006790|NCT00738374|54665591|FG003|Induction Treatment Phase|Non-compliance|0|||
28006791|NCT00738374|54665588|FG000|Induction Treatment Phase|Withdrawal by Subject|1|||
28006792|NCT00738374|54665589|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
28006793|NCT00738374|54665590|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
28006794|NCT00738374|54665591|FG003|Induction Treatment Phase|Withdrawal by Subject|0|||
28006795|NCT00738374|54665588|FG000|Maintenance Treatment/Observation Phase|Adverse Event|0|||
28006796|NCT00738374|54665589|FG001|Maintenance Treatment/Observation Phase|Adverse Event|1|||
28006797|NCT00738374|54665590|FG002|Maintenance Treatment/Observation Phase|Adverse Event|2|||
28006798|NCT00738374|54665591|FG003|Maintenance Treatment/Observation Phase|Adverse Event|0|||
28174001|NCT02392624|54845960|FG001|Overall Study|Sponsor/Investigator Decision|1|||
28174002|NCT02392624|54845961|FG002|Overall Study|Sponsor/Investigator Decision|0|||
28174003|NCT02392624|54845959|FG000|Overall Study|Other|49|||
28174004|NCT02392624|54845960|FG001|Overall Study|Other|1|||
28174005|NCT02392624|54845961|FG002|Overall Study|Other|1|||
28174006|NCT02387164|54845971|FG000|Overall Study|Lost to Follow-up|2|||
28174007|NCT02387164|54845972|FG001|Overall Study|Lost to Follow-up|0|||
28174008|NCT02387164|54845971|FG000|Overall Study|Diagnosed|1|||
28174009|NCT02387164|54845972|FG001|Overall Study|Diagnosed|2|||
28174010|NCT02392234|54845990|FG000|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
28174011|NCT02392234|54845991|FG001|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
28174012|NCT02392234|54845992|FG002|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
28174013|NCT02392234|54845993|FG003|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
28174014|NCT02392234|54845994|FG004|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
28174015|NCT02392234|54845995|FG005|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
28174016|NCT02392234|54845990|FG000|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
28174017|NCT02392234|54845991|FG001|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
28174018|NCT02392234|54845992|FG002|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
28174019|NCT02392234|54845993|FG003|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
28174020|NCT02392234|54845994|FG004|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2|||
28174021|NCT02392234|54845995|FG005|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
28174022|NCT02392234|54845990|FG000|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
28174023|NCT02392234|54845991|FG001|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
28174024|NCT02392234|54845992|FG002|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
28174025|NCT02392234|54845993|FG003|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
28174026|NCT02392234|54845994|FG004|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
28174027|NCT02392234|54845995|FG005|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
28174028|NCT02392234|54845990|FG000|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
28174029|NCT02392234|54845991|FG001|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
28174030|NCT02392234|54845992|FG002|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
28174031|NCT02392234|54845993|FG003|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
28174032|NCT02392234|54845994|FG004|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
28174033|NCT02392234|54845995|FG005|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
28174034|NCT02392234|54845990|FG000|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
28174035|NCT02392234|54845991|FG001|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
28174036|NCT02392234|54845992|FG002|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
28174037|NCT02392234|54845993|FG003|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
28174038|NCT02392234|54845994|FG004|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
28174039|NCT02392234|54845995|FG005|Treatment Period 1 (8 Weeks)|Noncompliance|1|||
28174040|NCT02392234|54845990|FG000|Treatment Period 1 (8 Weeks)|Other|1|||
28174041|NCT02392234|54845991|FG001|Treatment Period 1 (8 Weeks)|Other|0|||
28174042|NCT02392234|54845992|FG002|Treatment Period 1 (8 Weeks)|Other|0|||
28174043|NCT02392234|54845993|FG003|Treatment Period 1 (8 Weeks)|Other|0|||
28174044|NCT02392234|54845994|FG004|Treatment Period 1 (8 Weeks)|Other|0|||
28174045|NCT02392234|54845995|FG005|Treatment Period 1 (8 Weeks)|Other|0|||
28174046|NCT02392234|54845990|FG000|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
28174047|NCT02392234|54845991|FG001|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
28006799|NCT00738374|54665588|FG000|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0|||
27740018|NCT02216812|54189791|FG001|Overall Study|Lost to Follow-up|5|||
28174048|NCT02392234|54845992|FG002|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
28174049|NCT02392234|54845993|FG003|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
28174050|NCT02392234|54845994|FG004|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
28174051|NCT02392234|54845995|FG005|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
28174052|NCT02392234|54845990|FG000|Treatment Period 2 (8 Weeks)|Adverse Event|1|||
28174053|NCT02392234|54845991|FG001|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
28174054|NCT02392234|54845992|FG002|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
28174055|NCT02392234|54845993|FG003|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
28174056|NCT02392234|54845994|FG004|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
28174057|NCT02392234|54845995|FG005|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
28174058|NCT02963090|54846009|FG000|Non-cross Over Phase|Patient deterioration before starting protocol treatment|1|||
28174059|NCT02963090|54846010|FG001|Non-cross Over Phase|Patient deterioration before starting protocol treatment|0|||
28174060|NCT02427802|54846022|FG000|Overall Study|Adverse Event|11|||
28174061|NCT02427802|54846023|FG001|Overall Study|Adverse Event|3|||
28174062|NCT02427802|54846024|FG002|Overall Study|Adverse Event|7|||
28174063|NCT02427802|54846022|FG000|Overall Study|Death|0|||
28174064|NCT02427802|54846023|FG001|Overall Study|Death|4|||
28174065|NCT02427802|54846024|FG002|Overall Study|Death|1|||
28174066|NCT02427802|54846022|FG000|Overall Study|Lost to Follow-up|13|||
28174067|NCT02427802|54846023|FG001|Overall Study|Lost to Follow-up|8|||
28174068|NCT02427802|54846024|FG002|Overall Study|Lost to Follow-up|8|||
28174069|NCT02427802|54846022|FG000|Overall Study|Physician Decision|4|||
28174070|NCT02427802|54846023|FG001|Overall Study|Physician Decision|2|||
28174071|NCT02427802|54846024|FG002|Overall Study|Physician Decision|4|||
28174072|NCT02427802|54846022|FG000|Overall Study|Withdrawal by Subject|10|||
28174073|NCT02427802|54846023|FG001|Overall Study|Withdrawal by Subject|5|||
28174074|NCT02427802|54846024|FG002|Overall Study|Withdrawal by Subject|11|||
28174075|NCT02427802|54846022|FG000|Overall Study|Protocol Violation|3|||
28174076|NCT02427802|54846023|FG001|Overall Study|Protocol Violation|1|||
28174077|NCT02427802|54846024|FG002|Overall Study|Protocol Violation|1|||
27917347|NCT01335698|54574819|FG002|Treatment Stage 1|No longer meets study criteria|0|||
28174078|NCT02427802|54846022|FG000|Overall Study|protocol specific treatment unrelated|18|||
28174079|NCT02427802|54846023|FG001|Overall Study|protocol specific treatment unrelated|11|||
28174080|NCT02427802|54846024|FG002|Overall Study|protocol specific treatment unrelated|11|||
28174081|NCT02427646|54846034|FG000|Overall Study|Lack of Efficacy|2|||
28174082|NCT02427646|54846035|FG001|Overall Study|Lack of Efficacy|3|||
28174083|NCT02427646|54846034|FG000|Overall Study|Physician Decision|1|||
28174084|NCT02427646|54846035|FG001|Overall Study|Physician Decision|4|||
28174085|NCT02427646|54846034|FG000|Overall Study|Protocol Violation|3|||
28174086|NCT02427646|54846035|FG001|Overall Study|Protocol Violation|3|||
28174087|NCT02427646|54846034|FG000|Overall Study|Bothersome hand weakness|2|||
28174088|NCT02427646|54846035|FG001|Overall Study|Bothersome hand weakness|4|||
28174089|NCT02392000|54846043|FG000|Overall Study|Greater than mild sleep apnea exclusion|18|||
28174090|NCT02392000|54846043|FG000|Overall Study|Withdrawal by Subject|1|||
28174091|NCT02392000|54846043|FG000|Overall Study|Lost to Follow-up|8|||
28174092|NCT02385526|54846051|FG000|Overall Study|Withdrawal by Subject|0|||
28174093|NCT02385526|54846052|FG001|Overall Study|Withdrawal by Subject|2|||
28174094|NCT02385526|54846053|FG002|Overall Study|Withdrawal by Subject|0|||
28174095|NCT02385526|54846051|FG000|Overall Study|Lost to Follow-up|0|||
28174096|NCT02385526|54846052|FG001|Overall Study|Lost to Follow-up|1|||
28174097|NCT02385526|54846053|FG002|Overall Study|Lost to Follow-up|0|||
28174098|NCT02385526|54846051|FG000|Overall Study|Physician Decision|1|||
28174099|NCT02385526|54846052|FG001|Overall Study|Physician Decision|0|||
28174100|NCT02385526|54846053|FG002|Overall Study|Physician Decision|0|||
28174101|NCT02385526|54846051|FG000|Overall Study|Protocol Violation|1|||
28174102|NCT02385526|54846052|FG001|Overall Study|Protocol Violation|0|||
28174103|NCT02385526|54846053|FG002|Overall Study|Protocol Violation|0|||
28174104|NCT02808143|54846063|FG000|Maintenance Phase|Disease recurrence|1|||
28174105|NCT02808143|54846064|FG001|Maintenance Phase|Disease recurrence|3|||
28174106|NCT02808143|54846063|FG000|Maintenance Phase|Disease progression|1|||
28174107|NCT02808143|54846064|FG001|Maintenance Phase|Disease progression|2|||
28174108|NCT02808143|54846063|FG000|Survival Follow-Up|Still in survival Follow-up|2|||
28174109|NCT02808143|54846064|FG001|Survival Follow-Up|Still in survival Follow-up|3|||
28174110|NCT02808143|54846063|FG000|Survival Follow-Up|Disease recurrence|0|||
28174111|NCT02808143|54846064|FG001|Survival Follow-Up|Disease recurrence|2|||
28174112|NCT02808143|54846063|FG000|Survival Follow-Up|Adverse Event|0|||
28174113|NCT02808143|54846064|FG001|Survival Follow-Up|Adverse Event|1|||
28174114|NCT02808143|54846063|FG000|Survival Follow-Up|Death|1|||
28174115|NCT02808143|54846064|FG001|Survival Follow-Up|Death|0|||
28174116|NCT02427100|54846074|FG000|Overall Study|Lost to Follow-up|0|||
28174117|NCT02427100|54846075|FG001|Overall Study|Lost to Follow-up|2|||
28174118|NCT02806973|54846081|FG000|Period 1|Withdrawal by Subject|0|||
27917348|NCT01335698|54574820|FG003|Treatment Stage 1|No longer meets study criteria|1|||
28174119|NCT02806973|54846082|FG001|Period 1|Withdrawal by Subject|2|||
28174120|NCT02806973|54846083|FG002|Period 1|Withdrawal by Subject|1|||
28174121|NCT02806973|54846084|FG003|Period 1|Withdrawal by Subject|1|||
28174122|NCT02806973|54846081|FG000|Period 1|Adverse Event|0|||
28174123|NCT02806973|54846082|FG001|Period 1|Adverse Event|0|||
28174124|NCT02806973|54846083|FG002|Period 1|Adverse Event|0|||
28174125|NCT02806973|54846084|FG003|Period 1|Adverse Event|1|||
28174126|NCT02806973|54846081|FG000|Period 3|Withdrawal by Subject|0|||
28174127|NCT02806973|54846082|FG001|Period 3|Withdrawal by Subject|0|||
28174128|NCT02806973|54846083|FG002|Period 3|Withdrawal by Subject|0|||
28174129|NCT02806973|54846084|FG003|Period 3|Withdrawal by Subject|3|||
28174130|NCT02806973|54846081|FG000|Period 3|Adverse Event|0|||
28174131|NCT02806973|54846082|FG001|Period 3|Adverse Event|0|||
28174132|NCT02806973|54846083|FG002|Period 3|Adverse Event|1|||
28174133|NCT02806973|54846084|FG003|Period 3|Adverse Event|0|||
28174134|NCT02806505|54846096|FG000|Overall Study|Adverse event/intercurrent illness|1|||
28174135|NCT02806505|54846097|FG001|Overall Study|Adverse event/intercurrent illness|3|||
28174136|NCT02806505|54846096|FG000|Overall Study|Death|4|||
28174137|NCT02806505|54846097|FG001|Overall Study|Death|0|||
28174138|NCT02806505|54846096|FG000|Overall Study|Did not cooperate/refused treatment|3|||
28174139|NCT02806505|54846097|FG001|Overall Study|Did not cooperate/refused treatment|3|||
28174140|NCT02806505|54846096|FG000|Overall Study|Failure to return|0|||
28174141|NCT02806505|54846097|FG001|Overall Study|Failure to return|1|||
28174142|NCT02806505|54846096|FG000|Overall Study|Insufficient therapeutic response|2|||
28174143|NCT02806505|54846097|FG001|Overall Study|Insufficient therapeutic response|4|||
28174144|NCT02807363|54846107|FG000|Dosing Period|Adverse Event|0|||
28174145|NCT02807363|54846108|FG001|Dosing Period|Adverse Event|1|||
28174146|NCT02807363|54846109|FG002|Dosing Period|Adverse Event|0|||
28174147|NCT02807363|54846110|FG003|Dosing Period|Adverse Event|0|||
28006800|NCT00738374|54665589|FG001|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4|||
28006801|NCT00738374|54665590|FG002|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5|||
28006802|NCT00738374|54665591|FG003|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11|||
28006803|NCT00738374|54665588|FG000|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
28174148|NCT02383966|54846124|FG000|Overall Study|Ongoing at clinical cut-off date|25|||
28174149|NCT02383966|54846125|FG001|Overall Study|Ongoing at clinical cut-off date|4|||
28174150|NCT02383966|54846124|FG000|Overall Study|Randomized, but not treated|1|||
28174151|NCT02383966|54846125|FG001|Overall Study|Randomized, but not treated|3|||
28174152|NCT02383576|54846133|FG000|Overall Study|Death|53|||
28174153|NCT02383576|54846134|FG001|Overall Study|Death|33|||
28174154|NCT02383576|54846133|FG000|Overall Study|Lost to Follow-up|7|||
28174155|NCT02383576|54846134|FG001|Overall Study|Lost to Follow-up|1|||
28174156|NCT02383576|54846133|FG000|Overall Study|Withdrew Consent|1|||
28174157|NCT02383576|54846134|FG001|Overall Study|Withdrew Consent|6|||
28174158|NCT02383576|54846133|FG000|Overall Study|Investigator's Decision|0|||
28174159|NCT02383576|54846134|FG001|Overall Study|Investigator's Decision|1|||
28174160|NCT02383576|54846133|FG000|Overall Study|Administrative/Other|2|||
28174161|NCT02383576|54846134|FG001|Overall Study|Administrative/Other|4|||
28174162|NCT02748317|54846140|FG000|Overall Study|Withdrawal by Subject|14|||
28174163|NCT02748317|54846140|FG000|Overall Study|Lost to Follow-up|8|||
28174164|NCT02748317|54846140|FG000|Overall Study|Death|1|||
28174165|NCT02426086|54846146|FG000|Overall Study|Death|33|||
28174166|NCT02426086|54846147|FG001|Overall Study|Death|36|||
28174167|NCT02426086|54846146|FG000|Overall Study|Lost to Follow-up|2|||
28174168|NCT02426086|54846147|FG001|Overall Study|Lost to Follow-up|0|||
28174169|NCT02426086|54846146|FG000|Overall Study|Study Terminated by Sponsor|5|||
28174170|NCT02426086|54846147|FG001|Overall Study|Study Terminated by Sponsor|14|||
28174171|NCT02426086|54846146|FG000|Overall Study|Withdrawal by Subject|8|||
28174172|NCT02426086|54846147|FG001|Overall Study|Withdrawal by Subject|9|||
28174173|NCT02422264|54846160|FG000|Overall Study|Serious Adverse Event|1|||
28174174|NCT02422264|54846161|FG001|Overall Study|Serious Adverse Event|0|||
28174175|NCT02422264|54846160|FG000|Overall Study|Withdrawal by Subject|1|||
28174176|NCT02422264|54846161|FG001|Overall Study|Withdrawal by Subject|2|||
28174177|NCT02422264|54846160|FG000|Overall Study|Migrated/moved from study area|3|||
28174178|NCT02422264|54846161|FG001|Overall Study|Migrated/moved from study area|1|||
28006804|NCT00738374|54665589|FG001|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
28174179|NCT02422264|54846160|FG000|Overall Study|Subject vaccinated outside of the study|0|||
28174180|NCT02422264|54846161|FG001|Overall Study|Subject vaccinated outside of the study|1|||
28174181|NCT02390362|54846169|FG000|Overall Study|Withdrawal by Subject|0|||
28006805|NCT00738374|54665590|FG002|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
28006806|NCT00738374|54665591|FG003|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1|||
28174182|NCT02390362|54846170|FG001|Overall Study|Withdrawal by Subject|1|||
28174183|NCT02389894|54846179|FG000|Overall Study|Death|4|||
28174184|NCT02389894|54846180|FG001|Overall Study|Death|5|||
28174185|NCT02389894|54846181|FG002|Overall Study|Death|3|||
28174186|NCT02389894|54846179|FG000|Overall Study|Withdrawal by Subject|2|||
28174187|NCT02389894|54846180|FG001|Overall Study|Withdrawal by Subject|4|||
28174188|NCT02389894|54846181|FG002|Overall Study|Withdrawal by Subject|5|||
28174189|NCT02389894|54846179|FG000|Overall Study|Lost to Follow-up|2|||
28174190|NCT02389894|54846180|FG001|Overall Study|Lost to Follow-up|1|||
28174191|NCT02389894|54846181|FG002|Overall Study|Lost to Follow-up|1|||
28174192|NCT02389816|54846192|FG000|Overall Study|Randomized but Not Treated|1|||
28174193|NCT02389816|54846193|FG001|Overall Study|Randomized but Not Treated|0|||
28174194|NCT02389816|54846194|FG002|Overall Study|Randomized but Not Treated|0|||
28174195|NCT02389816|54846192|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|4|||
28174196|NCT02389816|54846193|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
28174197|NCT02389816|54846194|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|7|||
28174198|NCT02389816|54846192|FG000|Overall Study|Major Protocol Deviation|1|||
28174199|NCT02389816|54846193|FG001|Overall Study|Major Protocol Deviation|0|||
28174200|NCT02389816|54846194|FG002|Overall Study|Major Protocol Deviation|0|||
28174201|NCT02389816|54846192|FG000|Overall Study|Lost to Follow-up|1|||
28174202|NCT02389816|54846193|FG001|Overall Study|Lost to Follow-up|0|||
28174203|NCT02389816|54846194|FG002|Overall Study|Lost to Follow-up|0|||
28174204|NCT02389816|54846192|FG000|Overall Study|Withdrawal of Consent|6|||
28174205|NCT02389816|54846193|FG001|Overall Study|Withdrawal of Consent|4|||
28174206|NCT02389816|54846194|FG002|Overall Study|Withdrawal of Consent|4|||
28174207|NCT02389816|54846192|FG000|Overall Study|Lack of Efficacy|1|||
28174208|NCT02389816|54846193|FG001|Overall Study|Lack of Efficacy|0|||
28174209|NCT02389816|54846194|FG002|Overall Study|Lack of Efficacy|0|||
28174210|NCT02389816|54846192|FG000|Overall Study|Non Compliance with Study Drug|1|||
28174211|NCT02389816|54846193|FG001|Overall Study|Non Compliance with Study Drug|1|||
28174212|NCT02389816|54846194|FG002|Overall Study|Non Compliance with Study Drug|1|||
28174213|NCT02389816|54846192|FG000|Overall Study|Reason not Specified|0|||
28174214|NCT02389816|54846193|FG001|Overall Study|Reason not Specified|2|||
28174215|NCT02389816|54846194|FG002|Overall Study|Reason not Specified|0|||
28174216|NCT02388724|54846204|FG000|Overall Study|Reason not Specified|0|||
28174217|NCT02388724|54846205|FG001|Overall Study|Reason not Specified|1|||
28174218|NCT02388724|54846204|FG000|Overall Study|Major Protocol Deviation|3|||
28174219|NCT02388724|54846205|FG001|Overall Study|Major Protocol Deviation|3|||
28174220|NCT02388724|54846204|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
28174221|NCT02388724|54846205|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
28174222|NCT02388724|54846204|FG000|Overall Study|Voluntary Withdrawal|6|||
28174223|NCT02388724|54846205|FG001|Overall Study|Voluntary Withdrawal|5|||
28174224|NCT02388724|54846204|FG000|Overall Study|Randomized but not Treated|0|||
28174225|NCT02388724|54846205|FG001|Overall Study|Randomized but not Treated|2|||
28174226|NCT02382796|54846211|FG000|Overall Study|Global deterioration of health status|1|||
28174227|NCT02382796|54846211|FG000|Overall Study|Objective progression or relapse|3|||
28174228|NCT02382796|54846211|FG000|Overall Study|Commercial dacomitinib became available|3|||
28174229|NCT02382640|54846219|FG000|Intervention Period 4 (3 Days)|Laboratory Abnormality|1|||
28174230|NCT02382640|54846220|FG001|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
28174231|NCT02382640|54846221|FG002|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
28174232|NCT02382640|54846222|FG003|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
28174233|NCT02801669|54846234|FG000|Overall Study|Death|66|||
28174234|NCT02801669|54846235|FG001|Overall Study|Death|69|||
28174235|NCT02801669|54846234|FG000|Overall Study|Withdrawal by Subject|81|||
28174236|NCT02801669|54846235|FG001|Overall Study|Withdrawal by Subject|77|||
28174237|NCT02801669|54846234|FG000|Overall Study|Other|4|||
28174238|NCT02801669|54846235|FG001|Overall Study|Other|6|||
28174239|NCT02804399|54846241|FG000|Period 2|Adverse Event|0|||
28174240|NCT02804399|54846242|FG001|Period 2|Adverse Event|1|||
28174241|NCT01333943|54846253|FG000|Overall Study|Known neuropathy|1|||
28174242|NCT01333943|54846254|FG001|Overall Study|Known neuropathy|0|||
28174243|NCT01333865|54846260|FG000|Overall Study|Adverse Event|2|||
28174244|NCT01333475|54846266|FG000|Overall Study|pt withdrew-need emergent radiation trmt|1|||
28174245|NCT01333475|54846267|FG001|Overall Study|pt withdrew-need emergent radiation trmt|0|||
28174246|NCT01333475|54846266|FG000|Overall Study|Toxicity|1|||
28174247|NCT01333475|54846267|FG001|Overall Study|Toxicity|3|||
28174248|NCT01333397|54846279|FG000|Overall Study|Lost to Follow-up|1|||
28174249|NCT01333397|54846280|FG001|Overall Study|Lost to Follow-up|0|||
28174250|NCT01333397|54846281|FG002|Overall Study|Lost to Follow-up|0|||
28174251|NCT01333397|54846282|FG003|Overall Study|Lost to Follow-up|1|||
28174252|NCT01333397|54846283|FG004|Overall Study|Lost to Follow-up|0|||
28174253|NCT02798861|54846304|FG000|Overall Study|Lost to Follow-up|22|||
28174254|NCT02798861|54846304|FG000|Overall Study|Withdrawal by Subject|1|||
28174255|NCT02798315|54846308|FG000|Overall Study|Failure to return|1|||
28174256|NCT02796755|54846314|FG000|Overall Study|Adverse Event|2|||
28174257|NCT02796755|54846315|FG001|Overall Study|Adverse Event|0|||
28174258|NCT02382016|54846323|FG000|Double-blind (DB) Treatment Period|Physician Decision|3|||
28174259|NCT02382016|54846324|FG001|Double-blind (DB) Treatment Period|Physician Decision|0|||
28174260|NCT02382016|54846323|FG000|Double-blind (DB) Treatment Period|Lack of Efficacy|1|||
28174261|NCT02382016|54846324|FG001|Double-blind (DB) Treatment Period|Lack of Efficacy|0|||
28174262|NCT02382016|54846323|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|0|||
28174263|NCT02382016|54846324|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|1|||
28174264|NCT02382016|54846323|FG000|Open-label (OL) Treatment Period|Physician Decision|3|||
28006807|NCT00738374|54665588|FG000|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
28006808|NCT00738374|54665589|FG001|Maintenance Treatment/Observation Phase|Protocol Violation|1|||
28006809|NCT00738374|54665590|FG002|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
28006810|NCT00738374|54665591|FG003|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
28006811|NCT00738374|54665588|FG000|Maintenance Treatment/Observation Phase|Other|0|||
28006812|NCT00738374|54665589|FG001|Maintenance Treatment/Observation Phase|Other|1|||
28006813|NCT00738374|54665590|FG002|Maintenance Treatment/Observation Phase|Other|0|||
28006814|NCT00738374|54665591|FG003|Maintenance Treatment/Observation Phase|Other|0|||
28006815|NCT00697593|54665600|FG000|Overall Study|Adverse Event|3|||
28006816|NCT00697593|54665600|FG000|Overall Study|Protocol Violation|1|||
28006817|NCT00697593|54665600|FG000|Overall Study|Lack of Efficacy|3|||
28006818|NCT00697593|54665600|FG000|Overall Study|Suspension of the study by sponsor|12|||
28006819|NCT00697515|54665604|FG000|Dose Optimization Period|Adverse Event|4|||
28174265|NCT02382016|54846324|FG001|Open-label (OL) Treatment Period|Physician Decision|0|||
28174266|NCT02382016|54846323|FG000|Open-label (OL) Treatment Period|Withdrawal by Subject|2|||
28174267|NCT02382016|54846324|FG001|Open-label (OL) Treatment Period|Withdrawal by Subject|0|||
28174268|NCT02382016|54846323|FG000|Open-label (OL) Treatment Period|Death|4|||
28174269|NCT02382016|54846324|FG001|Open-label (OL) Treatment Period|Death|0|||
28174270|NCT02382016|54846323|FG000|OL Extension Period|Physician Decision|3|||
28174271|NCT02382016|54846324|FG001|OL Extension Period|Physician Decision|0|||
28174272|NCT02382016|54846323|FG000|OL Extension Period|Death|2|||
28174273|NCT02382016|54846324|FG001|OL Extension Period|Death|0|||
28174274|NCT02382016|54846323|FG000|OL Extension Period|Withdrawal by Subject|1|||
28174275|NCT02382016|54846324|FG001|OL Extension Period|Withdrawal by Subject|0|||
28174276|NCT02422186|54846334|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
28174277|NCT02422186|54846335|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
28174278|NCT02422186|54846334|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0|||
28174279|NCT02422186|54846335|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
28174280|NCT02422186|54846334|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
28174281|NCT02422186|54846335|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2|||
28174282|NCT02422186|54846334|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3|||
28174283|NCT02422186|54846335|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
28174284|NCT02422186|54846334|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|4|||
28174285|NCT02422186|54846335|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
28174286|NCT02422186|54846334|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
28174287|NCT02422186|54846335|FG001|Double-blind Induction Phase (4 Weeks)|Other|0|||
28174288|NCT02422186|54846334|FG000|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1|||
28174289|NCT02422186|54846335|FG001|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0|||
28174290|NCT02422186|54846334|FG000|Follow-up Phase (2 Weeks)|Other|3|||
28174291|NCT02422186|54846335|FG001|Follow-up Phase (2 Weeks)|Other|0|||
28174292|NCT02421952|54846343|FG000|Overall Study|Diary Not Returned|93|||
28174293|NCT02421952|54846343|FG000|Overall Study|Failed seriation task|13|||
28174294|NCT02421952|54846343|FG000|Overall Study|Subject uncooperative for baseline test|2|||
28174295|NCT02421952|54846343|FG000|Overall Study|Surgery cancelled|1|||
28174296|NCT02796677|54846354|FG000|Overall Study|Adverse Event|11|||
28174297|NCT02796677|54846355|FG001|Overall Study|Adverse Event|22|||
28174298|NCT02796677|54846356|FG002|Overall Study|Adverse Event|14|||
28174299|NCT02796677|54846357|FG003|Overall Study|Adverse Event|14|||
28174300|NCT02796677|54846354|FG000|Overall Study|Protocol Violation|7|||
28174301|NCT02796677|54846355|FG001|Overall Study|Protocol Violation|5|||
28174302|NCT02796677|54846356|FG002|Overall Study|Protocol Violation|4|||
28174303|NCT02796677|54846357|FG003|Overall Study|Protocol Violation|8|||
27740019|NCT02252536|54189799|FG000|Overall Study|Lost to Follow-up|5|||
28174304|NCT02796677|54846354|FG000|Overall Study|Lost to Follow-up|1|||
28174305|NCT02796677|54846355|FG001|Overall Study|Lost to Follow-up|5|||
28174306|NCT02796677|54846356|FG002|Overall Study|Lost to Follow-up|2|||
28174307|NCT02796677|54846357|FG003|Overall Study|Lost to Follow-up|2|||
28174308|NCT02796677|54846354|FG000|Overall Study|Lack of Efficacy|7|||
28174309|NCT02796677|54846355|FG001|Overall Study|Lack of Efficacy|9|||
28174310|NCT02796677|54846356|FG002|Overall Study|Lack of Efficacy|14|||
28174311|NCT02796677|54846357|FG003|Overall Study|Lack of Efficacy|20|||
28174312|NCT02796677|54846354|FG000|Overall Study|Withdrawal by Subject|4|||
28174313|NCT02796677|54846355|FG001|Overall Study|Withdrawal by Subject|14|||
28174314|NCT02796677|54846356|FG002|Overall Study|Withdrawal by Subject|6|||
28174315|NCT02796677|54846357|FG003|Overall Study|Withdrawal by Subject|7|||
28174316|NCT02796677|54846354|FG000|Overall Study|Progressive disease|6|||
28174317|NCT02796677|54846355|FG001|Overall Study|Progressive disease|15|||
28174318|NCT02796677|54846356|FG002|Overall Study|Progressive disease|13|||
28174319|NCT02796677|54846357|FG003|Overall Study|Progressive disease|18|||
28174320|NCT02796677|54846354|FG000|Overall Study|Reason not mentioned|2|||
28174321|NCT02796677|54846355|FG001|Overall Study|Reason not mentioned|3|||
28174322|NCT02796677|54846356|FG002|Overall Study|Reason not mentioned|0|||
28174323|NCT02796677|54846357|FG003|Overall Study|Reason not mentioned|5|||
28174324|NCT02421172|54846371|FG000|Period 1|Adverse Event|1|||
28006820|NCT00697515|54665605|FG001|Dose Optimization Period|Adverse Event|0|||
28006821|NCT00697515|54665604|FG000|Dose Optimization Period|Withdrawal by Subject|5|||
28006822|NCT00697515|54665605|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
28006823|NCT00697515|54665604|FG000|Dose Optimization Period|Lost to Follow-up|2|||
28006824|NCT00697515|54665605|FG001|Dose Optimization Period|Lost to Follow-up|0|||
28006825|NCT00697515|54665604|FG000|Dose Optimization Period|sponsor request|2|||
28006826|NCT00697515|54665605|FG001|Dose Optimization Period|sponsor request|0|||
28006827|NCT00697515|54665604|FG000|Dose Optimization Period|called to active duty|1|||
28006828|NCT00697515|54665605|FG001|Dose Optimization Period|called to active duty|0|||
28006829|NCT00697515|54665604|FG000|Dose Optimization Period|elevated QTc|1|||
28006830|NCT00697515|54665605|FG001|Dose Optimization Period|elevated QTc|0|||
28006831|NCT00697515|54665604|FG000|First Intervention (Crossover Period)|Natural disaster|8|||
28006832|NCT00697515|54665605|FG001|First Intervention (Crossover Period)|Natural disaster|9|||
28006833|NCT00697515|54665604|FG000|First Intervention (Crossover Period)|Adverse Event|0|||
28006834|NCT00697515|54665605|FG001|First Intervention (Crossover Period)|Adverse Event|2|||
28006835|NCT00697515|54665604|FG000|First Intervention (Crossover Period)|Withdrawal by Subject|2|||
28006836|NCT00697515|54665605|FG001|First Intervention (Crossover Period)|Withdrawal by Subject|1|||
28006837|NCT00697515|54665604|FG000|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
28006838|NCT00697515|54665605|FG001|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
28006839|NCT00738062|54665614|FG000|Open Label Treatment|Lack of Efficacy|5|||
28006840|NCT00738062|54665615|FG001|Open Label Treatment|Lack of Efficacy|0|||
28006841|NCT00738062|54665616|FG002|Open Label Treatment|Lack of Efficacy|0|||
28006842|NCT00738062|54665614|FG000|Open Label Treatment|Adverse Event|11|||
28006843|NCT00738062|54665615|FG001|Open Label Treatment|Adverse Event|0|||
28006844|NCT00738062|54665616|FG002|Open Label Treatment|Adverse Event|0|||
28006845|NCT00738062|54665614|FG000|Open Label Treatment|Protocol Violation|2|||
28006846|NCT00738062|54665615|FG001|Open Label Treatment|Protocol Violation|0|||
28006847|NCT00738062|54665616|FG002|Open Label Treatment|Protocol Violation|0|||
28006848|NCT00738062|54665614|FG000|Open Label Treatment|Withdrawal by Subject|9|||
28006849|NCT00738062|54665615|FG001|Open Label Treatment|Withdrawal by Subject|0|||
28006850|NCT00738062|54665616|FG002|Open Label Treatment|Withdrawal by Subject|0|||
28006851|NCT00738062|54665614|FG000|Open Label Treatment|Investigator Decision|1|||
28006852|NCT00738062|54665615|FG001|Open Label Treatment|Investigator Decision|0|||
28006853|NCT00738062|54665616|FG002|Open Label Treatment|Investigator Decision|0|||
28006854|NCT00738062|54665614|FG000|Open-Label Extension|Adverse Event|5|||
28006855|NCT00738062|54665615|FG001|Open-Label Extension|Adverse Event|0|||
28006856|NCT00738062|54665616|FG002|Open-Label Extension|Adverse Event|0|||
28006857|NCT00738062|54665614|FG000|Open-Label Extension|Physician Decision|1|||
28006858|NCT00738062|54665615|FG001|Open-Label Extension|Physician Decision|0|||
28006859|NCT00738062|54665616|FG002|Open-Label Extension|Physician Decision|0|||
28006860|NCT00738062|54665614|FG000|Open-Label Extension|Lack of Efficacy|2|||
28006861|NCT00738062|54665615|FG001|Open-Label Extension|Lack of Efficacy|0|||
28006862|NCT00738062|54665616|FG002|Open-Label Extension|Lack of Efficacy|0|||
28006863|NCT00738062|54665614|FG000|Open-Label Extension|Withdrawal by Subject|6|||
28006864|NCT00738062|54665615|FG001|Open-Label Extension|Withdrawal by Subject|0|||
28006865|NCT00738062|54665616|FG002|Open-Label Extension|Withdrawal by Subject|0|||
28006866|NCT00738062|54665614|FG000|Open-Label Extension|Protocol Violation|1|||
28006867|NCT00738062|54665615|FG001|Open-Label Extension|Protocol Violation|0|||
28006868|NCT00738062|54665616|FG002|Open-Label Extension|Protocol Violation|0|||
28006869|NCT00738062|54665614|FG000|Open-Label Extension|Study Terminated|2|||
28006870|NCT00738062|54665615|FG001|Open-Label Extension|Study Terminated|0|||
28006871|NCT00738062|54665616|FG002|Open-Label Extension|Study Terminated|0|||
28174325|NCT02421172|54846372|FG001|Period 1|Adverse Event|0|||
28174326|NCT02421172|54846373|FG002|Period 1|Adverse Event|0|||
28174327|NCT02421172|54846374|FG003|Period 1|Adverse Event|0|||
28174328|NCT02421172|54846375|FG004|Period 1|Adverse Event|0|||
28174329|NCT02421172|54846371|FG000|Period 1|Lost to Follow-up|3|||
28174330|NCT02421172|54846372|FG001|Period 1|Lost to Follow-up|1|||
28174331|NCT02421172|54846373|FG002|Period 1|Lost to Follow-up|0|||
28174332|NCT02421172|54846374|FG003|Period 1|Lost to Follow-up|0|||
28174333|NCT02421172|54846375|FG004|Period 1|Lost to Follow-up|0|||
28174334|NCT02421172|54846371|FG000|Period 1|Patient/guardian decision|0|||
28174335|NCT02421172|54846372|FG001|Period 1|Patient/guardian decision|1|||
28174336|NCT02421172|54846373|FG002|Period 1|Patient/guardian decision|0|||
28174337|NCT02421172|54846374|FG003|Period 1|Patient/guardian decision|0|||
28174338|NCT02421172|54846375|FG004|Period 1|Patient/guardian decision|0|||
28006872|NCT04245345|54665625|FG000|Overall Study|Death|1|||
28006873|NCT04245345|54665625|FG000|Overall Study|Exited prior to implant|5|||
28006874|NCT04245345|54665625|FG000|Overall Study|Exited prior to 1-month|9|||
28006875|NCT04245345|54665625|FG000|Overall Study|Missed 1-month visit|3|||
28174339|NCT02421172|54846371|FG000|Period 2|Adverse Event|0|||
28174340|NCT02421172|54846372|FG001|Period 2|Adverse Event|0|||
28174341|NCT02421172|54846373|FG002|Period 2|Adverse Event|4|||
28174342|NCT02421172|54846374|FG003|Period 2|Adverse Event|0|||
28174343|NCT02421172|54846375|FG004|Period 2|Adverse Event|0|||
28174344|NCT02421172|54846371|FG000|Period 2|Lost to Follow-up|0|||
28174345|NCT02421172|54846372|FG001|Period 2|Lost to Follow-up|0|||
28174346|NCT02421172|54846373|FG002|Period 2|Lost to Follow-up|0|||
28174347|NCT02421172|54846374|FG003|Period 2|Lost to Follow-up|1|||
28174348|NCT02421172|54846375|FG004|Period 2|Lost to Follow-up|0|||
28174349|NCT02421172|54846371|FG000|Period 2|Patient/guardian decision|0|||
28174350|NCT02421172|54846372|FG001|Period 2|Patient/guardian decision|0|||
28174351|NCT02421172|54846373|FG002|Period 2|Patient/guardian decision|3|||
28174352|NCT02421172|54846374|FG003|Period 2|Patient/guardian decision|2|||
28174353|NCT02421172|54846375|FG004|Period 2|Patient/guardian decision|1|||
28174354|NCT02379052|54846388|FG000|Overall Study|Protocol Violation|0|||
28174355|NCT02379052|54846389|FG001|Overall Study|Protocol Violation|1|||
28174356|NCT02379052|54846388|FG000|Overall Study|Adverse Event|0|||
28174357|NCT02379052|54846389|FG001|Overall Study|Adverse Event|1|||
28174358|NCT02379052|54846388|FG000|Overall Study|Physician Decision|1|||
28174359|NCT02379052|54846389|FG001|Overall Study|Physician Decision|1|||
28174360|NCT02379052|54846388|FG000|Overall Study|Withdrawal by Subject|2|||
28174361|NCT02379052|54846389|FG001|Overall Study|Withdrawal by Subject|0|||
28174362|NCT02379052|54846388|FG000|Overall Study|Lost to Follow-up|2|||
28174363|NCT02379052|54846389|FG001|Overall Study|Lost to Follow-up|1|||
28174364|NCT02379052|54846388|FG000|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1|||
28174365|NCT02379052|54846389|FG001|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0|||
28174366|NCT02379052|54846388|FG000|Overall Study|Subject was Incarcerated|0|||
28174367|NCT02379052|54846389|FG001|Overall Study|Subject was Incarcerated|1|||
28174368|NCT02378662|54846397|FG000|Overall Study|Early Discontinuation|2|||
28174369|NCT02378662|54846398|FG001|Overall Study|Early Discontinuation|0|||
28174370|NCT02378506|54846404|FG000|Overall Study|Lack of Efficacy|3|||
28174371|NCT02378506|54846404|FG000|Overall Study|Withdrawal by Subject|4|||
28174372|NCT02378506|54846404|FG000|Overall Study|Protocol Violation|2|||
28174373|NCT02378506|54846404|FG000|Overall Study|Death|1|||
28174374|NCT02378506|54846404|FG000|Overall Study|Adverse Event|14|||
28174375|NCT02378506|54846404|FG000|Overall Study|Randomized But Not Treated|1|||
28174376|NCT02347774|54846411|FG000|Study Participation|Lost to Follow-up|3|||
28174377|NCT02347774|54846412|FG001|Study Participation|Lost to Follow-up|6|||
28174378|NCT02347774|54846413|FG002|Study Participation|Lost to Follow-up|2|||
28174379|NCT02347774|54846411|FG000|Study Participation|Withdrawal by Subject|8|||
28174380|NCT02347774|54846412|FG001|Study Participation|Withdrawal by Subject|9|||
28174381|NCT02347774|54846413|FG002|Study Participation|Withdrawal by Subject|15|||
28174382|NCT02347774|54846411|FG000|Study Participation|Adverse Event|1|||
28174383|NCT02347774|54846412|FG001|Study Participation|Adverse Event|4|||
28174384|NCT02347774|54846413|FG002|Study Participation|Adverse Event|6|||
28174385|NCT02347774|54846411|FG000|Study Participation|withdrew consent|1|||
28174386|NCT02347774|54846412|FG001|Study Participation|withdrew consent|1|||
28174387|NCT02347774|54846413|FG002|Study Participation|withdrew consent|1|||
28174388|NCT02347774|54846411|FG000|Study Participation|Met Prolonged QT criteria|1|||
28174389|NCT02347774|54846412|FG001|Study Participation|Met Prolonged QT criteria|0|||
28174390|NCT02347774|54846413|FG002|Study Participation|Met Prolonged QT criteria|0|||
28174391|NCT02347774|54846411|FG000|Study Participation|non-compliance with study drug|0|||
28174392|NCT02347774|54846412|FG001|Study Participation|non-compliance with study drug|1|||
28174393|NCT02347774|54846413|FG002|Study Participation|non-compliance with study drug|0|||
28174394|NCT02347774|54846411|FG000|Study Participation|incarceration|1|||
28174395|NCT02347774|54846412|FG001|Study Participation|incarceration|0|||
28174396|NCT02347774|54846413|FG002|Study Participation|incarceration|0|||
28174397|NCT02347774|54846411|FG000|Study Participation|randomized in error|0|||
28174398|NCT02347774|54846412|FG001|Study Participation|randomized in error|0|||
28174399|NCT02347774|54846413|FG002|Study Participation|randomized in error|1|||
28174400|NCT02347774|54846411|FG000|On Study Treatment|Adverse Event|9|||
28174401|NCT02347774|54846412|FG001|On Study Treatment|Adverse Event|15|||
28174402|NCT02347774|54846413|FG002|On Study Treatment|Adverse Event|19|||
28174403|NCT02347774|54846411|FG000|On Study Treatment|Lack of Efficacy|3|||
28174404|NCT02347774|54846412|FG001|On Study Treatment|Lack of Efficacy|0|||
28174405|NCT02347774|54846413|FG002|On Study Treatment|Lack of Efficacy|2|||
28174406|NCT02347774|54846411|FG000|On Study Treatment|non-complicance with study medication|0|||
28174407|NCT02347774|54846412|FG001|On Study Treatment|non-complicance with study medication|2|||
28174408|NCT02347774|54846413|FG002|On Study Treatment|non-complicance with study medication|0|||
28174409|NCT02347774|54846411|FG000|On Study Treatment|Protocol Violation|0|||
28174410|NCT02347774|54846412|FG001|On Study Treatment|Protocol Violation|0|||
28174411|NCT02347774|54846413|FG002|On Study Treatment|Protocol Violation|1|||
28174412|NCT02347774|54846411|FG000|On Study Treatment|withdrew consent|9|||
28174413|NCT02347774|54846412|FG001|On Study Treatment|withdrew consent|8|||
28174414|NCT02347774|54846413|FG002|On Study Treatment|withdrew consent|12|||
28174415|NCT02347774|54846411|FG000|On Study Treatment|Lost to Follow-up|2|||
28174416|NCT02347774|54846412|FG001|On Study Treatment|Lost to Follow-up|6|||
28174417|NCT02347774|54846413|FG002|On Study Treatment|Lost to Follow-up|1|||
28174418|NCT02347774|54846411|FG000|On Study Treatment|Met Prolonged QT criteria|1|||
28174419|NCT02347774|54846412|FG001|On Study Treatment|Met Prolonged QT criteria|0|||
28174420|NCT02347774|54846413|FG002|On Study Treatment|Met Prolonged QT criteria|0|||
28174421|NCT02347774|54846411|FG000|On Study Treatment|ranomized in error|0|||
28174422|NCT02347774|54846412|FG001|On Study Treatment|ranomized in error|0|||
28174423|NCT02347774|54846413|FG002|On Study Treatment|ranomized in error|1|||
28174424|NCT02794883|54846424|FG000|Pre-Surgical Treatment|Withdrawal by Subject|0|||
28174425|NCT02794883|54846425|FG001|Pre-Surgical Treatment|Withdrawal by Subject|0|||
28174426|NCT02794883|54846426|FG002|Pre-Surgical Treatment|Withdrawal by Subject|1|||
28174427|NCT02794883|54846424|FG000|Pre-Surgical Treatment|Progressive Disease|0|||
28174428|NCT02794883|54846425|FG001|Pre-Surgical Treatment|Progressive Disease|1|||
28174429|NCT02794883|54846426|FG002|Pre-Surgical Treatment|Progressive Disease|0|||
28174430|NCT02794883|54846424|FG000|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|1|||
28174431|NCT02794883|54846425|FG001|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|4|||
28174432|NCT02794883|54846426|FG002|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|0|||
28174433|NCT02794883|54846424|FG000|Post-Surgery Treatment (Adjuvant)|Protocol Violation|1|||
28174434|NCT02794883|54846425|FG001|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
28174435|NCT02794883|54846426|FG002|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
28174436|NCT02794883|54846424|FG000|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
28174437|NCT02794883|54846425|FG001|Post-Surgery Treatment (Adjuvant)|Progressive Disease|6|||
28174438|NCT02794883|54846426|FG002|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
28174439|NCT02794883|54846424|FG000|Post-Surgery Treatment (Adjuvant)|Adverse Event|0|||
28174440|NCT02794883|54846425|FG001|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
28174441|NCT02794883|54846426|FG002|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
28174442|NCT02794883|54846424|FG000|Follow-up Period (up to 2 Years)|Death|12|||
28174443|NCT02794883|54846425|FG001|Follow-up Period (up to 2 Years)|Death|10|||
28174444|NCT02794883|54846426|FG002|Follow-up Period (up to 2 Years)|Death|10|||
28174445|NCT01370603|54846436|FG000|Period 1|Adverse Event|5|||
28174446|NCT01370603|54846437|FG001|Period 1|Adverse Event|3|||
28174447|NCT01370603|54846436|FG000|Period 1|Lost to Follow-up|2|||
28174448|NCT01370603|54846437|FG001|Period 1|Lost to Follow-up|0|||
28174449|NCT01370603|54846436|FG000|Period 1|Protocol Violation|2|||
28174450|NCT01370603|54846437|FG001|Period 1|Protocol Violation|2|||
28174451|NCT01370603|54846436|FG000|Period 1|Withdrawal by Subject|5|||
28174452|NCT01370603|54846437|FG001|Period 1|Withdrawal by Subject|5|||
28174453|NCT01370603|54846436|FG000|Crossover Washout|Adverse Event|2|||
28174454|NCT01370603|54846437|FG001|Crossover Washout|Adverse Event|1|||
28174455|NCT01370603|54846436|FG000|Crossover Washout|Lost to Follow-up|2|||
28174456|NCT01370603|54846437|FG001|Crossover Washout|Lost to Follow-up|0|||
28174457|NCT01370603|54846436|FG000|Crossover Washout|Protocol Violation|1|||
28174458|NCT01370603|54846437|FG001|Crossover Washout|Protocol Violation|0|||
28174459|NCT01370603|54846436|FG000|Crossover Washout|Withdrawal by Subject|4|||
28174460|NCT01370603|54846437|FG001|Crossover Washout|Withdrawal by Subject|1|||
28174461|NCT01370603|54846436|FG000|Crossover Washout|Non-compliance with Study Drug|0|||
28174462|NCT01370603|54846437|FG001|Crossover Washout|Non-compliance with Study Drug|2|||
28174463|NCT01370603|54846436|FG000|Period 2|Adverse Event|1|||
28174464|NCT01370603|54846437|FG001|Period 2|Adverse Event|4|||
28174465|NCT01370603|54846436|FG000|Period 2|Lost to Follow-up|1|||
28174466|NCT01370603|54846437|FG001|Period 2|Lost to Follow-up|0|||
28174467|NCT01370603|54846436|FG000|Period 2|Withdrawal by Subject|1|||
28174468|NCT01370603|54846437|FG001|Period 2|Withdrawal by Subject|0|||
28174469|NCT02312206|54846445|FG000|Overall Study|Adverse Event|3|||
28174470|NCT02312206|54846446|FG001|Overall Study|Adverse Event|6|||
28174471|NCT02312206|54846445|FG000|Overall Study|Withdrawal by Subject|7|||
28174472|NCT02312206|54846446|FG001|Overall Study|Withdrawal by Subject|6|||
28174473|NCT02312206|54846445|FG000|Overall Study|Physician Decision|7|||
28174474|NCT02312206|54846446|FG001|Overall Study|Physician Decision|6|||
28174475|NCT02312206|54846445|FG000|Overall Study|Death|30|||
28174476|NCT02312206|54846446|FG001|Overall Study|Death|36|||
28174477|NCT02312206|54846445|FG000|Overall Study|Study Terminated by Sponsor|81|||
28174478|NCT02312206|54846446|FG001|Overall Study|Study Terminated by Sponsor|74|||
28174479|NCT02312206|54846445|FG000|Overall Study|Disease Progression|1|||
28174480|NCT02312206|54846446|FG001|Overall Study|Disease Progression|0|||
28174481|NCT02312206|54846445|FG000|Overall Study|Patient progression and new therapy|1|||
28174482|NCT02312206|54846446|FG001|Overall Study|Patient progression and new therapy|0|||
28174483|NCT02312206|54846445|FG000|Overall Study|Patient transferred to hospice|0|||
28174484|NCT02312206|54846446|FG001|Overall Study|Patient transferred to hospice|1|||
28174485|NCT02312206|54846445|FG000|Overall Study|Subject missed 3 consecutive tx visits|0|||
28174486|NCT02312206|54846446|FG001|Overall Study|Subject missed 3 consecutive tx visits|1|||
28174487|NCT02347072|54846452|FG000|Overall Study|Adverse Event|2|||
28174488|NCT02347072|54846452|FG000|Overall Study|Withdrawal by Subject|6|||
28174489|NCT02347072|54846452|FG000|Overall Study|Physician Decision|1|||
28174490|NCT02347072|54846452|FG000|Overall Study|Lost to Follow-up|2|||
28174491|NCT02347072|54846452|FG000|Overall Study|Protocol Violation|1|||
27740020|NCT02252536|54189800|FG001|Overall Study|Lost to Follow-up|3|||
27740021|NCT02206828|54189806|FG000|Overall Study|Lost to Follow-up|7|||
28174492|NCT02347072|54846452|FG000|Overall Study|Disc due to Protocol-specified Criteria|6|||
28174493|NCT02794103|54846460|FG000|Overall Study|Loss to follow up due to high sedation|3|||
28174494|NCT02346370|54846467|FG000|Overall Study|Not treated|1|||
28174495|NCT02346370|54846468|FG001|Overall Study|Not treated|0|||
28174496|NCT02346370|54846469|FG002|Overall Study|Not treated|0|||
28174497|NCT02346370|54846467|FG000|Overall Study|Withdrawal of consent|1|||
28174498|NCT02346370|54846468|FG001|Overall Study|Withdrawal of consent|0|||
28174499|NCT02346370|54846469|FG002|Overall Study|Withdrawal of consent|0|||
28174500|NCT02346370|54846467|FG000|Overall Study|Death|1|||
28174501|NCT02346370|54846468|FG001|Overall Study|Death|3|||
28174502|NCT02346370|54846469|FG002|Overall Study|Death|1|||
28174503|NCT02346370|54846467|FG000|Overall Study|Sponsor discontinued study|5|||
28174504|NCT02346370|54846468|FG001|Overall Study|Sponsor discontinued study|0|||
28174505|NCT02346370|54846469|FG002|Overall Study|Sponsor discontinued study|2|||
28174506|NCT02346370|54846467|FG000|Overall Study|Radiologic progression|0|||
28174507|NCT02346370|54846468|FG001|Overall Study|Radiologic progression|0|||
28174508|NCT02346370|54846469|FG002|Overall Study|Radiologic progression|1|||
28174509|NCT02346370|54846467|FG000|Overall Study|Physician Decision|0|||
28174510|NCT02346370|54846468|FG001|Overall Study|Physician Decision|1|||
28174511|NCT02346370|54846469|FG002|Overall Study|Physician Decision|0|||
28174512|NCT02346136|54846481|FG000|Overall Study|Withdrawal by Subject|7|||
28174513|NCT02346136|54846482|FG001|Overall Study|Withdrawal by Subject|5|||
28174514|NCT02346136|54846481|FG000|Overall Study|Death|1|||
28174515|NCT02346136|54846482|FG001|Overall Study|Death|0|||
28174516|NCT02346136|54846481|FG000|Overall Study|Study termination|14|||
28174517|NCT02346136|54846482|FG001|Overall Study|Study termination|18|||
28174518|NCT02793947|54846490|FG000|Overall Study|Death|1|||
28174519|NCT02793947|54846491|FG001|Overall Study|Death|0|||
28006876|NCT04245345|54665625|FG000|Overall Study|Predominant rhythm exclusion at 1-month|83|||
28006877|NCT04245345|54665625|FG000|Overall Study|Fewer than 500 evaluable beats|2|||
28006878|NCT00698685|54665631|FG000|Overall Study|Sister withdrew as donor|1|||
28006879|NCT00698685|54665631|FG000|Overall Study|Off study pre transplant by clinic MD|1|||
28006880|NCT00737672|54665637|FG000|Overall Study|Graft Abandonment|48|||
28006881|NCT00737672|54665638|FG001|Overall Study|Graft Abandonment|56|||
28006882|NCT00737672|54665637|FG000|Overall Study|Death|23|||
28006883|NCT00737672|54665638|FG001|Overall Study|Death|22|||
28006884|NCT00737672|54665637|FG000|Overall Study|Withdrawal by Subject|1|||
28006885|NCT00737672|54665638|FG001|Overall Study|Withdrawal by Subject|2|||
28006886|NCT00737672|54665637|FG000|Overall Study|Lost to Follow-up|1|||
28174520|NCT02793947|54846490|FG000|Overall Study|Physician Decision|1|||
28174521|NCT02793947|54846491|FG001|Overall Study|Physician Decision|5|||
28174522|NCT02345512|54846497|FG000|Overall Study|Adverse Event|1|||
28174523|NCT02345512|54846497|FG000|Overall Study|Withdrawal by Subject|1|||
28174524|NCT02345434|54846508|FG000|Overall Study|Deceased (excluded from intervention and analysis)|5|||
28174525|NCT02345434|54846509|FG001|Overall Study|Deceased (excluded from intervention and analysis)|2|||
28174526|NCT01370213|54846518|FG000|Overall Study|Early Death|1|||
28174527|NCT01370213|54846519|FG001|Overall Study|Early Death|0|||
28174528|NCT01370213|54846520|FG002|Overall Study|Early Death|0|||
28174529|NCT01370213|54846518|FG000|Overall Study|Not evaluable|0|||
28174530|NCT01370213|54846519|FG001|Overall Study|Not evaluable|2|||
28174531|NCT01370213|54846520|FG002|Overall Study|Not evaluable|0|||
28174532|NCT01370525|54846529|FG000|Overall Study|Voluntary Discontinuation by Subject|2|||
28174533|NCT01370525|54846530|FG001|Overall Study|Voluntary Discontinuation by Subject|3|||
28174534|NCT01370525|54846529|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
27917349|NCT01335698|54574821|FG004|Treatment Stage 1|No longer meets study criteria|0|||
27917350|NCT01335698|54574817|FG000|Treatment Stage 1|Other|1|||
27917351|NCT01335698|54574818|FG001|Treatment Stage 1|Other|0|||
27917352|NCT01335698|54574819|FG002|Treatment Stage 1|Other|0|||
27917353|NCT01335698|54574820|FG003|Treatment Stage 1|Other|1|||
27917354|NCT01335698|54574821|FG004|Treatment Stage 1|Other|0|||
27917355|NCT01335698|54574817|FG000|Treatment Stage 2|Lack of Efficacy|2|||
27917356|NCT01335698|54574818|FG001|Treatment Stage 2|Lack of Efficacy|1|||
27917357|NCT01335698|54574819|FG002|Treatment Stage 2|Lack of Efficacy|3|||
27917358|NCT01335698|54574820|FG003|Treatment Stage 2|Lack of Efficacy|1|||
27917359|NCT01335698|54574821|FG004|Treatment Stage 2|Lack of Efficacy|0|||
27917360|NCT01335698|54574817|FG000|Treatment Stage 2|Adverse Event|2|||
28006887|NCT00737672|54665638|FG001|Overall Study|Lost to Follow-up|0|||
27740022|NCT01209767|54189833|FG000|Overall Study|Withdrawal by Subject|1|||
28174535|NCT01370525|54846530|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
27917361|NCT01335698|54574818|FG001|Treatment Stage 2|Adverse Event|0|||
28006888|NCT00737672|54665637|FG000|Overall Study|Miscellaneous|7|||
28174536|NCT01370525|54846529|FG000|Overall Study|Adverse Event|0|||
28174537|NCT01370525|54846530|FG001|Overall Study|Adverse Event|1|||
28174538|NCT01370525|54846529|FG000|Overall Study|Protocol Violation|2|||
28174539|NCT01370525|54846530|FG001|Overall Study|Protocol Violation|1|||
27740023|NCT01209767|54189833|FG000|Overall Study|Lost to Follow-up|3|||
28174540|NCT01370525|54846529|FG000|Overall Study|Lost to follow up|2|||
27917362|NCT01335698|54574819|FG002|Treatment Stage 2|Adverse Event|0|||
28006889|NCT00737672|54665638|FG001|Overall Study|Miscellaneous|1|||
27740024|NCT02252146|54189841|FG000|Overall Study|Lack of Efficacy|4|||
27740025|NCT02252146|54189841|FG000|Overall Study|Entered hospice care|1|||
27740026|NCT02252146|54189841|FG000|Overall Study|Inability to travel to study site|1|||
28006890|NCT00737672|54665637|FG000|Overall Study|Physician Decision|0|||
28006891|NCT00737672|54665638|FG001|Overall Study|Physician Decision|2|||
28006892|NCT00737438|54665644|FG000|Overall Study|Withdrawal by Subject|2|||
27917363|NCT01335698|54574820|FG003|Treatment Stage 2|Adverse Event|3|||
27917364|NCT01335698|54574821|FG004|Treatment Stage 2|Adverse Event|0|||
27917365|NCT01335698|54574817|FG000|Treatment Stage 2|Withdrawal by Subject|3|||
27917366|NCT01335698|54574818|FG001|Treatment Stage 2|Withdrawal by Subject|1|||
27917367|NCT01335698|54574819|FG002|Treatment Stage 2|Withdrawal by Subject|1|||
27917368|NCT01335698|54574820|FG003|Treatment Stage 2|Withdrawal by Subject|0|||
27917369|NCT01335698|54574821|FG004|Treatment Stage 2|Withdrawal by Subject|0|||
27917370|NCT01335698|54574817|FG000|Treatment Stage 2|Poor compliance/noncompliance|1|||
27917371|NCT01335698|54574818|FG001|Treatment Stage 2|Poor compliance/noncompliance|0|||
27917372|NCT01335698|54574819|FG002|Treatment Stage 2|Poor compliance/noncompliance|1|||
27917373|NCT01335698|54574820|FG003|Treatment Stage 2|Poor compliance/noncompliance|3|||
27917374|NCT01335698|54574821|FG004|Treatment Stage 2|Poor compliance/noncompliance|1|||
27917375|NCT01335698|54574817|FG000|Treatment Stage 2|Lost to Follow-up|1|||
27917376|NCT01335698|54574818|FG001|Treatment Stage 2|Lost to Follow-up|0|||
27917377|NCT01335698|54574819|FG002|Treatment Stage 2|Lost to Follow-up|0|||
28006893|NCT00737438|54665644|FG000|Overall Study|Patient ineligible|1|||
28006894|NCT00737282|54665650|FG000|Overall Study|Study prematurely terminated|175|||
28006895|NCT03884478|54665659|FG000|Baseline to 2 Months Post-intervention|Lost to Follow-up|30|||
28006896|NCT03884478|54665660|FG001|Baseline to 2 Months Post-intervention|Lost to Follow-up|33|||
28006897|NCT03884478|54665661|FG002|Baseline to 2 Months Post-intervention|Lost to Follow-up|36|||
28006898|NCT03884478|54665659|FG000|Baseline to 2 Months Post-intervention|Withdrawn by research team|1|||
28006899|NCT03884478|54665660|FG001|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
28103468|NCT02858362|54760072|FG002|Overall Study|Early Study Termination|3|||
27740035|NCT02251990|54189860|FG000|Period 1 (Double-blind [DB])|Adverse Event|1|||
27740036|NCT02251990|54189861|FG001|Period 1 (Double-blind [DB])|Adverse Event|1|||
27740037|NCT02251990|54189860|FG000|Period 1 (Double-blind [DB])|Lack of Efficacy|5|||
27740038|NCT02251990|54189861|FG001|Period 1 (Double-blind [DB])|Lack of Efficacy|0|||
27740039|NCT02251990|54189860|FG000|Period 1 (Double-blind [DB])|Withdrawal by Subject|1|||
27740040|NCT02251990|54189861|FG001|Period 1 (Double-blind [DB])|Withdrawal by Subject|0|||
27740041|NCT02251990|54189860|FG000|Period 1 (Double-blind [DB])|Not Treated|1|||
27917378|NCT01335698|54574820|FG003|Treatment Stage 2|Lost to Follow-up|0|||
27917379|NCT01335698|54574821|FG004|Treatment Stage 2|Lost to Follow-up|0|||
27917380|NCT01335698|54574817|FG000|Treatment Stage 2|Capsules received at state hospital|1|||
27917381|NCT01335698|54574818|FG001|Treatment Stage 2|Capsules received at state hospital|0|||
27917382|NCT01335698|54574819|FG002|Treatment Stage 2|Capsules received at state hospital|0|||
27917383|NCT01335698|54574820|FG003|Treatment Stage 2|Capsules received at state hospital|0|||
27917384|NCT01335698|54574821|FG004|Treatment Stage 2|Capsules received at state hospital|0|||
27917385|NCT01335698|54574817|FG000|Treatment Stage 2|Subject no longer meets study criteria|0|||
28103469|NCT02858362|54760070|FG000|Overall Study|Lost to Follow-up|1|||
28103470|NCT02858362|54760071|FG001|Overall Study|Lost to Follow-up|0|||
28103471|NCT02858362|54760072|FG002|Overall Study|Lost to Follow-up|0|||
28103472|NCT03382262|54760089|FG000|Overall Study|Physician Decision|0|||
28103473|NCT03382262|54760090|FG001|Overall Study|Physician Decision|0|||
28103474|NCT03382262|54760091|FG002|Overall Study|Physician Decision|1|||
28103475|NCT03382262|54760092|FG003|Overall Study|Physician Decision|0|||
28103476|NCT03382262|54760089|FG000|Overall Study|Withdrawal by Subject|0|||
28103477|NCT03382262|54760090|FG001|Overall Study|Withdrawal by Subject|0|||
28103478|NCT03382262|54760091|FG002|Overall Study|Withdrawal by Subject|0|||
28103479|NCT03382262|54760092|FG003|Overall Study|Withdrawal by Subject|1|||
28103480|NCT03350750|54760104|FG000|Overall Study|Death|1|||
28103481|NCT03350750|54760105|FG001|Overall Study|Death|1|||
28103482|NCT03394508|54760115|FG000|Overall Study|Protocol Violation|0|||
28103483|NCT03394508|54760116|FG001|Overall Study|Protocol Violation|3|||
28103484|NCT03394508|54760115|FG000|Overall Study|Lost to Follow-up|1|||
28103485|NCT03394508|54760116|FG001|Overall Study|Lost to Follow-up|0|||
28103486|NCT02856880|54760126|FG000|Overall Study|Withdrawal of consent|1|||
28103487|NCT03393806|54760147|FG000|Overall Study|Physician Decision|1|||
28103488|NCT03393806|54760148|FG001|Overall Study|Physician Decision|0|||
28103489|NCT02856802|54760157|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
28103490|NCT02856802|54760158|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|2|||
28103491|NCT02856802|54760157|FG000|Double-Blind Treatment Period 1|Lost to Follow-up|1|||
28103492|NCT02856802|54760158|FG001|Double-Blind Treatment Period 1|Lost to Follow-up|0|||
28103493|NCT02856802|54760157|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
28103494|NCT02856802|54760158|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
28103495|NCT02856802|54760157|FG000|Double-Blind Treatment Period 1|Sponsor terminated|1|||
28103496|NCT02856802|54760158|FG001|Double-Blind Treatment Period 1|Sponsor terminated|0|||
28174541|NCT01370525|54846530|FG001|Overall Study|Lost to follow up|6|||
28174542|NCT02792777|54846538|FG000|Overall Study|Withdrawal by Subject|2|||
28174543|NCT02792777|54846539|FG001|Overall Study|Withdrawal by Subject|0|||
28174544|NCT02792777|54846538|FG000|Overall Study|Recording malfunction|2|||
28174545|NCT02792777|54846539|FG001|Overall Study|Recording malfunction|0|||
28174546|NCT02792777|54846538|FG000|Overall Study|Later determined to be ineligible|2|||
28174547|NCT02792777|54846539|FG001|Overall Study|Later determined to be ineligible|0|||
28174548|NCT02792777|54846538|FG000|Overall Study|Participant interviewed twice|1|||
28174549|NCT02792777|54846539|FG001|Overall Study|Participant interviewed twice|0|||
28174550|NCT02625974|54846548|FG000|Overall Study|Adverse Event|12|||
28174551|NCT02625974|54846549|FG001|Overall Study|Adverse Event|2|||
28174552|NCT02625974|54846548|FG000|Overall Study|Withdrawal by Subject|3|||
28174553|NCT02625974|54846549|FG001|Overall Study|Withdrawal by Subject|1|||
28174554|NCT02625974|54846548|FG000|Overall Study|positive parasitemia|1|||
28174555|NCT02625974|54846549|FG001|Overall Study|positive parasitemia|0|||
28174556|NCT02625974|54846548|FG000|Overall Study|non-compliance with study drug|0|||
28174557|NCT02625974|54846549|FG001|Overall Study|non-compliance with study drug|2|||
28174558|NCT02625974|54846548|FG000|Overall Study|Protocol Violation|0|||
28174559|NCT02625974|54846549|FG001|Overall Study|Protocol Violation|1|||
28174560|NCT02792699|54846594|FG000|Overall Study|Adverse Event|1|||
28174561|NCT02792699|54846595|FG001|Overall Study|Adverse Event|2|||
28174562|NCT02792699|54846596|FG002|Overall Study|Adverse Event|4|||
28174563|NCT02792699|54846594|FG000|Overall Study|Withdrawal by Subject|4|||
28174564|NCT02792699|54846595|FG001|Overall Study|Withdrawal by Subject|4|||
28174565|NCT02792699|54846596|FG002|Overall Study|Withdrawal by Subject|3|||
28174566|NCT02792699|54846594|FG000|Overall Study|Lost to Follow-up|0|||
28174567|NCT02792699|54846595|FG001|Overall Study|Lost to Follow-up|1|||
28174568|NCT02792699|54846596|FG002|Overall Study|Lost to Follow-up|2|||
28174569|NCT02792699|54846594|FG000|Overall Study|Physician Decision|2|||
28174570|NCT02792699|54846595|FG001|Overall Study|Physician Decision|0|||
28174571|NCT02792699|54846596|FG002|Overall Study|Physician Decision|0|||
28174572|NCT02792699|54846594|FG000|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
28174573|NCT02792699|54846595|FG001|Overall Study|Dissatisfaction with Treatment Efficacy|3|||
28174574|NCT02792699|54846596|FG002|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
28174575|NCT02792699|54846594|FG000|Overall Study|Other|1|||
28174576|NCT02792699|54846595|FG001|Overall Study|Other|0|||
28174577|NCT02792699|54846596|FG002|Overall Study|Other|0|||
28174578|NCT03010319|54846613|FG000|Overall Study|Adverse Event|15|||
28174579|NCT03010319|54846614|FG001|Overall Study|Adverse Event|9|||
28174580|NCT03010319|54846613|FG000|Overall Study|Withdrawal by Subject|1|||
28174581|NCT03010319|54846614|FG001|Overall Study|Withdrawal by Subject|6|||
28174582|NCT03010319|54846613|FG000|Overall Study|Physician Decision|2|||
28174583|NCT03010319|54846614|FG001|Overall Study|Physician Decision|4|||
28174584|NCT03010319|54846613|FG000|Overall Study|Sponsor requested withdrawal|2|||
28174585|NCT03010319|54846614|FG001|Overall Study|Sponsor requested withdrawal|2|||
28174586|NCT03010319|54846613|FG000|Overall Study|Death|1|||
28174587|NCT03010319|54846614|FG001|Overall Study|Death|0|||
28174588|NCT03010319|54846613|FG000|Overall Study|Lost to Follow-up|0|||
28174589|NCT03010319|54846614|FG001|Overall Study|Lost to Follow-up|1|||
28174590|NCT03010319|54846613|FG000|Overall Study|Other Reason|5|||
28174591|NCT03010319|54846614|FG001|Overall Study|Other Reason|7|||
28174592|NCT01369511|54846624|FG000|Overall Study|Adverse Event|1|||
28174593|NCT01369511|54846625|FG001|Overall Study|Adverse Event|1|||
28174594|NCT01369511|54846626|FG002|Overall Study|Adverse Event|5|||
28174595|NCT01369511|54846627|FG003|Overall Study|Adverse Event|0|||
28174596|NCT01369511|54846624|FG000|Overall Study|Entry criteria not met|2|||
28174597|NCT01369511|54846625|FG001|Overall Study|Entry criteria not met|0|||
28174598|NCT01369511|54846626|FG002|Overall Study|Entry criteria not met|0|||
28174599|NCT01369511|54846627|FG003|Overall Study|Entry criteria not met|1|||
28174600|NCT01369511|54846624|FG000|Overall Study|Lost to Follow-up|0|||
28174601|NCT01369511|54846625|FG001|Overall Study|Lost to Follow-up|1|||
28174602|NCT01369511|54846626|FG002|Overall Study|Lost to Follow-up|1|||
28174603|NCT01369511|54846627|FG003|Overall Study|Lost to Follow-up|2|||
28174604|NCT01369511|54846624|FG000|Overall Study|Protocol Violation|0|||
28174605|NCT01369511|54846625|FG001|Overall Study|Protocol Violation|1|||
28174606|NCT01369511|54846626|FG002|Overall Study|Protocol Violation|0|||
28174607|NCT01369511|54846627|FG003|Overall Study|Protocol Violation|2|||
28174608|NCT01369511|54846624|FG000|Overall Study|Physician Decision|3|||
28174609|NCT01369511|54846625|FG001|Overall Study|Physician Decision|4|||
28174610|NCT01369511|54846626|FG002|Overall Study|Physician Decision|0|||
28174611|NCT01369511|54846627|FG003|Overall Study|Physician Decision|0|||
28174612|NCT01369511|54846624|FG000|Overall Study|Sponsor decision|2|||
28174613|NCT01369511|54846625|FG001|Overall Study|Sponsor decision|0|||
28174614|NCT01369511|54846626|FG002|Overall Study|Sponsor decision|1|||
28174615|NCT01369511|54846627|FG003|Overall Study|Sponsor decision|0|||
28174616|NCT01369511|54846624|FG000|Overall Study|Withdrawal by Subject|5|||
28174617|NCT01369511|54846625|FG001|Overall Study|Withdrawal by Subject|6|||
27740042|NCT02251990|54189861|FG001|Period 1 (Double-blind [DB])|Not Treated|0|||
28174618|NCT01369511|54846626|FG002|Overall Study|Withdrawal by Subject|4|||
28174619|NCT01369511|54846627|FG003|Overall Study|Withdrawal by Subject|6|||
28174620|NCT01369433|54846639|FG000|Overall Study|Adverse Event|31|||
28174621|NCT01369433|54846640|FG001|Overall Study|Adverse Event|1|||
28174622|NCT01369433|54846639|FG000|Overall Study|Required significant surgical procedure|1|||
28174623|NCT01369433|54846640|FG001|Overall Study|Required significant surgical procedure|0|||
28174624|NCT01369433|54846639|FG000|Overall Study|Non-compliance|1|||
28174625|NCT01369433|54846640|FG001|Overall Study|Non-compliance|0|||
28174626|NCT01369433|54846639|FG000|Overall Study|Withdrawal by Subject|5|||
28174627|NCT01369433|54846640|FG001|Overall Study|Withdrawal by Subject|2|||
28174628|NCT01369433|54846639|FG000|Overall Study|Study terminated by Sponsor|67|||
28174629|NCT01369433|54846640|FG001|Overall Study|Study terminated by Sponsor|0|||
28174630|NCT01369433|54846639|FG000|Overall Study|Lost to Follow-up|1|||
28174631|NCT01369433|54846640|FG001|Overall Study|Lost to Follow-up|0|||
28174632|NCT01369433|54846639|FG000|Overall Study|Death|5|||
28174633|NCT01369433|54846640|FG001|Overall Study|Death|0|||
28174634|NCT01369433|54846639|FG000|Overall Study|Investigator discretion|6|||
28174635|NCT01369433|54846640|FG001|Overall Study|Investigator discretion|1|||
28174636|NCT01369433|54846639|FG000|Overall Study|Progressive Disease|92|||
28174637|NCT01369433|54846640|FG001|Overall Study|Progressive Disease|12|||
28174638|NCT02624492|54846649|FG000|Overall Study|Adverse Event|2|||
28174639|NCT02624492|54846650|FG001|Overall Study|Adverse Event|2|||
28174640|NCT02624492|54846651|FG002|Overall Study|Adverse Event|2|||
28174641|NCT02624492|54846649|FG000|Overall Study|Progressive disease|0|||
28174642|NCT02624492|54846650|FG001|Overall Study|Progressive disease|2|||
28174643|NCT02624492|54846651|FG002|Overall Study|Progressive disease|3|||
28174644|NCT01975831|54846668|FG000|Overall Study|Adverse Event|1|||
28174645|NCT01975831|54846669|FG001|Overall Study|Adverse Event|2|||
28174646|NCT01975831|54846670|FG002|Overall Study|Adverse Event|2|||
28174647|NCT01975831|54846671|FG003|Overall Study|Adverse Event|0|||
28174648|NCT01975831|54846672|FG004|Overall Study|Adverse Event|1|||
28174649|NCT01975831|54846673|FG005|Overall Study|Adverse Event|1|||
28174650|NCT01975831|54846674|FG006|Overall Study|Adverse Event|3|||
28174651|NCT01975831|54846675|FG007|Overall Study|Adverse Event|4|||
28174652|NCT01975831|54846676|FG008|Overall Study|Adverse Event|1|||
28174653|NCT01975831|54846668|FG000|Overall Study|Death|1|||
28174654|NCT01975831|54846669|FG001|Overall Study|Death|1|||
28174655|NCT01975831|54846670|FG002|Overall Study|Death|0|||
28174656|NCT01975831|54846671|FG003|Overall Study|Death|0|||
28174657|NCT01975831|54846672|FG004|Overall Study|Death|1|||
28174658|NCT01975831|54846673|FG005|Overall Study|Death|0|||
28174659|NCT01975831|54846674|FG006|Overall Study|Death|1|||
28174660|NCT01975831|54846675|FG007|Overall Study|Death|0|||
28174661|NCT01975831|54846676|FG008|Overall Study|Death|0|||
28174662|NCT01975831|54846668|FG000|Overall Study|Progressive Disease|1|||
28174663|NCT01975831|54846669|FG001|Overall Study|Progressive Disease|3|||
28174664|NCT01975831|54846670|FG002|Overall Study|Progressive Disease|2|||
28174665|NCT01975831|54846671|FG003|Overall Study|Progressive Disease|4|||
28174666|NCT01975831|54846672|FG004|Overall Study|Progressive Disease|13|||
27917386|NCT01335698|54574818|FG001|Treatment Stage 2|Subject no longer meets study criteria|0|||
27917387|NCT01335698|54574819|FG002|Treatment Stage 2|Subject no longer meets study criteria|0|||
27917388|NCT01335698|54574820|FG003|Treatment Stage 2|Subject no longer meets study criteria|1|||
27917389|NCT01335698|54574821|FG004|Treatment Stage 2|Subject no longer meets study criteria|0|||
27917390|NCT01335698|54574817|FG000|Treatment Stage 2|Switched to another formulation|1|||
27917391|NCT01335698|54574818|FG001|Treatment Stage 2|Switched to another formulation|1|||
27917392|NCT01335698|54574819|FG002|Treatment Stage 2|Switched to another formulation|0|||
27917393|NCT01335698|54574820|FG003|Treatment Stage 2|Switched to another formulation|0|||
27917394|NCT01335698|54574821|FG004|Treatment Stage 2|Switched to another formulation|0|||
27917395|NCT00107198|54574835|FG000|Overall Study|Lack of Efficacy|28|||
27917396|NCT00107198|54574835|FG000|Overall Study|Lost to Follow-up|12|||
27917397|NCT00107198|54574835|FG000|Overall Study|Protocol Violation|1|||
28174667|NCT01975831|54846673|FG005|Overall Study|Progressive Disease|9|||
28174668|NCT01975831|54846674|FG006|Overall Study|Progressive Disease|10|||
28174669|NCT01975831|54846675|FG007|Overall Study|Progressive Disease|8|||
28174670|NCT01975831|54846676|FG008|Overall Study|Progressive Disease|10|||
28174671|NCT01975831|54846668|FG000|Overall Study|Withdrawal by Subject|0|||
28174672|NCT01975831|54846669|FG001|Overall Study|Withdrawal by Subject|3|||
28174673|NCT01975831|54846670|FG002|Overall Study|Withdrawal by Subject|0|||
28174674|NCT01975831|54846671|FG003|Overall Study|Withdrawal by Subject|0|||
27917398|NCT00107198|54574835|FG000|Overall Study|Withdrawal by Subject|6|||
27917399|NCT00107198|54574835|FG000|Overall Study|Ineligible|5|||
28174675|NCT01975831|54846672|FG004|Overall Study|Withdrawal by Subject|3|||
28174676|NCT01975831|54846673|FG005|Overall Study|Withdrawal by Subject|1|||
28174677|NCT01975831|54846674|FG006|Overall Study|Withdrawal by Subject|1|||
28174678|NCT01975831|54846675|FG007|Overall Study|Withdrawal by Subject|0|||
28174679|NCT01975831|54846676|FG008|Overall Study|Withdrawal by Subject|0|||
28174680|NCT01975831|54846668|FG000|Overall Study|Physician Decision|0|||
28174681|NCT01975831|54846669|FG001|Overall Study|Physician Decision|0|||
28174682|NCT01975831|54846670|FG002|Overall Study|Physician Decision|0|||
28174683|NCT01975831|54846671|FG003|Overall Study|Physician Decision|0|||
28174684|NCT01975831|54846672|FG004|Overall Study|Physician Decision|0|||
28174685|NCT01975831|54846673|FG005|Overall Study|Physician Decision|1|||
28174686|NCT01975831|54846674|FG006|Overall Study|Physician Decision|0|||
28174687|NCT01975831|54846675|FG007|Overall Study|Physician Decision|1|||
28174688|NCT01975831|54846676|FG008|Overall Study|Physician Decision|0|||
28174689|NCT01975831|54846668|FG000|Overall Study|Initiation of Subsequent Therapy|0|||
28174690|NCT01975831|54846669|FG001|Overall Study|Initiation of Subsequent Therapy|0|||
28174691|NCT01975831|54846670|FG002|Overall Study|Initiation of Subsequent Therapy|0|||
28174692|NCT01975831|54846671|FG003|Overall Study|Initiation of Subsequent Therapy|0|||
28174693|NCT01975831|54846672|FG004|Overall Study|Initiation of Subsequent Therapy|0|||
28174694|NCT01975831|54846673|FG005|Overall Study|Initiation of Subsequent Therapy|1|||
28174695|NCT01975831|54846674|FG006|Overall Study|Initiation of Subsequent Therapy|0|||
28174696|NCT01975831|54846675|FG007|Overall Study|Initiation of Subsequent Therapy|2|||
28174697|NCT01975831|54846676|FG008|Overall Study|Initiation of Subsequent Therapy|0|||
28174698|NCT01975831|54846668|FG000|Overall Study|Entered Hospice|0|||
28174699|NCT01975831|54846669|FG001|Overall Study|Entered Hospice|0|||
28174700|NCT01975831|54846670|FG002|Overall Study|Entered Hospice|0|||
28174701|NCT01975831|54846671|FG003|Overall Study|Entered Hospice|0|||
28174702|NCT01975831|54846672|FG004|Overall Study|Entered Hospice|0|||
28174703|NCT01975831|54846673|FG005|Overall Study|Entered Hospice|1|||
28174704|NCT01975831|54846674|FG006|Overall Study|Entered Hospice|0|||
28174705|NCT01975831|54846675|FG007|Overall Study|Entered Hospice|0|||
28174706|NCT01975831|54846676|FG008|Overall Study|Entered Hospice|0|||
28174707|NCT01975831|54846668|FG000|Overall Study|Unable to Treat Within Protocol Windows|0|||
28174708|NCT01975831|54846669|FG001|Overall Study|Unable to Treat Within Protocol Windows|0|||
28174709|NCT01975831|54846670|FG002|Overall Study|Unable to Treat Within Protocol Windows|0|||
28174710|NCT01975831|54846671|FG003|Overall Study|Unable to Treat Within Protocol Windows|0|||
28174711|NCT01975831|54846672|FG004|Overall Study|Unable to Treat Within Protocol Windows|0|||
28174712|NCT01975831|54846673|FG005|Overall Study|Unable to Treat Within Protocol Windows|0|||
28174713|NCT01975831|54846674|FG006|Overall Study|Unable to Treat Within Protocol Windows|1|||
28174714|NCT01975831|54846675|FG007|Overall Study|Unable to Treat Within Protocol Windows|0|||
28174715|NCT01975831|54846676|FG008|Overall Study|Unable to Treat Within Protocol Windows|1|||
28174716|NCT00700713|54846699|FG000|Overall Study|Protocol Violation|1|||
28174717|NCT00700713|54846700|FG001|Overall Study|Protocol Violation|0|||
28174718|NCT00700713|54846701|FG002|Overall Study|Protocol Violation|1|||
28174719|NCT00700713|54846699|FG000|Overall Study|Withdrawal by Subject|0|||
28174720|NCT00700713|54846700|FG001|Overall Study|Withdrawal by Subject|0|||
28174721|NCT00700713|54846701|FG002|Overall Study|Withdrawal by Subject|1|||
28174722|NCT02622386|54846709|FG000|First Assignment|Withdrawal by Subject|3|||
28174723|NCT02622386|54846710|FG001|First Assignment|Withdrawal by Subject|2|||
28174724|NCT02622386|54846709|FG000|Washout|Withdrawal by Subject|4|||
28174725|NCT02622386|54846710|FG001|Washout|Withdrawal by Subject|4|||
28174726|NCT02622386|54846709|FG000|Second Assignment|Withdrawal by Subject|0|||
28174727|NCT02622386|54846710|FG001|Second Assignment|Withdrawal by Subject|2|||
28174728|NCT02792231|54846718|FG000|Overall Study|Patient/guardian decision|32|||
28174729|NCT02792231|54846719|FG001|Overall Study|Patient/guardian decision|42|||
27740043|NCT02251990|54189860|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0|||
28103497|NCT02856802|54760157|FG000|Double-Blind Treatment Period 1|Lack of diary compliance|0|||
28103498|NCT02856802|54760158|FG001|Double-Blind Treatment Period 1|Lack of diary compliance|2|||
28103499|NCT02856802|54760157|FG000|Double-Blind Treatment Period 2|Lost to Follow-up|1|||
28103500|NCT02856802|54760158|FG001|Double-Blind Treatment Period 2|Lost to Follow-up|0|||
28103501|NCT03381248|54760170|FG000|Overall Study|Withdrawal by Subject|5|||
28103502|NCT03381248|54760171|FG001|Overall Study|Withdrawal by Subject|3|||
28103503|NCT03381248|54760170|FG000|Overall Study|Lost to Follow-up|3|||
28103504|NCT03381248|54760171|FG001|Overall Study|Lost to Follow-up|2|||
28103505|NCT03381248|54760170|FG000|Overall Study|Lack of Efficacy|1|||
28103506|NCT03381248|54760171|FG001|Overall Study|Lack of Efficacy|0|||
28103507|NCT03381248|54760170|FG000|Overall Study|Adverse Event|2|||
28103508|NCT03381248|54760171|FG001|Overall Study|Adverse Event|0|||
28103509|NCT03381248|54760170|FG000|Overall Study|Protocol Violation|2|||
28103510|NCT03381248|54760171|FG001|Overall Study|Protocol Violation|1|||
28103511|NCT03380390|54760177|FG000|Overall Study|Adverse Event|3|||
28103512|NCT03350672|54760184|FG000|Overall Study|Withdrawal by Subject|7|||
28103513|NCT03350672|54760185|FG001|Overall Study|Withdrawal by Subject|0|||
28103514|NCT03350672|54760186|FG002|Overall Study|Withdrawal by Subject|0|||
28103515|NCT03392168|54760198|FG000|Period 2: Cohort 2|Lost to Follow-up|0|||
28103516|NCT03392168|54760199|FG001|Period 2: Cohort 2|Lost to Follow-up|1|||
28103517|NCT03392168|54760200|FG002|Period 2: Cohort 2|Lost to Follow-up|1|||
28103518|NCT03392168|54760201|FG003|Period 2: Cohort 2|Lost to Follow-up|1|||
28103519|NCT03392168|54760198|FG000|Period 2: Cohort 2|Other|0|||
28103520|NCT03392168|54760199|FG001|Period 2: Cohort 2|Other|1|||
28103521|NCT03392168|54760200|FG002|Period 2: Cohort 2|Other|0|||
28174730|NCT02792231|54846718|FG000|Overall Study|Adverse Event|15|||
28174731|NCT02792231|54846719|FG001|Overall Study|Adverse Event|11|||
28174732|NCT02792231|54846718|FG000|Overall Study|Physician Decision|14|||
28174733|NCT02792231|54846719|FG001|Overall Study|Physician Decision|12|||
28174734|NCT02792231|54846718|FG000|Overall Study|Lack of Efficacy|7|||
28174735|NCT02792231|54846719|FG001|Overall Study|Lack of Efficacy|9|||
28174736|NCT02792231|54846718|FG000|Overall Study|Lost to Follow-up|9|||
28174737|NCT02792231|54846719|FG001|Overall Study|Lost to Follow-up|5|||
28174738|NCT02792231|54846718|FG000|Overall Study|Pregnancy|1|||
28174739|NCT02792231|54846719|FG001|Overall Study|Pregnancy|3|||
28174740|NCT02792231|54846718|FG000|Overall Study|Non-compliance with study treatment|2|||
28174741|NCT02792231|54846719|FG001|Overall Study|Non-compliance with study treatment|1|||
28174742|NCT02792231|54846718|FG000|Overall Study|Protocol deviation|2|||
28174743|NCT02792231|54846719|FG001|Overall Study|Protocol deviation|0|||
28174744|NCT02792231|54846718|FG000|Overall Study|Technical problems|0|||
28174745|NCT02792231|54846719|FG001|Overall Study|Technical problems|1|||
28174746|NCT00700401|54846725|FG000|Overall Study|Detectable HCV RNA after Week 4|82|||
28174747|NCT00700401|54846725|FG000|Overall Study|Adverse Event|5|||
28174748|NCT00700401|54846725|FG000|Overall Study|Refused Treatment|2|||
28174749|NCT00700401|54846725|FG000|Overall Study|Lost to Follow-up|1|||
28174750|NCT00700401|54846725|FG000|Overall Study|Treatment never started|1|||
28174751|NCT00700401|54846725|FG000|Overall Study|HCV RNA not detected at baseline and SAE|1|||
28174752|NCT00700401|54846725|FG000|Overall Study|Withdrawal by Subject|2|||
28174753|NCT02621606|54846732|FG000|Overall Study|Withdrawal by Subject|0|||
28174754|NCT02621606|54846733|FG001|Overall Study|Withdrawal by Subject|1|||
28174755|NCT02621606|54846734|FG002|Overall Study|Withdrawal by Subject|0|||
28174756|NCT02871401|54846744|FG000|Overall Study|Adverse Event|1|||
28174757|NCT02871401|54846745|FG001|Overall Study|Adverse Event|0|||
28174758|NCT02619812|54846755|FG000|Overall Study|Withdrawal by Subject|0|||
28174759|NCT02619812|54846756|FG001|Overall Study|Withdrawal by Subject|0|||
28174760|NCT02619812|54846757|FG002|Overall Study|Withdrawal by Subject|1|||
28174761|NCT02619812|54846758|FG003|Overall Study|Withdrawal by Subject|2|||
28174762|NCT02623322|54846771|FG000|Overall Study|Lost to Follow-up|2|||
28174763|NCT02623322|54846772|FG001|Overall Study|Lost to Follow-up|1|||
28174764|NCT02623322|54846773|FG002|Overall Study|Lost to Follow-up|0|||
28174765|NCT00105157|54846787|FG000|Double-Blind (DB)|Never Treated|1|||
28174766|NCT00105157|54846788|FG001|Double-Blind (DB)|Never Treated|0|||
28174767|NCT00105157|54846789|FG002|Double-Blind (DB)|Never Treated|0|||
28174768|NCT00105157|54846790|FG003|Double-Blind (DB)|Never Treated|0|||
28174769|NCT00105157|54846787|FG000|Double-Blind (DB)|Adverse Event|2|||
28174770|NCT00105157|54846788|FG001|Double-Blind (DB)|Adverse Event|0|||
28174771|NCT00105157|54846789|FG002|Double-Blind (DB)|Adverse Event|1|||
28174772|NCT00105157|54846790|FG003|Double-Blind (DB)|Adverse Event|1|||
28174773|NCT00105157|54846787|FG000|Double-Blind (DB)|Lack of Efficacy|11|||
28174774|NCT00105157|54846788|FG001|Double-Blind (DB)|Lack of Efficacy|14|||
28174775|NCT00105157|54846789|FG002|Double-Blind (DB)|Lack of Efficacy|11|||
28174776|NCT00105157|54846790|FG003|Double-Blind (DB)|Lack of Efficacy|38|||
28174777|NCT00105157|54846787|FG000|Open-Label Continuation of DB|Adverse Event|3|||
28174778|NCT00105157|54846788|FG001|Open-Label Continuation of DB|Adverse Event|1|||
28174779|NCT00105157|54846789|FG002|Open-Label Continuation of DB|Adverse Event|0|||
28174780|NCT00105157|54846790|FG003|Open-Label Continuation of DB|Adverse Event|0|||
28174781|NCT00105157|54846787|FG000|Open-Label Continuation of DB|Lack of Efficacy|1|||
28174782|NCT00105157|54846788|FG001|Open-Label Continuation of DB|Lack of Efficacy|4|||
28174783|NCT00105157|54846789|FG002|Open-Label Continuation of DB|Lack of Efficacy|3|||
28174784|NCT00105157|54846790|FG003|Open-Label Continuation of DB|Lack of Efficacy|1|||
28174785|NCT00105157|54846787|FG000|Open-Label Continuation of DB|Lost to Follow-up|1|||
28174786|NCT00105157|54846788|FG001|Open-Label Continuation of DB|Lost to Follow-up|1|||
27740044|NCT02251990|54189861|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1|||
28006900|NCT03884478|54665661|FG002|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
28006901|NCT03884478|54665659|FG000|Baseline to 4 Months Post-intervention|Lost to Follow-up|42|||
28006902|NCT03884478|54665660|FG001|Baseline to 4 Months Post-intervention|Lost to Follow-up|50|||
28006903|NCT03884478|54665661|FG002|Baseline to 4 Months Post-intervention|Lost to Follow-up|51|||
28006904|NCT03884478|54665659|FG000|Baseline to 4 Months Post-intervention|Withdrawn by research team|1|||
28006905|NCT03884478|54665660|FG001|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
28006906|NCT03884478|54665661|FG002|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
28006907|NCT00582816|54665682|FG000|Overall Study|Engraftment Failure|3|||
28174787|NCT00105157|54846789|FG002|Open-Label Continuation of DB|Lost to Follow-up|1|||
28006908|NCT00737048|54665689|FG000|Overall Study|Physician Decision|0|||
28006909|NCT00737048|54665690|FG001|Overall Study|Physician Decision|0|||
28174788|NCT00105157|54846790|FG003|Open-Label Continuation of DB|Lost to Follow-up|0|||
28174789|NCT00105157|54846787|FG000|Open-Label Continuation of DB|Withdrawal by Subject|0|||
28006910|NCT00737048|54665691|FG002|Overall Study|Physician Decision|1|||
28006911|NCT00737048|54665689|FG000|Overall Study|Adverse Event|0|||
28174790|NCT00105157|54846788|FG001|Open-Label Continuation of DB|Withdrawal by Subject|1|||
28174791|NCT00105157|54846789|FG002|Open-Label Continuation of DB|Withdrawal by Subject|3|||
28174792|NCT00105157|54846790|FG003|Open-Label Continuation of DB|Withdrawal by Subject|0|||
28174793|NCT00105157|54846787|FG000|Open-Label Continuation of DB|Patient did not continue in extension|1|||
28006912|NCT00737048|54665690|FG001|Overall Study|Adverse Event|1|||
28006913|NCT00737048|54665691|FG002|Overall Study|Adverse Event|0|||
28006914|NCT00737048|54665689|FG000|Overall Study|Worsening of the symptoms|3|||
28006915|NCT00737048|54665690|FG001|Overall Study|Worsening of the symptoms|5|||
28006916|NCT00737048|54665691|FG002|Overall Study|Worsening of the symptoms|3|||
28174794|NCT00105157|54846788|FG001|Open-Label Continuation of DB|Patient did not continue in extension|0|||
28174795|NCT00105157|54846789|FG002|Open-Label Continuation of DB|Patient did not continue in extension|0|||
28174796|NCT00105157|54846790|FG003|Open-Label Continuation of DB|Patient did not continue in extension|0|||
28174797|NCT00105157|54846787|FG000|Open-Label Continuation of DB|Patient moved/site stopped trial|1|||
28174798|NCT00105157|54846788|FG001|Open-Label Continuation of DB|Patient moved/site stopped trial|3|||
28174799|NCT00105157|54846789|FG002|Open-Label Continuation of DB|Patient moved/site stopped trial|2|||
28174800|NCT00105157|54846790|FG003|Open-Label Continuation of DB|Patient moved/site stopped trial|0|||
28174801|NCT00105157|54846787|FG000|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
28174802|NCT00105157|54846788|FG001|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
28174803|NCT00105157|54846789|FG002|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
28174804|NCT00105157|54846790|FG003|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1|||
28174805|NCT00105157|54846787|FG000|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7|||
28174806|NCT00105157|54846788|FG001|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6|||
28174807|NCT00105157|54846789|FG002|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5|||
28174808|NCT00105157|54846790|FG003|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10|||
28174809|NCT00105157|54846787|FG000|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
28174810|NCT00105157|54846788|FG001|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
28174811|NCT00105157|54846789|FG002|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
28174812|NCT00105157|54846790|FG003|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
28174813|NCT00105157|54846787|FG000|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
28174814|NCT00105157|54846788|FG001|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
28174815|NCT00105157|54846789|FG002|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
28174816|NCT00105157|54846790|FG003|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5|||
28174817|NCT00105157|54846787|FG000|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
28174818|NCT00105157|54846788|FG001|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0|||
28174819|NCT00105157|54846789|FG002|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
28174820|NCT00105157|54846790|FG003|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
28174821|NCT02148133|54846811|FG000|Overall Study|Investigator discretion|1|||
28174822|NCT02148133|54846811|FG000|Overall Study|Lack of Efficacy|1|||
28174823|NCT02148133|54846811|FG000|Overall Study|Protocol deviation|1|||
28174824|NCT02148133|54846811|FG000|Overall Study|Protocol-defined stopping criteria|2|||
28174825|NCT00803569|54846815|FG000|Overall Study|Progressive Disease|3|||
28174826|NCT00803569|54846815|FG000|Overall Study|Noncompliance|1|||
28174827|NCT00112957|54846819|FG000|Overall Study|Progressive disease|18|||
28174828|NCT00112957|54846819|FG000|Overall Study|Physician Decision|1|||
28174829|NCT02376790|54846826|FG000|Overall Study|Withdrawal by Subject|43|||
28174830|NCT02376790|54846827|FG001|Overall Study|Withdrawal by Subject|36|||
28174831|NCT02376790|54846828|FG002|Overall Study|Withdrawal by Subject|37|||
28174832|NCT02376790|54846826|FG000|Overall Study|Decision by Sponsor|2|||
28174833|NCT02376790|54846827|FG001|Overall Study|Decision by Sponsor|1|||
28174834|NCT02376790|54846828|FG002|Overall Study|Decision by Sponsor|4|||
28174835|NCT02376790|54846826|FG000|Overall Study|Lost to Follow-up|15|||
28174836|NCT02376790|54846827|FG001|Overall Study|Lost to Follow-up|10|||
28174837|NCT02376790|54846828|FG002|Overall Study|Lost to Follow-up|12|||
28174838|NCT02376166|54846836|FG000|Overall Study|Adverse Event|1|||
27917400|NCT00107120|54574841|FG000|Overall Study|Adverse Event|4|||
27917401|NCT00107120|54574842|FG001|Overall Study|Adverse Event|1|||
27917402|NCT00107120|54574841|FG000|Overall Study|Lack of Efficacy|5|||
27917403|NCT00107120|54574842|FG001|Overall Study|Lack of Efficacy|5|||
27917404|NCT00107120|54574841|FG000|Overall Study|Protocol Violation|3|||
27917405|NCT00107120|54574842|FG001|Overall Study|Protocol Violation|0|||
27917406|NCT00107120|54574841|FG000|Overall Study|Withdrawal by Subject|8|||
27917407|NCT00107120|54574842|FG001|Overall Study|Withdrawal by Subject|9|||
27917408|NCT00107120|54574841|FG000|Overall Study|Lost to Follow-up|8|||
27917409|NCT00107120|54574842|FG001|Overall Study|Lost to Follow-up|6|||
27917410|NCT00107120|54574841|FG000|Overall Study|Pregnancy|0|||
27917411|NCT00107120|54574842|FG001|Overall Study|Pregnancy|1|||
27917412|NCT00107120|54574841|FG000|Overall Study|moving away from site|1|||
27917413|NCT00107120|54574842|FG001|Overall Study|moving away from site|1|||
27917414|NCT00107120|54574841|FG000|Overall Study|death of parent|0|||
27917415|NCT00107120|54574842|FG001|Overall Study|death of parent|1|||
28006917|NCT00731822|54665701|FG000|Overall Study|Adverse Event|2|||
28006918|NCT00731822|54665702|FG001|Overall Study|Adverse Event|1|||
28006919|NCT00731822|54665701|FG000|Overall Study|Protocol Violation|1|||
28006920|NCT00731822|54665702|FG001|Overall Study|Protocol Violation|0|||
28006921|NCT00731822|54665701|FG000|Overall Study|Lost to Follow-up|1|||
28174839|NCT02376166|54846836|FG000|Overall Study|Discontinued metformin early|2|||
28174840|NCT02311894|54846840|FG000|Overall Study|Discontinued in error|1|||
28174841|NCT02311894|54846840|FG000|Overall Study|Lost to Follow-up|1|||
28174842|NCT02311894|54846840|FG000|Overall Study|Adverse Event|1|||
28174843|NCT02311894|54846840|FG000|Overall Study|Withdrawal by Subject|1|||
28006922|NCT00731822|54665702|FG001|Overall Study|Lost to Follow-up|0|||
28006923|NCT00731666|54665708|FG000|Overall Study|Adverse Event|2|||
28006924|NCT00731666|54665708|FG000|Overall Study|Lost to Follow-up|8|||
28006925|NCT00731666|54665708|FG000|Overall Study|Withdrawal by Subject|2|||
28006926|NCT00731120|54665715|FG000|Overall Study|Adverse Event|7|||
28006927|NCT00731120|54665716|FG001|Overall Study|Adverse Event|6|||
28006928|NCT00731120|54665717|FG002|Overall Study|Adverse Event|8|||
28006929|NCT00731120|54665715|FG000|Overall Study|Lack of Efficacy|4|||
28006930|NCT00731120|54665716|FG001|Overall Study|Lack of Efficacy|5|||
28006931|NCT00731120|54665717|FG002|Overall Study|Lack of Efficacy|4|||
28006932|NCT00731120|54665715|FG000|Overall Study|Noncompliance with Study Drug|3|||
28006933|NCT00731120|54665716|FG001|Overall Study|Noncompliance with Study Drug|3|||
28006934|NCT00731120|54665717|FG002|Overall Study|Noncompliance with Study Drug|1|||
28006935|NCT00731120|54665715|FG000|Overall Study|Protocol Deviations|1|||
28006936|NCT00731120|54665716|FG001|Overall Study|Protocol Deviations|6|||
28006937|NCT00731120|54665717|FG002|Overall Study|Protocol Deviations|1|||
28006938|NCT00731120|54665715|FG000|Overall Study|Withdrawal of Consent|13|||
28006939|NCT00731120|54665716|FG001|Overall Study|Withdrawal of Consent|8|||
28006940|NCT00731120|54665717|FG002|Overall Study|Withdrawal of Consent|4|||
27917416|NCT01335464|54574850|FG000|Overall Study|Adverse Event|15|||
27917417|NCT01335464|54574851|FG001|Overall Study|Adverse Event|25|||
27917418|NCT01335464|54574850|FG000|Overall Study|Non compliant with protocol|2|||
27917419|NCT01335464|54574851|FG001|Overall Study|Non compliant with protocol|0|||
27917420|NCT01335464|54574850|FG000|Overall Study|Consent withdrawn, not due to AE|12|||
27917421|NCT01335464|54574851|FG001|Overall Study|Consent withdrawn, not due to AE|23|||
27917422|NCT01335464|54574850|FG000|Overall Study|Not treated|2|||
27917423|NCT01335464|54574851|FG001|Overall Study|Not treated|0|||
27917424|NCT01335464|54574850|FG000|Overall Study|Reason other than those stated above|1|||
27917425|NCT01335464|54574851|FG001|Overall Study|Reason other than those stated above|1|||
27917426|NCT00107042|54574859|FG000|Overall Study|Lost to Follow-up|9|||
27917427|NCT00107042|54574860|FG001|Overall Study|Lost to Follow-up|7|||
27917428|NCT00107042|54574859|FG000|Overall Study|Withdrawal by Subject|6|||
27917429|NCT00107042|54574860|FG001|Overall Study|Withdrawal by Subject|1|||
27917430|NCT00107042|54574859|FG000|Overall Study|Moved out of area|5|||
27917431|NCT00107042|54574860|FG001|Overall Study|Moved out of area|3|||
27917432|NCT00107042|54574859|FG000|Overall Study|Pregnancy|1|||
27917433|NCT00107042|54574860|FG001|Overall Study|Pregnancy|1|||
27917434|NCT00107042|54574859|FG000|Overall Study|Inadvertent enrollment|0|||
27917435|NCT00107042|54574860|FG001|Overall Study|Inadvertent enrollment|1|||
27917436|NCT00107042|54574859|FG000|Overall Study|vaccinated outside window|1|||
27917437|NCT00107042|54574860|FG001|Overall Study|vaccinated outside window|1|||
27917438|NCT00107042|54574859|FG000|Overall Study|Disallowed medications|0|||
27917439|NCT00107042|54574860|FG001|Overall Study|Disallowed medications|2|||
27917440|NCT00106964|54574911|FG000|Overall Study|Lost to Follow-up|8|||
27917441|NCT00106964|54574912|FG001|Overall Study|Lost to Follow-up|6|||
27917442|NCT00106964|54574913|FG002|Overall Study|Lost to Follow-up|2|||
27917443|NCT00106964|54574911|FG000|Overall Study|Pregnancy|2|||
27917444|NCT00106964|54574912|FG001|Overall Study|Pregnancy|3|||
27917445|NCT00106964|54574913|FG002|Overall Study|Pregnancy|2|||
27917446|NCT00106964|54574911|FG000|Overall Study|Death|1|||
27917447|NCT00106964|54574912|FG001|Overall Study|Death|1|||
27917448|NCT00106964|54574913|FG002|Overall Study|Death|0|||
27917449|NCT00106964|54574911|FG000|Overall Study|Incarceration|0|||
27917450|NCT00106964|54574912|FG001|Overall Study|Incarceration|1|||
27917451|NCT00106964|54574913|FG002|Overall Study|Incarceration|0|||
27917452|NCT00106964|54574911|FG000|Overall Study|Site Funding Terminated|0|||
27917453|NCT00106964|54574912|FG001|Overall Study|Site Funding Terminated|1|||
27917454|NCT00106964|54574913|FG002|Overall Study|Site Funding Terminated|1|||
27917455|NCT00106964|54574911|FG000|Overall Study|Failure to adhere|2|||
27917456|NCT00106964|54574912|FG001|Overall Study|Failure to adhere|0|||
27917457|NCT00106964|54574913|FG002|Overall Study|Failure to adhere|0|||
27917458|NCT00106964|54574911|FG000|Overall Study|Did not meet eligibility criteria|0|||
27917459|NCT00106964|54574912|FG001|Overall Study|Did not meet eligibility criteria|2|||
27917460|NCT00106964|54574913|FG002|Overall Study|Did not meet eligibility criteria|2|||
27917461|NCT00106964|54574911|FG000|Overall Study|Required disallowed medication|0|||
28006941|NCT00731120|54665715|FG000|Overall Study|Lost to Follow-up|10|||
28006942|NCT00731120|54665716|FG001|Overall Study|Lost to Follow-up|15|||
28006943|NCT00731120|54665717|FG002|Overall Study|Lost to Follow-up|17|||
28006944|NCT00731120|54665715|FG000|Overall Study|Other|4|||
27917462|NCT00106964|54574912|FG001|Overall Study|Required disallowed medication|1|||
27917463|NCT00106964|54574913|FG002|Overall Study|Required disallowed medication|0|||
28006945|NCT00731120|54665716|FG001|Overall Study|Other|0|||
28006946|NCT00731120|54665717|FG002|Overall Study|Other|1|||
28006947|NCT00731042|54665727|FG000|Second Intervention|Did not meet inclusion criteria|0|||
28006948|NCT00731042|54665728|FG001|Second Intervention|Did not meet inclusion criteria|2|||
28006949|NCT00726986|54665734|FG000|Induction Phase|Adverse Event|4|||
28006950|NCT00726986|54665734|FG000|Induction Phase|Withdrawal by Subject|2|||
28006951|NCT00726986|54665734|FG000|Induction Phase|Death|2|||
28006952|NCT00726986|54665734|FG000|Induction Phase|Lack of Efficacy|5|||
28006953|NCT00726986|54665734|FG000|Induction Phase|Secondary Disease|2|||
28006954|NCT00726986|54665734|FG000|Maintenance Phase|Adverse Event|1|||
28006955|NCT00726986|54665734|FG000|Maintenance Phase|Lack of Efficacy|2|||
28174844|NCT02310646|54846846|FG000|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1|||
28174845|NCT02310646|54846847|FG001|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0|||
28174846|NCT02310646|54846846|FG000|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1|||
28174847|NCT02310646|54846847|FG001|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0|||
28174848|NCT02375698|54846871|FG000|Overall Study|Withdrawal by Subject|0|||
28174849|NCT02375698|54846872|FG001|Overall Study|Withdrawal by Subject|2|||
28174850|NCT02375698|54846871|FG000|Overall Study|Physician Decision|2|||
28174851|NCT02375698|54846872|FG001|Overall Study|Physician Decision|0|||
28174852|NCT02374918|54846882|FG000|Overall Study|Protocol Violation|2|||
28174853|NCT02374918|54846883|FG001|Overall Study|Protocol Violation|0|||
28174854|NCT02374918|54846884|FG002|Overall Study|Protocol Violation|2|||
28174855|NCT02374918|54846885|FG003|Overall Study|Protocol Violation|1|||
28174856|NCT02374918|54846882|FG000|Overall Study|Withdrawal by Subject|1|||
28174857|NCT02374918|54846883|FG001|Overall Study|Withdrawal by Subject|1|||
28174858|NCT02374918|54846884|FG002|Overall Study|Withdrawal by Subject|1|||
28174859|NCT02374918|54846885|FG003|Overall Study|Withdrawal by Subject|0|||
28174860|NCT02374918|54846882|FG000|Overall Study|Lack of Efficacy|0|||
28174861|NCT02374918|54846883|FG001|Overall Study|Lack of Efficacy|0|||
28174862|NCT02374918|54846884|FG002|Overall Study|Lack of Efficacy|1|||
28174863|NCT02374918|54846885|FG003|Overall Study|Lack of Efficacy|1|||
28174864|NCT02344576|54846897|FG000|Enrollment|Agreed to Medical Record Review Only|7|||
28174865|NCT02344576|54846898|FG001|Enrollment|Agreed to Medical Record Review Only|8|||
28174866|NCT02344576|54846899|FG002|Enrollment|Agreed to Medical Record Review Only|0|||
28174867|NCT02344576|54846900|FG003|Enrollment|Agreed to Medical Record Review Only|0|||
28174868|NCT02344576|54846897|FG000|1-Month Follow-Up|Death|13|||
28174869|NCT02344576|54846898|FG001|1-Month Follow-Up|Death|8|||
28174870|NCT02344576|54846899|FG002|1-Month Follow-Up|Death|0|||
28174871|NCT02344576|54846900|FG003|1-Month Follow-Up|Death|0|||
28174872|NCT02344576|54846897|FG000|1-Month Follow-Up|Withdrawal by Subject|3|||
28174873|NCT02344576|54846898|FG001|1-Month Follow-Up|Withdrawal by Subject|14|||
28174874|NCT02344576|54846899|FG002|1-Month Follow-Up|Withdrawal by Subject|8|||
28174875|NCT02344576|54846900|FG003|1-Month Follow-Up|Withdrawal by Subject|10|||
28174876|NCT02344576|54846897|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
28174877|NCT02344576|54846898|FG001|1-Month Follow-Up|Lost to Follow-up|5|||
27740045|NCT02251990|54189860|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0|||
27740046|NCT02251990|54189861|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2|||
27740047|NCT02251912|54189870|FG000|Overall Study|Withdrawal by Subject|2|||
27740048|NCT02251912|54189871|FG001|Overall Study|Withdrawal by Subject|3|||
27917464|NCT00106184|54574932|FG000|Overall Study|Withdrawal by Subject|3|||
27917465|NCT00106184|54574933|FG001|Overall Study|Withdrawal by Subject|2|||
27917466|NCT01334918|54574943|FG000|Overall Study|Did not receive study drug|6|||
27917467|NCT01334918|54574944|FG001|Overall Study|Did not receive study drug|0|||
27917468|NCT01334918|54574943|FG000|Overall Study|Adverse Event|2|||
27917469|NCT01334918|54574944|FG001|Overall Study|Adverse Event|0|||
28174878|NCT02344576|54846899|FG002|1-Month Follow-Up|Lost to Follow-up|11|||
28174879|NCT02344576|54846900|FG003|1-Month Follow-Up|Lost to Follow-up|3|||
27917470|NCT01334918|54574943|FG000|Overall Study|Withdrawal by Subject|0|||
27917471|NCT01334918|54574944|FG001|Overall Study|Withdrawal by Subject|1|||
27917472|NCT01332968|54574963|FG000|Induction Period|Adverse Event|23|||
27917473|NCT01332968|54574964|FG001|Induction Period|Adverse Event|26|||
27917474|NCT01332968|54574965|FG002|Induction Period|Adverse Event|0|||
27917475|NCT01332968|54574966|FG003|Induction Period|Adverse Event|0|||
27917476|NCT01332968|54574967|FG004|Induction Period|Adverse Event|0|||
28006956|NCT00696657|54665747|FG000|Overall Study|Protocol Violation|0|||
28006957|NCT00696657|54665748|FG001|Overall Study|Protocol Violation|0|||
28006958|NCT00696657|54665749|FG002|Overall Study|Protocol Violation|0|||
28174880|NCT02344576|54846897|FG000|6-Month Follow-Up|Death|14|||
28174881|NCT02344576|54846898|FG001|6-Month Follow-Up|Death|14|||
28174882|NCT02344576|54846899|FG002|6-Month Follow-Up|Death|0|||
27740049|NCT02251912|54189870|FG000|Overall Study|Adverse Event|0|||
27917477|NCT01332968|54574968|FG005|Induction Period|Adverse Event|0|||
27917478|NCT01332968|54574969|FG006|Induction Period|Adverse Event|0|||
27917479|NCT01332968|54574970|FG007|Induction Period|Adverse Event|0|||
28006959|NCT00696657|54665750|FG003|Overall Study|Protocol Violation|0|||
28006960|NCT00696657|54665751|FG004|Overall Study|Protocol Violation|0|||
28174883|NCT02344576|54846900|FG003|6-Month Follow-Up|Death|0|||
28174884|NCT02344576|54846897|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
28174885|NCT02344576|54846898|FG001|6-Month Follow-Up|Withdrawal by Subject|0|||
28174886|NCT02344576|54846899|FG002|6-Month Follow-Up|Withdrawal by Subject|1|||
28174887|NCT02344576|54846900|FG003|6-Month Follow-Up|Withdrawal by Subject|2|||
28174888|NCT02344576|54846897|FG000|6-Month Follow-Up|Lost to Follow-up|4|||
28174889|NCT02344576|54846898|FG001|6-Month Follow-Up|Lost to Follow-up|5|||
28174890|NCT02344576|54846899|FG002|6-Month Follow-Up|Lost to Follow-up|13|||
28174891|NCT02344576|54846900|FG003|6-Month Follow-Up|Lost to Follow-up|6|||
28174892|NCT02344342|54846916|FG000|Overall Study|Industry partner dropped out|11|||
28174893|NCT02344342|54846917|FG001|Overall Study|Industry partner dropped out|9|||
28174894|NCT02344342|54846918|FG002|Overall Study|Industry partner dropped out|14|||
28174895|NCT02344342|54846919|FG003|Overall Study|Industry partner dropped out|10|||
28174896|NCT02343952|54846933|FG000|Study Treatment|Disease Progression|23|||
28174897|NCT02343952|54846933|FG000|Study Treatment|Death|3|||
28174898|NCT02343952|54846933|FG000|Study Treatment|Adverse Event|19|||
28174899|NCT02343952|54846933|FG000|Study Treatment|Withdrawal by Subject|7|||
28174900|NCT02343952|54846933|FG000|Study Treatment|other complicating Diseases|1|||
28174901|NCT02343952|54846933|FG000|Follow up|Withdrawal by Subject|3|||
28174902|NCT02343952|54846933|FG000|Follow up|Death|33|||
28174903|NCT02343952|54846933|FG000|Follow up|Patient does not meet eligibility for study.|1|||
28174904|NCT02343952|54846933|FG000|Follow up|Research department closed by the practice.|5|||
28174905|NCT02343952|54846933|FG000|Follow up|Patient went home to Russia|1|||
28174906|NCT02343952|54846933|FG000|Follow up|Disease Progression|1|||
28174907|NCT02343952|54846933|FG000|Follow up|study terminated|1|||
28174908|NCT02310568|54846942|FG000|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
28174909|NCT02310568|54846943|FG001|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
28174910|NCT02310568|54846944|FG002|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
28174911|NCT02310568|54846945|FG003|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
28174912|NCT02310568|54846946|FG004|Stage 1 ( 4 Weeks)|Lack of Efficacy|1|||
28174913|NCT02310568|54846942|FG000|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1|||
28174914|NCT02310568|54846943|FG001|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
28174915|NCT02310568|54846944|FG002|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
28174916|NCT02310568|54846945|FG003|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
28174917|NCT02310568|54846946|FG004|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
28174918|NCT02310568|54846942|FG000|Stage 1 ( 4 Weeks)|Other|1|||
28174919|NCT02310568|54846943|FG001|Stage 1 ( 4 Weeks)|Other|1|||
28174920|NCT02310568|54846944|FG002|Stage 1 ( 4 Weeks)|Other|0|||
28174921|NCT02310568|54846945|FG003|Stage 1 ( 4 Weeks)|Other|0|||
28174922|NCT02310568|54846946|FG004|Stage 1 ( 4 Weeks)|Other|0|||
28174923|NCT02310568|54846942|FG000|Stage 1 ( 4 Weeks)|Adverse Event|1|||
28174924|NCT02310568|54846943|FG001|Stage 1 ( 4 Weeks)|Adverse Event|1|||
28174925|NCT02310568|54846944|FG002|Stage 1 ( 4 Weeks)|Adverse Event|1|||
28174926|NCT02310568|54846945|FG003|Stage 1 ( 4 Weeks)|Adverse Event|0|||
28174927|NCT02310568|54846946|FG004|Stage 1 ( 4 Weeks)|Adverse Event|0|||
28174928|NCT02310568|54846942|FG000|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
28174929|NCT02310568|54846943|FG001|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
28174930|NCT02310568|54846944|FG002|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
28174931|NCT02310568|54846945|FG003|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1|||
28174932|NCT02310568|54846946|FG004|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
28174933|NCT02310568|54846942|FG000|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
28174934|NCT02310568|54846943|FG001|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
28174935|NCT02310568|54846944|FG002|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
28174936|NCT02310568|54846945|FG003|Stage 1 ( 4 Weeks)|Lost to Follow-up|1|||
28174937|NCT02310568|54846946|FG004|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
28174938|NCT02310568|54846942|FG000|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
28174939|NCT02310568|54846943|FG001|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
28174940|NCT02310568|54846944|FG002|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
28174941|NCT02310568|54846945|FG003|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
28174942|NCT02310568|54846946|FG004|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
28174943|NCT02310568|54846942|FG000|Stage 2 (4 Weeks)|Other|0|||
28174944|NCT02310568|54846943|FG001|Stage 2 (4 Weeks)|Other|1|||
28174945|NCT02310568|54846944|FG002|Stage 2 (4 Weeks)|Other|1|||
28174946|NCT02310568|54846945|FG003|Stage 2 (4 Weeks)|Other|0|||
28174947|NCT02310568|54846946|FG004|Stage 2 (4 Weeks)|Other|0|||
28174948|NCT02310568|54846942|FG000|Stage 2 (4 Weeks)|Adverse Event|0|||
28174949|NCT02310568|54846943|FG001|Stage 2 (4 Weeks)|Adverse Event|0|||
28174950|NCT02310568|54846944|FG002|Stage 2 (4 Weeks)|Adverse Event|0|||
28174951|NCT02310568|54846945|FG003|Stage 2 (4 Weeks)|Adverse Event|1|||
28174952|NCT02310568|54846946|FG004|Stage 2 (4 Weeks)|Adverse Event|1|||
28174953|NCT02310568|54846942|FG000|Stage 2 (4 Weeks)|Protocol Violation|0|||
28174954|NCT02310568|54846943|FG001|Stage 2 (4 Weeks)|Protocol Violation|0|||
28174955|NCT02310568|54846944|FG002|Stage 2 (4 Weeks)|Protocol Violation|0|||
28174956|NCT02310568|54846945|FG003|Stage 2 (4 Weeks)|Protocol Violation|1|||
28174957|NCT02310568|54846946|FG004|Stage 2 (4 Weeks)|Protocol Violation|0|||
28174958|NCT02310568|54846942|FG000|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
28174959|NCT02310568|54846943|FG001|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
27740050|NCT02251912|54189871|FG001|Overall Study|Adverse Event|2|||
28174960|NCT02310568|54846944|FG002|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
28174961|NCT02310568|54846945|FG003|Stage 2 (4 Weeks)|Lost to Follow-up|2|||
28174962|NCT02310568|54846946|FG004|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
28006961|NCT00696657|54665752|FG005|Overall Study|Protocol Violation|1|||
28006962|NCT00696657|54665753|FG006|Overall Study|Protocol Violation|0|||
28006963|NCT00696657|54665754|FG007|Overall Study|Protocol Violation|0|||
28006964|NCT00696657|54665755|FG008|Overall Study|Protocol Violation|1|||
28006965|NCT00696657|54665747|FG000|Overall Study|Lack of Efficacy|0|||
28006966|NCT00696657|54665748|FG001|Overall Study|Lack of Efficacy|1|||
28006967|NCT00696657|54665749|FG002|Overall Study|Lack of Efficacy|0|||
28006968|NCT00696657|54665750|FG003|Overall Study|Lack of Efficacy|0|||
28006969|NCT00696657|54665751|FG004|Overall Study|Lack of Efficacy|0|||
28006970|NCT00696657|54665752|FG005|Overall Study|Lack of Efficacy|0|||
28006971|NCT00696657|54665753|FG006|Overall Study|Lack of Efficacy|0|||
28006972|NCT00696657|54665754|FG007|Overall Study|Lack of Efficacy|0|||
28006973|NCT00696657|54665755|FG008|Overall Study|Lack of Efficacy|0|||
28006974|NCT00696657|54665747|FG000|Overall Study|Withdrawal criteria|1|||
28006975|NCT00696657|54665748|FG001|Overall Study|Withdrawal criteria|3|||
28006976|NCT00696657|54665749|FG002|Overall Study|Withdrawal criteria|2|||
28006977|NCT00696657|54665750|FG003|Overall Study|Withdrawal criteria|2|||
28006978|NCT00696657|54665751|FG004|Overall Study|Withdrawal criteria|0|||
28006979|NCT00696657|54665752|FG005|Overall Study|Withdrawal criteria|0|||
28006980|NCT00696657|54665753|FG006|Overall Study|Withdrawal criteria|1|||
28006981|NCT00696657|54665754|FG007|Overall Study|Withdrawal criteria|1|||
28006982|NCT00696657|54665755|FG008|Overall Study|Withdrawal criteria|2|||
28006983|NCT00696657|54665747|FG000|Overall Study|Unclassified|0|||
28006984|NCT00696657|54665748|FG001|Overall Study|Unclassified|1|||
28006985|NCT00696657|54665749|FG002|Overall Study|Unclassified|3|||
28006986|NCT00696657|54665750|FG003|Overall Study|Unclassified|2|||
28006987|NCT00696657|54665751|FG004|Overall Study|Unclassified|4|||
28006988|NCT00696657|54665752|FG005|Overall Study|Unclassified|2|||
28006989|NCT00696657|54665753|FG006|Overall Study|Unclassified|0|||
28006990|NCT00696657|54665754|FG007|Overall Study|Unclassified|0|||
28006991|NCT00696657|54665755|FG008|Overall Study|Unclassified|1|||
28006992|NCT00696657|54665747|FG000|Overall Study|Adverse Event|0|||
28006993|NCT00696657|54665748|FG001|Overall Study|Adverse Event|0|||
28006994|NCT00696657|54665749|FG002|Overall Study|Adverse Event|3|||
28006995|NCT00696657|54665750|FG003|Overall Study|Adverse Event|7|||
28006996|NCT00696657|54665751|FG004|Overall Study|Adverse Event|6|||
28006997|NCT00696657|54665752|FG005|Overall Study|Adverse Event|9|||
28006998|NCT00696657|54665753|FG006|Overall Study|Adverse Event|14|||
28006999|NCT00696657|54665754|FG007|Overall Study|Adverse Event|2|||
28007000|NCT00696657|54665755|FG008|Overall Study|Adverse Event|5|||
28007001|NCT00730886|54665777|FG000|Overall Study|Lost to Follow-up|1|||
28007002|NCT00730886|54665778|FG001|Overall Study|Lost to Follow-up|0|||
28007003|NCT00730886|54665777|FG000|Overall Study|Physician Decision|1|||
28007004|NCT00730886|54665778|FG001|Overall Study|Physician Decision|0|||
28007005|NCT00726752|54665784|FG000|Overall Study|Lack of Efficacy|6|||
28007006|NCT00730028|54665802|FG000|Overall Study|Adverse Event|23|||
28007007|NCT00730028|54665803|FG001|Overall Study|Adverse Event|26|||
28007008|NCT00730028|54665804|FG002|Overall Study|Adverse Event|16|||
28007009|NCT00730028|54665805|FG003|Overall Study|Adverse Event|20|||
28007010|NCT00730028|54665806|FG004|Overall Study|Adverse Event|43|||
28007011|NCT00730028|54665802|FG000|Overall Study|Lost to Follow-up|13|||
28007012|NCT00730028|54665803|FG001|Overall Study|Lost to Follow-up|26|||
28007013|NCT00730028|54665804|FG002|Overall Study|Lost to Follow-up|22|||
28007014|NCT00730028|54665805|FG003|Overall Study|Lost to Follow-up|26|||
28007015|NCT00730028|54665806|FG004|Overall Study|Lost to Follow-up|25|||
28007016|NCT00730028|54665802|FG000|Overall Study|Protocol Violation|6|||
28007017|NCT00730028|54665803|FG001|Overall Study|Protocol Violation|1|||
28007018|NCT00730028|54665804|FG002|Overall Study|Protocol Violation|1|||
28007019|NCT00730028|54665805|FG003|Overall Study|Protocol Violation|2|||
28007020|NCT00730028|54665806|FG004|Overall Study|Protocol Violation|0|||
28174963|NCT02310100|54846964|FG000|Overall Study|Physician Decision|3|||
28007021|NCT00730028|54665802|FG000|Overall Study|Withdrawal by Subject|9|||
28007022|NCT00730028|54665803|FG001|Overall Study|Withdrawal by Subject|5|||
28007023|NCT00730028|54665804|FG002|Overall Study|Withdrawal by Subject|4|||
28007024|NCT00730028|54665805|FG003|Overall Study|Withdrawal by Subject|5|||
28007025|NCT00730028|54665806|FG004|Overall Study|Withdrawal by Subject|9|||
28007026|NCT00730028|54665802|FG000|Overall Study|Physician Decision|3|||
28007027|NCT00730028|54665803|FG001|Overall Study|Physician Decision|3|||
28007028|NCT00730028|54665804|FG002|Overall Study|Physician Decision|2|||
28007029|NCT00730028|54665805|FG003|Overall Study|Physician Decision|3|||
28007030|NCT00730028|54665806|FG004|Overall Study|Physician Decision|2|||
28007031|NCT00730028|54665802|FG000|Overall Study|Treatment Failure|5|||
28007032|NCT00730028|54665803|FG001|Overall Study|Treatment Failure|5|||
28007033|NCT00730028|54665804|FG002|Overall Study|Treatment Failure|0|||
28007034|NCT00730028|54665805|FG003|Overall Study|Treatment Failure|0|||
28007035|NCT00730028|54665806|FG004|Overall Study|Treatment Failure|1|||
28007036|NCT00730028|54665802|FG000|Overall Study|Randomization Error|1|||
28007037|NCT00730028|54665803|FG001|Overall Study|Randomization Error|0|||
28007038|NCT00730028|54665804|FG002|Overall Study|Randomization Error|0|||
28007039|NCT00730028|54665805|FG003|Overall Study|Randomization Error|0|||
28007040|NCT00730028|54665806|FG004|Overall Study|Randomization Error|2|||
28007041|NCT00736502|54665818|FG000|Overall Study|Adverse Event|22|||
28007042|NCT00736502|54665818|FG000|Overall Study|Lack of Efficacy|16|||
28007043|NCT00736502|54665818|FG000|Overall Study|Lost to Follow-up|27|||
28007044|NCT00729560|54665822|FG000|Overall Study|Withdrawal by Subject|3|||
28007045|NCT00736190|54665826|FG000|Overall Study|Pregnancy|1|||
28007046|NCT00736190|54665826|FG000|Overall Study|Withdrawal by Subject|1|||
28007047|NCT00736190|54665826|FG000|Overall Study|Adverse Event|1|||
28007048|NCT00729326|54665832|FG000|Overall Study|Lost to Follow-up|2|||
28007049|NCT00729326|54665833|FG001|Overall Study|Lost to Follow-up|0|||
28007050|NCT00729326|54665832|FG000|Overall Study|Physician Decision|0|||
28007051|NCT00729326|54665833|FG001|Overall Study|Physician Decision|1|||
28007052|NCT00729326|54665832|FG000|Overall Study|Protocol Violation|3|||
28007053|NCT00729326|54665833|FG001|Overall Study|Protocol Violation|2|||
28007054|NCT00729326|54665832|FG000|Overall Study|Subject Decision|4|||
28007055|NCT00729326|54665833|FG001|Overall Study|Subject Decision|4|||
28007056|NCT00729326|54665832|FG000|Overall Study|Sponsor Decision|1|||
28007057|NCT00729326|54665833|FG001|Overall Study|Sponsor Decision|2|||
28007058|NCT00729248|54665839|FG000|Overall Study|Physician Decision|2|||
28007059|NCT00696423|54665846|FG000|Overall Study|Lost to Follow-up|0|||
28007060|NCT00696423|54665847|FG001|Overall Study|Lost to Follow-up|5|||
28007061|NCT00736034|54665853|FG000|Overall Study|Adverse Event|2|||
28007062|NCT00576693|54665859|FG000|Overall Study|Lost to Follow-up|7|||
28007063|NCT00576693|54665860|FG001|Overall Study|Lost to Follow-up|11|||
28007064|NCT00576693|54665859|FG000|Overall Study|Withdrawal by Subject|3|||
28007065|NCT00576693|54665860|FG001|Overall Study|Withdrawal by Subject|13|||
28007066|NCT00698451|54665866|FG000|Overall Study|Adverse Event|22|||
28007067|NCT00698451|54665866|FG000|Overall Study|Physician Decision|2|||
28007068|NCT00698451|54665866|FG000|Overall Study|Protocol Violation|6|||
28007069|NCT00698451|54665866|FG000|Overall Study|Withdrawal by Subject|6|||
28007070|NCT00698451|54665866|FG000|Overall Study|Disease progression|3|||
28007071|NCT00697827|54665872|FG000|Overall Study|enrolled but not treated|2|||
28007072|NCT00697827|54665873|FG001|Overall Study|enrolled but not treated|1|||
28007073|NCT00728936|54665886|FG000|Overall Study|Withdrawal by Subject|0|||
28007074|NCT00728936|54665887|FG001|Overall Study|Withdrawal by Subject|0|||
28007075|NCT00728936|54665888|FG002|Overall Study|Withdrawal by Subject|0|||
28007076|NCT00728936|54665889|FG003|Overall Study|Withdrawal by Subject|0|||
28007077|NCT00728936|54665890|FG004|Overall Study|Withdrawal by Subject|0|||
28007078|NCT00728936|54665891|FG005|Overall Study|Withdrawal by Subject|1|||
28007079|NCT00728936|54665892|FG006|Overall Study|Withdrawal by Subject|0|||
28007080|NCT00693693|54665911|FG000|Overall Study|Lost to Follow-up|1|||
28007081|NCT00693693|54665912|FG001|Overall Study|Lost to Follow-up|1|||
28007082|NCT00693693|54665913|FG002|Overall Study|Lost to Follow-up|2|||
28007083|NCT00728468|54665921|FG000|Overall Study|Enrolled but not treated|1|||
28007084|NCT00728468|54665921|FG000|Overall Study|Death|1|||
28007085|NCT00728468|54665921|FG000|Overall Study|Protocol Violation|4|||
28007086|NCT00728468|54665921|FG000|Overall Study|Objective progression or relapse|9|||
28007087|NCT00728468|54665921|FG000|Overall Study|Study terminated by sponsor|1|||
28007088|NCT00727844|54665927|FG000|Initial Randomization|Physician Decision|2|||
28007089|NCT00727844|54665928|FG001|Initial Randomization|Physician Decision|0|||
28007090|NCT00727844|54665929|FG002|Initial Randomization|Physician Decision|0|||
28007091|NCT00727844|54665930|FG003|Initial Randomization|Physician Decision|0|||
28007092|NCT00735878|54665938|FG000|Phase I- Dose Determination|Withdrawal by Subject|0|||
28007093|NCT00735878|54665939|FG001|Phase I- Dose Determination|Withdrawal by Subject|0|||
28007094|NCT00735878|54665940|FG002|Phase I- Dose Determination|Withdrawal by Subject|1|||
28007095|NCT00695955|54665951|FG000|Cohort 1|Adverse Event|26|||
28007096|NCT00695955|54665951|FG000|Cohort 1|Protocol Violation|2|||
28007097|NCT00695955|54665951|FG000|Cohort 1|Lost to Follow-up|30|||
28007098|NCT00695955|54665951|FG000|Cohort 1|Withdrawal by Subject|25|||
28007099|NCT00695955|54665951|FG000|Cohort 1|Lack of Efficacy|3|||
28007100|NCT00695955|54665951|FG000|Cohort 1|Other|16|||
27917480|NCT01332968|54574963|FG000|Induction Period|Death|1|||
27917481|NCT01332968|54574964|FG001|Induction Period|Death|4|||
27917482|NCT01332968|54574965|FG002|Induction Period|Death|0|||
27917483|NCT01332968|54574966|FG003|Induction Period|Death|0|||
27917484|NCT01332968|54574967|FG004|Induction Period|Death|0|||
27917485|NCT01332968|54574968|FG005|Induction Period|Death|0|||
27917486|NCT01332968|54574969|FG006|Induction Period|Death|0|||
27917487|NCT01332968|54574970|FG007|Induction Period|Death|0|||
27917488|NCT01332968|54574963|FG000|Induction Period|Non-compliance|1|||
27917489|NCT01332968|54574964|FG001|Induction Period|Non-compliance|0|||
27917490|NCT01332968|54574965|FG002|Induction Period|Non-compliance|0|||
28007101|NCT00695955|54665951|FG000|Cohort 2|Adverse Event|24|||
28007102|NCT00695955|54665951|FG000|Cohort 2|Protocol Violation|5|||
28007103|NCT00695955|54665951|FG000|Cohort 2|Lost to Follow-up|38|||
28007104|NCT00695955|54665951|FG000|Cohort 2|Withdrawal by Subject|28|||
28007105|NCT00695955|54665951|FG000|Cohort 2|Lack of Efficacy|4|||
28007106|NCT00695955|54665951|FG000|Cohort 2|Other|5|||
28007107|NCT00693225|54665959|FG000|Overall Study|Lost to Follow-up|1|||
28007108|NCT00693225|54665960|FG001|Overall Study|Lost to Follow-up|2|||
28007109|NCT00693225|54665959|FG000|Overall Study|Adverse Event|1|||
28007110|NCT00693225|54665960|FG001|Overall Study|Adverse Event|3|||
28007111|NCT00735644|54665971|FG000|Overall Study|Did not receive study vaccine|0|||
28007112|NCT00735644|54665972|FG001|Overall Study|Did not receive study vaccine|1|||
28007113|NCT00735644|54665973|FG002|Overall Study|Did not receive study vaccine|0|||
28007114|NCT00735644|54665974|FG003|Overall Study|Did not receive study vaccine|0|||
28007115|NCT00735644|54665975|FG004|Overall Study|Did not receive study vaccine|0|||
28007116|NCT00735644|54665971|FG000|Overall Study|Withdrawal by Subject|0|||
28007117|NCT00735644|54665972|FG001|Overall Study|Withdrawal by Subject|1|||
28007118|NCT00735644|54665973|FG002|Overall Study|Withdrawal by Subject|1|||
28007119|NCT00735644|54665974|FG003|Overall Study|Withdrawal by Subject|1|||
28007120|NCT00735644|54665975|FG004|Overall Study|Withdrawal by Subject|0|||
28007121|NCT03718299|54665994|FG000|Overall Study|Adverse Event|1|||
28007122|NCT03718299|54665994|FG000|Overall Study|Withdrawal by Subject|6|||
28007123|NCT03718299|54665994|FG000|Overall Study|Physician Decision|2|||
28007124|NCT03718299|54665994|FG000|Overall Study|Lost to Follow-up|1|||
28007125|NCT00724958|54665998|FG000|Overall Study|Adverse Event|28|||
28007126|NCT00724958|54665998|FG000|Overall Study|Loss of Response|40|||
28007127|NCT00724958|54665998|FG000|Overall Study|No Response|18|||
28007128|NCT00724958|54665998|FG000|Overall Study|Remission|7|||
28007129|NCT00724958|54665998|FG000|Overall Study|Other Reason|76|||
28007130|NCT00724958|54665998|FG000|Overall Study|No documentation for end of therapy|13|||
28007131|NCT00695565|54666004|FG000|Overall Study|Lost to Follow-up|4|||
28007132|NCT00695565|54666005|FG001|Overall Study|Lost to Follow-up|4|||
28007133|NCT00695565|54666004|FG000|Overall Study|Adverse Event|3|||
28007134|NCT00695565|54666005|FG001|Overall Study|Adverse Event|1|||
28007135|NCT00695565|54666004|FG000|Overall Study|Protocol Violation|3|||
28007136|NCT00695565|54666005|FG001|Overall Study|Protocol Violation|1|||
28007137|NCT00695565|54666004|FG000|Overall Study|Withdrawal by Subject|1|||
28007138|NCT00695565|54666005|FG001|Overall Study|Withdrawal by Subject|1|||
28007139|NCT00695565|54666004|FG000|Overall Study|Lack of Efficacy|1|||
28007140|NCT00695565|54666005|FG001|Overall Study|Lack of Efficacy|1|||
28007141|NCT00695565|54666004|FG000|Overall Study|Subject did not follow instructions|1|||
28007142|NCT00695565|54666005|FG001|Overall Study|Subject did not follow instructions|1|||
28007143|NCT00727532|54666011|FG000|Overall Study|Adverse Event|1|||
28007144|NCT00727532|54666011|FG000|Overall Study|Withdrawal by Subject|1|||
28007145|NCT00721214|54666015|FG000|Overall Study|Chose another center for transplant|1|||
28007146|NCT00721214|54666015|FG000|Overall Study|Death|3|||
28007147|NCT00720902|54666021|FG000|Overall Study|Withdrawal by Subject|1|||
28007148|NCT00720902|54666022|FG001|Overall Study|Withdrawal by Subject|0|||
28007149|NCT00720902|54666021|FG000|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|3|||
28007150|NCT00720902|54666022|FG001|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|0|||
28007151|NCT00695019|54666031|FG000|Overall Study|Withdrawal by Subject|8|||
28007152|NCT00695019|54666032|FG001|Overall Study|Withdrawal by Subject|6|||
28007153|NCT00695019|54666033|FG002|Overall Study|Withdrawal by Subject|4|||
28007154|NCT00695019|54666031|FG000|Overall Study|Protocol Violation|1|||
28007155|NCT00695019|54666032|FG001|Overall Study|Protocol Violation|3|||
28007156|NCT00695019|54666033|FG002|Overall Study|Protocol Violation|1|||
28007157|NCT00695019|54666031|FG000|Overall Study|Lack of Efficacy|0|||
28007158|NCT00695019|54666032|FG001|Overall Study|Lack of Efficacy|0|||
28007159|NCT00695019|54666033|FG002|Overall Study|Lack of Efficacy|1|||
28007160|NCT00695019|54666031|FG000|Overall Study|Various|4|||
28007161|NCT00695019|54666032|FG001|Overall Study|Various|5|||
28007162|NCT00695019|54666033|FG002|Overall Study|Various|4|||
28007163|NCT00694707|54666046|FG000|Overall Study|Did Not Receive Treatment|0|||
28007164|NCT00694707|54666047|FG001|Overall Study|Did Not Receive Treatment|0|||
28007165|NCT00694707|54666048|FG002|Overall Study|Did Not Receive Treatment|1|||
28007166|NCT00694707|54666049|FG003|Overall Study|Did Not Receive Treatment|1|||
28007167|NCT00694707|54666050|FG004|Overall Study|Did Not Receive Treatment|1|||
28007168|NCT00694707|54666046|FG000|Overall Study|Adverse Event|22|||
28007169|NCT00694707|54666047|FG001|Overall Study|Adverse Event|14|||
28007170|NCT00694707|54666048|FG002|Overall Study|Adverse Event|8|||
27917491|NCT01332968|54574966|FG003|Induction Period|Non-compliance|0|||
28007171|NCT00694707|54666049|FG003|Overall Study|Adverse Event|12|||
28007172|NCT00694707|54666050|FG004|Overall Study|Adverse Event|13|||
28007173|NCT00694707|54666046|FG000|Overall Study|Insufficient Therapeutic Response|33|||
28007174|NCT00694707|54666047|FG001|Overall Study|Insufficient Therapeutic Response|18|||
28007175|NCT00694707|54666048|FG002|Overall Study|Insufficient Therapeutic Response|17|||
28007176|NCT00694707|54666049|FG003|Overall Study|Insufficient Therapeutic Response|15|||
28007177|NCT00694707|54666050|FG004|Overall Study|Insufficient Therapeutic Response|10|||
28007178|NCT00694707|54666046|FG000|Overall Study|Protocol Violation|1|||
28007179|NCT00694707|54666047|FG001|Overall Study|Protocol Violation|2|||
28007180|NCT00694707|54666048|FG002|Overall Study|Protocol Violation|1|||
28007181|NCT00694707|54666049|FG003|Overall Study|Protocol Violation|3|||
28007182|NCT00694707|54666050|FG004|Overall Study|Protocol Violation|1|||
28007183|NCT00694707|54666046|FG000|Overall Study|Withdrawal of Consent|14|||
28007184|NCT00694707|54666047|FG001|Overall Study|Withdrawal of Consent|18|||
28007185|NCT00694707|54666048|FG002|Overall Study|Withdrawal of Consent|22|||
28007186|NCT00694707|54666049|FG003|Overall Study|Withdrawal of Consent|16|||
28007187|NCT00694707|54666050|FG004|Overall Study|Withdrawal of Consent|15|||
28007188|NCT00694707|54666046|FG000|Overall Study|Lost to Follow-up|0|||
28007189|NCT00694707|54666047|FG001|Overall Study|Lost to Follow-up|1|||
28007190|NCT00694707|54666048|FG002|Overall Study|Lost to Follow-up|2|||
28007191|NCT00694707|54666049|FG003|Overall Study|Lost to Follow-up|0|||
28007192|NCT00694707|54666050|FG004|Overall Study|Lost to Follow-up|0|||
28007193|NCT00694707|54666046|FG000|Overall Study|Jeopardizing Parole Status|1|||
28174964|NCT02310100|54846964|FG000|Overall Study|Withdrawal by Subject|10|||
28174965|NCT02310100|54846964|FG000|Overall Study|Enrollment closure|1|||
28174966|NCT02310100|54846964|FG000|Overall Study|Unapproved ablation operator|1|||
28174967|NCT02310100|54846964|FG000|Overall Study|Visit compliance|1|||
28174968|NCT02310100|54846964|FG000|Overall Study|Lost to Follow-up|2|||
28174969|NCT02780167|54846974|FG000|Overall Study|Adverse Event|9|||
28174970|NCT02780167|54846975|FG001|Overall Study|Adverse Event|8|||
28174971|NCT02780167|54846976|FG002|Overall Study|Adverse Event|8|||
28174972|NCT02780167|54846977|FG003|Overall Study|Adverse Event|12|||
27740051|NCT02206048|54189886|FG000|Overall Study|Change in OR schedule and availability of study staff|1|||
27917492|NCT01332968|54574967|FG004|Induction Period|Non-compliance|0|||
28174973|NCT02780167|54846978|FG004|Overall Study|Adverse Event|8|||
28174974|NCT02780167|54846974|FG000|Overall Study|Lack of Efficacy|6|||
28174975|NCT02780167|54846975|FG001|Overall Study|Lack of Efficacy|5|||
28174976|NCT02780167|54846976|FG002|Overall Study|Lack of Efficacy|6|||
28174977|NCT02780167|54846977|FG003|Overall Study|Lack of Efficacy|1|||
28174978|NCT02780167|54846978|FG004|Overall Study|Lack of Efficacy|0|||
28174979|NCT02780167|54846974|FG000|Overall Study|Lost to Follow-up|2|||
27917493|NCT01332968|54574968|FG005|Induction Period|Non-compliance|0|||
27917494|NCT01332968|54574969|FG006|Induction Period|Non-compliance|0|||
27917495|NCT01332968|54574970|FG007|Induction Period|Non-compliance|0|||
27917496|NCT01332968|54574963|FG000|Induction Period|Other|2|||
27917497|NCT01332968|54574964|FG001|Induction Period|Other|2|||
27917498|NCT01332968|54574965|FG002|Induction Period|Other|0|||
27917499|NCT01332968|54574966|FG003|Induction Period|Other|0|||
27917500|NCT01332968|54574967|FG004|Induction Period|Other|0|||
27917501|NCT01332968|54574968|FG005|Induction Period|Other|0|||
27917502|NCT01332968|54574969|FG006|Induction Period|Other|0|||
27917503|NCT01332968|54574970|FG007|Induction Period|Other|0|||
27917504|NCT01332968|54574963|FG000|Induction Period|Physician Decision|6|||
27917505|NCT01332968|54574964|FG001|Induction Period|Physician Decision|1|||
27917506|NCT01332968|54574965|FG002|Induction Period|Physician Decision|0|||
27917507|NCT01332968|54574966|FG003|Induction Period|Physician Decision|0|||
27917508|NCT01332968|54574967|FG004|Induction Period|Physician Decision|0|||
27917509|NCT01332968|54574968|FG005|Induction Period|Physician Decision|0|||
27917510|NCT01332968|54574969|FG006|Induction Period|Physician Decision|0|||
27917511|NCT01332968|54574970|FG007|Induction Period|Physician Decision|0|||
27917512|NCT01332968|54574963|FG000|Induction Period|Progressive Disease|15|||
27917513|NCT01332968|54574964|FG001|Induction Period|Progressive Disease|7|||
27917514|NCT01332968|54574965|FG002|Induction Period|Progressive Disease|0|||
27917515|NCT01332968|54574966|FG003|Induction Period|Progressive Disease|0|||
27917516|NCT01332968|54574967|FG004|Induction Period|Progressive Disease|0|||
28007194|NCT00694707|54666047|FG001|Overall Study|Jeopardizing Parole Status|0|||
28007195|NCT00694707|54666048|FG002|Overall Study|Jeopardizing Parole Status|0|||
28007196|NCT00694707|54666049|FG003|Overall Study|Jeopardizing Parole Status|0|||
28007197|NCT00694707|54666050|FG004|Overall Study|Jeopardizing Parole Status|0|||
28007198|NCT00694707|54666046|FG000|Overall Study|Death in the Family|1|||
28174980|NCT02780167|54846975|FG001|Overall Study|Lost to Follow-up|0|||
28174981|NCT02780167|54846976|FG002|Overall Study|Lost to Follow-up|1|||
28174982|NCT02780167|54846977|FG003|Overall Study|Lost to Follow-up|0|||
28174983|NCT02780167|54846978|FG004|Overall Study|Lost to Follow-up|0|||
28174984|NCT02780167|54846974|FG000|Overall Study|Does not meet entrance criteria|0|||
28174985|NCT02780167|54846975|FG001|Overall Study|Does not meet entrance criteria|0|||
28174986|NCT02780167|54846976|FG002|Overall Study|Does not meet entrance criteria|1|||
28174987|NCT02780167|54846977|FG003|Overall Study|Does not meet entrance criteria|0|||
28174988|NCT02780167|54846978|FG004|Overall Study|Does not meet entrance criteria|0|||
27740052|NCT02205814|54189898|FG000|Overall Study|Lost to Follow-up|0|||
27917517|NCT01332968|54574968|FG005|Induction Period|Progressive Disease|0|||
27917518|NCT01332968|54574969|FG006|Induction Period|Progressive Disease|0|||
27917519|NCT01332968|54574970|FG007|Induction Period|Progressive Disease|0|||
27917520|NCT01332968|54574963|FG000|Induction Period|Protocol Violation|3|||
28007199|NCT00694707|54666047|FG001|Overall Study|Death in the Family|0|||
27917521|NCT01332968|54574964|FG001|Induction Period|Protocol Violation|4|||
28007200|NCT00694707|54666048|FG002|Overall Study|Death in the Family|0|||
28007201|NCT00694707|54666049|FG003|Overall Study|Death in the Family|0|||
28174989|NCT02780167|54846974|FG000|Overall Study|No longer meets eligibility criteria|0|||
28007202|NCT00694707|54666050|FG004|Overall Study|Death in the Family|0|||
28007203|NCT00694707|54666046|FG000|Overall Study|Arrest by Police|0|||
28007204|NCT00694707|54666047|FG001|Overall Study|Arrest by Police|1|||
28007205|NCT00694707|54666048|FG002|Overall Study|Arrest by Police|0|||
28007206|NCT00694707|54666049|FG003|Overall Study|Arrest by Police|0|||
28007207|NCT00694707|54666050|FG004|Overall Study|Arrest by Police|0|||
28007208|NCT00694707|54666046|FG000|Overall Study|Administrative Reasons|0|||
28007209|NCT00694707|54666047|FG001|Overall Study|Administrative Reasons|1|||
28007210|NCT00694707|54666048|FG002|Overall Study|Administrative Reasons|0|||
28007211|NCT00694707|54666049|FG003|Overall Study|Administrative Reasons|2|||
28007212|NCT00694707|54666050|FG004|Overall Study|Administrative Reasons|0|||
28007213|NCT00694707|54666046|FG000|Overall Study|Notification of Past Head Injury|0|||
28007214|NCT00694707|54666047|FG001|Overall Study|Notification of Past Head Injury|0|||
28007215|NCT00694707|54666048|FG002|Overall Study|Notification of Past Head Injury|0|||
28007216|NCT00694707|54666049|FG003|Overall Study|Notification of Past Head Injury|1|||
28007217|NCT00694707|54666050|FG004|Overall Study|Notification of Past Head Injury|0|||
28007218|NCT00692913|54666064|FG000|Overall Study|Adverse Event|8|||
28007219|NCT00692913|54666065|FG001|Overall Study|Adverse Event|4|||
28007220|NCT00692913|54666064|FG000|Overall Study|Lost to Follow-up|3|||
28007221|NCT00692913|54666065|FG001|Overall Study|Lost to Follow-up|5|||
28007222|NCT00692913|54666064|FG000|Overall Study|Physician Decision|2|||
28007223|NCT00692913|54666065|FG001|Overall Study|Physician Decision|0|||
28007224|NCT00692913|54666064|FG000|Overall Study|Protocol Violation|1|||
28007225|NCT00692913|54666065|FG001|Overall Study|Protocol Violation|1|||
28007226|NCT00692913|54666064|FG000|Overall Study|Withdrawal by Subject|15|||
28007227|NCT00692913|54666065|FG001|Overall Study|Withdrawal by Subject|20|||
28007228|NCT00694551|54666074|FG000|Overall Study|Disease Progression|1|||
28007229|NCT00694551|54666075|FG001|Overall Study|Disease Progression|0|||
28007230|NCT00694551|54666076|FG002|Overall Study|Disease Progression|1|||
28007231|NCT00689871|54666089|FG000|Overall Study|Lost to Follow-up|123|||
28007232|NCT00689871|54666090|FG001|Overall Study|Lost to Follow-up|13|||
28007233|NCT00689871|54666091|FG002|Overall Study|Lost to Follow-up|37|||
28007234|NCT00689871|54666092|FG003|Overall Study|Lost to Follow-up|1|||
28007235|NCT00689871|54666089|FG000|Overall Study|Explanted of All Study Devices|36|||
28007236|NCT00689871|54666090|FG001|Overall Study|Explanted of All Study Devices|25|||
28007237|NCT00689871|54666091|FG002|Overall Study|Explanted of All Study Devices|29|||
28007238|NCT00689871|54666092|FG003|Overall Study|Explanted of All Study Devices|3|||
28007239|NCT00689871|54666089|FG000|Overall Study|Withdrawal by Subject|13|||
28007240|NCT00689871|54666090|FG001|Overall Study|Withdrawal by Subject|3|||
28007241|NCT00689871|54666091|FG002|Overall Study|Withdrawal by Subject|4|||
28007242|NCT00689871|54666092|FG003|Overall Study|Withdrawal by Subject|1|||
28007243|NCT00689871|54666089|FG000|Overall Study|Death|1|||
28007244|NCT00689871|54666090|FG001|Overall Study|Death|10|||
28007245|NCT00689871|54666091|FG002|Overall Study|Death|2|||
28007246|NCT00689871|54666092|FG003|Overall Study|Death|2|||
28007247|NCT00689871|54666089|FG000|Overall Study|Physician Decision|2|||
28174990|NCT02780167|54846975|FG001|Overall Study|No longer meets eligibility criteria|0|||
27917522|NCT01332968|54574965|FG002|Induction Period|Protocol Violation|0|||
27917523|NCT01332968|54574966|FG003|Induction Period|Protocol Violation|0|||
27917524|NCT01332968|54574967|FG004|Induction Period|Protocol Violation|0|||
27917525|NCT01332968|54574968|FG005|Induction Period|Protocol Violation|0|||
27917526|NCT01332968|54574969|FG006|Induction Period|Protocol Violation|0|||
27917527|NCT01332968|54574970|FG007|Induction Period|Protocol Violation|0|||
27917528|NCT01332968|54574963|FG000|Induction Period|Withdrawal by Subject|3|||
27917529|NCT01332968|54574964|FG001|Induction Period|Withdrawal by Subject|5|||
27917530|NCT01332968|54574965|FG002|Induction Period|Withdrawal by Subject|0|||
27917531|NCT01332968|54574966|FG003|Induction Period|Withdrawal by Subject|0|||
27917532|NCT01332968|54574967|FG004|Induction Period|Withdrawal by Subject|0|||
27917533|NCT01332968|54574968|FG005|Induction Period|Withdrawal by Subject|0|||
27917534|NCT01332968|54574969|FG006|Induction Period|Withdrawal by Subject|0|||
27917535|NCT01332968|54574970|FG007|Induction Period|Withdrawal by Subject|0|||
27917536|NCT01332968|54574963|FG000|Induction Period|Randomised but not treated|4|||
27917537|NCT01332968|54574964|FG001|Induction Period|Randomised but not treated|7|||
27917538|NCT01332968|54574965|FG002|Induction Period|Randomised but not treated|0|||
27917539|NCT01332968|54574966|FG003|Induction Period|Randomised but not treated|0|||
27917540|NCT01332968|54574967|FG004|Induction Period|Randomised but not treated|0|||
27917541|NCT01332968|54574968|FG005|Induction Period|Randomised but not treated|0|||
28007248|NCT00689871|54666090|FG001|Overall Study|Physician Decision|1|||
28007249|NCT00689871|54666091|FG002|Overall Study|Physician Decision|1|||
28007250|NCT00689871|54666092|FG003|Overall Study|Physician Decision|0|||
28007251|NCT00793793|54666114|FG000|Overall Study|Adverse Event|0|||
28007252|NCT00793793|54666115|FG001|Overall Study|Adverse Event|0|||
28007253|NCT00793793|54666116|FG002|Overall Study|Adverse Event|1|||
28007254|NCT00793793|54666117|FG003|Overall Study|Adverse Event|1|||
28007255|NCT00793793|54666118|FG004|Overall Study|Adverse Event|0|||
28007256|NCT00793793|54666119|FG005|Overall Study|Adverse Event|1|||
28007257|NCT00793793|54666120|FG006|Overall Study|Adverse Event|2|||
28007258|NCT00793793|54666121|FG007|Overall Study|Adverse Event|0|||
28007259|NCT00793793|54666122|FG008|Overall Study|Adverse Event|0|||
28007260|NCT00793793|54666123|FG009|Overall Study|Adverse Event|0|||
28007261|NCT00793793|54666124|FG010|Overall Study|Adverse Event|0|||
28007262|NCT00793793|54666125|FG011|Overall Study|Adverse Event|2|||
28007263|NCT00793793|54666114|FG000|Overall Study|Protocol Violation|0|||
28007264|NCT00793793|54666115|FG001|Overall Study|Protocol Violation|0|||
28007265|NCT00793793|54666116|FG002|Overall Study|Protocol Violation|0|||
28007266|NCT00793793|54666117|FG003|Overall Study|Protocol Violation|1|||
28007267|NCT00793793|54666118|FG004|Overall Study|Protocol Violation|0|||
28007268|NCT00793793|54666119|FG005|Overall Study|Protocol Violation|0|||
28174991|NCT02780167|54846976|FG002|Overall Study|No longer meets eligibility criteria|0|||
28174992|NCT02780167|54846977|FG003|Overall Study|No longer meets eligibility criteria|1|||
28174993|NCT02780167|54846978|FG004|Overall Study|No longer meets eligibility criteria|1|||
28174994|NCT02780167|54846974|FG000|Overall Study|Protocol Violation|5|||
28174995|NCT02780167|54846975|FG001|Overall Study|Protocol Violation|5|||
28174996|NCT02780167|54846976|FG002|Overall Study|Protocol Violation|1|||
28174997|NCT02780167|54846977|FG003|Overall Study|Protocol Violation|1|||
28174998|NCT02780167|54846978|FG004|Overall Study|Protocol Violation|2|||
28174999|NCT02780167|54846974|FG000|Overall Study|Withdrawal by Subject|6|||
28175000|NCT02780167|54846975|FG001|Overall Study|Withdrawal by Subject|4|||
28175001|NCT02780167|54846976|FG002|Overall Study|Withdrawal by Subject|4|||
28175002|NCT02780167|54846977|FG003|Overall Study|Withdrawal by Subject|3|||
28175003|NCT02780167|54846978|FG004|Overall Study|Withdrawal by Subject|4|||
28175004|NCT02780167|54846974|FG000|Overall Study|Other|0|||
28175005|NCT02780167|54846975|FG001|Overall Study|Other|0|||
28175006|NCT02780167|54846976|FG002|Overall Study|Other|3|||
28175007|NCT02780167|54846977|FG003|Overall Study|Other|1|||
28175008|NCT02780167|54846978|FG004|Overall Study|Other|2|||
27740053|NCT02205814|54189899|FG001|Overall Study|Lost to Follow-up|0|||
28007269|NCT00793793|54666120|FG006|Overall Study|Protocol Violation|0|||
28007270|NCT00793793|54666121|FG007|Overall Study|Protocol Violation|0|||
28007271|NCT00793793|54666122|FG008|Overall Study|Protocol Violation|0|||
28007272|NCT00793793|54666123|FG009|Overall Study|Protocol Violation|0|||
28007273|NCT00793793|54666124|FG010|Overall Study|Protocol Violation|0|||
28175009|NCT02779075|54846990|FG000|Overall Study|Withdrawal by Subject|1|||
28175010|NCT02779075|54846991|FG001|Overall Study|Withdrawal by Subject|3|||
28175011|NCT02779075|54846990|FG000|Overall Study|IV lost during 2nd study|1|||
28175012|NCT02779075|54846991|FG001|Overall Study|IV lost during 2nd study|0|||
28175013|NCT00105079|54847003|FG000|Overall Study|Adverse Event|5|||
28175014|NCT00105079|54847004|FG001|Overall Study|Adverse Event|12|||
27917542|NCT01332968|54574969|FG006|Induction Period|Randomised but not treated|0|||
27917543|NCT01332968|54574970|FG007|Induction Period|Randomised but not treated|0|||
27917544|NCT01332968|54574963|FG000|Maintenance/Observation Period|Adverse Event|0|||
27917545|NCT01332968|54574964|FG001|Maintenance/Observation Period|Adverse Event|0|||
28175015|NCT00105079|54847003|FG000|Overall Study|Death|3|||
28007274|NCT00793793|54666125|FG011|Overall Study|Protocol Violation|0|||
28175016|NCT00105079|54847004|FG001|Overall Study|Death|1|||
28175017|NCT00105079|54847003|FG000|Overall Study|Lost to Follow-up|12|||
28175018|NCT00105079|54847004|FG001|Overall Study|Lost to Follow-up|12|||
28175019|NCT00105079|54847003|FG000|Overall Study|Lack of Efficacy|9|||
28175020|NCT00105079|54847004|FG001|Overall Study|Lack of Efficacy|3|||
28175021|NCT00105079|54847003|FG000|Overall Study|Refused treatment|6|||
28175022|NCT00105079|54847004|FG001|Overall Study|Refused treatment|4|||
28175023|NCT00105079|54847003|FG000|Overall Study|Violation of selection criteria at entry|0|||
28175024|NCT00105079|54847004|FG001|Overall Study|Violation of selection criteria at entry|2|||
28175025|NCT00105079|54847003|FG000|Overall Study|Protocol Violation|1|||
28175026|NCT00105079|54847004|FG001|Overall Study|Protocol Violation|0|||
28175027|NCT00105079|54847003|FG000|Overall Study|Other|3|||
28175028|NCT00105079|54847004|FG001|Overall Study|Other|1|||
28175029|NCT02777827|54847010|FG000|Washout Between Periods 3 and 4|Protocol Violation|0|||
28175030|NCT02777827|54847011|FG001|Washout Between Periods 3 and 4|Protocol Violation|0|||
28175031|NCT02777827|54847012|FG002|Washout Between Periods 3 and 4|Protocol Violation|1|||
28175032|NCT02777827|54847013|FG003|Washout Between Periods 3 and 4|Protocol Violation|0|||
28175033|NCT02777827|54847014|FG004|Washout Between Periods 3 and 4|Protocol Violation|0|||
28175034|NCT02777827|54847015|FG005|Washout Between Periods 3 and 4|Protocol Violation|0|||
28175035|NCT02712333|54847031|FG000|First Period|Withdrawal by Subject|3|||
28175036|NCT02712333|54847032|FG001|First Period|Withdrawal by Subject|2|||
28175037|NCT02343406|54847048|FG000|Overall Study|Progressive disease|72|||
28175038|NCT02343406|54847049|FG001|Overall Study|Progressive disease|70|||
28175039|NCT02343406|54847050|FG002|Overall Study|Progressive disease|43|||
28175040|NCT02343406|54847051|FG003|Overall Study|Progressive disease|15|||
28175041|NCT02343406|54847052|FG004|Overall Study|Progressive disease|5|||
28175042|NCT02343406|54847048|FG000|Overall Study|Adverse Event|6|||
28175043|NCT02343406|54847049|FG001|Overall Study|Adverse Event|8|||
28175044|NCT02343406|54847050|FG002|Overall Study|Adverse Event|6|||
28175045|NCT02343406|54847051|FG003|Overall Study|Adverse Event|3|||
28175046|NCT02343406|54847052|FG004|Overall Study|Adverse Event|0|||
28175047|NCT02343406|54847048|FG000|Overall Study|Withdrawal by Subject|6|||
28175048|NCT02343406|54847049|FG001|Overall Study|Withdrawal by Subject|4|||
28175049|NCT02343406|54847050|FG002|Overall Study|Withdrawal by Subject|8|||
28175050|NCT02343406|54847051|FG003|Overall Study|Withdrawal by Subject|3|||
28175051|NCT02343406|54847052|FG004|Overall Study|Withdrawal by Subject|0|||
28175052|NCT02343406|54847048|FG000|Overall Study|Death|2|||
28175053|NCT02343406|54847049|FG001|Overall Study|Death|1|||
28175054|NCT02343406|54847050|FG002|Overall Study|Death|0|||
28175055|NCT02343406|54847051|FG003|Overall Study|Death|0|||
28175056|NCT02343406|54847052|FG004|Overall Study|Death|0|||
28175057|NCT02343406|54847048|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
28175058|NCT02343406|54847049|FG001|Overall Study|Start of a new anti-cancer treatment|1|||
28175059|NCT02343406|54847050|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
28175060|NCT02343406|54847051|FG003|Overall Study|Start of a new anti-cancer treatment|1|||
28175061|NCT02343406|54847052|FG004|Overall Study|Start of a new anti-cancer treatment|0|||
28175062|NCT02343406|54847048|FG000|Overall Study|Other primary malignancy|0|||
28175063|NCT02343406|54847049|FG001|Overall Study|Other primary malignancy|1|||
28175064|NCT02343406|54847050|FG002|Overall Study|Other primary malignancy|0|||
28175065|NCT02343406|54847051|FG003|Overall Study|Other primary malignancy|0|||
27917546|NCT01332968|54574965|FG002|Maintenance/Observation Period|Adverse Event|53|||
27917547|NCT01332968|54574966|FG003|Maintenance/Observation Period|Adverse Event|66|||
27917548|NCT01332968|54574967|FG004|Maintenance/Observation Period|Adverse Event|0|||
27917549|NCT01332968|54574968|FG005|Maintenance/Observation Period|Adverse Event|0|||
27917550|NCT01332968|54574969|FG006|Maintenance/Observation Period|Adverse Event|0|||
27917551|NCT01332968|54574970|FG007|Maintenance/Observation Period|Adverse Event|0|||
27917552|NCT01332968|54574963|FG000|Maintenance/Observation Period|Death|0|||
27917553|NCT01332968|54574964|FG001|Maintenance/Observation Period|Death|0|||
28175066|NCT02343406|54847052|FG004|Overall Study|Other primary malignancy|0|||
28175067|NCT02343406|54847048|FG000|Overall Study|Other, not specified|2|||
28175068|NCT02343406|54847049|FG001|Overall Study|Other, not specified|1|||
28175069|NCT02343406|54847050|FG002|Overall Study|Other, not specified|1|||
28175070|NCT02343406|54847051|FG003|Overall Study|Other, not specified|4|||
28175071|NCT02343406|54847052|FG004|Overall Study|Other, not specified|0|||
28175072|NCT02710071|54847065|FG000|First Intervention (6 Weeks).|Withdrawal by Subject|3|||
28175073|NCT02710071|54847066|FG001|First Intervention (6 Weeks).|Withdrawal by Subject|4|||
28175074|NCT02710071|54847065|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|1|||
28175075|NCT02710071|54847066|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
28175076|NCT02373202|54847077|FG000|Overall Study|Adverse Event|2|||
28175077|NCT02373202|54847078|FG001|Overall Study|Adverse Event|5|||
28175078|NCT02373202|54847079|FG002|Overall Study|Adverse Event|2|||
28175079|NCT02373202|54847080|FG003|Overall Study|Adverse Event|1|||
28175080|NCT02373202|54847077|FG000|Overall Study|Lack of Efficacy|0|||
28175081|NCT02373202|54847078|FG001|Overall Study|Lack of Efficacy|0|||
28175082|NCT02373202|54847079|FG002|Overall Study|Lack of Efficacy|1|||
28175083|NCT02373202|54847080|FG003|Overall Study|Lack of Efficacy|0|||
28175084|NCT02373202|54847077|FG000|Overall Study|Other|0|||
28175085|NCT02373202|54847078|FG001|Overall Study|Other|1|||
28175086|NCT02373202|54847079|FG002|Overall Study|Other|0|||
28175087|NCT02373202|54847080|FG003|Overall Study|Other|0|||
28175088|NCT02622074|54847096|FG000|Overall Study|Death|4|||
28175089|NCT02622074|54847097|FG001|Overall Study|Death|0|||
28175090|NCT02622074|54847098|FG002|Overall Study|Death|0|||
28175091|NCT02622074|54847099|FG003|Overall Study|Death|1|||
28175092|NCT02622074|54847100|FG004|Overall Study|Death|1|||
28175093|NCT02622074|54847101|FG005|Overall Study|Death|0|||
28175094|NCT02622074|54847096|FG000|Overall Study|Withdrawal by Subject|0|||
28175095|NCT02622074|54847097|FG001|Overall Study|Withdrawal by Subject|1|||
28175096|NCT02622074|54847098|FG002|Overall Study|Withdrawal by Subject|0|||
28175097|NCT02622074|54847099|FG003|Overall Study|Withdrawal by Subject|0|||
28175098|NCT02622074|54847100|FG004|Overall Study|Withdrawal by Subject|0|||
28175099|NCT02622074|54847101|FG005|Overall Study|Withdrawal by Subject|0|||
28175100|NCT02308696|54847117|FG000|Overall Study|Lost to Follow-up|28|||
28175101|NCT02308696|54847118|FG001|Overall Study|Lost to Follow-up|21|||
28175102|NCT02308696|54847117|FG000|Overall Study|Death|8|||
28175103|NCT02308696|54847118|FG001|Overall Study|Death|4|||
28175104|NCT02308696|54847117|FG000|Overall Study|Moved to a Higher Level of Care|17|||
28175105|NCT02308696|54847118|FG001|Overall Study|Moved to a Higher Level of Care|6|||
28175106|NCT02342704|54847126|FG000|Overall Study|Physician Decision|0|||
28175107|NCT02342704|54847127|FG001|Overall Study|Physician Decision|3|||
28175108|NCT02342704|54847126|FG000|Overall Study|Sponsor Termination|49|||
28175109|NCT02342704|54847127|FG001|Overall Study|Sponsor Termination|43|||
28175110|NCT02342704|54847126|FG000|Overall Study|Other|0|||
28175111|NCT02342704|54847127|FG001|Overall Study|Other|1|||
28175112|NCT02342704|54847126|FG000|Overall Study|Withdrawal by Subject|1|||
28175113|NCT02342704|54847127|FG001|Overall Study|Withdrawal by Subject|0|||
28175114|NCT02342704|54847126|FG000|Overall Study|Lost to Follow-up|2|||
28175115|NCT02342704|54847127|FG001|Overall Study|Lost to Follow-up|1|||
28175116|NCT02342704|54847126|FG000|Overall Study|Adverse Event|1|||
28175117|NCT02342704|54847127|FG001|Overall Study|Adverse Event|3|||
28175118|NCT02342548|54847136|FG000|Overall Study|Adverse Event|12|||
28175119|NCT02342548|54847137|FG001|Overall Study|Adverse Event|17|||
28175120|NCT02342548|54847138|FG002|Overall Study|Adverse Event|13|||
28175121|NCT02342548|54847136|FG000|Overall Study|Lost to Follow-up|0|||
28175122|NCT02342548|54847137|FG001|Overall Study|Lost to Follow-up|1|||
28175123|NCT02342548|54847138|FG002|Overall Study|Lost to Follow-up|0|||
28175124|NCT02342548|54847136|FG000|Overall Study|Study terminated by sponsor|20|||
28175125|NCT02342548|54847137|FG001|Overall Study|Study terminated by sponsor|39|||
28175126|NCT02342548|54847138|FG002|Overall Study|Study terminated by sponsor|25|||
28175127|NCT02342548|54847136|FG000|Overall Study|Protocol Violation|0|||
28175128|NCT02342548|54847137|FG001|Overall Study|Protocol Violation|1|||
28175129|NCT02342548|54847138|FG002|Overall Study|Protocol Violation|0|||
28175130|NCT02342548|54847136|FG000|Overall Study|Withdrawal by Subject|1|||
28175131|NCT02342548|54847137|FG001|Overall Study|Withdrawal by Subject|3|||
28175132|NCT02342548|54847138|FG002|Overall Study|Withdrawal by Subject|4|||
28175133|NCT02342548|54847136|FG000|Overall Study|Other|1|||
28175134|NCT02342548|54847137|FG001|Overall Study|Other|1|||
28175135|NCT02342548|54847138|FG002|Overall Study|Other|1|||
28175136|NCT03142191|54847151|FG000|Placebo Controlled Period|Death|0|||
28175137|NCT03142191|54847152|FG001|Placebo Controlled Period|Death|1|||
28175138|NCT03142191|54847153|FG002|Placebo Controlled Period|Death|1|||
28175139|NCT03142191|54847154|FG003|Placebo Controlled Period|Death|0|||
28175140|NCT03142191|54847155|FG004|Placebo Controlled Period|Death|0|||
28175141|NCT03142191|54847151|FG000|Placebo Controlled Period|Adverse Event|4|||
28175142|NCT03142191|54847152|FG001|Placebo Controlled Period|Adverse Event|5|||
28175143|NCT03142191|54847153|FG002|Placebo Controlled Period|Adverse Event|1|||
28175144|NCT03142191|54847154|FG003|Placebo Controlled Period|Adverse Event|0|||
28175145|NCT03142191|54847155|FG004|Placebo Controlled Period|Adverse Event|0|||
28175146|NCT03142191|54847151|FG000|Placebo Controlled Period|Progressive Disease|1|||
28175147|NCT03142191|54847152|FG001|Placebo Controlled Period|Progressive Disease|0|||
28175148|NCT03142191|54847153|FG002|Placebo Controlled Period|Progressive Disease|1|||
28175149|NCT03142191|54847154|FG003|Placebo Controlled Period|Progressive Disease|0|||
28175150|NCT03142191|54847155|FG004|Placebo Controlled Period|Progressive Disease|0|||
28175151|NCT03142191|54847151|FG000|Placebo Controlled Period|Withdrawal by participant|1|||
28175152|NCT03142191|54847152|FG001|Placebo Controlled Period|Withdrawal by participant|3|||
28175153|NCT03142191|54847153|FG002|Placebo Controlled Period|Withdrawal by participant|2|||
28175154|NCT03142191|54847154|FG003|Placebo Controlled Period|Withdrawal by participant|0|||
28175155|NCT03142191|54847155|FG004|Placebo Controlled Period|Withdrawal by participant|1|||
28175156|NCT03142191|54847151|FG000|Placebo Controlled Period|Other Reasons|1|||
28175157|NCT03142191|54847152|FG001|Placebo Controlled Period|Other Reasons|0|||
28175158|NCT03142191|54847153|FG002|Placebo Controlled Period|Other Reasons|0|||
28175159|NCT03142191|54847154|FG003|Placebo Controlled Period|Other Reasons|0|||
28175160|NCT03142191|54847155|FG004|Placebo Controlled Period|Other Reasons|0|||
28175161|NCT03142191|54847151|FG000|Active Treatment Extension Period|Death|2|||
28175162|NCT03142191|54847152|FG001|Active Treatment Extension Period|Death|1|||
28175163|NCT03142191|54847153|FG002|Active Treatment Extension Period|Death|1|||
28175164|NCT03142191|54847154|FG003|Active Treatment Extension Period|Death|1|||
28175165|NCT03142191|54847155|FG004|Active Treatment Extension Period|Death|0|||
28175166|NCT03142191|54847151|FG000|Active Treatment Extension Period|Adverse Event|6|||
28175167|NCT03142191|54847152|FG001|Active Treatment Extension Period|Adverse Event|5|||
28175168|NCT03142191|54847153|FG002|Active Treatment Extension Period|Adverse Event|4|||
28175169|NCT03142191|54847154|FG003|Active Treatment Extension Period|Adverse Event|1|||
28175170|NCT03142191|54847155|FG004|Active Treatment Extension Period|Adverse Event|0|||
28175171|NCT03142191|54847151|FG000|Active Treatment Extension Period|Progressive Disease|10|||
28175172|NCT03142191|54847152|FG001|Active Treatment Extension Period|Progressive Disease|5|||
28175173|NCT03142191|54847153|FG002|Active Treatment Extension Period|Progressive Disease|4|||
28175174|NCT03142191|54847154|FG003|Active Treatment Extension Period|Progressive Disease|1|||
28175175|NCT03142191|54847155|FG004|Active Treatment Extension Period|Progressive Disease|2|||
28175176|NCT03142191|54847151|FG000|Active Treatment Extension Period|Withdrawal by participant|2|||
28175177|NCT03142191|54847152|FG001|Active Treatment Extension Period|Withdrawal by participant|0|||
28175178|NCT03142191|54847153|FG002|Active Treatment Extension Period|Withdrawal by participant|3|||
28175179|NCT03142191|54847154|FG003|Active Treatment Extension Period|Withdrawal by participant|1|||
28175180|NCT03142191|54847155|FG004|Active Treatment Extension Period|Withdrawal by participant|1|||
28175181|NCT03142191|54847151|FG000|Active Treatment Extension Period|Physician Decision|2|||
28175182|NCT03142191|54847152|FG001|Active Treatment Extension Period|Physician Decision|0|||
28175183|NCT03142191|54847153|FG002|Active Treatment Extension Period|Physician Decision|0|||
28175184|NCT03142191|54847154|FG003|Active Treatment Extension Period|Physician Decision|0|||
28175185|NCT03142191|54847155|FG004|Active Treatment Extension Period|Physician Decision|0|||
28175186|NCT03142191|54847151|FG000|Active Treatment Extension Period|Other Reasons|3|||
28175187|NCT03142191|54847152|FG001|Active Treatment Extension Period|Other Reasons|3|||
28175188|NCT03142191|54847153|FG002|Active Treatment Extension Period|Other Reasons|3|||
28175189|NCT03142191|54847154|FG003|Active Treatment Extension Period|Other Reasons|8|||
28175190|NCT03142191|54847155|FG004|Active Treatment Extension Period|Other Reasons|3|||
28175191|NCT03142191|54847151|FG000|Active Treatment Extension Period|Unknown, participant missing|1|||
28175192|NCT03142191|54847152|FG001|Active Treatment Extension Period|Unknown, participant missing|0|||
28175193|NCT03142191|54847153|FG002|Active Treatment Extension Period|Unknown, participant missing|0|||
28175194|NCT03142191|54847154|FG003|Active Treatment Extension Period|Unknown, participant missing|0|||
28007275|NCT00793793|54666114|FG000|Overall Study|Lost to Follow-up|0|||
28007276|NCT00793793|54666115|FG001|Overall Study|Lost to Follow-up|0|||
28007277|NCT00793793|54666116|FG002|Overall Study|Lost to Follow-up|1|||
28007278|NCT00793793|54666117|FG003|Overall Study|Lost to Follow-up|0|||
28007279|NCT00793793|54666118|FG004|Overall Study|Lost to Follow-up|0|||
28007280|NCT00793793|54666119|FG005|Overall Study|Lost to Follow-up|0|||
28175195|NCT03142191|54847155|FG004|Active Treatment Extension Period|Unknown, participant missing|0|||
28175196|NCT02617628|54847184|FG000|Overall Study|Withdr, Transfers-other prisons, dropout|62|||
28007281|NCT00793793|54666120|FG006|Overall Study|Lost to Follow-up|0|||
28007282|NCT00793793|54666121|FG007|Overall Study|Lost to Follow-up|0|||
28007283|NCT00793793|54666122|FG008|Overall Study|Lost to Follow-up|1|||
28007284|NCT00793793|54666123|FG009|Overall Study|Lost to Follow-up|3|||
28007285|NCT00793793|54666124|FG010|Overall Study|Lost to Follow-up|1|||
28007286|NCT00793793|54666125|FG011|Overall Study|Lost to Follow-up|0|||
28007287|NCT00793793|54666114|FG000|Overall Study|Withdrawal by Subject|0|||
28007288|NCT00793793|54666115|FG001|Overall Study|Withdrawal by Subject|0|||
28007289|NCT00793793|54666116|FG002|Overall Study|Withdrawal by Subject|0|||
28007290|NCT00793793|54666117|FG003|Overall Study|Withdrawal by Subject|0|||
28175197|NCT02617628|54847185|FG001|Overall Study|Withdr, Transfers-other prisons, dropout|61|||
28175198|NCT02308540|54847201|FG000|Overall Study|Lost to Follow-up|0|||
28175199|NCT02308540|54847202|FG001|Overall Study|Lost to Follow-up|0|||
28007291|NCT00793793|54666118|FG004|Overall Study|Withdrawal by Subject|1|||
28007292|NCT00793793|54666119|FG005|Overall Study|Withdrawal by Subject|0|||
28007293|NCT00793793|54666120|FG006|Overall Study|Withdrawal by Subject|0|||
28007294|NCT00793793|54666121|FG007|Overall Study|Withdrawal by Subject|0|||
28007295|NCT00793793|54666122|FG008|Overall Study|Withdrawal by Subject|1|||
28007296|NCT00793793|54666123|FG009|Overall Study|Withdrawal by Subject|0|||
28175200|NCT02308540|54847203|FG002|Overall Study|Lost to Follow-up|0|||
28175201|NCT02308540|54847204|FG003|Overall Study|Lost to Follow-up|0|||
28175202|NCT02308540|54847205|FG004|Overall Study|Lost to Follow-up|0|||
28175203|NCT02308540|54847206|FG005|Overall Study|Lost to Follow-up|1|||
28175204|NCT02308228|54847257|FG000|Overall Study|Adverse Event|3|||
28175205|NCT02308228|54847258|FG001|Overall Study|Adverse Event|4|||
28175206|NCT02308228|54847257|FG000|Overall Study|Withdrawal by Subject|5|||
28175207|NCT02308228|54847258|FG001|Overall Study|Withdrawal by Subject|3|||
28175208|NCT02616614|54847276|FG000|Overall Study|Withdrawal by Subject|10|||
28175209|NCT02616614|54847277|FG001|Overall Study|Withdrawal by Subject|5|||
28175210|NCT02616614|54847278|FG002|Overall Study|Withdrawal by Subject|6|||
28175211|NCT02616614|54847276|FG000|Overall Study|Physician Decision|2|||
28175212|NCT02616614|54847277|FG001|Overall Study|Physician Decision|1|||
28175213|NCT02616614|54847278|FG002|Overall Study|Physician Decision|0|||
28175214|NCT02616614|54847276|FG000|Overall Study|Adverse Event|1|||
28175215|NCT02616614|54847277|FG001|Overall Study|Adverse Event|4|||
28175216|NCT02616614|54847278|FG002|Overall Study|Adverse Event|1|||
28175217|NCT02616614|54847276|FG000|Overall Study|Protocol Violation|0|||
28175218|NCT02616614|54847277|FG001|Overall Study|Protocol Violation|3|||
28175219|NCT02616614|54847278|FG002|Overall Study|Protocol Violation|1|||
28175220|NCT02616614|54847276|FG000|Overall Study|Prohibited Medication|12|||
28175221|NCT02616614|54847277|FG001|Overall Study|Prohibited Medication|9|||
28175222|NCT02616614|54847278|FG002|Overall Study|Prohibited Medication|5|||
28175223|NCT02616614|54847276|FG000|Overall Study|More than 3 applications missed|6|||
28175224|NCT02616614|54847277|FG001|Overall Study|More than 3 applications missed|8|||
28175225|NCT02616614|54847278|FG002|Overall Study|More than 3 applications missed|1|||
28175226|NCT02616614|54847276|FG000|Overall Study|Lost to Follow-up|31|||
28175227|NCT02616614|54847277|FG001|Overall Study|Lost to Follow-up|28|||
28175228|NCT02616614|54847278|FG002|Overall Study|Lost to Follow-up|13|||
28175229|NCT02616614|54847276|FG000|Overall Study|Pregnancy|2|||
28175230|NCT02616614|54847277|FG001|Overall Study|Pregnancy|0|||
28175231|NCT02616614|54847278|FG002|Overall Study|Pregnancy|1|||
28175232|NCT02616614|54847276|FG000|Overall Study|Other|1|||
28175233|NCT02616614|54847277|FG001|Overall Study|Other|2|||
28175234|NCT02616614|54847278|FG002|Overall Study|Other|1|||
28175235|NCT02616380|54847304|FG000|Overall Study|Lost to Follow-up|1|||
28175236|NCT02616380|54847304|FG000|Overall Study|Other|2|||
28175237|NCT04436822|54847314|FG000|Overall Study|Physician Decision|2|||
28175238|NCT04436822|54847315|FG001|Overall Study|Physician Decision|0|||
28175239|NCT04436822|54847314|FG000|Overall Study|Sponsor request|1|||
28175240|NCT04436822|54847315|FG001|Overall Study|Sponsor request|0|||
28175241|NCT04436822|54847314|FG000|Overall Study|Withdrawal by parent/guardian|0|||
28175242|NCT04436822|54847315|FG001|Overall Study|Withdrawal by parent/guardian|3|||
28175243|NCT04436822|54847314|FG000|Overall Study|Unsuccessful procedure|0|||
28175244|NCT04436822|54847315|FG001|Overall Study|Unsuccessful procedure|1|||
28175245|NCT04436822|54847314|FG000|Overall Study|Withdrawal due to Covid-19|8|||
28175246|NCT04436822|54847315|FG001|Overall Study|Withdrawal due to Covid-19|1|||
28175247|NCT04436822|54847314|FG000|Overall Study|Withdrawal by Subject|1|||
28175248|NCT04436822|54847315|FG001|Overall Study|Withdrawal by Subject|0|||
28175249|NCT04436822|54847314|FG000|Overall Study|The sponsor was not able to provide the investigational product|0|||
28175250|NCT04436822|54847315|FG001|Overall Study|The sponsor was not able to provide the investigational product|1|||
28175251|NCT01596062|54847325|FG000|Overall Study|Adverse Event|1|||
28007297|NCT00793793|54666124|FG010|Overall Study|Withdrawal by Subject|0|||
28007298|NCT00793793|54666125|FG011|Overall Study|Withdrawal by Subject|0|||
28007299|NCT00793793|54666114|FG000|Overall Study|reason not specified|0|||
28007300|NCT00793793|54666115|FG001|Overall Study|reason not specified|1|||
28007301|NCT00793793|54666116|FG002|Overall Study|reason not specified|0|||
28007302|NCT00793793|54666117|FG003|Overall Study|reason not specified|1|||
28007303|NCT00793793|54666118|FG004|Overall Study|reason not specified|1|||
28007304|NCT00793793|54666119|FG005|Overall Study|reason not specified|1|||
28007305|NCT00793793|54666120|FG006|Overall Study|reason not specified|2|||
28007306|NCT00793793|54666121|FG007|Overall Study|reason not specified|0|||
28007307|NCT00793793|54666122|FG008|Overall Study|reason not specified|7|||
28175252|NCT01596062|54847326|FG001|Overall Study|Adverse Event|0|||
28007308|NCT00793793|54666123|FG009|Overall Study|reason not specified|6|||
28007309|NCT00793793|54666124|FG010|Overall Study|reason not specified|2|||
28007310|NCT00793793|54666125|FG011|Overall Study|reason not specified|4|||
28007311|NCT00776789|54666173|FG000|Overall Study|Consent refusal|2|||
28175253|NCT01596062|54847327|FG002|Overall Study|Adverse Event|2|||
28175254|NCT01596062|54847325|FG000|Overall Study|Lack of Efficacy|0|||
28175255|NCT01596062|54847326|FG001|Overall Study|Lack of Efficacy|0|||
28175256|NCT01596062|54847327|FG002|Overall Study|Lack of Efficacy|1|||
28175257|NCT02614898|54847346|FG000|Overall Study|Participated until study termination|10|||
28175258|NCT02614898|54847347|FG001|Overall Study|Participated until study termination|26|||
28175259|NCT02614898|54847346|FG000|Overall Study|Lost to Follow-up|0|||
28007312|NCT00776789|54666174|FG001|Overall Study|Consent refusal|2|||
28007313|NCT00776789|54666173|FG000|Overall Study|Poor quality video|1|||
28007314|NCT00776789|54666174|FG001|Overall Study|Poor quality video|1|||
28007315|NCT00776555|54666184|FG000|Overall Study|Study terminated|3|||
28007316|NCT00776555|54666185|FG001|Overall Study|Study terminated|0|||
28007317|NCT00720434|54666195|FG000|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
28007318|NCT00720434|54666196|FG001|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1|||
28007319|NCT00720434|54666197|FG002|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
28007320|NCT00720434|54666198|FG003|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
28007321|NCT00720434|54666195|FG000|Open-Label Period (Week 5-72)|Adverse Event|0|||
28175260|NCT02614898|54847347|FG001|Overall Study|Lost to Follow-up|2|||
28175261|NCT02614898|54847346|FG000|Overall Study|Physician Decision|1|||
28175262|NCT02614898|54847347|FG001|Overall Study|Physician Decision|8|||
28175263|NCT02614898|54847346|FG000|Overall Study|Study Terminated by Sponsor|3|||
28175264|NCT02614898|54847347|FG001|Overall Study|Study Terminated by Sponsor|0|||
28175265|NCT02614898|54847346|FG000|Overall Study|Withdrawal by Subject|0|||
28175266|NCT02614898|54847347|FG001|Overall Study|Withdrawal by Subject|2|||
28175267|NCT02614898|54847346|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
28175268|NCT02614898|54847347|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
28175269|NCT02614898|54847346|FG000|Overall Study|Other-Additional Information Unavailable|0|||
28175270|NCT02614898|54847347|FG001|Overall Study|Other-Additional Information Unavailable|11|||
28175271|NCT02614898|54847346|FG000|Overall Study|Missing|0|||
28175272|NCT02614898|54847347|FG001|Overall Study|Missing|1|||
28175273|NCT02777593|54847359|FG000|Overall Study|Still in study|66|||
28175274|NCT02777593|54847360|FG001|Overall Study|Still in study|105|||
28175275|NCT02777593|54847361|FG002|Overall Study|Still in study|10|||
28175276|NCT02777593|54847362|FG003|Overall Study|Still in study|8|||
28175277|NCT02777593|54847363|FG004|Overall Study|Still in study|6|||
28175278|NCT02777593|54847359|FG000|Overall Study|Death|11|||
28175279|NCT02777593|54847360|FG001|Overall Study|Death|19|||
28175280|NCT02777593|54847361|FG002|Overall Study|Death|0|||
28175281|NCT02777593|54847362|FG003|Overall Study|Death|4|||
28175282|NCT02777593|54847363|FG004|Overall Study|Death|0|||
28175283|NCT02777593|54847359|FG000|Overall Study|Withdrawal by Subject|5|||
28175284|NCT02777593|54847360|FG001|Overall Study|Withdrawal by Subject|1|||
28175285|NCT02777593|54847361|FG002|Overall Study|Withdrawal by Subject|0|||
28175286|NCT02777593|54847362|FG003|Overall Study|Withdrawal by Subject|1|||
28175287|NCT02777593|54847363|FG004|Overall Study|Withdrawal by Subject|0|||
28175288|NCT02777593|54847359|FG000|Overall Study|Lost to Follow-up|1|||
28175289|NCT02777593|54847360|FG001|Overall Study|Lost to Follow-up|6|||
28175290|NCT02777593|54847361|FG002|Overall Study|Lost to Follow-up|0|||
28175291|NCT02777593|54847362|FG003|Overall Study|Lost to Follow-up|0|||
28175292|NCT02777593|54847363|FG004|Overall Study|Lost to Follow-up|0|||
28175293|NCT02777593|54847359|FG000|Overall Study|Physician Decision|0|||
28175294|NCT02777593|54847360|FG001|Overall Study|Physician Decision|1|||
28175295|NCT02777593|54847361|FG002|Overall Study|Physician Decision|0|||
28175296|NCT02777593|54847362|FG003|Overall Study|Physician Decision|0|||
28175297|NCT02777593|54847363|FG004|Overall Study|Physician Decision|0|||
28175298|NCT02777593|54847359|FG000|Overall Study|Discontinued due to Other|2|||
28175299|NCT02777593|54847360|FG001|Overall Study|Discontinued due to Other|0|||
28175300|NCT02777593|54847361|FG002|Overall Study|Discontinued due to Other|0|||
28175301|NCT02777593|54847362|FG003|Overall Study|Discontinued due to Other|0|||
28175302|NCT02777593|54847363|FG004|Overall Study|Discontinued due to Other|0|||
28007322|NCT00720434|54666196|FG001|Open-Label Period (Week 5-72)|Adverse Event|0|||
28007323|NCT00720434|54666197|FG002|Open-Label Period (Week 5-72)|Adverse Event|0|||
28007324|NCT00720434|54666198|FG003|Open-Label Period (Week 5-72)|Adverse Event|2|||
28007325|NCT00720434|54666195|FG000|Open-Label Period (Week 5-72)|Lost to Follow-up|1|||
28007326|NCT00720434|54666196|FG001|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
28007327|NCT00720434|54666197|FG002|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
28007328|NCT00720434|54666198|FG003|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
28007329|NCT00720434|54666195|FG000|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
28007330|NCT00720434|54666196|FG001|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
28007331|NCT00720434|54666197|FG002|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
28007332|NCT00720434|54666198|FG003|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
28007333|NCT00720434|54666195|FG000|Open-Label Period (Week 5-72)|Other|4|||
28007334|NCT00720434|54666196|FG001|Open-Label Period (Week 5-72)|Other|3|||
28007335|NCT00720434|54666197|FG002|Open-Label Period (Week 5-72)|Other|3|||
28007336|NCT00720434|54666198|FG003|Open-Label Period (Week 5-72)|Other|2|||
28007337|NCT00776009|54666214|FG000|Period 1: First Intervention|Withdrawal by Subject|0|||
28007338|NCT00776009|54666215|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
28007339|NCT00776009|54666216|FG002|Period 1: First Intervention|Withdrawal by Subject|1|||
28007340|NCT00776009|54666217|FG003|Period 1: First Intervention|Withdrawal by Subject|0|||
28007341|NCT00776009|54666218|FG004|Period 1: First Intervention|Withdrawal by Subject|1|||
28007342|NCT00776009|54666219|FG005|Period 1: First Intervention|Withdrawal by Subject|0|||
28007343|NCT00776009|54666214|FG000|Period 1: First Intervention|Protocol Violation|0|||
28007344|NCT00776009|54666215|FG001|Period 1: First Intervention|Protocol Violation|1|||
28007345|NCT00776009|54666216|FG002|Period 1: First Intervention|Protocol Violation|0|||
28007346|NCT00776009|54666217|FG003|Period 1: First Intervention|Protocol Violation|0|||
28007347|NCT00776009|54666218|FG004|Period 1: First Intervention|Protocol Violation|1|||
28007348|NCT00776009|54666219|FG005|Period 1: First Intervention|Protocol Violation|0|||
28007349|NCT00776009|54666214|FG000|Period 2: Second Intervention|Withdrawal by Subject|0|||
28007350|NCT00776009|54666215|FG001|Period 2: Second Intervention|Withdrawal by Subject|0|||
28007351|NCT00776009|54666216|FG002|Period 2: Second Intervention|Withdrawal by Subject|0|||
28007352|NCT00776009|54666217|FG003|Period 2: Second Intervention|Withdrawal by Subject|0|||
27740054|NCT02205814|54189900|FG002|Overall Study|Lost to Follow-up|0|||
27740055|NCT02205814|54189901|FG003|Overall Study|Lost to Follow-up|1|||
27917554|NCT01332968|54574965|FG002|Maintenance/Observation Period|Death|5|||
27917555|NCT01332968|54574966|FG003|Maintenance/Observation Period|Death|6|||
27917556|NCT01332968|54574967|FG004|Maintenance/Observation Period|Death|0|||
27917557|NCT01332968|54574968|FG005|Maintenance/Observation Period|Death|0|||
27917558|NCT01332968|54574969|FG006|Maintenance/Observation Period|Death|0|||
27917559|NCT01332968|54574970|FG007|Maintenance/Observation Period|Death|0|||
27917560|NCT01332968|54574963|FG000|Maintenance/Observation Period|Lost to Follow-up|0|||
27917561|NCT01332968|54574964|FG001|Maintenance/Observation Period|Lost to Follow-up|0|||
27917562|NCT01332968|54574965|FG002|Maintenance/Observation Period|Lost to Follow-up|1|||
27917563|NCT01332968|54574966|FG003|Maintenance/Observation Period|Lost to Follow-up|2|||
27917564|NCT01332968|54574967|FG004|Maintenance/Observation Period|Lost to Follow-up|0|||
27917565|NCT01332968|54574968|FG005|Maintenance/Observation Period|Lost to Follow-up|0|||
27917566|NCT01332968|54574969|FG006|Maintenance/Observation Period|Lost to Follow-up|0|||
27917567|NCT01332968|54574970|FG007|Maintenance/Observation Period|Lost to Follow-up|0|||
27917568|NCT01332968|54574963|FG000|Maintenance/Observation Period|Non-compliance|0|||
27917569|NCT01332968|54574964|FG001|Maintenance/Observation Period|Non-compliance|0|||
27917570|NCT01332968|54574965|FG002|Maintenance/Observation Period|Non-compliance|4|||
27917571|NCT01332968|54574966|FG003|Maintenance/Observation Period|Non-compliance|3|||
27917572|NCT01332968|54574967|FG004|Maintenance/Observation Period|Non-compliance|0|||
27917573|NCT01332968|54574968|FG005|Maintenance/Observation Period|Non-compliance|0|||
27917574|NCT01332968|54574969|FG006|Maintenance/Observation Period|Non-compliance|0|||
27917575|NCT01332968|54574970|FG007|Maintenance/Observation Period|Non-compliance|0|||
27917576|NCT01332968|54574963|FG000|Maintenance/Observation Period|Other|0|||
27917577|NCT01332968|54574964|FG001|Maintenance/Observation Period|Other|0|||
27917578|NCT01332968|54574965|FG002|Maintenance/Observation Period|Other|4|||
27917579|NCT01332968|54574966|FG003|Maintenance/Observation Period|Other|7|||
27917580|NCT01332968|54574967|FG004|Maintenance/Observation Period|Other|0|||
27917581|NCT01332968|54574968|FG005|Maintenance/Observation Period|Other|0|||
27917582|NCT01332968|54574969|FG006|Maintenance/Observation Period|Other|0|||
27917583|NCT01332968|54574970|FG007|Maintenance/Observation Period|Other|0|||
27917584|NCT01332968|54574963|FG000|Maintenance/Observation Period|Physician Decision|0|||
27917585|NCT01332968|54574964|FG001|Maintenance/Observation Period|Physician Decision|0|||
27917586|NCT01332968|54574965|FG002|Maintenance/Observation Period|Physician Decision|14|||
28007353|NCT00776009|54666218|FG004|Period 2: Second Intervention|Withdrawal by Subject|0|||
27917587|NCT01332968|54574966|FG003|Maintenance/Observation Period|Physician Decision|19|||
27917588|NCT01332968|54574967|FG004|Maintenance/Observation Period|Physician Decision|0|||
27917589|NCT01332968|54574968|FG005|Maintenance/Observation Period|Physician Decision|1|||
27917590|NCT01332968|54574969|FG006|Maintenance/Observation Period|Physician Decision|0|||
27917591|NCT01332968|54574970|FG007|Maintenance/Observation Period|Physician Decision|0|||
27917592|NCT01332968|54574963|FG000|Maintenance/Observation Period|Progressive Disease|0|||
27917593|NCT01332968|54574964|FG001|Maintenance/Observation Period|Progressive Disease|0|||
27917594|NCT01332968|54574965|FG002|Maintenance/Observation Period|Progressive Disease|72|||
27917595|NCT01332968|54574966|FG003|Maintenance/Observation Period|Progressive Disease|40|||
27917596|NCT01332968|54574967|FG004|Maintenance/Observation Period|Progressive Disease|0|||
27917597|NCT01332968|54574968|FG005|Maintenance/Observation Period|Progressive Disease|0|||
27917598|NCT01332968|54574969|FG006|Maintenance/Observation Period|Progressive Disease|0|||
27917599|NCT01332968|54574970|FG007|Maintenance/Observation Period|Progressive Disease|0|||
27917600|NCT01332968|54574963|FG000|Maintenance/Observation Period|Protocol Violation|0|||
27917601|NCT01332968|54574964|FG001|Maintenance/Observation Period|Protocol Violation|0|||
27917602|NCT01332968|54574965|FG002|Maintenance/Observation Period|Protocol Violation|1|||
27917603|NCT01332968|54574966|FG003|Maintenance/Observation Period|Protocol Violation|1|||
27917604|NCT01332968|54574967|FG004|Maintenance/Observation Period|Protocol Violation|0|||
27917605|NCT01332968|54574968|FG005|Maintenance/Observation Period|Protocol Violation|0|||
27917606|NCT01332968|54574969|FG006|Maintenance/Observation Period|Protocol Violation|0|||
27917607|NCT01332968|54574970|FG007|Maintenance/Observation Period|Protocol Violation|0|||
27917608|NCT01332968|54574963|FG000|Maintenance/Observation Period|Withdrawal by Subject|0|||
27917609|NCT01332968|54574964|FG001|Maintenance/Observation Period|Withdrawal by Subject|0|||
27917610|NCT01332968|54574965|FG002|Maintenance/Observation Period|Withdrawal by Subject|7|||
27917611|NCT01332968|54574966|FG003|Maintenance/Observation Period|Withdrawal by Subject|5|||
27917612|NCT01332968|54574967|FG004|Maintenance/Observation Period|Withdrawal by Subject|0|||
27917613|NCT01332968|54574968|FG005|Maintenance/Observation Period|Withdrawal by Subject|0|||
27917614|NCT01332968|54574969|FG006|Maintenance/Observation Period|Withdrawal by Subject|0|||
27917615|NCT01332968|54574970|FG007|Maintenance/Observation Period|Withdrawal by Subject|0|||
27917616|NCT01332968|54574963|FG000|Follow-Up Period|Adverse Event|0|||
27917617|NCT01332968|54574964|FG001|Follow-Up Period|Adverse Event|0|||
27917618|NCT01332968|54574965|FG002|Follow-Up Period|Adverse Event|0|||
27917619|NCT01332968|54574966|FG003|Follow-Up Period|Adverse Event|0|||
27917620|NCT01332968|54574967|FG004|Follow-Up Period|Adverse Event|0|||
27917621|NCT01332968|54574968|FG005|Follow-Up Period|Adverse Event|0|||
27917622|NCT01332968|54574969|FG006|Follow-Up Period|Adverse Event|0|||
27917623|NCT01332968|54574970|FG007|Follow-Up Period|Adverse Event|4|||
27917624|NCT01332968|54574963|FG000|Follow-Up Period|Death|0|||
27917625|NCT01332968|54574964|FG001|Follow-Up Period|Death|0|||
27917626|NCT01332968|54574965|FG002|Follow-Up Period|Death|0|||
27917627|NCT01332968|54574966|FG003|Follow-Up Period|Death|0|||
27917628|NCT01332968|54574967|FG004|Follow-Up Period|Death|0|||
27917629|NCT01332968|54574968|FG005|Follow-Up Period|Death|0|||
27917630|NCT01332968|54574969|FG006|Follow-Up Period|Death|27|||
27917631|NCT01332968|54574970|FG007|Follow-Up Period|Death|30|||
27917632|NCT01332968|54574963|FG000|Follow-Up Period|Lost to Follow-up|0|||
27917633|NCT01332968|54574964|FG001|Follow-Up Period|Lost to Follow-up|0|||
27917634|NCT01332968|54574965|FG002|Follow-Up Period|Lost to Follow-up|0|||
27917635|NCT01332968|54574966|FG003|Follow-Up Period|Lost to Follow-up|0|||
27917636|NCT01332968|54574967|FG004|Follow-Up Period|Lost to Follow-up|0|||
27917637|NCT01332968|54574968|FG005|Follow-Up Period|Lost to Follow-up|0|||
27917638|NCT01332968|54574969|FG006|Follow-Up Period|Lost to Follow-up|11|||
27917639|NCT01332968|54574970|FG007|Follow-Up Period|Lost to Follow-up|15|||
27917640|NCT01332968|54574963|FG000|Follow-Up Period|Non-compliance|0|||
27917641|NCT01332968|54574964|FG001|Follow-Up Period|Non-compliance|0|||
27917642|NCT01332968|54574965|FG002|Follow-Up Period|Non-compliance|0|||
28007354|NCT00776009|54666219|FG005|Period 2: Second Intervention|Withdrawal by Subject|1|||
27917643|NCT01332968|54574966|FG003|Follow-Up Period|Non-compliance|0|||
27917644|NCT01332968|54574967|FG004|Follow-Up Period|Non-compliance|0|||
27917645|NCT01332968|54574968|FG005|Follow-Up Period|Non-compliance|0|||
27917646|NCT01332968|54574969|FG006|Follow-Up Period|Non-compliance|4|||
27917647|NCT01332968|54574970|FG007|Follow-Up Period|Non-compliance|9|||
27917648|NCT01332968|54574963|FG000|Follow-Up Period|Other|0|||
27917649|NCT01332968|54574964|FG001|Follow-Up Period|Other|0|||
28007355|NCT00776009|54666214|FG000|Period 2: Second Intervention|Protocol Violation|1|||
27917650|NCT01332968|54574965|FG002|Follow-Up Period|Other|0|||
27917651|NCT01332968|54574966|FG003|Follow-Up Period|Other|0|||
27917652|NCT01332968|54574967|FG004|Follow-Up Period|Other|0|||
28007356|NCT00776009|54666215|FG001|Period 2: Second Intervention|Protocol Violation|0|||
28007357|NCT00776009|54666216|FG002|Period 2: Second Intervention|Protocol Violation|1|||
28007358|NCT00776009|54666217|FG003|Period 2: Second Intervention|Protocol Violation|0|||
28007359|NCT00776009|54666218|FG004|Period 2: Second Intervention|Protocol Violation|0|||
28007360|NCT00776009|54666219|FG005|Period 2: Second Intervention|Protocol Violation|0|||
28007361|NCT00776009|54666214|FG000|Period 3: Third Intervention|Withdrawal by Subject|1|||
28007362|NCT00776009|54666215|FG001|Period 3: Third Intervention|Withdrawal by Subject|0|||
28007363|NCT00776009|54666216|FG002|Period 3: Third Intervention|Withdrawal by Subject|0|||
28007364|NCT00776009|54666217|FG003|Period 3: Third Intervention|Withdrawal by Subject|0|||
28007365|NCT00776009|54666218|FG004|Period 3: Third Intervention|Withdrawal by Subject|0|||
28007366|NCT00776009|54666219|FG005|Period 3: Third Intervention|Withdrawal by Subject|0|||
28007367|NCT00694161|54666227|FG000|Part 2 (After Week 6 up to Month 12)|Adverse Event|1|||
27917653|NCT01332968|54574968|FG005|Follow-Up Period|Other|0|||
27917654|NCT01332968|54574969|FG006|Follow-Up Period|Other|18|||
27917655|NCT01332968|54574970|FG007|Follow-Up Period|Other|21|||
27917656|NCT01332968|54574963|FG000|Follow-Up Period|Physician Decision|0|||
27917657|NCT01332968|54574964|FG001|Follow-Up Period|Physician Decision|0|||
27917658|NCT01332968|54574965|FG002|Follow-Up Period|Physician Decision|0|||
27917659|NCT01332968|54574966|FG003|Follow-Up Period|Physician Decision|0|||
27917660|NCT01332968|54574967|FG004|Follow-Up Period|Physician Decision|0|||
27917661|NCT01332968|54574968|FG005|Follow-Up Period|Physician Decision|0|||
27917662|NCT01332968|54574969|FG006|Follow-Up Period|Physician Decision|12|||
27917663|NCT01332968|54574970|FG007|Follow-Up Period|Physician Decision|15|||
28007368|NCT00694161|54666227|FG000|Part 2 (After Week 6 up to Month 12)|Physician Decision|1|||
28007369|NCT00694161|54666227|FG000|Part 2 (After Week 6 up to Month 12)|Death|1|||
28007370|NCT00720356|54666231|FG000|Registration to Study|Determined to have methylated MGMT|67|||
28007371|NCT00720356|54666231|FG000|Reached 1st Response/2 Cycles|Progressive Disease|1|||
28007372|NCT00720356|54666231|FG000|Reached 1st Response/2 Cycles|Withdrawal by Subject|1|||
28007373|NCT00720356|54666231|FG000|Went on to be Treated Cycle 3|Adverse Event|1|||
28007374|NCT00720356|54666231|FG000|Went on to be Treated Cycle 3|Physician Decision|1|||
28007375|NCT00720356|54666231|FG000|Follow up Until Death|Withdrawal by Subject|1|||
28007376|NCT00720356|54666231|FG000|Follow up Until Death|Alive at last data collection|4|||
28007377|NCT00720278|54666238|FG000|Overall Study|Adverse Event|5|||
28007378|NCT00720278|54666239|FG001|Overall Study|Adverse Event|3|||
28007379|NCT00720278|54666240|FG002|Overall Study|Adverse Event|4|||
28007380|NCT00720278|54666238|FG000|Overall Study|Withdrawal by Subject|0|||
28007381|NCT00720278|54666239|FG001|Overall Study|Withdrawal by Subject|1|||
28007382|NCT00720278|54666240|FG002|Overall Study|Withdrawal by Subject|0|||
28007383|NCT00720278|54666238|FG000|Overall Study|Lost to Follow-up|0|||
28007384|NCT00720278|54666239|FG001|Overall Study|Lost to Follow-up|0|||
28007385|NCT00720278|54666240|FG002|Overall Study|Lost to Follow-up|1|||
28007386|NCT00720278|54666238|FG000|Overall Study|Non-compliance|1|||
28007387|NCT00720278|54666239|FG001|Overall Study|Non-compliance|0|||
28007388|NCT00720278|54666240|FG002|Overall Study|Non-compliance|0|||
28007389|NCT00720278|54666238|FG000|Overall Study|eligibility criteria violation|1|||
28007390|NCT00720278|54666239|FG001|Overall Study|eligibility criteria violation|0|||
28007391|NCT00720278|54666240|FG002|Overall Study|eligibility criteria violation|1|||
28007392|NCT00720122|54666248|FG000|Overall Study|Lost to Follow-up|1|||
28007393|NCT00720122|54666248|FG000|Overall Study|Physician Decision|1|||
28007394|NCT00720122|54666248|FG000|Overall Study|Withdrawal by Subject|7|||
28007395|NCT00717860|54666254|FG000|Overall Study|Clinical adverse experience|5|||
28007396|NCT00717860|54666255|FG001|Overall Study|Clinical adverse experience|9|||
28007397|NCT00717860|54666254|FG000|Overall Study|Laboratory adverse experience|2|||
28007398|NCT00717860|54666255|FG001|Overall Study|Laboratory adverse experience|2|||
28007399|NCT00717860|54666254|FG000|Overall Study|Lack of Efficacy|7|||
28007400|NCT00717860|54666255|FG001|Overall Study|Lack of Efficacy|13|||
28007401|NCT00717860|54666254|FG000|Overall Study|Discontinued for other reason|6|||
28007402|NCT00717860|54666255|FG001|Overall Study|Discontinued for other reason|1|||
28007403|NCT00717860|54666254|FG000|Overall Study|Withdrew consent|7|||
28007404|NCT00717860|54666255|FG001|Overall Study|Withdrew consent|3|||
28007405|NCT00717314|54666263|FG000|Overall Study|Adverse Event|3|||
28007406|NCT00717314|54666264|FG001|Overall Study|Adverse Event|2|||
28007407|NCT00717314|54666263|FG000|Overall Study|Protocol Violation|1|||
28007408|NCT00717314|54666264|FG001|Overall Study|Protocol Violation|0|||
28007409|NCT00717314|54666263|FG000|Overall Study|Lost to Follow-up|1|||
28007410|NCT00717314|54666264|FG001|Overall Study|Lost to Follow-up|5|||
28007411|NCT00717314|54666263|FG000|Overall Study|Withdrawal by Subject|1|||
28007412|NCT00717314|54666264|FG001|Overall Study|Withdrawal by Subject|3|||
28007413|NCT00689793|54666272|FG000|Overall Study|Lost to Follow-up|4|||
28007414|NCT00689793|54666273|FG001|Overall Study|Lost to Follow-up|5|||
28007415|NCT00723944|54666283|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
28007416|NCT00723944|54666284|FG001|Permanent Prosthesis Placement|Adverse Event|7|||
28007417|NCT00723944|54666283|FG000|Permanent Prosthesis Placement|Lost to Follow-up|2|||
28007418|NCT00723944|54666284|FG001|Permanent Prosthesis Placement|Lost to Follow-up|2|||
28007419|NCT00723944|54666283|FG000|One Year Post Placement Follow-up|Lost to Follow-up|1|||
28007420|NCT00723944|54666284|FG001|One Year Post Placement Follow-up|Lost to Follow-up|4|||
28007421|NCT00689481|54666292|FG000|Overall Study|Adverse Event|7|||
28007422|NCT00689481|54666293|FG001|Overall Study|Adverse Event|1|||
28007423|NCT00689481|54666292|FG000|Overall Study|Lost to Follow-up|4|||
28007424|NCT00689481|54666293|FG001|Overall Study|Lost to Follow-up|3|||
28007425|NCT00689481|54666292|FG000|Overall Study|Lack of Efficacy|4|||
28007426|NCT00689481|54666293|FG001|Overall Study|Lack of Efficacy|3|||
28007427|NCT00689481|54666292|FG000|Overall Study|Non-compliance with study treatment|1|||
28007428|NCT00689481|54666293|FG001|Overall Study|Non-compliance with study treatment|1|||
28007429|NCT00689481|54666292|FG000|Overall Study|Withdrawal by Subject|8|||
28007430|NCT00689481|54666293|FG001|Overall Study|Withdrawal by Subject|4|||
28007431|NCT00689481|54666292|FG000|Overall Study|Excluded medication started during study|0|||
28007432|NCT00689481|54666293|FG001|Overall Study|Excluded medication started during study|1|||
28007433|NCT00689481|54666292|FG000|Overall Study|Subject early term, left on vacation|0|||
28007434|NCT00689481|54666293|FG001|Overall Study|Subject early term, left on vacation|1|||
28007435|NCT00688701|54666302|FG000|Overall Study|Adverse Event|1|||
28007436|NCT00688701|54666303|FG001|Overall Study|Adverse Event|0|||
28007437|NCT00688701|54666304|FG002|Overall Study|Adverse Event|5|||
28007438|NCT00688701|54666305|FG003|Overall Study|Adverse Event|3|||
28007439|NCT00688701|54666302|FG000|Overall Study|Lack of Efficacy|0|||
28007440|NCT00688701|54666303|FG001|Overall Study|Lack of Efficacy|1|||
28007441|NCT00688701|54666304|FG002|Overall Study|Lack of Efficacy|0|||
28007442|NCT00688701|54666305|FG003|Overall Study|Lack of Efficacy|0|||
28007443|NCT00688701|54666302|FG000|Overall Study|Withdrawal by Subject|3|||
28007444|NCT00688701|54666303|FG001|Overall Study|Withdrawal by Subject|3|||
28007445|NCT00688701|54666304|FG002|Overall Study|Withdrawal by Subject|4|||
28007446|NCT00688701|54666305|FG003|Overall Study|Withdrawal by Subject|8|||
28007447|NCT00688701|54666302|FG000|Overall Study|Poor compliance to protocol|0|||
28007448|NCT00688701|54666303|FG001|Overall Study|Poor compliance to protocol|1|||
28007449|NCT00688701|54666304|FG002|Overall Study|Poor compliance to protocol|1|||
28007450|NCT00688701|54666305|FG003|Overall Study|Poor compliance to protocol|0|||
28007451|NCT00688623|54666325|FG000|Overall Study|Adverse Event|22|||
28007452|NCT00688623|54666325|FG000|Overall Study|abnormal lab value|1|||
28007453|NCT00688623|54666325|FG000|Overall Study|Withdrawal by Subject|4|||
28007454|NCT00688623|54666325|FG000|Overall Study|Death|3|||
28007455|NCT00688623|54666325|FG000|Overall Study|disease progression|23|||
28007456|NCT00688623|54666325|FG000|Overall Study|Protocol Violation|2|||
28007457|NCT00717236|54666331|FG000|Double-Blind Period|Adverse Event|33|||
28007458|NCT00717236|54666332|FG001|Double-Blind Period|Adverse Event|6|||
28007459|NCT00717236|54666331|FG000|Double-Blind Period|Lack of Efficacy|6|||
28007460|NCT00717236|54666332|FG001|Double-Blind Period|Lack of Efficacy|6|||
28007461|NCT00717236|54666331|FG000|Double-Blind Period|Lost to Follow-up|3|||
28007462|NCT00717236|54666332|FG001|Double-Blind Period|Lost to Follow-up|5|||
28007463|NCT00717236|54666331|FG000|Double-Blind Period|Withdrawal by Subject|10|||
28007464|NCT00717236|54666332|FG001|Double-Blind Period|Withdrawal by Subject|2|||
28007465|NCT00717236|54666331|FG000|Double-Blind Period|Loss of efficacy|3|||
28007466|NCT00717236|54666332|FG001|Double-Blind Period|Loss of efficacy|0|||
28007467|NCT00717236|54666331|FG000|Double-Blind Period|Other: Death|1|||
28007468|NCT00717236|54666332|FG001|Double-Blind Period|Other: Death|0|||
28007469|NCT00717236|54666331|FG000|Double-Blind Period|Other: Pregnancy|1|||
28007470|NCT00717236|54666332|FG001|Double-Blind Period|Other: Pregnancy|0|||
28007471|NCT00717236|54666331|FG000|Double-Blind Period|Other: Protocol Violation|2|||
28007472|NCT00717236|54666332|FG001|Double-Blind Period|Other: Protocol Violation|0|||
28007473|NCT00717236|54666331|FG000|Double-Blind Period|Other: Inclusion/Exclusion criteria|6|||
28103522|NCT03392168|54760201|FG003|Period 2: Cohort 2|Other|0|||
28103523|NCT03391232|54760212|FG000|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|0|||
28103524|NCT03391232|54760213|FG001|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|1|||
28103525|NCT03391232|54760212|FG000|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|0|||
28103526|NCT03391232|54760213|FG001|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|2|||
28103527|NCT03379376|54760221|FG000|Overall Study|Lost to Follow-up|2|||
28103528|NCT03379376|54760221|FG000|Overall Study|Did not wish to complete follow up|1|||
28103529|NCT03379376|54760221|FG000|Overall Study|Overwhelmed, didn't want to continue|1|||
28103530|NCT03379376|54760221|FG000|Overall Study|Death|1|||
28103531|NCT03349034|54760227|FG000|Overall Study|catheters dislodged during transport|2|||
28103532|NCT03349034|54760228|FG001|Overall Study|catheters dislodged during transport|0|||
28103533|NCT03349034|54760227|FG000|Overall Study|intubated for >48 hrs following surgery|1|||
28103534|NCT03349034|54760228|FG001|Overall Study|intubated for >48 hrs following surgery|1|||
28103535|NCT03349034|54760227|FG000|Overall Study|soft tissue flap used|1|||
28103536|NCT03349034|54760228|FG001|Overall Study|soft tissue flap used|0|||
28103537|NCT03349034|54760227|FG000|Overall Study|Other|0|||
28103538|NCT03349034|54760228|FG001|Overall Study|Other|1|||
28103539|NCT00358215|54760238|FG000|Overall Study|Ineligibility determined|4|||
28103540|NCT00358215|54760239|FG001|Overall Study|Ineligibility determined|3|||
28007474|NCT00717236|54666332|FG001|Double-Blind Period|Other: Inclusion/Exclusion criteria|2|||
28007475|NCT00717236|54666331|FG000|Double-Blind Period|Other: Site withdrew|2|||
28007476|NCT00717236|54666332|FG001|Double-Blind Period|Other: Site withdrew|0|||
28007477|NCT00717236|54666331|FG000|Double-Blind Period|Other: Screening failure|1|||
28007478|NCT00717236|54666332|FG001|Double-Blind Period|Other: Screening failure|0|||
28007479|NCT00717236|54666331|FG000|Double-Blind Period|Other: subject withdrew consent|1|||
28007480|NCT00717236|54666332|FG001|Double-Blind Period|Other: subject withdrew consent|1|||
28007481|NCT00717236|54666331|FG000|Double-Blind Period|Other: Abnormal chest X-ray|2|||
28007482|NCT00717236|54666332|FG001|Double-Blind Period|Other: Abnormal chest X-ray|1|||
28007483|NCT00717236|54666331|FG000|Double-Blind Period|Other: History of adenoid grown|1|||
28007484|NCT00717236|54666332|FG001|Double-Blind Period|Other: History of adenoid grown|0|||
28007485|NCT00717236|54666331|FG000|Double-Blind Period|Other: History of cancer|1|||
28007486|NCT00717236|54666332|FG001|Double-Blind Period|Other: History of cancer|0|||
28007487|NCT00717236|54666331|FG000|Double-Blind Period|Other: Sponsor request|1|||
28007488|NCT00717236|54666332|FG001|Double-Blind Period|Other: Sponsor request|0|||
28007489|NCT00717236|54666331|FG000|Double-Blind Period|Other: Inappropriate randomization|1|||
28007490|NCT00717236|54666332|FG001|Double-Blind Period|Other: Inappropriate randomization|0|||
28007491|NCT00717236|54666331|FG000|Double-Blind Period|Other: Detection of Hepatitis C Virus|1|||
28007492|NCT00717236|54666332|FG001|Double-Blind Period|Other: Detection of Hepatitis C Virus|0|||
28007493|NCT00717236|54666331|FG000|Double-Blind Period|Other: Subject moved|1|||
28007494|NCT00717236|54666332|FG001|Double-Blind Period|Other: Subject moved|1|||
28007495|NCT00717236|54666331|FG000|Double-Blind Period|Other: Stopped taking DMARD|1|||
28007496|NCT00717236|54666332|FG001|Double-Blind Period|Other: Stopped taking DMARD|0|||
28007497|NCT00717236|54666331|FG000|Double-Blind Period|Other: Prohibited medication taken|2|||
28007498|NCT00717236|54666332|FG001|Double-Blind Period|Other: Prohibited medication taken|2|||
28007499|NCT00717236|54666331|FG000|Double-Blind Period|Other: Transportation problems|0|||
28007500|NCT00717236|54666332|FG001|Double-Blind Period|Other: Transportation problems|1|||
28007501|NCT00717236|54666331|FG000|Double-Blind Period|Other: Investigator Decision|0|||
28007502|NCT00717236|54666332|FG001|Double-Blind Period|Other: Investigator Decision|1|||
28007503|NCT00717236|54666331|FG000|Open-Label Period|Adverse Event|29|||
28007504|NCT00717236|54666332|FG001|Open-Label Period|Adverse Event|4|||
28007505|NCT00717236|54666331|FG000|Open-Label Period|Lack of Efficacy|30|||
28007506|NCT00717236|54666332|FG001|Open-Label Period|Lack of Efficacy|8|||
28007507|NCT00717236|54666331|FG000|Open-Label Period|Lost to Follow-up|28|||
28007508|NCT00717236|54666332|FG001|Open-Label Period|Lost to Follow-up|4|||
28007509|NCT00717236|54666331|FG000|Open-Label Period|Withdrawal by Subject|20|||
28007510|NCT00717236|54666332|FG001|Open-Label Period|Withdrawal by Subject|2|||
28007511|NCT00717236|54666331|FG000|Open-Label Period|Loss of Efficacy|6|||
28007512|NCT00717236|54666332|FG001|Open-Label Period|Loss of Efficacy|1|||
28007513|NCT00717236|54666331|FG000|Open-Label Period|Other: Peripheral Neuropathy|0|||
28007514|NCT00717236|54666332|FG001|Open-Label Period|Other: Peripheral Neuropathy|1|||
28007515|NCT00717236|54666331|FG000|Open-Label Period|Other: Lack of Compliance|1|||
28007516|NCT00717236|54666332|FG001|Open-Label Period|Other: Lack of Compliance|1|||
28007517|NCT00717236|54666331|FG000|Open-Label Period|Other: History of Basal Cell Carcinoma|1|||
28007518|NCT00717236|54666332|FG001|Open-Label Period|Other: History of Basal Cell Carcinoma|0|||
28007519|NCT00717236|54666331|FG000|Open-Label Period|Other: Moved|1|||
28007520|NCT00717236|54666332|FG001|Open-Label Period|Other: Moved|0|||
28007521|NCT00717236|54666331|FG000|Open-Label Period|Other: Investigator Decision|1|||
28007522|NCT00717236|54666332|FG001|Open-Label Period|Other: Investigator Decision|0|||
28007523|NCT00717236|54666331|FG000|Open-Label Period|Other: Loss of Staff (unblinded)|1|||
28007524|NCT00717236|54666332|FG001|Open-Label Period|Other: Loss of Staff (unblinded)|0|||
28007525|NCT00717236|54666331|FG000|Open-Label Period|Other: Sponsor Request|3|||
28007526|NCT00717236|54666332|FG001|Open-Label Period|Other: Sponsor Request|0|||
28007527|NCT00717236|54666331|FG000|Open-Label Period|Other: Cataract Surgery|1|||
28007528|NCT00717236|54666332|FG001|Open-Label Period|Other: Cataract Surgery|0|||
28007529|NCT00717236|54666331|FG000|Open-Label Period|Other: Administration of Golimumab|1|||
28007530|NCT00717236|54666332|FG001|Open-Label Period|Other: Administration of Golimumab|0|||
28007531|NCT00717236|54666331|FG000|Open-Label Period|Other: Completion Accidently Performed|1|||
28007532|NCT00717236|54666332|FG001|Open-Label Period|Other: Completion Accidently Performed|0|||
28007533|NCT00717236|54666331|FG000|Open-Label Period|Other: Medical Monitor Recommendation|1|||
28007534|NCT00717236|54666332|FG001|Open-Label Period|Other: Medical Monitor Recommendation|0|||
28007535|NCT00719810|54666343|FG000|Overall Study|Adverse Event|0|||
28007536|NCT00719810|54666344|FG001|Overall Study|Adverse Event|2|||
28007537|NCT00719810|54666345|FG002|Overall Study|Adverse Event|3|||
28007538|NCT00719810|54666343|FG000|Overall Study|Lost to Follow-up|2|||
28007539|NCT00719810|54666344|FG001|Overall Study|Lost to Follow-up|0|||
28007540|NCT00719810|54666345|FG002|Overall Study|Lost to Follow-up|3|||
28007541|NCT00719810|54666343|FG000|Overall Study|Physician Decision|0|||
28007542|NCT00719810|54666344|FG001|Overall Study|Physician Decision|1|||
28007543|NCT00719810|54666345|FG002|Overall Study|Physician Decision|0|||
28007544|NCT00719810|54666343|FG000|Overall Study|Withdrawal by Subject|1|||
28007545|NCT00719810|54666344|FG001|Overall Study|Withdrawal by Subject|1|||
28007546|NCT00719810|54666345|FG002|Overall Study|Withdrawal by Subject|2|||
28007547|NCT00719732|54666353|FG000|Overall Study|Lost to Follow-up|20|||
28007548|NCT00719732|54666353|FG000|Overall Study|Unilateral (not bilateral) implantation|1|||
28007549|NCT00719732|54666353|FG000|Overall Study|Illness not associated with device|1|||
28007550|NCT00723710|54666357|FG000|Overall Study|Disease progression|48|||
28007551|NCT00723710|54666357|FG000|Overall Study|Adverse Event|88|||
28007552|NCT00723710|54666357|FG000|Overall Study|Withdrawal by Subject|36|||
28007553|NCT00723710|54666357|FG000|Overall Study|Physician Decision|2|||
28007554|NCT00688545|54666363|FG000|Overall Study|Lost to Follow-up|1|||
28007555|NCT00688545|54666364|FG001|Overall Study|Lost to Follow-up|4|||
28007556|NCT00688545|54666363|FG000|Overall Study|Insurance/cost of drug|0|||
28007557|NCT00688545|54666364|FG001|Overall Study|Insurance/cost of drug|1|||
28007558|NCT00688545|54666363|FG000|Overall Study|Withdrawal by Subject|2|||
28007559|NCT00688545|54666364|FG001|Overall Study|Withdrawal by Subject|3|||
28007560|NCT00688545|54666363|FG000|Overall Study|Unspecified, unrelated to AE/Toxicity|2|||
28007561|NCT00688545|54666364|FG001|Overall Study|Unspecified, unrelated to AE/Toxicity|7|||
28007562|NCT00688467|54666374|FG000|Treatment Period 1|Adverse Event|2|||
28007563|NCT00688467|54666375|FG001|Treatment Period 1|Adverse Event|1|||
28007564|NCT00688467|54666374|FG000|Treatment Period 1|Did not meet protocol eligibility|0|||
28007565|NCT00688467|54666375|FG001|Treatment Period 1|Did not meet protocol eligibility|1|||
28007566|NCT00688467|54666374|FG000|Treatment Period 2|Protocol Violation|0|||
28007567|NCT00688467|54666375|FG001|Treatment Period 2|Protocol Violation|1|||
28007568|NCT00688467|54666374|FG000|Treatment Period 2|Adverse Event|0|||
28007569|NCT00688467|54666375|FG001|Treatment Period 2|Adverse Event|1|||
28007570|NCT00688155|54666385|FG000|Overall Study|Withdrawal by Subject|2|||
28007571|NCT00688155|54666386|FG001|Overall Study|Withdrawal by Subject|2|||
28007572|NCT00688155|54666387|FG002|Overall Study|Withdrawal by Subject|1|||
28007573|NCT00688155|54666388|FG003|Overall Study|Withdrawal by Subject|1|||
28007574|NCT00690573|54666398|FG000|Overall Study|Lack of Efficacy|8|||
28007575|NCT00690573|54666398|FG000|Overall Study|Withdrawal by Subject|1|||
28007576|NCT00719264|54666404|FG000|Overall Study|Adverse Event|41|||
28007577|NCT00719264|54666405|FG001|Overall Study|Adverse Event|49|||
28007578|NCT00719264|54666404|FG000|Overall Study|Death|13|||
28007579|NCT00719264|54666405|FG001|Overall Study|Death|10|||
28007580|NCT00719264|54666404|FG000|Overall Study|Administrative Problems|6|||
28007581|NCT00719264|54666405|FG001|Overall Study|Administrative Problems|4|||
28007582|NCT00719264|54666404|FG000|Overall Study|Lost to Follow-up|1|||
28007583|NCT00719264|54666405|FG001|Overall Study|Lost to Follow-up|1|||
28007584|NCT00719264|54666404|FG000|Overall Study|Withdrawal by Subject|12|||
28007585|NCT00719264|54666405|FG001|Overall Study|Withdrawal by Subject|7|||
28007586|NCT00719264|54666404|FG000|Overall Study|Protocol Deviation|1|||
28007587|NCT00719264|54666405|FG001|Overall Study|Protocol Deviation|3|||
28007588|NCT00719264|54666404|FG000|Overall Study|New Cancer Therapy|4|||
28007589|NCT00719264|54666405|FG001|Overall Study|New Cancer Therapy|2|||
28007590|NCT00719264|54666404|FG000|Overall Study|Disease Progression|104|||
28007591|NCT00719264|54666405|FG001|Overall Study|Disease Progression|107|||
28007592|NCT00687609|54666411|FG000|Overall Study|Physician Decision|1|||
28007593|NCT00687609|54666411|FG000|Overall Study|Withdrawal by Subject|2|||
28007594|NCT00723554|54666415|FG000|Overall Study|Adverse Event|12|||
28007595|NCT00723554|54666415|FG000|Overall Study|Investigator's judgement|5|||
28007596|NCT00723554|54666415|FG000|Overall Study|Inhaled medication other than iloprost|4|||
28007597|NCT00723554|54666415|FG000|Overall Study|Withdrawal of consent|3|||
28007598|NCT00723554|54666415|FG000|Overall Study|Other|3|||
28007599|NCT00723554|54666415|FG000|Overall Study|Lost to Follow-up|1|||
28007600|NCT00723554|54666415|FG000|Overall Study|Non-compliance|1|||
28007601|NCT00687219|54666421|FG000|Overall Study|Adverse Event|8|||
28007602|NCT00687219|54666421|FG000|Overall Study|Discontinuance criteria met|7|||
28007603|NCT00687219|54666421|FG000|Overall Study|HCV-RNA positive conversion|34|||
28007604|NCT00687219|54666421|FG000|Overall Study|Withdrawal by Subject|1|||
27917664|NCT01332968|54574963|FG000|Follow-Up Period|Progressive Disease|0|||
27917665|NCT01332968|54574964|FG001|Follow-Up Period|Progressive Disease|0|||
27917666|NCT01332968|54574965|FG002|Follow-Up Period|Progressive Disease|0|||
27917667|NCT01332968|54574966|FG003|Follow-Up Period|Progressive Disease|0|||
27917668|NCT01332968|54574967|FG004|Follow-Up Period|Progressive Disease|0|||
27917669|NCT01332968|54574968|FG005|Follow-Up Period|Progressive Disease|0|||
27917670|NCT01332968|54574969|FG006|Follow-Up Period|Progressive Disease|126|||
27917671|NCT01332968|54574970|FG007|Follow-Up Period|Progressive Disease|106|||
27917672|NCT01332968|54574963|FG000|Follow-Up Period|Protocol Violation|0|||
27917673|NCT01332968|54574964|FG001|Follow-Up Period|Protocol Violation|0|||
28007605|NCT00687219|54666421|FG000|Overall Study|Lack of Efficacy|1|||
28007606|NCT00723398|54666430|FG000|Overall Study|Withdrawal by Subject|2|||
28007607|NCT00723398|54666431|FG001|Overall Study|Withdrawal by Subject|6|||
28007608|NCT00723398|54666432|FG002|Overall Study|Withdrawal by Subject|4|||
28007609|NCT00723398|54666433|FG003|Overall Study|Withdrawal by Subject|4|||
27740056|NCT02205814|54189898|FG000|Overall Study|Lack of Efficacy|1|||
27917674|NCT01332968|54574965|FG002|Follow-Up Period|Protocol Violation|0|||
28007610|NCT00723398|54666434|FG004|Overall Study|Withdrawal by Subject|4|||
28007611|NCT00723398|54666430|FG000|Overall Study|Protocol Violation|2|||
28007612|NCT00723398|54666431|FG001|Overall Study|Protocol Violation|1|||
28007613|NCT00723398|54666432|FG002|Overall Study|Protocol Violation|5|||
28007614|NCT00723398|54666433|FG003|Overall Study|Protocol Violation|0|||
28007615|NCT00723398|54666434|FG004|Overall Study|Protocol Violation|0|||
28007616|NCT00723398|54666430|FG000|Overall Study|Physician Decision|2|||
28007617|NCT00723398|54666431|FG001|Overall Study|Physician Decision|2|||
27740057|NCT02205814|54189899|FG001|Overall Study|Lack of Efficacy|0|||
27917675|NCT01332968|54574966|FG003|Follow-Up Period|Protocol Violation|0|||
27917676|NCT01332968|54574967|FG004|Follow-Up Period|Protocol Violation|0|||
27917677|NCT01332968|54574968|FG005|Follow-Up Period|Protocol Violation|0|||
27917678|NCT01332968|54574969|FG006|Follow-Up Period|Protocol Violation|1|||
27917679|NCT01332968|54574970|FG007|Follow-Up Period|Protocol Violation|0|||
27917680|NCT01332968|54574963|FG000|Follow-Up Period|Withdrawal by Subject|0|||
27917681|NCT01332968|54574964|FG001|Follow-Up Period|Withdrawal by Subject|0|||
27917682|NCT01332968|54574965|FG002|Follow-Up Period|Withdrawal by Subject|0|||
27917683|NCT01332968|54574966|FG003|Follow-Up Period|Withdrawal by Subject|0|||
27917684|NCT01332968|54574967|FG004|Follow-Up Period|Withdrawal by Subject|0|||
27917685|NCT01332968|54574968|FG005|Follow-Up Period|Withdrawal by Subject|0|||
27917686|NCT01332968|54574969|FG006|Follow-Up Period|Withdrawal by Subject|29|||
27917687|NCT01332968|54574970|FG007|Follow-Up Period|Withdrawal by Subject|32|||
27917688|NCT01332968|54574963|FG000|Follow-Up Period|No reason provided|0|||
27917689|NCT01332968|54574964|FG001|Follow-Up Period|No reason provided|0|||
27917690|NCT01332968|54574965|FG002|Follow-Up Period|No reason provided|0|||
27917691|NCT01332968|54574966|FG003|Follow-Up Period|No reason provided|0|||
27917692|NCT01332968|54574967|FG004|Follow-Up Period|No reason provided|0|||
27917693|NCT01332968|54574968|FG005|Follow-Up Period|No reason provided|0|||
27917694|NCT01332968|54574969|FG006|Follow-Up Period|No reason provided|2|||
27917695|NCT01332968|54574970|FG007|Follow-Up Period|No reason provided|3|||
27917696|NCT01332851|54574980|FG000|Overall Study|Withdrawal by Subject|4|||
27917697|NCT01332851|54574981|FG001|Overall Study|Withdrawal by Subject|2|||
27917698|NCT01332851|54574980|FG000|Overall Study|Lost to Follow-up|7|||
27917699|NCT01332851|54574981|FG001|Overall Study|Lost to Follow-up|11|||
27917700|NCT01332305|54574996|FG000|Overall Study|Adverse Event|1|||
27917701|NCT01332305|54574997|FG001|Overall Study|Adverse Event|4|||
27917702|NCT01332305|54574998|FG002|Overall Study|Adverse Event|6|||
27917703|NCT01332305|54574999|FG003|Overall Study|Adverse Event|3|||
27917704|NCT01332305|54575000|FG004|Overall Study|Adverse Event|5|||
27917705|NCT01332305|54574996|FG000|Overall Study|Withdrawal by Subject|6|||
28007618|NCT00723398|54666432|FG002|Overall Study|Physician Decision|5|||
28007619|NCT00723398|54666433|FG003|Overall Study|Physician Decision|0|||
28007620|NCT00723398|54666434|FG004|Overall Study|Physician Decision|1|||
28007621|NCT00723398|54666430|FG000|Overall Study|Adverse Event|0|||
28007622|NCT00723398|54666431|FG001|Overall Study|Adverse Event|5|||
28007623|NCT00723398|54666432|FG002|Overall Study|Adverse Event|3|||
28007624|NCT00723398|54666433|FG003|Overall Study|Adverse Event|1|||
28007625|NCT00723398|54666434|FG004|Overall Study|Adverse Event|4|||
27740058|NCT02205814|54189900|FG002|Overall Study|Lack of Efficacy|1|||
27917706|NCT01332305|54574997|FG001|Overall Study|Withdrawal by Subject|5|||
27917707|NCT01332305|54574998|FG002|Overall Study|Withdrawal by Subject|4|||
28007626|NCT00723398|54666430|FG000|Overall Study|Lost to Follow-up|0|||
27917708|NCT01332305|54574999|FG003|Overall Study|Withdrawal by Subject|1|||
27917709|NCT01332305|54575000|FG004|Overall Study|Withdrawal by Subject|0|||
27917710|NCT01332305|54574996|FG000|Overall Study|Lost to Follow-up|0|||
28007627|NCT00723398|54666431|FG001|Overall Study|Lost to Follow-up|1|||
28007628|NCT00723398|54666432|FG002|Overall Study|Lost to Follow-up|0|||
28007629|NCT00723398|54666433|FG003|Overall Study|Lost to Follow-up|0|||
28007630|NCT00723398|54666434|FG004|Overall Study|Lost to Follow-up|0|||
28007631|NCT00716456|54666449|FG000|Overall Study|Adverse Event|0|||
28007632|NCT00716456|54666450|FG001|Overall Study|Adverse Event|2|||
28007633|NCT00716456|54666451|FG002|Overall Study|Adverse Event|0|||
28007634|NCT00684645|54666459|FG000|Overall Study|Death|2|||
28007635|NCT00684645|54666459|FG000|Overall Study|Progressive disease|67|||
28007636|NCT00684645|54666459|FG000|Overall Study|Adverse Event|27|||
28007637|NCT00684645|54666459|FG000|Overall Study|Lost to Follow-up|3|||
28007638|NCT00684645|54666459|FG000|Overall Study|Other|15|||
28007639|NCT00716144|54666467|FG000|Overall Study|Withdrawal by Subject|4|||
28007640|NCT00716144|54666468|FG001|Overall Study|Withdrawal by Subject|2|||
28007641|NCT00716144|54666469|FG002|Overall Study|Withdrawal by Subject|6|||
28007642|NCT00716144|54666470|FG003|Overall Study|Withdrawal by Subject|6|||
28007643|NCT00716144|54666467|FG000|Overall Study|Lost to Follow-up|2|||
28007644|NCT00716144|54666468|FG001|Overall Study|Lost to Follow-up|2|||
28007645|NCT00716144|54666469|FG002|Overall Study|Lost to Follow-up|1|||
28007646|NCT00716144|54666470|FG003|Overall Study|Lost to Follow-up|2|||
28007647|NCT00716144|54666467|FG000|Overall Study|Adverse Event|0|||
28007648|NCT00716144|54666468|FG001|Overall Study|Adverse Event|0|||
28007649|NCT00716144|54666469|FG002|Overall Study|Adverse Event|0|||
28007650|NCT00716144|54666470|FG003|Overall Study|Adverse Event|2|||
28007651|NCT00716144|54666467|FG000|Overall Study|Non-compliance|1|||
28007652|NCT00716144|54666468|FG001|Overall Study|Non-compliance|0|||
28007653|NCT00716144|54666469|FG002|Overall Study|Non-compliance|0|||
28007654|NCT00716144|54666470|FG003|Overall Study|Non-compliance|0|||
28007655|NCT00716144|54666467|FG000|Overall Study|Protocol Violation|2|||
28007656|NCT00716144|54666468|FG001|Overall Study|Protocol Violation|0|||
28007657|NCT00716144|54666469|FG002|Overall Study|Protocol Violation|1|||
28007658|NCT00716144|54666470|FG003|Overall Study|Protocol Violation|0|||
28007659|NCT00716144|54666467|FG000|Overall Study|Physician Decision|0|||
28007660|NCT00716144|54666468|FG001|Overall Study|Physician Decision|1|||
28007661|NCT00716144|54666469|FG002|Overall Study|Physician Decision|2|||
28007662|NCT00716144|54666470|FG003|Overall Study|Physician Decision|2|||
28007663|NCT00716144|54666467|FG000|Overall Study|Intercurrent illness|0|||
28007664|NCT00716144|54666468|FG001|Overall Study|Intercurrent illness|0|||
27917711|NCT01332305|54574997|FG001|Overall Study|Lost to Follow-up|2|||
27917712|NCT01332305|54574998|FG002|Overall Study|Lost to Follow-up|3|||
27917713|NCT01332305|54574999|FG003|Overall Study|Lost to Follow-up|2|||
27917714|NCT01332305|54575000|FG004|Overall Study|Lost to Follow-up|3|||
27917715|NCT01332305|54574996|FG000|Overall Study|Protocol Violation|1|||
27917716|NCT01332305|54574997|FG001|Overall Study|Protocol Violation|2|||
27917717|NCT01332305|54574998|FG002|Overall Study|Protocol Violation|1|||
27917718|NCT01332305|54574999|FG003|Overall Study|Protocol Violation|0|||
28007665|NCT00716144|54666469|FG002|Overall Study|Intercurrent illness|1|||
28007666|NCT00716144|54666470|FG003|Overall Study|Intercurrent illness|0|||
27740059|NCT02205814|54189901|FG003|Overall Study|Lack of Efficacy|1|||
27917719|NCT01332305|54575000|FG004|Overall Study|Protocol Violation|3|||
27917720|NCT01332305|54574996|FG000|Overall Study|Withdrawal by Sponsor|1|||
27740060|NCT02205814|54189898|FG000|Overall Study|Physician Decision|0|||
28007667|NCT00716144|54666467|FG000|Overall Study|Withdrew consent, allowed use of data|0|||
28007668|NCT00716144|54666468|FG001|Overall Study|Withdrew consent, allowed use of data|0|||
28007669|NCT00716144|54666469|FG002|Overall Study|Withdrew consent, allowed use of data|1|||
28007670|NCT00716144|54666470|FG003|Overall Study|Withdrew consent, allowed use of data|0|||
28007671|NCT00716144|54666467|FG000|Overall Study|Adverse event: left foot pain|0|||
28007672|NCT00716144|54666468|FG001|Overall Study|Adverse event: left foot pain|1|||
28007673|NCT00716144|54666469|FG002|Overall Study|Adverse event: left foot pain|0|||
28007674|NCT00716144|54666470|FG003|Overall Study|Adverse event: left foot pain|0|||
28007675|NCT00716144|54666467|FG000|Overall Study|Clinical Depression|0|||
28007676|NCT00716144|54666468|FG001|Overall Study|Clinical Depression|1|||
28007677|NCT00716144|54666469|FG002|Overall Study|Clinical Depression|0|||
28007678|NCT00716144|54666470|FG003|Overall Study|Clinical Depression|0|||
28007679|NCT00576381|54666480|FG000|Overall Study|Reoperation|3|||
28007680|NCT00576381|54666480|FG000|Overall Study|Adverse Event|4|||
28007681|NCT00684567|54666484|FG000|Concomitant Radiotherapy Period|Adverse Event|2|||
28007682|NCT00684567|54666484|FG000|Monotherapy Period|Adverse Event|2|||
28007683|NCT00684567|54666484|FG000|Monotherapy Period|Death|1|||
28007684|NCT00684567|54666484|FG000|Monotherapy Period|Progression of primary disease|11|||
28007685|NCT00684411|54666488|FG000|Overall Study|New Primary Cancer|1|||
28007686|NCT00684411|54666488|FG000|Overall Study|Disease Progression|10|||
28007687|NCT00684411|54666488|FG000|Overall Study|Adverse Event|1|||
27917721|NCT01332305|54574997|FG001|Overall Study|Withdrawal by Sponsor|0|||
27917722|NCT01332305|54574998|FG002|Overall Study|Withdrawal by Sponsor|0|||
27917723|NCT01332305|54574999|FG003|Overall Study|Withdrawal by Sponsor|1|||
27917724|NCT01332305|54575000|FG004|Overall Study|Withdrawal by Sponsor|1|||
27917725|NCT01332305|54574996|FG000|Overall Study|Treatment Failure|1|||
27917726|NCT01332305|54574997|FG001|Overall Study|Treatment Failure|1|||
27740061|NCT02205814|54189899|FG001|Overall Study|Physician Decision|0|||
27740062|NCT02205814|54189900|FG002|Overall Study|Physician Decision|1|||
28007688|NCT00686829|54666492|FG000|Overall Study|Adverse Event|5|||
28007689|NCT00686829|54666492|FG000|Overall Study|Lack of Efficacy|6|||
28007690|NCT00686829|54666492|FG000|Overall Study|Lost to Follow-up|4|||
28007691|NCT00686829|54666492|FG000|Overall Study|Withdrawal by Subject|14|||
28007692|NCT00686829|54666492|FG000|Overall Study|Protocol Violation|3|||
28007693|NCT00686829|54666492|FG000|Overall Study|Sponsor discontinued VCV|47|||
28007694|NCT00687297|54666498|FG000|Randomization|Withdrawal by Subject|2|||
28007695|NCT00687297|54666499|FG001|Randomization|Withdrawal by Subject|0|||
27740063|NCT02205814|54189901|FG003|Overall Study|Physician Decision|0|||
27917727|NCT01332305|54574998|FG002|Overall Study|Treatment Failure|0|||
27917728|NCT01332305|54574999|FG003|Overall Study|Treatment Failure|0|||
27917729|NCT01332305|54575000|FG004|Overall Study|Treatment Failure|0|||
27917730|NCT01332305|54574996|FG000|Overall Study|Physician Decision|0|||
27917731|NCT01332305|54574997|FG001|Overall Study|Physician Decision|0|||
27917732|NCT01332305|54574998|FG002|Overall Study|Physician Decision|0|||
27917733|NCT01332305|54574999|FG003|Overall Study|Physician Decision|1|||
27917734|NCT01332305|54575000|FG004|Overall Study|Physician Decision|0|||
27917735|NCT01332227|54575014|FG000|Overall Study|Adverse Event|4|||
27917736|NCT01332227|54575015|FG001|Overall Study|Adverse Event|1|||
27917737|NCT01332227|54575014|FG000|Overall Study|Withdrawal by Subject|5|||
27917738|NCT01332227|54575015|FG001|Overall Study|Withdrawal by Subject|1|||
27917739|NCT01332227|54575014|FG000|Overall Study|Lost to Follow-up|2|||
27917740|NCT01332227|54575015|FG001|Overall Study|Lost to Follow-up|0|||
27917741|NCT01332227|54575014|FG000|Overall Study|Lack of Efficacy|3|||
27917742|NCT01332227|54575015|FG001|Overall Study|Lack of Efficacy|1|||
27917743|NCT01332227|54575014|FG000|Overall Study|Poor compliance/noncompliance|1|||
27917744|NCT01332227|54575015|FG001|Overall Study|Poor compliance/noncompliance|1|||
28007696|NCT00687297|54666498|FG000|Randomization|Withdrew before treatment, ineligible|1|||
28007697|NCT00687297|54666499|FG001|Randomization|Withdrew before treatment, ineligible|1|||
27917745|NCT01332227|54575014|FG000|Overall Study|Patient moved from area|1|||
27917746|NCT01332227|54575015|FG001|Overall Study|Patient moved from area|0|||
27917747|NCT01332227|54575014|FG000|Overall Study|Patient began prohibited medication|0|||
27917748|NCT01332227|54575015|FG001|Overall Study|Patient began prohibited medication|1|||
27917749|NCT01332149|54575023|FG000|Overall Study|Adverse Event|11|||
27917750|NCT01332149|54575024|FG001|Overall Study|Adverse Event|9|||
28007698|NCT00687297|54666498|FG000|Induction|Withdrawal by Subject|4|||
28007699|NCT00687297|54666499|FG001|Induction|Withdrawal by Subject|4|||
28007700|NCT00687297|54666498|FG000|Induction|Adverse Event|16|||
28007701|NCT00687297|54666499|FG001|Induction|Adverse Event|15|||
28007702|NCT00687297|54666498|FG000|Induction|Death|7|||
28007703|NCT00687297|54666499|FG001|Induction|Death|11|||
28007704|NCT00687297|54666498|FG000|Induction|Lack of Efficacy|17|||
28007705|NCT00687297|54666499|FG001|Induction|Lack of Efficacy|21|||
28007706|NCT00687297|54666498|FG000|Induction|Ineligible|0|||
27917751|NCT01332149|54575023|FG000|Overall Study|Other unspecified|5|||
27917752|NCT01332149|54575024|FG001|Overall Study|Other unspecified|7|||
27740064|NCT02205814|54189898|FG000|Overall Study|Protocol Violation|1|||
27917753|NCT01332149|54575023|FG000|Overall Study|Protocol Violation|1|||
27917754|NCT01332149|54575024|FG001|Overall Study|Protocol Violation|3|||
27917755|NCT01332149|54575023|FG000|Overall Study|Withdrawal by Subject|4|||
27917756|NCT01332149|54575024|FG001|Overall Study|Withdrawal by Subject|5|||
27917757|NCT01332149|54575023|FG000|Overall Study|Lost to Follow-up|1|||
27917758|NCT01332149|54575024|FG001|Overall Study|Lost to Follow-up|1|||
27917759|NCT01332149|54575023|FG000|Overall Study|Insufficient clinical response|4|||
27917760|NCT01332149|54575024|FG001|Overall Study|Insufficient clinical response|7|||
27917761|NCT01332149|54575023|FG000|Overall Study|Did not meet entrance criteria|3|||
27917762|NCT01332149|54575024|FG001|Overall Study|Did not meet entrance criteria|4|||
28007707|NCT00687297|54666499|FG001|Induction|Ineligible|1|||
27917763|NCT01332149|54575023|FG000|Overall Study|Randomized but not treated|1|||
27917764|NCT01332149|54575024|FG001|Overall Study|Randomized but not treated|2|||
28007708|NCT00687297|54666498|FG000|Induction|Patient Noncompliance|1|||
28007709|NCT00687297|54666499|FG001|Induction|Patient Noncompliance|0|||
28007710|NCT00687297|54666498|FG000|Induction|Physician Decision|0|||
28007711|NCT00687297|54666499|FG001|Induction|Physician Decision|2|||
28007712|NCT00687297|54666498|FG000|Induction|Other|0|||
28007713|NCT00687297|54666499|FG001|Induction|Other|1|||
28007714|NCT00684177|54666509|FG000|Overall Study|Adverse Event|4|||
28007715|NCT00684177|54666510|FG001|Overall Study|Adverse Event|3|||
28007716|NCT00684177|54666509|FG000|Overall Study|Lack of Efficacy|10|||
28007717|NCT00684177|54666510|FG001|Overall Study|Lack of Efficacy|15|||
28007718|NCT00684177|54666509|FG000|Overall Study|Protocol Violation|1|||
28007719|NCT00684177|54666510|FG001|Overall Study|Protocol Violation|0|||
28007720|NCT00684177|54666509|FG000|Overall Study|Lost to Follow-up|2|||
28007721|NCT00684177|54666510|FG001|Overall Study|Lost to Follow-up|1|||
28007722|NCT00684177|54666509|FG000|Overall Study|Physician Decision|2|||
28007723|NCT00684177|54666510|FG001|Overall Study|Physician Decision|0|||
28007724|NCT00684177|54666509|FG000|Overall Study|Withdrawal by Subject|1|||
27740065|NCT02205814|54189899|FG001|Overall Study|Protocol Violation|0|||
27740066|NCT02205814|54189900|FG002|Overall Study|Protocol Violation|0|||
27740067|NCT02205814|54189901|FG003|Overall Study|Protocol Violation|1|||
27740068|NCT02205814|54189898|FG000|Overall Study|Withdrawal by Subject|0|||
27740069|NCT02205814|54189899|FG001|Overall Study|Withdrawal by Subject|1|||
27740070|NCT02205814|54189900|FG002|Overall Study|Withdrawal by Subject|2|||
27740071|NCT02205814|54189901|FG003|Overall Study|Withdrawal by Subject|1|||
27740072|NCT02205814|54189898|FG000|Overall Study|not compliant with study procedures|0|||
27740073|NCT02205814|54189899|FG001|Overall Study|not compliant with study procedures|0|||
27740074|NCT02205814|54189900|FG002|Overall Study|not compliant with study procedures|1|||
27740075|NCT02205814|54189901|FG003|Overall Study|not compliant with study procedures|0|||
27740076|NCT02662985|54189913|FG000|Treatment Period 1|Adverse Event|0|||
27740077|NCT02662985|54189914|FG001|Treatment Period 1|Adverse Event|2|||
27740078|NCT02662985|54189913|FG000|Treatment Period 1|Protocol Violation|0|||
27740079|NCT02662985|54189914|FG001|Treatment Period 1|Protocol Violation|1|||
27740080|NCT02662985|54189913|FG000|Treatment Period 1|Physician Decision|1|||
27740081|NCT02662985|54189914|FG001|Treatment Period 1|Physician Decision|0|||
27740082|NCT02662985|54189913|FG000|Treatment Period 1|Withdrawal by Subject|0|||
28007725|NCT00684177|54666510|FG001|Overall Study|Withdrawal by Subject|2|||
28007726|NCT00684177|54666509|FG000|Overall Study|Other|1|||
28007727|NCT00684177|54666510|FG001|Overall Study|Other|2|||
28007728|NCT00684021|54666520|FG000|Overall Study|MRI Contraindicated|1|||
28007729|NCT00684021|54666521|FG001|Overall Study|MRI Contraindicated|1|||
28007730|NCT00684021|54666522|FG002|Overall Study|MRI Contraindicated|1|||
28007731|NCT00684021|54666523|FG003|Overall Study|MRI Contraindicated|0|||
28007732|NCT00684021|54666520|FG000|Overall Study|MRI not performed|0|||
28007733|NCT00684021|54666521|FG001|Overall Study|MRI not performed|1|||
28007734|NCT00684021|54666522|FG002|Overall Study|MRI not performed|1|||
28007735|NCT00684021|54666523|FG003|Overall Study|MRI not performed|2|||
28007736|NCT00684021|54666520|FG000|Overall Study|Death|1|||
28007737|NCT00684021|54666521|FG001|Overall Study|Death|0|||
28007738|NCT00684021|54666522|FG002|Overall Study|Death|0|||
28007739|NCT00684021|54666523|FG003|Overall Study|Death|0|||
28007740|NCT00686595|54666533|FG000|Overall Study|Adverse Event|3|||
28007741|NCT00686595|54666533|FG000|Overall Study|Protocol Violation|1|||
28007742|NCT00686595|54666533|FG000|Overall Study|Lost to Follow-up|1|||
28007743|NCT00686595|54666533|FG000|Overall Study|Lack of Efficacy|1|||
28007744|NCT00686595|54666533|FG000|Overall Study|Poor Compliance|1|||
27740083|NCT02662985|54189914|FG001|Treatment Period 1|Withdrawal by Subject|1|||
28007745|NCT00576303|54666537|FG000|Dose Titration Period|Early withdrawal|17|||
28007746|NCT00576303|54666537|FG000|Efficacy Evaluation Period|Early withdrawal|5|||
27740084|NCT02662985|54189913|FG000|Treatment Period 2|Lack of Efficacy|0|||
27740085|NCT02662985|54189914|FG001|Treatment Period 2|Lack of Efficacy|1|||
27740086|NCT02662985|54189913|FG000|Treatment Period 2|Lost to Follow-up|1|||
28007747|NCT00576303|54666537|FG000|Long Term Safety Period|Early withdrawal|16|||
28007748|NCT00686517|54666544|FG000|Treatment|Serious Adverse Event|1|||
28007749|NCT00686517|54666545|FG001|Treatment|Serious Adverse Event|2|||
28007750|NCT00686517|54666546|FG002|Treatment|Serious Adverse Event|1|||
28007751|NCT00686517|54666544|FG000|Treatment|Adverse Event|2|||
28007752|NCT00686517|54666545|FG001|Treatment|Adverse Event|0|||
28007753|NCT00686517|54666546|FG002|Treatment|Adverse Event|0|||
28007754|NCT00686517|54666544|FG000|Treatment|Poor Protocol Compliance|1|||
28007755|NCT00686517|54666545|FG001|Treatment|Poor Protocol Compliance|0|||
28007756|NCT00686517|54666546|FG002|Treatment|Poor Protocol Compliance|0|||
28007757|NCT00686517|54666544|FG000|Treatment|Protocol Violation|2|||
28007758|NCT00686517|54666545|FG001|Treatment|Protocol Violation|1|||
28007759|NCT00686517|54666546|FG002|Treatment|Protocol Violation|0|||
28007760|NCT00686205|54666556|FG000|Overall Study|Protocol Violation|127|||
28007761|NCT00686205|54666557|FG001|Overall Study|Protocol Violation|0|||
28007762|NCT00686205|54666556|FG000|Overall Study|Withdrawal by Subject|2|||
28007763|NCT00686205|54666557|FG001|Overall Study|Withdrawal by Subject|0|||
27917765|NCT01330628|54575032|FG000|Overall Study|Death|2|||
27917766|NCT01330628|54575033|FG001|Overall Study|Death|3|||
27917767|NCT01330628|54575032|FG000|Overall Study|Lost to Follow-up|5|||
27917768|NCT01330628|54575033|FG001|Overall Study|Lost to Follow-up|6|||
27917769|NCT01330628|54575032|FG000|Overall Study|Adverse Event|44|||
27917770|NCT01330628|54575033|FG001|Overall Study|Adverse Event|25|||
27917771|NCT01330628|54575032|FG000|Overall Study|Withdrawn|18|||
27917772|NCT01330628|54575033|FG001|Overall Study|Withdrawn|6|||
27917773|NCT01330628|54575032|FG000|Overall Study|Didn't receive study treatment|1|||
27917774|NCT01330628|54575033|FG001|Overall Study|Didn't receive study treatment|0|||
27917775|NCT01330433|54575041|FG000|Overall Study|Death|1|||
27917776|NCT01330433|54575042|FG001|Overall Study|Death|3|||
27917777|NCT01330433|54575041|FG000|Overall Study|Lost to Follow-up|1|||
27917778|NCT01330433|54575042|FG001|Overall Study|Lost to Follow-up|0|||
27917779|NCT01330316|54575050|FG000|Overall Study|Adverse Event|2|||
27917780|NCT01330316|54575051|FG001|Overall Study|Adverse Event|2|||
27917781|NCT01330316|54575050|FG000|Overall Study|Lack of Efficacy|0|||
27917782|NCT01330316|54575051|FG001|Overall Study|Lack of Efficacy|10|||
27917783|NCT01330316|54575050|FG000|Overall Study|Lost to Follow-up|0|||
27917784|NCT01330316|54575051|FG001|Overall Study|Lost to Follow-up|1|||
27917785|NCT01330316|54575050|FG000|Overall Study|Withdrawal by Subject|0|||
27917786|NCT01330316|54575051|FG001|Overall Study|Withdrawal by Subject|1|||
27917787|NCT01330316|54575050|FG000|Overall Study|other than above|0|||
27917788|NCT01330316|54575051|FG001|Overall Study|other than above|1|||
27917789|NCT01326702|54575064|FG000|Overall Study|Other|1|||
27917790|NCT01326702|54575065|FG001|Overall Study|Other|0|||
27917791|NCT01326702|54575066|FG002|Overall Study|Other|0|||
27917792|NCT01326702|54575067|FG003|Overall Study|Other|0|||
27917793|NCT01326702|54575068|FG004|Overall Study|Other|0|||
27917794|NCT01326702|54575069|FG005|Overall Study|Other|1|||
27917795|NCT01326702|54575070|FG006|Overall Study|Other|0|||
27917796|NCT01326702|54575064|FG000|Overall Study|progressive disease|1|||
27917797|NCT01326702|54575065|FG001|Overall Study|progressive disease|1|||
27917798|NCT01326702|54575066|FG002|Overall Study|progressive disease|3|||
27917799|NCT01326702|54575067|FG003|Overall Study|progressive disease|1|||
27917800|NCT01326702|54575068|FG004|Overall Study|progressive disease|3|||
27917801|NCT01326702|54575069|FG005|Overall Study|progressive disease|2|||
27917802|NCT01326702|54575070|FG006|Overall Study|progressive disease|3|||
27917803|NCT01326702|54575064|FG000|Overall Study|Death|0|||
27917804|NCT01326702|54575065|FG001|Overall Study|Death|1|||
27917805|NCT01326702|54575066|FG002|Overall Study|Death|0|||
27917806|NCT01326702|54575067|FG003|Overall Study|Death|0|||
28007764|NCT00686205|54666556|FG000|Overall Study|Specimen handling procedure altered|5878|||
28007765|NCT00686205|54666557|FG001|Overall Study|Specimen handling procedure altered|0|||
28007766|NCT00686205|54666556|FG000|Overall Study|Specimens not confirmed HIV positive|0|||
28007767|NCT00686205|54666557|FG001|Overall Study|Specimens not confirmed HIV positive|981|||
28007768|NCT00571701|54666565|FG000|First Intervention 12 Months|Withdrawal by Subject|2|||
28007769|NCT00571701|54666566|FG001|First Intervention 12 Months|Withdrawal by Subject|1|||
27917807|NCT01326702|54575068|FG004|Overall Study|Death|0|||
27917808|NCT01326702|54575069|FG005|Overall Study|Death|0|||
27917809|NCT01326702|54575070|FG006|Overall Study|Death|0|||
27917810|NCT01326702|54575064|FG000|Overall Study|Adverse Event|0|||
27917811|NCT01326702|54575065|FG001|Overall Study|Adverse Event|0|||
28007770|NCT00571701|54666565|FG000|First Intervention 12 Months|Death|1|||
28007771|NCT00571701|54666566|FG001|First Intervention 12 Months|Death|0|||
28007772|NCT00571701|54666565|FG000|Second Intervention 12 Months|Adverse Event|0|||
27917812|NCT01326702|54575066|FG002|Overall Study|Adverse Event|1|||
27917813|NCT01326702|54575067|FG003|Overall Study|Adverse Event|1|||
27917814|NCT01326702|54575068|FG004|Overall Study|Adverse Event|0|||
27917815|NCT01326702|54575069|FG005|Overall Study|Adverse Event|3|||
28007773|NCT00571701|54666566|FG001|Second Intervention 12 Months|Adverse Event|1|||
28103541|NCT00358215|54760238|FG000|Overall Study|Adverse Event|83|||
28103542|NCT00358215|54760239|FG001|Overall Study|Adverse Event|65|||
28103543|NCT00358215|54760238|FG000|Overall Study|Withdrawal by Subject|111|||
28103544|NCT00358215|54760239|FG001|Overall Study|Withdrawal by Subject|102|||
28103545|NCT00358215|54760238|FG000|Overall Study|Participant request|65|||
28103546|NCT00358215|54760239|FG001|Overall Study|Participant request|64|||
28103547|NCT00358215|54760238|FG000|Overall Study|Physician Decision|47|||
28103548|NCT00358215|54760239|FG001|Overall Study|Physician Decision|39|||
27740087|NCT02662985|54189914|FG001|Treatment Period 2|Lost to Follow-up|0|||
27740088|NCT02662985|54189913|FG000|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
28007774|NCT00571701|54666565|FG000|Second Intervention 12 Months|Withdrawal by Subject|3|||
28007775|NCT00571701|54666566|FG001|Second Intervention 12 Months|Withdrawal by Subject|0|||
28007776|NCT00686127|54666592|FG000|Overall Study|Withdrawal by Subject|14|||
28007777|NCT00686127|54666593|FG001|Overall Study|Withdrawal by Subject|6|||
28007778|NCT00718718|54666606|FG000|Prior to Week 12|Adverse Event|0|||
28007779|NCT00718718|54666607|FG001|Prior to Week 12|Adverse Event|0|||
28007780|NCT00718718|54666608|FG002|Prior to Week 12|Adverse Event|0|||
27740089|NCT02662985|54189914|FG001|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
27740090|NCT02662985|54189913|FG000|Treatment Period 3 (Extension Period)|Adverse Event|1|||
27740091|NCT02662985|54189914|FG001|Treatment Period 3 (Extension Period)|Adverse Event|1|||
27740092|NCT02662985|54189913|FG000|Treatment Period 3 (Extension Period)|Lack of Efficacy|0|||
27917816|NCT01326702|54575070|FG006|Overall Study|Adverse Event|1|||
27917817|NCT01326702|54575064|FG000|Overall Study|Withdrawal by Subject|0|||
27917818|NCT01326702|54575065|FG001|Overall Study|Withdrawal by Subject|0|||
27917819|NCT01326702|54575066|FG002|Overall Study|Withdrawal by Subject|1|||
27917820|NCT01326702|54575067|FG003|Overall Study|Withdrawal by Subject|0|||
27917821|NCT01326702|54575068|FG004|Overall Study|Withdrawal by Subject|1|||
27917822|NCT01326702|54575069|FG005|Overall Study|Withdrawal by Subject|1|||
27917823|NCT01326702|54575070|FG006|Overall Study|Withdrawal by Subject|3|||
27917824|NCT01326702|54575064|FG000|Overall Study|Not Treated|0|||
27917825|NCT01326702|54575065|FG001|Overall Study|Not Treated|0|||
27917826|NCT01326702|54575066|FG002|Overall Study|Not Treated|0|||
27917827|NCT01326702|54575067|FG003|Overall Study|Not Treated|1|||
27917828|NCT01326702|54575068|FG004|Overall Study|Not Treated|0|||
27917829|NCT01326702|54575069|FG005|Overall Study|Not Treated|1|||
27917830|NCT01326702|54575070|FG006|Overall Study|Not Treated|0|||
27917831|NCT01327703|54575089|FG000|Second Treatment Period|Adverse Event|1|||
27917832|NCT01327703|54575090|FG001|Second Treatment Period|Adverse Event|1|||
27917833|NCT01327703|54575089|FG000|Second Treatment Period|Protocol Violation|0|||
27917834|NCT01327703|54575090|FG001|Second Treatment Period|Protocol Violation|1|||
27917835|NCT01380080|54575101|FG000|Overall Study|Death|36|||
27917836|NCT01380080|54575102|FG001|Overall Study|Death|44|||
27917837|NCT01380080|54575101|FG000|Overall Study|Site is closing|28|||
27917838|NCT01380080|54575102|FG001|Overall Study|Site is closing|31|||
27917839|NCT01380080|54575101|FG000|Overall Study|Not able to get to clinic|7|||
27917840|NCT01380080|54575102|FG001|Overall Study|Not able to get to clinic|1|||
27917841|NCT01380080|54575101|FG000|Overall Study|Not willing to adhere to requirements|6|||
27917842|NCT01380080|54575102|FG001|Overall Study|Not willing to adhere to requirements|2|||
27917843|NCT01380080|54575101|FG000|Overall Study|Withdrawal by Subject|5|||
27917844|NCT01380080|54575102|FG001|Overall Study|Withdrawal by Subject|2|||
27917845|NCT01380080|54575101|FG000|Overall Study|Lost to Follow-up|3|||
27917846|NCT01380080|54575102|FG001|Overall Study|Lost to Follow-up|3|||
27917847|NCT01379768|54575111|FG000|Overall Study|Adverse Event|1|||
27917848|NCT01379768|54575112|FG001|Overall Study|Adverse Event|1|||
27917849|NCT01379768|54575113|FG002|Overall Study|Adverse Event|0|||
27917850|NCT01379768|54575111|FG000|Overall Study|Lost to Follow-up|2|||
27917851|NCT01379768|54575112|FG001|Overall Study|Lost to Follow-up|0|||
27917852|NCT01379768|54575113|FG002|Overall Study|Lost to Follow-up|0|||
27917853|NCT01379573|54575121|FG000|Overall Study|Lost to Follow-up|1|||
27917854|NCT01379573|54575121|FG000|Overall Study|Screen Failure|10|||
27917855|NCT01379534|54575127|FG000|Treatment Phase|Withdrawal by Subject|2|||
27917856|NCT01379534|54575128|FG001|Treatment Phase|Withdrawal by Subject|2|||
27917857|NCT01379534|54575127|FG000|Treatment Phase|Progressive disease|13|||
27917858|NCT01379534|54575128|FG001|Treatment Phase|Progressive disease|22|||
27917859|NCT01379534|54575127|FG000|Treatment Phase|Adverse Event|7|||
27917860|NCT01379534|54575128|FG001|Treatment Phase|Adverse Event|7|||
27917861|NCT01379534|54575127|FG000|Tumor Assessment Follow-up (f/u) Phase|Death|0|||
27917862|NCT01379534|54575128|FG001|Tumor Assessment Follow-up (f/u) Phase|Death|1|||
27917863|NCT01379534|54575127|FG000|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3|||
27917864|NCT01379534|54575128|FG001|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0|||
28007781|NCT00718718|54666609|FG003|Prior to Week 12|Adverse Event|0|||
28007782|NCT00718718|54666610|FG004|Prior to Week 12|Adverse Event|0|||
28007783|NCT00718718|54666611|FG005|Prior to Week 12|Adverse Event|0|||
28007784|NCT00718718|54666612|FG006|Prior to Week 12|Adverse Event|0|||
28007785|NCT00718718|54666613|FG007|Prior to Week 12|Adverse Event|1|||
28007786|NCT00718718|54666614|FG008|Prior to Week 12|Adverse Event|1|||
28007787|NCT00718718|54666615|FG009|Prior to Week 12|Adverse Event|0|||
28007788|NCT00718718|54666606|FG000|Prior to Week 12|Withdrawal by Subject|0|||
28007789|NCT00718718|54666607|FG001|Prior to Week 12|Withdrawal by Subject|0|||
28007790|NCT00718718|54666608|FG002|Prior to Week 12|Withdrawal by Subject|0|||
28007791|NCT00718718|54666609|FG003|Prior to Week 12|Withdrawal by Subject|0|||
28007792|NCT00718718|54666610|FG004|Prior to Week 12|Withdrawal by Subject|3|||
27917865|NCT01379534|54575127|FG000|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0|||
27917866|NCT01379534|54575128|FG001|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1|||
27917867|NCT01379534|54575127|FG000|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1|||
27917868|NCT01379534|54575128|FG001|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0|||
27917869|NCT01371851|54575136|FG000|Overall Study|Lost to Follow-up|5|||
27917870|NCT01371851|54575137|FG001|Overall Study|Lost to Follow-up|8|||
27917871|NCT01371851|54575136|FG000|Overall Study|was arrested and put in jail|0|||
27917872|NCT01371851|54575137|FG001|Overall Study|was arrested and put in jail|1|||
27917873|NCT01371851|54575136|FG000|Overall Study|non study related adverse event|1|||
27917874|NCT01371851|54575137|FG001|Overall Study|non study related adverse event|0|||
27917875|NCT01371851|54575136|FG000|Overall Study|Blood Pressure outside study parameters|2|||
27917876|NCT01371851|54575137|FG001|Overall Study|Blood Pressure outside study parameters|0|||
27917877|NCT01371734|54575146|FG000|Overall Study|Other|2|||
27917878|NCT01371734|54575147|FG001|Overall Study|Other|1|||
27917879|NCT01371734|54575148|FG002|Overall Study|Other|2|||
27917880|NCT01371734|54575146|FG000|Overall Study|Withdrawal by Subject|3|||
27917881|NCT01371734|54575147|FG001|Overall Study|Withdrawal by Subject|4|||
27917882|NCT01371734|54575148|FG002|Overall Study|Withdrawal by Subject|9|||
27917883|NCT01371734|54575146|FG000|Overall Study|Lost to Follow-up|5|||
27917884|NCT01371734|54575147|FG001|Overall Study|Lost to Follow-up|3|||
27917885|NCT01371734|54575148|FG002|Overall Study|Lost to Follow-up|1|||
27917886|NCT01371734|54575146|FG000|Overall Study|Protocol Violation|3|||
27917887|NCT01371734|54575147|FG001|Overall Study|Protocol Violation|1|||
27917888|NCT01371734|54575148|FG002|Overall Study|Protocol Violation|2|||
27917889|NCT01371734|54575146|FG000|Overall Study|Adverse Event|8|||
27917890|NCT01371734|54575147|FG001|Overall Study|Adverse Event|8|||
27917891|NCT01371734|54575148|FG002|Overall Study|Adverse Event|3|||
27917892|NCT01371734|54575146|FG000|Overall Study|Lack of Efficacy|2|||
27917893|NCT01371734|54575147|FG001|Overall Study|Lack of Efficacy|2|||
27917894|NCT01371734|54575148|FG002|Overall Study|Lack of Efficacy|0|||
27917895|NCT01365494|54575158|FG000|Overall Study|Adverse Event|1|||
27917896|NCT01365494|54575159|FG001|Overall Study|Adverse Event|0|||
27917897|NCT01365494|54575158|FG000|Overall Study|Withdrawal by Subject|0|||
27917898|NCT01365494|54575159|FG001|Overall Study|Withdrawal by Subject|1|||
27917899|NCT01365494|54575158|FG000|Overall Study|Lost to Follow-up|1|||
27917900|NCT01365494|54575159|FG001|Overall Study|Lost to Follow-up|2|||
27917901|NCT01357889|54575168|FG000|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2|||
27917902|NCT01357889|54575169|FG001|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1|||
27917903|NCT01357889|54575168|FG000|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
27917904|NCT01357889|54575169|FG001|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
27917905|NCT01357889|54575168|FG000|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1|||
27917906|NCT01357889|54575169|FG001|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0|||
27917907|NCT01357889|54575168|FG000|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
27917908|NCT01357889|54575169|FG001|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
27917909|NCT01357889|54575168|FG000|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0|||
27917910|NCT01357889|54575169|FG001|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2|||
27917911|NCT01357889|54575168|FG000|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0|||
27917912|NCT01357889|54575169|FG001|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2|||
27917913|NCT01357889|54575168|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5|||
27917914|NCT01357889|54575169|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2|||
27917915|NCT01357889|54575168|FG000|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2|||
27917916|NCT01357889|54575169|FG001|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1|||
27917917|NCT01357889|54575168|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
27917918|NCT01357889|54575169|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
27917919|NCT01357889|54575168|FG000|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1|||
27917920|NCT01357889|54575169|FG001|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0|||
27917921|NCT01357889|54575168|FG000|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0|||
27917922|NCT01357889|54575169|FG001|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4|||
27917923|NCT01357889|54575168|FG000|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1|||
27917924|NCT01357889|54575169|FG001|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0|||
28103549|NCT00358215|54760238|FG000|Overall Study|Lost to Follow-up|16|||
27917925|NCT01357889|54575168|FG000|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1|||
27917926|NCT01357889|54575169|FG001|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0|||
27917927|NCT01357850|54575181|FG000|Overall Study|Lost to Follow-up|1|||
27917928|NCT01357850|54575182|FG001|Overall Study|Lost to Follow-up|0|||
28103550|NCT00358215|54760239|FG001|Overall Study|Lost to Follow-up|22|||
28103551|NCT00358215|54760238|FG000|Overall Study|Death|265|||
28103552|NCT00358215|54760239|FG001|Overall Study|Death|281|||
28103553|NCT00358215|54760238|FG000|Overall Study|Protocol Violation|64|||
28103554|NCT00358215|54760239|FG001|Overall Study|Protocol Violation|59|||
28007793|NCT00718718|54666611|FG005|Prior to Week 12|Withdrawal by Subject|0|||
28007794|NCT00718718|54666612|FG006|Prior to Week 12|Withdrawal by Subject|1|||
28007795|NCT00718718|54666613|FG007|Prior to Week 12|Withdrawal by Subject|1|||
28007796|NCT00718718|54666614|FG008|Prior to Week 12|Withdrawal by Subject|1|||
28007797|NCT00718718|54666615|FG009|Prior to Week 12|Withdrawal by Subject|0|||
28007798|NCT00718718|54666606|FG000|Prior to Week 12|Other|1|||
28007799|NCT00718718|54666607|FG001|Prior to Week 12|Other|0|||
28007800|NCT00718718|54666608|FG002|Prior to Week 12|Other|1|||
28007801|NCT00718718|54666609|FG003|Prior to Week 12|Other|0|||
28007802|NCT00718718|54666610|FG004|Prior to Week 12|Other|0|||
28007803|NCT00718718|54666611|FG005|Prior to Week 12|Other|0|||
28007804|NCT00718718|54666612|FG006|Prior to Week 12|Other|0|||
28007805|NCT00718718|54666613|FG007|Prior to Week 12|Other|0|||
28007806|NCT00718718|54666614|FG008|Prior to Week 12|Other|0|||
28007807|NCT00718718|54666615|FG009|Prior to Week 12|Other|0|||
28007808|NCT00718718|54666606|FG000|Week 12 to End of Study|Adverse Event|0|||
28007809|NCT00718718|54666607|FG001|Week 12 to End of Study|Adverse Event|0|||
28007810|NCT00718718|54666608|FG002|Week 12 to End of Study|Adverse Event|0|||
28007811|NCT00718718|54666609|FG003|Week 12 to End of Study|Adverse Event|0|||
28007812|NCT00718718|54666610|FG004|Week 12 to End of Study|Adverse Event|0|||
28007813|NCT00718718|54666611|FG005|Week 12 to End of Study|Adverse Event|0|||
28007814|NCT00718718|54666612|FG006|Week 12 to End of Study|Adverse Event|0|||
28007815|NCT00718718|54666613|FG007|Week 12 to End of Study|Adverse Event|1|||
28007816|NCT00718718|54666614|FG008|Week 12 to End of Study|Adverse Event|0|||
28007817|NCT00718718|54666615|FG009|Week 12 to End of Study|Adverse Event|0|||
27917929|NCT01357850|54575183|FG002|Overall Study|Lost to Follow-up|0|||
27917930|NCT01357850|54575184|FG003|Overall Study|Lost to Follow-up|0|||
27917931|NCT01357655|54575197|FG000|Overall Study|Administrative Reason by Sponsor|45|||
27917932|NCT01357655|54575198|FG001|Overall Study|Administrative Reason by Sponsor|0|||
27917933|NCT01357655|54575197|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
27740093|NCT02662985|54189914|FG001|Treatment Period 3 (Extension Period)|Lack of Efficacy|1|||
27740094|NCT02662985|54189913|FG000|Treatment Period 3 (Extension Period)|Withdrawal by Subject|1|||
27917934|NCT01357655|54575198|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
27917935|NCT01357655|54575197|FG000|Overall Study|Disease Progression|1|||
27917936|NCT01357655|54575198|FG001|Overall Study|Disease Progression|0|||
27917937|NCT01357655|54575197|FG000|Overall Study|Lost to Follow-up|2|||
27917938|NCT01357655|54575198|FG001|Overall Study|Lost to Follow-up|0|||
27917939|NCT01357655|54575197|FG000|Overall Study|Maximum Clinical Benefit|2|||
27917940|NCT01357655|54575198|FG001|Overall Study|Maximum Clinical Benefit|0|||
27917941|NCT01357655|54575197|FG000|Overall Study|Reason Unspecified|1|||
27917942|NCT01357655|54575198|FG001|Overall Study|Reason Unspecified|0|||
27917943|NCT01357655|54575197|FG000|Overall Study|Study Drug Toxicity|11|||
27917944|NCT01357655|54575198|FG001|Overall Study|Study Drug Toxicity|0|||
27917945|NCT01357655|54575197|FG000|Overall Study|Subject Withdrew Consent|1|||
27917946|NCT01357655|54575198|FG001|Overall Study|Subject Withdrew Consent|0|||
27917947|NCT01357616|54575205|FG000|Overall Study|Adverse Event|1|||
27917948|NCT01357616|54575206|FG001|Overall Study|Adverse Event|1|||
27917949|NCT01357616|54575205|FG000|Overall Study|Lost to Follow-up|4|||
27917950|NCT01357616|54575206|FG001|Overall Study|Lost to Follow-up|3|||
27917951|NCT01357616|54575205|FG000|Overall Study|Protocol Violation|0|||
27917952|NCT01357616|54575206|FG001|Overall Study|Protocol Violation|2|||
27917953|NCT01357616|54575205|FG000|Overall Study|Inadequate Control of IOP|1|||
27917954|NCT01357616|54575206|FG001|Overall Study|Inadequate Control of IOP|2|||
27917955|NCT01357616|54575205|FG000|Overall Study|Decision Unrelated to Adverse Event|3|||
27917956|NCT01357616|54575206|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
27917957|NCT01357616|54575205|FG000|Overall Study|Withdrawal by Subject|1|||
27917958|NCT01357616|54575206|FG001|Overall Study|Withdrawal by Subject|0|||
27917959|NCT01357577|54575214|FG000|Overall Study|Lost to Follow-up|20|||
27917960|NCT01357577|54575215|FG001|Overall Study|Lost to Follow-up|16|||
27917961|NCT01357577|54575214|FG000|Overall Study|Withdrawal by Subject|16|||
27917962|NCT01357577|54575215|FG001|Overall Study|Withdrawal by Subject|8|||
27917963|NCT01357577|54575214|FG000|Overall Study|look at data in database?|1|||
27917964|NCT01357577|54575215|FG001|Overall Study|look at data in database?|2|||
27917965|NCT01351025|54575224|FG000|Week 0 - 20|Lost to Follow-up|2|||
27917966|NCT01351025|54575225|FG001|Week 0 - 20|Lost to Follow-up|1|||
27917967|NCT01351025|54575224|FG000|Week 0 - 20|Withdrawal by Subject|1|||
27917968|NCT01351025|54575225|FG001|Week 0 - 20|Withdrawal by Subject|0|||
27917969|NCT01351025|54575224|FG000|Week 24 - 44|Lost to Follow-up|0|||
27917970|NCT01351025|54575225|FG001|Week 24 - 44|Lost to Follow-up|2|||
27917971|NCT01351025|54575224|FG000|Week 24 - 44|Site closed|0|||
28007818|NCT00718718|54666606|FG000|Week 12 to End of Study|Death|0|||
28007819|NCT00718718|54666607|FG001|Week 12 to End of Study|Death|0|||
28007820|NCT00718718|54666608|FG002|Week 12 to End of Study|Death|0|||
28007821|NCT00718718|54666609|FG003|Week 12 to End of Study|Death|0|||
28007822|NCT00718718|54666610|FG004|Week 12 to End of Study|Death|0|||
28007823|NCT00718718|54666611|FG005|Week 12 to End of Study|Death|1|||
28007824|NCT00718718|54666612|FG006|Week 12 to End of Study|Death|0|||
28007825|NCT00718718|54666613|FG007|Week 12 to End of Study|Death|0|||
28007826|NCT00718718|54666614|FG008|Week 12 to End of Study|Death|0|||
28007827|NCT00718718|54666615|FG009|Week 12 to End of Study|Death|0|||
28007828|NCT00718718|54666606|FG000|Week 12 to End of Study|Withdrawal by Subject|0|||
28007829|NCT00718718|54666607|FG001|Week 12 to End of Study|Withdrawal by Subject|0|||
28007830|NCT00718718|54666608|FG002|Week 12 to End of Study|Withdrawal by Subject|0|||
28007831|NCT00718718|54666609|FG003|Week 12 to End of Study|Withdrawal by Subject|0|||
28007832|NCT00718718|54666610|FG004|Week 12 to End of Study|Withdrawal by Subject|0|||
28007833|NCT00718718|54666611|FG005|Week 12 to End of Study|Withdrawal by Subject|2|||
28007834|NCT00718718|54666612|FG006|Week 12 to End of Study|Withdrawal by Subject|1|||
27740095|NCT02662985|54189914|FG001|Treatment Period 3 (Extension Period)|Withdrawal by Subject|2|||
27740096|NCT02662985|54189913|FG000|Treatment Period 3 (Extension Period)|Death|0|||
28007835|NCT00718718|54666613|FG007|Week 12 to End of Study|Withdrawal by Subject|0|||
27740097|NCT02662985|54189914|FG001|Treatment Period 3 (Extension Period)|Death|1|||
27740098|NCT01631812|54189920|FG000|Overall Study|Adverse Event|25|||
27740099|NCT01631812|54189920|FG000|Overall Study|Lack of Efficacy|5|||
27740100|NCT01631812|54189920|FG000|Overall Study|Withdrawal by Subject|4|||
27740101|NCT01631812|54189920|FG000|Overall Study|Physician Decision|3|||
27740102|NCT02323295|54189926|FG000|Overall Study|Adverse Event|0|||
27740103|NCT02323295|54189927|FG001|Overall Study|Adverse Event|1|||
27740104|NCT02323295|54189926|FG000|Overall Study|Withdrawal by Subject|0|||
27740105|NCT02323295|54189927|FG001|Overall Study|Withdrawal by Subject|1|||
27740106|NCT02323295|54189926|FG000|Overall Study|Patient did not have surgery as planned.|0|||
27740107|NCT02323295|54189927|FG001|Overall Study|Patient did not have surgery as planned.|1|||
27740108|NCT02215954|54189936|FG000|Overall Study|Adverse Event|0|||
27740109|NCT02215954|54189937|FG001|Overall Study|Adverse Event|0|||
27740110|NCT02215954|54189938|FG002|Overall Study|Adverse Event|1|||
27740111|NCT02215954|54189936|FG000|Overall Study|Withdrawal by Subject|0|||
27740112|NCT02215954|54189937|FG001|Overall Study|Withdrawal by Subject|0|||
27740113|NCT02215954|54189938|FG002|Overall Study|Withdrawal by Subject|2|||
27740114|NCT02215954|54189936|FG000|Overall Study|Not exposed|1|||
27740115|NCT02215954|54189937|FG001|Overall Study|Not exposed|1|||
27740116|NCT02215954|54189938|FG002|Overall Study|Not exposed|3|||
27740117|NCT01941719|54189949|FG000|Overall Study|Lost to Follow-up|20|||
27740118|NCT01941719|54189950|FG001|Overall Study|Lost to Follow-up|19|||
27740119|NCT02215252|54189960|FG000|Overall Study|Adverse Event|1|||
27740120|NCT02215252|54189961|FG001|Overall Study|Adverse Event|5|||
27740121|NCT02215252|54189962|FG002|Overall Study|Adverse Event|2|||
27740122|NCT02215252|54189960|FG000|Overall Study|Lost to Follow-up|0|||
27740123|NCT02215252|54189961|FG001|Overall Study|Lost to Follow-up|0|||
27740124|NCT02215252|54189962|FG002|Overall Study|Lost to Follow-up|1|||
27740125|NCT02215252|54189960|FG000|Overall Study|Does not Meet Entrance Criteria|0|||
27740126|NCT02215252|54189961|FG001|Overall Study|Does not Meet Entrance Criteria|1|||
27740127|NCT02215252|54189962|FG002|Overall Study|Does not Meet Entrance Criteria|0|||
27740128|NCT02215252|54189960|FG000|Overall Study|Protocol Violation|0|||
27740129|NCT02215252|54189961|FG001|Overall Study|Protocol Violation|1|||
27740130|NCT02215252|54189962|FG002|Overall Study|Protocol Violation|0|||
27740131|NCT02215252|54189960|FG000|Overall Study|Withdrawal by Subject|1|||
27740132|NCT02215252|54189961|FG001|Overall Study|Withdrawal by Subject|0|||
27740133|NCT02215252|54189962|FG002|Overall Study|Withdrawal by Subject|0|||
27740134|NCT02215252|54189960|FG000|Overall Study|Other|0|||
27740135|NCT02215252|54189961|FG001|Overall Study|Other|1|||
27740136|NCT02215252|54189962|FG002|Overall Study|Other|1|||
27740137|NCT02204410|54189970|FG000|Overall Study|Lost to Follow-up|5|||
27740138|NCT02204410|54189970|FG000|Overall Study|Physician Decision|2|||
27740139|NCT02204410|54189970|FG000|Overall Study|Protocol Violation|1|||
27740140|NCT02204410|54189970|FG000|Overall Study|Withdrawal by Subject|3|||
27740141|NCT02250274|54189976|FG000|Overall Study|Insufficient blood draw amount|7|||
27740142|NCT02250274|54189977|FG001|Overall Study|Insufficient blood draw amount|6|||
27740143|NCT02213458|54189991|FG000|Overall Study|No longer meets criteria: caregiver deceased|4|||
27740144|NCT02213458|54189992|FG001|Overall Study|No longer meets criteria: caregiver deceased|0|||
27740145|NCT02213458|54189991|FG000|Overall Study|No longer meets criteria: caregiver no longer caregiving|4|||
27740146|NCT02213458|54189992|FG001|Overall Study|No longer meets criteria: caregiver no longer caregiving|0|||
27740147|NCT02213458|54189991|FG000|Overall Study|No longer meets criteria: caregiver too sick to participate|2|||
27740148|NCT02213458|54189992|FG001|Overall Study|No longer meets criteria: caregiver too sick to participate|0|||
27740149|NCT02213458|54189991|FG000|Overall Study|No longer meets criteria: patient moved out of state|10|||
27740150|NCT02213458|54189992|FG001|Overall Study|No longer meets criteria: patient moved out of state|0|||
27740151|NCT02213458|54189991|FG000|Overall Study|Refused re-consent|6|||
27740152|NCT02213458|54189992|FG001|Overall Study|Refused re-consent|0|||
27740153|NCT02213458|54189991|FG000|Overall Study|Lost to Follow-up|2|||
27740154|NCT02213458|54189992|FG001|Overall Study|Lost to Follow-up|2|||
27740155|NCT02213458|54189991|FG000|Overall Study|Withdrawal by Subject|26|||
27740156|NCT02213458|54189992|FG001|Overall Study|Withdrawal by Subject|8|||
27740157|NCT02213380|54190000|FG000|Underwent Randomization|Withdrawal by Subject|2|||
27740158|NCT02213380|54190001|FG001|Underwent Randomization|Withdrawal by Subject|0|||
27740159|NCT02213380|54190000|FG000|Underwent Randomization|Not treated|3|||
27740160|NCT02213380|54190001|FG001|Underwent Randomization|Not treated|3|||
27740161|NCT02213380|54190000|FG000|Per-protocol Analysis|Protocol Violation|32|||
27740162|NCT02213380|54190001|FG001|Per-protocol Analysis|Protocol Violation|36|||
27740163|NCT02202850|54190009|FG000|Overall Study|Other|2|||
27740164|NCT02202850|54190010|FG001|Overall Study|Other|2|||
27740165|NCT02202850|54190009|FG000|Overall Study|Enbrel treatment discontinued|15|||
27740166|NCT02202850|54190010|FG001|Overall Study|Enbrel treatment discontinued|3|||
27740167|NCT02202850|54190009|FG000|Overall Study|Lost to Follow-up|7|||
27740168|NCT02202850|54190010|FG001|Overall Study|Lost to Follow-up|1|||
27740169|NCT02212678|54190016|FG000|Overall Study|Adverse Event|1|||
27746116|NCT00700427|54195663|FG003|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
28007836|NCT00718718|54666614|FG008|Week 12 to End of Study|Withdrawal by Subject|0|||
28007837|NCT00718718|54666615|FG009|Week 12 to End of Study|Withdrawal by Subject|0|||
28007838|NCT00718718|54666606|FG000|Week 12 to End of Study|Lost to Follow-up|0|||
28007839|NCT00718718|54666607|FG001|Week 12 to End of Study|Lost to Follow-up|0|||
28007840|NCT00718718|54666608|FG002|Week 12 to End of Study|Lost to Follow-up|0|||
28007841|NCT00718718|54666609|FG003|Week 12 to End of Study|Lost to Follow-up|0|||
28007842|NCT00718718|54666610|FG004|Week 12 to End of Study|Lost to Follow-up|0|||
28007843|NCT00718718|54666611|FG005|Week 12 to End of Study|Lost to Follow-up|0|||
28007844|NCT00718718|54666612|FG006|Week 12 to End of Study|Lost to Follow-up|0|||
28007845|NCT00718718|54666613|FG007|Week 12 to End of Study|Lost to Follow-up|0|||
28007846|NCT00718718|54666614|FG008|Week 12 to End of Study|Lost to Follow-up|1|||
28007847|NCT00718718|54666615|FG009|Week 12 to End of Study|Lost to Follow-up|0|||
28007848|NCT00718718|54666606|FG000|Week 12 to End of Study|Other|0|||
28007849|NCT00718718|54666607|FG001|Week 12 to End of Study|Other|1|||
28007850|NCT00718718|54666608|FG002|Week 12 to End of Study|Other|0|||
28007851|NCT00718718|54666609|FG003|Week 12 to End of Study|Other|1|||
28007852|NCT00718718|54666610|FG004|Week 12 to End of Study|Other|0|||
28007853|NCT00718718|54666611|FG005|Week 12 to End of Study|Other|0|||
28007854|NCT00718718|54666612|FG006|Week 12 to End of Study|Other|1|||
28007855|NCT00718718|54666613|FG007|Week 12 to End of Study|Other|0|||
28007856|NCT00718718|54666614|FG008|Week 12 to End of Study|Other|0|||
28007857|NCT00718718|54666615|FG009|Week 12 to End of Study|Other|0|||
28007858|NCT00683787|54666644|FG000|Overall Study|Progression|3|||
28007859|NCT00683787|54666645|FG001|Overall Study|Progression|3|||
28007860|NCT00683787|54666646|FG002|Overall Study|Progression|0|||
28007861|NCT00683787|54666644|FG000|Overall Study|Adverse Event|0|||
28007862|NCT00683787|54666645|FG001|Overall Study|Adverse Event|0|||
27917972|NCT01351025|54575225|FG001|Week 24 - 44|Site closed|1|||
27917973|NCT01351025|54575224|FG000|Week 24 - 44|unable to get to clinic|1|||
27917974|NCT01351025|54575225|FG001|Week 24 - 44|unable to get to clinic|1|||
27917975|NCT01349036|54575239|FG000|Overall Study|Disease progression|13|||
27917976|NCT01349036|54575240|FG001|Overall Study|Disease progression|22|||
27917977|NCT01349036|54575239|FG000|Overall Study|Other|1|||
27917978|NCT01349036|54575240|FG001|Overall Study|Other|0|||
27917979|NCT01349036|54575239|FG000|Overall Study|Withdrawal by Subject|0|||
27917980|NCT01349036|54575240|FG001|Overall Study|Withdrawal by Subject|2|||
27917981|NCT01348763|54575250|FG000|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1|||
27917982|NCT01348763|54575250|FG000|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1|||
27917983|NCT01346969|54575258|FG000|Overall Study|Withdrawal by Subject|0|||
27917984|NCT01346969|54575259|FG001|Overall Study|Withdrawal by Subject|0|||
27917985|NCT01346969|54575260|FG002|Overall Study|Withdrawal by Subject|1|||
27917986|NCT01346969|54575261|FG003|Overall Study|Withdrawal by Subject|0|||
27917987|NCT01346969|54575258|FG000|Overall Study|Lost to Follow-up|1|||
27917988|NCT01346969|54575259|FG001|Overall Study|Lost to Follow-up|0|||
27917989|NCT01346969|54575260|FG002|Overall Study|Lost to Follow-up|2|||
27917990|NCT01346969|54575261|FG003|Overall Study|Lost to Follow-up|0|||
27917991|NCT01346969|54575258|FG000|Overall Study|Physician Decision|0|||
27917992|NCT01346969|54575259|FG001|Overall Study|Physician Decision|0|||
27917993|NCT01346969|54575260|FG002|Overall Study|Physician Decision|0|||
27917994|NCT01346969|54575261|FG003|Overall Study|Physician Decision|1|||
27917995|NCT01346969|54575258|FG000|Overall Study|Randomized but not treated|1|||
27917996|NCT01346969|54575259|FG001|Overall Study|Randomized but not treated|0|||
27917997|NCT01346969|54575260|FG002|Overall Study|Randomized but not treated|0|||
27917998|NCT01346969|54575261|FG003|Overall Study|Randomized but not treated|0|||
27917999|NCT01346774|54575273|FG000|Overall Study|Did not take a single dose|6|||
27918000|NCT01346774|54575274|FG001|Overall Study|Did not take a single dose|4|||
27918001|NCT01346774|54575273|FG000|Overall Study|Lost to Follow-up|3|||
27918002|NCT01346774|54575274|FG001|Overall Study|Lost to Follow-up|4|||
27918003|NCT01346774|54575273|FG000|Overall Study|Withdrawal by Subject|1|||
27918004|NCT01346774|54575274|FG001|Overall Study|Withdrawal by Subject|4|||
27918005|NCT01346774|54575273|FG000|Overall Study|Protocol Violation|2|||
27918006|NCT01346774|54575274|FG001|Overall Study|Protocol Violation|3|||
27918007|NCT01346774|54575273|FG000|Overall Study|Adverse Event|1|||
27918008|NCT01346774|54575274|FG001|Overall Study|Adverse Event|2|||
27918009|NCT01346696|54575280|FG000|Overall Study|Death|1|||
27918010|NCT01346540|54575286|FG000|Overall Study|Progressive disease-RECIST 1.1 criteria|3|||
27918011|NCT01346540|54575287|FG001|Overall Study|Progressive disease-RECIST 1.1 criteria|8|||
27918012|NCT01346540|54575286|FG000|Overall Study|Adverse Event|0|||
27918013|NCT01346540|54575287|FG001|Overall Study|Adverse Event|4|||
27918014|NCT01342913|54575296|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66|||
27918015|NCT01342913|54575297|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
27918016|NCT01342913|54575298|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
27918017|NCT01342913|54575296|FG000|2-week Run-in Period|Physician Decision|6|||
27918018|NCT01342913|54575297|FG001|2-week Run-in Period|Physician Decision|0|||
27918019|NCT01342913|54575298|FG002|2-week Run-in Period|Physician Decision|0|||
27918020|NCT01342913|54575296|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
27918021|NCT01342913|54575297|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
27918022|NCT01342913|54575298|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
28007863|NCT00683787|54666646|FG002|Overall Study|Adverse Event|2|||
27918023|NCT01342913|54575296|FG000|2-week Run-in Period|Adverse Event|2|||
27918024|NCT01342913|54575297|FG001|2-week Run-in Period|Adverse Event|0|||
27918025|NCT01342913|54575298|FG002|2-week Run-in Period|Adverse Event|0|||
27918026|NCT01342913|54575296|FG000|2-week Run-in Period|Protocol Violation|5|||
27918027|NCT01342913|54575297|FG001|2-week Run-in Period|Protocol Violation|0|||
27918028|NCT01342913|54575298|FG002|2-week Run-in Period|Protocol Violation|0|||
27918029|NCT01342913|54575296|FG000|2-week Run-in Period|Continuation Criteria Not Met|88|||
27918030|NCT01342913|54575297|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
27918031|NCT01342913|54575298|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
27918032|NCT01342913|54575296|FG000|Double-Blind Treatment Period|Adverse Event|0|||
27918033|NCT01342913|54575297|FG001|Double-Blind Treatment Period|Adverse Event|3|||
28007864|NCT00723008|54666656|FG000|Enrollment|Lost to Follow-up|1|||
28007865|NCT00723008|54666657|FG001|Enrollment|Lost to Follow-up|0|||
28007866|NCT00723008|54666656|FG000|4-Week Double Blinded|Lack of Efficacy|0|||
28103555|NCT00358215|54760238|FG000|Overall Study|Pregnancy|1|||
28103556|NCT00358215|54760239|FG001|Overall Study|Pregnancy|0|||
28103557|NCT00358215|54760238|FG000|Overall Study|Other|21|||
28103558|NCT00358215|54760239|FG001|Overall Study|Other|14|||
28103559|NCT00358215|54760238|FG000|Overall Study|Did not receive investigational product|2|||
28103560|NCT00358215|54760239|FG001|Overall Study|Did not receive investigational product|3|||
28103561|NCT02855164|54760253|FG000|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
28103562|NCT02855164|54760254|FG001|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
28103563|NCT02855164|54760255|FG002|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
28103564|NCT02855164|54760256|FG003|Parts A + B (Randomized Set)|Withdrawal by Subject|2|||
28103565|NCT02855164|54760257|FG004|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
28103566|NCT02855164|54760258|FG005|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
28103567|NCT02855164|54760259|FG006|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
28103568|NCT02855164|54760260|FG007|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
28103569|NCT02855164|54760253|FG000|Parts A + B (Randomized Set)|Physician Decision|0|||
28103570|NCT02855164|54760254|FG001|Parts A + B (Randomized Set)|Physician Decision|0|||
28103571|NCT02855164|54760255|FG002|Parts A + B (Randomized Set)|Physician Decision|0|||
28103572|NCT02855164|54760256|FG003|Parts A + B (Randomized Set)|Physician Decision|2|||
28103573|NCT02855164|54760257|FG004|Parts A + B (Randomized Set)|Physician Decision|0|||
28103574|NCT02855164|54760258|FG005|Parts A + B (Randomized Set)|Physician Decision|0|||
28103575|NCT02855164|54760259|FG006|Parts A + B (Randomized Set)|Physician Decision|0|||
28103576|NCT02855164|54760260|FG007|Parts A + B (Randomized Set)|Physician Decision|0|||
28103577|NCT02855164|54760253|FG000|Parts A + B (Randomized Set)|Adverse Event|0|||
28103578|NCT02855164|54760254|FG001|Parts A + B (Randomized Set)|Adverse Event|0|||
28103579|NCT02855164|54760255|FG002|Parts A + B (Randomized Set)|Adverse Event|0|||
28103580|NCT02855164|54760256|FG003|Parts A + B (Randomized Set)|Adverse Event|4|||
28103581|NCT02855164|54760257|FG004|Parts A + B (Randomized Set)|Adverse Event|0|||
28103582|NCT02855164|54760258|FG005|Parts A + B (Randomized Set)|Adverse Event|0|||
28103583|NCT02855164|54760259|FG006|Parts A + B (Randomized Set)|Adverse Event|0|||
28103584|NCT02855164|54760260|FG007|Parts A + B (Randomized Set)|Adverse Event|0|||
28103585|NCT02855164|54760253|FG000|Part C (Randomized Set)|Adverse Event|0|||
28103586|NCT02855164|54760254|FG001|Part C (Randomized Set)|Adverse Event|0|||
28103587|NCT02855164|54760255|FG002|Part C (Randomized Set)|Adverse Event|0|||
28103588|NCT02855164|54760256|FG003|Part C (Randomized Set)|Adverse Event|0|||
28103589|NCT02855164|54760257|FG004|Part C (Randomized Set)|Adverse Event|0|||
28103590|NCT02855164|54760258|FG005|Part C (Randomized Set)|Adverse Event|5|||
28103591|NCT02855164|54760259|FG006|Part C (Randomized Set)|Adverse Event|9|||
28103592|NCT02855164|54760260|FG007|Part C (Randomized Set)|Adverse Event|2|||
28103593|NCT02855164|54760253|FG000|Part C (Randomized Set)|Lost to Follow-up|0|||
28103594|NCT02855164|54760254|FG001|Part C (Randomized Set)|Lost to Follow-up|0|||
28103595|NCT02855164|54760255|FG002|Part C (Randomized Set)|Lost to Follow-up|0|||
28103596|NCT02855164|54760256|FG003|Part C (Randomized Set)|Lost to Follow-up|0|||
28103597|NCT02855164|54760257|FG004|Part C (Randomized Set)|Lost to Follow-up|0|||
28103598|NCT02855164|54760258|FG005|Part C (Randomized Set)|Lost to Follow-up|1|||
28007867|NCT00723008|54666657|FG001|4-Week Double Blinded|Lack of Efficacy|1|||
28007868|NCT00723008|54666656|FG000|4-Week Double Blinded|Withdrawal by Subject|1|||
28007869|NCT00723008|54666657|FG001|4-Week Double Blinded|Withdrawal by Subject|1|||
28007870|NCT00723008|54666656|FG000|4-Week Double Blinded|Lost to Follow-up|4|||
28007871|NCT00723008|54666657|FG001|4-Week Double Blinded|Lost to Follow-up|3|||
28007872|NCT00723008|54666656|FG000|4-Week Unblinded Treatment|Adverse Event|1|||
27918034|NCT01342913|54575298|FG002|Double-Blind Treatment Period|Adverse Event|6|||
27918035|NCT01342913|54575296|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
27918036|NCT01342913|54575297|FG001|Double-Blind Treatment Period|Lack of Efficacy|2|||
27918037|NCT01342913|54575298|FG002|Double-Blind Treatment Period|Lack of Efficacy|3|||
27918038|NCT01342913|54575296|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
27918039|NCT01342913|54575297|FG001|Double-Blind Treatment Period|Protocol Violation|6|||
27918040|NCT01342913|54575298|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
27918041|NCT01342913|54575296|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
28103599|NCT02855164|54760259|FG006|Part C (Randomized Set)|Lost to Follow-up|1|||
28103600|NCT02855164|54760260|FG007|Part C (Randomized Set)|Lost to Follow-up|1|||
28103601|NCT02855164|54760253|FG000|Part C (Randomized Set)|Physician Decision|0|||
28103602|NCT02855164|54760254|FG001|Part C (Randomized Set)|Physician Decision|0|||
28103603|NCT02855164|54760255|FG002|Part C (Randomized Set)|Physician Decision|0|||
28103604|NCT02855164|54760256|FG003|Part C (Randomized Set)|Physician Decision|0|||
28103605|NCT02855164|54760257|FG004|Part C (Randomized Set)|Physician Decision|0|||
28103606|NCT02855164|54760258|FG005|Part C (Randomized Set)|Physician Decision|1|||
28103607|NCT02855164|54760259|FG006|Part C (Randomized Set)|Physician Decision|0|||
27746117|NCT00700427|54195664|FG004|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11|||
27918042|NCT01342913|54575297|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
27918043|NCT01342913|54575298|FG002|Double-Blind Treatment Period|Lost to Follow-up|3|||
27918044|NCT01342913|54575296|FG000|Double-Blind Treatment Period|Physician Decision|0|||
27918045|NCT01342913|54575297|FG001|Double-Blind Treatment Period|Physician Decision|2|||
27918046|NCT01342913|54575298|FG002|Double-Blind Treatment Period|Physician Decision|0|||
27918047|NCT01342913|54575296|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
27918048|NCT01342913|54575297|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
27918049|NCT01342913|54575298|FG002|Double-Blind Treatment Period|Withdrawal by Subject|2|||
27918050|NCT01342796|54575306|FG000|Overall Study|Withdrawal by Subject|2|||
27918051|NCT01342796|54575307|FG001|Overall Study|Withdrawal by Subject|0|||
27918052|NCT01342796|54575306|FG000|Overall Study|Lost to Follow-up|0|||
27918053|NCT01342796|54575307|FG001|Overall Study|Lost to Follow-up|3|||
27918054|NCT01342796|54575306|FG000|Overall Study|Inappropriate enrollment|1|||
27918055|NCT01342796|54575307|FG001|Overall Study|Inappropriate enrollment|0|||
27918056|NCT01342640|54575313|FG000|Overall Study|Adverse Event|3|||
27918057|NCT01342640|54575313|FG000|Overall Study|Protocol Violation|16|||
27918058|NCT01342640|54575313|FG000|Overall Study|Lost to Follow-up|21|||
27918059|NCT01342640|54575313|FG000|Overall Study|Other|1|||
27918060|NCT01342484|54575320|FG000|Overall Study|Other Reasons|1|||
27918061|NCT01342484|54575321|FG001|Overall Study|Other Reasons|0|||
27918062|NCT01342484|54575322|FG002|Overall Study|Other Reasons|0|||
27918063|NCT01342484|54575320|FG000|Overall Study|Protocol Violation|0|||
27918064|NCT01342484|54575321|FG001|Overall Study|Protocol Violation|0|||
27918065|NCT01342484|54575322|FG002|Overall Study|Protocol Violation|1|||
27918066|NCT01342484|54575320|FG000|Overall Study|Withdrawal by Subject|1|||
27918067|NCT01342484|54575321|FG001|Overall Study|Withdrawal by Subject|0|||
27918068|NCT01342484|54575322|FG002|Overall Study|Withdrawal by Subject|0|||
27918069|NCT01342445|54575332|FG000|Overall Study|Experienced side effects|0|||
27918070|NCT01342445|54575333|FG001|Overall Study|Experienced side effects|2|||
27918071|NCT01342211|54575348|FG000|Overall Study|Lost to Follow-up|0|||
27918072|NCT01342211|54575349|FG001|Overall Study|Lost to Follow-up|0|||
27918073|NCT01342211|54575350|FG002|Overall Study|Lost to Follow-up|0|||
27918074|NCT01342211|54575351|FG003|Overall Study|Lost to Follow-up|1|||
27918075|NCT01342211|54575352|FG004|Overall Study|Lost to Follow-up|0|||
27918076|NCT01342211|54575348|FG000|Overall Study|Adverse Event|0|||
27918077|NCT01342211|54575349|FG001|Overall Study|Adverse Event|0|||
27918078|NCT01342211|54575350|FG002|Overall Study|Adverse Event|0|||
27918079|NCT01342211|54575351|FG003|Overall Study|Adverse Event|0|||
27918080|NCT01342211|54575352|FG004|Overall Study|Adverse Event|1|||
27918081|NCT01342211|54575348|FG000|Overall Study|Withdrawal by Subject|0|||
27918082|NCT01342211|54575349|FG001|Overall Study|Withdrawal by Subject|0|||
27918083|NCT01342211|54575350|FG002|Overall Study|Withdrawal by Subject|0|||
27918084|NCT01342211|54575351|FG003|Overall Study|Withdrawal by Subject|1|||
27918085|NCT01342211|54575352|FG004|Overall Study|Withdrawal by Subject|0|||
27918086|NCT01342211|54575348|FG000|Overall Study|Randomized, but not Treated|0|||
27918087|NCT01342211|54575349|FG001|Overall Study|Randomized, but not Treated|2|||
27918088|NCT01342211|54575350|FG002|Overall Study|Randomized, but not Treated|0|||
27918089|NCT01342211|54575351|FG003|Overall Study|Randomized, but not Treated|0|||
27918090|NCT01342211|54575352|FG004|Overall Study|Randomized, but not Treated|1|||
27918091|NCT01342094|54575370|FG000|Overall Study|Adverse Event|5|||
27918092|NCT01342094|54575371|FG001|Overall Study|Adverse Event|0|||
27918093|NCT01342094|54575370|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
27918094|NCT01342094|54575371|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
27918095|NCT01342094|54575370|FG000|Overall Study|Withdrawal by Subject|0|||
27918096|NCT01342094|54575371|FG001|Overall Study|Withdrawal by Subject|2|||
27918097|NCT01340768|54575379|FG000|Overall Study|Lost to Follow-up|10|||
27918098|NCT01340768|54575380|FG001|Overall Study|Lost to Follow-up|4|||
27918099|NCT01340768|54575379|FG000|Overall Study|Withdrawal by Subject|5|||
27918100|NCT01340768|54575380|FG001|Overall Study|Withdrawal by Subject|1|||
28103608|NCT02855164|54760260|FG007|Part C (Randomized Set)|Physician Decision|1|||
27918101|NCT01340768|54575379|FG000|Overall Study|Other|2|||
27918102|NCT01340768|54575380|FG001|Overall Study|Other|0|||
27918103|NCT01340651|54575386|FG000|Overall Study|Adverse Event|3|||
27918104|NCT01340651|54575386|FG000|Overall Study|Consent Withdrawn|2|||
27918105|NCT01340651|54575386|FG000|Overall Study|Commercial Supply per Sponsor|12|||
28103609|NCT02855164|54760253|FG000|Part C (Randomized Set)|Withdrawal by Subject|0|||
28103610|NCT02855164|54760254|FG001|Part C (Randomized Set)|Withdrawal by Subject|0|||
28103611|NCT02855164|54760255|FG002|Part C (Randomized Set)|Withdrawal by Subject|0|||
28103612|NCT02855164|54760256|FG003|Part C (Randomized Set)|Withdrawal by Subject|0|||
28103613|NCT02855164|54760257|FG004|Part C (Randomized Set)|Withdrawal by Subject|0|||
28103614|NCT02855164|54760258|FG005|Part C (Randomized Set)|Withdrawal by Subject|5|||
28103615|NCT02855164|54760259|FG006|Part C (Randomized Set)|Withdrawal by Subject|4|||
28103616|NCT02855164|54760260|FG007|Part C (Randomized Set)|Withdrawal by Subject|3|||
27740170|NCT03104075|54190022|FG000|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|1|||
27740171|NCT03104075|54190023|FG001|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|0|||
27740172|NCT03038087|54190030|FG000|Overall Study|lost data|1|||
27740173|NCT02249182|54190041|FG000|Treatment Phase|Lost to Follow-up|4|||
27740174|NCT02249182|54190042|FG001|Treatment Phase|Lost to Follow-up|0|||
27740175|NCT02249182|54190043|FG002|Treatment Phase|Lost to Follow-up|0|||
27740176|NCT02249182|54190044|FG003|Treatment Phase|Lost to Follow-up|0|||
27740177|NCT02249182|54190045|FG004|Treatment Phase|Lost to Follow-up|0|||
27740178|NCT03641339|54190085|FG000|Overall Study|Physician Decision|1|||
27740179|NCT03641339|54190086|FG001|Overall Study|Physician Decision|0|||
27740180|NCT03641339|54190087|FG002|Overall Study|Physician Decision|0|||
27740181|NCT03641339|54190088|FG003|Overall Study|Physician Decision|0|||
27740182|NCT03641339|54190089|FG004|Overall Study|Physician Decision|0|||
27740183|NCT03641339|54190090|FG005|Overall Study|Physician Decision|0|||
27740184|NCT03641339|54190085|FG000|Overall Study|Withdrawal by Subject|0|||
27740185|NCT03641339|54190086|FG001|Overall Study|Withdrawal by Subject|2|||
27740186|NCT03641339|54190087|FG002|Overall Study|Withdrawal by Subject|0|||
27740187|NCT03641339|54190088|FG003|Overall Study|Withdrawal by Subject|2|||
27740188|NCT03641339|54190089|FG004|Overall Study|Withdrawal by Subject|0|||
27740189|NCT03641339|54190090|FG005|Overall Study|Withdrawal by Subject|1|||
27740190|NCT02248480|54190106|FG000|Overall Study|Lack of Efficacy|4|||
27740191|NCT02248480|54190107|FG001|Overall Study|Lack of Efficacy|6|||
27740192|NCT02248480|54190106|FG000|Overall Study|Adverse Event|11|||
27740193|NCT02248480|54190107|FG001|Overall Study|Adverse Event|2|||
27740194|NCT02248480|54190106|FG000|Overall Study|Withdrawal by Subject|2|||
27740195|NCT02248480|54190107|FG001|Overall Study|Withdrawal by Subject|4|||
27740196|NCT02248480|54190106|FG000|Overall Study|Entry Criteria Not Met|0|||
27740197|NCT02248480|54190107|FG001|Overall Study|Entry Criteria Not Met|1|||
27740198|NCT02248480|54190106|FG000|Overall Study|Other:Physician Decision|0|||
27740199|NCT02248480|54190107|FG001|Overall Study|Other:Physician Decision|1|||
27740200|NCT01653158|54190114|FG000|Overall Study|Death|0|||
27740201|NCT01653158|54190115|FG001|Overall Study|Death|0|||
27740202|NCT01653158|54190116|FG002|Overall Study|Death|0|||
27740203|NCT01653158|54190117|FG003|Overall Study|Death|1|||
27740204|NCT01653158|54190118|FG004|Overall Study|Death|0|||
27740205|NCT01653158|54190119|FG005|Overall Study|Death|0|||
27740206|NCT01653158|54190120|FG006|Overall Study|Death|0|||
27740207|NCT01653158|54190121|FG007|Overall Study|Death|2|||
27740208|NCT01653158|54190114|FG000|Overall Study|Adverse Event|0|||
27740209|NCT01653158|54190115|FG001|Overall Study|Adverse Event|0|||
27740210|NCT01653158|54190116|FG002|Overall Study|Adverse Event|0|||
27740211|NCT01653158|54190117|FG003|Overall Study|Adverse Event|1|||
27740212|NCT01653158|54190118|FG004|Overall Study|Adverse Event|0|||
27740213|NCT01653158|54190119|FG005|Overall Study|Adverse Event|0|||
27740214|NCT01653158|54190120|FG006|Overall Study|Adverse Event|0|||
27740215|NCT01653158|54190121|FG007|Overall Study|Adverse Event|3|||
27740216|NCT01653158|54190114|FG000|Overall Study|Other|0|||
27740217|NCT01653158|54190115|FG001|Overall Study|Other|0|||
27740218|NCT01653158|54190116|FG002|Overall Study|Other|0|||
27740219|NCT01653158|54190117|FG003|Overall Study|Other|0|||
27740220|NCT01653158|54190118|FG004|Overall Study|Other|0|||
27740221|NCT01653158|54190119|FG005|Overall Study|Other|0|||
27740222|NCT01653158|54190120|FG006|Overall Study|Other|0|||
27740223|NCT01653158|54190121|FG007|Overall Study|Other|1|||
27740224|NCT01653158|54190114|FG000|Overall Study|Progressive disease|0|||
27740225|NCT01653158|54190115|FG001|Overall Study|Progressive disease|0|||
27740226|NCT01653158|54190116|FG002|Overall Study|Progressive disease|0|||
27740227|NCT01653158|54190117|FG003|Overall Study|Progressive disease|0|||
27740228|NCT01653158|54190118|FG004|Overall Study|Progressive disease|1|||
27740229|NCT01653158|54190119|FG005|Overall Study|Progressive disease|1|||
27740230|NCT01653158|54190120|FG006|Overall Study|Progressive disease|2|||
27740231|NCT01653158|54190121|FG007|Overall Study|Progressive disease|9|||
27740232|NCT01653158|54190114|FG000|Overall Study|Withdrawal by Subject|1|||
27740233|NCT01653158|54190115|FG001|Overall Study|Withdrawal by Subject|0|||
27740234|NCT01653158|54190116|FG002|Overall Study|Withdrawal by Subject|0|||
27740235|NCT01653158|54190117|FG003|Overall Study|Withdrawal by Subject|0|||
27740236|NCT01653158|54190118|FG004|Overall Study|Withdrawal by Subject|0|||
27740237|NCT01653158|54190119|FG005|Overall Study|Withdrawal by Subject|0|||
27740238|NCT01653158|54190120|FG006|Overall Study|Withdrawal by Subject|0|||
27740239|NCT01653158|54190121|FG007|Overall Study|Withdrawal by Subject|0|||
27740240|NCT02247466|54190146|FG000|Overall Study|Procedure changed to open surgery|0|||
27740241|NCT02247466|54190147|FG001|Overall Study|Procedure changed to open surgery|3|||
27740242|NCT03317795|54190155|FG000|Overall Study|IUD Expulsion|1|||
27740243|NCT03317795|54190156|FG001|Overall Study|IUD Expulsion|0|||
27740244|NCT03317795|54190155|FG000|Overall Study|Lost to Follow-up|1|||
27740245|NCT03317795|54190156|FG001|Overall Study|Lost to Follow-up|3|||
27740246|NCT03317795|54190155|FG000|Overall Study|Treatment change|0|||
27918106|NCT01340495|54575392|FG000|Overall Study|Withdrawal by Subject|1|||
27918107|NCT01340300|54575400|FG000|Overall Study|Lost to Follow-up|3|||
27918108|NCT01340300|54575401|FG001|Overall Study|Lost to Follow-up|0|||
27918109|NCT01340300|54575402|FG002|Overall Study|Lost to Follow-up|5|||
27918110|NCT01340300|54575403|FG003|Overall Study|Lost to Follow-up|10|||
27918111|NCT01340300|54575400|FG000|Overall Study|Withdrawal by Subject|5|||
27918112|NCT01340300|54575401|FG001|Overall Study|Withdrawal by Subject|6|||
27918113|NCT01340300|54575402|FG002|Overall Study|Withdrawal by Subject|6|||
27918114|NCT01340300|54575403|FG003|Overall Study|Withdrawal by Subject|3|||
27918115|NCT01340300|54575400|FG000|Overall Study|Adverse Event|1|||
27918116|NCT01340300|54575401|FG001|Overall Study|Adverse Event|0|||
27918117|NCT01340300|54575402|FG002|Overall Study|Adverse Event|4|||
27918118|NCT01340300|54575403|FG003|Overall Study|Adverse Event|0|||
27918119|NCT01340300|54575400|FG000|Overall Study|Physician Decision|0|||
27918120|NCT01340300|54575401|FG001|Overall Study|Physician Decision|1|||
27918121|NCT01340300|54575402|FG002|Overall Study|Physician Decision|0|||
27918122|NCT01340300|54575403|FG003|Overall Study|Physician Decision|0|||
27918123|NCT01340300|54575400|FG000|Overall Study|Unrelated sickness|0|||
27918124|NCT01340300|54575401|FG001|Overall Study|Unrelated sickness|2|||
27918125|NCT01340300|54575402|FG002|Overall Study|Unrelated sickness|0|||
27918126|NCT01340300|54575403|FG003|Overall Study|Unrelated sickness|1|||
27918127|NCT01340066|54575415|FG000|Placebo Run in Period|Screen Failures|27|||
27918128|NCT01340066|54575416|FG001|Placebo Run in Period|Screen Failures|0|||
27918129|NCT01340066|54575417|FG002|Placebo Run in Period|Screen Failures|0|||
27918130|NCT01340066|54575415|FG000|5 Week Double Blind Randomization Period|Adverse Event|0|||
27918131|NCT01340066|54575416|FG001|5 Week Double Blind Randomization Period|Adverse Event|2|||
27918132|NCT01340066|54575417|FG002|5 Week Double Blind Randomization Period|Adverse Event|2|||
27918133|NCT01340066|54575415|FG000|5 Week Double Blind Randomization Period|Physician Decision|0|||
27918134|NCT01340066|54575416|FG001|5 Week Double Blind Randomization Period|Physician Decision|1|||
27918135|NCT01340066|54575417|FG002|5 Week Double Blind Randomization Period|Physician Decision|0|||
27918136|NCT01340066|54575415|FG000|5 Week Double Blind Randomization Period|Withdrawal by Subject|0|||
27918137|NCT01340066|54575416|FG001|5 Week Double Blind Randomization Period|Withdrawal by Subject|2|||
27918138|NCT01340066|54575417|FG002|5 Week Double Blind Randomization Period|Withdrawal by Subject|1|||
27918139|NCT01107535|54575424|FG000|Overall Study|Death|5|||
27918140|NCT01326546|54575430|FG000|Overall Study|Lost to Follow-up|8|||
27918141|NCT01326546|54575431|FG001|Overall Study|Lost to Follow-up|7|||
27918142|NCT01326546|54575430|FG000|Overall Study|Protocol Violation|3|||
27918143|NCT01326546|54575431|FG001|Overall Study|Protocol Violation|4|||
27918144|NCT01326546|54575430|FG000|Overall Study|Pregnancy|0|||
27918145|NCT01326546|54575431|FG001|Overall Study|Pregnancy|1|||
27918146|NCT01326546|54575430|FG000|Overall Study|Adverse Event|1|||
27918147|NCT01326546|54575431|FG001|Overall Study|Adverse Event|0|||
27918148|NCT01326546|54575430|FG000|Overall Study|Withdrawal by Subject|5|||
27918149|NCT01326546|54575431|FG001|Overall Study|Withdrawal by Subject|1|||
27918150|NCT01325532|54575439|FG000|Overall Study|Withdrawal by Subject|2|||
27740247|NCT03317795|54190156|FG001|Overall Study|Treatment change|3|||
27740248|NCT03317795|54190155|FG000|Overall Study|Intolerance of medication|0|||
27740249|NCT03317795|54190156|FG001|Overall Study|Intolerance of medication|1|||
27740250|NCT02202616|54190162|FG000|Overall Study|Screen failed|24|||
27740251|NCT02202616|54190162|FG000|Overall Study|Adverse Event|32|||
27918151|NCT01325532|54575440|FG001|Overall Study|Withdrawal by Subject|0|||
27918152|NCT01171963|54575448|FG000|Overall Study|Adverse Event|10|||
27918153|NCT01171963|54575449|FG001|Overall Study|Adverse Event|15|||
27918154|NCT01171963|54575448|FG000|Overall Study|Lost to Follow-up|23|||
27918155|NCT01171963|54575449|FG001|Overall Study|Lost to Follow-up|24|||
27918156|NCT01171963|54575448|FG000|Overall Study|Other - diarrhoea|1|||
27918157|NCT01171963|54575449|FG001|Overall Study|Other - diarrhoea|0|||
27918158|NCT01171963|54575448|FG000|Overall Study|Withdrawal by Subject|114|||
27918159|NCT01171963|54575449|FG001|Overall Study|Withdrawal by Subject|129|||
27918160|NCT01171183|54575460|FG000|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
27918161|NCT01171183|54575461|FG001|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
27918162|NCT01171183|54575460|FG000|Residential Facility (Weeks 1-2)|Protocol Violation|0|||
27918163|NCT01171183|54575461|FG001|Residential Facility (Weeks 1-2)|Protocol Violation|1|||
27918164|NCT01171183|54575460|FG000|Residential Facility (Weeks 1-2)|BP outside of study parameters|0|||
27918165|NCT01171183|54575461|FG001|Residential Facility (Weeks 1-2)|BP outside of study parameters|3|||
27918166|NCT01171183|54575460|FG000|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
27918167|NCT01171183|54575461|FG001|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
27918168|NCT01171183|54575460|FG000|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7|||
27918169|NCT01171183|54575461|FG001|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3|||
27918170|NCT01171183|54575460|FG000|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1|||
27918171|NCT01171183|54575461|FG001|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0|||
27918172|NCT01170091|54575467|FG000|Overall Study|Missing efficacy evaluation|3|||
27918173|NCT01170091|54575467|FG000|Overall Study|Treatment duration is less than 4 weeks|21|||
27918174|NCT01169779|54575473|FG000|Overall Study|Adverse Event|3|||
27918175|NCT01169779|54575474|FG001|Overall Study|Adverse Event|11|||
27918176|NCT01169779|54575473|FG000|Overall Study|Lack of Efficacy|1|||
27918177|NCT01169779|54575474|FG001|Overall Study|Lack of Efficacy|0|||
27918178|NCT01169779|54575473|FG000|Overall Study|Protocol Violation|1|||
27918179|NCT01169779|54575474|FG001|Overall Study|Protocol Violation|1|||
27918180|NCT01169779|54575473|FG000|Overall Study|Withdrawal by Subject|3|||
27918181|NCT01169779|54575474|FG001|Overall Study|Withdrawal by Subject|2|||
27918182|NCT01169779|54575473|FG000|Overall Study|Familial and personal reasons|3|||
27918183|NCT01169779|54575474|FG001|Overall Study|Familial and personal reasons|3|||
27918184|NCT01169701|54575482|FG000|Overall Study|Lost to Follow-up|1|||
27918185|NCT01169701|54575483|FG001|Overall Study|Lost to Follow-up|1|||
27918186|NCT01169701|54575482|FG000|Overall Study|Withdrawal by Subject|1|||
27918187|NCT01169701|54575483|FG001|Overall Study|Withdrawal by Subject|3|||
27918188|NCT01169701|54575482|FG000|Overall Study|Adverse Event|1|||
27918189|NCT01169701|54575483|FG001|Overall Study|Adverse Event|2|||
27918190|NCT01169701|54575482|FG000|Overall Study|Exclusion criteria|2|||
27740252|NCT02202616|54190162|FG000|Overall Study|Protocol deviation|18|||
27918191|NCT01169701|54575483|FG001|Overall Study|Exclusion criteria|0|||
28007873|NCT00723008|54666657|FG001|4-Week Unblinded Treatment|Adverse Event|0|||
28007874|NCT00723008|54666656|FG000|4-Week Unblinded Treatment|Lost to Follow-up|0|||
27918192|NCT01169701|54575482|FG000|Overall Study|Death|0|||
27918193|NCT01169701|54575483|FG001|Overall Study|Death|1|||
27918194|NCT01169701|54575482|FG000|Overall Study|Administrative problems|0|||
27918195|NCT01169701|54575483|FG001|Overall Study|Administrative problems|1|||
27918196|NCT01169701|54575482|FG000|Overall Study|Serious adverse event|0|||
27918197|NCT01169701|54575483|FG001|Overall Study|Serious adverse event|1|||
27918198|NCT01169701|54575482|FG000|Overall Study|Sponsor decision|0|||
27918199|NCT01169701|54575483|FG001|Overall Study|Sponsor decision|1|||
27918200|NCT01168999|54575493|FG000|Overall Study|Lost to Follow-up|2|||
27918201|NCT01168999|54575494|FG001|Overall Study|Lost to Follow-up|1|||
27918202|NCT01168999|54575495|FG002|Overall Study|Lost to Follow-up|0|||
27918203|NCT01168999|54575496|FG003|Overall Study|Lost to Follow-up|0|||
27918204|NCT01167907|54575508|FG000|Overall Study|Protocol Violation|1|||
27918205|NCT01167907|54575509|FG001|Overall Study|Protocol Violation|0|||
27918206|NCT01167907|54575508|FG000|Overall Study|saphenous catheter dislodged before comp|1|||
27918207|NCT01167907|54575509|FG001|Overall Study|saphenous catheter dislodged before comp|1|||
27918208|NCT01166659|54575515|FG000|Overall Study|Subject Decision|8|||
27918209|NCT01166659|54575515|FG000|Overall Study|Investigator Decision|2|||
27918210|NCT01166659|54575515|FG000|Overall Study|Death|1|||
27918211|NCT01166659|54575515|FG000|Overall Study|Lost to Follow-up|1|||
27918212|NCT01166659|54575515|FG000|Overall Study|Study Closed at Site|1|||
27918213|NCT01115491|54575520|FG000|Overall Study|Death|22|||
27918214|NCT01115491|54575520|FG000|Overall Study|Adverse Event|3|||
27918215|NCT01115491|54575520|FG000|Overall Study|Lost to Follow-up|3|||
27918216|NCT01115491|54575520|FG000|Overall Study|Withdrawal by Subject|1|||
27918217|NCT01115491|54575520|FG000|Overall Study|Physician Decision|1|||
27918218|NCT01113931|54575526|FG000|Overall Study|Adverse Event|2|||
27918219|NCT01113931|54575527|FG001|Overall Study|Adverse Event|2|||
27918220|NCT01113931|54575526|FG000|Overall Study|Physician Decision|0|||
27918221|NCT01113931|54575527|FG001|Overall Study|Physician Decision|2|||
27918222|NCT01113931|54575526|FG000|Overall Study|Lost to Follow-up|12|||
27918223|NCT01113931|54575527|FG001|Overall Study|Lost to Follow-up|9|||
27918224|NCT01113931|54575526|FG000|Overall Study|Various|2|||
27918225|NCT01113931|54575527|FG001|Overall Study|Various|4|||
27918226|NCT01113931|54575526|FG000|Overall Study|Withdrawal by Subject|3|||
27918227|NCT01113931|54575527|FG001|Overall Study|Withdrawal by Subject|0|||
27918228|NCT01107379|54575533|FG000|Overall Study|Withdrawal by Subject|18|||
27918229|NCT01107379|54575533|FG000|Overall Study|Lost to Follow-up|3|||
27918230|NCT01106911|54575537|FG000|Overall Study|Physician Decision|2|||
27918231|NCT01106911|54575537|FG000|Overall Study|deemed ineligible after screening|3|||
27918232|NCT01106677|54575545|FG000|Core Period: Baseline to Week 26|Adverse Event|7|||
27918233|NCT01106677|54575546|FG001|Core Period: Baseline to Week 26|Adverse Event|18|||
27918234|NCT01106677|54575547|FG002|Core Period: Baseline to Week 26|Adverse Event|6|||
27918235|NCT01106677|54575548|FG003|Core Period: Baseline to Week 26|Adverse Event|8|||
27918236|NCT01106677|54575545|FG000|Core Period: Baseline to Week 26|Death|0|||
27918237|NCT01106677|54575546|FG001|Core Period: Baseline to Week 26|Death|0|||
27918238|NCT01106677|54575547|FG002|Core Period: Baseline to Week 26|Death|1|||
27918239|NCT01106677|54575548|FG003|Core Period: Baseline to Week 26|Death|0|||
27918240|NCT01106677|54575545|FG000|Core Period: Baseline to Week 26|Lack of Efficacy|1|||
27918241|NCT01106677|54575546|FG001|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
27918242|NCT01106677|54575547|FG002|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
27918243|NCT01106677|54575548|FG003|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
27918244|NCT01106677|54575545|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
27918245|NCT01106677|54575546|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
27918246|NCT01106677|54575547|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|6|||
27918247|NCT01106677|54575548|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
27918248|NCT01106677|54575545|FG000|Core Period: Baseline to Week 26|Physician Decision|2|||
27918249|NCT01106677|54575546|FG001|Core Period: Baseline to Week 26|Physician Decision|1|||
27918250|NCT01106677|54575547|FG002|Core Period: Baseline to Week 26|Physician Decision|3|||
27918251|NCT01106677|54575548|FG003|Core Period: Baseline to Week 26|Physician Decision|1|||
27918252|NCT01106677|54575545|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
27918253|NCT01106677|54575546|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
27918254|NCT01106677|54575547|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
27918255|NCT01106677|54575548|FG003|Core Period: Baseline to Week 26|Protocol Violation|3|||
27918256|NCT01106677|54575545|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|5|||
27918257|NCT01106677|54575546|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
27918258|NCT01106677|54575547|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
27918259|NCT01106677|54575548|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
27918260|NCT01106677|54575545|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
27918261|NCT01106677|54575546|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
27918262|NCT01106677|54575547|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
27918263|NCT01106677|54575548|FG003|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
27918264|NCT01106677|54575545|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
27918265|NCT01106677|54575546|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
27918266|NCT01106677|54575547|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
27918267|NCT01106677|54575548|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
27918268|NCT01106677|54575545|FG000|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
27918269|NCT01106677|54575546|FG001|Core Period: Baseline to Week 26|Study terminated by sponsor|1|||
27918270|NCT01106677|54575547|FG002|Core Period: Baseline to Week 26|Study terminated by sponsor|2|||
27918271|NCT01106677|54575548|FG003|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
27918272|NCT01106677|54575545|FG000|Core Period: Baseline to Week 26|Product quality complaint|0|||
27918273|NCT01106677|54575546|FG001|Core Period: Baseline to Week 26|Product quality complaint|1|||
27918274|NCT01106677|54575547|FG002|Core Period: Baseline to Week 26|Product quality complaint|1|||
27918275|NCT01106677|54575548|FG003|Core Period: Baseline to Week 26|Product quality complaint|0|||
27918276|NCT01106677|54575545|FG000|Core Period: Baseline to Week 26|Other|8|||
27918277|NCT01106677|54575546|FG001|Core Period: Baseline to Week 26|Other|14|||
27918278|NCT01106677|54575547|FG002|Core Period: Baseline to Week 26|Other|8|||
27918279|NCT01106677|54575548|FG003|Core Period: Baseline to Week 26|Other|23|||
27918280|NCT01106677|54575545|FG000|Core Period: Baseline to Week 26|Pregnancy|0|||
27918281|NCT01106677|54575546|FG001|Core Period: Baseline to Week 26|Pregnancy|1|||
27918282|NCT01106677|54575547|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
27918283|NCT01106677|54575548|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
27918284|NCT01106677|54575545|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
27918285|NCT01106677|54575546|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
27918286|NCT01106677|54575547|FG002|Extension Period: Week 26 to Week 52|Adverse Event|5|||
27918287|NCT01106677|54575548|FG003|Extension Period: Week 26 to Week 52|Adverse Event|9|||
27918288|NCT01106677|54575545|FG000|Extension Period: Week 26 to Week 52|Death|0|||
27918289|NCT01106677|54575546|FG001|Extension Period: Week 26 to Week 52|Death|0|||
27918290|NCT01106677|54575547|FG002|Extension Period: Week 26 to Week 52|Death|0|||
27918291|NCT01106677|54575548|FG003|Extension Period: Week 26 to Week 52|Death|1|||
27918292|NCT01106677|54575545|FG000|Extension Period: Week 26 to Week 52|Lack of Efficacy|2|||
28007875|NCT00723008|54666657|FG001|4-Week Unblinded Treatment|Lost to Follow-up|1|||
27740253|NCT02202616|54190162|FG000|Overall Study|Patient withdrew consent|12|||
27740254|NCT02202616|54190162|FG000|Overall Study|Lost to Follow-up|6|||
27918293|NCT01106677|54575546|FG001|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
27918294|NCT01106677|54575547|FG002|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
27918295|NCT01106677|54575548|FG003|Extension Period: Week 26 to Week 52|Lack of Efficacy|4|||
27918296|NCT01106677|54575545|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
27918297|NCT01106677|54575546|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
28007876|NCT00718640|54666671|FG000|Overall Study|Adverse Event|4|||
28007877|NCT00718640|54666671|FG000|Overall Study|Death|1|||
27918298|NCT01106677|54575547|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
27918299|NCT01106677|54575548|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
27918300|NCT01106677|54575545|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
27918301|NCT01106677|54575546|FG001|Extension Period: Week 26 to Week 52|Physician Decision|3|||
27918302|NCT01106677|54575547|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
27918303|NCT01106677|54575548|FG003|Extension Period: Week 26 to Week 52|Physician Decision|3|||
28007878|NCT00718640|54666671|FG000|Overall Study|Unresolved toxicity after 2 weeks|2|||
28007879|NCT00715910|54666679|FG000|Booster and ESFU Phase|Lost to Follow-up|0|||
27918304|NCT01106677|54575545|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
27918305|NCT01106677|54575546|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
27918306|NCT01106677|54575547|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
27918307|NCT01106677|54575548|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
27918308|NCT01106677|54575545|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
27918309|NCT01106677|54575546|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3|||
27918310|NCT01106677|54575547|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
27918311|NCT01106677|54575548|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
27918312|NCT01106677|54575545|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
27918313|NCT01106677|54575546|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
27918314|NCT01106677|54575547|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3|||
27918315|NCT01106677|54575548|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
27918316|NCT01106677|54575545|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
27918317|NCT01106677|54575546|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
27918318|NCT01106677|54575547|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
27918319|NCT01106677|54575548|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
27918320|NCT01106677|54575545|FG000|Extension Period: Week 26 to Week 52|Other|6|||
27918321|NCT01106677|54575546|FG001|Extension Period: Week 26 to Week 52|Other|5|||
27918322|NCT01106677|54575547|FG002|Extension Period: Week 26 to Week 52|Other|8|||
27918323|NCT01106677|54575548|FG003|Extension Period: Week 26 to Week 52|Other|5|||
27918324|NCT01106287|54575569|FG000|Overall Study|Adverse Event|1|||
27918325|NCT01106287|54575570|FG001|Overall Study|Adverse Event|0|||
27918326|NCT01106287|54575571|FG002|Overall Study|Adverse Event|0|||
27918327|NCT01106287|54575572|FG003|Overall Study|Adverse Event|0|||
27918328|NCT01104493|54575588|FG000|Overall Study|Lost to Follow-up|0|||
27918329|NCT01104493|54575589|FG001|Overall Study|Lost to Follow-up|2|||
27918330|NCT01104415|54575595|FG000|Core Phase|Consent withdrawn by subjects|1|||
27918331|NCT01104415|54575596|FG001|Core Phase|Consent withdrawn by subjects|0|||
27918332|NCT01104415|54575595|FG000|Extension Period|Progressive disease|0|||
27918333|NCT01104415|54575596|FG001|Extension Period|Progressive disease|4|||
27918334|NCT01104415|54575595|FG000|Extension Period|Death|0|||
27918335|NCT01104415|54575596|FG001|Extension Period|Death|1|||
27918336|NCT01104415|54575595|FG000|Extension Period|Physician Decision|0|||
27918337|NCT01104415|54575596|FG001|Extension Period|Physician Decision|1|||
27918338|NCT01104415|54575595|FG000|Extension Period|Transition to Study LX1606.302|0|||
27918339|NCT01104415|54575596|FG001|Extension Period|Transition to Study LX1606.302|4|||
27918340|NCT01104415|54575595|FG000|Extension Period|Heart surgery/feeling miserable|0|||
27918341|NCT01104415|54575596|FG001|Extension Period|Heart surgery/feeling miserable|1|||
27918342|NCT01099579|54575606|FG000|Stage 1 (ATV Powder Formulation)|Adverse Event|4|||
27918343|NCT01099579|54575607|FG001|Stage 1 (ATV Powder Formulation)|Adverse Event|1|||
27918344|NCT01099579|54575608|FG002|Stage 1 (ATV Powder Formulation)|Adverse Event|0|||
27918345|NCT01099579|54575606|FG000|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
27918346|NCT01099579|54575607|FG001|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
27918347|NCT01099579|54575608|FG002|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1|||
27918348|NCT01099579|54575606|FG000|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
27918349|NCT01099579|54575607|FG001|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2|||
27918350|NCT01099579|54575608|FG002|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
27918351|NCT01099579|54575606|FG000|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
27918352|NCT01099579|54575607|FG001|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2|||
27918353|NCT01099579|54575608|FG002|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
27740255|NCT02202616|54190162|FG000|Overall Study|Administrative problems|6|||
27740256|NCT02202616|54190162|FG000|Overall Study|Abnormal test procedure result|1|||
27740257|NCT02202616|54190162|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
27740258|NCT02455388|54190169|FG000|Overall Study|Protocol Violation|1|||
27740259|NCT02455388|54190170|FG001|Overall Study|Protocol Violation|0|||
27740260|NCT02455388|54190171|FG002|Overall Study|Protocol Violation|4|||
27740261|NCT02455388|54190169|FG000|Overall Study|Withdrawal by Subject|0|||
27740262|NCT02455388|54190170|FG001|Overall Study|Withdrawal by Subject|0|||
27740263|NCT02455388|54190171|FG002|Overall Study|Withdrawal by Subject|7|||
27740264|NCT02455076|54190184|FG000|Inpatient|Withdrawal by Subject|1|||
27740265|NCT02455076|54190185|FG001|Inpatient|Withdrawal by Subject|0|||
27740266|NCT02455076|54190186|FG002|Inpatient|Withdrawal by Subject|0|||
27740267|NCT02455076|54190187|FG003|Inpatient|Withdrawal by Subject|0|||
27740268|NCT02455076|54190188|FG004|Inpatient|Withdrawal by Subject|0|||
27740269|NCT02455076|54190184|FG000|Inpatient|Discharged <24 h after admission|0|||
27740270|NCT02455076|54190185|FG001|Inpatient|Discharged <24 h after admission|1|||
27740271|NCT02455076|54190186|FG002|Inpatient|Discharged <24 h after admission|0|||
27740272|NCT02455076|54190187|FG003|Inpatient|Discharged <24 h after admission|0|||
27740273|NCT02455076|54190188|FG004|Inpatient|Discharged <24 h after admission|0|||
27740274|NCT02455076|54190184|FG000|Inpatient|Adverse Event|3|||
27740275|NCT02455076|54190185|FG001|Inpatient|Adverse Event|0|||
27740276|NCT02455076|54190186|FG002|Inpatient|Adverse Event|0|||
27740277|NCT02455076|54190187|FG003|Inpatient|Adverse Event|0|||
27740278|NCT02455076|54190188|FG004|Inpatient|Adverse Event|0|||
27740279|NCT02455076|54190184|FG000|Outpatient|Adverse Event|0|||
27740280|NCT02455076|54190185|FG001|Outpatient|Adverse Event|0|||
27740281|NCT02455076|54190186|FG002|Outpatient|Adverse Event|0|||
27740282|NCT02455076|54190187|FG003|Outpatient|Adverse Event|5|||
27740283|NCT02455076|54190188|FG004|Outpatient|Adverse Event|0|||
27740284|NCT02455076|54190184|FG000|Outpatient|Lost to Follow-up|0|||
27740285|NCT02455076|54190185|FG001|Outpatient|Lost to Follow-up|0|||
27740286|NCT02455076|54190186|FG002|Outpatient|Lost to Follow-up|0|||
27740287|NCT02455076|54190187|FG003|Outpatient|Lost to Follow-up|1|||
27740288|NCT02455076|54190188|FG004|Outpatient|Lost to Follow-up|12|||
27740289|NCT02433080|54190202|FG000|Overall Study|Lost to Follow-up|1|||
27740290|NCT02433080|54190203|FG001|Overall Study|Lost to Follow-up|2|||
27740291|NCT02433080|54190202|FG000|Overall Study|Withdrawal by Subject|0|||
27740292|NCT02433080|54190203|FG001|Overall Study|Withdrawal by Subject|2|||
27740293|NCT03092219|54190212|FG000|Overall Study|Protocol Violation|7|||
27740294|NCT03092219|54190213|FG001|Overall Study|Protocol Violation|4|||
27740295|NCT02432846|54190228|FG000|Overall Study (4 Arms/Strata)|Death|3|||
27740296|NCT02432846|54190229|FG001|Overall Study (4 Arms/Strata)|Death|2|||
28007880|NCT00715910|54666680|FG001|Booster and ESFU Phase|Lost to Follow-up|0|||
28007881|NCT00715910|54666681|FG002|Booster and ESFU Phase|Lost to Follow-up|0|||
28007882|NCT00715910|54666682|FG003|Booster and ESFU Phase|Lost to Follow-up|6|||
28007883|NCT00715910|54666683|FG004|Booster and ESFU Phase|Lost to Follow-up|1|||
27918354|NCT01099579|54575606|FG000|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
27918355|NCT01099579|54575607|FG001|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
27740297|NCT02432846|54190230|FG002|Overall Study (4 Arms/Strata)|Death|4|||
27740298|NCT02432846|54190231|FG003|Overall Study (4 Arms/Strata)|Death|3|||
27740299|NCT02432846|54190232|FG004|Overall Study (4 Arms/Strata)|Death|0|||
27740300|NCT02432846|54190233|FG005|Overall Study (4 Arms/Strata)|Death|0|||
27740301|NCT02432846|54190228|FG000|Overall Study (4 Arms/Strata)|Adverse Event|0|||
27740302|NCT02432846|54190229|FG001|Overall Study (4 Arms/Strata)|Adverse Event|1|||
27740303|NCT02432846|54190230|FG002|Overall Study (4 Arms/Strata)|Adverse Event|1|||
27740304|NCT02432846|54190231|FG003|Overall Study (4 Arms/Strata)|Adverse Event|0|||
27740305|NCT02432846|54190232|FG004|Overall Study (4 Arms/Strata)|Adverse Event|0|||
27740306|NCT02432846|54190233|FG005|Overall Study (4 Arms/Strata)|Adverse Event|0|||
27740307|NCT02432846|54190228|FG000|Overall Study (4 Arms/Strata)|Physician Decision|2|||
27740308|NCT02432846|54190229|FG001|Overall Study (4 Arms/Strata)|Physician Decision|0|||
27740309|NCT02432846|54190230|FG002|Overall Study (4 Arms/Strata)|Physician Decision|0|||
27740310|NCT02432846|54190231|FG003|Overall Study (4 Arms/Strata)|Physician Decision|0|||
27740311|NCT02432846|54190232|FG004|Overall Study (4 Arms/Strata)|Physician Decision|0|||
27740312|NCT02432846|54190233|FG005|Overall Study (4 Arms/Strata)|Physician Decision|0|||
27740313|NCT02432846|54190228|FG000|Overall Study (4 Arms/Strata)|Withdrawal by Subject|2|||
27740314|NCT02432846|54190229|FG001|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
27740315|NCT02432846|54190230|FG002|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
27740316|NCT02432846|54190231|FG003|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
27740317|NCT02432846|54190232|FG004|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
27740318|NCT02432846|54190233|FG005|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
27740319|NCT02432846|54190228|FG000|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
28007884|NCT00715910|54666684|FG005|Booster and ESFU Phase|Lost to Follow-up|13|||
28007885|NCT00715910|54666679|FG000|Booster and ESFU Phase|Other|0|||
28007886|NCT00715910|54666680|FG001|Booster and ESFU Phase|Other|0|||
28007887|NCT00715910|54666681|FG002|Booster and ESFU Phase|Other|0|||
28007888|NCT00715910|54666682|FG003|Booster and ESFU Phase|Other|5|||
28007889|NCT00715910|54666683|FG004|Booster and ESFU Phase|Other|1|||
28007890|NCT00715910|54666684|FG005|Booster and ESFU Phase|Other|0|||
28007891|NCT00715676|54666703|FG000|Overall Study|Adverse Event|3|||
28007892|NCT00715676|54666704|FG001|Overall Study|Adverse Event|5|||
28007893|NCT00715676|54666705|FG002|Overall Study|Adverse Event|21|||
28007894|NCT00715676|54666703|FG000|Overall Study|Withdrawal by Subject|1|||
28007895|NCT00715676|54666704|FG001|Overall Study|Withdrawal by Subject|3|||
28007896|NCT00715676|54666705|FG002|Overall Study|Withdrawal by Subject|8|||
28007897|NCT00715676|54666703|FG000|Overall Study|Lost to Follow-up|1|||
28007898|NCT00715676|54666704|FG001|Overall Study|Lost to Follow-up|2|||
27740320|NCT02432846|54190229|FG001|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
27740321|NCT02432846|54190230|FG002|Overall Study (4 Arms/Strata)|Other (reason not specified)|2|||
27740322|NCT02432846|54190231|FG003|Overall Study (4 Arms/Strata)|Other (reason not specified)|1|||
27740323|NCT02432846|54190232|FG004|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
27740324|NCT02432846|54190233|FG005|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
27740325|NCT02432846|54190228|FG000|Overall Study (4 Arms/Strata)|Disease progression|8|||
27740326|NCT02432846|54190229|FG001|Overall Study (4 Arms/Strata)|Disease progression|5|||
27740327|NCT02432846|54190230|FG002|Overall Study (4 Arms/Strata)|Disease progression|15|||
27740328|NCT02432846|54190231|FG003|Overall Study (4 Arms/Strata)|Disease progression|9|||
27740329|NCT02432846|54190232|FG004|Overall Study (4 Arms/Strata)|Disease progression|0|||
27740330|NCT02432846|54190233|FG005|Overall Study (4 Arms/Strata)|Disease progression|0|||
27740331|NCT02432846|54190228|FG000|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
27740332|NCT02432846|54190229|FG001|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
27740333|NCT02432846|54190230|FG002|Overall Study (4 Arms/Strata)|Lost to Follow-up|1|||
27740334|NCT02432846|54190231|FG003|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
27740335|NCT02432846|54190232|FG004|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
27740336|NCT02432846|54190233|FG005|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
27740337|NCT02432846|54190228|FG000|Overall Study (2 Total/Combined Groups)|Death|0|||
27740338|NCT02432846|54190229|FG001|Overall Study (2 Total/Combined Groups)|Death|0|||
27740339|NCT02432846|54190230|FG002|Overall Study (2 Total/Combined Groups)|Death|0|||
27740340|NCT02432846|54190231|FG003|Overall Study (2 Total/Combined Groups)|Death|0|||
27740341|NCT02432846|54190232|FG004|Overall Study (2 Total/Combined Groups)|Death|7|||
27740342|NCT02432846|54190233|FG005|Overall Study (2 Total/Combined Groups)|Death|5|||
27740343|NCT02432846|54190228|FG000|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
27740344|NCT02432846|54190229|FG001|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
27740345|NCT02432846|54190230|FG002|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
28007899|NCT00715676|54666705|FG002|Overall Study|Lost to Follow-up|1|||
28007900|NCT00715676|54666703|FG000|Overall Study|Terminated by Sponsor|1|||
28103617|NCT01002742|54760300|FG000|Overall Study|Determined to be ineligible|0|||
27918356|NCT01099579|54575608|FG002|Stage 2 (ATV Capsule)|No longer met study criteria|1|||
27918357|NCT01099579|54575606|FG000|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
27918358|NCT01099579|54575607|FG001|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
27918359|NCT01099579|54575608|FG002|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
27918360|NCT01099579|54575606|FG000|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
27918361|NCT01099579|54575607|FG001|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
27918362|NCT01099579|54575608|FG002|Stage 2 (ATV Capsule)|Lack of Efficacy|2|||
27918363|NCT01099579|54575606|FG000|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
27918364|NCT01099579|54575607|FG001|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
27918365|NCT01099579|54575608|FG002|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
27918366|NCT01099579|54575606|FG000|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2|||
27918367|NCT01099579|54575607|FG001|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0|||
28103618|NCT01002742|54760301|FG001|Overall Study|Determined to be ineligible|1|||
28103619|NCT02853760|54760307|FG000|Washout (1 Week)|acute illness (not connected with the study)|0|||
28103620|NCT02853760|54760308|FG001|Washout (1 Week)|acute illness (not connected with the study)|0|||
28103621|NCT02853760|54760309|FG002|Washout (1 Week)|acute illness (not connected with the study)|1|||
28103622|NCT02853760|54760310|FG003|Washout (1 Week)|acute illness (not connected with the study)|2|||
28103623|NCT02853760|54760311|FG004|Washout (1 Week)|acute illness (not connected with the study)|0|||
28103624|NCT02853760|54760312|FG005|Washout (1 Week)|acute illness (not connected with the study)|2|||
27740346|NCT02432846|54190231|FG003|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
27740347|NCT02432846|54190232|FG004|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
27740348|NCT02432846|54190233|FG005|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
27740349|NCT02432846|54190228|FG000|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
27740350|NCT02432846|54190229|FG001|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
27740351|NCT02432846|54190230|FG002|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
27740352|NCT02432846|54190231|FG003|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
27740353|NCT02432846|54190232|FG004|Overall Study (2 Total/Combined Groups)|Physician Decision|2|||
27740354|NCT02432846|54190233|FG005|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
27740355|NCT02432846|54190228|FG000|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
27740356|NCT02432846|54190229|FG001|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
27740357|NCT02432846|54190230|FG002|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
27740358|NCT02432846|54190231|FG003|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
27740359|NCT02432846|54190232|FG004|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|3|||
27740360|NCT02432846|54190233|FG005|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|1|||
27740361|NCT02432846|54190228|FG000|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
27740362|NCT02432846|54190229|FG001|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
27740363|NCT02432846|54190230|FG002|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
27740364|NCT02432846|54190231|FG003|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
27740365|NCT02432846|54190232|FG004|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|2|||
27740366|NCT02432846|54190233|FG005|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|1|||
27740367|NCT02432846|54190228|FG000|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
27740368|NCT02432846|54190229|FG001|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
27740369|NCT02432846|54190230|FG002|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
27740370|NCT02432846|54190231|FG003|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
27740371|NCT02432846|54190232|FG004|Overall Study (2 Total/Combined Groups)|Disease progression|23|||
27740372|NCT02432846|54190233|FG005|Overall Study (2 Total/Combined Groups)|Disease progression|14|||
27740373|NCT02432846|54190228|FG000|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
27740374|NCT02432846|54190229|FG001|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
27740375|NCT02432846|54190230|FG002|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
27918368|NCT01099579|54575608|FG002|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1|||
27918369|NCT01099579|54575606|FG000|Stage 2 (ATV Capsule)|Adverse Event|0|||
27918370|NCT01099579|54575607|FG001|Stage 2 (ATV Capsule)|Adverse Event|1|||
27918371|NCT01099579|54575608|FG002|Stage 2 (ATV Capsule)|Adverse Event|0|||
27918372|NCT01103713|54575618|FG000|Overall Study|Lost to Follow-up|2|||
28007901|NCT00715676|54666704|FG001|Overall Study|Terminated by Sponsor|0|||
28007902|NCT00715676|54666705|FG002|Overall Study|Terminated by Sponsor|0|||
28007903|NCT00715676|54666703|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
28007904|NCT00715676|54666704|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
28007905|NCT00715676|54666705|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
28007906|NCT00715676|54666703|FG000|Overall Study|Use of Exclusionary Medication|0|||
28007907|NCT00715676|54666704|FG001|Overall Study|Use of Exclusionary Medication|0|||
28007908|NCT00715676|54666705|FG002|Overall Study|Use of Exclusionary Medication|1|||
28007909|NCT00715676|54666703|FG000|Overall Study|Elevated Blood Glucose|0|||
28007910|NCT00715676|54666704|FG001|Overall Study|Elevated Blood Glucose|1|||
28007911|NCT00715676|54666705|FG002|Overall Study|Elevated Blood Glucose|0|||
28007912|NCT00718328|54666715|FG000|Overall Study|Lost to Follow-up|1|||
28007913|NCT00718328|54666716|FG001|Overall Study|Lost to Follow-up|0|||
28007914|NCT00715520|54666725|FG000|Overall Study|Screen failure|8|||
28007915|NCT00715520|54666726|FG001|Overall Study|Screen failure|1|||
27918373|NCT01103713|54575618|FG000|Overall Study|Withdrawal by Subject|8|||
27918374|NCT01103713|54575618|FG000|Overall Study|Study terminated by sponsor|2|||
27918375|NCT01103713|54575618|FG000|Overall Study|Other|1|||
27918376|NCT01103479|54575628|FG000|Overall Study|Up to date with CRC screening|1|||
27918377|NCT01103479|54575629|FG001|Overall Study|Up to date with CRC screening|9|||
27918378|NCT01103479|54575630|FG002|Overall Study|Up to date with CRC screening|12|||
27918379|NCT01103479|54575628|FG000|Overall Study|Family history of CRC|1|||
27918380|NCT01103479|54575629|FG001|Overall Study|Family history of CRC|0|||
27918381|NCT01103479|54575630|FG002|Overall Study|Family history of CRC|2|||
27918382|NCT01103479|54575628|FG000|Overall Study|Active cancer|1|||
27918383|NCT01103479|54575629|FG001|Overall Study|Active cancer|0|||
27918384|NCT01103479|54575630|FG002|Overall Study|Active cancer|0|||
27918385|NCT01103479|54575628|FG000|Overall Study|Saw non-study physician|2|||
27918386|NCT01103479|54575629|FG001|Overall Study|Saw non-study physician|0|||
28007916|NCT00715520|54666727|FG002|Overall Study|Screen failure|1|||
28007917|NCT00715520|54666725|FG000|Overall Study|Withdrawal by Subject|2|||
27740376|NCT02432846|54190231|FG003|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
27740377|NCT02432846|54190232|FG004|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|1|||
27740378|NCT02432846|54190233|FG005|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
27740379|NCT02432144|54190246|FG000|Overall Study|Participant Non-Compliance|1|||
27740380|NCT02246998|54190254|FG000|Overall Study|Adverse Event|0|||
27740381|NCT02246998|54190255|FG001|Overall Study|Adverse Event|1|||
27740382|NCT02246998|54190256|FG002|Overall Study|Adverse Event|1|||
27740383|NCT02246998|54190257|FG003|Overall Study|Adverse Event|0|||
27740384|NCT02246998|54190254|FG000|Overall Study|Lost to Follow-up|1|||
27740385|NCT02246998|54190255|FG001|Overall Study|Lost to Follow-up|0|||
27740386|NCT02246998|54190256|FG002|Overall Study|Lost to Follow-up|0|||
27740387|NCT02246998|54190257|FG003|Overall Study|Lost to Follow-up|1|||
27740388|NCT02246998|54190254|FG000|Overall Study|Randomized but Never Dosed|1|||
27740389|NCT02246998|54190255|FG001|Overall Study|Randomized but Never Dosed|2|||
27740390|NCT02246998|54190256|FG002|Overall Study|Randomized but Never Dosed|2|||
27740391|NCT02246998|54190257|FG003|Overall Study|Randomized but Never Dosed|1|||
27740392|NCT02486588|54190276|FG000|Overall Study|Randomized in error- ineligible|738|||
27740393|NCT02486588|54190277|FG001|Overall Study|Randomized in error- ineligible|750|||
27740394|NCT02486588|54190278|FG002|Overall Study|Randomized in error- ineligible|755|||
27740395|NCT02486588|54190279|FG003|Overall Study|Randomized in error- ineligible|738|||
27740396|NCT02486588|54190280|FG004|Overall Study|Randomized in error- ineligible|746|||
27740397|NCT02486588|54190281|FG005|Overall Study|Randomized in error- ineligible|746|||
27740398|NCT00805961|54190300|FG000|Modality Therapy|Withdrawal by Subject|1|||
27740399|NCT00805961|54190300|FG000|Modality Therapy|Adverse Event|1|||
27740400|NCT00805961|54190300|FG000|Modality Therapy|Disease Progression|2|||
27740401|NCT00805961|54190300|FG000|Treatment-Free Interval|Adverse Event|3|||
27740402|NCT00805961|54190300|FG000|Treatment-Free Interval|Intercurrent Illness|2|||
27740403|NCT00805961|54190300|FG000|Treatment-Free Interval|Physician Decision|1|||
27740404|NCT00805961|54190300|FG000|Treatment-Free Interval|Lack of Efficacy|1|||
27740405|NCT00805961|54190300|FG000|Maintenance Treatment|Lack of Efficacy|13|||
27740406|NCT00805961|54190300|FG000|Maintenance Treatment|Intercurrent Illness|7|||
27740407|NCT00805961|54190300|FG000|Maintenance Treatment|Adverse Event|6|||
27740408|NCT00805961|54190300|FG000|Maintenance Treatment|Withdrawal by Subject|5|||
27740409|NCT00805961|54190300|FG000|Maintenance Treatment|Symptomatic Deterioration|2|||
27740410|NCT00805961|54190300|FG000|Maintenance Treatment|Withdrawn Consent|1|||
27740411|NCT02202538|54190304|FG000|Overall Study|Withdrawal by Subject|5|||
27740412|NCT02202538|54190304|FG000|Overall Study|Did not meet all inclusion criteria|2|||
27740413|NCT02202538|54190304|FG000|Overall Study|Investigator Decision|1|||
27740414|NCT02454608|54190311|FG000|Double-Blind Period|Lack of Efficacy|0|||
27740415|NCT02454608|54190312|FG001|Double-Blind Period|Lack of Efficacy|2|||
27740416|NCT02454608|54190313|FG002|Double-Blind Period|Lack of Efficacy|0|||
27740417|NCT02454608|54190311|FG000|Open Label Period|Lost to Follow-up|0|||
27740418|NCT02454608|54190312|FG001|Open Label Period|Lost to Follow-up|0|||
27740419|NCT02454608|54190313|FG002|Open Label Period|Lost to Follow-up|11|||
27740420|NCT02454608|54190311|FG000|Open Label Period|Withdrawal by Subject|0|||
27740421|NCT02454608|54190312|FG001|Open Label Period|Withdrawal by Subject|0|||
27740422|NCT02454608|54190313|FG002|Open Label Period|Withdrawal by Subject|8|||
27740423|NCT02246764|54190324|FG000|Overall Study|Adverse Event|15|||
27740424|NCT02246764|54190325|FG001|Overall Study|Adverse Event|29|||
27740425|NCT02246764|54190326|FG002|Overall Study|Adverse Event|1|||
27740426|NCT02246764|54190324|FG000|Overall Study|Withdrawal by Subject|0|||
27740427|NCT02246764|54190325|FG001|Overall Study|Withdrawal by Subject|0|||
27740428|NCT02246764|54190326|FG002|Overall Study|Withdrawal by Subject|1|||
27740429|NCT02246764|54190324|FG000|Overall Study|Disallowed Concomitant Medication|1|||
27740430|NCT02246764|54190325|FG001|Overall Study|Disallowed Concomitant Medication|0|||
27740431|NCT02246764|54190326|FG002|Overall Study|Disallowed Concomitant Medication|0|||
27740432|NCT02246764|54190324|FG000|Overall Study|Physician Decision|0|||
27740433|NCT02246764|54190325|FG001|Overall Study|Physician Decision|2|||
27740434|NCT02246764|54190326|FG002|Overall Study|Physician Decision|1|||
27740435|NCT02246764|54190324|FG000|Overall Study|Protocol Violation|2|||
27740436|NCT02246764|54190325|FG001|Overall Study|Protocol Violation|1|||
27740437|NCT02246764|54190326|FG002|Overall Study|Protocol Violation|1|||
27918387|NCT01103479|54575630|FG002|Overall Study|Saw non-study physician|0|||
28007918|NCT00715520|54666726|FG001|Overall Study|Withdrawal by Subject|0|||
27740438|NCT02454530|54190336|FG000|Overall Study|Other|8|||
27740439|NCT02454530|54190337|FG001|Overall Study|Other|13|||
27740440|NCT02454530|54190336|FG000|Overall Study|Missing information|56|||
27740441|NCT02454530|54190337|FG001|Overall Study|Missing information|69|||
27740442|NCT02454530|54190336|FG000|Overall Study|Death|2|||
27740443|NCT02454530|54190337|FG001|Overall Study|Death|41|||
27740444|NCT02454530|54190336|FG000|Overall Study|Lost to Follow-up|4|||
27740445|NCT02454530|54190337|FG001|Overall Study|Lost to Follow-up|4|||
27740446|NCT02431676|54190347|FG000|Overall Study|no lab obtained|0|||
27740447|NCT02431676|54190348|FG001|Overall Study|no lab obtained|1|||
27740448|NCT02431676|54190349|FG002|Overall Study|no lab obtained|2|||
27740449|NCT01654250|54190359|FG000|Overall Study|Lost to Follow-up|1|||
27740450|NCT01654250|54190360|FG001|Overall Study|Lost to Follow-up|0|||
27740451|NCT01652690|54190369|FG000|Overall Study|Withdrawal by Subject|16|||
27740452|NCT01652690|54190370|FG001|Overall Study|Withdrawal by Subject|4|||
27740453|NCT01652690|54190369|FG000|Overall Study|Other|8|||
27740454|NCT01652690|54190370|FG001|Overall Study|Other|9|||
27740455|NCT01652690|54190369|FG000|Overall Study|Lost to Follow-up|6|||
27740456|NCT01652690|54190370|FG001|Overall Study|Lost to Follow-up|6|||
27740457|NCT01652690|54190369|FG000|Overall Study|Death|5|||
27740458|NCT01652690|54190370|FG001|Overall Study|Death|2|||
27740459|NCT02429258|54190378|FG000|Overall Study|Withdrawal by Subject|2|||
27740460|NCT02429258|54190379|FG001|Overall Study|Withdrawal by Subject|0|||
27740461|NCT02429258|54190378|FG000|Overall Study|Protocol Violation|0|||
27740462|NCT02429258|54190379|FG001|Overall Study|Protocol Violation|1|||
27740463|NCT02201524|54190389|FG000|Overall Study|Adverse Event|0|||
27740464|NCT02201524|54190390|FG001|Overall Study|Adverse Event|2|||
27740465|NCT02201524|54190391|FG002|Overall Study|Adverse Event|1|||
27740466|NCT02201524|54190392|FG003|Overall Study|Adverse Event|0|||
27740467|NCT02201524|54190389|FG000|Overall Study|Insufficient clinical response|1|||
27740468|NCT02201524|54190390|FG001|Overall Study|Insufficient clinical response|0|||
27740469|NCT02201524|54190391|FG002|Overall Study|Insufficient clinical response|0|||
27740470|NCT02201524|54190392|FG003|Overall Study|Insufficient clinical response|0|||
27740471|NCT02201524|54190389|FG000|Overall Study|Lost to Follow-up|0|||
27740472|NCT02201524|54190390|FG001|Overall Study|Lost to Follow-up|0|||
27740473|NCT02201524|54190391|FG002|Overall Study|Lost to Follow-up|2|||
27740474|NCT02201524|54190392|FG003|Overall Study|Lost to Follow-up|0|||
27740475|NCT02201524|54190389|FG000|Overall Study|No longer meets eligibility criteria|0|||
27740476|NCT02201524|54190390|FG001|Overall Study|No longer meets eligibility criteria|0|||
27740477|NCT02201524|54190391|FG002|Overall Study|No longer meets eligibility criteria|0|||
27740478|NCT02201524|54190392|FG003|Overall Study|No longer meets eligibility criteria|2|||
27740479|NCT02201524|54190389|FG000|Overall Study|Protocol Violation|0|||
27740480|NCT02201524|54190390|FG001|Overall Study|Protocol Violation|0|||
27740481|NCT02201524|54190391|FG002|Overall Study|Protocol Violation|0|||
27740482|NCT02201524|54190392|FG003|Overall Study|Protocol Violation|1|||
27740483|NCT02201524|54190389|FG000|Overall Study|Withdrawal by Subject|0|||
27740484|NCT02201524|54190390|FG001|Overall Study|Withdrawal by Subject|0|||
27740485|NCT02201524|54190391|FG002|Overall Study|Withdrawal by Subject|1|||
27740486|NCT02201524|54190392|FG003|Overall Study|Withdrawal by Subject|1|||
27740487|NCT02201524|54190389|FG000|Overall Study|Other|1|||
27740488|NCT02201524|54190390|FG001|Overall Study|Other|1|||
27740489|NCT02201524|54190391|FG002|Overall Study|Other|0|||
27740490|NCT02201524|54190392|FG003|Overall Study|Other|0|||
27740491|NCT02453048|54190407|FG000|Overall Study|Only part of initial 6 mo. study|0|||
27740492|NCT02453048|54190408|FG001|Overall Study|Only part of initial 6 mo. study|0|||
27740493|NCT02453048|54190409|FG002|Overall Study|Only part of initial 6 mo. study|0|||
27740494|NCT02453048|54190410|FG003|Overall Study|Only part of initial 6 mo. study|0|||
27740495|NCT02453048|54190411|FG004|Overall Study|Only part of initial 6 mo. study|6|||
27740496|NCT02453048|54190407|FG000|Overall Study|Lost to Follow-up|0|||
27740497|NCT02453048|54190408|FG001|Overall Study|Lost to Follow-up|1|||
27740498|NCT02453048|54190409|FG002|Overall Study|Lost to Follow-up|2|||
27740499|NCT02453048|54190410|FG003|Overall Study|Lost to Follow-up|0|||
27740500|NCT02453048|54190411|FG004|Overall Study|Lost to Follow-up|0|||
27740501|NCT02137252|54190425|FG000|Overall Study|trial terminated early|2|||
27740502|NCT02137252|54190426|FG001|Overall Study|trial terminated early|1|||
27740503|NCT02201290|54190432|FG000|Overall Study|Withdrawal by Subject|2|||
27740504|NCT02201290|54190432|FG000|Overall Study|Lack of Efficacy|2|||
27740505|NCT02201290|54190432|FG000|Overall Study|Adverse Event|1|||
27740506|NCT02200510|54190438|FG000|Overall Study|Death|1|||
27740507|NCT02200510|54190439|FG001|Overall Study|Death|1|||
27740508|NCT02200510|54190438|FG000|Overall Study|Protocol Violation|0|||
27740509|NCT02200510|54190439|FG001|Overall Study|Protocol Violation|1|||
27740510|NCT02200510|54190438|FG000|Overall Study|Lost to Follow-up|7|||
27740511|NCT02200510|54190439|FG001|Overall Study|Lost to Follow-up|1|||
27740512|NCT02200510|54190438|FG000|Overall Study|potential COI - joined study team|1|||
27740513|NCT02200510|54190439|FG001|Overall Study|potential COI - joined study team|0|||
27740514|NCT02452892|54190449|FG000|Week 1 Initial Randommization|Adverse Event|1|||
27740515|NCT02452892|54190450|FG001|Week 1 Initial Randommization|Adverse Event|0|||
27740516|NCT02452892|54190451|FG002|Week 1 Initial Randommization|Adverse Event|0|||
27740517|NCT02452892|54190452|FG003|Week 1 Initial Randommization|Adverse Event|0|||
27740518|NCT02452892|54190449|FG000|Week 1 Initial Randommization|Lost to Follow-up|0|||
27740519|NCT02452892|54190450|FG001|Week 1 Initial Randommization|Lost to Follow-up|0|||
27740520|NCT02452892|54190451|FG002|Week 1 Initial Randommization|Lost to Follow-up|1|||
27740521|NCT02452892|54190452|FG003|Week 1 Initial Randommization|Lost to Follow-up|0|||
27740522|NCT02452892|54190449|FG000|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
27740523|NCT02452892|54190450|FG001|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
27740524|NCT02452892|54190451|FG002|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
27740525|NCT02452892|54190452|FG003|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2|||
27740526|NCT02452892|54190449|FG000|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2|||
27740527|NCT02452892|54190450|FG001|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
27740528|NCT02452892|54190451|FG002|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
27740529|NCT02452892|54190452|FG003|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
27740530|NCT02452892|54190449|FG000|Follow-up|Withdrawal by Subject|0|||
27740531|NCT02452892|54190450|FG001|Follow-up|Withdrawal by Subject|0|||
27740532|NCT02452892|54190451|FG002|Follow-up|Withdrawal by Subject|0|||
27740533|NCT02452892|54190452|FG003|Follow-up|Withdrawal by Subject|1|||
27740534|NCT02452892|54190449|FG000|Follow-up|Subject left town on Day 42|1|||
27740535|NCT02452892|54190450|FG001|Follow-up|Subject left town on Day 42|0|||
27740536|NCT02452892|54190451|FG002|Follow-up|Subject left town on Day 42|0|||
27740537|NCT02452892|54190452|FG003|Follow-up|Subject left town on Day 42|0|||
27740538|NCT02135848|54190467|FG000|Overall Study|Adverse Event|2|||
27740539|NCT02135848|54190468|FG001|Overall Study|Adverse Event|0|||
27740540|NCT02135848|54190467|FG000|Overall Study|Withdrawal by Subject|1|||
27740541|NCT02135848|54190468|FG001|Overall Study|Withdrawal by Subject|1|||
27740542|NCT02738333|54190488|FG000|Overall Study|Death|1|||
27740543|NCT02738333|54190489|FG001|Overall Study|Death|0|||
27740544|NCT02738333|54190490|FG002|Overall Study|Death|0|||
27740545|NCT02738333|54190488|FG000|Overall Study|Lost to Follow-up|1|||
27740546|NCT02738333|54190489|FG001|Overall Study|Lost to Follow-up|0|||
27740547|NCT02738333|54190490|FG002|Overall Study|Lost to Follow-up|0|||
27740548|NCT02135692|54190498|FG000|Overall Study|Adverse Event|3|||
27740549|NCT02135692|54190498|FG000|Overall Study|Lack of Efficacy|2|||
27740550|NCT02135692|54190498|FG000|Overall Study|Protocol Violation|2|||
27740551|NCT02135692|54190498|FG000|Overall Study|Subject met Liver Stopping Criteria|1|||
27740552|NCT02135692|54190498|FG000|Overall Study|Product commercially available|159|||
27740553|NCT02135692|54190498|FG000|Overall Study|Study closed/terminated|153|||
27740554|NCT02135692|54190498|FG000|Overall Study|Lost to Follow-up|4|||
27740555|NCT02135692|54190498|FG000|Overall Study|Withdrawal by Subject|15|||
27740556|NCT02429414|54190504|FG000|Overall Study|Physician Decision|0|||
27740557|NCT02429414|54190505|FG001|Overall Study|Physician Decision|1|||
27740558|NCT02135614|54190513|FG000|Overall Study|Randomized but Not Treated|2|||
27740559|NCT02135614|54190514|FG001|Overall Study|Randomized but Not Treated|1|||
27740560|NCT02135614|54190513|FG000|Overall Study|Adverse Event|0|||
27740561|NCT02135614|54190514|FG001|Overall Study|Adverse Event|1|||
27740562|NCT02135614|54190513|FG000|Overall Study|Death|1|||
27740563|NCT02135614|54190514|FG001|Overall Study|Death|0|||
27740564|NCT02135614|54190513|FG000|Overall Study|Investigator's Discretion|0|||
27740565|NCT02135614|54190514|FG001|Overall Study|Investigator's Discretion|1|||
27740566|NCT02135614|54190513|FG000|Overall Study|Withdrew Consent|2|||
27740567|NCT02135614|54190514|FG001|Overall Study|Withdrew Consent|2|||
27740568|NCT02135614|54190513|FG000|Overall Study|Lost to Follow-up|3|||
27740569|NCT02135614|54190514|FG001|Overall Study|Lost to Follow-up|0|||
27740570|NCT02168842|54190522|FG000|Overall Study|Withdrawal by Subject|5|||
27740571|NCT02168842|54190523|FG001|Overall Study|Withdrawal by Subject|3|||
27740572|NCT02168842|54190522|FG000|Overall Study|Lost to Follow-up|0|||
27740573|NCT02168842|54190523|FG001|Overall Study|Lost to Follow-up|2|||
27740574|NCT02168842|54190522|FG000|Overall Study|Death|2|||
27740575|NCT02168842|54190523|FG001|Overall Study|Death|1|||
27740576|NCT02168842|54190522|FG000|Overall Study|Physician Decision|1|||
27740577|NCT02168842|54190523|FG001|Overall Study|Physician Decision|2|||
27740578|NCT02200042|54190533|FG000|Overall Study|Withdrawal by Subject|0|||
27740579|NCT02200042|54190534|FG001|Overall Study|Withdrawal by Subject|1|||
27740580|NCT02199028|54190542|FG000|Week 1|Adverse Event|1|||
27740581|NCT02199028|54190543|FG001|Week 1|Adverse Event|0|||
27740582|NCT02199028|54190542|FG000|Week 3|Adverse Event|1|||
27740583|NCT02199028|54190543|FG001|Week 3|Adverse Event|0|||
27740584|NCT03347123|54190552|FG000|Overall Study|Death|1|||
27740585|NCT03347123|54190553|FG001|Overall Study|Death|2|||
27740586|NCT03347123|54190554|FG002|Overall Study|Death|0|||
27740587|NCT03347123|54190555|FG003|Overall Study|Death|0|||
27740588|NCT03347123|54190556|FG004|Overall Study|Death|0|||
27740589|NCT03347123|54190557|FG005|Overall Study|Death|0|||
27740590|NCT03347123|54190558|FG006|Overall Study|Death|0|||
27740591|NCT03347123|54190552|FG000|Overall Study|Withdrawal by Subject|1|||
27740592|NCT03347123|54190553|FG001|Overall Study|Withdrawal by Subject|0|||
27740593|NCT03347123|54190554|FG002|Overall Study|Withdrawal by Subject|0|||
27740594|NCT03347123|54190555|FG003|Overall Study|Withdrawal by Subject|0|||
27740595|NCT03347123|54190556|FG004|Overall Study|Withdrawal by Subject|0|||
27740596|NCT03347123|54190557|FG005|Overall Study|Withdrawal by Subject|0|||
27740597|NCT03347123|54190558|FG006|Overall Study|Withdrawal by Subject|0|||
27740598|NCT03347123|54190552|FG000|Overall Study|Reason not Specified|3|||
27740599|NCT03347123|54190553|FG001|Overall Study|Reason not Specified|4|||
27740600|NCT03347123|54190554|FG002|Overall Study|Reason not Specified|0|||
27740601|NCT03347123|54190555|FG003|Overall Study|Reason not Specified|0|||
27740602|NCT03347123|54190556|FG004|Overall Study|Reason not Specified|0|||
27740603|NCT03347123|54190557|FG005|Overall Study|Reason not Specified|0|||
27740604|NCT03347123|54190558|FG006|Overall Study|Reason not Specified|0|||
27740605|NCT02198794|54190569|FG000|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79|||
27740606|NCT02198794|54190570|FG001|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
27740607|NCT02198794|54190571|FG002|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
27740608|NCT02198794|54190572|FG003|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
27740609|NCT02198794|54190569|FG000|Part A: Open-Label (158 Weeks)|Adverse Event|33|||
27740610|NCT02198794|54190570|FG001|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
27740611|NCT02198794|54190571|FG002|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
27740612|NCT02198794|54190572|FG003|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
27740613|NCT02198794|54190569|FG000|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24|||
27740614|NCT02198794|54190570|FG001|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
27740615|NCT02198794|54190571|FG002|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
27740616|NCT02198794|54190572|FG003|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
27740617|NCT02198794|54190569|FG000|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9|||
28007919|NCT00715520|54666727|FG002|Overall Study|Withdrawal by Subject|1|||
27740618|NCT02198794|54190570|FG001|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
28007920|NCT00790205|54666737|FG000|Overall Study|Lost to Follow-up|61|||
27740619|NCT02198794|54190571|FG002|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
27740620|NCT02198794|54190572|FG003|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
27740621|NCT02198794|54190569|FG000|Part A: Open-Label (158 Weeks)|Death|8|||
27740622|NCT02198794|54190570|FG001|Part A: Open-Label (158 Weeks)|Death|0|||
27740623|NCT02198794|54190571|FG002|Part A: Open-Label (158 Weeks)|Death|0|||
27740624|NCT02198794|54190572|FG003|Part A: Open-Label (158 Weeks)|Death|0|||
27740625|NCT02198794|54190569|FG000|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3|||
27740626|NCT02198794|54190570|FG001|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
27740627|NCT02198794|54190571|FG002|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
27740628|NCT02198794|54190572|FG003|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
27740629|NCT02198794|54190569|FG000|Part A: Open-Label (158 Weeks)|Other than specified|5|||
27740630|NCT02198794|54190570|FG001|Part A: Open-Label (158 Weeks)|Other than specified|0|||
27740631|NCT02198794|54190571|FG002|Part A: Open-Label (158 Weeks)|Other than specified|0|||
27740632|NCT02198794|54190572|FG003|Part A: Open-Label (158 Weeks)|Other than specified|0|||
27740633|NCT02198794|54190569|FG000|Part A: Open-Label (158 Weeks)|Study terminated|1|||
27740634|NCT02198794|54190570|FG001|Part A: Open-Label (158 Weeks)|Study terminated|0|||
27740635|NCT02198794|54190571|FG002|Part A: Open-Label (158 Weeks)|Study terminated|0|||
27740636|NCT02198794|54190572|FG003|Part A: Open-Label (158 Weeks)|Study terminated|0|||
27740637|NCT02198794|54190569|FG000|Part A: Open-Label (158 Weeks)|Protocol deviation|1|||
27740638|NCT02198794|54190570|FG001|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
27740639|NCT02198794|54190571|FG002|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
27740640|NCT02198794|54190572|FG003|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
27740641|NCT02198794|54190569|FG000|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142|||
27740642|NCT02198794|54190570|FG001|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
27740643|NCT02198794|54190571|FG002|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
27740644|NCT02198794|54190572|FG003|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
27740645|NCT02198794|54190569|FG000|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
27740646|NCT02198794|54190570|FG001|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3|||
27740647|NCT02198794|54190571|FG002|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1|||
27740648|NCT02198794|54190572|FG003|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
27740649|NCT02198794|54190569|FG000|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
27740650|NCT02198794|54190570|FG001|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
27740651|NCT02198794|54190571|FG002|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
27740652|NCT02198794|54190572|FG003|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
27740653|NCT02198794|54190569|FG000|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
27740654|NCT02198794|54190570|FG001|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
27740655|NCT02198794|54190571|FG002|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
27740656|NCT02198794|54190572|FG003|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|3|||
27740657|NCT02198794|54190569|FG000|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
27740658|NCT02198794|54190570|FG001|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
27740659|NCT02198794|54190571|FG002|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
27740660|NCT02198794|54190572|FG003|Part C: Safety Assessment (52 Weeks)|Adverse Event|2|||
27740661|NCT02198794|54190569|FG000|Part C: Safety Assessment (52 Weeks)|Death|0|||
27740662|NCT02198794|54190570|FG001|Part C: Safety Assessment (52 Weeks)|Death|0|||
27740663|NCT02198794|54190571|FG002|Part C: Safety Assessment (52 Weeks)|Death|0|||
27740664|NCT02198794|54190572|FG003|Part C: Safety Assessment (52 Weeks)|Death|2|||
27740665|NCT02133664|54190583|FG000|Overall Study|Lost to Follow-up|2|||
27740666|NCT02133664|54190584|FG001|Overall Study|Lost to Follow-up|1|||
27740667|NCT02133664|54190583|FG000|Overall Study|Adverse Event|3|||
27740668|NCT02133664|54190584|FG001|Overall Study|Adverse Event|6|||
27740669|NCT02133508|54190590|FG000|Overall Study|Decision of Investigator or Sponsor|1|||
27740670|NCT02133508|54190590|FG000|Overall Study|Death|12|||
27740671|NCT02133508|54190590|FG000|Overall Study|Lost to Follow-up|2|||
27740672|NCT02133352|54190594|FG000|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6|||
27740673|NCT02167594|54190601|FG000|Overall Study|Withdrawal by Subject|2|||
27740674|NCT02167594|54190602|FG001|Overall Study|Withdrawal by Subject|0|||
27740675|NCT02167594|54190603|FG002|Overall Study|Withdrawal by Subject|0|||
27740676|NCT02167594|54190601|FG000|Overall Study|Death|0|||
27740677|NCT02167594|54190602|FG001|Overall Study|Death|1|||
27740678|NCT02167594|54190603|FG002|Overall Study|Death|0|||
27740679|NCT02555657|54190614|FG000|Overall Study|Death|274|||
27740680|NCT02555657|54190615|FG001|Overall Study|Death|262|||
27740681|NCT02555657|54190614|FG000|Overall Study|Physician Decision|0|||
27740682|NCT02555657|54190615|FG001|Overall Study|Physician Decision|1|||
27740683|NCT02555657|54190614|FG000|Overall Study|Sponsor Decision|27|||
27740684|NCT02555657|54190615|FG001|Overall Study|Sponsor Decision|15|||
27740685|NCT02555657|54190614|FG000|Overall Study|Withdrawal by Subject|11|||
27740686|NCT02555657|54190615|FG001|Overall Study|Withdrawal by Subject|32|||
27740687|NCT02195518|54190647|FG000|Overall Study|Adverse Event|1|||
27740688|NCT02195518|54190647|FG000|Overall Study|Protocol Violation|4|||
27740689|NCT02195518|54190647|FG000|Overall Study|Pregnancy|2|||
27740690|NCT02195518|54190647|FG000|Overall Study|Withdrawal by Subject|1|||
27740691|NCT02195518|54190647|FG000|Overall Study|Lost to Follow-up|1|||
27740692|NCT02133742|54190677|FG000|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2|||
27740693|NCT02133742|54190677|FG000|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31|||
27740694|NCT02133742|54190677|FG000|Period 2:Dose Expansion Phase (1344days)|Death|13|||
27740695|NCT02133742|54190677|FG000|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5|||
27740696|NCT02133742|54190677|FG000|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1|||
27740697|NCT03032705|54190685|FG000|Overall Study|Lost to Follow-up|16|||
27740698|NCT03032705|54190686|FG001|Overall Study|Lost to Follow-up|17|||
27740699|NCT03032705|54190685|FG000|Overall Study|did not quality|6|||
27740700|NCT03032705|54190686|FG001|Overall Study|did not quality|6|||
27740701|NCT04476251|54190692|FG000|Overall Study|Not treated|1|||
27740702|NCT03795233|54190698|FG000|Overall Study|Withdrawal by Subject|2|||
27740703|NCT03795233|54190699|FG001|Overall Study|Withdrawal by Subject|1|||
27740704|NCT03795233|54190698|FG000|Overall Study|Lost to Follow-up|1|||
27740705|NCT03795233|54190699|FG001|Overall Study|Lost to Follow-up|0|||
27740706|NCT03795233|54190698|FG000|Overall Study|Death|1|||
27740707|NCT03795233|54190699|FG001|Overall Study|Death|0|||
27740708|NCT03645863|54190708|FG000|Overall Study|Withdrawal by Subject|1|||
27740709|NCT03645863|54190709|FG001|Overall Study|Withdrawal by Subject|0|||
27740710|NCT03645863|54190710|FG002|Overall Study|Withdrawal by Subject|0|||
27740711|NCT03564119|54190720|FG000|Overall Study|Adverse Event|4|||
27740712|NCT03564119|54190721|FG001|Overall Study|Adverse Event|0|||
27740713|NCT03564119|54190720|FG000|Overall Study|Lost to Follow-up|1|||
27740714|NCT03564119|54190721|FG001|Overall Study|Lost to Follow-up|4|||
27740715|NCT03564119|54190720|FG000|Overall Study|Protocol Violation|1|||
27740716|NCT03564119|54190721|FG001|Overall Study|Protocol Violation|0|||
27740717|NCT03564119|54190720|FG000|Overall Study|Withdrawal by Subject|9|||
27740718|NCT03564119|54190721|FG001|Overall Study|Withdrawal by Subject|4|||
27740719|NCT03564119|54190720|FG000|Overall Study|Other Than Specified|0|||
27740720|NCT03564119|54190721|FG001|Overall Study|Other Than Specified|1|||
27740721|NCT04531241|54190727|FG000|Period 1|Withdrawal by Subject|2|||
27740722|NCT04531241|54190728|FG001|Period 1|Withdrawal by Subject|0|||
27740723|NCT04531241|54190727|FG000|Period 1|Dispesed incorrect lens power|1|||
27740724|NCT04531241|54190728|FG001|Period 1|Dispesed incorrect lens power|0|||
27740725|NCT04531241|54190727|FG000|Period 1|Protocol Violation|1|||
27740726|NCT04531241|54190728|FG001|Period 1|Protocol Violation|0|||
27740727|NCT04531241|54190727|FG000|Period 1|No longer eligible|0|||
27740728|NCT04531241|54190728|FG001|Period 1|No longer eligible|1|||
27740729|NCT04531241|54190727|FG000|Period 1|Lens Discomfort|0|||
27740730|NCT04531241|54190728|FG001|Period 1|Lens Discomfort|1|||
27740731|NCT04531241|54190727|FG000|Period 2|Covid-19 Related|1|||
27740732|NCT04531241|54190728|FG001|Period 2|Covid-19 Related|1|||
27740733|NCT03181529|54190736|FG000|Overall Study|Withdrawal by Subject|1|||
27740734|NCT03181529|54190737|FG001|Overall Study|Withdrawal by Subject|1|||
27746118|NCT00700427|54195660|FG000|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
27740735|NCT03181529|54190736|FG000|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|1|||
27740736|NCT03181529|54190737|FG001|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|0|||
27740737|NCT03470441|54190751|FG000|Overall Study|Death|0|||
27740738|NCT03470441|54190752|FG001|Overall Study|Death|1|||
27740739|NCT03470441|54190753|FG002|Overall Study|Death|1|||
27740740|NCT03470441|54190754|FG003|Overall Study|Death|0|||
27740741|NCT03470441|54190751|FG000|Overall Study|Adverse Event|0|||
27740742|NCT03470441|54190752|FG001|Overall Study|Adverse Event|0|||
27740743|NCT03470441|54190753|FG002|Overall Study|Adverse Event|0|||
27740744|NCT03470441|54190754|FG003|Overall Study|Adverse Event|1|||
27740745|NCT03470441|54190751|FG000|Overall Study|Withdrawal by Subject|1|||
27740746|NCT03470441|54190752|FG001|Overall Study|Withdrawal by Subject|4|||
27740747|NCT03470441|54190753|FG002|Overall Study|Withdrawal by Subject|1|||
27740748|NCT03470441|54190754|FG003|Overall Study|Withdrawal by Subject|3|||
27740749|NCT03361865|54190766|FG000|Overall Study|Death|17|||
27740750|NCT03361865|54190767|FG001|Overall Study|Death|18|||
27740751|NCT03361865|54190766|FG000|Overall Study|Physician Decision|1|||
27740752|NCT03361865|54190767|FG001|Overall Study|Physician Decision|9|||
27740753|NCT03361865|54190766|FG000|Overall Study|Withdrawal by Subject|1|||
27740754|NCT03361865|54190767|FG001|Overall Study|Withdrawal by Subject|0|||
27740755|NCT02149121|54190781|FG000|Main Study Period|Lack of Efficacy|2|||
27740756|NCT02149121|54190782|FG001|Main Study Period|Lack of Efficacy|2|||
27740757|NCT02149121|54190783|FG002|Main Study Period|Lack of Efficacy|1|||
27740758|NCT02149121|54190784|FG003|Main Study Period|Lack of Efficacy|0|||
27740759|NCT02149121|54190785|FG004|Main Study Period|Lack of Efficacy|0|||
27740760|NCT02149121|54190786|FG005|Main Study Period|Lack of Efficacy|0|||
27740761|NCT02149121|54190787|FG006|Main Study Period|Lack of Efficacy|0|||
27740762|NCT02149121|54190781|FG000|Main Study Period|Withdrawal by Subject|9|||
27740763|NCT02149121|54190782|FG001|Main Study Period|Withdrawal by Subject|5|||
27740764|NCT02149121|54190783|FG002|Main Study Period|Withdrawal by Subject|1|||
27740765|NCT02149121|54190784|FG003|Main Study Period|Withdrawal by Subject|0|||
27740766|NCT02149121|54190785|FG004|Main Study Period|Withdrawal by Subject|0|||
27740767|NCT02149121|54190786|FG005|Main Study Period|Withdrawal by Subject|0|||
27740768|NCT02149121|54190787|FG006|Main Study Period|Withdrawal by Subject|0|||
27740769|NCT02149121|54190781|FG000|Main Study Period|Adverse Event|2|||
27740770|NCT02149121|54190782|FG001|Main Study Period|Adverse Event|5|||
27740771|NCT02149121|54190783|FG002|Main Study Period|Adverse Event|1|||
27740772|NCT02149121|54190784|FG003|Main Study Period|Adverse Event|0|||
27740773|NCT02149121|54190785|FG004|Main Study Period|Adverse Event|0|||
27740774|NCT02149121|54190786|FG005|Main Study Period|Adverse Event|0|||
27740775|NCT02149121|54190787|FG006|Main Study Period|Adverse Event|0|||
27740776|NCT02149121|54190781|FG000|Main Study Period|Protocol Violation|2|||
27740777|NCT02149121|54190782|FG001|Main Study Period|Protocol Violation|0|||
27740778|NCT02149121|54190783|FG002|Main Study Period|Protocol Violation|0|||
27740779|NCT02149121|54190784|FG003|Main Study Period|Protocol Violation|0|||
27740780|NCT02149121|54190785|FG004|Main Study Period|Protocol Violation|0|||
27740781|NCT02149121|54190786|FG005|Main Study Period|Protocol Violation|0|||
27740782|NCT02149121|54190787|FG006|Main Study Period|Protocol Violation|0|||
27740783|NCT02149121|54190781|FG000|Main Study Period|Lost to Follow-up|2|||
27740784|NCT02149121|54190782|FG001|Main Study Period|Lost to Follow-up|1|||
27740785|NCT02149121|54190783|FG002|Main Study Period|Lost to Follow-up|0|||
27740786|NCT02149121|54190784|FG003|Main Study Period|Lost to Follow-up|0|||
27740787|NCT02149121|54190785|FG004|Main Study Period|Lost to Follow-up|0|||
27740788|NCT02149121|54190786|FG005|Main Study Period|Lost to Follow-up|0|||
27740789|NCT02149121|54190787|FG006|Main Study Period|Lost to Follow-up|0|||
27740790|NCT02149121|54190781|FG000|Main Study Period|Death|1|||
27740791|NCT02149121|54190782|FG001|Main Study Period|Death|0|||
27740792|NCT02149121|54190783|FG002|Main Study Period|Death|0|||
27740793|NCT02149121|54190784|FG003|Main Study Period|Death|0|||
27740794|NCT02149121|54190785|FG004|Main Study Period|Death|0|||
27740795|NCT02149121|54190786|FG005|Main Study Period|Death|0|||
27740796|NCT02149121|54190787|FG006|Main Study Period|Death|0|||
27740797|NCT02149121|54190781|FG000|Main Study Period|Physician Decision|1|||
27740798|NCT02149121|54190782|FG001|Main Study Period|Physician Decision|0|||
27740799|NCT02149121|54190783|FG002|Main Study Period|Physician Decision|0|||
27740800|NCT02149121|54190784|FG003|Main Study Period|Physician Decision|0|||
27740801|NCT02149121|54190785|FG004|Main Study Period|Physician Decision|0|||
27740802|NCT02149121|54190786|FG005|Main Study Period|Physician Decision|0|||
27740803|NCT02149121|54190787|FG006|Main Study Period|Physician Decision|0|||
27740804|NCT02149121|54190781|FG000|Main Study Period|Developed any malignancy|0|||
27740805|NCT02149121|54190782|FG001|Main Study Period|Developed any malignancy|1|||
27740806|NCT02149121|54190783|FG002|Main Study Period|Developed any malignancy|1|||
27740807|NCT02149121|54190784|FG003|Main Study Period|Developed any malignancy|0|||
27740808|NCT02149121|54190785|FG004|Main Study Period|Developed any malignancy|0|||
27740809|NCT02149121|54190786|FG005|Main Study Period|Developed any malignancy|0|||
27740810|NCT02149121|54190787|FG006|Main Study Period|Developed any malignancy|0|||
27740811|NCT02149121|54190781|FG000|Main Study Period|Unmet predefined eligibility criteria|2|||
27740812|NCT02149121|54190782|FG001|Main Study Period|Unmet predefined eligibility criteria|2|||
27740813|NCT02149121|54190783|FG002|Main Study Period|Unmet predefined eligibility criteria|0|||
27740814|NCT02149121|54190784|FG003|Main Study Period|Unmet predefined eligibility criteria|0|||
27740815|NCT02149121|54190785|FG004|Main Study Period|Unmet predefined eligibility criteria|0|||
27740816|NCT02149121|54190786|FG005|Main Study Period|Unmet predefined eligibility criteria|0|||
27740817|NCT02149121|54190787|FG006|Main Study Period|Unmet predefined eligibility criteria|0|||
27740818|NCT02149121|54190781|FG000|Main Study Period|Disease progression|0|||
27740819|NCT02149121|54190782|FG001|Main Study Period|Disease progression|1|||
27740820|NCT02149121|54190783|FG002|Main Study Period|Disease progression|0|||
27740821|NCT02149121|54190784|FG003|Main Study Period|Disease progression|0|||
27740822|NCT02149121|54190785|FG004|Main Study Period|Disease progression|0|||
27740823|NCT02149121|54190786|FG005|Main Study Period|Disease progression|0|||
27740824|NCT02149121|54190787|FG006|Main Study Period|Disease progression|0|||
27740825|NCT02149121|54190781|FG000|Extension Study Period|Withdrawal by Subject|0|||
27740826|NCT02149121|54190782|FG001|Extension Study Period|Withdrawal by Subject|0|||
27740827|NCT02149121|54190783|FG002|Extension Study Period|Withdrawal by Subject|0|||
27740828|NCT02149121|54190784|FG003|Extension Study Period|Withdrawal by Subject|1|||
27740829|NCT02149121|54190785|FG004|Extension Study Period|Withdrawal by Subject|0|||
27740830|NCT02149121|54190786|FG005|Extension Study Period|Withdrawal by Subject|2|||
27740831|NCT02149121|54190787|FG006|Extension Study Period|Withdrawal by Subject|0|||
27740832|NCT01865617|54190839|FG000|Overall Study|Death|27|||
27740833|NCT01865617|54190840|FG001|Overall Study|Death|3|||
27740834|NCT01865617|54190841|FG002|Overall Study|Death|1|||
27740835|NCT01865617|54190842|FG003|Overall Study|Death|1|||
27740836|NCT01865617|54190843|FG004|Overall Study|Death|5|||
27740837|NCT01865617|54190844|FG005|Overall Study|Death|1|||
27740838|NCT01865617|54190845|FG006|Overall Study|Death|11|||
27740839|NCT01865617|54190846|FG007|Overall Study|Death|1|||
27740840|NCT01865617|54190847|FG008|Overall Study|Death|11|||
27740841|NCT01865617|54190848|FG009|Overall Study|Death|3|||
27740842|NCT01865617|54190849|FG010|Overall Study|Death|32|||
27740843|NCT01865617|54190850|FG011|Overall Study|Death|6|||
27740844|NCT01865617|54190851|FG012|Overall Study|Death|13|||
27740845|NCT01865617|54190839|FG000|Overall Study|Lost to Follow-up|2|||
27740846|NCT01865617|54190840|FG001|Overall Study|Lost to Follow-up|0|||
27740847|NCT01865617|54190841|FG002|Overall Study|Lost to Follow-up|0|||
27740848|NCT01865617|54190842|FG003|Overall Study|Lost to Follow-up|0|||
27740849|NCT01865617|54190843|FG004|Overall Study|Lost to Follow-up|0|||
27740850|NCT01865617|54190844|FG005|Overall Study|Lost to Follow-up|0|||
27740851|NCT01865617|54190845|FG006|Overall Study|Lost to Follow-up|0|||
27740852|NCT01865617|54190846|FG007|Overall Study|Lost to Follow-up|0|||
27740853|NCT01865617|54190847|FG008|Overall Study|Lost to Follow-up|0|||
27740854|NCT01865617|54190848|FG009|Overall Study|Lost to Follow-up|0|||
27740855|NCT01865617|54190849|FG010|Overall Study|Lost to Follow-up|0|||
27740856|NCT01865617|54190850|FG011|Overall Study|Lost to Follow-up|0|||
27740857|NCT01865617|54190851|FG012|Overall Study|Lost to Follow-up|0|||
27740858|NCT01865617|54190839|FG000|Overall Study|Withdrawal by Subject|1|||
27740859|NCT01865617|54190840|FG001|Overall Study|Withdrawal by Subject|0|||
27740860|NCT01865617|54190841|FG002|Overall Study|Withdrawal by Subject|0|||
27740861|NCT01865617|54190842|FG003|Overall Study|Withdrawal by Subject|0|||
27740862|NCT01865617|54190843|FG004|Overall Study|Withdrawal by Subject|0|||
27740863|NCT01865617|54190844|FG005|Overall Study|Withdrawal by Subject|0|||
27740864|NCT01865617|54190845|FG006|Overall Study|Withdrawal by Subject|0|||
27740865|NCT01865617|54190846|FG007|Overall Study|Withdrawal by Subject|0|||
27740866|NCT01865617|54190847|FG008|Overall Study|Withdrawal by Subject|0|||
27740867|NCT01865617|54190848|FG009|Overall Study|Withdrawal by Subject|0|||
27740868|NCT01865617|54190849|FG010|Overall Study|Withdrawal by Subject|0|||
27740869|NCT01865617|54190850|FG011|Overall Study|Withdrawal by Subject|0|||
27740870|NCT01865617|54190851|FG012|Overall Study|Withdrawal by Subject|0|||
27740871|NCT01865617|54190839|FG000|Overall Study|Patient proceeded to new therapy|0|||
27740872|NCT01865617|54190840|FG001|Overall Study|Patient proceeded to new therapy|0|||
27740873|NCT01865617|54190841|FG002|Overall Study|Patient proceeded to new therapy|0|||
27740874|NCT01865617|54190842|FG003|Overall Study|Patient proceeded to new therapy|0|||
27740875|NCT01865617|54190843|FG004|Overall Study|Patient proceeded to new therapy|2|||
27740876|NCT01865617|54190844|FG005|Overall Study|Patient proceeded to new therapy|0|||
27740877|NCT01865617|54190845|FG006|Overall Study|Patient proceeded to new therapy|0|||
27740878|NCT01865617|54190846|FG007|Overall Study|Patient proceeded to new therapy|0|||
27740879|NCT01865617|54190847|FG008|Overall Study|Patient proceeded to new therapy|0|||
27740880|NCT01865617|54190848|FG009|Overall Study|Patient proceeded to new therapy|0|||
27740881|NCT01865617|54190849|FG010|Overall Study|Patient proceeded to new therapy|0|||
27740882|NCT01865617|54190850|FG011|Overall Study|Patient proceeded to new therapy|0|||
27740883|NCT01865617|54190851|FG012|Overall Study|Patient proceeded to new therapy|0|||
27740884|NCT01865617|54190839|FG000|Overall Study|Other|0|||
27740885|NCT01865617|54190840|FG001|Overall Study|Other|0|||
27740886|NCT01865617|54190841|FG002|Overall Study|Other|0|||
27740887|NCT01865617|54190842|FG003|Overall Study|Other|0|||
27740888|NCT01865617|54190843|FG004|Overall Study|Other|0|||
27740889|NCT01865617|54190844|FG005|Overall Study|Other|0|||
27740890|NCT01865617|54190845|FG006|Overall Study|Other|1|||
27740891|NCT01865617|54190846|FG007|Overall Study|Other|0|||
27740892|NCT01865617|54190847|FG008|Overall Study|Other|0|||
27740893|NCT01865617|54190848|FG009|Overall Study|Other|0|||
27740894|NCT01865617|54190849|FG010|Overall Study|Other|0|||
27740895|NCT01865617|54190850|FG011|Overall Study|Other|0|||
27740896|NCT01865617|54190851|FG012|Overall Study|Other|0|||
27740897|NCT02458313|54190884|FG000|Overall Study|Withdrawal by Subject|6|||
27740898|NCT02458313|54190885|FG001|Overall Study|Withdrawal by Subject|8|||
27740899|NCT02458313|54190884|FG000|Overall Study|Excluded for motion during MRI|1|||
27740900|NCT02458313|54190885|FG001|Overall Study|Excluded for motion during MRI|2|||
27740901|NCT01328431|54190902|FG000|Baseline|Protocol Violation|0|||
27740902|NCT01328431|54190903|FG001|Baseline|Protocol Violation|2|||
27740903|NCT01328431|54190902|FG000|1 Month (1M)|Lost to Follow-up|55|||
27740904|NCT01328431|54190903|FG001|1 Month (1M)|Lost to Follow-up|58|||
27740905|NCT01328431|54190902|FG000|3 Month (3M)|Death|2|||
27740906|NCT01328431|54190903|FG001|3 Month (3M)|Death|2|||
27740907|NCT01328431|54190902|FG000|3 Month (3M)|Lost to Follow-up|75|||
27740908|NCT01328431|54190903|FG001|3 Month (3M)|Lost to Follow-up|70|||
27740909|NCT01328431|54190902|FG000|12 Month (12M)|Death|2|||
27740910|NCT01328431|54190903|FG001|12 Month (12M)|Death|6|||
27740911|NCT01328431|54190902|FG000|12 Month (12M)|Lost to Follow-up|82|||
27740912|NCT01328431|54190903|FG001|12 Month (12M)|Lost to Follow-up|91|||
27740913|NCT00893789|54190913|FG000|Overall Study|Withdrawal by Subject|3|||
27740914|NCT00893789|54190914|FG001|Overall Study|Withdrawal by Subject|1|||
27740915|NCT00893789|54190915|FG002|Overall Study|Withdrawal by Subject|3|||
27740916|NCT00893789|54190916|FG003|Overall Study|Withdrawal by Subject|1|||
27740917|NCT00893789|54190913|FG000|Overall Study|Noncompliance With Study Drug|1|||
27740918|NCT00893789|54190914|FG001|Overall Study|Noncompliance With Study Drug|0|||
27740919|NCT00893789|54190915|FG002|Overall Study|Noncompliance With Study Drug|1|||
27740920|NCT00893789|54190916|FG003|Overall Study|Noncompliance With Study Drug|2|||
27740921|NCT00893789|54190913|FG000|Overall Study|Noncompliance With Study Procedures|1|||
27740922|NCT00893789|54190914|FG001|Overall Study|Noncompliance With Study Procedures|0|||
27740923|NCT00893789|54190915|FG002|Overall Study|Noncompliance With Study Procedures|0|||
27740924|NCT00893789|54190916|FG003|Overall Study|Noncompliance With Study Procedures|0|||
27740925|NCT00893789|54190913|FG000|Overall Study|Taking Excluded Concomitant Medication|1|||
27740926|NCT00893789|54190914|FG001|Overall Study|Taking Excluded Concomitant Medication|0|||
27740927|NCT00893789|54190915|FG002|Overall Study|Taking Excluded Concomitant Medication|1|||
27740928|NCT00893789|54190916|FG003|Overall Study|Taking Excluded Concomitant Medication|0|||
27740929|NCT00893789|54190913|FG000|Overall Study|Adverse Event|0|||
27740930|NCT00893789|54190914|FG001|Overall Study|Adverse Event|2|||
27740931|NCT00893789|54190915|FG002|Overall Study|Adverse Event|1|||
27740932|NCT00893789|54190916|FG003|Overall Study|Adverse Event|5|||
27740933|NCT00893789|54190913|FG000|Overall Study|Protocol Violation|0|||
27740934|NCT00893789|54190914|FG001|Overall Study|Protocol Violation|1|||
27740935|NCT00893789|54190915|FG002|Overall Study|Protocol Violation|1|||
27740936|NCT00893789|54190916|FG003|Overall Study|Protocol Violation|4|||
27740937|NCT00893789|54190913|FG000|Overall Study|Lost to Follow-up|0|||
27740938|NCT00893789|54190914|FG001|Overall Study|Lost to Follow-up|0|||
27740939|NCT00893789|54190915|FG002|Overall Study|Lost to Follow-up|0|||
27740940|NCT00893789|54190916|FG003|Overall Study|Lost to Follow-up|1|||
27740941|NCT02164864|54190929|FG000|Overall Study|Trial disease worsening|7|||
27740942|NCT02164864|54190930|FG001|Overall Study|Trial disease worsening|5|||
27740943|NCT02164864|54190931|FG002|Overall Study|Trial disease worsening|1|||
27740944|NCT02164864|54190929|FG000|Overall Study|Other pre-existing disease worsening|6|||
27740945|NCT02164864|54190930|FG001|Overall Study|Other pre-existing disease worsening|4|||
27740946|NCT02164864|54190931|FG002|Overall Study|Other pre-existing disease worsening|9|||
27740947|NCT02164864|54190929|FG000|Overall Study|Other Adverse Event (AE)|52|||
27740948|NCT02164864|54190930|FG001|Overall Study|Other Adverse Event (AE)|32|||
27740949|NCT02164864|54190931|FG002|Overall Study|Other Adverse Event (AE)|49|||
27740950|NCT02164864|54190929|FG000|Overall Study|Protocol Violation|2|||
27740951|NCT02164864|54190930|FG001|Overall Study|Protocol Violation|4|||
27740952|NCT02164864|54190931|FG002|Overall Study|Protocol Violation|1|||
27740953|NCT02164864|54190929|FG000|Overall Study|Lost to Follow-up|4|||
27740954|NCT02164864|54190930|FG001|Overall Study|Lost to Follow-up|3|||
27740955|NCT02164864|54190931|FG002|Overall Study|Lost to Follow-up|2|||
27740956|NCT02164864|54190929|FG000|Overall Study|Consent withdrawn, not due to AE|21|||
27740957|NCT02164864|54190930|FG001|Overall Study|Consent withdrawn, not due to AE|8|||
27740958|NCT02164864|54190931|FG002|Overall Study|Consent withdrawn, not due to AE|56|||
27740959|NCT02164864|54190929|FG000|Overall Study|Other than stated|3|||
27740960|NCT02164864|54190930|FG001|Overall Study|Other than stated|4|||
27740961|NCT02164864|54190931|FG002|Overall Study|Other than stated|14|||
27740962|NCT02419807|54190942|FG000|Overall Study|Withdrawal by Subject|4|||
27740963|NCT02419807|54190942|FG000|Overall Study|Physician Decision|1|||
27740964|NCT02419807|54190942|FG000|Overall Study|Protocol Violation|5|||
27740965|NCT03857867|54190946|FG000|Overall Study|Physician Decision|1|||
27740966|NCT01628926|54190954|FG000|Overall Study|Adverse Event|13|||
27740967|NCT01628926|54190955|FG001|Overall Study|Adverse Event|11|||
27740968|NCT01628926|54190956|FG002|Overall Study|Adverse Event|9|||
27740969|NCT01628926|54190954|FG000|Overall Study|Lack of Efficacy|2|||
27740970|NCT01628926|54190955|FG001|Overall Study|Lack of Efficacy|1|||
27740971|NCT01628926|54190956|FG002|Overall Study|Lack of Efficacy|5|||
27740972|NCT01628926|54190954|FG000|Overall Study|Withdrawal by Subject|6|||
27740973|NCT01628926|54190955|FG001|Overall Study|Withdrawal by Subject|4|||
27740974|NCT01628926|54190956|FG002|Overall Study|Withdrawal by Subject|2|||
27740975|NCT01628926|54190954|FG000|Overall Study|Protocol Violation|0|||
27740976|NCT01628926|54190955|FG001|Overall Study|Protocol Violation|1|||
27740977|NCT01628926|54190956|FG002|Overall Study|Protocol Violation|0|||
27740978|NCT01628926|54190954|FG000|Overall Study|Discontinuation criteria|3|||
27740979|NCT01628926|54190955|FG001|Overall Study|Discontinuation criteria|4|||
27740980|NCT01628926|54190956|FG002|Overall Study|Discontinuation criteria|0|||
27740981|NCT01628926|54190954|FG000|Overall Study|Physician Decision|2|||
27740982|NCT01628926|54190955|FG001|Overall Study|Physician Decision|2|||
27740983|NCT01628926|54190956|FG002|Overall Study|Physician Decision|1|||
27740984|NCT01628848|54190967|FG000|Overall Study|Adverse Event|9|||
27740985|NCT01628848|54190968|FG001|Overall Study|Adverse Event|7|||
27740986|NCT01628848|54190967|FG000|Overall Study|Lack of Efficacy|0|||
27740987|NCT01628848|54190968|FG001|Overall Study|Lack of Efficacy|4|||
27740988|NCT01628848|54190967|FG000|Overall Study|Withdrawal by Subject|0|||
27740989|NCT01628848|54190968|FG001|Overall Study|Withdrawal by Subject|2|||
27740990|NCT01628848|54190967|FG000|Overall Study|Physician Decision|3|||
27740991|NCT01628848|54190968|FG001|Overall Study|Physician Decision|1|||
27740992|NCT02164318|54190978|FG000|Overall Study|Withdrawal by Subject|0|||
27740993|NCT02164318|54190979|FG001|Overall Study|Withdrawal by Subject|1|||
27740994|NCT02164318|54190980|FG002|Overall Study|Withdrawal by Subject|0|||
27740995|NCT02164318|54190981|FG003|Overall Study|Withdrawal by Subject|1|||
27740996|NCT03436199|54190994|FG000|Overall Study|Adverse Event|15|||
27740997|NCT03436199|54190995|FG001|Overall Study|Adverse Event|40|||
27740998|NCT03436199|54190996|FG002|Overall Study|Adverse Event|7|||
27740999|NCT03436199|54190994|FG000|Overall Study|Withdrawal by Subject|4|||
27918388|NCT01103323|54575641|FG000|Without/Before Drug Switch|Adverse Event|50|||
27918389|NCT01103323|54575642|FG001|Without/Before Drug Switch|Adverse Event|7|||
27918390|NCT01103323|54575641|FG000|Without/Before Drug Switch|Withdrawal by Subject|17|||
27918391|NCT01103323|54575642|FG001|Without/Before Drug Switch|Withdrawal by Subject|5|||
27918392|NCT01103323|54575641|FG000|Without/Before Drug Switch|Protocol Violation|2|||
27918393|NCT01103323|54575642|FG001|Without/Before Drug Switch|Protocol Violation|0|||
27918394|NCT01103323|54575641|FG000|Without/Before Drug Switch|Physician Decision|2|||
27918395|NCT01103323|54575642|FG001|Without/Before Drug Switch|Physician Decision|0|||
27918396|NCT01103323|54575641|FG000|Without/Before Drug Switch|did not receive study treatment|5|||
27918397|NCT01103323|54575642|FG001|Without/Before Drug Switch|did not receive study treatment|2|||
27918398|NCT01103323|54575641|FG000|Without/Before Drug Switch|Switch to Regorafenib|0|||
27918399|NCT01103323|54575642|FG001|Without/Before Drug Switch|Switch to Regorafenib|4|||
27918400|NCT01103323|54575641|FG000|Switched From Placebo to Regorafenib|Adverse Event|0|||
27918401|NCT01103323|54575642|FG001|Switched From Placebo to Regorafenib|Adverse Event|1|||
27918402|NCT01103245|54575653|FG000|Overall Study|Withdrawal by Subject|1|||
27918403|NCT01103245|54575654|FG001|Overall Study|Withdrawal by Subject|0|||
27918404|NCT01103245|54575655|FG002|Overall Study|Withdrawal by Subject|3|||
27918405|NCT01103245|54575656|FG003|Overall Study|Withdrawal by Subject|0|||
27918406|NCT01103245|54575653|FG000|Overall Study|Inadequate IV access|1|||
27918407|NCT01103245|54575654|FG001|Overall Study|Inadequate IV access|0|||
27918408|NCT01103245|54575655|FG002|Overall Study|Inadequate IV access|0|||
27918409|NCT01103245|54575656|FG003|Overall Study|Inadequate IV access|0|||
27918410|NCT01103245|54575653|FG000|Overall Study|Adverse Event|0|||
27741000|NCT03436199|54190995|FG001|Overall Study|Withdrawal by Subject|10|||
27741001|NCT03436199|54190996|FG002|Overall Study|Withdrawal by Subject|3|||
27918411|NCT01103245|54575654|FG001|Overall Study|Adverse Event|2|||
27918412|NCT01103245|54575655|FG002|Overall Study|Adverse Event|1|||
27741002|NCT03436199|54190994|FG000|Overall Study|Lost to Follow-up|1|||
27741003|NCT03436199|54190995|FG001|Overall Study|Lost to Follow-up|0|||
27741004|NCT03436199|54190996|FG002|Overall Study|Lost to Follow-up|2|||
27741005|NCT03436199|54190994|FG000|Overall Study|Protocol Violation|1|||
27741006|NCT03436199|54190995|FG001|Overall Study|Protocol Violation|1|||
27741007|NCT03436199|54190996|FG002|Overall Study|Protocol Violation|0|||
27741008|NCT03436199|54190994|FG000|Overall Study|Physician Decision|0|||
27741009|NCT03436199|54190995|FG001|Overall Study|Physician Decision|1|||
27741010|NCT03436199|54190996|FG002|Overall Study|Physician Decision|0|||
27741011|NCT03436199|54190994|FG000|Overall Study|Could not return to clinic|1|||
27741012|NCT03436199|54190995|FG001|Overall Study|Could not return to clinic|0|||
27741013|NCT03436199|54190996|FG002|Overall Study|Could not return to clinic|0|||
27741014|NCT03436199|54190994|FG000|Overall Study|Withdrawn per physician|0|||
27741015|NCT03436199|54190995|FG001|Overall Study|Withdrawn per physician|1|||
27741016|NCT03436199|54190996|FG002|Overall Study|Withdrawn per physician|0|||
27741017|NCT02131636|54191006|FG000|Overall Study|Personal Reasons|4|||
27741018|NCT02131636|54191007|FG001|Overall Study|Personal Reasons|4|||
27741019|NCT02131636|54191006|FG000|Overall Study|Lost to Follow-up|4|||
27741020|NCT02131636|54191007|FG001|Overall Study|Lost to Follow-up|0|||
27741021|NCT02131636|54191006|FG000|Overall Study|Adverse Event|4|||
27741022|NCT02131636|54191007|FG001|Overall Study|Adverse Event|1|||
27741023|NCT02131324|54191015|FG000|Overall Study|Withdrawal by Subject|1|||
27741024|NCT02131324|54191016|FG001|Overall Study|Withdrawal by Subject|2|||
27741025|NCT02131324|54191015|FG000|Overall Study|Lost to Follow-up|1|||
27741026|NCT02131324|54191016|FG001|Overall Study|Lost to Follow-up|1|||
27741027|NCT02734693|54191025|FG000|Overall Study|Adverse Event|1|||
27741028|NCT02734693|54191026|FG001|Overall Study|Adverse Event|3|||
27741029|NCT02734693|54191027|FG002|Overall Study|Adverse Event|3|||
27741030|NCT02734693|54191025|FG000|Overall Study|Lack of Efficacy|1|||
27741031|NCT02734693|54191026|FG001|Overall Study|Lack of Efficacy|0|||
27741032|NCT02734693|54191027|FG002|Overall Study|Lack of Efficacy|0|||
27741033|NCT02734693|54191025|FG000|Overall Study|Lost to Follow-up|2|||
27741034|NCT02734693|54191026|FG001|Overall Study|Lost to Follow-up|0|||
27741035|NCT02734693|54191027|FG002|Overall Study|Lost to Follow-up|0|||
27741036|NCT02734693|54191025|FG000|Overall Study|Protocol Violation|1|||
27741037|NCT02734693|54191026|FG001|Overall Study|Protocol Violation|0|||
27741038|NCT02734693|54191027|FG002|Overall Study|Protocol Violation|0|||
27741039|NCT02734693|54191025|FG000|Overall Study|Withdrawal by Subject|1|||
27741040|NCT02734693|54191026|FG001|Overall Study|Withdrawal by Subject|0|||
27741041|NCT02734693|54191027|FG002|Overall Study|Withdrawal by Subject|0|||
27741042|NCT02193880|54191035|FG000|Overall Study|patients did not collect enough HPC|3|||
27741043|NCT01378325|54191041|FG000|Overall Study|Protocol Violation|0|||
27741044|NCT01378325|54191042|FG001|Overall Study|Protocol Violation|1|||
27741045|NCT01093573|54191051|FG000|Overall Study|Physician Decision|0|||
27741046|NCT01093573|54191052|FG001|Overall Study|Physician Decision|0|||
27741047|NCT01093573|54191053|FG002|Overall Study|Physician Decision|1|||
27741048|NCT01093573|54191051|FG000|Overall Study|Insurance Denied|0|||
27741049|NCT01093573|54191052|FG001|Overall Study|Insurance Denied|0|||
27741050|NCT01093573|54191053|FG002|Overall Study|Insurance Denied|1|||
27741051|NCT02733367|54191081|FG000|Overall Study|Withdrawal by Subject|6|||
27741052|NCT03688555|54191088|FG000|Treatment Period|Adverse Event|0|||
27741053|NCT03688555|54191089|FG001|Treatment Period|Adverse Event|0|||
27741054|NCT03688555|54191090|FG002|Treatment Period|Adverse Event|1|||
27741055|NCT03443869|54191099|FG000|Overall Study|Death|3|||
27741056|NCT03443869|54191100|FG001|Overall Study|Death|3|||
27741057|NCT03443869|54191099|FG000|Overall Study|Withdrawal by Subject|34|||
27741058|NCT03443869|54191100|FG001|Overall Study|Withdrawal by Subject|22|||
27741059|NCT03443869|54191099|FG000|Overall Study|Lost to Follow-up|1|||
27918413|NCT01103245|54575656|FG003|Overall Study|Adverse Event|0|||
27918414|NCT01103245|54575653|FG000|Overall Study|Physician Decision|1|||
27918415|NCT01103245|54575654|FG001|Overall Study|Physician Decision|0|||
27741060|NCT03443869|54191100|FG001|Overall Study|Lost to Follow-up|2|||
27741061|NCT03443869|54191099|FG000|Overall Study|Physician Decision|3|||
27741062|NCT03443869|54191100|FG001|Overall Study|Physician Decision|3|||
27741063|NCT03443869|54191099|FG000|Overall Study|Other|4|||
27741064|NCT03443869|54191100|FG001|Overall Study|Other|4|||
27741065|NCT01328951|54191141|FG000|Overall Study|Disease Progression|17|||
27918416|NCT01103245|54575655|FG002|Overall Study|Physician Decision|0|||
27918417|NCT01103245|54575656|FG003|Overall Study|Physician Decision|0|||
27741066|NCT01328951|54191142|FG001|Overall Study|Disease Progression|14|||
27741067|NCT01328951|54191141|FG000|Overall Study|Adverse Event|2|||
27741068|NCT01328951|54191142|FG001|Overall Study|Adverse Event|0|||
27741069|NCT01328951|54191141|FG000|Overall Study|Death|243|||
27741070|NCT01328951|54191142|FG001|Overall Study|Death|258|||
27741071|NCT01328951|54191141|FG000|Overall Study|Lost to Follow-up|6|||
27741072|NCT01328951|54191142|FG001|Overall Study|Lost to Follow-up|7|||
27741073|NCT01328951|54191141|FG000|Overall Study|Withdrawal by Subject|6|||
27918418|NCT01099267|54575666|FG000|MDS-003 Study|Adverse Event|37|||
27741074|NCT01328951|54191142|FG001|Overall Study|Withdrawal by Subject|6|||
27741075|NCT01328951|54191141|FG000|Overall Study|Study Closed by the Sponsor|36|||
27741076|NCT01328951|54191142|FG001|Overall Study|Study Closed by the Sponsor|31|||
27741077|NCT01328951|54191141|FG000|Overall Study|Other|11|||
27741078|NCT01328951|54191142|FG001|Overall Study|Other|6|||
27741079|NCT02611817|54191155|FG000|Open-label Induction Phase|Reason not Specified|9|||
27741080|NCT02611817|54191156|FG001|Open-label Induction Phase|Reason not Specified|0|||
27741081|NCT02611817|54191157|FG002|Open-label Induction Phase|Reason not Specified|0|||
27741082|NCT02611817|54191155|FG000|Open-label Induction Phase|Lack of Efficacy|8|||
27741083|NCT02611817|54191156|FG001|Open-label Induction Phase|Lack of Efficacy|0|||
27741084|NCT02611817|54191157|FG002|Open-label Induction Phase|Lack of Efficacy|0|||
27741085|NCT02611817|54191155|FG000|Open-label Induction Phase|Pregnancy|1|||
27741086|NCT02611817|54191156|FG001|Open-label Induction Phase|Pregnancy|0|||
27741087|NCT02611817|54191157|FG002|Open-label Induction Phase|Pregnancy|0|||
27741088|NCT02611817|54191155|FG000|Open-label Induction Phase|Withdrawal by Subject|9|||
27741089|NCT02611817|54191156|FG001|Open-label Induction Phase|Withdrawal by Subject|0|||
27741090|NCT02611817|54191157|FG002|Open-label Induction Phase|Withdrawal by Subject|0|||
27741091|NCT02611817|54191155|FG000|Open-label Induction Phase|Lost to Follow-up|2|||
27741092|NCT02611817|54191156|FG001|Open-label Induction Phase|Lost to Follow-up|0|||
27741093|NCT02611817|54191157|FG002|Open-label Induction Phase|Lost to Follow-up|0|||
27741094|NCT02611817|54191155|FG000|Open-label Induction Phase|Protocol Violation|5|||
27741095|NCT02611817|54191156|FG001|Open-label Induction Phase|Protocol Violation|0|||
27741096|NCT02611817|54191157|FG002|Open-label Induction Phase|Protocol Violation|0|||
27741097|NCT02611817|54191155|FG000|Open-label Induction Phase|Adverse Event|16|||
27741098|NCT02611817|54191156|FG001|Open-label Induction Phase|Adverse Event|0|||
27741099|NCT02611817|54191157|FG002|Open-label Induction Phase|Adverse Event|0|||
27741100|NCT02611817|54191155|FG000|Double-blind Maintenance Phase|Adverse Event|0|||
27741101|NCT02611817|54191156|FG001|Double-blind Maintenance Phase|Adverse Event|12|||
27741102|NCT02611817|54191157|FG002|Double-blind Maintenance Phase|Adverse Event|11|||
27741103|NCT02611817|54191155|FG000|Double-blind Maintenance Phase|Randomized but not Treated|0|||
27741104|NCT02611817|54191156|FG001|Double-blind Maintenance Phase|Randomized but not Treated|1|||
27741105|NCT02611817|54191157|FG002|Double-blind Maintenance Phase|Randomized but not Treated|0|||
27741106|NCT02611817|54191155|FG000|Double-blind Maintenance Phase|Reason not Specified|0|||
27741107|NCT02611817|54191156|FG001|Double-blind Maintenance Phase|Reason not Specified|1|||
27741108|NCT02611817|54191157|FG002|Double-blind Maintenance Phase|Reason not Specified|2|||
27741109|NCT02611817|54191155|FG000|Double-blind Maintenance Phase|Lack of Efficacy|0|||
27741110|NCT02611817|54191156|FG001|Double-blind Maintenance Phase|Lack of Efficacy|43|||
27741111|NCT02611817|54191157|FG002|Double-blind Maintenance Phase|Lack of Efficacy|78|||
27741112|NCT02611817|54191155|FG000|Double-blind Maintenance Phase|Pregnancy|0|||
27741113|NCT02611817|54191156|FG001|Double-blind Maintenance Phase|Pregnancy|0|||
27741114|NCT02611817|54191157|FG002|Double-blind Maintenance Phase|Pregnancy|1|||
27741115|NCT02611817|54191155|FG000|Double-blind Maintenance Phase|Withdrawal by Subject|0|||
27741116|NCT02611817|54191156|FG001|Double-blind Maintenance Phase|Withdrawal by Subject|5|||
27741117|NCT02611817|54191157|FG002|Double-blind Maintenance Phase|Withdrawal by Subject|14|||
27741118|NCT02611817|54191155|FG000|Double-blind Maintenance Phase|Lost to Follow-up|0|||
27741119|NCT02611817|54191156|FG001|Double-blind Maintenance Phase|Lost to Follow-up|0|||
27741120|NCT02611817|54191157|FG002|Double-blind Maintenance Phase|Lost to Follow-up|1|||
27741121|NCT02735915|54191164|FG000|Overall Study|Not vaccinated but subject ID assigned|8|||
27741122|NCT02735915|54191164|FG000|Overall Study|Withdrawal following SAE|2|||
27741123|NCT02735915|54191164|FG000|Overall Study|Withdrawal by Subject|1|||
27741124|NCT02557139|54191173|FG000|Overall Study|Significant liver elevation|1|||
27741125|NCT02557139|54191174|FG001|Overall Study|Significant liver elevation|0|||
27741126|NCT02557139|54191175|FG002|Overall Study|Significant liver elevation|1|||
27741127|NCT02557139|54191173|FG000|Overall Study|Withdrawal by Subject|1|||
27741128|NCT02557139|54191174|FG001|Overall Study|Withdrawal by Subject|0|||
27741129|NCT02557139|54191175|FG002|Overall Study|Withdrawal by Subject|0|||
27741130|NCT02557139|54191173|FG000|Overall Study|Illness of prohibited medication|0|||
27741131|NCT02557139|54191174|FG001|Overall Study|Illness of prohibited medication|0|||
27741132|NCT02557139|54191175|FG002|Overall Study|Illness of prohibited medication|1|||
27741133|NCT01328717|54191192|FG000|Overall Study|Adverse Event|1|||
27741134|NCT01677741|54191204|FG000|Overall Study|Death|0|||
27741135|NCT01677741|54191205|FG001|Overall Study|Death|0|||
27741136|NCT01677741|54191206|FG002|Overall Study|Death|0|||
27741137|NCT01677741|54191207|FG003|Overall Study|Death|1|||
27741138|NCT01677741|54191208|FG004|Overall Study|Death|0|||
27918419|NCT01099267|54575666|FG000|MDS-003 Study|Lack of Efficacy|52|||
27741139|NCT01677741|54191209|FG005|Overall Study|Death|1|||
27741140|NCT01677741|54191210|FG006|Overall Study|Death|0|||
27741141|NCT01677741|54191211|FG007|Overall Study|Death|0|||
27741142|NCT01677741|54191204|FG000|Overall Study|Withdrawal by Subject|2|||
27741143|NCT01677741|54191205|FG001|Overall Study|Withdrawal by Subject|7|||
27918420|NCT01099267|54575666|FG000|MDS-003 Study|Withdrawal by Subject|8|||
27741144|NCT01677741|54191206|FG002|Overall Study|Withdrawal by Subject|5|||
27741145|NCT01677741|54191207|FG003|Overall Study|Withdrawal by Subject|4|||
27741146|NCT01677741|54191208|FG004|Overall Study|Withdrawal by Subject|11|||
27741147|NCT01677741|54191209|FG005|Overall Study|Withdrawal by Subject|20|||
27741148|NCT01677741|54191210|FG006|Overall Study|Withdrawal by Subject|4|||
27741149|NCT01677741|54191211|FG007|Overall Study|Withdrawal by Subject|2|||
27741150|NCT01677741|54191204|FG000|Overall Study|Enrolled in a rollover study|0|||
27741151|NCT01677741|54191205|FG001|Overall Study|Enrolled in a rollover study|3|||
27741152|NCT01677741|54191206|FG002|Overall Study|Enrolled in a rollover study|2|||
27741153|NCT01677741|54191207|FG003|Overall Study|Enrolled in a rollover study|1|||
27741154|NCT01677741|54191208|FG004|Overall Study|Enrolled in a rollover study|6|||
27741155|NCT01677741|54191209|FG005|Overall Study|Enrolled in a rollover study|6|||
27741156|NCT01677741|54191210|FG006|Overall Study|Enrolled in a rollover study|7|||
27741157|NCT01677741|54191211|FG007|Overall Study|Enrolled in a rollover study|0|||
27741158|NCT01677741|54191204|FG000|Overall Study|Progressive disease|1|||
27741159|NCT01677741|54191205|FG001|Overall Study|Progressive disease|0|||
27741160|NCT01677741|54191206|FG002|Overall Study|Progressive disease|1|||
27741161|NCT01677741|54191207|FG003|Overall Study|Progressive disease|0|||
27741162|NCT01677741|54191208|FG004|Overall Study|Progressive disease|0|||
27741163|NCT01677741|54191209|FG005|Overall Study|Progressive disease|1|||
27741164|NCT01677741|54191210|FG006|Overall Study|Progressive disease|0|||
27741165|NCT01677741|54191211|FG007|Overall Study|Progressive disease|0|||
27741166|NCT01677507|54191263|FG000|Initial Assignment|Adverse Event|0|||
27741167|NCT01677507|54191264|FG001|Initial Assignment|Adverse Event|1|||
27741168|NCT01677507|54191263|FG000|Initial Assignment|Protocol Violation|0|||
27741169|NCT01677507|54191264|FG001|Initial Assignment|Protocol Violation|1|||
27741170|NCT01677507|54191263|FG000|Second Assigment|Withdrawal by Subject|2|||
27741171|NCT01677507|54191264|FG001|Second Assigment|Withdrawal by Subject|2|||
27741172|NCT01677507|54191263|FG000|Second Assigment|Adverse Event|1|||
27741173|NCT01677507|54191264|FG001|Second Assigment|Adverse Event|3|||
27741174|NCT02732951|54191274|FG000|Overall Study|Other than listed|1|||
27741175|NCT02732951|54191275|FG001|Overall Study|Other than listed|0|||
27741176|NCT02732951|54191274|FG000|Overall Study|Lost to Follow-up|0|||
27741177|NCT02732951|54191275|FG001|Overall Study|Lost to Follow-up|1|||
27741178|NCT02732951|54191274|FG000|Overall Study|Adverse Event|4|||
27741179|NCT02732951|54191275|FG001|Overall Study|Adverse Event|4|||
27741180|NCT02732951|54191274|FG000|Overall Study|Protocol Violation|0|||
27741181|NCT02732951|54191275|FG001|Overall Study|Protocol Violation|1|||
27741182|NCT01377233|54191286|FG000|Open-label|Adverse Event|1|||
27741183|NCT01377233|54191287|FG001|Open-label|Adverse Event|0|||
27741184|NCT01377233|54191288|FG002|Open-label|Adverse Event|0|||
27741185|NCT01377233|54191289|FG003|Open-label|Adverse Event|0|||
27741186|NCT01377233|54191290|FG004|Open-label|Adverse Event|0|||
27741187|NCT01377233|54191286|FG000|Open-label|Withdrawal by Subject|3|||
27741188|NCT01377233|54191287|FG001|Open-label|Withdrawal by Subject|0|||
27741189|NCT01377233|54191288|FG002|Open-label|Withdrawal by Subject|0|||
27741190|NCT01377233|54191289|FG003|Open-label|Withdrawal by Subject|0|||
27741191|NCT01377233|54191290|FG004|Open-label|Withdrawal by Subject|0|||
27741192|NCT01377233|54191286|FG000|Double-blind|Adverse Event|0|||
27741193|NCT01377233|54191287|FG001|Double-blind|Adverse Event|1|||
27741194|NCT01377233|54191288|FG002|Double-blind|Adverse Event|2|||
27741195|NCT01377233|54191289|FG003|Double-blind|Adverse Event|2|||
27741196|NCT01377233|54191290|FG004|Double-blind|Adverse Event|0|||
27741197|NCT01377233|54191286|FG000|Double-blind|Protocol Violation|0|||
27741198|NCT01377233|54191287|FG001|Double-blind|Protocol Violation|0|||
27741199|NCT01377233|54191288|FG002|Double-blind|Protocol Violation|0|||
27741200|NCT01377233|54191289|FG003|Double-blind|Protocol Violation|0|||
27741201|NCT01377233|54191290|FG004|Double-blind|Protocol Violation|1|||
27741202|NCT01377233|54191286|FG000|Double-blind|Withdrawal by Subject|0|||
27741203|NCT01377233|54191287|FG001|Double-blind|Withdrawal by Subject|0|||
27741204|NCT01377233|54191288|FG002|Double-blind|Withdrawal by Subject|0|||
27741205|NCT01377233|54191289|FG003|Double-blind|Withdrawal by Subject|1|||
27741206|NCT01377233|54191290|FG004|Double-blind|Withdrawal by Subject|0|||
27741207|NCT01377233|54191286|FG000|Double-blind|Administrative or other|0|||
27741208|NCT01377233|54191287|FG001|Double-blind|Administrative or other|0|||
27918421|NCT01099267|54575666|FG000|MDS-003 Study|Lost to Follow-up|1|||
27741209|NCT01377233|54191288|FG002|Double-blind|Administrative or other|0|||
27741210|NCT01377233|54191289|FG003|Double-blind|Administrative or other|1|||
27741211|NCT01377233|54191290|FG004|Double-blind|Administrative or other|1|||
27741212|NCT03248531|54191309|FG000|Overall Study|Adverse Event|0|||
27741213|NCT03248531|54191310|FG001|Overall Study|Adverse Event|0|||
27741214|NCT03248531|54191311|FG002|Overall Study|Adverse Event|1|||
27741215|NCT03248531|54191309|FG000|Overall Study|Lost to Follow-up|1|||
27918422|NCT01099267|54575666|FG000|MDS-003 Study|Death|11|||
27741216|NCT03248531|54191310|FG001|Overall Study|Lost to Follow-up|0|||
27741217|NCT03248531|54191311|FG002|Overall Study|Lost to Follow-up|5|||
27741218|NCT03248531|54191309|FG000|Overall Study|Withdrawal by Subject|3|||
27741219|NCT03248531|54191310|FG001|Overall Study|Withdrawal by Subject|3|||
27741220|NCT03248531|54191311|FG002|Overall Study|Withdrawal by Subject|2|||
27741221|NCT03248531|54191309|FG000|Overall Study|Sponsor Request|0|||
27741222|NCT03248531|54191310|FG001|Overall Study|Sponsor Request|2|||
27741223|NCT03248531|54191311|FG002|Overall Study|Sponsor Request|0|||
27741224|NCT02656329|54191328|FG000|Overall Study|Lost to Follow-up|2|||
27741225|NCT02656329|54191329|FG001|Overall Study|Lost to Follow-up|3|||
27741226|NCT02656329|54191328|FG000|Overall Study|Withdrawal by Subject|7|||
27741227|NCT02656329|54191329|FG001|Overall Study|Withdrawal by Subject|6|||
27741228|NCT02656329|54191328|FG000|Overall Study|Study termination by Sponsor|150|||
27741229|NCT02656329|54191329|FG001|Overall Study|Study termination by Sponsor|142|||
27741230|NCT02656329|54191328|FG000|Overall Study|Other than specified above|5|||
27741231|NCT02656329|54191329|FG001|Overall Study|Other than specified above|6|||
27741232|NCT02712905|54191354|FG000|Monotherapy|Death|2|||
27741233|NCT02712905|54191355|FG001|Monotherapy|Death|5|||
27741234|NCT02712905|54191356|FG002|Monotherapy|Death|0|||
27741235|NCT02712905|54191357|FG003|Monotherapy|Death|3|||
27741236|NCT02712905|54191358|FG004|Monotherapy|Death|15|||
27741237|NCT02712905|54191359|FG005|Monotherapy|Death|1|||
27741238|NCT02712905|54191360|FG006|Monotherapy|Death|3|||
27741239|NCT02712905|54191361|FG007|Monotherapy|Death|3|||
27741240|NCT02712905|54191362|FG008|Monotherapy|Death|0|||
27741241|NCT02712905|54191363|FG009|Monotherapy|Death|27|||
27741242|NCT02712905|54191364|FG010|Monotherapy|Death|2|||
27741243|NCT02712905|54191365|FG011|Monotherapy|Death|5|||
27741244|NCT02712905|54191366|FG012|Monotherapy|Death|0|||
27741245|NCT02712905|54191367|FG013|Monotherapy|Death|0|||
27741246|NCT02712905|54191368|FG014|Monotherapy|Death|0|||
27741247|NCT02712905|54191369|FG015|Monotherapy|Death|0|||
27741248|NCT02712905|54191370|FG016|Monotherapy|Death|0|||
27741249|NCT02712905|54191371|FG017|Monotherapy|Death|0|||
27741250|NCT02712905|54191354|FG000|Monotherapy|Lost to Follow-up|0|||
27741251|NCT02712905|54191355|FG001|Monotherapy|Lost to Follow-up|1|||
27741252|NCT02712905|54191356|FG002|Monotherapy|Lost to Follow-up|0|||
27741253|NCT02712905|54191357|FG003|Monotherapy|Lost to Follow-up|1|||
27741254|NCT02712905|54191358|FG004|Monotherapy|Lost to Follow-up|0|||
27741255|NCT02712905|54191359|FG005|Monotherapy|Lost to Follow-up|0|||
27741256|NCT02712905|54191360|FG006|Monotherapy|Lost to Follow-up|0|||
27741257|NCT02712905|54191361|FG007|Monotherapy|Lost to Follow-up|0|||
27741258|NCT02712905|54191362|FG008|Monotherapy|Lost to Follow-up|0|||
27741259|NCT02712905|54191363|FG009|Monotherapy|Lost to Follow-up|2|||
27741260|NCT02712905|54191364|FG010|Monotherapy|Lost to Follow-up|0|||
27741261|NCT02712905|54191365|FG011|Monotherapy|Lost to Follow-up|0|||
27741262|NCT02712905|54191366|FG012|Monotherapy|Lost to Follow-up|0|||
27741263|NCT02712905|54191367|FG013|Monotherapy|Lost to Follow-up|0|||
27741264|NCT02712905|54191368|FG014|Monotherapy|Lost to Follow-up|0|||
27741265|NCT02712905|54191369|FG015|Monotherapy|Lost to Follow-up|0|||
27741266|NCT02712905|54191370|FG016|Monotherapy|Lost to Follow-up|0|||
27741267|NCT02712905|54191371|FG017|Monotherapy|Lost to Follow-up|0|||
27741268|NCT02712905|54191354|FG000|Monotherapy|Physician Decision|1|||
27741269|NCT02712905|54191355|FG001|Monotherapy|Physician Decision|0|||
27741270|NCT02712905|54191356|FG002|Monotherapy|Physician Decision|0|||
27741271|NCT02712905|54191357|FG003|Monotherapy|Physician Decision|1|||
27741272|NCT02712905|54191358|FG004|Monotherapy|Physician Decision|0|||
27741273|NCT02712905|54191359|FG005|Monotherapy|Physician Decision|0|||
27741274|NCT02712905|54191360|FG006|Monotherapy|Physician Decision|0|||
27741275|NCT02712905|54191361|FG007|Monotherapy|Physician Decision|0|||
27741276|NCT02712905|54191362|FG008|Monotherapy|Physician Decision|0|||
27741277|NCT02712905|54191363|FG009|Monotherapy|Physician Decision|1|||
27741278|NCT02712905|54191364|FG010|Monotherapy|Physician Decision|0|||
27741279|NCT02712905|54191365|FG011|Monotherapy|Physician Decision|0|||
27741280|NCT02712905|54191366|FG012|Monotherapy|Physician Decision|0|||
27741281|NCT02712905|54191367|FG013|Monotherapy|Physician Decision|0|||
27918423|NCT01099267|54575666|FG000|MDS-003 Study|Study Closed by Sponsor|2|||
27918424|NCT01099267|54575666|FG000|MDS-003 Study|Disease Progression|7|||
27918425|NCT01099267|54575666|FG000|MDS-003 Study|Investigator Decision|2|||
27741282|NCT02712905|54191368|FG014|Monotherapy|Physician Decision|0|||
27741283|NCT02712905|54191369|FG015|Monotherapy|Physician Decision|0|||
27741284|NCT02712905|54191370|FG016|Monotherapy|Physician Decision|0|||
27741285|NCT02712905|54191371|FG017|Monotherapy|Physician Decision|0|||
27741286|NCT02712905|54191354|FG000|Monotherapy|Study Terminated by Sponsor|0|||
27741287|NCT02712905|54191355|FG001|Monotherapy|Study Terminated by Sponsor|0|||
27741288|NCT02712905|54191356|FG002|Monotherapy|Study Terminated by Sponsor|0|||
27741289|NCT02712905|54191357|FG003|Monotherapy|Study Terminated by Sponsor|0|||
27741290|NCT02712905|54191358|FG004|Monotherapy|Study Terminated by Sponsor|1|||
27741291|NCT02712905|54191359|FG005|Monotherapy|Study Terminated by Sponsor|0|||
27741292|NCT02712905|54191360|FG006|Monotherapy|Study Terminated by Sponsor|0|||
27741293|NCT02712905|54191361|FG007|Monotherapy|Study Terminated by Sponsor|0|||
27741294|NCT02712905|54191362|FG008|Monotherapy|Study Terminated by Sponsor|0|||
27741295|NCT02712905|54191363|FG009|Monotherapy|Study Terminated by Sponsor|2|||
27741296|NCT02712905|54191364|FG010|Monotherapy|Study Terminated by Sponsor|0|||
27741297|NCT02712905|54191365|FG011|Monotherapy|Study Terminated by Sponsor|0|||
27741298|NCT02712905|54191366|FG012|Monotherapy|Study Terminated by Sponsor|0|||
27741299|NCT02712905|54191367|FG013|Monotherapy|Study Terminated by Sponsor|0|||
27741300|NCT02712905|54191368|FG014|Monotherapy|Study Terminated by Sponsor|0|||
27741301|NCT02712905|54191369|FG015|Monotherapy|Study Terminated by Sponsor|0|||
27741302|NCT02712905|54191370|FG016|Monotherapy|Study Terminated by Sponsor|0|||
27741303|NCT02712905|54191371|FG017|Monotherapy|Study Terminated by Sponsor|0|||
27741304|NCT02712905|54191354|FG000|Monotherapy|Withdrawal by Subject|0|||
27741305|NCT02712905|54191355|FG001|Monotherapy|Withdrawal by Subject|0|||
27741306|NCT02712905|54191356|FG002|Monotherapy|Withdrawal by Subject|1|||
27741307|NCT02712905|54191357|FG003|Monotherapy|Withdrawal by Subject|0|||
27741308|NCT02712905|54191358|FG004|Monotherapy|Withdrawal by Subject|2|||
27741309|NCT02712905|54191359|FG005|Monotherapy|Withdrawal by Subject|0|||
27741310|NCT02712905|54191360|FG006|Monotherapy|Withdrawal by Subject|0|||
27741311|NCT02712905|54191361|FG007|Monotherapy|Withdrawal by Subject|0|||
27741312|NCT02712905|54191362|FG008|Monotherapy|Withdrawal by Subject|0|||
27741313|NCT02712905|54191363|FG009|Monotherapy|Withdrawal by Subject|4|||
27741314|NCT02712905|54191364|FG010|Monotherapy|Withdrawal by Subject|1|||
27741315|NCT02712905|54191365|FG011|Monotherapy|Withdrawal by Subject|2|||
27741316|NCT02712905|54191366|FG012|Monotherapy|Withdrawal by Subject|0|||
27741317|NCT02712905|54191367|FG013|Monotherapy|Withdrawal by Subject|0|||
27741318|NCT02712905|54191368|FG014|Monotherapy|Withdrawal by Subject|0|||
27741319|NCT02712905|54191369|FG015|Monotherapy|Withdrawal by Subject|0|||
27741320|NCT02712905|54191370|FG016|Monotherapy|Withdrawal by Subject|0|||
27741321|NCT02712905|54191371|FG017|Monotherapy|Withdrawal by Subject|0|||
27741322|NCT02712905|54191354|FG000|Monotherapy|Started New Cancer Drug|0|||
27741323|NCT02712905|54191355|FG001|Monotherapy|Started New Cancer Drug|0|||
27741324|NCT02712905|54191356|FG002|Monotherapy|Started New Cancer Drug|0|||
27741325|NCT02712905|54191357|FG003|Monotherapy|Started New Cancer Drug|0|||
27741326|NCT02712905|54191358|FG004|Monotherapy|Started New Cancer Drug|0|||
27741327|NCT02712905|54191359|FG005|Monotherapy|Started New Cancer Drug|1|||
27741328|NCT02712905|54191360|FG006|Monotherapy|Started New Cancer Drug|0|||
27741329|NCT02712905|54191361|FG007|Monotherapy|Started New Cancer Drug|0|||
27918426|NCT01099267|54575666|FG000|MDS-003 Study|Non-Compliance|2|||
27918427|NCT01099267|54575666|FG000|MDS-003 Study|Loss of Response|1|||
27918428|NCT01099267|54575666|FG000|MDS-003 Study|Secondary Malign Disease|1|||
27918429|NCT01098487|54575670|FG000|Overall Study|Adverse Event|22|||
27918430|NCT01098487|54575670|FG000|Overall Study|Lack of Efficacy|11|||
27918431|NCT01098487|54575670|FG000|Overall Study|Withdrawal by Subject|7|||
27918432|NCT01098487|54575670|FG000|Overall Study|Lost to Follow-up|3|||
27918433|NCT01098487|54575670|FG000|Overall Study|Physician Decision|1|||
27918434|NCT01098097|54575674|FG000|Overall Study|Adverse Event|17|||
27918435|NCT01098097|54575674|FG000|Overall Study|Lost to Follow-up|18|||
27918436|NCT01098097|54575674|FG000|Overall Study|Status unknown|16|||
27918437|NCT01098097|54575674|FG000|Overall Study|No reason reported|31|||
27918438|NCT01097863|54575681|FG000|Overall Study|Discomfort|1|||
27918439|NCT01097863|54575682|FG001|Overall Study|Discomfort|0|||
27918440|NCT01097863|54575683|FG002|Overall Study|Discomfort|1|||
27918441|NCT01097863|54575681|FG000|Overall Study|Did not return for final visit|0|||
27918442|NCT01097863|54575682|FG001|Overall Study|Did not return for final visit|0|||
27918443|NCT01097863|54575683|FG002|Overall Study|Did not return for final visit|1|||
27918444|NCT01326962|54575691|FG000|Overall Study|Adverse Event|1|||
27918445|NCT01326962|54575691|FG000|Overall Study|Withdrawal by Subject|1|||
27918446|NCT01326962|54575691|FG000|Overall Study|Lost to Follow-up|3|||
27918447|NCT01326962|54575691|FG000|Overall Study|Other|2|||
27918448|NCT01326728|54575697|FG000|Overall Study|Death|13|||
27918449|NCT01326728|54575698|FG001|Overall Study|Death|0|||
27918450|NCT01326728|54575697|FG000|Overall Study|Early closure of study|34|||
27918451|NCT01326728|54575698|FG001|Overall Study|Early closure of study|9|||
27918452|NCT01097707|54575708|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
27741330|NCT02712905|54191362|FG008|Monotherapy|Started New Cancer Drug|0|||
27741331|NCT02712905|54191363|FG009|Monotherapy|Started New Cancer Drug|0|||
27741332|NCT02712905|54191364|FG010|Monotherapy|Started New Cancer Drug|0|||
27741333|NCT02712905|54191365|FG011|Monotherapy|Started New Cancer Drug|0|||
27918453|NCT01097707|54575709|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
27918454|NCT01097707|54575710|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
27918455|NCT01097707|54575711|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
27918456|NCT01097707|54575712|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
27918457|NCT01097707|54575708|FG000|Overall Study|Adverse Event|4|||
27741334|NCT02712905|54191366|FG012|Monotherapy|Started New Cancer Drug|0|||
27741335|NCT02712905|54191367|FG013|Monotherapy|Started New Cancer Drug|0|||
27741336|NCT02712905|54191368|FG014|Monotherapy|Started New Cancer Drug|0|||
27741337|NCT02712905|54191369|FG015|Monotherapy|Started New Cancer Drug|0|||
27741338|NCT02712905|54191370|FG016|Monotherapy|Started New Cancer Drug|0|||
27918458|NCT01097707|54575709|FG001|Overall Study|Adverse Event|2|||
27918459|NCT01097707|54575710|FG002|Overall Study|Adverse Event|3|||
27918460|NCT01097707|54575711|FG003|Overall Study|Adverse Event|1|||
27741339|NCT02712905|54191371|FG017|Monotherapy|Started New Cancer Drug|0|||
27741340|NCT02712905|54191354|FG000|Monotherapy|Adverse Event|0|||
27918461|NCT01097707|54575712|FG004|Overall Study|Adverse Event|3|||
27918462|NCT01097707|54575708|FG000|Overall Study|Entry Criteria Not Met|2|||
27918463|NCT01097707|54575709|FG001|Overall Study|Entry Criteria Not Met|1|||
27918464|NCT01097707|54575710|FG002|Overall Study|Entry Criteria Not Met|1|||
27918465|NCT01097707|54575711|FG003|Overall Study|Entry Criteria Not Met|0|||
27918466|NCT01097707|54575712|FG004|Overall Study|Entry Criteria Not Met|1|||
27918467|NCT01097707|54575708|FG000|Overall Study|Lack of Efficacy|1|||
27918468|NCT01097707|54575709|FG001|Overall Study|Lack of Efficacy|0|||
27918469|NCT01097707|54575710|FG002|Overall Study|Lack of Efficacy|0|||
27918470|NCT01097707|54575711|FG003|Overall Study|Lack of Efficacy|1|||
27918471|NCT01097707|54575712|FG004|Overall Study|Lack of Efficacy|0|||
27918472|NCT01097707|54575708|FG000|Overall Study|Lost to Follow-up|1|||
27918473|NCT01097707|54575709|FG001|Overall Study|Lost to Follow-up|1|||
27918474|NCT01097707|54575710|FG002|Overall Study|Lost to Follow-up|2|||
27918475|NCT01097707|54575711|FG003|Overall Study|Lost to Follow-up|0|||
27918476|NCT01097707|54575712|FG004|Overall Study|Lost to Follow-up|3|||
27918477|NCT01097707|54575708|FG000|Overall Study|Protocol Violation|2|||
27918478|NCT01097707|54575709|FG001|Overall Study|Protocol Violation|2|||
27918479|NCT01097707|54575710|FG002|Overall Study|Protocol Violation|3|||
27918480|NCT01097707|54575711|FG003|Overall Study|Protocol Violation|2|||
27918481|NCT01097707|54575712|FG004|Overall Study|Protocol Violation|2|||
27918482|NCT01097707|54575708|FG000|Overall Study|Sponsor Decision|31|||
27918483|NCT01097707|54575709|FG001|Overall Study|Sponsor Decision|31|||
27918484|NCT01097707|54575710|FG002|Overall Study|Sponsor Decision|34|||
27918485|NCT01097707|54575711|FG003|Overall Study|Sponsor Decision|35|||
27918486|NCT01097707|54575712|FG004|Overall Study|Sponsor Decision|36|||
27918487|NCT01097707|54575708|FG000|Overall Study|Withdrawal by Subject|3|||
27918488|NCT01097707|54575709|FG001|Overall Study|Withdrawal by Subject|6|||
27918489|NCT01097707|54575710|FG002|Overall Study|Withdrawal by Subject|1|||
27918490|NCT01097707|54575711|FG003|Overall Study|Withdrawal by Subject|4|||
27918491|NCT01097707|54575712|FG004|Overall Study|Withdrawal by Subject|3|||
27918492|NCT01097707|54575708|FG000|Overall Study|Reason unknown|0|||
27918493|NCT01097707|54575709|FG001|Overall Study|Reason unknown|0|||
27918494|NCT01097707|54575710|FG002|Overall Study|Reason unknown|0|||
27918495|NCT01097707|54575711|FG003|Overall Study|Reason unknown|0|||
27918496|NCT01097707|54575712|FG004|Overall Study|Reason unknown|1|||
27918497|NCT01326104|54575726|FG000|Overall Study|progressed prior to vaccine|0|||
27918498|NCT01326104|54575727|FG001|Overall Study|progressed prior to vaccine|2|||
27918499|NCT01326104|54575726|FG000|Overall Study|unable to make vaccine|0|||
27918500|NCT01326104|54575727|FG001|Overall Study|unable to make vaccine|2|||
27918501|NCT01326026|54575735|FG000|Overall Study|Adverse Event|4|||
27918502|NCT01326026|54575736|FG001|Overall Study|Adverse Event|3|||
27918503|NCT01326026|54575735|FG000|Overall Study|Withdrawal Criteria|5|||
27918504|NCT01326026|54575736|FG001|Overall Study|Withdrawal Criteria|7|||
27918505|NCT01326026|54575735|FG000|Overall Study|Other|3|||
27918506|NCT01326026|54575736|FG001|Overall Study|Other|3|||
27918507|NCT01097629|54575745|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10|||
27918508|NCT01097629|54575746|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19|||
27918509|NCT01097629|54575747|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17|||
27918510|NCT01097629|54575748|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
27918511|NCT01097629|54575749|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
27918512|NCT01097629|54575750|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
27918513|NCT01097629|54575751|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
27918514|NCT01097629|54575752|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
27918515|NCT01097629|54575745|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
27918516|NCT01097629|54575746|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9|||
27918517|NCT01097629|54575747|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19|||
27918518|NCT01097629|54575748|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
27918519|NCT01097629|54575749|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
27918520|NCT01097629|54575750|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
27918521|NCT01097629|54575751|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
27918522|NCT01097629|54575752|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
27918523|NCT01097629|54575745|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
27918524|NCT01097629|54575746|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4|||
27918525|NCT01097629|54575747|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8|||
27918526|NCT01097629|54575748|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
27918527|NCT01097629|54575749|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
27918528|NCT01097629|54575750|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
27918529|NCT01097629|54575751|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
27918530|NCT01097629|54575752|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
27918531|NCT01097629|54575745|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2|||
27918532|NCT01097629|54575746|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4|||
28007921|NCT00790205|54666738|FG001|Overall Study|Lost to Follow-up|71|||
27918533|NCT01097629|54575747|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
27918534|NCT01097629|54575748|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
27918535|NCT01097629|54575749|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
27918536|NCT01097629|54575750|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
27918537|NCT01097629|54575751|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
27918538|NCT01097629|54575752|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
27918539|NCT01097629|54575745|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
27918540|NCT01097629|54575746|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4|||
27918541|NCT01097629|54575747|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8|||
27918542|NCT01097629|54575748|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
27918543|NCT01097629|54575749|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
27918544|NCT01097629|54575750|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
27918545|NCT01097629|54575751|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
27918546|NCT01097629|54575752|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
27918547|NCT01097629|54575745|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2|||
27918548|NCT01097629|54575746|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1|||
27918549|NCT01097629|54575747|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
27918550|NCT01097629|54575748|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
27918551|NCT01097629|54575749|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
27918552|NCT01097629|54575750|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
27918553|NCT01097629|54575751|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
27918554|NCT01097629|54575752|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
27918555|NCT01097629|54575745|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
27918556|NCT01097629|54575746|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5|||
27918557|NCT01097629|54575747|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4|||
27918558|NCT01097629|54575748|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
27918559|NCT01097629|54575749|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
27918560|NCT01097629|54575750|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
27918561|NCT01097629|54575751|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
27918562|NCT01097629|54575752|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
27918563|NCT01097629|54575745|FG000|DB RO Phase|Withdrawal by Subject|0|||
27918564|NCT01097629|54575746|FG001|DB RO Phase|Withdrawal by Subject|0|||
27918565|NCT01097629|54575747|FG002|DB RO Phase|Withdrawal by Subject|0|||
27918566|NCT01097629|54575748|FG003|DB RO Phase|Withdrawal by Subject|0|||
27918567|NCT01097629|54575749|FG004|DB RO Phase|Withdrawal by Subject|0|||
27918568|NCT01097629|54575750|FG005|DB RO Phase|Withdrawal by Subject|0|||
27918569|NCT01097629|54575751|FG006|DB RO Phase|Withdrawal by Subject|0|||
27918570|NCT01097629|54575752|FG007|DB RO Phase|Withdrawal by Subject|1|||
27918571|NCT01097629|54575745|FG000|DB RO Phase|Protocol Violation|0|||
27918572|NCT01097629|54575746|FG001|DB RO Phase|Protocol Violation|0|||
28007922|NCT00790205|54666737|FG000|Overall Study|Withdrawal by Subject|299|||
28007923|NCT00790205|54666738|FG001|Overall Study|Withdrawal by Subject|363|||
28007924|NCT00715208|54666746|FG000|Overall Study|Withdrawal by Subject|1|||
28007925|NCT00715208|54666747|FG001|Overall Study|Withdrawal by Subject|1|||
28007926|NCT00715208|54666746|FG000|Overall Study|Adverse Event|0|||
28007927|NCT00715208|54666747|FG001|Overall Study|Adverse Event|6|||
28007928|NCT00715208|54666746|FG000|Overall Study|Lack of Efficacy|0|||
28007929|NCT00715208|54666747|FG001|Overall Study|Lack of Efficacy|2|||
28007930|NCT00775463|54666755|FG000|Overall Study|Withdrawal by Subject|0|||
28007931|NCT00775463|54666756|FG001|Overall Study|Withdrawal by Subject|1|||
28007932|NCT00775463|54666755|FG000|Overall Study|Adverse Event|7|||
28007933|NCT00775463|54666756|FG001|Overall Study|Adverse Event|9|||
28007934|NCT00775463|54666755|FG000|Overall Study|Protocol Violation|2|||
28007935|NCT00775463|54666756|FG001|Overall Study|Protocol Violation|2|||
28007936|NCT00775463|54666755|FG000|Overall Study|Lost to Follow-up|1|||
28007937|NCT00775463|54666756|FG001|Overall Study|Lost to Follow-up|0|||
28007938|NCT00775463|54666755|FG000|Overall Study|Lack of Efficacy|1|||
28007939|NCT00775463|54666756|FG001|Overall Study|Lack of Efficacy|1|||
28007940|NCT00587795|54666771|FG000|Overall Study|Withdrawal by Subject|1|||
28007941|NCT00587795|54666772|FG001|Overall Study|Withdrawal by Subject|0|||
28007942|NCT00587639|54666778|FG000|Overall Study|Withdrawal by Subject|1|||
28007943|NCT00774995|54666786|FG000|Overall Study|Protocol Violation|0|||
28007944|NCT00774995|54666787|FG001|Overall Study|Protocol Violation|0|||
28007945|NCT00774995|54666788|FG002|Overall Study|Protocol Violation|1|||
28007946|NCT00774995|54666789|FG003|Overall Study|Protocol Violation|0|||
28007947|NCT00713648|54666799|FG000|Overall Study|Adverse Event|1|||
28007948|NCT00713648|54666799|FG000|Overall Study|Unclassified|2|||
28007949|NCT00713648|54666799|FG000|Overall Study|According to Protocol|2|||
28007950|NCT00713648|54666799|FG000|Overall Study|Development of antibodies|3|||
28007951|NCT00768053|54666803|FG000|Overall Study|Adverse Event|10|||
28007952|NCT00768053|54666803|FG000|Overall Study|Lost to Follow-up|1|||
28007953|NCT00683475|54666809|FG000|Overall Study|Withdrawal by Subject|1|||
28007954|NCT00683475|54666810|FG001|Overall Study|Withdrawal by Subject|0|||
28007955|NCT00683475|54666809|FG000|Overall Study|Never Treated: Adverse Event|2|||
28007956|NCT00683475|54666810|FG001|Overall Study|Never Treated: Adverse Event|3|||
27918573|NCT01097629|54575747|FG002|DB RO Phase|Protocol Violation|0|||
27918574|NCT01097629|54575748|FG003|DB RO Phase|Protocol Violation|1|||
27918575|NCT01097629|54575749|FG004|DB RO Phase|Protocol Violation|0|||
27918576|NCT01097629|54575750|FG005|DB RO Phase|Protocol Violation|1|||
27918577|NCT01097629|54575751|FG006|DB RO Phase|Protocol Violation|1|||
27918578|NCT01097629|54575752|FG007|DB RO Phase|Protocol Violation|0|||
27918579|NCT01097629|54575745|FG000|DB RO Phase|Lost to Follow-up|0|||
27918580|NCT01097629|54575746|FG001|DB RO Phase|Lost to Follow-up|0|||
27918581|NCT01097629|54575747|FG002|DB RO Phase|Lost to Follow-up|0|||
27918582|NCT01097629|54575748|FG003|DB RO Phase|Lost to Follow-up|0|||
27918583|NCT01097629|54575749|FG004|DB RO Phase|Lost to Follow-up|0|||
27918584|NCT01097629|54575750|FG005|DB RO Phase|Lost to Follow-up|0|||
27918585|NCT01097629|54575751|FG006|DB RO Phase|Lost to Follow-up|2|||
27918586|NCT01097629|54575752|FG007|DB RO Phase|Lost to Follow-up|0|||
27918587|NCT01324622|54575777|FG000|Overall Study|Lost to Follow-up|7|||
27918588|NCT01324622|54575778|FG001|Overall Study|Lost to Follow-up|7|||
27918589|NCT01324622|54575777|FG000|Overall Study|Death|1|||
27918590|NCT01324622|54575778|FG001|Overall Study|Death|0|||
27918591|NCT01324622|54575777|FG000|Overall Study|Lack of Efficacy|1|||
27918592|NCT01324622|54575778|FG001|Overall Study|Lack of Efficacy|0|||
27918593|NCT01097005|54575785|FG000|Overall Study|Case Report Form not collected|18|||
27918594|NCT01097005|54575785|FG000|Overall Study|Subjects cannot visit the hospital|1|||
27918595|NCT01097005|54575785|FG000|Overall Study|Poor medication compliance|1|||
27918596|NCT01097005|54575785|FG000|Overall Study|No examination data available|244|||
27918597|NCT01097005|54575785|FG000|Overall Study|Deviation from exclusion criteria|37|||
27918598|NCT01097005|54575785|FG000|Overall Study|Adverse Event|14|||
27918599|NCT01097005|54575785|FG000|Overall Study|Discontinuance by complication|50|||
27918600|NCT01096849|54575794|FG000|Overall Study|Consent Withdrawn|1|||
27918601|NCT01096849|54575795|FG001|Overall Study|Consent Withdrawn|4|||
27918602|NCT01096849|54575796|FG002|Overall Study|Consent Withdrawn|2|||
27918603|NCT01096849|54575794|FG000|Overall Study|Lack of Efficacy|0|||
27918604|NCT01096849|54575795|FG001|Overall Study|Lack of Efficacy|2|||
27918605|NCT01096849|54575796|FG002|Overall Study|Lack of Efficacy|0|||
27918606|NCT01096849|54575794|FG000|Overall Study|Unacceptable/ Intolerable AE(s)|0|||
27918607|NCT01096849|54575795|FG001|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
27918608|NCT01096849|54575796|FG002|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
27918609|NCT01096849|54575794|FG000|Overall Study|Investigator or Medical Monitor Decision|0|||
27918610|NCT01096849|54575795|FG001|Overall Study|Investigator or Medical Monitor Decision|1|||
27918611|NCT01096849|54575796|FG002|Overall Study|Investigator or Medical Monitor Decision|0|||
27918612|NCT01096849|54575794|FG000|Overall Study|Administrative Reasons|0|||
27918613|NCT01096849|54575795|FG001|Overall Study|Administrative Reasons|1|||
27918614|NCT01096849|54575796|FG002|Overall Study|Administrative Reasons|2|||
27918615|NCT01096849|54575794|FG000|Overall Study|Lost to Follow-up|1|||
27918616|NCT01096849|54575795|FG001|Overall Study|Lost to Follow-up|3|||
27918617|NCT01096849|54575796|FG002|Overall Study|Lost to Follow-up|1|||
27918618|NCT01324388|54575807|FG000|Part 1 of Study|Adverse Event|2|||
27918619|NCT01324388|54575808|FG001|Part 1 of Study|Adverse Event|0|||
27918620|NCT01324388|54575809|FG002|Part 1 of Study|Adverse Event|0|||
27918621|NCT01324388|54575810|FG003|Part 1 of Study|Adverse Event|0|||
27918622|NCT01324388|54575807|FG000|Part 1 of Study|Protocol Violation|1|||
27918623|NCT01324388|54575808|FG001|Part 1 of Study|Protocol Violation|2|||
27918624|NCT01324388|54575809|FG002|Part 1 of Study|Protocol Violation|0|||
27918625|NCT01324388|54575810|FG003|Part 1 of Study|Protocol Violation|0|||
27918626|NCT01324388|54575807|FG000|Part 1 of Study|Physician Decision|1|||
27918627|NCT01324388|54575808|FG001|Part 1 of Study|Physician Decision|0|||
27918628|NCT01324388|54575809|FG002|Part 1 of Study|Physician Decision|0|||
27918629|NCT01324388|54575810|FG003|Part 1 of Study|Physician Decision|0|||
27918630|NCT01324388|54575807|FG000|Part 2 of Study: First Intervention|Protocol Violation|0|||
27918631|NCT01324388|54575808|FG001|Part 2 of Study: First Intervention|Protocol Violation|0|||
27918632|NCT01324388|54575809|FG002|Part 2 of Study: First Intervention|Protocol Violation|0|||
27918633|NCT01324388|54575810|FG003|Part 2 of Study: First Intervention|Protocol Violation|1|||
27918634|NCT01324388|54575807|FG000|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
27918635|NCT01324388|54575808|FG001|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
27918636|NCT01324388|54575809|FG002|Part 2 of Study: Second Intervention|Withdrawal by Subject|1|||
27918637|NCT01324388|54575810|FG003|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
27918638|NCT01102777|54575824|FG000|Overall Study|Death|2|||
27918639|NCT01102777|54575825|FG001|Overall Study|Death|6|||
27918640|NCT01102777|54575824|FG000|Overall Study|Lost to Follow-up|7|||
27918641|NCT01102777|54575825|FG001|Overall Study|Lost to Follow-up|10|||
27918642|NCT01324310|54575832|FG000|Overall Study|Adverse Event|1|||
27918643|NCT01324310|54575832|FG000|Overall Study|Disease Progression|1|||
27918644|NCT01102231|54575838|FG000|Overall Study|Protocol Violation|3|||
27918645|NCT01102231|54575838|FG000|Overall Study|Lack of Efficacy|2|||
27918646|NCT01102231|54575838|FG000|Overall Study|Death|2|||
27918647|NCT01102231|54575838|FG000|Overall Study|Adverse Event|3|||
27918648|NCT01102231|54575838|FG000|Overall Study|Withdrawal by Subject|1|||
27918649|NCT01102231|54575838|FG000|Overall Study|Did not received the treatment|4|||
27918650|NCT01094743|54575843|FG000|Period 1|Unsatisfactory comfort at lens fitting|2|||
27918651|NCT01095835|54575851|FG000|Overall Study|Adverse Event|8|||
27918652|NCT01095835|54575852|FG001|Overall Study|Adverse Event|6|||
27918653|NCT01095835|54575853|FG002|Overall Study|Adverse Event|6|||
27918654|NCT01095835|54575851|FG000|Overall Study|Lack of Efficacy|0|||
27918655|NCT01095835|54575852|FG001|Overall Study|Lack of Efficacy|1|||
27918656|NCT01095835|54575853|FG002|Overall Study|Lack of Efficacy|0|||
27918657|NCT01095835|54575851|FG000|Overall Study|Physician Decision|0|||
27918658|NCT01095835|54575852|FG001|Overall Study|Physician Decision|0|||
27918659|NCT01095835|54575853|FG002|Overall Study|Physician Decision|1|||
27918660|NCT01095835|54575851|FG000|Overall Study|Withdrawal by Subject|1|||
27918661|NCT01095835|54575852|FG001|Overall Study|Withdrawal by Subject|3|||
27918662|NCT01095835|54575853|FG002|Overall Study|Withdrawal by Subject|0|||
27918663|NCT01095835|54575851|FG000|Overall Study|Non study compliance|0|||
27918664|NCT01095835|54575852|FG001|Overall Study|Non study compliance|0|||
27918665|NCT01095835|54575853|FG002|Overall Study|Non study compliance|1|||
27918666|NCT01095835|54575851|FG000|Overall Study|Protocol Violation|1|||
27918667|NCT01095835|54575852|FG001|Overall Study|Protocol Violation|2|||
27918668|NCT01095835|54575853|FG002|Overall Study|Protocol Violation|0|||
27918669|NCT01324232|54575866|FG000|Overall Study|Protocol Violation|0|||
27918670|NCT01324232|54575867|FG001|Overall Study|Protocol Violation|0|||
27918671|NCT01324232|54575868|FG002|Overall Study|Protocol Violation|0|||
27918672|NCT01324232|54575869|FG003|Overall Study|Protocol Violation|2|||
27918673|NCT01324232|54575866|FG000|Overall Study|Missing|0|||
27918674|NCT01324232|54575867|FG001|Overall Study|Missing|0|||
27918675|NCT01324232|54575868|FG002|Overall Study|Missing|1|||
27918676|NCT01324232|54575869|FG003|Overall Study|Missing|0|||
27918677|NCT01324232|54575866|FG000|Overall Study|Participant's Personal Reason/Decision|0|||
27918678|NCT01324232|54575867|FG001|Overall Study|Participant's Personal Reason/Decision|1|||
27918679|NCT01324232|54575868|FG002|Overall Study|Participant's Personal Reason/Decision|0|||
27918680|NCT01324232|54575869|FG003|Overall Study|Participant's Personal Reason/Decision|0|||
27918681|NCT01324232|54575866|FG000|Overall Study|Lack of Efficacy|2|||
27918682|NCT01324232|54575867|FG001|Overall Study|Lack of Efficacy|1|||
27918683|NCT01324232|54575868|FG002|Overall Study|Lack of Efficacy|2|||
27918684|NCT01324232|54575869|FG003|Overall Study|Lack of Efficacy|2|||
27918685|NCT01324232|54575866|FG000|Overall Study|Participant Refused Medication|0|||
27918686|NCT01324232|54575867|FG001|Overall Study|Participant Refused Medication|1|||
27918687|NCT01324232|54575868|FG002|Overall Study|Participant Refused Medication|0|||
27918688|NCT01324232|54575869|FG003|Overall Study|Participant Refused Medication|0|||
27918689|NCT01324232|54575866|FG000|Overall Study|Intercurrent illness|0|||
27918690|NCT01324232|54575867|FG001|Overall Study|Intercurrent illness|0|||
27918691|NCT01324232|54575868|FG002|Overall Study|Intercurrent illness|0|||
27918692|NCT01324232|54575869|FG003|Overall Study|Intercurrent illness|1|||
27918693|NCT01324232|54575866|FG000|Overall Study|Adverse Event|2|||
27918694|NCT01324232|54575867|FG001|Overall Study|Adverse Event|5|||
27918695|NCT01324232|54575868|FG002|Overall Study|Adverse Event|6|||
27918696|NCT01324232|54575869|FG003|Overall Study|Adverse Event|6|||
27918697|NCT01324232|54575866|FG000|Overall Study|Withdrawal by Subject|0|||
27918698|NCT01324232|54575867|FG001|Overall Study|Withdrawal by Subject|3|||
27918699|NCT01324232|54575868|FG002|Overall Study|Withdrawal by Subject|4|||
27918700|NCT01324232|54575869|FG003|Overall Study|Withdrawal by Subject|0|||
27918701|NCT01324232|54575866|FG000|Overall Study|Lost to Follow-up|1|||
27918702|NCT01324232|54575867|FG001|Overall Study|Lost to Follow-up|0|||
27918703|NCT01324232|54575868|FG002|Overall Study|Lost to Follow-up|0|||
27918704|NCT01324232|54575869|FG003|Overall Study|Lost to Follow-up|0|||
27918705|NCT01094119|54575886|FG000|Overall Study|Lack of Efficacy|2|||
27918706|NCT01094119|54575887|FG001|Overall Study|Lack of Efficacy|4|||
27918707|NCT01323920|54575893|FG000|Overall Study|Death|5|||
28007957|NCT00683475|54666809|FG000|Overall Study|Never Treated: Progressive Disease|1|||
28007958|NCT00683475|54666810|FG001|Overall Study|Never Treated: Progressive Disease|0|||
28007959|NCT00685035|54666817|FG000|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1|||
28007960|NCT00685035|54666818|FG001|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0|||
28007961|NCT00773747|54666844|FG000|Overall Study|Lack of Efficacy|112|||
28007962|NCT00773747|54666845|FG001|Overall Study|Lack of Efficacy|144|||
28007963|NCT00773747|54666844|FG000|Overall Study|Physician Decision|26|||
28007964|NCT00773747|54666845|FG001|Overall Study|Physician Decision|18|||
28007965|NCT00773747|54666844|FG000|Overall Study|Lost to Follow-up|0|||
28007966|NCT00773747|54666845|FG001|Overall Study|Lost to Follow-up|1|||
28007967|NCT00773747|54666844|FG000|Overall Study|Protocol Violation|2|||
28007968|NCT00773747|54666845|FG001|Overall Study|Protocol Violation|2|||
28007969|NCT00773747|54666844|FG000|Overall Study|Withdrawal by Subject|89|||
27918708|NCT01323920|54575893|FG000|Overall Study|Withdrawal by Subject|1|||
27918709|NCT01093885|54575897|FG000|Overall Study|Adverse Event|4|||
27918710|NCT01093885|54575897|FG000|Overall Study|Lost to Follow-up|1|||
27918711|NCT01101997|54575902|FG000|Overall Study|Withdrawal by Subject|2|||
27918712|NCT01324830|54575932|FG000|Overall Study|Progressive Disease|3|||
27918713|NCT01324830|54575933|FG001|Overall Study|Progressive Disease|2|||
27918714|NCT01324830|54575934|FG002|Overall Study|Progressive Disease|3|||
27918715|NCT01324830|54575935|FG003|Overall Study|Progressive Disease|3|||
27918716|NCT01324830|54575936|FG004|Overall Study|Progressive Disease|6|||
27918717|NCT01324830|54575937|FG005|Overall Study|Progressive Disease|6|||
27918718|NCT01324830|54575938|FG006|Overall Study|Progressive Disease|3|||
27918719|NCT01324830|54575939|FG007|Overall Study|Progressive Disease|3|||
27918720|NCT01324830|54575940|FG008|Overall Study|Progressive Disease|3|||
27918721|NCT01324830|54575941|FG009|Overall Study|Progressive Disease|6|||
27918722|NCT01324830|54575942|FG010|Overall Study|Progressive Disease|2|||
27918723|NCT01324830|54575943|FG011|Overall Study|Progressive Disease|1|||
27918724|NCT01324830|54575944|FG012|Overall Study|Progressive Disease|1|||
27918725|NCT01324830|54575945|FG013|Overall Study|Progressive Disease|1|||
27918726|NCT01324830|54575946|FG014|Overall Study|Progressive Disease|1|||
27918727|NCT01324830|54575947|FG015|Overall Study|Progressive Disease|3|||
27918728|NCT01324830|54575948|FG016|Overall Study|Progressive Disease|2|||
27918729|NCT01324830|54575949|FG017|Overall Study|Progressive Disease|3|||
27918730|NCT01324830|54575950|FG018|Overall Study|Progressive Disease|4|||
27918731|NCT01324830|54575932|FG000|Overall Study|Dose limiting toxicity|0|||
27918732|NCT01324830|54575933|FG001|Overall Study|Dose limiting toxicity|0|||
27918733|NCT01324830|54575934|FG002|Overall Study|Dose limiting toxicity|0|||
27741341|NCT02712905|54191355|FG001|Monotherapy|Adverse Event|0|||
27918734|NCT01324830|54575935|FG003|Overall Study|Dose limiting toxicity|0|||
27918735|NCT01324830|54575936|FG004|Overall Study|Dose limiting toxicity|1|||
27918736|NCT01324830|54575937|FG005|Overall Study|Dose limiting toxicity|0|||
27918737|NCT01324830|54575938|FG006|Overall Study|Dose limiting toxicity|0|||
27918738|NCT01324830|54575939|FG007|Overall Study|Dose limiting toxicity|0|||
27918739|NCT01324830|54575940|FG008|Overall Study|Dose limiting toxicity|0|||
27918740|NCT01324830|54575941|FG009|Overall Study|Dose limiting toxicity|0|||
27918741|NCT01324830|54575942|FG010|Overall Study|Dose limiting toxicity|0|||
27918742|NCT01324830|54575943|FG011|Overall Study|Dose limiting toxicity|0|||
27918743|NCT01324830|54575944|FG012|Overall Study|Dose limiting toxicity|0|||
27918744|NCT01324830|54575945|FG013|Overall Study|Dose limiting toxicity|0|||
27918745|NCT01324830|54575946|FG014|Overall Study|Dose limiting toxicity|0|||
27918746|NCT01324830|54575947|FG015|Overall Study|Dose limiting toxicity|0|||
27918747|NCT01324830|54575948|FG016|Overall Study|Dose limiting toxicity|1|||
27918748|NCT01324830|54575949|FG017|Overall Study|Dose limiting toxicity|1|||
27918749|NCT01324830|54575950|FG018|Overall Study|Dose limiting toxicity|1|||
27918750|NCT01324830|54575932|FG000|Overall Study|Reason not mentioned above|0|||
27918751|NCT01324830|54575933|FG001|Overall Study|Reason not mentioned above|0|||
27918752|NCT01324830|54575934|FG002|Overall Study|Reason not mentioned above|0|||
27918753|NCT01324830|54575935|FG003|Overall Study|Reason not mentioned above|0|||
27918754|NCT01324830|54575936|FG004|Overall Study|Reason not mentioned above|0|||
27918755|NCT01324830|54575937|FG005|Overall Study|Reason not mentioned above|0|||
27918756|NCT01324830|54575938|FG006|Overall Study|Reason not mentioned above|0|||
27918757|NCT01324830|54575939|FG007|Overall Study|Reason not mentioned above|0|||
27918758|NCT01324830|54575940|FG008|Overall Study|Reason not mentioned above|0|||
27918759|NCT01324830|54575941|FG009|Overall Study|Reason not mentioned above|0|||
27918760|NCT01324830|54575942|FG010|Overall Study|Reason not mentioned above|0|||
27918761|NCT01324830|54575943|FG011|Overall Study|Reason not mentioned above|0|||
27918762|NCT01324830|54575944|FG012|Overall Study|Reason not mentioned above|0|||
27918763|NCT01324830|54575945|FG013|Overall Study|Reason not mentioned above|0|||
27918764|NCT01324830|54575946|FG014|Overall Study|Reason not mentioned above|0|||
27918765|NCT01324830|54575947|FG015|Overall Study|Reason not mentioned above|0|||
27918766|NCT01324830|54575948|FG016|Overall Study|Reason not mentioned above|0|||
27918767|NCT01324830|54575949|FG017|Overall Study|Reason not mentioned above|1|||
27918768|NCT01324830|54575950|FG018|Overall Study|Reason not mentioned above|0|||
27918769|NCT01324830|54575932|FG000|Overall Study|Adverse Event, serious fatal|0|||
27918770|NCT01324830|54575933|FG001|Overall Study|Adverse Event, serious fatal|1|||
27918771|NCT01324830|54575934|FG002|Overall Study|Adverse Event, serious fatal|0|||
27918772|NCT01324830|54575935|FG003|Overall Study|Adverse Event, serious fatal|0|||
27918773|NCT01324830|54575936|FG004|Overall Study|Adverse Event, serious fatal|0|||
27918774|NCT01324830|54575937|FG005|Overall Study|Adverse Event, serious fatal|0|||
27918775|NCT01324830|54575938|FG006|Overall Study|Adverse Event, serious fatal|0|||
27918776|NCT01324830|54575939|FG007|Overall Study|Adverse Event, serious fatal|0|||
27918777|NCT01324830|54575940|FG008|Overall Study|Adverse Event, serious fatal|0|||
27918778|NCT01324830|54575941|FG009|Overall Study|Adverse Event, serious fatal|0|||
27918779|NCT01324830|54575942|FG010|Overall Study|Adverse Event, serious fatal|0|||
27918780|NCT01324830|54575943|FG011|Overall Study|Adverse Event, serious fatal|0|||
27918781|NCT01324830|54575944|FG012|Overall Study|Adverse Event, serious fatal|0|||
27918782|NCT01324830|54575945|FG013|Overall Study|Adverse Event, serious fatal|0|||
27918783|NCT01324830|54575946|FG014|Overall Study|Adverse Event, serious fatal|0|||
27918784|NCT01324830|54575947|FG015|Overall Study|Adverse Event, serious fatal|0|||
27918785|NCT01324830|54575948|FG016|Overall Study|Adverse Event, serious fatal|0|||
27918786|NCT01324830|54575949|FG017|Overall Study|Adverse Event, serious fatal|0|||
27918787|NCT01324830|54575950|FG018|Overall Study|Adverse Event, serious fatal|0|||
27918788|NCT01324830|54575932|FG000|Overall Study|Adverse Event, non-fatal|0|||
27918789|NCT01324830|54575933|FG001|Overall Study|Adverse Event, non-fatal|0|||
27918790|NCT01324830|54575934|FG002|Overall Study|Adverse Event, non-fatal|0|||
27918791|NCT01324830|54575935|FG003|Overall Study|Adverse Event, non-fatal|0|||
27918792|NCT01324830|54575936|FG004|Overall Study|Adverse Event, non-fatal|0|||
27918793|NCT01324830|54575937|FG005|Overall Study|Adverse Event, non-fatal|0|||
27918794|NCT01324830|54575938|FG006|Overall Study|Adverse Event, non-fatal|0|||
27918795|NCT01324830|54575939|FG007|Overall Study|Adverse Event, non-fatal|0|||
27918796|NCT01324830|54575940|FG008|Overall Study|Adverse Event, non-fatal|2|||
27918797|NCT01324830|54575941|FG009|Overall Study|Adverse Event, non-fatal|0|||
27918798|NCT01324830|54575942|FG010|Overall Study|Adverse Event, non-fatal|1|||
27918799|NCT01324830|54575943|FG011|Overall Study|Adverse Event, non-fatal|0|||
27918800|NCT01324830|54575944|FG012|Overall Study|Adverse Event, non-fatal|0|||
27918801|NCT01324830|54575945|FG013|Overall Study|Adverse Event, non-fatal|0|||
27918802|NCT01324830|54575946|FG014|Overall Study|Adverse Event, non-fatal|0|||
27918803|NCT01324830|54575947|FG015|Overall Study|Adverse Event, non-fatal|0|||
27918804|NCT01324830|54575948|FG016|Overall Study|Adverse Event, non-fatal|0|||
27918805|NCT01324830|54575949|FG017|Overall Study|Adverse Event, non-fatal|1|||
27741342|NCT02712905|54191356|FG002|Monotherapy|Adverse Event|0|||
27918806|NCT01324830|54575950|FG018|Overall Study|Adverse Event, non-fatal|0|||
27918807|NCT01324830|54575932|FG000|Overall Study|Withdrawal by Subject|0|||
27918808|NCT01324830|54575933|FG001|Overall Study|Withdrawal by Subject|0|||
27918809|NCT01324830|54575934|FG002|Overall Study|Withdrawal by Subject|0|||
27918810|NCT01324830|54575935|FG003|Overall Study|Withdrawal by Subject|0|||
27918811|NCT01324830|54575936|FG004|Overall Study|Withdrawal by Subject|0|||
27918812|NCT01324830|54575937|FG005|Overall Study|Withdrawal by Subject|1|||
27918813|NCT01324830|54575938|FG006|Overall Study|Withdrawal by Subject|0|||
27918814|NCT01324830|54575939|FG007|Overall Study|Withdrawal by Subject|0|||
27918815|NCT01324830|54575940|FG008|Overall Study|Withdrawal by Subject|0|||
27918816|NCT01324830|54575941|FG009|Overall Study|Withdrawal by Subject|0|||
27918817|NCT01324830|54575942|FG010|Overall Study|Withdrawal by Subject|1|||
27918818|NCT01324830|54575943|FG011|Overall Study|Withdrawal by Subject|0|||
27918819|NCT01324830|54575944|FG012|Overall Study|Withdrawal by Subject|0|||
27918820|NCT01324830|54575945|FG013|Overall Study|Withdrawal by Subject|0|||
27918821|NCT01324830|54575946|FG014|Overall Study|Withdrawal by Subject|0|||
27918822|NCT01324830|54575947|FG015|Overall Study|Withdrawal by Subject|0|||
27918823|NCT01324830|54575948|FG016|Overall Study|Withdrawal by Subject|0|||
27918824|NCT01324830|54575949|FG017|Overall Study|Withdrawal by Subject|0|||
27918825|NCT01324830|54575950|FG018|Overall Study|Withdrawal by Subject|1|||
27918826|NCT01324440|54575998|FG000|Overall Study|Subject moved|0|||
27918827|NCT01324440|54575999|FG001|Overall Study|Subject moved|1|||
27918828|NCT01325493|54576007|FG000|Overall Study|Protocol Violation|0|||
27918829|NCT01325493|54576008|FG001|Overall Study|Protocol Violation|1|||
27918830|NCT01325493|54576007|FG000|Overall Study|loss of neuromonitoring signals|0|||
27918831|NCT01325493|54576008|FG001|Overall Study|loss of neuromonitoring signals|2|||
27918832|NCT01325493|54576007|FG000|Overall Study|Allergy|1|||
27918833|NCT01325493|54576008|FG001|Overall Study|Allergy|0|||
27918834|NCT01323972|54576018|FG000|Overall Study|Withdrawal by Subject|1|||
27918835|NCT01323972|54576019|FG001|Overall Study|Withdrawal by Subject|0|||
27918836|NCT01323972|54576020|FG002|Overall Study|Withdrawal by Subject|1|||
27918837|NCT01323972|54576021|FG003|Overall Study|Withdrawal by Subject|0|||
27918838|NCT01323972|54576018|FG000|Overall Study|Migrated/moved from study area|1|||
27918839|NCT01323972|54576019|FG001|Overall Study|Migrated/moved from study area|2|||
27918840|NCT01323972|54576020|FG002|Overall Study|Migrated/moved from study area|0|||
27918841|NCT01323972|54576021|FG003|Overall Study|Migrated/moved from study area|0|||
27918842|NCT01323972|54576018|FG000|Overall Study|Lost to Follow-up|0|||
27918843|NCT01323972|54576019|FG001|Overall Study|Lost to Follow-up|1|||
27918844|NCT01323972|54576020|FG002|Overall Study|Lost to Follow-up|1|||
27918845|NCT01323972|54576021|FG003|Overall Study|Lost to Follow-up|1|||
27918846|NCT01325337|54576038|FG000|Overall Study|Adverse Event|0|||
27918847|NCT01325337|54576039|FG001|Overall Study|Adverse Event|2|||
27918848|NCT01325337|54576040|FG002|Overall Study|Adverse Event|2|||
27918849|NCT01325337|54576041|FG003|Overall Study|Adverse Event|1|||
27918850|NCT01325337|54576042|FG004|Overall Study|Adverse Event|2|||
27918851|NCT01325337|54576038|FG000|Overall Study|Lost to Follow-up|2|||
27918852|NCT01325337|54576039|FG001|Overall Study|Lost to Follow-up|2|||
27918853|NCT01325337|54576040|FG002|Overall Study|Lost to Follow-up|2|||
27918854|NCT01325337|54576041|FG003|Overall Study|Lost to Follow-up|1|||
27918855|NCT01325337|54576042|FG004|Overall Study|Lost to Follow-up|2|||
27918856|NCT01325337|54576038|FG000|Overall Study|Personal Reasons|2|||
27918857|NCT01325337|54576039|FG001|Overall Study|Personal Reasons|5|||
27918858|NCT01325337|54576040|FG002|Overall Study|Personal Reasons|4|||
27918859|NCT01325337|54576041|FG003|Overall Study|Personal Reasons|8|||
27918860|NCT01325337|54576042|FG004|Overall Study|Personal Reasons|3|||
27918861|NCT01325337|54576038|FG000|Overall Study|Withdrawal by Subject|1|||
27918862|NCT01325337|54576039|FG001|Overall Study|Withdrawal by Subject|0|||
27918863|NCT01325337|54576040|FG002|Overall Study|Withdrawal by Subject|1|||
27918864|NCT01325337|54576041|FG003|Overall Study|Withdrawal by Subject|0|||
27918865|NCT01325337|54576042|FG004|Overall Study|Withdrawal by Subject|1|||
27918866|NCT01324947|54576054|FG000|Overall Study|Adverse Event|7|||
27918867|NCT01324947|54576054|FG000|Overall Study|Death|10|||
27918868|NCT01324947|54576054|FG000|Overall Study|Other|3|||
27918869|NCT01324947|54576054|FG000|Overall Study|Progressive Disease|50|||
27918870|NCT01324947|54576054|FG000|Overall Study|Withdrawal by Subject|3|||
28007970|NCT00773747|54666845|FG001|Overall Study|Withdrawal by Subject|61|||
28007971|NCT00773747|54666844|FG000|Overall Study|Adverse Event|61|||
28007972|NCT00773747|54666845|FG001|Overall Study|Adverse Event|62|||
28007973|NCT00773747|54666844|FG000|Overall Study|Death|5|||
28007974|NCT00773747|54666845|FG001|Overall Study|Death|8|||
28007975|NCT00773747|54666844|FG000|Overall Study|Not Treated|2|||
28007976|NCT00773747|54666845|FG001|Overall Study|Not Treated|0|||
28007977|NCT00784277|54666855|FG000|IR Treatment|Adverse Event|4|||
28007978|NCT00784277|54666856|FG001|IR Treatment|Adverse Event|8|||
28007979|NCT00784277|54666857|FG002|IR Treatment|Adverse Event|19|||
28007980|NCT00784277|54666858|FG003|IR Treatment|Adverse Event|35|||
28007981|NCT00784277|54666859|FG004|IR Treatment|Adverse Event|0|||
27918871|NCT01324947|54576054|FG000|Overall Study|1 discontinued before starting drug|1|||
28007982|NCT00784277|54666860|FG005|IR Treatment|Adverse Event|0|||
28007983|NCT00784277|54666861|FG006|IR Treatment|Adverse Event|0|||
28007984|NCT00784277|54666855|FG000|IR Treatment|Lack of Efficacy|4|||
27918872|NCT01101841|54576062|FG000|Overall Study|Adverse Event|15|||
27918873|NCT01101841|54576063|FG001|Overall Study|Adverse Event|15|||
27918874|NCT01101841|54576062|FG000|Overall Study|Lost to Follow-up|9|||
27918875|NCT01101841|54576063|FG001|Overall Study|Lost to Follow-up|3|||
27918876|NCT01101841|54576062|FG000|Overall Study|Withdrawal by Subject|21|||
27918877|NCT01101841|54576063|FG001|Overall Study|Withdrawal by Subject|40|||
28007985|NCT00784277|54666856|FG001|IR Treatment|Lack of Efficacy|4|||
28007986|NCT00784277|54666857|FG002|IR Treatment|Lack of Efficacy|1|||
27918878|NCT01101841|54576062|FG000|Overall Study|Protocol Violation|1|||
27918879|NCT01101841|54576063|FG001|Overall Study|Protocol Violation|1|||
27918880|NCT01101841|54576062|FG000|Overall Study|Physician Decision|0|||
27918881|NCT01101841|54576063|FG001|Overall Study|Physician Decision|2|||
27918882|NCT01101841|54576062|FG000|Overall Study|Lack of Efficacy|0|||
27918883|NCT01101841|54576063|FG001|Overall Study|Lack of Efficacy|2|||
27918884|NCT01101841|54576062|FG000|Overall Study|Other|0|||
27918885|NCT01101841|54576063|FG001|Overall Study|Other|1|||
27918886|NCT01101841|54576062|FG000|Overall Study|Suicidality Tracking Scale|3|||
27918887|NCT01101841|54576063|FG001|Overall Study|Suicidality Tracking Scale|1|||
27918888|NCT01101841|54576062|FG000|Overall Study|Eligibility Criteria|1|||
27918889|NCT01101841|54576063|FG001|Overall Study|Eligibility Criteria|2|||
27918890|NCT01324401|54576072|FG000|Overall Study|Withdrawn before any treatment|0|||
27918891|NCT01324401|54576073|FG001|Overall Study|Withdrawn before any treatment|3|||
27918892|NCT01324401|54576072|FG000|Overall Study|Adverse Event|1|||
27918893|NCT01324401|54576073|FG001|Overall Study|Adverse Event|3|||
27918894|NCT01323660|54576079|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|6|||
27918895|NCT01323660|54576080|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
27918896|NCT01323660|54576081|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
27918897|NCT01323660|54576082|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
27918898|NCT01323660|54576083|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
27918899|NCT01323660|54576084|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|4|||
27918900|NCT01323660|54576079|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
27918901|NCT01323660|54576080|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
27918902|NCT01323660|54576081|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
27918903|NCT01323660|54576082|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
27918904|NCT01323660|54576083|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
27918905|NCT01323660|54576084|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3|||
27918906|NCT01323660|54576079|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
27918907|NCT01323660|54576080|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
27918908|NCT01323660|54576081|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
27918909|NCT01323660|54576082|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
27918910|NCT01323660|54576083|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
27918911|NCT01323660|54576084|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
27918912|NCT01323660|54576079|FG000|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
27918913|NCT01323660|54576080|FG001|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
27918914|NCT01323660|54576081|FG002|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
27918915|NCT01323660|54576082|FG003|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
27918916|NCT01323660|54576083|FG004|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1|||
27918917|NCT01323660|54576084|FG005|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
27918918|NCT01323660|54576079|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
27918919|NCT01323660|54576080|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
27918920|NCT01323660|54576081|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
27918921|NCT01323660|54576082|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
27918922|NCT01323660|54576083|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
27918923|NCT01323660|54576084|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
27918924|NCT01323660|54576079|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5|||
27918925|NCT01323660|54576080|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
27918926|NCT01323660|54576081|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
27918927|NCT01323660|54576082|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
27918928|NCT01323660|54576083|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3|||
27918929|NCT01323660|54576084|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
27918930|NCT01323660|54576079|FG000|Washout Period (14 Days)|Adverse Event|0|||
27918931|NCT01323660|54576080|FG001|Washout Period (14 Days)|Adverse Event|0|||
27918932|NCT01323660|54576081|FG002|Washout Period (14 Days)|Adverse Event|0|||
27918933|NCT01323660|54576082|FG003|Washout Period (14 Days)|Adverse Event|0|||
27918934|NCT01323660|54576083|FG004|Washout Period (14 Days)|Adverse Event|1|||
27918935|NCT01323660|54576084|FG005|Washout Period (14 Days)|Adverse Event|0|||
27918936|NCT01323660|54576079|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
27918937|NCT01323660|54576080|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
27918938|NCT01323660|54576081|FG002|Washout Period (14 Days)|Lack of Efficacy|1|||
27918939|NCT01323660|54576082|FG003|Washout Period (14 Days)|Lack of Efficacy|3|||
27918940|NCT01323660|54576083|FG004|Washout Period (14 Days)|Lack of Efficacy|2|||
27918941|NCT01323660|54576084|FG005|Washout Period (14 Days)|Lack of Efficacy|2|||
27918942|NCT01323660|54576079|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
28007987|NCT00784277|54666858|FG003|IR Treatment|Lack of Efficacy|0|||
27918943|NCT01323660|54576080|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
27918944|NCT01323660|54576081|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
27918945|NCT01323660|54576082|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
27918946|NCT01323660|54576083|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
27918947|NCT01323660|54576084|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|2|||
27918948|NCT01323660|54576079|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9|||
27918949|NCT01323660|54576080|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
27918950|NCT01323660|54576081|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
27918951|NCT01323660|54576082|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
27918952|NCT01323660|54576083|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
27918953|NCT01323660|54576084|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
27918954|NCT01323660|54576079|FG000|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
27918955|NCT01323660|54576080|FG001|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
27918956|NCT01323660|54576081|FG002|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
27918957|NCT01323660|54576082|FG003|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
27918958|NCT01323660|54576083|FG004|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
27918959|NCT01323660|54576084|FG005|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1|||
27918960|NCT01323660|54576079|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
27918961|NCT01323660|54576080|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
27918962|NCT01323660|54576081|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
27918963|NCT01323660|54576082|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
27918964|NCT01323660|54576083|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
27918965|NCT01323660|54576084|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
27918966|NCT01323660|54576079|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
27918967|NCT01323660|54576080|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
27918968|NCT01323660|54576081|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
27918969|NCT01323660|54576082|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
27918970|NCT01323660|54576083|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
27918971|NCT01323660|54576084|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
27918972|NCT01092637|54576100|FG000|Overall Study|Death|47|||
27918973|NCT01092637|54576101|FG001|Overall Study|Death|49|||
27918974|NCT01324323|54576108|FG000|Overall Study|Withdrawal by Subject|1|||
27918975|NCT01323582|54576122|FG000|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
27918976|NCT01323582|54576123|FG001|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
27918977|NCT01323582|54576122|FG000|Weeks 5-7 (Washout)|Withdrawal by Subject|0|||
27918978|NCT01323582|54576123|FG001|Weeks 5-7 (Washout)|Withdrawal by Subject|1|||
27918979|NCT01323582|54576122|FG000|Weeks 8-11 (Period 2)|Withdrawal by Subject|0|||
27918980|NCT01323582|54576123|FG001|Weeks 8-11 (Period 2)|Withdrawal by Subject|1|||
27918981|NCT01323621|54576133|FG000|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121|||
27918982|NCT01323621|54576134|FG001|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
27918983|NCT01323621|54576135|FG002|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
27918984|NCT01323621|54576133|FG000|2-week, Single-blind Run In Period|Physician Decision|7|||
27918985|NCT01323621|54576134|FG001|2-week, Single-blind Run In Period|Physician Decision|0|||
27918986|NCT01323621|54576135|FG002|2-week, Single-blind Run In Period|Physician Decision|0|||
27918987|NCT01323621|54576133|FG000|2-week, Single-blind Run In Period|Withdrawal by Subject|12|||
27918988|NCT01323621|54576134|FG001|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
27918989|NCT01323621|54576135|FG002|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
27918990|NCT01323621|54576133|FG000|2-week, Single-blind Run In Period|Protocol Violation|1|||
27918991|NCT01323621|54576134|FG001|2-week, Single-blind Run In Period|Protocol Violation|0|||
27918992|NCT01323621|54576135|FG002|2-week, Single-blind Run In Period|Protocol Violation|0|||
27918993|NCT01323621|54576133|FG000|2-week, Single-blind Run In Period|Lost to Follow-up|1|||
27918994|NCT01323621|54576134|FG001|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
27918995|NCT01323621|54576135|FG002|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
27918996|NCT01323621|54576133|FG000|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86|||
27918997|NCT01323621|54576134|FG001|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
27918998|NCT01323621|54576135|FG002|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
27918999|NCT01323621|54576133|FG000|12-week, Double-blind Treatment Period|Adverse Event|0|||
27919000|NCT01323621|54576134|FG001|12-week, Double-blind Treatment Period|Adverse Event|1|||
27919001|NCT01323621|54576135|FG002|12-week, Double-blind Treatment Period|Adverse Event|5|||
27919002|NCT01323621|54576133|FG000|12-week, Double-blind Treatment Period|Lack of Efficacy|0|||
27919003|NCT01323621|54576134|FG001|12-week, Double-blind Treatment Period|Lack of Efficacy|2|||
27919004|NCT01323621|54576135|FG002|12-week, Double-blind Treatment Period|Lack of Efficacy|6|||
27919005|NCT01323621|54576133|FG000|12-week, Double-blind Treatment Period|Protocol Violation|0|||
27919006|NCT01323621|54576134|FG001|12-week, Double-blind Treatment Period|Protocol Violation|4|||
27919007|NCT01323621|54576135|FG002|12-week, Double-blind Treatment Period|Protocol Violation|4|||
27919008|NCT01323621|54576133|FG000|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
27919009|NCT01323621|54576134|FG001|12-week, Double-blind Treatment Period|Lost to Follow-up|1|||
27919010|NCT01323621|54576135|FG002|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
27919011|NCT01323621|54576133|FG000|12-week, Double-blind Treatment Period|Physician Decision|0|||
27919012|NCT01323621|54576134|FG001|12-week, Double-blind Treatment Period|Physician Decision|2|||
27919013|NCT01323621|54576135|FG002|12-week, Double-blind Treatment Period|Physician Decision|1|||
27919014|NCT01323621|54576133|FG000|12-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
27919015|NCT01323621|54576134|FG001|12-week, Double-blind Treatment Period|Withdrawal by Subject|5|||
27919016|NCT01323621|54576135|FG002|12-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
27919017|NCT01323192|54576143|FG000|Overall Study|Adverse Event|6|||
27919018|NCT01323192|54576144|FG001|Overall Study|Adverse Event|1|||
27919019|NCT01323192|54576143|FG000|Overall Study|Withdrawal by Subject|3|||
27919020|NCT01323192|54576144|FG001|Overall Study|Withdrawal by Subject|1|||
27919021|NCT01323192|54576143|FG000|Overall Study|Noncompliance with study medication|0|||
27919022|NCT01323192|54576144|FG001|Overall Study|Noncompliance with study medication|3|||
27919023|NCT01323192|54576143|FG000|Overall Study|Nonmedical reasons|0|||
27919024|NCT01323192|54576144|FG001|Overall Study|Nonmedical reasons|1|||
27919025|NCT01323387|54576150|FG000|Overall Study|Withdrawal by Subject|41|||
27919026|NCT01323387|54576150|FG000|Overall Study|Radiographic Data Unavailable|1|||
27919027|NCT01323387|54576150|FG000|Overall Study|Revision|14|||
27919028|NCT01323387|54576150|FG000|Overall Study|Protocol Violation|12|||
27919029|NCT01323387|54576150|FG000|Overall Study|Randomized but Never Treated|16|||
27919030|NCT01321749|54576158|FG000|Overall Study|Lost to Follow-up|4|||
27919031|NCT01321749|54576159|FG001|Overall Study|Lost to Follow-up|11|||
27919032|NCT01321749|54576158|FG000|Overall Study|Protocol Violation|4|||
27919033|NCT01321749|54576159|FG001|Overall Study|Protocol Violation|7|||
27919034|NCT01321749|54576158|FG000|Overall Study|Withdrawal by Subject|5|||
27919035|NCT01321749|54576159|FG001|Overall Study|Withdrawal by Subject|4|||
27919036|NCT01320735|54576165|FG000|Overall Study|Adverse Event|3|||
27919037|NCT01320735|54576165|FG000|Overall Study|Withdrawal by Subject|3|||
27919038|NCT01320735|54576165|FG000|Overall Study|Lost to Follow-up|13|||
27919039|NCT01320735|54576165|FG000|Overall Study|Administrative Reason|6|||
27919040|NCT01320735|54576165|FG000|Overall Study|Progression/Hormone-Refractory Pca|55|||
27919041|NCT01320735|54576165|FG000|Overall Study|Protocol Violation|1|||
27919042|NCT01320735|54576165|FG000|Overall Study|Other|1|||
27919043|NCT01320735|54576165|FG000|Overall Study|No Decrease of Prostate Specific Antigen|7|||
27919044|NCT01320735|54576165|FG000|Overall Study|Investigator Unable to be Contacted|17|||
27919045|NCT01320033|54576172|FG000|Overall Study|Lack of Efficacy|0|||
27919046|NCT01320033|54576173|FG001|Overall Study|Lack of Efficacy|0|||
27919047|NCT01320033|54576174|FG002|Overall Study|Lack of Efficacy|1|||
27919048|NCT01320033|54576172|FG000|Overall Study|Adverse Event|9|||
27919049|NCT01320033|54576173|FG001|Overall Study|Adverse Event|7|||
27919050|NCT01320033|54576174|FG002|Overall Study|Adverse Event|8|||
27919051|NCT01320033|54576172|FG000|Overall Study|Withdrawal by Subject|22|||
27919052|NCT01320033|54576173|FG001|Overall Study|Withdrawal by Subject|23|||
27919053|NCT01320033|54576174|FG002|Overall Study|Withdrawal by Subject|23|||
27919054|NCT01320033|54576172|FG000|Overall Study|Protocol Violation|3|||
27919055|NCT01320033|54576173|FG001|Overall Study|Protocol Violation|5|||
27919056|NCT01320033|54576174|FG002|Overall Study|Protocol Violation|3|||
27919057|NCT01320033|54576172|FG000|Overall Study|Lost to Follow-up|22|||
27919058|NCT01320033|54576173|FG001|Overall Study|Lost to Follow-up|26|||
27919059|NCT01320033|54576174|FG002|Overall Study|Lost to Follow-up|17|||
27919060|NCT01320033|54576172|FG000|Overall Study|Other|2|||
27919061|NCT01320033|54576173|FG001|Overall Study|Other|3|||
27919062|NCT01320033|54576174|FG002|Overall Study|Other|1|||
27919063|NCT01101061|54576188|FG000|Overall Study|Adverse Event|0|||
27919064|NCT01101061|54576189|FG001|Overall Study|Adverse Event|0|||
27919065|NCT01101061|54576190|FG002|Overall Study|Adverse Event|1|||
27919066|NCT01101061|54576191|FG003|Overall Study|Adverse Event|0|||
27919067|NCT01101061|54576192|FG004|Overall Study|Adverse Event|0|||
27919068|NCT01101061|54576193|FG005|Overall Study|Adverse Event|0|||
27919069|NCT01317615|54576211|FG000|Overall Study|Disease progression|25|||
27919070|NCT01317615|54576211|FG000|Overall Study|New cancer therapy|5|||
27919071|NCT01317615|54576211|FG000|Overall Study|Death|6|||
27919072|NCT01317615|54576211|FG000|Overall Study|Withdrawal by Subject|5|||
27919073|NCT01317615|54576211|FG000|Overall Study|Abnormal laboratory value(s)|1|||
27919074|NCT01317615|54576211|FG000|Overall Study|Adverse Event|7|||
27919075|NCT01078675|54576217|FG000|Overall Study|Withdrawal by Subject|7|||
27919076|NCT01078675|54576218|FG001|Overall Study|Withdrawal by Subject|3|||
27919077|NCT01078675|54576217|FG000|Overall Study|Protocol Violation|56|||
27919078|NCT01078675|54576218|FG001|Overall Study|Protocol Violation|0|||
27919079|NCT01078675|54576217|FG000|Overall Study|Provided in CRF for specific reasons|2|||
27919080|NCT01078675|54576218|FG001|Overall Study|Provided in CRF for specific reasons|3|||
27919081|NCT01078675|54576217|FG000|Overall Study|Adverse Event|3|||
27919082|NCT01078675|54576218|FG001|Overall Study|Adverse Event|0|||
27919083|NCT01100437|54576224|FG000|Titration/Stabilization|Adverse Event|0|||
27919084|NCT01100437|54576225|FG001|Titration/Stabilization|Adverse Event|0|||
28007988|NCT00784277|54666859|FG004|IR Treatment|Lack of Efficacy|0|||
27919085|NCT01100437|54576226|FG002|Titration/Stabilization|Adverse Event|4|||
27919086|NCT01100437|54576224|FG000|Titration/Stabilization|Non-compliance|0|||
27919087|NCT01100437|54576225|FG001|Titration/Stabilization|Non-compliance|0|||
27919088|NCT01100437|54576226|FG002|Titration/Stabilization|Non-compliance|1|||
27919089|NCT01100437|54576224|FG000|Titration/Stabilization|Sponsor canceled study|0|||
27919090|NCT01100437|54576225|FG001|Titration/Stabilization|Sponsor canceled study|0|||
27919091|NCT01100437|54576226|FG002|Titration/Stabilization|Sponsor canceled study|1|||
27919092|NCT01100437|54576224|FG000|Maintenance|Withdrawal by Subject|0|||
27919093|NCT01100437|54576225|FG001|Maintenance|Withdrawal by Subject|0|||
27919094|NCT01100437|54576226|FG002|Maintenance|Withdrawal by Subject|1|||
27919095|NCT01100437|54576224|FG000|Maintenance|Sponsor termination of study|0|||
27919096|NCT01100437|54576225|FG001|Maintenance|Sponsor termination of study|0|||
27919097|NCT01100437|54576226|FG002|Maintenance|Sponsor termination of study|1|||
27919098|NCT01322490|54576238|FG000|Treatment Period|Adverse Event|12|||
27919099|NCT01322490|54576239|FG001|Treatment Period|Adverse Event|18|||
27919100|NCT01322490|54576240|FG002|Treatment Period|Adverse Event|15|||
27919101|NCT01322490|54576238|FG000|Treatment Period|Death|5|||
27919102|NCT01322490|54576239|FG001|Treatment Period|Death|7|||
27919103|NCT01322490|54576240|FG002|Treatment Period|Death|3|||
27919104|NCT01322490|54576238|FG000|Treatment Period|Lack of Efficacy|89|||
27919105|NCT01322490|54576239|FG001|Treatment Period|Lack of Efficacy|100|||
27919106|NCT01322490|54576240|FG002|Treatment Period|Lack of Efficacy|112|||
27919107|NCT01322490|54576238|FG000|Treatment Period|Physician Decision|0|||
27919108|NCT01322490|54576239|FG001|Treatment Period|Physician Decision|2|||
27919109|NCT01322490|54576240|FG002|Treatment Period|Physician Decision|1|||
27919110|NCT01322490|54576238|FG000|Treatment Period|Protocol Violation|7|||
27919111|NCT01322490|54576239|FG001|Treatment Period|Protocol Violation|5|||
27919112|NCT01322490|54576240|FG002|Treatment Period|Protocol Violation|4|||
27919113|NCT01322490|54576238|FG000|Treatment Period|Withdrawal by Subject|14|||
27919114|NCT01322490|54576239|FG001|Treatment Period|Withdrawal by Subject|16|||
27919115|NCT01322490|54576240|FG002|Treatment Period|Withdrawal by Subject|11|||
27919116|NCT01322490|54576238|FG000|Treatment Period|Non-compliance with study drug|0|||
27919117|NCT01322490|54576239|FG001|Treatment Period|Non-compliance with study drug|0|||
27919118|NCT01322490|54576240|FG002|Treatment Period|Non-compliance with study drug|1|||
27919119|NCT01322490|54576238|FG000|Treatment Period|Other per report|2|||
27919120|NCT01322490|54576239|FG001|Treatment Period|Other per report|2|||
27919121|NCT01322490|54576240|FG002|Treatment Period|Other per report|1|||
27919122|NCT01322490|54576238|FG000|Treatment Period|Randomized but Not Treated|3|||
27919123|NCT01322490|54576239|FG001|Treatment Period|Randomized but Not Treated|3|||
27919124|NCT01322490|54576240|FG002|Treatment Period|Randomized but Not Treated|5|||
27919125|NCT01322490|54576238|FG000|Long Term Follow-up Period|Death|235|||
27919126|NCT01322490|54576239|FG001|Long Term Follow-up Period|Death|239|||
27919127|NCT01322490|54576240|FG002|Long Term Follow-up Period|Death|236|||
27919128|NCT01322490|54576238|FG000|Long Term Follow-up Period|Lost to Follow-up|2|||
27919129|NCT01322490|54576239|FG001|Long Term Follow-up Period|Lost to Follow-up|2|||
27919130|NCT01322490|54576240|FG002|Long Term Follow-up Period|Lost to Follow-up|3|||
27919131|NCT01322490|54576238|FG000|Long Term Follow-up Period|Withdrawal by Subject|9|||
27919132|NCT01322490|54576239|FG001|Long Term Follow-up Period|Withdrawal by Subject|6|||
27919133|NCT01322490|54576240|FG002|Long Term Follow-up Period|Withdrawal by Subject|6|||
27919134|NCT01322490|54576238|FG000|Long Term Follow-up Period|Study Terminated by Sponsor|160|||
27919135|NCT01322490|54576239|FG001|Long Term Follow-up Period|Study Terminated by Sponsor|158|||
27919136|NCT01322490|54576240|FG002|Long Term Follow-up Period|Study Terminated by Sponsor|165|||
27919137|NCT01322490|54576238|FG000|Long Term Follow-up Period|Other per report|3|||
27919138|NCT01322490|54576239|FG001|Long Term Follow-up Period|Other per report|2|||
27919139|NCT01322490|54576240|FG002|Long Term Follow-up Period|Other per report|2|||
27919140|NCT01322490|54576238|FG000|Long Term Follow-up Period|Unknown/Missing|0|||
27919141|NCT01322490|54576239|FG001|Long Term Follow-up Period|Unknown/Missing|1|||
27919142|NCT01322490|54576240|FG002|Long Term Follow-up Period|Unknown/Missing|1|||
27919143|NCT01314261|54576252|FG000|Overall Study|Adverse Event|1|||
27919144|NCT01314261|54576253|FG001|Overall Study|Adverse Event|0|||
27919145|NCT01314261|54576254|FG002|Overall Study|Adverse Event|0|||
27919146|NCT01314261|54576255|FG003|Overall Study|Adverse Event|0|||
27919147|NCT01314261|54576252|FG000|Overall Study|Withdrawal by Subject|0|||
27919148|NCT01314261|54576253|FG001|Overall Study|Withdrawal by Subject|3|||
27919149|NCT01314261|54576254|FG002|Overall Study|Withdrawal by Subject|1|||
27919150|NCT01314261|54576255|FG003|Overall Study|Withdrawal by Subject|0|||
27919151|NCT01314261|54576252|FG000|Overall Study|Lost to Follow-up|1|||
27919152|NCT01314261|54576253|FG001|Overall Study|Lost to Follow-up|0|||
27919153|NCT01314261|54576254|FG002|Overall Study|Lost to Follow-up|2|||
27919154|NCT01314261|54576255|FG003|Overall Study|Lost to Follow-up|2|||
27919155|NCT01314261|54576252|FG000|Overall Study|Virologic Failure|0|||
27919156|NCT01314261|54576253|FG001|Overall Study|Virologic Failure|1|||
27919157|NCT01314261|54576254|FG002|Overall Study|Virologic Failure|0|||
27919158|NCT01314261|54576255|FG003|Overall Study|Virologic Failure|1|||
27919159|NCT01321710|54576268|FG000|Overall Study|Lost to Follow-up|4|||
27919160|NCT01321710|54576269|FG001|Overall Study|Lost to Follow-up|5|||
27919161|NCT01321710|54576270|FG002|Overall Study|Lost to Follow-up|0|||
27919162|NCT01321008|54576280|FG000|Overall Study|Early Study Termination|1|||
27919163|NCT01320150|54576286|FG000|Overall Study|Protocol Violation|15|||
27919164|NCT01320150|54576286|FG000|Overall Study|Withdrawal by Subject|5|||
27919165|NCT01320150|54576286|FG000|Overall Study|Death|2|||
27919166|NCT01320150|54576286|FG000|Overall Study|Lost to Follow-up|44|||
27919167|NCT01323530|54576297|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
27919168|NCT01323530|54576298|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
27919169|NCT01323530|54576299|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
27919170|NCT01323530|54576300|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
27919171|NCT01323530|54576301|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
27919172|NCT01323530|54576302|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
27919173|NCT01323530|54576303|FG006|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
27919174|NCT01323530|54576297|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
27919175|NCT01323530|54576298|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
27919176|NCT01323530|54576299|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
27919177|NCT01323530|54576300|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
27919178|NCT01323530|54576301|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2|||
27919179|NCT01323530|54576302|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
27919180|NCT01323530|54576303|FG006|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
27919181|NCT01323530|54576297|FG000|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
27919182|NCT01323530|54576298|FG001|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
27919183|NCT01323530|54576299|FG002|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
27919184|NCT01323530|54576300|FG003|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
27919185|NCT01323530|54576301|FG004|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
27919186|NCT01323530|54576302|FG005|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
27919187|NCT01323530|54576303|FG006|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
27919188|NCT01323530|54576297|FG000|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
27919189|NCT01323530|54576298|FG001|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
27919190|NCT01323530|54576299|FG002|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
27919191|NCT01323530|54576300|FG003|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
27919192|NCT01323530|54576301|FG004|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
27919193|NCT01323530|54576302|FG005|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
27919194|NCT01323530|54576303|FG006|Phase 2 (Dose-confirmation Phase)|Adverse Event|2|||
27919195|NCT01323530|54576297|FG000|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
27919196|NCT01323530|54576298|FG001|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
27919197|NCT01323530|54576299|FG002|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
27919198|NCT01323530|54576300|FG003|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
27919199|NCT01323530|54576301|FG004|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
27919200|NCT01323530|54576302|FG005|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
27919201|NCT01323530|54576303|FG006|Phase 2 (Dose-confirmation Phase)|Clinical progression|3|||
27919202|NCT01323530|54576297|FG000|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
27919203|NCT01323530|54576298|FG001|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
27919204|NCT01323530|54576299|FG002|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
27919205|NCT01323530|54576300|FG003|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
27919206|NCT01323530|54576301|FG004|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
27919207|NCT01323530|54576302|FG005|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
27919208|NCT01323530|54576303|FG006|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8|||
27919209|NCT01323530|54576297|FG000|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
27919210|NCT01323530|54576298|FG001|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
27919211|NCT01323530|54576299|FG002|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
27919212|NCT01323530|54576300|FG003|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
27919213|NCT01323530|54576301|FG004|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
27919214|NCT01323530|54576302|FG005|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
27919215|NCT01323530|54576303|FG006|Phase 2 (Dose-confirmation Phase)|Investigators decision|3|||
27919216|NCT01323530|54576297|FG000|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
27919217|NCT01323530|54576298|FG001|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
27919218|NCT01323530|54576299|FG002|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
27919219|NCT01323530|54576300|FG003|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
27919220|NCT01323530|54576301|FG004|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
27919221|NCT01323530|54576302|FG005|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
27919222|NCT01323530|54576303|FG006|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1|||
27919223|NCT01313637|54576324|FG000|Overall Study|Adverse Event|17|||
27919224|NCT01313637|54576325|FG001|Overall Study|Adverse Event|24|||
27919225|NCT01313637|54576326|FG002|Overall Study|Adverse Event|25|||
28007989|NCT00784277|54666860|FG005|IR Treatment|Lack of Efficacy|0|||
28007990|NCT00784277|54666861|FG006|IR Treatment|Lack of Efficacy|0|||
27741343|NCT02712905|54191357|FG003|Monotherapy|Adverse Event|0|||
27919226|NCT01313637|54576327|FG003|Overall Study|Adverse Event|18|||
27919227|NCT01313637|54576324|FG000|Overall Study|Lack of Efficacy|44|||
27919228|NCT01313637|54576325|FG001|Overall Study|Lack of Efficacy|38|||
27919229|NCT01313637|54576326|FG002|Overall Study|Lack of Efficacy|37|||
27919230|NCT01313637|54576327|FG003|Overall Study|Lack of Efficacy|24|||
27919231|NCT01313637|54576324|FG000|Overall Study|Protocol Violation|4|||
27919232|NCT01313637|54576325|FG001|Overall Study|Protocol Violation|3|||
27919233|NCT01313637|54576326|FG002|Overall Study|Protocol Violation|11|||
27919234|NCT01313637|54576327|FG003|Overall Study|Protocol Violation|5|||
27919235|NCT01313637|54576324|FG000|Overall Study|Met Protocol- Defined Stopping Criteria|16|||
27919236|NCT01313637|54576325|FG001|Overall Study|Met Protocol- Defined Stopping Criteria|15|||
27919237|NCT01313637|54576326|FG002|Overall Study|Met Protocol- Defined Stopping Criteria|14|||
27919238|NCT01313637|54576327|FG003|Overall Study|Met Protocol- Defined Stopping Criteria|13|||
27919239|NCT01313637|54576324|FG000|Overall Study|Lost to Follow-up|0|||
27919240|NCT01313637|54576325|FG001|Overall Study|Lost to Follow-up|2|||
27919241|NCT01313637|54576326|FG002|Overall Study|Lost to Follow-up|1|||
27919242|NCT01313637|54576327|FG003|Overall Study|Lost to Follow-up|3|||
27919243|NCT01313637|54576324|FG000|Overall Study|Withdrawal by Subject|11|||
27919244|NCT01313637|54576325|FG001|Overall Study|Withdrawal by Subject|13|||
27919245|NCT01313637|54576326|FG002|Overall Study|Withdrawal by Subject|18|||
27919246|NCT01313637|54576327|FG003|Overall Study|Withdrawal by Subject|15|||
27919247|NCT01320722|54576342|FG000|Overall Study|Did not Receive Intervention|3|||
27919248|NCT01320722|54576343|FG001|Overall Study|Did not Receive Intervention|2|||
27919249|NCT01320722|54576344|FG002|Overall Study|Did not Receive Intervention|1|||
27919250|NCT01320722|54576345|FG003|Overall Study|Did not Receive Intervention|1|||
27919251|NCT01320722|54576346|FG004|Overall Study|Did not Receive Intervention|2|||
27919252|NCT01320722|54576342|FG000|Overall Study|Lost to Follow-up|0|||
27919253|NCT01320722|54576343|FG001|Overall Study|Lost to Follow-up|1|||
27919254|NCT01320722|54576344|FG002|Overall Study|Lost to Follow-up|0|||
27919255|NCT01320722|54576345|FG003|Overall Study|Lost to Follow-up|1|||
27919256|NCT01320722|54576346|FG004|Overall Study|Lost to Follow-up|3|||
28007991|NCT00784277|54666855|FG000|IR Treatment|Lost to Follow-up|1|||
27919257|NCT01320722|54576342|FG000|Overall Study|Not Available for the 8 Week Visit|0|||
27919258|NCT01320722|54576343|FG001|Overall Study|Not Available for the 8 Week Visit|3|||
27919259|NCT01320722|54576344|FG002|Overall Study|Not Available for the 8 Week Visit|0|||
27919260|NCT01320722|54576345|FG003|Overall Study|Not Available for the 8 Week Visit|0|||
27919261|NCT01320722|54576346|FG004|Overall Study|Not Available for the 8 Week Visit|0|||
27919262|NCT01320722|54576342|FG000|Overall Study|Participant Developed a Rash|0|||
27919263|NCT01320722|54576343|FG001|Overall Study|Participant Developed a Rash|0|||
28007992|NCT00784277|54666856|FG001|IR Treatment|Lost to Follow-up|0|||
28007993|NCT00784277|54666857|FG002|IR Treatment|Lost to Follow-up|1|||
27919264|NCT01320722|54576344|FG002|Overall Study|Participant Developed a Rash|2|||
27919265|NCT01320722|54576345|FG003|Overall Study|Participant Developed a Rash|1|||
27919266|NCT01320722|54576346|FG004|Overall Study|Participant Developed a Rash|1|||
27919267|NCT01320722|54576342|FG000|Overall Study|Non-compliant with Medication|0|||
27919268|NCT01320722|54576343|FG001|Overall Study|Non-compliant with Medication|0|||
27919269|NCT01320722|54576344|FG002|Overall Study|Non-compliant with Medication|1|||
27919270|NCT01320722|54576345|FG003|Overall Study|Non-compliant with Medication|0|||
27919271|NCT01320722|54576346|FG004|Overall Study|Non-compliant with Medication|0|||
27919272|NCT01320722|54576342|FG000|Overall Study|Adverse Event|0|||
27919273|NCT01320722|54576343|FG001|Overall Study|Adverse Event|0|||
27919274|NCT01320722|54576344|FG002|Overall Study|Adverse Event|3|||
27919275|NCT01320722|54576345|FG003|Overall Study|Adverse Event|6|||
27919276|NCT01320722|54576346|FG004|Overall Study|Adverse Event|0|||
27919277|NCT01320722|54576342|FG000|Overall Study|Not Compliant with Study Procedures|0|||
27919278|NCT01320722|54576343|FG001|Overall Study|Not Compliant with Study Procedures|0|||
27919279|NCT01320722|54576344|FG002|Overall Study|Not Compliant with Study Procedures|0|||
27919280|NCT01320722|54576345|FG003|Overall Study|Not Compliant with Study Procedures|4|||
27919281|NCT01320722|54576346|FG004|Overall Study|Not Compliant with Study Procedures|0|||
27919282|NCT01320722|54576342|FG000|Overall Study|Pregnancy|0|||
27919283|NCT01320722|54576343|FG001|Overall Study|Pregnancy|0|||
27919284|NCT01320722|54576344|FG002|Overall Study|Pregnancy|0|||
27919285|NCT01320722|54576345|FG003|Overall Study|Pregnancy|1|||
27919286|NCT01320722|54576346|FG004|Overall Study|Pregnancy|0|||
27919287|NCT01320722|54576342|FG000|Overall Study|Started an Exclusionary Medication|0|||
27919288|NCT01320722|54576343|FG001|Overall Study|Started an Exclusionary Medication|0|||
27919289|NCT01320722|54576344|FG002|Overall Study|Started an Exclusionary Medication|0|||
27919290|NCT01320722|54576345|FG003|Overall Study|Started an Exclusionary Medication|0|||
27919291|NCT01320722|54576346|FG004|Overall Study|Started an Exclusionary Medication|1|||
27919292|NCT01320722|54576342|FG000|Overall Study|Withdrew due to Health Condition|0|||
27919293|NCT01320722|54576343|FG001|Overall Study|Withdrew due to Health Condition|0|||
27919294|NCT01320722|54576344|FG002|Overall Study|Withdrew due to Health Condition|0|||
27919295|NCT01320722|54576345|FG003|Overall Study|Withdrew due to Health Condition|0|||
27919296|NCT01320722|54576346|FG004|Overall Study|Withdrew due to Health Condition|1|||
27919297|NCT01313559|54576363|FG000|Overall Study|Withdrawal by Subject|1|||
27919298|NCT01313559|54576364|FG001|Overall Study|Withdrawal by Subject|2|||
27919299|NCT01313559|54576363|FG000|Overall Study|Disease progression|1|||
27919300|NCT01313559|54576364|FG001|Overall Study|Disease progression|0|||
27919301|NCT01313559|54576363|FG000|Overall Study|Rising PSA|2|||
27919302|NCT01313559|54576364|FG001|Overall Study|Rising PSA|0|||
27919303|NCT01312779|54576370|FG000|Overall Study|Withdrawal by Subject|2|||
27919304|NCT01312779|54576370|FG000|Overall Study|Death|3|||
27919305|NCT01312779|54576370|FG000|Overall Study|Not Implanted with Device|27|||
27919306|NCT01312467|54576383|FG000|Overall Study|Adverse Event|4|||
27919307|NCT01312467|54576383|FG000|Overall Study|Lost to Follow-up|1|||
27919308|NCT01312467|54576383|FG000|Overall Study|Withdrawal by Subject|2|||
27919309|NCT01312467|54576383|FG000|Overall Study|Deported to country of origin|1|||
27919310|NCT01312467|54576383|FG000|Overall Study|Another medical condition|1|||
27919311|NCT01312467|54576383|FG000|Overall Study|Ineligible|4|||
27919312|NCT01310127|54576390|FG000|Overall Study|Protocol Violation|1|||
27919313|NCT01310127|54576391|FG001|Overall Study|Protocol Violation|1|||
27919314|NCT01310127|54576390|FG000|Overall Study|advanced psc cataract outlier|1|||
27919315|NCT01310127|54576391|FG001|Overall Study|advanced psc cataract outlier|0|||
27919316|NCT01309893|54576397|FG000|Week 2 - Crossover Intervention|Lost to Follow-up|1|||
27919317|NCT01309893|54576398|FG001|Week 2 - Crossover Intervention|Lost to Follow-up|0|||
27919318|NCT01309893|54576397|FG000|Week 2 - Crossover Intervention|Missed crossover visit|0|||
27919319|NCT01309893|54576398|FG001|Week 2 - Crossover Intervention|Missed crossover visit|1|||
27919320|NCT01318902|54576408|FG000|Overall Study|Symptomatic Deterioration|0|||
27919321|NCT01318902|54576409|FG001|Overall Study|Symptomatic Deterioration|1|||
27919322|NCT01318902|54576410|FG002|Overall Study|Symptomatic Deterioration|1|||
27919323|NCT01318902|54576411|FG003|Overall Study|Symptomatic Deterioration|2|||
27919324|NCT01318902|54576408|FG000|Overall Study|Withdrawal by Patient|0|||
27919325|NCT01318902|54576409|FG001|Overall Study|Withdrawal by Patient|1|||
27919326|NCT01318902|54576410|FG002|Overall Study|Withdrawal by Patient|0|||
27919327|NCT01318902|54576411|FG003|Overall Study|Withdrawal by Patient|3|||
27919328|NCT01318902|54576408|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
27919329|NCT01318902|54576409|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
28007994|NCT00784277|54666858|FG003|IR Treatment|Lost to Follow-up|0|||
27919330|NCT01318902|54576410|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
27919331|NCT01318902|54576411|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
27919332|NCT01318902|54576408|FG000|Overall Study|Adverse Event|0|||
27919333|NCT01318902|54576409|FG001|Overall Study|Adverse Event|1|||
27919334|NCT01318902|54576410|FG002|Overall Study|Adverse Event|0|||
27919335|NCT01318902|54576411|FG003|Overall Study|Adverse Event|0|||
27919336|NCT01318902|54576408|FG000|Overall Study|Terminated by Sponsor|0|||
27919337|NCT01318902|54576409|FG001|Overall Study|Terminated by Sponsor|0|||
27919338|NCT01318902|54576410|FG002|Overall Study|Terminated by Sponsor|1|||
27919339|NCT01318902|54576411|FG003|Overall Study|Terminated by Sponsor|0|||
27919340|NCT01313858|54576426|FG000|Overall Study|Premature Treatment Termination|251|||
27919341|NCT01313858|54576427|FG001|Overall Study|Premature Treatment Termination|219|||
27919342|NCT01313858|54576428|FG002|Overall Study|Premature Treatment Termination|191|||
27919343|NCT01313858|54576426|FG000|Overall Study|Lost to Follow-up|35|||
27919344|NCT01313858|54576427|FG001|Overall Study|Lost to Follow-up|51|||
27919345|NCT01313858|54576428|FG002|Overall Study|Lost to Follow-up|47|||
27919346|NCT01090765|54576440|FG000|Overall Study|Patient withdrew consent|0|||
27919347|NCT01090765|54576441|FG001|Overall Study|Patient withdrew consent|0|||
27919348|NCT01090765|54576442|FG002|Overall Study|Patient withdrew consent|0|||
27919349|NCT01090765|54576443|FG003|Overall Study|Patient withdrew consent|0|||
27919350|NCT01090765|54576444|FG004|Overall Study|Patient withdrew consent|1|||
27919351|NCT01090765|54576445|FG005|Overall Study|Patient withdrew consent|1|||
27919352|NCT01090765|54576440|FG000|Overall Study|Developed a DVT, needed anticoagulation|0|||
28007995|NCT00784277|54666859|FG004|IR Treatment|Lost to Follow-up|0|||
28007996|NCT00784277|54666860|FG005|IR Treatment|Lost to Follow-up|0|||
28007997|NCT00784277|54666861|FG006|IR Treatment|Lost to Follow-up|0|||
28007998|NCT00784277|54666855|FG000|IR Treatment|Withdrawal by Subject|5|||
28007999|NCT00784277|54666856|FG001|IR Treatment|Withdrawal by Subject|1|||
28008000|NCT00784277|54666857|FG002|IR Treatment|Withdrawal by Subject|4|||
28008001|NCT00784277|54666858|FG003|IR Treatment|Withdrawal by Subject|6|||
28008002|NCT00784277|54666859|FG004|IR Treatment|Withdrawal by Subject|0|||
28008003|NCT00784277|54666860|FG005|IR Treatment|Withdrawal by Subject|0|||
28008004|NCT00784277|54666861|FG006|IR Treatment|Withdrawal by Subject|0|||
28008005|NCT00784277|54666855|FG000|IR Treatment|Resolution Of Pain|0|||
28008006|NCT00784277|54666856|FG001|IR Treatment|Resolution Of Pain|1|||
28008007|NCT00784277|54666857|FG002|IR Treatment|Resolution Of Pain|0|||
28008008|NCT00784277|54666858|FG003|IR Treatment|Resolution Of Pain|0|||
28008009|NCT00784277|54666859|FG004|IR Treatment|Resolution Of Pain|0|||
28008010|NCT00784277|54666860|FG005|IR Treatment|Resolution Of Pain|0|||
28008011|NCT00784277|54666861|FG006|IR Treatment|Resolution Of Pain|0|||
28008012|NCT00784277|54666855|FG000|IR Treatment|Other|2|||
28008013|NCT00784277|54666856|FG001|IR Treatment|Other|3|||
28008014|NCT00784277|54666857|FG002|IR Treatment|Other|3|||
28008015|NCT00784277|54666858|FG003|IR Treatment|Other|2|||
28008016|NCT00784277|54666859|FG004|IR Treatment|Other|0|||
28008017|NCT00784277|54666860|FG005|IR Treatment|Other|0|||
28008018|NCT00784277|54666861|FG006|IR Treatment|Other|0|||
28008019|NCT00784277|54666855|FG000|ER Treatment|Adverse Event|0|||
28008020|NCT00784277|54666856|FG001|ER Treatment|Adverse Event|0|||
28008021|NCT00784277|54666857|FG002|ER Treatment|Adverse Event|0|||
28008022|NCT00784277|54666858|FG003|ER Treatment|Adverse Event|0|||
28008023|NCT00784277|54666859|FG004|ER Treatment|Adverse Event|1|||
28008024|NCT00784277|54666860|FG005|ER Treatment|Adverse Event|7|||
28008025|NCT00784277|54666861|FG006|ER Treatment|Adverse Event|7|||
27741344|NCT02712905|54191358|FG004|Monotherapy|Adverse Event|0|||
27741345|NCT02712905|54191359|FG005|Monotherapy|Adverse Event|0|||
27919353|NCT01090765|54576441|FG001|Overall Study|Developed a DVT, needed anticoagulation|0|||
27919354|NCT01090765|54576442|FG002|Overall Study|Developed a DVT, needed anticoagulation|0|||
28008026|NCT00784277|54666855|FG000|ER Treatment|Lack of Efficacy|0|||
28008027|NCT00784277|54666856|FG001|ER Treatment|Lack of Efficacy|0|||
28008028|NCT00784277|54666857|FG002|ER Treatment|Lack of Efficacy|0|||
28008029|NCT00784277|54666858|FG003|ER Treatment|Lack of Efficacy|0|||
28008030|NCT00784277|54666859|FG004|ER Treatment|Lack of Efficacy|3|||
28008031|NCT00784277|54666860|FG005|ER Treatment|Lack of Efficacy|4|||
28008032|NCT00784277|54666861|FG006|ER Treatment|Lack of Efficacy|0|||
28008033|NCT00784277|54666855|FG000|ER Treatment|Lost to Follow-up|0|||
28008034|NCT00784277|54666856|FG001|ER Treatment|Lost to Follow-up|0|||
28008035|NCT00784277|54666857|FG002|ER Treatment|Lost to Follow-up|0|||
28008036|NCT00784277|54666858|FG003|ER Treatment|Lost to Follow-up|0|||
28008037|NCT00784277|54666859|FG004|ER Treatment|Lost to Follow-up|0|||
28008038|NCT00784277|54666860|FG005|ER Treatment|Lost to Follow-up|2|||
28008039|NCT00784277|54666861|FG006|ER Treatment|Lost to Follow-up|0|||
28008040|NCT00784277|54666855|FG000|ER Treatment|Withdrawal by Subject|0|||
28008041|NCT00784277|54666856|FG001|ER Treatment|Withdrawal by Subject|0|||
28008042|NCT00784277|54666857|FG002|ER Treatment|Withdrawal by Subject|0|||
28008043|NCT00784277|54666858|FG003|ER Treatment|Withdrawal by Subject|0|||
28008044|NCT00784277|54666859|FG004|ER Treatment|Withdrawal by Subject|2|||
28008045|NCT00784277|54666860|FG005|ER Treatment|Withdrawal by Subject|5|||
28008046|NCT00784277|54666861|FG006|ER Treatment|Withdrawal by Subject|3|||
28008047|NCT00784277|54666855|FG000|ER Treatment|Study Medication Non-Compliant|0|||
28008048|NCT00784277|54666856|FG001|ER Treatment|Study Medication Non-Compliant|0|||
28008049|NCT00784277|54666857|FG002|ER Treatment|Study Medication Non-Compliant|0|||
28008050|NCT00784277|54666858|FG003|ER Treatment|Study Medication Non-Compliant|0|||
28008051|NCT00784277|54666859|FG004|ER Treatment|Study Medication Non-Compliant|2|||
28008052|NCT00784277|54666860|FG005|ER Treatment|Study Medication Non-Compliant|3|||
28008053|NCT00784277|54666861|FG006|ER Treatment|Study Medication Non-Compliant|3|||
28008054|NCT00784277|54666855|FG000|ER Treatment|Other|0|||
28008055|NCT00784277|54666856|FG001|ER Treatment|Other|0|||
28008056|NCT00784277|54666857|FG002|ER Treatment|Other|0|||
28008057|NCT00784277|54666858|FG003|ER Treatment|Other|0|||
28008058|NCT00784277|54666859|FG004|ER Treatment|Other|1|||
28008059|NCT00784277|54666860|FG005|ER Treatment|Other|3|||
28008060|NCT00784277|54666861|FG006|ER Treatment|Other|2|||
28008061|NCT00682929|54666877|FG000|Overall Study|Adverse Event|4|||
28008062|NCT00682929|54666878|FG001|Overall Study|Adverse Event|1|||
28008063|NCT00682929|54666879|FG002|Overall Study|Adverse Event|1|||
28008064|NCT00682929|54666877|FG000|Overall Study|Withdrawal by Subject|1|||
28008065|NCT00682929|54666878|FG001|Overall Study|Withdrawal by Subject|2|||
28008066|NCT00682929|54666879|FG002|Overall Study|Withdrawal by Subject|1|||
28008067|NCT00682929|54666877|FG000|Overall Study|dosing compliance < 80%|0|||
28008068|NCT00682929|54666878|FG001|Overall Study|dosing compliance < 80%|2|||
28008069|NCT00682929|54666879|FG002|Overall Study|dosing compliance < 80%|0|||
28008070|NCT00682929|54666877|FG000|Overall Study|lag in DEA renewal|1|||
28008071|NCT00682929|54666878|FG001|Overall Study|lag in DEA renewal|0|||
28008072|NCT00682929|54666879|FG002|Overall Study|lag in DEA renewal|0|||
28008073|NCT00680745|54666891|FG000|Overall Study|Withdrawal by Subject|8|||
28008074|NCT00680745|54666892|FG001|Overall Study|Withdrawal by Subject|3|||
28008075|NCT00680745|54666893|FG002|Overall Study|Withdrawal by Subject|2|||
28008076|NCT00680745|54666894|FG003|Overall Study|Withdrawal by Subject|8|||
28008077|NCT00680745|54666891|FG000|Overall Study|Lost to Follow-up|0|||
28008078|NCT00680745|54666892|FG001|Overall Study|Lost to Follow-up|1|||
28008079|NCT00680745|54666893|FG002|Overall Study|Lost to Follow-up|1|||
28008080|NCT00680745|54666894|FG003|Overall Study|Lost to Follow-up|0|||
28008081|NCT00680745|54666891|FG000|Overall Study|Death|1|||
28008082|NCT00680745|54666892|FG001|Overall Study|Death|0|||
28008083|NCT00680745|54666893|FG002|Overall Study|Death|1|||
28008084|NCT00680745|54666894|FG003|Overall Study|Death|0|||
28008085|NCT00680745|54666891|FG000|Overall Study|Adverse Event|5|||
28008086|NCT00680745|54666892|FG001|Overall Study|Adverse Event|3|||
28008087|NCT00680745|54666893|FG002|Overall Study|Adverse Event|3|||
28008088|NCT00680745|54666894|FG003|Overall Study|Adverse Event|3|||
28008089|NCT00680745|54666891|FG000|Overall Study|Poor/Non-compliance|0|||
28008090|NCT00680745|54666892|FG001|Overall Study|Poor/Non-compliance|3|||
28008091|NCT00680745|54666893|FG002|Overall Study|Poor/Non-compliance|0|||
28008092|NCT00680745|54666894|FG003|Overall Study|Poor/Non-compliance|0|||
28008093|NCT00680745|54666891|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
28008094|NCT00680745|54666892|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
28008095|NCT00680745|54666893|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
28008096|NCT00680745|54666894|FG003|Overall Study|Subject No Longer Meets Study Criteria|2|||
28008097|NCT00680745|54666891|FG000|Overall Study|False Treatment|0|||
28008098|NCT00680745|54666892|FG001|Overall Study|False Treatment|1|||
28008099|NCT00680745|54666893|FG002|Overall Study|False Treatment|3|||
28008100|NCT00680745|54666894|FG003|Overall Study|False Treatment|0|||
28008101|NCT00680121|54666907|FG000|Overall Study|Lost to Follow-up|27|||
28008102|NCT00680121|54666908|FG001|Overall Study|Lost to Follow-up|23|||
28008103|NCT00767819|54666917|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
28008104|NCT00767819|54666918|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
28008105|NCT00767819|54666919|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
28008106|NCT00767819|54666917|FG000|Overall Study|Withdrawal by Subject|1|||
28008107|NCT00767819|54666918|FG001|Overall Study|Withdrawal by Subject|1|||
28008108|NCT00767819|54666919|FG002|Overall Study|Withdrawal by Subject|0|||
28008109|NCT00767819|54666917|FG000|Overall Study|Administrative problems|0|||
28008110|NCT00767819|54666918|FG001|Overall Study|Administrative problems|1|||
28008111|NCT00767819|54666919|FG002|Overall Study|Administrative problems|0|||
28008112|NCT00767819|54666917|FG000|Overall Study|Death|2|||
28008113|NCT00767819|54666918|FG001|Overall Study|Death|3|||
28008114|NCT00767819|54666919|FG002|Overall Study|Death|0|||
28008115|NCT00767819|54666917|FG000|Overall Study|Adverse Event|2|||
28008116|NCT00767819|54666918|FG001|Overall Study|Adverse Event|0|||
28008117|NCT00767819|54666919|FG002|Overall Study|Adverse Event|0|||
28008118|NCT00767819|54666917|FG000|Overall Study|Abnormal lab values|1|||
28008119|NCT00767819|54666918|FG001|Overall Study|Abnormal lab values|0|||
28008120|NCT00767819|54666919|FG002|Overall Study|Abnormal lab values|0|||
28008121|NCT00767819|54666917|FG000|Overall Study|Lost to Follow-up|1|||
28008122|NCT00767819|54666918|FG001|Overall Study|Lost to Follow-up|0|||
28008123|NCT00767819|54666919|FG002|Overall Study|Lost to Follow-up|0|||
28008124|NCT00584870|54666930|FG000|Overall Study|Adverse Event|4|||
28008125|NCT00584870|54666931|FG001|Overall Study|Adverse Event|3|||
28008126|NCT00584870|54666932|FG002|Overall Study|Adverse Event|2|||
28008127|NCT00584870|54666930|FG000|Overall Study|Lost to Follow-up|4|||
28008128|NCT00584870|54666931|FG001|Overall Study|Lost to Follow-up|1|||
27741346|NCT02712905|54191360|FG006|Monotherapy|Adverse Event|0|||
28008129|NCT00584870|54666932|FG002|Overall Study|Lost to Follow-up|1|||
28008130|NCT00584870|54666930|FG000|Overall Study|Lack of Efficacy|7|||
28008131|NCT00584870|54666931|FG001|Overall Study|Lack of Efficacy|14|||
28008132|NCT00584870|54666932|FG002|Overall Study|Lack of Efficacy|8|||
28008133|NCT00584870|54666930|FG000|Overall Study|Withdrawal by Subject|10|||
28008134|NCT00584870|54666931|FG001|Overall Study|Withdrawal by Subject|5|||
28008135|NCT00584870|54666932|FG002|Overall Study|Withdrawal by Subject|3|||
28008136|NCT00584870|54666930|FG000|Overall Study|Protocol Violation|1|||
28008137|NCT00584870|54666931|FG001|Overall Study|Protocol Violation|1|||
28008138|NCT00584870|54666932|FG002|Overall Study|Protocol Violation|2|||
28008139|NCT00584870|54666930|FG000|Overall Study|Did not met entrance criteria|1|||
28008140|NCT00584870|54666931|FG001|Overall Study|Did not met entrance criteria|0|||
28008141|NCT00584870|54666932|FG002|Overall Study|Did not met entrance criteria|0|||
28008142|NCT00584870|54666930|FG000|Overall Study|Other|2|||
28008143|NCT00584870|54666931|FG001|Overall Study|Other|0|||
28008144|NCT00584870|54666932|FG002|Overall Study|Other|0|||
28008145|NCT00584870|54666930|FG000|Overall Study|Randomized but not treated|0|||
28008146|NCT00584870|54666931|FG001|Overall Study|Randomized but not treated|1|||
28008147|NCT00584870|54666932|FG002|Overall Study|Randomized but not treated|2|||
28008148|NCT00679341|54666942|FG000|Overall Study|Disease progression|42|||
28008149|NCT00679341|54666943|FG001|Overall Study|Disease progression|36|||
28008150|NCT00679341|54666942|FG000|Overall Study|Adverse Event|5|||
28008151|NCT00679341|54666943|FG001|Overall Study|Adverse Event|6|||
28008152|NCT00679341|54666942|FG000|Overall Study|Subject/guardian decision to discontinue|3|||
28008153|NCT00679341|54666943|FG001|Overall Study|Subject/guardian decision to discontinue|0|||
28008154|NCT00679341|54666942|FG000|Overall Study|Death|1|||
28008155|NCT00679341|54666943|FG001|Overall Study|Death|1|||
28008156|NCT00679341|54666942|FG000|Overall Study|Other|1|||
28008157|NCT00679341|54666943|FG001|Overall Study|Other|0|||
28008158|NCT00679341|54666942|FG000|Overall Study|Physician Decision|1|||
28008159|NCT00679341|54666943|FG001|Overall Study|Physician Decision|0|||
28008160|NCT00679341|54666942|FG000|Overall Study|Not treated|0|||
28008161|NCT00679341|54666943|FG001|Overall Study|Not treated|2|||
28008162|NCT00679341|54666942|FG000|Overall Study|Physician/patient decision to withdraw|0|||
28008163|NCT00679341|54666943|FG001|Overall Study|Physician/patient decision to withdraw|6|||
28008164|NCT00679263|54666953|FG000|Visit 2/Dose 1|Adverse Event|1|||
28008165|NCT00679263|54666954|FG001|Visit 2/Dose 1|Adverse Event|0|||
28008166|NCT00679263|54666955|FG002|Visit 2/Dose 1|Adverse Event|0|||
28008167|NCT00679263|54666953|FG000|Visit 2/Dose 1|subject not compliance|1|||
28008168|NCT00679263|54666954|FG001|Visit 2/Dose 1|subject not compliance|1|||
28008169|NCT00679263|54666955|FG002|Visit 2/Dose 1|subject not compliance|0|||
28008170|NCT00680043|54666966|FG000|Overall Study|Withdrawal by Subject|1|||
28008171|NCT00680043|54666967|FG001|Overall Study|Withdrawal by Subject|0|||
28008172|NCT00680043|54666968|FG002|Overall Study|Withdrawal by Subject|0|||
28008173|NCT00680043|54666966|FG000|Overall Study|Patient Not Compliant With Study Reqs.|0|||
28008174|NCT00680043|54666967|FG001|Overall Study|Patient Not Compliant With Study Reqs.|1|||
28008175|NCT00680043|54666968|FG002|Overall Study|Patient Not Compliant With Study Reqs.|0|||
28008176|NCT00680043|54666966|FG000|Overall Study|Renal Transplant|1|||
28008177|NCT00680043|54666967|FG001|Overall Study|Renal Transplant|0|||
28008178|NCT00680043|54666968|FG002|Overall Study|Renal Transplant|4|||
28008179|NCT00682539|54666979|FG000|Bevacizumab vs Triamcinolone|Lost to Follow-up|3|||
28008180|NCT00682539|54666980|FG001|Bevacizumab vs Triamcinolone|Lost to Follow-up|1|||
28008181|NCT00682539|54666981|FG002|Bevacizumab vs Triamcinolone|Lost to Follow-up|0|||
28008182|NCT00682539|54666979|FG000|Ranibizumab vs Triamcinolone|Lost to Follow-up|0|||
27919355|NCT01090765|54576443|FG003|Overall Study|Developed a DVT, needed anticoagulation|1|||
27919356|NCT01090765|54576444|FG004|Overall Study|Developed a DVT, needed anticoagulation|0|||
27919357|NCT01090765|54576445|FG005|Overall Study|Developed a DVT, needed anticoagulation|0|||
27919358|NCT01090765|54576440|FG000|Overall Study|Vasovagal reaction with first infusion|0|||
27919359|NCT01090765|54576441|FG001|Overall Study|Vasovagal reaction with first infusion|0|||
27919360|NCT01090765|54576442|FG002|Overall Study|Vasovagal reaction with first infusion|0|||
27919361|NCT01090765|54576443|FG003|Overall Study|Vasovagal reaction with first infusion|0|||
27919362|NCT01090765|54576444|FG004|Overall Study|Vasovagal reaction with first infusion|1|||
27919363|NCT01090765|54576445|FG005|Overall Study|Vasovagal reaction with first infusion|0|||
27919364|NCT01313780|54576462|FG000|Overall Study|Lack of Efficacy|4|||
27919365|NCT01313780|54576463|FG001|Overall Study|Lack of Efficacy|2|||
27919366|NCT01313780|54576462|FG000|Overall Study|Adverse Event|6|||
27919367|NCT01313780|54576463|FG001|Overall Study|Adverse Event|11|||
27919368|NCT01313780|54576462|FG000|Overall Study|Withdrawal by Subject|2|||
27919369|NCT01313780|54576463|FG001|Overall Study|Withdrawal by Subject|8|||
27919370|NCT01313780|54576462|FG000|Overall Study|Protocol Violation|10|||
28008183|NCT00682539|54666980|FG001|Ranibizumab vs Triamcinolone|Lost to Follow-up|3|||
28008184|NCT00682539|54666981|FG002|Ranibizumab vs Triamcinolone|Lost to Follow-up|8|||
28008185|NCT00682461|54666991|FG000|Overall Study|Adverse Event|5|||
28008186|NCT00682461|54666992|FG001|Overall Study|Adverse Event|7|||
28008187|NCT00682461|54666991|FG000|Overall Study|Lost to Follow-up|8|||
28008188|NCT00682461|54666992|FG001|Overall Study|Lost to Follow-up|5|||
28008189|NCT00682461|54666991|FG000|Overall Study|Withdrawal by Subject|12|||
28008190|NCT00682461|54666992|FG001|Overall Study|Withdrawal by Subject|19|||
28008191|NCT00679029|54666999|FG000|Overall Study|Adverse Event|3|||
28008192|NCT00679029|54666999|FG000|Overall Study|Withdrawal by Subject|1|||
28008193|NCT00679029|54666999|FG000|Overall Study|Lost to Follow-up|1|||
28008194|NCT00677235|54667005|FG000|Overall Study|Withdrawal by Subject|1|||
28008195|NCT00677235|54667006|FG001|Overall Study|Withdrawal by Subject|1|||
28008196|NCT00677235|54667005|FG000|Overall Study|Lost to Follow-up|2|||
28008197|NCT00677235|54667006|FG001|Overall Study|Lost to Follow-up|1|||
28008198|NCT00677235|54667005|FG000|Overall Study|Death|37|||
28008199|NCT00677235|54667006|FG001|Overall Study|Death|36|||
28008200|NCT00677235|54667005|FG000|Overall Study|Adverse Experience|1|||
28008201|NCT00677235|54667006|FG001|Overall Study|Adverse Experience|0|||
28008202|NCT00676689|54667012|FG000|Overall Study|Screen Failure|2|||
28008203|NCT00676689|54667012|FG000|Overall Study|Death|2|||
28008204|NCT00676689|54667012|FG000|Overall Study|Lost to Follow-up|4|||
28008205|NCT00676689|54667012|FG000|Overall Study|Physician Decision|1|||
28008206|NCT00676689|54667012|FG000|Overall Study|Withdrawal by Subject|3|||
28008207|NCT00676689|54667012|FG000|Overall Study|Continuing FU|49|||
28008208|NCT00678795|54667018|FG000|Overall Study|Adverse Event|7|||
28008209|NCT00678795|54667019|FG001|Overall Study|Adverse Event|3|||
28008210|NCT00678795|54667018|FG000|Overall Study|Withdrawal by Subject|3|||
28008211|NCT00678795|54667019|FG001|Overall Study|Withdrawal by Subject|0|||
28008212|NCT00678795|54667018|FG000|Overall Study|Protocol Violation|0|||
28008213|NCT00678795|54667019|FG001|Overall Study|Protocol Violation|1|||
28008214|NCT00678795|54667018|FG000|Overall Study|Lost to Follow-up|0|||
28008215|NCT00678795|54667019|FG001|Overall Study|Lost to Follow-up|1|||
28008216|NCT00678795|54667018|FG000|Overall Study|Lack of Efficacy|1|||
28008217|NCT00678795|54667019|FG001|Overall Study|Lack of Efficacy|1|||
28008218|NCT00678639|54667027|FG000|Overall Study|Lost to Follow-up at 30 days|2|||
28008219|NCT00678639|54667028|FG001|Overall Study|Lost to Follow-up at 30 days|0|||
28008220|NCT00678561|54667078|FG000|Overall Study|Adverse Event|0|||
28008221|NCT00678561|54667079|FG001|Overall Study|Adverse Event|1|||
28008222|NCT00678561|54667080|FG002|Overall Study|Adverse Event|1|||
28008223|NCT00678561|54667081|FG003|Overall Study|Adverse Event|0|||
28008224|NCT00678561|54667082|FG004|Overall Study|Adverse Event|1|||
28008225|NCT00678561|54667083|FG005|Overall Study|Adverse Event|0|||
28008226|NCT00678561|54667084|FG006|Overall Study|Adverse Event|0|||
28008227|NCT00678561|54667085|FG007|Overall Study|Adverse Event|0|||
28008228|NCT00678561|54667078|FG000|Overall Study|Protocol Violation|0|||
28008229|NCT00678561|54667079|FG001|Overall Study|Protocol Violation|0|||
28008230|NCT00678561|54667080|FG002|Overall Study|Protocol Violation|0|||
28008231|NCT00678561|54667081|FG003|Overall Study|Protocol Violation|0|||
28008232|NCT00678561|54667082|FG004|Overall Study|Protocol Violation|1|||
28008233|NCT00678561|54667083|FG005|Overall Study|Protocol Violation|1|||
28008234|NCT00678561|54667084|FG006|Overall Study|Protocol Violation|0|||
28008235|NCT00678561|54667085|FG007|Overall Study|Protocol Violation|0|||
28008236|NCT00678561|54667078|FG000|Overall Study|Withdrawal by Subject|0|||
28008237|NCT00678561|54667079|FG001|Overall Study|Withdrawal by Subject|0|||
28008238|NCT00678561|54667080|FG002|Overall Study|Withdrawal by Subject|0|||
28008239|NCT00678561|54667081|FG003|Overall Study|Withdrawal by Subject|0|||
28008240|NCT00678561|54667082|FG004|Overall Study|Withdrawal by Subject|0|||
28008241|NCT00678561|54667083|FG005|Overall Study|Withdrawal by Subject|0|||
28008242|NCT00678561|54667084|FG006|Overall Study|Withdrawal by Subject|0|||
28008243|NCT00678561|54667085|FG007|Overall Study|Withdrawal by Subject|1|||
28008244|NCT00676143|54667112|FG000|Overall Study|Adverse Event|34|||
28008245|NCT00676143|54667113|FG001|Overall Study|Adverse Event|60|||
28008246|NCT00676143|54667112|FG000|Overall Study|Death|4|||
28008247|NCT00676143|54667113|FG001|Overall Study|Death|4|||
28008248|NCT00676143|54667112|FG000|Overall Study|Lack of Efficacy|0|||
28008249|NCT00676143|54667113|FG001|Overall Study|Lack of Efficacy|6|||
28008250|NCT00676143|54667112|FG000|Overall Study|Lost to Follow-up|0|||
28008251|NCT00676143|54667113|FG001|Overall Study|Lost to Follow-up|13|||
28008252|NCT00676143|54667112|FG000|Overall Study|Physician Decision|5|||
28008253|NCT00676143|54667113|FG001|Overall Study|Physician Decision|8|||
28008254|NCT00676143|54667112|FG000|Overall Study|Protocol Violation|4|||
28008255|NCT00676143|54667113|FG001|Overall Study|Protocol Violation|8|||
28008256|NCT00676143|54667112|FG000|Overall Study|Withdrawal by Subject|24|||
28008257|NCT00676143|54667113|FG001|Overall Study|Withdrawal by Subject|42|||
28008258|NCT00676143|54667112|FG000|Overall Study|Discontinuation of study by sponsor|65|||
28008259|NCT00676143|54667113|FG001|Overall Study|Discontinuation of study by sponsor|88|||
27741347|NCT02712905|54191361|FG007|Monotherapy|Adverse Event|0|||
28008260|NCT00676143|54667112|FG000|Overall Study|Failed to return|2|||
28008261|NCT00676143|54667113|FG001|Overall Study|Failed to return|1|||
28008262|NCT00676143|54667112|FG000|Overall Study|Loss of caregiver|5|||
28008263|NCT00676143|54667113|FG001|Overall Study|Loss of caregiver|3|||
28008264|NCT00676143|54667112|FG000|Overall Study|Other|11|||
28008265|NCT00676143|54667113|FG001|Overall Study|Other|20|||
28008266|NCT00676143|54667112|FG000|Overall Study|Participant participation unknown|1|||
28008267|NCT00676143|54667113|FG001|Overall Study|Participant participation unknown|4|||
28008268|NCT00676143|54667112|FG000|Overall Study|Vasogenic edema recurrence|1|||
28008269|NCT00676143|54667113|FG001|Overall Study|Vasogenic edema recurrence|3|||
28008270|NCT00675597|54667138|FG000|Overall Study|Withdrawal by Subject|3|||
28008271|NCT00675441|54667146|FG000|Overall Study|Withdrawal by Subject|2|||
28008272|NCT00675441|54667146|FG000|Overall Study|Death|1|||
28008273|NCT00674973|54667161|FG000|Overall Study|Insufficient Therapeutic Response|77|||
28008274|NCT00674973|54667162|FG001|Overall Study|Insufficient Therapeutic Response|72|||
28008275|NCT00674973|54667161|FG000|Overall Study|Refused Treatment|1|||
28008276|NCT00674973|54667162|FG001|Overall Study|Refused Treatment|5|||
28008277|NCT00674973|54667161|FG000|Overall Study|Failure to Return|1|||
28008278|NCT00674973|54667162|FG001|Overall Study|Failure to Return|0|||
27741348|NCT02712905|54191362|FG008|Monotherapy|Adverse Event|1|||
28008279|NCT00674973|54667161|FG000|Overall Study|Adverse Event|2|||
28008280|NCT00674973|54667162|FG001|Overall Study|Adverse Event|9|||
28008281|NCT00674973|54667161|FG000|Overall Study|Death|19|||
28008282|NCT00674973|54667162|FG001|Overall Study|Death|15|||
28008283|NCT00674973|54667161|FG000|Overall Study|Protocol Violation|0|||
28008284|NCT00674973|54667162|FG001|Overall Study|Protocol Violation|1|||
28008285|NCT00673179|54667170|FG000|Overall Study|Toxicity/Complications|3|||
28008286|NCT00673179|54667171|FG001|Overall Study|Toxicity/Complications|0|||
28008287|NCT00584012|54667177|FG000|Overall Study|Withdrawal by Subject|1|||
28008288|NCT00674817|54667181|FG000|Period 1|Withdrawal by Subject|2|||
28008289|NCT00674817|54667181|FG000|Period 1|Protocol Violation|1|||
28008290|NCT00674817|54667181|FG000|Period 3|Adverse Event|1|||
28008291|NCT00674817|54667181|FG000|Period 3|Protocol Violation|1|||
28008292|NCT00674817|54667181|FG000|Period 4|Adverse Event|1|||
28008293|NCT00672633|54667197|FG000|Overall Study|Withdrawal by Subject|0|||
28008294|NCT00672633|54667198|FG001|Overall Study|Withdrawal by Subject|1|||
28008295|NCT00672555|54667204|FG000|Overall Study|Lost to Follow-up|4|||
28008296|NCT00672555|54667204|FG000|Overall Study|Did not want to answer questionnaire|2|||
28008297|NCT00672477|54667210|FG000|Overall Study|Adverse Event|10|||
28008298|NCT00672477|54667211|FG001|Overall Study|Adverse Event|7|||
28008299|NCT00672477|54667210|FG000|Overall Study|Death|7|||
28008300|NCT00672477|54667211|FG001|Overall Study|Death|11|||
28008301|NCT00672477|54667210|FG000|Overall Study|Physician Decision|2|||
28008302|NCT00672477|54667211|FG001|Overall Study|Physician Decision|0|||
28008303|NCT00672477|54667210|FG000|Overall Study|Protocol Violation|1|||
28008304|NCT00672477|54667211|FG001|Overall Study|Protocol Violation|1|||
28008305|NCT00672477|54667210|FG000|Overall Study|Withdrawal by Subject|5|||
28008306|NCT00672477|54667211|FG001|Overall Study|Withdrawal by Subject|3|||
28008307|NCT00672477|54667210|FG000|Overall Study|Lack of Efficacy|1|||
28008308|NCT00672477|54667211|FG001|Overall Study|Lack of Efficacy|1|||
28008309|NCT00672477|54667210|FG000|Overall Study|no study drug for low GFR, health cond.|1|||
28008310|NCT00672477|54667211|FG001|Overall Study|no study drug for low GFR, health cond.|3|||
28008311|NCT00674661|54667219|FG000|Overall Study|Other|5|||
28008312|NCT00674661|54667220|FG001|Overall Study|Other|7|||
28008313|NCT00674661|54667219|FG000|Overall Study|Lost to Follow-up|6|||
28008314|NCT00674661|54667220|FG001|Overall Study|Lost to Follow-up|3|||
28008315|NCT00674661|54667219|FG000|Overall Study|Withdrawal by Subject|0|||
28008316|NCT00674661|54667220|FG001|Overall Study|Withdrawal by Subject|5|||
28008317|NCT00671931|54667231|FG000|Overall Study|Physician Decision|1|||
28008318|NCT00671931|54667232|FG001|Overall Study|Physician Decision|0|||
28008319|NCT00671931|54667233|FG002|Overall Study|Physician Decision|0|||
28008320|NCT00671931|54667234|FG003|Overall Study|Physician Decision|2|||
28008321|NCT00671931|54667235|FG004|Overall Study|Physician Decision|1|||
28008322|NCT00673881|54667251|FG000|Overall Study|Withdrawal by Subject|1|||
28008323|NCT00671853|54667257|FG000|Overall Study|Lack of Efficacy|3|||
28008324|NCT00671853|54667258|FG001|Overall Study|Lack of Efficacy|7|||
28008325|NCT00671853|54667257|FG000|Overall Study|Adverse Event|7|||
28008326|NCT00671853|54667258|FG001|Overall Study|Adverse Event|1|||
28008327|NCT00671853|54667257|FG000|Overall Study|Withdrawal by Subject|1|||
28008328|NCT00671853|54667258|FG001|Overall Study|Withdrawal by Subject|5|||
28008329|NCT00671853|54667257|FG000|Overall Study|Lost to Follow-up|8|||
28008330|NCT00671853|54667258|FG001|Overall Study|Lost to Follow-up|8|||
28008331|NCT00671853|54667257|FG000|Overall Study|Physician Decision|0|||
28008332|NCT00671853|54667258|FG001|Overall Study|Physician Decision|2|||
28008333|NCT00671853|54667257|FG000|Overall Study|Non-adherence with study procedures|1|||
28008334|NCT00671853|54667258|FG001|Overall Study|Non-adherence with study procedures|4|||
28008335|NCT00570921|54667266|FG000|Overall Study|Protocol Violation|1|||
28008336|NCT00570921|54667266|FG000|Overall Study|Physician Decision|1|||
28008337|NCT00670449|54667274|FG000|Overall Study|Adverse Event|6|||
28008338|NCT00670449|54667275|FG001|Overall Study|Adverse Event|2|||
28008339|NCT00670449|54667276|FG002|Overall Study|Adverse Event|8|||
28008340|NCT00670449|54667277|FG003|Overall Study|Adverse Event|5|||
28008341|NCT00670449|54667274|FG000|Overall Study|Protocol Deviation|1|||
28008342|NCT00670449|54667275|FG001|Overall Study|Protocol Deviation|2|||
28008343|NCT00670449|54667276|FG002|Overall Study|Protocol Deviation|0|||
28008344|NCT00670449|54667277|FG003|Overall Study|Protocol Deviation|1|||
28008345|NCT00670449|54667274|FG000|Overall Study|Administrative Problems|0|||
28008346|NCT00670449|54667275|FG001|Overall Study|Administrative Problems|2|||
28008347|NCT00670449|54667276|FG002|Overall Study|Administrative Problems|0|||
28008348|NCT00670449|54667277|FG003|Overall Study|Administrative Problems|1|||
28008349|NCT00670449|54667274|FG000|Overall Study|Subject Withdrew Consent|0|||
28008350|NCT00670449|54667275|FG001|Overall Study|Subject Withdrew Consent|2|||
28008351|NCT00670449|54667276|FG002|Overall Study|Subject Withdrew Consent|0|||
28008352|NCT00670449|54667277|FG003|Overall Study|Subject Withdrew Consent|1|||
28008353|NCT00670449|54667274|FG000|Overall Study|Unsatisfactory Therapeutic Effect|2|||
28008354|NCT00670449|54667275|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
28008355|NCT00670449|54667276|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
28008356|NCT00670449|54667277|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
28008357|NCT00670449|54667274|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
28008358|NCT00670449|54667275|FG001|Overall Study|Abnormal Laboratory Value(s)|2|||
28008359|NCT00670449|54667276|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
28008360|NCT00670449|54667277|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
28008361|NCT00668733|54667288|FG000|Overall Study|Lost to Follow-up|2|||
28008362|NCT00668733|54667289|FG001|Overall Study|Lost to Follow-up|3|||
28008363|NCT00668733|54667288|FG000|Overall Study|Withdrawal by Subject|0|||
28008364|NCT00668733|54667289|FG001|Overall Study|Withdrawal by Subject|4|||
28008365|NCT00673257|54667295|FG000|Overall Study|Withdrawal by Subject|4|||
28008366|NCT00673257|54667295|FG000|Overall Study|Unable to obtain specimen|1|||
28008367|NCT00667875|54667302|FG000|Overall Study|Adverse Event|0|||
28008368|NCT00667875|54667303|FG001|Overall Study|Adverse Event|2|||
28008369|NCT00667875|54667304|FG002|Overall Study|Adverse Event|6|||
28008370|NCT00667875|54667302|FG000|Overall Study|Withdrawal by Subject|10|||
28008371|NCT00667875|54667303|FG001|Overall Study|Withdrawal by Subject|9|||
28008372|NCT00667875|54667304|FG002|Overall Study|Withdrawal by Subject|7|||
28008373|NCT03468998|54667324|FG000|Overall Study|Withdrawal by Subject|1|||
28008374|NCT03468998|54667325|FG001|Overall Study|Withdrawal by Subject|1|||
28008375|NCT03468998|54667326|FG002|Overall Study|Withdrawal by Subject|0|||
28008376|NCT03468998|54667327|FG003|Overall Study|Withdrawal by Subject|4|||
28008377|NCT03468998|54667328|FG004|Overall Study|Withdrawal by Subject|1|||
28008378|NCT03468998|54667329|FG005|Overall Study|Withdrawal by Subject|0|||
28008379|NCT00667251|54667343|FG000|Overall Study|Adverse Event|13|||
28008380|NCT00667251|54667344|FG001|Overall Study|Adverse Event|4|||
28008381|NCT00667251|54667343|FG000|Overall Study|Withdrawal by Subject|6|||
28008382|NCT00667251|54667344|FG001|Overall Study|Withdrawal by Subject|2|||
28008383|NCT00667251|54667343|FG000|Overall Study|Other/missing|46|||
28008384|NCT00667251|54667344|FG001|Overall Study|Other/missing|84|||
28008385|NCT00667251|54667343|FG000|Overall Study|Intercurrent Illness|4|||
28008386|NCT00667251|54667344|FG001|Overall Study|Intercurrent Illness|3|||
28008387|NCT00667251|54667343|FG000|Overall Study|Symptomatic progression|1|||
28008388|NCT00667251|54667344|FG001|Overall Study|Symptomatic progression|2|||
28008389|NCT00669903|54667362|FG000|Overall Study|Adverse Event|0|||
28008390|NCT00669903|54667363|FG001|Overall Study|Adverse Event|1|||
28008391|NCT00669903|54667364|FG002|Overall Study|Adverse Event|3|||
28008392|NCT00669903|54667365|FG003|Overall Study|Adverse Event|1|||
28008393|NCT00669903|54667362|FG000|Overall Study|Withdrawal by Subject|0|||
28008394|NCT00669903|54667363|FG001|Overall Study|Withdrawal by Subject|2|||
28008395|NCT00669903|54667364|FG002|Overall Study|Withdrawal by Subject|2|||
28008396|NCT00669903|54667365|FG003|Overall Study|Withdrawal by Subject|2|||
28008397|NCT00669903|54667362|FG000|Overall Study|Lost to Follow-up|1|||
27741349|NCT02712905|54191363|FG009|Monotherapy|Adverse Event|0|||
28008398|NCT00669903|54667363|FG001|Overall Study|Lost to Follow-up|1|||
28008399|NCT00669903|54667364|FG002|Overall Study|Lost to Follow-up|0|||
28008400|NCT00669903|54667365|FG003|Overall Study|Lost to Follow-up|1|||
28008401|NCT00669903|54667362|FG000|Overall Study|Protocol Violation|0|||
28008402|NCT00669903|54667363|FG001|Overall Study|Protocol Violation|1|||
28008403|NCT00669903|54667364|FG002|Overall Study|Protocol Violation|0|||
28008404|NCT00669903|54667365|FG003|Overall Study|Protocol Violation|0|||
28008405|NCT03759392|54667377|FG000|Overall Study|Adverse Event|12|||
28008406|NCT03759392|54667378|FG001|Overall Study|Adverse Event|4|||
28008407|NCT03759392|54667377|FG000|Overall Study|Death|2|||
28008408|NCT03759392|54667378|FG001|Overall Study|Death|1|||
28008409|NCT03759392|54667377|FG000|Overall Study|Withdrawal by Subject|2|||
28008410|NCT03759392|54667378|FG001|Overall Study|Withdrawal by Subject|0|||
28008411|NCT03759392|54667377|FG000|Overall Study|Protocol Violation|2|||
28008412|NCT03759392|54667378|FG001|Overall Study|Protocol Violation|0|||
28008413|NCT03759392|54667377|FG000|Overall Study|Physician Decision|0|||
28008414|NCT03759392|54667378|FG001|Overall Study|Physician Decision|1|||
28008415|NCT03759392|54667377|FG000|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|1|||
28008416|NCT03759392|54667378|FG001|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|0|||
28008417|NCT03759392|54667377|FG000|Overall Study|No longer able to take medicines|1|||
28008418|NCT03759392|54667378|FG001|Overall Study|No longer able to take medicines|0|||
28008419|NCT03759392|54667377|FG000|Overall Study|Stopped taking study drug|1|||
28008420|NCT03759392|54667378|FG001|Overall Study|Stopped taking study drug|0|||
28008421|NCT00667719|54667384|FG000|Overall Study|Adverse Event|39|||
28008422|NCT00667719|54667384|FG000|Overall Study|Abnormal Test Procedure|1|||
28008423|NCT00667719|54667384|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
28008424|NCT00667719|54667384|FG000|Overall Study|Protocol Violation|3|||
28008425|NCT00667719|54667384|FG000|Overall Study|Withdrawal by Subject|17|||
28008426|NCT00667719|54667384|FG000|Overall Study|Lost to Follow-up|8|||
28008427|NCT00669669|54667393|FG000|Overall Study|To late to start treatment|1|||
28008428|NCT00467779|54667412|FG000|Stage 1|Adverse Event|1|||
28008429|NCT00467779|54667413|FG001|Stage 1|Adverse Event|0|||
28008430|NCT00467779|54667414|FG002|Stage 1|Adverse Event|0|||
28008431|NCT00467779|54667415|FG003|Stage 1|Adverse Event|0|||
28008432|NCT00467779|54667416|FG004|Stage 1|Adverse Event|0|||
28008433|NCT00467779|54667417|FG005|Stage 1|Adverse Event|1|||
28008434|NCT00467779|54667418|FG006|Stage 1|Adverse Event|2|||
27919371|NCT01313780|54576463|FG001|Overall Study|Protocol Violation|4|||
27919372|NCT01313780|54576462|FG000|Overall Study|missing data|3|||
27919373|NCT01313780|54576463|FG001|Overall Study|missing data|3|||
27919374|NCT01090453|54576471|FG000|Overall Study|Withdrawal by Subject|1|||
27919375|NCT01090453|54576472|FG001|Overall Study|Withdrawal by Subject|2|||
27919376|NCT01090453|54576471|FG000|Overall Study|Lost to Follow-up|7|||
27919377|NCT01090453|54576472|FG001|Overall Study|Lost to Follow-up|7|||
27919378|NCT01090453|54576471|FG000|Overall Study|Non serious AEs|1|||
27919379|NCT01090453|54576472|FG001|Overall Study|Non serious AEs|0|||
27919380|NCT01090453|54576471|FG000|Overall Study|Protocol Violation|2|||
27919381|NCT01090453|54576472|FG001|Overall Study|Protocol Violation|0|||
27919382|NCT01090453|54576471|FG000|Overall Study|Other|2|||
27919383|NCT01090453|54576472|FG001|Overall Study|Other|4|||
27919384|NCT01090453|54576471|FG000|Overall Study|Eligibility Criteria|0|||
27919385|NCT01090453|54576472|FG001|Overall Study|Eligibility Criteria|1|||
27919386|NCT01171612|54576478|FG000|Overall Study|Lost to Follow-up|51|||
27919387|NCT01171534|54576487|FG000|Overall Study|Lost to Follow-up|0|||
27919388|NCT01171534|54576488|FG001|Overall Study|Lost to Follow-up|2|||
27919389|NCT01171534|54576487|FG000|Overall Study|screen failure|0|||
27919390|NCT01171534|54576488|FG001|Overall Study|screen failure|1|||
27919391|NCT01170598|54576494|FG000|Overall Study|Withdrawal by Subject|1|||
27919392|NCT01170598|54576494|FG000|Overall Study|Death|3|||
27919393|NCT01170598|54576494|FG000|Overall Study|Lost to Follow-up|1|||
27919394|NCT01170598|54576494|FG000|Overall Study|Refused|1|||
27919395|NCT01170364|54576500|FG000|Overall Study|Protocol Violation|4|||
27919396|NCT01170364|54576501|FG001|Overall Study|Protocol Violation|1|||
27919397|NCT01076179|54576507|FG000|Overall Study|Withdrawal by Subject|1|||
27919398|NCT01170208|54576515|FG000|Overall Study|Withdrawal by Subject|5|||
27919399|NCT01170208|54576516|FG001|Overall Study|Withdrawal by Subject|0|||
27919400|NCT01170208|54576517|FG002|Overall Study|Withdrawal by Subject|1|||
27919401|NCT01170208|54576515|FG000|Overall Study|Protocol Violation|1|||
27919402|NCT01170208|54576516|FG001|Overall Study|Protocol Violation|0|||
27919403|NCT01170208|54576517|FG002|Overall Study|Protocol Violation|1|||
27919404|NCT01313624|54576530|FG000|Double-Blind Phase|Adverse Event|27|||
27919405|NCT01313624|54576531|FG001|Double-Blind Phase|Adverse Event|4|||
27919406|NCT01313624|54576530|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
27919407|NCT01313624|54576531|FG001|Double-Blind Phase|Withdrawal by Subject|4|||
27919408|NCT01313624|54576530|FG000|Double-Blind Phase|Lost to Follow-up|0|||
27919409|NCT01313624|54576531|FG001|Double-Blind Phase|Lost to Follow-up|2|||
28008435|NCT00467779|54667419|FG007|Stage 1|Adverse Event|1|||
28008436|NCT00467779|54667420|FG008|Stage 1|Adverse Event|0|||
27919410|NCT01313624|54576530|FG000|Double-Blind Phase|Physician Decision|1|||
27919411|NCT01313624|54576531|FG001|Double-Blind Phase|Physician Decision|0|||
27919412|NCT01313624|54576530|FG000|Double-Blind Phase|Lack of Efficacy|1|||
28008437|NCT00467779|54667421|FG009|Stage 1|Adverse Event|0|||
28008438|NCT00467779|54667422|FG010|Stage 1|Adverse Event|0|||
28008439|NCT00467779|54667423|FG011|Stage 1|Adverse Event|0|||
28008440|NCT00467779|54667424|FG012|Stage 1|Adverse Event|0|||
28008441|NCT00467779|54667425|FG013|Stage 1|Adverse Event|0|||
28008442|NCT00467779|54667426|FG014|Stage 1|Adverse Event|0|||
28008443|NCT00467779|54667412|FG000|Stage 1|Disease Progression|2|||
28008444|NCT00467779|54667413|FG001|Stage 1|Disease Progression|2|||
28008445|NCT00467779|54667414|FG002|Stage 1|Disease Progression|2|||
28008446|NCT00467779|54667415|FG003|Stage 1|Disease Progression|3|||
28008447|NCT00467779|54667416|FG004|Stage 1|Disease Progression|2|||
28008448|NCT00467779|54667417|FG005|Stage 1|Disease Progression|2|||
28008449|NCT00467779|54667418|FG006|Stage 1|Disease Progression|4|||
28008450|NCT00467779|54667419|FG007|Stage 1|Disease Progression|5|||
28008451|NCT00467779|54667420|FG008|Stage 1|Disease Progression|0|||
28008452|NCT00467779|54667421|FG009|Stage 1|Disease Progression|0|||
28008453|NCT00467779|54667422|FG010|Stage 1|Disease Progression|0|||
28008454|NCT00467779|54667423|FG011|Stage 1|Disease Progression|0|||
28008455|NCT00467779|54667424|FG012|Stage 1|Disease Progression|0|||
28008456|NCT00467779|54667425|FG013|Stage 1|Disease Progression|0|||
28008457|NCT00467779|54667426|FG014|Stage 1|Disease Progression|0|||
28008458|NCT00467779|54667412|FG000|Stage 1|Unspecified Reason|1|||
28008459|NCT00467779|54667413|FG001|Stage 1|Unspecified Reason|0|||
28008460|NCT00467779|54667414|FG002|Stage 1|Unspecified Reason|1|||
28008461|NCT00467779|54667415|FG003|Stage 1|Unspecified Reason|0|||
28008462|NCT00467779|54667416|FG004|Stage 1|Unspecified Reason|1|||
28008463|NCT00467779|54667417|FG005|Stage 1|Unspecified Reason|2|||
28008464|NCT00467779|54667418|FG006|Stage 1|Unspecified Reason|0|||
28008465|NCT00467779|54667419|FG007|Stage 1|Unspecified Reason|0|||
28008466|NCT00467779|54667420|FG008|Stage 1|Unspecified Reason|0|||
28008467|NCT00467779|54667421|FG009|Stage 1|Unspecified Reason|0|||
28008468|NCT00467779|54667422|FG010|Stage 1|Unspecified Reason|0|||
28008469|NCT00467779|54667423|FG011|Stage 1|Unspecified Reason|0|||
28008470|NCT00467779|54667424|FG012|Stage 1|Unspecified Reason|0|||
28008471|NCT00467779|54667425|FG013|Stage 1|Unspecified Reason|0|||
28008472|NCT00467779|54667426|FG014|Stage 1|Unspecified Reason|0|||
28008473|NCT00467779|54667412|FG000|Stage 1|Physician Decision|0|||
28008474|NCT00467779|54667413|FG001|Stage 1|Physician Decision|1|||
28008475|NCT00467779|54667414|FG002|Stage 1|Physician Decision|0|||
28008476|NCT00467779|54667415|FG003|Stage 1|Physician Decision|0|||
28008477|NCT00467779|54667416|FG004|Stage 1|Physician Decision|0|||
28008478|NCT00467779|54667417|FG005|Stage 1|Physician Decision|0|||
27919413|NCT01313624|54576531|FG001|Double-Blind Phase|Lack of Efficacy|0|||
27919414|NCT01313624|54576530|FG000|Open-Label Phase|Adverse Event|1|||
27919415|NCT01313624|54576531|FG001|Open-Label Phase|Adverse Event|10|||
27919416|NCT01313624|54576530|FG000|Open-Label Phase|Withdrawal by Subject|2|||
27919417|NCT01313624|54576531|FG001|Open-Label Phase|Withdrawal by Subject|2|||
27919418|NCT01313624|54576530|FG000|Open-Label Phase|Lost to Follow-up|1|||
27919419|NCT01313624|54576531|FG001|Open-Label Phase|Lost to Follow-up|1|||
27919420|NCT01169350|54576539|FG000|Overall Study|Physician Decision|3|||
27919421|NCT01169350|54576539|FG000|Overall Study|Lost to Follow-up|2|||
27919422|NCT01169038|54576543|FG000|Overall Study|Death|1|||
27919423|NCT01169038|54576543|FG000|Overall Study|Adverse Event|5|||
27919424|NCT01169038|54576543|FG000|Overall Study|Required antibiotic administration|1|||
27919425|NCT01167634|54576551|FG000|Overall Study|Lost to Follow-up|1|||
27919426|NCT01167634|54576552|FG001|Overall Study|Lost to Follow-up|3|||
27919427|NCT01167634|54576553|FG002|Overall Study|Lost to Follow-up|3|||
27919428|NCT01167634|54576554|FG003|Overall Study|Lost to Follow-up|4|||
27919429|NCT01167634|54576551|FG000|Overall Study|Withdrawal by Subject|1|||
27919430|NCT01167634|54576552|FG001|Overall Study|Withdrawal by Subject|1|||
27919431|NCT01167634|54576553|FG002|Overall Study|Withdrawal by Subject|0|||
27919432|NCT01167634|54576554|FG003|Overall Study|Withdrawal by Subject|0|||
27919433|NCT01166386|54576566|FG000|Overall Study|Withdrawal by Subject|3|||
27919434|NCT01166386|54576567|FG001|Overall Study|Withdrawal by Subject|5|||
27919435|NCT01114828|54576575|FG000|Overall Study|Adverse Event|1|||
27919436|NCT01114828|54576576|FG001|Overall Study|Adverse Event|1|||
27919437|NCT01114828|54576575|FG000|Overall Study|Lack of Efficacy|0|||
27919438|NCT01114828|54576576|FG001|Overall Study|Lack of Efficacy|2|||
28008479|NCT00467779|54667418|FG006|Stage 1|Physician Decision|0|||
28008480|NCT00467779|54667419|FG007|Stage 1|Physician Decision|0|||
28008481|NCT00467779|54667420|FG008|Stage 1|Physician Decision|0|||
28008482|NCT00467779|54667421|FG009|Stage 1|Physician Decision|0|||
28008483|NCT00467779|54667422|FG010|Stage 1|Physician Decision|0|||
28008484|NCT00467779|54667423|FG011|Stage 1|Physician Decision|0|||
27741350|NCT02712905|54191364|FG010|Monotherapy|Adverse Event|0|||
28008485|NCT00467779|54667424|FG012|Stage 1|Physician Decision|0|||
28008486|NCT00467779|54667425|FG013|Stage 1|Physician Decision|0|||
28008487|NCT00467779|54667426|FG014|Stage 1|Physician Decision|0|||
28008488|NCT00467779|54667412|FG000|Stage 1|Withdrawal by Subject|0|||
28008489|NCT00467779|54667413|FG001|Stage 1|Withdrawal by Subject|0|||
28008490|NCT00467779|54667414|FG002|Stage 1|Withdrawal by Subject|0|||
27919439|NCT01114828|54576575|FG000|Overall Study|Protocol Violation|2|||
27919440|NCT01114828|54576576|FG001|Overall Study|Protocol Violation|0|||
27919441|NCT01114828|54576575|FG000|Overall Study|Withdrawal by Subject|0|||
27919442|NCT01114828|54576576|FG001|Overall Study|Withdrawal by Subject|1|||
27919443|NCT01313312|54576582|FG000|Overall Study|Adverse Event|5|||
27919444|NCT01313312|54576582|FG000|Overall Study|Withdrawal by Subject|18|||
27919445|NCT01313312|54576582|FG000|Overall Study|Lack of Efficacy|3|||
27919446|NCT01313312|54576582|FG000|Overall Study|Investigator Decision|1|||
27919447|NCT01313312|54576582|FG000|Overall Study|Observational Phase|1|||
27919448|NCT01313312|54576582|FG000|Overall Study|Subject Withdrawn Early in Error|4|||
27919449|NCT01313312|54576582|FG000|Overall Study|Did Not Receive Treatment with Dysport®|4|||
27919450|NCT01114672|54576588|FG000|Overall Study|Death|0|||
27919451|NCT01114672|54576589|FG001|Overall Study|Death|1|||
27919452|NCT01114672|54576588|FG000|Overall Study|Withdrawal by Subject|2|||
27919453|NCT01114672|54576589|FG001|Overall Study|Withdrawal by Subject|1|||
27919454|NCT01114672|54576588|FG000|Overall Study|Lost to Follow-up|1|||
27919455|NCT01114672|54576589|FG001|Overall Study|Lost to Follow-up|0|||
27919456|NCT01114672|54576588|FG000|Overall Study|transplanted|1|||
27919457|NCT01114672|54576589|FG001|Overall Study|transplanted|0|||
27919458|NCT01114516|54576597|FG000|Overall Study|Lost to Follow-up|2|||
27919459|NCT01114516|54576598|FG001|Overall Study|Lost to Follow-up|1|||
27919460|NCT01114438|54576604|FG000|Overall Study|Adverse Event|10|||
27919461|NCT01114438|54576604|FG000|Overall Study|concomitant medication|1|||
27919462|NCT01114438|54576604|FG000|Overall Study|Physician Decision|1|||
27919463|NCT01114438|54576604|FG000|Overall Study|Withdrawal by Subject|2|||
27919464|NCT01313078|54576613|FG000|Overall Study|Death|1|||
27919465|NCT01313078|54576613|FG000|Overall Study|Discontinued study drug|1|||
27919466|NCT01313078|54576613|FG000|Overall Study|Withdrawal by Subject|1|||
27919467|NCT01114360|54576617|FG000|Intervention 1 (4 Weeks)|Physician Decision|0|||
27919468|NCT01114360|54576618|FG001|Intervention 1 (4 Weeks)|Physician Decision|1|||
27919469|NCT01310036|54576638|FG000|Overall Study|Administrative/other|10|||
27919470|NCT01310036|54576638|FG000|Overall Study|Withdrew Consent|11|||
27919471|NCT01310036|54576638|FG000|Overall Study|Refused Treatment/Did not Cooperate|4|||
27919472|NCT01310036|54576638|FG000|Overall Study|Progression of Disease|164|||
27919473|NCT01310036|54576638|FG000|Overall Study|Death|1|||
27919474|NCT01310036|54576638|FG000|Overall Study|Adverse event or intercurrent illness|12|||
27919475|NCT01309100|54576642|FG000|Overall Study|Protocol Violation|1|||
27919476|NCT01309100|54576642|FG000|Overall Study|Positive Slit lamp finding|1|||
27919477|NCT01308788|54576651|FG000|2-year Treatment|medication change by treating physician|4|||
27919478|NCT01308788|54576652|FG001|2-year Treatment|medication change by treating physician|11|||
27919479|NCT01075321|54576658|FG000|Overall Study|Withdrawal by Subject|0|||
27919480|NCT01075321|54576659|FG001|Overall Study|Withdrawal by Subject|0|||
27919481|NCT01075321|54576660|FG002|Overall Study|Withdrawal by Subject|1|||
27919482|NCT01075321|54576661|FG003|Overall Study|Withdrawal by Subject|1|||
27919483|NCT01075321|54576658|FG000|Overall Study|Protocol Violation|0|||
27919484|NCT01075321|54576659|FG001|Overall Study|Protocol Violation|0|||
27919485|NCT01075321|54576660|FG002|Overall Study|Protocol Violation|1|||
27919486|NCT01075321|54576661|FG003|Overall Study|Protocol Violation|0|||
27919487|NCT01075321|54576658|FG000|Overall Study|Treatment Incomplete due to progression|1|||
27919488|NCT01075321|54576659|FG001|Overall Study|Treatment Incomplete due to progression|0|||
27919489|NCT01075321|54576660|FG002|Overall Study|Treatment Incomplete due to progression|0|||
27919490|NCT01075321|54576661|FG003|Overall Study|Treatment Incomplete due to progression|0|||
27919491|NCT01075321|54576658|FG000|Overall Study|Ineligible (miscalculated lab value)|0|||
27919492|NCT01075321|54576659|FG001|Overall Study|Ineligible (miscalculated lab value)|0|||
27919493|NCT01075321|54576660|FG002|Overall Study|Ineligible (miscalculated lab value)|0|||
27919494|NCT01075321|54576661|FG003|Overall Study|Ineligible (miscalculated lab value)|1|||
27919495|NCT01114204|54576675|FG000|Overall Study|Adverse Event|3|||
27919496|NCT01114204|54576676|FG001|Overall Study|Adverse Event|2|||
27919497|NCT01114204|54576675|FG000|Overall Study|Lost to Follow-up|1|||
27919498|NCT01114204|54576676|FG001|Overall Study|Lost to Follow-up|0|||
27919499|NCT01114204|54576675|FG000|Overall Study|Withdrawal by Subject|10|||
27919500|NCT01114204|54576676|FG001|Overall Study|Withdrawal by Subject|6|||
27919501|NCT01114204|54576675|FG000|Overall Study|Death|1|||
27919502|NCT01114204|54576676|FG001|Overall Study|Death|0|||
27919503|NCT01114204|54576675|FG000|Overall Study|Other-Personal reasons|2|||
27919504|NCT01114204|54576676|FG001|Overall Study|Other-Personal reasons|0|||
27919505|NCT01114204|54576675|FG000|Overall Study|Other-Medical monitor request|1|||
27919506|NCT01114204|54576676|FG001|Overall Study|Other-Medical monitor request|0|||
27919507|NCT01114204|54576675|FG000|Overall Study|Other-Participant request|2|||
27919508|NCT01114204|54576676|FG001|Overall Study|Other-Participant request|0|||
27919509|NCT01114204|54576675|FG000|Overall Study|Other-Protocol Violation|1|||
27919510|NCT01114204|54576676|FG001|Overall Study|Other-Protocol Violation|0|||
27919511|NCT01075243|54576685|FG000|Overall Study|Lost to Follow-up|5|||
27919512|NCT01075243|54576686|FG001|Overall Study|Lost to Follow-up|2|||
27919513|NCT01075243|54576687|FG002|Overall Study|Lost to Follow-up|0|||
28008491|NCT00467779|54667415|FG003|Stage 1|Withdrawal by Subject|0|||
28008492|NCT00467779|54667416|FG004|Stage 1|Withdrawal by Subject|0|||
28008493|NCT00467779|54667417|FG005|Stage 1|Withdrawal by Subject|0|||
28008494|NCT00467779|54667418|FG006|Stage 1|Withdrawal by Subject|1|||
28008495|NCT00467779|54667419|FG007|Stage 1|Withdrawal by Subject|1|||
28008496|NCT00467779|54667420|FG008|Stage 1|Withdrawal by Subject|0|||
28008497|NCT00467779|54667421|FG009|Stage 1|Withdrawal by Subject|0|||
28008498|NCT00467779|54667422|FG010|Stage 1|Withdrawal by Subject|0|||
28008499|NCT00467779|54667423|FG011|Stage 1|Withdrawal by Subject|0|||
28008500|NCT00467779|54667424|FG012|Stage 1|Withdrawal by Subject|0|||
28008501|NCT00467779|54667425|FG013|Stage 1|Withdrawal by Subject|0|||
28008502|NCT00467779|54667426|FG014|Stage 1|Withdrawal by Subject|0|||
28008503|NCT00467779|54667412|FG000|Stage 1A|Adverse Event|0|||
28008504|NCT00467779|54667413|FG001|Stage 1A|Adverse Event|0|||
28008505|NCT00467779|54667414|FG002|Stage 1A|Adverse Event|0|||
28008506|NCT00467779|54667415|FG003|Stage 1A|Adverse Event|0|||
28008507|NCT00467779|54667416|FG004|Stage 1A|Adverse Event|0|||
28008508|NCT00467779|54667417|FG005|Stage 1A|Adverse Event|0|||
28008509|NCT00467779|54667418|FG006|Stage 1A|Adverse Event|0|||
28008510|NCT00467779|54667419|FG007|Stage 1A|Adverse Event|0|||
28008511|NCT00467779|54667420|FG008|Stage 1A|Adverse Event|0|||
28008512|NCT00467779|54667421|FG009|Stage 1A|Adverse Event|0|||
28008513|NCT00467779|54667422|FG010|Stage 1A|Adverse Event|0|||
28008514|NCT00467779|54667423|FG011|Stage 1A|Adverse Event|0|||
28008515|NCT00467779|54667424|FG012|Stage 1A|Adverse Event|1|||
28008516|NCT00467779|54667425|FG013|Stage 1A|Adverse Event|0|||
28008517|NCT00467779|54667426|FG014|Stage 1A|Adverse Event|0|||
28008518|NCT00467779|54667412|FG000|Stage 1A|Death|0|||
28008519|NCT00467779|54667413|FG001|Stage 1A|Death|0|||
28008520|NCT00467779|54667414|FG002|Stage 1A|Death|0|||
28008521|NCT00467779|54667415|FG003|Stage 1A|Death|0|||
28008522|NCT00467779|54667416|FG004|Stage 1A|Death|0|||
28008523|NCT00467779|54667417|FG005|Stage 1A|Death|0|||
28008524|NCT00467779|54667418|FG006|Stage 1A|Death|0|||
28008525|NCT00467779|54667419|FG007|Stage 1A|Death|0|||
28008526|NCT00467779|54667420|FG008|Stage 1A|Death|0|||
28008527|NCT00467779|54667421|FG009|Stage 1A|Death|0|||
28008528|NCT00467779|54667422|FG010|Stage 1A|Death|0|||
28008529|NCT00467779|54667423|FG011|Stage 1A|Death|1|||
28008530|NCT00467779|54667424|FG012|Stage 1A|Death|1|||
28008531|NCT00467779|54667425|FG013|Stage 1A|Death|0|||
28008532|NCT00467779|54667426|FG014|Stage 1A|Death|0|||
28008533|NCT00467779|54667412|FG000|Stage 1A|Disease Progression|0|||
28008534|NCT00467779|54667413|FG001|Stage 1A|Disease Progression|0|||
28008535|NCT00467779|54667414|FG002|Stage 1A|Disease Progression|0|||
28008536|NCT00467779|54667415|FG003|Stage 1A|Disease Progression|0|||
28008537|NCT00467779|54667416|FG004|Stage 1A|Disease Progression|0|||
28008538|NCT00467779|54667417|FG005|Stage 1A|Disease Progression|0|||
28008539|NCT00467779|54667418|FG006|Stage 1A|Disease Progression|0|||
28008540|NCT00467779|54667419|FG007|Stage 1A|Disease Progression|0|||
28008541|NCT00467779|54667420|FG008|Stage 1A|Disease Progression|0|||
28008542|NCT00467779|54667421|FG009|Stage 1A|Disease Progression|2|||
28008543|NCT00467779|54667422|FG010|Stage 1A|Disease Progression|2|||
28008544|NCT00467779|54667423|FG011|Stage 1A|Disease Progression|5|||
28008545|NCT00467779|54667424|FG012|Stage 1A|Disease Progression|2|||
28008546|NCT00467779|54667425|FG013|Stage 1A|Disease Progression|0|||
28008547|NCT00467779|54667426|FG014|Stage 1A|Disease Progression|0|||
28008548|NCT00467779|54667412|FG000|Stage 1A|Physician Decision|0|||
28008549|NCT00467779|54667413|FG001|Stage 1A|Physician Decision|0|||
28008550|NCT00467779|54667414|FG002|Stage 1A|Physician Decision|0|||
28008551|NCT00467779|54667415|FG003|Stage 1A|Physician Decision|0|||
28008552|NCT00467779|54667416|FG004|Stage 1A|Physician Decision|0|||
28008553|NCT00467779|54667417|FG005|Stage 1A|Physician Decision|0|||
28008554|NCT00467779|54667418|FG006|Stage 1A|Physician Decision|0|||
28008555|NCT00467779|54667419|FG007|Stage 1A|Physician Decision|0|||
28008556|NCT00467779|54667420|FG008|Stage 1A|Physician Decision|0|||
28008557|NCT00467779|54667421|FG009|Stage 1A|Physician Decision|1|||
28008558|NCT00467779|54667422|FG010|Stage 1A|Physician Decision|0|||
28008559|NCT00467779|54667423|FG011|Stage 1A|Physician Decision|0|||
28008560|NCT00467779|54667424|FG012|Stage 1A|Physician Decision|0|||
28008561|NCT00467779|54667425|FG013|Stage 1A|Physician Decision|0|||
28008562|NCT00467779|54667426|FG014|Stage 1A|Physician Decision|0|||
28008563|NCT00467779|54667412|FG000|Stage 1A|Withdrawal by Subject|0|||
28008564|NCT00467779|54667413|FG001|Stage 1A|Withdrawal by Subject|0|||
27741351|NCT02712905|54191365|FG011|Monotherapy|Adverse Event|0|||
28008565|NCT00467779|54667414|FG002|Stage 1A|Withdrawal by Subject|0|||
28008566|NCT00467779|54667415|FG003|Stage 1A|Withdrawal by Subject|0|||
28008567|NCT00467779|54667416|FG004|Stage 1A|Withdrawal by Subject|0|||
28008568|NCT00467779|54667417|FG005|Stage 1A|Withdrawal by Subject|0|||
28008569|NCT00467779|54667418|FG006|Stage 1A|Withdrawal by Subject|0|||
28008570|NCT00467779|54667419|FG007|Stage 1A|Withdrawal by Subject|0|||
28008571|NCT00467779|54667420|FG008|Stage 1A|Withdrawal by Subject|0|||
28008572|NCT00467779|54667421|FG009|Stage 1A|Withdrawal by Subject|0|||
28008573|NCT00467779|54667422|FG010|Stage 1A|Withdrawal by Subject|1|||
28008574|NCT00467779|54667423|FG011|Stage 1A|Withdrawal by Subject|1|||
28008575|NCT00467779|54667424|FG012|Stage 1A|Withdrawal by Subject|1|||
28008576|NCT00467779|54667425|FG013|Stage 1A|Withdrawal by Subject|0|||
28008577|NCT00467779|54667426|FG014|Stage 1A|Withdrawal by Subject|0|||
28008578|NCT00467779|54667412|FG000|Stage 1A|Unspecified Reason|0|||
28008579|NCT00467779|54667413|FG001|Stage 1A|Unspecified Reason|0|||
28008580|NCT00467779|54667414|FG002|Stage 1A|Unspecified Reason|0|||
28008581|NCT00467779|54667415|FG003|Stage 1A|Unspecified Reason|0|||
28008582|NCT00467779|54667416|FG004|Stage 1A|Unspecified Reason|0|||
28008583|NCT00467779|54667417|FG005|Stage 1A|Unspecified Reason|0|||
28008584|NCT00467779|54667418|FG006|Stage 1A|Unspecified Reason|0|||
28008585|NCT00467779|54667419|FG007|Stage 1A|Unspecified Reason|0|||
28008586|NCT00467779|54667420|FG008|Stage 1A|Unspecified Reason|0|||
28008587|NCT00467779|54667421|FG009|Stage 1A|Unspecified Reason|0|||
28008588|NCT00467779|54667422|FG010|Stage 1A|Unspecified Reason|0|||
28008589|NCT00467779|54667423|FG011|Stage 1A|Unspecified Reason|1|||
28008590|NCT00467779|54667424|FG012|Stage 1A|Unspecified Reason|1|||
28008591|NCT00467779|54667425|FG013|Stage 1A|Unspecified Reason|0|||
28008592|NCT00467779|54667426|FG014|Stage 1A|Unspecified Reason|0|||
28008593|NCT00467779|54667412|FG000|Stage 2|Adverse Event|0|||
28008594|NCT00467779|54667413|FG001|Stage 2|Adverse Event|0|||
28008595|NCT00467779|54667414|FG002|Stage 2|Adverse Event|0|||
28008596|NCT00467779|54667415|FG003|Stage 2|Adverse Event|0|||
28008597|NCT00467779|54667416|FG004|Stage 2|Adverse Event|0|||
28008598|NCT00467779|54667417|FG005|Stage 2|Adverse Event|0|||
28008599|NCT00467779|54667418|FG006|Stage 2|Adverse Event|0|||
28008600|NCT00467779|54667419|FG007|Stage 2|Adverse Event|0|||
28008601|NCT00467779|54667420|FG008|Stage 2|Adverse Event|1|||
28008602|NCT00467779|54667421|FG009|Stage 2|Adverse Event|0|||
28008603|NCT00467779|54667422|FG010|Stage 2|Adverse Event|0|||
28008604|NCT00467779|54667423|FG011|Stage 2|Adverse Event|0|||
28008605|NCT00467779|54667424|FG012|Stage 2|Adverse Event|0|||
28008606|NCT00467779|54667425|FG013|Stage 2|Adverse Event|0|||
28008607|NCT00467779|54667426|FG014|Stage 2|Adverse Event|0|||
28008608|NCT00467779|54667412|FG000|Stage 2|Death|0|||
28008609|NCT00467779|54667413|FG001|Stage 2|Death|0|||
28008610|NCT00467779|54667414|FG002|Stage 2|Death|0|||
28008611|NCT00467779|54667415|FG003|Stage 2|Death|0|||
28008612|NCT00467779|54667416|FG004|Stage 2|Death|0|||
28008613|NCT00467779|54667417|FG005|Stage 2|Death|0|||
28008614|NCT00467779|54667418|FG006|Stage 2|Death|0|||
28008615|NCT00467779|54667419|FG007|Stage 2|Death|0|||
28008616|NCT00467779|54667420|FG008|Stage 2|Death|1|||
28008617|NCT00467779|54667421|FG009|Stage 2|Death|0|||
28008618|NCT00467779|54667422|FG010|Stage 2|Death|0|||
28008619|NCT00467779|54667423|FG011|Stage 2|Death|0|||
28008620|NCT00467779|54667424|FG012|Stage 2|Death|0|||
28008621|NCT00467779|54667425|FG013|Stage 2|Death|0|||
28008622|NCT00467779|54667426|FG014|Stage 2|Death|0|||
28008623|NCT00467779|54667412|FG000|Stage 2|Disease Progression|0|||
28008624|NCT00467779|54667413|FG001|Stage 2|Disease Progression|0|||
28008625|NCT00467779|54667414|FG002|Stage 2|Disease Progression|0|||
28008626|NCT00467779|54667415|FG003|Stage 2|Disease Progression|0|||
28008627|NCT00467779|54667416|FG004|Stage 2|Disease Progression|0|||
28008628|NCT00467779|54667417|FG005|Stage 2|Disease Progression|0|||
28008629|NCT00467779|54667418|FG006|Stage 2|Disease Progression|0|||
28008630|NCT00467779|54667419|FG007|Stage 2|Disease Progression|0|||
28008631|NCT00467779|54667420|FG008|Stage 2|Disease Progression|16|||
28008632|NCT00467779|54667421|FG009|Stage 2|Disease Progression|0|||
28008633|NCT00467779|54667422|FG010|Stage 2|Disease Progression|0|||
28008634|NCT00467779|54667423|FG011|Stage 2|Disease Progression|0|||
28008635|NCT00467779|54667424|FG012|Stage 2|Disease Progression|0|||
28008636|NCT00467779|54667425|FG013|Stage 2|Disease Progression|0|||
28008637|NCT00467779|54667426|FG014|Stage 2|Disease Progression|0|||
28008638|NCT00467779|54667412|FG000|Stage 2|Unspecified Reason|0|||
28008639|NCT00467779|54667413|FG001|Stage 2|Unspecified Reason|0|||
28008640|NCT00467779|54667414|FG002|Stage 2|Unspecified Reason|0|||
28008641|NCT00467779|54667415|FG003|Stage 2|Unspecified Reason|0|||
28008642|NCT00467779|54667416|FG004|Stage 2|Unspecified Reason|0|||
28008643|NCT00467779|54667417|FG005|Stage 2|Unspecified Reason|0|||
28008644|NCT00467779|54667418|FG006|Stage 2|Unspecified Reason|0|||
28008645|NCT00467779|54667419|FG007|Stage 2|Unspecified Reason|0|||
28008646|NCT00467779|54667420|FG008|Stage 2|Unspecified Reason|3|||
28008647|NCT00467779|54667421|FG009|Stage 2|Unspecified Reason|0|||
28008648|NCT00467779|54667422|FG010|Stage 2|Unspecified Reason|0|||
28008649|NCT00467779|54667423|FG011|Stage 2|Unspecified Reason|0|||
28008650|NCT00467779|54667424|FG012|Stage 2|Unspecified Reason|0|||
28008651|NCT00467779|54667425|FG013|Stage 2|Unspecified Reason|0|||
28008652|NCT00467779|54667426|FG014|Stage 2|Unspecified Reason|0|||
28008653|NCT00467779|54667412|FG000|Stage 2A|Adverse Event|0|||
28008654|NCT00467779|54667413|FG001|Stage 2A|Adverse Event|0|||
28008655|NCT00467779|54667414|FG002|Stage 2A|Adverse Event|0|||
28008656|NCT00467779|54667415|FG003|Stage 2A|Adverse Event|0|||
28008657|NCT00467779|54667416|FG004|Stage 2A|Adverse Event|0|||
28008658|NCT00467779|54667417|FG005|Stage 2A|Adverse Event|0|||
28008659|NCT00467779|54667418|FG006|Stage 2A|Adverse Event|0|||
28008660|NCT00467779|54667419|FG007|Stage 2A|Adverse Event|0|||
28008661|NCT00467779|54667420|FG008|Stage 2A|Adverse Event|0|||
28008662|NCT00467779|54667421|FG009|Stage 2A|Adverse Event|0|||
28008663|NCT00467779|54667422|FG010|Stage 2A|Adverse Event|0|||
28008664|NCT00467779|54667423|FG011|Stage 2A|Adverse Event|0|||
28008665|NCT00467779|54667424|FG012|Stage 2A|Adverse Event|0|||
28008666|NCT00467779|54667425|FG013|Stage 2A|Adverse Event|2|||
28008667|NCT00467779|54667426|FG014|Stage 2A|Adverse Event|0|||
28008668|NCT00467779|54667412|FG000|Stage 2A|Death|0|||
28008669|NCT00467779|54667413|FG001|Stage 2A|Death|0|||
28008670|NCT00467779|54667414|FG002|Stage 2A|Death|0|||
28008671|NCT00467779|54667415|FG003|Stage 2A|Death|0|||
28008672|NCT00467779|54667416|FG004|Stage 2A|Death|0|||
28008673|NCT00467779|54667417|FG005|Stage 2A|Death|0|||
28008674|NCT00467779|54667418|FG006|Stage 2A|Death|0|||
28008675|NCT00467779|54667419|FG007|Stage 2A|Death|0|||
28008676|NCT00467779|54667420|FG008|Stage 2A|Death|0|||
28008677|NCT00467779|54667421|FG009|Stage 2A|Death|0|||
28008678|NCT00467779|54667422|FG010|Stage 2A|Death|0|||
28008679|NCT00467779|54667423|FG011|Stage 2A|Death|0|||
28008680|NCT00467779|54667424|FG012|Stage 2A|Death|0|||
28008681|NCT00467779|54667425|FG013|Stage 2A|Death|1|||
28008682|NCT00467779|54667426|FG014|Stage 2A|Death|0|||
28008683|NCT00467779|54667412|FG000|Stage 2A|Disease Progression|0|||
28008684|NCT00467779|54667413|FG001|Stage 2A|Disease Progression|0|||
28008685|NCT00467779|54667414|FG002|Stage 2A|Disease Progression|0|||
28008686|NCT00467779|54667415|FG003|Stage 2A|Disease Progression|0|||
28008687|NCT00467779|54667416|FG004|Stage 2A|Disease Progression|0|||
28008688|NCT00467779|54667417|FG005|Stage 2A|Disease Progression|0|||
28008689|NCT00467779|54667418|FG006|Stage 2A|Disease Progression|0|||
28008690|NCT00467779|54667419|FG007|Stage 2A|Disease Progression|0|||
28008691|NCT00467779|54667420|FG008|Stage 2A|Disease Progression|0|||
28008692|NCT00467779|54667421|FG009|Stage 2A|Disease Progression|0|||
28008693|NCT00467779|54667422|FG010|Stage 2A|Disease Progression|0|||
28008694|NCT00467779|54667423|FG011|Stage 2A|Disease Progression|0|||
28008695|NCT00467779|54667424|FG012|Stage 2A|Disease Progression|0|||
28008696|NCT00467779|54667425|FG013|Stage 2A|Disease Progression|10|||
28008697|NCT00467779|54667426|FG014|Stage 2A|Disease Progression|0|||
28008698|NCT00467779|54667412|FG000|Stage 2A|Unspecified Reason|0|||
28008699|NCT00467779|54667413|FG001|Stage 2A|Unspecified Reason|0|||
28008700|NCT00467779|54667414|FG002|Stage 2A|Unspecified Reason|0|||
28008701|NCT00467779|54667415|FG003|Stage 2A|Unspecified Reason|0|||
28008702|NCT00467779|54667416|FG004|Stage 2A|Unspecified Reason|0|||
28008703|NCT00467779|54667417|FG005|Stage 2A|Unspecified Reason|0|||
28008704|NCT00467779|54667418|FG006|Stage 2A|Unspecified Reason|0|||
28008705|NCT00467779|54667419|FG007|Stage 2A|Unspecified Reason|0|||
28008706|NCT00467779|54667420|FG008|Stage 2A|Unspecified Reason|0|||
28008707|NCT00467779|54667421|FG009|Stage 2A|Unspecified Reason|0|||
28008708|NCT00467779|54667422|FG010|Stage 2A|Unspecified Reason|0|||
28008709|NCT00467779|54667423|FG011|Stage 2A|Unspecified Reason|0|||
28008710|NCT00467779|54667424|FG012|Stage 2A|Unspecified Reason|0|||
28008711|NCT00467779|54667425|FG013|Stage 2A|Unspecified Reason|7|||
28008712|NCT00467779|54667426|FG014|Stage 2A|Unspecified Reason|0|||
28008713|NCT00467779|54667412|FG000|Stage 2A|Withdrawal by Subject|0|||
28008714|NCT00467779|54667413|FG001|Stage 2A|Withdrawal by Subject|0|||
28008715|NCT00467779|54667414|FG002|Stage 2A|Withdrawal by Subject|0|||
28008716|NCT00467779|54667415|FG003|Stage 2A|Withdrawal by Subject|0|||
28008717|NCT00467779|54667416|FG004|Stage 2A|Withdrawal by Subject|0|||
28008718|NCT00467779|54667417|FG005|Stage 2A|Withdrawal by Subject|0|||
28008719|NCT00467779|54667418|FG006|Stage 2A|Withdrawal by Subject|0|||
28008720|NCT00467779|54667419|FG007|Stage 2A|Withdrawal by Subject|0|||
28008721|NCT00467779|54667420|FG008|Stage 2A|Withdrawal by Subject|0|||
28008722|NCT00467779|54667421|FG009|Stage 2A|Withdrawal by Subject|0|||
28008723|NCT00467779|54667422|FG010|Stage 2A|Withdrawal by Subject|0|||
28008724|NCT00467779|54667423|FG011|Stage 2A|Withdrawal by Subject|0|||
28008725|NCT00467779|54667424|FG012|Stage 2A|Withdrawal by Subject|0|||
28008726|NCT00467779|54667425|FG013|Stage 2A|Withdrawal by Subject|1|||
28008727|NCT00467779|54667426|FG014|Stage 2A|Withdrawal by Subject|0|||
28008728|NCT00467779|54667412|FG000|Stage 3|Adverse Event|0|||
28008729|NCT00467779|54667413|FG001|Stage 3|Adverse Event|0|||
28008730|NCT00467779|54667414|FG002|Stage 3|Adverse Event|0|||
28008731|NCT00467779|54667415|FG003|Stage 3|Adverse Event|0|||
28008732|NCT00467779|54667416|FG004|Stage 3|Adverse Event|0|||
28008733|NCT00467779|54667417|FG005|Stage 3|Adverse Event|0|||
28008734|NCT00467779|54667418|FG006|Stage 3|Adverse Event|0|||
28008735|NCT00467779|54667419|FG007|Stage 3|Adverse Event|0|||
28008736|NCT00467779|54667420|FG008|Stage 3|Adverse Event|0|||
27741352|NCT02712905|54191366|FG012|Monotherapy|Adverse Event|0|||
28008737|NCT00467779|54667421|FG009|Stage 3|Adverse Event|0|||
28008738|NCT00467779|54667422|FG010|Stage 3|Adverse Event|0|||
28008739|NCT00467779|54667423|FG011|Stage 3|Adverse Event|0|||
28008740|NCT00467779|54667424|FG012|Stage 3|Adverse Event|0|||
28008741|NCT00467779|54667425|FG013|Stage 3|Adverse Event|0|||
28008742|NCT00467779|54667426|FG014|Stage 3|Adverse Event|2|||
28008743|NCT00467779|54667412|FG000|Stage 3|Death|0|||
28008744|NCT00467779|54667413|FG001|Stage 3|Death|0|||
28008745|NCT00467779|54667414|FG002|Stage 3|Death|0|||
28008746|NCT00467779|54667415|FG003|Stage 3|Death|0|||
28008747|NCT00467779|54667416|FG004|Stage 3|Death|0|||
28008748|NCT00467779|54667417|FG005|Stage 3|Death|0|||
28008749|NCT00467779|54667418|FG006|Stage 3|Death|0|||
28008750|NCT00467779|54667419|FG007|Stage 3|Death|0|||
28008751|NCT00467779|54667420|FG008|Stage 3|Death|0|||
28008752|NCT00467779|54667421|FG009|Stage 3|Death|0|||
28008753|NCT00467779|54667422|FG010|Stage 3|Death|0|||
28008754|NCT00467779|54667423|FG011|Stage 3|Death|0|||
28008755|NCT00467779|54667424|FG012|Stage 3|Death|0|||
28008756|NCT00467779|54667425|FG013|Stage 3|Death|0|||
28008757|NCT00467779|54667426|FG014|Stage 3|Death|1|||
28008758|NCT00467779|54667412|FG000|Stage 3|Disease Progression|0|||
28008759|NCT00467779|54667413|FG001|Stage 3|Disease Progression|0|||
28008760|NCT00467779|54667414|FG002|Stage 3|Disease Progression|0|||
28008761|NCT00467779|54667415|FG003|Stage 3|Disease Progression|0|||
28008762|NCT00467779|54667416|FG004|Stage 3|Disease Progression|0|||
28008763|NCT00467779|54667417|FG005|Stage 3|Disease Progression|0|||
28008764|NCT00467779|54667418|FG006|Stage 3|Disease Progression|0|||
28008765|NCT00467779|54667419|FG007|Stage 3|Disease Progression|0|||
28008766|NCT00467779|54667420|FG008|Stage 3|Disease Progression|0|||
28008767|NCT00467779|54667421|FG009|Stage 3|Disease Progression|0|||
28008768|NCT00467779|54667422|FG010|Stage 3|Disease Progression|0|||
28008769|NCT00467779|54667423|FG011|Stage 3|Disease Progression|0|||
28008770|NCT00467779|54667424|FG012|Stage 3|Disease Progression|0|||
28008771|NCT00467779|54667425|FG013|Stage 3|Disease Progression|0|||
28008772|NCT00467779|54667426|FG014|Stage 3|Disease Progression|9|||
28008773|NCT00467779|54667412|FG000|Stage 3|Unspecified Reason|0|||
28008774|NCT00467779|54667413|FG001|Stage 3|Unspecified Reason|0|||
28008775|NCT00467779|54667414|FG002|Stage 3|Unspecified Reason|0|||
28008776|NCT00467779|54667415|FG003|Stage 3|Unspecified Reason|0|||
28008777|NCT00467779|54667416|FG004|Stage 3|Unspecified Reason|0|||
28008778|NCT00467779|54667417|FG005|Stage 3|Unspecified Reason|0|||
28008779|NCT00467779|54667418|FG006|Stage 3|Unspecified Reason|0|||
28008780|NCT00467779|54667419|FG007|Stage 3|Unspecified Reason|0|||
28008781|NCT00467779|54667420|FG008|Stage 3|Unspecified Reason|0|||
28008782|NCT00467779|54667421|FG009|Stage 3|Unspecified Reason|0|||
28008783|NCT00467779|54667422|FG010|Stage 3|Unspecified Reason|0|||
28008784|NCT00467779|54667423|FG011|Stage 3|Unspecified Reason|0|||
28008785|NCT00467779|54667424|FG012|Stage 3|Unspecified Reason|0|||
28008786|NCT00467779|54667425|FG013|Stage 3|Unspecified Reason|0|||
28008787|NCT00467779|54667426|FG014|Stage 3|Unspecified Reason|5|||
28008788|NCT00570687|54667466|FG000|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
28008789|NCT00570687|54667467|FG001|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
28008790|NCT00570687|54667468|FG002|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
28008791|NCT00570687|54667469|FG003|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
28008792|NCT00570687|54667470|FG004|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
28008793|NCT00570687|54667471|FG005|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
28008794|NCT00570687|54667472|FG006|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
28008795|NCT00570687|54667473|FG007|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
28008796|NCT00570687|54667474|FG008|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
28008797|NCT00570687|54667475|FG009|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
28008798|NCT00570687|54667466|FG000|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
28008799|NCT00570687|54667467|FG001|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
28008800|NCT00570687|54667468|FG002|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
28008801|NCT00570687|54667469|FG003|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
28008802|NCT00570687|54667470|FG004|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
28008803|NCT00570687|54667471|FG005|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
28008804|NCT00570687|54667472|FG006|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
28008805|NCT00570687|54667473|FG007|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
28008806|NCT00570687|54667474|FG008|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
28008807|NCT00570687|54667475|FG009|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
28008808|NCT00570687|54667466|FG000|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
28008809|NCT00570687|54667467|FG001|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
28008810|NCT00570687|54667468|FG002|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
28008811|NCT00570687|54667469|FG003|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
28008812|NCT00570687|54667470|FG004|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
28008813|NCT00570687|54667471|FG005|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
27741353|NCT02712905|54191367|FG013|Monotherapy|Adverse Event|0|||
28008814|NCT00570687|54667472|FG006|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
28008815|NCT00570687|54667473|FG007|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
28008816|NCT00570687|54667474|FG008|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
28008817|NCT00570687|54667475|FG009|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
27741354|NCT02712905|54191368|FG014|Monotherapy|Adverse Event|0|||
28008818|NCT03836677|54667489|FG000|Period 1|Adverse Event|0|||
28008819|NCT03836677|54667490|FG001|Period 1|Adverse Event|1|||
28008820|NCT03836677|54667489|FG000|Period 2|Severe non-compliance to protocol|1|||
28008821|NCT03836677|54667490|FG001|Period 2|Severe non-compliance to protocol|0|||
28008822|NCT00434161|54667521|FG000|Overall Study|Adverse Event|5|||
28008823|NCT00434161|54667522|FG001|Overall Study|Adverse Event|1|||
28008824|NCT00434161|54667523|FG002|Overall Study|Adverse Event|4|||
28008825|NCT00434161|54667521|FG000|Overall Study|Lost to Follow-up|0|||
28008826|NCT00434161|54667522|FG001|Overall Study|Lost to Follow-up|1|||
28008827|NCT00434161|54667523|FG002|Overall Study|Lost to Follow-up|0|||
28008828|NCT00434161|54667521|FG000|Overall Study|Death|1|||
28008829|NCT00434161|54667522|FG001|Overall Study|Death|0|||
28008830|NCT00434161|54667523|FG002|Overall Study|Death|1|||
28008831|NCT00434161|54667521|FG000|Overall Study|Non-Compliance|1|||
28008832|NCT00434161|54667522|FG001|Overall Study|Non-Compliance|1|||
28008833|NCT00434161|54667523|FG002|Overall Study|Non-Compliance|0|||
28008834|NCT00434161|54667521|FG000|Overall Study|Withdrawal by Subject|2|||
28008835|NCT00434161|54667522|FG001|Overall Study|Withdrawal by Subject|0|||
28008836|NCT00434161|54667523|FG002|Overall Study|Withdrawal by Subject|3|||
28008837|NCT00434161|54667521|FG000|Overall Study|Logistical error study assessments|1|||
28008838|NCT00434161|54667522|FG001|Overall Study|Logistical error study assessments|0|||
28008839|NCT00434161|54667523|FG002|Overall Study|Logistical error study assessments|3|||
28008840|NCT00441103|54667540|FG000|Overall Study|Adverse Event|2|||
28008841|NCT00441103|54667541|FG001|Overall Study|Adverse Event|1|||
28008842|NCT00441103|54667540|FG000|Overall Study|Death|1|||
28008843|NCT00441103|54667541|FG001|Overall Study|Death|0|||
28008844|NCT00441103|54667540|FG000|Overall Study|Disease Progression|2|||
28008845|NCT00441103|54667541|FG001|Overall Study|Disease Progression|0|||
28008846|NCT00441103|54667540|FG000|Overall Study|Lost to Follow-up|1|||
28008847|NCT00441103|54667541|FG001|Overall Study|Lost to Follow-up|0|||
28008848|NCT00441103|54667540|FG000|Overall Study|Protocol Violation|1|||
28008849|NCT00441103|54667541|FG001|Overall Study|Protocol Violation|0|||
28008850|NCT00441103|54667540|FG000|Overall Study|Participant unable to use Rebiject II|1|||
28008851|NCT00441103|54667541|FG001|Overall Study|Participant unable to use Rebiject II|0|||
28008852|NCT00441103|54667540|FG000|Overall Study|Participant refused MRI|1|||
28008853|NCT00441103|54667541|FG001|Overall Study|Participant refused MRI|0|||
28008854|NCT00441103|54667540|FG000|Overall Study|Inclusion criteria absent|1|||
28008855|NCT00441103|54667541|FG001|Overall Study|Inclusion criteria absent|0|||
28008856|NCT00441103|54667540|FG000|Overall Study|Non-compliant|0|||
28008857|NCT00441103|54667541|FG001|Overall Study|Non-compliant|1|||
28008858|NCT00441103|54667540|FG000|Overall Study|Participant decided to withdraw|1|||
28008859|NCT00441103|54667541|FG001|Overall Study|Participant decided to withdraw|0|||
28008860|NCT00441103|54667540|FG000|Overall Study|Participant's reason|0|||
28008861|NCT00441103|54667541|FG001|Overall Study|Participant's reason|1|||
28008862|NCT00441103|54667540|FG000|Overall Study|Participant decided to stop|0|||
28008863|NCT00441103|54667541|FG001|Overall Study|Participant decided to stop|1|||
28008864|NCT00433771|54667548|FG000|Overall Study|screen fail|14|||
28008865|NCT00433771|54667548|FG000|Overall Study|Treated and later found to be ineligible|2|||
28008866|NCT00433771|54667548|FG000|Overall Study|Death|2|||
28008867|NCT00433771|54667548|FG000|Overall Study|Failure to deploy stent|1|||
28008868|NCT00433537|54667552|FG000|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
28008869|NCT00433537|54667553|FG001|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0|||
28008870|NCT00433537|54667554|FG002|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
28008871|NCT00433537|54667552|FG000|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
28008872|NCT00433537|54667553|FG001|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
28008873|NCT00433537|54667554|FG002|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2|||
28008874|NCT00433537|54667552|FG000|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
28008875|NCT00433537|54667553|FG001|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
28008876|NCT00433537|54667554|FG002|Step 1 - VcR-CVAD Induction|Adverse Event|4|||
28008877|NCT00433537|54667552|FG000|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
28008878|NCT00433537|54667553|FG001|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
28008879|NCT00433537|54667554|FG002|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2|||
28008880|NCT00433537|54667552|FG000|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1|||
28008881|NCT00433537|54667553|FG001|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
28008882|NCT00433537|54667554|FG002|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
28008883|NCT00433537|54667552|FG000|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8|||
28008884|NCT00433537|54667553|FG001|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
28008885|NCT00433537|54667554|FG002|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
28008886|NCT00433537|54667552|FG000|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2|||
28008887|NCT00433537|54667553|FG001|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
28008888|NCT00433537|54667554|FG002|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
28008889|NCT00433537|54667552|FG000|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4|||
28008890|NCT00433537|54667553|FG001|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
28008891|NCT00433537|54667554|FG002|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
28008892|NCT00433537|54667552|FG000|Step 2 - Maintenance Rituximab or ASCT|Other|1|||
28008893|NCT00433537|54667553|FG001|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
28008894|NCT00433537|54667554|FG002|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
28008895|NCT00570765|54667564|FG000|DB Phase|Withdrawal by Subject|1|||
28008896|NCT00570765|54667565|FG001|DB Phase|Withdrawal by Subject|0|||
28008897|NCT00570765|54667566|FG002|DB Phase|Withdrawal by Subject|0|||
28008898|NCT00570765|54667567|FG003|DB Phase|Withdrawal by Subject|0|||
28008899|NCT00570765|54667564|FG000|DB Phase|Protocol Violation|0|||
28008900|NCT00570765|54667565|FG001|DB Phase|Protocol Violation|1|||
28008901|NCT00570765|54667566|FG002|DB Phase|Protocol Violation|0|||
28008902|NCT00570765|54667567|FG003|DB Phase|Protocol Violation|0|||
28008903|NCT00570765|54667564|FG000|DB Phase|Adverse Event|3|||
28008904|NCT00570765|54667565|FG001|DB Phase|Adverse Event|6|||
28008905|NCT00570765|54667566|FG002|DB Phase|Adverse Event|0|||
28008906|NCT00570765|54667567|FG003|DB Phase|Adverse Event|0|||
28008907|NCT00570765|54667564|FG000|DB Phase|Did Not Receive Study Drug|0|||
28008908|NCT00570765|54667565|FG001|DB Phase|Did Not Receive Study Drug|0|||
28008909|NCT00570765|54667566|FG002|DB Phase|Did Not Receive Study Drug|1|||
28008910|NCT00570765|54667567|FG003|DB Phase|Did Not Receive Study Drug|0|||
28008911|NCT00570765|54667564|FG000|LTSE Phase|Withdrawal by Subject|0|||
28008912|NCT00570765|54667565|FG001|LTSE Phase|Withdrawal by Subject|0|||
28008913|NCT00570765|54667566|FG002|LTSE Phase|Withdrawal by Subject|0|||
28008914|NCT00570765|54667567|FG003|LTSE Phase|Withdrawal by Subject|1|||
28008915|NCT00570765|54667564|FG000|LTSE Phase|Adverse Event|0|||
28008916|NCT00570765|54667565|FG001|LTSE Phase|Adverse Event|0|||
28008917|NCT00570765|54667566|FG002|LTSE Phase|Adverse Event|0|||
28008918|NCT00570765|54667567|FG003|LTSE Phase|Adverse Event|7|||
28008919|NCT00570765|54667564|FG000|LTSE Phase|Physician Decision|0|||
28008920|NCT00570765|54667565|FG001|LTSE Phase|Physician Decision|0|||
28008921|NCT00570765|54667566|FG002|LTSE Phase|Physician Decision|0|||
28008922|NCT00570765|54667567|FG003|LTSE Phase|Physician Decision|4|||
28008923|NCT00667563|54667578|FG000|Overall Study|Protocol Violation|24|||
28008924|NCT00667095|54667584|FG000|Overall Study|Withdrawal by Subject|0|||
28008925|NCT00667095|54667585|FG001|Overall Study|Withdrawal by Subject|1|||
28008926|NCT00433381|54667593|FG000|Overall Study|Ineligible / no protocol treatment|3|||
28008927|NCT00433381|54667594|FG001|Overall Study|Ineligible / no protocol treatment|3|||
28008928|NCT00667017|54667608|FG000|Overall Study|Withdrawal by Subject|1|||
28008929|NCT00666705|54667612|FG000|Overall Study|Withdrawal by Subject|1|||
28008930|NCT00433147|54667625|FG000|Overall Study|Adverse Event|0|||
28008931|NCT00433147|54667626|FG001|Overall Study|Adverse Event|1|||
28008932|NCT00433147|54667627|FG002|Overall Study|Adverse Event|0|||
28008933|NCT00433147|54667628|FG003|Overall Study|Adverse Event|0|||
28008934|NCT00666237|54667640|FG000|Overall Study|Death|5|||
28008935|NCT00666237|54667641|FG001|Overall Study|Death|5|||
28008936|NCT00666237|54667640|FG000|Overall Study|Lost to Follow-up|29|||
28008937|NCT00666237|54667641|FG001|Overall Study|Lost to Follow-up|25|||
28008938|NCT00662025|54667647|FG000|Overall Study|Objective progression or relapse|51|||
28008939|NCT00662025|54667647|FG000|Overall Study|Adverse Event|7|||
28008940|NCT00662025|54667647|FG000|Overall Study|Withdrawal by Subject|1|||
28008941|NCT00662025|54667647|FG000|Overall Study|Results of other clinical study|2|||
28103625|NCT02852434|54760322|FG000|Overall Study|Withdrawal by Subject|0|||
28103626|NCT02852434|54760323|FG001|Overall Study|Withdrawal by Subject|1|||
28103627|NCT02852434|54760322|FG000|Overall Study|Unsuccessful Dilator Procedure|2|||
28103628|NCT02852434|54760323|FG001|Overall Study|Unsuccessful Dilator Procedure|0|||
28103629|NCT02850016|54760331|FG000|Overall Study|Withdrawal by Subject|1|||
28103630|NCT02850016|54760332|FG001|Overall Study|Withdrawal by Subject|2|||
28103631|NCT02849704|54760340|FG000|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1|||
28103632|NCT02849704|54760341|FG001|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0|||
28103633|NCT02849704|54760340|FG000|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1|||
28103634|NCT02849704|54760341|FG001|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0|||
28103635|NCT02849704|54760340|FG000|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1|||
28103636|NCT02849704|54760341|FG001|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0|||
28008942|NCT00662025|54667647|FG000|Overall Study|Target lesion cannot be evaluated|1|||
28008943|NCT00662025|54667647|FG000|Overall Study|Domestic circumstances|1|||
28008944|NCT00440947|54667651|FG000|36-Week Induction Phase|Adverse Event|16|||
28008945|NCT00440947|54667652|FG001|36-Week Induction Phase|Adverse Event|0|||
28008946|NCT00440947|54667653|FG002|36-Week Induction Phase|Adverse Event|0|||
28008947|NCT00440947|54667654|FG003|36-Week Induction Phase|Adverse Event|0|||
28008948|NCT00440947|54667655|FG004|36-Week Induction Phase|Adverse Event|0|||
28008949|NCT00440947|54667651|FG000|36-Week Induction Phase|Insufficient Viral Load Response|11|||
28008950|NCT00440947|54667652|FG001|36-Week Induction Phase|Insufficient Viral Load Response|0|||
28008951|NCT00440947|54667653|FG002|36-Week Induction Phase|Insufficient Viral Load Response|0|||
28008952|NCT00440947|54667654|FG003|36-Week Induction Phase|Insufficient Viral Load Response|0|||
28008953|NCT00440947|54667655|FG004|36-Week Induction Phase|Insufficient Viral Load Response|0|||
28008954|NCT00440947|54667651|FG000|36-Week Induction Phase|Protocol-defined Virologic Failure|5|||
28008955|NCT00440947|54667652|FG001|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
28008956|NCT00440947|54667653|FG002|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
28008957|NCT00440947|54667654|FG003|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
28008958|NCT00440947|54667655|FG004|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
28008959|NCT00440947|54667651|FG000|36-Week Induction Phase|Non-compliance|10|||
28008960|NCT00440947|54667652|FG001|36-Week Induction Phase|Non-compliance|0|||
28008961|NCT00440947|54667653|FG002|36-Week Induction Phase|Non-compliance|0|||
28008962|NCT00440947|54667654|FG003|36-Week Induction Phase|Non-compliance|0|||
28008963|NCT00440947|54667655|FG004|36-Week Induction Phase|Non-compliance|0|||
28008964|NCT00440947|54667651|FG000|36-Week Induction Phase|Lost to Follow-up|16|||
28008965|NCT00440947|54667652|FG001|36-Week Induction Phase|Lost to Follow-up|0|||
28008966|NCT00440947|54667653|FG002|36-Week Induction Phase|Lost to Follow-up|0|||
28008967|NCT00440947|54667654|FG003|36-Week Induction Phase|Lost to Follow-up|0|||
28008968|NCT00440947|54667655|FG004|36-Week Induction Phase|Lost to Follow-up|0|||
28008969|NCT00440947|54667651|FG000|36-Week Induction Phase|Withdrawal by Subject|7|||
28008970|NCT00440947|54667652|FG001|36-Week Induction Phase|Withdrawal by Subject|0|||
28008971|NCT00440947|54667653|FG002|36-Week Induction Phase|Withdrawal by Subject|0|||
28008972|NCT00440947|54667654|FG003|36-Week Induction Phase|Withdrawal by Subject|0|||
28008973|NCT00440947|54667655|FG004|36-Week Induction Phase|Withdrawal by Subject|0|||
28008974|NCT00440947|54667651|FG000|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1|||
28008975|NCT00440947|54667652|FG001|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
28008976|NCT00440947|54667653|FG002|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
28008977|NCT00440947|54667654|FG003|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
28008978|NCT00440947|54667655|FG004|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
28008979|NCT00440947|54667651|FG000|36-Week Induction Phase|Took Exclusionary Medications|1|||
28008980|NCT00440947|54667652|FG001|36-Week Induction Phase|Took Exclusionary Medications|0|||
28008981|NCT00440947|54667653|FG002|36-Week Induction Phase|Took Exclusionary Medications|0|||
28008982|NCT00440947|54667654|FG003|36-Week Induction Phase|Took Exclusionary Medications|0|||
28008983|NCT00440947|54667655|FG004|36-Week Induction Phase|Took Exclusionary Medications|0|||
28008984|NCT00440947|54667651|FG000|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1|||
28008985|NCT00440947|54667652|FG001|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
28008986|NCT00440947|54667653|FG002|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
28008987|NCT00440947|54667654|FG003|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
28008988|NCT00440947|54667655|FG004|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
28008989|NCT00440947|54667651|FG000|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1|||
28008990|NCT00440947|54667652|FG001|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
28008991|NCT00440947|54667653|FG002|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
28008992|NCT00440947|54667654|FG003|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
28008993|NCT00440947|54667655|FG004|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
28008994|NCT00440947|54667651|FG000|36-Week Induction Phase|Incarceration|3|||
28008995|NCT00440947|54667652|FG001|36-Week Induction Phase|Incarceration|0|||
28008996|NCT00440947|54667653|FG002|36-Week Induction Phase|Incarceration|0|||
28008997|NCT00440947|54667654|FG003|36-Week Induction Phase|Incarceration|0|||
28008998|NCT00440947|54667655|FG004|36-Week Induction Phase|Incarceration|0|||
28008999|NCT00440947|54667651|FG000|36-Week Induction Phase|Pregnancy|1|||
28009000|NCT00440947|54667652|FG001|36-Week Induction Phase|Pregnancy|0|||
28009001|NCT00440947|54667653|FG002|36-Week Induction Phase|Pregnancy|0|||
28009002|NCT00440947|54667654|FG003|36-Week Induction Phase|Pregnancy|0|||
28009003|NCT00440947|54667655|FG004|36-Week Induction Phase|Pregnancy|0|||
28009004|NCT00440947|54667651|FG000|48-Week Randomization Phase|Adverse Event|0|||
28009005|NCT00440947|54667652|FG001|48-Week Randomization Phase|Adverse Event|2|||
28009006|NCT00440947|54667653|FG002|48-Week Randomization Phase|Adverse Event|5|||
28009007|NCT00440947|54667654|FG003|48-Week Randomization Phase|Adverse Event|0|||
28009008|NCT00440947|54667655|FG004|48-Week Randomization Phase|Adverse Event|0|||
27741355|NCT02712905|54191369|FG015|Monotherapy|Adverse Event|0|||
28009009|NCT00440947|54667651|FG000|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
28009010|NCT00440947|54667652|FG001|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
28009011|NCT00440947|54667653|FG002|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
28009012|NCT00440947|54667654|FG003|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
28009013|NCT00440947|54667655|FG004|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
28009014|NCT00440947|54667651|FG000|48-Week Randomization Phase|Non-compliance|0|||
28009015|NCT00440947|54667652|FG001|48-Week Randomization Phase|Non-compliance|3|||
28009016|NCT00440947|54667653|FG002|48-Week Randomization Phase|Non-compliance|4|||
28009017|NCT00440947|54667654|FG003|48-Week Randomization Phase|Non-compliance|0|||
28009018|NCT00440947|54667655|FG004|48-Week Randomization Phase|Non-compliance|0|||
28009019|NCT00440947|54667651|FG000|48-Week Randomization Phase|Lost to Follow-up|0|||
28009020|NCT00440947|54667652|FG001|48-Week Randomization Phase|Lost to Follow-up|2|||
28009021|NCT00440947|54667653|FG002|48-Week Randomization Phase|Lost to Follow-up|8|||
28009022|NCT00440947|54667654|FG003|48-Week Randomization Phase|Lost to Follow-up|0|||
28009023|NCT00440947|54667655|FG004|48-Week Randomization Phase|Lost to Follow-up|0|||
28009024|NCT00440947|54667651|FG000|48-Week Randomization Phase|Protocol Violation|0|||
28009025|NCT00440947|54667652|FG001|48-Week Randomization Phase|Protocol Violation|0|||
28009026|NCT00440947|54667653|FG002|48-Week Randomization Phase|Protocol Violation|1|||
28009027|NCT00440947|54667654|FG003|48-Week Randomization Phase|Protocol Violation|0|||
28009028|NCT00440947|54667655|FG004|48-Week Randomization Phase|Protocol Violation|0|||
28009029|NCT00440947|54667651|FG000|48-Week Randomization Phase|Withdrawal by Subject|0|||
28009030|NCT00440947|54667652|FG001|48-Week Randomization Phase|Withdrawal by Subject|2|||
28009031|NCT00440947|54667653|FG002|48-Week Randomization Phase|Withdrawal by Subject|4|||
28009032|NCT00440947|54667654|FG003|48-Week Randomization Phase|Withdrawal by Subject|0|||
28009033|NCT00440947|54667655|FG004|48-Week Randomization Phase|Withdrawal by Subject|0|||
28009034|NCT00440947|54667651|FG000|48-Week Randomization Phase|Pregnancy|0|||
28009035|NCT00440947|54667652|FG001|48-Week Randomization Phase|Pregnancy|0|||
28009036|NCT00440947|54667653|FG002|48-Week Randomization Phase|Pregnancy|1|||
28009037|NCT00440947|54667654|FG003|48-Week Randomization Phase|Pregnancy|0|||
28009038|NCT00440947|54667655|FG004|48-Week Randomization Phase|Pregnancy|0|||
28009039|NCT00440947|54667651|FG000|48-Week Randomization Phase|Incarceration|0|||
28009040|NCT00440947|54667652|FG001|48-Week Randomization Phase|Incarceration|3|||
28009041|NCT00440947|54667653|FG002|48-Week Randomization Phase|Incarceration|0|||
28009042|NCT00440947|54667654|FG003|48-Week Randomization Phase|Incarceration|0|||
28009043|NCT00440947|54667655|FG004|48-Week Randomization Phase|Incarceration|0|||
28009044|NCT00440947|54667651|FG000|48-Week Randomization Phase|Trying to Get Pregnant|0|||
28009045|NCT00440947|54667652|FG001|48-Week Randomization Phase|Trying to Get Pregnant|1|||
28009046|NCT00440947|54667653|FG002|48-Week Randomization Phase|Trying to Get Pregnant|0|||
28009047|NCT00440947|54667654|FG003|48-Week Randomization Phase|Trying to Get Pregnant|0|||
28009048|NCT00440947|54667655|FG004|48-Week Randomization Phase|Trying to Get Pregnant|0|||
28009049|NCT00440947|54667651|FG000|48-Week Randomization Phase|Physician Decision|0|||
28009050|NCT00440947|54667652|FG001|48-Week Randomization Phase|Physician Decision|2|||
28009051|NCT00440947|54667653|FG002|48-Week Randomization Phase|Physician Decision|0|||
28009052|NCT00440947|54667654|FG003|48-Week Randomization Phase|Physician Decision|0|||
28009053|NCT00440947|54667655|FG004|48-Week Randomization Phase|Physician Decision|0|||
28009054|NCT00440947|54667651|FG000|Optional 60-Week Extension Phase|Adverse Event|0|||
28009055|NCT00440947|54667652|FG001|Optional 60-Week Extension Phase|Adverse Event|0|||
28009056|NCT00440947|54667653|FG002|Optional 60-Week Extension Phase|Adverse Event|0|||
28009057|NCT00440947|54667654|FG003|Optional 60-Week Extension Phase|Adverse Event|1|||
28009058|NCT00440947|54667655|FG004|Optional 60-Week Extension Phase|Adverse Event|3|||
28009059|NCT00440947|54667651|FG000|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
28009060|NCT00440947|54667652|FG001|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
28009061|NCT00440947|54667653|FG002|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
28009062|NCT00440947|54667654|FG003|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
28009063|NCT00440947|54667655|FG004|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
28009064|NCT00440947|54667651|FG000|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
28009065|NCT00440947|54667652|FG001|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
28009066|NCT00440947|54667653|FG002|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
27919514|NCT01075243|54576685|FG000|Overall Study|Withdrawal by Subject|1|||
27919515|NCT01075243|54576686|FG001|Overall Study|Withdrawal by Subject|1|||
27919516|NCT01075243|54576687|FG002|Overall Study|Withdrawal by Subject|0|||
27919517|NCT01308476|54576699|FG000|Overall Study|Lost to Follow-up|2|||
27919518|NCT01308476|54576700|FG001|Overall Study|Lost to Follow-up|2|||
27919519|NCT01308476|54576699|FG000|Overall Study|Other|1|||
27919520|NCT01308476|54576700|FG001|Overall Study|Other|0|||
27919521|NCT01078441|54576706|FG000|Overall Study|Withdrawal by Subject|1|||
28009067|NCT00440947|54667654|FG003|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3|||
28009068|NCT00440947|54667655|FG004|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2|||
28009069|NCT00440947|54667651|FG000|Optional 60-Week Extension Phase|Non-compliance|0|||
28009070|NCT00440947|54667652|FG001|Optional 60-Week Extension Phase|Non-compliance|0|||
28009071|NCT00440947|54667653|FG002|Optional 60-Week Extension Phase|Non-compliance|0|||
28009072|NCT00440947|54667654|FG003|Optional 60-Week Extension Phase|Non-compliance|1|||
28009073|NCT00440947|54667655|FG004|Optional 60-Week Extension Phase|Non-compliance|1|||
28009074|NCT00440947|54667651|FG000|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
28009075|NCT00440947|54667652|FG001|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
28009076|NCT00440947|54667653|FG002|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
28009077|NCT00440947|54667654|FG003|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
28009078|NCT00440947|54667655|FG004|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
28009079|NCT00440947|54667651|FG000|Optional 60-Week Extension Phase|Protocol Violation|0|||
28009080|NCT00440947|54667652|FG001|Optional 60-Week Extension Phase|Protocol Violation|0|||
28009081|NCT00440947|54667653|FG002|Optional 60-Week Extension Phase|Protocol Violation|0|||
28009082|NCT00440947|54667654|FG003|Optional 60-Week Extension Phase|Protocol Violation|1|||
28009083|NCT00440947|54667655|FG004|Optional 60-Week Extension Phase|Protocol Violation|0|||
28009084|NCT00440947|54667651|FG000|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
28009085|NCT00440947|54667652|FG001|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
28009086|NCT00440947|54667653|FG002|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
28009087|NCT00440947|54667654|FG003|Optional 60-Week Extension Phase|Withdrawal by Subject|4|||
28009088|NCT00440947|54667655|FG004|Optional 60-Week Extension Phase|Withdrawal by Subject|3|||
28009089|NCT00440947|54667651|FG000|Optional 60-Week Extension Phase|Pregnancy|0|||
28009090|NCT00440947|54667652|FG001|Optional 60-Week Extension Phase|Pregnancy|0|||
28009091|NCT00440947|54667653|FG002|Optional 60-Week Extension Phase|Pregnancy|0|||
28009092|NCT00440947|54667654|FG003|Optional 60-Week Extension Phase|Pregnancy|3|||
28009093|NCT00440947|54667655|FG004|Optional 60-Week Extension Phase|Pregnancy|0|||
28009094|NCT00440947|54667651|FG000|Optional 60-Week Extension Phase|Participant Moved|0|||
28009095|NCT00440947|54667652|FG001|Optional 60-Week Extension Phase|Participant Moved|0|||
28009096|NCT00440947|54667653|FG002|Optional 60-Week Extension Phase|Participant Moved|0|||
28009097|NCT00440947|54667654|FG003|Optional 60-Week Extension Phase|Participant Moved|1|||
28009098|NCT00440947|54667655|FG004|Optional 60-Week Extension Phase|Participant Moved|1|||
28009099|NCT00440947|54667651|FG000|Optional 60-Week Extension Phase|Sponsor Request|0|||
28009100|NCT00440947|54667652|FG001|Optional 60-Week Extension Phase|Sponsor Request|0|||
28009101|NCT00440947|54667653|FG002|Optional 60-Week Extension Phase|Sponsor Request|0|||
28009102|NCT00440947|54667654|FG003|Optional 60-Week Extension Phase|Sponsor Request|1|||
28009103|NCT00440947|54667655|FG004|Optional 60-Week Extension Phase|Sponsor Request|1|||
28009104|NCT00440947|54667651|FG000|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
28009105|NCT00440947|54667652|FG001|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
28009106|NCT00440947|54667653|FG002|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
28009107|NCT00440947|54667654|FG003|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
28009108|NCT00440947|54667655|FG004|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
28009109|NCT00440947|54667651|FG000|Optional 60-Week Extension Phase|Other|0|||
28009110|NCT00440947|54667652|FG001|Optional 60-Week Extension Phase|Other|0|||
28009111|NCT00440947|54667653|FG002|Optional 60-Week Extension Phase|Other|0|||
28009112|NCT00440947|54667654|FG003|Optional 60-Week Extension Phase|Other|1|||
28009113|NCT00440947|54667655|FG004|Optional 60-Week Extension Phase|Other|0|||
28009114|NCT00440947|54667651|FG000|Optional 60-Week Extension Phase|Physician Decision|0|||
28009115|NCT00440947|54667652|FG001|Optional 60-Week Extension Phase|Physician Decision|0|||
28009116|NCT00440947|54667653|FG002|Optional 60-Week Extension Phase|Physician Decision|0|||
28009117|NCT00440947|54667654|FG003|Optional 60-Week Extension Phase|Physician Decision|0|||
28009118|NCT00440947|54667655|FG004|Optional 60-Week Extension Phase|Physician Decision|1|||
28009119|NCT00440947|54667651|FG000|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
28009120|NCT00440947|54667652|FG001|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
28009121|NCT00440947|54667653|FG002|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
28009122|NCT00440947|54667654|FG003|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
28009123|NCT00440947|54667655|FG004|Optional 60-Week Extension Phase|Participant Remained in Cuba|1|||
28009124|NCT00664521|54667678|FG000|Overall Study|Adverse Event|4|||
28009125|NCT00664521|54667679|FG001|Overall Study|Adverse Event|1|||
28009126|NCT00664521|54667678|FG000|Overall Study|Lost to Follow-up|1|||
28009127|NCT00664521|54667679|FG001|Overall Study|Lost to Follow-up|0|||
28009128|NCT00664521|54667678|FG000|Overall Study|Other|1|||
28009129|NCT00664521|54667679|FG001|Overall Study|Other|0|||
28009130|NCT00664209|54667685|FG000|Motor Fluctuations Screen|Negative for motor fluctuation|7|||
28009131|NCT00664209|54667685|FG000|Study Treatment Period|Physician Decision|4|||
28009132|NCT00664209|54667685|FG000|Study Treatment Period|Withdrawal by Subject|2|||
28009133|NCT00440557|54667693|FG000|Overall Study|Withdrawal by Subject|10|||
28009134|NCT00440557|54667694|FG001|Overall Study|Withdrawal by Subject|5|||
28009135|NCT00440557|54667695|FG002|Overall Study|Withdrawal by Subject|11|||
28009136|NCT00440557|54667693|FG000|Overall Study|Lost to Follow-up|1|||
28009137|NCT00440557|54667694|FG001|Overall Study|Lost to Follow-up|2|||
28009138|NCT00440557|54667695|FG002|Overall Study|Lost to Follow-up|6|||
28009139|NCT00440557|54667693|FG000|Overall Study|Adverse Event|3|||
28009140|NCT00440557|54667694|FG001|Overall Study|Adverse Event|3|||
28009141|NCT00440557|54667695|FG002|Overall Study|Adverse Event|5|||
28009142|NCT00440557|54667693|FG000|Overall Study|Death|2|||
28009143|NCT00440557|54667694|FG001|Overall Study|Death|6|||
28009144|NCT00440557|54667695|FG002|Overall Study|Death|3|||
28009145|NCT00440557|54667693|FG000|Overall Study|Began Dialysis|4|||
28009146|NCT00440557|54667694|FG001|Overall Study|Began Dialysis|1|||
28009147|NCT00440557|54667695|FG002|Overall Study|Began Dialysis|4|||
28009148|NCT00440557|54667693|FG000|Overall Study|Principal Investigator decision|0|||
28009149|NCT00440557|54667694|FG001|Overall Study|Principal Investigator decision|3|||
28009150|NCT00440557|54667695|FG002|Overall Study|Principal Investigator decision|1|||
28009151|NCT00440557|54667693|FG000|Overall Study|Patient moved|1|||
28009152|NCT00440557|54667694|FG001|Overall Study|Patient moved|2|||
28009153|NCT00440557|54667695|FG002|Overall Study|Patient moved|1|||
28009154|NCT00440557|54667693|FG000|Overall Study|Principal Investigator's office closed|3|||
28009155|NCT00440557|54667694|FG001|Overall Study|Principal Investigator's office closed|6|||
28009156|NCT00440557|54667695|FG002|Overall Study|Principal Investigator's office closed|4|||
28009157|NCT00440557|54667693|FG000|Overall Study|Patient transferred to nursing home|0|||
28009158|NCT00440557|54667694|FG001|Overall Study|Patient transferred to nursing home|1|||
28009159|NCT00440557|54667695|FG002|Overall Study|Patient transferred to nursing home|0|||
28009160|NCT00440557|54667693|FG000|Overall Study|Patient had surgery|1|||
28009161|NCT00440557|54667694|FG001|Overall Study|Patient had surgery|0|||
28009162|NCT00440557|54667695|FG002|Overall Study|Patient had surgery|0|||
28009163|NCT00582608|54667755|FG000|Overall Study|Not Treated|7|||
28009164|NCT00582608|54667755|FG000|Overall Study|Patient Ineligible|1|||
28009165|NCT00582608|54667755|FG000|Overall Study|Lack of accrual|4|||
28009166|NCT03014570|54667761|FG000|Overall Study|COVID-19 Restrictions|38|||
28009167|NCT03014570|54667762|FG001|Overall Study|COVID-19 Restrictions|24|||
28009168|NCT03014570|54667761|FG000|Overall Study|Death|70|||
28009169|NCT03014570|54667762|FG001|Overall Study|Death|79|||
28009170|NCT03014570|54667761|FG000|Overall Study|Transfer from facility|11|||
28009171|NCT03014570|54667762|FG001|Overall Study|Transfer from facility|14|||
28009172|NCT03014570|54667761|FG000|Overall Study|Hospitalized|5|||
28009173|NCT03014570|54667762|FG001|Overall Study|Hospitalized|3|||
28009174|NCT03014570|54667761|FG000|Overall Study|Transfer within facility|1|||
28009175|NCT03014570|54667762|FG001|Overall Study|Transfer within facility|0|||
28009176|NCT03014570|54667761|FG000|Overall Study|Site refusal|0|||
28009177|NCT03014570|54667762|FG001|Overall Study|Site refusal|11|||
28009178|NCT00427999|54667769|FG000|Overall Study|Adverse Event|6|||
28009179|NCT00427999|54667769|FG000|Overall Study|Abnormal laboratory values|1|||
28009180|NCT00427999|54667769|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
28009181|NCT00427999|54667769|FG000|Overall Study|Protocol Violation|2|||
28009182|NCT00427999|54667769|FG000|Overall Study|Withdrawal by Subject|9|||
28009183|NCT00427999|54667769|FG000|Overall Study|Death|1|||
28009184|NCT00661713|54667782|FG000|Overall Study|Death|1|||
28009185|NCT00661713|54667783|FG001|Overall Study|Death|0|||
28009186|NCT00661713|54667784|FG002|Overall Study|Death|0|||
28009187|NCT00661713|54667785|FG003|Overall Study|Death|0|||
28009188|NCT00661713|54667786|FG004|Overall Study|Death|1|||
28009189|NCT00661713|54667787|FG005|Overall Study|Death|0|||
28009190|NCT00661713|54667788|FG006|Overall Study|Death|0|||
28009191|NCT00661713|54667789|FG007|Overall Study|Death|0|||
28009192|NCT00661713|54667782|FG000|Overall Study|Unable to Classify|1|||
28009193|NCT00661713|54667783|FG001|Overall Study|Unable to Classify|0|||
28009194|NCT00661713|54667784|FG002|Overall Study|Unable to Classify|0|||
28009195|NCT00661713|54667785|FG003|Overall Study|Unable to Classify|0|||
28009196|NCT00661713|54667786|FG004|Overall Study|Unable to Classify|0|||
28009197|NCT00661713|54667787|FG005|Overall Study|Unable to Classify|0|||
28009198|NCT00661713|54667788|FG006|Overall Study|Unable to Classify|0|||
28009199|NCT00661713|54667789|FG007|Overall Study|Unable to Classify|0|||
28009200|NCT00661713|54667782|FG000|Overall Study|Protocol Violation|1|||
28009201|NCT00661713|54667783|FG001|Overall Study|Protocol Violation|6|||
28009202|NCT00661713|54667784|FG002|Overall Study|Protocol Violation|3|||
28009203|NCT00661713|54667785|FG003|Overall Study|Protocol Violation|3|||
28009204|NCT00661713|54667786|FG004|Overall Study|Protocol Violation|0|||
28009205|NCT00661713|54667787|FG005|Overall Study|Protocol Violation|2|||
28009206|NCT00661713|54667788|FG006|Overall Study|Protocol Violation|2|||
28009207|NCT00661713|54667789|FG007|Overall Study|Protocol Violation|1|||
28009208|NCT00661713|54667782|FG000|Overall Study|Withdrawal by Subject|11|||
28009209|NCT00661713|54667783|FG001|Overall Study|Withdrawal by Subject|25|||
28009210|NCT00661713|54667784|FG002|Overall Study|Withdrawal by Subject|12|||
28009211|NCT00661713|54667785|FG003|Overall Study|Withdrawal by Subject|21|||
28009212|NCT00661713|54667786|FG004|Overall Study|Withdrawal by Subject|12|||
28009213|NCT00661713|54667787|FG005|Overall Study|Withdrawal by Subject|26|||
28009214|NCT00661713|54667788|FG006|Overall Study|Withdrawal by Subject|45|||
28009215|NCT00661713|54667789|FG007|Overall Study|Withdrawal by Subject|9|||
28009216|NCT00661713|54667782|FG000|Overall Study|Lost to Follow-up|2|||
28009217|NCT00661713|54667783|FG001|Overall Study|Lost to Follow-up|7|||
28009218|NCT00661713|54667784|FG002|Overall Study|Lost to Follow-up|2|||
28009219|NCT00661713|54667785|FG003|Overall Study|Lost to Follow-up|2|||
28009220|NCT00661713|54667786|FG004|Overall Study|Lost to Follow-up|5|||
28009221|NCT00661713|54667787|FG005|Overall Study|Lost to Follow-up|7|||
28009222|NCT00661713|54667788|FG006|Overall Study|Lost to Follow-up|14|||
27741356|NCT02712905|54191370|FG016|Monotherapy|Adverse Event|0|||
28009223|NCT00661713|54667789|FG007|Overall Study|Lost to Follow-up|1|||
28009224|NCT00661713|54667782|FG000|Overall Study|Administrative Reason|0|||
28009225|NCT00661713|54667783|FG001|Overall Study|Administrative Reason|1|||
28009226|NCT00661713|54667784|FG002|Overall Study|Administrative Reason|0|||
28009227|NCT00661713|54667785|FG003|Overall Study|Administrative Reason|2|||
28009228|NCT00661713|54667786|FG004|Overall Study|Administrative Reason|2|||
28009229|NCT00661713|54667787|FG005|Overall Study|Administrative Reason|2|||
28009230|NCT00661713|54667788|FG006|Overall Study|Administrative Reason|1|||
28009231|NCT00661713|54667789|FG007|Overall Study|Administrative Reason|0|||
28009232|NCT00661713|54667782|FG000|Overall Study|Adverse Event|0|||
28009233|NCT00661713|54667783|FG001|Overall Study|Adverse Event|0|||
28009234|NCT00661713|54667784|FG002|Overall Study|Adverse Event|0|||
28009235|NCT00661713|54667785|FG003|Overall Study|Adverse Event|0|||
28009236|NCT00661713|54667786|FG004|Overall Study|Adverse Event|0|||
28009237|NCT00661713|54667787|FG005|Overall Study|Adverse Event|0|||
28009238|NCT00661713|54667788|FG006|Overall Study|Adverse Event|1|||
28009239|NCT00661713|54667789|FG007|Overall Study|Adverse Event|0|||
28009240|NCT00661713|54667782|FG000|Overall Study|Inappropriate Enrollment|0|||
28009241|NCT00661713|54667783|FG001|Overall Study|Inappropriate Enrollment|0|||
28009242|NCT00661713|54667784|FG002|Overall Study|Inappropriate Enrollment|0|||
28009243|NCT00661713|54667785|FG003|Overall Study|Inappropriate Enrollment|0|||
28009244|NCT00661713|54667786|FG004|Overall Study|Inappropriate Enrollment|0|||
28009245|NCT00661713|54667787|FG005|Overall Study|Inappropriate Enrollment|0|||
28009246|NCT00661713|54667788|FG006|Overall Study|Inappropriate Enrollment|1|||
28009247|NCT00661713|54667789|FG007|Overall Study|Inappropriate Enrollment|0|||
28009248|NCT03835975|54667814|FG000|Overall Study|Lost to Follow-up|1|||
28009249|NCT03835975|54667815|FG001|Overall Study|Lost to Follow-up|1|||
28009250|NCT03835975|54667816|FG002|Overall Study|Lost to Follow-up|0|||
28009251|NCT03835975|54667817|FG003|Overall Study|Lost to Follow-up|0|||
28009252|NCT03835975|54667818|FG004|Overall Study|Lost to Follow-up|0|||
28009253|NCT03835975|54667814|FG000|Overall Study|No longer met eligibility criteria|0|||
28009254|NCT03835975|54667815|FG001|Overall Study|No longer met eligibility criteria|1|||
28009255|NCT03835975|54667816|FG002|Overall Study|No longer met eligibility criteria|0|||
28009256|NCT03835975|54667817|FG003|Overall Study|No longer met eligibility criteria|0|||
28009257|NCT03835975|54667818|FG004|Overall Study|No longer met eligibility criteria|0|||
28009258|NCT03835975|54667814|FG000|Overall Study|Protocol Violation|1|||
28009259|NCT03835975|54667815|FG001|Overall Study|Protocol Violation|1|||
28009260|NCT03835975|54667816|FG002|Overall Study|Protocol Violation|2|||
28009261|NCT03835975|54667817|FG003|Overall Study|Protocol Violation|0|||
28009262|NCT03835975|54667818|FG004|Overall Study|Protocol Violation|0|||
28009263|NCT03835975|54667814|FG000|Overall Study|Withdrawal by Subject|1|||
28009264|NCT03835975|54667815|FG001|Overall Study|Withdrawal by Subject|0|||
28009265|NCT03835975|54667816|FG002|Overall Study|Withdrawal by Subject|1|||
28009266|NCT03835975|54667817|FG003|Overall Study|Withdrawal by Subject|1|||
28009267|NCT03835975|54667818|FG004|Overall Study|Withdrawal by Subject|0|||
28009268|NCT00427921|54667832|FG000|Overall Study|Adverse Event|26|||
28009269|NCT00427921|54667832|FG000|Overall Study|Withdrawal by Subject|4|||
28009270|NCT00427921|54667832|FG000|Overall Study|Lost to Follow-up|2|||
28009271|NCT00427921|54667832|FG000|Overall Study|Other reason not specified|10|||
28009272|NCT00427921|54667832|FG000|Overall Study|Adverse Event + Hospitalization|1|||
28009273|NCT00427921|54667832|FG000|Overall Study|Adverse Event + Withdrew Consent|1|||
28009274|NCT00427921|54667832|FG000|Overall Study|Adverse Event + No Response|1|||
28009275|NCT00427921|54667832|FG000|Overall Study|Adverse Event + Worsening of CD|1|||
28009276|NCT00427921|54667832|FG000|Overall Study|Adverse Event + No Therapeutic Benefit|1|||
28009277|NCT00427921|54667832|FG000|Overall Study|Adverse Event + Lost Response|1|||
28009278|NCT00427921|54667832|FG000|Overall Study|Adverse Event + Withdrawn from Study|1|||
28009279|NCT00427921|54667832|FG000|Overall Study|Withdrew Consent + Lack of Efficacy|1|||
28009280|NCT00432991|54667838|FG000|Overall Study|Protocol Violation|7|||
28009281|NCT00432991|54667839|FG001|Overall Study|Protocol Violation|12|||
28009282|NCT00432835|54667847|FG000|Overall Study|Adverse event: lead dislodgement.|6|||
28009283|NCT00432835|54667848|FG001|Overall Study|Adverse event: lead dislodgement.|7|||
28009284|NCT00580970|54667856|FG000|Pre-treatment|Non-compliance|1|||
28009285|NCT00580970|54667856|FG000|Treatment (Lovastatin)|Non-compliance|6|||
28009286|NCT00580970|54667856|FG000|Treatment (Lovastatin)|Intolerance of Lovastatin|7|||
28009287|NCT00580970|54667856|FG000|Treatment (Lovastatin)|Physician Decision|4|||
28009288|NCT00580970|54667856|FG000|Treatment (Lovastatin)|Development of metastatic second primary|1|||
28009289|NCT00580970|54667856|FG000|Treatment (Lovastatin)|Death|1|||
28009290|NCT00665925|54667864|FG000|Overall Study|Lack of Efficacy|10|||
28009291|NCT00665925|54667865|FG001|Overall Study|Lack of Efficacy|8|||
28009292|NCT00665925|54667866|FG002|Overall Study|Lack of Efficacy|9|||
28009293|NCT00665925|54667867|FG003|Overall Study|Lack of Efficacy|8|||
28009294|NCT00665925|54667864|FG000|Overall Study|Lost to Follow-up|1|||
28009295|NCT00665925|54667865|FG001|Overall Study|Lost to Follow-up|2|||
28009296|NCT00665925|54667866|FG002|Overall Study|Lost to Follow-up|2|||
28009297|NCT00665925|54667867|FG003|Overall Study|Lost to Follow-up|2|||
27741357|NCT02712905|54191371|FG017|Monotherapy|Adverse Event|0|||
28009298|NCT00665925|54667864|FG000|Overall Study|Withdrawal by Subject|2|||
28009299|NCT00665925|54667865|FG001|Overall Study|Withdrawal by Subject|2|||
28009300|NCT00665925|54667866|FG002|Overall Study|Withdrawal by Subject|3|||
28009301|NCT00665925|54667867|FG003|Overall Study|Withdrawal by Subject|2|||
28009302|NCT00665925|54667864|FG000|Overall Study|Physician Decision|0|||
28009303|NCT00665925|54667865|FG001|Overall Study|Physician Decision|0|||
28009304|NCT00665925|54667866|FG002|Overall Study|Physician Decision|1|||
28009305|NCT00665925|54667867|FG003|Overall Study|Physician Decision|2|||
28009306|NCT00665925|54667864|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
28009307|NCT00665925|54667865|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
28009308|NCT00665925|54667866|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
28009309|NCT00665925|54667867|FG003|Overall Study|Severe Non-Compliance to Protocol|1|||
28009310|NCT00665925|54667864|FG000|Overall Study|Adverse Event|1|||
28009311|NCT00665925|54667865|FG001|Overall Study|Adverse Event|5|||
28009312|NCT00665925|54667866|FG002|Overall Study|Adverse Event|10|||
28009313|NCT00665925|54667867|FG003|Overall Study|Adverse Event|5|||
28009314|NCT00665925|54667864|FG000|Overall Study|Enrolled by mistake|0|||
28009315|NCT00665925|54667865|FG001|Overall Study|Enrolled by mistake|0|||
28009316|NCT00665925|54667866|FG002|Overall Study|Enrolled by mistake|0|||
28009317|NCT00665925|54667867|FG003|Overall Study|Enrolled by mistake|1|||
28009318|NCT00665925|54667864|FG000|Overall Study|Due to exclusion criteria|1|||
28009319|NCT00665925|54667865|FG001|Overall Study|Due to exclusion criteria|0|||
28009320|NCT00665925|54667866|FG002|Overall Study|Due to exclusion criteria|0|||
28009321|NCT00665925|54667867|FG003|Overall Study|Due to exclusion criteria|0|||
28009322|NCT00426751|54667880|FG000|Overall Study|Adverse Event|8|||
28009323|NCT00426751|54667881|FG001|Overall Study|Adverse Event|1|||
28009324|NCT00426751|54667880|FG000|Overall Study|Lost to Follow-up|7|||
28009325|NCT00426751|54667881|FG001|Overall Study|Lost to Follow-up|6|||
28009326|NCT00426751|54667880|FG000|Overall Study|Consent Withdrawn|0|||
28009327|NCT00426751|54667881|FG001|Overall Study|Consent Withdrawn|1|||
28009328|NCT00426751|54667880|FG000|Overall Study|Other Reasons|7|||
28009329|NCT00426751|54667881|FG001|Overall Study|Other Reasons|12|||
28009330|NCT00440401|54667889|FG000|Overall Study|Adverse Event|2|||
28009331|NCT00440401|54667890|FG001|Overall Study|Adverse Event|1|||
28009332|NCT00440401|54667889|FG000|Overall Study|Other|2|||
28009333|NCT00440401|54667890|FG001|Overall Study|Other|5|||
28009334|NCT02598960|54667909|FG000|Treatment Period|Disease Progression|4|||
28009335|NCT02598960|54667910|FG001|Treatment Period|Disease Progression|4|||
28009336|NCT02598960|54667911|FG002|Treatment Period|Disease Progression|4|||
28009337|NCT02598960|54667912|FG003|Treatment Period|Disease Progression|6|||
28009338|NCT02598960|54667913|FG004|Treatment Period|Disease Progression|8|||
28009339|NCT02598960|54667914|FG005|Treatment Period|Disease Progression|2|||
28009340|NCT02598960|54667915|FG006|Treatment Period|Disease Progression|2|||
28009341|NCT02598960|54667916|FG007|Treatment Period|Disease Progression|3|||
28009342|NCT02598960|54667917|FG008|Treatment Period|Disease Progression|7|||
28009343|NCT02598960|54667918|FG009|Treatment Period|Disease Progression|9|||
28009344|NCT02598960|54667919|FG010|Treatment Period|Disease Progression|7|||
28009345|NCT02598960|54667920|FG011|Treatment Period|Disease Progression|143|||
28009346|NCT02598960|54667921|FG012|Treatment Period|Disease Progression|23|||
28009347|NCT02598960|54667909|FG000|Treatment Period|Study drug toxicity|0|||
28009348|NCT02598960|54667910|FG001|Treatment Period|Study drug toxicity|0|||
28009349|NCT02598960|54667911|FG002|Treatment Period|Study drug toxicity|0|||
28009350|NCT02598960|54667912|FG003|Treatment Period|Study drug toxicity|0|||
28009351|NCT02598960|54667913|FG004|Treatment Period|Study drug toxicity|0|||
28009352|NCT02598960|54667914|FG005|Treatment Period|Study drug toxicity|0|||
28009353|NCT02598960|54667915|FG006|Treatment Period|Study drug toxicity|0|||
28009354|NCT02598960|54667916|FG007|Treatment Period|Study drug toxicity|0|||
28009355|NCT02598960|54667917|FG008|Treatment Period|Study drug toxicity|0|||
28009356|NCT02598960|54667918|FG009|Treatment Period|Study drug toxicity|1|||
28009357|NCT02598960|54667919|FG010|Treatment Period|Study drug toxicity|0|||
28009358|NCT02598960|54667920|FG011|Treatment Period|Study drug toxicity|3|||
28009359|NCT02598960|54667921|FG012|Treatment Period|Study drug toxicity|0|||
28009360|NCT02598960|54667909|FG000|Treatment Period|Adverse Event unrelated to study drug|0|||
28009361|NCT02598960|54667910|FG001|Treatment Period|Adverse Event unrelated to study drug|1|||
28009362|NCT02598960|54667911|FG002|Treatment Period|Adverse Event unrelated to study drug|0|||
28009363|NCT02598960|54667912|FG003|Treatment Period|Adverse Event unrelated to study drug|0|||
28009364|NCT02598960|54667913|FG004|Treatment Period|Adverse Event unrelated to study drug|0|||
28009365|NCT02598960|54667914|FG005|Treatment Period|Adverse Event unrelated to study drug|0|||
28009366|NCT02598960|54667915|FG006|Treatment Period|Adverse Event unrelated to study drug|0|||
28009367|NCT02598960|54667916|FG007|Treatment Period|Adverse Event unrelated to study drug|0|||
27741358|NCT02712905|54191354|FG000|Combination Therapy|Death|0|||
28009368|NCT02598960|54667917|FG008|Treatment Period|Adverse Event unrelated to study drug|0|||
28009369|NCT02598960|54667918|FG009|Treatment Period|Adverse Event unrelated to study drug|1|||
28009370|NCT02598960|54667919|FG010|Treatment Period|Adverse Event unrelated to study drug|0|||
28009371|NCT02598960|54667920|FG011|Treatment Period|Adverse Event unrelated to study drug|11|||
28009372|NCT02598960|54667921|FG012|Treatment Period|Adverse Event unrelated to study drug|2|||
28009373|NCT02598960|54667909|FG000|Treatment Period|participant request to discontinue|0|||
28009374|NCT02598960|54667910|FG001|Treatment Period|participant request to discontinue|1|||
28009375|NCT02598960|54667911|FG002|Treatment Period|participant request to discontinue|0|||
28009376|NCT02598960|54667912|FG003|Treatment Period|participant request to discontinue|0|||
28103637|NCT03347396|54760362|FG000|Part A (26 Weeks)|Adverse Event|1|||
28009377|NCT02598960|54667913|FG004|Treatment Period|participant request to discontinue|1|||
28009378|NCT02598960|54667914|FG005|Treatment Period|participant request to discontinue|0|||
28009379|NCT02598960|54667915|FG006|Treatment Period|participant request to discontinue|0|||
28009380|NCT02598960|54667916|FG007|Treatment Period|participant request to discontinue|0|||
28009381|NCT02598960|54667917|FG008|Treatment Period|participant request to discontinue|0|||
28009382|NCT02598960|54667918|FG009|Treatment Period|participant request to discontinue|0|||
28009383|NCT02598960|54667919|FG010|Treatment Period|participant request to discontinue|1|||
28009384|NCT02598960|54667920|FG011|Treatment Period|participant request to discontinue|4|||
28009385|NCT02598960|54667921|FG012|Treatment Period|participant request to discontinue|0|||
28009386|NCT02598960|54667909|FG000|Treatment Period|participant withdrew consent|0|||
28009387|NCT02598960|54667910|FG001|Treatment Period|participant withdrew consent|0|||
28009388|NCT02598960|54667911|FG002|Treatment Period|participant withdrew consent|0|||
28009389|NCT02598960|54667912|FG003|Treatment Period|participant withdrew consent|0|||
28009390|NCT02598960|54667913|FG004|Treatment Period|participant withdrew consent|0|||
28009391|NCT02598960|54667914|FG005|Treatment Period|participant withdrew consent|0|||
28009392|NCT02598960|54667915|FG006|Treatment Period|participant withdrew consent|0|||
28009393|NCT02598960|54667916|FG007|Treatment Period|participant withdrew consent|0|||
28009394|NCT02598960|54667917|FG008|Treatment Period|participant withdrew consent|0|||
28009395|NCT02598960|54667918|FG009|Treatment Period|participant withdrew consent|0|||
28009396|NCT02598960|54667919|FG010|Treatment Period|participant withdrew consent|0|||
28009397|NCT02598960|54667920|FG011|Treatment Period|participant withdrew consent|3|||
28009398|NCT02598960|54667921|FG012|Treatment Period|participant withdrew consent|0|||
28009399|NCT02598960|54667909|FG000|Treatment Period|No longer meets study criteria|0|||
28009400|NCT02598960|54667910|FG001|Treatment Period|No longer meets study criteria|0|||
28009401|NCT02598960|54667911|FG002|Treatment Period|No longer meets study criteria|0|||
28009402|NCT02598960|54667912|FG003|Treatment Period|No longer meets study criteria|0|||
28009403|NCT02598960|54667913|FG004|Treatment Period|No longer meets study criteria|0|||
28009404|NCT02598960|54667914|FG005|Treatment Period|No longer meets study criteria|0|||
28009405|NCT02598960|54667915|FG006|Treatment Period|No longer meets study criteria|0|||
28009406|NCT02598960|54667916|FG007|Treatment Period|No longer meets study criteria|0|||
28009407|NCT02598960|54667917|FG008|Treatment Period|No longer meets study criteria|0|||
28009408|NCT02598960|54667918|FG009|Treatment Period|No longer meets study criteria|0|||
28009409|NCT02598960|54667919|FG010|Treatment Period|No longer meets study criteria|0|||
28009410|NCT02598960|54667920|FG011|Treatment Period|No longer meets study criteria|1|||
28009411|NCT02598960|54667921|FG012|Treatment Period|No longer meets study criteria|0|||
28009412|NCT02598960|54667909|FG000|Treatment Period|Other Reasons|0|||
28009413|NCT02598960|54667910|FG001|Treatment Period|Other Reasons|0|||
28009414|NCT02598960|54667911|FG002|Treatment Period|Other Reasons|0|||
28009415|NCT02598960|54667912|FG003|Treatment Period|Other Reasons|0|||
28009416|NCT02598960|54667913|FG004|Treatment Period|Other Reasons|0|||
28009417|NCT02598960|54667914|FG005|Treatment Period|Other Reasons|0|||
28009418|NCT02598960|54667915|FG006|Treatment Period|Other Reasons|0|||
28009419|NCT02598960|54667916|FG007|Treatment Period|Other Reasons|0|||
28009420|NCT02598960|54667917|FG008|Treatment Period|Other Reasons|0|||
28009421|NCT02598960|54667918|FG009|Treatment Period|Other Reasons|0|||
28009422|NCT02598960|54667919|FG010|Treatment Period|Other Reasons|0|||
28009423|NCT02598960|54667920|FG011|Treatment Period|Other Reasons|0|||
28009424|NCT02598960|54667921|FG012|Treatment Period|Other Reasons|1|||
28009425|NCT02598960|54667909|FG000|Participants Entering Follow Up Period|Death|1|||
28009426|NCT02598960|54667910|FG001|Participants Entering Follow Up Period|Death|0|||
28009427|NCT02598960|54667911|FG002|Participants Entering Follow Up Period|Death|0|||
28009428|NCT02598960|54667912|FG003|Participants Entering Follow Up Period|Death|0|||
28009429|NCT02598960|54667913|FG004|Participants Entering Follow Up Period|Death|0|||
28009430|NCT02598960|54667914|FG005|Participants Entering Follow Up Period|Death|0|||
28009431|NCT02598960|54667915|FG006|Participants Entering Follow Up Period|Death|0|||
28009432|NCT02598960|54667916|FG007|Participants Entering Follow Up Period|Death|0|||
28009433|NCT02598960|54667917|FG008|Participants Entering Follow Up Period|Death|0|||
28009434|NCT02598960|54667918|FG009|Participants Entering Follow Up Period|Death|1|||
28009435|NCT02598960|54667919|FG010|Participants Entering Follow Up Period|Death|0|||
28009436|NCT02598960|54667920|FG011|Participants Entering Follow Up Period|Death|11|||
28009437|NCT02598960|54667921|FG012|Participants Entering Follow Up Period|Death|2|||
28009438|NCT02598960|54667909|FG000|Participants Entering Follow Up Period|participant withdrew consent|0|||
28009439|NCT02598960|54667910|FG001|Participants Entering Follow Up Period|participant withdrew consent|0|||
28009440|NCT02598960|54667911|FG002|Participants Entering Follow Up Period|participant withdrew consent|0|||
28009441|NCT02598960|54667912|FG003|Participants Entering Follow Up Period|participant withdrew consent|0|||
28009442|NCT02598960|54667913|FG004|Participants Entering Follow Up Period|participant withdrew consent|0|||
28009443|NCT02598960|54667914|FG005|Participants Entering Follow Up Period|participant withdrew consent|0|||
28009444|NCT02598960|54667915|FG006|Participants Entering Follow Up Period|participant withdrew consent|0|||
28009445|NCT02598960|54667916|FG007|Participants Entering Follow Up Period|participant withdrew consent|0|||
28103638|NCT03347396|54760363|FG001|Part A (26 Weeks)|Adverse Event|0|||
28009446|NCT02598960|54667917|FG008|Participants Entering Follow Up Period|participant withdrew consent|0|||
28009447|NCT02598960|54667918|FG009|Participants Entering Follow Up Period|participant withdrew consent|0|||
28009448|NCT02598960|54667919|FG010|Participants Entering Follow Up Period|participant withdrew consent|0|||
28009449|NCT02598960|54667920|FG011|Participants Entering Follow Up Period|participant withdrew consent|7|||
28009450|NCT02598960|54667921|FG012|Participants Entering Follow Up Period|participant withdrew consent|0|||
28009451|NCT02598960|54667909|FG000|Participants Entering Follow Up Period|lost to follow up|0|||
27919522|NCT01308008|54576712|FG000|4 Weeks|Illness, disinterest, time|9|||
27919523|NCT01308008|54576713|FG001|4 Weeks|Illness, disinterest, time|2|||
27919524|NCT01113892|54576721|FG000|Overall Study|Lost to Follow-up|2|||
27919525|NCT01113892|54576722|FG001|Overall Study|Lost to Follow-up|2|||
27919526|NCT01113892|54576721|FG000|Overall Study|Withdrawal by Subject|1|||
27919527|NCT01113892|54576722|FG001|Overall Study|Withdrawal by Subject|1|||
27919528|NCT01113892|54576721|FG000|Overall Study|Death|2|||
27919529|NCT01113892|54576722|FG001|Overall Study|Death|4|||
27919530|NCT01113892|54576721|FG000|Overall Study|Graft no longer evaluable|9|||
27919531|NCT01113892|54576722|FG001|Overall Study|Graft no longer evaluable|9|||
27919532|NCT01090063|54576728|FG000|Screen|Screen Failed|4|||
27919533|NCT01090063|54576728|FG000|Treatment|Withdrawal by Subject|4|||
27919534|NCT01113580|54576744|FG000|Overall Study|Protocol Violation|1|||
27919535|NCT01113580|54576745|FG001|Overall Study|Protocol Violation|0|||
27919536|NCT01306214|54576754|FG000|Overall Study|Death|0|||
27919537|NCT01306214|54576755|FG001|Overall Study|Death|0|||
27919538|NCT01306214|54576756|FG002|Overall Study|Death|1|||
27919539|NCT01306214|54576754|FG000|Overall Study|Lost to Follow-up|3|||
27919540|NCT01306214|54576755|FG001|Overall Study|Lost to Follow-up|5|||
27919541|NCT01306214|54576756|FG002|Overall Study|Lost to Follow-up|4|||
27919542|NCT01306214|54576754|FG000|Overall Study|Withdrawal by Subject|24|||
27919543|NCT01306214|54576755|FG001|Overall Study|Withdrawal by Subject|22|||
27919544|NCT01306214|54576756|FG002|Overall Study|Withdrawal by Subject|16|||
27919545|NCT01306214|54576754|FG000|Overall Study|Not treated|1|||
27919546|NCT01306214|54576755|FG001|Overall Study|Not treated|1|||
27919547|NCT01306214|54576756|FG002|Overall Study|Not treated|1|||
27919548|NCT01077739|54576766|FG000|Overall Study|Premature withdrawal|1|||
27919549|NCT01077739|54576767|FG001|Overall Study|Premature withdrawal|3|||
27919550|NCT01077739|54576766|FG000|Overall Study|Withdrawal by Subject|1|||
27919551|NCT01077739|54576767|FG001|Overall Study|Withdrawal by Subject|0|||
27919552|NCT01077739|54576766|FG000|Overall Study|Death|0|||
27919553|NCT01077739|54576767|FG001|Overall Study|Death|3|||
27919554|NCT01077739|54576766|FG000|Overall Study|Unacceptable toxicity|1|||
27919555|NCT01077739|54576767|FG001|Overall Study|Unacceptable toxicity|2|||
27919556|NCT01077739|54576766|FG000|Overall Study|Other|2|||
27919557|NCT01077739|54576767|FG001|Overall Study|Other|2|||
27919558|NCT01306058|54576773|FG000|Overall Study|Death|1|||
27919559|NCT01306058|54576773|FG000|Overall Study|Enrolled but did not get treatment|1|||
27919560|NCT01305200|54576780|FG000|Overall Study|Physician Decision|4|||
27919561|NCT01305200|54576781|FG001|Overall Study|Physician Decision|6|||
27919562|NCT01305200|54576782|FG002|Overall Study|Physician Decision|1|||
27919563|NCT01305200|54576780|FG000|Overall Study|Withdrawal by Subject|24|||
27919564|NCT01305200|54576781|FG001|Overall Study|Withdrawal by Subject|21|||
27919565|NCT01305200|54576782|FG002|Overall Study|Withdrawal by Subject|1|||
27919566|NCT01305200|54576780|FG000|Overall Study|Ineligible|1|||
27919567|NCT01305200|54576781|FG001|Overall Study|Ineligible|2|||
27919568|NCT01305200|54576782|FG002|Overall Study|Ineligible|1|||
27919569|NCT01305200|54576780|FG000|Overall Study|Death|0|||
27919570|NCT01305200|54576781|FG001|Overall Study|Death|2|||
27919571|NCT01305200|54576782|FG002|Overall Study|Death|0|||
27919572|NCT01077271|54576792|FG000|Overall Study|Parental desire|8|||
27919573|NCT01077271|54576792|FG000|Overall Study|Screen failure, did not take palivizumab|4|||
27919574|NCT01077271|54576792|FG000|Overall Study|Noncompliance|2|||
27919575|NCT01077271|54576792|FG000|Overall Study|Quota used up (insurance reimb issue)|2|||
27919576|NCT01077271|54576792|FG000|Overall Study|Changed doctors|2|||
27919577|NCT01077271|54576792|FG000|Overall Study|Parents thought too many injections|2|||
27919578|NCT01077271|54576792|FG000|Overall Study|End of RSV season nearly reached|1|||
27919579|NCT01077271|54576792|FG000|Overall Study|Mother unconvinced of the necessity|1|||
27919580|NCT01305044|54576806|FG000|Overall Study|Withdrawal by Subject|3|||
27919581|NCT01305044|54576807|FG001|Overall Study|Withdrawal by Subject|6|||
27919582|NCT01304498|54576815|FG000|Overall Study|Adverse Event|1|||
27919583|NCT01304498|54576816|FG001|Overall Study|Adverse Event|1|||
27919584|NCT01304498|54576815|FG000|Overall Study|Withdrawal by Subject|2|||
27919585|NCT01304498|54576816|FG001|Overall Study|Withdrawal by Subject|3|||
27919586|NCT01304498|54576815|FG000|Overall Study|Protocol Violation|1|||
27919587|NCT01304498|54576816|FG001|Overall Study|Protocol Violation|0|||
27919588|NCT01304498|54576815|FG000|Overall Study|Lost to Follow-up|2|||
27919589|NCT01304498|54576816|FG001|Overall Study|Lost to Follow-up|1|||
28009452|NCT02598960|54667910|FG001|Participants Entering Follow Up Period|lost to follow up|0|||
28009453|NCT02598960|54667911|FG002|Participants Entering Follow Up Period|lost to follow up|0|||
28009454|NCT02598960|54667912|FG003|Participants Entering Follow Up Period|lost to follow up|0|||
28009455|NCT02598960|54667913|FG004|Participants Entering Follow Up Period|lost to follow up|0|||
28009456|NCT02598960|54667914|FG005|Participants Entering Follow Up Period|lost to follow up|0|||
28009457|NCT02598960|54667915|FG006|Participants Entering Follow Up Period|lost to follow up|0|||
28009458|NCT02598960|54667916|FG007|Participants Entering Follow Up Period|lost to follow up|0|||
28009459|NCT02598960|54667917|FG008|Participants Entering Follow Up Period|lost to follow up|0|||
28009460|NCT02598960|54667918|FG009|Participants Entering Follow Up Period|lost to follow up|0|||
28009461|NCT02598960|54667919|FG010|Participants Entering Follow Up Period|lost to follow up|0|||
28009462|NCT02598960|54667920|FG011|Participants Entering Follow Up Period|lost to follow up|3|||
28009463|NCT02598960|54667921|FG012|Participants Entering Follow Up Period|lost to follow up|0|||
28009464|NCT02598960|54667909|FG000|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
28009465|NCT02598960|54667910|FG001|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
28009466|NCT02598960|54667911|FG002|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
28009467|NCT02598960|54667912|FG003|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
28009468|NCT02598960|54667913|FG004|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
28009469|NCT02598960|54667914|FG005|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
28009470|NCT02598960|54667915|FG006|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
28009471|NCT02598960|54667916|FG007|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
28009472|NCT02598960|54667917|FG008|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
28009473|NCT02598960|54667918|FG009|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
28009474|NCT02598960|54667919|FG010|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
28009475|NCT02598960|54667920|FG011|Participants Entering Follow Up Period|follow up no longer required per protocol|2|||
28009476|NCT02598960|54667921|FG012|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
28009477|NCT02598960|54667909|FG000|Participants Entering Follow Up Period|Other Reasons|0|||
28009478|NCT02598960|54667910|FG001|Participants Entering Follow Up Period|Other Reasons|0|||
28009479|NCT02598960|54667911|FG002|Participants Entering Follow Up Period|Other Reasons|0|||
28009480|NCT02598960|54667912|FG003|Participants Entering Follow Up Period|Other Reasons|0|||
28009481|NCT02598960|54667913|FG004|Participants Entering Follow Up Period|Other Reasons|0|||
28009482|NCT02598960|54667914|FG005|Participants Entering Follow Up Period|Other Reasons|0|||
28009483|NCT02598960|54667915|FG006|Participants Entering Follow Up Period|Other Reasons|0|||
28009484|NCT02598960|54667916|FG007|Participants Entering Follow Up Period|Other Reasons|0|||
28009485|NCT02598960|54667917|FG008|Participants Entering Follow Up Period|Other Reasons|0|||
28009486|NCT02598960|54667918|FG009|Participants Entering Follow Up Period|Other Reasons|0|||
28009487|NCT02598960|54667919|FG010|Participants Entering Follow Up Period|Other Reasons|1|||
28009488|NCT02598960|54667920|FG011|Participants Entering Follow Up Period|Other Reasons|6|||
27741359|NCT02712905|54191355|FG001|Combination Therapy|Death|0|||
27741360|NCT02712905|54191356|FG002|Combination Therapy|Death|0|||
27741361|NCT02712905|54191357|FG003|Combination Therapy|Death|0|||
27741362|NCT02712905|54191358|FG004|Combination Therapy|Death|0|||
28009489|NCT02598960|54667921|FG012|Participants Entering Follow Up Period|Other Reasons|3|||
28009490|NCT00426361|54667952|FG000|Overall Study|Lost to Follow-up|3|||
28009491|NCT00426361|54667953|FG001|Overall Study|Lost to Follow-up|2|||
28009492|NCT00426361|54667954|FG002|Overall Study|Lost to Follow-up|5|||
28009493|NCT00426361|54667952|FG000|Overall Study|Withdrawal by Subject|1|||
28009494|NCT00426361|54667953|FG001|Overall Study|Withdrawal by Subject|3|||
28009495|NCT00426361|54667954|FG002|Overall Study|Withdrawal by Subject|0|||
28009496|NCT00665847|54667962|FG000|Overall Study|Adverse Event|8|||
28009497|NCT00665847|54667962|FG000|Overall Study|Withdrawal by Subject|2|||
28009498|NCT00665847|54667962|FG000|Overall Study|Subject non-compliant|8|||
28009499|NCT00665847|54667962|FG000|Overall Study|Subject reached a virologic endpoint|4|||
28009500|NCT00665847|54667962|FG000|Overall Study|Resistance to TMC125|1|||
28009501|NCT00665847|54667962|FG000|Overall Study|Subject ineligible to continue the trial|1|||
28009502|NCT00665847|54667962|FG000|Overall Study|Switch to Commercial Medication|1|||
28009503|NCT00426127|54667966|FG000|Overall Study|Adverse Event|1|||
28009504|NCT00426127|54667966|FG000|Overall Study|Removed due to disease progression|1|||
28009505|NCT00425503|54667970|FG000|Overall Study|Adverse Event|2|||
28009506|NCT00425503|54667970|FG000|Overall Study|Protocol Violation|1|||
28009507|NCT00425269|54667976|FG000|Overall Study|Pregnancy|5|||
28009508|NCT00425269|54667977|FG001|Overall Study|Pregnancy|7|||
28009509|NCT00425269|54667976|FG000|Overall Study|Lost to Follow-up|9|||
28009510|NCT00425269|54667977|FG001|Overall Study|Lost to Follow-up|9|||
28009511|NCT00425269|54667976|FG000|Overall Study|moved or medical reason|5|||
28009512|NCT00425269|54667977|FG001|Overall Study|moved or medical reason|4|||
28009513|NCT00430573|54667983|FG000|Overall Study|Withdrawal by Subject|5|||
28009514|NCT02075840|54668007|FG000|Overall Study|Withdrawal by Subject|13|||
28009515|NCT02075840|54668008|FG001|Overall Study|Withdrawal by Subject|22|||
28009516|NCT02075840|54668007|FG000|Overall Study|Reason not specified|1|||
28009517|NCT02075840|54668008|FG001|Overall Study|Reason not specified|0|||
28009518|NCT02075840|54668007|FG000|Overall Study|Adverse Event|0|||
28009519|NCT02075840|54668008|FG001|Overall Study|Adverse Event|2|||
28009520|NCT02075840|54668007|FG000|Overall Study|Death|35|||
28009521|NCT02075840|54668008|FG001|Overall Study|Death|40|||
28009522|NCT02075840|54668007|FG000|Overall Study|Lost to Follow-up|3|||
28009523|NCT02075840|54668008|FG001|Overall Study|Lost to Follow-up|2|||
28009524|NCT02075840|54668007|FG000|Overall Study|Physician Decision|1|||
27919590|NCT01077193|54576822|FG000|Overall Study|Lost to Follow-up|1|||
27919591|NCT01077193|54576822|FG000|Overall Study|Withdrawal by Subject|2|||
27919592|NCT01077193|54576822|FG000|Overall Study|Lack of Efficacy|1|||
27919593|NCT01077193|54576822|FG000|Overall Study|Study Terminated by Sponsor|40|||
27919594|NCT01074931|54576826|FG000|Overall Study|Economic reasons|1|||
27919595|NCT01074931|54576826|FG000|Overall Study|Death|5|||
27919596|NCT01303172|54576836|FG000|Overall Study|Physician Decision|9|||
27919597|NCT01303172|54576837|FG001|Overall Study|Physician Decision|6|||
27919598|NCT01303172|54576836|FG000|Overall Study|Adverse Event|5|||
27919599|NCT01303172|54576837|FG001|Overall Study|Adverse Event|2|||
27919600|NCT01303172|54576836|FG000|Overall Study|Withdrawal by Subject|4|||
27919601|NCT01303172|54576837|FG001|Overall Study|Withdrawal by Subject|2|||
27919602|NCT01303172|54576836|FG000|Overall Study|Death|20|||
27919603|NCT01303172|54576837|FG001|Overall Study|Death|7|||
27919604|NCT01303172|54576836|FG000|Overall Study|Lack of Efficacy|25|||
27919605|NCT01303172|54576837|FG001|Overall Study|Lack of Efficacy|17|||
27919606|NCT01302938|54576846|FG000|Overall Study|Withdrawal by Subject|1|||
27919607|NCT01302938|54576847|FG001|Overall Study|Withdrawal by Subject|0|||
27919608|NCT01302938|54576846|FG000|Overall Study|Adverse Event|1|||
27919609|NCT01302938|54576847|FG001|Overall Study|Adverse Event|0|||
27919610|NCT01302548|54576856|FG000|Overall Study|Lost to Follow-up|2|||
27919611|NCT01302548|54576857|FG001|Overall Study|Lost to Follow-up|1|||
27919612|NCT01076959|54576863|FG000|Overall Study|Adverse Event|767|||
27919613|NCT01076959|54576863|FG000|Overall Study|Lack of Efficacy|849|||
27919614|NCT01076959|54576863|FG000|Overall Study|Non-compliance|274|||
27919615|NCT01076959|54576863|FG000|Overall Study|Lost to Follow-up|241|||
28009525|NCT02075840|54668008|FG001|Overall Study|Physician Decision|3|||
28009526|NCT02075840|54668007|FG000|Overall Study|Ongoing at CCOD|99|||
28103639|NCT03347396|54760362|FG000|Part A (26 Weeks)|Death|0|||
27919616|NCT01076959|54576863|FG000|Overall Study|Other|119|||
27919617|NCT01302392|54576882|FG000|Overall Study|Lost to Follow-up|1|||
27919618|NCT01302392|54576883|FG001|Overall Study|Lost to Follow-up|0|||
27919619|NCT01302392|54576882|FG000|Overall Study|Withdrawal by Subject|6|||
27919620|NCT01302392|54576883|FG001|Overall Study|Withdrawal by Subject|1|||
27919621|NCT01076647|54576891|FG000|Overall Study|Adverse Event|4|||
27919622|NCT01076647|54576892|FG001|Overall Study|Adverse Event|1|||
28009527|NCT02075840|54668008|FG001|Overall Study|Ongoing at CCOD|82|||
28009528|NCT00430495|54668018|FG000|Overall Study|Adverse Event|2|||
28009529|NCT00430495|54668019|FG001|Overall Study|Adverse Event|3|||
28009530|NCT00430495|54668020|FG002|Overall Study|Adverse Event|2|||
28009531|NCT00430495|54668021|FG003|Overall Study|Adverse Event|0|||
28009532|NCT00430495|54668018|FG000|Overall Study|Death|0|||
28009533|NCT00430495|54668019|FG001|Overall Study|Death|0|||
28009534|NCT00430495|54668020|FG002|Overall Study|Death|1|||
28009535|NCT00430495|54668021|FG003|Overall Study|Death|0|||
28009536|NCT00430495|54668018|FG000|Overall Study|Lost to Follow-up|0|||
28009537|NCT00430495|54668019|FG001|Overall Study|Lost to Follow-up|1|||
28009538|NCT00430495|54668020|FG002|Overall Study|Lost to Follow-up|4|||
28009539|NCT00430495|54668021|FG003|Overall Study|Lost to Follow-up|0|||
28009540|NCT00430495|54668018|FG000|Overall Study|Protocol Violation|1|||
28009541|NCT00430495|54668019|FG001|Overall Study|Protocol Violation|0|||
28009542|NCT00430495|54668020|FG002|Overall Study|Protocol Violation|1|||
28009543|NCT00430495|54668021|FG003|Overall Study|Protocol Violation|0|||
28009544|NCT00430495|54668018|FG000|Overall Study|Disease Progression|1|||
28009545|NCT00430495|54668019|FG001|Overall Study|Disease Progression|1|||
28009546|NCT00430495|54668020|FG002|Overall Study|Disease Progression|0|||
28009547|NCT00430495|54668021|FG003|Overall Study|Disease Progression|0|||
28009548|NCT00430495|54668018|FG000|Overall Study|Other|8|||
28009549|NCT00430495|54668019|FG001|Overall Study|Other|2|||
28009550|NCT00430495|54668020|FG002|Overall Study|Other|5|||
27919623|NCT01076647|54576891|FG000|Overall Study|Lack of Efficacy|0|||
28009551|NCT00430495|54668021|FG003|Overall Study|Other|4|||
28009552|NCT00430495|54668018|FG000|Overall Study|Randomized but not Treated|2|||
28009553|NCT00430495|54668019|FG001|Overall Study|Randomized but not Treated|0|||
28009554|NCT00430495|54668020|FG002|Overall Study|Randomized but not Treated|0|||
28009555|NCT00430495|54668021|FG003|Overall Study|Randomized but not Treated|0|||
28009556|NCT00425113|54668033|FG000|Overall Study|uncontrolled diabetes mellitus|1|||
28009557|NCT00425113|54668034|FG001|Overall Study|uncontrolled diabetes mellitus|0|||
28009558|NCT00425113|54668033|FG000|Overall Study|diagnosis of abdominal TB|0|||
28009559|NCT00425113|54668034|FG001|Overall Study|diagnosis of abdominal TB|1|||
28009560|NCT00425113|54668033|FG000|Overall Study|missing study drug more than 14 days|0|||
28009561|NCT00425113|54668034|FG001|Overall Study|missing study drug more than 14 days|1|||
28009562|NCT00425113|54668033|FG000|Overall Study|Withdrawal by Subject|1|||
28009563|NCT00425113|54668034|FG001|Overall Study|Withdrawal by Subject|0|||
28009564|NCT00440011|54668043|FG000|Overall Study|Adverse Event|2|||
28009565|NCT00440011|54668044|FG001|Overall Study|Adverse Event|0|||
28009566|NCT00440011|54668043|FG000|Overall Study|Lost to Follow-up|0|||
28009567|NCT00440011|54668044|FG001|Overall Study|Lost to Follow-up|2|||
28009568|NCT00440011|54668043|FG000|Overall Study|Protocol Violation|1|||
28009569|NCT00440011|54668044|FG001|Overall Study|Protocol Violation|1|||
28009570|NCT00440011|54668043|FG000|Overall Study|Withdrawal by Subject|1|||
28009571|NCT00440011|54668044|FG001|Overall Study|Withdrawal by Subject|0|||
28009572|NCT00663117|54668081|FG000|Overall Study|Lack of Efficacy|1|||
28009573|NCT00663117|54668082|FG001|Overall Study|Lack of Efficacy|0|||
28009574|NCT00570141|54668103|FG000|Overall Study|Adverse Event|1|||
28009575|NCT00570141|54668103|FG000|Overall Study|Missed visits|1|||
28009576|NCT00570141|54668103|FG000|Overall Study|Lost to Follow-up|1|||
27741363|NCT02712905|54191359|FG005|Combination Therapy|Death|0|||
27919624|NCT01076647|54576892|FG001|Overall Study|Lack of Efficacy|1|||
27919625|NCT01076647|54576891|FG000|Overall Study|Protocol Violation|7|||
27919626|NCT01076647|54576892|FG001|Overall Study|Protocol Violation|9|||
27919627|NCT01076647|54576891|FG000|Overall Study|Withdrawal criteria|2|||
27919628|NCT01076647|54576892|FG001|Overall Study|Withdrawal criteria|2|||
27919629|NCT01076647|54576891|FG000|Overall Study|Unclassified|12|||
27919630|NCT01076647|54576892|FG001|Overall Study|Unclassified|12|||
27919631|NCT01074307|54576900|FG000|Overall Study|No primary endpoint evaluation|14|||
27919632|NCT01074307|54576901|FG001|Overall Study|No primary endpoint evaluation|6|||
27919633|NCT01074307|54576900|FG000|Overall Study|Exclusion criterion|0|||
27919634|NCT01074307|54576901|FG001|Overall Study|Exclusion criterion|1|||
27919635|NCT01074307|54576900|FG000|Overall Study|Protocol Violation|8|||
27919636|NCT01074307|54576901|FG001|Overall Study|Protocol Violation|5|||
27919637|NCT01076335|54576907|FG000|Overall Study|Withdrawal by Subject|3|||
27919638|NCT01076335|54576907|FG000|Overall Study|Withdrawal without treatment|1|||
28009577|NCT00579254|54668107|FG000|Overall Study|Lost to Follow-up|39|||
28009578|NCT00579254|54668107|FG000|Overall Study|Discontinued when study terminated|73|||
27919639|NCT01309737|54576914|FG000|Week 0 to 16|Death|1|||
27919640|NCT01309737|54576915|FG001|Week 0 to 16|Death|0|||
27919641|NCT01309737|54576916|FG002|Week 0 to 16|Death|1|||
27919642|NCT01309737|54576917|FG003|Week 0 to 16|Death|0|||
27919643|NCT01309737|54576918|FG004|Week 0 to 16|Death|0|||
28009579|NCT00661089|54668113|FG000|Overall Study|1 subject withdrawal|0|||
28009580|NCT00661089|54668114|FG001|Overall Study|1 subject withdrawal|1|||
28009581|NCT00661089|54668113|FG000|Overall Study|death at 8 weeks due to new stroke|0|||
28009582|NCT00661089|54668114|FG001|Overall Study|death at 8 weeks due to new stroke|1|||
27919644|NCT01309737|54576914|FG000|Week 0 to 16|Adverse Event|11|||
28009583|NCT00582426|54668127|FG000|Overall Study|Lost to Follow-up|0|||
28009584|NCT00582426|54668128|FG001|Overall Study|Lost to Follow-up|2|||
28009585|NCT00582426|54668127|FG000|Overall Study|Adverse Event|4|||
28009586|NCT00582426|54668128|FG001|Overall Study|Adverse Event|2|||
28009587|NCT00582426|54668127|FG000|Overall Study|Protocol Violation|6|||
28009588|NCT00582426|54668128|FG001|Overall Study|Protocol Violation|2|||
28009589|NCT00582426|54668127|FG000|Overall Study|Death|4|||
28009590|NCT00582426|54668128|FG001|Overall Study|Death|3|||
28009591|NCT00582426|54668127|FG000|Overall Study|Withdrawal by Subject|3|||
28009592|NCT00582426|54668128|FG001|Overall Study|Withdrawal by Subject|2|||
28009593|NCT00582426|54668127|FG000|Overall Study|Disease Progression|2|||
28009594|NCT00582426|54668128|FG001|Overall Study|Disease Progression|2|||
28009595|NCT00582426|54668127|FG000|Overall Study|Use of illicit drugs|1|||
28009596|NCT00582426|54668128|FG001|Overall Study|Use of illicit drugs|0|||
28009597|NCT02387970|54668136|FG000|Overall Study|Did not complete 1-year follow up|1|||
28009598|NCT02387970|54668137|FG001|Overall Study|Did not complete 1-year follow up|2|||
28009599|NCT00580034|54668143|FG000|Overall Study|Toxicity|10|||
28009600|NCT00580034|54668144|FG001|Overall Study|Toxicity|0|||
28009601|NCT00773513|54668150|FG000|Overall Study|Renal Transplant|254|||
28009602|NCT00773513|54668151|FG001|Overall Study|Renal Transplant|263|||
28009603|NCT00773513|54668150|FG000|Overall Study|Adverse Event / Intercurrent Illness|40|||
28009604|NCT00773513|54668151|FG001|Overall Study|Adverse Event / Intercurrent Illness|48|||
28009605|NCT00773513|54668150|FG000|Overall Study|Withdrew Consent|68|||
28009606|NCT00773513|54668151|FG001|Overall Study|Withdrew Consent|69|||
28009607|NCT00773513|54668150|FG000|Overall Study|Refused Treatment / Did not Cooperate|26|||
28009608|NCT00773513|54668151|FG001|Overall Study|Refused Treatment / Did not Cooperate|32|||
28009609|NCT00773513|54668150|FG000|Overall Study|Failure to Return|22|||
28009610|NCT00773513|54668151|FG001|Overall Study|Failure to Return|8|||
28009611|NCT00773513|54668150|FG000|Overall Study|Insufficient Therapeutic Response|1|||
28009612|NCT00773513|54668151|FG001|Overall Study|Insufficient Therapeutic Response|18|||
28009613|NCT00773513|54668150|FG000|Overall Study|Reason Not Specified|159|||
28009614|NCT00773513|54668151|FG001|Overall Study|Reason Not Specified|126|||
28009615|NCT00773513|54668150|FG000|Overall Study|Death|531|||
28009616|NCT00773513|54668151|FG001|Overall Study|Death|545|||
28009617|NCT00767039|54668159|FG000|Overall Study|Death|5|||
28009618|NCT00767039|54668160|FG001|Overall Study|Death|2|||
28009619|NCT00662649|54668170|FG000|Core Study (24 Months)|Withdrawal by Subject|31|||
28009620|NCT00662649|54668171|FG001|Core Study (24 Months)|Withdrawal by Subject|17|||
28009621|NCT00662649|54668172|FG002|Core Study (24 Months)|Withdrawal by Subject|28|||
28009622|NCT00662649|54668173|FG003|Core Study (24 Months)|Withdrawal by Subject|0|||
28009623|NCT00662649|54668174|FG004|Core Study (24 Months)|Withdrawal by Subject|0|||
28009624|NCT00662649|54668170|FG000|Core Study (24 Months)|Adverse Event|22|||
28009625|NCT00662649|54668171|FG001|Core Study (24 Months)|Adverse Event|13|||
28009626|NCT00662649|54668172|FG002|Core Study (24 Months)|Adverse Event|18|||
28009627|NCT00662649|54668173|FG003|Core Study (24 Months)|Adverse Event|0|||
28009628|NCT00662649|54668174|FG004|Core Study (24 Months)|Adverse Event|0|||
28009629|NCT00662649|54668170|FG000|Core Study (24 Months)|Unsatisfactory therapeutic effect|13|||
28009630|NCT00662649|54668171|FG001|Core Study (24 Months)|Unsatisfactory therapeutic effect|6|||
28009631|NCT00662649|54668172|FG002|Core Study (24 Months)|Unsatisfactory therapeutic effect|25|||
28009632|NCT00662649|54668173|FG003|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
28009633|NCT00662649|54668174|FG004|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
28009634|NCT00662649|54668170|FG000|Core Study (24 Months)|Abnormal laboratory value(s)|20|||
28009635|NCT00662649|54668171|FG001|Core Study (24 Months)|Abnormal laboratory value(s)|9|||
28009636|NCT00662649|54668172|FG002|Core Study (24 Months)|Abnormal laboratory value(s)|1|||
28009637|NCT00662649|54668173|FG003|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
28009638|NCT00662649|54668174|FG004|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
28009639|NCT00662649|54668170|FG000|Core Study (24 Months)|Lost to Follow-up|3|||
28009640|NCT00662649|54668171|FG001|Core Study (24 Months)|Lost to Follow-up|5|||
28009641|NCT00662649|54668172|FG002|Core Study (24 Months)|Lost to Follow-up|7|||
28009642|NCT00662649|54668173|FG003|Core Study (24 Months)|Lost to Follow-up|0|||
28009643|NCT00662649|54668174|FG004|Core Study (24 Months)|Lost to Follow-up|0|||
28009644|NCT00662649|54668170|FG000|Core Study (24 Months)|Protocol Violation|5|||
28009645|NCT00662649|54668171|FG001|Core Study (24 Months)|Protocol Violation|5|||
28009646|NCT00662649|54668172|FG002|Core Study (24 Months)|Protocol Violation|4|||
28009647|NCT00662649|54668173|FG003|Core Study (24 Months)|Protocol Violation|0|||
28009648|NCT00662649|54668174|FG004|Core Study (24 Months)|Protocol Violation|0|||
28103640|NCT03347396|54760363|FG001|Part A (26 Weeks)|Death|1|||
28103641|NCT03347396|54760362|FG000|Part B (149 Weeks)|Adverse Event|1|||
28103642|NCT03347396|54760363|FG001|Part B (149 Weeks)|Adverse Event|1|||
28103643|NCT03347396|54760362|FG000|Part B (149 Weeks)|Death|1|||
28103644|NCT03347396|54760363|FG001|Part B (149 Weeks)|Death|0|||
28103645|NCT03335150|54760374|FG000|Overall Study|Withdrawal by Subject|10|||
28103646|NCT03335150|54760375|FG001|Overall Study|Withdrawal by Subject|4|||
28103647|NCT03335150|54760374|FG000|Overall Study|Adverse Event|0|||
28103648|NCT03335150|54760375|FG001|Overall Study|Adverse Event|1|||
28103649|NCT03334448|54760381|FG000|Washout|Personal Reason|0|||
28103650|NCT03334448|54760382|FG001|Washout|Personal Reason|1|||
28103651|NCT03334448|54760383|FG002|Washout|Personal Reason|0|||
28103652|NCT03334448|54760384|FG003|Washout|Personal Reason|0|||
28103653|NCT03334448|54760381|FG000|Washout|Protocol Violation|0|||
28009649|NCT00662649|54668170|FG000|Core Study (24 Months)|Abnormal test procedure result(s)|2|||
28009650|NCT00662649|54668171|FG001|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
28009651|NCT00662649|54668172|FG002|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
28009652|NCT00662649|54668173|FG003|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
28009653|NCT00662649|54668174|FG004|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
28009654|NCT00662649|54668170|FG000|Core Study (24 Months)|Death|1|||
28009655|NCT00662649|54668171|FG001|Core Study (24 Months)|Death|0|||
28009656|NCT00662649|54668172|FG002|Core Study (24 Months)|Death|2|||
28009657|NCT00662649|54668173|FG003|Core Study (24 Months)|Death|0|||
28009658|NCT00662649|54668174|FG004|Core Study (24 Months)|Death|0|||
28009659|NCT00662649|54668170|FG000|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10|||
28009660|NCT00662649|54668171|FG001|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5|||
28009661|NCT00662649|54668172|FG002|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0|||
28009662|NCT00662649|54668173|FG003|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8|||
28009663|NCT00662649|54668174|FG004|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3|||
28009664|NCT00662649|54668170|FG000|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
28009665|NCT00662649|54668171|FG001|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
28009666|NCT00662649|54668172|FG002|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0|||
28009667|NCT00662649|54668173|FG003|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
28009668|NCT00662649|54668174|FG004|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
28009669|NCT00662649|54668170|FG000|Extension Study (Month 24 to 60)|Administrative problems|0|||
28009670|NCT00662649|54668171|FG001|Extension Study (Month 24 to 60)|Administrative problems|0|||
28009671|NCT00662649|54668172|FG002|Extension Study (Month 24 to 60)|Administrative problems|0|||
28009672|NCT00662649|54668173|FG003|Extension Study (Month 24 to 60)|Administrative problems|1|||
28009673|NCT00662649|54668174|FG004|Extension Study (Month 24 to 60)|Administrative problems|0|||
28009674|NCT00662649|54668170|FG000|Extension Study (Month 24 to 60)|Adverse Event|6|||
28009675|NCT00662649|54668171|FG001|Extension Study (Month 24 to 60)|Adverse Event|9|||
28009676|NCT00662649|54668172|FG002|Extension Study (Month 24 to 60)|Adverse Event|0|||
28009677|NCT00662649|54668173|FG003|Extension Study (Month 24 to 60)|Adverse Event|6|||
28009678|NCT00662649|54668174|FG004|Extension Study (Month 24 to 60)|Adverse Event|10|||
28009679|NCT00662649|54668170|FG000|Extension Study (Month 24 to 60)|Lost to Follow-up|2|||
28009680|NCT00662649|54668171|FG001|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
28009681|NCT00662649|54668172|FG002|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
28009682|NCT00662649|54668173|FG003|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
28009683|NCT00662649|54668174|FG004|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
28009684|NCT00662649|54668170|FG000|Extension Study (Month 24 to 60)|Protocol Violation|1|||
28009685|NCT00662649|54668171|FG001|Extension Study (Month 24 to 60)|Protocol Violation|1|||
28009686|NCT00662649|54668172|FG002|Extension Study (Month 24 to 60)|Protocol Violation|0|||
28009687|NCT00662649|54668173|FG003|Extension Study (Month 24 to 60)|Protocol Violation|0|||
28009688|NCT00662649|54668174|FG004|Extension Study (Month 24 to 60)|Protocol Violation|0|||
28009689|NCT00662649|54668170|FG000|Extension Study (Month 24 to 60)|Subject withdrew consent|19|||
28009690|NCT00662649|54668171|FG001|Extension Study (Month 24 to 60)|Subject withdrew consent|23|||
28009691|NCT00662649|54668172|FG002|Extension Study (Month 24 to 60)|Subject withdrew consent|0|||
28009692|NCT00662649|54668173|FG003|Extension Study (Month 24 to 60)|Subject withdrew consent|15|||
28009693|NCT00662649|54668174|FG004|Extension Study (Month 24 to 60)|Subject withdrew consent|9|||
28009694|NCT00662649|54668170|FG000|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
28009695|NCT00662649|54668171|FG001|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1|||
28009696|NCT00662649|54668172|FG002|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
28009697|NCT00662649|54668173|FG003|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
28009698|NCT00662649|54668174|FG004|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
28009699|NCT00662649|54668170|FG000|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
28009700|NCT00662649|54668171|FG001|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
28009701|NCT00662649|54668172|FG002|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0|||
28009702|NCT00662649|54668173|FG003|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
28009703|NCT00662649|54668174|FG004|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
28009704|NCT00766493|54668188|FG000|30 Days Post-Procedure|Discontinued|7|||
28009705|NCT00766493|54668188|FG000|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4|||
28009706|NCT00766493|54668188|FG000|30 Days Post-Procedure|Missed Visit - No Phone Contact|1|||
28009707|NCT03070392|54668194|FG000|Overall Study|Not Treated|7|||
28009708|NCT03070392|54668195|FG001|Overall Study|Not Treated|0|||
28009709|NCT03070392|54668196|FG002|Overall Study|Not Treated|3|||
28009710|NCT03070392|54668197|FG003|Overall Study|Not Treated|12|||
28009711|NCT03070392|54668194|FG000|Overall Study|Death|3|||
28009712|NCT03070392|54668195|FG001|Overall Study|Death|0|||
28009713|NCT03070392|54668196|FG002|Overall Study|Death|0|||
28009714|NCT03070392|54668197|FG003|Overall Study|Death|1|||
28009715|NCT03070392|54668194|FG000|Overall Study|Withdrawal by Subject|7|||
28009716|NCT03070392|54668195|FG001|Overall Study|Withdrawal by Subject|0|||
28009717|NCT03070392|54668196|FG002|Overall Study|Withdrawal by Subject|0|||
28009718|NCT03070392|54668197|FG003|Overall Study|Withdrawal by Subject|3|||
28009719|NCT03070392|54668194|FG000|Overall Study|Physician Decision|1|||
28009720|NCT03070392|54668195|FG001|Overall Study|Physician Decision|0|||
28009721|NCT03070392|54668196|FG002|Overall Study|Physician Decision|0|||
28009722|NCT03070392|54668197|FG003|Overall Study|Physician Decision|2|||
28009723|NCT03070392|54668194|FG000|Overall Study|Progressive Disease|154|||
28009724|NCT03070392|54668195|FG001|Overall Study|Progressive Disease|6|||
27919645|NCT01309737|54576915|FG001|Week 0 to 16|Adverse Event|10|||
27919646|NCT01309737|54576916|FG002|Week 0 to 16|Adverse Event|5|||
27919647|NCT01309737|54576917|FG003|Week 0 to 16|Adverse Event|0|||
27919648|NCT01309737|54576918|FG004|Week 0 to 16|Adverse Event|0|||
27919649|NCT01309737|54576914|FG000|Week 0 to 16|Lack of Efficacy|15|||
27919650|NCT01309737|54576915|FG001|Week 0 to 16|Lack of Efficacy|2|||
27919651|NCT01309737|54576916|FG002|Week 0 to 16|Lack of Efficacy|24|||
27919652|NCT01309737|54576917|FG003|Week 0 to 16|Lack of Efficacy|0|||
27919653|NCT01309737|54576918|FG004|Week 0 to 16|Lack of Efficacy|0|||
27919654|NCT01309737|54576914|FG000|Week 0 to 16|Lost to Follow-up|7|||
27919655|NCT01309737|54576915|FG001|Week 0 to 16|Lost to Follow-up|8|||
27919656|NCT01309737|54576916|FG002|Week 0 to 16|Lost to Follow-up|3|||
27919657|NCT01309737|54576917|FG003|Week 0 to 16|Lost to Follow-up|0|||
27919658|NCT01309737|54576918|FG004|Week 0 to 16|Lost to Follow-up|0|||
27919659|NCT01309737|54576914|FG000|Week 0 to 16|Withdrawal by Subject|7|||
27919660|NCT01309737|54576915|FG001|Week 0 to 16|Withdrawal by Subject|6|||
27919661|NCT01309737|54576916|FG002|Week 0 to 16|Withdrawal by Subject|7|||
27919662|NCT01309737|54576917|FG003|Week 0 to 16|Withdrawal by Subject|0|||
27919663|NCT01309737|54576918|FG004|Week 0 to 16|Withdrawal by Subject|0|||
27919664|NCT01309737|54576914|FG000|Week 0 to 16|Other|10|||
27919665|NCT01309737|54576915|FG001|Week 0 to 16|Other|14|||
27919666|NCT01309737|54576916|FG002|Week 0 to 16|Other|4|||
27919667|NCT01309737|54576917|FG003|Week 0 to 16|Other|0|||
27919668|NCT01309737|54576918|FG004|Week 0 to 16|Other|0|||
27919669|NCT01309737|54576914|FG000|Week 0 to 16|Randomized, but not treated|1|||
27919670|NCT01309737|54576915|FG001|Week 0 to 16|Randomized, but not treated|0|||
27919671|NCT01309737|54576916|FG002|Week 0 to 16|Randomized, but not treated|0|||
27919672|NCT01309737|54576917|FG003|Week 0 to 16|Randomized, but not treated|0|||
28009725|NCT03070392|54668196|FG002|Overall Study|Progressive Disease|2|||
28009726|NCT03070392|54668197|FG003|Overall Study|Progressive Disease|70|||
28009727|NCT03070392|54668194|FG000|Overall Study|Adverse Event|6|||
27919673|NCT01309737|54576918|FG004|Week 0 to 16|Randomized, but not treated|0|||
28009728|NCT03070392|54668195|FG001|Overall Study|Adverse Event|1|||
28009729|NCT03070392|54668196|FG002|Overall Study|Adverse Event|1|||
27919674|NCT01309737|54576914|FG000|Week 16 to 52|Death|0|||
28009730|NCT03070392|54668197|FG003|Overall Study|Adverse Event|3|||
27741364|NCT02712905|54191360|FG006|Combination Therapy|Death|0|||
27741365|NCT02712905|54191361|FG007|Combination Therapy|Death|0|||
27741366|NCT02712905|54191362|FG008|Combination Therapy|Death|0|||
28009731|NCT03070392|54668194|FG000|Overall Study|Alternate anticancer treatment|1|||
28009732|NCT03070392|54668195|FG001|Overall Study|Alternate anticancer treatment|0|||
28009733|NCT03070392|54668196|FG002|Overall Study|Alternate anticancer treatment|0|||
28009734|NCT03070392|54668197|FG003|Overall Study|Alternate anticancer treatment|1|||
28009735|NCT03070392|54668194|FG000|Overall Study|Ongoing|73|||
28009736|NCT03070392|54668195|FG001|Overall Study|Ongoing|0|||
28009737|NCT03070392|54668196|FG002|Overall Study|Ongoing|0|||
28009738|NCT03070392|54668197|FG003|Overall Study|Ongoing|11|||
28009739|NCT00784043|54668205|FG000|Overall Study|Withdrawal by Subject|8|||
28009740|NCT00784043|54668206|FG001|Overall Study|Withdrawal by Subject|5|||
28009741|NCT00784043|54668205|FG000|Overall Study|Protocol Terminated|23|||
28009742|NCT00784043|54668206|FG001|Overall Study|Protocol Terminated|1|||
28009743|NCT00773279|54668212|FG000|Period 1|Adverse Event|2|||
28009744|NCT00773279|54668213|FG001|Period 1|Adverse Event|1|||
28009745|NCT00773279|54668212|FG000|Period 1|Lack of Efficacy|0|||
28009746|NCT00773279|54668213|FG001|Period 1|Lack of Efficacy|2|||
28009747|NCT00773279|54668212|FG000|Period 1|Unclassified|5|||
28009748|NCT00773279|54668213|FG001|Period 1|Unclassified|1|||
28009749|NCT00773279|54668212|FG000|Period 2|Adverse Event|0|||
28009750|NCT00773279|54668213|FG001|Period 2|Adverse Event|1|||
28009751|NCT00773279|54668212|FG000|Period 2|Lack of Efficacy|1|||
28009752|NCT00773279|54668213|FG001|Period 2|Lack of Efficacy|0|||
28009753|NCT00773279|54668212|FG000|Period 2|Protocol Violation|0|||
28009754|NCT00773279|54668213|FG001|Period 2|Protocol Violation|3|||
28009755|NCT00773279|54668212|FG000|Period 2|Unclassified|2|||
28009756|NCT00773279|54668213|FG001|Period 2|Unclassified|2|||
28009757|NCT00766415|54668222|FG000|Overall Study|Withdrawal by Subject|0|||
28009758|NCT00766415|54668223|FG001|Overall Study|Withdrawal by Subject|1|||
28009759|NCT00772967|54668229|FG000|Crossover Treatment 1|Adverse Event (Pain)|0|||
28009760|NCT00772967|54668230|FG001|Crossover Treatment 1|Adverse Event (Pain)|0|||
28009761|NCT00772967|54668231|FG002|Crossover Treatment 1|Adverse Event (Pain)|0|||
28009762|NCT00772967|54668232|FG003|Crossover Treatment 1|Adverse Event (Pain)|1|||
28009763|NCT00772967|54668233|FG004|Crossover Treatment 1|Adverse Event (Pain)|0|||
28009764|NCT00772967|54668234|FG005|Crossover Treatment 1|Adverse Event (Pain)|0|||
28009765|NCT00772967|54668229|FG000|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
28009766|NCT00772967|54668230|FG001|Break 1 (4-7 Days)|Withdrawal by Subject|1|||
28009767|NCT00772967|54668231|FG002|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
28009768|NCT00772967|54668232|FG003|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
28009769|NCT00772967|54668233|FG004|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
28009770|NCT00772967|54668234|FG005|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
28009771|NCT00772967|54668229|FG000|Crossover Treatment 3|Adverse Event|0|||
28009772|NCT00772967|54668230|FG001|Crossover Treatment 3|Adverse Event|0|||
28009773|NCT00772967|54668231|FG002|Crossover Treatment 3|Adverse Event|0|||
28009774|NCT00772967|54668232|FG003|Crossover Treatment 3|Adverse Event|0|||
28009775|NCT00772967|54668233|FG004|Crossover Treatment 3|Adverse Event|1|||
28009776|NCT00772967|54668234|FG005|Crossover Treatment 3|Adverse Event|0|||
28009777|NCT00662259|54668257|FG000|Overall Study|Adverse Event|2|||
28009778|NCT00662259|54668258|FG001|Overall Study|Adverse Event|0|||
28009779|NCT00660699|54668264|FG000|Overall Study|Withdrawal by Subject|2|||
28009780|NCT00582114|54668270|FG000|Overall Study|Death|4|||
28009781|NCT00582114|54668271|FG001|Overall Study|Death|4|||
28009782|NCT00582114|54668270|FG000|Overall Study|Kidney Transplant|3|||
28009783|NCT00582114|54668271|FG001|Overall Study|Kidney Transplant|1|||
28009784|NCT00582114|54668270|FG000|Overall Study|Lost to Follow-up|7|||
28009785|NCT00582114|54668271|FG001|Overall Study|Lost to Follow-up|6|||
27919675|NCT01309737|54576915|FG001|Week 16 to 52|Death|0|||
27919676|NCT01309737|54576916|FG002|Week 16 to 52|Death|0|||
27919677|NCT01309737|54576917|FG003|Week 16 to 52|Death|0|||
27919678|NCT01309737|54576918|FG004|Week 16 to 52|Death|1|||
27919679|NCT01309737|54576914|FG000|Week 16 to 52|Adverse Event|7|||
27919680|NCT01309737|54576915|FG001|Week 16 to 52|Adverse Event|7|||
27919681|NCT01309737|54576916|FG002|Week 16 to 52|Adverse Event|0|||
27919682|NCT01309737|54576917|FG003|Week 16 to 52|Adverse Event|6|||
27919683|NCT01309737|54576918|FG004|Week 16 to 52|Adverse Event|5|||
28009786|NCT00582114|54668270|FG000|Overall Study|Withdrawal by Subject|8|||
28009787|NCT00582114|54668271|FG001|Overall Study|Withdrawal by Subject|16|||
28009788|NCT00582114|54668270|FG000|Overall Study|Adverse Event|1|||
28009789|NCT00582114|54668271|FG001|Overall Study|Adverse Event|1|||
28009790|NCT00582114|54668270|FG000|Overall Study|Physician Decision|0|||
28009791|NCT00582114|54668271|FG001|Overall Study|Physician Decision|6|||
27919684|NCT01309737|54576914|FG000|Week 16 to 52|Lack of Efficacy|107|||
27919685|NCT01309737|54576915|FG001|Week 16 to 52|Lack of Efficacy|76|||
28009792|NCT00582114|54668270|FG000|Overall Study|Stopped by data safety monitoring board|19|||
28009793|NCT00582114|54668271|FG001|Overall Study|Stopped by data safety monitoring board|20|||
28009794|NCT00582036|54668279|FG000|Overall Study|Withdrawal by Subject|0|||
28009795|NCT00582036|54668280|FG001|Overall Study|Withdrawal by Subject|1|||
28009796|NCT00581360|54668286|FG000|Overall Study|Withdrawal by Subject|1|||
28009797|NCT00660387|54668292|FG000|Overall Study|Adverse Event|1|||
28009798|NCT00660387|54668293|FG001|Overall Study|Adverse Event|2|||
28009799|NCT00660387|54668292|FG000|Overall Study|Lack of Efficacy|0|||
28009800|NCT00660387|54668293|FG001|Overall Study|Lack of Efficacy|1|||
28009801|NCT00660387|54668292|FG000|Overall Study|Protocol Violation|1|||
28009802|NCT00660387|54668293|FG001|Overall Study|Protocol Violation|0|||
28009803|NCT00582738|54668301|FG000|Overall Study|Administrative Problems|7|||
28009804|NCT00582738|54668302|FG001|Overall Study|Administrative Problems|8|||
28009805|NCT00582738|54668301|FG000|Overall Study|Adverse Event|0|||
28009806|NCT00582738|54668302|FG001|Overall Study|Adverse Event|5|||
28009807|NCT00582738|54668301|FG000|Overall Study|Graft Lost|0|||
28009808|NCT00582738|54668302|FG001|Overall Study|Graft Lost|1|||
28009809|NCT00582738|54668301|FG000|Overall Study|Other|1|||
28009810|NCT00582738|54668302|FG001|Overall Study|Other|0|||
28009811|NCT00582738|54668301|FG000|Overall Study|Protocol Violation|1|||
28009812|NCT00582738|54668302|FG001|Overall Study|Protocol Violation|1|||
28009813|NCT00582738|54668301|FG000|Overall Study|Withdrawal by Subject|0|||
28009814|NCT00582738|54668302|FG001|Overall Study|Withdrawal by Subject|3|||
28009815|NCT00772889|54668317|FG000|Overall Study|Adverse Event|7|||
28009816|NCT00772889|54668318|FG001|Overall Study|Adverse Event|4|||
28009817|NCT00772889|54668319|FG002|Overall Study|Adverse Event|0|||
28009818|NCT00772889|54668317|FG000|Overall Study|Withdrawal by Subject|9|||
28009819|NCT00772889|54668318|FG001|Overall Study|Withdrawal by Subject|8|||
28009820|NCT00772889|54668319|FG002|Overall Study|Withdrawal by Subject|9|||
28009821|NCT00772889|54668317|FG000|Overall Study|Lost to Follow-up|6|||
28009822|NCT00772889|54668318|FG001|Overall Study|Lost to Follow-up|6|||
28009823|NCT00772889|54668319|FG002|Overall Study|Lost to Follow-up|7|||
28009824|NCT01247324|54668329|FG000|Overall Study|Death|1|||
28009825|NCT01247324|54668330|FG001|Overall Study|Death|0|||
28009826|NCT01247324|54668329|FG000|Overall Study|Physician Decision|0|||
28009827|NCT01247324|54668330|FG001|Overall Study|Physician Decision|1|||
28009828|NCT01247324|54668329|FG000|Overall Study|Non-compliance with study drug|3|||
28009829|NCT01247324|54668330|FG001|Overall Study|Non-compliance with study drug|0|||
28009830|NCT01247324|54668329|FG000|Overall Study|Lack of Efficacy|12|||
28009831|NCT01247324|54668330|FG001|Overall Study|Lack of Efficacy|8|||
28009832|NCT01247324|54668329|FG000|Overall Study|Non-compliance|2|||
28009833|NCT01247324|54668330|FG001|Overall Study|Non-compliance|0|||
28009834|NCT01247324|54668329|FG000|Overall Study|Pregnancy|2|||
28009835|NCT01247324|54668330|FG001|Overall Study|Pregnancy|3|||
28009836|NCT01247324|54668329|FG000|Overall Study|Protocol Violation|1|||
28009837|NCT01247324|54668330|FG001|Overall Study|Protocol Violation|2|||
28009838|NCT01247324|54668329|FG000|Overall Study|Reason not specified|11|||
28009839|NCT01247324|54668330|FG001|Overall Study|Reason not specified|8|||
28009840|NCT01247324|54668329|FG000|Overall Study|Consent withdrawn by participant|13|||
28009841|NCT01247324|54668330|FG001|Overall Study|Consent withdrawn by participant|8|||
28009842|NCT01247324|54668329|FG000|Overall Study|Adverse Event|25|||
28009843|NCT01247324|54668330|FG001|Overall Study|Adverse Event|13|||
28009844|NCT01247324|54668329|FG000|Overall Study|Lost to Follow-up|1|||
28009845|NCT01247324|54668330|FG001|Overall Study|Lost to Follow-up|1|||
28009846|NCT00772577|54668339|FG000|Overall Study|Adverse Event|6|||
28009847|NCT00772577|54668340|FG001|Overall Study|Adverse Event|3|||
28009848|NCT00772577|54668339|FG000|Overall Study|Abnormal laboratory values|0|||
28009849|NCT00772577|54668340|FG001|Overall Study|Abnormal laboratory values|1|||
28009850|NCT00772577|54668339|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
28009851|NCT00772577|54668340|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
28009852|NCT00772577|54668339|FG000|Overall Study|Patient withdrew consent|8|||
28009853|NCT00772577|54668340|FG001|Overall Study|Patient withdrew consent|5|||
28009854|NCT00772577|54668339|FG000|Overall Study|Lost to Follow-up|4|||
28009855|NCT00772577|54668340|FG001|Overall Study|Lost to Follow-up|3|||
28009856|NCT00772577|54668339|FG000|Overall Study|Administrative problems|2|||
28009857|NCT00772577|54668340|FG001|Overall Study|Administrative problems|1|||
28009858|NCT00772577|54668339|FG000|Overall Study|Protocol Deviation|3|||
28009859|NCT00772577|54668340|FG001|Overall Study|Protocol Deviation|2|||
28009860|NCT02345850|54668349|FG000|Overall Study|Not transplanted|10|||
28009861|NCT02345850|54668350|FG001|Overall Study|Not transplanted|5|||
28009862|NCT02345850|54668351|FG002|Overall Study|Not transplanted|4|||
28009863|NCT02345850|54668349|FG000|Overall Study|Lost to Follow-up|2|||
28009864|NCT02345850|54668350|FG001|Overall Study|Lost to Follow-up|3|||
28009865|NCT02345850|54668351|FG002|Overall Study|Lost to Follow-up|2|||
28009866|NCT02345850|54668349|FG000|Overall Study|Withdrawal by Subject|1|||
28103654|NCT03334448|54760382|FG001|Washout|Protocol Violation|0|||
28009867|NCT02345850|54668350|FG001|Overall Study|Withdrawal by Subject|0|||
28009868|NCT02345850|54668351|FG002|Overall Study|Withdrawal by Subject|0|||
28009869|NCT00659607|54668359|FG000|Overall Study|No blood pressure recorded|147|||
28009870|NCT00659607|54668359|FG000|Overall Study|Unknown measuring date of blood pressure|85|||
28009871|NCT00659607|54668359|FG000|Overall Study|'Unable to evaluate' for the final asses|67|||
28009872|NCT00659607|54668359|FG000|Overall Study|No recorded efficacy data|15|||
28009873|NCT00659607|54668359|FG000|Overall Study|Inconsistent BP measuring date|2|||
28103655|NCT03334448|54760383|FG002|Washout|Protocol Violation|0|||
28009874|NCT02848092|54668367|FG000|1-month Post-training Follow-up|Lost to Follow-up|8|||
28009875|NCT02848092|54668368|FG001|1-month Post-training Follow-up|Lost to Follow-up|3|||
28009876|NCT02848092|54668367|FG000|1-month Post-training Follow-up|Adverse Event|2|||
28009877|NCT02848092|54668368|FG001|1-month Post-training Follow-up|Adverse Event|1|||
28009878|NCT02848092|54668367|FG000|1-month Post-training Follow-up|Withdrawal by Subject|1|||
28009879|NCT02848092|54668368|FG001|1-month Post-training Follow-up|Withdrawal by Subject|0|||
28009880|NCT02848092|54668367|FG000|1-month Post-training Follow-up|received new diagnosis of epilepsy|1|||
28009881|NCT02848092|54668368|FG001|1-month Post-training Follow-up|received new diagnosis of epilepsy|0|||
28009882|NCT02848092|54668367|FG000|1-month Post-training Follow-up|fatigue|0|||
28009883|NCT02848092|54668368|FG001|1-month Post-training Follow-up|fatigue|1|||
28009884|NCT02848092|54668367|FG000|6-month Post-training Follow-up|Lost to Follow-up|9|||
28009885|NCT02848092|54668368|FG001|6-month Post-training Follow-up|Lost to Follow-up|3|||
28009886|NCT02848092|54668367|FG000|6-month Post-training Follow-up|Adverse Event|1|||
28009887|NCT02848092|54668368|FG001|6-month Post-training Follow-up|Adverse Event|1|||
28009888|NCT02848092|54668367|FG000|6-month Post-training Follow-up|Withdrawal by Subject|1|||
28009889|NCT02848092|54668368|FG001|6-month Post-training Follow-up|Withdrawal by Subject|0|||
28009890|NCT02848092|54668367|FG000|6-month Post-training Follow-up|frustrated with task|1|||
28009891|NCT02848092|54668368|FG001|6-month Post-training Follow-up|frustrated with task|0|||
28009892|NCT02848092|54668367|FG000|6-month Post-training Follow-up|new diagnosis of epilepsy|1|||
28009893|NCT02848092|54668368|FG001|6-month Post-training Follow-up|new diagnosis of epilepsy|0|||
28009894|NCT02848092|54668367|FG000|12-month Naturalistic Driving|Did not have DriveCam installed in car|3|||
28103656|NCT03334448|54760384|FG003|Washout|Protocol Violation|1|||
28103657|NCT02849080|54760392|FG000|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7|||
28103658|NCT02849080|54760393|FG001|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4|||
28103659|NCT02849080|54760394|FG002|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
28103660|NCT02849080|54760395|FG003|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
28103661|NCT02849080|54760392|FG000|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5|||
28103662|NCT02849080|54760393|FG001|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1|||
28103663|NCT02849080|54760394|FG002|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
28103664|NCT02849080|54760395|FG003|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
28103665|NCT02849080|54760392|FG000|Main Phase: 0 - 52 Weeks|Death|0|||
28103666|NCT02849080|54760393|FG001|Main Phase: 0 - 52 Weeks|Death|2|||
28009895|NCT02848092|54668368|FG001|12-month Naturalistic Driving|Did not have DriveCam installed in car|2|||
28009896|NCT00660309|54668376|FG000|Overall Study|Adverse Event|2|||
28009897|NCT00660309|54668377|FG001|Overall Study|Adverse Event|0|||
28009898|NCT00660309|54668376|FG000|Overall Study|Withdrawal by Subject|0|||
28009899|NCT00660309|54668377|FG001|Overall Study|Withdrawal by Subject|3|||
28009900|NCT00581100|54668386|FG000|Overall Study|Death|1|||
28009901|NCT00581100|54668387|FG001|Overall Study|Death|0|||
28009902|NCT00581100|54668386|FG000|Overall Study|Adverse Event|2|||
28009903|NCT00581100|54668387|FG001|Overall Study|Adverse Event|1|||
28009904|NCT00581100|54668386|FG000|Overall Study|Withdrawal by Subject|1|||
28009905|NCT00581100|54668387|FG001|Overall Study|Withdrawal by Subject|4|||
28009906|NCT00581100|54668386|FG000|Overall Study|Other|3|||
28009907|NCT00581100|54668387|FG001|Overall Study|Other|0|||
28009908|NCT00579098|54668395|FG000|Overall Study|Lost to Follow-up|2|||
28009909|NCT00579098|54668396|FG001|Overall Study|Lost to Follow-up|0|||
28009910|NCT00579098|54668395|FG000|Overall Study|Adverse Event|2|||
27919686|NCT01309737|54576916|FG002|Week 16 to 52|Lack of Efficacy|0|||
27919687|NCT01309737|54576917|FG003|Week 16 to 52|Lack of Efficacy|25|||
27919688|NCT01309737|54576918|FG004|Week 16 to 52|Lack of Efficacy|21|||
27919689|NCT01309737|54576914|FG000|Week 16 to 52|Lost to Follow-up|4|||
27919690|NCT01309737|54576915|FG001|Week 16 to 52|Lost to Follow-up|2|||
27919691|NCT01309737|54576916|FG002|Week 16 to 52|Lost to Follow-up|0|||
27919692|NCT01309737|54576917|FG003|Week 16 to 52|Lost to Follow-up|1|||
27919693|NCT01309737|54576918|FG004|Week 16 to 52|Lost to Follow-up|4|||
27919694|NCT01309737|54576914|FG000|Week 16 to 52|Withdrawal by Subject|5|||
27919695|NCT01309737|54576915|FG001|Week 16 to 52|Withdrawal by Subject|6|||
27919696|NCT01309737|54576916|FG002|Week 16 to 52|Withdrawal by Subject|0|||
27919697|NCT01309737|54576917|FG003|Week 16 to 52|Withdrawal by Subject|0|||
27919698|NCT01309737|54576918|FG004|Week 16 to 52|Withdrawal by Subject|2|||
27919699|NCT01309737|54576914|FG000|Week 16 to 52|Other|10|||
27919700|NCT01309737|54576915|FG001|Week 16 to 52|Other|12|||
27919701|NCT01309737|54576916|FG002|Week 16 to 52|Other|0|||
27919702|NCT01309737|54576917|FG003|Week 16 to 52|Other|2|||
27919703|NCT01309737|54576918|FG004|Week 16 to 52|Other|0|||
27919704|NCT01074229|54576944|FG000|Overall Study|Lost to Follow-up|1|||
27919705|NCT01074229|54576945|FG001|Overall Study|Lost to Follow-up|0|||
27919706|NCT01074229|54576946|FG002|Overall Study|Lost to Follow-up|0|||
27919707|NCT01074229|54576944|FG000|Overall Study|Change to open surgical procedure|1|||
27919708|NCT01074229|54576945|FG001|Overall Study|Change to open surgical procedure|3|||
27919709|NCT01074229|54576946|FG002|Overall Study|Change to open surgical procedure|4|||
28009911|NCT00579098|54668396|FG001|Overall Study|Adverse Event|3|||
28009912|NCT00579098|54668395|FG000|Overall Study|Withdrawal by Subject|2|||
28009913|NCT00579098|54668396|FG001|Overall Study|Withdrawal by Subject|3|||
27741367|NCT02712905|54191363|FG009|Combination Therapy|Death|0|||
28009914|NCT00579098|54668395|FG000|Overall Study|AF returned after ablation|3|||
28009915|NCT00579098|54668396|FG001|Overall Study|AF returned after ablation|2|||
28009916|NCT00772109|54668406|FG000|Overall Study|Serious adverse event|1|||
28009917|NCT00772109|54668407|FG001|Overall Study|Serious adverse event|0|||
28009918|NCT00772109|54668408|FG002|Overall Study|Serious adverse event|1|||
28009919|NCT00772109|54668409|FG003|Overall Study|Serious adverse event|0|||
28009920|NCT00772109|54668406|FG000|Overall Study|Protocol Violation|5|||
28009921|NCT00772109|54668407|FG001|Overall Study|Protocol Violation|8|||
28009922|NCT00772109|54668408|FG002|Overall Study|Protocol Violation|7|||
28009923|NCT00772109|54668409|FG003|Overall Study|Protocol Violation|6|||
28009924|NCT00772109|54668406|FG000|Overall Study|Lost to Follow-up|7|||
28009925|NCT00772109|54668407|FG001|Overall Study|Lost to Follow-up|3|||
28009926|NCT00772109|54668408|FG002|Overall Study|Lost to Follow-up|5|||
28009927|NCT00772109|54668409|FG003|Overall Study|Lost to Follow-up|9|||
28009928|NCT00772109|54668406|FG000|Overall Study|Withdrawal by Subject|8|||
27741368|NCT02712905|54191364|FG010|Combination Therapy|Death|0|||
27741369|NCT02712905|54191365|FG011|Combination Therapy|Death|0|||
27741370|NCT02712905|54191366|FG012|Combination Therapy|Death|5|||
27741371|NCT02712905|54191367|FG013|Combination Therapy|Death|6|||
28009929|NCT00772109|54668407|FG001|Overall Study|Withdrawal by Subject|8|||
28009930|NCT00772109|54668408|FG002|Overall Study|Withdrawal by Subject|6|||
27741372|NCT02712905|54191368|FG014|Combination Therapy|Death|1|||
28009931|NCT00772109|54668409|FG003|Overall Study|Withdrawal by Subject|16|||
28009932|NCT00772031|54668421|FG000|Overall Study|Early termination of trial|12|||
28009933|NCT00772031|54668422|FG001|Overall Study|Early termination of trial|10|||
28009934|NCT00772031|54668421|FG000|Overall Study|Lost to Follow-up|20|||
28009935|NCT00772031|54668422|FG001|Overall Study|Lost to Follow-up|33|||
28009936|NCT00580866|54668436|FG000|Overall Study|Lost to Follow-up|2|||
28009937|NCT00580866|54668437|FG001|Overall Study|Lost to Follow-up|2|||
28009938|NCT00771953|54668445|FG000|Overall Study|Adverse Event|5|||
28009939|NCT00771953|54668446|FG001|Overall Study|Adverse Event|3|||
28009940|NCT00771953|54668445|FG000|Overall Study|Death|2|||
28009941|NCT00771953|54668446|FG001|Overall Study|Death|2|||
28009942|NCT00771953|54668445|FG000|Overall Study|Progression before active Tx|1|||
28009943|NCT00771953|54668446|FG001|Overall Study|Progression before active Tx|2|||
28009944|NCT00771953|54668445|FG000|Overall Study|Sponsor decision|1|||
28009945|NCT00771953|54668446|FG001|Overall Study|Sponsor decision|0|||
28009946|NCT00771953|54668445|FG000|Overall Study|Other complicating disease|1|||
28009947|NCT00771953|54668446|FG001|Overall Study|Other complicating disease|0|||
28009948|NCT00771953|54668445|FG000|Overall Study|Withdrawal by Subject|0|||
28009949|NCT00771953|54668446|FG001|Overall Study|Withdrawal by Subject|3|||
28009950|NCT00621244|54668458|FG000|Overall Study|Withdrawal by Subject|7|||
28009951|NCT00621244|54668459|FG001|Overall Study|Withdrawal by Subject|3|||
28009952|NCT00621244|54668460|FG002|Overall Study|Withdrawal by Subject|3|||
28009953|NCT00621244|54668461|FG003|Overall Study|Withdrawal by Subject|3|||
28009954|NCT00621244|54668458|FG000|Overall Study|Disease progression|44|||
28009955|NCT00621244|54668459|FG001|Overall Study|Disease progression|20|||
27919710|NCT01106014|54576958|FG000|Overall Study|Morbidity or Mortality primary endpoint|155|||
27919711|NCT01106014|54576959|FG001|Overall Study|Morbidity or Mortality primary endpoint|242|||
27919712|NCT01106014|54576958|FG000|Overall Study|Adverse Event|78|||
27919713|NCT01106014|54576959|FG001|Overall Study|Adverse Event|42|||
27919714|NCT01106014|54576958|FG000|Overall Study|Withdrawal by Subject|43|||
27919715|NCT01106014|54576959|FG001|Overall Study|Withdrawal by Subject|37|||
27919716|NCT01106014|54576958|FG000|Overall Study|Administrative reason|7|||
27919717|NCT01106014|54576959|FG001|Overall Study|Administrative reason|6|||
28009956|NCT00621244|54668460|FG002|Overall Study|Disease progression|20|||
27919718|NCT01106014|54576958|FG000|Overall Study|Lost to Follow-up|2|||
28009957|NCT00621244|54668461|FG003|Overall Study|Disease progression|15|||
28009958|NCT00621244|54668458|FG000|Overall Study|Death|3|||
27919719|NCT01106014|54576959|FG001|Overall Study|Lost to Follow-up|3|||
27919720|NCT01073605|54576968|FG000|Overall Study|Ongoing at Cutoff Date|1|||
27919721|NCT01073605|54576969|FG001|Overall Study|Ongoing at Cutoff Date|1|||
28009959|NCT00621244|54668459|FG001|Overall Study|Death|3|||
28009960|NCT00621244|54668460|FG002|Overall Study|Death|1|||
28009961|NCT00621244|54668461|FG003|Overall Study|Death|1|||
28009962|NCT00621244|54668458|FG000|Overall Study|Adverse Event|27|||
28009963|NCT00621244|54668459|FG001|Overall Study|Adverse Event|7|||
28009964|NCT00621244|54668460|FG002|Overall Study|Adverse Event|9|||
28009965|NCT00621244|54668461|FG003|Overall Study|Adverse Event|2|||
28009966|NCT00621244|54668458|FG000|Overall Study|Administrative problems|5|||
28009967|NCT00621244|54668459|FG001|Overall Study|Administrative problems|1|||
28009968|NCT00621244|54668460|FG002|Overall Study|Administrative problems|0|||
28009969|NCT00621244|54668461|FG003|Overall Study|Administrative problems|2|||
28009970|NCT00659529|54668535|FG000|Overall Study|Withdrawal by Subject|4|||
28009971|NCT00659529|54668535|FG000|Overall Study|Protocol Violation|3|||
28009972|NCT00659529|54668535|FG000|Overall Study|Screen failure|9|||
28009973|NCT00578942|54668539|FG000|Overall Study|Lost to Follow-up|1|||
28009974|NCT00765245|54668545|FG000|Overall Study|disease progression|3|||
28009975|NCT00765245|54668546|FG001|Overall Study|disease progression|2|||
28009976|NCT00765245|54668545|FG000|Overall Study|Withdrawal by Subject|3|||
28009977|NCT00765245|54668546|FG001|Overall Study|Withdrawal by Subject|0|||
28009978|NCT00765245|54668545|FG000|Overall Study|Adverse Event|5|||
28009979|NCT00765245|54668546|FG001|Overall Study|Adverse Event|0|||
28009980|NCT00765245|54668545|FG000|Overall Study|Physician Decision|1|||
28009981|NCT00765245|54668546|FG001|Overall Study|Physician Decision|0|||
28009982|NCT00765245|54668545|FG000|Overall Study|Death|1|||
28009983|NCT00765245|54668546|FG001|Overall Study|Death|0|||
28009984|NCT00782795|54668554|FG000|Overall Study|Withdrawal by Subject|1|||
28009985|NCT00782795|54668555|FG001|Overall Study|Withdrawal by Subject|2|||
28009986|NCT00656799|54668561|FG000|Overall Study|Death|2|||
28009987|NCT00764699|54668565|FG000|Overall Study|PI left and study terminated|3|||
28009988|NCT00782717|54668571|FG000|Overall Study|Adverse Event|2|||
28009989|NCT00782717|54668572|FG001|Overall Study|Adverse Event|5|||
28009990|NCT00782717|54668571|FG000|Overall Study|Patient decision unrelated to AE|6|||
28009991|NCT00782717|54668572|FG001|Overall Study|Patient decision unrelated to AE|3|||
28009992|NCT00782717|54668571|FG000|Overall Study|Noncompliance|2|||
28009993|NCT00782717|54668572|FG001|Overall Study|Noncompliance|1|||
28009994|NCT00782717|54668571|FG000|Overall Study|Treatment failure|3|||
28009995|NCT00782717|54668572|FG001|Overall Study|Treatment failure|14|||
28009996|NCT00782717|54668571|FG000|Overall Study|Enrollment close prior to surgery|1|||
28009997|NCT00782717|54668572|FG001|Overall Study|Enrollment close prior to surgery|0|||
28009998|NCT00782717|54668571|FG000|Overall Study|Did not meet entrance criteria|1|||
28009999|NCT00782717|54668572|FG001|Overall Study|Did not meet entrance criteria|3|||
28010000|NCT00782717|54668571|FG000|Overall Study|Exited in error|0|||
28010001|NCT00782717|54668572|FG001|Overall Study|Exited in error|2|||
28010002|NCT00656175|54668580|FG000|Overall Study|Adverse Event|1|||
28010003|NCT00656175|54668581|FG001|Overall Study|Adverse Event|0|||
27919722|NCT01073605|54576970|FG002|Overall Study|Ongoing at Cutoff Date|0|||
27919723|NCT01073605|54576968|FG000|Overall Study|Adverse Event|2|||
27919724|NCT01073605|54576969|FG001|Overall Study|Adverse Event|1|||
27919725|NCT01073605|54576970|FG002|Overall Study|Adverse Event|0|||
27919726|NCT01073605|54576968|FG000|Overall Study|Lost to Follow-up|3|||
27919727|NCT01073605|54576969|FG001|Overall Study|Lost to Follow-up|4|||
27919728|NCT01073605|54576970|FG002|Overall Study|Lost to Follow-up|9|||
27919729|NCT01073605|54576968|FG000|Overall Study|Other|25|||
27919730|NCT01073605|54576969|FG001|Overall Study|Other|21|||
27919731|NCT01073605|54576970|FG002|Overall Study|Other|29|||
27919732|NCT01073605|54576968|FG000|Overall Study|Withdrawal by Subject|31|||
27919733|NCT01073605|54576969|FG001|Overall Study|Withdrawal by Subject|39|||
27919734|NCT01073605|54576970|FG002|Overall Study|Withdrawal by Subject|22|||
27919735|NCT01073605|54576968|FG000|Overall Study|Randomized But Not Treated|0|||
27919736|NCT01073605|54576969|FG001|Overall Study|Randomized But Not Treated|1|||
27919737|NCT01073605|54576970|FG002|Overall Study|Randomized But Not Treated|1|||
27919738|NCT01073293|54576980|FG000|Overall Study|Lost to Follow-up|0|||
27919739|NCT01073293|54576981|FG001|Overall Study|Lost to Follow-up|1|||
27919740|NCT01073293|54576980|FG000|Overall Study|Withdrawal by Subject|5|||
27919741|NCT01073293|54576981|FG001|Overall Study|Withdrawal by Subject|10|||
27919742|NCT01105936|54576987|FG000|Period 1|Adverse Event|0|||
27919743|NCT01105936|54576988|FG001|Period 1|Adverse Event|0|||
27919744|NCT01105936|54576989|FG002|Period 1|Adverse Event|0|||
28010004|NCT00656175|54668580|FG000|Overall Study|Transportation issues|0|||
28010005|NCT00656175|54668581|FG001|Overall Study|Transportation issues|1|||
28010006|NCT00620776|54668589|FG000|Overall Study|Did not receive treatment|3|||
27919745|NCT01105936|54576990|FG003|Period 1|Adverse Event|1|||
28010007|NCT00620776|54668590|FG001|Overall Study|Did not receive treatment|5|||
28010008|NCT00620776|54668589|FG000|Overall Study|Adverse Event|2|||
28010009|NCT00620776|54668590|FG001|Overall Study|Adverse Event|3|||
28010010|NCT00620776|54668589|FG000|Overall Study|Lack of Efficacy|2|||
28010011|NCT00620776|54668590|FG001|Overall Study|Lack of Efficacy|1|||
28010012|NCT00620776|54668589|FG000|Overall Study|Lost to Follow-up|2|||
28010013|NCT00620776|54668590|FG001|Overall Study|Lost to Follow-up|5|||
28010014|NCT00620776|54668589|FG000|Overall Study|Withdrawal by Subject|3|||
28010015|NCT00620776|54668590|FG001|Overall Study|Withdrawal by Subject|2|||
28010016|NCT00656019|54668600|FG000|Overall Study|Not Eligible|10|||
28010017|NCT00656019|54668601|FG001|Overall Study|Not Eligible|0|||
28010018|NCT00656019|54668602|FG002|Overall Study|Not Eligible|0|||
28010019|NCT00656019|54668603|FG003|Overall Study|Not Eligible|0|||
28010020|NCT00656019|54668600|FG000|Overall Study|Withdrawal by Subject|2|||
28010021|NCT00656019|54668601|FG001|Overall Study|Withdrawal by Subject|0|||
28010022|NCT00656019|54668602|FG002|Overall Study|Withdrawal by Subject|0|||
28010023|NCT00656019|54668603|FG003|Overall Study|Withdrawal by Subject|0|||
28010024|NCT00656019|54668600|FG000|Overall Study|Lost to Follow-up|2|||
28010025|NCT00656019|54668601|FG001|Overall Study|Lost to Follow-up|1|||
28010026|NCT00656019|54668602|FG002|Overall Study|Lost to Follow-up|0|||
28010027|NCT00656019|54668603|FG003|Overall Study|Lost to Follow-up|0|||
28010028|NCT00782483|54668613|FG000|Overall Study|Early Termination of Protocol - PI Reloc|6|||
28010029|NCT00782171|54668619|FG000|Overall Study|Lost to Follow-up|2|||
28010030|NCT00782171|54668620|FG001|Overall Study|Lost to Follow-up|2|||
28010031|NCT00782171|54668619|FG000|Overall Study|Withdrawal by Subject|2|||
28010032|NCT00782171|54668620|FG001|Overall Study|Withdrawal by Subject|1|||
28010033|NCT00782171|54668619|FG000|Overall Study|complications|3|||
28010034|NCT00782171|54668620|FG001|Overall Study|complications|1|||
28010035|NCT00782171|54668619|FG000|Overall Study|others|7|||
28010036|NCT00782171|54668620|FG001|Overall Study|others|9|||
28010037|NCT00782171|54668619|FG000|Overall Study|not eligible|8|||
28010038|NCT00782171|54668620|FG001|Overall Study|not eligible|6|||
28010039|NCT00764465|54668632|FG000|Overall Study|Adverse Event|2|||
28010040|NCT00764465|54668633|FG001|Overall Study|Adverse Event|0|||
28010041|NCT00764465|54668634|FG002|Overall Study|Adverse Event|0|||
28010042|NCT00764465|54668635|FG003|Overall Study|Adverse Event|1|||
28010043|NCT00764465|54668636|FG004|Overall Study|Adverse Event|1|||
28010044|NCT00764465|54668637|FG005|Overall Study|Adverse Event|1|||
28010045|NCT00764465|54668632|FG000|Overall Study|Withdrawal by Subject|0|||
28010046|NCT00764465|54668633|FG001|Overall Study|Withdrawal by Subject|1|||
28010047|NCT00764465|54668634|FG002|Overall Study|Withdrawal by Subject|1|||
28010048|NCT00764465|54668635|FG003|Overall Study|Withdrawal by Subject|0|||
28010049|NCT00764465|54668636|FG004|Overall Study|Withdrawal by Subject|0|||
28010050|NCT00764465|54668637|FG005|Overall Study|Withdrawal by Subject|0|||
28010051|NCT00655863|54668657|FG000|Overall Study|Lost to Follow-up|0|||
28010052|NCT00655863|54668658|FG001|Overall Study|Lost to Follow-up|0|||
28010053|NCT00655863|54668659|FG002|Overall Study|Lost to Follow-up|1|||
28010054|NCT00781937|54668669|FG000|Main Trial Period Through Week 56|Adverse Event|18|||
28010055|NCT00781937|54668670|FG001|Main Trial Period Through Week 56|Adverse Event|18|||
28010056|NCT00781937|54668669|FG000|Main Trial Period Through Week 56|Lack of Efficacy|0|||
28010057|NCT00781937|54668670|FG001|Main Trial Period Through Week 56|Lack of Efficacy|2|||
28010058|NCT00781937|54668669|FG000|Main Trial Period Through Week 56|Protocol Violation|8|||
28010059|NCT00781937|54668670|FG001|Main Trial Period Through Week 56|Protocol Violation|5|||
28010060|NCT00781937|54668669|FG000|Main Trial Period Through Week 56|Withdrawal by Subject|17|||
28010061|NCT00781937|54668670|FG001|Main Trial Period Through Week 56|Withdrawal by Subject|24|||
28010062|NCT00781937|54668669|FG000|Main Trial Period Through Week 56|Unclassified|10|||
28010063|NCT00781937|54668670|FG001|Main Trial Period Through Week 56|Unclassified|15|||
28010064|NCT00781937|54668669|FG000|Follow up Period (Week 56-68)|Protocol Violation|1|||
28010065|NCT00781937|54668670|FG001|Follow up Period (Week 56-68)|Protocol Violation|1|||
28010066|NCT00781937|54668669|FG000|Follow up Period (Week 56-68)|Unclassified|5|||
28010067|NCT00781937|54668670|FG001|Follow up Period (Week 56-68)|Unclassified|4|||
28010068|NCT00659373|54668678|FG000|Overall Study|Withdrawal by Subject|3|||
28010069|NCT00659373|54668679|FG001|Overall Study|Withdrawal by Subject|5|||
28010070|NCT00659373|54668678|FG000|Overall Study|Assessment Missed|2|||
28010071|NCT00659373|54668679|FG001|Overall Study|Assessment Missed|2|||
28010072|NCT00439777|54668687|FG000|Treatment Period|Death|29|||
28010073|NCT00439777|54668688|FG001|Treatment Period|Death|21|||
28010074|NCT00439777|54668687|FG000|Treatment Period|Study terminated by sponsor|125|||
28010075|NCT00439777|54668688|FG001|Treatment Period|Study terminated by sponsor|132|||
28010076|NCT00439777|54668687|FG000|Treatment Period|Site closed by investigator|0|||
28010077|NCT00439777|54668688|FG001|Treatment Period|Site closed by investigator|1|||
28010078|NCT00439777|54668687|FG000|Treatment Period|Did not take study treatment|7|||
28010079|NCT00439777|54668688|FG001|Treatment Period|Did not take study treatment|8|||
28010080|NCT00439777|54668687|FG000|Treatment Period|Adverse Event|111|||
28010081|NCT00439777|54668688|FG001|Treatment Period|Adverse Event|92|||
28010082|NCT00439777|54668687|FG000|Treatment Period|Protocol Violation|23|||
28010083|NCT00439777|54668688|FG001|Treatment Period|Protocol Violation|30|||
28010084|NCT00439777|54668687|FG000|Treatment Period|Withdrawal by Subject|66|||
28010085|NCT00439777|54668688|FG001|Treatment Period|Withdrawal by Subject|118|||
28010086|NCT00439777|54668687|FG000|Treatment Period|Lack of Efficacy|1|||
28010087|NCT00439777|54668688|FG001|Treatment Period|Lack of Efficacy|4|||
28010088|NCT00439777|54668687|FG000|Treatment Period|Lost to Follow-up|8|||
28010089|NCT00439777|54668688|FG001|Treatment Period|Lost to Follow-up|10|||
28010090|NCT00439777|54668687|FG000|Treatment Period|Protocol driven decision point|1|||
28010091|NCT00439777|54668688|FG001|Treatment Period|Protocol driven decision point|3|||
28010092|NCT00439777|54668687|FG000|Treatment Period|Physician Decision|7|||
28010093|NCT00439777|54668688|FG001|Treatment Period|Physician Decision|18|||
28010094|NCT00439777|54668687|FG000|Treatment Period|Clinical endpoint reached|26|||
28010095|NCT00439777|54668688|FG001|Treatment Period|Clinical endpoint reached|13|||
28010096|NCT00439777|54668687|FG000|Treatment Period|Technical problems|3|||
28010097|NCT00439777|54668688|FG001|Treatment Period|Technical problems|1|||
28010098|NCT00439777|54668687|FG000|Treatment Period|Participant convenience|12|||
28010099|NCT00439777|54668688|FG001|Treatment Period|Participant convenience|8|||
28010100|NCT00439777|54668687|FG000|Observational Period|Protocol Violation|0|||
28010101|NCT00439777|54668688|FG001|Observational Period|Protocol Violation|2|||
28010102|NCT00439777|54668687|FG000|Observational Period|Withdrawal by Subject|9|||
28010103|NCT00439777|54668688|FG001|Observational Period|Withdrawal by Subject|5|||
28010104|NCT00439777|54668687|FG000|Observational Period|Lost to Follow-up|1|||
28010105|NCT00439777|54668688|FG001|Observational Period|Lost to Follow-up|11|||
28010106|NCT00439777|54668687|FG000|Observational Period|Death|27|||
28010107|NCT00439777|54668688|FG001|Observational Period|Death|20|||
28010108|NCT00439777|54668687|FG000|Observational Period|Study terminated by sponsor|3|||
28010109|NCT00439777|54668688|FG001|Observational Period|Study terminated by sponsor|1|||
28010110|NCT00439777|54668687|FG000|Observational Period|Protocol driven decision point|0|||
28010111|NCT00439777|54668688|FG001|Observational Period|Protocol driven decision point|1|||
28010112|NCT00439777|54668687|FG000|Observational Period|Lack of Efficacy|1|||
28010113|NCT00439777|54668688|FG001|Observational Period|Lack of Efficacy|0|||
28010114|NCT00439777|54668687|FG000|Observational Period|Technical problems|0|||
28010115|NCT00439777|54668688|FG001|Observational Period|Technical problems|1|||
28010116|NCT00620854|54668700|FG000|Washout 1|Withdrawal by Subject|0|||
27741373|NCT02712905|54191369|FG015|Combination Therapy|Death|3|||
27741374|NCT02712905|54191370|FG016|Combination Therapy|Death|1|||
27919746|NCT01105936|54576987|FG000|Period 2|Adverse Event|1|||
27919747|NCT01105936|54576988|FG001|Period 2|Adverse Event|0|||
27919748|NCT01105936|54576989|FG002|Period 2|Adverse Event|0|||
27919749|NCT01105936|54576990|FG003|Period 2|Adverse Event|0|||
27919750|NCT01105936|54576987|FG000|Period 3|Protocol Violation|0|||
27919751|NCT01105936|54576988|FG001|Period 3|Protocol Violation|2|||
27919752|NCT01105936|54576989|FG002|Period 3|Protocol Violation|0|||
27919753|NCT01105936|54576990|FG003|Period 3|Protocol Violation|0|||
27919754|NCT01309659|54577001|FG000|Overall Study|Protocol Violation|0|||
27919755|NCT01309659|54577002|FG001|Overall Study|Protocol Violation|1|||
27919756|NCT01104766|54577012|FG000|Overall Study|Did not meet inc/exc criteria|1|||
27919757|NCT01104766|54577013|FG001|Overall Study|Did not meet inc/exc criteria|0|||
27919758|NCT01104766|54577014|FG002|Overall Study|Did not meet inc/exc criteria|0|||
27919759|NCT01104766|54577015|FG003|Overall Study|Did not meet inc/exc criteria|0|||
27919760|NCT01104766|54577012|FG000|Overall Study|Adverse Event|17|||
27919761|NCT01104766|54577013|FG001|Overall Study|Adverse Event|15|||
27919762|NCT01104766|54577014|FG002|Overall Study|Adverse Event|20|||
27919763|NCT01104766|54577015|FG003|Overall Study|Adverse Event|14|||
27919764|NCT01104766|54577012|FG000|Overall Study|Lack of Efficacy|20|||
27919765|NCT01104766|54577013|FG001|Overall Study|Lack of Efficacy|15|||
27919766|NCT01104766|54577014|FG002|Overall Study|Lack of Efficacy|14|||
27919767|NCT01104766|54577015|FG003|Overall Study|Lack of Efficacy|8|||
27919768|NCT01104766|54577012|FG000|Overall Study|Protocol Violation|2|||
27919769|NCT01104766|54577013|FG001|Overall Study|Protocol Violation|0|||
27919770|NCT01104766|54577014|FG002|Overall Study|Protocol Violation|0|||
27919771|NCT01104766|54577015|FG003|Overall Study|Protocol Violation|0|||
27919772|NCT01104766|54577012|FG000|Overall Study|Withdrawal by Subject|17|||
27919773|NCT01104766|54577013|FG001|Overall Study|Withdrawal by Subject|19|||
27919774|NCT01104766|54577014|FG002|Overall Study|Withdrawal by Subject|25|||
28010117|NCT00620854|54668701|FG001|Washout 1|Withdrawal by Subject|0|||
28010118|NCT00620854|54668702|FG002|Washout 1|Withdrawal by Subject|1|||
28010119|NCT00620854|54668703|FG003|Washout 1|Withdrawal by Subject|1|||
28010120|NCT00620854|54668704|FG004|Washout 1|Withdrawal by Subject|0|||
28010121|NCT00620854|54668705|FG005|Washout 1|Withdrawal by Subject|0|||
28010122|NCT00430027|54668716|FG000|Overall Study|Study terminated|8|||
28010123|NCT00429793|54668720|FG000|Overall Study|Improper pre-protocol treatment|3|||
28010124|NCT00429793|54668720|FG000|Overall Study|Required test not done|1|||
28010125|NCT00429793|54668720|FG000|Overall Study|Never treated|1|||
28010126|NCT00429793|54668720|FG000|Overall Study|Non-measurable|1|||
28010127|NCT00424645|54668731|FG000|Overall Study|Death|1|||
28010128|NCT00424645|54668732|FG001|Overall Study|Death|0|||
28010129|NCT00763451|54668742|FG000|Overall Study|Adverse Event|4|||
27919775|NCT01104766|54577015|FG003|Overall Study|Withdrawal by Subject|15|||
27919776|NCT01104766|54577012|FG000|Overall Study|Lost to Follow-up|1|||
27919777|NCT01104766|54577013|FG001|Overall Study|Lost to Follow-up|2|||
28010130|NCT00763451|54668743|FG001|Overall Study|Adverse Event|6|||
28010131|NCT00763451|54668744|FG002|Overall Study|Adverse Event|19|||
28010132|NCT00763451|54668745|FG003|Overall Study|Adverse Event|14|||
28010133|NCT00763451|54668742|FG000|Overall Study|Lack of Efficacy|1|||
28010134|NCT00763451|54668743|FG001|Overall Study|Lack of Efficacy|4|||
28010135|NCT00763451|54668744|FG002|Overall Study|Lack of Efficacy|3|||
28010136|NCT00763451|54668745|FG003|Overall Study|Lack of Efficacy|2|||
28010137|NCT00763451|54668742|FG000|Overall Study|Withdrawal by Subject|1|||
28010138|NCT00763451|54668743|FG001|Overall Study|Withdrawal by Subject|6|||
28010139|NCT00763451|54668744|FG002|Overall Study|Withdrawal by Subject|9|||
28010140|NCT00763451|54668745|FG003|Overall Study|Withdrawal by Subject|7|||
28010141|NCT00763451|54668742|FG000|Overall Study|Protocol Violation|0|||
28010142|NCT00763451|54668743|FG001|Overall Study|Protocol Violation|0|||
28010143|NCT00763451|54668744|FG002|Overall Study|Protocol Violation|1|||
28010144|NCT00763451|54668745|FG003|Overall Study|Protocol Violation|0|||
28010145|NCT00763451|54668742|FG000|Overall Study|Poor Compliance to Protocol|1|||
28010146|NCT00763451|54668743|FG001|Overall Study|Poor Compliance to Protocol|1|||
28010147|NCT00763451|54668744|FG002|Overall Study|Poor Compliance to Protocol|2|||
28010148|NCT00763451|54668745|FG003|Overall Study|Poor Compliance to Protocol|2|||
28010149|NCT00763451|54668742|FG000|Overall Study|Familial and Personal Reasons|5|||
28010150|NCT00763451|54668743|FG001|Overall Study|Familial and Personal Reasons|3|||
28010151|NCT00763451|54668744|FG002|Overall Study|Familial and Personal Reasons|5|||
28010152|NCT00763451|54668745|FG003|Overall Study|Familial and Personal Reasons|4|||
28010153|NCT00763451|54668742|FG000|Overall Study|Randomized but not Treated|1|||
28010154|NCT00763451|54668743|FG001|Overall Study|Randomized but not Treated|1|||
28010155|NCT00763451|54668744|FG002|Overall Study|Randomized but not Treated|0|||
28010156|NCT00763451|54668745|FG003|Overall Study|Randomized but not Treated|0|||
28010157|NCT00763451|54668742|FG000|Overall Study|Study Site Reason|0|||
28010158|NCT00763451|54668743|FG001|Overall Study|Study Site Reason|1|||
28010159|NCT00763451|54668744|FG002|Overall Study|Study Site Reason|1|||
28010160|NCT00763451|54668745|FG003|Overall Study|Study Site Reason|1|||
28010161|NCT00762762|54668758|FG000|Overall Study|Did not return for appointments|6|||
28010162|NCT00762762|54668759|FG001|Overall Study|Did not return for appointments|8|||
28010163|NCT00424489|54668767|FG000|Overall Study|Death|3|||
28010164|NCT00578864|54668773|FG000|Overall Study|Death|1|||
28010165|NCT00578864|54668774|FG001|Overall Study|Death|0|||
28010166|NCT00770315|54668797|FG000|Overall Study|Adverse Event|11|||
28010167|NCT00770315|54668798|FG001|Overall Study|Adverse Event|17|||
28010168|NCT00770315|54668799|FG002|Overall Study|Adverse Event|16|||
28010169|NCT00770315|54668800|FG003|Overall Study|Adverse Event|6|||
28010170|NCT00770315|54668797|FG000|Overall Study|Lost to Follow-up|9|||
28010171|NCT00770315|54668798|FG001|Overall Study|Lost to Follow-up|5|||
28010172|NCT00770315|54668799|FG002|Overall Study|Lost to Follow-up|10|||
28010173|NCT00770315|54668800|FG003|Overall Study|Lost to Follow-up|3|||
28010174|NCT00770315|54668797|FG000|Overall Study|Withdrawal by Subject|13|||
28010175|NCT00770315|54668798|FG001|Overall Study|Withdrawal by Subject|17|||
28010176|NCT00770315|54668799|FG002|Overall Study|Withdrawal by Subject|24|||
28010177|NCT00770315|54668800|FG003|Overall Study|Withdrawal by Subject|20|||
28010178|NCT00770315|54668797|FG000|Overall Study|Noncompliance with Protocol|7|||
28010179|NCT00770315|54668798|FG001|Overall Study|Noncompliance with Protocol|4|||
28010180|NCT00770315|54668799|FG002|Overall Study|Noncompliance with Protocol|7|||
28010181|NCT00770315|54668800|FG003|Overall Study|Noncompliance with Protocol|9|||
28010182|NCT00587171|54668812|FG000|Overall Study|Lost to Follow-up|1|||
28010183|NCT00587171|54668813|FG001|Overall Study|Lost to Follow-up|1|||
28010184|NCT00763139|54668819|FG000|Overall Study|Adverse Event|4|||
28010185|NCT00763139|54668820|FG001|Overall Study|Adverse Event|2|||
28010186|NCT00763139|54668819|FG000|Overall Study|Withdrawal by Subject|0|||
28010187|NCT00763139|54668820|FG001|Overall Study|Withdrawal by Subject|1|||
28010188|NCT00763139|54668819|FG000|Overall Study|med change not allowed by protocol|1|||
28010189|NCT00763139|54668820|FG001|Overall Study|med change not allowed by protocol|0|||
28010190|NCT01366092|54668831|FG000|Overall Study|Progressive cGVHD|2|||
28010191|NCT01366092|54668831|FG000|Overall Study|Physician Decision|1|||
28010192|NCT01366092|54668831|FG000|Overall Study|Withdrawal by Subject|1|||
28010193|NCT00781859|54668837|FG000|Overall Study|Adverse Event|2|||
28010194|NCT00781859|54668838|FG001|Overall Study|Adverse Event|2|||
28010195|NCT00781859|54668837|FG000|Overall Study|Withdrawal by Subject|8|||
28010196|NCT00781859|54668838|FG001|Overall Study|Withdrawal by Subject|4|||
28010197|NCT00781859|54668837|FG000|Overall Study|Lost to Follow-up|6|||
28010198|NCT00781859|54668838|FG001|Overall Study|Lost to Follow-up|3|||
28010199|NCT00781859|54668837|FG000|Overall Study|Death|3|||
28010200|NCT00781859|54668838|FG001|Overall Study|Death|0|||
28010201|NCT00580788|54668848|FG000|Overall Study|Adverse Event|0|||
28010202|NCT00580788|54668849|FG001|Overall Study|Adverse Event|0|||
28010203|NCT00580788|54668850|FG002|Overall Study|Adverse Event|0|||
28010204|NCT00580788|54668851|FG003|Overall Study|Adverse Event|1|||
28010205|NCT00417079|54668870|FG000|Overall Study|Disease progression|267|||
28010206|NCT00417079|54668871|FG001|Overall Study|Disease progression|180|||
28010207|NCT00417079|54668870|FG000|Overall Study|Adverse Event|32|||
28010208|NCT00417079|54668871|FG001|Overall Study|Adverse Event|67|||
28010209|NCT00417079|54668870|FG000|Overall Study|Non-compliance to protocol|0|||
28010210|NCT00417079|54668871|FG001|Overall Study|Non-compliance to protocol|1|||
28010211|NCT00417079|54668870|FG000|Overall Study|Lost to Follow-up|2|||
28010212|NCT00417079|54668871|FG001|Overall Study|Lost to Follow-up|0|||
28010213|NCT00417079|54668870|FG000|Overall Study|Withdrawal by Subject|17|||
28010214|NCT00417079|54668871|FG001|Overall Study|Withdrawal by Subject|8|||
28010215|NCT00417079|54668870|FG000|Overall Study|Not treated|6|||
28010216|NCT00417079|54668871|FG001|Overall Study|Not treated|7|||
28010217|NCT00417079|54668870|FG000|Overall Study|Screened failure|2|||
28010218|NCT00417079|54668871|FG001|Overall Study|Screened failure|1|||
28010219|NCT00417079|54668870|FG000|Overall Study|Investigator's decision|1|||
28010220|NCT00417079|54668871|FG001|Overall Study|Investigator's decision|4|||
28010221|NCT00417079|54668870|FG000|Overall Study|Non-confirmed Disease progression|1|||
28010222|NCT00417079|54668871|FG001|Overall Study|Non-confirmed Disease progression|1|||
28010223|NCT00417079|54668870|FG000|Overall Study|Clinical deterioration|1|||
28010224|NCT00417079|54668871|FG001|Overall Study|Clinical deterioration|0|||
28010225|NCT00417079|54668870|FG000|Overall Study|Screening error|2|||
28010226|NCT00417079|54668871|FG001|Overall Study|Screening error|1|||
28010227|NCT00417079|54668870|FG000|Overall Study|Withdrawal by subject's family|0|||
28010228|NCT00417079|54668871|FG001|Overall Study|Withdrawal by subject's family|1|||
28010229|NCT00417079|54668870|FG000|Overall Study|Patient unable to come to the clinic|0|||
28010230|NCT00417079|54668871|FG001|Overall Study|Patient unable to come to the clinic|1|||
28010231|NCT00417079|54668870|FG000|Overall Study|abnormal liver function tests|0|||
28010232|NCT00417079|54668871|FG001|Overall Study|abnormal liver function tests|1|||
28010233|NCT00429169|54668879|FG000|Overall Study|Lost to Follow-up|0|||
28010234|NCT00429169|54668880|FG001|Overall Study|Lost to Follow-up|1|||
28010235|NCT00429169|54668879|FG000|Overall Study|Ineligibility discovered after entry|2|||
28010236|NCT00429169|54668880|FG001|Overall Study|Ineligibility discovered after entry|1|||
28010237|NCT00416455|54668890|FG000|Overall Study|PET / CT not done|3|||
28010238|NCT00416455|54668891|FG001|Overall Study|PET / CT not done|5|||
28010239|NCT00416455|54668890|FG000|Overall Study|PET / CT poor quality|2|||
28010240|NCT00416455|54668891|FG001|Overall Study|PET / CT poor quality|1|||
28010241|NCT00416455|54668890|FG000|Overall Study|Inadequate pathology|11|||
28010242|NCT00416455|54668891|FG001|Overall Study|Inadequate pathology|2|||
28010243|NCT00415909|54668908|FG000|Overall Study|Withdrawal by Subject|2|||
28010244|NCT00415909|54668908|FG000|Overall Study|Death|1|||
28010245|NCT00415597|54668912|FG000|Enrollment|Withdrawal by Subject|1|||
28010246|NCT00415597|54668912|FG000|Enrollment|Protocol Violation|1|||
28010247|NCT00415597|54668912|FG000|Treatment|Adverse Event|110|||
28010248|NCT00415597|54668912|FG000|Treatment|Lack of Efficacy|39|||
28010249|NCT00415597|54668912|FG000|Treatment|Protocol Violation|67|||
28010250|NCT00415597|54668912|FG000|Treatment|Physician Decision|3|||
28010251|NCT00415597|54668912|FG000|Treatment|Withdrawal by Subject|51|||
28010252|NCT00415597|54668912|FG000|Treatment|Lost to Follow-up|28|||
28010253|NCT00415597|54668912|FG000|Treatment|Drug Screen|2|||
28010254|NCT00415597|54668912|FG000|Treatment|Administrative|3|||
28010255|NCT00415597|54668912|FG000|Treatment|Sponsor Decision|1|||
28010256|NCT00415597|54668912|FG000|Treatment|Multiple Reasons|1|||
28010257|NCT00620542|54668918|FG000|Part A (Run-in - 2 Weeks)|Adverse Event|12|||
28010258|NCT00620542|54668919|FG001|Part A (Run-in - 2 Weeks)|Adverse Event|15|||
28010259|NCT00620542|54668920|FG002|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
28010260|NCT00620542|54668921|FG003|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
28010261|NCT00620542|54668918|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|406|||
28010262|NCT00620542|54668919|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|409|||
28010263|NCT00620542|54668920|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
28010264|NCT00620542|54668921|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
27741375|NCT02712905|54191371|FG017|Combination Therapy|Death|3|||
27919778|NCT01104766|54577014|FG002|Overall Study|Lost to Follow-up|1|||
27919779|NCT01104766|54577015|FG003|Overall Study|Lost to Follow-up|1|||
27919780|NCT01104376|54577025|FG000|Overall Study|Withdrawal by Subject|15|||
27919781|NCT01104376|54577025|FG000|Overall Study|Consented but excluded after labs|13|||
27919782|NCT01072357|54577031|FG000|Overall Study|Lost to Follow-up|0|||
27919783|NCT01072357|54577032|FG001|Overall Study|Lost to Follow-up|1|||
27919784|NCT01072201|54577040|FG000|Overall Study|Lost to Follow-up|0|||
27919785|NCT01072201|54577041|FG001|Overall Study|Lost to Follow-up|1|||
27919786|NCT01103362|54577047|FG000|Overall Study|study terminated|596|||
27919787|NCT01103284|54577053|FG000|Overall Study|Death|2|||
27919788|NCT01103284|54577054|FG001|Overall Study|Death|0|||
27919789|NCT01103284|54577053|FG000|Overall Study|Lost to Follow-up|9|||
28010265|NCT00620542|54668918|FG000|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43|||
28010266|NCT00620542|54668919|FG001|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40|||
28010267|NCT00620542|54668920|FG002|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
28010268|NCT00620542|54668921|FG003|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
28010269|NCT00620542|54668918|FG000|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7|||
28010270|NCT00620542|54668919|FG001|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6|||
28103667|NCT02849080|54760394|FG002|Main Phase: 0 - 52 Weeks|Death|0|||
27919790|NCT01103284|54577054|FG001|Overall Study|Lost to Follow-up|10|||
28010271|NCT00620542|54668920|FG002|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
28010272|NCT00620542|54668921|FG003|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
28010273|NCT00620542|54668918|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
28010274|NCT00620542|54668919|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|1|||
28010275|NCT00620542|54668920|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
28010276|NCT00620542|54668921|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
28010277|NCT00620542|54668918|FG000|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
28010278|NCT00620542|54668919|FG001|Part A (Run-in - 2 Weeks)|Safety reasons|1|||
28010279|NCT00620542|54668920|FG002|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
28010280|NCT00620542|54668921|FG003|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
28010281|NCT00620542|54668918|FG000|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
28010282|NCT00620542|54668919|FG001|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
28010283|NCT00620542|54668920|FG002|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
28010284|NCT00620542|54668921|FG003|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
28010285|NCT00620542|54668918|FG000|Part B (2 Year Core Study)|Adverse Event|0|||
28010286|NCT00620542|54668919|FG001|Part B (2 Year Core Study)|Adverse Event|0|||
28010287|NCT00620542|54668920|FG002|Part B (2 Year Core Study)|Adverse Event|46|||
28010288|NCT00620542|54668921|FG003|Part B (2 Year Core Study)|Adverse Event|49|||
28010289|NCT00620542|54668918|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
28010290|NCT00620542|54668919|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
28010291|NCT00620542|54668920|FG002|Part B (2 Year Core Study)|Protocol Violation|3|||
28010292|NCT00620542|54668921|FG003|Part B (2 Year Core Study)|Protocol Violation|5|||
28010293|NCT00620542|54668918|FG000|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
28010294|NCT00620542|54668919|FG001|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
28010295|NCT00620542|54668920|FG002|Part B (2 Year Core Study)|Withdrawal by Subject|55|||
28010296|NCT00620542|54668921|FG003|Part B (2 Year Core Study)|Withdrawal by Subject|54|||
28010297|NCT00620542|54668918|FG000|Part B (2 Year Core Study)|Lost to Follow-up|0|||
28010298|NCT00620542|54668919|FG001|Part B (2 Year Core Study)|Lost to Follow-up|0|||
28010299|NCT00620542|54668920|FG002|Part B (2 Year Core Study)|Lost to Follow-up|20|||
28010300|NCT00620542|54668921|FG003|Part B (2 Year Core Study)|Lost to Follow-up|9|||
28010301|NCT00620542|54668918|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
28010302|NCT00620542|54668919|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
28010303|NCT00620542|54668920|FG002|Part B (2 Year Core Study)|Protocol Violation|13|||
28010304|NCT00620542|54668921|FG003|Part B (2 Year Core Study)|Protocol Violation|16|||
28010305|NCT00620542|54668918|FG000|Part B (2 Year Core Study)|Safety reasons|0|||
28010306|NCT00620542|54668919|FG001|Part B (2 Year Core Study)|Safety reasons|0|||
28010307|NCT00620542|54668920|FG002|Part B (2 Year Core Study)|Safety reasons|2|||
28010308|NCT00620542|54668921|FG003|Part B (2 Year Core Study)|Safety reasons|3|||
28010309|NCT00620542|54668918|FG000|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
28010310|NCT00620542|54668919|FG001|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
28010311|NCT00620542|54668920|FG002|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
28010312|NCT00620542|54668921|FG003|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
28010313|NCT00620542|54668918|FG000|Part B (2 Year Core Study)|IVUS not available|0|||
28010314|NCT00620542|54668919|FG001|Part B (2 Year Core Study)|IVUS not available|0|||
28010315|NCT00620542|54668920|FG002|Part B (2 Year Core Study)|IVUS not available|3|||
28010316|NCT00620542|54668921|FG003|Part B (2 Year Core Study)|IVUS not available|2|||
28010317|NCT05096208|54668933|FG000|Overall Study|Lost to Follow-up|3|||
28010318|NCT05096208|54668934|FG001|Overall Study|Lost to Follow-up|5|||
28010319|NCT05096208|54668935|FG002|Overall Study|Lost to Follow-up|5|||
28010320|NCT05096208|54668936|FG003|Overall Study|Lost to Follow-up|2|||
28010321|NCT05096208|54668933|FG000|Overall Study|Withdrawal by Subject|0|||
28010322|NCT05096208|54668934|FG001|Overall Study|Withdrawal by Subject|1|||
28010323|NCT05096208|54668935|FG002|Overall Study|Withdrawal by Subject|2|||
28010324|NCT05096208|54668936|FG003|Overall Study|Withdrawal by Subject|3|||
28010325|NCT05096208|54668933|FG000|Overall Study|No longer met eligibility criteria|1|||
28010326|NCT05096208|54668934|FG001|Overall Study|No longer met eligibility criteria|0|||
28010327|NCT05096208|54668935|FG002|Overall Study|No longer met eligibility criteria|0|||
28010328|NCT05096208|54668936|FG003|Overall Study|No longer met eligibility criteria|0|||
28010329|NCT05096208|54668933|FG000|Overall Study|Other|0|||
28010330|NCT05096208|54668934|FG001|Overall Study|Other|0|||
28010331|NCT05096208|54668935|FG002|Overall Study|Other|1|||
28010332|NCT05096208|54668936|FG003|Overall Study|Other|0|||
28010333|NCT04555616|54668955|FG000|Overall Study|Death|1|||
28010334|NCT04555616|54668956|FG001|Overall Study|Death|0|||
28010335|NCT04555616|54668957|FG002|Overall Study|Death|1|||
28010336|NCT04555616|54668955|FG000|Overall Study|Withdrawal by Subject|2|||
28010337|NCT04555616|54668956|FG001|Overall Study|Withdrawal by Subject|1|||
28010338|NCT04555616|54668957|FG002|Overall Study|Withdrawal by Subject|0|||
28010339|NCT04177758|54668981|FG000|Overall Study|Lost to Follow-up|19|||
28010340|NCT04177758|54668982|FG001|Overall Study|Lost to Follow-up|11|||
28010341|NCT04003103|54668991|FG000|Overall Study|Death|1|||
28010342|NCT04003103|54668992|FG001|Overall Study|Death|0|||
28010343|NCT04003103|54668993|FG002|Overall Study|Death|0|||
28010344|NCT04003103|54668991|FG000|Overall Study|Lost to Follow-up|4|||
28010345|NCT04003103|54668992|FG001|Overall Study|Lost to Follow-up|3|||
28010346|NCT04003103|54668993|FG002|Overall Study|Lost to Follow-up|2|||
28010347|NCT04003103|54668991|FG000|Overall Study|Withdrawal by Subject|10|||
28010348|NCT04003103|54668992|FG001|Overall Study|Withdrawal by Subject|1|||
28010349|NCT04003103|54668993|FG002|Overall Study|Withdrawal by Subject|1|||
28010350|NCT04003103|54668991|FG000|Overall Study|Status not recorded|0|||
28010351|NCT04003103|54668992|FG001|Overall Study|Status not recorded|2|||
28010352|NCT04003103|54668993|FG002|Overall Study|Status not recorded|0|||
28010353|NCT03921528|54669042|FG000|Overall Study|Withdrawal by Subject|0|||
28010354|NCT03921528|54669043|FG001|Overall Study|Withdrawal by Subject|1|||
28010355|NCT03921528|54669044|FG002|Overall Study|Withdrawal by Subject|0|||
28010356|NCT03921528|54669045|FG003|Overall Study|Withdrawal by Subject|0|||
28010357|NCT03921528|54669046|FG004|Overall Study|Withdrawal by Subject|0|||
28010358|NCT03832322|54669064|FG000|Overall Study|Failed cecal intubation in 2nd exam|3|||
28010359|NCT03832322|54669065|FG001|Overall Study|Failed cecal intubation in 2nd exam|1|||
28010360|NCT03642990|54669081|FG000|300 mg/Day for One Week|Withdrawal by Subject|1|||
28010361|NCT03642990|54669081|FG000|1000 mg/Day for Weeks 2-12|Physician Decision|4|||
28010362|NCT03639311|54669087|FG000|Overall Study|Ongoing at the time of analysis|88|||
28010363|NCT03639311|54669088|FG001|Overall Study|Ongoing at the time of analysis|0|||
28010364|NCT03639311|54669087|FG000|Overall Study|Lost to Follow-up|1|||
28010365|NCT03639311|54669088|FG001|Overall Study|Lost to Follow-up|0|||
28010366|NCT03639311|54669087|FG000|Overall Study|Adverse Event|1|||
28010367|NCT03639311|54669088|FG001|Overall Study|Adverse Event|0|||
28010368|NCT03633825|54669099|FG000|Enrollment|Did not post on network|5066|||
28010369|NCT03633825|54669100|FG001|Enrollment|Did not post on network|5080|||
28010370|NCT03633825|54669099|FG000|Enrollment|Post not classified as crisis|13967|||
28010371|NCT03633825|54669100|FG001|Enrollment|Post not classified as crisis|13757|||
28010372|NCT03633825|54669099|FG000|Follow up|Lost to Follow-up|478|||
28010373|NCT03633825|54669100|FG001|Follow up|Lost to Follow-up|450|||
28010374|NCT03465540|54669112|FG000|Overall Study|Withdrawal by Subject|0|||
28010375|NCT03465540|54669113|FG001|Overall Study|Withdrawal by Subject|0|||
28010376|NCT03465540|54669114|FG002|Overall Study|Withdrawal by Subject|1|||
28010377|NCT03465540|54669115|FG003|Overall Study|Withdrawal by Subject|1|||
28010378|NCT03465540|54669116|FG004|Overall Study|Withdrawal by Subject|1|||
28010379|NCT03465540|54669117|FG005|Overall Study|Withdrawal by Subject|0|||
28010380|NCT03465540|54669112|FG000|Overall Study|Lost to Follow-up|0|||
28010381|NCT03465540|54669113|FG001|Overall Study|Lost to Follow-up|1|||
28010382|NCT03465540|54669114|FG002|Overall Study|Lost to Follow-up|0|||
28010383|NCT03465540|54669115|FG003|Overall Study|Lost to Follow-up|0|||
28010384|NCT03465540|54669116|FG004|Overall Study|Lost to Follow-up|1|||
28010385|NCT03465540|54669117|FG005|Overall Study|Lost to Follow-up|0|||
28010386|NCT03465540|54669112|FG000|Overall Study|Death|1|||
28010387|NCT03465540|54669113|FG001|Overall Study|Death|1|||
28010388|NCT03465540|54669114|FG002|Overall Study|Death|0|||
28010389|NCT03465540|54669115|FG003|Overall Study|Death|2|||
28010390|NCT03465540|54669116|FG004|Overall Study|Death|0|||
28010391|NCT03465540|54669117|FG005|Overall Study|Death|2|||
28010392|NCT03465540|54669112|FG000|Overall Study|Protocol specified criteria|0|||
28010393|NCT03465540|54669113|FG001|Overall Study|Protocol specified criteria|2|||
28010394|NCT03465540|54669114|FG002|Overall Study|Protocol specified criteria|2|||
28010395|NCT03465540|54669115|FG003|Overall Study|Protocol specified criteria|0|||
28010396|NCT03465540|54669116|FG004|Overall Study|Protocol specified criteria|2|||
28010397|NCT03465540|54669117|FG005|Overall Study|Protocol specified criteria|0|||
28010398|NCT03246061|54669142|FG000|Overall Study|Still in follow-up|15|||
28010399|NCT03246061|54669143|FG001|Overall Study|Still in follow-up|21|||
28010400|NCT03055832|54669176|FG000|Week 2|Withdrawal by Subject|1|||
28010401|NCT03055832|54669177|FG001|Week 2|Withdrawal by Subject|0|||
28010402|NCT03052049|54669197|FG000|Overall Study|Withdrawal by Subject|2|||
28010403|NCT02771275|54669222|FG000|Overall Study|Reoperation|2|||
28010404|NCT02771275|54669222|FG000|Overall Study|On Study|11|||
28010405|NCT02768870|54669226|FG000|Overall Study|Not Implanted with Device|2|||
28010406|NCT02768870|54669226|FG000|Overall Study|Death|1|||
28010407|NCT02768870|54669226|FG000|Overall Study|Reoperation|4|||
28010408|NCT02768870|54669226|FG000|Overall Study|On Study|19|||
28010409|NCT02750618|54669230|FG000|Overall Study|Withdrawal by Subject|1|||
28010410|NCT02537431|54669234|FG000|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
28010411|NCT02526160|54669240|FG000|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0|||
28010412|NCT02526160|54669241|FG001|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1|||
28010413|NCT02526160|54669240|FG000|Open-label Treatment Continuation Period|Withdrawal by Subject|0|||
28010414|NCT02526160|54669241|FG001|Open-label Treatment Continuation Period|Withdrawal by Subject|1|||
28010415|NCT02526160|54669240|FG000|Open-label Treatment Continuation Period|Other, Not Specified|3|||
28010416|NCT02526160|54669241|FG001|Open-label Treatment Continuation Period|Other, Not Specified|3|||
28010417|NCT02526160|54669240|FG000|Open-Label Treatment Extension Period I|Death|0|||
28010418|NCT02526160|54669241|FG001|Open-Label Treatment Extension Period I|Death|1|||
28010419|NCT02526160|54669240|FG000|Open-Label Treatment Extension Period I|Other, Not Specified|3|||
28010420|NCT02526160|54669241|FG001|Open-Label Treatment Extension Period I|Other, Not Specified|1|||
28010421|NCT02526160|54669240|FG000|Open-Label Treatment Extension Period I|Withdrawal by Subject|0|||
28010422|NCT02526160|54669241|FG001|Open-Label Treatment Extension Period I|Withdrawal by Subject|1|||
28010423|NCT02526160|54669240|FG000|Open-Label Treatment Extension Period I|Lost to Follow-up|0|||
28010424|NCT02526160|54669241|FG001|Open-Label Treatment Extension Period I|Lost to Follow-up|1|||
28010425|NCT02526160|54669240|FG000|Open-Label Treatment Extension Period II|Other, Not Specified|1|||
28010426|NCT02526160|54669241|FG001|Open-Label Treatment Extension Period II|Other, Not Specified|0|||
28010427|NCT02432196|54669252|FG000|Overall Study|Not Implanted with Device|1|||
28010428|NCT02432196|54669252|FG000|Overall Study|Death|2|||
28010429|NCT02432196|54669252|FG000|Overall Study|Reoperation|3|||
28010430|NCT02432196|54669252|FG000|Overall Study|On Study|20|||
28010431|NCT02157610|54669267|FG000|Overall Study|Death|4|||
28010432|NCT02157610|54669268|FG001|Overall Study|Death|4|||
28010433|NCT01511250|54669311|FG000|Overall Study|Withdrawal of Consent|1|||
28010434|NCT01511250|54669312|FG001|Overall Study|Withdrawal of Consent|0|||
28010435|NCT01511250|54669313|FG002|Overall Study|Withdrawal of Consent|0|||
28010436|NCT01511250|54669314|FG003|Overall Study|Withdrawal of Consent|0|||
28010437|NCT01511250|54669315|FG004|Overall Study|Withdrawal of Consent|0|||
28010438|NCT01511250|54669316|FG005|Overall Study|Withdrawal of Consent|0|||
28010439|NCT01511250|54669317|FG006|Overall Study|Withdrawal of Consent|0|||
28010440|NCT01511250|54669318|FG007|Overall Study|Withdrawal of Consent|1|||
28010441|NCT01511250|54669319|FG008|Overall Study|Withdrawal of Consent|1|||
28010442|NCT01511250|54669320|FG009|Overall Study|Withdrawal of Consent|0|||
28010443|NCT01511250|54669311|FG000|Overall Study|Sponsor/Investigator Decision|1|||
28010444|NCT01511250|54669312|FG001|Overall Study|Sponsor/Investigator Decision|0|||
28010445|NCT01511250|54669313|FG002|Overall Study|Sponsor/Investigator Decision|0|||
28010446|NCT01511250|54669314|FG003|Overall Study|Sponsor/Investigator Decision|0|||
28010447|NCT01511250|54669315|FG004|Overall Study|Sponsor/Investigator Decision|0|||
28010448|NCT01511250|54669316|FG005|Overall Study|Sponsor/Investigator Decision|0|||
28010449|NCT01511250|54669317|FG006|Overall Study|Sponsor/Investigator Decision|0|||
28010450|NCT01511250|54669318|FG007|Overall Study|Sponsor/Investigator Decision|0|||
28010451|NCT01511250|54669319|FG008|Overall Study|Sponsor/Investigator Decision|0|||
28010452|NCT01511250|54669320|FG009|Overall Study|Sponsor/Investigator Decision|0|||
28010453|NCT01511250|54669311|FG000|Overall Study|Lost to Follow-up|7|||
28010454|NCT01511250|54669312|FG001|Overall Study|Lost to Follow-up|3|||
28010455|NCT01511250|54669313|FG002|Overall Study|Lost to Follow-up|3|||
28010456|NCT01511250|54669314|FG003|Overall Study|Lost to Follow-up|3|||
28010457|NCT01511250|54669315|FG004|Overall Study|Lost to Follow-up|0|||
28010458|NCT01511250|54669316|FG005|Overall Study|Lost to Follow-up|0|||
28010459|NCT01511250|54669317|FG006|Overall Study|Lost to Follow-up|2|||
28010460|NCT01511250|54669318|FG007|Overall Study|Lost to Follow-up|3|||
28010461|NCT01511250|54669319|FG008|Overall Study|Lost to Follow-up|13|||
28010462|NCT01511250|54669320|FG009|Overall Study|Lost to Follow-up|5|||
28010463|NCT01511250|54669311|FG000|Overall Study|Protocol Violation|0|||
28010464|NCT01511250|54669312|FG001|Overall Study|Protocol Violation|2|||
28010465|NCT01511250|54669313|FG002|Overall Study|Protocol Violation|1|||
28010466|NCT01511250|54669314|FG003|Overall Study|Protocol Violation|0|||
28010467|NCT01511250|54669315|FG004|Overall Study|Protocol Violation|0|||
28010468|NCT01511250|54669316|FG005|Overall Study|Protocol Violation|0|||
28010469|NCT01511250|54669317|FG006|Overall Study|Protocol Violation|0|||
28010470|NCT01511250|54669318|FG007|Overall Study|Protocol Violation|0|||
28010471|NCT01511250|54669319|FG008|Overall Study|Protocol Violation|0|||
28010472|NCT01511250|54669320|FG009|Overall Study|Protocol Violation|0|||
28010473|NCT01424566|54669342|FG000|Single-blind Treatment|Adverse Event|71|||
28010474|NCT01424566|54669343|FG001|Single-blind Treatment|Adverse Event|0|||
28010475|NCT01424566|54669344|FG002|Single-blind Treatment|Adverse Event|0|||
28010476|NCT01424566|54669342|FG000|Single-blind Treatment|Withdrawal by Subject|16|||
28010477|NCT01424566|54669343|FG001|Single-blind Treatment|Withdrawal by Subject|0|||
28010478|NCT01424566|54669344|FG002|Single-blind Treatment|Withdrawal by Subject|0|||
28010479|NCT01424566|54669342|FG000|Single-blind Treatment|Withdrawal by Investigator|2|||
28010480|NCT01424566|54669343|FG001|Single-blind Treatment|Withdrawal by Investigator|0|||
28010481|NCT01424566|54669344|FG002|Single-blind Treatment|Withdrawal by Investigator|0|||
28010482|NCT01424566|54669342|FG000|Single-blind Treatment|Did Not Meet Inclusion Criteria|108|||
28010483|NCT01424566|54669343|FG001|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
28010484|NCT01424566|54669344|FG002|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
28010485|NCT01424566|54669342|FG000|Single-blind Treatment|Met Exclusion Criteria|1|||
28010486|NCT01424566|54669343|FG001|Single-blind Treatment|Met Exclusion Criteria|0|||
28010487|NCT01424566|54669344|FG002|Single-blind Treatment|Met Exclusion Criteria|0|||
28010488|NCT01424566|54669342|FG000|Single-blind Treatment|Did Not Administer Any Study Drug|2|||
28010489|NCT01424566|54669343|FG001|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
28010490|NCT01424566|54669344|FG002|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
28010491|NCT01424566|54669342|FG000|Double-blind Treatment|Adverse Event|0|||
28010492|NCT01424566|54669343|FG001|Double-blind Treatment|Adverse Event|21|||
28010493|NCT01424566|54669344|FG002|Double-blind Treatment|Adverse Event|13|||
28010494|NCT01424566|54669342|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
28010495|NCT01424566|54669343|FG001|Double-blind Treatment|Withdrawal by Subject|2|||
28010496|NCT01424566|54669344|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
28010497|NCT01424566|54669342|FG000|Double-blind Treatment|Withdrawal by Investigator|0|||
28010498|NCT01424566|54669343|FG001|Double-blind Treatment|Withdrawal by Investigator|1|||
28010499|NCT01424566|54669344|FG002|Double-blind Treatment|Withdrawal by Investigator|1|||
28010500|NCT01424566|54669342|FG000|Double-blind Treatment|Lack of Efficacy|0|||
28010501|NCT01424566|54669343|FG001|Double-blind Treatment|Lack of Efficacy|1|||
28010502|NCT01424566|54669344|FG002|Double-blind Treatment|Lack of Efficacy|1|||
28010503|NCT01361607|54669353|FG000|Overall Study|Adverse Event|38|||
28010504|NCT01361607|54669354|FG001|Overall Study|Adverse Event|29|||
28010505|NCT01361607|54669353|FG000|Overall Study|Withdrawal by Subject|19|||
28010506|NCT01361607|54669354|FG001|Overall Study|Withdrawal by Subject|8|||
28010507|NCT01361607|54669353|FG000|Overall Study|Withdrawal by Investigator|5|||
28010508|NCT01361607|54669354|FG001|Overall Study|Withdrawal by Investigator|3|||
28010509|NCT01361607|54669353|FG000|Overall Study|Lost to Follow-up|1|||
28010510|NCT01361607|54669354|FG001|Overall Study|Lost to Follow-up|0|||
28010511|NCT01361607|54669353|FG000|Overall Study|Met Withdrawal Criteria|1|||
28010512|NCT01361607|54669354|FG001|Overall Study|Met Withdrawal Criteria|1|||
28010513|NCT01337089|54669361|FG000|Overall Study|Adverse Event|237|||
28010514|NCT01337089|54669361|FG000|Overall Study|Withdrawal by Subject|129|||
28010515|NCT01337089|54669361|FG000|Overall Study|Withdrawal by Investigator|33|||
28010516|NCT01337089|54669361|FG000|Overall Study|Met Withdrawal Criteria|3|||
28010517|NCT01337089|54669361|FG000|Overall Study|Lost to Follow-up|2|||
28010518|NCT00114530|54669375|FG000|Overall Study|Death|3|||
28010519|NCT00114530|54669376|FG001|Overall Study|Death|11|||
28010520|NCT00114530|54669375|FG000|Overall Study|Lost to Follow-up|1|||
28010521|NCT00114530|54669376|FG001|Overall Study|Lost to Follow-up|1|||
28010522|NCT00114530|54669375|FG000|Overall Study|Physician Decision|1|||
28010523|NCT00114530|54669376|FG001|Overall Study|Physician Decision|1|||
28010524|NCT00114530|54669375|FG000|Overall Study|Withdrawal by Subject|2|||
27741376|NCT02712905|54191354|FG000|Combination Therapy|Study Terminated by Sponsor|0|||
28010525|NCT00114530|54669376|FG001|Overall Study|Withdrawal by Subject|6|||
28010526|NCT00114530|54669375|FG000|Overall Study|Breast Cancer|1|||
28010527|NCT00114530|54669376|FG001|Overall Study|Breast Cancer|0|||
28010528|NCT00114530|54669375|FG000|Overall Study|Subject decision after endpoint failure|0|||
28010529|NCT00114530|54669376|FG001|Overall Study|Subject decision after endpoint failure|1|||
28010530|NCT00114530|54669375|FG000|Overall Study|Ineligible|1|||
28010531|NCT00114530|54669376|FG001|Overall Study|Ineligible|0|||
28010532|NCT00618982|54669399|FG000|Overall Study|Adverse Event|23|||
28010533|NCT00618982|54669399|FG000|Overall Study|Withdrawal by Subject|1|||
28010534|NCT00618982|54669399|FG000|Overall Study|Protocol Violation|1|||
28010535|NCT00618982|54669399|FG000|Overall Study|ongoing, still treated with study med.|25|||
28010536|NCT00578786|54669409|FG000|Overall Study|Adverse Event|27|||
28010537|NCT00578786|54669410|FG001|Overall Study|Adverse Event|37|||
28010538|NCT00578786|54669411|FG002|Overall Study|Adverse Event|17|||
28010539|NCT00578786|54669409|FG000|Overall Study|Lack of Efficacy|2|||
28010540|NCT00578786|54669410|FG001|Overall Study|Lack of Efficacy|5|||
28010541|NCT00578786|54669411|FG002|Overall Study|Lack of Efficacy|2|||
28010542|NCT00578786|54669409|FG000|Overall Study|Early Escape from Prior Study|2|||
28010543|NCT00578786|54669410|FG001|Overall Study|Early Escape from Prior Study|1|||
28010544|NCT00578786|54669411|FG002|Overall Study|Early Escape from Prior Study|2|||
28010545|NCT00578786|54669409|FG000|Overall Study|Withdrawal by Subject|7|||
28010546|NCT00578786|54669410|FG001|Overall Study|Withdrawal by Subject|8|||
28010547|NCT00578786|54669411|FG002|Overall Study|Withdrawal by Subject|5|||
28010548|NCT00578786|54669409|FG000|Overall Study|Protocol Violation|0|||
28010549|NCT00578786|54669410|FG001|Overall Study|Protocol Violation|3|||
28010550|NCT00578786|54669411|FG002|Overall Study|Protocol Violation|1|||
28010551|NCT00578786|54669409|FG000|Overall Study|Physician Decision|1|||
28010552|NCT00578786|54669410|FG001|Overall Study|Physician Decision|0|||
28010553|NCT00578786|54669411|FG002|Overall Study|Physician Decision|1|||
28010554|NCT00578786|54669409|FG000|Overall Study|Sponsor Decision|0|||
28010555|NCT00578786|54669410|FG001|Overall Study|Sponsor Decision|0|||
28010556|NCT00578786|54669411|FG002|Overall Study|Sponsor Decision|1|||
28010557|NCT00578786|54669409|FG000|Overall Study|Lost to Follow-up|0|||
28010558|NCT00578786|54669410|FG001|Overall Study|Lost to Follow-up|4|||
28010559|NCT00578786|54669411|FG002|Overall Study|Lost to Follow-up|0|||
28010560|NCT00578786|54669409|FG000|Overall Study|Pregnancy|0|||
28010561|NCT00578786|54669410|FG001|Overall Study|Pregnancy|1|||
28010562|NCT00578786|54669411|FG002|Overall Study|Pregnancy|0|||
28010563|NCT00578786|54669409|FG000|Overall Study|Not Otherwise Specified|0|||
28010564|NCT00578786|54669410|FG001|Overall Study|Not Otherwise Specified|4|||
28010565|NCT00578786|54669411|FG002|Overall Study|Not Otherwise Specified|1|||
28010566|NCT00578786|54669409|FG000|Overall Study|Qualified but Not Enrolled in Extension|0|||
28010567|NCT00578786|54669410|FG001|Overall Study|Qualified but Not Enrolled in Extension|3|||
28010568|NCT00578786|54669411|FG002|Overall Study|Qualified but Not Enrolled in Extension|0|||
28010569|NCT00424255|54669431|FG000|Overall Study|Death|115|||
28010570|NCT00424255|54669432|FG001|Overall Study|Death|111|||
28010571|NCT00424255|54669431|FG000|Overall Study|Lost to Follow-up|26|||
28010572|NCT00424255|54669432|FG001|Overall Study|Lost to Follow-up|20|||
28010573|NCT00424255|54669431|FG000|Overall Study|Protocol Violation|0|||
28010574|NCT00424255|54669432|FG001|Overall Study|Protocol Violation|1|||
28010575|NCT00424255|54669431|FG000|Overall Study|Withdrawal by Subject|34|||
28010576|NCT00424255|54669432|FG001|Overall Study|Withdrawal by Subject|38|||
28010577|NCT00424255|54669431|FG000|Overall Study|Physician Decision|3|||
28010578|NCT00424255|54669432|FG001|Overall Study|Physician Decision|7|||
28010579|NCT00424255|54669431|FG000|Overall Study|Cognitive Disturbance|1|||
28010580|NCT00424255|54669432|FG001|Overall Study|Cognitive Disturbance|0|||
28010581|NCT00424255|54669431|FG000|Overall Study|Non-compliance by Participants|1|||
28010582|NCT00424255|54669432|FG001|Overall Study|Non-compliance by Participants|0|||
28010583|NCT00424255|54669431|FG000|Overall Study|Fatigue|1|||
28010584|NCT00424255|54669432|FG001|Overall Study|Fatigue|0|||
28010585|NCT00424255|54669431|FG000|Overall Study|Disease Progression|0|||
28010586|NCT00424255|54669432|FG001|Overall Study|Disease Progression|2|||
28010587|NCT00424255|54669431|FG000|Overall Study|Sponsor Terminated Study|161|||
28010588|NCT00424255|54669432|FG001|Overall Study|Sponsor Terminated Study|167|||
28010589|NCT00620074|54669438|FG000|Overall Study|Adverse Event|1|||
28010590|NCT00424177|54669442|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8|||
28010591|NCT00424177|54669442|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1|||
28010592|NCT00424177|54669442|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1|||
28010593|NCT00424177|54669442|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1|||
28010594|NCT00424177|54669442|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2|||
28010595|NCT00424177|54669442|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1|||
28010596|NCT00424177|54669442|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
28010597|NCT00424177|54669442|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1|||
28103668|NCT02849080|54760395|FG003|Main Phase: 0 - 52 Weeks|Death|0|||
28010598|NCT00424177|54669442|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
28010599|NCT00424177|54669442|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1|||
28010600|NCT00618826|54669454|FG000|Overall Study|Adverse Event|1|||
28010601|NCT00578448|54669459|FG000|Day 1 up to 3 Years of Planned Study|Death|1|||
28010602|NCT00578448|54669459|FG000|Day 1 up to 3 Years of Planned Study|Adverse Event|1|||
28010603|NCT00578448|54669459|FG000|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1|||
28010604|NCT00578448|54669459|FG000|1 Year Long Term Extension (LTE)|Adverse Event|1|||
28010605|NCT00578318|54669467|FG000|Overall Study|Lost to Follow-up|2|||
28010606|NCT00578318|54669468|FG001|Overall Study|Lost to Follow-up|0|||
28010607|NCT00578318|54669467|FG000|Overall Study|Physician Decision|1|||
28010608|NCT00578318|54669468|FG001|Overall Study|Physician Decision|0|||
28010609|NCT00618748|54669477|FG000|Overall Study|Adverse Event|4|||
28010610|NCT00618748|54669478|FG001|Overall Study|Adverse Event|3|||
28010611|NCT00618748|54669479|FG002|Overall Study|Adverse Event|8|||
28010612|NCT00618748|54669477|FG000|Overall Study|Physician Decision|3|||
28010613|NCT00618748|54669478|FG001|Overall Study|Physician Decision|1|||
28010614|NCT00618748|54669479|FG002|Overall Study|Physician Decision|1|||
28010615|NCT00618748|54669477|FG000|Overall Study|Withdrawal by Subject|4|||
28010616|NCT00618748|54669478|FG001|Overall Study|Withdrawal by Subject|1|||
28010617|NCT00618748|54669479|FG002|Overall Study|Withdrawal by Subject|5|||
28010618|NCT00658359|54669490|FG000|Overall Study|Death|3|||
28010619|NCT00658359|54669491|FG001|Overall Study|Death|1|||
28010620|NCT00658359|54669492|FG002|Overall Study|Death|2|||
28010621|NCT00658359|54669490|FG000|Overall Study|Adverse Event|13|||
28010622|NCT00658359|54669491|FG001|Overall Study|Adverse Event|6|||
28010623|NCT00658359|54669492|FG002|Overall Study|Adverse Event|9|||
28010624|NCT00658359|54669490|FG000|Overall Study|Protocol Violation|1|||
28010625|NCT00658359|54669491|FG001|Overall Study|Protocol Violation|0|||
28010626|NCT00658359|54669492|FG002|Overall Study|Protocol Violation|0|||
28010627|NCT00658359|54669490|FG000|Overall Study|Includes protocol Amendments 3 and 4|2|||
28010628|NCT00658359|54669491|FG001|Overall Study|Includes protocol Amendments 3 and 4|31|||
28010629|NCT00658359|54669492|FG002|Overall Study|Includes protocol Amendments 3 and 4|29|||
28010630|NCT00658359|54669490|FG000|Overall Study|Withdrawal by Subject|7|||
28010631|NCT00658359|54669491|FG001|Overall Study|Withdrawal by Subject|4|||
28010632|NCT00658359|54669492|FG002|Overall Study|Withdrawal by Subject|2|||
28010633|NCT00658359|54669490|FG000|Overall Study|Lost to Follow-up|2|||
28010634|NCT00658359|54669491|FG001|Overall Study|Lost to Follow-up|2|||
28010635|NCT00658359|54669492|FG002|Overall Study|Lost to Follow-up|4|||
28010636|NCT00658359|54669490|FG000|Overall Study|Lack of Efficacy|0|||
28010637|NCT00658359|54669491|FG001|Overall Study|Lack of Efficacy|1|||
28010638|NCT00658359|54669492|FG002|Overall Study|Lack of Efficacy|0|||
28010639|NCT00619918|54669504|FG000|Overall Study|Withdrawal by Subject|4|||
28010640|NCT00619918|54669505|FG001|Overall Study|Withdrawal by Subject|3|||
28010641|NCT00619918|54669504|FG000|Overall Study|Physician Decision|8|||
28010642|NCT00619918|54669505|FG001|Overall Study|Physician Decision|8|||
28010643|NCT00619918|54669504|FG000|Overall Study|Transfer to outside facility|3|||
28010644|NCT00619918|54669505|FG001|Overall Study|Transfer to outside facility|3|||
28010645|NCT00619918|54669504|FG000|Overall Study|Left before receiving first dose|5|||
28010646|NCT00619918|54669505|FG001|Overall Study|Left before receiving first dose|8|||
28010647|NCT01005914|54669511|FG000|Overall Study|Adverse Event|4|||
28010648|NCT01005914|54669511|FG000|Overall Study|Death|4|||
28010649|NCT01005914|54669511|FG000|Overall Study|Lack of Efficacy|1|||
28010650|NCT01005914|54669511|FG000|Overall Study|Withdrawal by Subject|1|||
28010651|NCT00618514|54669522|FG000|Overall Study|Lost to Follow-up|11|||
28010652|NCT00618514|54669523|FG001|Overall Study|Lost to Follow-up|12|||
28010653|NCT00618514|54669524|FG002|Overall Study|Lost to Follow-up|4|||
28010654|NCT00655629|54669532|FG000|Overall Study|Adverse Event|4|||
28010655|NCT00655629|54669533|FG001|Overall Study|Adverse Event|1|||
28010656|NCT00655629|54669532|FG000|Overall Study|Lack of Efficacy|2|||
28010657|NCT00655629|54669533|FG001|Overall Study|Lack of Efficacy|12|||
28010658|NCT00655629|54669532|FG000|Overall Study|Lost to Follow-up|4|||
28010659|NCT00655629|54669533|FG001|Overall Study|Lost to Follow-up|3|||
28010660|NCT00655629|54669532|FG000|Overall Study|Protocol Violation|5|||
28010661|NCT00655629|54669533|FG001|Overall Study|Protocol Violation|3|||
28010662|NCT00655629|54669532|FG000|Overall Study|consent withdrawn|6|||
28010663|NCT00655629|54669533|FG001|Overall Study|consent withdrawn|4|||
28010664|NCT00578292|54669539|FG000|Overall Study|Death|1|||
28010665|NCT00578292|54669539|FG000|Overall Study|Graft failure|2|||
28010666|NCT00570063|54669545|FG000|Overall Study|Adverse Event|4|||
28010667|NCT00570063|54669546|FG001|Overall Study|Adverse Event|1|||
28010668|NCT00570063|54669545|FG000|Overall Study|Lack of Efficacy|0|||
28010669|NCT00570063|54669546|FG001|Overall Study|Lack of Efficacy|1|||
28010670|NCT00570063|54669545|FG000|Overall Study|Withdrawal by Subject|4|||
28010671|NCT00570063|54669546|FG001|Overall Study|Withdrawal by Subject|3|||
28010672|NCT00570063|54669545|FG000|Overall Study|Sponsor's Decision|7|||
28010673|NCT00570063|54669546|FG001|Overall Study|Sponsor's Decision|3|||
28010674|NCT00577772|54669563|FG000|Overall Study|Lost to Follow-up|0|||
28010675|NCT00577772|54669564|FG001|Overall Study|Lost to Follow-up|1|||
28010676|NCT00578136|54669572|FG000|Overall Study|Not given intervention|1|||
28010677|NCT00578136|54669573|FG001|Overall Study|Not given intervention|1|||
28010678|NCT00655551|54669582|FG000|All Periods Combined|Adverse Event|0|||
28010679|NCT00655551|54669583|FG001|All Periods Combined|Adverse Event|3|||
28010680|NCT00655551|54669584|FG002|All Periods Combined|Adverse Event|4|||
28010681|NCT00655551|54669582|FG000|Period 2 (up to 7 Days)|Adverse Event|0|||
28010682|NCT00655551|54669583|FG001|Period 2 (up to 7 Days)|Adverse Event|1|||
28010683|NCT00655551|54669584|FG002|Period 2 (up to 7 Days)|Adverse Event|0|||
28010684|NCT00655551|54669582|FG000|Period 3 (up to 7 Days)|Adverse Event|0|||
28010685|NCT00655551|54669583|FG001|Period 3 (up to 7 Days)|Adverse Event|0|||
28010686|NCT00655551|54669584|FG002|Period 3 (up to 7 Days)|Adverse Event|4|||
28010687|NCT00655551|54669582|FG000|Period 4 (up to 7 Days)|Adverse Event|0|||
28010688|NCT00655551|54669583|FG001|Period 4 (up to 7 Days)|Adverse Event|2|||
28010689|NCT00655551|54669584|FG002|Period 4 (up to 7 Days)|Adverse Event|0|||
28010690|NCT00312728|54669592|FG000|Overall Study|Progressive disease|53|||
28010691|NCT00312728|54669592|FG000|Overall Study|Adverse Event|32|||
28010692|NCT00312728|54669592|FG000|Overall Study|Withdrawal by Subject|10|||
28010693|NCT00312728|54669592|FG000|Overall Study|Required non-protocol cancer treatment|2|||
28010694|NCT00312728|54669592|FG000|Overall Study|Protocol Violation|2|||
28010695|NCT00312728|54669592|FG000|Overall Study|Other|10|||
28010696|NCT00312728|54669592|FG000|Overall Study|Other|1|||
28010697|NCT00577824|54669599|FG000|Overall Study|Adverse Event|6|||
28010698|NCT00577824|54669600|FG001|Overall Study|Adverse Event|18|||
28010699|NCT00577824|54669601|FG002|Overall Study|Adverse Event|1|||
28010700|NCT00577824|54669599|FG000|Overall Study|Patient decision|0|||
28010701|NCT00577824|54669600|FG001|Overall Study|Patient decision|1|||
28010702|NCT00577824|54669601|FG002|Overall Study|Patient decision|1|||
28010703|NCT00577824|54669599|FG000|Overall Study|Protocol Violation|1|||
28010704|NCT00577824|54669600|FG001|Overall Study|Protocol Violation|1|||
28010705|NCT00577824|54669601|FG002|Overall Study|Protocol Violation|0|||
28010706|NCT00617344|54669612|FG000|Overall Study|Serious adverse event|1|||
28010707|NCT00617344|54669613|FG001|Overall Study|Serious adverse event|0|||
28010708|NCT00617344|54669614|FG002|Overall Study|Serious adverse event|0|||
28010709|NCT00617344|54669612|FG000|Overall Study|Other Adverse Event|1|||
28010710|NCT00617344|54669613|FG001|Overall Study|Other Adverse Event|1|||
28010711|NCT00617344|54669614|FG002|Overall Study|Other Adverse Event|0|||
28010712|NCT00617344|54669612|FG000|Overall Study|Protocol Violation|10|||
28010713|NCT00617344|54669613|FG001|Overall Study|Protocol Violation|8|||
28010714|NCT00617344|54669614|FG002|Overall Study|Protocol Violation|5|||
28010715|NCT00617344|54669612|FG000|Overall Study|Lost to Follow-up|5|||
28010716|NCT00617344|54669613|FG001|Overall Study|Lost to Follow-up|4|||
28010717|NCT00617344|54669614|FG002|Overall Study|Lost to Follow-up|1|||
28010718|NCT00617344|54669612|FG000|Overall Study|Withdrawal by Subject|8|||
28010719|NCT00617344|54669613|FG001|Overall Study|Withdrawal by Subject|9|||
28010720|NCT00617344|54669614|FG002|Overall Study|Withdrawal by Subject|2|||
28010721|NCT00654381|54669682|FG000|1st Stage|Adverse Event|3|||
28010722|NCT00654381|54669683|FG001|1st Stage|Adverse Event|3|||
28010723|NCT00654381|54669684|FG002|1st Stage|Adverse Event|3|||
28010724|NCT00654381|54669685|FG003|1st Stage|Adverse Event|3|||
28010725|NCT00654381|54669686|FG004|1st Stage|Adverse Event|2|||
28010726|NCT00654381|54669687|FG005|1st Stage|Adverse Event|1|||
28010727|NCT00654381|54669682|FG000|1st Stage|Withdrawal by Subject|0|||
28010728|NCT00654381|54669683|FG001|1st Stage|Withdrawal by Subject|0|||
28010729|NCT00654381|54669684|FG002|1st Stage|Withdrawal by Subject|0|||
28010730|NCT00654381|54669685|FG003|1st Stage|Withdrawal by Subject|1|||
28010731|NCT00654381|54669686|FG004|1st Stage|Withdrawal by Subject|0|||
28010732|NCT00654381|54669687|FG005|1st Stage|Withdrawal by Subject|1|||
28010733|NCT00654381|54669682|FG000|1st Stage|Investigator's decision|0|||
28010734|NCT00654381|54669683|FG001|1st Stage|Investigator's decision|0|||
28010735|NCT00654381|54669684|FG002|1st Stage|Investigator's decision|0|||
28010736|NCT00654381|54669685|FG003|1st Stage|Investigator's decision|1|||
28010737|NCT00654381|54669686|FG004|1st Stage|Investigator's decision|0|||
28010738|NCT00654381|54669687|FG005|1st Stage|Investigator's decision|0|||
28010739|NCT00654381|54669682|FG000|2nd Stage|Adverse Event|2|||
28010740|NCT00654381|54669683|FG001|2nd Stage|Adverse Event|0|||
28010741|NCT00654381|54669684|FG002|2nd Stage|Adverse Event|2|||
28010742|NCT00654381|54669685|FG003|2nd Stage|Adverse Event|3|||
28010743|NCT00654381|54669686|FG004|2nd Stage|Adverse Event|7|||
28010744|NCT00654381|54669687|FG005|2nd Stage|Adverse Event|2|||
28010745|NCT00654381|54669682|FG000|2nd Stage|Withdrawal by Subject|0|||
28010746|NCT00654381|54669683|FG001|2nd Stage|Withdrawal by Subject|0|||
28010747|NCT00654381|54669684|FG002|2nd Stage|Withdrawal by Subject|0|||
28010748|NCT00654381|54669685|FG003|2nd Stage|Withdrawal by Subject|0|||
28010749|NCT00654381|54669686|FG004|2nd Stage|Withdrawal by Subject|1|||
28010750|NCT00654381|54669687|FG005|2nd Stage|Withdrawal by Subject|1|||
28010751|NCT00654381|54669682|FG000|2nd Stage|Investigator's decision|0|||
28010752|NCT00654381|54669683|FG001|2nd Stage|Investigator's decision|0|||
28010753|NCT00654381|54669684|FG002|2nd Stage|Investigator's decision|1|||
28010754|NCT00654381|54669685|FG003|2nd Stage|Investigator's decision|1|||
28010755|NCT00654381|54669686|FG004|2nd Stage|Investigator's decision|0|||
28010756|NCT00654381|54669687|FG005|2nd Stage|Investigator's decision|0|||
28010757|NCT00654381|54669682|FG000|Extension Stage|Adverse Event|1|||
28010758|NCT00654381|54669683|FG001|Extension Stage|Adverse Event|2|||
28010759|NCT00654381|54669684|FG002|Extension Stage|Adverse Event|9|||
28010760|NCT00654381|54669685|FG003|Extension Stage|Adverse Event|7|||
28010761|NCT00654381|54669686|FG004|Extension Stage|Adverse Event|1|||
28010762|NCT00654381|54669687|FG005|Extension Stage|Adverse Event|1|||
28010763|NCT00654381|54669682|FG000|Extension Stage|Protocol Violation|0|||
28010764|NCT00654381|54669683|FG001|Extension Stage|Protocol Violation|0|||
28010765|NCT00654381|54669684|FG002|Extension Stage|Protocol Violation|0|||
28010766|NCT00654381|54669685|FG003|Extension Stage|Protocol Violation|1|||
28010767|NCT00654381|54669686|FG004|Extension Stage|Protocol Violation|0|||
28010768|NCT00654381|54669687|FG005|Extension Stage|Protocol Violation|0|||
28010769|NCT00654381|54669682|FG000|Extension Stage|Lack of Efficacy|0|||
28010770|NCT00654381|54669683|FG001|Extension Stage|Lack of Efficacy|0|||
28010771|NCT00654381|54669684|FG002|Extension Stage|Lack of Efficacy|1|||
28010772|NCT00654381|54669685|FG003|Extension Stage|Lack of Efficacy|0|||
28010773|NCT00654381|54669686|FG004|Extension Stage|Lack of Efficacy|0|||
28010774|NCT00654381|54669687|FG005|Extension Stage|Lack of Efficacy|0|||
28010775|NCT00654381|54669682|FG000|Extension Stage|Withdrawal by Subject|0|||
28010776|NCT00654381|54669683|FG001|Extension Stage|Withdrawal by Subject|0|||
28010777|NCT00654381|54669684|FG002|Extension Stage|Withdrawal by Subject|1|||
28010778|NCT00654381|54669685|FG003|Extension Stage|Withdrawal by Subject|1|||
28010779|NCT00654381|54669686|FG004|Extension Stage|Withdrawal by Subject|1|||
28010780|NCT00654381|54669687|FG005|Extension Stage|Withdrawal by Subject|1|||
28010781|NCT00654381|54669682|FG000|Extension Stage|Closure of the trial site|0|||
28010782|NCT00654381|54669683|FG001|Extension Stage|Closure of the trial site|0|||
28010783|NCT00654381|54669684|FG002|Extension Stage|Closure of the trial site|0|||
28010784|NCT00654381|54669685|FG003|Extension Stage|Closure of the trial site|0|||
28010785|NCT00654381|54669686|FG004|Extension Stage|Closure of the trial site|1|||
28010786|NCT00654381|54669687|FG005|Extension Stage|Closure of the trial site|1|||
28010787|NCT00657267|54669704|FG000|Overall Study|Progressive disease|45|||
28010788|NCT00657267|54669704|FG000|Overall Study|Adverse Event|9|||
28010789|NCT00653991|54669712|FG000|3 Month Follow-up|Participant would not respond|150|||
28010790|NCT00653991|54669713|FG001|3 Month Follow-up|Participant would not respond|157|||
28010791|NCT00653991|54669712|FG000|6 Month Follow-up|Participant would not respond|133|||
28010792|NCT00653991|54669713|FG001|6 Month Follow-up|Participant would not respond|141|||
28010793|NCT00652899|54669721|FG000|Overall Study|Death|1|||
28010794|NCT00652899|54669721|FG000|Overall Study|Treating physician decision|1|||
28010795|NCT00617890|54669733|FG000|Overall Study|Treatment ongoing at data cut-off|0|||
28010796|NCT00617890|54669734|FG001|Overall Study|Treatment ongoing at data cut-off|0|||
28010797|NCT00617890|54669735|FG002|Overall Study|Treatment ongoing at data cut-off|0|||
28010798|NCT00617890|54669736|FG003|Overall Study|Treatment ongoing at data cut-off|5|||
28010799|NCT00617890|54669733|FG000|Overall Study|Lack of Efficacy|23|||
28010800|NCT00617890|54669734|FG001|Overall Study|Lack of Efficacy|26|||
28010801|NCT00617890|54669735|FG002|Overall Study|Lack of Efficacy|30|||
28010802|NCT00617890|54669736|FG003|Overall Study|Lack of Efficacy|97|||
28010803|NCT00617890|54669733|FG000|Overall Study|Lost to Follow-up|0|||
28010804|NCT00617890|54669734|FG001|Overall Study|Lost to Follow-up|0|||
28010805|NCT00617890|54669735|FG002|Overall Study|Lost to Follow-up|1|||
28010806|NCT00617890|54669736|FG003|Overall Study|Lost to Follow-up|2|||
28010807|NCT00617890|54669733|FG000|Overall Study|Withdrawal by Subject|4|||
28010808|NCT00617890|54669734|FG001|Overall Study|Withdrawal by Subject|1|||
28010809|NCT00617890|54669735|FG002|Overall Study|Withdrawal by Subject|0|||
28010810|NCT00617890|54669736|FG003|Overall Study|Withdrawal by Subject|2|||
28010811|NCT00617890|54669733|FG000|Overall Study|Protocol Violation|2|||
28010812|NCT00617890|54669734|FG001|Overall Study|Protocol Violation|1|||
27919791|NCT01103284|54577053|FG000|Overall Study|Pregnancy|3|||
28010813|NCT00617890|54669735|FG002|Overall Study|Protocol Violation|0|||
28010814|NCT00617890|54669736|FG003|Overall Study|Protocol Violation|0|||
28010815|NCT00617890|54669733|FG000|Overall Study|Adverse Event|1|||
28010816|NCT00617890|54669734|FG001|Overall Study|Adverse Event|0|||
28010817|NCT00617890|54669735|FG002|Overall Study|Adverse Event|3|||
28010818|NCT00617890|54669736|FG003|Overall Study|Adverse Event|8|||
28010819|NCT00617890|54669733|FG000|Overall Study|Not treated|1|||
28010820|NCT00617890|54669734|FG001|Overall Study|Not treated|0|||
28010821|NCT00617890|54669735|FG002|Overall Study|Not treated|1|||
28010822|NCT00617890|54669736|FG003|Overall Study|Not treated|1|||
28010823|NCT00712166|54669751|FG000|Overall Study|Noncompliance|0|||
28010824|NCT00712166|54669752|FG001|Overall Study|Noncompliance|1|||
28010825|NCT00652743|54669763|FG000|Months 12-18|Lost to Follow-up|1|||
28010826|NCT00652743|54669764|FG001|Months 12-18|Lost to Follow-up|2|||
28010827|NCT00652743|54669765|FG002|Months 12-18|Lost to Follow-up|7|||
28010828|NCT00652743|54669763|FG000|Months 24-30|Other|5|||
28010829|NCT00652743|54669764|FG001|Months 24-30|Other|1|||
28010830|NCT00652743|54669765|FG002|Months 24-30|Other|11|||
28010831|NCT00652743|54669763|FG000|Months 36-42|Serious Adverse Events|0|||
28010832|NCT00652743|54669764|FG001|Months 36-42|Serious Adverse Events|1|||
28010833|NCT00652743|54669765|FG002|Months 36-42|Serious Adverse Events|1|||
28010834|NCT00652743|54669763|FG000|Months 36-42|Withdrawal by Subject|1|||
28010835|NCT00652743|54669764|FG001|Months 36-42|Withdrawal by Subject|1|||
28010836|NCT00652743|54669765|FG002|Months 36-42|Withdrawal by Subject|0|||
28010837|NCT00652743|54669763|FG000|Months 36-42|Lost to Follow-up|0|||
28010838|NCT00652743|54669764|FG001|Months 36-42|Lost to Follow-up|1|||
28010839|NCT00652743|54669765|FG002|Months 36-42|Lost to Follow-up|0|||
28010840|NCT00652743|54669763|FG000|Months 36-42|Migrated/moved from study area|1|||
28010841|NCT00652743|54669764|FG001|Months 36-42|Migrated/moved from study area|0|||
28010842|NCT00652743|54669765|FG002|Months 36-42|Migrated/moved from study area|0|||
28010843|NCT00652743|54669763|FG000|Months 36-42|Other|4|||
28010844|NCT00652743|54669764|FG001|Months 36-42|Other|2|||
28010845|NCT00652743|54669765|FG002|Months 36-42|Other|8|||
28010846|NCT00712010|54669776|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
28010847|NCT00653523|54669792|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
28010848|NCT00653523|54669792|FG000|Overall Study|Elevated creatine phosphokinase (2)|1|||
28010849|NCT00653523|54669792|FG000|Overall Study|Adverse Event|7|||
28010850|NCT00653523|54669792|FG000|Overall Study|Withdrawal by Subject|6|||
28010851|NCT00653523|54669792|FG000|Overall Study|Elevated alanine aminotransferase (3)|2|||
28010852|NCT00653523|54669792|FG000|Overall Study|Adverse reaction did not improve (4)|1|||
28010853|NCT02717442|54669798|FG000|Overall Study|Study Terminated by Sponsor|31|||
28010854|NCT02717442|54669799|FG001|Overall Study|Study Terminated by Sponsor|29|||
28010855|NCT02717442|54669798|FG000|Overall Study|Subject Randomized, but Did not Receive Drug|2|||
28010856|NCT02717442|54669799|FG001|Overall Study|Subject Randomized, but Did not Receive Drug|0|||
28010857|NCT02717442|54669798|FG000|Overall Study|Other - Not Specified|2|||
28010858|NCT02717442|54669799|FG001|Overall Study|Other - Not Specified|0|||
28010859|NCT00616018|54669812|FG000|Overall Study|Protocol Violation|3|||
28010860|NCT00424021|54669821|FG000|NCT00046319 Study Period|Adverse Event|1|||
28010861|NCT00424021|54669822|FG001|NCT00046319 Study Period|Adverse Event|0|||
28010862|NCT00424021|54669823|FG002|NCT00046319 Study Period|Adverse Event|1|||
28010863|NCT00424021|54669824|FG003|NCT00046319 Study Period|Adverse Event|1|||
28010864|NCT00424021|54669821|FG000|NCT00046319 Study Period|Withdrawal by Subject|0|||
28010865|NCT00424021|54669822|FG001|NCT00046319 Study Period|Withdrawal by Subject|1|||
28010866|NCT00424021|54669823|FG002|NCT00046319 Study Period|Withdrawal by Subject|0|||
28010867|NCT00424021|54669824|FG003|NCT00046319 Study Period|Withdrawal by Subject|0|||
28010868|NCT00424021|54669821|FG000|NCT00046319 Study Period|Sponsor discretion|0|||
28010869|NCT00424021|54669822|FG001|NCT00046319 Study Period|Sponsor discretion|1|||
28010870|NCT00424021|54669823|FG002|NCT00046319 Study Period|Sponsor discretion|0|||
28010871|NCT00424021|54669824|FG003|NCT00046319 Study Period|Sponsor discretion|0|||
28010872|NCT00424021|54669821|FG000|NCT00046319 Study Period|Lost to Follow-up|0|||
28010873|NCT00424021|54669822|FG001|NCT00046319 Study Period|Lost to Follow-up|1|||
28010874|NCT00424021|54669823|FG002|NCT00046319 Study Period|Lost to Follow-up|0|||
28010875|NCT00424021|54669824|FG003|NCT00046319 Study Period|Lost to Follow-up|0|||
28010876|NCT00424021|54669821|FG000|AMB-220-E Study Period|Adverse Event|1|||
28010877|NCT00424021|54669822|FG001|AMB-220-E Study Period|Adverse Event|1|||
28010878|NCT00424021|54669823|FG002|AMB-220-E Study Period|Adverse Event|3|||
28010879|NCT00424021|54669824|FG003|AMB-220-E Study Period|Adverse Event|7|||
28010880|NCT00424021|54669821|FG000|AMB-220-E Study Period|Death|0|||
28010881|NCT00424021|54669822|FG001|AMB-220-E Study Period|Death|0|||
28010882|NCT00424021|54669823|FG002|AMB-220-E Study Period|Death|1|||
28010883|NCT00424021|54669824|FG003|AMB-220-E Study Period|Death|1|||
28010884|NCT00424021|54669821|FG000|AMB-220-E Study Period|Lost to Follow-up|0|||
28010885|NCT00424021|54669822|FG001|AMB-220-E Study Period|Lost to Follow-up|1|||
28010886|NCT00424021|54669823|FG002|AMB-220-E Study Period|Lost to Follow-up|1|||
28010887|NCT00424021|54669824|FG003|AMB-220-E Study Period|Lost to Follow-up|1|||
28010888|NCT00424021|54669821|FG000|AMB-220-E Study Period|Physician Decision|0|||
28010889|NCT00424021|54669822|FG001|AMB-220-E Study Period|Physician Decision|0|||
28010890|NCT00424021|54669823|FG002|AMB-220-E Study Period|Physician Decision|0|||
28010891|NCT00424021|54669824|FG003|AMB-220-E Study Period|Physician Decision|1|||
28010892|NCT00617734|54669843|FG000|Overall Study|Withdrew Consent|2|||
28010893|NCT00617734|54669844|FG001|Overall Study|Withdrew Consent|0|||
28010894|NCT00617734|54669843|FG000|Overall Study|Adverse Event|4|||
28010895|NCT00617734|54669844|FG001|Overall Study|Adverse Event|1|||
28010896|NCT00617734|54669843|FG000|Overall Study|Protocol Violation|1|||
28010897|NCT00617734|54669844|FG001|Overall Study|Protocol Violation|0|||
28010898|NCT00617734|54669843|FG000|Overall Study|Found Ineligible After Randomization|1|||
28010899|NCT00617734|54669844|FG001|Overall Study|Found Ineligible After Randomization|4|||
28010900|NCT00617734|54669843|FG000|Overall Study|Lost to Follow-up|0|||
28010901|NCT00617734|54669844|FG001|Overall Study|Lost to Follow-up|1|||
28010902|NCT00577460|54669853|FG000|Overall Study|Adverse Event|11|||
28010903|NCT00577460|54669854|FG001|Overall Study|Adverse Event|7|||
28010904|NCT00577460|54669855|FG002|Overall Study|Adverse Event|14|||
28010905|NCT00577460|54669853|FG000|Overall Study|Protocol Violation|0|||
28010906|NCT00577460|54669854|FG001|Overall Study|Protocol Violation|1|||
28010907|NCT00577460|54669855|FG002|Overall Study|Protocol Violation|1|||
28010908|NCT00577460|54669853|FG000|Overall Study|Lost to Follow-up|0|||
28010909|NCT00577460|54669854|FG001|Overall Study|Lost to Follow-up|3|||
28010910|NCT00577460|54669855|FG002|Overall Study|Lost to Follow-up|4|||
28010911|NCT00577460|54669853|FG000|Overall Study|Withdrawal by Subject|5|||
28010912|NCT00577460|54669854|FG001|Overall Study|Withdrawal by Subject|5|||
28010913|NCT00577460|54669855|FG002|Overall Study|Withdrawal by Subject|6|||
28010914|NCT00577460|54669853|FG000|Overall Study|Other|0|||
28010915|NCT00577460|54669854|FG001|Overall Study|Other|3|||
28010916|NCT00577460|54669855|FG002|Overall Study|Other|2|||
28010917|NCT00415519|54669872|FG000|Overall Study|Adverse Event|1|||
28010918|NCT00415519|54669873|FG001|Overall Study|Adverse Event|0|||
28010919|NCT00415519|54669872|FG000|Overall Study|Withdrawal by Subject|2|||
28010920|NCT00415519|54669873|FG001|Overall Study|Withdrawal by Subject|0|||
28010921|NCT00415519|54669872|FG000|Overall Study|Patient's convenience|1|||
28010922|NCT00415519|54669873|FG001|Overall Study|Patient's convenience|0|||
28010923|NCT00423943|54669881|FG000|Overall Study|Withdrawal by Subject|3|||
28010924|NCT00423943|54669882|FG001|Overall Study|Withdrawal by Subject|1|||
28010925|NCT00428389|54669890|FG000|Core Phase|Adverse Event|6|||
28010926|NCT00428389|54669891|FG001|Core Phase|Adverse Event|4|||
28010927|NCT00428389|54669890|FG000|Core Phase|Lack of Efficacy|2|||
28010928|NCT00428389|54669891|FG001|Core Phase|Lack of Efficacy|0|||
28010929|NCT00428389|54669890|FG000|Core Phase|Abnormal test procedure result(s)|0|||
28010930|NCT00428389|54669891|FG001|Core Phase|Abnormal test procedure result(s)|1|||
28010931|NCT00428389|54669890|FG000|Core Phase|Withdrawal by Subject|3|||
28010932|NCT00428389|54669891|FG001|Core Phase|Withdrawal by Subject|4|||
28010933|NCT00428389|54669890|FG000|Core Phase|Protocol deviation|0|||
28010934|NCT00428389|54669891|FG001|Core Phase|Protocol deviation|2|||
28010935|NCT00428389|54669890|FG000|Extension Phase|Adverse Event|17|||
28010936|NCT00428389|54669891|FG001|Extension Phase|Adverse Event|11|||
28010937|NCT00428389|54669890|FG000|Extension Phase|Lack of Efficacy|4|||
28010938|NCT00428389|54669891|FG001|Extension Phase|Lack of Efficacy|3|||
28010939|NCT00428389|54669890|FG000|Extension Phase|Withdrawal by Subject|6|||
28010940|NCT00428389|54669891|FG001|Extension Phase|Withdrawal by Subject|6|||
28010941|NCT00428389|54669890|FG000|Extension Phase|Lost to Follow-up|0|||
28010942|NCT00428389|54669891|FG001|Extension Phase|Lost to Follow-up|3|||
28010943|NCT00428389|54669890|FG000|Extension Phase|Death|1|||
28010944|NCT00428389|54669891|FG001|Extension Phase|Death|0|||
28010945|NCT00428389|54669890|FG000|Extension Phase|Protocol Violation|3|||
28010946|NCT00428389|54669891|FG001|Extension Phase|Protocol Violation|2|||
28010947|NCT00428389|54669890|FG000|Extension Phase|Administrative problems|1|||
28010948|NCT00428389|54669891|FG001|Extension Phase|Administrative problems|1|||
28010949|NCT00616642|54669899|FG000|Overall Study|Withdrawal by Subject|0|||
28010950|NCT00616642|54669900|FG001|Overall Study|Withdrawal by Subject|1|||
28010951|NCT00406315|54669906|FG000|Overall Study|Death|1|||
28010952|NCT00406315|54669906|FG000|Overall Study|Adverse Event|39|||
28010953|NCT00406315|54669906|FG000|Overall Study|Laboratory Abnormality|4|||
28010954|NCT00406315|54669906|FG000|Overall Study|Lack of Efficacy|13|||
28010955|NCT00406315|54669906|FG000|Overall Study|Other|33|||
28010956|NCT00406315|54669906|FG000|Overall Study|Lost to Follow-up|21|||
28010957|NCT00406315|54669906|FG000|Overall Study|Withdrawal by Subject|30|||
28010958|NCT00711594|54669914|FG000|Overall Study|Progressive disease|2|||
28010959|NCT00711594|54669915|FG001|Overall Study|Progressive disease|2|||
28010960|NCT00711594|54669916|FG002|Overall Study|Progressive disease|6|||
28010961|NCT00711594|54669917|FG003|Overall Study|Progressive disease|44|||
28010962|NCT00711594|54669914|FG000|Overall Study|Other Adverse Event|1|||
28010963|NCT00711594|54669915|FG001|Overall Study|Other Adverse Event|0|||
28010964|NCT00711594|54669916|FG002|Overall Study|Other Adverse Event|0|||
28010965|NCT00711594|54669917|FG003|Overall Study|Other Adverse Event|16|||
28010966|NCT00711594|54669914|FG000|Overall Study|Withdrawal by Subject|0|||
28010967|NCT00711594|54669915|FG001|Overall Study|Withdrawal by Subject|1|||
28010968|NCT00711594|54669916|FG002|Overall Study|Withdrawal by Subject|0|||
28010969|NCT00711594|54669917|FG003|Overall Study|Withdrawal by Subject|2|||
28010970|NCT00710762|54669931|FG000|Overall Study|Progressive disease|27|||
28010971|NCT00710762|54669932|FG001|Overall Study|Progressive disease|30|||
27919792|NCT01103284|54577054|FG001|Overall Study|Pregnancy|1|||
28010972|NCT00710762|54669931|FG000|Overall Study|Adverse Event other disease worsening|2|||
28010973|NCT00710762|54669932|FG001|Overall Study|Adverse Event other disease worsening|1|||
28010974|NCT00710762|54669931|FG000|Overall Study|Other Adverse Event|7|||
28010975|NCT00710762|54669932|FG001|Overall Study|Other Adverse Event|7|||
28010976|NCT00710762|54669931|FG000|Overall Study|Lost to Follow-up|1|||
28010977|NCT00710762|54669932|FG001|Overall Study|Lost to Follow-up|0|||
28010978|NCT00710762|54669931|FG000|Overall Study|Reason other than listed above|2|||
28010979|NCT00710762|54669932|FG001|Overall Study|Reason other than listed above|2|||
28010980|NCT00573430|54669941|FG000|Overall Study|Incorrect enrollment of randomization|0|||
28010981|NCT00573430|54669942|FG001|Overall Study|Incorrect enrollment of randomization|4|||
28010982|NCT00573430|54669943|FG002|Overall Study|Incorrect enrollment of randomization|3|||
28010983|NCT00573430|54669941|FG000|Overall Study|Adverse Event|0|||
28010984|NCT00573430|54669942|FG001|Overall Study|Adverse Event|0|||
28010985|NCT00573430|54669943|FG002|Overall Study|Adverse Event|2|||
28010986|NCT00573430|54669941|FG000|Overall Study|Withdrawal by Subject|1|||
28010987|NCT00573430|54669942|FG001|Overall Study|Withdrawal by Subject|0|||
28010988|NCT00573430|54669943|FG002|Overall Study|Withdrawal by Subject|1|||
28010989|NCT00573430|54669941|FG000|Overall Study|Protocol Violation|0|||
28010990|NCT00573430|54669942|FG001|Overall Study|Protocol Violation|1|||
28010991|NCT00573430|54669943|FG002|Overall Study|Protocol Violation|1|||
28010992|NCT00573430|54669941|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
28010993|NCT00573430|54669942|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
28010994|NCT00573430|54669943|FG002|Overall Study|Eligibility criteria not fulfilled|3|||
28010995|NCT00711516|54669953|FG000|Overall Study|Adverse Event|1|||
28010996|NCT00711516|54669954|FG001|Overall Study|Adverse Event|1|||
28010997|NCT00711516|54669953|FG000|Overall Study|Withdrawal by Subject|0|||
28010998|NCT00711516|54669954|FG001|Overall Study|Withdrawal by Subject|1|||
28010999|NCT00711516|54669953|FG000|Overall Study|Protocol Violation|0|||
28011000|NCT00711516|54669954|FG001|Overall Study|Protocol Violation|1|||
28011001|NCT00615550|54669962|FG000|Overall Study|Lost to Follow-up|6|||
28011002|NCT00615550|54669963|FG001|Overall Study|Lost to Follow-up|1|||
28011003|NCT00186888|54669972|FG000|Overall Study|Toxicity|0|||
28011004|NCT00186888|54669973|FG001|Overall Study|Toxicity|1|||
28011005|NCT00186888|54669974|FG002|Overall Study|Toxicity|0|||
28011006|NCT00186888|54669972|FG000|Overall Study|Relapse or progression of disease|4|||
28011007|NCT00186888|54669973|FG001|Overall Study|Relapse or progression of disease|2|||
28011008|NCT00186888|54669974|FG002|Overall Study|Relapse or progression of disease|0|||
28011009|NCT00577382|54670011|FG000|Overall Study|Adverse Event|0|||
28011010|NCT00577382|54670012|FG001|Overall Study|Adverse Event|6|||
28011011|NCT00577382|54670011|FG000|Overall Study|Withdrawal by Subject|0|||
27919793|NCT01103284|54577053|FG000|Overall Study|Protocol Violation|12|||
28011012|NCT00577382|54670012|FG001|Overall Study|Withdrawal by Subject|1|||
28011013|NCT00577382|54670011|FG000|Overall Study|Progressive Disease|17|||
28011014|NCT00577382|54670012|FG001|Overall Study|Progressive Disease|19|||
28011015|NCT00577382|54670011|FG000|Overall Study|Intercurrent Illness|1|||
28011016|NCT00577382|54670012|FG001|Overall Study|Intercurrent Illness|2|||
28011017|NCT00577382|54670011|FG000|Overall Study|Death|1|||
28011018|NCT00577382|54670012|FG001|Overall Study|Death|1|||
28011019|NCT00577382|54670011|FG000|Overall Study|Lost to Follow-up|2|||
28011020|NCT00577382|54670012|FG001|Overall Study|Lost to Follow-up|2|||
28011021|NCT00614926|54670020|FG000|Overall Study|Burden of travel|1|||
28011022|NCT00614926|54670021|FG001|Overall Study|Burden of travel|0|||
28011023|NCT00614926|54670020|FG000|Overall Study|Adverse Event|3|||
28011024|NCT00614926|54670021|FG001|Overall Study|Adverse Event|0|||
28011025|NCT00423319|54670034|FG000|Overall Study|Death|2|||
28011026|NCT00423319|54670035|FG001|Overall Study|Death|0|||
28011027|NCT00423319|54670034|FG000|Overall Study|Adverse Event|93|||
28011028|NCT00423319|54670035|FG001|Overall Study|Adverse Event|112|||
28011029|NCT00423319|54670034|FG000|Overall Study|Withdrawal by Subject|86|||
28011030|NCT00423319|54670035|FG001|Overall Study|Withdrawal by Subject|99|||
28011031|NCT00423319|54670034|FG000|Overall Study|Lost to Follow-up|4|||
28011032|NCT00423319|54670035|FG001|Overall Study|Lost to Follow-up|3|||
28011033|NCT00423319|54670034|FG000|Overall Study|Poor compliance or noncompliance|1|||
28011034|NCT00423319|54670035|FG001|Overall Study|Poor compliance or noncompliance|1|||
28011035|NCT00423319|54670034|FG000|Overall Study|No longer meets study criteria|15|||
28011036|NCT00423319|54670035|FG001|Overall Study|No longer meets study criteria|15|||
28011037|NCT00423319|54670034|FG000|Overall Study|Other|23|||
28011038|NCT00423319|54670035|FG001|Overall Study|Other|22|||
28011039|NCT00710684|54670045|FG000|Overall Study|Adverse Event|11|||
28011040|NCT00710684|54670046|FG001|Overall Study|Adverse Event|19|||
28011041|NCT00710684|54670047|FG002|Overall Study|Adverse Event|16|||
28011042|NCT00710684|54670045|FG000|Overall Study|Lack of Efficacy|4|||
28011043|NCT00710684|54670046|FG001|Overall Study|Lack of Efficacy|3|||
28011044|NCT00710684|54670047|FG002|Overall Study|Lack of Efficacy|5|||
28011045|NCT00710684|54670045|FG000|Overall Study|Protocol Violation|5|||
28011046|NCT00710684|54670046|FG001|Overall Study|Protocol Violation|5|||
28011047|NCT00710684|54670047|FG002|Overall Study|Protocol Violation|5|||
28011048|NCT00710684|54670045|FG000|Overall Study|Lost to Follow-up|4|||
28011049|NCT00710684|54670046|FG001|Overall Study|Lost to Follow-up|6|||
28011050|NCT00710684|54670047|FG002|Overall Study|Lost to Follow-up|7|||
28011051|NCT00710684|54670045|FG000|Overall Study|Physician Decision|0|||
28011052|NCT00710684|54670046|FG001|Overall Study|Physician Decision|2|||
28011053|NCT00710684|54670047|FG002|Overall Study|Physician Decision|4|||
28011054|NCT00710684|54670045|FG000|Overall Study|Withdrawal by Subject|24|||
28011055|NCT00710684|54670046|FG001|Overall Study|Withdrawal by Subject|18|||
28011056|NCT00710684|54670047|FG002|Overall Study|Withdrawal by Subject|11|||
28011057|NCT00710684|54670045|FG000|Overall Study|Missing|1|||
28011058|NCT00710684|54670046|FG001|Overall Study|Missing|0|||
28011059|NCT00710684|54670047|FG002|Overall Study|Missing|0|||
28011060|NCT00710684|54670045|FG000|Overall Study|Did not continue after week 24|25|||
28011061|NCT00710684|54670046|FG001|Overall Study|Did not continue after week 24|21|||
28011062|NCT00710684|54670047|FG002|Overall Study|Did not continue after week 24|16|||
28011063|NCT00710606|54670063|FG000|Overall Study|Adverse Event|0|||
28011064|NCT00710606|54670064|FG001|Overall Study|Adverse Event|2|||
28011065|NCT00713544|54670078|FG000|Overall Study|Adverse Event|5|||
28011066|NCT00713544|54670079|FG001|Overall Study|Adverse Event|3|||
28011067|NCT00713544|54670080|FG002|Overall Study|Adverse Event|7|||
28011068|NCT00713544|54670081|FG003|Overall Study|Adverse Event|7|||
28011069|NCT00713544|54670082|FG004|Overall Study|Adverse Event|3|||
28011070|NCT00713544|54670083|FG005|Overall Study|Adverse Event|5|||
28011071|NCT00713544|54670078|FG000|Overall Study|Withdrawal by Subject|2|||
28011072|NCT00713544|54670079|FG001|Overall Study|Withdrawal by Subject|0|||
28011073|NCT00713544|54670080|FG002|Overall Study|Withdrawal by Subject|3|||
28011074|NCT00713544|54670081|FG003|Overall Study|Withdrawal by Subject|2|||
28011075|NCT00713544|54670082|FG004|Overall Study|Withdrawal by Subject|3|||
28011076|NCT00713544|54670083|FG005|Overall Study|Withdrawal by Subject|1|||
28011077|NCT00713544|54670078|FG000|Overall Study|Protocol Violation|0|||
28011078|NCT00713544|54670079|FG001|Overall Study|Protocol Violation|0|||
28011079|NCT00713544|54670080|FG002|Overall Study|Protocol Violation|0|||
28011080|NCT00713544|54670081|FG003|Overall Study|Protocol Violation|0|||
28011081|NCT00713544|54670082|FG004|Overall Study|Protocol Violation|0|||
28011082|NCT00713544|54670083|FG005|Overall Study|Protocol Violation|1|||
28011083|NCT00713544|54670078|FG000|Overall Study|Physician Decision|0|||
28011084|NCT00713544|54670079|FG001|Overall Study|Physician Decision|0|||
28011085|NCT00713544|54670080|FG002|Overall Study|Physician Decision|0|||
28011086|NCT00713544|54670081|FG003|Overall Study|Physician Decision|0|||
28011087|NCT00713544|54670082|FG004|Overall Study|Physician Decision|0|||
28011088|NCT00713544|54670083|FG005|Overall Study|Physician Decision|2|||
28011089|NCT00713544|54670078|FG000|Overall Study|Lack of Efficacy|0|||
28011090|NCT00713544|54670079|FG001|Overall Study|Lack of Efficacy|1|||
28011091|NCT00713544|54670080|FG002|Overall Study|Lack of Efficacy|0|||
28011092|NCT00713544|54670081|FG003|Overall Study|Lack of Efficacy|1|||
28011093|NCT00713544|54670082|FG004|Overall Study|Lack of Efficacy|1|||
28011094|NCT00713544|54670083|FG005|Overall Study|Lack of Efficacy|0|||
28011095|NCT00713544|54670078|FG000|Overall Study|Lost to Follow-up|0|||
28011096|NCT00713544|54670079|FG001|Overall Study|Lost to Follow-up|0|||
28011097|NCT00713544|54670080|FG002|Overall Study|Lost to Follow-up|1|||
28011098|NCT00713544|54670081|FG003|Overall Study|Lost to Follow-up|0|||
28011099|NCT00713544|54670082|FG004|Overall Study|Lost to Follow-up|0|||
28011100|NCT00713544|54670083|FG005|Overall Study|Lost to Follow-up|0|||
28011101|NCT00713544|54670078|FG000|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
28011102|NCT00713544|54670079|FG001|Overall Study|AZ decision - Hepatitis C ab reactive|1|||
28011103|NCT00713544|54670080|FG002|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
28011104|NCT00713544|54670081|FG003|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
28011105|NCT00713544|54670082|FG004|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
28011106|NCT00713544|54670083|FG005|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
28011107|NCT00713544|54670078|FG000|Overall Study|Incorrect enrollment|0|||
28011108|NCT00713544|54670079|FG001|Overall Study|Incorrect enrollment|1|||
28011109|NCT00713544|54670080|FG002|Overall Study|Incorrect enrollment|0|||
28011110|NCT00713544|54670081|FG003|Overall Study|Incorrect enrollment|0|||
28011111|NCT00713544|54670082|FG004|Overall Study|Incorrect enrollment|0|||
28011112|NCT00713544|54670083|FG005|Overall Study|Incorrect enrollment|0|||
28011113|NCT00713544|54670078|FG000|Overall Study|Hepatotoxicity - not an AE|0|||
28011114|NCT00713544|54670079|FG001|Overall Study|Hepatotoxicity - not an AE|0|||
28011115|NCT00713544|54670080|FG002|Overall Study|Hepatotoxicity - not an AE|0|||
28011116|NCT00713544|54670081|FG003|Overall Study|Hepatotoxicity - not an AE|0|||
27741377|NCT02712905|54191355|FG001|Combination Therapy|Study Terminated by Sponsor|0|||
27741378|NCT02712905|54191356|FG002|Combination Therapy|Study Terminated by Sponsor|0|||
27741379|NCT02712905|54191357|FG003|Combination Therapy|Study Terminated by Sponsor|0|||
27741380|NCT02712905|54191358|FG004|Combination Therapy|Study Terminated by Sponsor|0|||
27741381|NCT02712905|54191359|FG005|Combination Therapy|Study Terminated by Sponsor|0|||
27741382|NCT02712905|54191360|FG006|Combination Therapy|Study Terminated by Sponsor|0|||
27741383|NCT02712905|54191361|FG007|Combination Therapy|Study Terminated by Sponsor|0|||
27741384|NCT02712905|54191362|FG008|Combination Therapy|Study Terminated by Sponsor|0|||
28011117|NCT00713544|54670082|FG004|Overall Study|Hepatotoxicity - not an AE|1|||
28011118|NCT00713544|54670083|FG005|Overall Study|Hepatotoxicity - not an AE|0|||
28011119|NCT00415363|54670099|FG000|Overall Study|Withdrawal by Subject|4|||
28011120|NCT00415363|54670100|FG001|Overall Study|Withdrawal by Subject|4|||
28011121|NCT00415363|54670099|FG000|Overall Study|Adverse Event|4|||
28011122|NCT00415363|54670100|FG001|Overall Study|Adverse Event|4|||
28011123|NCT00415363|54670099|FG000|Overall Study|Lost to Follow-up|2|||
28011124|NCT00415363|54670100|FG001|Overall Study|Lost to Follow-up|1|||
28011125|NCT00415363|54670099|FG000|Overall Study|Physician Decision|3|||
28011126|NCT00415363|54670100|FG001|Overall Study|Physician Decision|1|||
28011127|NCT00415363|54670099|FG000|Overall Study|Death|16|||
28011128|NCT00415363|54670100|FG001|Overall Study|Death|12|||
28011129|NCT00415363|54670099|FG000|Overall Study|Progressive disease|26|||
28011130|NCT00415363|54670100|FG001|Overall Study|Progressive disease|32|||
28011131|NCT00415051|54670107|FG000|Overall Study|Protocol Violation|1|||
27919794|NCT01103284|54577054|FG001|Overall Study|Protocol Violation|5|||
28011132|NCT00713258|54670113|FG000|Overall Study|Adverse Event|2|||
28011133|NCT00713258|54670114|FG001|Overall Study|Adverse Event|4|||
28011134|NCT00713258|54670113|FG000|Overall Study|Non-Compliance|2|||
28011135|NCT00713258|54670114|FG001|Overall Study|Non-Compliance|1|||
28011136|NCT00713258|54670113|FG000|Overall Study|Other|1|||
28011137|NCT00713258|54670114|FG001|Overall Study|Other|1|||
28011138|NCT00710034|54670122|FG000|Completed 6 Weeks of Treatment|Adverse Event|5|||
28011139|NCT00710034|54670123|FG001|Completed 6 Weeks of Treatment|Adverse Event|12|||
28011140|NCT00710034|54670122|FG000|Completed 6 Weeks of Treatment|Lack of Efficacy|12|||
28011141|NCT00710034|54670123|FG001|Completed 6 Weeks of Treatment|Lack of Efficacy|8|||
28011142|NCT00710034|54670122|FG000|Completed 6 Weeks of Treatment|Lost to Follow-up|15|||
28011143|NCT00710034|54670123|FG001|Completed 6 Weeks of Treatment|Lost to Follow-up|17|||
28011144|NCT00710034|54670122|FG000|Completed 6 Weeks of Treatment|Product dissatisfaction|2|||
28011145|NCT00710034|54670123|FG001|Completed 6 Weeks of Treatment|Product dissatisfaction|6|||
28011146|NCT00710034|54670122|FG000|Completed 6 Weeks of Treatment|Withdrawal by Subject|6|||
28011147|NCT00710034|54670123|FG001|Completed 6 Weeks of Treatment|Withdrawal by Subject|4|||
28011148|NCT00710034|54670122|FG000|Completed 6 Weeks of Treatment|Physician Decision|1|||
28011149|NCT00710034|54670123|FG001|Completed 6 Weeks of Treatment|Physician Decision|0|||
28011150|NCT00710034|54670122|FG000|Completed 12 Weeks of Treatment|Adverse Event|0|||
28011151|NCT00710034|54670123|FG001|Completed 12 Weeks of Treatment|Adverse Event|1|||
28011152|NCT00710034|54670122|FG000|Completed 12 Weeks of Treatment|Lack of Efficacy|0|||
28011153|NCT00710034|54670123|FG001|Completed 12 Weeks of Treatment|Lack of Efficacy|2|||
28011154|NCT00710034|54670122|FG000|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
28011155|NCT00710034|54670123|FG001|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
28011156|NCT00710034|54670122|FG000|Completed 12 Weeks of Treatment|Product Dissatisfaction|0|||
28011157|NCT00710034|54670123|FG001|Completed 12 Weeks of Treatment|Product Dissatisfaction|1|||
28011158|NCT00710034|54670122|FG000|Completed 12 Weeks of Treatment|Withdrawal by Subject|8|||
28011159|NCT00710034|54670123|FG001|Completed 12 Weeks of Treatment|Withdrawal by Subject|2|||
28011160|NCT00414973|54670133|FG000|Overall Study|Withdrawal by Subject|14|||
28011161|NCT00414973|54670134|FG001|Overall Study|Withdrawal by Subject|4|||
28011162|NCT00414973|54670135|FG002|Overall Study|Withdrawal by Subject|1|||
28011163|NCT00414973|54670136|FG003|Overall Study|Withdrawal by Subject|0|||
28011164|NCT00414973|54670133|FG000|Overall Study|Adverse Event|10|||
28011165|NCT00414973|54670134|FG001|Overall Study|Adverse Event|0|||
28011166|NCT00414973|54670135|FG002|Overall Study|Adverse Event|1|||
28011167|NCT00414973|54670136|FG003|Overall Study|Adverse Event|0|||
28011168|NCT00414973|54670133|FG000|Overall Study|Protocol Violation|3|||
28011169|NCT00414973|54670134|FG001|Overall Study|Protocol Violation|4|||
28011170|NCT00414973|54670135|FG002|Overall Study|Protocol Violation|0|||
28011171|NCT00414973|54670136|FG003|Overall Study|Protocol Violation|0|||
28011172|NCT00414973|54670133|FG000|Overall Study|Lost to Follow-up|0|||
28011173|NCT00414973|54670134|FG001|Overall Study|Lost to Follow-up|2|||
28011174|NCT00414973|54670135|FG002|Overall Study|Lost to Follow-up|0|||
28011175|NCT00414973|54670136|FG003|Overall Study|Lost to Follow-up|0|||
28011176|NCT00414973|54670133|FG000|Overall Study|Sponsor Decision|1|||
28011177|NCT00414973|54670134|FG001|Overall Study|Sponsor Decision|0|||
28011178|NCT00414973|54670135|FG002|Overall Study|Sponsor Decision|0|||
28011179|NCT00414973|54670136|FG003|Overall Study|Sponsor Decision|0|||
28011180|NCT00414973|54670133|FG000|Overall Study|Death|0|||
28011181|NCT00414973|54670134|FG001|Overall Study|Death|0|||
28011182|NCT00414973|54670135|FG002|Overall Study|Death|1|||
28011183|NCT00414973|54670136|FG003|Overall Study|Death|0|||
28011184|NCT00423085|54670149|FG000|24-Week Double-Blind Treatment Phase|Adverse Event|21|||
28011185|NCT00423085|54670150|FG001|24-Week Double-Blind Treatment Phase|Adverse Event|38|||
28011186|NCT00423085|54670151|FG002|24-Week Double-Blind Treatment Phase|Adverse Event|34|||
28011187|NCT00423085|54670152|FG003|24-Week Double-Blind Treatment Phase|Adverse Event|0|||
28011188|NCT00423085|54670149|FG000|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8|||
28011189|NCT00423085|54670150|FG001|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16|||
28011190|NCT00423085|54670151|FG002|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11|||
28011191|NCT00423085|54670152|FG003|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0|||
28011192|NCT00423085|54670149|FG000|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
28011193|NCT00423085|54670150|FG001|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6|||
28011194|NCT00423085|54670151|FG002|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
28011195|NCT00423085|54670152|FG003|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
28011196|NCT00423085|54670149|FG000|24-Week Double-Blind Treatment Phase|Protocol Violation|8|||
28011197|NCT00423085|54670150|FG001|24-Week Double-Blind Treatment Phase|Protocol Violation|3|||
28011198|NCT00423085|54670151|FG002|24-Week Double-Blind Treatment Phase|Protocol Violation|7|||
28011199|NCT00423085|54670152|FG003|24-Week Double-Blind Treatment Phase|Protocol Violation|0|||
28011200|NCT00423085|54670149|FG000|24-Week Double-Blind Treatment Phase|Death|1|||
28011201|NCT00423085|54670150|FG001|24-Week Double-Blind Treatment Phase|Death|1|||
28011202|NCT00423085|54670151|FG002|24-Week Double-Blind Treatment Phase|Death|0|||
28011203|NCT00423085|54670152|FG003|24-Week Double-Blind Treatment Phase|Death|0|||
28011204|NCT00423085|54670149|FG000|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1|||
27919795|NCT01103284|54577053|FG000|Overall Study|Adverse Event|0|||
28011205|NCT00423085|54670150|FG001|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
28011206|NCT00423085|54670151|FG002|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
28011207|NCT00423085|54670152|FG003|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
28011208|NCT00423085|54670149|FG000|52-Week Open-Label Extension Phase|Adverse Event|0|||
28011209|NCT00423085|54670150|FG001|52-Week Open-Label Extension Phase|Adverse Event|0|||
28011210|NCT00423085|54670151|FG002|52-Week Open-Label Extension Phase|Adverse Event|0|||
28011211|NCT00423085|54670152|FG003|52-Week Open-Label Extension Phase|Adverse Event|97|||
28011212|NCT00423085|54670149|FG000|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
28011213|NCT00423085|54670150|FG001|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
28011214|NCT00423085|54670151|FG002|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
28011215|NCT00423085|54670152|FG003|52-Week Open-Label Extension Phase|Withdrawal by Subject|37|||
28011216|NCT00423085|54670149|FG000|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
28011217|NCT00423085|54670150|FG001|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
28011218|NCT00423085|54670151|FG002|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
28011219|NCT00423085|54670152|FG003|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18|||
28011220|NCT00423085|54670149|FG000|52-Week Open-Label Extension Phase|Protocol deviation|0|||
28011221|NCT00423085|54670150|FG001|52-Week Open-Label Extension Phase|Protocol deviation|0|||
28011222|NCT00423085|54670151|FG002|52-Week Open-Label Extension Phase|Protocol deviation|0|||
28011223|NCT00423085|54670152|FG003|52-Week Open-Label Extension Phase|Protocol deviation|9|||
28011224|NCT00423085|54670149|FG000|52-Week Open-Label Extension Phase|Death|0|||
28011225|NCT00423085|54670150|FG001|52-Week Open-Label Extension Phase|Death|0|||
28011226|NCT00423085|54670151|FG002|52-Week Open-Label Extension Phase|Death|0|||
28011227|NCT00423085|54670152|FG003|52-Week Open-Label Extension Phase|Death|2|||
28011228|NCT00414661|54670166|FG000|Overall Study|Death|2|||
28011229|NCT00414661|54670167|FG001|Overall Study|Death|5|||
28011230|NCT00414661|54670168|FG002|Overall Study|Death|0|||
28011231|NCT00414661|54670169|FG003|Overall Study|Death|0|||
28011232|NCT00414661|54670166|FG000|Overall Study|Lost to Follow-up|1|||
28011233|NCT00414661|54670167|FG001|Overall Study|Lost to Follow-up|4|||
28011234|NCT00414661|54670168|FG002|Overall Study|Lost to Follow-up|0|||
28011235|NCT00414661|54670169|FG003|Overall Study|Lost to Follow-up|1|||
28011236|NCT00414661|54670166|FG000|Overall Study|Withdrawal by Subject|5|||
28011237|NCT00414661|54670167|FG001|Overall Study|Withdrawal by Subject|2|||
28011238|NCT00414661|54670168|FG002|Overall Study|Withdrawal by Subject|2|||
28011239|NCT00414661|54670169|FG003|Overall Study|Withdrawal by Subject|2|||
28011240|NCT00414661|54670166|FG000|Overall Study|Other|6|||
28011241|NCT00414661|54670167|FG001|Overall Study|Other|3|||
28011242|NCT00414661|54670168|FG002|Overall Study|Other|0|||
28011243|NCT00414661|54670169|FG003|Overall Study|Other|0|||
28011244|NCT00405067|54670182|FG000|Overall Study|Adverse Event|4|||
28011245|NCT00405067|54670183|FG001|Overall Study|Adverse Event|9|||
28011246|NCT00405067|54670184|FG002|Overall Study|Adverse Event|4|||
28011247|NCT00405067|54670182|FG000|Overall Study|Lost to Follow-up|0|||
28011248|NCT00405067|54670183|FG001|Overall Study|Lost to Follow-up|0|||
28011249|NCT00405067|54670184|FG002|Overall Study|Lost to Follow-up|1|||
28011250|NCT00708708|54670192|FG000|Overall Study|Another therapy instead of Enbrel|141|||
28011251|NCT00708708|54670192|FG000|Overall Study|Lost to Follow-up|52|||
28011252|NCT00708708|54670192|FG000|Overall Study|Withdrawal by Subject|51|||
28011253|NCT00708708|54670192|FG000|Overall Study|Intolerance|42|||
28011254|NCT00708708|54670192|FG000|Overall Study|Another therapy along with Enbrel|15|||
28011255|NCT00708708|54670192|FG000|Overall Study|Other unspecified|11|||
28011256|NCT00708708|54670192|FG000|Overall Study|Good effectiveness|9|||
28011257|NCT00708708|54670192|FG000|Overall Study|Ineffectiveness (no systemic therapy)|9|||
28011258|NCT00708708|54670192|FG000|Overall Study|Administrative reasons|7|||
28011259|NCT00708708|54670192|FG000|Overall Study|Lack of effectiveness|4|||
28011260|NCT00708708|54670192|FG000|Overall Study|Lack of compliance|3|||
28011261|NCT00708708|54670192|FG000|Overall Study|Pregnancy|3|||
28011262|NCT00708708|54670192|FG000|Overall Study|Adverse Event|3|||
28011263|NCT00708708|54670192|FG000|Overall Study|Missing values|392|||
28011264|NCT00404755|54670199|FG000|Phase I (Bupropion)|Adverse Event|3|||
28011265|NCT00404755|54670199|FG000|Phase I (Bupropion)|Other|1|||
28011266|NCT00404755|54670199|FG000|Phase II (Escitalopram)|Lost to Follow-up|2|||
28011267|NCT00614614|54670209|FG000|Primary Vaccination Phase|Adverse Event|6|||
28011268|NCT00614614|54670210|FG001|Primary Vaccination Phase|Adverse Event|0|||
28011269|NCT00614614|54670211|FG002|Primary Vaccination Phase|Adverse Event|0|||
28011270|NCT00614614|54670212|FG003|Primary Vaccination Phase|Adverse Event|0|||
28011271|NCT00614614|54670213|FG004|Primary Vaccination Phase|Adverse Event|0|||
27919796|NCT01103284|54577054|FG001|Overall Study|Adverse Event|5|||
28103669|NCT02849080|54760392|FG000|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2|||
28011272|NCT00614614|54670209|FG000|Primary Vaccination Phase|Withdrawal by Subject|45|||
28011273|NCT00614614|54670210|FG001|Primary Vaccination Phase|Withdrawal by Subject|6|||
28011274|NCT00614614|54670211|FG002|Primary Vaccination Phase|Withdrawal by Subject|0|||
28011275|NCT00614614|54670212|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
28011276|NCT00614614|54670213|FG004|Primary Vaccination Phase|Withdrawal by Subject|0|||
28011277|NCT00614614|54670209|FG000|Primary Vaccination Phase|Lost to Follow-up|26|||
28011278|NCT00614614|54670210|FG001|Primary Vaccination Phase|Lost to Follow-up|8|||
28011279|NCT00614614|54670211|FG002|Primary Vaccination Phase|Lost to Follow-up|0|||
28011280|NCT00614614|54670212|FG003|Primary Vaccination Phase|Lost to Follow-up|0|||
28011281|NCT00614614|54670213|FG004|Primary Vaccination Phase|Lost to Follow-up|0|||
28011282|NCT00614614|54670209|FG000|Primary Vaccination Phase|Protocol Violation|9|||
28011283|NCT00614614|54670210|FG001|Primary Vaccination Phase|Protocol Violation|3|||
28011284|NCT00614614|54670211|FG002|Primary Vaccination Phase|Protocol Violation|0|||
28011285|NCT00614614|54670212|FG003|Primary Vaccination Phase|Protocol Violation|0|||
28011286|NCT00614614|54670213|FG004|Primary Vaccination Phase|Protocol Violation|0|||
28011287|NCT00614614|54670209|FG000|Primary Vaccination Phase|Other|4|||
28011288|NCT00614614|54670210|FG001|Primary Vaccination Phase|Other|0|||
28011289|NCT00614614|54670211|FG002|Primary Vaccination Phase|Other|0|||
28011290|NCT00614614|54670212|FG003|Primary Vaccination Phase|Other|0|||
28011291|NCT00614614|54670213|FG004|Primary Vaccination Phase|Other|0|||
28011292|NCT00614614|54670209|FG000|Booster Vaccination Phase|Adverse Event|0|||
28011293|NCT00614614|54670210|FG001|Booster Vaccination Phase|Adverse Event|0|||
28011294|NCT00614614|54670211|FG002|Booster Vaccination Phase|Adverse Event|1|||
28011295|NCT00614614|54670212|FG003|Booster Vaccination Phase|Adverse Event|1|||
28011296|NCT00614614|54670213|FG004|Booster Vaccination Phase|Adverse Event|0|||
28011297|NCT00614614|54670209|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
28011298|NCT00614614|54670210|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
28011299|NCT00614614|54670211|FG002|Booster Vaccination Phase|Withdrawal by Subject|4|||
28011300|NCT00614614|54670212|FG003|Booster Vaccination Phase|Withdrawal by Subject|3|||
28011301|NCT00614614|54670213|FG004|Booster Vaccination Phase|Withdrawal by Subject|4|||
28011302|NCT00614614|54670209|FG000|Booster Vaccination Phase|Lost to Follow-up|0|||
28011303|NCT00614614|54670210|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
28011304|NCT00614614|54670211|FG002|Booster Vaccination Phase|Lost to Follow-up|17|||
28011305|NCT00614614|54670212|FG003|Booster Vaccination Phase|Lost to Follow-up|10|||
28011306|NCT00614614|54670213|FG004|Booster Vaccination Phase|Lost to Follow-up|8|||
28011307|NCT00614614|54670209|FG000|Booster Vaccination Phase|Protocol Violation|0|||
28011308|NCT00614614|54670210|FG001|Booster Vaccination Phase|Protocol Violation|0|||
28011309|NCT00614614|54670211|FG002|Booster Vaccination Phase|Protocol Violation|2|||
28011310|NCT00614614|54670212|FG003|Booster Vaccination Phase|Protocol Violation|3|||
28011311|NCT00614614|54670213|FG004|Booster Vaccination Phase|Protocol Violation|0|||
28011312|NCT00614614|54670209|FG000|Booster Vaccination Phase|Other|0|||
28011313|NCT00614614|54670210|FG001|Booster Vaccination Phase|Other|1|||
28011314|NCT00614614|54670211|FG002|Booster Vaccination Phase|Other|3|||
28011315|NCT00614614|54670212|FG003|Booster Vaccination Phase|Other|2|||
28011316|NCT00614614|54670213|FG004|Booster Vaccination Phase|Other|1|||
28011317|NCT00713310|54670230|FG000|Overall Study|Adverse Event|5|||
28011318|NCT00713310|54670231|FG001|Overall Study|Adverse Event|2|||
28011319|NCT00713310|54670230|FG000|Overall Study|Lack of Efficacy|0|||
28011320|NCT00713310|54670231|FG001|Overall Study|Lack of Efficacy|2|||
28011321|NCT00713310|54670230|FG000|Overall Study|Withdrawal by Subject|0|||
28011322|NCT00713310|54670231|FG001|Overall Study|Withdrawal by Subject|2|||
28011323|NCT00422461|54670241|FG000|Overall Study|Adverse Event|1|||
28011324|NCT00422461|54670242|FG001|Overall Study|Adverse Event|2|||
28011325|NCT00422461|54670243|FG002|Overall Study|Adverse Event|1|||
28011326|NCT00422461|54670244|FG003|Overall Study|Adverse Event|1|||
28011327|NCT00422461|54670241|FG000|Overall Study|Other|0|||
28011328|NCT00422461|54670242|FG001|Overall Study|Other|0|||
28011329|NCT00422461|54670243|FG002|Overall Study|Other|0|||
28011330|NCT00422461|54670244|FG003|Overall Study|Other|2|||
28011331|NCT00422461|54670241|FG000|Overall Study|Participants no longer willing to participate in study|1|||
28011332|NCT00422461|54670242|FG001|Overall Study|Participants no longer willing to participate in study|0|||
28011333|NCT00422461|54670243|FG002|Overall Study|Participants no longer willing to participate in study|0|||
28011334|NCT00422461|54670244|FG003|Overall Study|Participants no longer willing to participate in study|0|||
28011335|NCT00422461|54670241|FG000|Overall Study|Randomized but not treated|1|||
28011336|NCT00422461|54670242|FG001|Overall Study|Randomized but not treated|1|||
28011337|NCT00422461|54670243|FG002|Overall Study|Randomized but not treated|0|||
28011338|NCT00422461|54670244|FG003|Overall Study|Randomized but not treated|0|||
28011339|NCT00712920|54670257|FG000|Overall Study|Adverse Event|3|||
28011340|NCT00712920|54670258|FG001|Overall Study|Adverse Event|4|||
28011341|NCT00712920|54670259|FG002|Overall Study|Adverse Event|7|||
28011342|NCT00712920|54670257|FG000|Overall Study|Withdrawal by Subject|4|||
28011343|NCT00712920|54670258|FG001|Overall Study|Withdrawal by Subject|2|||
28011344|NCT00712920|54670259|FG002|Overall Study|Withdrawal by Subject|1|||
28011345|NCT00712920|54670257|FG000|Overall Study|Lost to Follow-up|1|||
28011346|NCT00712920|54670258|FG001|Overall Study|Lost to Follow-up|4|||
28011347|NCT00712920|54670259|FG002|Overall Study|Lost to Follow-up|0|||
28011348|NCT00712920|54670257|FG000|Overall Study|Lack of Efficacy|1|||
28011349|NCT00712920|54670258|FG001|Overall Study|Lack of Efficacy|0|||
28011350|NCT00712920|54670259|FG002|Overall Study|Lack of Efficacy|1|||
28011351|NCT00712920|54670257|FG000|Overall Study|Other|5|||
28011352|NCT00712920|54670258|FG001|Overall Study|Other|7|||
28011353|NCT00712920|54670259|FG002|Overall Study|Other|3|||
28011354|NCT00712920|54670257|FG000|Overall Study|Non-compliance|3|||
28011355|NCT00712920|54670258|FG001|Overall Study|Non-compliance|0|||
28011356|NCT00712920|54670259|FG002|Overall Study|Non-compliance|0|||
28011357|NCT00612586|54670278|FG000|Overall Study|Adverse Event|6|||
28011358|NCT00612586|54670279|FG001|Overall Study|Adverse Event|2|||
28011359|NCT00612586|54670278|FG000|Overall Study|Death|1|||
28011360|NCT00612586|54670279|FG001|Overall Study|Death|0|||
28011361|NCT00612586|54670278|FG000|Overall Study|Entry Criteria Not Met|0|||
28011362|NCT00612586|54670279|FG001|Overall Study|Entry Criteria Not Met|2|||
28011363|NCT00612586|54670278|FG000|Overall Study|Withdrawal by Subject|7|||
28011364|NCT00612586|54670279|FG001|Overall Study|Withdrawal by Subject|9|||
28011365|NCT00612586|54670278|FG000|Overall Study|Physician Decision|1|||
28011366|NCT00612586|54670279|FG001|Overall Study|Physician Decision|2|||
28011367|NCT00612586|54670278|FG000|Overall Study|Sponsor Decision|1|||
28011368|NCT00612586|54670279|FG001|Overall Study|Sponsor Decision|1|||
28011369|NCT00612586|54670278|FG000|Overall Study|Progressive Disease|26|||
28011370|NCT00612586|54670279|FG001|Overall Study|Progressive Disease|24|||
28011371|NCT00612586|54670278|FG000|Overall Study|Randomized and Not Treated|1|||
28011372|NCT00612586|54670279|FG001|Overall Study|Randomized and Not Treated|1|||
28011373|NCT00614380|54670290|FG000|Overall Study|Adverse Event|14|||
28011374|NCT00614380|54670291|FG001|Overall Study|Adverse Event|4|||
28011375|NCT00614380|54670292|FG002|Overall Study|Adverse Event|0|||
28011376|NCT00614380|54670293|FG003|Overall Study|Adverse Event|0|||
28011377|NCT00614380|54670290|FG000|Overall Study|Lost to Follow-up|6|||
28011378|NCT00614380|54670291|FG001|Overall Study|Lost to Follow-up|1|||
28011379|NCT00614380|54670292|FG002|Overall Study|Lost to Follow-up|0|||
28011380|NCT00614380|54670293|FG003|Overall Study|Lost to Follow-up|0|||
28011381|NCT00614380|54670290|FG000|Overall Study|Non compliant with the protocol|12|||
28011382|NCT00614380|54670291|FG001|Overall Study|Non compliant with the protocol|2|||
28011383|NCT00614380|54670292|FG002|Overall Study|Non compliant with the protocol|1|||
28011384|NCT00614380|54670293|FG003|Overall Study|Non compliant with the protocol|2|||
28011385|NCT00614380|54670290|FG000|Overall Study|Consent withdrawn|3|||
28011386|NCT00614380|54670291|FG001|Overall Study|Consent withdrawn|1|||
28011387|NCT00614380|54670292|FG002|Overall Study|Consent withdrawn|0|||
28011388|NCT00614380|54670293|FG003|Overall Study|Consent withdrawn|0|||
28011389|NCT00612508|54670310|FG000|Overall Study|Withdrawal by Subject|3|||
28011390|NCT00612508|54670311|FG001|Overall Study|Withdrawal by Subject|4|||
28011391|NCT00613834|54670321|FG000|Overall Study|Withdrawal by Subject|0|||
28011392|NCT00613834|54670322|FG001|Overall Study|Withdrawal by Subject|3|||
28011393|NCT00613366|54670336|FG000|Overall Study|Withdrawal by Subject|3|||
28011394|NCT00613366|54670337|FG001|Overall Study|Withdrawal by Subject|2|||
28011395|NCT00612352|54670345|FG000|Overall Study|Adverse Event|1|||
28011396|NCT00612352|54670346|FG001|Overall Study|Adverse Event|0|||
28011397|NCT00612352|54670345|FG000|Overall Study|Withdrawal by Subject|3|||
28011398|NCT00612352|54670346|FG001|Overall Study|Withdrawal by Subject|5|||
28011399|NCT00612352|54670345|FG000|Overall Study|moved out of state|1|||
28011400|NCT00612352|54670346|FG001|Overall Study|moved out of state|0|||
28011401|NCT00612352|54670345|FG000|Overall Study|didn't return calls/show up on test date|4|||
27741385|NCT02712905|54191363|FG009|Combination Therapy|Study Terminated by Sponsor|0|||
27741386|NCT02712905|54191364|FG010|Combination Therapy|Study Terminated by Sponsor|0|||
28011402|NCT00612352|54670346|FG001|Overall Study|didn't return calls/show up on test date|1|||
28011403|NCT00704730|54670354|FG000|Overall Study|Adverse Event|35|||
27741387|NCT02712905|54191365|FG011|Combination Therapy|Study Terminated by Sponsor|0|||
28011404|NCT00704730|54670355|FG001|Overall Study|Adverse Event|9|||
28011405|NCT00704730|54670354|FG000|Overall Study|Death|11|||
28011406|NCT00704730|54670355|FG001|Overall Study|Death|5|||
28011407|NCT00704730|54670354|FG000|Overall Study|Physician Decision|2|||
28011408|NCT00704730|54670355|FG001|Overall Study|Physician Decision|0|||
28011409|NCT00704730|54670354|FG000|Overall Study|Did not receive drug|5|||
28011410|NCT00704730|54670355|FG001|Overall Study|Did not receive drug|2|||
28011411|NCT00704730|54670354|FG000|Overall Study|Disease progression per PI|58|||
28011412|NCT00704730|54670355|FG001|Overall Study|Disease progression per PI|67|||
28011413|NCT00704730|54670354|FG000|Overall Study|data unavailable|1|||
28011414|NCT00704730|54670355|FG001|Overall Study|data unavailable|0|||
28011415|NCT00704730|54670354|FG000|Overall Study|Withdrawal by Subject|9|||
28011416|NCT00704730|54670355|FG001|Overall Study|Withdrawal by Subject|13|||
28011417|NCT00651261|54670364|FG000|Overall Study|Adverse Event|32|||
28011418|NCT00651261|54670365|FG001|Overall Study|Adverse Event|22|||
28011419|NCT00651261|54670364|FG000|Overall Study|Death|18|||
28011420|NCT00651261|54670365|FG001|Overall Study|Death|18|||
28011421|NCT00651261|54670364|FG000|Overall Study|Withdrawal by Subject|22|||
28011422|NCT00651261|54670365|FG001|Overall Study|Withdrawal by Subject|40|||
28011423|NCT00651261|54670364|FG000|Overall Study|Induction failure|24|||
28011424|NCT00651261|54670365|FG001|Overall Study|Induction failure|35|||
28011425|NCT00651261|54670364|FG000|Overall Study|Disease progression|58|||
28011426|NCT00651261|54670365|FG001|Overall Study|Disease progression|58|||
28011427|NCT00651261|54670364|FG000|Overall Study|Alternative therapy|109|||
28011428|NCT00651261|54670365|FG001|Overall Study|Alternative therapy|107|||
28011429|NCT00651261|54670364|FG000|Overall Study|Other disease or participant decisions|23|||
28011430|NCT00651261|54670365|FG001|Overall Study|Other disease or participant decisions|23|||
28011431|NCT00651261|54670364|FG000|Overall Study|Never treated|5|||
28011432|NCT00651261|54670365|FG001|Overall Study|Never treated|3|||
28011433|NCT00651183|54670373|FG000|Overall Study|Lack of Efficacy|1|||
28011434|NCT00651183|54670374|FG001|Overall Study|Lack of Efficacy|0|||
28011435|NCT00651183|54670373|FG000|Overall Study|Efficacy insufficient + patients wish|0|||
28011436|NCT00651183|54670374|FG001|Overall Study|Efficacy insufficient + patients wish|1|||
28011437|NCT00651183|54670373|FG000|Overall Study|Tolerability insufficient|5|||
28011438|NCT00651183|54670374|FG001|Overall Study|Tolerability insufficient|2|||
28011439|NCT00651183|54670373|FG000|Overall Study|Tolerability insufficient +Patients wish|0|||
28011440|NCT00651183|54670374|FG001|Overall Study|Tolerability insufficient +Patients wish|1|||
28011441|NCT00651183|54670373|FG000|Overall Study|Withdrawal by Subject|6|||
28011442|NCT00651183|54670374|FG001|Overall Study|Withdrawal by Subject|3|||
28011443|NCT00651183|54670373|FG000|Overall Study|Lost to Follow-up|3|||
28011444|NCT00651183|54670374|FG001|Overall Study|Lost to Follow-up|1|||
28011445|NCT00651183|54670373|FG000|Overall Study|Other reasons|4|||
28011446|NCT00651183|54670374|FG001|Overall Study|Other reasons|2|||
28011447|NCT00651183|54670373|FG000|Overall Study|missing|1|||
28011448|NCT00651183|54670374|FG001|Overall Study|missing|0|||
28011449|NCT00699972|54670383|FG000|Overall Study|Adverse Event|7|||
28011450|NCT00699972|54670384|FG001|Overall Study|Adverse Event|9|||
28011451|NCT00699972|54670385|FG002|Overall Study|Adverse Event|24|||
28011452|NCT00699972|54670383|FG000|Overall Study|Lost to Follow-up|0|||
28011453|NCT00699972|54670384|FG001|Overall Study|Lost to Follow-up|2|||
28011454|NCT00699972|54670385|FG002|Overall Study|Lost to Follow-up|0|||
28011455|NCT00699972|54670383|FG000|Overall Study|Withdrawal by Subject|3|||
28011456|NCT00699972|54670384|FG001|Overall Study|Withdrawal by Subject|7|||
28011457|NCT00699972|54670385|FG002|Overall Study|Withdrawal by Subject|4|||
28011458|NCT00699972|54670383|FG000|Overall Study|Lack of Efficacy|2|||
28011459|NCT00699972|54670384|FG001|Overall Study|Lack of Efficacy|0|||
28011460|NCT00699972|54670385|FG002|Overall Study|Lack of Efficacy|2|||
28011461|NCT00699972|54670383|FG000|Overall Study|Administrative/Other|3|||
28011462|NCT00699972|54670384|FG001|Overall Study|Administrative/Other|1|||
28011463|NCT00699972|54670385|FG002|Overall Study|Administrative/Other|4|||
28011464|NCT00699972|54670383|FG000|Overall Study|Randomized, Not Treated|1|||
28011465|NCT00699972|54670384|FG001|Overall Study|Randomized, Not Treated|0|||
28011466|NCT00699972|54670385|FG002|Overall Study|Randomized, Not Treated|1|||
28011467|NCT00642759|54670393|FG000|Overall Study|Protocol Violation|1|||
28011468|NCT00611026|54670401|FG000|Randomized to Double-blind Treatment|Not treated|2|||
28011469|NCT00611026|54670402|FG001|Randomized to Double-blind Treatment|Not treated|1|||
28011470|NCT00611026|54670403|FG002|Randomized to Double-blind Treatment|Not treated|3|||
28011471|NCT00611026|54670401|FG000|Double-blind Treatment Period|Death|1|||
28011472|NCT00611026|54670402|FG001|Double-blind Treatment Period|Death|0|||
28011473|NCT00611026|54670403|FG002|Double-blind Treatment Period|Death|0|||
28011474|NCT00611026|54670401|FG000|Double-blind Treatment Period|Adverse Event|9|||
28011475|NCT00611026|54670402|FG001|Double-blind Treatment Period|Adverse Event|28|||
28011476|NCT00611026|54670403|FG002|Double-blind Treatment Period|Adverse Event|46|||
28011477|NCT00611026|54670401|FG000|Double-blind Treatment Period|Lack of Efficacy|11|||
28011478|NCT00611026|54670402|FG001|Double-blind Treatment Period|Lack of Efficacy|10|||
28011479|NCT00611026|54670403|FG002|Double-blind Treatment Period|Lack of Efficacy|4|||
28011480|NCT00611026|54670401|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
28011481|NCT00611026|54670402|FG001|Double-blind Treatment Period|Lost to Follow-up|11|||
28011482|NCT00611026|54670403|FG002|Double-blind Treatment Period|Lost to Follow-up|14|||
28011483|NCT00611026|54670401|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
28011484|NCT00611026|54670402|FG001|Double-blind Treatment Period|Withdrawal by Subject|19|||
28011485|NCT00611026|54670403|FG002|Double-blind Treatment Period|Withdrawal by Subject|16|||
28011486|NCT00611026|54670401|FG000|Double-blind Treatment Period|Other|13|||
28011487|NCT00611026|54670402|FG001|Double-blind Treatment Period|Other|20|||
28011488|NCT00611026|54670403|FG002|Double-blind Treatment Period|Other|18|||
28011489|NCT00646113|54670413|FG000|Overall Study|Lost to Follow-up|5|||
28011490|NCT00646113|54670413|FG000|Overall Study|Adverse Event|3|||
28011491|NCT00422383|54670422|FG000|Overall Study|Adverse Event|5|||
28011492|NCT00422383|54670423|FG001|Overall Study|Adverse Event|3|||
28011493|NCT00422383|54670424|FG002|Overall Study|Adverse Event|1|||
28011494|NCT00422383|54670425|FG003|Overall Study|Adverse Event|1|||
28011495|NCT00422383|54670426|FG004|Overall Study|Adverse Event|0|||
28011496|NCT00422383|54670422|FG000|Overall Study|Lack of Efficacy|4|||
28011497|NCT00422383|54670423|FG001|Overall Study|Lack of Efficacy|4|||
28011498|NCT00422383|54670424|FG002|Overall Study|Lack of Efficacy|2|||
28011499|NCT00422383|54670425|FG003|Overall Study|Lack of Efficacy|1|||
28011500|NCT00422383|54670426|FG004|Overall Study|Lack of Efficacy|1|||
28011501|NCT00422383|54670422|FG000|Overall Study|Lost to Follow-up|0|||
28011502|NCT00422383|54670423|FG001|Overall Study|Lost to Follow-up|1|||
28011503|NCT00422383|54670424|FG002|Overall Study|Lost to Follow-up|0|||
28011504|NCT00422383|54670425|FG003|Overall Study|Lost to Follow-up|0|||
28011505|NCT00422383|54670426|FG004|Overall Study|Lost to Follow-up|1|||
28011506|NCT00422383|54670422|FG000|Overall Study|Protocol Violation|1|||
28011507|NCT00422383|54670423|FG001|Overall Study|Protocol Violation|1|||
28011508|NCT00422383|54670424|FG002|Overall Study|Protocol Violation|1|||
28011509|NCT00422383|54670425|FG003|Overall Study|Protocol Violation|0|||
28011510|NCT00422383|54670426|FG004|Overall Study|Protocol Violation|0|||
28011511|NCT00422383|54670422|FG000|Overall Study|Withdrawal by Subject|5|||
28011512|NCT00422383|54670423|FG001|Overall Study|Withdrawal by Subject|5|||
28011513|NCT00422383|54670424|FG002|Overall Study|Withdrawal by Subject|0|||
28011514|NCT00422383|54670425|FG003|Overall Study|Withdrawal by Subject|0|||
28011515|NCT00422383|54670426|FG004|Overall Study|Withdrawal by Subject|1|||
28011516|NCT00612040|54670447|FG000|Overall Study|Adverse Event|0|||
28011517|NCT00612040|54670448|FG001|Overall Study|Adverse Event|2|||
28011518|NCT00612040|54670449|FG002|Overall Study|Adverse Event|1|||
28011519|NCT00612040|54670447|FG000|Overall Study|Protocol Violation|1|||
28011520|NCT00612040|54670448|FG001|Overall Study|Protocol Violation|2|||
28011521|NCT00612040|54670449|FG002|Overall Study|Protocol Violation|1|||
28011522|NCT00612040|54670447|FG000|Overall Study|Lack of Efficacy|2|||
28011523|NCT00612040|54670448|FG001|Overall Study|Lack of Efficacy|1|||
28011524|NCT00612040|54670449|FG002|Overall Study|Lack of Efficacy|0|||
28011525|NCT00612040|54670447|FG000|Overall Study|Unclassified|2|||
28011526|NCT00612040|54670448|FG001|Overall Study|Unclassified|2|||
28011527|NCT00612040|54670449|FG002|Overall Study|Unclassified|5|||
28011528|NCT00422227|54670459|FG000|Overall Study|Adverse Event|3|||
28011529|NCT00422227|54670460|FG001|Overall Study|Adverse Event|8|||
28011530|NCT00422227|54670459|FG000|Overall Study|Lost to Follow-up|1|||
28011531|NCT00422227|54670460|FG001|Overall Study|Lost to Follow-up|3|||
28011532|NCT00422227|54670459|FG000|Overall Study|Withdrawal by Subject|0|||
28011533|NCT00422227|54670460|FG001|Overall Study|Withdrawal by Subject|4|||
28011534|NCT00421993|54670470|FG000|Overall Study|Withdrawal by Subject|22|||
28011535|NCT00421993|54670471|FG001|Overall Study|Withdrawal by Subject|23|||
28011536|NCT00421993|54670472|FG002|Overall Study|Withdrawal by Subject|23|||
28011537|NCT00421993|54670473|FG003|Overall Study|Withdrawal by Subject|24|||
28011538|NCT00421993|54670470|FG000|Overall Study|Lost to Follow-up|18|||
28011539|NCT00421993|54670471|FG001|Overall Study|Lost to Follow-up|19|||
28011540|NCT00421993|54670472|FG002|Overall Study|Lost to Follow-up|22|||
28011541|NCT00421993|54670473|FG003|Overall Study|Lost to Follow-up|20|||
28011542|NCT00421993|54670470|FG000|Overall Study|Adverse Event|11|||
28011543|NCT00421993|54670471|FG001|Overall Study|Adverse Event|1|||
28011544|NCT00421993|54670472|FG002|Overall Study|Adverse Event|6|||
28011545|NCT00421993|54670473|FG003|Overall Study|Adverse Event|4|||
28011546|NCT00421993|54670470|FG000|Overall Study|Protocol Violation|2|||
28011547|NCT00421993|54670471|FG001|Overall Study|Protocol Violation|2|||
28011548|NCT00421993|54670472|FG002|Overall Study|Protocol Violation|0|||
28011549|NCT00421993|54670473|FG003|Overall Study|Protocol Violation|1|||
28011550|NCT00421993|54670470|FG000|Overall Study|Lack of Efficacy|0|||
28011551|NCT00421993|54670471|FG001|Overall Study|Lack of Efficacy|3|||
28011552|NCT00421993|54670472|FG002|Overall Study|Lack of Efficacy|0|||
28011553|NCT00421993|54670473|FG003|Overall Study|Lack of Efficacy|5|||
28011554|NCT00421993|54670470|FG000|Overall Study|Pregnancy|0|||
28011555|NCT00421993|54670471|FG001|Overall Study|Pregnancy|1|||
28011556|NCT00421993|54670472|FG002|Overall Study|Pregnancy|1|||
28011557|NCT00421993|54670473|FG003|Overall Study|Pregnancy|2|||
28011558|NCT00421993|54670470|FG000|Overall Study|Subject transportation issues|0|||
28011559|NCT00421993|54670471|FG001|Overall Study|Subject transportation issues|0|||
28011560|NCT00421993|54670472|FG002|Overall Study|Subject transportation issues|0|||
28011561|NCT00421993|54670473|FG003|Overall Study|Subject transportation issues|1|||
28011562|NCT00413959|54670483|FG000|Overall Study|Pt had only one cycle.|1|||
28011563|NCT00645567|54670487|FG000|Overall Study|Adverse Event|1|||
28011564|NCT00611884|54670499|FG000|Overall Study|Adverse Event|1|||
28011565|NCT00611884|54670500|FG001|Overall Study|Adverse Event|0|||
28011566|NCT00611884|54670501|FG002|Overall Study|Adverse Event|0|||
28011567|NCT00611884|54670502|FG003|Overall Study|Adverse Event|1|||
28011568|NCT00611884|54670499|FG000|Overall Study|Non-Compliance|1|||
28011569|NCT00611884|54670500|FG001|Overall Study|Non-Compliance|4|||
28011570|NCT00611884|54670501|FG002|Overall Study|Non-Compliance|2|||
28011571|NCT00611884|54670502|FG003|Overall Study|Non-Compliance|2|||
28011572|NCT00611884|54670499|FG000|Overall Study|Lack of Efficacy|0|||
28011573|NCT00611884|54670500|FG001|Overall Study|Lack of Efficacy|1|||
28011574|NCT00611884|54670501|FG002|Overall Study|Lack of Efficacy|0|||
28011575|NCT00611884|54670502|FG003|Overall Study|Lack of Efficacy|0|||
28011576|NCT00611884|54670499|FG000|Overall Study|Unclassified|7|||
28011577|NCT00611884|54670500|FG001|Overall Study|Unclassified|4|||
28011578|NCT00611884|54670501|FG002|Overall Study|Unclassified|2|||
28011579|NCT00611884|54670502|FG003|Overall Study|Unclassified|3|||
28011580|NCT00420745|54670514|FG000|Overall Study|Adverse Event|2|||
28011581|NCT00420745|54670515|FG001|Overall Study|Adverse Event|2|||
28011582|NCT00420745|54670514|FG000|Overall Study|Lost to Follow-up|10|||
28011583|NCT00420745|54670515|FG001|Overall Study|Lost to Follow-up|2|||
28011584|NCT00420745|54670514|FG000|Overall Study|Protocol Violation|1|||
28011585|NCT00420745|54670515|FG001|Overall Study|Protocol Violation|0|||
28011586|NCT00420745|54670514|FG000|Overall Study|Physician Decision|1|||
28011587|NCT00420745|54670515|FG001|Overall Study|Physician Decision|1|||
28011588|NCT00420745|54670514|FG000|Overall Study|Recurrent pneumonia & bronchitis|0|||
28011589|NCT00420745|54670515|FG001|Overall Study|Recurrent pneumonia & bronchitis|1|||
28011590|NCT00420745|54670514|FG000|Overall Study|Age limit exceeded for Dose 2|1|||
27919797|NCT01103284|54577053|FG000|Overall Study|Withdrawal by Subject|14|||
27919798|NCT01103284|54577054|FG001|Overall Study|Withdrawal by Subject|18|||
27919799|NCT01103284|54577053|FG000|Overall Study|Dermal Hypersensitivity|0|||
27919800|NCT01103284|54577054|FG001|Overall Study|Dermal Hypersensitivity|1|||
27919801|NCT01103284|54577053|FG000|Overall Study|Termination by the Sponsor|0|||
27919802|NCT01103284|54577054|FG001|Overall Study|Termination by the Sponsor|1|||
27919803|NCT01103284|54577053|FG000|Overall Study|Not described|2|||
27919804|NCT01103284|54577054|FG001|Overall Study|Not described|1|||
28011591|NCT00420745|54670515|FG001|Overall Study|Age limit exceeded for Dose 2|0|||
28011592|NCT00611806|54670523|FG000|Overall Study|Withdrawal by Subject|8|||
28011593|NCT00611806|54670524|FG001|Overall Study|Withdrawal by Subject|2|||
28011594|NCT00611806|54670523|FG000|Overall Study|Adverse Event|2|||
28011595|NCT00611806|54670524|FG001|Overall Study|Adverse Event|1|||
28011596|NCT00611806|54670523|FG000|Overall Study|Lost to Follow-up|6|||
28011597|NCT00611806|54670524|FG001|Overall Study|Lost to Follow-up|0|||
28011598|NCT00413413|54670533|FG000|Single-Blind|Adverse Event|0|||
28011599|NCT00413413|54670534|FG001|Single-Blind|Adverse Event|9|||
28011600|NCT00413413|54670535|FG002|Single-Blind|Adverse Event|0|||
28011601|NCT00413413|54670533|FG000|Single-Blind|Lack of Efficacy|0|||
28011602|NCT00413413|54670534|FG001|Single-Blind|Lack of Efficacy|5|||
28011603|NCT00413413|54670535|FG002|Single-Blind|Lack of Efficacy|0|||
27919805|NCT01103284|54577053|FG000|Overall Study|Missing CRF entries for study completion|0|||
27919806|NCT01103284|54577054|FG001|Overall Study|Missing CRF entries for study completion|2|||
28011604|NCT00413413|54670533|FG000|Single-Blind|Subject no longer requires study drug|0|||
27919807|NCT01070953|54577060|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|612|||
27919808|NCT01070953|54577060|FG000|Participants for Safety Evaluation|Off-label use|283|||
27919809|NCT01070953|54577060|FG000|Participants for Safety Evaluation|Duplicated participants|22|||
27919810|NCT01070953|54577060|FG000|Participants for Safety Evaluation|Treatment prior to date of contract|8|||
27919811|NCT01070953|54577060|FG000|Participants for Safety Evaluation|Uncontracted participants|4|||
27919812|NCT01070953|54577060|FG000|Participants for Safety Evaluation|Violation of inclusions & off label use|1|||
27919813|NCT01070953|54577060|FG000|Participants for Safety Evaluation|Duplicated participants & off-label use|1|||
27919814|NCT01070953|54577060|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|119|||
27919815|NCT01070953|54577060|FG000|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106|||
28011605|NCT00413413|54670534|FG001|Single-Blind|Subject no longer requires study drug|151|||
28011606|NCT00413413|54670535|FG002|Single-Blind|Subject no longer requires study drug|0|||
28011607|NCT00413413|54670533|FG000|Single-Blind|Protocol Violation|0|||
28011608|NCT00413413|54670534|FG001|Single-Blind|Protocol Violation|16|||
28011609|NCT00413413|54670535|FG002|Single-Blind|Protocol Violation|0|||
28011610|NCT00413413|54670533|FG000|Single-Blind|Withdrawal by Subject|0|||
28011611|NCT00413413|54670534|FG001|Single-Blind|Withdrawal by Subject|27|||
28011612|NCT00413413|54670535|FG002|Single-Blind|Withdrawal by Subject|0|||
28011613|NCT00413413|54670533|FG000|Single-Blind|Lost to Follow-up|0|||
28011614|NCT00413413|54670534|FG001|Single-Blind|Lost to Follow-up|8|||
28011615|NCT00413413|54670535|FG002|Single-Blind|Lost to Follow-up|0|||
28011616|NCT00413413|54670533|FG000|Double-Blind|Adverse Event|6|||
28011617|NCT00413413|54670534|FG001|Double-Blind|Adverse Event|0|||
28011618|NCT00413413|54670535|FG002|Double-Blind|Adverse Event|5|||
28011619|NCT00413413|54670533|FG000|Double-Blind|Unsatisfactory therapeutic effect|1|||
28011620|NCT00413413|54670534|FG001|Double-Blind|Unsatisfactory therapeutic effect|2|||
28011621|NCT00413413|54670535|FG002|Double-Blind|Unsatisfactory therapeutic effect|1|||
28011622|NCT00413413|54670533|FG000|Double-Blind|Protocol deviation|1|||
28011623|NCT00413413|54670534|FG001|Double-Blind|Protocol deviation|2|||
28011624|NCT00413413|54670535|FG002|Double-Blind|Protocol deviation|1|||
28011625|NCT00413413|54670533|FG000|Double-Blind|Subject withdrew consent|4|||
28011626|NCT00413413|54670534|FG001|Double-Blind|Subject withdrew consent|6|||
28011627|NCT00413413|54670535|FG002|Double-Blind|Subject withdrew consent|9|||
28011628|NCT00413413|54670533|FG000|Double-Blind|Lost to Follow-up|3|||
28011629|NCT00413413|54670534|FG001|Double-Blind|Lost to Follow-up|4|||
28011630|NCT00413413|54670535|FG002|Double-Blind|Lost to Follow-up|2|||
28011631|NCT00610714|54670545|FG000|Overall Study|Adverse Event|3|||
28011632|NCT00610714|54670546|FG001|Overall Study|Adverse Event|1|||
28011633|NCT00610714|54670545|FG000|Overall Study|Death|12|||
28011634|NCT00610714|54670546|FG001|Overall Study|Death|18|||
28011635|NCT00610714|54670545|FG000|Overall Study|Withdrawal by Subject|9|||
28011636|NCT00610714|54670546|FG001|Overall Study|Withdrawal by Subject|3|||
28011637|NCT00610714|54670545|FG000|Overall Study|Study completion at 120 PFS events|2|||
27919816|NCT01070953|54577060|FG000|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2|||
28011638|NCT00610714|54670546|FG001|Overall Study|Study completion at 120 PFS events|2|||
28011639|NCT00403585|54670552|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
28011640|NCT00403585|54670552|FG000|Open-Label Phase; Extension Study|Withdrawal by Subject|2|||
28011641|NCT00403585|54670552|FG000|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4|||
28011642|NCT00645411|54670560|FG000|Overall Study|Adverse Event|0|||
28011643|NCT00645411|54670561|FG001|Overall Study|Adverse Event|0|||
28011644|NCT00645411|54670562|FG002|Overall Study|Adverse Event|0|||
28011645|NCT00645411|54670563|FG003|Overall Study|Adverse Event|2|||
28011646|NCT00645411|54670560|FG000|Overall Study|Withdrawal by Subject|2|||
28011647|NCT00645411|54670561|FG001|Overall Study|Withdrawal by Subject|1|||
28011648|NCT00645411|54670562|FG002|Overall Study|Withdrawal by Subject|19|||
28011649|NCT00645411|54670563|FG003|Overall Study|Withdrawal by Subject|21|||
28011650|NCT00645411|54670560|FG000|Overall Study|Lost to Follow-up|10|||
28011651|NCT00645411|54670561|FG001|Overall Study|Lost to Follow-up|5|||
28011652|NCT00645411|54670562|FG002|Overall Study|Lost to Follow-up|124|||
28011653|NCT00645411|54670563|FG003|Overall Study|Lost to Follow-up|75|||
28011654|NCT00645411|54670560|FG000|Overall Study|Protocol Violation|1|||
28011655|NCT00645411|54670561|FG001|Overall Study|Protocol Violation|0|||
28011656|NCT00645411|54670562|FG002|Overall Study|Protocol Violation|1|||
28011657|NCT00645411|54670563|FG003|Overall Study|Protocol Violation|0|||
28011658|NCT00645411|54670560|FG000|Overall Study|Inappropriate enrollment|0|||
28011659|NCT00645411|54670561|FG001|Overall Study|Inappropriate enrollment|0|||
28011660|NCT00645411|54670562|FG002|Overall Study|Inappropriate enrollment|4|||
28011661|NCT00645411|54670563|FG003|Overall Study|Inappropriate enrollment|1|||
28011662|NCT00645411|54670560|FG000|Overall Study|Unable to classify|0|||
28011663|NCT00645411|54670561|FG001|Overall Study|Unable to classify|0|||
28011664|NCT00645411|54670562|FG002|Overall Study|Unable to classify|3|||
28011665|NCT00645411|54670563|FG003|Overall Study|Unable to classify|4|||
28011666|NCT00403273|54670582|FG000|Overall Study|Lost to Follow-up|3|||
28011667|NCT00403273|54670583|FG001|Overall Study|Lost to Follow-up|2|||
28011668|NCT00403273|54670582|FG000|Overall Study|Physician Decision|0|||
28011669|NCT00403273|54670583|FG001|Overall Study|Physician Decision|1|||
28011670|NCT00403273|54670582|FG000|Overall Study|pt. wanted to have a surgical procedure|0|||
28011671|NCT00403273|54670583|FG001|Overall Study|pt. wanted to have a surgical procedure|1|||
28011672|NCT00402727|54670606|FG000|Overall Study|Adverse Event|10|||
28011673|NCT00402727|54670607|FG001|Overall Study|Adverse Event|6|||
28011674|NCT00402727|54670606|FG000|Overall Study|Death|1|||
28011675|NCT00402727|54670607|FG001|Overall Study|Death|0|||
28011676|NCT00402727|54670606|FG000|Overall Study|Lack of Efficacy|1|||
28011677|NCT00402727|54670607|FG001|Overall Study|Lack of Efficacy|3|||
28011678|NCT00402727|54670606|FG000|Overall Study|Lost to Follow-up|24|||
28011679|NCT00402727|54670607|FG001|Overall Study|Lost to Follow-up|11|||
28011680|NCT00402727|54670606|FG000|Overall Study|Physician Decision|1|||
28011681|NCT00402727|54670607|FG001|Overall Study|Physician Decision|1|||
28011682|NCT00402727|54670606|FG000|Overall Study|Protocol Violation|0|||
28011683|NCT00402727|54670607|FG001|Overall Study|Protocol Violation|4|||
28011684|NCT00402727|54670606|FG000|Overall Study|Withdrawal by Subject|3|||
28011685|NCT00402727|54670607|FG001|Overall Study|Withdrawal by Subject|7|||
28011686|NCT00402727|54670606|FG000|Overall Study|supply problems|2|||
28011687|NCT00402727|54670607|FG001|Overall Study|supply problems|1|||
28011688|NCT00402727|54670606|FG000|Overall Study|non-compliance|0|||
28011689|NCT00402727|54670607|FG001|Overall Study|non-compliance|1|||
28011690|NCT00402649|54670613|FG000|Overall Study|Lost to Follow-up|1|||
28011691|NCT00402649|54670613|FG000|Overall Study|Withdrawal by Subject|1|||
28011692|NCT00402337|54670622|FG000|Overall Study|Adverse Event|0|||
28011693|NCT00402337|54670623|FG001|Overall Study|Adverse Event|2|||
28011694|NCT00402337|54670624|FG002|Overall Study|Adverse Event|2|||
28011695|NCT00402337|54670625|FG003|Overall Study|Adverse Event|3|||
28011696|NCT00402337|54670626|FG004|Overall Study|Adverse Event|2|||
28011697|NCT00402337|54670622|FG000|Overall Study|Noncompliance|0|||
28011698|NCT00402337|54670623|FG001|Overall Study|Noncompliance|0|||
28011699|NCT00402337|54670624|FG002|Overall Study|Noncompliance|0|||
28011700|NCT00402337|54670625|FG003|Overall Study|Noncompliance|0|||
28011701|NCT00402337|54670626|FG004|Overall Study|Noncompliance|2|||
28011702|NCT00402337|54670622|FG000|Overall Study|Withdrawal by Subject|5|||
28011703|NCT00402337|54670623|FG001|Overall Study|Withdrawal by Subject|3|||
28011704|NCT00402337|54670624|FG002|Overall Study|Withdrawal by Subject|1|||
28011705|NCT00402337|54670625|FG003|Overall Study|Withdrawal by Subject|6|||
28011706|NCT00402337|54670626|FG004|Overall Study|Withdrawal by Subject|4|||
28011707|NCT00402337|54670622|FG000|Overall Study|Lost to Follow-up|0|||
28011708|NCT00402337|54670623|FG001|Overall Study|Lost to Follow-up|0|||
28011709|NCT00402337|54670624|FG002|Overall Study|Lost to Follow-up|1|||
27741388|NCT02712905|54191366|FG012|Combination Therapy|Study Terminated by Sponsor|0|||
28011710|NCT00402337|54670625|FG003|Overall Study|Lost to Follow-up|2|||
28011711|NCT00402337|54670626|FG004|Overall Study|Lost to Follow-up|0|||
28011712|NCT00402337|54670622|FG000|Overall Study|Physician Decision|0|||
28011713|NCT00402337|54670623|FG001|Overall Study|Physician Decision|0|||
28011714|NCT00402337|54670624|FG002|Overall Study|Physician Decision|0|||
28011715|NCT00402337|54670625|FG003|Overall Study|Physician Decision|1|||
28011716|NCT00402337|54670626|FG004|Overall Study|Physician Decision|0|||
28011717|NCT00402337|54670622|FG000|Overall Study|Other Reason|0|||
28011718|NCT00402337|54670623|FG001|Overall Study|Other Reason|1|||
28011719|NCT00402337|54670624|FG002|Overall Study|Other Reason|0|||
28011720|NCT00402337|54670625|FG003|Overall Study|Other Reason|0|||
28011721|NCT00402337|54670626|FG004|Overall Study|Other Reason|0|||
28011722|NCT00650091|54670640|FG000|Amended Study Design|Withdrawal by Subject|12|||
28011723|NCT00650091|54670641|FG001|Amended Study Design|Withdrawal by Subject|11|||
28011724|NCT00650091|54670642|FG002|Amended Study Design|Withdrawal by Subject|0|||
28011725|NCT00650091|54670640|FG000|Amended Study Design|Physician Decision|5|||
28011726|NCT00650091|54670641|FG001|Amended Study Design|Physician Decision|0|||
28011727|NCT00650091|54670642|FG002|Amended Study Design|Physician Decision|0|||
28011728|NCT00650091|54670640|FG000|Amended Study Design|Adverse Event|1|||
28011729|NCT00650091|54670641|FG001|Amended Study Design|Adverse Event|4|||
28011730|NCT00650091|54670642|FG002|Amended Study Design|Adverse Event|0|||
28011731|NCT00650091|54670640|FG000|Amended Study Design|Lung transplantation|4|||
28011732|NCT00650091|54670641|FG001|Amended Study Design|Lung transplantation|2|||
28011733|NCT00650091|54670642|FG002|Amended Study Design|Lung transplantation|0|||
28011734|NCT00650091|54670640|FG000|Amended Study Design|Other|1|||
28011735|NCT00650091|54670641|FG001|Amended Study Design|Other|3|||
28011736|NCT00650091|54670642|FG002|Amended Study Design|Other|0|||
28011737|NCT00642369|54670652|FG000|Overall Study|Adverse Event|2|||
28011738|NCT00642369|54670653|FG001|Overall Study|Adverse Event|3|||
28011739|NCT00642369|54670652|FG000|Overall Study|Withdrawal by Subject|1|||
28011740|NCT00642369|54670653|FG001|Overall Study|Withdrawal by Subject|0|||
28011741|NCT00642369|54670652|FG000|Overall Study|misdiagnosis|0|||
28011742|NCT00642369|54670653|FG001|Overall Study|misdiagnosis|1|||
28011743|NCT00642369|54670652|FG000|Overall Study|Lack of Efficacy|2|||
28011744|NCT00642369|54670653|FG001|Overall Study|Lack of Efficacy|2|||
28011745|NCT00645099|54670678|FG000|Overall Study|Lack of Efficacy|15|||
28011746|NCT00645099|54670679|FG001|Overall Study|Lack of Efficacy|6|||
28011747|NCT00645099|54670678|FG000|Overall Study|Withdrawal by Subject|30|||
28011748|NCT00645099|54670679|FG001|Overall Study|Withdrawal by Subject|22|||
28011749|NCT00645099|54670678|FG000|Overall Study|Lost to Follow-up|6|||
28011750|NCT00645099|54670679|FG001|Overall Study|Lost to Follow-up|4|||
28011751|NCT00645099|54670678|FG000|Overall Study|Adverse Event|11|||
28011752|NCT00645099|54670679|FG001|Overall Study|Adverse Event|5|||
28011753|NCT00645099|54670678|FG000|Overall Study|Other|9|||
28011754|NCT00645099|54670679|FG001|Overall Study|Other|5|||
28011755|NCT00420511|54670687|FG000|Overall Study|Adverse Event|1|||
28011756|NCT00420511|54670688|FG001|Overall Study|Adverse Event|1|||
28011757|NCT00420511|54670687|FG000|Overall Study|Lost to Follow-up|1|||
28011758|NCT00420511|54670688|FG001|Overall Study|Lost to Follow-up|0|||
28011759|NCT00420199|54670698|FG000|Overall Study|Participant no longer met study criteria|1|||
28011760|NCT00420199|54670699|FG001|Overall Study|Participant no longer met study criteria|0|||
28011761|NCT00649389|54670714|FG000|Overall Study|Adverse Event|22|||
28011762|NCT00649389|54670715|FG001|Overall Study|Adverse Event|46|||
28011763|NCT00649389|54670716|FG002|Overall Study|Adverse Event|38|||
28011764|NCT00649389|54670717|FG003|Overall Study|Adverse Event|48|||
28011765|NCT00649389|54670714|FG000|Overall Study|Lost to Follow-up|15|||
28011766|NCT00649389|54670715|FG001|Overall Study|Lost to Follow-up|17|||
28011767|NCT00649389|54670716|FG002|Overall Study|Lost to Follow-up|21|||
28011768|NCT00649389|54670717|FG003|Overall Study|Lost to Follow-up|26|||
28011769|NCT00649389|54670714|FG000|Overall Study|Protocol Violation|11|||
28011770|NCT00649389|54670715|FG001|Overall Study|Protocol Violation|13|||
28011771|NCT00649389|54670716|FG002|Overall Study|Protocol Violation|9|||
28011772|NCT00649389|54670717|FG003|Overall Study|Protocol Violation|8|||
28011773|NCT00649389|54670714|FG000|Overall Study|Withdrawal by Subject|20|||
28011774|NCT00649389|54670715|FG001|Overall Study|Withdrawal by Subject|21|||
28011775|NCT00649389|54670716|FG002|Overall Study|Withdrawal by Subject|19|||
28011776|NCT00649389|54670717|FG003|Overall Study|Withdrawal by Subject|23|||
28011777|NCT00649389|54670714|FG000|Overall Study|Other|3|||
28011778|NCT00649389|54670715|FG001|Overall Study|Other|9|||
28011779|NCT00649389|54670716|FG002|Overall Study|Other|1|||
28011780|NCT00649389|54670717|FG003|Overall Study|Other|6|||
28011781|NCT00402103|54670729|FG000|Overall Study|Adverse Event|60|||
28011782|NCT00402103|54670730|FG001|Overall Study|Adverse Event|7|||
28011783|NCT00402103|54670729|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
28011784|NCT00402103|54670730|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
28011785|NCT00402103|54670729|FG000|Overall Study|Condition no longer requires study drug|2|||
28011786|NCT00402103|54670730|FG001|Overall Study|Condition no longer requires study drug|0|||
28011787|NCT00402103|54670729|FG000|Overall Study|Protocol Deviation|8|||
28011788|NCT00402103|54670730|FG001|Overall Study|Protocol Deviation|0|||
28011789|NCT00402103|54670729|FG000|Overall Study|Patient withdrew consent|12|||
28011790|NCT00402103|54670730|FG001|Overall Study|Patient withdrew consent|1|||
28011791|NCT00402103|54670729|FG000|Overall Study|Lost to Follow-up|6|||
28011792|NCT00402103|54670730|FG001|Overall Study|Lost to Follow-up|3|||
28011793|NCT00402103|54670729|FG000|Overall Study|Administrative problems|2|||
28011794|NCT00402103|54670730|FG001|Overall Study|Administrative problems|0|||
28011795|NCT00641667|54670740|FG000|Overall Study|Withdrawal by Subject|1|||
28011796|NCT00641667|54670740|FG000|Overall Study|Adverse Event|1|||
28011797|NCT00641667|54670740|FG000|Overall Study|Physician Decision|1|||
28011798|NCT00641667|54670740|FG000|Overall Study|Worsening of underlying disease|3|||
28011799|NCT00704184|54670749|FG000|Double-Blind Treatment|Withdrawal by Subject|1|||
28011800|NCT00704184|54670750|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
28011801|NCT00704184|54670751|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
28011802|NCT00704184|54670752|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
28011803|NCT00704184|54670753|FG004|Double-Blind Treatment|Withdrawal by Subject|0|||
28011804|NCT00704184|54670749|FG000|Open-Label Treatment|Adverse Event|0|||
28011805|NCT00704184|54670750|FG001|Open-Label Treatment|Adverse Event|0|||
28011806|NCT00704184|54670751|FG002|Open-Label Treatment|Adverse Event|2|||
28011807|NCT00704184|54670752|FG003|Open-Label Treatment|Adverse Event|0|||
28011808|NCT00704184|54670753|FG004|Open-Label Treatment|Adverse Event|1|||
28011809|NCT00704184|54670749|FG000|Open-Label Treatment|Lack of Efficacy|0|||
28011810|NCT00704184|54670750|FG001|Open-Label Treatment|Lack of Efficacy|2|||
28011811|NCT00704184|54670751|FG002|Open-Label Treatment|Lack of Efficacy|2|||
28011812|NCT00704184|54670752|FG003|Open-Label Treatment|Lack of Efficacy|2|||
28011813|NCT00704184|54670753|FG004|Open-Label Treatment|Lack of Efficacy|1|||
28011814|NCT00704184|54670749|FG000|Open-Label Treatment|Physician Decision|0|||
28011815|NCT00704184|54670750|FG001|Open-Label Treatment|Physician Decision|0|||
28011816|NCT00704184|54670751|FG002|Open-Label Treatment|Physician Decision|0|||
28011817|NCT00704184|54670752|FG003|Open-Label Treatment|Physician Decision|0|||
28011818|NCT00704184|54670753|FG004|Open-Label Treatment|Physician Decision|1|||
28011819|NCT00704184|54670749|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
28011820|NCT00704184|54670750|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
28011821|NCT00704184|54670751|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
28011822|NCT00704184|54670752|FG003|Open-Label Treatment|Withdrawal by Subject|3|||
28011823|NCT00704184|54670753|FG004|Open-Label Treatment|Withdrawal by Subject|0|||
28011824|NCT00641043|54670767|FG000|Overall Study|Adverse Event|6|||
28011825|NCT00641043|54670768|FG001|Overall Study|Adverse Event|4|||
28011826|NCT00641043|54670767|FG000|Overall Study|Protocol Violation|2|||
28011827|NCT00641043|54670768|FG001|Overall Study|Protocol Violation|3|||
28011828|NCT00641043|54670767|FG000|Overall Study|Lost to Follow-up|3|||
28011829|NCT00641043|54670768|FG001|Overall Study|Lost to Follow-up|2|||
28011830|NCT00641043|54670767|FG000|Overall Study|Withdrawal by Subject|4|||
28011831|NCT00641043|54670768|FG001|Overall Study|Withdrawal by Subject|4|||
28011832|NCT00641043|54670767|FG000|Overall Study|Other incl. lack of efficacy|4|||
28011833|NCT00641043|54670768|FG001|Overall Study|Other incl. lack of efficacy|2|||
28011834|NCT00402025|54670777|FG000|Overall Study|Adverse Event|0|||
28011835|NCT00402025|54670778|FG001|Overall Study|Adverse Event|0|||
28011836|NCT00402025|54670779|FG002|Overall Study|Adverse Event|2|||
28011837|NCT00402025|54670777|FG000|Overall Study|Death|0|||
28011838|NCT00402025|54670778|FG001|Overall Study|Death|1|||
28011839|NCT00402025|54670779|FG002|Overall Study|Death|5|||
28011840|NCT00402025|54670777|FG000|Overall Study|Disease Progression|1|||
28011841|NCT00402025|54670778|FG001|Overall Study|Disease Progression|1|||
28011842|NCT00402025|54670779|FG002|Overall Study|Disease Progression|2|||
28011843|NCT00402025|54670777|FG000|Overall Study|Physician Decision|1|||
28011844|NCT00402025|54670778|FG001|Overall Study|Physician Decision|1|||
28011845|NCT00402025|54670779|FG002|Overall Study|Physician Decision|0|||
28011846|NCT00402025|54670777|FG000|Overall Study|Participant Decision|0|||
28011847|NCT00402025|54670778|FG001|Overall Study|Participant Decision|0|||
28011848|NCT00402025|54670779|FG002|Overall Study|Participant Decision|1|||
28011849|NCT00609622|54670789|FG000|Overall Study|Adverse Event|14|||
28011850|NCT00609622|54670790|FG001|Overall Study|Adverse Event|10|||
28011851|NCT00609622|54670789|FG000|Overall Study|Withdrawal by Subject|4|||
28011852|NCT00609622|54670790|FG001|Overall Study|Withdrawal by Subject|20|||
28011853|NCT00609622|54670789|FG000|Overall Study|Death|1|||
28011854|NCT00609622|54670790|FG001|Overall Study|Death|4|||
28011855|NCT00609622|54670789|FG000|Overall Study|Protocol Violation|1|||
28011856|NCT00609622|54670790|FG001|Overall Study|Protocol Violation|1|||
28011857|NCT00609622|54670789|FG000|Overall Study|Objective progression or relapse|47|||
28011858|NCT00609622|54670790|FG001|Overall Study|Objective progression or relapse|41|||
28011859|NCT00609622|54670789|FG000|Overall Study|Study terminated by sponsor|16|||
28011860|NCT00609622|54670790|FG001|Overall Study|Study terminated by sponsor|3|||
28011861|NCT00609622|54670789|FG000|Overall Study|Other|7|||
28011862|NCT00609622|54670790|FG001|Overall Study|Other|14|||
28011863|NCT00609622|54670789|FG000|Overall Study|Global deterioration of health status|6|||
28011864|NCT00609622|54670790|FG001|Overall Study|Global deterioration of health status|2|||
28011865|NCT00699660|54670798|FG000|Overall Study|Lost to Follow-up|4|||
28011866|NCT00699660|54670799|FG001|Overall Study|Lost to Follow-up|2|||
28011867|NCT00699660|54670798|FG000|Overall Study|missing reports and recording failures|10|||
28011868|NCT00699660|54670799|FG001|Overall Study|missing reports and recording failures|6|||
28011869|NCT00627705|54670807|FG000|Overall Study|Unwilling to take the compound (taste)|1|||
28103670|NCT02849080|54760393|FG001|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
28103671|NCT02849080|54760394|FG002|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
28103672|NCT02849080|54760395|FG003|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
28103673|NCT02849080|54760392|FG000|Extension Phase: 53 - 104 Weeks|Other|0|||
28103674|NCT02849080|54760393|FG001|Extension Phase: 53 - 104 Weeks|Other|0|||
28103675|NCT02849080|54760394|FG002|Extension Phase: 53 - 104 Weeks|Other|1|||
28011870|NCT00627705|54670808|FG001|Overall Study|Unwilling to take the compound (taste)|3|||
28011871|NCT00627705|54670807|FG000|Overall Study|Adverse Event|1|||
28011872|NCT00627705|54670808|FG001|Overall Study|Adverse Event|0|||
28011873|NCT00627705|54670807|FG000|Overall Study|Withdrawal by Subject|0|||
28011874|NCT00627705|54670808|FG001|Overall Study|Withdrawal by Subject|2|||
28011875|NCT00627705|54670807|FG000|Overall Study|Lost to Follow-up|0|||
28011876|NCT00627705|54670808|FG001|Overall Study|Lost to Follow-up|1|||
28011877|NCT00610168|54670816|FG000|Overall Study|Withdrawal by Subject|2|||
28011878|NCT00610168|54670817|FG001|Overall Study|Withdrawal by Subject|0|||
28011879|NCT00644787|54670823|FG000|Period 1: Titration Phase|Adverse Event|11|||
28011880|NCT00644787|54670824|FG001|Period 1: Titration Phase|Adverse Event|0|||
28011881|NCT00644787|54670825|FG002|Period 1: Titration Phase|Adverse Event|0|||
28011882|NCT00644787|54670823|FG000|Period 1: Titration Phase|Withdrawal by Subject|2|||
28011883|NCT00644787|54670824|FG001|Period 1: Titration Phase|Withdrawal by Subject|0|||
28011884|NCT00644787|54670825|FG002|Period 1: Titration Phase|Withdrawal by Subject|0|||
28011885|NCT00644787|54670823|FG000|Period 1: Titration Phase|Physician Decision|1|||
28011886|NCT00644787|54670824|FG001|Period 1: Titration Phase|Physician Decision|0|||
28011887|NCT00644787|54670825|FG002|Period 1: Titration Phase|Physician Decision|0|||
28011888|NCT00644787|54670823|FG000|Period 1: Titration Phase|Worsening of underlying disease|5|||
28011889|NCT00644787|54670824|FG001|Period 1: Titration Phase|Worsening of underlying disease|0|||
28011890|NCT00644787|54670825|FG002|Period 1: Titration Phase|Worsening of underlying disease|0|||
28011891|NCT00644787|54670823|FG000|Period 1: Titration Phase|Worsening of complications|1|||
28011892|NCT00644787|54670824|FG001|Period 1: Titration Phase|Worsening of complications|0|||
28011893|NCT00644787|54670825|FG002|Period 1: Titration Phase|Worsening of complications|0|||
28011894|NCT00644787|54670823|FG000|Period 1: Titration Phase|Worsening of symptoms|1|||
28011895|NCT00644787|54670824|FG001|Period 1: Titration Phase|Worsening of symptoms|0|||
28011896|NCT00644787|54670825|FG002|Period 1: Titration Phase|Worsening of symptoms|0|||
28011897|NCT00644787|54670823|FG000|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3|||
28011898|NCT00644787|54670824|FG001|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
28011899|NCT00644787|54670825|FG002|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
28011900|NCT00644787|54670823|FG000|Period 1: Titration Phase|Participant was judged as ineligible|3|||
28011901|NCT00644787|54670824|FG001|Period 1: Titration Phase|Participant was judged as ineligible|0|||
28011902|NCT00644787|54670825|FG002|Period 1: Titration Phase|Participant was judged as ineligible|0|||
28011903|NCT00644787|54670823|FG000|Period 2: Double Blind Phase|Adverse Event|0|||
28011904|NCT00644787|54670824|FG001|Period 2: Double Blind Phase|Adverse Event|2|||
28011905|NCT00644787|54670825|FG002|Period 2: Double Blind Phase|Adverse Event|4|||
28011906|NCT00644787|54670823|FG000|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
28011907|NCT00644787|54670824|FG001|Period 2: Double Blind Phase|Withdrawal by Subject|1|||
28011908|NCT00644787|54670825|FG002|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
28011909|NCT00644787|54670823|FG000|Period 2: Double Blind Phase|Worsening of underlying disease|0|||
28011910|NCT00644787|54670824|FG001|Period 2: Double Blind Phase|Worsening of underlying disease|6|||
28011911|NCT00644787|54670825|FG002|Period 2: Double Blind Phase|Worsening of underlying disease|2|||
28011912|NCT00644787|54670823|FG000|Period 2: Double Blind Phase|Worsening of symptoms|0|||
28011913|NCT00644787|54670824|FG001|Period 2: Double Blind Phase|Worsening of symptoms|0|||
28011914|NCT00644787|54670825|FG002|Period 2: Double Blind Phase|Worsening of symptoms|1|||
28011915|NCT00699582|54670836|FG000|Overall Study|Adverse Event|4|||
28011916|NCT00699582|54670837|FG001|Overall Study|Adverse Event|11|||
28011917|NCT00699582|54670838|FG002|Overall Study|Adverse Event|23|||
28011918|NCT00699582|54670836|FG000|Overall Study|Withdrawal by Subject|6|||
28011919|NCT00699582|54670837|FG001|Overall Study|Withdrawal by Subject|7|||
28011920|NCT00699582|54670838|FG002|Overall Study|Withdrawal by Subject|4|||
28011921|NCT00699582|54670836|FG000|Overall Study|Lack of Efficacy|1|||
28011922|NCT00699582|54670837|FG001|Overall Study|Lack of Efficacy|0|||
28011923|NCT00699582|54670838|FG002|Overall Study|Lack of Efficacy|1|||
28011924|NCT00699582|54670836|FG000|Overall Study|Progressive Disease|1|||
28011925|NCT00699582|54670837|FG001|Overall Study|Progressive Disease|0|||
28011926|NCT00699582|54670838|FG002|Overall Study|Progressive Disease|0|||
28011927|NCT00699582|54670836|FG000|Overall Study|Administrative/Other|4|||
28011928|NCT00699582|54670837|FG001|Overall Study|Administrative/Other|3|||
28011929|NCT00699582|54670838|FG002|Overall Study|Administrative/Other|0|||
28011930|NCT00699582|54670836|FG000|Overall Study|Randomized, Not Treated|2|||
28011931|NCT00699582|54670837|FG001|Overall Study|Randomized, Not Treated|1|||
28011932|NCT00699582|54670838|FG002|Overall Study|Randomized, Not Treated|0|||
28011933|NCT00640341|54670849|FG000|Overall Study|Adverse Event|0|||
28011934|NCT00640341|54670850|FG001|Overall Study|Adverse Event|0|||
28011935|NCT00640341|54670851|FG002|Overall Study|Adverse Event|1|||
28011936|NCT00640341|54670849|FG000|Overall Study|Positive Slit Lamp Findings|0|||
28011937|NCT00640341|54670850|FG001|Overall Study|Positive Slit Lamp Findings|0|||
28011938|NCT00640341|54670851|FG002|Overall Study|Positive Slit Lamp Findings|1|||
28011939|NCT00640341|54670849|FG000|Overall Study|Study Related Symptoms/Complaints|2|||
28011940|NCT00640341|54670850|FG001|Overall Study|Study Related Symptoms/Complaints|1|||
28011941|NCT00640341|54670851|FG002|Overall Study|Study Related Symptoms/Complaints|2|||
28011942|NCT00640341|54670849|FG000|Overall Study|Inability to Maintain Wearing Schedule|1|||
28011943|NCT00640341|54670850|FG001|Overall Study|Inability to Maintain Wearing Schedule|1|||
28011944|NCT00640341|54670851|FG002|Overall Study|Inability to Maintain Wearing Schedule|0|||
28011945|NCT00640341|54670849|FG000|Overall Study|Failure to Follow Subject Instructions|1|||
28011946|NCT00640341|54670850|FG001|Overall Study|Failure to Follow Subject Instructions|0|||
28011947|NCT00640341|54670851|FG002|Overall Study|Failure to Follow Subject Instructions|0|||
28011948|NCT00640341|54670849|FG000|Overall Study|Lost to Follow-up|2|||
28011949|NCT00640341|54670850|FG001|Overall Study|Lost to Follow-up|0|||
28011950|NCT00640341|54670851|FG002|Overall Study|Lost to Follow-up|0|||
28011951|NCT00640341|54670849|FG000|Overall Study|Withdrawal by Subject|4|||
28011952|NCT00640341|54670850|FG001|Overall Study|Withdrawal by Subject|0|||
28011953|NCT00640341|54670851|FG002|Overall Study|Withdrawal by Subject|1|||
28011954|NCT00640341|54670849|FG000|Overall Study|Unacceptable Lens Movement|1|||
28011955|NCT00640341|54670850|FG001|Overall Study|Unacceptable Lens Movement|0|||
28011956|NCT00640341|54670851|FG002|Overall Study|Unacceptable Lens Movement|0|||
28011957|NCT00640341|54670849|FG000|Overall Study|Poor fit/Uncomfortable|4|||
28011958|NCT00640341|54670850|FG001|Overall Study|Poor fit/Uncomfortable|0|||
28011959|NCT00640341|54670851|FG002|Overall Study|Poor fit/Uncomfortable|0|||
28011960|NCT00640341|54670849|FG000|Overall Study|Ineligable at Baseline|5|||
28011961|NCT00640341|54670850|FG001|Overall Study|Ineligable at Baseline|3|||
28011962|NCT00640341|54670851|FG002|Overall Study|Ineligable at Baseline|2|||
28011963|NCT00640341|54670849|FG000|Overall Study|Adverse event and positive slit lamp|1|||
28011964|NCT00640341|54670850|FG001|Overall Study|Adverse event and positive slit lamp|0|||
28011965|NCT00640341|54670851|FG002|Overall Study|Adverse event and positive slit lamp|0|||
28011966|NCT00699348|54670859|FG000|Overall Study|Death|6|||
28011967|NCT00699348|54670859|FG000|Overall Study|Adverse Event|15|||
28011968|NCT00699348|54670859|FG000|Overall Study|Withdrawal by Subject|11|||
28011969|NCT00699348|54670859|FG000|Overall Study|Protocol Violation|10|||
28011970|NCT00699348|54670859|FG000|Overall Study|Lack of Efficacy|8|||
28011971|NCT00699348|54670859|FG000|Overall Study|Failure to return|1|||
28011972|NCT00699348|54670859|FG000|Overall Study|Blood transfusion|24|||
28011973|NCT00699348|54670859|FG000|Overall Study|Renal transplantation|10|||
28011974|NCT00699348|54670859|FG000|Overall Study|Other|5|||
28011975|NCT00643851|54670866|FG000|Overall Study|Death|0|||
28011976|NCT00643851|54670867|FG001|Overall Study|Death|1|||
28011977|NCT00643851|54670868|FG002|Overall Study|Death|0|||
28011978|NCT00643851|54670866|FG000|Overall Study|Lack of Efficacy|0|||
27919817|NCT01089361|54577072|FG000|Overall Study|Death|1|||
27919818|NCT01089361|54577073|FG001|Overall Study|Death|0|||
27919819|NCT01102972|54577083|FG000|Overall Study|Adverse Event|8|||
27919820|NCT01102972|54577084|FG001|Overall Study|Adverse Event|2|||
27919821|NCT01102972|54577083|FG000|Overall Study|Lack of Efficacy|2|||
27919822|NCT01102972|54577084|FG001|Overall Study|Lack of Efficacy|1|||
27919823|NCT01102972|54577083|FG000|Overall Study|Protocol Violation|1|||
27919824|NCT01102972|54577084|FG001|Overall Study|Protocol Violation|0|||
27919825|NCT01102972|54577083|FG000|Overall Study|Lost to Follow-up|10|||
27919826|NCT01102972|54577084|FG001|Overall Study|Lost to Follow-up|5|||
27919827|NCT01102972|54577083|FG000|Overall Study|Investigator Discretion|2|||
27919828|NCT01102972|54577084|FG001|Overall Study|Investigator Discretion|0|||
27919829|NCT01102972|54577083|FG000|Overall Study|Withdrawal by Subject|6|||
27919830|NCT01102972|54577084|FG001|Overall Study|Withdrawal by Subject|6|||
27919831|NCT01309269|54577090|FG000|Overall Study|Adverse Event|56|||
27919832|NCT01309269|54577090|FG000|Overall Study|Withdrawal by Subject|25|||
27919833|NCT01309269|54577090|FG000|Overall Study|Lack of Acceptance|15|||
27919834|NCT01309269|54577090|FG000|Overall Study|Other Erythropoiesis-stimulating Agents|119|||
27919835|NCT01309269|54577090|FG000|Overall Study|Kidney Transplant|25|||
27919836|NCT01309269|54577090|FG000|Overall Study|Administrative Problems|141|||
27919837|NCT01309269|54577090|FG000|Overall Study|Other|256|||
27919838|NCT01309269|54577090|FG000|Overall Study|Other|1|||
27919839|NCT01309269|54577090|FG000|Overall Study|Study Completion Data Not Recorded|95|||
27919840|NCT01309269|54577090|FG000|Overall Study|Enrolled but not Treated|107|||
27919841|NCT01088503|54577097|FG000|Overall Study|Withdrawal by Subject|118|||
27919842|NCT01088503|54577098|FG001|Overall Study|Withdrawal by Subject|327|||
27919843|NCT01088503|54577099|FG002|Overall Study|Withdrawal by Subject|10|||
27919844|NCT01088503|54577097|FG000|Overall Study|Death|64|||
27919845|NCT01088503|54577098|FG001|Overall Study|Death|358|||
27919846|NCT01088503|54577099|FG002|Overall Study|Death|7|||
27919847|NCT01087489|54577105|FG000|Overall Study|enrolled in another VA study|0|||
27919848|NCT01087489|54577106|FG001|Overall Study|enrolled in another VA study|1|||
27919849|NCT01087489|54577105|FG000|Overall Study|Death|0|||
28011979|NCT00643851|54670867|FG001|Overall Study|Lack of Efficacy|1|||
28011980|NCT00643851|54670868|FG002|Overall Study|Lack of Efficacy|0|||
28011981|NCT00643851|54670866|FG000|Overall Study|Adverse Event|2|||
28011982|NCT00643851|54670867|FG001|Overall Study|Adverse Event|6|||
28011983|NCT00643851|54670868|FG002|Overall Study|Adverse Event|6|||
28011984|NCT00643851|54670866|FG000|Overall Study|Lost to Follow-up|4|||
28011985|NCT00643851|54670867|FG001|Overall Study|Lost to Follow-up|6|||
28011986|NCT00643851|54670868|FG002|Overall Study|Lost to Follow-up|9|||
28011987|NCT00643851|54670866|FG000|Overall Study|Withdrawal by Subject|8|||
28011988|NCT00643851|54670867|FG001|Overall Study|Withdrawal by Subject|15|||
28011989|NCT00643851|54670868|FG002|Overall Study|Withdrawal by Subject|9|||
28011990|NCT00643851|54670866|FG000|Overall Study|Non-compl., not met criteria, etc.|3|||
28011991|NCT00643851|54670867|FG001|Overall Study|Non-compl., not met criteria, etc.|4|||
28011992|NCT00643851|54670868|FG002|Overall Study|Non-compl., not met criteria, etc.|6|||
28011993|NCT03667690|54670878|FG000|Overall Study|Adverse Event|0|||
28011994|NCT03667690|54670879|FG001|Overall Study|Adverse Event|3|||
28011995|NCT03667690|54670878|FG000|Overall Study|Death|22|||
28011996|NCT03667690|54670879|FG001|Overall Study|Death|21|||
28011997|NCT03667690|54670878|FG000|Overall Study|Lost to Follow-up|4|||
28011998|NCT03667690|54670879|FG001|Overall Study|Lost to Follow-up|5|||
28011999|NCT03667690|54670878|FG000|Overall Study|Withdrawal by Subject|7|||
28012000|NCT03667690|54670879|FG001|Overall Study|Withdrawal by Subject|8|||
28012001|NCT03667690|54670878|FG000|Overall Study|Subject could not return for additional investigational product|1|||
28012002|NCT03667690|54670879|FG001|Overall Study|Subject could not return for additional investigational product|0|||
28012003|NCT03667690|54670878|FG000|Overall Study|Subject discharged to hospice care|2|||
28012004|NCT03667690|54670879|FG001|Overall Study|Subject discharged to hospice care|0|||
28012005|NCT03667690|54670878|FG000|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|1|||
28012006|NCT03667690|54670879|FG001|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|0|||
28012007|NCT03667690|54670878|FG000|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|2|||
28012008|NCT03667690|54670879|FG001|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|1|||
28012009|NCT03667690|54670878|FG000|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
28012010|NCT03667690|54670879|FG001|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
28012011|NCT03667690|54670878|FG000|Overall Study|Subject was dropped due to exclusion criterion number 9|1|||
28012012|NCT03667690|54670879|FG001|Overall Study|Subject was dropped due to exclusion criterion number 9|0|||
28012013|NCT03667690|54670878|FG000|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|0|||
28012014|NCT03667690|54670879|FG001|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|1|||
28012015|NCT00627393|54670887|FG000|Intention-To-Treat Analysis|Adjudication indeterminate|5|||
28012016|NCT00627393|54670888|FG001|Intention-To-Treat Analysis|Adjudication indeterminate|3|||
28012017|NCT00627393|54670887|FG000|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4|||
28012018|NCT00627393|54670888|FG001|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5|||
28012019|NCT00627393|54670887|FG000|Per-Protocol Analysis|Received unstimulated/no granulocytes|6|||
28012020|NCT00627393|54670888|FG001|Per-Protocol Analysis|Received unstimulated/no granulocytes|3|||
28012021|NCT00627393|54670887|FG000|Per-Protocol Analysis|Withdrawal by patient/family/physician|4|||
28012022|NCT00627393|54670888|FG001|Per-Protocol Analysis|Withdrawal by patient/family/physician|10|||
28012023|NCT00577122|54670898|FG000|Overall Study|Adverse Event|0|||
28012024|NCT00577122|54670899|FG001|Overall Study|Adverse Event|2|||
28012025|NCT00577122|54670898|FG000|Overall Study|Progression, relapse during active trt|6|||
28012026|NCT00577122|54670899|FG001|Overall Study|Progression, relapse during active trt|8|||
28012027|NCT00577122|54670898|FG000|Overall Study|Prog, refract disease during active trt|8|||
28012028|NCT00577122|54670899|FG001|Overall Study|Prog, refract disease during active trt|5|||
28012029|NCT00577122|54670898|FG000|Overall Study|Alternative Therapy|0|||
28012030|NCT00577122|54670899|FG001|Overall Study|Alternative Therapy|1|||
28012031|NCT00696774|54670909|FG000|Period II|Adverse Event|0|||
28012032|NCT00696774|54670910|FG001|Period II|Adverse Event|0|||
28012033|NCT00696774|54670911|FG002|Period II|Adverse Event|15|||
28012034|NCT00696774|54670909|FG000|Period II|Lost to Follow-up|0|||
28012035|NCT00696774|54670910|FG001|Period II|Lost to Follow-up|0|||
28012036|NCT00696774|54670911|FG002|Period II|Lost to Follow-up|4|||
28012037|NCT00696774|54670909|FG000|Period II|Protocol Violation|0|||
28012038|NCT00696774|54670910|FG001|Period II|Protocol Violation|0|||
28012039|NCT00696774|54670911|FG002|Period II|Protocol Violation|11|||
28012040|NCT00696774|54670909|FG000|Period II|Withdrawal by Subject|0|||
28012041|NCT00696774|54670910|FG001|Period II|Withdrawal by Subject|0|||
28012042|NCT00696774|54670911|FG002|Period II|Withdrawal by Subject|4|||
28012043|NCT00696774|54670909|FG000|Period II|Sponsor Decision|0|||
28012044|NCT00696774|54670910|FG001|Period II|Sponsor Decision|0|||
28012045|NCT00696774|54670911|FG002|Period II|Sponsor Decision|0|||
28012046|NCT00696774|54670909|FG000|Period II|Lack of Efficacy|0|||
28012047|NCT00696774|54670910|FG001|Period II|Lack of Efficacy|0|||
28012048|NCT00696774|54670911|FG002|Period II|Lack of Efficacy|2|||
28012049|NCT00696774|54670909|FG000|Period III|Adverse Event|1|||
28012050|NCT00696774|54670910|FG001|Period III|Adverse Event|1|||
28012051|NCT00696774|54670911|FG002|Period III|Adverse Event|0|||
28012052|NCT00696774|54670909|FG000|Period III|Lost to Follow-up|2|||
28012053|NCT00696774|54670910|FG001|Period III|Lost to Follow-up|1|||
28012054|NCT00696774|54670911|FG002|Period III|Lost to Follow-up|0|||
28012055|NCT00696774|54670909|FG000|Period III|Protocol Violation|1|||
28012056|NCT00696774|54670910|FG001|Period III|Protocol Violation|1|||
28012057|NCT00696774|54670911|FG002|Period III|Protocol Violation|0|||
28012058|NCT00696774|54670909|FG000|Period III|Withdrawal by Subject|1|||
28012059|NCT00696774|54670910|FG001|Period III|Withdrawal by Subject|2|||
28012060|NCT00696774|54670911|FG002|Period III|Withdrawal by Subject|0|||
28012061|NCT00696774|54670909|FG000|Period III|Sponsor Decision|2|||
28012062|NCT00696774|54670910|FG001|Period III|Sponsor Decision|0|||
28012063|NCT00696774|54670911|FG002|Period III|Sponsor Decision|0|||
28012064|NCT00696774|54670909|FG000|Period III|Lack of Efficacy|0|||
28012065|NCT00696774|54670910|FG001|Period III|Lack of Efficacy|2|||
28012066|NCT00696774|54670911|FG002|Period III|Lack of Efficacy|0|||
28012067|NCT00608842|54670923|FG000|Overall Study|Participant's Request|0|||
28012068|NCT00608842|54670924|FG001|Overall Study|Participant's Request|1|||
28012069|NCT00608842|54670925|FG002|Overall Study|Participant's Request|2|||
28012070|NCT00608842|54670926|FG003|Overall Study|Participant's Request|1|||
28012071|NCT00608842|54670923|FG000|Overall Study|Lost to Follow-up|1|||
28012072|NCT00608842|54670924|FG001|Overall Study|Lost to Follow-up|0|||
28012073|NCT00608842|54670925|FG002|Overall Study|Lost to Follow-up|0|||
28012074|NCT00608842|54670926|FG003|Overall Study|Lost to Follow-up|0|||
28012075|NCT00626925|54670938|FG000|Overall Study|Lost to Follow-up|1|||
28012076|NCT00626925|54670939|FG001|Overall Study|Lost to Follow-up|2|||
28012077|NCT00626925|54670938|FG000|Overall Study|relapse|1|||
28012078|NCT00626925|54670939|FG001|Overall Study|relapse|0|||
28012079|NCT00626925|54670938|FG000|Overall Study|Adverse effect|6|||
28012080|NCT00626925|54670939|FG001|Overall Study|Adverse effect|2|||
28012081|NCT00626925|54670938|FG000|Overall Study|Lack of Efficacy|1|||
28012082|NCT00626925|54670939|FG001|Overall Study|Lack of Efficacy|4|||
28012083|NCT00626925|54670938|FG000|Overall Study|Time constraints|3|||
28012084|NCT00626925|54670939|FG001|Overall Study|Time constraints|1|||
28012085|NCT00698646|54670962|FG000|Overall Study|Adverse Event|8|||
28012086|NCT00698646|54670963|FG001|Overall Study|Adverse Event|7|||
28012087|NCT00698646|54670964|FG002|Overall Study|Adverse Event|8|||
28012088|NCT00698646|54670962|FG000|Overall Study|Unsatisfactory Therapeutic Effect|11|||
28012089|NCT00698646|54670963|FG001|Overall Study|Unsatisfactory Therapeutic Effect|11|||
28012090|NCT00698646|54670964|FG002|Overall Study|Unsatisfactory Therapeutic Effect|7|||
28012091|NCT00698646|54670962|FG000|Overall Study|Protocol Deviation|6|||
28012092|NCT00698646|54670963|FG001|Overall Study|Protocol Deviation|2|||
28012093|NCT00698646|54670964|FG002|Overall Study|Protocol Deviation|3|||
28012094|NCT00698646|54670962|FG000|Overall Study|Withdrawal by Subject|10|||
28012095|NCT00698646|54670963|FG001|Overall Study|Withdrawal by Subject|11|||
28012096|NCT00698646|54670964|FG002|Overall Study|Withdrawal by Subject|8|||
28012097|NCT00698646|54670962|FG000|Overall Study|Lost to Follow-up|0|||
28012098|NCT00698646|54670963|FG001|Overall Study|Lost to Follow-up|0|||
28012099|NCT00698646|54670964|FG002|Overall Study|Lost to Follow-up|2|||
28012100|NCT00698646|54670962|FG000|Overall Study|Administrative problems|1|||
28012101|NCT00698646|54670963|FG001|Overall Study|Administrative problems|0|||
28012102|NCT00698646|54670964|FG002|Overall Study|Administrative problems|1|||
28012103|NCT00609466|54670975|FG000|Overall Study|Withdrawal by Subject|0|||
28012104|NCT00609466|54670976|FG001|Overall Study|Withdrawal by Subject|1|||
28012105|NCT00609466|54670977|FG002|Overall Study|Withdrawal by Subject|1|||
28012106|NCT00609466|54670975|FG000|Overall Study|Adverse Event|2|||
28012107|NCT00609466|54670976|FG001|Overall Study|Adverse Event|3|||
28012108|NCT00609466|54670977|FG002|Overall Study|Adverse Event|1|||
28012109|NCT00609466|54670975|FG000|Overall Study|Lack of Efficacy|0|||
28012110|NCT00609466|54670976|FG001|Overall Study|Lack of Efficacy|2|||
28012111|NCT00609466|54670977|FG002|Overall Study|Lack of Efficacy|2|||
28012112|NCT00608530|54670989|FG000|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11|||
28012113|NCT00608530|54670990|FG001|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5|||
28012114|NCT00608530|54670991|FG002|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
28012115|NCT00608530|54670992|FG003|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
28012116|NCT00608530|54670989|FG000|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
28012117|NCT00608530|54670990|FG001|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
28012118|NCT00608530|54670991|FG002|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
28012119|NCT00608530|54670992|FG003|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
28012120|NCT00608530|54670989|FG000|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
28012121|NCT00608530|54670990|FG001|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
28012122|NCT00608530|54670991|FG002|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2|||
28012123|NCT00608530|54670992|FG003|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3|||
28012124|NCT00608530|54670989|FG000|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
28012125|NCT00608530|54670990|FG001|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
28012126|NCT00608530|54670991|FG002|Study 2 Nurse-delivered Treatments|Protocol Violation|2|||
28012127|NCT00608530|54670992|FG003|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
28012128|NCT00608530|54670989|FG000|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
28012129|NCT00608530|54670990|FG001|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
28012130|NCT00608530|54670991|FG002|Study 2 Nurse-delivered Treatments|Time demands of study|4|||
28012131|NCT00608530|54670992|FG003|Study 2 Nurse-delivered Treatments|Time demands of study|1|||
28012132|NCT00608530|54670989|FG000|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
28012133|NCT00608530|54670990|FG001|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
28012134|NCT00608530|54670991|FG002|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1|||
28012135|NCT00608530|54670992|FG003|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
28012136|NCT00642993|54671009|FG000|Overall Study|Adverse Event|85|||
28012137|NCT00642993|54671010|FG001|Overall Study|Adverse Event|4|||
28012138|NCT00642993|54671009|FG000|Overall Study|Lost to Follow-up|8|||
28012139|NCT00642993|54671010|FG001|Overall Study|Lost to Follow-up|4|||
28012140|NCT00642993|54671009|FG000|Overall Study|Withdrew - reason unrelated to treatment|11|||
28012141|NCT00642993|54671010|FG001|Overall Study|Withdrew - reason unrelated to treatment|3|||
28012142|NCT00642993|54671009|FG000|Overall Study|Protocol Violation|1|||
28012143|NCT00642993|54671010|FG001|Overall Study|Protocol Violation|4|||
28012144|NCT00642993|54671009|FG000|Overall Study|Did not meet protocol eligibility|0|||
28012145|NCT00642993|54671010|FG001|Overall Study|Did not meet protocol eligibility|1|||
28012146|NCT00642993|54671009|FG000|Overall Study|Administrative|1|||
28012147|NCT00642993|54671010|FG001|Overall Study|Administrative|0|||
28012148|NCT00696696|54671016|FG000|Overall Study|Adverse Event|5|||
28012149|NCT00696696|54671016|FG000|Overall Study|Withdrawal by Subject|8|||
28012150|NCT00696696|54671016|FG000|Overall Study|Physician Decision|2|||
28012151|NCT00696696|54671016|FG000|Overall Study|Death|3|||
28012152|NCT00699192|54671023|FG000|Overall Study|Missing|1|||
28012153|NCT00699192|54671024|FG001|Overall Study|Missing|1|||
28012154|NCT00699192|54671025|FG002|Overall Study|Missing|1|||
28012155|NCT00699192|54671023|FG000|Overall Study|Adverse Event|9|||
28012156|NCT00699192|54671024|FG001|Overall Study|Adverse Event|4|||
28012157|NCT00699192|54671025|FG002|Overall Study|Adverse Event|3|||
28012158|NCT00699192|54671023|FG000|Overall Study|Abnormal test procedure result(s)|0|||
28012159|NCT00699192|54671024|FG001|Overall Study|Abnormal test procedure result(s)|0|||
28012160|NCT00699192|54671025|FG002|Overall Study|Abnormal test procedure result(s)|1|||
28012161|NCT00699192|54671023|FG000|Overall Study|Lack of Efficacy|0|||
28012162|NCT00699192|54671024|FG001|Overall Study|Lack of Efficacy|0|||
28012163|NCT00699192|54671025|FG002|Overall Study|Lack of Efficacy|1|||
28012164|NCT00699192|54671023|FG000|Overall Study|Withdrawal by Subject|3|||
28012165|NCT00699192|54671024|FG001|Overall Study|Withdrawal by Subject|2|||
28012166|NCT00699192|54671025|FG002|Overall Study|Withdrawal by Subject|4|||
28012167|NCT00699192|54671023|FG000|Overall Study|Administrative problems|1|||
28012168|NCT00699192|54671024|FG001|Overall Study|Administrative problems|3|||
28012169|NCT00699192|54671025|FG002|Overall Study|Administrative problems|1|||
28012170|NCT00699192|54671023|FG000|Overall Study|Protocol Violation|2|||
28012171|NCT00699192|54671024|FG001|Overall Study|Protocol Violation|2|||
28012172|NCT00699192|54671025|FG002|Overall Study|Protocol Violation|0|||
28012173|NCT00401245|54671041|FG000|Double Blind Titration Phase|Adverse Event|3|||
28012174|NCT00401245|54671042|FG001|Double Blind Titration Phase|Adverse Event|2|||
28012175|NCT00401245|54671043|FG002|Double Blind Titration Phase|Adverse Event|5|||
28012176|NCT00401245|54671044|FG003|Double Blind Titration Phase|Adverse Event|12|||
28012177|NCT00401245|54671045|FG004|Double Blind Titration Phase|Adverse Event|0|||
28012178|NCT00401245|54671046|FG005|Double Blind Titration Phase|Adverse Event|0|||
28012179|NCT00401245|54671047|FG006|Double Blind Titration Phase|Adverse Event|0|||
28012180|NCT00401245|54671048|FG007|Double Blind Titration Phase|Adverse Event|0|||
28012181|NCT00401245|54671041|FG000|Double Blind Titration Phase|Other|0|||
28012182|NCT00401245|54671042|FG001|Double Blind Titration Phase|Other|0|||
28012183|NCT00401245|54671043|FG002|Double Blind Titration Phase|Other|1|||
28012184|NCT00401245|54671044|FG003|Double Blind Titration Phase|Other|0|||
28012185|NCT00401245|54671045|FG004|Double Blind Titration Phase|Other|0|||
28012186|NCT00401245|54671046|FG005|Double Blind Titration Phase|Other|0|||
28012187|NCT00401245|54671047|FG006|Double Blind Titration Phase|Other|0|||
28012188|NCT00401245|54671048|FG007|Double Blind Titration Phase|Other|0|||
28012189|NCT00401245|54671041|FG000|Double Blind Titration Phase|Protocol Violation|0|||
27919850|NCT01087489|54577106|FG001|Overall Study|Death|1|||
28012190|NCT00401245|54671042|FG001|Double Blind Titration Phase|Protocol Violation|0|||
28012191|NCT00401245|54671043|FG002|Double Blind Titration Phase|Protocol Violation|0|||
28012192|NCT00401245|54671044|FG003|Double Blind Titration Phase|Protocol Violation|1|||
27919851|NCT01087489|54577105|FG000|Overall Study|unable to survey by telephone|0|||
27919852|NCT01087489|54577106|FG001|Overall Study|unable to survey by telephone|1|||
27919853|NCT01082965|54577114|FG000|Overall Study|Protocol Violation|0|||
27919854|NCT01082965|54577115|FG001|Overall Study|Protocol Violation|1|||
27919855|NCT01082965|54577114|FG000|Overall Study|Other|1|||
27919856|NCT01082965|54577115|FG001|Overall Study|Other|1|||
27919857|NCT01102426|54577123|FG000|Overall Study|Randomized but not treated|4|||
27919858|NCT01102426|54577124|FG001|Overall Study|Randomized but not treated|1|||
28012193|NCT00401245|54671045|FG004|Double Blind Titration Phase|Protocol Violation|0|||
28012194|NCT00401245|54671046|FG005|Double Blind Titration Phase|Protocol Violation|0|||
28012195|NCT00401245|54671047|FG006|Double Blind Titration Phase|Protocol Violation|0|||
28012196|NCT00401245|54671048|FG007|Double Blind Titration Phase|Protocol Violation|0|||
28012197|NCT00401245|54671041|FG000|Double Blind Titration Phase|Withdrawal by Subject|1|||
28012198|NCT00401245|54671042|FG001|Double Blind Titration Phase|Withdrawal by Subject|1|||
28012199|NCT00401245|54671043|FG002|Double Blind Titration Phase|Withdrawal by Subject|0|||
28012200|NCT00401245|54671044|FG003|Double Blind Titration Phase|Withdrawal by Subject|2|||
28012201|NCT00401245|54671045|FG004|Double Blind Titration Phase|Withdrawal by Subject|0|||
28012202|NCT00401245|54671046|FG005|Double Blind Titration Phase|Withdrawal by Subject|0|||
28012203|NCT00401245|54671047|FG006|Double Blind Titration Phase|Withdrawal by Subject|0|||
28012204|NCT00401245|54671048|FG007|Double Blind Titration Phase|Withdrawal by Subject|0|||
28012205|NCT00401245|54671041|FG000|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
28012206|NCT00401245|54671042|FG001|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
28012207|NCT00401245|54671043|FG002|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
28012208|NCT00401245|54671044|FG003|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
28012209|NCT00401245|54671045|FG004|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
28012210|NCT00401245|54671046|FG005|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
28012211|NCT00401245|54671047|FG006|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
28012212|NCT00401245|54671048|FG007|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
28012213|NCT00401245|54671041|FG000|Open Label Phase|Adverse Event|5|||
28012214|NCT00401245|54671042|FG001|Open Label Phase|Adverse Event|14|||
28012215|NCT00401245|54671043|FG002|Open Label Phase|Adverse Event|6|||
28012216|NCT00401245|54671044|FG003|Open Label Phase|Adverse Event|7|||
28012217|NCT00401245|54671045|FG004|Open Label Phase|Adverse Event|0|||
28012218|NCT00401245|54671046|FG005|Open Label Phase|Adverse Event|0|||
28012219|NCT00401245|54671047|FG006|Open Label Phase|Adverse Event|0|||
28012220|NCT00401245|54671048|FG007|Open Label Phase|Adverse Event|0|||
28012221|NCT00401245|54671041|FG000|Open Label Phase|Lost to Follow-up|5|||
28012222|NCT00401245|54671042|FG001|Open Label Phase|Lost to Follow-up|7|||
28012223|NCT00401245|54671043|FG002|Open Label Phase|Lost to Follow-up|5|||
28012224|NCT00401245|54671044|FG003|Open Label Phase|Lost to Follow-up|4|||
28012225|NCT00401245|54671045|FG004|Open Label Phase|Lost to Follow-up|0|||
28012226|NCT00401245|54671046|FG005|Open Label Phase|Lost to Follow-up|0|||
28012227|NCT00401245|54671047|FG006|Open Label Phase|Lost to Follow-up|0|||
28012228|NCT00401245|54671048|FG007|Open Label Phase|Lost to Follow-up|0|||
28012229|NCT00401245|54671041|FG000|Open Label Phase|Other|4|||
28012230|NCT00401245|54671042|FG001|Open Label Phase|Other|8|||
27919859|NCT01102426|54577123|FG000|Overall Study|Adverse Events (treatment-related)|15|||
27919860|NCT01102426|54577124|FG001|Overall Study|Adverse Events (treatment-related)|8|||
28103676|NCT02849080|54760395|FG003|Extension Phase: 53 - 104 Weeks|Other|0|||
28103677|NCT02849080|54760392|FG000|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1|||
28103678|NCT02849080|54760393|FG001|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
28103679|NCT02849080|54760394|FG002|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
28103680|NCT02849080|54760395|FG003|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
28103681|NCT03346070|54760412|FG000|Overall Study|Death|0|||
28103682|NCT03346070|54760413|FG001|Overall Study|Death|0|||
28103683|NCT03346070|54760414|FG002|Overall Study|Death|0|||
28103684|NCT03346070|54760415|FG003|Overall Study|Death|0|||
28103685|NCT03346070|54760416|FG004|Overall Study|Death|1|||
28103686|NCT03346070|54760412|FG000|Overall Study|Lost to Follow-up|0|||
28103687|NCT03346070|54760413|FG001|Overall Study|Lost to Follow-up|1|||
28103688|NCT03346070|54760414|FG002|Overall Study|Lost to Follow-up|2|||
28012231|NCT00401245|54671043|FG002|Open Label Phase|Other|7|||
28012232|NCT00401245|54671044|FG003|Open Label Phase|Other|8|||
28012233|NCT00401245|54671045|FG004|Open Label Phase|Other|0|||
28012234|NCT00401245|54671046|FG005|Open Label Phase|Other|0|||
28012235|NCT00401245|54671047|FG006|Open Label Phase|Other|0|||
28012236|NCT00401245|54671048|FG007|Open Label Phase|Other|0|||
28012237|NCT00401245|54671041|FG000|Open Label Phase|Protocol Violation|0|||
28012238|NCT00401245|54671042|FG001|Open Label Phase|Protocol Violation|1|||
28012239|NCT00401245|54671043|FG002|Open Label Phase|Protocol Violation|0|||
28012240|NCT00401245|54671044|FG003|Open Label Phase|Protocol Violation|1|||
28012241|NCT00401245|54671045|FG004|Open Label Phase|Protocol Violation|0|||
28012242|NCT00401245|54671046|FG005|Open Label Phase|Protocol Violation|0|||
28012243|NCT00401245|54671047|FG006|Open Label Phase|Protocol Violation|0|||
28012244|NCT00401245|54671048|FG007|Open Label Phase|Protocol Violation|0|||
28012245|NCT00401245|54671041|FG000|Open Label Phase|Withdrawal by Subject|3|||
28012246|NCT00401245|54671042|FG001|Open Label Phase|Withdrawal by Subject|3|||
28012247|NCT00401245|54671043|FG002|Open Label Phase|Withdrawal by Subject|2|||
28012248|NCT00401245|54671044|FG003|Open Label Phase|Withdrawal by Subject|1|||
28012249|NCT00401245|54671045|FG004|Open Label Phase|Withdrawal by Subject|0|||
28012250|NCT00401245|54671046|FG005|Open Label Phase|Withdrawal by Subject|0|||
28012251|NCT00401245|54671047|FG006|Open Label Phase|Withdrawal by Subject|0|||
28012252|NCT00401245|54671048|FG007|Open Label Phase|Withdrawal by Subject|0|||
28012253|NCT00401245|54671041|FG000|Open Label Phase|Lack of Efficacy|4|||
28103689|NCT03346070|54760415|FG003|Overall Study|Lost to Follow-up|0|||
27919861|NCT01102426|54577123|FG000|Overall Study|Physician Decision|9|||
27919862|NCT01102426|54577124|FG001|Overall Study|Physician Decision|6|||
27919863|NCT01102426|54577123|FG000|Overall Study|Progressive Disease|85|||
27919864|NCT01102426|54577124|FG001|Overall Study|Progressive Disease|44|||
27919865|NCT01102426|54577123|FG000|Overall Study|Adverse Events (unrelated to|9|||
27919866|NCT01102426|54577124|FG001|Overall Study|Adverse Events (unrelated to|1|||
27919867|NCT01102426|54577123|FG000|Overall Study|Patient Refusal|24|||
27919868|NCT01102426|54577124|FG001|Overall Study|Patient Refusal|12|||
27919869|NCT01102426|54577123|FG000|Overall Study|Death (due to adverse events|0|||
27919870|NCT01102426|54577124|FG001|Overall Study|Death (due to adverse events|1|||
27919871|NCT01102426|54577123|FG000|Overall Study|Death (non-related to the study|19|||
27919872|NCT01102426|54577124|FG001|Overall Study|Death (non-related to the study|8|||
27919873|NCT01101334|54577132|FG000|Overall Study|Adverse Event|9|||
27919874|NCT01101334|54577133|FG001|Overall Study|Adverse Event|4|||
27919875|NCT01101334|54577132|FG000|Overall Study|Death|7|||
27919876|NCT01101334|54577133|FG001|Overall Study|Death|1|||
27919877|NCT01101334|54577132|FG000|Overall Study|Withdrawal by Subject|4|||
27919878|NCT01101334|54577133|FG001|Overall Study|Withdrawal by Subject|3|||
27919879|NCT01101334|54577132|FG000|Overall Study|Withdrawal by Sponsor|1|||
27919880|NCT01101334|54577133|FG001|Overall Study|Withdrawal by Sponsor|1|||
27919881|NCT01101334|54577132|FG000|Overall Study|Progressive Disease|22|||
27919882|NCT01101334|54577133|FG001|Overall Study|Progressive Disease|35|||
27919883|NCT01101334|54577132|FG000|Overall Study|Other|2|||
27919884|NCT01101334|54577133|FG001|Overall Study|Other|1|||
28012254|NCT00401245|54671042|FG001|Open Label Phase|Lack of Efficacy|2|||
28012255|NCT00401245|54671043|FG002|Open Label Phase|Lack of Efficacy|3|||
28012256|NCT00401245|54671044|FG003|Open Label Phase|Lack of Efficacy|0|||
28103690|NCT03346070|54760416|FG004|Overall Study|Lost to Follow-up|0|||
28103691|NCT03346070|54760412|FG000|Overall Study|Physician Decision|0|||
28103692|NCT03346070|54760413|FG001|Overall Study|Physician Decision|0|||
28103693|NCT03346070|54760414|FG002|Overall Study|Physician Decision|0|||
28103694|NCT03346070|54760415|FG003|Overall Study|Physician Decision|1|||
28103695|NCT03346070|54760416|FG004|Overall Study|Physician Decision|1|||
28103696|NCT03346070|54760412|FG000|Overall Study|Withdrawal by Subject|1|||
28103697|NCT03346070|54760413|FG001|Overall Study|Withdrawal by Subject|0|||
28103698|NCT03346070|54760414|FG002|Overall Study|Withdrawal by Subject|0|||
28103699|NCT03346070|54760415|FG003|Overall Study|Withdrawal by Subject|1|||
28103700|NCT03346070|54760416|FG004|Overall Study|Withdrawal by Subject|0|||
28103701|NCT03346070|54760412|FG000|Overall Study|Study medication not received as planned|2|||
28103702|NCT03346070|54760413|FG001|Overall Study|Study medication not received as planned|3|||
28103703|NCT03346070|54760414|FG002|Overall Study|Study medication not received as planned|2|||
28103704|NCT03346070|54760415|FG003|Overall Study|Study medication not received as planned|3|||
28103705|NCT03346070|54760416|FG004|Overall Study|Study medication not received as planned|2|||
28103706|NCT03346070|54760412|FG000|Overall Study|Screen Failure|0|||
28103707|NCT03346070|54760413|FG001|Overall Study|Screen Failure|0|||
27919885|NCT01327547|54577141|FG000|Overall Study|Adverse Event|4|||
27919886|NCT01327547|54577142|FG001|Overall Study|Adverse Event|1|||
28012257|NCT00401245|54671045|FG004|Open Label Phase|Lack of Efficacy|0|||
28012258|NCT00401245|54671046|FG005|Open Label Phase|Lack of Efficacy|0|||
28103708|NCT03346070|54760414|FG002|Overall Study|Screen Failure|0|||
28012259|NCT00401245|54671047|FG006|Open Label Phase|Lack of Efficacy|0|||
28012260|NCT00401245|54671048|FG007|Open Label Phase|Lack of Efficacy|0|||
28012261|NCT00401245|54671041|FG000|Double Blind Tapering Phase|Adverse Event|0|||
28012262|NCT00401245|54671042|FG001|Double Blind Tapering Phase|Adverse Event|0|||
28012263|NCT00401245|54671043|FG002|Double Blind Tapering Phase|Adverse Event|0|||
28012264|NCT00401245|54671044|FG003|Double Blind Tapering Phase|Adverse Event|0|||
28012265|NCT00401245|54671045|FG004|Double Blind Tapering Phase|Adverse Event|1|||
28012266|NCT00401245|54671046|FG005|Double Blind Tapering Phase|Adverse Event|1|||
28012267|NCT00401245|54671047|FG006|Double Blind Tapering Phase|Adverse Event|2|||
28012268|NCT00401245|54671048|FG007|Double Blind Tapering Phase|Adverse Event|4|||
28012269|NCT00401245|54671041|FG000|Double Blind Tapering Phase|Investigator request|0|||
28012270|NCT00401245|54671042|FG001|Double Blind Tapering Phase|Investigator request|0|||
28012271|NCT00401245|54671043|FG002|Double Blind Tapering Phase|Investigator request|0|||
28012272|NCT00401245|54671044|FG003|Double Blind Tapering Phase|Investigator request|0|||
28012273|NCT00401245|54671045|FG004|Double Blind Tapering Phase|Investigator request|0|||
28012274|NCT00401245|54671046|FG005|Double Blind Tapering Phase|Investigator request|0|||
28012275|NCT00401245|54671047|FG006|Double Blind Tapering Phase|Investigator request|0|||
28012276|NCT00401245|54671048|FG007|Double Blind Tapering Phase|Investigator request|1|||
28012277|NCT00401245|54671041|FG000|Double Blind Tapering Phase|Other|0|||
28012278|NCT00401245|54671042|FG001|Double Blind Tapering Phase|Other|0|||
28012279|NCT00401245|54671043|FG002|Double Blind Tapering Phase|Other|0|||
28012280|NCT00401245|54671044|FG003|Double Blind Tapering Phase|Other|0|||
28012281|NCT00401245|54671045|FG004|Double Blind Tapering Phase|Other|1|||
28012282|NCT00401245|54671046|FG005|Double Blind Tapering Phase|Other|0|||
28012283|NCT00401245|54671047|FG006|Double Blind Tapering Phase|Other|2|||
28012284|NCT00401245|54671048|FG007|Double Blind Tapering Phase|Other|2|||
28012285|NCT00401245|54671041|FG000|Double Blind Tapering Phase|Withdrawal by Subject|0|||
28012286|NCT00401245|54671042|FG001|Double Blind Tapering Phase|Withdrawal by Subject|0|||
28012287|NCT00401245|54671043|FG002|Double Blind Tapering Phase|Withdrawal by Subject|0|||
28012288|NCT00401245|54671044|FG003|Double Blind Tapering Phase|Withdrawal by Subject|0|||
28012289|NCT00401245|54671045|FG004|Double Blind Tapering Phase|Withdrawal by Subject|2|||
28012290|NCT00401245|54671046|FG005|Double Blind Tapering Phase|Withdrawal by Subject|2|||
28012291|NCT00401245|54671047|FG006|Double Blind Tapering Phase|Withdrawal by Subject|3|||
28012292|NCT00401245|54671048|FG007|Double Blind Tapering Phase|Withdrawal by Subject|0|||
28012293|NCT00401245|54671041|FG000|Double Blind Tapering Phase|Lack of Efficacy|0|||
28012294|NCT00401245|54671042|FG001|Double Blind Tapering Phase|Lack of Efficacy|0|||
28012295|NCT00401245|54671043|FG002|Double Blind Tapering Phase|Lack of Efficacy|0|||
28012296|NCT00401245|54671044|FG003|Double Blind Tapering Phase|Lack of Efficacy|0|||
28012297|NCT00401245|54671045|FG004|Double Blind Tapering Phase|Lack of Efficacy|0|||
28012298|NCT00401245|54671046|FG005|Double Blind Tapering Phase|Lack of Efficacy|1|||
28012299|NCT00401245|54671047|FG006|Double Blind Tapering Phase|Lack of Efficacy|0|||
28012300|NCT00401245|54671048|FG007|Double Blind Tapering Phase|Lack of Efficacy|0|||
28012301|NCT00696384|54671068|FG000|Open Label Phase|Adverse Event|27|||
28012302|NCT00696384|54671069|FG001|Open Label Phase|Adverse Event|0|||
28012303|NCT00696384|54671070|FG002|Open Label Phase|Adverse Event|0|||
28012304|NCT00696384|54671068|FG000|Open Label Phase|Protocol Violation|18|||
28012305|NCT00696384|54671069|FG001|Open Label Phase|Protocol Violation|0|||
28012306|NCT00696384|54671070|FG002|Open Label Phase|Protocol Violation|0|||
28012307|NCT00696384|54671068|FG000|Open Label Phase|Lost to Follow-up|24|||
28012308|NCT00696384|54671069|FG001|Open Label Phase|Lost to Follow-up|0|||
28012309|NCT00696384|54671070|FG002|Open Label Phase|Lost to Follow-up|0|||
28012310|NCT00696384|54671068|FG000|Open Label Phase|Withdrawal by Subject|37|||
28012311|NCT00696384|54671069|FG001|Open Label Phase|Withdrawal by Subject|0|||
28012312|NCT00696384|54671070|FG002|Open Label Phase|Withdrawal by Subject|0|||
28012313|NCT00696384|54671068|FG000|Open Label Phase|Other|6|||
28012314|NCT00696384|54671069|FG001|Open Label Phase|Other|0|||
28012315|NCT00696384|54671070|FG002|Open Label Phase|Other|0|||
28012316|NCT00696384|54671068|FG000|Open Label Phase|Lack of Efficacy|3|||
28012317|NCT00696384|54671069|FG001|Open Label Phase|Lack of Efficacy|0|||
28012318|NCT00696384|54671070|FG002|Open Label Phase|Lack of Efficacy|0|||
28012319|NCT00696384|54671068|FG000|Open Label Phase|Physician Decision|4|||
28012320|NCT00696384|54671069|FG001|Open Label Phase|Physician Decision|0|||
28012321|NCT00696384|54671070|FG002|Open Label Phase|Physician Decision|0|||
28012322|NCT00696384|54671068|FG000|Double Blind Phase|Adverse Event|0|||
28012323|NCT00696384|54671069|FG001|Double Blind Phase|Adverse Event|2|||
28012324|NCT00696384|54671070|FG002|Double Blind Phase|Adverse Event|2|||
27919887|NCT01327547|54577141|FG000|Overall Study|Death|1|||
28012325|NCT00696384|54671068|FG000|Double Blind Phase|Lost to Follow-up|0|||
28012326|NCT00696384|54671069|FG001|Double Blind Phase|Lost to Follow-up|2|||
28012327|NCT00696384|54671070|FG002|Double Blind Phase|Lost to Follow-up|1|||
28012328|NCT00696384|54671068|FG000|Double Blind Phase|Withdrawal by Subject|0|||
28012329|NCT00696384|54671069|FG001|Double Blind Phase|Withdrawal by Subject|4|||
28103709|NCT03346070|54760415|FG003|Overall Study|Screen Failure|1|||
28103710|NCT03346070|54760416|FG004|Overall Study|Screen Failure|1|||
28012330|NCT00696384|54671070|FG002|Double Blind Phase|Withdrawal by Subject|3|||
28012331|NCT00696384|54671068|FG000|Double Blind Phase|Lack of Efficacy|0|||
28012332|NCT00696384|54671069|FG001|Double Blind Phase|Lack of Efficacy|1|||
28012333|NCT00696384|54671070|FG002|Double Blind Phase|Lack of Efficacy|0|||
28012334|NCT00696384|54671068|FG000|Double Blind Phase|Physician Decision|0|||
28012335|NCT00696384|54671069|FG001|Double Blind Phase|Physician Decision|2|||
28012336|NCT00696384|54671070|FG002|Double Blind Phase|Physician Decision|0|||
28012337|NCT00636675|54671081|FG000|Overall Study|Lost to Follow-up|121|||
28012338|NCT00636675|54671082|FG001|Overall Study|Lost to Follow-up|31|||
28012339|NCT00636675|54671081|FG000|Overall Study|Withdrawal by Subject|19|||
28012340|NCT00636675|54671082|FG001|Overall Study|Withdrawal by Subject|10|||
28012341|NCT00699998|54671092|FG000|Overall Study|Withdrawal by Subject|194|||
28012342|NCT00699998|54671093|FG001|Overall Study|Withdrawal by Subject|83|||
28012343|NCT00699998|54671094|FG002|Overall Study|Withdrawal by Subject|202|||
28012344|NCT00699998|54671095|FG003|Overall Study|Withdrawal by Subject|80|||
28012345|NCT00699998|54671092|FG000|Overall Study|Physician Decision|3|||
28012346|NCT00699998|54671093|FG001|Overall Study|Physician Decision|2|||
28012347|NCT00699998|54671094|FG002|Overall Study|Physician Decision|1|||
28012348|NCT00699998|54671095|FG003|Overall Study|Physician Decision|1|||
28012349|NCT00699998|54671092|FG000|Overall Study|Lost to Follow-up|2|||
28012350|NCT00699998|54671093|FG001|Overall Study|Lost to Follow-up|1|||
28012351|NCT00699998|54671094|FG002|Overall Study|Lost to Follow-up|3|||
28012352|NCT00699998|54671095|FG003|Overall Study|Lost to Follow-up|1|||
28012353|NCT00696072|54671112|FG000|Overall Study|continuing active treatment|10|||
28012354|NCT00696072|54671113|FG001|Overall Study|continuing active treatment|13|||
28012355|NCT00696072|54671112|FG000|Overall Study|Adverse Event|10|||
28012356|NCT00696072|54671113|FG001|Overall Study|Adverse Event|6|||
28012357|NCT00696072|54671112|FG000|Overall Study|Patient Request|3|||
28012358|NCT00696072|54671113|FG001|Overall Study|Patient Request|7|||
28012359|NCT00696072|54671112|FG000|Overall Study|Investigator Request|1|||
27919888|NCT01327547|54577142|FG001|Overall Study|Death|2|||
27919889|NCT01327547|54577141|FG000|Overall Study|Lost to Follow-up|6|||
27919890|NCT01327547|54577142|FG001|Overall Study|Lost to Follow-up|6|||
27919891|NCT01327547|54577141|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
27919892|NCT01327547|54577142|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
27919893|NCT01327547|54577141|FG000|Overall Study|Withdrawal by Subject|3|||
27919894|NCT01327547|54577142|FG001|Overall Study|Withdrawal by Subject|7|||
27919895|NCT01327547|54577141|FG000|Overall Study|Does Not Meet Entrance Criteria|2|||
27919896|NCT01327547|54577142|FG001|Overall Study|Does Not Meet Entrance Criteria|2|||
27919897|NCT01327547|54577141|FG000|Overall Study|Protocol Violation|1|||
27919898|NCT01327547|54577142|FG001|Overall Study|Protocol Violation|0|||
28012360|NCT00696072|54671113|FG001|Overall Study|Investigator Request|4|||
27741389|NCT02712905|54191367|FG013|Combination Therapy|Study Terminated by Sponsor|1|||
28012361|NCT00696072|54671112|FG000|Overall Study|Sponsor Request|0|||
28012362|NCT00696072|54671113|FG001|Overall Study|Sponsor Request|1|||
28012363|NCT00696072|54671112|FG000|Overall Study|Disease Progression|32|||
28012364|NCT00696072|54671113|FG001|Overall Study|Disease Progression|30|||
28012365|NCT00696072|54671112|FG000|Overall Study|Non-specified|1|||
28012366|NCT00696072|54671113|FG001|Overall Study|Non-specified|2|||
28012367|NCT00634647|54671120|FG000|Overall Study|death on study|3|||
28012368|NCT00634647|54671120|FG000|Overall Study|refused further treatment|3|||
28012369|NCT00634647|54671120|FG000|Overall Study|declined to participate before treatment|1|||
27919899|NCT01327547|54577141|FG000|Overall Study|Non-compliance due to alcohol intake|0|||
28012370|NCT00576732|54671127|FG000|DOUBLE BLIND|Adverse Event|0|||
28012371|NCT00576732|54671128|FG001|DOUBLE BLIND|Adverse Event|0|||
28012372|NCT00576732|54671129|FG002|DOUBLE BLIND|Adverse Event|1|||
28012373|NCT00576732|54671130|FG003|DOUBLE BLIND|Adverse Event|0|||
28012374|NCT00576732|54671131|FG004|DOUBLE BLIND|Adverse Event|0|||
28012375|NCT00576732|54671132|FG005|DOUBLE BLIND|Adverse Event|0|||
28012376|NCT00576732|54671127|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
28012377|NCT00576732|54671128|FG001|DOUBLE BLIND|Lost to Follow-up|1|||
28012378|NCT00576732|54671129|FG002|DOUBLE BLIND|Lost to Follow-up|1|||
28012379|NCT00576732|54671130|FG003|DOUBLE BLIND|Lost to Follow-up|0|||
28012380|NCT00576732|54671131|FG004|DOUBLE BLIND|Lost to Follow-up|0|||
28012381|NCT00576732|54671132|FG005|DOUBLE BLIND|Lost to Follow-up|0|||
28012382|NCT00576732|54671127|FG000|DOUBLE BLIND|Withdrawal by Subject|1|||
28012383|NCT00576732|54671128|FG001|DOUBLE BLIND|Withdrawal by Subject|1|||
28012384|NCT00576732|54671129|FG002|DOUBLE BLIND|Withdrawal by Subject|3|||
28012385|NCT00576732|54671130|FG003|DOUBLE BLIND|Withdrawal by Subject|0|||
28012386|NCT00576732|54671131|FG004|DOUBLE BLIND|Withdrawal by Subject|0|||
28012387|NCT00576732|54671132|FG005|DOUBLE BLIND|Withdrawal by Subject|0|||
28012388|NCT00576732|54671127|FG000|DOUBLE BLIND|OTHER|0|||
27919900|NCT01327547|54577142|FG001|Overall Study|Non-compliance due to alcohol intake|1|||
27919901|NCT01327547|54577141|FG000|Overall Study|Required prohibited medication|2|||
27919902|NCT01327547|54577142|FG001|Overall Study|Required prohibited medication|0|||
27919903|NCT01327547|54577141|FG000|Overall Study|Non-compliance with study procedures|1|||
27919904|NCT01327547|54577142|FG001|Overall Study|Non-compliance with study procedures|0|||
27919905|NCT01327547|54577141|FG000|Overall Study|By investigator in subject's interest|0|||
27919906|NCT01327547|54577142|FG001|Overall Study|By investigator in subject's interest|1|||
27919907|NCT01308567|54577164|FG000|Overall Study|Lost to Follow-up|2|||
27919908|NCT01308567|54577165|FG001|Overall Study|Lost to Follow-up|4|||
27919909|NCT01308567|54577166|FG002|Overall Study|Lost to Follow-up|4|||
28012389|NCT00576732|54671128|FG001|DOUBLE BLIND|OTHER|2|||
28012390|NCT00576732|54671129|FG002|DOUBLE BLIND|OTHER|1|||
28103711|NCT02951780|54760439|FG000|Period 1|Adverse Event|0|||
28103712|NCT02951780|54760440|FG001|Period 1|Adverse Event|0|||
28103713|NCT02951780|54760441|FG002|Period 1|Adverse Event|0|||
28103714|NCT02951780|54760442|FG003|Period 1|Adverse Event|1|||
28103715|NCT02951780|54760443|FG004|Period 1|Adverse Event|0|||
28103716|NCT02951780|54760444|FG005|Period 1|Adverse Event|0|||
28103717|NCT02951780|54760445|FG006|Period 1|Adverse Event|0|||
28103718|NCT02951780|54760446|FG007|Period 1|Adverse Event|0|||
28103719|NCT02951780|54760447|FG008|Period 1|Adverse Event|0|||
28103720|NCT02951780|54760439|FG000|Period 1|Scheduling Conflicts|0|||
28103721|NCT02951780|54760440|FG001|Period 1|Scheduling Conflicts|0|||
28012391|NCT00576732|54671130|FG003|DOUBLE BLIND|OTHER|0|||
28012392|NCT00576732|54671131|FG004|DOUBLE BLIND|OTHER|0|||
28012393|NCT00576732|54671132|FG005|DOUBLE BLIND|OTHER|0|||
28012394|NCT00576732|54671127|FG000|DOUBLE BLIND|Lack of Efficacy|6|||
28012395|NCT00576732|54671128|FG001|DOUBLE BLIND|Lack of Efficacy|1|||
28012396|NCT00576732|54671129|FG002|DOUBLE BLIND|Lack of Efficacy|0|||
28012397|NCT00576732|54671130|FG003|DOUBLE BLIND|Lack of Efficacy|0|||
28012398|NCT00576732|54671131|FG004|DOUBLE BLIND|Lack of Efficacy|0|||
28012399|NCT00576732|54671132|FG005|DOUBLE BLIND|Lack of Efficacy|0|||
28012400|NCT00576732|54671127|FG000|DOUBLE BLIND|Protocol Violation|1|||
28012401|NCT00576732|54671128|FG001|DOUBLE BLIND|Protocol Violation|0|||
28012402|NCT00576732|54671129|FG002|DOUBLE BLIND|Protocol Violation|0|||
28012403|NCT00576732|54671130|FG003|DOUBLE BLIND|Protocol Violation|0|||
28012404|NCT00576732|54671131|FG004|DOUBLE BLIND|Protocol Violation|0|||
28012405|NCT00576732|54671132|FG005|DOUBLE BLIND|Protocol Violation|0|||
28012406|NCT00576732|54671127|FG000|OPEN LABEL|Adverse Event|0|||
28012407|NCT00576732|54671128|FG001|OPEN LABEL|Adverse Event|0|||
28012408|NCT00576732|54671129|FG002|OPEN LABEL|Adverse Event|0|||
28012409|NCT00576732|54671130|FG003|OPEN LABEL|Adverse Event|4|||
28012410|NCT00576732|54671131|FG004|OPEN LABEL|Adverse Event|0|||
28012411|NCT00576732|54671132|FG005|OPEN LABEL|Adverse Event|1|||
28012412|NCT00576732|54671127|FG000|OPEN LABEL|Lost to Follow-up|0|||
28012413|NCT00576732|54671128|FG001|OPEN LABEL|Lost to Follow-up|0|||
28012414|NCT00576732|54671129|FG002|OPEN LABEL|Lost to Follow-up|0|||
28012415|NCT00576732|54671130|FG003|OPEN LABEL|Lost to Follow-up|2|||
28012416|NCT00576732|54671131|FG004|OPEN LABEL|Lost to Follow-up|1|||
28012417|NCT00576732|54671132|FG005|OPEN LABEL|Lost to Follow-up|1|||
28012418|NCT00576732|54671127|FG000|OPEN LABEL|Withdrawal by Subject|0|||
28012419|NCT00576732|54671128|FG001|OPEN LABEL|Withdrawal by Subject|0|||
28012420|NCT00576732|54671129|FG002|OPEN LABEL|Withdrawal by Subject|0|||
28012421|NCT00576732|54671130|FG003|OPEN LABEL|Withdrawal by Subject|1|||
28012422|NCT00576732|54671131|FG004|OPEN LABEL|Withdrawal by Subject|0|||
28012423|NCT00576732|54671132|FG005|OPEN LABEL|Withdrawal by Subject|1|||
28012424|NCT00576732|54671127|FG000|OPEN LABEL|OTHER|0|||
28012425|NCT00576732|54671128|FG001|OPEN LABEL|OTHER|0|||
28012426|NCT00576732|54671129|FG002|OPEN LABEL|OTHER|0|||
28012427|NCT00576732|54671130|FG003|OPEN LABEL|OTHER|0|||
28012428|NCT00576732|54671131|FG004|OPEN LABEL|OTHER|0|||
28012429|NCT00576732|54671132|FG005|OPEN LABEL|OTHER|2|||
28012430|NCT00576732|54671127|FG000|OPEN LABEL|Lack of Efficacy|0|||
28012431|NCT00576732|54671128|FG001|OPEN LABEL|Lack of Efficacy|0|||
28012432|NCT00576732|54671129|FG002|OPEN LABEL|Lack of Efficacy|0|||
28012433|NCT00576732|54671130|FG003|OPEN LABEL|Lack of Efficacy|2|||
28012434|NCT00576732|54671131|FG004|OPEN LABEL|Lack of Efficacy|2|||
28012435|NCT00576732|54671132|FG005|OPEN LABEL|Lack of Efficacy|3|||
28012436|NCT00576732|54671127|FG000|OPEN LABEL|Protocol Violation|0|||
28012437|NCT00576732|54671128|FG001|OPEN LABEL|Protocol Violation|0|||
28012438|NCT00576732|54671129|FG002|OPEN LABEL|Protocol Violation|0|||
28012439|NCT00576732|54671130|FG003|OPEN LABEL|Protocol Violation|2|||
28012440|NCT00576732|54671131|FG004|OPEN LABEL|Protocol Violation|1|||
28012441|NCT00576732|54671132|FG005|OPEN LABEL|Protocol Violation|0|||
28012442|NCT00697788|54671144|FG000|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
28012443|NCT00697788|54671145|FG001|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2|||
28012444|NCT00697788|54671146|FG002|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
28012445|NCT00697788|54671147|FG003|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
28012446|NCT00697788|54671148|FG004|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
28012447|NCT00697788|54671149|FG005|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
28012448|NCT00697788|54671150|FG006|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
28012449|NCT00697788|54671151|FG007|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
28012450|NCT00697788|54671144|FG000|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
28012451|NCT00697788|54671145|FG001|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
28012452|NCT00697788|54671146|FG002|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
28012453|NCT00697788|54671147|FG003|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
28012454|NCT00697788|54671148|FG004|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1|||
28012455|NCT00697788|54671149|FG005|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
28012456|NCT00697788|54671150|FG006|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
28012457|NCT00697788|54671151|FG007|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
28012458|NCT00400153|54671181|FG000|Overall Study|AE due to study disease worsening|14|||
28012459|NCT00400153|54671182|FG001|Overall Study|AE due to study disease worsening|19|||
28012460|NCT00400153|54671183|FG002|Overall Study|AE due to study disease worsening|20|||
28012461|NCT00400153|54671181|FG000|Overall Study|AE due to other disease worsening|2|||
28012462|NCT00400153|54671182|FG001|Overall Study|AE due to other disease worsening|1|||
28012463|NCT00400153|54671183|FG002|Overall Study|AE due to other disease worsening|0|||
28012464|NCT00400153|54671181|FG000|Overall Study|AE due to other condition|3|||
28012465|NCT00400153|54671182|FG001|Overall Study|AE due to other condition|14|||
28012466|NCT00400153|54671183|FG002|Overall Study|AE due to other condition|15|||
28012467|NCT00400153|54671181|FG000|Overall Study|Protocol Violation|7|||
28012468|NCT00400153|54671182|FG001|Overall Study|Protocol Violation|4|||
28012469|NCT00400153|54671183|FG002|Overall Study|Protocol Violation|9|||
28012470|NCT00400153|54671181|FG000|Overall Study|Lost to Follow-up|2|||
28012471|NCT00400153|54671182|FG001|Overall Study|Lost to Follow-up|1|||
28012472|NCT00400153|54671183|FG002|Overall Study|Lost to Follow-up|4|||
28012473|NCT00400153|54671181|FG000|Overall Study|Withdrawal by Subject|12|||
28012474|NCT00400153|54671182|FG001|Overall Study|Withdrawal by Subject|11|||
28012475|NCT00400153|54671183|FG002|Overall Study|Withdrawal by Subject|10|||
28012476|NCT00400153|54671181|FG000|Overall Study|Other reasons - not mentioned above|8|||
28012477|NCT00400153|54671182|FG001|Overall Study|Other reasons - not mentioned above|5|||
28012478|NCT00400153|54671183|FG002|Overall Study|Other reasons - not mentioned above|3|||
28012479|NCT00631917|54671198|FG000|Overall Study|Adverse Event|34|||
28012480|NCT00631917|54671199|FG001|Overall Study|Adverse Event|45|||
28012481|NCT00631917|54671198|FG000|Overall Study|Abnormal laboratory value(s)|2|||
28012482|NCT00631917|54671199|FG001|Overall Study|Abnormal laboratory value(s)|1|||
28012483|NCT00631917|54671198|FG000|Overall Study|Abnormal test procedure result(s)|3|||
28012484|NCT00631917|54671199|FG001|Overall Study|Abnormal test procedure result(s)|2|||
28012485|NCT00631917|54671198|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
28012486|NCT00631917|54671199|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
28012487|NCT00631917|54671198|FG000|Overall Study|No longer required study drug|0|||
28012488|NCT00631917|54671199|FG001|Overall Study|No longer required study drug|1|||
28012489|NCT00631917|54671198|FG000|Overall Study|Protocol deviation|6|||
28012490|NCT00631917|54671199|FG001|Overall Study|Protocol deviation|5|||
28012491|NCT00631917|54671198|FG000|Overall Study|Subject withdrew consent|25|||
28012492|NCT00631917|54671199|FG001|Overall Study|Subject withdrew consent|33|||
28012493|NCT00631917|54671198|FG000|Overall Study|Lost to Follow-up|7|||
28012494|NCT00631917|54671199|FG001|Overall Study|Lost to Follow-up|7|||
28012495|NCT00631917|54671198|FG000|Overall Study|Administrative problems|2|||
28012496|NCT00631917|54671199|FG001|Overall Study|Administrative problems|0|||
28012497|NCT00631917|54671198|FG000|Overall Study|Death|1|||
28012498|NCT00631917|54671199|FG001|Overall Study|Death|0|||
28012499|NCT00419341|54671216|FG000|Wash in/Wash Out Period|Withdrawal by Subject|8|||
28012500|NCT00419341|54671216|FG000|Wash in/Wash Out Period|Adverse Event|2|||
28012501|NCT00419341|54671216|FG000|Wash in/Wash Out Period|Disqualifying laboratory results|1|||
28012502|NCT00419341|54671216|FG000|Efficacy Period|Withdrawal by Subject|6|||
28012503|NCT00419341|54671216|FG000|Efficacy Period|Protocol Violation|1|||
28012504|NCT00419341|54671216|FG000|Efficacy Period|Lost to Follow-up|1|||
28012505|NCT00419341|54671216|FG000|Efficacy Period|Non-compliance|1|||
28012506|NCT00419341|54671216|FG000|Efficacy Period|Termination of study site|1|||
28012507|NCT00694122|54671222|FG000|First Intervention (3-4 Weeks)|Withdrawal by Subject|7|||
28012508|NCT00694122|54671223|FG001|First Intervention (3-4 Weeks)|Withdrawal by Subject|0|||
28012509|NCT00694122|54671222|FG000|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
28012510|NCT00694122|54671223|FG001|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
28012511|NCT00694122|54671222|FG000|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2|||
28012512|NCT00694122|54671223|FG001|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1|||
28012513|NCT03922620|54671236|FG000|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|1|||
28012514|NCT03922620|54671237|FG001|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|0|||
28012515|NCT00419263|54671246|FG000|Overall Study|Lost to Follow-up|2|||
28012516|NCT00419263|54671247|FG001|Overall Study|Lost to Follow-up|1|||
28012517|NCT00419263|54671248|FG002|Overall Study|Lost to Follow-up|1|||
28012518|NCT00419263|54671246|FG000|Overall Study|Randomized in Error, Not Treated|1|||
28012519|NCT00419263|54671247|FG001|Overall Study|Randomized in Error, Not Treated|1|||
28012520|NCT00419263|54671248|FG002|Overall Study|Randomized in Error, Not Treated|0|||
28012521|NCT00419263|54671246|FG000|Overall Study|Adverse Event|0|||
28012522|NCT00419263|54671247|FG001|Overall Study|Adverse Event|0|||
28012523|NCT00419263|54671248|FG002|Overall Study|Adverse Event|1|||
28012524|NCT00419263|54671246|FG000|Overall Study|Withdrawal by Subject|0|||
28012525|NCT00419263|54671247|FG001|Overall Study|Withdrawal by Subject|0|||
28012526|NCT00419263|54671248|FG002|Overall Study|Withdrawal by Subject|1|||
28012527|NCT00399763|54671259|FG000|Overall Study|Lost to Follow-up|2|||
28012528|NCT00399763|54671260|FG001|Overall Study|Lost to Follow-up|3|||
28012529|NCT00699842|54671269|FG000|Overall Study|Death|0|||
28012530|NCT00699842|54671270|FG001|Overall Study|Death|1|||
28012531|NCT00699842|54671271|FG002|Overall Study|Death|0|||
28012532|NCT00399529|54671279|FG000|Overall Study|Off Study Prior to Treatment|2|||
28012533|NCT00712712|54671284|FG000|Overall Study|Protocol Violation|11|||
28012534|NCT00712712|54671284|FG000|Overall Study|Radiofrequency not done|3|||
28012535|NCT00712712|54671284|FG000|Overall Study|Death|8|||
28012536|NCT00712712|54671284|FG000|Overall Study|Withdrawal by Subject|1|||
28012537|NCT00411151|54671288|FG000|Overall Study|Death|38|||
28012538|NCT00411151|54671288|FG000|Overall Study|Withdrawal by Subject|2|||
28012539|NCT00411151|54671288|FG000|Overall Study|Lost to Follow-up|2|||
28012540|NCT00411151|54671288|FG000|Overall Study|Protocol Violation|1|||
28012541|NCT00411151|54671288|FG000|Overall Study|Trial prematurely closed|4|||
28012542|NCT00607048|54671294|FG000|Overall Study|Adverse Event|0|||
28012543|NCT00607048|54671295|FG001|Overall Study|Adverse Event|1|||
28012544|NCT00607048|54671296|FG002|Overall Study|Adverse Event|0|||
28012545|NCT00607048|54671297|FG003|Overall Study|Adverse Event|0|||
28012546|NCT00607048|54671298|FG004|Overall Study|Adverse Event|4|||
28012547|NCT00607048|54671299|FG005|Overall Study|Adverse Event|0|||
28012548|NCT00607048|54671294|FG000|Overall Study|Global deterioration of health|1|||
28012549|NCT00607048|54671295|FG001|Overall Study|Global deterioration of health|0|||
28012550|NCT00607048|54671296|FG002|Overall Study|Global deterioration of health|0|||
27919910|NCT01307319|54577177|FG000|Overall Study|Adverse Event|2|||
28012551|NCT00607048|54671297|FG003|Overall Study|Global deterioration of health|0|||
27919911|NCT01307319|54577178|FG001|Overall Study|Adverse Event|2|||
27919912|NCT01307319|54577179|FG002|Overall Study|Adverse Event|1|||
27919913|NCT01307319|54577177|FG000|Overall Study|Lost to Follow-up|1|||
27919914|NCT01307319|54577178|FG001|Overall Study|Lost to Follow-up|0|||
27919915|NCT01307319|54577179|FG002|Overall Study|Lost to Follow-up|1|||
27919916|NCT01307319|54577177|FG000|Overall Study|Protocol Violation|1|||
27919917|NCT01307319|54577178|FG001|Overall Study|Protocol Violation|1|||
27919918|NCT01307319|54577179|FG002|Overall Study|Protocol Violation|0|||
27919919|NCT01307319|54577177|FG000|Overall Study|Withdrawal by Subject|0|||
27919920|NCT01307319|54577178|FG001|Overall Study|Withdrawal by Subject|1|||
27919921|NCT01307319|54577179|FG002|Overall Study|Withdrawal by Subject|2|||
27919922|NCT01307319|54577177|FG000|Overall Study|Other|0|||
27919923|NCT01307319|54577178|FG001|Overall Study|Other|4|||
27919924|NCT01307319|54577179|FG002|Overall Study|Other|3|||
27919925|NCT01080391|54577189|FG000|Overall Study|Randomized but not treated|7|||
28012552|NCT00607048|54671298|FG004|Overall Study|Global deterioration of health|0|||
28012553|NCT00607048|54671299|FG005|Overall Study|Global deterioration of health|0|||
28103722|NCT02951780|54760441|FG002|Period 1|Scheduling Conflicts|0|||
27919926|NCT01080391|54577190|FG001|Overall Study|Randomized but not treated|4|||
27919927|NCT01070329|54577198|FG000|Overall Study|Adverse Event|13|||
28103723|NCT02951780|54760442|FG003|Period 1|Scheduling Conflicts|0|||
27919928|NCT01070329|54577199|FG001|Overall Study|Adverse Event|10|||
28103724|NCT02951780|54760443|FG004|Period 1|Scheduling Conflicts|0|||
28103725|NCT02951780|54760444|FG005|Period 1|Scheduling Conflicts|0|||
28103726|NCT02951780|54760445|FG006|Period 1|Scheduling Conflicts|0|||
28103727|NCT02951780|54760446|FG007|Period 1|Scheduling Conflicts|1|||
28103728|NCT02951780|54760447|FG008|Period 1|Scheduling Conflicts|0|||
28103729|NCT02951780|54760439|FG000|Period 2|Scheduling Conflicts|0|||
28103730|NCT02951780|54760440|FG001|Period 2|Scheduling Conflicts|0|||
28012554|NCT00607048|54671294|FG000|Overall Study|Objective disease progression - relapse|1|||
28012555|NCT00607048|54671295|FG001|Overall Study|Objective disease progression - relapse|2|||
28012556|NCT00607048|54671296|FG002|Overall Study|Objective disease progression - relapse|4|||
28012557|NCT00607048|54671297|FG003|Overall Study|Objective disease progression - relapse|2|||
28012558|NCT00607048|54671298|FG004|Overall Study|Objective disease progression - relapse|2|||
28012559|NCT00607048|54671299|FG005|Overall Study|Objective disease progression - relapse|2|||
28012560|NCT00607048|54671294|FG000|Overall Study|Withdrawal by Subject|0|||
28012561|NCT00607048|54671295|FG001|Overall Study|Withdrawal by Subject|0|||
28012562|NCT00607048|54671296|FG002|Overall Study|Withdrawal by Subject|0|||
28012563|NCT00607048|54671297|FG003|Overall Study|Withdrawal by Subject|1|||
28012564|NCT00607048|54671298|FG004|Overall Study|Withdrawal by Subject|0|||
28012565|NCT00607048|54671299|FG005|Overall Study|Withdrawal by Subject|2|||
28012566|NCT00607048|54671294|FG000|Overall Study|Other|1|||
28012567|NCT00607048|54671295|FG001|Overall Study|Other|1|||
28012568|NCT00607048|54671296|FG002|Overall Study|Other|0|||
28012569|NCT00607048|54671297|FG003|Overall Study|Other|0|||
28012570|NCT00607048|54671298|FG004|Overall Study|Other|0|||
28012571|NCT00607048|54671299|FG005|Overall Study|Other|1|||
28012572|NCT00699608|54671315|FG000|First Intervention|Withdrawal by Subject|0|||
28012573|NCT00699608|54671316|FG001|First Intervention|Withdrawal by Subject|0|||
28012574|NCT00699608|54671317|FG002|First Intervention|Withdrawal by Subject|1|||
28012575|NCT00699608|54671318|FG003|First Intervention|Withdrawal by Subject|0|||
28012576|NCT00699608|54671319|FG004|First Intervention|Withdrawal by Subject|0|||
28012577|NCT00699608|54671320|FG005|First Intervention|Withdrawal by Subject|0|||
28012578|NCT00699608|54671315|FG000|First Intervention|Protocol Violation|0|||
28012579|NCT00699608|54671316|FG001|First Intervention|Protocol Violation|0|||
28012580|NCT00699608|54671317|FG002|First Intervention|Protocol Violation|0|||
28012581|NCT00699608|54671318|FG003|First Intervention|Protocol Violation|0|||
28012582|NCT00699608|54671319|FG004|First Intervention|Protocol Violation|1|||
28012583|NCT00699608|54671320|FG005|First Intervention|Protocol Violation|0|||
28012584|NCT00699608|54671315|FG000|Second Intervention|Adverse Event|0|||
28012585|NCT00699608|54671316|FG001|Second Intervention|Adverse Event|0|||
28012586|NCT00699608|54671317|FG002|Second Intervention|Adverse Event|1|||
28012587|NCT00699608|54671318|FG003|Second Intervention|Adverse Event|0|||
28012588|NCT00699608|54671319|FG004|Second Intervention|Adverse Event|0|||
28012589|NCT00699608|54671320|FG005|Second Intervention|Adverse Event|0|||
28012590|NCT00699608|54671315|FG000|Second Intervention|Withdrawal by Subject|0|||
28012591|NCT00699608|54671316|FG001|Second Intervention|Withdrawal by Subject|0|||
28012592|NCT00699608|54671317|FG002|Second Intervention|Withdrawal by Subject|0|||
28012593|NCT00699608|54671318|FG003|Second Intervention|Withdrawal by Subject|1|||
28012594|NCT00699608|54671319|FG004|Second Intervention|Withdrawal by Subject|0|||
28012595|NCT00699608|54671320|FG005|Second Intervention|Withdrawal by Subject|0|||
28012596|NCT03823404|54671331|FG000|Overall Study|Lost to Follow-up|1|||
28012597|NCT03823404|54671332|FG001|Overall Study|Lost to Follow-up|2|||
28012598|NCT03823404|54671333|FG002|Overall Study|Lost to Follow-up|3|||
28012599|NCT03823404|54671331|FG000|Overall Study|Protocol Violation|2|||
28012600|NCT03823404|54671332|FG001|Overall Study|Protocol Violation|0|||
28012601|NCT03823404|54671333|FG002|Overall Study|Protocol Violation|2|||
28012602|NCT03823404|54671331|FG000|Overall Study|Adverse Event|35|||
28012603|NCT03823404|54671332|FG001|Overall Study|Adverse Event|38|||
28012604|NCT03823404|54671333|FG002|Overall Study|Adverse Event|8|||
28012605|NCT03823404|54671331|FG000|Overall Study|Withdrawal by Subject|38|||
28012606|NCT03823404|54671332|FG001|Overall Study|Withdrawal by Subject|40|||
28012607|NCT03823404|54671333|FG002|Overall Study|Withdrawal by Subject|35|||
28012608|NCT03823404|54671331|FG000|Overall Study|Death|4|||
28012609|NCT03823404|54671332|FG001|Overall Study|Death|0|||
28012610|NCT03823404|54671333|FG002|Overall Study|Death|0|||
28012611|NCT03823404|54671331|FG000|Overall Study|Other: Various reasons provided|5|||
28012612|NCT03823404|54671332|FG001|Overall Study|Other: Various reasons provided|5|||
28012613|NCT03823404|54671333|FG002|Overall Study|Other: Various reasons provided|6|||
28012614|NCT00706706|54671341|FG000|Overall Study|Death|53|||
28012615|NCT00706706|54671341|FG000|Overall Study|Lost to Follow-up|7|||
28012616|NCT00706706|54671341|FG000|Overall Study|Study endpoint had reached|45|||
28012617|NCT00410761|54671347|FG000|Overall Study|Adverse Event|29|||
28012618|NCT00410761|54671348|FG001|Overall Study|Adverse Event|3|||
28012619|NCT00410761|54671347|FG000|Overall Study|objective disease progression|71|||
28012620|NCT00410761|54671348|FG001|Overall Study|objective disease progression|55|||
28012621|NCT00410761|54671347|FG000|Overall Study|Withdrawal by Subject|8|||
28012622|NCT00410761|54671348|FG001|Overall Study|Withdrawal by Subject|4|||
28012623|NCT00410761|54671347|FG000|Overall Study|Other|12|||
28012624|NCT00410761|54671348|FG001|Overall Study|Other|9|||
28012625|NCT00410761|54671347|FG000|Overall Study|Never received randomised treatment|0|||
28012626|NCT00410761|54671348|FG001|Overall Study|Never received randomised treatment|1|||
28012627|NCT00410605|54671354|FG000|Overall Study|Adverse Event|12|||
28012628|NCT00410605|54671354|FG000|Overall Study|Physician Decision|3|||
28012629|NCT00410605|54671354|FG000|Overall Study|Withdrawal by Subject|5|||
28012630|NCT00410605|54671354|FG000|Overall Study|Started Non-Protocol Therapy|3|||
28012631|NCT00410605|54671354|FG000|Overall Study|Stopped treatmen to collect stem cells|1|||
28012632|NCT00410605|54671354|FG000|Overall Study|Transferred to another Institution|1|||
28012633|NCT00418717|54671358|FG000|Treatment Period A - Weeks 1-4|Protocol Violation|1|||
28012634|NCT00418717|54671358|FG000|Treatment Period B - Weeks 5-12|Adverse Event|2|||
28012635|NCT00572572|54671364|FG000|Overall Study|Withdrawal by Subject|3|||
28012636|NCT00572572|54671365|FG001|Overall Study|Withdrawal by Subject|6|||
28012637|NCT00418561|54671374|FG000|Overall Study|Participant's (guardian's) decision|0|||
28012638|NCT00418561|54671375|FG001|Overall Study|Participant's (guardian's) decision|1|||
28012639|NCT00418561|54671376|FG002|Overall Study|Participant's (guardian's) decision|0|||
28012640|NCT00398047|54671384|FG000|Overall Study|all patient progressed before completion|3|||
28012641|NCT00631371|54671391|FG000|Overall Study|Lost to Follow-up|24|||
27919929|NCT01070329|54577198|FG000|Overall Study|Lost to Follow-up|22|||
27919930|NCT01070329|54577199|FG001|Overall Study|Lost to Follow-up|12|||
27919931|NCT01070329|54577198|FG000|Overall Study|Withdrawal by Subject|9|||
27919932|NCT01070329|54577199|FG001|Overall Study|Withdrawal by Subject|11|||
28012642|NCT00631371|54671392|FG001|Overall Study|Lost to Follow-up|19|||
27741390|NCT02712905|54191368|FG014|Combination Therapy|Study Terminated by Sponsor|0|||
27741391|NCT02712905|54191369|FG015|Combination Therapy|Study Terminated by Sponsor|2|||
28012643|NCT00631371|54671391|FG000|Overall Study|Other reason|5|||
28012644|NCT00631371|54671392|FG001|Overall Study|Other reason|12|||
28012645|NCT00631371|54671391|FG000|Overall Study|subject request|38|||
28012646|NCT00631371|54671392|FG001|Overall Study|subject request|45|||
28012647|NCT00631371|54671391|FG000|Overall Study|Discontinuation of study by Sponsor|70|||
28012648|NCT00631371|54671392|FG001|Overall Study|Discontinuation of study by Sponsor|76|||
28012649|NCT00631371|54671391|FG000|Overall Study|Death|263|||
28012650|NCT00631371|54671392|FG001|Overall Study|Death|239|||
28012651|NCT00409747|54671398|FG000|Overall Study|Withdrawal by Subject|1|||
28012652|NCT00630747|54671402|FG000|Overall Study|Death|1|||
28103731|NCT02951780|54760441|FG002|Period 2|Scheduling Conflicts|0|||
28103732|NCT02951780|54760442|FG003|Period 2|Scheduling Conflicts|0|||
28103733|NCT02951780|54760443|FG004|Period 2|Scheduling Conflicts|0|||
28103734|NCT02951780|54760444|FG005|Period 2|Scheduling Conflicts|0|||
28103735|NCT02951780|54760445|FG006|Period 2|Scheduling Conflicts|0|||
28103736|NCT02951780|54760446|FG007|Period 2|Scheduling Conflicts|1|||
28103737|NCT02951780|54760447|FG008|Period 2|Scheduling Conflicts|0|||
28103738|NCT03334214|54760469|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
28103739|NCT03334214|54760470|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
28103740|NCT03334214|54760469|FG000|Overall Study|Withdrawal by Subject|0|||
28103741|NCT03334214|54760470|FG001|Overall Study|Withdrawal by Subject|1|||
28103742|NCT03334214|54760469|FG000|Overall Study|Other|1|||
28103743|NCT03334214|54760470|FG001|Overall Study|Other|0|||
28103744|NCT02250664|54760480|FG000|Overall Study|Lost to Follow-up|18|||
28103745|NCT02250664|54760481|FG001|Overall Study|Lost to Follow-up|28|||
28103746|NCT02250664|54760482|FG002|Overall Study|Lost to Follow-up|33|||
28103747|NCT02250664|54760480|FG000|Overall Study|Personal Reasons|7|||
28012653|NCT00630747|54671402|FG000|Overall Study|Transferred to Study TKT031NPU|7|||
28012654|NCT00630747|54671402|FG000|Overall Study|Returned to country of origin|1|||
28012655|NCT00397891|54671411|FG000|Overall Study|Withdrawal by Subject|1|||
28012656|NCT00397891|54671412|FG001|Overall Study|Withdrawal by Subject|0|||
27741392|NCT02712905|54191370|FG016|Combination Therapy|Study Terminated by Sponsor|0|||
27741393|NCT02712905|54191371|FG017|Combination Therapy|Study Terminated by Sponsor|1|||
27741394|NCT02712905|54191354|FG000|Combination Therapy|Withdrawal by Subject|0|||
27741395|NCT02712905|54191355|FG001|Combination Therapy|Withdrawal by Subject|0|||
27741396|NCT02712905|54191356|FG002|Combination Therapy|Withdrawal by Subject|0|||
27741397|NCT02712905|54191357|FG003|Combination Therapy|Withdrawal by Subject|0|||
27741398|NCT02712905|54191358|FG004|Combination Therapy|Withdrawal by Subject|0|||
27741399|NCT02712905|54191359|FG005|Combination Therapy|Withdrawal by Subject|0|||
27741400|NCT02712905|54191360|FG006|Combination Therapy|Withdrawal by Subject|0|||
27741401|NCT02712905|54191361|FG007|Combination Therapy|Withdrawal by Subject|0|||
27741402|NCT02712905|54191362|FG008|Combination Therapy|Withdrawal by Subject|0|||
27741403|NCT02712905|54191363|FG009|Combination Therapy|Withdrawal by Subject|0|||
27741404|NCT02712905|54191364|FG010|Combination Therapy|Withdrawal by Subject|0|||
27741405|NCT02712905|54191365|FG011|Combination Therapy|Withdrawal by Subject|0|||
28012657|NCT00397891|54671413|FG002|Overall Study|Withdrawal by Subject|0|||
28012658|NCT00397891|54671414|FG003|Overall Study|Withdrawal by Subject|0|||
27919933|NCT01070329|54577198|FG000|Overall Study|Protocol Violation|3|||
27741406|NCT02712905|54191366|FG012|Combination Therapy|Withdrawal by Subject|0|||
27741407|NCT02712905|54191367|FG013|Combination Therapy|Withdrawal by Subject|0|||
27741408|NCT02712905|54191368|FG014|Combination Therapy|Withdrawal by Subject|0|||
27741409|NCT02712905|54191369|FG015|Combination Therapy|Withdrawal by Subject|1|||
27741410|NCT02712905|54191370|FG016|Combination Therapy|Withdrawal by Subject|0|||
27741411|NCT02712905|54191371|FG017|Combination Therapy|Withdrawal by Subject|2|||
27741412|NCT02712905|54191354|FG000|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
28012659|NCT00397891|54671415|FG004|Overall Study|Withdrawal by Subject|1|||
28012660|NCT00397189|54671429|FG000|3 Weeks Period|Lost to Follow-up|5|||
28012661|NCT00397189|54671430|FG001|3 Weeks Period|Lost to Follow-up|4|||
28012662|NCT00397189|54671429|FG000|3 Weeks Period|Adverse Event|3|||
28012663|NCT00397189|54671430|FG001|3 Weeks Period|Adverse Event|2|||
28012664|NCT00397189|54671429|FG000|3 Weeks Period|Withdrawal by Subject|13|||
28012665|NCT00397189|54671430|FG001|3 Weeks Period|Withdrawal by Subject|9|||
28012666|NCT00397189|54671429|FG000|3 Weeks Period|Physician Decision|0|||
28012667|NCT00397189|54671430|FG001|3 Weeks Period|Physician Decision|2|||
28012668|NCT00397189|54671429|FG000|3 Weeks Period|Protocol Violation|0|||
28012669|NCT00397189|54671430|FG001|3 Weeks Period|Protocol Violation|3|||
28012670|NCT00397189|54671429|FG000|3 Weeks Period|Other|0|||
28012671|NCT00397189|54671430|FG001|3 Weeks Period|Other|2|||
28012672|NCT00606034|54671438|FG000|Overall Study|incarceration|1|||
28012673|NCT00397033|54671447|FG000|Overall Study|Adverse Event|7|||
27919934|NCT01070329|54577199|FG001|Overall Study|Protocol Violation|8|||
27919935|NCT01070329|54577198|FG000|Overall Study|Lack of Efficacy|2|||
28012674|NCT00397033|54671448|FG001|Overall Study|Adverse Event|10|||
28012675|NCT00397033|54671449|FG002|Overall Study|Adverse Event|4|||
28012676|NCT00397033|54671447|FG000|Overall Study|Lack of Efficacy|22|||
28012677|NCT00397033|54671448|FG001|Overall Study|Lack of Efficacy|12|||
28012678|NCT00397033|54671449|FG002|Overall Study|Lack of Efficacy|9|||
28012679|NCT00397033|54671447|FG000|Overall Study|Lost to Follow-up|3|||
28012680|NCT00397033|54671448|FG001|Overall Study|Lost to Follow-up|3|||
28012681|NCT00397033|54671449|FG002|Overall Study|Lost to Follow-up|3|||
28012682|NCT00397033|54671447|FG000|Overall Study|Withdrawal by Subject|12|||
27741413|NCT02712905|54191355|FG001|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
27919936|NCT01070329|54577199|FG001|Overall Study|Lack of Efficacy|6|||
27919937|NCT01070329|54577198|FG000|Overall Study|Physician Decision|2|||
27919938|NCT01070329|54577199|FG001|Overall Study|Physician Decision|1|||
27919939|NCT01070329|54577198|FG000|Overall Study|Entry Criteria Not Met|1|||
27919940|NCT01070329|54577199|FG001|Overall Study|Entry Criteria Not Met|0|||
27919941|NCT01070329|54577198|FG000|Overall Study|Sponsor Decision|0|||
27741414|NCT02712905|54191356|FG002|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
27919942|NCT01070329|54577199|FG001|Overall Study|Sponsor Decision|1|||
27919943|NCT01069861|54577205|FG000|Overall Study|Death|1|||
28012683|NCT00397033|54671448|FG001|Overall Study|Withdrawal by Subject|7|||
28012684|NCT00397033|54671449|FG002|Overall Study|Withdrawal by Subject|5|||
28012685|NCT00397033|54671447|FG000|Overall Study|Other|0|||
27919944|NCT01069861|54577205|FG000|Overall Study|Adverse Event|1|||
27919945|NCT01069861|54577205|FG000|Overall Study|Did not meet entrance criteria|1|||
28012686|NCT00397033|54671448|FG001|Overall Study|Other|5|||
28012687|NCT00397033|54671449|FG002|Overall Study|Other|2|||
28012688|NCT00572728|54671457|FG000|Overall Study|Withdrawal by Subject|10|||
28103748|NCT02250664|54760481|FG001|Overall Study|Personal Reasons|8|||
28103749|NCT02250664|54760482|FG002|Overall Study|Personal Reasons|14|||
28103750|NCT02250664|54760480|FG000|Overall Study|Adverse Event|6|||
28103751|NCT02250664|54760481|FG001|Overall Study|Adverse Event|3|||
28103752|NCT02250664|54760482|FG002|Overall Study|Adverse Event|8|||
28103753|NCT02250664|54760480|FG000|Overall Study|Incarcerated|2|||
28103754|NCT02250664|54760481|FG001|Overall Study|Incarcerated|1|||
28103755|NCT02250664|54760482|FG002|Overall Study|Incarcerated|2|||
28103756|NCT02250664|54760480|FG000|Overall Study|Withdrawal by Subject|0|||
28103757|NCT02250664|54760481|FG001|Overall Study|Withdrawal by Subject|1|||
28103758|NCT02250664|54760482|FG002|Overall Study|Withdrawal by Subject|2|||
28103759|NCT02250664|54760480|FG000|Overall Study|Death|0|||
28103760|NCT02250664|54760481|FG001|Overall Study|Death|1|||
28103761|NCT02250664|54760482|FG002|Overall Study|Death|1|||
28103762|NCT02250664|54760480|FG000|Overall Study|Physician Decision|1|||
28103763|NCT02250664|54760481|FG001|Overall Study|Physician Decision|3|||
28103764|NCT02250664|54760482|FG002|Overall Study|Physician Decision|1|||
28103765|NCT02250664|54760480|FG000|Overall Study|Protocol Violation|1|||
28103766|NCT02250664|54760481|FG001|Overall Study|Protocol Violation|0|||
28012689|NCT00572728|54671457|FG000|Overall Study|Ineligible|3|||
28012690|NCT00572728|54671457|FG000|Overall Study|Enrolled under Amendment 4|5|||
28012691|NCT00572728|54671457|FG000|Overall Study|Offstudy due to complicating disease|1|||
28012692|NCT00572728|54671457|FG000|Overall Study|FLT1 not completed|4|||
28012693|NCT00572728|54671457|FG000|Overall Study|First Chemotherapy not initiated|2|||
28012694|NCT00572728|54671457|FG000|Overall Study|FLT2 not completed|5|||
28012695|NCT00572728|54671457|FG000|Overall Study|Second chemotherapy not initiated|1|||
28012696|NCT00572728|54671457|FG000|Overall Study|FLT2 after second chemotherapy initiated|7|||
28012697|NCT00572728|54671457|FG000|Overall Study|Pathology missing|1|||
28012698|NCT00699374|54671465|FG000|Overall Study|Death|93|||
28012699|NCT00699374|54671466|FG001|Overall Study|Death|83|||
28012700|NCT00699374|54671465|FG000|Overall Study|Adverse Event|70|||
28012701|NCT00699374|54671466|FG001|Overall Study|Adverse Event|67|||
28012702|NCT00699374|54671465|FG000|Overall Study|Global deterioration of health status|7|||
28012703|NCT00699374|54671466|FG001|Overall Study|Global deterioration of health status|8|||
28012704|NCT00699374|54671465|FG000|Overall Study|Lost to Follow-up|3|||
28012705|NCT00699374|54671466|FG001|Overall Study|Lost to Follow-up|5|||
28012706|NCT00699374|54671465|FG000|Overall Study|Withdrawal by Subject|34|||
28012707|NCT00699374|54671466|FG001|Overall Study|Withdrawal by Subject|44|||
28012708|NCT00699374|54671465|FG000|Overall Study|Objective progression or relapse|281|||
28012709|NCT00699374|54671466|FG001|Overall Study|Objective progression or relapse|277|||
28012710|NCT00699374|54671465|FG000|Overall Study|Other|18|||
28012711|NCT00699374|54671466|FG001|Overall Study|Other|15|||
28012712|NCT00699374|54671465|FG000|Overall Study|Protocol Violation|2|||
28012713|NCT00699374|54671466|FG001|Overall Study|Protocol Violation|6|||
28012714|NCT00699374|54671465|FG000|Overall Study|Study terminated by sponsor|13|||
28012715|NCT00699374|54671466|FG001|Overall Study|Study terminated by sponsor|28|||
28012716|NCT00699374|54671465|FG000|Overall Study|Randomized but not treated|4|||
28012717|NCT00699374|54671466|FG001|Overall Study|Randomized but not treated|2|||
28012718|NCT00699374|54671465|FG000|Overall Study|Died 28 days after last dose|5|||
28103767|NCT02250664|54760482|FG002|Overall Study|Protocol Violation|1|||
28103768|NCT02250664|54760480|FG000|Overall Study|Reason unknown|1|||
28103769|NCT02250664|54760481|FG001|Overall Study|Reason unknown|0|||
28103770|NCT02250664|54760482|FG002|Overall Study|Reason unknown|0|||
28103771|NCT02646982|54760492|FG000|Overall Study|Adverse Event|1|||
28103772|NCT02646982|54760493|FG001|Overall Study|Adverse Event|1|||
28103773|NCT02646982|54760492|FG000|Overall Study|Withdrawal by Subject|2|||
28103774|NCT02646982|54760493|FG001|Overall Study|Withdrawal by Subject|1|||
28103775|NCT02845336|54760501|FG000|Overall Study|Lost to Follow-up|3|||
28103776|NCT02845336|54760502|FG001|Overall Study|Lost to Follow-up|1|||
28103777|NCT02845336|54760501|FG000|Overall Study|Inability to get medication|2|||
28103778|NCT02845336|54760502|FG001|Overall Study|Inability to get medication|0|||
28103779|NCT02844946|54760510|FG000|Overall Study|Lost to Follow-up|7|||
28103780|NCT02844946|54760511|FG001|Overall Study|Lost to Follow-up|0|||
28103781|NCT02951156|54760520|FG000|Overall Study|Death|3|||
28103782|NCT02951156|54760521|FG001|Overall Study|Death|8|||
28103783|NCT02951156|54760522|FG002|Overall Study|Death|5|||
28103784|NCT02951156|54760520|FG000|Overall Study|Progressive disease|1|||
28103785|NCT02951156|54760521|FG001|Overall Study|Progressive disease|0|||
28103786|NCT02951156|54760522|FG002|Overall Study|Progressive disease|1|||
28103787|NCT02951156|54760520|FG000|Overall Study|Withdrawal by Subject|0|||
28103788|NCT02951156|54760521|FG001|Overall Study|Withdrawal by Subject|0|||
28103789|NCT02951156|54760522|FG002|Overall Study|Withdrawal by Subject|1|||
28103790|NCT02951156|54760520|FG000|Overall Study|Study terminated by sponsor|0|||
28103791|NCT02951156|54760521|FG001|Overall Study|Study terminated by sponsor|0|||
28103792|NCT02951156|54760522|FG002|Overall Study|Study terminated by sponsor|1|||
28103793|NCT02951156|54760520|FG000|Overall Study|Other|5|||
28103794|NCT02951156|54760521|FG001|Overall Study|Other|1|||
28103795|NCT02951156|54760522|FG002|Overall Study|Other|2|||
28103796|NCT03345914|54760534|FG000|Overall Study|Transition to another study at week 16|80|||
28103797|NCT03345914|54760535|FG001|Overall Study|Transition to another study at week 16|86|||
28103798|NCT03345914|54760536|FG002|Overall Study|Transition to another study at week 16|78|||
28103799|NCT03345914|54760534|FG000|Overall Study|Transition to OLE during follow-up|37|||
27741415|NCT02712905|54191357|FG003|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
28012719|NCT00699374|54671466|FG001|Overall Study|Died 28 days after last dose|9|||
28012720|NCT00606892|54671472|FG000|First Intervention|Protocol Violation|1|||
28012721|NCT00606892|54671473|FG001|First Intervention|Protocol Violation|4|||
27919946|NCT01306929|54577209|FG000|Overall Study|Withdrawal by Subject|23|||
28012722|NCT00625443|54671508|FG000|Overall Study|Adverse Event|1|||
27741416|NCT02712905|54191358|FG004|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
27741417|NCT02712905|54191359|FG005|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
28012723|NCT00625443|54671509|FG001|Overall Study|Adverse Event|4|||
28012724|NCT00625443|54671510|FG002|Overall Study|Adverse Event|0|||
28012725|NCT00625443|54671508|FG000|Overall Study|Non-compliance with protocol|0|||
27919947|NCT01306929|54577209|FG000|Overall Study|Adverse Event|21|||
27919948|NCT01306929|54577209|FG000|Overall Study|Physician Decision|13|||
27741418|NCT02712905|54191360|FG006|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
27741419|NCT02712905|54191361|FG007|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
28012726|NCT00625443|54671509|FG001|Overall Study|Non-compliance with protocol|1|||
28012727|NCT00625443|54671510|FG002|Overall Study|Non-compliance with protocol|0|||
28012728|NCT00625443|54671508|FG000|Overall Study|Platelet count increase >=500,000/mm3|1|||
27746119|NCT00700427|54195661|FG001|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
27746200|NCT02124772|54195705|FG008|Overall Study|Other|1|||
27741420|NCT02712905|54191362|FG008|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
27741421|NCT02712905|54191363|FG009|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
27919949|NCT01306929|54577209|FG000|Overall Study|Death|8|||
28012729|NCT00625443|54671509|FG001|Overall Study|Platelet count increase >=500,000/mm3|0|||
28012730|NCT00625443|54671510|FG002|Overall Study|Platelet count increase >=500,000/mm3|0|||
27746201|NCT02124772|54195706|FG009|Overall Study|Other|1|||
27746202|NCT02124772|54195707|FG010|Overall Study|Other|1|||
27919950|NCT01306929|54577209|FG000|Overall Study|Withdrawal by parent/guardian|5|||
27741422|NCT02712905|54191364|FG010|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
27741423|NCT02712905|54191365|FG011|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
27741424|NCT02712905|54191366|FG012|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
27741425|NCT02712905|54191367|FG013|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
27919951|NCT01306929|54577209|FG000|Overall Study|Protocol Violation|3|||
28012731|NCT00625443|54671508|FG000|Overall Study|Withdrawal by Subject|0|||
28012732|NCT00625443|54671509|FG001|Overall Study|Withdrawal by Subject|1|||
28012733|NCT00625443|54671510|FG002|Overall Study|Withdrawal by Subject|2|||
27741426|NCT02712905|54191368|FG014|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
27741427|NCT02712905|54191369|FG015|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|1|||
28012734|NCT00625443|54671508|FG000|Overall Study|Physician Decision|0|||
27741428|NCT02712905|54191370|FG016|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
27746203|NCT02124772|54195708|FG011|Overall Study|Other|1|||
27741429|NCT02712905|54191371|FG017|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
27741430|NCT03776357|54191409|FG000|Overall Study|Lost to Follow-up|3|||
27741431|NCT04520997|54191415|FG000|Overall Study|Lost to Follow-up|1|||
27741432|NCT04520997|54191416|FG001|Overall Study|Lost to Follow-up|1|||
27741433|NCT04520997|54191415|FG000|Overall Study|Withdrawal by Subject|1|||
27741434|NCT04520997|54191416|FG001|Overall Study|Withdrawal by Subject|0|||
27741435|NCT04520997|54191415|FG000|Overall Study|Not Treated|0|||
27741436|NCT04520997|54191416|FG001|Overall Study|Not Treated|1|||
27741437|NCT02734433|54191427|FG000|Overall Study|Disease progression|1|||
27741438|NCT02734433|54191428|FG001|Overall Study|Disease progression|5|||
27741439|NCT02734433|54191427|FG000|Overall Study|Clinical progression|0|||
27741440|NCT02734433|54191428|FG001|Overall Study|Clinical progression|1|||
27741441|NCT02734433|54191427|FG000|Overall Study|Withdrawal by Subject|1|||
27741442|NCT02734433|54191428|FG001|Overall Study|Withdrawal by Subject|2|||
27741443|NCT02452424|54191454|FG000|Overall Study|Death|2|||
27741444|NCT02452424|54191455|FG001|Overall Study|Death|2|||
27741445|NCT02452424|54191456|FG002|Overall Study|Death|2|||
27741446|NCT02452424|54191457|FG003|Overall Study|Death|6|||
27741447|NCT02452424|54191458|FG004|Overall Study|Death|2|||
27741448|NCT02452424|54191459|FG005|Overall Study|Death|0|||
27741449|NCT02452424|54191460|FG006|Overall Study|Death|5|||
27741450|NCT02452424|54191461|FG007|Overall Study|Death|1|||
27741451|NCT02452424|54191462|FG008|Overall Study|Death|3|||
27741452|NCT02452424|54191463|FG009|Overall Study|Death|1|||
27741453|NCT02452424|54191464|FG010|Overall Study|Death|0|||
27741454|NCT02452424|54191454|FG000|Overall Study|Lost to Follow-up|0|||
27741455|NCT02452424|54191455|FG001|Overall Study|Lost to Follow-up|1|||
27741456|NCT02452424|54191456|FG002|Overall Study|Lost to Follow-up|1|||
27741457|NCT02452424|54191457|FG003|Overall Study|Lost to Follow-up|0|||
27741458|NCT02452424|54191458|FG004|Overall Study|Lost to Follow-up|0|||
27741459|NCT02452424|54191459|FG005|Overall Study|Lost to Follow-up|0|||
27741460|NCT02452424|54191460|FG006|Overall Study|Lost to Follow-up|0|||
27741461|NCT02452424|54191461|FG007|Overall Study|Lost to Follow-up|0|||
27741462|NCT02452424|54191462|FG008|Overall Study|Lost to Follow-up|0|||
27741463|NCT02452424|54191463|FG009|Overall Study|Lost to Follow-up|0|||
27741464|NCT02452424|54191464|FG010|Overall Study|Lost to Follow-up|0|||
28012735|NCT00625443|54671509|FG001|Overall Study|Physician Decision|4|||
28012736|NCT00625443|54671510|FG002|Overall Study|Physician Decision|2|||
28012737|NCT00625443|54671508|FG000|Overall Study|Other|0|||
28012738|NCT00625443|54671509|FG001|Overall Study|Other|1|||
27741465|NCT02452424|54191454|FG000|Overall Study|Withdrawal by Subject|0|||
27741466|NCT02452424|54191455|FG001|Overall Study|Withdrawal by Subject|0|||
28012739|NCT00625443|54671510|FG002|Overall Study|Other|1|||
28012740|NCT00625365|54671521|FG000|Overall Study|Withdrawal by Subject|1|||
28012741|NCT00625365|54671521|FG000|Overall Study|No IV access|5|||
27741467|NCT02452424|54191456|FG002|Overall Study|Withdrawal by Subject|3|||
27741468|NCT02452424|54191457|FG003|Overall Study|Withdrawal by Subject|2|||
27741469|NCT02452424|54191458|FG004|Overall Study|Withdrawal by Subject|0|||
27741470|NCT02452424|54191459|FG005|Overall Study|Withdrawal by Subject|0|||
27741471|NCT02452424|54191460|FG006|Overall Study|Withdrawal by Subject|1|||
27741472|NCT02452424|54191461|FG007|Overall Study|Withdrawal by Subject|0|||
27741473|NCT02452424|54191462|FG008|Overall Study|Withdrawal by Subject|1|||
27741474|NCT02452424|54191463|FG009|Overall Study|Withdrawal by Subject|1|||
27741475|NCT02452424|54191464|FG010|Overall Study|Withdrawal by Subject|0|||
27741476|NCT02452424|54191454|FG000|Overall Study|Other|0|||
27741477|NCT02452424|54191455|FG001|Overall Study|Other|0|||
27741478|NCT02452424|54191456|FG002|Overall Study|Other|1|||
27741479|NCT02452424|54191457|FG003|Overall Study|Other|0|||
27741480|NCT02452424|54191458|FG004|Overall Study|Other|0|||
27741481|NCT02452424|54191459|FG005|Overall Study|Other|1|||
27741482|NCT02452424|54191460|FG006|Overall Study|Other|4|||
27741483|NCT02452424|54191461|FG007|Overall Study|Other|3|||
27741484|NCT02452424|54191462|FG008|Overall Study|Other|0|||
27741485|NCT02452424|54191463|FG009|Overall Study|Other|0|||
27741486|NCT02452424|54191464|FG010|Overall Study|Other|1|||
27741487|NCT02452424|54191454|FG000|Overall Study|Progressive disease (per RECIST)|0|||
27741488|NCT02452424|54191455|FG001|Overall Study|Progressive disease (per RECIST)|0|||
27741489|NCT02452424|54191456|FG002|Overall Study|Progressive disease (per RECIST)|0|||
27741490|NCT02452424|54191457|FG003|Overall Study|Progressive disease (per RECIST)|0|||
27741491|NCT02452424|54191458|FG004|Overall Study|Progressive disease (per RECIST)|0|||
27741492|NCT02452424|54191459|FG005|Overall Study|Progressive disease (per RECIST)|0|||
27741493|NCT02452424|54191460|FG006|Overall Study|Progressive disease (per RECIST)|0|||
27741494|NCT02452424|54191461|FG007|Overall Study|Progressive disease (per RECIST)|0|||
27741495|NCT02452424|54191462|FG008|Overall Study|Progressive disease (per RECIST)|2|||
27741496|NCT02452424|54191463|FG009|Overall Study|Progressive disease (per RECIST)|0|||
27741497|NCT02452424|54191464|FG010|Overall Study|Progressive disease (per RECIST)|0|||
27741498|NCT02452424|54191454|FG000|Overall Study|Adverse Event|0|||
27741499|NCT02452424|54191455|FG001|Overall Study|Adverse Event|0|||
28012742|NCT00625365|54671521|FG000|Overall Study|VSD|1|||
28012743|NCT00606580|54671528|FG000|Overall Study|Lost to Follow-up|1|||
28103800|NCT03345914|54760535|FG001|Overall Study|Transition to OLE during follow-up|33|||
28103801|NCT03345914|54760536|FG002|Overall Study|Transition to OLE during follow-up|39|||
28103802|NCT03345914|54760534|FG000|Overall Study|Physician Decision|0|||
28103803|NCT03345914|54760535|FG001|Overall Study|Physician Decision|1|||
28103804|NCT03345914|54760536|FG002|Overall Study|Physician Decision|1|||
28103805|NCT03345914|54760534|FG000|Overall Study|Withdrawal by Subject|5|||
28103806|NCT03345914|54760535|FG001|Overall Study|Withdrawal by Subject|1|||
28103807|NCT03345914|54760536|FG002|Overall Study|Withdrawal by Subject|2|||
28103808|NCT03345914|54760534|FG000|Overall Study|Other|1|||
28103809|NCT03345914|54760535|FG001|Overall Study|Other|1|||
28103810|NCT03345914|54760536|FG002|Overall Study|Other|1|||
28103811|NCT03345914|54760534|FG000|Overall Study|Ongoing|0|||
28103812|NCT03345914|54760535|FG001|Overall Study|Ongoing|0|||
28103813|NCT03345914|54760536|FG002|Overall Study|Ongoing|1|||
28103814|NCT03369704|54760546|FG000|Treatment Epoch|technical problems|1|||
28103815|NCT03369704|54760547|FG001|Treatment Epoch|technical problems|0|||
28103816|NCT03369704|54760546|FG000|Treatment Epoch|Protocol Violation|1|||
28103817|NCT03369704|54760547|FG001|Treatment Epoch|Protocol Violation|0|||
27741500|NCT02452424|54191456|FG002|Overall Study|Adverse Event|0|||
27741501|NCT02452424|54191457|FG003|Overall Study|Adverse Event|0|||
27741502|NCT02452424|54191458|FG004|Overall Study|Adverse Event|0|||
27741503|NCT02452424|54191459|FG005|Overall Study|Adverse Event|0|||
27741504|NCT02452424|54191460|FG006|Overall Study|Adverse Event|0|||
27741505|NCT02452424|54191461|FG007|Overall Study|Adverse Event|0|||
27741506|NCT02452424|54191462|FG008|Overall Study|Adverse Event|0|||
27741507|NCT02452424|54191463|FG009|Overall Study|Adverse Event|0|||
27741508|NCT02452424|54191464|FG010|Overall Study|Adverse Event|1|||
27741509|NCT02419508|54191492|FG000|Overall Study|Adverse Event|9|||
27741510|NCT02419508|54191493|FG001|Overall Study|Adverse Event|3|||
28012744|NCT00606580|54671529|FG001|Overall Study|Lost to Follow-up|1|||
27919952|NCT01306929|54577209|FG000|Overall Study|Non-compliance with study drug|2|||
27919953|NCT01306929|54577209|FG000|Overall Study|Lost to Follow-up|2|||
27919954|NCT01306929|54577209|FG000|Overall Study|Various|17|||
27919955|NCT01064401|54577215|FG000|Overall Study|Adverse Event|47|||
27919956|NCT01064401|54577216|FG001|Overall Study|Adverse Event|56|||
27919957|NCT01064401|54577215|FG000|Overall Study|Lack of Efficacy|46|||
27919958|NCT01064401|54577216|FG001|Overall Study|Lack of Efficacy|23|||
27919959|NCT01064401|54577215|FG000|Overall Study|Lost to Follow-up|12|||
27919960|NCT01064401|54577216|FG001|Overall Study|Lost to Follow-up|9|||
27919961|NCT01064401|54577215|FG000|Overall Study|Consent Withdrawn|98|||
27919962|NCT01064401|54577216|FG001|Overall Study|Consent Withdrawn|80|||
27919963|NCT01064401|54577215|FG000|Overall Study|Investigator Decision|4|||
27919964|NCT01064401|54577216|FG001|Overall Study|Investigator Decision|6|||
27919965|NCT01064401|54577215|FG000|Overall Study|Death|4|||
27919966|NCT01064401|54577216|FG001|Overall Study|Death|0|||
27919967|NCT01064401|54577215|FG000|Overall Study|Pregnancy|4|||
28103818|NCT03369704|54760546|FG000|Treatment Epoch|Lost to Follow-up|0|||
28103819|NCT03369704|54760547|FG001|Treatment Epoch|Lost to Follow-up|1|||
28103820|NCT03369704|54760546|FG000|Treatment Epoch|Lack of Efficacy|0|||
28103821|NCT03369704|54760547|FG001|Treatment Epoch|Lack of Efficacy|2|||
28103822|NCT03369704|54760546|FG000|Treatment Epoch|Adverse Event|2|||
28103823|NCT03369704|54760547|FG001|Treatment Epoch|Adverse Event|0|||
28103824|NCT03369704|54760546|FG000|Follow-up Epoch|Lost to Follow-up|1|||
28103825|NCT03369704|54760547|FG001|Follow-up Epoch|Lost to Follow-up|0|||
28103826|NCT03366428|54760553|FG000|Overall Study|Progressive disease per RECIST v1.1|33|||
28103827|NCT03366428|54760553|FG000|Overall Study|Adverse Event|12|||
28103828|NCT03366428|54760553|FG000|Overall Study|Clinical progression|2|||
28103829|NCT03366428|54760553|FG000|Overall Study|Withdrawal by Subject|4|||
28103830|NCT02839876|54760561|FG000|Overall Study|Protocol Violation|10|||
28103831|NCT02839876|54760562|FG001|Overall Study|Protocol Violation|11|||
27741511|NCT02419508|54191492|FG000|Overall Study|Withdrawal by Subject|1|||
27741512|NCT02419508|54191493|FG001|Overall Study|Withdrawal by Subject|0|||
28012745|NCT00606580|54671530|FG002|Overall Study|Lost to Follow-up|4|||
28012746|NCT00606580|54671528|FG000|Overall Study|Clinical failures|1|||
28012747|NCT00606580|54671529|FG001|Overall Study|Clinical failures|0|||
28012748|NCT00606580|54671530|FG002|Overall Study|Clinical failures|12|||
27919968|NCT01064401|54577216|FG001|Overall Study|Pregnancy|7|||
27919969|NCT01064401|54577215|FG000|Overall Study|Noncompliance|7|||
27919970|NCT01064401|54577216|FG001|Overall Study|Noncompliance|8|||
27919971|NCT01064401|54577215|FG000|Overall Study|Site Closure|4|||
27919972|NCT01064401|54577216|FG001|Overall Study|Site Closure|5|||
27919973|NCT01064401|54577215|FG000|Overall Study|Other|2|||
27919974|NCT01064401|54577216|FG001|Overall Study|Other|1|||
27919975|NCT01306617|54577226|FG000|Overall Study|Adverse Event|1|||
28012749|NCT00606580|54671528|FG000|Overall Study|Withdrawal by investigator|0|||
27741513|NCT02419508|54191492|FG000|Overall Study|Other - Reason not specified|0|||
28012750|NCT00606580|54671529|FG001|Overall Study|Withdrawal by investigator|1|||
27746204|NCT02124772|54195709|FG012|Overall Study|Other|0|||
27919976|NCT01306617|54577227|FG001|Overall Study|Adverse Event|0|||
27919977|NCT01306617|54577228|FG002|Overall Study|Adverse Event|0|||
27741514|NCT02419508|54191493|FG001|Overall Study|Other - Reason not specified|1|||
27741515|NCT01328249|54191501|FG000|Overall Study|Adverse Event|3|||
27741516|NCT01328249|54191502|FG001|Overall Study|Adverse Event|0|||
27919978|NCT01306617|54577226|FG000|Overall Study|Virologic Failure|0|||
27741517|NCT01328249|54191501|FG000|Overall Study|Disease progression|1|||
27741518|NCT01328249|54191502|FG001|Overall Study|Disease progression|0|||
27741519|NCT01328249|54191501|FG000|Overall Study|Withdrawal by Subject|1|||
27741520|NCT01328249|54191502|FG001|Overall Study|Withdrawal by Subject|1|||
27741521|NCT01328249|54191501|FG000|Overall Study|Moved before end of treatment visit|1|||
27741522|NCT01328249|54191502|FG001|Overall Study|Moved before end of treatment visit|0|||
27741523|NCT01328249|54191501|FG000|Overall Study|Subject choice|1|||
27741524|NCT01328249|54191502|FG001|Overall Study|Subject choice|1|||
27741525|NCT01328249|54191501|FG000|Overall Study|Protocol Violation|0|||
27741526|NCT01328249|54191502|FG001|Overall Study|Protocol Violation|1|||
27741527|NCT01651052|54191510|FG000|Overall Study|Death|21|||
27741528|NCT01651052|54191510|FG000|Overall Study|Explant|1|||
27741529|NCT01651052|54191510|FG000|Overall Study|Withdrawal by Subject|1|||
27741530|NCT01651052|54191510|FG000|Overall Study|Lost to Follow-up|3|||
27741531|NCT02388074|54191514|FG000|Overall Study|Lost in Transit|2|||
27741532|NCT02388074|54191514|FG000|Overall Study|Sample Not Returned|1|||
27741533|NCT01602549|54191520|FG000|Overall Study|Protocol Violation|0|||
27741534|NCT01602549|54191521|FG001|Overall Study|Protocol Violation|1|||
27741535|NCT01602549|54191520|FG000|Overall Study|Withdrawal by Subject|1|||
27741536|NCT01602549|54191521|FG001|Overall Study|Withdrawal by Subject|0|||
27741537|NCT02427464|54191531|FG000|Overall Study|Adverse Event|6|||
27741538|NCT02427464|54191532|FG001|Overall Study|Adverse Event|1|||
27741539|NCT02427464|54191531|FG000|Overall Study|Lost to Follow-up|16|||
27741540|NCT02427464|54191532|FG001|Overall Study|Lost to Follow-up|5|||
27741541|NCT02427464|54191531|FG000|Overall Study|Physician Decision|2|||
27741542|NCT02427464|54191532|FG001|Overall Study|Physician Decision|0|||
27741543|NCT02427464|54191531|FG000|Overall Study|Withdrawal by Subject|10|||
27741544|NCT02427464|54191532|FG001|Overall Study|Withdrawal by Subject|8|||
27741545|NCT02427464|54191531|FG000|Overall Study|Noncompliance|16|||
27741546|NCT02427464|54191532|FG001|Overall Study|Noncompliance|10|||
27741547|NCT02426918|54191541|FG000|Overall Study|Adverse Event|2|||
27741548|NCT02426918|54191542|FG001|Overall Study|Adverse Event|2|||
27741549|NCT02426918|54191543|FG002|Overall Study|Adverse Event|0|||
27741550|NCT02426918|54191541|FG000|Overall Study|Physician Decision|1|||
27741551|NCT02426918|54191542|FG001|Overall Study|Physician Decision|1|||
27741552|NCT02426918|54191543|FG002|Overall Study|Physician Decision|1|||
27741553|NCT02426918|54191541|FG000|Overall Study|Withdrawal by Subject|5|||
27741554|NCT02426918|54191542|FG001|Overall Study|Withdrawal by Subject|5|||
27741555|NCT02426918|54191543|FG002|Overall Study|Withdrawal by Subject|4|||
27741556|NCT02426918|54191541|FG000|Overall Study|Other|9|||
27741557|NCT02426918|54191542|FG001|Overall Study|Other|11|||
27741558|NCT02426918|54191543|FG002|Overall Study|Other|9|||
27741559|NCT02387840|54191557|FG000|Overall Study|Death|0|||
27741560|NCT02387840|54191558|FG001|Overall Study|Death|0|||
27741561|NCT02387840|54191559|FG002|Overall Study|Death|0|||
27741562|NCT02387840|54191560|FG003|Overall Study|Death|0|||
27741563|NCT02387840|54191561|FG004|Overall Study|Death|0|||
27741564|NCT02387840|54191562|FG005|Overall Study|Death|1|||
27741565|NCT02387762|54191584|FG000|Overall Study|Withdrawal by Subject|1|||
27741566|NCT02387762|54191585|FG001|Overall Study|Withdrawal by Subject|0|||
27741567|NCT02418182|54191593|FG000|Overall Study|Unable to re-consent|18|||
27741568|NCT02418182|54191594|FG001|Overall Study|Unable to re-consent|15|||
27741569|NCT02418182|54191593|FG000|Overall Study|Lost to Follow-up|0|||
27741570|NCT02418182|54191594|FG001|Overall Study|Lost to Follow-up|2|||
27741571|NCT02387372|54191615|FG000|Overall Study|Not Treated|1|||
27741572|NCT02387372|54191616|FG001|Overall Study|Not Treated|0|||
27741573|NCT02426138|54191632|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
27741574|NCT02426138|54191633|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
27741575|NCT02426684|54191646|FG000|Overall Study|Physician Decision|1|||
27741576|NCT02656173|54191652|FG000|Overall Study|Deviation from the Eligible Criteria|3|||
27741577|NCT02656173|54191653|FG001|Overall Study|Deviation from the Eligible Criteria|2|||
27741578|NCT02656173|54191652|FG000|Overall Study|Adverse Event|7|||
27741579|NCT02656173|54191653|FG001|Overall Study|Adverse Event|5|||
27919979|NCT01306617|54577227|FG001|Overall Study|Virologic Failure|0|||
27919980|NCT01306617|54577228|FG002|Overall Study|Virologic Failure|5|||
27741580|NCT02656173|54191652|FG000|Overall Study|Withdrawal by Subject|1|||
27741581|NCT02656173|54191653|FG001|Overall Study|Withdrawal by Subject|3|||
27741582|NCT02656173|54191652|FG000|Overall Study|Protocol Violation|0|||
27741583|NCT02656173|54191653|FG001|Overall Study|Protocol Violation|1|||
27741584|NCT02656173|54191652|FG000|Overall Study|Miscellaneous|2|||
27741585|NCT02656173|54191653|FG001|Overall Study|Miscellaneous|0|||
27741586|NCT02656017|54191663|FG000|Overall Study|Study burden|3|||
27741587|NCT02656017|54191664|FG001|Overall Study|Study burden|3|||
27741588|NCT02656017|54191663|FG000|Overall Study|Adverse Event|2|||
27741589|NCT02656017|54191664|FG001|Overall Study|Adverse Event|1|||
27741590|NCT02656017|54191663|FG000|Overall Study|Unable/unwilling to take study medication|2|||
27741591|NCT02656017|54191664|FG001|Overall Study|Unable/unwilling to take study medication|1|||
27741592|NCT02656017|54191663|FG000|Overall Study|Began Tolvaptan|1|||
27741593|NCT02656017|54191664|FG001|Overall Study|Began Tolvaptan|1|||
27741594|NCT02656017|54191663|FG000|Overall Study|Withdrawal by Subject|1|||
27741595|NCT02656017|54191664|FG001|Overall Study|Withdrawal by Subject|0|||
27741596|NCT02657343|54191676|FG000|Overall Study|Death|0|||
27741597|NCT02657343|54191677|FG001|Overall Study|Death|2|||
27741598|NCT02657343|54191678|FG002|Overall Study|Death|0|||
27741599|NCT02657343|54191679|FG003|Overall Study|Death|0|||
27741600|NCT02657343|54191680|FG004|Overall Study|Death|0|||
27741601|NCT02657343|54191681|FG005|Overall Study|Death|0|||
27741602|NCT02657343|54191676|FG000|Overall Study|Patient went to hospice|1|||
27741603|NCT02657343|54191677|FG001|Overall Study|Patient went to hospice|0|||
27741604|NCT02657343|54191678|FG002|Overall Study|Patient went to hospice|0|||
27741605|NCT02657343|54191679|FG003|Overall Study|Patient went to hospice|0|||
27741606|NCT02657343|54191680|FG004|Overall Study|Patient went to hospice|0|||
27741607|NCT02657343|54191681|FG005|Overall Study|Patient went to hospice|0|||
27741608|NCT02657343|54191676|FG000|Overall Study|Withdrawal by Subject|0|||
27741609|NCT02657343|54191677|FG001|Overall Study|Withdrawal by Subject|0|||
27741610|NCT02657343|54191678|FG002|Overall Study|Withdrawal by Subject|0|||
27741611|NCT02657343|54191679|FG003|Overall Study|Withdrawal by Subject|0|||
27741612|NCT02657343|54191680|FG004|Overall Study|Withdrawal by Subject|1|||
27741613|NCT02657343|54191681|FG005|Overall Study|Withdrawal by Subject|0|||
27741614|NCT02655237|54191697|FG000|Overall Study|Adverse Event|10|||
27741615|NCT02655237|54191698|FG001|Overall Study|Adverse Event|7|||
27741616|NCT02655237|54191697|FG000|Overall Study|Protocol Deviation|2|||
27741617|NCT02655237|54191698|FG001|Overall Study|Protocol Deviation|0|||
27741618|NCT02655237|54191697|FG000|Overall Study|Withdrawal by Participant|1|||
27741619|NCT02655237|54191698|FG001|Overall Study|Withdrawal by Participant|2|||
27741620|NCT02655237|54191697|FG000|Overall Study|Lack of Efficacy|0|||
27741621|NCT02655237|54191698|FG001|Overall Study|Lack of Efficacy|1|||
27741622|NCT02655237|54191697|FG000|Overall Study|Recovery Leading to Surgery|2|||
27741623|NCT02655237|54191698|FG001|Overall Study|Recovery Leading to Surgery|1|||
27741624|NCT02655237|54191697|FG000|Overall Study|Reduction of Hemoglobin Concentration|1|||
27741625|NCT02655237|54191698|FG001|Overall Study|Reduction of Hemoglobin Concentration|0|||
27741626|NCT02655237|54191697|FG000|Overall Study|Randomized but Not Treated|1|||
27741627|NCT02655237|54191698|FG001|Overall Study|Randomized but Not Treated|0|||
27741628|NCT02657031|54191706|FG000|Overall Study|Adverse Event|1|||
27741629|NCT02657031|54191707|FG001|Overall Study|Adverse Event|2|||
27741630|NCT04375397|54191735|FG000|Overall Study|Death|1|||
27741631|NCT04375397|54191736|FG001|Overall Study|Death|1|||
27741632|NCT04375397|54191735|FG000|Overall Study|Withdrew consent|2|||
27741633|NCT04375397|54191736|FG001|Overall Study|Withdrew consent|0|||
27741634|NCT04375397|54191735|FG000|Overall Study|Lost to Follow-up|6|||
27741635|NCT04375397|54191736|FG001|Overall Study|Lost to Follow-up|4|||
27741636|NCT04375397|54191735|FG000|Overall Study|Other, not specified|0|||
27741637|NCT04375397|54191736|FG001|Overall Study|Other, not specified|1|||
27741638|NCT02387216|54191744|FG000|Overall Study|Progressive disease|2|||
27741639|NCT02387216|54191745|FG001|Overall Study|Progressive disease|0|||
27741640|NCT02387216|54191744|FG000|Overall Study|Withdrawal by Subject|3|||
27741641|NCT02387216|54191745|FG001|Overall Study|Withdrawal by Subject|5|||
27741642|NCT02387216|54191744|FG000|Overall Study|Physician Decision|2|||
27741643|NCT02387216|54191745|FG001|Overall Study|Physician Decision|0|||
27741644|NCT02387216|54191744|FG000|Overall Study|Sponsor Decision|28|||
27741645|NCT02387216|54191745|FG001|Overall Study|Sponsor Decision|12|||
27741646|NCT02387216|54191744|FG000|Overall Study|Death|60|||
27741647|NCT02387216|54191745|FG001|Overall Study|Death|23|||
27741648|NCT02387216|54191744|FG000|Overall Study|Other|5|||
27741649|NCT02387216|54191745|FG001|Overall Study|Other|4|||
27741650|NCT02387216|54191744|FG000|Overall Study|Lost to Follow-up|0|||
27741651|NCT02387216|54191745|FG001|Overall Study|Lost to Follow-up|3|||
27741652|NCT02417246|54191753|FG000|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
27741653|NCT02417246|54191754|FG001|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
27741654|NCT02417246|54191753|FG000|Phase 1 Brand Name Metoprolol ER|Physician Decision|1|||
27741655|NCT02417246|54191754|FG001|Phase 1 Brand Name Metoprolol ER|Physician Decision|0|||
27741656|NCT02417246|54191753|FG000|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2|||
27741657|NCT02417246|54191754|FG001|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3|||
27741658|NCT02417246|54191753|FG000|Phase 2 1st Generic Administered|Physician Decision|1|||
27741659|NCT02417246|54191754|FG001|Phase 2 1st Generic Administered|Physician Decision|0|||
27741660|NCT02424734|54191765|FG000|Overall Study|Treatment stopped to be discharged home|2|||
27741661|NCT02424734|54191766|FG001|Overall Study|Treatment stopped to be discharged home|2|||
27741662|NCT02424734|54191767|FG002|Overall Study|Treatment stopped to be discharged home|0|||
27741663|NCT02424578|54191778|FG000|Overall Study|Withdrawal by Subject|0|||
27741664|NCT02424578|54191779|FG001|Overall Study|Withdrawal by Subject|1|||
27741665|NCT02416934|54191787|FG000|Overall Study|given steroids|1|||
27741666|NCT02416934|54191788|FG001|Overall Study|given steroids|2|||
27741667|NCT02416934|54191787|FG000|Overall Study|Lost to Follow-up|0|||
27741668|NCT02416934|54191788|FG001|Overall Study|Lost to Follow-up|2|||
27741669|NCT02416934|54191787|FG000|Overall Study|Withdrawal by Subject|1|||
27741670|NCT02416934|54191788|FG001|Overall Study|Withdrawal by Subject|0|||
27741671|NCT02416934|54191787|FG000|Overall Study|recruited during continuing renewal proc|0|||
27741672|NCT02416934|54191788|FG001|Overall Study|recruited during continuing renewal proc|1|||
27741673|NCT02416934|54191787|FG000|Overall Study|Protocol Violation|0|||
27741674|NCT02416934|54191788|FG001|Overall Study|Protocol Violation|1|||
27741675|NCT02416934|54191787|FG000|Overall Study|surgery started late|0|||
27741676|NCT02416934|54191788|FG001|Overall Study|surgery started late|1|||
27741677|NCT02416934|54191787|FG000|Overall Study|re-operation|1|||
27741678|NCT02416934|54191788|FG001|Overall Study|re-operation|0|||
27741679|NCT02819635|54191808|FG000|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
27741680|NCT02819635|54191809|FG001|Substudy 1 and Substudy 2, Part 1|Adverse Event|1|||
27741681|NCT02819635|54191810|FG002|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
27741682|NCT02819635|54191811|FG003|Substudy 1 and Substudy 2, Part 1|Adverse Event|5|||
27741683|NCT02819635|54191812|FG004|Substudy 1 and Substudy 2, Part 1|Adverse Event|4|||
27741684|NCT02819635|54191813|FG005|Substudy 1 and Substudy 2, Part 1|Adverse Event|9|||
27741685|NCT02819635|54191814|FG006|Substudy 1 and Substudy 2, Part 1|Adverse Event|6|||
27741686|NCT02819635|54191815|FG007|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
27741687|NCT02819635|54191816|FG008|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
27741688|NCT02819635|54191817|FG009|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
28012751|NCT00606580|54671530|FG002|Overall Study|Withdrawal by investigator|6|||
28012752|NCT00606580|54671528|FG000|Overall Study|Withdrawal by Subject|0|||
28012753|NCT00606580|54671529|FG001|Overall Study|Withdrawal by Subject|1|||
27741689|NCT02819635|54191818|FG010|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
27741690|NCT02819635|54191819|FG011|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
27741691|NCT02819635|54191808|FG000|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
27741692|NCT02819635|54191809|FG001|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
27741693|NCT02819635|54191810|FG002|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
27741694|NCT02819635|54191811|FG003|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
27741695|NCT02819635|54191812|FG004|Substudy 1 and Substudy 2, Part 1|Withdrew consent|1|||
27741696|NCT02819635|54191813|FG005|Substudy 1 and Substudy 2, Part 1|Withdrew consent|3|||
27741697|NCT02819635|54191814|FG006|Substudy 1 and Substudy 2, Part 1|Withdrew consent|2|||
27741698|NCT02819635|54191815|FG007|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
27741699|NCT02819635|54191816|FG008|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
27741700|NCT02819635|54191817|FG009|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
27741701|NCT02819635|54191818|FG010|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
27741702|NCT02819635|54191819|FG011|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
27741703|NCT02819635|54191808|FG000|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
27741704|NCT02819635|54191809|FG001|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
27741705|NCT02819635|54191810|FG002|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
27919981|NCT01306617|54577226|FG000|Overall Study|Non-compliance|0|||
28012754|NCT00606580|54671530|FG002|Overall Study|Withdrawal by Subject|0|||
27741706|NCT02819635|54191811|FG003|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
27741707|NCT02819635|54191812|FG004|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
27741708|NCT02819635|54191813|FG005|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
27741709|NCT02819635|54191814|FG006|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
27741710|NCT02819635|54191815|FG007|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
27741711|NCT02819635|54191816|FG008|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
27741712|NCT02819635|54191817|FG009|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
27741713|NCT02819635|54191818|FG010|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
27741714|NCT02819635|54191819|FG011|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
27741715|NCT02819635|54191808|FG000|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
27741716|NCT02819635|54191809|FG001|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
27741717|NCT02819635|54191810|FG002|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
27741718|NCT02819635|54191811|FG003|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
27741719|NCT02819635|54191812|FG004|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
27741720|NCT02819635|54191813|FG005|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
27741721|NCT02819635|54191814|FG006|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|1|||
27741722|NCT02819635|54191815|FG007|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
27741723|NCT02819635|54191816|FG008|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
27741724|NCT02819635|54191817|FG009|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
27741725|NCT02819635|54191818|FG010|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
27741726|NCT02819635|54191819|FG011|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
27741727|NCT02819635|54191808|FG000|Substudy 1 and Substudy 2, Part 1|Other, not specified|2|||
27741728|NCT02819635|54191809|FG001|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
27741729|NCT02819635|54191810|FG002|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
27741730|NCT02819635|54191811|FG003|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
27741731|NCT02819635|54191812|FG004|Substudy 1 and Substudy 2, Part 1|Other, not specified|5|||
27741732|NCT02819635|54191813|FG005|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
27741733|NCT02819635|54191814|FG006|Substudy 1 and Substudy 2, Part 1|Other, not specified|3|||
27741734|NCT02819635|54191815|FG007|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
27741735|NCT02819635|54191816|FG008|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
27741736|NCT02819635|54191817|FG009|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
27741737|NCT02819635|54191818|FG010|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
27741738|NCT02819635|54191819|FG011|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
27741739|NCT02819635|54191808|FG000|Substudy 2, Part 2|Adverse Event|0|||
27741740|NCT02819635|54191809|FG001|Substudy 2, Part 2|Adverse Event|0|||
27741741|NCT02819635|54191810|FG002|Substudy 2, Part 2|Adverse Event|0|||
27741742|NCT02819635|54191811|FG003|Substudy 2, Part 2|Adverse Event|0|||
27741743|NCT02819635|54191812|FG004|Substudy 2, Part 2|Adverse Event|0|||
27741744|NCT02819635|54191813|FG005|Substudy 2, Part 2|Adverse Event|4|||
27741745|NCT02819635|54191814|FG006|Substudy 2, Part 2|Adverse Event|0|||
27741746|NCT02819635|54191815|FG007|Substudy 2, Part 2|Adverse Event|0|||
27741747|NCT02819635|54191816|FG008|Substudy 2, Part 2|Adverse Event|0|||
27741748|NCT02819635|54191817|FG009|Substudy 2, Part 2|Adverse Event|0|||
27741749|NCT02819635|54191818|FG010|Substudy 2, Part 2|Adverse Event|0|||
27741750|NCT02819635|54191819|FG011|Substudy 2, Part 2|Adverse Event|0|||
27741751|NCT02819635|54191808|FG000|Substudy 2, Part 2|Withdrew consent|0|||
27741752|NCT02819635|54191809|FG001|Substudy 2, Part 2|Withdrew consent|0|||
27741753|NCT02819635|54191810|FG002|Substudy 2, Part 2|Withdrew consent|0|||
27741754|NCT02819635|54191811|FG003|Substudy 2, Part 2|Withdrew consent|0|||
27741755|NCT02819635|54191812|FG004|Substudy 2, Part 2|Withdrew consent|0|||
27741756|NCT02819635|54191813|FG005|Substudy 2, Part 2|Withdrew consent|3|||
27741757|NCT02819635|54191814|FG006|Substudy 2, Part 2|Withdrew consent|1|||
27741758|NCT02819635|54191815|FG007|Substudy 2, Part 2|Withdrew consent|0|||
27741759|NCT02819635|54191816|FG008|Substudy 2, Part 2|Withdrew consent|0|||
27919982|NCT01306617|54577227|FG001|Overall Study|Non-compliance|1|||
27741760|NCT02819635|54191817|FG009|Substudy 2, Part 2|Withdrew consent|0|||
27741761|NCT02819635|54191818|FG010|Substudy 2, Part 2|Withdrew consent|0|||
27741762|NCT02819635|54191819|FG011|Substudy 2, Part 2|Withdrew consent|0|||
27741763|NCT02819635|54191808|FG000|Substudy 2, Part 2|Lost to Follow-up|0|||
27741764|NCT02819635|54191809|FG001|Substudy 2, Part 2|Lost to Follow-up|0|||
27741765|NCT02819635|54191810|FG002|Substudy 2, Part 2|Lost to Follow-up|0|||
27741766|NCT02819635|54191811|FG003|Substudy 2, Part 2|Lost to Follow-up|0|||
27741767|NCT02819635|54191812|FG004|Substudy 2, Part 2|Lost to Follow-up|0|||
27741768|NCT02819635|54191813|FG005|Substudy 2, Part 2|Lost to Follow-up|0|||
27741769|NCT02819635|54191814|FG006|Substudy 2, Part 2|Lost to Follow-up|1|||
27741770|NCT02819635|54191815|FG007|Substudy 2, Part 2|Lost to Follow-up|0|||
27741771|NCT02819635|54191816|FG008|Substudy 2, Part 2|Lost to Follow-up|0|||
27741772|NCT02819635|54191817|FG009|Substudy 2, Part 2|Lost to Follow-up|0|||
27741773|NCT02819635|54191818|FG010|Substudy 2, Part 2|Lost to Follow-up|0|||
27741774|NCT02819635|54191819|FG011|Substudy 2, Part 2|Lost to Follow-up|0|||
27741775|NCT02819635|54191808|FG000|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
27741776|NCT02819635|54191809|FG001|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
27741777|NCT02819635|54191810|FG002|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
27741778|NCT02819635|54191811|FG003|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
27741779|NCT02819635|54191812|FG004|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
27741780|NCT02819635|54191813|FG005|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
27741781|NCT02819635|54191814|FG006|Substudy 2, Part 2|COVID-19 Logistical Restrictions|2|||
27741782|NCT02819635|54191815|FG007|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
27741783|NCT02819635|54191816|FG008|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
27741784|NCT02819635|54191817|FG009|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
27741785|NCT02819635|54191818|FG010|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
27741786|NCT02819635|54191819|FG011|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
27741787|NCT02819635|54191808|FG000|Substudy 2, Part 2|Other, not specified|0|||
27741788|NCT02819635|54191809|FG001|Substudy 2, Part 2|Other, not specified|0|||
27741789|NCT02819635|54191810|FG002|Substudy 2, Part 2|Other, not specified|0|||
27741790|NCT02819635|54191811|FG003|Substudy 2, Part 2|Other, not specified|0|||
27741791|NCT02819635|54191812|FG004|Substudy 2, Part 2|Other, not specified|0|||
27741792|NCT02819635|54191813|FG005|Substudy 2, Part 2|Other, not specified|4|||
27741793|NCT02819635|54191814|FG006|Substudy 2, Part 2|Other, not specified|8|||
27741794|NCT02819635|54191815|FG007|Substudy 2, Part 2|Other, not specified|0|||
27741795|NCT02819635|54191816|FG008|Substudy 2, Part 2|Other, not specified|0|||
27741796|NCT02819635|54191817|FG009|Substudy 2, Part 2|Other, not specified|0|||
27741797|NCT02819635|54191818|FG010|Substudy 2, Part 2|Other, not specified|0|||
27741798|NCT02819635|54191819|FG011|Substudy 2, Part 2|Other, not specified|0|||
27741799|NCT02819635|54191808|FG000|Substudy 3|Adverse Event|0|||
27741800|NCT02819635|54191809|FG001|Substudy 3|Adverse Event|0|||
27741801|NCT02819635|54191810|FG002|Substudy 3|Adverse Event|0|||
27741802|NCT02819635|54191811|FG003|Substudy 3|Adverse Event|0|||
27741803|NCT02819635|54191812|FG004|Substudy 3|Adverse Event|0|||
27741804|NCT02819635|54191813|FG005|Substudy 3|Adverse Event|0|||
27741805|NCT02819635|54191814|FG006|Substudy 3|Adverse Event|0|||
27741806|NCT02819635|54191815|FG007|Substudy 3|Adverse Event|0|||
27741807|NCT02819635|54191816|FG008|Substudy 3|Adverse Event|32|||
27741808|NCT02819635|54191817|FG009|Substudy 3|Adverse Event|3|||
27741809|NCT02819635|54191818|FG010|Substudy 3|Adverse Event|12|||
27741810|NCT02819635|54191819|FG011|Substudy 3|Adverse Event|18|||
27741811|NCT02819635|54191808|FG000|Substudy 3|Withdrew consent|0|||
27741812|NCT02819635|54191809|FG001|Substudy 3|Withdrew consent|0|||
27741813|NCT02819635|54191810|FG002|Substudy 3|Withdrew consent|0|||
27741814|NCT02819635|54191811|FG003|Substudy 3|Withdrew consent|0|||
27741815|NCT02819635|54191812|FG004|Substudy 3|Withdrew consent|0|||
27741816|NCT02819635|54191813|FG005|Substudy 3|Withdrew consent|0|||
27741817|NCT02819635|54191814|FG006|Substudy 3|Withdrew consent|0|||
27741818|NCT02819635|54191815|FG007|Substudy 3|Withdrew consent|0|||
27741819|NCT02819635|54191816|FG008|Substudy 3|Withdrew consent|11|||
27741820|NCT02819635|54191817|FG009|Substudy 3|Withdrew consent|1|||
27741821|NCT02819635|54191818|FG010|Substudy 3|Withdrew consent|4|||
27741822|NCT02819635|54191819|FG011|Substudy 3|Withdrew consent|9|||
27741823|NCT02819635|54191808|FG000|Substudy 3|Lost to Follow-up|0|||
27741824|NCT02819635|54191809|FG001|Substudy 3|Lost to Follow-up|0|||
27741825|NCT02819635|54191810|FG002|Substudy 3|Lost to Follow-up|0|||
27741826|NCT02819635|54191811|FG003|Substudy 3|Lost to Follow-up|0|||
27741827|NCT02819635|54191812|FG004|Substudy 3|Lost to Follow-up|0|||
27741828|NCT02819635|54191813|FG005|Substudy 3|Lost to Follow-up|0|||
27741829|NCT02819635|54191814|FG006|Substudy 3|Lost to Follow-up|0|||
27741830|NCT02819635|54191815|FG007|Substudy 3|Lost to Follow-up|0|||
27741831|NCT02819635|54191816|FG008|Substudy 3|Lost to Follow-up|1|||
27741832|NCT02819635|54191817|FG009|Substudy 3|Lost to Follow-up|0|||
27741833|NCT02819635|54191818|FG010|Substudy 3|Lost to Follow-up|1|||
27741834|NCT02819635|54191819|FG011|Substudy 3|Lost to Follow-up|1|||
27741835|NCT02819635|54191808|FG000|Substudy 3|COVID-19 Logistical Restrictions|0|||
27741836|NCT02819635|54191809|FG001|Substudy 3|COVID-19 Logistical Restrictions|0|||
27741837|NCT02819635|54191810|FG002|Substudy 3|COVID-19 Logistical Restrictions|0|||
27741838|NCT02819635|54191811|FG003|Substudy 3|COVID-19 Logistical Restrictions|0|||
27741839|NCT02819635|54191812|FG004|Substudy 3|COVID-19 Logistical Restrictions|0|||
27741840|NCT02819635|54191813|FG005|Substudy 3|COVID-19 Logistical Restrictions|0|||
27741841|NCT02819635|54191814|FG006|Substudy 3|COVID-19 Logistical Restrictions|0|||
27741842|NCT02819635|54191815|FG007|Substudy 3|COVID-19 Logistical Restrictions|0|||
27741843|NCT02819635|54191816|FG008|Substudy 3|COVID-19 Logistical Restrictions|0|||
27741844|NCT02819635|54191817|FG009|Substudy 3|COVID-19 Logistical Restrictions|0|||
27741845|NCT02819635|54191818|FG010|Substudy 3|COVID-19 Logistical Restrictions|0|||
27741846|NCT02819635|54191819|FG011|Substudy 3|COVID-19 Logistical Restrictions|1|||
27741847|NCT02819635|54191808|FG000|Substudy 3|Other, not specified|0|||
27741848|NCT02819635|54191809|FG001|Substudy 3|Other, not specified|0|||
27741849|NCT02819635|54191810|FG002|Substudy 3|Other, not specified|0|||
27741850|NCT02819635|54191811|FG003|Substudy 3|Other, not specified|0|||
27741851|NCT02819635|54191812|FG004|Substudy 3|Other, not specified|0|||
27741852|NCT02819635|54191813|FG005|Substudy 3|Other, not specified|0|||
27741853|NCT02819635|54191814|FG006|Substudy 3|Other, not specified|0|||
27741854|NCT02819635|54191815|FG007|Substudy 3|Other, not specified|0|||
27741855|NCT02819635|54191816|FG008|Substudy 3|Other, not specified|202|||
27741856|NCT02819635|54191817|FG009|Substudy 3|Other, not specified|5|||
27741857|NCT02819635|54191818|FG010|Substudy 3|Other, not specified|89|||
27741858|NCT02819635|54191819|FG011|Substudy 3|Other, not specified|39|||
27741859|NCT02424344|54191854|FG000|Overall Study|Lack of Efficacy|0|||
27741860|NCT02424344|54191855|FG001|Overall Study|Lack of Efficacy|1|||
27741861|NCT02424344|54191854|FG000|Overall Study|Withdrawal by Subject|2|||
27741862|NCT02424344|54191855|FG001|Overall Study|Withdrawal by Subject|1|||
27741863|NCT02424344|54191854|FG000|Overall Study|Lost to Follow-up|1|||
27741864|NCT02424344|54191855|FG001|Overall Study|Lost to Follow-up|0|||
27741865|NCT02424344|54191854|FG000|Overall Study|Adverse Event|4|||
27741866|NCT02424344|54191855|FG001|Overall Study|Adverse Event|8|||
27741867|NCT02423798|54191861|FG000|Overall Study|Withdrawal by Subject|3|||
27919983|NCT01306617|54577228|FG002|Overall Study|Non-compliance|0|||
27919984|NCT01306305|54577238|FG000|Overall Study|Lost to Follow-up|1|||
27919985|NCT01306305|54577239|FG001|Overall Study|Lost to Follow-up|0|||
27919986|NCT01306305|54577238|FG000|Overall Study|Withdrew consent|1|||
27919987|NCT01306305|54577239|FG001|Overall Study|Withdrew consent|0|||
27919988|NCT01038427|54577248|FG000|Overall Study|Lost to follow up|1|||
27919989|NCT01038427|54577249|FG001|Overall Study|Lost to follow up|1|||
27919990|NCT01038427|54577250|FG002|Overall Study|Lost to follow up|0|||
27919991|NCT01038427|54577248|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
27741868|NCT01651208|54191884|FG000|Overall Study|Lost to Follow-up|14|||
27741869|NCT01651208|54191885|FG001|Overall Study|Lost to Follow-up|16|||
27741870|NCT02383940|54191894|FG000|Overall Study|Adverse Event|1|||
27919992|NCT01038427|54577249|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
27919993|NCT01038427|54577250|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
27919994|NCT01038427|54577248|FG000|Overall Study|Withdrew consent|0|||
27919995|NCT01038427|54577249|FG001|Overall Study|Withdrew consent|0|||
27919996|NCT01038427|54577250|FG002|Overall Study|Withdrew consent|1|||
27919997|NCT01038427|54577248|FG000|Overall Study|Adverse Event|2|||
27919998|NCT01038427|54577249|FG001|Overall Study|Adverse Event|2|||
27919999|NCT01038427|54577250|FG002|Overall Study|Adverse Event|1|||
27920000|NCT01038427|54577248|FG000|Overall Study|Enrolled in error|0|||
27920001|NCT01038427|54577249|FG001|Overall Study|Enrolled in error|1|||
27920002|NCT01038427|54577250|FG002|Overall Study|Enrolled in error|1|||
27920003|NCT01038427|54577248|FG000|Overall Study|Other|0|||
27920004|NCT01038427|54577249|FG001|Overall Study|Other|2|||
27920005|NCT01038427|54577250|FG002|Overall Study|Other|0|||
27920006|NCT01037413|54577258|FG000|Part A: Skin Testing|Adverse Event|1|||
27920007|NCT01037413|54577259|FG001|Part A: Skin Testing|Adverse Event|0|||
27920008|NCT01037413|54577258|FG000|Part A: Skin Testing|Protocol Violation|1|||
27920009|NCT01037413|54577259|FG001|Part A: Skin Testing|Protocol Violation|0|||
27920010|NCT01037413|54577258|FG000|Part B: Scar Revision|Withdrawal by Subject|0|||
27920011|NCT01037413|54577259|FG001|Part B: Scar Revision|Withdrawal by Subject|1|||
27920012|NCT01037413|54577258|FG000|Part B: Scar Revision|Assigned But Not Treated|0|||
27920013|NCT01037413|54577259|FG001|Part B: Scar Revision|Assigned But Not Treated|1|||
27920014|NCT01326845|54577274|FG000|Overall Study|Administrative Problems|5|||
27920015|NCT01326845|54577275|FG001|Overall Study|Administrative Problems|2|||
27920016|NCT01326845|54577274|FG000|Overall Study|Adverse Event|1|||
27920017|NCT01326845|54577275|FG001|Overall Study|Adverse Event|0|||
27920018|NCT01326845|54577274|FG000|Overall Study|Misisng|1|||
27920019|NCT01326845|54577275|FG001|Overall Study|Misisng|3|||
27920020|NCT01062763|54577283|FG000|Overall Study|Adverse Event|3|||
27920021|NCT01062763|54577284|FG001|Overall Study|Adverse Event|4|||
27920022|NCT01048099|54577290|FG000|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57|||
27920023|NCT01048099|54577290|FG000|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202|||
27920024|NCT01303965|54577298|FG000|Overall Study|Adverse Event|1|||
27920025|NCT01303965|54577299|FG001|Overall Study|Adverse Event|1|||
27920026|NCT01303965|54577298|FG000|Overall Study|Death|0|||
27920027|NCT01303965|54577299|FG001|Overall Study|Death|3|||
27920028|NCT01303965|54577298|FG000|Overall Study|Withdrawal by Subject|1|||
27920029|NCT01303965|54577299|FG001|Overall Study|Withdrawal by Subject|0|||
27920030|NCT01303965|54577298|FG000|Overall Study|Disease Progression|1|||
27920031|NCT01303965|54577299|FG001|Overall Study|Disease Progression|6|||
27920032|NCT01045993|54577309|FG000|Overall Study|Treated-later found eligibility not met|0|||
27920033|NCT01045993|54577310|FG001|Overall Study|Treated-later found eligibility not met|1|||
27920034|NCT01045993|54577311|FG002|Overall Study|Treated-later found eligibility not met|0|||
27920035|NCT01045993|54577312|FG003|Overall Study|Treated-later found eligibility not met|0|||
27920036|NCT01303419|54577322|FG000|Overall Study|Discontinuation of study|60|||
27920037|NCT01303419|54577322|FG000|Overall Study|Did not complete both imaging methods|5|||
27920038|NCT01303419|54577322|FG000|Overall Study|Did not meet all I/E after screening|31|||
27920039|NCT01326533|54577328|FG000|Overall Study|Lost to Follow-up|2|||
27920040|NCT01326533|54577329|FG001|Overall Study|Lost to Follow-up|0|||
27920041|NCT01326533|54577328|FG000|Overall Study|Withdrawal by Subject|1|||
27920042|NCT01326533|54577329|FG001|Overall Study|Withdrawal by Subject|0|||
27920043|NCT01326533|54577328|FG000|Overall Study|Adverse Event|1|||
27920044|NCT01326533|54577329|FG001|Overall Study|Adverse Event|0|||
27920045|NCT01045447|54577337|FG000|Overall Study|Adverse Event|0|||
27920046|NCT01045447|54577338|FG001|Overall Study|Adverse Event|1|||
27920047|NCT01045447|54577337|FG000|Overall Study|Lack of Efficacy|3|||
27920048|NCT01045447|54577338|FG001|Overall Study|Lack of Efficacy|1|||
27920049|NCT01045447|54577337|FG000|Overall Study|Protocol Violation|6|||
27920050|NCT01045447|54577338|FG001|Overall Study|Protocol Violation|3|||
27920051|NCT01045447|54577337|FG000|Overall Study|Withdrawal Criteria|10|||
27920052|NCT01045447|54577338|FG001|Overall Study|Withdrawal Criteria|10|||
27920053|NCT01045447|54577337|FG000|Overall Study|Unclassified|17|||
27920054|NCT01045447|54577338|FG001|Overall Study|Unclassified|13|||
27920055|NCT01301625|54577344|FG000|Overall Study|Death|5|||
27920056|NCT01301625|54577344|FG000|Overall Study|Not Due|21|||
27920057|NCT01301625|54577344|FG000|Overall Study|Expected|8|||
27920058|NCT01301625|54577344|FG000|Overall Study|Lost to Follow-up|1|||
27920059|NCT01301391|54577348|FG000|Overall Study|Death|13|||
27920060|NCT01301391|54577348|FG000|Overall Study|Lost to Follow-up|3|||
27920061|NCT01301391|54577348|FG000|Overall Study|Physician Decision|2|||
27920062|NCT01301391|54577348|FG000|Overall Study|Sponsor's decision|8|||
27920063|NCT01036321|54577354|FG000|Overall Study|Ineligible after randomization|0|||
27920064|NCT01036321|54577355|FG001|Overall Study|Ineligible after randomization|1|||
27920065|NCT01036321|54577354|FG000|Overall Study|Withdrawal by Subject|3|||
27920066|NCT01036321|54577355|FG001|Overall Study|Withdrawal by Subject|2|||
27920067|NCT01036321|54577354|FG000|Overall Study|Adverse Event|2|||
27920068|NCT01036321|54577355|FG001|Overall Study|Adverse Event|1|||
27920069|NCT01061359|54577361|FG000|Overall Study|Death|32|||
27920070|NCT01061359|54577361|FG000|Overall Study|Lost to Follow-up|1072|||
27920071|NCT01061359|54577361|FG000|Overall Study|Relapse|187|||
27920072|NCT01061359|54577361|FG000|Overall Study|Secondary neoplasm|11|||
27920073|NCT01301079|54577367|FG000|Overall Study|Lost to Follow-up|2|||
27920074|NCT01301079|54577368|FG001|Overall Study|Lost to Follow-up|2|||
27920075|NCT01036165|54577378|FG000|Overall Study|Adverse Event|6|||
27920076|NCT01036165|54577378|FG000|Overall Study|Lost to Follow-up|2|||
27920077|NCT01036165|54577378|FG000|Overall Study|Withdrawal by Subject|3|||
27920078|NCT01036165|54577378|FG000|Overall Study|Device Related Issues|3|||
27920079|NCT01036165|54577378|FG000|Overall Study|Problems finding proper area to inject|1|||
27920080|NCT01301001|54577382|FG000|First Intervention|Lost to Follow-up|4|||
27920081|NCT01301001|54577383|FG001|First Intervention|Lost to Follow-up|4|||
27920082|NCT01301001|54577382|FG000|First Intervention|Withdrawal by Subject|1|||
27920083|NCT01301001|54577383|FG001|First Intervention|Withdrawal by Subject|4|||
27920084|NCT01301001|54577382|FG000|First Intervention|Adverse Event|5|||
27920085|NCT01301001|54577383|FG001|First Intervention|Adverse Event|0|||
27920086|NCT01301001|54577382|FG000|First Intervention|Protocol Violation|0|||
27920087|NCT01301001|54577383|FG001|First Intervention|Protocol Violation|1|||
27920088|NCT01301001|54577382|FG000|Second Intervention|Adverse Event|2|||
27920089|NCT01301001|54577383|FG001|Second Intervention|Adverse Event|0|||
27920090|NCT01301001|54577382|FG000|Second Intervention|Withdrawal by Subject|2|||
27920091|NCT01301001|54577383|FG001|Second Intervention|Withdrawal by Subject|0|||
27920092|NCT01035463|54577392|FG000|Overall Study|Adverse Event|0|||
27920093|NCT01035463|54577393|FG001|Overall Study|Adverse Event|0|||
27920094|NCT01035463|54577394|FG002|Overall Study|Adverse Event|4|||
27920095|NCT01035463|54577395|FG003|Overall Study|Adverse Event|1|||
27920096|NCT01035463|54577396|FG004|Overall Study|Adverse Event|5|||
27920097|NCT01035463|54577397|FG005|Overall Study|Adverse Event|7|||
27920098|NCT01035463|54577392|FG000|Overall Study|Withdrawal by Subject|0|||
27920099|NCT01035463|54577393|FG001|Overall Study|Withdrawal by Subject|2|||
27920100|NCT01035463|54577394|FG002|Overall Study|Withdrawal by Subject|1|||
27920101|NCT01035463|54577395|FG003|Overall Study|Withdrawal by Subject|0|||
27920102|NCT01035463|54577396|FG004|Overall Study|Withdrawal by Subject|1|||
27920103|NCT01035463|54577397|FG005|Overall Study|Withdrawal by Subject|4|||
27920104|NCT01035463|54577392|FG000|Overall Study|Disease progression|0|||
27920105|NCT01035463|54577393|FG001|Overall Study|Disease progression|0|||
27920106|NCT01035463|54577394|FG002|Overall Study|Disease progression|0|||
27920107|NCT01035463|54577395|FG003|Overall Study|Disease progression|0|||
27920108|NCT01035463|54577396|FG004|Overall Study|Disease progression|0|||
27920109|NCT01035463|54577397|FG005|Overall Study|Disease progression|3|||
27920110|NCT01035463|54577392|FG000|Overall Study|Other Malignancy|0|||
27920111|NCT01035463|54577393|FG001|Overall Study|Other Malignancy|0|||
27920112|NCT01035463|54577394|FG002|Overall Study|Other Malignancy|0|||
27920113|NCT01035463|54577395|FG003|Overall Study|Other Malignancy|0|||
27920114|NCT01035463|54577396|FG004|Overall Study|Other Malignancy|0|||
27920115|NCT01035463|54577397|FG005|Overall Study|Other Malignancy|2|||
27920116|NCT01035463|54577392|FG000|Overall Study|Other|0|||
27920117|NCT01035463|54577393|FG001|Overall Study|Other|0|||
27920118|NCT01035463|54577394|FG002|Overall Study|Other|0|||
27920119|NCT01035463|54577395|FG003|Overall Study|Other|1|||
27920120|NCT01035463|54577396|FG004|Overall Study|Other|0|||
27920121|NCT01035463|54577397|FG005|Overall Study|Other|2|||
27920122|NCT01300923|54577404|FG000|Overall Study|Physician Decision|0|||
27920123|NCT01300923|54577405|FG001|Overall Study|Physician Decision|2|||
27920124|NCT01300767|54577410|FG000|Overall Study|Discomfort|2|||
27920125|NCT01300767|54577410|FG000|Overall Study|Biomicroscopy|1|||
27920126|NCT01300767|54577410|FG000|Overall Study|Unacceptable fit|1|||
27920127|NCT01300455|54577418|FG000|Washout|Withdrawal by Subject|1|||
27920128|NCT01300455|54577419|FG001|Washout|Withdrawal by Subject|0|||
27920129|NCT01107418|54577429|FG000|Overall Study|Disease Progression|45|||
27920130|NCT01107418|54577429|FG000|Overall Study|Adverse Event|3|||
27920131|NCT01107418|54577429|FG000|Overall Study|Withdrawal by Subject|1|||
27920132|NCT01107418|54577429|FG000|Overall Study|Study Closing|1|||
27920133|NCT01107418|54577429|FG000|Overall Study|Started Other Therapy|1|||
27920134|NCT01107418|54577429|FG000|Overall Study|Entered Extension Study|1|||
27920135|NCT01101178|54577444|FG000|Period 1|Withdrawal by Subject|1|||
27920136|NCT01101178|54577445|FG001|Period 1|Withdrawal by Subject|2|||
27920137|NCT01101178|54577444|FG000|Period 1|Positive drug screen|1|||
27920138|NCT01101178|54577445|FG001|Period 1|Positive drug screen|1|||
27920139|NCT01101178|54577444|FG000|Period 1|Adverse Event|2|||
27920140|NCT01101178|54577445|FG001|Period 1|Adverse Event|1|||
27920141|NCT01101178|54577444|FG000|Period 2|Withdrawal by Subject|0|||
27920142|NCT01101178|54577445|FG001|Period 2|Withdrawal by Subject|1|||
27920143|NCT01101022|54577454|FG000|Overall Study|Adverse Event|6|||
27920144|NCT01101022|54577455|FG001|Overall Study|Adverse Event|2|||
27920145|NCT01101022|54577454|FG000|Overall Study|Protocol Violation|4|||
27920146|NCT01101022|54577455|FG001|Overall Study|Protocol Violation|3|||
27920147|NCT01101022|54577454|FG000|Overall Study|Withdrawal by Subject|3|||
27920148|NCT01101022|54577455|FG001|Overall Study|Withdrawal by Subject|8|||
27920149|NCT01101022|54577454|FG000|Overall Study|Lost to Follow-up|1|||
27920150|NCT01101022|54577455|FG001|Overall Study|Lost to Follow-up|4|||
27920151|NCT01101022|54577454|FG000|Overall Study|Lack of Efficacy|0|||
27920152|NCT01101022|54577455|FG001|Overall Study|Lack of Efficacy|7|||
27920153|NCT01101022|54577454|FG000|Overall Study|Sponsor decision|1|||
27920154|NCT01101022|54577455|FG001|Overall Study|Sponsor decision|1|||
27920155|NCT01101022|54577454|FG000|Overall Study|Non-compliance|1|||
28012755|NCT00629265|54671540|FG000|Overall Study|Lost to Follow-up|4|||
28012756|NCT00629265|54671541|FG001|Overall Study|Lost to Follow-up|5|||
28012757|NCT00629265|54671540|FG000|Overall Study|Withdrawal by Subject|11|||
28012758|NCT00629265|54671541|FG001|Overall Study|Withdrawal by Subject|8|||
28012759|NCT00629265|54671540|FG000|Overall Study|Death|1|||
28012760|NCT00629265|54671541|FG001|Overall Study|Death|0|||
28012761|NCT00629265|54671540|FG000|Overall Study|Adverse Event|2|||
28012762|NCT00629265|54671541|FG001|Overall Study|Adverse Event|0|||
28012763|NCT00629265|54671540|FG000|Overall Study|HNC Recurrence|4|||
28012764|NCT00629265|54671541|FG001|Overall Study|HNC Recurrence|0|||
28012765|NCT00629265|54671540|FG000|Overall Study|Other CA Requiring Treatment|1|||
28012766|NCT00629265|54671541|FG001|Overall Study|Other CA Requiring Treatment|3|||
28012767|NCT00629265|54671540|FG000|Overall Study|Needed Esophageal Dilation|4|||
28012768|NCT00629265|54671541|FG001|Overall Study|Needed Esophageal Dilation|1|||
28012769|NCT00629265|54671540|FG000|Overall Study|Unrelated Medical Complications|3|||
28012770|NCT00629265|54671541|FG001|Overall Study|Unrelated Medical Complications|1|||
28012771|NCT00629265|54671540|FG000|Overall Study|Unknown Reason|2|||
28012772|NCT00629265|54671541|FG001|Overall Study|Unknown Reason|2|||
28012773|NCT00606502|54671549|FG000|Randomization|Randomized but not treated|3|||
28012774|NCT00606502|54671550|FG001|Randomization|Randomized but not treated|0|||
28012775|NCT00606502|54671549|FG000|Treatment|Treatment ongoing at time of data cutoff|0|||
28012776|NCT00606502|54671550|FG001|Treatment|Treatment ongoing at time of data cutoff|3|||
28012777|NCT00605722|54671556|FG000|Overall Study|Adverse Event|6|||
28012778|NCT00605722|54671556|FG000|Overall Study|Insufficient therapeutic response|44|||
28012779|NCT00605722|54671556|FG000|Overall Study|Failure to return|1|||
28012780|NCT00605566|54671560|FG000|Overall Study|Adverse Event|1|||
28012781|NCT00605566|54671560|FG000|Overall Study|Clinical deterioration|1|||
28012782|NCT00605566|54671560|FG000|Overall Study|Poor compliance in run-in period|1|||
28012783|NCT00396877|54671566|FG000|Overall Study|Lost to Follow-up|2|||
28012784|NCT00396877|54671567|FG001|Overall Study|Lost to Follow-up|1|||
28012785|NCT00396877|54671566|FG000|Overall Study|Parent(s)/guardian(s)'s request|4|||
28012786|NCT00396877|54671567|FG001|Overall Study|Parent(s)/guardian(s)'s request|7|||
28012787|NCT00628251|54671576|FG000|Randomised Part|Withdrawal by Subject|0|||
28012788|NCT00628251|54671577|FG001|Randomised Part|Withdrawal by Subject|0|||
28012789|NCT00628251|54671578|FG002|Randomised Part|Withdrawal by Subject|1|||
28012790|NCT00628251|54671576|FG000|Ongoing Initial Study Treatment at DCO|Adverse Event|1|||
28012791|NCT00628251|54671577|FG001|Ongoing Initial Study Treatment at DCO|Adverse Event|2|||
28012792|NCT00628251|54671578|FG002|Ongoing Initial Study Treatment at DCO|Adverse Event|3|||
28012793|NCT00628251|54671576|FG000|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19|||
28012794|NCT00628251|54671577|FG001|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15|||
28012795|NCT00628251|54671578|FG002|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13|||
28012796|NCT00628251|54671576|FG000|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
28012797|NCT00628251|54671577|FG001|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2|||
28012798|NCT00628251|54671578|FG002|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
28012799|NCT00628251|54671576|FG000|Ongoing Initial Study Treatment at DCO|Other reason|0|||
28012800|NCT00628251|54671577|FG001|Ongoing Initial Study Treatment at DCO|Other reason|1|||
28012801|NCT00628251|54671578|FG002|Ongoing Initial Study Treatment at DCO|Other reason|6|||
28012802|NCT00628251|54671576|FG000|Ongoing Initial Study Treatment at DCO|Other|1|||
28012803|NCT00628251|54671577|FG001|Ongoing Initial Study Treatment at DCO|Other|0|||
28012804|NCT00628251|54671578|FG002|Ongoing Initial Study Treatment at DCO|Other|2|||
28012805|NCT00625131|54671590|FG000|Overall Study|Lost to Follow-up|3|||
28012806|NCT00625131|54671591|FG001|Overall Study|Lost to Follow-up|2|||
28012807|NCT00625131|54671592|FG002|Overall Study|Lost to Follow-up|0|||
28012808|NCT00625131|54671590|FG000|Overall Study|Withdrawal by Subject|1|||
28012809|NCT00625131|54671591|FG001|Overall Study|Withdrawal by Subject|0|||
28012810|NCT00625131|54671592|FG002|Overall Study|Withdrawal by Subject|5|||
28012811|NCT00408499|54671598|FG000|Phase 1: Dose Levels 1-4|Adverse Event|0|||
28012812|NCT00408499|54671599|FG001|Phase 1: Dose Levels 1-4|Adverse Event|0|||
28012813|NCT00408499|54671600|FG002|Phase 1: Dose Levels 1-4|Adverse Event|1|||
28012814|NCT00408499|54671601|FG003|Phase 1: Dose Levels 1-4|Adverse Event|0|||
27920156|NCT01101022|54577455|FG001|Overall Study|Non-compliance|0|||
28012815|NCT00408499|54671602|FG004|Phase 1: Dose Levels 1-4|Adverse Event|0|||
28012816|NCT00408499|54671598|FG000|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
28012817|NCT00408499|54671599|FG001|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
28012818|NCT00408499|54671600|FG002|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
28012819|NCT00408499|54671601|FG003|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
28012820|NCT00408499|54671602|FG004|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
28012821|NCT00408499|54671598|FG000|Phase 1: Dose Levels 1-4|Physician Decision|1|||
27920157|NCT01101022|54577454|FG000|Overall Study|Work schedule|1|||
27920158|NCT01101022|54577455|FG001|Overall Study|Work schedule|1|||
27920159|NCT01101022|54577454|FG000|Overall Study|Vacation|0|||
27920160|NCT01101022|54577455|FG001|Overall Study|Vacation|1|||
27920161|NCT01299909|54577464|FG000|Overall Study|Lost to Follow-up|22|||
27920162|NCT01299909|54577465|FG001|Overall Study|Lost to Follow-up|18|||
27920163|NCT01299909|54577466|FG002|Overall Study|Lost to Follow-up|17|||
27920164|NCT01298661|54577476|FG000|Overall Study|Withdrawal by Subject|2|||
27920165|NCT01298661|54577477|FG001|Overall Study|Withdrawal by Subject|0|||
27920166|NCT01298661|54577478|FG002|Overall Study|Withdrawal by Subject|2|||
27920167|NCT01100944|54577487|FG000|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2|||
27920168|NCT01100944|54577488|FG001|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
27920169|NCT01100944|54577489|FG002|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
27920170|NCT01100944|54577487|FG000|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1|||
27920171|NCT01100944|54577488|FG001|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
27920172|NCT01100944|54577489|FG002|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
27920173|NCT01100944|54577487|FG000|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1|||
27920174|NCT01100944|54577488|FG001|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
27920175|NCT01100944|54577489|FG002|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
27920176|NCT01100944|54577487|FG000|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
27920177|NCT01100944|54577488|FG001|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2|||
27920178|NCT01100944|54577489|FG002|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
27920179|NCT01100320|54577510|FG000|Period 1|Withdrawal by Subject|2|||
27920180|NCT01100320|54577511|FG001|Period 1|Withdrawal by Subject|4|||
27920181|NCT01100320|54577510|FG000|Period 1|Positive Drug Screen|1|||
27920182|NCT01100320|54577511|FG001|Period 1|Positive Drug Screen|1|||
27920183|NCT01100320|54577510|FG000|Period 1|Adverse Event|2|||
27920184|NCT01100320|54577511|FG001|Period 1|Adverse Event|2|||
27920185|NCT01100320|54577510|FG000|Period 2|Withdrawal by Subject|1|||
27920186|NCT01100320|54577511|FG001|Period 2|Withdrawal by Subject|1|||
27920187|NCT01100086|54577517|FG000|Period 1|Withdrawal by Subject|1|||
27920188|NCT01100086|54577518|FG001|Period 1|Withdrawal by Subject|0|||
27920189|NCT01297959|54577526|FG000|Overall Study|Adverse Event|0|||
27920190|NCT01297959|54577527|FG001|Overall Study|Adverse Event|1|||
27920191|NCT01297959|54577526|FG000|Overall Study|Protocol Violation|2|||
27920192|NCT01297959|54577527|FG001|Overall Study|Protocol Violation|1|||
27920193|NCT01297959|54577526|FG000|Overall Study|Withdrawal by Subject|5|||
27920194|NCT01297959|54577527|FG001|Overall Study|Withdrawal by Subject|4|||
27920195|NCT01297959|54577526|FG000|Overall Study|Physician Decision|0|||
27920196|NCT01297959|54577527|FG001|Overall Study|Physician Decision|1|||
27920197|NCT01297959|54577526|FG000|Overall Study|Unrelated medical illness / complication|0|||
27920198|NCT01297959|54577527|FG001|Overall Study|Unrelated medical illness / complication|2|||
27920199|NCT01297959|54577526|FG000|Overall Study|Other|13|||
27920200|NCT01297959|54577527|FG001|Overall Study|Other|7|||
27920201|NCT01035229|54577535|FG000|Overall Study|Adverse Event|61|||
27920202|NCT01035229|54577536|FG001|Overall Study|Adverse Event|14|||
27920203|NCT01035229|54577535|FG000|Overall Study|Withdrawal by Subject|20|||
27920204|NCT01035229|54577536|FG001|Overall Study|Withdrawal by Subject|7|||
27920205|NCT01035229|54577535|FG000|Overall Study|Lost to Follow-up|1|||
27920206|NCT01035229|54577536|FG001|Overall Study|Lost to Follow-up|0|||
27920207|NCT01035229|54577535|FG000|Overall Study|Administrative problems|1|||
27920208|NCT01035229|54577536|FG001|Overall Study|Administrative problems|1|||
27920209|NCT01035229|54577535|FG000|Overall Study|Death|13|||
27920210|NCT01035229|54577536|FG001|Overall Study|Death|5|||
27920211|NCT01035229|54577535|FG000|Overall Study|New cancer therapy|2|||
27920212|NCT01035229|54577536|FG001|Overall Study|New cancer therapy|0|||
27920213|NCT01035229|54577535|FG000|Overall Study|Protocol Violation|0|||
27920214|NCT01035229|54577536|FG001|Overall Study|Protocol Violation|2|||
27920215|NCT01035229|54577535|FG000|Overall Study|Sponsor's decision to end study|3|||
27920216|NCT01035229|54577536|FG001|Overall Study|Sponsor's decision to end study|3|||
27920217|NCT01035229|54577535|FG000|Overall Study|Disease Progression|261|||
27920218|NCT01035229|54577536|FG001|Overall Study|Disease Progression|152|||
27920219|NCT01106404|54577546|FG000|Period I (First 6 Weeks)|Adverse Event|2|||
27920220|NCT01106404|54577547|FG001|Period I (First 6 Weeks)|Adverse Event|0|||
27920221|NCT01106404|54577546|FG000|Period I (First 6 Weeks)|Physician Decision|1|||
27920222|NCT01106404|54577547|FG001|Period I (First 6 Weeks)|Physician Decision|0|||
27920223|NCT01106404|54577546|FG000|Period I (First 6 Weeks)|Lost to Follow-up|0|||
27920224|NCT01106404|54577547|FG001|Period I (First 6 Weeks)|Lost to Follow-up|1|||
27920225|NCT01106404|54577546|FG000|Period I (First 6 Weeks)|Lack of Efficacy|0|||
27920226|NCT01106404|54577547|FG001|Period I (First 6 Weeks)|Lack of Efficacy|1|||
27920227|NCT01059799|54577561|FG000|Overall Study|Adverse Event|2|||
27920228|NCT01059799|54577562|FG001|Overall Study|Adverse Event|3|||
27920229|NCT01059799|54577561|FG000|Overall Study|Lack of Efficacy|1|||
27920230|NCT01059799|54577562|FG001|Overall Study|Lack of Efficacy|0|||
27920231|NCT01059799|54577561|FG000|Overall Study|Protocol Violation|3|||
27920232|NCT01059799|54577562|FG001|Overall Study|Protocol Violation|2|||
27920233|NCT01059799|54577561|FG000|Overall Study|Withdrawal criteria|13|||
27920234|NCT01059799|54577562|FG001|Overall Study|Withdrawal criteria|2|||
27920235|NCT01059799|54577561|FG000|Overall Study|Other|12|||
27920236|NCT01059799|54577562|FG001|Overall Study|Other|3|||
27920237|NCT01106248|54577568|FG000|Overall Study|Adverse Event|1|||
27920238|NCT01106248|54577568|FG000|Overall Study|Administrative|2|||
27920239|NCT01059175|54577574|FG000|Overall Study|Death|17|||
27920240|NCT01059175|54577575|FG001|Overall Study|Death|17|||
27920241|NCT01059175|54577574|FG000|Overall Study|Adverse Event|4|||
27920242|NCT01059175|54577575|FG001|Overall Study|Adverse Event|2|||
27920243|NCT01059175|54577574|FG000|Overall Study|Lost to Follow-up|0|||
27920244|NCT01059175|54577575|FG001|Overall Study|Lost to Follow-up|1|||
27920245|NCT01297491|54577583|FG000|Overall Study|Adverse Event|11|||
27920246|NCT01297491|54577584|FG001|Overall Study|Adverse Event|6|||
27920247|NCT01297491|54577583|FG000|Overall Study|Physician Decision|3|||
27920248|NCT01297491|54577584|FG001|Overall Study|Physician Decision|2|||
27920249|NCT01297491|54577583|FG000|Overall Study|Progressive disease|11|||
27920250|NCT01297491|54577584|FG001|Overall Study|Progressive disease|20|||
27920251|NCT01297491|54577583|FG000|Overall Study|Patient/Guardian decision|3|||
27920252|NCT01297491|54577584|FG001|Overall Study|Patient/Guardian decision|4|||
27920253|NCT01297491|54577583|FG000|Overall Study|Death|2|||
27920254|NCT01297491|54577584|FG001|Overall Study|Death|1|||
27920255|NCT01106092|54577594|FG000|Overall Study|Withdrawal by Subject|0|||
27920256|NCT01106092|54577595|FG001|Overall Study|Withdrawal by Subject|0|||
27920257|NCT01106092|54577596|FG002|Overall Study|Withdrawal by Subject|0|||
27920258|NCT01106092|54577597|FG003|Overall Study|Withdrawal by Subject|1|||
27920259|NCT01097668|54577609|FG000|Overall Study|Withdrawal by Subject|1|||
27920260|NCT01097668|54577610|FG001|Overall Study|Withdrawal by Subject|2|||
27920261|NCT01097668|54577609|FG000|Overall Study|Lost to Follow-up|1|||
27920262|NCT01097668|54577610|FG001|Overall Study|Lost to Follow-up|0|||
27920263|NCT01325207|54577626|FG000|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
27920264|NCT01325207|54577627|FG001|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
27920265|NCT01325207|54577628|FG002|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
27920266|NCT01325207|54577629|FG003|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
27920267|NCT01325207|54577630|FG004|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2|||
27920268|NCT01325207|54577631|FG005|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
28012822|NCT00408499|54671599|FG001|Phase 1: Dose Levels 1-4|Physician Decision|1|||
28012823|NCT00408499|54671600|FG002|Phase 1: Dose Levels 1-4|Physician Decision|0|||
28012824|NCT00408499|54671601|FG003|Phase 1: Dose Levels 1-4|Physician Decision|0|||
28012825|NCT00408499|54671602|FG004|Phase 1: Dose Levels 1-4|Physician Decision|0|||
28012826|NCT00408499|54671598|FG000|Phase II- MTD Expansion|Adverse Event|0|||
28012827|NCT00408499|54671599|FG001|Phase II- MTD Expansion|Adverse Event|0|||
28012828|NCT00408499|54671600|FG002|Phase II- MTD Expansion|Adverse Event|0|||
28012829|NCT00408499|54671601|FG003|Phase II- MTD Expansion|Adverse Event|0|||
28012830|NCT00408499|54671602|FG004|Phase II- MTD Expansion|Adverse Event|9|||
28012831|NCT00408499|54671598|FG000|Phase II- MTD Expansion|Death|0|||
28012832|NCT00408499|54671599|FG001|Phase II- MTD Expansion|Death|0|||
28012833|NCT00408499|54671600|FG002|Phase II- MTD Expansion|Death|0|||
28012834|NCT00408499|54671601|FG003|Phase II- MTD Expansion|Death|0|||
27741871|NCT02383940|54191895|FG001|Overall Study|Adverse Event|0|||
27741872|NCT02383940|54191894|FG000|Overall Study|Lost to Follow-up|2|||
27741873|NCT02383940|54191895|FG001|Overall Study|Lost to Follow-up|2|||
27741874|NCT02383940|54191894|FG000|Overall Study|Physician Decision|2|||
27741875|NCT02383940|54191895|FG001|Overall Study|Physician Decision|0|||
27741876|NCT02383940|54191894|FG000|Overall Study|Withdrawal by Subject|1|||
27741877|NCT02383940|54191895|FG001|Overall Study|Withdrawal by Subject|1|||
27741878|NCT02383940|54191894|FG000|Overall Study|Randomized but not treated|2|||
27741879|NCT02383940|54191895|FG001|Overall Study|Randomized but not treated|0|||
27741880|NCT02383940|54191894|FG000|Overall Study|Other than specified above|1|||
27741881|NCT02383940|54191895|FG001|Overall Study|Other than specified above|0|||
27741882|NCT02383862|54191903|FG000|3 Month Follow up|Lost to Follow-up|23|||
27741883|NCT02383862|54191904|FG001|3 Month Follow up|Lost to Follow-up|21|||
27741884|NCT02383472|54191919|FG000|Overall Study|Withdrawal by Subject|1|||
27741885|NCT02383472|54191920|FG001|Overall Study|Withdrawal by Subject|1|||
28012835|NCT00408499|54671602|FG004|Phase II- MTD Expansion|Death|2|||
28012836|NCT00408499|54671598|FG000|Phase II- MTD Expansion|Physician Decision|0|||
27920269|NCT01325207|54577626|FG000|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
27920270|NCT01325207|54577627|FG001|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
28012837|NCT00408499|54671599|FG001|Phase II- MTD Expansion|Physician Decision|0|||
28012838|NCT00408499|54671600|FG002|Phase II- MTD Expansion|Physician Decision|0|||
28012839|NCT00408499|54671601|FG003|Phase II- MTD Expansion|Physician Decision|0|||
27741886|NCT02234323|54191928|FG000|All Enrolled|Not Treated: Completed study in database|2|||
27741887|NCT02234323|54191928|FG000|All Enrolled|Not Treated:Consent withdrawn by subject|2|||
27741888|NCT02234323|54191928|FG000|All Enrolled|Not Treated: Exceeded lab value limit|1|||
27920271|NCT01325207|54577628|FG002|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
27741889|NCT02234323|54191928|FG000|All Treated|Death|1|||
27741890|NCT02234323|54191928|FG000|All Treated|Physician Decision|5|||
27741891|NCT02234323|54191928|FG000|All Treated|Lack of Efficacy|3|||
27741892|NCT02234323|54191928|FG000|All Treated|Exceeded lab value limit|2|||
27741893|NCT02234323|54191928|FG000|All Treated|Other|7|||
27741894|NCT02414828|54191938|FG000|Overall Study|Lost to Follow-up|0|||
27741895|NCT02414828|54191939|FG001|Overall Study|Lost to Follow-up|1|||
27741896|NCT02414828|54191940|FG002|Overall Study|Lost to Follow-up|1|||
27741897|NCT02414828|54191941|FG003|Overall Study|Lost to Follow-up|2|||
27741898|NCT02413346|54191954|FG000|Overall Study|Adverse Event|6|||
27741899|NCT02413346|54191955|FG001|Overall Study|Adverse Event|6|||
27741900|NCT02413346|54191954|FG000|Overall Study|Withdrawal by Subject|30|||
27741901|NCT02413346|54191955|FG001|Overall Study|Withdrawal by Subject|40|||
27741902|NCT02413346|54191954|FG000|Overall Study|Lost to Follow-up|17|||
27741903|NCT02413346|54191955|FG001|Overall Study|Lost to Follow-up|21|||
27741904|NCT02413346|54191954|FG000|Overall Study|Protocol Violation|2|||
27741905|NCT02413346|54191955|FG001|Overall Study|Protocol Violation|0|||
27741906|NCT02413346|54191954|FG000|Overall Study|Other Miscellaneous Reasons|4|||
27741907|NCT02413346|54191955|FG001|Overall Study|Other Miscellaneous Reasons|3|||
27741908|NCT03390101|54191968|FG000|Weeks 0-12|Withdrawal by Subject|0|||
27741909|NCT03390101|54191969|FG001|Weeks 0-12|Withdrawal by Subject|1|||
27741910|NCT03390101|54191970|FG002|Weeks 0-12|Withdrawal by Subject|1|||
27741911|NCT03390101|54191968|FG000|Weeks 0-12|Lost to Follow-up|0|||
27741912|NCT03390101|54191969|FG001|Weeks 0-12|Lost to Follow-up|1|||
27741913|NCT03390101|54191970|FG002|Weeks 0-12|Lost to Follow-up|0|||
27741914|NCT03390101|54191968|FG000|Weeks 12-54|Withdrawal by Subject|0|||
27741915|NCT03390101|54191969|FG001|Weeks 12-54|Withdrawal by Subject|3|||
27741916|NCT03390101|54191970|FG002|Weeks 12-54|Withdrawal by Subject|1|||
27741917|NCT03390101|54191968|FG000|Weeks 12-54|Pregnancy|1|||
27741918|NCT03390101|54191969|FG001|Weeks 12-54|Pregnancy|0|||
27741919|NCT03390101|54191970|FG002|Weeks 12-54|Pregnancy|0|||
27741920|NCT03390101|54191968|FG000|Weeks 12-54|Adverse Event|2|||
27741921|NCT03390101|54191969|FG001|Weeks 12-54|Adverse Event|1|||
27741922|NCT03390101|54191970|FG002|Weeks 12-54|Adverse Event|1|||
27741923|NCT02732639|54191978|FG000|Overall Study|Lost to Follow-up|1|||
27741924|NCT02732561|54191984|FG000|Overall Study|Lost to Follow-up|1|||
27741925|NCT02732561|54191985|FG001|Overall Study|Lost to Follow-up|1|||
27741926|NCT02732561|54191984|FG000|Overall Study|Withdrawal by Subject|1|||
27741927|NCT02732561|54191985|FG001|Overall Study|Withdrawal by Subject|0|||
27741928|NCT02412878|54191993|FG000|Overall Study|Withdrawal by Subject|19|||
27741929|NCT02412878|54191994|FG001|Overall Study|Withdrawal by Subject|10|||
27741930|NCT02412878|54191993|FG000|Overall Study|Lost to Follow-up|2|||
27741931|NCT02412878|54191994|FG001|Overall Study|Lost to Follow-up|3|||
27741932|NCT02380742|54192002|FG000|Overall Study|Withdrawal by Subject|1|||
27741933|NCT02380742|54192003|FG001|Overall Study|Withdrawal by Subject|0|||
27741934|NCT02922725|54192012|FG000|Overall Study|Withdrawal by Subject|1|||
27741935|NCT02922725|54192013|FG001|Overall Study|Withdrawal by Subject|0|||
27741936|NCT02922725|54192014|FG002|Overall Study|Withdrawal by Subject|0|||
27741937|NCT02805257|54192023|FG000|Overall Study|Lost to Follow-up|7|||
27741938|NCT02805257|54192024|FG001|Overall Study|Lost to Follow-up|6|||
27741939|NCT02805257|54192023|FG000|Overall Study|Death|0|||
27741940|NCT02805257|54192024|FG001|Overall Study|Death|1|||
27741941|NCT04794803|54192032|FG000|Overall Study|Death|1|||
27741942|NCT04794803|54192033|FG001|Overall Study|Death|3|||
27741943|NCT04794803|54192032|FG000|Overall Study|Lost to Follow-up|2|||
27741944|NCT04794803|54192033|FG001|Overall Study|Lost to Follow-up|2|||
27741945|NCT04794803|54192032|FG000|Overall Study|Withdrawal by Subject|1|||
27741946|NCT04794803|54192033|FG001|Overall Study|Withdrawal by Subject|0|||
27741947|NCT04794803|54192032|FG000|Overall Study|Physician Decision|1|||
27741948|NCT04794803|54192033|FG001|Overall Study|Physician Decision|1|||
27741949|NCT04794803|54192032|FG000|Overall Study|Patient transferred to another centre for oxygen rehabilitation|4|||
27741950|NCT04794803|54192033|FG001|Overall Study|Patient transferred to another centre for oxygen rehabilitation|1|||
27741951|NCT04794803|54192032|FG000|Overall Study|Refused to continue the treatment|1|||
27741952|NCT04794803|54192033|FG001|Overall Study|Refused to continue the treatment|0|||
27741953|NCT04794803|54192032|FG000|Overall Study|Patient admitted to ICU|0|||
27741954|NCT04794803|54192033|FG001|Overall Study|Patient admitted to ICU|1|||
27741955|NCT01791595|54192046|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|1|||
27741956|NCT01791595|54192047|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
27741957|NCT01791595|54192048|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
27741958|NCT01791595|54192049|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
27741959|NCT01791595|54192050|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
27741960|NCT01791595|54192051|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
27741961|NCT01791595|54192052|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
27741962|NCT01791595|54192046|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|2|||
27741963|NCT01791595|54192047|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
27741964|NCT01791595|54192048|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
27741965|NCT01791595|54192049|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
27746285|NCT02158546|54195847|FG003|Overall Study|Lack of Efficacy|0|||
27741966|NCT01791595|54192050|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
27741967|NCT01791595|54192051|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
27741968|NCT01791595|54192052|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
27741969|NCT01791595|54192046|FG000|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
27741970|NCT01791595|54192047|FG001|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|5|||
27741971|NCT01791595|54192048|FG002|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
27741972|NCT01791595|54192049|FG003|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
27741973|NCT01791595|54192050|FG004|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
27741974|NCT01791595|54192051|FG005|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
27741975|NCT01791595|54192052|FG006|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
27741976|NCT01791595|54192046|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
27741977|NCT01791595|54192047|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
27741978|NCT01791595|54192048|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|1|||
27741979|NCT01791595|54192049|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
27741980|NCT01791595|54192050|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
27741981|NCT01791595|54192051|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
27741982|NCT01791595|54192052|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
27741983|NCT01791595|54192046|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
27741984|NCT01791595|54192047|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
27741985|NCT01791595|54192048|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|6|||
27741986|NCT01791595|54192049|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
27741987|NCT01791595|54192050|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
27741988|NCT01791595|54192051|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
27741989|NCT01791595|54192052|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
27741990|NCT01791595|54192046|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
27741991|NCT01791595|54192047|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
27741992|NCT01791595|54192048|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|1|||
27741993|NCT01791595|54192049|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
27741994|NCT01791595|54192050|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
27741995|NCT01791595|54192051|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
27741996|NCT01791595|54192052|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
27741997|NCT01791595|54192046|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
27741998|NCT01791595|54192047|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
27741999|NCT01791595|54192048|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
27742000|NCT01791595|54192049|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|2|||
27742001|NCT01791595|54192050|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
27742002|NCT01791595|54192051|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
27742003|NCT01791595|54192052|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
27742004|NCT01791595|54192046|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
27742005|NCT01791595|54192047|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
27742006|NCT01791595|54192048|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
27742007|NCT01791595|54192049|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|2|||
27742008|NCT01791595|54192050|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
27742009|NCT01791595|54192051|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
27742010|NCT01791595|54192052|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
27742011|NCT01791595|54192046|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
27742012|NCT01791595|54192047|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
27742013|NCT01791595|54192048|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
27742014|NCT01791595|54192049|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
27742015|NCT01791595|54192050|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|4|||
27742016|NCT01791595|54192051|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
27742017|NCT01791595|54192052|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
27742018|NCT01791595|54192046|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
27742019|NCT01791595|54192047|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
27742020|NCT01791595|54192048|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
27742021|NCT01791595|54192049|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
27742022|NCT01791595|54192050|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|5|||
27742023|NCT01791595|54192051|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
27742024|NCT01791595|54192052|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
27742025|NCT01791595|54192046|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
27742026|NCT01791595|54192047|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
27742027|NCT01791595|54192048|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
27742028|NCT01791595|54192049|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
27742029|NCT01791595|54192050|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|1|||
27742030|NCT01791595|54192051|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
27742031|NCT01791595|54192052|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
27742032|NCT01791595|54192046|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
27742033|NCT01791595|54192047|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
27742034|NCT01791595|54192048|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
27742035|NCT01791595|54192049|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
27742036|NCT01791595|54192050|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|1|||
27742037|NCT01791595|54192051|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
27742038|NCT01791595|54192052|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
27742039|NCT01791595|54192046|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
27742040|NCT01791595|54192047|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
27742041|NCT01791595|54192048|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
27742042|NCT01791595|54192049|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
27742043|NCT01791595|54192050|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
27742044|NCT01791595|54192051|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|5|||
27742045|NCT01791595|54192052|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
27742046|NCT01791595|54192046|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
27742047|NCT01791595|54192047|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
27742048|NCT01791595|54192048|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
27742049|NCT01791595|54192049|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
27742050|NCT01791595|54192050|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
27742051|NCT01791595|54192051|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|3|||
27742052|NCT01791595|54192052|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
27742053|NCT01791595|54192046|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
27742054|NCT01791595|54192047|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
27742055|NCT01791595|54192048|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
27742056|NCT01791595|54192049|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
27742057|NCT01791595|54192050|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
27742058|NCT01791595|54192051|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
27742059|NCT01791595|54192052|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|1|||
27742060|NCT01791595|54192046|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
27742061|NCT01791595|54192047|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
27742062|NCT01791595|54192048|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
27742063|NCT01791595|54192049|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
27742064|NCT01791595|54192050|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
27742065|NCT01791595|54192051|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
27742066|NCT01791595|54192052|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|6|||
27742067|NCT01791595|54192046|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
27742068|NCT01791595|54192047|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
27742069|NCT01791595|54192048|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
27742070|NCT01791595|54192049|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
27742071|NCT01791595|54192050|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
27742072|NCT01791595|54192051|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
27742073|NCT01791595|54192052|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|2|||
27746286|NCT02158546|54195844|FG000|Overall Study|Adverse Event|2|||
27742074|NCT01791595|54192046|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
27742075|NCT01791595|54192047|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
27742076|NCT01791595|54192048|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
27742077|NCT01791595|54192049|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
27742078|NCT01791595|54192050|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
27742079|NCT01791595|54192051|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
27742080|NCT01791595|54192052|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|1|||
27742081|NCT01559363|54192105|FG000|Phase 1b: Up to 36 Months|Withdrawal by Subject|2|||
27742082|NCT01559363|54192106|FG001|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
27742083|NCT01559363|54192107|FG002|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
27742084|NCT01559363|54192108|FG003|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
27742085|NCT01559363|54192109|FG004|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
27742086|NCT01559363|54192110|FG005|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
27742087|NCT01559363|54192105|FG000|Phase 1b: Up to 36 Months|Investigator decision|1|||
27742088|NCT01559363|54192106|FG001|Phase 1b: Up to 36 Months|Investigator decision|0|||
27742089|NCT01559363|54192107|FG002|Phase 1b: Up to 36 Months|Investigator decision|0|||
27742090|NCT01559363|54192108|FG003|Phase 1b: Up to 36 Months|Investigator decision|0|||
27742091|NCT01559363|54192109|FG004|Phase 1b: Up to 36 Months|Investigator decision|0|||
27746287|NCT02158546|54195845|FG001|Overall Study|Adverse Event|2|||
27742092|NCT01559363|54192110|FG005|Phase 1b: Up to 36 Months|Investigator decision|0|||
27742093|NCT01559363|54192105|FG000|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
27742094|NCT01559363|54192106|FG001|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
27742095|NCT01559363|54192107|FG002|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
27742096|NCT01559363|54192108|FG003|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
27742097|NCT01559363|54192109|FG004|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
27742098|NCT01559363|54192110|FG005|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
27742099|NCT01559363|54192105|FG000|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|2|||
27742100|NCT01559363|54192106|FG001|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
27742101|NCT01559363|54192107|FG002|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|1|||
27742102|NCT01559363|54192108|FG003|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
27742103|NCT01559363|54192109|FG004|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
27742104|NCT01559363|54192110|FG005|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
27742105|NCT01559363|54192105|FG000|Phase 1b: Up to 36 Months|Unspecified reason|0|||
27742106|NCT01559363|54192106|FG001|Phase 1b: Up to 36 Months|Unspecified reason|1|||
27742107|NCT01559363|54192107|FG002|Phase 1b: Up to 36 Months|Unspecified reason|0|||
27742108|NCT01559363|54192108|FG003|Phase 1b: Up to 36 Months|Unspecified reason|0|||
27742109|NCT01559363|54192109|FG004|Phase 1b: Up to 36 Months|Unspecified reason|0|||
27742110|NCT01559363|54192110|FG005|Phase 1b: Up to 36 Months|Unspecified reason|0|||
27742111|NCT01559363|54192105|FG000|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
27742112|NCT01559363|54192106|FG001|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
27742113|NCT01559363|54192107|FG002|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
27742114|NCT01559363|54192108|FG003|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
27742115|NCT01559363|54192109|FG004|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
27742116|NCT01559363|54192110|FG005|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
27742117|NCT01559363|54192105|FG000|Phase 2a: Up to 28 Months|Unspecified reason|0|||
27742118|NCT01559363|54192106|FG001|Phase 2a: Up to 28 Months|Unspecified reason|0|||
27742119|NCT01559363|54192107|FG002|Phase 2a: Up to 28 Months|Unspecified reason|0|||
27742120|NCT01559363|54192108|FG003|Phase 2a: Up to 28 Months|Unspecified reason|1|||
27742121|NCT01559363|54192109|FG004|Phase 2a: Up to 28 Months|Unspecified reason|0|||
27742122|NCT01559363|54192110|FG005|Phase 2a: Up to 28 Months|Unspecified reason|0|||
27742123|NCT02732327|54192132|FG000|Overall Study|Protocol Violation|0|||
27742124|NCT02732327|54192133|FG001|Overall Study|Protocol Violation|1|||
27742125|NCT03179605|54192139|FG000|Overall Study|Withdrawal by Subject|1|||
27742126|NCT02412722|54192149|FG000|Overall Study|Adverse Event|0|||
27742127|NCT02412722|54192150|FG001|Overall Study|Adverse Event|2|||
27742128|NCT02412722|54192151|FG002|Overall Study|Adverse Event|0|||
27742129|NCT02412722|54192152|FG003|Overall Study|Adverse Event|3|||
27742130|NCT02412722|54192153|FG004|Overall Study|Adverse Event|0|||
27742131|NCT02412722|54192154|FG005|Overall Study|Adverse Event|3|||
27742132|NCT02412722|54192149|FG000|Overall Study|Progressive Disease|6|||
27742133|NCT02412722|54192150|FG001|Overall Study|Progressive Disease|4|||
27742134|NCT02412722|54192151|FG002|Overall Study|Progressive Disease|4|||
27742135|NCT02412722|54192152|FG003|Overall Study|Progressive Disease|9|||
27742136|NCT02412722|54192153|FG004|Overall Study|Progressive Disease|3|||
27742137|NCT02412722|54192154|FG005|Overall Study|Progressive Disease|3|||
27742138|NCT02412722|54192149|FG000|Overall Study|Withdrawal by Subject|2|||
27742139|NCT02412722|54192150|FG001|Overall Study|Withdrawal by Subject|0|||
27742140|NCT02412722|54192151|FG002|Overall Study|Withdrawal by Subject|1|||
27742141|NCT02412722|54192152|FG003|Overall Study|Withdrawal by Subject|2|||
27742142|NCT02412722|54192153|FG004|Overall Study|Withdrawal by Subject|1|||
27742143|NCT02412722|54192154|FG005|Overall Study|Withdrawal by Subject|1|||
27742144|NCT02412722|54192149|FG000|Overall Study|Lost to Follow-up|0|||
27742145|NCT02412722|54192150|FG001|Overall Study|Lost to Follow-up|0|||
27742146|NCT02412722|54192151|FG002|Overall Study|Lost to Follow-up|0|||
27742147|NCT02412722|54192152|FG003|Overall Study|Lost to Follow-up|0|||
27742148|NCT02412722|54192153|FG004|Overall Study|Lost to Follow-up|1|||
27742149|NCT02412722|54192154|FG005|Overall Study|Lost to Follow-up|0|||
27742150|NCT02412722|54192149|FG000|Overall Study|Received drug in run-in and discontinued|0|||
27742151|NCT02412722|54192150|FG001|Overall Study|Received drug in run-in and discontinued|2|||
27742152|NCT02412722|54192151|FG002|Overall Study|Received drug in run-in and discontinued|0|||
27742153|NCT02412722|54192152|FG003|Overall Study|Received drug in run-in and discontinued|0|||
27742154|NCT02412722|54192153|FG004|Overall Study|Received drug in run-in and discontinued|0|||
27742155|NCT02412722|54192154|FG005|Overall Study|Received drug in run-in and discontinued|0|||
27742156|NCT02412722|54192149|FG000|Overall Study|Reason not Specified|3|||
27742157|NCT02412722|54192150|FG001|Overall Study|Reason not Specified|0|||
27742158|NCT02412722|54192151|FG002|Overall Study|Reason not Specified|2|||
27742159|NCT02412722|54192152|FG003|Overall Study|Reason not Specified|1|||
27742160|NCT02412722|54192153|FG004|Overall Study|Reason not Specified|2|||
27742161|NCT02412722|54192154|FG005|Overall Study|Reason not Specified|6|||
27746288|NCT02158546|54195846|FG002|Overall Study|Adverse Event|0|||
27742162|NCT03074695|54192190|FG000|Overall Study|Delivered with caesarean before request for analgesia|1|||
27742163|NCT03074695|54192191|FG001|Overall Study|Delivered with caesarean before request for analgesia|1|||
27742164|NCT03074695|54192190|FG000|Overall Study|Research staff not available|1|||
27742165|NCT03074695|54192191|FG001|Overall Study|Research staff not available|2|||
27742166|NCT03074695|54192190|FG000|Overall Study|Did not receive neuraxial block|2|||
27742167|NCT03074695|54192191|FG001|Overall Study|Did not receive neuraxial block|2|||
27742168|NCT03469999|54192197|FG000|Overall Study|Lost to Follow-up|2|||
27742169|NCT02379728|54192204|FG000|Overall Study|Lost to Follow-up|1|||
27742170|NCT02379728|54192205|FG001|Overall Study|Lost to Follow-up|0|||
27742171|NCT02379728|54192206|FG002|Overall Study|Lost to Follow-up|3|||
27742172|NCT02379728|54192207|FG003|Overall Study|Lost to Follow-up|0|||
27742173|NCT02379728|54192204|FG000|Overall Study|Withdrawal by Subject|5|||
27742174|NCT02379728|54192205|FG001|Overall Study|Withdrawal by Subject|0|||
27742175|NCT02379728|54192206|FG002|Overall Study|Withdrawal by Subject|5|||
27742176|NCT02379728|54192207|FG003|Overall Study|Withdrawal by Subject|3|||
27742177|NCT02379728|54192204|FG000|Overall Study|Protocol Violation|0|||
27742178|NCT02379728|54192205|FG001|Overall Study|Protocol Violation|0|||
27742179|NCT02379728|54192206|FG002|Overall Study|Protocol Violation|2|||
27742180|NCT02379728|54192207|FG003|Overall Study|Protocol Violation|0|||
27742181|NCT03463993|54192218|FG000|Overall Study|Lost to Follow-up|7|||
27742182|NCT03463993|54192219|FG001|Overall Study|Lost to Follow-up|8|||
27742183|NCT03463993|54192218|FG000|Overall Study|Withdrawal by Subject|2|||
27742184|NCT03463993|54192219|FG001|Overall Study|Withdrawal by Subject|0|||
27742185|NCT03463993|54192218|FG000|Overall Study|Protocol Violation|4|||
27742186|NCT03463993|54192219|FG001|Overall Study|Protocol Violation|1|||
27742187|NCT03463993|54192218|FG000|Overall Study|Had a vaginal delivery prior to caesarean delivery|9|||
27742188|NCT03463993|54192219|FG001|Overall Study|Had a vaginal delivery prior to caesarean delivery|11|||
27742189|NCT03463993|54192218|FG000|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|7|||
27742190|NCT03463993|54192219|FG001|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|6|||
27742191|NCT02412488|54192234|FG000|Overall Study|Lost to Follow-up|10|||
27742192|NCT02412488|54192234|FG000|Overall Study|Withdrawal by Subject|5|||
27742193|NCT02412488|54192234|FG000|Overall Study|Physician Decision|1|||
27742194|NCT02412488|54192234|FG000|Overall Study|No Reveal LINQ Insertion Attempt|1|||
27742195|NCT02412488|54192234|FG000|Overall Study|Reveal LINQ explant|1|||
27742196|NCT02378480|54192240|FG000|Overall Study|Physician Decision|1|||
27742197|NCT02378480|54192241|FG001|Overall Study|Physician Decision|1|||
27742198|NCT02378480|54192240|FG000|Overall Study|Death|1|||
27742199|NCT02378480|54192241|FG001|Overall Study|Death|2|||
27742200|NCT02378480|54192240|FG000|Overall Study|Randomized, but Not Treated|6|||
27742201|NCT02378480|54192241|FG001|Overall Study|Randomized, but Not Treated|4|||
27742202|NCT02378480|54192240|FG000|Overall Study|Adverse Event|0|||
27742203|NCT02378480|54192241|FG001|Overall Study|Adverse Event|1|||
27742204|NCT02378480|54192240|FG000|Overall Study|Missed EOT/PTE Visit|1|||
27742205|NCT02378480|54192241|FG001|Overall Study|Missed EOT/PTE Visit|2|||
27742206|NCT02378480|54192240|FG000|Overall Study|Withdrawal by Subject|9|||
27742207|NCT02378480|54192241|FG001|Overall Study|Withdrawal by Subject|4|||
27742208|NCT02378480|54192240|FG000|Overall Study|Lost to Follow-up|10|||
27742209|NCT02378480|54192241|FG001|Overall Study|Lost to Follow-up|18|||
27742210|NCT02411396|54192247|FG000|Overall Study|Lost to Follow-up|31|||
27742211|NCT02411396|54192247|FG000|Overall Study|Death|10|||
27742212|NCT02345252|54192268|FG000|Double-Blind Phase|Adverse Event|2|||
27742213|NCT02345252|54192269|FG001|Double-Blind Phase|Adverse Event|3|||
27742214|NCT02345252|54192268|FG000|Double-Blind Phase|Death|1|||
27742215|NCT02345252|54192269|FG001|Double-Blind Phase|Death|2|||
27742216|NCT02345252|54192268|FG000|Double-Blind Phase|Lack of Efficacy|1|||
27742217|NCT02345252|54192269|FG001|Double-Blind Phase|Lack of Efficacy|0|||
27742218|NCT02345252|54192268|FG000|Double-Blind Phase|Investigator's Discretion|4|||
27742219|NCT02345252|54192269|FG001|Double-Blind Phase|Investigator's Discretion|6|||
27742220|NCT02345252|54192268|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
27742221|NCT02345252|54192269|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
27742222|NCT02345252|54192268|FG000|Double-Blind Phase|Protocol Violation|2|||
27742223|NCT02345252|54192269|FG001|Double-Blind Phase|Protocol Violation|1|||
27742224|NCT02345252|54192268|FG000|Double-Blind Phase|Withdrew Consent|21|||
27742225|NCT02345252|54192269|FG001|Double-Blind Phase|Withdrew Consent|23|||
27742226|NCT02345252|54192268|FG000|Double-Blind Phase|Lost to Follow-up|8|||
27742227|NCT02345252|54192269|FG001|Double-Blind Phase|Lost to Follow-up|10|||
27742228|NCT02345252|54192268|FG000|Double-Blind Phase|Randomized but Never Treated|0|||
27742229|NCT02345252|54192269|FG001|Double-Blind Phase|Randomized but Never Treated|2|||
27742230|NCT01239797|54192279|FG000|Randomized Participants|Participant no longer meets study criteria|1|||
27742231|NCT01239797|54192280|FG001|Randomized Participants|Participant no longer meets study criteria|1|||
27742232|NCT01239797|54192279|FG000|Randomized Participants|Participant withdrew consent|1|||
27742233|NCT01239797|54192280|FG001|Randomized Participants|Participant withdrew consent|7|||
27742234|NCT01239797|54192279|FG000|Randomized Participants|Adverse event unrelated to study drug|0|||
27742235|NCT01239797|54192280|FG001|Randomized Participants|Adverse event unrelated to study drug|1|||
27742236|NCT01239797|54192279|FG000|Treated Participants|Disease progression|185|||
27742237|NCT01239797|54192280|FG001|Treated Participants|Disease progression|185|||
27742238|NCT01239797|54192279|FG000|Treated Participants|Study drug toxicity|39|||
27742239|NCT01239797|54192280|FG001|Treated Participants|Study drug toxicity|45|||
27742240|NCT01239797|54192279|FG000|Treated Participants|Adverse event unrelated to study drug|31|||
27742241|NCT01239797|54192280|FG001|Treated Participants|Adverse event unrelated to study drug|37|||
27746289|NCT02158546|54195847|FG003|Overall Study|Adverse Event|0|||
27920272|NCT01325207|54577629|FG003|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
27920273|NCT01325207|54577630|FG004|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2|||
27920274|NCT01325207|54577631|FG005|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5|||
27920275|NCT01325207|54577626|FG000|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
27920276|NCT01325207|54577627|FG001|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
27920277|NCT01325207|54577628|FG002|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
27920278|NCT01325207|54577629|FG003|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
27920279|NCT01325207|54577630|FG004|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0|||
27920280|NCT01325207|54577631|FG005|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4|||
27920281|NCT01325207|54577626|FG000|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
27920282|NCT01325207|54577627|FG001|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1|||
27920283|NCT01325207|54577628|FG002|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
27920284|NCT01325207|54577629|FG003|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
27920285|NCT01325207|54577630|FG004|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
27920286|NCT01325207|54577631|FG005|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
27920287|NCT01325207|54577626|FG000|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
27920288|NCT01325207|54577627|FG001|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
27920289|NCT01325207|54577628|FG002|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
27920290|NCT01325207|54577629|FG003|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
27920291|NCT01325207|54577630|FG004|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
27920292|NCT01325207|54577631|FG005|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1|||
27920293|NCT01325207|54577626|FG000|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
27920294|NCT01325207|54577627|FG001|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
27920295|NCT01325207|54577628|FG002|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
27920296|NCT01325207|54577629|FG003|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
27920297|NCT01325207|54577630|FG004|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
27920298|NCT01325207|54577631|FG005|Follow-up Every 3 Months Until Death|Lost to Follow-up|1|||
27920299|NCT01325207|54577626|FG000|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
27920300|NCT01325207|54577627|FG001|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
27920301|NCT01325207|54577628|FG002|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
27920302|NCT01325207|54577629|FG003|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
27920303|NCT01325207|54577630|FG004|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1|||
27920304|NCT01325207|54577631|FG005|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
27920305|NCT01324349|54577648|FG000|Overall Study|Death|1|||
27920306|NCT01324349|54577649|FG001|Overall Study|Death|1|||
27920307|NCT01324349|54577648|FG000|Overall Study|Withdrawal by Subject|0|||
27920308|NCT01324349|54577649|FG001|Overall Study|Withdrawal by Subject|1|||
27920309|NCT01095250|54577659|FG000|Overall Study|administrative reasons|8|||
27920310|NCT01095250|54577660|FG001|Overall Study|administrative reasons|10|||
27920311|NCT01095250|54577661|FG002|Overall Study|administrative reasons|7|||
27920312|NCT01095250|54577662|FG003|Overall Study|administrative reasons|5|||
27920313|NCT01095250|54577659|FG000|Overall Study|Withdrawal by Subject|0|||
27920314|NCT01095250|54577660|FG001|Overall Study|Withdrawal by Subject|0|||
27920315|NCT01095250|54577661|FG002|Overall Study|Withdrawal by Subject|1|||
27920316|NCT01095250|54577662|FG003|Overall Study|Withdrawal by Subject|0|||
27920317|NCT01324271|54577672|FG000|Overall Study|Lost to Follow-up|3|||
27920318|NCT01324271|54577673|FG001|Overall Study|Lost to Follow-up|0|||
27920319|NCT01324271|54577672|FG000|Overall Study|Physician Decision|1|||
27920320|NCT01324271|54577673|FG001|Overall Study|Physician Decision|0|||
27920321|NCT01095094|54577679|FG000|Overall Study|Withdrawal by Subject|1|||
27920322|NCT01095094|54577679|FG000|Overall Study|Death|1|||
27920323|NCT01095094|54577679|FG000|Overall Study|Physician Decision|1|||
27920324|NCT01323647|54577685|FG000|Overall Study|Migrated/moved from study area|2|||
27920325|NCT01323647|54577686|FG001|Overall Study|Migrated/moved from study area|0|||
27920326|NCT01323647|54577685|FG000|Overall Study|Withdrawal by Subject|5|||
27920327|NCT01323647|54577686|FG001|Overall Study|Withdrawal by Subject|0|||
27920328|NCT01323647|54577685|FG000|Overall Study|Lost to Follow-up|2|||
27920329|NCT01323647|54577686|FG001|Overall Study|Lost to Follow-up|0|||
27920330|NCT01094782|54577698|FG000|Overall Study|Withdrawal by Subject|5|||
27920331|NCT01094782|54577699|FG001|Overall Study|Withdrawal by Subject|5|||
27920332|NCT01094782|54577700|FG002|Overall Study|Withdrawal by Subject|1|||
27920333|NCT01094782|54577701|FG003|Overall Study|Withdrawal by Subject|5|||
27920334|NCT01094782|54577702|FG004|Overall Study|Withdrawal by Subject|5|||
27920335|NCT01094782|54577703|FG005|Overall Study|Withdrawal by Subject|0|||
27920336|NCT01094782|54577698|FG000|Overall Study|Lost to Follow-up|1|||
27920337|NCT01094782|54577699|FG001|Overall Study|Lost to Follow-up|0|||
27920338|NCT01094782|54577700|FG002|Overall Study|Lost to Follow-up|0|||
27920339|NCT01094782|54577701|FG003|Overall Study|Lost to Follow-up|2|||
27920340|NCT01094782|54577702|FG004|Overall Study|Lost to Follow-up|1|||
27920341|NCT01094782|54577703|FG005|Overall Study|Lost to Follow-up|4|||
27920342|NCT01094782|54577698|FG000|Overall Study|Positive Drug Screen|2|||
27920343|NCT01094782|54577699|FG001|Overall Study|Positive Drug Screen|2|||
27920344|NCT01094782|54577700|FG002|Overall Study|Positive Drug Screen|1|||
27920345|NCT01094782|54577701|FG003|Overall Study|Positive Drug Screen|1|||
27920346|NCT01094782|54577702|FG004|Overall Study|Positive Drug Screen|3|||
27920347|NCT01094782|54577703|FG005|Overall Study|Positive Drug Screen|2|||
27920348|NCT01094782|54577698|FG000|Overall Study|Sensory Deficit at Site of QST|0|||
27920349|NCT01094782|54577699|FG001|Overall Study|Sensory Deficit at Site of QST|1|||
27920350|NCT01094782|54577700|FG002|Overall Study|Sensory Deficit at Site of QST|0|||
27920351|NCT01094782|54577701|FG003|Overall Study|Sensory Deficit at Site of QST|0|||
27920352|NCT01094782|54577702|FG004|Overall Study|Sensory Deficit at Site of QST|0|||
27920353|NCT01094782|54577703|FG005|Overall Study|Sensory Deficit at Site of QST|0|||
27920354|NCT01094782|54577698|FG000|Overall Study|Unable to Complete Questionnaires|0|||
27920355|NCT01094782|54577699|FG001|Overall Study|Unable to Complete Questionnaires|1|||
27920356|NCT01094782|54577700|FG002|Overall Study|Unable to Complete Questionnaires|0|||
27920357|NCT01094782|54577701|FG003|Overall Study|Unable to Complete Questionnaires|0|||
27920358|NCT01094782|54577702|FG004|Overall Study|Unable to Complete Questionnaires|0|||
27920359|NCT01094782|54577703|FG005|Overall Study|Unable to Complete Questionnaires|0|||
27920360|NCT01094782|54577698|FG000|Overall Study|Healthy Subject Had Pain|0|||
28012840|NCT00408499|54671602|FG004|Phase II- MTD Expansion|Physician Decision|1|||
27920361|NCT01094782|54577699|FG001|Overall Study|Healthy Subject Had Pain|1|||
27920362|NCT01094782|54577700|FG002|Overall Study|Healthy Subject Had Pain|0|||
27920363|NCT01094782|54577701|FG003|Overall Study|Healthy Subject Had Pain|0|||
27920364|NCT01094782|54577702|FG004|Overall Study|Healthy Subject Had Pain|0|||
27920365|NCT01094782|54577703|FG005|Overall Study|Healthy Subject Had Pain|0|||
27920366|NCT01094782|54577698|FG000|Overall Study|Hypertension|0|||
27920367|NCT01094782|54577699|FG001|Overall Study|Hypertension|0|||
27742242|NCT01239797|54192279|FG000|Treated Participants|Participants request to discontinue study treatment|28|||
27742243|NCT01239797|54192280|FG001|Treated Participants|Participants request to discontinue study treatment|18|||
27742244|NCT01239797|54192279|FG000|Treated Participants|Administrative reason by sponsor|13|||
27742245|NCT01239797|54192280|FG001|Treated Participants|Administrative reason by sponsor|4|||
27742246|NCT01239797|54192279|FG000|Treated Participants|Other reasons|14|||
27742247|NCT01239797|54192280|FG001|Treated Participants|Other reasons|14|||
27742248|NCT01239797|54192279|FG000|Treated Participants|Participant withdrew consent|6|||
27742249|NCT01239797|54192280|FG001|Treated Participants|Participant withdrew consent|11|||
27742250|NCT01239797|54192279|FG000|Treated Participants|Death|1|||
27742251|NCT01239797|54192280|FG001|Treated Participants|Death|1|||
27920368|NCT01094782|54577700|FG002|Overall Study|Hypertension|1|||
27920369|NCT01094782|54577701|FG003|Overall Study|Hypertension|0|||
27920370|NCT01094782|54577702|FG004|Overall Study|Hypertension|0|||
27920371|NCT01094782|54577703|FG005|Overall Study|Hypertension|0|||
27920372|NCT01094782|54577698|FG000|Overall Study|Wrong Pain Condition|0|||
27920373|NCT01094782|54577699|FG001|Overall Study|Wrong Pain Condition|0|||
27920374|NCT01094782|54577700|FG002|Overall Study|Wrong Pain Condition|0|||
27920375|NCT01094782|54577701|FG003|Overall Study|Wrong Pain Condition|2|||
27920376|NCT01094782|54577702|FG004|Overall Study|Wrong Pain Condition|1|||
27920377|NCT01094782|54577703|FG005|Overall Study|Wrong Pain Condition|1|||
27920378|NCT01094782|54577698|FG000|Overall Study|Recent Interventional Injection|0|||
27920379|NCT01094782|54577699|FG001|Overall Study|Recent Interventional Injection|0|||
27920380|NCT01094782|54577700|FG002|Overall Study|Recent Interventional Injection|0|||
27920381|NCT01094782|54577701|FG003|Overall Study|Recent Interventional Injection|0|||
27920382|NCT01094782|54577702|FG004|Overall Study|Recent Interventional Injection|0|||
27920383|NCT01094782|54577703|FG005|Overall Study|Recent Interventional Injection|1|||
27920384|NCT01094782|54577698|FG000|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
27920385|NCT01094782|54577699|FG001|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
27920386|NCT01094782|54577700|FG002|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
27920387|NCT01094782|54577701|FG003|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
27920388|NCT01094782|54577702|FG004|Overall Study|Low Visual Analog Scale (VAS) Score|1|||
27920389|NCT01094782|54577703|FG005|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
27920390|NCT01094782|54577698|FG000|Overall Study|Noncompliance With Study Schedule|0|||
27920391|NCT01094782|54577699|FG001|Overall Study|Noncompliance With Study Schedule|0|||
27920392|NCT01094782|54577700|FG002|Overall Study|Noncompliance With Study Schedule|0|||
27920393|NCT01094782|54577701|FG003|Overall Study|Noncompliance With Study Schedule|1|||
27920394|NCT01094782|54577702|FG004|Overall Study|Noncompliance With Study Schedule|0|||
27920395|NCT01094782|54577703|FG005|Overall Study|Noncompliance With Study Schedule|0|||
27920396|NCT01097044|54577719|FG000|Overall Study|Withdrawal by Subject|4|||
27920397|NCT01097044|54577720|FG001|Overall Study|Withdrawal by Subject|4|||
27920398|NCT01097044|54577719|FG000|Overall Study|Lost to Follow-up|1|||
27920399|NCT01097044|54577720|FG001|Overall Study|Lost to Follow-up|0|||
27920400|NCT01097044|54577719|FG000|Overall Study|Withdrawal by Sponsor|0|||
27920401|NCT01097044|54577720|FG001|Overall Study|Withdrawal by Sponsor|1|||
27920402|NCT01322009|54577730|FG000|Overall Study|Death|0|||
27920403|NCT01322009|54577731|FG001|Overall Study|Death|1|||
27920404|NCT01322009|54577730|FG000|Overall Study|Adverse Event|0|||
27920405|NCT01322009|54577731|FG001|Overall Study|Adverse Event|1|||
27920406|NCT01322009|54577730|FG000|Overall Study|ng tube discontinued|0|||
27920407|NCT01322009|54577731|FG001|Overall Study|ng tube discontinued|1|||
27920408|NCT01321697|54577737|FG000|Overall Study|Study Terminated|7|||
27920409|NCT01320683|54577741|FG000|Overall Study|Positive antibody response|1|||
27920410|NCT01320293|54577745|FG000|Overall Study|Lack of Efficacy|1|||
27920411|NCT01320293|54577745|FG000|Overall Study|Adverse Event|1|||
27920412|NCT01318811|54577751|FG000|Overall Study|Physician Decision|1|||
27920413|NCT01318811|54577752|FG001|Overall Study|Physician Decision|1|||
27920414|NCT01318811|54577751|FG000|Overall Study|CRRT stopped for head CT|0|||
27920415|NCT01318811|54577752|FG001|Overall Study|CRRT stopped for head CT|1|||
27920416|NCT01318811|54577751|FG000|Overall Study|Death|0|||
27920417|NCT01318811|54577752|FG001|Overall Study|Death|1|||
27920418|NCT01318811|54577751|FG000|Overall Study|CRRT stopped for head MRI|0|||
27742252|NCT01239797|54192279|FG000|Treated Participants|Participant no longer meets study criteria|1|||
27920419|NCT01318811|54577752|FG001|Overall Study|CRRT stopped for head MRI|1|||
27920420|NCT01093846|54577761|FG000|Overall Study|Adverse Event|0|||
27920421|NCT01093846|54577762|FG001|Overall Study|Adverse Event|0|||
27920422|NCT01093846|54577763|FG002|Overall Study|Adverse Event|1|||
27920423|NCT01093846|54577761|FG000|Overall Study|Lack of Efficacy|0|||
27920424|NCT01093846|54577762|FG001|Overall Study|Lack of Efficacy|0|||
27920425|NCT01093846|54577763|FG002|Overall Study|Lack of Efficacy|4|||
27920426|NCT01093846|54577761|FG000|Overall Study|Condition no longer required study drug|1|||
27920427|NCT01093846|54577762|FG001|Overall Study|Condition no longer required study drug|1|||
27920428|NCT01093846|54577763|FG002|Overall Study|Condition no longer required study drug|1|||
27920429|NCT01093846|54577761|FG000|Overall Study|Administrative Problems|18|||
27920430|NCT01093846|54577762|FG001|Overall Study|Administrative Problems|17|||
27920431|NCT01093846|54577763|FG002|Overall Study|Administrative Problems|15|||
27920432|NCT01315847|54577771|FG000|Part I, Period 1|Reached maximum number of arterial lines|3|||
27920433|NCT01315847|54577772|FG001|Part I, Period 1|Reached maximum number of arterial lines|0|||
27920434|NCT01315847|54577771|FG000|Part III, Period 1|[11C]MK-4232 synthesis failure|0|||
27920435|NCT01315847|54577772|FG001|Part III, Period 1|[11C]MK-4232 synthesis failure|1|||
27920436|NCT01093534|54577781|FG000|Overall Study|Adverse Event|2|||
27920437|NCT01093534|54577782|FG001|Overall Study|Adverse Event|5|||
27920438|NCT01093534|54577783|FG002|Overall Study|Adverse Event|2|||
27920439|NCT01093534|54577781|FG000|Overall Study|Lack of Efficacy|2|||
27920440|NCT01093534|54577782|FG001|Overall Study|Lack of Efficacy|1|||
27920441|NCT01093534|54577783|FG002|Overall Study|Lack of Efficacy|1|||
27920442|NCT01093534|54577781|FG000|Overall Study|Withdrawal by Subject|5|||
27920443|NCT01093534|54577782|FG001|Overall Study|Withdrawal by Subject|7|||
27920444|NCT01093534|54577783|FG002|Overall Study|Withdrawal by Subject|2|||
27920445|NCT01093534|54577781|FG000|Overall Study|Other|1|||
27920446|NCT01093534|54577782|FG001|Overall Study|Other|3|||
27920447|NCT01093534|54577783|FG002|Overall Study|Other|4|||
27920448|NCT01314911|54577794|FG000|Overall Study|Lost to Follow-up|3|||
27920449|NCT01314911|54577795|FG001|Overall Study|Lost to Follow-up|2|||
27920450|NCT01314911|54577794|FG000|Overall Study|Withdrawal by Subject|1|||
27920451|NCT01314911|54577795|FG001|Overall Study|Withdrawal by Subject|3|||
27920452|NCT01314911|54577794|FG000|Overall Study|Received Non-randomized Study Drug|0|||
27920453|NCT01314911|54577795|FG001|Overall Study|Received Non-randomized Study Drug|1|||
27920454|NCT01314911|54577794|FG000|Overall Study|Never Started Treatment|1|||
27920455|NCT01314911|54577795|FG001|Overall Study|Never Started Treatment|0|||
27920456|NCT01093222|54577801|FG000|Overall Study|Ineligible|6|||
27920457|NCT01093222|54577801|FG000|Overall Study|Adverse Event|7|||
27920458|NCT01093222|54577801|FG000|Overall Study|Progression/relapse|24|||
27920459|NCT01093222|54577801|FG000|Overall Study|Death|2|||
27920460|NCT01093222|54577801|FG000|Overall Study|Not protocol specified|1|||
27920461|NCT01313663|54577807|FG000|Overall Study|Study Closed/Terminated|2|||
27920462|NCT01313663|54577808|FG001|Overall Study|Study Closed/Terminated|4|||
27920463|NCT01313663|54577807|FG000|Overall Study|Lost to Follow-up|0|||
27920464|NCT01313663|54577808|FG001|Overall Study|Lost to Follow-up|1|||
27920465|NCT01313663|54577807|FG000|Overall Study|Physician Decision|0|||
27920466|NCT01313663|54577808|FG001|Overall Study|Physician Decision|2|||
27920467|NCT01313663|54577807|FG000|Overall Study|Withdrawal by Subject|2|||
27920468|NCT01313663|54577808|FG001|Overall Study|Withdrawal by Subject|1|||
27920469|NCT01092832|54577816|FG000|Overall Study|Other|1|||
27920470|NCT01092832|54577817|FG001|Overall Study|Other|0|||
27920471|NCT01313273|54577825|FG000|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1|||
27742253|NCT01239797|54192280|FG001|Treated Participants|Participant no longer meets study criteria|1|||
27742254|NCT01239797|54192279|FG000|Treated Participants|Poor/non-compliance|0|||
27742255|NCT01239797|54192280|FG001|Treated Participants|Poor/non-compliance|1|||
27742256|NCT02639065|54192286|FG000|Study Treatment|Disease Progression|11|||
27742257|NCT02639065|54192286|FG000|Study Treatment|Adverse Event|8|||
27920472|NCT01313273|54577826|FG001|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0|||
27920473|NCT01313273|54577825|FG000|Overall Study|Withdrawal by Subject|1|||
27920474|NCT01313273|54577826|FG001|Overall Study|Withdrawal by Subject|0|||
27920475|NCT01313273|54577825|FG000|Overall Study|Screening Chromogranin A-in normal range|0|||
27920476|NCT01313273|54577826|FG001|Overall Study|Screening Chromogranin A-in normal range|1|||
27920477|NCT01091974|54577836|FG000|Overall Study|Did not start intervention|3|||
27920478|NCT01091974|54577837|FG001|Overall Study|Did not start intervention|1|||
27920479|NCT01091974|54577838|FG002|Overall Study|Did not start intervention|3|||
27920480|NCT01091974|54577839|FG003|Overall Study|Did not start intervention|1|||
27920481|NCT01091974|54577836|FG000|Overall Study|resumed sleep medication|0|||
27920482|NCT01091974|54577837|FG001|Overall Study|resumed sleep medication|0|||
27920483|NCT01091974|54577838|FG002|Overall Study|resumed sleep medication|1|||
27920484|NCT01091974|54577839|FG003|Overall Study|resumed sleep medication|2|||
27920485|NCT01091974|54577836|FG000|Overall Study|Withdrawal by Subject|1|||
27920486|NCT01091974|54577837|FG001|Overall Study|Withdrawal by Subject|3|||
27920487|NCT01091974|54577838|FG002|Overall Study|Withdrawal by Subject|2|||
27920488|NCT01091974|54577839|FG003|Overall Study|Withdrawal by Subject|2|||
27920489|NCT01091974|54577836|FG000|Overall Study|side-effects|1|||
27920490|NCT01091974|54577837|FG001|Overall Study|side-effects|1|||
27920491|NCT01091974|54577838|FG002|Overall Study|side-effects|0|||
27920492|NCT01091974|54577839|FG003|Overall Study|side-effects|2|||
27920493|NCT01313117|54577849|FG000|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
27920494|NCT01313117|54577849|FG000|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
27920495|NCT01313039|54577854|FG000|Overall Study|Physician Decision|1|||
27920496|NCT01313039|54577854|FG000|Overall Study|Adverse Event|1|||
27920497|NCT01091662|54577860|FG000|Overall Study|Adverse Event|1|||
27920498|NCT01091662|54577861|FG001|Overall Study|Adverse Event|9|||
27920499|NCT01091662|54577860|FG000|Overall Study|Physician Decision|1|||
27920500|NCT01091662|54577861|FG001|Overall Study|Physician Decision|1|||
27920501|NCT01091662|54577860|FG000|Overall Study|Withdrawal by Subject|7|||
27920502|NCT01091662|54577861|FG001|Overall Study|Withdrawal by Subject|6|||
27920503|NCT01091662|54577860|FG000|Overall Study|met exit criteria|7|||
27920504|NCT01091662|54577861|FG001|Overall Study|met exit criteria|13|||
27920505|NCT01091662|54577860|FG000|Overall Study|met exclusion criteria|1|||
27920506|NCT01091662|54577861|FG001|Overall Study|met exclusion criteria|0|||
27920507|NCT01091662|54577860|FG000|Overall Study|Lost to Follow-up|0|||
27920508|NCT01091662|54577861|FG001|Overall Study|Lost to Follow-up|1|||
27920509|NCT01091662|54577860|FG000|Overall Study|Pregnancy|0|||
27920510|NCT01091662|54577861|FG001|Overall Study|Pregnancy|1|||
27920511|NCT01091662|54577860|FG000|Overall Study|Protocol Violation|0|||
27920512|NCT01091662|54577861|FG001|Overall Study|Protocol Violation|2|||
27920513|NCT01091662|54577860|FG000|Overall Study|unable to swallow capsule|0|||
27920514|NCT01091662|54577861|FG001|Overall Study|unable to swallow capsule|1|||
27920515|NCT01312961|54577874|FG000|Overall Study|Adverse Event|3|||
27920516|NCT01312961|54577875|FG001|Overall Study|Adverse Event|3|||
27920517|NCT01312961|54577874|FG000|Overall Study|Lack of Efficacy|11|||
27920518|NCT01312961|54577875|FG001|Overall Study|Lack of Efficacy|1|||
27920519|NCT01312961|54577874|FG000|Overall Study|Poor compliance to protocol|1|||
27920520|NCT01312961|54577875|FG001|Overall Study|Poor compliance to protocol|0|||
27920521|NCT01312961|54577874|FG000|Overall Study|Other than specified above|2|||
27920522|NCT01312961|54577875|FG001|Overall Study|Other than specified above|3|||
27920523|NCT01311557|54577884|FG000|Overall Study|Serious adverse event|0|||
27920524|NCT01311557|54577885|FG001|Overall Study|Serious adverse event|1|||
27920525|NCT01311557|54577884|FG000|Overall Study|Protocol Violation|4|||
27920526|NCT01311557|54577885|FG001|Overall Study|Protocol Violation|2|||
27920527|NCT01311557|54577884|FG000|Overall Study|Lost to Follow-up|0|||
27920528|NCT01311557|54577885|FG001|Overall Study|Lost to Follow-up|1|||
27920529|NCT01311557|54577884|FG000|Overall Study|Withdrawal by Subject|1|||
27920530|NCT01311557|54577885|FG001|Overall Study|Withdrawal by Subject|2|||
27920531|NCT01310777|54577894|FG000|Overall Study|Adverse Event|23|||
27920532|NCT01310777|54577895|FG001|Overall Study|Adverse Event|1|||
27920533|NCT01310777|54577896|FG002|Overall Study|Adverse Event|15|||
27920534|NCT01310777|54577894|FG000|Overall Study|Lost to Follow-up|0|||
27920535|NCT01310777|54577895|FG001|Overall Study|Lost to Follow-up|4|||
27920536|NCT01310777|54577896|FG002|Overall Study|Lost to Follow-up|1|||
27920537|NCT01310777|54577894|FG000|Overall Study|Patient's Decision Unrelated to AE|1|||
27920538|NCT01310777|54577895|FG001|Overall Study|Patient's Decision Unrelated to AE|1|||
27920539|NCT01310777|54577896|FG002|Overall Study|Patient's Decision Unrelated to AE|2|||
27920540|NCT01310777|54577894|FG000|Overall Study|Inadequate Control of IOP|5|||
27920541|NCT01310777|54577895|FG001|Overall Study|Inadequate Control of IOP|7|||
27920542|NCT01310777|54577896|FG002|Overall Study|Inadequate Control of IOP|10|||
27920543|NCT01310777|54577894|FG000|Overall Study|Other|4|||
27920544|NCT01310777|54577895|FG001|Overall Study|Other|1|||
27920545|NCT01310777|54577896|FG002|Overall Study|Other|2|||
27920546|NCT01310699|54577906|FG000|Overall Study|Patients did not complete tandem.|4|||
27920547|NCT01310699|54577907|FG001|Overall Study|Patients did not complete tandem.|6|||
27920548|NCT01310075|54577917|FG000|Overall Study|Lost to Follow-up|1|||
27920549|NCT01310075|54577918|FG001|Overall Study|Lost to Follow-up|0|||
27920550|NCT01310075|54577917|FG000|Overall Study|Physician Decision|10|||
27920551|NCT01310075|54577918|FG001|Overall Study|Physician Decision|7|||
27920552|NCT01310075|54577917|FG000|Overall Study|Protocol Violation|2|||
27920553|NCT01310075|54577918|FG001|Overall Study|Protocol Violation|2|||
27920554|NCT01310075|54577917|FG000|Overall Study|Withdrawal by Subject|1|||
27920555|NCT01310075|54577918|FG001|Overall Study|Withdrawal by Subject|1|||
27920556|NCT01309997|54577926|FG000|Overall Study|Adverse Event|1|||
27920557|NCT01309997|54577927|FG001|Overall Study|Adverse Event|0|||
27920558|NCT01309997|54577926|FG000|Overall Study|Death|1|||
27920559|NCT01309997|54577927|FG001|Overall Study|Death|3|||
27920560|NCT01309997|54577926|FG000|Overall Study|Lack of Efficacy|2|||
27920561|NCT01309997|54577927|FG001|Overall Study|Lack of Efficacy|2|||
27920562|NCT01309997|54577926|FG000|Overall Study|Withdrawal by Subject|1|||
27920563|NCT01309997|54577927|FG001|Overall Study|Withdrawal by Subject|1|||
27920564|NCT01309919|54577946|FG000|Overall Study|Did not receive a postpartum IUD|17|||
27920565|NCT01309919|54577947|FG001|Overall Study|Did not receive a postpartum IUD|48|||
27920566|NCT01309841|54577956|FG000|Overall Study|Other|0|||
27920567|NCT01309841|54577957|FG001|Overall Study|Other|1|||
27920568|NCT01309841|54577958|FG002|Overall Study|Other|1|||
27920569|NCT01309841|54577956|FG000|Overall Study|Lost to Follow-up|7|||
27920570|NCT01309841|54577957|FG001|Overall Study|Lost to Follow-up|6|||
27920571|NCT01309841|54577958|FG002|Overall Study|Lost to Follow-up|4|||
27920572|NCT01309841|54577956|FG000|Overall Study|Study-Specific Withdrawal Criteria|3|||
27920573|NCT01309841|54577957|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
27920574|NCT01309841|54577958|FG002|Overall Study|Study-Specific Withdrawal Criteria|2|||
27920575|NCT01309841|54577956|FG000|Overall Study|Lack of Efficacy|0|||
27920576|NCT01309841|54577957|FG001|Overall Study|Lack of Efficacy|0|||
27920577|NCT01309841|54577958|FG002|Overall Study|Lack of Efficacy|2|||
27920578|NCT01309841|54577956|FG000|Overall Study|Adverse Event|9|||
27920579|NCT01309841|54577957|FG001|Overall Study|Adverse Event|22|||
27920580|NCT01309841|54577958|FG002|Overall Study|Adverse Event|11|||
27920581|NCT01309841|54577956|FG000|Overall Study|Death|1|||
27920582|NCT01309841|54577957|FG001|Overall Study|Death|0|||
27920583|NCT01309841|54577958|FG002|Overall Study|Death|0|||
27920584|NCT01309841|54577956|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
27920585|NCT01309841|54577957|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
27920586|NCT01309841|54577958|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
27920587|NCT01309841|54577956|FG000|Overall Study|Withdrawal by Subject|17|||
27920588|NCT01309841|54577957|FG001|Overall Study|Withdrawal by Subject|6|||
27920589|NCT01309841|54577958|FG002|Overall Study|Withdrawal by Subject|13|||
27920590|NCT01309841|54577956|FG000|Overall Study|Did Not Receive Treatment|2|||
27920591|NCT01309841|54577957|FG001|Overall Study|Did Not Receive Treatment|0|||
27920592|NCT01309841|54577958|FG002|Overall Study|Did Not Receive Treatment|1|||
27920593|NCT01309841|54577956|FG000|Overall Study|Severe non-compliance with protocol|0|||
27920594|NCT01309841|54577957|FG001|Overall Study|Severe non-compliance with protocol|5|||
27920595|NCT01309841|54577958|FG002|Overall Study|Severe non-compliance with protocol|2|||
27920596|NCT01308749|54577968|FG000|Period 1: Double Blind Treatment|Adverse Event|1|||
27920597|NCT01308749|54577969|FG001|Period 1: Double Blind Treatment|Adverse Event|0|||
27920598|NCT01308749|54577968|FG000|Period 2: Open Label Treatment|Adverse Event|0|||
27920599|NCT01308749|54577969|FG001|Period 2: Open Label Treatment|Adverse Event|1|||
27920600|NCT01308749|54577968|FG000|Period 2: Open Label Treatment|Lost to Follow-up|0|||
27920601|NCT01308749|54577969|FG001|Period 2: Open Label Treatment|Lost to Follow-up|1|||
27920602|NCT01307891|54577991|FG000|Overall Study|Progressive Disease|3|||
27920603|NCT01307891|54577992|FG001|Overall Study|Progressive Disease|1|||
27920604|NCT01307579|54578000|FG000|Overall Study|Death|3|||
27920605|NCT01307579|54578001|FG001|Overall Study|Death|6|||
27920606|NCT01307579|54578000|FG000|Overall Study|Physician Decision|26|||
27920607|NCT01307579|54578001|FG001|Overall Study|Physician Decision|29|||
27920608|NCT01307579|54578000|FG000|Overall Study|Withdrawal by Subject|7|||
27920609|NCT01307579|54578001|FG001|Overall Study|Withdrawal by Subject|3|||
27920610|NCT01307579|54578000|FG000|Overall Study|Institutional diagnosis of IFD|21|||
27920611|NCT01307579|54578001|FG001|Overall Study|Institutional diagnosis of IFD|36|||
27920612|NCT01307579|54578000|FG000|Overall Study|Begin conditioning for HSCT|42|||
27920613|NCT01307579|54578001|FG001|Overall Study|Begin conditioning for HSCT|44|||
27920614|NCT01307579|54578000|FG000|Overall Study|Refractory or relapsed AML|38|||
27920615|NCT01307579|54578001|FG001|Overall Study|Refractory or relapsed AML|23|||
27920616|NCT01307579|54578000|FG000|Overall Study|Ineligible|3|||
27920617|NCT01307579|54578001|FG001|Overall Study|Ineligible|4|||
27920618|NCT01057693|54578007|FG000|Single-Blind Phase (Up to Week 6)|Adverse Event|45|||
27920619|NCT01057693|54578008|FG001|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
27920620|NCT01057693|54578009|FG002|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
27920621|NCT01057693|54578007|FG000|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7|||
27920622|NCT01057693|54578008|FG001|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
27920623|NCT01057693|54578009|FG002|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
27920624|NCT01057693|54578007|FG000|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14|||
27920625|NCT01057693|54578008|FG001|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
27920626|NCT01057693|54578009|FG002|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
27920627|NCT01057693|54578007|FG000|Single-Blind Phase (Up to Week 6)|Protocol Violation|9|||
27920628|NCT01057693|54578008|FG001|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
27920629|NCT01057693|54578009|FG002|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
27920630|NCT01057693|54578007|FG000|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22|||
27920631|NCT01057693|54578008|FG001|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
27920632|NCT01057693|54578009|FG002|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
27920633|NCT01057693|54578007|FG000|Single-Blind Phase (Up to Week 6)|Other|2|||
27920634|NCT01057693|54578008|FG001|Single-Blind Phase (Up to Week 6)|Other|0|||
27920635|NCT01057693|54578009|FG002|Single-Blind Phase (Up to Week 6)|Other|0|||
27920636|NCT01057693|54578007|FG000|Between Single-Blind and Double-Blind|Adverse Event|5|||
27920637|NCT01057693|54578008|FG001|Between Single-Blind and Double-Blind|Adverse Event|0|||
27920638|NCT01057693|54578009|FG002|Between Single-Blind and Double-Blind|Adverse Event|0|||
27920639|NCT01057693|54578007|FG000|Between Single-Blind and Double-Blind|Lack of Efficacy|247|||
27920640|NCT01057693|54578008|FG001|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
27920641|NCT01057693|54578009|FG002|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
27920642|NCT01057693|54578007|FG000|Between Single-Blind and Double-Blind|Lost to Follow-up|1|||
27920643|NCT01057693|54578008|FG001|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
27920644|NCT01057693|54578009|FG002|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
27920645|NCT01057693|54578007|FG000|Between Single-Blind and Double-Blind|Protocol Violation|7|||
27920646|NCT01057693|54578008|FG001|Between Single-Blind and Double-Blind|Protocol Violation|0|||
27920647|NCT01057693|54578009|FG002|Between Single-Blind and Double-Blind|Protocol Violation|0|||
27920648|NCT01057693|54578007|FG000|Between Single-Blind and Double-Blind|Withdrawal by Subject|4|||
27920649|NCT01057693|54578008|FG001|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
27920650|NCT01057693|54578009|FG002|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
27920651|NCT01057693|54578007|FG000|Between Single-Blind and Double-Blind|Other|6|||
27920652|NCT01057693|54578008|FG001|Between Single-Blind and Double-Blind|Other|0|||
27920653|NCT01057693|54578009|FG002|Between Single-Blind and Double-Blind|Other|0|||
27920654|NCT01057693|54578007|FG000|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0|||
27920655|NCT01057693|54578008|FG001|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8|||
27920656|NCT01057693|54578009|FG002|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11|||
27920657|NCT01057693|54578007|FG000|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0|||
27920658|NCT01057693|54578008|FG001|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3|||
27920659|NCT01057693|54578009|FG002|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8|||
27920660|NCT01057693|54578007|FG000|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0|||
27920661|NCT01057693|54578008|FG001|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2|||
27920662|NCT01057693|54578009|FG002|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5|||
27920663|NCT01057693|54578007|FG000|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
27920664|NCT01057693|54578008|FG001|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
27920665|NCT01057693|54578009|FG002|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4|||
27920666|NCT01057693|54578007|FG000|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0|||
27920667|NCT01057693|54578008|FG001|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8|||
27920668|NCT01057693|54578009|FG002|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6|||
27920669|NCT01057693|54578007|FG000|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
27920670|NCT01057693|54578008|FG001|Double-Blind Phase (Week 7 to Week 19)|Other|1|||
27920671|NCT01057693|54578009|FG002|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
27920672|NCT01057693|54578007|FG000|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
27920673|NCT01057693|54578008|FG001|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
27920674|NCT01057693|54578009|FG002|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2|||
27920675|NCT01307501|54578017|FG000|Overall Study|Treatment Failure|1|||
27920676|NCT01307501|54578017|FG000|Overall Study|Death|20|||
27920677|NCT01307501|54578017|FG000|Overall Study|Lost to Follow-up|1|||
27920678|NCT01307501|54578017|FG000|Overall Study|Starting Hospice|1|||
27920679|NCT01034137|54578024|FG000|Overall Study|Adverse Event|9|||
27920680|NCT01034137|54578025|FG001|Overall Study|Adverse Event|10|||
27920681|NCT01034137|54578026|FG002|Overall Study|Adverse Event|8|||
27920682|NCT01034137|54578024|FG000|Overall Study|Withdrawal by Subject|4|||
27920683|NCT01034137|54578025|FG001|Overall Study|Withdrawal by Subject|3|||
27920684|NCT01034137|54578026|FG002|Overall Study|Withdrawal by Subject|3|||
27920685|NCT01034137|54578024|FG000|Overall Study|Lack of Efficacy|9|||
27920686|NCT01034137|54578025|FG001|Overall Study|Lack of Efficacy|4|||
27920687|NCT01034137|54578026|FG002|Overall Study|Lack of Efficacy|13|||
27920688|NCT01034137|54578024|FG000|Overall Study|Protocol Violation|2|||
27920689|NCT01034137|54578025|FG001|Overall Study|Protocol Violation|2|||
27920690|NCT01034137|54578026|FG002|Overall Study|Protocol Violation|1|||
27920691|NCT01034137|54578024|FG000|Overall Study|Refused treatment or did not cooperate|2|||
27920692|NCT01034137|54578025|FG001|Overall Study|Refused treatment or did not cooperate|0|||
27920693|NCT01034137|54578026|FG002|Overall Study|Refused treatment or did not cooperate|1|||
27920694|NCT01034137|54578024|FG000|Overall Study|Administrative or other|2|||
27920695|NCT01034137|54578025|FG001|Overall Study|Administrative or other|3|||
27920696|NCT01034137|54578026|FG002|Overall Study|Administrative or other|4|||
27920697|NCT01056289|54578035|FG000|Open-label Phase|Adverse Event|29|||
27920698|NCT01056289|54578036|FG001|Open-label Phase|Adverse Event|0|||
27920699|NCT01056289|54578037|FG002|Open-label Phase|Adverse Event|0|||
27920700|NCT01056289|54578038|FG003|Open-label Phase|Adverse Event|0|||
27920701|NCT01056289|54578035|FG000|Open-label Phase|Lost to Follow-up|30|||
27920702|NCT01056289|54578036|FG001|Open-label Phase|Lost to Follow-up|0|||
27920703|NCT01056289|54578037|FG002|Open-label Phase|Lost to Follow-up|0|||
27920704|NCT01056289|54578038|FG003|Open-label Phase|Lost to Follow-up|0|||
27920705|NCT01056289|54578035|FG000|Open-label Phase|Other|9|||
27920706|NCT01056289|54578036|FG001|Open-label Phase|Other|0|||
27920707|NCT01056289|54578037|FG002|Open-label Phase|Other|0|||
27920708|NCT01056289|54578038|FG003|Open-label Phase|Other|0|||
27920709|NCT01056289|54578035|FG000|Open-label Phase|Protocol Violation|6|||
27920710|NCT01056289|54578036|FG001|Open-label Phase|Protocol Violation|0|||
27920711|NCT01056289|54578037|FG002|Open-label Phase|Protocol Violation|0|||
27920712|NCT01056289|54578038|FG003|Open-label Phase|Protocol Violation|0|||
27920713|NCT01056289|54578035|FG000|Open-label Phase|Withdrawal by Subject|26|||
28012841|NCT00408499|54671598|FG000|Phase II- MTD Expansion|Withdrawal by Subject|0|||
28012842|NCT00408499|54671599|FG001|Phase II- MTD Expansion|Withdrawal by Subject|0|||
27920714|NCT01056289|54578036|FG001|Open-label Phase|Withdrawal by Subject|0|||
27920715|NCT01056289|54578037|FG002|Open-label Phase|Withdrawal by Subject|0|||
27920716|NCT01056289|54578038|FG003|Open-label Phase|Withdrawal by Subject|0|||
27920717|NCT01056289|54578035|FG000|Open-label Phase|Lack of Efficacy|18|||
27920718|NCT01056289|54578036|FG001|Open-label Phase|Lack of Efficacy|0|||
27920719|NCT01056289|54578037|FG002|Open-label Phase|Lack of Efficacy|0|||
27920720|NCT01056289|54578038|FG003|Open-label Phase|Lack of Efficacy|0|||
27920721|NCT01056289|54578035|FG000|Open-label Phase|Not randomized to Double-blind phase|1|||
27920722|NCT01056289|54578036|FG001|Open-label Phase|Not randomized to Double-blind phase|0|||
27920723|NCT01056289|54578037|FG002|Open-label Phase|Not randomized to Double-blind phase|0|||
27920724|NCT01056289|54578038|FG003|Open-label Phase|Not randomized to Double-blind phase|0|||
27920725|NCT01056289|54578035|FG000|Double-blind Phase|Adverse Event|0|||
27920726|NCT01056289|54578036|FG001|Double-blind Phase|Adverse Event|1|||
27920727|NCT01056289|54578037|FG002|Double-blind Phase|Adverse Event|2|||
27920728|NCT01056289|54578038|FG003|Double-blind Phase|Adverse Event|1|||
27920729|NCT01056289|54578035|FG000|Double-blind Phase|Lost to Follow-up|0|||
27920730|NCT01056289|54578036|FG001|Double-blind Phase|Lost to Follow-up|2|||
27920731|NCT01056289|54578037|FG002|Double-blind Phase|Lost to Follow-up|2|||
27920732|NCT01056289|54578038|FG003|Double-blind Phase|Lost to Follow-up|2|||
27920733|NCT01056289|54578035|FG000|Double-blind Phase|Other|0|||
27920734|NCT01056289|54578036|FG001|Double-blind Phase|Other|0|||
27920735|NCT01056289|54578037|FG002|Double-blind Phase|Other|1|||
27920736|NCT01056289|54578038|FG003|Double-blind Phase|Other|2|||
27920737|NCT01056289|54578035|FG000|Double-blind Phase|Protocol Violation|0|||
27920738|NCT01056289|54578036|FG001|Double-blind Phase|Protocol Violation|0|||
27920739|NCT01056289|54578037|FG002|Double-blind Phase|Protocol Violation|1|||
27920740|NCT01056289|54578038|FG003|Double-blind Phase|Protocol Violation|1|||
27920741|NCT01056289|54578035|FG000|Double-blind Phase|Withdrawal by Subject|0|||
27920742|NCT01056289|54578036|FG001|Double-blind Phase|Withdrawal by Subject|0|||
27920743|NCT01056289|54578037|FG002|Double-blind Phase|Withdrawal by Subject|4|||
27920744|NCT01056289|54578038|FG003|Double-blind Phase|Withdrawal by Subject|2|||
27920745|NCT01056289|54578035|FG000|Double-blind Phase|Discontinuation symptom|0|||
27920746|NCT01056289|54578036|FG001|Double-blind Phase|Discontinuation symptom|1|||
27920747|NCT01056289|54578037|FG002|Double-blind Phase|Discontinuation symptom|2|||
27920748|NCT01056289|54578038|FG003|Double-blind Phase|Discontinuation symptom|2|||
27920749|NCT01056289|54578035|FG000|Double-blind Phase|Physician Decision|0|||
27920750|NCT01056289|54578036|FG001|Double-blind Phase|Physician Decision|0|||
27920751|NCT01056289|54578037|FG002|Double-blind Phase|Physician Decision|1|||
27920752|NCT01056289|54578038|FG003|Double-blind Phase|Physician Decision|0|||
27920753|NCT01039675|54578050|FG000|Overall Study|Adverse Event|0|||
27920754|NCT01039675|54578051|FG001|Overall Study|Adverse Event|2|||
27920755|NCT01039675|54578050|FG000|Overall Study|Lack of Efficacy|0|||
27920756|NCT01039675|54578051|FG001|Overall Study|Lack of Efficacy|2|||
27920757|NCT01039675|54578050|FG000|Overall Study|Withdrawal by Subject|0|||
27920758|NCT01039675|54578051|FG001|Overall Study|Withdrawal by Subject|1|||
27920759|NCT01039675|54578050|FG000|Overall Study|Lost to Follow-up|0|||
27920760|NCT01039675|54578051|FG001|Overall Study|Lost to Follow-up|1|||
27920761|NCT01039675|54578050|FG000|Overall Study|Physician Decision|0|||
27920762|NCT01039675|54578051|FG001|Overall Study|Physician Decision|1|||
27920763|NCT01033825|54578064|FG000|Overall Study|Withdrawal by Subject|2|||
27920764|NCT01033825|54578065|FG001|Overall Study|Withdrawal by Subject|3|||
27920765|NCT01033825|54578066|FG002|Overall Study|Withdrawal by Subject|2|||
27920766|NCT01033825|54578067|FG003|Overall Study|Withdrawal by Subject|1|||
27920767|NCT01033825|54578068|FG004|Overall Study|Withdrawal by Subject|1|||
27920768|NCT01033825|54578069|FG005|Overall Study|Withdrawal by Subject|0|||
27920769|NCT01033825|54578070|FG006|Overall Study|Withdrawal by Subject|0|||
27920770|NCT01033825|54578064|FG000|Overall Study|Adverse Event|0|||
27920771|NCT01033825|54578065|FG001|Overall Study|Adverse Event|0|||
27920772|NCT01033825|54578066|FG002|Overall Study|Adverse Event|0|||
27920773|NCT01033825|54578067|FG003|Overall Study|Adverse Event|1|||
27920774|NCT01033825|54578068|FG004|Overall Study|Adverse Event|0|||
27920775|NCT01033825|54578069|FG005|Overall Study|Adverse Event|0|||
27920776|NCT01033825|54578070|FG006|Overall Study|Adverse Event|0|||
27920777|NCT01033825|54578064|FG000|Overall Study|Protocol Violation|1|||
27920778|NCT01033825|54578065|FG001|Overall Study|Protocol Violation|0|||
27920779|NCT01033825|54578066|FG002|Overall Study|Protocol Violation|0|||
27920780|NCT01033825|54578067|FG003|Overall Study|Protocol Violation|0|||
27920781|NCT01033825|54578068|FG004|Overall Study|Protocol Violation|0|||
27920782|NCT01033825|54578069|FG005|Overall Study|Protocol Violation|0|||
27920783|NCT01033825|54578070|FG006|Overall Study|Protocol Violation|0|||
27920784|NCT01033825|54578064|FG000|Overall Study|Other|0|||
27920785|NCT01033825|54578065|FG001|Overall Study|Other|0|||
27742258|NCT02639065|54192286|FG000|Study Treatment|Withdrawal by Subject|1|||
27920786|NCT01033825|54578066|FG002|Overall Study|Other|0|||
27920787|NCT01033825|54578067|FG003|Overall Study|Other|0|||
27920788|NCT01033825|54578068|FG004|Overall Study|Other|1|||
27920789|NCT01033825|54578069|FG005|Overall Study|Other|0|||
27920790|NCT01033825|54578070|FG006|Overall Study|Other|0|||
27920791|NCT01033747|54578090|FG000|Overall Study|Adverse Event|9|||
27920792|NCT01033747|54578091|FG001|Overall Study|Adverse Event|4|||
27920793|NCT01033747|54578090|FG000|Overall Study|Abnormal Laboratory Value|1|||
27920794|NCT01033747|54578091|FG001|Overall Study|Abnormal Laboratory Value|0|||
27920795|NCT01033747|54578090|FG000|Overall Study|Abnormal test procedure|0|||
27920796|NCT01033747|54578091|FG001|Overall Study|Abnormal test procedure|1|||
27920797|NCT01033747|54578090|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
27920798|NCT01033747|54578091|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
27920799|NCT01033747|54578090|FG000|Overall Study|Protocol Violation|1|||
27920800|NCT01033747|54578091|FG001|Overall Study|Protocol Violation|0|||
27920801|NCT01033747|54578090|FG000|Overall Study|Withdrawal by Subject|9|||
27920802|NCT01033747|54578091|FG001|Overall Study|Withdrawal by Subject|6|||
27920803|NCT01033747|54578090|FG000|Overall Study|Stopped at end of prolongation visit 1|1|||
27920804|NCT01033747|54578091|FG001|Overall Study|Stopped at end of prolongation visit 1|0|||
27920805|NCT01033747|54578090|FG000|Overall Study|Stopped at end of Extension 1|2|||
27920806|NCT01033747|54578091|FG001|Overall Study|Stopped at end of Extension 1|0|||
27920807|NCT01091428|54578101|FG000|Phase 1|Progressive Disease|24|||
27920808|NCT01091428|54578102|FG001|Phase 1|Progressive Disease|8|||
27920809|NCT01091428|54578103|FG002|Phase 1|Progressive Disease|0|||
27920810|NCT01091428|54578104|FG003|Phase 1|Progressive Disease|0|||
27920811|NCT01091428|54578101|FG000|Phase 1|Symptomatic Deterioration|3|||
27920812|NCT01091428|54578102|FG001|Phase 1|Symptomatic Deterioration|2|||
27920813|NCT01091428|54578103|FG002|Phase 1|Symptomatic Deterioration|0|||
27920814|NCT01091428|54578104|FG003|Phase 1|Symptomatic Deterioration|0|||
27920815|NCT01091428|54578101|FG000|Phase 1|Adverse Event|2|||
27920816|NCT01091428|54578102|FG001|Phase 1|Adverse Event|0|||
27920817|NCT01091428|54578103|FG002|Phase 1|Adverse Event|0|||
27920818|NCT01091428|54578104|FG003|Phase 1|Adverse Event|0|||
27920819|NCT01091428|54578101|FG000|Phase 1|Withdrawal by Subject|7|||
27920820|NCT01091428|54578102|FG001|Phase 1|Withdrawal by Subject|0|||
27920821|NCT01091428|54578103|FG002|Phase 1|Withdrawal by Subject|0|||
27920822|NCT01091428|54578104|FG003|Phase 1|Withdrawal by Subject|0|||
27920823|NCT01091428|54578101|FG000|Phase 1|Reason not specified|0|||
27920824|NCT01091428|54578102|FG001|Phase 1|Reason not specified|1|||
27920825|NCT01091428|54578103|FG002|Phase 1|Reason not specified|0|||
27920826|NCT01091428|54578104|FG003|Phase 1|Reason not specified|0|||
27920827|NCT01091428|54578101|FG000|Phase 1|Single-Patient IND|2|||
27920828|NCT01091428|54578102|FG001|Phase 1|Single-Patient IND|0|||
27920829|NCT01091428|54578103|FG002|Phase 1|Single-Patient IND|0|||
27920830|NCT01091428|54578104|FG003|Phase 1|Single-Patient IND|0|||
27920831|NCT01091428|54578101|FG000|Phase 2|Progressive Disease|0|||
27920832|NCT01091428|54578102|FG001|Phase 2|Progressive Disease|0|||
27920833|NCT01091428|54578103|FG002|Phase 2|Progressive Disease|44|||
27920834|NCT01091428|54578104|FG003|Phase 2|Progressive Disease|46|||
27920835|NCT01091428|54578101|FG000|Phase 2|Symptomatic Deterioration|0|||
27920836|NCT01091428|54578102|FG001|Phase 2|Symptomatic Deterioration|0|||
27920837|NCT01091428|54578103|FG002|Phase 2|Symptomatic Deterioration|1|||
27920838|NCT01091428|54578104|FG003|Phase 2|Symptomatic Deterioration|6|||
27920839|NCT01091428|54578101|FG000|Phase 2|Adverse Event|0|||
27920840|NCT01091428|54578102|FG001|Phase 2|Adverse Event|0|||
27920841|NCT01091428|54578103|FG002|Phase 2|Adverse Event|12|||
27920842|NCT01091428|54578104|FG003|Phase 2|Adverse Event|5|||
27920843|NCT01091428|54578101|FG000|Phase 2|Withdrawal by Subject|0|||
27920844|NCT01091428|54578102|FG001|Phase 2|Withdrawal by Subject|0|||
27920845|NCT01091428|54578103|FG002|Phase 2|Withdrawal by Subject|9|||
27920846|NCT01091428|54578104|FG003|Phase 2|Withdrawal by Subject|8|||
27920847|NCT01091428|54578101|FG000|Phase 2|Unsatisfactory Therapeutic Response|0|||
27920848|NCT01091428|54578102|FG001|Phase 2|Unsatisfactory Therapeutic Response|0|||
27920849|NCT01091428|54578103|FG002|Phase 2|Unsatisfactory Therapeutic Response|1|||
27920850|NCT01091428|54578104|FG003|Phase 2|Unsatisfactory Therapeutic Response|1|||
27920851|NCT01091428|54578101|FG000|Phase 2|Reason not specified|0|||
27920852|NCT01091428|54578102|FG001|Phase 2|Reason not specified|0|||
27920853|NCT01091428|54578103|FG002|Phase 2|Reason not specified|4|||
27920854|NCT01091428|54578104|FG003|Phase 2|Reason not specified|3|||
27920855|NCT01091428|54578101|FG000|Phase 2|Physician Decision|0|||
27920856|NCT01091428|54578102|FG001|Phase 2|Physician Decision|0|||
27920857|NCT01091428|54578103|FG002|Phase 2|Physician Decision|2|||
27920858|NCT01091428|54578104|FG003|Phase 2|Physician Decision|0|||
27920859|NCT01096342|54578123|FG000|Overall Study|Protocol Violation|1|||
27920860|NCT01039519|54578127|FG000|Treatment|Progressive disease|20|||
27920861|NCT01039519|54578127|FG000|Treatment|Treatment failure|2|||
27920862|NCT01039519|54578127|FG000|Treatment|Adverse Event|3|||
27920863|NCT01039519|54578127|FG000|Treatment|Physician Decision|2|||
27920864|NCT01039519|54578127|FG000|Survival Follow-up|Death|23|||
27920865|NCT01039519|54578127|FG000|Survival Follow-up|Sponsor decision|4|||
27920866|NCT01096186|54578131|FG000|Overall Study|Adverse Event|16|||
27920867|NCT01096186|54578131|FG000|Overall Study|Death|4|||
27920868|NCT01096186|54578131|FG000|Overall Study|Lack of Efficacy|4|||
27920869|NCT01096186|54578131|FG000|Overall Study|Lost to Follow-up|2|||
27920870|NCT01096186|54578131|FG000|Overall Study|Withdrawal by Subject|22|||
27920871|NCT01096186|54578131|FG000|Overall Study|Physician Decision|1|||
27920872|NCT01096186|54578131|FG000|Overall Study|Noncompliance with study drug|1|||
27920873|NCT01032889|54578138|FG000|Overall Study|Adverse Event|2|||
27920874|NCT01032889|54578139|FG001|Overall Study|Adverse Event|2|||
27920875|NCT01032889|54578140|FG002|Overall Study|Adverse Event|0|||
27920876|NCT01032889|54578138|FG000|Overall Study|Withdrawal of Consent|1|||
27920877|NCT01032889|54578139|FG001|Overall Study|Withdrawal of Consent|2|||
27920878|NCT01032889|54578140|FG002|Overall Study|Withdrawal of Consent|1|||
27920879|NCT01032889|54578138|FG000|Overall Study|Patient Request|0|||
27920880|NCT01032889|54578139|FG001|Overall Study|Patient Request|1|||
27920881|NCT01032889|54578140|FG002|Overall Study|Patient Request|0|||
27920882|NCT01032889|54578138|FG000|Overall Study|Lost to Follow-up|1|||
27920883|NCT01032889|54578139|FG001|Overall Study|Lost to Follow-up|1|||
27920884|NCT01032889|54578140|FG002|Overall Study|Lost to Follow-up|0|||
27920885|NCT01032889|54578138|FG000|Overall Study|Lack of Submental Fat|2|||
27920886|NCT01032889|54578139|FG001|Overall Study|Lack of Submental Fat|8|||
27920887|NCT01032889|54578140|FG002|Overall Study|Lack of Submental Fat|1|||
27920888|NCT01032889|54578138|FG000|Overall Study|Miscellaneous Reasons|2|||
27920889|NCT01032889|54578139|FG001|Overall Study|Miscellaneous Reasons|1|||
27920890|NCT01032889|54578140|FG002|Overall Study|Miscellaneous Reasons|1|||
27920891|NCT01049503|54578154|FG000|Overall Study|Lost to Follow-up|11|||
27920892|NCT01049503|54578155|FG001|Overall Study|Lost to Follow-up|12|||
27920893|NCT01049503|54578156|FG002|Overall Study|Lost to Follow-up|24|||
27920894|NCT01049503|54578157|FG003|Overall Study|Lost to Follow-up|26|||
27920895|NCT01049503|54578158|FG004|Overall Study|Lost to Follow-up|27|||
27920896|NCT01049503|54578159|FG005|Overall Study|Lost to Follow-up|8|||
27920897|NCT01029925|54578182|FG000|Completion of Cycle 1 (28 Days)|Death|2|||
27920898|NCT01029925|54578182|FG000|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2|||
27920899|NCT01029925|54578182|FG000|Completion of Cycle 2 (56 Days)|off study due to disease progression|1|||
27920900|NCT01029691|54578189|FG000|Continued APAP to Delivery|Death|0|||
27920901|NCT01029691|54578190|FG001|Continued APAP to Delivery|Death|0|||
27920902|NCT01029691|54578191|FG002|Continued APAP to Delivery|Death|1|||
27920903|NCT01029535|54578200|FG000|Overall Study|Lost to Follow-up|24|||
27920904|NCT01029535|54578200|FG000|Overall Study|Protocol Violation|2|||
27920905|NCT01029535|54578200|FG000|Overall Study|Participant Withdrew Consent|2|||
27920906|NCT01029535|54578200|FG000|Overall Study|Adverse Event|1|||
27920907|NCT01029535|54578200|FG000|Overall Study|Use of Another Treatment|1|||
27920908|NCT01029535|54578200|FG000|Overall Study|Death|1|||
27920909|NCT01028053|54578205|FG000|Overall Study|Screen Failure|113|||
27920910|NCT01028053|54578205|FG000|Overall Study|Patient Request|11|||
27920911|NCT01028053|54578205|FG000|Overall Study|Protocol Violation|1|||
27920912|NCT01028053|54578205|FG000|Overall Study|Physician Decision|2|||
27920913|NCT01028053|54578205|FG000|Overall Study|Technical Problem|1|||
27920914|NCT01028053|54578205|FG000|Overall Study|Terminated by Sponsor|1|||
27920915|NCT01028053|54578205|FG000|Overall Study|Various reasons|4|||
27920916|NCT01023217|54578213|FG000|Overall Study|Withdrawal by Subject|1|||
28012843|NCT00408499|54671600|FG002|Phase II- MTD Expansion|Withdrawal by Subject|0|||
28012844|NCT00408499|54671601|FG003|Phase II- MTD Expansion|Withdrawal by Subject|0|||
28012845|NCT00408499|54671602|FG004|Phase II- MTD Expansion|Withdrawal by Subject|5|||
28012846|NCT00408499|54671598|FG000|Phase II- MTD Expansion|treatment delay|0|||
28012847|NCT00408499|54671599|FG001|Phase II- MTD Expansion|treatment delay|0|||
28012848|NCT00408499|54671600|FG002|Phase II- MTD Expansion|treatment delay|0|||
28012849|NCT00408499|54671601|FG003|Phase II- MTD Expansion|treatment delay|0|||
28012850|NCT00408499|54671602|FG004|Phase II- MTD Expansion|treatment delay|3|||
28012851|NCT00621777|54671622|FG000|Open Phase|Adverse Event|20|||
28012852|NCT00621777|54671623|FG001|Open Phase|Adverse Event|0|||
28012853|NCT00621777|54671622|FG000|Open Phase|Did not abstain during open phase|56|||
28012854|NCT00621777|54671623|FG001|Open Phase|Did not abstain during open phase|0|||
28012855|NCT00621777|54671622|FG000|Open Phase|Withdrawal by Subject|17|||
28012856|NCT00621777|54671623|FG001|Open Phase|Withdrawal by Subject|0|||
28012857|NCT00621777|54671622|FG000|Open Phase|administrative|13|||
28012858|NCT00621777|54671623|FG001|Open Phase|administrative|0|||
28012859|NCT00621777|54671622|FG000|Open Phase|Lost to Follow-up|10|||
28012860|NCT00621777|54671623|FG001|Open Phase|Lost to Follow-up|0|||
28012861|NCT00621777|54671622|FG000|Randomized Phase|Adverse Event|3|||
28012862|NCT00621777|54671623|FG001|Randomized Phase|Adverse Event|3|||
28012863|NCT00621777|54671622|FG000|Randomized Phase|Lost to Follow-up|3|||
28012864|NCT00621777|54671623|FG001|Randomized Phase|Lost to Follow-up|3|||
28012865|NCT00621777|54671622|FG000|Randomized Phase|Withdrawal by Subject|1|||
28012866|NCT00621777|54671623|FG001|Randomized Phase|Withdrawal by Subject|9|||
28012867|NCT00621777|54671622|FG000|Randomized Phase|administrative|0|||
28012868|NCT00621777|54671623|FG001|Randomized Phase|administrative|3|||
28012869|NCT00621777|54671622|FG000|Randomized Phase|Death|0|||
28012870|NCT00621777|54671623|FG001|Randomized Phase|Death|1|||
28012871|NCT00408421|54671633|FG000|Treatment Initial Randomization|Adverse Event|5|||
28012872|NCT00408421|54671634|FG001|Treatment Initial Randomization|Adverse Event|9|||
27920917|NCT01023217|54578214|FG001|Overall Study|Withdrawal by Subject|0|||
27920918|NCT01095796|54578222|FG000|Overall Study|Randomized but Not Treated|5|||
28012873|NCT00408421|54671635|FG002|Treatment Initial Randomization|Adverse Event|0|||
28012874|NCT00408421|54671633|FG000|Treatment Initial Randomization|Lack of Efficacy|2|||
27920919|NCT01095796|54578223|FG001|Overall Study|Randomized but Not Treated|2|||
27920920|NCT01095796|54578222|FG000|Overall Study|Adverse Event|9|||
27920921|NCT01095796|54578223|FG001|Overall Study|Adverse Event|19|||
27920922|NCT01095796|54578222|FG000|Overall Study|Death|3|||
27920923|NCT01095796|54578223|FG001|Overall Study|Death|2|||
27920924|NCT01095796|54578222|FG000|Overall Study|Pregnancy|2|||
27920925|NCT01095796|54578223|FG001|Overall Study|Pregnancy|0|||
27920926|NCT01095796|54578222|FG000|Overall Study|Lack of Efficacy|5|||
27920927|NCT01095796|54578223|FG001|Overall Study|Lack of Efficacy|3|||
27920928|NCT01095796|54578222|FG000|Overall Study|Investigator's Discretion|7|||
27920929|NCT01095796|54578223|FG001|Overall Study|Investigator's Discretion|2|||
27920930|NCT01095796|54578222|FG000|Overall Study|Withdrew Consent|16|||
27920931|NCT01095796|54578223|FG001|Overall Study|Withdrew Consent|22|||
27920932|NCT01095796|54578222|FG000|Overall Study|Lost to Follow-up|27|||
27920933|NCT01095796|54578223|FG001|Overall Study|Lost to Follow-up|29|||
27920934|NCT01095796|54578222|FG000|Overall Study|Participant Noncompliance|5|||
27920935|NCT01095796|54578223|FG001|Overall Study|Participant Noncompliance|10|||
27920936|NCT01095796|54578222|FG000|Overall Study|Protocol Violation|1|||
27920937|NCT01095796|54578223|FG001|Overall Study|Protocol Violation|0|||
27920938|NCT01095796|54578222|FG000|Overall Study|Participant Transferred to Another Study|215|||
27920939|NCT01095796|54578223|FG001|Overall Study|Participant Transferred to Another Study|200|||
27920940|NCT01023061|54578229|FG000|Overall Study|Withdrawal prior to treatment|2|||
27920941|NCT01027897|54578233|FG000|Overall Study|Protocol Violation|1|||
27920942|NCT01027897|54578233|FG000|Overall Study|Withdrawal by Subject|1|||
27920943|NCT01027351|54578243|FG000|Overall Study|Withdrawal by Subject|1|||
27920944|NCT01027351|54578244|FG001|Overall Study|Withdrawal by Subject|0|||
27920945|NCT01027351|54578245|FG002|Overall Study|Withdrawal by Subject|1|||
27920946|NCT01027351|54578246|FG003|Overall Study|Withdrawal by Subject|0|||
27920947|NCT01027351|54578247|FG004|Overall Study|Withdrawal by Subject|3|||
27920948|NCT01027351|54578248|FG005|Overall Study|Withdrawal by Subject|5|||
27920949|NCT01027351|54578243|FG000|Overall Study|Lost to Follow-up|1|||
27920950|NCT01027351|54578244|FG001|Overall Study|Lost to Follow-up|1|||
27920951|NCT01027351|54578245|FG002|Overall Study|Lost to Follow-up|0|||
27920952|NCT01027351|54578246|FG003|Overall Study|Lost to Follow-up|1|||
27920953|NCT01027351|54578247|FG004|Overall Study|Lost to Follow-up|6|||
27920954|NCT01027351|54578248|FG005|Overall Study|Lost to Follow-up|0|||
27920955|NCT01027351|54578243|FG000|Overall Study|Inappropriate enrollment|0|||
27920956|NCT01027351|54578244|FG001|Overall Study|Inappropriate enrollment|0|||
27920957|NCT01027351|54578245|FG002|Overall Study|Inappropriate enrollment|0|||
27920958|NCT01027351|54578246|FG003|Overall Study|Inappropriate enrollment|0|||
27920959|NCT01027351|54578247|FG004|Overall Study|Inappropriate enrollment|1|||
27920960|NCT01027351|54578248|FG005|Overall Study|Inappropriate enrollment|0|||
27920961|NCT01027351|54578243|FG000|Overall Study|Protocol Violation|1|||
27920962|NCT01027351|54578244|FG001|Overall Study|Protocol Violation|0|||
27920963|NCT01027351|54578245|FG002|Overall Study|Protocol Violation|0|||
27920964|NCT01027351|54578246|FG003|Overall Study|Protocol Violation|1|||
27920965|NCT01027351|54578247|FG004|Overall Study|Protocol Violation|1|||
27920966|NCT01027351|54578248|FG005|Overall Study|Protocol Violation|0|||
27920967|NCT01027273|54578271|FG000|Overall Study|Lost to Follow-up|57|||
27920968|NCT01027273|54578272|FG001|Overall Study|Lost to Follow-up|31|||
27920969|NCT01027273|54578271|FG000|Overall Study|Death|2|||
27920970|NCT01027273|54578272|FG001|Overall Study|Death|2|||
27920971|NCT01022203|54578280|FG000|Post Treatment Assessment|Withdrawal by Subject|12|||
27920972|NCT01022203|54578281|FG001|Post Treatment Assessment|Withdrawal by Subject|12|||
27920973|NCT01022203|54578280|FG000|Post Treatment Assessment|Physician Decision|2|||
27920974|NCT01022203|54578281|FG001|Post Treatment Assessment|Physician Decision|0|||
27920975|NCT01022203|54578280|FG000|Post Treatment Assessment|Adverse Event|0|||
27920976|NCT01022203|54578281|FG001|Post Treatment Assessment|Adverse Event|2|||
27920977|NCT01022203|54578280|FG000|Follow-Up Assessment|Lost to Follow-up|2|||
27920978|NCT01022203|54578281|FG001|Follow-Up Assessment|Lost to Follow-up|2|||
27920979|NCT01296711|54578298|FG000|Overall Study|Adverse Event|3|||
27920980|NCT01296711|54578299|FG001|Overall Study|Adverse Event|1|||
27920981|NCT01296711|54578300|FG002|Overall Study|Adverse Event|4|||
27920982|NCT01296711|54578301|FG003|Overall Study|Adverse Event|3|||
27920983|NCT01296711|54578302|FG004|Overall Study|Adverse Event|1|||
27920984|NCT01296711|54578303|FG005|Overall Study|Adverse Event|6|||
27920985|NCT01296711|54578304|FG006|Overall Study|Adverse Event|11|||
27920986|NCT01296711|54578305|FG007|Overall Study|Adverse Event|3|||
27920987|NCT01296711|54578298|FG000|Overall Study|Lack of Efficacy|1|||
27920988|NCT01296711|54578299|FG001|Overall Study|Lack of Efficacy|4|||
27920989|NCT01296711|54578300|FG002|Overall Study|Lack of Efficacy|1|||
27920990|NCT01296711|54578301|FG003|Overall Study|Lack of Efficacy|1|||
27920991|NCT01296711|54578302|FG004|Overall Study|Lack of Efficacy|1|||
27920992|NCT01296711|54578303|FG005|Overall Study|Lack of Efficacy|0|||
27920993|NCT01296711|54578304|FG006|Overall Study|Lack of Efficacy|2|||
27920994|NCT01296711|54578305|FG007|Overall Study|Lack of Efficacy|3|||
27920995|NCT01296711|54578298|FG000|Overall Study|Lost to Follow-up|0|||
27920996|NCT01296711|54578299|FG001|Overall Study|Lost to Follow-up|0|||
27920997|NCT01296711|54578300|FG002|Overall Study|Lost to Follow-up|1|||
27920998|NCT01296711|54578301|FG003|Overall Study|Lost to Follow-up|1|||
27920999|NCT01296711|54578302|FG004|Overall Study|Lost to Follow-up|2|||
27921000|NCT01296711|54578303|FG005|Overall Study|Lost to Follow-up|0|||
27921001|NCT01296711|54578304|FG006|Overall Study|Lost to Follow-up|4|||
27921002|NCT01296711|54578305|FG007|Overall Study|Lost to Follow-up|2|||
27921003|NCT01296711|54578298|FG000|Overall Study|Protocol Violation|0|||
27921004|NCT01296711|54578299|FG001|Overall Study|Protocol Violation|0|||
27921005|NCT01296711|54578300|FG002|Overall Study|Protocol Violation|0|||
27921006|NCT01296711|54578301|FG003|Overall Study|Protocol Violation|1|||
27921007|NCT01296711|54578302|FG004|Overall Study|Protocol Violation|1|||
27921008|NCT01296711|54578303|FG005|Overall Study|Protocol Violation|0|||
27921009|NCT01296711|54578304|FG006|Overall Study|Protocol Violation|0|||
27921010|NCT01296711|54578305|FG007|Overall Study|Protocol Violation|0|||
27921011|NCT01296711|54578298|FG000|Overall Study|Withdrawal by Subject|4|||
27921012|NCT01296711|54578299|FG001|Overall Study|Withdrawal by Subject|2|||
27921013|NCT01296711|54578300|FG002|Overall Study|Withdrawal by Subject|2|||
27921014|NCT01296711|54578301|FG003|Overall Study|Withdrawal by Subject|1|||
27921015|NCT01296711|54578302|FG004|Overall Study|Withdrawal by Subject|1|||
27921016|NCT01296711|54578303|FG005|Overall Study|Withdrawal by Subject|1|||
27921017|NCT01296711|54578304|FG006|Overall Study|Withdrawal by Subject|2|||
27921018|NCT01296711|54578305|FG007|Overall Study|Withdrawal by Subject|1|||
27921019|NCT01296711|54578298|FG000|Overall Study|Study termination|8|||
27921020|NCT01296711|54578299|FG001|Overall Study|Study termination|1|||
27921021|NCT01296711|54578300|FG002|Overall Study|Study termination|5|||
27921022|NCT01296711|54578301|FG003|Overall Study|Study termination|4|||
27921023|NCT01296711|54578302|FG004|Overall Study|Study termination|4|||
27921024|NCT01296711|54578303|FG005|Overall Study|Study termination|4|||
27921025|NCT01296711|54578304|FG006|Overall Study|Study termination|8|||
27921026|NCT01296711|54578305|FG007|Overall Study|Study termination|10|||
27921027|NCT01296711|54578298|FG000|Overall Study|Continued elevated liver enzymes|0|||
27921028|NCT01296711|54578299|FG001|Overall Study|Continued elevated liver enzymes|0|||
27921029|NCT01296711|54578300|FG002|Overall Study|Continued elevated liver enzymes|0|||
27921030|NCT01296711|54578301|FG003|Overall Study|Continued elevated liver enzymes|1|||
27921031|NCT01296711|54578302|FG004|Overall Study|Continued elevated liver enzymes|0|||
27921032|NCT01296711|54578303|FG005|Overall Study|Continued elevated liver enzymes|0|||
27921033|NCT01296711|54578304|FG006|Overall Study|Continued elevated liver enzymes|0|||
27921034|NCT01296711|54578305|FG007|Overall Study|Continued elevated liver enzymes|0|||
27921035|NCT01296711|54578298|FG000|Overall Study|Methotrexate discontinued|0|||
27921036|NCT01296711|54578299|FG001|Overall Study|Methotrexate discontinued|0|||
27921037|NCT01296711|54578300|FG002|Overall Study|Methotrexate discontinued|0|||
27921038|NCT01296711|54578301|FG003|Overall Study|Methotrexate discontinued|1|||
27921039|NCT01296711|54578302|FG004|Overall Study|Methotrexate discontinued|0|||
27921040|NCT01296711|54578303|FG005|Overall Study|Methotrexate discontinued|0|||
27921041|NCT01296711|54578304|FG006|Overall Study|Methotrexate discontinued|0|||
27921042|NCT01296711|54578305|FG007|Overall Study|Methotrexate discontinued|0|||
27921043|NCT01296711|54578298|FG000|Overall Study|Investigator discretion|0|||
27921044|NCT01296711|54578299|FG001|Overall Study|Investigator discretion|0|||
27921045|NCT01296711|54578300|FG002|Overall Study|Investigator discretion|0|||
27921046|NCT01296711|54578301|FG003|Overall Study|Investigator discretion|0|||
27921047|NCT01296711|54578302|FG004|Overall Study|Investigator discretion|0|||
27921048|NCT01296711|54578303|FG005|Overall Study|Investigator discretion|0|||
27921049|NCT01296711|54578304|FG006|Overall Study|Investigator discretion|1|||
27921050|NCT01296711|54578305|FG007|Overall Study|Investigator discretion|0|||
27921051|NCT01296711|54578298|FG000|Overall Study|Other|0|||
27921052|NCT01296711|54578299|FG001|Overall Study|Other|0|||
27921053|NCT01296711|54578300|FG002|Overall Study|Other|0|||
27921054|NCT01296711|54578301|FG003|Overall Study|Other|0|||
27921055|NCT01296711|54578302|FG004|Overall Study|Other|0|||
27921056|NCT01296711|54578303|FG005|Overall Study|Other|0|||
27921057|NCT01296711|54578304|FG006|Overall Study|Other|1|||
27921058|NCT01296711|54578305|FG007|Overall Study|Other|0|||
27921059|NCT01296711|54578298|FG000|Overall Study|Required restricted steroid injections|0|||
27921060|NCT01296711|54578299|FG001|Overall Study|Required restricted steroid injections|0|||
27921061|NCT01296711|54578300|FG002|Overall Study|Required restricted steroid injections|0|||
27921062|NCT01296711|54578301|FG003|Overall Study|Required restricted steroid injections|0|||
27921063|NCT01296711|54578302|FG004|Overall Study|Required restricted steroid injections|0|||
27921064|NCT01296711|54578303|FG005|Overall Study|Required restricted steroid injections|0|||
27921065|NCT01296711|54578304|FG006|Overall Study|Required restricted steroid injections|1|||
27921066|NCT01296711|54578305|FG007|Overall Study|Required restricted steroid injections|0|||
27921067|NCT01296711|54578298|FG000|Overall Study|Ongoing missed appointments|0|||
27921068|NCT01296711|54578299|FG001|Overall Study|Ongoing missed appointments|0|||
27921069|NCT01296711|54578300|FG002|Overall Study|Ongoing missed appointments|0|||
27921070|NCT01296711|54578301|FG003|Overall Study|Ongoing missed appointments|0|||
27921071|NCT01296711|54578302|FG004|Overall Study|Ongoing missed appointments|0|||
27921072|NCT01296711|54578303|FG005|Overall Study|Ongoing missed appointments|0|||
27921073|NCT01296711|54578304|FG006|Overall Study|Ongoing missed appointments|1|||
27921074|NCT01296711|54578305|FG007|Overall Study|Ongoing missed appointments|0|||
27921075|NCT01296711|54578298|FG000|Overall Study|Failure to comply with visits|0|||
27921076|NCT01296711|54578299|FG001|Overall Study|Failure to comply with visits|0|||
27921077|NCT01296711|54578300|FG002|Overall Study|Failure to comply with visits|0|||
27921078|NCT01296711|54578301|FG003|Overall Study|Failure to comply with visits|0|||
27921079|NCT01296711|54578302|FG004|Overall Study|Failure to comply with visits|0|||
27921080|NCT01296711|54578303|FG005|Overall Study|Failure to comply with visits|0|||
27921081|NCT01296711|54578304|FG006|Overall Study|Failure to comply with visits|0|||
27921082|NCT01296711|54578305|FG007|Overall Study|Failure to comply with visits|1|||
27921083|NCT01296711|54578298|FG000|Overall Study|Patient decision due to transport|0|||
27921084|NCT01296711|54578299|FG001|Overall Study|Patient decision due to transport|0|||
27921085|NCT01296711|54578300|FG002|Overall Study|Patient decision due to transport|0|||
27921086|NCT01296711|54578301|FG003|Overall Study|Patient decision due to transport|0|||
27921087|NCT01296711|54578302|FG004|Overall Study|Patient decision due to transport|0|||
27921088|NCT01296711|54578303|FG005|Overall Study|Patient decision due to transport|0|||
27921089|NCT01296711|54578304|FG006|Overall Study|Patient decision due to transport|0|||
27921090|NCT01296711|54578305|FG007|Overall Study|Patient decision due to transport|1|||
27921091|NCT01294917|54578323|FG000|Overall Study|Relocation|5|||
27921092|NCT01294917|54578323|FG000|Overall Study|Inconvenience|1|||
27921093|NCT01294683|54578331|FG000|Precrossover (Periods I/II)|Adverse Event|49|||
27921094|NCT01294683|54578332|FG001|Precrossover (Periods I/II)|Adverse Event|52|||
27921095|NCT01294683|54578331|FG000|Precrossover (Periods I/II)|Lost to Follow-up|3|||
27921096|NCT01294683|54578332|FG001|Precrossover (Periods I/II)|Lost to Follow-up|6|||
27921097|NCT01294683|54578331|FG000|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
27921098|NCT01294683|54578332|FG001|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
27921099|NCT01294683|54578331|FG000|Precrossover (Periods I/II)|Physician Decision|1|||
27921100|NCT01294683|54578332|FG001|Precrossover (Periods I/II)|Physician Decision|0|||
27921101|NCT01294683|54578331|FG000|Precrossover (Periods I/II)|Protocol Violation|5|||
27921102|NCT01294683|54578332|FG001|Precrossover (Periods I/II)|Protocol Violation|5|||
27921103|NCT01294683|54578331|FG000|Precrossover (Periods I/II)|Study Terminated by Sponsor|187|||
27921104|NCT01294683|54578332|FG001|Precrossover (Periods I/II)|Study Terminated by Sponsor|192|||
27921105|NCT01294683|54578331|FG000|Precrossover (Periods I/II)|Technical Problems|0|||
27921106|NCT01294683|54578332|FG001|Precrossover (Periods I/II)|Technical Problems|1|||
27921107|NCT01294683|54578331|FG000|Precrossover (Periods I/II)|Withdrawal by Subject|11|||
27921108|NCT01294683|54578332|FG001|Precrossover (Periods I/II)|Withdrawal by Subject|9|||
27921109|NCT01294683|54578331|FG000|Post Crossover (Period III)|Adverse Event|6|||
27921110|NCT01294683|54578332|FG001|Post Crossover (Period III)|Adverse Event|6|||
27921111|NCT01294683|54578331|FG000|Post Crossover (Period III)|Lost to Follow-up|1|||
27921112|NCT01294683|54578332|FG001|Post Crossover (Period III)|Lost to Follow-up|3|||
27921113|NCT01294683|54578331|FG000|Post Crossover (Period III)|Study Terminated by Sponsor|23|||
27921114|NCT01294683|54578332|FG001|Post Crossover (Period III)|Study Terminated by Sponsor|21|||
27921115|NCT01294683|54578331|FG000|Post Crossover (Period III)|Withdrawal by Subject|3|||
27921116|NCT01294683|54578332|FG001|Post Crossover (Period III)|Withdrawal by Subject|2|||
27921117|NCT01294449|54578346|FG000|Overall Study|Death|11|||
27921118|NCT01294449|54578347|FG001|Overall Study|Death|12|||
27921119|NCT01294449|54578346|FG000|Overall Study|Withdrawal by Subject|1|||
27921120|NCT01294449|54578347|FG001|Overall Study|Withdrawal by Subject|3|||
27921121|NCT01294371|54578353|FG000|Overall Study|Adverse Event|1|||
27921122|NCT01294371|54578353|FG000|Overall Study|Withdrawal by Subject|12|||
27921123|NCT01294371|54578353|FG000|Overall Study|Lost to Follow-up|6|||
27921124|NCT01294371|54578353|FG000|Overall Study|Administrative Reason|1|||
27921125|NCT01294371|54578353|FG000|Overall Study|Other|14|||
27921126|NCT01293123|54578362|FG000|Overall Study|Lost to Follow-up|0|||
27921127|NCT01293123|54578363|FG001|Overall Study|Lost to Follow-up|1|||
27921128|NCT01292187|54578371|FG000|Overall Study|Adverse Event|10|||
27921129|NCT01292187|54578372|FG001|Overall Study|Adverse Event|5|||
27921130|NCT01292187|54578371|FG000|Overall Study|Withdrawal by Subject|6|||
27921131|NCT01292187|54578372|FG001|Overall Study|Withdrawal by Subject|5|||
27921132|NCT01292187|54578371|FG000|Overall Study|All other reasons|1|||
27921133|NCT01292187|54578372|FG001|Overall Study|All other reasons|3|||
27921134|NCT01026493|54578387|FG000|Overall Study|Protocol Violation|0|||
27921135|NCT01026493|54578388|FG001|Overall Study|Protocol Violation|1|||
27921136|NCT01026493|54578389|FG002|Overall Study|Protocol Violation|0|||
27921137|NCT01026493|54578390|FG003|Overall Study|Protocol Violation|0|||
27921138|NCT01026493|54578391|FG004|Overall Study|Protocol Violation|2|||
27921139|NCT01026493|54578392|FG005|Overall Study|Protocol Violation|3|||
27921140|NCT01026493|54578393|FG006|Overall Study|Protocol Violation|4|||
27921141|NCT01026493|54578394|FG007|Overall Study|Protocol Violation|1|||
27921142|NCT01026103|54578412|FG000|Overall Study|Physician Decision|1|||
27921143|NCT01026103|54578412|FG000|Overall Study|did not receive study device bc of error|1|||
27921144|NCT01291173|54578420|FG000|Overall Study|Adverse Event|0|||
27921145|NCT01291173|54578421|FG001|Overall Study|Adverse Event|3|||
28012875|NCT00408421|54671634|FG001|Treatment Initial Randomization|Lack of Efficacy|2|||
27921146|NCT01291173|54578422|FG002|Overall Study|Adverse Event|1|||
27921147|NCT01291173|54578423|FG003|Overall Study|Adverse Event|3|||
27921148|NCT01291173|54578420|FG000|Overall Study|Protocol Violation|7|||
27921149|NCT01291173|54578421|FG001|Overall Study|Protocol Violation|2|||
27921150|NCT01291173|54578422|FG002|Overall Study|Protocol Violation|2|||
27921151|NCT01291173|54578423|FG003|Overall Study|Protocol Violation|5|||
27921152|NCT01291173|54578420|FG000|Overall Study|Withdrawal by Subject|6|||
27921153|NCT01291173|54578421|FG001|Overall Study|Withdrawal by Subject|4|||
27921154|NCT01291173|54578422|FG002|Overall Study|Withdrawal by Subject|4|||
27921155|NCT01291173|54578423|FG003|Overall Study|Withdrawal by Subject|2|||
27921156|NCT01291173|54578420|FG000|Overall Study|Lost to Follow-up|4|||
27921157|NCT01291173|54578421|FG001|Overall Study|Lost to Follow-up|6|||
27921158|NCT01291173|54578422|FG002|Overall Study|Lost to Follow-up|3|||
27921159|NCT01291173|54578423|FG003|Overall Study|Lost to Follow-up|2|||
27921160|NCT01291173|54578420|FG000|Overall Study|Unable to meet visit schedule|0|||
27921161|NCT01291173|54578421|FG001|Overall Study|Unable to meet visit schedule|0|||
27921162|NCT01291173|54578422|FG002|Overall Study|Unable to meet visit schedule|1|||
27921163|NCT01291173|54578423|FG003|Overall Study|Unable to meet visit schedule|0|||
27921164|NCT01291173|54578420|FG000|Overall Study|Lack of compliance|0|||
27921165|NCT01291173|54578421|FG001|Overall Study|Lack of compliance|0|||
27921166|NCT01291173|54578422|FG002|Overall Study|Lack of compliance|0|||
27921167|NCT01291173|54578423|FG003|Overall Study|Lack of compliance|1|||
27921168|NCT01291173|54578420|FG000|Overall Study|Subject was unblinded|0|||
27921169|NCT01291173|54578421|FG001|Overall Study|Subject was unblinded|0|||
27921170|NCT01291173|54578422|FG002|Overall Study|Subject was unblinded|1|||
27921171|NCT01291173|54578423|FG003|Overall Study|Subject was unblinded|0|||
27921172|NCT01291173|54578420|FG000|Overall Study|Excluded therapy|0|||
27921173|NCT01291173|54578421|FG001|Overall Study|Excluded therapy|0|||
27921174|NCT01291173|54578422|FG002|Overall Study|Excluded therapy|1|||
27921175|NCT01291173|54578423|FG003|Overall Study|Excluded therapy|0|||
27921176|NCT01291017|54578433|FG000|Overall Study|Lost to Follow-up|2|||
27921177|NCT01291017|54578433|FG000|Overall Study|Withdrawal by Subject|3|||
27921178|NCT01290315|54578441|FG000|Overall Study|Adverse Event|0|||
27921179|NCT01290315|54578442|FG001|Overall Study|Adverse Event|0|||
27921180|NCT01290315|54578443|FG002|Overall Study|Adverse Event|0|||
27921181|NCT01290315|54578444|FG003|Overall Study|Adverse Event|3|||
27921182|NCT01290315|54578441|FG000|Overall Study|Selection criteria/compliance|2|||
27921183|NCT01290315|54578442|FG001|Overall Study|Selection criteria/compliance|1|||
27921184|NCT01290315|54578443|FG002|Overall Study|Selection criteria/compliance|0|||
27921185|NCT01290315|54578444|FG003|Overall Study|Selection criteria/compliance|2|||
27921186|NCT01290315|54578441|FG000|Overall Study|Lost to Follow-up|0|||
27921187|NCT01290315|54578442|FG001|Overall Study|Lost to Follow-up|1|||
27921188|NCT01290315|54578443|FG002|Overall Study|Lost to Follow-up|0|||
27921189|NCT01290315|54578444|FG003|Overall Study|Lost to Follow-up|0|||
27921190|NCT01290315|54578441|FG000|Overall Study|Withdrawal by Subject|1|||
27921191|NCT01290315|54578442|FG001|Overall Study|Withdrawal by Subject|1|||
27921192|NCT01290315|54578443|FG002|Overall Study|Withdrawal by Subject|0|||
27921193|NCT01290315|54578444|FG003|Overall Study|Withdrawal by Subject|0|||
27921194|NCT01289847|54578453|FG000|Overall Study|Patient could not comply with visits|1|||
27921195|NCT01079182|54578457|FG000|Overall Study|Lost to Follow-up|1634|||
27921196|NCT01079182|54578457|FG000|Overall Study|Adverse Drug Reaction (ADR)|261|||
27921197|NCT01079182|54578457|FG000|Overall Study|Lack of Efficacy|514|||
27921198|NCT01079182|54578457|FG000|Overall Study|ADR and Lack of Effectiveness|39|||
27921199|NCT01079182|54578457|FG000|Overall Study|Reasons not Evaluated|271|||
27921200|NCT01021813|54578463|FG000|DB Treatment Phase|Adverse Event|60|||
27921201|NCT01021813|54578464|FG001|DB Treatment Phase|Adverse Event|22|||
27921202|NCT01021813|54578465|FG002|DB Treatment Phase|Adverse Event|0|||
27921203|NCT01021813|54578466|FG003|DB Treatment Phase|Adverse Event|0|||
27921204|NCT01021813|54578467|FG004|DB Treatment Phase|Adverse Event|0|||
27921205|NCT01021813|54578463|FG000|DB Treatment Phase|Lack of Efficacy|44|||
27921206|NCT01021813|54578464|FG001|DB Treatment Phase|Lack of Efficacy|28|||
27921207|NCT01021813|54578465|FG002|DB Treatment Phase|Lack of Efficacy|0|||
27921208|NCT01021813|54578466|FG003|DB Treatment Phase|Lack of Efficacy|0|||
27921209|NCT01021813|54578467|FG004|DB Treatment Phase|Lack of Efficacy|0|||
27921210|NCT01021813|54578463|FG000|DB Treatment Phase|Lost to Follow-up|14|||
27921211|NCT01021813|54578464|FG001|DB Treatment Phase|Lost to Follow-up|12|||
27921212|NCT01021813|54578465|FG002|DB Treatment Phase|Lost to Follow-up|0|||
27921213|NCT01021813|54578466|FG003|DB Treatment Phase|Lost to Follow-up|0|||
27921214|NCT01021813|54578467|FG004|DB Treatment Phase|Lost to Follow-up|0|||
27921215|NCT01021813|54578463|FG000|DB Treatment Phase|Physician Decision|17|||
27921216|NCT01021813|54578464|FG001|DB Treatment Phase|Physician Decision|8|||
27921217|NCT01021813|54578465|FG002|DB Treatment Phase|Physician Decision|0|||
27921218|NCT01021813|54578466|FG003|DB Treatment Phase|Physician Decision|0|||
27921219|NCT01021813|54578467|FG004|DB Treatment Phase|Physician Decision|0|||
27921220|NCT01021813|54578463|FG000|DB Treatment Phase|Pregnancy|1|||
27921221|NCT01021813|54578464|FG001|DB Treatment Phase|Pregnancy|0|||
27921222|NCT01021813|54578465|FG002|DB Treatment Phase|Pregnancy|0|||
27921223|NCT01021813|54578466|FG003|DB Treatment Phase|Pregnancy|0|||
27921224|NCT01021813|54578467|FG004|DB Treatment Phase|Pregnancy|0|||
27921225|NCT01021813|54578463|FG000|DB Treatment Phase|Protocol Violation|4|||
27921226|NCT01021813|54578464|FG001|DB Treatment Phase|Protocol Violation|3|||
27921227|NCT01021813|54578465|FG002|DB Treatment Phase|Protocol Violation|0|||
27921228|NCT01021813|54578466|FG003|DB Treatment Phase|Protocol Violation|0|||
27921229|NCT01021813|54578467|FG004|DB Treatment Phase|Protocol Violation|0|||
27921230|NCT01021813|54578463|FG000|DB Treatment Phase|Withdrawal by Subject|60|||
27921231|NCT01021813|54578464|FG001|DB Treatment Phase|Withdrawal by Subject|24|||
27921232|NCT01021813|54578465|FG002|DB Treatment Phase|Withdrawal by Subject|0|||
27921233|NCT01021813|54578466|FG003|DB Treatment Phase|Withdrawal by Subject|0|||
27921234|NCT01021813|54578467|FG004|DB Treatment Phase|Withdrawal by Subject|0|||
27921235|NCT01021813|54578463|FG000|DB Randomized Discontinuation Phase|Adverse Event|0|||
27921236|NCT01021813|54578464|FG001|DB Randomized Discontinuation Phase|Adverse Event|0|||
27921237|NCT01021813|54578465|FG002|DB Randomized Discontinuation Phase|Adverse Event|0|||
27921238|NCT01021813|54578466|FG003|DB Randomized Discontinuation Phase|Adverse Event|3|||
27921239|NCT01021813|54578467|FG004|DB Randomized Discontinuation Phase|Adverse Event|1|||
27921240|NCT01021813|54578463|FG000|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
27921241|NCT01021813|54578464|FG001|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
27921242|NCT01021813|54578465|FG002|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
27921243|NCT01021813|54578466|FG003|DB Randomized Discontinuation Phase|Lack of Efficacy|1|||
27921244|NCT01021813|54578467|FG004|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
27921245|NCT01021813|54578463|FG000|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
27921246|NCT01021813|54578464|FG001|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
27921247|NCT01021813|54578465|FG002|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
27921248|NCT01021813|54578466|FG003|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
27921249|NCT01021813|54578467|FG004|DB Randomized Discontinuation Phase|Lost to Follow-up|1|||
27921250|NCT01021813|54578463|FG000|DB Randomized Discontinuation Phase|Protocol Violation|0|||
27921251|NCT01021813|54578464|FG001|DB Randomized Discontinuation Phase|Protocol Violation|0|||
27921252|NCT01021813|54578465|FG002|DB Randomized Discontinuation Phase|Protocol Violation|1|||
27921253|NCT01021813|54578466|FG003|DB Randomized Discontinuation Phase|Protocol Violation|0|||
27921254|NCT01021813|54578467|FG004|DB Randomized Discontinuation Phase|Protocol Violation|0|||
27921255|NCT01021813|54578463|FG000|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
27921256|NCT01021813|54578464|FG001|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
27921257|NCT01021813|54578465|FG002|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
27921258|NCT01021813|54578466|FG003|DB Randomized Discontinuation Phase|Withdrawal by Subject|1|||
27921259|NCT01021813|54578467|FG004|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
27921260|NCT01025635|54578486|FG000|Overall Study|Withdrawal by Subject|6|||
27921261|NCT01025635|54578487|FG001|Overall Study|Withdrawal by Subject|7|||
27921262|NCT01025635|54578486|FG000|Overall Study|Protocol Violation|4|||
27921263|NCT01025635|54578487|FG001|Overall Study|Protocol Violation|2|||
27921264|NCT01025635|54578486|FG000|Overall Study|Lack of Efficacy|0|||
27921265|NCT01025635|54578487|FG001|Overall Study|Lack of Efficacy|1|||
27921266|NCT01025635|54578486|FG000|Overall Study|Lost to Follow-up|9|||
27921267|NCT01025635|54578487|FG001|Overall Study|Lost to Follow-up|13|||
27921268|NCT01025635|54578486|FG000|Overall Study|Reason not known|4|||
27921269|NCT01025635|54578487|FG001|Overall Study|Reason not known|2|||
27921270|NCT01021423|54578495|FG000|Overall Study|Study terminated|4|||
27921271|NCT01021423|54578496|FG001|Overall Study|Study terminated|5|||
27921272|NCT01020877|54578504|FG000|Second Intervention|Withdrawal by Subject|1|||
27921273|NCT01020877|54578505|FG001|Second Intervention|Withdrawal by Subject|0|||
27921274|NCT01020799|54578514|FG000|Overall Study|Adverse Event|4|||
28012876|NCT00408421|54671635|FG002|Treatment Initial Randomization|Lack of Efficacy|0|||
28012877|NCT00408421|54671633|FG000|Treatment Initial Randomization|Lost to Follow-up|0|||
28012878|NCT00408421|54671634|FG001|Treatment Initial Randomization|Lost to Follow-up|3|||
27921275|NCT01020799|54578515|FG001|Overall Study|Adverse Event|3|||
27921276|NCT01020799|54578516|FG002|Overall Study|Adverse Event|2|||
27921277|NCT01020799|54578514|FG000|Overall Study|non-compliance; lack of efficacy; etc.|4|||
27921278|NCT01020799|54578515|FG001|Overall Study|non-compliance; lack of efficacy; etc.|3|||
27921279|NCT01020799|54578516|FG002|Overall Study|non-compliance; lack of efficacy; etc.|0|||
27921280|NCT01020799|54578514|FG000|Overall Study|Protocol Violation|3|||
27921281|NCT01020799|54578515|FG001|Overall Study|Protocol Violation|2|||
27921282|NCT01020799|54578516|FG002|Overall Study|Protocol Violation|0|||
27921283|NCT01020799|54578514|FG000|Overall Study|Withdrawal by Subject|2|||
27921284|NCT01020799|54578515|FG001|Overall Study|Withdrawal by Subject|2|||
27921285|NCT01020799|54578516|FG002|Overall Study|Withdrawal by Subject|3|||
27921286|NCT01020799|54578514|FG000|Overall Study|Lost to Follow-up|6|||
27921287|NCT01020799|54578515|FG001|Overall Study|Lost to Follow-up|4|||
27921288|NCT01020799|54578516|FG002|Overall Study|Lost to Follow-up|2|||
27921289|NCT01288989|54578529|FG000|Overall Study|Death|0|||
27921290|NCT01288989|54578530|FG001|Overall Study|Death|0|||
27921291|NCT01288989|54578531|FG002|Overall Study|Death|0|||
27921292|NCT01288989|54578532|FG003|Overall Study|Death|1|||
27921293|NCT01288989|54578533|FG004|Overall Study|Death|0|||
27921294|NCT01288989|54578529|FG000|Overall Study|Dose limiting toxicity|1|||
27921295|NCT01288989|54578530|FG001|Overall Study|Dose limiting toxicity|0|||
27921296|NCT01288989|54578531|FG002|Overall Study|Dose limiting toxicity|0|||
27921297|NCT01288989|54578532|FG003|Overall Study|Dose limiting toxicity|0|||
27921298|NCT01288989|54578533|FG004|Overall Study|Dose limiting toxicity|0|||
27921299|NCT01288989|54578529|FG000|Overall Study|Adverse Event|0|||
27921300|NCT01288989|54578530|FG001|Overall Study|Adverse Event|0|||
27921301|NCT01288989|54578531|FG002|Overall Study|Adverse Event|0|||
27921302|NCT01288989|54578532|FG003|Overall Study|Adverse Event|0|||
27921303|NCT01288989|54578533|FG004|Overall Study|Adverse Event|2|||
27921304|NCT01288989|54578529|FG000|Overall Study|Physician Decision|0|||
27921305|NCT01288989|54578530|FG001|Overall Study|Physician Decision|0|||
27921306|NCT01288989|54578531|FG002|Overall Study|Physician Decision|0|||
27921307|NCT01288989|54578532|FG003|Overall Study|Physician Decision|0|||
27921308|NCT01288989|54578533|FG004|Overall Study|Physician Decision|1|||
27921309|NCT01288989|54578529|FG000|Overall Study|Withdrawal by Subject|0|||
27921310|NCT01288989|54578530|FG001|Overall Study|Withdrawal by Subject|0|||
27921311|NCT01288989|54578531|FG002|Overall Study|Withdrawal by Subject|0|||
27921312|NCT01288989|54578532|FG003|Overall Study|Withdrawal by Subject|0|||
27921313|NCT01288989|54578533|FG004|Overall Study|Withdrawal by Subject|3|||
27921314|NCT01020487|54578554|FG000|Part 2 Double-blind Treatment Period|Adverse Event|0|||
27921315|NCT01020487|54578555|FG001|Part 2 Double-blind Treatment Period|Adverse Event|2|||
27921316|NCT01020487|54578556|FG002|Part 2 Double-blind Treatment Period|Adverse Event|1|||
27921317|NCT01020487|54578554|FG000|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
27921318|NCT01020487|54578555|FG001|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
27921319|NCT01020487|54578556|FG002|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1|||
27921320|NCT01020487|54578554|FG000|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
27921321|NCT01020487|54578555|FG001|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
27921322|NCT01020487|54578556|FG002|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3|||
27921323|NCT01020487|54578554|FG000|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
27921324|NCT01020487|54578555|FG001|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
27921325|NCT01020487|54578556|FG002|Part 2 Double-blind Treatment Period|Randomized in Error|1|||
27921326|NCT01020487|54578554|FG000|Part 2 Open-label Period|Adverse Event|0|||
27921327|NCT01020487|54578555|FG001|Part 2 Open-label Period|Adverse Event|4|||
27921328|NCT01020487|54578556|FG002|Part 2 Open-label Period|Adverse Event|1|||
27921329|NCT01024855|54578566|FG000|Overall Study|Inclusion/exclusion criteria|1|||
27921330|NCT01014013|54578573|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
27921331|NCT01014013|54578574|FG001|Overall Study|Inclusion/Exclusion criteria not met|3|||
27921332|NCT01014013|54578573|FG000|Overall Study|Clinical adverse experience|4|||
27921333|NCT01014013|54578574|FG001|Overall Study|Clinical adverse experience|2|||
27921334|NCT01014013|54578573|FG000|Overall Study|Laboratory adverse experience|1|||
27921335|NCT01014013|54578574|FG001|Overall Study|Laboratory adverse experience|1|||
27921336|NCT01014013|54578573|FG000|Overall Study|Protocol Violation|1|||
27921337|NCT01014013|54578574|FG001|Overall Study|Protocol Violation|3|||
27921338|NCT01014013|54578573|FG000|Overall Study|Withdrawal by Subject|7|||
27921339|NCT01014013|54578574|FG001|Overall Study|Withdrawal by Subject|4|||
27921340|NCT01014013|54578573|FG000|Overall Study|Clinical/microbiologic failure|1|||
27921341|NCT01014013|54578574|FG001|Overall Study|Clinical/microbiologic failure|2|||
27921342|NCT01014013|54578573|FG000|Overall Study|Pathogen culture = no growth|26|||
27921343|NCT01014013|54578574|FG001|Overall Study|Pathogen culture = no growth|34|||
27921344|NCT01014013|54578573|FG000|Overall Study|Negative urine culture|2|||
27921345|NCT01014013|54578574|FG001|Overall Study|Negative urine culture|0|||
27921346|NCT01014013|54578573|FG000|Overall Study|Pathogen resistant|7|||
27921347|NCT01014013|54578574|FG001|Overall Study|Pathogen resistant|4|||
27921348|NCT01014013|54578573|FG000|Overall Study|Physician Decision|0|||
27921349|NCT01014013|54578574|FG001|Overall Study|Physician Decision|1|||
27921350|NCT01014013|54578573|FG000|Overall Study|Another antibiotic therapy required|0|||
27921351|NCT01014013|54578574|FG001|Overall Study|Another antibiotic therapy required|1|||
27921352|NCT01014013|54578573|FG000|Overall Study|Appendectomy|1|||
27921353|NCT01014013|54578574|FG001|Overall Study|Appendectomy|0|||
27921354|NCT01014013|54578573|FG000|Overall Study|Inappropriate therapy duration, < 7 Days|0|||
27921355|NCT01014013|54578574|FG001|Overall Study|Inappropriate therapy duration, < 7 Days|1|||
27921356|NCT01013701|54578582|FG000|Overall Study|study prematurely terminated|7|||
27921357|NCT01020019|54578589|FG000|Overall Study|Lost to Follow-up|21|||
27921358|NCT01020019|54578590|FG001|Overall Study|Lost to Follow-up|18|||
27921359|NCT01020019|54578589|FG000|Overall Study|Adverse Event|1|||
27921360|NCT01020019|54578590|FG001|Overall Study|Adverse Event|5|||
27921361|NCT01020019|54578589|FG000|Overall Study|not interested in treatment|4|||
27921362|NCT01020019|54578590|FG001|Overall Study|not interested in treatment|4|||
27921363|NCT01020019|54578589|FG000|Overall Study|moving|0|||
27921364|NCT01020019|54578590|FG001|Overall Study|moving|2|||
27921365|NCT01024465|54578596|FG000|Overall Study|Adverse Event|2|||
27921366|NCT01024465|54578596|FG000|Overall Study|Physician Decision|1|||
27921367|NCT01024387|54578600|FG000|Overall Study|Radiographic Progression|29|||
27921368|NCT01024387|54578600|FG000|Overall Study|Symptomatic Progression|10|||
27921369|NCT01024387|54578600|FG000|Overall Study|Physician Decision|5|||
27921370|NCT01024387|54578600|FG000|Overall Study|Withdrawal by Subject|5|||
27921371|NCT01024387|54578600|FG000|Overall Study|Death|2|||
27921372|NCT01024387|54578600|FG000|Overall Study|Prolonged Treatment Delay|1|||
27921373|NCT01024387|54578600|FG000|Overall Study|Adverse Event|3|||
27921374|NCT01024387|54578600|FG000|Overall Study|Other|5|||
27921375|NCT01019317|54578604|FG000|Overall Study|Not Eligible|4|||
27921376|NCT01024309|54578610|FG000|Overall Study|Physician Decision|4|||
27921377|NCT01024309|54578611|FG001|Overall Study|Physician Decision|0|||
27921378|NCT01024309|54578610|FG000|Overall Study|Withdrawal by Subject|4|||
27921379|NCT01024309|54578611|FG001|Overall Study|Withdrawal by Subject|4|||
27921380|NCT01090492|54578625|FG000|First Intervention Period (4 Weeks)|Protocol Violation|1|||
27921381|NCT01090492|54578626|FG001|First Intervention Period (4 Weeks)|Protocol Violation|1|||
27921382|NCT01090492|54578627|FG002|First Intervention Period (4 Weeks)|Protocol Violation|1|||
27921383|NCT01090492|54578628|FG003|First Intervention Period (4 Weeks)|Protocol Violation|2|||
27921384|NCT01090492|54578629|FG004|First Intervention Period (4 Weeks)|Protocol Violation|0|||
27921385|NCT01090492|54578630|FG005|First Intervention Period (4 Weeks)|Protocol Violation|0|||
27921386|NCT01090492|54578631|FG006|First Intervention Period (4 Weeks)|Protocol Violation|1|||
27921387|NCT01090492|54578632|FG007|First Intervention Period (4 Weeks)|Protocol Violation|0|||
27921388|NCT01090492|54578625|FG000|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
27921389|NCT01090492|54578626|FG001|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2|||
27921390|NCT01090492|54578627|FG002|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
27921391|NCT01090492|54578628|FG003|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
27921392|NCT01090492|54578629|FG004|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
27921393|NCT01090492|54578630|FG005|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
27921394|NCT01090492|54578631|FG006|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
27921395|NCT01090492|54578632|FG007|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1|||
27921396|NCT01090492|54578625|FG000|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
27921397|NCT01090492|54578626|FG001|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
27921398|NCT01090492|54578627|FG002|First Intervention Period (4 Weeks)|Lost to Follow-up|1|||
27921399|NCT01090492|54578628|FG003|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
27921400|NCT01090492|54578629|FG004|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
27921401|NCT01090492|54578630|FG005|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
27921402|NCT01090492|54578631|FG006|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
27921403|NCT01090492|54578632|FG007|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
27921404|NCT01090492|54578625|FG000|First Intervention Period (4 Weeks)|Other|0|||
27921405|NCT01090492|54578626|FG001|First Intervention Period (4 Weeks)|Other|0|||
27921406|NCT01090492|54578627|FG002|First Intervention Period (4 Weeks)|Other|1|||
27921407|NCT01090492|54578628|FG003|First Intervention Period (4 Weeks)|Other|1|||
27921408|NCT01090492|54578629|FG004|First Intervention Period (4 Weeks)|Other|2|||
27921409|NCT01090492|54578630|FG005|First Intervention Period (4 Weeks)|Other|0|||
27921410|NCT01090492|54578631|FG006|First Intervention Period (4 Weeks)|Other|0|||
27921411|NCT01090492|54578632|FG007|First Intervention Period (4 Weeks)|Other|0|||
27921412|NCT01090492|54578625|FG000|First Intervention Period (4 Weeks)|Pregnancy|0|||
27921413|NCT01090492|54578626|FG001|First Intervention Period (4 Weeks)|Pregnancy|0|||
27921414|NCT01090492|54578627|FG002|First Intervention Period (4 Weeks)|Pregnancy|0|||
27921415|NCT01090492|54578628|FG003|First Intervention Period (4 Weeks)|Pregnancy|0|||
27921416|NCT01090492|54578629|FG004|First Intervention Period (4 Weeks)|Pregnancy|1|||
27921417|NCT01090492|54578630|FG005|First Intervention Period (4 Weeks)|Pregnancy|0|||
27921418|NCT01090492|54578631|FG006|First Intervention Period (4 Weeks)|Pregnancy|0|||
27921419|NCT01090492|54578632|FG007|First Intervention Period (4 Weeks)|Pregnancy|0|||
27921420|NCT01090492|54578625|FG000|First Intervention Period (4 Weeks)|Adverse Event|0|||
28012879|NCT00408421|54671635|FG002|Treatment Initial Randomization|Lost to Follow-up|0|||
28012880|NCT00408421|54671633|FG000|Treatment Initial Randomization|Physician Decision|1|||
27921421|NCT01090492|54578626|FG001|First Intervention Period (4 Weeks)|Adverse Event|2|||
27921422|NCT01090492|54578627|FG002|First Intervention Period (4 Weeks)|Adverse Event|0|||
27921423|NCT01090492|54578628|FG003|First Intervention Period (4 Weeks)|Adverse Event|3|||
27921424|NCT01090492|54578629|FG004|First Intervention Period (4 Weeks)|Adverse Event|1|||
27921425|NCT01090492|54578630|FG005|First Intervention Period (4 Weeks)|Adverse Event|2|||
27921426|NCT01090492|54578631|FG006|First Intervention Period (4 Weeks)|Adverse Event|0|||
27921427|NCT01090492|54578632|FG007|First Intervention Period (4 Weeks)|Adverse Event|5|||
27921428|NCT01090492|54578625|FG000|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
27921429|NCT01090492|54578626|FG001|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
27921430|NCT01090492|54578627|FG002|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
27921431|NCT01090492|54578628|FG003|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
27921432|NCT01090492|54578629|FG004|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
27921433|NCT01090492|54578630|FG005|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
27921434|NCT01090492|54578631|FG006|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
27921435|NCT01090492|54578632|FG007|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
27921436|NCT01090492|54578625|FG000|Second Intervention Period (4 Weeks)|Non-compliance|0|||
27921437|NCT01090492|54578626|FG001|Second Intervention Period (4 Weeks)|Non-compliance|1|||
27921438|NCT01090492|54578627|FG002|Second Intervention Period (4 Weeks)|Non-compliance|0|||
27921439|NCT01090492|54578628|FG003|Second Intervention Period (4 Weeks)|Non-compliance|0|||
27921440|NCT01090492|54578629|FG004|Second Intervention Period (4 Weeks)|Non-compliance|0|||
27921441|NCT01090492|54578630|FG005|Second Intervention Period (4 Weeks)|Non-compliance|0|||
27921442|NCT01090492|54578631|FG006|Second Intervention Period (4 Weeks)|Non-compliance|0|||
27921443|NCT01090492|54578632|FG007|Second Intervention Period (4 Weeks)|Non-compliance|0|||
27921444|NCT01090492|54578625|FG000|Second Intervention Period (4 Weeks)|Other|0|||
27921445|NCT01090492|54578626|FG001|Second Intervention Period (4 Weeks)|Other|1|||
27921446|NCT01090492|54578627|FG002|Second Intervention Period (4 Weeks)|Other|1|||
27921447|NCT01090492|54578628|FG003|Second Intervention Period (4 Weeks)|Other|0|||
27921448|NCT01090492|54578629|FG004|Second Intervention Period (4 Weeks)|Other|0|||
27921449|NCT01090492|54578630|FG005|Second Intervention Period (4 Weeks)|Other|0|||
27921450|NCT01090492|54578631|FG006|Second Intervention Period (4 Weeks)|Other|0|||
27921451|NCT01090492|54578632|FG007|Second Intervention Period (4 Weeks)|Other|0|||
27921452|NCT01090492|54578625|FG000|Second Intervention Period (4 Weeks)|Adverse Event|0|||
27921453|NCT01090492|54578626|FG001|Second Intervention Period (4 Weeks)|Adverse Event|0|||
27921454|NCT01090492|54578627|FG002|Second Intervention Period (4 Weeks)|Adverse Event|1|||
27921455|NCT01090492|54578628|FG003|Second Intervention Period (4 Weeks)|Adverse Event|0|||
27921456|NCT01090492|54578629|FG004|Second Intervention Period (4 Weeks)|Adverse Event|1|||
27921457|NCT01090492|54578630|FG005|Second Intervention Period (4 Weeks)|Adverse Event|1|||
27921458|NCT01090492|54578631|FG006|Second Intervention Period (4 Weeks)|Adverse Event|7|||
27921459|NCT01090492|54578632|FG007|Second Intervention Period (4 Weeks)|Adverse Event|1|||
27921460|NCT01090492|54578625|FG000|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
27921461|NCT01090492|54578626|FG001|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
27921462|NCT01090492|54578627|FG002|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
27921463|NCT01090492|54578628|FG003|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
27921464|NCT01090492|54578629|FG004|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
27921465|NCT01090492|54578630|FG005|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
27921466|NCT01090492|54578631|FG006|Second Intervention Period (4 Weeks)|Lost to Follow-up|1|||
27921467|NCT01090492|54578632|FG007|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
27921468|NCT01288911|54578653|FG000|Double-blind Period|Death|11|||
27921469|NCT01288911|54578654|FG001|Double-blind Period|Death|7|||
27921470|NCT01288911|54578653|FG000|Double-blind Period|Lost to Follow-up|0|||
27921471|NCT01288911|54578654|FG001|Double-blind Period|Lost to Follow-up|2|||
27921472|NCT01288911|54578653|FG000|Double-blind Period|Progressive Disease|75|||
27921473|NCT01288911|54578654|FG001|Double-blind Period|Progressive Disease|103|||
27921474|NCT01288911|54578653|FG000|Double-blind Period|Protocol Violation|1|||
27921475|NCT01288911|54578654|FG001|Double-blind Period|Protocol Violation|0|||
27921476|NCT01288911|54578653|FG000|Double-blind Period|Withdrawal by Subject|25|||
27921477|NCT01288911|54578654|FG001|Double-blind Period|Withdrawal by Subject|26|||
27921478|NCT01288911|54578653|FG000|Double-blind Period|Miscellaneous Reason|29|||
27921479|NCT01288911|54578654|FG001|Double-blind Period|Miscellaneous Reason|42|||
27921480|NCT01288911|54578653|FG000|Double-blind Period|Randomized but never received study drug|1|||
27921481|NCT01288911|54578654|FG001|Double-blind Period|Randomized but never received study drug|2|||
27921482|NCT01288911|54578653|FG000|Open-label Period (All Enzalutamide)|Death|0|||
27921483|NCT01288911|54578654|FG001|Open-label Period (All Enzalutamide)|Death|1|||
27921484|NCT01288911|54578653|FG000|Open-label Period (All Enzalutamide)|Lost to Follow-up|1|||
27921485|NCT01288911|54578654|FG001|Open-label Period (All Enzalutamide)|Lost to Follow-up|0|||
27921486|NCT01288911|54578653|FG000|Open-label Period (All Enzalutamide)|Progressive disease|18|||
27921487|NCT01288911|54578654|FG001|Open-label Period (All Enzalutamide)|Progressive disease|3|||
27921488|NCT01288911|54578653|FG000|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1|||
27921489|NCT01288911|54578654|FG001|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0|||
27921490|NCT01288911|54578653|FG000|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5|||
27921491|NCT01288911|54578654|FG001|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0|||
27921492|NCT01288911|54578653|FG000|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17|||
27921493|NCT01288911|54578654|FG001|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5|||
27921494|NCT01288443|54578669|FG000|Overall Study|Adverse Event|0|||
27921495|NCT01288443|54578670|FG001|Overall Study|Adverse Event|0|||
27921496|NCT01288443|54578671|FG002|Overall Study|Adverse Event|1|||
27921497|NCT01288443|54578672|FG003|Overall Study|Adverse Event|1|||
27921498|NCT01288443|54578673|FG004|Overall Study|Adverse Event|3|||
27921499|NCT01288443|54578674|FG005|Overall Study|Adverse Event|1|||
27921500|NCT01288443|54578669|FG000|Overall Study|Poor compliance to protocol|0|||
27921501|NCT01288443|54578670|FG001|Overall Study|Poor compliance to protocol|0|||
27921502|NCT01288443|54578671|FG002|Overall Study|Poor compliance to protocol|0|||
27921503|NCT01288443|54578672|FG003|Overall Study|Poor compliance to protocol|0|||
27921504|NCT01288443|54578673|FG004|Overall Study|Poor compliance to protocol|0|||
27921505|NCT01288443|54578674|FG005|Overall Study|Poor compliance to protocol|1|||
27921506|NCT01288443|54578669|FG000|Overall Study|Participant Moved|0|||
27921507|NCT01288443|54578670|FG001|Overall Study|Participant Moved|0|||
27921508|NCT01288443|54578671|FG002|Overall Study|Participant Moved|0|||
27921509|NCT01288443|54578672|FG003|Overall Study|Participant Moved|1|||
27921510|NCT01288443|54578673|FG004|Overall Study|Participant Moved|2|||
27921511|NCT01288443|54578674|FG005|Overall Study|Participant Moved|1|||
27921512|NCT01288443|54578669|FG000|Overall Study|Consent withdrawn by Participant|0|||
27921513|NCT01288443|54578670|FG001|Overall Study|Consent withdrawn by Participant|0|||
27921514|NCT01288443|54578671|FG002|Overall Study|Consent withdrawn by Participant|0|||
27921515|NCT01288443|54578672|FG003|Overall Study|Consent withdrawn by Participant|0|||
27921516|NCT01288443|54578673|FG004|Overall Study|Consent withdrawn by Participant|0|||
27921517|NCT01288443|54578674|FG005|Overall Study|Consent withdrawn by Participant|1|||
27921518|NCT01288443|54578669|FG000|Overall Study|Lost to Follow-up|0|||
27921519|NCT01288443|54578670|FG001|Overall Study|Lost to Follow-up|1|||
27921520|NCT01288443|54578671|FG002|Overall Study|Lost to Follow-up|0|||
27921521|NCT01288443|54578672|FG003|Overall Study|Lost to Follow-up|0|||
27921522|NCT01288443|54578673|FG004|Overall Study|Lost to Follow-up|0|||
27921523|NCT01288443|54578674|FG005|Overall Study|Lost to Follow-up|0|||
27921524|NCT01288443|54578669|FG000|Overall Study|Study drug auto-injector administration|0|||
27921525|NCT01288443|54578670|FG001|Overall Study|Study drug auto-injector administration|0|||
27921526|NCT01288443|54578671|FG002|Overall Study|Study drug auto-injector administration|0|||
27921527|NCT01288443|54578672|FG003|Overall Study|Study drug auto-injector administration|0|||
27921528|NCT01288443|54578673|FG004|Overall Study|Study drug auto-injector administration|1|||
27921529|NCT01288443|54578674|FG005|Overall Study|Study drug auto-injector administration|1|||
27921530|NCT01288443|54578669|FG000|Overall Study|Other than above|0|||
27921531|NCT01288443|54578670|FG001|Overall Study|Other than above|0|||
27921532|NCT01288443|54578671|FG002|Overall Study|Other than above|0|||
27921533|NCT01288443|54578672|FG003|Overall Study|Other than above|2|||
27921534|NCT01288443|54578673|FG004|Overall Study|Other than above|1|||
27921535|NCT01288443|54578674|FG005|Overall Study|Other than above|0|||
27921536|NCT01288287|54578688|FG000|Overall Study|Lost to Follow-up|8|||
27921537|NCT01288287|54578688|FG000|Overall Study|Withdrawal by Subject|4|||
27921538|NCT01288287|54578688|FG000|Overall Study|Lack of Efficacy|13|||
27921539|NCT01288287|54578688|FG000|Overall Study|Other Reason|13|||
27921540|NCT01288287|54578688|FG000|Overall Study|Unknown Reason|1|||
27921541|NCT01288287|54578688|FG000|Overall Study|Unknown Status|7|||
27921542|NCT01288209|54578695|FG000|Overall Study|Withdrawal by Subject|1|||
27921543|NCT01288209|54578696|FG001|Overall Study|Withdrawal by Subject|3|||
27921544|NCT01288209|54578695|FG000|Overall Study|Other|1|||
27921545|NCT01288209|54578696|FG001|Overall Study|Other|0|||
27921546|NCT01288053|54578702|FG000|Overall Study|Death|1|||
27921547|NCT01287195|54578706|FG000|Overall Study|Withdrawal by Subject|2|||
27921548|NCT01287117|54578714|FG000|Overall Study|Adverse Event|2|||
27921549|NCT01287117|54578715|FG001|Overall Study|Adverse Event|1|||
27921550|NCT01287117|54578716|FG002|Overall Study|Adverse Event|1|||
27921551|NCT01287117|54578717|FG003|Overall Study|Adverse Event|1|||
27921552|NCT01287117|54578714|FG000|Overall Study|Lost to Follow-up|1|||
27921553|NCT01287117|54578715|FG001|Overall Study|Lost to Follow-up|1|||
27921554|NCT01287117|54578716|FG002|Overall Study|Lost to Follow-up|0|||
27921555|NCT01287117|54578717|FG003|Overall Study|Lost to Follow-up|0|||
27921556|NCT01287117|54578714|FG000|Overall Study|Physician Decision|0|||
27921557|NCT01287117|54578715|FG001|Overall Study|Physician Decision|1|||
27921558|NCT01287117|54578716|FG002|Overall Study|Physician Decision|1|||
28012881|NCT00408421|54671634|FG001|Treatment Initial Randomization|Physician Decision|0|||
27921559|NCT01287117|54578717|FG003|Overall Study|Physician Decision|1|||
27921560|NCT01287117|54578714|FG000|Overall Study|Patient/Legal Guardian's Decision|2|||
27921561|NCT01287117|54578715|FG001|Overall Study|Patient/Legal Guardian's Decision|6|||
27921562|NCT01287117|54578716|FG002|Overall Study|Patient/Legal Guardian's Decision|8|||
27921563|NCT01287117|54578717|FG003|Overall Study|Patient/Legal Guardian's Decision|5|||
27921564|NCT01287117|54578714|FG000|Overall Study|Disease Progression|10|||
27921565|NCT01287117|54578715|FG001|Overall Study|Disease Progression|5|||
28012882|NCT00408421|54671635|FG002|Treatment Initial Randomization|Physician Decision|0|||
27921566|NCT01287117|54578716|FG002|Overall Study|Disease Progression|6|||
27921567|NCT01287117|54578717|FG003|Overall Study|Disease Progression|5|||
27921568|NCT01287039|54578729|FG000|Overall Study|Noncompliance with study procedures|0|||
27921569|NCT01287039|54578730|FG001|Overall Study|Noncompliance with study procedures|1|||
27921570|NCT01287039|54578729|FG000|Overall Study|Change of location/residence|0|||
27921571|NCT01287039|54578730|FG001|Overall Study|Change of location/residence|3|||
27921572|NCT01287039|54578729|FG000|Overall Study|Elective surgery|0|||
27921573|NCT01287039|54578730|FG001|Overall Study|Elective surgery|1|||
27921574|NCT01287039|54578729|FG000|Overall Study|Protocol Violation|2|||
27921575|NCT01287039|54578730|FG001|Overall Study|Protocol Violation|3|||
27921576|NCT01287039|54578729|FG000|Overall Study|Excluded medication taken|1|||
27921577|NCT01287039|54578730|FG001|Overall Study|Excluded medication taken|0|||
27921578|NCT01287039|54578729|FG000|Overall Study|Noncompliance with study medication|0|||
27921579|NCT01287039|54578730|FG001|Overall Study|Noncompliance with study medication|1|||
27921580|NCT01287039|54578729|FG000|Overall Study|Problem with travel|0|||
27921581|NCT01287039|54578730|FG001|Overall Study|Problem with travel|1|||
27921582|NCT01287039|54578729|FG000|Overall Study|Death|1|||
27921583|NCT01287039|54578730|FG001|Overall Study|Death|0|||
27921584|NCT01287039|54578729|FG000|Overall Study|Change of residence|1|||
27921585|NCT01287039|54578730|FG001|Overall Study|Change of residence|0|||
27921586|NCT01287039|54578729|FG000|Overall Study|Adverse Event|7|||
27921587|NCT01287039|54578730|FG001|Overall Study|Adverse Event|4|||
27921588|NCT01287039|54578729|FG000|Overall Study|Withdrawal by Subject|14|||
27921589|NCT01287039|54578730|FG001|Overall Study|Withdrawal by Subject|11|||
27921590|NCT01287039|54578729|FG000|Overall Study|Lost to Follow-up|3|||
27921591|NCT01287039|54578730|FG001|Overall Study|Lost to Follow-up|2|||
27921592|NCT01285401|54578738|FG000|Overall Study|Prematurely withdrawn from the study|17|||
27921593|NCT01285401|54578739|FG001|Overall Study|Prematurely withdrawn from the study|29|||
27921594|NCT01285323|54578747|FG000|Overall Study|Adverse Event|9|||
27921595|NCT01285323|54578748|FG001|Overall Study|Adverse Event|8|||
27921596|NCT01285323|54578747|FG000|Overall Study|Lack of Efficacy|4|||
27921597|NCT01285323|54578748|FG001|Overall Study|Lack of Efficacy|2|||
27921598|NCT01285323|54578747|FG000|Overall Study|Withdrawal by Subject|15|||
27921599|NCT01285323|54578748|FG001|Overall Study|Withdrawal by Subject|11|||
27921600|NCT01285323|54578747|FG000|Overall Study|Protocol Violation|1|||
27921601|NCT01285323|54578748|FG001|Overall Study|Protocol Violation|2|||
27921602|NCT01285323|54578747|FG000|Overall Study|Non-compliance with study procedures|2|||
27921603|NCT01285323|54578748|FG001|Overall Study|Non-compliance with study procedures|3|||
27921604|NCT01285323|54578747|FG000|Overall Study|Lost to Follow-up|1|||
27921605|NCT01285323|54578748|FG001|Overall Study|Lost to Follow-up|1|||
27921606|NCT01285323|54578747|FG000|Overall Study|Other|1|||
27921607|NCT01285323|54578748|FG001|Overall Study|Other|3|||
27921608|NCT01284621|54578754|FG000|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
27921609|NCT01284621|54578755|FG001|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
27921610|NCT01284621|54578756|FG002|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
27921611|NCT01284621|54578757|FG003|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
27921612|NCT01284621|54578758|FG004|Washout Period 1 (7 Days)|Required unexpected medical treatment|1|||
27921613|NCT01284621|54578759|FG005|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
27921614|NCT01283139|54578773|FG000|Overall Study|Lost to Follow-up|5|||
27921615|NCT01283139|54578774|FG001|Overall Study|Lost to Follow-up|2|||
27921616|NCT01283139|54578775|FG002|Overall Study|Lost to Follow-up|3|||
27921617|NCT01283139|54578776|FG003|Overall Study|Lost to Follow-up|1|||
27921618|NCT01283139|54578773|FG000|Overall Study|Withdrawal by Subject|8|||
27921619|NCT01283139|54578774|FG001|Overall Study|Withdrawal by Subject|8|||
27921620|NCT01283139|54578775|FG002|Overall Study|Withdrawal by Subject|6|||
27921621|NCT01283139|54578776|FG003|Overall Study|Withdrawal by Subject|8|||
27921622|NCT01283139|54578773|FG000|Overall Study|Death|2|||
27921623|NCT01283139|54578774|FG001|Overall Study|Death|0|||
27921624|NCT01283139|54578775|FG002|Overall Study|Death|2|||
27921625|NCT01283139|54578776|FG003|Overall Study|Death|2|||
27921626|NCT01283139|54578773|FG000|Overall Study|Lack of Efficacy|1|||
27921627|NCT01283139|54578774|FG001|Overall Study|Lack of Efficacy|2|||
27921628|NCT01283139|54578775|FG002|Overall Study|Lack of Efficacy|2|||
27921629|NCT01283139|54578776|FG003|Overall Study|Lack of Efficacy|1|||
27921630|NCT01283139|54578773|FG000|Overall Study|Early termination due to AE/SAE|1|||
27921631|NCT01283139|54578774|FG001|Overall Study|Early termination due to AE/SAE|1|||
27921632|NCT01283139|54578775|FG002|Overall Study|Early termination due to AE/SAE|0|||
27921633|NCT01283139|54578776|FG003|Overall Study|Early termination due to AE/SAE|0|||
27921634|NCT01283139|54578773|FG000|Overall Study|Participant's refusal to continue|0|||
28012883|NCT00408421|54671633|FG000|Treatment Initial Randomization|Protocol Violation|0|||
28012884|NCT00408421|54671634|FG001|Treatment Initial Randomization|Protocol Violation|1|||
28012885|NCT00408421|54671635|FG002|Treatment Initial Randomization|Protocol Violation|0|||
28012886|NCT00408421|54671633|FG000|Treatment Initial Randomization|Withdrawal by Subject|7|||
27921635|NCT01283139|54578774|FG001|Overall Study|Participant's refusal to continue|3|||
27921636|NCT01283139|54578775|FG002|Overall Study|Participant's refusal to continue|1|||
28012887|NCT00408421|54671634|FG001|Treatment Initial Randomization|Withdrawal by Subject|7|||
28012888|NCT00408421|54671635|FG002|Treatment Initial Randomization|Withdrawal by Subject|0|||
27921637|NCT01283139|54578776|FG003|Overall Study|Participant's refusal to continue|1|||
27921638|NCT01283139|54578773|FG000|Overall Study|Pregnancy|0|||
27921639|NCT01283139|54578774|FG001|Overall Study|Pregnancy|1|||
27921640|NCT01283139|54578775|FG002|Overall Study|Pregnancy|1|||
27921641|NCT01283139|54578776|FG003|Overall Study|Pregnancy|0|||
27921642|NCT01283139|54578773|FG000|Overall Study|Missed follow-up visit|0|||
27921643|NCT01283139|54578774|FG001|Overall Study|Missed follow-up visit|1|||
27921644|NCT01283139|54578775|FG002|Overall Study|Missed follow-up visit|2|||
27921645|NCT01283139|54578776|FG003|Overall Study|Missed follow-up visit|2|||
27921646|NCT01283139|54578773|FG000|Overall Study|Participant randomized in error|0|||
27921647|NCT01283139|54578774|FG001|Overall Study|Participant randomized in error|0|||
27921648|NCT01283139|54578775|FG002|Overall Study|Participant randomized in error|1|||
27921649|NCT01283139|54578776|FG003|Overall Study|Participant randomized in error|0|||
27921650|NCT01282203|54578786|FG000|Overall Study|Adverse Event|1|||
27921651|NCT01281969|54578795|FG000|Overall Study|not randomized didn't meet criteria|0|||
27921652|NCT01281969|54578796|FG001|Overall Study|not randomized didn't meet criteria|0|||
27921653|NCT01281969|54578797|FG002|Overall Study|not randomized didn't meet criteria|7|||
27921654|NCT01281969|54578795|FG000|Overall Study|AE during LP prior to IVIG admin|1|||
27921655|NCT01281969|54578796|FG001|Overall Study|AE during LP prior to IVIG admin|0|||
27921656|NCT01281969|54578797|FG002|Overall Study|AE during LP prior to IVIG admin|3|||
27921657|NCT01281969|54578795|FG000|Overall Study|not randomized, child consent not given|0|||
27921658|NCT01281969|54578796|FG001|Overall Study|not randomized, child consent not given|0|||
27921659|NCT01281969|54578797|FG002|Overall Study|not randomized, child consent not given|2|||
27921660|NCT01281813|54578808|FG000|Overall Study|Adverse Event|0|||
27921661|NCT01281813|54578809|FG001|Overall Study|Adverse Event|0|||
27921662|NCT01281813|54578810|FG002|Overall Study|Adverse Event|10|||
27921663|NCT01281813|54578808|FG000|Overall Study|Lost to Follow-up|0|||
27921664|NCT01281813|54578809|FG001|Overall Study|Lost to Follow-up|0|||
27921665|NCT01281813|54578810|FG002|Overall Study|Lost to Follow-up|31|||
27921666|NCT01281813|54578808|FG000|Overall Study|Withdrawal by Subject|0|||
27921667|NCT01281813|54578809|FG001|Overall Study|Withdrawal by Subject|0|||
27921668|NCT01281813|54578810|FG002|Overall Study|Withdrawal by Subject|13|||
27921669|NCT01281813|54578808|FG000|Overall Study|Subject Non-Compliant|0|||
27921670|NCT01281813|54578809|FG001|Overall Study|Subject Non-Compliant|0|||
27921671|NCT01281813|54578810|FG002|Overall Study|Subject Non-Compliant|6|||
27921672|NCT01281813|54578808|FG000|Overall Study|Subject Reached A Virologic Endpoint|0|||
27921673|NCT01281813|54578809|FG001|Overall Study|Subject Reached A Virologic Endpoint|0|||
27921674|NCT01281813|54578810|FG002|Overall Study|Subject Reached A Virologic Endpoint|5|||
27921675|NCT01281813|54578808|FG000|Overall Study|Sponsor's Decision|4|||
27921676|NCT01281813|54578809|FG001|Overall Study|Sponsor's Decision|3|||
27921677|NCT01281813|54578810|FG002|Overall Study|Sponsor's Decision|7|||
27921678|NCT01281813|54578808|FG000|Overall Study|Switched to Commercially Available Medication|0|||
27921679|NCT01281813|54578809|FG001|Overall Study|Switched to Commercially Available Medication|0|||
27921680|NCT01281813|54578810|FG002|Overall Study|Switched to Commercially Available Medication|26|||
27921681|NCT01281813|54578808|FG000|Overall Study|Other|0|||
27921682|NCT01281813|54578809|FG001|Overall Study|Other|1|||
27921683|NCT01281813|54578810|FG002|Overall Study|Other|39|||
27921684|NCT01090414|54578822|FG000|Study 101-99|Progressive Disease|28|||
27921685|NCT01090414|54578823|FG001|Study 101-99|Progressive Disease|48|||
27921686|NCT01090414|54578824|FG002|Study 101-99|Progressive Disease|10|||
27921687|NCT01090414|54578825|FG003|Study 101-99|Progressive Disease|4|||
27921688|NCT01090414|54578822|FG000|Study 101-99|Adverse Event|10|||
27921689|NCT01090414|54578823|FG001|Study 101-99|Adverse Event|28|||
27921690|NCT01090414|54578824|FG002|Study 101-99|Adverse Event|18|||
27921691|NCT01090414|54578825|FG003|Study 101-99|Adverse Event|0|||
27921692|NCT01090414|54578822|FG000|Study 101-99|Investigator Request|1|||
27921693|NCT01090414|54578823|FG001|Study 101-99|Investigator Request|11|||
27921694|NCT01090414|54578824|FG002|Study 101-99|Investigator Request|4|||
27921695|NCT01090414|54578825|FG003|Study 101-99|Investigator Request|0|||
27921696|NCT01090414|54578822|FG000|Study 101-99|Death|3|||
27921697|NCT01090414|54578823|FG001|Study 101-99|Death|8|||
27921698|NCT01090414|54578824|FG002|Study 101-99|Death|1|||
27921699|NCT01090414|54578825|FG003|Study 101-99|Death|0|||
27921700|NCT01090414|54578822|FG000|Study 101-99|Sponsor Discontinued Study|0|||
27921701|NCT01090414|54578823|FG001|Study 101-99|Sponsor Discontinued Study|7|||
27921702|NCT01090414|54578824|FG002|Study 101-99|Sponsor Discontinued Study|5|||
27921703|NCT01090414|54578825|FG003|Study 101-99|Sponsor Discontinued Study|0|||
27921704|NCT01090414|54578822|FG000|Study 101-99|Other (Unknown Reasons)|3|||
27921705|NCT01090414|54578823|FG001|Study 101-99|Other (Unknown Reasons)|3|||
27921706|NCT01090414|54578824|FG002|Study 101-99|Other (Unknown Reasons)|0|||
27921707|NCT01090414|54578825|FG003|Study 101-99|Other (Unknown Reasons)|0|||
27921708|NCT01090414|54578822|FG000|Study 101-99|Withdrew Consent|0|||
27921709|NCT01090414|54578823|FG001|Study 101-99|Withdrew Consent|2|||
27921710|NCT01090414|54578824|FG002|Study 101-99|Withdrew Consent|3|||
27921711|NCT01090414|54578825|FG003|Study 101-99|Withdrew Consent|1|||
27921712|NCT01090414|54578822|FG000|Study 101-99|Participant Request|3|||
27921713|NCT01090414|54578823|FG001|Study 101-99|Participant Request|1|||
27921714|NCT01090414|54578824|FG002|Study 101-99|Participant Request|0|||
27921715|NCT01090414|54578825|FG003|Study 101-99|Participant Request|0|||
27921716|NCT01090102|54578849|FG000|First 12 Weeks|Withdrawal by Subject|1|||
27921717|NCT01090102|54578850|FG001|First 12 Weeks|Withdrawal by Subject|1|||
27921718|NCT01090102|54578849|FG000|First 12 Weeks|Adverse Event|2|||
27921719|NCT01090102|54578850|FG001|First 12 Weeks|Adverse Event|0|||
27921720|NCT01090102|54578849|FG000|First 12 Weeks|Death|1|||
27921721|NCT01090102|54578850|FG001|First 12 Weeks|Death|1|||
27921722|NCT01090102|54578849|FG000|Second 12 Weeks|Withdrawal by Subject|0|||
27921723|NCT01090102|54578850|FG001|Second 12 Weeks|Withdrawal by Subject|1|||
27921724|NCT01287897|54578860|FG000|Overall Study|Adverse Event|5|||
27921725|NCT01287897|54578861|FG001|Overall Study|Adverse Event|3|||
27921726|NCT01287897|54578862|FG002|Overall Study|Adverse Event|6|||
27921727|NCT01287897|54578863|FG003|Overall Study|Adverse Event|4|||
27921728|NCT01287897|54578860|FG000|Overall Study|Lack of Efficacy|2|||
27921729|NCT01287897|54578861|FG001|Overall Study|Lack of Efficacy|0|||
27921730|NCT01287897|54578862|FG002|Overall Study|Lack of Efficacy|0|||
27921731|NCT01287897|54578863|FG003|Overall Study|Lack of Efficacy|0|||
27921732|NCT01287897|54578860|FG000|Overall Study|Protocol Violation|1|||
27921733|NCT01287897|54578861|FG001|Overall Study|Protocol Violation|1|||
27921734|NCT01287897|54578862|FG002|Overall Study|Protocol Violation|0|||
27921735|NCT01287897|54578863|FG003|Overall Study|Protocol Violation|1|||
27921736|NCT01287897|54578860|FG000|Overall Study|Lost to Follow-up|0|||
27921737|NCT01287897|54578861|FG001|Overall Study|Lost to Follow-up|0|||
27921738|NCT01287897|54578862|FG002|Overall Study|Lost to Follow-up|2|||
27921739|NCT01287897|54578863|FG003|Overall Study|Lost to Follow-up|0|||
27921740|NCT01287897|54578860|FG000|Overall Study|Withdrawal by Subject|1|||
27921741|NCT01287897|54578861|FG001|Overall Study|Withdrawal by Subject|5|||
27921742|NCT01287897|54578862|FG002|Overall Study|Withdrawal by Subject|3|||
27921743|NCT01287897|54578863|FG003|Overall Study|Withdrawal by Subject|2|||
27921744|NCT01287897|54578860|FG000|Overall Study|Not consented properly|0|||
27921745|NCT01287897|54578861|FG001|Overall Study|Not consented properly|1|||
27921746|NCT01287897|54578862|FG002|Overall Study|Not consented properly|0|||
27921747|NCT01287897|54578863|FG003|Overall Study|Not consented properly|0|||
27921748|NCT01287897|54578860|FG000|Overall Study|Not meeting entrance criteria|1|||
27921749|NCT01287897|54578861|FG001|Overall Study|Not meeting entrance criteria|1|||
27921750|NCT01287897|54578862|FG002|Overall Study|Not meeting entrance criteria|0|||
27921751|NCT01287897|54578863|FG003|Overall Study|Not meeting entrance criteria|0|||
27921752|NCT01287897|54578860|FG000|Overall Study|Other|1|||
27921753|NCT01287897|54578861|FG001|Overall Study|Other|0|||
27921754|NCT01287897|54578862|FG002|Overall Study|Other|1|||
27921755|NCT01287897|54578863|FG003|Overall Study|Other|0|||
27921756|NCT01090024|54578877|FG000|Period 1|Met exclusion criteria|0|||
27921757|NCT01090024|54578878|FG001|Period 1|Met exclusion criteria|0|||
27921758|NCT01090024|54578879|FG002|Period 1|Met exclusion criteria|0|||
27921759|NCT01090024|54578880|FG003|Period 1|Met exclusion criteria|0|||
27921760|NCT01090024|54578881|FG004|Period 1|Met exclusion criteria|0|||
27921761|NCT01090024|54578882|FG005|Period 1|Met exclusion criteria|0|||
27921762|NCT01090024|54578883|FG006|Period 1|Met exclusion criteria|0|||
27921763|NCT01090024|54578884|FG007|Period 1|Met exclusion criteria|0|||
27921764|NCT01090024|54578885|FG008|Period 1|Met exclusion criteria|0|||
27921765|NCT01090024|54578886|FG009|Period 1|Met exclusion criteria|0|||
27921766|NCT01090024|54578887|FG010|Period 1|Met exclusion criteria|0|||
27921767|NCT01090024|54578888|FG011|Period 1|Met exclusion criteria|0|||
27921768|NCT01090024|54578889|FG012|Period 1|Met exclusion criteria|0|||
27921769|NCT01090024|54578890|FG013|Period 1|Met exclusion criteria|0|||
27921770|NCT01090024|54578891|FG014|Period 1|Met exclusion criteria|1|||
27921771|NCT01090024|54578892|FG015|Period 1|Met exclusion criteria|0|||
27921772|NCT01090024|54578893|FG016|Period 1|Met exclusion criteria|0|||
27921773|NCT01090024|54578894|FG017|Period 1|Met exclusion criteria|0|||
27921774|NCT01090024|54578877|FG000|Period 1|Adverse Event|0|||
27921775|NCT01090024|54578878|FG001|Period 1|Adverse Event|0|||
27921776|NCT01090024|54578879|FG002|Period 1|Adverse Event|0|||
27921777|NCT01090024|54578880|FG003|Period 1|Adverse Event|0|||
27921778|NCT01090024|54578881|FG004|Period 1|Adverse Event|0|||
27921779|NCT01090024|54578882|FG005|Period 1|Adverse Event|0|||
27921780|NCT01090024|54578883|FG006|Period 1|Adverse Event|0|||
27921781|NCT01090024|54578884|FG007|Period 1|Adverse Event|0|||
27921782|NCT01090024|54578885|FG008|Period 1|Adverse Event|0|||
27921783|NCT01090024|54578886|FG009|Period 1|Adverse Event|1|||
27921784|NCT01090024|54578887|FG010|Period 1|Adverse Event|0|||
27921785|NCT01090024|54578888|FG011|Period 1|Adverse Event|1|||
27921786|NCT01090024|54578889|FG012|Period 1|Adverse Event|0|||
27921787|NCT01090024|54578890|FG013|Period 1|Adverse Event|0|||
27921788|NCT01090024|54578891|FG014|Period 1|Adverse Event|0|||
27921789|NCT01090024|54578892|FG015|Period 1|Adverse Event|0|||
27921790|NCT01090024|54578893|FG016|Period 1|Adverse Event|0|||
27921791|NCT01090024|54578894|FG017|Period 1|Adverse Event|1|||
27921792|NCT01090024|54578877|FG000|Period 1|Withdrawal by Subject|0|||
27921793|NCT01090024|54578878|FG001|Period 1|Withdrawal by Subject|0|||
27921794|NCT01090024|54578879|FG002|Period 1|Withdrawal by Subject|0|||
27921795|NCT01090024|54578880|FG003|Period 1|Withdrawal by Subject|1|||
27921796|NCT01090024|54578881|FG004|Period 1|Withdrawal by Subject|0|||
27921797|NCT01090024|54578882|FG005|Period 1|Withdrawal by Subject|0|||
27921798|NCT01090024|54578883|FG006|Period 1|Withdrawal by Subject|0|||
27921799|NCT01090024|54578884|FG007|Period 1|Withdrawal by Subject|0|||
27921800|NCT01090024|54578885|FG008|Period 1|Withdrawal by Subject|0|||
27921801|NCT01090024|54578886|FG009|Period 1|Withdrawal by Subject|0|||
27921802|NCT01090024|54578887|FG010|Period 1|Withdrawal by Subject|0|||
27921803|NCT01090024|54578888|FG011|Period 1|Withdrawal by Subject|0|||
27921804|NCT01090024|54578889|FG012|Period 1|Withdrawal by Subject|0|||
27921805|NCT01090024|54578890|FG013|Period 1|Withdrawal by Subject|0|||
27921806|NCT01090024|54578891|FG014|Period 1|Withdrawal by Subject|0|||
27921807|NCT01090024|54578892|FG015|Period 1|Withdrawal by Subject|0|||
27921808|NCT01090024|54578893|FG016|Period 1|Withdrawal by Subject|0|||
27921809|NCT01090024|54578894|FG017|Period 1|Withdrawal by Subject|0|||
27921810|NCT01090024|54578877|FG000|Period 1|Lost to Follow-up|0|||
27921811|NCT01090024|54578878|FG001|Period 1|Lost to Follow-up|1|||
27921812|NCT01090024|54578879|FG002|Period 1|Lost to Follow-up|0|||
27921813|NCT01090024|54578880|FG003|Period 1|Lost to Follow-up|0|||
27921814|NCT01090024|54578881|FG004|Period 1|Lost to Follow-up|0|||
27921815|NCT01090024|54578882|FG005|Period 1|Lost to Follow-up|0|||
27921816|NCT01090024|54578883|FG006|Period 1|Lost to Follow-up|0|||
27921817|NCT01090024|54578884|FG007|Period 1|Lost to Follow-up|0|||
27921818|NCT01090024|54578885|FG008|Period 1|Lost to Follow-up|0|||
27921819|NCT01090024|54578886|FG009|Period 1|Lost to Follow-up|0|||
27921820|NCT01090024|54578887|FG010|Period 1|Lost to Follow-up|0|||
27921821|NCT01090024|54578888|FG011|Period 1|Lost to Follow-up|0|||
27921822|NCT01090024|54578889|FG012|Period 1|Lost to Follow-up|0|||
27921823|NCT01090024|54578890|FG013|Period 1|Lost to Follow-up|0|||
27921824|NCT01090024|54578891|FG014|Period 1|Lost to Follow-up|0|||
27921825|NCT01090024|54578892|FG015|Period 1|Lost to Follow-up|0|||
27921826|NCT01090024|54578893|FG016|Period 1|Lost to Follow-up|0|||
27921827|NCT01090024|54578894|FG017|Period 1|Lost to Follow-up|0|||
27921828|NCT01090024|54578877|FG000|Period 2|Lost to Follow-up|0|||
27921829|NCT01090024|54578878|FG001|Period 2|Lost to Follow-up|0|||
27921830|NCT01090024|54578879|FG002|Period 2|Lost to Follow-up|0|||
27921831|NCT01090024|54578880|FG003|Period 2|Lost to Follow-up|1|||
27921832|NCT01090024|54578881|FG004|Period 2|Lost to Follow-up|0|||
27921833|NCT01090024|54578882|FG005|Period 2|Lost to Follow-up|0|||
27921834|NCT01090024|54578883|FG006|Period 2|Lost to Follow-up|0|||
27921835|NCT01090024|54578884|FG007|Period 2|Lost to Follow-up|0|||
27921836|NCT01090024|54578885|FG008|Period 2|Lost to Follow-up|0|||
27921837|NCT01090024|54578886|FG009|Period 2|Lost to Follow-up|0|||
27921838|NCT01090024|54578887|FG010|Period 2|Lost to Follow-up|0|||
27921839|NCT01090024|54578888|FG011|Period 2|Lost to Follow-up|0|||
27921840|NCT01090024|54578889|FG012|Period 2|Lost to Follow-up|0|||
27921841|NCT01090024|54578890|FG013|Period 2|Lost to Follow-up|0|||
27921842|NCT01090024|54578891|FG014|Period 2|Lost to Follow-up|0|||
27921843|NCT01090024|54578892|FG015|Period 2|Lost to Follow-up|0|||
27921844|NCT01090024|54578893|FG016|Period 2|Lost to Follow-up|0|||
27921845|NCT01090024|54578894|FG017|Period 2|Lost to Follow-up|0|||
27921846|NCT01090024|54578877|FG000|Period 2|Adverse Event|1|||
27921847|NCT01090024|54578878|FG001|Period 2|Adverse Event|0|||
27921848|NCT01090024|54578879|FG002|Period 2|Adverse Event|0|||
27921849|NCT01090024|54578880|FG003|Period 2|Adverse Event|0|||
27921850|NCT01090024|54578881|FG004|Period 2|Adverse Event|0|||
27921851|NCT01090024|54578882|FG005|Period 2|Adverse Event|0|||
27921852|NCT01090024|54578883|FG006|Period 2|Adverse Event|0|||
27921853|NCT01090024|54578884|FG007|Period 2|Adverse Event|0|||
27921854|NCT01090024|54578885|FG008|Period 2|Adverse Event|0|||
27921855|NCT01090024|54578886|FG009|Period 2|Adverse Event|0|||
27921856|NCT01090024|54578887|FG010|Period 2|Adverse Event|0|||
27921857|NCT01090024|54578888|FG011|Period 2|Adverse Event|0|||
27921858|NCT01090024|54578889|FG012|Period 2|Adverse Event|0|||
27921859|NCT01090024|54578890|FG013|Period 2|Adverse Event|0|||
27921860|NCT01090024|54578891|FG014|Period 2|Adverse Event|0|||
27921861|NCT01090024|54578892|FG015|Period 2|Adverse Event|0|||
27921862|NCT01090024|54578893|FG016|Period 2|Adverse Event|0|||
27921863|NCT01090024|54578894|FG017|Period 2|Adverse Event|0|||
27921864|NCT01090024|54578877|FG000|Period 3|Withdrawal by Subject|0|||
27921865|NCT01090024|54578878|FG001|Period 3|Withdrawal by Subject|0|||
27921866|NCT01090024|54578879|FG002|Period 3|Withdrawal by Subject|0|||
27921867|NCT01090024|54578880|FG003|Period 3|Withdrawal by Subject|0|||
27921868|NCT01090024|54578881|FG004|Period 3|Withdrawal by Subject|0|||
27921869|NCT01090024|54578882|FG005|Period 3|Withdrawal by Subject|0|||
27921870|NCT01090024|54578883|FG006|Period 3|Withdrawal by Subject|0|||
27921871|NCT01090024|54578884|FG007|Period 3|Withdrawal by Subject|0|||
27921872|NCT01090024|54578885|FG008|Period 3|Withdrawal by Subject|0|||
27921873|NCT01090024|54578886|FG009|Period 3|Withdrawal by Subject|0|||
27921874|NCT01090024|54578887|FG010|Period 3|Withdrawal by Subject|0|||
27921875|NCT01090024|54578888|FG011|Period 3|Withdrawal by Subject|0|||
27921876|NCT01090024|54578889|FG012|Period 3|Withdrawal by Subject|0|||
27921877|NCT01090024|54578890|FG013|Period 3|Withdrawal by Subject|0|||
27921878|NCT01090024|54578891|FG014|Period 3|Withdrawal by Subject|0|||
27921879|NCT01090024|54578892|FG015|Period 3|Withdrawal by Subject|1|||
27921880|NCT01090024|54578893|FG016|Period 3|Withdrawal by Subject|0|||
27921881|NCT01090024|54578894|FG017|Period 3|Withdrawal by Subject|0|||
27921882|NCT01090024|54578877|FG000|Period 3|Protocol Violation|0|||
27921883|NCT01090024|54578878|FG001|Period 3|Protocol Violation|0|||
27921884|NCT01090024|54578879|FG002|Period 3|Protocol Violation|0|||
27921885|NCT01090024|54578880|FG003|Period 3|Protocol Violation|0|||
27921886|NCT01090024|54578881|FG004|Period 3|Protocol Violation|0|||
27921887|NCT01090024|54578882|FG005|Period 3|Protocol Violation|0|||
27921888|NCT01090024|54578883|FG006|Period 3|Protocol Violation|0|||
27921889|NCT01090024|54578884|FG007|Period 3|Protocol Violation|0|||
27921890|NCT01090024|54578885|FG008|Period 3|Protocol Violation|1|||
27921891|NCT01090024|54578886|FG009|Period 3|Protocol Violation|0|||
27921892|NCT01090024|54578887|FG010|Period 3|Protocol Violation|0|||
27921893|NCT01090024|54578888|FG011|Period 3|Protocol Violation|0|||
27921894|NCT01090024|54578889|FG012|Period 3|Protocol Violation|0|||
27921895|NCT01090024|54578890|FG013|Period 3|Protocol Violation|0|||
27921896|NCT01090024|54578891|FG014|Period 3|Protocol Violation|0|||
27921897|NCT01090024|54578892|FG015|Period 3|Protocol Violation|0|||
27921898|NCT01090024|54578893|FG016|Period 3|Protocol Violation|0|||
27921899|NCT01090024|54578894|FG017|Period 3|Protocol Violation|0|||
27921900|NCT01090024|54578877|FG000|Period 3|Adverse Event|0|||
27921901|NCT01090024|54578878|FG001|Period 3|Adverse Event|0|||
27921902|NCT01090024|54578879|FG002|Period 3|Adverse Event|0|||
27921903|NCT01090024|54578880|FG003|Period 3|Adverse Event|0|||
27921904|NCT01090024|54578881|FG004|Period 3|Adverse Event|0|||
27921905|NCT01090024|54578882|FG005|Period 3|Adverse Event|1|||
27921906|NCT01090024|54578883|FG006|Period 3|Adverse Event|0|||
27921907|NCT01090024|54578884|FG007|Period 3|Adverse Event|0|||
27921908|NCT01090024|54578885|FG008|Period 3|Adverse Event|0|||
27921909|NCT01090024|54578886|FG009|Period 3|Adverse Event|0|||
27921910|NCT01090024|54578887|FG010|Period 3|Adverse Event|0|||
28012889|NCT00408421|54671633|FG000|Treatment Initial Randomization|Entry Criteria Not Met|1|||
28012890|NCT00408421|54671634|FG001|Treatment Initial Randomization|Entry Criteria Not Met|0|||
28012891|NCT00408421|54671635|FG002|Treatment Initial Randomization|Entry Criteria Not Met|0|||
28012892|NCT00408421|54671633|FG000|Treatment Initial Randomization|Sponsor Decision|1|||
28012893|NCT00408421|54671634|FG001|Treatment Initial Randomization|Sponsor Decision|0|||
28012894|NCT00408421|54671635|FG002|Treatment Initial Randomization|Sponsor Decision|0|||
28012895|NCT00408421|54671633|FG000|Treatment Re-Randomization|Adverse Event|2|||
28012896|NCT00408421|54671634|FG001|Treatment Re-Randomization|Adverse Event|2|||
28012897|NCT00408421|54671635|FG002|Treatment Re-Randomization|Adverse Event|4|||
28012898|NCT00408421|54671633|FG000|Treatment Re-Randomization|Lack of Efficacy|1|||
28012899|NCT00408421|54671634|FG001|Treatment Re-Randomization|Lack of Efficacy|0|||
28012900|NCT00408421|54671635|FG002|Treatment Re-Randomization|Lack of Efficacy|0|||
28012901|NCT00408421|54671633|FG000|Treatment Re-Randomization|Lost to Follow-up|0|||
28012902|NCT00408421|54671634|FG001|Treatment Re-Randomization|Lost to Follow-up|0|||
28012903|NCT00408421|54671635|FG002|Treatment Re-Randomization|Lost to Follow-up|1|||
28012904|NCT00408421|54671633|FG000|Treatment Re-Randomization|Physician Decision|1|||
28012905|NCT00408421|54671634|FG001|Treatment Re-Randomization|Physician Decision|3|||
28012906|NCT00408421|54671635|FG002|Treatment Re-Randomization|Physician Decision|0|||
28012907|NCT00408421|54671633|FG000|Treatment Re-Randomization|Protocol Violation|1|||
28012908|NCT00408421|54671634|FG001|Treatment Re-Randomization|Protocol Violation|1|||
28012909|NCT00408421|54671635|FG002|Treatment Re-Randomization|Protocol Violation|0|||
28012910|NCT00408421|54671633|FG000|Treatment Re-Randomization|Withdrawal by Subject|2|||
28012911|NCT00408421|54671634|FG001|Treatment Re-Randomization|Withdrawal by Subject|1|||
28012912|NCT00408421|54671635|FG002|Treatment Re-Randomization|Withdrawal by Subject|0|||
28012913|NCT00604786|54671645|FG000|Overall Study|Lost to Follow-up|2|||
28012914|NCT00604786|54671646|FG001|Overall Study|Lost to Follow-up|0|||
28012915|NCT00604708|54671654|FG000|Overall Study|Withdrawal by Subject|9|||
28012916|NCT00604708|54671655|FG001|Overall Study|Withdrawal by Subject|10|||
28012917|NCT00604708|54671654|FG000|Overall Study|Protocol Violation|2|||
28012918|NCT00604708|54671655|FG001|Overall Study|Protocol Violation|8|||
28012919|NCT00604708|54671654|FG000|Overall Study|Lost to Follow-up|5|||
28012920|NCT00604708|54671655|FG001|Overall Study|Lost to Follow-up|5|||
28012921|NCT00604708|54671654|FG000|Overall Study|administrative reasons|9|||
27921911|NCT01090024|54578888|FG011|Period 3|Adverse Event|0|||
28012922|NCT00604708|54671655|FG001|Overall Study|administrative reasons|11|||
27921912|NCT01090024|54578889|FG012|Period 3|Adverse Event|0|||
27921913|NCT01090024|54578890|FG013|Period 3|Adverse Event|0|||
27921914|NCT01090024|54578891|FG014|Period 3|Adverse Event|0|||
27921915|NCT01090024|54578892|FG015|Period 3|Adverse Event|0|||
27921916|NCT01090024|54578893|FG016|Period 3|Adverse Event|0|||
27921917|NCT01090024|54578894|FG017|Period 3|Adverse Event|0|||
27921918|NCT04868890|54578906|FG000|Overall Study|Death|2|||
27921919|NCT04868890|54578907|FG001|Overall Study|Death|1|||
27921920|NCT04868890|54578906|FG000|Overall Study|Withdrawal by Subject|1|||
27921921|NCT04868890|54578907|FG001|Overall Study|Withdrawal by Subject|5|||
28012923|NCT00604708|54671654|FG000|Overall Study|Adverse Event|6|||
28012924|NCT00604708|54671655|FG001|Overall Study|Adverse Event|6|||
28012925|NCT00407797|54671661|FG000|Overall Study|Lost to Follow-up|2|||
28012926|NCT00407797|54671661|FG000|Overall Study|Adverse Event|6|||
28012927|NCT00407797|54671661|FG000|Overall Study|Other|7|||
28012928|NCT00407797|54671661|FG000|Overall Study|Withdrawal by Subject|3|||
28012929|NCT00568126|54671667|FG000|Overall Study|Adverse Event|3|||
28012930|NCT00568126|54671668|FG001|Overall Study|Adverse Event|0|||
28012931|NCT00568126|54671667|FG000|Overall Study|Withdrawal by Subject|2|||
28012932|NCT00568126|54671668|FG001|Overall Study|Withdrawal by Subject|3|||
28012933|NCT00568126|54671667|FG000|Overall Study|Lost to Follow-up|4|||
28012934|NCT00568126|54671668|FG001|Overall Study|Lost to Follow-up|3|||
28012935|NCT00568126|54671667|FG000|Overall Study|Lack of Efficacy|0|||
28012936|NCT00568126|54671668|FG001|Overall Study|Lack of Efficacy|1|||
28012937|NCT00568126|54671667|FG000|Overall Study|Physician Decision|2|||
28012938|NCT00568126|54671668|FG001|Overall Study|Physician Decision|2|||
28012939|NCT00407563|54671674|FG000|Overall Study|Patient continues on treatment|1|||
28012940|NCT00567892|54671680|FG000|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
28012941|NCT00567892|54671681|FG001|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
28012942|NCT00567892|54671682|FG002|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
28012943|NCT00567892|54671683|FG003|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4|||
28012944|NCT00567892|54671680|FG000|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
28012945|NCT00567892|54671681|FG001|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
28012946|NCT00567892|54671682|FG002|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
28012947|NCT00567892|54671683|FG003|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
28012948|NCT00623103|54671697|FG000|Overall Study|Adverse Event|70|||
28012949|NCT00623103|54671698|FG001|Overall Study|Adverse Event|60|||
28012950|NCT00623103|54671697|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
28012951|NCT00623103|54671698|FG001|Overall Study|Unsatisfactory therapeutic effect|12|||
28012952|NCT00623103|54671697|FG000|Overall Study|Withdrawal by Subject|18|||
28012953|NCT00623103|54671698|FG001|Overall Study|Withdrawal by Subject|24|||
28012954|NCT00623103|54671697|FG000|Overall Study|Lost to Follow-up|4|||
28012955|NCT00623103|54671698|FG001|Overall Study|Lost to Follow-up|1|||
28012956|NCT00623103|54671697|FG000|Overall Study|Administrative problems|2|||
28012957|NCT00623103|54671698|FG001|Overall Study|Administrative problems|4|||
28012958|NCT00623103|54671697|FG000|Overall Study|Death|11|||
28012959|NCT00623103|54671698|FG001|Overall Study|Death|11|||
28012960|NCT00623103|54671697|FG000|Overall Study|Protocol deviation|2|||
28012961|NCT00623103|54671698|FG001|Overall Study|Protocol deviation|1|||
28012962|NCT00396565|54671707|FG000|Overall Study|Physician Decision|3|||
28012963|NCT00396565|54671708|FG001|Overall Study|Physician Decision|1|||
28012964|NCT00396565|54671709|FG002|Overall Study|Physician Decision|2|||
28012965|NCT00396565|54671707|FG000|Overall Study|Adverse Event|5|||
28012966|NCT00396565|54671708|FG001|Overall Study|Adverse Event|13|||
28012967|NCT00396565|54671709|FG002|Overall Study|Adverse Event|3|||
28012968|NCT00396565|54671707|FG000|Overall Study|Withdrawal by Subject|8|||
28012969|NCT00396565|54671708|FG001|Overall Study|Withdrawal by Subject|13|||
28012970|NCT00396565|54671709|FG002|Overall Study|Withdrawal by Subject|1|||
28012971|NCT00396565|54671707|FG000|Overall Study|Lack of Efficacy|32|||
28012972|NCT00396565|54671708|FG001|Overall Study|Lack of Efficacy|64|||
28012973|NCT00396565|54671709|FG002|Overall Study|Lack of Efficacy|11|||
28012974|NCT00394771|54671721|FG000|Overall Study|Did not meet protocol requirements|1|||
28012975|NCT00394771|54671722|FG001|Overall Study|Did not meet protocol requirements|0|||
28012976|NCT00394771|54671723|FG002|Overall Study|Did not meet protocol requirements|2|||
28012977|NCT00394771|54671724|FG003|Overall Study|Did not meet protocol requirements|0|||
27921922|NCT01281189|54578915|FG000|Overall Study|Adverse Event|7|||
27921923|NCT01281189|54578916|FG001|Overall Study|Adverse Event|9|||
27921924|NCT01281189|54578915|FG000|Overall Study|Lost to Follow-up|6|||
27921925|NCT01281189|54578916|FG001|Overall Study|Lost to Follow-up|4|||
27921926|NCT01281189|54578915|FG000|Overall Study|Withdrawal by Subject|21|||
27921927|NCT01281189|54578916|FG001|Overall Study|Withdrawal by Subject|24|||
27921928|NCT01281189|54578915|FG000|Overall Study|Physician Decision|2|||
27921929|NCT01281189|54578916|FG001|Overall Study|Physician Decision|3|||
27921930|NCT01281189|54578915|FG000|Overall Study|Death|103|||
27921931|NCT01281189|54578916|FG001|Overall Study|Death|91|||
27921932|NCT01281189|54578915|FG000|Overall Study|Other|8|||
27921933|NCT01281189|54578916|FG001|Overall Study|Other|12|||
27921934|NCT01280955|54578922|FG000|Overall Study|Death|2|||
27921935|NCT01280955|54578922|FG000|Overall Study|Withdrawal by Subject|1|||
28012978|NCT00394771|54671721|FG000|Overall Study|Protocol Violation|2|||
28012979|NCT00394771|54671722|FG001|Overall Study|Protocol Violation|4|||
27921936|NCT01280721|54578928|FG000|Overall Study|Adverse Event|4|||
28012980|NCT00394771|54671723|FG002|Overall Study|Protocol Violation|9|||
28012981|NCT00394771|54671724|FG003|Overall Study|Protocol Violation|7|||
28012982|NCT00394771|54671721|FG000|Overall Study|Withdrawal by Subject|10|||
28012983|NCT00394771|54671722|FG001|Overall Study|Withdrawal by Subject|6|||
27921937|NCT01280721|54578928|FG000|Overall Study|Physician Decision|3|||
28012984|NCT00394771|54671723|FG002|Overall Study|Withdrawal by Subject|8|||
28012985|NCT00394771|54671724|FG003|Overall Study|Withdrawal by Subject|12|||
28012986|NCT00394771|54671721|FG000|Overall Study|Adverse Event|10|||
28012987|NCT00394771|54671722|FG001|Overall Study|Adverse Event|5|||
28012988|NCT00394771|54671723|FG002|Overall Study|Adverse Event|12|||
28012989|NCT00394771|54671724|FG003|Overall Study|Adverse Event|8|||
28012990|NCT00394771|54671721|FG000|Overall Study|Participant pregnant|0|||
28012991|NCT00394771|54671722|FG001|Overall Study|Participant pregnant|1|||
28012992|NCT00394771|54671723|FG002|Overall Study|Participant pregnant|2|||
28012993|NCT00394771|54671724|FG003|Overall Study|Participant pregnant|2|||
28012994|NCT00394771|54671721|FG000|Overall Study|Lost to Follow-up|15|||
28012995|NCT00394771|54671722|FG001|Overall Study|Lost to Follow-up|15|||
28012996|NCT00394771|54671723|FG002|Overall Study|Lost to Follow-up|13|||
28012997|NCT00394771|54671724|FG003|Overall Study|Lost to Follow-up|10|||
28012998|NCT00394771|54671721|FG000|Overall Study|Other|3|||
28012999|NCT00394771|54671722|FG001|Overall Study|Other|3|||
28013000|NCT00394771|54671723|FG002|Overall Study|Other|1|||
28013001|NCT00394771|54671724|FG003|Overall Study|Other|0|||
28013002|NCT00396409|54671736|FG000|Period 1 - 2007|Adverse Event|0|||
28013003|NCT00396409|54671737|FG001|Period 1 - 2007|Adverse Event|1|||
28013004|NCT00396409|54671736|FG000|Period 1 - 2007|Lack of Efficacy|0|||
28013005|NCT00396409|54671737|FG001|Period 1 - 2007|Lack of Efficacy|1|||
28013006|NCT00396409|54671736|FG000|Period 1 - 2007|Withdrawal by Subject|1|||
28013007|NCT00396409|54671737|FG001|Period 1 - 2007|Withdrawal by Subject|1|||
28013008|NCT00396409|54671736|FG000|Period 1 - 2007|Lost to Follow-up|2|||
28013009|NCT00396409|54671737|FG001|Period 1 - 2007|Lost to Follow-up|3|||
28013010|NCT00396409|54671736|FG000|Between Period 1 and Period 2|Withdrawal by Subject|3|||
28013011|NCT00396409|54671737|FG001|Between Period 1 and Period 2|Withdrawal by Subject|2|||
28013012|NCT00396409|54671736|FG000|Period 2 - 2008|Protocol Violation|1|||
28013013|NCT00396409|54671737|FG001|Period 2 - 2008|Protocol Violation|0|||
28013014|NCT00396409|54671736|FG000|Period 2 - 2008|Withdrawal by Subject|3|||
28013015|NCT00396409|54671737|FG001|Period 2 - 2008|Withdrawal by Subject|1|||
28013016|NCT00396409|54671736|FG000|Period 2 - 2008|Lost to Follow-up|3|||
28013017|NCT00396409|54671737|FG001|Period 2 - 2008|Lost to Follow-up|1|||
28013018|NCT02924376|54671749|FG000|Overall Study|Progressive Disease|4|||
28013019|NCT02924376|54671750|FG001|Overall Study|Progressive Disease|0|||
28013020|NCT02924376|54671751|FG002|Overall Study|Progressive Disease|1|||
28013021|NCT02924376|54671752|FG003|Overall Study|Progressive Disease|0|||
28013022|NCT02924376|54671749|FG000|Overall Study|Death|73|||
28013023|NCT02924376|54671750|FG001|Overall Study|Death|18|||
28013024|NCT02924376|54671751|FG002|Overall Study|Death|15|||
28013025|NCT02924376|54671752|FG003|Overall Study|Death|2|||
28013026|NCT02924376|54671749|FG000|Overall Study|Lost to Follow-up|3|||
28013027|NCT02924376|54671750|FG001|Overall Study|Lost to Follow-up|0|||
28013028|NCT02924376|54671751|FG002|Overall Study|Lost to Follow-up|0|||
28013029|NCT02924376|54671752|FG003|Overall Study|Lost to Follow-up|0|||
28013030|NCT02924376|54671749|FG000|Overall Study|Study Terminated by Sponsor|19|||
27921938|NCT01280721|54578928|FG000|Overall Study|Withdrawal by Subject|6|||
27921939|NCT01280721|54578928|FG000|Overall Study|eGFR under the withdrawal criteria|7|||
27921940|NCT01280721|54578928|FG000|Overall Study|No tolerability for the lowest dose|2|||
27921941|NCT01087762|54578946|FG000|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2|||
27921942|NCT01087762|54578947|FG001|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
27921943|NCT01087762|54578948|FG002|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3|||
27921944|NCT01087762|54578949|FG003|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
27921945|NCT01087762|54578950|FG004|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
27921946|NCT01087762|54578946|FG000|Double Blind Period (Weeks 0-24)|Protocol Violation|6|||
27921947|NCT01087762|54578947|FG001|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
27921948|NCT01087762|54578948|FG002|Double Blind Period (Weeks 0-24)|Protocol Violation|1|||
27921949|NCT01087762|54578949|FG003|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
27921950|NCT01087762|54578950|FG004|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
27921951|NCT01087762|54578946|FG000|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
27921952|NCT01087762|54578947|FG001|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2|||
27921953|NCT01087762|54578948|FG002|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
27921954|NCT01087762|54578949|FG003|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
27921955|NCT01087762|54578950|FG004|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
27921956|NCT01087762|54578946|FG000|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
27921957|NCT01087762|54578947|FG001|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2|||
27921958|NCT01087762|54578948|FG002|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
28013031|NCT02924376|54671750|FG001|Overall Study|Study Terminated by Sponsor|0|||
28013032|NCT02924376|54671751|FG002|Overall Study|Study Terminated by Sponsor|0|||
27742259|NCT02639065|54192286|FG000|Follow up|Withdrawal by Subject|1|||
27921959|NCT01087762|54578949|FG003|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
28013033|NCT02924376|54671752|FG003|Overall Study|Study Terminated by Sponsor|0|||
28013034|NCT02924376|54671749|FG000|Overall Study|Physician Decision|1|||
28013035|NCT02924376|54671750|FG001|Overall Study|Physician Decision|0|||
28013036|NCT02924376|54671751|FG002|Overall Study|Physician Decision|0|||
28013037|NCT02924376|54671752|FG003|Overall Study|Physician Decision|0|||
28013038|NCT02924376|54671749|FG000|Overall Study|Withdrawal by Subject|7|||
28013039|NCT02924376|54671750|FG001|Overall Study|Withdrawal by Subject|2|||
28013040|NCT02924376|54671751|FG002|Overall Study|Withdrawal by Subject|1|||
28013041|NCT02924376|54671752|FG003|Overall Study|Withdrawal by Subject|0|||
28013042|NCT02924376|54671749|FG000|Overall Study|Rolled Over to Another Study|1|||
28013043|NCT02924376|54671750|FG001|Overall Study|Rolled Over to Another Study|0|||
28013044|NCT02924376|54671751|FG002|Overall Study|Rolled Over to Another Study|0|||
28013045|NCT02924376|54671752|FG003|Overall Study|Rolled Over to Another Study|0|||
28013046|NCT00693420|54671767|FG000|Overall Study|Adverse Event|4|||
28013047|NCT00693420|54671768|FG001|Overall Study|Adverse Event|4|||
28013048|NCT00693420|54671767|FG000|Overall Study|Lost to Follow-up|0|||
28013049|NCT00693420|54671768|FG001|Overall Study|Lost to Follow-up|3|||
28013050|NCT00693420|54671767|FG000|Overall Study|Withdrawal by Subject|1|||
28013051|NCT00693420|54671768|FG001|Overall Study|Withdrawal by Subject|0|||
28013052|NCT00693420|54671767|FG000|Overall Study|Protocol Violation|0|||
28013053|NCT00693420|54671768|FG001|Overall Study|Protocol Violation|2|||
28013054|NCT00693420|54671767|FG000|Overall Study|Sponsor Request - Conflict of Interest|0|||
28013055|NCT00693420|54671768|FG001|Overall Study|Sponsor Request - Conflict of Interest|2|||
28013056|NCT00693420|54671767|FG000|Overall Study|Personal Reasons|1|||
28013057|NCT00693420|54671768|FG001|Overall Study|Personal Reasons|4|||
28013058|NCT00695136|54671774|FG000|Overall Study|Withdrawal by Subject|1|||
28013059|NCT00695136|54671774|FG000|Overall Study|unrelated adverse event|1|||
28013060|NCT00605176|54671790|FG000|Overall Study|Adverse Event|2|||
28013061|NCT00605176|54671791|FG001|Overall Study|Adverse Event|1|||
28013062|NCT00605176|54671792|FG002|Overall Study|Adverse Event|3|||
28013063|NCT00605176|54671790|FG000|Overall Study|Withdrawal by Subject|4|||
28013064|NCT00605176|54671791|FG001|Overall Study|Withdrawal by Subject|2|||
28013065|NCT00605176|54671792|FG002|Overall Study|Withdrawal by Subject|4|||
28013066|NCT00605176|54671790|FG000|Overall Study|Lost to Follow-up|2|||
28013067|NCT00605176|54671791|FG001|Overall Study|Lost to Follow-up|2|||
28013068|NCT00605176|54671792|FG002|Overall Study|Lost to Follow-up|1|||
28013069|NCT00605176|54671790|FG000|Overall Study|Non-complicance with study procedures|1|||
28013070|NCT00605176|54671791|FG001|Overall Study|Non-complicance with study procedures|0|||
28013071|NCT00605176|54671792|FG002|Overall Study|Non-complicance with study procedures|0|||
28013072|NCT00605176|54671790|FG000|Overall Study|Use of concomitant therapy|1|||
28013073|NCT00605176|54671791|FG001|Overall Study|Use of concomitant therapy|0|||
28013074|NCT00605176|54671792|FG002|Overall Study|Use of concomitant therapy|1|||
28013075|NCT00605176|54671790|FG000|Overall Study|Other (not due to AE)|1|||
28013076|NCT00605176|54671791|FG001|Overall Study|Other (not due to AE)|1|||
28013077|NCT00605176|54671792|FG002|Overall Study|Other (not due to AE)|0|||
28013078|NCT00694356|54671803|FG000|Overall Study|Adverse Event|1|||
28013079|NCT00694356|54671804|FG001|Overall Study|Adverse Event|0|||
28013080|NCT00694356|54671805|FG002|Overall Study|Adverse Event|0|||
28013081|NCT00694356|54671803|FG000|Overall Study|Progressive Disease|2|||
28013082|NCT00694356|54671804|FG001|Overall Study|Progressive Disease|6|||
28013083|NCT00694356|54671805|FG002|Overall Study|Progressive Disease|6|||
28013084|NCT00692406|54671813|FG000|Overall Study|PI dropped, bad data|57|||
28013085|NCT00567502|54671830|FG000|Overall Study|Lost to Follow-up|91|||
28013086|NCT00567502|54671831|FG001|Overall Study|Lost to Follow-up|14|||
28013087|NCT00567502|54671832|FG002|Overall Study|Lost to Follow-up|351|||
28013088|NCT00567502|54671833|FG003|Overall Study|Lost to Follow-up|2|||
28013089|NCT00567502|54671830|FG000|Overall Study|Death|65|||
28013090|NCT00567502|54671831|FG001|Overall Study|Death|16|||
28013091|NCT00567502|54671832|FG002|Overall Study|Death|360|||
28013092|NCT00567502|54671833|FG003|Overall Study|Death|5|||
28013093|NCT00567502|54671830|FG000|Overall Study|Other|64|||
28013094|NCT00567502|54671831|FG001|Overall Study|Other|2|||
28013095|NCT00567502|54671832|FG002|Overall Study|Other|134|||
28013096|NCT00567502|54671833|FG003|Overall Study|Other|6|||
28013097|NCT00567502|54671830|FG000|Overall Study|Participant request|12|||
28013098|NCT00567502|54671831|FG001|Overall Study|Participant request|1|||
28013099|NCT00567502|54671832|FG002|Overall Study|Participant request|33|||
28013100|NCT00567502|54671833|FG003|Overall Study|Participant request|1|||
28013101|NCT00567502|54671830|FG000|Overall Study|Sponsor request|9|||
28013102|NCT00567502|54671831|FG001|Overall Study|Sponsor request|0|||
28013103|NCT00567502|54671832|FG002|Overall Study|Sponsor request|30|||
28013104|NCT00567502|54671833|FG003|Overall Study|Sponsor request|1|||
28013105|NCT00567502|54671830|FG000|Overall Study|Never Initiated Treatment|0|||
28013106|NCT00567502|54671831|FG001|Overall Study|Never Initiated Treatment|0|||
28013107|NCT00567502|54671832|FG002|Overall Study|Never Initiated Treatment|0|||
28013108|NCT00567502|54671833|FG003|Overall Study|Never Initiated Treatment|72|||
28013109|NCT00396331|54671858|FG000|Overall Study|Failed to mobilize - no transplant|8|||
28013110|NCT00396331|54671858|FG000|Overall Study|Did not go on to transplant|5|||
28013111|NCT00396331|54671858|FG000|Overall Study|Lost to Follow-up|3|||
28013112|NCT00396331|54671858|FG000|Overall Study|Death|16|||
28013113|NCT00396253|54671870|FG000|Overall Study|Protocol Violation|1|||
28013114|NCT00396253|54671870|FG000|Overall Study|Withdrawal by Subject|7|||
28013115|NCT00396253|54671870|FG000|Overall Study|Death|3|||
28013116|NCT00396253|54671870|FG000|Overall Study|Physician Decision|1|||
28013117|NCT00396253|54671870|FG000|Overall Study|Change in eligibility status|1|||
28013118|NCT00604162|54671874|FG000|Overall Study|Physician Decision|3|||
28013119|NCT00604162|54671874|FG000|Overall Study|Withdrawal by Subject|1|||
28013120|NCT00396097|54671883|FG000|Overall Study|Withdrawal by Subject|17|||
28013121|NCT00396097|54671884|FG001|Overall Study|Withdrawal by Subject|17|||
28013122|NCT00396097|54671883|FG000|Overall Study|Lost to Follow-up|4|||
28013123|NCT00396097|54671884|FG001|Overall Study|Lost to Follow-up|9|||
28013124|NCT00396097|54671883|FG000|Overall Study|Other|3|||
28013125|NCT00396097|54671884|FG001|Overall Study|Other|5|||
28013126|NCT00396097|54671883|FG000|Overall Study|Protocol Violation|0|||
28013127|NCT00396097|54671884|FG001|Overall Study|Protocol Violation|6|||
28013128|NCT00396097|54671883|FG000|Overall Study|Adverse Event|1|||
28013129|NCT00396097|54671884|FG001|Overall Study|Adverse Event|5|||
28013130|NCT00396097|54671883|FG000|Overall Study|Insufficient Clinical Response|1|||
28013131|NCT00396097|54671884|FG001|Overall Study|Insufficient Clinical Response|4|||
28013132|NCT00375505|54671896|FG000|Overall Study|Adverse Event|1|||
28013133|NCT00375505|54671897|FG001|Overall Study|Adverse Event|2|||
28013134|NCT00375427|54671905|FG000|Overall Study|Adverse Event|21|||
28013135|NCT00375427|54671906|FG001|Overall Study|Adverse Event|27|||
28013136|NCT00375427|54671905|FG000|Overall Study|Abnormal test procedure result(s)|0|||
28013137|NCT00375427|54671906|FG001|Overall Study|Abnormal test procedure result(s)|1|||
28013138|NCT00375427|54671905|FG000|Overall Study|Abnormal laboratory value(s)|1|||
28013139|NCT00375427|54671906|FG001|Overall Study|Abnormal laboratory value(s)|2|||
28013140|NCT00375427|54671905|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
28013141|NCT00375427|54671906|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
28013142|NCT00375427|54671905|FG000|Overall Study|Patient no longer requires study drug|3|||
28013143|NCT00375427|54671906|FG001|Overall Study|Patient no longer requires study drug|7|||
28013144|NCT00375427|54671905|FG000|Overall Study|Protocol Violation|10|||
28013145|NCT00375427|54671906|FG001|Overall Study|Protocol Violation|8|||
28013146|NCT00375427|54671905|FG000|Overall Study|Withdrawal by Subject|9|||
28013147|NCT00375427|54671906|FG001|Overall Study|Withdrawal by Subject|13|||
28013148|NCT00375427|54671905|FG000|Overall Study|Lost to Follow-up|1|||
28013149|NCT00375427|54671906|FG001|Overall Study|Lost to Follow-up|1|||
28013150|NCT00375427|54671905|FG000|Overall Study|Administrative reasons|0|||
28013151|NCT00375427|54671906|FG001|Overall Study|Administrative reasons|1|||
28013152|NCT00375427|54671905|FG000|Overall Study|Death|11|||
28013153|NCT00375427|54671906|FG001|Overall Study|Death|10|||
28013154|NCT00393913|54671912|FG000|Initial Assessment|diagnosed with other sleep disorder|21|||
28013155|NCT00393913|54671912|FG000|Initial Assessment|Withdrawal by Subject|16|||
28013156|NCT00393913|54671912|FG000|CPAP|Withdrawal by Subject|3|||
28013157|NCT00393913|54671912|FG000|CPAP|Physician Decision|1|||
28013158|NCT00393913|54671912|FG000|CPAP|TEchnical problem with CPAP|3|||
28013159|NCT00567268|54671917|FG000|Overall Study|Protocol Violation|7|||
28013160|NCT00567268|54671917|FG000|Overall Study|Lost to Follow-up|36|||
28013161|NCT00567268|54671917|FG000|Overall Study|No Visit After First Day of Treatment|2|||
28013162|NCT00567268|54671917|FG000|Overall Study|No Drug Administration|4|||
28013163|NCT00567268|54671917|FG000|Overall Study|"Safety Evaluation Not Assessable"|1|||
28013164|NCT03976648|54671958|FG000|Overall Study|Adverse Event|0|||
28013165|NCT03976648|54671959|FG001|Overall Study|Adverse Event|2|||
28013166|NCT03976648|54671958|FG000|Overall Study|Study terminated by sponsor|21|||
28013167|NCT03976648|54671959|FG001|Overall Study|Study terminated by sponsor|8|||
28013168|NCT00566254|54671967|FG000|Overall Study|Adverse Event|3|||
28013169|NCT00566254|54671968|FG001|Overall Study|Adverse Event|1|||
28013170|NCT00566254|54671967|FG000|Overall Study|Protocol Violation|1|||
28013171|NCT00566254|54671968|FG001|Overall Study|Protocol Violation|3|||
28013172|NCT00566254|54671967|FG000|Overall Study|Withdrawal by Subject|1|||
28013173|NCT00566254|54671968|FG001|Overall Study|Withdrawal by Subject|2|||
28013174|NCT00566254|54671967|FG000|Overall Study|Lack of Efficacy|5|||
28013175|NCT00566254|54671968|FG001|Overall Study|Lack of Efficacy|6|||
28013176|NCT00566254|54671967|FG000|Overall Study|Other|0|||
28013177|NCT00566254|54671968|FG001|Overall Study|Other|2|||
28013178|NCT00393523|54671979|FG000|Overall Study|Lost to Follow-up|0|||
28013179|NCT00393523|54671980|FG001|Overall Study|Lost to Follow-up|0|||
28013180|NCT00393523|54671981|FG002|Overall Study|Lost to Follow-up|0|||
28013181|NCT00393523|54671982|FG003|Overall Study|Lost to Follow-up|2|||
28013182|NCT00393523|54671983|FG004|Overall Study|Lost to Follow-up|1|||
28013183|NCT00393523|54671979|FG000|Overall Study|Protocol Violation|6|||
28013184|NCT00393523|54671980|FG001|Overall Study|Protocol Violation|2|||
28013185|NCT00393523|54671981|FG002|Overall Study|Protocol Violation|0|||
28013186|NCT00393523|54671982|FG003|Overall Study|Protocol Violation|1|||
28013187|NCT00393523|54671983|FG004|Overall Study|Protocol Violation|0|||
28013188|NCT00393523|54671979|FG000|Overall Study|Withdrawal by Subject|6|||
28013189|NCT00393523|54671980|FG001|Overall Study|Withdrawal by Subject|7|||
28013190|NCT00393523|54671981|FG002|Overall Study|Withdrawal by Subject|2|||
28013191|NCT00393523|54671982|FG003|Overall Study|Withdrawal by Subject|3|||
28013192|NCT00393523|54671983|FG004|Overall Study|Withdrawal by Subject|0|||
28013193|NCT00393523|54671979|FG000|Overall Study|Difficulties in specimen collection|0|||
28013194|NCT00393523|54671980|FG001|Overall Study|Difficulties in specimen collection|0|||
28013195|NCT00393523|54671981|FG002|Overall Study|Difficulties in specimen collection|1|||
28013196|NCT00393523|54671982|FG003|Overall Study|Difficulties in specimen collection|0|||
28013197|NCT00393523|54671983|FG004|Overall Study|Difficulties in specimen collection|0|||
28013198|NCT00393523|54671979|FG000|Overall Study|Vaccine supply issue|0|||
28013199|NCT00393523|54671980|FG001|Overall Study|Vaccine supply issue|0|||
28013200|NCT00393523|54671981|FG002|Overall Study|Vaccine supply issue|1|||
28013201|NCT00393523|54671982|FG003|Overall Study|Vaccine supply issue|0|||
28013202|NCT00393523|54671983|FG004|Overall Study|Vaccine supply issue|0|||
28013203|NCT00393367|54671996|FG000|Overall Study|Protocol Violation|2|||
28013204|NCT00393367|54671997|FG001|Overall Study|Protocol Violation|5|||
28013205|NCT00393367|54671996|FG000|Overall Study|Withdrawal by Subject|0|||
28013206|NCT00393367|54671997|FG001|Overall Study|Withdrawal by Subject|2|||
28013207|NCT00395863|54672007|FG000|Overall Study|Patients did not complete both exams|2|||
28013208|NCT00395863|54672008|FG001|Overall Study|Patients did not complete both exams|3|||
28013209|NCT00395629|54672020|FG000|Core Study|Adverse Event|0|||
28013210|NCT00395629|54672021|FG001|Core Study|Adverse Event|3|||
28013211|NCT00395629|54672022|FG002|Core Study|Adverse Event|4|||
28013212|NCT00395629|54672020|FG000|Core Study|Abnormal laboratory value(s)|0|||
28013213|NCT00395629|54672021|FG001|Core Study|Abnormal laboratory value(s)|0|||
28013214|NCT00395629|54672022|FG002|Core Study|Abnormal laboratory value(s)|1|||
28013215|NCT00395629|54672020|FG000|Core Study|Protocol Violation|1|||
28013216|NCT00395629|54672021|FG001|Core Study|Protocol Violation|0|||
28013217|NCT00395629|54672022|FG002|Core Study|Protocol Violation|0|||
28013218|NCT00395629|54672020|FG000|Core Study|Withdrawal by Subject|0|||
28013219|NCT00395629|54672021|FG001|Core Study|Withdrawal by Subject|1|||
28013220|NCT00395629|54672022|FG002|Core Study|Withdrawal by Subject|1|||
28013221|NCT00395629|54672020|FG000|Core Study|Lost to Follow-up|0|||
28013222|NCT00395629|54672021|FG001|Core Study|Lost to Follow-up|0|||
28013223|NCT00395629|54672022|FG002|Core Study|Lost to Follow-up|1|||
28013224|NCT00395629|54672020|FG000|Extension Study|Adverse Event|0|||
28013225|NCT00395629|54672021|FG001|Extension Study|Adverse Event|0|||
28013226|NCT00395629|54672022|FG002|Extension Study|Adverse Event|2|||
28013227|NCT00395629|54672020|FG000|Extension Study|Administrative problems|0|||
28013228|NCT00395629|54672021|FG001|Extension Study|Administrative problems|0|||
28013229|NCT00395629|54672022|FG002|Extension Study|Administrative problems|1|||
28013230|NCT00392665|54672035|FG000|Overall Study|Death|16|||
28013231|NCT00392665|54672036|FG001|Overall Study|Death|14|||
28013232|NCT00392665|54672035|FG000|Overall Study|Lost to Follow-up|1|||
28013233|NCT00392665|54672036|FG001|Overall Study|Lost to Follow-up|1|||
28013234|NCT00622869|54672045|FG000|Overall Study|Subject Withdrew Consent|13|||
28013235|NCT00622869|54672046|FG001|Overall Study|Subject Withdrew Consent|17|||
28013236|NCT00622869|54672047|FG002|Overall Study|Subject Withdrew Consent|11|||
28013237|NCT00622869|54672045|FG000|Overall Study|Administrative Problems|11|||
28013238|NCT00622869|54672046|FG001|Overall Study|Administrative Problems|17|||
28013239|NCT00622869|54672047|FG002|Overall Study|Administrative Problems|13|||
28013240|NCT00622869|54672045|FG000|Overall Study|Death|12|||
28013241|NCT00622869|54672046|FG001|Overall Study|Death|15|||
28013242|NCT00622869|54672047|FG002|Overall Study|Death|10|||
28013243|NCT00622869|54672045|FG000|Overall Study|Lost to Follow-up|2|||
28013244|NCT00622869|54672046|FG001|Overall Study|Lost to Follow-up|4|||
28013245|NCT00622869|54672047|FG002|Overall Study|Lost to Follow-up|2|||
28013246|NCT00622869|54672045|FG000|Overall Study|Graft Loss|5|||
28013247|NCT00622869|54672046|FG001|Overall Study|Graft Loss|3|||
28013248|NCT00622869|54672047|FG002|Overall Study|Graft Loss|2|||
28013249|NCT00622869|54672045|FG000|Overall Study|Missing|0|||
28013250|NCT00622869|54672046|FG001|Overall Study|Missing|1|||
28013251|NCT00622869|54672047|FG002|Overall Study|Missing|1|||
28013252|NCT00395083|54672057|FG000|Overall Study|Withdrawal by Subject|6|||
28013253|NCT00395083|54672058|FG001|Overall Study|Withdrawal by Subject|5|||
28013254|NCT00395083|54672057|FG000|Overall Study|Developed another disease|4|||
28013255|NCT00395083|54672058|FG001|Overall Study|Developed another disease|3|||
28013256|NCT00366457|54672064|FG000|Overall Study|never began study therapy|2|||
28013257|NCT00624819|54672072|FG000|Follow-up Period: Year 4|Parents decision|0|||
28013258|NCT00624819|54672073|FG001|Follow-up Period: Year 4|Parents decision|0|||
28013259|NCT00624819|54672074|FG002|Follow-up Period: Year 4|Parents decision|1|||
28013260|NCT00624819|54672075|FG003|Follow-up Period: Year 4|Parents decision|0|||
28013261|NCT00624819|54672072|FG000|Follow-up Period: Year 4|Lost to Follow-up|1|||
28013262|NCT00624819|54672073|FG001|Follow-up Period: Year 4|Lost to Follow-up|1|||
28013263|NCT00624819|54672074|FG002|Follow-up Period: Year 4|Lost to Follow-up|0|||
28013264|NCT00624819|54672075|FG003|Follow-up Period: Year 4|Lost to Follow-up|0|||
28013265|NCT03832387|54672087|FG000|Overall Study|Protocol Violation|2|||
28013266|NCT03832387|54672088|FG001|Overall Study|Protocol Violation|6|||
28013267|NCT03832387|54672087|FG000|Overall Study|EXCLUSION CRITERIA|3|||
28013268|NCT03832387|54672088|FG001|Overall Study|EXCLUSION CRITERIA|1|||
28013269|NCT00366301|54672098|FG000|Overall Study|Lost to Follow-up|4|||
28013270|NCT00366301|54672099|FG001|Overall Study|Lost to Follow-up|4|||
28013271|NCT00366301|54672100|FG002|Overall Study|Lost to Follow-up|3|||
28013272|NCT00366301|54672101|FG003|Overall Study|Lost to Follow-up|7|||
28013273|NCT00366301|54672098|FG000|Overall Study|Withdrawal by Subject|4|||
28013274|NCT00366301|54672099|FG001|Overall Study|Withdrawal by Subject|2|||
28013275|NCT00366301|54672100|FG002|Overall Study|Withdrawal by Subject|1|||
28013276|NCT00366301|54672101|FG003|Overall Study|Withdrawal by Subject|1|||
28013277|NCT00365989|54672111|FG000|Overall Study|Withdrawal by Subject|1|||
28013278|NCT00365989|54672111|FG000|Overall Study|Non-compliance|1|||
28013279|NCT00622713|54672116|FG000|Overall Study|Adverse Event|35|||
28013280|NCT00622713|54672116|FG000|Overall Study|Administrative problems|4|||
28013281|NCT00622713|54672116|FG000|Overall Study|Withdrawal by Subject|11|||
28013282|NCT00622713|54672116|FG000|Overall Study|Lost to Follow-up|5|||
28013283|NCT00622713|54672116|FG000|Overall Study|Death|2|||
28013284|NCT00622713|54672116|FG000|Overall Study|Subject no longer required study drug|1|||
28013285|NCT00622713|54672116|FG000|Overall Study|Did not meet eligibility criteria|1|||
28013286|NCT00392197|54672122|FG000|Overall Study|Adverse Event|4|||
28013287|NCT00392197|54672123|FG001|Overall Study|Adverse Event|12|||
28013288|NCT00392197|54672122|FG000|Overall Study|Lack of Efficacy|3|||
28013289|NCT00392197|54672123|FG001|Overall Study|Lack of Efficacy|4|||
28013290|NCT00392197|54672122|FG000|Overall Study|Lost to Follow-up|0|||
28013291|NCT00392197|54672123|FG001|Overall Study|Lost to Follow-up|1|||
28013292|NCT00392197|54672122|FG000|Overall Study|Physician Decision|3|||
28013293|NCT00392197|54672123|FG001|Overall Study|Physician Decision|2|||
28013294|NCT00392197|54672122|FG000|Overall Study|Protocol Violation|7|||
28013295|NCT00392197|54672123|FG001|Overall Study|Protocol Violation|5|||
28013296|NCT00392197|54672122|FG000|Overall Study|Withdrawal by Subject|4|||
28013297|NCT00392197|54672123|FG001|Overall Study|Withdrawal by Subject|6|||
28013298|NCT00391807|54672129|FG000|Overall Study|Did not receive study medication|23|||
28013299|NCT00391807|54672129|FG000|Overall Study|Adverse Event|177|||
28013300|NCT00391807|54672129|FG000|Overall Study|Pregnancy|25|||
28013301|NCT00391807|54672129|FG000|Overall Study|Lost to Follow-up|227|||
28013302|NCT00391807|54672129|FG000|Overall Study|Withdrawal by Subject|147|||
28013303|NCT00391807|54672129|FG000|Overall Study|Protocol Violation|20|||
28013304|NCT00391807|54672129|FG000|Overall Study|Various|96|||
28013305|NCT00624585|54672133|FG000|Overall Study|Death|3|||
28013306|NCT00624585|54672133|FG000|Overall Study|Disease Progression|6|||
28013307|NCT00624585|54672133|FG000|Overall Study|Adverse Event|3|||
28013308|NCT00622635|54672137|FG000|Treatment Period 1|Adverse Event|0|||
28013309|NCT00622635|54672138|FG001|Treatment Period 1|Adverse Event|0|||
28013310|NCT00622635|54672139|FG002|Treatment Period 1|Adverse Event|1|||
28013311|NCT00622635|54672140|FG003|Treatment Period 1|Adverse Event|0|||
28013312|NCT00622635|54672141|FG004|Treatment Period 1|Adverse Event|0|||
28013313|NCT00622635|54672142|FG005|Treatment Period 1|Adverse Event|0|||
27921960|NCT01087762|54578950|FG004|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
27921961|NCT01087762|54578946|FG000|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
27921962|NCT01087762|54578947|FG001|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
27921963|NCT01087762|54578948|FG002|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3|||
27921964|NCT01087762|54578949|FG003|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
27921965|NCT01087762|54578950|FG004|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
27921966|NCT01087762|54578946|FG000|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
27921967|NCT01087762|54578947|FG001|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
27921968|NCT01087762|54578948|FG002|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
28013314|NCT00622635|54672137|FG000|Treatment Period 1|Withdrawal by Subject|0|||
28013315|NCT00622635|54672138|FG001|Treatment Period 1|Withdrawal by Subject|1|||
28013316|NCT00622635|54672139|FG002|Treatment Period 1|Withdrawal by Subject|0|||
28013317|NCT00622635|54672140|FG003|Treatment Period 1|Withdrawal by Subject|0|||
28013318|NCT00622635|54672141|FG004|Treatment Period 1|Withdrawal by Subject|0|||
27921969|NCT01087762|54578949|FG003|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4|||
28013319|NCT00622635|54672142|FG005|Treatment Period 1|Withdrawal by Subject|0|||
28013320|NCT00622635|54672137|FG000|Treatment Period 1|Abnormal test procedure result(s)|0|||
28013321|NCT00622635|54672138|FG001|Treatment Period 1|Abnormal test procedure result(s)|0|||
28013322|NCT00622635|54672139|FG002|Treatment Period 1|Abnormal test procedure result(s)|0|||
28013323|NCT00622635|54672140|FG003|Treatment Period 1|Abnormal test procedure result(s)|0|||
28013324|NCT00622635|54672141|FG004|Treatment Period 1|Abnormal test procedure result(s)|1|||
28013325|NCT00622635|54672142|FG005|Treatment Period 1|Abnormal test procedure result(s)|0|||
28013326|NCT00622635|54672137|FG000|Treatment Period 2|Adverse Event|1|||
28013327|NCT00622635|54672138|FG001|Treatment Period 2|Adverse Event|0|||
28013328|NCT00622635|54672139|FG002|Treatment Period 2|Adverse Event|0|||
28013329|NCT00622635|54672140|FG003|Treatment Period 2|Adverse Event|0|||
28013330|NCT00622635|54672141|FG004|Treatment Period 2|Adverse Event|0|||
28013331|NCT00622635|54672142|FG005|Treatment Period 2|Adverse Event|0|||
28013332|NCT00622635|54672137|FG000|Treatment Period 3|Adverse Event|0|||
28013333|NCT00622635|54672138|FG001|Treatment Period 3|Adverse Event|0|||
28013334|NCT00622635|54672139|FG002|Treatment Period 3|Adverse Event|0|||
28013335|NCT00622635|54672140|FG003|Treatment Period 3|Adverse Event|2|||
28013336|NCT00622635|54672141|FG004|Treatment Period 3|Adverse Event|0|||
28013337|NCT00622635|54672142|FG005|Treatment Period 3|Adverse Event|0|||
28013338|NCT00622635|54672137|FG000|Treatment Period 3|Withdrawal by Subject|0|||
28013339|NCT00622635|54672138|FG001|Treatment Period 3|Withdrawal by Subject|0|||
28013340|NCT00622635|54672139|FG002|Treatment Period 3|Withdrawal by Subject|0|||
28013341|NCT00622635|54672140|FG003|Treatment Period 3|Withdrawal by Subject|1|||
28013342|NCT00622635|54672141|FG004|Treatment Period 3|Withdrawal by Subject|0|||
28013343|NCT00622635|54672142|FG005|Treatment Period 3|Withdrawal by Subject|0|||
28013344|NCT00391027|54672152|FG000|Overall Study|Adverse Event|8|||
28013345|NCT00391027|54672153|FG001|Overall Study|Adverse Event|8|||
28013346|NCT00391027|54672152|FG000|Overall Study|Lack of Efficacy|3|||
28013347|NCT00391027|54672153|FG001|Overall Study|Lack of Efficacy|0|||
28013348|NCT00391027|54672152|FG000|Overall Study|Withdrawal by Subject|10|||
28013349|NCT00391027|54672153|FG001|Overall Study|Withdrawal by Subject|1|||
28013350|NCT00391027|54672152|FG000|Overall Study|Other|4|||
28013351|NCT00391027|54672153|FG001|Overall Study|Other|3|||
28013352|NCT00622401|54672162|FG000|Overall Study|Disease progression prior to treatment|3|||
28013353|NCT00622401|54672163|FG001|Overall Study|Disease progression prior to treatment|2|||
28013354|NCT00622401|54672164|FG002|Overall Study|Disease progression prior to treatment|0|||
28013355|NCT00621621|54672174|FG000|Overall Study|Subjects were exited at EP study|30|||
28013356|NCT00621621|54672175|FG001|Overall Study|Subjects were exited at EP study|0|||
28013357|NCT00621543|54672183|FG000|Overall Study|Lost to Follow-up|23|||
28013358|NCT00623805|54672189|FG000|Overall Study|Adverse Event|9|||
28013359|NCT00623805|54672190|FG001|Overall Study|Adverse Event|6|||
28013360|NCT00623805|54672189|FG000|Overall Study|Death|2|||
28013361|NCT00623805|54672190|FG001|Overall Study|Death|0|||
28013362|NCT00623805|54672189|FG000|Overall Study|Lack of Efficacy|3|||
28013363|NCT00623805|54672190|FG001|Overall Study|Lack of Efficacy|7|||
28013364|NCT00623805|54672189|FG000|Overall Study|Lost to Follow-up|2|||
28013365|NCT00623805|54672190|FG001|Overall Study|Lost to Follow-up|2|||
28013366|NCT00623805|54672189|FG000|Overall Study|Protocol Violation|1|||
28013367|NCT00623805|54672190|FG001|Overall Study|Protocol Violation|1|||
28013368|NCT00623805|54672189|FG000|Overall Study|Reason not Specified|3|||
28013369|NCT00623805|54672190|FG001|Overall Study|Reason not Specified|6|||
28013370|NCT00621309|54672196|FG000|Overall Study|Withdrawal by Subject|2|||
28013371|NCT00621309|54672197|FG001|Overall Study|Withdrawal by Subject|0|||
28013372|NCT00621309|54672198|FG002|Overall Study|Withdrawal by Subject|1|||
28013373|NCT00621309|54672199|FG003|Overall Study|Withdrawal by Subject|1|||
28013374|NCT00621309|54672200|FG004|Overall Study|Withdrawal by Subject|1|||
28013375|NCT00621309|54672201|FG005|Overall Study|Withdrawal by Subject|1|||
28013376|NCT00567190|54672209|FG000|Overall Study|Death|235|||
28013377|NCT00567190|54672210|FG001|Overall Study|Death|280|||
28013378|NCT00567190|54672209|FG000|Overall Study|Withdrew Consent or Lost to Follow-up|48|||
28013379|NCT00567190|54672210|FG001|Overall Study|Withdrew Consent or Lost to Follow-up|53|||
28013380|NCT00691938|54672228|FG000|Overall Study|QTc prolongation|1|||
28013381|NCT00691938|54672229|FG001|Overall Study|QTc prolongation|0|||
28013382|NCT00691938|54672230|FG002|Overall Study|QTc prolongation|0|||
28013383|NCT00691938|54672231|FG003|Overall Study|QTc prolongation|0|||
28013384|NCT00691938|54672232|FG004|Overall Study|QTc prolongation|0|||
28013385|NCT00691938|54672233|FG005|Overall Study|QTc prolongation|0|||
28013386|NCT00691938|54672234|FG006|Overall Study|QTc prolongation|0|||
28013387|NCT00365365|54672248|FG000|Overall Study|Randomized but not treated|0|||
28013388|NCT00365365|54672249|FG001|Overall Study|Randomized but not treated|2|||
28013389|NCT00365365|54672250|FG002|Overall Study|Randomized but not treated|0|||
28013390|NCT00365365|54672248|FG000|Overall Study|Poor compliance to protocol|0|||
28013391|NCT00365365|54672249|FG001|Overall Study|Poor compliance to protocol|1|||
28013392|NCT00365365|54672250|FG002|Overall Study|Poor compliance to protocol|0|||
28013393|NCT00365365|54672248|FG000|Overall Study|Lost to Follow-up|3|||
28013394|NCT00365365|54672249|FG001|Overall Study|Lost to Follow-up|3|||
28013395|NCT00365365|54672250|FG002|Overall Study|Lost to Follow-up|3|||
28013396|NCT00365365|54672248|FG000|Overall Study|Death|1|||
28013397|NCT00365365|54672249|FG001|Overall Study|Death|3|||
28013398|NCT00365365|54672250|FG002|Overall Study|Death|0|||
28013399|NCT00365365|54672248|FG000|Overall Study|Subject's request|11|||
28013400|NCT00365365|54672249|FG001|Overall Study|Subject's request|13|||
28013401|NCT00365365|54672250|FG002|Overall Study|Subject's request|1|||
28013402|NCT00365365|54672248|FG000|Overall Study|Disease progression/relapse|9|||
28013403|NCT00365365|54672249|FG001|Overall Study|Disease progression/relapse|6|||
28013404|NCT00365365|54672250|FG002|Overall Study|Disease progression/relapse|7|||
28013405|NCT00365365|54672248|FG000|Overall Study|Adverse Event|6|||
28013406|NCT00365365|54672249|FG001|Overall Study|Adverse Event|6|||
28013407|NCT00365365|54672250|FG002|Overall Study|Adverse Event|3|||
28013408|NCT00365365|54672248|FG000|Overall Study|Moved|2|||
28013409|NCT00365365|54672249|FG001|Overall Study|Moved|0|||
28013410|NCT00365365|54672250|FG002|Overall Study|Moved|0|||
28013411|NCT00365365|54672248|FG000|Overall Study|New cancer|1|||
28013412|NCT00365365|54672249|FG001|Overall Study|New cancer|0|||
28013413|NCT00365365|54672250|FG002|Overall Study|New cancer|0|||
28013414|NCT00365365|54672248|FG000|Overall Study|Withdrew consent|1|||
28013415|NCT00365365|54672249|FG001|Overall Study|Withdrew consent|1|||
28013416|NCT00365365|54672250|FG002|Overall Study|Withdrew consent|0|||
28013417|NCT00365365|54672248|FG000|Overall Study|Second malignancy|0|||
28013418|NCT00365365|54672249|FG001|Overall Study|Second malignancy|1|||
28013419|NCT00365365|54672250|FG002|Overall Study|Second malignancy|0|||
28013420|NCT00365365|54672248|FG000|Overall Study|Patient/physician decision|0|||
28013421|NCT00365365|54672249|FG001|Overall Study|Patient/physician decision|0|||
28013422|NCT00365365|54672250|FG002|Overall Study|Patient/physician decision|1|||
28013423|NCT00623727|54672260|FG000|Double Blind (DB)|Adverse Event|1|||
28013424|NCT00623727|54672261|FG001|Double Blind (DB)|Adverse Event|3|||
28013425|NCT00623727|54672260|FG000|Double Blind (DB)|Physician Decision|0|||
28013426|NCT00623727|54672261|FG001|Double Blind (DB)|Physician Decision|1|||
28013427|NCT00623727|54672260|FG000|Double Blind (DB)|Withdrawal by Subject|8|||
28013428|NCT00623727|54672261|FG001|Double Blind (DB)|Withdrawal by Subject|2|||
28013429|NCT00623727|54672260|FG000|Double Blind (DB)|Lack of Efficacy|2|||
28013430|NCT00623727|54672261|FG001|Double Blind (DB)|Lack of Efficacy|2|||
28013431|NCT00623727|54672260|FG000|Double Blind (DB)|Termination of the double-blind period|22|||
28013432|NCT00623727|54672261|FG001|Double Blind (DB)|Termination of the double-blind period|21|||
28013433|NCT00623727|54672260|FG000|Double Blind (DB)|Lost to Follow-up|1|||
28013434|NCT00623727|54672261|FG001|Double Blind (DB)|Lost to Follow-up|1|||
28013435|NCT00623727|54672260|FG000|Double Blind (DB)|Protocol Violation|2|||
28013436|NCT00623727|54672261|FG001|Double Blind (DB)|Protocol Violation|2|||
28013437|NCT00623727|54672260|FG000|Open Label Follow-up|Withdrawal by Subject|0|||
28013438|NCT00623727|54672261|FG001|Open Label Follow-up|Withdrawal by Subject|1|||
28013439|NCT00623727|54672260|FG000|Open Label Follow-up|Study termination|0|||
28013440|NCT00623727|54672261|FG001|Open Label Follow-up|Study termination|6|||
28013441|NCT00623727|54672260|FG000|Open Label Follow-up|Participant convenience|0|||
28013442|NCT00623727|54672261|FG001|Open Label Follow-up|Participant convenience|1|||
28013443|NCT00372775|54672269|FG000|Overall Study|Adverse Event|8|||
28013444|NCT00372775|54672269|FG000|Overall Study|Death|15|||
28013445|NCT00372775|54672269|FG000|Overall Study|Objective progression or relapse|30|||
28013446|NCT00372775|54672269|FG000|Overall Study|Global deterioration of health status|6|||
28013447|NCT00372775|54672269|FG000|Overall Study|Withdrawal by Subject|1|||
28013448|NCT00372775|54672269|FG000|Overall Study|Other|1|||
28013449|NCT00372775|54672269|FG000|Overall Study|Not Treated|2|||
28013450|NCT00372697|54672275|FG000|Overall Study|Protocol Violation|1|||
28013451|NCT00372697|54672276|FG001|Overall Study|Protocol Violation|1|||
28013452|NCT00690378|54672288|FG000|Overall Study|Adverse Event|1|||
28013453|NCT00690378|54672289|FG001|Overall Study|Adverse Event|0|||
28013454|NCT00690378|54672288|FG000|Overall Study|Withdrawal by Subject|2|||
28013455|NCT00690378|54672289|FG001|Overall Study|Withdrawal by Subject|0|||
28013456|NCT00690378|54672288|FG000|Overall Study|Protocol Violation|1|||
28013457|NCT00690378|54672289|FG001|Overall Study|Protocol Violation|0|||
28013458|NCT00690378|54672288|FG000|Overall Study|Lost to Follow-up|2|||
28013459|NCT00690378|54672289|FG001|Overall Study|Lost to Follow-up|3|||
28013460|NCT00690378|54672288|FG000|Overall Study|Did not meet inc/exc criteria|13|||
28013461|NCT00690378|54672289|FG001|Overall Study|Did not meet inc/exc criteria|11|||
28013462|NCT00690378|54672288|FG000|Overall Study|Social problem|1|||
28013463|NCT00690378|54672289|FG001|Overall Study|Social problem|0|||
28013464|NCT00574275|54672297|FG000|Overall Study|Randomized but not treated|2|||
28013465|NCT00574275|54672298|FG001|Overall Study|Randomized but not treated|3|||
28013466|NCT00574275|54672297|FG000|Overall Study|Adverse Event|32|||
28013467|NCT00574275|54672298|FG001|Overall Study|Adverse Event|76|||
28013468|NCT00574275|54672297|FG000|Overall Study|Disease progression|160|||
28013469|NCT00574275|54672298|FG001|Overall Study|Disease progression|146|||
28013470|NCT00574275|54672297|FG000|Overall Study|Lost to Follow-up|2|||
28013471|NCT00574275|54672298|FG001|Overall Study|Lost to Follow-up|1|||
28013472|NCT00574275|54672297|FG000|Overall Study|Study stopped based on DMC decision|62|||
28013473|NCT00574275|54672298|FG001|Overall Study|Study stopped based on DMC decision|23|||
28013474|NCT00574275|54672297|FG000|Overall Study|Withdrawal by Subject|15|||
28013475|NCT00574275|54672298|FG001|Overall Study|Withdrawal by Subject|17|||
28013476|NCT00574275|54672297|FG000|Overall Study|Error calculating tumor measurement|1|||
28013477|NCT00574275|54672298|FG001|Overall Study|Error calculating tumor measurement|0|||
28013478|NCT00574275|54672297|FG000|Overall Study|Physician Decision|1|||
28013479|NCT00574275|54672298|FG001|Overall Study|Physician Decision|1|||
28013480|NCT00574275|54672297|FG000|Overall Study|Protocol Violation|0|||
28013481|NCT00574275|54672298|FG001|Overall Study|Protocol Violation|1|||
28013482|NCT00574275|54672297|FG000|Overall Study|Patient and Investigator decision|0|||
28013483|NCT00574275|54672298|FG001|Overall Study|Patient and Investigator decision|1|||
28013484|NCT00574275|54672297|FG000|Overall Study|Insurance change|0|||
28013485|NCT00574275|54672298|FG001|Overall Study|Insurance change|1|||
28013486|NCT00574275|54672297|FG000|Overall Study|Operation for curative intent|0|||
28013487|NCT00574275|54672298|FG001|Overall Study|Operation for curative intent|1|||
28013488|NCT00567112|54672304|FG000|Treatment Period 2 (3 Days)|Protocol Violation|0|||
28013489|NCT00567112|54672305|FG001|Treatment Period 2 (3 Days)|Protocol Violation|1|||
28013490|NCT00567112|54672306|FG002|Treatment Period 2 (3 Days)|Protocol Violation|0|||
28013491|NCT00567112|54672304|FG000|Washout Period 3 (3 Days)|Lost to Follow-up|2|||
28013492|NCT00567112|54672305|FG001|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
28013493|NCT00567112|54672306|FG002|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
28013494|NCT00567112|54672304|FG000|Washout Period 3 (3 Days)|Protocol Violation|1|||
28013495|NCT00567112|54672305|FG001|Washout Period 3 (3 Days)|Protocol Violation|0|||
28013496|NCT00567112|54672306|FG002|Washout Period 3 (3 Days)|Protocol Violation|0|||
28013497|NCT01618656|54672326|FG000|Overall Study|Withdrawal by Subject|7|||
28013498|NCT01618656|54672327|FG001|Overall Study|Withdrawal by Subject|3|||
28013499|NCT01618656|54672326|FG000|Overall Study|Physician Decision|1|||
28013500|NCT01618656|54672327|FG001|Overall Study|Physician Decision|1|||
28013501|NCT03978832|54672333|FG000|Overall Study|Adverse Event|1|||
28013502|NCT03978832|54672333|FG000|Overall Study|Lost to Follow-up|1|||
28013503|NCT03978832|54672333|FG000|Overall Study|Withdrawal by Subject|6|||
28013504|NCT03978832|54672333|FG000|Overall Study|Physician Decision|2|||
28013505|NCT03978832|54672333|FG000|Overall Study|did not pass screening criteria|44|||
28013506|NCT00566722|54672340|FG000|Overall Study|Adverse Event|0|||
28013507|NCT00566722|54672341|FG001|Overall Study|Adverse Event|1|||
28013508|NCT00566722|54672342|FG002|Overall Study|Adverse Event|0|||
28013509|NCT00566722|54672340|FG000|Overall Study|Withdrawal by Subject|0|||
28013510|NCT00566722|54672341|FG001|Overall Study|Withdrawal by Subject|0|||
28013511|NCT00566722|54672342|FG002|Overall Study|Withdrawal by Subject|1|||
28013512|NCT00566722|54672340|FG000|Overall Study|Lost to Follow-up|1|||
28013513|NCT00566722|54672341|FG001|Overall Study|Lost to Follow-up|1|||
28013514|NCT00566722|54672342|FG002|Overall Study|Lost to Follow-up|1|||
28013515|NCT00566722|54672340|FG000|Overall Study|Lack of Efficacy|1|||
28013516|NCT00566722|54672341|FG001|Overall Study|Lack of Efficacy|2|||
28013517|NCT00566722|54672342|FG002|Overall Study|Lack of Efficacy|4|||
28013518|NCT00566722|54672340|FG000|Overall Study|Did not meet exclusion criteria|0|||
28013519|NCT00566722|54672341|FG001|Overall Study|Did not meet exclusion criteria|0|||
28013520|NCT00566722|54672342|FG002|Overall Study|Did not meet exclusion criteria|2|||
28013521|NCT00566722|54672340|FG000|Overall Study|Serious adverse event|0|||
28013522|NCT00566722|54672341|FG001|Overall Study|Serious adverse event|1|||
28013523|NCT00566722|54672342|FG002|Overall Study|Serious adverse event|0|||
28013524|NCT00566722|54672340|FG000|Overall Study|Noncompliant with drug administration|0|||
28013525|NCT00566722|54672341|FG001|Overall Study|Noncompliant with drug administration|0|||
28013526|NCT00566722|54672342|FG002|Overall Study|Noncompliant with drug administration|1|||
28013527|NCT00691704|54672353|FG000|Induction Therapy|Disease Progression|1|||
28013528|NCT00691704|54672353|FG000|Induction Therapy|Active Hepatitis|1|||
28013529|NCT00691704|54672353|FG000|Two Years of Maintenance Therapy|Disease Progression|8|||
28013530|NCT00691704|54672353|FG000|Two Years of Maintenance Therapy|Physician Decision|4|||
28013531|NCT00691704|54672353|FG000|Two Years of Maintenance Therapy|Withdrawal by Subject|1|||
28013532|NCT00566020|54672357|FG000|6-week Dosage Adjustment Phase|Adverse Event|5|||
28013533|NCT00566020|54672358|FG001|6-week Dosage Adjustment Phase|Adverse Event|0|||
28013534|NCT00566020|54672357|FG000|6-week Dosage Adjustment Phase|Lack of Efficacy|2|||
28013535|NCT00566020|54672358|FG001|6-week Dosage Adjustment Phase|Lack of Efficacy|0|||
28013536|NCT00566020|54672357|FG000|46-week Long-term Administration Phase|Adverse Event|0|||
28013537|NCT00566020|54672358|FG001|46-week Long-term Administration Phase|Adverse Event|7|||
28013538|NCT00566020|54672357|FG000|46-week Long-term Administration Phase|Physician Decision|0|||
28013539|NCT00566020|54672358|FG001|46-week Long-term Administration Phase|Physician Decision|7|||
28013540|NCT00566020|54672357|FG000|46-week Long-term Administration Phase|Lost to Follow-up|0|||
28013541|NCT00566020|54672358|FG001|46-week Long-term Administration Phase|Lost to Follow-up|2|||
28013542|NCT00566020|54672357|FG000|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0|||
28013543|NCT00566020|54672358|FG001|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1|||
28013544|NCT00564070|54672365|FG000|Overall Study|Lost to Follow-up|9|||
28013545|NCT00564070|54672366|FG001|Overall Study|Lost to Follow-up|7|||
28013546|NCT00564070|54672365|FG000|Overall Study|Worsening depression, referred to care|3|||
28013547|NCT00564070|54672366|FG001|Overall Study|Worsening depression, referred to care|0|||
28013548|NCT00690612|54672372|FG000|Overall Study|Adverse Event|1|||
28013549|NCT00690612|54672372|FG000|Overall Study|Withdrawal by Subject|2|||
28013550|NCT00621153|54672378|FG000|Overall Study|Safety Reason|8|||
28013551|NCT00621153|54672379|FG001|Overall Study|Safety Reason|7|||
28013552|NCT00621153|54672378|FG000|Overall Study|Adverse Event|3|||
28013553|NCT00621153|54672379|FG001|Overall Study|Adverse Event|2|||
28013554|NCT00621153|54672378|FG000|Overall Study|Lost to Follow-up|5|||
28013555|NCT00621153|54672379|FG001|Overall Study|Lost to Follow-up|1|||
28013556|NCT00621153|54672378|FG000|Overall Study|Withdrawal by Subject|4|||
28013557|NCT00621153|54672379|FG001|Overall Study|Withdrawal by Subject|5|||
28013558|NCT00574119|54672385|FG000|Overall Study|Adverse Event|1|||
28013559|NCT00574119|54672385|FG000|Overall Study|Protocol Violation|1|||
28013560|NCT00574119|54672385|FG000|Overall Study|Withdrawal by Subject|1|||
28013561|NCT00574119|54672385|FG000|Overall Study|Physician Decision|1|||
28013562|NCT00705614|54672391|FG000|Initial Intervention|Adverse Event|40|||
28013563|NCT00705614|54672392|FG001|Initial Intervention|Adverse Event|21|||
28013564|NCT00705614|54672391|FG000|Initial Intervention|Lost to Follow-up|310|||
28013565|NCT00705614|54672392|FG001|Initial Intervention|Lost to Follow-up|191|||
28013566|NCT00705614|54672391|FG000|Initial Intervention|Withdrawal by Subject|114|||
28013567|NCT00705614|54672392|FG001|Initial Intervention|Withdrawal by Subject|71|||
28013568|NCT00705614|54672391|FG000|Initial Intervention|Administrative Reason|51|||
28013569|NCT00705614|54672392|FG001|Initial Intervention|Administrative Reason|38|||
28013570|NCT00705614|54672391|FG000|Initial Intervention|Status completion unknown|3|||
28013571|NCT00705614|54672392|FG001|Initial Intervention|Status completion unknown|0|||
28013572|NCT00705614|54672391|FG000|Switch to Remicade|Adverse Event|0|||
28013573|NCT00705614|54672392|FG001|Switch to Remicade|Adverse Event|5|||
28013574|NCT00705614|54672391|FG000|Switch to Remicade|Lost to Follow-up|0|||
28013575|NCT00705614|54672392|FG001|Switch to Remicade|Lost to Follow-up|23|||
28013576|NCT00705614|54672391|FG000|Switch to Remicade|Withdrawal by Subject|0|||
28013577|NCT00705614|54672392|FG001|Switch to Remicade|Withdrawal by Subject|12|||
28013578|NCT00705614|54672391|FG000|Switch to Remicade|Administrative Reason|0|||
28013579|NCT00705614|54672392|FG001|Switch to Remicade|Administrative Reason|9|||
28013580|NCT00620763|54672400|FG000|Period: First Intervention|Withdrawal by Subject|0|||
28013581|NCT00620763|54672401|FG001|Period: First Intervention|Withdrawal by Subject|2|||
28013582|NCT00620763|54672400|FG000|Period: First Intervention|Protocol Violation|0|||
28013583|NCT00620763|54672401|FG001|Period: First Intervention|Protocol Violation|3|||
28013584|NCT00620763|54672400|FG000|Period: Second Intervention|Withdrawal by Subject|1|||
28013585|NCT00620763|54672401|FG001|Period: Second Intervention|Withdrawal by Subject|0|||
28013586|NCT00562978|54672409|FG000|Overall Study|Patient had imaging dose only|1|||
28013587|NCT00562978|54672410|FG001|Overall Study|Patient had imaging dose only|11|||
28013588|NCT00620373|54672416|FG000|Overall Study|Unverified cancer status|33|||
28013589|NCT00372619|54672430|FG000|Overall Study|Ineligible|0|||
28013590|NCT00372619|54672431|FG001|Overall Study|Ineligible|0|||
28013591|NCT00372619|54672432|FG002|Overall Study|Ineligible|0|||
28013592|NCT00372619|54672433|FG003|Overall Study|Ineligible|0|||
28013593|NCT00372619|54672434|FG004|Overall Study|Ineligible|0|||
28013594|NCT00372619|54672435|FG005|Overall Study|Ineligible|2|||
28013595|NCT00372619|54672436|FG006|Overall Study|Ineligible|0|||
28013596|NCT00372619|54672430|FG000|Overall Study|Inevaluable|0|||
28013597|NCT00372619|54672431|FG001|Overall Study|Inevaluable|0|||
28013598|NCT00372619|54672432|FG002|Overall Study|Inevaluable|0|||
28013599|NCT00372619|54672433|FG003|Overall Study|Inevaluable|0|||
28013600|NCT00372619|54672434|FG004|Overall Study|Inevaluable|0|||
28013601|NCT00372619|54672435|FG005|Overall Study|Inevaluable|1|||
28013602|NCT00372619|54672436|FG006|Overall Study|Inevaluable|0|||
28013603|NCT00562588|54672454|FG000|Overall Study|Adverse Event|40|||
28013604|NCT00562588|54672455|FG001|Overall Study|Adverse Event|58|||
28013605|NCT00562588|54672454|FG000|Overall Study|Protocol Violation|30|||
28013606|NCT00562588|54672455|FG001|Overall Study|Protocol Violation|26|||
28013607|NCT00562588|54672454|FG000|Overall Study|Lost to Follow-up|12|||
28013608|NCT00562588|54672455|FG001|Overall Study|Lost to Follow-up|4|||
28013609|NCT00562588|54672454|FG000|Overall Study|Withdrawal by Subject|10|||
28013610|NCT00562588|54672455|FG001|Overall Study|Withdrawal by Subject|9|||
28013611|NCT00562588|54672454|FG000|Overall Study|Other|0|||
28013612|NCT00562588|54672455|FG001|Overall Study|Other|2|||
28013613|NCT00622167|54672461|FG000|Overall Study|Did not meet angiographic criteria|20|||
28013614|NCT00562354|54672467|FG000|Overall Study|Physician Decision|0|||
28013615|NCT00562354|54672468|FG001|Overall Study|Physician Decision|1|||
28013616|NCT00562354|54672467|FG000|Overall Study|Lost to Follow-up|0|||
28013617|NCT00562354|54672468|FG001|Overall Study|Lost to Follow-up|1|||
28013618|NCT00372385|54672480|FG000|Overall Study|Adverse Event|6|||
28013619|NCT00372385|54672481|FG001|Overall Study|Adverse Event|11|||
28013620|NCT00372385|54672482|FG002|Overall Study|Adverse Event|9|||
28013621|NCT00372385|54672483|FG003|Overall Study|Adverse Event|7|||
28013622|NCT00372385|54672480|FG000|Overall Study|Noncompliance|0|||
28013623|NCT00372385|54672481|FG001|Overall Study|Noncompliance|1|||
28013624|NCT00372385|54672482|FG002|Overall Study|Noncompliance|1|||
28013625|NCT00372385|54672483|FG003|Overall Study|Noncompliance|1|||
28013626|NCT00372385|54672480|FG000|Overall Study|Physician Decision|1|||
28013627|NCT00372385|54672481|FG001|Overall Study|Physician Decision|0|||
28013628|NCT00372385|54672482|FG002|Overall Study|Physician Decision|0|||
28013629|NCT00372385|54672483|FG003|Overall Study|Physician Decision|0|||
28013630|NCT00372385|54672480|FG000|Overall Study|Lost to Follow-up|2|||
28013631|NCT00372385|54672481|FG001|Overall Study|Lost to Follow-up|0|||
28013632|NCT00372385|54672482|FG002|Overall Study|Lost to Follow-up|0|||
28013633|NCT00372385|54672483|FG003|Overall Study|Lost to Follow-up|0|||
28013634|NCT00372385|54672480|FG000|Overall Study|Withdrawal by Subject|2|||
28013635|NCT00372385|54672481|FG001|Overall Study|Withdrawal by Subject|1|||
28013636|NCT00372385|54672482|FG002|Overall Study|Withdrawal by Subject|0|||
28013637|NCT00372385|54672483|FG003|Overall Study|Withdrawal by Subject|0|||
28013638|NCT00372385|54672480|FG000|Overall Study|Refusal of Treatment|3|||
28013639|NCT00372385|54672481|FG001|Overall Study|Refusal of Treatment|6|||
28013640|NCT00372385|54672482|FG002|Overall Study|Refusal of Treatment|0|||
28013641|NCT00372385|54672483|FG003|Overall Study|Refusal of Treatment|0|||
28013642|NCT00372385|54672480|FG000|Overall Study|No Response|1|||
28013643|NCT00372385|54672481|FG001|Overall Study|No Response|1|||
28013644|NCT00372385|54672482|FG002|Overall Study|No Response|0|||
28013645|NCT00372385|54672483|FG003|Overall Study|No Response|0|||
28013646|NCT00372385|54672480|FG000|Overall Study|Ineligibility due to Exclusion Criterion|1|||
28013647|NCT00372385|54672481|FG001|Overall Study|Ineligibility due to Exclusion Criterion|0|||
28013648|NCT00372385|54672482|FG002|Overall Study|Ineligibility due to Exclusion Criterion|0|||
28013649|NCT00372385|54672483|FG003|Overall Study|Ineligibility due to Exclusion Criterion|0|||
28013650|NCT00372385|54672480|FG000|Overall Study|Virologic Stopping Rule|17|||
28013651|NCT00372385|54672481|FG001|Overall Study|Virologic Stopping Rule|0|||
28013652|NCT00372385|54672482|FG002|Overall Study|Virologic Stopping Rule|0|||
28013653|NCT00372385|54672483|FG003|Overall Study|Virologic Stopping Rule|0|||
28013654|NCT03830281|54672496|FG000|Lead-in Period (2 Weeks)|Adverse Event|2|||
28013655|NCT03830281|54672497|FG001|Lead-in Period (2 Weeks)|Adverse Event|0|||
28013656|NCT03830281|54672496|FG000|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6|||
28013657|NCT03830281|54672497|FG001|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0|||
28013658|NCT03830281|54672496|FG000|Lead-in Period (2 Weeks)|Physician Decision|2|||
28013659|NCT03830281|54672497|FG001|Lead-in Period (2 Weeks)|Physician Decision|0|||
28013660|NCT03830281|54672496|FG000|Lead-in Period (2 Weeks)|Withdrawal by Subject|29|||
28013661|NCT03830281|54672497|FG001|Lead-in Period (2 Weeks)|Withdrawal by Subject|0|||
28013662|NCT03830281|54672496|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
28013663|NCT03830281|54672497|FG001|Treatment Period (16 Weeks)|Adverse Event|7|||
28013664|NCT03830281|54672496|FG000|Treatment Period (16 Weeks)|Lost to Follow-up|4|||
28013665|NCT03830281|54672497|FG001|Treatment Period (16 Weeks)|Lost to Follow-up|3|||
28013666|NCT03830281|54672496|FG000|Treatment Period (16 Weeks)|Sponsor Decision|1|||
28013667|NCT03830281|54672497|FG001|Treatment Period (16 Weeks)|Sponsor Decision|1|||
28013668|NCT03830281|54672496|FG000|Treatment Period (16 Weeks)|Physician Decision|1|||
28013669|NCT03830281|54672497|FG001|Treatment Period (16 Weeks)|Physician Decision|0|||
28013670|NCT03830281|54672496|FG000|Treatment Period (16 Weeks)|Withdrawal by Subject|5|||
28013671|NCT03830281|54672497|FG001|Treatment Period (16 Weeks)|Withdrawal by Subject|6|||
28013672|NCT00563368|54672511|FG000|Overall Study|Lost to Follow-up|14|||
28013673|NCT00563368|54672512|FG001|Overall Study|Lost to Follow-up|14|||
28013674|NCT00563368|54672513|FG002|Overall Study|Lost to Follow-up|12|||
28013675|NCT00563368|54672514|FG003|Overall Study|Lost to Follow-up|6|||
28013676|NCT00563368|54672515|FG004|Overall Study|Lost to Follow-up|9|||
28013677|NCT00563368|54672516|FG005|Overall Study|Lost to Follow-up|8|||
28013678|NCT00563368|54672517|FG006|Overall Study|Lost to Follow-up|9|||
28013679|NCT00563368|54672511|FG000|Overall Study|Adverse Event|3|||
28013680|NCT00563368|54672512|FG001|Overall Study|Adverse Event|4|||
28013681|NCT00563368|54672513|FG002|Overall Study|Adverse Event|5|||
28013682|NCT00563368|54672514|FG003|Overall Study|Adverse Event|9|||
28013683|NCT00563368|54672515|FG004|Overall Study|Adverse Event|6|||
28013684|NCT00563368|54672516|FG005|Overall Study|Adverse Event|10|||
28013685|NCT00563368|54672517|FG006|Overall Study|Adverse Event|17|||
28013686|NCT00563368|54672511|FG000|Overall Study|Withdrawal by Subject|11|||
28013687|NCT00563368|54672512|FG001|Overall Study|Withdrawal by Subject|6|||
28013688|NCT00563368|54672513|FG002|Overall Study|Withdrawal by Subject|5|||
28013689|NCT00563368|54672514|FG003|Overall Study|Withdrawal by Subject|7|||
28013690|NCT00563368|54672515|FG004|Overall Study|Withdrawal by Subject|8|||
28013691|NCT00563368|54672516|FG005|Overall Study|Withdrawal by Subject|5|||
28013692|NCT00563368|54672517|FG006|Overall Study|Withdrawal by Subject|4|||
28013693|NCT00563368|54672511|FG000|Overall Study|protocol non-compliance|1|||
28013694|NCT00563368|54672512|FG001|Overall Study|protocol non-compliance|1|||
28013695|NCT00563368|54672513|FG002|Overall Study|protocol non-compliance|2|||
28013696|NCT00563368|54672514|FG003|Overall Study|protocol non-compliance|1|||
28013697|NCT00563368|54672515|FG004|Overall Study|protocol non-compliance|0|||
28013698|NCT00563368|54672516|FG005|Overall Study|protocol non-compliance|1|||
28013699|NCT00563368|54672517|FG006|Overall Study|protocol non-compliance|3|||
28013700|NCT00563368|54672511|FG000|Overall Study|Pregnancy|1|||
28013701|NCT00563368|54672512|FG001|Overall Study|Pregnancy|0|||
28013702|NCT00563368|54672513|FG002|Overall Study|Pregnancy|1|||
28013703|NCT00563368|54672514|FG003|Overall Study|Pregnancy|2|||
28013704|NCT00563368|54672515|FG004|Overall Study|Pregnancy|1|||
28013705|NCT00563368|54672516|FG005|Overall Study|Pregnancy|2|||
28013706|NCT00563368|54672517|FG006|Overall Study|Pregnancy|0|||
28013707|NCT00563368|54672511|FG000|Overall Study|requirement for restricted medication|0|||
28013708|NCT00563368|54672512|FG001|Overall Study|requirement for restricted medication|0|||
28013709|NCT00563368|54672513|FG002|Overall Study|requirement for restricted medication|2|||
28013710|NCT00563368|54672514|FG003|Overall Study|requirement for restricted medication|0|||
28013711|NCT00563368|54672515|FG004|Overall Study|requirement for restricted medication|0|||
28013712|NCT00563368|54672516|FG005|Overall Study|requirement for restricted medication|0|||
28013713|NCT00563368|54672517|FG006|Overall Study|requirement for restricted medication|0|||
28013714|NCT00563368|54672511|FG000|Overall Study|Other|5|||
28013715|NCT00563368|54672512|FG001|Overall Study|Other|5|||
28013716|NCT00563368|54672513|FG002|Overall Study|Other|3|||
28013717|NCT00563368|54672514|FG003|Overall Study|Other|4|||
28013718|NCT00563368|54672515|FG004|Overall Study|Other|4|||
28013719|NCT00563368|54672516|FG005|Overall Study|Other|4|||
28013720|NCT00563368|54672517|FG006|Overall Study|Other|0|||
28013721|NCT00390013|54672536|FG000|Phase 1|tired|0|||
28013722|NCT00390013|54672537|FG001|Phase 1|tired|0|||
28013723|NCT00390013|54672538|FG002|Phase 1|tired|0|||
28013724|NCT00390013|54672539|FG003|Phase 1|tired|1|||
28013725|NCT00390013|54672536|FG000|Phase 2 First Treatment|tired|1|||
28013726|NCT00390013|54672537|FG001|Phase 2 First Treatment|tired|0|||
28013727|NCT00390013|54672538|FG002|Phase 2 First Treatment|tired|0|||
28013728|NCT00390013|54672539|FG003|Phase 2 First Treatment|tired|0|||
28013729|NCT00390013|54672536|FG000|Phase 2 First Treatment|Withdrawal by Subject|0|||
28013730|NCT00390013|54672537|FG001|Phase 2 First Treatment|Withdrawal by Subject|1|||
28013731|NCT00390013|54672538|FG002|Phase 2 First Treatment|Withdrawal by Subject|0|||
28013732|NCT00390013|54672539|FG003|Phase 2 First Treatment|Withdrawal by Subject|0|||
28013733|NCT00561652|54672547|FG000|Overall Study|Withdrawal by Subject|0|||
28013734|NCT00561652|54672548|FG001|Overall Study|Withdrawal by Subject|1|||
28013735|NCT00697346|54672557|FG000|Overall Study|Adverse Event|4|||
28013736|NCT00697346|54672558|FG001|Overall Study|Adverse Event|5|||
28013737|NCT00697346|54672559|FG002|Overall Study|Adverse Event|0|||
28013738|NCT00697346|54672557|FG000|Overall Study|Progressive Disease|19|||
28013739|NCT00697346|54672558|FG001|Overall Study|Progressive Disease|18|||
28013740|NCT00697346|54672559|FG002|Overall Study|Progressive Disease|0|||
28013741|NCT00697346|54672557|FG000|Overall Study|Symptomatic Deterioration|0|||
28013742|NCT00697346|54672558|FG001|Overall Study|Symptomatic Deterioration|1|||
28013743|NCT00697346|54672559|FG002|Overall Study|Symptomatic Deterioration|0|||
28013744|NCT00697346|54672557|FG000|Overall Study|Withdrawal by Subject|2|||
28013745|NCT00697346|54672558|FG001|Overall Study|Withdrawal by Subject|2|||
28013746|NCT00697346|54672559|FG002|Overall Study|Withdrawal by Subject|0|||
28013747|NCT00697346|54672557|FG000|Overall Study|Reason not Specified|3|||
28013748|NCT00697346|54672558|FG001|Overall Study|Reason not Specified|0|||
28013749|NCT00697346|54672559|FG002|Overall Study|Reason not Specified|1|||
28013750|NCT00562120|54672586|FG000|First Intervention Period|Adverse Event|1|||
28013751|NCT00562120|54672587|FG001|First Intervention Period|Adverse Event|0|||
28013752|NCT00562120|54672588|FG002|First Intervention Period|Adverse Event|0|||
28013753|NCT00562120|54672589|FG003|First Intervention Period|Adverse Event|0|||
28013754|NCT00562120|54672586|FG000|First Intervention Period|Randomized but not Treated|1|||
28013755|NCT00562120|54672587|FG001|First Intervention Period|Randomized but not Treated|0|||
28013756|NCT00562120|54672588|FG002|First Intervention Period|Randomized but not Treated|0|||
28013757|NCT00562120|54672589|FG003|First Intervention Period|Randomized but not Treated|0|||
28013758|NCT00561730|54672599|FG000|Overall Study|Adverse Event|2|||
28013759|NCT00561730|54672599|FG000|Overall Study|Handling of the drug|1|||
28013760|NCT00561730|54672599|FG000|Overall Study|Lost to Follow-up|5|||
28013761|NCT00561730|54672599|FG000|Overall Study|Not specified reasons|1|||
28013762|NCT00697112|54672605|FG000|Overall Study|Adverse Event|8|||
28013763|NCT00697112|54672605|FG000|Overall Study|Lost to Follow-up|1|||
28013764|NCT00697112|54672605|FG000|Overall Study|Did not meet inclusion criteria|1|||
28013765|NCT00621855|54672614|FG000|Overall Study|Adverse Event|32|||
28013766|NCT00621855|54672615|FG001|Overall Study|Adverse Event|31|||
28013767|NCT00621855|54672616|FG002|Overall Study|Adverse Event|48|||
28013768|NCT00621855|54672617|FG003|Overall Study|Adverse Event|34|||
28013769|NCT00621855|54672618|FG004|Overall Study|Adverse Event|31|||
28013770|NCT00621855|54672614|FG000|Overall Study|Lost to Follow-up|0|||
28013771|NCT00621855|54672615|FG001|Overall Study|Lost to Follow-up|1|||
28013772|NCT00621855|54672616|FG002|Overall Study|Lost to Follow-up|3|||
28013773|NCT00621855|54672617|FG003|Overall Study|Lost to Follow-up|4|||
28013774|NCT00621855|54672618|FG004|Overall Study|Lost to Follow-up|1|||
28013775|NCT00621855|54672614|FG000|Overall Study|Protocol Violation|16|||
28013776|NCT00621855|54672615|FG001|Overall Study|Protocol Violation|8|||
28013777|NCT00621855|54672616|FG002|Overall Study|Protocol Violation|6|||
28013778|NCT00621855|54672617|FG003|Overall Study|Protocol Violation|7|||
28013779|NCT00621855|54672618|FG004|Overall Study|Protocol Violation|8|||
28013780|NCT00621855|54672614|FG000|Overall Study|Withdrawal by Subject|16|||
28013781|NCT00621855|54672615|FG001|Overall Study|Withdrawal by Subject|11|||
28013782|NCT00621855|54672616|FG002|Overall Study|Withdrawal by Subject|13|||
27742260|NCT02639065|54192286|FG000|Follow up|Symptomatic Deterioration|2|||
27742261|NCT02639065|54192286|FG000|Follow up|Death|2|||
27742262|NCT02639065|54192286|FG000|Follow up|Study Terminated|1|||
27742263|NCT02639065|54192286|FG000|Follow up|Disease Progression|3|||
28013783|NCT00621855|54672617|FG003|Overall Study|Withdrawal by Subject|13|||
28013784|NCT00621855|54672618|FG004|Overall Study|Withdrawal by Subject|9|||
28013785|NCT00621855|54672614|FG000|Overall Study|Other|9|||
28013786|NCT00621855|54672615|FG001|Overall Study|Other|7|||
28013787|NCT00621855|54672616|FG002|Overall Study|Other|6|||
28013788|NCT00621855|54672617|FG003|Overall Study|Other|5|||
27742270|NCT01092143|54192304|FG000|Overall Study|Adverse Event|10|||
27742271|NCT01092143|54192305|FG001|Overall Study|Adverse Event|5|||
27742272|NCT01092143|54192306|FG002|Overall Study|Adverse Event|1|||
27742273|NCT01092143|54192307|FG003|Overall Study|Adverse Event|4|||
27742274|NCT01092143|54192308|FG004|Overall Study|Adverse Event|3|||
27742275|NCT01092143|54192304|FG000|Overall Study|Lost to Follow-up|1|||
27742276|NCT01092143|54192305|FG001|Overall Study|Lost to Follow-up|0|||
27742277|NCT01092143|54192306|FG002|Overall Study|Lost to Follow-up|1|||
27742278|NCT01092143|54192307|FG003|Overall Study|Lost to Follow-up|0|||
28013789|NCT00621855|54672618|FG004|Overall Study|Other|4|||
28013790|NCT00621855|54672614|FG000|Overall Study|Patients did not receive study drug|3|||
27742279|NCT01092143|54192308|FG004|Overall Study|Lost to Follow-up|0|||
27742280|NCT01092143|54192304|FG000|Overall Study|Consent withdrawn|2|||
27742281|NCT01092143|54192305|FG001|Overall Study|Consent withdrawn|1|||
27742282|NCT01092143|54192306|FG002|Overall Study|Consent withdrawn|0|||
27742283|NCT01092143|54192307|FG003|Overall Study|Consent withdrawn|1|||
27742284|NCT01092143|54192308|FG004|Overall Study|Consent withdrawn|3|||
27742285|NCT01092143|54192304|FG000|Overall Study|Not treated|0|||
27742286|NCT01092143|54192305|FG001|Overall Study|Not treated|0|||
27742287|NCT01092143|54192306|FG002|Overall Study|Not treated|1|||
27742288|NCT01092143|54192307|FG003|Overall Study|Not treated|0|||
27742289|NCT01092143|54192308|FG004|Overall Study|Not treated|0|||
27742290|NCT01092143|54192304|FG000|Overall Study|did not reversibility criteria|0|||
27742291|NCT01092143|54192305|FG001|Overall Study|did not reversibility criteria|0|||
27742292|NCT01092143|54192306|FG002|Overall Study|did not reversibility criteria|1|||
27742293|NCT01092143|54192307|FG003|Overall Study|did not reversibility criteria|0|||
27742294|NCT01092143|54192308|FG004|Overall Study|did not reversibility criteria|0|||
27742295|NCT01092143|54192304|FG000|Overall Study|Increased Albuterol use for >2 days|0|||
27742296|NCT01092143|54192305|FG001|Overall Study|Increased Albuterol use for >2 days|1|||
27742297|NCT01092143|54192306|FG002|Overall Study|Increased Albuterol use for >2 days|0|||
27742298|NCT01092143|54192307|FG003|Overall Study|Increased Albuterol use for >2 days|0|||
27742299|NCT01092143|54192308|FG004|Overall Study|Increased Albuterol use for >2 days|0|||
27742300|NCT01092143|54192304|FG000|Overall Study|Ineligible patient|1|||
27742301|NCT01092143|54192305|FG001|Overall Study|Ineligible patient|0|||
27742302|NCT01092143|54192306|FG002|Overall Study|Ineligible patient|0|||
27742303|NCT01092143|54192307|FG003|Overall Study|Ineligible patient|0|||
27742304|NCT01092143|54192308|FG004|Overall Study|Ineligible patient|0|||
27742305|NCT01092143|54192304|FG000|Overall Study|Drop in FEV1 at visit 9|1|||
27742306|NCT01092143|54192305|FG001|Overall Study|Drop in FEV1 at visit 9|0|||
27742307|NCT01092143|54192306|FG002|Overall Study|Drop in FEV1 at visit 9|0|||
27742308|NCT01092143|54192307|FG003|Overall Study|Drop in FEV1 at visit 9|0|||
27742309|NCT01092143|54192308|FG004|Overall Study|Drop in FEV1 at visit 9|0|||
27742310|NCT01092143|54192304|FG000|Overall Study|Patient travel|0|||
27742311|NCT01092143|54192305|FG001|Overall Study|Patient travel|0|||
27742312|NCT01092143|54192306|FG002|Overall Study|Patient travel|0|||
27742313|NCT01092143|54192307|FG003|Overall Study|Patient travel|0|||
27742314|NCT01092143|54192308|FG004|Overall Study|Patient travel|1|||
27742315|NCT01092143|54192304|FG000|Overall Study|Non compliance with study medication|0|||
27742316|NCT01092143|54192305|FG001|Overall Study|Non compliance with study medication|0|||
27742317|NCT01092143|54192306|FG002|Overall Study|Non compliance with study medication|0|||
27742318|NCT01092143|54192307|FG003|Overall Study|Non compliance with study medication|0|||
27742319|NCT01092143|54192308|FG004|Overall Study|Non compliance with study medication|1|||
27742320|NCT01092143|54192304|FG000|Overall Study|Randomized by mistake|0|||
27742321|NCT01092143|54192305|FG001|Overall Study|Randomized by mistake|0|||
27742322|NCT01092143|54192306|FG002|Overall Study|Randomized by mistake|0|||
27742323|NCT01092143|54192307|FG003|Overall Study|Randomized by mistake|1|||
27742324|NCT01092143|54192308|FG004|Overall Study|Randomized by mistake|0|||
27742325|NCT01092143|54192304|FG000|Overall Study|Pregnancy|0|||
27742326|NCT01092143|54192305|FG001|Overall Study|Pregnancy|0|||
27742327|NCT01092143|54192306|FG002|Overall Study|Pregnancy|0|||
27742328|NCT01092143|54192307|FG003|Overall Study|Pregnancy|1|||
27742329|NCT01092143|54192308|FG004|Overall Study|Pregnancy|0|||
27742330|NCT02377466|54192322|FG000|Overall Study|Other: Randomized and not treated|0|||
27742331|NCT02377466|54192323|FG001|Overall Study|Other: Randomized and not treated|2|||
27742332|NCT00950989|54192340|FG000|Overall Study|Death|0|||
27742333|NCT00950989|54192341|FG001|Overall Study|Death|0|||
27742334|NCT00950989|54192342|FG002|Overall Study|Death|1|||
27742335|NCT00950989|54192343|FG003|Overall Study|Death|0|||
27742336|NCT00950989|54192340|FG000|Overall Study|Administrative Decision|0|||
27742337|NCT00950989|54192341|FG001|Overall Study|Administrative Decision|1|||
27742338|NCT00950989|54192342|FG002|Overall Study|Administrative Decision|0|||
27742339|NCT00950989|54192343|FG003|Overall Study|Administrative Decision|0|||
27742340|NCT00950989|54192340|FG000|Overall Study|Disease Progression|0|||
27742341|NCT00950989|54192341|FG001|Overall Study|Disease Progression|0|||
27742342|NCT00950989|54192342|FG002|Overall Study|Disease Progression|1|||
27742343|NCT00950989|54192343|FG003|Overall Study|Disease Progression|0|||
27742344|NCT00950989|54192340|FG000|Overall Study|Withdrawal by Subject|2|||
27742345|NCT00950989|54192341|FG001|Overall Study|Withdrawal by Subject|1|||
27742346|NCT00950989|54192342|FG002|Overall Study|Withdrawal by Subject|0|||
27742347|NCT00950989|54192343|FG003|Overall Study|Withdrawal by Subject|0|||
27742348|NCT00950989|54192340|FG000|Overall Study|Adverse Event|2|||
27742349|NCT00950989|54192341|FG001|Overall Study|Adverse Event|1|||
27742350|NCT00950989|54192342|FG002|Overall Study|Adverse Event|1|||
27742351|NCT00950989|54192343|FG003|Overall Study|Adverse Event|0|||
27742352|NCT00593567|54192358|FG000|Overall Study|Adverse Event|2|||
27742353|NCT00593567|54192359|FG001|Overall Study|Adverse Event|0|||
27742354|NCT00593567|54192358|FG000|Overall Study|Physician Decision|2|||
27742355|NCT00593567|54192359|FG001|Overall Study|Physician Decision|0|||
27742356|NCT00593567|54192358|FG000|Overall Study|Protocol Violation|13|||
27742357|NCT00593567|54192359|FG001|Overall Study|Protocol Violation|7|||
27742358|NCT00593567|54192358|FG000|Overall Study|Lack of Efficacy|2|||
27742359|NCT00593567|54192359|FG001|Overall Study|Lack of Efficacy|1|||
27742360|NCT00593567|54192358|FG000|Overall Study|Withdrawal by Subject|1|||
27742361|NCT00593567|54192359|FG001|Overall Study|Withdrawal by Subject|2|||
27742362|NCT02411084|54192367|FG000|Overall Study|Lack of Efficacy|6|||
27742363|NCT02411084|54192368|FG001|Overall Study|Lack of Efficacy|3|||
27742364|NCT02411084|54192367|FG000|Overall Study|Death|5|||
27742365|NCT02411084|54192368|FG001|Overall Study|Death|4|||
27742366|NCT02411084|54192367|FG000|Overall Study|Adverse Event|2|||
27742367|NCT02411084|54192368|FG001|Overall Study|Adverse Event|1|||
27742368|NCT02411084|54192367|FG000|Overall Study|Other reasons|0|||
27742369|NCT02411084|54192368|FG001|Overall Study|Other reasons|5|||
27742370|NCT01602315|54192381|FG000|Overall Study|Protocol Violation|0|||
27742371|NCT01602315|54192382|FG001|Overall Study|Protocol Violation|0|||
27742372|NCT01602315|54192383|FG002|Overall Study|Protocol Violation|0|||
27742373|NCT01602315|54192384|FG003|Overall Study|Protocol Violation|0|||
27742374|NCT01602315|54192385|FG004|Overall Study|Protocol Violation|0|||
27742375|NCT01602315|54192386|FG005|Overall Study|Protocol Violation|1|||
27742376|NCT01602315|54192387|FG006|Overall Study|Protocol Violation|0|||
27742377|NCT01602315|54192381|FG000|Overall Study|Physician Decision|2|||
27742378|NCT01602315|54192382|FG001|Overall Study|Physician Decision|0|||
27742379|NCT01602315|54192383|FG002|Overall Study|Physician Decision|0|||
27742380|NCT01602315|54192384|FG003|Overall Study|Physician Decision|0|||
27742381|NCT01602315|54192385|FG004|Overall Study|Physician Decision|2|||
27742382|NCT01602315|54192386|FG005|Overall Study|Physician Decision|1|||
27742383|NCT01602315|54192387|FG006|Overall Study|Physician Decision|1|||
27742384|NCT01602315|54192381|FG000|Overall Study|Disease progression|6|||
27742385|NCT01602315|54192382|FG001|Overall Study|Disease progression|3|||
27742386|NCT01602315|54192383|FG002|Overall Study|Disease progression|10|||
27742387|NCT01602315|54192384|FG003|Overall Study|Disease progression|1|||
27742388|NCT01602315|54192385|FG004|Overall Study|Disease progression|41|||
27742389|NCT01602315|54192386|FG005|Overall Study|Disease progression|12|||
27742390|NCT01602315|54192387|FG006|Overall Study|Disease progression|15|||
27742391|NCT01602315|54192381|FG000|Overall Study|Death|1|||
27742392|NCT01602315|54192382|FG001|Overall Study|Death|1|||
27742393|NCT01602315|54192383|FG002|Overall Study|Death|1|||
27742394|NCT01602315|54192384|FG003|Overall Study|Death|1|||
27742395|NCT01602315|54192385|FG004|Overall Study|Death|7|||
27742396|NCT01602315|54192386|FG005|Overall Study|Death|2|||
27742397|NCT01602315|54192387|FG006|Overall Study|Death|2|||
27742398|NCT01602315|54192381|FG000|Overall Study|Withdrawal by Subject|2|||
27742399|NCT01602315|54192382|FG001|Overall Study|Withdrawal by Subject|0|||
27742400|NCT01602315|54192383|FG002|Overall Study|Withdrawal by Subject|2|||
27742401|NCT01602315|54192384|FG003|Overall Study|Withdrawal by Subject|0|||
27742402|NCT01602315|54192385|FG004|Overall Study|Withdrawal by Subject|6|||
27742403|NCT01602315|54192386|FG005|Overall Study|Withdrawal by Subject|0|||
27742404|NCT01602315|54192387|FG006|Overall Study|Withdrawal by Subject|1|||
27742405|NCT01602315|54192381|FG000|Overall Study|Adverse Event|5|||
27742406|NCT01602315|54192382|FG001|Overall Study|Adverse Event|1|||
27742407|NCT01602315|54192383|FG002|Overall Study|Adverse Event|5|||
27742408|NCT01602315|54192384|FG003|Overall Study|Adverse Event|4|||
27742409|NCT01602315|54192385|FG004|Overall Study|Adverse Event|15|||
27742410|NCT01602315|54192386|FG005|Overall Study|Adverse Event|3|||
27742411|NCT01602315|54192387|FG006|Overall Study|Adverse Event|9|||
27742412|NCT01602315|54192381|FG000|Overall Study|Subject/guardian decision|0|||
27742413|NCT01602315|54192382|FG001|Overall Study|Subject/guardian decision|0|||
27742414|NCT01602315|54192383|FG002|Overall Study|Subject/guardian decision|0|||
27742415|NCT01602315|54192384|FG003|Overall Study|Subject/guardian decision|0|||
27742416|NCT01602315|54192385|FG004|Overall Study|Subject/guardian decision|0|||
27742417|NCT01602315|54192386|FG005|Overall Study|Subject/guardian decision|0|||
27742418|NCT01602315|54192387|FG006|Overall Study|Subject/guardian decision|1|||
27742419|NCT01602315|54192381|FG000|Overall Study|Cross-over patients to combo treatment|0|||
27742420|NCT01602315|54192382|FG001|Overall Study|Cross-over patients to combo treatment|0|||
27742421|NCT01602315|54192383|FG002|Overall Study|Cross-over patients to combo treatment|0|||
27742422|NCT01602315|54192384|FG003|Overall Study|Cross-over patients to combo treatment|0|||
27742423|NCT01602315|54192385|FG004|Overall Study|Cross-over patients to combo treatment|0|||
27742424|NCT01602315|54192386|FG005|Overall Study|Cross-over patients to combo treatment|16|||
27742425|NCT01602315|54192387|FG006|Overall Study|Cross-over patients to combo treatment|0|||
27742426|NCT02344004|54192425|FG000|Overall Study|Adverse Event|11|||
27742427|NCT02344004|54192426|FG001|Overall Study|Adverse Event|1|||
27742428|NCT02344004|54192425|FG000|Overall Study|Death|9|||
27742429|NCT02344004|54192426|FG001|Overall Study|Death|7|||
27742430|NCT02344004|54192425|FG000|Overall Study|Physician Decision|4|||
27742431|NCT02344004|54192426|FG001|Overall Study|Physician Decision|1|||
27742432|NCT02344004|54192425|FG000|Overall Study|Withdrawal by Subject|22|||
27742433|NCT02344004|54192426|FG001|Overall Study|Withdrawal by Subject|5|||
27742434|NCT02344004|54192425|FG000|Overall Study|Rescue Medication|2|||
27742435|NCT02344004|54192426|FG001|Overall Study|Rescue Medication|0|||
27742436|NCT02344004|54192425|FG000|Overall Study|Other Not Specified|12|||
27742437|NCT02344004|54192426|FG001|Overall Study|Other Not Specified|0|||
27742438|NCT02344004|54192425|FG000|Overall Study|Protocol Violation|1|||
27742439|NCT02344004|54192426|FG001|Overall Study|Protocol Violation|0|||
27742440|NCT01328093|54192435|FG000|Double-Blind Phase|Adverse Event|78|||
27742441|NCT01328093|54192436|FG001|Double-Blind Phase|Adverse Event|15|||
27742442|NCT01328093|54192435|FG000|Double-Blind Phase|Withdrawal by Subject|42|||
27742443|NCT01328093|54192436|FG001|Double-Blind Phase|Withdrawal by Subject|14|||
27742444|NCT01328093|54192435|FG000|Double-Blind Phase|Lost to Follow-up|39|||
27742445|NCT01328093|54192436|FG001|Double-Blind Phase|Lost to Follow-up|14|||
27742446|NCT01328093|54192435|FG000|Double-Blind Phase|Protocol Violation|30|||
27742447|NCT01328093|54192436|FG001|Double-Blind Phase|Protocol Violation|10|||
27742448|NCT01328093|54192435|FG000|Double-Blind Phase|Lack of Efficacy|55|||
27742449|NCT01328093|54192436|FG001|Double-Blind Phase|Lack of Efficacy|13|||
27742450|NCT01328093|54192435|FG000|Double-Blind Phase|Sponsor Decision|17|||
27742451|NCT01328093|54192436|FG001|Double-Blind Phase|Sponsor Decision|3|||
27742452|NCT01328093|54192435|FG000|Double-Blind Phase|Entry Criteria Not Met|7|||
27742453|NCT01328093|54192436|FG001|Double-Blind Phase|Entry Criteria Not Met|5|||
27742454|NCT01328093|54192435|FG000|Double-Blind Phase|Scheduling conflict|8|||
27742455|NCT01328093|54192436|FG001|Double-Blind Phase|Scheduling conflict|3|||
27742456|NCT01328093|54192435|FG000|Double-Blind Phase|Subject is moving or has moved|8|||
27742457|NCT01328093|54192436|FG001|Double-Blind Phase|Subject is moving or has moved|1|||
27742458|NCT01328093|54192435|FG000|Double-Blind Phase|Death|1|||
27742459|NCT01328093|54192436|FG001|Double-Blind Phase|Death|0|||
27742460|NCT01328093|54192435|FG000|Open-Label Phase|Sponsor Decision|98|||
27742461|NCT01328093|54192436|FG001|Open-Label Phase|Sponsor Decision|34|||
27742462|NCT01328093|54192435|FG000|Open-Label Phase|Protocol Violation|8|||
27742463|NCT01328093|54192436|FG001|Open-Label Phase|Protocol Violation|3|||
27742464|NCT01328093|54192435|FG000|Open-Label Phase|Lost to Follow-up|10|||
27742465|NCT01328093|54192436|FG001|Open-Label Phase|Lost to Follow-up|1|||
27742466|NCT01328093|54192435|FG000|Open-Label Phase|Adverse Event|10|||
27742467|NCT01328093|54192436|FG001|Open-Label Phase|Adverse Event|4|||
27742468|NCT01328093|54192435|FG000|Open-Label Phase|Lack of Efficacy|5|||
27742469|NCT01328093|54192436|FG001|Open-Label Phase|Lack of Efficacy|6|||
27742470|NCT01328093|54192435|FG000|Open-Label Phase|Withdrawal by Subject|4|||
27742471|NCT01328093|54192436|FG001|Open-Label Phase|Withdrawal by Subject|1|||
27742472|NCT01328093|54192435|FG000|Open-Label Phase|Scheduling conflict|2|||
27742473|NCT01328093|54192436|FG001|Open-Label Phase|Scheduling conflict|1|||
27742474|NCT01328093|54192435|FG000|Open-Label Phase|Subject is moving or has moved|2|||
27742475|NCT01328093|54192436|FG001|Open-Label Phase|Subject is moving or has moved|0|||
27742476|NCT01328093|54192435|FG000|Open-Label Phase|Entry Criteria Not Met|1|||
27742477|NCT01328093|54192436|FG001|Open-Label Phase|Entry Criteria Not Met|0|||
27742478|NCT02654145|54192443|FG000|Overall Study|Lack of Efficacy|1|||
27742479|NCT02654145|54192443|FG000|Overall Study|Protocol Violation|1|||
27742480|NCT02654145|54192443|FG000|Overall Study|Withdrawal by Subject|5|||
27742481|NCT01111565|54192447|FG000|Phase B (Weeks 0 to 8)|Lost to Follow-up|3|||
27742482|NCT01111565|54192448|FG001|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
27742483|NCT01111565|54192449|FG002|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
27742484|NCT01111565|54192450|FG003|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
27742485|NCT01111565|54192451|FG004|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
27742486|NCT01111565|54192447|FG000|Phase B (Weeks 0 to 8)|Adverse Event|1|||
27742487|NCT01111565|54192448|FG001|Phase B (Weeks 0 to 8)|Adverse Event|0|||
27742488|NCT01111565|54192449|FG002|Phase B (Weeks 0 to 8)|Adverse Event|0|||
27742489|NCT01111565|54192450|FG003|Phase B (Weeks 0 to 8)|Adverse Event|0|||
27742490|NCT01111565|54192451|FG004|Phase B (Weeks 0 to 8)|Adverse Event|0|||
27742491|NCT01111565|54192447|FG000|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|58|||
27742492|NCT01111565|54192448|FG001|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
27742493|NCT01111565|54192449|FG002|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
27742494|NCT01111565|54192450|FG003|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
27742495|NCT01111565|54192451|FG004|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
27742496|NCT01111565|54192447|FG000|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|1|||
27742497|NCT01111565|54192448|FG001|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
27742498|NCT01111565|54192449|FG002|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
27742499|NCT01111565|54192450|FG003|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
27742500|NCT01111565|54192451|FG004|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
27742501|NCT01111565|54192447|FG000|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|1|||
27742502|NCT01111565|54192448|FG001|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
27742503|NCT01111565|54192449|FG002|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
27742504|NCT01111565|54192450|FG003|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
27742505|NCT01111565|54192451|FG004|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
27742506|NCT01111565|54192447|FG000|Phase B (Weeks 0 to 8)|Protocol Deviation|1|||
27742507|NCT01111565|54192448|FG001|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
27742508|NCT01111565|54192449|FG002|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
27742509|NCT01111565|54192450|FG003|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
27742510|NCT01111565|54192451|FG004|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
27742511|NCT01111565|54192447|FG000|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|1|||
27742512|NCT01111565|54192448|FG001|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
27742513|NCT01111565|54192449|FG002|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
27742514|NCT01111565|54192450|FG003|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
27742515|NCT01111565|54192451|FG004|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
27742516|NCT01111565|54192447|FG000|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
27742517|NCT01111565|54192448|FG001|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
27742518|NCT01111565|54192449|FG002|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
27742519|NCT01111565|54192450|FG003|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
27921970|NCT01087762|54578950|FG004|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14|||
27921971|NCT01087762|54578946|FG000|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
27921972|NCT01087762|54578947|FG001|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
27921973|NCT01087762|54578948|FG002|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
27921974|NCT01087762|54578949|FG003|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
27921975|NCT01087762|54578950|FG004|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
27921976|NCT01087762|54578946|FG000|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
27921977|NCT01087762|54578947|FG001|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
27921978|NCT01087762|54578948|FG002|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
27921979|NCT01087762|54578949|FG003|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5|||
27921980|NCT01087762|54578950|FG004|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2|||
27921981|NCT01087762|54578946|FG000|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
27921982|NCT01087762|54578947|FG001|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
27921983|NCT01087762|54578948|FG002|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
27921984|NCT01087762|54578949|FG003|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22|||
27921985|NCT01087762|54578950|FG004|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15|||
27921986|NCT01087762|54578946|FG000|Open-Label Period (Weeks 48-204)|Other|0|||
27921987|NCT01087762|54578947|FG001|Open-Label Period (Weeks 48-204)|Other|0|||
27921988|NCT01087762|54578948|FG002|Open-Label Period (Weeks 48-204)|Other|0|||
27921989|NCT01087762|54578949|FG003|Open-Label Period (Weeks 48-204)|Other|2|||
27921990|NCT01087762|54578950|FG004|Open-Label Period (Weeks 48-204)|Other|4|||
27921991|NCT01087762|54578946|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
27921992|NCT01087762|54578947|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
27921993|NCT01087762|54578948|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
27921994|NCT01087762|54578949|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7|||
27921995|NCT01087762|54578950|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4|||
27921996|NCT01087762|54578946|FG000|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
27921997|NCT01087762|54578947|FG001|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
27921998|NCT01087762|54578948|FG002|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
27921999|NCT01087762|54578949|FG003|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16|||
27922000|NCT01087762|54578950|FG004|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13|||
27922001|NCT01087762|54578946|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
27922002|NCT01087762|54578947|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
27922003|NCT01087762|54578948|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
27922004|NCT01087762|54578949|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2|||
27922005|NCT01087762|54578950|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4|||
27922006|NCT01078168|54578962|FG000|Overall Study|Physician Decision|0|||
27922007|NCT01078168|54578963|FG001|Overall Study|Physician Decision|1|||
27922008|NCT01086358|54578969|FG000|First Intervention|Lost to Follow-up|9|||
27922009|NCT01086358|54578970|FG001|First Intervention|Lost to Follow-up|4|||
27922010|NCT01086358|54578969|FG000|First Intervention|Withdrawal by Subject|0|||
27922011|NCT01086358|54578970|FG001|First Intervention|Withdrawal by Subject|1|||
27922012|NCT01086358|54578969|FG000|Second Intervention|Lost to Follow-up|4|||
27922013|NCT01086358|54578970|FG001|Second Intervention|Lost to Follow-up|4|||
27922014|NCT01277601|54578980|FG000|Overall Study|Adverse Event|5|||
27922015|NCT01277601|54578981|FG001|Overall Study|Adverse Event|3|||
27922016|NCT01277601|54578982|FG002|Overall Study|Adverse Event|0|||
27922017|NCT01277601|54578983|FG003|Overall Study|Adverse Event|7|||
27922018|NCT01277601|54578980|FG000|Overall Study|Withdrawal by Subject|18|||
27922019|NCT01277601|54578981|FG001|Overall Study|Withdrawal by Subject|21|||
27922020|NCT01277601|54578982|FG002|Overall Study|Withdrawal by Subject|8|||
27922021|NCT01277601|54578983|FG003|Overall Study|Withdrawal by Subject|17|||
27922022|NCT01277601|54578980|FG000|Overall Study|Lost to Follow-up|7|||
27922023|NCT01277601|54578981|FG001|Overall Study|Lost to Follow-up|9|||
27922024|NCT01277601|54578982|FG002|Overall Study|Lost to Follow-up|4|||
27922025|NCT01277601|54578983|FG003|Overall Study|Lost to Follow-up|2|||
27922026|NCT01277601|54578980|FG000|Overall Study|Physician Decision|3|||
27922027|NCT01277601|54578981|FG001|Overall Study|Physician Decision|5|||
27922028|NCT01277601|54578982|FG002|Overall Study|Physician Decision|1|||
27746367|NCT02120950|54195937|FG002|Overall Study|Adverse Event|3|||
27742520|NCT01111565|54192451|FG004|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
27742521|NCT01111565|54192447|FG000|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
27742522|NCT01111565|54192448|FG001|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
27742523|NCT01111565|54192449|FG002|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|2|||
27742524|NCT01111565|54192450|FG003|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
27742525|NCT01111565|54192451|FG004|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
27742526|NCT01111565|54192447|FG000|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
27742527|NCT01111565|54192448|FG001|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
27742528|NCT01111565|54192449|FG002|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
27742529|NCT01111565|54192450|FG003|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|2|||
27742530|NCT01111565|54192451|FG004|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
27742531|NCT01111565|54192447|FG000|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
27742532|NCT01111565|54192448|FG001|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
27742533|NCT01111565|54192449|FG002|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
27742534|NCT01111565|54192450|FG003|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|1|||
27742535|NCT01111565|54192451|FG004|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
27742536|NCT01111565|54192447|FG000|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
27742537|NCT01111565|54192448|FG001|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
27742538|NCT01111565|54192449|FG002|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
27742539|NCT01111565|54192450|FG003|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
27742540|NCT01111565|54192451|FG004|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|1|||
27742541|NCT02343458|54192465|FG000|Overall Study|Adverse Event|15|||
27742542|NCT02343458|54192466|FG001|Overall Study|Adverse Event|14|||
27742543|NCT02343458|54192467|FG002|Overall Study|Adverse Event|15|||
27742544|NCT02343458|54192468|FG003|Overall Study|Adverse Event|3|||
27742545|NCT02343458|54192465|FG000|Overall Study|Lack of Efficacy|3|||
27742546|NCT02343458|54192466|FG001|Overall Study|Lack of Efficacy|8|||
27742547|NCT02343458|54192467|FG002|Overall Study|Lack of Efficacy|4|||
27742548|NCT02343458|54192468|FG003|Overall Study|Lack of Efficacy|8|||
27742549|NCT02343458|54192465|FG000|Overall Study|Withdrawal by Subject|18|||
27742550|NCT02343458|54192466|FG001|Overall Study|Withdrawal by Subject|17|||
27742551|NCT02343458|54192467|FG002|Overall Study|Withdrawal by Subject|23|||
27742552|NCT02343458|54192468|FG003|Overall Study|Withdrawal by Subject|14|||
27742553|NCT02343458|54192465|FG000|Overall Study|Physician Decision|1|||
27742554|NCT02343458|54192466|FG001|Overall Study|Physician Decision|4|||
27742555|NCT02343458|54192467|FG002|Overall Study|Physician Decision|2|||
27742556|NCT02343458|54192468|FG003|Overall Study|Physician Decision|2|||
27742557|NCT02343458|54192465|FG000|Overall Study|Lost to Follow-up|5|||
27742558|NCT02343458|54192466|FG001|Overall Study|Lost to Follow-up|5|||
27742559|NCT02343458|54192467|FG002|Overall Study|Lost to Follow-up|3|||
27742560|NCT02343458|54192468|FG003|Overall Study|Lost to Follow-up|1|||
27742561|NCT02343458|54192465|FG000|Overall Study|Protocol Violation|2|||
27742562|NCT02343458|54192466|FG001|Overall Study|Protocol Violation|5|||
27742563|NCT02343458|54192467|FG002|Overall Study|Protocol Violation|2|||
27742564|NCT02343458|54192468|FG003|Overall Study|Protocol Violation|2|||
27742565|NCT02343458|54192465|FG000|Overall Study|Protocol Specified Criteria|17|||
27742566|NCT02343458|54192466|FG001|Overall Study|Protocol Specified Criteria|13|||
27742567|NCT02343458|54192467|FG002|Overall Study|Protocol Specified Criteria|14|||
27742568|NCT02343458|54192468|FG003|Overall Study|Protocol Specified Criteria|8|||
27742569|NCT01328041|54192491|FG000|Overall Study|Adverse Event|7|||
27742570|NCT01328041|54192491|FG000|Overall Study|Lack of Efficacy|27|||
27742571|NCT01328041|54192491|FG000|Overall Study|Protocol Violation|7|||
27742572|NCT01328041|54192491|FG000|Overall Study|Lost to Follow-up|7|||
27742573|NCT01328041|54192491|FG000|Overall Study|Physician Decision|2|||
27742574|NCT01328041|54192491|FG000|Overall Study|Withdrawal by Subject|7|||
27742575|NCT02410772|54192498|FG000|Overall Study|Death|3|||
27742576|NCT02410772|54192499|FG001|Overall Study|Death|4|||
27742577|NCT02410772|54192500|FG002|Overall Study|Death|8|||
27742578|NCT02410772|54192498|FG000|Overall Study|Lost to Follow-up|31|||
27742579|NCT02410772|54192499|FG001|Overall Study|Lost to Follow-up|23|||
27742580|NCT02410772|54192500|FG002|Overall Study|Lost to Follow-up|22|||
27742581|NCT02410772|54192498|FG000|Overall Study|Pregnancy|8|||
27742582|NCT02410772|54192499|FG001|Overall Study|Pregnancy|4|||
27742583|NCT02410772|54192500|FG002|Overall Study|Pregnancy|5|||
27742584|NCT02410772|54192498|FG000|Overall Study|Protocol Violation|8|||
27742585|NCT02410772|54192499|FG001|Overall Study|Protocol Violation|8|||
27742586|NCT02410772|54192500|FG002|Overall Study|Protocol Violation|4|||
27742587|NCT02410772|54192498|FG000|Overall Study|Baseline Drug Resistance|49|||
27742588|NCT02410772|54192499|FG001|Overall Study|Baseline Drug Resistance|40|||
27742589|NCT02410772|54192500|FG002|Overall Study|Baseline Drug Resistance|51|||
27742590|NCT02410772|54192498|FG000|Overall Study|No positive Mycobacterium tuberculosis culture|4|||
27742591|NCT02410772|54192499|FG001|Overall Study|No positive Mycobacterium tuberculosis culture|6|||
27922029|NCT01277601|54578983|FG003|Overall Study|Physician Decision|6|||
27922030|NCT01277601|54578980|FG000|Overall Study|Pregnancy|2|||
27742592|NCT02410772|54192500|FG002|Overall Study|No positive Mycobacterium tuberculosis culture|3|||
27742593|NCT02410772|54192498|FG000|Overall Study|Reinfection with a new strain of MTB|0|||
27742594|NCT02410772|54192499|FG001|Overall Study|Reinfection with a new strain of MTB|1|||
27742595|NCT02410772|54192500|FG002|Overall Study|Reinfection with a new strain of MTB|0|||
27742596|NCT01648790|54192517|FG000|Treatment 3|Withdrawal by Subject|0|||
27742597|NCT01648790|54192518|FG001|Treatment 3|Withdrawal by Subject|0|||
27742598|NCT01648790|54192519|FG002|Treatment 3|Withdrawal by Subject|0|||
27742599|NCT01648790|54192520|FG003|Treatment 3|Withdrawal by Subject|1|||
27742600|NCT01648790|54192521|FG004|Treatment 3|Withdrawal by Subject|0|||
27742601|NCT01936857|54192544|FG000|Overall Study|Sent to prison or 06 center|11|||
27742602|NCT01936857|54192545|FG001|Overall Study|Sent to prison or 06 center|12|||
27742603|NCT01936857|54192544|FG000|Overall Study|Lost to Follow-up|10|||
27742604|NCT01936857|54192545|FG001|Overall Study|Lost to Follow-up|7|||
27742605|NCT01936857|54192544|FG000|Overall Study|Death|7|||
27742606|NCT01936857|54192545|FG001|Overall Study|Death|3|||
27742607|NCT01936857|54192544|FG000|Overall Study|Moved|2|||
27742608|NCT01936857|54192545|FG001|Overall Study|Moved|1|||
27742609|NCT01936857|54192544|FG000|Overall Study|Withdrawal by Subject|1|||
27742610|NCT01936857|54192545|FG001|Overall Study|Withdrawal by Subject|0|||
27742611|NCT01936857|54192544|FG000|Overall Study|Side effect of medication|1|||
27742612|NCT01936857|54192545|FG001|Overall Study|Side effect of medication|0|||
27742613|NCT01936857|54192544|FG000|Overall Study|Other|2|||
27742614|NCT01936857|54192545|FG001|Overall Study|Other|2|||
27742615|NCT01602224|54192554|FG000|Overall Study|Adverse Event|0|||
27742616|NCT01602224|54192555|FG001|Overall Study|Adverse Event|1|||
27742617|NCT01602224|54192556|FG002|Overall Study|Adverse Event|0|||
27742618|NCT01602224|54192554|FG000|Overall Study|Investigator Decison|1|||
27742619|NCT01602224|54192555|FG001|Overall Study|Investigator Decison|0|||
27742620|NCT01602224|54192556|FG002|Overall Study|Investigator Decison|0|||
27742621|NCT01602224|54192554|FG000|Overall Study|Lost to Follow-up|0|||
27742622|NCT01602224|54192555|FG001|Overall Study|Lost to Follow-up|0|||
27742623|NCT01602224|54192556|FG002|Overall Study|Lost to Follow-up|1|||
27742624|NCT01602224|54192554|FG000|Overall Study|Protocol Violation|0|||
27742625|NCT01602224|54192555|FG001|Overall Study|Protocol Violation|1|||
27742626|NCT01602224|54192556|FG002|Overall Study|Protocol Violation|0|||
27742627|NCT01602224|54192554|FG000|Overall Study|Sponsor Decision|2|||
27742628|NCT01602224|54192555|FG001|Overall Study|Sponsor Decision|3|||
27742629|NCT01602224|54192556|FG002|Overall Study|Sponsor Decision|2|||
27742630|NCT01602224|54192554|FG000|Overall Study|Withdrawal by Subject|5|||
27742631|NCT01602224|54192555|FG001|Overall Study|Withdrawal by Subject|3|||
27742632|NCT01602224|54192556|FG002|Overall Study|Withdrawal by Subject|3|||
27742633|NCT04498247|54192574|FG000|Overall Study|Lost to Follow-up|0|||
27742634|NCT04498247|54192575|FG001|Overall Study|Lost to Follow-up|0|||
27742635|NCT04498247|54192576|FG002|Overall Study|Lost to Follow-up|0|||
27742636|NCT04498247|54192577|FG003|Overall Study|Lost to Follow-up|1|||
27742637|NCT04498247|54192578|FG004|Overall Study|Lost to Follow-up|0|||
27742638|NCT04498247|54192579|FG005|Overall Study|Lost to Follow-up|0|||
27742639|NCT04498247|54192580|FG006|Overall Study|Lost to Follow-up|0|||
27742640|NCT04498247|54192581|FG007|Overall Study|Lost to Follow-up|0|||
27742641|NCT04498247|54192574|FG000|Overall Study|Mistakenly Randomized; Not Treated|1|||
27742642|NCT04498247|54192575|FG001|Overall Study|Mistakenly Randomized; Not Treated|0|||
27742643|NCT04498247|54192576|FG002|Overall Study|Mistakenly Randomized; Not Treated|0|||
27742644|NCT04498247|54192577|FG003|Overall Study|Mistakenly Randomized; Not Treated|0|||
27742645|NCT04498247|54192578|FG004|Overall Study|Mistakenly Randomized; Not Treated|0|||
27742646|NCT04498247|54192579|FG005|Overall Study|Mistakenly Randomized; Not Treated|0|||
27742647|NCT04498247|54192580|FG006|Overall Study|Mistakenly Randomized; Not Treated|0|||
27742648|NCT04498247|54192581|FG007|Overall Study|Mistakenly Randomized; Not Treated|0|||
27742649|NCT04498247|54192574|FG000|Overall Study|Withdrawal by Subject|0|||
27742650|NCT04498247|54192575|FG001|Overall Study|Withdrawal by Subject|8|||
27742651|NCT04498247|54192576|FG002|Overall Study|Withdrawal by Subject|0|||
27742652|NCT04498247|54192577|FG003|Overall Study|Withdrawal by Subject|7|||
27742653|NCT04498247|54192578|FG004|Overall Study|Withdrawal by Subject|0|||
27742654|NCT04498247|54192579|FG005|Overall Study|Withdrawal by Subject|0|||
27742655|NCT04498247|54192580|FG006|Overall Study|Withdrawal by Subject|1|||
27742656|NCT04498247|54192581|FG007|Overall Study|Withdrawal by Subject|0|||
28013791|NCT00621855|54672615|FG001|Overall Study|Patients did not receive study drug|3|||
27742657|NCT04498247|54192574|FG000|Overall Study|Received a non-study COVID-19 vaccine.|0|||
27742658|NCT04498247|54192575|FG001|Overall Study|Received a non-study COVID-19 vaccine.|4|||
27742659|NCT04498247|54192576|FG002|Overall Study|Received a non-study COVID-19 vaccine.|0|||
27742660|NCT04498247|54192577|FG003|Overall Study|Received a non-study COVID-19 vaccine.|3|||
27742661|NCT04498247|54192578|FG004|Overall Study|Received a non-study COVID-19 vaccine.|0|||
27742662|NCT04498247|54192579|FG005|Overall Study|Received a non-study COVID-19 vaccine.|0|||
27742663|NCT04498247|54192580|FG006|Overall Study|Received a non-study COVID-19 vaccine.|7|||
27922031|NCT01277601|54578981|FG001|Overall Study|Pregnancy|2|||
27742664|NCT04498247|54192581|FG007|Overall Study|Received a non-study COVID-19 vaccine.|0|||
28013792|NCT00621855|54672616|FG002|Overall Study|Patients did not receive study drug|5|||
27742665|NCT03887117|54192609|FG000|Overall Study|Discontinued prematurely|0|||
27742666|NCT03887117|54192610|FG001|Overall Study|Discontinued prematurely|1|||
27742667|NCT03887117|54192611|FG002|Overall Study|Discontinued prematurely|1|||
27742668|NCT03887117|54192612|FG003|Overall Study|Discontinued prematurely|2|||
27742669|NCT04038385|54192633|FG000|Overall Study|Completed baseline assessment only|7|||
27742670|NCT04038385|54192634|FG001|Overall Study|Completed baseline assessment only|4|||
27742671|NCT04038385|54192633|FG000|Overall Study|Moved out of area|4|||
27742672|NCT04038385|54192634|FG001|Overall Study|Moved out of area|2|||
27742673|NCT04038385|54192633|FG000|Overall Study|Discontinued study involvement|6|||
27742674|NCT04038385|54192634|FG001|Overall Study|Discontinued study involvement|1|||
27742675|NCT00783263|54192644|FG000|Overall Study|Adverse Event|3|||
27742676|NCT00783263|54192645|FG001|Overall Study|Adverse Event|0|||
27742677|NCT00783263|54192646|FG002|Overall Study|Adverse Event|2|||
27742678|NCT00783263|54192647|FG003|Overall Study|Adverse Event|1|||
27742679|NCT00783263|54192644|FG000|Overall Study|Lost to Follow-up|1|||
27742680|NCT00783263|54192645|FG001|Overall Study|Lost to Follow-up|1|||
27742681|NCT00783263|54192646|FG002|Overall Study|Lost to Follow-up|0|||
27742682|NCT00783263|54192647|FG003|Overall Study|Lost to Follow-up|0|||
27742683|NCT00783263|54192644|FG000|Overall Study|Withdrawal by Subject|0|||
27742684|NCT00783263|54192645|FG001|Overall Study|Withdrawal by Subject|1|||
27742685|NCT00783263|54192646|FG002|Overall Study|Withdrawal by Subject|1|||
27742686|NCT00783263|54192647|FG003|Overall Study|Withdrawal by Subject|2|||
27742687|NCT03987919|54192674|FG000|Overall Study|Adverse Event|1|||
27742688|NCT03987919|54192675|FG001|Overall Study|Adverse Event|4|||
27742689|NCT03987919|54192676|FG002|Overall Study|Adverse Event|1|||
27742690|NCT03987919|54192677|FG003|Overall Study|Adverse Event|3|||
27742691|NCT03987919|54192674|FG000|Overall Study|Death|4|||
27742692|NCT03987919|54192675|FG001|Overall Study|Death|4|||
27742693|NCT03987919|54192676|FG002|Overall Study|Death|4|||
27742694|NCT03987919|54192677|FG003|Overall Study|Death|1|||
27742695|NCT03987919|54192674|FG000|Overall Study|Lost to Follow-up|5|||
27742696|NCT03987919|54192675|FG001|Overall Study|Lost to Follow-up|6|||
27742697|NCT03987919|54192676|FG002|Overall Study|Lost to Follow-up|8|||
27742698|NCT03987919|54192677|FG003|Overall Study|Lost to Follow-up|12|||
27742699|NCT03987919|54192674|FG000|Overall Study|Physician Decision|0|||
27742700|NCT03987919|54192675|FG001|Overall Study|Physician Decision|2|||
27742701|NCT03987919|54192676|FG002|Overall Study|Physician Decision|0|||
27742702|NCT03987919|54192677|FG003|Overall Study|Physician Decision|4|||
27742703|NCT03987919|54192674|FG000|Overall Study|Pregnancy|1|||
27742704|NCT03987919|54192675|FG001|Overall Study|Pregnancy|0|||
27742705|NCT03987919|54192676|FG002|Overall Study|Pregnancy|1|||
27742706|NCT03987919|54192677|FG003|Overall Study|Pregnancy|1|||
27742707|NCT03987919|54192674|FG000|Overall Study|Protocol Violation|0|||
27742708|NCT03987919|54192675|FG001|Overall Study|Protocol Violation|1|||
27742709|NCT03987919|54192676|FG002|Overall Study|Protocol Violation|0|||
27742710|NCT03987919|54192677|FG003|Overall Study|Protocol Violation|0|||
27742711|NCT03987919|54192674|FG000|Overall Study|Site terminated by Sponsor|0|||
27742712|NCT03987919|54192675|FG001|Overall Study|Site terminated by Sponsor|0|||
27742713|NCT03987919|54192676|FG002|Overall Study|Site terminated by Sponsor|0|||
27742714|NCT03987919|54192677|FG003|Overall Study|Site terminated by Sponsor|1|||
27742715|NCT03987919|54192674|FG000|Overall Study|Withdrawal by Subject|7|||
27742716|NCT03987919|54192675|FG001|Overall Study|Withdrawal by Subject|7|||
27742717|NCT03987919|54192676|FG002|Overall Study|Withdrawal by Subject|8|||
27742718|NCT03987919|54192677|FG003|Overall Study|Withdrawal by Subject|4|||
27742719|NCT03987919|54192674|FG000|Overall Study|Other - as reported by the investigator|1|||
27742720|NCT03987919|54192675|FG001|Overall Study|Other - as reported by the investigator|3|||
27742721|NCT03987919|54192676|FG002|Overall Study|Other - as reported by the investigator|2|||
27742722|NCT03987919|54192677|FG003|Overall Study|Other - as reported by the investigator|0|||
27742723|NCT00535405|54192697|FG000|Overall Study|Adverse Event|6|||
27742724|NCT00535405|54192698|FG001|Overall Study|Adverse Event|8|||
27742725|NCT00535405|54192699|FG002|Overall Study|Adverse Event|3|||
27742726|NCT00535405|54192700|FG003|Overall Study|Adverse Event|8|||
27742727|NCT00535405|54192701|FG004|Overall Study|Adverse Event|6|||
27742728|NCT00535405|54192697|FG000|Overall Study|Lost to Follow-up|1|||
27742729|NCT00535405|54192698|FG001|Overall Study|Lost to Follow-up|3|||
27742730|NCT00535405|54192699|FG002|Overall Study|Lost to Follow-up|3|||
27742731|NCT00535405|54192700|FG003|Overall Study|Lost to Follow-up|2|||
27742732|NCT00535405|54192701|FG004|Overall Study|Lost to Follow-up|1|||
27742733|NCT00535405|54192697|FG000|Overall Study|Physician Decision|3|||
27742734|NCT00535405|54192698|FG001|Overall Study|Physician Decision|2|||
27742735|NCT00535405|54192699|FG002|Overall Study|Physician Decision|0|||
27742736|NCT00535405|54192700|FG003|Overall Study|Physician Decision|1|||
27742737|NCT00535405|54192701|FG004|Overall Study|Physician Decision|1|||
27742738|NCT00535405|54192697|FG000|Overall Study|Protocol Violation|2|||
27742739|NCT00535405|54192698|FG001|Overall Study|Protocol Violation|2|||
27742740|NCT00535405|54192699|FG002|Overall Study|Protocol Violation|2|||
27742741|NCT00535405|54192700|FG003|Overall Study|Protocol Violation|1|||
28013793|NCT00621855|54672617|FG003|Overall Study|Patients did not receive study drug|4|||
27742742|NCT00535405|54192701|FG004|Overall Study|Protocol Violation|0|||
27742743|NCT00535405|54192697|FG000|Overall Study|Withdrawal by Subject|5|||
27742744|NCT00535405|54192698|FG001|Overall Study|Withdrawal by Subject|11|||
27742745|NCT00535405|54192699|FG002|Overall Study|Withdrawal by Subject|10|||
27742746|NCT00535405|54192700|FG003|Overall Study|Withdrawal by Subject|10|||
27742747|NCT00535405|54192701|FG004|Overall Study|Withdrawal by Subject|8|||
27742748|NCT00271817|54192716|FG000|Part 1|Adverse Event|68|||
27742749|NCT00271817|54192717|FG001|Part 1|Adverse Event|25|||
27742750|NCT00271817|54192718|FG002|Part 1|Adverse Event|156|||
27742751|NCT00271817|54192716|FG000|Part 1|Lost to Follow-up|6|||
27742752|NCT00271817|54192717|FG001|Part 1|Lost to Follow-up|8|||
27742753|NCT00271817|54192718|FG002|Part 1|Lost to Follow-up|24|||
27742754|NCT00271817|54192716|FG000|Part 1|Protocol Violation|5|||
27742755|NCT00271817|54192717|FG001|Part 1|Protocol Violation|4|||
27742756|NCT00271817|54192718|FG002|Part 1|Protocol Violation|7|||
27742757|NCT00271817|54192716|FG000|Part 1|Patient Moved|3|||
27742758|NCT00271817|54192717|FG001|Part 1|Patient Moved|1|||
27742759|NCT00271817|54192718|FG002|Part 1|Patient Moved|5|||
27742760|NCT00271817|54192716|FG000|Part 1|Withdrawal by Subject|23|||
27742761|NCT00271817|54192717|FG001|Part 1|Withdrawal by Subject|17|||
27742762|NCT00271817|54192718|FG002|Part 1|Withdrawal by Subject|45|||
27742763|NCT00271817|54192716|FG000|Part 1|LDL < 50 mg/dL|1|||
27742764|NCT00271817|54192717|FG001|Part 1|LDL < 50 mg/dL|4|||
27742765|NCT00271817|54192718|FG002|Part 1|LDL < 50 mg/dL|48|||
27742766|NCT00271817|54192716|FG000|Part 2|Adverse Event|0|||
27742767|NCT00271817|54192717|FG001|Part 2|Adverse Event|17|||
27742768|NCT00271817|54192718|FG002|Part 2|Adverse Event|33|||
27742769|NCT00271817|54192716|FG000|Part 2|Lack of Efficacy|0|||
27742770|NCT00271817|54192717|FG001|Part 2|Lack of Efficacy|1|||
27742771|NCT00271817|54192718|FG002|Part 2|Lack of Efficacy|6|||
27742772|NCT00271817|54192716|FG000|Part 2|Lost to Follow-up|0|||
27742773|NCT00271817|54192717|FG001|Part 2|Lost to Follow-up|6|||
27742774|NCT00271817|54192718|FG002|Part 2|Lost to Follow-up|18|||
27742775|NCT00271817|54192716|FG000|Part 2|Protocol Violation|0|||
27742776|NCT00271817|54192717|FG001|Part 2|Protocol Violation|3|||
27742777|NCT00271817|54192718|FG002|Part 2|Protocol Violation|5|||
27742778|NCT00271817|54192716|FG000|Part 2|Patient Moved|0|||
27742779|NCT00271817|54192717|FG001|Part 2|Patient Moved|0|||
27742780|NCT00271817|54192718|FG002|Part 2|Patient Moved|5|||
27742781|NCT00271817|54192716|FG000|Part 2|Withdrawal by Subject|0|||
27742782|NCT00271817|54192717|FG001|Part 2|Withdrawal by Subject|2|||
27742783|NCT00271817|54192718|FG002|Part 2|Withdrawal by Subject|13|||
27742784|NCT00271817|54192716|FG000|Part 2|LDL < 50 mg/dL|0|||
27742785|NCT00271817|54192717|FG001|Part 2|LDL < 50 mg/dL|3|||
27742786|NCT00271817|54192718|FG002|Part 2|LDL < 50 mg/dL|4|||
27742787|NCT02731157|54192730|FG000|First Rejuvenated RCE|Withdrawal by Subject|1|||
27742788|NCT03268811|54192738|FG000|Overall Study|Adverse Event|0|||
27742789|NCT03268811|54192739|FG001|Overall Study|Adverse Event|1|||
27742790|NCT02732015|54192748|FG000|Overall Study|Lost to Follow-up|0|||
27742791|NCT02732015|54192749|FG001|Overall Study|Lost to Follow-up|1|||
27742792|NCT01441115|54192769|FG000|Overall Study|Taken off study - Principal Investigator discretion|1|||
27742793|NCT02006147|54192780|FG000|Overall Study|Protocol Violation|1|||
27742794|NCT02006147|54192781|FG001|Overall Study|Protocol Violation|1|||
27742795|NCT02006147|54192782|FG002|Overall Study|Protocol Violation|0|||
27742796|NCT02006147|54192783|FG003|Overall Study|Protocol Violation|0|||
27742797|NCT02006147|54192780|FG000|Overall Study|Withdrawal by Subject|0|||
27742798|NCT02006147|54192781|FG001|Overall Study|Withdrawal by Subject|1|||
27742799|NCT02006147|54192782|FG002|Overall Study|Withdrawal by Subject|0|||
27742800|NCT02006147|54192783|FG003|Overall Study|Withdrawal by Subject|0|||
27742801|NCT02006147|54192780|FG000|Overall Study|Withdrawal by Sponsor|1|||
27742802|NCT02006147|54192781|FG001|Overall Study|Withdrawal by Sponsor|0|||
27742803|NCT02006147|54192782|FG002|Overall Study|Withdrawal by Sponsor|0|||
27742804|NCT02006147|54192783|FG003|Overall Study|Withdrawal by Sponsor|0|||
27742805|NCT02732119|54192794|FG000|Phase I|Adverse Event|1|||
27742806|NCT02732119|54192795|FG001|Phase I|Adverse Event|3|||
27742807|NCT02732119|54192796|FG002|Phase I|Adverse Event|1|||
27742808|NCT02732119|54192797|FG003|Phase I|Adverse Event|0|||
27742809|NCT02732119|54192798|FG004|Phase I|Adverse Event|0|||
27742810|NCT02732119|54192794|FG000|Phase I|Progressive disease|7|||
27742811|NCT02732119|54192795|FG001|Phase I|Progressive disease|3|||
27742812|NCT02732119|54192796|FG002|Phase I|Progressive disease|2|||
27742813|NCT02732119|54192797|FG003|Phase I|Progressive disease|0|||
27742814|NCT02732119|54192798|FG004|Phase I|Progressive disease|0|||
27742815|NCT02732119|54192794|FG000|Phase I|Protocol deviation|0|||
27742816|NCT02732119|54192795|FG001|Phase I|Protocol deviation|1|||
27742817|NCT02732119|54192796|FG002|Phase I|Protocol deviation|0|||
27742818|NCT02732119|54192797|FG003|Phase I|Protocol deviation|0|||
27742819|NCT02732119|54192798|FG004|Phase I|Protocol deviation|0|||
27742820|NCT02732119|54192794|FG000|Phase I|Physician Decision|0|||
27742821|NCT02732119|54192795|FG001|Phase I|Physician Decision|3|||
27742822|NCT02732119|54192796|FG002|Phase I|Physician Decision|4|||
27742823|NCT02732119|54192797|FG003|Phase I|Physician Decision|0|||
27742824|NCT02732119|54192798|FG004|Phase I|Physician Decision|0|||
27742825|NCT02732119|54192794|FG000|Phase II|Adverse Event|0|||
27742826|NCT02732119|54192795|FG001|Phase II|Adverse Event|0|||
27742827|NCT02732119|54192796|FG002|Phase II|Adverse Event|0|||
27742828|NCT02732119|54192797|FG003|Phase II|Adverse Event|3|||
27742829|NCT02732119|54192798|FG004|Phase II|Adverse Event|3|||
27742830|NCT02732119|54192794|FG000|Phase II|Death|0|||
27742831|NCT02732119|54192795|FG001|Phase II|Death|0|||
27742832|NCT02732119|54192796|FG002|Phase II|Death|0|||
27742833|NCT02732119|54192797|FG003|Phase II|Death|1|||
27742834|NCT02732119|54192798|FG004|Phase II|Death|0|||
27742835|NCT02732119|54192794|FG000|Phase II|Progressive dissease|0|||
27742836|NCT02732119|54192795|FG001|Phase II|Progressive dissease|0|||
27742837|NCT02732119|54192796|FG002|Phase II|Progressive dissease|0|||
27742838|NCT02732119|54192797|FG003|Phase II|Progressive dissease|30|||
27742839|NCT02732119|54192798|FG004|Phase II|Progressive dissease|23|||
27742840|NCT02732119|54192794|FG000|Phase II|Study terminated by sponsor|0|||
27742841|NCT02732119|54192795|FG001|Phase II|Study terminated by sponsor|0|||
27742842|NCT02732119|54192796|FG002|Phase II|Study terminated by sponsor|0|||
27742843|NCT02732119|54192797|FG003|Phase II|Study terminated by sponsor|2|||
27742844|NCT02732119|54192798|FG004|Phase II|Study terminated by sponsor|2|||
27742845|NCT02732119|54192794|FG000|Phase II|Other|0|||
27742846|NCT02732119|54192795|FG001|Phase II|Other|0|||
27742847|NCT02732119|54192796|FG002|Phase II|Other|0|||
27742848|NCT02732119|54192797|FG003|Phase II|Other|2|||
27742849|NCT02732119|54192798|FG004|Phase II|Other|0|||
27742850|NCT02732119|54192794|FG000|Phase II|Physician Decision|0|||
27742851|NCT02732119|54192795|FG001|Phase II|Physician Decision|0|||
27742852|NCT02732119|54192796|FG002|Phase II|Physician Decision|0|||
27742853|NCT02732119|54192797|FG003|Phase II|Physician Decision|8|||
27742854|NCT02732119|54192798|FG004|Phase II|Physician Decision|5|||
27742855|NCT03252925|54192821|FG000|Overall Study|Withdrawal by Subject|1|||
27742856|NCT03252925|54192822|FG001|Overall Study|Withdrawal by Subject|0|||
27742857|NCT03252925|54192821|FG000|Overall Study|Protocol Violation|6|||
27742858|NCT03252925|54192822|FG001|Overall Study|Protocol Violation|0|||
27742859|NCT03252925|54192821|FG000|Overall Study|Adverse Event|1|||
27742860|NCT03252925|54192822|FG001|Overall Study|Adverse Event|0|||
27742861|NCT03252925|54192821|FG000|Overall Study|Lost to Follow-up|6|||
27742862|NCT03252925|54192822|FG001|Overall Study|Lost to Follow-up|6|||
27742863|NCT01327885|54192830|FG000|Overall Study|Disease progression-according to RECIST|173|||
27742864|NCT01327885|54192831|FG001|Overall Study|Disease progression-according to RECIST|165|||
27742865|NCT01327885|54192830|FG000|Overall Study|Clinical progression|24|||
27742866|NCT01327885|54192831|FG001|Overall Study|Clinical progression|27|||
27742867|NCT01327885|54192830|FG000|Overall Study|Adverse Event|14|||
27742868|NCT01327885|54192831|FG001|Overall Study|Adverse Event|10|||
27742869|NCT01327885|54192830|FG000|Overall Study|Subject choice|5|||
27742870|NCT01327885|54192831|FG001|Overall Study|Subject choice|10|||
27742871|NCT01327885|54192830|FG000|Overall Study|Other|8|||
27742872|NCT01327885|54192831|FG001|Overall Study|Other|6|||
27742873|NCT01327885|54192830|FG000|Overall Study|Withdrawal of consent from study|3|||
27742874|NCT01327885|54192831|FG001|Overall Study|Withdrawal of consent from study|4|||
27742875|NCT01327885|54192830|FG000|Overall Study|Not treated|1|||
27742876|NCT01327885|54192831|FG001|Overall Study|Not treated|1|||
27742877|NCT01327885|54192830|FG000|Overall Study|Administrative decision|0|||
27742878|NCT01327885|54192831|FG001|Overall Study|Administrative decision|1|||
27742879|NCT03420781|54192849|FG000|Treatment Period (40 Weeks)|Adverse Event|1|||
27742880|NCT03420781|54192850|FG001|Treatment Period (40 Weeks)|Adverse Event|6|||
27742881|NCT03420781|54192851|FG002|Treatment Period (40 Weeks)|Adverse Event|0|||
27742882|NCT03420781|54192852|FG003|Treatment Period (40 Weeks)|Adverse Event|0|||
27742883|NCT03420781|54192853|FG004|Treatment Period (40 Weeks)|Adverse Event|0|||
27742884|NCT03420781|54192849|FG000|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
27742885|NCT03420781|54192850|FG001|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
27742886|NCT03420781|54192851|FG002|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
27742887|NCT03420781|54192852|FG003|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
27742888|NCT03420781|54192853|FG004|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
27742889|NCT03420781|54192849|FG000|Treatment Period (40 Weeks)|Withdrawal by Subject|22|||
27742890|NCT03420781|54192850|FG001|Treatment Period (40 Weeks)|Withdrawal by Subject|16|||
27742891|NCT03420781|54192851|FG002|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
27742892|NCT03420781|54192852|FG003|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
27742893|NCT03420781|54192853|FG004|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
27742894|NCT03420781|54192849|FG000|Treatment Period (40 Weeks)|Lost to Follow-up|10|||
27742895|NCT03420781|54192850|FG001|Treatment Period (40 Weeks)|Lost to Follow-up|6|||
27742896|NCT03420781|54192851|FG002|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
27742897|NCT03420781|54192852|FG003|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
27742898|NCT03420781|54192853|FG004|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
27742899|NCT03420781|54192849|FG000|Treatment Period (40 Weeks)|Death|2|||
27742900|NCT03420781|54192850|FG001|Treatment Period (40 Weeks)|Death|2|||
27742901|NCT03420781|54192851|FG002|Treatment Period (40 Weeks)|Death|0|||
27742902|NCT03420781|54192852|FG003|Treatment Period (40 Weeks)|Death|0|||
27742903|NCT03420781|54192853|FG004|Treatment Period (40 Weeks)|Death|0|||
27742904|NCT03420781|54192849|FG000|Treatment Period (40 Weeks)|Physician Decision|3|||
27742905|NCT03420781|54192850|FG001|Treatment Period (40 Weeks)|Physician Decision|4|||
27742906|NCT03420781|54192851|FG002|Treatment Period (40 Weeks)|Physician Decision|0|||
27742907|NCT03420781|54192852|FG003|Treatment Period (40 Weeks)|Physician Decision|0|||
27742908|NCT03420781|54192853|FG004|Treatment Period (40 Weeks)|Physician Decision|0|||
27742909|NCT03420781|54192849|FG000|Treatment Period (40 Weeks)|Protocol Deviation|0|||
27742910|NCT03420781|54192850|FG001|Treatment Period (40 Weeks)|Protocol Deviation|2|||
27742911|NCT03420781|54192851|FG002|Treatment Period (40 Weeks)|Protocol Deviation|0|||
27742912|NCT03420781|54192852|FG003|Treatment Period (40 Weeks)|Protocol Deviation|0|||
27742913|NCT03420781|54192853|FG004|Treatment Period (40 Weeks)|Protocol Deviation|0|||
27742914|NCT03420781|54192849|FG000|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|101|||
27742915|NCT03420781|54192850|FG001|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|89|||
27742916|NCT03420781|54192851|FG002|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
27742917|NCT03420781|54192852|FG003|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
27742918|NCT03420781|54192853|FG004|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
27742919|NCT03420781|54192849|FG000|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|1|||
27742920|NCT03420781|54192850|FG001|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
27742921|NCT03420781|54192851|FG002|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
27742922|NCT03420781|54192852|FG003|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
27742923|NCT03420781|54192853|FG004|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
27742924|NCT03420781|54192849|FG000|Treatment Period (40 Weeks)|Reason Not Specified|3|||
27742925|NCT03420781|54192850|FG001|Treatment Period (40 Weeks)|Reason Not Specified|0|||
27742926|NCT03420781|54192851|FG002|Treatment Period (40 Weeks)|Reason Not Specified|0|||
27742927|NCT03420781|54192852|FG003|Treatment Period (40 Weeks)|Reason Not Specified|0|||
27742928|NCT03420781|54192853|FG004|Treatment Period (40 Weeks)|Reason Not Specified|0|||
27922032|NCT01277601|54578982|FG002|Overall Study|Pregnancy|4|||
27922033|NCT01277601|54578983|FG003|Overall Study|Pregnancy|1|||
27922034|NCT01277601|54578980|FG000|Overall Study|Noncompliance with Study Drug|1|||
27922035|NCT01277601|54578981|FG001|Overall Study|Noncompliance with Study Drug|3|||
27922036|NCT01277601|54578982|FG002|Overall Study|Noncompliance with Study Drug|2|||
27922037|NCT01277601|54578983|FG003|Overall Study|Noncompliance with Study Drug|0|||
27922038|NCT01277601|54578980|FG000|Overall Study|Subject Never Dosed with Study Drug|1|||
27922039|NCT01277601|54578981|FG001|Overall Study|Subject Never Dosed with Study Drug|2|||
27922040|NCT01277601|54578982|FG002|Overall Study|Subject Never Dosed with Study Drug|3|||
27922041|NCT01277601|54578983|FG003|Overall Study|Subject Never Dosed with Study Drug|1|||
27922042|NCT01277601|54578980|FG000|Overall Study|Protocol Violation|0|||
27922043|NCT01277601|54578981|FG001|Overall Study|Protocol Violation|2|||
27922044|NCT01277601|54578982|FG002|Overall Study|Protocol Violation|5|||
27922045|NCT01277601|54578983|FG003|Overall Study|Protocol Violation|0|||
27922046|NCT01277601|54578980|FG000|Overall Study|Subject Terminated from Study by Sponsor|0|||
27922047|NCT01277601|54578981|FG001|Overall Study|Subject Terminated from Study by Sponsor|1|||
27922048|NCT01277601|54578982|FG002|Overall Study|Subject Terminated from Study by Sponsor|0|||
27922049|NCT01277601|54578983|FG003|Overall Study|Subject Terminated from Study by Sponsor|2|||
27922050|NCT01277523|54579013|FG000|Overall Study|Adverse Event|1|||
27922051|NCT01277523|54579014|FG001|Overall Study|Adverse Event|0|||
27922052|NCT01277523|54579015|FG002|Overall Study|Adverse Event|0|||
27922053|NCT01277523|54579013|FG000|Overall Study|Protocol Violation|2|||
27922054|NCT01277523|54579014|FG001|Overall Study|Protocol Violation|0|||
27922055|NCT01277523|54579015|FG002|Overall Study|Protocol Violation|0|||
27742929|NCT03420781|54192849|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
27746368|NCT02120950|54195935|FG000|Overall Study|Death|3|||
27922056|NCT01277523|54579013|FG000|Overall Study|Other Reason not Defined|0|||
28013794|NCT00621855|54672618|FG004|Overall Study|Patients did not receive study drug|2|||
27922057|NCT01277523|54579014|FG001|Overall Study|Other Reason not Defined|1|||
27922058|NCT01277523|54579015|FG002|Overall Study|Other Reason not Defined|0|||
27922059|NCT01081834|54579028|FG000|Core Period: Baseline to Week 26|Pregnancy|1|||
27922060|NCT01081834|54579029|FG001|Core Period: Baseline to Week 26|Pregnancy|0|||
27922061|NCT01081834|54579030|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
27922062|NCT01081834|54579031|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
27922063|NCT01081834|54579032|FG004|Core Period: Baseline to Week 26|Pregnancy|0|||
27922064|NCT01081834|54579028|FG000|Core Period: Baseline to Week 26|Adverse Event|2|||
27922065|NCT01081834|54579029|FG001|Core Period: Baseline to Week 26|Adverse Event|5|||
27922066|NCT01081834|54579030|FG002|Core Period: Baseline to Week 26|Adverse Event|3|||
27922067|NCT01081834|54579031|FG003|Core Period: Baseline to Week 26|Adverse Event|1|||
27922068|NCT01081834|54579032|FG004|Core Period: Baseline to Week 26|Adverse Event|1|||
27922069|NCT01081834|54579028|FG000|Core Period: Baseline to Week 26|Death|1|||
27922070|NCT01081834|54579029|FG001|Core Period: Baseline to Week 26|Death|0|||
27922071|NCT01081834|54579030|FG002|Core Period: Baseline to Week 26|Death|0|||
27922072|NCT01081834|54579031|FG003|Core Period: Baseline to Week 26|Death|0|||
27922073|NCT01081834|54579032|FG004|Core Period: Baseline to Week 26|Death|0|||
27922074|NCT01081834|54579028|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
27922075|NCT01081834|54579029|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
27922076|NCT01081834|54579030|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
27922077|NCT01081834|54579031|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
27922078|NCT01081834|54579032|FG004|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
27922079|NCT01081834|54579028|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
27922080|NCT01081834|54579029|FG001|Core Period: Baseline to Week 26|Protocol Violation|4|||
27922081|NCT01081834|54579030|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
27922082|NCT01081834|54579031|FG003|Core Period: Baseline to Week 26|Protocol Violation|0|||
27922083|NCT01081834|54579032|FG004|Core Period: Baseline to Week 26|Protocol Violation|2|||
27922084|NCT01081834|54579028|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
27922085|NCT01081834|54579029|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
27922086|NCT01081834|54579030|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
27922087|NCT01081834|54579031|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
27922088|NCT01081834|54579032|FG004|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
27922089|NCT01081834|54579028|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
27922090|NCT01081834|54579029|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|4|||
27922091|NCT01081834|54579030|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
27922092|NCT01081834|54579031|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
27922093|NCT01081834|54579032|FG004|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
27922094|NCT01081834|54579028|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
27922095|NCT01081834|54579029|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
27922096|NCT01081834|54579030|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
27922097|NCT01081834|54579031|FG003|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
27922098|NCT01081834|54579032|FG004|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
27922099|NCT01081834|54579028|FG000|Core Period: Baseline to Week 26|Other|4|||
27922100|NCT01081834|54579029|FG001|Core Period: Baseline to Week 26|Other|4|||
27922101|NCT01081834|54579030|FG002|Core Period: Baseline to Week 26|Other|3|||
27922102|NCT01081834|54579031|FG003|Core Period: Baseline to Week 26|Other|1|||
27922103|NCT01081834|54579032|FG004|Core Period: Baseline to Week 26|Other|0|||
27922104|NCT01081834|54579028|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3|||
27922105|NCT01081834|54579029|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
27922106|NCT01081834|54579030|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
27922107|NCT01081834|54579031|FG003|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
27922108|NCT01081834|54579032|FG004|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
27922109|NCT01081834|54579028|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
27922110|NCT01081834|54579029|FG001|Extension Period: Week 26 to Week 52|Adverse Event|0|||
27922111|NCT01081834|54579030|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
27922112|NCT01081834|54579031|FG003|Extension Period: Week 26 to Week 52|Adverse Event|0|||
27922113|NCT01081834|54579032|FG004|Extension Period: Week 26 to Week 52|Adverse Event|0|||
27922114|NCT01081834|54579028|FG000|Extension Period: Week 26 to Week 52|Death|1|||
27922115|NCT01081834|54579029|FG001|Extension Period: Week 26 to Week 52|Death|0|||
27922116|NCT01081834|54579030|FG002|Extension Period: Week 26 to Week 52|Death|0|||
27922117|NCT01081834|54579031|FG003|Extension Period: Week 26 to Week 52|Death|0|||
27922118|NCT01081834|54579032|FG004|Extension Period: Week 26 to Week 52|Death|0|||
27922119|NCT01081834|54579028|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
27922120|NCT01081834|54579029|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
27922121|NCT01081834|54579030|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
27922122|NCT01081834|54579031|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
27922123|NCT01081834|54579032|FG004|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
27922124|NCT01081834|54579028|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
27922125|NCT01081834|54579029|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
27922126|NCT01081834|54579030|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
27922127|NCT01081834|54579031|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
27922128|NCT01081834|54579032|FG004|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
27922129|NCT01081834|54579028|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
27922130|NCT01081834|54579029|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
27922131|NCT01081834|54579030|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
27922132|NCT01081834|54579031|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
27922133|NCT01081834|54579032|FG004|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
27922134|NCT01081834|54579028|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
27922135|NCT01081834|54579029|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
27922136|NCT01081834|54579030|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
27922137|NCT01081834|54579031|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
27922138|NCT01081834|54579032|FG004|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
27922139|NCT01081834|54579028|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
27922140|NCT01081834|54579029|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
27922141|NCT01081834|54579030|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
27922142|NCT01081834|54579031|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
27922143|NCT01081834|54579032|FG004|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
27922144|NCT01081834|54579028|FG000|Extension Period: Week 26 to Week 52|Other|4|||
27922145|NCT01081834|54579029|FG001|Extension Period: Week 26 to Week 52|Other|5|||
27922146|NCT01081834|54579030|FG002|Extension Period: Week 26 to Week 52|Other|4|||
27922147|NCT01081834|54579031|FG003|Extension Period: Week 26 to Week 52|Other|0|||
27922148|NCT01081834|54579032|FG004|Extension Period: Week 26 to Week 52|Other|0|||
27922149|NCT01081834|54579028|FG000|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7|||
27922150|NCT01081834|54579029|FG001|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1|||
27922151|NCT01081834|54579030|FG002|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
27922152|NCT01081834|54579031|FG003|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
27922153|NCT01081834|54579032|FG004|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
27922154|NCT01081834|54579028|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
27922155|NCT01081834|54579029|FG001|Extension Period: Week 26 to Week 52|Physician Decision|1|||
27922156|NCT01081834|54579030|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
27922157|NCT01081834|54579031|FG003|Extension Period: Week 26 to Week 52|Physician Decision|0|||
27922158|NCT01081834|54579032|FG004|Extension Period: Week 26 to Week 52|Physician Decision|0|||
27922159|NCT01276509|54579055|FG000|Overall Study|Adverse Event|9|||
27922160|NCT01276509|54579056|FG001|Overall Study|Adverse Event|8|||
27922161|NCT01276509|54579057|FG002|Overall Study|Adverse Event|4|||
27922162|NCT01276509|54579058|FG003|Overall Study|Adverse Event|3|||
27922163|NCT01276509|54579055|FG000|Overall Study|Lack of Efficacy|2|||
27922164|NCT01276509|54579056|FG001|Overall Study|Lack of Efficacy|1|||
27922165|NCT01276509|54579057|FG002|Overall Study|Lack of Efficacy|1|||
27922166|NCT01276509|54579058|FG003|Overall Study|Lack of Efficacy|2|||
27922167|NCT01276509|54579055|FG000|Overall Study|Pregnancy|1|||
27922168|NCT01276509|54579056|FG001|Overall Study|Pregnancy|0|||
27922169|NCT01276509|54579057|FG002|Overall Study|Pregnancy|0|||
27922170|NCT01276509|54579058|FG003|Overall Study|Pregnancy|0|||
27922171|NCT01276509|54579055|FG000|Overall Study|Withdrawal by Subject|1|||
27922172|NCT01276509|54579056|FG001|Overall Study|Withdrawal by Subject|2|||
27922173|NCT01276509|54579057|FG002|Overall Study|Withdrawal by Subject|0|||
27922174|NCT01276509|54579058|FG003|Overall Study|Withdrawal by Subject|0|||
27922175|NCT01276509|54579055|FG000|Overall Study|Other|0|||
27922176|NCT01276509|54579056|FG001|Overall Study|Other|1|||
27922177|NCT01276509|54579057|FG002|Overall Study|Other|0|||
27922178|NCT01276509|54579058|FG003|Overall Study|Other|0|||
27922179|NCT01079962|54579070|FG000|Overall Study|Adverse Event|2|||
27922180|NCT01079962|54579071|FG001|Overall Study|Adverse Event|2|||
27922181|NCT01079962|54579070|FG000|Overall Study|Withdrawal by Subject|5|||
27922182|NCT01079962|54579071|FG001|Overall Study|Withdrawal by Subject|7|||
27922183|NCT01079962|54579070|FG000|Overall Study|Protocol Violation|2|||
27922184|NCT01079962|54579071|FG001|Overall Study|Protocol Violation|2|||
27922185|NCT01079962|54579070|FG000|Overall Study|No blood pressure (BP) control|3|||
27922186|NCT01079962|54579071|FG001|Overall Study|No blood pressure (BP) control|0|||
27922187|NCT01079962|54579070|FG000|Overall Study|Inclusion/exclusion criteria|1|||
27922188|NCT01079962|54579071|FG001|Overall Study|Inclusion/exclusion criteria|3|||
27922189|NCT01079962|54579070|FG000|Overall Study|Participant not returning for next visit|1|||
27922190|NCT01079962|54579071|FG001|Overall Study|Participant not returning for next visit|0|||
27922191|NCT01079962|54579070|FG000|Overall Study|Due to arrhythmia/bradycardia|1|||
28013795|NCT00561574|54672632|FG000|Overall Study|Adverse Event|21|||
27922192|NCT01079962|54579071|FG001|Overall Study|Due to arrhythmia/bradycardia|1|||
27922193|NCT01274637|54579079|FG000|Overall Study|Withdrawal by Subject|0|||
27922194|NCT01274637|54579080|FG001|Overall Study|Withdrawal by Subject|1|||
27922195|NCT01274637|54579079|FG000|Overall Study|Lost to Follow-up|0|||
27922196|NCT01274637|54579080|FG001|Overall Study|Lost to Follow-up|1|||
27922197|NCT01079806|54579088|FG000|Day 1 to Week 96|Adverse Event|0|||
27922198|NCT01079806|54579089|FG001|Day 1 to Week 96|Adverse Event|3|||
27922199|NCT01079806|54579088|FG000|Day 1 to Week 96|Withdrawal by Subject|3|||
27922200|NCT01079806|54579089|FG001|Day 1 to Week 96|Withdrawal by Subject|2|||
27922201|NCT01079806|54579088|FG000|Day 1 to Week 96|Pregnancy|0|||
27922202|NCT01079806|54579089|FG001|Day 1 to Week 96|Pregnancy|1|||
27922203|NCT01079806|54579088|FG000|Day 1 to Week 96|Poor compliance or noncompliance|2|||
27922204|NCT01079806|54579089|FG001|Day 1 to Week 96|Poor compliance or noncompliance|0|||
27922205|NCT01079806|54579088|FG000|Day 1 to Week 96|Lost to Follow-up|1|||
27922206|NCT01079806|54579089|FG001|Day 1 to Week 96|Lost to Follow-up|0|||
27922207|NCT01079806|54579088|FG000|Day 1 to Week 96|Subject request to stop study treatment|1|||
27922208|NCT01079806|54579089|FG001|Day 1 to Week 96|Subject request to stop study treatment|0|||
27922209|NCT01079806|54579088|FG000|Day 1 to Week 96|Removal by Medical Monitor|0|||
27922210|NCT01079806|54579089|FG001|Day 1 to Week 96|Removal by Medical Monitor|1|||
27922211|NCT01079806|54579088|FG000|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13|||
27922212|NCT01079806|54579089|FG001|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8|||
27922213|NCT01079806|54579088|FG000|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0|||
27922214|NCT01079806|54579089|FG001|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1|||
27922215|NCT01079806|54579088|FG000|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
27922216|NCT01079806|54579089|FG001|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
27922217|NCT01078090|54579097|FG000|Overall Study|Lost to Follow-up|2363|||
27922218|NCT01078090|54579097|FG000|Overall Study|Adverse drug reaction (ADR)|453|||
27922219|NCT01078090|54579097|FG000|Overall Study|Lack of Efficacy|1193|||
27922220|NCT01078090|54579097|FG000|Overall Study|ADR and lack of efficacy|61|||
27922221|NCT01078090|54579097|FG000|Overall Study|Other|523|||
27922222|NCT01077622|54579115|FG000|Overall Study|Physician Decision|2|||
27922223|NCT01077622|54579115|FG000|Overall Study|Withdrawal by Subject|1|||
27922224|NCT01313676|54579123|FG000|Overall Study|Adverse Event|395|||
27922225|NCT01313676|54579124|FG001|Overall Study|Adverse Event|365|||
27922226|NCT01313676|54579125|FG002|Overall Study|Adverse Event|372|||
27922227|NCT01313676|54579126|FG003|Overall Study|Adverse Event|333|||
27922228|NCT01313676|54579123|FG000|Overall Study|Lack of Efficacy|98|||
27922229|NCT01313676|54579124|FG001|Overall Study|Lack of Efficacy|90|||
27922230|NCT01313676|54579125|FG002|Overall Study|Lack of Efficacy|65|||
27922231|NCT01313676|54579126|FG003|Overall Study|Lack of Efficacy|46|||
27922232|NCT01313676|54579123|FG000|Overall Study|Protocol Violation|37|||
27922233|NCT01313676|54579124|FG001|Overall Study|Protocol Violation|44|||
27922234|NCT01313676|54579125|FG002|Overall Study|Protocol Violation|46|||
27922235|NCT01313676|54579126|FG003|Overall Study|Protocol Violation|44|||
27922236|NCT01313676|54579123|FG000|Overall Study|Met Protocol-Defined Stopping Critera|3|||
27922237|NCT01313676|54579124|FG001|Overall Study|Met Protocol-Defined Stopping Critera|4|||
27922238|NCT01313676|54579125|FG002|Overall Study|Met Protocol-Defined Stopping Critera|2|||
27922239|NCT01313676|54579126|FG003|Overall Study|Met Protocol-Defined Stopping Critera|11|||
27922240|NCT01313676|54579123|FG000|Overall Study|Study Closed/terminated|7|||
27922241|NCT01313676|54579124|FG001|Overall Study|Study Closed/terminated|6|||
27922242|NCT01313676|54579125|FG002|Overall Study|Study Closed/terminated|9|||
27922243|NCT01313676|54579126|FG003|Overall Study|Study Closed/terminated|9|||
27922244|NCT01313676|54579123|FG000|Overall Study|Lost to Follow-up|0|||
27922245|NCT01313676|54579124|FG001|Overall Study|Lost to Follow-up|0|||
27922246|NCT01313676|54579125|FG002|Overall Study|Lost to Follow-up|1|||
27922247|NCT01313676|54579126|FG003|Overall Study|Lost to Follow-up|0|||
27922248|NCT01313676|54579123|FG000|Overall Study|Physician Decision|53|||
27922249|NCT01313676|54579124|FG001|Overall Study|Physician Decision|64|||
27922250|NCT01313676|54579125|FG002|Overall Study|Physician Decision|62|||
27922251|NCT01313676|54579126|FG003|Overall Study|Physician Decision|48|||
27922252|NCT01313676|54579123|FG000|Overall Study|Decision by Participant or Proxy|643|||
27922253|NCT01313676|54579124|FG001|Overall Study|Decision by Participant or Proxy|527|||
27922254|NCT01313676|54579125|FG002|Overall Study|Decision by Participant or Proxy|515|||
27922255|NCT01313676|54579126|FG003|Overall Study|Decision by Participant or Proxy|492|||
27922256|NCT01313676|54579123|FG000|Overall Study|Sponsor Terminated Study Treatment|1|||
27922257|NCT01313676|54579124|FG001|Overall Study|Sponsor Terminated Study Treatment|1|||
27922258|NCT01313676|54579125|FG002|Overall Study|Sponsor Terminated Study Treatment|0|||
27922259|NCT01313676|54579126|FG003|Overall Study|Sponsor Terminated Study Treatment|1|||
27922260|NCT01313676|54579123|FG000|Overall Study|Investigator Site Closed|12|||
27922261|NCT01313676|54579124|FG001|Overall Study|Investigator Site Closed|11|||
27922262|NCT01313676|54579125|FG002|Overall Study|Investigator Site Closed|15|||
27922263|NCT01313676|54579126|FG003|Overall Study|Investigator Site Closed|10|||
27922264|NCT01313676|54579123|FG000|Overall Study|Missing|1|||
27922265|NCT01313676|54579124|FG001|Overall Study|Missing|1|||
27922266|NCT01313676|54579125|FG002|Overall Study|Missing|1|||
27922267|NCT01313676|54579126|FG003|Overall Study|Missing|0|||
27922268|NCT01313286|54579137|FG000|Period 1|Withdrawal by Subject|2|||
27922269|NCT01313286|54579138|FG001|Period 1|Withdrawal by Subject|0|||
27922270|NCT01313208|54579146|FG000|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3|||
27922271|NCT01313208|54579147|FG001|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2|||
27922272|NCT01313208|54579146|FG000|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1|||
27922273|NCT01313208|54579147|FG001|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2|||
27922274|NCT01313208|54579146|FG000|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0|||
27922275|NCT01313208|54579147|FG001|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1|||
27922276|NCT01313208|54579146|FG000|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1|||
27922277|NCT01313208|54579147|FG001|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0|||
27922278|NCT01313208|54579146|FG000|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1|||
27922279|NCT01313208|54579147|FG001|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0|||
27922280|NCT01313208|54579146|FG000|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3|||
27922281|NCT01313208|54579147|FG001|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1|||
27922282|NCT01313208|54579146|FG000|Open-label Phase (Weeks 13 - 24)|Noncompliance|0|||
27922283|NCT01313208|54579147|FG001|Open-label Phase (Weeks 13 - 24)|Noncompliance|2|||
27922284|NCT01313208|54579146|FG000|Open-label Phase (Weeks 13 - 24)|Adverse Event|1|||
27922285|NCT01313208|54579147|FG001|Open-label Phase (Weeks 13 - 24)|Adverse Event|0|||
27922286|NCT01313208|54579146|FG000|Open-label Phase (Weeks 13 - 24)|Other|2|||
27922287|NCT01313208|54579147|FG001|Open-label Phase (Weeks 13 - 24)|Other|0|||
27922288|NCT01312428|54579157|FG000|Overall Study|Study Termination|3|||
27922289|NCT01312428|54579158|FG001|Overall Study|Study Termination|4|||
27922290|NCT01075984|54579171|FG000|Treatment Phase|Adverse Event|0|||
27922291|NCT01075984|54579172|FG001|Treatment Phase|Adverse Event|1|||
27922292|NCT01075984|54579173|FG002|Treatment Phase|Adverse Event|3|||
27922293|NCT01075984|54579174|FG003|Treatment Phase|Adverse Event|7|||
27922294|NCT01075984|54579175|FG004|Treatment Phase|Adverse Event|35|||
27922295|NCT01075984|54579171|FG000|Treatment Phase|Protocol Violation|0|||
27922296|NCT01075984|54579172|FG001|Treatment Phase|Protocol Violation|0|||
27922297|NCT01075984|54579173|FG002|Treatment Phase|Protocol Violation|1|||
27922298|NCT01075984|54579174|FG003|Treatment Phase|Protocol Violation|0|||
27922299|NCT01075984|54579175|FG004|Treatment Phase|Protocol Violation|3|||
27922300|NCT01075984|54579171|FG000|Treatment Phase|Withdrawal by Subject|0|||
27922301|NCT01075984|54579172|FG001|Treatment Phase|Withdrawal by Subject|0|||
27922302|NCT01075984|54579173|FG002|Treatment Phase|Withdrawal by Subject|2|||
27922303|NCT01075984|54579174|FG003|Treatment Phase|Withdrawal by Subject|0|||
27922304|NCT01075984|54579175|FG004|Treatment Phase|Withdrawal by Subject|15|||
27922305|NCT01075984|54579171|FG000|Treatment Phase|Treatment Failure|0|||
27922306|NCT01075984|54579172|FG001|Treatment Phase|Treatment Failure|0|||
27922307|NCT01075984|54579173|FG002|Treatment Phase|Treatment Failure|1|||
27922308|NCT01075984|54579174|FG003|Treatment Phase|Treatment Failure|0|||
27922309|NCT01075984|54579175|FG004|Treatment Phase|Treatment Failure|5|||
27922310|NCT01075984|54579171|FG000|Treatment Phase|Progression of disease|0|||
27922311|NCT01075984|54579172|FG001|Treatment Phase|Progression of disease|0|||
27922312|NCT01075984|54579173|FG002|Treatment Phase|Progression of disease|0|||
27922313|NCT01075984|54579174|FG003|Treatment Phase|Progression of disease|0|||
27922314|NCT01075984|54579175|FG004|Treatment Phase|Progression of disease|2|||
27922315|NCT01075984|54579171|FG000|Follow-up Phase|Protocol Violation|0|||
27922316|NCT01075984|54579172|FG001|Follow-up Phase|Protocol Violation|0|||
27922317|NCT01075984|54579173|FG002|Follow-up Phase|Protocol Violation|1|||
27922318|NCT01075984|54579174|FG003|Follow-up Phase|Protocol Violation|0|||
27922319|NCT01075984|54579175|FG004|Follow-up Phase|Protocol Violation|3|||
27922320|NCT01075984|54579171|FG000|Follow-up Phase|Adverse Event|0|||
27922321|NCT01075984|54579172|FG001|Follow-up Phase|Adverse Event|0|||
27922322|NCT01075984|54579173|FG002|Follow-up Phase|Adverse Event|0|||
27922323|NCT01075984|54579174|FG003|Follow-up Phase|Adverse Event|2|||
27922324|NCT01075984|54579175|FG004|Follow-up Phase|Adverse Event|27|||
27922325|NCT01075984|54579171|FG000|Follow-up Phase|Administrative|0|||
27922326|NCT01075984|54579172|FG001|Follow-up Phase|Administrative|0|||
27922327|NCT01075984|54579173|FG002|Follow-up Phase|Administrative|0|||
27922328|NCT01075984|54579174|FG003|Follow-up Phase|Administrative|0|||
27922329|NCT01075984|54579175|FG004|Follow-up Phase|Administrative|1|||
27922330|NCT01075984|54579171|FG000|Follow-up Phase|Withdrawal by Subject|0|||
27922331|NCT01075984|54579172|FG001|Follow-up Phase|Withdrawal by Subject|0|||
27922332|NCT01075984|54579173|FG002|Follow-up Phase|Withdrawal by Subject|0|||
27922333|NCT01075984|54579174|FG003|Follow-up Phase|Withdrawal by Subject|0|||
27922334|NCT01075984|54579175|FG004|Follow-up Phase|Withdrawal by Subject|10|||
27922335|NCT01075984|54579171|FG000|Follow-up Phase|Progression of disease|0|||
27922336|NCT01075984|54579172|FG001|Follow-up Phase|Progression of disease|0|||
27922337|NCT01075984|54579173|FG002|Follow-up Phase|Progression of disease|0|||
27922338|NCT01075984|54579174|FG003|Follow-up Phase|Progression of disease|0|||
27922339|NCT01075984|54579175|FG004|Follow-up Phase|Progression of disease|2|||
27922340|NCT01075984|54579171|FG000|Follow-up Phase|Treatment failure|0|||
27922341|NCT01075984|54579172|FG001|Follow-up Phase|Treatment failure|0|||
27922342|NCT01075984|54579173|FG002|Follow-up Phase|Treatment failure|0|||
27922343|NCT01075984|54579174|FG003|Follow-up Phase|Treatment failure|0|||
27922344|NCT01075984|54579175|FG004|Follow-up Phase|Treatment failure|4|||
27922345|NCT01024231|54579194|FG000|Overall Study|Other Reasons|1|||
27922346|NCT01024231|54579195|FG001|Overall Study|Other Reasons|2|||
27922347|NCT01024231|54579196|FG002|Overall Study|Other Reasons|0|||
27922348|NCT01024231|54579197|FG003|Overall Study|Other Reasons|0|||
27922349|NCT01024231|54579198|FG004|Overall Study|Other Reasons|2|||
27922350|NCT01024231|54579199|FG005|Overall Study|Other Reasons|0|||
27922351|NCT01024231|54579200|FG006|Overall Study|Other Reasons|1|||
27922352|NCT01024231|54579194|FG000|Overall Study|Maximum Clinical Benefit|1|||
27922353|NCT01024231|54579195|FG001|Overall Study|Maximum Clinical Benefit|2|||
27922354|NCT01024231|54579196|FG002|Overall Study|Maximum Clinical Benefit|0|||
27922355|NCT01024231|54579197|FG003|Overall Study|Maximum Clinical Benefit|1|||
27922356|NCT01024231|54579198|FG004|Overall Study|Maximum Clinical Benefit|1|||
27922357|NCT01024231|54579199|FG005|Overall Study|Maximum Clinical Benefit|0|||
27922358|NCT01024231|54579200|FG006|Overall Study|Maximum Clinical Benefit|0|||
27922359|NCT01024231|54579194|FG000|Overall Study|Disease Progression|3|||
27922360|NCT01024231|54579195|FG001|Overall Study|Disease Progression|1|||
27922361|NCT01024231|54579196|FG002|Overall Study|Disease Progression|3|||
27922362|NCT01024231|54579197|FG003|Overall Study|Disease Progression|0|||
27922363|NCT01024231|54579198|FG004|Overall Study|Disease Progression|4|||
27922364|NCT01024231|54579199|FG005|Overall Study|Disease Progression|11|||
27922365|NCT01024231|54579200|FG006|Overall Study|Disease Progression|6|||
27922366|NCT01024231|54579194|FG000|Overall Study|AE unrelated to Study Drug|0|||
27922367|NCT01024231|54579195|FG001|Overall Study|AE unrelated to Study Drug|1|||
27922368|NCT01024231|54579196|FG002|Overall Study|AE unrelated to Study Drug|0|||
27922369|NCT01024231|54579197|FG003|Overall Study|AE unrelated to Study Drug|0|||
27922370|NCT01024231|54579198|FG004|Overall Study|AE unrelated to Study Drug|0|||
27922371|NCT01024231|54579199|FG005|Overall Study|AE unrelated to Study Drug|0|||
27922372|NCT01024231|54579200|FG006|Overall Study|AE unrelated to Study Drug|0|||
27922373|NCT01024231|54579194|FG000|Overall Study|No longer meets criteria|0|||
27922374|NCT01024231|54579195|FG001|Overall Study|No longer meets criteria|0|||
27922375|NCT01024231|54579196|FG002|Overall Study|No longer meets criteria|0|||
27922376|NCT01024231|54579197|FG003|Overall Study|No longer meets criteria|0|||
27922377|NCT01024231|54579198|FG004|Overall Study|No longer meets criteria|1|||
27922378|NCT01024231|54579199|FG005|Overall Study|No longer meets criteria|0|||
27922379|NCT01024231|54579200|FG006|Overall Study|No longer meets criteria|1|||
27922380|NCT01024231|54579194|FG000|Overall Study|Study Drug Toxicity|1|||
27922381|NCT01024231|54579195|FG001|Overall Study|Study Drug Toxicity|6|||
27922382|NCT01024231|54579196|FG002|Overall Study|Study Drug Toxicity|6|||
27922383|NCT01024231|54579197|FG003|Overall Study|Study Drug Toxicity|4|||
27922384|NCT01024231|54579198|FG004|Overall Study|Study Drug Toxicity|2|||
27922385|NCT01024231|54579199|FG005|Overall Study|Study Drug Toxicity|0|||
27922386|NCT01024231|54579200|FG006|Overall Study|Study Drug Toxicity|7|||
27922387|NCT01024231|54579194|FG000|Overall Study|Death|6|||
27922388|NCT01024231|54579195|FG001|Overall Study|Death|2|||
27922389|NCT01024231|54579196|FG002|Overall Study|Death|1|||
27922390|NCT01024231|54579197|FG003|Overall Study|Death|0|||
27922391|NCT01024231|54579198|FG004|Overall Study|Death|4|||
27922392|NCT01024231|54579199|FG005|Overall Study|Death|3|||
27922393|NCT01024231|54579200|FG006|Overall Study|Death|5|||
27922394|NCT01024231|54579194|FG000|Overall Study|Lost to Follow-up|0|||
27922395|NCT01024231|54579195|FG001|Overall Study|Lost to Follow-up|0|||
27922396|NCT01024231|54579196|FG002|Overall Study|Lost to Follow-up|0|||
27922397|NCT01024231|54579197|FG003|Overall Study|Lost to Follow-up|0|||
27922398|NCT01024231|54579198|FG004|Overall Study|Lost to Follow-up|0|||
27922399|NCT01024231|54579199|FG005|Overall Study|Lost to Follow-up|0|||
27922400|NCT01024231|54579200|FG006|Overall Study|Lost to Follow-up|1|||
27922401|NCT01024231|54579194|FG000|Overall Study|Withdrew Consent|0|||
27922402|NCT01024231|54579195|FG001|Overall Study|Withdrew Consent|1|||
27922403|NCT01024231|54579196|FG002|Overall Study|Withdrew Consent|0|||
27922404|NCT01024231|54579197|FG003|Overall Study|Withdrew Consent|0|||
27922405|NCT01024231|54579198|FG004|Overall Study|Withdrew Consent|0|||
27922406|NCT01024231|54579199|FG005|Overall Study|Withdrew Consent|0|||
27922407|NCT01024231|54579200|FG006|Overall Study|Withdrew Consent|0|||
27922408|NCT01024231|54579194|FG000|Overall Study|Continuing on Treatment|0|||
27922409|NCT01024231|54579195|FG001|Overall Study|Continuing on Treatment|0|||
27922410|NCT01024231|54579196|FG002|Overall Study|Continuing on Treatment|0|||
27922411|NCT01024231|54579197|FG003|Overall Study|Continuing on Treatment|0|||
27742930|NCT03420781|54192850|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
27922412|NCT01024231|54579198|FG004|Overall Study|Continuing on Treatment|3|||
27922413|NCT01024231|54579199|FG005|Overall Study|Continuing on Treatment|2|||
27922414|NCT01024231|54579200|FG006|Overall Study|Continuing on Treatment|0|||
27922415|NCT01077544|54579223|FG000|Overall Study|New Cancer Therapy|3|||
27922416|NCT01077544|54579224|FG001|Overall Study|New Cancer Therapy|3|||
27922417|NCT01077544|54579223|FG000|Overall Study|Adverse Event|0|||
27922418|NCT01077544|54579224|FG001|Overall Study|Adverse Event|1|||
27922419|NCT01077544|54579223|FG000|Overall Study|Disease Progression|0|||
27922420|NCT01077544|54579224|FG001|Overall Study|Disease Progression|1|||
27922421|NCT01075516|54579232|FG000|Overall Study|Death|5|||
27922422|NCT01075516|54579233|FG001|Overall Study|Death|9|||
27922423|NCT01075516|54579232|FG000|Overall Study|Lost to Follow-up|10|||
27922424|NCT01075516|54579233|FG001|Overall Study|Lost to Follow-up|2|||
27922425|NCT01075516|54579232|FG000|Overall Study|Withdrawal by Subject|3|||
27922426|NCT01075516|54579233|FG001|Overall Study|Withdrawal by Subject|5|||
27922427|NCT01012999|54579239|FG000|Overall Study|Protocol Violation|1|||
27922428|NCT01017601|54579245|FG000|Overall Study|Disease Progression|12|||
27922429|NCT01017601|54579246|FG001|Overall Study|Disease Progression|12|||
27922430|NCT01017601|54579245|FG000|Overall Study|Withdrawal by Subject|0|||
27922431|NCT01017601|54579246|FG001|Overall Study|Withdrawal by Subject|1|||
27922432|NCT01016977|54579254|FG000|Overall Study|Lost to Follow-up|1|||
27922433|NCT01016977|54579255|FG001|Overall Study|Lost to Follow-up|0|||
27922434|NCT01016977|54579254|FG000|Overall Study|Withdrawal by Subject|2|||
27922435|NCT01016977|54579255|FG001|Overall Study|Withdrawal by Subject|2|||
27922436|NCT01012765|54579264|FG000|Treatment Period 1|Adverse Event|1|||
27922437|NCT01012765|54579265|FG001|Treatment Period 1|Adverse Event|0|||
27922438|NCT01012765|54579266|FG002|Treatment Period 1|Adverse Event|1|||
27922439|NCT01012765|54579267|FG003|Treatment Period 1|Adverse Event|0|||
27922440|NCT01012765|54579268|FG004|Treatment Period 1|Adverse Event|0|||
27922441|NCT01012765|54579269|FG005|Treatment Period 1|Adverse Event|0|||
27922442|NCT01012765|54579264|FG000|Treatment Period 1|Withdrawal by Subject|2|||
27922443|NCT01012765|54579265|FG001|Treatment Period 1|Withdrawal by Subject|0|||
27922444|NCT01012765|54579266|FG002|Treatment Period 1|Withdrawal by Subject|0|||
27922445|NCT01012765|54579267|FG003|Treatment Period 1|Withdrawal by Subject|0|||
27922446|NCT01012765|54579268|FG004|Treatment Period 1|Withdrawal by Subject|0|||
27922447|NCT01012765|54579269|FG005|Treatment Period 1|Withdrawal by Subject|0|||
27922448|NCT01012765|54579264|FG000|Treatment Period 1|Administrative problems|0|||
27922449|NCT01012765|54579265|FG001|Treatment Period 1|Administrative problems|0|||
27922450|NCT01012765|54579266|FG002|Treatment Period 1|Administrative problems|1|||
27922451|NCT01012765|54579267|FG003|Treatment Period 1|Administrative problems|1|||
27922452|NCT01012765|54579268|FG004|Treatment Period 1|Administrative problems|1|||
27922453|NCT01012765|54579269|FG005|Treatment Period 1|Administrative problems|0|||
27922454|NCT01012765|54579264|FG000|Treatment Period 1|Protocol Violation|0|||
27922455|NCT01012765|54579265|FG001|Treatment Period 1|Protocol Violation|0|||
27922456|NCT01012765|54579266|FG002|Treatment Period 1|Protocol Violation|0|||
27922457|NCT01012765|54579267|FG003|Treatment Period 1|Protocol Violation|2|||
27922458|NCT01012765|54579268|FG004|Treatment Period 1|Protocol Violation|1|||
27922459|NCT01012765|54579269|FG005|Treatment Period 1|Protocol Violation|0|||
27922460|NCT01012765|54579264|FG000|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
27922461|NCT01012765|54579265|FG001|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
27922462|NCT01012765|54579266|FG002|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
27922463|NCT01012765|54579267|FG003|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
27922464|NCT01012765|54579268|FG004|Treatment Period 1|Unsatisfactory therapeutic effect|1|||
27922465|NCT01012765|54579269|FG005|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
27922466|NCT01012765|54579264|FG000|Treatment Period 2|Withdrawal by Subject|1|||
27922467|NCT01012765|54579265|FG001|Treatment Period 2|Withdrawal by Subject|0|||
27922468|NCT01012765|54579266|FG002|Treatment Period 2|Withdrawal by Subject|1|||
27922469|NCT01012765|54579267|FG003|Treatment Period 2|Withdrawal by Subject|0|||
27922470|NCT01012765|54579268|FG004|Treatment Period 2|Withdrawal by Subject|1|||
27922471|NCT01012765|54579269|FG005|Treatment Period 2|Withdrawal by Subject|0|||
27922472|NCT01012765|54579264|FG000|Treatment Period 2|Abnormal laboratory value(s)|0|||
27922473|NCT01012765|54579265|FG001|Treatment Period 2|Abnormal laboratory value(s)|0|||
27922474|NCT01012765|54579266|FG002|Treatment Period 2|Abnormal laboratory value(s)|0|||
27922475|NCT01012765|54579267|FG003|Treatment Period 2|Abnormal laboratory value(s)|0|||
27922476|NCT01012765|54579268|FG004|Treatment Period 2|Abnormal laboratory value(s)|0|||
27922477|NCT01012765|54579269|FG005|Treatment Period 2|Abnormal laboratory value(s)|1|||
27922478|NCT01012765|54579264|FG000|Treatment Period 2|Adverse Event|0|||
27922479|NCT01012765|54579265|FG001|Treatment Period 2|Adverse Event|1|||
27922480|NCT01012765|54579266|FG002|Treatment Period 2|Adverse Event|1|||
27922481|NCT01012765|54579267|FG003|Treatment Period 2|Adverse Event|0|||
27922482|NCT01012765|54579268|FG004|Treatment Period 2|Adverse Event|0|||
27742931|NCT03420781|54192851|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
27922483|NCT01012765|54579269|FG005|Treatment Period 2|Adverse Event|0|||
27922484|NCT01012765|54579264|FG000|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
27922485|NCT01012765|54579265|FG001|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
27922486|NCT01012765|54579266|FG002|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
27922487|NCT01012765|54579267|FG003|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
27922488|NCT01012765|54579268|FG004|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
27922489|NCT01012765|54579269|FG005|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
27922490|NCT01010503|54579277|FG000|Overall Study|Adverse Event|1|||
27922491|NCT01010503|54579277|FG000|Overall Study|Death|1|||
27922492|NCT01009645|54579285|FG000|Overall Study|Lost to Follow-up|2|||
27922493|NCT01009645|54579286|FG001|Overall Study|Lost to Follow-up|8|||
27922494|NCT01009645|54579287|FG002|Overall Study|Lost to Follow-up|4|||
27922495|NCT01009645|54579288|FG003|Overall Study|Lost to Follow-up|5|||
27922496|NCT01006291|54579301|FG000|Overall Study|Adverse Event|2|||
27922497|NCT01006291|54579302|FG001|Overall Study|Adverse Event|1|||
27922498|NCT01006291|54579303|FG002|Overall Study|Adverse Event|2|||
27922499|NCT01006291|54579301|FG000|Overall Study|Lack of Efficacy|2|||
27922500|NCT01006291|54579302|FG001|Overall Study|Lack of Efficacy|2|||
27922501|NCT01006291|54579303|FG002|Overall Study|Lack of Efficacy|1|||
27922502|NCT01006291|54579301|FG000|Overall Study|Protocol Violation|3|||
27922503|NCT01006291|54579302|FG001|Overall Study|Protocol Violation|3|||
27922504|NCT01006291|54579303|FG002|Overall Study|Protocol Violation|3|||
27922505|NCT01006291|54579301|FG000|Overall Study|Withdrawal criteria|5|||
27922506|NCT01006291|54579302|FG001|Overall Study|Withdrawal criteria|4|||
27922507|NCT01006291|54579303|FG002|Overall Study|Withdrawal criteria|4|||
27922508|NCT01006291|54579301|FG000|Overall Study|Other|14|||
27922509|NCT01006291|54579302|FG001|Overall Study|Other|14|||
27922510|NCT01006291|54579303|FG002|Overall Study|Other|17|||
27922511|NCT01006135|54579311|FG000|Overall Study|Adverse Event|22|||
27922512|NCT01006135|54579311|FG000|Overall Study|Protocol Violation|14|||
27922513|NCT01006135|54579311|FG000|Overall Study|Lost to Follow-up|32|||
27922514|NCT01006135|54579311|FG000|Overall Study|Other|72|||
27922515|NCT01012609|54579317|FG000|Overall Study|Withdrawal by Subject|1|||
27922516|NCT01012609|54579318|FG001|Overall Study|Withdrawal by Subject|1|||
27922517|NCT01012219|54579325|FG000|Period 1|Withdrawal by Subject|1|||
27922518|NCT01012219|54579325|FG000|Period 2|Withdrawal by Subject|1|||
27922519|NCT01011907|54579334|FG000|Overall Study|Withdrawal by Subject|13|||
27922520|NCT01011907|54579335|FG001|Overall Study|Withdrawal by Subject|11|||
27922521|NCT01011907|54579334|FG000|Overall Study|Adverse Event|1|||
27922522|NCT01011907|54579335|FG001|Overall Study|Adverse Event|4|||
27922523|NCT01011673|54579343|FG000|Randomized|Secondary headache|2|||
27922524|NCT01011673|54579344|FG001|Randomized|Secondary headache|1|||
27922525|NCT01011673|54579343|FG000|24 Hour Follow-up|Lost to Follow-up|3|||
27922526|NCT01011673|54579344|FG001|24 Hour Follow-up|Lost to Follow-up|3|||
27922527|NCT01311648|54579353|FG000|Main Study|Protocol Violation|0|||
27922528|NCT01311648|54579354|FG001|Main Study|Protocol Violation|1|||
27922529|NCT01311648|54579353|FG000|Main Study|Adverse Event|0|||
27922530|NCT01311648|54579354|FG001|Main Study|Adverse Event|1|||
27922531|NCT01311648|54579353|FG000|Main Study|Inhibitor management|0|||
27922532|NCT01311648|54579354|FG001|Main Study|Inhibitor management|17|||
27922533|NCT01311648|54579353|FG000|Main Study|Withdrawal by Subject|0|||
27922534|NCT01311648|54579354|FG001|Main Study|Withdrawal by Subject|2|||
27922535|NCT01311648|54579353|FG000|Extension Study|Physician Decision|0|||
27922536|NCT01311648|54579354|FG001|Extension Study|Physician Decision|1|||
27922537|NCT01311648|54579353|FG000|Extension Study|ITI therapy with marketed product|0|||
27922538|NCT01311648|54579354|FG001|Extension Study|ITI therapy with marketed product|1|||
27922539|NCT01311648|54579353|FG000|Extension Study|Incorrect visit planning|0|||
27922540|NCT01311648|54579354|FG001|Extension Study|Incorrect visit planning|1|||
27922541|NCT01311648|54579353|FG000|Extension Study|Family's decision|0|||
27922542|NCT01311648|54579354|FG001|Extension Study|Family's decision|1|||
27922543|NCT01311648|54579353|FG000|Extension Study|Failure of ITI therapy|0|||
27922544|NCT01311648|54579354|FG001|Extension Study|Failure of ITI therapy|3|||
27922545|NCT01311648|54579353|FG000|Extension Study|Long travel|0|||
27922546|NCT01311648|54579354|FG001|Extension Study|Long travel|1|||
27922547|NCT01311648|54579353|FG000|Extension Study|Diagnosed with von Willebrand disease|1|||
27922548|NCT01311648|54579354|FG001|Extension Study|Diagnosed with von Willebrand disease|0|||
27922549|NCT01311648|54579353|FG000|Extension Study|Withdrawal by Subject|0|||
27922550|NCT01311648|54579354|FG001|Extension Study|Withdrawal by Subject|1|||
27922551|NCT01311648|54579353|FG000|Extension Study|Inhibitor management|0|||
27922552|NCT01311648|54579354|FG001|Extension Study|Inhibitor management|2|||
27922553|NCT01011439|54579367|FG000|Overall Study|Death|37|||
27922554|NCT01011439|54579367|FG000|Overall Study|Lost to Follow-up|4|||
27922555|NCT01011439|54579367|FG000|Overall Study|Withdrawal by Subject|1|||
27922556|NCT01011439|54579367|FG000|Overall Study|Sponsor's decision|15|||
27922557|NCT01311024|54579374|FG000|Overall Study|Protocol Violation|35|||
27922558|NCT01311024|54579375|FG001|Overall Study|Protocol Violation|22|||
27922559|NCT01310868|54579381|FG000|Overall Study|Do not have histologically confirmed GBM|13|||
27922560|NCT01273155|54579389|FG000|Overall Study|Off study trmt prior to end of C1/PD|2|||
27922561|NCT01273155|54579390|FG001|Overall Study|Off study trmt prior to end of C1/PD|3|||
27922562|NCT01273155|54579391|FG002|Overall Study|Off study trmt prior to end of C1/PD|8|||
27922563|NCT01273155|54579392|FG003|Overall Study|Off study trmt prior to end of C1/PD|0|||
27922564|NCT01273155|54579393|FG004|Overall Study|Off study trmt prior to end of C1/PD|0|||
27922565|NCT01273155|54579394|FG005|Overall Study|Off study trmt prior to end of C1/PD|2|||
27922566|NCT01273155|54579395|FG006|Overall Study|Off study trmt prior to end of C1/PD|3|||
27922567|NCT01273155|54579389|FG000|Overall Study|Change in liver function/no longer eval.|0|||
27922568|NCT01273155|54579390|FG001|Overall Study|Change in liver function/no longer eval.|1|||
27922569|NCT01273155|54579391|FG002|Overall Study|Change in liver function/no longer eval.|0|||
27922570|NCT01273155|54579392|FG003|Overall Study|Change in liver function/no longer eval.|0|||
27922571|NCT01273155|54579393|FG004|Overall Study|Change in liver function/no longer eval.|1|||
27922572|NCT01273155|54579394|FG005|Overall Study|Change in liver function/no longer eval.|0|||
27922573|NCT01273155|54579395|FG006|Overall Study|Change in liver function/no longer eval.|0|||
27922574|NCT01273155|54579389|FG000|Overall Study|Off study prior to C1/due to toxicity|0|||
27922575|NCT01273155|54579390|FG001|Overall Study|Off study prior to C1/due to toxicity|0|||
27922576|NCT01273155|54579391|FG002|Overall Study|Off study prior to C1/due to toxicity|2|||
27922577|NCT01273155|54579392|FG003|Overall Study|Off study prior to C1/due to toxicity|0|||
27922578|NCT01273155|54579393|FG004|Overall Study|Off study prior to C1/due to toxicity|0|||
27922579|NCT01273155|54579394|FG005|Overall Study|Off study prior to C1/due to toxicity|0|||
27922580|NCT01273155|54579395|FG006|Overall Study|Off study prior to C1/due to toxicity|1|||
27922581|NCT01273155|54579389|FG000|Overall Study|Died during Cycle 1|0|||
27922582|NCT01273155|54579390|FG001|Overall Study|Died during Cycle 1|0|||
27922583|NCT01273155|54579391|FG002|Overall Study|Died during Cycle 1|1|||
27922584|NCT01273155|54579392|FG003|Overall Study|Died during Cycle 1|1|||
27922585|NCT01273155|54579393|FG004|Overall Study|Died during Cycle 1|0|||
27922586|NCT01273155|54579394|FG005|Overall Study|Died during Cycle 1|2|||
27922587|NCT01273155|54579395|FG006|Overall Study|Died during Cycle 1|2|||
27922588|NCT01273155|54579389|FG000|Overall Study|Withdrew during C1/refused further trmt|0|||
27922589|NCT01273155|54579390|FG001|Overall Study|Withdrew during C1/refused further trmt|0|||
27922590|NCT01273155|54579391|FG002|Overall Study|Withdrew during C1/refused further trmt|1|||
27922591|NCT01273155|54579392|FG003|Overall Study|Withdrew during C1/refused further trmt|0|||
28013796|NCT00561574|54672633|FG001|Overall Study|Adverse Event|24|||
28013797|NCT00561574|54672632|FG000|Overall Study|Lack of Efficacy|11|||
28013798|NCT00561574|54672633|FG001|Overall Study|Lack of Efficacy|21|||
28013799|NCT00561574|54672632|FG000|Overall Study|Withdrawal by Subject|4|||
28013800|NCT00561574|54672633|FG001|Overall Study|Withdrawal by Subject|4|||
28013801|NCT00561574|54672632|FG000|Overall Study|Reason Unrelated to Trial|6|||
28013802|NCT00561574|54672633|FG001|Overall Study|Reason Unrelated to Trial|2|||
28013803|NCT00561574|54672632|FG000|Overall Study|Lost to Follow-up|1|||
28013804|NCT00561574|54672633|FG001|Overall Study|Lost to Follow-up|0|||
28013805|NCT00561574|54672632|FG000|Overall Study|Other|5|||
28013806|NCT00561574|54672633|FG001|Overall Study|Other|7|||
28013807|NCT00619827|54672641|FG000|Overall Study|Adverse Event|1|||
28013808|NCT00619827|54672642|FG001|Overall Study|Adverse Event|2|||
28013809|NCT00619827|54672641|FG000|Overall Study|Withdrawal by Subject|2|||
28013810|NCT00619827|54672642|FG001|Overall Study|Withdrawal by Subject|2|||
28013811|NCT00687804|54672651|FG000|Core Study|Adverse Event|5|||
28013812|NCT00687804|54672652|FG001|Core Study|Adverse Event|3|||
28013813|NCT00687804|54672653|FG002|Core Study|Adverse Event|3|||
28013814|NCT00687804|54672651|FG000|Core Study|Abnormal laboratory value(s)|1|||
28013815|NCT00687804|54672652|FG001|Core Study|Abnormal laboratory value(s)|0|||
28013816|NCT00687804|54672653|FG002|Core Study|Abnormal laboratory value(s)|0|||
28013817|NCT00687804|54672651|FG000|Core Study|Lack of Efficacy|1|||
28013818|NCT00687804|54672652|FG001|Core Study|Lack of Efficacy|1|||
28013819|NCT00687804|54672653|FG002|Core Study|Lack of Efficacy|1|||
28013820|NCT00687804|54672651|FG000|Core Study|Withdrawal by Subject|4|||
28013821|NCT00687804|54672652|FG001|Core Study|Withdrawal by Subject|7|||
28013822|NCT00687804|54672653|FG002|Core Study|Withdrawal by Subject|7|||
28013823|NCT00687804|54672651|FG000|Core Study|Lost to Follow-up|0|||
28013824|NCT00687804|54672652|FG001|Core Study|Lost to Follow-up|1|||
28013825|NCT00687804|54672653|FG002|Core Study|Lost to Follow-up|0|||
28013826|NCT00687804|54672651|FG000|Core Study|Death|2|||
28013827|NCT00687804|54672652|FG001|Core Study|Death|2|||
28013828|NCT00687804|54672653|FG002|Core Study|Death|2|||
28013829|NCT00687804|54672651|FG000|Core Study|Protocol Violation|1|||
28013830|NCT00687804|54672652|FG001|Core Study|Protocol Violation|1|||
28013831|NCT00687804|54672653|FG002|Core Study|Protocol Violation|0|||
28013832|NCT00687804|54672651|FG000|Open-Label Extension Study|Adverse Event|2|||
28013833|NCT00687804|54672652|FG001|Open-Label Extension Study|Adverse Event|2|||
28013834|NCT00687804|54672653|FG002|Open-Label Extension Study|Adverse Event|2|||
28013835|NCT00687804|54672651|FG000|Open-Label Extension Study|Subject withdrew consent|3|||
28013836|NCT00687804|54672652|FG001|Open-Label Extension Study|Subject withdrew consent|4|||
28013837|NCT00687804|54672653|FG002|Open-Label Extension Study|Subject withdrew consent|4|||
28013838|NCT00687804|54672651|FG000|Open-Label Extension Study|Lost to Follow-up|2|||
28013839|NCT00687804|54672652|FG001|Open-Label Extension Study|Lost to Follow-up|1|||
28013840|NCT00687804|54672653|FG002|Open-Label Extension Study|Lost to Follow-up|2|||
28013841|NCT00687804|54672651|FG000|Open-Label Extension Study|Administrative problems|1|||
28013842|NCT00687804|54672652|FG001|Open-Label Extension Study|Administrative problems|1|||
28013843|NCT00687804|54672653|FG002|Open-Label Extension Study|Administrative problems|0|||
28013844|NCT00687804|54672651|FG000|Open-Label Extension Study|Death|2|||
28013845|NCT00687804|54672652|FG001|Open-Label Extension Study|Death|3|||
28013846|NCT00687804|54672653|FG002|Open-Label Extension Study|Death|3|||
28013847|NCT00689052|54672680|FG000|Overall Study|Adverse Event|4|||
28013848|NCT00689052|54672681|FG001|Overall Study|Adverse Event|6|||
28013849|NCT00689052|54672680|FG000|Overall Study|Protocol Violation|1|||
28013850|NCT00689052|54672681|FG001|Overall Study|Protocol Violation|0|||
28013851|NCT00689052|54672680|FG000|Overall Study|Lost to Follow-up|2|||
28013852|NCT00689052|54672681|FG001|Overall Study|Lost to Follow-up|0|||
28013853|NCT00689052|54672680|FG000|Overall Study|Withdrawal by Subject|2|||
28013854|NCT00689052|54672681|FG001|Overall Study|Withdrawal by Subject|0|||
28013855|NCT00689052|54672680|FG000|Overall Study|Early termination of the trial|22|||
28013856|NCT00689052|54672681|FG001|Overall Study|Early termination of the trial|24|||
28013857|NCT00560950|54672691|FG000|Overall Study|Lost to Follow-up|1|||
28013858|NCT00560950|54672692|FG001|Overall Study|Lost to Follow-up|0|||
28013859|NCT00576758|54672702|FG000|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
28013860|NCT00576758|54672703|FG001|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
28013861|NCT00576758|54672702|FG000|Induction Treatment Period|Insufficient therapeutic response|2|||
28013862|NCT00576758|54672703|FG001|Induction Treatment Period|Insufficient therapeutic response|0|||
28013863|NCT00576758|54672702|FG000|Induction Treatment Period|Violation of selection criteria at entry|1|||
28013864|NCT00576758|54672703|FG001|Induction Treatment Period|Violation of selection criteria at entry|1|||
28013865|NCT00576758|54672702|FG000|Induction Treatment Period|Death|1|||
28013866|NCT00576758|54672703|FG001|Induction Treatment Period|Death|0|||
28013867|NCT00576758|54672702|FG000|Induction Treatment Period|Refused treatment/ Did not Cooperate|0|||
28013868|NCT00576758|54672703|FG001|Induction Treatment Period|Refused treatment/ Did not Cooperate|1|||
28013869|NCT00576758|54672702|FG000|Induction Treatment Period|Withdrew consent|1|||
28013870|NCT00576758|54672703|FG001|Induction Treatment Period|Withdrew consent|0|||
28013871|NCT00576758|54672702|FG000|Extension Treatment Period|Adverse event or Intercurrent illness|6|||
28013872|NCT00576758|54672703|FG001|Extension Treatment Period|Adverse event or Intercurrent illness|7|||
28013873|NCT00576758|54672702|FG000|Extension Treatment Period|Death|1|||
28013874|NCT00576758|54672703|FG001|Extension Treatment Period|Death|1|||
28013875|NCT00576758|54672702|FG000|Extension Treatment Period|Refused treatment/did not cooperate|2|||
28013876|NCT00576758|54672703|FG001|Extension Treatment Period|Refused treatment/did not cooperate|1|||
28013877|NCT00576758|54672702|FG000|Extension Treatment Period|Insufficient therapeutic response|30|||
28013878|NCT00576758|54672703|FG001|Extension Treatment Period|Insufficient therapeutic response|33|||
28013879|NCT00576758|54672702|FG000|Extension Treatment Period|Administrative/Other|3|||
28013880|NCT00576758|54672703|FG001|Extension Treatment Period|Administrative/Other|1|||
28013881|NCT00576758|54672702|FG000|Follow-up Period|Administrative/Other|6|||
28013882|NCT00576758|54672703|FG001|Follow-up Period|Administrative/Other|8|||
28013883|NCT00576758|54672702|FG000|Follow-up Period|Death|3|||
28013884|NCT00576758|54672703|FG001|Follow-up Period|Death|3|||
28013885|NCT00576758|54672702|FG000|Follow-up Period|Insufficient therapeutic response|16|||
28013886|NCT00576758|54672703|FG001|Follow-up Period|Insufficient therapeutic response|5|||
28013887|NCT00576758|54672702|FG000|Follow-up Period|Withdrew consent|2|||
28013888|NCT00576758|54672703|FG001|Follow-up Period|Withdrew consent|1|||
28013889|NCT00560794|54672710|FG000|Overall Study|Adverse Event|2|||
28013890|NCT00560794|54672710|FG000|Overall Study|Patient was not Compliant|1|||
28013891|NCT00560794|54672710|FG000|Overall Study|Minimal Residual Disease Relapse|1|||
28013892|NCT00560794|54672710|FG000|Overall Study|Hematological Relapse|1|||
28013893|NCT00560794|54672710|FG000|Overall Study|Received Bone Marrow Transplant|6|||
28013894|NCT00619359|54672718|FG000|Overall Study|Adverse Event|32|||
28013895|NCT00619359|54672719|FG001|Overall Study|Adverse Event|36|||
28013896|NCT00619359|54672718|FG000|Overall Study|Lost to Follow-up|12|||
28013897|NCT00619359|54672719|FG001|Overall Study|Lost to Follow-up|16|||
28013898|NCT00619359|54672718|FG000|Overall Study|Physician Decision|0|||
28013899|NCT00619359|54672719|FG001|Overall Study|Physician Decision|7|||
28013900|NCT00619359|54672718|FG000|Overall Study|Protocol Violation|1|||
28013901|NCT00619359|54672719|FG001|Overall Study|Protocol Violation|1|||
28013902|NCT00619359|54672718|FG000|Overall Study|Withdrawal by Subject|19|||
28013903|NCT00619359|54672719|FG001|Overall Study|Withdrawal by Subject|20|||
28013904|NCT00619359|54672718|FG000|Overall Study|Progressive Disease|3|||
28013905|NCT00619359|54672719|FG001|Overall Study|Progressive Disease|1|||
28013906|NCT00372229|54672727|FG000|Study Phase|Graft loss|0|||
28013907|NCT00372229|54672728|FG001|Study Phase|Graft loss|3|||
28013908|NCT00372229|54672727|FG000|Study Phase|Protocol Violation|3|||
28013909|NCT00372229|54672728|FG001|Study Phase|Protocol Violation|4|||
28013910|NCT00372229|54672727|FG000|Study Phase|Consent withdrawn|16|||
28013911|NCT00372229|54672728|FG001|Study Phase|Consent withdrawn|14|||
28013912|NCT00372229|54672727|FG000|Study Phase|Refused treatment/did not cooperate|3|||
28013913|NCT00372229|54672728|FG001|Study Phase|Refused treatment/did not cooperate|1|||
28013914|NCT00372229|54672727|FG000|Study Phase|Death|3|||
28013915|NCT00372229|54672728|FG001|Study Phase|Death|2|||
28013916|NCT00372229|54672727|FG000|Study Phase|Reason not specified|3|||
28013917|NCT00372229|54672728|FG001|Study Phase|Reason not specified|2|||
28013918|NCT00372229|54672727|FG000|Study Phase|Lost to Follow-up|3|||
28013919|NCT00372229|54672728|FG001|Study Phase|Lost to Follow-up|3|||
28013920|NCT00372229|54672727|FG000|Follow-Up Phase|Graft loss|8|||
28013921|NCT00372229|54672728|FG001|Follow-Up Phase|Graft loss|7|||
28013922|NCT00372229|54672727|FG000|Follow-Up Phase|Consent withdrawn|13|||
28013923|NCT00372229|54672728|FG001|Follow-Up Phase|Consent withdrawn|19|||
28013924|NCT00372229|54672727|FG000|Follow-Up Phase|Refused treatment/did not cooperate|0|||
28013925|NCT00372229|54672728|FG001|Follow-Up Phase|Refused treatment/did not cooperate|1|||
28013926|NCT00372229|54672727|FG000|Follow-Up Phase|Adverse event/intercurrent illness|1|||
28013927|NCT00372229|54672728|FG001|Follow-Up Phase|Adverse event/intercurrent illness|0|||
28013928|NCT00372229|54672727|FG000|Follow-Up Phase|Death|9|||
28013929|NCT00372229|54672728|FG001|Follow-Up Phase|Death|12|||
28013930|NCT00372229|54672727|FG000|Follow-Up Phase|Administrative|1|||
28013931|NCT00372229|54672728|FG001|Follow-Up Phase|Administrative|0|||
28013932|NCT00372229|54672727|FG000|Follow-Up Phase|Reason not specified|2|||
28013933|NCT00372229|54672728|FG001|Follow-Up Phase|Reason not specified|3|||
28013934|NCT00372229|54672727|FG000|Follow-Up Phase|Lost to Follow-up|12|||
28013935|NCT00372229|54672728|FG001|Follow-Up Phase|Lost to Follow-up|10|||
28013936|NCT00698828|54672741|FG000|Overall Study|Adverse Event|3|||
28013937|NCT00698828|54672742|FG001|Overall Study|Adverse Event|4|||
28013938|NCT00698828|54672743|FG002|Overall Study|Adverse Event|4|||
28013939|NCT00698828|54672741|FG000|Overall Study|Death|0|||
28013940|NCT00698828|54672742|FG001|Overall Study|Death|0|||
28013941|NCT00698828|54672743|FG002|Overall Study|Death|1|||
28013942|NCT00698828|54672741|FG000|Overall Study|Exacerbation of COPD|1|||
28013943|NCT00698828|54672742|FG001|Overall Study|Exacerbation of COPD|3|||
28013944|NCT00698828|54672743|FG002|Overall Study|Exacerbation of COPD|0|||
28013945|NCT00698828|54672741|FG000|Overall Study|Exacerbation of COPD (Not treated)|1|||
28013946|NCT00698828|54672742|FG001|Overall Study|Exacerbation of COPD (Not treated)|0|||
28013947|NCT00698828|54672743|FG002|Overall Study|Exacerbation of COPD (Not treated)|0|||
28013948|NCT00698828|54672741|FG000|Overall Study|Investigator/Sponsor decision|1|||
28013949|NCT00698828|54672742|FG001|Overall Study|Investigator/Sponsor decision|0|||
28013950|NCT00698828|54672743|FG002|Overall Study|Investigator/Sponsor decision|2|||
28013951|NCT00698828|54672741|FG000|Overall Study|Lost to Follow-up|1|||
28013952|NCT00698828|54672742|FG001|Overall Study|Lost to Follow-up|1|||
28013953|NCT00698828|54672743|FG002|Overall Study|Lost to Follow-up|0|||
28013954|NCT00698828|54672741|FG000|Overall Study|Withdrew consent|0|||
28013955|NCT00698828|54672742|FG001|Overall Study|Withdrew consent|7|||
28013956|NCT00698828|54672743|FG002|Overall Study|Withdrew consent|4|||
28013957|NCT00698828|54672741|FG000|Overall Study|Withdrew consent (not treated)|2|||
28013958|NCT00698828|54672742|FG001|Overall Study|Withdrew consent (not treated)|0|||
28013959|NCT00698828|54672743|FG002|Overall Study|Withdrew consent (not treated)|0|||
28013960|NCT00619515|54672751|FG000|Overall Study|Study Termination by IRB|73|||
28013961|NCT03167606|54672757|FG000|Overall Study|Lost to Follow-up|73|||
28013962|NCT03167606|54672758|FG001|Overall Study|Lost to Follow-up|64|||
28013963|NCT03167606|54672757|FG000|Overall Study|Withdrawal by Subject|6|||
28013964|NCT03167606|54672758|FG001|Overall Study|Withdrawal by Subject|5|||
28013965|NCT03167606|54672757|FG000|Overall Study|Withdrawal by Investigator|0|||
28013966|NCT03167606|54672758|FG001|Overall Study|Withdrawal by Investigator|2|||
28013967|NCT00688740|54672766|FG000|Overall Study|Adverse Event|45|||
28013968|NCT00688740|54672767|FG001|Overall Study|Adverse Event|8|||
28013969|NCT00688740|54672766|FG000|Overall Study|Death|2|||
28013970|NCT00688740|54672767|FG001|Overall Study|Death|2|||
28013971|NCT00688740|54672766|FG000|Overall Study|Lost to Follow-up|0|||
28013972|NCT00688740|54672767|FG001|Overall Study|Lost to Follow-up|1|||
28013973|NCT00688740|54672766|FG000|Overall Study|Consent Withdrawn|17|||
28013974|NCT00688740|54672767|FG001|Overall Study|Consent Withdrawn|17|||
28013975|NCT00688740|54672766|FG000|Overall Study|Breast Cancer Relapse|1|||
28013976|NCT00688740|54672767|FG001|Overall Study|Breast Cancer Relapse|4|||
28013977|NCT00688740|54672766|FG000|Overall Study|Violation of Inclusion Criteria|1|||
28013978|NCT00688740|54672767|FG001|Overall Study|Violation of Inclusion Criteria|3|||
28013979|NCT00552760|54672775|FG000|Overall Study|Adverse Event|3|||
28013980|NCT00552760|54672776|FG001|Overall Study|Adverse Event|5|||
28013981|NCT00552760|54672775|FG000|Overall Study|Relapsed- Depressed Event|10|||
28013982|NCT00552760|54672776|FG001|Overall Study|Relapsed- Depressed Event|16|||
28013983|NCT00552760|54672775|FG000|Overall Study|Relapse- Manic Event|3|||
28013984|NCT00552760|54672776|FG001|Overall Study|Relapse- Manic Event|3|||
28013985|NCT00552760|54672775|FG000|Overall Study|Relapsed- Mixed Event|3|||
28013986|NCT00552760|54672776|FG001|Overall Study|Relapsed- Mixed Event|5|||
28013987|NCT00552760|54672775|FG000|Overall Study|Protocol Violation|0|||
28013988|NCT00552760|54672776|FG001|Overall Study|Protocol Violation|1|||
28013989|NCT00552760|54672775|FG000|Overall Study|Lost to Follow-up|1|||
28013990|NCT00552760|54672776|FG001|Overall Study|Lost to Follow-up|1|||
28013991|NCT00552760|54672775|FG000|Overall Study|Non-compliance|1|||
28013992|NCT00552760|54672776|FG001|Overall Study|Non-compliance|1|||
28013993|NCT00552760|54672775|FG000|Overall Study|Medical Condition|1|||
28013994|NCT00552760|54672776|FG001|Overall Study|Medical Condition|1|||
28013995|NCT00552760|54672775|FG000|Overall Study|Withdrawal by Subject|3|||
28013996|NCT00552760|54672776|FG001|Overall Study|Withdrawal by Subject|0|||
28013997|NCT00552760|54672775|FG000|Overall Study|Medication Change|1|||
28013998|NCT00552760|54672776|FG001|Overall Study|Medication Change|0|||
27746369|NCT02120950|54195936|FG001|Overall Study|Death|0|||
28013999|NCT00686790|54672782|FG000|Overall Study|Adverse Event|2|||
28014000|NCT00686790|54672782|FG000|Overall Study|Withdrawal by Subject|1|||
28014001|NCT00686790|54672782|FG000|Overall Study|Death|1|||
28014002|NCT00686790|54672782|FG000|Overall Study|Lost to Follow-up|12|||
28014003|NCT00686712|54672789|FG000|Overall Study|Protocol Violation|8|||
28014004|NCT00686712|54672790|FG001|Overall Study|Protocol Violation|8|||
28014005|NCT00686712|54672791|FG002|Overall Study|Protocol Violation|10|||
28014006|NCT00686712|54672789|FG000|Overall Study|Lost to Follow-up|1|||
28014007|NCT00686712|54672790|FG001|Overall Study|Lost to Follow-up|2|||
28014008|NCT00686712|54672791|FG002|Overall Study|Lost to Follow-up|3|||
28014009|NCT00686712|54672789|FG000|Overall Study|Adverse Event|1|||
28014010|NCT00686712|54672790|FG001|Overall Study|Adverse Event|1|||
28014011|NCT00686712|54672791|FG002|Overall Study|Adverse Event|0|||
27922592|NCT01273155|54579393|FG004|Overall Study|Withdrew during C1/refused further trmt|1|||
27922593|NCT01273155|54579394|FG005|Overall Study|Withdrew during C1/refused further trmt|1|||
27922594|NCT01273155|54579395|FG006|Overall Study|Withdrew during C1/refused further trmt|0|||
27922595|NCT01005901|54579420|FG000|Overall Study|Withdrawal by Subject|38|||
27922596|NCT01005901|54579421|FG001|Overall Study|Withdrawal by Subject|14|||
27922597|NCT01005901|54579420|FG000|Overall Study|Adverse Event|30|||
27922598|NCT01005901|54579421|FG001|Overall Study|Adverse Event|16|||
27922599|NCT01005901|54579420|FG000|Overall Study|Administrative problems|21|||
27922600|NCT01005901|54579421|FG001|Overall Study|Administrative problems|13|||
27922601|NCT01005901|54579420|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
27922602|NCT01005901|54579421|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
27922603|NCT01005901|54579420|FG000|Overall Study|Protocol Violation|4|||
27922604|NCT01005901|54579421|FG001|Overall Study|Protocol Violation|3|||
27922605|NCT01005901|54579420|FG000|Overall Study|Death|2|||
27922606|NCT01005901|54579421|FG001|Overall Study|Death|3|||
27922607|NCT01005901|54579420|FG000|Overall Study|Lost to Follow-up|1|||
27922608|NCT01005901|54579421|FG001|Overall Study|Lost to Follow-up|2|||
27922609|NCT01005901|54579420|FG000|Overall Study|Patient's inability to use the device|1|||
27922610|NCT01005901|54579421|FG001|Overall Study|Patient's inability to use the device|1|||
28014012|NCT00686634|54672802|FG000|Overall Study|Protocol Violation|6|||
28014013|NCT00560404|54672809|FG000|Overall Study|Adverse Event|2|||
27742932|NCT03420781|54192852|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|2|||
27742933|NCT03420781|54192853|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
27742934|NCT03420781|54192849|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
27742935|NCT03420781|54192850|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
27742936|NCT03420781|54192851|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
27742937|NCT03420781|54192852|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
27742938|NCT03420781|54192853|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|2|||
27742939|NCT03420781|54192849|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
27742940|NCT03420781|54192850|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
27742941|NCT03420781|54192851|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|6|||
27742942|NCT03420781|54192852|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
27742943|NCT03420781|54192853|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
27742944|NCT03269695|54192871|FG000|Overall Study|Adverse Event|2|||
27742945|NCT03269695|54192872|FG001|Overall Study|Adverse Event|1|||
27742946|NCT03269695|54192871|FG000|Overall Study|Lack of Efficacy|0|||
27742947|NCT03269695|54192872|FG001|Overall Study|Lack of Efficacy|1|||
27742948|NCT03269695|54192871|FG000|Overall Study|Withdrawal by Subject|0|||
27742949|NCT03269695|54192872|FG001|Overall Study|Withdrawal by Subject|1|||
27742950|NCT00462943|54192882|FG000|Overall Study|Failure to achieve a response|5|||
27742951|NCT00462943|54192883|FG001|Overall Study|Failure to achieve a response|5|||
27742952|NCT00462943|54192884|FG002|Overall Study|Failure to achieve a response|1|||
27742953|NCT00462943|54192882|FG000|Overall Study|Adverse Event|6|||
27742954|NCT00462943|54192883|FG001|Overall Study|Adverse Event|4|||
27742955|NCT00462943|54192884|FG002|Overall Study|Adverse Event|1|||
27742956|NCT00462943|54192882|FG000|Overall Study|Protocol Violation|1|||
27742957|NCT00462943|54192883|FG001|Overall Study|Protocol Violation|0|||
27742958|NCT00462943|54192884|FG002|Overall Study|Protocol Violation|0|||
27742959|NCT00462943|54192882|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|8|||
27742960|NCT00462943|54192883|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|2|||
27742961|NCT00462943|54192884|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|4|||
27742962|NCT00462943|54192882|FG000|Overall Study|Disease Progression|15|||
27742963|NCT00462943|54192883|FG001|Overall Study|Disease Progression|15|||
27742964|NCT00462943|54192884|FG002|Overall Study|Disease Progression|9|||
27742965|NCT00462943|54192882|FG000|Overall Study|Death|5|||
27742966|NCT00462943|54192883|FG001|Overall Study|Death|2|||
27742967|NCT00462943|54192884|FG002|Overall Study|Death|7|||
27742968|NCT00462943|54192882|FG000|Overall Study|Stem Cell Transplant|1|||
27742969|NCT00462943|54192883|FG001|Overall Study|Stem Cell Transplant|1|||
27742970|NCT00462943|54192884|FG002|Overall Study|Stem Cell Transplant|0|||
27742971|NCT00462943|54192882|FG000|Overall Study|Bone Marrow Transplant|1|||
27742972|NCT00462943|54192883|FG001|Overall Study|Bone Marrow Transplant|0|||
27742973|NCT00462943|54192884|FG002|Overall Study|Bone Marrow Transplant|0|||
27742974|NCT00462943|54192882|FG000|Overall Study|Required Lymphocyte Infusion|1|||
27742975|NCT00462943|54192883|FG001|Overall Study|Required Lymphocyte Infusion|0|||
27742976|NCT00462943|54192884|FG002|Overall Study|Required Lymphocyte Infusion|0|||
27742977|NCT00462943|54192882|FG000|Overall Study|Transplant - not specified|1|||
27742978|NCT00462943|54192883|FG001|Overall Study|Transplant - not specified|0|||
27742979|NCT00462943|54192884|FG002|Overall Study|Transplant - not specified|1|||
27742980|NCT00462943|54192882|FG000|Overall Study|Physician Decision|1|||
27742981|NCT00462943|54192883|FG001|Overall Study|Physician Decision|0|||
27742982|NCT00462943|54192884|FG002|Overall Study|Physician Decision|0|||
27742983|NCT00462943|54192882|FG000|Overall Study|Withdrawal by Subject|0|||
27742984|NCT00462943|54192883|FG001|Overall Study|Withdrawal by Subject|1|||
27742985|NCT00462943|54192884|FG002|Overall Study|Withdrawal by Subject|0|||
27742986|NCT02730793|54192908|FG000|Overall Study|Physician Decision|0|||
27742987|NCT02730793|54192909|FG001|Overall Study|Physician Decision|1|||
27742988|NCT02730793|54192908|FG000|Overall Study|Withdrawal by Subject|0|||
27742989|NCT02730793|54192909|FG001|Overall Study|Withdrawal by Subject|1|||
27742990|NCT02855125|54192917|FG000|Overall Study|Withdrawal by Subject|2|||
27742991|NCT02855125|54192918|FG001|Overall Study|Withdrawal by Subject|2|||
27742992|NCT02855125|54192917|FG000|Overall Study|Clinical Disease Progression|5|||
27742993|NCT02855125|54192918|FG001|Overall Study|Clinical Disease Progression|4|||
27742994|NCT02855125|54192917|FG000|Overall Study|Radiologic Disease Progression|36|||
27742995|NCT02855125|54192918|FG001|Overall Study|Radiologic Disease Progression|39|||
27742996|NCT02855125|54192917|FG000|Overall Study|Adverse Event|11|||
27742997|NCT02855125|54192918|FG001|Overall Study|Adverse Event|7|||
27742998|NCT02855125|54192917|FG000|Overall Study|Physician Decision|1|||
27742999|NCT02855125|54192918|FG001|Overall Study|Physician Decision|0|||
27743000|NCT02855125|54192917|FG000|Overall Study|On Treatment|9|||
27743001|NCT02855125|54192918|FG001|Overall Study|On Treatment|11|||
27743002|NCT02855125|54192917|FG000|Overall Study|Randomized but not treated|0|||
27743003|NCT02855125|54192918|FG001|Overall Study|Randomized but not treated|1|||
27743004|NCT02730871|54192941|FG000|Overall Study|Adverse Event|6|||
27743005|NCT02730871|54192942|FG001|Overall Study|Adverse Event|0|||
27743006|NCT03376789|54192950|FG000|Overall Study|Withdrawal by Subject|3|||
27743007|NCT03376789|54192951|FG001|Overall Study|Withdrawal by Subject|5|||
27743008|NCT03376789|54192950|FG000|Overall Study|Protocol Violation|0|||
27743009|NCT03376789|54192951|FG001|Overall Study|Protocol Violation|1|||
27743010|NCT03376789|54192950|FG000|Overall Study|Adverse Event|0|||
27743011|NCT03376789|54192951|FG001|Overall Study|Adverse Event|1|||
27743012|NCT03376789|54192950|FG000|Overall Study|Lost to Follow-up|1|||
27743013|NCT03376789|54192951|FG001|Overall Study|Lost to Follow-up|1|||
27743014|NCT03376789|54192950|FG000|Overall Study|Per sponsor due to noncompliance|1|||
27743015|NCT03376789|54192951|FG001|Overall Study|Per sponsor due to noncompliance|0|||
27743016|NCT03376789|54192950|FG000|Overall Study|Subject off study medication|0|||
27743017|NCT03376789|54192951|FG001|Overall Study|Subject off study medication|1|||
27743018|NCT04032093|54192967|FG000|Overall Study|Lost to Follow-up|7|||
27743019|NCT04032093|54192968|FG001|Overall Study|Lost to Follow-up|7|||
27743020|NCT04032093|54192969|FG002|Overall Study|Lost to Follow-up|6|||
27743021|NCT04032093|54192970|FG003|Overall Study|Lost to Follow-up|10|||
27743022|NCT04032093|54192971|FG004|Overall Study|Lost to Follow-up|13|||
27743023|NCT04032093|54192972|FG005|Overall Study|Lost to Follow-up|7|||
27743024|NCT04032093|54192973|FG006|Overall Study|Lost to Follow-up|7|||
27743025|NCT04032093|54192974|FG007|Overall Study|Lost to Follow-up|5|||
27743026|NCT04032093|54192975|FG008|Overall Study|Lost to Follow-up|9|||
27743027|NCT04032093|54192976|FG009|Overall Study|Lost to Follow-up|12|||
27743028|NCT04032093|54192967|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
27743029|NCT04032093|54192968|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
27743030|NCT04032093|54192969|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
27743031|NCT04032093|54192970|FG003|Overall Study|No Longer Meets Eligibility Criteria|2|||
27743032|NCT04032093|54192971|FG004|Overall Study|No Longer Meets Eligibility Criteria|1|||
27743033|NCT04032093|54192972|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
27743034|NCT04032093|54192973|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
27743035|NCT04032093|54192974|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
27743036|NCT04032093|54192975|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
27743037|NCT04032093|54192976|FG009|Overall Study|No Longer Meets Eligibility Criteria|1|||
27743038|NCT04032093|54192967|FG000|Overall Study|Other|1|||
27743039|NCT04032093|54192968|FG001|Overall Study|Other|0|||
27743040|NCT04032093|54192969|FG002|Overall Study|Other|0|||
27743041|NCT04032093|54192970|FG003|Overall Study|Other|1|||
27743042|NCT04032093|54192971|FG004|Overall Study|Other|1|||
27743043|NCT04032093|54192972|FG005|Overall Study|Other|0|||
27743044|NCT04032093|54192973|FG006|Overall Study|Other|0|||
27743045|NCT04032093|54192974|FG007|Overall Study|Other|0|||
27743046|NCT04032093|54192975|FG008|Overall Study|Other|0|||
27743047|NCT04032093|54192976|FG009|Overall Study|Other|1|||
27743048|NCT04032093|54192967|FG000|Overall Study|Withdrawal by Subject|1|||
27743049|NCT04032093|54192968|FG001|Overall Study|Withdrawal by Subject|3|||
27743050|NCT04032093|54192969|FG002|Overall Study|Withdrawal by Subject|2|||
27743051|NCT04032093|54192970|FG003|Overall Study|Withdrawal by Subject|2|||
27743052|NCT04032093|54192971|FG004|Overall Study|Withdrawal by Subject|3|||
27743053|NCT04032093|54192972|FG005|Overall Study|Withdrawal by Subject|0|||
27743054|NCT04032093|54192973|FG006|Overall Study|Withdrawal by Subject|0|||
27743055|NCT04032093|54192974|FG007|Overall Study|Withdrawal by Subject|0|||
27743056|NCT04032093|54192975|FG008|Overall Study|Withdrawal by Subject|0|||
27743057|NCT04032093|54192976|FG009|Overall Study|Withdrawal by Subject|0|||
27743058|NCT04032093|54192967|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
27743059|NCT04032093|54192968|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
27743060|NCT04032093|54192969|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
27743061|NCT04032093|54192970|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
27743062|NCT04032093|54192971|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
27743063|NCT04032093|54192972|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
27743064|NCT04032093|54192973|FG006|Overall Study|Withdrawal by Parent/Guardian|3|||
27743065|NCT04032093|54192974|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
27743066|NCT04032093|54192975|FG008|Overall Study|Withdrawal by Parent/Guardian|2|||
27743067|NCT04032093|54192976|FG009|Overall Study|Withdrawal by Parent/Guardian|3|||
27743068|NCT04032093|54192967|FG000|Overall Study|Adverse Event|0|||
27743069|NCT04032093|54192968|FG001|Overall Study|Adverse Event|0|||
27743070|NCT04032093|54192969|FG002|Overall Study|Adverse Event|0|||
27743071|NCT04032093|54192970|FG003|Overall Study|Adverse Event|0|||
27743072|NCT04032093|54192971|FG004|Overall Study|Adverse Event|0|||
27743073|NCT04032093|54192972|FG005|Overall Study|Adverse Event|0|||
27743074|NCT04032093|54192973|FG006|Overall Study|Adverse Event|0|||
27743075|NCT04032093|54192974|FG007|Overall Study|Adverse Event|0|||
27743076|NCT04032093|54192975|FG008|Overall Study|Adverse Event|0|||
27743077|NCT04032093|54192976|FG009|Overall Study|Adverse Event|1|||
27743078|NCT04032093|54192967|FG000|Overall Study|Physician Decision|0|||
27743079|NCT04032093|54192968|FG001|Overall Study|Physician Decision|0|||
27743080|NCT04032093|54192969|FG002|Overall Study|Physician Decision|0|||
27743081|NCT04032093|54192970|FG003|Overall Study|Physician Decision|0|||
27743082|NCT04032093|54192971|FG004|Overall Study|Physician Decision|0|||
27743083|NCT04032093|54192972|FG005|Overall Study|Physician Decision|1|||
27743084|NCT04032093|54192973|FG006|Overall Study|Physician Decision|0|||
27743085|NCT04032093|54192974|FG007|Overall Study|Physician Decision|0|||
27743086|NCT04032093|54192975|FG008|Overall Study|Physician Decision|0|||
27743087|NCT04032093|54192976|FG009|Overall Study|Physician Decision|0|||
27743088|NCT01675167|54193000|FG000|Open-label Titration Phase|Adverse Event|81|||
27743089|NCT01675167|54193001|FG001|Open-label Titration Phase|Adverse Event|0|||
27743090|NCT01675167|54193002|FG002|Open-label Titration Phase|Adverse Event|0|||
27743091|NCT01675167|54193000|FG000|Open-label Titration Phase|Lack of Efficacy|63|||
27743092|NCT01675167|54193001|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
27743093|NCT01675167|54193002|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
27743094|NCT01675167|54193000|FG000|Open-label Titration Phase|Withdrawal by Subject|46|||
27743095|NCT01675167|54193001|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
27743096|NCT01675167|54193002|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
27743097|NCT01675167|54193000|FG000|Open-label Titration Phase|Protocol Violation|43|||
27743098|NCT01675167|54193001|FG001|Open-label Titration Phase|Protocol Violation|0|||
27743099|NCT01675167|54193002|FG002|Open-label Titration Phase|Protocol Violation|0|||
27743100|NCT01675167|54193000|FG000|Open-label Titration Phase|Lost to Follow-up|15|||
27743101|NCT01675167|54193001|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
27743102|NCT01675167|54193002|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
27743103|NCT01675167|54193000|FG000|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1|||
27743104|NCT01675167|54193001|FG001|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
27743105|NCT01675167|54193002|FG002|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
27743106|NCT01675167|54193000|FG000|Open-label Titration Phase|Other|55|||
27743107|NCT01675167|54193001|FG001|Open-label Titration Phase|Other|0|||
27743108|NCT01675167|54193002|FG002|Open-label Titration Phase|Other|0|||
27743109|NCT01675167|54193000|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
27743110|NCT01675167|54193001|FG001|Double-blind Treatment Phase|Lack of Efficacy|19|||
27743111|NCT01675167|54193002|FG002|Double-blind Treatment Phase|Lack of Efficacy|61|||
27743112|NCT01675167|54193000|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
27743113|NCT01675167|54193001|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
27743114|NCT01675167|54193002|FG002|Double-blind Treatment Phase|Withdrawal by Subject|6|||
27922611|NCT01005901|54579420|FG000|Overall Study|No longer requires study drug|0|||
27922612|NCT01005901|54579421|FG001|Overall Study|No longer requires study drug|1|||
27922613|NCT04968925|54579429|FG000|Phase I- Period 1|COVID-19 related|0|||
27922614|NCT04968925|54579430|FG001|Phase I- Period 1|COVID-19 related|1|||
27922615|NCT04968925|54579431|FG002|Phase I- Period 1|COVID-19 related|0|||
27922616|NCT04968925|54579432|FG003|Phase I- Period 1|COVID-19 related|0|||
27922617|NCT04968925|54579429|FG000|Phase I- Period 1|Subject enrolled in error|1|||
27922618|NCT04968925|54579430|FG001|Phase I- Period 1|Subject enrolled in error|1|||
27922619|NCT04968925|54579431|FG002|Phase I- Period 1|Subject enrolled in error|0|||
27743115|NCT01675167|54193000|FG000|Double-blind Treatment Phase|Adverse Event|0|||
27743116|NCT01675167|54193001|FG001|Double-blind Treatment Phase|Adverse Event|5|||
27746370|NCT02120950|54195937|FG002|Overall Study|Death|1|||
27743117|NCT01675167|54193002|FG002|Double-blind Treatment Phase|Adverse Event|13|||
27743118|NCT01675167|54193000|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
27743119|NCT01675167|54193001|FG001|Double-blind Treatment Phase|Protocol Violation|4|||
27743120|NCT01675167|54193002|FG002|Double-blind Treatment Phase|Protocol Violation|11|||
27743121|NCT01675167|54193000|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
27743122|NCT01675167|54193001|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
27743123|NCT01675167|54193002|FG002|Double-blind Treatment Phase|Lost to Follow-up|5|||
27743124|NCT01675167|54193000|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
27743125|NCT01675167|54193001|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
27743126|NCT01675167|54193002|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9|||
27743127|NCT01675167|54193000|FG000|Double-blind Treatment Phase|Other|0|||
27743128|NCT01675167|54193001|FG001|Double-blind Treatment Phase|Other|7|||
27743129|NCT01675167|54193002|FG002|Double-blind Treatment Phase|Other|5|||
27743130|NCT01675011|54193012|FG000|Overall Study|Trial terminated by Sponsor|3|||
27743131|NCT01675011|54193013|FG001|Overall Study|Trial terminated by Sponsor|1|||
27743132|NCT02649231|54193050|FG000|Overall Study|Adverse Event|0|||
27743133|NCT02649231|54193051|FG001|Overall Study|Adverse Event|0|||
27743134|NCT02649231|54193052|FG002|Overall Study|Adverse Event|0|||
27743135|NCT02649231|54193053|FG003|Overall Study|Adverse Event|1|||
27743136|NCT02649231|54193050|FG000|Overall Study|Lost to Follow-up|2|||
27743137|NCT02649231|54193051|FG001|Overall Study|Lost to Follow-up|1|||
27743138|NCT02649231|54193052|FG002|Overall Study|Lost to Follow-up|1|||
27743139|NCT02649231|54193053|FG003|Overall Study|Lost to Follow-up|0|||
27743140|NCT02649231|54193050|FG000|Overall Study|Withdrawal by Subject|0|||
27743141|NCT02649231|54193051|FG001|Overall Study|Withdrawal by Subject|1|||
27743142|NCT02649231|54193052|FG002|Overall Study|Withdrawal by Subject|0|||
27743143|NCT02649231|54193053|FG003|Overall Study|Withdrawal by Subject|1|||
27743144|NCT02649231|54193050|FG000|Overall Study|Protocol Violation|2|||
27743145|NCT02649231|54193051|FG001|Overall Study|Protocol Violation|1|||
27743146|NCT02649231|54193052|FG002|Overall Study|Protocol Violation|1|||
27743147|NCT02649231|54193053|FG003|Overall Study|Protocol Violation|0|||
27743148|NCT01376245|54193067|FG000|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66|||
27743149|NCT01376245|54193068|FG001|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
27743150|NCT01376245|54193069|FG002|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
27743151|NCT01376245|54193070|FG003|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
27743152|NCT01376245|54193071|FG004|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
27743153|NCT01376245|54193067|FG000|2-wk Single-blind Placebo Run-in Period|Adverse Event|4|||
27743154|NCT01376245|54193068|FG001|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
27743155|NCT01376245|54193069|FG002|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
27743156|NCT01376245|54193070|FG003|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
27743157|NCT01376245|54193071|FG004|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
27743158|NCT01376245|54193067|FG000|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1|||
27743159|NCT01376245|54193068|FG001|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
27743160|NCT01376245|54193069|FG002|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
27743161|NCT01376245|54193070|FG003|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
27743162|NCT01376245|54193071|FG004|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
27743163|NCT01376245|54193067|FG000|2-wk Single-blind Placebo Run-in Period|Physician Decision|2|||
27743164|NCT01376245|54193068|FG001|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
27743165|NCT01376245|54193069|FG002|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
27743166|NCT01376245|54193070|FG003|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
27743167|NCT01376245|54193071|FG004|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
27743168|NCT01376245|54193067|FG000|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28|||
27743169|NCT01376245|54193068|FG001|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
27743170|NCT01376245|54193069|FG002|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
27743171|NCT01376245|54193070|FG003|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
27743172|NCT01376245|54193071|FG004|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
27743173|NCT01376245|54193067|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
27743174|NCT01376245|54193068|FG001|24-week, Double-blind Treatment Period|Adverse Event|16|||
27743175|NCT01376245|54193069|FG002|24-week, Double-blind Treatment Period|Adverse Event|7|||
27743176|NCT01376245|54193070|FG003|24-week, Double-blind Treatment Period|Adverse Event|8|||
27743177|NCT01376245|54193071|FG004|24-week, Double-blind Treatment Period|Adverse Event|18|||
27743178|NCT01376245|54193067|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy|0|||
27743179|NCT01376245|54193068|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
27743180|NCT01376245|54193069|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy|5|||
27743181|NCT01376245|54193070|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
27743182|NCT01376245|54193071|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy|3|||
27743183|NCT01376245|54193067|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
27743184|NCT01376245|54193068|FG001|24-week, Double-blind Treatment Period|Protocol Violation|2|||
27743185|NCT01376245|54193069|FG002|24-week, Double-blind Treatment Period|Protocol Violation|0|||
27743186|NCT01376245|54193070|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
27743187|NCT01376245|54193071|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
27743188|NCT01376245|54193067|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
27743189|NCT01376245|54193068|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2|||
27743190|NCT01376245|54193069|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3|||
27743191|NCT01376245|54193070|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1|||
27743192|NCT01376245|54193071|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
27743193|NCT01376245|54193067|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
27743194|NCT01376245|54193068|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
27743195|NCT01376245|54193069|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
27743196|NCT01376245|54193070|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
27743197|NCT01376245|54193071|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
27743198|NCT01376245|54193067|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
27743199|NCT01376245|54193068|FG001|24-week, Double-blind Treatment Period|Physician Decision|0|||
27743200|NCT01376245|54193069|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
27743201|NCT01376245|54193070|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
27743202|NCT01376245|54193071|FG004|24-week, Double-blind Treatment Period|Physician Decision|0|||
27743203|NCT01376245|54193067|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
27743204|NCT01376245|54193068|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
27743205|NCT01376245|54193069|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
27743206|NCT01376245|54193070|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
27743207|NCT01376245|54193071|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
27743208|NCT01674621|54193086|FG000|Overall Study|Adverse Event|3|||
27743209|NCT01674621|54193087|FG001|Overall Study|Adverse Event|2|||
27743210|NCT01674621|54193088|FG002|Overall Study|Adverse Event|5|||
27743211|NCT01674621|54193089|FG003|Overall Study|Adverse Event|5|||
27743212|NCT01674621|54193090|FG004|Overall Study|Adverse Event|1|||
27743213|NCT01674621|54193086|FG000|Overall Study|Inability to Complete Study Procedures|0|||
27743214|NCT01674621|54193087|FG001|Overall Study|Inability to Complete Study Procedures|0|||
27743215|NCT01674621|54193088|FG002|Overall Study|Inability to Complete Study Procedures|0|||
27743216|NCT01674621|54193089|FG003|Overall Study|Inability to Complete Study Procedures|0|||
27743217|NCT01674621|54193090|FG004|Overall Study|Inability to Complete Study Procedures|2|||
27743218|NCT01674621|54193086|FG000|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
27743219|NCT01674621|54193087|FG001|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
27743220|NCT01674621|54193088|FG002|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
27743221|NCT01674621|54193089|FG003|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1|||
27743222|NCT01674621|54193090|FG004|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
27743223|NCT01674621|54193086|FG000|Overall Study|Withdrawal by Subject|2|||
27743224|NCT01674621|54193087|FG001|Overall Study|Withdrawal by Subject|5|||
27743225|NCT01674621|54193088|FG002|Overall Study|Withdrawal by Subject|2|||
27743226|NCT01674621|54193089|FG003|Overall Study|Withdrawal by Subject|0|||
27743227|NCT01674621|54193090|FG004|Overall Study|Withdrawal by Subject|1|||
27743228|NCT01674621|54193086|FG000|Overall Study|Other than specified|0|||
27743229|NCT01674621|54193087|FG001|Overall Study|Other than specified|1|||
27743230|NCT01674621|54193088|FG002|Overall Study|Other than specified|0|||
27743231|NCT01674621|54193089|FG003|Overall Study|Other than specified|0|||
27743232|NCT01674621|54193090|FG004|Overall Study|Other than specified|2|||
27743233|NCT02730169|54193107|FG000|Overall Study|Protocol Violation|1|||
27743234|NCT02730169|54193108|FG001|Overall Study|Protocol Violation|0|||
27743235|NCT02730169|54193109|FG002|Overall Study|Protocol Violation|0|||
27743236|NCT02730169|54193110|FG003|Overall Study|Protocol Violation|1|||
27743237|NCT02730169|54193107|FG000|Overall Study|Adverse Event|2|||
27743238|NCT02730169|54193108|FG001|Overall Study|Adverse Event|3|||
27743239|NCT02730169|54193109|FG002|Overall Study|Adverse Event|3|||
27743240|NCT02730169|54193110|FG003|Overall Study|Adverse Event|0|||
27743241|NCT02730169|54193107|FG000|Overall Study|Adverse Event of Special Interest|0|||
27743242|NCT02730169|54193108|FG001|Overall Study|Adverse Event of Special Interest|1|||
27743243|NCT02730169|54193109|FG002|Overall Study|Adverse Event of Special Interest|2|||
27743244|NCT02730169|54193110|FG003|Overall Study|Adverse Event of Special Interest|0|||
27743245|NCT02730169|54193107|FG000|Overall Study|Withdrawal by Subject|6|||
27743246|NCT02730169|54193108|FG001|Overall Study|Withdrawal by Subject|11|||
27743247|NCT02730169|54193109|FG002|Overall Study|Withdrawal by Subject|6|||
27743248|NCT02730169|54193110|FG003|Overall Study|Withdrawal by Subject|8|||
27743249|NCT02730169|54193107|FG000|Overall Study|Lost to Follow-up|5|||
27743250|NCT02730169|54193108|FG001|Overall Study|Lost to Follow-up|6|||
27743251|NCT02730169|54193109|FG002|Overall Study|Lost to Follow-up|5|||
27743252|NCT02730169|54193110|FG003|Overall Study|Lost to Follow-up|6|||
27743253|NCT02730169|54193107|FG000|Overall Study|Other|0|||
27743254|NCT02730169|54193108|FG001|Overall Study|Other|0|||
27743255|NCT02730169|54193109|FG002|Overall Study|Other|1|||
27743256|NCT02730169|54193110|FG003|Overall Study|Other|1|||
27743257|NCT02648217|54193122|FG000|Overall Study|Adverse Event|0|||
27743258|NCT02648217|54193123|FG001|Overall Study|Adverse Event|1|||
27743259|NCT02648217|54193122|FG000|Overall Study|Lost to Follow-up|1|||
27743260|NCT02648217|54193123|FG001|Overall Study|Lost to Follow-up|1|||
27743261|NCT02648217|54193122|FG000|Overall Study|Withdrawal by Subject|4|||
27743262|NCT02648217|54193123|FG001|Overall Study|Withdrawal by Subject|3|||
27743263|NCT02648217|54193122|FG000|Overall Study|Unclassified|5|||
27743264|NCT02648217|54193123|FG001|Overall Study|Unclassified|0|||
27743265|NCT00709735|54193131|FG000|Overall Study|Lost to Follow-up|1|||
27743266|NCT00709735|54193132|FG001|Overall Study|Lost to Follow-up|1|||
27743267|NCT00709735|54193131|FG000|Overall Study|Relapse into Opioid Abuse|0|||
27743268|NCT00709735|54193132|FG001|Overall Study|Relapse into Opioid Abuse|1|||
27743269|NCT00709735|54193131|FG000|Overall Study|Did not meet PTSD Diagnostic Criteria|2|||
27743270|NCT00709735|54193132|FG001|Overall Study|Did not meet PTSD Diagnostic Criteria|0|||
27743271|NCT02647905|54193138|FG000|Overall Study|Lost to Follow-up|1|||
27743272|NCT02647905|54193138|FG000|Overall Study|Withdrawal by Subject|2|||
27922620|NCT04968925|54579432|FG003|Phase I- Period 1|Subject enrolled in error|0|||
27922621|NCT04968925|54579429|FG000|Phase II- Period 1|COVID-19 Related|0|||
27922622|NCT04968925|54579430|FG001|Phase II- Period 1|COVID-19 Related|0|||
27922623|NCT04968925|54579431|FG002|Phase II- Period 1|COVID-19 Related|6|||
27922624|NCT04968925|54579432|FG003|Phase II- Period 1|COVID-19 Related|6|||
27922625|NCT04968925|54579429|FG000|Phase II- Period 1|Subject enrolled in error|0|||
27922626|NCT04968925|54579430|FG001|Phase II- Period 1|Subject enrolled in error|0|||
27922627|NCT04968925|54579431|FG002|Phase II- Period 1|Subject enrolled in error|1|||
27922628|NCT04968925|54579432|FG003|Phase II- Period 1|Subject enrolled in error|0|||
27922629|NCT04968925|54579429|FG000|Phase II -Period 2|COVID-19 related|0|||
27922630|NCT04968925|54579430|FG001|Phase II -Period 2|COVID-19 related|0|||
27922631|NCT04968925|54579431|FG002|Phase II -Period 2|COVID-19 related|4|||
27922632|NCT04968925|54579432|FG003|Phase II -Period 2|COVID-19 related|3|||
27922633|NCT04968925|54579429|FG000|Phase II -Period 2|Incorrectly dispensed|0|||
27922634|NCT04968925|54579430|FG001|Phase II -Period 2|Incorrectly dispensed|0|||
27922635|NCT04968925|54579431|FG002|Phase II -Period 2|Incorrectly dispensed|0|||
27922636|NCT04968925|54579432|FG003|Phase II -Period 2|Incorrectly dispensed|1|||
27743273|NCT04185909|54193151|FG000|Overall Study|Lost to Follow-up|1|||
27743274|NCT04076943|54193155|FG000|Overall Study|Withdrawal by Subject|12|||
27743275|NCT04076943|54193155|FG000|Overall Study|Adverse Event|1|||
27743276|NCT04076943|54193155|FG000|Overall Study|Progressive Disease|2|||
27743277|NCT04076943|54193155|FG000|Overall Study|Death|13|||
27743278|NCT04076943|54193155|FG000|Overall Study|Other than specified|6|||
27743279|NCT00708643|54193161|FG000|Overall Study|Adverse Event|0|||
27743280|NCT00708643|54193162|FG001|Overall Study|Adverse Event|1|||
27743281|NCT01285557|54193225|FG000|Overall Study|Death|173|||
27743282|NCT01285557|54193226|FG001|Overall Study|Death|90|||
27743283|NCT01285557|54193225|FG000|Overall Study|Lost to Follow-up|6|||
27743284|NCT01285557|54193226|FG001|Overall Study|Lost to Follow-up|2|||
27743285|NCT01285557|54193225|FG000|Overall Study|Withdrew Consent|6|||
27743286|NCT01285557|54193226|FG001|Overall Study|Withdrew Consent|1|||
27743287|NCT01285557|54193225|FG000|Overall Study|Sponsor Study Termination|23|||
27743288|NCT01285557|54193226|FG001|Overall Study|Sponsor Study Termination|13|||
27743289|NCT01285557|54193225|FG000|Overall Study|Randomized but not treated|1|||
27743290|NCT01285557|54193226|FG001|Overall Study|Randomized but not treated|1|||
27743291|NCT01285557|54193225|FG000|Overall Study|Study follow-up ongoing|28|||
27743292|NCT01285557|54193226|FG001|Overall Study|Study follow-up ongoing|14|||
27743293|NCT01285557|54193225|FG000|Overall Study|Sponsor Decision|2|||
27743294|NCT01285557|54193226|FG001|Overall Study|Sponsor Decision|1|||
27743295|NCT01376167|54193288|FG000|Overall Study|Lost to Follow-up|2|||
27743296|NCT01376167|54193289|FG001|Overall Study|Lost to Follow-up|4|||
27743297|NCT01376167|54193290|FG002|Overall Study|Lost to Follow-up|2|||
27743298|NCT01376167|54193288|FG000|Overall Study|Physician Decision|1|||
27743299|NCT01376167|54193289|FG001|Overall Study|Physician Decision|1|||
27743300|NCT01376167|54193290|FG002|Overall Study|Physician Decision|0|||
27743301|NCT01376167|54193288|FG000|Overall Study|Withdrawal by Subject|1|||
27743302|NCT01376167|54193289|FG001|Overall Study|Withdrawal by Subject|5|||
27743303|NCT01376167|54193290|FG002|Overall Study|Withdrawal by Subject|4|||
27743304|NCT02647281|54193310|FG000|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
27743305|NCT02647281|54193311|FG001|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
27743306|NCT02647281|54193312|FG002|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
27743307|NCT02647281|54193313|FG003|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
27743308|NCT02647281|54193314|FG004|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
27743309|NCT02647281|54193315|FG005|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
27743310|NCT02647281|54193316|FG006|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
27743311|NCT02647281|54193317|FG007|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
27743312|NCT02647281|54193318|FG008|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1|||
27743313|NCT02729545|54193349|FG000|Overall Study|Pregnancy|1|||
27743314|NCT02729545|54193350|FG001|Overall Study|Pregnancy|1|||
27743315|NCT02729545|54193349|FG000|Overall Study|Lost to Follow-up|0|||
27743316|NCT02729545|54193350|FG001|Overall Study|Lost to Follow-up|1|||
27743317|NCT02729545|54193349|FG000|Overall Study|Withdrawal by Subject|2|||
27743318|NCT02729545|54193350|FG001|Overall Study|Withdrawal by Subject|3|||
27743319|NCT01376089|54193358|FG000|Overall Study|Patient received no contrast media|3|||
27743320|NCT01376089|54193359|FG001|Overall Study|Patient received no contrast media|4|||
27743321|NCT00706849|54193371|FG000|Treatment Period|Adverse Event|0|||
27743322|NCT00706849|54193372|FG001|Treatment Period|Adverse Event|9|||
27743323|NCT00706849|54193371|FG000|Treatment Period|Other|0|||
27743324|NCT00706849|54193372|FG001|Treatment Period|Other|1|||
27743325|NCT00706849|54193371|FG000|Follow-up Period|Withdrawal by Subject|0|||
27743326|NCT00706849|54193372|FG001|Follow-up Period|Withdrawal by Subject|2|||
27743327|NCT00706849|54193371|FG000|Follow-up Period|Protocol non-compliance|0|||
27743328|NCT00706849|54193372|FG001|Follow-up Period|Protocol non-compliance|1|||
27743329|NCT00707161|54193378|FG000|Overall Study|Physician Decision|6|||
27743330|NCT02130466|54193396|FG000|Overall Study|Death|4|||
27743331|NCT02130466|54193397|FG001|Overall Study|Death|1|||
27743332|NCT02130466|54193398|FG002|Overall Study|Death|1|||
27743333|NCT02130466|54193399|FG003|Overall Study|Death|3|||
27743334|NCT02130466|54193400|FG004|Overall Study|Death|2|||
27743335|NCT02130466|54193401|FG005|Overall Study|Death|30|||
27743336|NCT02130466|54193402|FG006|Overall Study|Death|45|||
27743337|NCT02130466|54193403|FG007|Overall Study|Death|2|||
27743338|NCT02130466|54193404|FG008|Overall Study|Death|3|||
27743339|NCT02130466|54193405|FG009|Overall Study|Death|4|||
27743340|NCT02130466|54193406|FG010|Overall Study|Death|5|||
27743341|NCT02130466|54193407|FG011|Overall Study|Death|3|||
27743342|NCT02130466|54193408|FG012|Overall Study|Death|11|||
27743343|NCT02130466|54193409|FG013|Overall Study|Death|7|||
27743344|NCT02130466|54193396|FG000|Overall Study|Lost to Follow-up|1|||
27743345|NCT02130466|54193397|FG001|Overall Study|Lost to Follow-up|0|||
27743346|NCT02130466|54193398|FG002|Overall Study|Lost to Follow-up|0|||
27743347|NCT02130466|54193399|FG003|Overall Study|Lost to Follow-up|0|||
27743348|NCT02130466|54193400|FG004|Overall Study|Lost to Follow-up|0|||
27743349|NCT02130466|54193401|FG005|Overall Study|Lost to Follow-up|1|||
27743350|NCT02130466|54193402|FG006|Overall Study|Lost to Follow-up|0|||
27743351|NCT02130466|54193403|FG007|Overall Study|Lost to Follow-up|0|||
27743352|NCT02130466|54193404|FG008|Overall Study|Lost to Follow-up|0|||
27743353|NCT02130466|54193405|FG009|Overall Study|Lost to Follow-up|0|||
27743354|NCT02130466|54193406|FG010|Overall Study|Lost to Follow-up|0|||
27743355|NCT02130466|54193407|FG011|Overall Study|Lost to Follow-up|0|||
27743356|NCT02130466|54193408|FG012|Overall Study|Lost to Follow-up|1|||
27743357|NCT02130466|54193409|FG013|Overall Study|Lost to Follow-up|0|||
27743358|NCT02130466|54193396|FG000|Overall Study|Physician Decision|0|||
27743359|NCT02130466|54193397|FG001|Overall Study|Physician Decision|0|||
27743360|NCT02130466|54193398|FG002|Overall Study|Physician Decision|0|||
27743361|NCT02130466|54193399|FG003|Overall Study|Physician Decision|0|||
27743362|NCT02130466|54193400|FG004|Overall Study|Physician Decision|0|||
27743363|NCT02130466|54193401|FG005|Overall Study|Physician Decision|1|||
27743364|NCT02130466|54193402|FG006|Overall Study|Physician Decision|1|||
27743365|NCT02130466|54193403|FG007|Overall Study|Physician Decision|0|||
27743366|NCT02130466|54193404|FG008|Overall Study|Physician Decision|0|||
27743367|NCT02130466|54193405|FG009|Overall Study|Physician Decision|0|||
27743368|NCT02130466|54193406|FG010|Overall Study|Physician Decision|0|||
27743369|NCT02130466|54193407|FG011|Overall Study|Physician Decision|0|||
27743370|NCT02130466|54193408|FG012|Overall Study|Physician Decision|0|||
27743371|NCT02130466|54193409|FG013|Overall Study|Physician Decision|0|||
27743372|NCT02130466|54193396|FG000|Overall Study|Participation in Study Discontinued by Sponsor|1|||
27743373|NCT02130466|54193397|FG001|Overall Study|Participation in Study Discontinued by Sponsor|2|||
27743374|NCT02130466|54193398|FG002|Overall Study|Participation in Study Discontinued by Sponsor|1|||
27743375|NCT02130466|54193399|FG003|Overall Study|Participation in Study Discontinued by Sponsor|5|||
27743376|NCT02130466|54193400|FG004|Overall Study|Participation in Study Discontinued by Sponsor|0|||
27746601|NCT01375049|54196235|FG000|Overall Study|Adverse Event|2|||
27922637|NCT01266993|54579444|FG000|Booster Phase (Month 68-69)|Lost to Follow-up|5|||
27743377|NCT02130466|54193401|FG005|Overall Study|Participation in Study Discontinued by Sponsor|27|||
27743378|NCT02130466|54193402|FG006|Overall Study|Participation in Study Discontinued by Sponsor|14|||
27743379|NCT02130466|54193403|FG007|Overall Study|Participation in Study Discontinued by Sponsor|1|||
27743380|NCT02130466|54193404|FG008|Overall Study|Participation in Study Discontinued by Sponsor|0|||
27743381|NCT02130466|54193405|FG009|Overall Study|Participation in Study Discontinued by Sponsor|1|||
27743382|NCT02130466|54193406|FG010|Overall Study|Participation in Study Discontinued by Sponsor|1|||
27743383|NCT02130466|54193407|FG011|Overall Study|Participation in Study Discontinued by Sponsor|0|||
27743384|NCT02130466|54193408|FG012|Overall Study|Participation in Study Discontinued by Sponsor|0|||
27743385|NCT02130466|54193409|FG013|Overall Study|Participation in Study Discontinued by Sponsor|2|||
27743386|NCT02130466|54193396|FG000|Overall Study|Withdrawal by Subject|1|||
27743387|NCT02130466|54193397|FG001|Overall Study|Withdrawal by Subject|0|||
27743388|NCT02130466|54193398|FG002|Overall Study|Withdrawal by Subject|0|||
27743389|NCT02130466|54193399|FG003|Overall Study|Withdrawal by Subject|0|||
27743390|NCT02130466|54193400|FG004|Overall Study|Withdrawal by Subject|0|||
27743391|NCT02130466|54193401|FG005|Overall Study|Withdrawal by Subject|1|||
27743392|NCT02130466|54193402|FG006|Overall Study|Withdrawal by Subject|0|||
27743393|NCT02130466|54193403|FG007|Overall Study|Withdrawal by Subject|0|||
27743394|NCT02130466|54193404|FG008|Overall Study|Withdrawal by Subject|1|||
27743395|NCT02130466|54193405|FG009|Overall Study|Withdrawal by Subject|0|||
27743396|NCT02130466|54193406|FG010|Overall Study|Withdrawal by Subject|0|||
27743397|NCT02130466|54193407|FG011|Overall Study|Withdrawal by Subject|0|||
27743398|NCT02130466|54193408|FG012|Overall Study|Withdrawal by Subject|0|||
27743399|NCT02130466|54193409|FG013|Overall Study|Withdrawal by Subject|0|||
27743400|NCT02163538|54193458|FG000|Overall Study|Protocol Violation|1|||
27743401|NCT02163538|54193459|FG001|Overall Study|Protocol Violation|0|||
27743402|NCT02163538|54193458|FG000|Overall Study|Physician Decision|0|||
27743403|NCT02163538|54193459|FG001|Overall Study|Physician Decision|1|||
27743404|NCT02163226|54193467|FG000|Overall Study|Death|2|||
27743405|NCT02163226|54193468|FG001|Overall Study|Death|1|||
27743406|NCT02163226|54193467|FG000|Overall Study|Withdrawal by Subject|5|||
27743407|NCT02163226|54193468|FG001|Overall Study|Withdrawal by Subject|2|||
27743408|NCT02163226|54193467|FG000|Overall Study|Returned home, local radiotherapy|3|||
27743409|NCT02163226|54193468|FG001|Overall Study|Returned home, local radiotherapy|0|||
27743410|NCT02163226|54193467|FG000|Overall Study|Repeat imaging showed no disease|2|||
27743411|NCT02163226|54193468|FG001|Overall Study|Repeat imaging showed no disease|0|||
27743412|NCT02163226|54193467|FG000|Overall Study|Incomplete radiotherapy|3|||
27743413|NCT02163226|54193468|FG001|Overall Study|Incomplete radiotherapy|0|||
27743414|NCT02163226|54193467|FG000|Overall Study|Treatment was to >3 radiotherapy fields|1|||
27743415|NCT02163226|54193468|FG001|Overall Study|Treatment was to >3 radiotherapy fields|0|||
27743416|NCT02163226|54193467|FG000|Overall Study|"Insurance denied for single-fraction treatment"|0|||
27743417|NCT02163226|54193468|FG001|Overall Study|"Insurance denied for single-fraction treatment"|5|||
27743418|NCT02163226|54193467|FG000|Overall Study|ineligible|0|||
27743419|NCT02163226|54193468|FG001|Overall Study|ineligible|3|||
27743420|NCT02193178|54193474|FG000|Overall Study|Lost to Follow-up|1|||
27743421|NCT02193178|54193474|FG000|Overall Study|Dry eyes|1|||
27743422|NCT02129608|54193495|FG000|Overall Study|Lost to Follow-up|0|||
27743423|NCT02129608|54193496|FG001|Overall Study|Lost to Follow-up|1|||
27743424|NCT02129608|54193497|FG002|Overall Study|Lost to Follow-up|1|||
27743425|NCT02129608|54193495|FG000|Overall Study|Withdrawal by Subject|0|||
27743426|NCT02129608|54193496|FG001|Overall Study|Withdrawal by Subject|0|||
27743427|NCT02129608|54193497|FG002|Overall Study|Withdrawal by Subject|2|||
27743428|NCT01631188|54193505|FG000|Overall Study|Physician Decision|75|||
27743429|NCT02129062|54193509|FG000|Overall Study|Death|1|||
27743430|NCT02129062|54193509|FG000|Overall Study|Disease Progression|2|||
27743431|NCT02162758|54193515|FG000|Overall Study|Study termination|0|||
27743432|NCT02162758|54193516|FG001|Overall Study|Study termination|1|||
27743433|NCT02192164|54193522|FG000|Overall Study|Other|8|||
27743434|NCT02192164|54193522|FG000|Overall Study|Withdrawal by Subject|1|||
27743435|NCT02192164|54193522|FG000|Overall Study|Physician Decision|4|||
27743436|NCT02192164|54193522|FG000|Overall Study|Did not meet the exclusion criteria|1|||
27743437|NCT02191618|54193529|FG000|Overall Study|Withdrawal by Subject|3|||
27743438|NCT02191618|54193529|FG000|Overall Study|Missed Visit|4|||
27743439|NCT02646891|54193543|FG000|Overall Study|Adverse Event|0|||
27743440|NCT02646891|54193544|FG001|Overall Study|Adverse Event|1|||
27743441|NCT02646891|54193545|FG002|Overall Study|Adverse Event|0|||
27743442|NCT02646891|54193546|FG003|Overall Study|Adverse Event|0|||
27743443|NCT02646891|54193547|FG004|Overall Study|Adverse Event|0|||
27743444|NCT02646891|54193548|FG005|Overall Study|Adverse Event|0|||
27743445|NCT02646891|54193549|FG006|Overall Study|Adverse Event|0|||
27743446|NCT02646891|54193550|FG007|Overall Study|Adverse Event|0|||
27743447|NCT02646891|54193551|FG008|Overall Study|Adverse Event|0|||
27743448|NCT02646891|54193552|FG009|Overall Study|Adverse Event|0|||
27743449|NCT02646891|54193543|FG000|Overall Study|Lost to Follow-up|0|||
27743450|NCT02646891|54193544|FG001|Overall Study|Lost to Follow-up|0|||
27743451|NCT02646891|54193545|FG002|Overall Study|Lost to Follow-up|0|||
27743452|NCT02646891|54193546|FG003|Overall Study|Lost to Follow-up|0|||
27743453|NCT02646891|54193547|FG004|Overall Study|Lost to Follow-up|0|||
27743454|NCT02646891|54193548|FG005|Overall Study|Lost to Follow-up|0|||
27743455|NCT02646891|54193549|FG006|Overall Study|Lost to Follow-up|2|||
27743456|NCT02646891|54193550|FG007|Overall Study|Lost to Follow-up|2|||
27743457|NCT02646891|54193551|FG008|Overall Study|Lost to Follow-up|2|||
27743458|NCT02646891|54193552|FG009|Overall Study|Lost to Follow-up|2|||
27743459|NCT02646891|54193543|FG000|Overall Study|Protocol Violation|0|||
27743460|NCT02646891|54193544|FG001|Overall Study|Protocol Violation|0|||
27743461|NCT02646891|54193545|FG002|Overall Study|Protocol Violation|0|||
27743462|NCT02646891|54193546|FG003|Overall Study|Protocol Violation|0|||
27743463|NCT02646891|54193547|FG004|Overall Study|Protocol Violation|0|||
27743464|NCT02646891|54193548|FG005|Overall Study|Protocol Violation|0|||
27743465|NCT02646891|54193549|FG006|Overall Study|Protocol Violation|1|||
27743466|NCT02646891|54193550|FG007|Overall Study|Protocol Violation|1|||
27743467|NCT02646891|54193551|FG008|Overall Study|Protocol Violation|0|||
27743468|NCT02646891|54193552|FG009|Overall Study|Protocol Violation|0|||
27743469|NCT02646891|54193543|FG000|Overall Study|Withdrawal by Subject|2|||
27743470|NCT02646891|54193544|FG001|Overall Study|Withdrawal by Subject|0|||
27743471|NCT02646891|54193545|FG002|Overall Study|Withdrawal by Subject|1|||
27743472|NCT02646891|54193546|FG003|Overall Study|Withdrawal by Subject|0|||
27743473|NCT02646891|54193547|FG004|Overall Study|Withdrawal by Subject|0|||
27743474|NCT02646891|54193548|FG005|Overall Study|Withdrawal by Subject|0|||
27743475|NCT02646891|54193549|FG006|Overall Study|Withdrawal by Subject|5|||
27743476|NCT02646891|54193550|FG007|Overall Study|Withdrawal by Subject|9|||
27743477|NCT02646891|54193551|FG008|Overall Study|Withdrawal by Subject|7|||
27743478|NCT02646891|54193552|FG009|Overall Study|Withdrawal by Subject|3|||
27743479|NCT02646891|54193543|FG000|Overall Study|Death|0|||
27743480|NCT02646891|54193544|FG001|Overall Study|Death|0|||
27743481|NCT02646891|54193545|FG002|Overall Study|Death|0|||
27743482|NCT02646891|54193546|FG003|Overall Study|Death|0|||
27743483|NCT02646891|54193547|FG004|Overall Study|Death|0|||
27743484|NCT02646891|54193548|FG005|Overall Study|Death|0|||
27743485|NCT02646891|54193549|FG006|Overall Study|Death|1|||
27743486|NCT02646891|54193550|FG007|Overall Study|Death|1|||
27743487|NCT02646891|54193551|FG008|Overall Study|Death|1|||
27743488|NCT02646891|54193552|FG009|Overall Study|Death|0|||
27743489|NCT02646423|54193588|FG000|Overall Study|Adverse Event|5|||
27743490|NCT02646423|54193589|FG001|Overall Study|Adverse Event|7|||
27743491|NCT02646423|54193588|FG000|Overall Study|Ineligible|2|||
27743492|NCT02646423|54193589|FG001|Overall Study|Ineligible|1|||
27743493|NCT02647359|54193615|FG000|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|0|||
27743494|NCT02647359|54193616|FG001|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|1|||
27743495|NCT02647359|54193615|FG000|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|4|||
27743496|NCT02647359|54193616|FG001|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|0|||
27743497|NCT02647359|54193615|FG000|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|2|||
27743498|NCT02647359|54193616|FG001|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|1|||
27743499|NCT02647359|54193615|FG000|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|8|||
27743500|NCT02647359|54193616|FG001|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|3|||
27743501|NCT02647359|54193615|FG000|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|1|||
27743502|NCT02647359|54193616|FG001|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|0|||
27743503|NCT02647359|54193615|FG000|Open-Label Sub-Study (96 Weeks)|Other than specified|7|||
27743504|NCT02647359|54193616|FG001|Open-Label Sub-Study (96 Weeks)|Other than specified|4|||
27743505|NCT02645409|54193628|FG000|Overall Study|Withdrawal by Subject|3|||
27743506|NCT02645409|54193629|FG001|Overall Study|Withdrawal by Subject|0|||
27743507|NCT02645409|54193628|FG000|Overall Study|Physician Decision|1|||
27743508|NCT02645409|54193629|FG001|Overall Study|Physician Decision|0|||
27743509|NCT01597479|54193636|FG000|Overall Study|Protocol Violation|1|||
27743510|NCT01597479|54193637|FG001|Overall Study|Protocol Violation|0|||
27743511|NCT01597479|54193636|FG000|Overall Study|Lost to Follow-up|1|||
27743512|NCT01597479|54193637|FG001|Overall Study|Lost to Follow-up|0|||
27743513|NCT04248465|54193646|FG000|Randomized-Controlled Period|Death|12|||
27743514|NCT04248465|54193647|FG001|Randomized-Controlled Period|Death|5|||
27743515|NCT04248465|54193646|FG000|Randomized-Controlled Period|Adverse Event|2|||
27743516|NCT04248465|54193647|FG001|Randomized-Controlled Period|Adverse Event|0|||
27743517|NCT04248465|54193646|FG000|Randomized-Controlled Period|Study Terminated by Sponsor|194|||
27743518|NCT04248465|54193647|FG001|Randomized-Controlled Period|Study Terminated by Sponsor|99|||
27743519|NCT04248465|54193646|FG000|Randomized-Controlled Period|Withdrawal by Subject|30|||
27743520|NCT04248465|54193647|FG001|Randomized-Controlled Period|Withdrawal by Subject|17|||
27743521|NCT04248465|54193646|FG000|Randomized-Controlled Period|Physician Decision|1|||
27743522|NCT04248465|54193647|FG001|Randomized-Controlled Period|Physician Decision|1|||
27743523|NCT04248465|54193646|FG000|Randomized-Controlled Period|Lost to Follow-up|1|||
27743524|NCT04248465|54193647|FG001|Randomized-Controlled Period|Lost to Follow-up|0|||
27743525|NCT04248465|54193646|FG000|Open-label Extension Period|Study Terminated by Sponsor|14|||
27743526|NCT04248465|54193647|FG001|Open-label Extension Period|Study Terminated by Sponsor|4|||
27743527|NCT04248465|54193646|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
27743528|NCT04248465|54193647|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
27743529|NCT02643693|54193655|FG000|Overall Study|Physician Decision|0|||
27743530|NCT02643693|54193656|FG001|Overall Study|Physician Decision|1|||
27743531|NCT02643693|54193657|FG002|Overall Study|Physician Decision|0|||
27743532|NCT02643693|54193658|FG003|Overall Study|Physician Decision|0|||
27743533|NCT02643693|54193659|FG004|Overall Study|Physician Decision|0|||
27743534|NCT02643693|54193660|FG005|Overall Study|Physician Decision|0|||
27743535|NCT02643693|54193655|FG000|Overall Study|Withdrawal by Subject|0|||
27743536|NCT02643693|54193656|FG001|Overall Study|Withdrawal by Subject|1|||
27743537|NCT02643693|54193657|FG002|Overall Study|Withdrawal by Subject|0|||
27743538|NCT02643693|54193658|FG003|Overall Study|Withdrawal by Subject|0|||
27743539|NCT02643693|54193659|FG004|Overall Study|Withdrawal by Subject|0|||
27743540|NCT02643693|54193660|FG005|Overall Study|Withdrawal by Subject|0|||
27743541|NCT02643693|54193655|FG000|Overall Study|Protocol Adherence Issues|2|||
27743542|NCT02643693|54193656|FG001|Overall Study|Protocol Adherence Issues|0|||
27743543|NCT02643693|54193657|FG002|Overall Study|Protocol Adherence Issues|1|||
27743544|NCT02643693|54193658|FG003|Overall Study|Protocol Adherence Issues|0|||
27743545|NCT02643693|54193659|FG004|Overall Study|Protocol Adherence Issues|0|||
27743546|NCT02643693|54193660|FG005|Overall Study|Protocol Adherence Issues|1|||
27743547|NCT02726113|54193670|FG000|Total Enrollment|Physician Decision|0|||
27743548|NCT02726113|54193671|FG001|Total Enrollment|Physician Decision|1|||
27743549|NCT02726113|54193670|FG000|Total Enrollment|Protocol Violation|1|||
27743550|NCT02726113|54193671|FG001|Total Enrollment|Protocol Violation|0|||
27743551|NCT02726113|54193670|FG000|Total Enrollment|Withdrawal by Subject|2|||
27743552|NCT02726113|54193671|FG001|Total Enrollment|Withdrawal by Subject|1|||
27743553|NCT02726113|54193670|FG000|Total Enrollment|Insurance non-coverage for surgery|1|||
27743554|NCT02726113|54193671|FG001|Total Enrollment|Insurance non-coverage for surgery|1|||
27743555|NCT02726113|54193670|FG000|Genomic Analysis|Protocol Violation|1|||
27743556|NCT02726113|54193671|FG001|Genomic Analysis|Protocol Violation|0|||
27743557|NCT02726113|54193670|FG000|Genomic Analysis|Withdrawal by Subject|2|||
27743558|NCT02726113|54193671|FG001|Genomic Analysis|Withdrawal by Subject|1|||
27743559|NCT02726113|54193670|FG000|Genomic Analysis|Insurance non-coverage for surgery|1|||
27743560|NCT02726113|54193671|FG001|Genomic Analysis|Insurance non-coverage for surgery|1|||
27743561|NCT01361919|54193689|FG000|Overall Study|technical issues|10|||
27743562|NCT01361919|54193690|FG001|Overall Study|technical issues|12|||
27743563|NCT01361919|54193691|FG002|Overall Study|technical issues|10|||
27743564|NCT02642679|54193699|FG000|Overall Study|Withdrawal by Subject|1|||
27743565|NCT02642679|54193699|FG000|Overall Study|Physician Decision|1|||
27743566|NCT02642679|54193699|FG000|Overall Study|Physician Decision|1|||
27743567|NCT00705523|54193705|FG000|Overall Study|Lost to Follow-up|2|||
27743568|NCT00705523|54193706|FG001|Overall Study|Lost to Follow-up|3|||
27743569|NCT02725411|54193715|FG000|Treatment Period (56 Weeks)|Adverse Event|3|||
27743570|NCT02725411|54193716|FG001|Treatment Period (56 Weeks)|Adverse Event|5|||
27743571|NCT02725411|54193717|FG002|Treatment Period (56 Weeks)|Adverse Event|4|||
27743572|NCT02725411|54193715|FG000|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
27743573|NCT02725411|54193716|FG001|Treatment Period (56 Weeks)|Lack of Efficacy|4|||
27743574|NCT02725411|54193717|FG002|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
27743575|NCT02725411|54193715|FG000|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
27743576|NCT02725411|54193716|FG001|Treatment Period (56 Weeks)|Lost to Follow-up|1|||
27743577|NCT02725411|54193717|FG002|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
27743578|NCT02725411|54193715|FG000|Treatment Period (56 Weeks)|Other|1|||
27743579|NCT02725411|54193716|FG001|Treatment Period (56 Weeks)|Other|4|||
27743580|NCT02725411|54193717|FG002|Treatment Period (56 Weeks)|Other|5|||
27743581|NCT02725411|54193715|FG000|Treatment Period (56 Weeks)|Withdrawal by Subject|0|||
27743582|NCT02725411|54193716|FG001|Treatment Period (56 Weeks)|Withdrawal by Subject|1|||
27743583|NCT02725411|54193717|FG002|Treatment Period (56 Weeks)|Withdrawal by Subject|4|||
27743584|NCT02725411|54193715|FG000|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25|||
27743585|NCT02725411|54193716|FG001|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
27743586|NCT02725411|54193717|FG002|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
27743587|NCT02725411|54193715|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
27743588|NCT02725411|54193716|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
27743589|NCT02725411|54193717|FG002|Follow-up Period (24 Weeks)|Adverse Event|0|||
27743590|NCT02725411|54193715|FG000|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
27743591|NCT02725411|54193716|FG001|Follow-up Period (24 Weeks)|Lack of Efficacy|2|||
27743592|NCT02725411|54193717|FG002|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
27743593|NCT02725411|54193715|FG000|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
27743594|NCT02725411|54193716|FG001|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
27743595|NCT02725411|54193717|FG002|Follow-up Period (24 Weeks)|Lost to Follow-up|0|||
27743596|NCT02725411|54193715|FG000|Follow-up Period (24 Weeks)|Other|1|||
27743597|NCT02725411|54193716|FG001|Follow-up Period (24 Weeks)|Other|4|||
27743598|NCT02725411|54193717|FG002|Follow-up Period (24 Weeks)|Other|2|||
27743599|NCT02725411|54193715|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
27743600|NCT02725411|54193716|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
27743601|NCT02725411|54193717|FG002|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
27743602|NCT02190604|54193753|FG000|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
27743603|NCT02190604|54193754|FG001|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
27743604|NCT02190604|54193755|FG002|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
27743605|NCT02190604|54193756|FG003|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
27743606|NCT02190604|54193757|FG004|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
27743607|NCT02190604|54193758|FG005|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
27743608|NCT02190604|54193759|FG006|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
27743609|NCT02190604|54193760|FG007|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
27743610|NCT02190604|54193761|FG008|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
27743611|NCT02190604|54193762|FG009|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
27743612|NCT02190604|54193763|FG010|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
27743613|NCT02190604|54193764|FG011|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
27743614|NCT02190604|54193765|FG012|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
27743615|NCT02190604|54193766|FG013|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
27743616|NCT02190604|54193767|FG014|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2|||
27743617|NCT02190604|54193768|FG015|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
27743618|NCT02190604|54193769|FG016|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
27743619|NCT02190604|54193770|FG017|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
27743620|NCT02190604|54193771|FG018|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
27743621|NCT02190604|54193753|FG000|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
27743622|NCT02190604|54193754|FG001|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
27743623|NCT02190604|54193755|FG002|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
27743624|NCT02190604|54193756|FG003|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
27743625|NCT02190604|54193757|FG004|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
27743626|NCT02190604|54193758|FG005|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
27743627|NCT02190604|54193759|FG006|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
27743628|NCT02190604|54193760|FG007|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
27743629|NCT02190604|54193761|FG008|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
27743630|NCT02190604|54193762|FG009|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
27743631|NCT02190604|54193763|FG010|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
27743632|NCT02190604|54193764|FG011|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
27743633|NCT02190604|54193765|FG012|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
27743634|NCT02190604|54193766|FG013|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1|||
27743635|NCT02190604|54193767|FG014|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
27743636|NCT02190604|54193768|FG015|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
27743637|NCT02190604|54193769|FG016|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
27743638|NCT02190604|54193770|FG017|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
27743639|NCT02190604|54193771|FG018|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
27743640|NCT02127970|54193830|FG000|Overall Study|Adverse Event|2|||
27743641|NCT02127970|54193831|FG001|Overall Study|Adverse Event|1|||
27743642|NCT02127970|54193830|FG000|Overall Study|Death|1|||
27743643|NCT02127970|54193831|FG001|Overall Study|Death|1|||
27743644|NCT02127970|54193830|FG000|Overall Study|Lost to Follow-up|14|||
27743645|NCT02127970|54193831|FG001|Overall Study|Lost to Follow-up|14|||
27743646|NCT02127970|54193830|FG000|Overall Study|Reason not Specified|4|||
27743647|NCT02127970|54193831|FG001|Overall Study|Reason not Specified|7|||
27743648|NCT02127970|54193830|FG000|Overall Study|Pregnancy|0|||
27743649|NCT02127970|54193831|FG001|Overall Study|Pregnancy|1|||
27743650|NCT02127970|54193830|FG000|Overall Study|Subject Withdrew Consent|5|||
27743651|NCT02127970|54193831|FG001|Overall Study|Subject Withdrew Consent|3|||
27743652|NCT03549871|54193839|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|0|||
27743653|NCT03549871|54193840|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|2|||
27743654|NCT03549871|54193839|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|1|||
27743655|NCT03549871|54193840|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|0|||
27743656|NCT03549871|54193839|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|1|||
27743657|NCT03549871|54193840|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|0|||
27743658|NCT03549871|54193839|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|4|||
27743659|NCT03549871|54193840|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|0|||
27743660|NCT03549871|54193839|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|1|||
27743661|NCT03549871|54193840|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|0|||
27743662|NCT03549871|54193839|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|0|||
27743663|NCT03549871|54193840|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|2|||
27743664|NCT03549871|54193839|FG000|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|1|||
27743665|NCT03549871|54193840|FG001|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|0|||
27743666|NCT03549871|54193839|FG000|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|1|||
27743667|NCT03549871|54193840|FG001|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|0|||
27743668|NCT03549871|54193839|FG000|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|4|||
27743669|NCT03549871|54193840|FG001|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|5|||
27743670|NCT03549871|54193839|FG000|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|0|||
27743671|NCT03549871|54193840|FG001|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|2|||
27743672|NCT03549871|54193839|FG000|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|0|||
27743673|NCT03549871|54193840|FG001|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|2|||
27743674|NCT00705367|54193863|FG000|Long-term Extension Period|Adverse Event|2|||
27743675|NCT00705367|54193864|FG001|Long-term Extension Period|Adverse Event|0|||
27743676|NCT00705367|54193863|FG000|Long-term Extension Period|Withdrawal by Subject|2|||
27743677|NCT00705367|54193864|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
27922638|NCT01266993|54579445|FG001|Booster Phase (Month 68-69)|Lost to Follow-up|1|||
27743678|NCT00705367|54193863|FG000|Long-term Extension Period|Lack of Efficacy|1|||
27743679|NCT00705367|54193864|FG001|Long-term Extension Period|Lack of Efficacy|0|||
27743680|NCT00705367|54193863|FG000|Long-term Extension Period|No longer met study criteria|1|||
27743681|NCT00705367|54193864|FG001|Long-term Extension Period|No longer met study criteria|0|||
27743682|NCT00705367|54193863|FG000|Long-term Extension Period|Administrative reason by sponsor|3|||
27743683|NCT00705367|54193864|FG001|Long-term Extension Period|Administrative reason by sponsor|0|||
27743684|NCT02864251|54193875|FG000|Pre-Treatment|Adverse Event Unrelated to Study drug|1|||
27743685|NCT02864251|54193876|FG001|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
27743686|NCT02864251|54193877|FG002|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
27743687|NCT02864251|54193875|FG000|Pre-Treatment|Withdrawal by Participant|0|||
27743688|NCT02864251|54193876|FG001|Pre-Treatment|Withdrawal by Participant|0|||
27743689|NCT02864251|54193877|FG002|Pre-Treatment|Withdrawal by Participant|4|||
27743690|NCT02864251|54193875|FG000|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
27743691|NCT02864251|54193876|FG001|Pre-Treatment|Participant no Longer Meets Study Criteria|1|||
27743692|NCT02864251|54193877|FG002|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
27743693|NCT02864251|54193875|FG000|Pre-Treatment|Other Reasons|0|||
27743694|NCT02864251|54193876|FG001|Pre-Treatment|Other Reasons|1|||
27743695|NCT02864251|54193877|FG002|Pre-Treatment|Other Reasons|1|||
27743696|NCT02864251|54193875|FG000|Treatment|Disease Progression|109|||
27743697|NCT02864251|54193876|FG001|Treatment|Disease Progression|52|||
27743698|NCT02864251|54193877|FG002|Treatment|Disease Progression|100|||
27743699|NCT02864251|54193875|FG000|Treatment|Study Drug Toxicity|9|||
27743700|NCT02864251|54193876|FG001|Treatment|Study Drug Toxicity|4|||
27743701|NCT02864251|54193877|FG002|Treatment|Study Drug Toxicity|10|||
27743702|NCT02864251|54193875|FG000|Treatment|Death|0|||
27743703|NCT02864251|54193876|FG001|Treatment|Death|2|||
27743704|NCT02864251|54193877|FG002|Treatment|Death|3|||
27743705|NCT02864251|54193875|FG000|Treatment|Adverse Event Unrelated to Study Drug|1|||
27743706|NCT02864251|54193876|FG001|Treatment|Adverse Event Unrelated to Study Drug|1|||
27743707|NCT02864251|54193877|FG002|Treatment|Adverse Event Unrelated to Study Drug|6|||
27743708|NCT02864251|54193875|FG000|Treatment|Participant Requested to Discontinue Study Treatment|8|||
27743709|NCT02864251|54193876|FG001|Treatment|Participant Requested to Discontinue Study Treatment|0|||
27743710|NCT02864251|54193877|FG002|Treatment|Participant Requested to Discontinue Study Treatment|5|||
27743711|NCT02864251|54193875|FG000|Treatment|Withdrawal by Participant|8|||
27743712|NCT02864251|54193876|FG001|Treatment|Withdrawal by Participant|5|||
27743713|NCT02864251|54193877|FG002|Treatment|Withdrawal by Participant|13|||
27743714|NCT02864251|54193875|FG000|Treatment|Maximum Clinical Benefit|1|||
27743715|NCT02864251|54193876|FG001|Treatment|Maximum Clinical Benefit|0|||
27743716|NCT02864251|54193877|FG002|Treatment|Maximum Clinical Benefit|1|||
27743717|NCT02864251|54193875|FG000|Treatment|Participant no Longer Meets Study Criteria|0|||
27743718|NCT02864251|54193876|FG001|Treatment|Participant no Longer Meets Study Criteria|1|||
27743719|NCT02864251|54193877|FG002|Treatment|Participant no Longer Meets Study Criteria|0|||
27743720|NCT02864251|54193875|FG000|Treatment|Other Reasons|0|||
27743721|NCT02864251|54193876|FG001|Treatment|Other Reasons|1|||
27743722|NCT02864251|54193877|FG002|Treatment|Other Reasons|3|||
27743723|NCT02864251|54193875|FG000|Treatment|Not Reported|1|||
27743724|NCT02864251|54193876|FG001|Treatment|Not Reported|0|||
27743725|NCT02864251|54193877|FG002|Treatment|Not Reported|0|||
27743726|NCT02864251|54193875|FG000|Treatment|Ongoing Treatment|1|||
27743727|NCT02864251|54193876|FG001|Treatment|Ongoing Treatment|0|||
27743728|NCT02864251|54193877|FG002|Treatment|Ongoing Treatment|2|||
27743729|NCT00705289|54193885|FG000|Overall Study|Subject or treating physician's choice|131|||
27743730|NCT02038777|54193914|FG000|Overall Study|Death|0|||
27743731|NCT02038777|54193915|FG001|Overall Study|Death|2|||
27743732|NCT02038777|54193916|FG002|Overall Study|Death|0|||
27743733|NCT02038777|54193917|FG003|Overall Study|Death|1|||
27743734|NCT02038777|54193918|FG004|Overall Study|Death|2|||
27743735|NCT02038777|54193919|FG005|Overall Study|Death|4|||
27743736|NCT02038777|54193920|FG006|Overall Study|Death|0|||
27743737|NCT02038777|54193921|FG007|Overall Study|Death|10|||
27743738|NCT02038777|54193914|FG000|Overall Study|Lost to Follow-up|0|||
27743739|NCT02038777|54193915|FG001|Overall Study|Lost to Follow-up|0|||
27743740|NCT02038777|54193916|FG002|Overall Study|Lost to Follow-up|0|||
27743741|NCT02038777|54193917|FG003|Overall Study|Lost to Follow-up|1|||
27743742|NCT02038777|54193918|FG004|Overall Study|Lost to Follow-up|0|||
27743743|NCT02038777|54193919|FG005|Overall Study|Lost to Follow-up|0|||
27743744|NCT02038777|54193920|FG006|Overall Study|Lost to Follow-up|0|||
27743745|NCT02038777|54193921|FG007|Overall Study|Lost to Follow-up|0|||
27743746|NCT02038777|54193914|FG000|Overall Study|Other|0|||
27743747|NCT02038777|54193915|FG001|Overall Study|Other|1|||
27743748|NCT02038777|54193916|FG002|Overall Study|Other|0|||
27743749|NCT02038777|54193917|FG003|Overall Study|Other|2|||
27743750|NCT02038777|54193918|FG004|Overall Study|Other|1|||
27743751|NCT02038777|54193919|FG005|Overall Study|Other|0|||
27743752|NCT02038777|54193920|FG006|Overall Study|Other|0|||
27743753|NCT02038777|54193921|FG007|Overall Study|Other|0|||
27743754|NCT02038777|54193914|FG000|Overall Study|Randomized but not treated|0|||
27743755|NCT02038777|54193915|FG001|Overall Study|Randomized but not treated|1|||
27743756|NCT02038777|54193916|FG002|Overall Study|Randomized but not treated|0|||
27743757|NCT02038777|54193917|FG003|Overall Study|Randomized but not treated|0|||
27743758|NCT02038777|54193918|FG004|Overall Study|Randomized but not treated|0|||
27743759|NCT02038777|54193919|FG005|Overall Study|Randomized but not treated|0|||
27743760|NCT02038777|54193920|FG006|Overall Study|Randomized but not treated|0|||
27743761|NCT02038777|54193921|FG007|Overall Study|Randomized but not treated|0|||
27743762|NCT02038777|54193914|FG000|Overall Study|Started Chemotherapy|1|||
27743763|NCT02038777|54193915|FG001|Overall Study|Started Chemotherapy|0|||
27743764|NCT02038777|54193916|FG002|Overall Study|Started Chemotherapy|3|||
27743765|NCT02038777|54193917|FG003|Overall Study|Started Chemotherapy|0|||
27743766|NCT02038777|54193918|FG004|Overall Study|Started Chemotherapy|0|||
27743767|NCT02038777|54193919|FG005|Overall Study|Started Chemotherapy|0|||
27743768|NCT02038777|54193920|FG006|Overall Study|Started Chemotherapy|0|||
27743769|NCT02038777|54193921|FG007|Overall Study|Started Chemotherapy|0|||
27743770|NCT00703963|54193940|FG000|Overall Study|Withdrawal by Subject|7|||
27743771|NCT00703963|54193941|FG001|Overall Study|Withdrawal by Subject|13|||
27743772|NCT00703963|54193940|FG000|Overall Study|Physician Decision|0|||
27743773|NCT00703963|54193941|FG001|Overall Study|Physician Decision|1|||
27743774|NCT02721355|54193949|FG000|Overall Study|Lost to Follow-up|6|||
27743775|NCT02721355|54193950|FG001|Overall Study|Lost to Follow-up|1|||
27743776|NCT02733991|54193958|FG000|Overall Study|Adverse Event|1|||
27743777|NCT02733991|54193959|FG001|Overall Study|Adverse Event|0|||
27743778|NCT02733991|54193958|FG000|Overall Study|Withdrawal by Subject|0|||
27743779|NCT02733991|54193959|FG001|Overall Study|Withdrawal by Subject|5|||
27743780|NCT00702949|54193968|FG000|Overall Study|Refusal|3|||
27743781|NCT00702949|54193969|FG001|Overall Study|Refusal|2|||
27743782|NCT00702949|54193970|FG002|Overall Study|Refusal|2|||
27743783|NCT00702949|54193968|FG000|Overall Study|Adverse Event|1|||
27743784|NCT00702949|54193969|FG001|Overall Study|Adverse Event|6|||
27743785|NCT00702949|54193970|FG002|Overall Study|Adverse Event|3|||
27743786|NCT00702949|54193968|FG000|Overall Study|Other Medical Reason/unknown|1|||
27743787|NCT00702949|54193969|FG001|Overall Study|Other Medical Reason/unknown|1|||
27743788|NCT00702949|54193970|FG002|Overall Study|Other Medical Reason/unknown|3|||
27743789|NCT00702715|54193982|FG000|Overall Study|Lost to Follow-up|1|||
27743790|NCT00702715|54193983|FG001|Overall Study|Lost to Follow-up|0|||
27743791|NCT00702403|54193989|FG000|From Consent to Engraftment|Progressive leukemia|6|||
27743792|NCT00702403|54193989|FG000|From Consent to Engraftment|Critically ill|2|||
27743793|NCT00702403|54193989|FG000|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2|||
27743794|NCT00702403|54193989|FG000|From Consent to Engraftment|Myocardial infarction|1|||
27743795|NCT00702403|54193989|FG000|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4|||
27743796|NCT00702403|54193989|FG000|From Consent to Engraftment|Miscellaneous (unanticipated) other|2|||
27743797|NCT00702403|54193989|FG000|From Engraftment to Study Completion|Failed pre-1st dose criteria|11|||
27743798|NCT00702403|54193989|FG000|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4|||
27743799|NCT00702403|54193989|FG000|From Engraftment to Study Completion|Non-compliance|2|||
27743800|NCT00702403|54193989|FG000|From Engraftment to Study Completion|Adenocarcinoma|1|||
27743801|NCT00702403|54193989|FG000|From Engraftment to Study Completion|Liver GVHD|1|||
27743802|NCT00702403|54193989|FG000|From Engraftment to Study Completion|Suicide|1|||
27743803|NCT00702403|54193989|FG000|From Engraftment to Study Completion|Acute respiratory distress syndrome|1|||
27743804|NCT00702403|54193989|FG000|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1|||
27743805|NCT00702403|54193989|FG000|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5|||
27743806|NCT00702325|54193998|FG000|Overall Study|Adverse Event|1|||
27743807|NCT00702325|54193999|FG001|Overall Study|Adverse Event|0|||
27743808|NCT00702325|54193998|FG000|Overall Study|Withdrawal by Subject|7|||
27743809|NCT00702325|54193999|FG001|Overall Study|Withdrawal by Subject|7|||
27743810|NCT00702325|54193998|FG000|Overall Study|Lost to Follow-up|3|||
27743811|NCT00702325|54193999|FG001|Overall Study|Lost to Follow-up|4|||
27743812|NCT00702325|54193998|FG000|Overall Study|Incorrect enrollment|5|||
27743813|NCT00702325|54193999|FG001|Overall Study|Incorrect enrollment|7|||
27743814|NCT00702325|54193998|FG000|Overall Study|Developed study discontinuation criteria|18|||
27743815|NCT00702325|54193999|FG001|Overall Study|Developed study discontinuation criteria|28|||
27743816|NCT00702325|54193998|FG000|Overall Study|Severe noncompliance to protocol|3|||
27743817|NCT00702325|54193999|FG001|Overall Study|Severe noncompliance to protocol|3|||
27743818|NCT00702325|54193998|FG000|Overall Study|Termination due to lab results|1|||
27743819|NCT00702325|54193999|FG001|Overall Study|Termination due to lab results|0|||
27743820|NCT00702325|54193998|FG000|Overall Study|Didn't follow study medication dosage|0|||
27743821|NCT00702325|54193999|FG001|Overall Study|Didn't follow study medication dosage|2|||
27743822|NCT00702325|54193998|FG000|Overall Study|Withdrew consent|0|||
27743823|NCT00702325|54193999|FG001|Overall Study|Withdrew consent|1|||
27743824|NCT00702325|54193998|FG000|Overall Study|Incorrectly Discontinued|0|||
27743825|NCT00702325|54193999|FG001|Overall Study|Incorrectly Discontinued|1|||
27743826|NCT02719171|54194010|FG000|Overall Study|Adverse Event|1|||
27743827|NCT02719171|54194011|FG001|Overall Study|Adverse Event|2|||
27743828|NCT02719171|54194012|FG002|Overall Study|Adverse Event|0|||
27743829|NCT02719171|54194013|FG003|Overall Study|Adverse Event|0|||
27743830|NCT02719171|54194014|FG004|Overall Study|Adverse Event|2|||
27743831|NCT02719171|54194010|FG000|Overall Study|Lost to Follow-up|0|||
27743832|NCT02719171|54194011|FG001|Overall Study|Lost to Follow-up|0|||
27743833|NCT02719171|54194012|FG002|Overall Study|Lost to Follow-up|1|||
27743834|NCT02719171|54194013|FG003|Overall Study|Lost to Follow-up|0|||
27743835|NCT02719171|54194014|FG004|Overall Study|Lost to Follow-up|0|||
27743836|NCT02719171|54194010|FG000|Overall Study|Subject Withdrawal|0|||
27743837|NCT02719171|54194011|FG001|Overall Study|Subject Withdrawal|2|||
27743838|NCT02719171|54194012|FG002|Overall Study|Subject Withdrawal|2|||
27743839|NCT02719171|54194013|FG003|Overall Study|Subject Withdrawal|1|||
27743840|NCT02719171|54194014|FG004|Overall Study|Subject Withdrawal|0|||
27743841|NCT02719171|54194010|FG000|Overall Study|Other|0|||
27743842|NCT02719171|54194011|FG001|Overall Study|Other|0|||
27743843|NCT02719171|54194012|FG002|Overall Study|Other|0|||
27743844|NCT02719171|54194013|FG003|Overall Study|Other|1|||
27743845|NCT02719171|54194014|FG004|Overall Study|Other|0|||
27743846|NCT02718625|54194031|FG000|Overall Study|Adverse Event|0|||
27743847|NCT02718625|54194032|FG001|Overall Study|Adverse Event|1|||
27743848|NCT02718625|54194031|FG000|Overall Study|Termination of Study by Sponsor|0|||
27743849|NCT02718625|54194032|FG001|Overall Study|Termination of Study by Sponsor|1|||
27743850|NCT02716987|54194044|FG000|Overall Study|Ligand synthesis failure|0|||
27743851|NCT02716987|54194045|FG001|Overall Study|Ligand synthesis failure|0|||
27743852|NCT02716987|54194046|FG002|Overall Study|Ligand synthesis failure|1|||
27743853|NCT02716987|54194047|FG003|Overall Study|Ligand synthesis failure|0|||
27743854|NCT02716987|54194048|FG004|Overall Study|Ligand synthesis failure|0|||
27743855|NCT02716987|54194049|FG005|Overall Study|Ligand synthesis failure|0|||
27743856|NCT02716987|54194044|FG000|Overall Study|Withdrawal by Subject|0|||
27743857|NCT02716987|54194045|FG001|Overall Study|Withdrawal by Subject|0|||
27743858|NCT02716987|54194046|FG002|Overall Study|Withdrawal by Subject|0|||
27743859|NCT02716987|54194047|FG003|Overall Study|Withdrawal by Subject|0|||
27743860|NCT02716987|54194048|FG004|Overall Study|Withdrawal by Subject|1|||
27743861|NCT02716987|54194049|FG005|Overall Study|Withdrawal by Subject|1|||
27743862|NCT00701779|54194074|FG000|Overall Study|Adverse Event|6|||
27743863|NCT00701779|54194074|FG000|Overall Study|Lost to Follow-up|1|||
27743864|NCT00701779|54194074|FG000|Overall Study|Withdrawal by Subject|2|||
27743865|NCT03707977|54194097|FG000|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
27743866|NCT03707977|54194098|FG001|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
27743867|NCT03707977|54194099|FG002|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|3|||
27743868|NCT03707977|54194097|FG000|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
27743869|NCT03707977|54194098|FG001|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
27743870|NCT03707977|54194099|FG002|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|14|||
27743871|NCT03332095|54194115|FG000|Overall Study|Lost to Follow-up|1|||
27743872|NCT03332095|54194116|FG001|Overall Study|Lost to Follow-up|0|||
27743873|NCT03332095|54194115|FG000|Overall Study|Pregnancy|0|||
27743874|NCT03332095|54194116|FG001|Overall Study|Pregnancy|1|||
27743875|NCT02764489|54194123|FG000|Part 1: Day 1 up to Day 16|Adverse Event|2|||
27743876|NCT02764489|54194124|FG001|Part 1: Day 1 up to Day 16|Adverse Event|0|||
27743877|NCT02764489|54194123|FG000|Part 1: Day 1 up to Day 16|Withdrawal by Subject|1|||
27743878|NCT02764489|54194124|FG001|Part 1: Day 1 up to Day 16|Withdrawal by Subject|0|||
27743879|NCT02764489|54194123|FG000|Part 2: Day 19 up to Day 41|Adverse Event|1|||
27743880|NCT02764489|54194124|FG001|Part 2: Day 19 up to Day 41|Adverse Event|0|||
27743881|NCT02764489|54194123|FG000|Part 2: Day 19 up to Day 41|Physician Decision|1|||
27743882|NCT02764489|54194124|FG001|Part 2: Day 19 up to Day 41|Physician Decision|0|||
27743883|NCT02001623|54194149|FG000|Overall Study|Disease Progression|2|||
27743884|NCT02001623|54194150|FG001|Overall Study|Disease Progression|2|||
27743885|NCT02001623|54194151|FG002|Overall Study|Disease Progression|3|||
27743886|NCT02001623|54194152|FG003|Overall Study|Disease Progression|2|||
27743887|NCT02001623|54194153|FG004|Overall Study|Disease Progression|3|||
27743888|NCT02001623|54194154|FG005|Overall Study|Disease Progression|2|||
27743889|NCT02001623|54194155|FG006|Overall Study|Disease Progression|3|||
27743890|NCT02001623|54194156|FG007|Overall Study|Disease Progression|3|||
27743891|NCT02001623|54194157|FG008|Overall Study|Disease Progression|7|||
27743892|NCT02001623|54194158|FG009|Overall Study|Disease Progression|40|||
27743893|NCT02001623|54194159|FG010|Overall Study|Disease Progression|5|||
27743894|NCT02001623|54194160|FG011|Overall Study|Disease Progression|9|||
27743895|NCT02001623|54194161|FG012|Overall Study|Disease Progression|9|||
27743896|NCT02001623|54194162|FG013|Overall Study|Disease Progression|20|||
27743897|NCT02001623|54194163|FG014|Overall Study|Disease Progression|9|||
27743898|NCT02001623|54194149|FG000|Overall Study|Physician Decision|0|||
27743899|NCT02001623|54194150|FG001|Overall Study|Physician Decision|0|||
27743900|NCT02001623|54194151|FG002|Overall Study|Physician Decision|0|||
27743901|NCT02001623|54194152|FG003|Overall Study|Physician Decision|0|||
27743902|NCT02001623|54194153|FG004|Overall Study|Physician Decision|0|||
27743903|NCT02001623|54194154|FG005|Overall Study|Physician Decision|0|||
27743904|NCT02001623|54194155|FG006|Overall Study|Physician Decision|0|||
27743905|NCT02001623|54194156|FG007|Overall Study|Physician Decision|0|||
27743906|NCT02001623|54194157|FG008|Overall Study|Physician Decision|3|||
27743907|NCT02001623|54194158|FG009|Overall Study|Physician Decision|2|||
27743908|NCT02001623|54194159|FG010|Overall Study|Physician Decision|3|||
27743909|NCT02001623|54194160|FG011|Overall Study|Physician Decision|3|||
27743910|NCT02001623|54194161|FG012|Overall Study|Physician Decision|1|||
27743911|NCT02001623|54194162|FG013|Overall Study|Physician Decision|2|||
27743912|NCT02001623|54194163|FG014|Overall Study|Physician Decision|1|||
27743913|NCT02001623|54194149|FG000|Overall Study|Death|0|||
27743914|NCT02001623|54194150|FG001|Overall Study|Death|1|||
27743915|NCT02001623|54194151|FG002|Overall Study|Death|0|||
27743916|NCT02001623|54194152|FG003|Overall Study|Death|0|||
27743917|NCT02001623|54194153|FG004|Overall Study|Death|0|||
27743918|NCT02001623|54194154|FG005|Overall Study|Death|0|||
27743919|NCT02001623|54194155|FG006|Overall Study|Death|0|||
27743920|NCT02001623|54194156|FG007|Overall Study|Death|0|||
27743921|NCT02001623|54194157|FG008|Overall Study|Death|0|||
27743922|NCT02001623|54194158|FG009|Overall Study|Death|0|||
27743923|NCT02001623|54194159|FG010|Overall Study|Death|0|||
27743924|NCT02001623|54194160|FG011|Overall Study|Death|0|||
27743925|NCT02001623|54194161|FG012|Overall Study|Death|0|||
27743926|NCT02001623|54194162|FG013|Overall Study|Death|0|||
27743927|NCT02001623|54194163|FG014|Overall Study|Death|0|||
27743928|NCT02001623|54194149|FG000|Overall Study|Adverse Event|0|||
27743929|NCT02001623|54194150|FG001|Overall Study|Adverse Event|0|||
27743930|NCT02001623|54194151|FG002|Overall Study|Adverse Event|0|||
27743931|NCT02001623|54194152|FG003|Overall Study|Adverse Event|0|||
27743932|NCT02001623|54194153|FG004|Overall Study|Adverse Event|0|||
27743933|NCT02001623|54194154|FG005|Overall Study|Adverse Event|1|||
27743934|NCT02001623|54194155|FG006|Overall Study|Adverse Event|0|||
27743935|NCT02001623|54194156|FG007|Overall Study|Adverse Event|3|||
27743936|NCT02001623|54194157|FG008|Overall Study|Adverse Event|4|||
27743937|NCT02001623|54194158|FG009|Overall Study|Adverse Event|6|||
27743938|NCT02001623|54194159|FG010|Overall Study|Adverse Event|4|||
27743939|NCT02001623|54194160|FG011|Overall Study|Adverse Event|0|||
27743940|NCT02001623|54194161|FG012|Overall Study|Adverse Event|3|||
27743941|NCT02001623|54194162|FG013|Overall Study|Adverse Event|5|||
27743942|NCT02001623|54194163|FG014|Overall Study|Adverse Event|6|||
27743943|NCT02001623|54194149|FG000|Overall Study|Other - Miscellaneous|0|||
27743944|NCT02001623|54194150|FG001|Overall Study|Other - Miscellaneous|0|||
27743945|NCT02001623|54194151|FG002|Overall Study|Other - Miscellaneous|0|||
27743946|NCT02001623|54194152|FG003|Overall Study|Other - Miscellaneous|0|||
27743947|NCT02001623|54194153|FG004|Overall Study|Other - Miscellaneous|0|||
27743948|NCT02001623|54194154|FG005|Overall Study|Other - Miscellaneous|0|||
27743949|NCT02001623|54194155|FG006|Overall Study|Other - Miscellaneous|0|||
27743950|NCT02001623|54194156|FG007|Overall Study|Other - Miscellaneous|0|||
27743951|NCT02001623|54194157|FG008|Overall Study|Other - Miscellaneous|0|||
27743952|NCT02001623|54194158|FG009|Overall Study|Other - Miscellaneous|1|||
27743953|NCT02001623|54194159|FG010|Overall Study|Other - Miscellaneous|0|||
27743954|NCT02001623|54194160|FG011|Overall Study|Other - Miscellaneous|0|||
27743955|NCT02001623|54194161|FG012|Overall Study|Other - Miscellaneous|0|||
27743956|NCT02001623|54194162|FG013|Overall Study|Other - Miscellaneous|1|||
27743957|NCT02001623|54194163|FG014|Overall Study|Other - Miscellaneous|0|||
27743958|NCT02001623|54194149|FG000|Overall Study|Withdrawal by Subject|1|||
27743959|NCT02001623|54194150|FG001|Overall Study|Withdrawal by Subject|0|||
27743960|NCT02001623|54194151|FG002|Overall Study|Withdrawal by Subject|0|||
27743961|NCT02001623|54194152|FG003|Overall Study|Withdrawal by Subject|0|||
27743962|NCT02001623|54194153|FG004|Overall Study|Withdrawal by Subject|0|||
27743963|NCT02001623|54194154|FG005|Overall Study|Withdrawal by Subject|0|||
27743964|NCT02001623|54194155|FG006|Overall Study|Withdrawal by Subject|0|||
27743965|NCT02001623|54194156|FG007|Overall Study|Withdrawal by Subject|0|||
27743966|NCT02001623|54194157|FG008|Overall Study|Withdrawal by Subject|1|||
27743967|NCT02001623|54194158|FG009|Overall Study|Withdrawal by Subject|3|||
27743968|NCT02001623|54194159|FG010|Overall Study|Withdrawal by Subject|2|||
27743969|NCT02001623|54194160|FG011|Overall Study|Withdrawal by Subject|2|||
27743970|NCT02001623|54194161|FG012|Overall Study|Withdrawal by Subject|1|||
27743971|NCT02001623|54194162|FG013|Overall Study|Withdrawal by Subject|5|||
27743972|NCT02001623|54194163|FG014|Overall Study|Withdrawal by Subject|2|||
27743973|NCT02001623|54194149|FG000|Overall Study|Lost to Follow-up|0|||
27743974|NCT02001623|54194150|FG001|Overall Study|Lost to Follow-up|0|||
27743975|NCT02001623|54194151|FG002|Overall Study|Lost to Follow-up|0|||
27743976|NCT02001623|54194152|FG003|Overall Study|Lost to Follow-up|0|||
27743977|NCT02001623|54194153|FG004|Overall Study|Lost to Follow-up|0|||
27743978|NCT02001623|54194154|FG005|Overall Study|Lost to Follow-up|0|||
27743979|NCT02001623|54194155|FG006|Overall Study|Lost to Follow-up|0|||
27743980|NCT02001623|54194156|FG007|Overall Study|Lost to Follow-up|0|||
27743981|NCT02001623|54194157|FG008|Overall Study|Lost to Follow-up|0|||
27743982|NCT02001623|54194158|FG009|Overall Study|Lost to Follow-up|1|||
27743983|NCT02001623|54194159|FG010|Overall Study|Lost to Follow-up|0|||
27743984|NCT02001623|54194160|FG011|Overall Study|Lost to Follow-up|0|||
27743985|NCT02001623|54194161|FG012|Overall Study|Lost to Follow-up|0|||
27743986|NCT02001623|54194162|FG013|Overall Study|Lost to Follow-up|0|||
27743987|NCT02001623|54194163|FG014|Overall Study|Lost to Follow-up|0|||
27743988|NCT02001623|54194149|FG000|Overall Study|Start of New Anti-cancer Treatment|0|||
27743989|NCT02001623|54194150|FG001|Overall Study|Start of New Anti-cancer Treatment|0|||
27743990|NCT02001623|54194151|FG002|Overall Study|Start of New Anti-cancer Treatment|0|||
27743991|NCT02001623|54194152|FG003|Overall Study|Start of New Anti-cancer Treatment|0|||
27743992|NCT02001623|54194153|FG004|Overall Study|Start of New Anti-cancer Treatment|0|||
27743993|NCT02001623|54194154|FG005|Overall Study|Start of New Anti-cancer Treatment|0|||
27743994|NCT02001623|54194155|FG006|Overall Study|Start of New Anti-cancer Treatment|0|||
27743995|NCT02001623|54194156|FG007|Overall Study|Start of New Anti-cancer Treatment|0|||
27743996|NCT02001623|54194157|FG008|Overall Study|Start of New Anti-cancer Treatment|0|||
27743997|NCT02001623|54194158|FG009|Overall Study|Start of New Anti-cancer Treatment|0|||
27743998|NCT02001623|54194159|FG010|Overall Study|Start of New Anti-cancer Treatment|0|||
27743999|NCT02001623|54194160|FG011|Overall Study|Start of New Anti-cancer Treatment|1|||
27744000|NCT02001623|54194161|FG012|Overall Study|Start of New Anti-cancer Treatment|0|||
27744001|NCT02001623|54194162|FG013|Overall Study|Start of New Anti-cancer Treatment|1|||
27744002|NCT02001623|54194163|FG014|Overall Study|Start of New Anti-cancer Treatment|0|||
27744003|NCT02001623|54194149|FG000|Overall Study|Dose Delay Due to Toxicity|0|||
27744004|NCT02001623|54194150|FG001|Overall Study|Dose Delay Due to Toxicity|0|||
27744005|NCT02001623|54194151|FG002|Overall Study|Dose Delay Due to Toxicity|0|||
27744006|NCT02001623|54194152|FG003|Overall Study|Dose Delay Due to Toxicity|0|||
27744007|NCT02001623|54194153|FG004|Overall Study|Dose Delay Due to Toxicity|0|||
27744008|NCT02001623|54194154|FG005|Overall Study|Dose Delay Due to Toxicity|0|||
27744009|NCT02001623|54194155|FG006|Overall Study|Dose Delay Due to Toxicity|0|||
27744010|NCT02001623|54194156|FG007|Overall Study|Dose Delay Due to Toxicity|0|||
27744011|NCT02001623|54194157|FG008|Overall Study|Dose Delay Due to Toxicity|0|||
27744012|NCT02001623|54194158|FG009|Overall Study|Dose Delay Due to Toxicity|0|||
27744013|NCT02001623|54194159|FG010|Overall Study|Dose Delay Due to Toxicity|0|||
27744014|NCT02001623|54194160|FG011|Overall Study|Dose Delay Due to Toxicity|0|||
27744015|NCT02001623|54194161|FG012|Overall Study|Dose Delay Due to Toxicity|0|||
27744016|NCT02001623|54194162|FG013|Overall Study|Dose Delay Due to Toxicity|1|||
27744017|NCT02001623|54194163|FG014|Overall Study|Dose Delay Due to Toxicity|0|||
27744018|NCT02713867|54194214|FG000|Randomization|Other Reason|2|||
27744019|NCT02713867|54194215|FG001|Randomization|Other Reason|1|||
27744020|NCT02713867|54194214|FG000|Randomization|Participant Withdrew consent|0|||
27744021|NCT02713867|54194215|FG001|Randomization|Participant Withdrew consent|2|||
27744022|NCT02713867|54194214|FG000|Treatment Period|Other Reasons|22|||
27744023|NCT02713867|54194215|FG001|Treatment Period|Other Reasons|28|||
27744024|NCT02713867|54194214|FG000|Treatment Period|Administrative reason by sponsor|21|||
27744025|NCT02713867|54194215|FG001|Treatment Period|Administrative reason by sponsor|16|||
27744026|NCT02713867|54194214|FG000|Treatment Period|No longer meets study criteria|2|||
27744027|NCT02713867|54194215|FG001|Treatment Period|No longer meets study criteria|1|||
27744028|NCT02713867|54194214|FG000|Treatment Period|Poor/Non Compliance|1|||
27744029|NCT02713867|54194215|FG001|Treatment Period|Poor/Non Compliance|0|||
27744030|NCT02713867|54194214|FG000|Treatment Period|Maximum Clinical Benefit|5|||
27744031|NCT02713867|54194215|FG001|Treatment Period|Maximum Clinical Benefit|6|||
27744032|NCT02713867|54194214|FG000|Treatment Period|Withdrew consent|3|||
27744033|NCT02713867|54194215|FG001|Treatment Period|Withdrew consent|6|||
27744034|NCT02713867|54194214|FG000|Treatment Period|Requested to Discontinue|8|||
27744035|NCT02713867|54194215|FG001|Treatment Period|Requested to Discontinue|8|||
27744036|NCT02713867|54194214|FG000|Treatment Period|AE unrelated to Study Drug|11|||
27744037|NCT02713867|54194215|FG001|Treatment Period|AE unrelated to Study Drug|10|||
27744038|NCT02713867|54194214|FG000|Treatment Period|Death|7|||
27744039|NCT02713867|54194215|FG001|Treatment Period|Death|3|||
27744040|NCT02713867|54194214|FG000|Treatment Period|Study Drug Toxicity|16|||
27744041|NCT02713867|54194215|FG001|Treatment Period|Study Drug Toxicity|19|||
27744042|NCT02713867|54194214|FG000|Treatment Period|Disease Progression|82|||
27744043|NCT02713867|54194215|FG001|Treatment Period|Disease Progression|83|||
27744044|NCT01854775|54194224|FG000|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
27744045|NCT01854775|54194225|FG001|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
27744046|NCT01854775|54194226|FG002|Treatment Phase (48 Weeks)|Withdrawal by Subject|0|||
27744047|NCT01854775|54194224|FG000|Treatment Phase (48 Weeks)|Lost to Follow-up|1|||
27744048|NCT01854775|54194225|FG001|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
27744049|NCT01854775|54194226|FG002|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
27744050|NCT01854775|54194224|FG000|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
27744051|NCT01854775|54194225|FG001|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
27744052|NCT01854775|54194226|FG002|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|9|||
27744053|NCT01854775|54194224|FG000|Extension Phase|Pregnancy|3|||
27744054|NCT01854775|54194225|FG001|Extension Phase|Pregnancy|0|||
27744055|NCT01854775|54194226|FG002|Extension Phase|Pregnancy|0|||
27744056|NCT01854775|54194224|FG000|Extension Phase|Investigator's Discretion|1|||
27744057|NCT01854775|54194225|FG001|Extension Phase|Investigator's Discretion|0|||
27744058|NCT01854775|54194226|FG002|Extension Phase|Investigator's Discretion|0|||
27744059|NCT01854775|54194224|FG000|Extension Phase|Non-Compliance with Study Drug|1|||
27744060|NCT01854775|54194225|FG001|Extension Phase|Non-Compliance with Study Drug|0|||
27744061|NCT01854775|54194226|FG002|Extension Phase|Non-Compliance with Study Drug|0|||
27744062|NCT01854775|54194224|FG000|Extension Phase|Lost to Follow-up|2|||
27744063|NCT01854775|54194225|FG001|Extension Phase|Lost to Follow-up|0|||
27744064|NCT01854775|54194226|FG002|Extension Phase|Lost to Follow-up|0|||
27744065|NCT01854775|54194224|FG000|Extension Phase|Still on Study|32|||
27744066|NCT01854775|54194225|FG001|Extension Phase|Still on Study|47|||
27744067|NCT01854775|54194226|FG002|Extension Phase|Still on Study|18|||
27744068|NCT02730455|54194237|FG000|Overall Study|Death|5|||
27744069|NCT02730455|54194238|FG001|Overall Study|Death|6|||
27744070|NCT02730455|54194239|FG002|Overall Study|Death|4|||
27744071|NCT02730455|54194237|FG000|Overall Study|Consent withdrawn|2|||
27744072|NCT02730455|54194238|FG001|Overall Study|Consent withdrawn|4|||
27744073|NCT02730455|54194239|FG002|Overall Study|Consent withdrawn|1|||
27744074|NCT02730455|54194237|FG000|Overall Study|Lost to Follow-up|3|||
27744075|NCT02730455|54194238|FG001|Overall Study|Lost to Follow-up|1|||
27744076|NCT02730455|54194239|FG002|Overall Study|Lost to Follow-up|4|||
28014014|NCT00560404|54672810|FG001|Overall Study|Adverse Event|3|||
27744077|NCT02730455|54194237|FG000|Overall Study|Other|1|||
27744078|NCT02730455|54194238|FG001|Overall Study|Other|1|||
27744079|NCT02730455|54194239|FG002|Overall Study|Other|2|||
27744080|NCT02730455|54194237|FG000|Overall Study|Other|2|||
27744081|NCT02730455|54194238|FG001|Overall Study|Other|2|||
27744082|NCT02730455|54194239|FG002|Overall Study|Other|0|||
27744083|NCT04440449|54194249|FG000|Overall Study|Lost to Follow-up|2|||
27744084|NCT04440449|54194250|FG001|Overall Study|Lost to Follow-up|0|||
27744085|NCT00701311|54194257|FG000|Overall Study|Lack of Efficacy|3|||
27744086|NCT00701311|54194257|FG000|Overall Study|Adverse Event|3|||
27744087|NCT00701311|54194257|FG000|Overall Study|Withdrawal by Subject|2|||
27744088|NCT02730377|54194267|FG000|Overall Study|Other|5|||
27744089|NCT02730377|54194268|FG001|Overall Study|Other|4|||
27744090|NCT02730377|54194267|FG000|Overall Study|Death|1|||
27744091|NCT02730377|54194268|FG001|Overall Study|Death|8|||
27744092|NCT02730377|54194267|FG000|Overall Study|Inadequate glycaemic control|368|||
27744093|NCT02730377|54194268|FG001|Overall Study|Inadequate glycaemic control|473|||
27744094|NCT02730377|54194267|FG000|Overall Study|Adverse Event|79|||
27744095|NCT02730377|54194268|FG001|Overall Study|Adverse Event|41|||
27744096|NCT02730377|54194267|FG000|Overall Study|Protocol Violation|23|||
27744097|NCT02730377|54194268|FG001|Overall Study|Protocol Violation|30|||
27744098|NCT02730377|54194267|FG000|Overall Study|Lack of Efficacy|4|||
27744099|NCT02730377|54194268|FG001|Overall Study|Lack of Efficacy|13|||
27744100|NCT02730377|54194267|FG000|Overall Study|Pregnancy|0|||
27744101|NCT02730377|54194268|FG001|Overall Study|Pregnancy|1|||
27744102|NCT02730377|54194267|FG000|Overall Study|Withdrawal by Subject|45|||
27744103|NCT02730377|54194268|FG001|Overall Study|Withdrawal by Subject|42|||
27744104|NCT02730377|54194267|FG000|Overall Study|Lost to Follow-up|25|||
27744105|NCT02730377|54194268|FG001|Overall Study|Lost to Follow-up|21|||
27744106|NCT02714569|54194285|FG000|Part A Second Intervention|Withdrawal by Subject|0|||
27744107|NCT02714569|54194286|FG001|Part A Second Intervention|Withdrawal by Subject|1|||
27744108|NCT02714569|54194287|FG002|Part A Second Intervention|Withdrawal by Subject|0|||
27744109|NCT02714569|54194288|FG003|Part A Second Intervention|Withdrawal by Subject|0|||
27744110|NCT02714569|54194289|FG004|Part A Second Intervention|Withdrawal by Subject|0|||
27744111|NCT02714569|54194290|FG005|Part A Second Intervention|Withdrawal by Subject|0|||
27744112|NCT02714569|54194291|FG006|Part A Second Intervention|Withdrawal by Subject|0|||
27744113|NCT02714569|54194292|FG007|Part A Second Intervention|Withdrawal by Subject|0|||
27744114|NCT02714569|54194293|FG008|Part A Second Intervention|Withdrawal by Subject|0|||
27744115|NCT02714569|54194294|FG009|Part A Second Intervention|Withdrawal by Subject|0|||
27744116|NCT02714569|54194295|FG010|Part A Second Intervention|Withdrawal by Subject|0|||
27744117|NCT02714569|54194285|FG000|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
27744118|NCT02714569|54194286|FG001|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
27744119|NCT02714569|54194287|FG002|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
27744120|NCT02714569|54194288|FG003|Part A Third Intervention|Positive Urine Drug Screen (UDS)|1|||
27744121|NCT02714569|54194289|FG004|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
27744122|NCT02714569|54194290|FG005|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
27744123|NCT02714569|54194291|FG006|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
27744124|NCT02714569|54194292|FG007|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
27744125|NCT02714569|54194293|FG008|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
27744126|NCT02714569|54194294|FG009|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
27744127|NCT02714569|54194295|FG010|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
27744128|NCT02714569|54194285|FG000|Part A Third Intervention|Adverse Event|0|||
27744129|NCT02714569|54194286|FG001|Part A Third Intervention|Adverse Event|0|||
27744130|NCT02714569|54194287|FG002|Part A Third Intervention|Adverse Event|1|||
27744131|NCT02714569|54194288|FG003|Part A Third Intervention|Adverse Event|0|||
27744132|NCT02714569|54194289|FG004|Part A Third Intervention|Adverse Event|0|||
27744133|NCT02714569|54194290|FG005|Part A Third Intervention|Adverse Event|0|||
27744134|NCT02714569|54194291|FG006|Part A Third Intervention|Adverse Event|0|||
27744135|NCT02714569|54194292|FG007|Part A Third Intervention|Adverse Event|0|||
27744136|NCT02714569|54194293|FG008|Part A Third Intervention|Adverse Event|0|||
27744137|NCT02714569|54194294|FG009|Part A Third Intervention|Adverse Event|0|||
27744138|NCT02714569|54194295|FG010|Part A Third Intervention|Adverse Event|0|||
27744139|NCT02714569|54194285|FG000|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
27744140|NCT02714569|54194286|FG001|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
27744141|NCT02714569|54194287|FG002|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
27744142|NCT02714569|54194288|FG003|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
27744143|NCT02714569|54194289|FG004|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
27744144|NCT02714569|54194290|FG005|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
27744145|NCT02714569|54194291|FG006|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
27744146|NCT02714569|54194292|FG007|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
27744147|NCT02714569|54194293|FG008|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
27744148|NCT02714569|54194294|FG009|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
27744149|NCT02714569|54194295|FG010|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
27744150|NCT02714569|54194285|FG000|Part B (Overall)|Lost to Follow-up|0|||
27744151|NCT02714569|54194286|FG001|Part B (Overall)|Lost to Follow-up|0|||
27744152|NCT02714569|54194287|FG002|Part B (Overall)|Lost to Follow-up|0|||
27744153|NCT02714569|54194288|FG003|Part B (Overall)|Lost to Follow-up|0|||
27744154|NCT02714569|54194289|FG004|Part B (Overall)|Lost to Follow-up|0|||
27744155|NCT02714569|54194290|FG005|Part B (Overall)|Lost to Follow-up|0|||
27744156|NCT02714569|54194291|FG006|Part B (Overall)|Lost to Follow-up|1|||
27744157|NCT02714569|54194292|FG007|Part B (Overall)|Lost to Follow-up|0|||
27744158|NCT02714569|54194293|FG008|Part B (Overall)|Lost to Follow-up|0|||
27744159|NCT02714569|54194294|FG009|Part B (Overall)|Lost to Follow-up|0|||
27744160|NCT02714569|54194295|FG010|Part B (Overall)|Lost to Follow-up|0|||
27744161|NCT02714569|54194285|FG000|Part B (Overall)|Withdrawal by Subject|0|||
27744162|NCT02714569|54194286|FG001|Part B (Overall)|Withdrawal by Subject|0|||
27744163|NCT02714569|54194287|FG002|Part B (Overall)|Withdrawal by Subject|0|||
27744164|NCT02714569|54194288|FG003|Part B (Overall)|Withdrawal by Subject|0|||
27744165|NCT02714569|54194289|FG004|Part B (Overall)|Withdrawal by Subject|0|||
27744166|NCT02714569|54194290|FG005|Part B (Overall)|Withdrawal by Subject|0|||
27744167|NCT02714569|54194291|FG006|Part B (Overall)|Withdrawal by Subject|0|||
27744168|NCT02714569|54194292|FG007|Part B (Overall)|Withdrawal by Subject|1|||
27744169|NCT02714569|54194293|FG008|Part B (Overall)|Withdrawal by Subject|0|||
27744170|NCT02714569|54194294|FG009|Part B (Overall)|Withdrawal by Subject|1|||
27744171|NCT02714569|54194295|FG010|Part B (Overall)|Withdrawal by Subject|0|||
27744172|NCT02714569|54194285|FG000|Part B (Overall)|Adverse Event|0|||
27744173|NCT02714569|54194286|FG001|Part B (Overall)|Adverse Event|0|||
27744174|NCT02714569|54194287|FG002|Part B (Overall)|Adverse Event|0|||
27744175|NCT02714569|54194288|FG003|Part B (Overall)|Adverse Event|0|||
27744176|NCT02714569|54194289|FG004|Part B (Overall)|Adverse Event|0|||
27744177|NCT02714569|54194290|FG005|Part B (Overall)|Adverse Event|0|||
27744178|NCT02714569|54194291|FG006|Part B (Overall)|Adverse Event|0|||
27744179|NCT02714569|54194292|FG007|Part B (Overall)|Adverse Event|0|||
27744180|NCT02714569|54194293|FG008|Part B (Overall)|Adverse Event|0|||
27744181|NCT02714569|54194294|FG009|Part B (Overall)|Adverse Event|1|||
27744182|NCT02714569|54194295|FG010|Part B (Overall)|Adverse Event|0|||
27744183|NCT02713789|54194358|FG000|Overall Study|Lost to Follow-up|0|||
27744184|NCT02713789|54194359|FG001|Overall Study|Lost to Follow-up|1|||
27744185|NCT02713789|54194360|FG002|Overall Study|Lost to Follow-up|1|||
27744186|NCT04445051|54194370|FG000|Overall Study|Adverse Event|0|||
27744187|NCT04445051|54194371|FG001|Overall Study|Adverse Event|0|||
27744188|NCT04445051|54194372|FG002|Overall Study|Adverse Event|1|||
27744189|NCT04445051|54194373|FG003|Overall Study|Adverse Event|0|||
27744190|NCT04445051|54194374|FG004|Overall Study|Adverse Event|0|||
27744191|NCT04445051|54194375|FG005|Overall Study|Adverse Event|0|||
27744192|NCT04086121|54194389|FG000|Overall Study|Other than listed|8|||
27744193|NCT04086121|54194389|FG000|Overall Study|Withdrawal by Subject|3|||
27744194|NCT04086121|54194389|FG000|Overall Study|Lost to Follow-up|2|||
27744195|NCT04086121|54194389|FG000|Overall Study|Adverse Event|1|||
27744196|NCT02729909|54194396|FG000|Overall Study|Lost to Follow-up|0|||
27744197|NCT02729909|54194397|FG001|Overall Study|Lost to Follow-up|1|||
27744198|NCT02729909|54194396|FG000|Overall Study|Lack of Efficacy|0|||
27744199|NCT02729909|54194397|FG001|Overall Study|Lack of Efficacy|2|||
27744200|NCT02729909|54194396|FG000|Overall Study|Significant Protocol Deviation|0|||
27744201|NCT02729909|54194397|FG001|Overall Study|Significant Protocol Deviation|2|||
27744202|NCT02729909|54194396|FG000|Overall Study|Voluntary Withdrawal|1|||
27744203|NCT02729909|54194397|FG001|Overall Study|Voluntary Withdrawal|0|||
27744204|NCT02713243|54194405|FG000|Overall Study|Abnormal laboratory value(s)#|1|||
27744205|NCT02713243|54194406|FG001|Overall Study|Abnormal laboratory value(s)#|0|||
27744206|NCT02713243|54194405|FG000|Overall Study|Administrative problems|0|||
27744207|NCT02713243|54194406|FG001|Overall Study|Administrative problems|1|||
27744208|NCT02713243|54194405|FG000|Overall Study|Protocol deviation|0|||
27744209|NCT02713243|54194406|FG001|Overall Study|Protocol deviation|1|||
27744210|NCT03434041|54194414|FG000|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
27744211|NCT03434041|54194415|FG001|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
27744212|NCT03434041|54194414|FG000|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|2|||
27744213|NCT03434041|54194415|FG001|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|1|||
27744214|NCT03434041|54194414|FG000|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|3|||
27744215|NCT03434041|54194415|FG001|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|14|||
27744216|NCT03434041|54194414|FG000|Double Blind Treatment Phase (4 Weeks)|Adverse Event|7|||
27744217|NCT03434041|54194415|FG001|Double Blind Treatment Phase (4 Weeks)|Adverse Event|2|||
27744218|NCT03434041|54194414|FG000|Double Blind Treatment Phase (4 Weeks)|Death|1|||
27744219|NCT03434041|54194415|FG001|Double Blind Treatment Phase (4 Weeks)|Death|0|||
27744220|NCT03434041|54194414|FG000|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
27744221|NCT03434041|54194415|FG001|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
27744222|NCT03434041|54194414|FG000|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|0|||
27744223|NCT03434041|54194415|FG001|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|1|||
27744224|NCT03434041|54194414|FG000|Double Blind Treatment Phase (4 Weeks)|Other|2|||
27744225|NCT03434041|54194415|FG001|Double Blind Treatment Phase (4 Weeks)|Other|0|||
27744226|NCT03434041|54194414|FG000|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|4|||
27744227|NCT03434041|54194415|FG001|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|3|||
27744228|NCT03434041|54194414|FG000|Follow-up Phase (Up to 8 Weeks)|Adverse Event|2|||
27744229|NCT03434041|54194415|FG001|Follow-up Phase (Up to 8 Weeks)|Adverse Event|0|||
27744230|NCT03434041|54194414|FG000|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|1|||
27744231|NCT03434041|54194415|FG001|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|0|||
27744232|NCT00708461|54194430|FG000|Overall Study|Lost to Follow-up|18|||
27744233|NCT00708461|54194431|FG001|Overall Study|Lost to Follow-up|11|||
27744234|NCT00708461|54194430|FG000|Overall Study|Withdrawal by Subject|8|||
27744235|NCT00708461|54194431|FG001|Overall Study|Withdrawal by Subject|9|||
27744236|NCT00708461|54194430|FG000|Overall Study|left workforce|115|||
27744237|NCT00708461|54194431|FG001|Overall Study|left workforce|180|||
27744238|NCT00700999|54194439|FG000|Overall Study|Lost to Follow-up|7|||
27744239|NCT00700999|54194440|FG001|Overall Study|Lost to Follow-up|7|||
27744240|NCT00700999|54194439|FG000|Overall Study|Excluded - did not meet study criteria|0|||
27744241|NCT00700999|54194440|FG001|Overall Study|Excluded - did not meet study criteria|1|||
27744242|NCT00700999|54194439|FG000|Overall Study|Withdrawal by Subject|8|||
27744243|NCT00700999|54194440|FG001|Overall Study|Withdrawal by Subject|1|||
27744244|NCT02729831|54194450|FG000|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38|||
27744245|NCT02729831|54194451|FG001|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23|||
27744246|NCT02729831|54194452|FG002|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18|||
27744247|NCT02729831|54194453|FG003|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17|||
27744248|NCT02729831|54194450|FG000|1 Week Post-visit|Lost to Follow-up|43|||
27744249|NCT02729831|54194451|FG001|1 Week Post-visit|Lost to Follow-up|40|||
27744250|NCT02729831|54194452|FG002|1 Week Post-visit|Lost to Follow-up|38|||
27744251|NCT02729831|54194453|FG003|1 Week Post-visit|Lost to Follow-up|36|||
27744252|NCT02729831|54194450|FG000|6 Month Follow-up|Lost to Follow-up|54|||
27744253|NCT02729831|54194451|FG001|6 Month Follow-up|Lost to Follow-up|51|||
27744254|NCT02729831|54194452|FG002|6 Month Follow-up|Lost to Follow-up|48|||
27744255|NCT02729831|54194453|FG003|6 Month Follow-up|Lost to Follow-up|42|||
27744256|NCT02729831|54194450|FG000|6 Month Follow-up|Death|1|||
27744257|NCT02729831|54194451|FG001|6 Month Follow-up|Death|3|||
27744258|NCT02729831|54194452|FG002|6 Month Follow-up|Death|0|||
27744259|NCT02729831|54194453|FG003|6 Month Follow-up|Death|1|||
27744260|NCT02729753|54194465|FG000|Overall Study|Device Malfunction. No units in stock.|0|||
27744261|NCT02729753|54194466|FG001|Overall Study|Device Malfunction. No units in stock.|1|||
27744262|NCT00709319|54194475|FG000|Overall Study|Death|4|||
27744263|NCT00709319|54194475|FG000|Overall Study|Withdrawal by Subject|2|||
27744264|NCT02729051|54194520|FG000|Overall Study|Adverse Event|21|||
27744265|NCT02729051|54194521|FG001|Overall Study|Adverse Event|11|||
27744266|NCT02729051|54194520|FG000|Overall Study|Lack of Efficacy|1|||
27744267|NCT02729051|54194521|FG001|Overall Study|Lack of Efficacy|1|||
27744268|NCT02729051|54194520|FG000|Overall Study|Lost to Follow-up|1|||
27744269|NCT02729051|54194521|FG001|Overall Study|Lost to Follow-up|2|||
27744270|NCT02729051|54194520|FG000|Overall Study|Physician Decision|1|||
27744271|NCT02729051|54194521|FG001|Overall Study|Physician Decision|1|||
27744272|NCT02729051|54194520|FG000|Overall Study|Withdrawal by Subject|6|||
27744273|NCT02729051|54194521|FG001|Overall Study|Withdrawal by Subject|17|||
27744274|NCT00707993|54194529|FG000|Overall Study|Adverse Event|16|||
27744275|NCT00707993|54194530|FG001|Overall Study|Adverse Event|20|||
27744276|NCT00707993|54194529|FG000|Overall Study|Protocol Violation|4|||
27744277|NCT00707993|54194530|FG001|Overall Study|Protocol Violation|7|||
27744278|NCT00707993|54194529|FG000|Overall Study|Lost to Follow-up|0|||
27744279|NCT00707993|54194530|FG001|Overall Study|Lost to Follow-up|4|||
27744280|NCT00707993|54194529|FG000|Overall Study|Withdrawal by Subject|12|||
27744281|NCT00707993|54194530|FG001|Overall Study|Withdrawal by Subject|16|||
27744282|NCT00707993|54194529|FG000|Overall Study|Hyperglycemic Rescue|55|||
27744283|NCT00707993|54194530|FG001|Overall Study|Hyperglycemic Rescue|47|||
27744284|NCT00707993|54194529|FG000|Overall Study|Other|2|||
27744285|NCT00707993|54194530|FG001|Overall Study|Other|0|||
27744286|NCT00708227|54194540|FG000|Overall Study|Physician Decision|0|||
27744287|NCT00708227|54194541|FG001|Overall Study|Physician Decision|3|||
27744288|NCT00708227|54194542|FG002|Overall Study|Physician Decision|1|||
27744289|NCT00708227|54194543|FG003|Overall Study|Physician Decision|2|||
27744290|NCT00708227|54194540|FG000|Overall Study|Withdrawal by Subject|1|||
27744291|NCT00708227|54194541|FG001|Overall Study|Withdrawal by Subject|2|||
27744292|NCT00708227|54194542|FG002|Overall Study|Withdrawal by Subject|0|||
27744293|NCT00708227|54194543|FG003|Overall Study|Withdrawal by Subject|1|||
27744294|NCT02425891|54194575|FG000|Overall Study|Death|333|||
27744295|NCT02425891|54194576|FG001|Overall Study|Death|314|||
27744296|NCT02425891|54194575|FG000|Overall Study|Lost to Follow-up|4|||
27744297|NCT02425891|54194576|FG001|Overall Study|Lost to Follow-up|6|||
27744298|NCT02425891|54194575|FG000|Overall Study|Non-Compliance|1|||
27744299|NCT02425891|54194576|FG001|Overall Study|Non-Compliance|1|||
27744300|NCT02425891|54194575|FG000|Overall Study|Accidentally randomized screen failure participant|0|||
27744301|NCT02425891|54194576|FG001|Overall Study|Accidentally randomized screen failure participant|1|||
27744302|NCT02425891|54194575|FG000|Overall Study|Physician Decision|0|||
27744303|NCT02425891|54194576|FG001|Overall Study|Physician Decision|1|||
27744304|NCT02425891|54194575|FG000|Overall Study|Protocol Violation|1|||
27744305|NCT02425891|54194576|FG001|Overall Study|Protocol Violation|1|||
27744306|NCT02425891|54194575|FG000|Overall Study|Study Terminated By Sponsor|85|||
27744307|NCT02425891|54194576|FG001|Overall Study|Study Terminated By Sponsor|95|||
27744308|NCT02425891|54194575|FG000|Overall Study|Withdrawal by Subject|27|||
27744309|NCT02425891|54194576|FG001|Overall Study|Withdrawal by Subject|32|||
27744310|NCT03241225|54194586|FG000|Overall Study|Lost to Follow-up|2|||
27744311|NCT03241225|54194587|FG001|Overall Study|Lost to Follow-up|1|||
27744312|NCT03241225|54194586|FG000|Overall Study|Protocol Violation|4|||
27744313|NCT03241225|54194587|FG001|Overall Study|Protocol Violation|1|||
27744314|NCT03241225|54194586|FG000|Overall Study|Withdrawal by Subject|1|||
27744315|NCT03241225|54194587|FG001|Overall Study|Withdrawal by Subject|0|||
27744316|NCT01597245|54194597|FG000|Induction Period (Week 0 - Week 12)|Adverse Event|1|||
27744317|NCT01597245|54194598|FG001|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
27744318|NCT01597245|54194599|FG002|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
27744319|NCT01597245|54194600|FG003|Induction Period (Week 0 - Week 12)|Adverse Event|4|||
27744320|NCT01597245|54194601|FG004|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
27744321|NCT01597245|54194602|FG005|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
27744322|NCT01597245|54194603|FG006|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
27744323|NCT01597245|54194604|FG007|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
27744324|NCT01597245|54194605|FG008|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
27744325|NCT01597245|54194606|FG009|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
27744326|NCT01597245|54194607|FG010|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
27744327|NCT01597245|54194608|FG011|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
27744328|NCT01597245|54194609|FG012|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
27744329|NCT01597245|54194610|FG013|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
27744330|NCT01597245|54194611|FG014|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
27744331|NCT01597245|54194612|FG015|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
27744332|NCT01597245|54194613|FG016|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
27744333|NCT01597245|54194614|FG017|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
27744334|NCT01597245|54194615|FG018|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
27744335|NCT01597245|54194616|FG019|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
27744336|NCT01597245|54194617|FG020|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
27744337|NCT01597245|54194597|FG000|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
27744338|NCT01597245|54194598|FG001|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8|||
27744339|NCT01597245|54194599|FG002|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6|||
27744340|NCT01597245|54194600|FG003|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
27744341|NCT01597245|54194601|FG004|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
27744342|NCT01597245|54194602|FG005|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
27744343|NCT01597245|54194603|FG006|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
27744344|NCT01597245|54194604|FG007|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
27744345|NCT01597245|54194605|FG008|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
27744346|NCT01597245|54194606|FG009|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
27744347|NCT01597245|54194607|FG010|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
27744348|NCT01597245|54194608|FG011|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
27744349|NCT01597245|54194609|FG012|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
27744350|NCT01597245|54194610|FG013|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
27744351|NCT01597245|54194611|FG014|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
27744352|NCT01597245|54194612|FG015|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
27744353|NCT01597245|54194613|FG016|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
27744354|NCT01597245|54194614|FG017|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
27744355|NCT01597245|54194615|FG018|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
27744356|NCT01597245|54194616|FG019|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
27744357|NCT01597245|54194617|FG020|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
27744358|NCT01597245|54194597|FG000|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
27744359|NCT01597245|54194598|FG001|Induction Period (Week 0 - Week 12)|Protocol Violation|4|||
27744360|NCT01597245|54194599|FG002|Induction Period (Week 0 - Week 12)|Protocol Violation|5|||
27744361|NCT01597245|54194600|FG003|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
27744362|NCT01597245|54194601|FG004|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
27744363|NCT01597245|54194602|FG005|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
27744364|NCT01597245|54194603|FG006|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
27744365|NCT01597245|54194604|FG007|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
27744366|NCT01597245|54194605|FG008|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
27744367|NCT01597245|54194606|FG009|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
27744368|NCT01597245|54194607|FG010|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
27744369|NCT01597245|54194608|FG011|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
27744370|NCT01597245|54194609|FG012|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
27744371|NCT01597245|54194610|FG013|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
27744372|NCT01597245|54194611|FG014|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
27744373|NCT01597245|54194612|FG015|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
27744374|NCT01597245|54194613|FG016|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
27744375|NCT01597245|54194614|FG017|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
27744376|NCT01597245|54194615|FG018|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
27744377|NCT01597245|54194616|FG019|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
27744378|NCT01597245|54194617|FG020|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
27744379|NCT01597245|54194597|FG000|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1|||
27744380|NCT01597245|54194598|FG001|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5|||
27744381|NCT01597245|54194599|FG002|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2|||
27744382|NCT01597245|54194600|FG003|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
27744383|NCT01597245|54194601|FG004|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
27744384|NCT01597245|54194602|FG005|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
27744385|NCT01597245|54194603|FG006|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
27744386|NCT01597245|54194604|FG007|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
27744387|NCT01597245|54194605|FG008|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
27744388|NCT01597245|54194606|FG009|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
27744389|NCT01597245|54194607|FG010|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
27744390|NCT01597245|54194608|FG011|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
27744391|NCT01597245|54194609|FG012|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
27744392|NCT01597245|54194610|FG013|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
27744393|NCT01597245|54194611|FG014|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
27744394|NCT01597245|54194612|FG015|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
27744395|NCT01597245|54194613|FG016|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
27744396|NCT01597245|54194614|FG017|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
27744397|NCT01597245|54194615|FG018|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
27744398|NCT01597245|54194616|FG019|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
27744399|NCT01597245|54194617|FG020|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
27744400|NCT01597245|54194597|FG000|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
27744401|NCT01597245|54194598|FG001|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
27744402|NCT01597245|54194599|FG002|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
27744403|NCT01597245|54194600|FG003|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
27744404|NCT01597245|54194601|FG004|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
27744405|NCT01597245|54194602|FG005|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
27744406|NCT01597245|54194603|FG006|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
27744407|NCT01597245|54194604|FG007|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
27744408|NCT01597245|54194605|FG008|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
27744409|NCT01597245|54194606|FG009|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
27744410|NCT01597245|54194607|FG010|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
27744411|NCT01597245|54194608|FG011|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
27744412|NCT01597245|54194609|FG012|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
27744413|NCT01597245|54194610|FG013|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
27744414|NCT01597245|54194611|FG014|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
27744415|NCT01597245|54194612|FG015|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
27746602|NCT01375049|54196235|FG000|Overall Study|Lost to Follow-up|1|||
27744416|NCT01597245|54194613|FG016|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
27744417|NCT01597245|54194614|FG017|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
27744418|NCT01597245|54194615|FG018|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
27744419|NCT01597245|54194616|FG019|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
27744420|NCT01597245|54194617|FG020|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
27744421|NCT01597245|54194597|FG000|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
27744422|NCT01597245|54194598|FG001|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
27744423|NCT01597245|54194599|FG002|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1|||
27744424|NCT01597245|54194600|FG003|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
27744425|NCT01597245|54194601|FG004|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
27744426|NCT01597245|54194602|FG005|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
27744427|NCT01597245|54194603|FG006|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
27744428|NCT01597245|54194604|FG007|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
27744429|NCT01597245|54194605|FG008|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
27744430|NCT01597245|54194606|FG009|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
27744431|NCT01597245|54194607|FG010|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
27744432|NCT01597245|54194608|FG011|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
27744433|NCT01597245|54194609|FG012|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
27744434|NCT01597245|54194610|FG013|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
27744435|NCT01597245|54194611|FG014|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
27744436|NCT01597245|54194612|FG015|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
27744437|NCT01597245|54194613|FG016|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
27744438|NCT01597245|54194614|FG017|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
27744439|NCT01597245|54194615|FG018|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
27744440|NCT01597245|54194616|FG019|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
27744441|NCT01597245|54194617|FG020|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
27744442|NCT01597245|54194597|FG000|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
27744443|NCT01597245|54194598|FG001|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
27744444|NCT01597245|54194599|FG002|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
27744445|NCT01597245|54194600|FG003|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
27744446|NCT01597245|54194601|FG004|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
27744447|NCT01597245|54194602|FG005|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
27744448|NCT01597245|54194603|FG006|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
27744449|NCT01597245|54194604|FG007|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
27744450|NCT01597245|54194605|FG008|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
27744451|NCT01597245|54194606|FG009|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
27744452|NCT01597245|54194607|FG010|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
27744453|NCT01597245|54194608|FG011|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
27744454|NCT01597245|54194609|FG012|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
27744455|NCT01597245|54194610|FG013|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
27744456|NCT01597245|54194611|FG014|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
27744457|NCT01597245|54194612|FG015|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
27744458|NCT01597245|54194613|FG016|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
27744459|NCT01597245|54194614|FG017|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
27744460|NCT01597245|54194615|FG018|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
27744461|NCT01597245|54194616|FG019|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
27744462|NCT01597245|54194617|FG020|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
27744463|NCT01597245|54194597|FG000|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
27744464|NCT01597245|54194598|FG001|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
27744465|NCT01597245|54194599|FG002|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
27744466|NCT01597245|54194600|FG003|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
27744467|NCT01597245|54194601|FG004|Maintenance Period (Week 12 to Week 60)|Relapsed|150|||
27744468|NCT01597245|54194602|FG005|Maintenance Period (Week 12 to Week 60)|Relapsed|22|||
27744469|NCT01597245|54194603|FG006|Maintenance Period (Week 12 to Week 60)|Relapsed|80|||
27744470|NCT01597245|54194604|FG007|Maintenance Period (Week 12 to Week 60)|Relapsed|2|||
27744471|NCT01597245|54194605|FG008|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
27744472|NCT01597245|54194606|FG009|Maintenance Period (Week 12 to Week 60)|Relapsed|114|||
27744473|NCT01597245|54194607|FG010|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
27744474|NCT01597245|54194608|FG011|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
27744475|NCT01597245|54194609|FG012|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
27744476|NCT01597245|54194610|FG013|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
27744477|NCT01597245|54194611|FG014|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
27744478|NCT01597245|54194612|FG015|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
27744479|NCT01597245|54194613|FG016|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
27744480|NCT01597245|54194614|FG017|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
27744481|NCT01597245|54194615|FG018|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
27744482|NCT01597245|54194616|FG019|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
27744483|NCT01597245|54194617|FG020|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
27744484|NCT01597245|54194597|FG000|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
27744485|NCT01597245|54194598|FG001|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
27744486|NCT01597245|54194599|FG002|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
27744487|NCT01597245|54194600|FG003|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
27744488|NCT01597245|54194601|FG004|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
27744489|NCT01597245|54194602|FG005|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1|||
27744490|NCT01597245|54194603|FG006|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
27744491|NCT01597245|54194604|FG007|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
27744492|NCT01597245|54194605|FG008|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3|||
27744493|NCT01597245|54194606|FG009|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
27744494|NCT01597245|54194607|FG010|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2|||
27744495|NCT01597245|54194608|FG011|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10|||
27744496|NCT01597245|54194609|FG012|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4|||
27744497|NCT01597245|54194610|FG013|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
27744498|NCT01597245|54194611|FG014|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
27744499|NCT01597245|54194612|FG015|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
27744500|NCT01597245|54194613|FG016|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
27744501|NCT01597245|54194614|FG017|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
27744502|NCT01597245|54194615|FG018|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
27744503|NCT01597245|54194616|FG019|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
27744504|NCT01597245|54194617|FG020|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
27744505|NCT01597245|54194597|FG000|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
27744506|NCT01597245|54194598|FG001|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
27744507|NCT01597245|54194599|FG002|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
27744508|NCT01597245|54194600|FG003|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
27744509|NCT01597245|54194601|FG004|Maintenance Period (Week 12 to Week 60)|Adverse Event|4|||
27744510|NCT01597245|54194602|FG005|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
27744511|NCT01597245|54194603|FG006|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
27744512|NCT01597245|54194604|FG007|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
27744513|NCT01597245|54194605|FG008|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
27744514|NCT01597245|54194606|FG009|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
27744515|NCT01597245|54194607|FG010|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
27744516|NCT01597245|54194608|FG011|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
27744517|NCT01597245|54194609|FG012|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
27744518|NCT01597245|54194610|FG013|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
27744519|NCT01597245|54194611|FG014|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
27744520|NCT01597245|54194612|FG015|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
27744521|NCT01597245|54194613|FG016|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
27744522|NCT01597245|54194614|FG017|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
27744523|NCT01597245|54194615|FG018|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
27744524|NCT01597245|54194616|FG019|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
27744525|NCT01597245|54194617|FG020|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
27744526|NCT01597245|54194597|FG000|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
27744527|NCT01597245|54194598|FG001|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
27744528|NCT01597245|54194599|FG002|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
27744529|NCT01597245|54194600|FG003|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
27744530|NCT01597245|54194601|FG004|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
27744531|NCT01597245|54194602|FG005|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
27744532|NCT01597245|54194603|FG006|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
27744533|NCT01597245|54194604|FG007|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
27744534|NCT01597245|54194605|FG008|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
27744535|NCT01597245|54194606|FG009|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
27744536|NCT01597245|54194607|FG010|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6|||
27744537|NCT01597245|54194608|FG011|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5|||
27744538|NCT01597245|54194609|FG012|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
27744539|NCT01597245|54194610|FG013|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
27744540|NCT01597245|54194611|FG014|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
27744541|NCT01597245|54194612|FG015|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
27744542|NCT01597245|54194613|FG016|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
27744543|NCT01597245|54194614|FG017|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
27922639|NCT01266993|54579444|FG000|Booster Phase (Month 68-69)|Withdrawal by Subject|0|||
27922640|NCT01266993|54579445|FG001|Booster Phase (Month 68-69)|Withdrawal by Subject|1|||
27744544|NCT01597245|54194615|FG018|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
27744545|NCT01597245|54194616|FG019|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
27744546|NCT01597245|54194617|FG020|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
27744547|NCT01597245|54194597|FG000|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
27744548|NCT01597245|54194598|FG001|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
27744549|NCT01597245|54194599|FG002|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
27744550|NCT01597245|54194600|FG003|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
27744551|NCT01597245|54194601|FG004|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
27744552|NCT01597245|54194602|FG005|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
27744553|NCT01597245|54194603|FG006|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
27744554|NCT01597245|54194604|FG007|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
27744555|NCT01597245|54194605|FG008|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3|||
27744556|NCT01597245|54194606|FG009|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
27744557|NCT01597245|54194607|FG010|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2|||
27744558|NCT01597245|54194608|FG011|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
27744559|NCT01597245|54194609|FG012|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
27744560|NCT01597245|54194610|FG013|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
27744561|NCT01597245|54194611|FG014|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
27744562|NCT01597245|54194612|FG015|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
27744563|NCT01597245|54194613|FG016|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
27744564|NCT01597245|54194614|FG017|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
27744565|NCT01597245|54194615|FG018|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
27744566|NCT01597245|54194616|FG019|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
27744567|NCT01597245|54194617|FG020|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
27744568|NCT01597245|54194597|FG000|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
27744569|NCT01597245|54194598|FG001|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
27744570|NCT01597245|54194599|FG002|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
27744571|NCT01597245|54194600|FG003|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
27744572|NCT01597245|54194601|FG004|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3|||
27744573|NCT01597245|54194602|FG005|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4|||
27744574|NCT01597245|54194603|FG006|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
27744575|NCT01597245|54194604|FG007|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
27744576|NCT01597245|54194605|FG008|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
27744577|NCT01597245|54194606|FG009|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
27744578|NCT01597245|54194607|FG010|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
27744579|NCT01597245|54194608|FG011|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
27744580|NCT01597245|54194609|FG012|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
27744581|NCT01597245|54194610|FG013|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
27744582|NCT01597245|54194611|FG014|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
27744583|NCT01597245|54194612|FG015|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
27744584|NCT01597245|54194613|FG016|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
27744585|NCT01597245|54194614|FG017|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
27744586|NCT01597245|54194615|FG018|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
27744587|NCT01597245|54194616|FG019|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
27744588|NCT01597245|54194617|FG020|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
27744589|NCT01597245|54194597|FG000|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
27744590|NCT01597245|54194598|FG001|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
27744591|NCT01597245|54194599|FG002|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
27744592|NCT01597245|54194600|FG003|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
27744593|NCT01597245|54194601|FG004|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
27744594|NCT01597245|54194602|FG005|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
27744595|NCT01597245|54194603|FG006|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
27744596|NCT01597245|54194604|FG007|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
27744597|NCT01597245|54194605|FG008|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
27744598|NCT01597245|54194606|FG009|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
27744599|NCT01597245|54194607|FG010|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
27744600|NCT01597245|54194608|FG011|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
27744601|NCT01597245|54194609|FG012|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
27744602|NCT01597245|54194610|FG013|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
27744603|NCT01597245|54194611|FG014|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
27744604|NCT01597245|54194612|FG015|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
27922641|NCT01309386|54579453|FG000|Overall Study|Other|2|||
27922642|NCT01309386|54579454|FG001|Overall Study|Other|0|||
28014015|NCT00560404|54672809|FG000|Overall Study|Death|3|||
27744605|NCT01597245|54194613|FG016|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
27744606|NCT01597245|54194614|FG017|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
27744607|NCT01597245|54194615|FG018|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
27744608|NCT01597245|54194616|FG019|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
27744609|NCT01597245|54194617|FG020|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
27744610|NCT01597245|54194597|FG000|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
27744611|NCT01597245|54194598|FG001|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
27744612|NCT01597245|54194599|FG002|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
27744613|NCT01597245|54194600|FG003|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
27744614|NCT01597245|54194601|FG004|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
27744615|NCT01597245|54194602|FG005|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
27744616|NCT01597245|54194603|FG006|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
27744617|NCT01597245|54194604|FG007|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
27744618|NCT01597245|54194605|FG008|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
27744619|NCT01597245|54194606|FG009|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
27744620|NCT01597245|54194607|FG010|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1|||
27744621|NCT01597245|54194608|FG011|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
27744622|NCT01597245|54194609|FG012|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
27744623|NCT01597245|54194610|FG013|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
27744624|NCT01597245|54194611|FG014|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
27744625|NCT01597245|54194612|FG015|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
27744626|NCT01597245|54194613|FG016|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
27744627|NCT01597245|54194614|FG017|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
27744628|NCT01597245|54194615|FG018|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
27744629|NCT01597245|54194616|FG019|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
27744630|NCT01597245|54194617|FG020|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
27744631|NCT01597245|54194597|FG000|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
27744632|NCT01597245|54194598|FG001|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
27744633|NCT01597245|54194599|FG002|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
27744634|NCT01597245|54194600|FG003|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
27744635|NCT01597245|54194601|FG004|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
27744636|NCT01597245|54194602|FG005|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
27744637|NCT01597245|54194603|FG006|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
27744638|NCT01597245|54194604|FG007|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
27744639|NCT01597245|54194605|FG008|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
27744640|NCT01597245|54194606|FG009|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
27744641|NCT01597245|54194607|FG010|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
27744642|NCT01597245|54194608|FG011|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
27744643|NCT01597245|54194609|FG012|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
27744644|NCT01597245|54194610|FG013|Long Term Extension (Week 60 - Week 264)|Adverse Event|1|||
27744645|NCT01597245|54194611|FG014|Long Term Extension (Week 60 - Week 264)|Adverse Event|69|||
27744646|NCT01597245|54194612|FG015|Long Term Extension (Week 60 - Week 264)|Adverse Event|70|||
27744647|NCT01597245|54194613|FG016|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
27744648|NCT01597245|54194614|FG017|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
27744649|NCT01597245|54194615|FG018|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
27744650|NCT01597245|54194616|FG019|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
27744651|NCT01597245|54194617|FG020|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
27744652|NCT01597245|54194597|FG000|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
27744653|NCT01597245|54194598|FG001|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
27744654|NCT01597245|54194599|FG002|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
27744655|NCT01597245|54194600|FG003|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
27744656|NCT01597245|54194601|FG004|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
27744657|NCT01597245|54194602|FG005|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
27744658|NCT01597245|54194603|FG006|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
27744659|NCT01597245|54194604|FG007|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
27744660|NCT01597245|54194605|FG008|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
27744661|NCT01597245|54194606|FG009|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
27744662|NCT01597245|54194607|FG010|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
27744663|NCT01597245|54194608|FG011|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
27744664|NCT01597245|54194609|FG012|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
27744665|NCT01597245|54194610|FG013|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1|||
27744666|NCT01597245|54194611|FG014|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62|||
27744667|NCT01597245|54194612|FG015|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63|||
27744668|NCT01597245|54194613|FG016|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
27744669|NCT01597245|54194614|FG017|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
27744670|NCT01597245|54194615|FG018|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
27744671|NCT01597245|54194616|FG019|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
27744672|NCT01597245|54194617|FG020|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
27744673|NCT01597245|54194597|FG000|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
27744674|NCT01597245|54194598|FG001|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
27744675|NCT01597245|54194599|FG002|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
27744676|NCT01597245|54194600|FG003|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
27744677|NCT01597245|54194601|FG004|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
27744678|NCT01597245|54194602|FG005|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
27744679|NCT01597245|54194603|FG006|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
27744680|NCT01597245|54194604|FG007|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
27744681|NCT01597245|54194605|FG008|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
27744682|NCT01597245|54194606|FG009|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
27744683|NCT01597245|54194607|FG010|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
27744684|NCT01597245|54194608|FG011|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
27744685|NCT01597245|54194609|FG012|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
27744686|NCT01597245|54194610|FG013|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
27744687|NCT01597245|54194611|FG014|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
27744688|NCT01597245|54194612|FG015|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
27744689|NCT01597245|54194613|FG016|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
27744690|NCT01597245|54194614|FG017|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
27744691|NCT01597245|54194615|FG018|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
27744692|NCT01597245|54194616|FG019|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
27744693|NCT01597245|54194617|FG020|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
27744694|NCT01597245|54194597|FG000|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
27744695|NCT01597245|54194598|FG001|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
27744696|NCT01597245|54194599|FG002|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
27744697|NCT01597245|54194600|FG003|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
27744698|NCT01597245|54194601|FG004|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
27744699|NCT01597245|54194602|FG005|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
27744700|NCT01597245|54194603|FG006|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
27744701|NCT01597245|54194604|FG007|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
27744702|NCT01597245|54194605|FG008|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
27744703|NCT01597245|54194606|FG009|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
27744704|NCT01597245|54194607|FG010|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
27744705|NCT01597245|54194608|FG011|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
27744706|NCT01597245|54194609|FG012|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
27744707|NCT01597245|54194610|FG013|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
27744708|NCT01597245|54194611|FG014|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
27744709|NCT01597245|54194612|FG015|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
27744710|NCT01597245|54194613|FG016|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
27744711|NCT01597245|54194614|FG017|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
27744712|NCT01597245|54194615|FG018|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
27744713|NCT01597245|54194616|FG019|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
27744714|NCT01597245|54194617|FG020|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
27744715|NCT01597245|54194597|FG000|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
27744716|NCT01597245|54194598|FG001|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
27744717|NCT01597245|54194599|FG002|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
27744718|NCT01597245|54194600|FG003|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
27744719|NCT01597245|54194601|FG004|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
27744720|NCT01597245|54194602|FG005|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
27744721|NCT01597245|54194603|FG006|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
27744722|NCT01597245|54194604|FG007|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
27744723|NCT01597245|54194605|FG008|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
27744724|NCT01597245|54194606|FG009|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
27744725|NCT01597245|54194607|FG010|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
27744726|NCT01597245|54194608|FG011|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
27744727|NCT01597245|54194609|FG012|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
27744728|NCT01597245|54194610|FG013|Long Term Extension (Week 60 - Week 264)|Physician Decision|1|||
27744729|NCT01597245|54194611|FG014|Long Term Extension (Week 60 - Week 264)|Physician Decision|11|||
27744730|NCT01597245|54194612|FG015|Long Term Extension (Week 60 - Week 264)|Physician Decision|12|||
27744731|NCT01597245|54194613|FG016|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
27744732|NCT01597245|54194614|FG017|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
27744733|NCT01597245|54194615|FG018|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
27744734|NCT01597245|54194616|FG019|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
27744735|NCT01597245|54194617|FG020|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
27744736|NCT01597245|54194597|FG000|Long Term Extension (Week 60 - Week 264)|Death|0|||
27744737|NCT01597245|54194598|FG001|Long Term Extension (Week 60 - Week 264)|Death|0|||
27744738|NCT01597245|54194599|FG002|Long Term Extension (Week 60 - Week 264)|Death|0|||
27744739|NCT01597245|54194600|FG003|Long Term Extension (Week 60 - Week 264)|Death|0|||
27744740|NCT01597245|54194601|FG004|Long Term Extension (Week 60 - Week 264)|Death|0|||
27744741|NCT01597245|54194602|FG005|Long Term Extension (Week 60 - Week 264)|Death|0|||
27744742|NCT01597245|54194603|FG006|Long Term Extension (Week 60 - Week 264)|Death|0|||
27744743|NCT01597245|54194604|FG007|Long Term Extension (Week 60 - Week 264)|Death|0|||
27744744|NCT01597245|54194605|FG008|Long Term Extension (Week 60 - Week 264)|Death|0|||
27744745|NCT01597245|54194606|FG009|Long Term Extension (Week 60 - Week 264)|Death|0|||
27744746|NCT01597245|54194607|FG010|Long Term Extension (Week 60 - Week 264)|Death|0|||
27744747|NCT01597245|54194608|FG011|Long Term Extension (Week 60 - Week 264)|Death|0|||
27744748|NCT01597245|54194609|FG012|Long Term Extension (Week 60 - Week 264)|Death|0|||
27744749|NCT01597245|54194610|FG013|Long Term Extension (Week 60 - Week 264)|Death|0|||
27744750|NCT01597245|54194611|FG014|Long Term Extension (Week 60 - Week 264)|Death|8|||
27744751|NCT01597245|54194612|FG015|Long Term Extension (Week 60 - Week 264)|Death|8|||
27744752|NCT01597245|54194613|FG016|Long Term Extension (Week 60 - Week 264)|Death|0|||
27744753|NCT01597245|54194614|FG017|Long Term Extension (Week 60 - Week 264)|Death|0|||
27744754|NCT01597245|54194615|FG018|Long Term Extension (Week 60 - Week 264)|Death|0|||
27744755|NCT01597245|54194616|FG019|Long Term Extension (Week 60 - Week 264)|Death|0|||
27744756|NCT01597245|54194617|FG020|Long Term Extension (Week 60 - Week 264)|Death|0|||
27744757|NCT01597245|54194597|FG000|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
27922643|NCT01309386|54579453|FG000|Overall Study|Withdrawal by Subject|2|||
27922644|NCT01309386|54579454|FG001|Overall Study|Withdrawal by Subject|0|||
27922645|NCT01309386|54579453|FG000|Overall Study|Progressive disease|9|||
27922646|NCT01309386|54579454|FG001|Overall Study|Progressive disease|11|||
27922647|NCT01309386|54579453|FG000|Overall Study|Physician Decision|1|||
27922648|NCT01309386|54579454|FG001|Overall Study|Physician Decision|1|||
27922649|NCT01309386|54579453|FG000|Overall Study|Lack of Efficacy|3|||
27922650|NCT01309386|54579454|FG001|Overall Study|Lack of Efficacy|1|||
27922651|NCT01309386|54579453|FG000|Overall Study|Adverse Event|5|||
27922652|NCT01309386|54579454|FG001|Overall Study|Adverse Event|8|||
27922653|NCT01266603|54579460|FG000|Overall Study|Adverse Event|1|||
27922654|NCT01266603|54579460|FG000|Overall Study|Lack of Efficacy|14|||
27922655|NCT01266603|54579460|FG000|Overall Study|Withdrawal by Subject|1|||
27922656|NCT01266603|54579460|FG000|Overall Study|Failed screening; MAGE-A3 negative|26|||
27922657|NCT01309308|54579466|FG000|Overall Study|Lost to Follow-up|6|||
27922658|NCT01309308|54579467|FG001|Overall Study|Lost to Follow-up|4|||
27922659|NCT01266291|54579473|FG000|Overall Study|Adverse Event|1|||
27922660|NCT01004263|54579477|FG000|Overall Study|Adverse Event|15|||
27922661|NCT01004263|54579477|FG000|Overall Study|Withdrawal by Subject|58|||
27922662|NCT01004263|54579477|FG000|Overall Study|Protocol Violation|10|||
27922663|NCT01004263|54579477|FG000|Overall Study|Lost to Follow-up|64|||
27922664|NCT01004263|54579477|FG000|Overall Study|Lack of Efficacy|13|||
27922665|NCT01004263|54579477|FG000|Overall Study|Pregnancy|2|||
27922666|NCT01004263|54579477|FG000|Overall Study|Physician Decision|15|||
27922667|NCT01004263|54579477|FG000|Overall Study|Lack of Qualifying Event|2|||
27922668|NCT01308762|54579484|FG000|Overall Study|Protocol Violation|0|||
27922669|NCT01308762|54579485|FG001|Overall Study|Protocol Violation|1|||
27922670|NCT01308762|54579486|FG002|Overall Study|Protocol Violation|0|||
27922671|NCT01265823|54579497|FG000|Overall Study|Unsatisfactory Response Efficacy|1|||
27922672|NCT01265823|54579497|FG000|Overall Study|Failure to Return|4|||
27922673|NCT01265823|54579497|FG000|Overall Study|Protocol Violation|1|||
27922674|NCT01265823|54579497|FG000|Overall Study|Participant Request|1|||
27922675|NCT01004185|54579507|FG000|Overall Study|Adverse Event|1|||
27922676|NCT01004185|54579508|FG001|Overall Study|Adverse Event|1|||
27922677|NCT01004185|54579507|FG000|Overall Study|Lost to Follow-up|0|||
27922678|NCT01004185|54579508|FG001|Overall Study|Lost to Follow-up|1|||
27922679|NCT01004185|54579507|FG000|Overall Study|Lack of Efficacy|2|||
27922680|NCT01004185|54579508|FG001|Overall Study|Lack of Efficacy|1|||
27922681|NCT01004185|54579507|FG000|Overall Study|Sponsor Terminated Study|4|||
27922682|NCT01004185|54579508|FG001|Overall Study|Sponsor Terminated Study|5|||
27922683|NCT01004185|54579507|FG000|Overall Study|Withdrawal by Subject|2|||
27922684|NCT01004185|54579508|FG001|Overall Study|Withdrawal by Subject|1|||
27922685|NCT01265511|54579516|FG000|Overall Study|Lack of Efficacy|2|||
27922686|NCT01265511|54579517|FG001|Overall Study|Lack of Efficacy|1|||
27922687|NCT01265511|54579516|FG000|Overall Study|Met stopping rules|0|||
27922688|NCT01265511|54579517|FG001|Overall Study|Met stopping rules|2|||
27922689|NCT01264965|54579523|FG000|Overall Study|Withdrawal by Subject|10|||
27922690|NCT01264887|54579527|FG000|Overall Study|Adverse Event|5|||
27922691|NCT01264887|54579527|FG000|Overall Study|Death|7|||
27744758|NCT01597245|54194598|FG001|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
27744759|NCT01597245|54194599|FG002|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
27744760|NCT01597245|54194600|FG003|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
27744761|NCT01597245|54194601|FG004|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
27744762|NCT01597245|54194602|FG005|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
27744763|NCT01597245|54194603|FG006|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
27744764|NCT01597245|54194604|FG007|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
27744765|NCT01597245|54194605|FG008|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
27744766|NCT01597245|54194606|FG009|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
27744767|NCT01597245|54194607|FG010|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
27744768|NCT01597245|54194608|FG011|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
27744769|NCT01597245|54194609|FG012|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
27744770|NCT01597245|54194610|FG013|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
27744771|NCT01597245|54194611|FG014|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
27744772|NCT01597245|54194612|FG015|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
27744773|NCT01597245|54194613|FG016|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
27744774|NCT01597245|54194614|FG017|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
27744775|NCT01597245|54194615|FG018|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
27744776|NCT01597245|54194616|FG019|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
27744777|NCT01597245|54194617|FG020|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
27744778|NCT01597245|54194597|FG000|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
27744779|NCT01597245|54194598|FG001|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
27744780|NCT01597245|54194599|FG002|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
27744781|NCT01597245|54194600|FG003|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
27744782|NCT01597245|54194601|FG004|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
27744783|NCT01597245|54194602|FG005|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
27744784|NCT01597245|54194603|FG006|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
27744785|NCT01597245|54194604|FG007|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
27744786|NCT01597245|54194605|FG008|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
27744787|NCT01597245|54194606|FG009|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
27744788|NCT01597245|54194607|FG010|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
27744789|NCT01597245|54194608|FG011|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
27744790|NCT01597245|54194609|FG012|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
27744791|NCT01597245|54194610|FG013|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
27744792|NCT01597245|54194611|FG014|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
27744793|NCT01597245|54194612|FG015|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
27744794|NCT01597245|54194613|FG016|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
27744795|NCT01597245|54194614|FG017|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
27744796|NCT01597245|54194615|FG018|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
27744797|NCT01597245|54194616|FG019|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
27744798|NCT01597245|54194617|FG020|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
27744799|NCT01597245|54194597|FG000|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
27744800|NCT01597245|54194598|FG001|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
27744801|NCT01597245|54194599|FG002|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
27744802|NCT01597245|54194600|FG003|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
27744803|NCT01597245|54194601|FG004|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
27744804|NCT01597245|54194602|FG005|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
27744805|NCT01597245|54194603|FG006|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
27744806|NCT01597245|54194604|FG007|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
27744807|NCT01597245|54194605|FG008|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
27744808|NCT01597245|54194606|FG009|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
27744809|NCT01597245|54194607|FG010|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
27744810|NCT01597245|54194608|FG011|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
27744811|NCT01597245|54194609|FG012|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
27744812|NCT01597245|54194610|FG013|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
27744813|NCT01597245|54194611|FG014|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
27744814|NCT01597245|54194612|FG015|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
27744815|NCT01597245|54194613|FG016|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
27744816|NCT01597245|54194614|FG017|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
27744817|NCT01597245|54194615|FG018|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
27744818|NCT01597245|54194616|FG019|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
27744819|NCT01597245|54194617|FG020|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
27744820|NCT01597245|54194597|FG000|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
27744821|NCT01597245|54194598|FG001|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
27744822|NCT01597245|54194599|FG002|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
27744823|NCT01597245|54194600|FG003|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
27744824|NCT01597245|54194601|FG004|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
27744825|NCT01597245|54194602|FG005|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
27744826|NCT01597245|54194603|FG006|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
27744827|NCT01597245|54194604|FG007|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
27744828|NCT01597245|54194605|FG008|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
27744829|NCT01597245|54194606|FG009|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
27744830|NCT01597245|54194607|FG010|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
27744831|NCT01597245|54194608|FG011|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
27744832|NCT01597245|54194609|FG012|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
27744833|NCT01597245|54194610|FG013|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23|||
27744834|NCT01597245|54194611|FG014|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
27744835|NCT01597245|54194612|FG015|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
27744836|NCT01597245|54194613|FG016|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
27744837|NCT01597245|54194614|FG017|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
27744838|NCT01597245|54194615|FG018|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
27744839|NCT01597245|54194616|FG019|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
27744840|NCT01597245|54194617|FG020|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
27744841|NCT01597245|54194597|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
27744842|NCT01597245|54194598|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
27744843|NCT01597245|54194599|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
27744844|NCT01597245|54194600|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
27744845|NCT01597245|54194601|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
27744846|NCT01597245|54194602|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
27744847|NCT01597245|54194603|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
27744848|NCT01597245|54194604|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
27744849|NCT01597245|54194605|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
27744850|NCT01597245|54194606|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
27744851|NCT01597245|54194607|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
27744852|NCT01597245|54194608|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
27744853|NCT01597245|54194609|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
27744854|NCT01597245|54194610|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
27744855|NCT01597245|54194611|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
27744856|NCT01597245|54194612|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
27744857|NCT01597245|54194613|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9|||
27744858|NCT01597245|54194614|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5|||
27744859|NCT01597245|54194615|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8|||
27744860|NCT01597245|54194616|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63|||
27744861|NCT01597245|54194617|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13|||
27744862|NCT01597245|54194597|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
27744863|NCT01597245|54194598|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
27744864|NCT01597245|54194599|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
27744865|NCT01597245|54194600|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
27744866|NCT01597245|54194601|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
27744867|NCT01597245|54194602|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
27744868|NCT01597245|54194603|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
27744869|NCT01597245|54194604|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
27744870|NCT01597245|54194605|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
27744871|NCT01597245|54194606|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
27744872|NCT01597245|54194607|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
27744873|NCT01597245|54194608|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
27744874|NCT01597245|54194609|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
27744875|NCT01597245|54194610|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
27744876|NCT01597245|54194611|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
27744877|NCT01597245|54194612|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
27744878|NCT01597245|54194613|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
27744879|NCT01597245|54194614|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
27744880|NCT01597245|54194615|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
27744881|NCT01597245|54194616|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41|||
27744882|NCT01597245|54194617|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13|||
27744883|NCT01597245|54194597|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
27744884|NCT01597245|54194598|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
27744885|NCT01597245|54194599|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
27744886|NCT01597245|54194600|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
27744887|NCT01597245|54194601|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
27744888|NCT01597245|54194602|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
27744889|NCT01597245|54194603|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
27744890|NCT01597245|54194604|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
27744891|NCT01597245|54194605|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
27744892|NCT01597245|54194606|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
27744893|NCT01597245|54194607|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
27744894|NCT01597245|54194608|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
27744895|NCT01597245|54194609|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
27744896|NCT01597245|54194610|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
27744897|NCT01597245|54194611|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
27744898|NCT01597245|54194612|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
27744899|NCT01597245|54194613|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2|||
27744900|NCT01597245|54194614|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
27744901|NCT01597245|54194615|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
27744902|NCT01597245|54194616|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29|||
27744903|NCT01597245|54194617|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3|||
27744904|NCT01597245|54194597|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
27744905|NCT01597245|54194598|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
27744906|NCT01597245|54194599|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
27744907|NCT01597245|54194600|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
27744908|NCT01597245|54194601|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
27744909|NCT01597245|54194602|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
27744910|NCT01597245|54194603|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
27744911|NCT01597245|54194604|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
27744912|NCT01597245|54194605|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
27744913|NCT01597245|54194606|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
27744914|NCT01597245|54194607|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
27744915|NCT01597245|54194608|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
27744916|NCT01597245|54194609|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
27744917|NCT01597245|54194610|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
27744918|NCT01597245|54194611|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
27744919|NCT01597245|54194612|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
27744920|NCT01597245|54194613|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
27744921|NCT01597245|54194614|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
27744922|NCT01597245|54194615|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1|||
27744923|NCT01597245|54194616|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14|||
27744924|NCT01597245|54194617|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4|||
27744925|NCT01597245|54194597|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
27744926|NCT01597245|54194598|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
27744927|NCT01597245|54194599|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
27744928|NCT01597245|54194600|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
27744929|NCT01597245|54194601|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
27744930|NCT01597245|54194602|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
27744931|NCT01597245|54194603|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
27744932|NCT01597245|54194604|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
27744933|NCT01597245|54194605|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
27744934|NCT01597245|54194606|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
27744935|NCT01597245|54194607|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
27744936|NCT01597245|54194608|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
27744937|NCT01597245|54194609|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
27744938|NCT01597245|54194610|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
27744939|NCT01597245|54194611|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
27744940|NCT01597245|54194612|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
27744941|NCT01597245|54194613|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
27744942|NCT01597245|54194614|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
27744943|NCT01597245|54194615|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
27744944|NCT01597245|54194616|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9|||
27744945|NCT01597245|54194617|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
27744946|NCT01597245|54194597|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
27744947|NCT01597245|54194598|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
27744948|NCT01597245|54194599|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
27744949|NCT01597245|54194600|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
27744950|NCT01597245|54194601|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
27744951|NCT01597245|54194602|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
27744952|NCT01597245|54194603|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
27744953|NCT01597245|54194604|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
27744954|NCT01597245|54194605|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
27744955|NCT01597245|54194606|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
27744956|NCT01597245|54194607|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
27744957|NCT01597245|54194608|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
27744958|NCT01597245|54194609|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
27744959|NCT01597245|54194610|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
27744960|NCT01597245|54194611|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
27744961|NCT01597245|54194612|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
27744962|NCT01597245|54194613|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1|||
27744963|NCT01597245|54194614|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
27744964|NCT01597245|54194615|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
27744965|NCT01597245|54194616|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6|||
27744966|NCT01597245|54194617|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2|||
27744967|NCT01597245|54194597|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
27744968|NCT01597245|54194598|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
27744969|NCT01597245|54194599|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
27744970|NCT01597245|54194600|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
27744971|NCT01597245|54194601|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
27744972|NCT01597245|54194602|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
27744973|NCT01597245|54194603|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
27744974|NCT01597245|54194604|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
27744975|NCT01597245|54194605|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
27744976|NCT01597245|54194606|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
27744977|NCT01597245|54194607|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
27744978|NCT01597245|54194608|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
27744979|NCT01597245|54194609|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
27744980|NCT01597245|54194610|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
27744981|NCT01597245|54194611|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
27744982|NCT01597245|54194612|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
27744983|NCT01597245|54194613|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2|||
27744984|NCT01597245|54194614|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
27744985|NCT01597245|54194615|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
27744986|NCT01597245|54194616|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3|||
27744987|NCT01597245|54194617|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
27744988|NCT01597245|54194597|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
27744989|NCT01597245|54194598|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
27744990|NCT01597245|54194599|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
27744991|NCT01597245|54194600|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
27744992|NCT01597245|54194601|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
27922692|NCT01264887|54579527|FG000|Overall Study|Lack of Efficacy|5|||
28014016|NCT00560404|54672810|FG001|Overall Study|Death|3|||
28014017|NCT00560404|54672809|FG000|Overall Study|Protocol Violation|12|||
28014018|NCT00560404|54672810|FG001|Overall Study|Protocol Violation|7|||
28014019|NCT00560404|54672809|FG000|Overall Study|Administrative Reasons|1|||
28014020|NCT00560404|54672810|FG001|Overall Study|Administrative Reasons|1|||
28014021|NCT00560404|54672809|FG000|Overall Study|Withdrew Consent|4|||
28014022|NCT00560404|54672810|FG001|Overall Study|Withdrew Consent|0|||
28014023|NCT00560404|54672809|FG000|Overall Study|Failure to return|1|||
28014024|NCT00560404|54672810|FG001|Overall Study|Failure to return|2|||
28014025|NCT00560404|54672809|FG000|Overall Study|Other withdrawal reason|13|||
28014026|NCT00560404|54672810|FG001|Overall Study|Other withdrawal reason|5|||
28014027|NCT03967444|54672818|FG000|Overall Study|Lost to Follow-up|1|||
28014028|NCT03967444|54672819|FG001|Overall Study|Lost to Follow-up|2|||
28014029|NCT00619983|54672829|FG000|Test Drug Alone|Withdrawal by Subject|1|||
28014030|NCT00619983|54672830|FG001|Test Drug Alone|Withdrawal by Subject|0|||
28014031|NCT00619983|54672831|FG002|Test Drug Alone|Withdrawal by Subject|0|||
28014032|NCT00619983|54672832|FG003|Test Drug Alone|Withdrawal by Subject|1|||
28014033|NCT00619983|54672829|FG000|Test Drug Alone|Failure of daily diary device|1|||
28014034|NCT00619983|54672830|FG001|Test Drug Alone|Failure of daily diary device|1|||
28014035|NCT00619983|54672831|FG002|Test Drug Alone|Failure of daily diary device|2|||
27744993|NCT01597245|54194602|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
27744994|NCT01597245|54194603|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
27744995|NCT01597245|54194604|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
27744996|NCT01597245|54194605|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
27744997|NCT01597245|54194606|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
27744998|NCT01597245|54194607|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
27744999|NCT01597245|54194608|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
27745000|NCT01597245|54194609|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
27745001|NCT01597245|54194610|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
27745002|NCT01597245|54194611|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
27745003|NCT01597245|54194612|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
27745004|NCT01597245|54194613|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
27745005|NCT01597245|54194614|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
27745006|NCT01597245|54194615|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
27745007|NCT01597245|54194616|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
27745008|NCT01597245|54194617|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
27745009|NCT01597245|54194597|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
27745010|NCT01597245|54194598|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
27745011|NCT01597245|54194599|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
27745012|NCT01597245|54194600|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
27745013|NCT01597245|54194601|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
27745014|NCT01597245|54194602|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
27745015|NCT01597245|54194603|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
27745016|NCT01597245|54194604|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
27745017|NCT01597245|54194605|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
27745018|NCT01597245|54194606|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
27745019|NCT01597245|54194607|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
27745020|NCT01597245|54194608|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
27745021|NCT01597245|54194609|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
27745022|NCT01597245|54194610|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
27745023|NCT01597245|54194611|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
27745024|NCT01597245|54194612|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
27745025|NCT01597245|54194613|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
27745026|NCT01597245|54194614|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
27745027|NCT01597245|54194615|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
27745028|NCT01597245|54194616|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1|||
27745029|NCT01597245|54194617|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
27745030|NCT00707057|54194652|FG000|Overall Study|Withdrawal by Subject|8|||
27745031|NCT00707057|54194653|FG001|Overall Study|Withdrawal by Subject|3|||
27745032|NCT00707057|54194652|FG000|Overall Study|Dosed incorrectly|0|||
27745033|NCT00707057|54194653|FG001|Overall Study|Dosed incorrectly|1|||
27745034|NCT02639247|54194661|FG000|Overall Study|Lost to Follow-up|2|||
27745035|NCT02639247|54194662|FG001|Overall Study|Lost to Follow-up|1|||
27745036|NCT02639247|54194661|FG000|Overall Study|Death|2|||
27745037|NCT02639247|54194662|FG001|Overall Study|Death|0|||
27745038|NCT02639247|54194661|FG000|Overall Study|Withdrew Consent|0|||
27745039|NCT02639247|54194662|FG001|Overall Study|Withdrew Consent|1|||
27745040|NCT02639247|54194661|FG000|Overall Study|Protocol Violation|1|||
27745041|NCT02639247|54194662|FG001|Overall Study|Protocol Violation|0|||
27745042|NCT00706901|54194671|FG000|Overall Study|Lost to Follow-up|2|||
27745043|NCT00706901|54194672|FG001|Overall Study|Lost to Follow-up|3|||
27745044|NCT00706901|54194673|FG002|Overall Study|Lost to Follow-up|2|||
27745045|NCT00706901|54194671|FG000|Overall Study|Withdrawal by Subject|4|||
27745046|NCT00706901|54194672|FG001|Overall Study|Withdrawal by Subject|2|||
27745047|NCT00706901|54194673|FG002|Overall Study|Withdrawal by Subject|5|||
27745048|NCT00706901|54194671|FG000|Overall Study|In Jail|1|||
27745049|NCT00706901|54194672|FG001|Overall Study|In Jail|0|||
27745050|NCT00706901|54194673|FG002|Overall Study|In Jail|1|||
27745051|NCT00706901|54194671|FG000|Overall Study|Death|1|||
27745052|NCT00706901|54194672|FG001|Overall Study|Death|0|||
27745053|NCT00706901|54194673|FG002|Overall Study|Death|0|||
27745054|NCT01673373|54194682|FG000|Overall Study|Death|2|||
27745055|NCT01236547|54194691|FG000|Overall Study|Protocol Violation|0|||
27745056|NCT01236547|54194692|FG001|Overall Study|Protocol Violation|1|||
27745057|NCT01236547|54194693|FG002|Overall Study|Protocol Violation|1|||
27745058|NCT01236547|54194694|FG003|Overall Study|Protocol Violation|6|||
27745059|NCT01236547|54194695|FG004|Overall Study|Protocol Violation|12|||
27745060|NCT02167945|54194708|FG000|Overall Study|Adverse Event|16|||
27745061|NCT02167945|54194708|FG000|Overall Study|Withdrew Consent|42|||
27745062|NCT02167945|54194708|FG000|Overall Study|Lost to Follow-up|122|||
27745063|NCT02167945|54194708|FG000|Overall Study|COVID-19 logistical restrictions|6|||
27745064|NCT02167945|54194708|FG000|Overall Study|Other, not specified|63|||
27745065|NCT01375075|54194726|FG000|Overall Study|Adverse Event|0|||
27745066|NCT01375075|54194727|FG001|Overall Study|Adverse Event|0|||
27745067|NCT01375075|54194728|FG002|Overall Study|Adverse Event|3|||
27745068|NCT01375075|54194729|FG003|Overall Study|Adverse Event|1|||
27745069|NCT01375075|54194730|FG004|Overall Study|Adverse Event|0|||
27745070|NCT01375075|54194731|FG005|Overall Study|Adverse Event|1|||
27745071|NCT01375075|54194726|FG000|Overall Study|Entry Criterion Not Met|1|||
27745072|NCT01375075|54194727|FG001|Overall Study|Entry Criterion Not Met|0|||
27745073|NCT01375075|54194728|FG002|Overall Study|Entry Criterion Not Met|0|||
27745074|NCT01375075|54194729|FG003|Overall Study|Entry Criterion Not Met|0|||
27745075|NCT01375075|54194730|FG004|Overall Study|Entry Criterion Not Met|0|||
27745076|NCT01375075|54194731|FG005|Overall Study|Entry Criterion Not Met|1|||
27745077|NCT01375075|54194726|FG000|Overall Study|Withdrawal by Subject|0|||
27745078|NCT01375075|54194727|FG001|Overall Study|Withdrawal by Subject|1|||
27745079|NCT01375075|54194728|FG002|Overall Study|Withdrawal by Subject|0|||
27745080|NCT01375075|54194729|FG003|Overall Study|Withdrawal by Subject|0|||
27745081|NCT01375075|54194730|FG004|Overall Study|Withdrawal by Subject|0|||
27745082|NCT01375075|54194731|FG005|Overall Study|Withdrawal by Subject|1|||
27745083|NCT00706433|54194753|FG000|Overall Study|Lost to Follow-up|3|||
27745084|NCT00706433|54194754|FG001|Overall Study|Lost to Follow-up|1|||
27745085|NCT00706433|54194755|FG002|Overall Study|Lost to Follow-up|6|||
27745086|NCT00706433|54194756|FG003|Overall Study|Lost to Follow-up|0|||
27745087|NCT00706433|54194753|FG000|Overall Study|Withdrawal by Subject|1|||
27745088|NCT00706433|54194754|FG001|Overall Study|Withdrawal by Subject|2|||
27745089|NCT00706433|54194755|FG002|Overall Study|Withdrawal by Subject|3|||
27745090|NCT00706433|54194756|FG003|Overall Study|Withdrawal by Subject|1|||
27745091|NCT00706433|54194753|FG000|Overall Study|Adverse Event|0|||
27745092|NCT00706433|54194754|FG001|Overall Study|Adverse Event|0|||
27745093|NCT00706433|54194755|FG002|Overall Study|Adverse Event|1|||
27745094|NCT00706433|54194756|FG003|Overall Study|Adverse Event|0|||
27745095|NCT00706433|54194753|FG000|Overall Study|Protocol Violation|1|||
27745096|NCT00706433|54194754|FG001|Overall Study|Protocol Violation|0|||
27745097|NCT00706433|54194755|FG002|Overall Study|Protocol Violation|0|||
27745098|NCT00706433|54194756|FG003|Overall Study|Protocol Violation|0|||
27745099|NCT00706433|54194753|FG000|Overall Study|new job|0|||
27745100|NCT00706433|54194754|FG001|Overall Study|new job|0|||
27745101|NCT00706433|54194755|FG002|Overall Study|new job|0|||
27745102|NCT00706433|54194756|FG003|Overall Study|new job|1|||
27745103|NCT02638623|54194768|FG000|Overall Study|Surgery timing|5|||
27745104|NCT02638623|54194769|FG001|Overall Study|Surgery timing|6|||
27745105|NCT02638623|54194768|FG000|Overall Study|Not given intervention|2|||
27745106|NCT02638623|54194769|FG001|Overall Study|Not given intervention|0|||
27745107|NCT02637141|54194778|FG000|Overall Study|Adverse Event|1|||
27745108|NCT02637141|54194779|FG001|Overall Study|Adverse Event|1|||
27745109|NCT02637141|54194780|FG002|Overall Study|Adverse Event|0|||
27745110|NCT02637141|54194778|FG000|Overall Study|Withdrawal by Subject|1|||
27745111|NCT02637141|54194779|FG001|Overall Study|Withdrawal by Subject|1|||
27745112|NCT02637141|54194780|FG002|Overall Study|Withdrawal by Subject|1|||
27745113|NCT02637063|54194791|FG000|Overall Study|Lost to Follow-up|3|||
27745114|NCT02637063|54194792|FG001|Overall Study|Lost to Follow-up|2|||
27745115|NCT02637063|54194793|FG002|Overall Study|Lost to Follow-up|3|||
27745116|NCT02637063|54194791|FG000|Overall Study|Withdrawal by Subject|2|||
27745117|NCT02637063|54194792|FG001|Overall Study|Withdrawal by Subject|2|||
27745118|NCT02637063|54194793|FG002|Overall Study|Withdrawal by Subject|3|||
27745119|NCT02635737|54194801|FG000|Overall Study|Protocol Violation|1|||
27745120|NCT02636907|54194805|FG000|Autoinjector Assessment Period|Adverse Event|2|||
27745121|NCT02636907|54194805|FG000|Autoinjector Assessment Period|Withdrawal by Subject|2|||
27745122|NCT02636907|54194805|FG000|Extension Phase|Adverse Event|2|||
27745123|NCT02636907|54194805|FG000|Extension Phase|Withdrawal by Subject|4|||
27745124|NCT02636907|54194805|FG000|Extension Phase|Physician Decision|1|||
27745125|NCT02636907|54194805|FG000|Extension Phase|Lost to Follow-up|2|||
27745126|NCT02636907|54194805|FG000|Extension Phase|Lack of Efficacy|1|||
27745127|NCT01374919|54194809|FG000|Overall Study|Withdrawal by Subject|2|||
27745128|NCT02726945|54194820|FG000|Overall Study|Withdrawal by Subject|0|||
27745129|NCT02726945|54194821|FG001|Overall Study|Withdrawal by Subject|0|||
27745130|NCT02726945|54194822|FG002|Overall Study|Withdrawal by Subject|1|||
27745131|NCT02726945|54194820|FG000|Overall Study|Elected to have total knee replacement|0|||
27745132|NCT02726945|54194821|FG001|Overall Study|Elected to have total knee replacement|1|||
27745133|NCT02726945|54194822|FG002|Overall Study|Elected to have total knee replacement|0|||
27745134|NCT02635347|54194832|FG000|Overall Study|Failed screening|20|||
27745135|NCT02635347|54194833|FG001|Overall Study|Failed screening|7|||
27745136|NCT02726399|54194853|FG000|Overall Study|Participant Non-Compliance|1|||
27745137|NCT02726399|54194853|FG000|Overall Study|Adverse Event|2|||
27745138|NCT02726399|54194853|FG000|Overall Study|Progression of disease|4|||
27745139|NCT02634801|54194860|FG000|Treatment Period (Weeks 0 to 24)|Adverse Event|2|||
27745140|NCT02634801|54194861|FG001|Treatment Period (Weeks 0 to 24)|Adverse Event|20|||
27745141|NCT02634801|54194862|FG002|Treatment Period (Weeks 0 to 24)|Adverse Event|0|||
27745142|NCT02634801|54194860|FG000|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
27745143|NCT02634801|54194861|FG001|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2|||
27745144|NCT02634801|54194862|FG002|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
27745145|NCT02634801|54194860|FG000|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2|||
27745146|NCT02634801|54194861|FG001|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
27745147|NCT02634801|54194862|FG002|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
27745148|NCT02634801|54194860|FG000|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
27745149|NCT02634801|54194861|FG001|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
27745150|NCT02634801|54194862|FG002|Treatment Period (Weeks 0 to 24)|Protocol Violation|1|||
27745151|NCT02634801|54194860|FG000|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0|||
27745152|NCT02634801|54194861|FG001|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8|||
27745153|NCT02634801|54194862|FG002|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3|||
27745154|NCT02634801|54194860|FG000|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
27745155|NCT02634801|54194861|FG001|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
27745156|NCT02634801|54194862|FG002|Extension Period (Weeks 24 to 36)|Adverse Event|1|||
27745157|NCT02634801|54194860|FG000|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1|||
27745158|NCT02634801|54194861|FG001|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
27745159|NCT02634801|54194862|FG002|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
27745160|NCT02634801|54194860|FG000|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
27745161|NCT02634801|54194861|FG001|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
27745162|NCT02634801|54194862|FG002|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
27745163|NCT02634801|54194860|FG000|Extension Period (Weeks 24 to 36)|Missing|1|||
27745164|NCT02634801|54194861|FG001|Extension Period (Weeks 24 to 36)|Missing|0|||
27745165|NCT02634801|54194862|FG002|Extension Period (Weeks 24 to 36)|Missing|0|||
27745166|NCT02634801|54194860|FG000|Follow-up Period|Lost to Follow-up|3|||
27745167|NCT02634801|54194861|FG001|Follow-up Period|Lost to Follow-up|1|||
27745168|NCT02634801|54194862|FG002|Follow-up Period|Lost to Follow-up|2|||
27745169|NCT02634801|54194860|FG000|Follow-up Period|Physician Decision|0|||
27745170|NCT02634801|54194861|FG001|Follow-up Period|Physician Decision|0|||
27745171|NCT02634801|54194862|FG002|Follow-up Period|Physician Decision|1|||
27745172|NCT02634801|54194860|FG000|Follow-up Period|Withdrawal by Subject|1|||
27745173|NCT02634801|54194861|FG001|Follow-up Period|Withdrawal by Subject|2|||
27745174|NCT02634801|54194862|FG002|Follow-up Period|Withdrawal by Subject|5|||
27745175|NCT02634801|54194860|FG000|Follow-up Period|Adverse Event|1|||
27745176|NCT02634801|54194861|FG001|Follow-up Period|Adverse Event|5|||
27745177|NCT02634801|54194862|FG002|Follow-up Period|Adverse Event|0|||
27745178|NCT02724839|54194877|FG000|Overall Study|Withdrawal by Subject|1|||
27745179|NCT02724839|54194878|FG001|Overall Study|Withdrawal by Subject|1|||
27745180|NCT02724839|54194879|FG002|Overall Study|Withdrawal by Subject|0|||
27745181|NCT02724839|54194877|FG000|Overall Study|Lost to Follow-up|0|||
27745182|NCT02724839|54194878|FG001|Overall Study|Lost to Follow-up|3|||
27745183|NCT02724839|54194879|FG002|Overall Study|Lost to Follow-up|2|||
27745184|NCT02724839|54194877|FG000|Overall Study|Physician Decision|0|||
27745185|NCT02724839|54194878|FG001|Overall Study|Physician Decision|0|||
27745186|NCT02724839|54194879|FG002|Overall Study|Physician Decision|3|||
27745187|NCT01375751|54194897|FG000|Overall Study|Other|0|||
27745188|NCT01375751|54194898|FG001|Overall Study|Other|1|||
27745189|NCT01375751|54194899|FG002|Overall Study|Other|0|||
27745190|NCT00705575|54194909|FG000|Overall Study|Abnormal laboratory value(s)|0|||
27745191|NCT00705575|54194910|FG001|Overall Study|Abnormal laboratory value(s)|3|||
27745192|NCT00705575|54194909|FG000|Overall Study|Abnormal test procedure result(s)|2|||
27745193|NCT00705575|54194910|FG001|Overall Study|Abnormal test procedure result(s)|12|||
27745194|NCT00705575|54194909|FG000|Overall Study|Adverse Event|11|||
27745195|NCT00705575|54194910|FG001|Overall Study|Adverse Event|15|||
27745196|NCT00705575|54194909|FG000|Overall Study|Lost to Follow-up|3|||
27745197|NCT00705575|54194910|FG001|Overall Study|Lost to Follow-up|4|||
27745198|NCT00705575|54194909|FG000|Overall Study|Protocol Violation|2|||
27745199|NCT00705575|54194910|FG001|Overall Study|Protocol Violation|2|||
27745200|NCT00705575|54194909|FG000|Overall Study|Withdrawal by Subject|5|||
27745201|NCT00705575|54194910|FG001|Overall Study|Withdrawal by Subject|10|||
27745202|NCT02636595|54194916|FG000|Overall Study|Lost to Follow-up|1|||
27745203|NCT02636595|54194916|FG000|Overall Study|Other|1|||
27745204|NCT02636361|54194920|FG000|Period 4|Physician Decision|0|||
27745205|NCT02636361|54194921|FG001|Period 4|Physician Decision|0|||
27745206|NCT02636361|54194922|FG002|Period 4|Physician Decision|0|||
27745207|NCT02636361|54194923|FG003|Period 4|Physician Decision|1|||
27745208|NCT02636361|54194924|FG004|Period 4|Physician Decision|0|||
27745209|NCT02636283|54194940|FG000|Overall Study|Adverse Event|2|||
27745210|NCT02636283|54194941|FG001|Overall Study|Adverse Event|0|||
27745211|NCT02636283|54194940|FG000|Overall Study|Trial Terminated Prematurely|0|||
27745212|NCT02636283|54194941|FG001|Overall Study|Trial Terminated Prematurely|3|||
27745213|NCT04430855|54194949|FG000|Period 1 (Weeks 1-12)|Adverse Event|1|||
27745214|NCT04430855|54194950|FG001|Period 1 (Weeks 1-12)|Adverse Event|0|||
27745215|NCT04430855|54194949|FG000|Period 1 (Weeks 1-12)|Withdrawal by Subject|1|||
27745216|NCT04430855|54194950|FG001|Period 1 (Weeks 1-12)|Withdrawal by Subject|2|||
27745217|NCT04430855|54194949|FG000|Period 1 (Weeks 1-12)|Lost to Follow-up|0|||
27745218|NCT04430855|54194950|FG001|Period 1 (Weeks 1-12)|Lost to Follow-up|2|||
27745219|NCT04430855|54194949|FG000|Period 1 (Weeks 1-12)|Lack of Efficacy|0|||
27745220|NCT04430855|54194950|FG001|Period 1 (Weeks 1-12)|Lack of Efficacy|1|||
27745221|NCT04430855|54194949|FG000|Period 1 (Weeks 1-12)|Other|0|||
27922693|NCT01264887|54579527|FG000|Overall Study|Physician Decision|4|||
27922694|NCT01264887|54579527|FG000|Overall Study|Withdrawal by Subject|6|||
27922695|NCT01264887|54579527|FG000|Overall Study|Sponsor Decision Administrative Reasons|2|||
27922696|NCT01264887|54579527|FG000|Overall Study|Other|2|||
27922697|NCT01306968|54579537|FG000|Overall Study|Lost to Follow-up|1|||
27922698|NCT01306968|54579538|FG001|Overall Study|Lost to Follow-up|1|||
27922699|NCT01306968|54579539|FG002|Overall Study|Lost to Follow-up|0|||
27922700|NCT01306968|54579540|FG003|Overall Study|Lost to Follow-up|0|||
27922701|NCT01306968|54579537|FG000|Overall Study|Physician Decision|0|||
27922702|NCT01306968|54579538|FG001|Overall Study|Physician Decision|1|||
27922703|NCT01306968|54579539|FG002|Overall Study|Physician Decision|0|||
27922704|NCT01306968|54579540|FG003|Overall Study|Physician Decision|0|||
27922705|NCT01306968|54579537|FG000|Overall Study|Relocated and left active duty|0|||
27922706|NCT01306968|54579538|FG001|Overall Study|Relocated and left active duty|1|||
27922707|NCT01306968|54579539|FG002|Overall Study|Relocated and left active duty|1|||
27922708|NCT01306968|54579540|FG003|Overall Study|Relocated and left active duty|1|||
27922709|NCT01306968|54579537|FG000|Overall Study|Withdrew - time commitment|0|||
27922710|NCT01306968|54579538|FG001|Overall Study|Withdrew - time commitment|0|||
27922711|NCT01306968|54579539|FG002|Overall Study|Withdrew - time commitment|0|||
27922712|NCT01306968|54579540|FG003|Overall Study|Withdrew - time commitment|2|||
27922713|NCT01306968|54579537|FG000|Overall Study|Withdrew over privacy concerns|0|||
27922714|NCT01306968|54579538|FG001|Overall Study|Withdrew over privacy concerns|0|||
27922715|NCT01306968|54579539|FG002|Overall Study|Withdrew over privacy concerns|0|||
27922716|NCT01306968|54579540|FG003|Overall Study|Withdrew over privacy concerns|1|||
27922717|NCT01264419|54579552|FG000|Overall Study|Lost to Follow-up|3|||
27922718|NCT01263873|54579558|FG000|Overall Study|One provider unable to complete numbers|1|||
27922719|NCT01263873|54579559|FG001|Overall Study|One provider unable to complete numbers|1|||
27922720|NCT01263639|54579567|FG000|Overall Study|Lost to Follow-up|66|||
27922721|NCT01263639|54579568|FG001|Overall Study|Lost to Follow-up|70|||
27922722|NCT01263639|54579567|FG000|Overall Study|Exclusion =Admission greater than 7 days|7|||
27922723|NCT01263639|54579568|FG001|Overall Study|Exclusion =Admission greater than 7 days|9|||
27922724|NCT01011283|54579576|FG000|Overall Study|Adverse Event|4|||
27922725|NCT01011283|54579577|FG001|Overall Study|Adverse Event|2|||
27922726|NCT01011283|54579576|FG000|Overall Study|Progressive Disease|0|||
27922727|NCT01011283|54579577|FG001|Overall Study|Progressive Disease|2|||
27922728|NCT01011283|54579576|FG000|Overall Study|Terminated by Sponsor|5|||
27922729|NCT01011283|54579577|FG001|Overall Study|Terminated by Sponsor|5|||
27922730|NCT01011283|54579576|FG000|Overall Study|Other|2|||
27922731|NCT01011283|54579577|FG001|Overall Study|Other|2|||
27922732|NCT01263561|54579585|FG000|Overall Study|Death|1|||
27922733|NCT01263561|54579586|FG001|Overall Study|Death|2|||
27922734|NCT01009099|54579594|FG000|Overall Study|Lost to Follow-up|1|||
27922735|NCT01009099|54579595|FG001|Overall Study|Lost to Follow-up|0|||
27922736|NCT01009099|54579594|FG000|Overall Study|Physician Decision|3|||
27922737|NCT01009099|54579595|FG001|Overall Study|Physician Decision|2|||
27922738|NCT01009099|54579594|FG000|Overall Study|Withdrawal by Subject|1|||
27922739|NCT01009099|54579595|FG001|Overall Study|Withdrawal by Subject|1|||
27922740|NCT01009099|54579594|FG000|Overall Study|Death|0|||
27922741|NCT01009099|54579595|FG001|Overall Study|Death|1|||
27922742|NCT01263483|54579604|FG000|Overall Study|Adverse Event|4|||
27922743|NCT01263483|54579605|FG001|Overall Study|Adverse Event|0|||
27922744|NCT01263483|54579606|FG002|Overall Study|Adverse Event|3|||
27922745|NCT01263483|54579604|FG000|Overall Study|Withdrawal by Subject|1|||
27922746|NCT01263483|54579605|FG001|Overall Study|Withdrawal by Subject|0|||
27922747|NCT01263483|54579606|FG002|Overall Study|Withdrawal by Subject|0|||
27922748|NCT01263483|54579604|FG000|Overall Study|Lack of Efficacy|2|||
27922749|NCT01263483|54579605|FG001|Overall Study|Lack of Efficacy|0|||
27922750|NCT01263483|54579606|FG002|Overall Study|Lack of Efficacy|0|||
27922751|NCT01263483|54579604|FG000|Overall Study|Protocol Violation|0|||
27922752|NCT01263483|54579605|FG001|Overall Study|Protocol Violation|1|||
27922753|NCT01263483|54579606|FG002|Overall Study|Protocol Violation|1|||
27922754|NCT01263483|54579604|FG000|Overall Study|Participant Unavailability|0|||
27922755|NCT01263483|54579605|FG001|Overall Study|Participant Unavailability|1|||
27922756|NCT01263483|54579606|FG002|Overall Study|Participant Unavailability|1|||
27922757|NCT01306890|54579614|FG000|Overall Study|Adverse Event|2|||
27922758|NCT01306890|54579614|FG000|Overall Study|Death|1223|||
27922759|NCT01306890|54579614|FG000|Overall Study|Lost to Follow-up|58|||
27745222|NCT04430855|54194950|FG001|Period 1 (Weeks 1-12)|Other|1|||
27922760|NCT01306890|54579614|FG000|Overall Study|Withdrawal by Subject|88|||
27922761|NCT01306890|54579614|FG000|Overall Study|Unspecified reasons|104|||
27922762|NCT01306890|54579614|FG000|Overall Study|Study Termination|3|||
27745223|NCT04430855|54194949|FG000|Period 2 (Weeks 12-48)|Withdrawal by Subject|2|||
27745224|NCT04430855|54194950|FG001|Period 2 (Weeks 12-48)|Withdrawal by Subject|5|||
27745225|NCT04430855|54194949|FG000|Period 2 (Weeks 12-48)|Lost to Follow-up|1|||
27745226|NCT04430855|54194950|FG001|Period 2 (Weeks 12-48)|Lost to Follow-up|2|||
27745227|NCT04430855|54194949|FG000|Period 2 (Weeks 12-48)|Lack of Efficacy|2|||
27745228|NCT04430855|54194950|FG001|Period 2 (Weeks 12-48)|Lack of Efficacy|3|||
27745229|NCT01375673|54194960|FG000|Overall Study|Withdrawal by Subject|0|||
27745230|NCT01375673|54194961|FG001|Overall Study|Withdrawal by Subject|1|||
27745231|NCT03652961|54194967|FG000|Overall Study|Lost to Follow-up|3|||
27745232|NCT03652961|54194967|FG000|Overall Study|Screen Failure|1|||
27745233|NCT02723591|54194973|FG000|Overall Study|Adverse Event|48|||
27745234|NCT02723591|54194974|FG001|Overall Study|Adverse Event|40|||
27745235|NCT02723591|54194973|FG000|Overall Study|Death|2|||
27745236|NCT02723591|54194974|FG001|Overall Study|Death|2|||
27745237|NCT02723591|54194973|FG000|Overall Study|Lack of Efficacy|4|||
27745238|NCT02723591|54194974|FG001|Overall Study|Lack of Efficacy|3|||
27745239|NCT02723591|54194973|FG000|Overall Study|Lost to Follow-up|1|||
27745240|NCT02723591|54194974|FG001|Overall Study|Lost to Follow-up|7|||
27745241|NCT02723591|54194973|FG000|Overall Study|Protocol Violation|20|||
27745242|NCT02723591|54194974|FG001|Overall Study|Protocol Violation|23|||
27745243|NCT02723591|54194973|FG000|Overall Study|Withdrawal by Subject|4|||
27745244|NCT02723591|54194974|FG001|Overall Study|Withdrawal by Subject|8|||
27745245|NCT02723591|54194973|FG000|Overall Study|Randomized but Never Received StudyDrug|12|||
27745246|NCT02723591|54194974|FG001|Overall Study|Randomized but Never Received StudyDrug|12|||
27745247|NCT02723591|54194973|FG000|Overall Study|Miscellaneous|5|||
27745248|NCT02723591|54194974|FG001|Overall Study|Miscellaneous|6|||
27745249|NCT00705341|54194982|FG000|Phase 2: Trial|Withdrawal by Subject|0|||
27745250|NCT00705341|54194983|FG001|Phase 2: Trial|Withdrawal by Subject|0|||
27745251|NCT00705341|54194984|FG002|Phase 2: Trial|Withdrawal by Subject|6|||
27745252|NCT00705341|54194985|FG003|Phase 2: Trial|Withdrawal by Subject|4|||
27745253|NCT00705341|54194982|FG000|Phase 2: Trial|Did not meet post-diluent threshold|0|||
27745254|NCT00705341|54194983|FG001|Phase 2: Trial|Did not meet post-diluent threshold|0|||
27745255|NCT00705341|54194984|FG002|Phase 2: Trial|Did not meet post-diluent threshold|1|||
27745256|NCT00705341|54194985|FG003|Phase 2: Trial|Did not meet post-diluent threshold|0|||
27745257|NCT02723201|54194996|FG000|Second Intervention Period|Protocol Violation|1|||
27745258|NCT02723201|54194997|FG001|Second Intervention Period|Protocol Violation|0|||
27745259|NCT02723201|54194998|FG002|Second Intervention Period|Protocol Violation|0|||
27745260|NCT02723201|54194996|FG000|Second Intervention Period|Adverse Event|1|||
27745261|NCT02723201|54194997|FG001|Second Intervention Period|Adverse Event|0|||
27745262|NCT02723201|54194998|FG002|Second Intervention Period|Adverse Event|0|||
27745263|NCT03846479|54195012|FG000|Overall Study|Death|8|||
27745264|NCT03846479|54195012|FG000|Overall Study|Lost to Follow-up|1|||
27745265|NCT00705263|54195016|FG000|Overall Study|Withdrawal by Subject|2|||
27745266|NCT00704405|54195034|FG000|Overall Study (NC Population)|Adverse Event|1|||
27745267|NCT00704405|54195035|FG001|Overall Study (NC Population)|Adverse Event|0|||
27745268|NCT00704405|54195036|FG002|Overall Study (NC Population)|Adverse Event|0|||
27745269|NCT00704405|54195037|FG003|Overall Study (NC Population)|Adverse Event|0|||
27745270|NCT00704405|54195038|FG004|Overall Study (NC Population)|Adverse Event|0|||
27745271|NCT00704405|54195034|FG000|Overall Study (NC Population)|Lost to Follow-up|2|||
27745272|NCT00704405|54195035|FG001|Overall Study (NC Population)|Lost to Follow-up|1|||
27745273|NCT00704405|54195036|FG002|Overall Study (NC Population)|Lost to Follow-up|1|||
27745274|NCT00704405|54195037|FG003|Overall Study (NC Population)|Lost to Follow-up|2|||
27745275|NCT00704405|54195038|FG004|Overall Study (NC Population)|Lost to Follow-up|2|||
27745276|NCT00704405|54195034|FG000|Overall Study (NC Population)|Withdrawal by Subject|2|||
27745277|NCT00704405|54195035|FG001|Overall Study (NC Population)|Withdrawal by Subject|3|||
27745278|NCT00704405|54195036|FG002|Overall Study (NC Population)|Withdrawal by Subject|2|||
27745279|NCT00704405|54195037|FG003|Overall Study (NC Population)|Withdrawal by Subject|2|||
27745280|NCT00704405|54195038|FG004|Overall Study (NC Population)|Withdrawal by Subject|2|||
27745281|NCT00704405|54195034|FG000|Overall Study (NC Population)|Other|0|||
27745282|NCT00704405|54195035|FG001|Overall Study (NC Population)|Other|0|||
27745283|NCT00704405|54195036|FG002|Overall Study (NC Population)|Other|0|||
27745284|NCT00704405|54195037|FG003|Overall Study (NC Population)|Other|0|||
27745285|NCT00704405|54195038|FG004|Overall Study (NC Population)|Other|1|||
27745286|NCT00704405|54195034|FG000|Overall Study (C Population)|Withdrawal by Subject|1|||
27745287|NCT00704405|54195035|FG001|Overall Study (C Population)|Withdrawal by Subject|1|||
27745288|NCT00704405|54195036|FG002|Overall Study (C Population)|Withdrawal by Subject|1|||
27745289|NCT00704405|54195037|FG003|Overall Study (C Population)|Withdrawal by Subject|1|||
27745290|NCT00704405|54195038|FG004|Overall Study (C Population)|Withdrawal by Subject|0|||
27745291|NCT00704405|54195034|FG000|Overall Study (C Population)|Lost to Follow-up|0|||
27745292|NCT00704405|54195035|FG001|Overall Study (C Population)|Lost to Follow-up|2|||
27745293|NCT00704405|54195036|FG002|Overall Study (C Population)|Lost to Follow-up|0|||
27745294|NCT00704405|54195037|FG003|Overall Study (C Population)|Lost to Follow-up|0|||
27745295|NCT00704405|54195038|FG004|Overall Study (C Population)|Lost to Follow-up|0|||
27745296|NCT01534481|54195058|FG000|Overall Study|Lost to Follow-up|29|||
27745297|NCT01534481|54195059|FG001|Overall Study|Lost to Follow-up|24|||
27745298|NCT01534481|54195058|FG000|Overall Study|Incomplete Follow-up or No Study Data|6|||
27745299|NCT01534481|54195059|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
27745300|NCT00704171|54195067|FG000|Overall Study|Withdrawal by Subject|1|||
27745301|NCT00704171|54195068|FG001|Overall Study|Withdrawal by Subject|0|||
27745302|NCT00703781|54195076|FG000|Overall Study|Withdrawal by Subject|1|||
27745303|NCT00703781|54195077|FG001|Overall Study|Withdrawal by Subject|2|||
27745304|NCT00703781|54195076|FG000|Overall Study|Cancelled surgery|1|||
27745305|NCT00703781|54195077|FG001|Overall Study|Cancelled surgery|0|||
27745306|NCT00703157|54195085|FG000|Overall Study|Lost to Follow-up|0|||
27745307|NCT00703157|54195086|FG001|Overall Study|Lost to Follow-up|1|||
27745308|NCT00703157|54195085|FG000|Overall Study|source data permanently lost/ other|4|||
27745309|NCT00703157|54195086|FG001|Overall Study|source data permanently lost/ other|1|||
27745310|NCT03307967|54195094|FG000|Overall Study|Lost to Follow-up|4|||
27745311|NCT02722967|54195101|FG000|Overall Study|Adverse Event|1|||
27745312|NCT02722967|54195102|FG001|Overall Study|Adverse Event|0|||
27745313|NCT02722967|54195103|FG002|Overall Study|Adverse Event|0|||
27745314|NCT02722967|54195101|FG000|Overall Study|Lost to Follow-up|0|||
27745315|NCT02722967|54195102|FG001|Overall Study|Lost to Follow-up|1|||
27745316|NCT02722967|54195103|FG002|Overall Study|Lost to Follow-up|0|||
27745317|NCT02722967|54195101|FG000|Overall Study|Non-compliance with patch wearing|2|||
27745318|NCT02722967|54195102|FG001|Overall Study|Non-compliance with patch wearing|1|||
27745319|NCT02722967|54195103|FG002|Overall Study|Non-compliance with patch wearing|1|||
27745320|NCT02722967|54195101|FG000|Overall Study|Withdrawal by Subject|1|||
27745321|NCT02722967|54195102|FG001|Overall Study|Withdrawal by Subject|0|||
27745322|NCT02722967|54195103|FG002|Overall Study|Withdrawal by Subject|1|||
27745323|NCT02722967|54195101|FG000|Overall Study|Physician Decision|1|||
27745324|NCT02722967|54195102|FG001|Overall Study|Physician Decision|0|||
27745325|NCT02722967|54195103|FG002|Overall Study|Physician Decision|0|||
27745326|NCT02722967|54195101|FG000|Overall Study|Non-adherence of the patch to the skin|0|||
27745327|NCT02722967|54195102|FG001|Overall Study|Non-adherence of the patch to the skin|0|||
27745328|NCT02722967|54195103|FG002|Overall Study|Non-adherence of the patch to the skin|2|||
27745329|NCT02722499|54195114|FG000|Overall Study|Lost to Follow-up|2|||
27745330|NCT02722499|54195115|FG001|Overall Study|Lost to Follow-up|0|||
27745331|NCT02722499|54195116|FG002|Overall Study|Lost to Follow-up|1|||
27745332|NCT02721875|54195126|FG000|Overall Study|Progressive disease/relapse|1|||
27745333|NCT02721875|54195127|FG001|Overall Study|Progressive disease/relapse|0|||
27745334|NCT02721251|54195136|FG000|Overall Study|Withdrawal by Subject|8|||
27745335|NCT02721251|54195137|FG001|Overall Study|Withdrawal by Subject|7|||
27745336|NCT02721251|54195138|FG002|Overall Study|Withdrawal by Subject|9|||
27745337|NCT02721251|54195136|FG000|Overall Study|poor adherence|2|||
27745338|NCT02721251|54195137|FG001|Overall Study|poor adherence|2|||
27745339|NCT02721251|54195138|FG002|Overall Study|poor adherence|2|||
27745340|NCT00702221|54195149|FG000|Overall Study|Adverse Event|4|||
27745341|NCT00702221|54195150|FG001|Overall Study|Adverse Event|3|||
27745342|NCT00702143|54195159|FG000|Overall Study|Lost to Follow-up|0|||
27745343|NCT00702143|54195160|FG001|Overall Study|Lost to Follow-up|0|||
27745344|NCT00702143|54195161|FG002|Overall Study|Lost to Follow-up|1|||
27745345|NCT00702923|54195167|FG000|Overall Study|Adverse Event|1|||
27745346|NCT02633787|54195172|FG000|Overall Study|Withdrawal by Subject|1|||
27745347|NCT02719691|54195183|FG000|Overall Study|Physician Decision|0|||
27745348|NCT02719691|54195184|FG001|Overall Study|Physician Decision|0|||
27745349|NCT02719691|54195185|FG002|Overall Study|Physician Decision|1|||
27745350|NCT02719691|54195186|FG003|Overall Study|Physician Decision|0|||
27745351|NCT02719691|54195187|FG004|Overall Study|Physician Decision|0|||
27745352|NCT02719691|54195188|FG005|Overall Study|Physician Decision|0|||
27745353|NCT02719691|54195189|FG006|Overall Study|Physician Decision|0|||
27745354|NCT02719691|54195183|FG000|Overall Study|Withdrawal by Subject|0|||
27745355|NCT02719691|54195184|FG001|Overall Study|Withdrawal by Subject|0|||
27745356|NCT02719691|54195185|FG002|Overall Study|Withdrawal by Subject|0|||
27745357|NCT02719691|54195186|FG003|Overall Study|Withdrawal by Subject|0|||
27745358|NCT02719691|54195187|FG004|Overall Study|Withdrawal by Subject|0|||
27745359|NCT02719691|54195188|FG005|Overall Study|Withdrawal by Subject|1|||
27745360|NCT02719691|54195189|FG006|Overall Study|Withdrawal by Subject|0|||
27745361|NCT02720081|54195208|FG000|Overall Study|Adverse Event|0|||
27745362|NCT02720081|54195209|FG001|Overall Study|Adverse Event|3|||
27745363|NCT02720081|54195208|FG000|Overall Study|Protocol Violation|4|||
27745364|NCT02720081|54195209|FG001|Overall Study|Protocol Violation|1|||
27745365|NCT04248933|54195215|FG000|Overall Study|Lost to Follow-up|9|||
27745366|NCT04248933|54195215|FG000|Overall Study|Withdrawal by Subject|2|||
27745367|NCT02718131|54195221|FG000|Overall Study|Withdrawal by Subject|1|||
27745368|NCT02718131|54195222|FG001|Overall Study|Withdrawal by Subject|0|||
27745369|NCT02718131|54195221|FG000|Overall Study|Adverse Event|1|||
27745370|NCT02718131|54195222|FG001|Overall Study|Adverse Event|0|||
27922763|NCT01306890|54579614|FG000|Overall Study|No discontinuation documentation|41|||
27745371|NCT02718131|54195221|FG000|Overall Study|Data was incomplete. Patient was inevaluable|1|||
27745372|NCT02718131|54195222|FG001|Overall Study|Data was incomplete. Patient was inevaluable|0|||
27745373|NCT02717195|54195257|FG000|Prospective Confirmation (PC) Period|Adverse Event|19|||
27745374|NCT02717195|54195258|FG001|Prospective Confirmation (PC) Period|Adverse Event|7|||
27745375|NCT02717195|54195259|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
27745376|NCT02717195|54195260|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
27745377|NCT02717195|54195261|FG004|Prospective Confirmation (PC) Period|Adverse Event|0|||
27745378|NCT02717195|54195257|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
27745379|NCT02717195|54195258|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|1|||
27745380|NCT02717195|54195259|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
27745381|NCT02717195|54195260|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
27745382|NCT02717195|54195261|FG004|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
27745383|NCT02717195|54195257|FG000|Prospective Confirmation (PC) Period|Non-compliance with IMP|7|||
27745384|NCT02717195|54195258|FG001|Prospective Confirmation (PC) Period|Non-compliance with IMP|1|||
27745385|NCT02717195|54195259|FG002|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
27745386|NCT02717195|54195260|FG003|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
27745387|NCT02717195|54195261|FG004|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
27745388|NCT02717195|54195257|FG000|Prospective Confirmation (PC) Period|Protocol Violation|3|||
27745389|NCT02717195|54195258|FG001|Prospective Confirmation (PC) Period|Protocol Violation|1|||
27745390|NCT02717195|54195259|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
27745391|NCT02717195|54195260|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
27745392|NCT02717195|54195261|FG004|Prospective Confirmation (PC) Period|Protocol Violation|0|||
27745393|NCT02717195|54195257|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|43|||
27745394|NCT02717195|54195258|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|12|||
27745395|NCT02717195|54195259|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
27745396|NCT02717195|54195260|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
27745397|NCT02717195|54195261|FG004|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
27745398|NCT02717195|54195257|FG000|Prospective Confirmation (PC) Period|Lost to Follow-up|9|||
27745399|NCT02717195|54195258|FG001|Prospective Confirmation (PC) Period|Lost to Follow-up|4|||
27745400|NCT02717195|54195259|FG002|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
27745401|NCT02717195|54195260|FG003|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
27745402|NCT02717195|54195261|FG004|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
27745403|NCT02717195|54195257|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189|||
27745404|NCT02717195|54195258|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75|||
27745405|NCT02717195|54195259|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
27745406|NCT02717195|54195260|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
27745407|NCT02717195|54195261|FG004|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
27745408|NCT02717195|54195257|FG000|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
27745409|NCT02717195|54195258|FG001|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
27745410|NCT02717195|54195259|FG002|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
27745411|NCT02717195|54195260|FG003|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
27745412|NCT02717195|54195261|FG004|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
27745413|NCT02717195|54195257|FG000|Prospective Confirmation (PC) Period|Lack of results for blood levels|1|||
27745414|NCT02717195|54195258|FG001|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
27745415|NCT02717195|54195259|FG002|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
27745416|NCT02717195|54195260|FG003|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
27745417|NCT02717195|54195261|FG004|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
27745418|NCT02717195|54195257|FG000|Prospective Confirmation (PC) Period|Technical error|1|||
27745419|NCT02717195|54195258|FG001|Prospective Confirmation (PC) Period|Technical error|0|||
27745420|NCT02717195|54195259|FG002|Prospective Confirmation (PC) Period|Technical error|0|||
27745421|NCT02717195|54195260|FG003|Prospective Confirmation (PC) Period|Technical error|0|||
27745422|NCT02717195|54195261|FG004|Prospective Confirmation (PC) Period|Technical error|0|||
27745423|NCT02717195|54195257|FG000|Prospective Confirmation (PC) Period|Patient decision|5|||
27745424|NCT02717195|54195258|FG001|Prospective Confirmation (PC) Period|Patient decision|2|||
27745425|NCT02717195|54195259|FG002|Prospective Confirmation (PC) Period|Patient decision|0|||
27745426|NCT02717195|54195260|FG003|Prospective Confirmation (PC) Period|Patient decision|0|||
27745427|NCT02717195|54195261|FG004|Prospective Confirmation (PC) Period|Patient decision|0|||
27745428|NCT02717195|54195257|FG000|Prospective Confirmation (PC) Period|Low level of drug in the blood|1|||
27745429|NCT02717195|54195258|FG001|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
27745430|NCT02717195|54195259|FG002|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
27745431|NCT02717195|54195260|FG003|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
27745432|NCT02717195|54195261|FG004|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
27745433|NCT02717195|54195257|FG000|Prospective Confirmation (PC) Period|Change of place of residence|1|||
27745434|NCT02717195|54195258|FG001|Prospective Confirmation (PC) Period|Change of place of residence|0|||
27745435|NCT02717195|54195259|FG002|Prospective Confirmation (PC) Period|Change of place of residence|0|||
27745436|NCT02717195|54195260|FG003|Prospective Confirmation (PC) Period|Change of place of residence|0|||
27745437|NCT02717195|54195261|FG004|Prospective Confirmation (PC) Period|Change of place of residence|0|||
27745438|NCT02717195|54195257|FG000|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
27745439|NCT02717195|54195258|FG001|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1|||
27745440|NCT02717195|54195259|FG002|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
27745441|NCT02717195|54195260|FG003|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
27745442|NCT02717195|54195261|FG004|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
27745443|NCT02717195|54195257|FG000|Prospective Confirmation (PC) Period|Investigator decision|2|||
27745444|NCT02717195|54195258|FG001|Prospective Confirmation (PC) Period|Investigator decision|1|||
27745445|NCT02717195|54195259|FG002|Prospective Confirmation (PC) Period|Investigator decision|0|||
27745446|NCT02717195|54195260|FG003|Prospective Confirmation (PC) Period|Investigator decision|0|||
27745447|NCT02717195|54195261|FG004|Prospective Confirmation (PC) Period|Investigator decision|0|||
27745448|NCT02717195|54195257|FG000|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
27745449|NCT02717195|54195258|FG001|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1|||
27745450|NCT02717195|54195259|FG002|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
27745451|NCT02717195|54195260|FG003|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
27745452|NCT02717195|54195261|FG004|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
27745453|NCT02717195|54195257|FG000|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1|||
27745454|NCT02717195|54195258|FG001|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
27745455|NCT02717195|54195259|FG002|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
27745456|NCT02717195|54195260|FG003|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
27745457|NCT02717195|54195261|FG004|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
27745458|NCT02717195|54195257|FG000|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
27745459|NCT02717195|54195258|FG001|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1|||
27745460|NCT02717195|54195259|FG002|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
27745461|NCT02717195|54195260|FG003|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
27745462|NCT02717195|54195261|FG004|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
27745463|NCT02717195|54195257|FG000|Prospective Confirmation (PC) Period|Duplicate subject|1|||
27745464|NCT02717195|54195258|FG001|Prospective Confirmation (PC) Period|Duplicate subject|0|||
27745465|NCT02717195|54195259|FG002|Prospective Confirmation (PC) Period|Duplicate subject|0|||
27745466|NCT02717195|54195260|FG003|Prospective Confirmation (PC) Period|Duplicate subject|0|||
27745467|NCT02717195|54195261|FG004|Prospective Confirmation (PC) Period|Duplicate subject|0|||
27745468|NCT02717195|54195257|FG000|Prospective Confirmation (PC) Period|Sponsor requested|0|||
27745469|NCT02717195|54195258|FG001|Prospective Confirmation (PC) Period|Sponsor requested|1|||
27745470|NCT02717195|54195259|FG002|Prospective Confirmation (PC) Period|Sponsor requested|0|||
27745471|NCT02717195|54195260|FG003|Prospective Confirmation (PC) Period|Sponsor requested|0|||
27745472|NCT02717195|54195261|FG004|Prospective Confirmation (PC) Period|Sponsor requested|0|||
27745473|NCT02717195|54195257|FG000|Prospective Confirmation (PC) Period|Patient fraud with payment|1|||
27745474|NCT02717195|54195258|FG001|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
27745475|NCT02717195|54195259|FG002|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
27745476|NCT02717195|54195260|FG003|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
27745477|NCT02717195|54195261|FG004|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
27745478|NCT02717195|54195257|FG000|Prospective Confirmation (PC) Period|Noncompliance with protocol|1|||
27745479|NCT02717195|54195258|FG001|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
27745480|NCT02717195|54195259|FG002|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
27745481|NCT02717195|54195260|FG003|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
27745482|NCT02717195|54195261|FG004|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
27745483|NCT02717195|54195257|FG000|Double-blind Treatment (DBT) Period|Adverse Event|0|||
27745484|NCT02717195|54195258|FG001|Double-blind Treatment (DBT) Period|Adverse Event|0|||
27745485|NCT02717195|54195259|FG002|Double-blind Treatment (DBT) Period|Adverse Event|10|||
27745486|NCT02717195|54195260|FG003|Double-blind Treatment (DBT) Period|Adverse Event|11|||
27745487|NCT02717195|54195261|FG004|Double-blind Treatment (DBT) Period|Adverse Event|8|||
27745488|NCT02717195|54195257|FG000|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
27745489|NCT02717195|54195258|FG001|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
27745490|NCT02717195|54195259|FG002|Double-blind Treatment (DBT) Period|Lack of Efficacy|6|||
27745491|NCT02717195|54195260|FG003|Double-blind Treatment (DBT) Period|Lack of Efficacy|9|||
27745492|NCT02717195|54195261|FG004|Double-blind Treatment (DBT) Period|Lack of Efficacy|2|||
27745493|NCT02717195|54195257|FG000|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
27745494|NCT02717195|54195258|FG001|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
27745495|NCT02717195|54195259|FG002|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4|||
27745496|NCT02717195|54195260|FG003|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3|||
27745497|NCT02717195|54195261|FG004|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2|||
27745498|NCT02717195|54195257|FG000|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
27745499|NCT02717195|54195258|FG001|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
27745500|NCT02717195|54195259|FG002|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
27745501|NCT02717195|54195260|FG003|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
27745502|NCT02717195|54195261|FG004|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
27745503|NCT02717195|54195257|FG000|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
27745504|NCT02717195|54195258|FG001|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
27745505|NCT02717195|54195259|FG002|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14|||
27745506|NCT02717195|54195260|FG003|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13|||
27745507|NCT02717195|54195261|FG004|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8|||
27745508|NCT02717195|54195257|FG000|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
27745509|NCT02717195|54195258|FG001|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
27922764|NCT01011049|54579622|FG000|Overall Study|Protocol Violation|0|||
27922765|NCT01011049|54579623|FG001|Overall Study|Protocol Violation|0|||
27922766|NCT01011049|54579624|FG002|Overall Study|Protocol Violation|2|||
27922767|NCT01011049|54579625|FG003|Overall Study|Protocol Violation|0|||
27922768|NCT01011049|54579622|FG000|Overall Study|Lost to Follow-up|1|||
27922769|NCT01011049|54579623|FG001|Overall Study|Lost to Follow-up|2|||
27922770|NCT01011049|54579624|FG002|Overall Study|Lost to Follow-up|1|||
27922771|NCT01011049|54579625|FG003|Overall Study|Lost to Follow-up|0|||
27922772|NCT01011049|54579622|FG000|Overall Study|Withdrawal by Subject|0|||
27922773|NCT01011049|54579623|FG001|Overall Study|Withdrawal by Subject|0|||
27922774|NCT01011049|54579624|FG002|Overall Study|Withdrawal by Subject|1|||
27922775|NCT01011049|54579625|FG003|Overall Study|Withdrawal by Subject|0|||
27922776|NCT01263093|54579637|FG000|Washout|Physician Decision|1|||
27922777|NCT01263093|54579638|FG001|Washout|Physician Decision|0|||
27922778|NCT01263093|54579637|FG000|Period 2|Adverse Event|1|||
27922779|NCT01263093|54579638|FG001|Period 2|Adverse Event|0|||
27922780|NCT01010971|54579648|FG000|Overall Study|Adverse Event|2|||
27922781|NCT01010971|54579649|FG001|Overall Study|Adverse Event|4|||
27922782|NCT01010971|54579650|FG002|Overall Study|Adverse Event|3|||
27922783|NCT01010971|54579648|FG000|Overall Study|Withdrawal by Subject|0|||
27922784|NCT01010971|54579649|FG001|Overall Study|Withdrawal by Subject|2|||
27922785|NCT01010971|54579650|FG002|Overall Study|Withdrawal by Subject|5|||
27922786|NCT01010971|54579648|FG000|Overall Study|Lost to Follow-up|0|||
27922787|NCT01010971|54579649|FG001|Overall Study|Lost to Follow-up|2|||
27922788|NCT01010971|54579650|FG002|Overall Study|Lost to Follow-up|3|||
27922789|NCT01010971|54579648|FG000|Overall Study|Other|1|||
27922790|NCT01010971|54579649|FG001|Overall Study|Other|0|||
27922791|NCT01010971|54579650|FG002|Overall Study|Other|2|||
27922792|NCT01306656|54579660|FG000|Overall Study|Lost to Follow-up|1|||
27922793|NCT01306656|54579661|FG001|Overall Study|Lost to Follow-up|0|||
27922794|NCT01008943|54579669|FG000|Overall Study|Withdrawal by Subject|1|||
27922795|NCT01003639|54579675|FG000|Overall Study|Lost to Follow-up|6|||
27922796|NCT01003639|54579676|FG001|Overall Study|Lost to Follow-up|9|||
27922797|NCT01003639|54579675|FG000|Overall Study|Withdrawal by Subject|9|||
27922798|NCT01003639|54579676|FG001|Overall Study|Withdrawal by Subject|5|||
27922799|NCT01003639|54579675|FG000|Overall Study|Lack of Efficacy|1|||
27922800|NCT01003639|54579676|FG001|Overall Study|Lack of Efficacy|6|||
27922801|NCT01003639|54579675|FG000|Overall Study|Adverse Event|0|||
27922802|NCT01003639|54579676|FG001|Overall Study|Adverse Event|1|||
27922803|NCT01003639|54579675|FG000|Overall Study|Protocol Violation|0|||
27922804|NCT01003639|54579676|FG001|Overall Study|Protocol Violation|1|||
27922805|NCT01003639|54579675|FG000|Overall Study|Physician Decision|1|||
27922806|NCT01003639|54579676|FG001|Overall Study|Physician Decision|0|||
27922807|NCT01003249|54579682|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
27922808|NCT01003249|54579683|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
27922809|NCT01003249|54579682|FG000|First Intervention (4 Weeks)|Non-Serious Event|1|||
27922810|NCT01003249|54579683|FG001|First Intervention (4 Weeks)|Non-Serious Event|1|||
27922811|NCT01003249|54579682|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
27922812|NCT01003249|54579683|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
27922813|NCT01003249|54579682|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
27922814|NCT01003249|54579683|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
27922815|NCT01001767|54579695|FG000|Overall Study|no baseline study performed|1|||
27922816|NCT01001767|54579696|FG001|Overall Study|no baseline study performed|0|||
27922817|NCT01001767|54579695|FG000|Overall Study|Protocol Violation|1|||
27922818|NCT01001767|54579696|FG001|Overall Study|Protocol Violation|0|||
27922819|NCT01001767|54579695|FG000|Overall Study|Lost to Follow-up|1|||
27922820|NCT01001767|54579696|FG001|Overall Study|Lost to Follow-up|0|||
27922821|NCT01001767|54579695|FG000|Overall Study|Physician Decision|1|||
27922822|NCT01001767|54579696|FG001|Overall Study|Physician Decision|0|||
27922823|NCT01306032|54579708|FG000|First Intervention|Adverse Event|1|||
27922824|NCT01306032|54579709|FG001|First Intervention|Adverse Event|0|||
27922825|NCT01306032|54579710|FG002|First Intervention|Adverse Event|1|||
27922826|NCT01306032|54579711|FG003|First Intervention|Adverse Event|0|||
27922827|NCT01306032|54579712|FG004|First Intervention|Adverse Event|0|||
27922828|NCT01306032|54579713|FG005|First Intervention|Adverse Event|1|||
27922829|NCT01306032|54579708|FG000|First Intervention|Withdrawal by Subject|0|||
27922830|NCT01306032|54579709|FG001|First Intervention|Withdrawal by Subject|2|||
27922831|NCT01306032|54579710|FG002|First Intervention|Withdrawal by Subject|0|||
27922832|NCT01306032|54579711|FG003|First Intervention|Withdrawal by Subject|1|||
27922833|NCT01306032|54579712|FG004|First Intervention|Withdrawal by Subject|0|||
27922834|NCT01306032|54579713|FG005|First Intervention|Withdrawal by Subject|0|||
27922835|NCT01306032|54579708|FG000|First Intervention|Death|0|||
27922836|NCT01306032|54579709|FG001|First Intervention|Death|0|||
27922837|NCT01306032|54579710|FG002|First Intervention|Death|1|||
27922838|NCT01306032|54579711|FG003|First Intervention|Death|0|||
27922839|NCT01306032|54579712|FG004|First Intervention|Death|0|||
27922840|NCT01306032|54579713|FG005|First Intervention|Death|0|||
27922841|NCT01306032|54579708|FG000|First Intervention|Ineligible|0|||
27922842|NCT01306032|54579709|FG001|First Intervention|Ineligible|0|||
27922843|NCT01306032|54579710|FG002|First Intervention|Ineligible|0|||
27922844|NCT01306032|54579711|FG003|First Intervention|Ineligible|0|||
27922845|NCT01306032|54579712|FG004|First Intervention|Ineligible|0|||
27922846|NCT01306032|54579713|FG005|First Intervention|Ineligible|1|||
27922847|NCT01306032|54579708|FG000|First Intervention|Progressive disease|0|||
27922848|NCT01306032|54579709|FG001|First Intervention|Progressive disease|0|||
27922849|NCT01306032|54579710|FG002|First Intervention|Progressive disease|0|||
27922850|NCT01306032|54579711|FG003|First Intervention|Progressive disease|0|||
27922851|NCT01306032|54579712|FG004|First Intervention|Progressive disease|2|||
27922852|NCT01306032|54579713|FG005|First Intervention|Progressive disease|0|||
27922853|NCT01306032|54579708|FG000|Disease Progression/Crossover|Withdrawal by Subject|0|||
27922854|NCT01306032|54579709|FG001|Disease Progression/Crossover|Withdrawal by Subject|0|||
27922855|NCT01306032|54579710|FG002|Disease Progression/Crossover|Withdrawal by Subject|0|||
27922856|NCT01306032|54579711|FG003|Disease Progression/Crossover|Withdrawal by Subject|1|||
27922857|NCT01306032|54579712|FG004|Disease Progression/Crossover|Withdrawal by Subject|0|||
27922858|NCT01306032|54579713|FG005|Disease Progression/Crossover|Withdrawal by Subject|0|||
27922859|NCT01306032|54579708|FG000|Disease Progression/Crossover|other/symptomatic progression|0|||
27922860|NCT01306032|54579709|FG001|Disease Progression/Crossover|other/symptomatic progression|2|||
27922861|NCT01306032|54579710|FG002|Disease Progression/Crossover|other/symptomatic progression|0|||
27922862|NCT01306032|54579711|FG003|Disease Progression/Crossover|other/symptomatic progression|2|||
27922863|NCT01306032|54579712|FG004|Disease Progression/Crossover|other/symptomatic progression|0|||
27922864|NCT01306032|54579713|FG005|Disease Progression/Crossover|other/symptomatic progression|0|||
27922865|NCT01263015|54579741|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|13|||
27922866|NCT01263015|54579742|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|48|||
27922867|NCT01263015|54579741|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18|||
27922868|NCT01263015|54579742|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14|||
27922869|NCT01263015|54579741|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14|||
27922870|NCT01263015|54579742|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12|||
27922871|NCT01263015|54579741|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17|||
27922872|NCT01263015|54579742|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18|||
27922873|NCT01263015|54579741|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9|||
27922874|NCT01263015|54579742|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15|||
27922875|NCT01263015|54579741|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|1|||
27922876|NCT01263015|54579742|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|2|||
27922877|NCT01263015|54579741|FG000|Open-label Phase: 48 Weeks Duration|Adverse Event|3|||
27922878|NCT01263015|54579742|FG001|Open-label Phase: 48 Weeks Duration|Adverse Event|10|||
27922879|NCT01263015|54579741|FG000|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7|||
27922880|NCT01263015|54579742|FG001|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2|||
27922881|NCT01263015|54579741|FG000|Open-label Phase: 48 Weeks Duration|Protocol Violation|3|||
27922882|NCT01263015|54579742|FG001|Open-label Phase: 48 Weeks Duration|Protocol Violation|2|||
27922883|NCT01263015|54579741|FG000|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
27922884|NCT01263015|54579742|FG001|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
27922885|NCT01263015|54579741|FG000|Open-label Phase: 48 Weeks Duration|Physician Decision|0|||
27922886|NCT01263015|54579742|FG001|Open-label Phase: 48 Weeks Duration|Physician Decision|2|||
27922887|NCT01263015|54579741|FG000|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3|||
27922888|NCT01263015|54579742|FG001|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7|||
27922889|NCT01305564|54579748|FG000|Overall Study|Death|21|||
27922890|NCT01305564|54579748|FG000|Overall Study|Lost to Follow-up|12|||
27922891|NCT01305564|54579748|FG000|Overall Study|Withdrawal by Subject|1|||
27922892|NCT01305564|54579748|FG000|Overall Study|Physician Decision|3|||
27922893|NCT01305408|54579765|FG000|Overall Study|Adverse Event|10|||
27922894|NCT01305408|54579766|FG001|Overall Study|Adverse Event|7|||
27922895|NCT01305408|54579765|FG000|Overall Study|Lack of Efficacy|3|||
27922896|NCT01305408|54579766|FG001|Overall Study|Lack of Efficacy|4|||
27922897|NCT01305408|54579765|FG000|Overall Study|Withdrawal by Subject|9|||
27922898|NCT01305408|54579766|FG001|Overall Study|Withdrawal by Subject|9|||
27922899|NCT01305408|54579765|FG000|Overall Study|Protocol Violation|4|||
27922900|NCT01305408|54579766|FG001|Overall Study|Protocol Violation|6|||
27922901|NCT01305408|54579765|FG000|Overall Study|Lost to Follow-up|5|||
27922902|NCT01305408|54579766|FG001|Overall Study|Lost to Follow-up|3|||
27922903|NCT01305408|54579765|FG000|Overall Study|Noncompliance with study medication|0|||
27922904|NCT01305408|54579766|FG001|Overall Study|Noncompliance with study medication|1|||
27922905|NCT01305408|54579765|FG000|Overall Study|Noncompliance with study procedures|0|||
27922906|NCT01305408|54579766|FG001|Overall Study|Noncompliance with study procedures|1|||
27922907|NCT01305408|54579765|FG000|Overall Study|Other|1|||
27922908|NCT01305408|54579766|FG001|Overall Study|Other|0|||
27922909|NCT01304940|54579774|FG000|Overall Study|not meet symptom severity requirement|3|||
27922910|NCT01304940|54579775|FG001|Overall Study|not meet symptom severity requirement|0|||
27922911|NCT01261611|54579784|FG000|Treatment Cycle 1|Withdrawal by Subject|3|||
27922912|NCT01261611|54579785|FG001|Treatment Cycle 1|Withdrawal by Subject|2|||
27922913|NCT01261611|54579786|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
27922914|NCT01261611|54579784|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
27922915|NCT01261611|54579785|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
27922916|NCT01261611|54579786|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
27922917|NCT01261611|54579784|FG000|Treatment Cycle 1|Adverse Event|0|||
27922918|NCT01261611|54579785|FG001|Treatment Cycle 1|Adverse Event|1|||
27922919|NCT01261611|54579786|FG002|Treatment Cycle 1|Adverse Event|0|||
27922920|NCT01261611|54579784|FG000|Treatment Cycle 1|Protocol Violation|0|||
27922921|NCT01261611|54579785|FG001|Treatment Cycle 1|Protocol Violation|0|||
27922922|NCT01261611|54579786|FG002|Treatment Cycle 1|Protocol Violation|2|||
27922923|NCT01261611|54579784|FG000|Treatment Cycle 2|Completed study|4|||
27922924|NCT01261611|54579785|FG001|Treatment Cycle 2|Completed study|0|||
27922925|NCT01261611|54579786|FG002|Treatment Cycle 2|Completed study|0|||
27922926|NCT01261611|54579784|FG000|Treatment Cycle 2|Withdrawal by Subject|4|||
27922927|NCT01261611|54579785|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
27922928|NCT01261611|54579786|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
27922929|NCT01261611|54579784|FG000|Treatment Cycle 2|Adverse Event|1|||
27922930|NCT01261611|54579785|FG001|Treatment Cycle 2|Adverse Event|0|||
27922931|NCT01261611|54579786|FG002|Treatment Cycle 2|Adverse Event|0|||
27922932|NCT01261611|54579784|FG000|Treatment Cycle 2|Protocol Violation|2|||
27922933|NCT01261611|54579785|FG001|Treatment Cycle 2|Protocol Violation|0|||
27922934|NCT01261611|54579786|FG002|Treatment Cycle 2|Protocol Violation|0|||
27922935|NCT01261611|54579784|FG000|Treatment Cycle 2|Not otherwise specified|2|||
27922936|NCT01261611|54579785|FG001|Treatment Cycle 2|Not otherwise specified|0|||
27922937|NCT01261611|54579786|FG002|Treatment Cycle 2|Not otherwise specified|0|||
27922938|NCT01261611|54579784|FG000|Treatment Cycle 3|Completed study|24|||
27922939|NCT01261611|54579785|FG001|Treatment Cycle 3|Completed study|0|||
27922940|NCT01261611|54579786|FG002|Treatment Cycle 3|Completed study|0|||
27922941|NCT01261611|54579784|FG000|Treatment Cycle 3|Withdrawal by Subject|4|||
27922942|NCT01261611|54579785|FG001|Treatment Cycle 3|Withdrawal by Subject|0|||
27922943|NCT01261611|54579786|FG002|Treatment Cycle 3|Withdrawal by Subject|0|||
27922944|NCT01261611|54579784|FG000|Treatment Cycle 3|Adverse Event|1|||
27922945|NCT01261611|54579785|FG001|Treatment Cycle 3|Adverse Event|0|||
27922946|NCT01261611|54579786|FG002|Treatment Cycle 3|Adverse Event|0|||
27922947|NCT01261611|54579784|FG000|Treatment Cycle 3|Lost to Follow-up|1|||
27922948|NCT01261611|54579785|FG001|Treatment Cycle 3|Lost to Follow-up|0|||
27922949|NCT01261611|54579786|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
27922950|NCT01261611|54579784|FG000|Treatment Cycle 4|Completed study|87|||
27922951|NCT01261611|54579785|FG001|Treatment Cycle 4|Completed study|0|||
27922952|NCT01261611|54579786|FG002|Treatment Cycle 4|Completed study|0|||
27922953|NCT01261611|54579784|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
27922954|NCT01261611|54579785|FG001|Treatment Cycle 4|Withdrawal by Subject|0|||
27922955|NCT01261611|54579786|FG002|Treatment Cycle 4|Withdrawal by Subject|0|||
27922956|NCT01261611|54579784|FG000|Treatment Cycle 4|Adverse Event|1|||
27922957|NCT01261611|54579785|FG001|Treatment Cycle 4|Adverse Event|0|||
27922958|NCT01261611|54579786|FG002|Treatment Cycle 4|Adverse Event|0|||
27922959|NCT01261611|54579784|FG000|Treatment Cycle 4|Lost to Follow-up|2|||
27922960|NCT01261611|54579785|FG001|Treatment Cycle 4|Lost to Follow-up|0|||
27922961|NCT01261611|54579786|FG002|Treatment Cycle 4|Lost to Follow-up|0|||
27922962|NCT01261611|54579784|FG000|Treatment Cycle 4|Not otherwise specified|3|||
27922963|NCT01261611|54579785|FG001|Treatment Cycle 4|Not otherwise specified|0|||
27922964|NCT01261611|54579786|FG002|Treatment Cycle 4|Not otherwise specified|0|||
27922965|NCT01261611|54579784|FG000|Treatment Cycle 5|Withdrawal by Subject|1|||
27922966|NCT01261611|54579785|FG001|Treatment Cycle 5|Withdrawal by Subject|0|||
27922967|NCT01261611|54579786|FG002|Treatment Cycle 5|Withdrawal by Subject|0|||
27922968|NCT01261611|54579784|FG000|Treatment Cycle 5|Adverse Event|1|||
27922969|NCT01261611|54579785|FG001|Treatment Cycle 5|Adverse Event|0|||
27922970|NCT01261611|54579786|FG002|Treatment Cycle 5|Adverse Event|0|||
27922971|NCT01261611|54579784|FG000|Treatment Cycle 5|Lost to Follow-up|1|||
27922972|NCT01261611|54579785|FG001|Treatment Cycle 5|Lost to Follow-up|0|||
27922973|NCT01261611|54579786|FG002|Treatment Cycle 5|Lost to Follow-up|0|||
27922974|NCT01304706|54579798|FG000|Overall Study|Adverse Event|2|||
27922975|NCT01304706|54579798|FG000|Overall Study|Lack of Efficacy|1|||
27922976|NCT01304706|54579798|FG000|Overall Study|Death|3|||
27922977|NCT01304706|54579798|FG000|Overall Study|Withdrawal by Subject|3|||
27922978|NCT01304706|54579798|FG000|Overall Study|Lost to Follow-up|7|||
27922979|NCT01304706|54579798|FG000|Overall Study|Discontinued due to failed drug admin.|1|||
27922980|NCT01303380|54579802|FG000|Overall Study|Lack of compliance to study procedures|1|||
27922981|NCT01008553|54579806|FG000|Period 1 (Titration Period)|Physician Decision|2|||
27922982|NCT01008553|54579807|FG001|Period 1 (Titration Period)|Physician Decision|0|||
27922983|NCT01008553|54579808|FG002|Period 1 (Titration Period)|Physician Decision|0|||
27922984|NCT01008553|54579806|FG000|Period 1 (Titration Period)|Adverse Event|33|||
27922985|NCT01008553|54579807|FG001|Period 1 (Titration Period)|Adverse Event|0|||
27922986|NCT01008553|54579808|FG002|Period 1 (Titration Period)|Adverse Event|0|||
27922987|NCT01008553|54579806|FG000|Period 1 (Titration Period)|Withdrawal by Subject|6|||
27922988|NCT01008553|54579807|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
27922989|NCT01008553|54579808|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
27922990|NCT01008553|54579806|FG000|Period 1 (Titration Period)|Determined to increase dosage|3|||
27922991|NCT01008553|54579807|FG001|Period 1 (Titration Period)|Determined to increase dosage|0|||
27922992|NCT01008553|54579808|FG002|Period 1 (Titration Period)|Determined to increase dosage|0|||
27922993|NCT01008553|54579806|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50|||
27922994|NCT01008553|54579807|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
27922995|NCT01008553|54579808|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
27922996|NCT01008553|54579806|FG000|Period 1 (Titration Period)|Not appropriate for this study|1|||
27922997|NCT01008553|54579807|FG001|Period 1 (Titration Period)|Not appropriate for this study|0|||
27922998|NCT01008553|54579808|FG002|Period 1 (Titration Period)|Not appropriate for this study|0|||
27922999|NCT01008553|54579806|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
27923000|NCT01008553|54579807|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
27923001|NCT01008553|54579808|FG002|Period 2 (Double-Blind Period)|Physician Decision|2|||
27923002|NCT01008553|54579806|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
27923003|NCT01008553|54579807|FG001|Period 2 (Double-Blind Period)|Adverse Event|14|||
27923004|NCT01008553|54579808|FG002|Period 2 (Double-Blind Period)|Adverse Event|4|||
27923005|NCT01008553|54579806|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
27923006|NCT01008553|54579807|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
27923007|NCT01008553|54579808|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
27923008|NCT01008553|54579806|FG000|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
27923009|NCT01008553|54579807|FG001|Period 2 (Double-Blind Period)|Impossible to perform required tests|1|||
27923010|NCT01008553|54579808|FG002|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
27923011|NCT01008553|54579806|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
27923012|NCT01008553|54579807|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1|||
27923013|NCT01008553|54579808|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4|||
27923014|NCT01008553|54579806|FG000|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
27923015|NCT01008553|54579807|FG001|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
27923016|NCT01008553|54579808|FG002|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3|||
27923017|NCT01008553|54579806|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
27923018|NCT01008553|54579807|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
27923019|NCT01008553|54579808|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
27923020|NCT01008553|54579806|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
27923021|NCT01008553|54579807|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18|||
27923022|NCT01008553|54579808|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35|||
27923023|NCT01302834|54579819|FG000|Overall Study|Protocol Violation|17|||
27923024|NCT01302834|54579820|FG001|Overall Study|Protocol Violation|23|||
27923025|NCT01302834|54579819|FG000|Overall Study|HIV positive|1|||
27923026|NCT01302834|54579820|FG001|Overall Study|HIV positive|3|||
27923027|NCT01259115|54579826|FG000|Period 1|Adverse Event|1|||
27923028|NCT01259115|54579827|FG001|Period 1|Adverse Event|0|||
27923029|NCT01259115|54579826|FG000|Period 1|Protocol Violation|2|||
27923030|NCT01259115|54579827|FG001|Period 1|Protocol Violation|0|||
27923031|NCT01259115|54579826|FG000|Period 1|Lost to Follow-up|0|||
27923032|NCT01259115|54579827|FG001|Period 1|Lost to Follow-up|1|||
27923033|NCT01259115|54579826|FG000|Period 2|Adverse Event|1|||
27923034|NCT01259115|54579827|FG001|Period 2|Adverse Event|0|||
27923035|NCT01302366|54579838|FG000|Overall Study|patient choice or noncompliance|5|||
27923036|NCT01302054|54579842|FG000|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4|||
27923037|NCT01302054|54579843|FG001|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
27923038|NCT01302054|54579844|FG002|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
27923039|NCT01302054|54579842|FG000|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17|||
27923040|NCT01302054|54579843|FG001|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
27923041|NCT01302054|54579844|FG002|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
27923042|NCT01302054|54579842|FG000|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16|||
27923043|NCT01302054|54579843|FG001|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
27923044|NCT01302054|54579844|FG002|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
27923045|NCT01302054|54579842|FG000|Tolterodine Open-Label Run-In Phase|Protocol Violation|8|||
27923046|NCT01302054|54579843|FG001|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
27923047|NCT01302054|54579844|FG002|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
27923048|NCT01302054|54579842|FG000|Tolterodine Open-Label Run-In Phase|Adverse Event|13|||
27923049|NCT01302054|54579843|FG001|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
27923050|NCT01302054|54579844|FG002|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
27923051|NCT01302054|54579842|FG000|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314|||
27923052|NCT01302054|54579843|FG001|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
27923053|NCT01302054|54579844|FG002|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
27923054|NCT01302054|54579842|FG000|Tolterodine Open-Label Run-In Phase|Other|7|||
27923055|NCT01302054|54579843|FG001|Tolterodine Open-Label Run-In Phase|Other|0|||
27923056|NCT01302054|54579844|FG002|Tolterodine Open-Label Run-In Phase|Other|0|||
27923057|NCT01302054|54579842|FG000|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2|||
27923058|NCT01302054|54579843|FG001|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
27923059|NCT01302054|54579844|FG002|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
27923060|NCT01302054|54579842|FG000|Double-Blind Treatment Phase|Lack of Efficacy|0|||
27923061|NCT01302054|54579843|FG001|Double-Blind Treatment Phase|Lack of Efficacy|2|||
27923062|NCT01302054|54579844|FG002|Double-Blind Treatment Phase|Lack of Efficacy|4|||
27923063|NCT01302054|54579842|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
27923064|NCT01302054|54579843|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
27923065|NCT01302054|54579844|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
27923066|NCT01302054|54579842|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
27923067|NCT01302054|54579843|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|6|||
27923068|NCT01302054|54579844|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|14|||
27923069|NCT01302054|54579842|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
27923070|NCT01302054|54579843|FG001|Double-Blind Treatment Phase|Protocol Violation|3|||
27923071|NCT01302054|54579844|FG002|Double-Blind Treatment Phase|Protocol Violation|6|||
27923072|NCT01302054|54579842|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
27923073|NCT01302054|54579843|FG001|Double-Blind Treatment Phase|Adverse Event|10|||
27923074|NCT01302054|54579844|FG002|Double-Blind Treatment Phase|Adverse Event|10|||
27923075|NCT01302054|54579842|FG000|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
27923076|NCT01302054|54579843|FG001|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
27923077|NCT01302054|54579844|FG002|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2|||
27923078|NCT01302054|54579842|FG000|Double-Blind Treatment Phase|Other|0|||
27923079|NCT01302054|54579843|FG001|Double-Blind Treatment Phase|Other|4|||
27923080|NCT01302054|54579844|FG002|Double-Blind Treatment Phase|Other|9|||
27923081|NCT01301508|54579855|FG000|Overall Study|Withdrawal by Subject|1|||
27923082|NCT01301508|54579856|FG001|Overall Study|Withdrawal by Subject|2|||
27923083|NCT01301508|54579855|FG000|Overall Study|Lost to Follow-up|0|||
27923084|NCT01301508|54579856|FG001|Overall Study|Lost to Follow-up|1|||
27923085|NCT01301274|54579864|FG000|Overall Study|Physician Decision|2|||
27923086|NCT01301274|54579865|FG001|Overall Study|Physician Decision|1|||
27923087|NCT01300650|54579876|FG000|Overall Study|Adverse Event|1|||
27923088|NCT01300572|54579881|FG000|Overall Study|HAMA + post dosimetry|1|||
27923089|NCT01077154|54579888|FG000|Overall Study|Protocol-specified Criteria: Study Ended|1524|||
27923090|NCT01077154|54579889|FG001|Overall Study|Protocol-specified Criteria: Study Ended|1514|||
27923091|NCT01077154|54579888|FG000|Overall Study|Withdrawal by Subject|369|||
27923092|NCT01077154|54579889|FG001|Overall Study|Withdrawal by Subject|385|||
27923093|NCT01077154|54579888|FG000|Overall Study|Death|215|||
27923094|NCT01077154|54579889|FG001|Overall Study|Death|214|||
27923095|NCT01077154|54579888|FG000|Overall Study|Lost to Follow-up|43|||
27923096|NCT01077154|54579889|FG001|Overall Study|Lost to Follow-up|35|||
27923097|NCT01077154|54579888|FG000|Overall Study|Noncompliance|22|||
27923098|NCT01077154|54579889|FG001|Overall Study|Noncompliance|20|||
27923099|NCT01077154|54579888|FG000|Overall Study|Disease Progression|18|||
27923100|NCT01077154|54579889|FG001|Overall Study|Disease Progression|20|||
27923101|NCT01077154|54579888|FG000|Overall Study|Ineligibility Determined|10|||
27923102|NCT01077154|54579889|FG001|Overall Study|Ineligibility Determined|14|||
27923103|NCT01077154|54579888|FG000|Overall Study|Other|14|||
27923104|NCT01077154|54579889|FG001|Overall Study|Other|11|||
27923105|NCT01077154|54579888|FG000|Overall Study|Adverse Event|9|||
27923106|NCT01077154|54579889|FG001|Overall Study|Adverse Event|9|||
27923107|NCT01077154|54579888|FG000|Overall Study|Administrative Decision|1|||
27923108|NCT01077154|54579889|FG001|Overall Study|Administrative Decision|6|||
27923109|NCT01077154|54579888|FG000|Overall Study|Protocol Deviation|1|||
27923110|NCT01077154|54579889|FG001|Overall Study|Protocol Deviation|0|||
27923111|NCT01258101|54579899|FG000|Overall Study|Adverse Event|5|||
27923112|NCT01258101|54579900|FG001|Overall Study|Adverse Event|6|||
27923113|NCT01258101|54579901|FG002|Overall Study|Adverse Event|0|||
27923114|NCT01258101|54579902|FG003|Overall Study|Adverse Event|0|||
27923115|NCT01258101|54579899|FG000|Overall Study|Extra exclusion criterion amended|2|||
27923116|NCT01258101|54579900|FG001|Overall Study|Extra exclusion criterion amended|1|||
27923117|NCT01258101|54579901|FG002|Overall Study|Extra exclusion criterion amended|1|||
27923118|NCT01258101|54579902|FG003|Overall Study|Extra exclusion criterion amended|1|||
27923119|NCT01258101|54579899|FG000|Overall Study|Informed consent has been withdrawn|2|||
27923120|NCT01258101|54579900|FG001|Overall Study|Informed consent has been withdrawn|2|||
27923121|NCT01258101|54579901|FG002|Overall Study|Informed consent has been withdrawn|1|||
27923122|NCT01258101|54579902|FG003|Overall Study|Informed consent has been withdrawn|1|||
27923123|NCT01258101|54579899|FG000|Overall Study|Patient is not able to attend visits|8|||
27923124|NCT01258101|54579900|FG001|Overall Study|Patient is not able to attend visits|9|||
27923125|NCT01258101|54579901|FG002|Overall Study|Patient is not able to attend visits|7|||
27923126|NCT01258101|54579902|FG003|Overall Study|Patient is not able to attend visits|6|||
27923127|NCT01258101|54579899|FG000|Overall Study|Patient´s compliance|4|||
27923128|NCT01258101|54579900|FG001|Overall Study|Patient´s compliance|3|||
27923129|NCT01258101|54579901|FG002|Overall Study|Patient´s compliance|1|||
27923130|NCT01258101|54579902|FG003|Overall Study|Patient´s compliance|2|||
27923131|NCT01258101|54579899|FG000|Overall Study|Lost to Follow-up|5|||
27923132|NCT01258101|54579900|FG001|Overall Study|Lost to Follow-up|5|||
27923133|NCT01258101|54579901|FG002|Overall Study|Lost to Follow-up|0|||
27923134|NCT01258101|54579902|FG003|Overall Study|Lost to Follow-up|6|||
27923135|NCT01258101|54579899|FG000|Overall Study|PCR positive at week 24|0|||
27923136|NCT01258101|54579900|FG001|Overall Study|PCR positive at week 24|0|||
27923137|NCT01258101|54579901|FG002|Overall Study|PCR positive at week 24|0|||
27923138|NCT01258101|54579902|FG003|Overall Study|PCR positive at week 24|1|||
27923139|NCT01258101|54579899|FG000|Overall Study|Other reason|7|||
27923140|NCT01258101|54579900|FG001|Overall Study|Other reason|8|||
27923141|NCT01258101|54579901|FG002|Overall Study|Other reason|1|||
27923142|NCT01258101|54579902|FG003|Overall Study|Other reason|8|||
27923143|NCT01300338|54579914|FG000|Overall Study|Lost to Follow-up|5|||
27923144|NCT01300338|54579915|FG001|Overall Study|Lost to Follow-up|0|||
27923145|NCT01300260|54579923|FG000|Period 1 of Study: First Intervention|Adverse Event|0|||
27923146|NCT01300260|54579924|FG001|Period 1 of Study: First Intervention|Adverse Event|1|||
27923147|NCT01300260|54579923|FG000|Period 1 of Study: First Intervention|Withdrawal by Subject|1|||
27923148|NCT01300260|54579924|FG001|Period 1 of Study: First Intervention|Withdrawal by Subject|0|||
27923149|NCT01300260|54579923|FG000|Period 2 of Study: Second Intervention|Adverse Event|0|||
27923150|NCT01300260|54579924|FG001|Period 2 of Study: Second Intervention|Adverse Event|1|||
27923151|NCT01256385|54579943|FG000|Overall Study|Physician Decision|1|||
27923152|NCT01256385|54579944|FG001|Overall Study|Physician Decision|1|||
27923153|NCT01256385|54579943|FG000|Overall Study|Withdrawal by Subject|2|||
27923154|NCT01256385|54579944|FG001|Overall Study|Withdrawal by Subject|2|||
27923155|NCT01298778|54579952|FG000|Overall Study|Lost to Follow-up|2|||
27923156|NCT01298778|54579953|FG001|Overall Study|Lost to Follow-up|3|||
27923157|NCT01298778|54579952|FG000|Overall Study|Incorrect use of VAS|1|||
27923158|NCT01298778|54579953|FG001|Overall Study|Incorrect use of VAS|0|||
27923159|NCT01298778|54579952|FG000|Overall Study|Withdrawal by Subject|0|||
27923160|NCT01298778|54579953|FG001|Overall Study|Withdrawal by Subject|1|||
27923161|NCT01298778|54579952|FG000|Overall Study|Protocol Violation|0|||
27923162|NCT01298778|54579953|FG001|Overall Study|Protocol Violation|1|||
27923163|NCT01298778|54579952|FG000|Overall Study|not meet inclusion/exclusion criteria|0|||
27923164|NCT01298778|54579953|FG001|Overall Study|not meet inclusion/exclusion criteria|1|||
27923165|NCT01298700|54579963|FG000|Overall Study|Adverse Event|50|||
27923166|NCT01298700|54579964|FG001|Overall Study|Adverse Event|51|||
27923167|NCT01298700|54579963|FG000|Overall Study|Lack of Efficacy|9|||
27923168|NCT01298700|54579964|FG001|Overall Study|Lack of Efficacy|14|||
27923169|NCT01298700|54579963|FG000|Overall Study|Lost to Follow-up|5|||
27923170|NCT01298700|54579964|FG001|Overall Study|Lost to Follow-up|2|||
27923171|NCT01298700|54579963|FG000|Overall Study|Withdrawal by Subject|12|||
27923172|NCT01298700|54579964|FG001|Overall Study|Withdrawal by Subject|9|||
27923173|NCT01298700|54579963|FG000|Overall Study|Protocol Violation|6|||
27923174|NCT01298700|54579964|FG001|Overall Study|Protocol Violation|4|||
27923175|NCT01298700|54579963|FG000|Overall Study|Other Miscellaneous Reasons|16|||
27923176|NCT01298700|54579964|FG001|Overall Study|Other Miscellaneous Reasons|15|||
27923177|NCT01298700|54579963|FG000|Overall Study|Did not Receive Study Drug|3|||
27923178|NCT01298700|54579964|FG001|Overall Study|Did not Receive Study Drug|5|||
27923179|NCT01297920|54579973|FG000|Overall Study|Adverse Event|42|||
27923180|NCT01297920|54579974|FG001|Overall Study|Adverse Event|10|||
27923181|NCT01297920|54579975|FG002|Overall Study|Adverse Event|38|||
27923182|NCT01297920|54579973|FG000|Overall Study|Patient Decision Unrelated to AE|6|||
27923183|NCT01297920|54579974|FG001|Overall Study|Patient Decision Unrelated to AE|5|||
27923184|NCT01297920|54579975|FG002|Overall Study|Patient Decision Unrelated to AE|2|||
27923185|NCT01297920|54579973|FG000|Overall Study|Noncompliance|1|||
27923186|NCT01297920|54579974|FG001|Overall Study|Noncompliance|0|||
27745510|NCT02717195|54195259|FG002|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
27745511|NCT02717195|54195260|FG003|Double-blind Treatment (DBT) Period|Lost to Follow-up|3|||
27923187|NCT01297920|54579975|FG002|Overall Study|Noncompliance|0|||
27923188|NCT01297920|54579973|FG000|Overall Study|Protocol Violation|1|||
27923189|NCT01297920|54579974|FG001|Overall Study|Protocol Violation|3|||
27923190|NCT01297920|54579975|FG002|Overall Study|Protocol Violation|0|||
27923191|NCT01297920|54579973|FG000|Overall Study|Inadequate Control of IOP|7|||
27923192|NCT01297920|54579974|FG001|Overall Study|Inadequate Control of IOP|9|||
27923193|NCT01297920|54579975|FG002|Overall Study|Inadequate Control of IOP|17|||
27923194|NCT01297920|54579973|FG000|Overall Study|Patient Did Not Meet Entrance Criteria|1|||
27923195|NCT01297920|54579974|FG001|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
27923196|NCT01297920|54579975|FG002|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
27923197|NCT01255761|54579985|FG000|Overall Study|Adverse Event|29|||
27923198|NCT01255761|54579986|FG001|Overall Study|Adverse Event|43|||
27923199|NCT01255761|54579985|FG000|Overall Study|Lack of Efficacy|86|||
27923200|NCT01255761|54579986|FG001|Overall Study|Lack of Efficacy|74|||
27923201|NCT01255761|54579985|FG000|Overall Study|Protocol Violation|9|||
27923202|NCT01255761|54579986|FG001|Overall Study|Protocol Violation|5|||
27923203|NCT01255761|54579985|FG000|Overall Study|Lost to Follow-up|10|||
27923204|NCT01255761|54579986|FG001|Overall Study|Lost to Follow-up|8|||
27923205|NCT01255761|54579985|FG000|Overall Study|Withdrawal by Subject|11|||
27923206|NCT01255761|54579986|FG001|Overall Study|Withdrawal by Subject|27|||
27923207|NCT01255761|54579985|FG000|Overall Study|Other Reasons|37|||
27923208|NCT01255761|54579986|FG001|Overall Study|Other Reasons|18|||
27923209|NCT01297062|54579998|FG000|Overall Study|Adverse Event|2|||
27923210|NCT01297062|54579999|FG001|Overall Study|Adverse Event|0|||
27923211|NCT01297062|54580000|FG002|Overall Study|Adverse Event|1|||
27923212|NCT01297062|54580001|FG003|Overall Study|Adverse Event|0|||
27923213|NCT01297062|54580002|FG004|Overall Study|Adverse Event|0|||
27923214|NCT01297062|54580003|FG005|Overall Study|Adverse Event|0|||
27923215|NCT01297062|54580004|FG006|Overall Study|Adverse Event|0|||
27923216|NCT01297062|54579998|FG000|Overall Study|Physician Decision|1|||
27923217|NCT01297062|54579999|FG001|Overall Study|Physician Decision|0|||
27923218|NCT01297062|54580000|FG002|Overall Study|Physician Decision|1|||
27923219|NCT01297062|54580001|FG003|Overall Study|Physician Decision|0|||
27923220|NCT01297062|54580002|FG004|Overall Study|Physician Decision|0|||
27923221|NCT01297062|54580003|FG005|Overall Study|Physician Decision|0|||
27923222|NCT01297062|54580004|FG006|Overall Study|Physician Decision|6|||
27923223|NCT01297062|54579998|FG000|Overall Study|Protocol Violation|0|||
27923224|NCT01297062|54579999|FG001|Overall Study|Protocol Violation|0|||
27923225|NCT01297062|54580000|FG002|Overall Study|Protocol Violation|0|||
27923226|NCT01297062|54580001|FG003|Overall Study|Protocol Violation|0|||
27923227|NCT01297062|54580002|FG004|Overall Study|Protocol Violation|1|||
27923228|NCT01297062|54580003|FG005|Overall Study|Protocol Violation|0|||
27923229|NCT01297062|54580004|FG006|Overall Study|Protocol Violation|0|||
27923230|NCT01297062|54579998|FG000|Overall Study|Subject Decision|1|||
27923231|NCT01297062|54579999|FG001|Overall Study|Subject Decision|1|||
27923232|NCT01297062|54580000|FG002|Overall Study|Subject Decision|0|||
27923233|NCT01297062|54580001|FG003|Overall Study|Subject Decision|1|||
27923234|NCT01297062|54580002|FG004|Overall Study|Subject Decision|1|||
27923235|NCT01297062|54580003|FG005|Overall Study|Subject Decision|1|||
27923236|NCT01297062|54580004|FG006|Overall Study|Subject Decision|2|||
27923237|NCT01254747|54580016|FG000|Overall Study|Unacceptable subjective vision|0|||
27923238|NCT01254747|54580017|FG001|Overall Study|Unacceptable subjective vision|0|||
27923239|NCT01254747|54580018|FG002|Overall Study|Unacceptable subjective vision|0|||
27923240|NCT01254747|54580019|FG003|Overall Study|Unacceptable subjective vision|2|||
27923241|NCT01254747|54580016|FG000|Overall Study|Difficult removal handling|0|||
27923242|NCT01254747|54580017|FG001|Overall Study|Difficult removal handling|0|||
27923243|NCT01254747|54580018|FG002|Overall Study|Difficult removal handling|1|||
27923244|NCT01254747|54580019|FG003|Overall Study|Difficult removal handling|0|||
27923245|NCT01254747|54580016|FG000|Overall Study|Symptoms and problems|0|||
27923246|NCT01254747|54580017|FG001|Overall Study|Symptoms and problems|2|||
27923247|NCT01254747|54580018|FG002|Overall Study|Symptoms and problems|1|||
27923248|NCT01254747|54580019|FG003|Overall Study|Symptoms and problems|0|||
27923249|NCT01254747|54580016|FG000|Overall Study|Lost to Follow-up|0|||
27923250|NCT01254747|54580017|FG001|Overall Study|Lost to Follow-up|0|||
27923251|NCT01254747|54580018|FG002|Overall Study|Lost to Follow-up|1|||
27923252|NCT01254747|54580019|FG003|Overall Study|Lost to Follow-up|0|||
27923253|NCT01254747|54580016|FG000|Overall Study|Biomicroscopy|0|||
27923254|NCT01254747|54580017|FG001|Overall Study|Biomicroscopy|0|||
27923255|NCT01254747|54580018|FG002|Overall Study|Biomicroscopy|1|||
27923256|NCT01254747|54580019|FG003|Overall Study|Biomicroscopy|0|||
27923257|NCT01254747|54580016|FG000|Overall Study|Discomfort|0|||
27923258|NCT01254747|54580017|FG001|Overall Study|Discomfort|4|||
27923259|NCT01254747|54580018|FG002|Overall Study|Discomfort|0|||
27923260|NCT01254747|54580019|FG003|Overall Study|Discomfort|0|||
27923261|NCT01296672|54580031|FG000|Overall Study|Lost to Follow-up|73|||
27923262|NCT01296672|54580032|FG001|Overall Study|Lost to Follow-up|18|||
27923263|NCT01254669|54580042|FG000|Overall Study|Withdrawal by Subject|0|||
27923264|NCT01254669|54580043|FG001|Overall Study|Withdrawal by Subject|1|||
27923265|NCT01254669|54580042|FG000|Overall Study|time constraint|2|||
27923266|NCT01254669|54580043|FG001|Overall Study|time constraint|2|||
27923267|NCT01254669|54580042|FG000|Overall Study|called to clinic during intervention|1|||
27923268|NCT01254669|54580043|FG001|Overall Study|called to clinic during intervention|1|||
27923269|NCT01295814|54580053|FG000|Overall Study|Lack of Efficacy|0|||
27923270|NCT01295814|54580054|FG001|Overall Study|Lack of Efficacy|2|||
27923271|NCT01295814|54580053|FG000|Overall Study|Withdrawal by Subject|2|||
27923272|NCT01295814|54580054|FG001|Overall Study|Withdrawal by Subject|0|||
27923273|NCT01254045|54580060|FG000|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1|||
27923274|NCT01254045|54580061|FG001|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
27923275|NCT01254045|54580062|FG002|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
27923276|NCT01254045|54580063|FG003|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
27923277|NCT01254045|54580064|FG004|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
27923278|NCT01254045|54580065|FG005|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
27923279|NCT01075282|54580078|FG000|Overall Study|Withdrawal by Subject|11|||
27923280|NCT01075282|54580079|FG001|Overall Study|Withdrawal by Subject|7|||
27923281|NCT01075282|54580080|FG002|Overall Study|Withdrawal by Subject|11|||
27923282|NCT01075282|54580078|FG000|Overall Study|Adverse Event|9|||
27923283|NCT01075282|54580079|FG001|Overall Study|Adverse Event|8|||
27923284|NCT01075282|54580080|FG002|Overall Study|Adverse Event|5|||
27923285|NCT01075282|54580078|FG000|Overall Study|Entry Criteria Not Met|3|||
27923286|NCT01075282|54580079|FG001|Overall Study|Entry Criteria Not Met|2|||
27923287|NCT01075282|54580080|FG002|Overall Study|Entry Criteria Not Met|0|||
27923288|NCT01075282|54580078|FG000|Overall Study|Lost to Follow-up|3|||
27923289|NCT01075282|54580079|FG001|Overall Study|Lost to Follow-up|3|||
27923290|NCT01075282|54580080|FG002|Overall Study|Lost to Follow-up|3|||
27923291|NCT01075282|54580078|FG000|Overall Study|Physician Decision|3|||
27923292|NCT01075282|54580079|FG001|Overall Study|Physician Decision|3|||
27923293|NCT01075282|54580080|FG002|Overall Study|Physician Decision|3|||
27923294|NCT01075282|54580078|FG000|Overall Study|Lack of Efficacy|1|||
27923295|NCT01075282|54580079|FG001|Overall Study|Lack of Efficacy|1|||
27923296|NCT01075282|54580080|FG002|Overall Study|Lack of Efficacy|0|||
27923297|NCT01075282|54580078|FG000|Overall Study|Treatment Non-compliance|1|||
27923298|NCT01075282|54580079|FG001|Overall Study|Treatment Non-compliance|2|||
27923299|NCT01075282|54580080|FG002|Overall Study|Treatment Non-compliance|2|||
27923300|NCT01075282|54580078|FG000|Overall Study|Protocol Violation|0|||
27923301|NCT01075282|54580079|FG001|Overall Study|Protocol Violation|2|||
27923302|NCT01075282|54580080|FG002|Overall Study|Protocol Violation|1|||
27923303|NCT01075282|54580078|FG000|Overall Study|Death|0|||
27923304|NCT01075282|54580079|FG001|Overall Study|Death|1|||
27923305|NCT01075282|54580080|FG002|Overall Study|Death|2|||
27923306|NCT01253811|54580089|FG000|Overall Study|Withdrawal criteria|1|||
27923307|NCT01295580|54580095|FG000|Overall Study|Protocol Violation|4|||
27923308|NCT01295580|54580096|FG001|Overall Study|Protocol Violation|2|||
27923309|NCT01295580|54580095|FG000|Overall Study|Withdrawal by Subject|1|||
27923310|NCT01295580|54580096|FG001|Overall Study|Withdrawal by Subject|4|||
27923311|NCT01295580|54580095|FG000|Overall Study|Adverse Event|2|||
27923312|NCT01295580|54580096|FG001|Overall Study|Adverse Event|1|||
27923313|NCT01295580|54580095|FG000|Overall Study|Lost to Follow-up|1|||
27923314|NCT01295580|54580096|FG001|Overall Study|Lost to Follow-up|0|||
27923315|NCT01295580|54580095|FG000|Overall Study|Lack of Efficacy|1|||
27923316|NCT01295580|54580096|FG001|Overall Study|Lack of Efficacy|0|||
27923317|NCT01295580|54580095|FG000|Overall Study|Other: inconvenience|1|||
27923318|NCT01295580|54580096|FG001|Overall Study|Other: inconvenience|0|||
27923319|NCT01295580|54580095|FG000|Overall Study|Other: family objection|0|||
27923320|NCT01295580|54580096|FG001|Overall Study|Other: family objection|1|||
27923321|NCT01253577|54580102|FG000|Overall Study|Lost to Follow-up|3|||
27923322|NCT01295034|54580110|FG000|Overall Study|Lost to Follow-up|5|||
27923323|NCT01295034|54580111|FG001|Overall Study|Lost to Follow-up|5|||
27923324|NCT01253421|54580122|FG000|Assessment and Scheduling|Found to be Ineligible|74|||
27923325|NCT01253421|54580123|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
27923326|NCT01253421|54580124|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
27923327|NCT01253421|54580125|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
27923328|NCT01253421|54580126|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
27923329|NCT01253421|54580122|FG000|Assessment and Scheduling|Lost to Follow-up|17|||
27923330|NCT01253421|54580123|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
27923331|NCT01253421|54580124|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
27923332|NCT01253421|54580125|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
27923333|NCT01253421|54580126|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
27923334|NCT01253421|54580122|FG000|Assessment and Scheduling|Withdrawal by Subject|7|||
27923335|NCT01253421|54580123|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
27923336|NCT01253421|54580124|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
27923337|NCT01253421|54580125|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
27923338|NCT01253421|54580126|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
27923339|NCT01253421|54580122|FG000|Assessment and Scheduling|Physician Decision|1|||
27923340|NCT01253421|54580123|FG001|Assessment and Scheduling|Physician Decision|0|||
27923341|NCT01253421|54580124|FG002|Assessment and Scheduling|Physician Decision|0|||
27923342|NCT01253421|54580125|FG003|Assessment and Scheduling|Physician Decision|0|||
27923343|NCT01253421|54580126|FG004|Assessment and Scheduling|Physician Decision|0|||
27923344|NCT01253421|54580122|FG000|Drug+Scanning Visit|Physician Decision|0|||
27923345|NCT01253421|54580123|FG001|Drug+Scanning Visit|Physician Decision|0|||
27923346|NCT01253421|54580124|FG002|Drug+Scanning Visit|Physician Decision|0|||
27923347|NCT01253421|54580125|FG003|Drug+Scanning Visit|Physician Decision|0|||
27923348|NCT01253421|54580126|FG004|Drug+Scanning Visit|Physician Decision|1|||
27923349|NCT01077076|54580136|FG000|First Intervention|Withdrawal by Subject|1|||
27923350|NCT01077076|54580137|FG001|First Intervention|Withdrawal by Subject|0|||
27923351|NCT01077076|54580138|FG002|First Intervention|Withdrawal by Subject|0|||
27923352|NCT01077076|54580139|FG003|First Intervention|Withdrawal by Subject|0|||
27923353|NCT01077076|54580140|FG004|First Intervention|Withdrawal by Subject|0|||
27923354|NCT01077076|54580141|FG005|First Intervention|Withdrawal by Subject|0|||
27923355|NCT01077076|54580136|FG000|Third Intervention|Death in the participant's family|0|||
27923356|NCT01077076|54580137|FG001|Third Intervention|Death in the participant's family|0|||
27923357|NCT01077076|54580138|FG002|Third Intervention|Death in the participant's family|0|||
27923358|NCT01077076|54580139|FG003|Third Intervention|Death in the participant's family|0|||
27923359|NCT01077076|54580140|FG004|Third Intervention|Death in the participant's family|0|||
27923360|NCT01077076|54580141|FG005|Third Intervention|Death in the participant's family|1|||
27923361|NCT01294800|54580153|FG000|Overall Study|Adverse Event|7|||
27923362|NCT01294800|54580154|FG001|Overall Study|Adverse Event|6|||
27923363|NCT01294800|54580155|FG002|Overall Study|Adverse Event|12|||
27923364|NCT01294800|54580156|FG003|Overall Study|Adverse Event|5|||
27923365|NCT01294800|54580153|FG000|Overall Study|Subject Withdrew Consent|2|||
27923366|NCT01294800|54580154|FG001|Overall Study|Subject Withdrew Consent|2|||
27923367|NCT01294800|54580155|FG002|Overall Study|Subject Withdrew Consent|2|||
27923368|NCT01294800|54580156|FG003|Overall Study|Subject Withdrew Consent|11|||
27923369|NCT01294800|54580153|FG000|Overall Study|Lost to Follow-up|0|||
27923370|NCT01294800|54580154|FG001|Overall Study|Lost to Follow-up|0|||
27923371|NCT01294800|54580155|FG002|Overall Study|Lost to Follow-up|1|||
27923372|NCT01294800|54580156|FG003|Overall Study|Lost to Follow-up|0|||
27923373|NCT01294800|54580153|FG000|Overall Study|Non-compliance With Protocol|0|||
27923374|NCT01294800|54580154|FG001|Overall Study|Non-compliance With Protocol|1|||
27923375|NCT01294800|54580155|FG002|Overall Study|Non-compliance With Protocol|1|||
27923376|NCT01294800|54580156|FG003|Overall Study|Non-compliance With Protocol|0|||
27923377|NCT01294800|54580153|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
27923378|NCT01294800|54580154|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
27923379|NCT01294800|54580155|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
27923380|NCT01294800|54580156|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
27923381|NCT01294644|54580169|FG000|Overall Study|Adverse Event|2|||
27923382|NCT01294644|54580170|FG001|Overall Study|Adverse Event|0|||
27923383|NCT01294644|54580171|FG002|Overall Study|Adverse Event|1|||
27923384|NCT01294644|54580169|FG000|Overall Study|Withdrawal by Subject|3|||
27923385|NCT01294644|54580170|FG001|Overall Study|Withdrawal by Subject|7|||
27923386|NCT01294644|54580171|FG002|Overall Study|Withdrawal by Subject|4|||
27923387|NCT01294644|54580169|FG000|Overall Study|Lost to Follow-up|3|||
27923388|NCT01294644|54580170|FG001|Overall Study|Lost to Follow-up|2|||
27923389|NCT01294644|54580171|FG002|Overall Study|Lost to Follow-up|5|||
27923390|NCT01294644|54580169|FG000|Overall Study|Miscellaneous Reason|2|||
27923391|NCT01294644|54580170|FG001|Overall Study|Miscellaneous Reason|1|||
27923392|NCT01294644|54580171|FG002|Overall Study|Miscellaneous Reason|4|||
27745512|NCT02717195|54195261|FG004|Double-blind Treatment (DBT) Period|Lost to Follow-up|2|||
27745513|NCT02717195|54195257|FG000|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
27745514|NCT02717195|54195258|FG001|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
27745515|NCT02717195|54195259|FG002|Double-blind Treatment (DBT) Period|Enrolled but not treated|1|||
27745516|NCT02717195|54195260|FG003|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
27745517|NCT02717195|54195261|FG004|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
27745518|NCT02717195|54195257|FG000|Double-blind Treatment (DBT) Period|Patient decision|0|||
27745519|NCT02717195|54195258|FG001|Double-blind Treatment (DBT) Period|Patient decision|0|||
27745520|NCT02717195|54195259|FG002|Double-blind Treatment (DBT) Period|Patient decision|0|||
27745521|NCT02717195|54195260|FG003|Double-blind Treatment (DBT) Period|Patient decision|2|||
27745522|NCT02717195|54195261|FG004|Double-blind Treatment (DBT) Period|Patient decision|2|||
27745523|NCT02717195|54195257|FG000|Double-blind Treatment (DBT) Period|Investigator decision|0|||
27745524|NCT02717195|54195258|FG001|Double-blind Treatment (DBT) Period|Investigator decision|0|||
27745525|NCT02717195|54195259|FG002|Double-blind Treatment (DBT) Period|Investigator decision|0|||
27745526|NCT02717195|54195260|FG003|Double-blind Treatment (DBT) Period|Investigator decision|1|||
27745527|NCT02717195|54195261|FG004|Double-blind Treatment (DBT) Period|Investigator decision|1|||
27923393|NCT01293240|54580179|FG000|Overall Study|Noncompliance|2|||
27923394|NCT01253265|54580188|FG000|Overall Study|Met Predefined Discontinuation Criteria|1|||
27923395|NCT01253265|54580189|FG001|Overall Study|Met Predefined Discontinuation Criteria|0|||
27745528|NCT02717195|54195257|FG000|Double-blind Treatment (DBT) Period|Family circumstances|0|||
27745529|NCT02717195|54195258|FG001|Double-blind Treatment (DBT) Period|Family circumstances|0|||
27745530|NCT02717195|54195259|FG002|Double-blind Treatment (DBT) Period|Family circumstances|0|||
27745531|NCT02717195|54195260|FG003|Double-blind Treatment (DBT) Period|Family circumstances|0|||
27745532|NCT02717195|54195261|FG004|Double-blind Treatment (DBT) Period|Family circumstances|1|||
27745533|NCT02717195|54195257|FG000|Double-blind Treatment (DBT) Period|Change of residence|0|||
27745534|NCT02717195|54195258|FG001|Double-blind Treatment (DBT) Period|Change of residence|0|||
27745535|NCT02717195|54195259|FG002|Double-blind Treatment (DBT) Period|Change of residence|0|||
27745536|NCT02717195|54195260|FG003|Double-blind Treatment (DBT) Period|Change of residence|1|||
27745537|NCT02717195|54195261|FG004|Double-blind Treatment (DBT) Period|Change of residence|1|||
27745538|NCT02717195|54195257|FG000|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
27745539|NCT02717195|54195258|FG001|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
27745540|NCT02717195|54195259|FG002|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
27745541|NCT02717195|54195260|FG003|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
27745542|NCT02717195|54195261|FG004|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1|||
27745543|NCT02717195|54195257|FG000|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
27745544|NCT02717195|54195258|FG001|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
27745545|NCT02717195|54195259|FG002|Double-blind Treatment (DBT) Period|Psychosocial issues|1|||
27745546|NCT02717195|54195260|FG003|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
27745547|NCT02717195|54195261|FG004|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
27745548|NCT02717195|54195257|FG000|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
27745549|NCT02717195|54195258|FG001|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
27745550|NCT02717195|54195259|FG002|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
27745551|NCT02717195|54195260|FG003|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
27745552|NCT02717195|54195261|FG004|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
27745553|NCT00701441|54195276|FG000|Overall Study|failure in cpap compliance|0|||
27745554|NCT00701441|54195277|FG001|Overall Study|failure in cpap compliance|4|||
27745555|NCT02628873|54195289|FG000|Break (1 Hour)|Withdrawal by Subject|0|||
27745556|NCT02628873|54195290|FG001|Break (1 Hour)|Withdrawal by Subject|1|||
27745557|NCT02628873|54195289|FG000|Second Test (1 Hour)|Physician Decision|1|||
27745558|NCT02628873|54195290|FG001|Second Test (1 Hour)|Physician Decision|0|||
27745559|NCT02629965|54195300|FG000|Period 1|Adverse Event|1|||
27745560|NCT02629965|54195301|FG001|Period 1|Adverse Event|0|||
27745561|NCT02629965|54195300|FG000|Period 1|Unexpected worsening of disease|2|||
27745562|NCT02629965|54195301|FG001|Period 1|Unexpected worsening of disease|0|||
27745563|NCT02629965|54195300|FG000|Period 1|Other than listed above|1|||
27745564|NCT02629965|54195301|FG001|Period 1|Other than listed above|2|||
27745565|NCT02629965|54195300|FG000|Period 2|Adverse Event|1|||
27745566|NCT02629965|54195301|FG001|Period 2|Adverse Event|0|||
27745567|NCT01671111|54195307|FG000|Overall Study|Adverse Event|2|||
27745568|NCT01671111|54195307|FG000|Overall Study|Lack of Efficacy|1|||
27745569|NCT01671111|54195307|FG000|Overall Study|Withdrawal by Subject|2|||
27745570|NCT01671111|54195307|FG000|Overall Study|Physician Decision|1|||
27745571|NCT01671111|54195307|FG000|Overall Study|Other|24|||
27745572|NCT01671345|54195313|FG000|Overall Study|Lost to Follow-up|10|||
27745573|NCT01671345|54195314|FG001|Overall Study|Lost to Follow-up|6|||
27745574|NCT01671345|54195313|FG000|Overall Study|visit with non-participating physician|3|||
27745575|NCT01671345|54195314|FG001|Overall Study|visit with non-participating physician|3|||
27745576|NCT04338321|54195336|FG000|Overall Study|Adverse Event|4|||
27745577|NCT04338321|54195337|FG001|Overall Study|Adverse Event|10|||
27745578|NCT04338321|54195336|FG000|Overall Study|Death|1|||
27745579|NCT04338321|54195337|FG001|Overall Study|Death|1|||
27745580|NCT04338321|54195336|FG000|Overall Study|Lost to Follow-up|4|||
27745581|NCT04338321|54195337|FG001|Overall Study|Lost to Follow-up|9|||
27745582|NCT04338321|54195336|FG000|Overall Study|Withdrawal by Subject|45|||
27745583|NCT04338321|54195337|FG001|Overall Study|Withdrawal by Subject|69|||
27745584|NCT04338321|54195336|FG000|Overall Study|Physician Decision|5|||
27923396|NCT01253265|54580190|FG002|Overall Study|Met Predefined Discontinuation Criteria|0|||
27923397|NCT01253265|54580191|FG003|Overall Study|Met Predefined Discontinuation Criteria|0|||
27923398|NCT01253265|54580192|FG004|Overall Study|Met Predefined Discontinuation Criteria|0|||
27923399|NCT01253265|54580188|FG000|Overall Study|Withdrawal by Subject|0|||
27923400|NCT01253265|54580189|FG001|Overall Study|Withdrawal by Subject|0|||
27923401|NCT01253265|54580190|FG002|Overall Study|Withdrawal by Subject|0|||
27923402|NCT01253265|54580191|FG003|Overall Study|Withdrawal by Subject|0|||
27923403|NCT01253265|54580192|FG004|Overall Study|Withdrawal by Subject|1|||
27923404|NCT01293084|54580204|FG000|Overall Study|Physician Decision|3|||
27923405|NCT01293084|54580204|FG000|Overall Study|Withdrawal by Subject|2|||
27923406|NCT01293006|54580214|FG000|Period 2|Lost to Follow-up|1|||
27923407|NCT01293006|54580215|FG001|Period 2|Lost to Follow-up|0|||
27923408|NCT01293006|54580216|FG002|Period 2|Lost to Follow-up|0|||
27923409|NCT01293006|54580217|FG003|Period 2|Lost to Follow-up|0|||
27923410|NCT01253187|54580236|FG000|Period 2|Withdrawal by Subject|0|||
27923411|NCT01253187|54580237|FG001|Period 2|Withdrawal by Subject|0|||
27923412|NCT01253187|54580238|FG002|Period 2|Withdrawal by Subject|0|||
27923413|NCT01253187|54580239|FG003|Period 2|Withdrawal by Subject|0|||
27923414|NCT01253187|54580240|FG004|Period 2|Withdrawal by Subject|1|||
27923415|NCT01253187|54580241|FG005|Period 2|Withdrawal by Subject|0|||
27923416|NCT01253187|54580236|FG000|Period 3|Pregnancy|1|||
27923417|NCT01253187|54580237|FG001|Period 3|Pregnancy|0|||
27923418|NCT01253187|54580238|FG002|Period 3|Pregnancy|0|||
27923419|NCT01253187|54580239|FG003|Period 3|Pregnancy|0|||
27923420|NCT01253187|54580240|FG004|Period 3|Pregnancy|0|||
27923421|NCT01253187|54580241|FG005|Period 3|Pregnancy|0|||
27923422|NCT01253187|54580236|FG000|Period 3|difficulty with blood sampling|0|||
27923423|NCT01253187|54580237|FG001|Period 3|difficulty with blood sampling|1|||
27923424|NCT01253187|54580238|FG002|Period 3|difficulty with blood sampling|0|||
27923425|NCT01253187|54580239|FG003|Period 3|difficulty with blood sampling|0|||
27923426|NCT01253187|54580240|FG004|Period 3|difficulty with blood sampling|0|||
27923427|NCT01253187|54580241|FG005|Period 3|difficulty with blood sampling|0|||
27923428|NCT01253187|54580236|FG000|Period 3|non-compliance|0|||
27923429|NCT01253187|54580237|FG001|Period 3|non-compliance|0|||
27923430|NCT01253187|54580238|FG002|Period 3|non-compliance|0|||
27923431|NCT01253187|54580239|FG003|Period 3|non-compliance|0|||
27923432|NCT01253187|54580240|FG004|Period 3|non-compliance|1|||
27923433|NCT01253187|54580241|FG005|Period 3|non-compliance|0|||
27923434|NCT01252563|54580252|FG000|Overall Study|Contract Deviation|41|||
27923435|NCT01252563|54580252|FG000|Overall Study|Centralized Registration Deviation|30|||
27923436|NCT01252563|54580252|FG000|Overall Study|Lost to Follow-up|161|||
27923437|NCT01252563|54580252|FG000|Overall Study|No visit after first day of treatment|194|||
27923438|NCT01252563|54580252|FG000|Overall Study|No drug administration|6|||
27923439|NCT01292226|54580287|FG000|Overall Study|Adverse Event|5|||
27923440|NCT01292226|54580287|FG000|Overall Study|Death|1|||
27923441|NCT01292226|54580287|FG000|Overall Study|Graft loss|1|||
27923442|NCT01292226|54580287|FG000|Overall Study|Protocol Violation|3|||
27923443|NCT01292226|54580287|FG000|Overall Study|Withdrawal by Subject|1|||
27923444|NCT01292226|54580287|FG000|Overall Study|Other|2|||
27923445|NCT01290822|54580291|FG000|Overall Study|Withdrawal by Subject|1|||
27923446|NCT01290822|54580291|FG000|Overall Study|Physician Decision|10|||
27923447|NCT01075048|54580298|FG000|Overall Study|Death|4|||
27923448|NCT01075048|54580299|FG001|Overall Study|Death|17|||
27923449|NCT01075048|54580300|FG002|Overall Study|Death|12|||
27923450|NCT01075048|54580298|FG000|Overall Study|Start of other or new therapy|4|||
27923451|NCT01075048|54580299|FG001|Overall Study|Start of other or new therapy|36|||
27923452|NCT01075048|54580300|FG002|Overall Study|Start of other or new therapy|46|||
27923453|NCT01075048|54580298|FG000|Overall Study|Withdrawal by Subject|1|||
27923454|NCT01075048|54580299|FG001|Overall Study|Withdrawal by Subject|6|||
27923455|NCT01075048|54580300|FG002|Overall Study|Withdrawal by Subject|3|||
27923456|NCT01075048|54580298|FG000|Overall Study|Lost to Follow-up|0|||
27923457|NCT01075048|54580299|FG001|Overall Study|Lost to Follow-up|1|||
27923458|NCT01075048|54580300|FG002|Overall Study|Lost to Follow-up|1|||
27923459|NCT01290666|54580311|FG000|Overall Study|Lost to Follow-up|11|||
27923460|NCT01290666|54580311|FG000|Overall Study|Withdrawal by Subject|23|||
27923461|NCT01290666|54580311|FG000|Overall Study|Early Termination of Study|4|||
27923462|NCT01252251|54580315|FG000|Overall Study|Withdrawal by Subject|1|||
27923463|NCT01289574|54580322|FG000|Overall Study|Lack of Efficacy|4|||
27923464|NCT01289574|54580323|FG001|Overall Study|Lack of Efficacy|0|||
27923465|NCT01289574|54580324|FG002|Overall Study|Lack of Efficacy|1|||
27923466|NCT01289574|54580322|FG000|Overall Study|Lost to Follow-up|2|||
27923467|NCT01289574|54580323|FG001|Overall Study|Lost to Follow-up|0|||
27923468|NCT01289574|54580324|FG002|Overall Study|Lost to Follow-up|1|||
27923469|NCT01289574|54580322|FG000|Overall Study|Withdrawal by Subject|1|||
27923470|NCT01289574|54580323|FG001|Overall Study|Withdrawal by Subject|1|||
27923471|NCT01289574|54580324|FG002|Overall Study|Withdrawal by Subject|1|||
27923472|NCT01289574|54580322|FG000|Overall Study|Adverse Event|0|||
27923473|NCT01289574|54580323|FG001|Overall Study|Adverse Event|1|||
27923474|NCT01289574|54580324|FG002|Overall Study|Adverse Event|0|||
27923475|NCT01289574|54580322|FG000|Overall Study|Subject wanted alternate treatment|0|||
27923476|NCT01289574|54580323|FG001|Overall Study|Subject wanted alternate treatment|1|||
27923477|NCT01289574|54580324|FG002|Overall Study|Subject wanted alternate treatment|0|||
27923478|NCT01252095|54580335|FG000|Overall Study|Disease progression|1|||
27923479|NCT01252095|54580336|FG001|Overall Study|Disease progression|0|||
27923480|NCT01289418|54580345|FG000|Day 8 Survey|email address invalid|283|||
27923481|NCT01289418|54580345|FG000|Day 8 Survey|participants did not complete the survey|1935|||
27923482|NCT01289418|54580345|FG000|Day 29 Survey|email address invalid|283|||
27923483|NCT01289418|54580345|FG000|Day 29 Survey|participants did not complete the survey|2185|||
27923484|NCT01074658|54580351|FG000|Overall Study|No implant attempted|19|||
27923485|NCT01074502|54580355|FG000|Overall Study|Withdrawal by Subject|1|||
27923486|NCT01289028|54580359|FG000|Overall Study|Progressive Disease|49|||
27923487|NCT01289028|54580359|FG000|Overall Study|Adverse Event|14|||
27923488|NCT01289028|54580359|FG000|Overall Study|Withdrawal by Subject|6|||
27923489|NCT01289028|54580359|FG000|Overall Study|Death|4|||
27923490|NCT01289028|54580359|FG000|Overall Study|Lack of Efficacy|2|||
27923491|NCT01289028|54580359|FG000|Overall Study|No longer required|2|||
27923492|NCT01289028|54580359|FG000|Overall Study|Lost to Follow-up|2|||
27923493|NCT01289028|54580359|FG000|Overall Study|New Cancer Therapy|2|||
27923494|NCT01289028|54580359|FG000|Overall Study|Abnormal Lab Value|1|||
27923495|NCT01289028|54580359|FG000|Overall Study|Missing reason for discon|1|||
27923496|NCT01250925|54580368|FG000|Overall Study|Lost to Follow-up|1|||
27923497|NCT01250925|54580369|FG001|Overall Study|Lost to Follow-up|1|||
27923498|NCT01250925|54580370|FG002|Overall Study|Lost to Follow-up|0|||
27923499|NCT01250925|54580368|FG000|Overall Study|Withdrawal by Subject|2|||
27923500|NCT01250925|54580369|FG001|Overall Study|Withdrawal by Subject|0|||
27923501|NCT01250925|54580370|FG002|Overall Study|Withdrawal by Subject|0|||
27923502|NCT01250925|54580368|FG000|Overall Study|Protocol Violation|2|||
27923503|NCT01250925|54580369|FG001|Overall Study|Protocol Violation|0|||
27923504|NCT01250925|54580370|FG002|Overall Study|Protocol Violation|0|||
27923505|NCT01250925|54580368|FG000|Overall Study|Physician Decision|0|||
27923506|NCT01250925|54580369|FG001|Overall Study|Physician Decision|2|||
27923507|NCT01250925|54580370|FG002|Overall Study|Physician Decision|1|||
27923508|NCT01250925|54580368|FG000|Overall Study|Adverse Event|0|||
27923509|NCT01250925|54580369|FG001|Overall Study|Adverse Event|0|||
27923510|NCT01250925|54580370|FG002|Overall Study|Adverse Event|1|||
27923511|NCT01285908|54580378|FG000|Baseline Measurement|unable to insert catheter|1|||
27923512|NCT01285908|54580379|FG001|Baseline Measurement|unable to insert catheter|0|||
27923513|NCT01285908|54580380|FG002|Baseline Measurement|unable to insert catheter|0|||
27923514|NCT01285908|54580378|FG000|Baseline Measurement|History of stroke, exclusion criteria|1|||
27923515|NCT01285908|54580379|FG001|Baseline Measurement|History of stroke, exclusion criteria|0|||
27923516|NCT01285908|54580380|FG002|Baseline Measurement|History of stroke, exclusion criteria|0|||
27923517|NCT01285908|54580378|FG000|Baseline Measurement|unable to tolerate procedure|1|||
27923518|NCT01285908|54580379|FG001|Baseline Measurement|unable to tolerate procedure|0|||
27923519|NCT01285908|54580380|FG002|Baseline Measurement|unable to tolerate procedure|0|||
27923520|NCT01250769|54580414|FG000|Overall Study|Withdrawal by Subject|0|||
27923521|NCT01250769|54580415|FG001|Overall Study|Withdrawal by Subject|1|||
27923522|NCT01250769|54580416|FG002|Overall Study|Withdrawal by Subject|1|||
27923523|NCT01250769|54580417|FG003|Overall Study|Withdrawal by Subject|0|||
27923524|NCT01250769|54580414|FG000|Overall Study|Adverse Event|0|||
27923525|NCT01250769|54580415|FG001|Overall Study|Adverse Event|0|||
27923526|NCT01250769|54580416|FG002|Overall Study|Adverse Event|1|||
27923527|NCT01250769|54580417|FG003|Overall Study|Adverse Event|0|||
27923528|NCT01074268|54580429|FG000|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3|||
27923529|NCT01074268|54580430|FG001|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1|||
27923530|NCT01074268|54580429|FG000|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0|||
27923531|NCT01074268|54580430|FG001|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2|||
27923532|NCT01074268|54580429|FG000|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3|||
27923533|NCT01074268|54580430|FG001|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4|||
27923534|NCT01074268|54580429|FG000|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6|||
27923535|NCT01074268|54580430|FG001|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3|||
27923536|NCT01074268|54580429|FG000|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8|||
27923537|NCT01074268|54580430|FG001|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5|||
27923538|NCT01074268|54580429|FG000|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
27923539|NCT01074268|54580430|FG001|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
27923540|NCT01074268|54580429|FG000|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0|||
27923541|NCT01074268|54580430|FG001|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2|||
27923542|NCT01074268|54580429|FG000|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
27923543|NCT01074268|54580430|FG001|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
27923544|NCT01074268|54580429|FG000|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3|||
27923545|NCT01074268|54580430|FG001|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2|||
27923546|NCT01074190|54580439|FG000|Overall Study|Emergency Cesarean Delivery|1|||
27923547|NCT01074190|54580440|FG001|Overall Study|Emergency Cesarean Delivery|2|||
27923548|NCT01074190|54580441|FG002|Overall Study|Emergency Cesarean Delivery|1|||
27923549|NCT01074190|54580439|FG000|Overall Study|Protocol Violation|2|||
27923550|NCT01074190|54580440|FG001|Overall Study|Protocol Violation|1|||
27923551|NCT01074190|54580441|FG002|Overall Study|Protocol Violation|0|||
27923552|NCT01074190|54580439|FG000|Overall Study|Delivered in under 90 minutes|0|||
27923553|NCT01074190|54580440|FG001|Overall Study|Delivered in under 90 minutes|2|||
27923554|NCT01074190|54580441|FG002|Overall Study|Delivered in under 90 minutes|1|||
27923555|NCT01074190|54580439|FG000|Overall Study|Subject withdrew consent|1|||
27923556|NCT01074190|54580440|FG001|Overall Study|Subject withdrew consent|1|||
27923557|NCT01074190|54580441|FG002|Overall Study|Subject withdrew consent|1|||
27923558|NCT01073566|54580454|FG000|Period 2 (6 Weeks)|Adverse Event|1|||
27923559|NCT01073566|54580455|FG001|Period 2 (6 Weeks)|Adverse Event|0|||
27923560|NCT01072396|54580463|FG000|Period One|Adverse Event|1|||
27745585|NCT04338321|54195337|FG001|Overall Study|Physician Decision|9|||
27923561|NCT01072396|54580464|FG001|Period One|Adverse Event|1|||
27923562|NCT01072396|54580463|FG000|Period One|Protocol Violation|2|||
27923563|NCT01072396|54580464|FG001|Period One|Protocol Violation|1|||
27923564|NCT01072396|54580463|FG000|Period One|Withdrawal by Subject|2|||
27923565|NCT01072396|54580464|FG001|Period One|Withdrawal by Subject|0|||
27923566|NCT01072396|54580463|FG000|Washout Period|Missing termination information|0|||
27923567|NCT01072396|54580464|FG001|Washout Period|Missing termination information|1|||
27923568|NCT01072396|54580463|FG000|Period Two|Adverse Event|0|||
27923569|NCT01072396|54580464|FG001|Period Two|Adverse Event|3|||
27923570|NCT01072396|54580463|FG000|Period Two|Lost to Follow-up|1|||
27923571|NCT01072396|54580464|FG001|Period Two|Lost to Follow-up|0|||
27923572|NCT01045096|54580473|FG000|Overall Study|Withdrawal by Subject|2|||
27923573|NCT01045096|54580474|FG001|Overall Study|Withdrawal by Subject|0|||
27923574|NCT01045096|54580475|FG002|Overall Study|Withdrawal by Subject|0|||
27923575|NCT01045096|54580473|FG000|Overall Study|Other|1|||
27923576|NCT01045096|54580474|FG001|Overall Study|Other|0|||
27923577|NCT01045096|54580475|FG002|Overall Study|Other|0|||
27923578|NCT01285518|54580491|FG000|Overall Study|Lost to Follow-up|0|||
27923579|NCT01285518|54580492|FG001|Overall Study|Lost to Follow-up|0|||
27923580|NCT01285518|54580493|FG002|Overall Study|Lost to Follow-up|0|||
27923581|NCT01285518|54580494|FG003|Overall Study|Lost to Follow-up|0|||
27923582|NCT01285518|54580495|FG004|Overall Study|Lost to Follow-up|0|||
27923583|NCT01285518|54580496|FG005|Overall Study|Lost to Follow-up|1|||
27923584|NCT01285518|54580497|FG006|Overall Study|Lost to Follow-up|0|||
27923585|NCT01285518|54580498|FG007|Overall Study|Lost to Follow-up|0|||
27923586|NCT01073020|54580521|FG000|Overall Study|Withdrawal by Subject|6|||
27923587|NCT01073020|54580522|FG001|Overall Study|Withdrawal by Subject|4|||
27923588|NCT01073020|54580523|FG002|Overall Study|Withdrawal by Subject|1|||
27923589|NCT01073020|54580524|FG003|Overall Study|Withdrawal by Subject|2|||
27923590|NCT01073020|54580521|FG000|Overall Study|Physician Decision|1|||
27923591|NCT01073020|54580522|FG001|Overall Study|Physician Decision|0|||
27923592|NCT01073020|54580523|FG002|Overall Study|Physician Decision|2|||
27923593|NCT01073020|54580524|FG003|Overall Study|Physician Decision|0|||
27923594|NCT01073020|54580521|FG000|Overall Study|Death|0|||
27923595|NCT01073020|54580522|FG001|Overall Study|Death|1|||
27923596|NCT01073020|54580523|FG002|Overall Study|Death|0|||
27923597|NCT01073020|54580524|FG003|Overall Study|Death|0|||
27923598|NCT01284114|54580534|FG000|Overall Study|viral infection|1|||
27923599|NCT01284114|54580534|FG000|Overall Study|From the results of ALLTITUDE study|1|||
27923600|NCT01284114|54580534|FG000|Overall Study|Symptomatic hypotension|1|||
27923601|NCT01284114|54580534|FG000|Overall Study|dizziness|1|||
27923602|NCT01283334|54580539|FG000|Overall Study|Withdrawal by Subject|1|||
27923603|NCT01283334|54580539|FG000|Overall Study|Inability to Swallow Everolimus Pills|1|||
27923604|NCT01283334|54580539|FG000|Overall Study|Adverse Event|4|||
27923605|NCT01283334|54580539|FG000|Overall Study|Physician Decision|1|||
27923606|NCT01282866|54580545|FG000|Overall Study|Adverse Event|1|||
27923607|NCT01071070|54580551|FG000|Overall Study|Adverse Event|0|||
27923608|NCT01071070|54580552|FG001|Overall Study|Adverse Event|3|||
27923609|NCT01071070|54580551|FG000|Overall Study|Withdrawal by Subject|1|||
27923610|NCT01071070|54580552|FG001|Overall Study|Withdrawal by Subject|0|||
27923611|NCT01071070|54580551|FG000|Overall Study|Missed 3 consecutive doses of study drug|2|||
27923612|NCT01071070|54580552|FG001|Overall Study|Missed 3 consecutive doses of study drug|0|||
27923613|NCT01071070|54580551|FG000|Overall Study|Hypercalcemia|1|||
27923614|NCT01071070|54580552|FG001|Overall Study|Hypercalcemia|0|||
27923615|NCT01282476|54580558|FG000|Overall Study|Death|11|||
27923616|NCT01282164|54580564|FG000|Overall Study|Lack of hypoglycemia during ITT|1|||
27923617|NCT01282164|54580565|FG001|Overall Study|Lack of hypoglycemia during ITT|0|||
27923618|NCT01250379|54580581|FG000|Overall Study|Death|141|||
27923619|NCT01250379|54580582|FG001|Overall Study|Death|148|||
27923620|NCT01250379|54580581|FG000|Overall Study|Withdrawal by Subject|32|||
27923621|NCT01250379|54580582|FG001|Overall Study|Withdrawal by Subject|20|||
27923622|NCT01250379|54580581|FG000|Overall Study|Physician Decision|11|||
27923623|NCT01250379|54580582|FG001|Overall Study|Physician Decision|3|||
27923624|NCT01250379|54580581|FG000|Overall Study|Protocol Violation|2|||
27923625|NCT01250379|54580582|FG001|Overall Study|Protocol Violation|8|||
27923626|NCT01250379|54580581|FG000|Overall Study|Lost to Follow-up|9|||
27923627|NCT01250379|54580582|FG001|Overall Study|Lost to Follow-up|6|||
27923628|NCT01250379|54580581|FG000|Overall Study|Adverse Event|5|||
27923629|NCT01250379|54580582|FG001|Overall Study|Adverse Event|4|||
27923630|NCT01250379|54580581|FG000|Overall Study|Other|0|||
27745586|NCT04338321|54195336|FG000|Overall Study|Other|3|||
27745587|NCT04338321|54195337|FG001|Overall Study|Other|10|||
27745588|NCT02487095|54195353|FG000|Dose Expansion|Unable to scan/restage participant|0|||
27745589|NCT02487095|54195354|FG001|Dose Expansion|Unable to scan/restage participant|0|||
27745590|NCT02487095|54195355|FG002|Dose Expansion|Unable to scan/restage participant|0|||
27745591|NCT02487095|54195356|FG003|Dose Expansion|Unable to scan/restage participant|0|||
27745592|NCT02487095|54195357|FG004|Dose Expansion|Unable to scan/restage participant|1|||
27745593|NCT03855137|54195380|FG000|DB Treatment Period (Day 1 to Week 12)|Adverse Event|10|||
27745594|NCT03855137|54195381|FG001|DB Treatment Period (Day 1 to Week 12)|Adverse Event|13|||
27745595|NCT03855137|54195382|FG002|DB Treatment Period (Day 1 to Week 12)|Adverse Event|9|||
27923631|NCT01250379|54580582|FG001|Overall Study|Other|4|||
27923632|NCT01250379|54580581|FG000|Overall Study|Participant noncompliance|2|||
27923633|NCT01250379|54580582|FG001|Overall Study|Participant noncompliance|0|||
27923634|NCT01072630|54580591|FG000|Overall Study|Adverse Event|11|||
27923635|NCT01072630|54580592|FG001|Overall Study|Adverse Event|19|||
27923636|NCT01072630|54580593|FG002|Overall Study|Adverse Event|2|||
27923637|NCT01072630|54580591|FG000|Overall Study|Lack of Efficacy|10|||
27923638|NCT01072630|54580592|FG001|Overall Study|Lack of Efficacy|10|||
27923639|NCT01072630|54580593|FG002|Overall Study|Lack of Efficacy|1|||
27923640|NCT01072630|54580591|FG000|Overall Study|Withdrawal by Subject|8|||
27923641|NCT01072630|54580592|FG001|Overall Study|Withdrawal by Subject|7|||
27923642|NCT01072630|54580593|FG002|Overall Study|Withdrawal by Subject|2|||
27923643|NCT01072630|54580591|FG000|Overall Study|Protocol Violation|10|||
27923644|NCT01072630|54580592|FG001|Overall Study|Protocol Violation|8|||
27923645|NCT01072630|54580593|FG002|Overall Study|Protocol Violation|4|||
27923646|NCT01072630|54580591|FG000|Overall Study|Lost to Follow-up|11|||
27923647|NCT01072630|54580592|FG001|Overall Study|Lost to Follow-up|11|||
27923648|NCT01072630|54580593|FG002|Overall Study|Lost to Follow-up|1|||
27923649|NCT01072630|54580591|FG000|Overall Study|Noncompliance with study medication|1|||
27923650|NCT01072630|54580592|FG001|Overall Study|Noncompliance with study medication|1|||
27923651|NCT01072630|54580593|FG002|Overall Study|Noncompliance with study medication|1|||
27923652|NCT01072630|54580591|FG000|Overall Study|Noncompliance with study procedures|1|||
27923653|NCT01072630|54580592|FG001|Overall Study|Noncompliance with study procedures|2|||
27923654|NCT01072630|54580593|FG002|Overall Study|Noncompliance with study procedures|1|||
27923655|NCT01072630|54580591|FG000|Overall Study|Other|3|||
27923656|NCT01072630|54580592|FG001|Overall Study|Other|2|||
27923657|NCT01072630|54580593|FG002|Overall Study|Other|1|||
27923658|NCT01281306|54580609|FG000|Overall Study|Lack of Efficacy|0|||
27923659|NCT01281306|54580610|FG001|Overall Study|Lack of Efficacy|1|||
27923660|NCT01281306|54580611|FG002|Overall Study|Lack of Efficacy|3|||
27923661|NCT01281306|54580612|FG003|Overall Study|Lack of Efficacy|0|||
27923662|NCT01281306|54580613|FG004|Overall Study|Lack of Efficacy|2|||
27923663|NCT01281306|54580614|FG005|Overall Study|Lack of Efficacy|0|||
27923664|NCT01281306|54580615|FG006|Overall Study|Lack of Efficacy|1|||
27923665|NCT01281306|54580609|FG000|Overall Study|Withdrawal by Subject|1|||
27923666|NCT01281306|54580610|FG001|Overall Study|Withdrawal by Subject|0|||
27923667|NCT01281306|54580611|FG002|Overall Study|Withdrawal by Subject|2|||
27923668|NCT01281306|54580612|FG003|Overall Study|Withdrawal by Subject|4|||
27923669|NCT01281306|54580613|FG004|Overall Study|Withdrawal by Subject|1|||
27923670|NCT01281306|54580614|FG005|Overall Study|Withdrawal by Subject|3|||
27923671|NCT01281306|54580615|FG006|Overall Study|Withdrawal by Subject|1|||
27923672|NCT01281306|54580609|FG000|Overall Study|Protocol deviation|0|||
27923673|NCT01281306|54580610|FG001|Overall Study|Protocol deviation|1|||
27923674|NCT01281306|54580611|FG002|Overall Study|Protocol deviation|1|||
27923675|NCT01281306|54580612|FG003|Overall Study|Protocol deviation|1|||
27923676|NCT01281306|54580613|FG004|Overall Study|Protocol deviation|1|||
27923677|NCT01281306|54580614|FG005|Overall Study|Protocol deviation|0|||
27923678|NCT01281306|54580615|FG006|Overall Study|Protocol deviation|0|||
27923679|NCT01281306|54580609|FG000|Overall Study|Condition no longer requires study drug|1|||
27923680|NCT01281306|54580610|FG001|Overall Study|Condition no longer requires study drug|0|||
27923681|NCT01281306|54580611|FG002|Overall Study|Condition no longer requires study drug|0|||
27923682|NCT01281306|54580612|FG003|Overall Study|Condition no longer requires study drug|0|||
27923683|NCT01281306|54580613|FG004|Overall Study|Condition no longer requires study drug|0|||
27923684|NCT01281306|54580614|FG005|Overall Study|Condition no longer requires study drug|1|||
27923685|NCT01281306|54580615|FG006|Overall Study|Condition no longer requires study drug|1|||
27923686|NCT01281306|54580609|FG000|Overall Study|Lost to Follow-up|1|||
27923687|NCT01281306|54580610|FG001|Overall Study|Lost to Follow-up|0|||
27923688|NCT01281306|54580611|FG002|Overall Study|Lost to Follow-up|0|||
27923689|NCT01281306|54580612|FG003|Overall Study|Lost to Follow-up|2|||
27923690|NCT01281306|54580613|FG004|Overall Study|Lost to Follow-up|0|||
27923691|NCT01281306|54580614|FG005|Overall Study|Lost to Follow-up|0|||
27923692|NCT01281306|54580615|FG006|Overall Study|Lost to Follow-up|1|||
27923693|NCT01281306|54580609|FG000|Overall Study|Death|1|||
27923694|NCT01281306|54580610|FG001|Overall Study|Death|0|||
27923695|NCT01281306|54580611|FG002|Overall Study|Death|0|||
27923696|NCT01281306|54580612|FG003|Overall Study|Death|0|||
27923697|NCT01281306|54580613|FG004|Overall Study|Death|0|||
27923698|NCT01281306|54580614|FG005|Overall Study|Death|0|||
27923699|NCT01281306|54580615|FG006|Overall Study|Death|0|||
27923700|NCT01281306|54580609|FG000|Overall Study|Adverse Event|3|||
27923701|NCT01281306|54580610|FG001|Overall Study|Adverse Event|2|||
27923702|NCT01281306|54580611|FG002|Overall Study|Adverse Event|2|||
27923703|NCT01281306|54580612|FG003|Overall Study|Adverse Event|3|||
27923704|NCT01281306|54580613|FG004|Overall Study|Adverse Event|5|||
27923705|NCT01281306|54580614|FG005|Overall Study|Adverse Event|3|||
27923706|NCT01281306|54580615|FG006|Overall Study|Adverse Event|3|||
27923707|NCT01281306|54580609|FG000|Overall Study|Randomized in error|1|||
27923708|NCT01281306|54580610|FG001|Overall Study|Randomized in error|0|||
27923709|NCT01281306|54580611|FG002|Overall Study|Randomized in error|0|||
27923710|NCT01281306|54580612|FG003|Overall Study|Randomized in error|1|||
27923711|NCT01281306|54580613|FG004|Overall Study|Randomized in error|0|||
27923712|NCT01281306|54580614|FG005|Overall Study|Randomized in error|0|||
27923713|NCT01281306|54580615|FG006|Overall Study|Randomized in error|0|||
27923714|NCT01250145|54580633|FG000|Overall Study|Adverse Event|2|||
27923715|NCT01250145|54580634|FG001|Overall Study|Adverse Event|1|||
27923716|NCT01250145|54580633|FG000|Overall Study|Withdrawal by Subject|0|||
27923717|NCT01250145|54580634|FG001|Overall Study|Withdrawal by Subject|4|||
27923718|NCT01067326|54580656|FG000|Overall Study|Adverse Event|0|||
27923719|NCT01067326|54580657|FG001|Overall Study|Adverse Event|2|||
27923720|NCT01067326|54580656|FG000|Overall Study|Withdrawal by Subject|1|||
27923721|NCT01067326|54580657|FG001|Overall Study|Withdrawal by Subject|0|||
27923722|NCT01067326|54580656|FG000|Overall Study|Early Study Termination|1|||
27923723|NCT01067326|54580657|FG001|Overall Study|Early Study Termination|1|||
27923724|NCT01279200|54580665|FG000|Overall Study|Withdrawal by Subject|1|||
27923725|NCT01279200|54580666|FG001|Overall Study|Withdrawal by Subject|3|||
27923726|NCT01279200|54580665|FG000|Overall Study|Patient withdrawal due to high cost|0|||
27923727|NCT01279200|54580666|FG001|Overall Study|Patient withdrawal due to high cost|1|||
27923728|NCT01279200|54580665|FG000|Overall Study|Inconvenience of ultrasound visit|0|||
27923729|NCT01279200|54580666|FG001|Overall Study|Inconvenience of ultrasound visit|1|||
27923730|NCT01279200|54580665|FG000|Overall Study|ultrasound screening failure|0|||
27923731|NCT01279200|54580666|FG001|Overall Study|ultrasound screening failure|1|||
28014036|NCT00619983|54672832|FG003|Test Drug Alone|Failure of daily diary device|2|||
28014037|NCT00576420|54672845|FG000|Overall Study|Death|0|||
28014038|NCT00576420|54672846|FG001|Overall Study|Death|0|||
28014039|NCT00576420|54672847|FG002|Overall Study|Death|1|||
28014040|NCT03961204|54672896|FG000|Overall Study|Withdrawal by Subject|2|||
28014041|NCT03961204|54672896|FG000|Overall Study|Lost to Follow-up|3|||
28014042|NCT03961204|54672896|FG000|Overall Study|Other|1|||
28014043|NCT03961204|54672896|FG000|Overall Study|Missing|1|||
28014044|NCT00364351|54672902|FG000|Overall Study|Adverse Event|90|||
28014045|NCT00364351|54672903|FG001|Overall Study|Adverse Event|44|||
28014046|NCT00364351|54672902|FG000|Overall Study|Condition under investigation worsened|469|||
28014047|NCT00364351|54672903|FG001|Overall Study|Condition under investigation worsened|497|||
28014048|NCT00364351|54672902|FG000|Overall Study|Prohibited concomitant medication|0|||
28014049|NCT00364351|54672903|FG001|Overall Study|Prohibited concomitant medication|2|||
28014050|NCT00364351|54672902|FG000|Overall Study|Lost to Follow-up|1|||
28014051|NCT00364351|54672903|FG001|Overall Study|Lost to Follow-up|1|||
28014052|NCT00364351|54672902|FG000|Overall Study|Withdrawal by Subject|30|||
28014053|NCT00364351|54672903|FG001|Overall Study|Withdrawal by Subject|29|||
28014054|NCT00364351|54672902|FG000|Overall Study|Incorrect enrollment|1|||
28014055|NCT00364351|54672903|FG001|Overall Study|Incorrect enrollment|1|||
28014056|NCT00364351|54672902|FG000|Overall Study|Sponsor decision|1|||
28014057|NCT00364351|54672903|FG001|Overall Study|Sponsor decision|0|||
28014058|NCT00364351|54672902|FG000|Overall Study|Poor treatment compliance|0|||
28014059|NCT00364351|54672903|FG001|Overall Study|Poor treatment compliance|3|||
28014060|NCT00364351|54672902|FG000|Overall Study|Investigator error|0|||
28014061|NCT00364351|54672903|FG001|Overall Study|Investigator error|2|||
28014062|NCT00364351|54672902|FG000|Overall Study|Patient could not travel to site|0|||
28014063|NCT00364351|54672903|FG001|Overall Study|Patient could not travel to site|1|||
28014064|NCT00364351|54672902|FG000|Overall Study|Randomised treatment not started|0|||
28014065|NCT00364351|54672903|FG001|Overall Study|Randomised treatment not started|3|||
28014066|NCT00388297|54672913|FG000|Overall Study|Lost to Follow-up|16|||
28014067|NCT00388297|54672914|FG001|Overall Study|Lost to Follow-up|12|||
28014068|NCT00388297|54672915|FG002|Overall Study|Lost to Follow-up|11|||
28014069|NCT00388297|54672916|FG003|Overall Study|Lost to Follow-up|8|||
28014070|NCT00686166|54672926|FG000|Overall Study|Adverse Event|7|||
28014071|NCT00686166|54672926|FG000|Overall Study|Withdrawal by Subject|1|||
28014072|NCT00686166|54672926|FG000|Overall Study|Progression/Relapse|1|||
28014073|NCT00686166|54672926|FG000|Overall Study|Death|1|||
28014074|NCT00686166|54672926|FG000|Overall Study|Not Protocol Specified|1|||
28014075|NCT00686166|54672926|FG000|Overall Study|Ineligible|5|||
27923732|NCT01279200|54580665|FG000|Overall Study|Lost to Follow-up|0|||
28014076|NCT00686166|54672926|FG000|Overall Study|Did not begin protocol therapy|4|||
27923733|NCT01279200|54580666|FG001|Overall Study|Lost to Follow-up|1|||
27923734|NCT01279200|54580665|FG000|Overall Study|Adverse Event|1|||
27923735|NCT01279200|54580666|FG001|Overall Study|Adverse Event|0|||
27923736|NCT01273818|54580675|FG000|Overall Study|Physician Decision|13|||
27923737|NCT01273818|54580676|FG001|Overall Study|Physician Decision|2|||
27923738|NCT01273818|54580677|FG002|Overall Study|Physician Decision|9|||
27923739|NCT01245387|54580685|FG000|Overall Study|Lost to Follow-up|106|||
27923740|NCT01245387|54580685|FG000|Overall Study|Lack of Efficacy|195|||
27923741|NCT01245387|54580685|FG000|Overall Study|Adverse Event|9|||
27923742|NCT01245387|54580685|FG000|Overall Study|Death|3|||
27923743|NCT01245387|54580685|FG000|Overall Study|Other|131|||
28014077|NCT00363649|54672937|FG000|Overall Study|Withdrawal by Subject|1|||
28014078|NCT00363649|54672938|FG001|Overall Study|Withdrawal by Subject|1|||
28014079|NCT00363649|54672937|FG000|Overall Study|Adverse Event|6|||
28014080|NCT00363649|54672938|FG001|Overall Study|Adverse Event|0|||
28014081|NCT00684060|54672946|FG000|Overall Study|Lost to Follow-up|1|||
28014082|NCT00684060|54672947|FG001|Overall Study|Lost to Follow-up|0|||
28014083|NCT00684060|54672946|FG000|Overall Study|New stenosis identified|1|||
28014084|NCT00684060|54672947|FG001|Overall Study|New stenosis identified|0|||
28014085|NCT00684060|54672946|FG000|Overall Study|Unable to collect MRI|1|||
28014086|NCT00684060|54672947|FG001|Overall Study|Unable to collect MRI|2|||
28014087|NCT00684060|54672946|FG000|Overall Study|Death|0|||
28014088|NCT00684060|54672947|FG001|Overall Study|Death|1|||
28014089|NCT03131648|54672955|FG000|Initial Treatment Period|Not dosed|2|||
28014090|NCT03131648|54672956|FG001|Initial Treatment Period|Not dosed|2|||
28014091|NCT03131648|54672957|FG002|Initial Treatment Period|Not dosed|0|||
28014092|NCT03131648|54672958|FG003|Initial Treatment Period|Not dosed|0|||
28014093|NCT03131648|54672959|FG004|Initial Treatment Period|Not dosed|0|||
28014094|NCT03131648|54672960|FG005|Initial Treatment Period|Not dosed|0|||
28014095|NCT03131648|54672961|FG006|Initial Treatment Period|Not dosed|0|||
28014096|NCT03131648|54672962|FG007|Initial Treatment Period|Not dosed|0|||
28014097|NCT03131648|54672955|FG000|Initial Treatment Period|Discontinued IMP before Week 16|51|||
28014098|NCT03131648|54672956|FG001|Initial Treatment Period|Discontinued IMP before Week 16|18|||
28014099|NCT03131648|54672957|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
28014100|NCT03131648|54672958|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
28014101|NCT03131648|54672959|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
28014102|NCT03131648|54672960|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
28014103|NCT03131648|54672961|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
28014104|NCT03131648|54672962|FG007|Initial Treatment Period|Discontinued IMP before Week 16|0|||
28014105|NCT03131648|54672955|FG000|Open-label Treatment|Discontinued IMP|0|||
28014106|NCT03131648|54672956|FG001|Open-label Treatment|Discontinued IMP|0|||
28014107|NCT03131648|54672957|FG002|Open-label Treatment|Discontinued IMP|0|||
28014108|NCT03131648|54672958|FG003|Open-label Treatment|Discontinued IMP|0|||
28014109|NCT03131648|54672959|FG004|Open-label Treatment|Discontinued IMP|0|||
28014110|NCT03131648|54672960|FG005|Open-label Treatment|Discontinued IMP|0|||
28014111|NCT03131648|54672961|FG006|Open-label Treatment|Discontinued IMP|112|||
28014112|NCT03131648|54672962|FG007|Open-label Treatment|Discontinued IMP|0|||
28014113|NCT03131648|54672955|FG000|Open-label Treatment|Completed Week 50|0|||
28014114|NCT03131648|54672956|FG001|Open-label Treatment|Completed Week 50|0|||
28014115|NCT03131648|54672957|FG002|Open-label Treatment|Completed Week 50|0|||
28014116|NCT03131648|54672958|FG003|Open-label Treatment|Completed Week 50|0|||
28014117|NCT03131648|54672959|FG004|Open-label Treatment|Completed Week 50|0|||
28014118|NCT03131648|54672960|FG005|Open-label Treatment|Completed Week 50|0|||
28014119|NCT03131648|54672961|FG006|Open-label Treatment|Completed Week 50|6|||
28014120|NCT03131648|54672962|FG007|Open-label Treatment|Completed Week 50|0|||
28014121|NCT03131648|54672955|FG000|Maintenance Treatment Period|Not dosed|0|||
28014122|NCT03131648|54672956|FG001|Maintenance Treatment Period|Not dosed|0|||
28014123|NCT03131648|54672957|FG002|Maintenance Treatment Period|Not dosed|3|||
28014124|NCT03131648|54672958|FG003|Maintenance Treatment Period|Not dosed|2|||
28014125|NCT03131648|54672959|FG004|Maintenance Treatment Period|Not dosed|1|||
28014126|NCT03131648|54672960|FG005|Maintenance Treatment Period|Not dosed|0|||
28014127|NCT03131648|54672961|FG006|Maintenance Treatment Period|Not dosed|0|||
28014128|NCT03131648|54672962|FG007|Maintenance Treatment Period|Not dosed|0|||
28014129|NCT03131648|54672955|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
28014130|NCT03131648|54672956|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
28014131|NCT03131648|54672957|FG002|Maintenance Treatment Period|Discontinued IMP|3|||
28014132|NCT03131648|54672958|FG003|Maintenance Treatment Period|Discontinued IMP|5|||
28014133|NCT03131648|54672959|FG004|Maintenance Treatment Period|Discontinued IMP|4|||
28014134|NCT03131648|54672960|FG005|Maintenance Treatment Period|Discontinued IMP|4|||
28014135|NCT03131648|54672961|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
28014136|NCT03131648|54672962|FG007|Maintenance Treatment Period|Discontinued IMP|0|||
28014137|NCT03131648|54672955|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
28014138|NCT03131648|54672956|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
28014139|NCT03131648|54672957|FG002|Maintenance Treatment Period|Transfer to open-label treatment|21|||
28014140|NCT03131648|54672958|FG003|Maintenance Treatment Period|Transfer to open-label treatment|18|||
28014141|NCT03131648|54672959|FG004|Maintenance Treatment Period|Transfer to open-label treatment|9|||
28014142|NCT03131648|54672960|FG005|Maintenance Treatment Period|Transfer to open-label treatment|10|||
28014143|NCT03131648|54672961|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
28014144|NCT03131648|54672962|FG007|Maintenance Treatment Period|Transfer to open-label treatment|0|||
28014145|NCT03131648|54672955|FG000|Maintenance Treatment Period|Completed Week 50|0|||
28014146|NCT03131648|54672956|FG001|Maintenance Treatment Period|Completed Week 50|0|||
28014147|NCT03131648|54672957|FG002|Maintenance Treatment Period|Completed Week 50|0|||
28014148|NCT03131648|54672958|FG003|Maintenance Treatment Period|Completed Week 50|0|||
28014149|NCT03131648|54672959|FG004|Maintenance Treatment Period|Completed Week 50|1|||
28014150|NCT03131648|54672960|FG005|Maintenance Treatment Period|Completed Week 50|0|||
28014151|NCT03131648|54672961|FG006|Maintenance Treatment Period|Completed Week 50|0|||
28014152|NCT03131648|54672962|FG007|Maintenance Treatment Period|Completed Week 50|0|||
28014153|NCT03131648|54672955|FG000|Open-label (Short Term Extension)|Discontinued IMP|0|||
28014154|NCT03131648|54672956|FG001|Open-label (Short Term Extension)|Discontinued IMP|0|||
28014155|NCT03131648|54672957|FG002|Open-label (Short Term Extension)|Discontinued IMP|0|||
28014156|NCT03131648|54672958|FG003|Open-label (Short Term Extension)|Discontinued IMP|0|||
28014157|NCT03131648|54672959|FG004|Open-label (Short Term Extension)|Discontinued IMP|0|||
28014158|NCT03131648|54672960|FG005|Open-label (Short Term Extension)|Discontinued IMP|0|||
28014159|NCT03131648|54672961|FG006|Open-label (Short Term Extension)|Discontinued IMP|0|||
28014160|NCT03131648|54672962|FG007|Open-label (Short Term Extension)|Discontinued IMP|3|||
28014161|NCT00618813|54672979|FG000|Overall Study|Lack of Efficacy|1|||
28014162|NCT00618813|54672979|FG000|Overall Study|Physician Decision|2|||
28014163|NCT00618813|54672979|FG000|Overall Study|Withdrawal by Subject|1|||
28014164|NCT00554788|54672986|FG000|Overall Study|Adverse Event|0|||
28014165|NCT00554788|54672987|FG001|Overall Study|Adverse Event|1|||
28014166|NCT00554788|54672988|FG002|Overall Study|Adverse Event|2|||
28014167|NCT00554788|54672986|FG000|Overall Study|Lost to Follow-up|4|||
28014168|NCT00554788|54672987|FG001|Overall Study|Lost to Follow-up|3|||
28014169|NCT00554788|54672988|FG002|Overall Study|Lost to Follow-up|3|||
28014170|NCT00554788|54672986|FG000|Overall Study|Physician Decision|1|||
28014171|NCT00554788|54672987|FG001|Overall Study|Physician Decision|1|||
28014172|NCT00554788|54672988|FG002|Overall Study|Physician Decision|3|||
28014173|NCT00554788|54672986|FG000|Overall Study|Withdrawal by Subject|0|||
28014174|NCT00554788|54672987|FG001|Overall Study|Withdrawal by Subject|0|||
28014175|NCT00554788|54672988|FG002|Overall Study|Withdrawal by Subject|1|||
28014176|NCT00554788|54672986|FG000|Overall Study|Refusal of further protocol therapy|0|||
28014177|NCT00554788|54672987|FG001|Overall Study|Refusal of further protocol therapy|1|||
28014178|NCT00554788|54672988|FG002|Overall Study|Refusal of further protocol therapy|1|||
28014179|NCT00554788|54672986|FG000|Overall Study|Progressive disease|0|||
28014180|NCT00554788|54672987|FG001|Overall Study|Progressive disease|0|||
28014181|NCT00554788|54672988|FG002|Overall Study|Progressive disease|3|||
28014182|NCT00554788|54672986|FG000|Overall Study|Ineligible|2|||
28014183|NCT00554788|54672987|FG001|Overall Study|Ineligible|0|||
28014184|NCT00554788|54672988|FG002|Overall Study|Ineligible|1|||
28014185|NCT00685698|54672997|FG000|Overall Study|Withdrawal by Subject|1|||
28014186|NCT00685698|54672997|FG000|Overall Study|Protocol Violation|6|||
28014187|NCT00685698|54672997|FG000|Overall Study|Adverse Event|3|||
28014188|NCT00685698|54672997|FG000|Overall Study|CULTURE GRAM NEG SPECIES|1|||
28014189|NCT00685698|54672997|FG000|Overall Study|CULTURE RESULTS: GRAM-VE|1|||
28014190|NCT00685698|54672997|FG000|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1|||
28014191|NCT00549328|54673013|FG000|Overall Study|Adverse Event|2|||
28014192|NCT00549328|54673013|FG000|Overall Study|Disease Progression|10|||
28014193|NCT00549328|54673013|FG000|Overall Study|Death|1|||
28014194|NCT00549328|54673013|FG000|Overall Study|Use of Prohibited Medication|1|||
28014195|NCT00696410|54673019|FG000|Overall Study|Lost to Follow-up|2|||
28014196|NCT00696410|54673020|FG001|Overall Study|Lost to Follow-up|0|||
28014197|NCT00696410|54673019|FG000|Overall Study|Withdrawal by Subject|8|||
28014198|NCT00696410|54673020|FG001|Overall Study|Withdrawal by Subject|0|||
28014199|NCT00696410|54673019|FG000|Overall Study|Physician Decision|3|||
28014200|NCT00696410|54673020|FG001|Overall Study|Physician Decision|0|||
28014201|NCT00683904|54673033|FG000|Dose Level 1|Disease progression|2|||
28014202|NCT00683904|54673034|FG001|Dose Level 1|Disease progression|0|||
28014203|NCT00683904|54673033|FG000|Dose Level 1|Adverse Event|1|||
28014204|NCT00683904|54673034|FG001|Dose Level 1|Adverse Event|0|||
28014205|NCT00683904|54673033|FG000|Dose Level 2|Adverse Event|0|||
28014206|NCT00683904|54673034|FG001|Dose Level 2|Adverse Event|2|||
28014207|NCT00363415|54673048|FG000|Overall Study|Progressive Disease|196|||
28014208|NCT00363415|54673049|FG001|Overall Study|Progressive Disease|107|||
28014209|NCT00363415|54673048|FG000|Overall Study|Sponsor Decision|67|||
28014210|NCT00363415|54673049|FG001|Overall Study|Sponsor Decision|31|||
28014211|NCT00363415|54673048|FG000|Overall Study|Death|32|||
28014212|NCT00363415|54673049|FG001|Overall Study|Death|29|||
28014213|NCT00363415|54673048|FG000|Overall Study|Adverse Event|24|||
28014214|NCT00363415|54673049|FG001|Overall Study|Adverse Event|15|||
28014215|NCT00363415|54673048|FG000|Overall Study|Physician Decision|18|||
28014216|NCT00363415|54673049|FG001|Overall Study|Physician Decision|35|||
28014217|NCT00363415|54673048|FG000|Overall Study|Entry Criteria Not Met|11|||
28014218|NCT00363415|54673049|FG001|Overall Study|Entry Criteria Not Met|10|||
28014219|NCT00363415|54673048|FG000|Overall Study|Withdrawal by Subject|9|||
28014220|NCT00363415|54673049|FG001|Overall Study|Withdrawal by Subject|15|||
28014221|NCT00363415|54673048|FG000|Overall Study|Lost to Follow-up|3|||
28014222|NCT00363415|54673049|FG001|Overall Study|Lost to Follow-up|3|||
28014223|NCT00363415|54673048|FG000|Overall Study|Protocol Violation|1|||
28014224|NCT00363415|54673049|FG001|Overall Study|Protocol Violation|4|||
28014225|NCT00696020|54673059|FG000|Overall Study|Adverse Event|3|||
28014226|NCT00696020|54673060|FG001|Overall Study|Adverse Event|1|||
28014227|NCT00696020|54673061|FG002|Overall Study|Adverse Event|2|||
28014228|NCT00696020|54673062|FG003|Overall Study|Adverse Event|1|||
28014229|NCT00696020|54673059|FG000|Overall Study|Lack of Efficacy|1|||
28014230|NCT00696020|54673060|FG001|Overall Study|Lack of Efficacy|0|||
28014231|NCT00696020|54673061|FG002|Overall Study|Lack of Efficacy|0|||
28014232|NCT00696020|54673062|FG003|Overall Study|Lack of Efficacy|0|||
28014233|NCT00696020|54673059|FG000|Overall Study|Protocol Violation|0|||
28014234|NCT00696020|54673060|FG001|Overall Study|Protocol Violation|0|||
28014235|NCT00696020|54673061|FG002|Overall Study|Protocol Violation|0|||
28014236|NCT00696020|54673062|FG003|Overall Study|Protocol Violation|1|||
28014237|NCT00696020|54673059|FG000|Overall Study|Withdrawal by Subject|0|||
28014238|NCT00696020|54673060|FG001|Overall Study|Withdrawal by Subject|1|||
28014239|NCT00696020|54673061|FG002|Overall Study|Withdrawal by Subject|0|||
28014240|NCT00696020|54673062|FG003|Overall Study|Withdrawal by Subject|1|||
28014241|NCT00696020|54673059|FG000|Overall Study|Other not stated above|0|||
28014242|NCT00696020|54673060|FG001|Overall Study|Other not stated above|0|||
28014243|NCT00696020|54673061|FG002|Overall Study|Other not stated above|1|||
28014244|NCT00696020|54673062|FG003|Overall Study|Other not stated above|1|||
28014245|NCT00576576|54673074|FG000|Overall Study|Lost to Follow-up|6|||
28014246|NCT00576576|54673074|FG000|Overall Study|Protocol Violation|1|||
28014247|NCT00695864|54673093|FG000|Placebo|Withdrawal by Subject|1|||
28014248|NCT00695864|54673093|FG000|Placebo|Physician Decision|4|||
28014249|NCT00684996|54673099|FG000|Overall Study|Adverse Event|1|||
28014250|NCT00684996|54673099|FG000|Overall Study|Refusal unrelated to adverse event|1|||
28014251|NCT00684996|54673099|FG000|Overall Study|Progression/relapse|2|||
28014252|NCT00684996|54673099|FG000|Overall Study|Other reasons not protocol specified|1|||
28014253|NCT00684762|54673106|FG000|Washout Period of 7 Days|Withdrawal by Subject|2|||
28014254|NCT00684762|54673107|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
28014255|NCT00695786|54673117|FG000|Overall Study|Adverse Event|0|||
28014256|NCT00695786|54673118|FG001|Overall Study|Adverse Event|3|||
28014257|NCT00695786|54673119|FG002|Overall Study|Adverse Event|4|||
28014258|NCT00695786|54673120|FG003|Overall Study|Adverse Event|2|||
28014259|NCT00695786|54673117|FG000|Overall Study|Lost to Follow-up|0|||
28014260|NCT00695786|54673118|FG001|Overall Study|Lost to Follow-up|5|||
28014261|NCT00695786|54673119|FG002|Overall Study|Lost to Follow-up|1|||
28014262|NCT00695786|54673120|FG003|Overall Study|Lost to Follow-up|1|||
28014263|NCT00695786|54673117|FG000|Overall Study|Withdrawal by Subject|0|||
28014264|NCT00695786|54673118|FG001|Overall Study|Withdrawal by Subject|4|||
28014265|NCT00695786|54673119|FG002|Overall Study|Withdrawal by Subject|3|||
28014266|NCT00695786|54673120|FG003|Overall Study|Withdrawal by Subject|1|||
28014267|NCT00695786|54673117|FG000|Overall Study|Deemed Ineligible|1|||
28014268|NCT00695786|54673118|FG001|Overall Study|Deemed Ineligible|0|||
28014269|NCT00695786|54673119|FG002|Overall Study|Deemed Ineligible|0|||
28014270|NCT00695786|54673120|FG003|Overall Study|Deemed Ineligible|0|||
28014271|NCT00695786|54673117|FG000|Overall Study|Lack of Efficacy|0|||
28014272|NCT00695786|54673118|FG001|Overall Study|Lack of Efficacy|0|||
28014273|NCT00695786|54673119|FG002|Overall Study|Lack of Efficacy|0|||
28014274|NCT00695786|54673120|FG003|Overall Study|Lack of Efficacy|4|||
28014275|NCT00387127|54673132|FG000|Overall Study|Lost to Follow-up|0|||
28014276|NCT00387127|54673133|FG001|Overall Study|Lost to Follow-up|4|||
28014277|NCT00387127|54673132|FG000|Overall Study|Death|16|||
28014278|NCT00387127|54673133|FG001|Overall Study|Death|16|||
28014279|NCT00387127|54673132|FG000|Overall Study|Physician Decision|0|||
28014280|NCT00387127|54673133|FG001|Overall Study|Physician Decision|1|||
28014281|NCT00387127|54673132|FG000|Overall Study|Withdrawal by Subject|3|||
28014282|NCT00387127|54673133|FG001|Overall Study|Withdrawal by Subject|2|||
28014283|NCT00387127|54673132|FG000|Overall Study|Required by Protocol Amendment #4|12|||
28014284|NCT00387127|54673133|FG001|Overall Study|Required by Protocol Amendment #4|10|||
28014285|NCT00387127|54673132|FG000|Overall Study|Serious Adverse Event|1|||
28014286|NCT00387127|54673133|FG001|Overall Study|Serious Adverse Event|1|||
28014287|NCT00387127|54673132|FG000|Overall Study|Sponsor Unblinded|1|||
28014288|NCT00387127|54673133|FG001|Overall Study|Sponsor Unblinded|0|||
28014289|NCT00683592|54673143|FG000|Overall Study|Adverse Event|12|||
28014290|NCT00683592|54673144|FG001|Overall Study|Adverse Event|4|||
28014291|NCT00683592|54673143|FG000|Overall Study|Withdrawal by Subject|11|||
28014292|NCT00683592|54673144|FG001|Overall Study|Withdrawal by Subject|11|||
28014293|NCT00683592|54673143|FG000|Overall Study|Lost to Follow-up|17|||
28014294|NCT00683592|54673144|FG001|Overall Study|Lost to Follow-up|17|||
28014295|NCT00683592|54673143|FG000|Overall Study|Lack of Efficacy|3|||
28014296|NCT00683592|54673144|FG001|Overall Study|Lack of Efficacy|7|||
28014297|NCT00683592|54673143|FG000|Overall Study|Physician Decision|0|||
28014298|NCT00683592|54673144|FG001|Overall Study|Physician Decision|1|||
28014299|NCT00683592|54673143|FG000|Overall Study|Non-compliance|3|||
28014300|NCT00683592|54673144|FG001|Overall Study|Non-compliance|5|||
28014301|NCT00683592|54673143|FG000|Overall Study|Other|1|||
28014302|NCT00683592|54673144|FG001|Overall Study|Other|1|||
28014303|NCT00695396|54673153|FG000|Overall Study|Study Closed Prematurely|5|||
28014304|NCT00695396|54673154|FG001|Overall Study|Study Closed Prematurely|6|||
28014305|NCT00695396|54673155|FG002|Overall Study|Study Closed Prematurely|8|||
28014306|NCT00695396|54673153|FG000|Overall Study|Withdrawal by Subject|2|||
28014307|NCT00695396|54673154|FG001|Overall Study|Withdrawal by Subject|2|||
28014308|NCT00695396|54673155|FG002|Overall Study|Withdrawal by Subject|0|||
28014309|NCT02656706|54673163|FG000|Overall Study|Insurance Denial|1|||
28014310|NCT00575328|54673169|FG000|Overall Study|Adverse Event|1|||
28014311|NCT00575328|54673170|FG001|Overall Study|Adverse Event|1|||
28014312|NCT00575328|54673169|FG000|Overall Study|Lost to Follow-up|2|||
28014313|NCT00575328|54673170|FG001|Overall Study|Lost to Follow-up|1|||
28014314|NCT00575094|54673176|FG000|Overall Study|Adverse Event|2|||
28014315|NCT00575094|54673176|FG000|Overall Study|Withdrawal by Subject|1|||
28014316|NCT00553696|54673184|FG000|Overall Study|Adverse Event|2|||
28014317|NCT00553696|54673185|FG001|Overall Study|Adverse Event|4|||
28014318|NCT00553696|54673186|FG002|Overall Study|Adverse Event|0|||
28014319|NCT00553696|54673187|FG003|Overall Study|Adverse Event|1|||
28014320|NCT00553696|54673184|FG000|Overall Study|Global deterioration of health status|0|||
28014321|NCT00553696|54673185|FG001|Overall Study|Global deterioration of health status|2|||
28014322|NCT00553696|54673186|FG002|Overall Study|Global deterioration of health status|0|||
28014323|NCT00553696|54673187|FG003|Overall Study|Global deterioration of health status|0|||
28014324|NCT00553696|54673184|FG000|Overall Study|Objective progression or relapse|2|||
28014325|NCT00553696|54673185|FG001|Overall Study|Objective progression or relapse|9|||
28014326|NCT00553696|54673186|FG002|Overall Study|Objective progression or relapse|6|||
28014327|NCT00553696|54673187|FG003|Overall Study|Objective progression or relapse|0|||
28014328|NCT00553696|54673184|FG000|Overall Study|Withdrawal by Subject|0|||
28014329|NCT00553696|54673185|FG001|Overall Study|Withdrawal by Subject|1|||
28014330|NCT00553696|54673186|FG002|Overall Study|Withdrawal by Subject|0|||
28014331|NCT00553696|54673187|FG003|Overall Study|Withdrawal by Subject|0|||
28014332|NCT00553540|54673202|FG000|Overall Study|discharged after first visit|2|||
28014333|NCT00553540|54673203|FG001|Overall Study|discharged after first visit|5|||
28014334|NCT00617409|54673212|FG000|Overall Study|Withdrawal by Subject|4|||
28014335|NCT00617409|54673213|FG001|Overall Study|Withdrawal by Subject|1|||
28014336|NCT00617409|54673214|FG002|Overall Study|Withdrawal by Subject|2|||
28014337|NCT00617409|54673212|FG000|Overall Study|Adverse Event|0|||
28014338|NCT00617409|54673213|FG001|Overall Study|Adverse Event|2|||
28014339|NCT00617409|54673214|FG002|Overall Study|Adverse Event|3|||
28014340|NCT00617409|54673212|FG000|Overall Study|Disease Progression|8|||
28014341|NCT00617409|54673213|FG001|Overall Study|Disease Progression|8|||
28014342|NCT00617409|54673214|FG002|Overall Study|Disease Progression|18|||
28014343|NCT00617409|54673212|FG000|Overall Study|Death|3|||
28014344|NCT00617409|54673213|FG001|Overall Study|Death|5|||
28014345|NCT00617409|54673214|FG002|Overall Study|Death|4|||
28014346|NCT00617409|54673212|FG000|Overall Study|Alternative Therapy|1|||
28014347|NCT00617409|54673213|FG001|Overall Study|Alternative Therapy|2|||
28014348|NCT00617409|54673214|FG002|Overall Study|Alternative Therapy|0|||
28014349|NCT00695318|54673225|FG000|Overall Study|Lost to Follow-up|1|||
28014350|NCT00695318|54673226|FG001|Overall Study|Lost to Follow-up|0|||
28014351|NCT00695318|54673225|FG000|Overall Study|Withdrawal by Subject|2|||
28014352|NCT00695318|54673226|FG001|Overall Study|Withdrawal by Subject|0|||
28014353|NCT00695318|54673225|FG000|Overall Study|Death|1|||
28014354|NCT00695318|54673226|FG001|Overall Study|Death|1|||
28014355|NCT00695318|54673225|FG000|Overall Study|Study Terminated|1|||
28014356|NCT00695318|54673226|FG001|Overall Study|Study Terminated|0|||
28014357|NCT00386425|54673240|FG000|Overall Study|Physician Decision|3|||
28014358|NCT00386425|54673241|FG001|Overall Study|Physician Decision|0|||
28014359|NCT00386425|54673242|FG002|Overall Study|Physician Decision|0|||
28014360|NCT00386425|54673240|FG000|Overall Study|Withdrawal by Subject|0|||
28014361|NCT00386425|54673241|FG001|Overall Study|Withdrawal by Subject|1|||
28014362|NCT00386425|54673242|FG002|Overall Study|Withdrawal by Subject|0|||
28014363|NCT00694304|54673254|FG000|Overall Study|Adverse Event|42|||
28014364|NCT00694304|54673254|FG000|Overall Study|Lack of Efficacy|35|||
28014365|NCT00694304|54673254|FG000|Overall Study|Non-compliance With Study Product|16|||
28014366|NCT00694304|54673254|FG000|Overall Study|Protocol Violation|6|||
28014367|NCT00694304|54673254|FG000|Overall Study|Withdrawal of Consent|61|||
28014368|NCT00694304|54673254|FG000|Overall Study|Lost to Follow-up|15|||
28014369|NCT00694304|54673254|FG000|Overall Study|Administrative or Other Reasons|32|||
28014370|NCT00371839|54673261|FG000|Overall Study|Death|4|||
28014371|NCT00371839|54673262|FG001|Overall Study|Death|0|||
28014372|NCT00371839|54673263|FG002|Overall Study|Death|0|||
28014373|NCT00371839|54673261|FG000|Overall Study|Withdrawal by Subject|7|||
28014374|NCT00371839|54673262|FG001|Overall Study|Withdrawal by Subject|4|||
28014375|NCT00371839|54673263|FG002|Overall Study|Withdrawal by Subject|0|||
27923744|NCT01245387|54580685|FG000|Overall Study|Missing discontinuation status|369|||
27923745|NCT01037218|54580693|FG000|Overall Study|Adverse Event|4|||
27923746|NCT01037218|54580694|FG001|Overall Study|Adverse Event|2|||
27923747|NCT01037218|54580695|FG002|Overall Study|Adverse Event|2|||
27923748|NCT01037218|54580696|FG003|Overall Study|Adverse Event|1|||
27923749|NCT01037218|54580693|FG000|Overall Study|Lack of Efficacy|0|||
27923750|NCT01037218|54580694|FG001|Overall Study|Lack of Efficacy|2|||
27923751|NCT01037218|54580695|FG002|Overall Study|Lack of Efficacy|1|||
27923752|NCT01037218|54580696|FG003|Overall Study|Lack of Efficacy|5|||
27923753|NCT01037218|54580693|FG000|Overall Study|Lost to Follow-up|3|||
28014376|NCT00371839|54673261|FG000|Overall Study|Lost to Follow-up|6|||
28014377|NCT00371839|54673262|FG001|Overall Study|Lost to Follow-up|3|||
28014378|NCT00371839|54673263|FG002|Overall Study|Lost to Follow-up|2|||
28014379|NCT00682890|54673271|FG000|Overall Study|Lost to Follow-up|1|||
28014380|NCT00682890|54673272|FG001|Overall Study|Lost to Follow-up|1|||
28014381|NCT00682890|54673271|FG000|Overall Study|subject moved away|0|||
28014382|NCT00682890|54673272|FG001|Overall Study|subject moved away|1|||
28014383|NCT00682890|54673271|FG000|Overall Study|heavy menstrual bleeding|1|||
28014384|NCT00682890|54673272|FG001|Overall Study|heavy menstrual bleeding|0|||
28014385|NCT00385723|54673281|FG000|Overall Study|Lost to Follow-up|1|||
28014386|NCT00385723|54673282|FG001|Overall Study|Lost to Follow-up|1|||
28014387|NCT00385723|54673283|FG002|Overall Study|Lost to Follow-up|0|||
28014388|NCT00385723|54673281|FG000|Overall Study|Withdrawal by Subject|1|||
28014389|NCT00385723|54673282|FG001|Overall Study|Withdrawal by Subject|0|||
28014390|NCT00385723|54673283|FG002|Overall Study|Withdrawal by Subject|2|||
28014391|NCT00698516|54673291|FG000|Overall Study|Study Termination|2|||
28014392|NCT00698516|54673291|FG000|Overall Study|Withdrawal by Subject|3|||
28014393|NCT00679302|54673301|FG000|Overall Study|Lost to Follow-up|8|||
28014394|NCT00679302|54673302|FG001|Overall Study|Lost to Follow-up|4|||
28014395|NCT00690482|54673331|FG000|Overall Study|Adverse Event|2|||
28014396|NCT00690482|54673332|FG001|Overall Study|Adverse Event|1|||
28014397|NCT00690482|54673331|FG000|Overall Study|Incorrect enrolment|0|||
28014398|NCT00690482|54673332|FG001|Overall Study|Incorrect enrolment|1|||
28014399|NCT00690482|54673331|FG000|Overall Study|Study-specific discontinuation criteria|1|||
28014400|NCT00690482|54673332|FG001|Overall Study|Study-specific discontinuation criteria|0|||
28014401|NCT00690482|54673331|FG000|Overall Study|Intake of prohibited medicine|1|||
28014402|NCT00690482|54673332|FG001|Overall Study|Intake of prohibited medicine|0|||
28014403|NCT00690482|54673331|FG000|Overall Study|withdrew consent at rand.day|0|||
28014404|NCT00690482|54673332|FG001|Overall Study|withdrew consent at rand.day|1|||
28014405|NCT00385255|54673340|FG000|Overall Study|Serious Adverse Event|1|||
28014406|NCT00385255|54673341|FG001|Overall Study|Serious Adverse Event|2|||
28014407|NCT00385255|54673340|FG000|Overall Study|Protocol Violation|0|||
28014408|NCT00385255|54673341|FG001|Overall Study|Protocol Violation|4|||
28014409|NCT00385255|54673340|FG000|Overall Study|Withdrawal by Subject|0|||
28014410|NCT00385255|54673341|FG001|Overall Study|Withdrawal by Subject|8|||
28014411|NCT00385255|54673340|FG000|Overall Study|Migrated/moved from study area|0|||
27923754|NCT01037218|54580694|FG001|Overall Study|Lost to Follow-up|5|||
27923755|NCT01037218|54580695|FG002|Overall Study|Lost to Follow-up|4|||
27923756|NCT01037218|54580696|FG003|Overall Study|Lost to Follow-up|2|||
27923757|NCT01037218|54580693|FG000|Overall Study|Withdrawal by Subject|6|||
27923758|NCT01037218|54580694|FG001|Overall Study|Withdrawal by Subject|7|||
27923759|NCT01037218|54580695|FG002|Overall Study|Withdrawal by Subject|7|||
27923760|NCT01037218|54580696|FG003|Overall Study|Withdrawal by Subject|4|||
27923761|NCT01037218|54580693|FG000|Overall Study|Partner Withdrew Consent|0|||
27923762|NCT01037218|54580694|FG001|Overall Study|Partner Withdrew Consent|3|||
27923763|NCT01037218|54580695|FG002|Overall Study|Partner Withdrew Consent|2|||
27923764|NCT01037218|54580696|FG003|Overall Study|Partner Withdrew Consent|1|||
27923765|NCT01037218|54580693|FG000|Overall Study|Protocol Violation|0|||
27923766|NCT01037218|54580694|FG001|Overall Study|Protocol Violation|0|||
27923767|NCT01037218|54580695|FG002|Overall Study|Protocol Violation|2|||
27923768|NCT01037218|54580696|FG003|Overall Study|Protocol Violation|2|||
27923769|NCT01037218|54580693|FG000|Overall Study|Various|3|||
27923770|NCT01037218|54580694|FG001|Overall Study|Various|2|||
27923771|NCT01037218|54580695|FG002|Overall Study|Various|3|||
27923772|NCT01037218|54580696|FG003|Overall Study|Various|1|||
27923773|NCT01038856|54580706|FG000|Overall Study|Adverse Event|2|||
27923774|NCT01066546|54580712|FG000|Overall Study|Study terminated by sponsor|5|||
27923775|NCT01272804|54580722|FG000|Overall Study|Adverse Event|1|||
27923776|NCT01272804|54580723|FG001|Overall Study|Adverse Event|0|||
27923777|NCT01272804|54580724|FG002|Overall Study|Adverse Event|0|||
27923778|NCT01272804|54580725|FG003|Overall Study|Adverse Event|0|||
27923779|NCT01272804|54580726|FG004|Overall Study|Adverse Event|2|||
27923780|NCT01272804|54580727|FG005|Overall Study|Adverse Event|1|||
27923781|NCT01269918|54580743|FG000|Overall Study|Did not receive study drug|0|||
27923782|NCT01269918|54580744|FG001|Overall Study|Did not receive study drug|3|||
27923783|NCT01036594|54580750|FG000|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1|||
27923784|NCT01036594|54580751|FG001|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0|||
27923785|NCT01036594|54580750|FG000|First Treatment Regimen|Withdrawal by Subject|1|||
27923786|NCT01036594|54580751|FG001|First Treatment Regimen|Withdrawal by Subject|0|||
27923787|NCT01036594|54580750|FG000|Week 12 Evaluation|Adverse Event|5|||
27923788|NCT01036594|54580751|FG001|Week 12 Evaluation|Adverse Event|0|||
27923789|NCT01036594|54580750|FG000|Week 12 Evaluation|Physician Decision|1|||
27923790|NCT01036594|54580751|FG001|Week 12 Evaluation|Physician Decision|0|||
27923791|NCT01036594|54580750|FG000|Treatment Regiments Post Week 12|Physician Decision|1|||
27923792|NCT01036594|54580751|FG001|Treatment Regiments Post Week 12|Physician Decision|1|||
27923793|NCT01036594|54580750|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|1|||
27923794|NCT01036594|54580751|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
28014412|NCT00385255|54673341|FG001|Overall Study|Migrated/moved from study area|1|||
28014413|NCT00385255|54673340|FG000|Overall Study|Lost to Follow-up|20|||
28014414|NCT00385255|54673341|FG001|Overall Study|Lost to Follow-up|58|||
28014415|NCT00571662|54673351|FG000|Overall Study|Withdrawal by Subject|2|||
28014416|NCT00571662|54673351|FG000|Overall Study|psychiatric instability|1|||
28014417|NCT00571662|54673351|FG000|Overall Study|Adverse Event|5|||
28014418|NCT00698204|54673359|FG000|Overall Study|Withdrawal by Subject|1|||
28014419|NCT00698204|54673360|FG001|Overall Study|Withdrawal by Subject|0|||
28014420|NCT00549718|54673372|FG000|Overall Study|Insufficient clinical response|20|||
28014421|NCT00549718|54673373|FG001|Overall Study|Insufficient clinical response|7|||
28014422|NCT00549718|54673374|FG002|Overall Study|Insufficient clinical response|18|||
28014423|NCT00549718|54673375|FG003|Overall Study|Insufficient clinical response|32|||
28014424|NCT00549718|54673372|FG000|Overall Study|Adverse Event|6|||
28014425|NCT00549718|54673373|FG001|Overall Study|Adverse Event|8|||
28014426|NCT00549718|54673374|FG002|Overall Study|Adverse Event|7|||
28014427|NCT00549718|54673375|FG003|Overall Study|Adverse Event|3|||
28014428|NCT00549718|54673372|FG000|Overall Study|Lost to Follow-up|4|||
28014429|NCT00549718|54673373|FG001|Overall Study|Lost to Follow-up|2|||
28014430|NCT00549718|54673374|FG002|Overall Study|Lost to Follow-up|0|||
28014431|NCT00549718|54673375|FG003|Overall Study|Lost to Follow-up|6|||
28014432|NCT00549718|54673372|FG000|Overall Study|Withdrawal by Subject|9|||
28014433|NCT00549718|54673373|FG001|Overall Study|Withdrawal by Subject|18|||
28014434|NCT00549718|54673374|FG002|Overall Study|Withdrawal by Subject|12|||
28014435|NCT00549718|54673375|FG003|Overall Study|Withdrawal by Subject|13|||
28014436|NCT00549718|54673372|FG000|Overall Study|Administrative|2|||
28014437|NCT00549718|54673373|FG001|Overall Study|Administrative|2|||
28014438|NCT00549718|54673374|FG002|Overall Study|Administrative|2|||
28014439|NCT00549718|54673375|FG003|Overall Study|Administrative|1|||
28014440|NCT00371761|54673387|FG000|Overall Study|Adverse Event|1|||
28014441|NCT00371761|54673388|FG001|Overall Study|Adverse Event|1|||
28014442|NCT00371761|54673387|FG000|Overall Study|Withdrawal by Subject|1|||
28014443|NCT00371761|54673388|FG001|Overall Study|Withdrawal by Subject|3|||
28014444|NCT00371761|54673387|FG000|Overall Study|Investigator Judgment|2|||
28014445|NCT00371761|54673388|FG001|Overall Study|Investigator Judgment|3|||
28014446|NCT00371761|54673387|FG000|Overall Study|Study termination|4|||
28014447|NCT00371761|54673388|FG001|Overall Study|Study termination|3|||
28014448|NCT00549640|54673396|FG000|Overall Study|Withdrawal by Subject|6|||
28014449|NCT00549640|54673397|FG001|Overall Study|Withdrawal by Subject|12|||
28014450|NCT00549640|54673396|FG000|Overall Study|Adverse Event|5|||
28014451|NCT00549640|54673397|FG001|Overall Study|Adverse Event|0|||
28014452|NCT00549640|54673396|FG000|Overall Study|Lost to Follow-up|7|||
28014453|NCT00549640|54673397|FG001|Overall Study|Lost to Follow-up|4|||
28014454|NCT00549562|54673419|FG000|Overall Study|Adverse Event|1|||
28014455|NCT00549562|54673419|FG000|Overall Study|Lack of Efficacy|1|||
28014456|NCT00681564|54673425|FG000|Overall Study|Lost to Follow-up|6|||
28014457|NCT00681564|54673426|FG001|Overall Study|Lost to Follow-up|6|||
28014458|NCT00681564|54673425|FG000|Overall Study|Withdrawal by Subject|0|||
28014459|NCT00681564|54673426|FG001|Overall Study|Withdrawal by Subject|1|||
28014460|NCT00681564|54673425|FG000|Overall Study|Death|0|||
28014461|NCT00681564|54673426|FG001|Overall Study|Death|1|||
28014462|NCT00677352|54673434|FG000|Treatment Phase|Adverse Event|14|||
28014463|NCT00677352|54673435|FG001|Treatment Phase|Adverse Event|22|||
28014464|NCT00677352|54673434|FG000|Treatment Phase|Lack of Efficacy|2|||
28014465|NCT00677352|54673435|FG001|Treatment Phase|Lack of Efficacy|3|||
28014466|NCT00677352|54673434|FG000|Treatment Phase|Lost to Follow-up|0|||
28014467|NCT00677352|54673435|FG001|Treatment Phase|Lost to Follow-up|1|||
28014468|NCT00677352|54673434|FG000|Treatment Phase|Withdrawal by Subject|7|||
28014469|NCT00677352|54673435|FG001|Treatment Phase|Withdrawal by Subject|7|||
28014470|NCT00677352|54673434|FG000|Treatment Phase|Physician Decision|1|||
28014471|NCT00677352|54673435|FG001|Treatment Phase|Physician Decision|0|||
28014472|NCT00677352|54673434|FG000|Treatment Phase|Pregnancy|0|||
28014473|NCT00677352|54673435|FG001|Treatment Phase|Pregnancy|1|||
28014474|NCT00677352|54673434|FG000|Treatment Phase|Protocol Violation|1|||
28014475|NCT00677352|54673435|FG001|Treatment Phase|Protocol Violation|1|||
28014476|NCT00677352|54673434|FG000|Treatment Phase|Transference or work related matter|0|||
28014477|NCT00677352|54673435|FG001|Treatment Phase|Transference or work related matter|5|||
28014478|NCT00677352|54673434|FG000|Treatment Phase|Not treated|0|||
28014479|NCT00677352|54673435|FG001|Treatment Phase|Not treated|2|||
28014480|NCT00677352|54673434|FG000|Tapering Phase|Adverse Event|1|||
28014481|NCT00677352|54673435|FG001|Tapering Phase|Adverse Event|5|||
28014482|NCT00677352|54673434|FG000|Tapering Phase|Withdrawal by Subject|5|||
28014483|NCT00677352|54673435|FG001|Tapering Phase|Withdrawal by Subject|3|||
28014484|NCT00677352|54673434|FG000|Tapering Phase|Pregnancy|0|||
28014485|NCT00677352|54673435|FG001|Tapering Phase|Pregnancy|1|||
28014486|NCT00677352|54673434|FG000|Tapering Phase|Job transfer|0|||
28014487|NCT00677352|54673435|FG001|Tapering Phase|Job transfer|1|||
28014488|NCT00371683|54673448|FG000|DB Treatment Period-Randomized Patients|Death|1|||
28014489|NCT00371683|54673449|FG001|DB Treatment Period-Randomized Patients|Death|1|||
28014490|NCT00371683|54673448|FG000|DB Treatment Period-Randomized Patients|Adverse Event|60|||
28014491|NCT00371683|54673449|FG001|DB Treatment Period-Randomized Patients|Adverse Event|58|||
28014492|NCT00371683|54673448|FG000|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18|||
28014493|NCT00371683|54673449|FG001|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37|||
28014494|NCT00371683|54673448|FG000|DB Treatment Period-Randomized Patients|Lost to Follow-up|0|||
28014495|NCT00371683|54673449|FG001|DB Treatment Period-Randomized Patients|Lost to Follow-up|1|||
28014496|NCT00371683|54673448|FG000|DB Treatment Period-Randomized Patients|No longer meets study criteria|1|||
28014497|NCT00371683|54673449|FG001|DB Treatment Period-Randomized Patients|No longer meets study criteria|2|||
27923795|NCT01036594|54580750|FG000|Treatment Regiments Post Week 12|Adverse Event|0|||
27923796|NCT01036594|54580751|FG001|Treatment Regiments Post Week 12|Adverse Event|1|||
27923797|NCT01036594|54580750|FG000|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0|||
27923798|NCT01036594|54580751|FG001|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1|||
27923799|NCT01036594|54580750|FG000|Treatment Regiments Post Week 12|Lack of Efficacy|0|||
27923800|NCT01036594|54580751|FG001|Treatment Regiments Post Week 12|Lack of Efficacy|1|||
27923801|NCT01036438|54580759|FG000|Overall Study|Adverse Event|7|||
27923802|NCT01036438|54580760|FG001|Overall Study|Adverse Event|8|||
27923803|NCT01036438|54580759|FG000|Overall Study|Death|0|||
27923804|NCT01036438|54580760|FG001|Overall Study|Death|1|||
27923805|NCT01036438|54580759|FG000|Overall Study|No effect of study treatment|3|||
27923806|NCT01036438|54580760|FG001|Overall Study|No effect of study treatment|1|||
27923807|NCT01268514|54580766|FG000|Overall Study|Adverse Event|20|||
27923808|NCT01268514|54580766|FG000|Overall Study|Death|8|||
27923809|NCT01268514|54580766|FG000|Overall Study|Lost to Follow-up|5|||
27923810|NCT01268514|54580766|FG000|Overall Study|Withdrawal by Subject|3|||
27923811|NCT01268514|54580766|FG000|Overall Study|Withdrawal by Surgeon|5|||
27923812|NCT01268046|54580776|FG000|Overall Study|Withdrawal by Subject|1|||
27923813|NCT01268046|54580777|FG001|Overall Study|Withdrawal by Subject|0|||
27923814|NCT01268046|54580778|FG002|Overall Study|Withdrawal by Subject|0|||
27923815|NCT01268046|54580779|FG003|Overall Study|Withdrawal by Subject|1|||
27923816|NCT01268046|54580776|FG000|Overall Study|Lost to Follow-up|0|||
27923817|NCT01268046|54580777|FG001|Overall Study|Lost to Follow-up|0|||
27923818|NCT01268046|54580778|FG002|Overall Study|Lost to Follow-up|1|||
27923819|NCT01268046|54580779|FG003|Overall Study|Lost to Follow-up|0|||
27923820|NCT01267266|54580789|FG000|Enrollment Phase|Withdrawal by Subject|2|||
27923821|NCT01267266|54580790|FG001|Enrollment Phase|Withdrawal by Subject|0|||
27923822|NCT01267266|54580789|FG000|Lead-in Phase|Lack of Efficacy|20|||
27923823|NCT01267266|54580790|FG001|Lead-in Phase|Lack of Efficacy|0|||
27923824|NCT01267266|54580789|FG000|Lead-in Phase|Adverse Event|2|||
27923825|NCT01267266|54580790|FG001|Lead-in Phase|Adverse Event|0|||
27923826|NCT01267266|54580789|FG000|Lead-in Phase|Withdrawal by Subject|1|||
27923827|NCT01267266|54580790|FG001|Lead-in Phase|Withdrawal by Subject|0|||
27923828|NCT01034176|54580801|FG000|Overall Study|Physician Decision|2|||
27923829|NCT01034176|54580802|FG001|Overall Study|Physician Decision|0|||
27923830|NCT01034176|54580801|FG000|Overall Study|Withdrawal by Subject|0|||
27923831|NCT01034176|54580802|FG001|Overall Study|Withdrawal by Subject|1|||
27923832|NCT01034176|54580801|FG000|Overall Study|Lost to Follow-up|0|||
27923833|NCT01034176|54580802|FG001|Overall Study|Lost to Follow-up|1|||
27923834|NCT01033942|54580811|FG000|Overall Study|Withdrawal by Subject|1|||
27923835|NCT01033942|54580812|FG001|Overall Study|Withdrawal by Subject|1|||
27923836|NCT01033942|54580813|FG002|Overall Study|Withdrawal by Subject|1|||
27923837|NCT01033942|54580811|FG000|Overall Study|Lost to Follow-up|1|||
27923838|NCT01033942|54580812|FG001|Overall Study|Lost to Follow-up|0|||
27923839|NCT01033942|54580813|FG002|Overall Study|Lost to Follow-up|0|||
27923840|NCT01033942|54580811|FG000|Overall Study|Enrolled in Extension Study|0|||
27923841|NCT01033942|54580812|FG001|Overall Study|Enrolled in Extension Study|3|||
27923842|NCT01033942|54580813|FG002|Overall Study|Enrolled in Extension Study|0|||
27923843|NCT01062256|54580826|FG000|Overall Study|Adverse Event|1|||
27923844|NCT01062256|54580827|FG001|Overall Study|Adverse Event|0|||
27923845|NCT01062256|54580828|FG002|Overall Study|Adverse Event|0|||
27923846|NCT01062256|54580826|FG000|Overall Study|Withdrawal by Subject|1|||
27923847|NCT01062256|54580827|FG001|Overall Study|Withdrawal by Subject|1|||
27923848|NCT01062256|54580828|FG002|Overall Study|Withdrawal by Subject|1|||
27923849|NCT01062256|54580826|FG000|Overall Study|Ineligible|1|||
27923850|NCT01062256|54580827|FG001|Overall Study|Ineligible|4|||
27923851|NCT01062256|54580828|FG002|Overall Study|Ineligible|3|||
27923852|NCT01062256|54580826|FG000|Overall Study|Administrative|0|||
27923853|NCT01062256|54580827|FG001|Overall Study|Administrative|2|||
27923854|NCT01062256|54580828|FG002|Overall Study|Administrative|0|||
27923855|NCT01029886|54580838|FG000|Overall Study|Adverse Event|12|||
27923856|NCT01029886|54580839|FG001|Overall Study|Adverse Event|25|||
27923857|NCT01029886|54580838|FG000|Overall Study|Lost to Follow-up|1|||
27923858|NCT01029886|54580839|FG001|Overall Study|Lost to Follow-up|0|||
27923859|NCT01029886|54580838|FG000|Overall Study|Physician Decision|2|||
27923860|NCT01029886|54580839|FG001|Overall Study|Physician Decision|6|||
27923861|NCT01029886|54580838|FG000|Overall Study|Protocol Violation|17|||
27923862|NCT01029886|54580839|FG001|Overall Study|Protocol Violation|5|||
27923863|NCT01029886|54580838|FG000|Overall Study|Withdrawal by Subject|8|||
27923864|NCT01029886|54580839|FG001|Overall Study|Withdrawal by Subject|18|||
27923865|NCT01029886|54580838|FG000|Overall Study|Entry Criteria Not Met|13|||
27923866|NCT01029886|54580839|FG001|Overall Study|Entry Criteria Not Met|5|||
27923867|NCT01029886|54580838|FG000|Overall Study|Sponsor Decision|1|||
27923868|NCT01029886|54580839|FG001|Overall Study|Sponsor Decision|0|||
27923869|NCT01029886|54580838|FG000|Overall Study|Loss Glucose Control|7|||
27923870|NCT01029886|54580839|FG001|Overall Study|Loss Glucose Control|1|||
27923871|NCT01244763|54580855|FG000|Overall Study|Adverse Event|1|||
27923872|NCT01244763|54580856|FG001|Overall Study|Adverse Event|0|||
27923873|NCT01244763|54580857|FG002|Overall Study|Adverse Event|0|||
27923874|NCT01244763|54580858|FG003|Overall Study|Adverse Event|0|||
27923875|NCT01244763|54580859|FG004|Overall Study|Adverse Event|0|||
27923876|NCT01244763|54580860|FG005|Overall Study|Adverse Event|1|||
27923877|NCT01244763|54580855|FG000|Overall Study|Death|1|||
27923878|NCT01244763|54580856|FG001|Overall Study|Death|0|||
27923879|NCT01244763|54580857|FG002|Overall Study|Death|1|||
27923880|NCT01244763|54580858|FG003|Overall Study|Death|0|||
27923881|NCT01244763|54580859|FG004|Overall Study|Death|2|||
27923882|NCT01244763|54580860|FG005|Overall Study|Death|0|||
27923883|NCT01244763|54580855|FG000|Overall Study|Physician Decision|0|||
27923884|NCT01244763|54580856|FG001|Overall Study|Physician Decision|0|||
27923885|NCT01244763|54580857|FG002|Overall Study|Physician Decision|1|||
27923886|NCT01244763|54580858|FG003|Overall Study|Physician Decision|0|||
27923887|NCT01244763|54580859|FG004|Overall Study|Physician Decision|0|||
27923888|NCT01244763|54580860|FG005|Overall Study|Physician Decision|0|||
27923889|NCT01244763|54580855|FG000|Overall Study|Withdrawal by Subject|1|||
27923890|NCT01244763|54580856|FG001|Overall Study|Withdrawal by Subject|2|||
27923891|NCT01244763|54580857|FG002|Overall Study|Withdrawal by Subject|0|||
27923892|NCT01244763|54580858|FG003|Overall Study|Withdrawal by Subject|1|||
27923893|NCT01244763|54580859|FG004|Overall Study|Withdrawal by Subject|1|||
27923894|NCT01244763|54580860|FG005|Overall Study|Withdrawal by Subject|2|||
27923895|NCT01244763|54580855|FG000|Overall Study|Lost to Follow-up|0|||
27923896|NCT01244763|54580856|FG001|Overall Study|Lost to Follow-up|1|||
27923897|NCT01244763|54580857|FG002|Overall Study|Lost to Follow-up|0|||
27923898|NCT01244763|54580858|FG003|Overall Study|Lost to Follow-up|0|||
27923899|NCT01244763|54580859|FG004|Overall Study|Lost to Follow-up|0|||
27923900|NCT01244763|54580860|FG005|Overall Study|Lost to Follow-up|0|||
27923901|NCT01244763|54580855|FG000|Overall Study|Enrolled into the Extension Study|0|||
27923902|NCT01244763|54580856|FG001|Overall Study|Enrolled into the Extension Study|0|||
27923903|NCT01244763|54580857|FG002|Overall Study|Enrolled into the Extension Study|0|||
27923904|NCT01244763|54580858|FG003|Overall Study|Enrolled into the Extension Study|0|||
27923905|NCT01244763|54580859|FG004|Overall Study|Enrolled into the Extension Study|0|||
27923906|NCT01244763|54580860|FG005|Overall Study|Enrolled into the Extension Study|1|||
27923907|NCT01244061|54580876|FG000|Overall Study|Death|1|||
27923908|NCT01244061|54580877|FG001|Overall Study|Death|0|||
27923909|NCT01244061|54580876|FG000|Overall Study|Did not meet entrance criteria|1|||
27923910|NCT01244061|54580877|FG001|Overall Study|Did not meet entrance criteria|0|||
27923911|NCT01244061|54580876|FG000|Overall Study|Lack of Efficacy|1|||
27923912|NCT01244061|54580877|FG001|Overall Study|Lack of Efficacy|3|||
27923913|NCT01244061|54580876|FG000|Overall Study|Lost to Follow-up|34|||
27923914|NCT01244061|54580877|FG001|Overall Study|Lost to Follow-up|30|||
27923915|NCT01244061|54580876|FG000|Overall Study|Withdrawal by Subject|29|||
27923916|NCT01244061|54580877|FG001|Overall Study|Withdrawal by Subject|46|||
27923917|NCT01244061|54580876|FG000|Overall Study|Other|8|||
27923918|NCT01244061|54580877|FG001|Overall Study|Other|19|||
27923919|NCT01244061|54580876|FG000|Overall Study|Protocol Violation|1|||
27923920|NCT01244061|54580877|FG001|Overall Study|Protocol Violation|1|||
27923921|NCT01244061|54580876|FG000|Overall Study|Adverse Event|5|||
27923922|NCT01244061|54580877|FG001|Overall Study|Adverse Event|2|||
27923923|NCT01244061|54580876|FG000|Overall Study|Randomized but not treated|2|||
27923924|NCT01244061|54580877|FG001|Overall Study|Randomized but not treated|2|||
27923925|NCT01243671|54580883|FG000|Overall Study|Adverse Event|3|||
27923926|NCT01243671|54580883|FG000|Overall Study|Anti-adalimumab antibody positive|1|||
27923927|NCT01243671|54580883|FG000|Overall Study|Other|1|||
27923928|NCT01240785|54580889|FG000|Overall Study|Lost to Follow-up|1|||
27923929|NCT01240785|54580890|FG001|Overall Study|Lost to Follow-up|0|||
27923930|NCT01240785|54580889|FG000|Overall Study|Protocol Violation|0|||
27923931|NCT01240785|54580890|FG001|Overall Study|Protocol Violation|3|||
27923932|NCT01240551|54580898|FG000|Overall Study|Refused further treatment|3|||
27923933|NCT01240551|54580899|FG001|Overall Study|Refused further treatment|2|||
27923934|NCT01240551|54580898|FG000|Overall Study|Lost to Follow-up|1|||
27923935|NCT01240551|54580899|FG001|Overall Study|Lost to Follow-up|1|||
27923936|NCT01239381|54580905|FG000|Overall Study|Protocol Violation|1|||
27923937|NCT01239381|54580905|FG000|Overall Study|Withdrawal by Subject|1|||
27923938|NCT01266876|54580915|FG000|Overall Study|Adverse Event|0|||
27923939|NCT01266876|54580916|FG001|Overall Study|Adverse Event|0|||
27923940|NCT01266876|54580917|FG002|Overall Study|Adverse Event|0|||
27923941|NCT01266876|54580918|FG003|Overall Study|Adverse Event|1|||
27923942|NCT01266876|54580919|FG004|Overall Study|Adverse Event|0|||
27923943|NCT01266642|54580933|FG000|Overall Study|Protocol Violation|0|||
27923944|NCT01266642|54580934|FG001|Overall Study|Protocol Violation|1|||
27923945|NCT01033240|54580943|FG000|Overall Study|Serious Adverse Event (SAE) or Adverse Event|10|||
27923946|NCT01033240|54580944|FG001|Overall Study|Serious Adverse Event (SAE) or Adverse Event|8|||
27923947|NCT01033240|54580945|FG002|Overall Study|Serious Adverse Event (SAE) or Adverse Event|6|||
27923948|NCT01033240|54580943|FG000|Overall Study|Death|2|||
27923949|NCT01033240|54580944|FG001|Overall Study|Death|0|||
27923950|NCT01033240|54580945|FG002|Overall Study|Death|0|||
27923951|NCT01033240|54580943|FG000|Overall Study|Withdrew Consent|2|||
27923952|NCT01033240|54580944|FG001|Overall Study|Withdrew Consent|9|||
27923953|NCT01033240|54580945|FG002|Overall Study|Withdrew Consent|2|||
27923954|NCT01033240|54580943|FG000|Overall Study|Disease Progression|35|||
27923955|NCT01033240|54580944|FG001|Overall Study|Disease Progression|32|||
27923956|NCT01033240|54580945|FG002|Overall Study|Disease Progression|41|||
27923957|NCT01033240|54580943|FG000|Overall Study|Investigator Discretion|0|||
27923958|NCT01033240|54580944|FG001|Overall Study|Investigator Discretion|0|||
27923959|NCT01033240|54580945|FG002|Overall Study|Investigator Discretion|2|||
27923960|NCT01033240|54580943|FG000|Overall Study|Other|0|||
27923961|NCT01033240|54580944|FG001|Overall Study|Other|1|||
27923962|NCT01033240|54580945|FG002|Overall Study|Other|2|||
27923963|NCT01266018|54580953|FG000|Overall Study|Physician Decision|1|||
27923964|NCT01266018|54580954|FG001|Overall Study|Physician Decision|0|||
27923965|NCT01266018|54580953|FG000|Overall Study|Progressive disease|0|||
27923966|NCT01266018|54580954|FG001|Overall Study|Progressive disease|1|||
27923967|NCT01032382|54580962|FG000|Overall Study|Disease dissemination|1|||
27923968|NCT01032382|54580963|FG001|Overall Study|Disease dissemination|1|||
27923969|NCT01032382|54580962|FG000|Overall Study|Treatment failure|3|||
27923970|NCT01032382|54580963|FG001|Overall Study|Treatment failure|1|||
27923971|NCT01032382|54580962|FG000|Overall Study|Index lesion relapse|1|||
27923972|NCT01032382|54580963|FG001|Overall Study|Index lesion relapse|3|||
27923973|NCT01029652|54580971|FG000|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0|||
27923974|NCT01029652|54580972|FG001|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4|||
27923975|NCT01029652|54580971|FG000|Core Study (0-12 Weeks)|Patient Withdrew Consent|1|||
27923976|NCT01029652|54580972|FG001|Core Study (0-12 Weeks)|Patient Withdrew Consent|3|||
27923977|NCT01029652|54580971|FG000|Core Study (0-12 Weeks)|Lost to Follow-up|3|||
27923978|NCT01029652|54580972|FG001|Core Study (0-12 Weeks)|Lost to Follow-up|1|||
27923979|NCT01029652|54580971|FG000|Core Study (0-12 Weeks)|Administrative problems|2|||
27923980|NCT01029652|54580972|FG001|Core Study (0-12 Weeks)|Administrative problems|1|||
27923981|NCT01029652|54580971|FG000|Core Study (0-12 Weeks)|Death|0|||
27923982|NCT01029652|54580972|FG001|Core Study (0-12 Weeks)|Death|1|||
27923983|NCT01029652|54580971|FG000|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0|||
27923984|NCT01029652|54580972|FG001|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1|||
27923985|NCT01029652|54580971|FG000|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2|||
27923986|NCT01029652|54580972|FG001|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3|||
27923987|NCT01029652|54580971|FG000|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1|||
27923988|NCT01029652|54580972|FG001|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0|||
27923989|NCT01029652|54580971|FG000|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0|||
27923990|NCT01029652|54580972|FG001|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1|||
27923991|NCT01029652|54580971|FG000|Extension Study 2 (25-72 Weeks)|Death|1|||
27923992|NCT01029652|54580972|FG001|Extension Study 2 (25-72 Weeks)|Death|1|||
27923993|NCT01029652|54580971|FG000|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0|||
27923994|NCT01029652|54580972|FG001|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1|||
27923995|NCT01029652|54580971|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0|||
27923996|NCT01029652|54580972|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1|||
27923997|NCT01029340|54581001|FG000|Part B Treatment Period|Withdrawal by Subject|0|||
27923998|NCT01029340|54581002|FG001|Part B Treatment Period|Withdrawal by Subject|0|||
27923999|NCT01029340|54581003|FG002|Part B Treatment Period|Withdrawal by Subject|1|||
27924000|NCT01029340|54581004|FG003|Part B Treatment Period|Withdrawal by Subject|0|||
27924001|NCT01029340|54581005|FG004|Part B Treatment Period|Withdrawal by Subject|0|||
27924002|NCT01029340|54581006|FG005|Part B Treatment Period|Withdrawal by Subject|0|||
27924003|NCT01029340|54581001|FG000|Part B Treatment Period|Protocol Violation|0|||
28014498|NCT00371683|54673448|FG000|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1|||
27924004|NCT01029340|54581002|FG001|Part B Treatment Period|Protocol Violation|0|||
27924005|NCT01029340|54581003|FG002|Part B Treatment Period|Protocol Violation|1|||
27924006|NCT01029340|54581004|FG003|Part B Treatment Period|Protocol Violation|0|||
27924007|NCT01029340|54581005|FG004|Part B Treatment Period|Protocol Violation|0|||
27924008|NCT01029340|54581006|FG005|Part B Treatment Period|Protocol Violation|0|||
27924009|NCT01029340|54581001|FG000|Extension Period|Adverse Event|0|||
27924010|NCT01029340|54581002|FG001|Extension Period|Adverse Event|0|||
27924011|NCT01029340|54581003|FG002|Extension Period|Adverse Event|0|||
27924012|NCT01029340|54581004|FG003|Extension Period|Adverse Event|0|||
27924013|NCT01029340|54581005|FG004|Extension Period|Adverse Event|0|||
27924014|NCT01029340|54581006|FG005|Extension Period|Adverse Event|1|||
27924015|NCT01029340|54581001|FG000|Extension Period|starting another study|0|||
27924016|NCT01029340|54581002|FG001|Extension Period|starting another study|0|||
27924017|NCT01029340|54581003|FG002|Extension Period|starting another study|0|||
27924018|NCT01029340|54581004|FG003|Extension Period|starting another study|0|||
27924019|NCT01029340|54581005|FG004|Extension Period|starting another study|0|||
27924020|NCT01029340|54581006|FG005|Extension Period|starting another study|8|||
27924021|NCT01029340|54581001|FG000|Extension Period|non-compliance|0|||
27924022|NCT01029340|54581002|FG001|Extension Period|non-compliance|0|||
27924023|NCT01029340|54581003|FG002|Extension Period|non-compliance|0|||
27924024|NCT01029340|54581004|FG003|Extension Period|non-compliance|0|||
27924025|NCT01029340|54581005|FG004|Extension Period|non-compliance|0|||
27924026|NCT01029340|54581006|FG005|Extension Period|non-compliance|1|||
27924027|NCT01029340|54581001|FG000|Extension Period|Withdrawal by Subject|0|||
27924028|NCT01029340|54581002|FG001|Extension Period|Withdrawal by Subject|0|||
27924029|NCT01029340|54581003|FG002|Extension Period|Withdrawal by Subject|0|||
27924030|NCT01029340|54581004|FG003|Extension Period|Withdrawal by Subject|0|||
27924031|NCT01029340|54581005|FG004|Extension Period|Withdrawal by Subject|0|||
27924032|NCT01029340|54581006|FG005|Extension Period|Withdrawal by Subject|1|||
27924033|NCT01029340|54581001|FG000|Extension Period|Physician Decision|0|||
27924034|NCT01029340|54581002|FG001|Extension Period|Physician Decision|0|||
27924035|NCT01029340|54581003|FG002|Extension Period|Physician Decision|0|||
27924036|NCT01029340|54581004|FG003|Extension Period|Physician Decision|0|||
27924037|NCT01029340|54581005|FG004|Extension Period|Physician Decision|0|||
27924038|NCT01029340|54581006|FG005|Extension Period|Physician Decision|1|||
27924039|NCT01265550|54581023|FG000|Pre Randomization|Withdrawal by Subject|0|||
27924040|NCT01265550|54581024|FG001|Pre Randomization|Withdrawal by Subject|0|||
27924041|NCT01265550|54581025|FG002|Pre Randomization|Withdrawal by Subject|0|||
27924042|NCT01265550|54581026|FG003|Pre Randomization|Withdrawal by Subject|70|||
27924043|NCT01265550|54581023|FG000|Pre Randomization|Technical Exclusions|0|||
27924044|NCT01265550|54581024|FG001|Pre Randomization|Technical Exclusions|0|||
27924045|NCT01265550|54581025|FG002|Pre Randomization|Technical Exclusions|0|||
27924046|NCT01265550|54581026|FG003|Pre Randomization|Technical Exclusions|54|||
27924047|NCT01265550|54581023|FG000|Pre Randomization|GERD, PPI-Responsive|0|||
27924048|NCT01265550|54581024|FG001|Pre Randomization|GERD, PPI-Responsive|0|||
27924049|NCT01265550|54581025|FG002|Pre Randomization|GERD, PPI-Responsive|0|||
27924050|NCT01265550|54581026|FG003|Pre Randomization|GERD, PPI-Responsive|42|||
27924051|NCT01265550|54581023|FG000|Pre Randomization|Non-GERD organic disorders|0|||
27924052|NCT01265550|54581024|FG001|Pre Randomization|Non-GERD organic disorders|0|||
27924053|NCT01265550|54581025|FG002|Pre Randomization|Non-GERD organic disorders|0|||
27924054|NCT01265550|54581026|FG003|Pre Randomization|Non-GERD organic disorders|23|||
27924055|NCT01265550|54581023|FG000|Pre Randomization|Functional heartburn|0|||
27924056|NCT01265550|54581024|FG001|Pre Randomization|Functional heartburn|0|||
27924057|NCT01265550|54581025|FG002|Pre Randomization|Functional heartburn|0|||
27924058|NCT01265550|54581026|FG003|Pre Randomization|Functional heartburn|99|||
27924059|NCT01265394|54581040|FG000|Overall Study|Subjects withdrawn|37|||
27924060|NCT01029262|54581047|FG000|Overall Study|Adverse Event|9|||
27924061|NCT01029262|54581048|FG001|Overall Study|Adverse Event|52|||
27924062|NCT01029262|54581047|FG000|Overall Study|Lack of therapeutic effect|57|||
27924063|NCT01029262|54581048|FG001|Overall Study|Lack of therapeutic effect|76|||
27924064|NCT01029262|54581047|FG000|Overall Study|Withdrawal by Subject|10|||
27924065|NCT01029262|54581048|FG001|Overall Study|Withdrawal by Subject|17|||
27924066|NCT01029262|54581047|FG000|Overall Study|Protocol Violation|2|||
27924067|NCT01029262|54581048|FG001|Overall Study|Protocol Violation|3|||
27924068|NCT01029262|54581047|FG000|Overall Study|Miscellaneous|1|||
27924069|NCT01029262|54581048|FG001|Overall Study|Miscellaneous|9|||
27924070|NCT01029262|54581047|FG000|Overall Study|Death|0|||
27924071|NCT01029262|54581048|FG001|Overall Study|Death|3|||
27924072|NCT01028560|54581061|FG000|Overall Study|Lack of Efficacy|3|||
27924073|NCT01028560|54581062|FG001|Overall Study|Lack of Efficacy|6|||
27924074|NCT01028560|54581061|FG000|Overall Study|Withdrawal by Subject|7|||
27924075|NCT01028560|54581062|FG001|Overall Study|Withdrawal by Subject|12|||
27924076|NCT01061710|54581069|FG000|Overall Study|Protocol Violation|14|||
27924077|NCT01028014|54581079|FG000|Overall Study|Lost to Follow-up|1|||
27924078|NCT01028014|54581080|FG001|Overall Study|Lost to Follow-up|2|||
27924079|NCT01028014|54581081|FG002|Overall Study|Lost to Follow-up|0|||
27924080|NCT01028014|54581082|FG003|Overall Study|Lost to Follow-up|1|||
27924081|NCT01028014|54581083|FG004|Overall Study|Lost to Follow-up|1|||
27924082|NCT01028014|54581084|FG005|Overall Study|Lost to Follow-up|2|||
27924083|NCT01264770|54581104|FG000|Overall Study|Not reported|0|||
27924084|NCT01264770|54581105|FG001|Overall Study|Not reported|0|||
27924085|NCT01264770|54581106|FG002|Overall Study|Not reported|1|||
27924086|NCT01264770|54581107|FG003|Overall Study|Not reported|0|||
27924087|NCT01264770|54581108|FG004|Overall Study|Not reported|0|||
27924088|NCT01264770|54581109|FG005|Overall Study|Not reported|0|||
27924089|NCT01264770|54581104|FG000|Overall Study|e.g., change in circumstances|8|||
27924090|NCT01264770|54581105|FG001|Overall Study|e.g., change in circumstances|3|||
27924091|NCT01264770|54581106|FG002|Overall Study|e.g., change in circumstances|3|||
27924092|NCT01264770|54581107|FG003|Overall Study|e.g., change in circumstances|3|||
27924093|NCT01264770|54581108|FG004|Overall Study|e.g., change in circumstances|4|||
27924094|NCT01264770|54581109|FG005|Overall Study|e.g., change in circumstances|4|||
27924095|NCT01264770|54581104|FG000|Overall Study|Severe non-compliance to protocol|0|||
27924096|NCT01264770|54581105|FG001|Overall Study|Severe non-compliance to protocol|0|||
27924097|NCT01264770|54581106|FG002|Overall Study|Severe non-compliance to protocol|1|||
27924098|NCT01264770|54581107|FG003|Overall Study|Severe non-compliance to protocol|1|||
27924099|NCT01264770|54581108|FG004|Overall Study|Severe non-compliance to protocol|0|||
27924100|NCT01264770|54581109|FG005|Overall Study|Severe non-compliance to protocol|0|||
27924101|NCT01264770|54581104|FG000|Overall Study|Lack of therapeutic response|1|||
27924102|NCT01264770|54581105|FG001|Overall Study|Lack of therapeutic response|0|||
27924103|NCT01264770|54581106|FG002|Overall Study|Lack of therapeutic response|2|||
27924104|NCT01264770|54581107|FG003|Overall Study|Lack of therapeutic response|1|||
27924105|NCT01264770|54581108|FG004|Overall Study|Lack of therapeutic response|1|||
27924106|NCT01264770|54581109|FG005|Overall Study|Lack of therapeutic response|0|||
27924107|NCT01264770|54581104|FG000|Overall Study|Dev. of study specific discont. criteria|2|||
27924108|NCT01264770|54581105|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
27924109|NCT01264770|54581106|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
27924110|NCT01264770|54581107|FG003|Overall Study|Dev. of study specific discont. criteria|0|||
27924111|NCT01264770|54581108|FG004|Overall Study|Dev. of study specific discont. criteria|1|||
27924112|NCT01264770|54581109|FG005|Overall Study|Dev. of study specific discont. criteria|1|||
27924113|NCT01264770|54581104|FG000|Overall Study|Lost to Follow-up|0|||
27924114|NCT01264770|54581105|FG001|Overall Study|Lost to Follow-up|0|||
27924115|NCT01264770|54581106|FG002|Overall Study|Lost to Follow-up|1|||
27924116|NCT01264770|54581107|FG003|Overall Study|Lost to Follow-up|1|||
27924117|NCT01264770|54581108|FG004|Overall Study|Lost to Follow-up|0|||
27924118|NCT01264770|54581109|FG005|Overall Study|Lost to Follow-up|0|||
27924119|NCT01264770|54581104|FG000|Overall Study|Adverse Event|7|||
27924120|NCT01264770|54581105|FG001|Overall Study|Adverse Event|7|||
27924121|NCT01264770|54581106|FG002|Overall Study|Adverse Event|8|||
27924122|NCT01264770|54581107|FG003|Overall Study|Adverse Event|0|||
27924123|NCT01264770|54581108|FG004|Overall Study|Adverse Event|2|||
27924124|NCT01264770|54581109|FG005|Overall Study|Adverse Event|1|||
27924125|NCT01027702|54581129|FG000|Overall Study|Received subsequent therapy|1|||
27924126|NCT01027702|54581130|FG001|Overall Study|Received subsequent therapy|2|||
27924127|NCT01027702|54581131|FG002|Overall Study|Received subsequent therapy|0|||
27924128|NCT01027702|54581132|FG003|Overall Study|Received subsequent therapy|4|||
27924129|NCT01027702|54581133|FG004|Overall Study|Received subsequent therapy|1|||
27924130|NCT01027702|54581134|FG005|Overall Study|Received subsequent therapy|0|||
27924131|NCT01027702|54581135|FG006|Overall Study|Received subsequent therapy|1|||
27924132|NCT01027702|54581129|FG000|Overall Study|Death|0|||
27924133|NCT01027702|54581130|FG001|Overall Study|Death|0|||
27924134|NCT01027702|54581131|FG002|Overall Study|Death|1|||
27924135|NCT01027702|54581132|FG003|Overall Study|Death|0|||
27924136|NCT01027702|54581133|FG004|Overall Study|Death|0|||
27924137|NCT01027702|54581134|FG005|Overall Study|Death|0|||
27924138|NCT01027702|54581135|FG006|Overall Study|Death|0|||
27924139|NCT01302080|54581149|FG000|Overall Study|Withdrew Consent|92|||
27924140|NCT01302080|54581150|FG001|Overall Study|Withdrew Consent|39|||
27924141|NCT01302080|54581149|FG000|Overall Study|Patient/Family Moved|28|||
27924142|NCT01302080|54581150|FG001|Overall Study|Patient/Family Moved|3|||
27924143|NCT01302080|54581149|FG000|Overall Study|Lost to Follow-up|192|||
27924144|NCT01302080|54581150|FG001|Overall Study|Lost to Follow-up|93|||
27924145|NCT01302080|54581149|FG000|Overall Study|Death|1|||
27924146|NCT01302080|54581150|FG001|Overall Study|Death|0|||
27924147|NCT01302080|54581149|FG000|Overall Study|Other|52|||
27924148|NCT01302080|54581150|FG001|Overall Study|Other|8|||
27924149|NCT01302080|54581149|FG000|Overall Study|Reason Missing For Discontinuation|1|||
27924150|NCT01302080|54581150|FG001|Overall Study|Reason Missing For Discontinuation|0|||
27924151|NCT01238991|54581190|FG000|Overall Study|Adverse Event|1|||
27924152|NCT01238991|54581191|FG001|Overall Study|Adverse Event|0|||
27924153|NCT01238991|54581192|FG002|Overall Study|Adverse Event|3|||
27924154|NCT01238991|54581193|FG003|Overall Study|Adverse Event|1|||
27924155|NCT01238991|54581194|FG004|Overall Study|Adverse Event|1|||
27924156|NCT01238991|54581195|FG005|Overall Study|Adverse Event|0|||
27924157|NCT01238991|54581196|FG006|Overall Study|Adverse Event|1|||
27924158|NCT01238991|54581197|FG007|Overall Study|Adverse Event|1|||
27924159|NCT01238991|54581198|FG008|Overall Study|Adverse Event|0|||
27924160|NCT01238991|54581199|FG009|Overall Study|Adverse Event|0|||
27924161|NCT01238991|54581190|FG000|Overall Study|Death|0|||
27924162|NCT01238991|54581191|FG001|Overall Study|Death|0|||
27924163|NCT01238991|54581192|FG002|Overall Study|Death|0|||
27924164|NCT01238991|54581193|FG003|Overall Study|Death|1|||
27924165|NCT01238991|54581194|FG004|Overall Study|Death|0|||
27924166|NCT01238991|54581195|FG005|Overall Study|Death|0|||
27924167|NCT01238991|54581196|FG006|Overall Study|Death|0|||
27924168|NCT01238991|54581197|FG007|Overall Study|Death|0|||
27924169|NCT01238991|54581198|FG008|Overall Study|Death|0|||
27924170|NCT01238991|54581199|FG009|Overall Study|Death|0|||
27924171|NCT01238991|54581190|FG000|Overall Study|Lack of Efficacy|0|||
27924172|NCT01238991|54581191|FG001|Overall Study|Lack of Efficacy|0|||
27924173|NCT01238991|54581192|FG002|Overall Study|Lack of Efficacy|1|||
27924174|NCT01238991|54581193|FG003|Overall Study|Lack of Efficacy|0|||
27924175|NCT01238991|54581194|FG004|Overall Study|Lack of Efficacy|0|||
27924176|NCT01238991|54581195|FG005|Overall Study|Lack of Efficacy|0|||
27924177|NCT01238991|54581196|FG006|Overall Study|Lack of Efficacy|0|||
27924178|NCT01238991|54581197|FG007|Overall Study|Lack of Efficacy|0|||
27924179|NCT01238991|54581198|FG008|Overall Study|Lack of Efficacy|1|||
27924180|NCT01238991|54581199|FG009|Overall Study|Lack of Efficacy|0|||
27924181|NCT01238991|54581190|FG000|Overall Study|Withdrawal by Subject|0|||
27924182|NCT01238991|54581191|FG001|Overall Study|Withdrawal by Subject|0|||
27924183|NCT01238991|54581192|FG002|Overall Study|Withdrawal by Subject|1|||
27924184|NCT01238991|54581193|FG003|Overall Study|Withdrawal by Subject|0|||
27924185|NCT01238991|54581194|FG004|Overall Study|Withdrawal by Subject|0|||
27924186|NCT01238991|54581195|FG005|Overall Study|Withdrawal by Subject|0|||
27924187|NCT01238991|54581196|FG006|Overall Study|Withdrawal by Subject|0|||
27924188|NCT01238991|54581197|FG007|Overall Study|Withdrawal by Subject|0|||
27924189|NCT01238991|54581198|FG008|Overall Study|Withdrawal by Subject|0|||
27924190|NCT01238991|54581199|FG009|Overall Study|Withdrawal by Subject|0|||
27924191|NCT01238991|54581190|FG000|Overall Study|Study Terminated by Sponsor|0|||
27924192|NCT01238991|54581191|FG001|Overall Study|Study Terminated by Sponsor|0|||
27924193|NCT01238991|54581192|FG002|Overall Study|Study Terminated by Sponsor|0|||
27924194|NCT01238991|54581193|FG003|Overall Study|Study Terminated by Sponsor|0|||
27924195|NCT01238991|54581194|FG004|Overall Study|Study Terminated by Sponsor|1|||
27924196|NCT01238991|54581195|FG005|Overall Study|Study Terminated by Sponsor|0|||
27924197|NCT01238991|54581196|FG006|Overall Study|Study Terminated by Sponsor|7|||
27924198|NCT01238991|54581197|FG007|Overall Study|Study Terminated by Sponsor|4|||
27924199|NCT01238991|54581198|FG008|Overall Study|Study Terminated by Sponsor|2|||
27924200|NCT01238991|54581199|FG009|Overall Study|Study Terminated by Sponsor|2|||
27924201|NCT01238991|54581190|FG000|Overall Study|Caregiver's request|0|||
27924202|NCT01238991|54581191|FG001|Overall Study|Caregiver's request|0|||
27924203|NCT01238991|54581192|FG002|Overall Study|Caregiver's request|0|||
27924204|NCT01238991|54581193|FG003|Overall Study|Caregiver's request|0|||
27924205|NCT01238991|54581194|FG004|Overall Study|Caregiver's request|0|||
27924206|NCT01238991|54581195|FG005|Overall Study|Caregiver's request|0|||
27924207|NCT01238991|54581196|FG006|Overall Study|Caregiver's request|0|||
27924208|NCT01238991|54581197|FG007|Overall Study|Caregiver's request|0|||
27924209|NCT01238991|54581198|FG008|Overall Study|Caregiver's request|1|||
27924210|NCT01238991|54581199|FG009|Overall Study|Caregiver's request|0|||
27924211|NCT01238991|54581190|FG000|Overall Study|Admission to a nursing home|1|||
27924212|NCT01238991|54581191|FG001|Overall Study|Admission to a nursing home|0|||
27924213|NCT01238991|54581192|FG002|Overall Study|Admission to a nursing home|1|||
27924214|NCT01238991|54581193|FG003|Overall Study|Admission to a nursing home|0|||
27924215|NCT01238991|54581194|FG004|Overall Study|Admission to a nursing home|0|||
27924216|NCT01238991|54581195|FG005|Overall Study|Admission to a nursing home|0|||
27924217|NCT01238991|54581196|FG006|Overall Study|Admission to a nursing home|0|||
27924218|NCT01238991|54581197|FG007|Overall Study|Admission to a nursing home|0|||
27924219|NCT01238991|54581198|FG008|Overall Study|Admission to a nursing home|0|||
27924220|NCT01238991|54581199|FG009|Overall Study|Admission to a nursing home|0|||
27924221|NCT01238835|54581224|FG000|Overall Study|Death|124|||
27924222|NCT01238835|54581224|FG000|Overall Study|Withdrawal by Subject|9|||
27924223|NCT01238835|54581224|FG000|Overall Study|Lost to Follow-up|1|||
27924224|NCT01238835|54581224|FG000|Overall Study|Site early discontinuation|2|||
27924225|NCT01032070|54581230|FG000|Overall Study|Disease progression|13|||
27924226|NCT01032070|54581231|FG001|Overall Study|Disease progression|8|||
27924227|NCT01032070|54581230|FG000|Overall Study|Medical or ethical reasons|0|||
27924228|NCT01032070|54581231|FG001|Overall Study|Medical or ethical reasons|2|||
27924229|NCT01032070|54581230|FG000|Overall Study|Withdrawal by Subject|0|||
27924230|NCT01032070|54581231|FG001|Overall Study|Withdrawal by Subject|2|||
27924231|NCT01237899|54581248|FG000|Washout Period of at Least 7 Days|Adverse Event|0|||
27924232|NCT01237899|54581249|FG001|Washout Period of at Least 7 Days|Adverse Event|0|||
27924233|NCT01237899|54581250|FG002|Washout Period of at Least 7 Days|Adverse Event|1|||
27924234|NCT01237899|54581251|FG003|Washout Period of at Least 7 Days|Adverse Event|0|||
28014499|NCT00371683|54673449|FG001|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0|||
27924235|NCT01237899|54581252|FG004|Washout Period of at Least 7 Days|Adverse Event|0|||
27924236|NCT01237899|54581253|FG005|Washout Period of at Least 7 Days|Adverse Event|0|||
27924237|NCT01237899|54581254|FG006|Washout Period of at Least 7 Days|Adverse Event|0|||
27924238|NCT01237899|54581255|FG007|Washout Period of at Least 7 Days|Adverse Event|0|||
27924239|NCT01237899|54581256|FG008|Washout Period of at Least 7 Days|Adverse Event|0|||
27924240|NCT01237899|54581257|FG009|Washout Period of at Least 7 Days|Adverse Event|0|||
27924241|NCT01237899|54581258|FG010|Washout Period of at Least 7 Days|Adverse Event|0|||
27924242|NCT01264380|54581276|FG000|Period C|Disease Progression|0|||
27924243|NCT01264380|54581277|FG001|Period C|Disease Progression|0|||
27924244|NCT01264380|54581278|FG002|Period C|Disease Progression|4|||
27924245|NCT01264380|54581276|FG000|Period C|Death|0|||
27924246|NCT01264380|54581277|FG001|Period C|Death|0|||
27924247|NCT01264380|54581278|FG002|Period C|Death|2|||
27924248|NCT01264380|54581276|FG000|Period C|Follow-up for survival status|0|||
27924249|NCT01264380|54581277|FG001|Period C|Follow-up for survival status|0|||
27924250|NCT01264380|54581278|FG002|Period C|Follow-up for survival status|6|||
27924251|NCT01264380|54581276|FG000|Period C|Withdrawal by Subject|0|||
27924252|NCT01264380|54581277|FG001|Period C|Withdrawal by Subject|0|||
27924253|NCT01264380|54581278|FG002|Period C|Withdrawal by Subject|1|||
27924254|NCT01264380|54581276|FG000|Period C|Adverse Event|0|||
27924255|NCT01264380|54581277|FG001|Period C|Adverse Event|0|||
27924256|NCT01264380|54581278|FG002|Period C|Adverse Event|1|||
27924257|NCT01263444|54581286|FG000|Overall Study|Adverse Event|8|||
27924258|NCT01263444|54581286|FG000|Overall Study|Withdrawal by Subject|1|||
27924259|NCT01263444|54581286|FG000|Overall Study|Protocol Violation|1|||
27924260|NCT01263054|54581292|FG000|Overall Study|Death|1|||
27924261|NCT01263054|54581293|FG001|Overall Study|Death|0|||
27924262|NCT01263054|54581292|FG000|Overall Study|Lost to Follow-up|2|||
27924263|NCT01263054|54581293|FG001|Overall Study|Lost to Follow-up|2|||
27924264|NCT01263054|54581292|FG000|Overall Study|Withdrawal by Subject|1|||
27924265|NCT01263054|54581293|FG001|Overall Study|Withdrawal by Subject|3|||
27924266|NCT01263054|54581292|FG000|Overall Study|Qualification Violation|1|||
27924267|NCT01263054|54581293|FG001|Overall Study|Qualification Violation|0|||
27924268|NCT01263054|54581292|FG000|Overall Study|Other|0|||
27924269|NCT01263054|54581293|FG001|Overall Study|Other|1|||
27924270|NCT01031836|54581305|FG000|Stage I|Adverse Event|1|||
27924271|NCT01031836|54581306|FG001|Stage I|Adverse Event|1|||
27924272|NCT01031836|54581307|FG002|Stage I|Adverse Event|0|||
27924273|NCT01031836|54581308|FG003|Stage I|Adverse Event|0|||
27924274|NCT01031836|54581309|FG004|Stage I|Adverse Event|0|||
27924275|NCT01031836|54581310|FG005|Stage I|Adverse Event|0|||
27924276|NCT01031836|54581305|FG000|Stage I|Other|0|||
27924277|NCT01031836|54581306|FG001|Stage I|Other|1|||
27924278|NCT01031836|54581307|FG002|Stage I|Other|0|||
27924279|NCT01031836|54581308|FG003|Stage I|Other|0|||
27924280|NCT01031836|54581309|FG004|Stage I|Other|0|||
27924281|NCT01031836|54581310|FG005|Stage I|Other|1|||
27924282|NCT01031836|54581305|FG000|Stage II|Adverse Event|0|||
27924283|NCT01031836|54581306|FG001|Stage II|Adverse Event|0|||
28014500|NCT00371683|54673448|FG000|DB Treatment Period-Randomized Patients|non-specified|9|||
28014501|NCT00371683|54673449|FG001|DB Treatment Period-Randomized Patients|non-specified|8|||
28014502|NCT00371683|54673448|FG000|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17|||
28014503|NCT00371683|54673449|FG001|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19|||
28014504|NCT00371683|54673448|FG000|Follow-Up Period - Randomized Patients|Death|0|||
28014505|NCT00371683|54673449|FG001|Follow-Up Period - Randomized Patients|Death|2|||
28014506|NCT00371683|54673448|FG000|Follow-Up Period - Randomized Patients|Lost to Follow-up|38|||
28014507|NCT00371683|54673449|FG001|Follow-Up Period - Randomized Patients|Lost to Follow-up|39|||
28014508|NCT00371683|54673448|FG000|Follow-Up Period - Randomized Patients|non-specified|6|||
28014509|NCT00371683|54673449|FG001|Follow-Up Period - Randomized Patients|non-specified|12|||
28014510|NCT03951766|54673465|FG000|Treatment Phase|Lost to Follow-up|1|||
28014511|NCT03951766|54673465|FG000|Follow-up Phase|Lost to Follow-up|10|||
28014512|NCT00371137|54673474|FG000|Overall Study|Adverse Event|20|||
28014513|NCT00371137|54673475|FG001|Overall Study|Adverse Event|35|||
28014514|NCT00371137|54673476|FG002|Overall Study|Adverse Event|42|||
28014515|NCT00371137|54673474|FG000|Overall Study|Withdrawal by Subject|11|||
28014516|NCT00371137|54673475|FG001|Overall Study|Withdrawal by Subject|10|||
28014517|NCT00371137|54673476|FG002|Overall Study|Withdrawal by Subject|15|||
28014518|NCT00371137|54673474|FG000|Overall Study|Lost to Follow-up|6|||
28014519|NCT00371137|54673475|FG001|Overall Study|Lost to Follow-up|3|||
28014520|NCT00371137|54673476|FG002|Overall Study|Lost to Follow-up|5|||
28014521|NCT00371137|54673474|FG000|Overall Study|Lack of Efficacy|30|||
28014522|NCT00371137|54673475|FG001|Overall Study|Lack of Efficacy|12|||
28014523|NCT00371137|54673476|FG002|Overall Study|Lack of Efficacy|13|||
27924284|NCT01031836|54581307|FG002|Stage II|Adverse Event|2|||
27924285|NCT01031836|54581308|FG003|Stage II|Adverse Event|2|||
27924286|NCT01031836|54581309|FG004|Stage II|Adverse Event|1|||
27924287|NCT01031836|54581310|FG005|Stage II|Adverse Event|1|||
27924288|NCT01031836|54581305|FG000|Stage II|Other|2|||
27924289|NCT01031836|54581306|FG001|Stage II|Other|0|||
27924290|NCT01031836|54581307|FG002|Stage II|Other|0|||
27924291|NCT01031836|54581308|FG003|Stage II|Other|1|||
27924292|NCT01031836|54581309|FG004|Stage II|Other|1|||
27924293|NCT01031836|54581310|FG005|Stage II|Other|0|||
27924294|NCT01237587|54581326|FG000|Double Blind Treatment (Acute Phase)|Adverse Event|5|||
27924295|NCT01237587|54581327|FG001|Double Blind Treatment (Acute Phase)|Adverse Event|1|||
27924296|NCT01237587|54581326|FG000|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1|||
27924297|NCT01237587|54581327|FG001|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3|||
28014524|NCT00371137|54673474|FG000|Overall Study|Sponsor Decision|2|||
28014525|NCT00371137|54673475|FG001|Overall Study|Sponsor Decision|1|||
28014526|NCT00371137|54673476|FG002|Overall Study|Sponsor Decision|2|||
28014527|NCT00371137|54673474|FG000|Overall Study|Physician Decision|1|||
28014528|NCT00371137|54673475|FG001|Overall Study|Physician Decision|1|||
28014529|NCT00371137|54673476|FG002|Overall Study|Physician Decision|1|||
28014530|NCT00371137|54673474|FG000|Overall Study|Protocol Violation|2|||
28014531|NCT00371137|54673475|FG001|Overall Study|Protocol Violation|1|||
28014532|NCT00371137|54673476|FG002|Overall Study|Protocol Violation|1|||
28014533|NCT00616239|54673484|FG000|Overall Study|Withdrawal by Subject|2|||
28014534|NCT00547534|54673488|FG000|Overall Study|Adverse Event|7|||
28014535|NCT00547534|54673488|FG000|Overall Study|Disease Progression|4|||
28014536|NCT00384397|54673496|FG000|Overall Study|Adverse Event|0|||
28014537|NCT00384397|54673497|FG001|Overall Study|Adverse Event|1|||
28014538|NCT00384397|54673498|FG002|Overall Study|Adverse Event|2|||
28014539|NCT00384397|54673496|FG000|Overall Study|Protocol Violation|7|||
28014540|NCT00384397|54673497|FG001|Overall Study|Protocol Violation|15|||
28014541|NCT00384397|54673498|FG002|Overall Study|Protocol Violation|13|||
28014542|NCT00384397|54673496|FG000|Overall Study|Lost to Follow-up|11|||
28014543|NCT00384397|54673497|FG001|Overall Study|Lost to Follow-up|13|||
28014544|NCT00384397|54673498|FG002|Overall Study|Lost to Follow-up|3|||
28014545|NCT00384397|54673496|FG000|Overall Study|Withdrawal by Subject|14|||
28014546|NCT00384397|54673497|FG001|Overall Study|Withdrawal by Subject|17|||
28014547|NCT00384397|54673498|FG002|Overall Study|Withdrawal by Subject|15|||
28014548|NCT00384085|54673509|FG000|Overall Study|Adverse Event|5|||
28014549|NCT00384085|54673510|FG001|Overall Study|Adverse Event|5|||
28014550|NCT00384085|54673511|FG002|Overall Study|Adverse Event|4|||
28014551|NCT00384085|54673509|FG000|Overall Study|Lack of Efficacy|0|||
28014552|NCT00384085|54673510|FG001|Overall Study|Lack of Efficacy|3|||
28014553|NCT00384085|54673511|FG002|Overall Study|Lack of Efficacy|2|||
28014554|NCT00384085|54673509|FG000|Overall Study|No longer Requires Study Treatment|1|||
28014555|NCT00384085|54673510|FG001|Overall Study|No longer Requires Study Treatment|0|||
28014556|NCT00384085|54673511|FG002|Overall Study|No longer Requires Study Treatment|1|||
28014557|NCT00384085|54673509|FG000|Overall Study|Protocol Violation|2|||
28014558|NCT00384085|54673510|FG001|Overall Study|Protocol Violation|2|||
28014559|NCT00384085|54673511|FG002|Overall Study|Protocol Violation|2|||
28014560|NCT00384085|54673509|FG000|Overall Study|Lost to Follow-up|9|||
28014561|NCT00384085|54673510|FG001|Overall Study|Lost to Follow-up|9|||
28014562|NCT00384085|54673511|FG002|Overall Study|Lost to Follow-up|10|||
28014563|NCT00384085|54673509|FG000|Overall Study|Progressive Disease|0|||
28014564|NCT00384085|54673510|FG001|Overall Study|Progressive Disease|1|||
28014565|NCT00384085|54673511|FG002|Overall Study|Progressive Disease|0|||
28014566|NCT00384085|54673509|FG000|Overall Study|Withdrawal by Subject|14|||
28014567|NCT00384085|54673510|FG001|Overall Study|Withdrawal by Subject|19|||
28014568|NCT00384085|54673511|FG002|Overall Study|Withdrawal by Subject|29|||
28014569|NCT00384085|54673509|FG000|Overall Study|Patient non-compliant|4|||
27924298|NCT01237587|54581326|FG000|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2|||
27924299|NCT01237587|54581327|FG001|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3|||
28014570|NCT00384085|54673510|FG001|Overall Study|Patient non-compliant|4|||
28014571|NCT00384085|54673511|FG002|Overall Study|Patient non-compliant|5|||
28014572|NCT00384085|54673509|FG000|Overall Study|Physician Decision|1|||
28014573|NCT00384085|54673510|FG001|Overall Study|Physician Decision|0|||
28014574|NCT00384085|54673511|FG002|Overall Study|Physician Decision|0|||
28014575|NCT00384085|54673509|FG000|Overall Study|Loss of site personnel|1|||
28014576|NCT00384085|54673510|FG001|Overall Study|Loss of site personnel|0|||
27924300|NCT01237587|54581326|FG000|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2|||
27924301|NCT01237587|54581327|FG001|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4|||
27924302|NCT01237587|54581326|FG000|Double Blind Treatment (Acute Phase)|Protocol Violation|4|||
27924303|NCT01237587|54581327|FG001|Double Blind Treatment (Acute Phase)|Protocol Violation|3|||
27924304|NCT01237587|54581326|FG000|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3|||
27924305|NCT01237587|54581327|FG001|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4|||
27924306|NCT01237587|54581326|FG000|Open Label Treatment (Extension Phase)|Lost to Follow-up|4|||
27924307|NCT01237587|54581327|FG001|Open Label Treatment (Extension Phase)|Lost to Follow-up|3|||
27924308|NCT01237587|54581326|FG000|Open Label Treatment (Extension Phase)|Adverse Event|5|||
27924309|NCT01237587|54581327|FG001|Open Label Treatment (Extension Phase)|Adverse Event|5|||
27924310|NCT01237587|54581326|FG000|Open Label Treatment (Extension Phase)|Lack of Efficacy|2|||
27924311|NCT01237587|54581327|FG001|Open Label Treatment (Extension Phase)|Lack of Efficacy|4|||
27924312|NCT01237587|54581326|FG000|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2|||
27924313|NCT01237587|54581327|FG001|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4|||
27924314|NCT01237587|54581326|FG000|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0|||
27924315|NCT01237587|54581327|FG001|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5|||
28014577|NCT00384085|54673511|FG002|Overall Study|Loss of site personnel|1|||
28014578|NCT00384085|54673509|FG000|Overall Study|Sponsor decision|1|||
28014579|NCT00384085|54673510|FG001|Overall Study|Sponsor decision|2|||
28014580|NCT00384085|54673511|FG002|Overall Study|Sponsor decision|1|||
28014581|NCT00384085|54673509|FG000|Overall Study|Patient moved|1|||
28014582|NCT00384085|54673510|FG001|Overall Study|Patient moved|0|||
28014583|NCT00384085|54673511|FG002|Overall Study|Patient moved|1|||
28014584|NCT00384085|54673509|FG000|Overall Study|Patient required surgery|0|||
28014585|NCT00384085|54673510|FG001|Overall Study|Patient required surgery|1|||
28014586|NCT00384085|54673511|FG002|Overall Study|Patient required surgery|0|||
28014587|NCT00361231|54673521|FG000|Overall Study|Physician Decision|3|||
28014588|NCT00361231|54673521|FG000|Overall Study|Symptomatic deterioration|5|||
28014589|NCT00361231|54673521|FG000|Overall Study|Radiographic disease progression|16|||
28014590|NCT00361231|54673521|FG000|Overall Study|Withdrawal by Subject|4|||
28014591|NCT00361231|54673521|FG000|Overall Study|Adverse Event|6|||
28014592|NCT00676650|54673527|FG000|Overall Study|Death|45|||
28014593|NCT00676650|54673528|FG001|Overall Study|Death|14|||
28014594|NCT00676650|54673527|FG000|Overall Study|Adverse Event|159|||
28014595|NCT00676650|54673528|FG001|Overall Study|Adverse Event|21|||
28014596|NCT00676650|54673527|FG000|Overall Study|Global deterioration of health status|66|||
28014597|NCT00676650|54673528|FG001|Overall Study|Global deterioration of health status|31|||
28014598|NCT00676650|54673527|FG000|Overall Study|Lost to Follow-up|0|||
28014599|NCT00676650|54673528|FG001|Overall Study|Lost to Follow-up|1|||
28014600|NCT00676650|54673527|FG000|Overall Study|Objective progression or relapse|189|||
28014601|NCT00676650|54673528|FG001|Overall Study|Objective progression or relapse|140|||
28014602|NCT00676650|54673527|FG000|Overall Study|Other|14|||
28014603|NCT00676650|54673528|FG001|Overall Study|Other|10|||
28014604|NCT00676650|54673527|FG000|Overall Study|Protocol Violation|3|||
28014605|NCT00676650|54673528|FG001|Overall Study|Protocol Violation|1|||
28014606|NCT00676650|54673527|FG000|Overall Study|Study terminated by sponsor|57|||
28014607|NCT00676650|54673528|FG001|Overall Study|Study terminated by sponsor|43|||
28014608|NCT00676650|54673527|FG000|Overall Study|Withdrawal by Subject|48|||
28014609|NCT00676650|54673528|FG001|Overall Study|Withdrawal by Subject|24|||
28014610|NCT00676650|54673527|FG000|Overall Study|Randomized but not treated|3|||
28014611|NCT00676650|54673528|FG001|Overall Study|Randomized but not treated|4|||
28014612|NCT00573183|54673536|FG000|Overall Study|Lost to Follow-up|52|||
28014613|NCT00573183|54673537|FG001|Overall Study|Lost to Follow-up|50|||
28014614|NCT00573183|54673536|FG000|Overall Study|Withdrawal by Subject|8|||
28014615|NCT00573183|54673537|FG001|Overall Study|Withdrawal by Subject|2|||
28014616|NCT00573183|54673536|FG000|Overall Study|Death|0|||
28014617|NCT00573183|54673537|FG001|Overall Study|Death|1|||
28014618|NCT00573183|54673536|FG000|Overall Study|Adverse Event|2|||
28014619|NCT00573183|54673537|FG001|Overall Study|Adverse Event|0|||
28014620|NCT00573183|54673536|FG000|Overall Study|Incarceration|5|||
28014621|NCT00573183|54673537|FG001|Overall Study|Incarceration|8|||
28014622|NCT00573183|54673536|FG000|Overall Study|Other|5|||
28014623|NCT00573183|54673537|FG001|Overall Study|Other|2|||
28014624|NCT00615459|54673545|FG000|Period I|Adverse Event|2|||
28014625|NCT00615459|54673546|FG001|Period I|Adverse Event|0|||
28014626|NCT00615459|54673547|FG002|Period I|Adverse Event|1|||
28014627|NCT00615459|54673548|FG003|Period I|Adverse Event|0|||
28014628|NCT00615459|54673545|FG000|Period I|Subject withdrew consent|1|||
28014629|NCT00615459|54673546|FG001|Period I|Subject withdrew consent|0|||
28014630|NCT00615459|54673547|FG002|Period I|Subject withdrew consent|0|||
28014631|NCT00615459|54673548|FG003|Period I|Subject withdrew consent|1|||
28014632|NCT00615459|54673545|FG000|Period I|Abnormal test procedure results|1|||
28014633|NCT00615459|54673546|FG001|Period I|Abnormal test procedure results|1|||
28014634|NCT00615459|54673547|FG002|Period I|Abnormal test procedure results|1|||
28014635|NCT00615459|54673548|FG003|Period I|Abnormal test procedure results|0|||
28014636|NCT00615459|54673545|FG000|Period II|Adverse Event|1|||
28014637|NCT00615459|54673546|FG001|Period II|Adverse Event|0|||
28014638|NCT00615459|54673547|FG002|Period II|Adverse Event|0|||
28014639|NCT00615459|54673548|FG003|Period II|Adverse Event|0|||
28014640|NCT00615459|54673545|FG000|Period II|Lost to Follow-up|0|||
28014641|NCT00615459|54673546|FG001|Period II|Lost to Follow-up|0|||
28014642|NCT00615459|54673547|FG002|Period II|Lost to Follow-up|0|||
28014643|NCT00615459|54673548|FG003|Period II|Lost to Follow-up|1|||
28014644|NCT00615459|54673545|FG000|Period III|Adverse Event|0|||
28014645|NCT00615459|54673546|FG001|Period III|Adverse Event|1|||
28014646|NCT00615459|54673547|FG002|Period III|Adverse Event|0|||
28014647|NCT00615459|54673548|FG003|Period III|Adverse Event|0|||
28014648|NCT00615459|54673545|FG000|Period III|Administrative problems|0|||
28014649|NCT00615459|54673546|FG001|Period III|Administrative problems|1|||
28014650|NCT00615459|54673547|FG002|Period III|Administrative problems|1|||
28014651|NCT00615459|54673548|FG003|Period III|Administrative problems|0|||
28014652|NCT00615459|54673545|FG000|Period III|Unsatisfactory therapeutic effect|0|||
28014653|NCT00615459|54673546|FG001|Period III|Unsatisfactory therapeutic effect|1|||
28014654|NCT00615459|54673547|FG002|Period III|Unsatisfactory therapeutic effect|0|||
28014655|NCT00615459|54673548|FG003|Period III|Unsatisfactory therapeutic effect|0|||
28014656|NCT00383149|54673562|FG000|Overall Study|Adverse Event not Related to Study Drug|3|||
28014657|NCT00383149|54673562|FG000|Overall Study|Death|2|||
28014658|NCT00383149|54673562|FG000|Overall Study|Disease Progression|38|||
28014659|NCT00383149|54673562|FG000|Overall Study|Lost to Follow-up|1|||
28014660|NCT00383149|54673562|FG000|Overall Study|Other|1|||
28014661|NCT00383149|54673562|FG000|Overall Study|Study Drug Toxicity|4|||
28014662|NCT00383149|54673562|FG000|Overall Study|Request to Discontinue Treatment|4|||
28014663|NCT00383149|54673562|FG000|Overall Study|Participant Withdrew Consent|1|||
28014664|NCT00382993|54673568|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
28014665|NCT00382993|54673569|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|2|||
28014666|NCT00382993|54673568|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1|||
28014667|NCT00382993|54673569|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3|||
28014668|NCT00382993|54673568|FG000|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0|||
28014669|NCT00382993|54673569|FG001|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5|||
28014670|NCT00382993|54673568|FG000|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
28014671|NCT00382993|54673569|FG001|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
28014672|NCT00382993|54673568|FG000|Migraine Attack 1 (Period 1)|Other (no additional data present)|3|||
28014673|NCT00382993|54673569|FG001|Migraine Attack 1 (Period 1)|Other (no additional data present)|5|||
28014674|NCT00382993|54673568|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
28014675|NCT00382993|54673569|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
28014676|NCT00382993|54673568|FG000|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0|||
28014677|NCT00382993|54673569|FG001|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1|||
28014678|NCT00382993|54673568|FG000|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0|||
28014679|NCT00382993|54673569|FG001|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1|||
28014680|NCT00382993|54673568|FG000|Migraine Attack 2 (Period 2)|Protocol Violation|0|||
28014681|NCT00382993|54673569|FG001|Migraine Attack 2 (Period 2)|Protocol Violation|1|||
28014682|NCT00382993|54673568|FG000|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
28014683|NCT00382993|54673569|FG001|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
28014684|NCT00369967|54673577|FG000|Overall Study|Lost to Follow-up|23|||
28014685|NCT00369967|54673578|FG001|Overall Study|Lost to Follow-up|12|||
28014686|NCT00616629|54673593|FG000|Overall Study|Protocol Violation|1|||
28014687|NCT00616629|54673594|FG001|Overall Study|Protocol Violation|2|||
28014688|NCT00616629|54673595|FG002|Overall Study|Protocol Violation|1|||
28014689|NCT00616629|54673596|FG003|Overall Study|Protocol Violation|0|||
28014690|NCT00616629|54673597|FG004|Overall Study|Protocol Violation|0|||
28014691|NCT00616629|54673593|FG000|Overall Study|AV-block|1|||
28014692|NCT00616629|54673594|FG001|Overall Study|AV-block|0|||
28014693|NCT00616629|54673595|FG002|Overall Study|AV-block|0|||
28014694|NCT00616629|54673596|FG003|Overall Study|AV-block|0|||
28014695|NCT00616629|54673597|FG004|Overall Study|AV-block|0|||
28014696|NCT00369655|54673609|FG000|Overall Study|Refusal of further treatment|2|||
28014697|NCT00615069|54673613|FG000|Overall Study|Death|10|||
28014698|NCT00615069|54673613|FG000|Overall Study|Physician Decision|2|||
28014699|NCT00615069|54673613|FG000|Overall Study|Withdrawal by Subject|4|||
28014700|NCT00676338|54673621|FG000|Overall Study|Adverse Event|6|||
28014701|NCT00676338|54673622|FG001|Overall Study|Adverse Event|6|||
28014702|NCT00676338|54673623|FG002|Overall Study|Adverse Event|5|||
28014703|NCT00676338|54673624|FG003|Overall Study|Adverse Event|1|||
28014704|NCT00676338|54673621|FG000|Overall Study|Lost to Follow-up|4|||
28014705|NCT00676338|54673622|FG001|Overall Study|Lost to Follow-up|1|||
28014706|NCT00676338|54673623|FG002|Overall Study|Lost to Follow-up|3|||
28014707|NCT00676338|54673624|FG003|Overall Study|Lost to Follow-up|4|||
28014708|NCT00676338|54673621|FG000|Overall Study|Physician Decision|3|||
28014709|NCT00676338|54673622|FG001|Overall Study|Physician Decision|3|||
28014710|NCT00676338|54673623|FG002|Overall Study|Physician Decision|2|||
28014711|NCT00676338|54673624|FG003|Overall Study|Physician Decision|3|||
28014712|NCT00676338|54673621|FG000|Overall Study|Protocol Violation|5|||
28014713|NCT00676338|54673622|FG001|Overall Study|Protocol Violation|9|||
28014714|NCT00676338|54673623|FG002|Overall Study|Protocol Violation|2|||
28014715|NCT00676338|54673624|FG003|Overall Study|Protocol Violation|5|||
28014716|NCT00676338|54673621|FG000|Overall Study|Withdrawal by Subject|17|||
28014717|NCT00676338|54673622|FG001|Overall Study|Withdrawal by Subject|9|||
28014718|NCT00676338|54673623|FG002|Overall Study|Withdrawal by Subject|12|||
28014719|NCT00676338|54673624|FG003|Overall Study|Withdrawal by Subject|6|||
28014720|NCT00676338|54673621|FG000|Overall Study|Entry Criteria Not Met|0|||
28014721|NCT00676338|54673622|FG001|Overall Study|Entry Criteria Not Met|2|||
28014722|NCT00676338|54673623|FG002|Overall Study|Entry Criteria Not Met|1|||
28014723|NCT00676338|54673624|FG003|Overall Study|Entry Criteria Not Met|1|||
28014724|NCT00676338|54673621|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
28014725|NCT00676338|54673622|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
28014726|NCT00676338|54673623|FG002|Overall Study|Lack of Efficacy-Loss of Glucose Control|5|||
28014727|NCT00676338|54673624|FG003|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
28014728|NCT00382291|54673637|FG000|Overall Study|Adverse Event|1|||
28014729|NCT00382291|54673638|FG001|Overall Study|Adverse Event|2|||
28014730|NCT00382291|54673639|FG002|Overall Study|Adverse Event|2|||
28014731|NCT00382291|54673637|FG000|Overall Study|Protocol Violation|1|||
28014732|NCT00382291|54673638|FG001|Overall Study|Protocol Violation|0|||
28014733|NCT00382291|54673639|FG002|Overall Study|Protocol Violation|0|||
28014734|NCT00382291|54673637|FG000|Overall Study|Temporary study suspension|2|||
28014735|NCT00382291|54673638|FG001|Overall Study|Temporary study suspension|2|||
28014736|NCT00382291|54673639|FG002|Overall Study|Temporary study suspension|5|||
28014737|NCT00382291|54673637|FG000|Overall Study|Withdrawal by Subject|0|||
28014738|NCT00382291|54673638|FG001|Overall Study|Withdrawal by Subject|2|||
28014739|NCT00382291|54673639|FG002|Overall Study|Withdrawal by Subject|0|||
28014740|NCT00382291|54673637|FG000|Overall Study|Physician Decision|0|||
28014741|NCT00382291|54673638|FG001|Overall Study|Physician Decision|1|||
28014742|NCT00382291|54673639|FG002|Overall Study|Physician Decision|0|||
28014743|NCT00382291|54673637|FG000|Overall Study|Lack of Efficacy|0|||
28014744|NCT00382291|54673638|FG001|Overall Study|Lack of Efficacy|0|||
28014745|NCT00382291|54673639|FG002|Overall Study|Lack of Efficacy|1|||
28014746|NCT00547378|54673661|FG000|Randomized Cohort|Withdrawal by Subject|7|||
28014747|NCT00547378|54673662|FG001|Randomized Cohort|Withdrawal by Subject|5|||
28014748|NCT00547378|54673663|FG002|Randomized Cohort|Withdrawal by Subject|0|||
28014749|NCT00547378|54673661|FG000|Randomized Cohort|Death|0|||
28014750|NCT00547378|54673662|FG001|Randomized Cohort|Death|1|||
28014751|NCT00547378|54673663|FG002|Randomized Cohort|Death|0|||
28014752|NCT00547378|54673661|FG000|Randomized Cohort|Lost to Follow-up|1|||
28014753|NCT00547378|54673662|FG001|Randomized Cohort|Lost to Follow-up|0|||
28014754|NCT00547378|54673663|FG002|Randomized Cohort|Lost to Follow-up|0|||
28014755|NCT00547378|54673661|FG000|Randomized Cohort|Adverse Event|1|||
28014756|NCT00547378|54673662|FG001|Randomized Cohort|Adverse Event|0|||
28014757|NCT00547378|54673663|FG002|Randomized Cohort|Adverse Event|0|||
28014758|NCT00547378|54673661|FG000|Randomized Cohort|Other reasons|2|||
28014759|NCT00547378|54673662|FG001|Randomized Cohort|Other reasons|0|||
28014760|NCT00547378|54673663|FG002|Randomized Cohort|Other reasons|0|||
28014761|NCT00547378|54673661|FG000|All Implanted Cohort|Withdrawal by Subject|5|||
28014762|NCT00547378|54673662|FG001|All Implanted Cohort|Withdrawal by Subject|4|||
28014763|NCT00547378|54673663|FG002|All Implanted Cohort|Withdrawal by Subject|27|||
28014764|NCT00547378|54673661|FG000|All Implanted Cohort|Adverse Event|4|||
28014765|NCT00547378|54673662|FG001|All Implanted Cohort|Adverse Event|10|||
28014766|NCT00547378|54673663|FG002|All Implanted Cohort|Adverse Event|17|||
28014767|NCT00547378|54673661|FG000|All Implanted Cohort|Lost to Follow-up|0|||
28014768|NCT00547378|54673662|FG001|All Implanted Cohort|Lost to Follow-up|1|||
28014769|NCT00547378|54673663|FG002|All Implanted Cohort|Lost to Follow-up|14|||
28014770|NCT00547378|54673661|FG000|All Implanted Cohort|Death|3|||
28014771|NCT00547378|54673662|FG001|All Implanted Cohort|Death|1|||
28014772|NCT00547378|54673663|FG002|All Implanted Cohort|Death|4|||
28014773|NCT00547378|54673661|FG000|All Implanted Cohort|Physician Decision|0|||
28014774|NCT00547378|54673662|FG001|All Implanted Cohort|Physician Decision|2|||
28014775|NCT00547378|54673663|FG002|All Implanted Cohort|Physician Decision|6|||
28014776|NCT00547378|54673661|FG000|All Implanted Cohort|Site closure|2|||
28014777|NCT00547378|54673662|FG001|All Implanted Cohort|Site closure|0|||
28014778|NCT00547378|54673663|FG002|All Implanted Cohort|Site closure|1|||
28014779|NCT00547378|54673661|FG000|All Implanted Cohort|Other reasons|1|||
28014780|NCT00547378|54673662|FG001|All Implanted Cohort|Other reasons|0|||
28014781|NCT00547378|54673663|FG002|All Implanted Cohort|Other reasons|1|||
28014782|NCT00381043|54673673|FG000|Overall Study|Lost to Follow-up|8|||
28014783|NCT00381043|54673674|FG001|Overall Study|Lost to Follow-up|6|||
28014784|NCT00381043|54673673|FG000|Overall Study|Withdrawal by Subject|3|||
28014785|NCT00381043|54673674|FG001|Overall Study|Withdrawal by Subject|1|||
28014786|NCT00381043|54673673|FG000|Overall Study|wanted more care|0|||
28014787|NCT00381043|54673674|FG001|Overall Study|wanted more care|1|||
28014788|NCT00381043|54673673|FG000|Overall Study|incarcerated|1|||
28014789|NCT00381043|54673674|FG001|Overall Study|incarcerated|0|||
28014790|NCT00614991|54673686|FG000|Overall Study|Adverse Event|3|||
28014791|NCT00614991|54673687|FG001|Overall Study|Adverse Event|3|||
28014792|NCT00614991|54673688|FG002|Overall Study|Adverse Event|0|||
28014793|NCT00614991|54673689|FG003|Overall Study|Adverse Event|0|||
28014794|NCT00614991|54673690|FG004|Overall Study|Adverse Event|1|||
28014795|NCT00614991|54673691|FG005|Overall Study|Adverse Event|0|||
28014796|NCT00360529|54673713|FG000|Overall Study|Adverse Event|10|||
28014797|NCT00360529|54673714|FG001|Overall Study|Adverse Event|23|||
28014798|NCT00360529|54673715|FG002|Overall Study|Adverse Event|33|||
28014799|NCT00360529|54673713|FG000|Overall Study|Protocol Violation|3|||
28014800|NCT00360529|54673714|FG001|Overall Study|Protocol Violation|3|||
28014801|NCT00360529|54673715|FG002|Overall Study|Protocol Violation|11|||
28014802|NCT00360529|54673713|FG000|Overall Study|Lost to Follow-up|14|||
28014803|NCT00360529|54673714|FG001|Overall Study|Lost to Follow-up|10|||
28014804|NCT00360529|54673715|FG002|Overall Study|Lost to Follow-up|13|||
28014805|NCT00360529|54673713|FG000|Overall Study|Withdrawal by Subject|22|||
28014806|NCT00360529|54673714|FG001|Overall Study|Withdrawal by Subject|14|||
28014807|NCT00360529|54673715|FG002|Overall Study|Withdrawal by Subject|18|||
28014808|NCT00360529|54673713|FG000|Overall Study|Lack of Efficacy|8|||
28014809|NCT00360529|54673714|FG001|Overall Study|Lack of Efficacy|6|||
28014810|NCT00360529|54673715|FG002|Overall Study|Lack of Efficacy|5|||
28014811|NCT00360529|54673713|FG000|Overall Study|Reason discontinued not explained above|4|||
28014812|NCT00360529|54673714|FG001|Overall Study|Reason discontinued not explained above|9|||
28014813|NCT00360529|54673715|FG002|Overall Study|Reason discontinued not explained above|11|||
28014814|NCT00369577|54673730|FG000|Overall Study|Withdrawal by Subject|0|||
28014815|NCT00369577|54673731|FG001|Overall Study|Withdrawal by Subject|0|||
28014816|NCT00369577|54673732|FG002|Overall Study|Withdrawal by Subject|1|||
28014817|NCT00678288|54673742|FG000|Overall Study|Adverse Event|0|||
28014818|NCT00678288|54673743|FG001|Overall Study|Adverse Event|2|||
28014819|NCT00678288|54673742|FG000|Overall Study|Withdrawal by Subject|1|||
28014820|NCT00678288|54673743|FG001|Overall Study|Withdrawal by Subject|1|||
28014821|NCT00678288|54673742|FG000|Overall Study|Study terminated by the sponsor|2|||
28014822|NCT00678288|54673743|FG001|Overall Study|Study terminated by the sponsor|0|||
28014823|NCT00678288|54673742|FG000|Overall Study|Not compliant with study medication|0|||
28014824|NCT00678288|54673743|FG001|Overall Study|Not compliant with study medication|1|||
28014825|NCT00678288|54673742|FG000|Overall Study|Switch to commercial drug|0|||
28014826|NCT00678288|54673743|FG001|Overall Study|Switch to commercial drug|1|||
28014827|NCT00678288|54673742|FG000|Overall Study|Reason not reported|1|||
28014828|NCT00678288|54673743|FG001|Overall Study|Reason not reported|0|||
28014829|NCT00678288|54673742|FG000|Overall Study|Disease progression/recurrence/relapse|6|||
28014830|NCT00678288|54673743|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
28014831|NCT00369343|54673751|FG000|Double-blind Phase|Adverse Event|19|||
28014832|NCT00369343|54673752|FG001|Double-blind Phase|Adverse Event|4|||
28014833|NCT00369343|54673751|FG000|Double-blind Phase|Failed to return|2|||
28014834|NCT00369343|54673752|FG001|Double-blind Phase|Failed to return|0|||
28014835|NCT00369343|54673751|FG000|Double-blind Phase|Lost to Follow-up|9|||
28014836|NCT00369343|54673752|FG001|Double-blind Phase|Lost to Follow-up|2|||
28014837|NCT00369343|54673751|FG000|Double-blind Phase|Protocol Violation|2|||
28014838|NCT00369343|54673752|FG001|Double-blind Phase|Protocol Violation|0|||
28014839|NCT00369343|54673751|FG000|Double-blind Phase|Withdrawal by Subject|8|||
28014840|NCT00369343|54673752|FG001|Double-blind Phase|Withdrawal by Subject|6|||
28014841|NCT00369343|54673751|FG000|Double-blind Phase|Lack of Efficacy|0|||
28014842|NCT00369343|54673752|FG001|Double-blind Phase|Lack of Efficacy|4|||
28014843|NCT00369343|54673751|FG000|Double-blind Phase|Protocol deviation|4|||
28014844|NCT00369343|54673752|FG001|Double-blind Phase|Protocol deviation|0|||
28014845|NCT00369343|54673751|FG000|Open-label Phase|Adverse Event|19|||
28014846|NCT00369343|54673752|FG001|Open-label Phase|Adverse Event|7|||
28014847|NCT00369343|54673751|FG000|Open-label Phase|Failed to return|4|||
28014848|NCT00369343|54673752|FG001|Open-label Phase|Failed to return|0|||
28014849|NCT00369343|54673751|FG000|Open-label Phase|Physician Decision|2|||
28014850|NCT00369343|54673752|FG001|Open-label Phase|Physician Decision|0|||
28014851|NCT00369343|54673751|FG000|Open-label Phase|Lost to Follow-up|5|||
28014852|NCT00369343|54673752|FG001|Open-label Phase|Lost to Follow-up|3|||
28014853|NCT00369343|54673751|FG000|Open-label Phase|inadvertently reported study completers|3|||
28014854|NCT00369343|54673752|FG001|Open-label Phase|inadvertently reported study completers|2|||
28014855|NCT00369343|54673751|FG000|Open-label Phase|Protocol Violation|1|||
28014856|NCT00369343|54673752|FG001|Open-label Phase|Protocol Violation|3|||
28014857|NCT00369343|54673751|FG000|Open-label Phase|Withdrawal by Subject|15|||
28014858|NCT00369343|54673752|FG001|Open-label Phase|Withdrawal by Subject|6|||
28014859|NCT00369343|54673751|FG000|Open-label Phase|Lack of Efficacy|4|||
28014860|NCT00369343|54673752|FG001|Open-label Phase|Lack of Efficacy|3|||
28014861|NCT00369343|54673751|FG000|Open-label Phase|Lack of continuance tolerability|3|||
28014862|NCT00369343|54673752|FG001|Open-label Phase|Lack of continuance tolerability|4|||
28014863|NCT00369343|54673751|FG000|Open-label Phase|did not take study drug|1|||
28014864|NCT00369343|54673752|FG001|Open-label Phase|did not take study drug|2|||
28014865|NCT00369265|54673767|FG000|Overall Study|Study terminated|4|||
28014866|NCT00369265|54673768|FG001|Overall Study|Study terminated|7|||
28014867|NCT00368875|54673774|FG000|Overall Study|Adverse Event|0|||
28014868|NCT00368875|54673775|FG001|Overall Study|Adverse Event|12|||
28014869|NCT00368875|54673774|FG000|Overall Study|Progressive disease|3|||
28014870|NCT00368875|54673775|FG001|Overall Study|Progressive disease|27|||
28014871|NCT00368875|54673774|FG000|Overall Study|Withdrawal by Subject|2|||
28014872|NCT00368875|54673775|FG001|Overall Study|Withdrawal by Subject|6|||
28014873|NCT00368875|54673774|FG000|Overall Study|Other Reason|0|||
28014874|NCT00368875|54673775|FG001|Overall Study|Other Reason|2|||
28014875|NCT00368875|54673774|FG000|Overall Study|Alternative Therapy|1|||
28014876|NCT00368875|54673775|FG001|Overall Study|Alternative Therapy|1|||
28014877|NCT00614055|54673784|FG000|Overall Study|Adverse Event|1|||
28014878|NCT00614055|54673785|FG001|Overall Study|Adverse Event|0|||
28014879|NCT00614055|54673786|FG002|Overall Study|Adverse Event|0|||
28014880|NCT00614055|54673784|FG000|Overall Study|Protocol Violation|2|||
28014881|NCT00614055|54673785|FG001|Overall Study|Protocol Violation|2|||
28014882|NCT00614055|54673786|FG002|Overall Study|Protocol Violation|1|||
28014883|NCT00614055|54673784|FG000|Overall Study|Lack of Efficacy|0|||
28014884|NCT00614055|54673785|FG001|Overall Study|Lack of Efficacy|0|||
28014885|NCT00614055|54673786|FG002|Overall Study|Lack of Efficacy|2|||
28014886|NCT00614055|54673784|FG000|Overall Study|Unclassified|1|||
28014887|NCT00614055|54673785|FG001|Overall Study|Unclassified|4|||
28014888|NCT00614055|54673786|FG002|Overall Study|Unclassified|2|||
28014889|NCT00613821|54673799|FG000|Overall Study|Withdrawal by Subject|1|||
28014890|NCT00613821|54673800|FG001|Overall Study|Withdrawal by Subject|0|||
28014891|NCT00613821|54673799|FG000|Overall Study|Physician Decision|1|||
28014892|NCT00613821|54673800|FG001|Overall Study|Physician Decision|1|||
28014893|NCT00548548|54673808|FG000|Overall Study|Death|345|||
28014894|NCT00548548|54673809|FG001|Overall Study|Death|348|||
28014895|NCT00548548|54673808|FG000|Overall Study|Lost to Follow-up|17|||
28014896|NCT00548548|54673809|FG001|Overall Study|Lost to Follow-up|18|||
28014897|NCT00613509|54673817|FG000|Cycle 1|Adverse Event|2|||
28014898|NCT00613509|54673818|FG001|Cycle 1|Adverse Event|1|||
28014899|NCT00613509|54673817|FG000|Cycle 1|Disease Progression|2|||
28014900|NCT00613509|54673818|FG001|Cycle 1|Disease Progression|6|||
28014901|NCT00613509|54673817|FG000|Cycle 1|Unacceptable Toxicity|1|||
28014902|NCT00613509|54673818|FG001|Cycle 1|Unacceptable Toxicity|0|||
28014903|NCT00613509|54673817|FG000|Cycle 1|Other administrative reason|0|||
28014904|NCT00613509|54673818|FG001|Cycle 1|Other administrative reason|1|||
27745596|NCT03855137|54195380|FG000|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|5|||
27745597|NCT03855137|54195381|FG001|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|2|||
27745598|NCT03855137|54195382|FG002|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|1|||
27745599|NCT03855137|54195380|FG000|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|8|||
27745600|NCT03855137|54195381|FG001|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|7|||
27745601|NCT03855137|54195382|FG002|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|14|||
27745602|NCT03855137|54195380|FG000|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|0|||
27745603|NCT03855137|54195381|FG001|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|1|||
27745604|NCT03855137|54195382|FG002|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|3|||
27745605|NCT03855137|54195380|FG000|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|5|||
27745606|NCT03855137|54195381|FG001|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|3|||
27745607|NCT03855137|54195382|FG002|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|2|||
27745608|NCT03855137|54195380|FG000|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|1|||
27745609|NCT03855137|54195381|FG001|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
27745610|NCT03855137|54195382|FG002|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
27745611|NCT03855137|54195380|FG000|FU Period (Week 12 to Week 16)|Withdrawal by Subject|5|||
27745612|NCT03855137|54195381|FG001|FU Period (Week 12 to Week 16)|Withdrawal by Subject|6|||
27745613|NCT03855137|54195382|FG002|FU Period (Week 12 to Week 16)|Withdrawal by Subject|3|||
27745614|NCT03855137|54195380|FG000|FU Period (Week 12 to Week 16)|Lost to Follow-up|0|||
27745615|NCT03855137|54195381|FG001|FU Period (Week 12 to Week 16)|Lost to Follow-up|3|||
27745616|NCT03855137|54195382|FG002|FU Period (Week 12 to Week 16)|Lost to Follow-up|1|||
27924316|NCT01237587|54581326|FG000|Open Label Treatment (Extension Phase)|Sponsor Decision|1|||
27924317|NCT01237587|54581327|FG001|Open Label Treatment (Extension Phase)|Sponsor Decision|0|||
27924318|NCT01237587|54581326|FG000|Open Label Treatment (Extension Phase)|Physician Decision|4|||
27924319|NCT01237587|54581327|FG001|Open Label Treatment (Extension Phase)|Physician Decision|4|||
27924320|NCT01237587|54581326|FG000|Taper Phase|Adverse Event|0|||
27924321|NCT01237587|54581327|FG001|Taper Phase|Adverse Event|2|||
27924322|NCT01237587|54581326|FG000|Taper Phase|Protocol Violation|2|||
27924323|NCT01237587|54581327|FG001|Taper Phase|Protocol Violation|0|||
27924324|NCT01237587|54581326|FG000|Taper Phase|Lack of Efficacy|2|||
27924325|NCT01237587|54581327|FG001|Taper Phase|Lack of Efficacy|5|||
27924326|NCT01237587|54581326|FG000|Taper Phase|Parent/Guardian Decision|0|||
27924327|NCT01237587|54581327|FG001|Taper Phase|Parent/Guardian Decision|2|||
27924328|NCT01237587|54581326|FG000|Taper Phase|Sponsor Decision|1|||
27924329|NCT01237587|54581327|FG001|Taper Phase|Sponsor Decision|0|||
27924330|NCT01237587|54581326|FG000|Taper Phase|Withdrawal by Subject|0|||
27924331|NCT01237587|54581327|FG001|Taper Phase|Withdrawal by Subject|1|||
27924332|NCT01031680|54581342|FG000|Overall Study|Adverse Event|8|||
27924333|NCT01031680|54581343|FG001|Overall Study|Adverse Event|3|||
27924334|NCT01031680|54581342|FG000|Overall Study|Lost to Follow-up|2|||
27924335|NCT01031680|54581343|FG001|Overall Study|Lost to Follow-up|10|||
27924336|NCT01031680|54581342|FG000|Overall Study|Withdrawal by Subject|12|||
27924337|NCT01031680|54581343|FG001|Overall Study|Withdrawal by Subject|16|||
27924338|NCT01031680|54581342|FG000|Overall Study|Death|2|||
27924339|NCT01031680|54581343|FG001|Overall Study|Death|1|||
27924340|NCT01031680|54581342|FG000|Overall Study|Subject No Longer Meets Study Criteria|26|||
27924341|NCT01031680|54581343|FG001|Overall Study|Subject No Longer Meets Study Criteria|17|||
27924342|NCT01031680|54581342|FG000|Overall Study|Poor/Non-compliance|5|||
27924343|NCT01031680|54581343|FG001|Overall Study|Poor/Non-compliance|6|||
27924344|NCT01031680|54581342|FG000|Overall Study|Safety|1|||
27924345|NCT01031680|54581343|FG001|Overall Study|Safety|0|||
27924346|NCT01031680|54581342|FG000|Overall Study|Incorrect Enrolment|1|||
27924347|NCT01031680|54581343|FG001|Overall Study|Incorrect Enrolment|2|||
27745617|NCT03855137|54195380|FG000|FU Period (Week 12 to Week 16)|Protocol Deviation|2|||
27745618|NCT03855137|54195381|FG001|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
27745619|NCT03855137|54195382|FG002|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
27745620|NCT03855137|54195380|FG000|FU Period (Week 12 to Week 16)|Reason not Specified|1|||
27745621|NCT03855137|54195381|FG001|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
27745622|NCT03855137|54195382|FG002|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
27745623|NCT00701363|54195404|FG000|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4|||
27745624|NCT00701363|54195405|FG001|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
27745625|NCT00701363|54195406|FG002|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
27745626|NCT00701363|54195407|FG003|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
27745627|NCT00701363|54195404|FG000|Treatment Phase 1|Does not meet entry Criteria|1|||
27745628|NCT00701363|54195405|FG001|Treatment Phase 1|Does not meet entry Criteria|0|||
27745629|NCT00701363|54195406|FG002|Treatment Phase 1|Does not meet entry Criteria|0|||
27745630|NCT00701363|54195407|FG003|Treatment Phase 1|Does not meet entry Criteria|0|||
27745631|NCT00701363|54195404|FG000|Treatment Phase 1|Adverse Event|7|||
27745632|NCT00701363|54195405|FG001|Treatment Phase 1|Adverse Event|0|||
27745633|NCT00701363|54195406|FG002|Treatment Phase 1|Adverse Event|0|||
27745634|NCT00701363|54195407|FG003|Treatment Phase 1|Adverse Event|0|||
27745635|NCT00701363|54195404|FG000|Treatment Phase 1|Protocol Violation|1|||
27745636|NCT00701363|54195405|FG001|Treatment Phase 1|Protocol Violation|0|||
27745637|NCT00701363|54195406|FG002|Treatment Phase 1|Protocol Violation|0|||
27745638|NCT00701363|54195407|FG003|Treatment Phase 1|Protocol Violation|0|||
27745639|NCT00701363|54195404|FG000|Treatment Phase 1|Withdrawal by Subject|5|||
27745640|NCT00701363|54195405|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
27745641|NCT00701363|54195406|FG002|Treatment Phase 1|Withdrawal by Subject|0|||
27745642|NCT00701363|54195407|FG003|Treatment Phase 1|Withdrawal by Subject|0|||
27745643|NCT00701363|54195404|FG000|Treatment Phase 1|Lack of Efficacy|1|||
27745644|NCT00701363|54195405|FG001|Treatment Phase 1|Lack of Efficacy|0|||
27745645|NCT00701363|54195406|FG002|Treatment Phase 1|Lack of Efficacy|0|||
27745646|NCT00701363|54195407|FG003|Treatment Phase 1|Lack of Efficacy|0|||
27745647|NCT00701363|54195404|FG000|Treatment Phase 2|Adverse Event|0|||
27745648|NCT00701363|54195405|FG001|Treatment Phase 2|Adverse Event|0|||
27745649|NCT00701363|54195406|FG002|Treatment Phase 2|Adverse Event|1|||
27745650|NCT00701363|54195407|FG003|Treatment Phase 2|Adverse Event|0|||
27745651|NCT00701363|54195404|FG000|Treatment Phase 2|Withdrawal by Subject|0|||
27745652|NCT00701363|54195405|FG001|Treatment Phase 2|Withdrawal by Subject|0|||
27745653|NCT00701363|54195406|FG002|Treatment Phase 2|Withdrawal by Subject|1|||
27745654|NCT00701363|54195407|FG003|Treatment Phase 2|Withdrawal by Subject|0|||
27745655|NCT01670877|54195431|FG000|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
27745656|NCT01670877|54195432|FG001|Part I and Part 2|Grade 2 vomiting and progressive disease|1|||
27745657|NCT01670877|54195433|FG002|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
27745658|NCT01670877|54195434|FG003|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
27745659|NCT01670877|54195435|FG004|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
27745660|NCT01670877|54195436|FG005|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
27745661|NCT01670877|54195431|FG000|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
27745662|NCT01670877|54195432|FG001|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
27745663|NCT01670877|54195433|FG002|Part I and Part 2|Grade 3 diarrhea and withdrawal|1|||
27745664|NCT01670877|54195434|FG003|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
27745665|NCT01670877|54195435|FG004|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
27745666|NCT01670877|54195436|FG005|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
27745667|NCT01670877|54195431|FG000|Part I and Part 2|Grade 2 vomiting|0|||
27745668|NCT01670877|54195432|FG001|Part I and Part 2|Grade 2 vomiting|0|||
27745669|NCT01670877|54195433|FG002|Part I and Part 2|Grade 2 vomiting|0|||
27745670|NCT01670877|54195434|FG003|Part I and Part 2|Grade 2 vomiting|1|||
27745671|NCT01670877|54195435|FG004|Part I and Part 2|Grade 2 vomiting|0|||
27745672|NCT01670877|54195436|FG005|Part I and Part 2|Grade 2 vomiting|0|||
27745673|NCT01670877|54195431|FG000|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
27745674|NCT01670877|54195432|FG001|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
27745675|NCT01670877|54195433|FG002|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
27745676|NCT01670877|54195434|FG003|Part I and Part 2|Grade 3 dizziness and progressive disease|1|||
27745677|NCT01670877|54195435|FG004|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
27745678|NCT01670877|54195436|FG005|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
27745679|NCT01670877|54195431|FG000|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
27745680|NCT01670877|54195432|FG001|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
27745681|NCT01670877|54195433|FG002|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
27745682|NCT01670877|54195434|FG003|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|1|||
27745683|NCT01670877|54195435|FG004|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
27745684|NCT01670877|54195436|FG005|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
27745685|NCT00701129|54195450|FG000|Overall Study|Death|2|||
27745686|NCT01670721|54195454|FG000|Overall Study|Participant's decision|15|||
27745687|NCT01670721|54195454|FG000|Overall Study|Other than specified above|38|||
27745688|NCT02711137|54195473|FG000|Overall Study|Death|1|||
27745689|NCT02711137|54195474|FG001|Overall Study|Death|4|||
27745690|NCT02711137|54195475|FG002|Overall Study|Death|5|||
27745691|NCT02711137|54195476|FG003|Overall Study|Death|5|||
27745692|NCT02711137|54195477|FG004|Overall Study|Death|3|||
27745693|NCT02711137|54195478|FG005|Overall Study|Death|1|||
27745694|NCT02711137|54195479|FG006|Overall Study|Death|61|||
27745695|NCT02711137|54195480|FG007|Overall Study|Death|3|||
27745696|NCT02711137|54195481|FG008|Overall Study|Death|0|||
27745697|NCT02711137|54195482|FG009|Overall Study|Death|1|||
27745698|NCT02711137|54195483|FG010|Overall Study|Death|1|||
27745699|NCT02711137|54195484|FG011|Overall Study|Death|1|||
27745700|NCT02711137|54195485|FG012|Overall Study|Death|0|||
27745701|NCT02711137|54195486|FG013|Overall Study|Death|0|||
27745702|NCT02711137|54195487|FG014|Overall Study|Death|0|||
27745703|NCT02711137|54195473|FG000|Overall Study|Study Terminated by Sponsor|0|||
27745704|NCT02711137|54195474|FG001|Overall Study|Study Terminated by Sponsor|0|||
27745705|NCT02711137|54195475|FG002|Overall Study|Study Terminated by Sponsor|1|||
27745706|NCT02711137|54195476|FG003|Overall Study|Study Terminated by Sponsor|0|||
27745707|NCT02711137|54195477|FG004|Overall Study|Study Terminated by Sponsor|0|||
27745708|NCT02711137|54195478|FG005|Overall Study|Study Terminated by Sponsor|0|||
27745709|NCT02711137|54195479|FG006|Overall Study|Study Terminated by Sponsor|1|||
27745710|NCT02711137|54195480|FG007|Overall Study|Study Terminated by Sponsor|0|||
27745711|NCT02711137|54195481|FG008|Overall Study|Study Terminated by Sponsor|0|||
27745712|NCT02711137|54195482|FG009|Overall Study|Study Terminated by Sponsor|0|||
27745713|NCT02711137|54195483|FG010|Overall Study|Study Terminated by Sponsor|0|||
27745714|NCT02711137|54195484|FG011|Overall Study|Study Terminated by Sponsor|0|||
27745715|NCT02711137|54195485|FG012|Overall Study|Study Terminated by Sponsor|0|||
27745716|NCT02711137|54195486|FG013|Overall Study|Study Terminated by Sponsor|0|||
27745717|NCT02711137|54195487|FG014|Overall Study|Study Terminated by Sponsor|0|||
27745718|NCT02711137|54195473|FG000|Overall Study|Physician Decision|1|||
27745719|NCT02711137|54195474|FG001|Overall Study|Physician Decision|0|||
27745720|NCT02711137|54195475|FG002|Overall Study|Physician Decision|2|||
27745721|NCT02711137|54195476|FG003|Overall Study|Physician Decision|1|||
27745722|NCT02711137|54195477|FG004|Overall Study|Physician Decision|1|||
27745723|NCT02711137|54195478|FG005|Overall Study|Physician Decision|0|||
27745724|NCT02711137|54195479|FG006|Overall Study|Physician Decision|12|||
27745725|NCT02711137|54195480|FG007|Overall Study|Physician Decision|2|||
27745726|NCT02711137|54195481|FG008|Overall Study|Physician Decision|1|||
27745727|NCT02711137|54195482|FG009|Overall Study|Physician Decision|1|||
27745728|NCT02711137|54195483|FG010|Overall Study|Physician Decision|3|||
27745729|NCT02711137|54195484|FG011|Overall Study|Physician Decision|2|||
27745730|NCT02711137|54195485|FG012|Overall Study|Physician Decision|1|||
27745731|NCT02711137|54195486|FG013|Overall Study|Physician Decision|1|||
27745732|NCT02711137|54195487|FG014|Overall Study|Physician Decision|2|||
27745733|NCT02711137|54195473|FG000|Overall Study|Other|0|||
27745734|NCT02711137|54195474|FG001|Overall Study|Other|1|||
27745735|NCT02711137|54195475|FG002|Overall Study|Other|0|||
27745736|NCT02711137|54195476|FG003|Overall Study|Other|0|||
27745737|NCT02711137|54195477|FG004|Overall Study|Other|0|||
27745738|NCT02711137|54195478|FG005|Overall Study|Other|0|||
27745739|NCT02711137|54195479|FG006|Overall Study|Other|3|||
27745740|NCT02711137|54195480|FG007|Overall Study|Other|0|||
27745741|NCT02711137|54195481|FG008|Overall Study|Other|0|||
27745742|NCT02711137|54195482|FG009|Overall Study|Other|0|||
27745743|NCT02711137|54195483|FG010|Overall Study|Other|0|||
27745744|NCT02711137|54195484|FG011|Overall Study|Other|0|||
27745745|NCT02711137|54195485|FG012|Overall Study|Other|0|||
27745746|NCT02711137|54195486|FG013|Overall Study|Other|0|||
27745747|NCT02711137|54195487|FG014|Overall Study|Other|1|||
27745748|NCT02711137|54195473|FG000|Overall Study|Withdrawal by Subject|1|||
27745749|NCT02711137|54195474|FG001|Overall Study|Withdrawal by Subject|0|||
27745750|NCT02711137|54195475|FG002|Overall Study|Withdrawal by Subject|0|||
27745751|NCT02711137|54195476|FG003|Overall Study|Withdrawal by Subject|1|||
27745752|NCT02711137|54195477|FG004|Overall Study|Withdrawal by Subject|1|||
27745753|NCT02711137|54195478|FG005|Overall Study|Withdrawal by Subject|0|||
27745754|NCT02711137|54195479|FG006|Overall Study|Withdrawal by Subject|7|||
27745755|NCT02711137|54195480|FG007|Overall Study|Withdrawal by Subject|0|||
27745756|NCT02711137|54195481|FG008|Overall Study|Withdrawal by Subject|0|||
27745757|NCT02711137|54195482|FG009|Overall Study|Withdrawal by Subject|0|||
27745758|NCT02711137|54195483|FG010|Overall Study|Withdrawal by Subject|0|||
27745759|NCT02711137|54195484|FG011|Overall Study|Withdrawal by Subject|0|||
27745760|NCT02711137|54195485|FG012|Overall Study|Withdrawal by Subject|0|||
27745761|NCT02711137|54195486|FG013|Overall Study|Withdrawal by Subject|1|||
27745762|NCT02711137|54195487|FG014|Overall Study|Withdrawal by Subject|0|||
27745763|NCT02711137|54195473|FG000|Overall Study|Lost to Follow-up|1|||
27745764|NCT02711137|54195474|FG001|Overall Study|Lost to Follow-up|0|||
27745765|NCT02711137|54195475|FG002|Overall Study|Lost to Follow-up|0|||
27745766|NCT02711137|54195476|FG003|Overall Study|Lost to Follow-up|0|||
27745767|NCT02711137|54195477|FG004|Overall Study|Lost to Follow-up|0|||
27745768|NCT02711137|54195478|FG005|Overall Study|Lost to Follow-up|0|||
27745769|NCT02711137|54195479|FG006|Overall Study|Lost to Follow-up|2|||
27745770|NCT02711137|54195480|FG007|Overall Study|Lost to Follow-up|0|||
27745771|NCT02711137|54195481|FG008|Overall Study|Lost to Follow-up|0|||
27745772|NCT02711137|54195482|FG009|Overall Study|Lost to Follow-up|0|||
27745773|NCT02711137|54195483|FG010|Overall Study|Lost to Follow-up|0|||
27924348|NCT01031680|54581342|FG000|Overall Study|Administrative Reason by Sponsor|0|||
27924349|NCT01031680|54581343|FG001|Overall Study|Administrative Reason by Sponsor|1|||
27924350|NCT01031680|54581342|FG000|Overall Study|Various|0|||
27924351|NCT01031680|54581343|FG001|Overall Study|Various|2|||
27924352|NCT01031446|54581349|FG000|Overall Study|Disease Progression|38|||
27924353|NCT01031446|54581349|FG000|Overall Study|Adverse Event|9|||
27924354|NCT01031446|54581349|FG000|Overall Study|Physician Decision|4|||
27924355|NCT01031446|54581349|FG000|Overall Study|Withdrawal by Subject|3|||
27924356|NCT01031446|54581349|FG000|Overall Study|Still on treatment|1|||
27924357|NCT01030900|54581355|FG000|Overall Study|Not treated due to congestive heart failure|1|||
27924358|NCT01030900|54581355|FG000|Overall Study|Not treated due to rapid disease|1|||
27924359|NCT01030822|54581362|FG000|Overall Study|Moved/migrated from study area|6|||
27924360|NCT01030822|54581363|FG001|Overall Study|Moved/migrated from study area|7|||
27924361|NCT01030822|54581364|FG002|Overall Study|Moved/migrated from study area|3|||
27924362|NCT01030822|54581362|FG000|Overall Study|Withdrawal by Subject|16|||
27924363|NCT01030822|54581363|FG001|Overall Study|Withdrawal by Subject|13|||
27924364|NCT01030822|54581364|FG002|Overall Study|Withdrawal by Subject|16|||
27924365|NCT01030822|54581362|FG000|Overall Study|Lost to Follow-up|9|||
27924366|NCT01030822|54581363|FG001|Overall Study|Lost to Follow-up|4|||
27924367|NCT01030822|54581364|FG002|Overall Study|Lost to Follow-up|7|||
27924368|NCT01026454|54581375|FG000|Second Intervention|Pregnancy|1|||
27924369|NCT01026454|54581376|FG001|Second Intervention|Pregnancy|1|||
27924370|NCT01026220|54581382|FG000|Induction|Death|1|||
27924371|NCT01026220|54581383|FG001|Induction|Death|0|||
27924372|NCT01026220|54581384|FG002|Induction|Death|0|||
27924373|NCT01026220|54581382|FG000|Induction|Lack of Efficacy|2|||
27924374|NCT01026220|54581383|FG001|Induction|Lack of Efficacy|0|||
27924375|NCT01026220|54581384|FG002|Induction|Lack of Efficacy|0|||
27924376|NCT01026220|54581382|FG000|Induction|Physician Decision|12|||
27924377|NCT01026220|54581383|FG001|Induction|Physician Decision|0|||
27924378|NCT01026220|54581384|FG002|Induction|Physician Decision|0|||
27924379|NCT01026220|54581382|FG000|Induction|Withdrawal by Subject|9|||
27924380|NCT01026220|54581383|FG001|Induction|Withdrawal by Subject|0|||
27924381|NCT01026220|54581384|FG002|Induction|Withdrawal by Subject|0|||
27924382|NCT01026220|54581382|FG000|Induction|Ineligible|1|||
27924383|NCT01026220|54581383|FG001|Induction|Ineligible|0|||
27924384|NCT01026220|54581384|FG002|Induction|Ineligible|0|||
27924385|NCT01026220|54581382|FG000|Consolidation Maintenance|Death|0|||
27924386|NCT01026220|54581383|FG001|Consolidation Maintenance|Death|1|||
27924387|NCT01026220|54581384|FG002|Consolidation Maintenance|Death|0|||
27924388|NCT01026220|54581382|FG000|Consolidation Maintenance|Lack of Efficacy|0|||
27924389|NCT01026220|54581383|FG001|Consolidation Maintenance|Lack of Efficacy|1|||
27924390|NCT01026220|54581384|FG002|Consolidation Maintenance|Lack of Efficacy|1|||
27924391|NCT01026220|54581382|FG000|Consolidation Maintenance|Physician Decision|0|||
27924392|NCT01026220|54581383|FG001|Consolidation Maintenance|Physician Decision|2|||
27924393|NCT01026220|54581384|FG002|Consolidation Maintenance|Physician Decision|7|||
27924394|NCT01026220|54581382|FG000|Consolidation Maintenance|Withdrawal by Subject|0|||
27924395|NCT01026220|54581383|FG001|Consolidation Maintenance|Withdrawal by Subject|2|||
27924396|NCT01026220|54581384|FG002|Consolidation Maintenance|Withdrawal by Subject|6|||
27924397|NCT01026142|54581401|FG000|Overall Study|Death|136|||
27924398|NCT01026142|54581402|FG001|Overall Study|Death|134|||
27924399|NCT01026142|54581401|FG000|Overall Study|Withdrew consent or lost to follow-up|36|||
27924400|NCT01026142|54581402|FG001|Overall Study|Withdrew consent or lost to follow-up|29|||
27924401|NCT01030666|54581410|FG000|Overall Study|Lost to Follow-up|3|||
27924402|NCT01030666|54581411|FG001|Overall Study|Lost to Follow-up|2|||
27924403|NCT01025752|54581420|FG000|Overall Study|Lost to Follow-up|7|||
27924404|NCT01025752|54581421|FG001|Overall Study|Lost to Follow-up|10|||
27924405|NCT01025752|54581420|FG000|Overall Study|Physician Decision|1|||
27924406|NCT01025752|54581421|FG001|Overall Study|Physician Decision|3|||
27924407|NCT01030198|54581429|FG000|Overall Study|Could not measure efficacy accurately|0|||
27924408|NCT01030198|54581430|FG001|Overall Study|Could not measure efficacy accurately|7|||
27924409|NCT01301456|54581448|FG000|Stage 1|Withdrawal by Subject|0|||
27924410|NCT01301456|54581449|FG001|Stage 1|Withdrawal by Subject|0|||
27924411|NCT01301456|54581450|FG002|Stage 1|Withdrawal by Subject|1|||
27924412|NCT01301456|54581451|FG003|Stage 1|Withdrawal by Subject|0|||
27924413|NCT01301456|54581452|FG004|Stage 1|Withdrawal by Subject|1|||
27924414|NCT01301456|54581453|FG005|Stage 1|Withdrawal by Subject|0|||
27924415|NCT01301456|54581454|FG006|Stage 1|Withdrawal by Subject|0|||
27924416|NCT01301456|54581455|FG007|Stage 1|Withdrawal by Subject|0|||
27924417|NCT01301456|54581456|FG008|Stage 1|Withdrawal by Subject|0|||
27924418|NCT01301456|54581457|FG009|Stage 1|Withdrawal by Subject|0|||
27924419|NCT01301456|54581458|FG010|Stage 1|Withdrawal by Subject|0|||
27924420|NCT01301456|54581459|FG011|Stage 1|Withdrawal by Subject|0|||
27924421|NCT01301456|54581448|FG000|Stage 1|Randomized but not treated|0|||
27924422|NCT01301456|54581449|FG001|Stage 1|Randomized but not treated|0|||
27924423|NCT01301456|54581450|FG002|Stage 1|Randomized but not treated|0|||
27924424|NCT01301456|54581451|FG003|Stage 1|Randomized but not treated|0|||
27924425|NCT01301456|54581452|FG004|Stage 1|Randomized but not treated|0|||
27924426|NCT01301456|54581453|FG005|Stage 1|Randomized but not treated|0|||
27924427|NCT01301456|54581454|FG006|Stage 1|Randomized but not treated|1|||
27924428|NCT01301456|54581455|FG007|Stage 1|Randomized but not treated|0|||
27924429|NCT01301456|54581456|FG008|Stage 1|Randomized but not treated|0|||
27924430|NCT01301456|54581457|FG009|Stage 1|Randomized but not treated|0|||
27924431|NCT01301456|54581458|FG010|Stage 1|Randomized but not treated|0|||
27924432|NCT01301456|54581459|FG011|Stage 1|Randomized but not treated|0|||
27924433|NCT01301456|54581448|FG000|Stage 2|Adverse Event|0|||
27924434|NCT01301456|54581449|FG001|Stage 2|Adverse Event|0|||
27924435|NCT01301456|54581450|FG002|Stage 2|Adverse Event|0|||
27924436|NCT01301456|54581451|FG003|Stage 2|Adverse Event|0|||
27924437|NCT01301456|54581452|FG004|Stage 2|Adverse Event|0|||
27924438|NCT01301456|54581453|FG005|Stage 2|Adverse Event|0|||
27924439|NCT01301456|54581454|FG006|Stage 2|Adverse Event|0|||
27924440|NCT01301456|54581455|FG007|Stage 2|Adverse Event|0|||
27924441|NCT01301456|54581456|FG008|Stage 2|Adverse Event|0|||
27924442|NCT01301456|54581457|FG009|Stage 2|Adverse Event|0|||
27924443|NCT01301456|54581458|FG010|Stage 2|Adverse Event|1|||
27924444|NCT01301456|54581459|FG011|Stage 2|Adverse Event|0|||
27924445|NCT01023256|54581507|FG000|Overall Study|Protocol Violation|2|||
27924446|NCT01023256|54581508|FG001|Overall Study|Protocol Violation|3|||
27924447|NCT01023256|54581509|FG002|Overall Study|Protocol Violation|0|||
27924448|NCT01023256|54581510|FG003|Overall Study|Protocol Violation|0|||
27924449|NCT01023256|54581507|FG000|Overall Study|Randomized but not treated|1|||
27924450|NCT01023256|54581508|FG001|Overall Study|Randomized but not treated|0|||
27924451|NCT01023256|54581509|FG002|Overall Study|Randomized but not treated|1|||
27924452|NCT01023256|54581510|FG003|Overall Study|Randomized but not treated|0|||
27924453|NCT01023256|54581507|FG000|Overall Study|Other|1|||
27924454|NCT01023256|54581508|FG001|Overall Study|Other|0|||
27924455|NCT01023256|54581509|FG002|Overall Study|Other|0|||
27924456|NCT01023256|54581510|FG003|Overall Study|Other|2|||
27924457|NCT01023256|54581507|FG000|Overall Study|Adverse Event|0|||
27924458|NCT01023256|54581508|FG001|Overall Study|Adverse Event|0|||
27924459|NCT01023256|54581509|FG002|Overall Study|Adverse Event|0|||
27924460|NCT01023256|54581510|FG003|Overall Study|Adverse Event|1|||
27924461|NCT01023256|54581507|FG000|Overall Study|Withdrawal by Subject|0|||
27924462|NCT01023256|54581508|FG001|Overall Study|Withdrawal by Subject|0|||
27924463|NCT01023256|54581509|FG002|Overall Study|Withdrawal by Subject|0|||
27924464|NCT01023256|54581510|FG003|Overall Study|Withdrawal by Subject|2|||
27924465|NCT01023022|54581523|FG000|Overall Study|Death|5|||
27924466|NCT01023022|54581523|FG000|Overall Study|Lost to Follow-up|7|||
27924467|NCT01023022|54581523|FG000|Overall Study|due to technical issues|2|||
27924468|NCT01058668|54581530|FG000|Double-blind Treatment Phase|Adverse Event|8|||
27924469|NCT01058668|54581531|FG001|Double-blind Treatment Phase|Adverse Event|15|||
27924470|NCT01058668|54581532|FG002|Double-blind Treatment Phase|Adverse Event|25|||
27924471|NCT01058668|54581530|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|15|||
27924472|NCT01058668|54581531|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|2|||
27924473|NCT01058668|54581532|FG002|Double-blind Treatment Phase|Insufficient Therapeutic Response|5|||
27924474|NCT01058668|54581530|FG000|Double-blind Treatment Phase|Protocol Violation|1|||
27924475|NCT01058668|54581531|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
27924476|NCT01058668|54581532|FG002|Double-blind Treatment Phase|Protocol Violation|2|||
27924477|NCT01058668|54581530|FG000|Double-blind Treatment Phase|Withdrawal of Consent|14|||
27924478|NCT01058668|54581531|FG001|Double-blind Treatment Phase|Withdrawal of Consent|18|||
27924479|NCT01058668|54581532|FG002|Double-blind Treatment Phase|Withdrawal of Consent|17|||
27924480|NCT01058668|54581530|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
27924481|NCT01058668|54581531|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
27924482|NCT01058668|54581532|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
27924483|NCT01058668|54581530|FG000|Double-blind Treatment Phase|Other Unspecified|1|||
27924484|NCT01058668|54581531|FG001|Double-blind Treatment Phase|Other Unspecified|1|||
27924485|NCT01058668|54581532|FG002|Double-blind Treatment Phase|Other Unspecified|0|||
27924486|NCT01301066|54581542|FG000|Overall Study|Lost to Follow-up|5|||
27924487|NCT01301066|54581543|FG001|Overall Study|Lost to Follow-up|11|||
27924488|NCT01301066|54581542|FG000|Overall Study|Protocol Violation|8|||
27924489|NCT01301066|54581543|FG001|Overall Study|Protocol Violation|7|||
27924490|NCT01301066|54581542|FG000|Overall Study|Withdrawal by Subject|4|||
27924491|NCT01301066|54581543|FG001|Overall Study|Withdrawal by Subject|9|||
27924492|NCT01301066|54581542|FG000|Overall Study|Adverse Event|6|||
27924493|NCT01301066|54581543|FG001|Overall Study|Adverse Event|6|||
27924494|NCT01301066|54581542|FG000|Overall Study|Sponsor Decision|2|||
27924495|NCT01301066|54581543|FG001|Overall Study|Sponsor Decision|1|||
27924496|NCT01301066|54581542|FG000|Overall Study|Physician Decision|0|||
27924497|NCT01301066|54581543|FG001|Overall Study|Physician Decision|1|||
27924498|NCT01301066|54581542|FG000|Overall Study|Other|2|||
27924499|NCT01301066|54581543|FG001|Overall Study|Other|0|||
27924500|NCT01022398|54581551|FG000|Overall Study|Study terminated|2|||
27924501|NCT01022398|54581552|FG001|Overall Study|Study terminated|2|||
27924502|NCT01262976|54581563|FG000|Up to Month 2|Serious Adverse Event|0|||
27924503|NCT01262976|54581564|FG001|Up to Month 2|Serious Adverse Event|0|||
27924504|NCT01262976|54581565|FG002|Up to Month 2|Serious Adverse Event|1|||
27924505|NCT01262976|54581566|FG003|Up to Month 2|Serious Adverse Event|0|||
27924506|NCT01262976|54581567|FG004|Up to Month 2|Serious Adverse Event|0|||
27924507|NCT01262976|54581568|FG005|Up to Month 2|Serious Adverse Event|0|||
27924508|NCT01262976|54581563|FG000|Up to Month 2|Withdrawal by Subject|1|||
27924509|NCT01262976|54581564|FG001|Up to Month 2|Withdrawal by Subject|0|||
27924510|NCT01262976|54581565|FG002|Up to Month 2|Withdrawal by Subject|0|||
27924511|NCT01262976|54581566|FG003|Up to Month 2|Withdrawal by Subject|0|||
27924512|NCT01262976|54581567|FG004|Up to Month 2|Withdrawal by Subject|0|||
27924513|NCT01262976|54581568|FG005|Up to Month 2|Withdrawal by Subject|0|||
27924514|NCT01262976|54581563|FG000|Up to Month 2|Migrated/moved from study area|0|||
27924515|NCT01262976|54581564|FG001|Up to Month 2|Migrated/moved from study area|1|||
27924516|NCT01262976|54581565|FG002|Up to Month 2|Migrated/moved from study area|0|||
27924517|NCT01262976|54581566|FG003|Up to Month 2|Migrated/moved from study area|0|||
27924518|NCT01262976|54581567|FG004|Up to Month 2|Migrated/moved from study area|1|||
27924519|NCT01262976|54581568|FG005|Up to Month 2|Migrated/moved from study area|1|||
27924520|NCT01262976|54581563|FG000|Up to Month 2|Lost to Follow-up|1|||
27924521|NCT01262976|54581564|FG001|Up to Month 2|Lost to Follow-up|0|||
27924522|NCT01262976|54581565|FG002|Up to Month 2|Lost to Follow-up|0|||
27924523|NCT01262976|54581566|FG003|Up to Month 2|Lost to Follow-up|1|||
27924524|NCT01262976|54581567|FG004|Up to Month 2|Lost to Follow-up|1|||
27924525|NCT01262976|54581568|FG005|Up to Month 2|Lost to Follow-up|1|||
27924526|NCT01262976|54581563|FG000|Up to Month 2|Other|1|||
27924527|NCT01262976|54581564|FG001|Up to Month 2|Other|0|||
27924528|NCT01262976|54581565|FG002|Up to Month 2|Other|0|||
27924529|NCT01262976|54581566|FG003|Up to Month 2|Other|1|||
27924530|NCT01262976|54581567|FG004|Up to Month 2|Other|0|||
27924531|NCT01262976|54581568|FG005|Up to Month 2|Other|2|||
27924532|NCT01262976|54581563|FG000|Up to Month 7|Serious Adverse Event|0|||
27924533|NCT01262976|54581564|FG001|Up to Month 7|Serious Adverse Event|0|||
27924534|NCT01262976|54581565|FG002|Up to Month 7|Serious Adverse Event|2|||
27924535|NCT01262976|54581566|FG003|Up to Month 7|Serious Adverse Event|0|||
27924536|NCT01262976|54581567|FG004|Up to Month 7|Serious Adverse Event|0|||
27924537|NCT01262976|54581568|FG005|Up to Month 7|Serious Adverse Event|0|||
27924538|NCT01262976|54581563|FG000|Up to Month 7|Withdrawal by Subject|1|||
27924539|NCT01262976|54581564|FG001|Up to Month 7|Withdrawal by Subject|0|||
27924540|NCT01262976|54581565|FG002|Up to Month 7|Withdrawal by Subject|0|||
27924541|NCT01262976|54581566|FG003|Up to Month 7|Withdrawal by Subject|0|||
27924542|NCT01262976|54581567|FG004|Up to Month 7|Withdrawal by Subject|0|||
27924543|NCT01262976|54581568|FG005|Up to Month 7|Withdrawal by Subject|0|||
27924544|NCT01262976|54581563|FG000|Up to Month 7|Migrated/moved from study area|0|||
27924545|NCT01262976|54581564|FG001|Up to Month 7|Migrated/moved from study area|0|||
27924546|NCT01262976|54581565|FG002|Up to Month 7|Migrated/moved from study area|1|||
27924547|NCT01262976|54581566|FG003|Up to Month 7|Migrated/moved from study area|3|||
27924548|NCT01262976|54581567|FG004|Up to Month 7|Migrated/moved from study area|1|||
27924549|NCT01262976|54581568|FG005|Up to Month 7|Migrated/moved from study area|1|||
27924550|NCT01262976|54581563|FG000|Up to Month 7|Lost to Follow-up|1|||
27924551|NCT01262976|54581564|FG001|Up to Month 7|Lost to Follow-up|0|||
27924552|NCT01262976|54581565|FG002|Up to Month 7|Lost to Follow-up|1|||
27924553|NCT01262976|54581566|FG003|Up to Month 7|Lost to Follow-up|3|||
27924554|NCT01262976|54581567|FG004|Up to Month 7|Lost to Follow-up|1|||
27924555|NCT01262976|54581568|FG005|Up to Month 7|Lost to Follow-up|3|||
27924556|NCT01262976|54581563|FG000|Up to Month 7|Other|3|||
27924557|NCT01262976|54581564|FG001|Up to Month 7|Other|0|||
27924558|NCT01262976|54581565|FG002|Up to Month 7|Other|2|||
27924559|NCT01262976|54581566|FG003|Up to Month 7|Other|0|||
27924560|NCT01262976|54581567|FG004|Up to Month 7|Other|0|||
27924561|NCT01262976|54581568|FG005|Up to Month 7|Other|0|||
27924562|NCT01262976|54581563|FG000|Up to Year 1|Serious Adverse Event|0|||
27924563|NCT01262976|54581564|FG001|Up to Year 1|Serious Adverse Event|0|||
27924564|NCT01262976|54581565|FG002|Up to Year 1|Serious Adverse Event|2|||
27924565|NCT01262976|54581566|FG003|Up to Year 1|Serious Adverse Event|0|||
27924566|NCT01262976|54581567|FG004|Up to Year 1|Serious Adverse Event|0|||
27924567|NCT01262976|54581568|FG005|Up to Year 1|Serious Adverse Event|0|||
27924568|NCT01262976|54581563|FG000|Up to Year 1|Withdrawal by Subject|1|||
27924569|NCT01262976|54581564|FG001|Up to Year 1|Withdrawal by Subject|0|||
27924570|NCT01262976|54581565|FG002|Up to Year 1|Withdrawal by Subject|0|||
27924571|NCT01262976|54581566|FG003|Up to Year 1|Withdrawal by Subject|0|||
27924572|NCT01262976|54581567|FG004|Up to Year 1|Withdrawal by Subject|0|||
27924573|NCT01262976|54581568|FG005|Up to Year 1|Withdrawal by Subject|0|||
27924574|NCT01262976|54581563|FG000|Up to Year 1|Migrated/moved from study area|1|||
27924575|NCT01262976|54581564|FG001|Up to Year 1|Migrated/moved from study area|0|||
27924576|NCT01262976|54581565|FG002|Up to Year 1|Migrated/moved from study area|0|||
27924577|NCT01262976|54581566|FG003|Up to Year 1|Migrated/moved from study area|3|||
27924578|NCT01262976|54581567|FG004|Up to Year 1|Migrated/moved from study area|3|||
27924579|NCT01262976|54581568|FG005|Up to Year 1|Migrated/moved from study area|2|||
27924580|NCT01262976|54581563|FG000|Up to Year 1|Lost to Follow-up|4|||
27924581|NCT01262976|54581564|FG001|Up to Year 1|Lost to Follow-up|0|||
27924582|NCT01262976|54581565|FG002|Up to Year 1|Lost to Follow-up|0|||
27924583|NCT01262976|54581566|FG003|Up to Year 1|Lost to Follow-up|1|||
27924584|NCT01262976|54581567|FG004|Up to Year 1|Lost to Follow-up|6|||
27924585|NCT01262976|54581568|FG005|Up to Year 1|Lost to Follow-up|5|||
27924586|NCT01262976|54581563|FG000|Up to Year 1|Other|3|||
27924587|NCT01262976|54581564|FG001|Up to Year 1|Other|1|||
27924588|NCT01262976|54581565|FG002|Up to Year 1|Other|0|||
27924589|NCT01262976|54581566|FG003|Up to Year 1|Other|0|||
27924590|NCT01262976|54581567|FG004|Up to Year 1|Other|2|||
27924591|NCT01262976|54581568|FG005|Up to Year 1|Other|1|||
27924592|NCT01262976|54581563|FG000|Up to Year 1|Subjects with unknown completion status|0|||
27924593|NCT01262976|54581564|FG001|Up to Year 1|Subjects with unknown completion status|0|||
27924594|NCT01262976|54581565|FG002|Up to Year 1|Subjects with unknown completion status|1|||
27924595|NCT01262976|54581566|FG003|Up to Year 1|Subjects with unknown completion status|0|||
27924596|NCT01262976|54581567|FG004|Up to Year 1|Subjects with unknown completion status|0|||
27924597|NCT01262976|54581568|FG005|Up to Year 1|Subjects with unknown completion status|1|||
27924598|NCT01262976|54581563|FG000|Up to Year 2|Serious Adverse Event|0|||
27924599|NCT01262976|54581564|FG001|Up to Year 2|Serious Adverse Event|0|||
27924600|NCT01262976|54581565|FG002|Up to Year 2|Serious Adverse Event|2|||
27924601|NCT01262976|54581566|FG003|Up to Year 2|Serious Adverse Event|0|||
27924602|NCT01262976|54581567|FG004|Up to Year 2|Serious Adverse Event|0|||
27924603|NCT01262976|54581568|FG005|Up to Year 2|Serious Adverse Event|0|||
27924604|NCT01262976|54581563|FG000|Up to Year 2|Withdrawal by Subject|1|||
27924605|NCT01262976|54581564|FG001|Up to Year 2|Withdrawal by Subject|0|||
27924606|NCT01262976|54581565|FG002|Up to Year 2|Withdrawal by Subject|0|||
27924607|NCT01262976|54581566|FG003|Up to Year 2|Withdrawal by Subject|0|||
27924608|NCT01262976|54581567|FG004|Up to Year 2|Withdrawal by Subject|0|||
27924609|NCT01262976|54581568|FG005|Up to Year 2|Withdrawal by Subject|0|||
27924610|NCT01262976|54581563|FG000|Up to Year 2|Migrated/moved from study area|0|||
27924611|NCT01262976|54581564|FG001|Up to Year 2|Migrated/moved from study area|0|||
27924612|NCT01262976|54581565|FG002|Up to Year 2|Migrated/moved from study area|0|||
27924613|NCT01262976|54581566|FG003|Up to Year 2|Migrated/moved from study area|2|||
27924614|NCT01262976|54581567|FG004|Up to Year 2|Migrated/moved from study area|1|||
27924615|NCT01262976|54581568|FG005|Up to Year 2|Migrated/moved from study area|2|||
27924616|NCT01262976|54581563|FG000|Up to Year 2|Lost to Follow-up|1|||
27924617|NCT01262976|54581564|FG001|Up to Year 2|Lost to Follow-up|1|||
27924618|NCT01262976|54581565|FG002|Up to Year 2|Lost to Follow-up|2|||
27924619|NCT01262976|54581566|FG003|Up to Year 2|Lost to Follow-up|2|||
27924620|NCT01262976|54581567|FG004|Up to Year 2|Lost to Follow-up|3|||
27924621|NCT01262976|54581568|FG005|Up to Year 2|Lost to Follow-up|3|||
27924622|NCT01262976|54581563|FG000|Up to Year 2|Subjects with unknown completion status|0|||
27924623|NCT01262976|54581564|FG001|Up to Year 2|Subjects with unknown completion status|0|||
27924624|NCT01262976|54581565|FG002|Up to Year 2|Subjects with unknown completion status|1|||
27924625|NCT01262976|54581566|FG003|Up to Year 2|Subjects with unknown completion status|0|||
27924626|NCT01262976|54581567|FG004|Up to Year 2|Subjects with unknown completion status|0|||
27924627|NCT01262976|54581568|FG005|Up to Year 2|Subjects with unknown completion status|0|||
27924628|NCT01262976|54581563|FG000|Up to Year 2|Other|3|||
27924629|NCT01262976|54581564|FG001|Up to Year 2|Other|0|||
27924630|NCT01262976|54581565|FG002|Up to Year 2|Other|0|||
27924631|NCT01262976|54581566|FG003|Up to Year 2|Other|0|||
27924632|NCT01262976|54581567|FG004|Up to Year 2|Other|0|||
27924633|NCT01262976|54581568|FG005|Up to Year 2|Other|0|||
27924634|NCT01262976|54581563|FG000|Up to Year 3|Serious Adverse Event|0|||
27924635|NCT01262976|54581564|FG001|Up to Year 3|Serious Adverse Event|0|||
27924636|NCT01262976|54581565|FG002|Up to Year 3|Serious Adverse Event|2|||
27924637|NCT01262976|54581566|FG003|Up to Year 3|Serious Adverse Event|0|||
27924638|NCT01262976|54581567|FG004|Up to Year 3|Serious Adverse Event|0|||
27924639|NCT01262976|54581568|FG005|Up to Year 3|Serious Adverse Event|0|||
27924640|NCT01262976|54581563|FG000|Up to Year 3|Withdrawal by Subject|1|||
27924641|NCT01262976|54581564|FG001|Up to Year 3|Withdrawal by Subject|0|||
27924642|NCT01262976|54581565|FG002|Up to Year 3|Withdrawal by Subject|0|||
27924643|NCT01262976|54581566|FG003|Up to Year 3|Withdrawal by Subject|0|||
27924644|NCT01262976|54581567|FG004|Up to Year 3|Withdrawal by Subject|0|||
27924645|NCT01262976|54581568|FG005|Up to Year 3|Withdrawal by Subject|0|||
27924646|NCT01262976|54581563|FG000|Up to Year 3|Migrated/moved from study area|0|||
27924647|NCT01262976|54581564|FG001|Up to Year 3|Migrated/moved from study area|0|||
27924648|NCT01262976|54581565|FG002|Up to Year 3|Migrated/moved from study area|0|||
27924649|NCT01262976|54581566|FG003|Up to Year 3|Migrated/moved from study area|2|||
27924650|NCT01262976|54581567|FG004|Up to Year 3|Migrated/moved from study area|1|||
27924651|NCT01262976|54581568|FG005|Up to Year 3|Migrated/moved from study area|1|||
27924652|NCT01262976|54581563|FG000|Up to Year 3|Lost to Follow-up|2|||
27924653|NCT01262976|54581564|FG001|Up to Year 3|Lost to Follow-up|2|||
27924654|NCT01262976|54581565|FG002|Up to Year 3|Lost to Follow-up|4|||
27924655|NCT01262976|54581566|FG003|Up to Year 3|Lost to Follow-up|3|||
27924656|NCT01262976|54581567|FG004|Up to Year 3|Lost to Follow-up|1|||
27924657|NCT01262976|54581568|FG005|Up to Year 3|Lost to Follow-up|3|||
27924658|NCT01262976|54581563|FG000|Up to Year 3|Subjects with unknown completion status|0|||
27924659|NCT01262976|54581564|FG001|Up to Year 3|Subjects with unknown completion status|0|||
27924660|NCT01262976|54581565|FG002|Up to Year 3|Subjects with unknown completion status|1|||
27924661|NCT01262976|54581566|FG003|Up to Year 3|Subjects with unknown completion status|0|||
27924662|NCT01262976|54581567|FG004|Up to Year 3|Subjects with unknown completion status|0|||
27924663|NCT01262976|54581568|FG005|Up to Year 3|Subjects with unknown completion status|0|||
27924664|NCT01262976|54581563|FG000|Up to Year 3|Other|3|||
27924665|NCT01262976|54581564|FG001|Up to Year 3|Other|0|||
27924666|NCT01262976|54581565|FG002|Up to Year 3|Other|0|||
27924667|NCT01262976|54581566|FG003|Up to Year 3|Other|0|||
27924668|NCT01262976|54581567|FG004|Up to Year 3|Other|0|||
27924669|NCT01262976|54581568|FG005|Up to Year 3|Other|0|||
27924670|NCT01300286|54581583|FG000|Overall Study|did not get dosed|1|||
27924671|NCT01300052|54581590|FG000|Overall Study|Adverse Event|3|||
27924672|NCT01300052|54581591|FG001|Overall Study|Adverse Event|0|||
27924673|NCT01300052|54581590|FG000|Overall Study|Withdrawal by Subject|2|||
27924674|NCT01300052|54581591|FG001|Overall Study|Withdrawal by Subject|2|||
27924675|NCT01300052|54581590|FG000|Overall Study|Protocol Violation|1|||
27924676|NCT01300052|54581591|FG001|Overall Study|Protocol Violation|1|||
27924677|NCT01299896|54581599|FG000|Overall Study|Withdrawal by Subject|1|||
27924678|NCT01299896|54581600|FG001|Overall Study|Withdrawal by Subject|7|||
27924679|NCT01299896|54581599|FG000|Overall Study|Lost to Follow-up|0|||
27924680|NCT01299896|54581600|FG001|Overall Study|Lost to Follow-up|11|||
27924681|NCT01299584|54581606|FG000|Overall Study|Protocol Violation|9|||
27924682|NCT01236573|54581621|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
27924683|NCT01236573|54581622|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
27924684|NCT01236573|54581623|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
27924685|NCT01236573|54581624|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
27924686|NCT01236573|54581625|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
27924687|NCT01236573|54581626|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
27924688|NCT01236573|54581627|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
27924689|NCT01236573|54581628|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
27924690|NCT01236573|54581629|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
27924691|NCT01236573|54581630|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
27924692|NCT01236573|54581631|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
27924693|NCT01236573|54581621|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
27924694|NCT01236573|54581622|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
27924695|NCT01236573|54581623|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
27924696|NCT01236573|54581624|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
27924697|NCT01236573|54581625|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
27924698|NCT01236573|54581626|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
27924699|NCT01236573|54581627|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
27924700|NCT01236573|54581628|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
27924701|NCT01236573|54581629|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1|||
27924702|NCT01236573|54581630|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
27924703|NCT01236573|54581631|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
27924704|NCT01236573|54581621|FG000|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
27924705|NCT01236573|54581622|FG001|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
27924706|NCT01236573|54581623|FG002|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
27924707|NCT01236573|54581624|FG003|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
27924708|NCT01236573|54581625|FG004|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
27924709|NCT01236573|54581626|FG005|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
27924710|NCT01236573|54581627|FG006|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
27924711|NCT01236573|54581628|FG007|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
27924712|NCT01236573|54581629|FG008|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
27924713|NCT01236573|54581630|FG009|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
27924714|NCT01236573|54581631|FG010|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1|||
27924715|NCT01236339|54581658|FG000|Overall Study|Termination of study by sponsor|11|||
27924716|NCT01236339|54581659|FG001|Overall Study|Termination of study by sponsor|13|||
27924717|NCT01262898|54581670|FG000|Overall Study|Protocol Violation|1|||
27924718|NCT01262898|54581671|FG001|Overall Study|Protocol Violation|1|||
27924719|NCT01262898|54581672|FG002|Overall Study|Protocol Violation|0|||
27924720|NCT01262898|54581673|FG003|Overall Study|Protocol Violation|0|||
27924721|NCT01262898|54581670|FG000|Overall Study|Lost to Follow-up|1|||
27924722|NCT01262898|54581671|FG001|Overall Study|Lost to Follow-up|0|||
27924723|NCT01262898|54581672|FG002|Overall Study|Lost to Follow-up|0|||
27924724|NCT01262898|54581673|FG003|Overall Study|Lost to Follow-up|0|||
27924725|NCT01262898|54581670|FG000|Overall Study|Withdrawal by Subject|1|||
27924726|NCT01262898|54581671|FG001|Overall Study|Withdrawal by Subject|1|||
27924727|NCT01262898|54581672|FG002|Overall Study|Withdrawal by Subject|0|||
27924728|NCT01262898|54581673|FG003|Overall Study|Withdrawal by Subject|0|||
27924729|NCT01262820|54581686|FG000|Overall Study|Adverse Event|5|||
27924730|NCT01262820|54581686|FG000|Overall Study|Lack of Efficacy|9|||
27924731|NCT01262820|54581686|FG000|Overall Study|Drug held for 21+ days|1|||
27924732|NCT01057810|54581692|FG000|Overall Study|Disease progression|156|||
27924733|NCT01057810|54581693|FG001|Overall Study|Disease progression|197|||
27924734|NCT01057810|54581692|FG000|Overall Study|Study drug toxicity|5|||
27924735|NCT01057810|54581693|FG001|Overall Study|Study drug toxicity|114|||
27924736|NCT01057810|54581692|FG000|Overall Study|Adverse event unrelated to study drug|13|||
27924737|NCT01057810|54581693|FG001|Overall Study|Adverse event unrelated to study drug|29|||
27924738|NCT01057810|54581692|FG000|Overall Study|Withdrawal by Subject|10|||
27924739|NCT01057810|54581693|FG001|Overall Study|Withdrawal by Subject|25|||
27924740|NCT01057810|54581692|FG000|Overall Study|Death|2|||
27924741|NCT01057810|54581693|FG001|Overall Study|Death|12|||
27924742|NCT01057810|54581692|FG000|Overall Study|Maximum clinical benefit|5|||
27924743|NCT01057810|54581693|FG001|Overall Study|Maximum clinical benefit|5|||
27924744|NCT01057810|54581692|FG000|Overall Study|Poor/non-compliance|0|||
27924745|NCT01057810|54581693|FG001|Overall Study|Poor/non-compliance|1|||
27924746|NCT01057810|54581692|FG000|Overall Study|No longer met study criteria|0|||
27924747|NCT01057810|54581693|FG001|Overall Study|No longer met study criteria|1|||
27924748|NCT01057810|54581692|FG000|Overall Study|Other|7|||
27924749|NCT01057810|54581693|FG001|Overall Study|Other|14|||
27924750|NCT01262352|54581701|FG000|Period 1|Illness after randomization|1|||
27924751|NCT01262352|54581702|FG001|Period 1|Illness after randomization|0|||
27924752|NCT01262352|54581701|FG000|Washout|Adverse Event|1|||
27924753|NCT01262352|54581702|FG001|Washout|Adverse Event|1|||
27924754|NCT01262352|54581701|FG000|Washout|Extended Washout|0|||
27924755|NCT01262352|54581702|FG001|Washout|Extended Washout|1|||
27924756|NCT01299272|54581708|FG000|Acute Open-label (OL) Period|Remission Criteria Not Met|140|||
27924757|NCT01299272|54581709|FG001|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
27924758|NCT01299272|54581710|FG002|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
27924759|NCT01299272|54581711|FG003|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
27924760|NCT01299272|54581708|FG000|Acute Open-label (OL) Period|Adverse Event|140|||
27924761|NCT01299272|54581709|FG001|Acute Open-label (OL) Period|Adverse Event|0|||
27924762|NCT01299272|54581710|FG002|Acute Open-label (OL) Period|Adverse Event|0|||
27924763|NCT01299272|54581711|FG003|Acute Open-label (OL) Period|Adverse Event|0|||
27924764|NCT01299272|54581708|FG000|Acute Open-label (OL) Period|Withdrawal by Subject|56|||
27924765|NCT01299272|54581709|FG001|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
27924766|NCT01299272|54581710|FG002|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
27924767|NCT01299272|54581711|FG003|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
27924768|NCT01299272|54581708|FG000|Acute Open-label (OL) Period|Protocol Violation|36|||
27924769|NCT01299272|54581709|FG001|Acute Open-label (OL) Period|Protocol Violation|0|||
27924770|NCT01299272|54581710|FG002|Acute Open-label (OL) Period|Protocol Violation|0|||
27924771|NCT01299272|54581711|FG003|Acute Open-label (OL) Period|Protocol Violation|0|||
27924772|NCT01299272|54581708|FG000|Acute Open-label (OL) Period|Lost to Follow-up|14|||
27924773|NCT01299272|54581709|FG001|Acute Open-label (OL) Period|Lost to Follow-up|0|||
27924774|NCT01299272|54581710|FG002|Acute Open-label (OL) Period|Lost to Follow-up|0|||
27924775|NCT01299272|54581711|FG003|Acute Open-label (OL) Period|Lost to Follow-up|0|||
27924776|NCT01299272|54581708|FG000|Acute Open-label (OL) Period|Sponsor Decision|13|||
27924777|NCT01299272|54581709|FG001|Acute Open-label (OL) Period|Sponsor Decision|0|||
27924778|NCT01299272|54581710|FG002|Acute Open-label (OL) Period|Sponsor Decision|0|||
27924779|NCT01299272|54581711|FG003|Acute Open-label (OL) Period|Sponsor Decision|0|||
27924780|NCT01299272|54581708|FG000|Acute Open-label (OL) Period|Lack of Efficacy|10|||
27924781|NCT01299272|54581709|FG001|Acute Open-label (OL) Period|Lack of Efficacy|0|||
27924782|NCT01299272|54581710|FG002|Acute Open-label (OL) Period|Lack of Efficacy|0|||
27924783|NCT01299272|54581711|FG003|Acute Open-label (OL) Period|Lack of Efficacy|0|||
27924784|NCT01299272|54581708|FG000|Acute Open-label (OL) Period|Physician Decision|5|||
27924785|NCT01299272|54581709|FG001|Acute Open-label (OL) Period|Physician Decision|0|||
27924786|NCT01299272|54581710|FG002|Acute Open-label (OL) Period|Physician Decision|0|||
27924787|NCT01299272|54581711|FG003|Acute Open-label (OL) Period|Physician Decision|0|||
27924788|NCT01299272|54581708|FG000|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
27924789|NCT01299272|54581709|FG001|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80|||
27924790|NCT01299272|54581710|FG002|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
27924791|NCT01299272|54581711|FG003|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
27924792|NCT01299272|54581708|FG000|Stabilization Open-label (OL) Period|Protocol Violation|0|||
27924793|NCT01299272|54581709|FG001|Stabilization Open-label (OL) Period|Protocol Violation|44|||
27924794|NCT01299272|54581710|FG002|Stabilization Open-label (OL) Period|Protocol Violation|0|||
27924795|NCT01299272|54581711|FG003|Stabilization Open-label (OL) Period|Protocol Violation|0|||
27924796|NCT01299272|54581708|FG000|Stabilization Open-label (OL) Period|Adverse Event|0|||
27924797|NCT01299272|54581709|FG001|Stabilization Open-label (OL) Period|Adverse Event|42|||
27924798|NCT01299272|54581710|FG002|Stabilization Open-label (OL) Period|Adverse Event|0|||
27924799|NCT01299272|54581711|FG003|Stabilization Open-label (OL) Period|Adverse Event|0|||
27924800|NCT01299272|54581708|FG000|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
27924801|NCT01299272|54581709|FG001|Stabilization Open-label (OL) Period|Withdrawal by Subject|42|||
27924802|NCT01299272|54581710|FG002|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
27924803|NCT01299272|54581711|FG003|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
27924804|NCT01299272|54581708|FG000|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
27924805|NCT01299272|54581709|FG001|Stabilization Open-label (OL) Period|Sponsor Decision|12|||
27924806|NCT01299272|54581710|FG002|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
27924807|NCT01299272|54581711|FG003|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
27924808|NCT01299272|54581708|FG000|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
27924809|NCT01299272|54581709|FG001|Stabilization Open-label (OL) Period|Lack of Efficacy|11|||
27924810|NCT01299272|54581710|FG002|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
27924811|NCT01299272|54581711|FG003|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
27924812|NCT01299272|54581708|FG000|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
27924813|NCT01299272|54581709|FG001|Stabilization Open-label (OL) Period|Lost to Follow-up|9|||
27924814|NCT01299272|54581710|FG002|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
27924815|NCT01299272|54581711|FG003|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
27924816|NCT01299272|54581708|FG000|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
27924817|NCT01299272|54581709|FG001|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6|||
27924818|NCT01299272|54581710|FG002|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
27924819|NCT01299272|54581711|FG003|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
27924820|NCT01299272|54581708|FG000|Stabilization Open-label (OL) Period|Physician Decision|0|||
27924821|NCT01299272|54581709|FG001|Stabilization Open-label (OL) Period|Physician Decision|3|||
27924822|NCT01299272|54581710|FG002|Stabilization Open-label (OL) Period|Physician Decision|0|||
27924823|NCT01299272|54581711|FG003|Stabilization Open-label (OL) Period|Physician Decision|0|||
27924824|NCT01299272|54581708|FG000|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
27924825|NCT01299272|54581709|FG001|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
27924826|NCT01299272|54581710|FG002|Double-blind (DB) Randomized Period|Withdrawal by Subject|22|||
27924827|NCT01299272|54581711|FG003|Double-blind (DB) Randomized Period|Withdrawal by Subject|15|||
27924828|NCT01299272|54581708|FG000|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
27924829|NCT01299272|54581709|FG001|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
27924830|NCT01299272|54581710|FG002|Double-blind (DB) Randomized Period|Lack of Efficacy|20|||
27924831|NCT01299272|54581711|FG003|Double-blind (DB) Randomized Period|Lack of Efficacy|10|||
27924832|NCT01299272|54581708|FG000|Double-blind (DB) Randomized Period|Adverse Event|0|||
27924833|NCT01299272|54581709|FG001|Double-blind (DB) Randomized Period|Adverse Event|0|||
27924834|NCT01299272|54581710|FG002|Double-blind (DB) Randomized Period|Adverse Event|8|||
27924835|NCT01299272|54581711|FG003|Double-blind (DB) Randomized Period|Adverse Event|9|||
27924836|NCT01299272|54581708|FG000|Double-blind (DB) Randomized Period|Protocol Violation|0|||
27924837|NCT01299272|54581709|FG001|Double-blind (DB) Randomized Period|Protocol Violation|0|||
27924838|NCT01299272|54581710|FG002|Double-blind (DB) Randomized Period|Protocol Violation|8|||
27924839|NCT01299272|54581711|FG003|Double-blind (DB) Randomized Period|Protocol Violation|7|||
27924840|NCT01299272|54581708|FG000|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
27924841|NCT01299272|54581709|FG001|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
27924842|NCT01299272|54581710|FG002|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
27924843|NCT01299272|54581711|FG003|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
27924844|NCT01299272|54581708|FG000|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
27924845|NCT01299272|54581709|FG001|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
27924846|NCT01299272|54581710|FG002|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4|||
27924847|NCT01299272|54581711|FG003|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10|||
27924848|NCT01299272|54581708|FG000|Double-blind (DB) Randomized Period|Physician Decision|0|||
27924849|NCT01299272|54581709|FG001|Double-blind (DB) Randomized Period|Physician Decision|0|||
27924850|NCT01299272|54581710|FG002|Double-blind (DB) Randomized Period|Physician Decision|2|||
27924851|NCT01299272|54581711|FG003|Double-blind (DB) Randomized Period|Physician Decision|1|||
27924852|NCT01299272|54581708|FG000|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
27924853|NCT01299272|54581709|FG001|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
27924854|NCT01299272|54581710|FG002|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
27924855|NCT01299272|54581711|FG003|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
27924856|NCT01299116|54581728|FG000|Overall Study|Lost to Follow-up|65|||
27924857|NCT01299116|54581729|FG001|Overall Study|Lost to Follow-up|9|||
27924858|NCT01299116|54581730|FG002|Overall Study|Lost to Follow-up|11|||
27924859|NCT01299038|54581743|FG000|Overall Study|Withdrawal by Subject|1|||
27924860|NCT01299038|54581744|FG001|Overall Study|Withdrawal by Subject|0|||
27924861|NCT01298648|54581750|FG000|Overall Study|Withdrawal by Subject|2|||
27924862|NCT01298648|54581750|FG000|Overall Study|Lost to Follow-up|21|||
27924863|NCT01261338|54581756|FG000|Overall Study|Withdrawal by Subject|3|||
27924864|NCT01261338|54581757|FG001|Overall Study|Withdrawal by Subject|2|||
27924865|NCT01260948|54581765|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
27924866|NCT01260948|54581766|FG001|Washout of 28 Days|Withdrawal by Subject|3|||
27924867|NCT01260948|54581765|FG000|Second Intervention|Emesis|0|||
27924868|NCT01260948|54581766|FG001|Second Intervention|Emesis|1|||
27924869|NCT01025284|54581775|FG000|Overall Study|Investigator Decision|0|||
27924870|NCT01025284|54581776|FG001|Overall Study|Investigator Decision|1|||
27924871|NCT01025284|54581777|FG002|Overall Study|Investigator Decision|0|||
27924872|NCT01025284|54581775|FG000|Overall Study|Withdrawal by Subject|0|||
27924873|NCT01025284|54581776|FG001|Overall Study|Withdrawal by Subject|1|||
27924874|NCT01025284|54581777|FG002|Overall Study|Withdrawal by Subject|0|||
27924875|NCT01021852|54581795|FG000|Treatment Period 1|Adverse Event|3|||
27924876|NCT01021852|54581796|FG001|Treatment Period 1|Adverse Event|1|||
27924877|NCT01021852|54581797|FG002|Treatment Period 1|Adverse Event|1|||
27924878|NCT01021852|54581798|FG003|Treatment Period 1|Adverse Event|0|||
27924879|NCT01021852|54581799|FG004|Treatment Period 1|Adverse Event|2|||
27924880|NCT01021852|54581800|FG005|Treatment Period 1|Adverse Event|2|||
27924881|NCT01021852|54581801|FG006|Treatment Period 1|Adverse Event|0|||
27924882|NCT01021852|54581802|FG007|Treatment Period 1|Adverse Event|0|||
27924883|NCT01021852|54581795|FG000|Treatment Period 1|Pregnancy|0|||
27924884|NCT01021852|54581796|FG001|Treatment Period 1|Pregnancy|0|||
27924885|NCT01021852|54581797|FG002|Treatment Period 1|Pregnancy|1|||
27924886|NCT01021852|54581798|FG003|Treatment Period 1|Pregnancy|0|||
27924887|NCT01021852|54581799|FG004|Treatment Period 1|Pregnancy|0|||
27924888|NCT01021852|54581800|FG005|Treatment Period 1|Pregnancy|0|||
27924889|NCT01021852|54581801|FG006|Treatment Period 1|Pregnancy|0|||
27924890|NCT01021852|54581802|FG007|Treatment Period 1|Pregnancy|0|||
27924891|NCT01021852|54581795|FG000|Treatment Period 1|Withdrawal by Subject|0|||
27924892|NCT01021852|54581796|FG001|Treatment Period 1|Withdrawal by Subject|0|||
27924893|NCT01021852|54581797|FG002|Treatment Period 1|Withdrawal by Subject|0|||
27924894|NCT01021852|54581798|FG003|Treatment Period 1|Withdrawal by Subject|0|||
27924895|NCT01021852|54581799|FG004|Treatment Period 1|Withdrawal by Subject|1|||
27924896|NCT01021852|54581800|FG005|Treatment Period 1|Withdrawal by Subject|0|||
27924897|NCT01021852|54581801|FG006|Treatment Period 1|Withdrawal by Subject|0|||
27924898|NCT01021852|54581802|FG007|Treatment Period 1|Withdrawal by Subject|1|||
27924899|NCT01021852|54581795|FG000|Treatment Period 1|Not Treated|0|||
27924900|NCT01021852|54581796|FG001|Treatment Period 1|Not Treated|0|||
27924901|NCT01021852|54581797|FG002|Treatment Period 1|Not Treated|0|||
27924902|NCT01021852|54581798|FG003|Treatment Period 1|Not Treated|2|||
27924903|NCT01021852|54581799|FG004|Treatment Period 1|Not Treated|0|||
27924904|NCT01021852|54581800|FG005|Treatment Period 1|Not Treated|0|||
27924905|NCT01021852|54581801|FG006|Treatment Period 1|Not Treated|0|||
27924906|NCT01021852|54581802|FG007|Treatment Period 1|Not Treated|0|||
27924907|NCT01021852|54581795|FG000|Washout Period-Placebo|Adverse Event|0|||
27924908|NCT01021852|54581796|FG001|Washout Period-Placebo|Adverse Event|0|||
27924909|NCT01021852|54581797|FG002|Washout Period-Placebo|Adverse Event|0|||
27924910|NCT01021852|54581798|FG003|Washout Period-Placebo|Adverse Event|1|||
27924911|NCT01021852|54581799|FG004|Washout Period-Placebo|Adverse Event|0|||
27924912|NCT01021852|54581800|FG005|Washout Period-Placebo|Adverse Event|1|||
27924913|NCT01021852|54581801|FG006|Washout Period-Placebo|Adverse Event|0|||
27924914|NCT01021852|54581802|FG007|Washout Period-Placebo|Adverse Event|0|||
27924915|NCT01021852|54581795|FG000|Washout Period-Placebo|Lost to Follow-up|0|||
27924916|NCT01021852|54581796|FG001|Washout Period-Placebo|Lost to Follow-up|0|||
27924917|NCT01021852|54581797|FG002|Washout Period-Placebo|Lost to Follow-up|0|||
27924918|NCT01021852|54581798|FG003|Washout Period-Placebo|Lost to Follow-up|0|||
27924919|NCT01021852|54581799|FG004|Washout Period-Placebo|Lost to Follow-up|1|||
27924920|NCT01021852|54581800|FG005|Washout Period-Placebo|Lost to Follow-up|0|||
27924921|NCT01021852|54581801|FG006|Washout Period-Placebo|Lost to Follow-up|0|||
27924922|NCT01021852|54581802|FG007|Washout Period-Placebo|Lost to Follow-up|0|||
27924923|NCT01021852|54581795|FG000|Washout Period-Placebo|Protocol Violation|0|||
27924924|NCT01021852|54581796|FG001|Washout Period-Placebo|Protocol Violation|0|||
27924925|NCT01021852|54581797|FG002|Washout Period-Placebo|Protocol Violation|0|||
27924926|NCT01021852|54581798|FG003|Washout Period-Placebo|Protocol Violation|0|||
27924927|NCT01021852|54581799|FG004|Washout Period-Placebo|Protocol Violation|0|||
27924928|NCT01021852|54581800|FG005|Washout Period-Placebo|Protocol Violation|0|||
27924929|NCT01021852|54581801|FG006|Washout Period-Placebo|Protocol Violation|1|||
27924930|NCT01021852|54581802|FG007|Washout Period-Placebo|Protocol Violation|0|||
27924931|NCT01021852|54581795|FG000|Washout Period-No Drug|Adverse Event|1|||
27924932|NCT01021852|54581796|FG001|Washout Period-No Drug|Adverse Event|0|||
27924933|NCT01021852|54581797|FG002|Washout Period-No Drug|Adverse Event|0|||
27924934|NCT01021852|54581798|FG003|Washout Period-No Drug|Adverse Event|0|||
27924935|NCT01021852|54581799|FG004|Washout Period-No Drug|Adverse Event|0|||
27924936|NCT01021852|54581800|FG005|Washout Period-No Drug|Adverse Event|1|||
27924937|NCT01021852|54581801|FG006|Washout Period-No Drug|Adverse Event|0|||
27924938|NCT01021852|54581802|FG007|Washout Period-No Drug|Adverse Event|0|||
27924939|NCT01021852|54581795|FG000|Treatment Period 2|Adverse Event|0|||
27924940|NCT01021852|54581796|FG001|Treatment Period 2|Adverse Event|1|||
27924941|NCT01021852|54581797|FG002|Treatment Period 2|Adverse Event|0|||
27924942|NCT01021852|54581798|FG003|Treatment Period 2|Adverse Event|0|||
27924943|NCT01021852|54581799|FG004|Treatment Period 2|Adverse Event|1|||
27924944|NCT01021852|54581800|FG005|Treatment Period 2|Adverse Event|0|||
27924945|NCT01021852|54581801|FG006|Treatment Period 2|Adverse Event|1|||
27924946|NCT01021852|54581802|FG007|Treatment Period 2|Adverse Event|0|||
27924947|NCT01021852|54581795|FG000|Treatment Period 2|Lack of Efficacy|0|||
27924948|NCT01021852|54581796|FG001|Treatment Period 2|Lack of Efficacy|0|||
27924949|NCT01021852|54581797|FG002|Treatment Period 2|Lack of Efficacy|0|||
27924950|NCT01021852|54581798|FG003|Treatment Period 2|Lack of Efficacy|0|||
27924951|NCT01021852|54581799|FG004|Treatment Period 2|Lack of Efficacy|0|||
27924952|NCT01021852|54581800|FG005|Treatment Period 2|Lack of Efficacy|1|||
27924953|NCT01021852|54581801|FG006|Treatment Period 2|Lack of Efficacy|0|||
27924954|NCT01021852|54581802|FG007|Treatment Period 2|Lack of Efficacy|0|||
27924955|NCT01021852|54581795|FG000|Treatment Period 2|Physician Decision|0|||
27924956|NCT01021852|54581796|FG001|Treatment Period 2|Physician Decision|0|||
27924957|NCT01021852|54581797|FG002|Treatment Period 2|Physician Decision|1|||
27924958|NCT01021852|54581798|FG003|Treatment Period 2|Physician Decision|0|||
27924959|NCT01021852|54581799|FG004|Treatment Period 2|Physician Decision|0|||
27924960|NCT01021852|54581800|FG005|Treatment Period 2|Physician Decision|0|||
27924961|NCT01021852|54581801|FG006|Treatment Period 2|Physician Decision|0|||
27924962|NCT01021852|54581802|FG007|Treatment Period 2|Physician Decision|0|||
27924963|NCT01021852|54581795|FG000|Treatment Period 2|Protocol Violation|0|||
27924964|NCT01021852|54581796|FG001|Treatment Period 2|Protocol Violation|0|||
27924965|NCT01021852|54581797|FG002|Treatment Period 2|Protocol Violation|0|||
27924966|NCT01021852|54581798|FG003|Treatment Period 2|Protocol Violation|0|||
27924967|NCT01021852|54581799|FG004|Treatment Period 2|Protocol Violation|1|||
27924968|NCT01021852|54581800|FG005|Treatment Period 2|Protocol Violation|0|||
27924969|NCT01021852|54581801|FG006|Treatment Period 2|Protocol Violation|1|||
27924970|NCT01021852|54581802|FG007|Treatment Period 2|Protocol Violation|0|||
27924971|NCT01021852|54581795|FG000|Treatment Period 2|Withdrawal by Subject|0|||
27924972|NCT01021852|54581796|FG001|Treatment Period 2|Withdrawal by Subject|0|||
27924973|NCT01021852|54581797|FG002|Treatment Period 2|Withdrawal by Subject|0|||
27924974|NCT01021852|54581798|FG003|Treatment Period 2|Withdrawal by Subject|0|||
27924975|NCT01021852|54581799|FG004|Treatment Period 2|Withdrawal by Subject|0|||
27924976|NCT01021852|54581800|FG005|Treatment Period 2|Withdrawal by Subject|0|||
27924977|NCT01021852|54581801|FG006|Treatment Period 2|Withdrawal by Subject|1|||
27924978|NCT01021852|54581802|FG007|Treatment Period 2|Withdrawal by Subject|2|||
27924979|NCT01056718|54581816|FG000|Overall Study|Withdrawal by Subject|2|||
27924980|NCT01056718|54581816|FG000|Overall Study|Ischemia on baseline stress test|1|||
27924981|NCT01298570|54581823|FG000|Overall Study|Disease progression, relapse during acti|64|||
27924982|NCT01298570|54581824|FG001|Overall Study|Disease progression, relapse during acti|40|||
27924983|NCT01298570|54581823|FG000|Overall Study|Adverse Event|20|||
27924984|NCT01298570|54581824|FG001|Overall Study|Adverse Event|2|||
27924985|NCT01298570|54581823|FG000|Overall Study|Withdrawal by Subject|21|||
27924986|NCT01298570|54581824|FG001|Overall Study|Withdrawal by Subject|6|||
27924987|NCT01298570|54581823|FG000|Overall Study|Treatment delay > 4 weeks|4|||
27924988|NCT01298570|54581824|FG001|Overall Study|Treatment delay > 4 weeks|5|||
27924989|NCT01298570|54581823|FG000|Overall Study|Physician Decision|4|||
27924990|NCT01298570|54581824|FG001|Overall Study|Physician Decision|2|||
27924991|NCT01298570|54581823|FG000|Overall Study|Other complicating disease|2|||
27924992|NCT01298570|54581824|FG001|Overall Study|Other complicating disease|1|||
27924993|NCT01298570|54581823|FG000|Overall Study|Surgery|2|||
27924994|NCT01298570|54581824|FG001|Overall Study|Surgery|1|||
27924995|NCT01298570|54581823|FG000|Overall Study|Symptomatic progression/deterioration|3|||
27924996|NCT01298570|54581824|FG001|Overall Study|Symptomatic progression/deterioration|2|||
27924997|NCT01298570|54581823|FG000|Overall Study|Death|0|||
27924998|NCT01298570|54581824|FG001|Overall Study|Death|1|||
27924999|NCT01298570|54581823|FG000|Overall Study|Ineligibility|0|||
27925000|NCT01298570|54581824|FG001|Overall Study|Ineligibility|1|||
27925001|NCT01259856|54581832|FG000|Overall Study|Adverse Event|12|||
27925002|NCT01259856|54581833|FG001|Overall Study|Adverse Event|9|||
27925003|NCT01259856|54581832|FG000|Overall Study|Death|0|||
27925004|NCT01259856|54581833|FG001|Overall Study|Death|1|||
27925005|NCT01259856|54581832|FG000|Overall Study|Lack of Efficacy|3|||
27925006|NCT01259856|54581833|FG001|Overall Study|Lack of Efficacy|1|||
27925007|NCT01259856|54581832|FG000|Overall Study|Lost to Follow-up|1|||
27925008|NCT01259856|54581833|FG001|Overall Study|Lost to Follow-up|1|||
27925009|NCT01259856|54581832|FG000|Overall Study|Physician Decision|2|||
27925010|NCT01259856|54581833|FG001|Overall Study|Physician Decision|1|||
27925011|NCT01259856|54581832|FG000|Overall Study|Withdrawal by Subject|9|||
27925012|NCT01259856|54581833|FG001|Overall Study|Withdrawal by Subject|10|||
27925013|NCT01259856|54581832|FG000|Overall Study|Treatment never started|0|||
27925014|NCT01259856|54581833|FG001|Overall Study|Treatment never started|6|||
27925015|NCT01259856|54581832|FG000|Overall Study|Study closure by sponsor|40|||
27925016|NCT01259856|54581833|FG001|Overall Study|Study closure by sponsor|41|||
27925017|NCT01259856|54581832|FG000|Overall Study|Patient developed other disease|0|||
27925018|NCT01259856|54581833|FG001|Overall Study|Patient developed other disease|1|||
27925019|NCT01259856|54581832|FG000|Overall Study|Transfer to another study|0|||
27925020|NCT01259856|54581833|FG001|Overall Study|Transfer to another study|1|||
27925021|NCT01259856|54581832|FG000|Overall Study|Unknown/missing|2|||
27925022|NCT01259856|54581833|FG001|Overall Study|Unknown/missing|2|||
27925023|NCT01020838|54581839|FG000|Overall Study|Death|90|||
27925024|NCT01020838|54581839|FG000|Overall Study|Adverse Event|1|||
27925025|NCT01020838|54581839|FG000|Overall Study|Withdrawal by Subject|9|||
27925026|NCT01020838|54581839|FG000|Overall Study|Lost to Follow-up|6|||
27925027|NCT01020838|54581839|FG000|Overall Study|Most common: Study ended by sponsor|77|||
27925028|NCT01259466|54581854|FG000|Overall Study|Withdrawal by Subject|1|||
27925029|NCT01259466|54581855|FG001|Overall Study|Withdrawal by Subject|9|||
27925030|NCT01259388|54581863|FG000|Overall Study|Adverse Event|3|||
27925031|NCT01259388|54581864|FG001|Overall Study|Adverse Event|0|||
27925032|NCT01259388|54581863|FG000|Overall Study|Withdrawal by Subject|1|||
27925033|NCT01259388|54581864|FG001|Overall Study|Withdrawal by Subject|1|||
27925034|NCT01259388|54581863|FG000|Overall Study|Physician Decision|1|||
27745774|NCT02711137|54195484|FG011|Overall Study|Lost to Follow-up|0|||
27745775|NCT02711137|54195485|FG012|Overall Study|Lost to Follow-up|0|||
27745776|NCT02711137|54195486|FG013|Overall Study|Lost to Follow-up|0|||
27745777|NCT02711137|54195487|FG014|Overall Study|Lost to Follow-up|0|||
27745778|NCT02710045|54195527|FG000|Overall Study|Death|1|||
27745779|NCT02710045|54195528|FG001|Overall Study|Death|2|||
27745780|NCT02710045|54195529|FG002|Overall Study|Death|0|||
27745781|NCT02710045|54195527|FG000|Overall Study|Withdrawal by Subject|6|||
27745782|NCT02710045|54195528|FG001|Overall Study|Withdrawal by Subject|6|||
27745783|NCT02710045|54195529|FG002|Overall Study|Withdrawal by Subject|2|||
27745784|NCT02710045|54195527|FG000|Overall Study|Protocol Violation|1|||
27745785|NCT02710045|54195528|FG001|Overall Study|Protocol Violation|2|||
27745786|NCT02710045|54195529|FG002|Overall Study|Protocol Violation|3|||
27745787|NCT02710045|54195527|FG000|Overall Study|Lost to Follow-up|3|||
27745788|NCT02710045|54195528|FG001|Overall Study|Lost to Follow-up|6|||
27745789|NCT02710045|54195529|FG002|Overall Study|Lost to Follow-up|7|||
27745790|NCT02710045|54195527|FG000|Overall Study|Physician Decision|0|||
27745791|NCT02710045|54195528|FG001|Overall Study|Physician Decision|0|||
27745792|NCT02710045|54195529|FG002|Overall Study|Physician Decision|1|||
27745793|NCT02710045|54195527|FG000|Overall Study|Poor Attendance|0|||
27745794|NCT02710045|54195528|FG001|Overall Study|Poor Attendance|1|||
27745795|NCT02710045|54195529|FG002|Overall Study|Poor Attendance|0|||
27745796|NCT02714153|54195537|FG000|Overall Study|Death|1|||
27745797|NCT04369469|54195543|FG000|Overall Study|Lost to Follow-up|2|||
27745798|NCT04369469|54195544|FG001|Overall Study|Lost to Follow-up|4|||
27745799|NCT04369469|54195543|FG000|Overall Study|Physician Decision|2|||
27745800|NCT04369469|54195544|FG001|Overall Study|Physician Decision|1|||
27745801|NCT04369469|54195543|FG000|Overall Study|Withdrawal by Subject|2|||
27745802|NCT04369469|54195544|FG001|Overall Study|Withdrawal by Subject|3|||
27745803|NCT04369469|54195543|FG000|Overall Study|Adverse Event|1|||
27745804|NCT04369469|54195544|FG001|Overall Study|Adverse Event|0|||
27745805|NCT04369469|54195543|FG000|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|2|||
27745806|NCT04369469|54195544|FG001|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|0|||
27745807|NCT04369469|54195543|FG000|Overall Study|Not Qualified due to History of Anaphylaxis|1|||
27745808|NCT04369469|54195544|FG001|Overall Study|Not Qualified due to History of Anaphylaxis|0|||
27745809|NCT04369469|54195543|FG000|Overall Study|Unable to Provide Consent|0|||
27745810|NCT04369469|54195544|FG001|Overall Study|Unable to Provide Consent|1|||
27745811|NCT01670097|54195565|FG000|Overall Study|Started Phase 1 cancer treatment|1|||
27745812|NCT01670097|54195566|FG001|Overall Study|Started Phase 1 cancer treatment|0|||
27745813|NCT01670097|54195565|FG000|Overall Study|Study burden|1|||
27745814|NCT01670097|54195566|FG001|Overall Study|Study burden|0|||
27745815|NCT01670097|54195565|FG000|Overall Study|COPD exacerbation|0|||
27745816|NCT01670097|54195566|FG001|Overall Study|COPD exacerbation|1|||
27745817|NCT01670097|54195565|FG000|Overall Study|Neutropenia|0|||
27745818|NCT01670097|54195566|FG001|Overall Study|Neutropenia|1|||
27745819|NCT01670097|54195565|FG000|Overall Study|Clinical deterioration|0|||
27745820|NCT01670097|54195566|FG001|Overall Study|Clinical deterioration|1|||
27745821|NCT01670097|54195565|FG000|Overall Study|Disease progression|0|||
27745822|NCT01670097|54195566|FG001|Overall Study|Disease progression|1|||
27745823|NCT01670019|54195574|FG000|Overall Study|Adverse Event|3|||
27745824|NCT01670019|54195575|FG001|Overall Study|Adverse Event|0|||
27745825|NCT01670019|54195574|FG000|Overall Study|Withdrawal by Subject|6|||
27745826|NCT01670019|54195575|FG001|Overall Study|Withdrawal by Subject|0|||
27745827|NCT01669629|54195581|FG000|Period 1|protocol deviation|1|||
27745828|NCT01669629|54195582|FG001|Period 1|protocol deviation|2|||
27745829|NCT00701051|54195590|FG000|Screening|Failed Screening|40|||
27925035|NCT01259388|54581864|FG001|Overall Study|Physician Decision|0|||
27925036|NCT01298492|54581870|FG000|Overall Study|Death|2|||
27925037|NCT01298492|54581870|FG000|Overall Study|Insufficient Clinical Response|22|||
27925038|NCT01298492|54581870|FG000|Overall Study|Lost to Follow-up|12|||
27925039|NCT01298492|54581870|FG000|Overall Study|Withdrawal by Subject|47|||
27925040|NCT01298492|54581870|FG000|Overall Study|Other (Unspecified)|7|||
27925041|NCT01298492|54581870|FG000|Overall Study|Withdrawn Due to Pregnancy|1|||
27925042|NCT01298492|54581870|FG000|Overall Study|Protocol Violation|2|||
27925043|NCT01298492|54581870|FG000|Overall Study|Adverse Event(Related to Study Drug)|8|||
27925044|NCT01298492|54581870|FG000|Overall Study|Adverse Event(Not Related to Study Drug)|18|||
27925045|NCT01297322|54581876|FG000|Overall Study|Lost to Follow-up|1|||
27925046|NCT01297322|54581877|FG001|Overall Study|Lost to Follow-up|0|||
27925047|NCT01297322|54581876|FG000|Overall Study|Withdrawal by Subject|0|||
27925048|NCT01297322|54581877|FG001|Overall Study|Withdrawal by Subject|1|||
27925049|NCT01297322|54581876|FG000|Overall Study|Protocol Violation|0|||
27925050|NCT01297322|54581877|FG001|Overall Study|Protocol Violation|3|||
27925051|NCT01297244|54581886|FG000|Overall Study|Progressive disease|22|||
27925052|NCT01297244|54581887|FG001|Overall Study|Progressive disease|3|||
27925053|NCT01297244|54581886|FG000|Overall Study|Adverse Event|9|||
27925054|NCT01297244|54581887|FG001|Overall Study|Adverse Event|1|||
27925055|NCT01297244|54581886|FG000|Overall Study|Death|1|||
27925056|NCT01297244|54581887|FG001|Overall Study|Death|1|||
27925057|NCT01297244|54581886|FG000|Overall Study|Clinical progression|1|||
27925058|NCT01297244|54581887|FG001|Overall Study|Clinical progression|1|||
27925059|NCT01297244|54581886|FG000|Overall Study|Withdrawal by Subject|2|||
27925060|NCT01297244|54581887|FG001|Overall Study|Withdrawal by Subject|0|||
27925061|NCT03456726|54581900|FG000|Overall Study|Disease Progression|6|||
27925062|NCT03456726|54581901|FG001|Overall Study|Disease Progression|1|||
27925063|NCT03456726|54581900|FG000|Overall Study|Adverse Event|4|||
27925064|NCT03456726|54581901|FG001|Overall Study|Adverse Event|2|||
27925065|NCT03456726|54581900|FG000|Overall Study|Withdrawal by Subject|1|||
27925066|NCT03456726|54581901|FG001|Overall Study|Withdrawal by Subject|0|||
27925067|NCT03456726|54581900|FG000|Overall Study|Discontinued from study due to switch to commercial tazemetostat|6|||
27925068|NCT03456726|54581901|FG001|Overall Study|Discontinued from study due to switch to commercial tazemetostat|0|||
27925069|NCT03181932|54581909|FG000|Period 1 (Double-blind Period)|Adverse Event|5|||
27925070|NCT03181932|54581910|FG001|Period 1 (Double-blind Period)|Adverse Event|1|||
27925071|NCT03181932|54581909|FG000|Period 1 (Double-blind Period)|Lost to Follow-up|0|||
27925072|NCT03181932|54581910|FG001|Period 1 (Double-blind Period)|Lost to Follow-up|1|||
27925073|NCT03181932|54581909|FG000|Period 1 (Double-blind Period)|Protocol Violation|1|||
27925074|NCT03181932|54581910|FG001|Period 1 (Double-blind Period)|Protocol Violation|2|||
27925075|NCT03181932|54581909|FG000|Period 1 (Double-blind Period)|Withdrawal by Subject|5|||
27925076|NCT03181932|54581910|FG001|Period 1 (Double-blind Period)|Withdrawal by Subject|9|||
27925077|NCT03181932|54581909|FG000|Period 2 (Open-label Period)|Adverse Event|1|||
27925078|NCT03181932|54581910|FG001|Period 2 (Open-label Period)|Adverse Event|6|||
27925079|NCT03181932|54581909|FG000|Period 2 (Open-label Period)|Lost to Follow-up|0|||
27925080|NCT03181932|54581910|FG001|Period 2 (Open-label Period)|Lost to Follow-up|1|||
27925081|NCT03181932|54581909|FG000|Period 2 (Open-label Period)|Protocol Violation|3|||
27925082|NCT03181932|54581910|FG001|Period 2 (Open-label Period)|Protocol Violation|1|||
27745830|NCT00701051|54195591|FG001|Screening|Failed Screening|0|||
27745831|NCT00701051|54195592|FG002|Screening|Failed Screening|0|||
27745832|NCT00701051|54195590|FG000|Screening|Time conflicts|19|||
27745833|NCT00701051|54195591|FG001|Screening|Time conflicts|0|||
27745834|NCT00701051|54195592|FG002|Screening|Time conflicts|0|||
27745835|NCT00701051|54195590|FG000|Exercise Intervention|time conflict; non-study related illness|0|||
27745836|NCT00701051|54195591|FG001|Exercise Intervention|time conflict; non-study related illness|5|||
27745837|NCT00701051|54195592|FG002|Exercise Intervention|time conflict; non-study related illness|3|||
27745838|NCT00700817|54195603|FG000|Week 0-26 (Main Period)|Adverse Event|14|||
27745839|NCT00700817|54195604|FG001|Week 0-26 (Main Period)|Adverse Event|15|||
27745840|NCT00700817|54195605|FG002|Week 0-26 (Main Period)|Adverse Event|4|||
27745841|NCT00700817|54195606|FG003|Week 0-26 (Main Period)|Adverse Event|0|||
27745842|NCT00700817|54195607|FG004|Week 0-26 (Main Period)|Adverse Event|0|||
27745843|NCT00700817|54195603|FG000|Week 0-26 (Main Period)|Lack of Efficacy|4|||
27745844|NCT00700817|54195604|FG001|Week 0-26 (Main Period)|Lack of Efficacy|0|||
27745845|NCT00700817|54195605|FG002|Week 0-26 (Main Period)|Lack of Efficacy|4|||
27745846|NCT00700817|54195606|FG003|Week 0-26 (Main Period)|Lack of Efficacy|0|||
27745847|NCT00700817|54195607|FG004|Week 0-26 (Main Period)|Lack of Efficacy|0|||
27745848|NCT00700817|54195603|FG000|Week 0-26 (Main Period)|Protocol Violation|14|||
27745849|NCT00700817|54195604|FG001|Week 0-26 (Main Period)|Protocol Violation|4|||
27745850|NCT00700817|54195605|FG002|Week 0-26 (Main Period)|Protocol Violation|4|||
27925083|NCT03181932|54581909|FG000|Period 2 (Open-label Period)|Withdrawal by Subject|2|||
27925084|NCT03181932|54581910|FG001|Period 2 (Open-label Period)|Withdrawal by Subject|5|||
27925085|NCT03181932|54581909|FG000|Period 2 (Open-label Period)|Reason missing|2|||
27925086|NCT03181932|54581910|FG001|Period 2 (Open-label Period)|Reason missing|0|||
27925087|NCT02864862|54581920|FG000|Overall Study|Lost to Follow-up|1|||
27925088|NCT02864862|54581921|FG001|Overall Study|Lost to Follow-up|0|||
27925089|NCT02864862|54581922|FG002|Overall Study|Lost to Follow-up|1|||
27925090|NCT02864862|54581920|FG000|Overall Study|Protocol Violation|0|||
27925091|NCT02864862|54581921|FG001|Overall Study|Protocol Violation|0|||
27925092|NCT02864862|54581922|FG002|Overall Study|Protocol Violation|1|||
27925093|NCT01598298|54581934|FG000|Overall Study|Not eligible|5|||
27925094|NCT01598298|54581935|FG001|Overall Study|Not eligible|5|||
27925095|NCT01598298|54581934|FG000|Overall Study|Adverse Event|21|||
27925096|NCT01598298|54581935|FG001|Overall Study|Adverse Event|19|||
27925097|NCT01598298|54581934|FG000|Overall Study|Progression/relapse|0|||
27925098|NCT01598298|54581935|FG001|Overall Study|Progression/relapse|2|||
27925099|NCT01598298|54581934|FG000|Overall Study|Withdrawal by Subject|10|||
27925100|NCT01598298|54581935|FG001|Overall Study|Withdrawal by Subject|15|||
27925101|NCT01598298|54581934|FG000|Overall Study|Other reason (not protocol specified)|4|||
27925102|NCT01598298|54581935|FG001|Overall Study|Other reason (not protocol specified)|0|||
27925103|NCT01235949|54581959|FG000|Primary Phase|Migrated/moved from study area|1|||
27925104|NCT01235949|54581960|FG001|Primary Phase|Migrated/moved from study area|1|||
27925105|NCT01235949|54581961|FG002|Primary Phase|Migrated/moved from study area|0|||
27925106|NCT01235949|54581962|FG003|Primary Phase|Migrated/moved from study area|0|||
27925107|NCT01235949|54581963|FG004|Primary Phase|Migrated/moved from study area|1|||
27925108|NCT01235949|54581964|FG005|Primary Phase|Migrated/moved from study area|2|||
27925109|NCT01235949|54581965|FG006|Primary Phase|Migrated/moved from study area|0|||
27925110|NCT01235949|54581966|FG007|Primary Phase|Migrated/moved from study area|0|||
27925111|NCT01235949|54581967|FG008|Primary Phase|Migrated/moved from study area|0|||
27925112|NCT01235949|54581968|FG009|Primary Phase|Migrated/moved from study area|0|||
27925113|NCT01235949|54581969|FG010|Primary Phase|Migrated/moved from study area|0|||
27925114|NCT01235949|54581970|FG011|Primary Phase|Migrated/moved from study area|0|||
27925115|NCT01235949|54581971|FG012|Primary Phase|Migrated/moved from study area|0|||
27925116|NCT01235949|54581972|FG013|Primary Phase|Migrated/moved from study area|0|||
27925117|NCT01235949|54581973|FG014|Primary Phase|Migrated/moved from study area|0|||
27925118|NCT01235949|54581974|FG015|Primary Phase|Migrated/moved from study area|0|||
27925119|NCT01235949|54581975|FG016|Primary Phase|Migrated/moved from study area|0|||
27925120|NCT01235949|54581976|FG017|Primary Phase|Migrated/moved from study area|0|||
27925121|NCT01235949|54581959|FG000|Primary Phase|Adverse Event|0|||
27925122|NCT01235949|54581960|FG001|Primary Phase|Adverse Event|0|||
27925123|NCT01235949|54581961|FG002|Primary Phase|Adverse Event|0|||
27925124|NCT01235949|54581962|FG003|Primary Phase|Adverse Event|1|||
27925125|NCT01235949|54581963|FG004|Primary Phase|Adverse Event|0|||
27925126|NCT01235949|54581964|FG005|Primary Phase|Adverse Event|0|||
27925127|NCT01235949|54581965|FG006|Primary Phase|Adverse Event|0|||
27925128|NCT01235949|54581966|FG007|Primary Phase|Adverse Event|0|||
27925129|NCT01235949|54581967|FG008|Primary Phase|Adverse Event|0|||
27925130|NCT01235949|54581968|FG009|Primary Phase|Adverse Event|0|||
27925131|NCT01235949|54581969|FG010|Primary Phase|Adverse Event|0|||
27925132|NCT01235949|54581970|FG011|Primary Phase|Adverse Event|0|||
27925133|NCT01235949|54581971|FG012|Primary Phase|Adverse Event|0|||
27925134|NCT01235949|54581972|FG013|Primary Phase|Adverse Event|0|||
27925135|NCT01235949|54581973|FG014|Primary Phase|Adverse Event|0|||
27925136|NCT01235949|54581974|FG015|Primary Phase|Adverse Event|0|||
27925137|NCT01235949|54581975|FG016|Primary Phase|Adverse Event|0|||
27925138|NCT01235949|54581976|FG017|Primary Phase|Adverse Event|0|||
27925139|NCT01235949|54581959|FG000|Primary Phase|Withdrawal by Subject|3|||
27925140|NCT01235949|54581960|FG001|Primary Phase|Withdrawal by Subject|2|||
27925141|NCT01235949|54581961|FG002|Primary Phase|Withdrawal by Subject|2|||
27925142|NCT01235949|54581962|FG003|Primary Phase|Withdrawal by Subject|0|||
27925143|NCT01235949|54581963|FG004|Primary Phase|Withdrawal by Subject|0|||
27925144|NCT01235949|54581964|FG005|Primary Phase|Withdrawal by Subject|3|||
27925145|NCT01235949|54581965|FG006|Primary Phase|Withdrawal by Subject|0|||
27925146|NCT01235949|54581966|FG007|Primary Phase|Withdrawal by Subject|0|||
27925147|NCT01235949|54581967|FG008|Primary Phase|Withdrawal by Subject|0|||
27925148|NCT01235949|54581968|FG009|Primary Phase|Withdrawal by Subject|0|||
27925149|NCT01235949|54581969|FG010|Primary Phase|Withdrawal by Subject|0|||
27925150|NCT01235949|54581970|FG011|Primary Phase|Withdrawal by Subject|0|||
27925151|NCT01235949|54581971|FG012|Primary Phase|Withdrawal by Subject|0|||
27925152|NCT01235949|54581972|FG013|Primary Phase|Withdrawal by Subject|0|||
27925153|NCT01235949|54581973|FG014|Primary Phase|Withdrawal by Subject|0|||
27925154|NCT01235949|54581974|FG015|Primary Phase|Withdrawal by Subject|0|||
27925155|NCT01235949|54581975|FG016|Primary Phase|Withdrawal by Subject|0|||
27925156|NCT01235949|54581976|FG017|Primary Phase|Withdrawal by Subject|0|||
27925157|NCT01235949|54581959|FG000|Primary Phase|Lost to Follow-up|0|||
27925158|NCT01235949|54581960|FG001|Primary Phase|Lost to Follow-up|0|||
27925159|NCT01235949|54581961|FG002|Primary Phase|Lost to Follow-up|1|||
27925160|NCT01235949|54581962|FG003|Primary Phase|Lost to Follow-up|1|||
27925161|NCT01235949|54581963|FG004|Primary Phase|Lost to Follow-up|0|||
27925162|NCT01235949|54581964|FG005|Primary Phase|Lost to Follow-up|2|||
27925163|NCT01235949|54581965|FG006|Primary Phase|Lost to Follow-up|0|||
27925164|NCT01235949|54581966|FG007|Primary Phase|Lost to Follow-up|0|||
27925165|NCT01235949|54581967|FG008|Primary Phase|Lost to Follow-up|0|||
27925166|NCT01235949|54581968|FG009|Primary Phase|Lost to Follow-up|0|||
27925167|NCT01235949|54581969|FG010|Primary Phase|Lost to Follow-up|0|||
27925168|NCT01235949|54581970|FG011|Primary Phase|Lost to Follow-up|0|||
27925169|NCT01235949|54581971|FG012|Primary Phase|Lost to Follow-up|0|||
27925170|NCT01235949|54581972|FG013|Primary Phase|Lost to Follow-up|0|||
27925171|NCT01235949|54581973|FG014|Primary Phase|Lost to Follow-up|0|||
27925172|NCT01235949|54581974|FG015|Primary Phase|Lost to Follow-up|0|||
27925173|NCT01235949|54581975|FG016|Primary Phase|Lost to Follow-up|0|||
27925174|NCT01235949|54581976|FG017|Primary Phase|Lost to Follow-up|0|||
27925175|NCT01235949|54581959|FG000|Booster Phase|Migrated/moved from study area|0|||
27925176|NCT01235949|54581960|FG001|Booster Phase|Migrated/moved from study area|0|||
27925177|NCT01235949|54581961|FG002|Booster Phase|Migrated/moved from study area|0|||
27925178|NCT01235949|54581962|FG003|Booster Phase|Migrated/moved from study area|0|||
27925179|NCT01235949|54581963|FG004|Booster Phase|Migrated/moved from study area|0|||
27925180|NCT01235949|54581964|FG005|Booster Phase|Migrated/moved from study area|0|||
27925181|NCT01235949|54581965|FG006|Booster Phase|Migrated/moved from study area|0|||
27925182|NCT01235949|54581966|FG007|Booster Phase|Migrated/moved from study area|0|||
27925183|NCT01235949|54581967|FG008|Booster Phase|Migrated/moved from study area|0|||
27925184|NCT01235949|54581968|FG009|Booster Phase|Migrated/moved from study area|0|||
27925185|NCT01235949|54581969|FG010|Booster Phase|Migrated/moved from study area|0|||
27925186|NCT01235949|54581970|FG011|Booster Phase|Migrated/moved from study area|1|||
27925187|NCT01235949|54581971|FG012|Booster Phase|Migrated/moved from study area|1|||
27925188|NCT01235949|54581972|FG013|Booster Phase|Migrated/moved from study area|0|||
27925189|NCT01235949|54581973|FG014|Booster Phase|Migrated/moved from study area|0|||
27925190|NCT01235949|54581974|FG015|Booster Phase|Migrated/moved from study area|0|||
27925191|NCT01235949|54581975|FG016|Booster Phase|Migrated/moved from study area|0|||
27925192|NCT01235949|54581976|FG017|Booster Phase|Migrated/moved from study area|1|||
27925193|NCT01235949|54581959|FG000|Booster Phase|Adverse Event|0|||
27925194|NCT01235949|54581960|FG001|Booster Phase|Adverse Event|0|||
27925195|NCT01235949|54581961|FG002|Booster Phase|Adverse Event|0|||
27925196|NCT01235949|54581962|FG003|Booster Phase|Adverse Event|0|||
27925197|NCT01235949|54581963|FG004|Booster Phase|Adverse Event|0|||
27925198|NCT01235949|54581964|FG005|Booster Phase|Adverse Event|0|||
27925199|NCT01235949|54581965|FG006|Booster Phase|Adverse Event|0|||
27925200|NCT01235949|54581966|FG007|Booster Phase|Adverse Event|0|||
27925201|NCT01235949|54581967|FG008|Booster Phase|Adverse Event|0|||
27925202|NCT01235949|54581968|FG009|Booster Phase|Adverse Event|0|||
27925203|NCT01235949|54581969|FG010|Booster Phase|Adverse Event|0|||
27925204|NCT01235949|54581970|FG011|Booster Phase|Adverse Event|0|||
27925205|NCT01235949|54581971|FG012|Booster Phase|Adverse Event|0|||
27925206|NCT01235949|54581972|FG013|Booster Phase|Adverse Event|0|||
27925207|NCT01235949|54581973|FG014|Booster Phase|Adverse Event|0|||
27925208|NCT01235949|54581974|FG015|Booster Phase|Adverse Event|1|||
27925209|NCT01235949|54581975|FG016|Booster Phase|Adverse Event|0|||
27925210|NCT01235949|54581976|FG017|Booster Phase|Adverse Event|0|||
27925211|NCT01235949|54581959|FG000|Booster Phase|Withdrawal by Subject|0|||
27925212|NCT01235949|54581960|FG001|Booster Phase|Withdrawal by Subject|0|||
27925213|NCT01235949|54581961|FG002|Booster Phase|Withdrawal by Subject|0|||
27925214|NCT01235949|54581962|FG003|Booster Phase|Withdrawal by Subject|0|||
27925215|NCT01235949|54581963|FG004|Booster Phase|Withdrawal by Subject|0|||
27925216|NCT01235949|54581964|FG005|Booster Phase|Withdrawal by Subject|0|||
27925217|NCT01235949|54581965|FG006|Booster Phase|Withdrawal by Subject|0|||
27925218|NCT01235949|54581966|FG007|Booster Phase|Withdrawal by Subject|1|||
27925219|NCT01235949|54581967|FG008|Booster Phase|Withdrawal by Subject|1|||
27925220|NCT01235949|54581968|FG009|Booster Phase|Withdrawal by Subject|0|||
27925221|NCT01235949|54581969|FG010|Booster Phase|Withdrawal by Subject|1|||
27925222|NCT01235949|54581970|FG011|Booster Phase|Withdrawal by Subject|1|||
27925223|NCT01235949|54581971|FG012|Booster Phase|Withdrawal by Subject|2|||
27925224|NCT01235949|54581972|FG013|Booster Phase|Withdrawal by Subject|0|||
27925225|NCT01235949|54581973|FG014|Booster Phase|Withdrawal by Subject|2|||
27925226|NCT01235949|54581974|FG015|Booster Phase|Withdrawal by Subject|0|||
27925227|NCT01235949|54581975|FG016|Booster Phase|Withdrawal by Subject|0|||
27925228|NCT01235949|54581976|FG017|Booster Phase|Withdrawal by Subject|0|||
27925229|NCT01235949|54581959|FG000|Booster Phase|Lost to Follow-up|0|||
27925230|NCT01235949|54581960|FG001|Booster Phase|Lost to Follow-up|0|||
27925231|NCT01235949|54581961|FG002|Booster Phase|Lost to Follow-up|0|||
27925232|NCT01235949|54581962|FG003|Booster Phase|Lost to Follow-up|0|||
27925233|NCT01235949|54581963|FG004|Booster Phase|Lost to Follow-up|0|||
27925234|NCT01235949|54581964|FG005|Booster Phase|Lost to Follow-up|0|||
27925235|NCT01235949|54581965|FG006|Booster Phase|Lost to Follow-up|0|||
27925236|NCT01235949|54581966|FG007|Booster Phase|Lost to Follow-up|0|||
27925237|NCT01235949|54581967|FG008|Booster Phase|Lost to Follow-up|1|||
27925238|NCT01235949|54581968|FG009|Booster Phase|Lost to Follow-up|1|||
27925239|NCT01235949|54581969|FG010|Booster Phase|Lost to Follow-up|1|||
27925240|NCT01235949|54581970|FG011|Booster Phase|Lost to Follow-up|1|||
27925241|NCT01235949|54581971|FG012|Booster Phase|Lost to Follow-up|0|||
27925242|NCT01235949|54581972|FG013|Booster Phase|Lost to Follow-up|0|||
27925243|NCT01235949|54581973|FG014|Booster Phase|Lost to Follow-up|0|||
27925244|NCT01235949|54581974|FG015|Booster Phase|Lost to Follow-up|0|||
27925245|NCT01235949|54581975|FG016|Booster Phase|Lost to Follow-up|0|||
27925246|NCT01235949|54581976|FG017|Booster Phase|Lost to Follow-up|1|||
27925247|NCT01235793|54582014|FG000|Overall Study|Death|6|||
27925248|NCT01258998|54582019|FG000|Overall Study|Ineligible|1|||
27925249|NCT01235715|54582025|FG000|Overall Study|Physician Decision|0|||
27925250|NCT01235715|54582026|FG001|Overall Study|Physician Decision|2|||
27925251|NCT01235403|54582033|FG000|Overall Study|Adverse Event|14|||
27925252|NCT01235403|54582033|FG000|Overall Study|Lost to Follow-up|2|||
27925253|NCT01235403|54582033|FG000|Overall Study|Withdrawal by Subject|4|||
27925254|NCT01235403|54582033|FG000|Overall Study|Lack of Efficacy|2|||
27925255|NCT01235403|54582033|FG000|Overall Study|Other reasons for premature termination|4|||
27925256|NCT01024036|54582039|FG000|Blinded Treatment|Adverse Event|1|||
27925257|NCT01024036|54582040|FG001|Blinded Treatment|Adverse Event|1|||
27925258|NCT01024036|54582039|FG000|Blinded Treatment|Lack of Efficacy|16|||
27925259|NCT01024036|54582040|FG001|Blinded Treatment|Lack of Efficacy|14|||
27925260|NCT01024036|54582039|FG000|Blinded Treatment|Physician Decision|1|||
27745851|NCT00700817|54195606|FG003|Week 0-26 (Main Period)|Protocol Violation|0|||
27745852|NCT00700817|54195607|FG004|Week 0-26 (Main Period)|Protocol Violation|0|||
27745853|NCT00700817|54195603|FG000|Week 0-26 (Main Period)|Withdrawal criteria|10|||
27745854|NCT00700817|54195604|FG001|Week 0-26 (Main Period)|Withdrawal criteria|7|||
27745855|NCT00700817|54195605|FG002|Week 0-26 (Main Period)|Withdrawal criteria|5|||
27745856|NCT00700817|54195606|FG003|Week 0-26 (Main Period)|Withdrawal criteria|0|||
27745857|NCT00700817|54195607|FG004|Week 0-26 (Main Period)|Withdrawal criteria|0|||
27745858|NCT00700817|54195603|FG000|Week 0-26 (Main Period)|Unclassified|14|||
27745859|NCT00700817|54195604|FG001|Week 0-26 (Main Period)|Unclassified|4|||
27745860|NCT00700817|54195605|FG002|Week 0-26 (Main Period)|Unclassified|8|||
27745861|NCT00700817|54195606|FG003|Week 0-26 (Main Period)|Unclassified|0|||
27745862|NCT00700817|54195607|FG004|Week 0-26 (Main Period)|Unclassified|0|||
27745863|NCT00700817|54195603|FG000|Week 26-52 (Extension Period 1)|Adverse Event|5|||
27745864|NCT00700817|54195604|FG001|Week 26-52 (Extension Period 1)|Adverse Event|10|||
27745865|NCT00700817|54195605|FG002|Week 26-52 (Extension Period 1)|Adverse Event|3|||
27745866|NCT00700817|54195606|FG003|Week 26-52 (Extension Period 1)|Adverse Event|0|||
27745867|NCT00700817|54195607|FG004|Week 26-52 (Extension Period 1)|Adverse Event|0|||
27745868|NCT00700817|54195603|FG000|Week 26-52 (Extension Period 1)|Protocol Violation|3|||
27745869|NCT00700817|54195604|FG001|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
27745870|NCT00700817|54195605|FG002|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
27745871|NCT00700817|54195606|FG003|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
27745872|NCT00700817|54195607|FG004|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
27745873|NCT00700817|54195603|FG000|Week 26-52 (Extension Period 1)|Lack of Efficacy|2|||
27745874|NCT00700817|54195604|FG001|Week 26-52 (Extension Period 1)|Lack of Efficacy|3|||
27745875|NCT00700817|54195605|FG002|Week 26-52 (Extension Period 1)|Lack of Efficacy|7|||
27745876|NCT00700817|54195606|FG003|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
27745877|NCT00700817|54195607|FG004|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
27745878|NCT00700817|54195603|FG000|Week 26-52 (Extension Period 1)|Withdrawal criteria|6|||
27745879|NCT00700817|54195604|FG001|Week 26-52 (Extension Period 1)|Withdrawal criteria|8|||
27745880|NCT00700817|54195605|FG002|Week 26-52 (Extension Period 1)|Withdrawal criteria|2|||
27745881|NCT00700817|54195606|FG003|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
27745882|NCT00700817|54195607|FG004|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
27745883|NCT00700817|54195603|FG000|Week 26-52 (Extension Period 1)|Unclassified|4|||
27745884|NCT00700817|54195604|FG001|Week 26-52 (Extension Period 1)|Unclassified|3|||
27745885|NCT00700817|54195605|FG002|Week 26-52 (Extension Period 1)|Unclassified|1|||
27745886|NCT00700817|54195606|FG003|Week 26-52 (Extension Period 1)|Unclassified|0|||
27745887|NCT00700817|54195607|FG004|Week 26-52 (Extension Period 1)|Unclassified|0|||
27745888|NCT00700817|54195603|FG000|Week 52-78 (Extension Period 2)|Adverse Event|0|||
27745889|NCT00700817|54195604|FG001|Week 52-78 (Extension Period 2)|Adverse Event|3|||
27745890|NCT00700817|54195605|FG002|Week 52-78 (Extension Period 2)|Adverse Event|0|||
27745891|NCT00700817|54195606|FG003|Week 52-78 (Extension Period 2)|Adverse Event|6|||
27745892|NCT00700817|54195607|FG004|Week 52-78 (Extension Period 2)|Adverse Event|0|||
27745893|NCT00700817|54195603|FG000|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
27925261|NCT01024036|54582040|FG001|Blinded Treatment|Physician Decision|0|||
27925262|NCT01024036|54582039|FG000|Blinded Treatment|Death|0|||
27925263|NCT01024036|54582040|FG001|Blinded Treatment|Death|2|||
27925264|NCT01024036|54582039|FG000|Blinded Treatment|Withdrawal by Subject|4|||
27745894|NCT00700817|54195604|FG001|Week 52-78 (Extension Period 2)|Protocol Violation|2|||
27745895|NCT00700817|54195605|FG002|Week 52-78 (Extension Period 2)|Protocol Violation|0|||
27745896|NCT00700817|54195606|FG003|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
27745897|NCT00700817|54195607|FG004|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
27745898|NCT00700817|54195603|FG000|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
27745899|NCT00700817|54195604|FG001|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
27745900|NCT00700817|54195605|FG002|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
27745901|NCT00700817|54195606|FG003|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
27745902|NCT00700817|54195607|FG004|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
27745903|NCT00700817|54195603|FG000|Week 52-78 (Extension Period 2)|Withdrawal criteria|4|||
27745904|NCT00700817|54195604|FG001|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
27745905|NCT00700817|54195605|FG002|Week 52-78 (Extension Period 2)|Withdrawal criteria|0|||
27745906|NCT00700817|54195606|FG003|Week 52-78 (Extension Period 2)|Withdrawal criteria|1|||
27745907|NCT00700817|54195607|FG004|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
27745908|NCT00700817|54195603|FG000|Week 52-78 (Extension Period 2)|Unclassified|2|||
27745909|NCT00700817|54195604|FG001|Week 52-78 (Extension Period 2)|Unclassified|4|||
27745910|NCT00700817|54195605|FG002|Week 52-78 (Extension Period 2)|Unclassified|0|||
27745911|NCT00700817|54195606|FG003|Week 52-78 (Extension Period 2)|Unclassified|0|||
27745912|NCT00700817|54195607|FG004|Week 52-78 (Extension Period 2)|Unclassified|1|||
27745913|NCT02625909|54195619|FG000|Overall Study|Death|2|||
27745914|NCT02625909|54195620|FG001|Overall Study|Death|0|||
27745915|NCT02625909|54195619|FG000|Overall Study|Lost to Follow-up|3|||
27745916|NCT02625909|54195620|FG001|Overall Study|Lost to Follow-up|5|||
27745917|NCT02625909|54195619|FG000|Overall Study|Lack of Efficacy|9|||
27745918|NCT02625909|54195620|FG001|Overall Study|Lack of Efficacy|2|||
27745919|NCT02625909|54195619|FG000|Overall Study|Reinfection|3|||
27745920|NCT02625909|54195620|FG001|Overall Study|Reinfection|2|||
27745921|NCT02623959|54195628|FG000|Overall Study|Progression|0|||
27745922|NCT02623959|54195629|FG001|Overall Study|Progression|1|||
27745923|NCT00700739|54195639|FG000|Overall Study|Lost to Follow-up|4|||
27745924|NCT00700739|54195640|FG001|Overall Study|Lost to Follow-up|4|||
27745925|NCT02623335|54195649|FG000|Overall Study|Death|8|||
27745926|NCT02623335|54195650|FG001|Overall Study|Death|7|||
27745927|NCT02623335|54195649|FG000|Overall Study|Lost to Follow-up|15|||
27745928|NCT02623335|54195650|FG001|Overall Study|Lost to Follow-up|23|||
27745929|NCT02623335|54195649|FG000|Overall Study|Withdrawal by Subject|2|||
27745930|NCT02623335|54195650|FG001|Overall Study|Withdrawal by Subject|5|||
27745931|NCT02623335|54195649|FG000|Overall Study|Protocol Violation|2|||
27745932|NCT02623335|54195650|FG001|Overall Study|Protocol Violation|1|||
27745933|NCT00700427|54195660|FG000|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298|||
27745934|NCT00700427|54195661|FG001|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
27745935|NCT00700427|54195662|FG002|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
27745936|NCT00700427|54195663|FG003|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
27745937|NCT00700427|54195664|FG004|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
27745938|NCT00700427|54195660|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173|||
27745939|NCT00700427|54195661|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
27745940|NCT00700427|54195662|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
27745941|NCT00700427|54195663|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
27745942|NCT00700427|54195664|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
27745943|NCT00700427|54195660|FG000|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164|||
27745944|NCT00700427|54195661|FG001|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
27745945|NCT00700427|54195662|FG002|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
27745946|NCT00700427|54195663|FG003|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
27745947|NCT00700427|54195664|FG004|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
27745948|NCT00700427|54195660|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161|||
27745949|NCT00700427|54195661|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
27745950|NCT00700427|54195662|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
27745951|NCT00700427|54195663|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
27745952|NCT00700427|54195664|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
27745953|NCT00700427|54195660|FG000|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108|||
27745954|NCT00700427|54195661|FG001|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
27745955|NCT00700427|54195662|FG002|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
27745956|NCT00700427|54195663|FG003|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
27745957|NCT00700427|54195664|FG004|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
27745958|NCT00700427|54195660|FG000|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90|||
27745959|NCT00700427|54195661|FG001|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
27745960|NCT00700427|54195662|FG002|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
27745961|NCT00700427|54195663|FG003|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
27745962|NCT00700427|54195664|FG004|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
27745963|NCT00700427|54195660|FG000|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8|||
27745964|NCT00700427|54195661|FG001|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
27745965|NCT00700427|54195662|FG002|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
27745966|NCT00700427|54195663|FG003|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
27745967|NCT00700427|54195664|FG004|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
27745968|NCT00700427|54195660|FG000|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7|||
27745969|NCT00700427|54195661|FG001|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
27745970|NCT00700427|54195662|FG002|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
27745971|NCT00700427|54195663|FG003|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
27745972|NCT00700427|54195664|FG004|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
27745973|NCT00700427|54195660|FG000|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2|||
27745974|NCT00700427|54195661|FG001|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
27745975|NCT00700427|54195662|FG002|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
27745976|NCT00700427|54195663|FG003|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
27745977|NCT00700427|54195664|FG004|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
27745978|NCT00700427|54195660|FG000|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
27745979|NCT00700427|54195661|FG001|Study Period 3A (Blinded Maintenance)|Adverse Event|50|||
27745980|NCT00700427|54195662|FG002|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
27745981|NCT00700427|54195663|FG003|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
27745982|NCT00700427|54195664|FG004|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
27745983|NCT00700427|54195660|FG000|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
27745984|NCT00700427|54195661|FG001|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162|||
27745985|NCT00700427|54195662|FG002|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
27745986|NCT00700427|54195663|FG003|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
27745987|NCT00700427|54195664|FG004|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
27745988|NCT00700427|54195660|FG000|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
27745989|NCT00700427|54195661|FG001|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81|||
27745990|NCT00700427|54195662|FG002|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
27745991|NCT00700427|54195663|FG003|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
27745992|NCT00700427|54195664|FG004|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
27745993|NCT00700427|54195660|FG000|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
27745994|NCT00700427|54195661|FG001|Study Period 3A (Blinded Maintenance)|Protocol Violation|56|||
27745995|NCT00700427|54195662|FG002|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
27745996|NCT00700427|54195663|FG003|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
27745997|NCT00700427|54195664|FG004|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
27745998|NCT00700427|54195660|FG000|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
27745999|NCT00700427|54195661|FG001|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49|||
27746000|NCT00700427|54195662|FG002|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
27746001|NCT00700427|54195663|FG003|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
27746002|NCT00700427|54195664|FG004|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
27746003|NCT00700427|54195660|FG000|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
27746004|NCT00700427|54195661|FG001|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41|||
27746005|NCT00700427|54195662|FG002|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
27746006|NCT00700427|54195663|FG003|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
27746007|NCT00700427|54195664|FG004|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
27746008|NCT00700427|54195660|FG000|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
27746009|NCT00700427|54195661|FG001|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32|||
27746010|NCT00700427|54195662|FG002|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
27746011|NCT00700427|54195663|FG003|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
27746012|NCT00700427|54195664|FG004|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
27746013|NCT00700427|54195660|FG000|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
27746014|NCT00700427|54195661|FG001|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3|||
27746015|NCT00700427|54195662|FG002|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
27746016|NCT00700427|54195663|FG003|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
27746017|NCT00700427|54195664|FG004|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
27746018|NCT00700427|54195660|FG000|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
27746019|NCT00700427|54195661|FG001|Study Period 3A (Blinded Maintenance)|Physician Decision|2|||
27746020|NCT00700427|54195662|FG002|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
27746021|NCT00700427|54195663|FG003|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
27746022|NCT00700427|54195664|FG004|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
27746023|NCT00700427|54195660|FG000|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
27746024|NCT00700427|54195661|FG001|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5|||
27746025|NCT00700427|54195662|FG002|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
27746026|NCT00700427|54195663|FG003|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
27746027|NCT00700427|54195664|FG004|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
27746028|NCT00700427|54195660|FG000|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
27746029|NCT00700427|54195661|FG001|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
27746030|NCT00700427|54195662|FG002|Study Period 3B (Randomized Withdrawal)|Adverse Event|8|||
27746031|NCT00700427|54195663|FG003|Study Period 3B (Randomized Withdrawal)|Adverse Event|5|||
27746032|NCT00700427|54195664|FG004|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
27746033|NCT00700427|54195660|FG000|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
27746034|NCT00700427|54195661|FG001|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
27746035|NCT00700427|54195662|FG002|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25|||
27746036|NCT00700427|54195663|FG003|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34|||
27746037|NCT00700427|54195664|FG004|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
27746038|NCT00700427|54195660|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
27746039|NCT00700427|54195661|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
27746040|NCT00700427|54195662|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23|||
27746041|NCT00700427|54195663|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25|||
27746042|NCT00700427|54195664|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
27746043|NCT00700427|54195660|FG000|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
27746044|NCT00700427|54195661|FG001|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
27746045|NCT00700427|54195662|FG002|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19|||
27746046|NCT00700427|54195663|FG003|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9|||
27746047|NCT00700427|54195664|FG004|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
27746048|NCT00700427|54195660|FG000|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
27746049|NCT00700427|54195661|FG001|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
27746050|NCT00700427|54195662|FG002|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3|||
27746051|NCT00700427|54195663|FG003|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11|||
27746052|NCT00700427|54195664|FG004|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
27746053|NCT00700427|54195660|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
27746054|NCT00700427|54195661|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
27746055|NCT00700427|54195662|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
27746056|NCT00700427|54195663|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5|||
27746057|NCT00700427|54195664|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
27746058|NCT00700427|54195660|FG000|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
27746059|NCT00700427|54195661|FG001|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
27746060|NCT00700427|54195662|FG002|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
27746061|NCT00700427|54195663|FG003|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3|||
27746062|NCT00700427|54195664|FG004|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
27746063|NCT00700427|54195660|FG000|Study Period 3B (Randomized Withdrawal)|Missing|0|||
27746064|NCT00700427|54195661|FG001|Study Period 3B (Randomized Withdrawal)|Missing|0|||
27746065|NCT00700427|54195662|FG002|Study Period 3B (Randomized Withdrawal)|Missing|1|||
27746066|NCT00700427|54195663|FG003|Study Period 3B (Randomized Withdrawal)|Missing|1|||
27746067|NCT00700427|54195664|FG004|Study Period 3B (Randomized Withdrawal)|Missing|0|||
27746068|NCT00700427|54195660|FG000|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
27746069|NCT00700427|54195661|FG001|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
27746070|NCT00700427|54195662|FG002|Study Period 3B (Randomized Withdrawal)|Physician Decision|2|||
27746071|NCT00700427|54195663|FG003|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
27746072|NCT00700427|54195664|FG004|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
27746073|NCT00700427|54195660|FG000|Study Period 3B (Randomized Withdrawal)|Death|0|||
27746074|NCT00700427|54195661|FG001|Study Period 3B (Randomized Withdrawal)|Death|0|||
27746075|NCT00700427|54195662|FG002|Study Period 3B (Randomized Withdrawal)|Death|1|||
27746076|NCT00700427|54195663|FG003|Study Period 3B (Randomized Withdrawal)|Death|0|||
27746077|NCT00700427|54195664|FG004|Study Period 3B (Randomized Withdrawal)|Death|0|||
27746078|NCT00700427|54195660|FG000|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
27746079|NCT00700427|54195661|FG001|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
27746080|NCT00700427|54195662|FG002|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
27746081|NCT00700427|54195663|FG003|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
27746082|NCT00700427|54195664|FG004|Study Period 4 (Open-Label Extension)|Adverse Event|16|||
27746083|NCT00700427|54195660|FG000|Study Period 4 (Open-Label Extension)|Death|0|||
27746084|NCT00700427|54195661|FG001|Study Period 4 (Open-Label Extension)|Death|0|||
27746085|NCT00700427|54195662|FG002|Study Period 4 (Open-Label Extension)|Death|0|||
27746086|NCT00700427|54195663|FG003|Study Period 4 (Open-Label Extension)|Death|0|||
27746087|NCT00700427|54195664|FG004|Study Period 4 (Open-Label Extension)|Death|1|||
27746088|NCT00700427|54195660|FG000|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
27746089|NCT00700427|54195661|FG001|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
27746090|NCT00700427|54195662|FG002|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
27746091|NCT00700427|54195663|FG003|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
27746092|NCT00700427|54195664|FG004|Study Period 4 (Open-Label Extension)|Protocol Violation|12|||
27746093|NCT00700427|54195660|FG000|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
27746094|NCT00700427|54195661|FG001|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
27746095|NCT00700427|54195662|FG002|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
27746096|NCT00700427|54195663|FG003|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
27746097|NCT00700427|54195664|FG004|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38|||
27746098|NCT00700427|54195660|FG000|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
27746099|NCT00700427|54195661|FG001|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
27746100|NCT00700427|54195662|FG002|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
27746101|NCT00700427|54195663|FG003|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
27746102|NCT00700427|54195664|FG004|Study Period 4 (Open-Label Extension)|Physician Decision|2|||
27746103|NCT00700427|54195660|FG000|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
27746104|NCT00700427|54195661|FG001|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
27746105|NCT00700427|54195662|FG002|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
27746106|NCT00700427|54195663|FG003|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
27746107|NCT00700427|54195664|FG004|Study Period 4 (Open-Label Extension)|Sponsor Decision|2|||
27746108|NCT00700427|54195660|FG000|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
27746109|NCT00700427|54195661|FG001|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
27746110|NCT00700427|54195662|FG002|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
27746111|NCT00700427|54195663|FG003|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
27746112|NCT00700427|54195664|FG004|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1|||
27746113|NCT00700427|54195660|FG000|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
27746114|NCT00700427|54195661|FG001|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
27746115|NCT00700427|54195662|FG002|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
27925265|NCT01024036|54582040|FG001|Blinded Treatment|Withdrawal by Subject|3|||
27925266|NCT01024036|54582039|FG000|Unblinded Treatment|Adverse Event|0|||
27925267|NCT01024036|54582040|FG001|Unblinded Treatment|Adverse Event|1|||
27925268|NCT01024036|54582039|FG000|Unblinded Treatment|Lack of Efficacy|0|||
27925269|NCT01024036|54582040|FG001|Unblinded Treatment|Lack of Efficacy|2|||
27925270|NCT01024036|54582039|FG000|Follow-Up Period|Lost to Follow-up|1|||
27925271|NCT01024036|54582040|FG001|Follow-Up Period|Lost to Follow-up|1|||
27925272|NCT01024036|54582039|FG000|Follow-Up Period|Withdrawal by Subject|0|||
27925273|NCT01024036|54582040|FG001|Follow-Up Period|Withdrawal by Subject|1|||
27925274|NCT01024036|54582039|FG000|Follow-Up Period|Adverse Event|4|||
27925275|NCT01024036|54582040|FG001|Follow-Up Period|Adverse Event|1|||
27925276|NCT01234467|54582049|FG000|Overall Study|Adverse Event|3|||
27925277|NCT01234467|54582049|FG000|Overall Study|Death|2|||
27925278|NCT01234467|54582049|FG000|Overall Study|Withdrawal by Subject|2|||
27925279|NCT01234467|54582049|FG000|Overall Study|Disease Progression|2|||
27925280|NCT01234467|54582049|FG000|Overall Study|Clinical deterioration|1|||
27925281|NCT01234467|54582049|FG000|Overall Study|Physician Decision|1|||
27925282|NCT01234467|54582049|FG000|Overall Study|Other complicating disease (stroke)|1|||
27925283|NCT01233999|54582053|FG000|Overall Study|Withdrawal by Subject|1|||
27925284|NCT01233999|54582053|FG000|Overall Study|Lost to Follow-up|1|||
27925285|NCT01233687|54582057|FG000|Phase II AMG 102 + Erlotinib|Death|1|||
27925286|NCT01233687|54582057|FG000|Phase II AMG 102 + Erlotinib|Physician Decision|2|||
27925287|NCT01233687|54582057|FG000|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1|||
27925288|NCT01023958|54582061|FG000|Overall Study|Progressive disease|48|||
27925289|NCT01023958|54582061|FG000|Overall Study|Other adverse event|1|||
27925290|NCT01023958|54582061|FG000|Overall Study|Refused to continue medication|1|||
27925291|NCT01233609|54582067|FG000|Overall Study|Death|1|||
27925292|NCT01233609|54582068|FG001|Overall Study|Death|0|||
27925293|NCT01233609|54582067|FG000|Overall Study|Lost to Follow-up|3|||
27925294|NCT01233609|54582068|FG001|Overall Study|Lost to Follow-up|1|||
27925295|NCT01233609|54582067|FG000|Overall Study|Adverse Event|2|||
27925296|NCT01233609|54582068|FG001|Overall Study|Adverse Event|1|||
27925297|NCT01233609|54582067|FG000|Overall Study|Withdrawal by Subject|3|||
27925298|NCT01233609|54582068|FG001|Overall Study|Withdrawal by Subject|0|||
27925299|NCT01232283|54582084|FG000|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12|||
27925300|NCT01232283|54582085|FG001|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8|||
27925301|NCT01232283|54582086|FG002|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
27925302|NCT01232283|54582087|FG003|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
27925303|NCT01232283|54582088|FG004|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
27925304|NCT01232283|54582089|FG005|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
27925305|NCT01232283|54582090|FG006|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
27925306|NCT01232283|54582091|FG007|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
27925307|NCT01232283|54582092|FG008|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
27925308|NCT01232283|54582093|FG009|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
27925309|NCT01232283|54582084|FG000|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3|||
27925310|NCT01232283|54582085|FG001|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2|||
27925311|NCT01232283|54582086|FG002|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
27925312|NCT01232283|54582087|FG003|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
27925313|NCT01232283|54582088|FG004|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
27925314|NCT01232283|54582089|FG005|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
27925315|NCT01232283|54582090|FG006|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
27925316|NCT01232283|54582091|FG007|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
27925317|NCT01232283|54582092|FG008|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
27925318|NCT01232283|54582093|FG009|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
27925319|NCT01232283|54582084|FG000|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1|||
27925320|NCT01232283|54582085|FG001|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
27925321|NCT01232283|54582086|FG002|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
27925322|NCT01232283|54582087|FG003|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
27925323|NCT01232283|54582088|FG004|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
27925324|NCT01232283|54582089|FG005|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
27925325|NCT01232283|54582090|FG006|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
27925326|NCT01232283|54582091|FG007|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
27925327|NCT01232283|54582092|FG008|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
27925328|NCT01232283|54582093|FG009|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
27925329|NCT01232283|54582084|FG000|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9|||
27925330|NCT01232283|54582085|FG001|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7|||
27925331|NCT01232283|54582086|FG002|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
27925332|NCT01232283|54582087|FG003|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
27925333|NCT01232283|54582088|FG004|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
27925334|NCT01232283|54582089|FG005|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
27925335|NCT01232283|54582090|FG006|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
27925336|NCT01232283|54582091|FG007|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
27925337|NCT01232283|54582092|FG008|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
27925338|NCT01232283|54582093|FG009|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
27925339|NCT01232283|54582084|FG000|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
27925340|NCT01232283|54582085|FG001|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
27925341|NCT01232283|54582086|FG002|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
27925342|NCT01232283|54582087|FG003|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
27925343|NCT01232283|54582088|FG004|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
27925344|NCT01232283|54582089|FG005|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
27925345|NCT01232283|54582090|FG006|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
27925346|NCT01232283|54582091|FG007|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
27925347|NCT01232283|54582092|FG008|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
27925348|NCT01232283|54582093|FG009|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
27925349|NCT01232283|54582084|FG000|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3|||
27925350|NCT01232283|54582085|FG001|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2|||
27925351|NCT01232283|54582086|FG002|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
27925352|NCT01232283|54582087|FG003|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
27925353|NCT01232283|54582088|FG004|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
27925354|NCT01232283|54582089|FG005|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
27925355|NCT01232283|54582090|FG006|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
27925356|NCT01232283|54582091|FG007|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
27925357|NCT01232283|54582092|FG008|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
27925358|NCT01232283|54582093|FG009|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
27925359|NCT01232283|54582084|FG000|Placebo Controlled Phase (Weeks 0-16)|Other|2|||
27925360|NCT01232283|54582085|FG001|Placebo Controlled Phase (Weeks 0-16)|Other|1|||
27925361|NCT01232283|54582086|FG002|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
27925362|NCT01232283|54582087|FG003|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
27925363|NCT01232283|54582088|FG004|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
27925364|NCT01232283|54582089|FG005|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
27925365|NCT01232283|54582090|FG006|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
27925366|NCT01232283|54582091|FG007|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
27925367|NCT01232283|54582092|FG008|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
27925368|NCT01232283|54582093|FG009|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
27925369|NCT01232283|54582084|FG000|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
27925370|NCT01232283|54582085|FG001|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
27925371|NCT01232283|54582086|FG002|Maintenance Phase (Weeks16-32)|Adverse Event|8|||
27925372|NCT01232283|54582087|FG003|Maintenance Phase (Weeks16-32)|Adverse Event|2|||
27925373|NCT01232283|54582088|FG004|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
27925374|NCT01232283|54582089|FG005|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
27925375|NCT01232283|54582090|FG006|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
27925376|NCT01232283|54582091|FG007|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
27925377|NCT01232283|54582092|FG008|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
27925378|NCT01232283|54582093|FG009|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
27925379|NCT01232283|54582084|FG000|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
27925380|NCT01232283|54582085|FG001|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
27925381|NCT01232283|54582086|FG002|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19|||
27925382|NCT01232283|54582087|FG003|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3|||
27925383|NCT01232283|54582088|FG004|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
27925384|NCT01232283|54582089|FG005|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
27925385|NCT01232283|54582090|FG006|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
27925386|NCT01232283|54582091|FG007|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
27925387|NCT01232283|54582092|FG008|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
27925388|NCT01232283|54582093|FG009|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
27925389|NCT01232283|54582084|FG000|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
27925390|NCT01232283|54582085|FG001|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
27925391|NCT01232283|54582086|FG002|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1|||
27925392|NCT01232283|54582087|FG003|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
27925393|NCT01232283|54582088|FG004|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
27925394|NCT01232283|54582089|FG005|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
27925395|NCT01232283|54582090|FG006|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
27925396|NCT01232283|54582091|FG007|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
27925397|NCT01232283|54582092|FG008|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
27925398|NCT01232283|54582093|FG009|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
27925399|NCT01232283|54582084|FG000|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
27925400|NCT01232283|54582085|FG001|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
27925401|NCT01232283|54582086|FG002|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7|||
27925402|NCT01232283|54582087|FG003|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1|||
27925403|NCT01232283|54582088|FG004|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
27925404|NCT01232283|54582089|FG005|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
27925405|NCT01232283|54582090|FG006|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
27925406|NCT01232283|54582091|FG007|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
27925407|NCT01232283|54582092|FG008|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
27925408|NCT01232283|54582093|FG009|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
27925409|NCT01232283|54582084|FG000|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
27925410|NCT01232283|54582085|FG001|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
27925411|NCT01232283|54582086|FG002|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3|||
27925412|NCT01232283|54582087|FG003|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2|||
27925413|NCT01232283|54582088|FG004|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
27925414|NCT01232283|54582089|FG005|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
27925415|NCT01232283|54582090|FG006|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
27925416|NCT01232283|54582091|FG007|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
27925417|NCT01232283|54582092|FG008|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
27925418|NCT01232283|54582093|FG009|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
27925419|NCT01232283|54582084|FG000|Maintenance Phase (Weeks16-32)|Other|0|||
27925420|NCT01232283|54582085|FG001|Maintenance Phase (Weeks16-32)|Other|0|||
27925421|NCT01232283|54582086|FG002|Maintenance Phase (Weeks16-32)|Other|2|||
27925422|NCT01232283|54582087|FG003|Maintenance Phase (Weeks16-32)|Other|0|||
27925423|NCT01232283|54582088|FG004|Maintenance Phase (Weeks16-32)|Other|0|||
27925424|NCT01232283|54582089|FG005|Maintenance Phase (Weeks16-32)|Other|0|||
27925425|NCT01232283|54582090|FG006|Maintenance Phase (Weeks16-32)|Other|0|||
27925426|NCT01232283|54582091|FG007|Maintenance Phase (Weeks16-32)|Other|0|||
27925427|NCT01232283|54582092|FG008|Maintenance Phase (Weeks16-32)|Other|0|||
27925428|NCT01232283|54582093|FG009|Maintenance Phase (Weeks16-32)|Other|0|||
27925429|NCT01232283|54582084|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
27925430|NCT01232283|54582085|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
27925431|NCT01232283|54582086|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
27925432|NCT01232283|54582087|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
27925433|NCT01232283|54582088|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2|||
27925434|NCT01232283|54582089|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
27925435|NCT01232283|54582090|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
27925436|NCT01232283|54582091|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
27925437|NCT01232283|54582092|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
27925438|NCT01232283|54582093|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
27925439|NCT01232283|54582084|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
27925440|NCT01232283|54582085|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
27925441|NCT01232283|54582086|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
27925442|NCT01232283|54582087|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
27925443|NCT01232283|54582088|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4|||
27925444|NCT01232283|54582089|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
27925445|NCT01232283|54582090|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13|||
27925446|NCT01232283|54582091|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5|||
27925447|NCT01232283|54582092|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
27925448|NCT01232283|54582093|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
27925449|NCT01232283|54582084|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
27925450|NCT01232283|54582085|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
27925451|NCT01232283|54582086|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
27925452|NCT01232283|54582087|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
27925453|NCT01232283|54582088|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
27925454|NCT01232283|54582089|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
27925455|NCT01232283|54582090|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
27925456|NCT01232283|54582091|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4|||
27925457|NCT01232283|54582092|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
27925458|NCT01232283|54582093|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
27925459|NCT01232283|54582084|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
27925460|NCT01232283|54582085|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
27925461|NCT01232283|54582086|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
27925462|NCT01232283|54582087|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
27925463|NCT01232283|54582088|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Death|1|||
27925464|NCT01232283|54582089|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
27925465|NCT01232283|54582090|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
27925466|NCT01232283|54582091|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
27925467|NCT01232283|54582092|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
27925468|NCT01232283|54582093|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
27925469|NCT01232283|54582084|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
27925470|NCT01232283|54582085|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
27925471|NCT01232283|54582086|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
27925472|NCT01232283|54582087|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
27925473|NCT01232283|54582088|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2|||
27925474|NCT01232283|54582089|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
27925475|NCT01232283|54582090|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
27925476|NCT01232283|54582091|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
27925477|NCT01232283|54582092|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
27925478|NCT01232283|54582093|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
27925479|NCT01232283|54582084|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
27925480|NCT01232283|54582085|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
27925481|NCT01232283|54582086|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
27925482|NCT01232283|54582087|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
27925483|NCT01232283|54582088|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
27925484|NCT01232283|54582089|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
27925485|NCT01232283|54582090|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
27925486|NCT01232283|54582091|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1|||
27925487|NCT01232283|54582092|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
27925488|NCT01232283|54582093|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
27925489|NCT01232283|54582084|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
27925490|NCT01232283|54582085|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
27925491|NCT01232283|54582086|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
27925492|NCT01232283|54582087|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
27925493|NCT01232283|54582088|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
27925494|NCT01232283|54582089|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Other|1|||
27925495|NCT01232283|54582090|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
27925496|NCT01232283|54582091|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
27925497|NCT01232283|54582092|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
27925498|NCT01232283|54582093|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
27925499|NCT01232283|54582084|FG000|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
27925500|NCT01232283|54582085|FG001|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
27925501|NCT01232283|54582086|FG002|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
27925502|NCT01232283|54582087|FG003|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
27925503|NCT01232283|54582088|FG004|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
27925504|NCT01232283|54582089|FG005|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
27925505|NCT01232283|54582090|FG006|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
27925506|NCT01232283|54582091|FG007|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
27925507|NCT01232283|54582092|FG008|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11|||
27925508|NCT01232283|54582093|FG009|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6|||
27925509|NCT01232283|54582084|FG000|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
27925510|NCT01232283|54582085|FG001|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
27925511|NCT01232283|54582086|FG002|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
27925512|NCT01232283|54582087|FG003|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
27925513|NCT01232283|54582088|FG004|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
27925514|NCT01232283|54582089|FG005|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
27925515|NCT01232283|54582090|FG006|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
27925516|NCT01232283|54582091|FG007|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
27925517|NCT01232283|54582092|FG008|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46|||
27925518|NCT01232283|54582093|FG009|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30|||
27925519|NCT01232283|54582084|FG000|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
27925520|NCT01232283|54582085|FG001|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
27925521|NCT01232283|54582086|FG002|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
27925522|NCT01232283|54582087|FG003|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
27925523|NCT01232283|54582088|FG004|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
27925524|NCT01232283|54582089|FG005|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
27925525|NCT01232283|54582090|FG006|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
27925526|NCT01232283|54582091|FG007|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
27925527|NCT01232283|54582092|FG008|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3|||
27925528|NCT01232283|54582093|FG009|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2|||
27925529|NCT01232283|54582084|FG000|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
27925530|NCT01232283|54582085|FG001|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
27925531|NCT01232283|54582086|FG002|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
27925532|NCT01232283|54582087|FG003|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
27925533|NCT01232283|54582088|FG004|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
27925534|NCT01232283|54582089|FG005|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
27925535|NCT01232283|54582090|FG006|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
27925536|NCT01232283|54582091|FG007|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
27925537|NCT01232283|54582092|FG008|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30|||
27925538|NCT01232283|54582093|FG009|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14|||
27925539|NCT01232283|54582084|FG000|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
27925540|NCT01232283|54582085|FG001|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
27925541|NCT01232283|54582086|FG002|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
27925542|NCT01232283|54582087|FG003|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
27925543|NCT01232283|54582088|FG004|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
27925544|NCT01232283|54582089|FG005|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
27925545|NCT01232283|54582090|FG006|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
27925546|NCT01232283|54582091|FG007|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
27925547|NCT01232283|54582092|FG008|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9|||
27925548|NCT01232283|54582093|FG009|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6|||
27925549|NCT01232283|54582084|FG000|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
27925550|NCT01232283|54582085|FG001|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
27925551|NCT01232283|54582086|FG002|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
27925552|NCT01232283|54582087|FG003|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
27925553|NCT01232283|54582088|FG004|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
27925554|NCT01232283|54582089|FG005|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
27925555|NCT01232283|54582090|FG006|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
27925556|NCT01232283|54582091|FG007|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
27925557|NCT01232283|54582092|FG008|Long-Term Extension Phase (Weeks 52-260)|Death|1|||
27925558|NCT01232283|54582093|FG009|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
27925559|NCT01232283|54582084|FG000|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
27925560|NCT01232283|54582085|FG001|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
27925561|NCT01232283|54582086|FG002|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
27925562|NCT01232283|54582087|FG003|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
27925563|NCT01232283|54582088|FG004|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
27925564|NCT01232283|54582089|FG005|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
27925565|NCT01232283|54582090|FG006|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
27925566|NCT01232283|54582091|FG007|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
27925567|NCT01232283|54582092|FG008|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1|||
27925568|NCT01232283|54582093|FG009|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
27925569|NCT01232283|54582084|FG000|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
27925570|NCT01232283|54582085|FG001|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
27925571|NCT01232283|54582086|FG002|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
27925572|NCT01232283|54582087|FG003|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
27746120|NCT00700427|54195662|FG002|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
27746121|NCT00700427|54195663|FG003|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
27746122|NCT00700427|54195664|FG004|Study Period 4 (Open-Label Extension)|Clinical Relapse|1|||
27746123|NCT02128763|54195674|FG000|Overall Study|Death|1|||
27746124|NCT02128763|54195675|FG001|Overall Study|Death|0|||
27746125|NCT02128763|54195674|FG000|Overall Study|Lost to Follow-up|19|||
27746126|NCT02128763|54195675|FG001|Overall Study|Lost to Follow-up|16|||
27746127|NCT02124772|54195697|FG000|Overall Study|Lack of Efficacy|2|||
27746128|NCT02124772|54195698|FG001|Overall Study|Lack of Efficacy|0|||
27746129|NCT02124772|54195699|FG002|Overall Study|Lack of Efficacy|0|||
27746130|NCT02124772|54195700|FG003|Overall Study|Lack of Efficacy|1|||
27746131|NCT02124772|54195701|FG004|Overall Study|Lack of Efficacy|2|||
27746132|NCT02124772|54195702|FG005|Overall Study|Lack of Efficacy|3|||
27746133|NCT02124772|54195703|FG006|Overall Study|Lack of Efficacy|0|||
27746134|NCT02124772|54195704|FG007|Overall Study|Lack of Efficacy|2|||
27746135|NCT02124772|54195705|FG008|Overall Study|Lack of Efficacy|0|||
27746136|NCT02124772|54195706|FG009|Overall Study|Lack of Efficacy|1|||
27746137|NCT02124772|54195707|FG010|Overall Study|Lack of Efficacy|0|||
27746138|NCT02124772|54195708|FG011|Overall Study|Lack of Efficacy|0|||
27746139|NCT02124772|54195709|FG012|Overall Study|Lack of Efficacy|1|||
27746140|NCT02124772|54195697|FG000|Overall Study|Adverse Event|1|||
27746141|NCT02124772|54195698|FG001|Overall Study|Adverse Event|4|||
27746142|NCT02124772|54195699|FG002|Overall Study|Adverse Event|1|||
27746143|NCT02124772|54195700|FG003|Overall Study|Adverse Event|5|||
27746144|NCT02124772|54195701|FG004|Overall Study|Adverse Event|2|||
27746145|NCT02124772|54195702|FG005|Overall Study|Adverse Event|1|||
27746146|NCT02124772|54195703|FG006|Overall Study|Adverse Event|1|||
27746147|NCT02124772|54195704|FG007|Overall Study|Adverse Event|5|||
27746148|NCT02124772|54195705|FG008|Overall Study|Adverse Event|0|||
27746149|NCT02124772|54195706|FG009|Overall Study|Adverse Event|3|||
27746150|NCT02124772|54195707|FG010|Overall Study|Adverse Event|1|||
27746151|NCT02124772|54195708|FG011|Overall Study|Adverse Event|3|||
27746152|NCT02124772|54195709|FG012|Overall Study|Adverse Event|1|||
27746153|NCT02124772|54195697|FG000|Overall Study|Withdrawal consent|0|||
27746154|NCT02124772|54195698|FG001|Overall Study|Withdrawal consent|1|||
27746155|NCT02124772|54195699|FG002|Overall Study|Withdrawal consent|1|||
27746156|NCT02124772|54195700|FG003|Overall Study|Withdrawal consent|1|||
27746157|NCT02124772|54195701|FG004|Overall Study|Withdrawal consent|0|||
27746158|NCT02124772|54195702|FG005|Overall Study|Withdrawal consent|1|||
27746159|NCT02124772|54195703|FG006|Overall Study|Withdrawal consent|1|||
27746160|NCT02124772|54195704|FG007|Overall Study|Withdrawal consent|0|||
27746161|NCT02124772|54195705|FG008|Overall Study|Withdrawal consent|0|||
27746162|NCT02124772|54195706|FG009|Overall Study|Withdrawal consent|1|||
27746163|NCT02124772|54195707|FG010|Overall Study|Withdrawal consent|0|||
27746164|NCT02124772|54195708|FG011|Overall Study|Withdrawal consent|1|||
27746165|NCT02124772|54195709|FG012|Overall Study|Withdrawal consent|0|||
27746166|NCT02124772|54195697|FG000|Overall Study|Investigator discretion|0|||
27746167|NCT02124772|54195698|FG001|Overall Study|Investigator discretion|2|||
27746168|NCT02124772|54195699|FG002|Overall Study|Investigator discretion|2|||
27746169|NCT02124772|54195700|FG003|Overall Study|Investigator discretion|1|||
27746170|NCT02124772|54195701|FG004|Overall Study|Investigator discretion|1|||
27746171|NCT02124772|54195702|FG005|Overall Study|Investigator discretion|0|||
27746172|NCT02124772|54195703|FG006|Overall Study|Investigator discretion|1|||
27746173|NCT02124772|54195704|FG007|Overall Study|Investigator discretion|0|||
27746174|NCT02124772|54195705|FG008|Overall Study|Investigator discretion|0|||
27746175|NCT02124772|54195706|FG009|Overall Study|Investigator discretion|1|||
27746176|NCT02124772|54195707|FG010|Overall Study|Investigator discretion|0|||
27746177|NCT02124772|54195708|FG011|Overall Study|Investigator discretion|1|||
27746178|NCT02124772|54195709|FG012|Overall Study|Investigator discretion|0|||
27746179|NCT02124772|54195697|FG000|Overall Study|Progressive disease|0|||
27746180|NCT02124772|54195698|FG001|Overall Study|Progressive disease|0|||
27746181|NCT02124772|54195699|FG002|Overall Study|Progressive disease|0|||
27746182|NCT02124772|54195700|FG003|Overall Study|Progressive disease|0|||
27746183|NCT02124772|54195701|FG004|Overall Study|Progressive disease|0|||
27746184|NCT02124772|54195702|FG005|Overall Study|Progressive disease|0|||
27746185|NCT02124772|54195703|FG006|Overall Study|Progressive disease|1|||
27746186|NCT02124772|54195704|FG007|Overall Study|Progressive disease|1|||
27746187|NCT02124772|54195705|FG008|Overall Study|Progressive disease|0|||
27746188|NCT02124772|54195706|FG009|Overall Study|Progressive disease|0|||
27746189|NCT02124772|54195707|FG010|Overall Study|Progressive disease|0|||
27746190|NCT02124772|54195708|FG011|Overall Study|Progressive disease|0|||
27746191|NCT02124772|54195709|FG012|Overall Study|Progressive disease|0|||
27746192|NCT02124772|54195697|FG000|Overall Study|Other|0|||
27746193|NCT02124772|54195698|FG001|Overall Study|Other|7|||
27746194|NCT02124772|54195699|FG002|Overall Study|Other|2|||
27746195|NCT02124772|54195700|FG003|Overall Study|Other|5|||
27746196|NCT02124772|54195701|FG004|Overall Study|Other|4|||
27746197|NCT02124772|54195702|FG005|Overall Study|Other|3|||
27746198|NCT02124772|54195703|FG006|Overall Study|Other|4|||
27746199|NCT02124772|54195704|FG007|Overall Study|Other|1|||
27746205|NCT02159482|54195761|FG000|Overall Study|Withdrawal by Subject|2|||
27746206|NCT02159482|54195761|FG000|Overall Study|Physician Decision|3|||
27746207|NCT02622321|54195769|FG000|Overall Study|Withdrawal by Subject|2|||
27746208|NCT02622321|54195770|FG001|Overall Study|Withdrawal by Subject|0|||
27746209|NCT02622321|54195771|FG002|Overall Study|Withdrawal by Subject|0|||
27746210|NCT02622321|54195772|FG003|Overall Study|Withdrawal by Subject|0|||
27746211|NCT02622321|54195769|FG000|Overall Study|Death|0|||
27746212|NCT02622321|54195770|FG001|Overall Study|Death|0|||
27746213|NCT02622321|54195771|FG002|Overall Study|Death|1|||
27746214|NCT02622321|54195772|FG003|Overall Study|Death|0|||
27746215|NCT02622321|54195769|FG000|Overall Study|Physician Decision|1|||
27746216|NCT02622321|54195770|FG001|Overall Study|Physician Decision|0|||
27746217|NCT02622321|54195771|FG002|Overall Study|Physician Decision|0|||
27746218|NCT02622321|54195772|FG003|Overall Study|Physician Decision|0|||
27746219|NCT02187172|54195798|FG000|Overall Study|Lost to Follow-up|1|||
27746220|NCT02187172|54195799|FG001|Overall Study|Lost to Follow-up|2|||
27746221|NCT02187172|54195798|FG000|Overall Study|Lack of Efficacy|1|||
27746222|NCT02187172|54195799|FG001|Overall Study|Lack of Efficacy|2|||
27746223|NCT02187172|54195798|FG000|Overall Study|Adverse Event|0|||
27746224|NCT02187172|54195799|FG001|Overall Study|Adverse Event|1|||
27746225|NCT02187172|54195798|FG000|Overall Study|Physician Decision|1|||
27746226|NCT02187172|54195799|FG001|Overall Study|Physician Decision|1|||
27746227|NCT02621931|54195810|FG000|Overall Study|Death|0|||
27746228|NCT02621931|54195811|FG001|Overall Study|Death|1|||
27746229|NCT02621931|54195812|FG002|Overall Study|Death|0|||
27746230|NCT02621931|54195810|FG000|Overall Study|Adverse Event|8|||
27746231|NCT02621931|54195811|FG001|Overall Study|Adverse Event|5|||
27746232|NCT02621931|54195812|FG002|Overall Study|Adverse Event|7|||
27746233|NCT02621931|54195810|FG000|Overall Study|Withdrawal by Subject|12|||
27746234|NCT02621931|54195811|FG001|Overall Study|Withdrawal by Subject|10|||
27746235|NCT02621931|54195812|FG002|Overall Study|Withdrawal by Subject|11|||
27746236|NCT02621931|54195810|FG000|Overall Study|Protocol Violation|2|||
27746237|NCT02621931|54195811|FG001|Overall Study|Protocol Violation|2|||
27746238|NCT02621931|54195812|FG002|Overall Study|Protocol Violation|2|||
27746239|NCT02621931|54195810|FG000|Overall Study|Pregnancy|2|||
27746240|NCT02621931|54195811|FG001|Overall Study|Pregnancy|0|||
27746241|NCT02621931|54195812|FG002|Overall Study|Pregnancy|0|||
27746242|NCT02621931|54195810|FG000|Overall Study|Noncompliance to study procedures|0|||
27746243|NCT02621931|54195811|FG001|Overall Study|Noncompliance to study procedures|1|||
27746244|NCT02621931|54195812|FG002|Overall Study|Noncompliance to study procedures|2|||
27746245|NCT02621931|54195810|FG000|Overall Study|Lost to Follow-up|8|||
27746246|NCT02621931|54195811|FG001|Overall Study|Lost to Follow-up|7|||
27746247|NCT02621931|54195812|FG002|Overall Study|Lost to Follow-up|10|||
27746248|NCT02621931|54195810|FG000|Overall Study|Lack of Efficacy|0|||
27746249|NCT02621931|54195811|FG001|Overall Study|Lack of Efficacy|0|||
27746250|NCT02621931|54195812|FG002|Overall Study|Lack of Efficacy|1|||
27746251|NCT02621931|54195810|FG000|Overall Study|Other|1|||
27746252|NCT02621931|54195811|FG001|Overall Study|Other|1|||
27746253|NCT02621931|54195812|FG002|Overall Study|Other|3|||
27746254|NCT02621073|54195824|FG000|Overall Study|Lost to Follow-up|0|||
27746255|NCT02621073|54195825|FG001|Overall Study|Lost to Follow-up|1|||
27746256|NCT02621073|54195824|FG000|Overall Study|Physician Decision|3|||
27746257|NCT02621073|54195825|FG001|Overall Study|Physician Decision|2|||
27746258|NCT02158936|54195833|FG000|Overall Study|Study closed/ terminated|57|||
27746259|NCT02158936|54195834|FG001|Overall Study|Study closed/ terminated|77|||
27746260|NCT02158936|54195833|FG000|Overall Study|Azacitidine tx discontinued|53|||
27746261|NCT02158936|54195834|FG001|Overall Study|Azacitidine tx discontinued|46|||
27746262|NCT02158936|54195833|FG000|Overall Study|Adverse Event|39|||
27746263|NCT02158936|54195834|FG001|Overall Study|Adverse Event|24|||
27746264|NCT02158936|54195833|FG000|Overall Study|Withdrawal by Subject|15|||
27746265|NCT02158936|54195834|FG001|Overall Study|Withdrawal by Subject|16|||
27746266|NCT02158936|54195833|FG000|Overall Study|Physician Decision|15|||
27746267|NCT02158936|54195834|FG001|Overall Study|Physician Decision|13|||
27746268|NCT02158936|54195833|FG000|Overall Study|Lost to Follow-up|0|||
27746269|NCT02158936|54195834|FG001|Overall Study|Lost to Follow-up|1|||
27746270|NCT02158546|54195844|FG000|Overall Study|Physician Decision|0|||
27746271|NCT02158546|54195845|FG001|Overall Study|Physician Decision|1|||
27746272|NCT02158546|54195846|FG002|Overall Study|Physician Decision|0|||
27746273|NCT02158546|54195847|FG003|Overall Study|Physician Decision|0|||
27746274|NCT02158546|54195844|FG000|Overall Study|Non-compliance|0|||
27746275|NCT02158546|54195845|FG001|Overall Study|Non-compliance|1|||
27746276|NCT02158546|54195846|FG002|Overall Study|Non-compliance|0|||
27746277|NCT02158546|54195847|FG003|Overall Study|Non-compliance|1|||
27746278|NCT02158546|54195844|FG000|Overall Study|Failure to meet eligibility criteria|0|||
27746279|NCT02158546|54195845|FG001|Overall Study|Failure to meet eligibility criteria|1|||
27746280|NCT02158546|54195846|FG002|Overall Study|Failure to meet eligibility criteria|0|||
27746281|NCT02158546|54195847|FG003|Overall Study|Failure to meet eligibility criteria|0|||
27746282|NCT02158546|54195844|FG000|Overall Study|Lack of Efficacy|1|||
27746283|NCT02158546|54195845|FG001|Overall Study|Lack of Efficacy|1|||
27746284|NCT02158546|54195846|FG002|Overall Study|Lack of Efficacy|0|||
27746290|NCT02158546|54195844|FG000|Overall Study|Withdrawal by Subject|6|||
27746291|NCT02158546|54195845|FG001|Overall Study|Withdrawal by Subject|2|||
27746292|NCT02158546|54195846|FG002|Overall Study|Withdrawal by Subject|1|||
27746293|NCT02158546|54195847|FG003|Overall Study|Withdrawal by Subject|0|||
27746294|NCT02158546|54195844|FG000|Overall Study|Lost to Follow-up|5|||
27746295|NCT02158546|54195845|FG001|Overall Study|Lost to Follow-up|4|||
27746296|NCT02158546|54195846|FG002|Overall Study|Lost to Follow-up|0|||
27746297|NCT02158546|54195847|FG003|Overall Study|Lost to Follow-up|1|||
27746298|NCT02158546|54195844|FG000|Overall Study|Site Excluded|5|||
27746299|NCT02158546|54195845|FG001|Overall Study|Site Excluded|5|||
27746300|NCT02158546|54195846|FG002|Overall Study|Site Excluded|3|||
27746301|NCT02158546|54195847|FG003|Overall Study|Site Excluded|4|||
27746302|NCT02123446|54195857|FG000|Washout Period (1 Day)|Physician Decision|1|||
27746303|NCT02123446|54195858|FG001|Washout Period (1 Day)|Physician Decision|0|||
27746304|NCT02123134|54195866|FG000|Overall Study|Withdrawal of consent|3|||
27746305|NCT02123134|54195867|FG001|Overall Study|Withdrawal of consent|2|||
27746306|NCT02123134|54195866|FG000|Overall Study|Administrative decision|0|||
27746307|NCT02123134|54195867|FG001|Overall Study|Administrative decision|1|||
27746308|NCT02185534|54195879|FG000|First Period|Withdrawal by Subject|0|||
27746309|NCT02185534|54195880|FG001|First Period|Withdrawal by Subject|0|||
27746310|NCT02185534|54195881|FG002|First Period|Withdrawal by Subject|0|||
27746311|NCT02185534|54195882|FG003|First Period|Withdrawal by Subject|1|||
27746312|NCT02185534|54195883|FG004|First Period|Withdrawal by Subject|0|||
27746313|NCT02185534|54195884|FG005|First Period|Withdrawal by Subject|0|||
27746314|NCT02185534|54195879|FG000|First Washout Period|Withdrawal by Subject|1|||
27746315|NCT02185534|54195880|FG001|First Washout Period|Withdrawal by Subject|0|||
27746316|NCT02185534|54195881|FG002|First Washout Period|Withdrawal by Subject|0|||
27746317|NCT02185534|54195882|FG003|First Washout Period|Withdrawal by Subject|0|||
27746318|NCT02185534|54195883|FG004|First Washout Period|Withdrawal by Subject|1|||
27746319|NCT02185534|54195884|FG005|First Washout Period|Withdrawal by Subject|0|||
27746320|NCT02185534|54195879|FG000|First Washout Period|Protocol Violation|0|||
27746321|NCT02185534|54195880|FG001|First Washout Period|Protocol Violation|0|||
27746322|NCT02185534|54195881|FG002|First Washout Period|Protocol Violation|0|||
27746323|NCT02185534|54195882|FG003|First Washout Period|Protocol Violation|0|||
27746324|NCT02185534|54195883|FG004|First Washout Period|Protocol Violation|0|||
27746325|NCT02185534|54195884|FG005|First Washout Period|Protocol Violation|1|||
27746326|NCT02121808|54195893|FG000|Overall Study|Technical problem|3|||
27746327|NCT02157376|54195904|FG000|Overall Study|Death|10|||
27746328|NCT02157376|54195905|FG001|Overall Study|Death|4|||
27746329|NCT02157376|54195904|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
27746330|NCT02157376|54195905|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
27746331|NCT02157376|54195904|FG000|Overall Study|Withdrawal by Subject|3|||
27746332|NCT02157376|54195905|FG001|Overall Study|Withdrawal by Subject|8|||
27746333|NCT02157376|54195904|FG000|Overall Study|Not treated|8|||
27746334|NCT02157376|54195905|FG001|Overall Study|Not treated|3|||
27746335|NCT02157376|54195904|FG000|Overall Study|Investigator's misjudgement|1|||
27746336|NCT02157376|54195905|FG001|Overall Study|Investigator's misjudgement|2|||
27746337|NCT02157298|54195913|FG000|Overall Study|Adverse Event|1|||
27746338|NCT02157298|54195914|FG001|Overall Study|Adverse Event|0|||
27746339|NCT02157298|54195913|FG000|Overall Study|Subject no longer meets study criteria|1|||
27746340|NCT02157298|54195914|FG001|Overall Study|Subject no longer meets study criteria|2|||
27746341|NCT02157298|54195913|FG000|Overall Study|Poor/Non-compliance|1|||
27746342|NCT02157298|54195914|FG001|Overall Study|Poor/Non-compliance|0|||
27746343|NCT02157298|54195913|FG000|Overall Study|Withdrawal by Subject|1|||
27746344|NCT02157298|54195914|FG001|Overall Study|Withdrawal by Subject|0|||
27746345|NCT02184988|54195920|FG000|Overall Study|Pregnancy|2|||
27746346|NCT02184988|54195920|FG000|Overall Study|Adverse Event|2|||
27746347|NCT02184988|54195920|FG000|Overall Study|moving away/travelling/unable to complet|6|||
27746348|NCT02184988|54195920|FG000|Overall Study|work scheduling issues|4|||
27746349|NCT02184988|54195920|FG000|Overall Study|various other reasons|9|||
27746350|NCT02184988|54195920|FG000|Overall Study|Lost to Follow-up|32|||
27746351|NCT02121262|54195926|FG000|Overall Study|Adverse Event|6|||
27746352|NCT02121262|54195927|FG001|Overall Study|Adverse Event|3|||
27746353|NCT02121262|54195926|FG000|Overall Study|Lack of Efficacy|3|||
27746354|NCT02121262|54195927|FG001|Overall Study|Lack of Efficacy|0|||
27746355|NCT02121262|54195926|FG000|Overall Study|Personal Reasons|19|||
27746356|NCT02121262|54195927|FG001|Overall Study|Personal Reasons|5|||
27746357|NCT02121262|54195926|FG000|Overall Study|Protocol Violation|1|||
27746358|NCT02121262|54195927|FG001|Overall Study|Protocol Violation|1|||
27746359|NCT02121262|54195926|FG000|Overall Study|Participant Dropped-out|0|||
27746360|NCT02121262|54195927|FG001|Overall Study|Participant Dropped-out|1|||
27746361|NCT02121262|54195926|FG000|Overall Study|Participant was Deemed Unsuitable|1|||
27746362|NCT02121262|54195927|FG001|Overall Study|Participant was Deemed Unsuitable|0|||
27746363|NCT02121262|54195926|FG000|Overall Study|Consent Withdrawn|1|||
27746364|NCT02121262|54195927|FG001|Overall Study|Consent Withdrawn|0|||
27746365|NCT02120950|54195935|FG000|Overall Study|Adverse Event|5|||
27746366|NCT02120950|54195936|FG001|Overall Study|Adverse Event|4|||
27746371|NCT02120950|54195935|FG000|Overall Study|Withdrawal by Subject|6|||
27746372|NCT02120950|54195936|FG001|Overall Study|Withdrawal by Subject|3|||
27746373|NCT02120950|54195937|FG002|Overall Study|Withdrawal by Subject|2|||
27746374|NCT02120950|54195935|FG000|Overall Study|Protocol Violation|1|||
27746375|NCT02120950|54195936|FG001|Overall Study|Protocol Violation|1|||
27746376|NCT02120950|54195937|FG002|Overall Study|Protocol Violation|7|||
27746377|NCT02120950|54195935|FG000|Overall Study|Other reasons|5|||
27746378|NCT02120950|54195936|FG001|Overall Study|Other reasons|4|||
27746379|NCT02120950|54195937|FG002|Overall Study|Other reasons|1|||
27746380|NCT02120950|54195935|FG000|Overall Study|Lost to Follow-up|0|||
27746381|NCT02120950|54195936|FG001|Overall Study|Lost to Follow-up|2|||
27746382|NCT02120950|54195937|FG002|Overall Study|Lost to Follow-up|1|||
27746383|NCT02120794|54195944|FG000|Overall Study|Withdrawal by Subject|43|||
27746384|NCT02120794|54195944|FG000|Overall Study|Adverse Event|10|||
27746385|NCT02120794|54195944|FG000|Overall Study|Physician Decision|4|||
27746386|NCT02120794|54195944|FG000|Overall Study|Due to insurance coverage|1|||
27746387|NCT02184442|54195950|FG000|Overall Study|Death|61|||
27746388|NCT02184442|54195951|FG001|Overall Study|Death|65|||
27746389|NCT02184442|54195950|FG000|Overall Study|Withdrawal by Subject|3|||
27746390|NCT02184442|54195951|FG001|Overall Study|Withdrawal by Subject|11|||
27746391|NCT02155738|54195961|FG000|Overall Study|Missing critical information|1|||
27746392|NCT02155738|54195962|FG001|Overall Study|Missing critical information|0|||
27746393|NCT02155738|54195963|FG002|Overall Study|Missing critical information|0|||
27746394|NCT02155738|54195964|FG003|Overall Study|Missing critical information|1|||
27746395|NCT02181790|54195976|FG000|Overall Study|study terminated|2|||
27746396|NCT02181790|54195977|FG001|Overall Study|study terminated|0|||
27746397|NCT02618967|54195993|FG000|Overall Study|Lost to Follow-up|0|||
27746398|NCT02618967|54195994|FG001|Overall Study|Lost to Follow-up|0|||
27746399|NCT02618967|54195995|FG002|Overall Study|Lost to Follow-up|1|||
27746400|NCT02618967|54195996|FG003|Overall Study|Lost to Follow-up|0|||
27746401|NCT02618967|54195997|FG004|Overall Study|Lost to Follow-up|2|||
27746402|NCT02618967|54195998|FG005|Overall Study|Lost to Follow-up|0|||
27746403|NCT02618967|54195999|FG006|Overall Study|Lost to Follow-up|0|||
27746404|NCT02618967|54196000|FG007|Overall Study|Lost to Follow-up|0|||
27746405|NCT02618967|54195993|FG000|Overall Study|Withdrawal by Subject|1|||
27746406|NCT02618967|54195994|FG001|Overall Study|Withdrawal by Subject|0|||
27746407|NCT02618967|54195995|FG002|Overall Study|Withdrawal by Subject|0|||
27746408|NCT02618967|54195996|FG003|Overall Study|Withdrawal by Subject|0|||
27746409|NCT02618967|54195997|FG004|Overall Study|Withdrawal by Subject|0|||
27746410|NCT02618967|54195998|FG005|Overall Study|Withdrawal by Subject|0|||
27746411|NCT02618967|54195999|FG006|Overall Study|Withdrawal by Subject|0|||
27746412|NCT02618967|54196000|FG007|Overall Study|Withdrawal by Subject|0|||
27746413|NCT02616783|54196020|FG000|Overall Study|Randomized but Not Treated|1|||
27746414|NCT02616783|54196021|FG001|Overall Study|Randomized but Not Treated|0|||
27746415|NCT02616783|54196020|FG000|Overall Study|Adverse Event|1|||
27746416|NCT02616783|54196021|FG001|Overall Study|Adverse Event|0|||
27746417|NCT02616783|54196020|FG000|Overall Study|Death|1|||
27746418|NCT02616783|54196021|FG001|Overall Study|Death|0|||
27746419|NCT02616783|54196020|FG000|Overall Study|Non-Compliance with Study Drug|1|||
27746420|NCT02616783|54196021|FG001|Overall Study|Non-Compliance with Study Drug|0|||
27746421|NCT02616783|54196020|FG000|Overall Study|Protocol Violation|1|||
27746422|NCT02616783|54196021|FG001|Overall Study|Protocol Violation|1|||
27746423|NCT02616783|54196020|FG000|Overall Study|Withdrew Consent|1|||
27746424|NCT02616783|54196021|FG001|Overall Study|Withdrew Consent|1|||
27746425|NCT02616393|54196030|FG000|Overall Study|Death|5|||
27746426|NCT02616393|54196031|FG001|Overall Study|Death|12|||
27746427|NCT02616393|54196032|FG002|Overall Study|Death|1|||
27746428|NCT02616393|54196030|FG000|Overall Study|Termination by Sponsor|4|||
27746429|NCT02616393|54196031|FG001|Overall Study|Termination by Sponsor|5|||
27746430|NCT02616393|54196032|FG002|Overall Study|Termination by Sponsor|2|||
27746431|NCT02616393|54196030|FG000|Overall Study|Other|3|||
27746432|NCT02616393|54196031|FG001|Overall Study|Other|0|||
27746433|NCT02616393|54196032|FG002|Overall Study|Other|0|||
27746434|NCT02616393|54196030|FG000|Overall Study|Withdrawal by Subject|1|||
27746435|NCT02616393|54196031|FG001|Overall Study|Withdrawal by Subject|1|||
27746436|NCT02616393|54196032|FG002|Overall Study|Withdrawal by Subject|0|||
27746437|NCT02616393|54196030|FG000|Overall Study|Lost to Follow-up|0|||
27746438|NCT02616393|54196031|FG001|Overall Study|Lost to Follow-up|2|||
27746439|NCT02616393|54196032|FG002|Overall Study|Lost to Follow-up|0|||
27746440|NCT02155660|54196060|FG000|Overall Study|Other Reason|8|||
27746441|NCT02155660|54196061|FG001|Overall Study|Other Reason|6|||
27746442|NCT02155660|54196062|FG002|Overall Study|Other Reason|10|||
27746443|NCT02155660|54196063|FG003|Overall Study|Other Reason|10|||
27746444|NCT02155660|54196060|FG000|Overall Study|Study-specific withdrawal criteria|0|||
27746445|NCT02155660|54196061|FG001|Overall Study|Study-specific withdrawal criteria|1|||
27746446|NCT02155660|54196062|FG002|Overall Study|Study-specific withdrawal criteria|1|||
27746447|NCT02155660|54196063|FG003|Overall Study|Study-specific withdrawal criteria|1|||
27746448|NCT02155660|54196060|FG000|Overall Study|Severe non-compliance|0|||
27746449|NCT02155660|54196061|FG001|Overall Study|Severe non-compliance|4|||
27746450|NCT02155660|54196062|FG002|Overall Study|Severe non-compliance|0|||
27746451|NCT02155660|54196063|FG003|Overall Study|Severe non-compliance|1|||
27746452|NCT02155660|54196060|FG000|Overall Study|Adverse Event|2|||
27746453|NCT02155660|54196061|FG001|Overall Study|Adverse Event|6|||
27746454|NCT02155660|54196062|FG002|Overall Study|Adverse Event|3|||
27746455|NCT02155660|54196063|FG003|Overall Study|Adverse Event|1|||
27746456|NCT02155660|54196060|FG000|Overall Study|Lost to Follow-up|3|||
27746457|NCT02155660|54196061|FG001|Overall Study|Lost to Follow-up|6|||
27746458|NCT02155660|54196062|FG002|Overall Study|Lost to Follow-up|5|||
27746459|NCT02155660|54196063|FG003|Overall Study|Lost to Follow-up|8|||
27746460|NCT02155660|54196060|FG000|Overall Study|Death|17|||
27746461|NCT02155660|54196061|FG001|Overall Study|Death|19|||
27746462|NCT02155660|54196062|FG002|Overall Study|Death|17|||
27746463|NCT02155660|54196063|FG003|Overall Study|Death|19|||
27746464|NCT02155660|54196060|FG000|Overall Study|Withdrawal by Subject|28|||
27746465|NCT02155660|54196061|FG001|Overall Study|Withdrawal by Subject|31|||
27746466|NCT02155660|54196062|FG002|Overall Study|Withdrawal by Subject|24|||
27746467|NCT02155660|54196063|FG003|Overall Study|Withdrawal by Subject|21|||
27746468|NCT02119936|54196073|FG000|Overall Study|Lost to Follow-up|10|||
27746469|NCT02181634|54196077|FG000|Overall Study|Lack of Efficacy|33|||
27746470|NCT02181634|54196077|FG000|Overall Study|Adverse Event|17|||
27746471|NCT02181634|54196077|FG000|Overall Study|Physician Decision|8|||
27746472|NCT02181634|54196077|FG000|Overall Study|Withdrawal by Subject|5|||
27746473|NCT02181634|54196077|FG000|Overall Study|Death|2|||
27746474|NCT02181634|54196077|FG000|Overall Study|Treatment delayed greater than 4 weeks|3|||
27746475|NCT02181634|54196077|FG000|Overall Study|Ineligible|1|||
27746476|NCT02181634|54196077|FG000|Overall Study|Max number of dose reduction|1|||
27746477|NCT02181634|54196077|FG000|Overall Study|Symptomatic progression|1|||
27746478|NCT02181634|54196077|FG000|Overall Study|Patient opted to proceed to surgery|1|||
27746479|NCT01595529|54196083|FG000|Overall Study|Adverse Event|2|||
27746480|NCT01595529|54196084|FG001|Overall Study|Adverse Event|0|||
27746481|NCT01595529|54196083|FG000|Overall Study|Subject Non-Compliant|2|||
27746482|NCT01595529|54196084|FG001|Overall Study|Subject Non-Compliant|0|||
27746483|NCT01595529|54196083|FG000|Overall Study|Lost to Follow-up|8|||
27746484|NCT01595529|54196084|FG001|Overall Study|Lost to Follow-up|14|||
27746485|NCT01595529|54196083|FG000|Overall Study|Protocol Violation|1|||
27746486|NCT01595529|54196084|FG001|Overall Study|Protocol Violation|2|||
27746487|NCT01595529|54196083|FG000|Overall Study|Physician Decision|1|||
27746488|NCT01595529|54196084|FG001|Overall Study|Physician Decision|0|||
27746489|NCT01595529|54196083|FG000|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
27746490|NCT01595529|54196084|FG001|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
27746491|NCT01595529|54196083|FG000|Overall Study|Administrative Decision|1|||
27746492|NCT01595529|54196084|FG001|Overall Study|Administrative Decision|0|||
27746493|NCT01595529|54196083|FG000|Overall Study|Entry Failure/Screening Failure|6|||
27746494|NCT01595529|54196084|FG001|Overall Study|Entry Failure/Screening Failure|1|||
27746495|NCT02615145|54196093|FG000|Overall Study|Did Not Start Treatment|0|||
27746496|NCT02615145|54196094|FG001|Overall Study|Did Not Start Treatment|0|||
27746497|NCT02615145|54196095|FG002|Overall Study|Did Not Start Treatment|1|||
27746498|NCT02615145|54196096|FG003|Overall Study|Did Not Start Treatment|1|||
27746499|NCT02615145|54196093|FG000|Overall Study|Failure to Return|20|||
27746500|NCT02615145|54196094|FG001|Overall Study|Failure to Return|10|||
27746501|NCT02615145|54196095|FG002|Overall Study|Failure to Return|7|||
27746502|NCT02615145|54196096|FG003|Overall Study|Failure to Return|0|||
27746503|NCT02615145|54196093|FG000|Overall Study|Death|2|||
27746504|NCT02615145|54196094|FG001|Overall Study|Death|3|||
27746505|NCT02615145|54196095|FG002|Overall Study|Death|0|||
27746506|NCT02615145|54196096|FG003|Overall Study|Death|0|||
27746507|NCT02615145|54196093|FG000|Overall Study|Other, Not Specified|5|||
27746508|NCT02615145|54196094|FG001|Overall Study|Other, Not Specified|2|||
27746509|NCT02615145|54196095|FG002|Overall Study|Other, Not Specified|0|||
27746510|NCT02615145|54196096|FG003|Overall Study|Other, Not Specified|0|||
27746511|NCT02119156|54196125|FG000|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
27746512|NCT02119156|54196126|FG001|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
27746513|NCT02119156|54196127|FG002|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1|||
27746514|NCT02119156|54196125|FG000|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4|||
27746515|NCT02119156|54196126|FG001|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
27746516|NCT02119156|54196127|FG002|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
27746517|NCT02119156|54196125|FG000|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1|||
27746518|NCT02119156|54196126|FG001|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2|||
27746519|NCT02119156|54196127|FG002|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0|||
27746520|NCT02119156|54196125|FG000|Treatment Phase (Up to 52 Weeks)|Physician Decision|1|||
27746521|NCT02119156|54196126|FG001|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
27746522|NCT02119156|54196127|FG002|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
27746523|NCT02119156|54196125|FG000|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0|||
27746524|NCT02119156|54196126|FG001|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10|||
27746525|NCT02119156|54196127|FG002|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7|||
27746526|NCT02181556|54196142|FG000|Overall Study|Withdrawal by Subject|1|||
27746527|NCT02614131|54196153|FG000|Overall Study|Withdrawal by Subject|1|||
27746528|NCT02614131|54196154|FG001|Overall Study|Withdrawal by Subject|0|||
27746529|NCT02614131|54196155|FG002|Overall Study|Withdrawal by Subject|0|||
27746530|NCT02614131|54196156|FG003|Overall Study|Withdrawal by Subject|0|||
27746531|NCT02614131|54196157|FG004|Overall Study|Withdrawal by Subject|0|||
27746532|NCT02614131|54196158|FG005|Overall Study|Withdrawal by Subject|0|||
27746533|NCT02614131|54196159|FG006|Overall Study|Withdrawal by Subject|0|||
27746534|NCT02614131|54196153|FG000|Overall Study|Adverse Event|0|||
27746535|NCT02614131|54196154|FG001|Overall Study|Adverse Event|0|||
27746536|NCT02614131|54196155|FG002|Overall Study|Adverse Event|0|||
27746537|NCT02614131|54196156|FG003|Overall Study|Adverse Event|0|||
27746538|NCT02614131|54196157|FG004|Overall Study|Adverse Event|0|||
27746539|NCT02614131|54196158|FG005|Overall Study|Adverse Event|0|||
27746540|NCT02614131|54196159|FG006|Overall Study|Adverse Event|1|||
27746541|NCT01903733|54196185|FG000|Overall Study|Death|23|||
27746542|NCT01903733|54196186|FG001|Overall Study|Death|54|||
27746543|NCT01903733|54196187|FG002|Overall Study|Death|30|||
27746544|NCT01903733|54196188|FG003|Overall Study|Death|98|||
27746545|NCT01903733|54196185|FG000|Overall Study|Participant refused further follow-up|35|||
27746546|NCT01903733|54196186|FG001|Overall Study|Participant refused further follow-up|38|||
27746547|NCT01903733|54196187|FG002|Overall Study|Participant refused further follow-up|13|||
27746548|NCT01903733|54196188|FG003|Overall Study|Participant refused further follow-up|9|||
27746549|NCT01903733|54196185|FG000|Overall Study|Lost to Follow-up|18|||
27746550|NCT01903733|54196186|FG001|Overall Study|Lost to Follow-up|19|||
27746551|NCT01903733|54196187|FG002|Overall Study|Lost to Follow-up|6|||
27746552|NCT01903733|54196188|FG003|Overall Study|Lost to Follow-up|9|||
27746553|NCT01903733|54196185|FG000|Overall Study|Other|10|||
27746554|NCT01903733|54196186|FG001|Overall Study|Other|15|||
27746555|NCT01903733|54196187|FG002|Overall Study|Other|12|||
27746556|NCT01903733|54196188|FG003|Overall Study|Other|3|||
27746557|NCT01903733|54196185|FG000|Overall Study|Missing|2|||
27746558|NCT01903733|54196186|FG001|Overall Study|Missing|0|||
27746559|NCT01903733|54196187|FG002|Overall Study|Missing|0|||
27746560|NCT01903733|54196188|FG003|Overall Study|Missing|0|||
27746561|NCT01903733|54196185|FG000|Overall Study|Investigator request|18|||
27746562|NCT01903733|54196186|FG001|Overall Study|Investigator request|0|||
27746563|NCT01903733|54196187|FG002|Overall Study|Investigator request|0|||
27746564|NCT01903733|54196188|FG003|Overall Study|Investigator request|0|||
27746565|NCT01375205|54196210|FG000|Overall Study|Lost to Follow-up|15|||
27746566|NCT01375205|54196211|FG001|Overall Study|Lost to Follow-up|12|||
27746567|NCT01375205|54196210|FG000|Overall Study|Withdrawal by Subject|6|||
27746568|NCT01375205|54196211|FG001|Overall Study|Withdrawal by Subject|1|||
27746569|NCT00700271|54196219|FG000|Overall Study|Adverse Event|4|||
27746570|NCT00700271|54196220|FG001|Overall Study|Adverse Event|6|||
27746571|NCT00700271|54196219|FG000|Overall Study|Protocol Violation|1|||
27746572|NCT00700271|54196220|FG001|Overall Study|Protocol Violation|0|||
27746573|NCT00700271|54196219|FG000|Overall Study|Administrative Reasons|1|||
27746574|NCT00700271|54196220|FG001|Overall Study|Administrative Reasons|0|||
27746575|NCT00700271|54196219|FG000|Overall Study|Withdrawal by Subject|6|||
27746576|NCT00700271|54196220|FG001|Overall Study|Withdrawal by Subject|4|||
27746577|NCT00700271|54196219|FG000|Overall Study|Lost to Follow-up|2|||
27746578|NCT00700271|54196220|FG001|Overall Study|Lost to Follow-up|2|||
27746579|NCT02613507|54196228|FG000|Overall Study|Disease Progression|237|||
27746580|NCT02613507|54196229|FG001|Overall Study|Disease Progression|109|||
27746581|NCT02613507|54196228|FG000|Overall Study|Study Drug Toxicity|15|||
27746582|NCT02613507|54196229|FG001|Overall Study|Study Drug Toxicity|14|||
27746583|NCT02613507|54196228|FG000|Overall Study|Death|3|||
27746584|NCT02613507|54196229|FG001|Overall Study|Death|0|||
27746585|NCT02613507|54196228|FG000|Overall Study|Adverse Event Unrelated to Study Drug|17|||
27746586|NCT02613507|54196229|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
27746587|NCT02613507|54196228|FG000|Overall Study|Request to Discontinue Study Treatment|8|||
27746588|NCT02613507|54196229|FG001|Overall Study|Request to Discontinue Study Treatment|17|||
27746589|NCT02613507|54196228|FG000|Overall Study|Participant Withdrew Consent|0|||
27746590|NCT02613507|54196229|FG001|Overall Study|Participant Withdrew Consent|2|||
27746591|NCT02613507|54196228|FG000|Overall Study|Lost to Follow-up|1|||
27746592|NCT02613507|54196229|FG001|Overall Study|Lost to Follow-up|0|||
27746593|NCT02613507|54196228|FG000|Overall Study|Maximum Clinical Benefit|4|||
27746594|NCT02613507|54196229|FG001|Overall Study|Maximum Clinical Benefit|10|||
27746595|NCT02613507|54196228|FG000|Overall Study|Brain Radiotherapy Activity Limited|1|||
27746596|NCT02613507|54196229|FG001|Overall Study|Brain Radiotherapy Activity Limited|0|||
27746597|NCT02613507|54196228|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
27746598|NCT02613507|54196229|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
27746599|NCT02613507|54196228|FG000|Overall Study|Randomized but not Treated|1|||
27746600|NCT02613507|54196229|FG001|Overall Study|Randomized but not Treated|10|||
27746603|NCT01375049|54196235|FG000|Overall Study|Withdrawal by Subject|2|||
27746604|NCT01375049|54196235|FG000|Overall Study|Protocol-Specified Withdrawal Criteria|45|||
27746605|NCT01594749|54196245|FG000|Overall Study|Adverse Event|2|||
27746606|NCT01594749|54196246|FG001|Overall Study|Adverse Event|1|||
27746607|NCT01594749|54196245|FG000|Overall Study|Withdrawal by Subject|2|||
27746608|NCT01594749|54196246|FG001|Overall Study|Withdrawal by Subject|2|||
27746609|NCT01594749|54196245|FG000|Overall Study|Protocol Violation|2|||
27746610|NCT01594749|54196246|FG001|Overall Study|Protocol Violation|0|||
27746611|NCT01594749|54196245|FG000|Overall Study|Physician Decision|1|||
27746612|NCT01594749|54196246|FG001|Overall Study|Physician Decision|1|||
27746613|NCT01594749|54196245|FG000|Overall Study|Non-compliance with Protocol|0|||
27746614|NCT01594749|54196246|FG001|Overall Study|Non-compliance with Protocol|1|||
27746615|NCT01594749|54196245|FG000|Overall Study|Lost to Follow-up|1|||
27746616|NCT01594749|54196246|FG001|Overall Study|Lost to Follow-up|0|||
27746617|NCT01594749|54196245|FG000|Overall Study|Death|9|||
27746618|NCT01594749|54196246|FG001|Overall Study|Death|3|||
27746619|NCT01594749|54196245|FG000|Overall Study|Not Treated|4|||
27746620|NCT01594749|54196246|FG001|Overall Study|Not Treated|10|||
27746621|NCT01594749|54196245|FG000|Overall Study|Lost Source Documentation|1|||
27746622|NCT01594749|54196246|FG001|Overall Study|Lost Source Documentation|0|||
27746623|NCT02179918|54196257|FG000|Overall Study|Death|0|||
27746624|NCT02179918|54196258|FG001|Overall Study|Death|0|||
27746625|NCT02179918|54196259|FG002|Overall Study|Death|0|||
27746626|NCT02179918|54196260|FG003|Overall Study|Death|1|||
27746627|NCT02179918|54196261|FG004|Overall Study|Death|0|||
27746628|NCT02179918|54196257|FG000|Overall Study|Lost to Follow-up|0|||
27746629|NCT02179918|54196258|FG001|Overall Study|Lost to Follow-up|0|||
27746630|NCT02179918|54196259|FG002|Overall Study|Lost to Follow-up|1|||
27746631|NCT02179918|54196260|FG003|Overall Study|Lost to Follow-up|0|||
27746632|NCT02179918|54196261|FG004|Overall Study|Lost to Follow-up|0|||
27746633|NCT02179918|54196257|FG000|Overall Study|Progressive Disease|4|||
27746634|NCT02179918|54196258|FG001|Overall Study|Progressive Disease|1|||
27746635|NCT02179918|54196259|FG002|Overall Study|Progressive Disease|1|||
27746636|NCT02179918|54196260|FG003|Overall Study|Progressive Disease|2|||
27746637|NCT02179918|54196261|FG004|Overall Study|Progressive Disease|6|||
27746638|NCT02179918|54196257|FG000|Overall Study|Other|0|||
27746639|NCT02179918|54196258|FG001|Overall Study|Other|1|||
27746640|NCT02179918|54196259|FG002|Overall Study|Other|0|||
27746641|NCT02179918|54196260|FG003|Overall Study|Other|0|||
27746642|NCT02179918|54196261|FG004|Overall Study|Other|1|||
27746643|NCT02179918|54196257|FG000|Overall Study|Subject refused further follow-up|0|||
27746644|NCT02179918|54196258|FG001|Overall Study|Subject refused further follow-up|1|||
27746645|NCT02179918|54196259|FG002|Overall Study|Subject refused further follow-up|0|||
27746646|NCT02179918|54196260|FG003|Overall Study|Subject refused further follow-up|0|||
27746647|NCT02179918|54196261|FG004|Overall Study|Subject refused further follow-up|1|||
27746648|NCT02611479|54196274|FG000|Baseline Enrollment|Exited study|13|||
27746649|NCT02611479|54196274|FG000|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2|||
27746650|NCT02611479|54196274|FG000|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18|||
27746651|NCT02611479|54196274|FG000|Data Cleaning|No baseline function or pain metrics|2|||
27746652|NCT02153788|54196280|FG000|Overall Study|Physician Decision|2|||
27746653|NCT02153788|54196281|FG001|Overall Study|Physician Decision|1|||
27746654|NCT02153398|54196292|FG000|Overall Study|Withdrawal by Subject|1|||
27746655|NCT02153398|54196293|FG001|Overall Study|Withdrawal by Subject|0|||
27746656|NCT02153398|54196294|FG002|Overall Study|Withdrawal by Subject|0|||
27746657|NCT02153398|54196295|FG003|Overall Study|Withdrawal by Subject|0|||
27746658|NCT02153398|54196296|FG004|Overall Study|Withdrawal by Subject|0|||
27746659|NCT02153398|54196292|FG000|Overall Study|Adverse Event|0|||
27746660|NCT02153398|54196293|FG001|Overall Study|Adverse Event|0|||
27746661|NCT02153398|54196294|FG002|Overall Study|Adverse Event|1|||
27746662|NCT02153398|54196295|FG003|Overall Study|Adverse Event|1|||
27746663|NCT02153398|54196296|FG004|Overall Study|Adverse Event|0|||
27746664|NCT02118766|54196310|FG000|Overall Study|Adverse Event|7|||
27746665|NCT02118766|54196311|FG001|Overall Study|Adverse Event|2|||
27746666|NCT02118766|54196310|FG000|Overall Study|Withdrawal by Subject|3|||
27746667|NCT02118766|54196311|FG001|Overall Study|Withdrawal by Subject|6|||
27746668|NCT02118766|54196310|FG000|Overall Study|Lost to Follow-up|5|||
27746669|NCT02118766|54196311|FG001|Overall Study|Lost to Follow-up|4|||
27746670|NCT02118766|54196310|FG000|Overall Study|Withdrawal by parent/guardian|12|||
27746671|NCT02118766|54196311|FG001|Overall Study|Withdrawal by parent/guardian|18|||
27746672|NCT02118766|54196310|FG000|Overall Study|Other|3|||
27746673|NCT02118766|54196311|FG001|Overall Study|Other|1|||
27746674|NCT02614287|54196319|FG000|Open Label (OL) Treatment Phase|Adverse Event|7|||
27746675|NCT02614287|54196320|FG001|Open Label (OL) Treatment Phase|Adverse Event|6|||
27746676|NCT02614287|54196319|FG000|Open Label (OL) Treatment Phase|Lack of Efficacy|13|||
27746677|NCT02614287|54196320|FG001|Open Label (OL) Treatment Phase|Lack of Efficacy|5|||
27746678|NCT02614287|54196319|FG000|Open Label (OL) Treatment Phase|Lost to Follow-up|7|||
27746679|NCT02614287|54196320|FG001|Open Label (OL) Treatment Phase|Lost to Follow-up|4|||
27746680|NCT02614287|54196319|FG000|Open Label (OL) Treatment Phase|Physician Decision|1|||
27746681|NCT02614287|54196320|FG001|Open Label (OL) Treatment Phase|Physician Decision|0|||
27746682|NCT02614287|54196319|FG000|Open Label (OL) Treatment Phase|Withdrawal by Subject|10|||
27746683|NCT02614287|54196320|FG001|Open Label (OL) Treatment Phase|Withdrawal by Subject|7|||
27746684|NCT02614287|54196319|FG000|Post Treatment Follow-up Phase|Adverse Event|1|||
27746685|NCT02614287|54196320|FG001|Post Treatment Follow-up Phase|Adverse Event|0|||
27746686|NCT02614287|54196319|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
27746687|NCT02614287|54196320|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
27746688|NCT02614287|54196319|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|6|||
27746689|NCT02614287|54196320|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|3|||
27746690|NCT01374971|54196331|FG000|Overall Study|Withdrawal by Subject|1|||
27746691|NCT02178592|54196337|FG000|Randomized Phase (Up to Week 52)|Adverse Event|0|||
27746692|NCT02178592|54196338|FG001|Randomized Phase (Up to Week 52)|Adverse Event|2|||
27746693|NCT02178592|54196337|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
27746694|NCT02178592|54196338|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
27746695|NCT02178592|54196337|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|3|||
27746696|NCT02178592|54196338|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|2|||
27746697|NCT02178592|54196337|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3|||
27746698|NCT02178592|54196338|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1|||
27746699|NCT02178592|54196337|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|11|||
27746700|NCT02178592|54196338|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|3|||
27746701|NCT02178592|54196337|FG000|Randomized Phase (Up to Week 52)|Physician Decision|1|||
27746702|NCT02178592|54196338|FG001|Randomized Phase (Up to Week 52)|Physician Decision|0|||
27746703|NCT02178592|54196337|FG000|OLE Phase (Week 52 to Week 252)|Adverse Event|1|||
27746704|NCT02178592|54196338|FG001|OLE Phase (Week 52 to Week 252)|Adverse Event|0|||
27746705|NCT02178592|54196337|FG000|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0|||
27746706|NCT02178592|54196338|FG001|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1|||
27746707|NCT02178592|54196337|FG000|OLE Phase (Week 52 to Week 252)|Protocol Violation|2|||
27746708|NCT02178592|54196338|FG001|OLE Phase (Week 52 to Week 252)|Protocol Violation|0|||
27746709|NCT02178592|54196337|FG000|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4|||
27746710|NCT02178592|54196338|FG001|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1|||
27746711|NCT02178592|54196337|FG000|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2|||
27746712|NCT02178592|54196338|FG001|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0|||
27746713|NCT02178592|54196337|FG000|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3|||
27746714|NCT02178592|54196338|FG001|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1|||
27746715|NCT02610777|54196349|FG000|Overall Study|Lost to Follow-up|1|||
27746716|NCT02610777|54196350|FG001|Overall Study|Lost to Follow-up|0|||
27746717|NCT02610777|54196349|FG000|Overall Study|Site Terminated by Sponsor|9|||
27746718|NCT02610777|54196350|FG001|Overall Study|Site Terminated by Sponsor|8|||
27746719|NCT02610777|54196349|FG000|Overall Study|Withdrawal by Subject|2|||
27746720|NCT02610777|54196350|FG001|Overall Study|Withdrawal by Subject|2|||
27746721|NCT02610777|54196349|FG000|Overall Study|Reason not Specified|0|||
27746722|NCT02610777|54196350|FG001|Overall Study|Reason not Specified|1|||
27746723|NCT02610777|54196349|FG000|Overall Study|Death|50|||
27746724|NCT02610777|54196350|FG001|Overall Study|Death|47|||
27746725|NCT01628692|54196364|FG000|Overall Study|Lack of Efficacy|4|||
27746726|NCT01628692|54196365|FG001|Overall Study|Lack of Efficacy|4|||
27746727|NCT01628692|54196366|FG002|Overall Study|Lack of Efficacy|5|||
27746728|NCT01628692|54196367|FG003|Overall Study|Lack of Efficacy|1|||
27746729|NCT01628692|54196368|FG004|Overall Study|Lack of Efficacy|4|||
27746730|NCT01628692|54196369|FG005|Overall Study|Lack of Efficacy|7|||
27746731|NCT01628692|54196364|FG000|Overall Study|Adverse Event|2|||
27746732|NCT01628692|54196365|FG001|Overall Study|Adverse Event|0|||
27746733|NCT01628692|54196366|FG002|Overall Study|Adverse Event|2|||
27746734|NCT01628692|54196367|FG003|Overall Study|Adverse Event|0|||
27746735|NCT01628692|54196368|FG004|Overall Study|Adverse Event|0|||
27746736|NCT01628692|54196369|FG005|Overall Study|Adverse Event|0|||
27746737|NCT01628692|54196364|FG000|Overall Study|Withdrawal by Subject|0|||
27746738|NCT01628692|54196365|FG001|Overall Study|Withdrawal by Subject|1|||
27746739|NCT01628692|54196366|FG002|Overall Study|Withdrawal by Subject|1|||
27746740|NCT01628692|54196367|FG003|Overall Study|Withdrawal by Subject|0|||
27746741|NCT01628692|54196368|FG004|Overall Study|Withdrawal by Subject|0|||
27746742|NCT01628692|54196369|FG005|Overall Study|Withdrawal by Subject|0|||
27746743|NCT01628692|54196364|FG000|Overall Study|Death|0|||
27746744|NCT01628692|54196365|FG001|Overall Study|Death|1|||
27746745|NCT01628692|54196366|FG002|Overall Study|Death|0|||
27746746|NCT01628692|54196367|FG003|Overall Study|Death|0|||
27746747|NCT01628692|54196368|FG004|Overall Study|Death|0|||
27746748|NCT01628692|54196369|FG005|Overall Study|Death|0|||
27746749|NCT01628692|54196364|FG000|Overall Study|Poor compliance/noncompliance|1|||
27746750|NCT01628692|54196365|FG001|Overall Study|Poor compliance/noncompliance|0|||
27746751|NCT01628692|54196366|FG002|Overall Study|Poor compliance/noncompliance|0|||
27746752|NCT01628692|54196367|FG003|Overall Study|Poor compliance/noncompliance|0|||
27746753|NCT01628692|54196368|FG004|Overall Study|Poor compliance/noncompliance|0|||
27746754|NCT01628692|54196369|FG005|Overall Study|Poor compliance/noncompliance|0|||
27746755|NCT01628692|54196364|FG000|Overall Study|Administrative reason by sponsor|0|||
27746756|NCT01628692|54196365|FG001|Overall Study|Administrative reason by sponsor|0|||
27746757|NCT01628692|54196366|FG002|Overall Study|Administrative reason by sponsor|0|||
27746758|NCT01628692|54196367|FG003|Overall Study|Administrative reason by sponsor|0|||
27746759|NCT01628692|54196368|FG004|Overall Study|Administrative reason by sponsor|0|||
27746760|NCT01628692|54196369|FG005|Overall Study|Administrative reason by sponsor|1|||
27746761|NCT01628692|54196364|FG000|Overall Study|Completed 12 Week only|0|||
27746762|NCT01628692|54196365|FG001|Overall Study|Completed 12 Week only|0|||
27746763|NCT01628692|54196366|FG002|Overall Study|Completed 12 Week only|0|||
27746764|NCT01628692|54196367|FG003|Overall Study|Completed 12 Week only|0|||
27746765|NCT01628692|54196368|FG004|Overall Study|Completed 12 Week only|0|||
27746766|NCT01628692|54196369|FG005|Overall Study|Completed 12 Week only|1|||
27746767|NCT02612727|54196388|FG000|Overall Study|Parent request|4|||
27746768|NCT02612727|54196389|FG001|Overall Study|Parent request|1|||
27746769|NCT02612727|54196388|FG000|Overall Study|Needed treatment incompatible with PT|1|||
27746770|NCT02612727|54196389|FG001|Overall Study|Needed treatment incompatible with PT|1|||
27746771|NCT02612727|54196388|FG000|Overall Study|Direct hyperbilirubinemia|0|||
27746772|NCT02612727|54196389|FG001|Overall Study|Direct hyperbilirubinemia|2|||
27746773|NCT01594827|54196397|FG000|Overall Study|Adverse Event|1|||
27746774|NCT01594827|54196398|FG001|Overall Study|Adverse Event|0|||
27746775|NCT01594827|54196397|FG000|Overall Study|Physician Decision|3|||
27746776|NCT01594827|54196398|FG001|Overall Study|Physician Decision|0|||
27746777|NCT02610231|54196406|FG000|Overall Study|Withdrawal by Subject|27|||
27746778|NCT02610231|54196406|FG000|Overall Study|Adverse Event|20|||
27746779|NCT02610231|54196406|FG000|Overall Study|Death|5|||
27746780|NCT02610231|54196406|FG000|Overall Study|Surgery|2|||
27746781|NCT02610231|54196406|FG000|Overall Study|Physician Decision|1|||
27746782|NCT02610231|54196406|FG000|Overall Study|Non Compliance|2|||
27746783|NCT02610231|54196406|FG000|Overall Study|Other|3|||
27746784|NCT02178358|54196416|FG000|Overall Study|Withdrawal by Subject|0|||
27746785|NCT02178358|54196417|FG001|Overall Study|Withdrawal by Subject|2|||
27746786|NCT02178358|54196418|FG002|Overall Study|Withdrawal by Subject|2|||
27746787|NCT02178358|54196416|FG000|Overall Study|Lost to Follow-up|1|||
27746788|NCT02178358|54196417|FG001|Overall Study|Lost to Follow-up|0|||
27746789|NCT02178358|54196418|FG002|Overall Study|Lost to Follow-up|0|||
27746790|NCT01598896|54196429|FG000|Overall Study|Withdrawal by Subject|0|||
27746791|NCT01598896|54196430|FG001|Overall Study|Withdrawal by Subject|1|||
27746792|NCT01598896|54196429|FG000|Overall Study|Lack of Efficacy|0|||
27746793|NCT01598896|54196430|FG001|Overall Study|Lack of Efficacy|1|||
27746794|NCT01598662|54196438|FG000|Overall Study|Lost to Follow-up|10|||
27746795|NCT01598662|54196439|FG001|Overall Study|Lost to Follow-up|17|||
27746796|NCT01598662|54196438|FG000|Overall Study|Physician Decision|1|||
27746797|NCT01598662|54196439|FG001|Overall Study|Physician Decision|2|||
27746798|NCT01598662|54196438|FG000|Overall Study|IUD expelled before month 6|0|||
27746799|NCT01598662|54196439|FG001|Overall Study|IUD expelled before month 6|2|||
27746800|NCT01629706|54196445|FG000|Phase 1 PureVision|Screen Failure|4|||
27746801|NCT01629706|54196445|FG000|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1|||
27746802|NCT01629706|54196445|FG000|Phase 1 PureVision|Inconvenience prior to Dispense|1|||
27746803|NCT01629706|54196445|FG000|Phase 1 PureVision|No Solution-Induced Corneal Staining|3|||
27746804|NCT01629706|54196445|FG000|Phase 2 Habitual|Screen Failure|6|||
27746805|NCT01629706|54196445|FG000|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1|||
27746806|NCT01629706|54196445|FG000|Phase 2 Habitual|Relocation prior to Dispense|1|||
27746807|NCT01629706|54196445|FG000|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1|||
27746808|NCT01629706|54196445|FG000|Phase 2 Habitual|Lost to Follow Up after Dispense|1|||
27746809|NCT02153086|54196453|FG000|Overall Study|Not enrolled >=28 days and <=56 days|2|||
27746810|NCT02153086|54196453|FG000|Overall Study|Other|2|||
27925573|NCT01232283|54582088|FG004|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
27925574|NCT01232283|54582089|FG005|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
27925575|NCT01232283|54582090|FG006|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
27925576|NCT01232283|54582091|FG007|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
27925577|NCT01232283|54582092|FG008|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7|||
27925578|NCT01232283|54582093|FG009|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3|||
27925579|NCT01232127|54582115|FG000|Period 1: Days 1-10|Discontinued due to dosing error|1|||
27925580|NCT01232127|54582116|FG001|Period 1: Days 1-10|Discontinued due to dosing error|0|||
27925581|NCT01232127|54582117|FG002|Period 1: Days 1-10|Discontinued due to dosing error|0|||
27925582|NCT01258608|54582131|FG000|Overall Study|Metastatic Hepatocellular Carcinoma|1|||
27925583|NCT01258608|54582132|FG001|Overall Study|Metastatic Hepatocellular Carcinoma|0|||
27925584|NCT01258608|54582131|FG000|Overall Study|Clinical progression|1|||
27925585|NCT01258608|54582132|FG001|Overall Study|Clinical progression|0|||
27925586|NCT01258608|54582131|FG000|Overall Study|Sponsor decision|0|||
27925587|NCT01258608|54582132|FG001|Overall Study|Sponsor decision|1|||
27925588|NCT01258608|54582131|FG000|Overall Study|Physician Decision|6|||
27925589|NCT01258608|54582132|FG001|Overall Study|Physician Decision|1|||
27925805|NCT01226511|54582390|FG001|Acute Treatment Period|Protocol Violation|5|||
27925806|NCT01226511|54582389|FG000|Acute Treatment Period|Withdrawal by Subject|10|||
27925807|NCT01226511|54582390|FG001|Acute Treatment Period|Withdrawal by Subject|6|||
27925808|NCT01226511|54582389|FG000|Extension Treatment Period|Adverse Event|8|||
27925809|NCT01226511|54582390|FG001|Extension Treatment Period|Adverse Event|8|||
27925810|NCT01226511|54582389|FG000|Extension Treatment Period|Lack of Efficacy|3|||
27925811|NCT01226511|54582390|FG001|Extension Treatment Period|Lack of Efficacy|2|||
27925812|NCT01226511|54582389|FG000|Extension Treatment Period|Lost to Follow-up|4|||
27925813|NCT01226511|54582390|FG001|Extension Treatment Period|Lost to Follow-up|3|||
27925814|NCT01226511|54582389|FG000|Extension Treatment Period|Protocol Violation|2|||
27925815|NCT01226511|54582390|FG001|Extension Treatment Period|Protocol Violation|2|||
27925816|NCT01226511|54582389|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
27925817|NCT01226511|54582390|FG001|Extension Treatment Period|Withdrawal by Subject|3|||
27925818|NCT01226511|54582389|FG000|Extension Treatment Period|Parent/Caregiver Decision|8|||
27925819|NCT01226511|54582390|FG001|Extension Treatment Period|Parent/Caregiver Decision|8|||
27925820|NCT01226511|54582389|FG000|Extension Treatment Period|Sponsor Decision|1|||
27925821|NCT01226511|54582390|FG001|Extension Treatment Period|Sponsor Decision|1|||
27925822|NCT01226511|54582389|FG000|Taper Period|Adverse Event|1|||
27925823|NCT01226511|54582390|FG001|Taper Period|Adverse Event|0|||
27925824|NCT01226511|54582389|FG000|Taper Period|Lost to Follow-up|2|||
27925825|NCT01226511|54582390|FG001|Taper Period|Lost to Follow-up|2|||
27925826|NCT01226511|54582389|FG000|Taper Period|Protocol Violation|1|||
27925827|NCT01226511|54582390|FG001|Taper Period|Protocol Violation|0|||
27925828|NCT01226511|54582389|FG000|Taper Period|Parent/Caregiver Decision|1|||
27925829|NCT01226511|54582390|FG001|Taper Period|Parent/Caregiver Decision|1|||
27925830|NCT01226121|54582405|FG000|Overall Study|Lost to Follow-up|2|||
27925831|NCT01226121|54582406|FG001|Overall Study|Lost to Follow-up|0|||
27925832|NCT01226121|54582407|FG002|Overall Study|Lost to Follow-up|1|||
27925833|NCT01226043|54582417|FG000|4-week Crossover Phase - Period 1|Protocol Violation|1|||
27925834|NCT01226043|54582418|FG001|4-week Crossover Phase - Period 1|Protocol Violation|2|||
27925835|NCT01226043|54582419|FG002|4-week Crossover Phase - Period 1|Protocol Violation|0|||
27925836|NCT01226043|54582420|FG003|4-week Crossover Phase - Period 1|Protocol Violation|0|||
27925837|NCT01226043|54582417|FG000|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
27925838|NCT01226043|54582418|FG001|4-week Crossover Phase - Period 1|Lost to Follow-up|1|||
27925839|NCT01226043|54582419|FG002|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
27925840|NCT01226043|54582420|FG003|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
27925841|NCT01226043|54582417|FG000|4-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
27925842|NCT01226043|54582418|FG001|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
27925843|NCT01226043|54582419|FG002|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
27925844|NCT01226043|54582420|FG003|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
27925845|NCT01226043|54582417|FG000|4-week Crossover Phase - Period 1|Physician Decision|0|||
27925846|NCT01226043|54582418|FG001|4-week Crossover Phase - Period 1|Physician Decision|6|||
27925847|NCT01226043|54582419|FG002|4-week Crossover Phase - Period 1|Physician Decision|0|||
27925848|NCT01226043|54582420|FG003|4-week Crossover Phase - Period 1|Physician Decision|0|||
27925849|NCT01226043|54582417|FG000|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
27925850|NCT01226043|54582418|FG001|4-week Crossover Phase - Period 2|Withdrawal by Subject|1|||
27925851|NCT01226043|54582419|FG002|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
27925852|NCT01226043|54582420|FG003|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
27925853|NCT01226043|54582417|FG000|4-week Crossover Phase - Period 2|Physician Decision|4|||
27925854|NCT01226043|54582418|FG001|4-week Crossover Phase - Period 2|Physician Decision|5|||
27925855|NCT01226043|54582419|FG002|4-week Crossover Phase - Period 2|Physician Decision|0|||
27925856|NCT01226043|54582420|FG003|4-week Crossover Phase - Period 2|Physician Decision|0|||
27925857|NCT01226043|54582417|FG000|6-week Re-randomization Phase|Adverse Event|0|||
27925858|NCT01226043|54582418|FG001|6-week Re-randomization Phase|Adverse Event|0|||
27925859|NCT01226043|54582419|FG002|6-week Re-randomization Phase|Adverse Event|1|||
27925860|NCT01226043|54582420|FG003|6-week Re-randomization Phase|Adverse Event|1|||
27925861|NCT01226043|54582417|FG000|6-week Re-randomization Phase|Protocol Violation|0|||
27925862|NCT01226043|54582418|FG001|6-week Re-randomization Phase|Protocol Violation|0|||
27925863|NCT01226043|54582419|FG002|6-week Re-randomization Phase|Protocol Violation|1|||
27925864|NCT01226043|54582420|FG003|6-week Re-randomization Phase|Protocol Violation|1|||
27925865|NCT01226043|54582417|FG000|6-week Re-randomization Phase|Lost to Follow-up|0|||
27925866|NCT01226043|54582418|FG001|6-week Re-randomization Phase|Lost to Follow-up|0|||
27925867|NCT01226043|54582419|FG002|6-week Re-randomization Phase|Lost to Follow-up|1|||
27925868|NCT01226043|54582420|FG003|6-week Re-randomization Phase|Lost to Follow-up|3|||
27925869|NCT01226043|54582417|FG000|6-week Re-randomization Phase|Withdrawal by Subject|0|||
27925870|NCT01226043|54582418|FG001|6-week Re-randomization Phase|Withdrawal by Subject|0|||
27925871|NCT01226043|54582419|FG002|6-week Re-randomization Phase|Withdrawal by Subject|1|||
27925872|NCT01226043|54582420|FG003|6-week Re-randomization Phase|Withdrawal by Subject|3|||
27925873|NCT01226043|54582417|FG000|6-week Re-randomization Phase|Physician Decision|0|||
27925874|NCT01226043|54582418|FG001|6-week Re-randomization Phase|Physician Decision|0|||
27925875|NCT01226043|54582419|FG002|6-week Re-randomization Phase|Physician Decision|3|||
27925876|NCT01226043|54582420|FG003|6-week Re-randomization Phase|Physician Decision|2|||
27925877|NCT01226043|54582417|FG000|6-week Re-randomization Phase|completed in error|0|||
27925878|NCT01226043|54582418|FG001|6-week Re-randomization Phase|completed in error|0|||
27925879|NCT01226043|54582419|FG002|6-week Re-randomization Phase|completed in error|0|||
27925880|NCT01226043|54582420|FG003|6-week Re-randomization Phase|completed in error|1|||
27925881|NCT01226043|54582417|FG000|30-week Observational Phase|Adverse Event|0|||
27925882|NCT01226043|54582418|FG001|30-week Observational Phase|Adverse Event|0|||
27925883|NCT01226043|54582419|FG002|30-week Observational Phase|Adverse Event|1|||
27925884|NCT01226043|54582420|FG003|30-week Observational Phase|Adverse Event|1|||
27925885|NCT01226043|54582417|FG000|30-week Observational Phase|Protocol Violation|0|||
27925886|NCT01226043|54582418|FG001|30-week Observational Phase|Protocol Violation|0|||
27925887|NCT01226043|54582419|FG002|30-week Observational Phase|Protocol Violation|0|||
27925888|NCT01226043|54582420|FG003|30-week Observational Phase|Protocol Violation|1|||
27925889|NCT01226043|54582417|FG000|30-week Observational Phase|Lost to Follow-up|0|||
27925890|NCT01226043|54582418|FG001|30-week Observational Phase|Lost to Follow-up|0|||
27925891|NCT01226043|54582419|FG002|30-week Observational Phase|Lost to Follow-up|2|||
27925892|NCT01226043|54582420|FG003|30-week Observational Phase|Lost to Follow-up|2|||
27925893|NCT01226043|54582417|FG000|30-week Observational Phase|Withdrawal by Subject|0|||
27925894|NCT01226043|54582418|FG001|30-week Observational Phase|Withdrawal by Subject|0|||
27925895|NCT01226043|54582419|FG002|30-week Observational Phase|Withdrawal by Subject|1|||
27925896|NCT01226043|54582420|FG003|30-week Observational Phase|Withdrawal by Subject|7|||
27925897|NCT01226043|54582417|FG000|30-week Observational Phase|Physician Decision|0|||
27925898|NCT01226043|54582418|FG001|30-week Observational Phase|Physician Decision|0|||
27925899|NCT01226043|54582419|FG002|30-week Observational Phase|Physician Decision|2|||
27925900|NCT01226043|54582420|FG003|30-week Observational Phase|Physician Decision|2|||
27925901|NCT01001377|54582452|FG000|Overall Study|Ineligibility determined|2|||
27925902|NCT01001377|54582453|FG001|Overall Study|Ineligibility determined|0|||
27925903|NCT01001377|54582452|FG000|Overall Study|Withdrawal by Subject|19|||
27925904|NCT01001377|54582453|FG001|Overall Study|Withdrawal by Subject|20|||
27925905|NCT01001377|54582452|FG000|Overall Study|Lost to Follow-up|14|||
27925906|NCT01001377|54582453|FG001|Overall Study|Lost to Follow-up|17|||
27925907|NCT01001377|54582452|FG000|Overall Study|Death|391|||
27925908|NCT01001377|54582453|FG001|Overall Study|Death|384|||
27925909|NCT01225887|54582459|FG000|Overall Study|Ineligible:required test not done|2|||
27925910|NCT01225887|54582459|FG000|Overall Study|Ineligible;improper pre-protocol therapy|1|||
27925911|NCT01225887|54582459|FG000|Overall Study|Ineligible:inadequate pathology|2|||
27925912|NCT01001299|54582463|FG000|Overall Study|Insufficient Therapeutic Response|20|||
27925913|NCT01001299|54582463|FG000|Overall Study|Adverse event or Intercurrent Illness|1|||
27925914|NCT01001299|54582463|FG000|Overall Study|Death|1|||
27925915|NCT01001299|54582463|FG000|Overall Study|Began Taking Commercially Available Drug|2|||
27925916|NCT01001299|54582463|FG000|Overall Study|Withdrew Consent|1|||
